{"text_format":"3","workbook":"xlsx","n_sheets":2,"sheets":["Table S2A-Summary of lncRNAs","Table S2B-Type statistics "],"read":"whole","date_system":"1900"}

{"sheet":"Table S2A-Summary of lncRNAs","index":0,"n_rows":17661,"n_cols":20,"rows_kept":4500,"cut":true,"bounds":{"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0}}
["gene_id","gene_name","transcript_id","GO","KEGG","KO_ENTRY","EC","Description","FPKM.Mth_12_1","FPKM.Mth_12_2","FPKM.Mth_12_3","FPKM.Mth_2_1","FPKM.Mth_2_2","FPKM.Mth_2_3","fc","log2(fc)","pval","qval","regulation","significant"]
["MSTRG.9596","ENSOARG00000008077","ENSOART00000008787","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":1.117816,"d":"1.12"},{"v":0.66341,"d":"0.66"},{"v":0.639338,"d":"0.64"},{"v":50.790291,"d":"50.79"},{"v":116.282791,"d":"116.28"},{"v":83.604317,"d":"83.60"},{"v":0.00965609189203371,"d":"0.01"},{"v":-6.69434487912109,"d":"-6.69"},{"v":5.85644305791596e-38,"d":"0.00"},{"v":1.91248004499304e-34,"d":"0.00"},"down","yes"]
["MSTRG.4683","CST7","ENSOART00000006881","GO:0004869(cysteine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005770(late endosome);GO:0005783(endoplasmic reticulum);GO:0010466(negative regulation of peptidase activity);GO:0010951(negative regulation of endopeptidase activity);GO:0030414(peptidase inhibitor activity);GO:0031410(cytoplasmic vesicle);GO:0031643(positive regulation of myelination);GO:0042803(protein homodimerization activity);GO:0097340(inhibition of cysteine-type endopeptidase activity);GO:1903979(negative regulation of microglial cell activation)","NA","NA","NA","cystatin F [Source:HGNC Symbol;Acc:HGNC:2479]",{"v":2.72952601612078,"d":"2.73"},{"v":3.06803625844422,"d":"3.07"},{"v":1.94866407215967,"d":"1.95"},{"v":0.116498537871034,"d":"0.12"},{"v":0.0502304019959058,"d":"0.05"},{"v":0.0974366745138178,"d":"0.10"},{"v":29.3233711165738,"d":"29.32"},{"v":4.87397906512548,"d":"4.87"},{"v":8.85723868091439e-26,"d":"0.00"},{"v":1.80776241477463e-22,"d":"0.00"},"up","yes"]
["MSTRG.19747","ENSOARG00000000856","ENSOART00000000914","GO:0005739(mitochondrion);GO:0009055(electron transfer activity);GO:0020037(heme binding);GO:0022900(electron transport chain);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0070469(respirasome)","NA","NA","NA","cytochrome c pseudogene [Source:NCBI gene;Acc:101107359]",{"v":0.425241,"d":"0.43"},{"v":0.434541,"d":"0.43"},{"v":0.474507,"d":"0.47"},{"v":15.333853,"d":"15.33"},{"v":11.779398,"d":"11.78"},{"v":10.955817,"d":"10.96"},{"v":0.035049163798809,"d":"0.04"},{"v":-4.83447616487412,"d":"-4.83"},{"v":9.63085955992209e-23,"d":"0.00"},{"v":1.57252674894408e-19,"d":"0.00"},"down","yes"]
["MSTRG.995","HSPA6","ENSOART00000008110","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005814(centriole);GO:0005829(cytosol);GO:0008180(COP9 signalosome);GO:0019899(enzyme binding);GO:0031072(heat shock protein binding);GO:0034605(cellular response to heat);GO:0042026(protein refolding);GO:0042623(ATPase activity, coupled);GO:0051082(unfolded protein binding)","NA","NA","NA","heat shock protein family A (Hsp70) member 6 [Source:HGNC Symbol;Acc:HGNC:5239]",{"v":21.073044,"d":"21.07"},{"v":29.760611,"d":"29.76"},{"v":68.479019,"d":"68.48"},{"v":2.139171,"d":"2.14"},{"v":2.977478,"d":"2.98"},{"v":2.442815,"d":"2.44"},{"v":15.7832187573087,"d":"15.78"},{"v":3.98031954685908,"d":"3.98"},{"v":6.0678471357927e-17,"d":"0.00"},{"v":7.62121600255563e-14,"d":"0.00"},"up","yes"]
["MSTRG.14580","TMEM250","ENSOART00000020672","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0048524(positive regulation of viral process)","NA","NA","NA","transmembrane protein 250 [Source:HGNC Symbol;Acc:HGNC:31009]",{"v":0.0787833244751528,"d":"0.08"},{"v":0.0985749877757109,"d":"0.10"},{"v":0.0609321796439011,"d":"0.06"},{"v":1.51703596651608,"d":"1.52"},{"v":1.02315231198512,"d":"1.02"},{"v":0.654377825405262,"d":"0.65"},{"v":0.0745924435883084,"d":"0.07"},{"v":-3.74482670071293,"d":"-3.74"},{"v":8.64669156350743e-14,"d":"0.00"},{"v":8.82394874055933e-11,"d":"0.00"},"down","yes"]
["MSTRG.5398","ENSOARG00000018232;ENSOARG00000018268","ENSOART00000019853;ENSOART00000019877","GO:0016787(hydrolase activity);GO:0016787(hydrolase activity)","00983(Drug metabolism - other enzymes);00983(Drug metabolism - other enzymes)","K01044","EC:3.1.1.1","liver carboxylesterase-like [Source:NCBI gene;Acc:101116336];liver carboxylesterase-like [Source:NCBI gene;Acc:101116756]",{"v":14.4920386314455,"d":"14.49"},{"v":6.43687330487461,"d":"6.44"},{"v":4.65221712397859,"d":"4.65"},{"v":1.01132329473091,"d":"1.01"},{"v":0.988707777120316,"d":"0.99"},{"v":1.06023599098338,"d":"1.06"},{"v":8.35911655259391,"d":"8.36"},{"v":3.06335047669126,"d":"3.06"},{"v":1.09892563598277e-12,"d":"0.00"},{"v":1.05548575201922e-9,"d":"0.00"},"up","yes"]
["MSTRG.22348","NRK","ENSOART00000000837;ENSOART00000000834","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007256(activation of JNKK activity);GO:0007567(parturition);GO:0008285(negative regulation of cell population proliferation);GO:0060721(regulation of spongiotrophoblast cell proliferation);GO:0060721(regulation of spongiotrophoblast cell proliferation)","NA","K16313","EC:2.7.11.1","Nik related kinase [Source:NCBI gene;Acc:101102458]",{"v":3.7882466561879,"d":"3.79"},{"v":2.81756571544715,"d":"2.82"},{"v":3.53779013586269,"d":"3.54"},{"v":14.2447049461608,"d":"14.24"},{"v":18.9924213210479,"d":"18.99"},{"v":17.4695133976513,"d":"17.47"},{"v":0.200044857528339,"d":"0.20"},{"v":-2.32160455250088,"d":"-2.32"},{"v":1.03233794516036e-10,"d":"0.00"},{"v":9.36445220476573e-8,"d":"0.00"},"down","yes"]
["MSTRG.15856","ENSOARG00000019913","ENSOART00000021681","GO:0005515(protein binding);GO:0005576(extracellular region)","NA","NA","NA",null,{"v":1.57529586921163,"d":"1.58"},{"v":0.389976934175277,"d":"0.39"},{"v":1.73199214657482,"d":"1.73"},{"v":0.11193827344049,"d":"0.11"},{"v":0.15684662964026,"d":"0.16"},{"v":0.0993717427286644,"d":"0.10"},{"v":10.0426407944723,"d":"10.04"},{"v":3.32806678251552,"d":"3.33"},{"v":1.67702012457504e-10,"d":"0.00"},{"v":1.44117813652954e-7,"d":"0.00"},"up","yes"]
["MSTRG.12485","SCD","ENSOART00000015974","GO:0004768(stearoyl-CoA 9-desaturase activity);GO:0005506(iron ion binding);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006636(unsaturated fatty acid biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016717(oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water);GO:0055114(oxidation-reduction process)","01040(Biosynthesis of unsaturated fatty acids);03320(PPAR signaling pathway);04152(AMPK signaling pathway)","K00507","EC:1.14.19.1","stearoyl-CoA desaturase [Source:NCBI gene;Acc:443185]",{"v":27.4122237796358,"d":"27.41"},{"v":29.0982907502787,"d":"29.10"},{"v":18.4398606469714,"d":"18.44"},{"v":4.81869942530658,"d":"4.82"},{"v":6.51889992939428,"d":"6.52"},{"v":6.10251616666667,"d":"6.10"},{"v":4.29758478864759,"d":"4.30"},{"v":2.1035261034508,"d":"2.10"},{"v":1.59133509690551e-9,"d":"0.00"},{"v":9.62345165269379e-7,"d":"0.00"},"up","yes"]
["ENSOARG00000019622","NELL2","ENSOART00000021371","GO:0005509(calcium ion binding);GO:0005515(protein binding)","NA","NA","NA","neural EGFL like 2 [Source:NCBI gene;Acc:101113484]",{"v":0.531344,"d":"0.53"},{"v":0.264169,"d":"0.26"},{"v":0.787997,"d":"0.79"},{"v":0.041302,"d":"0.04"},{"v":0.026965,"d":"0.03"},{"v":0.053616,"d":"0.05"},{"v":12.9920497526316,"d":"12.99"},{"v":3.69955715728737,"d":"3.70"},{"v":2.86170075465615e-9,"d":"0.00"},{"v":1.55752833073419e-6,"d":"0.00"},"up","yes"]
["MSTRG.16011","MYL6","ENSOART00000010956","GO:0005509(calcium ion binding);GO:0005903(brush border);GO:0008307(structural constituent of muscle);GO:0016461(unconventional myosin complex)","NA","NA","NA","myosin light chain 6 [Source:HGNC Symbol;Acc:HGNC:7587]",{"v":36.2801943249686,"d":"36.28"},{"v":56.9772115746549,"d":"56.98"},{"v":44.7873223105395,"d":"44.79"},{"v":193.853972494981,"d":"193.85"},{"v":173.228305176286,"d":"173.23"},{"v":234.577681570891,"d":"234.58"},{"v":0.229439779213565,"d":"0.23"},{"v":-2.12381255401789,"d":"-2.12"},{"v":9.64931881787668e-9,"d":"0.00"},{"v":4.77436598964516e-6,"d":"0.00"},"down","yes"]
["MSTRG.5763","PLAUR","ENSOART00000009657","GO:0001934(positive regulation of protein phosphorylation);GO:0005102(signaling receptor binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0009986(cell surface);GO:0019899(enzyme binding);GO:0019904(protein domain specific binding);GO:0030162(regulation of proteolysis);GO:0030377(urokinase plasminogen activator receptor activity);GO:0038195(urokinase plasminogen activator signaling pathway);GO:0043066(negative regulation of apoptotic process);GO:0043388(positive regulation of DNA binding);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway);GO:2001268(negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway)","04610(Complement and coagulation cascades);05205(Proteoglycans in cancer)","K03985","NA","plasminogen activator, urokinase receptor [Source:NCBI gene;Acc:100302564]",{"v":2.066023,"d":"2.07"},{"v":5.749392,"d":"5.75"},{"v":5.490728,"d":"5.49"},{"v":0.73656,"d":"0.74"},{"v":0.54468,"d":"0.54"},{"v":0.75229,"d":"0.75"},{"v":6.54337187058957,"d":"6.54"},{"v":2.71003426376266,"d":"2.71"},{"v":2.61537432637756e-8,"d":"0.00"},{"v":1.09943668516784e-5,"d":"0.00"},"up","yes"]
["MSTRG.17003","LSMEM1","ENSOART00000002508","GO:0005829(cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","leucine rich single-pass membrane protein 1 [Source:NCBI gene;Acc:101112307]",{"v":6.80928661779023,"d":"6.81"},{"v":12.5077121384948,"d":"12.51"},{"v":9.02987935152922,"d":"9.03"},{"v":2.33530523532426,"d":"2.34"},{"v":3.06485809252202,"d":"3.06"},{"v":1.85536849835068,"d":"1.86"},{"v":3.90693319068142,"d":"3.91"},{"v":1.9660365853663,"d":"1.97"},{"v":2.68608467679319e-8,"d":"0.00"},{"v":1.09943668516784e-5,"d":"0.00"},"up","yes"]
["MSTRG.12238","IGF2","ENSOART00000003898","GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005178(integrin binding);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0042104(positive regulation of activated T cell proliferation);GO:0043410(positive regulation of MAPK cascade);GO:0045840(positive regulation of mitotic nuclear division);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0051897(positive regulation of protein kinase B signaling)","NA","NA","NA","insulin like growth factor 2 [Source:HGNC Symbol;Acc:HGNC:5466]",{"v":14.301458985782,"d":"14.30"},{"v":8.76292066692996,"d":"8.76"},{"v":8.52230336729858,"d":"8.52"},{"v":25.7259511034755,"d":"25.73"},{"v":104.479040978673,"d":"104.48"},{"v":83.3612447880463,"d":"83.36"},{"v":0.147901107791719,"d":"0.15"},{"v":-2.75729523650289,"d":"-2.76"},{"v":3.26146416890422e-8,"d":"0.00"},{"v":1.25563330019579e-5,"d":"0.00"},"down","yes"]
["MSTRG.2988","ENSOARG00000004349","ENSOART00000004734","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0015934(large ribosomal subunit)","NA","NA","NA",null,{"v":0.289246257142857,"d":"0.29"},{"v":0.140995328571429,"d":"0.14"},{"v":0.117102071428571,"d":"0.12"},{"v":10.1094382952381,"d":"10.11"},{"v":0.371963480952381,"d":"0.37"},{"v":10.2744767428571,"d":"10.27"},{"v":0.0263705367441114,"d":"0.03"},{"v":-5.24492925375666,"d":"-5.24"},{"v":3.27316944470295e-8,"d":"0.00"},{"v":1.25563330019579e-5,"d":"0.00"},"down","yes"]
["MSTRG.12605","HABP2","ENSOART00000013653","GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016787(hydrolase activity)","NA","K08648","EC:3.4.21.-","hyaluronan binding protein 2 [Source:NCBI gene;Acc:101122483]",{"v":2.54836455603572,"d":"2.55"},{"v":3.39840830236243,"d":"3.40"},{"v":1.86913686603284,"d":"1.87"},{"v":0.901365604868914,"d":"0.90"},{"v":0.641986405070585,"d":"0.64"},{"v":0.404199084989916,"d":"0.40"},{"v":4.01319880375938,"d":"4.01"},{"v":2.00475262536626,"d":"2.00"},{"v":3.30672659899676e-8,"d":"0.00"},{"v":1.25563330019579e-5,"d":"0.00"},"up","yes"]
["MSTRG.4305","ENSOARG00000013759;ENSOARG00000021947;oar-mir-29b-2","ENSOART00000014967;ENSOART00000023849;ENSOART00000023364","NA","05206(MicroRNAs in cancer)","K16996","NA","oar-mir-29b-1 [Source:miRBase;Acc:MI0025276]",{"v":2.50836222613301,"d":"2.51"},{"v":8.01089338960318,"d":"8.01"},{"v":7.44176666648157,"d":"7.44"},{"v":1.49405910452351,"d":"1.49"},{"v":0.951553270812866,"d":"0.95"},{"v":0.976952048737773,"d":"0.98"},{"v":5.2478259155272,"d":"5.25"},{"v":2.39171986268252,"d":"2.39"},{"v":3.63343877620393e-8,"d":"0.00"},{"v":1.34833609858768e-5,"d":"0.00"},"up","yes"]
["MSTRG.18315","PCDH1","ENSOART00000001406;ENSOART00000001404","GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0043231(intracellular membrane-bounded organelle);GO:0043231(intracellular membrane-bounded organelle)","NA","K16498","NA","protocadherin 1 [Source:NCBI gene;Acc:101108128]",{"v":0.901399941820393,"d":"0.90"},{"v":0.48592860247314,"d":"0.49"},{"v":0.834475960064869,"d":"0.83"},{"v":2.7507470383134,"d":"2.75"},{"v":3.23071978937766,"d":"3.23"},{"v":3.1165516292317,"d":"3.12"},{"v":0.24420751781041,"d":"0.24"},{"v":-2.03382048120884,"d":"-2.03"},{"v":3.96585014836006e-8,"d":"0.00"},{"v":1.43898669383162e-5,"d":"0.00"},"down","yes"]
["MSTRG.12240","ENSOARG00000003707","ENSOART00000004027","NA","NA","NA","NA",null,{"v":3.88177823073787,"d":"3.88"},{"v":2.50967038728088,"d":"2.51"},{"v":2.50468855483082,"d":"2.50"},{"v":5.94757679779861,"d":"5.95"},{"v":46.9846569445577,"d":"46.98"},{"v":36.5781344374236,"d":"36.58"},{"v":0.0993866671957135,"d":"0.10"},{"v":-3.33080386374948,"d":"-3.33"},{"v":5.42606042119276e-8,"d":"0.00"},{"v":1.88503647994118e-5,"d":"0.00"},"down","yes"]
["MSTRG.262","CYP4B1","ENSOART00000003098","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","NA","K07426","EC:1.14.14.1","cytochrome P450 4B1 [Source:NCBI gene;Acc:101105114]",{"v":6.772009,"d":"6.77"},{"v":4.118384,"d":"4.12"},{"v":3.159682,"d":"3.16"},{"v":1.052226,"d":"1.05"},{"v":1.165891,"d":"1.17"},{"v":1.425057,"d":"1.43"},{"v":3.85654788928555,"d":"3.86"},{"v":1.94731002589488,"d":"1.95"},{"v":1.40107873233515e-7,"d":"0.00"},{"v":4.15942064392152e-5,"d":"0.00"},"up","yes"]
["MSTRG.5810","FOSB","ENSOART00000010858","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0043231(intracellular membrane-bounded organelle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071277(cellular response to calcium ion)","04380(Osteoclast differentiation);04657(IL-17 signaling pathway);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)","K09029","NA","FosB proto-oncogene, AP-1 transcription factor subunit [Source:NCBI gene;Acc:101117101]",{"v":104.468407,"d":"104.47"},{"v":48.35453,"d":"48.35"},{"v":38.144245,"d":"38.14"},{"v":20.966871,"d":"20.97"},{"v":8.435846,"d":"8.44"},{"v":11.873988,"d":"11.87"},{"v":4.62651226642243,"d":"4.63"},{"v":2.20992501593319,"d":"2.21"},{"v":1.96183376526757e-7,"d":"0.00"},{"v":5.42929181682861e-5,"d":"0.00"},"up","yes"]
["MSTRG.19347","DRD1","ENSOART00000012561","GO:0001588(dopamine neurotransmitter receptor activity, coupled via Gs);GO:0004930(G protein-coupled receptor activity);GO:0004952(dopamine neurotransmitter receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005929(cilium);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007187(G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007190(activation of adenylate cyclase activity);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035240(dopamine binding);GO:0042311(vasodilation);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051482(positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway);GO:0060158(phospholipase C-activating dopamine receptor signaling pathway);GO:0060170(ciliary membrane);GO:0071870(cellular response to catecholamine stimulus);GO:0097730(non-motile cilium);GO:1903351(cellular response to dopamine)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04540(Gap junction);04728(Dopaminergic synapse);05012(Parkinson disease);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05034(Alcoholism)","K04144","NA","dopamine receptor D1 [Source:NCBI gene;Acc:100568292]",{"v":3.015666,"d":"3.02"},{"v":1.401068,"d":"1.40"},{"v":0.72544,"d":"0.73"},{"v":0.213216,"d":"0.21"},{"v":0.238581,"d":"0.24"},{"v":0.198203,"d":"0.20"},{"v":7.91103692307692,"d":"7.91"},{"v":2.98386680541063,"d":"2.98"},{"v":2.10848319870062e-7,"d":"0.00"},{"v":5.73788561139729e-5,"d":"0.00"},"up","yes"]
["MSTRG.11439","RF00017","ENSOART00000026697","NA","NA","NA","NA","RNA, 7SL, cytoplasmic 471, pseudogene [Source:HGNC Symbol;Acc:HGNC:46487]",{"v":36.615025,"d":"36.62"},{"v":46.531593,"d":"46.53"},{"v":22.849005,"d":"22.85"},{"v":92.231064,"d":"92.23"},{"v":202.028091,"d":"202.03"},{"v":319.001678,"d":"319.00"},{"v":0.172839381379505,"d":"0.17"},{"v":-2.53249612248002,"d":"-2.53"},{"v":3.24510679480506e-7,"d":"0.00"},{"v":7.79207408023191e-5,"d":"0.00"},"down","yes"]
["MSTRG.6536","ENSOARG00000019163","ENSOART00000020869","GO:0005344(oxygen carrier activity);GO:0005833(hemoglobin complex);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0046872(metal ion binding)","NA","NA","NA","hemoglobin subunit beta [Source:NCBI gene;Acc:101105437]",{"v":0.501936,"d":"0.50"},{"v":0.064815,"d":"0.06"},{"v":0.679836,"d":"0.68"},{"v":19.413136,"d":"19.41"},{"v":1.187696,"d":"1.19"},{"v":9.945065,"d":"9.95"},{"v":0.040810292786622,"d":"0.04"},{"v":-4.61492312876723,"d":"-4.61"},{"v":3.83727953764834e-7,"d":"0.00"},{"v":9.08044931749596e-5,"d":"0.00"},"down","yes"]
["MSTRG.16355","A2M","ENSOART00000001080","GO:0001869(negative regulation of complement activation, lectin pathway);GO:0002020(protease binding);GO:0004866(endopeptidase inhibitor activity);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010951(negative regulation of endopeptidase activity);GO:0019838(growth factor binding);GO:0019899(enzyme binding);GO:0019959(interleukin-8 binding);GO:0019966(interleukin-1 binding);GO:0043120(tumor necrosis factor binding);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades)","K03910","NA","alpha-2-macroglobulin [Source:NCBI gene;Acc:101122940]",{"v":1.570734,"d":"1.57"},{"v":1.646494,"d":"1.65"},{"v":2.566228,"d":"2.57"},{"v":0.372347,"d":"0.37"},{"v":0.541122,"d":"0.54"},{"v":0.564449,"d":"0.56"},{"v":3.91324552512386,"d":"3.91"},{"v":1.96836563075141,"d":"1.97"},{"v":4.15497795260543e-7,"d":"0.00"},{"v":9.69178285859163e-5,"d":"0.00"},"up","yes"]
["MSTRG.6021","CACNG7","ENSOART00000000945","GO:0005244(voltage-gated ion channel activity);GO:0005246(calcium channel regulator activity);GO:0005262(calcium channel activity);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:1990454(L-type voltage-gated calcium channel complex);GO:2000311(regulation of AMPA receptor activity)","NA","NA","NA","calcium voltage-gated channel auxiliary subunit gamma 7 [Source:HGNC Symbol;Acc:HGNC:13626]",{"v":1.620857,"d":"1.62"},{"v":0.648952,"d":"0.65"},{"v":0.83848,"d":"0.84"},{"v":6.907109,"d":"6.91"},{"v":4.568383,"d":"4.57"},{"v":4.667478,"d":"4.67"},{"v":0.192547529977445,"d":"0.19"},{"v":-2.37671347869688,"d":"-2.38"},{"v":4.8434200148775e-7,"d":"0.00"},{"v":0.000109838002781833,"d":"0.00"},"down","yes"]
["MSTRG.8465","DLK1","ENSOART00000002494","GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045746(negative regulation of Notch signaling pathway)","NA","NA","NA","delta like non-canonical Notch ligand 1 [Source:HGNC Symbol;Acc:HGNC:2907]",{"v":8.07866536864407,"d":"8.08"},{"v":6.57636080190678,"d":"6.58"},{"v":7.52310276165254,"d":"7.52"},{"v":19.6155608898305,"d":"19.62"},{"v":29.167586779661,"d":"29.17"},{"v":33.5190337870763,"d":"33.52"},{"v":0.269471945210919,"d":"0.27"},{"v":-1.89179301341946,"d":"-1.89"},{"v":5.16585617853698e-7,"d":"0.00"},{"v":0.00011354944533314,"d":"0.00"},"down","yes"]
["MSTRG.12122","FOSL1","ENSOART00000000075","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001701(in utero embryonic development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007296(vitellogenesis);GO:0031668(cellular response to extracellular stimulus);GO:0060674(placenta blood vessel development);GO:0061614(pri-miRNA transcription by RNA polymerase II);GO:2000144(positive regulation of DNA-templated transcription, initiation)","04310(Wnt signaling pathway);04380(Osteoclast differentiation);04657(IL-17 signaling pathway);05166(Human T-cell leukemia virus 1 infection)","K04502","NA","FOS like 1, AP-1 transcription factor subunit [Source:NCBI gene;Acc:101111137]",{"v":0.945419705289673,"d":"0.95"},{"v":0.83239862720403,"d":"0.83"},{"v":2.03812218891688,"d":"2.04"},{"v":0.281557639798489,"d":"0.28"},{"v":0.262285390428212,"d":"0.26"},{"v":0.231982934508816,"d":"0.23"},{"v":4.91855222029267,"d":"4.92"},{"v":2.29823371963366,"d":"2.30"},{"v":5.21570823125029e-7,"d":"0.00"},{"v":0.00011354944533314,"d":"0.00"},"up","yes"]
["MSTRG.17828","FBN3","ENSOART00000003739","GO:0005201(extracellular matrix structural constituent);GO:0005509(calcium ion binding);GO:0062023(collagen-containing extracellular matrix)","NA","NA","NA","fibrillin 3 [Source:NCBI gene;Acc:101103811]",{"v":0.503058,"d":"0.50"},{"v":0.330307,"d":"0.33"},{"v":0.427145,"d":"0.43"},{"v":1.921777,"d":"1.92"},{"v":1.340803,"d":"1.34"},{"v":1.266876,"d":"1.27"},{"v":0.27829169772264,"d":"0.28"},{"v":-1.84533022550292,"d":"-1.85"},{"v":6.28815575537512e-7,"d":"0.00"},{"v":0.000131632060479186,"d":"0.00"},"down","yes"]
["MSTRG.1362","STXBP5L","ENSOART00000021751;ENSOART00000021752","GO:0005515(protein binding);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0017157(regulation of exocytosis);GO:0031594(neuromuscular junction);GO:0042593(glucose homeostasis);GO:0046676(negative regulation of insulin secretion);GO:0098992(neuronal dense core vesicle);GO:2000300(regulation of synaptic vesicle exocytosis);GO:2000300(regulation of synaptic vesicle exocytosis)","NA","K08518","NA","syntaxin binding protein 5 like [Source:NCBI gene;Acc:101109405]",{"v":0.4820622858661,"d":"0.48"},{"v":0.81497685706695,"d":"0.81"},{"v":0.53293934325186,"d":"0.53"},{"v":0.161037808182784,"d":"0.16"},{"v":0.0864217943676939,"d":"0.09"},{"v":0.115103146652497,"d":"0.12"},{"v":5.04734281226565,"d":"5.05"},{"v":2.33552407687998,"d":"2.34"},{"v":6.91591366019131e-7,"d":"0.00"},{"v":0.000141153797804505,"d":"0.00"},"up","yes"]
["MSTRG.18006","CTXN3","ENSOART00000018079","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031224(intrinsic component of membrane)","NA","NA","NA","cortexin 3 [Source:NCBI gene;Acc:101105654]",{"v":3.51082314350356,"d":"3.51"},{"v":4.03168333290239,"d":"4.03"},{"v":3.20072063736264,"d":"3.20"},{"v":1.30376569489334,"d":"1.30"},{"v":0.34851476664512,"d":"0.35"},{"v":0.516082462184874,"d":"0.52"},{"v":4.95453366972407,"d":"4.95"},{"v":2.30874927455872,"d":"2.31"},{"v":7.20040497969195e-7,"d":"0.00"},{"v":0.000145145941368408,"d":"0.00"},"up","yes"]
["MSTRG.17848","TUBB4A","ENSOART00000006013","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005509(calcium ion binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0005929(cilium);GO:0005930(axoneme);GO:0007010(cytoskeleton organization);GO:0007017(microtubule-based process);GO:0031115(negative regulation of microtubule polymerization);GO:0033269(internode region of axon);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0043209(myelin sheath)","NA","NA","NA","tubulin beta 4A class IVa [Source:HGNC Symbol;Acc:HGNC:20774]",{"v":0.08635,"d":"0.09"},{"v":0.246532,"d":"0.25"},{"v":0.234472,"d":"0.23"},{"v":1.195335,"d":"1.20"},{"v":1.385552,"d":"1.39"},{"v":1.458861,"d":"1.46"},{"v":0.140442918716712,"d":"0.14"},{"v":-2.8319442108277,"d":"-2.83"},{"v":1.22982998136037e-6,"d":"0.00"},{"v":0.000233496092275025,"d":"0.00"},"down","yes"]
["MSTRG.6587","UCP2","ENSOART00000009316","GO:0001666(response to hypoxia);GO:0005739(mitochondrion);GO:0006839(mitochondrial transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0031966(mitochondrial membrane);GO:0051881(regulation of mitochondrial membrane potential);GO:0055085(transmembrane transport);GO:0120162(positive regulation of cold-induced thermogenesis)","NA","K15103","NA","uncoupling protein 2 [Source:NCBI gene;Acc:101104932]",{"v":2.15842256860123,"d":"2.16"},{"v":1.59440682134261,"d":"1.59"},{"v":1.45127298689489,"d":"1.45"},{"v":6.07782294009093,"d":"6.08"},{"v":4.82511223348489,"d":"4.83"},{"v":6.36536994677721,"d":"6.37"},{"v":0.301367293464429,"d":"0.30"},{"v":-1.73040524104731,"d":"-1.73"},{"v":1.26333925502925e-6,"d":"0.00"},{"v":0.000237101188001351,"d":"0.00"},"down","yes"]
["MSTRG.14804","OLFML2A","ENSOART00000014461","GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042803(protein homodimerization activity);GO:0050840(extracellular matrix binding)","NA","NA","NA","olfactomedin like 2A [Source:NCBI gene;Acc:101112387]",{"v":2.11372632624456,"d":"2.11"},{"v":1.10941665635573,"d":"1.11"},{"v":1.73351476413726,"d":"1.73"},{"v":5.54199555775737,"d":"5.54"},{"v":5.6524982580957,"d":"5.65"},{"v":6.67732052827453,"d":"6.68"},{"v":0.277344966285767,"d":"0.28"},{"v":-1.85024655359739,"d":"-1.85"},{"v":1.70331522178647e-6,"d":"0.00"},{"v":0.000309019232681439,"d":"0.00"},"down","yes"]
["ENSOARG00000003744","ENSOARG00000003744","ENSOART00000004073","GO:0004252(serine-type endopeptidase activity);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0007219(Notch signaling pathway);GO:0009617(response to bacterium);GO:0030492(hemoglobin binding)","NA","K16142","NA","haptoglobin [Source:NCBI gene;Acc:101102413]",{"v":0.249282,"d":"0.25"},{"v":2.359685,"d":"2.36"},{"v":1.146117,"d":"1.15"},{"v":0.116894,"d":"0.12"},{"v":0.087651,"d":"0.09"},{"v":0.114185,"d":"0.11"},{"v":11.7813949110532,"d":"11.78"},{"v":3.55843845851405,"d":"3.56"},{"v":1.76592598274894e-6,"d":"0.00"},{"v":0.000316857576333239,"d":"0.00"},"up","yes"]
["MSTRG.18003","FBN2","ENSOART00000018723","GO:0001527(microfibril);GO:0005201(extracellular matrix structural constituent);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0030326(embryonic limb morphogenesis);GO:0030501(positive regulation of bone mineralization);GO:0035108(limb morphogenesis);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0043010(camera-type eye development);GO:0045669(positive regulation of osteoblast differentiation);GO:0048048(embryonic eye morphogenesis);GO:0060346(bone trabecula formation);GO:0062023(collagen-containing extracellular matrix)","NA","NA","NA","fibrillin 2 [Source:NCBI gene;Acc:101104991]",{"v":0.33151,"d":"0.33"},{"v":0.166097,"d":"0.17"},{"v":0.381079,"d":"0.38"},{"v":0.947211,"d":"0.95"},{"v":1.218775,"d":"1.22"},{"v":1.072816,"d":"1.07"},{"v":0.271299696616218,"d":"0.27"},{"v":-1.88204066057581,"d":"-1.88"},{"v":2.71198985228151e-6,"d":"0.00"},{"v":0.000463988989441991,"d":"0.00"},"down","yes"]
["MSTRG.22289","CAPN6","ENSOART00000019304","GO:0001578(microtubule bundle formation);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0005622(intracellular);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005876(spindle microtubule);GO:0006508(proteolysis);GO:0008017(microtubule binding);GO:0048471(perinuclear region of cytoplasm);GO:0051493(regulation of cytoskeleton organization)","NA","K08575","EC:3.4.22.-","calpain 6 [Source:NCBI gene;Acc:101110122]",{"v":7.7692913166578,"d":"7.77"},{"v":7.25740579324109,"d":"7.26"},{"v":9.71219817456094,"d":"9.71"},{"v":29.8957751905269,"d":"29.90"},{"v":20.6647459635444,"d":"20.66"},{"v":29.4757709169771,"d":"29.48"},{"v":0.309095969394722,"d":"0.31"},{"v":-1.69387325328314,"d":"-1.69"},{"v":3.69673394184587e-6,"d":"0.00"},{"v":0.000615921140841422,"d":"0.00"},"down","yes"]
["ENSOARG00000010953","XDH","ENSOART00000011926","GO:0001933(negative regulation of protein phosphorylation);GO:0001937(negative regulation of endothelial cell proliferation);GO:0004854(xanthine dehydrogenase activity);GO:0004855(xanthine oxidase activity);GO:0005506(iron ion binding);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0009055(electron transfer activity);GO:0009115(xanthine catabolic process);GO:0010629(negative regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0022900(electron transport chain);GO:0042803(protein homodimerization activity);GO:0043546(molybdopterin cofactor binding);GO:0045602(negative regulation of endothelial cell differentiation);GO:0046872(metal ion binding);GO:0050660(flavin adenine dinucleotide binding);GO:0051536(iron-sulfur cluster binding);GO:0051537(2 iron, 2 sulfur cluster binding);GO:0051898(negative regulation of protein kinase B signaling);GO:0055114(oxidation-reduction process);GO:0071949(FAD binding);GO:1900745(positive regulation of p38MAPK cascade);GO:1900747(negative regulation of vascular endothelial growth factor signaling pathway);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2001213(negative regulation of vasculogenesis)","00230(Purine metabolism);00232(Caffeine metabolism);00983(Drug metabolism - other enzymes);04146(Peroxisome)","K00106","1.17.3.2;EC:1.17.1.4","xanthine dehydrogenase [Source:NCBI gene;Acc:780499]",{"v":0.066398,"d":"0.07"},0,{"v":0.023072,"d":"0.02"},{"v":1.228835,"d":"1.23"},{"v":0.261891,"d":"0.26"},{"v":0.397638,"d":"0.40"},{"v":0.0473796365531222,"d":"0.05"},{"v":-4.39958905799733,"d":"-4.40"},{"v":3.78239360545307e-6,"d":"0.00"},{"v":0.000622271750871124,"d":"0.00"},"down","yes"]
["MSTRG.8244","CYP1A1","ENSOART00000003721","GO:0002933(lipid hydroxylation);GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0008202(steroid metabolic process);GO:0009308(amine metabolic process);GO:0009404(toxin metabolic process);GO:0009636(response to toxic substance);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0017144(drug metabolic process);GO:0020037(heme binding);GO:0043231(intracellular membrane-bounded organelle);GO:0046483(heterocycle metabolic process);GO:0046872(metal ion binding);GO:0050665(hydrogen peroxide biosynthetic process);GO:0055114(oxidation-reduction process);GO:0070330(aromatase activity);GO:0070576(vitamin D 24-hydroxylase activity);GO:0071407(cellular response to organic cyclic compound);GO:0101020(estrogen 16-alpha-hydroxylase activity)","00140(Steroid hormone biosynthesis);00380(Tryptophan metabolism);00830(Retinol metabolism);00980(Metabolism of xenobiotics by cytochrome P450);04913(Ovarian steroidogenesis);05204(Chemical carcinogenesis)","K07408","EC:1.14.14.1","cytochrome P4501A1 [Source:NCBI gene;Acc:100170113]",{"v":3.21544048908297,"d":"3.22"},{"v":1.24258920921,"d":"1.24"},{"v":0.524607541881699,"d":"0.52"},{"v":10.1581065879317,"d":"10.16"},{"v":7.48871174910679,"d":"7.49"},{"v":9.26675623938071,"d":"9.27"},{"v":0.185134725453389,"d":"0.19"},{"v":-2.43335257006961,"d":"-2.43"},{"v":4.11281044538489e-6,"d":"0.00"},{"v":0.000664890781705391,"d":"0.00"},"down","yes"]
["MSTRG.106","GJA4","ENSOART00000000502","GO:0001568(blood vessel development);GO:0005886(plasma membrane);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction)","NA","K07613","NA","gap junction protein alpha 4 [Source:NCBI gene;Acc:101107643]",{"v":1.973748,"d":"1.97"},{"v":1.517677,"d":"1.52"},{"v":1.095019,"d":"1.10"},{"v":4.379524,"d":"4.38"},{"v":7.181019,"d":"7.18"},{"v":7.268703,"d":"7.27"},{"v":0.243580863514131,"d":"0.24"},{"v":-2.03752729989322,"d":"-2.04"},{"v":4.38224377692845e-6,"d":"0.00"},{"v":0.000694692003783376,"d":"0.00"},"down","yes"]
["ENSOARG00000008610","ENSOARG00000008610","ENSOART00000009375","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","NA","NA","NA","cytochrome P450 2J2-like [Source:NCBI gene;Acc:101121563]",{"v":0.371153,"d":"0.37"},{"v":0.176018,"d":"0.18"},{"v":0.299544,"d":"0.30"},{"v":1.375215,"d":"1.38"},{"v":1.358404,"d":"1.36"},{"v":1.463187,"d":"1.46"},{"v":0.201752237296649,"d":"0.20"},{"v":-2.3093434227777,"d":"-2.31"},{"v":4.53139398378252e-6,"d":"0.00"},{"v":0.000711428855453856,"d":"0.00"},"down","yes"]
["MSTRG.2195","FREM2","ENSOART00000010687","GO:0001654(eye development);GO:0002009(morphogenesis of an epithelium);GO:0005604(basement membrane);GO:0007154(cell communication);GO:0007507(heart development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042733(embryonic digit morphogenesis);GO:0048839(inner ear development)","NA","NA","NA","FRAS1 related extracellular matrix protein 2 [Source:NCBI gene;Acc:101101900]",{"v":1.00160746144121,"d":"1.00"},{"v":0.773573831135994,"d":"0.77"},{"v":0.93209075167058,"d":"0.93"},{"v":3.23349532111252,"d":"3.23"},{"v":2.39070657395702,"d":"2.39"},{"v":2.47471644049124,"d":"2.47"},{"v":0.334275755363612,"d":"0.33"},{"v":-1.58088937315101,"d":"-1.58"},{"v":5.01569465860063e-6,"d":"0.00"},{"v":0.000772606248921049,"d":"0.00"},"down","yes"]
["MSTRG.10989","C1QA","ENSOART00000008713","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005623(cell);GO:0006958(complement activation, classical pathway);GO:0007568(aging);GO:0016322(neuron remodeling);GO:0045202(synapse);GO:0050808(synapse organization);GO:0061890(positive regulation of astrocyte activation);GO:0098794(postsynapse);GO:0098883(synapse pruning);GO:0106003(amyloid-beta complex);GO:0150062(complement-mediated synapse pruning);GO:0150064(vertebrate eye-specific patterning);GO:1901216(positive regulation of neuron death);GO:1903980(positive regulation of microglial cell activation)","04610(Complement and coagulation cascades);05020(Prion diseases);05133(Pertussis);05142(Chagas disease (American trypanosomiasis));05150(Staphylococcus aureus infection);05322(Systemic lupus erythematosus)","K03986","NA","complement C1q A chain [Source:NCBI gene;Acc:101102126]",{"v":0.503853,"d":"0.50"},{"v":0.331496,"d":"0.33"},{"v":0.14062,"d":"0.14"},{"v":1.31042912074934,"d":"1.31"},{"v":1.200689,"d":"1.20"},{"v":1.98010748136836,"d":"1.98"},{"v":0.217305717071931,"d":"0.22"},{"v":-2.20220196416557,"d":"-2.20"},{"v":7.50850344877822e-6,"d":"0.00"},{"v":0.00111453494828773,"d":"0.00"},"down","yes"]
["MSTRG.14244","ASB5","ENSOART00000007356","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction)","NA","K10327","NA","ankyrin repeat and SOCS box containing 5 [Source:NCBI gene;Acc:101108021]",{"v":12.4774227190314,"d":"12.48"},{"v":10.9245474851935,"d":"10.92"},{"v":15.1797308828725,"d":"15.18"},{"v":6.2265067296548,"d":"6.23"},{"v":4.76132137373341,"d":"4.76"},{"v":4.08283117858632,"d":"4.08"},{"v":2.5600539674627,"d":"2.56"},{"v":1.35617422341674,"d":"1.36"},{"v":7.765446475977e-6,"d":"0.00"},{"v":0.00114229018071849,"d":"0.00"},"up","yes"]
["ENSOARG00000021148","ESR2","ENSOART00000023044","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005496(steroid binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0019899(enzyme binding);GO:0030284(estrogen receptor activity);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0034056(estrogen response element binding);GO:0042802(identical protein binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0051091(positive regulation of DNA-binding transcription factor activity)","01522(Endocrine resistance);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);05200(Pathways in cancer);05224(Breast cancer)","K08551","NA","estrogen receptor 2 [Source:NCBI gene;Acc:443066]",{"v":0.867765,"d":"0.87"},{"v":0.665413,"d":"0.67"},{"v":0.090067,"d":"0.09"},{"v":0.05019,"d":"0.05"},{"v":0.063871,"d":"0.06"},{"v":0.039836,"d":"0.04"},{"v":10.5476065160464,"d":"10.55"},{"v":3.39884375171659,"d":"3.40"},{"v":7.94461473553183e-6,"d":"0.00"},{"v":0.00115821133394432,"d":"0.00"},"up","yes"]
["MSTRG.497","ENSOARG00000015226;ENSOARG00000015072","ENSOART00000016566;ENSOART00000016407","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0016020(membrane);GO:0005525(GTP binding)","04621(NOD-like receptor signaling pathway)","K20899","NA","guanylate-binding protein 1-like [Source:NCBI gene;Acc:101119517]",{"v":0.204267819198641,"d":"0.20"},{"v":0.219734166218321,"d":"0.22"},{"v":0.303072165510406,"d":"0.30"},{"v":1.09472677743169,"d":"1.09"},{"v":0.694781859549766,"d":"0.69"},{"v":0.8194801945349,"d":"0.82"},{"v":0.278680438238898,"d":"0.28"},{"v":-1.84331635777111,"d":"-1.84"},{"v":8.18570722680242e-6,"d":"0.00"},{"v":0.00118279847432947,"d":"0.00"},"down","yes"]
["ENSOARG00000015032","ENSOARG00000015032","ENSOART00000016365","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0062023(collagen-containing extracellular matrix)","NA","K08623","EC:3.4.24.-","ADAM metallopeptidase with thrombospondin type 1 motif 8 [Source:NCBI gene;Acc:101120031]",{"v":0.10648,"d":"0.11"},{"v":0.193598,"d":"0.19"},{"v":0.427279,"d":"0.43"},{"v":1.719893,"d":"1.72"},{"v":1.080576,"d":"1.08"},{"v":1.15933,"d":"1.16"},{"v":0.183685333523242,"d":"0.18"},{"v":-2.44469165677779,"d":"-2.44"},{"v":8.50318529088445e-6,"d":"0.00"},{"v":0.00120730442982227,"d":"0.00"},"down","yes"]
["MSTRG.16776","PEG10","ENSOART00000002679","GO:0001890(placenta development);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0008270(zinc ion binding)","NA","NA","NA","paternally expressed 10 [Source:NCBI gene;Acc:100359412]",{"v":1.3593739682937,"d":"1.36"},{"v":1.25847499457655,"d":"1.26"},{"v":2.51046006257822,"d":"2.51"},{"v":5.5264229470171,"d":"5.53"},{"v":5.69041168043387,"d":"5.69"},{"v":6.46714477012933,"d":"6.47"},{"v":0.289997455332377,"d":"0.29"},{"v":-1.78588785394187,"d":"-1.79"},{"v":8.82035142075622e-6,"d":"0.00"},{"v":0.00124154049998369,"d":"0.00"},"down","yes"]
["MSTRG.11871","VWA5A","ENSOART00000011007;ENSOART00000011008","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005654(nucleoplasm)","NA","NA","NA","von Willebrand factor A domain containing 5A [Source:NCBI gene;Acc:101105613]",{"v":2.04312142248062,"d":"2.04"},{"v":1.27500307054264,"d":"1.28"},{"v":1.50742374392765,"d":"1.51"},{"v":4.1815189749354,"d":"4.18"},{"v":4.74438491111111,"d":"4.74"},{"v":5.19556231395349,"d":"5.20"},{"v":0.341717224586135,"d":"0.34"},{"v":-1.54912512485299,"d":"-1.55"},{"v":1.06352203076708e-5,"d":"0.00"},{"v":0.00144709897653041,"d":"0.00"},"down","yes"]
["ENSOARG00000020466","PLA2G4E","ENSOART00000022290","GO:0004620(phospholipase activity);GO:0004623(phospholipase A2 activity);GO:0005737(cytoplasm);GO:0006629(lipid metabolic process);GO:0009395(phospholipid catabolic process);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0102567(phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine));GO:0102568(phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine))","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);00590(Arachidonic acid metabolism);00591(Linoleic acid metabolism);00592(alpha-Linolenic acid metabolism);04010(MAPK signaling pathway);04014(Ras signaling pathway);04072(Phospholipase D signaling pathway);04217(Necroptosis);04270(Vascular smooth muscle contraction);04370(VEGF signaling pathway);04611(Platelet activation);04664(Fc epsilon RI signaling pathway);04724(Glutamatergic synapse);04726(Serotonergic synapse);04730(Long-term depression);04750(Inflammatory mediator regulation of TRP channels);04912(GnRH signaling pathway);04913(Ovarian steroidogenesis);04921(Oxytocin signaling pathway);05231(Choline metabolism in cancer)","K16342","EC:3.1.1.4","phospholipase A2 group IVE [Source:NCBI gene;Acc:101115878]",{"v":0.077585,"d":"0.08"},{"v":0.056125,"d":"0.06"},{"v":0.140664,"d":"0.14"},{"v":0.518526,"d":"0.52"},{"v":0.484775,"d":"0.48"},{"v":0.51437,"d":"0.51"},{"v":0.180786217829819,"d":"0.18"},{"v":-2.4676433962629,"d":"-2.47"},{"v":1.23334373809477e-5,"d":"0.00"},{"v":0.00163889433244808,"d":"0.00"},"down","yes"]
["MSTRG.11789","ENSOARG00000005183","ENSOART00000005647;ENSOART00000005643","GO:0005515(protein binding);GO:0099562(maintenance of postsynaptic density structure);GO:1904115(axon cytoplasm);GO:1904115(axon cytoplasm)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection);05165(Human papillomavirus infection)","K12075","NA","discs large MAGUK scaffold protein 2 [Source:NCBI gene;Acc:101104867]",{"v":0.97663299596014,"d":"0.98"},{"v":2.26898689631026,"d":"2.27"},{"v":2.72329645354161,"d":"2.72"},{"v":0.550370713708591,"d":"0.55"},{"v":0.642746128198222,"d":"0.64"},{"v":0.463360894155669,"d":"0.46"},{"v":3.6033785518907,"d":"3.60"},{"v":1.84935022163631,"d":"1.85"},{"v":1.24908819885946e-5,"d":"0.00"},{"v":0.00164476710572397,"d":"0.00"},"up","yes"]
["MSTRG.1849","SLCO2A1","ENSOART00000009087","GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0015132(prostaglandin transmembrane transporter activity);GO:0015732(prostaglandin transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K14345","NA","solute carrier organic anion transporter family member 2A1 [Source:NCBI gene;Acc:654334]",{"v":0.886844,"d":"0.89"},{"v":0.51821,"d":"0.52"},{"v":0.596059,"d":"0.60"},{"v":3.168602,"d":"3.17"},{"v":1.944145,"d":"1.94"},{"v":2.182676,"d":"2.18"},{"v":0.274297048985371,"d":"0.27"},{"v":-1.86618899379878,"d":"-1.87"},{"v":1.34091394477095e-5,"d":"0.00"},{"v":0.00173765419763652,"d":"0.00"},"down","yes"]
["MSTRG.11979","RF00004","ENSOART00000023161","NA","NA","NA","NA","RNA, U2 small nuclear 2, pseudogene [Source:HGNC Symbol;Acc:HGNC:10152]",{"v":410.238831,"d":"410.24"},{"v":671.335327,"d":"671.34"},{"v":511.623444,"d":"511.62"},{"v":1182.075439,"d":"1182.08"},{"v":1876.533813,"d":"1876.53"},{"v":2320.276855,"d":"2320.28"},{"v":0.296194708403778,"d":"0.30"},{"v":-1.75538222815601,"d":"-1.76"},{"v":1.5346881515024e-5,"d":"0.00"},{"v":0.00194251070835125,"d":"0.00"},"down","yes"]
["MSTRG.12226","RF01972","ENSOART00000026111","NA","NA","NA","NA",null,{"v":0.609907332288401,"d":"0.61"},{"v":0.148299777429467,"d":"0.15"},{"v":1.15299180250784,"d":"1.15"},{"v":2.18482601253918,"d":"2.18"},{"v":8.35226627586207,"d":"8.35"},{"v":4.70342545141066,"d":"4.70"},{"v":0.125402492543491,"d":"0.13"},{"v":-2.99536207095478,"d":"-3.00"},{"v":1.68374013000596e-5,"d":"0.00"},{"v":0.00209863426280438,"d":"0.00"},"down","yes"]
["MSTRG.6873","NEURL1B","ENSOART00000004256","GO:0005769(early endosome);GO:0016567(protein ubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0070086(ubiquitin-dependent endocytosis)","NA","NA","NA","neuralized E3 ubiquitin protein ligase 1B [Source:HGNC Symbol;Acc:HGNC:35422]",{"v":1.94435790926884,"d":"1.94"},{"v":0.589881182860338,"d":"0.59"},{"v":1.16081119292604,"d":"1.16"},{"v":5.35987033160911,"d":"5.36"},{"v":3.49963243576122,"d":"3.50"},{"v":4.30695594044457,"d":"4.31"},{"v":0.28064116305336,"d":"0.28"},{"v":-1.83320146305879,"d":"-1.83"},{"v":2.01339281304178e-5,"d":"0.00"},{"v":0.0024015404234835,"d":"0.00"},"down","yes"]
["MSTRG.19394","HOMER1","ENSOART00000018827","GO:0003009(skeletal muscle contraction);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030018(Z disc);GO:0030424(axon);GO:0043005(neuron projection);GO:0043034(costamere);GO:0044325(ion channel binding);GO:0045177(apical part of cell);GO:0048148(behavioral response to cocaine);GO:0048741(skeletal muscle fiber development);GO:0048875(chemical homeostasis within a tissue);GO:0051592(response to calcium ion);GO:0051928(positive regulation of calcium ion transport);GO:0090279(regulation of calcium ion import);GO:0098794(postsynapse);GO:0098962(regulation of postsynaptic neurotransmitter receptor activity);GO:0098978(glutamatergic synapse);GO:0099524(postsynaptic cytosol);GO:2001256(regulation of store-operated calcium entry);GO:2001257(regulation of cation channel activity)","04068(FoxO signaling pathway);04724(Glutamatergic synapse)","K15010","NA","homer scaffold protein 1 [Source:NCBI gene;Acc:443063]",{"v":3.58853745603914,"d":"3.59"},{"v":6.21679959637432,"d":"6.22"},{"v":6.55331217341536,"d":"6.55"},{"v":2.24673777031912,"d":"2.25"},{"v":2.3114196118373,"d":"2.31"},{"v":1.56593168371184,"d":"1.57"},{"v":2.67119714456823,"d":"2.67"},{"v":1.41748645631561,"d":"1.42"},{"v":2.48730794198706e-5,"d":"0.00"},{"v":0.00290091171976891,"d":"0.00"},"up","yes"]
["MSTRG.686","CASQ2","ENSOART00000021954","GO:0002027(regulation of heart rate);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0010649(regulation of cell communication by electrical coupling);GO:0010880(regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0010881(regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion);GO:0030018(Z disc);GO:0030314(junctional membrane complex);GO:0033018(sarcoplasmic reticulum lumen);GO:0043267(negative regulation of potassium ion transport);GO:0045214(sarcomere organization);GO:0048306(calcium-dependent protein binding);GO:0051208(sequestering of calcium ion);GO:0051258(protein polymerization);GO:0060048(cardiac muscle contraction);GO:0060306(regulation of membrane repolarization);GO:0060315(negative regulation of ryanodine-sensitive calcium-release channel activity);GO:0071313(cellular response to caffeine);GO:1901017(negative regulation of potassium ion transmembrane transporter activity)","NA","NA","NA","calsequestrin 2 [Source:NCBI gene;Acc:101105292]",{"v":2.4186136539415,"d":"2.42"},{"v":1.86436413544869,"d":"1.86"},{"v":2.95249969092712,"d":"2.95"},{"v":7.43905730639564,"d":"7.44"},{"v":6.1733504476946,"d":"6.17"},{"v":6.97165098671294,"d":"6.97"},{"v":0.351508785095654,"d":"0.35"},{"v":-1.5083673485325,"d":"-1.51"},{"v":2.55635875774357e-5,"d":"0.00"},{"v":0.00293945252087584,"d":"0.00"},"down","yes"]
["MSTRG.11270","PTK7","ENSOART00000006173","GO:0001736(establishment of planar polarity);GO:0001843(neural tube closure);GO:0003281(ventricular septum development);GO:0003401(axis elongation);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0007507(heart development);GO:0010976(positive regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0016477(cell migration);GO:0031532(actin cytoskeleton reorganization);GO:0042060(wound healing);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0060026(convergent extension);GO:0060484(lung-associated mesenchyme development);GO:0060976(coronary vasculature development);GO:0071300(cellular response to retinoic acid);GO:0090103(cochlea morphogenesis);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1904929(coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway)","NA","K05127","EC:2.7.10.1","protein tyrosine kinase 7 (inactive) [Source:NCBI gene;Acc:101111135]",{"v":0.812241411119422,"d":"0.81"},{"v":0.400810272749938,"d":"0.40"},{"v":0.585764664921466,"d":"0.59"},{"v":1.73452047569185,"d":"1.73"},{"v":1.9096626811269,"d":"1.91"},{"v":2.15419595512341,"d":"2.15"},{"v":0.310227447026711,"d":"0.31"},{"v":-1.68860176203499,"d":"-1.69"},{"v":2.64706184034052e-5,"d":"0.00"},{"v":0.0030224633376979,"d":"0.00"},"down","yes"]
["MSTRG.22155","ARHGAP36","ENSOART00000013929;ENSOART00000013928","GO:0007165(signal transduction);GO:0007165(signal transduction)","NA","K20648","NA","Rho GTPase activating protein 36 [Source:NCBI gene;Acc:100913153]",{"v":0.533223231155779,"d":"0.53"},{"v":0.272414358668342,"d":"0.27"},{"v":0.252647414572864,"d":"0.25"},{"v":1.01102933668342,"d":"1.01"},{"v":1.42606737562814,"d":"1.43"},{"v":1.60390745163317,"d":"1.60"},{"v":0.261886640414622,"d":"0.26"},{"v":-1.93298562931558,"d":"-1.93"},{"v":2.89383123464592e-5,"d":"0.00"},{"v":0.00325874502967017,"d":"0.00"},"down","yes"]
["ENSOARG00000020976","GLDN","ENSOART00000022852","GO:0009986(cell surface);GO:0034113(heterotypic cell-cell adhesion);GO:0045162(clustering of voltage-gated sodium channels)","NA","K16364","NA","gliomedin [Source:NCBI gene;Acc:101105662]",{"v":0.44018,"d":"0.44"},{"v":0.767219,"d":"0.77"},{"v":0.723779,"d":"0.72"},{"v":0.096526,"d":"0.10"},{"v":0.181532,"d":"0.18"},{"v":0.131996,"d":"0.13"},{"v":4.70956995907856,"d":"4.71"},{"v":2.23559533027761,"d":"2.24"},{"v":3.15102637571772e-5,"d":"0.00"},{"v":0.00349999718794007,"d":"0.00"},"up","yes"]
["ENSOARG00000018591","COL11A1","ENSOART00000020259","GO:0001502(cartilage condensation);GO:0002063(chondrocyte development);GO:0003007(heart morphogenesis);GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005592(collagen type XI trimer);GO:0006029(proteoglycan metabolic process);GO:0007601(visual perception);GO:0007605(sensory perception of sound);GO:0030199(collagen fibril organization);GO:0031012(extracellular matrix);GO:0035987(endodermal cell differentiation);GO:0035989(tendon development);GO:0042472(inner ear morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0048705(skeletal system morphogenesis);GO:0050910(detection of mechanical stimulus involved in sensory perception of sound);GO:0051216(cartilage development);GO:0055010(ventricular cardiac muscle tissue morphogenesis)","04974(Protein digestion and absorption)","K19721","NA","collagen type XI alpha 1 chain [Source:NCBI gene;Acc:101117548]",{"v":0.183235,"d":"0.18"},{"v":0.15355,"d":"0.15"},{"v":0.106393,"d":"0.11"},{"v":0.314466,"d":"0.31"},{"v":0.762696,"d":"0.76"},{"v":0.833857,"d":"0.83"},{"v":0.231906642477129,"d":"0.23"},{"v":-2.10838395135205,"d":"-2.11"},{"v":3.29085514038952e-5,"d":"0.00"},{"v":0.00360624716324028,"d":"0.00"},"down","yes"]
["MSTRG.2604","RF00012","ENSOART00000025889","NA","NA","NA","NA",null,{"v":2.202334,"d":"2.20"},{"v":2.689811,"d":"2.69"},{"v":0.882857,"d":"0.88"},{"v":6.292189,"d":"6.29"},{"v":11.110863,"d":"11.11"},{"v":12.640894,"d":"12.64"},{"v":0.192218492204719,"d":"0.19"},{"v":-2.37918095893852,"d":"-2.38"},{"v":3.53866467288668e-5,"d":"0.00"},{"v":0.00385195445192624,"d":"0.00"},"down","yes"]
["MSTRG.17244","MEST","ENSOART00000006037","GO:0003824(catalytic activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","mesoderm specific transcript [Source:NCBI gene;Acc:101118099]",{"v":1.335175,"d":"1.34"},{"v":0.567631,"d":"0.57"},{"v":1.598135,"d":"1.60"},{"v":3.278138,"d":"3.28"},{"v":4.169639,"d":"4.17"},{"v":3.990237,"d":"3.99"},{"v":0.306079447008895,"d":"0.31"},{"v":-1.70802192259307,"d":"-1.71"},{"v":3.81421719023345e-5,"d":"0.00"},{"v":0.00409727225540341,"d":"0.00"},"down","yes"]
["ENSOARG00000003849","RCOR2","ENSOART00000004187","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0019899(enzyme binding);GO:0045892(negative regulation of transcription, DNA-templated)","NA","NA","NA","REST corepressor 2 [Source:NCBI gene;Acc:101115081]",{"v":0.241748,"d":"0.24"},{"v":0.072929,"d":"0.07"},{"v":0.133561,"d":"0.13"},{"v":0.70427,"d":"0.70"},{"v":0.692468,"d":"0.69"},{"v":0.661981,"d":"0.66"},{"v":0.217726654293277,"d":"0.22"},{"v":-2.19941006052227,"d":"-2.20"},{"v":3.91715237901205e-5,"d":"0.00"},{"v":0.00412640413190379,"d":"0.00"},"down","yes"]
["MSTRG.18367","MIR145;oar-mir-143","ENSOART00000025935;ENSOART00000026857","NA","05206(MicroRNAs in cancer)","K17023","NA","microRNA 145 [Source:HGNC Symbol;Acc:HGNC:31532];oar-mir-143 [Source:miRBase;Acc:MI0025253]",{"v":0.959936099132715,"d":"0.96"},{"v":0.602183314945543,"d":"0.60"},{"v":0.976556304659137,"d":"0.98"},{"v":2.06347645018152,"d":"2.06"},{"v":3.17906008405607,"d":"3.18"},{"v":2.13112417592779,"d":"2.13"},{"v":0.344289738641969,"d":"0.34"},{"v":-1.53830491203633,"d":"-1.54"},{"v":4.13765949636933e-5,"d":"0.00"},{"v":0.00428230550342786,"d":"0.00"},"down","yes"]
["MSTRG.9170","MYL3","ENSOART00000007610","GO:0002026(regulation of the force of heart contraction);GO:0003785(actin monomer binding);GO:0005509(calcium ion binding);GO:0006942(regulation of striated muscle contraction);GO:0031672(A band);GO:0031674(I band);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060048(cardiac muscle contraction)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04371(Apelin signaling pathway);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","K12749","NA","myosin light chain 3 [Source:NCBI gene;Acc:101115408]",{"v":19.3398869920276,"d":"19.34"},{"v":21.556962202498,"d":"21.56"},{"v":13.0233096409779,"d":"13.02"},{"v":53.8726352248206,"d":"53.87"},{"v":40.0161700116928,"d":"40.02"},{"v":59.4911113664629,"d":"59.49"},{"v":0.351546408615384,"d":"0.35"},{"v":-1.50821293884782,"d":"-1.51"},{"v":4.33517302990526e-5,"d":"0.00"},{"v":0.0044263468626174,"d":"0.00"},"down","yes"]
["MSTRG.5916","FCGRT","ENSOART00000014354","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019864(IgG binding)","NA","NA","NA","Fc fragment of IgG receptor and transporter [Source:NCBI gene;Acc:100144766]",{"v":22.8823735651249,"d":"22.88"},{"v":20.2993053657629,"d":"20.30"},{"v":17.2309707884104,"d":"17.23"},{"v":47.6761804572036,"d":"47.68"},{"v":57.4197189463052,"d":"57.42"},{"v":58.8990294550771,"d":"58.90"},{"v":0.368381206295668,"d":"0.37"},{"v":-1.44072863355489,"d":"-1.44"},{"v":4.33742955670495e-5,"d":"0.00"},{"v":0.0044263468626174,"d":"0.00"},"down","yes"]
["ENSOARG00000019004","DPYSL5","ENSOART00000020690","GO:0005737(cytoplasm);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0008017(microtubule binding);GO:0016787(hydrolase activity);GO:0016810(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds);GO:0030425(dendrite);GO:0043025(neuronal cell body)","04360(Axon guidance)","K07529","NA","dihydropyrimidinase like 5 [Source:NCBI gene;Acc:101111869]",{"v":0.171619,"d":"0.17"},{"v":0.128827,"d":"0.13"},{"v":0.242374,"d":"0.24"},{"v":0.800415,"d":"0.80"},{"v":0.724653,"d":"0.72"},{"v":0.847308,"d":"0.85"},{"v":0.228808586834465,"d":"0.23"},{"v":-2.1277868996284,"d":"-2.13"},{"v":4.49984489958213e-5,"d":"0.00"},{"v":0.00456356941120354,"d":"0.00"},"down","yes"]
["MSTRG.21037","FBXO32","ENSOART00000010855","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0014894(response to denervation involved in regulation of muscle adaptation);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0030018(Z disc);GO:0071549(cellular response to dexamethasone stimulus)","04068(FoxO signaling pathway)","K10305","NA","F-box protein 32 [Source:NCBI gene;Acc:100142676]",{"v":8.85119582339068,"d":"8.85"},{"v":14.1886790448113,"d":"14.19"},{"v":13.7469921625971,"d":"13.75"},{"v":6.82483790843507,"d":"6.82"},{"v":4.20717460946171,"d":"4.21"},{"v":3.22302158074362,"d":"3.22"},{"v":2.58062287162875,"d":"2.58"},{"v":1.36771932353779,"d":"1.37"},{"v":4.85674696879366e-5,"d":"0.00"},{"v":0.00489512126583104,"d":"0.00"},"up","yes"]
["MSTRG.21841","ENSOARG00000014471","ENSOART00000015752","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006396(RNA processing)","NA","NA","NA","heterogeneous nuclear ribonucleoprotein K-like [Source:NCBI gene;Acc:101119962]",{"v":0.0320376592716618,"d":"0.03"},0,{"v":0.124904550439514,"d":"0.12"},{"v":3.06361361364588,"d":"3.06"},{"v":0.306176610715781,"d":"0.31"},{"v":0.463691341984094,"d":"0.46"},{"v":0.0409398628883404,"d":"0.04"},{"v":-4.61034991913403,"d":"-4.61"},{"v":5.00830319501979e-5,"d":"0.00"},{"v":0.00499513742218948,"d":"0.00"},"down","yes"]
["MSTRG.11458","ENSOARG00000009229","ENSOART00000010046","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":0.804673,"d":"0.80"},{"v":0.385409,"d":"0.39"},{"v":0.684688,"d":"0.68"},{"v":3.845061,"d":"3.85"},{"v":1.563694,"d":"1.56"},{"v":4.607162,"d":"4.61"},{"v":0.18717906707893,"d":"0.19"},{"v":-2.41750899281879,"d":"-2.42"},{"v":5.01716399582971e-5,"d":"0.00"},{"v":0.00499513742218948,"d":"0.00"},"down","yes"]
["MSTRG.1974","ENSOARG00000013777","ENSOART00000014988","NA","00590(Arachidonic acid metabolism);00790(Folate biosynthesis);00980(Metabolism of xenobiotics by cytochrome P450);05204(Chemical carcinogenesis)","K00079","1.1.1.189;1.1.1.197;EC:1.1.1.184","carbonyl reductase [NADPH] 1-like [Source:NCBI gene;Acc:101115172]",{"v":1.98684501981833,"d":"1.99"},{"v":0.554236227910818,"d":"0.55"},{"v":0.796158867877787,"d":"0.80"},{"v":6.79033709413708,"d":"6.79"},{"v":2.99439145582164,"d":"2.99"},{"v":4.70184508009909,"d":"4.70"},{"v":0.230367801305519,"d":"0.23"},{"v":-2.11798901067258,"d":"-2.12"},{"v":5.10932892081764e-5,"d":"0.00"},{"v":0.00502560979633195,"d":"0.01"},"down","yes"]
["MSTRG.2232","HSPH1","ENSOART00000012788","GO:0000166(nucleotide binding);GO:0000774(adenyl-nucleotide exchange factor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005874(microtubule);GO:0032991(protein-containing complex);GO:0043014(alpha-tubulin binding);GO:0050790(regulation of catalytic activity);GO:0051085(chaperone cofactor-dependent protein refolding)","04141(Protein processing in endoplasmic reticulum)","K09485","NA","heat shock protein family H (Hsp110) member 1 [Source:NCBI gene;Acc:101110772]",{"v":15.4300751344816,"d":"15.43"},{"v":26.8818077259916,"d":"26.88"},{"v":26.3348938500348,"d":"26.33"},{"v":8.56558619258873,"d":"8.57"},{"v":9.66378470998608,"d":"9.66"},{"v":8.58838635803758,"d":"8.59"},{"v":2.55975084133267,"d":"2.56"},{"v":1.35600338933951,"d":"1.36"},{"v":5.29411874943622e-5,"d":"0.00"},{"v":0.00517618987669429,"d":"0.01"},"up","yes"]
["MSTRG.9457","ABCA1","ENSOART00000008003","GO:0000166(nucleotide binding);GO:0002790(peptide secretion);GO:0005102(signaling receptor binding);GO:0005524(ATP binding);GO:0005548(phospholipid transporter activity);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006497(protein lipidation);GO:0006911(phagocytosis, engulfment);GO:0007040(lysosome organization);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0008203(cholesterol metabolic process);GO:0008509(anion transmembrane transporter activity);GO:0009897(external side of plasma membrane);GO:0010875(positive regulation of cholesterol efflux);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016197(endosomal transport);GO:0016887(ATPase activity);GO:0017127(cholesterol transporter activity);GO:0019905(syntaxin binding);GO:0030139(endocytic vesicle);GO:0031267(small GTPase binding);GO:0032367(intracellular cholesterol transport);GO:0032489(regulation of Cdc42 protein signal transduction);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0034185(apolipoprotein binding);GO:0034186(apolipoprotein A-I binding);GO:0034188(apolipoprotein A-I receptor activity);GO:0034380(high-density lipoprotein particle assembly);GO:0034616(response to laminar fluid shear stress);GO:0038027(apolipoprotein A-I-mediated signaling pathway);GO:0042157(lipoprotein metabolic process);GO:0042158(lipoprotein biosynthetic process);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0042632(cholesterol homeostasis);GO:0043231(intracellular membrane-bounded organelle);GO:0043691(reverse cholesterol transport);GO:0045121(membrane raft);GO:0045332(phospholipid translocation);GO:0045335(phagocytic vesicle);GO:0048471(perinuclear region of cytoplasm);GO:0050702(interleukin-1 beta secretion);GO:0051117(ATPase binding);GO:0055085(transmembrane transport);GO:0055091(phospholipid homeostasis);GO:0060155(platelet dense granule organization);GO:0071222(cellular response to lipopolysaccharide);GO:0071300(cellular response to retinoic acid);GO:0071404(cellular response to low-density lipoprotein particle stimulus);GO:0090554(phosphatidylcholine-translocating ATPase activity);GO:0090556(phosphatidylserine-translocating ATPase activity);GO:0098656(anion transmembrane transport)","02010(ABC transporters);04975(Fat digestion and absorption);04979(Cholesterol metabolism)","K05641","NA","ATP binding cassette subfamily A member 1 [Source:NCBI gene;Acc:101119015]",{"v":15.128877,"d":"15.13"},{"v":15.110843,"d":"15.11"},{"v":12.793837,"d":"12.79"},{"v":6.547328,"d":"6.55"},{"v":6.557853,"d":"6.56"},{"v":5.509989,"d":"5.51"},{"v":2.31174665608748,"d":"2.31"},{"v":1.20898330180359,"d":"1.21"},{"v":5.83491159489138e-5,"d":"0.00"},{"v":0.00567097836436824,"d":"0.01"},"up","yes"]
["MSTRG.9915","BNC2","ENSOART00000015307","GO:0003416(endochondral bone growth);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0043586(tongue development);GO:0060021(roof of mouth development);GO:0060485(mesenchyme development)","NA","NA","NA","basonuclin 2 [Source:NCBI gene;Acc:101122574]",{"v":2.19652811942991,"d":"2.20"},{"v":1.24788593775934,"d":"1.25"},{"v":1.61500913692946,"d":"1.62"},{"v":5.01496590672921,"d":"5.01"},{"v":3.7081014602201,"d":"3.71"},{"v":5.40103858957243,"d":"5.40"},{"v":0.35821192574547,"d":"0.36"},{"v":-1.48111472594025,"d":"-1.48"},{"v":6.53622866879014e-5,"d":"0.00"},{"v":0.00624114278970792,"d":"0.01"},"down","yes"]
["MSTRG.10105","LIMS2","ENSOART00000017452","GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0016020(membrane);GO:0030054(cell junction);GO:0043066(negative regulation of apoptotic process);GO:0045216(cell-cell junction organization);GO:0046872(metal ion binding);GO:0050680(negative regulation of epithelial cell proliferation);GO:0098609(cell-cell adhesion);GO:2000178(negative regulation of neural precursor cell proliferation);GO:2000346(negative regulation of hepatocyte proliferation);GO:2001046(positive regulation of integrin-mediated signaling pathway)","NA","NA","NA","LIM zinc finger domain containing 2 [Source:NCBI gene;Acc:101108888]",{"v":4.75093192458665,"d":"4.75"},{"v":3.25770208385869,"d":"3.26"},{"v":3.80142791090758,"d":"3.80"},{"v":10.424254963126,"d":"10.42"},{"v":9.47387445105269,"d":"9.47"},{"v":11.3956993802783,"d":"11.40"},{"v":0.377392680100711,"d":"0.38"},{"v":-1.40586165415573,"d":"-1.41"},{"v":6.64233694579658e-5,"d":"0.00"},{"v":0.00630558590993991,"d":"0.01"},"down","yes"]
["MSTRG.6744","MDK","ENSOART00000003819","GO:0001662(behavioral fear response);GO:0007614(short-term memory);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0009611(response to wounding);GO:0010469(regulation of signaling receptor activity);GO:0010996(response to auditory stimulus);GO:0021542(dentate gyrus development);GO:0021681(cerebellar granular layer development);GO:0021766(hippocampus development);GO:0021987(cerebral cortex development);GO:0030421(defecation);GO:0043524(negative regulation of neuron apoptotic process);GO:0044849(estrous cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048477(oogenesis);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0050795(regulation of behavior);GO:1901215(negative regulation of neuron death)","NA","K06828","NA","midkine [Source:NCBI gene;Acc:101114137]",{"v":1.66537,"d":"1.67"},{"v":0.71893,"d":"0.72"},{"v":1.194896,"d":"1.19"},{"v":5.186605,"d":"5.19"},{"v":4.035106,"d":"4.04"},{"v":5.153198,"d":"5.15"},{"v":0.248989124035498,"d":"0.25"},{"v":-2.00584536882989,"d":"-2.01"},{"v":7.01131325887097e-5,"d":"0.00"},{"v":0.00657935189027846,"d":"0.01"},"down","yes"]
["MSTRG.20108","SLC8A3","ENSOART00000023092","GO:0002244(hematopoietic progenitor cell differentiation);GO:0005432(calcium:sodium antiporter activity);GO:0005741(mitochondrial outer membrane);GO:0005789(endoplasmic reticulum membrane);GO:0005887(integral component of plasma membrane);GO:0006816(calcium ion transport);GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0006874(cellular calcium ion homeostasis);GO:0007154(cell communication);GO:0007612(learning);GO:0007613(memory);GO:0014819(regulation of skeletal muscle contraction);GO:0015368(calcium:cation antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030001(metal ion transport);GO:0031226(intrinsic component of plasma membrane);GO:0031594(neuromuscular junction);GO:0035725(sodium ion transmembrane transport);GO:0042383(sarcolemma);GO:0042552(myelination);GO:0048471(perinuclear region of cytoplasm);GO:0048709(oligodendrocyte differentiation);GO:0051560(mitochondrial calcium ion homeostasis);GO:0055085(transmembrane transport);GO:0060078(regulation of postsynaptic membrane potential);GO:0060291(long-term synaptic potentiation);GO:0070588(calcium ion transmembrane transport);GO:0071456(cellular response to hypoxia);GO:0099580(ion antiporter activity involved in regulation of postsynaptic membrane potential)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04371(Apelin signaling pathway);04740(Olfactory transduction);04974(Protein digestion and absorption)","K05849","NA","solute carrier family 8 member A3 [Source:NCBI gene;Acc:101120753]",{"v":3.93041668108074,"d":"3.93"},{"v":5.02398586128321,"d":"5.02"},{"v":4.55109949795605,"d":"4.55"},{"v":2.66146175480646,"d":"2.66"},{"v":1.55768920731668,"d":"1.56"},{"v":1.48317059598556,"d":"1.48"},{"v":2.36842168627183,"d":"2.37"},{"v":1.24392596886033,"d":"1.24"},{"v":7.25163006010432e-5,"d":"0.00"},{"v":0.00672753497848769,"d":"0.01"},"up","yes"]
["MSTRG.9486","NFIL3","ENSOART00000003638","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0006955(immune response);GO:0007623(circadian rhythm);GO:0010628(positive regulation of gene expression);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048511(rhythmic process);GO:0071353(cellular response to interleukin-4)","NA","K09059","NA","nuclear factor, interleukin 3 regulated [Source:NCBI gene;Acc:100217409]",{"v":16.850304,"d":"16.85"},{"v":40.485695,"d":"40.49"},{"v":26.301439,"d":"26.30"},{"v":7.855633,"d":"7.86"},{"v":11.590892,"d":"11.59"},{"v":10.200109,"d":"10.20"},{"v":2.82114448473307,"d":"2.82"},{"v":1.49628055534922,"d":"1.50"},{"v":8.24751669096171e-5,"d":"0.00"},{"v":0.00750911583139433,"d":"0.01"},"up","yes"]
["ENSOARG00000002007","SIGLEC1","ENSOART00000002164","GO:0016020(membrane);GO:0016021(integral component of membrane)","04514(Cell adhesion molecules (CAMs))","K06548","NA","sialic acid binding Ig like lectin 1 [Source:NCBI gene;Acc:101110959]",{"v":0.060503,"d":"0.06"},{"v":0.00257,"d":"0.00"},{"v":0.025703,"d":"0.03"},{"v":0.222589,"d":"0.22"},{"v":0.163673,"d":"0.16"},{"v":0.268195,"d":"0.27"},{"v":0.13564833136478,"d":"0.14"},{"v":-2.88205679401703,"d":"-2.88"},{"v":8.27805517914612e-5,"d":"0.00"},{"v":0.00750911583139433,"d":"0.01"},"down","yes"]
["MSTRG.19511","NYNRIN","ENSOART00000020769","GO:0003676(nucleic acid binding);GO:0015074(DNA integration)","NA","NA","NA","NYN domain and retroviral integrase containing [Source:NCBI gene;Acc:101118362]",{"v":1.574145,"d":"1.57"},{"v":0.817542,"d":"0.82"},{"v":1.019989,"d":"1.02"},{"v":2.827902,"d":"2.83"},{"v":3.309739,"d":"3.31"},{"v":2.977781,"d":"2.98"},{"v":0.374275156981213,"d":"0.37"},{"v":-1.41782880430237,"d":"-1.42"},{"v":9.42508673214879e-5,"d":"0.00"},{"v":0.00827380732056589,"d":"0.01"},"down","yes"]
["MSTRG.21708","MAOB","ENSOART00000003571","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism);00330(Arginine and proline metabolism);00340(Histidine metabolism);00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00380(Tryptophan metabolism);00982(Drug metabolism - cytochrome P450);04726(Serotonergic synapse);04728(Dopaminergic synapse);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)","K00274","EC:1.4.3.4","monoamine oxidase B [Source:NCBI gene;Acc:101106659]",{"v":13.9185404634731,"d":"13.92"},{"v":12.7667061652695,"d":"12.77"},{"v":13.092473639521,"d":"13.09"},{"v":7.50055853772455,"d":"7.50"},{"v":3.27838445748503,"d":"3.28"},{"v":5.30198444191617,"d":"5.30"},{"v":2.47359615443755,"d":"2.47"},{"v":1.30660998149935,"d":"1.31"},{"v":0.000103193299518479,"d":"0.00"},{"v":0.00879254481636031,"d":"0.01"},"up","yes"]
["MSTRG.12282","ENSOARG00000008178","ENSOART00000008899","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K06566","NA","interferon induced transmembrane protein 3 [Source:NCBI gene;Acc:101104700]",{"v":14.998305,"d":"15.00"},{"v":7.758789,"d":"7.76"},{"v":9.147378,"d":"9.15"},{"v":20.978971,"d":"20.98"},{"v":35.218208,"d":"35.22"},{"v":40.075413,"d":"40.08"},{"v":0.331397247515679,"d":"0.33"},{"v":-1.59336647486261,"d":"-1.59"},{"v":0.000103929516753891,"d":"0.00"},{"v":0.00879254481636031,"d":"0.01"},"down","yes"]
["MSTRG.19237","ENSOARG00000016260","ENSOART00000017707","NA","NA","NA","NA",null,{"v":3.994355,"d":"3.99"},{"v":3.467664,"d":"3.47"},{"v":3.120821,"d":"3.12"},{"v":10.081907,"d":"10.08"},{"v":8.152989,"d":"8.15"},{"v":11.63295,"d":"11.63"},{"v":0.354322169733967,"d":"0.35"},{"v":-1.4968663580097,"d":"-1.50"},{"v":0.000109354046510294,"d":"0.00"},{"v":0.00915657882779525,"d":"0.01"},"down","yes"]
["MSTRG.15612","ENSOARG00000015299","ENSOART00000016649","GO:0005524(ATP binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport)","01523(Antifolate resistance);02010(ABC transporters);04024(cAMP signaling pathway);04976(Bile secretion)","K05673","NA","multidrug resistance-associated protein 4-like [Source:NCBI gene;Acc:101104054]",{"v":0.805803008843537,"d":"0.81"},{"v":1.22499293673469,"d":"1.22"},0,{"v":0.0351142965986395,"d":"0.04"},{"v":0.0175932952380952,"d":"0.02"},{"v":0.0153102367346939,"d":"0.02"},{"v":29.8568182523733,"d":"29.86"},{"v":4.8999885250584,"d":"4.90"},{"v":0.000112421902667537,"d":"0.00"},{"v":0.00926907969255124,"d":"0.01"},"up","yes"]
["MSTRG.11233","ENSOARG00000008698;BTBD9","ENSOART00000009471;ENSOART00000016501","GO:0005515(protein binding);GO:0007616(long-term memory);GO:0008344(adult locomotory behavior);GO:0042428(serotonin metabolic process);GO:0042748(circadian sleep/wake cycle, non-REM sleep);GO:0048512(circadian behavior);GO:0050951(sensory perception of temperature stimulus);GO:0060586(multicellular organismal iron ion homeostasis);GO:1900242(regulation of synaptic vesicle endocytosis)","NA","NA","NA","BTB domain containing 9 [Source:HGNC Symbol;Acc:HGNC:21228]",{"v":1.36111616935289,"d":"1.36"},{"v":2.69095445178741,"d":"2.69"},{"v":2.95102552250293,"d":"2.95"},{"v":0.955712064525124,"d":"0.96"},{"v":1.07096181947465,"d":"1.07"},{"v":0.61880221991709,"d":"0.62"},{"v":2.64719690088091,"d":"2.65"},{"v":1.4044655077761,"d":"1.40"},{"v":0.000112968327953068,"d":"0.00"},{"v":0.00926907969255124,"d":"0.01"},"up","yes"]
["MSTRG.12579","DUSP5","ENSOART00000010383","GO:0004725(protein tyrosine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0035970(peptidyl-threonine dephosphorylation)","NA","NA","NA","dual specificity phosphatase 5 [Source:HGNC Symbol;Acc:HGNC:3071]",{"v":7.117109,"d":"7.12"},{"v":1.564432,"d":"1.56"},{"v":5.112262,"d":"5.11"},{"v":1.798155,"d":"1.80"},{"v":0.393719,"d":"0.39"},{"v":0.591913,"d":"0.59"},{"v":4.95504972183576,"d":"4.96"},{"v":2.30889953432114,"d":"2.31"},{"v":0.000115949716945567,"d":"0.00"},{"v":0.00932324579129408,"d":"0.01"},"up","yes"]
["MSTRG.9587","DNAI1","ENSOART00000010073","GO:0003351(epithelial cilium movement);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0008286(insulin receptor signaling pathway)","05016(Huntington disease)","K10409","NA","dynein axonemal intermediate chain 1 [Source:NCBI gene;Acc:101122250]",{"v":0.102305,"d":"0.10"},{"v":0.044298,"d":"0.04"},{"v":0.024567,"d":"0.02"},{"v":0.09777,"d":"0.10"},{"v":0.609249,"d":"0.61"},{"v":0.502752,"d":"0.50"},{"v":0.141489587698829,"d":"0.14"},{"v":-2.82123220669226,"d":"-2.82"},{"v":0.000116018111781821,"d":"0.00"},{"v":0.00932324579129408,"d":"0.01"},"down","yes"]
["MSTRG.14208","RF00090","ENSOART00000024393","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 74C-1 [Source:HGNC Symbol;Acc:HGNC:52217]",{"v":6.614625,"d":"6.61"},{"v":5.264902,"d":"5.26"},{"v":4.010785,"d":"4.01"},{"v":13.889637,"d":"13.89"},{"v":14.469927,"d":"14.47"},{"v":29.186478,"d":"29.19"},{"v":0.276132144761581,"d":"0.28"},{"v":-1.85656925191343,"d":"-1.86"},{"v":0.000116483472649681,"d":"0.00"},{"v":0.00932324579129408,"d":"0.01"},"down","yes"]
["MSTRG.15957","SLC26A10","ENSOART00000006277","GO:0008271(secondary active sulfate transmembrane transporter activity);GO:0008272(sulfate transport);GO:0015116(sulfate transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:1902358(sulfate transmembrane transport)","NA","K14707","NA","solute carrier family 26 member 10 [Source:NCBI gene;Acc:101119634]",{"v":2.26741037845999,"d":"2.27"},{"v":1.4633114448918,"d":"1.46"},{"v":1.13696737443382,"d":"1.14"},{"v":5.06735697131354,"d":"5.07"},{"v":5.27937195218923,"d":"5.28"},{"v":3.86019835681933,"d":"3.86"},{"v":0.34262786750009,"d":"0.34"},{"v":-1.54528559767112,"d":"-1.55"},{"v":0.000118545130470324,"d":"0.00"},{"v":0.00939614024426916,"d":"0.01"},"down","yes"]
["MSTRG.4537","ENSOARG00000004506","ENSOART00000004898","NA","NA","NA","NA",null,{"v":488.083496,"d":"488.08"},{"v":43.251617,"d":"43.25"},{"v":168.037338,"d":"168.04"},{"v":63.447163,"d":"63.45"},{"v":28.567642,"d":"28.57"},{"v":48.222225,"d":"48.22"},{"v":4.98707403458273,"d":"4.99"},{"v":2.31819362039476,"d":"2.32"},{"v":0.000122644865120866,"d":"0.00"},{"v":0.00953593027473098,"d":"0.01"},"up","yes"]
["MSTRG.21057","ENSOARG00000011310","ENSOART00000012296","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05202(Transcriptional misregulation in cancer);05322(Systemic lupus erythematosus)","K11253","NA","histone H3.3C [Source:NCBI gene;Acc:101111106]",{"v":5.049003,"d":"5.05"},{"v":2.218277,"d":"2.22"},{"v":0.140752,"d":"0.14"},{"v":0.267507,"d":"0.27"},{"v":0.278594,"d":"0.28"},{"v":0.038545,"d":"0.04"},{"v":12.6709701255118,"d":"12.67"},{"v":3.66345508043042,"d":"3.66"},{"v":0.000130888957124641,"d":"0.00"},{"v":0.0100335910419303,"d":"0.01"},"up","yes"]
["MSTRG.5045","EMILIN3","ENSOART00000002712","GO:0005515(protein binding);GO:0005737(cytoplasm)","NA","NA","NA","elastin microfibril interfacer 3 [Source:HGNC Symbol;Acc:HGNC:16123]",{"v":0.926635,"d":"0.93"},{"v":0.683135,"d":"0.68"},{"v":0.638616,"d":"0.64"},{"v":2.18306,"d":"2.18"},{"v":2.122982,"d":"2.12"},{"v":2.252179,"d":"2.25"},{"v":0.342834741311706,"d":"0.34"},{"v":-1.54441478188239,"d":"-1.54"},{"v":0.000132586588351234,"d":"0.00"},{"v":0.0100749723914346,"d":"0.01"},"down","yes"]
["MSTRG.3629","MIF4GD","ENSOART00000011740","GO:0005730(nucleolus);GO:0005829(cytosol);GO:0008022(protein C-terminus binding);GO:0042802(identical protein binding)","NA","NA","NA","MIF4G domain containing [Source:HGNC Symbol;Acc:HGNC:24030]",{"v":6.20392196494465,"d":"6.20"},{"v":5.2647265202952,"d":"5.26"},{"v":5.17084919188192,"d":"5.17"},{"v":10.3493078942189,"d":"10.35"},{"v":15.885347702952,"d":"15.89"},{"v":19.9794574434194,"d":"19.98"},{"v":0.360052299662381,"d":"0.36"},{"v":-1.47372161337869,"d":"-1.47"},{"v":0.000133178320329227,"d":"0.00"},{"v":0.0100749723914346,"d":"0.01"},"down","yes"]
["MSTRG.11536","HIST1H2BD","ENSOART00000001054","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005829(cytosol);GO:0046982(protein heterodimerization activity)","NA","NA","NA","histone cluster 1 H2B family member d [Source:HGNC Symbol;Acc:HGNC:4747]",{"v":2.04524897085762,"d":"2.05"},{"v":1.79856616153206,"d":"1.80"},{"v":1.38404241673605,"d":"1.38"},{"v":3.94003110824313,"d":"3.94"},{"v":4.87135033513739,"d":"4.87"},{"v":5.47042388551207,"d":"5.47"},{"v":0.366050189645814,"d":"0.37"},{"v":-1.44988662291114,"d":"-1.45"},{"v":0.000144682898547418,"d":"0.00"},{"v":0.0108366163645975,"d":"0.01"},"down","yes"]
["MSTRG.1602","RF00024","ENSOART00000025023","NA","NA","NA","NA",null,{"v":31.771299,"d":"31.77"},{"v":31.261221,"d":"31.26"},{"v":19.315508,"d":"19.32"},{"v":54.863529,"d":"54.86"},{"v":74.943367,"d":"74.94"},{"v":114.576462,"d":"114.58"},{"v":0.336962502986803,"d":"0.34"},{"v":-1.56934003690695,"d":"-1.57"},{"v":0.00014874353467439,"d":"0.00"},{"v":0.0109516124514128,"d":"0.01"},"down","yes"]
["MSTRG.12283","ENSOARG00000008211","ENSOART00000008933","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.993606,"d":"0.99"},{"v":1.357526,"d":"1.36"},{"v":1.7669,"d":"1.77"},{"v":3.238907,"d":"3.24"},{"v":6.176849,"d":"6.18"},{"v":9.501175,"d":"9.50"},{"v":0.217690279675916,"d":"0.22"},{"v":-2.19965110525943,"d":"-2.20"},{"v":0.000149781570586995,"d":"0.00"},{"v":0.0109669662984056,"d":"0.01"},"down","yes"]
["MSTRG.18525","LYSMD3","ENSOART00000017788","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","LysM domain containing 3 [Source:NCBI gene;Acc:101106842]",{"v":2.8407489911268,"d":"2.84"},{"v":2.61430290602042,"d":"2.61"},{"v":2.45842487205419,"d":"2.46"},{"v":0.874478501574277,"d":"0.87"},{"v":1.27143507766435,"d":"1.27"},{"v":1.22653071500811,"d":"1.23"},{"v":2.34651074376573,"d":"2.35"},{"v":1.23051706592427,"d":"1.23"},{"v":0.000156611749342266,"d":"0.00"},{"v":0.011290499230031,"d":"0.01"},"up","yes"]
["MSTRG.10988","C1QC","ENSOART00000008698","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005623(cell);GO:0030853(negative regulation of granulocyte differentiation);GO:0045202(synapse);GO:0045650(negative regulation of macrophage differentiation);GO:0098794(postsynapse);GO:0098883(synapse pruning)","NA","NA","NA","complement C1q C chain [Source:NCBI gene;Acc:101101871]",{"v":2.734599,"d":"2.73"},{"v":1.862799,"d":"1.86"},{"v":6.062249,"d":"6.06"},{"v":11.980435,"d":"11.98"},{"v":11.275341,"d":"11.28"},{"v":13.727098,"d":"13.73"},{"v":0.288231980024051,"d":"0.29"},{"v":-1.79469768004617,"d":"-1.79"},{"v":0.000156966151715889,"d":"0.00"},{"v":0.011290499230031,"d":"0.01"},"down","yes"]
["MSTRG.13728","NPTX2","ENSOART00000000649","GO:0008306(associative learning);GO:0098962(regulation of postsynaptic neurotransmitter receptor activity);GO:0098978(glutamatergic synapse)","NA","NA","NA","neuronal pentraxin 2 [Source:HGNC Symbol;Acc:HGNC:7953]",{"v":0.139656,"d":"0.14"},{"v":0.139942,"d":"0.14"},0,{"v":1.092815,"d":"1.09"},{"v":0.387922,"d":"0.39"},{"v":1.055212,"d":"1.06"},{"v":0.110253794536089,"d":"0.11"},{"v":-3.18109978591461,"d":"-3.18"},{"v":0.000159400344046291,"d":"0.00"},{"v":0.0114153018315256,"d":"0.01"},"down","yes"]
["MSTRG.22154","IGSF1","ENSOART00000013854","GO:0006355(regulation of transcription, DNA-templated);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0034711(inhibin binding);GO:0038102(activin receptor antagonist activity)","NA","NA","NA","immunoglobulin superfamily member 1 [Source:NCBI gene;Acc:101111779]",{"v":0.121307,"d":"0.12"},{"v":0.075212,"d":"0.08"},{"v":0.134857,"d":"0.13"},{"v":0.252173,"d":"0.25"},{"v":0.550442,"d":"0.55"},{"v":0.438074,"d":"0.44"},{"v":0.26709030224335,"d":"0.27"},{"v":-1.90460050064186,"d":"-1.90"},{"v":0.000165068840525383,"d":"0.00"},{"v":0.0117184522960803,"d":"0.01"},"down","yes"]
["MSTRG.1455","FAM43A","ENSOART00000022214","GO:0005515(protein binding)","NA","NA","NA","family with sequence similarity 43 member A [Source:NCBI gene;Acc:101105543]",{"v":1.767181,"d":"1.77"},{"v":0.969981,"d":"0.97"},{"v":1.374142,"d":"1.37"},{"v":3.430526,"d":"3.43"},{"v":4.759816,"d":"4.76"},{"v":4.116838,"d":"4.12"},{"v":0.334057355137408,"d":"0.33"},{"v":-1.58183227102495,"d":"-1.58"},{"v":0.000170300695407057,"d":"0.00"},{"v":0.0120154405991,"d":"0.01"},"down","yes"]
["ENSOARG00000020784","CA12","ENSOART00000022644;ENSOART00000022645","GO:0004089(carbonate dehydratase activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0055064(chloride ion homeostasis);GO:0055064(chloride ion homeostasis)","00910(Nitrogen metabolism);00910(Nitrogen metabolism)","K01672","EC:4.2.1.1","carbonic anhydrase 12 [Source:NCBI gene;Acc:101111288]",{"v":0.951073044585987,"d":"0.95"},{"v":2.33270643949045,"d":"2.33"},{"v":2.01144279936306,"d":"2.01"},{"v":0.631913463375796,"d":"0.63"},{"v":0.48613047133758,"d":"0.49"},{"v":0.0858609076433121,"d":"0.09"},{"v":4.39837277593626,"d":"4.40"},{"v":2.13696988232016,"d":"2.14"},{"v":0.000174521734459696,"d":"0.00"},{"v":0.0120284206255471,"d":"0.01"},"up","yes"]
["MSTRG.14048","PALD1","ENSOART00000006643","GO:0005829(cytosol)","NA","NA","NA","phosphatase domain containing paladin 1 [Source:NCBI gene;Acc:101110645]",{"v":0.817952015772871,"d":"0.82"},{"v":0.653936503154574,"d":"0.65"},{"v":0.770983556782334,"d":"0.77"},{"v":2.34902593330329,"d":"2.35"},{"v":1.90172431095088,"d":"1.90"},{"v":1.72439748129788,"d":"1.72"},{"v":0.375366799069818,"d":"0.38"},{"v":-1.4136270444404,"d":"-1.41"},{"v":0.000178392118568449,"d":"0.00"},{"v":0.0121873912635382,"d":"0.01"},"down","yes"]
["MSTRG.10937","ENSOARG00000005764","ENSOART00000006273","GO:0031110(regulation of microtubule polymerization or depolymerization)","04010(MAPK signaling pathway);05206(MicroRNAs in cancer)","K04381","NA","stathmin 1 [Source:NCBI gene;Acc:101113917]",{"v":2.791353,"d":"2.79"},{"v":1.900503,"d":"1.90"},{"v":2.823921,"d":"2.82"},{"v":6.98966,"d":"6.99"},{"v":5.631061,"d":"5.63"},{"v":8.414497,"d":"8.41"},{"v":0.357294942224987,"d":"0.36"},{"v":-1.48481260323839,"d":"-1.48"},{"v":0.000181216270726094,"d":"0.00"},{"v":0.012283635709699,"d":"0.01"},"down","yes"]
["MSTRG.14714","PTGES","ENSOART00000009273","GO:0001516(prostaglandin biosynthetic process);GO:0005641(nuclear envelope lumen);GO:0005737(cytoplasm);GO:0006693(prostaglandin metabolic process);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043295(glutathione binding);GO:0050220(prostaglandin-E synthase activity)","00590(Arachidonic acid metabolism)","K15729","EC:5.3.99.3","prostaglandin E synthase [Source:NCBI gene;Acc:101104140]",{"v":1.28086788640429,"d":"1.28"},{"v":0.245030649150268,"d":"0.25"},{"v":0.74783188618068,"d":"0.75"},{"v":3.03532956171735,"d":"3.04"},{"v":2.36550450782648,"d":"2.37"},{"v":2.95615016949911,"d":"2.96"},{"v":0.272075470851388,"d":"0.27"},{"v":-1.87792119958691,"d":"-1.88"},{"v":0.000183970198316526,"d":"0.00"},{"v":0.0124126669343481,"d":"0.01"},"down","yes"]
["MSTRG.13058","LIPG","ENSOART00000004356","GO:0004465(lipoprotein lipase activity);GO:0004620(phospholipase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0006629(lipid metabolic process);GO:0008970(phospholipase A1 activity);GO:0009986(cell surface);GO:0010983(positive regulation of high-density lipoprotein particle clearance);GO:0032376(positive regulation of cholesterol transport);GO:0034375(high-density lipoprotein particle remodeling);GO:0042632(cholesterol homeostasis);GO:0043691(reverse cholesterol transport);GO:0046872(metal ion binding);GO:0050746(regulation of lipoprotein metabolic process);GO:0052689(carboxylic ester hydrolase activity);GO:0055091(phospholipid homeostasis)","00561(Glycerolipid metabolism);04979(Cholesterol metabolism)","K22284","EC:3.1.1.3","lipase G, endothelial type [Source:NCBI gene;Acc:101111679]",{"v":3.48408452790901,"d":"3.48"},{"v":3.86443068923884,"d":"3.86"},{"v":5.05373815643045,"d":"5.05"},{"v":2.31393840186643,"d":"2.31"},{"v":1.6416854642753,"d":"1.64"},{"v":1.58431591169437,"d":"1.58"},{"v":2.23869822975271,"d":"2.24"},{"v":1.16266007004815,"d":"1.16"},{"v":0.000217842992977218,"d":"0.00"},{"v":0.014284901161976,"d":"0.01"},"up","yes"]
["MSTRG.4879","ENSOARG00000004809","ENSOART00000005239","GO:0071107(response to parathyroid hormone)","NA","NA","NA","neuroendocrine secretory protein 55-like [Source:NCBI gene;Acc:101102411]",{"v":2.32167044751381,"d":"2.32"},{"v":1.49616049907919,"d":"1.50"},{"v":2.65917502117864,"d":"2.66"},{"v":4.77594238674033,"d":"4.78"},{"v":6.93928059484346,"d":"6.94"},{"v":6.87814105248619,"d":"6.88"},{"v":0.348350409097749,"d":"0.35"},{"v":-1.52138883731403,"d":"-1.52"},{"v":0.000222914374407734,"d":"0.00"},{"v":0.0145009797025079,"d":"0.01"},"down","yes"]
["MSTRG.7054","CCDC152","ENSOART00000009584","NA","NA","NA","NA","coiled-coil domain containing 152 [Source:NCBI gene;Acc:101116092]",{"v":20.1098358450407,"d":"20.11"},{"v":5.34965274886946,"d":"5.35"},{"v":2.81036692432921,"d":"2.81"},{"v":1.6686823258969,"d":"1.67"},{"v":2.07600900934579,"d":"2.08"},{"v":2.87394664425686,"d":"2.87"},{"v":4.27124970512089,"d":"4.27"},{"v":2.09465824305357,"d":"2.09"},{"v":0.000231479057839375,"d":"0.00"},{"v":0.0149983732396878,"d":"0.01"},"up","yes"]
["MSTRG.8479","RF00600","ENSOART00000025644","NA","NA","NA","NA",null,{"v":2.245725,"d":"2.25"},{"v":2.670387,"d":"2.67"},{"v":1.95694,"d":"1.96"},{"v":6.725915,"d":"6.73"},{"v":7.573559,"d":"7.57"},{"v":13.771052,"d":"13.77"},{"v":0.24484941963681,"d":"0.24"},{"v":-2.03003331843671,"d":"-2.03"},{"v":0.000248805495699334,"d":"0.00"},{"v":0.0159940792668454,"d":"0.02"},"down","yes"]
["MSTRG.17118","MPP6","ENSOART00000011788;ENSOART00000011786","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005886(plasma membrane)","NA","NA","NA","membrane palmitoylated protein 6 [Source:NCBI gene;Acc:101109532]",{"v":4.22232948698885,"d":"4.22"},{"v":4.03126355390335,"d":"4.03"},{"v":4.0374695464684,"d":"4.04"},{"v":1.652637,"d":"1.65"},{"v":2.06225536431227,"d":"2.06"},{"v":1.595431,"d":"1.60"},{"v":2.31456010192562,"d":"2.31"},{"v":1.21073802541842,"d":"1.21"},{"v":0.000254438984673396,"d":"0.00"},{"v":0.0162284364912001,"d":"0.02"},"up","yes"]
["MSTRG.15956","B4GALNT1","ENSOART00000006179","GO:0000139(Golgi membrane);GO:0001574(ganglioside biosynthetic process);GO:0003947((N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0006687(glycosphingolipid metabolic process);GO:0007283(spermatogenesis);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0016758(transferase activity, transferring hexosyl groups);GO:0019915(lipid storage);GO:0030173(integral component of Golgi membrane);GO:0030259(lipid glycosylation)","00604(Glycosphingolipid biosynthesis - ganglio series)","K00725","EC:2.4.1.92","beta-1,4-N-acetyl-galactosaminyltransferase 1 [Source:NCBI gene;Acc:101119388]",{"v":0.471912158120882,"d":"0.47"},{"v":0.463139584932684,"d":"0.46"},{"v":0.323110429103409,"d":"0.32"},{"v":1.20825475050129,"d":"1.21"},{"v":1.59057023632197,"d":"1.59"},{"v":0.930012577484961,"d":"0.93"},{"v":0.337414046725951,"d":"0.34"},{"v":-1.56740805985098,"d":"-1.57"},{"v":0.000269639127834955,"d":"0.00"},{"v":0.0168851032585912,"d":"0.02"},"down","yes"]
["MSTRG.22145","GPC3","ENSOART00000013247","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001822(kidney development);GO:0005764(lysosome);GO:0005886(plasma membrane);GO:0008285(negative regulation of cell population proliferation);GO:0009617(response to bacterium);GO:0009887(animal organ morphogenesis);GO:0009948(anterior/posterior axis specification);GO:0009966(regulation of signal transduction);GO:0010171(body morphogenesis);GO:0010466(negative regulation of peptidase activity);GO:0016020(membrane);GO:0030282(bone mineralization);GO:0030316(osteoclast differentiation);GO:0030324(lung development);GO:0030513(positive regulation of BMP signaling pathway);GO:0031225(anchored component of membrane);GO:0035116(embryonic hindlimb morphogenesis);GO:0040008(regulation of growth);GO:0045732(positive regulation of protein catabolic process);GO:0045807(positive regulation of endocytosis);GO:0045879(negative regulation of smoothened signaling pathway);GO:0045880(positive regulation of smoothened signaling pathway);GO:0045926(negative regulation of growth);GO:0046326(positive regulation of glucose import);GO:0046658(anchored component of plasma membrane);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060422(peptidyl-dipeptidase inhibitor activity);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0060976(coronary vasculature development);GO:0062023(collagen-containing extracellular matrix);GO:0072111(cell proliferation involved in kidney development);GO:0072138(mesenchymal cell proliferation involved in ureteric bud development);GO:0072180(mesonephric duct morphogenesis);GO:0072203(cell proliferation involved in metanephros development);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:2000050(regulation of non-canonical Wnt signaling pathway);GO:2000096(positive regulation of Wnt signaling pathway, planar cell polarity pathway)","05205(Proteoglycans in cancer)","K08109","NA","glypican 3 [Source:NCBI gene;Acc:101119285]",{"v":6.116109,"d":"6.12"},{"v":5.073216,"d":"5.07"},{"v":7.209566,"d":"7.21"},{"v":13.811106,"d":"13.81"},{"v":14.810191,"d":"14.81"},{"v":16.786129,"d":"16.79"},{"v":0.405195639145016,"d":"0.41"},{"v":-1.30330944744553,"d":"-1.30"},{"v":0.000269905190500508,"d":"0.00"},{"v":0.0168851032585912,"d":"0.02"},"down","yes"]
["MSTRG.4944","ENSOARG00000005107","ENSOART00000005564","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","03040(Spliceosome)","K12741","NA","heterogeneous nuclear ribonucleoprotein A1-like [Source:NCBI gene;Acc:101109899]",{"v":4.593869,"d":"4.59"},{"v":3.28404,"d":"3.28"},{"v":4.933273,"d":"4.93"},{"v":9.389156,"d":"9.39"},{"v":10.528856,"d":"10.53"},{"v":14.682058,"d":"14.68"},{"v":0.370264626632258,"d":"0.37"},{"v":-1.43337136719762,"d":"-1.43"},{"v":0.000274693304307556,"d":"0.00"},{"v":0.0169586300442999,"d":"0.02"},"down","yes"]
["MSTRG.19972","ARMH4","ENSOART00000022996","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","armadillo-like helical domain containing 4 [Source:NCBI gene;Acc:101122031]",{"v":0.09921,"d":"0.10"},{"v":0.054107,"d":"0.05"},{"v":0.125815,"d":"0.13"},{"v":0.436714,"d":"0.44"},{"v":0.282773,"d":"0.28"},{"v":0.282641,"d":"0.28"},{"v":0.278539268436767,"d":"0.28"},{"v":-1.84404736198857,"d":"-1.84"},{"v":0.000275445478439094,"d":"0.00"},{"v":0.0169586300442999,"d":"0.02"},"down","yes"]
["MSTRG.20200","VASH1","ENSOART00000002331","GO:0001525(angiogenesis);GO:0001937(negative regulation of endothelial cell proliferation);GO:0003779(actin binding);GO:0004181(metallocarboxypeptidase activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0006508(proteolysis);GO:0009611(response to wounding);GO:0010596(negative regulation of endothelial cell migration);GO:0016525(negative regulation of angiogenesis);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0045177(apical part of cell);GO:0045765(regulation of angiogenesis);GO:0060674(placenta blood vessel development);GO:0060716(labyrinthine layer blood vessel development);GO:1901491(negative regulation of lymphangiogenesis);GO:2000772(regulation of cellular senescence)","NA","NA","NA","vasohibin 1 [Source:NCBI gene;Acc:101112736]",{"v":5.932059,"d":"5.93"},{"v":3.048963,"d":"3.05"},{"v":4.296799,"d":"4.30"},{"v":8.893504,"d":"8.89"},{"v":13.172596,"d":"13.17"},{"v":13.52056,"d":"13.52"},{"v":0.373112312310287,"d":"0.37"},{"v":-1.42231812654207,"d":"-1.42"},{"v":0.000276733306242597,"d":"0.00"},{"v":0.0169586300442999,"d":"0.02"},"down","yes"]
["MSTRG.7852","ENSOARG00000014601","ENSOART00000015891","GO:0005515(protein binding)","NA","NA","NA",null,{"v":1.247181,"d":"1.25"},{"v":0.595504,"d":"0.60"},{"v":0.48297,"d":"0.48"},{"v":2.474338,"d":"2.47"},{"v":3.556596,"d":"3.56"},{"v":3.371745,"d":"3.37"},{"v":0.24733961459282,"d":"0.25"},{"v":-2.01543477064851,"d":"-2.02"},{"v":0.000286731762800461,"d":"0.00"},{"v":0.0173398378629849,"d":"0.02"},"down","yes"]
["MSTRG.2031","RFTN1","ENSOART00000016799","GO:0001765(membrane raft assembly);GO:0003725(double-stranded RNA binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0032991(protein-containing complex);GO:0033227(dsRNA transport);GO:0034138(toll-like receptor 3 signaling pathway);GO:0040010(positive regulation of growth rate);GO:0043330(response to exogenous dsRNA);GO:0045121(membrane raft);GO:0050853(B cell receptor signaling pathway)","NA","NA","NA","raftlin, lipid raft linker 1 [Source:HGNC Symbol;Acc:HGNC:30278]",{"v":3.63953518186046,"d":"3.64"},{"v":2.58290153627907,"d":"2.58"},{"v":2.95047959302326,"d":"2.95"},{"v":9.01655900976744,"d":"9.02"},{"v":5.76809808604651,"d":"5.77"},{"v":7.4781453855814,"d":"7.48"},{"v":0.412028823362577,"d":"0.41"},{"v":-1.27918283061541,"d":"-1.28"},{"v":0.000300947796631798,"d":"0.00"},{"v":0.0180657192036911,"d":"0.02"},"down","yes"]
["MSTRG.19328","CCDC112","ENSOART00000017808","NA","NA","NA","NA","coiled-coil domain containing 112 [Source:NCBI gene;Acc:101123303]",{"v":0.896470356233591,"d":"0.90"},{"v":0.0597670759805872,"d":"0.06"},{"v":0.390922995743496,"d":"0.39"},{"v":4.62111514161827,"d":"4.62"},{"v":2.99520841518816,"d":"3.00"},{"v":0.908588011456759,"d":"0.91"},{"v":0.158026322873885,"d":"0.16"},{"v":-2.66176320283583,"d":"-2.66"},{"v":0.000310171403658099,"d":"0.00"},{"v":0.0183495604309038,"d":"0.02"},"down","yes"]
["MSTRG.8204","DNAJA4","ENSOART00000000795","GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006457(protein folding);GO:0009408(response to heat);GO:0016020(membrane);GO:0031072(heat shock protein binding);GO:0042026(protein refolding);GO:0046872(metal ion binding);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding);GO:0090084(negative regulation of inclusion body assembly)","NA","K09505","NA","DnaJ heat shock protein family (Hsp40) member A4 [Source:NCBI gene;Acc:101121551]",{"v":3.68416263655947,"d":"3.68"},{"v":5.75186064009848,"d":"5.75"},{"v":7.44225312909679,"d":"7.44"},{"v":2.39230587751962,"d":"2.39"},{"v":2.04000578119711,"d":"2.04"},{"v":2.70174648684413,"d":"2.70"},{"v":2.36587312037219,"d":"2.37"},{"v":1.24237270532685,"d":"1.24"},{"v":0.000328666924270789,"d":"0.00"},{"v":0.0191659769267623,"d":"0.02"},"up","yes"]
["MSTRG.11577","ENSOARG00000009518","ENSOART00000010364","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001841(neural tube formation);GO:0002328(pro-B cell differentiation);GO:0003183(mitral valve morphogenesis);GO:0003211(cardiac ventricle formation);GO:0003215(cardiac right ventricle morphogenesis);GO:0003289(atrial septum primum morphogenesis);GO:0003357(noradrenergic neuron differentiation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0007507(heart development);GO:0008284(positive regulation of cell population proliferation);GO:0014009(glial cell proliferation);GO:0021510(spinal cord development);GO:0021522(spinal cord motor neuron differentiation);GO:0021782(glial cell development);GO:0030217(T cell differentiation);GO:0031018(endocrine pancreas development);GO:0032024(positive regulation of insulin secretion);GO:0035019(somatic stem cell population maintenance);GO:0035910(ascending aorta morphogenesis);GO:0042593(glucose homeostasis);GO:0044798(nuclear transcription factor complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0048485(sympathetic nervous system development);GO:0050821(protein stabilization);GO:0060174(limb bud formation);GO:0060412(ventricular septum morphogenesis);GO:0060548(negative regulation of cell death);GO:0060563(neuroepithelial cell differentiation);GO:0060993(kidney morphogenesis);GO:0071333(cellular response to glucose stimulus);GO:0090263(positive regulation of canonical Wnt signaling pathway)","NA","K09268","NA","SRY-box 4 [Source:NCBI gene;Acc:101110976]",{"v":2.16945853394919,"d":"2.17"},{"v":0.893798797690531,"d":"0.89"},{"v":1.56417770854503,"d":"1.56"},{"v":4.64495126789838,"d":"4.64"},{"v":3.77794404803695,"d":"3.78"},{"v":4.46819303879908,"d":"4.47"},{"v":0.35896387588448,"d":"0.36"},{"v":-1.47808942828908,"d":"-1.48"},{"v":0.000335207939433719,"d":"0.00"},{"v":0.0194271138341081,"d":"0.02"},"down","yes"]
["MSTRG.19606","RF00009","ENSOART00000025817","NA","NA","NA","NA","ribonuclease P RNA component H1 [Source:HGNC Symbol;Acc:HGNC:19273]",{"v":4998.9375,"d":"4998.94"},{"v":4005.466064,"d":"4005.47"},{"v":3011.48877,"d":"3011.49"},{"v":6796.665039,"d":"6796.67"},{"v":10879.180664,"d":"10879.18"},{"v":15199.039062,"d":"15199.04"},{"v":0.365503709591482,"d":"0.37"},{"v":-1.45204204635103,"d":"-1.45"},{"v":0.000335524626483249,"d":"0.00"},{"v":0.0194271138341081,"d":"0.02"},"down","yes"]
["MSTRG.8484","RTL1","ENSOART00000015109","NA","NA","NA","NA","retrotransposon Gag like 1 [Source:NCBI gene;Acc:101123586]",{"v":1.131946,"d":"1.13"},{"v":1.070363,"d":"1.07"},{"v":1.058577,"d":"1.06"},{"v":1.66182,"d":"1.66"},{"v":3.474294,"d":"3.47"},{"v":4.320619,"d":"4.32"},{"v":0.344821620743654,"d":"0.34"},{"v":-1.53607785885439,"d":"-1.54"},{"v":0.000343816099191601,"d":"0.00"},{"v":0.0196976465529841,"d":"0.02"},"down","yes"]
["ENSOARG00000012259","FMO3","ENSOART00000013330","GO:0004497(monooxygenase activity);GO:0004499(N,N-dimethylaniline monooxygenase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0031090(organelle membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0050660(flavin adenine dinucleotide binding);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process)","00982(Drug metabolism - cytochrome P450)","K00485","EC:1.14.13.8","flavin containing monooxygenase 3 [Source:NCBI gene;Acc:101104165]",{"v":1.308762,"d":"1.31"},{"v":1.740859,"d":"1.74"},{"v":1.522451,"d":"1.52"},{"v":0.488004,"d":"0.49"},{"v":0.713059,"d":"0.71"},{"v":0.599084,"d":"0.60"},{"v":2.53983258033927,"d":"2.54"},{"v":1.34473340114121,"d":"1.34"},{"v":0.000351229976348903,"d":"0.00"},{"v":0.0199821709192505,"d":"0.02"},"up","yes"]
["MSTRG.9175","LRRC2","ENSOART00000008973","GO:0005515(protein binding)","NA","NA","NA","leucine rich repeat containing 2 [Source:NCBI gene;Acc:101116941]",{"v":9.6202043939785,"d":"9.62"},{"v":16.0765817466667,"d":"16.08"},{"v":12.297017238853,"d":"12.30"},{"v":6.85753697060932,"d":"6.86"},{"v":5.52326933419355,"d":"5.52"},{"v":4.77998509820789,"d":"4.78"},{"v":2.21398899894747,"d":"2.21"},{"v":1.14664805355426,"d":"1.15"},{"v":0.00037697221817894,"d":"0.00"},{"v":0.0211876880341178,"d":"0.02"},"up","yes"]
["MSTRG.756","ENSOARG00000013007","ENSOART00000014136","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA","histone H3 [Source:NCBI gene;Acc:101121897]",{"v":2.454517,"d":"2.45"},{"v":1.096882,"d":"1.10"},{"v":2.539039,"d":"2.54"},{"v":10.083012,"d":"10.08"},{"v":3.117378,"d":"3.12"},{"v":10.715644,"d":"10.72"},{"v":0.254659196420276,"d":"0.25"},{"v":-1.97336027715964,"d":"-1.97"},{"v":0.000383323833390485,"d":"0.00"},{"v":0.0211876880341178,"d":"0.02"},"down","yes"]
["ENSOARG00000012678","ENSOARG00000012678","ENSOART00000013787","NA","NA","NA","NA",null,{"v":0.439618,"d":"0.44"},{"v":0.872911,"d":"0.87"},{"v":1.407089,"d":"1.41"},{"v":0.148069,"d":"0.15"},{"v":0.355558,"d":"0.36"},{"v":0.275962,"d":"0.28"},{"v":3.48852792946027,"d":"3.49"},{"v":1.8026183840313,"d":"1.80"},{"v":0.000389861778486334,"d":"0.00"},{"v":0.0212898432077755,"d":"0.02"},"up","yes"]
["MSTRG.12464","PYROXD2;MIR1287","ENSOART00000012798;ENSOART00000026450","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","NA","NA","NA","pyridine nucleotide-disulphide oxidoreductase domain 2 [Source:NCBI gene;Acc:101117632];microRNA 1287 [Source:HGNC Symbol;Acc:HGNC:35280]",{"v":1.70462637708091,"d":"1.70"},{"v":1.49043453581107,"d":"1.49"},{"v":1.32454447773906,"d":"1.32"},{"v":3.86983525900116,"d":"3.87"},{"v":3.42517091444057,"d":"3.43"},{"v":3.95686144560588,"d":"3.96"},{"v":0.401676018919746,"d":"0.40"},{"v":-1.3158957634973,"d":"-1.32"},{"v":0.000392421018486523,"d":"0.00"},{"v":0.0213581679661598,"d":"0.02"},"down","yes"]
["MSTRG.11452","ENSOARG00000009196","ENSOART00000010004","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 1 [Source:NCBI gene;Acc:101120200]",{"v":1.753872,"d":"1.75"},{"v":1.284302,"d":"1.28"},{"v":2.142804,"d":"2.14"},{"v":6.676388,"d":"6.68"},{"v":2.574014,"d":"2.57"},{"v":12.279468,"d":"12.28"},{"v":0.240641397277364,"d":"0.24"},{"v":-2.05504324576752,"d":"-2.06"},{"v":0.000399097901331637,"d":"0.00"},{"v":0.0216156567818154,"d":"0.02"},"down","yes"]
["MSTRG.3807","RF00026","ENSOART00000026883","NA","NA","NA","NA","RNA, U6 small nuclear 1205, pseudogene [Source:HGNC Symbol;Acc:HGNC:48168]",{"v":2.93669565872074,"d":"2.94"},{"v":4.15431893571351,"d":"4.15"},{"v":5.22960718908424,"d":"5.23"},{"v":2.13209001305145,"d":"2.13"},{"v":2.16166218725057,"d":"2.16"},{"v":1.06168409427246,"d":"1.06"},{"v":2.30058226927288,"d":"2.30"},{"v":1.20199904842107,"d":"1.20"},{"v":0.000412872139016367,"d":"0.00"},{"v":0.022102873068391,"d":"0.02"},"up","yes"]
["MSTRG.17079","ENSOARG00000008467","ENSOART00000009210","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":0.375723037418808,"d":"0.38"},{"v":1.37493905634002,"d":"1.37"},{"v":2.70947806389438,"d":"2.71"},{"v":0.385254179469077,"d":"0.39"},{"v":0.521048895156735,"d":"0.52"},{"v":0.326647923185541,"d":"0.33"},{"v":3.61745127387101,"d":"3.62"},{"v":1.85497358416043,"d":"1.85"},{"v":0.000414434572341468,"d":"0.00"},{"v":0.0221140120823251,"d":"0.02"},"up","yes"]
["MSTRG.18130","CFD","ENSOART00000010642","GO:0004252(serine-type endopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0006957(complement activation, alternative pathway);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0009617(response to bacterium);GO:0016787(hydrolase activity)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)","K01334","EC:3.4.21.46","complement factor D [Source:NCBI gene;Acc:101115705]",{"v":2.742696,"d":"2.74"},{"v":1.723073,"d":"1.72"},{"v":1.906426,"d":"1.91"},{"v":4.510008,"d":"4.51"},{"v":6.981595,"d":"6.98"},{"v":6.724581,"d":"6.72"},{"v":0.34980954298661,"d":"0.35"},{"v":-1.51535844761847,"d":"-1.52"},{"v":0.000425844947864845,"d":"0.00"},{"v":0.0225468757520931,"d":"0.02"},"down","yes"]
["MSTRG.9671","NR4A3","ENSOART00000011899","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001223(transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001707(mesoderm formation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0007369(gastrulation);GO:0007411(axon guidance);GO:0008270(zinc ion binding);GO:0009444(pyruvate oxidation);GO:0010828(positive regulation of glucose transmembrane transport);GO:0019901(protein kinase binding);GO:0021766(hippocampus development);GO:0030522(intracellular receptor signaling pathway);GO:0030534(adult behavior);GO:0032765(positive regulation of mast cell cytokine production);GO:0035035(histone acetyltransferase binding);GO:0035497(cAMP response element binding);GO:0035726(common myeloid progenitor cell proliferation);GO:0038097(positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway);GO:0042472(inner ear morphogenesis);GO:0042542(response to hydrogen peroxide);GO:0042629(mast cell granule);GO:0043066(negative regulation of apoptotic process);GO:0043303(mast cell degranulation);GO:0043401(steroid hormone mediated signaling pathway);GO:0043524(negative regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0044320(cellular response to leptin stimulus);GO:0045333(cellular respiration);GO:0045444(fat cell differentiation);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046321(positive regulation of fatty acid oxidation);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048660(regulation of smooth muscle cell proliferation);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0048752(semicircular canal morphogenesis);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050885(neuromuscular process controlling balance);GO:0060005(vestibular reflex);GO:0071376(cellular response to corticotropin-releasing hormone stimulus);GO:0071870(cellular response to catecholamine stimulus);GO:0097009(energy homeostasis);GO:1900625(positive regulation of monocyte aggregation);GO:1903204(negative regulation of oxidative stress-induced neuron death);GO:1903208(negative regulation of hydrogen peroxide-induced neuron death);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration);GO:2000108(positive regulation of leukocyte apoptotic process);GO:2000253(positive regulation of feeding behavior)","05202(Transcriptional misregulation in cancer)","K08559","NA","nuclear receptor subfamily 4 group A member 3 [Source:NCBI gene;Acc:101122759]",{"v":4.01904567432801,"d":"4.02"},{"v":3.57629895675886,"d":"3.58"},{"v":6.68377333086612,"d":"6.68"},{"v":2.00648403259317,"d":"2.01"},{"v":2.29216584287755,"d":"2.29"},{"v":2.06043520555772,"d":"2.06"},{"v":2.2454673557605,"d":"2.25"},{"v":1.16701574860389,"d":"1.17"},{"v":0.000435682000714119,"d":"0.00"},{"v":0.0228740054908686,"d":"0.02"},"up","yes"]
["MSTRG.5417","ENSOARG00000000123","ENSOART00000000128","GO:0005576(extracellular region);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0050902(leukocyte adhesive activation);GO:0050918(positive chemotaxis);GO:0060326(cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04668(TNF signaling pathway);05163(Human cytomegalovirus infection)","K05508","NA","C-X3-C motif chemokine ligand 1 [Source:NCBI gene;Acc:101119927]",{"v":12.6739912234848,"d":"12.67"},{"v":6.90162806818182,"d":"6.90"},{"v":11.8153746212121,"d":"11.82"},{"v":6.29738257954545,"d":"6.30"},{"v":2.36565710606061,"d":"2.37"},{"v":4.13733003156566,"d":"4.14"},{"v":2.45235056537216,"d":"2.45"},{"v":1.29416522812041,"d":"1.29"},{"v":0.000437993054600155,"d":"0.00"},{"v":0.0229216365240748,"d":"0.02"},"up","yes"]
["MSTRG.2948","RF00602","ENSOART00000024634","NA","NA","NA","NA",null,{"v":30.436747,"d":"30.44"},{"v":30.783768,"d":"30.78"},{"v":22.536667,"d":"22.54"},{"v":48.756802,"d":"48.76"},{"v":74.685951,"d":"74.69"},{"v":118.673416,"d":"118.67"},{"v":0.345937994748298,"d":"0.35"},{"v":-1.53141461970022,"d":"-1.53"},{"v":0.000445361017979298,"d":"0.00"},{"v":0.0230852530208444,"d":"0.02"},"down","yes"]
["MSTRG.5886","ENSOARG00000012344","ENSOART00000013423","NA","04141(Protein processing in endoplasmic reticulum)","K14019","NA","protein phosphatase 1 regulatory subunit 15A [Source:NCBI gene;Acc:101102415]",{"v":37.5147809382837,"d":"37.51"},{"v":28.096511398328,"d":"28.10"},{"v":41.9488737442833,"d":"41.95"},{"v":18.5850909685272,"d":"18.59"},{"v":15.490047529137,"d":"15.49"},{"v":18.0808956938776,"d":"18.08"},{"v":2.0622765466769,"d":"2.06"},{"v":1.04423780785999,"d":"1.04"},{"v":0.000454216892555493,"d":"0.00"},{"v":0.0233957521187574,"d":"0.02"},"up","yes"]
["MSTRG.3215","ORMDL3","ENSOART00000013404","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006672(ceramide metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035339(SPOTS complex);GO:0090156(cellular sphingolipid homeostasis);GO:1900060(negative regulation of ceramide biosynthetic process)","NA","NA","NA","ORMDL sphingolipid biosynthesis regulator 3 [Source:NCBI gene;Acc:101105342]",{"v":14.1541936482717,"d":"14.15"},{"v":19.297846202547,"d":"19.30"},{"v":15.756159742268,"d":"15.76"},{"v":6.21147935900546,"d":"6.21"},{"v":7.52685411097635,"d":"7.53"},{"v":8.50712358702244,"d":"8.51"},{"v":2.21205612754955,"d":"2.21"},{"v":1.14538799222275,"d":"1.15"},{"v":0.000464207452225345,"d":"0.00"},{"v":0.0238351549683504,"d":"0.02"},"up","yes"]
["MSTRG.9338","PXDN","ENSOART00000005754","GO:0004601(peroxidase activity);GO:0005201(extracellular matrix structural constituent);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0006979(response to oxidative stress);GO:0020037(heme binding);GO:0030198(extracellular matrix organization);GO:0042744(hydrogen peroxide catabolic process);GO:0055114(oxidation-reduction process);GO:0062023(collagen-containing extracellular matrix);GO:0098869(cellular oxidant detoxification)","NA","K19511","EC:1.11.1.7","peroxidasin [Source:NCBI gene;Acc:101112956]",{"v":8.242326,"d":"8.24"},{"v":4.283007,"d":"4.28"},{"v":6.360117,"d":"6.36"},{"v":14.144204,"d":"14.14"},{"v":16.449448,"d":"16.45"},{"v":15.619035,"d":"15.62"},{"v":0.408663750714171,"d":"0.41"},{"v":-1.29101381576721,"d":"-1.29"},{"v":0.000466804846238934,"d":"0.00"},{"v":0.0238933841046687,"d":"0.02"},"down","yes"]
["MSTRG.2793","DOC2B","ENSOART00000013138","GO:0005509(calcium ion binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008104(protein localization);GO:0016020(membrane);GO:0019905(syntaxin binding);GO:0031340(positive regulation of vesicle fusion);GO:0032024(positive regulation of insulin secretion);GO:0045956(positive regulation of calcium ion-dependent exocytosis);GO:0048791(calcium ion-regulated exocytosis of neurotransmitter);GO:0061669(spontaneous neurotransmitter secretion);GO:0098793(presynapse)","NA","NA","NA","double C2 domain beta [Source:HGNC Symbol;Acc:HGNC:2986]",{"v":1.462411,"d":"1.46"},{"v":0.59153,"d":"0.59"},{"v":0.421482,"d":"0.42"},{"v":2.342929,"d":"2.34"},{"v":3.160603,"d":"3.16"},{"v":2.986585,"d":"2.99"},{"v":0.291565239913655,"d":"0.29"},{"v":-1.77810936148239,"d":"-1.78"},{"v":0.000468542091306696,"d":"0.00"},{"v":0.0239073602089242,"d":"0.02"},"down","yes"]
["MSTRG.21032","KLHL38","ENSOART00000010796","GO:0005515(protein binding)","NA","K13959","NA","kelch like family member 38 [Source:NCBI gene;Acc:101107608]",{"v":21.2273965691665,"d":"21.23"},{"v":20.278987842378,"d":"20.28"},{"v":30.3299882865985,"d":"30.33"},{"v":13.1038670729811,"d":"13.10"},{"v":10.0283997741471,"d":"10.03"},{"v":11.3952220529725,"d":"11.40"},{"v":2.08055595661732,"d":"2.08"},{"v":1.05696909023257,"d":"1.06"},{"v":0.000478800413992641,"d":"0.00"},{"v":0.024203879751306,"d":"0.02"},"up","yes"]
["MSTRG.4266","ATF3","ENSOART00000011421","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006094(gluconeogenesis);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010628(positive regulation of gene expression);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0034198(cellular response to amino acid starvation);GO:0035914(skeletal muscle cell differentiation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:1903984(positive regulation of TRAIL-activated apoptotic signaling pathway);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress);GO:1990622(CHOP-ATF3 complex)","NA","K09032","NA","activating transcription factor 3 [Source:NCBI gene;Acc:101116073]",{"v":43.9845430987149,"d":"43.98"},{"v":22.5317088737885,"d":"22.53"},{"v":50.7077454420274,"d":"50.71"},{"v":17.0941582403618,"d":"17.09"},{"v":17.6796898875727,"d":"17.68"},{"v":17.2053887250341,"d":"17.21"},{"v":2.25520812754749,"d":"2.26"},{"v":1.17326058236087,"d":"1.17"},{"v":0.000487995269727991,"d":"0.00"},{"v":0.0245010527707304,"d":"0.02"},"up","yes"]
["MSTRG.10502","ENSOARG00000023771","ENSOART00000025673","NA","NA","NA","NA",null,{"v":458.92807,"d":"458.93"},{"v":290.162933,"d":"290.16"},{"v":475.526154,"d":"475.53"},{"v":1014.203674,"d":"1014.20"},{"v":974.313843,"d":"974.31"},{"v":882.647278,"d":"882.65"},{"v":0.426522768436216,"d":"0.43"},{"v":-1.22930533802547,"d":"-1.23"},{"v":0.000488988014744387,"d":"0.00"},{"v":0.0245010527707304,"d":"0.02"},"down","yes"]
["MSTRG.3231","IGFBP4","ENSOART00000015894","GO:0001558(regulation of cell growth);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010906(regulation of glucose metabolic process);GO:0040008(regulation of growth);GO:0043410(positive regulation of MAPK cascade);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation)","NA","NA","NA","insulin like growth factor binding protein 4 [Source:NCBI gene;Acc:443470]",{"v":8.10619,"d":"8.11"},{"v":4.583793,"d":"4.58"},{"v":6.007769,"d":"6.01"},{"v":12.677684,"d":"12.68"},{"v":15.875178,"d":"15.88"},{"v":17.743656,"d":"17.74"},{"v":0.403869509149695,"d":"0.40"},{"v":-1.30803886357526,"d":"-1.31"},{"v":0.000491946599118818,"d":"0.00"},{"v":0.0245642326312295,"d":"0.02"},"down","yes"]
["MSTRG.19673","NUSAP1","ENSOART00000022159","GO:0000070(mitotic sister chromatid segregation);GO:0000226(microtubule cytoskeleton organization);GO:0000281(mitotic cytokinesis);GO:0005730(nucleolus);GO:0005819(spindle);GO:0005874(microtubule);GO:0005876(spindle microtubule);GO:0007076(mitotic chromosome condensation);GO:0008017(microtubule binding);GO:0040001(establishment of mitotic spindle localization);GO:0045840(positive regulation of mitotic nuclear division)","NA","NA","NA","nucleolar and spindle associated protein 1 [Source:NCBI gene;Acc:101112734]",{"v":0.217608881299612,"d":"0.22"},{"v":0.153523447480155,"d":"0.15"},{"v":0.298881010707033,"d":"0.30"},{"v":2.8533234816319,"d":"2.85"},{"v":0.196206134576334,"d":"0.20"},{"v":0.821142001292228,"d":"0.82"},{"v":0.173100021313477,"d":"0.17"},{"v":-2.5303221925465,"d":"-2.53"},{"v":0.000508825277930463,"d":"0.00"},{"v":0.0252525809667131,"d":"0.03"},"down","yes"]
["ENSOARG00000011935","DDX25","ENSOART00000012983","GO:0003676(nucleic acid binding);GO:0004004(ATP-dependent RNA helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006406(mRNA export from nucleus);GO:0006417(regulation of translation);GO:0007286(spermatid development);GO:0033391(chromatoid body)","NA","K18656","EC:3.6.4.13","DEAD-box helicase 25 [Source:NCBI gene;Acc:101113022]",{"v":0.632839,"d":"0.63"},{"v":0.84461,"d":"0.84"},{"v":0.776165,"d":"0.78"},{"v":0.375699,"d":"0.38"},{"v":0.073009,"d":"0.07"},{"v":0.128859,"d":"0.13"},{"v":3.90190921572735,"d":"3.90"},{"v":1.96418021168769,"d":"1.96"},{"v":0.000524509797338381,"d":"0.00"},{"v":0.0258737038397012,"d":"0.03"},"up","yes"]
["ENSOARG00000006897","CRISPLD1","ENSOART00000007501","GO:0005576(extracellular region);GO:0060325(face morphogenesis)","NA","NA","NA","cysteine rich secretory protein LCCL domain containing 1 [Source:NCBI gene;Acc:101109455]",{"v":0.19606,"d":"0.20"},{"v":0.293056,"d":"0.29"},{"v":0.250213,"d":"0.25"},{"v":1.509631,"d":"1.51"},{"v":0.547433,"d":"0.55"},{"v":0.835433,"d":"0.84"},{"v":0.255602339431986,"d":"0.26"},{"v":-1.96802705409745,"d":"-1.97"},{"v":0.000535019187018793,"d":"0.00"},{"v":0.0262693336798768,"d":"0.03"},"down","yes"]
["MSTRG.21282","ENSOARG00000014618","ENSOART00000015910","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005885(Arp2/3 protein complex);GO:0015629(actin cytoskeleton);GO:0030833(regulation of actin filament polymerization);GO:0034314(Arp2/3 complex-mediated actin nucleation)","NA","NA","NA","actin-related protein 2/3 complex subunit 1A pseudogene [Source:NCBI gene;Acc:101105166]",{"v":8.694447,"d":"8.69"},{"v":5.510412,"d":"5.51"},{"v":4.145494,"d":"4.15"},{"v":12.394791,"d":"12.39"},{"v":15.532278,"d":"15.53"},{"v":18.88941,"d":"18.89"},{"v":0.391963543435208,"d":"0.39"},{"v":-1.35120861950383,"d":"-1.35"},{"v":0.00053864169327251,"d":"0.00"},{"v":0.0262693336798768,"d":"0.03"},"down","yes"]
["MSTRG.745","RF00003","ENSOART00000024392","NA","NA","NA","NA",null,{"v":2.566969,"d":"2.57"},{"v":2.672542,"d":"2.67"},{"v":3.10278,"d":"3.10"},{"v":6.392491,"d":"6.39"},{"v":16.414682,"d":"16.41"},{"v":8.464715,"d":"8.46"},{"v":0.266766464500001,"d":"0.27"},{"v":-1.90635077971592,"d":"-1.91"},{"v":0.000540939729144395,"d":"0.00"},{"v":0.0262693336798768,"d":"0.03"},"down","yes"]
["MSTRG.879","EFNA1","ENSOART00000003960","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001934(positive regulation of protein phosphorylation);GO:0003180(aortic valve morphogenesis);GO:0003183(mitral valve morphogenesis);GO:0003199(endocardial cushion to mesenchymal transition involved in heart valve formation);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0014028(notochord formation);GO:0016020(membrane);GO:0016477(cell migration);GO:0030182(neuron differentiation);GO:0033628(regulation of cell adhesion mediated by integrin);GO:0034446(substrate adhesion-dependent cell spreading);GO:0043409(negative regulation of MAPK cascade);GO:0043410(positive regulation of MAPK cascade);GO:0043535(regulation of blood vessel endothelial cell migration);GO:0045765(regulation of angiogenesis);GO:0046658(anchored component of plasma membrane);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050770(regulation of axonogenesis);GO:0050821(protein stabilization);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070244(negative regulation of thymocyte apoptotic process);GO:1902004(positive regulation of amyloid-beta formation);GO:1902961(positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:1903051(negative regulation of proteolysis involved in cellular protein catabolic process)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04360(Axon guidance)","K05462","NA","ephrin A1 [Source:NCBI gene;Acc:101105624]",{"v":2.422575,"d":"2.42"},{"v":1.346047,"d":"1.35"},{"v":1.432153,"d":"1.43"},{"v":4.749628,"d":"4.75"},{"v":3.724701,"d":"3.72"},{"v":4.798887,"d":"4.80"},{"v":0.391824784588754,"d":"0.39"},{"v":-1.35171943778114,"d":"-1.35"},{"v":0.000541763918359463,"d":"0.00"},{"v":0.0262693336798768,"d":"0.03"},"down","yes"]
["MSTRG.6284","APOA1","ENSOART00000002803","GO:0001540(amyloid-beta binding);GO:0001932(regulation of protein phosphorylation);GO:0001935(endothelial cell proliferation);GO:0002740(negative regulation of cytokine secretion involved in immune response);GO:0005102(signaling receptor binding);GO:0005319(lipid transporter activity);GO:0005543(phospholipid binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006644(phospholipid metabolic process);GO:0006656(phosphatidylcholine biosynthetic process);GO:0006695(cholesterol biosynthetic process);GO:0006869(lipid transport);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008035(high-density lipoprotein particle binding);GO:0008203(cholesterol metabolic process);GO:0008211(glucocorticoid metabolic process);GO:0008289(lipid binding);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0010873(positive regulation of cholesterol esterification);GO:0010875(positive regulation of cholesterol efflux);GO:0010903(negative regulation of very-low-density lipoprotein particle remodeling);GO:0015485(cholesterol binding);GO:0017127(cholesterol transporter activity);GO:0018158(protein oxidation);GO:0018206(peptidyl-methionine modification);GO:0019899(enzyme binding);GO:0019915(lipid storage);GO:0030139(endocytic vesicle);GO:0030300(regulation of intestinal cholesterol absorption);GO:0030301(cholesterol transport);GO:0030325(adrenal gland development);GO:0031072(heat shock protein binding);GO:0031410(cytoplasmic vesicle);GO:0032489(regulation of Cdc42 protein signal transduction);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0034115(negative regulation of heterotypic cell-cell adhesion);GO:0034190(apolipoprotein receptor binding);GO:0034191(apolipoprotein A-I receptor binding);GO:0034361(very-low-density lipoprotein particle);GO:0034364(high-density lipoprotein particle);GO:0034366(spherical high-density lipoprotein particle);GO:0034375(high-density lipoprotein particle remodeling);GO:0034380(high-density lipoprotein particle assembly);GO:0035025(positive regulation of Rho protein signal transduction);GO:0042157(lipoprotein metabolic process);GO:0042158(lipoprotein biosynthetic process);GO:0042632(cholesterol homeostasis);GO:0042802(identical protein binding);GO:0043534(blood vessel endothelial cell migration);GO:0043691(reverse cholesterol transport);GO:0045499(chemorepellent activity);GO:0050713(negative regulation of interleukin-1 beta secretion);GO:0050728(negative regulation of inflammatory response);GO:0050766(positive regulation of phagocytosis);GO:0050821(protein stabilization);GO:0050919(negative chemotaxis);GO:0051180(vitamin transport);GO:0051345(positive regulation of hydrolase activity);GO:0051346(negative regulation of hydrolase activity);GO:0051496(positive regulation of stress fiber assembly);GO:0055091(phospholipid homeostasis);GO:0060228(phosphatidylcholine-sterol O-acyltransferase activator activity);GO:0060354(negative regulation of cell adhesion molecule production);GO:0060761(negative regulation of response to cytokine stimulus);GO:0070328(triglyceride homeostasis);GO:0070508(cholesterol import);GO:0070653(high-density lipoprotein particle receptor binding);GO:0071813(lipoprotein particle binding);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1902995(positive regulation of phospholipid efflux)","NA","NA","NA","apolipoprotein A1 [Source:HGNC Symbol;Acc:HGNC:600]",{"v":0.876659,"d":"0.88"},{"v":0.705963,"d":"0.71"},{"v":0.449243,"d":"0.45"},{"v":2.37141,"d":"2.37"},{"v":1.727587,"d":"1.73"},{"v":2.894424,"d":"2.89"},{"v":0.290539494190325,"d":"0.29"},{"v":-1.78319380664578,"d":"-1.78"},{"v":0.000542948729096165,"d":"0.00"},{"v":0.0262693336798768,"d":"0.03"},"down","yes"]
["MSTRG.7156","FBXL7","ENSOART00000014236;ENSOART00000014235","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005813(centrosome);GO:0008283(cell population proliferation);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process)","NA","K10273","NA","F-box and leucine rich repeat protein 7 [Source:NCBI gene;Acc:101102932]",{"v":1.76809314367716,"d":"1.77"},{"v":0.866141493825013,"d":"0.87"},{"v":1.16001596955992,"d":"1.16"},{"v":2.85782659610367,"d":"2.86"},{"v":2.92830901130631,"d":"2.93"},{"v":3.41728961819447,"d":"3.42"},{"v":0.412265055026065,"d":"0.41"},{"v":-1.27835591616735,"d":"-1.28"},{"v":0.000587586019323908,"d":"0.00"},{"v":0.0279711502143463,"d":"0.03"},"down","yes"]
["MSTRG.15649","SOCS2","ENSOART00000017273","GO:0001558(regulation of cell growth);GO:0005131(growth hormone receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005737(cytoplasm);GO:0007595(lactation);GO:0008269(JAK pathway signal transduction adaptor activity);GO:0016567(protein ubiquitination);GO:0032355(response to estradiol);GO:0032870(cellular response to hormone stimulus);GO:0035556(intracellular signal transduction);GO:0040014(regulation of multicellular organism growth);GO:0040015(negative regulation of multicellular organism growth);GO:0045666(positive regulation of neuron differentiation);GO:0046426(negative regulation of receptor signaling pathway via JAK-STAT);GO:0060396(growth hormone receptor signaling pathway);GO:0060749(mammary gland alveolus development)","04630(Jak-STAT signaling pathway);04910(Insulin signaling pathway);04917(Prolactin signaling pathway);04930(Type II diabetes mellitus)","K04695","NA","suppressor of cytokine signaling 2 [Source:NCBI gene;Acc:101115017]",{"v":0.356085,"d":"0.36"},{"v":3.290121,"d":"3.29"},{"v":2.09309870676955,"d":"2.09"},{"v":7.13313632620133,"d":"7.13"},{"v":8.64375631076815,"d":"8.64"},{"v":9.69178004700105,"d":"9.69"},{"v":0.225347617364518,"d":"0.23"},{"v":-2.14977589859298,"d":"-2.15"},{"v":0.000603460905273244,"d":"0.00"},{"v":0.0285508649124258,"d":"0.03"},"down","yes"]
["MSTRG.6488","RF00319","ENSOART00000023984","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 23 [Source:HGNC Symbol;Acc:HGNC:32613]",{"v":8.398671,"d":"8.40"},{"v":8.586245,"d":"8.59"},{"v":7.033875,"d":"7.03"},{"v":13.592867,"d":"13.59"},{"v":26.787386,"d":"26.79"},{"v":31.71314,"d":"31.71"},{"v":0.333162166469263,"d":"0.33"},{"v":-1.58570351575115,"d":"-1.59"},{"v":0.000619314854919296,"d":"0.00"},{"v":0.0291185448283481,"d":"0.03"},"down","yes"]
["MSTRG.4916","REM1","ENSOART00000000839","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:1901842(negative regulation of high voltage-gated calcium channel activity)","NA","K07847","NA","RRAD and GEM like GTPase 1 [Source:NCBI gene;Acc:100302062]",{"v":1.79152,"d":"1.79"},{"v":0.935472,"d":"0.94"},{"v":1.342097,"d":"1.34"},{"v":3.131726,"d":"3.13"},{"v":4.270363,"d":"4.27"},{"v":3.946384,"d":"3.95"},{"v":0.358558283568195,"d":"0.36"},{"v":-1.47972044714457,"d":"-1.48"},{"v":0.000639694067892051,"d":"0.00"},{"v":0.0297972739171265,"d":"0.03"},"down","yes"]
["MSTRG.2228","ENSOARG00000011616","ENSOART00000012631;ENSOART00000012632","GO:0000166(nucleotide binding);GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006414(translational elongation);GO:0006414(translational elongation)","03013(RNA transport);05134(Legionellosis);05134(Legionellosis)","K03231","NA","elongation factor 1-alpha 1-like [Source:NCBI gene;Acc:101110773]",{"v":32.0721647086093,"d":"32.07"},{"v":48.0854198145695,"d":"48.09"},{"v":36.4478916516556,"d":"36.45"},{"v":92.5456029536424,"d":"92.55"},{"v":88.784735618543,"d":"88.78"},{"v":93.6489086821192,"d":"93.65"},{"v":0.424051914241354,"d":"0.42"},{"v":-1.23768719841541,"d":"-1.24"},{"v":0.00064231552756988,"d":"0.00"},{"v":0.0297972739171265,"d":"0.03"},"down","yes"]
["MSTRG.19402","CMYA5","ENSOART00000018981;ENSOART00000018985","GO:0005515(protein binding);GO:0005515(protein binding)","NA","K14079","EC:2.7.7.19","terminal nucleotidyltransferase 2 [Source:NCBI gene;Acc:101114360]",{"v":165.054380944763,"d":"165.05"},{"v":156.309621715833,"d":"156.31"},{"v":71.8403335322142,"d":"71.84"},{"v":58.8320227303327,"d":"58.83"},{"v":61.5211611184568,"d":"61.52"},{"v":53.6554405578475,"d":"53.66"},{"v":2.25968303314633,"d":"2.26"},{"v":1.17612041928723,"d":"1.18"},{"v":0.000644196331010881,"d":"0.00"},{"v":0.0297972739171265,"d":"0.03"},"up","yes"]
["MSTRG.3003","ENSOARG00000016680","ENSOART00000018164","GO:0005515(protein binding)","NA","NA","NA","tripartite motif containing 16 [Source:NCBI gene;Acc:101106187]",{"v":0.306911,"d":"0.31"},{"v":1.204757,"d":"1.20"},{"v":1.063385,"d":"1.06"},{"v":0.350123,"d":"0.35"},{"v":0.259242,"d":"0.26"},{"v":0.168367,"d":"0.17"},{"v":3.31097730323556,"d":"3.31"},{"v":1.72725712108776,"d":"1.73"},{"v":0.000677324700918483,"d":"0.00"},{"v":0.0310656115634747,"d":"0.03"},"up","yes"]
["MSTRG.16479","TUBA8","ENSOART00000014946","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007010(cytoskeleton organization);GO:0007017(microtubule-based process);GO:0015630(microtubule cytoskeleton)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction)","K07374","NA","tubulin alpha 8 [Source:NCBI gene;Acc:101118605]",{"v":11.6472763087161,"d":"11.65"},{"v":14.7624123397704,"d":"14.76"},{"v":15.4146619134916,"d":"15.41"},{"v":5.57297147025052,"d":"5.57"},{"v":6.72758757985386,"d":"6.73"},{"v":7.4038484191023,"d":"7.40"},{"v":2.12258859482781,"d":"2.12"},{"v":1.08582477175299,"d":"1.09"},{"v":0.000686739931211726,"d":"0.00"},{"v":0.0314092145569329,"d":"0.03"},"up","yes"]
["MSTRG.11984","RF00099","ENSOART00000024112","NA","NA","NA","NA","small nucleolar RNA, C/D box 22 [Source:HGNC Symbol;Acc:HGNC:10145]",{"v":5.715752,"d":"5.72"},{"v":7.356873,"d":"7.36"},{"v":4.080535,"d":"4.08"},{"v":15.564544,"d":"15.56"},{"v":16.998405,"d":"17.00"},{"v":22.196711,"d":"22.20"},{"v":0.313244457690205,"d":"0.31"},{"v":-1.67463911106598,"d":"-1.67"},{"v":0.000716594992499568,"d":"0.00"},{"v":0.032683136976349,"d":"0.03"},"down","yes"]
["MSTRG.19077","RASGEF1B","ENSOART00000000296","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005622(intracellular);GO:0007264(small GTPase mediated signal transduction);GO:0043547(positive regulation of GTPase activity)","NA","NA","NA","RasGEF domain family member 1B [Source:NCBI gene;Acc:101114193]",{"v":3.92680869043707,"d":"3.93"},{"v":5.30384558724942,"d":"5.30"},{"v":3.26220521524811,"d":"3.26"},{"v":2.26162794117647,"d":"2.26"},{"v":1.74219427538613,"d":"1.74"},{"v":1.9702811666119,"d":"1.97"},{"v":2.09116894898732,"d":"2.09"},{"v":1.06430962434727,"d":"1.06"},{"v":0.000733280847206309,"d":"0.00"},{"v":0.0333497068199183,"d":"0.03"},"up","yes"]
["MSTRG.11510","TRIM39","ENSOART00000015011","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process);GO:2001235(positive regulation of apoptotic signaling pathway)","NA","K12015","EC:2.3.2.27","E3 ubiquitin-protein ligase TRIM39 [Source:NCBI gene;Acc:101106373]",{"v":2.90506600223314,"d":"2.91"},{"v":4.25752413890129,"d":"4.26"},{"v":2.57449993300581,"d":"2.57"},{"v":1.79088947253238,"d":"1.79"},{"v":1.57336754399285,"d":"1.57"},{"v":1.27417546851273,"d":"1.27"},{"v":2.09921996397465,"d":"2.10"},{"v":1.06985334543366,"d":"1.07"},{"v":0.000735294858841903,"d":"0.00"},{"v":0.0333497068199183,"d":"0.03"},"up","yes"]
["MSTRG.5397","MT2A","ENSOART00000019964","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008144(drug binding);GO:0008270(zinc ion binding);GO:0035690(cellular response to drug);GO:0036016(cellular response to interleukin-3);GO:0036018(cellular response to erythropoietin);GO:0045926(negative regulation of growth);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0071294(cellular response to zinc ion)","04978(Mineral absorption)","K14739","NA","metallothionein-2 [Source:NCBI gene;Acc:101117955]",{"v":3.091027,"d":"3.09"},{"v":7.089145,"d":"7.09"},{"v":9.011033,"d":"9.01"},{"v":0.832691,"d":"0.83"},{"v":2.586367,"d":"2.59"},{"v":1.468296,"d":"1.47"},{"v":3.92670655737235,"d":"3.93"},{"v":1.97331978948847,"d":"1.97"},{"v":0.000772454252306985,"d":"0.00"},{"v":0.0349125171562342,"d":"0.03"},"up","yes"]
["MSTRG.8243","CYP1A2","ENSOART00000003636","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006706(steroid catabolic process);GO:0006725(cellular aromatic compound metabolic process);GO:0006778(porphyrin-containing compound metabolic process);GO:0009403(toxin biosynthetic process);GO:0009404(toxin metabolic process);GO:0009791(post-embryonic development);GO:0009820(alkaloid metabolic process);GO:0010468(regulation of gene expression);GO:0016098(monoterpenoid metabolic process);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0017144(drug metabolic process);GO:0018894(dibenzo-p-dioxin metabolic process);GO:0019899(enzyme binding);GO:0020037(heme binding);GO:0030324(lung development);GO:0032451(demethylase activity);GO:0032787(monocarboxylic acid metabolic process);GO:0034875(caffeine oxidase activity);GO:0042737(drug catabolic process);GO:0042738(exogenous drug catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045333(cellular respiration);GO:0046483(heterocycle metabolic process);GO:0046872(metal ion binding);GO:0050665(hydrogen peroxide biosynthetic process);GO:0055114(oxidation-reduction process);GO:0070330(aromatase activity);GO:0070989(oxidative demethylation);GO:0071276(cellular response to cadmium ion);GO:0071615(oxidative deethylation)","00140(Steroid hormone biosynthesis);00232(Caffeine metabolism);00380(Tryptophan metabolism);00591(Linoleic acid metabolism);00830(Retinol metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);05204(Chemical carcinogenesis)","K07409","EC:1.14.14.1","cytochrome P450 1A2 [Source:NCBI gene;Acc:101109214]",{"v":0.526078,"d":"0.53"},{"v":0.207322,"d":"0.21"},{"v":0.026404,"d":"0.03"},{"v":1.62527158817585,"d":"1.63"},{"v":1.456894,"d":"1.46"},{"v":1.06564974431531,"d":"1.07"},{"v":0.183181732814432,"d":"0.18"},{"v":-2.44865245221679,"d":"-2.45"},{"v":0.000776933904584372,"d":"0.00"},{"v":0.0349470435097896,"d":"0.03"},"down","yes"]
["MSTRG.750","ENSOARG00000012430","ENSOART00000013516","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05202(Transcriptional misregulation in cancer);05322(Systemic lupus erythematosus)","K11253","NA","histone H3 [Source:NCBI gene;Acc:101120877]",{"v":1.01352754237288,"d":"1.01"},{"v":0.699800525423729,"d":"0.70"},{"v":1.8299403559322,"d":"1.83"},{"v":3.53531061581921,"d":"3.54"},{"v":3.18262219774011,"d":"3.18"},{"v":5.8404604180791,"d":"5.84"},{"v":0.282143452460322,"d":"0.28"},{"v":-1.8254992247048,"d":"-1.83"},{"v":0.000781540663582378,"d":"0.00"},{"v":0.0350576811949809,"d":"0.04"},"down","yes"]
["MSTRG.17190","ASB15","ENSOART00000000831","GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction)","NA","K10337","NA","ankyrin repeat and SOCS box containing 15 [Source:NCBI gene;Acc:101106002]",{"v":15.4843008157541,"d":"15.48"},{"v":13.8667178362445,"d":"13.87"},{"v":11.4585498463218,"d":"11.46"},{"v":7.02549800235136,"d":"7.03"},{"v":7.80232938495129,"d":"7.80"},{"v":5.05169272186765,"d":"5.05"},{"v":2.05284475048747,"d":"2.05"},{"v":1.03762452556101,"d":"1.04"},{"v":0.000821760374633709,"d":"0.00"},{"v":0.0365604997193984,"d":"0.04"},"up","yes"]
["MSTRG.19646","BMF","ENSOART00000021901","GO:0006915(apoptotic process);GO:0010507(negative regulation of autophagy);GO:0034644(cellular response to UV);GO:0043065(positive regulation of apoptotic process);GO:0043276(anoikis)","05206(MicroRNAs in cancer)","K17460","NA","Bcl2 modifying factor [Source:NCBI gene;Acc:101108051]",{"v":0.928112,"d":"0.93"},{"v":0.804636586206896,"d":"0.80"},{"v":0.570257,"d":"0.57"},{"v":1.709046,"d":"1.71"},{"v":1.78137,"d":"1.78"},{"v":1.923095,"d":"1.92"},{"v":0.425418104111527,"d":"0.43"},{"v":-1.23304666488883,"d":"-1.23"},{"v":0.000824734646206846,"d":"0.00"},{"v":0.0365931176719168,"d":"0.04"},"down","yes"]
["MSTRG.9060","ENSOARG00000006615;ENSOARG00000006651;ENSOARG00000006608","ENSOART00000007190;ENSOART00000007228;ENSOART00000007181","GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0006302(double-strand break repair);GO:0006471(protein ADP-ribosylation);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0006471(protein ADP-ribosylation)","NA","NA","NA",null,{"v":0.679055609207854,"d":"0.68"},{"v":1.91759301936357,"d":"1.92"},{"v":2.23059403981043,"d":"2.23"},{"v":0.611305376844956,"d":"0.61"},{"v":0.749450106973595,"d":"0.75"},{"v":0.454406619363575,"d":"0.45"},{"v":2.65940031467124,"d":"2.66"},{"v":1.41110095979106,"d":"1.41"},{"v":0.000863673365090945,"d":"0.00"},{"v":0.0379087599602283,"d":"0.04"},"up","yes"]
["MSTRG.18786","SNCA","ENSOART00000020147","GO:0000149(SNARE binding);GO:0000287(magnesium ion binding);GO:0001774(microglial cell activation);GO:0001921(positive regulation of receptor recycling);GO:0001956(positive regulation of neurotransmitter secretion);GO:0001963(synaptic transmission, dopaminergic);GO:0003779(actin binding);GO:0005507(copper ion binding);GO:0005509(calcium ion binding);GO:0005543(phospholipid binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006631(fatty acid metabolic process);GO:0006638(neutral lipid metabolic process);GO:0006644(phospholipid metabolic process);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007006(mitochondrial membrane organization);GO:0007268(chemical synaptic transmission);GO:0008198(ferrous iron binding);GO:0008270(zinc ion binding);GO:0008344(adult locomotory behavior);GO:0010040(response to iron(II) ion);GO:0010517(regulation of phospholipase activity);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0014048(regulation of glutamate secretion);GO:0014059(regulation of dopamine secretion);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0016079(synaptic vesicle exocytosis);GO:0016082(synaptic vesicle priming);GO:0016234(inclusion body);GO:0016491(oxidoreductase activity);GO:0019894(kinesin binding);GO:0022898(regulation of transmembrane transporter activity);GO:0030424(axon);GO:0030426(growth cone);GO:0030544(Hsp70 protein binding);GO:0030672(synaptic vesicle membrane);GO:0031092(platelet alpha granule membrane);GO:0031115(negative regulation of microtubule polymerization);GO:0031623(receptor internalization);GO:0031648(protein destabilization);GO:0032026(response to magnesium ion);GO:0032410(negative regulation of transporter activity);GO:0032496(response to lipopolysaccharide);GO:0032769(negative regulation of monooxygenase activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034341(response to interferon-gamma);GO:0034599(cellular response to oxidative stress);GO:0035067(negative regulation of histone acetylation);GO:0035493(SNARE complex assembly);GO:0040012(regulation of locomotion);GO:0042393(histone binding);GO:0042416(dopamine biosynthetic process);GO:0042417(dopamine metabolic process);GO:0042493(response to drug);GO:0042775(mitochondrial ATP synthesis coupled electron transport);GO:0042802(identical protein binding);GO:0043014(alpha-tubulin binding);GO:0043025(neuronal cell body);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043030(regulation of macrophage activation);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0045202(synapse);GO:0045807(positive regulation of endocytosis);GO:0045920(negative regulation of exocytosis);GO:0045921(positive regulation of exocytosis);GO:0046928(regulation of neurotransmitter secretion);GO:0048156(tau protein binding);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048488(synaptic vesicle endocytosis);GO:0048489(synaptic vesicle transport);GO:0050544(arachidonic acid binding);GO:0050729(positive regulation of inflammatory response);GO:0050806(positive regulation of synaptic transmission);GO:0050808(synapse organization);GO:0050812(regulation of acyl-CoA biosynthetic process);GO:0051219(phosphoprotein binding);GO:0051259(protein complex oligomerization);GO:0051262(protein tetramerization);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051585(negative regulation of dopamine uptake involved in synaptic transmission);GO:0051612(negative regulation of serotonin uptake);GO:0051621(regulation of norepinephrine uptake);GO:0051622(negative regulation of norepinephrine uptake);GO:0055114(oxidation-reduction process);GO:0060079(excitatory postsynaptic potential);GO:0060291(long-term synaptic potentiation);GO:0060732(positive regulation of inositol phosphate biosynthetic process);GO:0061024(membrane organization);GO:0070495(negative regulation of thrombin-activated receptor signaling pathway);GO:0070555(response to interleukin-1);GO:0070840(dynein complex binding);GO:0071280(cellular response to copper ion);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0098794(postsynapse);GO:0099512(supramolecular fiber);GO:1901215(negative regulation of neuron death);GO:1901216(positive regulation of neuron death);GO:1903136(cuprous ion binding);GO:1903284(positive regulation of glutathione peroxidase activity);GO:1903285(positive regulation of hydrogen peroxide catabolic process);GO:1904715(negative regulation of chaperone-mediated autophagy);GO:1905606(regulation of presynapse assembly);GO:2000377(regulation of reactive oxygen species metabolic process)","NA","NA","NA","synuclein alpha [Source:HGNC Symbol;Acc:HGNC:11138]",{"v":0.278472711678832,"d":"0.28"},{"v":0.216013787591241,"d":"0.22"},{"v":0.133138640145985,"d":"0.13"},{"v":0.872094073722628,"d":"0.87"},{"v":0.84947096350365,"d":"0.85"},{"v":0.550568704379562,"d":"0.55"},{"v":0.276227199096335,"d":"0.28"},{"v":-1.8560727113181,"d":"-1.86"},{"v":0.0008772293154134,"d":"0.00"},{"v":0.0383397763905573,"d":"0.04"},"down","yes"]
["MSTRG.12125","CST6","ENSOART00000001444","GO:0001533(cornified envelope);GO:0004869(cysteine-type endopeptidase inhibitor activity);GO:0008544(epidermis development);GO:0010466(negative regulation of peptidase activity);GO:0010951(negative regulation of endopeptidase activity);GO:0030414(peptidase inhibitor activity)","NA","K13902","NA","cystatin E/M [Source:NCBI gene;Acc:101112685]",{"v":3.691345,"d":"3.69"},{"v":2.906252,"d":"2.91"},{"v":4.103526,"d":"4.10"},{"v":6.890021,"d":"6.89"},{"v":10.373903,"d":"10.37"},{"v":12.129792,"d":"12.13"},{"v":0.364061590579429,"d":"0.36"},{"v":-1.45774555405986,"d":"-1.46"},{"v":0.000878189390621534,"d":"0.00"},{"v":0.0383397763905573,"d":"0.04"},"down","yes"]
["MSTRG.12738","FUOM","ENSOART00000000710","GO:0005996(monosaccharide metabolic process);GO:0016853(isomerase activity);GO:0048029(monosaccharide binding)","NA","K02431","EC:5.1.3.29","fucose mutarotase [Source:NCBI gene;Acc:101113117]",{"v":5.922761,"d":"5.92"},{"v":4.070696,"d":"4.07"},{"v":5.252605,"d":"5.25"},{"v":14.581791,"d":"14.58"},{"v":9.625747,"d":"9.63"},{"v":16.881498,"d":"16.88"},{"v":0.371049396242832,"d":"0.37"},{"v":-1.43031683534359,"d":"-1.43"},{"v":0.000896091480228857,"d":"0.00"},{"v":0.0388100310057739,"d":"0.04"},"down","yes"]
["MSTRG.9216","MKRN2OS","ENSOART00000017381","NA","NA","NA","NA","MKRN2 opposite strand [Source:NCBI gene;Acc:101107556]",{"v":5.320766,"d":"5.32"},{"v":5.790473,"d":"5.79"},{"v":9.198376,"d":"9.20"},{"v":3.822886,"d":"3.82"},{"v":2.570127,"d":"2.57"},{"v":2.110645,"d":"2.11"},{"v":2.38833864202911,"d":"2.39"},{"v":1.25600741052993,"d":"1.26"},{"v":0.000902276853559533,"d":"0.00"},{"v":0.0389745409124869,"d":"0.04"},"up","yes"]
["MSTRG.2182","THSD1","ENSOART00000010221","GO:0005829(cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","thrombospondin type 1 domain containing 1 [Source:NCBI gene;Acc:101107367]",{"v":1.60108068421053,"d":"1.60"},{"v":0.837101037864445,"d":"0.84"},{"v":1.49630335024612,"d":"1.50"},{"v":3.17248526164332,"d":"3.17"},{"v":3.31607943544112,"d":"3.32"},{"v":3.39452847216963,"d":"3.39"},{"v":0.398102598542846,"d":"0.40"},{"v":-1.32878780649592,"d":"-1.33"},{"v":0.000905614029856922,"d":"0.00"},{"v":0.0390154772546275,"d":"0.04"},"down","yes"]
["MSTRG.12459","CRTAC1","ENSOART00000012485","GO:0005509(calcium ion binding);GO:0007413(axonal fasciculation);GO:0021772(olfactory bulb development);GO:0030426(growth cone);GO:1900121(negative regulation of receptor binding)","NA","NA","NA","cartilage acidic protein 1 [Source:NCBI gene;Acc:101110105]",{"v":0.273451,"d":"0.27"},{"v":0.267082,"d":"0.27"},{"v":0.578277393955185,"d":"0.58"},{"v":1.114549,"d":"1.11"},{"v":1.29382922720167,"d":"1.29"},{"v":1.191847,"d":"1.19"},{"v":0.310761222798496,"d":"0.31"},{"v":-1.68612160133005,"d":"-1.69"},{"v":0.000920175671507079,"d":"0.00"},{"v":0.0395384956957042,"d":"0.04"},"down","yes"]
["MSTRG.17298","PTN","ENSOART00000010588","GO:0001503(ossification);GO:0004864(protein phosphatase inhibitor activity);GO:0005178(integrin binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0007229(integrin-mediated signaling pathway);GO:0007406(negative regulation of neuroblast proliferation);GO:0007612(learning);GO:0007613(memory);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0010996(response to auditory stimulus);GO:0019901(protein kinase binding);GO:0030282(bone mineralization);GO:0030501(positive regulation of bone mineralization);GO:0031641(regulation of myelination);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0032991(protein-containing complex);GO:0035374(chondroitin sulfate binding);GO:0043113(receptor clustering);GO:0043932(ossification involved in bone remodeling);GO:0044849(estrous cycle);GO:0045597(positive regulation of cell differentiation);GO:0046697(decidualization);GO:0048167(regulation of synaptic plasticity);GO:0048477(oogenesis);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0140059(dendrite arborization);GO:1900006(positive regulation of dendrite development);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1903706(regulation of hemopoiesis);GO:2000036(regulation of stem cell population maintenance);GO:2000738(positive regulation of stem cell differentiation)","NA","NA","NA","pleiotrophin [Source:HGNC Symbol;Acc:HGNC:9630]",{"v":0.644961313922356,"d":"0.64"},{"v":0.33175986746988,"d":"0.33"},{"v":0.380487658634538,"d":"0.38"},{"v":1.5143164210174,"d":"1.51"},{"v":1.19272734404284,"d":"1.19"},{"v":1.41994924698795,"d":"1.42"},{"v":0.328861433994337,"d":"0.33"},{"v":-1.60444826350766,"d":"-1.60"},{"v":0.000924914481085792,"d":"0.00"},{"v":0.0396378048482121,"d":"0.04"},"down","yes"]
["MSTRG.12375","PANK1;oar-mir-107","ENSOART00000016657;ENSOART00000026255","GO:0004594(pantothenate kinase activity);GO:0005524(ATP binding);GO:0015937(coenzyme A biosynthetic process);GO:0016310(phosphorylation);GO:0042803(protein homodimerization activity);GO:0071944(cell periphery);GO:1905502(acetyl-CoA binding)","00770(Pantothenate and CoA biosynthesis);05206(MicroRNAs in cancer)","K09680;K17396","EC:2.7.1.33","pantothenate kinase 1 [Source:NCBI gene;Acc:101122150];oar-mir-107 [Source:miRBase;Acc:MI0025250]",{"v":2.65609240803315,"d":"2.66"},{"v":1.73998849101332,"d":"1.74"},{"v":5.9491978900787,"d":"5.95"},{"v":1.81097645958832,"d":"1.81"},{"v":1.33909228679809,"d":"1.34"},{"v":0.909130082147722,"d":"0.91"},{"v":2.5486011467098,"d":"2.55"},{"v":1.34970561083048,"d":"1.35"},{"v":0.00093050385918642,"d":"0.00"},{"v":0.0397729502952772,"d":"0.04"},"up","yes"]
["MSTRG.8654","ENSOARG00000008994","ENSOART00000009795","NA","NA","NA","NA",null,0,{"v":0.178779513942045,"d":"0.18"},{"v":0.0964494166211044,"d":"0.10"},{"v":3.23255748605795,"d":"3.23"},{"v":0.129489147621651,"d":"0.13"},{"v":1.36723392345544,"d":"1.37"},{"v":0.0581967864325395,"d":"0.06"},{"v":-4.10291669859717,"d":"-4.10"},{"v":0.000953499564543643,"d":"0.00"},{"v":0.0405435960673661,"d":"0.04"},"down","yes"]
["MSTRG.12383","ANKRD1","ENSOART00000017322","GO:0001085(RNA polymerase II transcription factor binding);GO:0001650(fibrillar center);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0031432(titin binding);GO:0035994(response to muscle stretch);GO:0042826(histone deacetylase binding);GO:0043065(positive regulation of apoptotic process);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0050714(positive regulation of protein secretion);GO:0055008(cardiac muscle tissue morphogenesis);GO:0070412(R-SMAD binding);GO:0071222(cellular response to lipopolysaccharide);GO:0071260(cellular response to mechanical stimulus);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:1903507(negative regulation of nucleic acid-templated transcription);GO:1903508(positive regulation of nucleic acid-templated transcription);GO:2000279(negative regulation of DNA biosynthetic process)","NA","K21433","NA","ankyrin repeat domain 1 [Source:NCBI gene;Acc:100820746]",{"v":97.5447296762062,"d":"97.54"},{"v":29.9505714019446,"d":"29.95"},{"v":93.0433142381215,"d":"93.04"},{"v":22.4657704439552,"d":"22.47"},{"v":34.5919197473858,"d":"34.59"},{"v":28.95019410255,"d":"28.95"},{"v":2.56416742635694,"d":"2.56"},{"v":1.35849046526746,"d":"1.36"},{"v":0.000962933007088823,"d":"0.00"},{"v":0.0407325651288764,"d":"0.04"},"up","yes"]
["MSTRG.7723","RF00015","ENSOART00000026969;ENSOART00000024819","NA","NA","NA","NA","RNA, U4 small nuclear 1 [Source:HGNC Symbol;Acc:HGNC:10192];RNA, U4 small nuclear 2 [Source:HGNC Symbol;Acc:HGNC:10193]",{"v":100.332024106624,"d":"100.33"},{"v":99.1035067948304,"d":"99.10"},{"v":75.1436862988692,"d":"75.14"},{"v":151.80309312601,"d":"151.80"},{"v":171.42092655412,"d":"171.42"},{"v":478.935819319871,"d":"478.94"},{"v":0.342299880710337,"d":"0.34"},{"v":-1.54666730531097,"d":"-1.55"},{"v":0.000970174950987714,"d":"0.00"},{"v":0.0408043065464105,"d":"0.04"},"down","yes"]
["MSTRG.2607","RF01848","ENSOART00000023892","NA","NA","NA","NA",null,{"v":2.219224,"d":"2.22"},{"v":0.893491,"d":"0.89"},{"v":1.196635,"d":"1.20"},{"v":3.012776,"d":"3.01"},{"v":5.305096,"d":"5.31"},{"v":8.596536,"d":"8.60"},{"v":0.254773918188564,"d":"0.25"},{"v":-1.97271050185354,"d":"-1.97"},{"v":0.000972126117500838,"d":"0.00"},{"v":0.0408043065464105,"d":"0.04"},"down","yes"]
["MSTRG.14051","UNC5B","ENSOART00000006944","GO:0005042(netrin receptor activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033564(anterior/posterior axon guidance);GO:0038007(netrin-activated signaling pathway);GO:0043524(negative regulation of neuron apoptotic process);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)","04360(Axon guidance)","K07521","NA","unc-5 netrin receptor B [Source:NCBI gene;Acc:101107068]",{"v":0.590004,"d":"0.59"},{"v":0.681892,"d":"0.68"},{"v":0.646355,"d":"0.65"},{"v":1.7667,"d":"1.77"},{"v":1.505295,"d":"1.51"},{"v":1.607574,"d":"1.61"},{"v":0.393118941447493,"d":"0.39"},{"v":-1.34696221681851,"d":"-1.35"},{"v":0.000988541675565139,"d":"0.00"},{"v":0.0411268847669364,"d":"0.04"},"down","yes"]
["MSTRG.9580","SIGMAR1","ENSOART00000009992","GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0014069(postsynaptic density);GO:0016021(integral component of membrane);GO:0036474(cell death in response to hydrogen peroxide);GO:0038023(signaling receptor activity);GO:0043523(regulation of neuron apoptotic process);GO:0070207(protein homotrimerization)","NA","K20719","NA","sigma non-opioid intracellular receptor 1 [Source:NCBI gene;Acc:101116710]",{"v":0.241281691056911,"d":"0.24"},{"v":0.826746367886179,"d":"0.83"},{"v":0.34472643902439,"d":"0.34"},{"v":1.52777821341463,"d":"1.53"},{"v":1.60265783943089,"d":"1.60"},{"v":2.05931410772358,"d":"2.06"},{"v":0.27222013666503,"d":"0.27"},{"v":-1.87715430507606,"d":"-1.88"},{"v":0.000989768925102319,"d":"0.00"},{"v":0.0411268847669364,"d":"0.04"},"down","yes"]
["MSTRG.2069","SUGT1","ENSOART00000007418","GO:0005515(protein binding);GO:0031647(regulation of protein stability);GO:0032991(protein-containing complex);GO:0043947(positive regulation by host of symbiont catalytic activity)","04621(NOD-like receptor signaling pathway)","K12795","NA","SGT1 homolog, MIS12 kinetochore complex assembly cochaperone [Source:NCBI gene;Acc:101122608]",{"v":8.37661463817824,"d":"8.38"},{"v":11.2275407178334,"d":"11.23"},{"v":8.70635285633961,"d":"8.71"},{"v":5.38860586786618,"d":"5.39"},{"v":5.0712812403711,"d":"5.07"},{"v":3.64884641907975,"d":"3.65"},{"v":2.00659457899159,"d":"2.01"},{"v":1.00474915782556,"d":"1.00"},{"v":0.00100330409179297,"d":"0.00"},{"v":0.0414732891412547,"d":"0.04"},"up","yes"]
["MSTRG.4894","CASS4","ENSOART00000019885","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0030335(positive regulation of cell migration);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1990782(protein tyrosine kinase binding)","NA","NA","NA","Cas scaffold protein family member 4 [Source:NCBI gene;Acc:101105178]",{"v":0.273509,"d":"0.27"},{"v":0.102211,"d":"0.10"},{"v":0.236359,"d":"0.24"},{"v":3.60130906524008,"d":"3.60"},{"v":0.055913,"d":"0.06"},{"v":1.410739,"d":"1.41"},{"v":0.120774211190789,"d":"0.12"},{"v":-3.04961566472018,"d":"-3.05"},{"v":0.00101466308573577,"d":"0.00"},{"v":0.0418369163229636,"d":"0.04"},"down","yes"]
["ENSOARG00000014203","CCRL2","ENSOART00000015471","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0005887(integral component of plasma membrane);GO:0006935(chemotaxis);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042379(chemokine receptor binding);GO:0048020(CCR chemokine receptor binding);GO:0070098(chemokine-mediated signaling pathway)","NA","K08373","NA","C-C motif chemokine receptor like 2 [Source:NCBI gene;Acc:101117199]",{"v":0.306162,"d":"0.31"},{"v":0.152334,"d":"0.15"},{"v":0.298355,"d":"0.30"},{"v":0.939625,"d":"0.94"},{"v":0.73675,"d":"0.74"},{"v":0.929691,"d":"0.93"},{"v":0.290418968667716,"d":"0.29"},{"v":-1.78379240908426,"d":"-1.78"},{"v":0.00108944077728763,"d":"0.00"},{"v":0.0445824286003819,"d":"0.04"},"down","yes"]
["MSTRG.3822","ENSOARG00000013206","ENSOART00000014356","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding)","NA","NA","NA",null,{"v":2.362923,"d":"2.36"},{"v":0.825305,"d":"0.83"},{"v":1.279105,"d":"1.28"},{"v":4.143685,"d":"4.14"},{"v":3.940434,"d":"3.94"},{"v":4.818202,"d":"4.82"},{"v":0.3462425868958,"d":"0.35"},{"v":-1.53014491170577,"d":"-1.53"},{"v":0.00115093320575697,"d":"0.00"},{"v":0.0466313582719598,"d":"0.05"},"down","yes"]
["ENSOARG00000016200","CACNA1D","ENSOART00000017652;ENSOART00000017651","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005262(calcium channel activity);GO:0005886(plasma membrane);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007605(sensory perception of sound);GO:0008331(high voltage-gated calcium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030018(Z disc);GO:0030506(ankyrin binding);GO:0034765(regulation of ion transmembrane transport);GO:0045762(positive regulation of adenylate cyclase activity);GO:0051393(alpha-actinin binding);GO:0051928(positive regulation of calcium ion transport);GO:0055085(transmembrane transport);GO:0060372(regulation of atrial cardiac muscle cell membrane repolarization);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0086002(cardiac muscle cell action potential involved in contraction);GO:0086046(membrane depolarization during SA node cell action potential);GO:0086059(voltage-gated calcium channel activity involved SA node cell action potential);GO:0086091(regulation of heart rate by cardiac conduction);GO:0098683(cochlear hair cell ribbon synapse);GO:0099059(integral component of presynaptic active zone membrane);GO:0099533(positive regulation of presynaptic cytosolic calcium concentration);GO:0099635(voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels);GO:0099703(induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:1901379(regulation of potassium ion transmembrane transport);GO:1990454(L-type voltage-gated calcium channel complex);GO:1990454(L-type voltage-gated calcium channel complex)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04218(Cellular senescence);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04530(Tight junction);04713(Circadian entrainment);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04727(GABAergic synapse);04728(Dopaminergic synapse);04911(Insulin secretion);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04930(Type II diabetes mellitus);04934(Cushing syndrome);04973(Carbohydrate digestion and absorption);05010(Alzheimer disease);05031(Amphetamine addiction);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05414(Dilated cardiomyopathy (DCM))","K04851","NA","calcium voltage-gated channel subunit alpha1 D [Source:NCBI gene;Acc:101106371]",{"v":0.00839502899985854,"d":"0.01"},{"v":0.0331460524826708,"d":"0.03"},{"v":0.0436315412363842,"d":"0.04"},{"v":0.077760184891781,"d":"0.08"},{"v":0.160038499080492,"d":"0.16"},{"v":0.148522218559909,"d":"0.15"},{"v":0.220471173474281,"d":"0.22"},{"v":-2.18133805862558,"d":"-2.18"},{"v":0.00119028881707228,"d":"0.00"},{"v":0.0477077918917193,"d":"0.05"},"down","yes"]
["MSTRG.3584","CYGB","ENSOART00000007510","GO:0005344(oxygen carrier activity);GO:0005506(iron ion binding);GO:0015671(oxygen transport);GO:0016607(nuclear speck);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0046872(metal ion binding)","NA","K21894","NA","cytoglobin [Source:NCBI gene;Acc:100307038]",{"v":1.668797,"d":"1.67"},{"v":1.040475,"d":"1.04"},{"v":0.750117,"d":"0.75"},{"v":4.424232,"d":"4.42"},{"v":2.596008,"d":"2.60"},{"v":4.269664,"d":"4.27"},{"v":0.306414385808772,"d":"0.31"},{"v":-1.70644406313438,"d":"-1.71"},{"v":0.00119280383725477,"d":"0.00"},{"v":0.0477077918917193,"d":"0.05"},"down","yes"]
["MSTRG.17833","ENSOARG00000003676","ENSOART00000003988","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K06734","NA","CD320 molecule [Source:NCBI gene;Acc:101102807]",{"v":3.488036,"d":"3.49"},{"v":3.71129,"d":"3.71"},{"v":3.567828,"d":"3.57"},{"v":7.764697,"d":"7.76"},{"v":7.353703,"d":"7.35"},{"v":11.41361,"d":"11.41"},{"v":0.405817501199495,"d":"0.41"},{"v":-1.30109701109079,"d":"-1.30"},{"v":0.00119518224019879,"d":"0.00"},{"v":0.0477077918917193,"d":"0.05"},"down","yes"]
["MSTRG.16394","RF01296","ENSOART00000024884","NA","NA","NA","NA","small Cajal body-specific RNA 10 [Source:HGNC Symbol;Acc:HGNC:32567]",{"v":550.220703,"d":"550.22"},{"v":446.918457,"d":"446.92"},{"v":431.208771,"d":"431.21"},{"v":755.494385,"d":"755.49"},{"v":1069.905518,"d":"1069.91"},{"v":1604.967773,"d":"1604.97"},{"v":0.416383334356023,"d":"0.42"},{"v":-1.26401576862054,"d":"-1.26"},{"v":0.00121091583382859,"d":"0.00"},{"v":0.0481066514227571,"d":"0.05"},"down","yes"]
["MSTRG.5782","PVR","ENSOART00000009988","GO:0016020(membrane);GO:0016021(integral component of membrane)","04514(Cell adhesion molecules (CAMs))","K06539","NA","poliovirus receptor [Source:NCBI gene;Acc:101110963]",{"v":2.34241783226152,"d":"2.34"},{"v":3.98471788987138,"d":"3.98"},{"v":2.94361202920686,"d":"2.94"},{"v":0.937648990353698,"d":"0.94"},{"v":1.79279511387996,"d":"1.79"},{"v":1.38432056993569,"d":"1.38"},{"v":2.25304445951365,"d":"2.25"},{"v":1.17187578267543,"d":"1.17"},{"v":0.00121661248807667,"d":"0.00"},{"v":0.0481994372076046,"d":"0.05"},"up","yes"]
["MSTRG.11465","ENSOARG00000009253","ENSOART00000010070","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11254","NA","uncharacterized LOC101120961 [Source:NCBI gene;Acc:101120961]",{"v":16.205231,"d":"16.21"},{"v":7.415297,"d":"7.42"},{"v":8.418184,"d":"8.42"},{"v":34.793346,"d":"34.79"},{"v":19.61517,"d":"19.62"},{"v":29.722218,"d":"29.72"},{"v":0.380820545319384,"d":"0.38"},{"v":-1.39281678055134,"d":"-1.39"},{"v":0.00122210723934029,"d":"0.00"},{"v":0.0481994372076046,"d":"0.05"},"down","yes"]
["MSTRG.1532","ABCC5","ENSOART00000022478","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0008514(organic anion transmembrane transporter activity);GO:0015711(organic anion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport)","01523(Antifolate resistance);02010(ABC transporters)","K05668","NA","ATP binding cassette subfamily C member 5 [Source:NCBI gene;Acc:101123431]",{"v":3.26295612449267,"d":"3.26"},{"v":4.53354187347802,"d":"4.53"},{"v":5.65226238348365,"d":"5.65"},{"v":3.11719720107103,"d":"3.12"},{"v":1.90411859856257,"d":"1.90"},{"v":1.14958752584555,"d":"1.15"},{"v":2.17938276976817,"d":"2.18"},{"v":1.12391960239677,"d":"1.12"},{"v":0.00122594517093358,"d":"0.00"},{"v":0.0482342957855504,"d":"0.05"},"up","yes"]
["MSTRG.1697","TIPARP","ENSOART00000003165","GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0006471(protein ADP-ribosylation);GO:0006807(nitrogen compound metabolic process);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0030097(hemopoiesis);GO:0035326(enhancer binding);GO:0045732(positive regulation of protein catabolic process);GO:0046872(metal ion binding);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0070213(protein auto-ADP-ribosylation);GO:0071407(cellular response to organic cyclic compound);GO:0140289(protein mono-ADP-ribosylation);GO:1990404(protein ADP-ribosylase activity)","NA","K15259","EC:2.4.2.30","TCDD inducible poly(ADP-ribose) polymerase [Source:NCBI gene;Acc:101110289]",{"v":14.326066632032,"d":"14.33"},{"v":16.9049711875192,"d":"16.90"},{"v":15.1044007805103,"d":"15.10"},{"v":8.32390952966492,"d":"8.32"},{"v":7.82189839409776,"d":"7.82"},{"v":8.07138971011374,"d":"8.07"},{"v":1.91332784662272,"d":"1.91"},{"v":0.936084099074468,"d":"0.94"},{"v":0.00123231902444425,"d":"0.00"},{"v":0.0483001813630575,"d":"0.05"},"up","no"]
["MSTRG.7477","FNIP2","ENSOART00000003652","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001932(regulation of protein phosphorylation);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007005(mitochondrion organization);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0031334(positive regulation of protein complex assembly);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0038202(TORC1 signaling);GO:0042030(ATPase inhibitor activity);GO:0043086(negative regulation of catalytic activity);GO:0051087(chaperone binding)","04150(mTOR signaling pathway)","K20401","NA","folliculin interacting protein 2 [Source:NCBI gene;Acc:101111832]",{"v":0.622783034204004,"d":"0.62"},{"v":2.39919526402288,"d":"2.40"},{"v":2.84841859176358,"d":"2.85"},{"v":0.667165970371783,"d":"0.67"},{"v":0.808638126901811,"d":"0.81"},{"v":0.6696826714204,"d":"0.67"},{"v":2.73616084501137,"d":"2.74"},{"v":1.45215304143711,"d":"1.45"},{"v":0.00123701185227159,"d":"0.00"},{"v":0.0483001813630575,"d":"0.05"},"up","yes"]
["MSTRG.13147","ENSOARG00000010944","ENSOART00000011904","GO:0005344(oxygen carrier activity);GO:0005506(iron ion binding);GO:0005833(hemoglobin complex);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0046872(metal ion binding)","05143(African trypanosomiasis);05144(Malaria)","K13822","NA","hemoglobin subunit alpha-1/2 [Source:NCBI gene;Acc:101108797]",{"v":0.828249,"d":"0.83"},{"v":0.142758,"d":"0.14"},{"v":0.483635,"d":"0.48"},{"v":2.716049,"d":"2.72"},{"v":0.963392,"d":"0.96"},{"v":2.998448,"d":"3.00"},{"v":0.217829616515039,"d":"0.22"},{"v":-2.1987279760273,"d":"-2.20"},{"v":0.00123900101364401,"d":"0.00"},{"v":0.0483001813630575,"d":"0.05"},"down","yes"]
["MSTRG.4018","ZBTB48","ENSOART00000012421","GO:0000781(chromosome, telomeric region);GO:0003676(nucleic acid binding);GO:0003691(double-stranded telomeric DNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0010833(telomere maintenance via telomere lengthening);GO:0042802(identical protein binding);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated)","NA","K10519","NA","zinc finger and BTB domain containing 48 [Source:NCBI gene;Acc:101121027]",{"v":2.44759082730816,"d":"2.45"},{"v":4.70039046243784,"d":"4.70"},{"v":3.33180846620078,"d":"3.33"},{"v":1.69565037709985,"d":"1.70"},{"v":1.89631311396318,"d":"1.90"},{"v":1.38522983026475,"d":"1.39"},{"v":2.10556212696015,"d":"2.11"},{"v":1.07420544446212,"d":"1.07"},{"v":0.00123945222875558,"d":"0.00"},{"v":0.0483001813630575,"d":"0.05"},"up","yes"]
["MSTRG.13600","ENSOARG00000010813;ENSOARG00000010731","ENSOART00000011755;ENSOART00000011673","NA","NA","NA","NA",null,{"v":1.91899687572167,"d":"1.92"},{"v":0.821679943178365,"d":"0.82"},{"v":3.7303649562443,"d":"3.73"},{"v":0.972213139167426,"d":"0.97"},{"v":0.64091876086296,"d":"0.64"},{"v":0.668584399574597,"d":"0.67"},{"v":2.83604135021721,"d":"2.84"},{"v":1.50387856759803,"d":"1.50"},{"v":0.00126396587007322,"d":"0.00"},{"v":0.0489564537069081,"d":"0.05"},"up","yes"]
["MSTRG.9454","FSD1L","ENSOART00000007917","GO:0005515(protein binding);GO:0005622(intracellular)","NA","NA","NA","fibronectin type III and SPRY domain containing 1 like [Source:NCBI gene;Acc:101118501]",{"v":1.677472,"d":"1.68"},{"v":2.385149,"d":"2.39"},{"v":1.63942230201613,"d":"1.64"},{"v":1.159169,"d":"1.16"},{"v":0.930158,"d":"0.93"},{"v":0.760492,"d":"0.76"},{"v":2.00084401922232,"d":"2.00"},{"v":1.00060870274306,"d":"1.00"},{"v":0.00129285063553069,"d":"0.00"},{"v":0.0494371549811361,"d":"0.05"},"up","yes"]
["MSTRG.4906","TCF15","ENSOART00000020701","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001756(somitogenesis);GO:0003016(respiratory system process);GO:0007517(muscle organ development);GO:0009952(anterior/posterior pattern specification);GO:0010468(regulation of gene expression);GO:0036342(post-anal tail morphogenesis);GO:0042755(eating behavior);GO:0043583(ear development);GO:0043588(skin development);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0048339(paraxial mesoderm development);GO:0048644(muscle organ morphogenesis);GO:0048705(skeletal system morphogenesis);GO:0050884(neuromuscular process controlling posture);GO:0060231(mesenchymal to epithelial transition);GO:0090575(RNA polymerase II transcription factor complex);GO:1903053(regulation of extracellular matrix organization)","NA","NA","NA","transcription factor 15 [Source:HGNC Symbol;Acc:HGNC:11627]",{"v":1.88622673694192,"d":"1.89"},{"v":1.41304201841169,"d":"1.41"},{"v":1.01989810248913,"d":"1.02"},{"v":3.01676384772817,"d":"3.02"},{"v":3.61457637977084,"d":"3.61"},{"v":3.20111010011853,"d":"3.20"},{"v":0.439276753395946,"d":"0.44"},{"v":-1.1867979411152,"d":"-1.19"},{"v":0.00130841734156996,"d":"0.00"},{"v":0.0498114309156197,"d":"0.05"},"down","yes"]
["MSTRG.8762","TRANK1","ENSOART00000018109","GO:0005515(protein binding);GO:0005524(ATP binding)","NA","NA","NA","tetratricopeptide repeat and ankyrin repeat containing 1 [Source:NCBI gene;Acc:101114219]",{"v":1.39502980982378,"d":"1.40"},{"v":0.685984,"d":"0.69"},{"v":0.787247,"d":"0.79"},{"v":2.091539,"d":"2.09"},{"v":2.42157149570103,"d":"2.42"},{"v":2.12110901711075,"d":"2.12"},{"v":0.432343368241689,"d":"0.43"},{"v":-1.20975053506098,"d":"-1.21"},{"v":0.0013087398250123,"d":"0.00"},{"v":0.0498114309156197,"d":"0.05"},"down","yes"]
["MSTRG.13798","TTYH3","ENSOART00000005327","GO:0005229(intracellular calcium activated chloride channel activity);GO:0005254(chloride channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034220(ion transmembrane transport);GO:0034707(chloride channel complex);GO:1902476(chloride transmembrane transport)","NA","K22641","NA","tweety family member 3 [Source:NCBI gene;Acc:101112110]",{"v":1.25748470086957,"d":"1.26"},{"v":1.07094329321739,"d":"1.07"},{"v":1.58382037530435,"d":"1.58"},{"v":3.07386555095652,"d":"3.07"},{"v":3.23921653286956,"d":"3.24"},{"v":2.85885446678261,"d":"2.86"},{"v":0.426545511714391,"d":"0.43"},{"v":-1.22922841190969,"d":"-1.23"},{"v":0.00136251382211513,"d":"0.00"},{"v":0.0514979761284627,"d":"0.05"},"down","yes"]
["ENSOARG00000013491","GRIA3","ENSOART00000014678","GO:0004970(ionotropic glutamate receptor activity);GO:0004971(AMPA glutamate receptor activity);GO:0005216(ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0032281(AMPA glutamate receptor complex);GO:0034220(ion transmembrane transport);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0038023(signaling receptor activity);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0060078(regulation of postsynaptic membrane potential);GO:0098688(parallel fiber to Purkinje cell synapse);GO:1904315(transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04713(Circadian entrainment);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);05031(Amphetamine addiction);05033(Nicotine addiction);05202(Transcriptional misregulation in cancer)","K05199","NA","glutamate ionotropic receptor AMPA type subunit 3 [Source:NCBI gene;Acc:443273]",{"v":0.771645,"d":"0.77"},{"v":0.535008,"d":"0.54"},{"v":1.378413,"d":"1.38"},{"v":0.337845,"d":"0.34"},{"v":0.412185,"d":"0.41"},{"v":0.239886,"d":"0.24"},{"v":2.71241802334744,"d":"2.71"},{"v":1.4395795360466,"d":"1.44"},{"v":0.00137064794150038,"d":"0.00"},{"v":0.0516857727224437,"d":"0.05"},"up","yes"]
["MSTRG.9183","CLEC3B","ENSOART00000012097","GO:0001503(ossification);GO:0001652(granular component);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0008201(heparin binding);GO:0030246(carbohydrate binding);GO:0030282(bone mineralization);GO:0036143(kringle domain binding);GO:0071310(cellular response to organic substance);GO:0071560(cellular response to transforming growth factor beta stimulus)","NA","K17520","NA","C-type lectin domain family 3 member B [Source:NCBI gene;Acc:101120024]",{"v":22.850733,"d":"22.85"},{"v":14.793547,"d":"14.79"},{"v":22.065702,"d":"22.07"},{"v":41.707298,"d":"41.71"},{"v":39.405727,"d":"39.41"},{"v":54.470345,"d":"54.47"},{"v":0.440393110157979,"d":"0.44"},{"v":-1.18313619641803,"d":"-1.18"},{"v":0.00137583793118934,"d":"0.00"},{"v":0.0517324936964249,"d":"0.05"},"down","yes"]
["MSTRG.9585","CNTFR","ENSOART00000010050","GO:0001967(suckling behavior);GO:0003360(brainstem development);GO:0004896(cytokine receptor activity);GO:0004897(ciliary neurotrophic factor receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0007548(sex differentiation);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0019955(cytokine binding);GO:0043524(negative regulation of neuron apoptotic process);GO:0060538(skeletal muscle organ development);GO:0070110(ciliary neurotrophic factor receptor complex);GO:0070120(ciliary neurotrophic factor-mediated signaling pathway);GO:0097059(CNTFR-CLCF1 complex)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway)","K05059","NA","ciliary neurotrophic factor receptor [Source:NCBI gene;Acc:100885760]",{"v":0.706194321215139,"d":"0.71"},{"v":0.784977868027888,"d":"0.78"},{"v":1.2362259688745,"d":"1.24"},{"v":2.13069386952191,"d":"2.13"},{"v":2.52803348082669,"d":"2.53"},{"v":2.06791334088645,"d":"2.07"},{"v":0.40546214422771,"d":"0.41"},{"v":-1.30236087066527,"d":"-1.30"},{"v":0.00138190430902721,"d":"0.00"},{"v":0.0517324936964249,"d":"0.05"},"down","yes"]
["MSTRG.13184","SOX8","ENSOART00000015753","GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001755(neural crest cell migration);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007165(signal transduction);GO:0007283(spermatogenesis);GO:0007422(peripheral nervous system development);GO:0008134(transcription factor binding);GO:0008584(male gonad development);GO:0010628(positive regulation of gene expression);GO:0010817(regulation of hormone levels);GO:0014015(positive regulation of gliogenesis);GO:0033690(positive regulation of osteoblast proliferation);GO:0035914(skeletal muscle cell differentiation);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0044798(nuclear transcription factor complex);GO:0045165(cell fate commitment);GO:0045444(fat cell differentiation);GO:0045662(negative regulation of myoblast differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046533(negative regulation of photoreceptor cell differentiation);GO:0046982(protein heterodimerization activity);GO:0048469(cell maturation);GO:0048484(enteric nervous system development);GO:0048709(oligodendrocyte differentiation);GO:0060009(Sertoli cell development);GO:0060018(astrocyte fate commitment);GO:0060041(retina development in camera-type eye);GO:0060221(retinal rod cell differentiation);GO:0060612(adipose tissue development);GO:0061138(morphogenesis of a branching epithelium);GO:0072034(renal vesicle induction);GO:0072197(ureter morphogenesis);GO:0072289(metanephric nephron tubule formation);GO:0090184(positive regulation of kidney development);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis)","NA","NA","NA","SRY-box 8 [Source:HGNC Symbol;Acc:HGNC:11203]",{"v":0.495233,"d":"0.50"},{"v":0.644413,"d":"0.64"},{"v":0.521762,"d":"0.52"},{"v":1.619563,"d":"1.62"},{"v":1.779403,"d":"1.78"},{"v":1.442233,"d":"1.44"},{"v":0.34318110038443,"d":"0.34"},{"v":-1.54295799173653,"d":"-1.54"},{"v":0.00138305816027343,"d":"0.00"},{"v":0.0517324936964249,"d":"0.05"},"down","yes"]
["ENSOARG00000002721","CBX2","ENSOART00000002947","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000791(euchromatin);GO:0000792(heterochromatin);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0031519(PcG protein complex);GO:0035064(methylated histone binding);GO:0035102(PRC1 complex);GO:0045137(development of primary sexual characteristics)","NA","K11451","NA","chromobox 2 [Source:NCBI gene;Acc:101111469]",{"v":0.202297,"d":"0.20"},{"v":0.143996,"d":"0.14"},{"v":0.229463,"d":"0.23"},{"v":0.61534,"d":"0.62"},{"v":0.475864,"d":"0.48"},{"v":0.414175,"d":"0.41"},{"v":0.382465810935319,"d":"0.38"},{"v":-1.38659730550974,"d":"-1.39"},{"v":0.00138772857906872,"d":"0.00"},{"v":0.0517324936964249,"d":"0.05"},"down","yes"]
["MSTRG.4642","RF00567","ENSOART00000025735","NA","NA","NA","NA","small nucleolar RNA, C/D box 17 [Source:HGNC Symbol;Acc:HGNC:32713]",{"v":76.081902,"d":"76.08"},{"v":76.229065,"d":"76.23"},{"v":76.129448,"d":"76.13"},{"v":121.96093,"d":"121.96"},{"v":175.811752,"d":"175.81"},{"v":239.667801,"d":"239.67"},{"v":0.425052489021375,"d":"0.43"},{"v":-1.23428708663695,"d":"-1.23"},{"v":0.00144735218973143,"d":"0.00"},{"v":0.0533461998960152,"d":"0.05"},"down","yes"]
["MSTRG.13973","ARID5B","ENSOART00000004794","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001822(kidney development);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006807(nitrogen compound metabolic process);GO:0008584(male gonad development);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010761(fibroblast migration);GO:0030325(adrenal gland development);GO:0035264(multicellular organism growth);GO:0044212(transcription regulatory region DNA binding);GO:0045444(fat cell differentiation);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048468(cell development);GO:0048644(muscle organ morphogenesis);GO:0048705(skeletal system morphogenesis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0060612(adipose tissue development);GO:0060613(fat pad development);GO:1903508(positive regulation of nucleic acid-templated transcription);GO:1990830(cellular response to leukemia inhibitory factor)","NA","NA","NA","AT-rich interaction domain 5B [Source:NCBI gene;Acc:101121742]",{"v":6.58578419367307,"d":"6.59"},{"v":4.94414584590178,"d":"4.94"},{"v":7.84982791910684,"d":"7.85"},{"v":3.25668702510188,"d":"3.26"},{"v":3.87717091280511,"d":"3.88"},{"v":2.70667899878167,"d":"2.71"},{"v":1.96938013477982,"d":"1.97"},{"v":0.977741610797482,"d":"0.98"},{"v":0.00145690515313875,"d":"0.00"},{"v":0.0535773588748864,"d":"0.05"},"up","no"]
["MSTRG.22253","LONRF3","ENSOART00000018023","GO:0005515(protein binding)","NA","NA","NA","LON peptidase N-terminal domain and ring finger 3 [Source:NCBI gene;Acc:101104461]",{"v":6.498787,"d":"6.50"},{"v":7.644202,"d":"7.64"},{"v":8.393591,"d":"8.39"},{"v":3.854607,"d":"3.85"},{"v":4.456108,"d":"4.46"},{"v":3.381419,"d":"3.38"},{"v":1.92749929140395,"d":"1.93"},{"v":0.946730329770297,"d":"0.95"},{"v":0.00150808819268742,"d":"0.00"},{"v":0.0553242889489662,"d":"0.06"},"up","no"]
["MSTRG.19034","BTC","ENSOART00000016474","GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043066(negative regulation of apoptotic process)","04012(ErbB signaling pathway)","K09783","NA","betacellulin [Source:NCBI gene;Acc:101103979]",{"v":9.20925892400104,"d":"9.21"},{"v":5.77845336902586,"d":"5.78"},{"v":6.14629605850091,"d":"6.15"},{"v":4.78149914599112,"d":"4.78"},{"v":2.36701767249935,"d":"2.37"},{"v":3.04045876886916,"d":"3.04"},{"v":2.07420345355882,"d":"2.07"},{"v":1.05255741153035,"d":"1.05"},{"v":0.00152294165238803,"d":"0.00"},{"v":0.0554184389758994,"d":"0.06"},"up","yes"]
["ENSOARG00000010625","ABCG1","ENSOART00000011566","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005548(phospholipid transporter activity);GO:0005739(mitochondrion);GO:0005768(endosome);GO:0006355(regulation of transcription, DNA-templated);GO:0008203(cholesterol metabolic process);GO:0009897(external side of plasma membrane);GO:0010033(response to organic substance);GO:0010872(regulation of cholesterol esterification);GO:0010875(positive regulation of cholesterol efflux);GO:0010888(negative regulation of lipid storage);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0017127(cholesterol transporter activity);GO:0019534(toxin transmembrane transporter activity);GO:0030301(cholesterol transport);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux);GO:0033700(phospholipid efflux);GO:0033993(response to lipid);GO:0034041(sterol-transporting ATPase activity);GO:0034374(low-density lipoprotein particle remodeling);GO:0034375(high-density lipoprotein particle remodeling);GO:0034436(glycoprotein transport);GO:0034437(glycoprotein transporter activity);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0042987(amyloid precursor protein catabolic process);GO:0043531(ADP binding);GO:0043691(reverse cholesterol transport);GO:0045542(positive regulation of cholesterol biosynthetic process);GO:0046982(protein heterodimerization activity);GO:0055037(recycling endosome);GO:0055085(transmembrane transport);GO:0055091(phospholipid homeostasis);GO:0071403(cellular response to high density lipoprotein particle stimulus);GO:1901998(toxin transport)","02010(ABC transporters)","K05679","NA","ATP binding cassette subfamily G member 1 [Source:NCBI gene;Acc:101103525]",{"v":1.519413,"d":"1.52"},{"v":2.190581,"d":"2.19"},{"v":0.937571,"d":"0.94"},{"v":0.486701,"d":"0.49"},{"v":0.73359,"d":"0.73"},{"v":0.581926,"d":"0.58"},{"v":2.57880432822463,"d":"2.58"},{"v":1.36670230999819,"d":"1.37"},{"v":0.00152364433633235,"d":"0.00"},{"v":0.0554184389758994,"d":"0.06"},"up","yes"]
["MSTRG.15105","ENSOARG00000020279","ENSOART00000022082","GO:0001671(ATPase activator activity);GO:0032781(positive regulation of ATPase activity);GO:0051087(chaperone binding);GO:0051879(Hsp90 protein binding)","NA","NA","NA","activator of HSP90 ATPase homolog 2, pseudogene [Source:NCBI gene;Acc:101119030]",{"v":2.10121840585242,"d":"2.10"},{"v":3.73017586132316,"d":"3.73"},{"v":3.46658648346056,"d":"3.47"},{"v":1.48422262340967,"d":"1.48"},{"v":1.67620929643766,"d":"1.68"},{"v":1.07576415648855,"d":"1.08"},{"v":2.19488913711437,"d":"2.19"},{"v":1.13414807170845,"d":"1.13"},{"v":0.00152393919035882,"d":"0.00"},{"v":0.0554184389758994,"d":"0.06"},"up","yes"]
["MSTRG.4669","CD93","ENSOART00000005628","GO:0001849(complement component C1q binding);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031410(cytoplasmic vesicle);GO:0098609(cell-cell adhesion)","NA","K06702","NA","CD93 molecule [Source:NCBI gene;Acc:100302099]",{"v":13.802214,"d":"13.80"},{"v":7.689259,"d":"7.69"},{"v":8.034279,"d":"8.03"},{"v":23.928812,"d":"23.93"},{"v":19.717764,"d":"19.72"},{"v":22.329916,"d":"22.33"},{"v":0.447519277017638,"d":"0.45"},{"v":-1.15997826668083,"d":"-1.16"},{"v":0.00154111962238291,"d":"0.00"},{"v":0.0559186693205957,"d":"0.06"},"down","yes"]
["MSTRG.455","DNAJB4","ENSOART00000014493","GO:0001671(ATPase activator activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006457(protein folding);GO:0032781(positive regulation of ATPase activity);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding)","NA","K09510","NA","DnaJ heat shock protein family (Hsp40) member B4 [Source:NCBI gene;Acc:101101935]",{"v":11.4014315594481,"d":"11.40"},{"v":9.62504433808712,"d":"9.63"},{"v":13.87293126337,"d":"13.87"},{"v":7.28295589598512,"d":"7.28"},{"v":5.44868257169431,"d":"5.45"},{"v":5.17268917067121,"d":"5.17"},{"v":1.94921629372731,"d":"1.95"},{"v":0.962894187350097,"d":"0.96"},{"v":0.00155058513938575,"d":"0.00"},{"v":0.0561373706339035,"d":"0.06"},"up","no"]
["MSTRG.21397","ENSOARG00000007688","ENSOART00000008369","GO:0005743(mitochondrial inner membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","NA","NA",null,{"v":22.2875206687179,"d":"22.29"},{"v":18.7960294358974,"d":"18.80"},{"v":19.7628722789744,"d":"19.76"},{"v":36.7349490789744,"d":"36.73"},{"v":44.9227132625641,"d":"44.92"},{"v":51.0477798564103,"d":"51.05"},{"v":0.458507363193355,"d":"0.46"},{"v":-1.12498319256705,"d":"-1.12"},{"v":0.0015569960579959,"d":"0.00"},{"v":0.0562447602543299,"d":"0.06"},"down","yes"]
["MSTRG.5246","MLYCD","ENSOART00000010571","GO:0005102(signaling receptor binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005777(peroxisome);GO:0006085(acetyl-CoA biosynthetic process);GO:0006633(fatty acid biosynthetic process);GO:0010906(regulation of glucose metabolic process);GO:0042802(identical protein binding);GO:0046321(positive regulation of fatty acid oxidation);GO:0050080(malonyl-CoA decarboxylase activity);GO:2001294(malonyl-CoA catabolic process)","00410(beta-Alanine metabolism);00640(Propanoate metabolism);04146(Peroxisome);04152(AMPK signaling pathway)","K01578","EC:4.1.1.9","malonyl-CoA decarboxylase [Source:NCBI gene;Acc:101122299]",{"v":9.336027,"d":"9.34"},{"v":6.902317,"d":"6.90"},{"v":4.436828,"d":"4.44"},{"v":16.376461,"d":"16.38"},{"v":14.238175,"d":"14.24"},{"v":16.23196,"d":"16.23"},{"v":0.441337765501681,"d":"0.44"},{"v":-1.18004489012771,"d":"-1.18"},{"v":0.00156796720249601,"d":"0.00"},{"v":0.0563915605338214,"d":"0.06"},"down","yes"]
["MSTRG.625","GSTM3","ENSOART00000021038","GO:0004364(glutathione transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006749(glutathione metabolic process);GO:0016740(transferase activity);GO:0018916(nitrobenzene metabolic process);GO:0019899(enzyme binding);GO:0035686(sperm fibrous sheath);GO:0042178(xenobiotic catabolic process);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043295(glutathione binding);GO:0043627(response to estrogen);GO:0045171(intercellular bridge);GO:0070458(cellular detoxification of nitrogen compound)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);00983(Drug metabolism - other enzymes);01524(Platinum drug resistance);05200(Pathways in cancer);05204(Chemical carcinogenesis);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis)","K00799","EC:2.5.1.18","glutathione S-transferase mu 3 [Source:NCBI gene;Acc:100037663]",{"v":7.76865751317441,"d":"7.77"},{"v":5.85811520828105,"d":"5.86"},{"v":4.16113040526976,"d":"4.16"},{"v":2.38260990464241,"d":"2.38"},{"v":3.06624467754078,"d":"3.07"},{"v":3.10724380050188,"d":"3.11"},{"v":2.07897365494564,"d":"2.08"},{"v":1.05587147627223,"d":"1.06"},{"v":0.00158255863627118,"d":"0.00"},{"v":0.0565681861834843,"d":"0.06"},"up","yes"]
["MSTRG.860","IL6R","ENSOART00000002776","GO:0004896(cytokine receptor activity);GO:0004897(ciliary neurotrophic factor receptor activity);GO:0004915(interleukin-6 receptor activity);GO:0005138(interleukin-6 receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005896(interleukin-6 receptor complex);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0019899(enzyme binding);GO:0019981(interleukin-6 binding);GO:0031018(endocrine pancreas development);GO:0032722(positive regulation of chemokine production);GO:0032755(positive regulation of interleukin-6 production);GO:0034097(response to cytokine);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0070102(interleukin-6-mediated signaling pathway);GO:0070110(ciliary neurotrophic factor receptor complex);GO:0070119(ciliary neurotrophic factor binding);GO:0070120(ciliary neurotrophic factor-mediated signaling pathway);GO:0072126(positive regulation of glomerular mesangial cell proliferation)","01521(EGFR tyrosine kinase inhibitor resistance);04060(Cytokine-cytokine receptor interaction);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);04630(Jak-STAT signaling pathway);04640(Hematopoietic cell lineage);04659(Th17 cell differentiation);04932(Non-alcoholic fatty liver disease (NAFLD));05163(Human cytomegalovirus infection);05200(Pathways in cancer)","K05055","NA","interleukin 6 receptor [Source:NCBI gene;Acc:101103369]",{"v":7.02067034784872,"d":"7.02"},{"v":3.94175623195697,"d":"3.94"},{"v":7.26521476006246,"d":"7.27"},{"v":16.7911515154407,"d":"16.79"},{"v":12.5337323625954,"d":"12.53"},{"v":12.4025031731436,"d":"12.40"},{"v":0.436826809153218,"d":"0.44"},{"v":-1.19486669411149,"d":"-1.19"},{"v":0.00158327174705122,"d":"0.00"},{"v":0.0565681861834843,"d":"0.06"},"down","yes"]
["MSTRG.3647","TTYH2","ENSOART00000014182","GO:0005254(chloride channel activity);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034707(chloride channel complex);GO:1902476(chloride transmembrane transport)","NA","K22641","NA","tweety family member 2 [Source:NCBI gene;Acc:101106445]",{"v":0.601859,"d":"0.60"},{"v":0.345666,"d":"0.35"},{"v":0.170268,"d":"0.17"},{"v":1.314499,"d":"1.31"},{"v":1.053326,"d":"1.05"},{"v":1.388404,"d":"1.39"},{"v":0.297583826758166,"d":"0.30"},{"v":-1.74863197465726,"d":"-1.75"},{"v":0.00159530416631703,"d":"0.00"},{"v":0.056873638488263,"d":"0.06"},"down","yes"]
["ENSOARG00000010042","STC1","ENSOART00000010928","GO:0001886(endothelial cell morphogenesis);GO:0003421(growth plate cartilage axis specification);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006874(cellular calcium ion homeostasis);GO:0010469(regulation of signaling receptor activity);GO:0010596(negative regulation of endothelial cell migration);GO:0030336(negative regulation of cell migration);GO:0035988(chondrocyte proliferation);GO:0044070(regulation of anion transport);GO:0051926(negative regulation of calcium ion transport);GO:0060348(bone development);GO:0086004(regulation of cardiac muscle cell contraction);GO:0090280(positive regulation of calcium ion import);GO:1903403(negative regulation of renal phosphate excretion)","NA","NA","NA","stanniocalcin 1 [Source:NCBI gene;Acc:101112949]",{"v":1.653181,"d":"1.65"},{"v":2.042328,"d":"2.04"},{"v":1.102238,"d":"1.10"},{"v":0.825726,"d":"0.83"},{"v":0.206593,"d":"0.21"},{"v":0.507193,"d":"0.51"},{"v":3.11640766684508,"d":"3.12"},{"v":1.63988396910752,"d":"1.64"},{"v":0.00164269411242805,"d":"0.00"},{"v":0.0579971855184936,"d":"0.06"},"up","yes"]
["MSTRG.10934","SLC30A2","ENSOART00000005985","GO:0005737(cytoplasm);GO:0005770(late endosome);GO:0006812(cation transport);GO:0008324(cation transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport);GO:0061090(positive regulation of sequestering of zinc ion);GO:0098655(cation transmembrane transport)","NA","K14689","NA","solute carrier family 30 member 2 [Source:NCBI gene;Acc:101117314]",{"v":0.241063,"d":"0.24"},{"v":0.12778,"d":"0.13"},{"v":0.217964,"d":"0.22"},{"v":0.864165,"d":"0.86"},{"v":0.309146,"d":"0.31"},{"v":0.561686,"d":"0.56"},{"v":0.338217875881053,"d":"0.34"},{"v":-1.56397518214299,"d":"-1.56"},{"v":0.00164298664670603,"d":"0.00"},{"v":0.0579971855184936,"d":"0.06"},"down","yes"]
["ENSOARG00000005123","METTL21C","ENSOART00000005578","GO:0005634(nucleus);GO:0006479(protein methylation);GO:0007519(skeletal muscle tissue development);GO:0008628(hormone-mediated apoptotic signaling pathway);GO:0010880(regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0016279(protein-lysine N-methyltransferase activity);GO:0018022(peptidyl-lysine methylation);GO:0031072(heat shock protein binding);GO:0032991(protein-containing complex);GO:0071549(cellular response to dexamethasone stimulus)","NA","K21805","EC:2.1.1.-","methyltransferase like 21C [Source:NCBI gene;Acc:101113506]",{"v":2.27878,"d":"2.28"},{"v":2.418737,"d":"2.42"},{"v":4.735141,"d":"4.74"},{"v":1.612902,"d":"1.61"},{"v":0.945639,"d":"0.95"},{"v":1.113926,"d":"1.11"},{"v":2.56847998906457,"d":"2.57"},{"v":1.36091483374336,"d":"1.36"},{"v":0.00164457967265204,"d":"0.00"},{"v":0.0579971855184936,"d":"0.06"},"up","yes"]
["MSTRG.8919","LMOD3","ENSOART00000010917","GO:0003779(actin binding);GO:0003785(actin monomer binding);GO:0005523(tropomyosin binding);GO:0005737(cytoplasm);GO:0005865(striated muscle thin filament);GO:0006941(striated muscle contraction);GO:0030240(skeletal muscle thin filament assembly);GO:0031430(M band);GO:0031672(A band);GO:0045010(actin nucleation);GO:0048741(skeletal muscle fiber development);GO:0048743(positive regulation of skeletal muscle fiber development);GO:0051694(pointed-end actin filament capping)","NA","K22030","NA","leiomodin 3 [Source:NCBI gene;Acc:101116095]",{"v":64.8407609504267,"d":"64.84"},{"v":69.9890989577408,"d":"69.99"},{"v":57.066780997562,"d":"57.07"},{"v":34.0138800650142,"d":"34.01"},{"v":32.3155223839902,"d":"32.32"},{"v":35.9733036737099,"d":"35.97"},{"v":1.87577287227911,"d":"1.88"},{"v":0.907485149882031,"d":"0.91"},{"v":0.0016974808669859,"d":"0.00"},{"v":0.0591393267090976,"d":"0.06"},"up","no"]
["MSTRG.16421","RAD51AP1","ENSOART00000010715","GO:0000724(double-strand break repair via homologous recombination);GO:0000790(nuclear chromatin);GO:0003690(double-stranded DNA binding);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0032991(protein-containing complex);GO:0036297(interstrand cross-link repair);GO:0071479(cellular response to ionizing radiation)","NA","K20778","NA","RAD51 associated protein 1 [Source:NCBI gene;Acc:101112216]",{"v":2.29634670034247,"d":"2.30"},{"v":0.0947807311643836,"d":"0.09"},{"v":2.07890798458904,"d":"2.08"},{"v":0.159181636130137,"d":"0.16"},0,{"v":0.253575702054795,"d":"0.25"},{"v":10.8296933877724,"d":"10.83"},{"v":3.43692049257025,"d":"3.44"},{"v":0.00170704596998038,"d":"0.00"},{"v":0.0593035033996589,"d":"0.06"},"up","yes"]
["MSTRG.2445","CLYBL","ENSOART00000004735","GO:0000287(magnesium ion binding);GO:0003824(catalytic activity);GO:0004474(malate synthase activity);GO:0046872(metal ion binding);GO:0047777((3S)-citramalyl-CoA lyase activity);GO:0070207(protein homotrimerization);GO:0106064(regulation of cobalamin metabolic process)","NA","K11390","EC:4.1.-.-","citrate lyase beta like [Source:NCBI gene;Acc:101111978]",{"v":2.77704924409449,"d":"2.78"},{"v":3.40299259985684,"d":"3.40"},{"v":1.66373981496063,"d":"1.66"},{"v":1.49653644022906,"d":"1.50"},{"v":1.28406734788833,"d":"1.28"},{"v":1.0686700400859,"d":"1.07"},{"v":2.03773023406162,"d":"2.04"},{"v":1.0269630722388,"d":"1.03"},{"v":0.00175681906610159,"d":"0.00"},{"v":0.0603861454427092,"d":"0.06"},"up","yes"]
["MSTRG.11263","UBR2","ENSOART00000003934;ENSOART00000003932","GO:0000151(ubiquitin ligase complex);GO:0000785(chromatin);GO:0006342(chromatin silencing);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007131(reciprocal meiotic recombination);GO:0007140(male meiotic nuclear division);GO:0007141(male meiosis I);GO:0007283(spermatogenesis);GO:0008270(zinc ion binding);GO:0010529(negative regulation of transposition);GO:0016567(protein ubiquitination);GO:0030163(protein catabolic process);GO:0032007(negative regulation of TOR signaling);GO:0033522(histone H2A ubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0070728(leucine binding);GO:0071233(cellular response to leucine);GO:0071596(ubiquitin-dependent protein catabolic process via the N-end rule pathway);GO:0071596(ubiquitin-dependent protein catabolic process via the N-end rule pathway)","NA","K10626","EC:2.3.2.27","ubiquitin protein ligase E3 component n-recognin 2 [Source:NCBI gene;Acc:101109127]",{"v":14.9775479634349,"d":"14.98"},{"v":15.7243022761219,"d":"15.72"},{"v":13.2618296889751,"d":"13.26"},{"v":7.66825358105263,"d":"7.67"},{"v":8.95343811878116,"d":"8.95"},{"v":6.70680743069252,"d":"6.71"},{"v":1.88454815213567,"d":"1.88"},{"v":0.914218657809289,"d":"0.91"},{"v":0.00176487409295663,"d":"0.00"},{"v":0.0603861454427092,"d":"0.06"},"up","no"]
["MSTRG.4919","COX4I2","ENSOART00000001245","GO:0004129(cytochrome-c oxidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022900(electron transport chain);GO:0031966(mitochondrial membrane);GO:1902600(proton transmembrane transport)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);04714(Thermogenesis);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K02263","NA","cytochrome c oxidase subunit 4 isoform 2, mitochondrial [Source:NCBI gene;Acc:101102327]",{"v":1.4795511011236,"d":"1.48"},{"v":1.13875364419476,"d":"1.14"},{"v":1.46526209363296,"d":"1.47"},{"v":3.59341459550562,"d":"3.59"},{"v":2.88347935205993,"d":"2.88"},{"v":3.90028244569288,"d":"3.90"},{"v":0.393514255149814,"d":"0.39"},{"v":-1.34551219622846,"d":"-1.35"},{"v":0.00176829671477302,"d":"0.00"},{"v":0.0603861454427092,"d":"0.06"},"down","yes"]
["MSTRG.20041","GPX2","ENSOART00000023053","GO:0004601(peroxidase activity);GO:0004602(glutathione peroxidase activity);GO:0006979(response to oxidative stress);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0098869(cellular oxidant detoxification)","00480(Glutathione metabolism);00590(Arachidonic acid metabolism);04918(Thyroid hormone synthesis)","K00432","EC:1.11.1.9","glutathione peroxidase 2 [Source:NCBI gene;Acc:101110596]",{"v":1.242901,"d":"1.24"},{"v":1.485511,"d":"1.49"},{"v":5.198955,"d":"5.20"},{"v":7.761735,"d":"7.76"},{"v":9.075479,"d":"9.08"},{"v":10.828605,"d":"10.83"},{"v":0.286540116524293,"d":"0.29"},{"v":-1.80319095988752,"d":"-1.80"},{"v":0.00176946274637268,"d":"0.00"},{"v":0.0603861454427092,"d":"0.06"},"down","yes"]
["MSTRG.16447","RHNO1","ENSOART00000011941","GO:0000077(DNA damage checkpoint);GO:0000725(recombinational repair);GO:0005634(nucleus);GO:0005694(chromosome);GO:0034644(cellular response to UV);GO:0070318(positive regulation of G0 to G1 transition);GO:0071479(cellular response to ionizing radiation)","NA","NA","NA","RAD9-HUS1-RAD1 interacting nuclear orphan 1 [Source:NCBI gene;Acc:101118432]",{"v":0.247385,"d":"0.25"},{"v":0.129467,"d":"0.13"},{"v":0.11253,"d":"0.11"},{"v":0.552996,"d":"0.55"},{"v":0.50334,"d":"0.50"},{"v":0.488444,"d":"0.49"},{"v":0.316797213842748,"d":"0.32"},{"v":-1.65836844757882,"d":"-1.66"},{"v":0.00182057578127479,"d":"0.00"},{"v":0.0614181019765594,"d":"0.06"},"down","yes"]
["MSTRG.7242","LPCAT1","ENSOART00000017649","GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005811(lipid droplet);GO:0008654(phospholipid biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0036151(phosphatidylcholine acyl-chain remodeling);GO:0043129(surfactant homeostasis);GO:0045732(positive regulation of protein catabolic process);GO:0047159(1-alkenylglycerophosphocholine O-acyltransferase activity);GO:0047184(1-acylglycerophosphocholine O-acyltransferase activity);GO:0047191(1-alkylglycerophosphocholine O-acyltransferase activity);GO:0060041(retina development in camera-type eye);GO:2001246(negative regulation of phosphatidylcholine biosynthetic process)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism)","K13510","2.3.1.67;EC:2.3.1.23","lysophosphatidylcholine acyltransferase 1 [Source:NCBI gene;Acc:101111661]",{"v":0.60857,"d":"0.61"},{"v":0.365906,"d":"0.37"},{"v":0.396988,"d":"0.40"},{"v":0.950166,"d":"0.95"},{"v":1.421057,"d":"1.42"},{"v":1.529863,"d":"1.53"},{"v":0.351559540087042,"d":"0.35"},{"v":-1.50815905021531,"d":"-1.51"},{"v":0.00182982191449703,"d":"0.00"},{"v":0.0615472291566257,"d":"0.06"},"down","yes"]
["MSTRG.5780","CEACAM16","ENSOART00000010051","GO:0005615(extracellular space);GO:0007605(sensory perception of sound);GO:0032426(stereocilium tip);GO:0042802(identical protein binding)","NA","K06499","NA","carcinoembryonic antigen related cell adhesion molecule 16 [Source:NCBI gene;Acc:101110784]",{"v":0.276031778567523,"d":"0.28"},{"v":0.215616562602515,"d":"0.22"},{"v":0.414690079825041,"d":"0.41"},{"v":0.768447241115364,"d":"0.77"},{"v":0.774833017495899,"d":"0.77"},{"v":1.30898200328048,"d":"1.31"},{"v":0.317761249764584,"d":"0.32"},{"v":-1.65398489273415,"d":"-1.65"},{"v":0.00183994073028944,"d":"0.00"},{"v":0.0615472291566257,"d":"0.06"},"down","yes"]
["MSTRG.10225","CHRNA1","ENSOART00000000268","GO:0003009(skeletal muscle contraction);GO:0004888(transmembrane signaling receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0005892(acetylcholine-gated channel complex);GO:0006811(ion transport);GO:0007274(neuromuscular synaptic transmission);GO:0007528(neuromuscular junction development);GO:0009986(cell surface);GO:0015464(acetylcholine receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019228(neuronal action potential);GO:0022848(acetylcholine-gated cation-selective channel activity);GO:0030054(cell junction);GO:0031594(neuromuscular junction);GO:0034220(ion transmembrane transport);GO:0042166(acetylcholine binding);GO:0042391(regulation of membrane potential);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0046716(muscle cell cellular homeostasis);GO:0048630(skeletal muscle tissue growth);GO:0050881(musculoskeletal movement);GO:0050905(neuromuscular process);GO:0060078(regulation of postsynaptic membrane potential);GO:0060079(excitatory postsynaptic potential);GO:0070050(neuron cellular homeostasis);GO:0099060(integral component of postsynaptic specialization membrane);GO:1904315(transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential)","04080(Neuroactive ligand-receptor interaction)","K04803","NA","cholinergic receptor nicotinic alpha 1 subunit [Source:NCBI gene;Acc:101110120]",{"v":1.129075,"d":"1.13"},{"v":0.542936,"d":"0.54"},{"v":0.889101,"d":"0.89"},{"v":2.047808,"d":"2.05"},{"v":1.93621,"d":"1.94"},{"v":1.963629,"d":"1.96"},{"v":0.430609281283842,"d":"0.43"},{"v":-1.21554867942804,"d":"-1.22"},{"v":0.00184176946457068,"d":"0.00"},{"v":0.0615472291566257,"d":"0.06"},"down","yes"]
["MSTRG.2601","RF00012;ENSOARG00000011009","ENSOART00000026392;ENSOART00000011987","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007094(mitotic spindle assembly checkpoint);GO:0007140(male meiotic nuclear division);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0043063(intercellular bridge organization);GO:0051306(mitotic sister chromatid separation)","NA","K17540","NA","testis expressed 14, intercellular bridge forming factor [Source:NCBI gene;Acc:101102402]",{"v":1.78482259399107,"d":"1.78"},{"v":3.96959982663419,"d":"3.97"},{"v":1.48474590621194,"d":"1.48"},{"v":4.8859246045473,"d":"4.89"},{"v":6.1833713361754,"d":"6.18"},{"v":8.98252489159561,"d":"8.98"},{"v":0.361022990748528,"d":"0.36"},{"v":-1.46983738081442,"d":"-1.47"},{"v":0.00187450129418922,"d":"0.00"},{"v":0.0623357579053394,"d":"0.06"},"down","yes"]
["MSTRG.5537","PKD1L3","ENSOART00000004121","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050915(sensory perception of sour taste)","04742(Taste transduction)","K04989","NA","polycystin 1 like 3, transient receptor potential channel interacting [Source:NCBI gene;Acc:101114721]",{"v":0.11266326239205,"d":"0.11"},{"v":0.934363017981782,"d":"0.93"},{"v":0.0959928589849758,"d":"0.10"},{"v":0.103927152017035,"d":"0.10"},{"v":0.0926191497693127,"d":"0.09"},{"v":0.0506855557790134,"d":"0.05"},{"v":4.62326801495081,"d":"4.62"},{"v":2.2089129993103,"d":"2.21"},{"v":0.00192221271053416,"d":"0.00"},{"v":0.0635418896786307,"d":"0.06"},"up","yes"]
["MSTRG.15756","ENSOARG00000018874","ENSOART00000020554","GO:0005198(structural molecule activity);GO:0005882(intermediate filament)","NA","NA","NA",null,{"v":0.54376,"d":"0.54"},{"v":1.829895,"d":"1.83"},{"v":8.343345,"d":"8.34"},{"v":0.331335,"d":"0.33"},{"v":0.796794,"d":"0.80"},{"v":0.940949,"d":"0.94"},{"v":5.1796017356523,"d":"5.18"},{"v":2.372841172026,"d":"2.37"},{"v":0.00192244570683755,"d":"0.00"},{"v":0.0635418896786307,"d":"0.06"},"up","yes"]
["MSTRG.8888","ENSOARG00000009348","ENSOART00000010175","GO:0005515(protein binding);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","NA","NA",null,{"v":5.96407215071043,"d":"5.96"},{"v":5.24228584900131,"d":"5.24"},{"v":4.78573312171657,"d":"4.79"},{"v":2.90743319480176,"d":"2.91"},{"v":3.49462301222691,"d":"3.49"},{"v":1.30021068810579,"d":"1.30"},{"v":2.07628368883589,"d":"2.08"},{"v":1.05400357689188,"d":"1.05"},{"v":0.00201448856622989,"d":"0.00"},{"v":0.0660493359626541,"d":"0.07"},"up","yes"]
["MSTRG.2896","ARRB2","ENSOART00000008492","GO:0001664(G protein-coupled receptor binding);GO:0001932(regulation of protein phosphorylation);GO:0001933(negative regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0002031(G protein-coupled receptor internalization);GO:0002032(desensitization of G protein-coupled receptor signaling pathway by arrestin);GO:0002092(positive regulation of receptor internalization);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006366(transcription by RNA polymerase II);GO:0007165(signal transduction);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007628(adult walking behavior);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0010628(positive regulation of gene expression);GO:0016567(protein ubiquitination);GO:0019899(enzyme binding);GO:0030139(endocytic vesicle);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0031410(cytoplasmic vesicle);GO:0031623(receptor internalization);GO:0031625(ubiquitin protein ligase binding);GO:0031701(angiotensin receptor binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032226(positive regulation of synaptic transmission, dopaminergic);GO:0032691(negative regulation of interleukin-1 beta production);GO:0032695(negative regulation of interleukin-12 production);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032947(protein-containing complex scaffold activity);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043422(protein kinase B binding);GO:0045953(negative regulation of natural killer cell mediated cytotoxicity);GO:0051897(positive regulation of protein kinase B signaling);GO:0060326(cell chemotaxis);GO:0060765(regulation of androgen receptor signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:2000727(positive regulation of cardiac muscle cell differentiation)","04010(MAPK signaling pathway);04062(Chemokine signaling pathway);04144(Endocytosis);04340(Hedgehog signaling pathway);04740(Olfactory transduction);04926(Relaxin signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05032(Morphine addiction)","K04439","NA","arrestin beta 2 [Source:NCBI gene;Acc:101112493]",{"v":0.853824,"d":"0.85"},{"v":0.838914,"d":"0.84"},{"v":0.997289,"d":"1.00"},{"v":2.310335,"d":"2.31"},{"v":2.032363,"d":"2.03"},{"v":2.329677,"d":"2.33"},{"v":0.403158845238764,"d":"0.40"},{"v":-1.31057971993917,"d":"-1.31"},{"v":0.00202861847875531,"d":"0.00"},{"v":0.0662823686596241,"d":"0.07"},"down","yes"]
["ENSOARG00000007307","CD1E","ENSOART00000007950","GO:0016020(membrane);GO:0016021(integral component of membrane)","04530(Tight junction);04640(Hematopoietic cell lineage)","K06448","NA","CD1e molecule [Source:NCBI gene;Acc:101110634]",{"v":0.153642,"d":"0.15"},{"v":0.083573,"d":"0.08"},{"v":0.059577,"d":"0.06"},{"v":0.288122,"d":"0.29"},{"v":0.328805,"d":"0.33"},{"v":0.341515,"d":"0.34"},{"v":0.309660887148101,"d":"0.31"},{"v":-1.69123892524575,"d":"-1.69"},{"v":0.00205480446779251,"d":"0.00"},{"v":0.0669548423978554,"d":"0.07"},"down","yes"]
["ENSOARG00000009686","ADAMTS4","ENSOART00000010544","GO:0002020(protease binding);GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0016607(nuclear speck)","NA","K07764","EC:3.4.24.82","ADAM metallopeptidase with thrombospondin type 1 motif 4 [Source:NCBI gene;Acc:101106565]",{"v":0.714199,"d":"0.71"},{"v":1.511014,"d":"1.51"},{"v":1.000153,"d":"1.00"},{"v":0.606808,"d":"0.61"},{"v":0.157751,"d":"0.16"},{"v":0.448529,"d":"0.45"},{"v":2.6588062861062,"d":"2.66"},{"v":1.41077866991674,"d":"1.41"},{"v":0.00205850875084048,"d":"0.00"},{"v":0.0669548423978554,"d":"0.07"},"up","yes"]
["MSTRG.3313","RF00004","ENSOART00000025586;ENSOART00000025208","NA","NA","NA","NA",null,{"v":48.1923965,"d":"48.19"},{"v":134.718689,"d":"134.72"},{"v":187.436119,"d":"187.44"},{"v":425.956340617801,"d":"425.96"},{"v":369.7789765,"d":"369.78"},{"v":264.420048513089,"d":"264.42"},{"v":0.349332952986197,"d":"0.35"},{"v":-1.51732535462411,"d":"-1.52"},{"v":0.0020754366578086,"d":"0.00"},{"v":0.0673712321047689,"d":"0.07"},"down","yes"]
["MSTRG.3369","ENSOARG00000011103","ENSOART00000012074","GO:0000166(nucleotide binding);GO:0005525(GTP binding);GO:0005794(Golgi apparatus)","NA","K06883","NA","ADP-ribosylation factor 2 [Source:NCBI gene;Acc:101120590]",{"v":9.18549166421794,"d":"9.19"},{"v":11.8735248962351,"d":"11.87"},{"v":9.16366581573309,"d":"9.16"},{"v":3.34172090970309,"d":"3.34"},{"v":3.38441585644322,"d":"3.38"},{"v":6.82866425589226,"d":"6.83"},{"v":2.22966625087653,"d":"2.23"},{"v":1.15682777550871,"d":"1.16"},{"v":0.00209132187920651,"d":"0.00"},{"v":0.067752189769214,"d":"0.07"},"up","yes"]
["MSTRG.881","DPM3","ENSOART00000007240","GO:0004582(dolichyl-phosphate beta-D-mannosyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006486(protein glycosylation);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0031647(regulation of protein stability);GO:0033185(dolichol-phosphate-mannose synthase complex);GO:0097502(mannosylation)","00510(N-Glycan biosynthesis)","K09659","NA","dolichyl-phosphate mannosyltransferase subunit 3 [Source:NCBI gene;Acc:101116108]",{"v":2.96349503867403,"d":"2.96"},{"v":3.82804732044199,"d":"3.83"},{"v":3.73691041436464,"d":"3.74"},{"v":6.85138367403315,"d":"6.85"},{"v":10.3004050055249,"d":"10.30"},{"v":9.8310196961326,"d":"9.83"},{"v":0.390191140480616,"d":"0.39"},{"v":-1.35774707380814,"d":"-1.36"},{"v":0.00215998524224711,"d":"0.00"},{"v":0.0694256673925408,"d":"0.07"},"down","yes"]
["MSTRG.13684","EPHB4","ENSOART00000017228","GO:0000166(nucleotide binding);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007155(cell adhesion);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway)","04360(Axon guidance)","K05113","EC:2.7.10.1","EPH receptor B4 [Source:NCBI gene;Acc:101120886]",{"v":5.648035,"d":"5.65"},{"v":3.997592,"d":"4.00"},{"v":4.786479,"d":"4.79"},{"v":9.404551,"d":"9.40"},{"v":10.328475,"d":"10.33"},{"v":10.504107,"d":"10.50"},{"v":0.477297434250794,"d":"0.48"},{"v":-1.06703951379497,"d":"-1.07"},{"v":0.00217228581333607,"d":"0.00"},{"v":0.0696557132853382,"d":"0.07"},"down","yes"]
["MSTRG.17279","BPGM","ENSOART00000008398","GO:0003824(catalytic activity);GO:0004082(bisphosphoglycerate mutase activity);GO:0004619(phosphoglycerate mutase activity);GO:0006096(glycolytic process);GO:0016853(isomerase activity);GO:0016868(intramolecular transferase activity, phosphotransferases)","00010(Glycolysis / Gluconeogenesis);00260(Glycine, serine and threonine metabolism)","K01837","5.4.2.11;EC:5.4.2.4","bisphosphoglycerate mutase [Source:NCBI gene;Acc:101121089]",{"v":36.5258629133002,"d":"36.53"},{"v":29.5456871420137,"d":"29.55"},{"v":18.675156685519,"d":"18.68"},{"v":18.6200063940336,"d":"18.62"},{"v":10.8576497498446,"d":"10.86"},{"v":12.422643075202,"d":"12.42"},{"v":2.02257998917205,"d":"2.02"},{"v":1.01619675961441,"d":"1.02"},{"v":0.00217567453304278,"d":"0.00"},{"v":0.0696557132853382,"d":"0.07"},"up","yes"]
["ENSOARG00000010070","FCGR3A","ENSOART00000010960","NA","04145(Phagosome);04380(Osteoclast differentiation);04650(Natural killer cell mediated cytotoxicity);05140(Leishmaniasis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05322(Systemic lupus erythematosus)","K06463","NA","Fc fragment of IgG, low affinity IIIa, receptor (CD16a) [Source:NCBI gene;Acc:100192433]",{"v":1.20796,"d":"1.21"},{"v":0.320459,"d":"0.32"},{"v":0.524837,"d":"0.52"},{"v":2.381507,"d":"2.38"},{"v":1.662794,"d":"1.66"},{"v":2.461465,"d":"2.46"},{"v":0.315605572041786,"d":"0.32"},{"v":-1.66380541841404,"d":"-1.66"},{"v":0.00218137956143886,"d":"0.00"},{"v":0.0697016936970132,"d":"0.07"},"down","yes"]
["MSTRG.5076","RF00020;UBE2C;DNTTIP1","ENSOART00000026571;ENSOART00000007085;ENSOART00000006906","GO:0000151(ubiquitin ligase complex);GO:0000166(nucleotide binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005524(ATP binding);GO:0005680(anaphase-promoting complex);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0010458(exit from mitosis);GO:0010994(free ubiquitin chain polymerization);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031536(positive regulation of exit from mitosis);GO:0044389(ubiquitin-like protein ligase binding);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070936(protein K48-linked ubiquitination);GO:0070979(protein K11-linked ubiquitination);GO:0000118(histone deacetylase complex);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0031491(nucleosome binding);GO:0042803(protein homodimerization activity)","04120(Ubiquitin mediated proteolysis)","K06688;K08707","EC:2.3.2.23","RNA, U5A small nuclear 8, pseudogene [Source:HGNC Symbol;Acc:HGNC:42530];ubiquitin conjugating enzyme E2 C [Source:NCBI gene;Acc:101115053];deoxynucleotidyltransferase terminal interacting protein 1 [Source:NCBI gene;Acc:101114798]",{"v":7.98516961116054,"d":"7.99"},{"v":2.73371311008008,"d":"2.73"},{"v":5.17429168501335,"d":"5.17"},{"v":2.54966180475404,"d":"2.55"},{"v":2.27852631549511,"d":"2.28"},{"v":2.49540042455828,"d":"2.50"},{"v":2.17013480604704,"d":"2.17"},{"v":1.11778466385633,"d":"1.12"},{"v":0.00219880150588049,"d":"0.00"},{"v":0.0701211542734701,"d":"0.07"},"up","yes"]
["MSTRG.1540","MCF2L2","ENSOART00000022501","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0035023(regulation of Rho protein signal transduction)","NA","K20685","NA","probable guanine nucleotide exchange factor MCF2L2 [Source:NCBI gene;Acc:101109765]",{"v":0.199312,"d":"0.20"},{"v":0.156299,"d":"0.16"},{"v":0.149331,"d":"0.15"},{"v":0.535535,"d":"0.54"},{"v":0.550725,"d":"0.55"},{"v":0.35651,"d":"0.36"},{"v":0.349980939442877,"d":"0.35"},{"v":-1.51465174231557,"d":"-1.51"},{"v":0.00221758926149514,"d":"0.00"},{"v":0.0704451312484293,"d":"0.07"},"down","yes"]
["MSTRG.235","HPDL","ENSOART00000010751","GO:0003868(4-hydroxyphenylpyruvate dioxygenase activity);GO:0009072(aromatic amino acid family metabolic process);GO:0016701(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen);GO:0055114(oxidation-reduction process)","NA","NA","NA","4-hydroxyphenylpyruvate dioxygenase like [Source:NCBI gene;Acc:101119084]",{"v":0.938892,"d":"0.94"},{"v":0.655093,"d":"0.66"},{"v":0.486515,"d":"0.49"},{"v":1.909058,"d":"1.91"},{"v":1.846449,"d":"1.85"},{"v":1.913977,"d":"1.91"},{"v":0.36696461265258,"d":"0.37"},{"v":-1.44628714792827,"d":"-1.45"},{"v":0.00223509970641187,"d":"0.00"},{"v":0.0707261783067695,"d":"0.07"},"down","yes"]
["MSTRG.12482","RF00586;CWF19L1","ENSOART00000023786;ENSOART00000015380","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 12 [Source:HGNC Symbol;Acc:HGNC:32600];CWF19 like cell cycle control factor 1 [Source:NCBI gene;Acc:101121304]",{"v":5.20679857374392,"d":"5.21"},{"v":4.25054540464614,"d":"4.25"},{"v":4.35451305510535,"d":"4.35"},{"v":7.69593489789303,"d":"7.70"},{"v":9.2942631982712,"d":"9.29"},{"v":14.2361828449487,"d":"14.24"},{"v":0.442313730161109,"d":"0.44"},{"v":-1.17685806827843,"d":"-1.18"},{"v":0.00225253097657504,"d":"0.00"},{"v":0.0711398951363969,"d":"0.07"},"down","yes"]
["MSTRG.6880","CREBRF","ENSOART00000004444","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006986(response to unfolded protein);GO:0016604(nuclear body);GO:0042711(maternal behavior);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1900170(negative regulation of glucocorticoid mediated signaling pathway);GO:1902213(positive regulation of prolactin signaling pathway)","NA","K21554","NA","CREB3 regulatory factor [Source:NCBI gene;Acc:101108688]",{"v":1.99396280067176,"d":"1.99"},{"v":2.11875310516562,"d":"2.12"},{"v":1.80712169990734,"d":"1.81"},{"v":0.686780191799861,"d":"0.69"},{"v":0.816806001389854,"d":"0.82"},{"v":1.32286294556405,"d":"1.32"},{"v":2.09444335105032,"d":"2.09"},{"v":1.06656686378715,"d":"1.07"},{"v":0.00226215097483673,"d":"0.00"},{"v":0.071305793662421,"d":"0.07"},"up","yes"]
["ENSOARG00000017276","ENSOARG00000017276","ENSOART00000018805","NA","NA","NA","NA",null,{"v":0.236222,"d":"0.24"},{"v":0.154922,"d":"0.15"},{"v":0.290633,"d":"0.29"},{"v":0.669516,"d":"0.67"},{"v":0.555989,"d":"0.56"},{"v":0.820671,"d":"0.82"},{"v":0.333195678182131,"d":"0.33"},{"v":-1.58555840698595,"d":"-1.59"},{"v":0.00228587609836898,"d":"0.00"},{"v":0.0719148071949301,"d":"0.07"},"down","yes"]
["ENSOARG00000000548","PLP1","ENSOART00000000585;ENSOART00000000587","GO:0005886(plasma membrane);GO:0006954(inflammatory response);GO:0008366(axon ensheathment);GO:0010628(positive regulation of gene expression);GO:0014002(astrocyte development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022010(central nervous system myelination);GO:0042552(myelination);GO:0042759(long-chain fatty acid biosynthetic process);GO:0043209(myelin sheath);GO:0048469(cell maturation);GO:0061564(axon development);GO:0061564(axon development)","NA","K17271","NA","proteolipid protein 1 [Source:NCBI gene;Acc:101121072]",{"v":0.595118,"d":"0.60"},{"v":0.203227,"d":"0.20"},{"v":0.468522820539419,"d":"0.47"},{"v":1.659442,"d":"1.66"},{"v":0.789896,"d":"0.79"},{"v":1.957085,"d":"1.96"},{"v":0.287504812983097,"d":"0.29"},{"v":-1.79834198714783,"d":"-1.80"},{"v":0.00229947181949698,"d":"0.00"},{"v":0.0720497874218765,"d":"0.07"},"down","yes"]
["MSTRG.1497","RF00092","ENSOART00000024217","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 63 [Source:HGNC Symbol;Acc:HGNC:10106]",{"v":216.749893,"d":"216.75"},{"v":231.860901,"d":"231.86"},{"v":134.397064,"d":"134.40"},{"v":319.419098,"d":"319.42"},{"v":357.191895,"d":"357.19"},{"v":930.298889,"d":"930.30"},{"v":0.362813039194441,"d":"0.36"},{"v":-1.46270178884696,"d":"-1.46"},{"v":0.00230340452193897,"d":"0.00"},{"v":0.0720497874218765,"d":"0.07"},"down","yes"]
["MSTRG.19054","CCDC158","ENSOART00000018701","NA","NA","NA","NA","coiled-coil domain containing 158 [Source:NCBI gene;Acc:101109802]",{"v":0.238177,"d":"0.24"},{"v":0.329987,"d":"0.33"},{"v":0.233305,"d":"0.23"},{"v":0.106238,"d":"0.11"},{"v":0.101162,"d":"0.10"},{"v":0.089505,"d":"0.09"},{"v":2.69941226991799,"d":"2.70"},{"v":1.43264533039675,"d":"1.43"},{"v":0.00230820013599483,"d":"0.00"},{"v":0.0720617434426837,"d":"0.07"},"up","yes"]
["MSTRG.580","ENSOARG00000018733","ENSOART00000020395","GO:0003824(catalytic activity);GO:0004556(alpha-amylase activity);GO:0005975(carbohydrate metabolic process);GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0043169(cation binding);GO:0103025(alpha-amylase activity (releasing maltohexaose))","00500(Starch and sucrose metabolism);04973(Carbohydrate digestion and absorption)","K01176","EC:3.2.1.1","alpha-amylase 2B [Source:NCBI gene;Acc:101118573]",{"v":1.62999103956835,"d":"1.63"},{"v":0.746252819244604,"d":"0.75"},{"v":1.00634337027878,"d":"1.01"},{"v":0.502709051258993,"d":"0.50"},{"v":0.517719166366907,"d":"0.52"},{"v":0.49850614073741,"d":"0.50"},{"v":2.22694760340832,"d":"2.23"},{"v":1.1550676141687,"d":"1.16"},{"v":0.00238755959594748,"d":"0.00"},{"v":0.0739735732118226,"d":"0.07"},"up","yes"]
["MSTRG.6226","ENSOARG00000021831","ENSOART00000023733","NA","NA","NA","NA",null,{"v":704.158752,"d":"704.16"},{"v":567.198608,"d":"567.20"},{"v":753.865234,"d":"753.87"},{"v":1143.230347,"d":"1143.23"},{"v":1283.851929,"d":"1283.85"},{"v":2234.36792,"d":"2234.37"},{"v":0.434461918254076,"d":"0.43"},{"v":-1.20269836837417,"d":"-1.20"},{"v":0.00240292430695486,"d":"0.00"},{"v":0.0742966861248835,"d":"0.07"},"down","yes"]
["MSTRG.13764","FSCN1","ENSOART00000003207","GO:0001725(stress fiber);GO:0001726(ruffle);GO:0002102(podosome);GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005902(microvillus);GO:0005911(cell-cell junction);GO:0007015(actin filament organization);GO:0007043(cell-cell junction assembly);GO:0008144(drug binding);GO:0010592(positive regulation of lamellipodium assembly);GO:0015629(actin cytoskeleton);GO:0016477(cell migration);GO:0030027(lamellipodium);GO:0030035(microspike assembly);GO:0030036(actin cytoskeleton organization);GO:0030175(filopodium);GO:0030426(growth cone);GO:0030674(protein binding, bridging);GO:0031253(cell projection membrane);GO:0032534(regulation of microvillus assembly);GO:0032956(regulation of actin cytoskeleton organization);GO:0035089(establishment of apical/basal cell polarity);GO:0044393(microspike);GO:0048870(cell motility);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:0051491(positive regulation of filopodium assembly);GO:0071437(invadopodium);GO:0071803(positive regulation of podosome assembly);GO:0090091(positive regulation of extracellular matrix disassembly)","NA","NA","NA","fascin actin-bundling protein 1 [Source:HGNC Symbol;Acc:HGNC:11148]",{"v":7.33262247035728,"d":"7.33"},{"v":5.58727878327444,"d":"5.59"},{"v":5.62188820769533,"d":"5.62"},{"v":13.3918097000393,"d":"13.39"},{"v":11.2100346007067,"d":"11.21"},{"v":14.325052281115,"d":"14.33"},{"v":0.476323341685735,"d":"0.48"},{"v":-1.06998684681708,"d":"-1.07"},{"v":0.00249004834028714,"d":"0.00"},{"v":0.0758535621272545,"d":"0.08"},"down","yes"]
["MSTRG.6212","ENDOD1","ENSOART00000018461","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","endonuclease domain containing 1 [Source:HGNC Symbol;Acc:HGNC:29129]",{"v":2.08402317012253,"d":"2.08"},{"v":3.03367418944392,"d":"3.03"},{"v":3.62919031032045,"d":"3.63"},{"v":1.49903928039585,"d":"1.50"},{"v":1.83250287629595,"d":"1.83"},{"v":0.719203470311027,"d":"0.72"},{"v":2.15932780660897,"d":"2.16"},{"v":1.11058227488893,"d":"1.11"},{"v":0.00257993384054202,"d":"0.00"},{"v":0.0781542852474399,"d":"0.08"},"up","yes"]
["MSTRG.9139","ENSOARG00000017257;MIR711","ENSOART00000018813;ENSOART00000023572","GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0010951(negative regulation of endopeptidase activity);GO:0042802(identical protein binding)","04974(Protein digestion and absorption)","K16628","NA","collagen type VII alpha 1 chain [Source:NCBI gene;Acc:101119261];microRNA 711 [Source:HGNC Symbol;Acc:HGNC:37316]",{"v":0.0350675675915649,"d":"0.04"},{"v":0.0214999391786903,"d":"0.02"},{"v":0.028597876581576,"d":"0.03"},{"v":0.0422470668146504,"d":"0.04"},{"v":0.139621646614872,"d":"0.14"},{"v":0.12496632963374,"d":"0.12"},{"v":0.27756081085651,"d":"0.28"},{"v":-1.84912420843414,"d":"-1.85"},{"v":0.00258774121739791,"d":"0.00"},{"v":0.078245627032728,"d":"0.08"},"down","yes"]
["MSTRG.11468","ENSOARG00000020031","ENSOART00000021810","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05202(Transcriptional misregulation in cancer);05322(Systemic lupus erythematosus)","K11253","NA","histone H3.1 [Source:NCBI gene;Acc:101118484]",{"v":2.234816,"d":"2.23"},{"v":1.67638,"d":"1.68"},{"v":3.585066,"d":"3.59"},{"v":7.404926,"d":"7.40"},{"v":4.071077,"d":"4.07"},{"v":10.179996,"d":"10.18"},{"v":0.346151752223483,"d":"0.35"},{"v":-1.53052344377814,"d":"-1.53"},{"v":0.00260773339734089,"d":"0.00"},{"v":0.0784079826909451,"d":"0.08"},"down","yes"]
["MSTRG.3257","CNP","ENSOART00000019757","GO:0004113(2',3'-cyclic-nucleotide 3'-phosphodiesterase activity);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007409(axonogenesis);GO:0008344(adult locomotory behavior);GO:0009214(cyclic nucleotide catabolic process);GO:0009636(response to toxic substance);GO:0016020(membrane);GO:0043209(myelin sheath);GO:0048709(oligodendrocyte differentiation)","NA","K01121","EC:3.1.4.37","2',3'-cyclic nucleotide 3' phosphodiesterase [Source:NCBI gene;Acc:101120423]",{"v":2.02500618718873,"d":"2.03"},{"v":1.68824084028851,"d":"1.69"},{"v":1.77574373553151,"d":"1.78"},{"v":3.60725889198008,"d":"3.61"},{"v":3.94002028713721,"d":"3.94"},{"v":3.88478093645887,"d":"3.88"},{"v":0.480140124134758,"d":"0.48"},{"v":-1.05847259136027,"d":"-1.06"},{"v":0.00261231887456358,"d":"0.00"},{"v":0.0784079826909451,"d":"0.08"},"down","yes"]
["MSTRG.16319","EMP1","ENSOART00000022671","GO:0005886(plasma membrane);GO:0008219(cell death);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016049(cell growth);GO:0032060(bleb assembly)","NA","NA","NA","epithelial membrane protein 1 [Source:NCBI gene;Acc:101109432]",{"v":8.92702776917664,"d":"8.93"},{"v":17.3775194092189,"d":"17.38"},{"v":15.4771828979592,"d":"15.48"},{"v":7.62295878571429,"d":"7.62"},{"v":2.1817788346235,"d":"2.18"},{"v":7.09504460837438,"d":"7.10"},{"v":2.472323578547,"d":"2.47"},{"v":1.3058675760152,"d":"1.31"},{"v":0.00261775722124781,"d":"0.00"},{"v":0.0784270457037327,"d":"0.08"},"up","yes"]
["MSTRG.13638","ENSOARG00000011945","ENSOART00000012990","GO:0005201(extracellular matrix structural constituent);GO:0062023(collagen-containing extracellular matrix)","NA","NA","NA",null,{"v":7.92703859960698,"d":"7.93"},{"v":3.42256560329157,"d":"3.42"},{"v":4.85806852444117,"d":"4.86"},{"v":6.88947926160648,"d":"6.89"},{"v":29.824630057971,"d":"29.82"},{"v":11.5332049975436,"d":"11.53"},{"v":0.335929014013289,"d":"0.34"},{"v":-1.57377168911729,"d":"-1.57"},{"v":0.0026474497946713,"d":"0.00"},{"v":0.0789356678462568,"d":"0.08"},"down","yes"]
["MSTRG.12546","CALHM2","ENSOART00000004422","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043065(positive regulation of apoptotic process)","NA","K19739","NA","calcium homeostasis modulator family member 2 [Source:NCBI gene;Acc:101112099]",{"v":0.700640255337691,"d":"0.70"},{"v":0.639595331154684,"d":"0.64"},{"v":0.870356893681917,"d":"0.87"},{"v":1.30182997995643,"d":"1.30"},{"v":2.23341416906318,"d":"2.23"},{"v":1.93782969847495,"d":"1.94"},{"v":0.403903280272063,"d":"0.40"},{"v":-1.30791823205255,"d":"-1.31"},{"v":0.00266795090910367,"d":"0.00"},{"v":0.0792394917313245,"d":"0.08"},"down","yes"]
["MSTRG.18220","CXCL14","ENSOART00000016023","GO:0005576(extracellular region);GO:0005794(Golgi apparatus);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0045662(negative regulation of myoblast differentiation);GO:0048839(inner ear development);GO:0060326(cell chemotaxis);GO:2000503(positive regulation of natural killer cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)","K10033","NA","C-X-C motif chemokine ligand 14 [Source:NCBI gene;Acc:101105243]",{"v":2.19304498369211,"d":"2.19"},{"v":1.40594447488584,"d":"1.41"},{"v":3.01742537181996,"d":"3.02"},{"v":1.04393088062622,"d":"1.04"},{"v":0.467473515981735,"d":"0.47"},{"v":1.09628500978474,"d":"1.10"},{"v":2.53727104699582,"d":"2.54"},{"v":1.34327764524711,"d":"1.34"},{"v":0.00267399313718519,"d":"0.00"},{"v":0.0792394917313245,"d":"0.08"},"up","yes"]
["MSTRG.9792","ANXA1","ENSOART00000013776","GO:0001533(cornified envelope);GO:0001780(neutrophil homeostasis);GO:0002548(monocyte chemotaxis);GO:0002685(regulation of leukocyte migration);GO:0004859(phospholipase inhibitor activity);GO:0005198(structural molecule activity);GO:0005509(calcium ion binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0006909(phagocytosis);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007187(G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0008360(regulation of cell shape);GO:0009986(cell surface);GO:0014839(myoblast migration involved in skeletal muscle regeneration);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0018149(peptide cross-linking);GO:0019834(phospholipase A2 inhibitor activity);GO:0019898(extrinsic component of membrane);GO:0030216(keratinocyte differentiation);GO:0030674(protein binding, bridging);GO:0031232(extrinsic component of external side of plasma membrane);GO:0031340(positive regulation of vesicle fusion);GO:0031514(motile cilium);GO:0031532(actin cytoskeleton reorganization);GO:0032652(regulation of interleukin-1 production);GO:0032743(positive regulation of interleukin-2 production);GO:0033031(positive regulation of neutrophil apoptotic process);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0042102(positive regulation of T cell proliferation);GO:0042127(regulation of cell population proliferation);GO:0042383(sarcolemma);GO:0043086(negative regulation of catalytic activity);GO:0045627(positive regulation of T-helper 1 cell differentiation);GO:0045629(negative regulation of T-helper 2 cell differentiation);GO:0045920(negative regulation of exocytosis);GO:0046632(alpha-beta T cell differentiation);GO:0046883(regulation of hormone secretion);GO:0048306(calcium-dependent protein binding);GO:0050482(arachidonic acid secretion);GO:0050727(regulation of inflammatory response);GO:0070062(extracellular exosome);GO:0071385(cellular response to glucocorticoid stimulus);GO:0071621(granulocyte chemotaxis);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:0090303(positive regulation of wound healing);GO:0097350(neutrophil clearance);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:2000483(negative regulation of interleukin-8 secretion)","NA","K17091","NA","annexin A1 [Source:NCBI gene;Acc:101123269]",{"v":5.49874052941176,"d":"5.50"},{"v":4.93909705882353,"d":"4.94"},{"v":6.55075694117647,"d":"6.55"},{"v":3.71675770588235,"d":"3.72"},{"v":2.30322941176471,"d":"2.30"},{"v":2.98038685294118,"d":"2.98"},{"v":1.88754318264194,"d":"1.89"},{"v":0.916509650355986,"d":"0.92"},{"v":0.00268717949186551,"d":"0.00"},{"v":0.0794859904767753,"d":"0.08"},"up","no"]
["MSTRG.18184","ENSOARG00000013524","ENSOART00000014711","GO:0000166(nucleotide binding);GO:0005524(ATP binding)","04530(Tight junction);04612(Antigen processing and presentation)","K09489","NA","heat shock protein family A (Hsp70) member 4 [Source:NCBI gene;Acc:101122782]",{"v":6.73530100712907,"d":"6.74"},{"v":7.84661409310677,"d":"7.85"},{"v":8.75837726854631,"d":"8.76"},{"v":4.16725529186321,"d":"4.17"},{"v":4.8438179506325,"d":"4.84"},{"v":3.76213530392367,"d":"3.76"},{"v":1.8272849992201,"d":"1.83"},{"v":0.869701666748789,"d":"0.87"},{"v":0.00269851296314334,"d":"0.00"},{"v":0.079676889081744,"d":"0.08"},"up","no"]
["MSTRG.4966","EDEM2","ENSOART00000012897","GO:0003824(catalytic activity);GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity);GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum);GO:0008152(metabolic process);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0036509(trimming of terminal mannose on B branch);GO:0044322(endoplasmic reticulum quality control compartment);GO:0097466(ubiquitin-dependent glycoprotein ERAD pathway);GO:1904154(positive regulation of retrograde protein transport, ER to cytosol);GO:1904382(mannose trimming involved in glycoprotein ERAD pathway)","04141(Protein processing in endoplasmic reticulum)","K10085","NA","ER degradation enhancing alpha-mannosidase like protein 2 [Source:NCBI gene;Acc:101115389]",{"v":1.303772,"d":"1.30"},{"v":0.738709,"d":"0.74"},{"v":1.378176,"d":"1.38"},{"v":2.536136,"d":"2.54"},{"v":2.50335,"d":"2.50"},{"v":3.370797,"d":"3.37"},{"v":0.406723174475817,"d":"0.41"},{"v":-1.29788089914801,"d":"-1.30"},{"v":0.00276036439876647,"d":"0.00"},{"v":0.0812094232487549,"d":"0.08"},"down","yes"]
["MSTRG.2599","RF00003","ENSOART00000025987;ENSOART00000025387","NA","NA","NA","NA",null,{"v":536.7239715,"d":"536.72"},{"v":502.1890625,"d":"502.19"},{"v":530.128774481707,"d":"530.13"},{"v":723.862308,"d":"723.86"},{"v":1066.1468335,"d":"1066.15"},{"v":1983.468647,"d":"1983.47"},{"v":0.415807882389953,"d":"0.42"},{"v":-1.26601098753979,"d":"-1.27"},{"v":0.00276686023867187,"d":"0.00"},{"v":0.0812541258579755,"d":"0.08"},"down","yes"]
["MSTRG.17724","JUNB","ENSOART00000011803","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001570(vasculogenesis);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001829(trophectodermal cell differentiation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0009987(cellular process);GO:0030316(osteoclast differentiation);GO:0033687(osteoblast proliferation);GO:0035976(transcription factor AP-1 complex);GO:0045597(positive regulation of cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046697(decidualization);GO:0051726(regulation of cell cycle);GO:0060136(embryonic process involved in female pregnancy);GO:0060716(labyrinthine layer blood vessel development);GO:0071277(cellular response to calcium ion)","NA","NA","NA","JunB proto-oncogene, AP-1 transcription factor subunit [Source:HGNC Symbol;Acc:HGNC:6205]",{"v":35.059479,"d":"35.06"},{"v":11.912909,"d":"11.91"},{"v":10.380897,"d":"10.38"},{"v":9.751328,"d":"9.75"},{"v":2.615344,"d":"2.62"},{"v":7.814665,"d":"7.81"},{"v":2.84189719442275,"d":"2.84"},{"v":1.50685436605883,"d":"1.51"},{"v":0.00278587870856258,"d":"0.00"},{"v":0.0814324371131989,"d":"0.08"},"up","yes"]
["MSTRG.17628","USHBP1","ENSOART00000019103","GO:0030165(PDZ domain binding)","NA","K21881","NA","USH1 protein network component harmonin binding protein 1 [Source:NCBI gene;Acc:101113408]",{"v":2.538973,"d":"2.54"},{"v":1.081195,"d":"1.08"},{"v":1.094428,"d":"1.09"},{"v":3.433925,"d":"3.43"},{"v":3.936294,"d":"3.94"},{"v":4.066602,"d":"4.07"},{"v":0.412229587225331,"d":"0.41"},{"v":-1.27848003879384,"d":"-1.28"},{"v":0.0028285899377037,"d":"0.00"},{"v":0.0824736008979037,"d":"0.08"},"down","yes"]
["MSTRG.20802","UNC93A","ENSOART00000005404","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","unc-93 homolog A [Source:NCBI gene;Acc:101115038]",{"v":2.07744701976285,"d":"2.08"},{"v":2.57925722213439,"d":"2.58"},{"v":1.69417987233202,"d":"1.69"},{"v":0.980853433201581,"d":"0.98"},{"v":1.14557796798419,"d":"1.15"},{"v":0.969059228063241,"d":"0.97"},{"v":2.05165670805795,"d":"2.05"},{"v":1.03678935325733,"d":"1.04"},{"v":0.00290569903975745,"d":"0.00"},{"v":0.0842704332525037,"d":"0.08"},"up","yes"]
["MSTRG.236","MUTYH","ENSOART00000001642;ENSOART00000001645","GO:0000701(purine-specific mismatch base pair DNA N-glycosylase activity);GO:0003677(DNA binding);GO:0003824(catalytic activity);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0032407(MutSalpha complex binding);GO:0046872(metal ion binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding)","03410(Base excision repair);03410(Base excision repair)","K03575","EC:3.2.2.31","mutY DNA glycosylase [Source:NCBI gene;Acc:101119344]",{"v":0.841560349514563,"d":"0.84"},{"v":0.474404520183955,"d":"0.47"},{"v":0.878490401635156,"d":"0.88"},{"v":2.72779015278488,"d":"2.73"},{"v":1.43687183239653,"d":"1.44"},{"v":1.55791346397547,"d":"1.56"},{"v":0.383473366289472,"d":"0.38"},{"v":-1.38280171443797,"d":"-1.38"},{"v":0.00291705377817862,"d":"0.00"},{"v":0.0844497412945046,"d":"0.08"},"down","yes"]
["MSTRG.12236","ENSOARG00000003783","ENSOART00000004113","GO:0003779(actin binding);GO:0007165(signal transduction)","NA","NA","NA","lymphocyte specific protein 1 [Source:NCBI gene;Acc:101120878]",{"v":3.288533,"d":"3.29"},{"v":3.1411702260274,"d":"3.14"},{"v":5.1599636130137,"d":"5.16"},{"v":6.51050039246575,"d":"6.51"},{"v":10.8718010780822,"d":"10.87"},{"v":9.19910176849315,"d":"9.20"},{"v":0.436006584559047,"d":"0.44"},{"v":-1.19757817218114,"d":"-1.20"},{"v":0.00292234539453846,"d":"0.00"},{"v":0.0844531957557946,"d":"0.08"},"down","yes"]
["MSTRG.4594","CUBN","ENSOART00000010866;ENSOART00000010868","GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005903(brush border);GO:0005905(clathrin-coated pit);GO:0006898(receptor-mediated endocytosis);GO:0009617(response to bacterium);GO:0016324(apical plasma membrane);GO:0030139(endocytic vesicle);GO:0042803(protein homodimerization activity);GO:0042953(lipoprotein transport);GO:0045177(apical part of cell);GO:0070062(extracellular exosome);GO:0070062(extracellular exosome)","04977(Vitamin digestion and absorption);04977(Vitamin digestion and absorption)","K14616","NA","cubilin [Source:NCBI gene;Acc:101110433]",{"v":0.450768,"d":"0.45"},{"v":0.0927592362985404,"d":"0.09"},{"v":0.051108,"d":"0.05"},{"v":0.0234926359129716,"d":"0.02"},{"v":0.078173,"d":"0.08"},{"v":0.022709,"d":"0.02"},{"v":4.78100082009183,"d":"4.78"},{"v":2.25731265315315,"d":"2.26"},{"v":0.00294648317239843,"d":"0.00"},{"v":0.0845450081874432,"d":"0.08"},"up","yes"]
["MSTRG.10987","C1QB","ENSOART00000008685","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005623(cell);GO:0006958(complement activation, classical pathway);GO:0042803(protein homodimerization activity);GO:0045202(synapse);GO:0048839(inner ear development);GO:0098794(postsynapse);GO:0098883(synapse pruning)","04610(Complement and coagulation cascades);05020(Prion diseases);05133(Pertussis);05142(Chagas disease (American trypanosomiasis));05150(Staphylococcus aureus infection);05322(Systemic lupus erythematosus)","K03988","NA","complement C1q B chain [Source:NCBI gene;Acc:101123189]",{"v":6.032784,"d":"6.03"},{"v":2.647182,"d":"2.65"},{"v":8.207493,"d":"8.21"},{"v":12.784041,"d":"12.78"},{"v":11.684304,"d":"11.68"},{"v":19.700413,"d":"19.70"},{"v":0.382339458130111,"d":"0.38"},{"v":-1.38707399826935,"d":"-1.39"},{"v":0.00295330309477322,"d":"0.00"},{"v":0.0845450081874432,"d":"0.08"},"down","yes"]
["MSTRG.11516","ENSOARG00000018513","ENSOART00000020152","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":1.602763,"d":"1.60"},{"v":1.29601,"d":"1.30"},{"v":2.066613,"d":"2.07"},{"v":6.562019,"d":"6.56"},{"v":2.101788,"d":"2.10"},{"v":7.263105,"d":"7.26"},{"v":0.311760748097308,"d":"0.31"},{"v":-1.68148879639011,"d":"-1.68"},{"v":0.00295658988700576,"d":"0.00"},{"v":0.0845450081874432,"d":"0.08"},"down","yes"]
["MSTRG.13879","ENSOARG00000017785","ENSOART00000019350","NA","NA","NA","NA",null,{"v":1.09183886066763,"d":"1.09"},{"v":0.526829507982584,"d":"0.53"},{"v":0.678760502177068,"d":"0.68"},{"v":1.82974048185776,"d":"1.83"},{"v":1.71943908417997,"d":"1.72"},{"v":1.90547838026125,"d":"1.91"},{"v":0.421186606648012,"d":"0.42"},{"v":-1.24746853418781,"d":"-1.25"},{"v":0.00297551625854794,"d":"0.00"},{"v":0.0849374641076412,"d":"0.08"},"down","yes"]
["ENSOARG00000006228","ENSOARG00000006228","ENSOART00000006774","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding)","NA","K04592","NA","adhesion G protein-coupled receptor L1 [Source:NCBI gene;Acc:101118356]",{"v":0.330266,"d":"0.33"},{"v":0.233393,"d":"0.23"},{"v":0.292836,"d":"0.29"},{"v":0.62712,"d":"0.63"},{"v":0.779978,"d":"0.78"},{"v":0.650122,"d":"0.65"},{"v":0.41633612350648,"d":"0.42"},{"v":-1.26417935518728,"d":"-1.26"},{"v":0.00301573224920486,"d":"0.00"},{"v":0.0857586965527071,"d":"0.09"},"down","yes"]
["MSTRG.15133","ATOH8","ENSOART00000022410","GO:0001704(formation of primary germ layer);GO:0001937(negative regulation of endothelial cell proliferation);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0010595(positive regulation of endothelial cell migration);GO:0010629(negative regulation of gene expression);GO:0030154(cell differentiation);GO:0033613(activating transcription factor binding);GO:0035148(tube formation);GO:0045603(positive regulation of endothelial cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:0051450(myoblast proliferation);GO:0060395(SMAD protein signal transduction);GO:0070888(E-box binding);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II)","NA","NA","NA","atonal bHLH transcription factor 8 [Source:HGNC Symbol;Acc:HGNC:24126]",{"v":0.496283875909879,"d":"0.50"},{"v":0.56625321559792,"d":"0.57"},{"v":1.03324526256499,"d":"1.03"},{"v":1.12693777261698,"d":"1.13"},{"v":2.13445251473137,"d":"2.13"},{"v":1.85360540051993,"d":"1.85"},{"v":0.409732965961937,"d":"0.41"},{"v":-1.28724412221441,"d":"-1.29"},{"v":0.00302267876821785,"d":"0.00"},{"v":0.0857586965527071,"d":"0.09"},"down","yes"]
["MSTRG.17421","ENSOARG00000001140","ENSOART00000001216","GO:0005525(GTP binding)","NA","NA","NA",null,{"v":1.84733934050554,"d":"1.85"},{"v":3.49171738959682,"d":"3.49"},{"v":0.74669769291832,"d":"0.75"},{"v":1.14352494819302,"d":"1.14"},{"v":0.624795064549822,"d":"0.62"},{"v":0.542548080426154,"d":"0.54"},{"v":2.63353604691258,"d":"2.63"},{"v":1.39700120672791,"d":"1.40"},{"v":0.00305973319300199,"d":"0.00"},{"v":0.0864348158742847,"d":"0.09"},"up","yes"]
["MSTRG.5156","TSHZ2","ENSOART00000016236","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0010468(regulation of gene expression)","NA","NA","NA","teashirt zinc finger homeobox 2 [Source:HGNC Symbol;Acc:HGNC:13010]",{"v":1.21162144994745,"d":"1.21"},{"v":0.587411172096689,"d":"0.59"},{"v":1.4921199123752,"d":"1.49"},{"v":2.90639809616395,"d":"2.91"},{"v":2.69581185220704,"d":"2.70"},{"v":2.00680830228586,"d":"2.01"},{"v":0.432533137127806,"d":"0.43"},{"v":-1.20911743048799,"d":"-1.21"},{"v":0.0030844747890219,"d":"0.00"},{"v":0.0869832544993949,"d":"0.09"},"down","yes"]
["MSTRG.18531","ENSOARG00000010413","ENSOART00000011326","NA","NA","NA","NA",null,{"v":1.184507,"d":"1.18"},{"v":0.790013,"d":"0.79"},{"v":0.545627,"d":"0.55"},{"v":2.412558,"d":"2.41"},{"v":2.47767,"d":"2.48"},{"v":2.58269,"d":"2.58"},{"v":0.337237341557876,"d":"0.34"},{"v":-1.56816380327621,"d":"-1.57"},{"v":0.00312467512529806,"d":"0.00"},{"v":0.0878135894076881,"d":"0.09"},"down","yes"]
["MSTRG.10941","MAN1C1","ENSOART00000006431","GO:0003824(catalytic activity);GO:0004571(mannosyl-oligosaccharide 1,2-alpha-mannosidase activity);GO:0005509(calcium ion binding);GO:0008152(metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)","K01230","EC:3.2.1.113","mannosidase alpha class 1C member 1 [Source:NCBI gene;Acc:101118089]",{"v":2.38432268616527,"d":"2.38"},{"v":1.74109420380687,"d":"1.74"},{"v":2.1544278454039,"d":"2.15"},{"v":4.07979169591458,"d":"4.08"},{"v":4.13560533797586,"d":"4.14"},{"v":4.65837753760446,"d":"4.66"},{"v":0.487801359306141,"d":"0.49"},{"v":-1.035634316537,"d":"-1.04"},{"v":0.0031305505193069,"d":"0.00"},{"v":0.0878256965053627,"d":"0.09"},"down","yes"]
["MSTRG.4087","ENSOARG00000007039","ENSOART00000007660","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007213(G protein-coupled acetylcholine receptor signaling pathway);GO:0043113(receptor clustering);GO:0043236(laminin binding)","04512(ECM-receptor interaction)","K06254","NA","agrin [Source:NCBI gene;Acc:101107299]",{"v":2.18372979081291,"d":"2.18"},{"v":1.31182998366144,"d":"1.31"},{"v":1.67359651211999,"d":"1.67"},{"v":3.52554921441007,"d":"3.53"},{"v":3.81127033025311,"d":"3.81"},{"v":3.39045954144904,"d":"3.39"},{"v":0.481870215652956,"d":"0.48"},{"v":-1.05328346388152,"d":"-1.05"},{"v":0.00320106831017105,"d":"0.00"},{"v":0.0890409597418618,"d":"0.09"},"down","yes"]
["MSTRG.3191","RF00412","ENSOART00000025099","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 21 [Source:HGNC Symbol;Acc:HGNC:32611]",{"v":3.790176,"d":"3.79"},{"v":1.896039,"d":"1.90"},{"v":1.721186,"d":"1.72"},{"v":6.721166,"d":"6.72"},{"v":5.669998,"d":"5.67"},{"v":11.462737,"d":"11.46"},{"v":0.31053205930552,"d":"0.31"},{"v":-1.6871858750294,"d":"-1.69"},{"v":0.00323603704692348,"d":"0.00"},{"v":0.0898605661601471,"d":"0.09"},"down","yes"]
["MSTRG.17250","MIR29B1;MIR29A","ENSOART00000024169;ENSOART00000026159","NA","NA","NA","NA","microRNA 29b-1 [Source:HGNC Symbol;Acc:HGNC:31619];microRNA 29a [Source:HGNC Symbol;Acc:HGNC:31616]",{"v":1.13315575896656,"d":"1.13"},{"v":1.80217290495092,"d":"1.80"},{"v":2.72945099030257,"d":"2.73"},{"v":0.992281798184109,"d":"0.99"},{"v":1.01863364606755,"d":"1.02"},{"v":0.757276768283697,"d":"0.76"},{"v":2.04638233883035,"d":"2.05"},{"v":1.03307571830022,"d":"1.03"},{"v":0.00325791571469706,"d":"0.00"},{"v":0.0900088795085848,"d":"0.09"},"up","yes"]
["MSTRG.17986","FNIP1","ENSOART00000017631","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001932(regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0002327(immature B cell differentiation);GO:0002904(positive regulation of B cell apoptotic process);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0007005(mitochondrion organization);GO:0009267(cellular response to starvation);GO:0031334(positive regulation of protein complex assembly);GO:0031929(TOR signaling);GO:0032007(negative regulation of TOR signaling);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0038202(TORC1 signaling);GO:0042030(ATPase inhibitor activity);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0051087(chaperone binding);GO:2000973(regulation of pro-B cell differentiation)","04150(mTOR signaling pathway)","K20400","NA","folliculin interacting protein 1 [Source:NCBI gene;Acc:101123298]",{"v":3.92749667369142,"d":"3.93"},{"v":5.61432650289105,"d":"5.61"},{"v":5.77938788036366,"d":"5.78"},{"v":2.77807195781345,"d":"2.78"},{"v":3.32857298729458,"d":"3.33"},{"v":2.03688400190201,"d":"2.04"},{"v":1.88139701554956,"d":"1.88"},{"v":0.91180432091138,"d":"0.91"},{"v":0.0032721145599812,"d":"0.00"},{"v":0.0901835161295505,"d":"0.09"},"up","no"]
["MSTRG.18833","PPARGC1A","ENSOART00000006081","GO:0002021(response to dietary excess);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003723(RNA binding);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007005(mitochondrion organization);GO:0008134(transcription factor binding);GO:0010628(positive regulation of gene expression);GO:0010822(positive regulation of mitochondrion organization);GO:0014850(response to muscle activity);GO:0016922(nuclear receptor binding);GO:0022904(respiratory electron transport chain);GO:0030374(nuclear receptor transcription coactivator activity);GO:0031490(chromatin DNA binding);GO:0031625(ubiquitin protein ligase binding);GO:0032922(circadian regulation of gene expression);GO:0034599(cellular response to oxidative stress);GO:0042752(regulation of circadian rhythm);GO:0043231(intracellular membrane-bounded organelle);GO:0043524(negative regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050873(brown fat cell differentiation);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060612(adipose tissue development);GO:0097009(energy homeostasis);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1901215(negative regulation of neuron death);GO:1901857(positive regulation of cellular respiration);GO:1901860(positive regulation of mitochondrial DNA metabolic process);GO:1901863(positive regulation of muscle tissue development);GO:2001171(positive regulation of ATP biosynthetic process)","04152(AMPK signaling pathway);04211(Longevity regulating pathway);04371(Apelin signaling pathway);04714(Thermogenesis);04910(Insulin signaling pathway);04920(Adipocytokine signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);05016(Huntington disease)","K07202","NA","PPARG coactivator 1 alpha [Source:NCBI gene;Acc:443270]",{"v":0.825914275472707,"d":"0.83"},{"v":3.24993751373021,"d":"3.25"},{"v":5.50452775011692,"d":"5.50"},{"v":0.991078379902452,"d":"0.99"},{"v":1.44616383283223,"d":"1.45"},{"v":1.01749182294381,"d":"1.02"},{"v":2.77311637896846,"d":"2.77"},{"v":1.47150816301912,"d":"1.47"},{"v":0.00328935117609263,"d":"0.00"},{"v":0.0904183939448492,"d":"0.09"},"up","yes"]
["MSTRG.15698","RARG","ENSOART00000018108","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001843(neural tube closure);GO:0002063(chondrocyte development);GO:0002068(glandular epithelial cell development);GO:0003417(growth plate cartilage development);GO:0003430(growth plate cartilage chondrocyte growth);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell population proliferation);GO:0009952(anterior/posterior pattern specification);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0031076(embryonic camera-type eye development);GO:0032331(negative regulation of chondrocyte differentiation);GO:0032526(response to retinoic acid);GO:0035116(embryonic hindlimb morphogenesis);GO:0035264(multicellular organism growth);GO:0043065(positive regulation of apoptotic process);GO:0043068(positive regulation of programmed cell death);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045596(negative regulation of cell differentiation);GO:0045637(regulation of myeloid cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0046965(retinoid X receptor binding);GO:0048048(embryonic eye morphogenesis);GO:0048384(retinoic acid receptor signaling pathway);GO:0048608(reproductive structure development);GO:0048732(gland development);GO:0060173(limb development);GO:0060324(face development);GO:0060348(bone development);GO:0060349(bone morphogenesis);GO:0060429(epithelium development);GO:0060534(trachea cartilage development);GO:0060740(prostate gland epithelium morphogenesis);GO:0061037(negative regulation of cartilage development);GO:0070384(Harderian gland development);GO:1990830(cellular response to leukemia inhibitory factor)","NA","K08529","NA","retinoic acid receptor gamma [Source:NCBI gene;Acc:101106414]",{"v":1.60542041933928,"d":"1.61"},{"v":1.11627094405594,"d":"1.12"},{"v":0.855127027972028,"d":"0.86"},{"v":2.54555107619966,"d":"2.55"},{"v":2.38991806245479,"d":"2.39"},{"v":2.9568242843019,"d":"2.96"},{"v":0.453203929413387,"d":"0.45"},{"v":-1.14176772507794,"d":"-1.14"},{"v":0.00331910319340653,"d":"0.00"},{"v":0.0909300619831239,"d":"0.09"},"down","yes"]
["MSTRG.10986","EPHB2","ENSOART00000008616","GO:0000166(nucleotide binding);GO:0000902(cell morphogenesis);GO:0001525(angiogenesis);GO:0001540(amyloid-beta binding);GO:0001655(urogenital system development);GO:0001933(negative regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0007611(learning or memory);GO:0007612(learning);GO:0008046(axon guidance receptor activity);GO:0009887(animal organ morphogenesis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0030424(axon);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0031915(positive regulation of synaptic plasticity);GO:0038023(signaling receptor activity);GO:0042472(inner ear morphogenesis);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0044877(protein-containing complex binding);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048013(ephrin receptor signaling pathway);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050771(negative regulation of axonogenesis);GO:0050878(regulation of body fluid levels);GO:0051389(inactivation of MAPKK activity);GO:0051963(regulation of synapse assembly);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071679(commissural neuron axon guidance);GO:0098978(glutamatergic synapse);GO:0099055(integral component of postsynaptic membrane);GO:0099056(integral component of presynaptic membrane);GO:0099557(trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission);GO:0106028(neuron projection retraction);GO:1900273(positive regulation of long-term synaptic potentiation);GO:1904782(negative regulation of NMDA glutamate receptor activity);GO:1904783(positive regulation of NMDA glutamate receptor activity)","04360(Axon guidance)","K05111","EC:2.7.10.1","EPH receptor B2 [Source:NCBI gene;Acc:101122928]",{"v":0.483297,"d":"0.48"},{"v":0.425035,"d":"0.43"},{"v":0.634458,"d":"0.63"},{"v":1.211416,"d":"1.21"},{"v":1.174957,"d":"1.17"},{"v":1.243908,"d":"1.24"},{"v":0.424978121528333,"d":"0.42"},{"v":-1.23453952369594,"d":"-1.23"},{"v":0.00334632045197792,"d":"0.00"},{"v":0.0913690975583537,"d":"0.09"},"down","yes"]
["MSTRG.9679","COL15A1","ENSOART00000011990","GO:0005198(structural molecule activity);GO:0005581(collagen trimer);GO:0005604(basement membrane);GO:0007155(cell adhesion)","04974(Protein digestion and absorption)","K08135","NA","collagen type XV alpha 1 chain [Source:NCBI gene;Acc:101102453]",{"v":27.643329028169,"d":"27.64"},{"v":17.4609879023798,"d":"17.46"},{"v":23.789814541525,"d":"23.79"},{"v":55.0311003953375,"d":"55.03"},{"v":38.8776986983973,"d":"38.88"},{"v":48.2511220126275,"d":"48.25"},{"v":0.484624153811453,"d":"0.48"},{"v":-1.04506178395777,"d":"-1.05"},{"v":0.00340317204106856,"d":"0.00"},{"v":0.0925055377257343,"d":"0.09"},"down","yes"]
["MSTRG.15981","PTGES3","ENSOART00000009014","GO:0001516(prostaglandin biosynthetic process);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005978(glycogen biosynthetic process);GO:0007004(telomere maintenance via telomerase);GO:0008283(cell population proliferation);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043588(skin development);GO:0051973(positive regulation of telomerase activity);GO:0060430(lung saccule development);GO:0070182(DNA polymerase binding);GO:1905323(telomerase holoenzyme complex assembly)","NA","NA","NA","prostaglandin E synthase 3 [Source:HGNC Symbol;Acc:HGNC:16049]",{"v":8.96622619452199,"d":"8.97"},{"v":10.608132005794,"d":"10.61"},{"v":13.0633379819331,"d":"13.06"},{"v":6.95844879847248,"d":"6.96"},{"v":6.1798637313142,"d":"6.18"},{"v":4.91924556707927,"d":"4.92"},{"v":1.80742578853525,"d":"1.81"},{"v":0.853936412481993,"d":"0.85"},{"v":0.00340493803118363,"d":"0.00"},{"v":0.0925055377257343,"d":"0.09"},"up","no"]
["MSTRG.17865","RFX2","ENSOART00000007054","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","K09173","NA","regulatory factor X2 [Source:NCBI gene;Acc:101107090]",{"v":1.02126,"d":"1.02"},{"v":1.969199,"d":"1.97"},{"v":1.726395,"d":"1.73"},{"v":0.89915,"d":"0.90"},{"v":0.730489,"d":"0.73"},{"v":0.479109,"d":"0.48"},{"v":2.23680306987843,"d":"2.24"},{"v":1.16143824584,"d":"1.16"},{"v":0.00342207899242035,"d":"0.00"},{"v":0.0926628620037139,"d":"0.09"},"up","yes"]
["MSTRG.19851","NEDD4","ENSOART00000022759","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000151(ubiquitin ligase complex);GO:0000785(chromatin);GO:0002250(adaptive immune response);GO:0003151(outflow tract morphogenesis);GO:0003197(endocardial cushion development);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006622(protein targeting to lysosome);GO:0007041(lysosomal transport);GO:0007528(neuromuscular junction development);GO:0010766(negative regulation of sodium ion transport);GO:0010768(negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0019089(transmission of virus);GO:0019871(sodium channel inhibitor activity);GO:0019904(protein domain specific binding);GO:0030948(negative regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031175(neuron projection development);GO:0031623(receptor internalization);GO:0031698(beta-2 adrenergic receptor binding);GO:0032801(receptor catabolic process);GO:0034644(cellular response to UV);GO:0034765(regulation of ion transmembrane transport);GO:0035255(ionotropic glutamate receptor binding);GO:0042110(T cell activation);GO:0042391(regulation of membrane potential);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043130(ubiquitin binding);GO:0043162(ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway);GO:0043197(dendritic spine);GO:0044111(development involved in symbiotic interaction);GO:0045732(positive regulation of protein catabolic process);GO:0046824(positive regulation of nucleocytoplasmic transport);GO:0048471(perinuclear region of cytoplasm);GO:0048514(blood vessel morphogenesis);GO:0048814(regulation of dendrite morphogenesis);GO:0050807(regulation of synapse organization);GO:0050815(phosphoserine residue binding);GO:0050816(phosphothreonine residue binding);GO:0050847(progesterone receptor signaling pathway);GO:0061630(ubiquitin protein ligase activity);GO:0070063(RNA polymerase binding);GO:0070064(proline-rich region binding);GO:0098978(glutamatergic synapse);GO:0099524(postsynaptic cytosol);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:2000650(negative regulation of sodium ion transmembrane transporter activity)","04120(Ubiquitin mediated proteolysis);04144(Endocytosis);04530(Tight junction);05169(Epstein-Barr virus infection)","K10591","EC:2.3.2.26","neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase [Source:NCBI gene;Acc:101121425]",{"v":4.48018889095173,"d":"4.48"},{"v":5.60299303087747,"d":"5.60"},{"v":5.07056866093414,"d":"5.07"},{"v":3.18071211891733,"d":"3.18"},{"v":2.81519756810631,"d":"2.82"},{"v":2.43374812311902,"d":"2.43"},{"v":1.79767090480591,"d":"1.80"},{"v":0.846128934389281,"d":"0.85"},{"v":0.0034672972187031,"d":"0.00"},{"v":0.0932489400261104,"d":"0.09"},"up","no"]
["MSTRG.12093","RF01957;RF01871;RF01684","ENSOART00000024423;ENSOART00000026396;ENSOART00000023618;ENSOART00000024876","NA","NA","NA","NA",null,{"v":76.0686896164537,"d":"76.07"},{"v":183.7097828543,"d":"183.71"},{"v":74.9336788043825,"d":"74.93"},{"v":51.0922795137805,"d":"51.09"},{"v":68.2432895818547,"d":"68.24"},{"v":24.3698570874734,"d":"24.37"},{"v":2.32915457798127,"d":"2.33"},{"v":1.21980638943571,"d":"1.22"},{"v":0.00347341984592385,"d":"0.00"},{"v":0.0932489400261104,"d":"0.09"},"up","yes"]
["MSTRG.575","ENSOARG00000010720","ENSOART00000011661","GO:0007034(vacuolar transport)","NA","NA","NA",null,{"v":2.089704,"d":"2.09"},{"v":2.615402,"d":"2.62"},{"v":0.175513,"d":"0.18"},{"v":0.379706,"d":"0.38"},{"v":0.419585,"d":"0.42"},{"v":0.30155,"d":"0.30"},{"v":4.43353672328701,"d":"4.43"},{"v":2.14845802551978,"d":"2.15"},{"v":0.00352942181376565,"d":"0.00"},{"v":0.0941640512666104,"d":"0.09"},"up","yes"]
["MSTRG.6440","ARNTL","ENSOART00000008513","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006606(protein import into nucleus);GO:0007283(spermatogenesis);GO:0007623(circadian rhythm);GO:0016604(nuclear body);GO:0017162(aryl hydrocarbon receptor binding);GO:0032007(negative regulation of TOR signaling);GO:0032922(circadian regulation of gene expression);GO:0033391(chromatoid body);GO:0042176(regulation of protein catabolic process);GO:0042634(regulation of hair cycle);GO:0042753(positive regulation of circadian rhythm);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043425(bHLH transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0045599(negative regulation of fat cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0050767(regulation of neurogenesis);GO:0050796(regulation of insulin secretion);GO:0051726(regulation of cell cycle);GO:0051775(response to redox state);GO:0051879(Hsp90 protein binding);GO:0060137(maternal process involved in parturition);GO:0070491(repressing transcription factor binding);GO:0070888(E-box binding);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0090403(oxidative stress-induced premature senescence);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1901985(positive regulation of protein acetylation);GO:2000074(regulation of type B pancreatic cell development);GO:2000323(negative regulation of glucocorticoid receptor signaling pathway);GO:2000772(regulation of cellular senescence);GO:2001016(positive regulation of skeletal muscle cell differentiation)","04710(Circadian rhythm);04728(Dopaminergic synapse)","K02296","NA","aryl hydrocarbon receptor nuclear translocator like [Source:NCBI gene;Acc:443262]",{"v":2.68513546148203,"d":"2.69"},{"v":2.00541034629494,"d":"2.01"},{"v":1.3749492567865,"d":"1.37"},{"v":1.2182528488628,"d":"1.22"},{"v":1.03268995377843,"d":"1.03"},{"v":0.741517512839325,"d":"0.74"},{"v":2.0269258152516,"d":"2.03"},{"v":1.01929328765673,"d":"1.02"},{"v":0.00356245499231383,"d":"0.00"},{"v":0.0945704951870562,"d":"0.09"},"up","yes"]
["MSTRG.10166","FRZB","ENSOART00000018258","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0008285(negative regulation of cell population proliferation);GO:0010721(negative regulation of cell development);GO:0014033(neural crest cell differentiation);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030308(negative regulation of cell growth);GO:0042472(inner ear morphogenesis);GO:0043065(positive regulation of apoptotic process);GO:0045600(positive regulation of fat cell differentiation);GO:0060029(convergent extension involved in organogenesis);GO:0061037(negative regulation of cartilage development);GO:0061053(somite development);GO:0070367(negative regulation of hepatocyte differentiation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090103(cochlea morphogenesis)","NA","NA","NA","frizzled related protein [Source:NCBI gene;Acc:101118419]",{"v":11.147420563578,"d":"11.15"},{"v":7.87533453108704,"d":"7.88"},{"v":13.2709354725231,"d":"13.27"},{"v":7.15399283393502,"d":"7.15"},{"v":4.66206545527477,"d":"4.66"},{"v":5.32177650180505,"d":"5.32"},{"v":1.8843506756244,"d":"1.88"},{"v":0.914067473924138,"d":"0.91"},{"v":0.00357719000785749,"d":"0.00"},{"v":0.0945704951870562,"d":"0.09"},"up","no"]
["MSTRG.10940","ENSOARG00000005889","ENSOART00000006404","GO:0003016(respiratory system process);GO:0005509(calcium ion binding);GO:0007005(mitochondrion organization);GO:0014816(skeletal muscle satellite cell differentiation);GO:0014834(skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration);GO:0014858(positive regulation of skeletal muscle cell proliferation);GO:0014873(response to muscle activity involved in regulation of muscle adaptation);GO:0033555(multicellular organismal response to stress);GO:0034599(cellular response to oxidative stress);GO:0043403(skeletal muscle tissue regeneration);GO:0048286(lung alveolus development);GO:0048741(skeletal muscle fiber development);GO:0071313(cellular response to caffeine)","NA","K19874","NA","selenoprotein N [Source:NCBI gene;Acc:101117829]",{"v":6.09848665736285,"d":"6.10"},{"v":2.44913967115816,"d":"2.45"},{"v":6.83714640776387,"d":"6.84"},{"v":10.5378363060635,"d":"10.54"},{"v":11.825940253128,"d":"11.83"},{"v":13.5475583994225,"d":"13.55"},{"v":0.428409936695894,"d":"0.43"},{"v":-1.2229361520176,"d":"-1.22"},{"v":0.00357919376409069,"d":"0.00"},{"v":0.0945704951870562,"d":"0.09"},"down","yes"]
["MSTRG.1813","RBP1","ENSOART00000007598","GO:0002138(retinoic acid biosynthetic process);GO:0005654(nucleoplasm);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0006776(vitamin A metabolic process);GO:0008289(lipid binding);GO:0030852(regulation of granulocyte differentiation);GO:0033189(response to vitamin A);GO:0042572(retinol metabolic process);GO:0042573(retinoic acid metabolic process)","NA","NA","NA","retinol binding protein 1 [Source:HGNC Symbol;Acc:HGNC:9919]",{"v":2.29483911802853,"d":"2.29"},{"v":1.6000964150454,"d":"1.60"},{"v":2.26401688197147,"d":"2.26"},{"v":4.46051414785992,"d":"4.46"},{"v":3.76689212970169,"d":"3.77"},{"v":7.01790178988327,"d":"7.02"},{"v":0.403990026819946,"d":"0.40"},{"v":-1.30760841684842,"d":"-1.31"},{"v":0.00358411787628811,"d":"0.00"},{"v":0.0945704951870562,"d":"0.09"},"down","yes"]
["MSTRG.13248","PDPK1","ENSOART00000020280","GO:0003323(type B pancreatic cell development);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004676(3-phosphoinositide-dependent protein kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006469(negative regulation of protein kinase activity);GO:0006972(hyperosmotic response);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0010518(positive regulation of phospholipase activity);GO:0010594(regulation of endothelial cell migration);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0014069(postsynaptic density);GO:0016004(phospholipase activator activity);GO:0016477(cell migration);GO:0018107(peptidyl-threonine phosphorylation);GO:0019722(calcium-mediated signaling);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0032148(activation of protein kinase B activity);GO:0032869(cellular response to insulin stimulus);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0035556(intracellular signal transduction);GO:0042995(cell projection);GO:0043122(regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043274(phospholipase binding);GO:0043304(regulation of mast cell degranulation);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045766(positive regulation of angiogenesis);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0097191(extrinsic apoptotic signaling pathway);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903672(positive regulation of sprouting angiogenesis);GO:1905564(positive regulation of vascular endothelial cell proliferation);GO:2000352(negative regulation of endothelial cell apoptotic process)","01524(Platinum drug resistance);03320(PPAR signaling pathway);04068(FoxO signaling pathway);04071(Sphingolipid signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04210(Apoptosis);04510(Focal adhesion);04660(T cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04722(Neurotrophin signaling pathway);04910(Insulin signaling pathway);04919(Thyroid hormone signaling pathway);04931(Insulin resistance);04960(Aldosterone-regulated sodium reabsorption);05145(Toxoplasmosis);05205(Proteoglycans in cancer);05213(Endometrial cancer);05215(Prostate cancer);05223(Non-small cell lung cancer);05231(Choline metabolism in cancer)","K06276","EC:2.7.11.1","3-phosphoinositide dependent protein kinase 1 [Source:NCBI gene;Acc:101117211]",{"v":3.83200863303499,"d":"3.83"},{"v":3.67592118486574,"d":"3.68"},{"v":3.57199765630594,"d":"3.57"},{"v":2.26935259690806,"d":"2.27"},{"v":2.04611175313263,"d":"2.05"},{"v":1.86367014890155,"d":"1.86"},{"v":1.7931196474366,"d":"1.79"},{"v":0.842471756474209,"d":"0.84"},{"v":0.0035851994439483,"d":"0.00"},{"v":0.0945704951870562,"d":"0.09"},"up","no"]
["MSTRG.8433","RF00231","ENSOART00000024789","NA","NA","NA","NA","small Cajal body-specific RNA 13 [Source:HGNC Symbol;Acc:HGNC:32570]",{"v":16.203846,"d":"16.20"},{"v":22.478565,"d":"22.48"},{"v":7.541242,"d":"7.54"},{"v":27.307795,"d":"27.31"},{"v":36.024384,"d":"36.02"},{"v":63.858864,"d":"63.86"},{"v":0.363419089188537,"d":"0.36"},{"v":-1.46029389338266,"d":"-1.46"},{"v":0.00363976127026345,"d":"0.00"},{"v":0.0957005185521122,"d":"0.10"},"down","yes"]
["MSTRG.8853","LMCD1","ENSOART00000008314","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0008270(zinc ion binding);GO:0010611(regulation of cardiac muscle hypertrophy);GO:0046872(metal ion binding);GO:0070886(positive regulation of calcineurin-NFAT signaling cascade)","NA","NA","NA","LIM and cysteine rich domains 1 [Source:NCBI gene;Acc:101107740]",{"v":10.5510091008481,"d":"10.55"},{"v":4.97863726695283,"d":"4.98"},{"v":14.9616217601752,"d":"14.96"},{"v":5.35377073523687,"d":"5.35"},{"v":5.60174136760975,"d":"5.60"},{"v":3.58225223473289,"d":"3.58"},{"v":2.09738357425134,"d":"2.10"},{"v":1.06859072889534,"d":"1.07"},{"v":0.00364694368335597,"d":"0.00"},{"v":0.0957352033148492,"d":"0.10"},"up","yes"]
["MSTRG.11451","ENSOARG00000018192","ENSOART00000019797","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":1.098072,"d":"1.10"},{"v":0.336398,"d":"0.34"},{"v":0.623224,"d":"0.62"},{"v":3.498645,"d":"3.50"},{"v":0.831119,"d":"0.83"},{"v":3.596072,"d":"3.60"},{"v":0.259618543709458,"d":"0.26"},{"v":-1.9455346608484,"d":"-1.95"},{"v":0.00367795423432658,"d":"0.00"},{"v":0.0963942804784661,"d":"0.10"},"down","yes"]
["ENSOARG00000020229","CHST14","ENSOART00000022024","GO:0000139(Golgi membrane);GO:0001537(N-acetylgalactosamine 4-O-sulfotransferase activity);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0008146(sulfotransferase activity);GO:0016021(integral component of membrane);GO:0016051(carbohydrate biosynthetic process);GO:0016740(transferase activity);GO:0050655(dermatan sulfate proteoglycan metabolic process)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)","K08105","EC:2.8.2.35","carbohydrate sulfotransferase 14 [Source:NCBI gene;Acc:101108574]",{"v":0.296938,"d":"0.30"},{"v":0.424229,"d":"0.42"},{"v":0.33289,"d":"0.33"},{"v":0.87638,"d":"0.88"},{"v":1.027296,"d":"1.03"},{"v":1.13983,"d":"1.14"},{"v":0.346329857736439,"d":"0.35"},{"v":-1.52978132458749,"d":"-1.53"},{"v":0.0036948332179144,"d":"0.00"},{"v":0.0966814692020935,"d":"0.10"},"down","yes"]
["MSTRG.11802","PRCP","ENSOART00000006325","GO:0002155(regulation of thyroid hormone mediated signaling pathway);GO:0002353(plasma kallikrein-kinin cascade);GO:0003085(negative regulation of systemic arterial blood pressure);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0042593(glucose homeostasis);GO:0043535(regulation of blood vessel endothelial cell migration);GO:0045178(basal part of cell);GO:0060055(angiogenesis involved in wound healing);GO:0097009(energy homeostasis);GO:2000377(regulation of reactive oxygen species metabolic process)","04614(Renin-angiotensin system);04974(Protein digestion and absorption)","K01285","EC:3.4.16.2","prolylcarboxypeptidase [Source:NCBI gene;Acc:101107644]",{"v":2.80941358420895,"d":"2.81"},{"v":1.1745524527169,"d":"1.17"},{"v":1.67501660102071,"d":"1.68"},{"v":4.42386732933053,"d":"4.42"},{"v":4.15840200090063,"d":"4.16"},{"v":3.83610285860102,"d":"3.84"},{"v":0.455694397936927,"d":"0.46"},{"v":-1.133861459938,"d":"-1.13"},{"v":0.00374156459112033,"d":"0.00"},{"v":0.0977476266301004,"d":"0.10"},"down","yes"]
["MSTRG.21629","ENSOARG00000018334","ENSOART00000019952","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA","NA","NA",null,{"v":1.84748850368421,"d":"1.85"},{"v":1.80728119157895,"d":"1.81"},{"v":2.16009797578947,"d":"2.16"},{"v":1.13774039473684,"d":"1.14"},{"v":0.894596532631579,"d":"0.89"},{"v":0.860990053684211,"d":"0.86"},{"v":2.00975130330313,"d":"2.01"},{"v":1.00701698613565,"d":"1.01"},{"v":0.00379592785987792,"d":"0.00"},{"v":0.0989468916428226,"d":"0.10"},"up","yes"]
["MSTRG.15284","SIX2","ENSOART00000006556","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001656(metanephros development);GO:0001822(kidney development);GO:0002062(chondrocyte differentiation);GO:0003337(mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006606(protein import into nucleus);GO:0007501(mesodermal cell fate specification);GO:0008134(transcription factor binding);GO:0008283(cell population proliferation);GO:0009948(anterior/posterior axis specification);GO:0016477(cell migration);GO:0030278(regulation of ossification);GO:0032330(regulation of chondrocyte differentiation);GO:0042474(middle ear morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0044877(protein-containing complex binding);GO:0045596(negative regulation of cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048557(embryonic digestive tract morphogenesis);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0072006(nephron development);GO:0072028(nephron morphogenesis);GO:0072038(mesenchymal stem cell maintenance involved in nephron morphogenesis);GO:0072137(condensed mesenchymal cell proliferation);GO:0072161(mesenchymal cell differentiation involved in kidney development);GO:0090189(regulation of branching involved in ureteric bud morphogenesis);GO:0097168(mesenchymal stem cell proliferation);GO:1902732(positive regulation of chondrocyte proliferation)","NA","K19472","NA","SIX homeobox 2 [Source:NCBI gene;Acc:101110829]",{"v":0.667575117073171,"d":"0.67"},{"v":1.06230511829268,"d":"1.06"},{"v":1.26335201341463,"d":"1.26"},{"v":0.580589,"d":"0.58"},{"v":0.503415406097561,"d":"0.50"},{"v":0.319829136585366,"d":"0.32"},{"v":2.13218459152927,"d":"2.13"},{"v":1.09233234323584,"d":"1.09"},{"v":0.00379958972685263,"d":"0.00"},{"v":0.0989468916428226,"d":"0.10"},"up","yes"]
["MSTRG.9045","ENSOARG00000003517","ENSOART00000003841","GO:0005540(hyaluronic acid binding);GO:0006898(receptor-mediated endocytosis);GO:0007155(cell adhesion)","NA","K19020","NA","stabilin 1 [Source:NCBI gene;Acc:101111323]",{"v":1.52385019216145,"d":"1.52"},{"v":1.13835754197134,"d":"1.14"},{"v":1.63949593682363,"d":"1.64"},{"v":2.87289052617724,"d":"2.87"},{"v":2.76259196256215,"d":"2.76"},{"v":3.26986322228722,"d":"3.27"},{"v":0.483047352741179,"d":"0.48"},{"v":-1.04976347266627,"d":"-1.05"},{"v":0.00381929425039077,"d":"0.00"},{"v":0.09930165051016,"d":"0.10"},"down","yes"]
["MSTRG.690","IGSF3","ENSOART00000022036","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032808(lacrimal gland development)","NA","K06522","NA","immunoglobulin superfamily member 3 [Source:NCBI gene;Acc:101110899]",{"v":0.631017780543785,"d":"0.63"},{"v":0.350684111405367,"d":"0.35"},{"v":0.707434709569209,"d":"0.71"},{"v":0.99233766154661,"d":"0.99"},{"v":1.43830153478107,"d":"1.44"},{"v":1.49145701412429,"d":"1.49"},{"v":0.430671893518826,"d":"0.43"},{"v":-1.21533892130558,"d":"-1.22"},{"v":0.00390184691051069,"d":"0.00"},{"v":0.100965699452961,"d":"0.10"},"down","yes"]
["MSTRG.19693","ZNF106","ENSOART00000022342;ENSOART00000022341","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","NA","NA","zinc finger protein 106 [Source:NCBI gene;Acc:101117165]",{"v":29.231552690982,"d":"29.23"},{"v":47.7062045873986,"d":"47.71"},{"v":33.2664931644935,"d":"33.27"},{"v":21.4909675089815,"d":"21.49"},{"v":21.5373363648217,"d":"21.54"},{"v":17.0019795304094,"d":"17.00"},{"v":1.83581093064006,"d":"1.84"},{"v":0.876417483874985,"d":"0.88"},{"v":0.00392494060759879,"d":"0.00"},{"v":0.101314235854041,"d":"0.10"},"up","no"]
["MSTRG.7590","HIP1R","ENSOART00000008415","GO:0003779(actin binding);GO:0005543(phospholipid binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005905(clathrin-coated pit);GO:0005938(cell cortex);GO:0006897(endocytosis);GO:0006898(receptor-mediated endocytosis);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0016324(apical plasma membrane);GO:0017124(SH3 domain binding);GO:0030100(regulation of endocytosis);GO:0030136(clathrin-coated vesicle);GO:0030276(clathrin binding);GO:0030837(negative regulation of actin filament polymerization);GO:0032051(clathrin light chain binding);GO:0032092(positive regulation of protein binding);GO:0032587(ruffle membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0034316(negative regulation of Arp2/3 complex-mediated actin nucleation);GO:0035091(phosphatidylinositol binding);GO:0035615(clathrin adaptor activity);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:0046982(protein heterodimerization activity);GO:0048268(clathrin coat assembly);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051015(actin filament binding);GO:0055123(digestive system development);GO:0060453(regulation of gastric acid secretion);GO:0061024(membrane organization);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding);GO:1901030(positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway);GO:1905445(positive regulation of clathrin coat assembly);GO:2000369(regulation of clathrin-dependent endocytosis);GO:2000588(positive regulation of platelet-derived growth factor receptor-beta signaling pathway)","NA","K20040","NA","huntingtin interacting protein 1 related [Source:NCBI gene;Acc:101123327]",{"v":1.21486706450627,"d":"1.21"},{"v":0.674711546621828,"d":"0.67"},{"v":0.814864265056558,"d":"0.81"},{"v":1.92713749067563,"d":"1.93"},{"v":1.89781975664934,"d":"1.90"},{"v":2.12174605044329,"d":"2.12"},{"v":0.454780193456029,"d":"0.45"},{"v":-1.13675867140698,"d":"-1.14"},{"v":0.00393393101001116,"d":"0.00"},{"v":0.101314235854041,"d":"0.10"},"down","yes"]
["ENSOARG00000006121","N4BP3","ENSOART00000006654","NA","NA","NA","NA","NEDD4 binding protein 3 [Source:NCBI gene;Acc:101107786]",{"v":0.842886,"d":"0.84"},{"v":0.542566,"d":"0.54"},{"v":0.306694,"d":"0.31"},{"v":1.093334,"d":"1.09"},{"v":1.676822,"d":"1.68"},{"v":1.668684,"d":"1.67"},{"v":0.381213560299538,"d":"0.38"},{"v":-1.39132865604627,"d":"-1.39"},{"v":0.00405185540277287,"d":"0.00"},{"v":0.104023105371817,"d":"0.10"},"down","yes"]
["MSTRG.2137","ENSOARG00000008182","ENSOART00000008903","GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex)","04919(Thyroid hormone signaling pathway)","K15146","NA","mediator complex subunit 4 [Source:NCBI gene;Acc:101113861]",{"v":6.47777438867636,"d":"6.48"},{"v":2.94526607268554,"d":"2.95"},{"v":1.8871780351951,"d":"1.89"},{"v":2.41982261208875,"d":"2.42"},{"v":1.28950319472073,"d":"1.29"},{"v":1.29935226128539,"d":"1.30"},{"v":2.25812446773187,"d":"2.26"},{"v":1.17512500959652,"d":"1.18"},{"v":0.00405893630242745,"d":"0.00"},{"v":0.104041306037732,"d":"0.10"},"up","yes"]
["ENSOARG00000013509","CD274","ENSOART00000014691","GO:0002845(positive regulation of tolerance induction to tumor cell);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031295(T cell costimulation);GO:0031901(early endosome membrane);GO:0032689(negative regulation of interferon-gamma production);GO:0032693(negative regulation of interleukin-10 production);GO:0034097(response to cytokine);GO:0042130(negative regulation of T cell proliferation);GO:0046007(negative regulation of activated T cell proliferation);GO:0055038(recycling endosome membrane);GO:0070062(extracellular exosome);GO:1901998(toxin transport);GO:1903556(negative regulation of tumor necrosis factor superfamily cytokine production);GO:1905404(positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process);GO:2000562(negative regulation of CD4-positive, alpha-beta T cell proliferation);GO:2001181(positive regulation of interleukin-10 secretion);GO:2001186(negative regulation of CD8-positive, alpha-beta T cell activation)","04514(Cell adhesion molecules (CAMs))","K06745","NA","CD274 molecule [Source:NCBI gene;Acc:101115003]",0.52,{"v":0.261719,"d":"0.26"},{"v":0.185325,"d":"0.19"},{"v":0.177474,"d":"0.18"},{"v":0.102045,"d":"0.10"},{"v":0.076864,"d":"0.08"},{"v":2.71349643501514,"d":"2.71"},{"v":1.4401530132724,"d":"1.44"},{"v":0.00408007446808525,"d":"0.00"},{"v":0.104419209897956,"d":"0.10"},"up","yes"]
["MSTRG.615","SYPL2","ENSOART00000020920","GO:0006874(cellular calcium ion homeostasis);GO:0007507(heart development);GO:0008021(synaptic vesicle);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033292(T-tubule organization)","NA","NA","NA","synaptophysin like 2 [Source:HGNC Symbol;Acc:HGNC:27638]",{"v":28.0026358072562,"d":"28.00"},{"v":28.9302360044018,"d":"28.93"},{"v":30.4534422460984,"d":"30.45"},{"v":62.0389549666533,"d":"62.04"},{"v":50.4269391495265,"d":"50.43"},{"v":61.2920940056022,"d":"61.29"},{"v":0.502919693087778,"d":"0.50"},{"v":-0.991600048005134,"d":"-0.99"},{"v":0.00409595490138128,"d":"0.00"},{"v":0.104516002719389,"d":"0.10"},"down","no"]
["ENSOARG00000019328","EFS","ENSOART00000021049","GO:0005515(protein binding);GO:0017124(SH3 domain binding);GO:0019904(protein domain specific binding)","NA","NA","NA","embryonal Fyn-associated substrate [Source:NCBI gene;Acc:101120836]",{"v":0.306606,"d":"0.31"},{"v":0.200874,"d":"0.20"},{"v":0.233313,"d":"0.23"},{"v":0.709252,"d":"0.71"},{"v":0.612684,"d":"0.61"},{"v":0.652677,"d":"0.65"},{"v":0.375158575376542,"d":"0.38"},{"v":-1.41442755914015,"d":"-1.41"},{"v":0.0040966586073254,"d":"0.00"},{"v":0.104516002719389,"d":"0.10"},"down","yes"]
["MSTRG.2631","ENSOARG00000016407","ENSOART00000017870","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,{"v":0.533546,"d":"0.53"},{"v":0.379048,"d":"0.38"},{"v":0.302619,"d":"0.30"},{"v":0.973808,"d":"0.97"},{"v":1.020565,"d":"1.02"},{"v":0.911718,"d":"0.91"},{"v":0.418160683887738,"d":"0.42"},{"v":-1.25787067099576,"d":"-1.26"},{"v":0.00413074647913328,"d":"0.00"},{"v":0.10505736528238,"d":"0.11"},"down","yes"]
["MSTRG.601","C1orf194","ENSOART00000020773","NA","NA","NA","NA","chromosome 1 open reading frame, human C1orf194 [Source:NCBI gene;Acc:101102854]",{"v":7.328146,"d":"7.33"},{"v":6.510035,"d":"6.51"},{"v":6.352824,"d":"6.35"},{"v":10.984734,"d":"10.98"},{"v":12.78817,"d":"12.79"},{"v":18.948532,"d":"18.95"},{"v":0.472619998073099,"d":"0.47"},{"v":-1.08124741921402,"d":"-1.08"},{"v":0.00415979772068527,"d":"0.00"},{"v":0.105304150671859,"d":"0.11"},"down","yes"]
["MSTRG.7827","ENSOARG00000009298","ENSOART00000010116","NA","NA","NA","NA",null,{"v":0.519761940639269,"d":"0.52"},{"v":0.942279904109589,"d":"0.94"},{"v":1.79178686757991,"d":"1.79"},{"v":1.90762052054795,"d":"1.91"},{"v":3.693243,"d":"3.69"},{"v":5.28714146575342,"d":"5.29"},{"v":0.298845262876215,"d":"0.30"},{"v":-1.74252942071732,"d":"-1.74"},{"v":0.00418575636805698,"d":"0.00"},{"v":0.105633740305463,"d":"0.11"},"down","yes"]
["MSTRG.19624","ACTC1","ENSOART00000021769","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005884(actin filament);GO:0016887(ATPase activity);GO:0017022(myosin binding);GO:0030017(sarcomere);GO:0030048(actin filament-based movement);GO:0030240(skeletal muscle thin filament assembly);GO:0031032(actomyosin structure organization);GO:0031674(I band);GO:0033275(actin-myosin filament sliding);GO:0042643(actomyosin, actin portion);GO:0043066(negative regulation of apoptotic process);GO:0045202(synapse);GO:0055003(cardiac myofibril assembly);GO:0055008(cardiac muscle tissue morphogenesis);GO:0060047(heart contraction);GO:0070252(actin-mediated cell contraction);GO:0098978(glutamatergic synapse)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","K12314","NA","actin, alpha, cardiac muscle 1 [Source:NCBI gene;Acc:101111554]",{"v":23.03701115396,"d":"23.04"},{"v":12.7094408238342,"d":"12.71"},{"v":54.611444315322,"d":"54.61"},{"v":55.975219376758,"d":"55.98"},{"v":95.9042274566987,"d":"95.90"},{"v":97.4696473856403,"d":"97.47"},{"v":0.36237507329271,"d":"0.36"},{"v":-1.46444437480623,"d":"-1.46"},{"v":0.00419403274130891,"d":"0.00"},{"v":0.105679269444586,"d":"0.11"},"down","yes"]
["MSTRG.21476","FRMPD4","ENSOART00000012135;ENSOART00000012137","GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005856(cytoskeleton);GO:0032991(protein-containing complex);GO:0043197(dendritic spine);GO:0051835(positive regulation of synapse structural plasticity);GO:0051835(positive regulation of synapse structural plasticity)","NA","NA","NA","FERM and PDZ domain containing 4 [Source:NCBI gene;Acc:101119442]",{"v":0.0720074736641947,"d":"0.07"},{"v":0.0659902000380301,"d":"0.07"},{"v":0.0524872249477087,"d":"0.05"},{"v":0.131696142992964,"d":"0.13"},{"v":0.19596051302529,"d":"0.20"},{"v":0.231305876402358,"d":"0.23"},{"v":0.340782946264806,"d":"0.34"},{"v":-1.55307495402664,"d":"-1.55"},{"v":0.00422668523518173,"d":"0.00"},{"v":0.106337929923031,"d":"0.11"},"down","yes"]
["MSTRG.8421","ASB2","ENSOART00000015436","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0035914(skeletal muscle cell differentiation);GO:0061630(ubiquitin protein ligase activity)","NA","K10324","NA","ankyrin repeat and SOCS box containing 2 [Source:NCBI gene;Acc:101114059]",{"v":25.7219269907848,"d":"25.72"},{"v":25.2609886983156,"d":"25.26"},{"v":22.3657301762973,"d":"22.37"},{"v":18.4543083226074,"d":"18.45"},{"v":10.8878668545963,"d":"10.89"},{"v":11.8976033475338,"d":"11.90"},{"v":1.77858971336133,"d":"1.78"},{"v":0.830733746824387,"d":"0.83"},{"v":0.00426145403378721,"d":"0.00"},{"v":0.107047725328735,"d":"0.11"},"up","no"]
["MSTRG.15882","CPM","ENSOART00000000158","GO:0004181(metallocarboxypeptidase activity);GO:0006508(proteolysis);GO:0008270(zinc ion binding)","NA","K01296","EC:3.4.17.12","carboxypeptidase M [Source:NCBI gene;Acc:101104474]",{"v":1.38805381076843,"d":"1.39"},{"v":1.57007884736017,"d":"1.57"},{"v":2.01059225300575,"d":"2.01"},{"v":1.14076480005227,"d":"1.14"},{"v":0.663266487192891,"d":"0.66"},{"v":0.735328034500784,"d":"0.74"},{"v":1.95668445524208,"d":"1.96"},{"v":0.968411118477648,"d":"0.97"},{"v":0.00429020757129325,"d":"0.00"},{"v":0.107604468854188,"d":"0.11"},"up","no"]
["MSTRG.99","RF00478","ENSOART00000026961","NA","NA","NA","NA","small Cajal body-specific RNA 5 [Source:HGNC Symbol;Acc:HGNC:32561]",{"v":461.447693,"d":"461.45"},{"v":389.143341,"d":"389.14"},{"v":288.915497,"d":"288.92"},{"v":569.755615,"d":"569.76"},{"v":722.608215,"d":"722.61"},{"v":1255.066772,"d":"1255.07"},{"v":0.447316025058884,"d":"0.45"},{"v":-1.16063365119083,"d":"-1.16"},{"v":0.00429680418260026,"d":"0.00"},{"v":0.107604629898002,"d":"0.11"},"down","yes"]
["MSTRG.3566","RF00424","ENSOART00000025210","NA","NA","NA","NA",null,{"v":8.574868,"d":"8.57"},{"v":12.483614,"d":"12.48"},{"v":12.669047,"d":"12.67"},{"v":18.388676,"d":"18.39"},{"v":29.268373,"d":"29.27"},{"v":34.695,"d":"34.70"},{"v":0.409553003350287,"d":"0.41"},{"v":-1.28787792086658,"d":"-1.29"},{"v":0.00433493723368034,"d":"0.00"},{"v":0.108074859233103,"d":"0.11"},"down","yes"]
["MSTRG.11967","RAB3IL1","ENSOART00000015476","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0017112(Rab guanyl-nucleotide exchange factor activity)","NA","K16779","NA","RAB3A interacting protein like 1 [Source:NCBI gene;Acc:101109571]",{"v":1.801776,"d":"1.80"},{"v":0.720161,"d":"0.72"},{"v":1.363478,"d":"1.36"},{"v":3.050678,"d":"3.05"},{"v":2.942732,"d":"2.94"},{"v":3.531275,"d":"3.53"},{"v":0.407931075935845,"d":"0.41"},{"v":-1.29360267995891,"d":"-1.29"},{"v":0.00433543806943179,"d":"0.00"},{"v":0.108074859233103,"d":"0.11"},"down","yes"]
["MSTRG.4587","PTER","ENSOART00000009762","GO:0008270(zinc ion binding);GO:0009056(catabolic process);GO:0016788(hydrolase activity, acting on ester bonds);GO:0030855(epithelial cell differentiation);GO:0046872(metal ion binding)","NA","K07048","NA","phosphotriesterase related [Source:NCBI gene;Acc:101109988]",{"v":7.42966740575916,"d":"7.43"},{"v":5.16508868272251,"d":"5.17"},{"v":4.93245663089005,"d":"4.93"},{"v":3.34005055602094,"d":"3.34"},{"v":3.04948890837696,"d":"3.05"},{"v":3.10142748324607,"d":"3.10"},{"v":1.84672571467786,"d":"1.85"},{"v":0.884969605649505,"d":"0.88"},{"v":0.00437483647358564,"d":"0.00"},{"v":0.108890746860833,"d":"0.11"},"up","no"]
["MSTRG.2067","CNMD","ENSOART00000007389","GO:0005576(extracellular region);GO:0007585(respiratory gaseous exchange);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016525(negative regulation of angiogenesis)","NA","NA","NA","chondromodulin [Source:NCBI gene;Acc:101106181]",{"v":0.940890343507855,"d":"0.94"},{"v":1.84490873924397,"d":"1.84"},{"v":1.29728603724475,"d":"1.30"},{"v":0.776259348816302,"d":"0.78"},{"v":0.760817870199923,"d":"0.76"},{"v":0.610817732051886,"d":"0.61"},{"v":1.90097058422998,"d":"1.90"},{"v":0.926736207781377,"d":"0.93"},{"v":0.0044420441026528,"d":"0.00"},{"v":0.110227501684065,"d":"0.11"},"up","no"]
["MSTRG.17495","FLT4","ENSOART00000000660","GO:0000166(nucleotide binding);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001946(lymphangiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0010575(positive regulation of vascular endothelial growth factor production);GO:0010595(positive regulation of endothelial cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019838(growth factor binding);GO:0019903(protein phosphatase binding);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0036328(VEGF-C-activated receptor activity);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043235(receptor complex);GO:0043410(positive regulation of MAPK cascade);GO:0046330(positive regulation of JNK cascade);GO:0046777(protein autophosphorylation);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090037(positive regulation of protein kinase C signaling)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);05200(Pathways in cancer);05224(Breast cancer)","K05097","EC:2.7.10.1","fms related tyrosine kinase 4 [Source:NCBI gene;Acc:101117247]",{"v":0.827554899420389,"d":"0.83"},{"v":0.307293605523355,"d":"0.31"},{"v":0.373585302591204,"d":"0.37"},{"v":1.02432169041937,"d":"1.02"},{"v":1.07152930105694,"d":"1.07"},{"v":1.59546696812138,"d":"1.60"},{"v":0.408643694215751,"d":"0.41"},{"v":-1.29108462244099,"d":"-1.29"},{"v":0.00445984915477411,"d":"0.00"},{"v":0.11033396515023,"d":"0.11"},"down","yes"]
["MSTRG.16194","IL2RB","ENSOART00000020903","GO:0004896(cytokine receptor activity);GO:0004911(interleukin-2 receptor activity);GO:0005515(protein binding);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0019976(interleukin-2 binding);GO:0035723(interleukin-15-mediated signaling pathway);GO:0038110(interleukin-2-mediated signaling pathway);GO:0042010(interleukin-15 receptor activity);GO:0043066(negative regulation of apoptotic process);GO:0050766(positive regulation of phagocytosis)","04060(Cytokine-cytokine receptor interaction);04144(Endocytosis);04151(PI3K-Akt signaling pathway);04630(Jak-STAT signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);05162(Measles);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer)","K05069","NA","interleukin 2 receptor subunit beta [Source:NCBI gene;Acc:101107088]",{"v":1.822924,"d":"1.82"},{"v":1.1347,"d":"1.13"},{"v":1.356192,"d":"1.36"},{"v":0.794377,"d":"0.79"},{"v":0.509125,"d":"0.51"},{"v":0.697924,"d":"0.70"},{"v":2.15537122031991,"d":"2.16"},{"v":1.10793636657299,"d":"1.11"},{"v":0.00446670433954086,"d":"0.00"},{"v":0.110336381930443,"d":"0.11"},"up","yes"]
["ENSOARG00000019777","PARP2","ENSOART00000021535","GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006284(base-excision repair);GO:0006471(protein ADP-ribosylation);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018312(peptidyl-serine ADP-ribosylation);GO:0030592(DNA ADP-ribosylation);GO:0070212(protein poly-ADP-ribosylation);GO:0097191(extrinsic apoptotic signaling pathway);GO:0140294(NAD DNA ADP-ribosyltransferase activity);GO:1990404(protein ADP-ribosylase activity)","03410(Base excision repair);04210(Apoptosis);04217(Necroptosis)","K10798","EC:2.4.2.30","poly(ADP-ribose) polymerase 2 [Source:NCBI gene;Acc:101118027]",{"v":0.924128,"d":"0.92"},{"v":0.953651,"d":"0.95"},{"v":0.97426,"d":"0.97"},{"v":0.683568,"d":"0.68"},{"v":0.270281,"d":"0.27"},{"v":0.437614,"d":"0.44"},{"v":2.04966930489708,"d":"2.05"},{"v":1.03539116306235,"d":"1.04"},{"v":0.00448306860659062,"d":"0.00"},{"v":0.110573329619957,"d":"0.11"},"up","yes"]
["MSTRG.21110","PDE7A","ENSOART00000018649","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)","00230(Purine metabolism);05032(Morphine addiction)","K18436","EC:3.1.4.53","phosphodiesterase 7A [Source:NCBI gene;Acc:101120417]",{"v":4.31667575021522,"d":"4.32"},{"v":6.61045056741275,"d":"6.61"},{"v":5.60782187451162,"d":"5.61"},{"v":3.43516863330243,"d":"3.44"},{"v":3.40243870902589,"d":"3.40"},{"v":2.37253024014966,"d":"2.37"},{"v":1.79529871775171,"d":"1.80"},{"v":0.844223912440345,"d":"0.84"},{"v":0.00454010619251193,"d":"0.00"},{"v":0.111642852276107,"d":"0.11"},"up","no"]
["MSTRG.1887","PDE9A","ENSOART00000011959;ENSOART00000011956","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0016787(hydrolase activity);GO:0042383(sarcolemma);GO:0046068(cGMP metabolic process);GO:0046069(cGMP catabolic process);GO:0046872(metal ion binding);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity)","00230(Purine metabolism);00230(Purine metabolism)","K13761","EC:3.1.4.35","phosphodiesterase 9A [Source:NCBI gene;Acc:101121743]",{"v":1.05866608219178,"d":"1.06"},{"v":0.62968254109589,"d":"0.63"},{"v":0.564943737442922,"d":"0.56"},{"v":2.2322638630137,"d":"2.23"},{"v":1.56423655707763,"d":"1.56"},{"v":1.53808159589041,"d":"1.54"},{"v":0.422393423510972,"d":"0.42"},{"v":-1.24334072217482,"d":"-1.24"},{"v":0.0045497348170248,"d":"0.00"},{"v":0.111711383597565,"d":"0.11"},"down","yes"]
["MSTRG.4257","VASH2","ENSOART00000010689","GO:0000768(syncytium formation by plasma membrane fusion);GO:0001938(positive regulation of endothelial cell proliferation);GO:0003779(actin binding);GO:0004181(metallocarboxypeptidase activity);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0045765(regulation of angiogenesis);GO:0045766(positive regulation of angiogenesis);GO:0060674(placenta blood vessel development);GO:0060711(labyrinthine layer development);GO:0060716(labyrinthine layer blood vessel development);GO:0140253(cell-cell fusion)","NA","NA","NA","vasohibin 2 [Source:NCBI gene;Acc:101113869]",{"v":1.360726,"d":"1.36"},{"v":1.24131,"d":"1.24"},{"v":1.620737,"d":"1.62"},{"v":3.390072,"d":"3.39"},{"v":3.080286,"d":"3.08"},{"v":3.136168,"d":"3.14"},{"v":0.439573369186738,"d":"0.44"},{"v":-1.18582410920535,"d":"-1.19"},{"v":0.00460696472555763,"d":"0.00"},{"v":0.112608562932492,"d":"0.11"},"down","yes"]
["MSTRG.6796","APLNR","ENSOART00000013887","GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043951(negative regulation of cAMP-mediated signaling);GO:0045766(positive regulation of angiogenesis);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:1904325(positive regulation of inhibitory G protein-coupled receptor phosphorylation)","NA","NA","NA","apelin receptor [Source:HGNC Symbol;Acc:HGNC:339]",{"v":1.728976,"d":"1.73"},{"v":0.754885,"d":"0.75"},{"v":0.604783,"d":"0.60"},{"v":3.38224,"d":"3.38"},{"v":2.795456,"d":"2.80"},{"v":2.412209,"d":"2.41"},{"v":0.359566723962605,"d":"0.36"},{"v":-1.47566858180883,"d":"-1.48"},{"v":0.00464128832437936,"d":"0.00"},{"v":0.113277960777976,"d":"0.11"},"down","yes"]
["MSTRG.4194","QSOX1","ENSOART00000019663","GO:0003756(protein disulfide isomerase activity);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016242(negative regulation of macroautophagy);GO:0016491(oxidoreductase activity);GO:0016971(flavin-linked sulfhydryl oxidase activity);GO:0016972(thiol oxidase activity);GO:0030173(integral component of Golgi membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0045171(intercellular bridge);GO:0045454(cell redox homeostasis);GO:0055114(oxidation-reduction process);GO:0070062(extracellular exosome)","NA","K10758","EC:1.8.3.2","quiescin sulfhydryl oxidase 1 [Source:NCBI gene;Acc:101119660]",{"v":2.65482570558676,"d":"2.65"},{"v":1.59027196659769,"d":"1.59"},{"v":2.62682406207508,"d":"2.63"},{"v":5.31969461602128,"d":"5.32"},{"v":4.18037202867278,"d":"4.18"},{"v":4.50833124889152,"d":"4.51"},{"v":0.490557291880335,"d":"0.49"},{"v":-1.02750645714854,"d":"-1.03"},{"v":0.00465771101357727,"d":"0.00"},{"v":0.113509112581626,"d":"0.11"},"down","yes"]
["MSTRG.8852","CAV3","ENSOART00000008178","GO:0000139(Golgi membrane);GO:0001778(plasma membrane repair);GO:0002027(regulation of heart rate);GO:0005246(calcium channel regulator activity);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006469(negative regulation of protein kinase activity);GO:0006641(triglyceride metabolic process);GO:0006897(endocytosis);GO:0007009(plasma membrane organization);GO:0007015(actin filament organization);GO:0007520(myoblast fusion);GO:0008022(protein C-terminus binding);GO:0008104(protein localization);GO:0010614(negative regulation of cardiac muscle hypertrophy);GO:0010831(positive regulation of myotube differentiation);GO:0014819(regulation of skeletal muscle contraction);GO:0014902(myotube differentiation);GO:0016010(dystrophin-associated glycoprotein complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017015(regulation of transforming growth factor beta receptor signaling pathway);GO:0017080(sodium channel regulator activity);GO:0023051(regulation of signaling);GO:0030315(T-tubule);GO:0031122(cytoplasmic microtubule organization);GO:0031579(membrane raft organization);GO:0032947(protein-containing complex scaffold activity);GO:0035995(detection of muscle stretch);GO:0038009(regulation of signal transduction by receptor internalization);GO:0042383(sarcolemma);GO:0042391(regulation of membrane potential);GO:0042593(glucose homeostasis);GO:0042632(cholesterol homeostasis);GO:0043014(alpha-tubulin binding);GO:0043231(intracellular membrane-bounded organelle);GO:0043407(negative regulation of MAP kinase activity);GO:0043409(negative regulation of MAPK cascade);GO:0044325(ion channel binding);GO:0044877(protein-containing complex binding);GO:0045121(membrane raft);GO:0045792(negative regulation of cell size);GO:0046716(muscle cell cellular homeostasis);GO:0051001(negative regulation of nitric-oxide synthase activity);GO:0051394(regulation of nerve growth factor receptor activity);GO:0051647(nucleus localization);GO:0051896(regulation of protein kinase B signaling);GO:0051924(regulation of calcium ion transport);GO:0051926(negative regulation of calcium ion transport);GO:0055013(cardiac muscle cell development);GO:0055117(regulation of cardiac muscle contraction);GO:0060299(negative regulation of sarcomere organization);GO:0060307(regulation of ventricular cardiac muscle cell membrane repolarization);GO:0060347(heart trabecula formation);GO:0060373(regulation of ventricular cardiac muscle cell membrane depolarization);GO:0060762(regulation of branching involved in mammary gland duct morphogenesis);GO:0070836(caveola assembly);GO:0071253(connexin binding);GO:0072659(protein localization to plasma membrane);GO:0090279(regulation of calcium ion import);GO:0098909(regulation of cardiac muscle cell action potential involved in regulation of contraction);GO:1900744(regulation of p38MAPK cascade);GO:1900825(regulation of membrane depolarization during cardiac muscle cell action potential);GO:1900826(negative regulation of membrane depolarization during cardiac muscle cell action potential);GO:1901019(regulation of calcium ion transmembrane transporter activity);GO:2000649(regulation of sodium ion transmembrane transporter activity)","04144(Endocytosis);04510(Focal adhesion);05100(Bacterial invasion of epithelial cells);05205(Proteoglycans in cancer);05418(Fluid shear stress and atherosclerosis)","K12959","NA","caveolin 3 [Source:NCBI gene;Acc:101107228]",{"v":28.380692,"d":"28.38"},{"v":28.224588,"d":"28.22"},{"v":37.238289,"d":"37.24"},{"v":44.94413,"d":"44.94"},{"v":73.050507,"d":"73.05"},{"v":84.378006,"d":"84.38"},{"v":0.463716674392596,"d":"0.46"},{"v":-1.10868449060107,"d":"-1.11"},{"v":0.00475706984189991,"d":"0.00"},{"v":0.115413724188026,"d":"0.12"},"down","yes"]
["MSTRG.2452","ITGBL1","ENSOART00000005283","NA","NA","NA","NA","integrin subunit beta like 1 [Source:NCBI gene;Acc:101112990]",{"v":1.4664253805205,"d":"1.47"},{"v":1.1045961305205,"d":"1.10"},{"v":4.32166477996845,"d":"4.32"},{"v":0.52027778115142,"d":"0.52"},{"v":1.10578349171924,"d":"1.11"},{"v":0.912739191246057,"d":"0.91"},{"v":2.71493817195575,"d":"2.71"},{"v":1.44091934350717,"d":"1.44"},{"v":0.00495064491470889,"d":"0.00"},{"v":0.119048792588169,"d":"0.12"},"up","yes"]
["MSTRG.18317","PCDH12","ENSOART00000001725","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005977(glycogen metabolic process);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0060711(labyrinthine layer development)","NA","K16499","NA","protocadherin 12 [Source:NCBI gene;Acc:101106077]",{"v":3.705154,"d":"3.71"},{"v":1.34101,"d":"1.34"},{"v":2.120513,"d":"2.12"},{"v":6.897008,"d":"6.90"},{"v":4.285927,"d":"4.29"},{"v":4.885531,"d":"4.89"},{"v":0.446008785157214,"d":"0.45"},{"v":-1.1648559673025,"d":"-1.16"},{"v":0.00497943102218415,"d":"0.00"},{"v":0.119564926073857,"d":"0.12"},"down","yes"]
["MSTRG.3633","ENSOARG00000011123","ENSOART00000012098","GO:0005515(protein binding);GO:0005634(nucleus);GO:0016925(protein sumoylation)","NA","NA","NA",null,{"v":18.9821415986842,"d":"18.98"},{"v":19.2155492960526,"d":"19.22"},{"v":20.2116134703947,"d":"20.21"},{"v":11.2131874736842,"d":"11.21"},{"v":9.97819642105263,"d":"9.98"},{"v":11.7939811578947,"d":"11.79"},{"v":1.77076422443509,"d":"1.77"},{"v":0.824372131410707,"d":"0.82"},{"v":0.0049880116763166,"d":"0.00"},{"v":0.119595087593095,"d":"0.12"},"up","no"]
["MSTRG.12934","COLEC12","ENSOART00000010122","GO:0005581(collagen trimer);GO:0006910(phagocytosis, recognition);GO:0008329(signaling pattern recognition receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030169(low-density lipoprotein particle binding);GO:0030246(carbohydrate binding);GO:0034138(toll-like receptor 3 signaling pathway);GO:0060355(positive regulation of cell adhesion molecule production);GO:0071360(cellular response to exogenous dsRNA)","04145(Phagosome)","K10062","NA","collectin subfamily member 12 [Source:NCBI gene;Acc:101102949]",{"v":6.285295,"d":"6.29"},{"v":4.280829,"d":"4.28"},{"v":5.273697,"d":"5.27"},{"v":9.453326,"d":"9.45"},{"v":10.344122,"d":"10.34"},{"v":12.095397,"d":"12.10"},{"v":0.496657510485502,"d":"0.50"},{"v":-1.00967676674296,"d":"-1.01"},{"v":0.00506548923061922,"d":"0.01"},{"v":0.12092004116601,"d":"0.12"},"down","yes"]
["MSTRG.195","P3H1","ENSOART00000022278","GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006457(protein folding);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0018126(protein hydroxylation);GO:0019511(peptidyl-proline hydroxylation);GO:0019797(procollagen-proline 3-dioxygenase activity);GO:0031418(L-ascorbic acid binding);GO:0032963(collagen metabolic process);GO:0046872(metal ion binding);GO:0050708(regulation of protein secretion);GO:0050821(protein stabilization);GO:0055114(oxidation-reduction process);GO:0060348(bone development);GO:1901874(negative regulation of post-translational protein modification)","NA","K08134","EC:1.14.11.7","prolyl 3-hydroxylase 1 [Source:NCBI gene;Acc:101105862]",{"v":4.527849,"d":"4.53"},{"v":3.582851,"d":"3.58"},{"v":3.71449,"d":"3.71"},{"v":7.415586,"d":"7.42"},{"v":7.801844,"d":"7.80"},{"v":7.954838,"d":"7.95"},{"v":0.510316469669693,"d":"0.51"},{"v":-0.970535891676828,"d":"-0.97"},{"v":0.00510393022438306,"d":"0.01"},{"v":0.121659814166024,"d":"0.12"},"down","no"]
["MSTRG.3552","ENSOARG00000005372","ENSOART00000005855","GO:0003824(catalytic activity);GO:0006520(cellular amino acid metabolic process);GO:0016829(lyase activity)","00260(Glycine, serine and threonine metabolism)","K01620","EC:4.1.2.48","probable low-specificity L-threonine aldolase 2 [Source:NCBI gene;Acc:101113775]",{"v":0.195691,"d":"0.20"},{"v":0.625445,"d":"0.63"},{"v":0.346552,"d":"0.35"},{"v":1.452852,"d":"1.45"},{"v":1.026219,"d":"1.03"},{"v":1.150794,"d":"1.15"},{"v":0.32168909863039,"d":"0.32"},{"v":-1.63626104798081,"d":"-1.64"},{"v":0.00526075887154766,"d":"0.01"},{"v":0.124390679922478,"d":"0.12"},"down","yes"]
["MSTRG.4277","DTL","ENSOART00000011795","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006974(cellular response to DNA damage stimulus);GO:0009411(response to UV);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0019985(translesion synthesis);GO:0031464(Cul4A-RING E3 ubiquitin ligase complex);GO:0031465(Cul4B-RING E3 ubiquitin ligase complex);GO:0045732(positive regulation of protein catabolic process);GO:0051726(regulation of cell cycle);GO:0072425(signal transduction involved in G2 DNA damage checkpoint);GO:0080008(Cul4-RING E3 ubiquitin ligase complex)","NA","K11790","NA","denticleless E3 ubiquitin protein ligase homolog [Source:NCBI gene;Acc:101117523]",{"v":0.610633,"d":"0.61"},{"v":0.157754,"d":"0.16"},{"v":0.290324,"d":"0.29"},{"v":1.035568,"d":"1.04"},{"v":1.095639,"d":"1.10"},{"v":0.865299,"d":"0.87"},{"v":0.353315161057578,"d":"0.35"},{"v":-1.50097243704491,"d":"-1.50"},{"v":0.00526420626080549,"d":"0.01"},{"v":0.124390679922478,"d":"0.12"},"down","yes"]
["MSTRG.7927","ENSOARG00000016870","ENSOART00000018374","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","NA","NA",null,{"v":2.93334000295366,"d":"2.93"},{"v":2.04744108879454,"d":"2.05"},{"v":2.92099022798597,"d":"2.92"},{"v":1.63873311630054,"d":"1.64"},{"v":1.74421284604024,"d":"1.74"},{"v":0.852062296104855,"d":"0.85"},{"v":1.86582193883002,"d":"1.87"},{"v":0.899811311900108,"d":"0.90"},{"v":0.00527676815172485,"d":"0.01"},{"v":0.124507327140699,"d":"0.12"},"up","no"]
["MSTRG.10935","EXTL1","ENSOART00000006092;ENSOART00000006090","GO:0006486(protein glycosylation);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0016757(transferase activity, transferring glycosyl groups)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin);00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)","K02368","EC:2.4.1.224","exostosin like glycosyltransferase 1 [Source:NCBI gene;Acc:101113394]",{"v":0.449573730077121,"d":"0.45"},{"v":0.438930676092545,"d":"0.44"},{"v":0.700834541131105,"d":"0.70"},{"v":1.62299012210797,"d":"1.62"},{"v":0.851557152956298,"d":"0.85"},{"v":1.43609972750643,"d":"1.44"},{"v":0.406413298427602,"d":"0.41"},{"v":-1.2989804849484,"d":"-1.30"},{"v":0.00531179253705063,"d":"0.01"},{"v":0.124792731719371,"d":"0.12"},"down","yes"]
["MSTRG.988","MPZ","ENSOART00000010876","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042552(myelination);GO:0043209(myelin sheath);GO:0098742(cell-cell adhesion via plasma-membrane adhesion molecules);GO:0098743(cell aggregation)","04514(Cell adhesion molecules (CAMs))","K06770","NA","myelin protein zero [Source:NCBI gene;Acc:101106820]",{"v":6.155493,"d":"6.16"},{"v":3.434859,"d":"3.43"},{"v":2.697167,"d":"2.70"},{"v":6.379069,"d":"6.38"},{"v":10.648205,"d":"10.65"},{"v":11.491958,"d":"11.49"},{"v":0.430850276753596,"d":"0.43"},{"v":-1.21474148430224,"d":"-1.21"},{"v":0.00532228323049517,"d":"0.01"},{"v":0.12485954107403,"d":"0.12"},"down","yes"]
["MSTRG.9613","ENSOARG00000009583","ENSOART00000010433","GO:0005524(ATP binding);GO:0006457(protein folding);GO:0009408(response to heat);GO:0031072(heat shock protein binding);GO:0046872(metal ion binding);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum)","K09502","NA","dnaJ homolog subfamily A member 1 [Source:NCBI gene;Acc:101105132]",{"v":6.50466036109374,"d":"6.50"},{"v":6.25100829228845,"d":"6.25"},{"v":6.70617229032258,"d":"6.71"},{"v":4.11182506639264,"d":"4.11"},{"v":3.87262604852113,"d":"3.87"},{"v":3.16199362898758,"d":"3.16"},{"v":1.74601331553302,"d":"1.75"},{"v":0.804064561361511,"d":"0.80"},{"v":0.00534168441243556,"d":"0.01"},{"v":0.124955620467404,"d":"0.12"},"up","no"]
["MSTRG.1699","KCNAB1","ENSOART00000003273","GO:0005249(voltage-gated potassium channel activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006813(potassium ion transport);GO:0007611(learning or memory);GO:0008076(voltage-gated potassium channel complex);GO:0015459(potassium channel regulator activity);GO:0016021(integral component of membrane);GO:0019904(protein domain specific binding);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0034705(potassium channel complex);GO:0055085(transmembrane transport);GO:0070402(NADPH binding);GO:0071805(potassium ion transmembrane transport);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:1901379(regulation of potassium ion transmembrane transport);GO:1903817(negative regulation of voltage-gated potassium channel activity)","NA","K04882","NA","potassium voltage-gated channel subfamily A member regulatory beta subunit 1 [Source:NCBI gene;Acc:101110988]",{"v":0.831238,"d":"0.83"},{"v":0.505679,"d":"0.51"},{"v":0.714863,"d":"0.71"},{"v":1.827453,"d":"1.83"},{"v":1.364567,"d":"1.36"},{"v":1.935781,"d":"1.94"},{"v":0.400128632136856,"d":"0.40"},{"v":-1.32146422710389,"d":"-1.32"},{"v":0.00543918909465104,"d":"0.01"},{"v":0.126895667175893,"d":"0.13"},"down","yes"]
["MSTRG.14219","DEPP1","ENSOART00000004028","GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0010506(regulation of autophagy)","NA","NA","NA","DEPP1, autophagy regulator [Source:NCBI gene;Acc:101120888]",{"v":4.47851906466513,"d":"4.48"},{"v":3.51938266974596,"d":"3.52"},{"v":5.06184011547344,"d":"5.06"},{"v":10.8863012794457,"d":"10.89"},{"v":6.90524906004619,"d":"6.91"},{"v":8.66047624018476,"d":"8.66"},{"v":0.493714226792682,"d":"0.49"},{"v":-1.01825187673255,"d":"-1.02"},{"v":0.00544966490953895,"d":"0.01"},{"v":0.126895667175893,"d":"0.13"},"down","yes"]
["MSTRG.3489","PPP1R27","ENSOART00000019695","GO:0005515(protein binding);GO:0010923(negative regulation of phosphatase activity);GO:0019902(phosphatase binding)","NA","K17566","NA","protein phosphatase 1 regulatory subunit 27 [Source:NCBI gene;Acc:101115471]",{"v":338.643127,"d":"338.64"},{"v":346.899078,"d":"346.90"},{"v":321.350128,"d":"321.35"},{"v":154.103531,"d":"154.10"},{"v":198.755432,"d":"198.76"},{"v":212.275925,"d":"212.28"},{"v":1.78168496474067,"d":"1.78"},{"v":0.833242263915943,"d":"0.83"},{"v":0.00545393457696354,"d":"0.01"},{"v":0.126895667175893,"d":"0.13"},"up","no"]
["MSTRG.3408","SMURF2","ENSOART00000016591","GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030579(ubiquitin-dependent SMAD protein catabolic process);GO:0042802(identical protein binding);GO:0046332(SMAD binding);GO:0061630(ubiquitin protein ligase activity);GO:1901165(positive regulation of trophoblast cell migration)","04120(Ubiquitin mediated proteolysis);04144(Endocytosis);04340(Hedgehog signaling pathway);04350(TGF-beta signaling pathway)","K04678","EC:2.3.2.26","SMAD specific E3 ubiquitin protein ligase 2 [Source:NCBI gene;Acc:101106698]",{"v":3.83606024420152,"d":"3.84"},{"v":4.15116262576046,"d":"4.15"},{"v":4.26854975617871,"d":"4.27"},{"v":2.59266415712928,"d":"2.59"},{"v":2.54090408773764,"d":"2.54"},{"v":1.97187995,"d":"1.97"},{"v":1.72484159901334,"d":"1.72"},{"v":0.786463877942468,"d":"0.79"},{"v":0.00545570543590624,"d":"0.01"},{"v":0.126895667175893,"d":"0.13"},"up","no"]
["MSTRG.9805","CEMIP2","ENSOART00000013932","GO:0004415(hyalurononglucosaminidase activity);GO:0005509(calcium ion binding);GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030214(hyaluronan catabolic process)","NA","K22144","EC:3.2.1.35","cell migration inducing hyaluronidase 2 [Source:NCBI gene;Acc:101102701]",{"v":5.86899359193253,"d":"5.87"},{"v":6.3302714663733,"d":"6.33"},{"v":5.55545933010634,"d":"5.56"},{"v":3.57589919985332,"d":"3.58"},{"v":3.68117021268794,"d":"3.68"},{"v":2.8519750876421,"d":"2.85"},{"v":1.7563207272547,"d":"1.76"},{"v":0.812556324012594,"d":"0.81"},{"v":0.00551566711011799,"d":"0.01"},{"v":0.128107841499298,"d":"0.13"},"up","no"]
["MSTRG.21372","ENPP2","ENSOART00000016823;ENSOART00000016825","GO:0003676(nucleic acid binding);GO:0003824(catalytic activity);GO:0004528(phosphodiesterase I activity);GO:0004551(nucleotide diphosphatase activity);GO:0004622(lysophospholipase activity);GO:0005044(scavenger receptor activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0006644(phospholipid metabolic process);GO:0006898(receptor-mediated endocytosis);GO:0006935(chemotaxis);GO:0006955(immune response);GO:0008270(zinc ion binding);GO:0009395(phospholipid catabolic process);GO:0010634(positive regulation of epithelial cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0030247(polysaccharide binding);GO:0030334(regulation of cell migration);GO:0034638(phosphatidylcholine catabolic process);GO:0045765(regulation of angiogenesis);GO:0046872(metal ion binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:2000394(positive regulation of lamellipodium morphogenesis);GO:2000394(positive regulation of lamellipodium morphogenesis)","00565(Ether lipid metabolism);00565(Ether lipid metabolism)","K01122","EC:3.1.4.39","ectonucleotide pyrophosphatase/phosphodiesterase 2 [Source:NCBI gene;Acc:101120171]",{"v":1.54572414202899,"d":"1.55"},{"v":1.7234583057971,"d":"1.72"},{"v":1.30517672681159,"d":"1.31"},{"v":2.9680475826087,"d":"2.97"},{"v":3.02250181086957,"d":"3.02"},{"v":3.22408187971014,"d":"3.22"},{"v":0.496423463839251,"d":"0.50"},{"v":-1.01035678770976,"d":"-1.01"},{"v":0.00553016655935079,"d":"0.01"},{"v":0.128262158495852,"d":"0.13"},"down","yes"]
["MSTRG.19711","RF00017","ENSOART00000026242","NA","NA","NA","NA",null,{"v":5356.173828,"d":"5356.17"},{"v":6309.276855,"d":"6309.28"},{"v":3811.641357,"d":"3811.64"},{"v":6478.075195,"d":"6478.08"},{"v":12122.242188,"d":"12122.24"},{"v":16994.574219,"d":"16994.57"},{"v":0.434812169483623,"d":"0.43"},{"v":-1.20153577593893,"d":"-1.20"},{"v":0.00554001036273282,"d":"0.01"},{"v":0.128308211635038,"d":"0.13"},"down","yes"]
["MSTRG.12946","EMILIN2","ENSOART00000010852","GO:0005515(protein binding);GO:0005576(extracellular region)","NA","NA","NA","elastin microfibril interfacer 2 [Source:NCBI gene;Acc:101123002]",{"v":1.464724,"d":"1.46"},{"v":0.976035,"d":"0.98"},{"v":2.731466,"d":"2.73"},{"v":2.968015,"d":"2.97"},{"v":4.406128,"d":"4.41"},{"v":4.959466,"d":"4.96"},{"v":0.419360221326945,"d":"0.42"},{"v":-1.2537380746929,"d":"-1.25"},{"v":0.00557771835467422,"d":"0.01"},{"v":0.128736711264808,"d":"0.13"},"down","yes"]
["MSTRG.1493","ADIPOQ","ENSOART00000022339","GO:0001934(positive regulation of protein phosphorylation);GO:0005102(signaling receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0006006(glucose metabolic process);GO:0006635(fatty acid beta-oxidation);GO:0009617(response to bacterium);GO:0009749(response to glucose);GO:0009967(positive regulation of signal transduction);GO:0009986(cell surface);GO:0010469(regulation of signaling receptor activity);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0010739(positive regulation of protein kinase A signaling);GO:0010745(negative regulation of macrophage derived foam cell differentiation);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0010875(positive regulation of cholesterol efflux);GO:0010906(regulation of glucose metabolic process);GO:0019395(fatty acid oxidation);GO:0030336(negative regulation of cell migration);GO:0030853(negative regulation of granulocyte differentiation);GO:0031953(negative regulation of protein autophosphorylation);GO:0032270(positive regulation of cellular protein metabolic process);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032757(positive regulation of interleukin-8 production);GO:0032869(cellular response to insulin stimulus);GO:0033034(positive regulation of myeloid cell apoptotic process);GO:0033691(sialic acid binding);GO:0034115(negative regulation of heterotypic cell-cell adhesion);GO:0034383(low-density lipoprotein particle clearance);GO:0034612(response to tumor necrosis factor);GO:0035690(cellular response to drug);GO:0042593(glucose homeostasis);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043407(negative regulation of MAP kinase activity);GO:0045599(negative regulation of fat cell differentiation);GO:0045650(negative regulation of macrophage differentiation);GO:0045715(negative regulation of low-density lipoprotein particle receptor biosynthetic process);GO:0045721(negative regulation of gluconeogenesis);GO:0045776(negative regulation of blood pressure);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045923(positive regulation of fatty acid metabolic process);GO:0046326(positive regulation of glucose import);GO:0050728(negative regulation of inflammatory response);GO:0050765(negative regulation of phagocytosis);GO:0050805(negative regulation of synaptic transmission);GO:0050873(brown fat cell differentiation);GO:0051260(protein homooligomerization);GO:0070208(protein heterotrimerization);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070994(detection of oxidative stress);GO:0071639(positive regulation of monocyte chemotactic protein-1 production);GO:0072659(protein localization to plasma membrane);GO:0090317(negative regulation of intracellular protein transport);GO:0120162(positive regulation of cold-induced thermogenesis);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900121(negative regulation of receptor binding);GO:1904706(negative regulation of vascular smooth muscle cell proliferation);GO:1904753(negative regulation of vascular associated smooth muscle cell migration);GO:2000279(negative regulation of DNA biosynthetic process);GO:2000478(positive regulation of metanephric glomerular visceral epithelial cell development);GO:2000481(positive regulation of cAMP-dependent protein kinase activity);GO:2000534(positive regulation of renal albumin absorption);GO:2000584(negative regulation of platelet-derived growth factor receptor-alpha signaling pathway);GO:2000590(negative regulation of metanephric mesenchymal cell migration)","03320(PPAR signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04920(Adipocytokine signaling pathway);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD))","K07296","NA","Ovis aries adiponectin, C1Q and collagen domain containing (ADIPOQ), mRNA. [Source:RefSeq mRNA;Acc:NM_001308565]",{"v":15.2459303756708,"d":"15.25"},{"v":26.8865165764758,"d":"26.89"},{"v":15.6865634096601,"d":"15.69"},{"v":0.646187014758497,"d":"0.65"},{"v":9.7910535460644,"d":"9.79"},{"v":6.16293806216458,"d":"6.16"},{"v":3.48303543443445,"d":"3.48"},{"v":1.80034515016346,"d":"1.80"},{"v":0.00558216508914039,"d":"0.01"},{"v":0.128736711264808,"d":"0.13"},"up","yes"]
["MSTRG.6389","ABCC8","ENSOART00000003929","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006813(potassium ion transport);GO:0008281(sulfonylurea receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","02010(ABC transporters);04911(Insulin secretion);04930(Type II diabetes mellitus)","K05032","NA","ATP binding cassette subfamily C member 8 [Source:NCBI gene;Acc:101120522]",{"v":0.357373,"d":"0.36"},{"v":0.259856,"d":"0.26"},{"v":0.394769,"d":"0.39"},{"v":0.788198,"d":"0.79"},{"v":0.90541,"d":"0.91"},{"v":0.615496,"d":"0.62"},{"v":0.438264365745328,"d":"0.44"},{"v":-1.19012671342939,"d":"-1.19"},{"v":0.00563361215479221,"d":"0.01"},{"v":0.129423480518356,"d":"0.13"},"down","yes"]
["ENSOARG00000014172","KCNN1","ENSOART00000015439","GO:0005516(calmodulin binding);GO:0006813(potassium ion transport);GO:0015269(calcium-activated potassium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016286(small conductance calcium-activated potassium channel activity);GO:0071805(potassium ion transmembrane transport)","04911(Insulin secretion)","K04942","NA","potassium calcium-activated channel subfamily N member 1 [Source:NCBI gene;Acc:101112056]",{"v":0.230989,"d":"0.23"},{"v":0.3164,"d":"0.32"},{"v":0.258488,"d":"0.26"},{"v":0.122724,"d":"0.12"},{"v":0.021619,"d":"0.02"},{"v":0.119249,"d":"0.12"},{"v":3.05728929557801,"d":"3.06"},{"v":1.61225307350344,"d":"1.61"},{"v":0.00563572358210138,"d":"0.01"},{"v":0.129423480518356,"d":"0.13"},"up","yes"]
["ENSOARG00000003055","AGT","ENSOART00000003308","GO:0001822(kidney development);GO:0003014(renal system process);GO:0003081(regulation of systemic arterial blood pressure by renin-angiotensin);GO:0005615(extracellular space);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008217(regulation of blood pressure);GO:0010536(positive regulation of activation of Janus kinase activity);GO:0010595(positive regulation of endothelial cell migration);GO:0010873(positive regulation of cholesterol esterification);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0031702(type 1 angiotensin receptor binding);GO:0031703(type 2 angiotensin receptor binding);GO:0032270(positive regulation of cellular protein metabolic process);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051387(negative regulation of neurotrophin TRK receptor signaling pathway);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:1901201(regulation of extracellular matrix assembly);GO:1903598(positive regulation of gap junction assembly);GO:1903779(regulation of cardiac conduction);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","04072(Phospholipase D signaling pathway);04080(Neuroactive ligand-receptor interaction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04614(Renin-angiotensin system);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04931(Insulin resistance);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome);05200(Pathways in cancer);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","K09821","NA","angiotensinogen [Source:NCBI gene;Acc:101119440]",{"v":0.503326,"d":"0.50"},{"v":0.336994,"d":"0.34"},{"v":0.430995,"d":"0.43"},{"v":0.913987,"d":"0.91"},{"v":1.444145,"d":"1.44"},{"v":0.963317,"d":"0.96"},{"v":0.38275915120178,"d":"0.38"},{"v":-1.38549122405819,"d":"-1.39"},{"v":0.00565152281239032,"d":"0.01"},{"v":0.129604023147063,"d":"0.13"},"down","yes"]
["MSTRG.9188","CXCR6","ENSOART00000015547","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0015026(coreceptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016494(C-X-C chemokine receptor activity);GO:0019958(C-X-C chemokine binding);GO:0070098(chemokine-mediated signaling pathway)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)","K04191","NA","C-X-C motif chemokine receptor 6 [Source:NCBI gene;Acc:101118482]",{"v":11.727715,"d":"11.73"},{"v":19.513229,"d":"19.51"},{"v":17.332371,"d":"17.33"},{"v":11.105508,"d":"11.11"},{"v":9.402329,"d":"9.40"},{"v":5.673888,"d":"5.67"},{"v":1.85523738409138,"d":"1.86"},{"v":0.891603796517342,"d":"0.89"},{"v":0.00569214060415461,"d":"0.01"},{"v":0.130169848437866,"d":"0.13"},"up","no"]
["MSTRG.6615","RF00067","ENSOART00000023932","NA","NA","NA","NA","small nucleolar RNA, C/D box 15A [Source:HGNC Symbol;Acc:HGNC:10114]",{"v":15.416744,"d":"15.42"},{"v":19.620192,"d":"19.62"},{"v":16.396452,"d":"16.40"},{"v":26.076277,"d":"26.08"},{"v":33.014626,"d":"33.01"},{"v":67.070396,"d":"67.07"},{"v":0.407679600699102,"d":"0.41"},{"v":-1.29449232522434,"d":"-1.29"},{"v":0.0057281555212335,"d":"0.01"},{"v":0.130810242448532,"d":"0.13"},"down","yes"]
["ENSOARG00000010137","ASGR1","ENSOART00000011030","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding);GO:0031668(cellular response to extracellular stimulus);GO:0042803(protein homodimerization activity)","04918(Thyroid hormone synthesis)","K10063","NA","asialoglycoprotein receptor 1 [Source:NCBI gene;Acc:101116157]",{"v":0.264212,"d":"0.26"},{"v":0.431613,"d":"0.43"},{"v":0.198625,"d":"0.20"},{"v":0.028324,"d":"0.03"},{"v":0.181625,"d":"0.18"},{"v":0.05513,"d":"0.06"},{"v":3.37427710229781,"d":"3.37"},{"v":1.75457845545574,"d":"1.75"},{"v":0.00578965578733412,"d":"0.01"},{"v":0.13179135269661,"d":"0.13"},"up","yes"]
["MSTRG.14058","VSIR","ENSOART00000007483","GO:0005886(plasma membrane);GO:0010628(positive regulation of gene expression);GO:0010950(positive regulation of endopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019899(enzyme binding);GO:0030335(positive regulation of cell migration);GO:0031638(zymogen activation);GO:0032689(negative regulation of interferon-gamma production);GO:0032693(negative regulation of interleukin-10 production);GO:0032700(negative regulation of interleukin-17 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0042802(identical protein binding);GO:0045591(positive regulation of regulatory T cell differentiation);GO:0061133(endopeptidase activator activity);GO:0120158(positive regulation of collagen catabolic process);GO:2000562(negative regulation of CD4-positive, alpha-beta T cell proliferation);GO:2000565(negative regulation of CD8-positive, alpha-beta T cell proliferation)","04514(Cell adhesion molecules (CAMs))","K23268","NA","V-set immunoregulatory receptor [Source:NCBI gene;Acc:101112625]",{"v":5.617847,"d":"5.62"},{"v":2.680753,"d":"2.68"},{"v":4.252008,"d":"4.25"},{"v":8.113154,"d":"8.11"},{"v":9.707814,"d":"9.71"},{"v":9.369863,"d":"9.37"},{"v":0.461575006663092,"d":"0.46"},{"v":-1.11536298775713,"d":"-1.12"},{"v":0.00579533263327819,"d":"0.01"},{"v":0.13179135269661,"d":"0.13"},"down","yes"]
["MSTRG.752","ENSOARG00000012716","ENSOART00000013821","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 2-A [Source:NCBI gene;Acc:101121387]",{"v":17.245323,"d":"17.25"},{"v":8.186396,"d":"8.19"},{"v":15.308721,"d":"15.31"},{"v":24.663191,"d":"24.66"},{"v":28.324064,"d":"28.32"},{"v":33.836758,"d":"33.84"},{"v":0.469230096517193,"d":"0.47"},{"v":-1.09163254378951,"d":"-1.09"},{"v":0.00582371811317015,"d":"0.01"},{"v":0.13225266947405,"d":"0.13"},"down","yes"]
["MSTRG.14588","KCNT1","ENSOART00000005396","GO:0006813(potassium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K04946","NA","potassium sodium-activated channel subfamily T member 1 [Source:NCBI gene;Acc:101118349]",{"v":1.44952623078927,"d":"1.45"},{"v":1.12409323183121,"d":"1.12"},{"v":1.72571361786924,"d":"1.73"},{"v":0.974670539984371,"d":"0.97"},{"v":0.598240380828341,"d":"0.60"},{"v":0.663442948163584,"d":"0.66"},{"v":1.92247440806752,"d":"1.92"},{"v":0.942964393193699,"d":"0.94"},{"v":0.00592948004467803,"d":"0.01"},{"v":0.133955216880663,"d":"0.13"},"up","no"]
["MSTRG.11940","VPS37C","ENSOART00000017714","GO:0000813(ESCRT I complex);GO:0015031(protein transport);GO:0032509(endosome transport via multivesicular body sorting pathway);GO:0048306(calcium-dependent protein binding)","04144(Endocytosis)","K12185","NA","VPS37C, ESCRT-I subunit [Source:NCBI gene;Acc:101122144]",{"v":2.35666388893273,"d":"2.36"},{"v":1.83956462635628,"d":"1.84"},{"v":3.38657553797593,"d":"3.39"},{"v":4.27762862990728,"d":"4.28"},{"v":5.39230896468731,"d":"5.39"},{"v":6.29615623140659,"d":"6.30"},{"v":0.474931698128703,"d":"0.47"},{"v":-1.0742080464044,"d":"-1.07"},{"v":0.00593352238289859,"d":"0.01"},{"v":0.133955216880663,"d":"0.13"},"down","yes"]
["MSTRG.11543","HIST1H1C","ENSOART00000001430","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005719(nuclear euchromatin);GO:0006334(nucleosome assembly);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016584(nucleosome positioning);GO:0031490(chromatin DNA binding);GO:0035327(transcriptionally active chromatin);GO:0080182(histone H3-K4 trimethylation);GO:0098532(histone H3-K27 trimethylation)","NA","NA","NA","histone cluster 1 H1 family member c [Source:HGNC Symbol;Acc:HGNC:4716]",{"v":2.23545274922601,"d":"2.24"},{"v":0.859949814241486,"d":"0.86"},{"v":0.926484557275542,"d":"0.93"},{"v":2.90947605696594,"d":"2.91"},{"v":2.6710759504644,"d":"2.67"},{"v":4.35331214860681,"d":"4.35"},{"v":0.404866329715089,"d":"0.40"},{"v":-1.30448242710859,"d":"-1.30"},{"v":0.00593656119468545,"d":"0.01"},{"v":0.133955216880663,"d":"0.13"},"down","yes"]
["ENSOARG00000018480","FAM83G","ENSOART00000020117","GO:0005634(nucleus);GO:0005829(cytosol);GO:0030509(BMP signaling pathway)","NA","NA","NA","family with sequence similarity 83 member G [Source:HGNC Symbol;Acc:HGNC:32554]",{"v":0.086231,"d":"0.09"},{"v":0.106938,"d":"0.11"},{"v":0.133275,"d":"0.13"},{"v":0.103872,"d":"0.10"},{"v":0.636455,"d":"0.64"},{"v":0.431097,"d":"0.43"},{"v":0.278672794820663,"d":"0.28"},{"v":-1.84335592736874,"d":"-1.84"},{"v":0.00597975864344744,"d":"0.01"},{"v":0.134179372467055,"d":"0.13"},"down","yes"]
["ENSOARG00000009637","KIFC1","ENSOART00000010493","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0007080(mitotic metaphase plate congression);GO:0008017(microtubule binding);GO:0090307(mitotic spindle assembly)","NA","K10405","NA","kinesin family member C1 [Source:NCBI gene;Acc:101113367]",{"v":0.189335,"d":"0.19"},{"v":0.095931,"d":"0.10"},{"v":0.127449,"d":"0.13"},{"v":0.687696,"d":"0.69"},{"v":0.141355,"d":"0.14"},{"v":0.596507,"d":"0.60"},{"v":0.289511194914553,"d":"0.29"},{"v":-1.78830895898566,"d":"-1.79"},{"v":0.00598117523986831,"d":"0.01"},{"v":0.134179372467055,"d":"0.13"},"down","yes"]
["MSTRG.17569","ISYNA1","ENSOART00000012879","GO:0004512(inositol-3-phosphate synthase activity);GO:0006021(inositol biosynthetic process);GO:0008654(phospholipid biosynthetic process)","00562(Inositol phosphate metabolism)","K01858","EC:5.5.1.4","inositol-3-phosphate synthase 1 [Source:NCBI gene;Acc:101109704]",{"v":1.950388,"d":"1.95"},{"v":0.797144,"d":"0.80"},{"v":0.352908,"d":"0.35"},{"v":2.731735,"d":"2.73"},{"v":2.527464,"d":"2.53"},{"v":3.615622,"d":"3.62"},{"v":0.349352398206116,"d":"0.35"},{"v":-1.51724505088709,"d":"-1.52"},{"v":0.00598251979152476,"d":"0.01"},{"v":0.134179372467055,"d":"0.13"},"down","yes"]
["MSTRG.17837","ANGPTL4","ENSOART00000004119","GO:0001525(angiogenesis);GO:0004857(enzyme inhibitor activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0051005(negative regulation of lipoprotein lipase activity);GO:0070328(triglyceride homeostasis);GO:2000352(negative regulation of endothelial cell apoptotic process)","03320(PPAR signaling pathway);04979(Cholesterol metabolism)","K08767","NA","angiopoietin like 4 [Source:NCBI gene;Acc:101104317]",{"v":1.143824,"d":"1.14"},{"v":0.572398306930693,"d":"0.57"},{"v":1.69230919009901,"d":"1.69"},{"v":1.37907056831683,"d":"1.38"},{"v":4.10251536633663,"d":"4.10"},{"v":3.25454750693069,"d":"3.25"},{"v":0.390164770240921,"d":"0.39"},{"v":-1.35784457858392,"d":"-1.36"},{"v":0.00604366188850936,"d":"0.01"},{"v":0.135179330569289,"d":"0.14"},"down","yes"]
["MSTRG.17448","IQCA1L","ENSOART00000003797","GO:0005515(protein binding);GO:0005524(ATP binding)","NA","NA","NA","IQ motif containing with AAA domain 1 like [Source:HGNC Symbol;Acc:HGNC:22831]",{"v":0.0528039139000365,"d":"0.05"},{"v":0.068972881430135,"d":"0.07"},{"v":0.349539644290405,"d":"0.35"},{"v":0.448823046698285,"d":"0.45"},{"v":0.69770601058008,"d":"0.70"},{"v":0.649795744983583,"d":"0.65"},{"v":0.262378184071773,"d":"0.26"},{"v":-1.93028032554074,"d":"-1.93"},{"v":0.0060978836913847,"d":"0.01"},{"v":0.135733556064949,"d":"0.14"},"down","yes"]
["ENSOARG00000009322","ARAP2","ENSOART00000010145","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0007165(signal transduction);GO:0043547(positive regulation of GTPase activity)","04144(Endocytosis)","K18440","NA","ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 [Source:NCBI gene;Acc:101109800]",{"v":0.313227,"d":"0.31"},{"v":0.322732,"d":"0.32"},{"v":0.366559,"d":"0.37"},{"v":0.203233,"d":"0.20"},{"v":0.158361,"d":"0.16"},{"v":0.138554,"d":"0.14"},{"v":2.00444268496525,"d":"2.00"},{"v":1.00320116565602,"d":"1.00"},{"v":0.00610169219449242,"d":"0.01"},{"v":0.135733556064949,"d":"0.14"},"up","yes"]
["MSTRG.7053","ENSOARG00000008775","ENSOART00000009557","GO:0008430(selenium binding)","NA","NA","NA","selenoprotein P [Source:NCBI gene;Acc:101101920]",{"v":12.7363834262728,"d":"12.74"},{"v":16.4110900826129,"d":"16.41"},{"v":22.5273594574928,"d":"22.53"},{"v":30.3990114935159,"d":"30.40"},{"v":34.1326589548511,"d":"34.13"},{"v":42.162564824928,"d":"42.16"},{"v":0.484326382151899,"d":"0.48"},{"v":-1.04594850354589,"d":"-1.05"},{"v":0.00616215367018654,"d":"0.01"},{"v":0.13689203418613,"d":"0.14"},"down","yes"]
["MSTRG.1727","IGSF10","ENSOART00000004324","GO:0005515(protein binding);GO:0005576(extracellular region)","NA","NA","NA","immunoglobulin superfamily member 10 [Source:NCBI gene;Acc:101116950]",{"v":0.907494,"d":"0.91"},{"v":0.574734,"d":"0.57"},{"v":0.779158,"d":"0.78"},{"v":1.809264,"d":"1.81"},{"v":1.237495,"d":"1.24"},{"v":1.524173,"d":"1.52"},{"v":0.494731927755652,"d":"0.49"},{"v":-1.01528108738921,"d":"-1.02"},{"v":0.00622171317279853,"d":"0.01"},{"v":0.13784007148637,"d":"0.14"},"down","yes"]
["MSTRG.16817","TMEM106B","ENSOART00000007884","GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0007040(lysosome organization);GO:0007041(lysosomal transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032418(lysosome localization);GO:0048813(dendrite morphogenesis);GO:1900006(positive regulation of dendrite development)","NA","NA","NA","transmembrane protein 106B [Source:NCBI gene;Acc:101122854]",{"v":9.15243214647412,"d":"9.15"},{"v":2.84734072805701,"d":"2.85"},{"v":2.81093116372843,"d":"2.81"},{"v":2.93262318867217,"d":"2.93"},{"v":1.71258943942236,"d":"1.71"},{"v":1.99597454182296,"d":"2.00"},{"v":2.23012899039308,"d":"2.23"},{"v":1.15712715786688,"d":"1.16"},{"v":0.0062807015807849,"d":"0.01"},{"v":0.138770359148925,"d":"0.14"},"up","yes"]
["MSTRG.17110","NFE2L3","ENSOART00000011116","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II)","NA","K09040","NA","nuclear factor, erythroid 2 like 3 [Source:NCBI gene;Acc:101115536]",{"v":20.4170040978604,"d":"20.42"},{"v":6.932109,"d":"6.93"},{"v":8.30467951631007,"d":"8.30"},{"v":8.70636749140652,"d":"8.71"},{"v":4.19230657769204,"d":"4.19"},{"v":3.30400704454577,"d":"3.30"},{"v":2.20048721344928,"d":"2.20"},{"v":1.13782298857094,"d":"1.14"},{"v":0.00635086740373957,"d":"0.01"},{"v":0.140131031038189,"d":"0.14"},"up","yes"]
["MSTRG.9734","RF00030","ENSOART00000024742","NA","NA","NA","NA","RNA component of mitochondrial RNA processing endoribonuclease [Source:HGNC Symbol;Acc:HGNC:10031]",{"v":5366.561523,"d":"5366.56"},{"v":5073.616699,"d":"5073.62"},{"v":3852.449707,"d":"3852.45"},{"v":7265.746094,"d":"7265.75"},{"v":9030.444336,"d":"9030.44"},{"v":13135.489258,"d":"13135.49"},{"v":0.485620531363266,"d":"0.49"},{"v":-1.04209867685678,"d":"-1.04"},{"v":0.00636077170522007,"d":"0.01"},{"v":0.140160162486954,"d":"0.14"},"down","yes"]
["MSTRG.19950","LGALS3","ENSOART00000022975","GO:0001772(immunological synapse);GO:0002548(monocyte chemotaxis);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005743(mitochondrial inner membrane);GO:0019863(IgE binding);GO:0019903(protein phosphatase binding);GO:0030246(carbohydrate binding);GO:0030593(neutrophil chemotaxis);GO:0030855(epithelial cell differentiation);GO:0042056(chemoattractant activity);GO:0042129(regulation of T cell proliferation);GO:0043236(laminin binding);GO:0045806(negative regulation of endocytosis);GO:0048245(eosinophil chemotaxis);GO:0048246(macrophage chemotaxis);GO:0050918(positive chemotaxis);GO:0070232(regulation of T cell apoptotic process);GO:0071674(mononuclear cell migration);GO:0071677(positive regulation of mononuclear cell migration);GO:0090073(positive regulation of protein homodimerization activity);GO:0090280(positive regulation of calcium ion import);GO:1902041(regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1903078(positive regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA","K06831","NA","galectin 3 [Source:NCBI gene;Acc:101118449]",{"v":5.657193,"d":"5.66"},{"v":6.61758,"d":"6.62"},{"v":11.967523,"d":"11.97"},{"v":3.514405,"d":"3.51"},{"v":3.075978,"d":"3.08"},{"v":4.917369,"d":"4.92"},{"v":2.10660570370303,"d":"2.11"},{"v":1.07492030820121,"d":"1.07"},{"v":0.00638217984797499,"d":"0.01"},{"v":0.140442361937649,"d":"0.14"},"up","yes"]
["MSTRG.2939","RF00554","ENSOART00000026601","NA","NA","NA","NA",null,{"v":87.302849,"d":"87.30"},{"v":77.789635,"d":"77.79"},{"v":48.233749,"d":"48.23"},{"v":113.151909,"d":"113.15"},{"v":143.445709,"d":"143.45"},{"v":204.192139,"d":"204.19"},{"v":0.462957845219637,"d":"0.46"},{"v":-1.11104726049759,"d":"-1.11"},{"v":0.00640139925217246,"d":"0.01"},{"v":0.140675702543031,"d":"0.14"},"down","yes"]
["MSTRG.11067","PADI2","ENSOART00000012128","GO:0004668(protein-arginine deiminase activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0010848(regulation of chromatin disassembly);GO:0018101(protein citrullination);GO:0030331(estrogen receptor binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0035327(transcriptionally active chromatin);GO:0036413(histone H3-R26 citrullination);GO:0042803(protein homodimerization activity);GO:0048096(chromatin-mediated maintenance of transcription);GO:0070100(negative regulation of chemokine-mediated signaling pathway);GO:1901624(negative regulation of lymphocyte chemotaxis);GO:1990830(cellular response to leukemia inhibitory factor)","NA","K01481","EC:3.5.3.15","peptidyl arginine deiminase 2 [Source:NCBI gene;Acc:101108464]",{"v":5.15084630079965,"d":"5.15"},{"v":15.4427019359185,"d":"15.44"},{"v":4.21332740530179,"d":"4.21"},{"v":8.68864464169131,"d":"8.69"},{"v":58.2056053450542,"d":"58.21"},{"v":20.299014722204,"d":"20.30"},{"v":0.284504493837054,"d":"0.28"},{"v":-1.81347665435821,"d":"-1.81"},{"v":0.00641208239656346,"d":"0.01"},{"v":0.140721077111678,"d":"0.14"},"down","yes"]
["MSTRG.16948","LAMB1","ENSOART00000007864","GO:0005201(extracellular matrix structural constituent);GO:0005604(basement membrane);GO:0005606(laminin-1 complex);GO:0005607(laminin-2 complex);GO:0005615(extracellular space);GO:0021812(neuronal-glial interaction involved in cerebral cortex radial glia guided migration);GO:0030335(positive regulation of cell migration);GO:0031175(neuron projection development);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035987(endodermal cell differentiation);GO:0042476(odontogenesis);GO:0043257(laminin-8 complex);GO:0043259(laminin-10 complex)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);05145(Toxoplasmosis);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K05636","NA","laminin subunit beta 1 [Source:NCBI gene;Acc:101105743]",{"v":11.652016449895,"d":"11.65"},{"v":7.3208459217437,"d":"7.32"},{"v":11.478301320063,"d":"11.48"},{"v":22.7588357454832,"d":"22.76"},{"v":17.6100359019958,"d":"17.61"},{"v":19.1489790555672,"d":"19.15"},{"v":0.511630768450165,"d":"0.51"},{"v":-0.966825067267316,"d":"-0.97"},{"v":0.00643589420129648,"d":"0.01"},{"v":0.140895226054779,"d":"0.14"},"down","no"]
["MSTRG.14830","LHX6","ENSOART00000015572","GO:0005634(nucleus);GO:0046872(metal ion binding)","NA","K09375","NA","LIM homeobox 6 [Source:NCBI gene;Acc:101113740]",{"v":0.393733,"d":"0.39"},{"v":0.252334,"d":"0.25"},{"v":0.234401,"d":"0.23"},{"v":1.006791,"d":"1.01"},{"v":0.996001,"d":"1.00"},{"v":0.50241,"d":"0.50"},{"v":0.351455890582875,"d":"0.35"},{"v":-1.50858445944593,"d":"-1.51"},{"v":0.00643727576168946,"d":"0.01"},{"v":0.140895226054779,"d":"0.14"},"down","yes"]
["MSTRG.18383","CSF1R","ENSOART00000006925","GO:0000166(nucleotide binding);GO:0001934(positive regulation of protein phosphorylation);GO:0002931(response to ischemia);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005011(macrophage colony-stimulating factor receptor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019221(cytokine-mediated signaling pathway);GO:0019903(protein phosphatase binding);GO:0019955(cytokine binding);GO:0021772(olfactory bulb development);GO:0021879(forebrain neuron differentiation);GO:0030097(hemopoiesis);GO:0030316(osteoclast differentiation);GO:0030335(positive regulation of cell migration);GO:0031529(ruffle organization);GO:0036006(cellular response to macrophage colony-stimulating factor stimulus);GO:0038145(macrophage colony-stimulating factor signaling pathway);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0045217(cell-cell junction maintenance);GO:0046488(phosphatidylinositol metabolic process);GO:0046777(protein autophosphorylation);GO:0048015(phosphatidylinositol-mediated signaling);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0061518(microglial cell proliferation);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071345(cellular response to cytokine stimulus);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090197(positive regulation of chemokine secretion);GO:1990682(CSF1-CSF1R complex);GO:2000147(positive regulation of cell motility);GO:2000249(regulation of actin cytoskeleton reorganization)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04060(Cytokine-cytokine receptor interaction);04151(PI3K-Akt signaling pathway);04380(Osteoclast differentiation);04640(Hematopoietic cell lineage);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05221(Acute myeloid leukemia)","K05090","EC:2.7.10.1","colony stimulating factor 1 receptor [Source:NCBI gene;Acc:101109969]",{"v":2.306791,"d":"2.31"},{"v":1.200345,"d":"1.20"},{"v":3.030805,"d":"3.03"},{"v":4.339933,"d":"4.34"},{"v":4.323337,"d":"4.32"},{"v":5.631068,"d":"5.63"},{"v":0.457379768129171,"d":"0.46"},{"v":-1.12853554432201,"d":"-1.13"},{"v":0.00651037719899811,"d":"0.01"},{"v":0.141924484519681,"d":"0.14"},"down","yes"]
["MSTRG.5875","KDELR1","ENSOART00000012738","GO:0002369(T cell cytokine production);GO:0005783(endoplasmic reticulum);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0006621(protein retention in ER lumen);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030217(T cell differentiation);GO:0046923(ER retention sequence binding);GO:0070231(T cell apoptotic process)","NA","K10949","NA","KDEL endoplasmic reticulum protein retention receptor 1 [Source:NCBI gene;Acc:101122047]",{"v":5.25093769715142,"d":"5.25"},{"v":3.99685782908546,"d":"4.00"},{"v":5.54034635382309,"d":"5.54"},{"v":7.92095432383808,"d":"7.92"},{"v":10.4815669115442,"d":"10.48"},{"v":11.5305368890555,"d":"11.53"},{"v":0.494040462507462,"d":"0.49"},{"v":-1.01729888978126,"d":"-1.02"},{"v":0.00658852619378536,"d":"0.01"},{"v":0.142865147001497,"d":"0.14"},"down","yes"]
["ENSOARG00000007488","SPTA1","ENSOART00000008172","GO:0002260(lymphocyte homeostasis);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0007009(plasma membrane organization);GO:0008091(spectrin);GO:0008360(regulation of cell shape);GO:0014731(spectrin-associated cytoskeleton);GO:0016020(membrane);GO:0030036(actin cytoskeleton organization);GO:0030097(hemopoiesis);GO:0030863(cortical cytoskeleton);GO:0032092(positive regulation of protein binding);GO:0032437(cuticular plate);GO:0042102(positive regulation of T cell proliferation);GO:0046982(protein heterodimerization activity)","04210(Apoptosis)","K06114","NA","spectrin alpha, erythrocytic 1 [Source:NCBI gene;Acc:101112688]",0,{"v":0.003776,"d":"0.00"},{"v":0.047993,"d":"0.05"},{"v":0.117131,"d":"0.12"},{"v":0.087285,"d":"0.09"},{"v":0.146975,"d":"0.15"},{"v":0.147325913298861,"d":"0.15"},{"v":-2.76291688515362,"d":"-2.76"},{"v":0.0066748683050017,"d":"0.01"},{"v":0.144163028682629,"d":"0.14"},"down","yes"]
["MSTRG.18201","UBE2B","ENSOART00000015159","GO:0000166(nucleotide binding);GO:0000209(protein polyubiquitination);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0001701(in utero embryonic development);GO:0001741(XY body);GO:0004842(ubiquitin-protein transferase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005657(replication fork);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006301(postreplication repair);GO:0006344(maintenance of chromatin silencing);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0006974(cellular response to DNA damage stimulus);GO:0007283(spermatogenesis);GO:0007288(sperm axoneme assembly);GO:0009411(response to UV);GO:0010845(positive regulation of reciprocal meiotic recombination);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0031056(regulation of histone modification);GO:0031625(ubiquitin protein ligase binding);GO:0033128(negative regulation of histone phosphorylation);GO:0033503(HULC complex);GO:0033522(histone H2A ubiquitination);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043951(negative regulation of cAMP-mediated signaling);GO:0045141(meiotic telomere clustering);GO:0050821(protein stabilization);GO:0051026(chiasma assembly);GO:0051865(protein autoubiquitination);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070076(histone lysine demethylation);GO:0070193(synaptonemal complex organization);GO:0070534(protein K63-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination);GO:0070979(protein K11-linked ubiquitination);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04120(Ubiquitin mediated proteolysis)","K10574","EC:2.3.2.23","ubiquitin conjugating enzyme E2 B [Source:NCBI gene;Acc:100381250]",{"v":10.1926099362601,"d":"10.19"},{"v":11.2198240816338,"d":"11.22"},{"v":10.2814558509586,"d":"10.28"},{"v":7.96830379427619,"d":"7.97"},{"v":5.40681165329258,"d":"5.41"},{"v":5.32693570997499,"d":"5.33"},{"v":1.69467453606383,"d":"1.69"},{"v":0.761008228941486,"d":"0.76"},{"v":0.00675153178388812,"d":"0.01"},{"v":0.145051330220165,"d":"0.15"},"up","no"]
["MSTRG.12105","SIPA1","ENSOART00000018710","GO:0005096(GTPase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction)","04015(Rap1 signaling pathway);04670(Leukocyte transendothelial migration)","K08013","NA","signal-induced proliferation-associated 1 [Source:NCBI gene;Acc:101101937]",{"v":2.20555703142477,"d":"2.21"},{"v":1.43535423328895,"d":"1.44"},{"v":1.46169115073236,"d":"1.46"},{"v":2.97599731105193,"d":"2.98"},{"v":3.57355542237017,"d":"3.57"},{"v":3.65025570199734,"d":"3.65"},{"v":0.500264534158013,"d":"0.50"},{"v":-0.99923691760774,"d":"-1.00"},{"v":0.00688347994335016,"d":"0.01"},{"v":0.147111859312855,"d":"0.15"},"down","no"]
["MSTRG.11464","ENSOARG00000009247","ENSOART00000010065","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 1-D [Source:NCBI gene;Acc:101123417]",{"v":2.540777,"d":"2.54"},{"v":1.036004,"d":"1.04"},{"v":4.620056,"d":"4.62"},{"v":13.547855,"d":"13.55"},{"v":3.407767,"d":"3.41"},{"v":9.315956,"d":"9.32"},{"v":0.312003983925138,"d":"0.31"},{"v":-1.68036364415771,"d":"-1.68"},{"v":0.00691037339345468,"d":"0.01"},{"v":0.147377108546766,"d":"0.15"},"down","yes"]
["MSTRG.20982","NDRG1","ENSOART00000005909","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0008017(microtubule binding);GO:0008285(negative regulation of cell population proliferation);GO:0015630(microtubule cytoskeleton);GO:0017137(Rab GTPase binding);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0032287(peripheral nervous system myelin maintenance);GO:0042127(regulation of cell population proliferation);GO:0043015(gamma-tubulin binding);GO:0045296(cadherin binding);GO:0045576(mast cell activation);GO:0048471(perinuclear region of cytoplasm);GO:0055038(recycling endosome membrane);GO:0071456(cellular response to hypoxia)","NA","K18266","NA","N-myc downstream regulated 1 [Source:NCBI gene;Acc:101120172]",{"v":4.67660351756345,"d":"4.68"},{"v":7.30139866497462,"d":"7.30"},{"v":10.1375952069036,"d":"10.14"},{"v":1.64402448690355,"d":"1.64"},{"v":4.01444128467005,"d":"4.01"},{"v":4.3292387315736,"d":"4.33"},{"v":2.21428230906039,"d":"2.21"},{"v":1.1468391696881,"d":"1.15"},{"v":0.00691394323535171,"d":"0.01"},{"v":0.147377108546766,"d":"0.15"},"up","yes"]
["MSTRG.11462","ENSOARG00000018233","ENSOART00000019840","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":2.852705,"d":"2.85"},{"v":1.057014,"d":"1.06"},{"v":0.966192,"d":"0.97"},{"v":5.419755,"d":"5.42"},{"v":2.628411,"d":"2.63"},{"v":6.176573,"d":"6.18"},{"v":0.342776834077588,"d":"0.34"},{"v":-1.54465848395129,"d":"-1.54"},{"v":0.00697713281691297,"d":"0.01"},{"v":0.148144538428756,"d":"0.15"},"down","yes"]
["MSTRG.22316","ATG4A","ENSOART00000020081","GO:0004197(cysteine-type endopeptidase activity);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006914(autophagy);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0015031(protein transport);GO:0016787(hydrolase activity)","04136(Autophagy - other);04140(Autophagy - animal)","K08342","EC:3.4.22.-","autophagy related 4A cysteine peptidase [Source:NCBI gene;Acc:101113390]",{"v":6.792995,"d":"6.79"},{"v":7.67814,"d":"7.68"},{"v":7.218701,"d":"7.22"},{"v":4.44813,"d":"4.45"},{"v":4.369305,"d":"4.37"},{"v":3.879326,"d":"3.88"},{"v":1.70829678529823,"d":"1.71"},{"v":0.77255863858979,"d":"0.77"},{"v":0.00697941584094807,"d":"0.01"},{"v":0.148144538428756,"d":"0.15"},"up","no"]
["ENSOARG00000000307","SMOX","ENSOART00000000328","GO:0005654(nucleoplasm);GO:0006598(polyamine catabolic process);GO:0016491(oxidoreductase activity);GO:0031965(nuclear membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0046208(spermine catabolic process);GO:0046592(polyamine oxidase activity);GO:0055114(oxidation-reduction process)","00330(Arginine and proline metabolism);00410(beta-Alanine metabolism)","K12259","1.5.3.-;EC:1.5.3.16","spermine oxidase [Source:NCBI gene;Acc:101118975]",{"v":0.905829,"d":"0.91"},{"v":1.044951,"d":"1.04"},{"v":0.922361,"d":"0.92"},{"v":2.07358,"d":"2.07"},{"v":2.543514,"d":"2.54"},{"v":1.765433,"d":"1.77"},{"v":0.450157280964107,"d":"0.45"},{"v":-1.15149894050633,"d":"-1.15"},{"v":0.00698623803222329,"d":"0.01"},{"v":0.148144538428756,"d":"0.15"},"down","yes"]
["MSTRG.5883","MAMSTR","ENSOART00000013087","GO:0005634(nucleus);GO:0010831(positive regulation of myotube differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","MEF2 activating motif and SAP domain containing transcriptional regulator [Source:NCBI gene;Acc:101107726]",{"v":1.854976,"d":"1.85"},{"v":0.829386,"d":"0.83"},{"v":1.333891,"d":"1.33"},{"v":2.187893,"d":"2.19"},{"v":3.664781,"d":"3.66"},{"v":3.550114,"d":"3.55"},{"v":0.427346974110232,"d":"0.43"},{"v":-1.22652018767144,"d":"-1.23"},{"v":0.00701648251765372,"d":"0.01"},{"v":0.148164083888996,"d":"0.15"},"down","yes"]
["MSTRG.201","TIE1","ENSOART00000022354","GO:0000166(nucleotide binding);GO:0001568(blood vessel development);GO:0001701(in utero embryonic development);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016525(negative regulation of angiogenesis);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030336(negative regulation of cell migration);GO:0032526(response to retinoic acid);GO:0045026(plasma membrane fusion)","NA","K05120","EC:2.7.10.1","tyrosine kinase with immunoglobulin like and EGF like domains 1 [Source:NCBI gene;Acc:443265]",{"v":4.23964939032731,"d":"4.24"},{"v":2.77517963654128,"d":"2.78"},{"v":2.41389498070347,"d":"2.41"},{"v":6.17882687225208,"d":"6.18"},{"v":6.26448415852467,"d":"6.26"},{"v":6.19434430312653,"d":"6.19"},{"v":0.505896468126037,"d":"0.51"},{"v":-0.983085927762021,"d":"-0.98"},{"v":0.00702345669586494,"d":"0.01"},{"v":0.148164083888996,"d":"0.15"},"down","no"]
["MSTRG.9023","ITIH4","ENSOART00000000789","GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006953(acute-phase response);GO:0010951(negative regulation of endopeptidase activity);GO:0030212(hyaluronan metabolic process);GO:0034097(response to cytokine)","NA","NA","NA","inter-alpha-trypsin inhibitor heavy chain family member 4 [Source:NCBI gene;Acc:101108959]",{"v":2.459888,"d":"2.46"},{"v":1.270382,"d":"1.27"},{"v":1.319439,"d":"1.32"},{"v":1.033783,"d":"1.03"},{"v":1.025119,"d":"1.03"},{"v":0.595435,"d":"0.60"},{"v":1.90243703041475,"d":"1.90"},{"v":0.927848702132594,"d":"0.93"},{"v":0.0070573894631622,"d":"0.01"},{"v":0.148496205096021,"d":"0.15"},"up","no"]
["MSTRG.8155","BTBD1","ENSOART00000015302","GO:0000932(P-body);GO:0005515(protein binding);GO:0032991(protein-containing complex)","NA","NA","NA","BTB domain containing 1 [Source:HGNC Symbol;Acc:HGNC:1120]",{"v":9.47556100953493,"d":"9.48"},{"v":11.6556504962055,"d":"11.66"},{"v":8.45612510838685,"d":"8.46"},{"v":7.42333781046896,"d":"7.42"},{"v":5.20812633780891,"d":"5.21"},{"v":4.31537908153337,"d":"4.32"},{"v":1.74589073687069,"d":"1.75"},{"v":0.803963273567991,"d":"0.80"},{"v":0.00712299951472924,"d":"0.01"},{"v":0.149140194965782,"d":"0.15"},"up","no"]
["MSTRG.10451","INSIG2","ENSOART00000013288","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006641(triglyceride metabolic process);GO:0006695(cholesterol biosynthetic process);GO:0006991(response to sterol depletion);GO:0008202(steroid metabolic process);GO:0008203(cholesterol metabolic process);GO:0010894(negative regulation of steroid biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016126(sterol biosynthetic process);GO:0032933(SREBP signaling pathway);GO:0032937(SREBP-SCAP-Insig complex);GO:0042472(inner ear morphogenesis);GO:0042474(middle ear morphogenesis);GO:0045717(negative regulation of fatty acid biosynthetic process);GO:0060021(roof of mouth development);GO:0060363(cranial suture morphogenesis)","NA","NA","NA","insulin induced gene 2 [Source:NCBI gene;Acc:101110569]",{"v":2.03919349213483,"d":"2.04"},{"v":1.30261527340824,"d":"1.30"},{"v":0.861714348314607,"d":"0.86"},{"v":0.82797331835206,"d":"0.83"},{"v":0.656133300374532,"d":"0.66"},{"v":0.546799938576779,"d":"0.55"},{"v":2.06977672051987,"d":"2.07"},{"v":1.04947514377637,"d":"1.05"},{"v":0.00712937508359326,"d":"0.01"},{"v":0.149140194965782,"d":"0.15"},"up","yes"]
["MSTRG.19923","GATM","ENSOART00000022929","GO:0005739(mitochondrion);GO:0005758(mitochondrial intermembrane space);GO:0006600(creatine metabolic process);GO:0006601(creatine biosynthetic process);GO:0007275(multicellular organism development);GO:0007611(learning or memory);GO:0014889(muscle atrophy);GO:0015067(amidinotransferase activity);GO:0015068(glycine amidinotransferase activity);GO:0120162(positive regulation of cold-induced thermogenesis)","00260(Glycine, serine and threonine metabolism);00330(Arginine and proline metabolism)","K00613","EC:2.1.4.1","glycine amidinotransferase [Source:NCBI gene;Acc:100174904]",{"v":4.050057,"d":"4.05"},{"v":1.105202,"d":"1.11"},{"v":3.316167,"d":"3.32"},{"v":10.819442,"d":"10.82"},{"v":4.948375,"d":"4.95"},{"v":5.822963,"d":"5.82"},{"v":0.392363129076393,"d":"0.39"},{"v":-1.34973861907409,"d":"-1.35"},{"v":0.00718202710565011,"d":"0.01"},{"v":0.149731941530853,"d":"0.15"},"down","yes"]
["MSTRG.8426","ENSOARG00000014413","ENSOART00000015692","GO:0016021(integral component of membrane)","NA","NA","NA","interferon alpha-inducible protein 27-like protein 1 [Source:NCBI gene;Acc:101117112]",{"v":8.91418423036649,"d":"8.91"},{"v":7.92908282984293,"d":"7.93"},{"v":4.47520644502618,"d":"4.48"},{"v":13.7731091230366,"d":"13.77"},{"v":12.9123001928447,"d":"12.91"},{"v":17.3228751954625,"d":"17.32"},{"v":0.484419552862608,"d":"0.48"},{"v":-1.04567099647649,"d":"-1.05"},{"v":0.00718948077904145,"d":"0.01"},{"v":0.149731941530853,"d":"0.15"},"down","yes"]
["MSTRG.8597","ENSOARG00000013927","ENSOART00000015167","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane)","NA","NA","NA","ras-related protein Rap-2c-like [Source:NCBI gene;Acc:101104530]",{"v":11.067734,"d":"11.07"},{"v":6.806192,"d":"6.81"},{"v":6.278214,"d":"6.28"},{"v":16.529852,"d":"16.53"},{"v":15.129935,"d":"15.13"},{"v":18.159369,"d":"18.16"},{"v":0.484796249860194,"d":"0.48"},{"v":-1.04454955599611,"d":"-1.04"},{"v":0.00724208384046822,"d":"0.01"},{"v":0.15047177580775,"d":"0.15"},"down","yes"]
["MSTRG.19726","RF00017","ENSOART00000024926;ENSOART00000025843","NA","NA","NA","NA",null,{"v":5193.131908255,"d":"5193.13"},{"v":9558.05634557333,"d":"9558.06"},{"v":7393.13666437167,"d":"7393.14"},{"v":10643.0915393033,"d":"10643.09"},{"v":15863.780071445,"d":"15863.78"},{"v":22585.0840943683,"d":"22585.08"},{"v":0.451078483228812,"d":"0.45"},{"v":-1.14854962478985,"d":"-1.15"},{"v":0.00724343555762441,"d":"0.01"},{"v":0.15047177580775,"d":"0.15"},"down","yes"]
["ENSOARG00000019275","BARD1","ENSOART00000020989","GO:0003723(RNA binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0016607(nuclear speck);GO:0031436(BRCA1-BARD1 complex);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042325(regulation of phosphorylation);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046826(negative regulation of protein export from nucleus);GO:0046982(protein heterodimerization activity);GO:0070531(BRCA1-A complex);GO:0085020(protein K6-linked ubiquitination)","03440(Homologous recombination)","K10683","NA","BRCA1 associated RING domain 1 [Source:NCBI gene;Acc:101108373]",{"v":0.462548,"d":"0.46"},{"v":0.214509,"d":"0.21"},{"v":0.359738,"d":"0.36"},{"v":1.318716,"d":"1.32"},{"v":0.625238,"d":"0.63"},{"v":0.769542,"d":"0.77"},{"v":0.382088272840646,"d":"0.38"},{"v":-1.38802211610918,"d":"-1.39"},{"v":0.00728632354636352,"d":"0.01"},{"v":0.150984301047519,"d":"0.15"},"down","yes"]
["MSTRG.19418","SPG21","ENSOART00000019279;ENSOART00000019276","GO:0005829(cytosol);GO:0030140(trans-Golgi network transport vesicle);GO:0042609(CD4 receptor binding);GO:0043231(intracellular membrane-bounded organelle);GO:0043231(intracellular membrane-bounded organelle)","04144(Endocytosis);04144(Endocytosis)","K19367","NA","SPG21, maspardin [Source:NCBI gene;Acc:101117420]",{"v":7.25393321820809,"d":"7.25"},{"v":5.57527774132948,"d":"5.58"},{"v":7.84744541570328,"d":"7.85"},{"v":12.1439691791908,"d":"12.14"},{"v":12.5449377210983,"d":"12.54"},{"v":16.017478789499,"d":"16.02"},{"v":0.507946260147286,"d":"0.51"},{"v":-0.977252224504385,"d":"-0.98"},{"v":0.00728660149592389,"d":"0.01"},{"v":0.150984301047519,"d":"0.15"},"down","no"]
["MSTRG.12739","ZNF511","ENSOART00000001031","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 511 [Source:NCBI gene;Acc:101113376]",{"v":1.572338,"d":"1.57"},{"v":2.27741,"d":"2.28"},{"v":1.263813,"d":"1.26"},{"v":4.508429,"d":"4.51"},{"v":3.473475,"d":"3.47"},{"v":4.197283,"d":"4.20"},{"v":0.419860619596366,"d":"0.42"},{"v":-1.25201761649617,"d":"-1.25"},{"v":0.0073727803885921,"d":"0.01"},{"v":0.152190591889926,"d":"0.15"},"down","yes"]
["ENSOARG00000003687","ENSOARG00000003687","ENSOART00000004001","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 416-like [Source:NCBI gene;Acc:101106962]",{"v":0.130742,"d":"0.13"},{"v":0.187976,"d":"0.19"},{"v":0.184029,"d":"0.18"},{"v":0.595886,"d":"0.60"},{"v":0.657579,"d":"0.66"},{"v":0.245245,"d":"0.25"},{"v":0.335453156381155,"d":"0.34"},{"v":-1.57581677637544,"d":"-1.58"},{"v":0.00755683661366722,"d":"0.01"},{"v":0.154621589258093,"d":"0.15"},"down","yes"]
["ENSOARG00000018575","ZKSCAN2","ENSOART00000020219;ENSOART00000020220","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0046872(metal ion binding)","NA","K09229","NA","zinc finger with KRAB and SCAN domains 2 [Source:NCBI gene;Acc:101108275]",{"v":0.352535908763505,"d":"0.35"},{"v":0.451241,"d":"0.45"},{"v":0.368205975990396,"d":"0.37"},{"v":0.953356,"d":"0.95"},{"v":0.768232605042017,"d":"0.77"},{"v":0.883021,"d":"0.88"},{"v":0.449964893965364,"d":"0.45"},{"v":-1.15211564739563,"d":"-1.15"},{"v":0.00757467602922393,"d":"0.01"},{"v":0.154653045709028,"d":"0.15"},"down","yes"]
["MSTRG.19196","RGS12","ENSOART00000014800","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0030695(GTPase regulator activity);GO:0050790(regulation of catalytic activity)","NA","NA","NA","regulator of G protein signaling 12 [Source:HGNC Symbol;Acc:HGNC:9994]",{"v":0.682483,"d":"0.68"},{"v":0.466399,"d":"0.47"},{"v":0.559367,"d":"0.56"},{"v":1.110906,"d":"1.11"},{"v":1.48237,"d":"1.48"},{"v":1.098969,"d":"1.10"},{"v":0.462658626391261,"d":"0.46"},{"v":-1.11198000434586,"d":"-1.11"},{"v":0.00760303372963654,"d":"0.01"},{"v":0.154984188186648,"d":"0.15"},"down","yes"]
["MSTRG.1975","CBR3","ENSOART00000015021","GO:0004090(carbonyl reductase (NADPH) activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016491(oxidoreductase activity);GO:0050890(cognition);GO:0055114(oxidation-reduction process);GO:0070402(NADPH binding)","00590(Arachidonic acid metabolism);00980(Metabolism of xenobiotics by cytochrome P450)","K00084","EC:1.1.1.184","carbonyl reductase 3 [Source:NCBI gene;Acc:101115420]",{"v":0.753077,"d":"0.75"},{"v":0.448246,"d":"0.45"},{"v":0.557626,"d":"0.56"},{"v":1.645803,"d":"1.65"},{"v":1.262817,"d":"1.26"},{"v":1.570184,"d":"1.57"},{"v":0.392727388829696,"d":"0.39"},{"v":-1.34839987974299,"d":"-1.35"},{"v":0.00762997454253312,"d":"0.01"},{"v":0.155248688532987,"d":"0.16"},"down","yes"]
["MSTRG.3322","ENSOARG00000006241","ENSOART00000006788","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K16663","NA","CD300 molecule like family member g [Source:NCBI gene;Acc:101114629]",{"v":3.38993152016365,"d":"3.39"},{"v":1.81478697501461,"d":"1.81"},{"v":1.35539352308591,"d":"1.36"},{"v":4.66386444696084,"d":"4.66"},{"v":4.72156886893629,"d":"4.72"},{"v":4.27365355260082,"d":"4.27"},{"v":0.480274566039535,"d":"0.48"},{"v":-1.05806868527145,"d":"-1.06"},{"v":0.00764445123196155,"d":"0.01"},{"v":0.155248688532987,"d":"0.16"},"down","yes"]
["MSTRG.18756","BMPR1B","ENSOART00000018678","GO:0000166(nucleotide binding);GO:0001501(skeletal system development);GO:0001502(cartilage condensation);GO:0001550(ovarian cumulus expansion);GO:0001654(eye development);GO:0002062(chondrocyte differentiation);GO:0002063(chondrocyte development);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0005025(transforming growth factor beta receptor activity, type I);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006954(inflammatory response);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0009953(dorsal/ventral pattern formation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030154(cell differentiation);GO:0030166(proteoglycan biosynthetic process);GO:0030501(positive regulation of bone mineralization);GO:0030509(BMP signaling pathway);GO:0031290(retinal ganglion cell axon guidance);GO:0035108(limb morphogenesis);GO:0042698(ovulation cycle);GO:0043010(camera-type eye development);GO:0045597(positive regulation of cell differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046332(SMAD binding);GO:0046872(metal ion binding);GO:0060041(retina development in camera-type eye);GO:0060350(endochondral bone morphogenesis);GO:0061036(positive regulation of cartilage development);GO:0071363(cellular response to growth factor stimulus);GO:0071773(cellular response to BMP stimulus);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902731(negative regulation of chondrocyte proliferation)","04060(Cytokine-cytokine receptor interaction);04350(TGF-beta signaling pathway);04360(Axon guidance);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);05418(Fluid shear stress and atherosclerosis)","K13578","EC:2.7.11.30","bone morphogenetic protein receptor type 1B [Source:NCBI gene;Acc:443454]",{"v":1.9132479969651,"d":"1.91"},{"v":2.20773439231936,"d":"2.21"},{"v":1.70231165203689,"d":"1.70"},{"v":1.25792689634645,"d":"1.26"},{"v":1.23339228749854,"d":"1.23"},{"v":0.912592085560873,"d":"0.91"},{"v":1.71076552249195,"d":"1.71"},{"v":0.77464203760681,"d":"0.77"},{"v":0.00766353680230453,"d":"0.01"},{"v":0.155248688532987,"d":"0.16"},"up","no"]
["MSTRG.17133","IGFBP3","ENSOART00000013982","GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0032868(response to insulin)","04115(p53 signaling pathway);04218(Cellular senescence);05202(Transcriptional misregulation in cancer)","K10138","NA","insulin like growth factor binding protein 3 [Source:NCBI gene;Acc:100286737]",{"v":7.58573709149278,"d":"7.59"},{"v":3.14894817977528,"d":"3.15"},{"v":5.50064900321027,"d":"5.50"},{"v":12.0008479566613,"d":"12.00"},{"v":9.81821985553772,"d":"9.82"},{"v":11.926735399679,"d":"11.93"},{"v":0.48110676674496,"d":"0.48"},{"v":-1.05557100388389,"d":"-1.06"},{"v":0.00766354991166021,"d":"0.01"},{"v":0.155248688532987,"d":"0.16"},"down","yes"]
["MSTRG.12462","LOXL4","ENSOART00000012719","GO:0005044(scavenger receptor activity);GO:0005507(copper ion binding);GO:0006898(receptor-mediated endocytosis);GO:0016020(membrane);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0043235(receptor complex);GO:0055114(oxidation-reduction process)","NA","K00280","EC:1.4.3.-","lysyl oxidase like 4 [Source:NCBI gene;Acc:101117380]",{"v":0.464608,"d":"0.46"},{"v":0.960355,"d":"0.96"},{"v":1.42115,"d":"1.42"},{"v":0.260469,"d":"0.26"},{"v":0.403577,"d":"0.40"},{"v":0.492293,"d":"0.49"},{"v":2.46131368050373,"d":"2.46"},{"v":1.29942853283417,"d":"1.30"},{"v":0.00769108987395532,"d":"0.01"},{"v":0.155613525975146,"d":"0.16"},"up","yes"]
["MSTRG.12284","ENSOARG00000015728","ENSOART00000017121","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":4.680196,"d":"4.68"},{"v":2.881505,"d":"2.88"},{"v":2.193688,"d":"2.19"},{"v":6.211501,"d":"6.21"},{"v":9.12122,"d":"9.12"},{"v":12.005226,"d":"12.01"},{"v":0.356844242912608,"d":"0.36"},{"v":-1.4866335976965,"d":"-1.49"},{"v":0.00774783263875008,"d":"0.01"},{"v":0.156567588274148,"d":"0.16"},"down","yes"]
["MSTRG.18686","SGMS2","ENSOART00000009357","GO:0002950(ceramide phosphoethanolamine synthase activity);GO:0005794(Golgi apparatus);GO:0005887(integral component of plasma membrane);GO:0006686(sphingomyelin biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030173(integral component of Golgi membrane);GO:0033188(sphingomyelin synthase activity);GO:0046513(ceramide biosynthetic process);GO:0047493(ceramide cholinephosphotransferase activity);GO:1905373(ceramide phosphoethanolamine biosynthetic process)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","K04714","EC:2.7.8.27","sphingomyelin synthase 2 [Source:NCBI gene;Acc:101123121]",{"v":1.19897,"d":"1.20"},{"v":2.059681,"d":"2.06"},{"v":2.805253,"d":"2.81"},{"v":0.968505,"d":"0.97"},{"v":1.075437,"d":"1.08"},{"v":0.690858,"d":"0.69"},{"v":2.21731168641217,"d":"2.22"},{"v":1.14881158339188,"d":"1.15"},{"v":0.00777753153560763,"d":"0.01"},{"v":0.156832020820573,"d":"0.16"},"up","yes"]
["MSTRG.6616","RF00067","ENSOART00000026779","NA","NA","NA","NA",null,{"v":41.607807,"d":"41.61"},{"v":42.402054,"d":"42.40"},{"v":41.94492,"d":"41.94"},{"v":59.562897,"d":"59.56"},{"v":63.776978,"d":"63.78"},{"v":177.83522,"d":"177.84"},{"v":0.418211143919453,"d":"0.42"},{"v":-1.25769658948037,"d":"-1.26"},{"v":0.00778463902227415,"d":"0.01"},{"v":0.156832020820573,"d":"0.16"},"down","yes"]
["MSTRG.19278","ENSOARG00000015964","ENSOART00000017382","GO:0007052(mitotic spindle organization)","03013(RNA transport)","K14283","NA","transforming acidic coiled-coil-containing protein 3 [Source:NCBI gene;Acc:101104153]",{"v":0.251196,"d":"0.25"},{"v":0.134767,"d":"0.13"},{"v":0.182861,"d":"0.18"},{"v":0.785717,"d":"0.79"},{"v":0.434278,"d":"0.43"},{"v":0.351778,"d":"0.35"},{"v":0.36189958728137,"d":"0.36"},{"v":-1.46633863245865,"d":"-1.47"},{"v":0.0077944880741837,"d":"0.01"},{"v":0.156832020820573,"d":"0.16"},"down","yes"]
["ENSOARG00000020415","FAM124B","ENSOART00000022231","GO:0005654(nucleoplasm);GO:0005739(mitochondrion)","NA","NA","NA","family with sequence similarity 124 member B [Source:NCBI gene;Acc:101122416]",{"v":0.632476,"d":"0.63"},{"v":0.236383,"d":"0.24"},{"v":0.120444,"d":"0.12"},{"v":0.635616,"d":"0.64"},{"v":1.504142,"d":"1.50"},{"v":1.057088,"d":"1.06"},{"v":0.30946220118204,"d":"0.31"},{"v":-1.69216489060926,"d":"-1.69"},{"v":0.00779933861503586,"d":"0.01"},{"v":0.156832020820573,"d":"0.16"},"down","yes"]
["ENSOARG00000009855","ENSOARG00000009855","ENSOART00000010724","NA","NA","NA","NA",null,0,{"v":1.594308,"d":"1.59"},0,{"v":4.613188,"d":"4.61"},{"v":4.096231,"d":"4.10"},{"v":5.161517,"d":"5.16"},{"v":0.114938746743551,"d":"0.11"},{"v":-3.12106287121496,"d":"-3.12"},{"v":0.00784776493337804,"d":"0.01"},{"v":0.157159698522271,"d":"0.16"},"down","yes"]
["MSTRG.4562","OPTN","ENSOART00000005680","GO:0001920(negative regulation of receptor recycling);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0006914(autophagy);GO:0007030(Golgi organization);GO:0008022(protein C-terminus binding);GO:0010508(positive regulation of autophagy);GO:0016192(vesicle-mediated transport);GO:0017137(Rab GTPase binding);GO:0030674(protein binding, bridging);GO:0031410(cytoplasmic vesicle);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0034067(protein localization to Golgi apparatus);GO:0034620(cellular response to unfolded protein);GO:0042802(identical protein binding);GO:0043001(Golgi to plasma membrane protein transport);GO:0050829(defense response to Gram-negative bacterium);GO:0061734(parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding);GO:0090161(Golgi ribbon formation);GO:1904417(positive regulation of xenophagy)","04137(Mitophagy - animal)","K19946","NA","optineurin [Source:NCBI gene;Acc:101106703]",{"v":18.979595,"d":"18.98"},{"v":19.650208,"d":"19.65"},{"v":15.711104,"d":"15.71"},{"v":11.010324,"d":"11.01"},{"v":10.121741,"d":"10.12"},{"v":10.675718,"d":"10.68"},{"v":1.7084154214709,"d":"1.71"},{"v":0.77265882602595,"d":"0.77"},{"v":0.00785413486000571,"d":"0.01"},{"v":0.157159698522271,"d":"0.16"},"up","no"]
["MSTRG.2449","TMTC4","ENSOART00000004970","GO:0000030(mannosyltransferase activity);GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035269(protein O-linked mannosylation)","NA","NA","NA","transmembrane and tetratricopeptide repeat containing 4 [Source:NCBI gene;Acc:101112235]",{"v":0.825638,"d":"0.83"},{"v":0.500212,"d":"0.50"},{"v":0.821563,"d":"0.82"},{"v":1.765147,"d":"1.77"},{"v":1.203194,"d":"1.20"},{"v":1.819022,"d":"1.82"},{"v":0.448558632382796,"d":"0.45"},{"v":-1.15663151861854,"d":"-1.16"},{"v":0.00788275571054892,"d":"0.01"},{"v":0.15753933322135,"d":"0.16"},"down","yes"]
["MSTRG.9577","CCL21","ENSOART00000009915","GO:0001768(establishment of T cell polarity);GO:0001954(positive regulation of cell-matrix adhesion);GO:0002407(dendritic cell chemotaxis);GO:0005576(extracellular region);GO:0005623(cell);GO:0006955(immune response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008009(chemokine activity);GO:0030838(positive regulation of actin filament polymerization);GO:0031274(positive regulation of pseudopodium assembly);GO:0031529(ruffle organization);GO:0031732(CCR7 chemokine receptor binding);GO:0033630(positive regulation of cell adhesion mediated by integrin);GO:0034695(response to prostaglandin E);GO:0035759(mesangial cell-matrix adhesion);GO:0042379(chemokine receptor binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045860(positive regulation of protein kinase activity);GO:0046330(positive regulation of JNK cascade);GO:0051209(release of sequestered calcium ion into cytosol);GO:0051491(positive regulation of filopodium assembly);GO:0051897(positive regulation of protein kinase B signaling);GO:0060326(cell chemotaxis);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090023(positive regulation of neutrophil chemotaxis);GO:0090630(activation of GTPase activity);GO:1903237(negative regulation of leukocyte tethering or rolling);GO:2000147(positive regulation of cell motility);GO:2000406(positive regulation of T cell migration);GO:2000529(positive regulation of myeloid dendritic cell chemotaxis);GO:2000669(negative regulation of dendritic cell apoptotic process)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04064(NF-kappa B signaling pathway)","K16062","NA","C-C motif chemokine ligand 21 [Source:NCBI gene;Acc:101119957]",{"v":4.814512,"d":"4.81"},{"v":1.273156,"d":"1.27"},{"v":1.76112,"d":"1.76"},{"v":7.26942,"d":"7.27"},{"v":4.990962,"d":"4.99"},{"v":8.658568,"d":"8.66"},{"v":0.375199902480765,"d":"0.38"},{"v":-1.41426864200885,"d":"-1.41"},{"v":0.00791866086858504,"d":"0.01"},{"v":0.158063440907404,"d":"0.16"},"down","yes"]
["MSTRG.4183","RALGPS2","ENSOART00000017618","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005622(intracellular);GO:0007264(small GTPase mediated signal transduction);GO:0032485(regulation of Ral protein signal transduction)","NA","NA","NA","Ral GEF with PH domain and SH3 binding motif 2 [Source:NCBI gene;Acc:101119920]",{"v":1.2693,"d":"1.27"},{"v":0.875542,"d":"0.88"},{"v":1.175784,"d":"1.18"},{"v":2.241021,"d":"2.24"},{"v":2.537714,"d":"2.54"},{"v":2.3102,"d":"2.31"},{"v":0.468423818246323,"d":"0.47"},{"v":-1.09411365954308,"d":"-1.09"},{"v":0.00797111515546594,"d":"0.01"},{"v":0.158529072178378,"d":"0.16"},"down","yes"]
["MSTRG.20403","HS3ST5","ENSOART00000010289","GO:0006477(protein sulfation);GO:0008146(sulfotransferase activity);GO:0008467([heparan sulfate]-glucosamine 3-sulfotransferase 1 activity);GO:0015015(heparan sulfate proteoglycan biosynthetic process, enzymatic modification);GO:0016740(transferase activity);GO:0046596(regulation of viral entry into host cell);GO:0050819(negative regulation of coagulation)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)","K08104","EC:2.8.2.23","heparan sulfate-glucosamine 3-sulfotransferase 5 [Source:NCBI gene;Acc:101107448]",{"v":1.18684821978582,"d":"1.19"},{"v":0.766424439061703,"d":"0.77"},{"v":0.509755131565528,"d":"0.51"},{"v":0.480386858745538,"d":"0.48"},{"v":0.347035170831208,"d":"0.35"},{"v":0.214182559918409,"d":"0.21"},{"v":2.36464759780564,"d":"2.36"},{"v":1.2416251954969,"d":"1.24"},{"v":0.00807157564095645,"d":"0.01"},{"v":0.159555311217357,"d":"0.16"},"up","yes"]
["MSTRG.15959","ARHGEF25;DTX3","ENSOART00000006392;ENSOART00000006471;ENSOART00000006394","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0035023(regulation of Rho protein signal transduction);GO:0007219(Notch signaling pathway);GO:0016567(protein ubiquitination);GO:0035023(regulation of Rho protein signal transduction)","04330(Notch signaling pathway)","K20690;K06058","EC:2.3.2.27","Rho guanine nucleotide exchange factor 25 [Source:NCBI gene;Acc:101118430];deltex E3 ubiquitin ligase 3 [Source:NCBI gene;Acc:101118862]",{"v":2.57691722902065,"d":"2.58"},{"v":1.99415527959841,"d":"1.99"},{"v":1.95673292422807,"d":"1.96"},{"v":4.0453784580413,"d":"4.05"},{"v":4.3939010070089,"d":"4.39"},{"v":4.06414566849782,"d":"4.06"},{"v":0.522081378752158,"d":"0.52"},{"v":-0.937653392361279,"d":"-0.94"},{"v":0.00808516527410111,"d":"0.01"},{"v":0.159630687539931,"d":"0.16"},"down","no"]
["MSTRG.6610","SLCO2B1","ENSOART00000012037;ENSOART00000012036","GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0055085(transmembrane transport)","NA","K14352","NA","solute carrier organic anion transporter family member 2B1 [Source:NCBI gene;Acc:101108157]",{"v":2.48484648270385,"d":"2.48"},{"v":1.70335728344511,"d":"1.70"},{"v":1.21983271126015,"d":"1.22"},{"v":3.99399740045888,"d":"3.99"},{"v":3.64469911189552,"d":"3.64"},{"v":3.2848823286269,"d":"3.28"},{"v":0.495079182027791,"d":"0.50"},{"v":-1.01426880932536,"d":"-1.01"},{"v":0.00815411700106451,"d":"0.01"},{"v":0.160739844861186,"d":"0.16"},"down","yes"]
["MSTRG.11011","HSPG2","ENSOART00000009010","GO:0005509(calcium ion binding);GO:0008022(protein C-terminus binding)","04512(ECM-receptor interaction);05161(Hepatitis B);05205(Proteoglycans in cancer)","K06255","NA","heparan sulfate proteoglycan 2 [Source:NCBI gene;Acc:101122677]",{"v":18.3927293935348,"d":"18.39"},{"v":12.0835065474901,"d":"12.08"},{"v":15.5818507629961,"d":"15.58"},{"v":29.7928803888568,"d":"29.79"},{"v":29.1240152320631,"d":"29.12"},{"v":27.7259801245204,"d":"27.73"},{"v":0.531585387808932,"d":"0.53"},{"v":-0.911626646453342,"d":"-0.91"},{"v":0.00823912853963168,"d":"0.01"},{"v":0.161875616088575,"d":"0.16"},"down","no"]
["MSTRG.10855","ENSOARG00000002009","ENSOART00000002162","GO:0016020(membrane);GO:0016021(integral component of membrane)","04514(Cell adhesion molecules (CAMs))","K16337","NA","syndecan 3 [Source:NCBI gene;Acc:101121322]",{"v":2.674739,"d":"2.67"},{"v":1.342239,"d":"1.34"},{"v":1.735555,"d":"1.74"},{"v":3.34174,"d":"3.34"},{"v":4.427437,"d":"4.43"},{"v":4.650063,"d":"4.65"},{"v":0.463195251883368,"d":"0.46"},{"v":-1.11030763024637,"d":"-1.11"},{"v":0.00824889812989482,"d":"0.01"},{"v":0.161875616088575,"d":"0.16"},"down","yes"]
["MSTRG.8158","ENSOARG00000014330","ENSOART00000015611","NA","NA","NA","NA","ADAMTS like 3 [Source:NCBI gene;Acc:101107392]",{"v":1.182454,"d":"1.18"},{"v":1.04841,"d":"1.05"},{"v":1.702754,"d":"1.70"},{"v":2.121462,"d":"2.12"},{"v":3.124804,"d":"3.12"},{"v":2.760209,"d":"2.76"},{"v":0.491304600339101,"d":"0.49"},{"v":-1.02531034703528,"d":"-1.03"},{"v":0.0082682670148133,"d":"0.01"},{"v":0.161875616088575,"d":"0.16"},"down","yes"]
["MSTRG.161","HEYL","ENSOART00000021869","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003151(outflow tract morphogenesis);GO:0003181(atrioventricular valve morphogenesis);GO:0003184(pulmonary valve morphogenesis);GO:0003198(epithelial to mesenchymal transition involved in endocardial cushion formation);GO:0003203(endocardial cushion morphogenesis);GO:0003208(cardiac ventricle morphogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0010629(negative regulation of gene expression);GO:0014031(mesenchymal cell development);GO:0032835(glomerulus development);GO:0035914(skeletal muscle cell differentiation);GO:0035939(microsatellite binding);GO:0042803(protein homodimerization activity);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043565(sequence-specific DNA binding);GO:0045666(positive regulation of neuron differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0050683(AF-1 domain binding);GO:0060317(cardiac epithelial to mesenchymal transition);GO:0060412(ventricular septum morphogenesis);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0071773(cellular response to BMP stimulus);GO:0072014(proximal tubule development)","05165(Human papillomavirus infection);05200(Pathways in cancer);05224(Breast cancer)","K09091","NA","hes related family bHLH transcription factor with YRPW motif-like [Source:NCBI gene;Acc:101119343]",{"v":5.24251,"d":"5.24"},{"v":3.724867,"d":"3.72"},{"v":3.691237,"d":"3.69"},{"v":7.801641,"d":"7.80"},{"v":8.422091,"d":"8.42"},{"v":9.3388,"d":"9.34"},{"v":0.495201883757055,"d":"0.50"},{"v":-1.01391129228633,"d":"-1.01"},{"v":0.00832782600396285,"d":"0.01"},{"v":0.161999239072236,"d":"0.16"},"down","yes"]
["MSTRG.18661","RF00492","ENSOART00000025490","NA","NA","NA","NA",null,{"v":35.54665,"d":"35.55"},{"v":25.177691,"d":"25.18"},{"v":22.072847,"d":"22.07"},{"v":60.924469,"d":"60.92"},{"v":47.628426,"d":"47.63"},{"v":61.964806,"d":"61.96"},{"v":0.485563595535457,"d":"0.49"},{"v":-1.04226783332103,"d":"-1.04"},{"v":0.00833055608014451,"d":"0.01"},{"v":0.161999239072236,"d":"0.16"},"down","yes"]
["MSTRG.18258","RF00090","ENSOART00000025622","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 74A [Source:HGNC Symbol;Acc:HGNC:10119]",{"v":21.641542,"d":"21.64"},{"v":38.554134,"d":"38.55"},{"v":24.675972,"d":"24.68"},{"v":55.03928,"d":"55.04"},{"v":62.446922,"d":"62.45"},{"v":59.872757,"d":"59.87"},{"v":0.47853036846027,"d":"0.48"},{"v":-1.06331761106051,"d":"-1.06"},{"v":0.00834589549307077,"d":"0.01"},{"v":0.162035412141331,"d":"0.16"},"down","yes"]
["MSTRG.9781","GCNT1","ENSOART00000009111","GO:0005802(trans-Golgi network);GO:0008375(acetylglucosaminyltransferase activity);GO:0009101(glycoprotein biosynthetic process);GO:0016020(membrane);GO:0031985(Golgi cisterna);GO:0048729(tissue morphogenesis);GO:0050901(leukocyte tethering or rolling);GO:0060352(cell adhesion molecule production);GO:0060993(kidney morphogenesis)","00512(Mucin type O-glycan biosynthesis)","K00727","EC:2.4.1.102","glucosaminyl (N-acetyl) transferase 1 [Source:NCBI gene;Acc:101121316]",{"v":3.202295,"d":"3.20"},{"v":3.399645,"d":"3.40"},{"v":1.200938,"d":"1.20"},{"v":1.904752,"d":"1.90"},{"v":0.773094,"d":"0.77"},{"v":0.557641,"d":"0.56"},{"v":2.41165487606657,"d":"2.41"},{"v":1.27002346270542,"d":"1.27"},{"v":0.00845657133546732,"d":"0.01"},{"v":0.163794658084828,"d":"0.16"},"up","yes"]
["MSTRG.392","RAVER2","ENSOART00000010913","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus)","NA","NA","NA","ribonucleoprotein, PTB binding 2 [Source:NCBI gene;Acc:101110463]",{"v":14.5160491072607,"d":"14.52"},{"v":15.6046335064173,"d":"15.60"},{"v":14.4697449211588,"d":"14.47"},{"v":11.057963456179,"d":"11.06"},{"v":9.09595141950862,"d":"9.10"},{"v":4.13070832508251,"d":"4.13"},{"v":1.83615892106667,"d":"1.84"},{"v":0.876690930599511,"d":"0.88"},{"v":0.00849078983335081,"d":"0.01"},{"v":0.164092006815948,"d":"0.16"},"up","no"]
["MSTRG.14965","KCNK3","ENSOART00000020673","GO:0005216(ion channel activity);GO:0005252(open rectifier potassium channel activity);GO:0005267(potassium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022841(potassium ion leak channel activity);GO:0034220(ion transmembrane transport);GO:0044548(S100 protein binding);GO:0071805(potassium ion transmembrane transport)","NA","NA","NA","potassium two pore domain channel subfamily K member 3 [Source:HGNC Symbol;Acc:HGNC:6278]",{"v":0.662196,"d":"0.66"},{"v":0.097598,"d":"0.10"},{"v":0.225912,"d":"0.23"},{"v":0.694543,"d":"0.69"},{"v":1.522598,"d":"1.52"},{"v":0.999117,"d":"1.00"},{"v":0.306476035193694,"d":"0.31"},{"v":-1.70615382768885,"d":"-1.71"},{"v":0.00849202264572982,"d":"0.01"},{"v":0.164092006815948,"d":"0.16"},"down","yes"]
["MSTRG.5308","CYBA","ENSOART00000014024","GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0009055(electron transfer activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016175(superoxide-generating NADPH oxidase activity);GO:0016491(oxidoreductase activity);GO:0017004(cytochrome complex assembly);GO:0017124(SH3 domain binding);GO:0020037(heme binding);GO:0022900(electron transport chain);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0034137(positive regulation of toll-like receptor 2 signaling pathway);GO:0042554(superoxide anion generation);GO:0043020(NADPH oxidase complex);GO:0045087(innate immune response);GO:0045730(respiratory burst);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0050766(positive regulation of phagocytosis);GO:0051279(regulation of release of sequestered calcium ion into cytosol);GO:0055114(oxidation-reduction process);GO:0070257(positive regulation of mucus secretion);GO:0072593(reactive oxygen species metabolic process);GO:1900426(positive regulation of defense response to bacterium);GO:1903428(positive regulation of reactive oxygen species biosynthetic process)","04145(Phagosome);04380(Osteoclast differentiation);04621(NOD-like receptor signaling pathway);04670(Leukocyte transendothelial migration);05140(Leishmaniasis);05418(Fluid shear stress and atherosclerosis)","K08009","NA","cytochrome b-245 light chain [Source:NCBI gene;Acc:101106452]",{"v":3.474215,"d":"3.47"},{"v":2.226111,"d":"2.23"},{"v":3.061509,"d":"3.06"},{"v":5.767484,"d":"5.77"},{"v":6.234007,"d":"6.23"},{"v":6.861859,"d":"6.86"},{"v":0.46448987056912,"d":"0.46"},{"v":-1.10628095971978,"d":"-1.11"},{"v":0.00852146304870703,"d":"0.01"},{"v":0.164347361526019,"d":"0.16"},"down","yes"]
["MSTRG.1292","BBX","ENSOART00000020507","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0060348(bone development)","NA","K21643","NA","BBX, HMG-box containing [Source:NCBI gene;Acc:101115417]",{"v":3.13593360277241,"d":"3.14"},{"v":1.51143963799568,"d":"1.51"},{"v":2.64582894636973,"d":"2.65"},{"v":1.58222648948983,"d":"1.58"},{"v":1.25265433746165,"d":"1.25"},{"v":1.20945554402909,"d":"1.21"},{"v":1.80331246418298,"d":"1.80"},{"v":0.850649397585683,"d":"0.85"},{"v":0.0085253683986121,"d":"0.01"},{"v":0.164347361526019,"d":"0.16"},"up","no"]
["MSTRG.2490","COL4A1","ENSOART00000006670","GO:0001569(branching involved in blood vessel morphogenesis);GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005587(collagen type IV trimer);GO:0005604(basement membrane);GO:0007420(brain development);GO:0007528(neuromuscular junction development);GO:0030020(extracellular matrix structural constituent conferring tensile strength);GO:0038063(collagen-activated tyrosine kinase receptor signaling pathway);GO:0048407(platelet-derived growth factor binding);GO:0048514(blood vessel morphogenesis);GO:0061304(retinal blood vessel morphogenesis);GO:0061333(renal tubule morphogenesis);GO:0071230(cellular response to amino acid stimulus);GO:0071711(basement membrane organization)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);04974(Protein digestion and absorption);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K06237","NA","collagen type IV alpha 1 chain [Source:NCBI gene;Acc:101115552]",{"v":49.7623851347626,"d":"49.76"},{"v":36.6167297699081,"d":"36.62"},{"v":51.8232121965288,"d":"51.82"},{"v":81.8274426171516,"d":"81.83"},{"v":86.2139039231751,"d":"86.21"},{"v":93.3598191678152,"d":"93.36"},{"v":0.528698205024473,"d":"0.53"},{"v":-0.919483666232981,"d":"-0.92"},{"v":0.00855965828830772,"d":"0.01"},{"v":0.164813797796567,"d":"0.16"},"down","no"]
["MSTRG.10635","ENSOARG00000019193","ENSOART00000020901","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":2.013993,"d":"2.01"},{"v":0.251087,"d":"0.25"},{"v":1.202391,"d":"1.20"},{"v":0.273496,"d":"0.27"},{"v":0.580674,"d":"0.58"},{"v":0.377984,"d":"0.38"},{"v":2.81415391257911,"d":"2.81"},{"v":1.49270123505715,"d":"1.49"},{"v":0.00867652855048812,"d":"0.01"},{"v":0.165890349147974,"d":"0.17"},"up","yes"]
["MSTRG.5186","ST3GAL2","ENSOART00000005553","GO:0003836(beta-galactoside (CMP) alpha-2,3-sialyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0009101(glycoprotein biosynthetic process);GO:0009247(glycolipid biosynthetic process);GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030259(lipid glycosylation);GO:0047288(monosialoganglioside sialyltransferase activity);GO:0097503(sialylation);GO:1990743(protein sialylation)","00512(Mucin type O-glycan biosynthesis);00533(Glycosaminoglycan biosynthesis - keratan sulfate);00603(Glycosphingolipid biosynthesis - globo and isoglobo series);00604(Glycosphingolipid biosynthesis - ganglio series)","K03368","EC:2.4.99.4","ST3 beta-galactoside alpha-2,3-sialyltransferase 2 [Source:NCBI gene;Acc:101114207]",{"v":2.53487010618944,"d":"2.53"},{"v":1.2104372494562,"d":"1.21"},{"v":1.95410008077912,"d":"1.95"},{"v":3.93867245926439,"d":"3.94"},{"v":4.14969723739371,"d":"4.15"},{"v":3.24155030561598,"d":"3.24"},{"v":0.50304039527912,"d":"0.50"},{"v":-0.991253838536741,"d":"-0.99"},{"v":0.00871250355488409,"d":"0.01"},{"v":0.166383342741693,"d":"0.17"},"down","no"]
["MSTRG.13201","TMEM204","ENSOART00000017353","GO:0001945(lymph vessel development);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway);GO:0051145(smooth muscle cell differentiation)","NA","NA","NA","transmembrane protein 204 [Source:HGNC Symbol;Acc:HGNC:14158]",{"v":1.532122,"d":"1.53"},{"v":0.858307,"d":"0.86"},{"v":1.345467,"d":"1.35"},{"v":3.04023,"d":"3.04"},{"v":2.904756,"d":"2.90"},{"v":3.193784,"d":"3.19"},{"v":0.408796369752166,"d":"0.41"},{"v":-1.29054571016712,"d":"-1.29"},{"v":0.00879733001306309,"d":"0.01"},{"v":0.166893341034059,"d":"0.17"},"down","yes"]
["MSTRG.13727","ARPC1B","ENSOART00000020393","GO:0003779(actin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005885(Arp2/3 protein complex);GO:0015629(actin cytoskeleton);GO:0030833(regulation of actin filament polymerization);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0051015(actin filament binding)","04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05132(Salmonella infection)","K05757","NA","actin related protein 2/3 complex subunit 1B [Source:NCBI gene;Acc:101113558]",{"v":9.099571,"d":"9.10"},{"v":5.979165,"d":"5.98"},{"v":6.543836,"d":"6.54"},{"v":13.067833,"d":"13.07"},{"v":11.605198,"d":"11.61"},{"v":17.448767,"d":"17.45"},{"v":0.51333449725959,"d":"0.51"},{"v":-0.962028878654094,"d":"-0.96"},{"v":0.00881075820500725,"d":"0.01"},{"v":0.166893341034059,"d":"0.17"},"down","no"]
["MSTRG.1965","RUNX1","ENSOART00000014799","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0030097(hemopoiesis);GO:0030854(positive regulation of granulocyte differentiation);GO:0032743(positive regulation of interleukin-2 production);GO:0043231(intracellular membrane-bounded organelle);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","runt related transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:10471]",{"v":0.423155530542636,"d":"0.42"},{"v":0.602474299472868,"d":"0.60"},{"v":1.28891053693023,"d":"1.29"},{"v":0.381113799751938,"d":"0.38"},{"v":0.450072513426357,"d":"0.45"},{"v":0.304123086015504,"d":"0.30"},{"v":2.0386868712523,"d":"2.04"},{"v":1.02764020400457,"d":"1.03"},{"v":0.00894829420453266,"d":"0.01"},{"v":0.169106189550474,"d":"0.17"},"up","yes"]
["MSTRG.1864","ENSOARG00000009070","ENSOART00000009876","NA","NA","NA","NA",null,{"v":0.501661,"d":"0.50"},{"v":0.660011,"d":"0.66"},{"v":0.423121,"d":"0.42"},{"v":1.846528,"d":"1.85"},{"v":1.118974,"d":"1.12"},{"v":1.267103,"d":"1.27"},{"v":0.374424969965305,"d":"0.37"},{"v":-1.41725144510523,"d":"-1.42"},{"v":0.00899196332320091,"d":"0.01"},{"v":0.169735002475404,"d":"0.17"},"down","yes"]
["MSTRG.8143","PDE8A","ENSOART00000014565","GO:0001934(positive regulation of protein phosphorylation);GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016787(hydrolase activity);GO:0019900(kinase binding);GO:0046872(metal ion binding);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity);GO:0060548(negative regulation of cell death);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071364(cellular response to epidermal growth factor stimulus);GO:1903206(negative regulation of hydrogen peroxide-induced cell death)","00230(Purine metabolism);04927(Cortisol synthesis and secretion);04934(Cushing syndrome);05032(Morphine addiction)","K18437","EC:3.1.4.53","phosphodiesterase 8A [Source:NCBI gene;Acc:101105363]",{"v":6.43590774342152,"d":"6.44"},{"v":6.90672331711469,"d":"6.91"},{"v":5.78720460280871,"d":"5.79"},{"v":4.52187268097028,"d":"4.52"},{"v":3.92040541822115,"d":"3.92"},{"v":3.15941380172353,"d":"3.16"},{"v":1.64888326864087,"d":"1.65"},{"v":0.721489267960374,"d":"0.72"},{"v":0.00901406812265327,"d":"0.01"},{"v":0.16995577864513,"d":"0.17"},"up","no"]
["MSTRG.11544","ENSOARG00000001377","ENSOART00000001474","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":0.948591,"d":"0.95"},{"v":0.165196,"d":"0.17"},{"v":0.861323,"d":"0.86"},{"v":2.527152,"d":"2.53"},{"v":1.094,"d":"1.09"},{"v":2.9576,"d":"2.96"},{"v":0.300225635500472,"d":"0.30"},{"v":-1.73588092462309,"d":"-1.74"},{"v":0.00906167035702626,"d":"0.01"},{"v":0.170459623951065,"d":"0.17"},"down","yes"]
["MSTRG.6952","SREK1IP1","ENSOART00000007047","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","NA","NA","NA","SREK1 interacting protein 1 [Source:NCBI gene;Acc:101104603]",{"v":2.18182354165316,"d":"2.18"},{"v":1.90689620388979,"d":"1.91"},{"v":1.21904759675851,"d":"1.22"},{"v":1.32723044554295,"d":"1.33"},{"v":0.815881575040519,"d":"0.82"},{"v":0.792530404700162,"d":"0.79"},{"v":1.80804286536656,"d":"1.81"},{"v":0.854428881801045,"d":"0.85"},{"v":0.00910201886016,"d":"0.01"},{"v":0.170743591556983,"d":"0.17"},"up","no"]
["MSTRG.407","GADD45A","ENSOART00000012345","GO:0000185(activation of MAPKKK activity);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006469(negative regulation of protein kinase activity);GO:0007098(centrosome cycle);GO:0016607(nuclear speck);GO:0019900(kinase binding);GO:0042770(signal transduction in response to DNA damage);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0046330(positive regulation of JNK cascade);GO:0046982(protein heterodimerization activity);GO:0047485(protein N-terminus binding);GO:0051726(regulation of cell cycle);GO:0071260(cellular response to mechanical stimulus);GO:0071479(cellular response to ionizing radiation);GO:0071850(mitotic cell cycle arrest);GO:1900745(positive regulation of p38MAPK cascade);GO:2000379(positive regulation of reactive oxygen species metabolic process)","04010(MAPK signaling pathway);04068(FoxO signaling pathway);04110(Cell cycle);04115(p53 signaling pathway);04210(Apoptosis);04218(Cellular senescence);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05216(Thyroid cancer);05217(Basal cell carcinoma);05218(Melanoma);05220(Chronic myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K04402","NA","growth arrest and DNA damage inducible alpha [Source:NCBI gene;Acc:101115240]",{"v":5.33813,"d":"5.34"},{"v":8.062179,"d":"8.06"},{"v":10.084364,"d":"10.08"},{"v":2.769032,"d":"2.77"},{"v":5.156616,"d":"5.16"},{"v":3.418005,"d":"3.42"},{"v":2.0702919068487,"d":"2.07"},{"v":1.04983419906384,"d":"1.05"},{"v":0.00931539393056301,"d":"0.01"},{"v":0.17348979584305,"d":"0.17"},"up","yes"]
["MSTRG.9374","TLR4","ENSOART00000006304","GO:0000187(activation of MAPK activity);GO:0001530(lipopolysaccharide binding);GO:0001875(lipopolysaccharide receptor activity);GO:0002218(activation of innate immune response);GO:0002322(B cell proliferation involved in immune response);GO:0002376(immune system process);GO:0002537(nitric oxide production involved in inflammatory response);GO:0002730(regulation of dendritic cell cytokine production);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004888(transmembrane signaling receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0009617(response to bacterium);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010572(positive regulation of platelet activation);GO:0010628(positive regulation of gene expression);GO:0014002(astrocyte development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030890(positive regulation of B cell proliferation);GO:0031226(intrinsic component of plasma membrane);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032496(response to lipopolysaccharide);GO:0032497(detection of lipopolysaccharide);GO:0032609(interferon-gamma production);GO:0032689(negative regulation of interferon-gamma production);GO:0032700(negative regulation of interleukin-17 production);GO:0032707(negative regulation of interleukin-23 production);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032722(positive regulation of chemokine production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032729(positive regulation of interferon-gamma production);GO:0032732(positive regulation of interleukin-1 production);GO:0032733(positive regulation of interleukin-10 production);GO:0032735(positive regulation of interleukin-12 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0034142(toll-like receptor 4 signaling pathway);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0042116(macrophage activation);GO:0042535(positive regulation of tumor necrosis factor biosynthetic process);GO:0042802(identical protein binding);GO:0043032(positive regulation of macrophage activation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043235(receptor complex);GO:0045084(positive regulation of interleukin-12 biosynthetic process);GO:0045087(innate immune response);GO:0045348(positive regulation of MHC class II biosynthetic process);GO:0045359(positive regulation of interferon-beta biosynthetic process);GO:0045416(positive regulation of interleukin-8 biosynthetic process);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046330(positive regulation of JNK cascade);GO:0046696(lipopolysaccharide receptor complex);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0050671(positive regulation of lymphocyte proliferation);GO:0050702(interleukin-1 beta secretion);GO:0050707(regulation of cytokine secretion);GO:0050718(positive regulation of interleukin-1 beta secretion);GO:0050727(regulation of inflammatory response);GO:0050729(positive regulation of inflammatory response);GO:0050829(defense response to Gram-negative bacterium);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051770(positive regulation of nitric-oxide synthase biosynthetic process);GO:0060729(intestinal epithelial structure maintenance);GO:0060907(positive regulation of macrophage cytokine production);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070430(positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway);GO:0070434(positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway);GO:0071222(cellular response to lipopolysaccharide);GO:0071223(cellular response to lipoteichoic acid);GO:0071260(cellular response to mechanical stimulus);GO:0071346(cellular response to interferon-gamma);GO:0120163(negative regulation of cold-induced thermogenesis);GO:0140052(cellular response to oxidised low-density lipoprotein particle stimulus);GO:1900017(positive regulation of cytokine production involved in inflammatory response);GO:1900227(positive regulation of NLRP3 inflammasome complex assembly);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1903223(positive regulation of oxidative stress-induced neuron death);GO:1903428(positive regulation of reactive oxygen species biosynthetic process);GO:1903974(positive regulation of cellular response to macrophage colony-stimulating factor stimulus);GO:1904646(cellular response to amyloid-beta)","04064(NF-kappa B signaling pathway);04066(HIF-1 signaling pathway);04145(Phagosome);04151(PI3K-Akt signaling pathway);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);05132(Salmonella infection);05133(Pertussis);05134(Legionellosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05144(Malaria);05145(Toxoplasmosis);05146(Amoebiasis);05152(Tuberculosis);05161(Hepatitis B);05162(Measles);05164(Influenza A);05170(Human immunodeficiency virus 1 infection);05205(Proteoglycans in cancer);05321(Inflammatory bowel disease (IBD));05323(Rheumatoid arthritis)","K10160","NA","toll like receptor 4 [Source:NCBI gene;Acc:554263]",{"v":1.220006,"d":"1.22"},{"v":0.876607,"d":"0.88"},{"v":1.644109,"d":"1.64"},{"v":0.646812,"d":"0.65"},{"v":0.576644,"d":"0.58"},{"v":0.657611,"d":"0.66"},{"v":1.98861709869983,"d":"1.99"},{"v":0.991765517003341,"d":"0.99"},{"v":0.009318382591521,"d":"0.01"},{"v":0.17348979584305,"d":"0.17"},"up","no"]
["MSTRG.20697","AKAP12","ENSOART00000003378","GO:0005623(cell);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006605(protein targeting);GO:0007165(signal transduction);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0008179(adenylate cyclase binding);GO:0010738(regulation of protein kinase A signaling);GO:0010739(positive regulation of protein kinase A signaling);GO:0051018(protein kinase A binding);GO:0090036(regulation of protein kinase C signaling)","NA","NA","NA","A-kinase anchoring protein 12 [Source:HGNC Symbol;Acc:HGNC:370]",{"v":4.21606267446375,"d":"4.22"},{"v":4.43745489925265,"d":"4.44"},{"v":5.99278079782588,"d":"5.99"},{"v":1.82613947432787,"d":"1.83"},{"v":3.76953299893235,"d":"3.77"},{"v":2.31794790992915,"d":"2.32"},{"v":1.85077090665796,"d":"1.85"},{"v":0.888126325633426,"d":"0.89"},{"v":0.00933659984684655,"d":"0.01"},{"v":0.173630982117666,"d":"0.17"},"up","no"]
["MSTRG.11453","ENSOARG00000009204","ENSOART00000010019","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":2.190864,"d":"2.19"},{"v":0.667579,"d":"0.67"},{"v":1.191312,"d":"1.19"},{"v":4.898514,"d":"4.90"},{"v":1.766304,"d":"1.77"},{"v":5.356775,"d":"5.36"},{"v":0.336873407708945,"d":"0.34"},{"v":-1.56972154615643,"d":"-1.57"},{"v":0.00936074237754985,"d":"0.01"},{"v":0.173684319932539,"d":"0.17"},"down","yes"]
["ENSOARG00000010629","POLE","ENSOART00000011573","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000166(nucleotide binding);GO:0000731(DNA synthesis involved in DNA repair);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006287(base-excision repair, gap-filling);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0008270(zinc ion binding);GO:0008622(epsilon DNA polymerase complex);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0046872(metal ion binding);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding)","03030(DNA replication);03410(Base excision repair);03420(Nucleotide excision repair)","K02324","EC:2.7.7.7","DNA polymerase epsilon, catalytic subunit [Source:NCBI gene;Acc:101116176]",{"v":0.204364,"d":"0.20"},{"v":0.068025,"d":"0.07"},{"v":0.215142,"d":"0.22"},{"v":0.471176,"d":"0.47"},{"v":0.37499,"d":"0.37"},{"v":0.355049,"d":"0.36"},{"v":0.405864895127017,"d":"0.41"},{"v":-1.3009285339017,"d":"-1.30"},{"v":0.00937735166885823,"d":"0.01"},{"v":0.173723745834277,"d":"0.17"},"down","yes"]
["ENSOARG00000015786","ICAM5","ENSOART00000017189","GO:0005886(plasma membrane);GO:0006909(phagocytosis);GO:0016020(membrane);GO:0098609(cell-cell adhesion)","NA","K06769","NA","intercellular adhesion molecule 5 [Source:NCBI gene;Acc:101116726]",{"v":0.133825,"d":"0.13"},{"v":0.084533,"d":"0.08"},0,{"v":0.349482,"d":"0.35"},{"v":0.210719,"d":"0.21"},{"v":0.491768,"d":"0.49"},{"v":0.207570755411994,"d":"0.21"},{"v":-2.26832489779123,"d":"-2.27"},{"v":0.0093841464861485,"d":"0.01"},{"v":0.173723745834277,"d":"0.17"},"down","yes"]
["MSTRG.20612","SGK1","ENSOART00000016010","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016607(nuclear speck);GO:0016740(transferase activity)","04068(FoxO signaling pathway);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04960(Aldosterone-regulated sodium reabsorption)","K13302","EC:2.7.11.1","serum/glucocorticoid regulated kinase 1 [Source:NCBI gene;Acc:101107709]",{"v":9.04784418333982,"d":"9.05"},{"v":4.0933490027248,"d":"4.09"},{"v":8.19494755936162,"d":"8.19"},{"v":12.891700925652,"d":"12.89"},{"v":15.098961820942,"d":"15.10"},{"v":14.9043560482678,"d":"14.90"},{"v":0.497403692663308,"d":"0.50"},{"v":-1.00751087690378,"d":"-1.01"},{"v":0.00941547891801396,"d":"0.01"},{"v":0.174053307801431,"d":"0.17"},"down","yes"]
["MSTRG.17189","LMOD2","ENSOART00000001002","GO:0003779(actin binding);GO:0003785(actin monomer binding);GO:0005523(tropomyosin binding);GO:0005884(actin filament);GO:0030016(myofibril);GO:0030017(sarcomere);GO:0030041(actin filament polymerization);GO:0030838(positive regulation of actin filament polymerization);GO:0031430(M band);GO:0045010(actin nucleation);GO:0045214(sarcomere organization);GO:0051694(pointed-end actin filament capping)","NA","K22030","NA","leiomodin 2 [Source:NCBI gene;Acc:101106254]",{"v":155.072632,"d":"155.07"},{"v":100.348274,"d":"100.35"},{"v":135.985321,"d":"135.99"},{"v":65.540291,"d":"65.54"},{"v":70.106133,"d":"70.11"},{"v":88.122932,"d":"88.12"},{"v":1.74915025898363,"d":"1.75"},{"v":0.806654227841168,"d":"0.81"},{"v":0.00950508463802587,"d":"0.01"},{"v":0.174970712479917,"d":"0.17"},"up","no"]
["MSTRG.16308","H2AFJ","ENSOART00000022062","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A.J [Source:NCBI gene;Acc:101107687]",{"v":1.075953,"d":"1.08"},{"v":0.982715,"d":"0.98"},{"v":1.356357,"d":"1.36"},{"v":2.218573,"d":"2.22"},{"v":3.529424,"d":"3.53"},{"v":3.028013,"d":"3.03"},{"v":0.389131849211658,"d":"0.39"},{"v":-1.36166902971593,"d":"-1.36"},{"v":0.00955306208207391,"d":"0.01"},{"v":0.175161304465662,"d":"0.18"},"down","yes"]
["MSTRG.8470","oar-mir-493","ENSOART00000025470","NA","NA","NA","NA","oar-mir-493 [Source:miRBase;Acc:MI0016912]",{"v":1.51906618144186,"d":"1.52"},{"v":0.175265603838503,"d":"0.18"},{"v":0.55100618848449,"d":"0.55"},{"v":0.455130824095479,"d":"0.46"},{"v":5.66913285979248,"d":"5.67"},{"v":2.74744850024192,"d":"2.75"},{"v":0.253089587124052,"d":"0.25"},{"v":-1.98227994308288,"d":"-1.98"},{"v":0.00956907665258271,"d":"0.01"},{"v":0.175161304465662,"d":"0.18"},"down","yes"]
["MSTRG.11342","RF00100","ENSOART00000025617","NA","NA","NA","NA",null,{"v":15473.155273,"d":"15473.16"},{"v":13383.922852,"d":"13383.92"},{"v":12008.418945,"d":"12008.42"},{"v":17107.472656,"d":"17107.47"},{"v":25909.789062,"d":"25909.79"},{"v":42247.207031,"d":"42247.21"},{"v":0.47927932548667,"d":"0.48"},{"v":-1.06106138664583,"d":"-1.06"},{"v":0.00962900760336451,"d":"0.01"},{"v":0.175667526422051,"d":"0.18"},"down","yes"]
["MSTRG.17771","ENSOARG00000016237","ENSOART00000017688","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007608(sensory perception of smell);GO:0008081(phosphoric diester hydrolase activity);GO:0010738(regulation of protein kinase A signaling);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0030552(cAMP binding);GO:0035690(cellular response to drug);GO:0043949(regulation of cAMP-mediated signaling);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm)","00230(Purine metabolism);04024(cAMP signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05032(Morphine addiction)","K13293","EC:3.1.4.53","cAMP-specific 3',5'-cyclic phosphodiesterase 4A [Source:NCBI gene;Acc:101117505]",{"v":14.1757768949953,"d":"14.18"},{"v":14.7724747609065,"d":"14.77"},{"v":12.364430671577,"d":"12.36"},{"v":6.19917902209632,"d":"6.20"},{"v":7.99449027063267,"d":"7.99"},{"v":9.16602895203022,"d":"9.17"},{"v":1.76854520527667,"d":"1.77"},{"v":0.822563095824225,"d":"0.82"},{"v":0.0096791190662662,"d":"0.01"},{"v":0.176373115314685,"d":"0.18"},"up","no"]
["MSTRG.15070","ENSOARG00000019540","ENSOART00000021280","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":1.74736,"d":"1.75"},{"v":3.882906,"d":"3.88"},{"v":5.914999,"d":"5.91"},{"v":0.560084,"d":"0.56"},{"v":0.962274,"d":"0.96"},{"v":2.30424,"d":"2.30"},{"v":3.01710945335779,"d":"3.02"},{"v":1.59316703488442,"d":"1.59"},{"v":0.00979426690786082,"d":"0.01"},{"v":0.177771868569034,"d":"0.18"},"up","yes"]
["MSTRG.17836","KANK3","ENSOART00000004041","GO:0005515(protein binding)","NA","K22808","NA","KN motif and ankyrin repeat domains 3 [Source:NCBI gene;Acc:101104065]",{"v":5.06794033978763,"d":"5.07"},{"v":2.75558822829482,"d":"2.76"},{"v":2.31414430262336,"d":"2.31"},{"v":6.62804590974391,"d":"6.63"},{"v":7.57301069862586,"d":"7.57"},{"v":6.311601532792,"d":"6.31"},{"v":0.494215464467914,"d":"0.49"},{"v":-1.01678794022611,"d":"-1.02"},{"v":0.00980710745667472,"d":"0.01"},{"v":0.177771868569034,"d":"0.18"},"down","yes"]
["MSTRG.13885","TSNAX-DISC1","ENSOART00000003554","GO:0005737(cytoplasm);GO:0043565(sequence-specific DNA binding)","NA","NA","NA","translin associated factor X [Source:NCBI gene;Acc:101111933]",{"v":4.65007626971091,"d":"4.65"},{"v":3.94356131373193,"d":"3.94"},{"v":3.74629517411301,"d":"3.75"},{"v":4.44749592509855,"d":"4.45"},{"v":7.60387430617608,"d":"7.60"},{"v":17.0871461642576,"d":"17.09"},{"v":0.423492143184336,"d":"0.42"},{"v":-1.23959289060531,"d":"-1.24"},{"v":0.00981693014596436,"d":"0.01"},{"v":0.177771868569034,"d":"0.18"},"down","yes"]
["MSTRG.11652","C6orf52","ENSOART00000017455","NA","NA","NA","NA","chromosome 20 open reading frame, human C6orf52 [Source:NCBI gene;Acc:101117119]",{"v":0.778507039113429,"d":"0.78"},{"v":0.902623963494133,"d":"0.90"},{"v":0.479990794002608,"d":"0.48"},{"v":1.5456304041721,"d":"1.55"},{"v":2.12435130247718,"d":"2.12"},{"v":1.81275388787484,"d":"1.81"},{"v":0.394168523969784,"d":"0.39"},{"v":-1.34311551923086,"d":"-1.34"},{"v":0.00982056745769653,"d":"0.01"},{"v":0.177771868569034,"d":"0.18"},"down","yes"]
["MSTRG.19940","ENSOARG00000021922","ENSOART00000023824","NA","NA","NA","NA",null,{"v":3.04800815485431,"d":"3.05"},{"v":3.57327496318311,"d":"3.57"},{"v":2.76420300741137,"d":"2.76"},{"v":2.47705087995053,"d":"2.48"},{"v":1.81335675645842,"d":"1.81"},{"v":1.1782833096717,"d":"1.18"},{"v":1.71622170972658,"d":"1.72"},{"v":0.779235939120483,"d":"0.78"},{"v":0.00984232466755041,"d":"0.01"},{"v":0.177826718217096,"d":"0.18"},"up","no"]
["MSTRG.15902","ENSOARG00000002903","ENSOART00000003144","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K06890","NA","transmembrane BAX inhibitor motif containing 4 [Source:NCBI gene;Acc:101115532]",{"v":6.73170208679928,"d":"6.73"},{"v":4.72420719814002,"d":"4.72"},{"v":5.16895340273831,"d":"5.17"},{"v":3.77322817101524,"d":"3.77"},{"v":3.25727918599845,"d":"3.26"},{"v":2.83139141772152,"d":"2.83"},{"v":1.68576691643481,"d":"1.69"},{"v":0.753405074981227,"d":"0.75"},{"v":0.00984537930354331,"d":"0.01"},{"v":0.177826718217096,"d":"0.18"},"up","no"]
["MSTRG.1256","COL8A1","ENSOART00000019447","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0010811(positive regulation of cell-substrate adhesion);GO:0035987(endodermal cell differentiation);GO:0048593(camera-type eye morphogenesis);GO:0050673(epithelial cell proliferation)","NA","NA","NA","collagen type VIII alpha 1 chain [Source:NCBI gene;Acc:101107564]",{"v":1.77024625815368,"d":"1.77"},{"v":6.32703766777225,"d":"6.33"},{"v":4.33401623493643,"d":"4.33"},{"v":1.58675736760641,"d":"1.59"},{"v":2.49157414151465,"d":"2.49"},{"v":1.86321569375345,"d":"1.86"},{"v":2.09226649833702,"d":"2.09"},{"v":1.06506662373698,"d":"1.07"},{"v":0.00990199510093139,"d":"0.01"},{"v":0.178257746425587,"d":"0.18"},"up","yes"]
["MSTRG.15666","ZNF385A","ENSOART00000017637","GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0003676(nucleic acid binding);GO:0003730(mRNA 3'-UTR binding);GO:0006915(apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0007599(hemostasis);GO:0007611(learning or memory);GO:0007626(locomotory behavior);GO:0008270(zinc ion binding);GO:0008298(intracellular mRNA localization);GO:0010609(mRNA localization resulting in posttranscriptional regulation of gene expression);GO:0030220(platelet formation);GO:0030425(dendrite);GO:0035855(megakaryocyte development);GO:0043025(neuronal cell body);GO:0045600(positive regulation of fat cell differentiation);GO:0046872(metal ion binding);GO:0070889(platelet alpha granule organization);GO:1902164(positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:2000765(regulation of cytoplasmic translation)","NA","NA","NA","zinc finger protein 385A [Source:NCBI gene;Acc:101107591]",{"v":1.39231458348135,"d":"1.39"},{"v":0.612610060390764,"d":"0.61"},{"v":0.983553055062167,"d":"0.98"},{"v":1.76302256216696,"d":"1.76"},{"v":2.67658229040853,"d":"2.68"},{"v":2.39922476998224,"d":"2.40"},{"v":0.436986716130031,"d":"0.44"},{"v":-1.19433867068692,"d":"-1.19"},{"v":0.0100917599664975,"d":"0.01"},{"v":0.181410963443237,"d":"0.18"},"down","yes"]
["MSTRG.13547","PRR14","ENSOART00000007453","NA","NA","NA","NA","proline rich 14 [Source:NCBI gene;Acc:101103694]",{"v":1.2693498705036,"d":"1.27"},{"v":0.801156867625899,"d":"0.80"},{"v":1.03263435971223,"d":"1.03"},{"v":1.69950101294964,"d":"1.70"},{"v":2.60427664028777,"d":"2.60"},{"v":2.31816866906475,"d":"2.32"},{"v":0.468614655994811,"d":"0.47"},{"v":-1.09352601947337,"d":"-1.09"},{"v":0.010180759241903,"d":"0.01"},{"v":0.182251391366135,"d":"0.18"},"down","yes"]
["MSTRG.6336","H2AFX","ENSOART00000018551","GO:0000077(DNA damage checkpoint);GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000785(chromatin);GO:0000786(nucleosome);GO:0000790(nuclear chromatin);GO:0000794(condensed nuclear chromosome);GO:0001673(male germ cell nucleus);GO:0001741(XY body);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005694(chromosome);GO:0005813(centrosome);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0007283(spermatogenesis);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0035861(site of double-strand break);GO:0042393(histone binding);GO:0046982(protein heterodimerization activity);GO:0090734(site of DNA damage)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2AX [Source:NCBI gene;Acc:101106791]",{"v":2.803971,"d":"2.80"},{"v":1.507442,"d":"1.51"},{"v":2.339802,"d":"2.34"},{"v":7.081212,"d":"7.08"},{"v":2.219696,"d":"2.22"},{"v":8.44808,"d":"8.45"},{"v":0.374737703355256,"d":"0.37"},{"v":-1.41604695653932,"d":"-1.42"},{"v":0.0101869701850799,"d":"0.01"},{"v":0.182251391366135,"d":"0.18"},"down","yes"]
["MSTRG.14730","ENSOARG00000009155","ENSOART00000009969","GO:0003824(catalytic activity);GO:0006575(cellular modified amino acid metabolic process);GO:0009058(biosynthetic process);GO:0009617(response to bacterium);GO:0016212(kynurenine-oxoglutarate transaminase activity);GO:0030170(pyridoxal phosphate binding);GO:0047804(cysteine-S-conjugate beta-lyase activity);GO:0070189(kynurenine metabolic process);GO:0070548(L-glutamine aminotransferase activity);GO:0097052(L-kynurenine metabolic process)","00270(Cysteine and methionine metabolism);00380(Tryptophan metabolism);00450(Selenocompound metabolism);05204(Chemical carcinogenesis)","K00816","2.6.1.64;4.4.1.13;EC:2.6.1.7","kynurenine aminotransferase 1 [Source:NCBI gene;Acc:101117485]",{"v":2.55264297913931,"d":"2.55"},{"v":2.43120757388767,"d":"2.43"},{"v":1.57513200656455,"d":"1.58"},{"v":1.54483797417943,"d":"1.54"},{"v":1.09075723107221,"d":"1.09"},{"v":1.21349808971554,"d":"1.21"},{"v":1.70403314675891,"d":"1.70"},{"v":0.768953399061163,"d":"0.77"},{"v":0.0101911287752162,"d":"0.01"},{"v":0.182251391366135,"d":"0.18"},"up","no"]
["MSTRG.8467","RF01872","ENSOART00000025888","NA","NA","NA","NA",null,{"v":1.6574631550278,"d":"1.66"},{"v":1.63262621213835,"d":"1.63"},{"v":3.16160987776835,"d":"3.16"},{"v":3.3568204443502,"d":"3.36"},{"v":7.34797208802186,"d":"7.35"},{"v":3.62145060691735,"d":"3.62"},{"v":0.450341319926426,"d":"0.45"},{"v":-1.15090924030757,"d":"-1.15"},{"v":0.0102684171402488,"d":"0.01"},{"v":0.182709647349141,"d":"0.18"},"down","yes"]
["MSTRG.18309","DIAPH1","ENSOART00000000693","GO:0003779(actin binding);GO:0007010(cytoskeleton organization);GO:0007015(actin filament organization);GO:0008360(regulation of cell shape);GO:0016043(cellular component organization);GO:0017048(Rho GTPase binding);GO:0030036(actin cytoskeleton organization);GO:0030041(actin filament polymerization);GO:0032886(regulation of microtubule-based process);GO:0035372(protein localization to microtubule);GO:0044325(ion channel binding);GO:0051279(regulation of release of sequestered calcium ion into cytosol);GO:0051493(regulation of cytoskeleton organization);GO:0071420(cellular response to histamine);GO:0072686(mitotic spindle)","04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04933(AGE-RAGE signaling pathway in diabetic complications)","K05740","NA","diaphanous related formin 1 [Source:NCBI gene;Acc:101106682]",{"v":9.73449783082505,"d":"9.73"},{"v":9.43317798978769,"d":"9.43"},{"v":10.1134373486966,"d":"10.11"},{"v":6.36711607565171,"d":"6.37"},{"v":5.85484525087342,"d":"5.85"},{"v":5.42702452338081,"d":"5.43"},{"v":1.65908191090002,"d":"1.66"},{"v":0.730385115668125,"d":"0.73"},{"v":0.0102723821819275,"d":"0.01"},{"v":0.182709647349141,"d":"0.18"},"up","no"]
["MSTRG.18246","ENSOARG00000013423","ENSOART00000014602","NA","03010(Ribosome)","K02975","NA","40S ribosomal protein S25 [Source:NCBI gene;Acc:101110758]",{"v":30.672844,"d":"30.67"},{"v":27.693001,"d":"27.69"},{"v":22.193993,"d":"22.19"},{"v":40.386341,"d":"40.39"},{"v":51.946609,"d":"51.95"},{"v":66.551743,"d":"66.55"},{"v":0.50703334902123,"d":"0.51"},{"v":-0.979847454393923,"d":"-0.98"},{"v":0.0103674535933703,"d":"0.01"},{"v":0.183823265078026,"d":"0.18"},"down","no"]
["MSTRG.13912","NID1","ENSOART00000003910","GO:0005509(calcium ion binding);GO:0005518(collagen binding);GO:0005604(basement membrane);GO:0007160(cell-matrix adhesion);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0032836(glomerular basement membrane development);GO:0043236(laminin binding);GO:0043237(laminin-1 binding);GO:0043394(proteoglycan binding);GO:0050840(extracellular matrix binding);GO:0071944(cell periphery)","NA","K06826","NA","nidogen 1 [Source:NCBI gene;Acc:101117471]",{"v":26.6015473606408,"d":"26.60"},{"v":17.7866588022923,"d":"17.79"},{"v":17.9410887257098,"d":"17.94"},{"v":34.217403345142,"d":"34.22"},{"v":40.4462237624381,"d":"40.45"},{"v":42.7969485024746,"d":"42.80"},{"v":0.530640128101905,"d":"0.53"},{"v":-0.914194315618184,"d":"-0.91"},{"v":0.0103687669731052,"d":"0.01"},{"v":0.183823265078026,"d":"0.18"},"down","no"]
["MSTRG.19976","DACT1","ENSOART00000023004","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008013(beta-catenin binding);GO:0021915(neural tube development);GO:0030177(positive regulation of Wnt signaling pathway);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030877(beta-catenin destruction complex);GO:0031647(regulation of protein stability);GO:0032091(negative regulation of protein binding);GO:0032092(positive regulation of protein binding);GO:0042826(histone deacetylase binding);GO:0045732(positive regulation of protein catabolic process);GO:0046329(negative regulation of JNK cascade);GO:0051018(protein kinase A binding);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1903364(positive regulation of cellular protein catabolic process);GO:1904864(negative regulation of beta-catenin-TCF complex assembly);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA","K22154","NA","dishevelled binding antagonist of beta catenin 1 [Source:NCBI gene;Acc:101116320]",{"v":2.719951,"d":"2.72"},{"v":1.393046,"d":"1.39"},{"v":2.062484,"d":"2.06"},{"v":3.884372,"d":"3.88"},{"v":4.625083,"d":"4.63"},{"v":4.030282,"d":"4.03"},{"v":0.492472928259979,"d":"0.49"},{"v":-1.02188367455904,"d":"-1.02"},{"v":0.0103987557999055,"d":"0.01"},{"v":0.183930829028512,"d":"0.18"},"down","yes"]
["MSTRG.17570","SSBP4","ENSOART00000013121;ENSOART00000013119","GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005515(protein binding)","NA","NA","NA","single stranded DNA binding protein 4 [Source:NCBI gene;Acc:101109967]",{"v":1.6537988100159,"d":"1.65"},{"v":1.09683710095389,"d":"1.10"},{"v":0.766988887122417,"d":"0.77"},{"v":2.49822969872814,"d":"2.50"},{"v":2.53732019395866,"d":"2.54"},{"v":2.74567133227345,"d":"2.75"},{"v":0.45206590281851,"d":"0.45"},{"v":-1.14539498875392,"d":"-1.15"},{"v":0.0104198932417549,"d":"0.01"},{"v":0.183930829028512,"d":"0.18"},"down","yes"]
["MSTRG.14937","UBXN2A;MFSD2B","ENSOART00000019250;ENSOART00000019302","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005801(cis-Golgi network);GO:0005829(cytosol);GO:0031396(regulation of protein ubiquitination);GO:0033130(acetylcholine receptor binding);GO:0042176(regulation of protein catabolic process);GO:1990830(cellular response to leukemia inhibitory factor);GO:0005887(integral component of plasma membrane);GO:0006869(lipid transport);GO:0008643(carbohydrate transport);GO:0015293(symporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046624(sphingolipid transporter activity);GO:0055085(transmembrane transport)","NA","NA","NA","UBX domain protein 2A [Source:NCBI gene;Acc:101105733];major facilitator superfamily domain containing 2B [Source:NCBI gene;Acc:101107855]",{"v":4.95824291873396,"d":"4.96"},{"v":5.80903105841378,"d":"5.81"},{"v":3.88344500403275,"d":"3.88"},{"v":3.4222618529879,"d":"3.42"},{"v":2.79342957155078,"d":"2.79"},{"v":2.47235234816082,"d":"2.47"},{"v":1.68630814536381,"d":"1.69"},{"v":0.753868189404393,"d":"0.75"},{"v":0.0104973549111709,"d":"0.01"},{"v":0.184500334757371,"d":"0.18"},"up","no"]
["MSTRG.10883","RF00045","ENSOART00000025844","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 73A [Source:HGNC Symbol;Acc:HGNC:10115]",{"v":65.176674,"d":"65.18"},{"v":63.428928,"d":"63.43"},{"v":47.827568,"d":"47.83"},{"v":89.467117,"d":"89.47"},{"v":90.008423,"d":"90.01"},{"v":195.262085,"d":"195.26"},{"v":0.470817868902275,"d":"0.47"},{"v":-1.08675901901506,"d":"-1.09"},{"v":0.0105118093203424,"d":"0.01"},{"v":0.184555723207044,"d":"0.18"},"down","yes"]
["MSTRG.14424","ADAM9","ENSOART00000001955","GO:0000186(activation of MAPKK activity);GO:0004222(metalloendopeptidase activity);GO:0005178(integrin binding);GO:0005518(collagen binding);GO:0006508(proteolysis);GO:0006509(membrane protein ectodomain proteolysis);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008237(metallopeptidase activity);GO:0010042(response to manganese ion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017124(SH3 domain binding);GO:0030216(keratinocyte differentiation);GO:0033627(cell adhesion mediated by integrin);GO:0033630(positive regulation of cell adhesion mediated by integrin);GO:0033631(cell-cell adhesion mediated by integrin);GO:0034241(positive regulation of macrophage fusion);GO:0034612(response to tumor necrosis factor);GO:0042117(monocyte activation);GO:0042542(response to hydrogen peroxide);GO:0043236(laminin binding);GO:0050714(positive regulation of protein secretion);GO:0051549(positive regulation of keratinocyte migration);GO:0051592(response to calcium ion);GO:0071222(cellular response to lipopolysaccharide)","NA","K06834","EC:3.4.24.-","ADAM metallopeptidase domain 9 [Source:NCBI gene;Acc:101115001]",{"v":3.46757899383097,"d":"3.47"},{"v":3.5033154611351,"d":"3.50"},{"v":3.77805947902529,"d":"3.78"},{"v":2.43937098272671,"d":"2.44"},{"v":2.24381810549044,"d":"2.24"},{"v":1.82915726896977,"d":"1.83"},{"v":1.65055010044559,"d":"1.65"},{"v":0.72294693048254,"d":"0.72"},{"v":0.0105950190319496,"d":"0.01"},{"v":0.184897685546628,"d":"0.18"},"up","no"]
["MSTRG.11526","ENSOARG00000020059","ENSOART00000021838","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11254","NA","histone H4 [Source:NCBI gene;Acc:101109129]",{"v":12.888152,"d":"12.89"},{"v":9.21701,"d":"9.22"},{"v":11.358762,"d":"11.36"},{"v":20.989893,"d":"20.99"},{"v":15.240835,"d":"15.24"},{"v":37.597767,"d":"37.60"},{"v":0.453265693686428,"d":"0.45"},{"v":-1.14157112276874,"d":"-1.14"},{"v":0.0106264931085701,"d":"0.01"},{"v":0.184897685546628,"d":"0.18"},"down","yes"]
["MSTRG.9652","BMP1","ENSOART00000011330","GO:0004222(metalloendopeptidase activity);GO:0005509(calcium ion binding);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0061036(positive regulation of cartilage development)","NA","K05502","EC:3.4.24.19","bone morphogenetic protein 1 [Source:NCBI gene;Acc:101122334]",{"v":2.62608162647482,"d":"2.63"},{"v":1.82946507453237,"d":"1.83"},{"v":3.40259884402878,"d":"3.40"},{"v":6.02559875223022,"d":"6.03"},{"v":4.7365545971223,"d":"4.74"},{"v":4.57477649093525,"d":"4.57"},{"v":0.512367574662422,"d":"0.51"},{"v":-0.964748917712743,"d":"-0.96"},{"v":0.0106541063562332,"d":"0.01"},{"v":0.184897685546628,"d":"0.18"},"down","no"]
["MSTRG.9213","TMEM40","ENSOART00000016738","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 40 [Source:NCBI gene;Acc:101102938]",{"v":2.2322462548853,"d":"2.23"},{"v":2.27517398130841,"d":"2.28"},{"v":2.1682728173322,"d":"2.17"},{"v":0.885845536108751,"d":"0.89"},{"v":0.606537950722175,"d":"0.61"},{"v":1.58855836873407,"d":"1.59"},{"v":2.16677021718792,"d":"2.17"},{"v":1.11554616584472,"d":"1.12"},{"v":0.0106548587257782,"d":"0.01"},{"v":0.184897685546628,"d":"0.18"},"up","yes"]
["MSTRG.18010","MEGF10","ENSOART00000019438","GO:0001849(complement component C1q binding);GO:0001891(phagocytic cup);GO:0005044(scavenger receptor activity);GO:0005112(Notch binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0014719(skeletal muscle satellite cell activation);GO:0014816(skeletal muscle satellite cell differentiation);GO:0014841(skeletal muscle satellite cell proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033002(muscle cell proliferation);GO:0034109(homotypic cell-cell adhesion);GO:0043652(engulfment of apoptotic cell);GO:0043654(recognition of apoptotic cell);GO:0048641(regulation of skeletal muscle tissue development);GO:0051147(regulation of muscle cell differentiation);GO:0051451(myoblast migration);GO:0055001(muscle cell development);GO:1902742(apoptotic process involved in development)","NA","NA","NA","multiple EGF like domains 10 [Source:NCBI gene;Acc:101106165]",{"v":2.62205307046477,"d":"2.62"},{"v":1.73523578910545,"d":"1.74"},{"v":2.34578819490255,"d":"2.35"},{"v":4.36372947176412,"d":"4.36"},{"v":4.26748021389305,"d":"4.27"},{"v":3.92455195702149,"d":"3.92"},{"v":0.53386463085506,"d":"0.53"},{"v":-0.905454122922328,"d":"-0.91"},{"v":0.0107112133109957,"d":"0.01"},{"v":0.185530622431222,"d":"0.19"},"down","no"]
["MSTRG.11736","RF00561","ENSOART00000024113","NA","NA","NA","NA",null,{"v":6.813773,"d":"6.81"},{"v":6.065531,"d":"6.07"},{"v":7.056308,"d":"7.06"},{"v":9.778181,"d":"9.78"},{"v":16.161259,"d":"16.16"},{"v":23.15015,"d":"23.15"},{"v":0.406106712237768,"d":"0.41"},{"v":-1.30006922218776,"d":"-1.30"},{"v":0.0107150524836258,"d":"0.01"},{"v":0.185530622431222,"d":"0.19"},"down","yes"]
["MSTRG.17268","PLXNA4","ENSOART00000007014","GO:0005515(protein binding);GO:0007165(signal transduction);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0008045(motor neuron axon guidance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017154(semaphorin receptor activity);GO:0021602(cranial nerve morphogenesis);GO:0021610(facial nerve morphogenesis);GO:0021612(facial nerve structural organization);GO:0021615(glossopharyngeal nerve morphogenesis);GO:0021636(trigeminal nerve morphogenesis);GO:0021637(trigeminal nerve structural organization);GO:0021644(vagus nerve morphogenesis);GO:0021784(postganglionic parasympathetic fiber development);GO:0021785(branchiomotor neuron axon guidance);GO:0021793(chemorepulsion of branchiomotor axon);GO:0021960(anterior commissure morphogenesis);GO:0048485(sympathetic nervous system development);GO:0048812(neuron projection morphogenesis);GO:0048841(regulation of axon extension involved in axon guidance);GO:0050923(regulation of negative chemotaxis);GO:0071526(semaphorin-plexin signaling pathway);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance)","04360(Axon guidance)","K06820","NA","plexin A4 [Source:NCBI gene;Acc:101119554]",{"v":0.917833,"d":"0.92"},{"v":0.530418,"d":"0.53"},{"v":0.698413,"d":"0.70"},{"v":1.60285,"d":"1.60"},{"v":1.281613,"d":"1.28"},{"v":1.318936,"d":"1.32"},{"v":0.510697176261402,"d":"0.51"},{"v":-0.969460012741155,"d":"-0.97"},{"v":0.0107319102620373,"d":"0.01"},{"v":0.185625668176425,"d":"0.19"},"down","no"]
["MSTRG.17543","RFXANK","ENSOART00000010054","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007265(Ras protein signal transduction);GO:0042826(histone deacetylase binding);GO:0045171(intercellular bridge);GO:0045944(positive regulation of transcription by RNA polymerase II)","04612(Antigen processing and presentation);05152(Tuberculosis);05340(Primary immunodeficiency)","K08062","NA","regulatory factor X associated ankyrin containing protein [Source:NCBI gene;Acc:101105568]",{"v":1.98857286768244,"d":"1.99"},{"v":1.40998998877306,"d":"1.41"},{"v":1.42588235765838,"d":"1.43"},{"v":3.25365017000802,"d":"3.25"},{"v":3.13646818925421,"d":"3.14"},{"v":3.65266317080994,"d":"3.65"},{"v":0.480389342301984,"d":"0.48"},{"v":-1.05772395046046,"d":"-1.06"},{"v":0.0107518797571453,"d":"0.01"},{"v":0.185774277962613,"d":"0.19"},"down","yes"]
["MSTRG.9681","GABBR2","ENSOART00000012055","GO:0004930(G protein-coupled receptor activity);GO:0004965(G protein-coupled GABA receptor activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0038039(G protein-coupled receptor heterodimeric complex);GO:0043005(neuron projection);GO:0046982(protein heterodimerization activity);GO:1902710(GABA receptor complex)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04727(GABAergic synapse);04742(Taste transduction);04915(Estrogen signaling pathway);05032(Morphine addiction)","K04615","NA","gamma-aminobutyric acid type B receptor subunit 2 [Source:NCBI gene;Acc:101103544]",{"v":0.375186,"d":"0.38"},{"v":0.188921,"d":"0.19"},{"v":0.330186,"d":"0.33"},{"v":0.671982,"d":"0.67"},{"v":0.676473,"d":"0.68"},{"v":0.784406,"d":"0.78"},{"v":0.419292677769437,"d":"0.42"},{"v":-1.25397045868818,"d":"-1.25"},{"v":0.0107669327741469,"d":"0.01"},{"v":0.185837714943204,"d":"0.19"},"down","yes"]
["MSTRG.14498","THRB","ENSOART00000004838","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007605(sensory perception of sound);GO:0007621(negative regulation of female receptivity);GO:0008016(regulation of heart contraction);GO:0008050(female courtship behavior);GO:0008270(zinc ion binding);GO:0009887(animal organ morphogenesis);GO:0016604(nuclear body);GO:0019899(enzyme binding);GO:0030522(intracellular receptor signaling pathway);GO:0031490(chromatin DNA binding);GO:0042480(negative regulation of eye photoreceptor cell development);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046549(retinal cone cell development);GO:0046872(metal ion binding);GO:0060509(type I pneumocyte differentiation);GO:0070324(thyroid hormone binding);GO:0097474(retinal cone cell apoptotic process)","04080(Neuroactive ligand-receptor interaction);04919(Thyroid hormone signaling pathway)","K08362","NA","thyroid hormone receptor beta [Source:NCBI gene;Acc:443445]",{"v":1.68827351749439,"d":"1.69"},{"v":1.73216893761679,"d":"1.73"},{"v":2.19365202634872,"d":"2.19"},{"v":1.592501724187,"d":"1.59"},{"v":0.955060418099532,"d":"0.96"},{"v":0.618155938748221,"d":"0.62"},{"v":1.77340317038745,"d":"1.77"},{"v":0.82652055981044,"d":"0.83"},{"v":0.0107977377803929,"d":"0.01"},{"v":0.18617261085349,"d":"0.19"},"up","no"]
["ENSOARG00000014405","ENSOARG00000014405","ENSOART00000015689","NA","NA","NA","NA",null,{"v":0.234205,"d":"0.23"},0,{"v":0.012589,"d":"0.01"},{"v":0.967816,"d":"0.97"},{"v":0.217299,"d":"0.22"},{"v":0.571613,"d":"0.57"},{"v":0.140485038093547,"d":"0.14"},{"v":-2.8315116058479,"d":"-2.83"},{"v":0.0108536189629023,"d":"0.01"},{"v":0.186938702981296,"d":"0.19"},"down","yes"]
["MSTRG.5446","CDH5","ENSOART00000001989","GO:0001955(blood vessel maturation);GO:0005102(signaling receptor binding);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0005913(cell-cell adherens junction);GO:0005923(bicellular tight junction);GO:0007043(cell-cell junction assembly);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008013(beta-catenin binding);GO:0008285(negative regulation of cell population proliferation);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019903(protein phosphatase binding);GO:0030054(cell junction);GO:0043184(vascular endothelial growth factor receptor 2 binding);GO:0044325(ion channel binding);GO:0045766(positive regulation of angiogenesis);GO:0046872(metal ion binding);GO:0050728(negative regulation of inflammatory response);GO:0071944(cell periphery);GO:0098609(cell-cell adhesion);GO:1903142(positive regulation of establishment of endothelial barrier);GO:2000114(regulation of establishment of cell polarity)","04514(Cell adhesion molecules (CAMs));04670(Leukocyte transendothelial migration);05418(Fluid shear stress and atherosclerosis)","K06533","NA","cadherin 5 [Source:NCBI gene;Acc:101107462]",{"v":17.0837958530534,"d":"17.08"},{"v":10.3277110381679,"d":"10.33"},{"v":11.7527977633588,"d":"11.75"},{"v":23.8218035400763,"d":"23.82"},{"v":23.4242306641221,"d":"23.42"},{"v":25.4480702232824,"d":"25.45"},{"v":0.538754895779068,"d":"0.54"},{"v":-0.892299020552744,"d":"-0.89"},{"v":0.0111345217996007,"d":"0.01"},{"v":0.19077069458959,"d":"0.19"},"down","no"]
["MSTRG.19478","THSD4;ENSOARG00000018784","ENSOART00000020472;ENSOART00000020458","GO:0001527(microfibril);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0031012(extracellular matrix);GO:0048251(elastic fiber assembly)","NA","NA","NA","thrombospondin type 1 domain containing 4 [Source:NCBI gene;Acc:101115035]",{"v":0.836236296922231,"d":"0.84"},{"v":0.656102350233581,"d":"0.66"},{"v":0.868048090684254,"d":"0.87"},{"v":1.42155996688651,"d":"1.42"},{"v":1.60025434102775,"d":"1.60"},{"v":1.47075872671063,"d":"1.47"},{"v":0.525397521564643,"d":"0.53"},{"v":-0.928518699963651,"d":"-0.93"},{"v":0.0111559539946743,"d":"0.01"},{"v":0.190937543841764,"d":"0.19"},"down","no"]
["MSTRG.19392","JMY","ENSOART00000018810","GO:0003713(transcription coactivator activity);GO:0003779(actin binding);GO:0006357(regulation of transcription by RNA polymerase II);GO:0031252(cell leading edge);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0070060('de novo' actin filament nucleation);GO:1903508(positive regulation of nucleic acid-templated transcription)","NA","NA","NA","junction mediating and regulatory protein, p53 cofactor [Source:NCBI gene;Acc:101108836]",{"v":3.54737473598593,"d":"3.55"},{"v":6.98692588437019,"d":"6.99"},{"v":5.30769258122664,"d":"5.31"},{"v":2.69024976742141,"d":"2.69"},{"v":3.53025328028138,"d":"3.53"},{"v":2.6519144383381,"d":"2.65"},{"v":1.78553288621813,"d":"1.79"},{"v":0.836354705946873,"d":"0.84"},{"v":0.0112204627789172,"d":"0.01"},{"v":0.191439619910303,"d":"0.19"},"up","no"]
["MSTRG.5027","RF00056","ENSOART00000024592","NA","NA","NA","NA",null,{"v":9.332279,"d":"9.33"},{"v":9.879429,"d":"9.88"},{"v":4.006624,"d":"4.01"},{"v":12.949183,"d":"12.95"},{"v":13.043049,"d":"13.04"},{"v":37.010559,"d":"37.01"},{"v":0.368528625977856,"d":"0.37"},{"v":-1.44015140785388,"d":"-1.44"},{"v":0.0113348278144474,"d":"0.01"},{"v":0.192763283674898,"d":"0.19"},"down","yes"]
["MSTRG.10357","ENSOARG00000009240","ENSOART00000010058","GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","NA","NA","NA",null,{"v":0.587267,"d":"0.59"},{"v":0.525356,"d":"0.53"},{"v":0.731703,"d":"0.73"},{"v":1.985546,"d":"1.99"},{"v":1.310206,"d":"1.31"},{"v":1.342919,"d":"1.34"},{"v":0.397597932683736,"d":"0.40"},{"v":-1.33061783928162,"d":"-1.33"},{"v":0.0113490033479097,"d":"0.01"},{"v":0.192763283674898,"d":"0.19"},"down","yes"]
["MSTRG.10520","COQ10B;RF00026","ENSOART00000016822;ENSOART00000023925","NA","NA","K18588","NA","coenzyme Q10B [Source:NCBI gene;Acc:101122002];RNA, U6 small nuclear 956, pseudogene [Source:HGNC Symbol;Acc:HGNC:47919]",{"v":12.5438904823316,"d":"12.54"},{"v":5.9317806392401,"d":"5.93"},{"v":4.77377900615963,"d":"4.77"},{"v":6.23491799384037,"d":"6.23"},{"v":3.08006811774622,"d":"3.08"},{"v":2.43503823789146,"d":"2.44"},{"v":1.9786725062203,"d":"1.98"},{"v":0.98453284899496,"d":"0.98"},{"v":0.0113634631842621,"d":"0.01"},{"v":0.192763283674898,"d":"0.19"},"up","no"]
["MSTRG.5836","CCDC8","ENSOART00000011540","GO:0000226(microtubule cytoskeleton organization);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007088(regulation of mitotic nuclear division);GO:0010923(negative regulation of phosphatase activity);GO:1990393(3M complex)","NA","K17561","NA","coiled-coil domain containing 8 [Source:NCBI gene;Acc:101116079]",{"v":3.49243153097595,"d":"3.49"},{"v":4.32288820876945,"d":"4.32"},{"v":5.0283864115983,"d":"5.03"},{"v":8.3346958582744,"d":"8.33"},{"v":7.64872756492221,"d":"7.65"},{"v":8.43437746874116,"d":"8.43"},{"v":0.525997660812461,"d":"0.53"},{"v":-0.926871711228655,"d":"-0.93"},{"v":0.0113688781344271,"d":"0.01"},{"v":0.192763283674898,"d":"0.19"},"down","no"]
["MSTRG.1473","P3H2","ENSOART00000022298","GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0008285(negative regulation of cell population proliferation);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0019511(peptidyl-proline hydroxylation);GO:0019797(procollagen-proline 3-dioxygenase activity);GO:0031418(L-ascorbic acid binding);GO:0032963(collagen metabolic process);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","NA","K22459","EC:1.14.11.7","prolyl 3-hydroxylase 2 [Source:NCBI gene;Acc:101108618]",{"v":1.67270093490196,"d":"1.67"},{"v":1.52890351947712,"d":"1.53"},{"v":1.74651914928105,"d":"1.75"},{"v":3.03010192941176,"d":"3.03"},{"v":3.12540114352941,"d":"3.13"},{"v":3.1452703654902,"d":"3.15"},{"v":0.532012056461259,"d":"0.53"},{"v":-0.910469154424471,"d":"-0.91"},{"v":0.0114325574592446,"d":"0.01"},{"v":0.192913373937488,"d":"0.19"},"down","no"]
["MSTRG.13922","RF00026","ENSOART00000025074","NA","NA","NA","NA",null,{"v":59.0829517542243,"d":"59.08"},{"v":29.2158983857314,"d":"29.22"},{"v":41.4981201805769,"d":"41.50"},{"v":35.6919140945554,"d":"35.69"},{"v":21.9294910622973,"d":"21.93"},{"v":11.0675852971497,"d":"11.07"},{"v":1.88963281397259,"d":"1.89"},{"v":0.91810592284542,"d":"0.92"},{"v":0.0114398217885426,"d":"0.01"},{"v":0.192913373937488,"d":"0.19"},"up","no"]
["MSTRG.3005","ENSOARG00000016719","ENSOART00000018208","GO:0005515(protein binding);GO:0008270(zinc ion binding)","NA","NA","NA",null,{"v":3.72168,"d":"3.72"},{"v":6.216466,"d":"6.22"},{"v":5.094303,"d":"5.09"},{"v":3.19991,"d":"3.20"},{"v":2.486665,"d":"2.49"},{"v":2.773375,"d":"2.77"},{"v":1.77689572633408,"d":"1.78"},{"v":0.829359022101185,"d":"0.83"},{"v":0.0114486195091515,"d":"0.01"},{"v":0.192913373937488,"d":"0.19"},"up","no"]
["MSTRG.3236","ENSOARG00000016951","ENSOART00000018463","GO:0005198(structural molecule activity);GO:0005882(intermediate filament)","04915(Estrogen signaling pathway)","K07604","NA","keratin, type I cytoskeletal 13 [Source:NCBI gene;Acc:101117431]",{"v":0.570690573831776,"d":"0.57"},{"v":0.25941039376947,"d":"0.26"},{"v":0.983012089719626,"d":"0.98"},{"v":0.175496147663551,"d":"0.18"},{"v":0.300770097196262,"d":"0.30"},{"v":0.196107873520249,"d":"0.20"},{"v":2.69658365448267,"d":"2.70"},{"v":1.4311327903978,"d":"1.43"},{"v":0.0115066935065893,"d":"0.01"},{"v":0.193435848920917,"d":"0.19"},"up","yes"]
["MSTRG.18681","ETNPPL","ENSOART00000008182","GO:0003824(catalytic activity);GO:0008483(transaminase activity);GO:0030170(pyridoxal phosphate binding);GO:0050459(ethanolamine-phosphate phospho-lyase activity)","00564(Glycerophospholipid metabolism)","K14286","EC:4.2.3.2","ethanolamine-phosphate phospho-lyase [Source:NCBI gene;Acc:101120832]",{"v":36.094349,"d":"36.09"},{"v":34.245129,"d":"34.25"},{"v":32.635166,"d":"32.64"},{"v":26.898182,"d":"26.90"},{"v":15.075868,"d":"15.08"},{"v":19.19961,"d":"19.20"},{"v":1.68331670853109,"d":"1.68"},{"v":0.751306638843361,"d":"0.75"},{"v":0.0115116821983909,"d":"0.01"},{"v":0.193435848920917,"d":"0.19"},"up","no"]
["ENSOARG00000006560","PCDH17","ENSOART00000007130","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030534(adult behavior);GO:0050805(negative regulation of synaptic transmission);GO:0098978(glutamatergic synapse);GO:0098982(GABA-ergic synapse);GO:0099055(integral component of postsynaptic membrane);GO:0099056(integral component of presynaptic membrane);GO:0099560(synaptic membrane adhesion);GO:1904071(presynaptic active zone assembly);GO:2000807(regulation of synaptic vesicle clustering)","NA","K16499","NA","protocadherin 17 [Source:NCBI gene;Acc:101105669]",{"v":0.248907,"d":"0.25"},{"v":0.2303,"d":"0.23"},{"v":0.126647,"d":"0.13"},{"v":0.426752,"d":"0.43"},{"v":0.576893,"d":"0.58"},{"v":0.471874,"d":"0.47"},{"v":0.410603997644219,"d":"0.41"},{"v":-1.28418042128056,"d":"-1.28"},{"v":0.0115346066415876,"d":"0.01"},{"v":0.19354454231994,"d":"0.19"},"down","yes"]
["MSTRG.21293","MATN2","ENSOART00000004147","GO:0001764(neuron migration);GO:0005509(calcium ion binding);GO:0005604(basement membrane);GO:0007411(axon guidance);GO:0008347(glial cell migration);GO:0031012(extracellular matrix);GO:0031104(dendrite regeneration);GO:0031175(neuron projection development);GO:0048678(response to axon injury)","NA","NA","NA","matrilin 2 [Source:NCBI gene;Acc:101107106]",{"v":1.07187540811586,"d":"1.07"},{"v":0.958738316846564,"d":"0.96"},{"v":1.39708973029102,"d":"1.40"},{"v":2.0271625213827,"d":"2.03"},{"v":2.17618857398552,"d":"2.18"},{"v":2.21333228296215,"d":"2.21"},{"v":0.534186160225555,"d":"0.53"},{"v":-0.904585495987729,"d":"-0.90"},{"v":0.0115453444524511,"d":"0.01"},{"v":0.19354454231994,"d":"0.19"},"down","no"]
["MSTRG.11973","ASRGL1","ENSOART00000016117","GO:0001917(photoreceptor inner segment);GO:0004067(asparaginase activity);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008798(beta-aspartyl-peptidase activity);GO:0016787(hydrolase activity);GO:0033345(asparagine catabolic process via L-aspartate)","NA","K13051","EC:3.4.19.5","asparaginase like 1 [Source:NCBI gene;Acc:100135685]",{"v":6.15993858708778,"d":"6.16"},{"v":4.3033789577334,"d":"4.30"},{"v":4.46098339804923,"d":"4.46"},{"v":8.66497566651184,"d":"8.66"},{"v":9.70270246353925,"d":"9.70"},{"v":9.75972171295866,"d":"9.76"},{"v":0.530596536692652,"d":"0.53"},{"v":-0.914312836042659,"d":"-0.91"},{"v":0.0115924813280478,"d":"0.01"},{"v":0.194135420640374,"d":"0.19"},"down","no"]
["MSTRG.6384","RF00016","ENSOART00000026564","NA","NA","NA","NA",null,{"v":19.126608,"d":"19.13"},{"v":16.087015,"d":"16.09"},{"v":20.593962,"d":"20.59"},{"v":13.711792,"d":"13.71"},{"v":6.779512,"d":"6.78"},{"v":5.21969,"d":"5.22"},{"v":2.1705728296619,"d":"2.17"},{"v":1.11807583043659,"d":"1.12"},{"v":0.0116326851894295,"d":"0.01"},{"v":0.194609102226439,"d":"0.19"},"up","yes"]
["ENSOARG00000013587","GALNS","ENSOART00000014780;ENSOART00000014781","GO:0003824(catalytic activity);GO:0008484(sulfuric ester hydrolase activity);GO:0043890(N-acetylgalactosamine-6-sulfatase activity);GO:0043890(N-acetylgalactosamine-6-sulfatase activity)","00531(Glycosaminoglycan degradation);04142(Lysosome);04142(Lysosome)","K01132","EC:3.1.6.4","galactosamine (N-acetyl)-6-sulfatase [Source:NCBI gene;Acc:101107214]",{"v":0.793705243523316,"d":"0.79"},{"v":0.704208895336788,"d":"0.70"},{"v":0.517198299481865,"d":"0.52"},{"v":1.36919905129534,"d":"1.37"},{"v":1.78519729015544,"d":"1.79"},{"v":1.2043801746114,"d":"1.20"},{"v":0.462311483719397,"d":"0.46"},{"v":-1.11306289562898,"d":"-1.11"},{"v":0.011701488915421,"d":"0.01"},{"v":0.195359827209605,"d":"0.20"},"down","yes"]
["MSTRG.18365","AFAP1L1;GRPEL2","ENSOART00000005579;ENSOART00000005710","GO:0000774(adenyl-nucleotide exchange factor activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006457(protein folding);GO:0042803(protein homodimerization activity);GO:0050790(regulation of catalytic activity);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding)","NA","K03687","NA","actin filament associated protein 1 like 1 [Source:NCBI gene;Acc:101119212];GrpE like 2, mitochondrial [Source:NCBI gene;Acc:101119471]",{"v":3.02352213295464,"d":"3.02"},{"v":1.66772368593068,"d":"1.67"},{"v":2.14425738478637,"d":"2.14"},{"v":4.5618940987075,"d":"4.56"},{"v":4.28408288095826,"d":"4.28"},{"v":3.94912100246975,"d":"3.95"},{"v":0.534228281269546,"d":"0.53"},{"v":-0.904471742711933,"d":"-0.90"},{"v":0.0117676612610426,"d":"0.01"},{"v":0.195863784985019,"d":"0.20"},"down","no"]
["MSTRG.4928","ENSOARG00000002564","ENSOART00000002777","NA","NA","NA","NA",null,{"v":1.19837356021525,"d":"1.20"},{"v":0.781432119131564,"d":"0.78"},{"v":0.225915057339024,"d":"0.23"},{"v":2.43433461773984,"d":"2.43"},{"v":1.78556441844498,"d":"1.79"},{"v":1.3776167071813,"d":"1.38"},{"v":0.394053511917307,"d":"0.39"},{"v":-1.34353653592761,"d":"-1.34"},{"v":0.0118008160906936,"d":"0.01"},{"v":0.196215606037521,"d":"0.20"},"down","yes"]
["MSTRG.15953","AGAP2","ENSOART00000005926;ENSOART00000005923","GO:0003924(GTPase activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0033601(positive regulation of mammary gland epithelial cell proliferation);GO:0043066(negative regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046872(metal ion binding);GO:0060749(mammary gland alveolus development);GO:0060749(mammary gland alveolus development)","04068(FoxO signaling pathway);04144(Endocytosis);04144(Endocytosis)","K17848","NA","ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 [Source:NCBI gene;Acc:101116895]",{"v":0.856143997779892,"d":"0.86"},{"v":0.490916583254044,"d":"0.49"},{"v":0.420399376784015,"d":"0.42"},{"v":1.27294466920393,"d":"1.27"},{"v":1.39527910371075,"d":"1.40"},{"v":1.10677674944497,"d":"1.11"},{"v":0.468201248542652,"d":"0.47"},{"v":-1.09479931322708,"d":"-1.09"},{"v":0.0118567361606364,"d":"0.01"},{"v":0.196603687463459,"d":"0.20"},"down","yes"]
["MSTRG.11525","ENSOARG00000020057","ENSOART00000021837","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11254","NA","uncharacterized LOC101108868 [Source:NCBI gene;Acc:101108868]",{"v":3.72035,"d":"3.72"},{"v":2.651142,"d":"2.65"},{"v":3.808437,"d":"3.81"},{"v":13.011765,"d":"13.01"},{"v":4.063551,"d":"4.06"},{"v":7.720804,"d":"7.72"},{"v":0.410545238529254,"d":"0.41"},{"v":-1.28438689162767,"d":"-1.28"},{"v":0.0118758799564066,"d":"0.01"},{"v":0.196603687463459,"d":"0.20"},"down","yes"]
["ENSOARG00000010601","LRRC4C","ENSOART00000011532","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050770(regulation of axonogenesis);GO:0050804(modulation of chemical synaptic transmission);GO:0050839(cell adhesion molecule binding);GO:0098632(cell-cell adhesion mediator activity);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane);GO:0099560(synaptic membrane adhesion)","04360(Axon guidance);04514(Cell adhesion molecules (CAMs))","K07523","NA","uncharacterized LOC101108158 [Source:NCBI gene;Acc:101108158]",{"v":0.387875,"d":"0.39"},{"v":0.074017,"d":"0.07"},{"v":0.091005,"d":"0.09"},{"v":0.674414,"d":"0.67"},{"v":0.597045,"d":"0.60"},{"v":0.445794,"d":"0.45"},{"v":0.32196595376453,"d":"0.32"},{"v":-1.63501995602569,"d":"-1.64"},{"v":0.0118837647814342,"d":"0.01"},{"v":0.196603687463459,"d":"0.20"},"down","yes"]
["MSTRG.14976","EMILIN1","ENSOART00000020784","GO:0003180(aortic valve morphogenesis);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005615(extracellular space);GO:0007160(cell-matrix adhesion);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016477(cell migration);GO:0016525(negative regulation of angiogenesis);GO:0030023(extracellular matrix constituent conferring elasticity);GO:0030198(extracellular matrix organization);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030948(negative regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031012(extracellular matrix);GO:0032966(negative regulation of collagen biosynthetic process);GO:0034668(integrin alpha4-beta1 complex);GO:0042802(identical protein binding);GO:0048251(elastic fiber assembly);GO:0050866(negative regulation of cell activation);GO:0060394(negative regulation of pathway-restricted SMAD protein phosphorylation);GO:0062023(collagen-containing extracellular matrix);GO:0070207(protein homotrimerization);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0098640(integrin binding involved in cell-matrix adhesion);GO:1901203(positive regulation of extracellular matrix assembly);GO:1904027(negative regulation of collagen fibril organization);GO:1905522(negative regulation of macrophage migration);GO:1990971(EMILIN complex)","NA","NA","NA","elastin microfibril interfacer 1 [Source:NCBI gene;Acc:101113218]",{"v":1.54822286144201,"d":"1.55"},{"v":0.887420252037618,"d":"0.89"},{"v":1.32647403761756,"d":"1.33"},{"v":2.15896252476489,"d":"2.16"},{"v":2.64994159623824,"d":"2.65"},{"v":2.76758468338558,"d":"2.77"},{"v":0.496551535708463,"d":"0.50"},{"v":-1.00998463604089,"d":"-1.01"},{"v":0.0118964014707188,"d":"0.01"},{"v":0.196603687463459,"d":"0.20"},"down","yes"]
["MSTRG.22173","ENSOARG00000013797","ENSOART00000015012;ENSOART00000015016","NA","01524(Platinum drug resistance);04064(NF-kappa B signaling pathway);04120(Ubiquitin mediated proteolysis);04210(Apoptosis);04215(Apoptosis - multiple species);04217(Necroptosis);04510(Focal adhesion);04621(NOD-like receptor signaling pathway);05145(Toxoplasmosis);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05222(Small cell lung cancer);05222(Small cell lung cancer)","K04725","EC:2.3.2.27","X-linked inhibitor of apoptosis [Source:NCBI gene;Acc:101116381]",{"v":3.48620935855683,"d":"3.49"},{"v":2.45086643183269,"d":"2.45"},{"v":2.68153287515964,"d":"2.68"},{"v":1.89648688481801,"d":"1.90"},{"v":1.5122374563378,"d":"1.51"},{"v":1.75901254038953,"d":"1.76"},{"v":1.66777234660057,"d":"1.67"},{"v":0.737922372208668,"d":"0.74"},{"v":0.0119293283550706,"d":"0.01"},{"v":0.196749569072316,"d":"0.20"},"up","no"]
["MSTRG.2938","RF00554","ENSOART00000024072","NA","NA","NA","NA",null,{"v":35.548737,"d":"35.55"},{"v":37.571072,"d":"37.57"},{"v":29.130306,"d":"29.13"},{"v":49.26741,"d":"49.27"},{"v":57.073235,"d":"57.07"},{"v":114.676979,"d":"114.68"},{"v":0.462633310183445,"d":"0.46"},{"v":-1.1120589493059,"d":"-1.11"},{"v":0.0121937189922473,"d":"0.01"},{"v":0.199711127845611,"d":"0.20"},"down","yes"]
["MSTRG.9918","ADAMTSL1","ENSOART00000015405","GO:0006508(proteolysis);GO:0008233(peptidase activity)","NA","NA","NA","ADAMTS like 1 [Source:NCBI gene;Acc:101122835]",{"v":1.169403,"d":"1.17"},{"v":0.561098,"d":"0.56"},{"v":0.645072,"d":"0.65"},{"v":2.033243,"d":"2.03"},{"v":1.359947,"d":"1.36"},{"v":1.495171,"d":"1.50"},{"v":0.485965132280533,"d":"0.49"},{"v":-1.04107528988458,"d":"-1.04"},{"v":0.0121945121547081,"d":"0.01"},{"v":0.199711127845611,"d":"0.20"},"down","yes"]
["MSTRG.4085","ENSOARG00000006702","ENSOART00000007294","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation)","NA","NA","NA","tyrosine-protein phosphatase non-receptor type 11-like [Source:NCBI gene;Acc:101107037]",{"v":0.103773,"d":"0.10"},{"v":0.214908,"d":"0.21"},{"v":0.371013,"d":"0.37"},{"v":0.78256,"d":"0.78"},{"v":0.531042,"d":"0.53"},{"v":0.64824,"d":"0.65"},{"v":0.351554304577025,"d":"0.35"},{"v":-1.50818053534008,"d":"-1.51"},{"v":0.0122114123127998,"d":"0.01"},{"v":0.199787515273943,"d":"0.20"},"down","yes"]
["MSTRG.12278","ENSOARG00000005542","ENSOART00000006038","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006414(translational elongation)","03010(Ribosome)","K02943","NA","ribosomal protein lateral stalk subunit P2 [Source:NCBI gene;Acc:101103196]",{"v":13.5073290622407,"d":"13.51"},{"v":11.5594091253112,"d":"11.56"},{"v":12.1710929228216,"d":"12.17"},{"v":17.1615043717842,"d":"17.16"},{"v":23.8049897825726,"d":"23.80"},{"v":30.8275620049793,"d":"30.83"},{"v":0.518675682952496,"d":"0.52"},{"v":-0.947095361403876,"d":"-0.95"},{"v":0.0123322566602555,"d":"0.01"},{"v":0.201361086748652,"d":"0.20"},"down","no"]
["MSTRG.22373","PCDH19","ENSOART00000002567","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007420(brain development);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K16499","NA","protocadherin 19 [Source:NCBI gene;Acc:101101961]",{"v":0.222095,"d":"0.22"},{"v":0.13977,"d":"0.14"},{"v":0.206006,"d":"0.21"},{"v":0.541416,"d":"0.54"},{"v":0.393941,"d":"0.39"},{"v":0.407627,"d":"0.41"},{"v":0.422842714432934,"d":"0.42"},{"v":-1.24180697363525,"d":"-1.24"},{"v":0.0123976375631103,"d":"0.01"},{"v":0.201999366843693,"d":"0.20"},"down","yes"]
["MSTRG.21078","LYN","ENSOART00000016085","GO:0000166(nucleotide binding);GO:0001782(B cell homeostasis);GO:0001817(regulation of cytokine production);GO:0001933(negative regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0002431(Fc receptor mediated stimulatory signaling pathway);GO:0002513(tolerance induction to self antigen);GO:0002576(platelet degranulation);GO:0002762(negative regulation of myeloid leukocyte differentiation);GO:0002768(immune response-regulating cell surface receptor signaling pathway);GO:0002774(Fc receptor mediated inhibitory signaling pathway);GO:0002902(regulation of B cell apoptotic process);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0009725(response to hormone);GO:0010976(positive regulation of neuron projection development);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0017124(SH3 domain binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030097(hemopoiesis);GO:0030218(erythrocyte differentiation);GO:0030335(positive regulation of cell migration);GO:0030889(negative regulation of B cell proliferation);GO:0031175(neuron projection development);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0033003(regulation of mast cell activation);GO:0033628(regulation of cell adhesion mediated by integrin);GO:0034136(negative regulation of toll-like receptor 2 signaling pathway);GO:0034144(negative regulation of toll-like receptor 4 signaling pathway);GO:0035556(intracellular signal transduction);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043231(intracellular membrane-bounded organelle);GO:0043304(regulation of mast cell degranulation);GO:0043407(negative regulation of MAP kinase activity);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0044325(ion channel binding);GO:0044877(protein-containing complex binding);GO:0045121(membrane raft);GO:0045646(regulation of erythrocyte differentiation);GO:0046777(protein autophosphorylation);GO:0046875(ephrin receptor binding);GO:0048471(perinuclear region of cytoplasm);GO:0050707(regulation of cytokine secretion);GO:0050727(regulation of inflammatory response);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050853(B cell receptor signaling pathway);GO:0050855(regulation of B cell receptor signaling pathway);GO:0050861(positive regulation of B cell receptor signaling pathway);GO:0051272(positive regulation of cellular component movement);GO:0051279(regulation of release of sequestered calcium ion into cytosol);GO:0070304(positive regulation of stress-activated protein kinase signaling cascade);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070667(negative regulation of mast cell proliferation);GO:0070668(positive regulation of mast cell proliferation);GO:0071300(cellular response to retinoic acid);GO:0090025(regulation of monocyte chemotaxis);GO:0090330(regulation of platelet aggregation);GO:0097028(dendritic cell differentiation);GO:0140031(phosphorylation-dependent protein binding);GO:1902532(negative regulation of intracellular signal transduction);GO:1902961(positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:2000670(positive regulation of dendritic cell apoptotic process)","04062(Chemokine signaling pathway);04064(NF-kappa B signaling pathway);04611(Platelet activation);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04730(Long-term depression);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05203(Viral carcinogenesis)","K05854","EC:2.7.10.2","LYN proto-oncogene, Src family tyrosine kinase [Source:NCBI gene;Acc:100302103]",{"v":2.376094,"d":"2.38"},{"v":1.386774,"d":"1.39"},{"v":1.662507,"d":"1.66"},{"v":3.132299,"d":"3.13"},{"v":3.735609,"d":"3.74"},{"v":3.979714,"d":"3.98"},{"v":0.500144179065237,"d":"0.50"},{"v":-0.999584047123982,"d":"-1.00"},{"v":0.012408461841268,"d":"0.01"},{"v":0.201999366843693,"d":"0.20"},"down","no"]
["MSTRG.11149","COL11A2","ENSOART00000009097","GO:0001894(tissue homeostasis);GO:0002062(chondrocyte differentiation);GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0007605(sensory perception of sound);GO:0030199(collagen fibril organization);GO:0048705(skeletal system morphogenesis)","04974(Protein digestion and absorption)","K19721","NA","collagen type XI alpha 2 chain [Source:NCBI gene;Acc:101116356]",{"v":0.177078,"d":"0.18"},{"v":0.303722,"d":"0.30"},{"v":0.101706,"d":"0.10"},{"v":0.579885,"d":"0.58"},{"v":0.484545,"d":"0.48"},{"v":0.373708,"d":"0.37"},{"v":0.40504179710153,"d":"0.41"},{"v":-1.3038573045204,"d":"-1.30"},{"v":0.0124495023408829,"d":"0.01"},{"v":0.202179543191414,"d":"0.20"},"down","yes"]
["MSTRG.733","NUDT17","ENSOART00000022445","GO:0016787(hydrolase activity)","NA","NA","NA","nudix hydrolase 17 [Source:HGNC Symbol;Acc:HGNC:26618]",{"v":1.9184634911147,"d":"1.92"},{"v":1.52046992568659,"d":"1.52"},{"v":1.97933950080775,"d":"1.98"},{"v":4.39992845234249,"d":"4.40"},{"v":2.91941842487884,"d":"2.92"},{"v":3.83596818659128,"d":"3.84"},{"v":0.485712226558773,"d":"0.49"},{"v":-1.04182629192351,"d":"-1.04"},{"v":0.01252167504591,"d":"0.01"},{"v":0.202569381903847,"d":"0.20"},"down","yes"]
["MSTRG.8403","FBLN5","ENSOART00000013553","GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0008022(protein C-terminus binding);GO:0030198(extracellular matrix organization);GO:0034394(protein localization to cell surface);GO:0042803(protein homodimerization activity);GO:0046903(secretion);GO:0048251(elastic fiber assembly);GO:0062023(collagen-containing extracellular matrix);GO:0071953(elastic fiber);GO:2000121(regulation of removal of superoxide radicals)","NA","K17340","NA","fibulin 5 [Source:NCBI gene;Acc:101112927]",{"v":5.24481586763013,"d":"5.24"},{"v":3.64109320769919,"d":"3.64"},{"v":5.20631699629108,"d":"5.21"},{"v":8.11652152615424,"d":"8.12"},{"v":8.65775187990792,"d":"8.66"},{"v":9.70165101087096,"d":"9.70"},{"v":0.532265685975727,"d":"0.53"},{"v":-0.909781533073236,"d":"-0.91"},{"v":0.0125357028209362,"d":"0.01"},{"v":0.202569381903847,"d":"0.20"},"down","no"]
["MSTRG.3831","DISP1","ENSOART00000015438","GO:0007225(patched ligand maturation);GO:0007368(determination of left/right symmetry);GO:0009880(embryonic pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0015833(peptide transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0060539(diaphragm development);GO:1904680(peptide transmembrane transporter activity)","NA","NA","NA","dispatched RND transporter family member 1 [Source:NCBI gene;Acc:101107807]",{"v":1.78478818047193,"d":"1.78"},{"v":1.09090347209113,"d":"1.09"},{"v":1.47925100781123,"d":"1.48"},{"v":2.58900337672905,"d":"2.59"},{"v":2.67469844003255,"d":"2.67"},{"v":2.83879388136697,"d":"2.84"},{"v":0.537481638080986,"d":"0.54"},{"v":-0.895712625956418,"d":"-0.90"},{"v":0.0125536938106757,"d":"0.01"},{"v":0.202569381903847,"d":"0.20"},"down","no"]
["MSTRG.18267","TMEM173","ENSOART00000018792","GO:0002218(activation of innate immune response);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0010468(regulation of gene expression);GO:0031323(regulation of cellular metabolic process);GO:0031625(ubiquitin protein ligase binding);GO:0032481(positive regulation of type I interferon production);GO:0032608(interferon-beta production);GO:0035438(cyclic-di-GMP binding);GO:0035458(cellular response to interferon-beta);GO:0045087(innate immune response);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048471(perinuclear region of cytoplasm);GO:0050727(regulation of inflammatory response);GO:0051607(defense response to virus);GO:0061507(cyclic-GMP-AMP binding);GO:0071407(cellular response to organic cyclic compound)","04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);05163(Human cytomegalovirus infection);05168(Herpes simplex virus 1 infection);05170(Human immunodeficiency virus 1 infection)","K12654","NA","transmembrane protein 173 [Source:NCBI gene;Acc:101116050]",{"v":0.742488,"d":"0.74"},{"v":0.410875,"d":"0.41"},{"v":0.45367,"d":"0.45"},{"v":1.174405,"d":"1.17"},{"v":1.284677,"d":"1.28"},{"v":1.363773,"d":"1.36"},{"v":0.420375086159428,"d":"0.42"},{"v":-1.25025092544293,"d":"-1.25"},{"v":0.0125551331753242,"d":"0.01"},{"v":0.202569381903847,"d":"0.20"},"down","yes"]
["MSTRG.18955","KIT","ENSOART00000000106","GO:0000166(nucleotide binding);GO:0000187(activation of MAPK activity);GO:0001541(ovarian follicle development);GO:0002020(protease binding);GO:0002318(myeloid progenitor cell differentiation);GO:0002320(lymphoid progenitor cell differentiation);GO:0002327(immature B cell differentiation);GO:0002371(dendritic cell cytokine production);GO:0002551(mast cell chemotaxis);GO:0002573(myeloid leukocyte differentiation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005020(stem cell factor receptor activity);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0006687(glycosphingolipid metabolic process);GO:0006954(inflammatory response);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0008584(male gonad development);GO:0009314(response to radiation);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019221(cytokine-mediated signaling pathway);GO:0019955(cytokine binding);GO:0030032(lamellipodium assembly);GO:0030097(hemopoiesis);GO:0030217(T cell differentiation);GO:0030218(erythrocyte differentiation);GO:0030318(melanocyte differentiation);GO:0031532(actin cytoskeleton reorganization);GO:0032762(mast cell cytokine production);GO:0035162(embryonic hemopoiesis);GO:0035234(ectopic germ cell programmed cell death);GO:0035556(intracellular signal transduction);GO:0035701(hematopoietic stem cell migration);GO:0035855(megakaryocyte development);GO:0038093(Fc receptor signaling pathway);GO:0038109(Kit signaling pathway);GO:0038162(erythropoietin-mediated signaling pathway);GO:0042169(SH2 domain binding);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042629(mast cell granule);GO:0042803(protein homodimerization activity);GO:0043069(negative regulation of programmed cell death);GO:0043303(mast cell degranulation);GO:0043406(positive regulation of MAP kinase activity);GO:0043410(positive regulation of MAPK cascade);GO:0043473(pigmentation);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0048066(developmental pigmentation);GO:0048070(regulation of developmental pigmentation);GO:0048565(digestive tract development);GO:0048863(stem cell differentiation);GO:0050910(detection of mechanical stimulus involved in sensory perception of sound);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060326(cell chemotaxis);GO:0060374(mast cell differentiation);GO:0097067(cellular response to thyroid hormone stimulus);GO:0097324(melanocyte migration);GO:0097326(melanocyte adhesion);GO:1905065(positive regulation of vascular smooth muscle cell differentiation)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04072(Phospholipase D signaling pathway);04151(PI3K-Akt signaling pathway);04640(Hematopoietic cell lineage);04916(Melanogenesis);05200(Pathways in cancer);05221(Acute myeloid leukemia);05224(Breast cancer);05230(Central carbon metabolism in cancer)","K05091","EC:2.7.10.1","KIT proto-oncogene receptor tyrosine kinase [Source:NCBI gene;Acc:780504]",{"v":2.50572760161943,"d":"2.51"},{"v":1.40972593582996,"d":"1.41"},{"v":1.90437756963563,"d":"1.90"},{"v":3.82507155364372,"d":"3.83"},{"v":3.41651108684211,"d":"3.42"},{"v":3.65947880222672,"d":"3.66"},{"v":0.533877470342636,"d":"0.53"},{"v":-0.905419426407069,"d":"-0.91"},{"v":0.0126148467441548,"d":"0.01"},{"v":0.202931248904985,"d":"0.20"},"down","no"]
["MSTRG.1474","TP63","ENSOART00000022302;ENSOART00000022303","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0001736(establishment of planar polarity);GO:0001738(morphogenesis of a polarized epithelium);GO:0001942(hair follicle development);GO:0002039(p53 binding);GO:0002064(epithelial cell development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006915(apoptotic process);GO:0007389(pattern specification process);GO:0007499(ectoderm and mesoderm interaction);GO:0007569(cell aging);GO:0008283(cell population proliferation);GO:0008544(epidermis development);GO:0009887(animal organ morphogenesis);GO:0009913(epidermal cell differentiation);GO:0009954(proximal/distal pattern formation);GO:0010259(multicellular organism aging);GO:0010481(epidermal cell division);GO:0010482(regulation of epidermal cell division);GO:0010838(positive regulation of keratinocyte proliferation);GO:0030154(cell differentiation);GO:0030216(keratinocyte differentiation);GO:0030326(embryonic limb morphogenesis);GO:0030850(prostate gland development);GO:0030855(epithelial cell differentiation);GO:0030859(polarized epithelial cell differentiation);GO:0031069(hair follicle morphogenesis);GO:0032502(developmental process);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0035115(embryonic forelimb morphogenesis);GO:0035116(embryonic hindlimb morphogenesis);GO:0036342(post-anal tail morphogenesis);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0042802(identical protein binding);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0043589(skin morphogenesis);GO:0044212(transcription regulatory region DNA binding);GO:0045617(negative regulation of keratinocyte differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048485(sympathetic nervous system development);GO:0048646(anatomical structure formation involved in morphogenesis);GO:0048807(female genitalia morphogenesis);GO:0050699(WW domain binding);GO:0051262(protein tetramerization);GO:0051289(protein homotetramerization);GO:0051402(neuron apoptotic process);GO:0060197(cloacal septation);GO:0060513(prostatic bud formation);GO:0060529(squamous basal epithelial stem cell differentiation involved in prostate gland acinus development);GO:0061436(establishment of skin barrier);GO:0097371(MDM2/MDM4 family protein binding);GO:0098773(skin epidermis development);GO:0140110(transcription regulator activity);GO:1904674(positive regulation of somatic stem cell population maintenance);GO:1904888(cranial skeletal system development);GO:2000271(positive regulation of fibroblast apoptotic process);GO:2000381(negative regulation of mesoderm development);GO:2001235(positive regulation of apoptotic signaling pathway);GO:2001235(positive regulation of apoptotic signaling pathway)","05206(MicroRNAs in cancer);05206(MicroRNAs in cancer)","K10149","NA","tumor protein p63 [Source:NCBI gene;Acc:101108874]",{"v":3.44554816545241,"d":"3.45"},{"v":3.43801255922444,"d":"3.44"},{"v":4.23686262761457,"d":"4.24"},{"v":2.28590416545241,"d":"2.29"},{"v":2.46185797074031,"d":"2.46"},{"v":2.01459276980024,"d":"2.01"},{"v":1.64446017798271,"d":"1.64"},{"v":0.717614072495314,"d":"0.72"},{"v":0.0126627398093534,"d":"0.01"},{"v":0.203231548260336,"d":"0.20"},"up","no"]
["MSTRG.13675","SERPINE1","ENSOART00000016611","GO:0001300(chronological cell aging);GO:0001525(angiogenesis);GO:0002020(protease binding);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010469(regulation of signaling receptor activity);GO:0010757(negative regulation of plasminogen activation);GO:0010951(negative regulation of endopeptidase activity);GO:0014912(negative regulation of smooth muscle cell migration);GO:0030194(positive regulation of blood coagulation);GO:0030336(negative regulation of cell migration);GO:0032757(positive regulation of interleukin-8 production);GO:0033629(negative regulation of cell adhesion mediated by integrin);GO:0035491(positive regulation of leukotriene production involved in inflammatory response);GO:0045766(positive regulation of angiogenesis);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0050729(positive regulation of inflammatory response);GO:0050829(defense response to Gram-negative bacterium);GO:0051918(negative regulation of fibrinolysis);GO:0061044(negative regulation of vascular wound healing);GO:0062023(collagen-containing extracellular matrix);GO:0070062(extracellular exosome);GO:0071222(cellular response to lipopolysaccharide);GO:0090026(positive regulation of monocyte chemotaxis);GO:0090399(replicative senescence);GO:0097187(dentinogenesis);GO:1901331(positive regulation of odontoblast differentiation);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2000098(negative regulation of smooth muscle cell-matrix adhesion);GO:2000352(negative regulation of endothelial cell apoptotic process)","04066(HIF-1 signaling pathway);04115(p53 signaling pathway);04218(Cellular senescence);04371(Apelin signaling pathway);04390(Hippo signaling pathway);04610(Complement and coagulation cascades);04933(AGE-RAGE signaling pathway in diabetic complications);05142(Chagas disease (American trypanosomiasis))","K03982","NA","serpin family E member 1 [Source:NCBI gene;Acc:100381267]",{"v":13.2727566346711,"d":"13.27"},{"v":10.9773979511791,"d":"10.98"},{"v":13.9256444493173,"d":"13.93"},{"v":11.9145078783616,"d":"11.91"},{"v":1.88744631237071,"d":"1.89"},{"v":3.58163714315267,"d":"3.58"},{"v":2.19608240333822,"d":"2.20"},{"v":1.1349321894328,"d":"1.13"},{"v":0.0127090876946166,"d":"0.01"},{"v":0.203644733932974,"d":"0.20"},"up","yes"]
["ENSOARG00000016433","REEP2","ENSOART00000017897","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005881(cytoplasmic microtubule);GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031883(taste receptor binding);GO:0032386(regulation of intracellular transport);GO:0032596(protein transport into membrane raft);GO:0050913(sensory perception of bitter taste);GO:0050916(sensory perception of sweet taste);GO:0071786(endoplasmic reticulum tubular network organization)","NA","K17338","NA","receptor accessory protein 2 [Source:NCBI gene;Acc:101111544]",{"v":1.941599,"d":"1.94"},{"v":0.850871,"d":"0.85"},{"v":0.710863,"d":"0.71"},{"v":2.969765,"d":"2.97"},{"v":3.053874,"d":"3.05"},{"v":2.476082,"d":"2.48"},{"v":0.412170352415097,"d":"0.41"},{"v":-1.27868735993255,"d":"-1.28"},{"v":0.0128178215136397,"d":"0.01"},{"v":0.20498471074898,"d":"0.20"},"down","yes"]
["MSTRG.10137","OSGEPL1","ENSOART00000017777","GO:0002949(tRNA threonylcarbamoyladenosine modification);GO:0004222(metalloendopeptidase activity);GO:0005739(mitochondrion);GO:0006508(proteolysis);GO:0008033(tRNA processing);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups);GO:0046872(metal ion binding);GO:0061711(N(6)-L-threonylcarbamoyladenine synthase activity)","NA","K01409","EC:2.3.1.234","O-sialoglycoprotein endopeptidase like 1 [Source:NCBI gene;Acc:101113042]",{"v":1.80982539470052,"d":"1.81"},{"v":3.87771075499126,"d":"3.88"},{"v":2.38763642202595,"d":"2.39"},{"v":2.07919765709817,"d":"2.08"},{"v":1.23002035467844,"d":"1.23"},{"v":1.20006921795933,"d":"1.20"},{"v":1.79078691604895,"d":"1.79"},{"v":0.840593682690562,"d":"0.84"},{"v":0.0129514150132314,"d":"0.01"},{"v":0.206323534591044,"d":"0.21"},"up","no"]
["MSTRG.8136","ZSCAN2","ENSOART00000014287;ENSOART00000014286","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0046872(metal ion binding)","NA","K09230","NA","zinc finger and SCAN domain containing 2 [Source:NCBI gene;Acc:101108082]",{"v":0.49765181987891,"d":"0.50"},{"v":0.251066947023209,"d":"0.25"},{"v":0.401268908173562,"d":"0.40"},{"v":0.944302409182644,"d":"0.94"},{"v":0.727559505045409,"d":"0.73"},{"v":1.04506790766902,"d":"1.05"},{"v":0.42326734603425,"d":"0.42"},{"v":-1.24035890207701,"d":"-1.24"},{"v":0.0129520837185093,"d":"0.01"},{"v":0.206323534591044,"d":"0.21"},"down","yes"]
["MSTRG.4905","ANGPT4","ENSOART00000020579","GO:0001525(angiogenesis);GO:0005615(extracellular space);GO:0007171(activation of transmembrane receptor protein tyrosine kinase activity);GO:0007219(Notch signaling pathway);GO:0010595(positive regulation of endothelial cell migration);GO:0016525(negative regulation of angiogenesis);GO:0030297(transmembrane receptor protein tyrosine kinase activator activity);GO:0030971(receptor tyrosine kinase binding);GO:0043066(negative regulation of apoptotic process);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0045766(positive regulation of angiogenesis);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0071456(cellular response to hypoxia)","NA","NA","NA","angiopoietin 4 [Source:HGNC Symbol;Acc:HGNC:487]",{"v":1.544335,"d":"1.54"},{"v":1.048071,"d":"1.05"},{"v":1.417834,"d":"1.42"},{"v":2.575871,"d":"2.58"},{"v":2.345718,"d":"2.35"},{"v":2.794046,"d":"2.79"},{"v":0.519755016923429,"d":"0.52"},{"v":-0.94409631615558,"d":"-0.94"},{"v":0.0130700757984775,"d":"0.01"},{"v":0.207862154013556,"d":"0.21"},"down","no"]
["MSTRG.1516","C3orf70","ENSOART00000002428","NA","NA","NA","NA","chromosome 3 open reading frame 70 [Source:HGNC Symbol;Acc:HGNC:33731]",{"v":1.762814,"d":"1.76"},{"v":0.975416,"d":"0.98"},{"v":1.525439,"d":"1.53"},{"v":3.30913,"d":"3.31"},{"v":3.141065,"d":"3.14"},{"v":3.428517,"d":"3.43"},{"v":0.431601710830319,"d":"0.43"},{"v":-1.21222751133686,"d":"-1.21"},{"v":0.0130741322986233,"d":"0.01"},{"v":0.207862154013556,"d":"0.21"},"down","yes"]
["MSTRG.12178","ENSOARG00000015675","ENSOART00000017054","NA","NA","NA","NA",null,{"v":8.75161,"d":"8.75"},{"v":7.412959,"d":"7.41"},{"v":6.658585,"d":"6.66"},{"v":13.039387,"d":"13.04"},{"v":13.889709,"d":"13.89"},{"v":21.724283,"d":"21.72"},{"v":0.469096997353462,"d":"0.47"},{"v":-1.09204182858157,"d":"-1.09"},{"v":0.0131957650113024,"d":"0.01"},{"v":0.208880648856021,"d":"0.21"},"down","yes"]
["MSTRG.2465","ENSOARG00000005325","ENSOART00000005804","NA","NA","NA","NA","protein-lysine methyltransferase METTL21E [Source:NCBI gene;Acc:101114712]",{"v":2.07420569488947,"d":"2.07"},{"v":3.55596203072399,"d":"3.56"},{"v":3.15628596978301,"d":"3.16"},{"v":2.43163055708781,"d":"2.43"},{"v":1.40876020036504,"d":"1.41"},{"v":1.18348114576151,"d":"1.18"},{"v":1.74894063078614,"d":"1.75"},{"v":0.806481316632828,"d":"0.81"},{"v":0.0132437900467465,"d":"0.01"},{"v":0.209336499402979,"d":"0.21"},"up","no"]
["MSTRG.21779","ENSOARG00000009190","ENSOART00000010008","NA","NA","NA","NA","melanoma-associated antigen D4 [Source:NCBI gene;Acc:101122329]",{"v":4.32638481066248,"d":"4.33"},{"v":2.61726377734222,"d":"2.62"},{"v":3.1004098251666,"d":"3.10"},{"v":5.64893232144257,"d":"5.65"},{"v":6.26138940885927,"d":"6.26"},{"v":6.63252387377499,"d":"6.63"},{"v":0.541667585851171,"d":"0.54"},{"v":-0.884520334392123,"d":"-0.88"},{"v":0.0133287372363684,"d":"0.01"},{"v":0.210069132814115,"d":"0.21"},"down","no"]
["MSTRG.5464","HSF4","ENSOART00000002970","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001654(eye development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007601(visual perception);GO:0008284(positive regulation of cell population proliferation);GO:0016607(nuclear speck);GO:0033169(histone H3-K9 demethylation);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045597(positive regulation of cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048468(cell development);GO:0070207(protein homotrimerization)","NA","K09417","NA","heat shock transcription factor 4 [Source:NCBI gene;Acc:101110783]",{"v":2.259706,"d":"2.26"},{"v":2.539277,"d":"2.54"},{"v":2.456925,"d":"2.46"},{"v":1.572083,"d":"1.57"},{"v":1.526624,"d":"1.53"},{"v":0.814439,"d":"0.81"},{"v":1.8542390189377,"d":"1.85"},{"v":0.890827225198644,"d":"0.89"},{"v":0.0133767007988131,"d":"0.01"},{"v":0.21062176532596,"d":"0.21"},"up","no"]
["MSTRG.11466","ENSOARG00000009266","ENSOART00000010084","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11254","NA","histone H4 [Source:NCBI gene;Acc:101123670]",{"v":1.799406,"d":"1.80"},{"v":0.651418,"d":"0.65"},{"v":1.740595,"d":"1.74"},{"v":3.401624,"d":"3.40"},{"v":2.253403,"d":"2.25"},{"v":6.058206,"d":"6.06"},{"v":0.357836218232831,"d":"0.36"},{"v":-1.48262867837378,"d":"-1.48"},{"v":0.0133944325683532,"d":"0.01"},{"v":0.210697779360377,"d":"0.21"},"down","yes"]
["ENSOARG00000003547","MYBL2","ENSOART00000003854","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0031523(Myb complex);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0090307(mitotic spindle assembly);GO:1990830(cellular response to leukemia inhibitory factor)","04218(Cellular senescence)","K21769","NA","MYB proto-oncogene like 2 [Source:NCBI gene;Acc:101105095]",{"v":0.265192,"d":"0.27"},{"v":0.123574,"d":"0.12"},{"v":0.247296,"d":"0.25"},{"v":0.527287,"d":"0.53"},{"v":0.395102,"d":"0.40"},{"v":0.463352,"d":"0.46"},{"v":0.459004965574375,"d":"0.46"},{"v":-1.12341833390454,"d":"-1.12"},{"v":0.0134322956701927,"d":"0.01"},{"v":0.211090013188553,"d":"0.21"},"down","yes"]
["MSTRG.1038","FAM78B","ENSOART00000012641;ENSOART00000012642","NA","NA","NA","NA","family with sequence similarity 78 member B [Source:NCBI gene;Acc:101113028]",{"v":0.336522973079448,"d":"0.34"},{"v":0.290358986868024,"d":"0.29"},{"v":0.311653105055811,"d":"0.31"},{"v":1.19523619107026,"d":"1.20"},{"v":0.317113538411031,"d":"0.32"},{"v":1.07495445305318,"d":"1.07"},{"v":0.36274631770738,"d":"0.36"},{"v":-1.46296712553611,"d":"-1.46"},{"v":0.0135545225722928,"d":"0.01"},{"v":0.212601579789046,"d":"0.21"},"down","yes"]
["MSTRG.187","FOXO6","ENSOART00000022166","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007613(memory);GO:0043565(sequence-specific DNA binding);GO:0060999(positive regulation of dendritic spine development)","NA","NA","NA","forkhead box O6 [Source:HGNC Symbol;Acc:HGNC:24814]",{"v":2.208981,"d":"2.21"},{"v":2.536848,"d":"2.54"},{"v":3.578847,"d":"3.58"},{"v":4.997954,"d":"5.00"},{"v":5.800329,"d":"5.80"},{"v":5.879899,"d":"5.88"},{"v":0.499135697164115,"d":"0.50"},{"v":-1.00249600875982,"d":"-1.00"},{"v":0.013665496830219,"d":"0.01"},{"v":0.213726276095609,"d":"0.21"},"down","yes"]
["MSTRG.17659","NOTCH3","ENSOART00000004330","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0015629(actin cytoskeleton);GO:0016021(integral component of membrane);GO:0030154(cell differentiation);GO:0038023(signaling receptor activity);GO:0042802(identical protein binding);GO:0043235(receptor complex);GO:0046872(metal ion binding);GO:0050793(regulation of developmental process)","01522(Endocrine resistance);04330(Notch signaling pathway);04371(Apelin signaling pathway);04658(Th1 and Th2 cell differentiation);04919(Thyroid hormone signaling pathway);05165(Human papillomavirus infection);05200(Pathways in cancer);05206(MicroRNAs in cancer);05224(Breast cancer)","K20995","NA","notch receptor 3 [Source:NCBI gene;Acc:101123554]",{"v":8.7966216261086,"d":"8.80"},{"v":4.34867004216586,"d":"4.35"},{"v":5.84029976225299,"d":"5.84"},{"v":12.1687726499144,"d":"12.17"},{"v":12.365287510347,"d":"12.37"},{"v":11.6384074401743,"d":"11.64"},{"v":0.524863043357837,"d":"0.52"},{"v":-0.929987076766021,"d":"-0.93"},{"v":0.0137010931457875,"d":"0.01"},{"v":0.21407794151619,"d":"0.21"},"down","no"]
["ENSOARG00000006069","ENSOARG00000006069","ENSOART00000006611","GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0048666(neuron development)","NA","NA","NA","teneurin transmembrane protein 4 [Source:NCBI gene;Acc:101108614]",{"v":0.213441,"d":"0.21"},{"v":0.197349,"d":"0.20"},{"v":0.353827,"d":"0.35"},{"v":0.500603,"d":"0.50"},{"v":0.58153,"d":"0.58"},{"v":0.543967,"d":"0.54"},{"v":0.470215238915196,"d":"0.47"},{"v":-1.08860679972644,"d":"-1.09"},{"v":0.0137422234991014,"d":"0.01"},{"v":0.21447269824542,"d":"0.21"},"down","yes"]
["MSTRG.12180","UNC93B1","ENSOART00000015399","GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034154(toll-like receptor 7 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway)","NA","NA","NA","unc-93 homolog B1, TLR signaling regulator [Source:NCBI gene;Acc:101112435]",{"v":0.648098,"d":"0.65"},{"v":0.31149,"d":"0.31"},{"v":0.508023,"d":"0.51"},{"v":0.997799,"d":"1.00"},{"v":1.056692,"d":"1.06"},{"v":1.304448,"d":"1.30"},{"v":0.436926958185308,"d":"0.44"},{"v":-1.19453597276189,"d":"-1.19"},{"v":0.013789417692608,"d":"0.01"},{"v":0.214636427154341,"d":"0.21"},"down","yes"]
["MSTRG.16304","MGP","ENSOART00000022577","GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0030500(regulation of bone mineralization);GO:0031012(extracellular matrix);GO:0062023(collagen-containing extracellular matrix)","NA","K19481","NA","matrix Gla protein [Source:NCBI gene;Acc:101106925]",{"v":23.7355317475062,"d":"23.74"},{"v":16.4422712331671,"d":"16.44"},{"v":26.0010217811721,"d":"26.00"},{"v":45.7455938048628,"d":"45.75"},{"v":33.9010450941397,"d":"33.90"},{"v":45.8152407899003,"d":"45.82"},{"v":0.527481534040008,"d":"0.53"},{"v":-0.922807505740936,"d":"-0.92"},{"v":0.0138272814130474,"d":"0.01"},{"v":0.215020810392607,"d":"0.22"},"down","no"]
["MSTRG.18394","MYOZ3","ENSOART00000008250","NA","NA","NA","NA","myozenin 3 [Source:NCBI gene;Acc:100528014]",{"v":34.9805095393105,"d":"34.98"},{"v":37.7263003287121,"d":"37.73"},{"v":28.522492754834,"d":"28.52"},{"v":23.0796525169646,"d":"23.08"},{"v":20.3160581770339,"d":"20.32"},{"v":19.67458050529,"d":"19.67"},{"v":1.60502354909055,"d":"1.61"},{"v":0.68259446489083,"d":"0.68"},{"v":0.0140213084385312,"d":"0.01"},{"v":0.216846521206063,"d":"0.22"},"up","no"]
["ENSOARG00000003351","IFT52","ENSOART00000003640","GO:0001841(neural tube formation);GO:0001947(heart looping);GO:0005813(centrosome);GO:0005814(centriole);GO:0005929(cilium);GO:0007224(smoothened signaling pathway);GO:0007368(determination of left/right symmetry);GO:0009953(dorsal/ventral pattern formation);GO:0030992(intraciliary transport particle B);GO:0032391(photoreceptor connecting cilium);GO:0035720(intraciliary anterograde transport);GO:0042733(embryonic digit morphogenesis);GO:0044292(dendrite terminus);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060271(cilium assembly);GO:0070613(regulation of protein processing);GO:0097542(ciliary tip);GO:0097546(ciliary base);GO:1905515(non-motile cilium assembly)","NA","K19681","NA","intraflagellar transport 52 [Source:NCBI gene;Acc:101107376]",{"v":0.361859,"d":"0.36"},{"v":0.3794,"d":"0.38"},{"v":0.364199,"d":"0.36"},{"v":1.024974,"d":"1.02"},{"v":0.770876,"d":"0.77"},{"v":0.839222,"d":"0.84"},{"v":0.419517189663129,"d":"0.42"},{"v":-1.25319816876656,"d":"-1.25"},{"v":0.0140243707982363,"d":"0.01"},{"v":0.216846521206063,"d":"0.22"},"down","yes"]
["MSTRG.15261","TTC7A","ENSOART00000005915","GO:0005515(protein binding);GO:0005623(cell);GO:0006879(cellular iron ion homeostasis);GO:0030097(hemopoiesis);GO:0072659(protein localization to plasma membrane)","NA","K21843","NA","tetratricopeptide repeat domain 7A [Source:NCBI gene;Acc:101108206]",{"v":1.333266,"d":"1.33"},{"v":0.891985,"d":"0.89"},{"v":2.333701,"d":"2.33"},{"v":3.266627,"d":"3.27"},{"v":3.176309,"d":"3.18"},{"v":3.245438,"d":"3.25"},{"v":0.470559043240899,"d":"0.47"},{"v":-1.0875523388909,"d":"-1.09"},{"v":0.0140551968082611,"d":"0.01"},{"v":0.217117552966213,"d":"0.22"},"down","yes"]
["MSTRG.7186","ANKRD33B","ENSOART00000015194","GO:0005515(protein binding)","NA","NA","NA","ankyrin repeat domain 33B [Source:NCBI gene;Acc:101105441]",{"v":3.89497498877427,"d":"3.89"},{"v":4.68055121692961,"d":"4.68"},{"v":5.33159785770631,"d":"5.33"},{"v":2.77715828671117,"d":"2.78"},{"v":3.17336904975728,"d":"3.17"},{"v":2.4920550318568,"d":"2.49"},{"v":1.64725950623671,"d":"1.65"},{"v":0.720067852495356,"d":"0.72"},{"v":0.0140802538046661,"d":"0.01"},{"v":0.21729903981341,"d":"0.22"},"up","no"]
["MSTRG.10662","ERBB4","ENSOART00000020943;ENSOART00000020942","GO:0000166(nucleotide binding);GO:0001755(neural crest cell migration);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005154(epidermal growth factor receptor binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007399(nervous system development);GO:0007416(synapse assembly);GO:0007507(heart development);GO:0007595(lactation);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0009880(embryonic pattern specification);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016323(basolateral plasma membrane);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021551(central nervous system morphogenesis);GO:0021889(olfactory bulb interneuron differentiation);GO:0030334(regulation of cell migration);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042803(protein homodimerization activity);GO:0043235(receptor complex);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0044212(transcription regulatory region DNA binding);GO:0045165(cell fate commitment);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046777(protein autophosphorylation);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060644(mammary gland epithelial cell differentiation);GO:0060749(mammary gland alveolus development);GO:0061026(cardiac muscle tissue regeneration);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0098978(glutamatergic synapse);GO:0098982(GABA-ergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0099061(integral component of postsynaptic density membrane);GO:2000010(positive regulation of protein localization to cell surface);GO:2001223(negative regulation of neuron migration);GO:2001223(negative regulation of neuron migration)","04010(MAPK signaling pathway);04012(ErbB signaling pathway);04020(Calcium signaling pathway);04151(PI3K-Akt signaling pathway);05205(Proteoglycans in cancer);05205(Proteoglycans in cancer)","K05085","EC:2.7.10.1","erb-b2 receptor tyrosine kinase 4 [Source:NCBI gene;Acc:101103044]",{"v":1.24904407388152,"d":"1.25"},{"v":2.13950228718019,"d":"2.14"},{"v":2.57971343494322,"d":"2.58"},{"v":1.50153743986865,"d":"1.50"},{"v":0.944995287180189,"d":"0.94"},{"v":0.984326675331783,"d":"0.98"},{"v":1.73958157302035,"d":"1.74"},{"v":0.798740331865317,"d":"0.80"},{"v":0.0141056041092729,"d":"0.01"},{"v":0.217419446399585,"d":"0.22"},"up","no"]
["MSTRG.18691","DKK2","ENSOART00000009761","GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0007275(multicellular organism development);GO:0030178(negative regulation of Wnt signaling pathway);GO:0039706(co-receptor binding);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04310(Wnt signaling pathway)","K02165","NA","dickkopf WNT signaling pathway inhibitor 2 [Source:NCBI gene;Acc:101123633]",{"v":2.51901817487345,"d":"2.52"},{"v":3.58032447676024,"d":"3.58"},{"v":1.70682751541647,"d":"1.71"},{"v":1.76332105200184,"d":"1.76"},{"v":1.27680462034054,"d":"1.28"},{"v":1.39430553382421,"d":"1.39"},{"v":1.76035432823826,"d":"1.76"},{"v":0.815865847125194,"d":"0.82"},{"v":0.0141146872356418,"d":"0.01"},{"v":0.217419446399585,"d":"0.22"},"up","no"]
["MSTRG.6100","ENSOARG00000003426;ENSOARG00000023149","ENSOART00000003723;ENSOART00000025051","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,{"v":2.59317748775216,"d":"2.59"},{"v":1.51460970489914,"d":"1.51"},{"v":2.35445157853026,"d":"2.35"},{"v":3.77458287507205,"d":"3.77"},{"v":4.81871916383285,"d":"4.82"},{"v":3.54192458501441,"d":"3.54"},{"v":0.532519002030343,"d":"0.53"},{"v":-0.909095088523866,"d":"-0.91"},{"v":0.0142164540148203,"d":"0.01"},{"v":0.218780641992446,"d":"0.22"},"down","no"]
["MSTRG.21671","ENSOARG00000018674","ENSOART00000020327","NA","NA","K16271","EC:2.3.2.27","E3 ubiquitin-protein ligase RLIM-like [Source:NCBI gene;Acc:101115436]",{"v":5.852401,"d":"5.85"},{"v":4.86864,"d":"4.87"},{"v":4.881175,"d":"4.88"},{"v":3.560119,"d":"3.56"},{"v":3.819101,"d":"3.82"},{"v":1.778879,"d":"1.78"},{"v":1.70365225359542,"d":"1.70"},{"v":0.768630885321899,"d":"0.77"},{"v":0.0142893116378813,"d":"0.01"},{"v":0.21948812833803,"d":"0.22"},"up","no"]
["MSTRG.15681","HOXC10","ENSOART00000017783","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001501(skeletal system development);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0016604(nuclear body);GO:0021520(spinal cord motor neuron cell fate specification);GO:0030326(embryonic limb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050905(neuromuscular process);GO:0120163(negative regulation of cold-induced thermogenesis)","NA","K17444","NA","homeobox C10 [Source:NCBI gene;Acc:101122425]",{"v":9.267542,"d":"9.27"},{"v":4.825527,"d":"4.83"},{"v":8.294423,"d":"8.29"},{"v":9.690609,"d":"9.69"},{"v":17.420132,"d":"17.42"},{"v":17.376049,"d":"17.38"},{"v":0.503239096369956,"d":"0.50"},{"v":-0.990684086128045,"d":"-0.99"},{"v":0.0143619342180379,"d":"0.01"},{"v":0.219956796047075,"d":"0.22"},"down","no"]
["MSTRG.3960","ENSOARG00000018605","ENSOART00000020252","NA","NA","NA","NA",null,{"v":1.01537143489311,"d":"1.02"},{"v":1.01093095634624,"d":"1.01"},{"v":0.753859497383764,"d":"0.75"},{"v":1.84019593242637,"d":"1.84"},{"v":1.88363179907311,"d":"1.88"},{"v":1.49029508641052,"d":"1.49"},{"v":0.533198389396109,"d":"0.53"},{"v":-0.907255672325734,"d":"-0.91"},{"v":0.0144513028282406,"d":"0.01"},{"v":0.220524179980853,"d":"0.22"},"down","no"]
["MSTRG.16863","ENSOARG00000025170","ENSOART00000027072","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport)","NA","NA","NA",null,{"v":0.372328,"d":"0.37"},{"v":0.385514,"d":"0.39"},{"v":0.287772,"d":"0.29"},{"v":0.154748,"d":"0.15"},{"v":0.138845,"d":"0.14"},{"v":0.180704,"d":"0.18"},{"v":2.20455537353177,"d":"2.20"},{"v":1.14048771470208,"d":"1.14"},{"v":0.0145265918996105,"d":"0.01"},{"v":0.221053301525481,"d":"0.22"},"up","yes"]
["MSTRG.11528","HIST1H1D","ENSOART00000021842","GO:0000786(nucleosome);GO:0000790(nuclear chromatin);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005719(nuclear euchromatin);GO:0006334(nucleosome assembly);GO:0031490(chromatin DNA binding)","NA","K11275","NA","histone H1.3 [Source:NCBI gene;Acc:101109397]",{"v":9.653237,"d":"9.65"},{"v":9.031016,"d":"9.03"},{"v":6.086888,"d":"6.09"},{"v":14.794503,"d":"14.79"},{"v":13.63055,"d":"13.63"},{"v":20.121811,"d":"20.12"},{"v":0.510252134926779,"d":"0.51"},{"v":-0.970717781290645,"d":"-0.97"},{"v":0.0145695865780334,"d":"0.01"},{"v":0.221295078740585,"d":"0.22"},"down","no"]
["MSTRG.21056","MCM4","ENSOART00000013914","GO:0000166(nucleotide binding);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003697(single-stranded DNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006260(DNA replication);GO:0006268(DNA unwinding involved in DNA replication);GO:0006270(DNA replication initiation);GO:0016787(hydrolase activity);GO:0042555(MCM complex)","03030(DNA replication);04110(Cell cycle)","K02212","EC:3.6.4.12","minichromosome maintenance complex component 4 [Source:NCBI gene;Acc:101105420]",{"v":1.29182153544128,"d":"1.29"},{"v":0.842703116400278,"d":"0.84"},{"v":0.800427608756081,"d":"0.80"},{"v":2.5248434628214,"d":"2.52"},{"v":1.49989494683808,"d":"1.50"},{"v":1.90906065218902,"d":"1.91"},{"v":0.494616051202,"d":"0.49"},{"v":-1.01561903628814,"d":"-1.02"},{"v":0.0146016877947944,"d":"0.01"},{"v":0.221461832321437,"d":"0.22"},"down","yes"]
["MSTRG.9052","TLR9","ENSOART00000006702","GO:0001816(cytokine production);GO:0001932(regulation of protein phosphorylation);GO:0002218(activation of innate immune response);GO:0002237(response to molecule of bacterial origin);GO:0002730(regulation of dendritic cell cytokine production);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0009615(response to virus);GO:0016021(integral component of membrane);GO:0030277(maintenance of gastrointestinal epithelium);GO:0032009(early phagosome);GO:0032640(tumor necrosis factor production);GO:0032715(negative regulation of interleukin-6 production);GO:0032728(positive regulation of interferon-beta production);GO:0032733(positive regulation of interleukin-10 production);GO:0032735(positive regulation of interleukin-12 production);GO:0032741(positive regulation of interleukin-18 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034165(positive regulation of toll-like receptor 9 signaling pathway);GO:0036019(endolysosome);GO:0045087(innate immune response);GO:0045335(phagocytic vesicle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050707(regulation of cytokine secretion);GO:0050727(regulation of inflammatory response);GO:0050729(positive regulation of inflammatory response);GO:0050864(regulation of B cell activation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051607(defense response to virus);GO:0051770(positive regulation of nitric-oxide synthase biosynthetic process);GO:1902350(cellular response to chloroquine)","04620(Toll-like receptor signaling pathway);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis);05144(Malaria);05152(Tuberculosis);05162(Measles);05168(Herpes simplex virus 1 infection)","K10161","NA","toll like receptor 9 [Source:NCBI gene;Acc:494547]",{"v":0.565948,"d":"0.57"},{"v":0.248649,"d":"0.25"},{"v":0.773373,"d":"0.77"},{"v":0.126036,"d":"0.13"},{"v":0.272257,"d":"0.27"},{"v":0.244298,"d":"0.24"},{"v":2.47119863178912,"d":"2.47"},{"v":1.30521097731176,"d":"1.31"},{"v":0.0146120193190412,"d":"0.01"},{"v":0.221461832321437,"d":"0.22"},"up","yes"]
["ENSOARG00000015286","SEMA3A","ENSOART00000016636","GO:0001764(neuron migration);GO:0002027(regulation of heart rate);GO:0005515(protein binding);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0008045(motor neuron axon guidance);GO:0010633(negative regulation of epithelial cell migration);GO:0010977(negative regulation of neuron projection development);GO:0021612(facial nerve structural organization);GO:0021637(trigeminal nerve structural organization);GO:0021675(nerve development);GO:0021772(olfactory bulb development);GO:0021785(branchiomotor neuron axon guidance);GO:0021828(gonadotrophin-releasing hormone neuronal migration to the hypothalamus);GO:0030215(semaphorin receptor binding);GO:0030517(negative regulation of axon extension);GO:0036486(ventral trunk neural crest cell migration);GO:0038191(neuropilin binding);GO:0045499(chemorepellent activity);GO:0048813(dendrite morphogenesis);GO:0048841(regulation of axon extension involved in axon guidance);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0048846(axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0060385(axonogenesis involved in innervation);GO:0060666(dichotomous subdivision of terminal units involved in salivary gland branching);GO:0061549(sympathetic ganglion development);GO:0061551(trigeminal ganglion development);GO:0071526(semaphorin-plexin signaling pathway);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:0150020(basal dendrite arborization);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance);GO:1903045(neural crest cell migration involved in sympathetic nervous system development);GO:1903375(facioacoustic ganglion development);GO:2000020(positive regulation of male gonad development);GO:2001224(positive regulation of neuron migration)","04360(Axon guidance)","K06840","NA","semaphorin 3A [Source:NCBI gene;Acc:101113580]",{"v":0.245732,"d":"0.25"},{"v":0.23798,"d":"0.24"},{"v":0.13316,"d":"0.13"},{"v":0.490279,"d":"0.49"},{"v":0.54133,"d":"0.54"},{"v":0.431369,"d":"0.43"},{"v":0.42165500779916,"d":"0.42"},{"v":-1.24586500613249,"d":"-1.25"},{"v":0.0146272961590266,"d":"0.01"},{"v":0.221461832321437,"d":"0.22"},"down","yes"]
["MSTRG.11456","ENSOARG00000018368","ENSOART00000019990","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11252","NA","histone H2B type 1 [Source:NCBI gene;Acc:101119426]",{"v":10.310066,"d":"10.31"},{"v":3.251242,"d":"3.25"},{"v":11.414955,"d":"11.41"},{"v":32.933403,"d":"32.93"},{"v":6.386118,"d":"6.39"},{"v":30.513418,"d":"30.51"},{"v":0.357657337034032,"d":"0.36"},{"v":-1.48335005740478,"d":"-1.48"},{"v":0.0146815202904842,"d":"0.01"},{"v":0.22180438563793,"d":"0.22"},"down","yes"]
["MSTRG.14968","SLC35F6","ENSOART00000020681","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport);GO:1901029(negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway)","NA","NA","NA","solute carrier family 35 member F6 [Source:NCBI gene;Acc:101111438]",{"v":0.445525,"d":"0.45"},{"v":0.308577,"d":"0.31"},{"v":0.349955,"d":"0.35"},{"v":0.65869,"d":"0.66"},{"v":0.80274,"d":"0.80"},{"v":1.26008,"d":"1.26"},{"v":0.405678097820695,"d":"0.41"},{"v":-1.30159267999028,"d":"-1.30"},{"v":0.0146955958526762,"d":"0.01"},{"v":0.22180438563793,"d":"0.22"},"down","yes"]
["MSTRG.11340","ENSOARG00000014759;ENSOARG00000014902","ENSOART00000016063;ENSOART00000016218","GO:0004364(glutathione transferase activity);GO:0005515(protein binding);GO:0005515(protein binding)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);00983(Drug metabolism - other enzymes);01524(Platinum drug resistance);05200(Pathways in cancer);05204(Chemical carcinogenesis);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis);05418(Fluid shear stress and atherosclerosis)","K00799","EC:2.5.1.18","microsomal glutathione-S-transferase 1-1 [Source:NCBI gene;Acc:443054];glutathione S-transferase A1-like [Source:NCBI gene;Acc:101106720]",{"v":9.57568304517454,"d":"9.58"},{"v":10.726094986653,"d":"10.73"},{"v":7.56131785728953,"d":"7.56"},{"v":5.21440429825462,"d":"5.21"},{"v":6.04964077772074,"d":"6.05"},{"v":5.42722151026694,"d":"5.43"},{"v":1.66932184236295,"d":"1.67"},{"v":0.739262130625023,"d":"0.74"},{"v":0.014698208308442,"d":"0.01"},{"v":0.22180438563793,"d":"0.22"},"up","no"]
["MSTRG.133","LSM10","ENSOART00000010444","GO:0005634(nucleus);GO:0005683(U7 snRNP);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0071208(histone pre-mRNA DCP binding);GO:0071209(U7 snRNA binding);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle)","NA","NA","NA","LSM10, U7 small nuclear RNA associated [Source:NCBI gene;Acc:101113285]",{"v":3.27235776363636,"d":"3.27"},{"v":2.68432229090909,"d":"2.68"},{"v":3.25171192727273,"d":"3.25"},{"v":4.51239831948052,"d":"4.51"},{"v":6.15726262857143,"d":"6.16"},{"v":7.51289383636364,"d":"7.51"},{"v":0.506441041481738,"d":"0.51"},{"v":-0.981533770802516,"d":"-0.98"},{"v":0.0148785790937085,"d":"0.01"},{"v":0.223905474140159,"d":"0.22"},"down","no"]
["MSTRG.15841","PRICKLE1","ENSOART00000021494","GO:0001843(neural tube closure);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006606(protein import into nucleus);GO:0008270(zinc ion binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031965(nuclear membrane);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0035904(aorta development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0060976(coronary vasculature development);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2000691(negative regulation of cardiac muscle cell myoblast differentiation)","04310(Wnt signaling pathway)","K04511","NA","prickle planar cell polarity protein 1 [Source:NCBI gene;Acc:101115695]",{"v":1.541663,"d":"1.54"},{"v":0.900364,"d":"0.90"},{"v":0.947688,"d":"0.95"},{"v":2.639933,"d":"2.64"},{"v":1.897669,"d":"1.90"},{"v":2.162722,"d":"2.16"},{"v":0.505903147370187,"d":"0.51"},{"v":-0.983066880290042,"d":"-0.98"},{"v":0.0148939247565656,"d":"0.01"},{"v":0.223930021570169,"d":"0.22"},"down","no"]
["MSTRG.6466","RF01291","ENSOART00000024292","NA","NA","NA","NA","small nucleolar RNA, C/D box 97 [Source:HGNC Symbol;Acc:HGNC:32760]",{"v":100.412025,"d":"100.41"},{"v":111.626244,"d":"111.63"},{"v":73.022789,"d":"73.02"},{"v":148.829605,"d":"148.83"},{"v":125.613396,"d":"125.61"},{"v":337.033142,"d":"337.03"},{"v":0.466185085490735,"d":"0.47"},{"v":-1.10102524535998,"d":"-1.10"},{"v":0.0149215250912335,"d":"0.01"},{"v":0.223932593464762,"d":"0.22"},"down","yes"]
["MSTRG.6075","ENSOARG00000002753","ENSOART00000002980","GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0015935(small ribosomal subunit);GO:0019843(rRNA binding)","03010(Ribosome)","K02997","NA","ribosomal protein S9 [Source:NCBI gene;Acc:101102330]",{"v":94.7119593059126,"d":"94.71"},{"v":98.2289407326478,"d":"98.23"},{"v":86.9330865784062,"d":"86.93"},{"v":134.919953681234,"d":"134.92"},{"v":172.579678167095,"d":"172.58"},{"v":211.309446691517,"d":"211.31"},{"v":0.539454682259326,"d":"0.54"},{"v":-0.890426325954086,"d":"-0.89"},{"v":0.0150906664424175,"d":"0.02"},{"v":0.225848214181296,"d":"0.23"},"down","no"]
["MSTRG.21040","WDYHV1","ENSOART00000010993","GO:0005634(nucleus);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0008418(protein-N-terminal asparagine amidohydrolase activity);GO:0016811(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides);GO:0070773(protein-N-terminal glutamine amidohydrolase activity)","NA","K21286","EC:3.5.1.122","WDYHV motif containing 1 [Source:NCBI gene;Acc:101103653]",{"v":0.696442401934444,"d":"0.70"},{"v":0.777623889306824,"d":"0.78"},{"v":1.01555986673831,"d":"1.02"},{"v":2.03565835249866,"d":"2.04"},{"v":1.45509407522837,"d":"1.46"},{"v":1.4580388747985,"d":"1.46"},{"v":0.503077621541454,"d":"0.50"},{"v":-0.991147079402749,"d":"-0.99"},{"v":0.0151857850648408,"d":"0.02"},{"v":0.226855899852443,"d":"0.23"},"down","no"]
["MSTRG.11524","ENSOARG00000000710","ENSOART00000000761","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":1.647339,"d":"1.65"},{"v":0.539769,"d":"0.54"},{"v":1.547462,"d":"1.55"},{"v":4.417522,"d":"4.42"},{"v":1.299312,"d":"1.30"},{"v":5.384761,"d":"5.38"},{"v":0.336399409274073,"d":"0.34"},{"v":-1.5717529227013,"d":"-1.57"},{"v":0.0152475745103734,"d":"0.02"},{"v":0.227546500330796,"d":"0.23"},"down","yes"]
["MSTRG.3688","CEP112","ENSOART00000016964","GO:0005813(centrosome)","NA","K16767","NA","centrosomal protein 112 [Source:NCBI gene;Acc:101117261]",{"v":0.824507002472008,"d":"0.82"},{"v":0.484653493238331,"d":"0.48"},{"v":0.609297624981824,"d":"0.61"},{"v":1.05083341587902,"d":"1.05"},{"v":1.68767595404973,"d":"1.69"},{"v":1.06570751606805,"d":"1.07"},{"v":0.504297777488436,"d":"0.50"},{"v":-0.987652227739018,"d":"-0.99"},{"v":0.0152598859543252,"d":"0.02"},{"v":0.227546500330796,"d":"0.23"},"down","no"]
["MSTRG.11073","CROCC","ENSOART00000012809","GO:0001917(photoreceptor inner segment);GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007098(centrosome cycle);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0010669(epithelial structure maintenance);GO:0015629(actin cytoskeleton);GO:0019894(kinesin binding);GO:0032053(ciliary basal body organization);GO:0033365(protein localization to organelle);GO:0035253(ciliary rootlet);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of cilium assembly);GO:0051656(establishment of organelle localization);GO:1903566(positive regulation of protein localization to cilium)","NA","K16469","NA","ciliary rootlet coiled-coil, rootletin [Source:NCBI gene;Acc:101109254]",{"v":0.199243,"d":"0.20"},{"v":0.104156,"d":"0.10"},{"v":0.078568,"d":"0.08"},{"v":0.222283,"d":"0.22"},{"v":0.422154,"d":"0.42"},{"v":0.298645,"d":"0.30"},{"v":0.405019924036298,"d":"0.41"},{"v":-1.30393521503493,"d":"-1.30"},{"v":0.0153481655904269,"d":"0.02"},{"v":0.228134510639861,"d":"0.23"},"down","yes"]
["MSTRG.3664","MAP2K6","ENSOART00000015093","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000187(activation of MAPK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004708(MAP kinase kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0019901(protein kinase binding);GO:0060048(cardiac muscle contraction);GO:0120163(negative regulation of cold-induced thermogenesis)","04010(MAPK signaling pathway);04015(Rap1 signaling pathway);04218(Cellular senescence);04380(Osteoclast differentiation);04620(Toll-like receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04668(TNF signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04912(GnRH signaling pathway);05014(Amyotrophic lateral sclerosis (ALS));05145(Toxoplasmosis);05161(Hepatitis B);05163(Human cytomegalovirus infection);05164(Influenza A);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05418(Fluid shear stress and atherosclerosis)","K04433","EC:2.7.12.2","mitogen-activated protein kinase kinase 6 [Source:NCBI gene;Acc:101115047]",{"v":6.59875666122947,"d":"6.60"},{"v":9.16737658910342,"d":"9.17"},{"v":7.81583471327119,"d":"7.82"},{"v":5.6354156581225,"d":"5.64"},{"v":4.57151422581003,"d":"4.57"},{"v":4.21171213415446,"d":"4.21"},{"v":1.63551934599822,"d":"1.64"},{"v":0.709748824667173,"d":"0.71"},{"v":0.0153552074469137,"d":"0.02"},{"v":0.228134510639861,"d":"0.23"},"up","no"]
["MSTRG.13258","PKMYT1","ENSOART00000000792","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006468(protein phosphorylation);GO:0010923(negative regulation of phosphatase activity);GO:0016301(kinase activity)","04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)","K06633","EC:2.7.11.1","protein kinase, membrane associated tyrosine/threonine 1 [Source:NCBI gene;Acc:101119784]",{"v":0.359015,"d":"0.36"},{"v":0.320609,"d":"0.32"},{"v":0.414571,"d":"0.41"},{"v":0.683426,"d":"0.68"},{"v":0.857223,"d":"0.86"},{"v":1.048458,"d":"1.05"},{"v":0.422614824339048,"d":"0.42"},{"v":-1.24258472036103,"d":"-1.24"},{"v":0.0153891547022834,"d":"0.02"},{"v":0.228431016344439,"d":"0.23"},"down","yes"]
["MSTRG.16984","FOXP2","ENSOART00000001909","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007519(skeletal muscle tissue development);GO:0009791(post-embryonic development);GO:0021549(cerebellum development);GO:0021757(caudate nucleus development);GO:0021758(putamen development);GO:0021987(cerebral cortex development);GO:0030324(lung development);GO:0042297(vocal learning);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0048286(lung alveolus development);GO:0048745(smooth muscle tissue development);GO:0050679(positive regulation of epithelial cell proliferation);GO:0060013(righting reflex);GO:0060501(positive regulation of epithelial cell proliferation involved in lung morphogenesis)","NA","K09409","NA","forkhead box P2 [Source:NCBI gene;Acc:101110051]",{"v":1.79937660757621,"d":"1.80"},{"v":1.25667784137319,"d":"1.26"},{"v":1.57773195975141,"d":"1.58"},{"v":0.992414055933708,"d":"0.99"},{"v":0.950421335306304,"d":"0.95"},{"v":0.727308476768275,"d":"0.73"},{"v":1.73540701840805,"d":"1.74"},{"v":0.795274068897362,"d":"0.80"},{"v":0.0154622939749733,"d":"0.02"},{"v":0.22930820710569,"d":"0.23"},"up","no"]
["MSTRG.3466","FASN","ENSOART00000018693","GO:0003824(catalytic activity);GO:0004312(fatty acid synthase activity);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006633(fatty acid biosynthetic process);GO:0008611(ether lipid biosynthetic process);GO:0009058(biosynthetic process);GO:0009888(tissue development);GO:0016491(oxidoreductase activity);GO:0016740(transferase activity);GO:0016788(hydrolase activity, acting on ester bonds);GO:0030223(neutrophil differentiation);GO:0030224(monocyte differentiation);GO:0030879(mammary gland development);GO:0031177(phosphopantetheine binding);GO:0042587(glycogen granule);GO:0048468(cell development);GO:0055114(oxidation-reduction process);GO:0071353(cellular response to interleukin-4);GO:0090557(establishment of endothelial intestinal barrier)","00061(Fatty acid biosynthesis);04152(AMPK signaling pathway);04910(Insulin signaling pathway)","K00665","EC:2.3.1.85","fatty acid synthase [Source:NCBI gene;Acc:100170327]",{"v":6.64818445438989,"d":"6.65"},{"v":11.2789669073318,"d":"11.28"},{"v":5.3602932730025,"d":"5.36"},{"v":3.32711321969198,"d":"3.33"},{"v":5.29889993747532,"d":"5.30"},{"v":4.21110907858365,"d":"4.21"},{"v":1.81407049080435,"d":"1.81"},{"v":0.859230516923759,"d":"0.86"},{"v":0.0154792077861098,"d":"0.02"},{"v":0.229350730246462,"d":"0.23"},"up","no"]
["MSTRG.11513","ENSOARG00000020040","ENSOART00000021819","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 1-H [Source:NCBI gene;Acc:101105785]",{"v":2.647579,"d":"2.65"},{"v":2.027231,"d":"2.03"},{"v":1.871842,"d":"1.87"},{"v":5.888074,"d":"5.89"},{"v":2.810045,"d":"2.81"},{"v":6.775665,"d":"6.78"},{"v":0.423080223945222,"d":"0.42"},{"v":-1.24099684356548,"d":"-1.24"},{"v":0.0156960908885707,"d":"0.02"},{"v":0.231513795870444,"d":"0.23"},"down","yes"]
["MSTRG.13652","POR","ENSOART00000014638","GO:0003958(NADPH-hemoprotein reductase activity);GO:0010181(FMN binding);GO:0016491(oxidoreductase activity);GO:0032770(positive regulation of monooxygenase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0055114(oxidation-reduction process);GO:0090346(cellular organofluorine metabolic process)","NA","K00327","EC:1.6.2.4","P450 (cytochrome) oxidoreductase [Source:NCBI gene;Acc:101115252]",{"v":4.756404815509,"d":"4.76"},{"v":5.51098037816979,"d":"5.51"},{"v":4.28628264424844,"d":"4.29"},{"v":8.87326977434767,"d":"8.87"},{"v":8.47313507828004,"d":"8.47"},{"v":9.31469841896362,"d":"9.31"},{"v":0.545876428656081,"d":"0.55"},{"v":-0.873353693086374,"d":"-0.87"},{"v":0.0157194489557432,"d":"0.02"},{"v":0.23155882350656,"d":"0.23"},"down","no"]
["ENSOARG00000010448","ERBB3","ENSOART00000011378","GO:0000166(nucleotide binding);GO:0003197(endocardial cushion development);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0006468(protein phosphorylation);GO:0007162(negative regulation of cell adhesion);GO:0007165(signal transduction);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007422(peripheral nervous system development);GO:0009968(negative regulation of signal transduction);GO:0010628(positive regulation of gene expression);GO:0014037(Schwann cell differentiation);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019838(growth factor binding);GO:0021545(cranial nerve development);GO:0030296(protein tyrosine kinase activator activity);GO:0031625(ubiquitin protein ligase binding);GO:0038132(neuregulin binding);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0043235(receptor complex);GO:0043524(negative regulation of neuron apoptotic process);GO:0046982(protein heterodimerization activity);GO:0051048(negative regulation of secretion);GO:0051402(neuron apoptotic process);GO:0055025(positive regulation of cardiac muscle tissue development);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070886(positive regulation of calcineurin-NFAT signaling cascade);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand)","01521(EGFR tyrosine kinase inhibitor resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04020(Calcium signaling pathway);04151(PI3K-Akt signaling pathway);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer)","K05084","EC:2.7.10.1","erb-b2 receptor tyrosine kinase 3 [Source:NCBI gene;Acc:101103889]",{"v":0.568381,"d":"0.57"},{"v":0.253467,"d":"0.25"},{"v":0.452524,"d":"0.45"},{"v":0.908809,"d":"0.91"},{"v":0.845892,"d":"0.85"},{"v":0.928338,"d":"0.93"},{"v":0.474973341796373,"d":"0.47"},{"v":-1.07408155141733,"d":"-1.07"},{"v":0.0158464639214284,"d":"0.02"},{"v":0.23310005667485,"d":"0.23"},"down","yes"]
["MSTRG.769","APH1A","ENSOART00000022642","GO:0001656(metanephros development);GO:0004175(endopeptidase activity);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005887(integral component of plasma membrane);GO:0006509(membrane protein ectodomain proteolysis);GO:0007220(Notch receptor processing);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0031293(membrane protein intracellular domain proteolysis);GO:0034205(amyloid-beta formation);GO:0042982(amyloid precursor protein metabolic process);GO:0042987(amyloid precursor protein catabolic process);GO:0043085(positive regulation of catalytic activity);GO:0070765(gamma-secretase complex)","04330(Notch signaling pathway);05010(Alzheimer disease)","K06172","NA","aph-1 homolog A, gamma-secretase subunit [Source:NCBI gene;Acc:101103438]",{"v":3.11142329818956,"d":"3.11"},{"v":2.78165541036564,"d":"2.78"},{"v":2.93607374653887,"d":"2.94"},{"v":5.1287413915513,"d":"5.13"},{"v":4.85512058963436,"d":"4.86"},{"v":5.84012670713525,"d":"5.84"},{"v":0.557959982719814,"d":"0.56"},{"v":-0.84176644021989,"d":"-0.84"},{"v":0.0159497801146195,"d":"0.02"},{"v":0.234197850459989,"d":"0.23"},"down","no"]
["MSTRG.1137","CYYR1","ENSOART00000016305","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","cysteine and tyrosine rich 1 [Source:NCBI gene;Acc:101111331]",{"v":2.50148357127546,"d":"2.50"},{"v":1.96482141827438,"d":"1.96"},{"v":2.04495478965702,"d":"2.04"},{"v":4.30945860182208,"d":"4.31"},{"v":4.52413513906752,"d":"4.52"},{"v":3.05590570176849,"d":"3.06"},{"v":0.547647931740948,"d":"0.55"},{"v":-0.868679373896488,"d":"-0.87"},{"v":0.0159958004400797,"d":"0.02"},{"v":0.234662560274592,"d":"0.23"},"down","no"]
["MSTRG.120","AGO4","ENSOART00000021311","GO:0000932(P-body);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006402(mRNA catabolic process);GO:0006417(regulation of translation);GO:0007130(synaptonemal complex assembly);GO:0007140(male meiotic nuclear division);GO:0008584(male gonad development);GO:0010501(RNA secondary structure unwinding);GO:0010586(miRNA metabolic process);GO:0016442(RISC complex);GO:0016604(nuclear body);GO:0022604(regulation of cell morphogenesis);GO:0031047(gene silencing by RNA);GO:0031054(pre-miRNA processing);GO:0035068(micro-ribonucleoprotein complex);GO:0035196(production of miRNAs involved in gene silencing by miRNA);GO:0035198(miRNA binding);GO:0035278(miRNA mediated inhibition of translation);GO:0035280(miRNA loading onto RISC involved in gene silencing by miRNA);GO:0043066(negative regulation of apoptotic process);GO:0070578(RISC-loading complex)","NA","K11593","NA","argonaute RISC catalytic component 4 [Source:NCBI gene;Acc:101116530]",{"v":13.6259826751269,"d":"13.63"},{"v":13.7527247972716,"d":"13.75"},{"v":13.2762487442893,"d":"13.28"},{"v":10.672885330901,"d":"10.67"},{"v":7.33672425317259,"d":"7.34"},{"v":7.37506868369289,"d":"7.38"},{"v":1.60155491386753,"d":"1.60"},{"v":0.679473265865417,"d":"0.68"},{"v":0.0161507374124562,"d":"0.02"},{"v":0.236122975566321,"d":"0.24"},"up","no"]
["MSTRG.15418","ACTG2","ENSOART00000013168","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0010628(positive regulation of gene expression);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0032982(myosin filament);GO:0044297(cell body);GO:0071944(cell periphery);GO:0090131(mesenchyme migration)","04270(Vascular smooth muscle contraction)","K12315","NA","actin, gamma 2, smooth muscle, enteric [Source:NCBI gene;Acc:101114256]",{"v":1.100253,"d":"1.10"},{"v":0.373971,"d":"0.37"},{"v":0.686561,"d":"0.69"},{"v":2.004112,"d":"2.00"},{"v":1.435331,"d":"1.44"},{"v":1.646578,"d":"1.65"},{"v":0.424847832912998,"d":"0.42"},{"v":-1.23498188895843,"d":"-1.23"},{"v":0.016178997928251,"d":"0.02"},{"v":0.236122975566321,"d":"0.24"},"down","yes"]
["MSTRG.2230","MEDAG","ENSOART00000012837","GO:0005737(cytoplasm);GO:0045600(positive regulation of fat cell differentiation)","NA","NA","NA","mesenteric estrogen dependent adipogenesis [Source:NCBI gene;Acc:101111297]",{"v":4.65799332896868,"d":"4.66"},{"v":3.52640992447354,"d":"3.53"},{"v":5.14832850958423,"d":"5.15"},{"v":3.20595897354212,"d":"3.21"},{"v":2.46303124696274,"d":"2.46"},{"v":2.50279287709233,"d":"2.50"},{"v":1.63155722610244,"d":"1.63"},{"v":0.706249590167322,"d":"0.71"},{"v":0.0161821172010481,"d":"0.02"},{"v":0.236122975566321,"d":"0.24"},"up","no"]
["ENSOARG00000013992","CHAF1B","ENSOART00000015243","GO:0000790(nuclear chromatin);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0031497(chromatin assembly);GO:0032991(protein-containing complex);GO:0033186(CAF-1 complex)","NA","K10751","NA","chromatin assembly factor 1 subunit B [Source:NCBI gene;Acc:101116195]",{"v":0.376996,"d":"0.38"},{"v":0.100191,"d":"0.10"},{"v":0.348677,"d":"0.35"},{"v":0.65199,"d":"0.65"},{"v":0.639811,"d":"0.64"},{"v":0.827822,"d":"0.83"},{"v":0.38962777814734,"d":"0.39"},{"v":-1.35983155820938,"d":"-1.36"},{"v":0.0162686436652392,"d":"0.02"},{"v":0.236750814408222,"d":"0.24"},"down","yes"]
["MSTRG.3746","RAB7B","ENSOART00000005403","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005764(lysosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0032755(positive regulation of interleukin-6 production);GO:0034144(negative regulation of toll-like receptor 4 signaling pathway);GO:0034164(negative regulation of toll-like receptor 9 signaling pathway);GO:0034499(late endosome to Golgi transport);GO:0045335(phagocytic vesicle);GO:0045654(positive regulation of megakaryocyte differentiation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0071346(cellular response to interferon-gamma)","04137(Mitophagy - animal);04140(Autophagy - animal);04145(Phagosome);05132(Salmonella infection);05146(Amoebiasis)","K07898","NA","RAB7B, member RAS oncogene family [Source:NCBI gene;Acc:101115978]",{"v":3.18638730866808,"d":"3.19"},{"v":4.79014034143763,"d":"4.79"},{"v":4.08176440063425,"d":"4.08"},{"v":2.59570737632135,"d":"2.60"},{"v":1.77255210676533,"d":"1.77"},{"v":2.26635616596195,"d":"2.27"},{"v":1.81748162796274,"d":"1.82"},{"v":0.861940780716527,"d":"0.86"},{"v":0.0163710213895584,"d":"0.02"},{"v":0.237816759118069,"d":"0.24"},"up","no"]
["MSTRG.14201","VSTM4","ENSOART00000002012","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","V-set and transmembrane domain containing 4 [Source:NCBI gene;Acc:101116120]",{"v":5.77374178432894,"d":"5.77"},{"v":2.74680444996121,"d":"2.75"},{"v":3.90771983708301,"d":"3.91"},{"v":8.55873419550039,"d":"8.56"},{"v":7.20522566020171,"d":"7.21"},{"v":8.2210319519007,"d":"8.22"},{"v":0.518168451799664,"d":"0.52"},{"v":-0.94850691383037,"d":"-0.95"},{"v":0.0164171776051551,"d":"0.02"},{"v":0.238142977193471,"d":"0.24"},"down","no"]
["MSTRG.759","HIST2H2AB","ENSOART00000014560","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 2-B [Source:NCBI gene;Acc:101122904]",{"v":2.626385,"d":"2.63"},{"v":1.341097,"d":"1.34"},{"v":1.799197,"d":"1.80"},{"v":4.410816,"d":"4.41"},{"v":2.708385,"d":"2.71"},{"v":6.896894,"d":"6.90"},{"v":0.411432642258775,"d":"0.41"},{"v":-1.28127183588917,"d":"-1.28"},{"v":0.016422647741294,"d":"0.02"},{"v":0.238142977193471,"d":"0.24"},"down","yes"]
["MSTRG.2968","ARHGEF15","ENSOART00000000910","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0030425(dendrite);GO:0035023(regulation of Rho protein signal transduction);GO:0050790(regulation of catalytic activity);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:2000297(negative regulation of synapse maturation)","NA","K20687","NA","Rho guanine nucleotide exchange factor 15 [Source:NCBI gene;Acc:101107803]",{"v":3.75454146062437,"d":"3.75"},{"v":2.18393337039275,"d":"2.18"},{"v":2.12775784410876,"d":"2.13"},{"v":5.4517594592145,"d":"5.45"},{"v":4.80326572668681,"d":"4.80"},{"v":4.70756931943605,"d":"4.71"},{"v":0.539093181483234,"d":"0.54"},{"v":-0.89139343258701,"d":"-0.89"},{"v":0.0164506972525344,"d":"0.02"},{"v":0.238226216749904,"d":"0.24"},"down","no"]
["MSTRG.15371","LTBP1","ENSOART00000011261","GO:0001527(microfibril);GO:0003281(ventricular septum development);GO:0005509(calcium ion binding);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0035904(aorta development);GO:0050431(transforming growth factor beta binding);GO:0050436(microfibril binding);GO:0060976(coronary vasculature development);GO:0062023(collagen-containing extracellular matrix);GO:1901388(regulation of transforming growth factor beta activation)","04350(TGF-beta signaling pathway)","K19559","NA","latent transforming growth factor beta binding protein 1 [Source:NCBI gene;Acc:101102219]",{"v":5.55602929970961,"d":"5.56"},{"v":3.31780772932905,"d":"3.32"},{"v":7.43110913602323,"d":"7.43"},{"v":10.1770444044017,"d":"10.18"},{"v":9.82553381323552,"d":"9.83"},{"v":11.6223947577564,"d":"11.62"},{"v":0.515571860812284,"d":"0.52"},{"v":-0.955754569307263,"d":"-0.96"},{"v":0.0164575681341188,"d":"0.02"},{"v":0.238226216749904,"d":"0.24"},"down","no"]
["MSTRG.22041","PRRG3","ENSOART00000009389","GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","proline rich and Gla domain 3 [Source:NCBI gene;Acc:105605547]",{"v":1.62826061989561,"d":"1.63"},{"v":0.869816,"d":"0.87"},{"v":1.10734673687442,"d":"1.11"},{"v":2.34529451028554,"d":"2.35"},{"v":2.39494246699417,"d":"2.39"},{"v":2.19904095302426,"d":"2.20"},{"v":0.519567510190804,"d":"0.52"},{"v":-0.944616876480538,"d":"-0.94"},{"v":0.0165679746476192,"d":"0.02"},{"v":0.238766010632239,"d":"0.24"},"down","no"]
["ENSOARG00000000907","PWWP3B","ENSOART00000000970","NA","NA","NA","NA","PWWP domain containing 3B [Source:HGNC Symbol;Acc:HGNC:26583]",{"v":1.020607,"d":"1.02"},{"v":0.668148,"d":"0.67"},{"v":0.938084,"d":"0.94"},{"v":1.745528,"d":"1.75"},{"v":1.745568,"d":"1.75"},{"v":1.839084,"d":"1.84"},{"v":0.492823694509379,"d":"0.49"},{"v":-1.02085647373808,"d":"-1.02"},{"v":0.0166225262561281,"d":"0.02"},{"v":0.239263162808524,"d":"0.24"},"down","yes"]
["ENSOARG00000004628","ENSOARG00000004628","ENSOART00000005035","GO:0001779(natural killer cell differentiation);GO:0003676(nucleic acid binding);GO:0010468(regulation of gene expression);GO:0032823(regulation of natural killer cell differentiation);GO:0032826(regulation of natural killer cell differentiation involved in immune response);GO:0033082(regulation of extrathymic T cell differentiation);GO:0051136(regulation of NK T cell differentiation);GO:1990841(promoter-specific chromatin binding)","NA","NA","NA","zinc finger protein 683 [Source:NCBI gene;Acc:101111348]",{"v":0.707475,"d":"0.71"},{"v":0.442593,"d":"0.44"},{"v":0.655978,"d":"0.66"},{"v":0.224488,"d":"0.22"},{"v":0.20702,"d":"0.21"},{"v":0.365415,"d":"0.37"},{"v":2.26627415697627,"d":"2.27"},{"v":1.18032239822167,"d":"1.18"},{"v":0.0166410834189323,"d":"0.02"},{"v":0.239263162808524,"d":"0.24"},"up","yes"]
["MSTRG.16831","MEOX2","ENSOART00000009008","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0001757(somite specification);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007519(skeletal muscle tissue development);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060021(roof of mouth development);GO:0060173(limb development);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis)","NA","NA","NA","mesenchyme homeobox 2 [Source:HGNC Symbol;Acc:HGNC:7014]",{"v":5.86327714164573,"d":"5.86"},{"v":2.25843147644472,"d":"2.26"},{"v":3.66178203203518,"d":"3.66"},{"v":6.97655752386935,"d":"6.98"},{"v":8.33281330590452,"d":"8.33"},{"v":7.54970208825377,"d":"7.55"},{"v":0.515484188373741,"d":"0.52"},{"v":-0.955999918903367,"d":"-0.96"},{"v":0.0166464326892751,"d":"0.02"},{"v":0.239263162808524,"d":"0.24"},"down","no"]
["MSTRG.13334","ENSOARG00000010676","ENSOART00000011617","GO:0005524(ATP binding);GO:0006457(protein folding);GO:0009408(response to heat);GO:0031072(heat shock protein binding);GO:0046872(metal ion binding);GO:0051082(unfolded protein binding)","NA","NA","NA",null,{"v":9.743933,"d":"9.74"},{"v":14.383467,"d":"14.38"},{"v":14.149864,"d":"14.15"},{"v":6.45713,"d":"6.46"},{"v":8.464529,"d":"8.46"},{"v":7.940651,"d":"7.94"},{"v":1.6742518144492,"d":"1.67"},{"v":0.743516531553391,"d":"0.74"},{"v":0.0166840292876014,"d":"0.02"},{"v":0.239592638705326,"d":"0.24"},"up","no"]
["MSTRG.14344","ENSOARG00000009903","ENSOART00000010776","NA","NA","NA","NA",null,{"v":2.606013,"d":"2.61"},{"v":1.829481,"d":"1.83"},{"v":1.983299,"d":"1.98"},{"v":3.567968,"d":"3.57"},{"v":4.800691,"d":"4.80"},{"v":3.956252,"d":"3.96"},{"v":0.520798324628876,"d":"0.52"},{"v":-0.941203287423561,"d":"-0.94"},{"v":0.0168147351000043,"d":"0.02"},{"v":0.241217007269509,"d":"0.24"},"down","no"]
["MSTRG.6570","ENSOARG00000006305","ENSOART00000006857","GO:0008289(lipid binding)","NA","NA","NA",null,{"v":5.77688637615894,"d":"5.78"},{"v":4.11670413642384,"d":"4.12"},{"v":3.05078337880795,"d":"3.05"},{"v":1.88725752582781,"d":"1.89"},{"v":2.44097507682119,"d":"2.44"},{"v":2.7628788013245,"d":"2.76"},{"v":1.82543654357727,"d":"1.83"},{"v":0.868241518207152,"d":"0.87"},{"v":0.0168266885889252,"d":"0.02"},{"v":0.241217007269509,"d":"0.24"},"up","no"]
["ENSOARG00000009019","TNFAIP6","ENSOART00000009826","GO:0005540(hyaluronic acid binding);GO:0007155(cell adhesion);GO:0050728(negative regulation of inflammatory response)","NA","K19018","NA","TNF alpha induced protein 6 [Source:NCBI gene;Acc:101119185]",{"v":1.392784,"d":"1.39"},{"v":0.95372,"d":"0.95"},{"v":1.491115,"d":"1.49"},{"v":0.77887,"d":"0.78"},{"v":0.505367,"d":"0.51"},{"v":0.761858,"d":"0.76"},{"v":1.87558202331759,"d":"1.88"},{"v":0.907338356598939,"d":"0.91"},{"v":0.016882124575788,"d":"0.02"},{"v":0.241799412345145,"d":"0.24"},"up","no"]
["ENSOARG00000015182","ASTN1","ENSOART00000016529","GO:0001764(neuron migration);GO:0005515(protein binding);GO:0005768(endosome);GO:0007158(neuron cell-cell adhesion);GO:0007626(locomotory behavior);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016477(cell migration);GO:0098609(cell-cell adhesion)","NA","NA","NA","astrotactin 1 [Source:NCBI gene;Acc:101118463]",{"v":0.176954,"d":"0.18"},{"v":0.063113,"d":"0.06"},{"v":0.020167,"d":"0.02"},{"v":0.240361,"d":"0.24"},{"v":0.286751,"d":"0.29"},{"v":0.252499,"d":"0.25"},{"v":0.333799805287509,"d":"0.33"},{"v":-1.58294498174116,"d":"-1.58"},{"v":0.0169143078848289,"d":"0.02"},{"v":0.241959836274671,"d":"0.24"},"down","yes"]
["MSTRG.17076","ENSOARG00000009105;CREB5","ENSOART00000009912;ENSOART00000009868","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated)","NA","NA","NA","cAMP responsive element binding protein 5 [Source:HGNC Symbol;Acc:HGNC:16844]",{"v":3.49933511764788,"d":"3.50"},{"v":1.6487731476702,"d":"1.65"},{"v":2.96429559933036,"d":"2.96"},{"v":2.22191700684989,"d":"2.22"},{"v":1.45565889750279,"d":"1.46"},{"v":1.0178754515625,"d":"1.02"},{"v":1.72771545262176,"d":"1.73"},{"v":0.788865631335481,"d":"0.79"},{"v":0.0169229625811902,"d":"0.02"},{"v":0.241959836274671,"d":"0.24"},"up","no"]
["MSTRG.9208","PLXND1","ENSOART00000014844","GO:0001525(angiogenesis);GO:0001569(branching involved in blood vessel morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003279(cardiac septum development);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007416(synapse assembly);GO:0017154(semaphorin receptor activity);GO:0019904(protein domain specific binding);GO:0030027(lamellipodium);GO:0030334(regulation of cell migration);GO:0032092(positive regulation of protein binding);GO:0035904(aorta development);GO:0043542(endothelial cell migration);GO:0045765(regulation of angiogenesis);GO:0060666(dichotomous subdivision of terminal units involved in salivary gland branching);GO:0060976(coronary vasculature development);GO:0071526(semaphorin-plexin signaling pathway)","NA","NA","NA","plexin D1 [Source:HGNC Symbol;Acc:HGNC:9107]",{"v":3.14099652346491,"d":"3.14"},{"v":1.35645107850877,"d":"1.36"},{"v":1.8779852754386,"d":"1.88"},{"v":4.4686262627193,"d":"4.47"},{"v":3.74977653135965,"d":"3.75"},{"v":3.8780491,"d":"3.88"},{"v":0.527049826944128,"d":"0.53"},{"v":-0.923988735136628,"d":"-0.92"},{"v":0.0169502325206145,"d":"0.02"},{"v":0.242137704808918,"d":"0.24"},"down","no"]
["MSTRG.10207","NFE2L2","ENSOART00000018975","GO:0000785(chromatin);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006954(inflammatory response);GO:0008134(transcription factor binding);GO:0010499(proteasomal ubiquitin-independent protein catabolic process);GO:0010628(positive regulation of gene expression);GO:0016567(protein ubiquitination);GO:0019904(protein domain specific binding);GO:0030194(positive regulation of blood coagulation);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0032993(protein-DNA complex);GO:0034599(cellular response to oxidative stress);GO:0034976(response to endoplasmic reticulum stress);GO:0035690(cellular response to drug);GO:0036003(positive regulation of transcription from RNA polymerase II promoter in response to stress);GO:0036499(PERK-mediated unfolded protein response);GO:0042149(cellular response to glucose starvation);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0045454(cell redox homeostasis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045995(regulation of embryonic development);GO:0046326(positive regulation of glucose import);GO:0061396(regulation of transcription from RNA polymerase II promoter in response to copper ion);GO:0061419(positive regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0070301(cellular response to hydrogen peroxide);GO:0071356(cellular response to tumor necrosis factor);GO:0071498(cellular response to fluid shear stress);GO:0071499(cellular response to laminar fluid shear stress);GO:1902037(negative regulation of hematopoietic stem cell differentiation);GO:1902176(negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway);GO:1903206(negative regulation of hydrogen peroxide-induced cell death);GO:1903788(positive regulation of glutathione biosynthetic process);GO:2000121(regulation of removal of superoxide radicals);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:2000379(positive regulation of reactive oxygen species metabolic process)","04141(Protein processing in endoplasmic reticulum);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis)","K05638","NA","nuclear factor, erythroid 2 like 2 [Source:NCBI gene;Acc:101104966]",{"v":3.80225168916222,"d":"3.80"},{"v":5.20645893531855,"d":"5.21"},{"v":5.08635451070831,"d":"5.09"},{"v":4.02118213114312,"d":"4.02"},{"v":2.59913042185898,"d":"2.60"},{"v":2.04251450175325,"d":"2.04"},{"v":1.62707451575543,"d":"1.63"},{"v":0.702280324181367,"d":"0.70"},{"v":0.0171766014440994,"d":"0.02"},{"v":0.243877868155874,"d":"0.24"},"up","no"]
["MSTRG.10938","AUNIP","ENSOART00000006307","GO:0000724(double-strand break repair via homologous recombination);GO:0000922(spindle pole);GO:0003684(damaged DNA binding);GO:0005813(centrosome);GO:0007051(spindle organization);GO:0090734(site of DNA damage);GO:2001033(negative regulation of double-strand break repair via nonhomologous end joining)","NA","K16800","NA","aurora kinase A and ninein interacting protein [Source:NCBI gene;Acc:101114173]",{"v":0.379268154413635,"d":"0.38"},{"v":0.152318796998219,"d":"0.15"},{"v":0.151242416687866,"d":"0.15"},{"v":0.256847640549479,"d":"0.26"},{"v":0.319052905367591,"d":"0.32"},{"v":1.48398586491987,"d":"1.48"},{"v":0.331488845456427,"d":"0.33"},{"v":-1.5929677701768,"d":"-1.59"},{"v":0.0172727380357216,"d":"0.02"},{"v":0.24484856813447,"d":"0.24"},"down","yes"]
["MSTRG.6828","MPEG1","ENSOART00000012767","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","macrophage expressed 1 [Source:HGNC Symbol;Acc:HGNC:29619]",{"v":2.182073,"d":"2.18"},{"v":1.079716,"d":"1.08"},{"v":2.280987,"d":"2.28"},{"v":4.172313,"d":"4.17"},{"v":3.177647,"d":"3.18"},{"v":3.710171,"d":"3.71"},{"v":0.501149217852845,"d":"0.50"},{"v":-0.996687863115996,"d":"-1.00"},{"v":0.0172749602211483,"d":"0.02"},{"v":0.24484856813447,"d":"0.24"},"down","no"]
["MSTRG.1561","GNB4","ENSOART00000022550","GO:0005515(protein binding);GO:0007165(signal transduction);GO:0044877(protein-containing complex binding)","04014(Ras signaling pathway);04062(Chemokine signaling pathway);04151(PI3K-Akt signaling pathway);04371(Apelin signaling pathway);04713(Circadian entrainment);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04727(GABAergic synapse);04728(Dopaminergic synapse);04926(Relaxin signaling pathway);05032(Morphine addiction);05034(Alcoholism);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer)","K04538","NA","G protein subunit beta 4 [Source:NCBI gene;Acc:101108976]",{"v":2.178094,"d":"2.18"},{"v":1.437064,"d":"1.44"},{"v":1.431934,"d":"1.43"},{"v":3.588588,"d":"3.59"},{"v":3.476866,"d":"3.48"},{"v":2.657836,"d":"2.66"},{"v":0.519072453871066,"d":"0.52"},{"v":-0.945992166044287,"d":"-0.95"},{"v":0.0173214523024761,"d":"0.02"},{"v":0.245294599475134,"d":"0.25"},"down","no"]
["ENSOARG00000013545","ENSOARG00000013545","ENSOART00000014734","GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007601(visual perception);GO:0007626(locomotory behavior);GO:0009306(protein secretion);GO:0032281(AMPA glutamate receptor complex);GO:0051152(positive regulation of smooth muscle cell differentiation);GO:0097060(synaptic membrane);GO:0098978(glutamatergic synapse);GO:0099243(extrinsic component of synaptic membrane)","NA","NA","NA",null,{"v":0.425363,"d":"0.43"},{"v":0.212741,"d":"0.21"},{"v":0.268001,"d":"0.27"},{"v":0.598799,"d":"0.60"},{"v":0.69087,"d":"0.69"},{"v":0.884026,"d":"0.88"},{"v":0.41685011006604,"d":"0.42"},{"v":-1.26239937869524,"d":"-1.26"},{"v":0.0173553973599245,"d":"0.02"},{"v":0.245562329369885,"d":"0.25"},"down","yes"]
["MSTRG.12372","IFIT2","ENSOART00000016507","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0009615(response to virus);GO:0032091(negative regulation of protein binding);GO:0035457(cellular response to interferon-alpha);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process)","NA","NA","NA","interferon induced protein with tetratricopeptide repeats 2 [Source:NCBI gene;Acc:101101941]",{"v":0.489056,"d":"0.49"},{"v":0.365356,"d":"0.37"},{"v":0.528025,"d":"0.53"},{"v":1.35332,"d":"1.35"},{"v":0.795093,"d":"0.80"},{"v":1.046191,"d":"1.05"},{"v":0.432741272470704,"d":"0.43"},{"v":-1.20842337128668,"d":"-1.21"},{"v":0.0174475933079438,"d":"0.02"},{"v":0.24612728585807,"d":"0.25"},"down","yes"]
["MSTRG.18380","PDE6A","ENSOART00000006453","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005515(protein binding);GO:0005623(cell);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007601(visual perception);GO:0008081(phosphoric diester hydrolase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity);GO:0051480(regulation of cytosolic calcium ion concentration)","00230(Purine metabolism);04744(Phototransduction)","K08718","EC:3.1.4.35","phosphodiesterase 6A [Source:NCBI gene;Acc:101122024]",{"v":0.0258830416493474,"d":"0.03"},{"v":0.512509553080057,"d":"0.51"},{"v":0.471128973065093,"d":"0.47"},{"v":2.38804766821847,"d":"2.39"},{"v":0.817709325214066,"d":"0.82"},{"v":0.685451029345748,"d":"0.69"},{"v":0.259436545639549,"d":"0.26"},{"v":-1.94654637513098,"d":"-1.95"},{"v":0.0174816616613696,"d":"0.02"},{"v":0.24612728585807,"d":"0.25"},"down","yes"]
["MSTRG.9222","SYN2","ENSOART00000018285;ENSOART00000018286","GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0007269(neurotransmitter secretion);GO:0008021(synaptic vesicle);GO:0014069(postsynaptic density);GO:0017156(calcium ion regulated exocytosis);GO:0030672(synaptic vesicle membrane);GO:0031201(SNARE complex);GO:0045202(synapse);GO:0097091(synaptic vesicle clustering);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099504(synaptic vesicle cycle);GO:0099504(synaptic vesicle cycle)","NA","K19941","NA","synapsin II [Source:NCBI gene;Acc:101107824]",{"v":0.408825146872957,"d":"0.41"},{"v":0.453372262802353,"d":"0.45"},{"v":0.265048802571366,"d":"0.27"},{"v":0.586545559163216,"d":"0.59"},{"v":1.39096915755066,"d":"1.39"},{"v":0.599595164305949,"d":"0.60"},{"v":0.437407120491346,"d":"0.44"},{"v":-1.19295138887278,"d":"-1.19"},{"v":0.0175008438805254,"d":"0.02"},{"v":0.24612728585807,"d":"0.25"},"down","yes"]
["MSTRG.4868","SYCP2","ENSOART00000016830","GO:0000795(synaptonemal complex);GO:0000800(lateral element);GO:0007140(male meiotic nuclear division);GO:0007143(female meiotic nuclear division);GO:0009566(fertilization);GO:0009887(animal organ morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0046982(protein heterodimerization activity);GO:0048808(male genitalia morphogenesis)","NA","K19529","NA","synaptonemal complex protein 2 [Source:NCBI gene;Acc:101123486]",{"v":0.443956,"d":"0.44"},{"v":0.333589,"d":"0.33"},{"v":0.253327,"d":"0.25"},{"v":0.215432,"d":"0.22"},{"v":0.15436,"d":"0.15"},{"v":0.130856,"d":"0.13"},{"v":2.05907543823205,"d":"2.06"},{"v":1.04199668687622,"d":"1.04"},{"v":0.0175566344305857,"d":"0.02"},{"v":0.246519453760565,"d":"0.25"},"up","yes"]
["MSTRG.16059","RF00563","ENSOART00000024324","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 53 [Source:HGNC Symbol;Acc:HGNC:32646]",{"v":50.76067,"d":"50.76"},{"v":84.642799,"d":"84.64"},{"v":116.244926,"d":"116.24"},{"v":146.81218,"d":"146.81"},{"v":186.704056,"d":"186.70"},{"v":166.392868,"d":"166.39"},{"v":0.503388301966191,"d":"0.50"},{"v":-0.990256404195896,"d":"-0.99"},{"v":0.0176774476378906,"d":"0.02"},{"v":0.246519453760565,"d":"0.25"},"down","no"]
["MSTRG.3317","RF00004","ENSOART00000025992;ENSOART00000023442","NA","NA","NA","NA",null,{"v":153.128756263021,"d":"153.13"},{"v":181.031432161458,"d":"181.03"},{"v":263.94815846875,"d":"263.95"},{"v":225.699461427083,"d":"225.70"},{"v":544.154032010417,"d":"544.15"},{"v":443.253898958333,"d":"443.25"},{"v":0.49303825089384,"d":"0.49"},{"v":-1.02022851677476,"d":"-1.02"},{"v":0.0176776401289173,"d":"0.02"},{"v":0.246519453760565,"d":"0.25"},"down","yes"]
["MSTRG.5905","ENSOARG00000012881;ENSOARG00000023203","ENSOART00000014006;ENSOART00000025105","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0035329(hippo signaling)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)","K09448","NA","TEA domain transcription factor 2 [Source:NCBI gene;Acc:101105097]",{"v":2.94195021108179,"d":"2.94"},{"v":2.04598443007916,"d":"2.05"},{"v":2.67328688654354,"d":"2.67"},{"v":4.82071557849604,"d":"4.82"},{"v":4.70096599736148,"d":"4.70"},{"v":4.85013925527705,"d":"4.85"},{"v":0.533072435129967,"d":"0.53"},{"v":-0.907596511804425,"d":"-0.91"},{"v":0.0176804652900786,"d":"0.02"},{"v":0.246519453760565,"d":"0.25"},"down","no"]
["MSTRG.11323","TNFRSF21","ENSOART00000012655","GO:0001783(B cell apoptotic process);GO:0002250(adaptive immune response);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0006915(apoptotic process);GO:0006959(humoral immune response);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030424(axon);GO:0030889(negative regulation of B cell proliferation);GO:0031226(intrinsic component of plasma membrane);GO:0031642(negative regulation of myelination);GO:0042130(negative regulation of T cell proliferation);GO:0042552(myelination);GO:0048713(regulation of oligodendrocyte differentiation);GO:0050852(T cell receptor signaling pathway);GO:0051402(neuron apoptotic process);GO:0071356(cellular response to tumor necrosis factor);GO:0097252(oligodendrocyte apoptotic process);GO:2000663(negative regulation of interleukin-5 secretion);GO:2000666(negative regulation of interleukin-13 secretion);GO:2001180(negative regulation of interleukin-10 secretion)","04060(Cytokine-cytokine receptor interaction)","K05157","NA","TNF receptor superfamily member 21 [Source:NCBI gene;Acc:101117284]",{"v":4.09039441829632,"d":"4.09"},{"v":2.60631635366258,"d":"2.61"},{"v":3.46136277129599,"d":"3.46"},{"v":6.59897430162413,"d":"6.60"},{"v":5.72043522671528,"d":"5.72"},{"v":6.07947890089493,"d":"6.08"},{"v":0.55210256762656,"d":"0.55"},{"v":-0.856991784296377,"d":"-0.86"},{"v":0.0176829751585255,"d":"0.02"},{"v":0.246519453760565,"d":"0.25"},"down","no"]
["MSTRG.7123","PDZD2;ENSOARG00000012446","ENSOART00000013439;ENSOART00000013535","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005515(protein binding)","NA","NA","NA","PDZ domain containing 2 [Source:NCBI gene;Acc:101119422]",{"v":2.71338649073551,"d":"2.71"},{"v":1.70355993170263,"d":"1.70"},{"v":2.07518948361767,"d":"2.08"},{"v":3.64602148486047,"d":"3.65"},{"v":4.48022205875042,"d":"4.48"},{"v":3.73824652790645,"d":"3.74"},{"v":0.547190470633142,"d":"0.55"},{"v":-0.869884989097067,"d":"-0.87"},{"v":0.0177425859232302,"d":"0.02"},{"v":0.246519453760565,"d":"0.25"},"down","no"]
["MSTRG.5330","RF00324","ENSOART00000023385","NA","NA","NA","NA",null,{"v":59.9315642161572,"d":"59.93"},{"v":51.8192435786026,"d":"51.82"},{"v":34.2682902925764,"d":"34.27"},{"v":61.5074426441048,"d":"61.51"},{"v":102.340585462882,"d":"102.34"},{"v":119.711351406114,"d":"119.71"},{"v":0.514950689827525,"d":"0.51"},{"v":-0.95749380423664,"d":"-0.96"},{"v":0.0177669422998576,"d":"0.02"},{"v":0.246519453760565,"d":"0.25"},"down","no"]
["MSTRG.7574","RFLNA","ENSOART00000001786","GO:0031005(filamin binding);GO:0032432(actin filament bundle);GO:0048705(skeletal system morphogenesis);GO:0061181(regulation of chondrocyte development);GO:0061182(negative regulation of chondrocyte development);GO:0061572(actin filament bundle organization);GO:1900158(negative regulation of bone mineralization involved in bone maturation)","NA","NA","NA","refilin A [Source:HGNC Symbol;Acc:HGNC:27051]",{"v":1.304556,"d":"1.30"},{"v":0.14494,"d":"0.14"},{"v":0.787549,"d":"0.79"},{"v":1.566625,"d":"1.57"},{"v":2.752418,"d":"2.75"},{"v":2.265525,"d":"2.27"},{"v":0.339740587385535,"d":"0.34"},{"v":-1.5574945136381,"d":"-1.56"},{"v":0.0178444687052992,"d":"0.02"},{"v":0.247036410874506,"d":"0.25"},"down","yes"]
["MSTRG.12628","GFRA1","ENSOART00000017617","GO:0007399(nervous system development);GO:0038023(signaling receptor activity)","NA","NA","NA","GDNF family receptor alpha 1 [Source:HGNC Symbol;Acc:HGNC:4243]",{"v":2.29298125218974,"d":"2.29"},{"v":1.7192826988966,"d":"1.72"},{"v":2.64836543464907,"d":"2.65"},{"v":4.95102758889774,"d":"4.95"},{"v":3.39716115424866,"d":"3.40"},{"v":3.88644003003071,"d":"3.89"},{"v":0.544407967680883,"d":"0.54"},{"v":-0.87723991333278,"d":"-0.88"},{"v":0.0178529498304702,"d":"0.02"},{"v":0.247036410874506,"d":"0.25"},"down","no"]
["ENSOARG00000003358","TRERF1","ENSOART00000003654","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol)","NA","NA","NA","transcriptional regulating factor 1 [Source:NCBI gene;Acc:101110370]",{"v":0.497047,"d":"0.50"},{"v":0.390493,"d":"0.39"},{"v":0.397925,"d":"0.40"},{"v":0.913855,"d":"0.91"},{"v":0.754239,"d":"0.75"},{"v":0.899841,"d":"0.90"},{"v":0.500583153389786,"d":"0.50"},{"v":-0.998318355459157,"d":"-1.00"},{"v":0.017957529073206,"d":"0.02"},{"v":0.24806305812801,"d":"0.25"},"down","no"]
["MSTRG.8638","SIVA1","ENSOART00000008454","GO:0001618(virus receptor activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005175(CD27 receptor binding);GO:0005654(nucleoplasm);GO:0046718(viral entry into host cell);GO:0097191(extrinsic apoptotic signaling pathway)","04115(p53 signaling pathway)","K22744","NA","SIVA1 apoptosis inducing factor [Source:NCBI gene;Acc:101106717]",{"v":2.784873,"d":"2.78"},{"v":4.335247,"d":"4.34"},{"v":3.18821,"d":"3.19"},{"v":4.457242,"d":"4.46"},{"v":7.928701,"d":"7.93"},{"v":10.247624,"d":"10.25"},{"v":0.455444340699811,"d":"0.46"},{"v":-1.13465334009781,"d":"-1.13"},{"v":0.0180543668237649,"d":"0.02"},{"v":0.24897947761692,"d":"0.25"},"down","yes"]
["ENSOARG00000002147","PIK3R6","ENSOART00000002318","GO:0005944(phosphatidylinositol 3-kinase complex, class IB);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0042269(regulation of natural killer cell mediated cytotoxicity);GO:0043406(positive regulation of MAP kinase activity);GO:0043551(regulation of phosphatidylinositol 3-kinase activity);GO:0045582(positive regulation of T cell differentiation);GO:0045766(positive regulation of angiogenesis);GO:0046854(phosphatidylinositol phosphorylation);GO:0046934(phosphatidylinositol-4,5-bisphosphate 3-kinase activity);GO:0046935(1-phosphatidylinositol-3-kinase regulator activity)","04022(cGMP-PKG signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04151(PI3K-Akt signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04371(Apelin signaling pathway);04611(Platelet activation);04725(Cholinergic synapse);04921(Oxytocin signaling pathway);05145(Toxoplasmosis);05167(Kaposi sarcoma-associated herpesvirus infection)","K21290","NA","phosphoinositide-3-kinase regulatory subunit 6 [Source:NCBI gene;Acc:101109720]",{"v":0.434129,"d":"0.43"},{"v":0.13196,"d":"0.13"},{"v":0.149749,"d":"0.15"},{"v":0.629877,"d":"0.63"},{"v":0.528151,"d":"0.53"},{"v":0.645711,"d":"0.65"},{"v":0.396863404295189,"d":"0.40"},{"v":-1.33328556070788,"d":"-1.33"},{"v":0.0180989820654705,"d":"0.02"},{"v":0.249173844152616,"d":"0.25"},"down","yes"]
["MSTRG.18911","YIPF7","ENSOART00000016303","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K20363","NA","Yip1 domain family member 7 [Source:NCBI gene;Acc:101120083]",{"v":7.97868351985244,"d":"7.98"},{"v":5.11360367139113,"d":"5.11"},{"v":3.09508100368896,"d":"3.10"},{"v":4.34534232962819,"d":"4.35"},{"v":2.38880224633531,"d":"2.39"},{"v":2.35591262586157,"d":"2.36"},{"v":1.78077737417125,"d":"1.78"},{"v":0.832507167616017,"d":"0.83"},{"v":0.0181951515075745,"d":"0.02"},{"v":0.249655826735863,"d":"0.25"},"up","no"]
["MSTRG.20766","ENSOARG00000004781;ENSOARG00000004788","ENSOART00000005206;ENSOART00000005212","GO:0004842(ubiquitin-protein transferase activity);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0046872(metal ion binding);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0098793(presynapse)","NA","NA","NA",null,{"v":2.82630815696569,"d":"2.83"},{"v":2.8485591902779,"d":"2.85"},{"v":2.64934510292387,"d":"2.65"},{"v":2.14319076418937,"d":"2.14"},{"v":1.58078986901421,"d":"1.58"},{"v":1.55326996867928,"d":"1.55"},{"v":1.57737675887468,"d":"1.58"},{"v":0.657527291226261,"d":"0.66"},{"v":0.0182597806733984,"d":"0.02"},{"v":0.250296215613334,"d":"0.25"},"up","no"]
["ENSOARG00000014041","OPCML","ENSOART00000015286","NA","NA","K06773","NA","opioid binding protein/cell adhesion molecule like [Source:NCBI gene;Acc:101117888]",{"v":0.311757,"d":"0.31"},{"v":0.2669,"d":"0.27"},{"v":0.269758,"d":"0.27"},{"v":1.069815,"d":"1.07"},{"v":0.315186,"d":"0.32"},{"v":0.578154,"d":"0.58"},{"v":0.432169135906233,"d":"0.43"},{"v":-1.21033205153072,"d":"-1.21"},{"v":0.0183638802145466,"d":"0.02"},{"v":0.251054457150876,"d":"0.25"},"down","yes"]
["MSTRG.16062","ENSOARG00000018422","ENSOART00000020047","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0008097(5S rRNA binding)","NA","NA","NA",null,{"v":2.603712,"d":"2.60"},{"v":1.048806,"d":"1.05"},{"v":10.499376,"d":"10.50"},{"v":1.766234,"d":"1.77"},{"v":1.795299,"d":"1.80"},{"v":1.675034,"d":"1.68"},{"v":2.70251368883469,"d":"2.70"},{"v":1.43430192555064,"d":"1.43"},{"v":0.0184536129460257,"d":"0.02"},{"v":0.251721463811786,"d":"0.25"},"up","yes"]
["MSTRG.2926","PLSCR3","ENSOART00000014119","GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0042593(glucose homeostasis);GO:0042632(cholesterol homeostasis);GO:0048306(calcium-dependent protein binding);GO:0071222(cellular response to lipopolysaccharide)","NA","NA","NA","phospholipid scramblase 3 [Source:NCBI gene;Acc:101120094]",{"v":1.57985116354282,"d":"1.58"},{"v":1.01083483902977,"d":"1.01"},{"v":1.30045309812569,"d":"1.30"},{"v":2.24184612348401,"d":"2.24"},{"v":2.44249539103271,"d":"2.44"},{"v":2.67694895259096,"d":"2.68"},{"v":0.528594696552865,"d":"0.53"},{"v":-0.91976614454894,"d":"-0.92"},{"v":0.0185311029618537,"d":"0.02"},{"v":0.252292612894882,"d":"0.25"},"down","no"]
["MSTRG.9388","RGS3","ENSOART00000006746","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol)","04360(Axon guidance)","K07524","NA","regulator of G protein signaling 3 [Source:NCBI gene;Acc:101104962]",{"v":2.60463058751799,"d":"2.60"},{"v":2.05629831939711,"d":"2.06"},{"v":2.31465628198137,"d":"2.31"},{"v":4.85650686071347,"d":"4.86"},{"v":3.75654486821177,"d":"3.76"},{"v":3.88761054896614,"d":"3.89"},{"v":0.558017250112697,"d":"0.56"},{"v":-0.841618373787424,"d":"-0.84"},{"v":0.0185418382823284,"d":"0.02"},{"v":0.252292612894882,"d":"0.25"},"down","no"]
["MSTRG.15800","SLC38A4","ENSOART00000021190","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K14991","NA","solute carrier family 38 member 4 [Source:NCBI gene;Acc:101111619]",{"v":0.81859,"d":"0.82"},{"v":0.248954,"d":"0.25"},{"v":0.504022,"d":"0.50"},{"v":1.846474,"d":"1.85"},{"v":0.760645,"d":"0.76"},{"v":0.949111,"d":"0.95"},{"v":0.441919110968638,"d":"0.44"},{"v":-1.17814577251952,"d":"-1.18"},{"v":0.0186514153262055,"d":"0.02"},{"v":0.253572280971094,"d":"0.25"},"down","yes"]
["MSTRG.20949","ADGRB1","ENSOART00000002291","GO:0001530(lipopolysaccharide binding);GO:0001786(phosphatidylserine binding);GO:0001891(phagocytic cup);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006910(phagocytosis, recognition);GO:0006911(phagocytosis, engulfment);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0010596(negative regulation of endothelial cell migration);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016525(negative regulation of angiogenesis);GO:0030165(PDZ domain binding);GO:0030425(dendrite);GO:0031397(negative regulation of protein ubiquitination);GO:0042177(negative regulation of protein catabolic process);GO:0043277(apoptotic cell clearance);GO:0043652(engulfment of apoptotic cell);GO:0048167(regulation of synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0050829(defense response to Gram-negative bacterium);GO:0051965(positive regulation of synapse assembly);GO:1901741(positive regulation of myoblast fusion);GO:1903428(positive regulation of reactive oxygen species biosynthetic process)","NA","NA","NA","adhesion G protein-coupled receptor B1 [Source:HGNC Symbol;Acc:HGNC:943]",{"v":0.134072,"d":"0.13"},{"v":0.174546,"d":"0.17"},{"v":0.109142,"d":"0.11"},{"v":0.201113,"d":"0.20"},{"v":0.497145,"d":"0.50"},{"v":0.322676,"d":"0.32"},{"v":0.409193934181837,"d":"0.41"},{"v":-1.28914333590051,"d":"-1.29"},{"v":0.0187015725856174,"d":"0.02"},{"v":0.253816504572467,"d":"0.25"},"down","yes"]
["MSTRG.15104","USP34","ENSOART00000022025","GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination);GO:0090263(positive regulation of canonical Wnt signaling pathway)","NA","K11853","EC:3.4.19.12","ubiquitin specific peptidase 34 [Source:NCBI gene;Acc:101120484]",{"v":11.3728345824811,"d":"11.37"},{"v":11.9966825144875,"d":"12.00"},{"v":10.7075294453981,"d":"10.71"},{"v":8.37176930034088,"d":"8.37"},{"v":8.03167318705868,"d":"8.03"},{"v":5.29786926923545,"d":"5.30"},{"v":1.57027588583201,"d":"1.57"},{"v":0.65101805220935,"d":"0.65"},{"v":0.0187270147180706,"d":"0.02"},{"v":0.253816504572467,"d":"0.25"},"up","no"]
["MSTRG.21676","CYBB","ENSOART00000020626","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0009055(electron transfer activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016175(superoxide-generating NADPH oxidase activity);GO:0016491(oxidoreductase activity);GO:0020037(heme binding);GO:0022900(electron transport chain);GO:0042554(superoxide anion generation);GO:0043020(NADPH oxidase complex);GO:0045087(innate immune response);GO:0045335(phagocytic vesicle);GO:0045730(respiratory burst);GO:0046982(protein heterodimerization activity);GO:0050660(flavin adenine dinucleotide binding);GO:0050665(hydrogen peroxide biosynthetic process);GO:0055114(oxidation-reduction process)","04066(HIF-1 signaling pathway);04145(Phagosome);04216(Ferroptosis);04217(Necroptosis);04621(NOD-like receptor signaling pathway);04670(Leukocyte transendothelial migration);04933(AGE-RAGE signaling pathway in diabetic complications);05140(Leishmaniasis)","K21421","EC:1.-.-.-","cytochrome b-245, beta polypeptide [Source:NCBI gene;Acc:100036757]",{"v":1.00208,"d":"1.00"},{"v":0.550184,"d":"0.55"},{"v":0.784663,"d":"0.78"},{"v":1.547754,"d":"1.55"},{"v":1.371241,"d":"1.37"},{"v":1.863063,"d":"1.86"},{"v":0.488686460933765,"d":"0.49"},{"v":-1.03301895963834,"d":"-1.03"},{"v":0.0187793061635388,"d":"0.02"},{"v":0.253816504572467,"d":"0.25"},"down","yes"]
["MSTRG.11713","ENSOARG00000002495","ENSOART00000002705","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA","NA","NA",null,{"v":0.547940126398601,"d":"0.55"},{"v":3.06901865939685,"d":"3.07"},{"v":2.26228606962413,"d":"2.26"},{"v":1.3213219229458,"d":"1.32"},{"v":0.73738025354021,"d":"0.74"},{"v":0.734688735096154,"d":"0.73"},{"v":2.10469821142563,"d":"2.10"},{"v":1.07361338289123,"d":"1.07"},{"v":0.0188248277215371,"d":"0.02"},{"v":0.253816504572467,"d":"0.25"},"up","yes"]
["MSTRG.11755","CHORDC1","ENSOART00000003479","GO:0005524(ATP binding);GO:0008270(zinc ion binding);GO:0010824(regulation of centrosome duplication);GO:0043531(ADP binding);GO:0051879(Hsp90 protein binding);GO:0061077(chaperone-mediated protein folding);GO:1900034(regulation of cellular response to heat);GO:2000299(negative regulation of Rho-dependent protein serine/threonine kinase activity)","NA","K16729","NA","cysteine and histidine rich domain containing 1 [Source:NCBI gene;Acc:101108786]",{"v":2.51090530200685,"d":"2.51"},{"v":4.84579523731441,"d":"4.85"},{"v":4.53946490667319,"d":"4.54"},{"v":2.34290326635666,"d":"2.34"},{"v":2.57077207048458,"d":"2.57"},{"v":2.2048660945505,"d":"2.20"},{"v":1.67115209775054,"d":"1.67"},{"v":0.740843044401216,"d":"0.74"},{"v":0.0188974823787262,"d":"0.02"},{"v":0.254017154425631,"d":"0.25"},"up","no"]
["MSTRG.14934","ENSOARG00000017679","ENSOART00000019236","GO:0005623(cell);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008199(ferric iron binding);GO:0046872(metal ion binding)","04216(Ferroptosis);04217(Necroptosis);04978(Mineral absorption)","K00522","EC:1.16.3.2","ferritin heavy chain [Source:NCBI gene;Acc:101105484]",{"v":410.533081,"d":"410.53"},{"v":321.672668,"d":"321.67"},{"v":474.872589,"d":"474.87"},{"v":642.048462,"d":"642.05"},{"v":678.247986,"d":"678.25"},{"v":854.199463,"d":"854.20"},{"v":0.55510720065916,"d":"0.56"},{"v":-0.849161687523979,"d":"-0.85"},{"v":0.0189305155015537,"d":"0.02"},{"v":0.254017154425631,"d":"0.25"},"down","no"]
["MSTRG.11378","ENSOARG00000001755","ENSOART00000001888","GO:0005576(extracellular region);GO:0005615(extracellular space)","04610(Complement and coagulation cascades);05133(Pertussis);05150(Staphylococcus aureus infection);05322(Systemic lupus erythematosus)","K03989","NA","complement C4 [Source:NCBI gene;Acc:101123419]",{"v":0.767584080157687,"d":"0.77"},{"v":0.728952637757337,"d":"0.73"},{"v":0.241018250985545,"d":"0.24"},{"v":2.05122694962768,"d":"2.05"},{"v":0.855263158125274,"d":"0.86"},{"v":1.33045682435392,"d":"1.33"},{"v":0.410095995239796,"d":"0.41"},{"v":-1.28596643967846,"d":"-1.29"},{"v":0.0189874078853963,"d":"0.02"},{"v":0.254017154425631,"d":"0.25"},"down","yes"]
["MSTRG.1677","ENSOARG00000002161","ENSOART00000002332","GO:0005515(protein binding);GO:0007165(signal transduction)","NA","NA","NA",null,{"v":1.427713088337,"d":"1.43"},{"v":0.390233676516819,"d":"0.39"},{"v":0.464638884313109,"d":"0.46"},{"v":2.3706970817353,"d":"2.37"},{"v":1.49086075227916,"d":"1.49"},{"v":1.42426207827727,"d":"1.42"},{"v":0.431831898748379,"d":"0.43"},{"v":-1.2114582779597,"d":"-1.21"},{"v":0.0190056520002349,"d":"0.02"},{"v":0.254017154425631,"d":"0.25"},"down","yes"]
["MSTRG.15778","RF00410","ENSOART00000025160","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 2C [Source:HGNC Symbol;Acc:HGNC:32624]",{"v":9.545135,"d":"9.55"},{"v":11.03468,"d":"11.03"},{"v":8.222858,"d":"8.22"},{"v":14.602956,"d":"14.60"},{"v":18.138422,"d":"18.14"},{"v":28.671505,"d":"28.67"},{"v":0.46900050271211,"d":"0.47"},{"v":-1.09233862575038,"d":"-1.09"},{"v":0.0190159410955801,"d":"0.02"},{"v":0.254017154425631,"d":"0.25"},"down","yes"]
["MSTRG.2159","SPRYD7","ENSOART00000009424","GO:0005515(protein binding)","NA","NA","NA","SPRY domain containing 7 [Source:HGNC Symbol;Acc:HGNC:14297]",{"v":3.81944636959337,"d":"3.82"},{"v":3.64959401139601,"d":"3.65"},{"v":2.43773704584305,"d":"2.44"},{"v":2.55989947837348,"d":"2.56"},{"v":1.68835237969438,"d":"1.69"},{"v":1.785988999741,"d":"1.79"},{"v":1.64176035731357,"d":"1.64"},{"v":0.715243556746209,"d":"0.72"},{"v":0.0190358460757099,"d":"0.02"},{"v":0.254017154425631,"d":"0.25"},"up","no"]
["MSTRG.1126","BACH1","ENSOART00000015671","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000117(regulation of transcription involved in G2/M transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia)","NA","K09042","NA","BTB domain and CNC homolog 1 [Source:NCBI gene;Acc:101117134]",{"v":2.49498428760373,"d":"2.49"},{"v":3.82915300224758,"d":"3.83"},{"v":4.75826507797372,"d":"4.76"},{"v":2.19662475389004,"d":"2.20"},{"v":2.47555522320194,"d":"2.48"},{"v":2.00748790707123,"d":"2.01"},{"v":1.65912475889711,"d":"1.66"},{"v":0.730422374705349,"d":"0.73"},{"v":0.0191349308664509,"d":"0.02"},{"v":0.254361507011212,"d":"0.25"},"up","no"]
["MSTRG.3511","BAIAP2","ENSOART00000000283","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0008093(cytoskeletal adaptor activity);GO:0008360(regulation of cell shape);GO:0009617(response to bacterium);GO:0015629(actin cytoskeleton);GO:0016358(dendrite development);GO:0032956(regulation of actin cytoskeleton organization);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0048167(regulation of synaptic plasticity);GO:0050804(modulation of chemical synaptic transmission);GO:0051017(actin filament bundle assembly);GO:0051764(actin crosslink formation);GO:0070064(proline-rich region binding);GO:0098685(Schaffer collateral - CA1 synapse);GO:0099564(modification of synaptic structure, modulating synaptic transmission)","04520(Adherens junction);04810(Regulation of actin cytoskeleton)","K05627","NA","BAI1 associated protein 2 [Source:NCBI gene;Acc:101109895]",{"v":2.60097447047472,"d":"2.60"},{"v":3.34065778232343,"d":"3.34"},{"v":3.36098673562331,"d":"3.36"},{"v":1.73460442647626,"d":"1.73"},{"v":2.18439372365882,"d":"2.18"},{"v":1.84212645445774,"d":"1.84"},{"v":1.61472275413126,"d":"1.61"},{"v":0.69128647725597,"d":"0.69"},{"v":0.0191456572829973,"d":"0.02"},{"v":0.254361507011212,"d":"0.25"},"up","no"]
["MSTRG.9575","FRMD3","ENSOART00000009853","GO:0005856(cytoskeleton);GO:0008092(cytoskeletal protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","FERM domain containing 3 [Source:NCBI gene;Acc:101119441]",{"v":3.650852703657,"d":"3.65"},{"v":4.29326771752837,"d":"4.29"},{"v":3.23774700630517,"d":"3.24"},{"v":2.9186764665826,"d":"2.92"},{"v":1.81618024968474,"d":"1.82"},{"v":1.98807355611601,"d":"1.99"},{"v":1.66324310597475,"d":"1.66"},{"v":0.73399905386335,"d":"0.73"},{"v":0.0191685059002192,"d":"0.02"},{"v":0.254458019787625,"d":"0.25"},"up","no"]
["ENSOARG00000006086","PLEKHG2","ENSOART00000006620","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0030833(regulation of actin filament polymerization);GO:0035023(regulation of Rho protein signal transduction)","NA","NA","NA","pleckstrin homology and RhoGEF domain containing G2 [Source:NCBI gene;Acc:101115645]",{"v":1.365994,"d":"1.37"},{"v":0.60958,"d":"0.61"},{"v":0.81585,"d":"0.82"},{"v":1.939347,"d":"1.94"},{"v":1.841326,"d":"1.84"},{"v":1.655206,"d":"1.66"},{"v":0.513518420847852,"d":"0.51"},{"v":-0.961512065297777,"d":"-0.96"},{"v":0.0192480873516146,"d":"0.02"},{"v":0.254892757726815,"d":"0.25"},"down","no"]
["MSTRG.13794","ENSOARG00000004594","ENSOART00000005001","GO:0006974(cellular response to DNA damage stimulus);GO:0008283(cell population proliferation)","NA","K23112","NA","BRCA1 associated ATM activator 1 [Source:NCBI gene;Acc:101111600]",{"v":0.392344,"d":"0.39"},{"v":0.229075,"d":"0.23"},{"v":0.39021,"d":"0.39"},{"v":0.575392,"d":"0.58"},{"v":0.869103,"d":"0.87"},{"v":0.983149,"d":"0.98"},{"v":0.41671225270262,"d":"0.42"},{"v":-1.26287657427232,"d":"-1.26"},{"v":0.0192827181267067,"d":"0.02"},{"v":0.255144425909941,"d":"0.26"},"down","yes"]
["MSTRG.8783","CSRNP1","ENSOART00000002423","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0009791(post-embryonic development);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis)","NA","K17494","NA","cysteine and serine rich nuclear protein 1 [Source:NCBI gene;Acc:101112518]",{"v":6.49158373255096,"d":"6.49"},{"v":3.58876243545398,"d":"3.59"},{"v":5.39656895058678,"d":"5.40"},{"v":4.12672732180358,"d":"4.13"},{"v":2.6335581846819,"d":"2.63"},{"v":2.56554406114886,"d":"2.57"},{"v":1.65957516233247,"d":"1.66"},{"v":0.730813970704995,"d":"0.73"},{"v":0.0193988156244337,"d":"0.02"},{"v":0.256281601244192,"d":"0.26"},"up","no"]
["MSTRG.21106","MTFR1","ENSOART00000018589","GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0009060(aerobic respiration)","NA","NA","NA","mitochondrial fission regulator 1 [Source:NCBI gene;Acc:101120170]",{"v":0.712628015096032,"d":"0.71"},{"v":1.93383133016964,"d":"1.93"},{"v":1.37289867827517,"d":"1.37"},{"v":0.752211570585158,"d":"0.75"},{"v":0.939835163590165,"d":"0.94"},{"v":0.522110997309618,"d":"0.52"},{"v":1.81529886800126,"d":"1.82"},{"v":0.860207090858668,"d":"0.86"},{"v":0.0195862430198158,"d":"0.02"},{"v":0.258532074395758,"d":"0.26"},"up","no"]
["MSTRG.21977","FUNDC2","ENSOART00000003742","GO:0005739(mitochondrion)","NA","NA","NA","FUN14 domain containing 2 [Source:NCBI gene;Acc:101104126]",{"v":31.985111,"d":"31.99"},{"v":37.133598,"d":"37.13"},{"v":28.483774,"d":"28.48"},{"v":24.734632,"d":"24.73"},{"v":17.001453,"d":"17.00"},{"v":20.273521,"d":"20.27"},{"v":1.57398972991378,"d":"1.57"},{"v":0.654426127471323,"d":"0.65"},{"v":0.0196359335110514,"d":"0.02"},{"v":0.258911492506203,"d":"0.26"},"up","no"]
["MSTRG.6601","DGAT2","ENSOART00000013256","GO:0003846(2-acylglycerol O-acyltransferase activity);GO:0004144(diacylglycerol O-acyltransferase activity);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005811(lipid droplet);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016747(transferase activity, transferring acyl groups other than amino-acyl groups);GO:0019432(triglyceride biosynthetic process);GO:0019915(lipid storage);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0034383(low-density lipoprotein particle clearance);GO:0035336(long-chain fatty-acyl-CoA metabolic process);GO:0035356(cellular triglyceride homeostasis);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0046339(diacylglycerol metabolic process);GO:0048471(perinuclear region of cytoplasm);GO:0055089(fatty acid homeostasis);GO:0060613(fat pad development);GO:0071400(cellular response to oleic acid);GO:0097006(regulation of plasma lipoprotein particle levels);GO:1990578(perinuclear endoplasmic reticulum membrane)","00561(Glycerolipid metabolism);04975(Fat digestion and absorption)","K11160","2.3.1.75;EC:2.3.1.20","diacylglycerol O-acyltransferase 2 [Source:NCBI gene;Acc:101110535]",{"v":0.957732832263978,"d":"0.96"},{"v":1.88884615948671,"d":"1.89"},{"v":0.846394940421632,"d":"0.85"},{"v":0.200903519706691,"d":"0.20"},{"v":0.985663904674611,"d":"0.99"},{"v":0.385614592117324,"d":"0.39"},{"v":2.34894808197645,"d":"2.35"},{"v":1.23201482629057,"d":"1.23"},{"v":0.0197103701284747,"d":"0.02"},{"v":0.259123126777565,"d":"0.26"},"up","yes"]
["MSTRG.7555","UBC","ENSOART00000019780","GO:0002020(protease binding);GO:0005515(protein binding)","NA","NA","NA","ubiquitin C [Source:HGNC Symbol;Acc:HGNC:12468]",{"v":208.817177984716,"d":"208.82"},{"v":190.523539703603,"d":"190.52"},{"v":358.15806115393,"d":"358.16"},{"v":136.609053749454,"d":"136.61"},{"v":132.325446292031,"d":"132.33"},{"v":177.55758725,"d":"177.56"},{"v":1.69655588621379,"d":"1.70"},{"v":0.762608954620365,"d":"0.76"},{"v":0.0197506890148532,"d":"0.02"},{"v":0.259295837492354,"d":"0.26"},"up","no"]
["MSTRG.9411","SVEP1","ENSOART00000007491;ENSOART00000007487","GO:0003682(chromatin binding);GO:0005509(calcium ion binding);GO:0005509(calcium ion binding)","NA","K17495","NA","sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 [Source:NCBI gene;Acc:101113459]",{"v":4.60965934403381,"d":"4.61"},{"v":3.03427214881755,"d":"3.03"},{"v":4.93906404846686,"d":"4.94"},{"v":7.5397555060696,"d":"7.54"},{"v":7.41694230671702,"d":"7.42"},{"v":7.91449366046219,"d":"7.91"},{"v":0.550167906907511,"d":"0.55"},{"v":-0.862056109896607,"d":"-0.86"},{"v":0.0197552683635772,"d":"0.02"},{"v":0.259295837492354,"d":"0.26"},"down","no"]
["MSTRG.3507","SLC38A10","ENSOART00000020367","GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0060348(bone development)","NA","K14996","NA","solute carrier family 38 member 10 [Source:NCBI gene;Acc:101118542]",{"v":1.7897307211704,"d":"1.79"},{"v":1.44508300946644,"d":"1.45"},{"v":1.72180657487091,"d":"1.72"},{"v":2.44334091802926,"d":"2.44"},{"v":3.36417866953528,"d":"3.36"},{"v":3.12798248859725,"d":"3.13"},{"v":0.554710889579564,"d":"0.55"},{"v":-0.850192047469477,"d":"-0.85"},{"v":0.0197745389753926,"d":"0.02"},{"v":0.259340299108603,"d":"0.26"},"down","no"]
["MSTRG.5705","PLD3","ENSOART00000007183","GO:0003824(catalytic activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism)","K16860","EC:3.1.4.4","phospholipase D family member 3 [Source:NCBI gene;Acc:101118551]",{"v":2.23125508676278,"d":"2.23"},{"v":1.48390489252949,"d":"1.48"},{"v":2.12676937876802,"d":"2.13"},{"v":2.92052189252949,"d":"2.92"},{"v":3.35301529619921,"d":"3.35"},{"v":4.56367910484928,"d":"4.56"},{"v":0.539061803308489,"d":"0.54"},{"v":-0.891477407781204,"d":"-0.89"},{"v":0.0198264407578808,"d":"0.02"},{"v":0.259635613635794,"d":"0.26"},"down","no"]
["MSTRG.16696","ENSOARG00000019964","ENSOART00000021734","GO:0004103(choline kinase activity);GO:0006656(phosphatidylcholine biosynthetic process);GO:0007517(muscle organ development);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0046474(glycerophospholipid biosynthetic process)","00564(Glycerophospholipid metabolism);05231(Choline metabolism in cancer)","K14156","2.7.1.82;EC:2.7.1.32","choline kinase beta [Source:NCBI gene;Acc:101118779]",{"v":3.68610771502486,"d":"3.69"},{"v":3.23880522552501,"d":"3.24"},{"v":3.35269001156539,"d":"3.35"},{"v":6.90313394075276,"d":"6.90"},{"v":5.69390336370092,"d":"5.69"},{"v":5.64963389215786,"d":"5.65"},{"v":0.563259064701283,"d":"0.56"},{"v":-0.828129468505031,"d":"-0.83"},{"v":0.0198927074414851,"d":"0.02"},{"v":0.260054545319912,"d":"0.26"},"down","no"]
["MSTRG.2361","KCTD12","ENSOART00000017378","GO:0005515(protein binding);GO:0042802(identical protein binding);GO:0051260(protein homooligomerization)","NA","NA","NA","potassium channel tetramerization domain containing 12 [Source:HGNC Symbol;Acc:HGNC:14678]",{"v":1.600935,"d":"1.60"},{"v":0.828744,"d":"0.83"},{"v":1.325413,"d":"1.33"},{"v":2.099598,"d":"2.10"},{"v":2.969277,"d":"2.97"},{"v":2.746281,"d":"2.75"},{"v":0.480488425311024,"d":"0.48"},{"v":-1.057426417161,"d":"-1.06"},{"v":0.0199411069681714,"d":"0.02"},{"v":0.260062615476281,"d":"0.26"},"down","yes"]
["MSTRG.10689","PNKD","ENSOART00000021243;ENSOART00000021245","GO:0004416(hydroxyacylglutathione hydrolase activity);GO:0005739(mitochondrion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019243(methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione);GO:0032225(regulation of synaptic transmission, dopaminergic);GO:0042053(regulation of dopamine metabolic process);GO:0046929(negative regulation of neurotransmitter secretion);GO:0050884(neuromuscular process controlling posture);GO:0050884(neuromuscular process controlling posture)","NA","NA","NA","PNKD, MBL domain containing [Source:NCBI gene;Acc:101109335]",{"v":3.5820550511658,"d":"3.58"},{"v":2.72023054695596,"d":"2.72"},{"v":2.65998461658031,"d":"2.66"},{"v":5.71525565123057,"d":"5.72"},{"v":4.83863359585492,"d":"4.84"},{"v":5.32772932189119,"d":"5.33"},{"v":0.564317180631013,"d":"0.56"},{"v":-0.825421821800141,"d":"-0.83"},{"v":0.0199598726023727,"d":"0.02"},{"v":0.260099600839219,"d":"0.26"},"down","no"]
["MSTRG.8832","IRAK2","ENSOART00000005414","GO:0001959(regulation of cytokine-mediated signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0042803(protein homodimerization activity);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0046982(protein heterodimerization activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070555(response to interleukin-1)","04722(Neurotrophin signaling pathway);05152(Tuberculosis)","K04731","EC:2.7.11.1","interleukin 1 receptor associated kinase 2 [Source:NCBI gene;Acc:101122222]",{"v":2.632132,"d":"2.63"},{"v":7.851636,"d":"7.85"},{"v":6.411158,"d":"6.41"},{"v":2.246526,"d":"2.25"},{"v":2.936044,"d":"2.94"},{"v":3.561839,"d":"3.56"},{"v":1.93208323169696,"d":"1.93"},{"v":0.950157244986321,"d":"0.95"},{"v":0.0201504626654128,"d":"0.02"},{"v":0.261339013670998,"d":"0.26"},"up","no"]
["MSTRG.8330","NFKBIA","ENSOART00000008168","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006606(protein import into nucleus);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0007253(cytoplasmic sequestering of NF-kappaB);GO:0008139(nuclear localization sequence binding);GO:0010468(regulation of gene expression);GO:0010745(negative regulation of macrophage derived foam cell differentiation);GO:0010875(positive regulation of cholesterol efflux);GO:0010888(negative regulation of lipid storage);GO:0019899(enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032270(positive regulation of cellular protein metabolic process);GO:0032495(response to muramyl dipeptide);GO:0032496(response to lipopolysaccharide);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0035994(response to muscle stretch);GO:0042127(regulation of cell population proliferation);GO:0042802(identical protein binding);GO:0042994(cytoplasmic sequestering of transcription factor);GO:0043330(response to exogenous dsRNA);GO:0045638(negative regulation of myeloid cell differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050729(positive regulation of inflammatory response);GO:0051059(NF-kappaB binding);GO:0070427(nucleotide-binding oligomerization domain containing 1 signaling pathway);GO:0070431(nucleotide-binding oligomerization domain containing 2 signaling pathway);GO:0071356(cellular response to tumor necrosis factor)","04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04064(NF-kappa B signaling pathway);04210(Apoptosis);04380(Osteoclast differentiation);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04625(C-type lectin receptor signaling pathway);04657(IL-17 signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04668(TNF signaling pathway);04722(Neurotrophin signaling pathway);04920(Adipocytokine signaling pathway);04926(Relaxin signaling pathway);04931(Insulin resistance);05134(Legionellosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05145(Toxoplasmosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05164(Influenza A);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05215(Prostate cancer);05220(Chronic myeloid leukemia);05222(Small cell lung cancer)","K04734","NA","NFKB inhibitor alpha [Source:NCBI gene;Acc:780520]",{"v":6.957565,"d":"6.96"},{"v":7.007618,"d":"7.01"},{"v":7.398245,"d":"7.40"},{"v":13.68125,"d":"13.68"},{"v":10.543293,"d":"10.54"},{"v":14.171984,"d":"14.17"},{"v":0.556389592214942,"d":"0.56"},{"v":-0.845832661708013,"d":"-0.85"},{"v":0.0201553007520647,"d":"0.02"},{"v":0.261339013670998,"d":"0.26"},"down","no"]
["MSTRG.17067","WIPF3","ENSOART00000009585","GO:0003779(actin binding)","04144(Endocytosis)","K19475","NA","WAS/WASL interacting protein family member 3 [Source:NCBI gene;Acc:101111451]",{"v":5.48494315444015,"d":"5.48"},{"v":3.67630853199117,"d":"3.68"},{"v":3.82438917071153,"d":"3.82"},{"v":7.15182909487038,"d":"7.15"},{"v":7.99484577220077,"d":"7.99"},{"v":7.9919348425262,"d":"7.99"},{"v":0.561210937913729,"d":"0.56"},{"v":-0.833384967754001,"d":"-0.83"},{"v":0.0201873650990599,"d":"0.02"},{"v":0.261339013670998,"d":"0.26"},"down","no"]
["MSTRG.17697","C19orf53","ENSOART00000008900","GO:0005634(nucleus);GO:0005730(nucleolus)","NA","NA","NA","chromosome 5 open reading frame, human C19orf53 [Source:NCBI gene;Acc:101102725]",{"v":13.3160353222892,"d":"13.32"},{"v":14.1827430210843,"d":"14.18"},{"v":15.2813762771084,"d":"15.28"},{"v":20.50576275,"d":"20.51"},{"v":25.6330775361446,"d":"25.63"},{"v":32.6538389487952,"d":"32.65"},{"v":0.542945804557836,"d":"0.54"},{"v":-0.881119895748619,"d":"-0.88"},{"v":0.0202003143739522,"d":"0.02"},{"v":0.261339013670998,"d":"0.26"},"down","no"]
["MSTRG.4759","ADRA1D","ENSOART00000000264","GO:0004930(G protein-coupled receptor activity);GO:0004935(adrenergic receptor activity);GO:0004937(alpha1-adrenergic receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0071875(adrenergic receptor signaling pathway)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion)","K04137","NA","adrenoceptor alpha 1D [Source:NCBI gene;Acc:100170316]",{"v":0.987328,"d":"0.99"},{"v":0.881682,"d":"0.88"},{"v":0.971174,"d":"0.97"},{"v":1.665198,"d":"1.67"},{"v":2.334796,"d":"2.33"},{"v":1.668953,"d":"1.67"},{"v":0.501007329932702,"d":"0.50"},{"v":-0.997096384121168,"d":"-1.00"},{"v":0.0202048971680083,"d":"0.02"},{"v":0.261339013670998,"d":"0.26"},"down","no"]
["MSTRG.5031","PPP1R16B","ENSOART00000000437;ENSOART00000000434","GO:0001938(positive regulation of endothelial cell proliferation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0016607(nuclear speck);GO:0019888(protein phosphatase regulator activity);GO:0035304(regulation of protein dephosphorylation);GO:0035307(positive regulation of protein dephosphorylation);GO:0035308(negative regulation of protein dephosphorylation);GO:0042995(cell projection);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0048471(perinuclear region of cytoplasm);GO:0061028(establishment of endothelial barrier);GO:1902309(negative regulation of peptidyl-serine dephosphorylation);GO:1903589(positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:1903589(positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis)","NA","K17459","NA","protein phosphatase 1 regulatory subunit 16B [Source:NCBI gene;Acc:101105769]",{"v":2.0332510215311,"d":"2.03"},{"v":0.921253303030303,"d":"0.92"},{"v":0.742673875598086,"d":"0.74"},{"v":2.44804470255183,"d":"2.45"},{"v":2.52587103588517,"d":"2.53"},{"v":2.47017653987241,"d":"2.47"},{"v":0.496659372551348,"d":"0.50"},{"v":-1.00967135780809,"d":"-1.01"},{"v":0.0202143939793163,"d":"0.02"},{"v":0.261339013670998,"d":"0.26"},"down","yes"]
["MSTRG.4021","PLEKHG5","ENSOART00000012939;ENSOART00000012935","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0030027(lamellipodium);GO:0030139(endocytic vesicle);GO:0035023(regulation of Rho protein signal transduction);GO:0035767(endothelial cell chemotaxis);GO:0043542(endothelial cell migration);GO:0098793(presynapse);GO:0099575(regulation of protein catabolic process at presynapse, modulating synaptic transmission);GO:0099575(regulation of protein catabolic process at presynapse, modulating synaptic transmission)","05200(Pathways in cancer);05200(Pathways in cancer)","K19464","NA","pleckstrin homology and RhoGEF domain containing G5 [Source:NCBI gene;Acc:101121531]",{"v":2.02930152999124,"d":"2.03"},{"v":0.978522836033275,"d":"0.98"},{"v":1.22130745731173,"d":"1.22"},{"v":2.56222855297723,"d":"2.56"},{"v":2.87924417403678,"d":"2.88"},{"v":2.44718907990368,"d":"2.45"},{"v":0.536102564268588,"d":"0.54"},{"v":-0.89941905911766,"d":"-0.90"},{"v":0.0202310456443007,"d":"0.02"},{"v":0.261339013670998,"d":"0.26"},"down","no"]
["MSTRG.8476","RF00181","ENSOART00000026307;ENSOART00000027060","NA","NA","NA","NA",null,{"v":0.736557351167315,"d":"0.74"},{"v":1.11900521498054,"d":"1.12"},{"v":1.615067692607,"d":"1.62"},{"v":1.42934609046693,"d":"1.43"},{"v":3.1597108463035,"d":"3.16"},{"v":3.11965753988327,"d":"3.12"},{"v":0.450221663970804,"d":"0.45"},{"v":-1.15129261616888,"d":"-1.15"},{"v":0.0202637883816967,"d":"0.02"},{"v":0.261555048771813,"d":"0.26"},"down","yes"]
["MSTRG.17225","KCP","ENSOART00000003947","GO:0002244(hematopoietic progenitor cell differentiation);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0030513(positive regulation of BMP signaling pathway)","NA","NA","NA","kielin cysteine rich BMP regulator [Source:NCBI gene;Acc:101105154]",{"v":1.12781091455827,"d":"1.13"},{"v":0.784324009954376,"d":"0.78"},{"v":0.99581171630029,"d":"1.00"},{"v":1.99140302799668,"d":"1.99"},{"v":2.1318934311489,"d":"2.13"},{"v":1.34518037909581,"d":"1.35"},{"v":0.531765375776576,"d":"0.53"},{"v":-0.911138251166082,"d":"-0.91"},{"v":0.020349805046732,"d":"0.02"},{"v":0.262457833177756,"d":"0.26"},"down","no"]
["ENSOARG00000012289","MANBA","ENSOART00000013368","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004567(beta-mannosidase activity);GO:0005975(carbohydrate metabolic process);GO:0043231(intracellular membrane-bounded organelle)","00511(Other glycan degradation);04142(Lysosome)","K01192","EC:3.2.1.25","mannosidase beta [Source:NCBI gene;Acc:101107963]",{"v":0.771519,"d":"0.77"},{"v":0.594775,"d":"0.59"},{"v":1.098336,"d":"1.10"},{"v":1.670349,"d":"1.67"},{"v":1.816126,"d":"1.82"},{"v":1.47645,"d":"1.48"},{"v":0.496608350922087,"d":"0.50"},{"v":-1.00981957293648,"d":"-1.01"},{"v":0.0204428363788329,"d":"0.02"},{"v":0.263449591470863,"d":"0.26"},"down","yes"]
["MSTRG.6916","ENSOARG00000005496","ENSOART00000005995","GO:0000439(transcription factor TFIIH core complex);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005675(transcription factor TFIIH holo complex);GO:0006281(DNA repair);GO:0006289(nucleotide-excision repair);GO:0006351(transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","03022(Basal transcription factors);03420(Nucleotide excision repair);05203(Viral carcinogenesis)","K03142","NA","general transcription factor IIH subunit 2 [Source:NCBI gene;Acc:101118051]",{"v":1.28163172412662,"d":"1.28"},{"v":0.9110194315237,"d":"0.91"},{"v":0.594257083811711,"d":"0.59"},{"v":0.61462177956372,"d":"0.61"},{"v":0.482166554042972,"d":"0.48"},{"v":0.492667956371986,"d":"0.49"},{"v":1.75337205372248,"d":"1.75"},{"v":0.810132158737444,"d":"0.81"},{"v":0.0205469775097705,"d":"0.02"},{"v":0.264407596599675,"d":"0.26"},"up","no"]
["MSTRG.12943","NDC80","ENSOART00000010464","GO:0000132(establishment of mitotic spindle orientation);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000942(condensed nuclear chromosome outer kinetochore);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0031262(Ndc80 complex);GO:0042802(identical protein binding);GO:0051310(metaphase plate congression);GO:0051315(attachment of mitotic spindle microtubules to kinetochore);GO:0051383(kinetochore organization);GO:0090267(positive regulation of mitotic cell cycle spindle assembly checkpoint);GO:1905342(positive regulation of protein localization to kinetochore)","NA","K11547","NA","NDC80, kinetochore complex component [Source:NCBI gene;Acc:101104623]",{"v":0.647797,"d":"0.65"},{"v":0.071854,"d":"0.07"},{"v":0.095029,"d":"0.10"},{"v":0.152442,"d":"0.15"},{"v":0.031111,"d":"0.03"},{"v":0.057668,"d":"0.06"},{"v":3.37731789520813,"d":"3.38"},{"v":1.75587798161225,"d":"1.76"},{"v":0.0205638948519799,"d":"0.02"},{"v":0.264407596599675,"d":"0.26"},"up","yes"]
["ENSOARG00000006674","GLI1","ENSOART00000007254","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001649(osteoblast differentiation);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0005930(axoneme);GO:0007224(smoothened signaling pathway);GO:0007283(spermatogenesis);GO:0007418(ventral midline development);GO:0008017(microtubule binding);GO:0008284(positive regulation of cell population proliferation);GO:0009611(response to wounding);GO:0009913(epidermal cell differentiation);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0021696(cerebellar cortex morphogenesis);GO:0021938(smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation);GO:0021983(pituitary gland development);GO:0030324(lung development);GO:0044212(transcription regulatory region DNA binding);GO:0045667(regulation of osteoblast differentiation);GO:0045740(positive regulation of DNA replication);GO:0045880(positive regulation of smoothened signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060032(notochord regression);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060070(canonical Wnt signaling pathway);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097421(liver regeneration);GO:0097542(ciliary tip);GO:1902808(positive regulation of cell cycle G1/S phase transition);GO:2000345(regulation of hepatocyte proliferation)","04024(cAMP signaling pathway);04340(Hedgehog signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)","K16797","NA","GLI family zinc finger 1 [Source:NCBI gene;Acc:101120651]",{"v":0.293867,"d":"0.29"},{"v":0.116863,"d":"0.12"},{"v":0.131313,"d":"0.13"},{"v":0.441047,"d":"0.44"},{"v":0.40676,"d":"0.41"},{"v":0.418517,"d":"0.42"},{"v":0.428044481507103,"d":"0.43"},{"v":-1.22416736855249,"d":"-1.22"},{"v":0.0206778678894497,"d":"0.02"},{"v":0.265335710688655,"d":"0.27"},"down","yes"]
["MSTRG.10556","FZD7","ENSOART00000019085","GO:0004888(transmembrane signaling receptor activity);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0007166(cell surface receptor signaling pathway);GO:0007275(multicellular organism development);GO:0010812(negative regulation of cell-substrate adhesion);GO:0014834(skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019827(stem cell population maintenance);GO:0030165(PDZ domain binding);GO:0033077(T cell differentiation in thymus);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035567(non-canonical Wnt signaling pathway);GO:0038031(non-canonical Wnt signaling pathway via JNK cascade);GO:0042327(positive regulation of phosphorylation);GO:0042666(negative regulation of ectodermal cell fate specification);GO:0042813(Wnt-activated receptor activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048103(somatic stem cell division);GO:0055038(recycling endosome membrane);GO:0060054(positive regulation of epithelial cell proliferation involved in wound healing);GO:0060070(canonical Wnt signaling pathway);GO:0060231(mesenchymal to epithelial transition);GO:0060828(regulation of canonical Wnt signaling pathway);GO:2000726(negative regulation of cardiac muscle cell differentiation)","NA","NA","NA","frizzled class receptor 7 [Source:HGNC Symbol;Acc:HGNC:4045]",{"v":6.79546011322935,"d":"6.80"},{"v":7.09742936568458,"d":"7.10"},{"v":4.59124508838821,"d":"4.59"},{"v":5.20274168457539,"d":"5.20"},{"v":2.06924489428076,"d":"2.07"},{"v":3.32968104910456,"d":"3.33"},{"v":1.74351198471383,"d":"1.74"},{"v":0.801996281079219,"d":"0.80"},{"v":0.0207167570031067,"d":"0.02"},{"v":0.265341948076013,"d":"0.27"},"up","no"]
["MSTRG.17726","HOOK2","ENSOART00000011942","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005829(cytosol);GO:0007032(endosome organization);GO:0007040(lysosome organization);GO:0008333(endosome to lysosome transport);GO:0030897(HOPS complex);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0045022(early endosome to late endosome transport);GO:0070695(FHF complex)","NA","K16611","NA","hook microtubule tethering protein 2 [Source:NCBI gene;Acc:101106005]",{"v":1.6247185732899,"d":"1.62"},{"v":1.40374338599349,"d":"1.40"},{"v":1.51631356297503,"d":"1.52"},{"v":2.99925522095548,"d":"3.00"},{"v":2.63837900760043,"d":"2.64"},{"v":2.58711263246471,"d":"2.59"},{"v":0.552573300923994,"d":"0.55"},{"v":-0.855762238772248,"d":"-0.86"},{"v":0.0207235347373437,"d":"0.02"},{"v":0.265341948076013,"d":"0.27"},"down","no"]
["MSTRG.8863","BHLHE40","ENSOART00000008535","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007623(circadian rhythm);GO:0009416(response to light stimulus);GO:0016604(nuclear body);GO:0019904(protein domain specific binding);GO:0032922(circadian regulation of gene expression);GO:0042752(regulation of circadian rhythm);GO:0042803(protein homodimerization activity);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043425(bHLH transcription factor binding);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0070888(E-box binding)","04710(Circadian rhythm)","K03729","NA","basic helix-loop-helix family member e40 [Source:NCBI gene;Acc:100169939]",{"v":32.0514014812715,"d":"32.05"},{"v":23.031418606803,"d":"23.03"},{"v":18.6423653636364,"d":"18.64"},{"v":19.8012970708645,"d":"19.80"},{"v":9.14831692083418,"d":"9.15"},{"v":14.6921789902814,"d":"14.69"},{"v":1.68932530985041,"d":"1.69"},{"v":0.756447171666101,"d":"0.76"},{"v":0.0207521844496,"d":"0.02"},{"v":0.265341948076013,"d":"0.27"},"up","no"]
["MSTRG.2418","ENSOARG00000001543","ENSOART00000001653","NA","NA","NA","NA",null,{"v":3.634788,"d":"3.63"},{"v":3.010973,"d":"3.01"},{"v":3.463706,"d":"3.46"},{"v":2.555151,"d":"2.56"},{"v":1.058593,"d":"1.06"},{"v":1.1937,"d":"1.19"},{"v":2.1028777454298,"d":"2.10"},{"v":1.07236497884334,"d":"1.07"},{"v":0.0208370450736229,"d":"0.02"},{"v":0.266218522662061,"d":"0.27"},"up","yes"]
["MSTRG.10509","HECW2","ENSOART00000016157","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0072686(mitotic spindle)","NA","K12168","EC:2.3.2.26","HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 [Source:NCBI gene;Acc:101119960]",{"v":1.36588920477227,"d":"1.37"},{"v":1.03401679687852,"d":"1.03"},{"v":1.02098057297216,"d":"1.02"},{"v":2.32273230614542,"d":"2.32"},{"v":2.02824944773768,"d":"2.03"},{"v":1.72442891408419,"d":"1.72"},{"v":0.563070837772274,"d":"0.56"},{"v":-0.828611661260414,"d":"-0.83"},{"v":0.0208557900061956,"d":"0.02"},{"v":0.266249678828116,"d":"0.27"},"down","no"]
["ENSOARG00000001001","ENSOARG00000001001","ENSOART00000001081","GO:0005876(spindle microtubule);GO:0051294(establishment of spindle orientation);GO:0051301(cell division);GO:0051988(regulation of attachment of spindle microtubules to kinetochore)","NA","K21764","NA","sperm associated antigen 5 [Source:NCBI gene;Acc:101105670]",{"v":0.233856,"d":"0.23"},{"v":0.192882,"d":"0.19"},{"v":0.259912,"d":"0.26"},{"v":0.977626,"d":"0.98"},{"v":0.31122,"d":"0.31"},{"v":0.398713,"d":"0.40"},{"v":0.406889477641967,"d":"0.41"},{"v":-1.29729112278254,"d":"-1.30"},{"v":0.0209506876093523,"d":"0.02"},{"v":0.267043581019129,"d":"0.27"},"down","yes"]
["ENSOARG00000002776","ZNF619","ENSOART00000003007","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger protein 619 [Source:HGNC Symbol;Acc:HGNC:26910]",{"v":0.285623,"d":"0.29"},{"v":0.216897,"d":"0.22"},{"v":0.217896,"d":"0.22"},{"v":0.462346,"d":"0.46"},{"v":0.442929,"d":"0.44"},{"v":0.522608,"d":"0.52"},{"v":0.504534335096083,"d":"0.50"},{"v":-0.986975642429263,"d":"-0.99"},{"v":0.0211012284332206,"d":"0.02"},{"v":0.268603784962037,"d":"0.27"},"down","no"]
["MSTRG.303","ZYG11B","ENSOART00000006140","GO:0005515(protein binding);GO:0031462(Cul2-RING ubiquitin ligase complex)","NA","K10350","NA","zyg-11 family member B, cell cycle regulator [Source:NCBI gene;Acc:101116266]",{"v":23.0840654820183,"d":"23.08"},{"v":26.4325899466703,"d":"26.43"},{"v":17.4696250527827,"d":"17.47"},{"v":17.2634244654724,"d":"17.26"},{"v":13.4041744904964,"d":"13.40"},{"v":12.0091217073704,"d":"12.01"},{"v":1.56962108241402,"d":"1.57"},{"v":0.650416324402902,"d":"0.65"},{"v":0.0211120717040876,"d":"0.02"},{"v":0.268603784962037,"d":"0.27"},"up","no"]
["MSTRG.18689","PAPSS1","ENSOART00000009512","GO:0000103(sulfate assimilation);GO:0004020(adenylylsulfate kinase activity);GO:0004781(sulfate adenylyltransferase (ATP) activity);GO:0005524(ATP binding);GO:0016310(phosphorylation);GO:0042803(protein homodimerization activity);GO:0050428(3'-phosphoadenosine 5'-phosphosulfate biosynthetic process)","00230(Purine metabolism);00450(Selenocompound metabolism);00920(Sulfur metabolism)","K13811","2.7.1.25;EC:2.7.7.4","3'-phosphoadenosine 5'-phosphosulfate synthase 1 [Source:NCBI gene;Acc:101123377]",{"v":3.124276,"d":"3.12"},{"v":2.005366,"d":"2.01"},{"v":2.355457,"d":"2.36"},{"v":5.604819,"d":"5.60"},{"v":4.328029,"d":"4.33"},{"v":3.945722,"d":"3.95"},{"v":0.53932782700235,"d":"0.54"},{"v":-0.890765622243048,"d":"-0.89"},{"v":0.0211417702991629,"d":"0.02"},{"v":0.268603784962037,"d":"0.27"},"down","no"]
["MSTRG.21678","SRPX","ENSOART00000000518","GO:0001845(phagolysosome assembly);GO:0005776(autophagosome);GO:0005783(endoplasmic reticulum);GO:0006914(autophagy);GO:0034976(response to endoplasmic reticulum stress);GO:0060244(negative regulation of cell proliferation involved in contact inhibition);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","NA","NA","NA","sushi repeat containing protein X-linked [Source:NCBI gene;Acc:101121073]",{"v":1.884652,"d":"1.88"},{"v":1.243726,"d":"1.24"},{"v":1.88672,"d":"1.89"},{"v":3.23898,"d":"3.24"},{"v":2.943573,"d":"2.94"},{"v":3.57901,"d":"3.58"},{"v":0.513759732944407,"d":"0.51"},{"v":-0.960834274632952,"d":"-0.96"},{"v":0.0211992290626261,"d":"0.02"},{"v":0.268603784962037,"d":"0.27"},"down","no"]
["MSTRG.5800","CKM","ENSOART00000010645","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0004111(creatine kinase activity);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0009408(response to heat);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016772(transferase activity, transferring phosphorus-containing groups);GO:0046314(phosphocreatine biosynthetic process)","NA","NA","NA","creatine kinase, M-type [Source:NCBI gene;Acc:101112841]",{"v":6365.83648013529,"d":"6365.84"},{"v":5465.86758114817,"d":"5465.87"},{"v":5056.5184804932,"d":"5056.52"},{"v":9493.28117709306,"d":"9493.28"},{"v":9131.45354852255,"d":"9131.45"},{"v":10977.9402897566,"d":"10977.94"},{"v":0.570496501853527,"d":"0.57"},{"v":-0.8097100546031,"d":"-0.81"},{"v":0.0212120921784589,"d":"0.02"},{"v":0.268603784962037,"d":"0.27"},"down","no"]
["MSTRG.9958","ENSOARG00000014566","ENSOART00000015854","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","NA","NA","NA",null,{"v":0.472012,"d":"0.47"},{"v":0.665477,"d":"0.67"},{"v":0.366729,"d":"0.37"},{"v":2.389495,"d":"2.39"},{"v":0.298999,"d":"0.30"},{"v":2.143176,"d":"2.14"},{"v":0.311324655864328,"d":"0.31"},{"v":-1.68350825696684,"d":"-1.68"},{"v":0.0212211466561139,"d":"0.02"},{"v":0.268603784962037,"d":"0.27"},"down","yes"]
["MSTRG.1406","ENSOARG00000002051","ENSOART00000002206","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007010(cytoskeleton organization);GO:0007017(microtubule-based process)","NA","NA","NA","tubulin alpha-1C chain-like [Source:NCBI gene;Acc:101121396]",{"v":2.808773,"d":"2.81"},{"v":3.125716,"d":"3.13"},{"v":3.668111,"d":"3.67"},{"v":5.259848,"d":"5.26"},{"v":3.018572,"d":"3.02"},{"v":14.604204,"d":"14.60"},{"v":0.419645928718664,"d":"0.42"},{"v":-1.25275551061256,"d":"-1.25"},{"v":0.0213071788918833,"d":"0.02"},{"v":0.268978141111825,"d":"0.27"},"down","yes"]
["ENSOARG00000009340","TMEM86A","ENSOART00000010162","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 86A [Source:NCBI gene;Acc:101121641]",{"v":0.307321,"d":"0.31"},{"v":0.26633,"d":"0.27"},{"v":0.164453,"d":"0.16"},{"v":0.510263,"d":"0.51"},{"v":0.607618,"d":"0.61"},{"v":0.534608,"d":"0.53"},{"v":0.446661974754446,"d":"0.45"},{"v":-1.16274465459194,"d":"-1.16"},{"v":0.0213692485717152,"d":"0.02"},{"v":0.269117905852706,"d":"0.27"},"down","yes"]
["MSTRG.4491","CCDC3","ENSOART00000016836","GO:0005783(endoplasmic reticulum);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway)","NA","NA","NA","coiled-coil domain containing 3 [Source:HGNC Symbol;Acc:HGNC:23813]",{"v":1.37296752267396,"d":"1.37"},{"v":0.809822460516028,"d":"0.81"},{"v":0.960299091086787,"d":"0.96"},{"v":2.37162676700547,"d":"2.37"},{"v":1.43073696520719,"d":"1.43"},{"v":2.40412004964816,"d":"2.40"},{"v":0.506420250941898,"d":"0.51"},{"v":-0.98159299788317,"d":"-0.98"},{"v":0.0213766694714885,"d":"0.02"},{"v":0.269117905852706,"d":"0.27"},"down","no"]
["MSTRG.3741","NUCKS1","ENSOART00000004642","GO:0000724(double-strand break repair via homologous recombination);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001678(cellular glucose homeostasis);GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006275(regulation of DNA replication);GO:0006325(chromatin organization);GO:0008134(transcription factor binding);GO:0019046(release from viral latency);GO:0031297(replication fork processing);GO:0036297(interstrand cross-link repair);GO:0042593(glucose homeostasis);GO:0043923(positive regulation by host of viral transcription);GO:0044829(positive regulation by host of viral genome replication);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046626(regulation of insulin receptor signaling pathway);GO:0046628(positive regulation of insulin receptor signaling pathway);GO:0060382(regulation of DNA strand elongation);GO:0071481(cellular response to X-ray);GO:1990968(modulation by host of RNA binding by virus);GO:1990969(modulation by host of viral RNA-binding transcription factor activity)","NA","NA","NA","nuclear casein kinase and cyclin dependent kinase substrate 1 [Source:NCBI gene;Acc:101111112]",{"v":9.532940960839,"d":"9.53"},{"v":8.07759633470936,"d":"8.08"},{"v":8.37694578154636,"d":"8.38"},{"v":3.35812942675443,"d":"3.36"},{"v":6.24121472319536,"d":"6.24"},{"v":5.6352746495593,"d":"5.64"},{"v":1.70581774438177,"d":"1.71"},{"v":0.770463512234881,"d":"0.77"},{"v":0.0215633710331522,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"up","no"]
["MSTRG.19477","LARP6","ENSOART00000020413","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005844(polysome);GO:0006396(RNA processing);GO:0006417(regulation of translation);GO:0017022(myosin binding);GO:0032967(positive regulation of collagen biosynthetic process);GO:0035613(RNA stem-loop binding);GO:0045727(positive regulation of translation);GO:0048027(mRNA 5'-UTR binding);GO:1902416(positive regulation of mRNA binding);GO:1990825(sequence-specific mRNA binding);GO:1990904(ribonucleoprotein complex)","NA","K18733","NA","La ribonucleoprotein domain family member 6 [Source:NCBI gene;Acc:101114526]",{"v":1.78083636881559,"d":"1.78"},{"v":1.85760304947526,"d":"1.86"},{"v":2.31641497151424,"d":"2.32"},{"v":3.3857061994003,"d":"3.39"},{"v":3.69003734482759,"d":"3.69"},{"v":4.36718256521739,"d":"4.37"},{"v":0.520396123583268,"d":"0.52"},{"v":-0.942317879388197,"d":"-0.94"},{"v":0.0216087475018637,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","no"]
["MSTRG.11519","ENSOARG00000020053","ENSOART00000021833","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":142.369095,"d":"142.37"},{"v":115.90686,"d":"115.91"},{"v":119.784988,"d":"119.78"},{"v":179.803574,"d":"179.80"},{"v":186.395798,"d":"186.40"},{"v":354.428101,"d":"354.43"},{"v":0.524627435346196,"d":"0.52"},{"v":-0.930634839699742,"d":"-0.93"},{"v":0.0216293962401149,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","no"]
["MSTRG.14395","ADGRA2","ENSOART00000000915","GO:0001525(angiogenesis);GO:0002040(sprouting angiogenesis);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007417(central nervous system development);GO:0009986(cell surface);GO:0010595(positive regulation of endothelial cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043542(endothelial cell migration);GO:0045765(regulation of angiogenesis);GO:0050920(regulation of chemotaxis);GO:0090210(regulation of establishment of blood-brain barrier);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1900747(negative regulation of vascular endothelial growth factor signaling pathway);GO:1990909(Wnt signalosome)","NA","K08461","NA","adhesion G protein-coupled receptor A2 [Source:NCBI gene;Acc:101117990]",{"v":2.25181006919528,"d":"2.25"},{"v":1.44823595233214,"d":"1.45"},{"v":1.80496078062532,"d":"1.80"},{"v":2.9551322409021,"d":"2.96"},{"v":3.65512831214762,"d":"3.66"},{"v":3.2809241404408,"d":"3.28"},{"v":0.556556870864583,"d":"0.56"},{"v":-0.845398980326011,"d":"-0.85"},{"v":0.0216506583752428,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","no"]
["MSTRG.14302","FGL1","ENSOART00000009862","NA","NA","NA","NA","fibrinogen like 1 [Source:NCBI gene;Acc:101118665]",{"v":2.383177,"d":"2.38"},{"v":0.798544,"d":"0.80"},{"v":0.237495,"d":"0.24"},{"v":2.023172,"d":"2.02"},{"v":4.297853,"d":"4.30"},{"v":3.322869,"d":"3.32"},{"v":0.354547239942704,"d":"0.35"},{"v":-1.49595022964959,"d":"-1.50"},{"v":0.0217277185274116,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","yes"]
["MSTRG.16981","PPP1R3A","ENSOART00000002032","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","04910(Insulin signaling pathway);04931(Insulin resistance)","K07189","NA","protein phosphatase 1 regulatory subunit 3A [Source:NCBI gene;Acc:101110321]",{"v":28.6245896528511,"d":"28.62"},{"v":29.8268572556314,"d":"29.83"},{"v":26.6313154918265,"d":"26.63"},{"v":21.5545699953662,"d":"21.55"},{"v":17.1912320422191,"d":"17.19"},{"v":16.7166402063329,"d":"16.72"},{"v":1.534060869987,"d":"1.53"},{"v":0.6173557286597,"d":"0.62"},{"v":0.0218094252483179,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"up","no"]
["MSTRG.3039","MFAP4","ENSOART00000019858","GO:0001527(microfibril);GO:0005576(extracellular region);GO:0009650(UV protection);GO:0010712(regulation of collagen metabolic process);GO:0048251(elastic fiber assembly);GO:0062023(collagen-containing extracellular matrix);GO:0071493(cellular response to UV-B);GO:0071953(elastic fiber);GO:0097435(supramolecular fiber organization)","NA","NA","NA","microfibril associated protein 4 [Source:NCBI gene;Acc:101109814]",{"v":11.455104,"d":"11.46"},{"v":6.827894,"d":"6.83"},{"v":9.680555,"d":"9.68"},{"v":11.067971,"d":"11.07"},{"v":20.845968,"d":"20.85"},{"v":21.056366,"d":"21.06"},{"v":0.527909986548123,"d":"0.53"},{"v":-0.921636136953878,"d":"-0.92"},{"v":0.0218341808681748,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","no"]
["MSTRG.18980","ENSOARG00000007762","ENSOART00000008449","GO:0000166(nucleotide binding);GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006414(translational elongation)","03013(RNA transport);05134(Legionellosis)","K03231","NA","elongation factor 1-alpha 1 [Source:NCBI gene;Acc:101114018]",{"v":4.702858,"d":"4.70"},{"v":5.185615,"d":"5.19"},{"v":8.154819,"d":"8.15"},{"v":11.188473,"d":"11.19"},{"v":10.879634,"d":"10.88"},{"v":11.008029,"d":"11.01"},{"v":0.545507854968307,"d":"0.55"},{"v":-0.874328124292222,"d":"-0.87"},{"v":0.0218479930080188,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","no"]
["MSTRG.14046","LRRC20","ENSOART00000006568;ENSOART00000006570","GO:0005515(protein binding);GO:0005515(protein binding)","NA","NA","NA","leucine rich repeat containing 20 [Source:NCBI gene;Acc:101109855]",{"v":30.9681869611806,"d":"30.97"},{"v":35.0198673224254,"d":"35.02"},{"v":21.9722354931023,"d":"21.97"},{"v":20.9340667420597,"d":"20.93"},{"v":15.2605979159448,"d":"15.26"},{"v":18.3435259287777,"d":"18.34"},{"v":1.61282009597924,"d":"1.61"},{"v":0.689585520258112,"d":"0.69"},{"v":0.0218648851185767,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"up","no"]
["MSTRG.13060","RF00492","ENSOART00000023155","NA","NA","NA","NA",null,{"v":11.828192,"d":"11.83"},{"v":6.401549,"d":"6.40"},{"v":3.230056,"d":"3.23"},{"v":11.53047,"d":"11.53"},{"v":9.892128,"d":"9.89"},{"v":34.854454,"d":"34.85"},{"v":0.381324114134479,"d":"0.38"},{"v":-1.3909103279403,"d":"-1.39"},{"v":0.0218686628484488,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","yes"]
["MSTRG.18784","MMRN1","ENSOART00000020021","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0007596(blood coagulation)","NA","NA","NA","multimerin 1 [Source:NCBI gene;Acc:101117586]",{"v":2.78762881136842,"d":"2.79"},{"v":1.03292959663158,"d":"1.03"},{"v":0.665053869473684,"d":"0.67"},{"v":3.00466083873684,"d":"3.00"},{"v":2.55420655326316,"d":"2.55"},{"v":4.16293003831579,"d":"4.16"},{"v":0.461397422608916,"d":"0.46"},{"v":-1.11591814981688,"d":"-1.12"},{"v":0.0218688875055288,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","yes"]
["MSTRG.7751","UNG","ENSOART00000018376","GO:0003684(damaged DNA binding);GO:0004844(uracil DNA N-glycosylase activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016447(somatic recombination of immunoglobulin gene segments);GO:0016787(hydrolase activity);GO:0016799(hydrolase activity, hydrolyzing N-glycosyl compounds);GO:0043024(ribosomal small subunit binding);GO:0045830(positive regulation of isotype switching);GO:0097510(base-excision repair, AP site formation via deaminated base removal)","03410(Base excision repair);05340(Primary immunodeficiency)","K03648","EC:3.2.2.27","uracil DNA glycosylase [Source:NCBI gene;Acc:101115316]",{"v":5.68230951252955,"d":"5.68"},{"v":4.68718612907801,"d":"4.69"},{"v":3.51308162316785,"d":"3.51"},{"v":8.15484704113475,"d":"8.15"},{"v":7.9167198141844,"d":"7.92"},{"v":8.78002111678487,"d":"8.78"},{"v":0.558619323656848,"d":"0.56"},{"v":-0.840062614964946,"d":"-0.84"},{"v":0.021875574663099,"d":"0.02"},{"v":0.270799380666475,"d":"0.27"},"down","no"]
["MSTRG.15046","ENSOARG00000019910","ENSOART00000021676","GO:0001569(branching involved in blood vessel morphogenesis);GO:0001837(epithelial to mesenchymal transition);GO:0004721(phosphoprotein phosphatase activity);GO:0005509(calcium ion binding);GO:0005955(calcineurin complex);GO:0006470(protein dephosphorylation);GO:0006606(protein import into nucleus);GO:0007507(heart development);GO:0014044(Schwann cell development);GO:0019902(phosphatase binding);GO:0022011(myelination in peripheral nervous system);GO:0033173(calcineurin-NFAT signaling cascade);GO:0034504(protein localization to nucleus);GO:0042383(sarcolemma);GO:0045202(synapse);GO:0060487(lung epithelial cell differentiation);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098688(parallel fiber to Purkinje cell synapse);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:0099149(regulation of postsynaptic neurotransmitter receptor internalization);GO:0099170(postsynaptic modulation of chemical synaptic transmission)","NA","NA","NA",null,{"v":71.185722,"d":"71.19"},{"v":71.487198,"d":"71.49"},{"v":60.175381,"d":"60.18"},{"v":52.543312,"d":"52.54"},{"v":36.82848,"d":"36.83"},{"v":40.238632,"d":"40.24"},{"v":1.56506162652473,"d":"1.57"},{"v":0.646219466442973,"d":"0.65"},{"v":0.0219031967534752,"d":"0.02"},{"v":0.270935906508139,"d":"0.27"},"up","no"]
["MSTRG.12009","COX8A","ENSOART00000004498","GO:0004129(cytochrome-c oxidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022900(electron transport chain);GO:1902600(proton transmembrane transport)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);04714(Thermogenesis);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K02273","NA","cytochrome c oxidase subunit 8A, mitochondrial [Source:NCBI gene;Acc:106991840]",{"v":3.36265,"d":"3.36"},{"v":3.669913,"d":"3.67"},{"v":5.937305,"d":"5.94"},{"v":9.30547,"d":"9.31"},{"v":8.717863,"d":"8.72"},{"v":10.515285,"d":"10.52"},{"v":0.454467276586414,"d":"0.45"},{"v":-1.13775167638901,"d":"-1.14"},{"v":0.0219696967750336,"d":"0.02"},{"v":0.271347359260778,"d":"0.27"},"down","yes"]
["MSTRG.12915","ENSOARG00000023593;MIR133A1","ENSOART00000025495;ENSOART00000026624","NA","NA","NA","NA","microRNA 133a-1 [Source:HGNC Symbol;Acc:HGNC:31517]",{"v":1.9370858771527,"d":"1.94"},{"v":1.75626471944473,"d":"1.76"},{"v":2.19548905552656,"d":"2.20"},{"v":3.04284800949796,"d":"3.04"},{"v":3.85129317774763,"d":"3.85"},{"v":3.56347275534913,"d":"3.56"},{"v":0.563115036034966,"d":"0.56"},{"v":-0.828498421313229,"d":"-0.83"},{"v":0.0219969453087958,"d":"0.02"},{"v":0.271435580292134,"d":"0.27"},"down","no"]
["ENSOARG00000004099","CDHR3","ENSOART00000004465","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K16503","NA","cadherin related family member 3 [Source:NCBI gene;Acc:101104990]",{"v":0.218851,"d":"0.22"},{"v":0.122754,"d":"0.12"},{"v":0.214003,"d":"0.21"},{"v":0.735909,"d":"0.74"},{"v":0.371807,"d":"0.37"},{"v":0.275067,"d":"0.28"},{"v":0.401804187641879,"d":"0.40"},{"v":-1.31543549483137,"d":"-1.32"},{"v":0.0220662033394791,"d":"0.02"},{"v":0.27192224009586,"d":"0.27"},"down","yes"]
["MSTRG.15269","PIGF","ENSOART00000006034","GO:0005789(endoplasmic reticulum membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","phosphatidylinositol glycan anchor biosynthesis class F [Source:HGNC Symbol;Acc:HGNC:8962]",{"v":1.74058196352313,"d":"1.74"},{"v":1.21429298932384,"d":"1.21"},{"v":1.34742647241993,"d":"1.35"},{"v":3.06262795373665,"d":"3.06"},{"v":2.63494113879003,"d":"2.63"},{"v":2.73478364412811,"d":"2.73"},{"v":0.510213644949306,"d":"0.51"},{"v":-0.970826612572879,"d":"-0.97"},{"v":0.0221164953235043,"d":"0.02"},{"v":0.27230295651303,"d":"0.27"},"down","no"]
["MSTRG.15936","SLC16A7","ENSOART00000005094","GO:0005887(integral component of plasma membrane);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015129(lactate transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035873(lactate transmembrane transport);GO:0050833(pyruvate transmembrane transporter activity);GO:0055085(transmembrane transport);GO:1901475(pyruvate transmembrane transport)","NA","K08184","NA","solute carrier family 16 member 7 [Source:NCBI gene;Acc:101113834]",{"v":1.266014,"d":"1.27"},{"v":0.923808,"d":"0.92"},{"v":0.578626,"d":"0.58"},{"v":1.602386,"d":"1.60"},{"v":2.21225,"d":"2.21"},{"v":1.936075,"d":"1.94"},{"v":0.481409690036589,"d":"0.48"},{"v":-1.05466291355057,"d":"-1.05"},{"v":0.0222890914490903,"d":"0.02"},{"v":0.273636304647178,"d":"0.27"},"down","yes"]
["ENSOARG00000016045","NAAA","ENSOART00000017475","GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0006631(fatty acid metabolic process);GO:0008134(transcription factor binding);GO:0016810(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds);GO:0017064(fatty acid amide hydrolase activity);GO:0019898(extrinsic component of membrane);GO:0070291(N-acylethanolamine metabolic process)","NA","K13720","EC:3.5.1.-","N-acylethanolamine acid amidase [Source:NCBI gene;Acc:101105252]",{"v":1.014131,"d":"1.01"},{"v":0.780791,"d":"0.78"},{"v":0.956803,"d":"0.96"},{"v":1.860387,"d":"1.86"},{"v":1.641568,"d":"1.64"},{"v":2.266782,"d":"2.27"},{"v":0.477006492062301,"d":"0.48"},{"v":-1.06791919343152,"d":"-1.07"},{"v":0.0223616007280033,"d":"0.02"},{"v":0.274148773254611,"d":"0.27"},"down","yes"]
["MSTRG.19892","TRPM7","ENSOART00000022863","GO:0001726(ruffle);GO:0003779(actin binding);GO:0004674(protein serine/threonine kinase activity);GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006811(ion transport);GO:0006812(cation transport);GO:0006816(calcium ion transport);GO:0010961(cellular magnesium ion homeostasis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016340(calcium-dependent cell-matrix adhesion);GO:0017022(myosin binding);GO:0031032(actomyosin structure organization);GO:0034220(ion transmembrane transport);GO:0046777(protein autophosphorylation);GO:0051262(protein tetramerization);GO:0055085(transmembrane transport);GO:0070266(necroptotic process);GO:0070588(calcium ion transmembrane transport)","04217(Necroptosis);04218(Cellular senescence);04621(NOD-like receptor signaling pathway);04978(Mineral absorption)","K04982","EC:2.7.11.1","transient receptor potential cation channel subfamily M member 7 [Source:NCBI gene;Acc:100037693]",{"v":4.56574174343717,"d":"4.57"},{"v":6.71600301050052,"d":"6.72"},{"v":5.83923185185509,"d":"5.84"},{"v":3.89184354620231,"d":"3.89"},{"v":3.85792193218411,"d":"3.86"},{"v":2.97557358907945,"d":"2.98"},{"v":1.5963109882211,"d":"1.60"},{"v":0.674741740193181,"d":"0.67"},{"v":0.022490030180746,"d":"0.02"},{"v":0.275275271957437,"d":"0.28"},"up","no"]
["MSTRG.9546","DAPK1","ENSOART00000009481","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0010508(positive regulation of autophagy);GO:0015629(actin cytoskeleton);GO:0017075(syntaxin-1 binding);GO:0017148(negative regulation of translation);GO:0035556(intracellular signal transduction);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0046777(protein autophosphorylation);GO:0071346(cellular response to interferon-gamma);GO:0071447(cellular response to hydroperoxide);GO:0097190(apoptotic signaling pathway);GO:2000310(regulation of NMDA receptor activity)","04140(Autophagy - animal);05200(Pathways in cancer);05219(Bladder cancer)","K08803","EC:2.7.11.1","death associated protein kinase 1 [Source:NCBI gene;Acc:101113985]",{"v":1.01465433363782,"d":"1.01"},{"v":0.658008437771181,"d":"0.66"},{"v":1.01353775199817,"d":"1.01"},{"v":1.57037168303266,"d":"1.57"},{"v":1.74401819821877,"d":"1.74"},{"v":1.67340650627997,"d":"1.67"},{"v":0.538554566927029,"d":"0.54"},{"v":-0.892835567301325,"d":"-0.89"},{"v":0.0225777714827904,"d":"0.02"},{"v":0.275935518541169,"d":"0.28"},"down","no"]
["MSTRG.11455","ENSOARG00000018308","ENSOART00000019922","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":3.746597,"d":"3.75"},0,0,{"v":16.288036,"d":"16.29"},{"v":2.682553,"d":"2.68"},{"v":19.850897,"d":"19.85"},{"v":0.096508335616004,"d":"0.10"},{"v":-3.37320263358558,"d":"-3.37"},{"v":0.0226527999933812,"d":"0.02"},{"v":0.276645413830911,"d":"0.28"},"down","yes"]
["MSTRG.13845","RHOU","ENSOART00000003278","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0007010(cytoskeleton organization);GO:0007264(small GTPase mediated signal transduction);GO:0008360(regulation of cell shape)","NA","NA","NA","ras homolog family member U [Source:HGNC Symbol;Acc:HGNC:17794]",{"v":1.42274850056243,"d":"1.42"},{"v":1.17683064679415,"d":"1.18"},{"v":1.18605255343082,"d":"1.19"},{"v":2.25232767491564,"d":"2.25"},{"v":2.26036435208099,"d":"2.26"},{"v":2.45477182789651,"d":"2.45"},{"v":0.543329937496383,"d":"0.54"},{"v":-0.88009955314659,"d":"-0.88"},{"v":0.0227228895124861,"d":"0.02"},{"v":0.276983904860538,"d":"0.28"},"down","no"]
["MSTRG.11191","ENSOARG00000012038;ENSOARG00000011986","ENSOART00000013093;ENSOART00000013039","GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation);GO:0015934(large ribosomal subunit);GO:0015934(large ribosomal subunit)","03010(Ribosome)","K02865","NA","60S ribosomal protein L10a [Source:NCBI gene;Acc:101118057]",{"v":100.988078131122,"d":"100.99"},{"v":86.4222329723539,"d":"86.42"},{"v":110.28874500158,"d":"110.29"},{"v":133.879773235387,"d":"133.88"},{"v":186.85450971406,"d":"186.85"},{"v":211.646915654028,"d":"211.65"},{"v":0.559184014923837,"d":"0.56"},{"v":-0.838604975089123,"d":"-0.84"},{"v":0.0228141364690044,"d":"0.02"},{"v":0.277577660406784,"d":"0.28"},"down","no"]
["MSTRG.2145","CDADC1","ENSOART00000009184","GO:0003824(catalytic activity);GO:0004126(cytidine deaminase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0009972(cytidine deamination);GO:0016787(hydrolase activity);GO:0042803(protein homodimerization activity);GO:0061676(importin-alpha family protein binding);GO:0070383(DNA cytosine deamination)","NA","NA","NA","cytidine and dCMP deaminase domain containing 1 [Source:NCBI gene;Acc:101115550]",{"v":2.87414748085586,"d":"2.87"},{"v":2.70912487781532,"d":"2.71"},{"v":4.24044987105856,"d":"4.24"},{"v":2.8359308704955,"d":"2.84"},{"v":1.62583361711712,"d":"1.63"},{"v":1.53987580968468,"d":"1.54"},{"v":1.6368395543721,"d":"1.64"},{"v":0.710912913469936,"d":"0.71"},{"v":0.0228765547704185,"d":"0.02"},{"v":0.277956431477802,"d":"0.28"},"up","no"]
["MSTRG.7229","ADAMTS16","ENSOART00000016814","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity)","NA","K08630","EC:3.4.24.-","ADAM metallopeptidase with thrombospondin type 1 motif 16 [Source:NCBI gene;Acc:101107994]",{"v":1.225799,"d":"1.23"},{"v":1.194245,"d":"1.19"},{"v":1.294742,"d":"1.29"},{"v":1.734061,"d":"1.73"},{"v":2.719195,"d":"2.72"},{"v":2.521713,"d":"2.52"},{"v":0.532588173510162,"d":"0.53"},{"v":-0.9089077020273,"d":"-0.91"},{"v":0.0228891935671748,"d":"0.02"},{"v":0.277956431477802,"d":"0.28"},"down","no"]
["ENSOARG00000013669","NPY1R","ENSOART00000014873","GO:0001601(peptide YY receptor activity);GO:0001602(pancreatic polypeptide receptor activity);GO:0003151(outflow tract morphogenesis);GO:0004930(G protein-coupled receptor activity);GO:0004983(neuropeptide Y receptor activity);GO:0006006(glucose metabolic process);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0007626(locomotory behavior);GO:0007631(feeding behavior);GO:0008217(regulation of blood pressure);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019233(sensory perception of pain);GO:0040014(regulation of multicellular organism growth)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04923(Regulation of lipolysis in adipocytes)","K04204","NA","neuropeptide Y receptor Y1 [Source:NCBI gene;Acc:443361]",{"v":0.505753,"d":"0.51"},{"v":0.591851,"d":"0.59"},{"v":0.335714,"d":"0.34"},{"v":1.287161,"d":"1.29"},{"v":0.933452,"d":"0.93"},{"v":0.955207,"d":"0.96"},{"v":0.451322178209092,"d":"0.45"},{"v":-1.14777041980228,"d":"-1.15"},{"v":0.022919705313713,"d":"0.02"},{"v":0.278033394028459,"d":"0.28"},"down","yes"]
["MSTRG.9074","ENSOARG00000008494","ENSOART00000009244","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0008097(5S rRNA binding)","NA","NA","NA",null,{"v":7.742237,"d":"7.74"},{"v":12.477831,"d":"12.48"},{"v":11.867577,"d":"11.87"},{"v":7.763911,"d":"7.76"},{"v":3.803993,"d":"3.80"},{"v":7.117177,"d":"7.12"},{"v":1.7172869092727,"d":"1.72"},{"v":0.780131092342783,"d":"0.78"},{"v":0.0229394897135412,"d":"0.02"},{"v":0.278066806267781,"d":"0.28"},"up","no"]
["MSTRG.7705","ENSOARG00000004740","ENSOART00000005159","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K08607","EC:3.4.24.-","disintegrin and metalloproteinase domain-containing protein 1a-like [Source:NCBI gene;Acc:101115991]",{"v":0.694301,"d":"0.69"},{"v":0.930185,"d":"0.93"},{"v":0.327689,"d":"0.33"},{"v":0.456887,"d":"0.46"},{"v":0.281142,"d":"0.28"},{"v":0.159329,"d":"0.16"},{"v":2.17546954504222,"d":"2.18"},{"v":1.12132682036082,"d":"1.12"},{"v":0.0230371004855917,"d":"0.02"},{"v":0.279042861074734,"d":"0.28"},"up","yes"]
["MSTRG.19929","ENSOARG00000021059","ENSOART00000022944","GO:0003939(L-iditol 2-dehydrogenase activity);GO:0006062(sorbitol catabolic process);GO:0008270(zinc ion binding);GO:0016491(oxidoreductase activity);GO:0032991(protein-containing complex);GO:0046370(fructose biosynthetic process);GO:0046872(metal ion binding);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process)","00040(Pentose and glucuronate interconversions);00051(Fructose and mannose metabolism)","K00008","EC:1.1.1.14","sorbitol dehydrogenase [Source:NCBI gene;Acc:101115280]",{"v":2.57413097533562,"d":"2.57"},{"v":2.38435214455198,"d":"2.38"},{"v":1.81201228879176,"d":"1.81"},{"v":1.6589713890103,"d":"1.66"},{"v":1.02005759725258,"d":"1.02"},{"v":1.36852760287231,"d":"1.37"},{"v":1.67273644224106,"d":"1.67"},{"v":0.742210151039631,"d":"0.74"},{"v":0.0230791427982746,"d":"0.02"},{"v":0.279344880363401,"d":"0.28"},"up","no"]
["MSTRG.5727","B9D2","ENSOART00000008085","GO:0005813(centrosome);GO:0016020(membrane);GO:0036038(MKS complex);GO:0036064(ciliary basal body);GO:0043015(gamma-tubulin binding);GO:0060271(cilium assembly)","NA","K16745","NA","B9 domain containing 2 [Source:NCBI gene;Acc:101102082]",{"v":1.18767369387755,"d":"1.19"},{"v":1.29722497959184,"d":"1.30"},{"v":0.623471017492711,"d":"0.62"},{"v":2.50310405830904,"d":"2.50"},{"v":1.79198423323615,"d":"1.79"},{"v":2.35459258309038,"d":"2.35"},{"v":0.467446445861577,"d":"0.47"},{"v":-1.09712700628414,"d":"-1.10"},{"v":0.023155504862595,"d":"0.02"},{"v":0.279647251032878,"d":"0.28"},"down","yes"]
["MSTRG.19878","MAPK6","ENSOART00000022829","GO:0000165(MAPK cascade);GO:0004672(protein kinase activity);GO:0004707(MAP kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0019901(protein kinase binding);GO:0032156(septin cytoskeleton);GO:0032991(protein-containing complex);GO:0046982(protein heterodimerization activity);GO:0060999(positive regulation of dendritic spine development)","04657(IL-17 signaling pathway)","K06855","EC:2.7.11.24","mitogen-activated protein kinase 6 [Source:NCBI gene;Acc:101103324]",{"v":16.1070819437306,"d":"16.11"},{"v":14.1434834171514,"d":"14.14"},{"v":16.4879551436494,"d":"16.49"},{"v":11.7230403844177,"d":"11.72"},{"v":9.60907711335047,"d":"9.61"},{"v":9.03978306736102,"d":"9.04"},{"v":1.53887374958,"d":"1.54"},{"v":0.621874876678388,"d":"0.62"},{"v":0.023193531907033,"d":"0.02"},{"v":0.279899474484874,"d":"0.28"},"up","no"]
["MSTRG.3562","SEPT9","ENSOART00000006747","GO:0000166(nucleotide binding);GO:0001725(stress fiber);GO:0005525(GTP binding);GO:0005874(microtubule);GO:0005930(axoneme);GO:0015629(actin cytoskeleton);GO:0031105(septin complex);GO:0048471(perinuclear region of cytoplasm);GO:0051291(protein heterooligomerization);GO:0097730(non-motile cilium);GO:1902857(positive regulation of non-motile cilium assembly)","05100(Bacterial invasion of epithelial cells)","K16938","NA","septin 9 [Source:NCBI gene;Acc:101102074]",{"v":4.50220141390677,"d":"4.50"},{"v":3.74792413310312,"d":"3.75"},{"v":4.66041218913828,"d":"4.66"},{"v":7.04034333762361,"d":"7.04"},{"v":7.39228290189923,"d":"7.39"},{"v":8.04017775278606,"d":"8.04"},{"v":0.57449607715026,"d":"0.57"},{"v":-0.799631053182533,"d":"-0.80"},{"v":0.0232380579089958,"d":"0.02"},{"v":0.279903802980339,"d":"0.28"},"down","no"]
["MSTRG.14463","HGSNAT","ENSOART00000004101;ENSOART00000004112","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005765(lysosomal membrane);GO:0006468(protein phosphorylation);GO:0006493(protein O-linked glycosylation);GO:0007041(lysosomal transport);GO:0015019(heparan-alpha-glucosaminide N-acetyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0019200(carbohydrate kinase activity);GO:0046835(carbohydrate phosphorylation);GO:0051259(protein complex oligomerization);GO:0051259(protein complex oligomerization)","00531(Glycosaminoglycan degradation);04142(Lysosome);04142(Lysosome)","K10532","EC:2.3.1.78","heparan-alpha-glucosaminide N-acetyltransferase [Source:NCBI gene;Acc:101102037]",{"v":1.54948516509537,"d":"1.55"},{"v":1.70475384564788,"d":"1.70"},{"v":1.31344207893006,"d":"1.31"},{"v":1.90444313264635,"d":"1.90"},{"v":3.48250257268143,"d":"3.48"},{"v":3.17133553650515,"d":"3.17"},{"v":0.533714768258194,"d":"0.53"},{"v":-0.905859162635372,"d":"-0.91"},{"v":0.0233111557642567,"d":"0.02"},{"v":0.280418166526231,"d":"0.28"},"down","no"]
["MSTRG.16084","IGF1","ENSOART00000017265","GO:0000187(activation of MAPK activity);GO:0001775(cell activation);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005178(integrin binding);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0008083(growth factor activity);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0009408(response to heat);GO:0010468(regulation of gene expression);GO:0010469(regulation of signaling receptor activity);GO:0010560(positive regulation of glycoprotein biosynthetic process);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0014834(skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration);GO:0014896(muscle hypertrophy);GO:0014904(myotube cell development);GO:0014911(positive regulation of smooth muscle cell migration);GO:0030166(proteoglycan biosynthetic process);GO:0030335(positive regulation of cell migration);GO:0032148(activation of protein kinase B activity);GO:0032691(negative regulation of interleukin-1 beta production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0035630(bone mineralization involved in bone maturation);GO:0035867(alphav-beta3 integrin-IGF-1-IGF1R complex);GO:0040014(regulation of multicellular organism growth);GO:0042104(positive regulation of activated T cell proliferation);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0042567(insulin-like growth factor ternary complex);GO:0043066(negative regulation of apoptotic process);GO:0043388(positive regulation of DNA binding);GO:0043410(positive regulation of MAPK cascade);GO:0043491(protein kinase B signaling);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0045445(myoblast differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0045821(positive regulation of glycolytic process);GO:0045840(positive regulation of mitotic nuclear division);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046326(positive regulation of glucose import);GO:0046579(positive regulation of Ras protein signal transduction);GO:0048009(insulin-like growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048146(positive regulation of fibroblast proliferation);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050714(positive regulation of protein secretion);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050821(protein stabilization);GO:0051450(myoblast proliferation);GO:0060283(negative regulation of oocyte development);GO:0061051(positive regulation of cell growth involved in cardiac muscle cell development);GO:0070371(ERK1 and ERK2 cascade);GO:0070886(positive regulation of calcineurin-NFAT signaling cascade);GO:0150079(negative regulation of neuroinflammatory response);GO:1902430(negative regulation of amyloid-beta formation);GO:1904075(positive regulation of trophectodermal cell proliferation);GO:1904646(cellular response to amyloid-beta);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905460(negative regulation of vascular associated smooth muscle cell apoptotic process);GO:2000679(positive regulation of transcription regulatory region DNA binding);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA","NA","NA","insulin like growth factor 1 [Source:HGNC Symbol;Acc:HGNC:5464]",{"v":2.72904665562914,"d":"2.73"},{"v":2.08860210430464,"d":"2.09"},{"v":2.72205196263009,"d":"2.72"},{"v":4.93134288410596,"d":"4.93"},{"v":3.81615791485336,"d":"3.82"},{"v":4.53525837251656,"d":"4.54"},{"v":0.567630612377211,"d":"0.57"},{"v":-0.816975698699121,"d":"-0.82"},{"v":0.0233223830317627,"d":"0.02"},{"v":0.280418166526231,"d":"0.28"},"down","no"]
["MSTRG.12624","FAM160B1","ENSOART00000016707","NA","NA","NA","NA","family with sequence similarity 160 member B1 [Source:NCBI gene;Acc:101119353]",{"v":3.43493550275057,"d":"3.43"},{"v":4.17563982181672,"d":"4.18"},{"v":3.05267107070978,"d":"3.05"},{"v":2.66604193854824,"d":"2.67"},{"v":2.20548682007245,"d":"2.21"},{"v":1.96935606306185,"d":"1.97"},{"v":1.55875251129494,"d":"1.56"},{"v":0.6403918843724,"d":"0.64"},{"v":0.0234376487173153,"d":"0.02"},{"v":0.281596709533719,"d":"0.28"},"up","no"]
["MSTRG.5509","CDH1","ENSOART00000003758","GO:0005509(calcium ion binding);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0008013(beta-catenin binding);GO:0009898(cytoplasmic side of plasma membrane);GO:0010468(regulation of gene expression);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016328(lateral plasma membrane);GO:0016342(catenin complex);GO:0016600(flotillin complex);GO:0022408(negative regulation of cell-cell adhesion);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030336(negative regulation of cell migration);GO:0030506(ankyrin binding);GO:0030864(cortical actin cytoskeleton);GO:0032794(GTPase activating protein binding);GO:0034332(adherens junction organization);GO:0042307(positive regulation of protein import into nucleus);GO:0042802(identical protein binding);GO:0043296(apical junction complex);GO:0045295(gamma-catenin binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0050839(cell adhesion molecule binding);GO:0071285(cellular response to lithium ion);GO:0071681(cellular response to indole-3-methanol);GO:0072659(protein localization to plasma membrane);GO:0098609(cell-cell adhesion)","04015(Rap1 signaling pathway);04371(Apelin signaling pathway);04390(Hippo signaling pathway);04514(Cell adhesion molecules (CAMs));04520(Adherens junction);05100(Bacterial invasion of epithelial cells);05200(Pathways in cancer);05213(Endometrial cancer);05216(Thyroid cancer);05218(Melanoma);05219(Bladder cancer);05226(Gastric cancer)","K05689","NA","cadherin 1 [Source:NCBI gene;Acc:101119747]",{"v":1.286986,"d":"1.29"},{"v":0.544656,"d":"0.54"},{"v":1.163229,"d":"1.16"},{"v":1.573097,"d":"1.57"},{"v":2.570906,"d":"2.57"},{"v":1.937936,"d":"1.94"},{"v":0.492420427103922,"d":"0.49"},{"v":-1.02203748442514,"d":"-1.02"},{"v":0.023494551940743,"d":"0.02"},{"v":0.281602641677267,"d":"0.28"},"down","yes"]
["ENSOARG00000020471","SLC2A1","ENSOART00000022295","GO:0001939(female pronucleus);GO:0005215(transporter activity);GO:0005355(glucose transmembrane transporter activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0022857(transmembrane transporter activity);GO:0030496(midbody);GO:0030864(cortical actin cytoskeleton);GO:0031982(vesicle);GO:0033300(dehydroascorbic acid transmembrane transporter activity);GO:0042149(cellular response to glucose starvation);GO:0042802(identical protein binding);GO:0043621(protein self-association);GO:0045121(membrane raft);GO:0055056(D-glucose transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0065003(protein-containing complex assembly);GO:0070837(dehydroascorbic acid transport);GO:1904659(glucose transmembrane transport)","04066(HIF-1 signaling pathway);04911(Insulin secretion);04919(Thyroid hormone signaling pathway);04920(Adipocytokine signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);04976(Bile secretion);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05211(Renal cell carcinoma);05230(Central carbon metabolism in cancer)","K07299","NA","solute carrier family 2 member 1 [Source:NCBI gene;Acc:443461]",{"v":0.499927,"d":"0.50"},{"v":0.369281,"d":"0.37"},{"v":0.371255,"d":"0.37"},{"v":0.524421,"d":"0.52"},{"v":1.057195,"d":"1.06"},{"v":1.309285,"d":"1.31"},{"v":0.429092175761121,"d":"0.43"},{"v":-1.22064050024139,"d":"-1.22"},{"v":0.0235154619975391,"d":"0.02"},{"v":0.281602641677267,"d":"0.28"},"down","yes"]
["MSTRG.7112","ADAMTS12","ENSOART00000013051","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0007160(cell-matrix adhesion);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0016477(cell migration);GO:0030167(proteoglycan catabolic process);GO:0032331(negative regulation of chondrocyte differentiation);GO:0050727(regulation of inflammatory response);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0062023(collagen-containing extracellular matrix);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0071773(cellular response to BMP stimulus);GO:1901509(regulation of endothelial tube morphogenesis);GO:1902203(negative regulation of hepatocyte growth factor receptor signaling pathway);GO:1902548(negative regulation of cellular response to vascular endothelial growth factor stimulus);GO:2001113(negative regulation of cellular response to hepatocyte growth factor stimulus)","NA","K08626","EC:3.4.24.-","ADAM metallopeptidase with thrombospondin type 1 motif 12 [Source:NCBI gene;Acc:101118642]",{"v":2.04372387322769,"d":"2.04"},{"v":1.32788324176397,"d":"1.33"},{"v":2.40804444047123,"d":"2.41"},{"v":4.05861498290242,"d":"4.06"},{"v":3.18946902877398,"d":"3.19"},{"v":3.22337472080901,"d":"3.22"},{"v":0.551943306383167,"d":"0.55"},{"v":-0.857408008681706,"d":"-0.86"},{"v":0.0235249050834538,"d":"0.02"},{"v":0.281602641677267,"d":"0.28"},"down","no"]
["MSTRG.19366","F2RL2","ENSOART00000018427","GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007596(blood coagulation);GO:0015057(thrombin-activated receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0032991(protein-containing complex);GO:0070493(thrombin-activated receptor signaling pathway)","04080(Neuroactive ligand-receptor interaction);04610(Complement and coagulation cascades)","K04235","NA","coagulation factor II thrombin receptor like 2 [Source:NCBI gene;Acc:101110677]",{"v":1.387797,"d":"1.39"},{"v":1.841061,"d":"1.84"},{"v":3.017627,"d":"3.02"},{"v":0.225117,"d":"0.23"},{"v":1.317783,"d":"1.32"},{"v":0.998156,"d":"1.00"},{"v":2.45822406117771,"d":"2.46"},{"v":1.29761641986748,"d":"1.30"},{"v":0.0236123201072779,"d":"0.02"},{"v":0.281602641677267,"d":"0.28"},"up","yes"]
["ENSOARG00000006638","PTH1R","ENSOART00000007223","GO:0001501(skeletal system development);GO:0001503(ossification);GO:0002062(chondrocyte differentiation);GO:0002076(osteoblast development);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0004991(parathyroid hormone receptor activity);GO:0005887(integral component of plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007200(phospholipase C-activating G protein-coupled receptor signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017046(peptide hormone binding);GO:0030282(bone mineralization);GO:0042803(protein homodimerization activity);GO:0043621(protein self-association);GO:0045453(bone resorption);GO:0048469(cell maturation)","04080(Neuroactive ligand-receptor interaction);04928(Parathyroid hormone synthesis, secretion and action);04961(Endocrine and other factor-regulated calcium reabsorption)","K04585","NA","parathyroid hormone 1 receptor [Source:NCBI gene;Acc:101102017]",{"v":0.1587,"d":"0.16"},{"v":0.186651,"d":"0.19"},{"v":0.081438,"d":"0.08"},{"v":0.250617,"d":"0.25"},{"v":0.395548,"d":"0.40"},{"v":0.406584,"d":"0.41"},{"v":0.405404327147307,"d":"0.41"},{"v":-1.30256660716631,"d":"-1.30"},{"v":0.0236705418780245,"d":"0.02"},{"v":0.281700151446344,"d":"0.28"},"down","yes"]
["MSTRG.3110","XYLT2","ENSOART00000005103","GO:0000287(magnesium ion binding);GO:0005615(extracellular space);GO:0006024(glycosaminoglycan biosynthetic process);GO:0008375(acetylglucosaminyltransferase activity);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0016020(membrane);GO:0030145(manganese ion binding);GO:0030158(protein xylosyltransferase activity);GO:0030166(proteoglycan biosynthetic process);GO:0030210(heparin biosynthetic process);GO:0050650(chondroitin sulfate proteoglycan biosynthetic process)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate);00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)","K00771","EC:2.4.2.26","xylosyltransferase 2 [Source:NCBI gene;Acc:101107112]",{"v":1.190576,"d":"1.19"},{"v":0.878233,"d":"0.88"},{"v":0.863875,"d":"0.86"},{"v":1.884634,"d":"1.88"},{"v":1.679973,"d":"1.68"},{"v":1.907922,"d":"1.91"},{"v":0.535891906648645,"d":"0.54"},{"v":-0.899986067093493,"d":"-0.90"},{"v":0.0237178983664154,"d":"0.02"},{"v":0.282015364805148,"d":"0.28"},"down","no"]
["ENSOARG00000019698","EHD3","ENSOART00000021451","GO:0001881(receptor recycling);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005829(cytosol);GO:0020018(ciliary pocket membrane);GO:0032456(endocytic recycling);GO:0051260(protein homooligomerization);GO:0055038(recycling endosome membrane);GO:0060271(cilium assembly);GO:0072659(protein localization to plasma membrane);GO:0086036(regulation of cardiac muscle cell membrane potential);GO:0090160(Golgi to lysosome transport);GO:1903358(regulation of Golgi organization)","04144(Endocytosis)","K12476","NA","EH domain containing 3 [Source:NCBI gene;Acc:101104895]",{"v":0.505689,"d":"0.51"},{"v":0.294421,"d":"0.29"},{"v":0.444312,"d":"0.44"},{"v":1.236966,"d":"1.24"},{"v":0.684321,"d":"0.68"},{"v":0.869183,"d":"0.87"},{"v":0.445954265768849,"d":"0.45"},{"v":-1.16503233077684,"d":"-1.17"},{"v":0.0240129752011873,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"down","yes"]
["MSTRG.16611","TSPO","ENSOART00000020843","GO:0005739(mitochondrion);GO:0010823(negative regulation of mitochondrion organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031397(negative regulation of protein ubiquitination);GO:0044325(ion channel binding);GO:0072655(establishment of protein localization to mitochondrion);GO:0072656(maintenance of protein location in mitochondrion);GO:1903147(negative regulation of autophagy of mitochondrion);GO:1903579(negative regulation of ATP metabolic process);GO:2000379(positive regulation of reactive oxygen species metabolic process)","04080(Neuroactive ligand-receptor interaction);04979(Cholesterol metabolism);05166(Human T-cell leukemia virus 1 infection)","K05770","NA","translocator protein [Source:NCBI gene;Acc:443123]",{"v":0.524644615135135,"d":"0.52"},{"v":0.775800405405406,"d":"0.78"},{"v":0.981733941621622,"d":"0.98"},{"v":1.16698502162162,"d":"1.17"},{"v":2.00492415135135,"d":"2.00"},{"v":2.16841272648649,"d":"2.17"},{"v":0.42734857657048,"d":"0.43"},{"v":-1.22651477788207,"d":"-1.23"},{"v":0.0240151612961204,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"down","yes"]
["MSTRG.9312","ENSOARG00000006991","ENSOART00000007608","GO:0000166(nucleotide binding);GO:0003677(DNA binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006260(DNA replication);GO:0006270(DNA replication initiation);GO:0042555(MCM complex);GO:1905775(negative regulation of DNA helicase activity)","03030(DNA replication);04110(Cell cycle)","K02540","EC:3.6.4.12","minichromosome maintenance complex component 2 [Source:NCBI gene;Acc:101116097]",{"v":0.476751992161781,"d":"0.48"},{"v":0.308854917541935,"d":"0.31"},{"v":0.244153055024298,"d":"0.24"},{"v":0.762038301771437,"d":"0.76"},{"v":0.609402176359931,"d":"0.61"},{"v":0.653509001254115,"d":"0.65"},{"v":0.508536126560806,"d":"0.51"},{"v":-0.975577827670312,"d":"-0.98"},{"v":0.0240729616779293,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"down","no"]
["MSTRG.18005","SLC12A2","ENSOART00000019177","GO:0005215(transporter activity);GO:0006811(ion transport);GO:0008519(ammonium transmembrane transporter activity);GO:0010818(T cell chemotaxis);GO:0015377(cation:chloride symporter activity);GO:0015696(ammonium transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019901(protein kinase binding);GO:0030321(transepithelial chloride transport);GO:0055085(transmembrane transport);GO:0070634(transepithelial ammonium transport);GO:0072488(ammonium transmembrane transport);GO:1902476(chloride transmembrane transport);GO:1990869(cellular response to chemokine)","04970(Salivary secretion);04972(Pancreatic secretion)","K10951","NA","solute carrier family 12 member 2 [Source:NCBI gene;Acc:101105242]",{"v":14.811342,"d":"14.81"},{"v":15.617595,"d":"15.62"},{"v":10.907403,"d":"10.91"},{"v":11.610763,"d":"11.61"},{"v":6.787651,"d":"6.79"},{"v":7.54841,"d":"7.55"},{"v":1.5931175237478,"d":"1.59"},{"v":0.671852697920427,"d":"0.67"},{"v":0.0240760213076097,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"up","no"]
["MSTRG.10932","TRIM63","ENSOART00000005959","GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0031432(titin binding);GO:0046872(metal ion binding)","NA","K10655","EC:2.3.2.27","tripartite motif containing 63 [Source:NCBI gene;Acc:101113132]",{"v":66.5446928364457,"d":"66.54"},{"v":69.6210334089636,"d":"69.62"},{"v":88.3537966288515,"d":"88.35"},{"v":62.9466471142235,"d":"62.95"},{"v":35.1261546381886,"d":"35.13"},{"v":44.6397397088391,"d":"44.64"},{"v":1.57322909798521,"d":"1.57"},{"v":0.653728775305702,"d":"0.65"},{"v":0.0241188638409512,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"up","no"]
["MSTRG.19876","MYO5A","ENSOART00000022817;ENSOART00000022813;ENSOART00000022818","GO:0000146(microfilament motor activity);GO:0000166(nucleotide binding);GO:0001726(ruffle);GO:0001750(photoreceptor outer segment);GO:0003774(motor activity);GO:0003779(actin binding);GO:0004864(protein phosphatase inhibitor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005777(peroxisome);GO:0005783(endoplasmic reticulum);GO:0005790(smooth endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005882(intermediate filament);GO:0005884(actin filament);GO:0006582(melanin metabolic process);GO:0006887(exocytosis);GO:0006892(post-Golgi vesicle-mediated transport);GO:0007049(cell cycle);GO:0007268(chemical synaptic transmission);GO:0007601(visual perception);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0016459(myosin complex);GO:0016461(unconventional myosin complex);GO:0017137(Rab GTPase binding);GO:0030048(actin filament-based movement);GO:0030050(vesicle transport along actin filament);GO:0030073(insulin secretion);GO:0030141(secretory granule);GO:0030318(melanocyte differentiation);GO:0031585(regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0031982(vesicle);GO:0031987(locomotion involved in locomotory behavior);GO:0032252(secretory granule localization);GO:0032400(melanosome localization);GO:0032402(melanosome transport);GO:0032433(filopodium tip);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0032593(insulin-responsive compartment);GO:0032869(cellular response to insulin stimulus);GO:0035371(microtubule plus-end);GO:0042438(melanin biosynthetic process);GO:0042470(melanosome);GO:0042476(odontogenesis);GO:0042552(myelination);GO:0042641(actomyosin);GO:0042759(long-chain fatty acid biosynthetic process);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0043473(pigmentation);GO:0048066(developmental pigmentation);GO:0048820(hair follicle maturation);GO:0050808(synapse organization);GO:0051015(actin filament binding);GO:0051301(cell division);GO:0051643(endoplasmic reticulum localization);GO:0055037(recycling endosome);GO:0072659(protein localization to plasma membrane);GO:0097718(disordered domain specific binding);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:0099089(establishment of endoplasmic reticulum localization to postsynapse);GO:0099566(regulation of postsynaptic cytosolic calcium ion concentration);GO:0099566(regulation of postsynaptic cytosolic calcium ion concentration)","NA","K10357","NA","cAMP regulated phosphoprotein 19 [Source:NCBI gene;Acc:101102906]",{"v":6.869647759874,"d":"6.87"},{"v":8.71694870281076,"d":"8.72"},{"v":7.4944308331718,"d":"7.49"},{"v":6.09722969966077,"d":"6.10"},{"v":4.41855501259995,"d":"4.42"},{"v":4.23107657475164,"d":"4.23"},{"v":1.56514846424874,"d":"1.57"},{"v":0.646299512414448,"d":"0.65"},{"v":0.0241426039222073,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"up","no"]
["MSTRG.488","SH3GLB1","ENSOART00000016179;ENSOART00000016176","GO:0005504(fatty acid binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006654(phosphatidic acid biosynthetic process);GO:0008654(phospholipid biosynthetic process);GO:0010508(positive regulation of autophagy);GO:0016020(membrane);GO:0032991(protein-containing complex);GO:0042171(lysophosphatidic acid acyltransferase activity);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0048102(autophagic cell death);GO:0051084('de novo' posttranslational protein folding);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway);GO:1903778(protein localization to vacuolar membrane);GO:2000786(positive regulation of autophagosome assembly);GO:2000786(positive regulation of autophagosome assembly)","04140(Autophagy - animal);04144(Endocytosis);04144(Endocytosis)","K11248","NA","SH3 domain containing GRB2 like, endophilin B1 [Source:NCBI gene;Acc:101116521]",{"v":10.895029697561,"d":"10.90"},{"v":7.8386789754524,"d":"7.84"},{"v":8.18436058536585,"d":"8.18"},{"v":4.57400459811172,"d":"4.57"},{"v":6.16204529598741,"d":"6.16"},{"v":5.88987315279308,"d":"5.89"},{"v":1.61904209363046,"d":"1.62"},{"v":0.695140494894628,"d":"0.70"},{"v":0.0241532302508938,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"up","no"]
["MSTRG.132","ENSOARG00000000604","ENSOART00000000648","NA","NA","NA","NA",null,{"v":1.193995,"d":"1.19"},{"v":3.523002,"d":"3.52"},{"v":3.269047,"d":"3.27"},{"v":5.487138,"d":"5.49"},{"v":5.925458,"d":"5.93"},{"v":8.967981,"d":"8.97"},{"v":0.391845824580923,"d":"0.39"},{"v":-1.35164197081475,"d":"-1.35"},{"v":0.0241882952182235,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"down","yes"]
["MSTRG.17590","HIST3H2BB","ENSOART00000001576","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005829(cytosol);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11252","NA","histone H2B type 3-B [Source:NCBI gene;Acc:101102231]",{"v":4.322384,"d":"4.32"},{"v":2.874713,"d":"2.87"},{"v":5.706044,"d":"5.71"},{"v":10.35824,"d":"10.36"},{"v":5.54681,"d":"5.55"},{"v":11.572811,"d":"11.57"},{"v":0.46958316733606,"d":"0.47"},{"v":-1.09054740031511,"d":"-1.09"},{"v":0.0241990288156087,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"down","yes"]
["MSTRG.3959","MTHFR","ENSOART00000020105","GO:0001843(neural tube closure);GO:0004489(methylenetetrahydrofolate reductase (NAD(P)H) activity);GO:0006555(methionine metabolic process);GO:0016491(oxidoreductase activity);GO:0031060(regulation of histone methylation);GO:0035999(tetrahydrofolate interconversion);GO:0044877(protein-containing complex binding);GO:0050660(flavin adenine dinucleotide binding);GO:0050667(homocysteine metabolic process);GO:0055114(oxidation-reduction process);GO:0070829(heterochromatin maintenance);GO:0072341(modified amino acid binding)","00670(One carbon pool by folate);01523(Antifolate resistance)","K00297","EC:1.5.1.20","methylenetetrahydrofolate reductase [Source:NCBI gene;Acc:101111645]",{"v":1.51895336589166,"d":"1.52"},{"v":1.76531583329338,"d":"1.77"},{"v":1.70503321692234,"d":"1.71"},{"v":4.03225312583893,"d":"4.03"},{"v":2.64642705177373,"d":"2.65"},{"v":2.37936803295781,"d":"2.38"},{"v":0.550814292452652,"d":"0.55"},{"v":-0.860362100078533,"d":"-0.86"},{"v":0.0242235893336019,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"down","no"]
["MSTRG.6727","TSPAN18","ENSOART00000001972","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K17353","NA","tetraspanin 18 [Source:NCBI gene;Acc:101111390]",{"v":2.4294209413781,"d":"2.43"},{"v":1.8070693835472,"d":"1.81"},{"v":1.39865370170504,"d":"1.40"},{"v":3.81411994647565,"d":"3.81"},{"v":4.01766966127615,"d":"4.02"},{"v":2.47782636570575,"d":"2.48"},{"v":0.54659107003968,"d":"0.55"},{"v":-0.871466204939723,"d":"-0.87"},{"v":0.0242304990274362,"d":"0.02"},{"v":0.283813190903858,"d":"0.28"},"down","no"]
["MSTRG.2940","RF01290","ENSOART00000026026","NA","NA","NA","NA","small nucleolar RNA, C/D box 10 [Source:HGNC Symbol;Acc:HGNC:32706]",{"v":10.849335,"d":"10.85"},{"v":11.542384,"d":"11.54"},{"v":6.917004,"d":"6.92"},{"v":17.809954,"d":"17.81"},{"v":15.602952,"d":"15.60"},{"v":27.755102,"d":"27.76"},{"v":0.479151176543137,"d":"0.48"},{"v":-1.06144718372979,"d":"-1.06"},{"v":0.0242641224394381,"d":"0.02"},{"v":0.283831375021548,"d":"0.28"},"down","yes"]
["MSTRG.607","TAF13","ENSOART00000020728","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005669(transcription factor TFIID complex);GO:0005730(nucleolus);GO:0006366(transcription by RNA polymerase II);GO:0008022(protein C-terminus binding);GO:0046982(protein heterodimerization activity)","03022(Basal transcription factors)","K03127","NA","TATA-box binding protein associated factor 13 [Source:NCBI gene;Acc:101102102]",{"v":1.909919,"d":"1.91"},{"v":1.940616,"d":"1.94"},{"v":1.82555,"d":"1.83"},{"v":1.511718,"d":"1.51"},{"v":0.941972,"d":"0.94"},{"v":1.021868,"d":"1.02"},{"v":1.63314351249497,"d":"1.63"},{"v":0.707651573304694,"d":"0.71"},{"v":0.0242668177076238,"d":"0.02"},{"v":0.283831375021548,"d":"0.28"},"up","no"]
["MSTRG.20532","PNRC1","ENSOART00000013990","NA","NA","K18774","NA","proline rich nuclear receptor coactivator 1 [Source:NCBI gene;Acc:101114874]",{"v":9.04436876113309,"d":"9.04"},{"v":14.5238937813577,"d":"14.52"},{"v":14.9954853168304,"d":"15.00"},{"v":9.37236082352941,"d":"9.37"},{"v":2.31347589205053,"d":"2.31"},{"v":8.45410247971163,"d":"8.45"},{"v":1.91478968657149,"d":"1.91"},{"v":0.937185940556029,"d":"0.94"},{"v":0.0243233523129618,"d":"0.02"},{"v":0.284278901701409,"d":"0.28"},"up","no"]
["MSTRG.9315","PLXNA1","ENSOART00000008136","GO:0005515(protein binding);GO:0007165(signal transduction);GO:0014910(regulation of smooth muscle cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017154(semaphorin receptor activity);GO:0060666(dichotomous subdivision of terminal units involved in salivary gland branching);GO:0071526(semaphorin-plexin signaling pathway);GO:0097485(neuron projection guidance);GO:1990138(neuron projection extension)","NA","NA","NA","plexin A1 [Source:HGNC Symbol;Acc:HGNC:9099]",{"v":1.556002,"d":"1.56"},{"v":1.019345,"d":"1.02"},{"v":1.060513,"d":"1.06"},{"v":2.046354,"d":"2.05"},{"v":2.33331,"d":"2.33"},{"v":2.11694,"d":"2.12"},{"v":0.559655475383754,"d":"0.56"},{"v":-0.837389119349943,"d":"-0.84"},{"v":0.0243399010643416,"d":"0.02"},{"v":0.284278901701409,"d":"0.28"},"down","no"]
["MSTRG.18033","SNCAIP","ENSOART00000000189","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008219(cell death);GO:0031625(ubiquitin protein ligase binding);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042417(dopamine metabolic process);GO:0042802(identical protein binding);GO:0046928(regulation of neurotransmitter secretion);GO:0090083(regulation of inclusion body assembly)","05012(Parkinson disease)","K04558","NA","synuclein alpha interacting protein [Source:NCBI gene;Acc:101111543]",{"v":1.37833123310895,"d":"1.38"},{"v":0.579665655198205,"d":"0.58"},{"v":0.732523651458489,"d":"0.73"},{"v":1.71613643031663,"d":"1.72"},{"v":2.09989765694341,"d":"2.10"},{"v":1.43517245076041,"d":"1.44"},{"v":0.512362353353538,"d":"0.51"},{"v":-0.964763619647813,"d":"-0.96"},{"v":0.0244629603455645,"d":"0.02"},{"v":0.28484018558639,"d":"0.28"},"down","no"]
["MSTRG.21752","PFKFB1","ENSOART00000006407","GO:0003824(catalytic activity);GO:0003873(6-phosphofructo-2-kinase activity);GO:0004331(fructose-2,6-bisphosphate 2-phosphatase activity);GO:0005524(ATP binding);GO:0006000(fructose metabolic process);GO:0006003(fructose 2,6-bisphosphate metabolic process);GO:0016311(dephosphorylation);GO:0042802(identical protein binding);GO:0043540(6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex);GO:0046835(carbohydrate phosphorylation)","00051(Fructose and mannose metabolism);04152(AMPK signaling pathway);04922(Glucagon signaling pathway)","K19028","3.1.3.46;EC:2.7.1.105","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [Source:NCBI gene;Acc:101116538]",{"v":2.72453251275582,"d":"2.72"},{"v":3.29467869259882,"d":"3.29"},{"v":3.07302560400897,"d":"3.07"},{"v":2.55557015302308,"d":"2.56"},{"v":1.73029074651902,"d":"1.73"},{"v":1.49718568376787,"d":"1.50"},{"v":1.5722226474198,"d":"1.57"},{"v":0.652805536669921,"d":"0.65"},{"v":0.0244772410173362,"d":"0.02"},{"v":0.28484018558639,"d":"0.28"},"up","no"]
["MSTRG.20410","ENSOARG00000009527","ENSOART00000010374","GO:0005516(calmodulin binding)","NA","NA","NA",null,{"v":16.899765,"d":"16.90"},{"v":9.067187,"d":"9.07"},{"v":12.128907,"d":"12.13"},{"v":26.111841,"d":"26.11"},{"v":20.951309,"d":"20.95"},{"v":24.927992,"d":"24.93"},{"v":0.52917425591054,"d":"0.53"},{"v":-0.91818521802819,"d":"-0.92"},{"v":0.0244997450524785,"d":"0.02"},{"v":0.28484018558639,"d":"0.28"},"down","no"]
["MSTRG.11550","ENSOARG00000020087","ENSOART00000021868","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":2.278714,"d":"2.28"},{"v":0.526629,"d":"0.53"},{"v":2.767474,"d":"2.77"},{"v":5.178944,"d":"5.18"},{"v":2.320836,"d":"2.32"},{"v":7.673258,"d":"7.67"},{"v":0.367284191867179,"d":"0.37"},{"v":-1.44503129194499,"d":"-1.45"},{"v":0.0246358023838278,"d":"0.02"},{"v":0.285488560200951,"d":"0.29"},"down","yes"]
["MSTRG.17795","RAB3D","ENSOART00000019769","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005881(cytoplasmic microtubule);GO:0017157(regulation of exocytosis);GO:0018125(peptidyl-cysteine methylation);GO:0030742(GTP-dependent protein binding);GO:0031489(myosin V binding);GO:0042588(zymogen granule);GO:0045453(bone resorption);GO:0099503(secretory vesicle);GO:1903307(positive regulation of regulated secretory pathway)","04972(Pancreatic secretion)","K07884","NA","transmembrane protein 205 [Source:NCBI gene;Acc:101117755]",{"v":2.446872,"d":"2.45"},{"v":1.6826,"d":"1.68"},{"v":1.001124,"d":"1.00"},{"v":3.464917,"d":"3.46"},{"v":3.215343,"d":"3.22"},{"v":4.03532,"d":"4.04"},{"v":0.478797787893889,"d":"0.48"},{"v":-1.06251160802343,"d":"-1.06"},{"v":0.024736293730856,"d":"0.02"},{"v":0.286044053850862,"d":"0.29"},"down","yes"]
["MSTRG.11142","PSMB8","ENSOART00000008301","GO:0000502(proteasome complex);GO:0004175(endopeptidase activity);GO:0004298(threonine-type endopeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005839(proteasome core complex);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016787(hydrolase activity);GO:0019882(antigen processing and presentation);GO:0045444(fat cell differentiation);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0052548(regulation of endopeptidase activity);GO:1990111(spermatoproteasome complex)","03050(Proteasome)","K02740","EC:3.4.25.1","proteasome subunit beta 8 [Source:NCBI gene;Acc:100174905]",{"v":2.062353,"d":"2.06"},{"v":1.139752,"d":"1.14"},{"v":1.460648,"d":"1.46"},{"v":2.748873,"d":"2.75"},{"v":2.48197,"d":"2.48"},{"v":3.16093,"d":"3.16"},{"v":0.555633833279332,"d":"0.56"},{"v":-0.847793645283333,"d":"-0.85"},{"v":0.0248938268298568,"d":"0.02"},{"v":0.286493259481499,"d":"0.29"},"down","no"]
["MSTRG.6268","C11orf71","ENSOART00000018531","NA","NA","NA","NA","chromosome 15 open reading frame, human C11orf71 [Source:NCBI gene;Acc:101114723]",{"v":3.064208,"d":"3.06"},{"v":1.388151,"d":"1.39"},{"v":0.765691,"d":"0.77"},{"v":4.140195,"d":"4.14"},{"v":3.713705,"d":"3.71"},{"v":4.75212,"d":"4.75"},{"v":0.413933184304007,"d":"0.41"},{"v":-1.27253018332869,"d":"-1.27"},{"v":0.024912651653727,"d":"0.02"},{"v":0.286493259481499,"d":"0.29"},"down","yes"]
["MSTRG.6686","LMO2","ENSOART00000019616","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005667(transcription factor complex);GO:0042789(mRNA transcription by RNA polymerase II);GO:0043425(bHLH transcription factor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048037(cofactor binding);GO:0070888(E-box binding);GO:0097067(cellular response to thyroid hormone stimulus)","05202(Transcriptional misregulation in cancer)","K15612","NA","LIM domain only 2 [Source:NCBI gene;Acc:101103346]",{"v":1.287223,"d":"1.29"},{"v":1.31471,"d":"1.31"},{"v":0.701142,"d":"0.70"},{"v":3.195595,"d":"3.20"},{"v":1.585132,"d":"1.59"},{"v":3.16958,"d":"3.17"},{"v":0.415465088329293,"d":"0.42"},{"v":-1.26720084294664,"d":"-1.27"},{"v":0.0249272362159285,"d":"0.02"},{"v":0.286493259481499,"d":"0.29"},"down","yes"]
["MSTRG.3101","ANKRD40","ENSOART00000003777","GO:0005515(protein binding)","NA","NA","NA","ankyrin repeat domain 40 [Source:NCBI gene;Acc:101104837]",{"v":8.11600667650397,"d":"8.12"},{"v":4.92091279341657,"d":"4.92"},{"v":4.2835853543322,"d":"4.28"},{"v":4.86619798505486,"d":"4.87"},{"v":2.56928305637533,"d":"2.57"},{"v":3.00376021074537,"d":"3.00"},{"v":1.65917276992168,"d":"1.66"},{"v":0.730464122177634,"d":"0.73"},{"v":0.0249283938365667,"d":"0.02"},{"v":0.286493259481499,"d":"0.29"},"up","no"]
["MSTRG.12428","SORBS1","ENSOART00000006595","GO:0005158(insulin receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0005899(insulin receptor complex);GO:0005925(focal adhesion);GO:0007015(actin filament organization)","03320(PPAR signaling pathway);04520(Adherens junction);04910(Insulin signaling pathway)","K06086","NA","sorbin and SH3 domain containing 1 [Source:NCBI gene;Acc:101108178]",{"v":4.9814665880485,"d":"4.98"},{"v":4.09520650414198,"d":"4.10"},{"v":4.21979365501054,"d":"4.22"},{"v":3.753216407684,"d":"3.75"},{"v":2.7534035859022,"d":"2.75"},{"v":2.06851096621147,"d":"2.07"},{"v":1.55058468605764,"d":"1.55"},{"v":0.632812321706078,"d":"0.63"},{"v":0.0249336592182317,"d":"0.02"},{"v":0.286493259481499,"d":"0.29"},"up","no"]
["MSTRG.1214","CADM2","ENSOART00000018472","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K06782","NA","cell adhesion molecule 2 [Source:NCBI gene;Acc:101120371]",{"v":0.673678,"d":"0.67"},{"v":0.177678,"d":"0.18"},{"v":0.288791,"d":"0.29"},{"v":0.619074,"d":"0.62"},{"v":0.858405,"d":"0.86"},{"v":1.432566,"d":"1.43"},{"v":0.391797034066484,"d":"0.39"},{"v":-1.35182161855234,"d":"-1.35"},{"v":0.0249640984990306,"d":"0.02"},{"v":0.286493259481499,"d":"0.29"},"down","yes"]
["MSTRG.2713","NOS2","ENSOART00000018238","GO:0001666(response to hypoxia);GO:0004517(nitric-oxide synthase activity);GO:0005102(signaling receptor binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0006527(arginine catabolic process);GO:0006801(superoxide metabolic process);GO:0006809(nitric oxide biosynthetic process);GO:0007623(circadian rhythm);GO:0009617(response to bacterium);GO:0010181(FMN binding);GO:0010629(negative regulation of gene expression);GO:0016491(oxidoreductase activity);GO:0018119(peptidyl-cysteine S-nitrosylation);GO:0020037(heme binding);GO:0030863(cortical cytoskeleton);GO:0032310(prostaglandin secretion);GO:0032496(response to lipopolysaccharide);GO:0034617(tetrahydrobiopterin binding);GO:0034618(arginine binding);GO:0035690(cellular response to drug);GO:0042127(regulation of cell population proliferation);GO:0042177(negative regulation of protein catabolic process);GO:0042742(defense response to bacterium);GO:0042803(protein homodimerization activity);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0050660(flavin adenine dinucleotide binding);GO:0050661(NADP binding);GO:0050796(regulation of insulin secretion);GO:0051712(positive regulation of killing of cells of other organism);GO:0055114(oxidation-reduction process);GO:0071222(cellular response to lipopolysaccharide);GO:0071346(cellular response to interferon-gamma);GO:0072604(interleukin-6 secretion);GO:0072606(interleukin-8 secretion);GO:1900015(regulation of cytokine production involved in inflammatory response)","00220(Arginine biosynthesis);00330(Arginine and proline metabolism);04020(Calcium signaling pathway);04066(HIF-1 signaling pathway);04146(Peroxisome);04371(Apelin signaling pathway);04926(Relaxin signaling pathway);05132(Salmonella infection);05133(Pertussis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05145(Toxoplasmosis);05146(Amoebiasis);05152(Tuberculosis);05200(Pathways in cancer);05222(Small cell lung cancer)","K13241","EC:1.14.13.39","nitric oxide synthase 2 [Source:NCBI gene;Acc:443078]",{"v":1.331142,"d":"1.33"},{"v":0.102531,"d":"0.10"},{"v":0.299768,"d":"0.30"},{"v":1.66357,"d":"1.66"},{"v":1.605903,"d":"1.61"},{"v":1.597198,"d":"1.60"},{"v":0.356186189697228,"d":"0.36"},{"v":-1.48929651455556,"d":"-1.49"},{"v":0.0250395289497639,"d":"0.03"},{"v":0.286493259481499,"d":"0.29"},"down","yes"]
["ENSOARG00000006429","CYP2R1","ENSOART00000006984","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0030343(vitamin D3 25-hydroxylase activity);GO:0036378(calcitriol biosynthetic process from calciol);GO:0042359(vitamin D metabolic process);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00100(Steroid biosynthesis)","K07419","EC:1.14.14.24","vitamin D 25-hydroxylase [Source:NCBI gene;Acc:101117786]",{"v":0.548478,"d":"0.55"},{"v":0.396989,"d":"0.40"},{"v":0.823474,"d":"0.82"},{"v":1.424352,"d":"1.42"},{"v":1.538531,"d":"1.54"},{"v":0.938493,"d":"0.94"},{"v":0.453414641398317,"d":"0.45"},{"v":-1.14109711639867,"d":"-1.14"},{"v":0.0250916807982127,"d":"0.03"},{"v":0.286493259481499,"d":"0.29"},"down","yes"]
["MSTRG.16911","RELN","ENSOART00000000521;ENSOART00000000531","GO:0000904(cell morphogenesis involved in differentiation);GO:0001764(neuron migration);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007411(axon guidance);GO:0007417(central nervous system development);GO:0007420(brain development);GO:0007612(learning);GO:0007616(long-term memory);GO:0008306(associative learning);GO:0010001(glial cell differentiation);GO:0010468(regulation of gene expression);GO:0010976(positive regulation of neuron projection development);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016358(dendrite development);GO:0016477(cell migration);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021511(spinal cord patterning);GO:0021517(ventral spinal cord development);GO:0021766(hippocampus development);GO:0021800(cerebral cortex tangential migration);GO:0021819(layer formation in cerebral cortex);GO:0021987(cerebral cortex development);GO:0030425(dendrite);GO:0030900(forebrain development);GO:0031012(extracellular matrix);GO:0032008(positive regulation of TOR signaling);GO:0032793(positive regulation of CREB transcription factor activity);GO:0035418(protein localization to synapse);GO:0038026(reelin-mediated signaling pathway);GO:0045860(positive regulation of protein kinase activity);GO:0048265(response to pain);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050795(regulation of behavior);GO:0050804(modulation of chemical synaptic transmission);GO:0051057(positive regulation of small GTPase mediated signal transduction);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060291(long-term synaptic potentiation);GO:0061003(positive regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070325(lipoprotein particle receptor binding);GO:0070326(very-low-density lipoprotein particle receptor binding);GO:0090129(positive regulation of synapse maturation);GO:0097114(NMDA glutamate receptor clustering);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:0097477(lateral motor column neuron migration);GO:1900273(positive regulation of long-term synaptic potentiation);GO:2000310(regulation of NMDA receptor activity);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000969(positive regulation of AMPA receptor activity);GO:2000969(positive regulation of AMPA receptor activity)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);05165(Human papillomavirus infection);05165(Human papillomavirus infection)","K06249","EC:3.4.21.-","Ovis aries reelin (RELN), mRNA. [Source:RefSeq mRNA;Acc:NM_001306121]",{"v":0.986163856751074,"d":"0.99"},{"v":0.583071186762958,"d":"0.58"},{"v":0.546355174878874,"d":"0.55"},{"v":1.23989913611848,"d":"1.24"},{"v":1.16407502495658,"d":"1.16"},{"v":1.40311064960234,"d":"1.40"},{"v":0.555698210993223,"d":"0.56"},{"v":-0.847626499183015,"d":"-0.85"},{"v":0.0250919001969282,"d":"0.03"},{"v":0.286493259481499,"d":"0.29"},"down","no"]
["MSTRG.17505","MRNIP","ENSOART00000002755","GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0010212(response to ionizing radiation);GO:0030870(Mre11 complex);GO:0045860(positive regulation of protein kinase activity);GO:0071168(protein localization to chromatin);GO:1905168(positive regulation of double-strand break repair via homologous recombination);GO:2001032(regulation of double-strand break repair via nonhomologous end joining)","NA","NA","NA","MRN complex interacting protein [Source:NCBI gene;Acc:101121512]",{"v":0.854309,"d":"0.85"},{"v":1.035428,"d":"1.04"},{"v":0.87772,"d":"0.88"},{"v":0.142522,"d":"0.14"},{"v":0.636549,"d":"0.64"},{"v":0.400292,"d":"0.40"},{"v":2.34656929206699,"d":"2.35"},{"v":1.23055306247375,"d":"1.23"},{"v":0.0251031133031155,"d":"0.03"},{"v":0.286493259481499,"d":"0.29"},"up","yes"]
["MSTRG.4810","TPD52L2","ENSOART00000010640","NA","NA","NA","NA","TPD52 like 2 [Source:NCBI gene;Acc:101116591]",{"v":4.17663486506863,"d":"4.18"},{"v":3.14427378020491,"d":"3.14"},{"v":3.61964036864489,"d":"3.62"},{"v":6.24502642161222,"d":"6.25"},{"v":6.73263515426252,"d":"6.73"},{"v":5.98464603479606,"d":"5.98"},{"v":0.576962954011028,"d":"0.58"},{"v":-0.793449406485212,"d":"-0.79"},{"v":0.0251058018844477,"d":"0.03"},{"v":0.286493259481499,"d":"0.29"},"down","no"]
["MSTRG.10260","UBR3","ENSOART00000003042","GO:0001701(in utero embryonic development);GO:0001967(suckling behavior);GO:0004842(ubiquitin-protein transferase activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007608(sensory perception of smell);GO:0008270(zinc ion binding);GO:0009792(embryo development ending in birth or egg hatching);GO:0016567(protein ubiquitination);GO:0042048(olfactory behavior);GO:0061630(ubiquitin protein ligase activity);GO:0071596(ubiquitin-dependent protein catabolic process via the N-end rule pathway)","NA","K11978","EC:2.3.2.27","ubiquitin protein ligase E3 component n-recognin 3 [Source:NCBI gene;Acc:101107938]",{"v":35.3094053323928,"d":"35.31"},{"v":39.9939418990625,"d":"39.99"},{"v":31.4875061120415,"d":"31.49"},{"v":24.6715738970602,"d":"24.67"},{"v":26.1602479961773,"d":"26.16"},{"v":18.5147283854555,"d":"18.51"},{"v":1.53995913155479,"d":"1.54"},{"v":0.622892064241221,"d":"0.62"},{"v":0.0251399229068543,"d":"0.03"},{"v":0.286493259481499,"d":"0.29"},"up","no"]
["MSTRG.7908","ENSOARG00000016620","ENSOART00000018100","GO:0005515(protein binding)","NA","NA","NA",null,{"v":2.718631,"d":"2.72"},{"v":2.377862,"d":"2.38"},{"v":2.080593,"d":"2.08"},{"v":4.076223,"d":"4.08"},{"v":4.00735,"d":"4.01"},{"v":5.360256,"d":"5.36"},{"v":0.533857281284967,"d":"0.53"},{"v":-0.905473984251772,"d":"-0.91"},{"v":0.0251829255421231,"d":"0.03"},{"v":0.286741149408498,"d":"0.29"},"down","no"]
["MSTRG.19696","ENSOARG00000020558","ENSOART00000022398","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0008289(lipid binding)","NA","K16491","NA","StAR related lipid transfer domain containing 9 [Source:NCBI gene;Acc:101117936]",{"v":2.71281406116459,"d":"2.71"},{"v":1.2971016592567,"d":"1.30"},{"v":1.86666463892606,"d":"1.87"},{"v":3.83439474532741,"d":"3.83"},{"v":4.04136877817585,"d":"4.04"},{"v":2.87836804191307,"d":"2.88"},{"v":0.546448620569749,"d":"0.55"},{"v":-0.871842240955205,"d":"-0.87"},{"v":0.0252835621996329,"d":"0.03"},{"v":0.287686413655474,"d":"0.29"},"down","no"]
["ENSOARG00000009659","EPHX2","ENSOART00000010519","GO:0000287(magnesium ion binding);GO:0003824(catalytic activity);GO:0004301(epoxide hydrolase activity);GO:0005102(signaling receptor binding);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0010628(positive regulation of gene expression);GO:0015643(toxic substance binding);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0042577(lipid phosphatase activity);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0046272(stilbene catabolic process);GO:0046839(phospholipid dephosphorylation);GO:0090181(regulation of cholesterol metabolic process);GO:0097176(epoxide metabolic process)","00590(Arachidonic acid metabolism);04146(Peroxisome)","K08726","3.1.3.76;EC:3.3.2.10","epoxide hydrolase 2 [Source:NCBI gene;Acc:101106654]",{"v":0.863261,"d":"0.86"},{"v":0.494625,"d":"0.49"},{"v":0.56137,"d":"0.56"},{"v":1.582866,"d":"1.58"},{"v":0.888471,"d":"0.89"},{"v":1.260144,"d":"1.26"},{"v":0.514341624679316,"d":"0.51"},{"v":-0.959201181935029,"d":"-0.96"},{"v":0.0255216810394532,"d":"0.03"},{"v":0.289789991663554,"d":"0.29"},"down","no"]
["MSTRG.17671","ENSOARG00000005443","ENSOART00000005931","GO:0006457(protein folding);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum);05164(Influenza A)","K09507","NA","DnaJ heat shock protein family (Hsp40) member B1 [Source:NCBI gene;Acc:101122104]",{"v":9.84829239326209,"d":"9.85"},{"v":10.2739451228485,"d":"10.27"},{"v":9.52860281319847,"d":"9.53"},{"v":6.09040406109797,"d":"6.09"},{"v":6.01688580805938,"d":"6.02"},{"v":7.04196188147484,"d":"7.04"},{"v":1.54840725452002,"d":"1.55"},{"v":0.630784972001153,"d":"0.63"},{"v":0.0256357841599837,"d":"0.03"},{"v":0.290642972164167,"d":"0.29"},"up","no"]
["MSTRG.9280","H1FX","ENSOART00000015623","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0006334(nucleosome assembly)","NA","K11275","NA","histone H1x [Source:NCBI gene;Acc:101106288]",{"v":24.823008,"d":"24.82"},{"v":19.866192,"d":"19.87"},{"v":21.66465,"d":"21.66"},{"v":34.43317,"d":"34.43"},{"v":37.543106,"d":"37.54"},{"v":43.659809,"d":"43.66"},{"v":0.573816123228316,"d":"0.57"},{"v":-0.80133958900676,"d":"-0.80"},{"v":0.0256430601659679,"d":"0.03"},{"v":0.290642972164167,"d":"0.29"},"down","no"]
["MSTRG.16431","TSPAN9","ENSOART00000011655;ENSOART00000011656","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0097197(tetraspanin-enriched microdomain);GO:0097197(tetraspanin-enriched microdomain)","NA","K17350","NA","tetraspanin 9 [Source:NCBI gene;Acc:100180629]",{"v":2.57577362585839,"d":"2.58"},{"v":2.58410328202699,"d":"2.58"},{"v":1.87853130286526,"d":"1.88"},{"v":3.63616895050912,"d":"3.64"},{"v":4.36386858110348,"d":"4.36"},{"v":4.43199507601231,"d":"4.43"},{"v":0.566151041659414,"d":"0.57"},{"v":-0.820741098397256,"d":"-0.82"},{"v":0.0256832070936807,"d":"0.03"},{"v":0.290642972164167,"d":"0.29"},"down","no"]
["MSTRG.14320","MTMR7","ENSOART00000010147","GO:0004725(protein tyrosine phosphatase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016020(membrane);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0046855(inositol phosphate dephosphorylation);GO:0046856(phosphatidylinositol dephosphorylation);GO:0052866(phosphatidylinositol phosphate phosphatase activity)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)","K18083","3.1.3.95;EC:3.1.3.64","myotubularin related protein 7 [Source:NCBI gene;Acc:101111072]",{"v":0.902963,"d":"0.90"},{"v":0.818214,"d":"0.82"},{"v":0.741726,"d":"0.74"},{"v":2.109349,"d":"2.11"},{"v":1.23649,"d":"1.24"},{"v":1.52762,"d":"1.53"},{"v":0.505370620743911,"d":"0.51"},{"v":-0.984586297915826,"d":"-0.98"},{"v":0.0257297191820394,"d":"0.03"},{"v":0.290858508581788,"d":"0.29"},"down","no"]
["MSTRG.7029","FST","ENSOART00000008836","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002244(hematopoietic progenitor cell differentiation);GO:0005515(protein binding);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0038102(activin receptor antagonist activity);GO:0048185(activin binding);GO:0051798(positive regulation of hair follicle development)","04350(TGF-beta signaling pathway)","K04661","NA","follistatin [Source:NCBI gene;Acc:443323]",{"v":3.22313628149435,"d":"3.22"},{"v":2.28018078627281,"d":"2.28"},{"v":2.65914977932233,"d":"2.66"},{"v":6.76457857949609,"d":"6.76"},{"v":3.24133394005213,"d":"3.24"},{"v":5.75955208166811,"d":"5.76"},{"v":0.517743501606654,"d":"0.52"},{"v":-0.949690554135809,"d":"-0.95"},{"v":0.0257582927124733,"d":"0.03"},{"v":0.290858508581788,"d":"0.29"},"down","no"]
["MSTRG.5079","ZSWIM3","ENSOART00000007465","GO:0008270(zinc ion binding)","NA","K17604","NA","zinc finger SWIM-type containing 3 [Source:NCBI gene;Acc:101113090]",{"v":0.17998,"d":"0.18"},{"v":0.061997,"d":"0.06"},{"v":0.159425,"d":"0.16"},{"v":0.381993,"d":"0.38"},{"v":0.235002,"d":"0.24"},{"v":0.355097,"d":"0.36"},{"v":0.412925937051226,"d":"0.41"},{"v":-1.27604505375291,"d":"-1.28"},{"v":0.0258805117975527,"d":"0.03"},{"v":0.291834942424337,"d":"0.29"},"down","yes"]
["MSTRG.16853","DNAH11","ENSOART00000011825","GO:0003279(cardiac septum development);GO:0003341(cilium movement);GO:0003351(epithelial cilium movement);GO:0003356(regulation of cilium beat frequency);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005930(axoneme);GO:0007018(microtubule-based movement);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0007611(learning or memory);GO:0030286(dynein complex);GO:0030317(flagellated sperm motility);GO:0031514(motile cilium);GO:0035545(determination of left/right asymmetry in nervous system);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0060411(cardiac septum morphogenesis);GO:0061371(determination of heart left/right asymmetry);GO:0097728(9+0 motile cilium);GO:0097729(9+2 motile cilium);GO:0120134(proximal portion of axoneme);GO:1905419(sperm flagellum movement involved in flagellated sperm motility)","05016(Huntington disease)","K10408","NA","dynein axonemal heavy chain 11 [Source:NCBI gene;Acc:101120490]",{"v":0.661721,"d":"0.66"},{"v":0.546568,"d":"0.55"},{"v":0.656422,"d":"0.66"},{"v":1.549677,"d":"1.55"},{"v":1.160085,"d":"1.16"},{"v":0.711508757457757,"d":"0.71"},{"v":0.545034617893151,"d":"0.55"},{"v":-0.875580229260782,"d":"-0.88"},{"v":0.0259103005471872,"d":"0.03"},{"v":0.291969211410955,"d":"0.29"},"down","no"]
["MSTRG.8087","AGBL1","ENSOART00000011692","GO:0004181(metallocarboxypeptidase activity);GO:0006508(proteolysis);GO:0008270(zinc ion binding)","NA","NA","NA","ATP/GTP binding protein like 1 [Source:NCBI gene;Acc:101115736]",{"v":1.09970396048217,"d":"1.10"},{"v":2.45838558594416,"d":"2.46"},{"v":3.05720957212714,"d":"3.06"},{"v":1.49100612469438,"d":"1.49"},{"v":1.38187439904475,"d":"1.38"},{"v":0.953620075112299,"d":"0.95"},{"v":1.72881172958372,"d":"1.73"},{"v":0.789780765692088,"d":"0.79"},{"v":0.0259953227951927,"d":"0.03"},{"v":0.29252352212261,"d":"0.29"},"up","no"]
["MSTRG.11611","ATXN1;ENSOARG00000012112","ENSOART00000013208;ENSOART00000013170","GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008022(protein C-terminus binding);GO:0008266(poly(U) RNA binding);GO:0016363(nuclear matrix);GO:0034046(poly(G) binding);GO:0042405(nuclear inclusion body);GO:0042802(identical protein binding);GO:0043621(protein self-association);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051168(nuclear export)","NA","NA","NA","ataxin 1 [Source:NCBI gene;Acc:101113284]",{"v":2.14151188595171,"d":"2.14"},{"v":4.02841199529285,"d":"4.03"},{"v":2.71763998216529,"d":"2.72"},{"v":2.35074371754345,"d":"2.35"},{"v":1.41759590282015,"d":"1.42"},{"v":1.7353434312632,"d":"1.74"},{"v":1.61483933214192,"d":"1.61"},{"v":0.691390631635696,"d":"0.69"},{"v":0.026187220702724,"d":"0.03"},{"v":0.294479985973883,"d":"0.29"},"up","no"]
["ENSOARG00000011966","ASB9","ENSOART00000013015","GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction);GO:0045732(positive regulation of protein catabolic process)","NA","K10331","NA","ankyrin repeat and SOCS box containing 9 [Source:NCBI gene;Acc:101123093]",{"v":0.104982,"d":"0.10"},{"v":0.064984,"d":"0.06"},{"v":0.064078,"d":"0.06"},{"v":0.174811,"d":"0.17"},{"v":0.191007,"d":"0.19"},{"v":0.159722,"d":"0.16"},{"v":0.445340031205998,"d":"0.45"},{"v":-1.16702079474674,"d":"-1.17"},{"v":0.0263209108206013,"d":"0.03"},{"v":0.29532107909088,"d":"0.30"},"down","yes"]
["MSTRG.5500","SLC7A6","ENSOART00000003684","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","NA","K13872","NA","solute carrier family 7 member 6 [Source:NCBI gene;Acc:101118550]",{"v":0.928949,"d":"0.93"},{"v":3.162396,"d":"3.16"},{"v":1.725571,"d":"1.73"},{"v":1.246912,"d":"1.25"},{"v":0.916651,"d":"0.92"},{"v":0.825981,"d":"0.83"},{"v":1.94575359988012,"d":"1.95"},{"v":0.960329026286463,"d":"0.96"},{"v":0.0263791152402598,"d":"0.03"},{"v":0.295562113827965,"d":"0.30"},"up","no"]
["MSTRG.8666","DBNL","ENSOART00000014822","GO:0001726(ruffle);GO:0002102(podosome);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005938(cell cortex);GO:0006898(receptor-mediated endocytosis);GO:0007416(synapse assembly);GO:0016601(Rac protein signal transduction);GO:0019904(protein domain specific binding);GO:0030027(lamellipodium);GO:0048812(neuron projection morphogenesis);GO:0051015(actin filament binding);GO:0071800(podosome assembly);GO:0097178(ruffle assembly)","NA","K20520","NA","drebrin like [Source:NCBI gene;Acc:101123075]",{"v":5.1433215522541,"d":"5.14"},{"v":2.95632150204918,"d":"2.96"},{"v":3.86491906045082,"d":"3.86"},{"v":6.55056123224044,"d":"6.55"},{"v":7.47876435928962,"d":"7.48"},{"v":7.18052511782787,"d":"7.18"},{"v":0.564104023112018,"d":"0.56"},{"v":-0.825966868806029,"d":"-0.83"},{"v":0.0263959308775183,"d":"0.03"},{"v":0.295562113827965,"d":"0.30"},"down","no"]
["MSTRG.9142","PFKFB4","ENSOART00000019474","GO:0003824(catalytic activity);GO:0003873(6-phosphofructo-2-kinase activity);GO:0005524(ATP binding);GO:0006000(fructose metabolic process);GO:0006003(fructose 2,6-bisphosphate metabolic process);GO:0046835(carbohydrate phosphorylation)","00051(Fructose and mannose metabolism);04152(AMPK signaling pathway)","K19030","3.1.3.46;EC:2.7.1.105","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 [Source:NCBI gene;Acc:101110626]",{"v":2.69038711540734,"d":"2.69"},{"v":2.20674907470061,"d":"2.21"},{"v":2.58915959218087,"d":"2.59"},{"v":5.45571595564148,"d":"5.46"},{"v":4.53010522114817,"d":"4.53"},{"v":3.32663069856614,"d":"3.33"},{"v":0.562352889789413,"d":"0.56"},{"v":-0.830452354875859,"d":"-0.83"},{"v":0.0264101619350197,"d":"0.03"},{"v":0.295562113827965,"d":"0.30"},"down","no"]
["MSTRG.6462","GALNT18","ENSOART00000010940","GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006493(protein O-linked glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030246(carbohydrate binding)","NA","NA","NA","polypeptide N-acetylgalactosaminyltransferase 18 [Source:HGNC Symbol;Acc:HGNC:30488]",{"v":1.41354003060515,"d":"1.41"},{"v":0.922459555993508,"d":"0.92"},{"v":0.9271660969163,"d":"0.93"},{"v":2.54288299420357,"d":"2.54"},{"v":1.76131161187109,"d":"1.76"},{"v":1.70857117505217,"d":"1.71"},{"v":0.542706269011433,"d":"0.54"},{"v":-0.881756520978622,"d":"-0.88"},{"v":0.0265206858199378,"d":"0.03"},{"v":0.296595724704072,"d":"0.30"},"down","no"]
["MSTRG.6883","ENSOARG00000005024","ENSOART00000005467","GO:0003674(molecular_function);GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006412(translation);GO:0008150(biological_process);GO:1904841(TORC2 complex binding)","NA","NA","NA",null,{"v":3.205597,"d":"3.21"},{"v":1.071131,"d":"1.07"},{"v":1.213835,"d":"1.21"},{"v":9.217722,"d":"9.22"},{"v":1.631281,"d":"1.63"},{"v":4.286919,"d":"4.29"},{"v":0.36275048193298,"d":"0.36"},{"v":-1.46295056389828,"d":"-1.46"},{"v":0.0265744026146676,"d":"0.03"},{"v":0.296993049892055,"d":"0.30"},"down","yes"]
["MSTRG.11549","ENSOARG00000020085","ENSOART00000021866","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11254","NA","histone H4 [Source:NCBI gene;Acc:101113369]",{"v":19.469275,"d":"19.47"},{"v":8.182365,"d":"8.18"},{"v":16.263273,"d":"16.26"},{"v":39.26844,"d":"39.27"},{"v":16.520937,"d":"16.52"},{"v":33.769173,"d":"33.77"},{"v":0.490348637846414,"d":"0.49"},{"v":-1.02812022475951,"d":"-1.03"},{"v":0.0266767756442273,"d":"0.03"},{"v":0.297914395669691,"d":"0.30"},"down","yes"]
["MSTRG.16195","C1QTNF6","ENSOART00000020915","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005615(extracellular space);GO:0042802(identical protein binding);GO:0051259(protein complex oligomerization);GO:0070208(protein heterotrimerization)","NA","K19470","NA","C1q and TNF related 6 [Source:NCBI gene;Acc:101102801]",{"v":3.35585760860367,"d":"3.36"},{"v":1.65661018229901,"d":"1.66"},{"v":5.18023569076164,"d":"5.18"},{"v":6.56415475,"d":"6.56"},{"v":5.67517374894217,"d":"5.68"},{"v":7.98634746720733,"d":"7.99"},{"v":0.50394871838762,"d":"0.50"},{"v":-0.988651161741573,"d":"-0.99"},{"v":0.026774088601847,"d":"0.03"},{"v":0.297996421046819,"d":"0.30"},"down","no"]
["MSTRG.8454","EVL","ENSOART00000001549","GO:0003779(actin binding);GO:0005522(profilin binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005925(focal adhesion);GO:0008154(actin polymerization or depolymerization);GO:0010633(negative regulation of epithelial cell migration);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium);GO:0030838(positive regulation of actin filament polymerization);GO:0045010(actin nucleation);GO:0045335(phagocytic vesicle);GO:0051289(protein homotetramerization);GO:0051496(positive regulation of stress fiber assembly);GO:0071346(cellular response to interferon-gamma);GO:1900028(negative regulation of ruffle assembly)","NA","NA","NA","Enah/Vasp-like [Source:NCBI gene;Acc:101118138]",{"v":3.69424968817204,"d":"3.69"},{"v":1.5379923223417,"d":"1.54"},{"v":2.41328762867383,"d":"2.41"},{"v":4.40286093620072,"d":"4.40"},{"v":4.62838639569893,"d":"4.63"},{"v":5.0467980953405,"d":"5.05"},{"v":0.543081756533754,"d":"0.54"},{"v":-0.880758694524069,"d":"-0.88"},{"v":0.026791345645151,"d":"0.03"},{"v":0.297996421046819,"d":"0.30"},"down","no"]
["MSTRG.21244","RIMS2","ENSOART00000017407","GO:0005515(protein binding);GO:0006887(exocytosis);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0017157(regulation of exocytosis);GO:0046872(metal ion binding);GO:0048786(presynaptic active zone);GO:0048791(calcium ion-regulated exocytosis of neurotransmitter);GO:1903861(positive regulation of dendrite extension)","NA","NA","NA","regulating synaptic membrane exocytosis 2 [Source:HGNC Symbol;Acc:HGNC:17283]",{"v":1.19116358949455,"d":"1.19"},{"v":0.942895918929633,"d":"0.94"},{"v":0.683954730029732,"d":"0.68"},{"v":3.16446320396432,"d":"3.16"},{"v":1.0355782382557,"d":"1.04"},{"v":1.64036368364718,"d":"1.64"},{"v":0.482503213000226,"d":"0.48"},{"v":-1.0513895455345,"d":"-1.05"},{"v":0.0267919369241015,"d":"0.03"},{"v":0.297996421046819,"d":"0.30"},"down","yes"]
["MSTRG.12939","TYMS","ENSOART00000010195","GO:0000900(translation repressor activity, mRNA regulatory element binding);GO:0004799(thymidylate synthase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0006231(dTMP biosynthetic process);GO:0017148(negative regulation of translation);GO:0032259(methylation);GO:0035999(tetrahydrofolate interconversion);GO:0046683(response to organophosphorus);GO:1990825(sequence-specific mRNA binding)","00240(Pyrimidine metabolism);00670(One carbon pool by folate);01523(Antifolate resistance)","K00560","EC:2.1.1.45","thymidylate synthetase [Source:NCBI gene;Acc:100037674]",{"v":0.297652,"d":"0.30"},{"v":0.098023,"d":"0.10"},{"v":0.379864,"d":"0.38"},{"v":1.033532,"d":"1.03"},{"v":0.276625,"d":"0.28"},{"v":0.87948,"d":"0.88"},{"v":0.354186104820114,"d":"0.35"},{"v":-1.4974204804834,"d":"-1.50"},{"v":0.0268569003174682,"d":"0.03"},{"v":0.29851563538708,"d":"0.30"},"down","yes"]
["ENSOARG00000004773","AGPAT4","ENSOART00000005198","GO:0005741(mitochondrial outer membrane);GO:0006644(phospholipid metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0042171(lysophosphatidic acid acyltransferase activity)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04072(Phospholipase D signaling pathway)","K13523","2.3.1.-;EC:2.3.1.51","1-acylglycerol-3-phosphate O-acyltransferase 4 [Source:NCBI gene;Acc:101112654]",{"v":0.2469,"d":"0.25"},{"v":0.18229,"d":"0.18"},{"v":0.574887,"d":"0.57"},{"v":1.593988,"d":"1.59"},{"v":0.436371,"d":"0.44"},{"v":0.725979,"d":"0.73"},{"v":0.364279344550632,"d":"0.36"},{"v":-1.45688290150638,"d":"-1.46"},{"v":0.0268987026297646,"d":"0.03"},{"v":0.298573770590616,"d":"0.30"},"down","yes"]
["MSTRG.7151","MYO10","ENSOART00000014112","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0008360(regulation of cell shape);GO:0016459(myosin complex);GO:0022409(positive regulation of cell-cell adhesion);GO:0030175(filopodium);GO:0030507(spectrin binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0051489(regulation of filopodium assembly)","04666(Fc gamma R-mediated phagocytosis)","K12559","NA","unconventional myosin-X [Source:NCBI gene;Acc:101102178]",{"v":5.7071732404793,"d":"5.71"},{"v":3.56229707794519,"d":"3.56"},{"v":4.09779584375371,"d":"4.10"},{"v":9.58089831984814,"d":"9.58"},{"v":6.90650937738759,"d":"6.91"},{"v":7.19678389820857,"d":"7.20"},{"v":0.564396133526863,"d":"0.56"},{"v":-0.825219990298618,"d":"-0.83"},{"v":0.0269304030780624,"d":"0.03"},{"v":0.298598347042846,"d":"0.30"},"down","no"]
["MSTRG.12627","ENSOARG00000016160","ENSOART00000017595","GO:0000166(nucleotide binding);GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006414(translational elongation)","NA","NA","NA",null,{"v":4.783824,"d":"4.78"},{"v":5.478421,"d":"5.48"},{"v":8.710812,"d":"8.71"},{"v":11.814833,"d":"11.81"},{"v":11.727708,"d":"11.73"},{"v":10.944802,"d":"10.94"},{"v":0.550145512804509,"d":"0.55"},{"v":-0.862114834730408,"d":"-0.86"},{"v":0.0271041834156571,"d":"0.03"},{"v":0.29965382837264,"d":"0.30"},"down","no"]
["MSTRG.8335","RALGAPA1","ENSOART00000008389","GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction)","NA","NA","NA","Ral GTPase activating protein catalytic alpha subunit 1 [Source:NCBI gene;Acc:101120113]",{"v":3.39510255843128,"d":"3.40"},{"v":5.4459234418701,"d":"5.45"},{"v":4.74762280119801,"d":"4.75"},{"v":2.87070362631857,"d":"2.87"},{"v":3.3927733649789,"d":"3.39"},{"v":2.36242117371157,"d":"2.36"},{"v":1.57533146595931,"d":"1.58"},{"v":0.655655418442797,"d":"0.66"},{"v":0.0274203012143859,"d":"0.03"},{"v":0.301665638581021,"d":"0.30"},"up","no"]
["MSTRG.10136","ORMDL1","ENSOART00000017763","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006672(ceramide metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0090155(negative regulation of sphingolipid biosynthetic process);GO:1900060(negative regulation of ceramide biosynthetic process)","NA","NA","NA","ORMDL sphingolipid biosynthesis regulator 1 [Source:NCBI gene;Acc:101112289]",{"v":1.70170523059393,"d":"1.70"},{"v":2.33211110753454,"d":"2.33"},{"v":1.54268541304657,"d":"1.54"},{"v":1.08326038683948,"d":"1.08"},{"v":1.34516225024925,"d":"1.35"},{"v":1.09108634468025,"d":"1.09"},{"v":1.58445447363858,"d":"1.58"},{"v":0.66398620714871,"d":"0.66"},{"v":0.0274334317096349,"d":"0.03"},{"v":0.301665638581021,"d":"0.30"},"up","no"]
["MSTRG.17849","ENSOARG00000005384","ENSOART00000005875","GO:0004866(endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006956(complement activation);GO:0010951(negative regulation of endopeptidase activity)","04080(Neuroactive ligand-receptor interaction);04145(Phagosome);04610(Complement and coagulation cascades);05133(Pertussis);05134(Legionellosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05150(Staphylococcus aureus infection);05152(Tuberculosis);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K03990","NA","complement C3 [Source:NCBI gene;Acc:101108131]",{"v":0.687784443659154,"d":"0.69"},{"v":0.689053791972263,"d":"0.69"},{"v":0.440701389385251,"d":"0.44"},{"v":0.831061937458328,"d":"0.83"},{"v":1.31309183557808,"d":"1.31"},{"v":1.29333679223897,"d":"1.29"},{"v":0.528740251210279,"d":"0.53"},{"v":-0.919368936485023,"d":"-0.92"},{"v":0.0274359060076443,"d":"0.03"},{"v":0.301665638581021,"d":"0.30"},"down","no"]
["MSTRG.19093","GPAT3","ENSOART00000003316","GO:0004366(glycerol-3-phosphate O-acyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0019432(triglyceride biosynthetic process);GO:0032006(regulation of TOR signaling)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism)","K13506","EC:2.3.1.15","glycerol-3-phosphate acyltransferase 3 [Source:NCBI gene;Acc:101119394]",{"v":11.8793606132075,"d":"11.88"},{"v":12.912286254717,"d":"12.91"},{"v":7.79100386603773,"d":"7.79"},{"v":28.6012904207547,"d":"28.60"},{"v":13.8175957207547,"d":"13.82"},{"v":18.9601407811321,"d":"18.96"},{"v":0.530843390121311,"d":"0.53"},{"v":-0.91364179623197,"d":"-0.91"},{"v":0.0274940324112088,"d":"0.03"},{"v":0.302101319791533,"d":"0.30"},"down","no"]
["MSTRG.12778","ENSOARG00000004060","ENSOART00000004414","GO:0016491(oxidoreductase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process)","NA","NA","NA","probable 2-ketogluconate reductase [Source:NCBI gene;Acc:101122400]",{"v":0.730934796541787,"d":"0.73"},{"v":1.05943798501441,"d":"1.06"},{"v":0.323557537752161,"d":"0.32"},{"v":0.480845035158501,"d":"0.48"},{"v":0.294808774639769,"d":"0.29"},{"v":0.204918778097983,"d":"0.20"},{"v":2.15581217076814,"d":"2.16"},{"v":1.10823148601907,"d":"1.11"},{"v":0.0275539818185802,"d":"0.03"},{"v":0.302370320230669,"d":"0.30"},"up","yes"]
["MSTRG.10114","MAP3K2","ENSOART00000017568","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0019901(protein kinase binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071260(cellular response to mechanical stimulus)","04010(MAPK signaling pathway);04540(Gap junction);04912(GnRH signaling pathway)","K04420","EC:2.7.11.25","mitogen-activated protein kinase kinase kinase 2 [Source:NCBI gene;Acc:101109858]",{"v":2.51092312309562,"d":"2.51"},{"v":5.83288165716422,"d":"5.83"},{"v":5.71757964875222,"d":"5.72"},{"v":2.49388534778951,"d":"2.49"},{"v":3.29070085559398,"d":"3.29"},{"v":2.48698832610524,"d":"2.49"},{"v":1.69996466560052,"d":"1.70"},{"v":0.765504759720219,"d":"0.77"},{"v":0.0275740695016822,"d":"0.03"},{"v":0.302370320230669,"d":"0.30"},"up","no"]
["MSTRG.2366","EDNRB","ENSOART00000000161","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001755(neural crest cell migration);GO:0004930(G protein-coupled receptor activity);GO:0004962(endothelin receptor activity);GO:0005886(plasma membrane);GO:0006885(regulation of pH);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007422(peripheral nervous system development);GO:0007497(posterior midgut development);GO:0008217(regulation of blood pressure);GO:0014043(negative regulation of neuron maturation);GO:0014826(vein smooth muscle contraction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017046(peptide hormone binding);GO:0019722(calcium-mediated signaling);GO:0030318(melanocyte differentiation);GO:0032269(negative regulation of cellular protein metabolic process);GO:0035645(enteric smooth muscle cell differentiation);GO:0042310(vasoconstriction);GO:0043473(pigmentation);GO:0048066(developmental pigmentation);GO:0048246(macrophage chemotaxis);GO:0048484(enteric nervous system development);GO:0086100(endothelin receptor signaling pathway)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04080(Neuroactive ligand-receptor interaction);04916(Melanogenesis);04926(Relaxin signaling pathway);05200(Pathways in cancer)","K04198","NA","endothelin receptor type B [Source:NCBI gene;Acc:443139]",{"v":4.638373,"d":"4.64"},{"v":2.195614,"d":"2.20"},{"v":1.025372,"d":"1.03"},{"v":4.059244,"d":"4.06"},{"v":6.998298,"d":"7.00"},{"v":5.785186,"d":"5.79"},{"v":0.466632186899889,"d":"0.47"},{"v":-1.09964227132155,"d":"-1.10"},{"v":0.0276543457422642,"d":"0.03"},{"v":0.30293431319106,"d":"0.30"},"down","yes"]
["MSTRG.22302","ACSL4","ENSOART00000019541;ENSOART00000019540","GO:0001676(long-chain fatty acid metabolic process);GO:0003824(catalytic activity);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005811(lipid droplet);GO:0006629(lipid metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031957(very long-chain fatty acid-CoA ligase activity);GO:0044233(mitochondria-associated endoplasmic reticulum membrane);GO:0047676(arachidonate-CoA ligase activity);GO:0060136(embryonic process involved in female pregnancy);GO:0060136(embryonic process involved in female pregnancy)","00061(Fatty acid biosynthesis);00071(Fatty acid degradation);03320(PPAR signaling pathway);04146(Peroxisome);04216(Ferroptosis);04714(Thermogenesis);04920(Adipocytokine signaling pathway);04920(Adipocytokine signaling pathway)","K01897","EC:6.2.1.3","acyl-CoA synthetase long chain family member 4 [Source:NCBI gene;Acc:101111781]",{"v":9.4042043222097,"d":"9.40"},{"v":9.47639719413754,"d":"9.48"},{"v":8.13773776798196,"d":"8.14"},{"v":7.29806909289741,"d":"7.30"},{"v":5.23795248229989,"d":"5.24"},{"v":5.21663699143179,"d":"5.22"},{"v":1.52193200713709,"d":"1.52"},{"v":0.605903907358359,"d":"0.61"},{"v":0.0276626078495756,"d":"0.03"},{"v":0.30293431319106,"d":"0.30"},"up","no"]
["MSTRG.12986","ANKRD12","ENSOART00000001039","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA","K21436","NA","ankyrin repeat domain 12 [Source:NCBI gene;Acc:101106986]",{"v":2.20680404070362,"d":"2.21"},{"v":2.60748465202495,"d":"2.61"},{"v":2.8361423402025,"d":"2.84"},{"v":1.8611934452342,"d":"1.86"},{"v":1.61320036408263,"d":"1.61"},{"v":1.50467073455717,"d":"1.50"},{"v":1.53651975496959,"d":"1.54"},{"v":0.619666315719324,"d":"0.62"},{"v":0.0277243857584235,"d":"0.03"},{"v":0.303407352991649,"d":"0.30"},"up","no"]
["MSTRG.16025","ENSOARG00000011042","ENSOART00000012011","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 198-like [Source:NCBI gene;Acc:101113745]",{"v":1.165002,"d":"1.17"},{"v":0.824331,"d":"0.82"},{"v":1.043039,"d":"1.04"},{"v":1.509874,"d":"1.51"},{"v":2.320105,"d":"2.32"},{"v":2.187963,"d":"2.19"},{"v":0.503888538639954,"d":"0.50"},{"v":-0.988823453494071,"d":"-0.99"},{"v":0.027789218037933,"d":"0.03"},{"v":0.303709740377088,"d":"0.30"},"down","no"]
["MSTRG.9750","ENSOARG00000012217","ENSOART00000013283","NA","NA","NA","NA","chromosome 2 open reading frame, human C9orf131 [Source:NCBI gene;Acc:101109944]",{"v":0.299402,"d":"0.30"},{"v":0.423297,"d":"0.42"},{"v":0.564062,"d":"0.56"},{"v":0.141289,"d":"0.14"},{"v":0.33454,"d":"0.33"},{"v":0.18955,"d":"0.19"},{"v":1.93387678300638,"d":"1.93"},{"v":0.951495876402826,"d":"0.95"},{"v":0.027836851405088,"d":"0.03"},{"v":0.304026829259048,"d":"0.30"},"up","no"]
["MSTRG.17583","ENSOARG00000013462","ENSOART00000014647","GO:0001678(cellular glucose homeostasis);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005925(focal adhesion);GO:0005942(phosphatidylinositol 3-kinase complex);GO:0007165(signal transduction);GO:0008134(transcription factor binding);GO:0008286(insulin receptor signaling pathway);GO:0030833(regulation of actin filament polymerization);GO:0032869(cellular response to insulin stimulus);GO:0034976(response to endoplasmic reticulum stress);GO:0035014(phosphatidylinositol 3-kinase regulator activity);GO:0036312(phosphatidylinositol 3-kinase regulatory subunit binding);GO:0042307(positive regulation of protein import into nucleus);GO:0043551(regulation of phosphatidylinositol 3-kinase activity);GO:0045785(positive regulation of cell adhesion);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0051492(regulation of stress fiber assembly);GO:1903076(regulation of protein localization to plasma membrane)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);01524(Platinum drug resistance);04012(ErbB signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04210(Apoptosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04218(Cellular senescence);04360(Axon guidance);04370(VEGF signaling pathway);04380(Osteoclast differentiation);04510(Focal adhesion);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04630(Jak-STAT signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04668(TNF signaling pathway);04670(Leukocyte transendothelial migration);04722(Neurotrophin signaling pathway);04725(Cholinergic synapse);04750(Inflammatory mediator regulation of TRP channels);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04923(Regulation of lipolysis in adipocytes);04926(Relaxin signaling pathway);04930(Type II diabetes mellitus);04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);04960(Aldosterone-regulated sodium reabsorption);04973(Carbohydrate digestion and absorption);05100(Bacterial invasion of epithelial cells);05142(Chagas disease (American trypanosomiasis));05146(Amoebiasis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05164(Influenza A);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05218(Melanoma);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);05418(Fluid shear stress and atherosclerosis)","K02649","NA","phosphoinositide-3-kinase regulatory subunit 2 [Source:NCBI gene;Acc:101111546]",{"v":1.45248452483737,"d":"1.45"},{"v":1.06658971052632,"d":"1.07"},{"v":1.44684402188054,"d":"1.45"},{"v":2.38159321732703,"d":"2.38"},{"v":2.1722233693081,"d":"2.17"},{"v":2.61168360171496,"d":"2.61"},{"v":0.553474028748496,"d":"0.55"},{"v":-0.853412473408676,"d":"-0.85"},{"v":0.0278649339055697,"d":"0.03"},{"v":0.30413010749341,"d":"0.30"},"down","no"]
["MSTRG.12633","SLC18A2","ENSOART00000019861","GO:0001975(response to amphetamine);GO:0005623(cell);GO:0007626(locomotory behavior);GO:0009636(response to toxic substance);GO:0009791(post-embryonic development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0098691(dopaminergic synapse);GO:0098700(neurotransmitter loading into synaptic vesicle);GO:0098793(presynapse)","04721(Synaptic vesicle cycle);04726(Serotonergic synapse);04728(Dopaminergic synapse);05012(Parkinson disease);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)","K08155","NA","solute carrier family 18 member A2 [Source:NCBI gene;Acc:101104796]",{"v":0.0684161393258427,"d":"0.07"},{"v":0.184824447940075,"d":"0.18"},{"v":0.138434440449438,"d":"0.14"},{"v":0.0668106981273408,"d":"0.07"},{"v":0.684203721348315,"d":"0.68"},{"v":0.525380868913858,"d":"0.53"},{"v":0.306860289502909,"d":"0.31"},{"v":-1.70434613479165,"d":"-1.70"},{"v":0.0279518468147333,"d":"0.03"},{"v":0.304513266017007,"d":"0.30"},"down","yes"]
["MSTRG.15180","SULT1C4","ENSOART00000000200","GO:0004062(aryl sulfotransferase activity);GO:0005829(cytosol);GO:0006068(ethanol catabolic process);GO:0008146(sulfotransferase activity);GO:0016740(transferase activity);GO:0050427(3'-phosphoadenosine 5'-phosphosulfate metabolic process);GO:0051923(sulfation)","NA","K01025","EC:2.8.2.-","sulfotransferase 1C4-like [Source:NCBI gene;Acc:101116298]",{"v":3.89796722713568,"d":"3.90"},{"v":1.9188592281407,"d":"1.92"},{"v":2.21970675075377,"d":"2.22"},{"v":4.18665751055276,"d":"4.19"},{"v":4.53978204723618,"d":"4.54"},{"v":5.79671730150754,"d":"5.80"},{"v":0.553359939845713,"d":"0.55"},{"v":-0.853709890183945,"d":"-0.85"},{"v":0.0281095386722756,"d":"0.03"},{"v":0.305421135090127,"d":"0.31"},"down","no"]
["MSTRG.19612","LPCAT4","ENSOART00000021635","GO:0005783(endoplasmic reticulum);GO:0006644(phospholipid metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016746(transferase activity, transferring acyl groups);GO:0071617(lysophospholipid acyltransferase activity)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism)","K13512","2.3.1.-;EC:2.3.1.23","lysophosphatidylcholine acyltransferase 4 [Source:NCBI gene;Acc:101110515]",{"v":0.920810032701112,"d":"0.92"},{"v":0.659180334859385,"d":"0.66"},{"v":0.621211628515369,"d":"0.62"},{"v":1.44324073773708,"d":"1.44"},{"v":1.48163137475474,"d":"1.48"},{"v":1.4072236442119,"d":"1.41"},{"v":0.50811480625044,"d":"0.51"},{"v":-0.976773590616216,"d":"-0.98"},{"v":0.0281141576457901,"d":"0.03"},{"v":0.305421135090127,"d":"0.31"},"down","no"]
["MSTRG.19053","STBD1","ENSOART00000018552","GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005887(integral component of plasma membrane);GO:0005980(glycogen catabolic process);GO:0016020(membrane);GO:0019899(enzyme binding);GO:0030246(carbohydrate binding);GO:0030247(polysaccharide binding);GO:0030315(T-tubule);GO:0046907(intracellular transport);GO:0048471(perinuclear region of cytoplasm);GO:0061723(glycophagy);GO:2001069(glycogen binding);GO:2001070(starch binding)","NA","NA","NA","starch binding domain 1 [Source:HGNC Symbol;Acc:HGNC:24854]",{"v":41.9687284725577,"d":"41.97"},{"v":34.3725892146641,"d":"34.37"},{"v":27.7170729970333,"d":"27.72"},{"v":29.5639513263403,"d":"29.56"},{"v":18.6440335325281,"d":"18.64"},{"v":19.3335954884509,"d":"19.33"},{"v":1.54065673543846,"d":"1.54"},{"v":0.623545459357082,"d":"0.62"},{"v":0.0282042692350783,"d":"0.03"},{"v":0.306196348451037,"d":"0.31"},"up","no"]
["MSTRG.8570","HSP90AA1","ENSOART00000004244","GO:0001934(positive regulation of protein phosphorylation);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006457(protein folding);GO:0007004(telomere maintenance via telomerase);GO:0009408(response to heat);GO:0009409(response to cold);GO:0016887(ATPase activity);GO:0021955(central nervous system neuron axonogenesis);GO:0030010(establishment of cell polarity);GO:0030235(nitric-oxide synthase regulator activity);GO:0030911(TPR domain binding);GO:0031396(regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032273(positive regulation of protein polymerization);GO:0032991(protein-containing complex);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043025(neuronal cell body);GO:0044294(dendritic growth cone);GO:0044295(axonal growth cone);GO:0045040(protein insertion into mitochondrial outer membrane);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0046677(response to antibiotic);GO:0048156(tau protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0048675(axon extension);GO:0050821(protein stabilization);GO:0051020(GTPase binding);GO:0051082(unfolded protein binding);GO:0051131(chaperone-mediated protein complex assembly);GO:0051897(positive regulation of protein kinase B signaling);GO:0051973(positive regulation of telomerase activity);GO:0070182(DNA polymerase binding);GO:0097110(scaffold protein binding);GO:0097718(disordered domain specific binding);GO:1902949(positive regulation of tau-protein kinase activity);GO:1903364(positive regulation of cellular protein catabolic process);GO:1903827(regulation of cellular protein localization);GO:1905323(telomerase holoenzyme complex assembly);GO:1990782(protein tyrosine kinase binding)","04141(Protein processing in endoplasmic reticulum);04151(PI3K-Akt signaling pathway);04217(Necroptosis);04612(Antigen processing and presentation);04621(NOD-like receptor signaling pathway);04657(IL-17 signaling pathway);04659(Th17 cell differentiation);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);05200(Pathways in cancer);05215(Prostate cancer);05418(Fluid shear stress and atherosclerosis)","K04079","NA","heat shock protein 90 alpha family class A member 1 [Source:NCBI gene;Acc:100127209]",{"v":136.108688,"d":"136.11"},{"v":214.93689,"d":"214.94"},{"v":218.619354,"d":"218.62"},{"v":98.529358,"d":"98.53"},{"v":136.673721,"d":"136.67"},{"v":120.450096,"d":"120.45"},{"v":1.60174285524092,"d":"1.60"},{"v":0.679642555208601,"d":"0.68"},{"v":0.0282794473824219,"d":"0.03"},{"v":0.306808516186169,"d":"0.31"},"up","no"]
["ENSOARG00000012121","FAM214B","ENSOART00000013186","GO:0005634(nucleus)","NA","NA","NA","family with sequence similarity 214 member B [Source:NCBI gene;Acc:101117991]",{"v":1.880737,"d":"1.88"},{"v":1.990415,"d":"1.99"},{"v":1.806107,"d":"1.81"},{"v":0.779969,"d":"0.78"},{"v":1.13784,"d":"1.14"},{"v":1.3047,"d":"1.30"},{"v":1.76175116966314,"d":"1.76"},{"v":0.817010171906744,"d":"0.82"},{"v":0.0283817110243082,"d":"0.03"},{"v":0.307395803316451,"d":"0.31"},"up","no"]
["MSTRG.13415","SMG1","ENSOART00000011912;ENSOART00000011903","GO:0000166(nucleotide binding);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0032204(regulation of telomere maintenance);GO:0042162(telomeric DNA binding);GO:0046777(protein autophosphorylation);GO:0046854(phosphatidylinositol phosphorylation);GO:2001020(regulation of response to DNA damage stimulus);GO:2001020(regulation of response to DNA damage stimulus)","03015(mRNA surveillance pathway);03015(mRNA surveillance pathway)","K08873","EC:2.7.11.1","SMG1, nonsense mediated mRNA decay associated PI3K related kinase [Source:NCBI gene;Acc:101111768]",{"v":6.54055192480726,"d":"6.54"},{"v":10.6321480543202,"d":"10.63"},{"v":12.1975175689639,"d":"12.20"},{"v":5.3692914439874,"d":"5.37"},{"v":8.22589939279334,"d":"8.23"},{"v":4.11184555006581,"d":"4.11"},{"v":1.65867494178239,"d":"1.66"},{"v":0.730031182359077,"d":"0.73"},{"v":0.0283900582680799,"d":"0.03"},{"v":0.307395803316451,"d":"0.31"},"up","no"]
["MSTRG.6256","ENSOARG00000016150","ENSOART00000017585","GO:0003676(nucleic acid binding)","NA","NA","NA",null,{"v":1.085271,"d":"1.09"},{"v":1.223059,"d":"1.22"},{"v":1.032716,"d":"1.03"},{"v":0.7749,"d":"0.77"},{"v":0.605186,"d":"0.61"},{"v":0.576649,"d":"0.58"},{"v":1.70745962023473,"d":"1.71"},{"v":0.771851460579231,"d":"0.77"},{"v":0.0284498242222998,"d":"0.03"},{"v":0.307838787211207,"d":"0.31"},"up","no"]
["MSTRG.5411","CPNE2","ENSOART00000020583","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0071277(cellular response to calcium ion)","NA","NA","NA","copine 2 [Source:NCBI gene;Acc:101121960]",{"v":4.607849,"d":"4.61"},{"v":2.541667,"d":"2.54"},{"v":4.065924,"d":"4.07"},{"v":6.507042,"d":"6.51"},{"v":6.945581,"d":"6.95"},{"v":6.552052,"d":"6.55"},{"v":0.560640950177896,"d":"0.56"},{"v":-0.834850969744712,"d":"-0.83"},{"v":0.0287675086554696,"d":"0.03"},{"v":0.310457475101192,"d":"0.31"},"down","no"]
["MSTRG.4781","ENSOARG00000004656","ENSOART00000005066","GO:0005763(mitochondrial small ribosomal subunit)","NA","K17405","NA","mitochondrial ribosomal protein S26 [Source:NCBI gene;Acc:101112501]",{"v":0.971029,"d":"0.97"},{"v":1.287567,"d":"1.29"},{"v":1.577592,"d":"1.58"},{"v":2.297577,"d":"2.30"},{"v":1.841307,"d":"1.84"},{"v":4.983019,"d":"4.98"},{"v":0.420546896848169,"d":"0.42"},{"v":-1.24966140480469,"d":"-1.25"},{"v":0.0288895486007931,"d":"0.03"},{"v":0.311387465196357,"d":"0.31"},"down","yes"]
["MSTRG.20917","PARP10","ENSOART00000016952","GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0043231(intracellular membrane-bounded organelle)","NA","K15261","EC:2.4.2.30","poly(ADP-ribose) polymerase family member 10 [Source:NCBI gene;Acc:101111201]",{"v":0.626409,"d":"0.63"},{"v":0.223812,"d":"0.22"},{"v":0.31046,"d":"0.31"},{"v":0.891328,"d":"0.89"},{"v":0.77226,"d":"0.77"},{"v":0.757247,"d":"0.76"},{"v":0.479454816210109,"d":"0.48"},{"v":-1.06053323272235,"d":"-1.06"},{"v":0.0288922102996375,"d":"0.03"},{"v":0.311387465196357,"d":"0.31"},"down","yes"]
["MSTRG.237","TOE1","ENSOART00000001676","GO:0000175(3'-5'-exoribonuclease activity);GO:0003676(nucleic acid binding);GO:0004535(poly(A)-specific ribonuclease activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0015030(Cajal body);GO:0016604(nuclear body);GO:0017069(snRNA binding);GO:0034472(snRNA 3'-end processing);GO:0046872(metal ion binding);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic)","NA","K13202","NA","target of EGR1, exonuclease [Source:NCBI gene;Acc:101119770]",{"v":3.1087,"d":"3.11"},{"v":2.543943,"d":"2.54"},{"v":2.554571,"d":"2.55"},{"v":6.102198,"d":"6.10"},{"v":4.382632,"d":"4.38"},{"v":4.365537,"d":"4.37"},{"v":0.552660685086099,"d":"0.55"},{"v":-0.85553410844115,"d":"-0.86"},{"v":0.0289787485373188,"d":"0.03"},{"v":0.311908375818947,"d":"0.31"},"down","no"]
["MSTRG.10235","MAP3K20","ENSOART00000000781;ENSOART00000000779","GO:0000077(DNA damage checkpoint);GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000186(activation of MAPKK activity);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0007050(cell cycle arrest);GO:0007093(mitotic cell cycle checkpoint);GO:0007257(activation of JUN kinase activity);GO:0035556(intracellular signal transduction);GO:0042733(embryonic digit morphogenesis);GO:0043065(positive regulation of apoptotic process);GO:0051403(stress-activated MAPK cascade);GO:0060173(limb development);GO:0071480(cellular response to gamma radiation);GO:0071480(cellular response to gamma radiation)","04010(MAPK signaling pathway);04010(MAPK signaling pathway)","K04424","EC:2.7.11.25","mitogen-activated protein kinase kinase kinase 20 [Source:NCBI gene;Acc:101111776]",{"v":33.5898507242975,"d":"33.59"},{"v":38.1026295159229,"d":"38.10"},{"v":34.2640032307438,"d":"34.26"},{"v":28.5729145694766,"d":"28.57"},{"v":20.4268683595592,"d":"20.43"},{"v":21.0522177186777,"d":"21.05"},{"v":1.51254043412424,"d":"1.51"},{"v":0.596973709878675,"d":"0.60"},{"v":0.0290326455965793,"d":"0.03"},{"v":0.312282633268081,"d":"0.31"},"up","no"]
["MSTRG.21469","CLCN4","ENSOART00000011153","GO:0005247(voltage-gated chloride channel activity);GO:0005254(chloride channel activity);GO:0005789(endoplasmic reticulum membrane);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0015297(antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:1902476(chloride transmembrane transport)","NA","K05012","NA","chloride voltage-gated channel 4 [Source:NCBI gene;Acc:100125626]",{"v":7.54451633654383,"d":"7.54"},{"v":8.11242541401452,"d":"8.11"},{"v":7.05751567992742,"d":"7.06"},{"v":5.93886430457845,"d":"5.94"},{"v":4.48702815661642,"d":"4.49"},{"v":4.48086201074819,"d":"4.48"},{"v":1.52376947465245,"d":"1.52"},{"v":0.607644659437759,"d":"0.61"},{"v":0.0290823084710294,"d":"0.03"},{"v":0.312610883946655,"d":"0.31"},"up","no"]
["MSTRG.19469","GLCE","ENSOART00000020249","GO:0005794(Golgi apparatus);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016857(racemase and epimerase activity, acting on carbohydrates and derivatives);GO:0030210(heparin biosynthetic process);GO:0047464(heparosan-N-sulfate-glucuronate 5-epimerase activity)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)","K01793","EC:5.1.3.17","glucuronic acid epimerase [Source:NCBI gene;Acc:101106592]",{"v":1.5627746375164,"d":"1.56"},{"v":1.15178595365107,"d":"1.15"},{"v":1.59989034134966,"d":"1.60"},{"v":2.61096495846087,"d":"2.61"},{"v":2.46736228363212,"d":"2.47"},{"v":2.33154194665501,"d":"2.33"},{"v":0.582257368196012,"d":"0.58"},{"v":-0.780271103701392,"d":"-0.78"},{"v":0.0292980092624272,"d":"0.03"},{"v":0.314515381483834,"d":"0.31"},"down","no"]
["ENSOARG00000003522","FGFR4","ENSOART00000003830","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005007(fibroblast growth factor-activated receptor activity);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0008201(heparin binding);GO:0008284(positive regulation of cell population proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010628(positive regulation of gene expression);GO:0010715(regulation of extracellular matrix disassembly);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0017134(fibroblast growth factor binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030133(transport vesicle);GO:0043085(positive regulation of catalytic activity);GO:0045862(positive regulation of proteolysis);GO:0046777(protein autophosphorylation);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070857(regulation of bile acid biosynthetic process);GO:2000573(positive regulation of DNA biosynthetic process)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04144(Endocytosis);04151(PI3K-Akt signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);05200(Pathways in cancer)","K05095","EC:2.7.10.1","fibroblast growth factor receptor 4 [Source:NCBI gene;Acc:101120660]",{"v":0.559818,"d":"0.56"},{"v":0.424117,"d":"0.42"},{"v":0.581342,"d":"0.58"},{"v":0.835874,"d":"0.84"},{"v":1.186723,"d":"1.19"},{"v":1.029857,"d":"1.03"},{"v":0.512792985578161,"d":"0.51"},{"v":-0.963551567214667,"d":"-0.96"},{"v":0.0293202921068638,"d":"0.03"},{"v":0.314547785493346,"d":"0.31"},"down","no"]
["MSTRG.16546","TNRC6B","ENSOART00000018766","GO:0003676(nucleic acid binding);GO:0031047(gene silencing by RNA);GO:0035278(miRNA mediated inhibition of translation);GO:0060213(positive regulation of nuclear-transcribed mRNA poly(A) tail shortening);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)","NA","K18412","NA","trinucleotide repeat containing 6B [Source:NCBI gene;Acc:101107854]",{"v":4.39047940848469,"d":"4.39"},{"v":4.85316005726518,"d":"4.85"},{"v":3.09633162924235,"d":"3.10"},{"v":3.4592764212247,"d":"3.46"},{"v":2.6482917929424,"d":"2.65"},{"v":1.82028708165542,"d":"1.82"},{"v":1.55653334155766,"d":"1.56"},{"v":0.638336480234467,"d":"0.64"},{"v":0.0294808582404885,"d":"0.03"},{"v":0.315571270750669,"d":"0.32"},"up","no"]
["ENSOARG00000009128","C7","ENSOART00000009940","GO:0005515(protein binding);GO:0005579(membrane attack complex);GO:0006955(immune response);GO:0006956(complement activation)","04610(Complement and coagulation cascades);05020(Prion diseases);05322(Systemic lupus erythematosus)","K03996","NA","complement C7 [Source:NCBI gene;Acc:101102931]",{"v":0.312248,"d":"0.31"},{"v":0.489987,"d":"0.49"},{"v":0.141273,"d":"0.14"},{"v":0.710156,"d":"0.71"},{"v":0.575911,"d":"0.58"},{"v":0.75865,"d":"0.76"},{"v":0.461436961692009,"d":"0.46"},{"v":-1.11579452451617,"d":"-1.12"},{"v":0.0295698369833628,"d":"0.03"},{"v":0.315867318451483,"d":"0.32"},"down","yes"]
["MSTRG.9739","FAM166B","ENSOART00000013036","NA","NA","NA","NA","family with sequence similarity 166 member B [Source:NCBI gene;Acc:101116962]",{"v":0.851026783882784,"d":"0.85"},{"v":0.724278384615385,"d":"0.72"},{"v":2.007682,"d":"2.01"},{"v":0.430155386446886,"d":"0.43"},{"v":0.763105014652015,"d":"0.76"},{"v":0.509450503663004,"d":"0.51"},{"v":2.10428391483121,"d":"2.10"},{"v":1.07332936949976,"d":"1.07"},{"v":0.0295787071234884,"d":"0.03"},{"v":0.315867318451483,"d":"0.32"},"up","yes"]
["MSTRG.1741","RF00406","ENSOART00000025032","NA","NA","NA","NA",null,{"v":4.70353,"d":"4.70"},{"v":2.812557,"d":"2.81"},{"v":1.962337,"d":"1.96"},{"v":4.367313,"d":"4.37"},{"v":7.051746,"d":"7.05"},{"v":11.703111,"d":"11.70"},{"v":0.409927960913703,"d":"0.41"},{"v":-1.28655769628877,"d":"-1.29"},{"v":0.0296511781847828,"d":"0.03"},{"v":0.315908114395046,"d":"0.32"},"down","yes"]
["MSTRG.15289","SLC3A1","ENSOART00000006861","GO:0003824(catalytic activity);GO:0005975(carbohydrate metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031526(brush border membrane)","04974(Protein digestion and absorption)","K14210","NA","solute carrier family 3 member 1 [Source:NCBI gene;Acc:101111950]",{"v":1.467151,"d":"1.47"},{"v":1.280991,"d":"1.28"},{"v":1.333198,"d":"1.33"},{"v":0.713014,"d":"0.71"},{"v":1.082629,"d":"1.08"},{"v":0.501038,"d":"0.50"},{"v":1.77706002705643,"d":"1.78"},{"v":0.829492414779075,"d":"0.83"},{"v":0.0296602402392163,"d":"0.03"},{"v":0.315908114395046,"d":"0.32"},"up","no"]
["MSTRG.4503","CREM","ENSOART00000018356","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA","cAMP responsive element modulator [Source:HGNC Symbol;Acc:HGNC:2352]",{"v":9.47091030800726,"d":"9.47"},{"v":8.35483865933095,"d":"8.35"},{"v":8.21103987279579,"d":"8.21"},{"v":8.20061944670358,"d":"8.20"},{"v":4.57918315488764,"d":"4.58"},{"v":4.15738943446704,"d":"4.16"},{"v":1.5372553363452,"d":"1.54"},{"v":0.620356814920788,"d":"0.62"},{"v":0.0296792655243753,"d":"0.03"},{"v":0.315908114395046,"d":"0.32"},"up","no"]
["MSTRG.2463","KDELC1","ENSOART00000005705","GO:0005515(protein binding);GO:0005788(endoplasmic reticulum lumen);GO:0018242(protein O-linked glycosylation via serine);GO:0035251(UDP-glucosyltransferase activity);GO:0035252(UDP-xylosyltransferase activity)","NA","NA","NA","KDEL motif containing 1 [Source:NCBI gene;Acc:101114030]",{"v":1.225029,"d":"1.23"},{"v":0.634046,"d":"0.63"},{"v":1.330065,"d":"1.33"},{"v":1.957626,"d":"1.96"},{"v":1.669437,"d":"1.67"},{"v":2.871411,"d":"2.87"},{"v":0.490752136578526,"d":"0.49"},{"v":-1.02693354614745,"d":"-1.03"},{"v":0.0297024988363878,"d":"0.03"},{"v":0.315949446905889,"d":"0.32"},"down","yes"]
["MSTRG.9056","RPL29","ENSOART00000007013","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02905","NA","ribosomal protein L29 [Source:NCBI gene;Acc:101113539]",{"v":106.408755267717,"d":"106.41"},{"v":96.0542827086614,"d":"96.05"},{"v":114.69967492126,"d":"114.70"},{"v":143.558576149606,"d":"143.56"},{"v":181.033383,"d":"181.03"},{"v":224.649677748032,"d":"224.65"},{"v":0.577455698167959,"d":"0.58"},{"v":-0.792217826254833,"d":"-0.79"},{"v":0.0297857011453766,"d":"0.03"},{"v":0.316519392876051,"d":"0.32"},"down","no"]
["MSTRG.3792","ESRRG","ENSOART00000012323","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005496(steroid binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048384(retinoic acid receptor signaling pathway);GO:0120162(positive regulation of cold-induced thermogenesis)","NA","K08554","NA","estrogen related receptor gamma [Source:NCBI gene;Acc:101102323]",{"v":1.09458012738305,"d":"1.09"},{"v":1.49358111166293,"d":"1.49"},{"v":2.25917865964434,"d":"2.26"},{"v":1.36213309876642,"d":"1.36"},{"v":0.963093805270747,"d":"0.96"},{"v":0.337065559275873,"d":"0.34"},{"v":1.82073906811055,"d":"1.82"},{"v":0.864524183096743,"d":"0.86"},{"v":0.0298142348262718,"d":"0.03"},{"v":0.316519392876051,"d":"0.32"},"up","no"]
["MSTRG.11088","EPHA2","ENSOART00000013484","GO:0000166(nucleotide binding);GO:0001501(skeletal system development);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0001649(osteoblast differentiation);GO:0001818(negative regulation of cytokine production);GO:0002043(blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005925(focal adhesion);GO:0006468(protein phosphorylation);GO:0006954(inflammatory response);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009986(cell surface);GO:0010591(regulation of lamellipodium assembly);GO:0014028(notochord formation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016525(negative regulation of angiogenesis);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021915(neural tube development);GO:0030027(lamellipodium);GO:0030182(neuron differentiation);GO:0030216(keratinocyte differentiation);GO:0030316(osteoclast differentiation);GO:0031256(leading edge membrane);GO:0032682(negative regulation of chemokine production);GO:0033598(mammary gland epithelial cell proliferation);GO:0033628(regulation of cell adhesion mediated by integrin);GO:0036342(post-anal tail morphogenesis);GO:0043491(protein kinase B signaling);GO:0043535(regulation of blood vessel endothelial cell migration);GO:0045765(regulation of angiogenesis);GO:0046058(cAMP metabolic process);GO:0046849(bone remodeling);GO:0048013(ephrin receptor signaling pathway);GO:0048320(axial mesoderm formation);GO:0048514(blood vessel morphogenesis);GO:0048570(notochord morphogenesis);GO:0048870(cell motility);GO:0050830(defense response to Gram-positive bacterium);GO:0051898(negative regulation of protein kinase B signaling);GO:0060035(notochord cell development);GO:0060326(cell chemotaxis);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0070160(tight junction);GO:0070309(lens fiber cell morphogenesis);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0070848(response to growth factor);GO:0072659(protein localization to plasma membrane);GO:0090630(activation of GTPase activity);GO:1901491(negative regulation of lymphangiogenesis);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903348(positive regulation of bicellular tight junction assembly);GO:1904238(pericyte cell differentiation)","NA","NA","NA","EPH receptor A2 [Source:HGNC Symbol;Acc:HGNC:3386]",{"v":3.55713327549304,"d":"3.56"},{"v":2.71897276135148,"d":"2.72"},{"v":2.46256757300107,"d":"2.46"},{"v":2.53161092019569,"d":"2.53"},{"v":1.34648247714417,"d":"1.35"},{"v":1.62944769622382,"d":"1.63"},{"v":1.58667424561896,"d":"1.59"},{"v":0.666005964045747,"d":"0.67"},{"v":0.0300506027824649,"d":"0.03"},{"v":0.31803871842614,"d":"0.32"},"up","no"]
["MSTRG.8161","MEX3B","ENSOART00000015801","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA","NA","NA","mex-3 RNA binding family member B [Source:HGNC Symbol;Acc:HGNC:25297]",{"v":0.625988,"d":"0.63"},{"v":0.325298,"d":"0.33"},{"v":0.355836,"d":"0.36"},{"v":0.656981,"d":"0.66"},{"v":1.082732,"d":"1.08"},{"v":1.186966,"d":"1.19"},{"v":0.446622947033139,"d":"0.45"},{"v":-1.16287071761763,"d":"-1.16"},{"v":0.0301588255841573,"d":"0.03"},{"v":0.318520895302795,"d":"0.32"},"down","yes"]
["MSTRG.19009","RUFY3","ENSOART00000012768","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0030335(positive regulation of cell migration);GO:0046872(metal ion binding);GO:0071437(invadopodium)","NA","NA","NA","RUN and FYVE domain containing 3 [Source:NCBI gene;Acc:101122279]",{"v":3.76003164335992,"d":"3.76"},{"v":3.09557047395589,"d":"3.10"},{"v":3.22222599249179,"d":"3.22"},{"v":1.96871704551854,"d":"1.97"},{"v":2.48421580478649,"d":"2.48"},{"v":2.13593222336931,"d":"2.14"},{"v":1.5295241285291,"d":"1.53"},{"v":0.613082865859642,"d":"0.61"},{"v":0.0302427695993253,"d":"0.03"},{"v":0.319200996779433,"d":"0.32"},"up","no"]
["MSTRG.1282","CEP97","ENSOART00000020244","GO:0005515(protein binding);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0032991(protein-containing complex);GO:1901673(regulation of mitotic spindle assembly);GO:1902018(negative regulation of cilium assembly)","NA","K16717","NA","centrosomal protein 97 [Source:NCBI gene;Acc:101112438]",{"v":7.067762,"d":"7.07"},{"v":7.392054,"d":"7.39"},{"v":5.895209,"d":"5.90"},{"v":5.718004,"d":"5.72"},{"v":3.688091,"d":"3.69"},{"v":3.763608,"d":"3.76"},{"v":1.54559483991401,"d":"1.55"},{"v":0.62816218274718,"d":"0.63"},{"v":0.0303183887578285,"d":"0.03"},{"v":0.319716288673646,"d":"0.32"},"up","no"]
["MSTRG.717","PRKAB2","ENSOART00000022352","GO:0004679(AMP-activated protein kinase activity);GO:0005515(protein binding);GO:0006468(protein phosphorylation);GO:0031588(nucleotide-activated protein kinase complex);GO:0042802(identical protein binding);GO:0050790(regulation of catalytic activity);GO:0120162(positive regulation of cold-induced thermogenesis)","04068(FoxO signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04371(Apelin signaling pathway);04530(Tight junction);04710(Circadian rhythm);04714(Thermogenesis);04910(Insulin signaling pathway);04920(Adipocytokine signaling pathway);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD));05410(Hypertrophic cardiomyopathy (HCM))","K07199","NA","protein kinase AMP-activated non-catalytic subunit beta 2 [Source:NCBI gene;Acc:101113114]",{"v":22.2147931602359,"d":"22.21"},{"v":22.547856220556,"d":"22.55"},{"v":17.0723239912384,"d":"17.07"},{"v":16.4594779909014,"d":"16.46"},{"v":11.7308448458298,"d":"11.73"},{"v":12.5194529548441,"d":"12.52"},{"v":1.51892198298048,"d":"1.52"},{"v":0.603047769999499,"d":"0.60"},{"v":0.0303503336259279,"d":"0.03"},{"v":0.319716288673646,"d":"0.32"},"up","no"]
["ENSOARG00000011811","STEAP4","ENSOART00000012846","GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0008823(cupric reductase activity);GO:0009055(electron transfer activity);GO:0015677(copper ion import);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0020037(heme binding);GO:0022900(electron transport chain);GO:0045444(fat cell differentiation);GO:0052851(ferric-chelate reductase (NADPH) activity);GO:0055114(oxidation-reduction process);GO:0070207(protein homotrimerization);GO:0071949(FAD binding);GO:0098706(iron ion import across cell outer membrane)","NA","K19876","EC:1.16.1.-","STEAP4 metalloreductase [Source:NCBI gene;Acc:101111187]",{"v":0.514375,"d":"0.51"},{"v":0.34256,"d":"0.34"},{"v":0.352943,"d":"0.35"},{"v":0.218209,"d":"0.22"},{"v":0.118745,"d":"0.12"},{"v":0.278244,"d":"0.28"},{"v":1.96664813604726,"d":"1.97"},{"v":0.975738860113318,"d":"0.98"},{"v":0.0305092326869212,"d":"0.03"},{"v":0.320769318294945,"d":"0.32"},"up","no"]
["MSTRG.16116","ENSOARG00000017803","ENSOART00000019369","GO:0005198(structural molecule activity);GO:0016032(viral process)","NA","NA","NA",null,{"v":0.724529,"d":"0.72"},{"v":1.138307,"d":"1.14"},{"v":1.234481,"d":"1.23"},{"v":0.311804,"d":"0.31"},{"v":0.763407,"d":"0.76"},{"v":0.417779,"d":"0.42"},{"v":2.07457317195695,"d":"2.07"},{"v":1.05281454318581,"d":"1.05"},{"v":0.0307630900036886,"d":"0.03"},{"v":0.322814738804773,"d":"0.32"},"up","yes"]
["MSTRG.10196","PRKRA","ENSOART00000018858","GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0008047(enzyme activator activity);GO:0019899(enzyme binding);GO:0030422(production of siRNA involved in RNA interference);GO:0031054(pre-miRNA processing);GO:0034599(cellular response to oxidative stress);GO:0035196(production of miRNAs involved in gene silencing by miRNA);GO:0042473(outer ear morphogenesis);GO:0042474(middle ear morphogenesis);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043085(positive regulation of catalytic activity);GO:0043583(ear development);GO:0048705(skeletal system morphogenesis);GO:0050821(protein stabilization);GO:0070578(RISC-loading complex);GO:0070883(pre-miRNA binding);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","NA","NA","NA","protein activator of interferon induced protein kinase EIF2AK2 [Source:NCBI gene;Acc:101102289]",{"v":2.085482,"d":"2.09"},{"v":1.10162,"d":"1.10"},{"v":2.202716,"d":"2.20"},{"v":3.628326,"d":"3.63"},{"v":3.22982,"d":"3.23"},{"v":3.663573,"d":"3.66"},{"v":0.512256409812883,"d":"0.51"},{"v":-0.965061963240097,"d":"-0.97"},{"v":0.030815009811802,"d":"0.03"},{"v":0.323097594827887,"d":"0.32"},"down","no"]
["MSTRG.21544","MAP3K15","ENSOART00000016064","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity)","NA","K13986","EC:2.7.11.25","mitogen-activated protein kinase kinase kinase 15 [Source:NCBI gene;Acc:101104888]",{"v":82.7048382502747,"d":"82.70"},{"v":87.1938136340085,"d":"87.19"},{"v":63.552778581567,"d":"63.55"},{"v":66.4801622644057,"d":"66.48"},{"v":40.2255864708745,"d":"40.23"},{"v":46.0725935338358,"d":"46.07"},{"v":1.52804008080301,"d":"1.53"},{"v":0.611682386055181,"d":"0.61"},{"v":0.0308296210645424,"d":"0.03"},{"v":0.323097594827887,"d":"0.32"},"up","no"]
["MSTRG.6223","CUL5","ENSOART00000011830","GO:0006511(ubiquitin-dependent protein catabolic process);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031466(Cul5-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding)","04120(Ubiquitin mediated proteolysis);05170(Human immunodeficiency virus 1 infection)","K10612","NA","cullin 5 [Source:NCBI gene;Acc:101105597]",{"v":7.36086950107991,"d":"7.36"},{"v":8.01224220475162,"d":"8.01"},{"v":6.95932695205184,"d":"6.96"},{"v":5.58451140431965,"d":"5.58"},{"v":4.4236389650108,"d":"4.42"},{"v":4.69644713434125,"d":"4.70"},{"v":1.51873852054142,"d":"1.52"},{"v":0.602873504079367,"d":"0.60"},{"v":0.0308579806147624,"d":"0.03"},{"v":0.323187368491238,"d":"0.32"},"up","no"]
["ENSOARG00000021004","GALK2","ENSOART00000022883","GO:0004335(galactokinase activity);GO:0005524(ATP binding);GO:0005534(galactose binding);GO:0005737(cytoplasm);GO:0006012(galactose metabolic process);GO:0016301(kinase activity);GO:0016773(phosphotransferase activity, alcohol group as acceptor);GO:0046835(carbohydrate phosphorylation)","NA","K18674","EC:2.7.1.157","galactokinase 2 [Source:NCBI gene;Acc:101108754]",{"v":1.004499,"d":"1.00"},{"v":0.906465,"d":"0.91"},{"v":0.94342,"d":"0.94"},{"v":0.824505,"d":"0.82"},{"v":0.440501,"d":"0.44"},{"v":0.481085,"d":"0.48"},{"v":1.63472808690956,"d":"1.63"},{"v":0.709050684475053,"d":"0.71"},{"v":0.0310152428577617,"d":"0.03"},{"v":0.324626208577906,"d":"0.32"},"up","no"]
["MSTRG.21235","ABRA","ENSOART00000016550","GO:0003779(actin binding);GO:0005886(plasma membrane);GO:0006606(protein import into nucleus);GO:0015629(actin cytoskeleton);GO:0030016(myofibril);GO:0035025(positive regulation of Rho protein signal transduction);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051091(positive regulation of DNA-binding transcription factor activity)","NA","NA","NA","actin binding Rho activating protein [Source:NCBI gene;Acc:101123385]",{"v":250.826263,"d":"250.83"},{"v":90.036804,"d":"90.04"},{"v":179.455429,"d":"179.46"},{"v":99.950066,"d":"99.95"},{"v":103.989151,"d":"103.99"},{"v":107.537277,"d":"107.54"},{"v":1.67049040946249,"d":"1.67"},{"v":0.740271699966731,"d":"0.74"},{"v":0.0311924613475258,"d":"0.03"},{"v":0.325814332406852,"d":"0.33"},"up","no"]
["MSTRG.3106","CHAD","ENSOART00000004781","GO:0005515(protein binding);GO:0060348(bone development);GO:1900155(negative regulation of bone trabecula formation)","NA","NA","NA","chondroadherin [Source:HGNC Symbol;Acc:HGNC:1909]",{"v":0.667558,"d":"0.67"},{"v":0.567078,"d":"0.57"},{"v":1.258025,"d":"1.26"},{"v":2.32774,"d":"2.33"},{"v":1.420747,"d":"1.42"},{"v":1.743139,"d":"1.74"},{"v":0.453902177606414,"d":"0.45"},{"v":-1.13954668523143,"d":"-1.14"},{"v":0.0312743180415283,"d":"0.03"},{"v":0.325920783549485,"d":"0.33"},"down","yes"]
["MSTRG.19592","NDRG2","ENSOART00000021461;ENSOART00000021460","GO:0001818(negative regulation of cytokine production);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0010574(regulation of vascular endothelial growth factor production);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0090361(regulation of platelet-derived growth factor production);GO:0090361(regulation of platelet-derived growth factor production)","NA","NA","NA","NDRG family member 2 [Source:NCBI gene;Acc:101110763]",{"v":129.717570174112,"d":"129.72"},{"v":167.524659430457,"d":"167.52"},{"v":111.151417688832,"d":"111.15"},{"v":83.4015249309645,"d":"83.40"},{"v":87.8352637588832,"d":"87.84"},{"v":93.0207605862944,"d":"93.02"},{"v":1.54543795782591,"d":"1.55"},{"v":0.62801573783669,"d":"0.63"},{"v":0.0312878154277359,"d":"0.03"},{"v":0.325920783549485,"d":"0.33"},"up","no"]
["ENSOARG00000007173","RNF215","ENSOART00000007799","NA","NA","NA","NA","ring finger protein 215 [Source:NCBI gene;Acc:101123498]",{"v":0.702727,"d":"0.70"},{"v":0.381424,"d":"0.38"},{"v":0.49738,"d":"0.50"},{"v":0.85139,"d":"0.85"},{"v":1.160995,"d":"1.16"},{"v":1.04996,"d":"1.05"},{"v":0.516444424125956,"d":"0.52"},{"v":-0.953314989459865,"d":"-0.95"},{"v":0.0312986151767267,"d":"0.03"},{"v":0.325920783549485,"d":"0.33"},"down","no"]
["MSTRG.10577","CYP20A1","ENSOART00000019758","GO:0005506(iron ion binding);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0055114(oxidation-reduction process)","NA","K07435","NA","cytochrome P450 20A1 [Source:NCBI gene;Acc:101104050]",{"v":1.72894438720703,"d":"1.73"},{"v":1.16853010449219,"d":"1.17"},{"v":0.959560265625,"d":"0.96"},{"v":3.50513765771484,"d":"3.51"},{"v":1.7846965703125,"d":"1.78"},{"v":2.198682078125,"d":"2.20"},{"v":0.515059939731372,"d":"0.52"},{"v":-0.957187760220072,"d":"-0.96"},{"v":0.0313304135242594,"d":"0.03"},{"v":0.326043971972025,"d":"0.33"},"down","no"]
["MSTRG.5879","RPL18","ENSOART00000012979","GO:0002181(cytoplasmic translation);GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005840(ribosome);GO:0006412(translation);GO:0022625(cytosolic large ribosomal subunit);GO:0042788(polysomal ribosome)","03010(Ribosome)","K02883","NA","ribosomal protein L18 [Source:NCBI gene;Acc:101122808]",{"v":191.627106,"d":"191.63"},{"v":171.652161,"d":"171.65"},{"v":169.017593,"d":"169.02"},{"v":220.343292,"d":"220.34"},{"v":298.926758,"d":"298.93"},{"v":419.537506,"d":"419.54"},{"v":0.566992517900016,"d":"0.57"},{"v":-0.818598397567767,"d":"-0.82"},{"v":0.0314270218648588,"d":"0.03"},{"v":0.326296405015641,"d":"0.33"},"down","no"]
["ENSOARG00000001683","KCNC1","ENSOART00000001811","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019894(kinesin binding);GO:0030673(axolemma);GO:0032590(dendrite membrane);GO:0032809(neuronal cell body membrane);GO:0034765(regulation of ion transmembrane transport);GO:0044325(ion channel binding);GO:0051260(protein homooligomerization);GO:0051262(protein tetramerization);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA","K04887","NA","potassium voltage-gated channel subfamily C member 1 [Source:NCBI gene;Acc:101113880]",{"v":0.278865,"d":"0.28"},{"v":0.173098,"d":"0.17"},{"v":0.264658,"d":"0.26"},{"v":0.446915,"d":"0.45"},{"v":0.428228,"d":"0.43"},{"v":0.699256,"d":"0.70"},{"v":0.455171147847528,"d":"0.46"},{"v":-1.13551898314908,"d":"-1.14"},{"v":0.0314320073916756,"d":"0.03"},{"v":0.326296405015641,"d":"0.33"},"down","yes"]
["MSTRG.7815","CASTOR1","ENSOART00000007010","GO:0005829(cytosol);GO:0034618(arginine binding);GO:0042802(identical protein binding);GO:0061700(GATOR2 complex);GO:1903432(regulation of TORC1 signaling);GO:1903577(cellular response to L-arginine);GO:1904262(negative regulation of TORC1 signaling)","NA","NA","NA","cytosolic arginine sensor for mTORC1 subunit 1 [Source:HGNC Symbol;Acc:HGNC:34423]",{"v":0.891156,"d":"0.89"},{"v":0.988226,"d":"0.99"},{"v":1.456602,"d":"1.46"},{"v":1.787748,"d":"1.79"},{"v":2.405972,"d":"2.41"},{"v":2.872327,"d":"2.87"},{"v":0.47211460665348,"d":"0.47"},{"v":-1.0827909760197,"d":"-1.08"},{"v":0.0315089809975824,"d":"0.03"},{"v":0.326653105859381,"d":"0.33"},"down","yes"]
["MSTRG.4058","ENSOARG00000005207","ENSOART00000005674","GO:0000287(magnesium ion binding);GO:0004749(ribose phosphate diphosphokinase activity);GO:0009116(nucleoside metabolic process);GO:0009156(ribonucleoside monophosphate biosynthetic process);GO:0009165(nucleotide biosynthetic process);GO:0044249(cellular biosynthetic process)","NA","NA","NA",null,{"v":4.252892,"d":"4.25"},{"v":3.625392,"d":"3.63"},{"v":6.919846,"d":"6.92"},{"v":4.102271,"d":"4.10"},{"v":1.761599,"d":"1.76"},{"v":2.504854,"d":"2.50"},{"v":1.76826598654705,"d":"1.77"},{"v":0.822335304485907,"d":"0.82"},{"v":0.031664095375032,"d":"0.03"},{"v":0.32805288660122,"d":"0.33"},"up","no"]
["MSTRG.16882","ENSOARG00000017020","ENSOART00000018530","GO:0006955(immune response);GO:0007166(cell surface receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","03320(PPAR signaling pathway);04145(Phagosome);04152(AMPK signaling pathway);04512(ECM-receptor interaction);04640(Hematopoietic cell lineage);04920(Adipocytokine signaling pathway);04931(Insulin resistance);04975(Fat digestion and absorption);04979(Cholesterol metabolism);05144(Malaria)","K06259","NA","platelet glycoprotein 4-like [Source:NCBI gene;Acc:101102230]",{"v":0.546369781002638,"d":"0.55"},{"v":0.478773994722955,"d":"0.48"},{"v":0.34601127176781,"d":"0.35"},{"v":1.02164854881266,"d":"1.02"},{"v":1.04631375197889,"d":"1.05"},{"v":0.821183501319261,"d":"0.82"},{"v":0.474588387505967,"d":"0.47"},{"v":-1.07525129459258,"d":"-1.08"},{"v":0.0318225192623764,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"down","yes"]
["MSTRG.7304","ENSOARG00000005549","ENSOART00000006047","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005840(ribosome);GO:0006412(translation);GO:0022627(cytosolic small ribosomal subunit);GO:0030154(cell differentiation)","03010(Ribosome)","K02984","NA","ribosomal protein S3A [Source:NCBI gene;Acc:101106110]",{"v":17.0418988477496,"d":"17.04"},{"v":8.14968203612869,"d":"8.15"},{"v":15.0417680747187,"d":"15.04"},{"v":8.08754178208509,"d":"8.09"},{"v":8.73337006293952,"d":"8.73"},{"v":8.44091355704993,"d":"8.44"},{"v":1.59265406668882,"d":"1.59"},{"v":0.671432939512525,"d":"0.67"},{"v":0.0318393932140742,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"up","no"]
["MSTRG.11324","ADGRF5","ENSOART00000012377","GO:0003094(glomerular filtration);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0006112(energy reserve metabolic process);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019216(regulation of lipid metabolic process);GO:0031410(cytoplasmic vesicle);GO:0042593(glucose homeostasis);GO:0043031(negative regulation of macrophage activation);GO:0043129(surfactant homeostasis);GO:0045177(apical part of cell);GO:0045444(fat cell differentiation);GO:0048821(erythrocyte development);GO:0061626(pharyngeal arch artery morphogenesis);GO:0071073(positive regulation of phospholipid biosynthetic process)","NA","K08458","NA","adhesion G protein-coupled receptor F5 [Source:NCBI gene;Acc:101121209]",{"v":8.60446122700603,"d":"8.60"},{"v":5.5719334212875,"d":"5.57"},{"v":5.84005744888852,"d":"5.84"},{"v":10.1742228828196,"d":"10.17"},{"v":13.0964905533427,"d":"13.10"},{"v":10.801885438063,"d":"10.80"},{"v":0.587464788672864,"d":"0.59"},{"v":-0.767425712536375,"d":"-0.77"},{"v":0.0319171901720759,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"down","no"]
["MSTRG.19761","PPIB","ENSOART00000022604","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0006457(protein folding);GO:0016018(cyclosporin A binding);GO:0016853(isomerase activity);GO:0034663(endoplasmic reticulum chaperone complex);GO:0040018(positive regulation of multicellular organism growth);GO:0044794(positive regulation by host of viral process);GO:0044829(positive regulation by host of viral genome replication);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0060348(bone development);GO:0061077(chaperone-mediated protein folding);GO:0070063(RNA polymerase binding)","NA","K03768","EC:5.2.1.8","peptidylprolyl isomerase B [Source:NCBI gene;Acc:554319]",{"v":17.149912,"d":"17.15"},{"v":14.90384,"d":"14.90"},{"v":17.717974,"d":"17.72"},{"v":26.938169,"d":"26.94"},{"v":25.177727,"d":"25.18"},{"v":33.190342,"d":"33.19"},{"v":0.583447672373033,"d":"0.58"},{"v":-0.777324824033032,"d":"-0.78"},{"v":0.0319637980008643,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"down","no"]
["MSTRG.1740","EIF2A","ENSOART00000004910","GO:0000049(tRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0009967(positive regulation of signal transduction);GO:0032933(SREBP signaling pathway);GO:0042255(ribosome assembly);GO:0043022(ribosome binding)","NA","K15026","NA","eukaryotic translation initiation factor 2A [Source:NCBI gene;Acc:101119523]",{"v":4.79198307485605,"d":"4.79"},{"v":5.59198931610808,"d":"5.59"},{"v":5.08632108991584,"d":"5.09"},{"v":3.838803243762,"d":"3.84"},{"v":3.51856372065554,"d":"3.52"},{"v":2.90575769644175,"d":"2.91"},{"v":1.50736681002028,"d":"1.51"},{"v":0.592030532133837,"d":"0.59"},{"v":0.0320346097666766,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"up","no"]
["MSTRG.9133","SLC26A6","ENSOART00000018013","GO:0005887(integral component of plasma membrane);GO:0006820(anion transport);GO:0006821(chloride transport);GO:0008271(secondary active sulfate transmembrane transporter activity);GO:0008272(sulfate transport);GO:0008509(anion transmembrane transporter activity);GO:0015106(bicarbonate transmembrane transporter activity);GO:0015108(chloride transmembrane transporter activity);GO:0015116(sulfate transmembrane transporter activity);GO:0015301(anion:anion antiporter activity);GO:0015701(bicarbonate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0019531(oxalate transmembrane transporter activity);GO:0019532(oxalate transport);GO:0030321(transepithelial chloride transport);GO:0031526(brush border membrane);GO:0051453(regulation of intracellular pH);GO:0051454(intracellular pH elevation);GO:0055085(transmembrane transport);GO:0071346(cellular response to interferon-gamma);GO:0098656(anion transmembrane transport);GO:1902358(sulfate transmembrane transport);GO:1902476(chloride transmembrane transport)","04978(Mineral absorption)","K14704","NA","solute carrier family 26 member 6 [Source:NCBI gene;Acc:105603547]",{"v":0.721082,"d":"0.72"},{"v":0.809463,"d":"0.81"},{"v":0.571727,"d":"0.57"},{"v":1.950009,"d":"1.95"},{"v":0.921414,"d":"0.92"},{"v":1.345221,"d":"1.35"},{"v":0.498565209678597,"d":"0.50"},{"v":-1.00414588108188,"d":"-1.00"},{"v":0.0320648227645884,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"down","yes"]
["MSTRG.10490","NABP1","ENSOART00000015433","GO:0000724(double-strand break repair via homologous recombination);GO:0000784(nuclear chromosome, telomeric region);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0007093(mitotic cell cycle checkpoint);GO:0010212(response to ionizing radiation);GO:0070876(SOSS complex)","NA","NA","NA","nucleic acid binding protein 1 [Source:NCBI gene;Acc:101118080]",{"v":1.91871499918712,"d":"1.92"},{"v":1.7887938741668,"d":"1.79"},{"v":1.27362479531783,"d":"1.27"},{"v":1.17029049065193,"d":"1.17"},{"v":1.02606766444481,"d":"1.03"},{"v":0.992095198179158,"d":"0.99"},{"v":1.5622413492592,"d":"1.56"},{"v":0.643617351355654,"d":"0.64"},{"v":0.0320834993093003,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"up","no"]
["ENSOARG00000009528","AFF2","ENSOART00000010379","GO:0002151(G-quadruplex RNA binding);GO:0005634(nucleus);GO:0007611(learning or memory);GO:0010468(regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016607(nuclear speck);GO:0035063(nuclear speck organization);GO:0043484(regulation of RNA splicing)","NA","K15194","NA","AF4/FMR2 family member 2 [Source:NCBI gene;Acc:101116804]",{"v":0.290851,"d":"0.29"},{"v":0.216808,"d":"0.22"},{"v":0.460341,"d":"0.46"},{"v":0.236057,"d":"0.24"},{"v":0.090896,"d":"0.09"},{"v":0.149663,"d":"0.15"},{"v":2.03098511170418,"d":"2.03"},{"v":1.02217966388356,"d":"1.02"},{"v":0.0320853516858275,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"up","yes"]
["MSTRG.7069","OXCT1","ENSOART00000009725","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008260(3-oxoacid CoA-transferase activity);GO:0008410(CoA-transferase activity);GO:0016740(transferase activity);GO:0042182(ketone catabolic process);GO:0046950(cellular ketone body metabolic process);GO:0046952(ketone body catabolic process)","00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);00650(Butanoate metabolism)","K01027","EC:2.8.3.5","3-oxoacid CoA-transferase 1 [Source:NCBI gene;Acc:101102177]",{"v":12.413272173309,"d":"12.41"},{"v":15.0202282423138,"d":"15.02"},{"v":13.9440400259622,"d":"13.94"},{"v":11.202238517422,"d":"11.20"},{"v":8.27149601776361,"d":"8.27"},{"v":7.73973482373036,"d":"7.74"},{"v":1.52048016722383,"d":"1.52"},{"v":0.604526998325672,"d":"0.60"},{"v":0.0320946247064161,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"up","no"]
["MSTRG.12744","ENSOARG00000016262","ENSOART00000017711","GO:0005515(protein binding)","NA","NA","NA",null,{"v":0.095117,"d":"0.10"},{"v":0.604198,"d":"0.60"},{"v":0.541948,"d":"0.54"},{"v":0.271354,"d":"0.27"},{"v":0.146745,"d":"0.15"},{"v":0.068654,"d":"0.07"},{"v":2.55008803232851,"d":"2.55"},{"v":1.3505470516377,"d":"1.35"},{"v":0.0321025229976148,"d":"0.03"},{"v":0.328839394921615,"d":"0.33"},"up","yes"]
["MSTRG.16053","ENSOARG00000012542","ENSOART00000013641","NA","NA","NA","NA",null,{"v":0.396935977457502,"d":"0.40"},{"v":0.591966120103474,"d":"0.59"},{"v":1.69187799556541,"d":"1.69"},{"v":0.216694863821138,"d":"0.22"},{"v":0.651556140243902,"d":"0.65"},{"v":0.337637063562454,"d":"0.34"},{"v":2.22307539571284,"d":"2.22"},{"v":1.15255687826885,"d":"1.15"},{"v":0.03216904980666,"d":"0.03"},{"v":0.329107923084677,"d":"0.33"},"up","yes"]
["ENSOARG00000016415","CDO1","ENSOART00000017874","GO:0005506(iron ion binding);GO:0005829(cytosol);GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen);GO:0017172(cysteine dioxygenase activity);GO:0042412(taurine biosynthetic process);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00270(Cysteine and methionine metabolism);00430(Taurine and hypotaurine metabolism)","K00456","EC:1.13.11.20","cysteine dioxygenase type 1 [Source:NCBI gene;Acc:101102489]",{"v":0.551614,"d":"0.55"},{"v":0.307053,"d":"0.31"},{"v":0.453551,"d":"0.45"},{"v":0.817302,"d":"0.82"},{"v":0.864807,"d":"0.86"},{"v":1.206074,"d":"1.21"},{"v":0.454340324003015,"d":"0.45"},{"v":-1.13815474049977,"d":"-1.14"},{"v":0.0322767852975395,"d":"0.03"},{"v":0.329701340770049,"d":"0.33"},"down","yes"]
["MSTRG.6174","BIRC2","ENSOART00000007056","GO:0000209(protein polyubiquitination);GO:0001890(placenta development);GO:0003713(transcription coactivator activity);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0009898(cytoplasmic side of plasma membrane);GO:0035631(CD40 receptor complex);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043130(ubiquitin binding);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0047485(protein N-terminus binding);GO:0051087(chaperone binding);GO:0051726(regulation of cell cycle);GO:0060544(regulation of necroptotic process);GO:0060546(negative regulation of necroptotic process);GO:0070266(necroptotic process);GO:0071356(cellular response to tumor necrosis factor);GO:0098770(FBXO family protein binding);GO:1901222(regulation of NIK/NF-kappaB signaling);GO:1902443(negative regulation of ripoptosome assembly involved in necroptotic process);GO:1902523(positive regulation of protein K63-linked ubiquitination);GO:1902524(positive regulation of protein K48-linked ubiquitination);GO:1902527(positive regulation of protein monoubiquitination);GO:1902916(positive regulation of protein polyubiquitination);GO:1903508(positive regulation of nucleic acid-templated transcription);GO:2000377(regulation of reactive oxygen species metabolic process)","01524(Platinum drug resistance);04064(NF-kappa B signaling pathway);04120(Ubiquitin mediated proteolysis);04210(Apoptosis);04215(Apoptosis - multiple species);04217(Necroptosis);04510(Focal adhesion);04621(NOD-like receptor signaling pathway);04668(TNF signaling pathway);05145(Toxoplasmosis);05168(Herpes simplex virus 1 infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K16060","NA","baculoviral IAP repeat containing 2 [Source:NCBI gene;Acc:101119930]",{"v":6.60599858095997,"d":"6.61"},{"v":6.77870869567815,"d":"6.78"},{"v":5.51625630153356,"d":"5.52"},{"v":4.97586604262099,"d":"4.98"},{"v":3.83813945727943,"d":"3.84"},{"v":3.72115604102768,"d":"3.72"},{"v":1.50783566023133,"d":"1.51"},{"v":0.592479197115058,"d":"0.59"},{"v":0.0322876313015255,"d":"0.03"},{"v":0.329701340770049,"d":"0.33"},"up","no"]
["MSTRG.4848","SLCO4A1","ENSOART00000013725","GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K14354","NA","solute carrier organic anion transporter family member 4A1 [Source:NCBI gene;Acc:101111649]",{"v":1.72002,"d":"1.72"},{"v":2.276503,"d":"2.28"},{"v":2.027431,"d":"2.03"},{"v":0.450987,"d":"0.45"},{"v":1.488588,"d":"1.49"},{"v":1.203181,"d":"1.20"},{"v":1.91677432164635,"d":"1.92"},{"v":0.938680486089079,"d":"0.94"},{"v":0.0324634707024606,"d":"0.03"},{"v":0.331082791773752,"d":"0.33"},"up","no"]
["MSTRG.11514","ENSOARG00000018500","ENSOART00000020137","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":13.3602,"d":"13.36"},{"v":5.504025,"d":"5.50"},{"v":11.583292,"d":"11.58"},{"v":27.800186,"d":"27.80"},{"v":9.49472,"d":"9.49"},{"v":26.521753,"d":"26.52"},{"v":0.477109229425502,"d":"0.48"},{"v":-1.06760850012328,"d":"-1.07"},{"v":0.0325377120024112,"d":"0.03"},{"v":0.331632809972141,"d":"0.33"},"down","yes"]
["MSTRG.1976","DOP1B","ENSOART00000015142","GO:0005829(cytosol);GO:0006895(Golgi to endosome transport);GO:0050890(cognition)","NA","NA","NA","DOP1 leucine zipper like protein B [Source:NCBI gene;Acc:101115672]",{"v":2.36909620112446,"d":"2.37"},{"v":1.91460356197291,"d":"1.91"},{"v":2.22262659800664,"d":"2.22"},{"v":3.87875733324815,"d":"3.88"},{"v":3.80499421134679,"d":"3.80"},{"v":3.31310436033734,"d":"3.31"},{"v":0.591653325036823,"d":"0.59"},{"v":-0.757176008138025,"d":"-0.76"},{"v":0.0325729654665113,"d":"0.03"},{"v":0.331773951241562,"d":"0.33"},"down","no"]
["MSTRG.15018","LBH","ENSOART00000021384","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0010468(regulation of gene expression);GO:0030879(mammary gland development);GO:0032991(protein-containing complex);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0043408(regulation of MAPK cascade);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060644(mammary gland epithelial cell differentiation);GO:1904674(positive regulation of somatic stem cell population maintenance);GO:1904677(positive regulation of somatic stem cell division);GO:2000103(positive regulation of mammary stem cell proliferation);GO:2000737(negative regulation of stem cell differentiation)","NA","NA","NA","limb bud and heart development [Source:NCBI gene;Acc:101103634]",{"v":2.34293113193944,"d":"2.34"},{"v":1.88160662292718,"d":"1.88"},{"v":1.93009549963951,"d":"1.93"},{"v":3.90806938788753,"d":"3.91"},{"v":2.93809450252343,"d":"2.94"},{"v":3.96167645710166,"d":"3.96"},{"v":0.569460045357035,"d":"0.57"},{"v":-0.812333472247004,"d":"-0.81"},{"v":0.03271534659875,"d":"0.03"},{"v":0.332398139285681,"d":"0.33"},"down","no"]
["MSTRG.5626","THAP8","ENSOART00000005679","GO:0003676(nucleic acid binding);GO:0003677(DNA binding)","NA","K23206","NA","THAP domain containing 8 [Source:NCBI gene;Acc:101105433]",{"v":0.258577928888889,"d":"0.26"},{"v":0.422476817777778,"d":"0.42"},{"v":0.510191111111111,"d":"0.51"},{"v":0.724672946666667,"d":"0.72"},{"v":0.975228862222222,"d":"0.98"},{"v":0.94317252,"d":"0.94"},{"v":0.450704637685525,"d":"0.45"},{"v":-1.14974579963444,"d":"-1.15"},{"v":0.0327347532698331,"d":"0.03"},{"v":0.332398139285681,"d":"0.33"},"down","yes"]
["MSTRG.12740","TUBGCP2","ENSOART00000001397","GO:0000226(microtubule cytoskeleton organization);GO:0000922(spindle pole);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007020(microtubule nucleation);GO:0043015(gamma-tubulin binding)","NA","K16569","NA","tubulin gamma complex associated protein 2 [Source:NCBI gene;Acc:101113640]",{"v":4.49446343083317,"d":"4.49"},{"v":5.33663411399169,"d":"5.34"},{"v":4.67319040273105,"d":"4.67"},{"v":7.73856998337621,"d":"7.74"},{"v":7.86346465070255,"d":"7.86"},{"v":9.26479355175143,"d":"9.26"},{"v":0.583278568507618,"d":"0.58"},{"v":-0.777743028923246,"d":"-0.78"},{"v":0.0327551034995371,"d":"0.03"},{"v":0.332398139285681,"d":"0.33"},"down","no"]
["MSTRG.643","INKA2","ENSOART00000021397","GO:0005634(nucleus);GO:0019901(protein kinase binding);GO:0030291(protein serine/threonine kinase inhibitor activity);GO:0071901(negative regulation of protein serine/threonine kinase activity)","NA","NA","NA","inka box actin regulator 2 [Source:HGNC Symbol;Acc:HGNC:28045]",{"v":2.503783,"d":"2.50"},{"v":2.499945,"d":"2.50"},{"v":2.001451,"d":"2.00"},{"v":4.055068,"d":"4.06"},{"v":4.332737,"d":"4.33"},{"v":4.652513,"d":"4.65"},{"v":0.537193878247448,"d":"0.54"},{"v":-0.896485230688596,"d":"-0.90"},{"v":0.0327756617007562,"d":"0.03"},{"v":0.332398139285681,"d":"0.33"},"down","no"]
["MSTRG.16892","PHTF2","ENSOART00000019493;ENSOART00000019495","GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","NA","NA","putative homeodomain transcription factor 2 [Source:NCBI gene;Acc:101116646]",{"v":8.10778510357634,"d":"8.11"},{"v":8.37939971801926,"d":"8.38"},{"v":5.85931152682256,"d":"5.86"},{"v":5.51219112008253,"d":"5.51"},{"v":5.06970172324622,"d":"5.07"},{"v":4.02210508830812,"d":"4.02"},{"v":1.53016293572657,"d":"1.53"},{"v":0.613685283015316,"d":"0.61"},{"v":0.0328106587865537,"d":"0.03"},{"v":0.332428861628374,"d":"0.33"},"up","no"]
["MSTRG.5082","NEURL2","ENSOART00000007482","GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction)","NA","K16782","NA","neuralized E3 ubiquitin protein ligase 2 [Source:NCBI gene;Acc:101115726]",{"v":5.131176,"d":"5.13"},{"v":6.288545,"d":"6.29"},{"v":5.162643,"d":"5.16"},{"v":7.792413,"d":"7.79"},{"v":11.278022,"d":"11.28"},{"v":10.967019,"d":"10.97"},{"v":0.552056242849344,"d":"0.55"},{"v":-0.857112840299853,"d":"-0.86"},{"v":0.0328275028514039,"d":"0.03"},{"v":0.332428861628374,"d":"0.33"},"down","no"]
["MSTRG.16266","KCNJ8","ENSOART00000022081","GO:0005242(inward rectifier potassium channel activity);GO:0005244(voltage-gated ion channel activity);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0007507(heart development);GO:0015272(ATP-activated inward rectifier potassium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030016(myofibril);GO:0032496(response to lipopolysaccharide);GO:0034765(regulation of ion transmembrane transport);GO:0043330(response to exogenous dsRNA);GO:0051607(defense response to virus);GO:0098915(membrane repolarization during ventricular cardiac muscle cell action potential);GO:1902282(voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization);GO:1990573(potassium ion import across plasma membrane)","04022(cGMP-PKG signaling pathway)","K05001","NA","potassium voltage-gated channel subfamily J member 8 [Source:NCBI gene;Acc:101118008]",{"v":2.636869,"d":"2.64"},{"v":1.193492,"d":"1.19"},{"v":1.265588,"d":"1.27"},{"v":3.834476,"d":"3.83"},{"v":2.460546,"d":"2.46"},{"v":3.089221,"d":"3.09"},{"v":0.543032506724304,"d":"0.54"},{"v":-0.880889532426326,"d":"-0.88"},{"v":0.0330633522477215,"d":"0.03"},{"v":0.334070801671285,"d":"0.33"},"down","no"]
["MSTRG.7488","ENSOARG00000006038","ENSOART00000006563","NA","NA","NA","NA",null,{"v":0.239894,"d":"0.24"},{"v":0.861952,"d":"0.86"},{"v":1.029241,"d":"1.03"},{"v":0.884146,"d":"0.88"},{"v":0.72148,"d":"0.72"},{"v":4.92223,"d":"4.92"},{"v":0.326460479520382,"d":"0.33"},{"v":-1.61501974155647,"d":"-1.62"},{"v":0.0331088258474364,"d":"0.03"},{"v":0.334323381841028,"d":"0.33"},"down","yes"]
["MSTRG.503","LRRC8C","ENSOART00000016949","GO:0005225(volume-sensitive anion channel activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006884(cell volume homeostasis);GO:0015698(inorganic anion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034214(protein hexamerization);GO:0034702(ion channel complex);GO:0045444(fat cell differentiation);GO:0098656(anion transmembrane transport)","NA","K22038","NA","leucine rich repeat containing 8 VRAC subunit C [Source:NCBI gene;Acc:101121640]",{"v":5.147895,"d":"5.15"},{"v":4.8392,"d":"4.84"},{"v":5.203516,"d":"5.20"},{"v":4.416211,"d":"4.42"},{"v":2.724131,"d":"2.72"},{"v":2.812465,"d":"2.81"},{"v":1.52626399768427,"d":"1.53"},{"v":0.610004526529356,"d":"0.61"},{"v":0.0333169947825735,"d":"0.03"},{"v":0.335040089544597,"d":"0.34"},"up","no"]
["MSTRG.11048","PAX7","ENSOART00000011524","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0007519(skeletal muscle tissue development);GO:0010453(regulation of cell fate commitment);GO:0010468(regulation of gene expression);GO:0014813(skeletal muscle satellite cell commitment);GO:0021527(spinal cord association neuron differentiation);GO:0021904(dorsal/ventral neural tube patterning);GO:0031062(positive regulation of histone methylation);GO:0043393(regulation of protein binding);GO:0043403(skeletal muscle tissue regeneration);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048663(neuron fate commitment);GO:0048706(embryonic skeletal system development);GO:0051216(cartilage development);GO:0060415(muscle tissue morphogenesis);GO:2000288(positive regulation of myoblast proliferation)","NA","NA","NA","paired box 7 [Source:HGNC Symbol;Acc:HGNC:8621]",{"v":0.817264333770492,"d":"0.82"},{"v":0.57348778295082,"d":"0.57"},{"v":0.376807900327869,"d":"0.38"},{"v":0.832836028196721,"d":"0.83"},{"v":1.54036044852459,"d":"1.54"},{"v":1.42059486032787,"d":"1.42"},{"v":0.465908601716612,"d":"0.47"},{"v":-1.10188112881244,"d":"-1.10"},{"v":0.0333644773150119,"d":"0.03"},{"v":0.335040089544597,"d":"0.34"},"down","yes"]
["MSTRG.11332","MCM3","ENSOART00000015409","GO:0000166(nucleotide binding);GO:0003677(DNA binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006260(DNA replication);GO:0006270(DNA replication initiation);GO:0016787(hydrolase activity);GO:0042555(MCM complex);GO:0048471(perinuclear region of cytoplasm)","03030(DNA replication);04110(Cell cycle)","K02541","EC:3.6.4.12","minichromosome maintenance complex component 3 [Source:NCBI gene;Acc:101104435]",{"v":1.826762,"d":"1.83"},{"v":1.172113,"d":"1.17"},{"v":1.198126,"d":"1.20"},{"v":2.995219,"d":"3.00"},{"v":1.842983,"d":"1.84"},{"v":2.79212,"d":"2.79"},{"v":0.550042449060472,"d":"0.55"},{"v":-0.862385133184866,"d":"-0.86"},{"v":0.0335178591463308,"d":"0.03"},{"v":0.336373450609274,"d":"0.34"},"down","no"]
["MSTRG.1042","ILDR2","ENSOART00000012919","GO:0009749(response to glucose);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030073(insulin secretion);GO:0030154(cell differentiation);GO:0031016(pancreas development);GO:0048873(homeostasis of number of cells within a tissue)","NA","NA","NA","immunoglobulin like domain containing receptor 2 [Source:NCBI gene;Acc:101110204]",{"v":1.34700233503982,"d":"1.35"},{"v":0.605472939704209,"d":"0.61"},{"v":0.853468895904437,"d":"0.85"},{"v":1.79865075255973,"d":"1.80"},{"v":1.96380849374289,"d":"1.96"},{"v":1.6707017701934,"d":"1.67"},{"v":0.516447821466938,"d":"0.52"},{"v":-0.953305498969431,"d":"-0.95"},{"v":0.0335882868737814,"d":"0.03"},{"v":0.336873186778319,"d":"0.34"},"down","no"]
["ENSOARG00000020932","C2orf40","ENSOART00000022803","NA","NA","NA","NA","chromosome 3 open reading frame, human C2orf40 [Source:NCBI gene;Acc:101114506]",{"v":0.207952,"d":"0.21"},{"v":0.178512,"d":"0.18"},{"v":0.113494,"d":"0.11"},{"v":0.347155,"d":"0.35"},{"v":0.403168,"d":"0.40"},{"v":0.345749,"d":"0.35"},{"v":0.456136093249349,"d":"0.46"},{"v":-1.13246376224568,"d":"-1.13"},{"v":0.0336755639371724,"d":"0.03"},{"v":0.337334115316657,"d":"0.34"},"down","yes"]
["MSTRG.9924","PLIN2","ENSOART00000015469","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0015909(long-chain fatty acid transport);GO:0019915(lipid storage)","03320(PPAR signaling pathway)","K17284","NA","perilipin 2 [Source:NCBI gene;Acc:100125354]",{"v":8.6527933596,"d":"8.65"},{"v":4.5069312472,"d":"4.51"},{"v":5.9739387952,"d":"5.97"},{"v":3.8704669796,"d":"3.87"},{"v":4.023836602,"d":"4.02"},{"v":4.220490238,"d":"4.22"},{"v":1.5793635192573,"d":"1.58"},{"v":0.659343271938858,"d":"0.66"},{"v":0.0337931937470495,"d":"0.03"},{"v":0.337889933037281,"d":"0.34"},"up","no"]
["MSTRG.16253","ETFRF1","ENSOART00000021779","GO:0005739(mitochondrion);GO:0022904(respiratory electron transport chain)","NA","NA","NA","electron transfer flavoprotein regulatory factor 1 [Source:NCBI gene;Acc:101114600]",{"v":5.07221091428571,"d":"5.07"},{"v":4.43515058241758,"d":"4.44"},{"v":2.23166083516484,"d":"2.23"},{"v":2.6095985040293,"d":"2.61"},{"v":2.01241232454212,"d":"2.01"},{"v":2.26184857216117,"d":"2.26"},{"v":1.70529664371397,"d":"1.71"},{"v":0.770022724111378,"d":"0.77"},{"v":0.0339245375817087,"d":"0.03"},{"v":0.338558520012209,"d":"0.34"},"up","no"]
["MSTRG.7684","DTX1","ENSOART00000008383","GO:0005112(Notch binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007219(Notch signaling pathway);GO:0008270(zinc ion binding);GO:0008593(regulation of Notch signaling pathway);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0045665(negative regulation of neuron differentiation)","NA","NA","NA","deltex E3 ubiquitin ligase 1 [Source:HGNC Symbol;Acc:HGNC:3060]",{"v":0.788898361492281,"d":"0.79"},{"v":0.754345002144082,"d":"0.75"},{"v":0.753057652658662,"d":"0.75"},{"v":1.21844256217839,"d":"1.22"},{"v":1.54317412607204,"d":"1.54"},{"v":1.55315930317324,"d":"1.55"},{"v":0.532194723633232,"d":"0.53"},{"v":-0.909973887845352,"d":"-0.91"},{"v":0.0339624642141259,"d":"0.03"},{"v":0.338558520012209,"d":"0.34"},"down","no"]
["MSTRG.2221","N4BP2L1","ENSOART00000011998","NA","NA","NA","NA","NEDD4 binding protein 2 like 1 [Source:NCBI gene;Acc:101109715]",{"v":1.439637,"d":"1.44"},{"v":1.020078,"d":"1.02"},{"v":0.936783,"d":"0.94"},{"v":2.508059,"d":"2.51"},{"v":2.927572,"d":"2.93"},{"v":1.704079,"d":"1.70"},{"v":0.475719321933244,"d":"0.48"},{"v":-1.07181747153957,"d":"-1.07"},{"v":0.0339636731859382,"d":"0.03"},{"v":0.338558520012209,"d":"0.34"},"down","yes"]
["MSTRG.12640","CACUL1","ENSOART00000000313","GO:0000082(G1/S transition of mitotic cell cycle);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008284(positive regulation of cell population proliferation);GO:0019901(protein kinase binding);GO:0031625(ubiquitin protein ligase binding);GO:0045860(positive regulation of protein kinase activity)","NA","NA","NA","CDK2 associated cullin domain 1 [Source:NCBI gene;Acc:101105965]",{"v":7.08892135389192,"d":"7.09"},{"v":7.90269903143282,"d":"7.90"},{"v":6.48229777511155,"d":"6.48"},{"v":5.79363982439266,"d":"5.79"},{"v":4.72130686633614,"d":"4.72"},{"v":3.66761967069906,"d":"3.67"},{"v":1.51410665835759,"d":"1.51"},{"v":0.598466836805615,"d":"0.60"},{"v":0.0339881316712051,"d":"0.03"},{"v":0.338595615575007,"d":"0.34"},"up","no"]
["MSTRG.18192","C5orf15","ENSOART00000014903","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","chromosome 5 open reading frame, human C5orf15 [Source:NCBI gene;Acc:101123295]",{"v":5.3552529912764,"d":"5.36"},{"v":1.3643159469697,"d":"1.36"},{"v":3.03915473645546,"d":"3.04"},{"v":2.46573089692378,"d":"2.47"},{"v":1.35946716597796,"d":"1.36"},{"v":1.61078622038568,"d":"1.61"},{"v":1.79520822102156,"d":"1.80"},{"v":0.84415118778833,"d":"0.84"},{"v":0.034153120597946,"d":"0.03"},{"v":0.339617632839989,"d":"0.34"},"up","no"]
["MSTRG.6132","ENSOARG00000019935","ENSOART00000021703","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0008270(zinc ion binding)","NA","NA","NA",null,{"v":2.743827,"d":"2.74"},{"v":2.251259,"d":"2.25"},{"v":2.898239,"d":"2.90"},{"v":3.702204,"d":"3.70"},{"v":5.707024,"d":"5.71"},{"v":8.322453,"d":"8.32"},{"v":0.445153789987537,"d":"0.45"},{"v":-1.16762425606181,"d":"-1.17"},{"v":0.0341932587931977,"d":"0.03"},{"v":0.339809817148711,"d":"0.34"},"down","yes"]
["MSTRG.13169","METTL26","ENSOART00000013717","NA","NA","NA","NA","methyltransferase like 26 [Source:NCBI gene;Acc:101110378]",{"v":2.513364,"d":"2.51"},{"v":2.747881,"d":"2.75"},{"v":1.426347,"d":"1.43"},{"v":4.681062,"d":"4.68"},{"v":4.174343,"d":"4.17"},{"v":4.205874,"d":"4.21"},{"v":0.512016625630614,"d":"0.51"},{"v":-0.965737438323385,"d":"-0.97"},{"v":0.0344154707617902,"d":"0.03"},{"v":0.340878764399366,"d":"0.34"},"down","no"]
["MSTRG.12715","ADAM12","ENSOART00000013317","GO:0004222(metalloendopeptidase activity);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017124(SH3 domain binding);GO:0045766(positive regulation of angiogenesis)","NA","K06835","EC:3.4.24.-","ADAM metallopeptidase domain 12 [Source:NCBI gene;Acc:101106128]",{"v":0.909227,"d":"0.91"},{"v":0.542164,"d":"0.54"},{"v":1.139101,"d":"1.14"},{"v":1.78588,"d":"1.79"},{"v":1.573741,"d":"1.57"},{"v":1.423559,"d":"1.42"},{"v":0.541583632646064,"d":"0.54"},{"v":-0.884743955415297,"d":"-0.88"},{"v":0.0344423764515947,"d":"0.03"},{"v":0.340878764399366,"d":"0.34"},"down","no"]
["MSTRG.3337","FZD2","ENSOART00000009415","GO:0003149(membranous septum morphogenesis);GO:0003150(muscular septum morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0007275(multicellular organism development);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0030165(PDZ domain binding);GO:0030855(epithelial cell differentiation);GO:0042813(Wnt-activated receptor activity);GO:0045745(positive regulation of G protein-coupled receptor signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060022(hard palate development);GO:0060070(canonical Wnt signaling pathway);GO:0060119(inner ear receptor cell development);GO:0060412(ventricular septum morphogenesis);GO:0090103(cochlea morphogenesis);GO:0090179(planar cell polarity pathway involved in neural tube closure)","NA","NA","NA","frizzled class receptor 2 [Source:HGNC Symbol;Acc:HGNC:4040]",{"v":1.292917,"d":"1.29"},{"v":0.971603,"d":"0.97"},{"v":0.944557,"d":"0.94"},{"v":1.575074,"d":"1.58"},{"v":2.199125,"d":"2.20"},{"v":2.231858,"d":"2.23"},{"v":0.534306783968251,"d":"0.53"},{"v":-0.904259760048928,"d":"-0.90"},{"v":0.0344472459508274,"d":"0.03"},{"v":0.340878764399366,"d":"0.34"},"down","no"]
["MSTRG.5621","ALKBH6;SYNE4","ENSOART00000005652;ENSOART00000005642","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005925(focal adhesion);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0005635(nuclear envelope);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031309(integral component of nuclear outer membrane);GO:0034993(meiotic nuclear membrane microtubule tethering complex);GO:0045198(establishment of epithelial cell apical/basal polarity)","NA","NA","NA","alkB homolog 6 [Source:HGNC Symbol;Acc:HGNC:28243];spectrin repeat containing nuclear envelope family member 4 [Source:NCBI gene;Acc:101119662]",{"v":0.262106456083803,"d":"0.26"},{"v":0.096387858178888,"d":"0.10"},{"v":0.349466649476229,"d":"0.35"},{"v":0.487903946011281,"d":"0.49"},{"v":0.537163991941982,"d":"0.54"},{"v":0.55821242707494,"d":"0.56"},{"v":0.44714819900284,"d":"0.45"},{"v":-1.16117502962747,"d":"-1.16"},{"v":0.0345349850495035,"d":"0.03"},{"v":0.341336099205989,"d":"0.34"},"down","yes"]
["MSTRG.15419","TET3","ENSOART00000013329","GO:0001939(female pronucleus);GO:0001940(male pronucleus);GO:0003677(DNA binding);GO:0005737(cytoplasm);GO:0006211(5-methylcytosine catabolic process);GO:0006493(protein O-linked glycosylation);GO:0008270(zinc ion binding);GO:0044727(DNA demethylation of male pronucleus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0055114(oxidation-reduction process);GO:0070579(methylcytosine dioxygenase activity);GO:0080111(DNA demethylation);GO:0080182(histone H3-K4 trimethylation)","NA","NA","NA","tet methylcytosine dioxygenase 3 [Source:NCBI gene;Acc:101105649]",{"v":0.710921,"d":"0.71"},{"v":0.460159,"d":"0.46"},{"v":0.551584,"d":"0.55"},{"v":1.305257,"d":"1.31"},{"v":0.941988,"d":"0.94"},{"v":0.861948,"d":"0.86"},{"v":0.554055023280961,"d":"0.55"},{"v":-0.851898837254171,"d":"-0.85"},{"v":0.034647839292917,"d":"0.03"},{"v":0.341707306057566,"d":"0.34"},"down","no"]
["MSTRG.9254","ENSOARG00000001554","ENSOART00000001669","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0030198(extracellular matrix organization);GO:0062023(collagen-containing extracellular matrix)","NA","NA","NA",null,{"v":5.35076511538461,"d":"5.35"},{"v":3.65865665217391,"d":"3.66"},{"v":7.27353849498328,"d":"7.27"},{"v":8.92168206688963,"d":"8.92"},{"v":9.63761830100334,"d":"9.64"},{"v":10.1248664013378,"d":"10.12"},{"v":0.567663700798462,"d":"0.57"},{"v":-0.816891603322779,"d":"-0.82"},{"v":0.0346562529906497,"d":"0.03"},{"v":0.341707306057566,"d":"0.34"},"down","no"]
["MSTRG.10924","ENSOARG00000004982","ENSOART00000005421","GO:0005623(cell);GO:0009055(electron transfer activity);GO:0015035(protein disulfide oxidoreductase activity);GO:0022900(electron transport chain);GO:0045454(cell redox homeostasis);GO:0055114(oxidation-reduction process)","NA","NA","NA",null,{"v":4.02320767567568,"d":"4.02"},{"v":4.7416188,"d":"4.74"},{"v":8.94032267459459,"d":"8.94"},{"v":9.21147978702703,"d":"9.21"},{"v":9.58835520324324,"d":"9.59"},{"v":15.8701199394595,"d":"15.87"},{"v":0.510677016631711,"d":"0.51"},{"v":-0.969516963852682,"d":"-0.97"},{"v":0.0347633209953895,"d":"0.03"},{"v":0.342156164311458,"d":"0.34"},"down","no"]
["MSTRG.11449","ZKSCAN8","ENSOART00000019593","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","K09229","NA","zinc finger with KRAB and SCAN domains 8 [Source:NCBI gene;Acc:101121465]",{"v":2.95473654192431,"d":"2.95"},{"v":1.9358556351719,"d":"1.94"},{"v":2.91569419020529,"d":"2.92"},{"v":2.7238044479347,"d":"2.72"},{"v":0.861990958199357,"d":"0.86"},{"v":0.983420560969577,"d":"0.98"},{"v":1.70845204593159,"d":"1.71"},{"v":0.77268975372702,"d":"0.77"},{"v":0.0350060616270322,"d":"0.04"},{"v":0.343599438546901,"d":"0.34"},"up","no"]
["MSTRG.20710","ENSOARG00000004106","ENSOART00000004480;ENSOART00000004479","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0009966(regulation of signal transduction);GO:0016020(membrane);GO:0016020(membrane)","NA","NA","NA","CNKSR family member 3 [Source:NCBI gene;Acc:101105165]",{"v":1.6249211937542,"d":"1.62"},{"v":3.85234618670248,"d":"3.85"},{"v":3.77766204499664,"d":"3.78"},{"v":1.94747023035594,"d":"1.95"},{"v":1.85970205910007,"d":"1.86"},{"v":1.68758016789792,"d":"1.69"},{"v":1.68432144983473,"d":"1.68"},{"v":0.752167500533948,"d":"0.75"},{"v":0.0350165032914039,"d":"0.04"},{"v":0.343599438546901,"d":"0.34"},"up","no"]
["ENSOARG00000011352","MST1R","ENSOART00000012341","GO:0000166(nucleotide binding);GO:0001725(stress fiber);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005773(vacuole);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0009615(response to virus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019899(enzyme binding);GO:0043406(positive regulation of MAP kinase activity);GO:0051897(positive regulation of protein kinase B signaling)","NA","K05100","EC:2.7.10.1","macrophage stimulating 1 receptor [Source:NCBI gene;Acc:101116433]",{"v":0.23619,"d":"0.24"},{"v":0.073971,"d":"0.07"},{"v":0.163156,"d":"0.16"},{"v":0.402227,"d":"0.40"},{"v":0.410773,"d":"0.41"},{"v":0.250529,"d":"0.25"},{"v":0.445043811687316,"d":"0.45"},{"v":-1.16798072781335,"d":"-1.17"},{"v":0.0351572101267762,"d":"0.04"},{"v":0.344670377986468,"d":"0.34"},"down","yes"]
["MSTRG.3048","SHMT1","ENSOART00000020191","GO:0000900(translation repressor activity, mRNA regulatory element binding);GO:0003824(catalytic activity);GO:0004372(glycine hydroxymethyltransferase activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006544(glycine metabolic process);GO:0006563(L-serine metabolic process);GO:0006565(L-serine catabolic process);GO:0006730(one-carbon metabolic process);GO:0009113(purine nucleobase biosynthetic process);GO:0016740(transferase activity);GO:0017148(negative regulation of translation);GO:0019264(glycine biosynthetic process from serine);GO:0030170(pyridoxal phosphate binding);GO:0035999(tetrahydrofolate interconversion);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046653(tetrahydrofolate metabolic process);GO:0046655(folic acid metabolic process);GO:0048027(mRNA 5'-UTR binding);GO:0051262(protein tetramerization);GO:0051289(protein homotetramerization);GO:0070905(serine binding);GO:1904482(cellular response to tetrahydrofolate)","00260(Glycine, serine and threonine metabolism);00630(Glyoxylate and dicarboxylate metabolism);00670(One carbon pool by folate);01523(Antifolate resistance)","K00600","EC:2.1.2.1","serine hydroxymethyltransferase 1 [Source:NCBI gene;Acc:443544]",{"v":0.94717932012352,"d":"0.95"},{"v":0.792539433350489,"d":"0.79"},{"v":0.803012041173443,"d":"0.80"},{"v":1.72441133916624,"d":"1.72"},{"v":1.17082805867216,"d":"1.17"},{"v":1.95198623932064,"d":"1.95"},{"v":0.524574464855683,"d":"0.52"},{"v":-0.930780512832866,"d":"-0.93"},{"v":0.0352100802597642,"d":"0.04"},{"v":0.344670377986468,"d":"0.34"},"down","no"]
["MSTRG.6724","RF00420","ENSOART00000024736","NA","NA","NA","NA",null,{"v":1.05233370342804,"d":"1.05"},{"v":1.32731573477421,"d":"1.33"},{"v":0.730578408573678,"d":"0.73"},{"v":1.96465152279396,"d":"1.96"},{"v":2.3350197750662,"d":"2.34"},{"v":1.36099236384456,"d":"1.36"},{"v":0.549445795166583,"d":"0.55"},{"v":-0.863950933825042,"d":"-0.86"},{"v":0.0352540376823305,"d":"0.04"},{"v":0.344692887004504,"d":"0.34"},"down","no"]
["ENSOARG00000003561","ARHGEF26","ENSOART00000003870","GO:0001886(endothelial cell morphogenesis);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0035023(regulation of Rho protein signal transduction);GO:0097178(ruffle assembly)","05100(Bacterial invasion of epithelial cells)","K13744","NA","Rho guanine nucleotide exchange factor 26 [Source:NCBI gene;Acc:101113898]",{"v":0.850693,"d":"0.85"},{"v":0.528826,"d":"0.53"},{"v":0.565265,"d":"0.57"},{"v":1.276278,"d":"1.28"},{"v":1.156602,"d":"1.16"},{"v":1.204642,"d":"1.20"},{"v":0.534645288743271,"d":"0.53"},{"v":-0.903346044291169,"d":"-0.90"},{"v":0.0352546007654043,"d":"0.04"},{"v":0.344692887004504,"d":"0.34"},"down","no"]
["MSTRG.9785","PCSK5","ENSOART00000013616","GO:0001822(kidney development);GO:0002001(renin secretion into blood stream);GO:0003279(cardiac septum development);GO:0004175(endopeptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0006465(signal peptide processing);GO:0006508(proteolysis);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0007566(embryo implantation);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0009952(anterior/posterior pattern specification);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0016486(peptide hormone processing);GO:0016787(hydrolase activity);GO:0019058(viral life cycle);GO:0030323(respiratory tube development);GO:0035108(limb morphogenesis);GO:0042089(cytokine biosynthetic process);GO:0042277(peptide binding);GO:0043043(peptide biosynthetic process);GO:0048566(embryonic digestive tract development);GO:0048706(embryonic skeletal system development);GO:0060976(coronary vasculature development)","NA","NA","NA","proprotein convertase subtilisin/kexin type 5 [Source:HGNC Symbol;Acc:HGNC:8747]",{"v":0.677815740515447,"d":"0.68"},{"v":0.550684997919001,"d":"0.55"},{"v":0.661931654234032,"d":"0.66"},{"v":1.0780791568753,"d":"1.08"},{"v":1.2061376212582,"d":"1.21"},{"v":1.03711585497039,"d":"1.04"},{"v":0.569178881340112,"d":"0.57"},{"v":-0.813045961398087,"d":"-0.81"},{"v":0.0354459205246687,"d":"0.04"},{"v":0.345736789914446,"d":"0.35"},"down","no"]
["MSTRG.14877","E2F6","ENSOART00000017420","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:0071339(MLL1 complex);GO:0090575(RNA polymerase II transcription factor complex)","NA","K09390","NA","E2F transcription factor 6 [Source:NCBI gene;Acc:101120153]",{"v":2.63989023524299,"d":"2.64"},{"v":2.64859536481495,"d":"2.65"},{"v":1.97201452886217,"d":"1.97"},{"v":2.03164909466213,"d":"2.03"},{"v":1.45474833722025,"d":"1.45"},{"v":1.32138196074455,"d":"1.32"},{"v":1.51015667234121,"d":"1.51"},{"v":0.594698230798334,"d":"0.59"},{"v":0.0355098754657098,"d":"0.04"},{"v":0.346050233745014,"d":"0.35"},"up","no"]
["MSTRG.11330","ENSOARG00000024221","ENSOART00000026123","NA","NA","NA","NA",null,{"v":2.44575524073637,"d":"2.45"},{"v":1.15251634434742,"d":"1.15"},{"v":2.2638951515223,"d":"2.26"},{"v":3.13919819494926,"d":"3.14"},{"v":4.63117087019117,"d":"4.63"},{"v":2.79273789780505,"d":"2.79"},{"v":0.55496614368955,"d":"0.55"},{"v":-0.849528333913013,"d":"-0.85"},{"v":0.0355205898920041,"d":"0.04"},{"v":0.346050233745014,"d":"0.35"},"down","no"]
["ENSOARG00000018205","UGT8","ENSOART00000019812","GO:0002175(protein localization to paranode region of axon);GO:0007010(cytoskeleton organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0016758(transferase activity, transferring hexosyl groups);GO:0030913(paranodal junction assembly);GO:0048812(neuron projection morphogenesis)","00565(Ether lipid metabolism);00600(Sphingolipid metabolism)","K04628","EC:2.4.1.47","UDP glycosyltransferase 8 [Source:NCBI gene;Acc:101113069]",{"v":0.404494,"d":"0.40"},{"v":0.280549,"d":"0.28"},{"v":0.184744,"d":"0.18"},{"v":0.527679,"d":"0.53"},{"v":0.543072,"d":"0.54"},{"v":0.842432,"d":"0.84"},{"v":0.454628229500262,"d":"0.45"},{"v":-1.13724082583151,"d":"-1.14"},{"v":0.0356114759574172,"d":"0.04"},{"v":0.346728789166791,"d":"0.35"},"down","yes"]
["MSTRG.8775","ACVR2B","ENSOART00000001510","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000166(nucleotide binding);GO:0001501(skeletal system development);GO:0001702(gastrulation with mouth forming second);GO:0001822(kidney development);GO:0001946(lymphangiogenesis);GO:0001974(blood vessel remodeling);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0007368(determination of left/right symmetry);GO:0007389(pattern specification process);GO:0007498(mesoderm development);GO:0007507(heart development);GO:0009749(response to glucose);GO:0009791(post-embryonic development);GO:0009952(anterior/posterior pattern specification);GO:0009966(regulation of signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019838(growth factor binding);GO:0030073(insulin secretion);GO:0030324(lung development);GO:0030501(positive regulation of bone mineralization);GO:0030509(BMP signaling pathway);GO:0031016(pancreas development);GO:0032147(activation of protein kinase activity);GO:0032924(activin receptor signaling pathway);GO:0032927(positive regulation of activin receptor signaling pathway);GO:0032991(protein-containing complex);GO:0035265(organ growth);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043235(receptor complex);GO:0045669(positive regulation of osteoblast differentiation);GO:0046872(metal ion binding);GO:0048185(activin binding);GO:0048617(embryonic foregut morphogenesis);GO:0048705(skeletal system morphogenesis);GO:0060021(roof of mouth development);GO:0060836(lymphatic endothelial cell differentiation);GO:0060840(artery development);GO:0060841(venous blood vessel development);GO:0061298(retina vasculature development in camera-type eye);GO:0120163(negative regulation of cold-induced thermogenesis)","04060(Cytokine-cytokine receptor interaction);04350(TGF-beta signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);05418(Fluid shear stress and atherosclerosis)","K13596","EC:2.7.11.30","activin A receptor type 2B [Source:NCBI gene;Acc:443156]",{"v":5.70441997882084,"d":"5.70"},{"v":5.29504951516886,"d":"5.30"},{"v":4.46742053878077,"d":"4.47"},{"v":4.36819075758443,"d":"4.37"},{"v":2.65312653734974,"d":"2.65"},{"v":3.13952622724671,"d":"3.14"},{"v":1.52220531681318,"d":"1.52"},{"v":0.606162964341288,"d":"0.61"},{"v":0.0360679904190756,"d":"0.04"},{"v":0.349071664601676,"d":"0.35"},"up","no"]
["MSTRG.2815","RTN4RL1","ENSOART00000015993","GO:0005515(protein binding);GO:0008201(heparin binding);GO:0009986(cell surface);GO:0010977(negative regulation of neuron projection development);GO:0022038(corpus callosum development);GO:0035374(chondroitin sulfate binding);GO:0038023(signaling receptor activity);GO:0046658(anchored component of plasma membrane);GO:0048681(negative regulation of axon regeneration)","NA","NA","NA","reticulon 4 receptor like 1 [Source:HGNC Symbol;Acc:HGNC:21329]",{"v":0.782754,"d":"0.78"},{"v":0.381974,"d":"0.38"},{"v":0.439942,"d":"0.44"},{"v":1.328553,"d":"1.33"},{"v":0.786891,"d":"0.79"},{"v":1.342652,"d":"1.34"},{"v":0.464032808805771,"d":"0.46"},{"v":-1.10770128214651,"d":"-1.11"},{"v":0.0360771191626204,"d":"0.04"},{"v":0.349071664601676,"d":"0.35"},"down","yes"]
["MSTRG.12407","RBP4","ENSOART00000003509","GO:0001654(eye development);GO:0005501(retinoid binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006094(gluconeogenesis);GO:0019841(retinol binding);GO:0030277(maintenance of gastrointestinal epithelium);GO:0032024(positive regulation of insulin secretion);GO:0032526(response to retinoic acid);GO:0034632(retinol transmembrane transporter activity);GO:0034633(retinol transport);GO:0042572(retinol metabolic process);GO:0042593(glucose homeostasis)","NA","K18271","NA","retinol binding protein 4 [Source:NCBI gene;Acc:101105458]",{"v":15.459214,"d":"15.46"},{"v":16.456564,"d":"16.46"},{"v":15.258698,"d":"15.26"},{"v":6.499539,"d":"6.50"},{"v":11.489494,"d":"11.49"},{"v":10.545684,"d":"10.55"},{"v":1.65323090465555,"d":"1.65"},{"v":0.725288238082628,"d":"0.73"},{"v":0.0360872715487279,"d":"0.04"},{"v":0.349071664601676,"d":"0.35"},"up","no"]
["MSTRG.678","CSDE1;NRAS","ENSOART00000021814;ENSOART00000021805","GO:0003676(nucleic acid binding);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0070937(CRD-mediated mRNA stability complex);GO:0070966(nuclear-transcribed mRNA catabolic process, no-go decay);GO:0000166(nucleotide binding);GO:0001938(positive regulation of endothelial cell proliferation);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0044877(protein-containing complex binding)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04062(Chemokine signaling pathway);04068(FoxO signaling pathway);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04137(Mitophagy - animal);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04218(Cellular senescence);04360(Axon guidance);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04540(Gap junction);04550(Signaling pathways regulating pluripotency of stem cells);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04714(Thermogenesis);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04725(Cholinergic synapse);04726(Serotonergic synapse);04730(Long-term depression);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04916(Melanogenesis);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05034(Alcoholism);05160(Hepatitis C);05161(Hepatitis B);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05216(Thyroid cancer);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer)","K07828","NA","cold shock domain containing E1 [Source:NCBI gene;Acc:101102685];NRAS proto-oncogene, GTPase [Source:NCBI gene;Acc:101102438]",{"v":56.3119958459675,"d":"56.31"},{"v":62.1710277791623,"d":"62.17"},{"v":57.1853511464174,"d":"57.19"},{"v":45.6635199080997,"d":"45.66"},{"v":37.938243981568,"d":"37.94"},{"v":35.9870725486327,"d":"35.99"},{"v":1.46893623187127,"d":"1.47"},{"v":0.554771768283631,"d":"0.55"},{"v":0.0362001698587299,"d":"0.04"},{"v":0.349956408202097,"d":"0.35"},"up","no"]
["MSTRG.3027","ZSWIM7","ENSOART00000018974","GO:0000724(double-strand break repair via homologous recombination);GO:0008270(zinc ion binding);GO:0050821(protein stabilization);GO:0097196(Shu complex)","NA","NA","NA","zinc finger SWIM-type containing 7 [Source:NCBI gene;Acc:101118034]",{"v":1.110771,"d":"1.11"},{"v":1.88652,"d":"1.89"},{"v":1.126738,"d":"1.13"},{"v":3.270776,"d":"3.27"},{"v":2.798048,"d":"2.80"},{"v":2.827814,"d":"2.83"},{"v":0.463549151938069,"d":"0.46"},{"v":-1.10920577330156,"d":"-1.11"},{"v":0.0363186834324304,"d":"0.04"},{"v":0.350103312622232,"d":"0.35"},"down","yes"]
["MSTRG.6593","PGM2L1","ENSOART00000010773","GO:0005975(carbohydrate metabolic process);GO:0016310(phosphorylation);GO:0016868(intramolecular transferase activity, phosphotransferases);GO:0047933(glucose-1,6-bisphosphate synthase activity);GO:0071704(organic substance metabolic process)","00500(Starch and sucrose metabolism)","K11809","EC:2.7.1.106","phosphoglucomutase 2 like 1 [Source:NCBI gene;Acc:101106106]",{"v":11.7304568573345,"d":"11.73"},{"v":9.80386355635063,"d":"9.80"},{"v":7.21363395125224,"d":"7.21"},{"v":7.96195545542636,"d":"7.96"},{"v":4.88215402504472,"d":"4.88"},{"v":5.71418249299344,"d":"5.71"},{"v":1.54906251103509,"d":"1.55"},{"v":0.631395363972963,"d":"0.63"},{"v":0.0363432488573057,"d":"0.04"},{"v":0.350103312622232,"d":"0.35"},"up","no"]
["MSTRG.13162","RAB11FIP3","ENSOART00000013181","GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005768(endosome);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0016192(vesicle-mediated transport);GO:0017137(Rab GTPase binding);GO:0030306(ADP-ribosylation factor binding);GO:0030496(midbody);GO:0032154(cleavage furrow);GO:0032456(endocytic recycling);GO:0032465(regulation of cytokinesis);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0045171(intercellular bridge);GO:0051959(dynein light intermediate chain binding);GO:0055037(recycling endosome);GO:0070164(negative regulation of adiponectin secretion)","04144(Endocytosis)","K12485","NA","RAB11 family interacting protein 3 [Source:NCBI gene;Acc:101123176]",{"v":2.20855283765303,"d":"2.21"},{"v":3.32252574159038,"d":"3.32"},{"v":2.89867160902173,"d":"2.90"},{"v":1.65900216918496,"d":"1.66"},{"v":2.17512345582883,"d":"2.18"},{"v":1.62022215297232,"d":"1.62"},{"v":1.5455102115578,"d":"1.55"},{"v":0.62808318646086,"d":"0.63"},{"v":0.036412833497222,"d":"0.04"},{"v":0.350559401735047,"d":"0.35"},"up","no"]
["MSTRG.1751","TM4SF18","ENSOART00000005346","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane 4 L six family member 18 [Source:NCBI gene;Acc:101121735]",{"v":1.39858903140265,"d":"1.40"},{"v":0.382823988136776,"d":"0.38"},{"v":1.44601931542219,"d":"1.45"},{"v":3.06168851919051,"d":"3.06"},{"v":1.64956688834613,"d":"1.65"},{"v":2.34909653942777,"d":"2.35"},{"v":0.45712060237298,"d":"0.46"},{"v":-1.12935325238052,"d":"-1.13"},{"v":0.0364786183149673,"d":"0.04"},{"v":0.350985786592095,"d":"0.35"},"down","yes"]
["ENSOARG00000009014","KPNA5","ENSOART00000009819","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006606(protein import into nucleus);GO:0008565(protein transporter activity);GO:0015031(protein transport);GO:0061608(nuclear import signal receptor activity)","NA","NA","NA","karyopherin subunit alpha 5 [Source:NCBI gene;Acc:101104498]",{"v":0.378867,"d":"0.38"},{"v":0.452642,"d":"0.45"},{"v":0.194489,"d":"0.19"},{"v":0.741242,"d":"0.74"},{"v":1.109663,"d":"1.11"},{"v":0.51271,"d":"0.51"},{"v":0.434080000338465,"d":"0.43"},{"v":-1.20396714103004,"d":"-1.20"},{"v":0.0365268614477935,"d":"0.04"},{"v":0.351242988056286,"d":"0.35"},"down","yes"]
["MSTRG.12487","HIF1AN","ENSOART00000016780","GO:0005112(Notch binding);GO:0005506(iron ion binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031406(carboxylic acid binding);GO:0036138(peptidyl-histidine hydroxylation);GO:0036139(peptidyl-histidine dioxygenase activity);GO:0036140(peptidyl-asparagine 3-dioxygenase activity);GO:0042264(peptidyl-aspartic acid hydroxylation);GO:0042265(peptidyl-asparagine hydroxylation);GO:0042803(protein homodimerization activity);GO:0045663(positive regulation of myoblast differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0048037(cofactor binding);GO:0048471(perinuclear region of cytoplasm);GO:0051059(NF-kappaB binding);GO:0055114(oxidation-reduction process);GO:0061428(negative regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0071532(ankyrin repeat binding)","NA","K18055","EC:1.14.11.30","hypoxia inducible factor 1 subunit alpha inhibitor [Source:NCBI gene;Acc:101122066]",{"v":23.5321650178602,"d":"23.53"},{"v":34.2556971790227,"d":"34.26"},{"v":25.9901012762426,"d":"25.99"},{"v":21.5099839247683,"d":"21.51"},{"v":15.8722014888795,"d":"15.87"},{"v":18.0735580310868,"d":"18.07"},{"v":1.51071752480635,"d":"1.51"},{"v":0.59523392942504,"d":"0.60"},{"v":0.0365787182057167,"d":"0.04"},{"v":0.351534614987017,"d":"0.35"},"up","no"]
["MSTRG.7203","SEMA5A","ENSOART00000015644","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","04360(Axon guidance)","K06841","NA","semaphorin 5A [Source:NCBI gene;Acc:101123150]",{"v":1.83070385254192,"d":"1.83"},{"v":1.57571304311951,"d":"1.58"},{"v":1.78103805438737,"d":"1.78"},{"v":3.13443710584686,"d":"3.13"},{"v":2.68827103300506,"d":"2.69"},{"v":2.87183601508296,"d":"2.87"},{"v":0.596633343647018,"d":"0.60"},{"v":-0.745083488032248,"d":"-0.75"},{"v":0.0366136689739676,"d":"0.04"},{"v":0.35166352176879,"d":"0.35"},"down","no"]
["MSTRG.7657","HSPB8","ENSOART00000002011","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0034620(cellular response to unfolded protein);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0101031(chaperone complex);GO:1905337(positive regulation of aggrephagy)","NA","K08879","NA","heat shock protein family B (small) member 8 [Source:NCBI gene;Acc:101108164]",{"v":147.564713,"d":"147.56"},{"v":168.872391,"d":"168.87"},{"v":195.911835,"d":"195.91"},{"v":88.537933,"d":"88.54"},{"v":117.343391,"d":"117.34"},{"v":123.085129,"d":"123.09"},{"v":1.55745041577233,"d":"1.56"},{"v":0.639186233195942,"d":"0.64"},{"v":0.0367426149415629,"d":"0.04"},{"v":0.352280338676359,"d":"0.35"},"up","no"]
["MSTRG.18154","APC2","ENSOART00000012941","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005881(cytoplasmic microtubule);GO:0005884(actin filament);GO:0008013(beta-catenin binding);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0016055(Wnt signaling pathway);GO:0016342(catenin complex);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030496(midbody);GO:0031258(lamellipodium membrane);GO:0031941(filamentous actin);GO:0045171(intercellular bridge);GO:0048471(perinuclear region of cytoplasm);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090630(activation of GTPase activity)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04810(Regulation of actin cytoskeleton);04934(Cushing syndrome);05165(Human papillomavirus infection);05200(Pathways in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05213(Endometrial cancer);05217(Basal cell carcinoma);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K02085","NA","APC2, WNT signaling pathway regulator [Source:NCBI gene;Acc:101115458]",{"v":0.484696824833966,"d":"0.48"},{"v":0.481716533562619,"d":"0.48"},{"v":0.660901457068311,"d":"0.66"},{"v":0.812606309060721,"d":"0.81"},{"v":1.05664337250949,"d":"1.06"},{"v":1.04414560685484,"d":"1.04"},{"v":0.558563001021603,"d":"0.56"},{"v":-0.84020808161767,"d":"-0.84"},{"v":0.036850338344653,"d":"0.04"},{"v":0.353082509611587,"d":"0.35"},"down","no"]
["MSTRG.12385","PCGF5","ENSOART00000017352","GO:0000805(X chromosome);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005813(centrosome);GO:0031519(PcG protein complex);GO:0036353(histone H2A-K119 monoubiquitination);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060819(inactivation of X chromosome by genetic imprinting)","04550(Signaling pathways regulating pluripotency of stem cells)","K11489","NA","polycomb group ring finger 5 [Source:NCBI gene;Acc:101123250]",{"v":3.50366845874181,"d":"3.50"},{"v":3.23242378712677,"d":"3.23"},{"v":3.00816517959778,"d":"3.01"},{"v":1.75593327382219,"d":"1.76"},{"v":2.7454944717943,"d":"2.75"},{"v":1.77790899546244,"d":"1.78"},{"v":1.5517972402595,"d":"1.55"},{"v":0.633940065526443,"d":"0.63"},{"v":0.0369113931114601,"d":"0.04"},{"v":0.353082509611587,"d":"0.35"},"up","no"]
["MSTRG.17886","ENSOARG00000008257","ENSOART00000008980","GO:0005515(protein binding)","NA","NA","NA",null,{"v":2.4834097633452,"d":"2.48"},{"v":2.07600202669039,"d":"2.08"},{"v":2.01300794483986,"d":"2.01"},{"v":3.75029827046263,"d":"3.75"},{"v":4.33722640569395,"d":"4.34"},{"v":4.29928601957295,"d":"4.30"},{"v":0.530598222280199,"d":"0.53"},{"v":-0.914308252927683,"d":"-0.91"},{"v":0.0369127782892564,"d":"0.04"},{"v":0.353082509611587,"d":"0.35"},"down","no"]
["MSTRG.11420","ZFP57","ENSOART00000018062;ENSOART00000018061","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006355(regulation of transcription, DNA-templated);GO:0043045(DNA methylation involved in embryo development);GO:0046872(metal ion binding);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection);05168(Herpes simplex virus 1 infection)","K09228","NA","ZFP57 zinc finger protein [Source:NCBI gene;Acc:101109748]",{"v":1.61354461111111,"d":"1.61"},{"v":1.14118600198413,"d":"1.14"},{"v":1.05184514285714,"d":"1.05"},{"v":2.06875969593254,"d":"2.07"},{"v":2.61043462946429,"d":"2.61"},{"v":2.26169088392857,"d":"2.26"},{"v":0.548427994578857,"d":"0.55"},{"v":-0.866625879333179,"d":"-0.87"},{"v":0.0369466639045794,"d":"0.04"},{"v":0.353199723790382,"d":"0.35"},"down","no"]
["MSTRG.15209","ENSOARG00000016958","ENSOART00000018468","NA","NA","NA","NA",null,{"v":9.054274,"d":"9.05"},{"v":8.366382,"d":"8.37"},{"v":7.247419,"d":"7.25"},{"v":3.339422,"d":"3.34"},{"v":6.586039,"d":"6.59"},{"v":4.947022,"d":"4.95"},{"v":1.6586386415772,"d":"1.66"},{"v":0.729999608542074,"d":"0.73"},{"v":0.0369983130674873,"d":"0.04"},{"v":0.353442841398274,"d":"0.35"},"up","no"]
["MSTRG.1801","ZBTB38","ENSOART00000016849","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0006974(cellular response to DNA damage stimulus);GO:0008327(methyl-CpG binding);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-templated)","NA","K10510","NA","zinc finger and BTB domain containing 38 [Source:NCBI gene;Acc:101107245]",{"v":3.50609161643454,"d":"3.51"},{"v":4.71323849554318,"d":"4.71"},{"v":4.04770180965645,"d":"4.05"},{"v":2.83240796490251,"d":"2.83"},{"v":2.78454349517177,"d":"2.78"},{"v":2.59999042349118,"d":"2.60"},{"v":1.49289505700037,"d":"1.49"},{"v":0.578112754845278,"d":"0.58"},{"v":0.0370569933009555,"d":"0.04"},{"v":0.353442841398274,"d":"0.35"},"up","no"]
["MSTRG.20636","HECA","ENSOART00000001234","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0045930(negative regulation of mitotic cell cycle)","NA","NA","NA","hdc homolog, cell cycle regulator [Source:HGNC Symbol;Acc:HGNC:21041]",{"v":6.91800881482732,"d":"6.92"},{"v":6.79063080258381,"d":"6.79"},{"v":6.84325326699316,"d":"6.84"},{"v":4.81857521236173,"d":"4.82"},{"v":5.16427024199949,"d":"5.16"},{"v":3.81178328126319,"d":"3.81"},{"v":1.48984748181945,"d":"1.49"},{"v":0.575164647140372,"d":"0.58"},{"v":0.0372075696918663,"d":"0.04"},{"v":0.354005843665194,"d":"0.35"},"up","no"]
["MSTRG.11171","IP6K3","ENSOART00000011266","GO:0000828(inositol hexakisphosphate kinase activity);GO:0000831(inositol hexakisphosphate 6-kinase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0032958(inositol phosphate biosynthetic process);GO:0046488(phosphatidylinositol metabolic process)","NA","NA","NA","inositol hexakisphosphate kinase 3 [Source:HGNC Symbol;Acc:HGNC:17269]",{"v":7.23785868244576,"d":"7.24"},{"v":5.85966829500043,"d":"5.86"},{"v":10.5405258548152,"d":"10.54"},{"v":6.05860539593517,"d":"6.06"},{"v":4.98540247363005,"d":"4.99"},{"v":4.29943046899923,"d":"4.30"},{"v":1.5405968538909,"d":"1.54"},{"v":0.623489384250501,"d":"0.62"},{"v":0.037269478519137,"d":"0.04"},{"v":0.354005843665194,"d":"0.35"},"up","no"]
["MSTRG.17329","DENND2A","ENSOART00000014371","GO:0005829(cytosol);GO:0015629(actin cytoskeleton);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0042147(retrograde transport, endosome to Golgi)","NA","K20161","NA","DENN domain containing 2A [Source:NCBI gene;Acc:101112131]",{"v":2.41861120222065,"d":"2.42"},{"v":1.92806571367824,"d":"1.93"},{"v":2.65521136026459,"d":"2.66"},{"v":4.03317675431136,"d":"4.03"},{"v":4.15001183345145,"d":"4.15"},{"v":3.58272950744153,"d":"3.58"},{"v":0.595099185589042,"d":"0.60"},{"v":-0.748797951455113,"d":"-0.75"},{"v":0.0373786789253766,"d":"0.04"},{"v":0.354630487794044,"d":"0.35"},"down","no"]
["MSTRG.4917","HM13","ENSOART00000000980","GO:0004190(aspartic-type endopeptidase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005791(rough endoplasmic reticulum);GO:0008233(peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031625(ubiquitin protein ligase binding);GO:0033619(membrane protein proteolysis);GO:0036513(Derlin-1 retrotranslocation complex);GO:0042500(aspartic endopeptidase activity, intramembrane cleaving);GO:0042803(protein homodimerization activity);GO:0071458(integral component of cytoplasmic side of endoplasmic reticulum membrane);GO:0071556(integral component of lumenal side of endoplasmic reticulum membrane);GO:1904211(membrane protein proteolysis involved in retrograde protein transport, ER to cytosol)","NA","K09595","EC:3.4.23.-","histocompatibility minor 13 [Source:NCBI gene;Acc:101111384]",{"v":1.60311870945517,"d":"1.60"},{"v":1.70301545408395,"d":"1.70"},{"v":2.11640092512012,"d":"2.12"},{"v":2.77653880464146,"d":"2.78"},{"v":3.2509756159913,"d":"3.25"},{"v":3.17644345897924,"d":"3.18"},{"v":0.589152531941816,"d":"0.59"},{"v":-0.763286897865374,"d":"-0.76"},{"v":0.0374075909466986,"d":"0.04"},{"v":0.354676376031834,"d":"0.35"},"down","no"]
["MSTRG.19208","HTRA3","ENSOART00000013897","GO:0004175(endopeptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005515(protein binding);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway)","NA","NA","NA","HtrA serine peptidase 3 [Source:HGNC Symbol;Acc:HGNC:30406]",{"v":0.593640593737455,"d":"0.59"},{"v":0.558904728221598,"d":"0.56"},{"v":1.00407874829386,"d":"1.00"},{"v":1.24239711882778,"d":"1.24"},{"v":1.24494875672421,"d":"1.24"},{"v":1.69268887635488,"d":"1.69"},{"v":0.515934483384162,"d":"0.52"},{"v":-0.954740220126268,"d":"-0.95"},{"v":0.037426959572688,"d":"0.04"},{"v":0.354676376031834,"d":"0.35"},"down","no"]
["MSTRG.8841","CIDEC","ENSOART00000006399","GO:0005622(intracellular);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0034389(lipid droplet organization);GO:0097194(execution phase of apoptosis)","NA","NA","NA","cell death inducing DFFA like effector c [Source:NCBI gene;Acc:101102430]",{"v":0.881002861342479,"d":"0.88"},{"v":2.01656014894659,"d":"2.02"},{"v":0.766887560019598,"d":"0.77"},{"v":0.0295233953944145,"d":"0.03"},{"v":0.667533466927976,"d":"0.67"},{"v":0.558523902008819,"d":"0.56"},{"v":2.91853035217575,"d":"2.92"},{"v":1.54524207205971,"d":"1.55"},{"v":0.0375768222659345,"d":"0.04"},{"v":0.355614308832308,"d":"0.36"},"up","yes"]
["MSTRG.16852","RAPGEF5","ENSOART00000012876","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005622(intracellular);GO:0005654(nucleoplasm);GO:0007264(small GTPase mediated signal transduction);GO:0016604(nuclear body);GO:0035556(intracellular signal transduction)","04014(Ras signaling pathway);04015(Rap1 signaling pathway)","K08019","NA","Rap guanine nucleotide exchange factor 5 [Source:NCBI gene;Acc:101108303]",{"v":2.219144,"d":"2.22"},{"v":1.427067,"d":"1.43"},{"v":1.334751,"d":"1.33"},{"v":2.802514,"d":"2.80"},{"v":3.309843,"d":"3.31"},{"v":2.679017,"d":"2.68"},{"v":0.566573780162236,"d":"0.57"},{"v":-0.819664256505596,"d":"-0.82"},{"v":0.0375912724794564,"d":"0.04"},{"v":0.355614308832308,"d":"0.36"},"down","no"]
["MSTRG.18451","RNF145","ENSOART00000014107","GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding)","NA","NA","NA","ring finger protein 145 [Source:NCBI gene;Acc:101115120]",{"v":2.41865504969254,"d":"2.42"},{"v":2.54086895595812,"d":"2.54"},{"v":4.61161167425627,"d":"4.61"},{"v":1.49069482948313,"d":"1.49"},{"v":2.35208592238657,"d":"2.35"},{"v":1.95596276450058,"d":"1.96"},{"v":1.65055337469004,"d":"1.65"},{"v":0.722949792395992,"d":"0.72"},{"v":0.0376661839604729,"d":"0.04"},{"v":0.35592062269451,"d":"0.36"},"up","no"]
["MSTRG.4412","PLCB4","ENSOART00000010392","GO:0004435(phosphatidylinositol phospholipase C activity);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005790(smooth endoplasmic reticulum);GO:0006629(lipid metabolic process);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0014069(postsynaptic density);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0030425(dendrite);GO:0035556(intracellular signal transduction);GO:0050804(modulation of chemical synaptic transmission);GO:0098688(parallel fiber to Purkinje cell synapse);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse)","00562(Inositol phosphate metabolism);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04062(Chemokine signaling pathway);04070(Phosphatidylinositol signaling system);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04310(Wnt signaling pathway);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04621(NOD-like receptor signaling pathway);04713(Circadian entrainment);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04916(Melanogenesis);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome);04961(Endocrine and other factor-regulated calcium reabsorption);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);05010(Alzheimer disease);05016(Huntington disease);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis);05146(Amoebiasis);05163(Human cytomegalovirus infection);05200(Pathways in cancer)","K05858","EC:3.1.4.11","phospholipase C beta 4 [Source:NCBI gene;Acc:101106864]",{"v":1.81887449675521,"d":"1.82"},{"v":0.979324175564593,"d":"0.98"},{"v":1.10380644760751,"d":"1.10"},{"v":2.861911870122,"d":"2.86"},{"v":2.51172945370771,"d":"2.51"},{"v":1.57181205317124,"d":"1.57"},{"v":0.561807114399233,"d":"0.56"},{"v":-0.831853200854692,"d":"-0.83"},{"v":0.0377584204733682,"d":"0.04"},{"v":0.356163772090789,"d":"0.36"},"down","no"]
["ENSOARG00000006601","ALG8","ENSOART00000007175","GO:0000033(alpha-1,3-mannosyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006486(protein glycosylation);GO:0006487(protein N-linked glycosylation);GO:0006490(oligosaccharide-lipid intermediate biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0016758(transferase activity, transferring hexosyl groups);GO:0018279(protein N-linked glycosylation via asparagine);GO:0042283(dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity);GO:0097502(mannosylation)","00510(N-Glycan biosynthesis)","K03849","EC:2.4.1.265","ALG8, alpha-1,3-glucosyltransferase [Source:NCBI gene;Acc:101109656]",{"v":0.274111,"d":"0.27"},{"v":0.156284,"d":"0.16"},{"v":0.44983,"d":"0.45"},{"v":0.738777,"d":"0.74"},{"v":0.436216,"d":"0.44"},{"v":0.873636,"d":"0.87"},{"v":0.429665400616705,"d":"0.43"},{"v":-1.21871448805346,"d":"-1.22"},{"v":0.0378982916429983,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"down","yes"]
["MSTRG.1371","KPNA1","ENSOART00000021927","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006606(protein import into nucleus);GO:0008565(protein transporter activity);GO:0014069(postsynaptic density);GO:0015031(protein transport);GO:0061608(nuclear import signal receptor activity);GO:0098978(glutamatergic synapse);GO:0099527(postsynapse to nucleus signaling pathway)","05164(Influenza A)","K15042","NA","karyopherin subunit alpha 1 [Source:NCBI gene;Acc:101113813]",{"v":18.0152182771982,"d":"18.02"},{"v":20.0848805373256,"d":"20.08"},{"v":18.8927425747189,"d":"18.89"},{"v":14.8212577022084,"d":"14.82"},{"v":11.6874483408752,"d":"11.69"},{"v":12.4262766337895,"d":"12.43"},{"v":1.46379521630289,"d":"1.46"},{"v":0.549713735938045,"d":"0.55"},{"v":0.0379234339226164,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"up","no"]
["MSTRG.21845","AR","ENSOART00000015813","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001091(RNA polymerase II general transcription initiation factor binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003073(regulation of systemic arterial blood pressure);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005102(signaling receptor binding);GO:0005496(steroid binding);GO:0005497(androgen binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007283(spermatogenesis);GO:0007338(single fertilization);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0009987(cellular process);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016607(nuclear speck);GO:0019102(male somatic sex determination);GO:0019899(enzyme binding);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0033327(Leydig cell differentiation);GO:0035264(multicellular organism growth);GO:0042327(positive regulation of phosphorylation);GO:0043410(positive regulation of MAPK cascade);GO:0043565(sequence-specific DNA binding);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0044212(transcription regulatory region DNA binding);GO:0045597(positive regulation of cell differentiation);GO:0045720(negative regulation of integrin biosynthetic process);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0046872(metal ion binding);GO:0048608(reproductive structure development);GO:0048638(regulation of developmental growth);GO:0048645(animal organ formation);GO:0048808(male genitalia morphogenesis);GO:0050680(negative regulation of epithelial cell proliferation);GO:0050790(regulation of catalytic activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051117(ATPase binding);GO:0051259(protein complex oligomerization);GO:0060520(activation of prostate induction by androgen receptor signaling pathway);GO:0060571(morphogenesis of an epithelial fold);GO:0060599(lateral sprouting involved in mammary gland duct morphogenesis);GO:0060685(regulation of prostatic bud formation);GO:0060736(prostate gland growth);GO:0060740(prostate gland epithelium morphogenesis);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0060748(tertiary branching involved in mammary gland duct morphogenesis);GO:0060749(mammary gland alveolus development);GO:0060769(positive regulation of epithelial cell proliferation involved in prostate gland development);GO:0061458(reproductive system development);GO:0070974(POU domain binding);GO:0071383(cellular response to steroid hormone stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0072520(seminiferous tubule development);GO:1903076(regulation of protein localization to plasma membrane);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04114(Oocyte meiosis);05200(Pathways in cancer);05215(Prostate cancer)","K08557","NA","androgen receptor [Source:NCBI gene;Acc:443042]",{"v":2.74268682469369,"d":"2.74"},{"v":3.07078795330965,"d":"3.07"},{"v":2.85678750888132,"d":"2.86"},{"v":2.2621829605597,"d":"2.26"},{"v":1.78833938766041,"d":"1.79"},{"v":1.82468825911694,"d":"1.82"},{"v":1.47573642314322,"d":"1.48"},{"v":0.561435068972297,"d":"0.56"},{"v":0.0379393620484385,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"up","no"]
["MSTRG.15454","SLC9A2","ENSOART00000014189","GO:0006811(ion transport);GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0006885(regulation of pH);GO:0008104(protein localization);GO:0015297(antiporter activity);GO:0015299(solute:proton antiporter activity);GO:0015385(sodium:proton antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035725(sodium ion transmembrane transport);GO:0055085(transmembrane transport);GO:1902600(proton transmembrane transport)","NA","K14722","NA","solute carrier family 9 member A2 [Source:NCBI gene;Acc:101108738]",{"v":5.794853,"d":"5.79"},{"v":5.886344,"d":"5.89"},{"v":4.64395,"d":"4.64"},{"v":3.914211,"d":"3.91"},{"v":3.747395,"d":"3.75"},{"v":3.196521,"d":"3.20"},{"v":1.50349567655637,"d":"1.50"},{"v":0.588320719312215,"d":"0.59"},{"v":0.0379433291690146,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"up","no"]
["MSTRG.13264","ENSOARG00000001222","ENSOART00000001303","GO:0006955(immune response)","NA","NA","NA",null,{"v":2.6225197018393,"d":"2.62"},{"v":1.07883939593417,"d":"1.08"},{"v":0.686629177153921,"d":"0.69"},{"v":0.81733317231365,"d":"0.82"},{"v":0.39073,"d":"0.39"},{"v":0.907326690222652,"d":"0.91"},{"v":2.07431658468208,"d":"2.07"},{"v":1.05263609680078,"d":"1.05"},{"v":0.0379454245182171,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"up","yes"]
["MSTRG.10973","ZNF436","ENSOART00000008260","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 436 [Source:NCBI gene;Acc:101121324]",{"v":1.5965923222,"d":"1.60"},{"v":1.6704945932,"d":"1.67"},{"v":2.0634320706,"d":"2.06"},{"v":2.946028586,"d":"2.95"},{"v":3.305033851,"d":"3.31"},{"v":2.7356207236,"d":"2.74"},{"v":0.593157552206849,"d":"0.59"},{"v":-0.753512736157256,"d":"-0.75"},{"v":0.037966816071642,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"down","no"]
["MSTRG.5709","LTBP4","ENSOART00000007426;ENSOART00000007430","GO:0005509(calcium ion binding);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030162(regulation of proteolysis);GO:0031012(extracellular matrix);GO:0046879(hormone secretion);GO:0050431(transforming growth factor beta binding);GO:0062023(collagen-containing extracellular matrix);GO:0062023(collagen-containing extracellular matrix)","NA","K08023","NA","latent transforming growth factor beta binding protein 4 [Source:NCBI gene;Acc:101120267]",{"v":14.8112247155186,"d":"14.81"},{"v":10.2400663072789,"d":"10.24"},{"v":15.7027457244748,"d":"15.70"},{"v":21.3124107941703,"d":"21.31"},{"v":21.9658043103729,"d":"21.97"},{"v":25.0030610411985,"d":"25.00"},{"v":0.596855229540315,"d":"0.60"},{"v":-0.74454705443953,"d":"-0.74"},{"v":0.0380210517856818,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"down","no"]
["MSTRG.12616","AFAP1L2","ENSOART00000016068","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006954(inflammatory response);GO:0007346(regulation of mitotic cell cycle);GO:0009966(regulation of signal transduction);GO:0017124(SH3 domain binding);GO:0030296(protein tyrosine kinase activator activity);GO:0032675(regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0035591(signaling adaptor activity);GO:0042169(SH2 domain binding);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated);GO:0061098(positive regulation of protein tyrosine kinase activity)","NA","NA","NA","actin filament associated protein 1 like 2 [Source:NCBI gene;Acc:101119095]",{"v":2.06962169522159,"d":"2.07"},{"v":1.33116628571429,"d":"1.33"},{"v":2.09375246521416,"d":"2.09"},{"v":3.14209402921515,"d":"3.14"},{"v":3.09152210027234,"d":"3.09"},{"v":3.16510025328052,"d":"3.17"},{"v":0.584605410183879,"d":"0.58"},{"v":-0.774464914376075,"d":"-0.77"},{"v":0.0380355148125115,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"down","no"]
["MSTRG.17806","ACP5","ENSOART00000020326","GO:0003993(acid phosphatase activity);GO:0005764(lysosome);GO:0008198(ferrous iron binding);GO:0008199(ferric iron binding);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0032496(response to lipopolysaccharide);GO:0032691(negative regulation of interleukin-1 beta production);GO:0032695(negative regulation of interleukin-12 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032929(negative regulation of superoxide anion generation);GO:0034097(response to cytokine);GO:0045019(negative regulation of nitric oxide biosynthetic process);GO:0045453(bone resorption);GO:0046872(metal ion binding);GO:0050728(negative regulation of inflammatory response);GO:0050830(defense response to Gram-positive bacterium);GO:0060349(bone morphogenesis)","00740(Riboflavin metabolism);04142(Lysosome);04380(Osteoclast differentiation);05323(Rheumatoid arthritis)","K14379","EC:3.1.3.2","acid phosphatase 5, tartrate resistant [Source:NCBI gene;Acc:100820744]",{"v":3.644001,"d":"3.64"},{"v":2.642492,"d":"2.64"},{"v":2.110304,"d":"2.11"},{"v":4.159016,"d":"4.16"},{"v":4.721558,"d":"4.72"},{"v":6.316178,"d":"6.32"},{"v":0.552538924106941,"d":"0.55"},{"v":-0.855851994839327,"d":"-0.86"},{"v":0.0381080730591611,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"down","no"]
["MSTRG.18153","ENSOARG00000011763","ENSOART00000012792","GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation);GO:0015935(small ribosomal subunit)","NA","NA","NA",null,{"v":50.135635,"d":"50.14"},{"v":28.607744,"d":"28.61"},{"v":47.53413,"d":"47.53"},{"v":45.771996,"d":"45.77"},{"v":78.541008,"d":"78.54"},{"v":108.164124,"d":"108.16"},{"v":0.54318250610873,"d":"0.54"},{"v":-0.880491078405958,"d":"-0.88"},{"v":0.0381211174596065,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"down","no"]
["MSTRG.9748","PHF24","ENSOART00000013309","GO:0046872(metal ion binding)","NA","NA","NA","PHD finger protein 24 [Source:NCBI gene;Acc:101119613]",{"v":2.118429,"d":"2.12"},{"v":1.252619,"d":"1.25"},{"v":1.912751,"d":"1.91"},{"v":3.749081,"d":"3.75"},{"v":3.580059,"d":"3.58"},{"v":2.54999,"d":"2.55"},{"v":0.534844566272536,"d":"0.53"},{"v":-0.902808410941567,"d":"-0.90"},{"v":0.0381224833269506,"d":"0.04"},{"v":0.356304469240097,"d":"0.36"},"down","no"]
["MSTRG.11461","ENSOARG00000009236","ENSOART00000010055","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 1 [Source:NCBI gene;Acc:101102344]",{"v":2.515821,"d":"2.52"},{"v":1.017453,"d":"1.02"},{"v":2.318081,"d":"2.32"},{"v":3.779013,"d":"3.78"},{"v":3.002034,"d":"3.00"},{"v":6.063055,"d":"6.06"},{"v":0.455567465907698,"d":"0.46"},{"v":-1.13426337341106,"d":"-1.13"},{"v":0.0381533727315857,"d":"0.04"},{"v":0.356389170458427,"d":"0.36"},"down","yes"]
["MSTRG.18384","PDGFRB","ENSOART00000007111","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005019(platelet-derived growth factor beta-receptor activity);GO:0005102(signaling receptor binding);GO:0005161(platelet-derived growth factor receptor binding);GO:0005524(ATP binding);GO:0005764(lysosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006935(chemotaxis);GO:0007165(signal transduction);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007275(multicellular organism development);GO:0008284(positive regulation of cell population proliferation);GO:0010863(positive regulation of phospholipase C activity);GO:0014911(positive regulation of smooth muscle cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030335(positive regulation of cell migration);GO:0031226(intrinsic component of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0035791(platelet-derived growth factor receptor-beta signaling pathway);GO:0038085(vascular endothelial growth factor binding);GO:0038091(positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway);GO:0043202(lysosomal lumen);GO:0043231(intracellular membrane-bounded organelle);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0046488(phosphatidylinositol metabolic process);GO:0046777(protein autophosphorylation);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048407(platelet-derived growth factor binding);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0060326(cell chemotaxis);GO:0070374(positive regulation of ERK1 and ERK2 cascade)","01521(EGFR tyrosine kinase inhibitor resistance);04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04072(Phospholipase D signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04540(Gap junction);04630(Jak-STAT signaling pathway);04810(Regulation of actin cytoskeleton);05165(Human papillomavirus infection);05200(Pathways in cancer);05206(MicroRNAs in cancer);05214(Glioma);05215(Prostate cancer);05218(Melanoma);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer)","K05089","EC:2.7.10.1","platelet derived growth factor receptor beta [Source:NCBI gene;Acc:101122783]",{"v":13.9601701220829,"d":"13.96"},{"v":9.61111324667309,"d":"9.61"},{"v":9.91324820135005,"d":"9.91"},{"v":17.9901023218901,"d":"17.99"},{"v":19.482813533269,"d":"19.48"},{"v":18.8237951326905,"d":"18.82"},{"v":0.594786639974988,"d":"0.59"},{"v":-0.749555852773257,"d":"-0.75"},{"v":0.0382578919552125,"d":"0.04"},{"v":0.356691379419537,"d":"0.36"},"down","no"]
["MSTRG.14222","CXCL12","ENSOART00000003243","GO:0005178(integrin binding);GO:0005576(extracellular region);GO:0006935(chemotaxis);GO:0006952(defense response);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0033622(integrin activation);GO:0038146(chemokine (C-X-C motif) ligand 12 signaling pathway);GO:0042379(chemokine receptor binding);GO:0045236(CXCR chemokine receptor binding);GO:0045785(positive regulation of cell adhesion);GO:0060326(cell chemotaxis);GO:0070098(chemokine-mediated signaling pathway);GO:0090026(positive regulation of monocyte chemotaxis);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage);GO:1903237(negative regulation of leukocyte tethering or rolling);GO:1990869(cellular response to chemokine);GO:2000406(positive regulation of T cell migration);GO:2000669(negative regulation of dendritic cell apoptotic process)","NA","NA","NA","C-X-C motif chemokine ligand 12 [Source:HGNC Symbol;Acc:HGNC:10672]",{"v":5.64833337790128,"d":"5.65"},{"v":5.55659211850278,"d":"5.56"},{"v":6.79501955148741,"d":"6.80"},{"v":12.5655979091206,"d":"12.57"},{"v":9.01706472278522,"d":"9.02"},{"v":9.22386274419745,"d":"9.22"},{"v":0.584290010903148,"d":"0.58"},{"v":-0.775243469892755,"d":"-0.78"},{"v":0.0382998281015184,"d":"0.04"},{"v":0.356691379419537,"d":"0.36"},"down","no"]
["MSTRG.12099","LTBP3","ENSOART00000016578","GO:0005509(calcium ion binding);GO:0036363(transforming growth factor beta activation);GO:0050431(transforming growth factor beta binding);GO:0062023(collagen-containing extracellular matrix);GO:1902462(positive regulation of mesenchymal stem cell proliferation);GO:2000741(positive regulation of mesenchymal stem cell differentiation)","NA","K08023","NA","latent transforming growth factor beta binding protein 3 [Source:NCBI gene;Acc:101122993]",{"v":3.72338259279712,"d":"3.72"},{"v":2.5172426060024,"d":"2.52"},{"v":4.24594308883553,"d":"4.25"},{"v":4.80283205042017,"d":"4.80"},{"v":6.93807059759904,"d":"6.94"},{"v":6.55274151668667,"d":"6.55"},{"v":0.573235610861334,"d":"0.57"},{"v":-0.802799858599895,"d":"-0.80"},{"v":0.038445116490303,"d":"0.04"},{"v":0.357274821885981,"d":"0.36"},"down","no"]
["MSTRG.8764","ITGA9","ENSOART00000000540","GO:0007155(cell adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009925(basal plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030593(neutrophil chemotaxis)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04514(Cell adhesion molecules (CAMs));04810(Regulation of actin cytoskeleton);05165(Human papillomavirus infection);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","K06585","NA","integrin subunit alpha 9 [Source:NCBI gene;Acc:101109832]",{"v":2.045229,"d":"2.05"},{"v":1.332313,"d":"1.33"},{"v":2.026747,"d":"2.03"},{"v":3.131203,"d":"3.13"},{"v":2.814703,"d":"2.81"},{"v":3.226791,"d":"3.23"},{"v":0.589171211040766,"d":"0.59"},{"v":-0.7632411579003,"d":"-0.76"},{"v":0.0385582800919953,"d":"0.04"},{"v":0.357919043400852,"d":"0.36"},"down","no"]
["MSTRG.13307","PPL","ENSOART00000004934","GO:0005856(cytoskeleton);GO:0009612(response to mechanical stimulus)","NA","K10386","NA","periplakin [Source:NCBI gene;Acc:101104034]",{"v":1.08649868751074,"d":"1.09"},{"v":1.64606935406288,"d":"1.65"},{"v":3.26239519515547,"d":"3.26"},{"v":0.822481271087442,"d":"0.82"},{"v":1.45385725219035,"d":"1.45"},{"v":1.09223843824085,"d":"1.09"},{"v":1.77967233796743,"d":"1.78"},{"v":0.831611645740218,"d":"0.83"},{"v":0.0387116813344275,"d":"0.04"},{"v":0.35852769871159,"d":"0.36"},"up","no"]
["MSTRG.15791","HDAC7","ENSOART00000021105","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001570(vasculogenesis);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0004407(histone deacetylase activity);GO:0005080(protein kinase C binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0007043(cell-cell junction assembly);GO:0016575(histone deacetylation);GO:0016787(hydrolase activity);GO:0019901(protein kinase binding);GO:0032041(NAD-dependent histone deacetylase activity (H3-K14 specific));GO:0032703(negative regulation of interleukin-2 production);GO:0033613(activating transcription factor binding);GO:0045668(negative regulation of osteoblast differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0070491(repressing transcription factor binding);GO:0070932(histone H3 deacetylation);GO:0071889(14-3-3 protein binding);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:1901223(negative regulation of NIK/NF-kappaB signaling)","05034(Alcoholism);05203(Viral carcinogenesis)","K11408","EC:3.5.1.98","histone deacetylase 7 [Source:NCBI gene;Acc:101107515]",{"v":4.10377367997025,"d":"4.10"},{"v":2.14019690580069,"d":"2.14"},{"v":1.87515130019831,"d":"1.88"},{"v":4.90067527887952,"d":"4.90"},{"v":5.54324373301934,"d":"5.54"},{"v":4.03333987481408,"d":"4.03"},{"v":0.560819002374882,"d":"0.56"},{"v":-0.834392861502532,"d":"-0.83"},{"v":0.0390608027452234,"d":"0.04"},{"v":0.361351154234566,"d":"0.36"},"down","no"]
["MSTRG.4239","IVNS1ABP","ENSOART00000004824","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0008380(RNA splicing);GO:0009615(response to virus);GO:0015629(actin cytoskeleton);GO:0031397(negative regulation of protein ubiquitination);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","05164(Influenza A)","K15046","NA","influenza virus NS1A binding protein [Source:NCBI gene;Acc:101108935]",{"v":20.3876596017234,"d":"20.39"},{"v":26.3242479932788,"d":"26.32"},{"v":13.3630386560103,"d":"13.36"},{"v":16.1883450937527,"d":"16.19"},{"v":12.7268893883671,"d":"12.73"},{"v":10.0899787541577,"d":"10.09"},{"v":1.54017735750099,"d":"1.54"},{"v":0.62309649251381,"d":"0.62"},{"v":0.0391636440862314,"d":"0.04"},{"v":0.361377650269263,"d":"0.36"},"up","no"]
["MSTRG.11961","FADS1","ENSOART00000014960","GO:0006629(lipid metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","01040(Biosynthesis of unsaturated fatty acids)","K10224","EC:1.14.19.44","fatty acid desaturase 1 [Source:NCBI gene;Acc:101109049]",{"v":4.08828593722195,"d":"4.09"},{"v":1.92524078423134,"d":"1.93"},{"v":3.86723250667326,"d":"3.87"},{"v":7.21028520860109,"d":"7.21"},{"v":4.91281102496293,"d":"4.91"},{"v":5.41283377706377,"d":"5.41"},{"v":0.563457953022066,"d":"0.56"},{"v":-0.827620138846296,"d":"-0.83"},{"v":0.0391739034128099,"d":"0.04"},{"v":0.361377650269263,"d":"0.36"},"down","no"]
["ENSOARG00000002728","PEX16","ENSOART00000002955","GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0005779(integral component of peroxisomal membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006625(protein targeting to peroxisome);GO:0007031(peroxisome organization);GO:0008022(protein C-terminus binding);GO:0016557(peroxisome membrane biogenesis);GO:0016558(protein import into peroxisome matrix);GO:0022615(protein to membrane docking);GO:0032581(ER-dependent peroxisome organization);GO:0045046(protein import into peroxisome membrane);GO:0106101(ER-dependent peroxisome localization)","04146(Peroxisome)","K13335","NA","peroxisomal biogenesis factor 16 [Source:NCBI gene;Acc:101112845]",{"v":0.992883,"d":"0.99"},{"v":0.982638,"d":"0.98"},{"v":0.803446,"d":"0.80"},{"v":1.719866,"d":"1.72"},{"v":1.898866,"d":"1.90"},{"v":1.837399,"d":"1.84"},{"v":0.509329229815047,"d":"0.51"},{"v":-0.973329580677332,"d":"-0.97"},{"v":0.0391742918098328,"d":"0.04"},{"v":0.361377650269263,"d":"0.36"},"down","no"]
["ENSOARG00000012921","ACSM1","ENSOART00000014044","GO:0003824(catalytic activity);GO:0003996(acyl-CoA ligase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006633(fatty acid biosynthetic process);GO:0015645(fatty acid ligase activity);GO:0047760(butyrate-CoA ligase activity)","00650(Butanoate metabolism)","K01896","EC:6.2.1.2","acyl-CoA synthetase medium chain family member 1 [Source:NCBI gene;Acc:101120375]",{"v":0.519673,"d":"0.52"},{"v":0.885983,"d":"0.89"},{"v":0.553903,"d":"0.55"},{"v":0.025602,"d":"0.03"},{"v":0.402491,"d":"0.40"},{"v":0.295102,"d":"0.30"},{"v":2.70958593463727,"d":"2.71"},{"v":1.43807240298629,"d":"1.44"},{"v":0.0391743288202227,"d":"0.04"},{"v":0.361377650269263,"d":"0.36"},"up","yes"]
["MSTRG.14242","GPM6A","ENSOART00000007083","GO:0001764(neuron migration);GO:0003407(neural retina development);GO:0009617(response to bacterium);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0044295(axonal growth cone);GO:0048812(neuron projection morphogenesis);GO:0048863(stem cell differentiation)","NA","NA","NA","glycoprotein M6A [Source:NCBI gene;Acc:101106904]",{"v":0.753700989800443,"d":"0.75"},{"v":0.722977155654102,"d":"0.72"},{"v":0.656396286474501,"d":"0.66"},{"v":1.47346211529933,"d":"1.47"},{"v":0.870450411529933,"d":"0.87"},{"v":1.78659654101996,"d":"1.79"},{"v":0.516419258955833,"d":"0.52"},{"v":-0.953385290442928,"d":"-0.95"},{"v":0.0393114203359679,"d":"0.04"},{"v":0.362028692185947,"d":"0.36"},"down","no"]
["MSTRG.10463","RALB","ENSOART00000014103;ENSOART00000014102","GO:0000166(nucleotide binding);GO:0001934(positive regulation of protein phosphorylation);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0009267(cellular response to starvation);GO:0016020(membrane);GO:0019003(GDP binding);GO:0030496(midbody);GO:0031625(ubiquitin protein ligase binding);GO:0032091(negative regulation of protein binding);GO:0032092(positive regulation of protein binding);GO:0051117(ATPase binding);GO:0071360(cellular response to exogenous dsRNA);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000786(positive regulation of autophagosome assembly);GO:2000786(positive regulation of autophagosome assembly)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04072(Phospholipase D signaling pathway);05200(Pathways in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05212(Pancreatic cancer)","K07835","NA","RAS like proto-oncogene B [Source:NCBI gene;Acc:101113566]",{"v":2.85156086589936,"d":"2.85"},{"v":2.95897841046574,"d":"2.96"},{"v":3.31498993495717,"d":"3.31"},{"v":1.4509877873394,"d":"1.45"},{"v":1.75886657855996,"d":"1.76"},{"v":2.52499298808887,"d":"2.52"},{"v":1.59124186713985,"d":"1.59"},{"v":0.670153140510302,"d":"0.67"},{"v":0.0393476834396076,"d":"0.04"},{"v":0.362158385119455,"d":"0.36"},"up","no"]
["MSTRG.10995","ENSOARG00000018515","ENSOART00000020154","GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA","SCAN domain-containing protein 1-like [Source:NCBI gene;Acc:101103215]",{"v":46.274342,"d":"46.27"},{"v":44.018414,"d":"44.02"},{"v":37.272018,"d":"37.27"},{"v":69.353111,"d":"69.35"},{"v":61.927898,"d":"61.93"},{"v":85.758492,"d":"85.76"},{"v":0.58774911208444,"d":"0.59"},{"v":-0.766727640494123,"d":"-0.77"},{"v":0.0394066126541937,"d":"0.04"},{"v":0.362169562152651,"d":"0.36"},"down","no"]
["MSTRG.19035","PARM1","ENSOART00000016575;ENSOART00000016576","GO:0005634(nucleus);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0043231(intracellular membrane-bounded organelle)","NA","NA","NA","prostate androgen-regulated mucin-like protein 1 [Source:NCBI gene;Acc:101104239]",{"v":0.711881488203267,"d":"0.71"},{"v":0.846307249546279,"d":"0.85"},{"v":0.727909704174229,"d":"0.73"},{"v":1.29957228402904,"d":"1.30"},{"v":1.37255049092559,"d":"1.37"},{"v":1.97739391742287,"d":"1.98"},{"v":0.491685177874863,"d":"0.49"},{"v":-1.02419322992355,"d":"-1.02"},{"v":0.0394269038619333,"d":"0.04"},{"v":0.362169562152651,"d":"0.36"},"down","yes"]
["MSTRG.17334","BRAF","ENSOART00000014779;ENSOART00000014782","GO:0000166(nucleotide binding);GO:0002318(myeloid progenitor cell differentiation);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0008542(visual learning);GO:0010628(positive regulation of gene expression);GO:0010764(negative regulation of fibroblast migration);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030154(cell differentiation);GO:0030878(thyroid gland development);GO:0035019(somatic stem cell population maintenance);GO:0035556(intracellular signal transduction);GO:0035690(cellular response to drug);GO:0042127(regulation of cell population proliferation);GO:0043005(neuron projection);GO:0043367(CD4-positive, alpha-beta T cell differentiation);GO:0043368(positive T cell selection);GO:0043369(CD4-positive or CD8-positive, alpha-beta T cell lineage commitment);GO:0043524(negative regulation of neuron apoptotic process);GO:0044297(cell body);GO:0045580(regulation of T cell differentiation);GO:0046632(alpha-beta T cell differentiation);GO:0046872(metal ion binding);GO:0048538(thymus development);GO:0048679(regulation of axon regeneration);GO:0048680(positive regulation of axon regeneration);GO:0050772(positive regulation of axonogenesis);GO:0050852(T cell receptor signaling pathway);GO:0051496(positive regulation of stress fiber assembly);GO:0060291(long-term synaptic potentiation);GO:0060323(head morphogenesis);GO:0060324(face development);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:2000301(negative regulation of synaptic vesicle exocytosis);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:2000352(negative regulation of endothelial cell apoptotic process)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04068(FoxO signaling pathway);04150(mTOR signaling pathway);04270(Vascular smooth muscle contraction);04510(Focal adhesion);04650(Natural killer cell mediated cytotoxicity);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04726(Serotonergic synapse);04730(Long-term depression);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04914(Progesterone-mediated oocyte maturation);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);05034(Alcoholism);05160(Hepatitis C);05161(Hepatitis B);05200(Pathways in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05216(Thyroid cancer);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05226(Gastric cancer)","K04365","EC:2.7.11.1","B-Raf proto-oncogene, serine/threonine kinase [Source:NCBI gene;Acc:101107438]",{"v":5.1659107754288,"d":"5.17"},{"v":5.80075334264061,"d":"5.80"},{"v":6.01912283765457,"d":"6.02"},{"v":3.68693105384922,"d":"3.69"},{"v":4.6707882576785,"d":"4.67"},{"v":2.98815176146789,"d":"2.99"},{"v":1.49708972069601,"d":"1.50"},{"v":0.582160684806126,"d":"0.58"},{"v":0.039437621356407,"d":"0.04"},{"v":0.362169562152651,"d":"0.36"},"up","no"]
["MSTRG.5784","BCAM","ENSOART00000010146","GO:0005055(laminin receptor activity);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0008022(protein C-terminus binding);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043236(laminin binding)","NA","K06578","NA","basal cell adhesion molecule (Lutheran blood group) [Source:NCBI gene;Acc:101111740]",{"v":22.408282892191,"d":"22.41"},{"v":18.0704305722415,"d":"18.07"},{"v":15.6950633876067,"d":"15.70"},{"v":30.0040727929181,"d":"30.00"},{"v":31.1386146607651,"d":"31.14"},{"v":33.2181601473285,"d":"33.22"},{"v":0.595308099494402,"d":"0.60"},{"v":-0.748291571727592,"d":"-0.75"},{"v":0.0394927738065978,"d":"0.04"},{"v":0.362472181401984,"d":"0.36"},"down","no"]
["MSTRG.2095","DNAJC15","ENSOART00000008091","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0009267(cellular response to starvation);GO:0019216(regulation of lipid metabolic process);GO:0031333(negative regulation of protein complex assembly);GO:1902957(negative regulation of mitochondrial electron transport, NADH to ubiquinone)","NA","NA","NA","DnaJ heat shock protein family (Hsp40) member C15 [Source:HGNC Symbol;Acc:HGNC:20325]",{"v":11.3255698042219,"d":"11.33"},{"v":10.7868803865894,"d":"10.79"},{"v":9.56563806167219,"d":"9.57"},{"v":8.89923222433775,"d":"8.90"},{"v":5.44244044370861,"d":"5.44"},{"v":6.8372637557947,"d":"6.84"},{"v":1.49573555623991,"d":"1.50"},{"v":0.580855131492503,"d":"0.58"},{"v":0.0396690919828511,"d":"0.04"},{"v":0.363681602412124,"d":"0.36"},"up","no"]
["MSTRG.16804","GLCCI1","ENSOART00000006362","NA","NA","NA","NA","glucocorticoid induced 1 [Source:NCBI gene;Acc:101116138]",{"v":0.788553,"d":"0.79"},{"v":0.408308,"d":"0.41"},{"v":0.767345,"d":"0.77"},{"v":1.594668,"d":"1.59"},{"v":1.530336,"d":"1.53"},{"v":0.957333,"d":"0.96"},{"v":0.48114744079188,"d":"0.48"},{"v":-1.05544903975974,"d":"-1.06"},{"v":0.0398942876502196,"d":"0.04"},{"v":0.36531301299996,"d":"0.37"},"down","yes"]
["MSTRG.15865","PTPRR","ENSOART00000021897","GO:0001701(in utero embryonic development);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0010633(negative regulation of epithelial cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0030054(cell junction);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0038128(ERBB2 signaling pathway);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","04010(MAPK signaling pathway)","K04458","EC:3.1.3.48","protein tyrosine phosphatase, receptor type R [Source:NCBI gene;Acc:101121162]",{"v":0.763701,"d":"0.76"},{"v":0.511585,"d":"0.51"},{"v":0.777115,"d":"0.78"},{"v":1.274402,"d":"1.27"},{"v":1.034881,"d":"1.03"},{"v":1.577484,"d":"1.58"},{"v":0.528048375423585,"d":"0.53"},{"v":-0.921257991465049,"d":"-0.92"},{"v":0.0399715480407863,"d":"0.04"},{"v":0.365633297708661,"d":"0.37"},"down","no"]
["MSTRG.1193","NRIP1","ENSOART00000001241","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001543(ovarian follicle rupture);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0016607(nuclear speck);GO:0019915(lipid storage);GO:0030331(estrogen receptor binding);GO:0030728(ovulation);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0035259(glucocorticoid receptor binding);GO:0042826(histone deacetylase binding);GO:0042974(retinoic acid receptor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046965(retinoid X receptor binding);GO:0071392(cellular response to estradiol stimulus)","NA","K17965","NA","nuclear receptor interacting protein 1 [Source:NCBI gene;Acc:101117463]",{"v":12.4606031424483,"d":"12.46"},{"v":10.5425355917329,"d":"10.54"},{"v":12.8747034559618,"d":"12.87"},{"v":9.9075638591415,"d":"9.91"},{"v":7.24785218569157,"d":"7.25"},{"v":7.19407403751987,"d":"7.19"},{"v":1.47345353306372,"d":"1.47"},{"v":0.559201564245032,"d":"0.56"},{"v":0.0400821098538911,"d":"0.04"},{"v":0.366178909389756,"d":"0.37"},"up","no"]
["MSTRG.2645","CA4","ENSOART00000019455","GO:0004089(carbonate dehydratase activity);GO:0005791(rough endoplasmic reticulum);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0009986(cell surface);GO:0015701(bicarbonate transport);GO:0016324(apical plasma membrane);GO:0030658(transport vesicle membrane);GO:0030667(secretory granule membrane);GO:0031225(anchored component of membrane);GO:0031362(anchored component of external side of plasma membrane);GO:0031526(brush border membrane);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome)","00910(Nitrogen metabolism);04964(Proximal tubule bicarbonate reclamation)","K18246","EC:4.2.1.1","carbonic anhydrase 4 [Source:NCBI gene;Acc:101109718]",{"v":1.5148695274554,"d":"1.51"},{"v":1.88746743842023,"d":"1.89"},{"v":0.841745911484497,"d":"0.84"},{"v":1.74205459743634,"d":"1.74"},{"v":3.20843265511866,"d":"3.21"},{"v":2.92325994508921,"d":"2.92"},{"v":0.539016909081097,"d":"0.54"},{"v":-0.891597563533316,"d":"-0.89"},{"v":0.0403193172899043,"d":"0.04"},{"v":0.367168886062218,"d":"0.37"},"down","no"]
["MSTRG.1756","AGTR1","ENSOART00000016737","GO:0004930(G protein-coupled receptor activity);GO:0004945(angiotensin type II receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019229(regulation of vasoconstriction);GO:0038166(angiotensin-activated signaling pathway)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04072(Phospholipase D signaling pathway);04080(Neuroactive ligand-receptor interaction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04614(Renin-angiotensin system);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome);05200(Pathways in cancer)","K04166","NA","angiotensin II receptor type 1 [Source:NCBI gene;Acc:443107]",{"v":3.86935216758591,"d":"3.87"},{"v":2.17510335511243,"d":"2.18"},{"v":3.76539926347051,"d":"3.77"},{"v":6.09137577938057,"d":"6.09"},{"v":4.85868021977089,"d":"4.86"},{"v":6.01365819643615,"d":"6.01"},{"v":0.578284606370017,"d":"0.58"},{"v":-0.790148396032815,"d":"-0.79"},{"v":0.0404283702140649,"d":"0.04"},{"v":0.367660095047976,"d":"0.37"},"down","no"]
["MSTRG.12392","PPP1R3C","ENSOART00000017667","GO:0005515(protein binding);GO:0005975(carbohydrate metabolic process);GO:0005977(glycogen metabolic process);GO:0005978(glycogen biosynthetic process);GO:0019888(protein phosphatase regulator activity);GO:0019903(protein phosphatase binding);GO:0043666(regulation of phosphoprotein phosphatase activity)","04910(Insulin signaling pathway);04931(Insulin resistance)","K07189","NA","protein phosphatase 1 regulatory subunit 3C [Source:NCBI gene;Acc:101123512]",{"v":103.499699551661,"d":"103.50"},{"v":83.6116181691653,"d":"83.61"},{"v":44.7372180332253,"d":"44.74"},{"v":69.8202378995138,"d":"69.82"},{"v":29.4737009655592,"d":"29.47"},{"v":42.4470702220421,"d":"42.45"},{"v":1.63571952286269,"d":"1.64"},{"v":0.709925390293594,"d":"0.71"},{"v":0.0404421537462083,"d":"0.04"},{"v":0.367660095047976,"d":"0.37"},"up","no"]
["MSTRG.17650","RAB8A","ENSOART00000000668","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0006904(vesicle docking involved in exocytosis);GO:0010506(regulation of autophagy);GO:0019003(GDP binding);GO:0030140(trans-Golgi network transport vesicle);GO:0030496(midbody);GO:0031489(myosin V binding);GO:0036064(ciliary basal body);GO:0045335(phagocytic vesicle);GO:0048210(Golgi vesicle fusion to target membrane);GO:0055037(recycling endosome);GO:0055038(recycling endosome membrane);GO:0060271(cilium assembly);GO:0097546(ciliary base);GO:0097730(non-motile cilium)","04144(Endocytosis);04152(AMPK signaling pathway);04530(Tight junction);04972(Pancreatic secretion)","K07901","NA","RAB8A, member RAS oncogene family [Source:NCBI gene;Acc:100302063]",{"v":3.590582,"d":"3.59"},{"v":2.36551,"d":"2.37"},{"v":2.280513,"d":"2.28"},{"v":5.116596,"d":"5.12"},{"v":5.064583,"d":"5.06"},{"v":4.713925,"d":"4.71"},{"v":0.552973983934587,"d":"0.55"},{"v":-0.854716488082832,"d":"-0.85"},{"v":0.0404858433914907,"d":"0.04"},{"v":0.367660095047976,"d":"0.37"},"down","no"]
["MSTRG.9002","APPL1","ENSOART00000015821","GO:0001726(ruffle);GO:0001786(phosphatidylserine binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006606(protein import into nucleus);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008283(cell population proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010008(endosome membrane);GO:0010762(regulation of fibroblast migration);GO:0012506(vesicle membrane);GO:0016020(membrane);GO:0031410(cytoplasmic vesicle);GO:0032009(early phagosome);GO:0033211(adiponectin-activated signaling pathway);GO:0034143(regulation of toll-like receptor 4 signaling pathway);GO:0035091(phosphatidylinositol binding);GO:0035729(cellular response to hepatocyte growth factor stimulus);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043422(protein kinase B binding);GO:0044354(macropinosome);GO:0044877(protein-containing complex binding);GO:0045088(regulation of innate immune response);GO:0046324(regulation of glucose import);GO:0046326(positive regulation of glucose import);GO:0048023(positive regulation of melanin biosynthetic process);GO:0048487(beta-tubulin binding);GO:0097708(intracellular vesicle);GO:1900017(positive regulation of cytokine production involved in inflammatory response);GO:1903076(regulation of protein localization to plasma membrane);GO:1905303(positive regulation of macropinocytosis);GO:1905450(negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis)","04211(Longevity regulating pathway);05200(Pathways in cancer);05210(Colorectal cancer)","K08733","NA","adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 [Source:NCBI gene;Acc:101109218]",{"v":5.827330656852,"d":"5.83"},{"v":6.06550385262334,"d":"6.07"},{"v":4.91134037086923,"d":"4.91"},{"v":4.00238929350039,"d":"4.00"},{"v":4.00235051620987,"d":"4.00"},{"v":3.33698944275646,"d":"3.34"},{"v":1.48162370184333,"d":"1.48"},{"v":0.567179082988816,"d":"0.57"},{"v":0.040554506263635,"d":"0.04"},{"v":0.368078920662942,"d":"0.37"},"up","no"]
["MSTRG.19894","ENSOARG00000020986","ENSOART00000022864","GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0019783(ubiquitin-like protein-specific protease activity);GO:0032464(positive regulation of protein homooligomerization);GO:0032741(positive regulation of interleukin-18 production);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0050718(positive regulation of interleukin-1 beta secretion);GO:1900227(positive regulation of NLRP3 inflammasome complex assembly);GO:2001056(positive regulation of cysteine-type endopeptidase activity)","NA","NA","NA","ubiquitin specific peptidase 50 [Source:NCBI gene;Acc:101106690]",{"v":0.667268,"d":"0.67"},{"v":1.140242,"d":"1.14"},{"v":0.938756,"d":"0.94"},{"v":0.550194,"d":"0.55"},{"v":0.483651,"d":"0.48"},{"v":0.444347,"d":"0.44"},{"v":1.85785473064392,"d":"1.86"},{"v":0.893637698936331,"d":"0.89"},{"v":0.0405936561569636,"d":"0.04"},{"v":0.368229565406056,"d":"0.37"},"up","no"]
["MSTRG.17607","MAP1S","ENSOART00000016919","GO:0000226(microtubule cytoskeleton organization);GO:0001578(microtubule bundle formation);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0005874(microtubule);GO:0006915(apoptotic process);GO:0008017(microtubule binding);GO:0010848(regulation of chromatin disassembly);GO:0015631(tubulin binding);GO:0030054(cell junction);GO:0042995(cell projection);GO:0045202(synapse);GO:0048471(perinuclear region of cytoplasm);GO:0048487(beta-tubulin binding);GO:0048812(neuron projection morphogenesis);GO:0051015(actin filament binding)","NA","K10429","NA","microtubule associated protein 1S [Source:NCBI gene;Acc:101113329]",{"v":1.37335801262878,"d":"1.37"},{"v":1.25068001927551,"d":"1.25"},{"v":1.36825788700565,"d":"1.37"},{"v":2.26792301628448,"d":"2.27"},{"v":2.44218916384181,"d":"2.44"},{"v":2.18743772748421,"d":"2.19"},{"v":0.578799134821046,"d":"0.58"},{"v":-0.788865329531754,"d":"-0.79"},{"v":0.0406991372461483,"d":"0.04"},{"v":0.368870026125217,"d":"0.37"},"down","no"]
["MSTRG.3046","ENSOARG00000018391","ENSOART00000020014;ENSOART00000020015","GO:0005515(protein binding);GO:0005515(protein binding)","NA","NA","NA","GRB2 related adaptor protein [Source:NCBI gene;Acc:101110605]",{"v":0.762058749226006,"d":"0.76"},{"v":0.596347120743034,"d":"0.60"},{"v":0.361970563467492,"d":"0.36"},{"v":1.34739392776058,"d":"1.35"},{"v":1.04615878224974,"d":"1.05"},{"v":1.2586520123839,"d":"1.26"},{"v":0.471051478272207,"d":"0.47"},{"v":-1.08604336330882,"d":"-1.09"},{"v":0.0408549729997159,"d":"0.04"},{"v":0.369368770287575,"d":"0.37"},"down","yes"]
["MSTRG.7718","ENSOARG00000012429","ENSOART00000013515","GO:0003774(motor activity);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0007017(microtubule-based process);GO:0030286(dynein complex)","04962(Vasopressin-regulated water reabsorption)","K10418","NA","dynein light chain LC8-type 1 [Source:NCBI gene;Acc:101118902]",{"v":42.9333493032544,"d":"42.93"},{"v":46.3938476745562,"d":"46.39"},{"v":57.3619402618343,"d":"57.36"},{"v":88.8836514097633,"d":"88.88"},{"v":66.5557076863905,"d":"66.56"},{"v":96.6885328653846,"d":"96.69"},{"v":0.581804480648345,"d":"0.58"},{"v":-0.781393687785245,"d":"-0.78"},{"v":0.040964029508614,"d":"0.04"},{"v":0.369945062951687,"d":"0.37"},"down","no"]
["MSTRG.6053","ISOC2","ENSOART00000001449","GO:0003824(catalytic activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0031648(protein destabilization)","NA","NA","NA","isochorismatase domain containing 2 [Source:NCBI gene;Acc:101120012]",{"v":4.638618,"d":"4.64"},{"v":5.076259,"d":"5.08"},{"v":3.888483,"d":"3.89"},{"v":7.695906,"d":"7.70"},{"v":7.026423,"d":"7.03"},{"v":8.993811,"d":"8.99"},{"v":0.573590811995544,"d":"0.57"},{"v":-0.801906180322143,"d":"-0.80"},{"v":0.0410897149558348,"d":"0.04"},{"v":0.37029761015939,"d":"0.37"},"down","no"]
["MSTRG.1549","FXR1","ENSOART00000022524;ENSOART00000022525","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0007517(muscle organ development);GO:0030424(axon);GO:0030425(dendrite);GO:0033592(RNA strand annealing activity);GO:0035770(ribonucleoprotein granule);GO:0042803(protein homodimerization activity);GO:0043034(costamere);GO:0043197(dendritic spine);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000637(positive regulation of gene silencing by miRNA);GO:2000637(positive regulation of gene silencing by miRNA)","03013(RNA transport);03013(RNA transport)","K15516","NA","FMR1 autosomal homolog 1 [Source:NCBI gene;Acc:101104706]",{"v":15.9277317009629,"d":"15.93"},{"v":28.3676597200428,"d":"28.37"},{"v":24.1851061175107,"d":"24.19"},{"v":14.067256985378,"d":"14.07"},{"v":14.6695267790656,"d":"14.67"},{"v":15.9204689092368,"d":"15.92"},{"v":1.53346866272579,"d":"1.53"},{"v":0.616798684640771,"d":"0.62"},{"v":0.0412004218761836,"d":"0.04"},{"v":0.370445005896034,"d":"0.37"},"up","no"]
["MSTRG.1577","ENSOARG00000014633","ENSOART00000015926","GO:0008270(zinc ion binding);GO:0016055(Wnt signaling pathway);GO:0016567(protein ubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0072572(poly-ADP-D-ribose binding)","NA","K15700","EC:2.3.2.27","E3 ubiquitin-protein ligase RNF146-B pseudogene [Source:NCBI gene;Acc:101113032]",{"v":0.540204,"d":"0.54"},{"v":0.787679,"d":"0.79"},{"v":0.405162,"d":"0.41"},{"v":2.366004,"d":"2.37"},{"v":0.650563,"d":"0.65"},{"v":1.134778,"d":"1.13"},{"v":0.417465905628176,"d":"0.42"},{"v":-1.26026971715619,"d":"-1.26"},{"v":0.0412135476082615,"d":"0.04"},{"v":0.370445005896034,"d":"0.37"},"down","yes"]
["MSTRG.1874","ENSOARG00000009775","ENSOART00000010634","NA","NA","NA","NA","SH3 domain binding glutamate rich protein [Source:NCBI gene;Acc:101123341]",{"v":127.37059,"d":"127.37"},{"v":179.118759,"d":"179.12"},{"v":113.65564,"d":"113.66"},{"v":96.93959,"d":"96.94"},{"v":93.895226,"d":"93.90"},{"v":90.0858,"d":"90.09"},{"v":1.49560041189715,"d":"1.50"},{"v":0.58072477363547,"d":"0.58"},{"v":0.0412245236082538,"d":"0.04"},{"v":0.370445005896034,"d":"0.37"},"up","no"]
["MSTRG.1595","ENSOARG00000014665","ENSOART00000015960","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0015934(large ribosomal subunit)","NA","NA","NA",null,{"v":74.81456,"d":"74.81"},{"v":44.293541,"d":"44.29"},{"v":35.570278,"d":"35.57"},{"v":84.388885,"d":"84.39"},{"v":94.003265,"d":"94.00"},{"v":87.191673,"d":"87.19"},{"v":0.582408887908809,"d":"0.58"},{"v":-0.779895722791477,"d":"-0.78"},{"v":0.0412356179243995,"d":"0.04"},{"v":0.370445005896034,"d":"0.37"},"down","no"]
["MSTRG.10777","CAB39","ENSOART00000022520","GO:0004674(protein serine/threonine kinase activity);GO:0010800(positive regulation of peptidyl-threonine phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0019900(kinase binding);GO:0023014(signal transduction by protein phosphorylation);GO:0030295(protein kinase activator activity);GO:0032147(activation of protein kinase activity);GO:0035556(intracellular signal transduction);GO:0043539(protein serine/threonine kinase activator activity);GO:0071902(positive regulation of protein serine/threonine kinase activity)","04150(mTOR signaling pathway);04152(AMPK signaling pathway)","K08272","NA","calcium binding protein 39 [Source:NCBI gene;Acc:101106309]",{"v":31.195253,"d":"31.20"},{"v":36.873611,"d":"36.87"},{"v":26.902184,"d":"26.90"},{"v":24.23546,"d":"24.24"},{"v":20.543444,"d":"20.54"},{"v":19.580929,"d":"19.58"},{"v":1.47562607876873,"d":"1.48"},{"v":0.561327191148519,"d":"0.56"},{"v":0.0412996550697521,"d":"0.04"},{"v":0.370720598119248,"d":"0.37"},"up","no"]
["MSTRG.16854","CDCA7L","ENSOART00000012795;ENSOART00000012794","GO:0001650(fibrillar center);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0008284(positive regulation of cell population proliferation);GO:0008284(positive regulation of cell population proliferation)","NA","NA","NA","cell division cycle associated 7 like [Source:NCBI gene;Acc:101108042]",{"v":2.98480903332113,"d":"2.98"},{"v":1.80434815452215,"d":"1.80"},{"v":1.77438817612596,"d":"1.77"},{"v":3.66313442804833,"d":"3.66"},{"v":3.91337491065544,"d":"3.91"},{"v":3.76769422702307,"d":"3.77"},{"v":0.578581416133879,"d":"0.58"},{"v":-0.789408109819066,"d":"-0.79"},{"v":0.0413635912728143,"d":"0.04"},{"v":0.370976086831762,"d":"0.37"},"down","no"]
["MSTRG.16530","ENSOARG00000016495","ENSOART00000017964","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02925","NA","ribosomal protein L3 [Source:NCBI gene;Acc:101106836]",{"v":46.2698591289641,"d":"46.27"},{"v":38.0431301479915,"d":"38.04"},{"v":41.9001464947146,"d":"41.90"},{"v":65.0345360338266,"d":"65.03"},{"v":67.0077109767442,"d":"67.01"},{"v":78.373703255814,"d":"78.37"},{"v":0.599826845882574,"d":"0.60"},{"v":-0.737382001898891,"d":"-0.74"},{"v":0.0414262442147298,"d":"0.04"},{"v":0.37124462982333,"d":"0.37"},"down","no"]
["ENSOARG00000017495","ALG14","ENSOART00000019039","GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane)","00510(N-Glycan biosynthesis)","K07441","EC:2.4.1.141","ALG14, UDP-N-acetylglucosaminyltransferase subunit [Source:NCBI gene;Acc:101108526]",{"v":0.274942,"d":"0.27"},{"v":0.128352,"d":"0.13"},{"v":0.185141,"d":"0.19"},{"v":0.349007,"d":"0.35"},{"v":0.38776,"d":"0.39"},{"v":0.430785,"d":"0.43"},{"v":0.503990400427561,"d":"0.50"},{"v":-0.988531840105515,"d":"-0.99"},{"v":0.04156186626207,"d":"0.04"},{"v":0.372087301385949,"d":"0.37"},"down","no"]
["MSTRG.9129","WDR6;P4HTM","ENSOART00000017206;ENSOART00000017250","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005506(iron ion binding);GO:0005509(calcium ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0031418(L-ascorbic acid binding);GO:0045646(regulation of erythrocyte differentiation);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","NA","K06711","EC:1.14.11.-","WD repeat domain 6 [Source:NCBI gene;Acc:101108523];prolyl 4-hydroxylase, transmembrane [Source:NCBI gene;Acc:101109046]",{"v":1.3418814388785,"d":"1.34"},{"v":1.19849273084112,"d":"1.20"},{"v":1.14712635028037,"d":"1.15"},{"v":2.36434454168224,"d":"2.36"},{"v":2.07315859514019,"d":"2.07"},{"v":1.77805433046729,"d":"1.78"},{"v":0.593269475731823,"d":"0.59"},{"v":-0.753240538186178,"d":"-0.75"},{"v":0.0415862613159802,"d":"0.04"},{"v":0.372087301385949,"d":"0.37"},"down","no"]
["ENSOARG00000016587","ESPL1","ENSOART00000018084","GO:0000070(mitotic sister chromatid segregation);GO:0000212(meiotic spindle organization);GO:0000278(mitotic cell cycle);GO:0005634(nucleus);GO:0005813(centrosome);GO:0006508(proteolysis);GO:0007059(chromosome segregation);GO:0007127(meiosis I);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0045143(homologous chromosome segregation)","04110(Cell cycle);04114(Oocyte meiosis);05166(Human T-cell leukemia virus 1 infection)","K02365","EC:3.4.22.49","extra spindle pole bodies like 1, separase [Source:NCBI gene;Acc:101105898]",{"v":0.234838,"d":"0.23"},{"v":0.086087,"d":"0.09"},{"v":0.131887,"d":"0.13"},{"v":0.557036,"d":"0.56"},{"v":0.208224,"d":"0.21"},{"v":0.24406,"d":"0.24"},{"v":0.448630761304641,"d":"0.45"},{"v":-1.15639954967462,"d":"-1.16"},{"v":0.0415918177473107,"d":"0.04"},{"v":0.372087301385949,"d":"0.37"},"down","yes"]
["ENSOARG00000001513","SLC26A11","ENSOART00000001625","GO:0005654(nucleoplasm);GO:0005765(lysosomal membrane);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0008271(secondary active sulfate transmembrane transporter activity);GO:0008272(sulfate transport);GO:0008509(anion transmembrane transporter activity);GO:0015116(sulfate transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport);GO:0098656(anion transmembrane transport);GO:1902358(sulfate transmembrane transport)","NA","K14708","NA","solute carrier family 26 member 11 [Source:NCBI gene;Acc:101120678]",{"v":0.663617,"d":"0.66"},{"v":0.532666,"d":"0.53"},{"v":0.874403,"d":"0.87"},{"v":1.250414,"d":"1.25"},{"v":1.272026,"d":"1.27"},{"v":1.374962,"d":"1.37"},{"v":0.53129905511415,"d":"0.53"},{"v":-0.912403947827069,"d":"-0.91"},{"v":0.0417827593671181,"d":"0.04"},{"v":0.373204913316441,"d":"0.37"},"down","no"]
["MSTRG.4702","ENSOARG00000010028;ENSOARG00000009642;ENSOARG00000010449;ENSOARG00000010355;ENSOARG00000010221","ENSOART00000010916;ENSOART00000010497;ENSOART00000011368;ENSOART00000011265;ENSOART00000011117","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0055114(oxidation-reduction process)","NA","NA","NA","dihydrodiol dehydrogenase 3-like [Source:NCBI gene;Acc:101107541];prostaglandin F synthase 1-like [Source:NCBI gene;Acc:101107119]",{"v":19.1020466252902,"d":"19.10"},{"v":19.867808069507,"d":"19.87"},{"v":8.35555793172197,"d":"8.36"},{"v":9.09073746988939,"d":"9.09"},{"v":9.96454095193227,"d":"9.96"},{"v":10.2319674645637,"d":"10.23"},{"v":1.6159051899284,"d":"1.62"},{"v":0.692342553267455,"d":"0.69"},{"v":0.0418049844718135,"d":"0.04"},{"v":0.373204913316441,"d":"0.37"},"up","no"]
["MSTRG.4340","ENSOARG00000018001","ENSOART00000019595","GO:0005515(protein binding)","NA","NA","NA","immunoglobulin-like and fibronectin type III domain containing 1 [Source:NCBI gene;Acc:101109031]",{"v":76.8304729048065,"d":"76.83"},{"v":75.3083775216396,"d":"75.31"},{"v":100.974285556076,"d":"100.97"},{"v":43.7134604102164,"d":"43.71"},{"v":66.4154339137536,"d":"66.42"},{"v":55.5504574876196,"d":"55.55"},{"v":1.52772891259475,"d":"1.53"},{"v":0.611388567488744,"d":"0.61"},{"v":0.0418725118443833,"d":"0.04"},{"v":0.373603482729557,"d":"0.37"},"up","no"]
["MSTRG.1061","DCAF6","ENSOART00000013518;ENSOART00000013517","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0030374(nuclear receptor transcription coactivator activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0080008(Cul4-RING E3 ubiquitin ligase complex);GO:0080008(Cul4-RING E3 ubiquitin ligase complex)","NA","K11795","NA","DDB1 and CUL4 associated factor 6 [Source:NCBI gene;Acc:101116363]",{"v":13.3291798621556,"d":"13.33"},{"v":15.6619440861579,"d":"15.66"},{"v":13.0941505358923,"d":"13.09"},{"v":10.3951426757959,"d":"10.40"},{"v":9.58605910230221,"d":"9.59"},{"v":8.79056015942506,"d":"8.79"},{"v":1.4627284410177,"d":"1.46"},{"v":0.548661954601513,"d":"0.55"},{"v":0.0420552007877559,"d":"0.04"},{"v":0.374684434971431,"d":"0.37"},"up","no"]
["MSTRG.20703","ESR1","ENSOART00000003629","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001093(TFIIB-class transcription factor binding);GO:0001223(transcription coactivator binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001547(antral ovarian follicle growth);GO:0002064(epithelial cell development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005496(steroid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008209(androgen metabolic process);GO:0008270(zinc ion binding);GO:0008584(male gonad development);GO:0010629(negative regulation of gene expression);GO:0017025(TBP-class protein binding);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030284(estrogen receptor activity);GO:0030331(estrogen receptor binding);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0032355(response to estradiol);GO:0032991(protein-containing complex);GO:0034056(estrogen response element binding);GO:0034121(regulation of toll-like receptor signaling pathway);GO:0035327(transcriptionally active chromatin);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043401(steroid hormone mediated signaling pathway);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043565(sequence-specific DNA binding);GO:0043627(response to estrogen);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045899(positive regulation of RNA polymerase II transcriptional preinitiation complex assembly);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048146(positive regulation of fibroblast proliferation);GO:0048863(stem cell differentiation);GO:0050727(regulation of inflammatory response);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051117(ATPase binding);GO:0060065(uterus development);GO:0060068(vagina development);GO:0060523(prostate epithelial cord elongation);GO:0060527(prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis);GO:0060687(regulation of branching involved in prostate gland morphogenesis);GO:0060745(mammary gland branching involved in pregnancy);GO:0060749(mammary gland alveolus development);GO:0060750(epithelial cell proliferation involved in mammary gland duct elongation);GO:0071168(protein localization to chromatin);GO:0071391(cellular response to estrogen stimulus);GO:0071392(cellular response to estradiol stimulus);GO:0097550(transcriptional preinitiation complex);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA)","01522(Endocrine resistance);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04961(Endocrine and other factor-regulated calcium reabsorption);05200(Pathways in cancer);05205(Proteoglycans in cancer);05224(Breast cancer)","K08550","NA","estrogen receptor 1 [Source:NCBI gene;Acc:443228]",{"v":9.97125972626644,"d":"9.97"},{"v":11.8453690892043,"d":"11.85"},{"v":15.4463993456179,"d":"15.45"},{"v":9.85854078799323,"d":"9.86"},{"v":7.50258113530408,"d":"7.50"},{"v":7.48363168980336,"d":"7.48"},{"v":1.49983488431295,"d":"1.50"},{"v":0.584803684258048,"d":"0.58"},{"v":0.0420625042444042,"d":"0.04"},{"v":0.374684434971431,"d":"0.37"},"up","no"]
["MSTRG.17835","ENSOARG00000003689","ENSOART00000004003","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA","uncharacterized LOC101103316 [Source:NCBI gene;Acc:101103316]",{"v":147.003184346269,"d":"147.00"},{"v":108.733063241791,"d":"108.73"},{"v":111.050288853731,"d":"111.05"},{"v":187.395235889552,"d":"187.40"},{"v":211.988393020896,"d":"211.99"},{"v":212.512208579104,"d":"212.51"},{"v":0.599426428436938,"d":"0.60"},{"v":-0.738345401869427,"d":"-0.74"},{"v":0.0421904177912989,"d":"0.04"},{"v":0.375553449370328,"d":"0.38"},"down","no"]
["MSTRG.20367","ENSOARG00000008072","ENSOART00000008789","GO:0005102(signaling receptor binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum)","NA","NA","NA","triadin [Source:NCBI gene;Acc:101119992]",{"v":6.46382509916771,"d":"6.46"},{"v":6.85707383395289,"d":"6.86"},{"v":5.58732199954767,"d":"5.59"},{"v":4.85089163328179,"d":"4.85"},{"v":4.48945969814626,"d":"4.49"},{"v":3.64047178722284,"d":"3.64"},{"v":1.45662726930628,"d":"1.46"},{"v":0.542631758996639,"d":"0.54"},{"v":0.0422060619545904,"d":"0.04"},{"v":0.375553449370328,"d":"0.38"},"up","no"]
["ENSOARG00000006106","CIITA","ENSOART00000006644","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006355(regulation of transcription, DNA-templated);GO:0034341(response to interferon-gamma);GO:0045892(negative regulation of transcription, DNA-templated)","04612(Antigen processing and presentation);05145(Toxoplasmosis);05152(Tuberculosis);05164(Influenza A);05340(Primary immunodeficiency)","K08060","NA","class II major histocompatibility complex transactivator [Source:NCBI gene;Acc:101106564]",{"v":0.198238,"d":"0.20"},{"v":0.074289,"d":"0.07"},{"v":0.115116,"d":"0.12"},{"v":0.294295,"d":"0.29"},{"v":0.245677,"d":"0.25"},{"v":0.294795,"d":"0.29"},{"v":0.464372693218587,"d":"0.46"},{"v":-1.1066449558372,"d":"-1.11"},{"v":0.0422996413215813,"d":"0.04"},{"v":0.375730640446584,"d":"0.38"},"down","yes"]
["MSTRG.9733","CCDC107","ENSOART00000012977","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","coiled-coil domain containing 107 [Source:NCBI gene;Acc:101116205]",{"v":1.782855,"d":"1.78"},{"v":1.288301,"d":"1.29"},{"v":0.879296,"d":"0.88"},{"v":2.418657,"d":"2.42"},{"v":2.387436,"d":"2.39"},{"v":2.71444,"d":"2.71"},{"v":0.525288832586733,"d":"0.53"},{"v":-0.92881718114097,"d":"-0.93"},{"v":0.0423068937779118,"d":"0.04"},{"v":0.375730640446584,"d":"0.38"},"down","no"]
["MSTRG.15511","ANKRD23","ENSOART00000014963","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0015629(actin cytoskeleton);GO:0031432(titin binding)","NA","K21438","NA","ankyrin repeat domain 23 [Source:NCBI gene;Acc:101113927]",{"v":31.7938619039933,"d":"31.79"},{"v":31.6623535796577,"d":"31.66"},{"v":29.1157013749826,"d":"29.12"},{"v":30.6841258456936,"d":"30.68"},{"v":57.2248892226242,"d":"57.22"},{"v":77.9940235672742,"d":"77.99"},{"v":0.557988073153795,"d":"0.56"},{"v":-0.841693809724956,"d":"-0.84"},{"v":0.0423619921344727,"d":"0.04"},{"v":0.375730640446584,"d":"0.38"},"down","no"]
["MSTRG.2134","SUCLA2","ENSOART00000008895;ENSOART00000008893","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0003824(catalytic activity);GO:0004775(succinate-CoA ligase (ADP-forming) activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006099(tricarboxylic acid cycle);GO:0016874(ligase activity);GO:0046872(metal ion binding);GO:0046872(metal ion binding)","00020(Citrate cycle (TCA cycle));00640(Propanoate metabolism);00640(Propanoate metabolism)","K01900","6.2.1.5;EC:6.2.1.4","succinate-CoA ligase ADP-forming beta subunit [Source:NCBI gene;Acc:101113602]",{"v":37.5539511632556,"d":"37.55"},{"v":34.1960358962399,"d":"34.20"},{"v":24.2828045540219,"d":"24.28"},{"v":28.9079727401237,"d":"28.91"},{"v":16.5442692908139,"d":"16.54"},{"v":18.6431643541171,"d":"18.64"},{"v":1.49827884757603,"d":"1.50"},{"v":0.583306151551747,"d":"0.58"},{"v":0.042500954655747,"d":"0.04"},{"v":0.376499076438068,"d":"0.38"},"up","no"]
["MSTRG.183","KCNQ4","ENSOART00000022104","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0007605(sensory perception of sound);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042472(inner ear morphogenesis);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","04725(Cholinergic synapse)","K04929","NA","potassium voltage-gated channel subfamily Q member 4 [Source:NCBI gene;Acc:101122655]",{"v":1.080729,"d":"1.08"},{"v":0.550333,"d":"0.55"},{"v":0.534122,"d":"0.53"},{"v":1.663408,"d":"1.66"},{"v":1.316161,"d":"1.32"},{"v":1.19447,"d":"1.19"},{"v":0.518726346351819,"d":"0.52"},{"v":-0.946954448174575,"d":"-0.95"},{"v":0.0425198614007715,"d":"0.04"},{"v":0.376499076438068,"d":"0.38"},"down","no"]
["MSTRG.11523","ENSOARG00000000671","ENSOART00000000720","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":8.29367,"d":"8.29"},{"v":2.013073,"d":"2.01"},{"v":4.44589,"d":"4.45"},{"v":16.646416,"d":"16.65"},{"v":3.905823,"d":"3.91"},{"v":13.776019,"d":"13.78"},{"v":0.429751867980018,"d":"0.43"},{"v":-1.21842418428315,"d":"-1.22"},{"v":0.0426047518932529,"d":"0.04"},{"v":0.376842030830462,"d":"0.38"},"down","yes"]
["MSTRG.6029","RPL28","ENSOART00000001531","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02903","NA","ribosomal protein L28 [Source:NCBI gene;Acc:101120598]",{"v":126.961064060659,"d":"126.96"},{"v":89.3116724332756,"d":"89.31"},{"v":105.205501795494,"d":"105.21"},{"v":133.171253904679,"d":"133.17"},{"v":177.586668651646,"d":"177.59"},{"v":244.020341211438,"d":"244.02"},{"v":0.579471582224792,"d":"0.58"},{"v":-0.787190182902625,"d":"-0.79"},{"v":0.0426801074064227,"d":"0.04"},{"v":0.377228714343835,"d":"0.38"},"down","no"]
["MSTRG.2585","ENSOARG00000007910","ENSOART00000008609","NA","NA","NA","NA",null,{"v":1.382984,"d":"1.38"},{"v":1.10912,"d":"1.11"},{"v":0.914137,"d":"0.91"},{"v":0.858015,"d":"0.86"},{"v":0.66339,"d":"0.66"},{"v":0.27546,"d":"0.28"},{"v":1.89565771496467,"d":"1.90"},{"v":0.922698490869904,"d":"0.92"},{"v":0.0426946756557697,"d":"0.04"},{"v":0.377228714343835,"d":"0.38"},"up","no"]
["ENSOARG00000010864","SPTLC3","ENSOART00000011820","GO:0003824(catalytic activity);GO:0004758(serine C-palmitoyltransferase activity);GO:0009058(biosynthetic process);GO:0016740(transferase activity);GO:0017059(serine C-palmitoyltransferase complex);GO:0030170(pyridoxal phosphate binding);GO:0046520(sphingoid biosynthetic process)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","K00654","EC:2.3.1.50","serine palmitoyltransferase long chain base subunit 3 [Source:NCBI gene;Acc:101110257]",{"v":1.193076,"d":"1.19"},{"v":0.874922,"d":"0.87"},{"v":0.946385,"d":"0.95"},{"v":0.649511,"d":"0.65"},{"v":0.646021,"d":"0.65"},{"v":0.558,"d":"0.56"},{"v":1.62629131841263,"d":"1.63"},{"v":0.701585711277739,"d":"0.70"},{"v":0.0427456911517056,"d":"0.04"},{"v":0.377475200175797,"d":"0.38"},"up","no"]
["MSTRG.18423","LARP1","ENSOART00000010771","GO:0000339(RNA cap binding);GO:0000340(RNA 7-methylguanosine cap binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005737(cytoplasm);GO:0005844(polysome);GO:0006413(translational initiation);GO:0008190(eukaryotic initiation factor 4E binding);GO:0008283(cell population proliferation);GO:0008494(translation activator activity);GO:0010494(cytoplasmic stress granule);GO:0016239(positive regulation of macroautophagy);GO:0017148(negative regulation of translation);GO:0031369(translation initiation factor binding);GO:0031929(TOR signaling);GO:0031931(TORC1 complex);GO:0038202(TORC1 signaling);GO:0042788(polysomal ribosome);GO:0043024(ribosomal small subunit binding);GO:0045070(positive regulation of viral genome replication);GO:0045727(positive regulation of translation);GO:0045947(negative regulation of translational initiation);GO:0048027(mRNA 5'-UTR binding);GO:0048255(mRNA stabilization);GO:0072752(cellular response to rapamycin);GO:1990928(response to amino acid starvation)","NA","K18757","NA","La ribonucleoprotein domain family member 1 [Source:NCBI gene;Acc:101112568]",{"v":12.6021647308061,"d":"12.60"},{"v":13.8415174096305,"d":"13.84"},{"v":12.4731806665709,"d":"12.47"},{"v":16.6867488266322,"d":"16.69"},{"v":23.3133126044419,"d":"23.31"},{"v":25.5093128876125,"d":"25.51"},{"v":0.594065554918702,"d":"0.59"},{"v":-0.751305954201852,"d":"-0.75"},{"v":0.0427838513594289,"d":"0.04"},{"v":0.377607959457705,"d":"0.38"},"down","no"]
["MSTRG.14215","MARCH8","ENSOART00000002990","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005764(lysosome);GO:0005768(endosome);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding)","NA","NA","NA","membrane associated ring-CH-type finger 8 [Source:HGNC Symbol;Acc:HGNC:23356]",{"v":1.23300772530027,"d":"1.23"},{"v":0.655954736923673,"d":"0.66"},{"v":0.811691927353739,"d":"0.81"},{"v":1.4389575887253,"d":"1.44"},{"v":1.85451730976366,"d":"1.85"},{"v":1.47398454358776,"d":"1.47"},{"v":0.566476636537734,"d":"0.57"},{"v":-0.819911639364472,"d":"-0.82"},{"v":0.0428781555550451,"d":"0.04"},{"v":0.378139907725748,"d":"0.38"},"down","no"]
["MSTRG.14168","TSPAN14","ENSOART00000011220","GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019899(enzyme binding);GO:0045747(positive regulation of Notch signaling pathway);GO:0051604(protein maturation);GO:0072659(protein localization to plasma membrane);GO:0097197(tetraspanin-enriched microdomain)","NA","K17296","NA","tetraspanin 14 [Source:NCBI gene;Acc:101109329]",{"v":1.5892500651492,"d":"1.59"},{"v":1.35463593243787,"d":"1.35"},{"v":2.00267963516448,"d":"2.00"},{"v":2.44602652256093,"d":"2.45"},{"v":3.13811263886431,"d":"3.14"},{"v":2.76001208043111,"d":"2.76"},{"v":0.592818309421136,"d":"0.59"},{"v":-0.754338088365154,"d":"-0.75"},{"v":0.0429118445242047,"d":"0.04"},{"v":0.378139907725748,"d":"0.38"},"down","no"]
["MSTRG.6554","ENSOARG00000003807","ENSOART00000004132","GO:0005515(protein binding)","NA","NA","NA","leucine-rich repeat-containing protein 51 [Source:NCBI gene;Acc:101119753]",{"v":2.272408,"d":"2.27"},{"v":2.547384,"d":"2.55"},{"v":1.337768,"d":"1.34"},{"v":1.180036,"d":"1.18"},{"v":1.259961,"d":"1.26"},{"v":0.867295,"d":"0.87"},{"v":1.86181322967552,"d":"1.86"},{"v":0.896708354241649,"d":"0.90"},{"v":0.042927476942617,"d":"0.04"},{"v":0.378139907725748,"d":"0.38"},"up","no"]
["MSTRG.15794","RAPGEF3","ENSOART00000021127","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005622(intracellular);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0007264(small GTPase mediated signal transduction);GO:0017034(Rap guanyl-nucleotide exchange factor activity);GO:0019904(protein domain specific binding);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0030864(cortical actin cytoskeleton);GO:0032486(Rap protein signal transduction);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034242(negative regulation of syncytium formation by plasma membrane fusion);GO:0035556(intracellular signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0045766(positive regulation of angiogenesis);GO:0046827(positive regulation of protein export from nucleus);GO:0051496(positive regulation of stress fiber assembly);GO:0060143(positive regulation of syncytium formation by plasma membrane fusion);GO:0061028(establishment of endothelial barrier);GO:0071320(cellular response to cAMP);GO:1901985(positive regulation of protein acetylation);GO:2000249(regulation of actin cytoskeleton reorganization)","04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04072(Phospholipase D signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04670(Leukocyte transendothelial migration);04720(Long-term potentiation);04726(Serotonergic synapse)","K08014","NA","Rap guanine nucleotide exchange factor 3 [Source:NCBI gene;Acc:101109786]",{"v":2.95480747356643,"d":"2.95"},{"v":2.37682067748252,"d":"2.38"},{"v":2.13240799916084,"d":"2.13"},{"v":5.0165143365035,"d":"5.02"},{"v":3.98862010741259,"d":"3.99"},{"v":3.44986536951049,"d":"3.45"},{"v":0.599280310077846,"d":"0.60"},{"v":-0.738697121312249,"d":"-0.74"},{"v":0.0431286513349376,"d":"0.04"},{"v":0.378822124113606,"d":"0.38"},"down","no"]
["MSTRG.3763","ENSOARG00000009057","ENSOART00000009861","GO:0005388(calcium-transporting ATPase activity);GO:0005524(ATP binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0070588(calcium ion transmembrane transport);GO:0099132(ATP hydrolysis coupled cation transmembrane transport)","NA","NA","NA",null,{"v":1.56275421873759,"d":"1.56"},{"v":1.17013532711393,"d":"1.17"},{"v":1.181117,"d":"1.18"},{"v":2.58372195831679,"d":"2.58"},{"v":2.11349171496626,"d":"2.11"},{"v":2.09989934736006,"d":"2.10"},{"v":0.575833671437347,"d":"0.58"},{"v":-0.796275943020778,"d":"-0.80"},{"v":0.0431302259142083,"d":"0.04"},{"v":0.378822124113606,"d":"0.38"},"down","no"]
["MSTRG.3262","DHX58","ENSOART00000020009","GO:0003677(DNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0009615(response to virus);GO:0009617(response to bacterium);GO:0016787(hydrolase activity);GO:0032480(negative regulation of type I interferon production);GO:0032481(positive regulation of type I interferon production);GO:0039534(negative regulation of MDA-5 signaling pathway);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0045088(regulation of innate immune response);GO:0045824(negative regulation of innate immune response);GO:0046872(metal ion binding);GO:1900245(positive regulation of MDA-5 signaling pathway);GO:1900246(positive regulation of RIG-I signaling pathway)","04622(RIG-I-like receptor signaling pathway)","K12649","EC:3.6.4.13","DExH-box helicase 58 [Source:NCBI gene;Acc:101121528]",{"v":0.342765,"d":"0.34"},{"v":0.111138,"d":"0.11"},{"v":0.109643,"d":"0.11"},{"v":0.486081,"d":"0.49"},{"v":0.496179,"d":"0.50"},{"v":0.287492,"d":"0.29"},{"v":0.443823675804409,"d":"0.44"},{"v":-1.17194146463378,"d":"-1.17"},{"v":0.0432295471083917,"d":"0.04"},{"v":0.379286429438915,"d":"0.38"},"down","yes"]
["MSTRG.6010","ENSOARG00000000443","ENSOART00000000471","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K13865","NA","cationic amino acid transporter 3-like [Source:NCBI gene;Acc:101112084]",{"v":0.512723,"d":"0.51"},{"v":0.505471,"d":"0.51"},{"v":0.357233,"d":"0.36"},{"v":0.818566,"d":"0.82"},{"v":0.793225,"d":"0.79"},{"v":0.90076,"d":"0.90"},{"v":0.547422519980689,"d":"0.55"},{"v":-0.869273309077126,"d":"-0.87"},{"v":0.043297518569215,"d":"0.04"},{"v":0.379412882332487,"d":"0.38"},"down","no"]
["MSTRG.40","GPC1","ENSOART00000020131","GO:0005507(copper ion binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0009966(regulation of signal transduction);GO:0016020(membrane);GO:0017134(fibroblast growth factor binding);GO:0030200(heparan sulfate proteoglycan catabolic process);GO:0031012(extracellular matrix);GO:0031225(anchored component of membrane);GO:0040037(negative regulation of fibroblast growth factor receptor signaling pathway);GO:0043236(laminin binding);GO:0045121(membrane raft);GO:0045202(synapse);GO:0046658(anchored component of plasma membrane);GO:0062023(collagen-containing extracellular matrix);GO:2001016(positive regulation of skeletal muscle cell differentiation)","NA","NA","NA","glypican 1 [Source:HGNC Symbol;Acc:HGNC:4449]",{"v":9.97799147834912,"d":"9.98"},{"v":10.4938220981055,"d":"10.49"},{"v":9.76259902976996,"d":"9.76"},{"v":15.4514420852503,"d":"15.45"},{"v":16.7532080317997,"d":"16.75"},{"v":18.1102782740189,"d":"18.11"},{"v":0.600903421172141,"d":"0.60"},{"v":-0.734794959179621,"d":"-0.73"},{"v":0.0433061502619062,"d":"0.04"},{"v":0.379412882332487,"d":"0.38"},"down","no"]
["MSTRG.10703","TTLL4","ENSOART00000021443;ENSOART00000021445","GO:0005524(ATP binding);GO:0006464(cellular protein modification process);GO:0015631(tubulin binding);GO:0018095(protein polyglutamylation);GO:0018200(peptidyl-glutamic acid modification);GO:0070739(protein-glutamic acid ligase activity);GO:0070739(protein-glutamic acid ligase activity)","NA","K16601","EC:6.-.-.-","tubulin tyrosine ligase like 4 [Source:NCBI gene;Acc:101112884]",{"v":2.51475420539613,"d":"2.51"},{"v":2.61615425608235,"d":"2.62"},{"v":2.87646539660012,"d":"2.88"},{"v":3.5648004628821,"d":"3.56"},{"v":4.91687139784779,"d":"4.92"},{"v":5.02918916094822,"d":"5.03"},{"v":0.592661995799587,"d":"0.59"},{"v":-0.754718546626577,"d":"-0.75"},{"v":0.0433441844991833,"d":"0.04"},{"v":0.37947659222663,"d":"0.38"},"down","no"]
["MSTRG.7360","USP38","ENSOART00000012402","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity)","NA","K11854","EC:3.4.19.12","ubiquitin specific peptidase 38 [Source:NCBI gene;Acc:101112596]",{"v":13.13076,"d":"13.13"},{"v":12.605064,"d":"12.61"},{"v":10.898579,"d":"10.90"},{"v":8.712987,"d":"8.71"},{"v":8.598837,"d":"8.60"},{"v":7.830112,"d":"7.83"},{"v":1.45710350229195,"d":"1.46"},{"v":0.543103359859386,"d":"0.54"},{"v":0.0434373416530952,"d":"0.04"},{"v":0.380088378623654,"d":"0.38"},"up","no"]
["MSTRG.14322","ENSOARG00000009404","ENSOART00000010238","NA","NA","NA","NA",null,{"v":1.828574,"d":"1.83"},{"v":3.314029,"d":"3.31"},{"v":2.208225,"d":"2.21"},{"v":1.405931,"d":"1.41"},{"v":1.492727,"d":"1.49"},{"v":1.193283,"d":"1.19"},{"v":1.79641593072823,"d":"1.80"},{"v":0.845121421196225,"d":"0.85"},{"v":0.0434686621861491,"d":"0.04"},{"v":0.380158712466761,"d":"0.38"},"up","no"]
["MSTRG.21696","DDX3X","ENSOART00000002644","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003924(GTPase activity);GO:0004003(ATP-dependent DNA helicase activity);GO:0004004(ATP-dependent RNA helicase activity);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006413(translational initiation);GO:0007059(chromosome segregation);GO:0008134(transcription factor binding);GO:0008143(poly(A) binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0010501(RNA secondary structure unwinding);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0017148(negative regulation of translation);GO:0022627(cytosolic small ribosomal subunit);GO:0030307(positive regulation of cell growth);GO:0030308(negative regulation of cell growth);GO:0031333(negative regulation of protein complex assembly);GO:0031369(translation initiation factor binding);GO:0032508(DNA duplex unwinding);GO:0033592(RNA strand annealing activity);GO:0034063(stress granule assembly);GO:0035556(intracellular signal transduction);GO:0035613(RNA stem-loop binding);GO:0042256(mature ribosome assembly);GO:0043024(ribosomal small subunit binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043273(CTPase activity);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043539(protein serine/threonine kinase activator activity);GO:0045070(positive regulation of viral genome replication);GO:0045087(innate immune response);GO:0045727(positive regulation of translation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045948(positive regulation of translational initiation);GO:0048027(mRNA 5'-UTR binding);GO:0071243(cellular response to arsenic-containing substance);GO:0071470(cellular response to osmotic stress);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1903608(protein localization to cytoplasmic stress granule);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04622(RIG-I-like receptor signaling pathway);05161(Hepatitis B);05203(Viral carcinogenesis)","K11594","EC:3.6.4.13","DEAD-box helicase 3 X-linked [Source:NCBI gene;Acc:101104719]",{"v":50.2608975374327,"d":"50.26"},{"v":49.4987533628088,"d":"49.50"},{"v":53.7192077456809,"d":"53.72"},{"v":39.3589568225896,"d":"39.36"},{"v":35.5165181779677,"d":"35.52"},{"v":31.1473434189114,"d":"31.15"},{"v":1.44760213823687,"d":"1.45"},{"v":0.533665143813316,"d":"0.53"},{"v":0.0435411821764089,"d":"0.04"},{"v":0.380589091314991,"d":"0.38"},"up","no"]
["MSTRG.12171","CORO1B","ENSOART00000013140","GO:0001725(stress fiber);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0016477(cell migration);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0031252(cell leading edge);GO:0031529(ruffle organization);GO:0034316(negative regulation of Arp2/3 complex-mediated actin nucleation);GO:0035767(endothelial cell chemotaxis);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0042060(wound healing);GO:0042802(identical protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:0071672(negative regulation of smooth muscle cell chemotaxis);GO:0071933(Arp2/3 complex binding);GO:0071944(cell periphery);GO:0090135(actin filament branching);GO:1902463(protein localization to cell leading edge);GO:2000394(positive regulation of lamellipodium morphogenesis)","NA","K13886","NA","coronin 1B [Source:NCBI gene;Acc:101109841]",{"v":2.02439368942436,"d":"2.02"},{"v":0.934142857652833,"d":"0.93"},{"v":1.3453298085676,"d":"1.35"},{"v":2.38092208165997,"d":"2.38"},{"v":2.61913920883534,"d":"2.62"},{"v":2.68409794466756,"d":"2.68"},{"v":0.560095935538427,"d":"0.56"},{"v":-0.836254135803717,"d":"-0.84"},{"v":0.0438966649790377,"d":"0.04"},{"v":0.381861949788651,"d":"0.38"},"down","no"]
["MSTRG.17111","ENSOARG00000025169","ENSOART00000027071","GO:0005739(mitochondrion);GO:0005758(mitochondrial intermembrane space);GO:0006915(apoptotic process);GO:0009055(electron transfer activity);GO:0020037(heme binding);GO:0022900(electron transport chain);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0070469(respirasome)","01524(Platinum drug resistance);04115(p53 signaling pathway);04210(Apoptosis);04215(Apoptosis - multiple species);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05134(Legionellosis);05145(Toxoplasmosis);05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05164(Influenza A);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05210(Colorectal cancer);05222(Small cell lung cancer);05416(Viral myocarditis)","K08738","NA","cytochrome c [Source:NCBI gene;Acc:101107954]",{"v":15.9977999375636,"d":"16.00"},{"v":13.7519727458432,"d":"13.75"},{"v":10.0581808808958,"d":"10.06"},{"v":11.16019891415,"d":"11.16"},{"v":7.79579534000679,"d":"7.80"},{"v":7.51494645571768,"d":"7.51"},{"v":1.50383599890173,"d":"1.50"},{"v":0.588647242233553,"d":"0.59"},{"v":0.0440876264013616,"d":"0.04"},{"v":0.383177241994753,"d":"0.38"},"up","no"]
["MSTRG.22123","ENSOARG00000009515","ENSOART00000010359","NA","NA","NA","NA","retrotransposon Gag like 8C [Source:NCBI gene;Acc:101105981]",{"v":14.229542,"d":"14.23"},{"v":25.268602,"d":"25.27"},{"v":15.75769,"d":"15.76"},{"v":36.355106,"d":"36.36"},{"v":30.226112,"d":"30.23"},{"v":31.753471,"d":"31.75"},{"v":0.561915988771775,"d":"0.56"},{"v":-0.831573643519981,"d":"-0.83"},{"v":0.0440954212217137,"d":"0.04"},{"v":0.383177241994753,"d":"0.38"},"down","no"]
["MSTRG.11141","ENSOARG00000007573","ENSOART00000008245","GO:0000166(nucleotide binding);GO:0001916(positive regulation of T cell mediated cytotoxicity);GO:0002237(response to molecule of bacterial origin);GO:0002481(antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent);GO:0002485(antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent);GO:0002489(antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent);GO:0005524(ATP binding);GO:0015440(peptide-transporting ATPase activity);GO:0015833(peptide transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0019885(antigen processing and presentation of endogenous peptide antigen via MHC class I);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0042287(MHC protein binding);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0042825(TAP complex);GO:0046978(TAP1 binding);GO:0055085(transmembrane transport);GO:1904680(peptide transmembrane transporter activity)","02010(ABC transporters);04145(Phagosome);04612(Antigen processing and presentation);05163(Human cytomegalovirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05340(Primary immunodeficiency)","K05654","NA","transporter 2, ATP binding cassette subfamily B member [Source:NCBI gene;Acc:101109491]",{"v":1.55999273795319,"d":"1.56"},{"v":1.143183,"d":"1.14"},{"v":0.986074,"d":"0.99"},{"v":2.16581188725715,"d":"2.17"},{"v":1.84880886935903,"d":"1.85"},{"v":2.17523596925195,"d":"2.18"},{"v":0.596015368584443,"d":"0.60"},{"v":-0.746578563034324,"d":"-0.75"},{"v":0.044184928599604,"d":"0.04"},{"v":0.383650396034702,"d":"0.38"},"down","no"]
["MSTRG.4652","SLC24A3","ENSOART00000001508","GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0008273(calcium, potassium:sodium antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035725(sodium ion transmembrane transport);GO:0055085(transmembrane transport)","NA","K13751","NA","solute carrier family 24 member 3 [Source:NCBI gene;Acc:101122806]",{"v":1.176869,"d":"1.18"},{"v":0.478409,"d":"0.48"},{"v":0.802837,"d":"0.80"},{"v":1.599079,"d":"1.60"},{"v":1.445215,"d":"1.45"},{"v":1.642817,"d":"1.64"},{"v":0.524441388309345,"d":"0.52"},{"v":-0.931146549006509,"d":"-0.93"},{"v":0.0442438569165448,"d":"0.04"},{"v":0.383650396034702,"d":"0.38"},"down","no"]
["MSTRG.12770","PAOX","ENSOART00000019988","GO:0005102(signaling receptor binding);GO:0009446(putrescine biosynthetic process);GO:0009447(putrescine catabolic process);GO:0016491(oxidoreductase activity);GO:0046203(spermidine catabolic process);GO:0046208(spermine catabolic process);GO:0046592(polyamine oxidase activity);GO:0055114(oxidation-reduction process);GO:1901307(positive regulation of spermidine biosynthetic process)","NA","NA","NA","polyamine oxidase [Source:HGNC Symbol;Acc:HGNC:20837]",{"v":0.561247891684902,"d":"0.56"},{"v":0.802534792122538,"d":"0.80"},{"v":0.6565957702407,"d":"0.66"},{"v":0.943224518599562,"d":"0.94"},{"v":1.37828020897155,"d":"1.38"},{"v":1.59034806673961,"d":"1.59"},{"v":0.516476094649194,"d":"0.52"},{"v":-0.953226520103312,"d":"-0.95"},{"v":0.0442909312622674,"d":"0.04"},{"v":0.383854737606317,"d":"0.38"},"down","no"]
["MSTRG.10690","TMBIM1","ENSOART00000021268","GO:0005123(death receptor binding);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902045(negative regulation of Fas signaling pathway);GO:1903077(negative regulation of protein localization to plasma membrane)","NA","K06890","NA","transmembrane BAX inhibitor motif containing 1 [Source:NCBI gene;Acc:101109777]",{"v":6.30608571407283,"d":"6.31"},{"v":6.56498665055416,"d":"6.56"},{"v":6.58234969097513,"d":"6.58"},{"v":5.08641867057837,"d":"5.09"},{"v":4.04246419353637,"d":"4.04"},{"v":4.1513121263854,"d":"4.15"},{"v":1.46484461030263,"d":"1.46"},{"v":0.550747632677689,"d":"0.55"},{"v":0.044484447435882,"d":"0.04"},{"v":0.384917716366827,"d":"0.38"},"up","no"]
["MSTRG.8346","TRAPPC6B","ENSOART00000009330","GO:0043087(regulation of GTPase activity);GO:0048193(Golgi vesicle transport)","NA","K20304","NA","trafficking protein particle complex 6B [Source:NCBI gene;Acc:101123500]",{"v":9.6739,"d":"9.67"},{"v":7.867474,"d":"7.87"},{"v":8.291263,"d":"8.29"},{"v":6.758265,"d":"6.76"},{"v":4.798012,"d":"4.80"},{"v":4.808906,"d":"4.81"},{"v":1.57851195431178,"d":"1.58"},{"v":0.658565186441854,"d":"0.66"},{"v":0.0445078790115489,"d":"0.04"},{"v":0.384917716366827,"d":"0.38"},"up","no"]
["MSTRG.3315","RF00004","ENSOART00000023328","NA","NA","NA","NA",null,{"v":58.978638,"d":"58.98"},{"v":177.222183,"d":"177.22"},{"v":92.88929,"d":"92.89"},{"v":84.889778,"d":"84.89"},{"v":294.44873,"d":"294.45"},{"v":346.654449,"d":"346.65"},{"v":0.453296561387992,"d":"0.45"},{"v":-1.14147287760193,"d":"-1.14"},{"v":0.0447896092113331,"d":"0.04"},{"v":0.386628586278596,"d":"0.39"},"down","yes"]
["MSTRG.10822","HDAC1","ENSOART00000022827","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000792(heterochromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0001046(core promoter sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0004407(histone deacetylase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0006346(methylation-dependent chromatin silencing);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006476(protein deacetylation);GO:0007492(endoderm development);GO:0007623(circadian rhythm);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell population proliferation);GO:0009913(epidermal cell differentiation);GO:0010629(negative regulation of gene expression);GO:0010870(positive regulation of receptor biosynthetic process);GO:0016575(histone deacetylation);GO:0016580(Sin3 complex);GO:0016581(NuRD complex);GO:0016787(hydrolase activity);GO:0017053(transcriptional repressor complex);GO:0019213(deacetylase activity);GO:0019899(enzyme binding);GO:0021766(hippocampus development);GO:0030182(neuron differentiation);GO:0032041(NAD-dependent histone deacetylase activity (H3-K14 specific));GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0033558(protein deacetylase activity);GO:0033613(activating transcription factor binding);GO:0035851(Krueppel-associated box domain binding);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042826(histone deacetylase binding);GO:0043025(neuronal cell body);GO:0043066(negative regulation of apoptotic process);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043922(negative regulation by host of viral transcription);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0047485(protein N-terminus binding);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0051059(NF-kappaB binding);GO:0052548(regulation of endopeptidase activity);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0060789(hair follicle placode formation);GO:0061029(eyelid development in camera-type eye);GO:0061198(fungiform papilla formation);GO:0070491(repressing transcription factor binding);GO:0070888(E-box binding);GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1990841(promoter-specific chromatin binding);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","04110(Cell cycle);04213(Longevity regulating pathway - multiple species);04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05016(Huntington disease);05034(Alcoholism);05165(Human papillomavirus infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05203(Viral carcinogenesis);05220(Chronic myeloid leukemia)","K06067","EC:3.5.1.98","histone deacetylase 1 [Source:NCBI gene;Acc:100820752]",{"v":7.525193,"d":"7.53"},{"v":6.503453,"d":"6.50"},{"v":5.468821,"d":"5.47"},{"v":10.71371,"d":"10.71"},{"v":9.619737,"d":"9.62"},{"v":11.944051,"d":"11.94"},{"v":0.604057569765785,"d":"0.60"},{"v":-0.727242042592528,"d":"-0.73"},{"v":0.0447981157800821,"d":"0.04"},{"v":0.386628586278596,"d":"0.39"},"down","no"]
["MSTRG.17619","PLVAP","ENSOART00000018326","GO:0000165(MAPK cascade);GO:0002693(positive regulation of cellular extravasation);GO:0005901(caveola);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033209(tumor necrosis factor-mediated signaling pathway)","NA","K17309","NA","plasmalemma vesicle associated protein [Source:NCBI gene;Acc:101111878]",{"v":2.43466371011021,"d":"2.43"},{"v":3.27769930330618,"d":"3.28"},{"v":3.39895438667944,"d":"3.40"},{"v":6.33395235936751,"d":"6.33"},{"v":3.98375890225204,"d":"3.98"},{"v":5.640598519885,"d":"5.64"},{"v":0.57094501390465,"d":"0.57"},{"v":-0.808576284477689,"d":"-0.81"},{"v":0.0448241005527549,"d":"0.04"},{"v":0.386628586278596,"d":"0.39"},"down","no"]
["MSTRG.14234","ENSOARG00000006172","ENSOART00000006713","NA","NA","NA","NA",null,{"v":0.826260787394167,"d":"0.83"},{"v":1.82571263875823,"d":"1.83"},{"v":1.74041759548448,"d":"1.74"},{"v":0.680328753527752,"d":"0.68"},{"v":0.801389444026341,"d":"0.80"},{"v":0.859801174035748,"d":"0.86"},{"v":1.87587216869982,"d":"1.88"},{"v":0.907561518756061,"d":"0.91"},{"v":0.0450463652157607,"d":"0.05"},{"v":0.387333731471748,"d":"0.39"},"up","no"]
["ENSOARG00000002667","KBTBD3","ENSOART00000002889","GO:0005515(protein binding)","NA","K10471","NA","kelch repeat and BTB domain containing 3 [Source:NCBI gene;Acc:101115566]",{"v":1.03289,"d":"1.03"},{"v":0.922123,"d":"0.92"},{"v":0.835629,"d":"0.84"},{"v":0.571957,"d":"0.57"},{"v":0.446336,"d":"0.45"},{"v":0.586152,"d":"0.59"},{"v":1.73931920383684,"d":"1.74"},{"v":0.798522723635061,"d":"0.80"},{"v":0.0450551248408721,"d":"0.05"},{"v":0.387333731471748,"d":"0.39"},"up","no"]
["MSTRG.13333","CARHSP1","ENSOART00000005837","GO:0000177(cytoplasmic exosome (RNase complex));GO:0003676(nucleic acid binding);GO:0003730(mRNA 3'-UTR binding);GO:0005829(cytosol);GO:0043186(P granule);GO:0043488(regulation of mRNA stability)","NA","NA","NA","calcium regulated heat stable protein 1 [Source:NCBI gene;Acc:101106225]",{"v":2.79718777906977,"d":"2.80"},{"v":1.7407292248062,"d":"1.74"},{"v":2.28867540697674,"d":"2.29"},{"v":4.15249072868217,"d":"4.15"},{"v":4.3898998372093,"d":"4.39"},{"v":4.15181004457364,"d":"4.15"},{"v":0.537772532539376,"d":"0.54"},{"v":-0.894932025398438,"d":"-0.89"},{"v":0.0450583767628376,"d":"0.05"},{"v":0.387333731471748,"d":"0.39"},"down","no"]
["MSTRG.7979","DGCR8;ENSOARG00000021266;MIR1306","ENSOART00000019659;ENSOART00000023168;ENSOART00000024383","GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0004525(ribonuclease III activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0020037(heme binding);GO:0031053(primary miRNA processing);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0070877(microprocessor complex);GO:0070878(primary miRNA binding);GO:0090501(RNA phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","NA","K18419","NA","DGCR8, microprocessor complex subunit [Source:NCBI gene;Acc:101122137];microRNA 1306 [Source:HGNC Symbol;Acc:HGNC:35371]",{"v":3.65289349413574,"d":"3.65"},{"v":3.27896167506249,"d":"3.28"},{"v":3.28362014900981,"d":"3.28"},{"v":5.79223120496058,"d":"5.79"},{"v":7.73444149259758,"d":"7.73"},{"v":4.03052037858104,"d":"4.03"},{"v":0.581839891713169,"d":"0.58"},{"v":-0.781305881976453,"d":"-0.78"},{"v":0.0450693552368905,"d":"0.05"},{"v":0.387333731471748,"d":"0.39"},"down","no"]
["MSTRG.5833","CCDC61","ENSOART00000011363","GO:0005813(centrosome)","NA","K16755","NA","coiled-coil domain containing 61 [Source:NCBI gene;Acc:101120433]",{"v":0.618987632754342,"d":"0.62"},{"v":0.375078434243176,"d":"0.38"},{"v":0.385969359801489,"d":"0.39"},{"v":0.956096885856079,"d":"0.96"},{"v":1.05433260297767,"d":"1.05"},{"v":0.777823389578164,"d":"0.78"},{"v":0.494946293244759,"d":"0.49"},{"v":-1.01465610842869,"d":"-1.01"},{"v":0.0450941615554646,"d":"0.05"},{"v":0.387333731471748,"d":"0.39"},"down","yes"]
["MSTRG.9050","ENSOARG00000005786","ENSOART00000006300;ENSOART00000006302","GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0006470(protein dephosphorylation)","NA","K17507","EC:3.1.3.16","protein phosphatase, Mg2+/Mn2+ dependent 1M [Source:NCBI gene;Acc:101112354]",{"v":0.386585680598267,"d":"0.39"},{"v":0.244249537880906,"d":"0.24"},{"v":0.466113926754263,"d":"0.47"},{"v":0.428876175566117,"d":"0.43"},{"v":1.24521673693039,"d":"1.25"},{"v":0.546116568772715,"d":"0.55"},{"v":0.494074615250425,"d":"0.49"},{"v":-1.0171991605209,"d":"-1.02"},{"v":0.0451297775125667,"d":"0.05"},{"v":0.387333731471748,"d":"0.39"},"down","yes"]
["MSTRG.17228","SMO","ENSOART00000004624;ENSOART00000004619","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001503(ossification);GO:0001570(vasculogenesis);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001708(cell fate specification);GO:0001755(neural crest cell migration);GO:0001947(heart looping);GO:0002052(positive regulation of neuroblast proliferation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003007(heart morphogenesis);GO:0003140(determination of left/right asymmetry in lateral mesoderm);GO:0003323(type B pancreatic cell development);GO:0004888(transmembrane signaling receptor activity);GO:0005113(patched binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0005929(cilium);GO:0007166(cell surface receptor signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007228(positive regulation of hh target transcription factor activity);GO:0007275(multicellular organism development);GO:0007368(determination of left/right symmetry);GO:0007371(ventral midline determination);GO:0007389(pattern specification process);GO:0007417(central nervous system development);GO:0007494(midgut development);GO:0008144(drug binding);GO:0008284(positive regulation of cell population proliferation);GO:0009952(anterior/posterior pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021542(dentate gyrus development);GO:0021696(cerebellar cortex morphogenesis);GO:0021794(thalamus development);GO:0021904(dorsal/ventral neural tube patterning);GO:0021910(smoothened signaling pathway involved in ventral spinal cord patterning);GO:0021938(smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation);GO:0021953(central nervous system neuron differentiation);GO:0021987(cerebral cortex development);GO:0030335(positive regulation of cell migration);GO:0030857(negative regulation of epithelial cell differentiation);GO:0031069(hair follicle morphogenesis);GO:0034504(protein localization to nucleus);GO:0035264(multicellular organism growth);GO:0040018(positive regulation of multicellular organism growth);GO:0042307(positive regulation of protein import into nucleus);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043392(negative regulation of DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046622(positive regulation of organ growth);GO:0048143(astrocyte activation);GO:0048468(cell development);GO:0048565(digestive tract development);GO:0048568(embryonic organ development);GO:0048589(developmental growth);GO:0048741(skeletal muscle fiber development);GO:0048853(forebrain morphogenesis);GO:0048873(homeostasis of number of cells within a tissue);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050821(protein stabilization);GO:0051451(myoblast migration);GO:0051799(negative regulation of hair follicle development);GO:0060170(ciliary membrane);GO:0060248(detection of cell density by contact stimulus involved in contact inhibition);GO:0060413(atrial septum morphogenesis);GO:0060644(mammary gland epithelial cell differentiation);GO:0060684(epithelial-mesenchymal cell signaling);GO:0061053(somite development);GO:0061113(pancreas morphogenesis);GO:0070986(left/right axis specification);GO:0071397(cellular response to cholesterol);GO:0072001(renal system development);GO:0072285(mesenchymal to epithelial transition involved in metanephric renal vesicle formation);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:2000036(regulation of stem cell population maintenance);GO:2000826(regulation of heart morphogenesis);GO:2000826(regulation of heart morphogenesis)","04340(Hedgehog signaling pathway);04360(Axon guidance);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma);05217(Basal cell carcinoma)","K06226","NA","smoothened, frizzled class receptor [Source:NCBI gene;Acc:780493]",{"v":1.54310312412178,"d":"1.54"},{"v":0.854850363934426,"d":"0.85"},{"v":1.21685221826698,"d":"1.22"},{"v":2.44463359578454,"d":"2.44"},{"v":2.16874043747073,"d":"2.17"},{"v":1.87328328852459,"d":"1.87"},{"v":0.557267869567577,"d":"0.56"},{"v":-0.843557120642029,"d":"-0.84"},{"v":0.0451417292758325,"d":"0.05"},{"v":0.387333731471748,"d":"0.39"},"down","no"]
["MSTRG.4069","VWA1","ENSOART00000003731","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042802(identical protein binding);GO:0048266(behavioral response to pain)","NA","NA","NA","von Willebrand factor A domain containing 1 [Source:HGNC Symbol;Acc:HGNC:30910]",{"v":1.27750976401945,"d":"1.28"},{"v":1.98855798800648,"d":"1.99"},{"v":2.1072631280389,"d":"2.11"},{"v":3.35990812933549,"d":"3.36"},{"v":3.18298187520259,"d":"3.18"},{"v":2.96274858314425,"d":"2.96"},{"v":0.565278264106079,"d":"0.57"},{"v":-0.82296687086281,"d":"-0.82"},{"v":0.0452355435222821,"d":"0.05"},{"v":0.387923295499907,"d":"0.39"},"down","no"]
["MSTRG.6432","SPON1","ENSOART00000007832","GO:0010954(positive regulation of protein processing);GO:0032092(positive regulation of protein binding);GO:0050693(LBD domain binding);GO:1902430(negative regulation of amyloid-beta formation);GO:1902993(positive regulation of amyloid precursor protein catabolic process)","NA","NA","NA","spondin 1 [Source:NCBI gene;Acc:101118982]",{"v":0.64781,"d":"0.65"},{"v":0.656306,"d":"0.66"},{"v":0.464169,"d":"0.46"},{"v":0.994025,"d":"0.99"},{"v":1.075274,"d":"1.08"},{"v":1.187196,"d":"1.19"},{"v":0.543002522650887,"d":"0.54"},{"v":-0.880969194449861,"d":"-0.88"},{"v":0.045325422981209,"d":"0.05"},{"v":0.388286204846369,"d":"0.39"},"down","no"]
["ENSOARG00000002876","TCTN2","ENSOART00000003116","NA","NA","K19361","NA","tectonic family member 2 [Source:NCBI gene;Acc:101121804]",{"v":0.518161,"d":"0.52"},{"v":0.26283,"d":"0.26"},{"v":0.550896,"d":"0.55"},{"v":1.144583,"d":"1.14"},{"v":0.832369,"d":"0.83"},{"v":0.725371,"d":"0.73"},{"v":0.492867432945655,"d":"0.49"},{"v":-1.02072843925872,"d":"-1.02"},{"v":0.0453740615751328,"d":"0.05"},{"v":0.388499044257351,"d":"0.39"},"down","yes"]
["MSTRG.14756","ENSOARG00000010644","ENSOART00000011576","NA","NA","NA","NA","SWI5 homologous recombination repair protein [Source:NCBI gene;Acc:101120905]",{"v":1.15598209206349,"d":"1.16"},{"v":1.2931311989418,"d":"1.29"},{"v":1.07552909206349,"d":"1.08"},{"v":2.09272549206349,"d":"2.09"},{"v":1.9248867005291,"d":"1.92"},{"v":2.71310582222222,"d":"2.71"},{"v":0.523665138743115,"d":"0.52"},{"v":-0.933283529505241,"d":"-0.93"},{"v":0.0455634228443082,"d":"0.05"},{"v":0.389682458284949,"d":"0.39"},"down","no"]
["MSTRG.3416","ENSOARG00000014197","ENSOART00000015463","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0098609(cell-cell adhesion)","NA","NA","NA",null,{"v":1.7829116433518,"d":"1.78"},{"v":1.73422756509695,"d":"1.73"},{"v":1.22329529570637,"d":"1.22"},{"v":2.36382906371191,"d":"2.36"},{"v":3.29772312811634,"d":"3.30"},{"v":2.9664891232687,"d":"2.97"},{"v":0.549421859612624,"d":"0.55"},{"v":-0.864013783440919,"d":"-0.86"},{"v":0.0456587771911214,"d":"0.05"},{"v":0.389745595375051,"d":"0.39"},"down","no"]
["ENSOARG00000002236","STXBP2","ENSOART00000002415","GO:0001909(leukocyte mediated cytotoxicity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006887(exocytosis);GO:0006904(vesicle docking involved in exocytosis);GO:0016192(vesicle-mediated transport);GO:0016324(apical plasma membrane);GO:0017075(syntaxin-1 binding);GO:0030348(syntaxin-3 binding);GO:0042581(specific granule);GO:0042582(azurophil granule);GO:0042589(zymogen granule membrane);GO:0043312(neutrophil degranulation);GO:0044194(cytolytic granule);GO:0045335(phagocytic vesicle);GO:0070820(tertiary granule);GO:0071346(cellular response to interferon-gamma)","NA","K15300","NA","syntaxin binding protein 2 [Source:NCBI gene;Acc:101102061]",{"v":0.090849,"d":"0.09"},{"v":0.094117,"d":"0.09"},{"v":0.073125,"d":"0.07"},{"v":0.233609,"d":"0.23"},{"v":0.172138,"d":"0.17"},{"v":0.135784,"d":"0.14"},{"v":0.476595061039904,"d":"0.48"},{"v":-1.06916409394701,"d":"-1.07"},{"v":0.0456628689338849,"d":"0.05"},{"v":0.389745595375051,"d":"0.39"},"down","yes"]
["MSTRG.8261","ISLR","ENSOART00000019063","GO:0005515(protein binding)","NA","NA","NA","immunoglobulin superfamily containing leucine rich repeat [Source:NCBI gene;Acc:101110878]",{"v":3.06558613647643,"d":"3.07"},{"v":1.69426499441687,"d":"1.69"},{"v":4.73123958622829,"d":"4.73"},{"v":4.71841864081886,"d":"4.72"},{"v":5.39278117307692,"d":"5.39"},{"v":7.92083833746898,"d":"7.92"},{"v":0.526345975837637,"d":"0.53"},{"v":-0.925916676465602,"d":"-0.93"},{"v":0.0457348313991465,"d":"0.05"},{"v":0.390155865770776,"d":"0.39"},"down","no"]
["MSTRG.13540","ITGAL","ENSOART00000006992","GO:0002291(T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007159(leukocyte cell-cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030369(ICAM-3 receptor activity);GO:0034687(integrin alphaL-beta2 complex);GO:0043113(receptor clustering);GO:0050839(cell adhesion molecule binding)","04015(Rap1 signaling pathway);04514(Cell adhesion molecules (CAMs));04650(Natural killer cell mediated cytotoxicity);04670(Leukocyte transendothelial migration);04810(Regulation of actin cytoskeleton);05144(Malaria);05150(Staphylococcus aureus infection);05166(Human T-cell leukemia virus 1 infection);05169(Epstein-Barr virus infection);05323(Rheumatoid arthritis);05416(Viral myocarditis)","K05718","NA","integrin subunit alpha L [Source:NCBI gene;Acc:641296]",{"v":1.21080559311489,"d":"1.21"},{"v":0.424881684985483,"d":"0.42"},{"v":0.895199122770635,"d":"0.90"},{"v":0.867770222936541,"d":"0.87"},{"v":2.33782906262961,"d":"2.34"},{"v":1.83133328494401,"d":"1.83"},{"v":0.502465809387373,"d":"0.50"},{"v":-0.992902664377837,"d":"-0.99"},{"v":0.0457780485246218,"d":"0.05"},{"v":0.390219525987692,"d":"0.39"},"down","no"]
["MSTRG.4017","KLHL21","ENSOART00000012344","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005827(polar microtubule);GO:0016567(protein ubiquitination);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0032465(regulation of cytokinesis);GO:0035853(chromosome passenger complex localization to spindle midzone)","NA","K10458","NA","kelch like family member 21 [Source:NCBI gene;Acc:101120765]",{"v":2.40499798088077,"d":"2.40"},{"v":3.40328657894737,"d":"3.40"},{"v":3.58535425220193,"d":"3.59"},{"v":2.2061318990333,"d":"2.21"},{"v":2.32119142556391,"d":"2.32"},{"v":1.81018290912997,"d":"1.81"},{"v":1.48222951829832,"d":"1.48"},{"v":0.567768861457963,"d":"0.57"},{"v":0.0458002103971592,"d":"0.05"},{"v":0.390219525987692,"d":"0.39"},"up","no"]
["MSTRG.9003","IL17RD","ENSOART00000015978","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0019221(cytokine-mediated signaling pathway);GO:0030368(interleukin-17 receptor activity)","NA","K05167","NA","interleukin 17 receptor D [Source:NCBI gene;Acc:101109490]",{"v":1.219273,"d":"1.22"},{"v":0.84303,"d":"0.84"},{"v":0.949816,"d":"0.95"},{"v":1.918255,"d":"1.92"},{"v":2.171574,"d":"2.17"},{"v":1.382969,"d":"1.38"},{"v":0.550380079805613,"d":"0.55"},{"v":-0.861499840119386,"d":"-0.86"},{"v":0.0459036183417107,"d":"0.05"},{"v":0.390219525987692,"d":"0.39"},"down","no"]
["MSTRG.17877","ENSOARG00000007383","ENSOART00000008036","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02920","NA","ribosomal protein L36 [Source:NCBI gene;Acc:101109011]",{"v":111.340919,"d":"111.34"},{"v":91.734016,"d":"91.73"},{"v":113.046936,"d":"113.05"},{"v":105.383186,"d":"105.38"},{"v":207.029831,"d":"207.03"},{"v":250.945755,"d":"250.95"},{"v":0.561137745095767,"d":"0.56"},{"v":-0.833573135508375,"d":"-0.83"},{"v":0.0459711885084186,"d":"0.05"},{"v":0.390219525987692,"d":"0.39"},"down","no"]
["MSTRG.15177","UXS1","ENSOART00000022809","GO:0042803(protein homodimerization activity);GO:0048040(UDP-glucuronate decarboxylase activity);GO:0051262(protein tetramerization);GO:0070403(NAD+ binding)","00520(Amino sugar and nucleotide sugar metabolism)","K08678","EC:4.1.1.35","UDP-glucuronate decarboxylase 1 [Source:NCBI gene;Acc:101107778]",{"v":5.69699542193935,"d":"5.70"},{"v":5.38205112542119,"d":"5.38"},{"v":7.96361344814676,"d":"7.96"},{"v":5.55271690003744,"d":"5.55"},{"v":3.02013616173718,"d":"3.02"},{"v":3.95369059977537,"d":"3.95"},{"v":1.5201846981908,"d":"1.52"},{"v":0.604246617732028,"d":"0.60"},{"v":0.0460454153497692,"d":"0.05"},{"v":0.390219525987692,"d":"0.39"},"up","no"]
["MSTRG.16190","TST","ENSOART00000020850","GO:0004792(thiosulfate sulfurtransferase activity);GO:0005739(mitochondrion);GO:0008097(5S rRNA binding);GO:0016740(transferase activity);GO:0030855(epithelial cell differentiation);GO:0035928(rRNA import into mitochondrion);GO:0051029(rRNA transport)","00270(Cysteine and methionine metabolism);00920(Sulfur metabolism);04122(Sulfur relay system)","K01011","2.8.1.2;EC:2.8.1.1","thiosulfate sulfurtransferase [Source:NCBI gene;Acc:101101881]",{"v":2.84640225287356,"d":"2.85"},{"v":2.87095168801314,"d":"2.87"},{"v":1.57688882101806,"d":"1.58"},{"v":4.00267572906404,"d":"4.00"},{"v":4.46578179967159,"d":"4.47"},{"v":4.75928453694581,"d":"4.76"},{"v":0.551435212879545,"d":"0.55"},{"v":-0.858736698731402,"d":"-0.86"},{"v":0.0460504104162807,"d":"0.05"},{"v":0.390219525987692,"d":"0.39"},"down","no"]
["MSTRG.6458","USP47","ENSOART00000010466;ENSOART00000010463","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0006284(base-excision repair);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0016579(protein deubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0030307(positive regulation of cell growth);GO:0034644(cellular response to UV);GO:0035520(monoubiquitinated protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0071987(WD40-repeat domain binding);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0101005(ubiquitinyl hydrolase activity);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","NA","K11857","EC:3.4.19.12","ubiquitin specific peptidase 47 [Source:NCBI gene;Acc:101122304]",{"v":7.37493109301407,"d":"7.37"},{"v":8.43671177264106,"d":"8.44"},{"v":6.06826672569938,"d":"6.07"},{"v":5.31490244792161,"d":"5.31"},{"v":5.17488688620199,"d":"5.17"},{"v":4.36074597763553,"d":"4.36"},{"v":1.4733414743662,"d":"1.47"},{"v":0.559091840611814,"d":"0.56"},{"v":0.0460513797910185,"d":"0.05"},{"v":0.390219525987692,"d":"0.39"},"up","no"]
["MSTRG.6671","HIPK3;ENSOARG00000022093","ENSOART00000018923;ENSOART00000023995","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0009299(mRNA transcription);GO:0016604(nuclear body);GO:0016605(PML body);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0043066(negative regulation of apoptotic process);GO:0043508(negative regulation of JUN kinase activity)","04218(Cellular senescence)","K08826","EC:2.7.11.1","homeodomain interacting protein kinase 3 [Source:NCBI gene;Acc:101123406]",{"v":39.3531438078929,"d":"39.35"},{"v":40.2418727995971,"d":"40.24"},{"v":33.2953529912301,"d":"33.30"},{"v":28.5804228748519,"d":"28.58"},{"v":27.0333729356483,"d":"27.03"},{"v":22.2392826007348,"d":"22.24"},{"v":1.4500437478196,"d":"1.45"},{"v":0.536096427005924,"d":"0.54"},{"v":0.0460529781098899,"d":"0.05"},{"v":0.390219525987692,"d":"0.39"},"up","no"]
["MSTRG.13886","DISC1","ENSOART00000003566","GO:0000226(microtubule cytoskeleton organization);GO:0001764(neuron migration);GO:0002052(positive regulation of neuroblast proliferation);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0030177(positive regulation of Wnt signaling pathway);GO:0045111(intermediate filament cytoskeleton);GO:0097546(ciliary base);GO:1905515(non-motile cilium assembly)","NA","K16534","NA","DISC1 scaffold protein [Source:NCBI gene;Acc:101114672]",{"v":1.367233,"d":"1.37"},{"v":1.101575,"d":"1.10"},{"v":1.19509,"d":"1.20"},{"v":2.305069,"d":"2.31"},{"v":2.134948,"d":"2.13"},{"v":1.914898,"d":"1.91"},{"v":0.576545555684065,"d":"0.58"},{"v":-0.794493488115484,"d":"-0.79"},{"v":0.0460912668754554,"d":"0.05"},{"v":0.390341392916201,"d":"0.39"},"down","no"]
["MSTRG.20570","LAMA2","ENSOART00000014832","GO:0005102(signaling receptor binding);GO:0005604(basement membrane);GO:0007155(cell adhesion);GO:0007411(axon guidance);GO:0030155(regulation of cell adhesion);GO:0030334(regulation of cell migration);GO:0031594(neuromuscular junction);GO:0032224(positive regulation of synaptic transmission, cholinergic);GO:0042383(sarcolemma);GO:0043083(synaptic cleft);GO:0045995(regulation of embryonic development)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);05145(Toxoplasmosis);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K05637","NA","laminin subunit alpha 2 [Source:NCBI gene;Acc:101117424]",{"v":10.4441152251623,"d":"10.44"},{"v":8.72998926553919,"d":"8.73"},{"v":10.5498066087743,"d":"10.55"},{"v":15.0671216672491,"d":"15.07"},{"v":16.8557864929481,"d":"16.86"},{"v":16.4912671618198,"d":"16.49"},{"v":0.613950581658641,"d":"0.61"},{"v":-0.703805560570907,"d":"-0.70"},{"v":0.0461555863457693,"d":"0.05"},{"v":0.390481043447524,"d":"0.39"},"down","no"]
["MSTRG.16955","ENSOARG00000008339","ENSOART00000009071","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005885(Arp2/3 protein complex);GO:0015629(actin cytoskeleton);GO:0030833(regulation of actin filament polymerization);GO:0034314(Arp2/3 complex-mediated actin nucleation)","NA","NA","NA","actin-related protein 2/3 complex subunit 1A pseudogene [Source:NCBI gene;Acc:101108907]",{"v":0.560141,"d":"0.56"},{"v":4.788499,"d":"4.79"},{"v":0.273109,"d":"0.27"},{"v":0.595178,"d":"0.60"},{"v":0.602554,"d":"0.60"},{"v":0.778351,"d":"0.78"},{"v":2.84489517899805,"d":"2.84"},{"v":1.50837549698682,"d":"1.51"},{"v":0.0462103160918375,"d":"0.05"},{"v":0.390741605980074,"d":"0.39"},"up","yes"]
["MSTRG.5755","RABAC1","ENSOART00000009019","GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042802(identical protein binding)","NA","K20359","NA","Rab acceptor 1 [Source:NCBI gene;Acc:100302072]",{"v":20.585264,"d":"20.59"},{"v":18.022438,"d":"18.02"},{"v":16.901985,"d":"16.90"},{"v":24.078012,"d":"24.08"},{"v":32.654533,"d":"32.65"},{"v":35.884918,"d":"35.88"},{"v":0.599343635659724,"d":"0.60"},{"v":-0.73854468066838,"d":"-0.74"},{"v":0.0463725076390109,"d":"0.05"},{"v":0.391302483064481,"d":"0.39"},"down","no"]
["MSTRG.18086","DBN1","ENSOART00000005781","GO:0003779(actin binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005921(gap junction);GO:0007015(actin filament organization);GO:0010643(cell communication by chemical coupling);GO:0010644(cell communication by electrical coupling);GO:0014069(postsynaptic density);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0030425(dendrite);GO:0030426(growth cone);GO:0031915(positive regulation of synaptic plasticity);GO:0032507(maintenance of protein location in cell);GO:0045211(postsynaptic membrane);GO:0048699(generation of neurons);GO:0051220(cytoplasmic sequestering of protein);GO:0061003(positive regulation of dendritic spine morphogenesis);GO:0061351(neural precursor cell proliferation);GO:0098978(glutamatergic synapse);GO:0099524(postsynaptic cytosol);GO:1902685(positive regulation of receptor localization to synapse)","NA","NA","NA","drebrin 1 [Source:NCBI gene;Acc:101123207]",{"v":1.88570867919922,"d":"1.89"},{"v":1.00979272021484,"d":"1.01"},{"v":2.56257113964844,"d":"2.56"},{"v":3.10765187011719,"d":"3.11"},{"v":2.99660376074219,"d":"3.00"},{"v":3.62875464355469,"d":"3.63"},{"v":0.560779490124506,"d":"0.56"},{"v":-0.834494509513075,"d":"-0.83"},{"v":0.0464432073241666,"d":"0.05"},{"v":0.391696636977785,"d":"0.39"},"down","no"]
["ENSOARG00000005827","GLMP","ENSOART00000006342","GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005764(lysosome);GO:0005829(cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","glycosylated lysosomal membrane protein [Source:NCBI gene;Acc:101103279]",{"v":0.631062,"d":"0.63"},{"v":0.352945,"d":"0.35"},{"v":0.494929,"d":"0.49"},{"v":0.954356,"d":"0.95"},{"v":1.118802,"d":"1.12"},{"v":0.933247,"d":"0.93"},{"v":0.491928399533662,"d":"0.49"},{"v":-1.0234797491498,"d":"-1.02"},{"v":0.0465088288913206,"d":"0.05"},{"v":0.392047577768448,"d":"0.39"},"down","yes"]
["MSTRG.17071","TRIL","ENSOART00000009858","GO:0001530(lipopolysaccharide binding);GO:0002718(regulation of cytokine production involved in immune response);GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034142(toll-like receptor 4 signaling pathway);GO:0046696(lipopolysaccharide receptor complex)","NA","NA","NA","TLR4 interactor with leucine rich repeats [Source:HGNC Symbol;Acc:HGNC:22200]",{"v":0.631045,"d":"0.63"},{"v":0.10101,"d":"0.10"},{"v":0.384917,"d":"0.38"},{"v":0.904213,"d":"0.90"},{"v":0.729647,"d":"0.73"},{"v":0.902232,"d":"0.90"},{"v":0.440430394480957,"d":"0.44"},{"v":-1.18301406092184,"d":"-1.18"},{"v":0.0465490967998185,"d":"0.05"},{"v":0.392184547238099,"d":"0.39"},"down","yes"]
["MSTRG.6217","ENSOARG00000009829","ENSOART00000010695","GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0008417(fucosyltransferase activity);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0032580(Golgi cisterna membrane);GO:0036065(fucosylation);GO:0071944(cell periphery)","NA","NA","NA",null,{"v":0.794668,"d":"0.79"},{"v":0.317742,"d":"0.32"},{"v":0.451882,"d":"0.45"},{"v":0.85244,"d":"0.85"},{"v":1.181884,"d":"1.18"},{"v":1.264902,"d":"1.26"},{"v":0.474139085955312,"d":"0.47"},{"v":-1.07661776744297,"d":"-1.08"},{"v":0.0466535218522662,"d":"0.05"},{"v":0.392792120465578,"d":"0.39"},"down","yes"]
["MSTRG.17158","STK17A","ENSOART00000018546","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0016607(nuclear speck);GO:0035556(intracellular signal transduction);GO:0043065(positive regulation of apoptotic process);GO:2000271(positive regulation of fibroblast apoptotic process);GO:2000377(regulation of reactive oxygen species metabolic process)","NA","K08804","EC:2.7.11.1","serine/threonine kinase 17a [Source:NCBI gene;Acc:101119390]",{"v":1.353112,"d":"1.35"},{"v":2.076762,"d":"2.08"},{"v":1.983039,"d":"1.98"},{"v":1.27138,"d":"1.27"},{"v":0.999843,"d":"1.00"},{"v":1.208407,"d":"1.21"},{"v":1.55560016438529,"d":"1.56"},{"v":0.637471292339012,"d":"0.64"},{"v":0.0466693234752096,"d":"0.05"},{"v":0.392792120465578,"d":"0.39"},"up","no"]
["MSTRG.2886","ENSOARG00000005695","ENSOART00000006202","GO:0001843(neural tube closure);GO:0003779(actin binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0017048(Rho GTPase binding);GO:0030036(actin cytoskeleton organization);GO:0060074(synapse maturation);GO:0098885(modification of postsynaptic actin cytoskeleton);GO:0098978(glutamatergic synapse)","04015(Rap1 signaling pathway);04810(Regulation of actin cytoskeleton);05132(Salmonella infection)","K05759","NA","profilin 1 [Source:NCBI gene;Acc:101109371]",{"v":112.040108,"d":"112.04"},{"v":123.033249,"d":"123.03"},{"v":137.830795,"d":"137.83"},{"v":176.143265,"d":"176.14"},{"v":187.68544,"d":"187.69"},{"v":272.878906,"d":"272.88"},{"v":0.585675662670852,"d":"0.59"},{"v":-0.771826149344787,"d":"-0.77"},{"v":0.0467184579981919,"d":"0.05"},{"v":0.39280071173763,"d":"0.39"},"down","no"]
["MSTRG.21043","HAS2","ENSOART00000012024","GO:0005887(integral component of plasma membrane);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030213(hyaluronan biosynthetic process);GO:0030335(positive regulation of cell migration);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0042802(identical protein binding);GO:0050501(hyaluronan synthase activity);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0071498(cellular response to fluid shear stress);GO:1900625(positive regulation of monocyte aggregation)","NA","K00752","EC:2.4.1.212","hyaluronan synthase 2 [Source:NCBI gene;Acc:101110341]",{"v":0.652405249317561,"d":"0.65"},{"v":1.36176769017288,"d":"1.36"},{"v":1.74559029481347,"d":"1.75"},{"v":0.94795594722475,"d":"0.95"},{"v":0.581029369426752,"d":"0.58"},{"v":0.622713328480437,"d":"0.62"},{"v":1.74734656398567,"d":"1.75"},{"v":0.805165776862141,"d":"0.81"},{"v":0.0468471691593326,"d":"0.05"},{"v":0.393368010935563,"d":"0.39"},"up","no"]
["ENSOARG00000011445","CDR2L","ENSOART00000012443","NA","NA","NA","NA","cerebellar degeneration related protein 2 like [Source:NCBI gene;Acc:101111563]",{"v":0.432206,"d":"0.43"},{"v":0.272833,"d":"0.27"},{"v":0.438092,"d":"0.44"},{"v":0.549398,"d":"0.55"},{"v":0.860665,"d":"0.86"},{"v":0.985667,"d":"0.99"},{"v":0.477153518969166,"d":"0.48"},{"v":-1.06747458248862,"d":"-1.07"},{"v":0.0468493453916816,"d":"0.05"},{"v":0.393368010935563,"d":"0.39"},"down","yes"]
["MSTRG.11092","BAG2","ENSOART00000006340","GO:0000774(adenyl-nucleotide exchange factor activity);GO:0005874(microtubule);GO:0010954(positive regulation of protein processing);GO:0019538(protein metabolic process);GO:0030424(axon);GO:0030425(dendrite);GO:0031072(heat shock protein binding);GO:0031397(negative regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032091(negative regulation of protein binding);GO:0042802(identical protein binding);GO:0044325(ion channel binding);GO:0048156(tau protein binding);GO:0050821(protein stabilization);GO:0051087(chaperone binding);GO:0101031(chaperone complex);GO:1901588(dendritic microtubule);GO:1901800(positive regulation of proteasomal protein catabolic process);GO:1904667(negative regulation of ubiquitin protein ligase activity)","NA","NA","NA","BCL2 associated athanogene 2 [Source:HGNC Symbol;Acc:HGNC:938]",{"v":6.78600628311876,"d":"6.79"},{"v":3.89533569462159,"d":"3.90"},{"v":5.31276658524846,"d":"5.31"},{"v":5.72579721321141,"d":"5.73"},{"v":2.40804275394056,"d":"2.41"},{"v":1.6152837830586,"d":"1.62"},{"v":1.64056883190588,"d":"1.64"},{"v":0.714196125015151,"d":"0.71"},{"v":0.0471345626544418,"d":"0.05"},{"v":0.394471111748706,"d":"0.39"},"up","no"]
["MSTRG.9475","ENSOARG00000007645","ENSOART00000008324","GO:0005515(protein binding)","NA","K10267","NA","F-box/WD repeat-containing protein 12-like [Source:NCBI gene;Acc:101123603]",{"v":1.80854609190372,"d":"1.81"},{"v":1.45210245689278,"d":"1.45"},{"v":1.47584025382932,"d":"1.48"},{"v":2.46728310284464,"d":"2.47"},{"v":2.61609479781182,"d":"2.62"},{"v":3.03131558205689,"d":"3.03"},{"v":0.583692879184644,"d":"0.58"},{"v":-0.776718626851664,"d":"-0.78"},{"v":0.0472504891876898,"d":"0.05"},{"v":0.395238723082274,"d":"0.40"},"down","no"]
["MSTRG.14751","SLC27A4","ENSOART00000011343","GO:0000038(very long-chain fatty acid metabolic process);GO:0001579(medium-chain fatty acid transport);GO:0001676(long-chain fatty acid metabolic process);GO:0003824(catalytic activity);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0006631(fatty acid metabolic process);GO:0015908(fatty acid transport);GO:0015909(long-chain fatty acid transport);GO:0016021(integral component of membrane);GO:0031526(brush border membrane);GO:0031957(very long-chain fatty acid-CoA ligase activity);GO:0042760(very long-chain fatty acid catabolic process);GO:0043588(skin development);GO:0044539(long-chain fatty acid import into cell)","03320(PPAR signaling pathway);04931(Insulin resistance)","K08745","EC:6.2.1.-","solute carrier family 27 member 4 [Source:NCBI gene;Acc:101120396]",{"v":0.224174,"d":"0.22"},{"v":0.306669,"d":"0.31"},{"v":0.345793,"d":"0.35"},{"v":0.639937,"d":"0.64"},{"v":0.547233,"d":"0.55"},{"v":0.620127,"d":"0.62"},{"v":0.485053646412294,"d":"0.49"},{"v":-1.04378377824142,"d":"-1.04"},{"v":0.047613952923403,"d":"0.05"},{"v":0.397058541028256,"d":"0.40"},"down","yes"]
["MSTRG.14343","ENSOARG00000009901","ENSOART00000010774","GO:0004672(protein kinase activity);GO:0006468(protein phosphorylation)","NA","K17537","EC:2.7.10.2","PEAK1 related, kinase-activating pseudokinase 1 [Source:NCBI gene;Acc:101113127]",{"v":1.3148373062352,"d":"1.31"},{"v":1.68903469850039,"d":"1.69"},{"v":1.80497427071823,"d":"1.80"},{"v":2.87795606314128,"d":"2.88"},{"v":2.93770650986583,"d":"2.94"},{"v":2.5555017284925,"d":"2.56"},{"v":0.574453696314665,"d":"0.57"},{"v":-0.799737485374404,"d":"-0.80"},{"v":0.047785187382381,"d":"0.05"},{"v":0.397876775972696,"d":"0.40"},"down","no"]
["MSTRG.12397","CPEB3","ENSOART00000018157","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006412(translation);GO:0006417(regulation of translation);GO:0008135(translation factor activity, RNA binding);GO:0017148(negative regulation of translation);GO:0030014(CCR4-NOT complex);GO:0043005(neuron projection);GO:0045182(translation regulator activity);GO:0060213(positive regulation of nuclear-transcribed mRNA poly(A) tail shortening);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0071230(cellular response to amino acid stimulus);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay)","04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)","K02602","NA","cytoplasmic polyadenylation element binding protein 3 [Source:NCBI gene;Acc:101102192]",{"v":8.15341462532982,"d":"8.15"},{"v":10.2183606185007,"d":"10.22"},{"v":7.03877075197889,"d":"7.04"},{"v":6.35768078721093,"d":"6.36"},{"v":5.07186978333075,"d":"5.07"},{"v":5.71430973413006,"d":"5.71"},{"v":1.48219511499898,"d":"1.48"},{"v":0.567735375385289,"d":"0.57"},{"v":0.0478095440016187,"d":"0.05"},{"v":0.397876775972696,"d":"0.40"},"up","no"]
["MSTRG.8260","STRA6","ENSOART00000004434","GO:0001568(blood vessel development);GO:0001822(kidney development);GO:0003184(pulmonary valve morphogenesis);GO:0003281(ventricular septum development);GO:0005887(integral component of plasma membrane);GO:0007507(heart development);GO:0007612(learning);GO:0007631(feeding behavior);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030324(lung development);GO:0030325(adrenal gland development);GO:0030540(female genitalia development);GO:0032991(protein-containing complex);GO:0034632(retinol transmembrane transporter activity);GO:0034633(retinol transport);GO:0038023(signaling receptor activity);GO:0042297(vocal learning);GO:0043010(camera-type eye development);GO:0043583(ear development);GO:0043585(nose morphogenesis);GO:0048286(lung alveolus development);GO:0048520(positive regulation of behavior);GO:0048546(digestive tract morphogenesis);GO:0048566(embryonic digestive tract development);GO:0048589(developmental growth);GO:0048745(smooth muscle tissue development);GO:0048844(artery morphogenesis);GO:0050890(cognition);GO:0050905(neuromuscular process);GO:0060322(head development);GO:0060323(head morphogenesis);GO:0060325(face morphogenesis);GO:0060426(lung vasculature development);GO:0060539(diaphragm development);GO:0060900(embryonic camera-type eye formation);GO:0061029(eyelid development in camera-type eye);GO:0061038(uterus morphogenesis);GO:0061143(alveolar primary septum development);GO:0061156(pulmonary artery morphogenesis);GO:0061205(paramesonephric duct development);GO:0097070(ductus arteriosus closure)","NA","K23088","NA","stimulated by retinoic acid 6 [Source:NCBI gene;Acc:101120527]",{"v":0.128416,"d":"0.13"},{"v":0.095623,"d":"0.10"},{"v":0.159726,"d":"0.16"},{"v":0.160585,"d":"0.16"},{"v":0.304871,"d":"0.30"},{"v":0.342275,"d":"0.34"},{"v":0.475114858783432,"d":"0.48"},{"v":-1.07365176846283,"d":"-1.07"},{"v":0.04792513097403,"d":"0.05"},{"v":0.398229790607614,"d":"0.40"},"down","yes"]
["MSTRG.1106","ENSOARG00000013569","ENSOART00000014762","GO:0030246(carbohydrate binding)","NA","NA","NA","eva-1 homolog C [Source:NCBI gene;Acc:101102355]",{"v":1.838729,"d":"1.84"},{"v":2.645018,"d":"2.65"},{"v":1.78756,"d":"1.79"},{"v":1.343853,"d":"1.34"},{"v":1.102081,"d":"1.10"},{"v":1.397224,"d":"1.40"},{"v":1.63181087012296,"d":"1.63"},{"v":0.70647385599361,"d":"0.71"},{"v":0.0479897544867894,"d":"0.05"},{"v":0.398563942655288,"d":"0.40"},"up","no"]
["MSTRG.2712","ENSOARG00000016186","ENSOART00000017629","GO:0030246(carbohydrate binding)","NA","K10093","NA","galectin-9 [Source:NCBI gene;Acc:101102156]",{"v":3.3219511863581,"d":"3.32"},{"v":1.55618968940317,"d":"1.56"},{"v":2.49334545188794,"d":"2.49"},{"v":5.01433342021925,"d":"5.01"},{"v":3.33932909013398,"d":"3.34"},{"v":4.79838642752741,"d":"4.80"},{"v":0.560481972236113,"d":"0.56"},{"v":-0.835260125039236,"d":"-0.84"},{"v":0.0482114171964035,"d":"0.05"},{"v":0.39977643389449,"d":"0.40"},"down","no"]
["MSTRG.16940","HBP1","ENSOART00000005504;ENSOART00000005507","GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016607(nuclear speck);GO:0016607(nuclear speck)","NA","K21644","NA","HMG-box transcription factor 1 [Source:NCBI gene;Acc:101103467]",{"v":8.55667047232657,"d":"8.56"},{"v":8.67741123290759,"d":"8.68"},{"v":8.78114985699975,"d":"8.78"},{"v":5.95676245279239,"d":"5.96"},{"v":6.45562286501377,"d":"6.46"},{"v":5.46834828900576,"d":"5.47"},{"v":1.45493088450929,"d":"1.45"},{"v":0.54095062052597,"d":"0.54"},{"v":0.0482410616342243,"d":"0.05"},{"v":0.39977643389449,"d":"0.40"},"up","no"]
["ENSOARG00000000381","ENSOARG00000000381","ENSOART00000000406","GO:0005319(lipid transporter activity);GO:0006869(lipid transport);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K06316","NA","RFT1 homolog [Source:NCBI gene;Acc:101107904]",{"v":0.888737,"d":"0.89"},{"v":0.773453,"d":"0.77"},{"v":0.814955,"d":"0.81"},{"v":1.817299,"d":"1.82"},{"v":1.378305,"d":"1.38"},{"v":1.327203,"d":"1.33"},{"v":0.547700797314588,"d":"0.55"},{"v":-0.868540114318311,"d":"-0.87"},{"v":0.0482581670263376,"d":"0.05"},{"v":0.39977643389449,"d":"0.40"},"down","no"]
["ENSOARG00000006316","SDCCAG8","ENSOART00000006872","GO:0001764(neuron migration);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005911(cell-cell junction);GO:0007098(centrosome cycle);GO:0030010(establishment of cell polarity);GO:0031023(microtubule organizing center organization);GO:0034451(centriolar satellite);GO:0035148(tube formation);GO:1902017(regulation of cilium assembly)","NA","K16488","NA","serologically defined colon cancer antigen 8 [Source:NCBI gene;Acc:101118887]",{"v":0.488568,"d":"0.49"},{"v":0.452774,"d":"0.45"},{"v":0.4714,"d":"0.47"},{"v":1.057612,"d":"1.06"},{"v":0.981599,"d":"0.98"},{"v":0.677732,"d":"0.68"},{"v":0.5199748393691,"d":"0.52"},{"v":-0.943486279317546,"d":"-0.94"},{"v":0.0483608207963347,"d":"0.05"},{"v":0.400382829573437,"d":"0.40"},"down","no"]
["MSTRG.17178","CPED1","ENSOART00000019828;ENSOART00000019829","GO:0005783(endoplasmic reticulum);GO:0005783(endoplasmic reticulum)","NA","NA","NA","cadherin like and PC-esterase domain containing 1 [Source:NCBI gene;Acc:101102975]",{"v":4.10935813825022,"d":"4.11"},{"v":5.22537822633622,"d":"5.23"},{"v":3.82506836309346,"d":"3.83"},{"v":2.89304377664975,"d":"2.89"},{"v":3.09459984502837,"d":"3.09"},{"v":2.94203200059719,"d":"2.94"},{"v":1.47371587550755,"d":"1.47"},{"v":0.559458407399435,"d":"0.56"},{"v":0.0483804092815036,"d":"0.05"},{"v":0.400382829573437,"d":"0.40"},"up","no"]
["MSTRG.6528","CAVIN3","ENSOART00000020333","GO:0005080(protein kinase C binding);GO:0005737(cytoplasm);GO:0005901(caveola);GO:0030866(cortical actin cytoskeleton organization);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0051898(negative regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1901003(negative regulation of fermentation)","NA","NA","NA","caveolae associated protein 3 [Source:HGNC Symbol;Acc:HGNC:9400]",{"v":4.09965,"d":"4.10"},{"v":2.768907,"d":"2.77"},{"v":3.196789,"d":"3.20"},{"v":5.124853,"d":"5.12"},{"v":4.832807,"d":"4.83"},{"v":8.117627,"d":"8.12"},{"v":0.556856773560497,"d":"0.56"},{"v":-0.844621788228942,"d":"-0.84"},{"v":0.0485637576312709,"d":"0.05"},{"v":0.400998672600696,"d":"0.40"},"down","no"]
["MSTRG.16773","SGCE","ENSOART00000002577;ENSOART00000002575","GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0016012(sarcoglycan complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032590(dendrite membrane);GO:0032590(dendrite membrane)","NA","NA","NA","sarcoglycan epsilon [Source:NCBI gene;Acc:101115114]",{"v":3.51020618238994,"d":"3.51"},{"v":2.08280311320755,"d":"2.08"},{"v":4.32729380503145,"d":"4.33"},{"v":5.34768706289308,"d":"5.35"},{"v":5.47327921383648,"d":"5.47"},{"v":6.74192126415094,"d":"6.74"},{"v":0.564844651970686,"d":"0.56"},{"v":-0.824073954170652,"d":"-0.82"},{"v":0.0485742615415148,"d":"0.05"},{"v":0.400998672600696,"d":"0.40"},"down","no"]
["MSTRG.6442","TEAD1","ENSOART00000008788","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0035329(hippo signaling);GO:0045944(positive regulation of transcription by RNA polymerase II)","04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species)","K09448","NA","TEA domain transcription factor 1 [Source:NCBI gene;Acc:101120947]",{"v":6.2699587071896,"d":"6.27"},{"v":7.30965344081866,"d":"7.31"},{"v":6.09676033629057,"d":"6.10"},{"v":5.94897891648733,"d":"5.95"},{"v":4.23722048836137,"d":"4.24"},{"v":3.3301633187887,"d":"3.33"},{"v":1.45574463238463,"d":"1.46"},{"v":0.541757299283567,"d":"0.54"},{"v":0.0485926005402037,"d":"0.05"},{"v":0.400998672600696,"d":"0.40"},"up","no"]
["MSTRG.11963","FADS2","ENSOART00000015072","GO:0004768(stearoyl-CoA 9-desaturase activity);GO:0006629(lipid metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00592(alpha-Linolenic acid metabolism);01040(Biosynthesis of unsaturated fatty acids);03320(PPAR signaling pathway)","K10226","EC:1.14.19.3","fatty acid desaturase 2 [Source:NCBI gene;Acc:101108615]",{"v":4.98586776015857,"d":"4.99"},{"v":2.21840050545094,"d":"2.22"},{"v":4.13209793359762,"d":"4.13"},{"v":6.75555810208127,"d":"6.76"},{"v":5.65830582755203,"d":"5.66"},{"v":7.19034448959366,"d":"7.19"},{"v":0.578261868920395,"d":"0.58"},{"v":-0.790205122167937,"d":"-0.79"},{"v":0.0486332746497663,"d":"0.05"},{"v":0.400998672600696,"d":"0.40"},"down","no"]
["ENSOARG00000010347","ZBED8","ENSOART00000011254","GO:0005654(nucleoplasm)","NA","NA","NA","chromosome 5 open reading frame, human C5orf54 [Source:NCBI gene;Acc:101116311]",{"v":0.566701,"d":"0.57"},{"v":0.22112,"d":"0.22"},{"v":0.516417,"d":"0.52"},{"v":1.038976,"d":"1.04"},{"v":1.010477,"d":"1.01"},{"v":0.679454,"d":"0.68"},{"v":0.477934205892689,"d":"0.48"},{"v":-1.06511606949641,"d":"-1.07"},{"v":0.0486512965716548,"d":"0.05"},{"v":0.400998672600696,"d":"0.40"},"down","yes"]
["MSTRG.11267","CNPY3","ENSOART00000004626","GO:0005102(signaling receptor binding)","NA","K22816","NA","canopy FGF signaling regulator 3 [Source:NCBI gene;Acc:101110884]",{"v":1.412096,"d":"1.41"},{"v":1.029183,"d":"1.03"},{"v":1.387429,"d":"1.39"},{"v":2.261527,"d":"2.26"},{"v":2.442208,"d":"2.44"},{"v":2.519807,"d":"2.52"},{"v":0.53003194277821,"d":"0.53"},{"v":-0.915848787477461,"d":"-0.92"},{"v":0.048858005188957,"d":"0.05"},{"v":0.401892839282378,"d":"0.40"},"down","no"]
["ENSOARG00000015941","HSPA4L","ENSOART00000017363","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005829(cytosol)","04141(Protein processing in endoplasmic reticulum)","K09485","NA","heat shock protein family A (Hsp70) member 4 like [Source:NCBI gene;Acc:101122219]",{"v":0.248624,"d":"0.25"},{"v":1.182756,"d":"1.18"},{"v":0.772558,"d":"0.77"},{"v":0.325025,"d":"0.33"},{"v":0.418497,"d":"0.42"},{"v":0.385664,"d":"0.39"},{"v":1.95179359290675,"d":"1.95"},{"v":0.964800492329638,"d":"0.96"},{"v":0.048880247478188,"d":"0.05"},{"v":0.401892839282378,"d":"0.40"},"up","no"]
["MSTRG.21149","STAU2","ENSOART00000006537","GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding)","NA","K17597","NA","staufen double-stranded RNA binding protein 2 [Source:NCBI gene;Acc:101107105]",{"v":12.9888284095528,"d":"12.99"},{"v":12.3750668733062,"d":"12.38"},{"v":10.438893287771,"d":"10.44"},{"v":8.28859270477642,"d":"8.29"},{"v":7.94618009789973,"d":"7.95"},{"v":8.18354376287263,"d":"8.18"},{"v":1.46622673493976,"d":"1.47"},{"v":0.552108216759616,"d":"0.55"},{"v":0.0490036686662435,"d":"0.05"},{"v":0.402189579325872,"d":"0.40"},"up","no"]
["MSTRG.1507","IGF2BP2","ENSOART00000022394","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding)","NA","K17392","NA","insulin like growth factor 2 mRNA binding protein 2 [Source:NCBI gene;Acc:101115925]",{"v":1.747961,"d":"1.75"},{"v":0.879291,"d":"0.88"},{"v":0.909352,"d":"0.91"},{"v":1.72688,"d":"1.73"},{"v":2.1917,"d":"2.19"},{"v":2.622265,"d":"2.62"},{"v":0.540695277139269,"d":"0.54"},{"v":-0.887112340053382,"d":"-0.89"},{"v":0.0490451469395605,"d":"0.05"},{"v":0.402189579325872,"d":"0.40"},"down","no"]
["ENSOARG00000010837","TPMT","ENSOART00000011792","GO:0008119(thiopurine S-methyltransferase activity);GO:0008757(S-adenosylmethionine-dependent methyltransferase activity);GO:0017144(drug metabolic process);GO:0032259(methylation);GO:1904047(S-adenosyl-L-methionine binding)","00983(Drug metabolism - other enzymes)","K00569","EC:2.1.1.67","thiopurine S-methyltransferase [Source:NCBI gene;Acc:101123418]",{"v":0.230969,"d":"0.23"},{"v":0.213692,"d":"0.21"},{"v":0.268029,"d":"0.27"},{"v":0.110749,"d":"0.11"},{"v":0.144917,"d":"0.14"},{"v":0.133289,"d":"0.13"},{"v":1.83231993418262,"d":"1.83"},{"v":0.873671428740582,"d":"0.87"},{"v":0.0490667345674386,"d":"0.05"},{"v":0.402189579325872,"d":"0.40"},"up","no"]
["MSTRG.2114","ENSOARG00000007620","ENSOART00000008296","GO:0006839(mitochondrial transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0031966(mitochondrial membrane);GO:0055085(transmembrane transport)","NA","K15106","NA","solute carrier family 25 member 30 [Source:NCBI gene;Acc:101111642]",{"v":39.587105,"d":"39.59"},{"v":30.991238,"d":"30.99"},{"v":20.038,"d":"20.04"},{"v":27.692896,"d":"27.69"},{"v":13.720229,"d":"13.72"},{"v":17.025703,"d":"17.03"},{"v":1.55061875984234,"d":"1.55"},{"v":0.632844024289334,"d":"0.63"},{"v":0.0491642480603483,"d":"0.05"},{"v":0.402786674525523,"d":"0.40"},"up","no"]
["MSTRG.6124","ZNF135","ENSOART00000004146","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0007010(cytoskeleton organization);GO:0022604(regulation of cell morphogenesis);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 135 [Source:NCBI gene;Acc:101111220]",{"v":1.006427,"d":"1.01"},{"v":1.490218,"d":"1.49"},{"v":1.057012,"d":"1.06"},{"v":0.90352,"d":"0.90"},{"v":0.626908,"d":"0.63"},{"v":0.663987,"d":"0.66"},{"v":1.61940972878877,"d":"1.62"},{"v":0.695468049819703,"d":"0.70"},{"v":0.0495092752237826,"d":"0.05"},{"v":0.404598321248209,"d":"0.40"},"up","no"]
["MSTRG.9703","FRMPD1","ENSOART00000012419","GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0032991(protein-containing complex);GO:0090150(establishment of protein localization to membrane)","NA","NA","NA","FERM and PDZ domain containing 1 [Source:NCBI gene;Acc:101106908]",{"v":0.819251,"d":"0.82"},{"v":0.365881,"d":"0.37"},{"v":0.41121,"d":"0.41"},{"v":1.492106,"d":"1.49"},{"v":0.670571,"d":"0.67"},{"v":0.890908,"d":"0.89"},{"v":0.522776343216252,"d":"0.52"},{"v":-0.935734237412782,"d":"-0.94"},{"v":0.0495937151573646,"d":"0.05"},{"v":0.404721493452656,"d":"0.40"},"down","no"]
["MSTRG.17959","LMNB2","ENSOART00000014889","GO:0005198(structural molecule activity);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005638(lamin filament);GO:0005882(intermediate filament);GO:0031965(nuclear membrane)","04210(Apoptosis)","K07611","NA","lamin B2 [Source:NCBI gene;Acc:101120243]",{"v":2.022214,"d":"2.02"},{"v":2.047218,"d":"2.05"},{"v":2.306752,"d":"2.31"},{"v":4.141863,"d":"4.14"},{"v":2.81317,"d":"2.81"},{"v":4.135467,"d":"4.14"},{"v":0.574923042243361,"d":"0.57"},{"v":-0.798559241446694,"d":"-0.80"},{"v":0.0496123261883523,"d":"0.05"},{"v":0.404721493452656,"d":"0.40"},"down","no"]
["MSTRG.21151","UBE2W","ENSOART00000006632","NA","NA","NA","NA","ubiquitin conjugating enzyme E2 W [Source:HGNC Symbol;Acc:HGNC:25616]",{"v":2.88693188705059,"d":"2.89"},{"v":3.22778165797009,"d":"3.23"},{"v":2.82937853149857,"d":"2.83"},{"v":2.60450553468024,"d":"2.60"},{"v":1.70150539739103,"d":"1.70"},{"v":1.78397114158447,"d":"1.78"},{"v":1.46865655240759,"d":"1.47"},{"v":0.55449705888301,"d":"0.55"},{"v":0.0496234952163289,"d":"0.05"},{"v":0.404721493452656,"d":"0.40"},"up","no"]
["MSTRG.18242","KIF20A","ENSOART00000017285","GO:0000166(nucleotide binding);GO:0000281(mitotic cytokinesis);GO:0001578(microtubule bundle formation);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005819(spindle);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0019901(protein kinase binding);GO:0030496(midbody);GO:0032154(cleavage furrow);GO:0032465(regulation of cytokinesis);GO:0045171(intercellular bridge);GO:0061952(midbody abscission)","NA","K10402","NA","kinesin family member 20A [Source:NCBI gene;Acc:101109352]",{"v":0.523103,"d":"0.52"},{"v":0.249272,"d":"0.25"},{"v":0.321981,"d":"0.32"},{"v":1.30312,"d":"1.30"},{"v":0.497163,"d":"0.50"},{"v":0.531689,"d":"0.53"},{"v":0.469283507692202,"d":"0.47"},{"v":-1.09146833511518,"d":"-1.09"},{"v":0.0497159759583753,"d":"0.05"},{"v":0.404760834171544,"d":"0.40"},"down","yes"]
["MSTRG.6563","ENSOARG00000004298","ENSOART00000004681","GO:0005542(folic acid binding);GO:0061714(folic acid receptor activity);GO:0071231(cellular response to folic acid);GO:1904447(folate import across plasma membrane)","01523(Antifolate resistance);04144(Endocytosis)","K13649","NA","folate receptor beta [Source:NCBI gene;Acc:101121452]",{"v":0.468793814748201,"d":"0.47"},{"v":0.265032330935252,"d":"0.27"},{"v":1.67340068705036,"d":"1.67"},{"v":1.99802281654676,"d":"2.00"},{"v":1.81593833273381,"d":"1.82"},{"v":2.00684060251799,"d":"2.01"},{"v":0.413555887209182,"d":"0.41"},{"v":-1.27384578906684,"d":"-1.27"},{"v":0.0497569697390265,"d":"0.05"},{"v":0.404760834171544,"d":"0.40"},"down","yes"]
["MSTRG.18939","SGCB","ENSOART00000020076","GO:0005886(plasma membrane);GO:0007517(muscle organ development);GO:0016010(dystrophin-associated glycoprotein complex);GO:0016011(dystroglycan complex);GO:0016012(sarcoglycan complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042383(sarcolemma);GO:0048747(muscle fiber development);GO:0055013(cardiac muscle cell development);GO:0097084(vascular smooth muscle cell development)","05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05416(Viral myocarditis)","K12566","NA","sarcoglycan beta [Source:NCBI gene;Acc:101113852]",{"v":27.4437926359658,"d":"27.44"},{"v":22.5463458201709,"d":"22.55"},{"v":22.3535341412794,"d":"22.35"},{"v":18.0961779410294,"d":"18.10"},{"v":17.1822723256928,"d":"17.18"},{"v":15.0547452967285,"d":"15.05"},{"v":1.43729544265114,"d":"1.44"},{"v":0.523356644841542,"d":"0.52"},{"v":0.0497770550598028,"d":"0.05"},{"v":0.404760834171544,"d":"0.40"},"up","no"]
["MSTRG.18506","VCAN","ENSOART00000017009","GO:0005509(calcium ion binding);GO:0005540(hyaluronic acid binding);GO:0007155(cell adhesion)","04514(Cell adhesion molecules (CAMs))","K06793","NA","versican [Source:NCBI gene;Acc:100294605]",{"v":2.0351514513398,"d":"2.04"},{"v":2.28248422990301,"d":"2.28"},{"v":6.29841488007562,"d":"6.30"},{"v":2.00503544180503,"d":"2.01"},{"v":2.10490481546934,"d":"2.10"},{"v":2.16265204496137,"d":"2.16"},{"v":1.69245027411307,"d":"1.69"},{"v":0.759113446595339,"d":"0.76"},{"v":0.0498878195125584,"d":"0.05"},{"v":0.405257869154753,"d":"0.41"},"up","no"]
["MSTRG.5633","ENSOARG00000005350","ENSOART00000005829","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 568 [Source:NCBI gene;Acc:101107128]",{"v":1.48310569856986,"d":"1.48"},{"v":1.3902616320132,"d":"1.39"},{"v":1.44444343289329,"d":"1.44"},{"v":2.67636256325633,"d":"2.68"},{"v":2.27886762651265,"d":"2.28"},{"v":2.3013889939494,"d":"2.30"},{"v":0.595016860353398,"d":"0.60"},{"v":-0.748997545788452,"d":"-0.75"},{"v":0.0499894775209972,"d":"0.05"},{"v":0.405760356164103,"d":"0.41"},"down","no"]
["MSTRG.22222","ENOX2","ENSOART00000017270","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0007624(ultradian rhythm);GO:0009897(external side of plasma membrane);GO:0015035(protein disulfide oxidoreductase activity);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","NA","NA","NA","ecto-NOX disulfide-thiol exchanger 2 [Source:NCBI gene;Acc:101104304]",{"v":6.922624,"d":"6.92"},{"v":3.947783,"d":"3.95"},{"v":4.141659,"d":"4.14"},{"v":3.707242,"d":"3.71"},{"v":3.497281,"d":"3.50"},{"v":2.600909,"d":"2.60"},{"v":1.53099486080776,"d":"1.53"},{"v":0.61446944005547,"d":"0.61"},{"v":0.0500634411985614,"d":"0.05"},{"v":0.405760356164103,"d":"0.41"},"up","no"]
["MSTRG.18124","PALM","ENSOART00000010045","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007194(negative regulation of adenylate cyclase activity);GO:0008104(protein localization);GO:0008360(regulation of cell shape);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0030175(filopodium);GO:0031527(filopodium membrane);GO:0031750(D3 dopamine receptor binding);GO:0043231(intracellular membrane-bounded organelle);GO:0044309(neuron spine);GO:0051491(positive regulation of filopodium assembly);GO:0060074(synapse maturation);GO:0060160(negative regulation of dopamine receptor signaling pathway);GO:0071257(cellular response to electrical stimulus);GO:0072659(protein localization to plasma membrane)","NA","K16519","NA","paralemmin [Source:NCBI gene;Acc:101109798]",{"v":2.3286569219097,"d":"2.33"},{"v":1.91163702257587,"d":"1.91"},{"v":1.95182833049593,"d":"1.95"},{"v":2.60329093560326,"d":"2.60"},{"v":4.02325005958549,"d":"4.02"},{"v":3.98921863286454,"d":"3.99"},{"v":0.58329526024856,"d":"0.58"},{"v":-0.777701743766166,"d":"-0.78"},{"v":0.050085522781522,"d":"0.05"},{"v":0.405760356164103,"d":"0.41"},"down","no"]
["MSTRG.1548","ENSOARG00000020670","ENSOART00000022519","NA","NA","K09539","NA","DnaJ heat shock protein family (Hsp40) member C19 [Source:NCBI gene;Acc:101104447]",{"v":9.39244801980198,"d":"9.39"},{"v":10.7050361866699,"d":"10.71"},{"v":9.42539040883844,"d":"9.43"},{"v":7.54731749432504,"d":"7.55"},{"v":6.65457554141512,"d":"6.65"},{"v":6.35723193962811,"d":"6.36"},{"v":1.43599859676331,"d":"1.44"},{"v":0.522054339381295,"d":"0.52"},{"v":0.0502186744431108,"d":"0.05"},{"v":0.406120976593375,"d":"0.41"},"up","no"]
["MSTRG.1537","KLHL24","ENSOART00000022495","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005912(adherens junction);GO:0016567(protein ubiquitination);GO:0030057(desmosome);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0045109(intermediate filament organization);GO:0051865(protein autoubiquitination);GO:2000312(regulation of kainate selective glutamate receptor activity)","NA","K10461","NA","kelch like family member 24 [Source:NCBI gene;Acc:101102691]",{"v":21.811275005884,"d":"21.81"},{"v":18.9274318098907,"d":"18.93"},{"v":15.6735608100308,"d":"15.67"},{"v":16.5935886384141,"d":"16.59"},{"v":10.6105880106472,"d":"10.61"},{"v":11.7295766185206,"d":"11.73"},{"v":1.44892960198566,"d":"1.45"},{"v":0.534987501497045,"d":"0.53"},{"v":0.0502427959773773,"d":"0.05"},{"v":0.406120976593375,"d":"0.41"},"up","no"]
["MSTRG.3778","RGS2","ENSOART00000010510","GO:0001965(G-protein alpha-subunit binding);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007283(spermatogenesis);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0009898(cytoplasmic side of plasma membrane);GO:0010519(negative regulation of phospholipase activity);GO:0010614(negative regulation of cardiac muscle hypertrophy);GO:0043407(negative regulation of MAP kinase activity);GO:0043547(positive regulation of GTPase activity);GO:0043951(negative regulation of cAMP-mediated signaling);GO:0045744(negative regulation of G protein-coupled receptor signaling pathway);GO:0050873(brown fat cell differentiation);GO:0055119(relaxation of cardiac muscle);GO:0060087(relaxation of vascular smooth muscle);GO:0060452(positive regulation of cardiac muscle contraction);GO:0140194(negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process)","04022(cGMP-PKG signaling pathway);04740(Olfactory transduction);04921(Oxytocin signaling pathway)","K18154","NA","regulator of G protein signaling 2 [Source:NCBI gene;Acc:443163]",{"v":2.734525,"d":"2.73"},{"v":1.685457,"d":"1.69"},{"v":1.097312,"d":"1.10"},{"v":1.419537,"d":"1.42"},{"v":0.553993,"d":"0.55"},{"v":1.090117,"d":"1.09"},{"v":1.80089089898412,"d":"1.80"},{"v":0.848710782986424,"d":"0.85"},{"v":0.0503098231533971,"d":"0.05"},{"v":0.40646154994986,"d":"0.41"},"up","no"]
["MSTRG.3722","ENSOARG00000002079","ENSOART00000002238","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding)","NA","K09269","NA","SRY-box 13 [Source:NCBI gene;Acc:101107210]",{"v":1.35398,"d":"1.35"},{"v":0.630032,"d":"0.63"},{"v":0.857774,"d":"0.86"},{"v":1.907298,"d":"1.91"},{"v":2.154988,"d":"2.15"},{"v":1.266832,"d":"1.27"},{"v":0.533256347485644,"d":"0.53"},{"v":-0.907098861454083,"d":"-0.91"},{"v":0.0504513051608784,"d":"0.05"},{"v":0.4070004499342,"d":"0.41"},"down","no"]
["ENSOARG00000005017","TLR5","ENSOART00000005460","GO:0001819(positive regulation of cytokine production);GO:0002376(immune system process);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034146(toll-like receptor 5 signaling pathway);GO:0042742(defense response to bacterium);GO:0045087(innate immune response);GO:0050707(regulation of cytokine secretion)","04620(Toll-like receptor signaling pathway);05132(Salmonella infection);05134(Legionellosis);05321(Inflammatory bowel disease (IBD))","K10168","NA","toll like receptor 5 [Source:NCBI gene;Acc:554256]",{"v":0.564837,"d":"0.56"},{"v":0.164513,"d":"0.16"},{"v":0.302595,"d":"0.30"},{"v":0.572235,"d":"0.57"},{"v":0.784709,"d":"0.78"},{"v":0.782633,"d":"0.78"},{"v":0.482312625346038,"d":"0.48"},{"v":-1.05195951931851,"d":"-1.05"},{"v":0.0505153183350212,"d":"0.05"},{"v":0.407151622978634,"d":"0.41"},"down","no"]
["MSTRG.1652","RF01295","ENSOART00000023550","NA","NA","NA","NA","small Cajal body-specific RNA 7 [Source:HGNC Symbol;Acc:HGNC:32563]",{"v":144.088165,"d":"144.09"},{"v":124.928688,"d":"124.93"},{"v":120.221085,"d":"120.22"},{"v":157.641357,"d":"157.64"},{"v":196.111404,"d":"196.11"},{"v":317.612762,"d":"317.61"},{"v":0.579770519434314,"d":"0.58"},{"v":-0.786446118761653,"d":"-0.79"},{"v":0.0505695197879737,"d":"0.05"},{"v":0.407151622978634,"d":"0.41"},"down","no"]
["MSTRG.4296","CD34","ENSOART00000014923","GO:0001894(tissue homeostasis);GO:0001935(endothelial cell proliferation);GO:0003094(glomerular filtration);GO:0003158(endothelium development);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0008134(transcription factor binding);GO:0008217(regulation of blood pressure);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030097(hemopoiesis);GO:0030195(negative regulation of blood coagulation);GO:0030246(carbohydrate binding);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032733(positive regulation of interleukin-10 production);GO:0038001(paracrine signaling);GO:0042482(positive regulation of odontogenesis);GO:0043199(sulfate binding);GO:0045019(negative regulation of nitric oxide biosynthetic process);GO:0045171(intercellular bridge);GO:0045766(positive regulation of angiogenesis);GO:0048471(perinuclear region of cytoplasm);GO:0048870(cell motility);GO:0050900(leukocyte migration);GO:0060290(transdifferentiation);GO:0061042(vascular wound healing);GO:0071425(hematopoietic stem cell proliferation);GO:0071636(positive regulation of transforming growth factor beta production);GO:0071657(positive regulation of granulocyte colony-stimulating factor production);GO:0071944(cell periphery);GO:0071971(extracellular exosome assembly);GO:0072011(glomerular endothelium development);GO:0072089(stem cell proliferation);GO:0072254(metanephric glomerular mesangial cell differentiation);GO:0098609(cell-cell adhesion);GO:1900035(negative regulation of cellular response to heat);GO:1900038(negative regulation of cellular response to hypoxia);GO:1900041(negative regulation of interleukin-2 secretion);GO:1900168(positive regulation of glial cell-derived neurotrophic factor secretion);GO:1901215(negative regulation of neuron death);GO:2001214(positive regulation of vasculogenesis)","04514(Cell adhesion molecules (CAMs));04640(Hematopoietic cell lineage)","K06474","NA","CD34 molecule [Source:NCBI gene;Acc:101105675]",{"v":12.4561875851979,"d":"12.46"},{"v":6.85307760090361,"d":"6.85"},{"v":13.0204350682014,"d":"13.02"},{"v":16.5707102504303,"d":"16.57"},{"v":15.2101328177711,"d":"15.21"},{"v":23.9332823851119,"d":"23.93"},{"v":0.580278340389534,"d":"0.58"},{"v":-0.785183015377087,"d":"-0.79"},{"v":0.0505980263430152,"d":"0.05"},{"v":0.407178203119148,"d":"0.41"},"down","no"]
["MSTRG.11771","PRSS23","ENSOART00000015725","GO:0004252(serine-type endopeptidase activity);GO:0005634(nucleus);GO:0006508(proteolysis)","NA","K09627","EC:3.4.21.-","serine protease 23 [Source:NCBI gene;Acc:101102187]",{"v":10.340634,"d":"10.34"},{"v":3.778918,"d":"3.78"},{"v":7.496428,"d":"7.50"},{"v":4.081009,"d":"4.08"},{"v":4.432605,"d":"4.43"},{"v":4.572085,"d":"4.57"},{"v":1.651878130469,"d":"1.65"},{"v":0.724107253916223,"d":"0.72"},{"v":0.0507297616003083,"d":"0.05"},{"v":0.407496123670475,"d":"0.41"},"up","no"]
["MSTRG.7354","ENSOARG00000025185","ENSOART00000027087","GO:0005739(mitochondrion);GO:0009055(electron transfer activity);GO:0020037(heme binding);GO:0022900(electron transport chain);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0070469(respirasome)","NA","NA","NA",null,{"v":8.295221,"d":"8.30"},{"v":9.053205,"d":"9.05"},{"v":6.449359,"d":"6.45"},{"v":5.741081,"d":"5.74"},{"v":4.472448,"d":"4.47"},{"v":4.672492,"d":"4.67"},{"v":1.59866662824135,"d":"1.60"},{"v":0.676869123354579,"d":"0.68"},{"v":0.0507373603271727,"d":"0.05"},{"v":0.407496123670475,"d":"0.41"},"up","no"]
["MSTRG.4191","TOR1AIP2","ENSOART00000019297","GO:0001671(ATPase activator activity);GO:0005783(endoplasmic reticulum);GO:0007029(endoplasmic reticulum organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032781(positive regulation of ATPase activity);GO:0051117(ATPase binding);GO:0090435(protein localization to nuclear envelope)","NA","K23001","NA","torsin-1A-interacting protein 2 [Source:NCBI gene;Acc:101122123]",{"v":3.65544830982803,"d":"3.66"},{"v":3.87937232375829,"d":"3.88"},{"v":4.26207377192814,"d":"4.26"},{"v":3.2561213788068,"d":"3.26"},{"v":2.92223751849361,"d":"2.92"},{"v":1.97067689220867,"d":"1.97"},{"v":1.44764297399474,"d":"1.45"},{"v":0.533705840571678,"d":"0.53"},{"v":0.0508024332522041,"d":"0.05"},{"v":0.407666888540247,"d":"0.41"},"up","no"]
["MSTRG.17241","TMEM209","ENSOART00000005475","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 209 [Source:NCBI gene;Acc:101115958]",{"v":1.673223,"d":"1.67"},{"v":1.2251815540107,"d":"1.23"},{"v":1.707734,"d":"1.71"},{"v":3.781626,"d":"3.78"},{"v":2.25205429090909,"d":"2.25"},{"v":2.2280211144385,"d":"2.23"},{"v":0.557529052191267,"d":"0.56"},{"v":-0.842881110732953,"d":"-0.84"},{"v":0.0508085569683613,"d":"0.05"},{"v":0.407666888540247,"d":"0.41"},"down","no"]
["MSTRG.22334","TCEAL1","ENSOART00000010825","GO:0005654(nucleoplasm)","NA","NA","NA","transcription elongation factor A like 1 [Source:NCBI gene;Acc:101119618]",{"v":2.801356,"d":"2.80"},{"v":2.775552,"d":"2.78"},{"v":0.977925,"d":"0.98"},{"v":1.08236,"d":"1.08"},{"v":1.366611,"d":"1.37"},{"v":0.923583,"d":"0.92"},{"v":1.94358133331594,"d":"1.94"},{"v":0.958717481598579,"d":"0.96"},{"v":0.0509140310907973,"d":"0.05"},{"v":0.40815005605725,"d":"0.41"},"up","no"]
["MSTRG.3138","ZNF652","ENSOART00000006663","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 652 [Source:NCBI gene;Acc:101112073]",{"v":3.24712719133059,"d":"3.25"},{"v":2.86716417900562,"d":"2.87"},{"v":1.90382481738912,"d":"1.90"},{"v":1.0095788759118,"d":"1.01"},{"v":2.0853553996814,"d":"2.09"},{"v":1.85586569246248,"d":"1.86"},{"v":1.61955971549266,"d":"1.62"},{"v":0.695601663351899,"d":"0.70"},{"v":0.0509187692423211,"d":"0.05"},{"v":0.40815005605725,"d":"0.41"},"up","no"]
["MSTRG.9125","NDUFAF3","ENSOART00000017037","GO:0005634(nucleus);GO:0005743(mitochondrial inner membrane);GO:0032981(mitochondrial respiratory chain complex I assembly)","04714(Thermogenesis)","K09008","NA","NADH:ubiquinone oxidoreductase complex assembly factor 3 [Source:NCBI gene;Acc:101108261]",{"v":8.478724,"d":"8.48"},{"v":5.937736,"d":"5.94"},{"v":7.996152,"d":"8.00"},{"v":12.919131,"d":"12.92"},{"v":11.281634,"d":"11.28"},{"v":13.920848,"d":"13.92"},{"v":0.587924020948432,"d":"0.59"},{"v":-0.766298371260252,"d":"-0.77"},{"v":0.0510789329618843,"d":"0.05"},{"v":0.408965287305041,"d":"0.41"},"down","no"]
["ENSOARG00000014084","CNTLN","ENSOART00000015346","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0010457(centriole-centriole cohesion);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030674(protein binding, bridging);GO:0033365(protein localization to organelle)","NA","K16467","NA","centlein [Source:NCBI gene;Acc:101122503]",{"v":0.141671,"d":"0.14"},{"v":0.155428,"d":"0.16"},{"v":0.156365,"d":"0.16"},{"v":0.45451,"d":"0.45"},{"v":0.217609,"d":"0.22"},{"v":0.266418,"d":"0.27"},{"v":0.483160493406227,"d":"0.48"},{"v":-1.04942560027621,"d":"-1.05"},{"v":0.0511350231230121,"d":"0.05"},{"v":0.408965287305041,"d":"0.41"},"down","no"]
["MSTRG.2978","NTN1","ENSOART00000002905","GO:0001764(neuron migration);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005737(cytoplasm);GO:0007097(nuclear migration);GO:0007409(axonogenesis);GO:0007411(axon guidance);GO:0008284(positive regulation of cell population proliferation);GO:0030334(regulation of cell migration);GO:0030517(negative regulation of axon extension);GO:0030879(mammary gland development);GO:0033564(anterior/posterior axon guidance);GO:0042472(inner ear morphogenesis);GO:0045773(positive regulation of axon extension);GO:0051963(regulation of synapse assembly);GO:0060603(mammary gland duct morphogenesis);GO:0061643(chemorepulsion of axon);GO:0098609(cell-cell adhesion)","NA","NA","NA","netrin 1 [Source:HGNC Symbol;Acc:HGNC:8029]",{"v":0.7319974703125,"d":"0.73"},{"v":0.9671831684375,"d":"0.97"},{"v":1.0940477734375,"d":"1.09"},{"v":2.10498507625,"d":"2.10"},{"v":1.321070585625,"d":"1.32"},{"v":1.591277611875,"d":"1.59"},{"v":0.556715741168977,"d":"0.56"},{"v":-0.844987218823263,"d":"-0.84"},{"v":0.0512306111177879,"d":"0.05"},{"v":0.408965287305041,"d":"0.41"},"down","no"]
["MSTRG.5323","CDH15","ENSOART00000015033","GO:0005509(calcium ion binding);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031594(neuromuscular junction);GO:0046872(metal ion binding);GO:0098609(cell-cell adhesion)","04514(Cell adhesion molecules (CAMs))","K06809","NA","cadherin 15 [Source:NCBI gene;Acc:101109639]",{"v":1.02302728096894,"d":"1.02"},{"v":0.934934131430627,"d":"0.93"},{"v":1.25694992133349,"d":"1.26"},{"v":1.31768017663988,"d":"1.32"},{"v":2.30547631226766,"d":"2.31"},{"v":1.79272481064876,"d":"1.79"},{"v":0.593608160133872,"d":"0.59"},{"v":-0.752417170543619,"d":"-0.75"},{"v":0.051238012744085,"d":"0.05"},{"v":0.408965287305041,"d":"0.41"},"down","no"]
["MSTRG.14391","EIF4EBP1","ENSOART00000001200","GO:0000082(G1/S transition of mitotic cell cycle);GO:0005829(cytosol);GO:0008190(eukaryotic initiation factor 4E binding);GO:0030371(translation repressor activity);GO:0031929(TOR signaling);GO:0045931(positive regulation of mitotic cell cycle);GO:0045947(negative regulation of translational initiation)","01521(EGFR tyrosine kinase inhibitor resistance);03013(RNA transport);04012(ErbB signaling pathway);04066(HIF-1 signaling pathway);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04218(Cellular senescence);04910(Insulin signaling pathway);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05168(Herpes simplex virus 1 infection);05221(Acute myeloid leukemia);05231(Choline metabolism in cancer)","K07205","NA","eukaryotic translation initiation factor 4E binding protein 1 [Source:NCBI gene;Acc:101111426]",{"v":43.115906,"d":"43.12"},{"v":34.327248,"d":"34.33"},{"v":39.865101,"d":"39.87"},{"v":44.019756,"d":"44.02"},{"v":73.761749,"d":"73.76"},{"v":81.079109,"d":"81.08"},{"v":0.589901904858848,"d":"0.59"},{"v":-0.761453027090614,"d":"-0.76"},{"v":0.051245028293943,"d":"0.05"},{"v":0.408965287305041,"d":"0.41"},"down","no"]
["MSTRG.8331","BRMS1L","ENSOART00000008552","NA","NA","K19196","NA","BRMS1 like transcriptional repressor [Source:NCBI gene;Acc:101120698]",{"v":1.38194909615385,"d":"1.38"},{"v":1.45733080408654,"d":"1.46"},{"v":1.56642398368819,"d":"1.57"},{"v":1.14036544007555,"d":"1.14"},{"v":0.941306746565934,"d":"0.94"},{"v":0.889770557692308,"d":"0.89"},{"v":1.48268173510318,"d":"1.48"},{"v":0.568208949468072,"d":"0.57"},{"v":0.0512659621358518,"d":"0.05"},{"v":0.408965287305041,"d":"0.41"},"up","no"]
["MSTRG.14490","RARB","ENSOART00000004759","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001657(ureteric bud development);GO:0002068(glandular epithelial cell development);GO:0003148(outflow tract septum morphogenesis);GO:0003417(growth plate cartilage development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell population proliferation);GO:0021756(striatum development);GO:0022008(neurogenesis);GO:0032331(negative regulation of chondrocyte differentiation);GO:0035116(embryonic hindlimb morphogenesis);GO:0035264(multicellular organism growth);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043068(positive regulation of programmed cell death);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048048(embryonic eye morphogenesis);GO:0048384(retinoic acid receptor signaling pathway);GO:0048566(embryonic digestive tract development);GO:0055012(ventricular cardiac muscle cell differentiation);GO:0060348(bone development);GO:0061037(negative regulation of cartilage development)","05200(Pathways in cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05226(Gastric cancer)","K08528","NA","retinoic acid receptor beta [Source:NCBI gene;Acc:101122663]",{"v":3.216986,"d":"3.22"},{"v":2.403778,"d":"2.40"},{"v":1.959307,"d":"1.96"},{"v":5.040479,"d":"5.04"},{"v":3.89038,"d":"3.89"},{"v":4.155221,"d":"4.16"},{"v":0.579246879126522,"d":"0.58"},{"v":-0.787749728746456,"d":"-0.79"},{"v":0.0514010102744019,"d":"0.05"},{"v":0.409563705950825,"d":"0.41"},"down","no"]
["ENSOARG00000003167","LCP2","ENSOART00000003443","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0036398(TCR signalosome);GO:0044853(plasma membrane raft);GO:0045576(mast cell activation);GO:0045860(positive regulation of protein kinase activity);GO:0050663(cytokine secretion);GO:0050852(T cell receptor signaling pathway)","04015(Rap1 signaling pathway);04380(Osteoclast differentiation);04611(Platelet activation);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway)","K07361","NA","lymphocyte cytosolic protein 2 [Source:NCBI gene;Acc:101105277]",{"v":1.032559,"d":"1.03"},{"v":1.061305,"d":"1.06"},{"v":1.239902,"d":"1.24"},{"v":0.705348,"d":"0.71"},{"v":0.601422,"d":"0.60"},{"v":0.673027,"d":"0.67"},{"v":1.68389284355921,"d":"1.68"},{"v":0.751800333781683,"d":"0.75"},{"v":0.0514169276166722,"d":"0.05"},{"v":0.409563705950825,"d":"0.41"},"up","no"]
["MSTRG.3906","DPT","ENSOART00000010048","GO:0008285(negative regulation of cell population proliferation);GO:0030199(collagen fibril organization)","NA","NA","NA","dermatopontin [Source:NCBI gene;Acc:101122371]",{"v":8.42365,"d":"8.42"},{"v":6.203079,"d":"6.20"},{"v":15.442823,"d":"15.44"},{"v":17.931313,"d":"17.93"},{"v":16.135159,"d":"16.14"},{"v":20.201181,"d":"20.20"},{"v":0.554097152497087,"d":"0.55"},{"v":-0.851789141830492,"d":"-0.85"},{"v":0.0514454032044645,"d":"0.05"},{"v":0.409563705950825,"d":"0.41"},"down","no"]
["MSTRG.10455","STEAP3","ENSOART00000013446","GO:0005737(cytoplasm);GO:0005771(multivesicular body);GO:0009306(protein secretion);GO:0016020(membrane);GO:0016021(integral component of membrane)","04115(p53 signaling pathway);04216(Ferroptosis)","K10142","EC:1.16.1.-","STEAP3 metalloreductase [Source:NCBI gene;Acc:101118766]",{"v":2.22734017133122,"d":"2.23"},{"v":2.9751828109029,"d":"2.98"},{"v":2.57129118228279,"d":"2.57"},{"v":4.89345658603066,"d":"4.89"},{"v":3.86002092333901,"d":"3.86"},{"v":4.23934496081772,"d":"4.24"},{"v":0.598316045828708,"d":"0.60"},{"v":-0.741020340724362,"d":"-0.74"},{"v":0.0514469929447161,"d":"0.05"},{"v":0.409563705950825,"d":"0.41"},"down","no"]
["MSTRG.19039","RF00003","ENSOART00000026678","NA","NA","NA","NA",null,{"v":187.637024,"d":"187.64"},{"v":132.212784,"d":"132.21"},{"v":174.036423,"d":"174.04"},{"v":172.447632,"d":"172.45"},{"v":248.110123,"d":"248.11"},{"v":460.798126,"d":"460.80"},{"v":0.560370948497705,"d":"0.56"},{"v":-0.835545931311197,"d":"-0.84"},{"v":0.0514904139283951,"d":"0.05"},{"v":0.409563705950825,"d":"0.41"},"down","no"]
["MSTRG.18015","LMNB1","ENSOART00000019747","GO:0003690(double-stranded DNA binding);GO:0005198(structural molecule activity);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005637(nuclear inner membrane);GO:0005638(lamin filament);GO:0005654(nucleoplasm);GO:0005882(intermediate filament);GO:0016363(nuclear matrix);GO:0031965(nuclear membrane);GO:0043274(phospholipase binding);GO:1990837(sequence-specific double-stranded DNA binding)","04210(Apoptosis)","K07611","NA","lamin B1 [Source:NCBI gene;Acc:100037680]",{"v":0.834126,"d":"0.83"},{"v":0.856201,"d":"0.86"},{"v":0.703223,"d":"0.70"},{"v":2.002049,"d":"2.00"},{"v":0.996393,"d":"1.00"},{"v":1.335411,"d":"1.34"},{"v":0.552291459816473,"d":"0.55"},{"v":-0.856498275962331,"d":"-0.86"},{"v":0.0515246080846952,"d":"0.05"},{"v":0.409563705950825,"d":"0.41"},"down","no"]
["MSTRG.8197","ADAMTS7","ENSOART00000000355","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0032331(negative regulation of chondrocyte differentiation);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0071773(cellular response to BMP stimulus)","NA","K08622","EC:3.4.24.-","ADAM metallopeptidase with thrombospondin type 1 motif 7 [Source:NCBI gene;Acc:101114142]",{"v":0.728064,"d":"0.73"},{"v":0.345342,"d":"0.35"},{"v":0.440661,"d":"0.44"},{"v":1.190282,"d":"1.19"},{"v":0.700383,"d":"0.70"},{"v":0.89496,"d":"0.89"},{"v":0.543528651559345,"d":"0.54"},{"v":-0.879572007430393,"d":"-0.88"},{"v":0.051535443057175,"d":"0.05"},{"v":0.409563705950825,"d":"0.41"},"down","no"]
["MSTRG.14288","FAT1","ENSOART00000009160","GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0048471(perinuclear region of cytoplasm)","NA","K16506","NA","FAT atypical cadherin 1 [Source:NCBI gene;Acc:101116884]",{"v":3.16033505419209,"d":"3.16"},{"v":2.34169360042452,"d":"2.34"},{"v":3.6799872200849,"d":"3.68"},{"v":4.96540347028389,"d":"4.97"},{"v":5.18875382541788,"d":"5.19"},{"v":5.06216253581852,"d":"5.06"},{"v":0.603432102924201,"d":"0.60"},{"v":-0.728736644180779,"d":"-0.73"},{"v":0.0515934525696113,"d":"0.05"},{"v":0.409736329550882,"d":"0.41"},"down","no"]
["MSTRG.11887","PKNOX2","ENSOART00000012373","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003785(actin monomer binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0015629(actin cytoskeleton);GO:0015630(microtubule cytoskeleton);GO:0043565(sequence-specific DNA binding);GO:0045171(intercellular bridge);GO:0051015(actin filament binding)","NA","NA","NA","PBX/knotted 1 homeobox 2 [Source:NCBI gene;Acc:101110008]",{"v":1.75858273493123,"d":"1.76"},{"v":3.55600849406686,"d":"3.56"},{"v":4.62352875654061,"d":"4.62"},{"v":2.87037992788223,"d":"2.87"},{"v":1.54983866092618,"d":"1.55"},{"v":1.87434551067494,"d":"1.87"},{"v":1.57884165264985,"d":"1.58"},{"v":0.658866485705892,"d":"0.66"},{"v":0.0517684703369381,"d":"0.05"},{"v":0.410827186139049,"d":"0.41"},"up","no"]
["MSTRG.20328","RF00100","ENSOART00000025333","NA","NA","NA","NA",null,{"v":16.562235,"d":"16.56"},{"v":12.562947,"d":"12.56"},{"v":12.643766,"d":"12.64"},{"v":17.299847,"d":"17.30"},{"v":26.090317,"d":"26.09"},{"v":29.149466,"d":"29.15"},{"v":0.57580867175639,"d":"0.58"},{"v":-0.796338578640178,"d":"-0.80"},{"v":0.0517945996371882,"d":"0.05"},{"v":0.410827186139049,"d":"0.41"},"down","no"]
["MSTRG.9969","DDX58","ENSOART00000016036","GO:0002230(positive regulation of defense response to virus by host);GO:0002735(positive regulation of myeloid dendritic cell cytokine production);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005923(bicellular tight junction);GO:0008270(zinc ion binding);GO:0009597(detection of virus);GO:0009615(response to virus);GO:0010628(positive regulation of gene expression);GO:0015629(actin cytoskeleton);GO:0016787(hydrolase activity);GO:0030334(regulation of cell migration);GO:0031625(ubiquitin protein ligase binding);GO:0032587(ruffle membrane);GO:0032725(positive regulation of granulocyte macrophage colony-stimulating factor production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0035549(positive regulation of interferon-beta secretion);GO:0039529(RIG-I signaling pathway);GO:0042802(identical protein binding);GO:0043330(response to exogenous dsRNA);GO:0045087(innate immune response);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051607(defense response to virus);GO:0060760(positive regulation of response to cytokine stimulus);GO:0071360(cellular response to exogenous dsRNA);GO:1902741(positive regulation of interferon-alpha secretion);GO:1904469(positive regulation of tumor necrosis factor secretion);GO:2000778(positive regulation of interleukin-6 secretion)","04064(NF-kappa B signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05164(Influenza A);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection)","K12646","EC:3.6.4.13","DExD/H-box helicase 58 [Source:NCBI gene;Acc:101107257]",{"v":1.011633,"d":"1.01"},{"v":0.91689,"d":"0.92"},{"v":1.196559,"d":"1.20"},{"v":1.791762,"d":"1.79"},{"v":1.785858,"d":"1.79"},{"v":1.812136,"d":"1.81"},{"v":0.579818826677868,"d":"0.58"},{"v":-0.786325916517663,"d":"-0.79"},{"v":0.0518386630755119,"d":"0.05"},{"v":0.410827186139049,"d":"0.41"},"down","no"]
["MSTRG.2885","RNF167","ENSOART00000006102","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045786(negative regulation of cell cycle);GO:0046872(metal ion binding)","NA","K15706","EC:2.3.2.27","ring finger protein 167 [Source:NCBI gene;Acc:101109627]",{"v":6.43673622532335,"d":"6.44"},{"v":3.93500162014976,"d":"3.94"},{"v":4.24521397821647,"d":"4.25"},{"v":8.34149973451327,"d":"8.34"},{"v":5.77712866303608,"d":"5.78"},{"v":10.8638834057182,"d":"10.86"},{"v":0.58508735786038,"d":"0.59"},{"v":-0.773276049092475,"d":"-0.77"},{"v":0.0518566162807803,"d":"0.05"},{"v":0.410827186139049,"d":"0.41"},"down","no"]
["MSTRG.1001","OLFML2B","ENSOART00000011446","GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0050840(extracellular matrix binding)","NA","NA","NA","olfactomedin like 2B [Source:NCBI gene;Acc:101107748]",{"v":3.58595816544567,"d":"3.59"},{"v":1.90268047008547,"d":"1.90"},{"v":4.41805481074481,"d":"4.42"},{"v":6.24731273382173,"d":"6.25"},{"v":5.6154387014652,"d":"5.62"},{"v":5.32846989377289,"d":"5.33"},{"v":0.576264667684186,"d":"0.58"},{"v":-0.795196527912105,"d":"-0.80"},{"v":0.0519079860911547,"d":"0.05"},{"v":0.411034722064197,"d":"0.41"},"down","no"]
["MSTRG.21096","GGH","ENSOART00000018287","GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008242(omega peptidase activity);GO:0016787(hydrolase activity);GO:0034722(gamma-glutamyl-peptidase activity)","00790(Folate biosynthesis);01523(Antifolate resistance)","K01307","EC:3.4.19.9","gamma-glutamyl hydrolase [Source:NCBI gene;Acc:101118706]",{"v":2.616771,"d":"2.62"},{"v":1.455347,"d":"1.46"},{"v":1.240115,"d":"1.24"},{"v":3.89483,"d":"3.89"},{"v":2.448641,"d":"2.45"},{"v":3.597177,"d":"3.60"},{"v":0.534395041450014,"d":"0.53"},{"v":-0.904021473506279,"d":"-0.90"},{"v":0.0520149414917282,"d":"0.05"},{"v":0.411650268802641,"d":"0.41"},"down","no"]
["MSTRG.19373","ENSOARG00000017022","ENSOART00000018550","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)","00230(Purine metabolism);04927(Cortisol synthesis and secretion);04934(Cushing syndrome);05032(Morphine addiction)","K18437","EC:3.1.4.53","phosphodiesterase 8B [Source:NCBI gene;Acc:101107286]",{"v":1.67181694148327,"d":"1.67"},{"v":1.37914792990714,"d":"1.38"},{"v":1.74068808955604,"d":"1.74"},{"v":3.17318029029386,"d":"3.17"},{"v":2.47317285701565,"d":"2.47"},{"v":2.27001659305432,"d":"2.27"},{"v":0.605284128723153,"d":"0.61"},{"v":-0.724315572540056,"d":"-0.72"},{"v":0.0520361437290943,"d":"0.05"},{"v":0.411650268802641,"d":"0.41"},"down","no"]
["MSTRG.14468","CSGALNACT1","ENSOART00000004275","GO:0001958(endochondral ossification);GO:0005794(Golgi apparatus);GO:0008376(acetylgalactosaminyltransferase activity);GO:0008955(peptidoglycan glycosyltransferase activity);GO:0015020(glucuronosyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0019276(UDP-N-acetylgalactosamine metabolic process);GO:0030198(extracellular matrix organization);GO:0030204(chondroitin sulfate metabolic process);GO:0030206(chondroitin sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane);GO:0046398(UDP-glucuronate metabolic process);GO:0047237(glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity);GO:0047238(glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity);GO:0050653(chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process);GO:0051216(cartilage development)","NA","NA","NA","chondroitin sulfate N-acetylgalactosaminyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:24290]",{"v":1.734268,"d":"1.73"},{"v":1.135886,"d":"1.14"},{"v":1.078967,"d":"1.08"},{"v":1.719069,"d":"1.72"},{"v":2.741369,"d":"2.74"},{"v":2.689037,"d":"2.69"},{"v":0.552365173666598,"d":"0.55"},{"v":-0.856305733586801,"d":"-0.86"},{"v":0.0521040888847839,"d":"0.05"},{"v":0.411943176790917,"d":"0.41"},"down","no"]
["MSTRG.4855","LAMA5","ENSOART00000014721","GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001738(morphogenesis of a polarized epithelium);GO:0001755(neural crest cell migration);GO:0001942(hair follicle development);GO:0005102(signaling receptor binding);GO:0005178(integrin binding);GO:0005604(basement membrane);GO:0005615(extracellular space);GO:0007155(cell adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0007517(muscle organ development);GO:0009887(animal organ morphogenesis);GO:0016331(morphogenesis of embryonic epithelium);GO:0016477(cell migration);GO:0030155(regulation of cell adhesion);GO:0030324(lung development);GO:0030334(regulation of cell migration);GO:0031012(extracellular matrix);GO:0031594(neuromuscular junction);GO:0034446(substrate adhesion-dependent cell spreading);GO:0042127(regulation of cell population proliferation);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043083(synaptic cleft);GO:0043259(laminin-10 complex);GO:0045995(regulation of embryonic development);GO:0048754(branching morphogenesis of an epithelial tube);GO:0060271(cilium assembly);GO:0060445(branching involved in salivary gland morphogenesis);GO:0072659(protein localization to plasma membrane)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);05145(Toxoplasmosis);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K06240","NA","laminin subunit alpha 5 [Source:NCBI gene;Acc:101121444]",{"v":3.03533989742439,"d":"3.04"},{"v":1.99509699623082,"d":"2.00"},{"v":3.0004713406623,"d":"3.00"},{"v":3.96626313443417,"d":"3.97"},{"v":5.1783939162703,"d":"5.18"},{"v":4.05392331113704,"d":"4.05"},{"v":0.608467578644724,"d":"0.61"},{"v":-0.716747701914835,"d":"-0.72"},{"v":0.0521236283225157,"d":"0.05"},{"v":0.411943176790917,"d":"0.41"},"down","no"]
["MSTRG.13803","LFNG","ENSOART00000005435","GO:0001541(ovarian follicle development);GO:0001756(somitogenesis);GO:0002315(marginal zone B cell differentiation);GO:0007386(compartment pattern specification);GO:0008593(regulation of Notch signaling pathway);GO:0014807(regulation of somitogenesis);GO:0016020(membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030217(T cell differentiation);GO:0032092(positive regulation of protein binding);GO:0033829(O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity);GO:0036066(protein O-linked fucosylation);GO:0045747(positive regulation of Notch signaling pathway);GO:0051446(positive regulation of meiotic cell cycle);GO:1902367(negative regulation of Notch signaling pathway involved in somitogenesis)","NA","NA","NA","LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase [Source:HGNC Symbol;Acc:HGNC:6560]",{"v":0.475844247557003,"d":"0.48"},{"v":0.750263973941368,"d":"0.75"},{"v":0.502537928338762,"d":"0.50"},{"v":1.03859919218241,"d":"1.04"},{"v":1.31214040390879,"d":"1.31"},{"v":1.18061519218241,"d":"1.18"},{"v":0.489513587130175,"d":"0.49"},{"v":-1.03057919049603,"d":"-1.03"},{"v":0.0522338409426442,"d":"0.05"},{"v":0.412544447682192,"d":"0.41"},"down","no"]
["MSTRG.18054","ENSOARG00000021319","ENSOART00000023221","NA","NA","NA","NA",null,{"v":4139.708984,"d":"4139.71"},{"v":2650.561523,"d":"2650.56"},{"v":3714.015381,"d":"3714.02"},{"v":4061.603516,"d":"4061.60"},{"v":8434.945312,"d":"8434.95"},{"v":5520.779297,"d":"5520.78"},{"v":0.583010189697591,"d":"0.58"},{"v":-0.778406996199643,"d":"-0.78"},{"v":0.0522502399440699,"d":"0.05"},{"v":0.412544447682192,"d":"0.41"},"down","no"]
["MSTRG.13994","LRRTM3","ENSOART00000005161","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051965(positive regulation of synapse assembly);GO:0098978(glutamatergic synapse);GO:0099054(presynapse assembly);GO:0099061(integral component of postsynaptic density membrane);GO:1902004(positive regulation of amyloid-beta formation)","NA","NA","NA","leucine rich repeat transmembrane neuronal 3 [Source:NCBI gene;Acc:101101950]",{"v":1.683673,"d":"1.68"},{"v":1.23151,"d":"1.23"},{"v":1.487337,"d":"1.49"},{"v":1.147313,"d":"1.15"},{"v":0.970294,"d":"0.97"},{"v":0.618577,"d":"0.62"},{"v":1.60899997953354,"d":"1.61"},{"v":0.686164307710296,"d":"0.69"},{"v":0.0522765852847744,"d":"0.05"},{"v":0.412552964973319,"d":"0.41"},"up","no"]
["MSTRG.14039","TSPAN15","ENSOART00000006097","GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019899(enzyme binding);GO:0051604(protein maturation);GO:0072659(protein localization to plasma membrane);GO:0097197(tetraspanin-enriched microdomain)","NA","K17297","NA","tetraspanin 15 [Source:NCBI gene;Acc:101104803]",{"v":1.19589429947644,"d":"1.20"},{"v":1.8568802513089,"d":"1.86"},{"v":1.98609920052356,"d":"1.99"},{"v":3.14650489633508,"d":"3.15"},{"v":2.84611738376963,"d":"2.85"},{"v":2.93679586858639,"d":"2.94"},{"v":0.564300346047465,"d":"0.56"},{"v":-0.82546486059695,"d":"-0.83"},{"v":0.0523338053994406,"d":"0.05"},{"v":0.412805011865733,"d":"0.41"},"down","no"]
["MSTRG.2525","GAS6","ENSOART00000009349","GO:0001764(neuron migration);GO:0001786(phosphatidylserine binding);GO:0001934(positive regulation of protein phosphorylation);GO:0001961(positive regulation of cytokine-mediated signaling pathway);GO:0005102(signaling receptor binding);GO:0005245(voltage-gated calcium channel activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006909(phagocytosis);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0007167(enzyme linked receptor protein signaling pathway);GO:0007596(blood coagulation);GO:0009267(cellular response to starvation);GO:0010469(regulation of signaling receptor activity);GO:0010628(positive regulation of gene expression);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0010934(macrophage cytokine production);GO:0018105(peptidyl-serine phosphorylation);GO:0019064(fusion of virus membrane with host plasma membrane);GO:0019079(viral genome replication);GO:0030296(protein tyrosine kinase activator activity);GO:0030971(receptor tyrosine kinase binding);GO:0031589(cell-substrate adhesion);GO:0032689(negative regulation of interferon-gamma production);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032825(positive regulation of natural killer cell differentiation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035457(cellular response to interferon-alpha);GO:0035690(cellular response to drug);GO:0035754(B cell chemotaxis);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043277(apoptotic cell clearance);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043491(protein kinase B signaling);GO:0045860(positive regulation of protein kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046718(viral entry into host cell);GO:0046813(receptor-mediated virion attachment to host cell);GO:0046827(positive regulation of protein export from nucleus);GO:0048018(receptor ligand activity);GO:0048146(positive regulation of fibroblast proliferation);GO:0050711(negative regulation of interleukin-1 secretion);GO:0050766(positive regulation of phagocytosis);GO:0051897(positive regulation of protein kinase B signaling);GO:0060090(molecular adaptor activity);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070168(negative regulation of biomineral tissue development);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070588(calcium ion transmembrane transport);GO:0071307(cellular response to vitamin K);GO:0071363(cellular response to growth factor stimulus);GO:0072659(protein localization to plasma membrane);GO:0097028(dendritic cell differentiation);GO:0097241(hematopoietic stem cell migration to bone marrow);GO:1900142(negative regulation of oligodendrocyte apoptotic process);GO:1900165(negative regulation of interleukin-6 secretion);GO:2000270(negative regulation of fibroblast apoptotic process);GO:2000352(negative regulation of endothelial cell apoptotic process);GO:2000510(positive regulation of dendritic cell chemotaxis);GO:2000669(negative regulation of dendritic cell apoptotic process)","NA","NA","NA","growth arrest specific 6 [Source:HGNC Symbol;Acc:HGNC:4168]",{"v":2.80825870465981,"d":"2.81"},{"v":1.66556013891927,"d":"1.67"},{"v":2.99942393152483,"d":"3.00"},{"v":3.34937904134763,"d":"3.35"},{"v":4.63532451957996,"d":"4.64"},{"v":4.75187859024284,"d":"4.75"},{"v":0.58675417678024,"d":"0.59"},{"v":-0.769171888349922,"d":"-0.77"},{"v":0.0524067184590547,"d":"0.05"},{"v":0.412981128860736,"d":"0.41"},"down","no"]
["MSTRG.11905","DCPS","ENSOART00000013895","GO:0000290(deadenylation-dependent decapping of nuclear-transcribed mRNA);GO:0000340(RNA 7-methylguanosine cap binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0016787(hydrolase activity);GO:0036245(cellular response to menadione);GO:0043069(negative regulation of programmed cell death);GO:0045292(mRNA cis splicing, via spliceosome);GO:0050072(m7G(5')pppN diphosphatase activity)","03018(RNA degradation)","K12584","EC:3.6.1.59","decapping enzyme, scavenger [Source:NCBI gene;Acc:101114475]",{"v":2.4080524263776,"d":"2.41"},{"v":2.14918715447154,"d":"2.15"},{"v":2.53845020596206,"d":"2.54"},{"v":3.8175269232159,"d":"3.82"},{"v":4.48157877416441,"d":"4.48"},{"v":4.00147605149052,"d":"4.00"},{"v":0.576858065063676,"d":"0.58"},{"v":-0.793711704990966,"d":"-0.79"},{"v":0.0525328596681645,"d":"0.05"},{"v":0.413376642246646,"d":"0.41"},"down","no"]
["ENSOARG00000013410","CPT1C","ENSOART00000014590","GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030424(axon);GO:0030425(dendrite);GO:0032281(AMPA glutamate receptor complex);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:0099072(regulation of postsynaptic membrane neurotransmitter receptor levels)","00071(Fatty acid degradation);03320(PPAR signaling pathway);04152(AMPK signaling pathway);04714(Thermogenesis);04920(Adipocytokine signaling pathway);04922(Glucagon signaling pathway)","K19524","EC:2.3.1.21","carnitine palmitoyltransferase 1C [Source:NCBI gene;Acc:101113171]",{"v":0.385085,"d":"0.39"},{"v":0.039234,"d":"0.04"},{"v":0.1164,"d":"0.12"},{"v":0.500691,"d":"0.50"},{"v":0.564896,"d":"0.56"},{"v":0.322444,"d":"0.32"},{"v":0.389558302372209,"d":"0.39"},{"v":-1.36008883271419,"d":"-1.36"},{"v":0.0525809005174691,"d":"0.05"},{"v":0.413555367846453,"d":"0.41"},"down","no"]
["ENSOARG00000019447","PKDREJ","ENSOART00000021180","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","polycystin family receptor for egg jelly [Source:HGNC Symbol;Acc:HGNC:9015]",{"v":0.467861,"d":"0.47"},{"v":0.591129,"d":"0.59"},{"v":0.46919,"d":"0.47"},{"v":1.147496,"d":"1.15"},{"v":0.80744,"d":"0.81"},{"v":0.729523,"d":"0.73"},{"v":0.569269264309867,"d":"0.57"},{"v":-0.812816886296128,"d":"-0.81"},{"v":0.0526324511190264,"d":"0.05"},{"v":0.413761512696901,"d":"0.41"},"down","no"]
["MSTRG.12871","ENSOARG00000003832","ENSOART00000004161","GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation);GO:0015934(large ribosomal subunit)","NA","NA","NA","60S ribosomal protein L10a pseudogene [Source:NCBI gene;Acc:101112102]",{"v":24.033115,"d":"24.03"},{"v":17.433064,"d":"17.43"},{"v":36.885788,"d":"36.89"},{"v":32.863312,"d":"32.86"},{"v":49.83271,"d":"49.83"},{"v":55.150002,"d":"55.15"},{"v":0.568402081731425,"d":"0.57"},{"v":-0.815016256530976,"d":"-0.82"},{"v":0.0529203329714485,"d":"0.05"},{"v":0.415571378528833,"d":"0.42"},"down","no"]
["MSTRG.15862","KIF21A","ENSOART00000021815","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding)","NA","K10395","NA","kinesin family member 21A [Source:NCBI gene;Acc:101119971]",{"v":0.576935,"d":"0.58"},{"v":0.565517,"d":"0.57"},{"v":0.31826,"d":"0.32"},{"v":0.314675,"d":"0.31"},{"v":0.320252,"d":"0.32"},{"v":0.251608,"d":"0.25"},{"v":1.64766422081474,"d":"1.65"},{"v":0.720422264169807,"d":"0.72"},{"v":0.0530535091842414,"d":"0.05"},{"v":0.415870234258422,"d":"0.42"},"up","no"]
["MSTRG.2527","ENSOARG00000008284","ENSOART00000009016","NA","NA","NA","NA",null,{"v":10.2384786370771,"d":"10.24"},{"v":10.5538864906912,"d":"10.55"},{"v":14.9567468032368,"d":"14.96"},{"v":7.43733578966902,"d":"7.44"},{"v":9.13648157781699,"d":"9.14"},{"v":7.79037570509856,"d":"7.79"},{"v":1.46728076831862,"d":"1.47"},{"v":0.553144961197711,"d":"0.55"},{"v":0.0531786006612855,"d":"0.05"},{"v":0.416450931221808,"d":"0.42"},"up","no"]
["MSTRG.15028","MXD1","ENSOART00000021498","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0046983(protein dimerization activity)","NA","K09114","NA","MAX dimerization protein 1 [Source:NCBI gene;Acc:101106754]",{"v":7.52995278722131,"d":"7.53"},{"v":7.14262748975011,"d":"7.14"},{"v":7.4721353100404,"d":"7.47"},{"v":6.22664514768816,"d":"6.23"},{"v":4.9908318588957,"d":"4.99"},{"v":4.19782941792608,"d":"4.20"},{"v":1.43654073277469,"d":"1.44"},{"v":0.52259890072905,"d":"0.52"},{"v":0.0533620578025345,"d":"0.05"},{"v":0.416887885071667,"d":"0.42"},"up","no"]
["MSTRG.5825","SIX5","ENSOART00000011172","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0002088(lens development in camera-type eye);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0007286(spermatid development);GO:0008285(negative regulation of cell population proliferation);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1902723(negative regulation of skeletal muscle satellite cell proliferation)","NA","K19474","NA","SIX homeobox 5 [Source:NCBI gene;Acc:101118127]",{"v":0.5273,"d":"0.53"},{"v":0.205244,"d":"0.21"},{"v":0.387564,"d":"0.39"},{"v":0.457924,"d":"0.46"},{"v":0.953211,"d":"0.95"},{"v":0.938831,"d":"0.94"},{"v":0.476648598320146,"d":"0.48"},{"v":-1.06900204100696,"d":"-1.07"},{"v":0.0534572263812123,"d":"0.05"},{"v":0.417032772265855,"d":"0.42"},"down","no"]
["MSTRG.19744","NID2","ENSOART00000022563","GO:0005509(calcium ion binding);GO:0005604(basement membrane);GO:0005886(plasma membrane);GO:0007160(cell-matrix adhesion);GO:0031012(extracellular matrix)","NA","K06826","NA","nidogen 2 [Source:NCBI gene;Acc:101107101]",{"v":12.24886,"d":"12.25"},{"v":8.724614,"d":"8.72"},{"v":12.133184,"d":"12.13"},{"v":20.028875,"d":"20.03"},{"v":16.221943,"d":"16.22"},{"v":18.161631,"d":"18.16"},{"v":0.6084390357067,"d":"0.61"},{"v":-0.716815379671963,"d":"-0.72"},{"v":0.0535463687902955,"d":"0.05"},{"v":0.417394142364327,"d":"0.42"},"down","no"]
["MSTRG.17763","DNMT1","ENSOART00000016743;ENSOART00000016745","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000792(heterochromatin);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003723(RNA binding);GO:0003886(DNA (cytosine-5-)-methyltransferase activity);GO:0005634(nucleus);GO:0005657(replication fork);GO:0005721(pericentric heterochromatin);GO:0006306(DNA methylation);GO:0007265(Ras protein signal transduction);GO:0008168(methyltransferase activity);GO:0008270(zinc ion binding);GO:0008327(methyl-CpG binding);GO:0009008(DNA-methyltransferase activity);GO:0010216(maintenance of DNA methylation);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016458(gene silencing);GO:0016740(transferase activity);GO:0032259(methylation);GO:0032776(DNA methylation on cytosine);GO:0042127(regulation of cell population proliferation);GO:0043045(DNA methylation involved in embryo development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0051571(positive regulation of histone H3-K4 methylation);GO:0051573(negative regulation of histone H3-K9 methylation);GO:0071230(cellular response to amino acid stimulus);GO:0090116(C-5 methylation of cytosine);GO:0090309(positive regulation of methylation-dependent chromatin silencing);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905460(negative regulation of vascular associated smooth muscle cell apoptotic process);GO:1905931(negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching);GO:1990841(promoter-specific chromatin binding);GO:1990841(promoter-specific chromatin binding)","00270(Cysteine and methionine metabolism);05206(MicroRNAs in cancer);05206(MicroRNAs in cancer)","K00558","EC:2.1.1.37","DNA methyltransferase 1 [Source:NCBI gene;Acc:443549]",{"v":1.25938035950548,"d":"1.26"},{"v":0.799832909662726,"d":"0.80"},{"v":1.15313749636699,"d":"1.15"},{"v":1.8879366131656,"d":"1.89"},{"v":1.5445786163106,"d":"1.54"},{"v":1.82597590879514,"d":"1.83"},{"v":0.610888310176218,"d":"0.61"},{"v":-0.711019461298733,"d":"-0.71"},{"v":0.0536322258993246,"d":"0.05"},{"v":0.417799133818785,"d":"0.42"},"down","no"]
["MSTRG.13087","FECH","ENSOART00000005676","GO:0004325(ferrochelatase activity);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006783(heme biosynthetic process);GO:0016829(lyase activity)","NA","NA","NA","ferrochelatase [Source:HGNC Symbol;Acc:HGNC:3647]",{"v":18.213750720339,"d":"18.21"},{"v":20.5474894498588,"d":"20.55"},{"v":14.333380322387,"d":"14.33"},{"v":13.6368954961158,"d":"13.64"},{"v":11.2681178266243,"d":"11.27"},{"v":11.5348447415254,"d":"11.53"},{"v":1.45704795004818,"d":"1.46"},{"v":0.543048355891398,"d":"0.54"},{"v":0.0536698055696335,"d":"0.05"},{"v":0.417892506123498,"d":"0.42"},"up","no"]
["MSTRG.15746","NCKAP5L","ENSOART00000019902","GO:0001578(microtubule bundle formation);GO:0005813(centrosome);GO:0007019(microtubule depolymerization);GO:0035371(microtubule plus-end)","NA","NA","NA","NCK associated protein 5 like [Source:NCBI gene;Acc:101122265]",{"v":2.56227655426765,"d":"2.56"},{"v":1.63661775114155,"d":"1.64"},{"v":2.24194377625571,"d":"2.24"},{"v":3.41221127344573,"d":"3.41"},{"v":3.38118899438005,"d":"3.38"},{"v":3.79587791570074,"d":"3.80"},{"v":0.608241465568896,"d":"0.61"},{"v":-0.717283922498521,"d":"-0.72"},{"v":0.0538825302542935,"d":"0.05"},{"v":0.418949501901002,"d":"0.42"},"down","no"]
["MSTRG.20023","RHOJ","ENSOART00000023037","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0005886(plasma membrane);GO:0007264(small GTPase mediated signal transduction);GO:0007266(Rho protein signal transduction);GO:0008360(regulation of cell shape);GO:0010594(regulation of endothelial cell migration);GO:0030036(actin cytoskeleton organization);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:1903670(regulation of sprouting angiogenesis)","NA","K07864","NA","ras homolog family member J [Source:NCBI gene;Acc:101107285]",{"v":8.648567,"d":"8.65"},{"v":4.754912,"d":"4.75"},{"v":7.425443,"d":"7.43"},{"v":12.068536,"d":"12.07"},{"v":12.061549,"d":"12.06"},{"v":11.269306,"d":"11.27"},{"v":0.588397749554505,"d":"0.59"},{"v":-0.765136366161316,"d":"-0.77"},{"v":0.0540600371483174,"d":"0.05"},{"v":0.419730045914278,"d":"0.42"},"down","no"]
["MSTRG.13288","ENSOARG00000003187","ENSOART00000003463","GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0007015(actin filament organization);GO:0007030(Golgi organization);GO:0016021(integral component of membrane);GO:0016477(cell migration);GO:0030010(establishment of cell polarity)","NA","K18619","NA","coronin-7 [Source:NCBI gene;Acc:101102529]",{"v":1.35664271200672,"d":"1.36"},{"v":1.08968331606093,"d":"1.09"},{"v":1.2478922029507,"d":"1.25"},{"v":1.70224245663908,"d":"1.70"},{"v":1.97600033597217,"d":"1.98"},{"v":2.36096250809644,"d":"2.36"},{"v":0.611706018767975,"d":"0.61"},{"v":-0.709089623611451,"d":"-0.71"},{"v":0.0542356380366428,"d":"0.05"},{"v":0.420693348153114,"d":"0.42"},"down","no"]
["MSTRG.18013","MARCH3","ENSOART00000019653","GO:0005764(lysosome);GO:0005768(endosome);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding)","NA","K10658","EC:2.3.2.27","membrane associated ring-CH-type finger 3 [Source:NCBI gene;Acc:101106841]",{"v":1.82709229828326,"d":"1.83"},{"v":1.78906056276824,"d":"1.79"},{"v":1.79508661319742,"d":"1.80"},{"v":1.33651181974249,"d":"1.34"},{"v":0.838325587982833,"d":"0.84"},{"v":1.24408826072961,"d":"1.24"},{"v":1.58273095088796,"d":"1.58"},{"v":0.662416031969587,"d":"0.66"},{"v":0.0544100875696523,"d":"0.05"},{"v":0.421846111033847,"d":"0.42"},"up","no"]
["MSTRG.13605","ENSOARG00000010757","ENSOART00000011700","NA","NA","NA","NA",null,{"v":4.24106363513514,"d":"4.24"},{"v":3.29437412530713,"d":"3.29"},{"v":4.99637017813268,"d":"5.00"},{"v":5.48202000900901,"d":"5.48"},{"v":7.62484368263718,"d":"7.62"},{"v":7.73524587428337,"d":"7.74"},{"v":0.601273489083879,"d":"0.60"},{"v":-0.733906745218156,"d":"-0.73"},{"v":0.0545888481017106,"d":"0.05"},{"v":0.422208764882356,"d":"0.42"},"down","no"]
["MSTRG.11346","ELOVL5","ENSOART00000016744","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006636(unsaturated fatty acid biosynthetic process);GO:0009922(fatty acid elongase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0019367(fatty acid elongation, saturated fatty acid);GO:0030425(dendrite);GO:0034625(fatty acid elongation, monounsaturated fatty acid);GO:0034626(fatty acid elongation, polyunsaturated fatty acid);GO:0035338(long-chain fatty-acyl-CoA biosynthetic process);GO:0042759(long-chain fatty acid biosynthetic process);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0045723(positive regulation of fatty acid biosynthetic process);GO:0097447(dendritic tree);GO:0102336(3-oxo-arachidoyl-CoA synthase activity);GO:0102337(3-oxo-cerotoyl-CoA synthase activity);GO:0102338(3-oxo-lignoceronyl-CoA synthase activity);GO:0102756(very-long-chain 3-ketoacyl-CoA synthase activity)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)","K10244","EC:2.3.1.199","ELOVL fatty acid elongase 5 [Source:NCBI gene;Acc:101108431]",{"v":2.32369088426614,"d":"2.32"},{"v":2.5451807660558,"d":"2.55"},{"v":3.1745904389962,"d":"3.17"},{"v":1.72747662159485,"d":"1.73"},{"v":2.07300133399373,"d":"2.07"},{"v":1.69572368416708,"d":"1.70"},{"v":1.46345833295805,"d":"1.46"},{"v":0.549381670454193,"d":"0.55"},{"v":0.0546304143789656,"d":"0.05"},{"v":0.422208764882356,"d":"0.42"},"up","no"]
["MSTRG.20181","FOS","ENSOART00000001920","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007399(nervous system development);GO:0008134(transcription factor binding);GO:0010468(regulation of gene expression);GO:0031668(cellular response to extracellular stimulus);GO:0032993(protein-DNA complex);GO:0034614(cellular response to reactive oxygen species);GO:0035914(skeletal muscle cell differentiation);GO:0035976(transcription factor AP-1 complex);GO:0035994(response to muscle stretch);GO:0042493(response to drug);GO:0044212(transcription regulatory region DNA binding);GO:0045672(positive regulation of osteoclast differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0060395(SMAD protein signal transduction);GO:0070412(R-SMAD binding);GO:0071276(cellular response to cadmium ion);GO:0071277(cellular response to calcium ion)","01522(Endocrine resistance);04010(MAPK signaling pathway);04024(cAMP signaling pathway);04210(Apoptosis);04380(Osteoclast differentiation);04620(Toll-like receptor signaling pathway);04657(IL-17 signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04668(TNF signaling pathway);04713(Circadian entrainment);04725(Cholinergic synapse);04728(Dopaminergic synapse);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05031(Amphetamine addiction);05132(Salmonella infection);05133(Pertussis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05161(Hepatitis B);05162(Measles);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05210(Colorectal cancer);05224(Breast cancer);05231(Choline metabolism in cancer);05323(Rheumatoid arthritis);05418(Fluid shear stress and atherosclerosis)","K04379","NA","Fos proto-oncogene, AP-1 transcription factor subunit [Source:NCBI gene;Acc:443218]",{"v":418.992777944573,"d":"418.99"},{"v":82.1618670669746,"d":"82.16"},{"v":111.277399006928,"d":"111.28"},{"v":170.584929926097,"d":"170.58"},{"v":39.2994819006928,"d":"39.30"},{"v":92.5537746882217,"d":"92.55"},{"v":2.02498252973778,"d":"2.02"},{"v":1.0179094613951,"d":"1.02"},{"v":0.0546547840914449,"d":"0.05"},{"v":0.422208764882356,"d":"0.42"},"up","no"]
["MSTRG.19504","CD276","ENSOART00000020717","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045078(positive regulation of interferon-gamma biosynthetic process)","NA","NA","NA","CD276 molecule [Source:HGNC Symbol;Acc:HGNC:19137]",{"v":1.27803751826995,"d":"1.28"},{"v":1.05411632736764,"d":"1.05"},{"v":1.56305675428785,"d":"1.56"},{"v":1.86090321588367,"d":"1.86"},{"v":2.32094354101417,"d":"2.32"},{"v":2.53790656301268,"d":"2.54"},{"v":0.579665713082651,"d":"0.58"},{"v":-0.786706941392463,"d":"-0.79"},{"v":0.0546637266634799,"d":"0.05"},{"v":0.422208764882356,"d":"0.42"},"down","no"]
["MSTRG.6568","PDE2A","ENSOART00000006165","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000287(magnesium ion binding);GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity);GO:0004118(cGMP-stimulated cyclic-nucleotide phosphodiesterase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0008081(phosphoric diester hydrolase activity);GO:0008144(drug binding);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0019933(cAMP-mediated signaling);GO:0019934(cGMP-mediated signaling);GO:0030552(cAMP binding);GO:0030553(cGMP binding);GO:0030911(TPR domain binding);GO:0035690(cellular response to drug);GO:0036006(cellular response to macrophage colony-stimulating factor stimulus);GO:0042301(phosphate ion binding);GO:0042803(protein homodimerization activity);GO:0043116(negative regulation of vascular permeability);GO:0043117(positive regulation of vascular permeability);GO:0043951(negative regulation of cAMP-mediated signaling);GO:0046069(cGMP catabolic process);GO:0046872(metal ion binding);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity);GO:0048471(perinuclear region of cytoplasm);GO:0071320(cellular response to cAMP);GO:0071321(cellular response to cGMP);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:1904613(cellular response to 2,3,7,8-tetrachlorodibenzodioxine)","00230(Purine metabolism);04022(cGMP-PKG signaling pathway);04740(Olfactory transduction);04925(Aldosterone synthesis and secretion);05032(Morphine addiction)","K18283","EC:3.1.4.17","phosphodiesterase 2A [Source:NCBI gene;Acc:101122722]",{"v":3.42752705149286,"d":"3.43"},{"v":2.6812020164431,"d":"2.68"},{"v":2.09792409541324,"d":"2.10"},{"v":4.4966789372566,"d":"4.50"},{"v":4.43719995845954,"d":"4.44"},{"v":4.55920342557334,"d":"4.56"},{"v":0.608211894653654,"d":"0.61"},{"v":-0.717354063803035,"d":"-0.72"},{"v":0.0547095204314309,"d":"0.05"},{"v":0.422215582137323,"d":"0.42"},"down","no"]
["MSTRG.18551","RGMB","ENSOART00000019767","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0030509(BMP signaling pathway);GO:0042802(identical protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046658(anchored component of plasma membrane)","04350(TGF-beta signaling pathway)","K06847","NA","repulsive guidance molecule BMP co-receptor b [Source:NCBI gene;Acc:101111545]",{"v":16.3236607817837,"d":"16.32"},{"v":12.6337768711575,"d":"12.63"},{"v":13.8673777527514,"d":"13.87"},{"v":24.2494355872865,"d":"24.25"},{"v":21.3629100119545,"d":"21.36"},{"v":23.1870267178368,"d":"23.19"},{"v":0.622459391174741,"d":"0.62"},{"v":-0.683948375075054,"d":"-0.68"},{"v":0.0547378748891881,"d":"0.05"},{"v":0.422215582137323,"d":"0.42"},"down","no"]
["MSTRG.7617","CAMKK2","ENSOART00000016320;ENSOART00000016318","GO:0001934(positive regulation of protein phosphorylation);GO:0004672(protein kinase activity);GO:0005509(calcium ion binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0046777(protein autophosphorylation);GO:0061762(CAMKK-AMPK signaling cascade);GO:0061762(CAMKK-AMPK signaling cascade)","04140(Autophagy - animal);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04920(Adipocytokine signaling pathway);04921(Oxytocin signaling pathway);05034(Alcoholism);05034(Alcoholism)","K07359","EC:2.7.11.17","calcium/calmodulin dependent protein kinase kinase 2 [Source:NCBI gene;Acc:101103267]",{"v":2.73173548861646,"d":"2.73"},{"v":2.19037473730298,"d":"2.19"},{"v":2.05958981611208,"d":"2.06"},{"v":4.35858643957968,"d":"4.36"},{"v":3.87160214185639,"d":"3.87"},{"v":3.54499406654991,"d":"3.54"},{"v":0.592916496562851,"d":"0.59"},{"v":-0.754099157868991,"d":"-0.75"},{"v":0.0547507466934029,"d":"0.05"},{"v":0.422215582137323,"d":"0.42"},"down","no"]
["MSTRG.14565","TMEM141","ENSOART00000001816","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 141 [Source:NCBI gene;Acc:101108998]",{"v":1.992286,"d":"1.99"},{"v":1.550552,"d":"1.55"},{"v":2.274082,"d":"2.27"},{"v":3.523144,"d":"3.52"},{"v":3.131515,"d":"3.13"},{"v":5.113889,"d":"5.11"},{"v":0.494276779089485,"d":"0.49"},{"v":-1.01660896401024,"d":"-1.02"},{"v":0.0552581659067799,"d":"0.06"},{"v":0.425191014573941,"d":"0.43"},"down","no"]
["MSTRG.3395","CCDC47","ENSOART00000014676","GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum);GO:0005791(rough endoplasmic reticulum);GO:0006983(ER overload response);GO:0007029(endoplasmic reticulum organization);GO:0009791(post-embryonic development);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0055074(calcium ion homeostasis)","NA","NA","NA","coiled-coil domain containing 47 [Source:NCBI gene;Acc:101103333]",{"v":22.1720300400513,"d":"22.17"},{"v":22.6983006949696,"d":"22.70"},{"v":20.0611996312079,"d":"20.06"},{"v":17.030938912528,"d":"17.03"},{"v":14.0306677033002,"d":"14.03"},{"v":14.0901330817046,"d":"14.09"},{"v":1.43807372210238,"d":"1.44"},{"v":0.524137636684898,"d":"0.52"},{"v":0.0552887954976632,"d":"0.06"},{"v":0.425226308471901,"d":"0.43"},"up","no"]
["MSTRG.8126","RCCD1","ENSOART00000013400","GO:0005829(cytosol);GO:0005886(plasma membrane)","NA","NA","NA","RCC1 domain containing 1 [Source:NCBI gene;Acc:101104096]",{"v":0.660551,"d":"0.66"},{"v":0.744753,"d":"0.74"},{"v":0.618952,"d":"0.62"},{"v":1.480768,"d":"1.48"},{"v":1.404091,"d":"1.40"},{"v":1.108394,"d":"1.11"},{"v":0.506919045700335,"d":"0.51"},{"v":-0.980172725749401,"d":"-0.98"},{"v":0.0553409643761121,"d":"0.06"},{"v":0.425354710351566,"d":"0.43"},"down","no"]
["MSTRG.5869","NOP53;RF00603","ENSOART00000012410;ENSOART00000024473","GO:0000027(ribosomal large subunit assembly);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001650(fibrillar center);GO:0001932(regulation of protein phosphorylation);GO:0002039(p53 binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0008097(5S rRNA binding);GO:0014067(negative regulation of phosphatidylinositol 3-kinase signaling);GO:0031333(negative regulation of protein complex assembly);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0033553(rDNA heterochromatin);GO:0039535(regulation of RIG-I signaling pathway);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0050821(protein stabilization);GO:0051726(regulation of cell cycle);GO:0051898(negative regulation of protein kinase B signaling);GO:0071456(cellular response to hypoxia);GO:1901796(regulation of signal transduction by p53 class mediator);GO:1901797(negative regulation of signal transduction by p53 class mediator);GO:1901837(negative regulation of transcription of nucleolar large rRNA by RNA polymerase I);GO:1902570(protein localization to nucleolus);GO:1903006(positive regulation of protein K63-linked deubiquitination);GO:1903715(regulation of aerobic respiration);GO:1990173(protein localization to nucleoplasm)","NA","NA","NA","NOP53 ribosome biogenesis factor [Source:HGNC Symbol;Acc:HGNC:4333];small nucleolar RNA, C/D box 23 [Source:HGNC Symbol;Acc:HGNC:32718]",{"v":2.27309498040363,"d":"2.27"},{"v":1.44586757589939,"d":"1.45"},{"v":1.8654111339573,"d":"1.87"},{"v":2.03658444486692,"d":"2.04"},{"v":3.9580268452764,"d":"3.96"},{"v":3.64727950628839,"d":"3.65"},{"v":0.579178276145483,"d":"0.58"},{"v":-0.787920604146046,"d":"-0.79"},{"v":0.0553575918359308,"d":"0.06"},{"v":0.425354710351566,"d":"0.43"},"down","no"]
["MSTRG.8489","oar-mir-370;RF00181;RF02145;RF02146","ENSOART00000026970;ENSOART00000023114;ENSOART00000023471;ENSOART00000024017;ENSOART00000023857;ENSOART00000024564;ENSOART00000026295;ENSOART00000025968;ENSOART00000025666;ENSOART00000026163","NA","NA","K17153","NA","oar-mir-370 [Source:miRBase;Acc:MI0016915];small nucleolar RNA, C/D box 113-9 [Source:HGNC Symbol;Acc:HGNC:32988];small nucleolar RNA, C/D box 113-2 [Source:HGNC Symbol;Acc:HGNC:32981];small nucleolar RNA, C/D box 113-6 [Source:HGNC Symbol;Acc:HGNC:32985];small nucleolar RNA, C/D box 113-4 [Source:HGNC Symbol;Acc:HGNC:32983];small nucleolar RNA, C/D box 113-7 [Source:HGNC Symbol;Acc:HGNC:32986];small nucleolar RNA, C/D box 113-1 [Source:HGNC Symbol;Acc:HGNC:32980]",{"v":1.8924450035476,"d":"1.89"},{"v":2.34078791080862,"d":"2.34"},{"v":3.14014596718467,"d":"3.14"},{"v":3.51354118432114,"d":"3.51"},{"v":6.15441128739444,"d":"6.15"},{"v":3.24876478120541,"d":"3.25"},{"v":0.570840000378074,"d":"0.57"},{"v":-0.808841662797688,"d":"-0.81"},{"v":0.0555243579790116,"d":"0.06"},{"v":0.425602643467185,"d":"0.43"},"down","no"]
["MSTRG.8130","MAN2A2","ENSOART00000013686","GO:0003824(catalytic activity);GO:0004559(alpha-mannosidase activity);GO:0005975(carbohydrate metabolic process);GO:0006013(mannose metabolic process);GO:0008152(metabolic process);GO:0015923(mannosidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0016799(hydrolase activity, hydrolyzing N-glycosyl compounds);GO:0030246(carbohydrate binding);GO:0046872(metal ion binding)","00510(N-Glycan biosynthesis)","K01231","EC:3.2.1.114","mannosidase alpha class 2A member 2 [Source:NCBI gene;Acc:101106798]",{"v":18.772599331376,"d":"18.77"},{"v":17.875423134797,"d":"17.88"},{"v":9.53253430405923,"d":"9.53"},{"v":13.5761885084248,"d":"13.58"},{"v":7.96711643451621,"d":"7.97"},{"v":9.03485691051825,"d":"9.03"},{"v":1.51024633172997,"d":"1.51"},{"v":0.594783882385494,"d":"0.59"},{"v":0.0555938228065104,"d":"0.06"},{"v":0.425602643467185,"d":"0.43"},"up","no"]
["MSTRG.861","SHE","ENSOART00000002895","NA","NA","NA","NA","Src homology 2 domain containing E [Source:NCBI gene;Acc:101103617]",{"v":2.726344,"d":"2.73"},{"v":1.357132,"d":"1.36"},{"v":1.187898,"d":"1.19"},{"v":2.793062,"d":"2.79"},{"v":3.142677,"d":"3.14"},{"v":3.725099,"d":"3.73"},{"v":0.545643555973095,"d":"0.55"},{"v":-0.873969282859774,"d":"-0.87"},{"v":0.0555972068844042,"d":"0.06"},{"v":0.425602643467185,"d":"0.43"},"down","no"]
["MSTRG.5820","EML2","ENSOART00000011014","GO:0005515(protein binding);GO:0008017(microtubule binding);GO:0010968(regulation of microtubule nucleation);GO:0015631(tubulin binding);GO:0031115(negative regulation of microtubule polymerization);GO:0072686(mitotic spindle)","NA","K18595","NA","EMAP like 2 [Source:NCBI gene;Acc:101117612]",{"v":1.31197391557223,"d":"1.31"},{"v":1.10439449530957,"d":"1.10"},{"v":1.09595970637899,"d":"1.10"},{"v":0.770914472795497,"d":"0.77"},{"v":0.828947081144465,"d":"0.83"},{"v":0.633810575984991,"d":"0.63"},{"v":1.57244569165072,"d":"1.57"},{"v":0.653010190879333,"d":"0.65"},{"v":0.0556207988290151,"d":"0.06"},{"v":0.425602643467185,"d":"0.43"},"up","no"]
["MSTRG.13423","GPRC5B","ENSOART00000013468","GO:0004930(G protein-coupled receptor activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030295(protein kinase activator activity);GO:0032147(activation of protein kinase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0070062(extracellular exosome)","NA","K04619","NA","G protein-coupled receptor class C group 5 member B [Source:NCBI gene;Acc:101112533]",{"v":7.498645,"d":"7.50"},{"v":6.167521,"d":"6.17"},{"v":7.224589,"d":"7.22"},{"v":10.863991,"d":"10.86"},{"v":10.830562,"d":"10.83"},{"v":11.957439,"d":"11.96"},{"v":0.620788065086905,"d":"0.62"},{"v":-0.687827273518009,"d":"-0.69"},{"v":0.0556529445489742,"d":"0.06"},{"v":0.425602643467185,"d":"0.43"},"down","no"]
["MSTRG.5803","ERCC2","ENSOART00000010734","GO:0000166(nucleotide binding);GO:0001701(in utero embryonic development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005675(transcription factor TFIIH holo complex);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005829(cytosol);GO:0006139(nucleobase-containing compound metabolic process);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006289(nucleotide-excision repair);GO:0006366(transcription by RNA polymerase II);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0006979(response to oxidative stress);GO:0007059(chromosome segregation);GO:0007568(aging);GO:0008022(protein C-terminus binding);GO:0008026(ATP-dependent helicase activity);GO:0008094(DNA-dependent ATPase activity);GO:0008283(cell population proliferation);GO:0008353(RNA polymerase II CTD heptapeptide repeat kinase activity);GO:0009411(response to UV);GO:0009650(UV protection);GO:0009791(post-embryonic development);GO:0016787(hydrolase activity);GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides);GO:0021510(spinal cord development);GO:0022405(hair cycle process);GO:0030198(extracellular matrix organization);GO:0030282(bone mineralization);GO:0030674(protein binding, bridging);GO:0032289(central nervous system myelin formation);GO:0032508(DNA duplex unwinding);GO:0033683(nucleotide-excision repair, DNA incision);GO:0035264(multicellular organism growth);GO:0035315(hair cell differentiation);GO:0040016(embryonic cleavage);GO:0043139(5'-3' DNA helicase activity);GO:0043249(erythrocyte maturation);GO:0043388(positive regulation of DNA binding);GO:0043588(skin development);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0048820(hair follicle maturation);GO:0060218(hematopoietic stem cell differentiation);GO:0070516(CAK-ERCC2 complex);GO:0071817(MMXD complex);GO:1901990(regulation of mitotic cell cycle phase transition)","03022(Basal transcription factors);03420(Nucleotide excision repair)","K10844","EC:3.6.4.12","ERCC excision repair 2, TFIIH core complex helicase subunit [Source:NCBI gene;Acc:101116341]",{"v":0.864039731467635,"d":"0.86"},{"v":0.616370826532792,"d":"0.62"},{"v":0.558010550523392,"d":"0.56"},{"v":1.0514919450972,"d":"1.05"},{"v":1.33481756590472,"d":"1.33"},{"v":1.10567813843196,"d":"1.11"},{"v":0.583742359127269,"d":"0.58"},{"v":-0.776596334041667,"d":"-0.78"},{"v":0.0556731962288926,"d":"0.06"},{"v":0.425602643467185,"d":"0.43"},"down","no"]
["MSTRG.6470","MRVI1","ENSOART00000011710;ENSOART00000011712","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","04022(cGMP-PKG signaling pathway);04270(Vascular smooth muscle contraction);04270(Vascular smooth muscle contraction)","K12337","NA","murine retrovirus integration site 1 homolog [Source:NCBI gene;Acc:101102086]",{"v":1.58357074903632,"d":"1.58"},{"v":1.36882667681071,"d":"1.37"},{"v":1.9109997046054,"d":"1.91"},{"v":3.04021041509434,"d":"3.04"},{"v":2.65507106431325,"d":"2.66"},{"v":2.31412111503348,"d":"2.31"},{"v":0.607210971493414,"d":"0.61"},{"v":-0.719730236320844,"d":"-0.72"},{"v":0.0556765829523461,"d":"0.06"},{"v":0.425602643467185,"d":"0.43"},"down","no"]
["MSTRG.3559","TMC6","ENSOART00000006472","GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane)","NA","K21988","NA","transmembrane channel-like protein 6 [Source:NCBI gene;Acc:101115049]",{"v":0.708101982690227,"d":"0.71"},{"v":0.819505536963577,"d":"0.82"},{"v":0.849521063108547,"d":"0.85"},{"v":1.0453412971511,"d":"1.05"},{"v":1.67503284024522,"d":"1.68"},{"v":1.55932450450775,"d":"1.56"},{"v":0.555442983645397,"d":"0.56"},{"v":-0.848289268662287,"d":"-0.85"},{"v":0.0557473545891914,"d":"0.06"},{"v":0.425921395697312,"d":"0.43"},"down","no"]
["MSTRG.241","AKR1A1","ENSOART00000001929","GO:0004032(alditol:NADP+ 1-oxidoreductase activity);GO:0005829(cytosol);GO:0016324(apical plasma membrane);GO:0016491(oxidoreductase activity);GO:0019853(L-ascorbic acid biosynthetic process);GO:0042840(D-glucuronate catabolic process);GO:0044597(daunorubicin metabolic process);GO:0044598(doxorubicin metabolic process);GO:0045202(synapse);GO:0046185(aldehyde catabolic process);GO:0047939(L-glucuronate reductase activity);GO:0047941(glucuronolactone reductase activity);GO:0055114(oxidation-reduction process);GO:0110095(cellular detoxification of aldehyde)","00010(Glycolysis / Gluconeogenesis);00040(Pentose and glucuronate interconversions);00561(Glycerolipid metabolism)","K00002","EC:1.1.1.2","aldo-keto reductase family 1 member A1 [Source:NCBI gene;Acc:101121637]",{"v":7.45443867215113,"d":"7.45"},{"v":4.88948704875076,"d":"4.89"},{"v":5.58009399695308,"d":"5.58"},{"v":10.1120816898233,"d":"10.11"},{"v":8.77078744850701,"d":"8.77"},{"v":10.1505562669104,"d":"10.15"},{"v":0.617358078410533,"d":"0.62"},{"v":-0.695820574556008,"d":"-0.70"},{"v":0.0557704522293516,"d":"0.06"},{"v":0.425921395697312,"d":"0.43"},"down","no"]
["MSTRG.17229","AHCYL2","ENSOART00000004765;ENSOART00000004767","GO:0004013(adenosylhomocysteinase activity);GO:0005829(cytosol);GO:0006730(one-carbon metabolic process);GO:0016787(hydrolase activity);GO:0043005(neuron projection);GO:0043231(intracellular membrane-bounded organelle);GO:0043231(intracellular membrane-bounded organelle)","00270(Cysteine and methionine metabolism);00270(Cysteine and methionine metabolism)","K01251","EC:3.3.1.1","adenosylhomocysteinase like 2 [Source:NCBI gene;Acc:101114101]",{"v":19.0326643310637,"d":"19.03"},{"v":15.3454293787265,"d":"15.35"},{"v":9.4602691589989,"d":"9.46"},{"v":11.5111559188443,"d":"11.51"},{"v":8.6521330798675,"d":"8.65"},{"v":9.06258184394553,"d":"9.06"},{"v":1.49998482867459,"d":"1.50"},{"v":0.584947908916743,"d":"0.58"},{"v":0.0558392545982483,"d":"0.06"},{"v":0.4261267756063,"d":"0.43"},"up","no"]
["MSTRG.19201","AFAP1","ENSOART00000012999","GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0009966(regulation of signal transduction);GO:0015629(actin cytoskeleton);GO:0051493(regulation of cytoskeleton organization)","NA","K18616","NA","actin filament associated protein 1 [Source:NCBI gene;Acc:101109449]",{"v":0.77653300441655,"d":"0.78"},{"v":0.764460569502557,"d":"0.76"},{"v":0.91929540330079,"d":"0.92"},{"v":1.15514183379823,"d":"1.16"},{"v":1.76440661064621,"d":"1.76"},{"v":1.31878641073919,"d":"1.32"},{"v":0.580484803887281,"d":"0.58"},{"v":-0.784669794624111,"d":"-0.78"},{"v":0.0558495406539369,"d":"0.06"},{"v":0.4261267756063,"d":"0.43"},"down","no"]
["MSTRG.10713","TUBA4A","ENSOART00000021797","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007010(cytoskeleton organization);GO:0007017(microtubule-based process);GO:0015630(microtubule cytoskeleton);GO:0019899(enzyme binding);GO:0019901(protein kinase binding)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction)","K07374","NA","tubulin alpha 4a [Source:NCBI gene;Acc:100302357]",{"v":382.990693644553,"d":"382.99"},{"v":400.773462385475,"d":"400.77"},{"v":511.050935346369,"d":"511.05"},{"v":362.665636013966,"d":"362.67"},{"v":219.03216337919,"d":"219.03"},{"v":307.971287511872,"d":"307.97"},{"v":1.45538954925453,"d":"1.46"},{"v":0.541405356266533,"d":"0.54"},{"v":0.056088689661814,"d":"0.06"},{"v":0.426793953314747,"d":"0.43"},"up","no"]
["ENSOARG00000014713","ASPM","ENSOART00000016018","GO:0000922(spindle pole);GO:0001764(neuron migration);GO:0002052(positive regulation of neuroblast proliferation);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0007051(spindle organization);GO:0007283(spermatogenesis);GO:0007420(brain development);GO:0008584(male gonad development);GO:0021873(forebrain neuroblast division);GO:0021987(cerebral cortex development);GO:0030496(midbody);GO:0036449(microtubule minus-end);GO:0045665(negative regulation of neuron differentiation);GO:0045769(negative regulation of asymmetric cell division);GO:0048477(oogenesis);GO:0048589(developmental growth);GO:0051445(regulation of meiotic cell cycle);GO:0051653(spindle localization);GO:0051661(maintenance of centrosome location);GO:0072687(meiotic spindle);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0090306(spindle assembly involved in meiosis);GO:0097150(neuronal stem cell population maintenance);GO:0097431(mitotic spindle pole)","NA","K16743","NA","abnormal spindle microtubule assembly [Source:NCBI gene;Acc:443284]",{"v":0.118315,"d":"0.12"},{"v":0.02164,"d":"0.02"},{"v":0.112583,"d":"0.11"},{"v":0.414177,"d":"0.41"},{"v":0.067041,"d":"0.07"},{"v":0.183139,"d":"0.18"},{"v":0.38012393938801,"d":"0.38"},{"v":-1.39545820899609,"d":"-1.40"},{"v":0.0561103077274337,"d":"0.06"},{"v":0.426793953314747,"d":"0.43"},"down","no"]
["MSTRG.13645","FZD9","ENSOART00000013910","GO:0001503(ossification);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0007275(multicellular organism development);GO:0007405(neuroblast proliferation);GO:0007611(learning or memory);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0030183(B cell differentiation);GO:0030501(positive regulation of bone mineralization);GO:0031527(filopodium membrane);GO:0042803(protein homodimerization activity);GO:0042813(Wnt-activated receptor activity);GO:0043524(negative regulation of neuron apoptotic process);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0071157(negative regulation of cell cycle arrest);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1904393(regulation of skeletal muscle acetylcholine-gated channel clustering);GO:1904394(negative regulation of skeletal muscle acetylcholine-gated channel clustering);GO:1990523(bone regeneration);GO:2000179(positive regulation of neural precursor cell proliferation)","04150(mTOR signaling pathway);04310(Wnt signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);04934(Cushing syndrome);05165(Human papillomavirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K02842","NA","frizzled class receptor 9 [Source:NCBI gene;Acc:101114236]",{"v":1.346057,"d":"1.35"},{"v":0.848354,"d":"0.85"},{"v":0.83221,"d":"0.83"},{"v":1.413877,"d":"1.41"},{"v":1.887351,"d":"1.89"},{"v":2.193615,"d":"2.19"},{"v":0.550811187871974,"d":"0.55"},{"v":-0.86037023163182,"d":"-0.86"},{"v":0.0561357515402648,"d":"0.06"},{"v":0.426793953314747,"d":"0.43"},"down","no"]
["MSTRG.3330","ATXN7L3","ENSOART00000008065","GO:0000124(SAGA complex);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0006325(chromatin organization);GO:0008270(zinc ion binding);GO:0010390(histone monoubiquitination);GO:0016578(histone deubiquitination);GO:0030374(nuclear receptor transcription coactivator activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0071819(DUBm complex)","NA","K11363","NA","ataxin 7 like 3 [Source:NCBI gene;Acc:101113945]",{"v":2.65297870762303,"d":"2.65"},{"v":1.75967917835317,"d":"1.76"},{"v":1.37699811450627,"d":"1.38"},{"v":3.26633516645224,"d":"3.27"},{"v":2.93888932325507,"d":"2.94"},{"v":3.47882958089418,"d":"3.48"},{"v":0.597854571884156,"d":"0.60"},{"v":-0.74213350333591,"d":"-0.74"},{"v":0.0561375428104261,"d":"0.06"},{"v":0.426793953314747,"d":"0.43"},"down","no"]
["MSTRG.13537","DCTPP1","ENSOART00000006833","GO:0000287(magnesium ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006253(dCTP catabolic process);GO:0009143(nucleoside triphosphate catabolic process);GO:0016462(pyrophosphatase activity);GO:0016787(hydrolase activity);GO:0032556(pyrimidine deoxyribonucleotide binding);GO:0042262(DNA protection);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0047429(nucleoside-triphosphate diphosphatase activity);GO:0047840(dCTP diphosphatase activity);GO:0051289(protein homotetramerization)","00240(Pyrimidine metabolism)","K16904","EC:3.6.1.12","dCTP pyrophosphatase 1 [Source:NCBI gene;Acc:101121995]",{"v":5.551622,"d":"5.55"},{"v":3.508703,"d":"3.51"},{"v":3.222616,"d":"3.22"},{"v":7.032053,"d":"7.03"},{"v":7.166025,"d":"7.17"},{"v":7.41388,"d":"7.41"},{"v":0.568340036566793,"d":"0.57"},{"v":-0.815173745639497,"d":"-0.82"},{"v":0.0561460933194559,"d":"0.06"},{"v":0.426793953314747,"d":"0.43"},"down","no"]
["MSTRG.1925","ENSOARG00000012283","ENSOART00000013355","GO:0005515(protein binding);GO:0005634(nucleus);GO:0016925(protein sumoylation)","03013(RNA transport);05418(Fluid shear stress and atherosclerosis)","K12160","NA","small ubiquitin-like modifier 3 [Source:NCBI gene;Acc:101104960]",{"v":16.306988,"d":"16.31"},{"v":18.166033,"d":"18.17"},{"v":16.727976,"d":"16.73"},{"v":10.821755,"d":"10.82"},{"v":9.632123,"d":"9.63"},{"v":13.090969,"d":"13.09"},{"v":1.52634462753698,"d":"1.53"},{"v":0.610080739567422,"d":"0.61"},{"v":0.0563430248183761,"d":"0.06"},{"v":0.427996974588938,"d":"0.43"},"up","no"]
["MSTRG.11584","RNF144B","ENSOART00000011050","GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0031966(mitochondrial membrane);GO:0043066(negative regulation of apoptotic process);GO:0046872(metal ion binding)","NA","K11975","EC:2.3.2.31","ring finger protein 144B [Source:NCBI gene;Acc:101122473]",{"v":7.20567262033195,"d":"7.21"},{"v":8.57615739864761,"d":"8.58"},{"v":6.06433484785616,"d":"6.06"},{"v":4.76912217888428,"d":"4.77"},{"v":5.73452693937298,"d":"5.73"},{"v":4.45108438566159,"d":"4.45"},{"v":1.46081940284064,"d":"1.46"},{"v":0.546777832671955,"d":"0.55"},{"v":0.0563567794810274,"d":"0.06"},{"v":0.427996974588938,"d":"0.43"},"up","no"]
["MSTRG.10730","CHPF","ENSOART00000022003","GO:0005794(Golgi apparatus);GO:0008376(acetylgalactosaminyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030206(chondroitin sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)","K00747","2.4.1.226;EC:2.4.1.175","chondroitin polymerizing factor [Source:NCBI gene;Acc:101114088]",{"v":1.401337,"d":"1.40"},{"v":0.83151,"d":"0.83"},{"v":1.369982,"d":"1.37"},{"v":1.69495,"d":"1.69"},{"v":2.515969,"d":"2.52"},{"v":2.115538,"d":"2.12"},{"v":0.569486048826381,"d":"0.57"},{"v":-0.812267595421983,"d":"-0.81"},{"v":0.0564197553587026,"d":"0.06"},{"v":0.428001162436496,"d":"0.43"},"down","no"]
["MSTRG.15909","TBC1D30","ENSOART00000003500","GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0017137(Rab GTPase binding);GO:0036064(ciliary basal body);GO:0043547(positive regulation of GTPase activity);GO:1902018(negative regulation of cilium assembly)","NA","NA","NA","TBC1 domain family member 30 [Source:NCBI gene;Acc:101109787]",{"v":0.591942,"d":"0.59"},{"v":0.25854,"d":"0.26"},{"v":0.257577,"d":"0.26"},{"v":0.8335,"d":"0.83"},{"v":0.690203,"d":"0.69"},{"v":0.668288,"d":"0.67"},{"v":0.505503444129105,"d":"0.51"},{"v":-0.984207173261442,"d":"-0.98"},{"v":0.0564359690547388,"d":"0.06"},{"v":0.428001162436496,"d":"0.43"},"down","no"]
["MSTRG.16844","ENSOARG00000009234","ENSOART00000010053","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006805(xenobiotic metabolic process);GO:0009410(response to xenobiotic stimulus);GO:0034751(aryl hydrocarbon receptor complex);GO:0046983(protein dimerization activity)","04659(Th17 cell differentiation);04934(Cushing syndrome)","K09093","NA","aryl hydrocarbon receptor [Source:NCBI gene;Acc:443467]",{"v":4.917622,"d":"4.92"},{"v":2.604195,"d":"2.60"},{"v":2.429214,"d":"2.43"},{"v":6.520564,"d":"6.52"},{"v":4.579604,"d":"4.58"},{"v":5.613062,"d":"5.61"},{"v":0.595398435849923,"d":"0.60"},{"v":-0.748072663359321,"d":"-0.75"},{"v":0.0564626204529628,"d":"0.06"},{"v":0.428004487816145,"d":"0.43"},"down","no"]
["MSTRG.15713","ENSOARG00000017224","ENSOART00000018743","GO:0005515(protein binding)","NA","NA","NA","general receptor for phosphoinositides 1 associated scaffold protein [Source:NCBI gene;Acc:101113577]",{"v":3.57551393998235,"d":"3.58"},{"v":0.834270727714034,"d":"0.83"},{"v":1.24987133009709,"d":"1.25"},{"v":5.11733073036187,"d":"5.12"},{"v":2.6037364721977,"d":"2.60"},{"v":3.60300605781112,"d":"3.60"},{"v":0.499789772431074,"d":"0.50"},{"v":-1.00060671609969,"d":"-1.00"},{"v":0.0567105965967365,"d":"0.06"},{"v":0.429317750581907,"d":"0.43"},"down","no"]
["MSTRG.11239","DAAM2","ENSOART00000000261;ENSOART00000000260","GO:0003779(actin binding);GO:0007368(determination of left/right symmetry);GO:0016043(cellular component organization);GO:0017048(Rho GTPase binding);GO:0021516(dorsal spinal cord development);GO:0030036(actin cytoskeleton organization);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:2000050(regulation of non-canonical Wnt signaling pathway);GO:2000050(regulation of non-canonical Wnt signaling pathway)","04310(Wnt signaling pathway);04310(Wnt signaling pathway)","K04512","NA","dishevelled associated activator of morphogenesis 2 [Source:NCBI gene;Acc:101103274]",{"v":2.15232067279074,"d":"2.15"},{"v":1.72865826823443,"d":"1.73"},{"v":2.09922087415028,"d":"2.10"},{"v":3.66718913907771,"d":"3.67"},{"v":3.37886727319493,"d":"3.38"},{"v":2.68650298805806,"d":"2.69"},{"v":0.614452948005871,"d":"0.61"},{"v":-0.70262555504217,"d":"-0.70"},{"v":0.0569597684468965,"d":"0.06"},{"v":0.430773089023125,"d":"0.43"},"down","no"]
["MSTRG.10810","FNDC5","ENSOART00000022753","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0014850(response to muscle activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0090336(positive regulation of brown fat cell differentiation)","NA","NA","NA","fibronectin type III domain containing 5 [Source:NCBI gene;Acc:101104971]",{"v":2.6154578762215,"d":"2.62"},{"v":2.99921445602606,"d":"3.00"},{"v":1.67040742888165,"d":"1.67"},{"v":2.88445116250452,"d":"2.88"},{"v":4.29940736807818,"d":"4.30"},{"v":5.60816775027144,"d":"5.61"},{"v":0.569501625558166,"d":"0.57"},{"v":-0.812228134988466,"d":"-0.81"},{"v":0.0570672124138042,"d":"0.06"},{"v":0.431273459287282,"d":"0.43"},"down","no"]
["MSTRG.2190","ENSOARG00000009621","ENSOART00000010471","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":4.72378743355382,"d":"4.72"},{"v":3.00771558508719,"d":"3.01"},{"v":4.6750574906795,"d":"4.68"},{"v":6.75656167528563,"d":"6.76"},{"v":6.62011127360192,"d":"6.62"},{"v":6.86466603066747,"d":"6.86"},{"v":0.612931808604751,"d":"0.61"},{"v":-0.706201518296144,"d":"-0.71"},{"v":0.0570814649468603,"d":"0.06"},{"v":0.431273459287282,"d":"0.43"},"down","no"]
["MSTRG.9882","UHRF2","ENSOART00000014858;ENSOART00000014857","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005720(nuclear heterochromatin);GO:0016567(protein ubiquitination);GO:0030154(cell differentiation);GO:0042393(histone binding);GO:0046872(metal ion binding);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0071158(positive regulation of cell cycle arrest);GO:0071158(positive regulation of cell cycle arrest)","NA","K15713","EC:2.3.2.27","ubiquitin like with PHD and ring finger domains 2 [Source:NCBI gene;Acc:101117220]",{"v":6.55287640245399,"d":"6.55"},{"v":7.29510401840491,"d":"7.30"},{"v":5.88730601840491,"d":"5.89"},{"v":5.61952797055215,"d":"5.62"},{"v":3.92960809325153,"d":"3.93"},{"v":4.20007259263804,"d":"4.20"},{"v":1.43537616835988,"d":"1.44"},{"v":0.52142887286546,"d":"0.52"},{"v":0.0571051701971523,"d":"0.06"},{"v":0.431273459287282,"d":"0.43"},"up","no"]
["MSTRG.19777","LACTB","ENSOART00000022655","GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0019216(regulation of lipid metabolic process)","NA","K17382","NA","lactamase beta [Source:NCBI gene;Acc:101101990]",{"v":3.153636,"d":"3.15"},{"v":3.815446,"d":"3.82"},{"v":2.561868,"d":"2.56"},{"v":2.252051,"d":"2.25"},{"v":2.381063,"d":"2.38"},{"v":1.594985,"d":"1.59"},{"v":1.53031446674178,"d":"1.53"},{"v":0.613828145069577,"d":"0.61"},{"v":0.0571813133689808,"d":"0.06"},{"v":0.431648860235191,"d":"0.43"},"up","no"]
["MSTRG.14114","SAMD8","ENSOART00000009528","GO:0002950(ceramide phosphoethanolamine synthase activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0046513(ceramide biosynthetic process);GO:1905373(ceramide phosphoethanolamine biosynthetic process);GO:2000303(regulation of ceramide biosynthetic process)","NA","K22697","NA","sterile alpha motif domain containing 8 [Source:NCBI gene;Acc:101103290]",{"v":4.21159969120763,"d":"4.21"},{"v":5.01617711652542,"d":"5.02"},{"v":4.17167712923729,"d":"4.17"},{"v":3.91911084427966,"d":"3.92"},{"v":2.85329651959746,"d":"2.85"},{"v":2.60883530826271,"d":"2.61"},{"v":1.4283239870517,"d":"1.43"},{"v":0.514323263328446,"d":"0.51"},{"v":0.0573366662813224,"d":"0.06"},{"v":0.432421749210823,"d":"0.43"},"up","no"]
["MSTRG.6133","RPS5","ENSOART00000004185","GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation);GO:0006450(regulation of translational fidelity);GO:0015935(small ribosomal subunit);GO:0022627(cytosolic small ribosomal subunit);GO:1990904(ribonucleoprotein complex)","03010(Ribosome)","K02989","NA","ribosomal protein S5 [Source:NCBI gene;Acc:101111994]",{"v":58.384083,"d":"58.38"},{"v":44.91806,"d":"44.92"},{"v":47.441711,"d":"47.44"},{"v":66.465103,"d":"66.47"},{"v":79.381058,"d":"79.38"},{"v":97.892418,"d":"97.89"},{"v":0.618465302532185,"d":"0.62"},{"v":-0.693235436256304,"d":"-0.69"},{"v":0.0573944122443384,"d":"0.06"},{"v":0.432657416032113,"d":"0.43"},"down","no"]
["MSTRG.982","B4GALT3","ENSOART00000010523","GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006682(galactosylceramide biosynthetic process);GO:0008378(galactosyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis);00515(Mannose type O-glycan biosynthesis);00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)","K07968","2.4.1.-;2.4.1.38;EC:2.4.1.90","beta-1,4-galactosyltransferase 3 [Source:NCBI gene;Acc:101103686]",{"v":2.16382724001717,"d":"2.16"},{"v":1.66547377071705,"d":"1.67"},{"v":1.29820907685702,"d":"1.30"},{"v":3.06517350708459,"d":"3.07"},{"v":2.70814774495492,"d":"2.71"},{"v":2.91638140575354,"d":"2.92"},{"v":0.590067380843327,"d":"0.59"},{"v":-0.761048387094214,"d":"-0.76"},{"v":0.0574650518658184,"d":"0.06"},{"v":0.432990017012036,"d":"0.43"},"down","no"]
["MSTRG.11180","RPS10","ENSOART00000011521","GO:0005730(nucleolus);GO:0005829(cytosol);GO:0022627(cytosolic small ribosomal subunit)","03010(Ribosome)","K02947","NA","ribosomal protein S10 [Source:NCBI gene;Acc:101115487]",{"v":109.049719511714,"d":"109.05"},{"v":91.9169333230579,"d":"91.92"},{"v":117.590535274969,"d":"117.59"},{"v":127.138095776819,"d":"127.14"},{"v":180.178169823674,"d":"180.18"},{"v":215.233814040691,"d":"215.23"},{"v":0.609620399117502,"d":"0.61"},{"v":-0.714016915787649,"d":"-0.71"},{"v":0.057535927405622,"d":"0.06"},{"v":0.433289496322229,"d":"0.43"},"down","no"]
["MSTRG.16037","METTL7B","ENSOART00000012504","GO:0008168(methyltransferase activity);GO:0032259(methylation)","NA","NA","NA","methyltransferase like 7B [Source:NCBI gene;Acc:101115696]",{"v":11.221672,"d":"11.22"},{"v":15.355683,"d":"15.36"},{"v":10.784274,"d":"10.78"},{"v":10.145605,"d":"10.15"},{"v":6.017162,"d":"6.02"},{"v":8.546107,"d":"8.55"},{"v":1.51207331422711,"d":"1.51"},{"v":0.596528091614313,"d":"0.60"},{"v":0.0577941847149561,"d":"0.06"},{"v":0.434367842196442,"d":"0.43"},"up","no"]
["MSTRG.6367","oar-mir-125b","ENSOART00000023465","NA","05206(MicroRNAs in cancer)","K16994","NA","oar-mir-125b [Source:miRBase;Acc:MI0014121]",{"v":2.97656723301968,"d":"2.98"},{"v":3.05623044054748,"d":"3.06"},{"v":2.85514293806672,"d":"2.86"},{"v":2.34774655038494,"d":"2.35"},{"v":2.48797389478186,"d":"2.49"},{"v":1.15893829854577,"d":"1.16"},{"v":1.48264329824544,"d":"1.48"},{"v":0.568171548735656,"d":"0.57"},{"v":0.0578383976470914,"d":"0.06"},{"v":0.434367842196442,"d":"0.43"},"up","no"]
["MSTRG.1840","KY","ENSOART00000008870","NA","NA","NA","NA","kyphoscoliosis peptidase [Source:NCBI gene;Acc:101113821]",{"v":29.411402201384,"d":"29.41"},{"v":20.6478579148332,"d":"20.65"},{"v":33.5370646238467,"d":"33.54"},{"v":50.574115091022,"d":"50.57"},{"v":41.0495059430447,"d":"41.05"},{"v":44.1370295697303,"d":"44.14"},{"v":0.615762552464711,"d":"0.62"},{"v":-0.699553962185039,"d":"-0.70"},{"v":0.0578939106656697,"d":"0.06"},{"v":0.434367842196442,"d":"0.43"},"down","no"]
["MSTRG.12654","BAG3","ENSOART00000003282;ENSOART00000003281","GO:0000774(adenyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0010664(negative regulation of striated muscle cell apoptotic process);GO:0030018(Z disc);GO:0034605(cellular response to heat);GO:0034620(cellular response to unfolded protein);GO:0042307(positive regulation of protein import into nucleus);GO:0044877(protein-containing complex binding);GO:0046716(muscle cell cellular homeostasis);GO:0046827(positive regulation of protein export from nucleus);GO:0050790(regulation of catalytic activity);GO:0050821(protein stabilization);GO:0051087(chaperone binding);GO:0071260(cellular response to mechanical stimulus);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097201(negative regulation of transcription from RNA polymerase II promoter in response to stress);GO:0101031(chaperone complex);GO:1905337(positive regulation of aggrephagy);GO:1905337(positive regulation of aggrephagy)","NA","K09557","NA","BCL2 associated athanogene 3 [Source:NCBI gene;Acc:101108530]",{"v":34.3408932208272,"d":"34.34"},{"v":51.5254805320039,"d":"51.53"},{"v":68.1524998298868,"d":"68.15"},{"v":23.6393693769079,"d":"23.64"},{"v":37.1274445209256,"d":"37.13"},{"v":38.1326500445593,"d":"38.13"},{"v":1.55732768857505,"d":"1.56"},{"v":0.639072544250491,"d":"0.64"},{"v":0.0579263320641305,"d":"0.06"},{"v":0.434367842196442,"d":"0.43"},"up","no"]
["MSTRG.7702","TMEM116","ENSOART00000011476","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 116 [Source:NCBI gene;Acc:101110707]",{"v":2.9562478344379,"d":"2.96"},{"v":2.3851061763623,"d":"2.39"},{"v":1.90299168507609,"d":"1.90"},{"v":2.24283796391753,"d":"2.24"},{"v":1.37792524975454,"d":"1.38"},{"v":1.29828445814924,"d":"1.30"},{"v":1.47271304918946,"d":"1.47"},{"v":0.558476355804897,"d":"0.56"},{"v":0.0580560409427866,"d":"0.06"},{"v":0.435033977289499,"d":"0.44"},"up","no"]
["MSTRG.11998","C11orf95","ENSOART00000003588","NA","NA","NA","NA","chromosome 11 open reading frame 95 [Source:HGNC Symbol;Acc:HGNC:28449]",{"v":0.96540970695553,"d":"0.97"},{"v":0.677765671037628,"d":"0.68"},{"v":1.36757809806157,"d":"1.37"},{"v":1.37285844925884,"d":"1.37"},{"v":2.08327812200684,"d":"2.08"},{"v":2.11065223033067,"d":"2.11"},{"v":0.540842051559663,"d":"0.54"},{"v":-0.886720766458809,"d":"-0.89"},{"v":0.0581983289359797,"d":"0.06"},{"v":0.435650299716928,"d":"0.44"},"down","no"]
["MSTRG.18489","RASGRF2","ENSOART00000016402","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005783(endoplasmic reticulum);GO:0007264(small GTPase mediated signal transduction);GO:0034976(response to endoplasmic reticulum stress);GO:0035023(regulation of Rho protein signal transduction);GO:0046578(regulation of Ras protein signal transduction)","04010(MAPK signaling pathway);04014(Ras signaling pathway)","K12326","NA","Ras protein specific guanine nucleotide releasing factor 2 [Source:NCBI gene;Acc:101121934]",{"v":2.11235368660775,"d":"2.11"},{"v":0.981568045547247,"d":"0.98"},{"v":0.892182104010877,"d":"0.89"},{"v":2.59742615703603,"d":"2.60"},{"v":2.59465982121006,"d":"2.59"},{"v":1.83098040516655,"d":"1.83"},{"v":0.5675731395022,"d":"0.57"},{"v":-0.817121779667753,"d":"-0.82"},{"v":0.0583399498191726,"d":"0.06"},{"v":0.436360375926455,"d":"0.44"},"down","no"]
["MSTRG.12441","FRAT2","ENSOART00000016219","GO:0016055(Wnt signaling pathway)","04310(Wnt signaling pathway);05200(Pathways in cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K03096","NA","FRAT2, WNT signaling pathway regulator [Source:NCBI gene;Acc:101108269]",{"v":0.549482,"d":"0.55"},{"v":0.966374,"d":"0.97"},{"v":1.246904,"d":"1.25"},{"v":1.37924,"d":"1.38"},{"v":2.474135,"d":"2.47"},{"v":1.923147,"d":"1.92"},{"v":0.478273951003736,"d":"0.48"},{"v":-1.06409087722219,"d":"-1.06"},{"v":0.0584078575279901,"d":"0.06"},{"v":0.43666826818545,"d":"0.44"},"down","no"]
["MSTRG.11220","PI16","ENSOART00000015374","GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0061052(negative regulation of cell growth involved in cardiac muscle cell development)","NA","K20412","NA","peptidase inhibitor 16 [Source:NCBI gene;Acc:101122471]",{"v":8.25052022597865,"d":"8.25"},{"v":4.2899123024911,"d":"4.29"},{"v":11.6868426441281,"d":"11.69"},{"v":9.30380334875445,"d":"9.30"},{"v":16.5156399822064,"d":"16.52"},{"v":17.960490905694,"d":"17.96"},{"v":0.553387655669741,"d":"0.55"},{"v":-0.853637632548962,"d":"-0.85"},{"v":0.058465626146383,"d":"0.06"},{"v":0.436900111541484,"d":"0.44"},"down","no"]
["MSTRG.7683","PLBD2","ENSOART00000008223","GO:0006629(lipid metabolic process);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity)","NA","NA","NA","phospholipase B domain containing 2 [Source:NCBI gene;Acc:101108861]",{"v":2.72709,"d":"2.73"},{"v":1.99234,"d":"1.99"},{"v":2.515787,"d":"2.52"},{"v":4.184194,"d":"4.18"},{"v":3.641655,"d":"3.64"},{"v":4.240604,"d":"4.24"},{"v":0.599614236263134,"d":"0.60"},{"v":-0.737893458195311,"d":"-0.74"},{"v":0.0585348105495031,"d":"0.06"},{"v":0.43721701127735,"d":"0.44"},"down","no"]
["MSTRG.16907","NAPEPLD","ENSOART00000020610","GO:0001659(temperature homeostasis);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0042802(identical protein binding);GO:0048874(host-mediated regulation of intestinal microbiota composition);GO:0050729(positive regulation of inflammatory response);GO:0070290(N-acylphosphatidylethanolamine-specific phospholipase D activity);GO:0070291(N-acylethanolamine metabolic process);GO:0070292(N-acylphosphatidylethanolamine metabolic process);GO:0090336(positive regulation of brown fat cell differentiation)","04723(Retrograde endocannabinoid signaling)","K13985","EC:3.1.4.54","N-acyl phosphatidylethanolamine phospholipase D [Source:NCBI gene;Acc:101119039]",{"v":4.92961752429235,"d":"4.93"},{"v":5.16712805703422,"d":"5.17"},{"v":6.13556229805661,"d":"6.14"},{"v":4.9430874547951,"d":"4.94"},{"v":3.26622242606675,"d":"3.27"},{"v":3.11122505935784,"d":"3.11"},{"v":1.43388169950458,"d":"1.43"},{"v":0.519926001321269,"d":"0.52"},{"v":0.0587114196035633,"d":"0.06"},{"v":0.437821825388493,"d":"0.44"},"up","no"]
["MSTRG.5432","CSNK2A2","ENSOART00000001351","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0031519(PcG protein complex);GO:0047485(protein N-terminus binding);GO:0051726(regulation of cell cycle);GO:1905818(regulation of chromosome separation);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process)","03008(Ribosome biogenesis in eukaryotes);04064(NF-kappa B signaling pathway);04137(Mitophagy - animal);04310(Wnt signaling pathway);04520(Adherens junction);05162(Measles)","K03097","EC:2.7.11.1","casein kinase 2 alpha 2 [Source:NCBI gene;Acc:101122459]",{"v":6.6148961174743,"d":"6.61"},{"v":4.03136810621635,"d":"4.03"},{"v":5.74037519725893,"d":"5.74"},{"v":7.25338425208027,"d":"7.25"},{"v":9.95273403034753,"d":"9.95"},{"v":9.91851892413118,"d":"9.92"},{"v":0.604123819100782,"d":"0.60"},{"v":-0.727083825311516,"d":"-0.73"},{"v":0.0587230400294463,"d":"0.06"},{"v":0.437821825388493,"d":"0.44"},"down","no"]
["MSTRG.17606","ARRDC2","ENSOART00000015251","GO:0005886(plasma membrane);GO:0031410(cytoplasmic vesicle)","NA","NA","NA","arrestin domain containing 2 [Source:NCBI gene;Acc:101110324]",{"v":12.5999588656078,"d":"12.60"},{"v":11.9691578054368,"d":"11.97"},{"v":10.8125492593158,"d":"10.81"},{"v":18.4114871612706,"d":"18.41"},{"v":13.4944482733659,"d":"13.49"},{"v":28.306160046121,"d":"28.31"},{"v":0.587617249455595,"d":"0.59"},{"v":-0.767051348178359,"d":"-0.77"},{"v":0.0590383899551867,"d":"0.06"},{"v":0.43920423719203,"d":"0.44"},"down","no"]
["ENSOARG00000007687","ACKR1","ENSOART00000008367","GO:0006954(inflammatory response);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019956(chemokine binding);GO:0019957(C-C chemokine binding);GO:0070098(chemokine-mediated signaling pathway)","05144(Malaria)","K06574","NA","atypical chemokine receptor 1 (Duffy blood group) [Source:NCBI gene;Acc:101113185]",{"v":0.121561,"d":"0.12"},{"v":0.58843,"d":"0.59"},{"v":0.496461,"d":"0.50"},{"v":0.250062,"d":"0.25"},{"v":0.13743,"d":"0.14"},{"v":0.208513,"d":"0.21"},{"v":2.0242313403411,"d":"2.02"},{"v":1.01737417861451,"d":"1.02"},{"v":0.0592088157021413,"d":"0.06"},{"v":0.439836916644478,"d":"0.44"},"up","no"]
["ENSOARG00000007527","RAD51D","ENSOART00000008196","GO:0000400(four-way junction DNA binding);GO:0000723(telomere maintenance);GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0003677(DNA binding);GO:0003697(single-stranded DNA binding);GO:0005524(ATP binding);GO:0005657(replication fork);GO:0005813(centrosome);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008094(DNA-dependent ATPase activity);GO:0033063(Rad51B-Rad51C-Rad51D-XRCC2 complex);GO:0036297(interstrand cross-link repair);GO:0042148(strand invasion);GO:0043015(gamma-tubulin binding);GO:0051276(chromosome organization);GO:0051726(regulation of cell cycle)","03440(Homologous recombination)","K10871","NA","RAD51 paralog D [Source:NCBI gene;Acc:101117517]",{"v":0.316501,"d":"0.32"},{"v":0.245666,"d":"0.25"},{"v":0.325432,"d":"0.33"},{"v":0.672162,"d":"0.67"},{"v":0.433382,"d":"0.43"},{"v":0.696755,"d":"0.70"},{"v":0.492481547179464,"d":"0.49"},{"v":-1.0218584257324,"d":"-1.02"},{"v":0.0592549366941693,"d":"0.06"},{"v":0.439979357136151,"d":"0.44"},"down","no"]
["ENSOARG00000013527","ADCY1","ENSOART00000014716","GO:0000166(nucleotide binding);GO:0004016(adenylate cyclase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006171(cAMP biosynthetic process);GO:0007409(axonogenesis);GO:0007616(long-term memory);GO:0009190(cyclic nucleotide biosynthetic process);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0016849(phosphorus-oxygen lyase activity);GO:0032793(positive regulation of CREB transcription factor activity);GO:0035556(intracellular signal transduction);GO:0042752(regulation of circadian rhythm);GO:0046872(metal ion binding);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane);GO:0150076(neuroinflammatory response);GO:1900273(positive regulation of long-term synaptic potentiation);GO:2000300(regulation of synaptic vesicle exocytosis)","00230(Purine metabolism);01522(Endocrine resistance);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04114(Oocyte meiosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04713(Circadian entrainment);04714(Thermogenesis);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04727(GABAergic synapse);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04913(Ovarian steroidogenesis);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);05032(Morphine addiction);05142(Chagas disease (American trypanosomiasis));05146(Amoebiasis);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05414(Dilated cardiomyopathy (DCM))","K08041","EC:4.6.1.1","adenylate cyclase 1 [Source:NCBI gene;Acc:101117327]",{"v":0.268717,"d":"0.27"},{"v":0.460779,"d":"0.46"},{"v":0.353682,"d":"0.35"},{"v":0.133621,"d":"0.13"},{"v":0.16943,"d":"0.17"},{"v":0.272286,"d":"0.27"},{"v":1.88268440931141,"d":"1.88"},{"v":0.91279118408392,"d":"0.91"},{"v":0.0593620108006091,"d":"0.06"},{"v":0.440269176546641,"d":"0.44"},"up","no"]
["ENSOARG00000009042","ENSOARG00000009042","ENSOART00000009855","GO:0016020(membrane);GO:0016021(integral component of membrane)","04144(Endocytosis);04145(Phagosome);04218(Cellular senescence);04514(Cell adhesion molecules (CAMs));04612(Antigen processing and presentation);04650(Natural killer cell mediated cytotoxicity);04940(Type I diabetes mellitus);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05203(Viral carcinogenesis);05320(Autoimmune thyroid disease);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis)","K06751","NA","BOLA class I histocompatibility antigen, alpha chain BL3-7 [Source:NCBI gene;Acc:101104866]",{"v":0.304456,"d":"0.30"},{"v":0.242714,"d":"0.24"},{"v":0.268446,"d":"0.27"},{"v":0.068596,"d":"0.07"},{"v":0.255292,"d":"0.26"},{"v":0.08499,"d":"0.08"},{"v":1.99476616496852,"d":"1.99"},{"v":0.996219637468932,"d":"1.00"},{"v":0.059374860776317,"d":"0.06"},{"v":0.440269176546641,"d":"0.44"},"up","no"]
["MSTRG.18614","USP53","ENSOART00000018010","GO:0001508(action potential);GO:0005911(cell-cell junction);GO:0006915(apoptotic process);GO:0007605(sensory perception of sound);GO:0010996(response to auditory stimulus);GO:0016579(protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0051402(neuron apoptotic process)","NA","NA","NA","ubiquitin specific peptidase 53 [Source:NCBI gene;Acc:101110058]",{"v":6.22147609223301,"d":"6.22"},{"v":5.66550285436893,"d":"5.67"},{"v":4.09382502427184,"d":"4.09"},{"v":4.92153144660194,"d":"4.92"},{"v":2.92310964563107,"d":"2.92"},{"v":3.11700577184466,"d":"3.12"},{"v":1.45788348858823,"d":"1.46"},{"v":0.543875426693292,"d":"0.54"},{"v":0.0594216382678185,"d":"0.06"},{"v":0.440416027978638,"d":"0.44"},"up","no"]
["MSTRG.3359","ENSOARG00000010472","ENSOART00000011397","GO:0007165(signal transduction)","NA","NA","NA",null,{"v":1.93139034150718,"d":"1.93"},{"v":1.00110025837321,"d":"1.00"},{"v":1.47926589952153,"d":"1.48"},{"v":2.70398903169856,"d":"2.70"},{"v":1.98433160406699,"d":"1.98"},{"v":3.1859969138756,"d":"3.19"},{"v":0.560271600883428,"d":"0.56"},{"v":-0.835801727971597,"d":"-0.84"},{"v":0.0596411935546933,"d":"0.06"},{"v":0.44152067410401,"d":"0.44"},"down","no"]
["MSTRG.11381","ENSOARG00000001878","ENSOART00000002020","GO:0004866(endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010951(negative regulation of endopeptidase activity)","04610(Complement and coagulation cascades);05133(Pertussis);05150(Staphylococcus aureus infection);05322(Systemic lupus erythematosus)","K03989","NA","complement C4-A [Source:NCBI gene;Acc:101123672]",{"v":1.55058131485072,"d":"1.55"},{"v":1.33157801609151,"d":"1.33"},{"v":0.388689019387359,"d":"0.39"},{"v":2.98371549806126,"d":"2.98"},{"v":1.24843048701047,"d":"1.25"},{"v":2.31864583947266,"d":"2.32"},{"v":0.499305799655308,"d":"0.50"},{"v":-1.00200443058796,"d":"-1.00"},{"v":0.0596518010211566,"d":"0.06"},{"v":0.44152067410401,"d":"0.44"},"down","no"]
["MSTRG.12250","ENSOARG00000003938","ENSOART00000004276","GO:0004190(aspartic-type endopeptidase activity);GO:0006508(proteolysis)","NA","NA","NA",null,{"v":7.81025,"d":"7.81"},{"v":9.806146,"d":"9.81"},{"v":8.68417,"d":"8.68"},{"v":14.717776,"d":"14.72"},{"v":14.369297,"d":"14.37"},{"v":15.683675,"d":"15.68"},{"v":0.58744977859204,"d":"0.59"},{"v":-0.76746257473857,"d":"-0.77"},{"v":0.0598667322679858,"d":"0.06"},{"v":0.442522802123697,"d":"0.44"},"down","no"]
["MSTRG.8668","PGAM2","ENSOART00000014833","GO:0003824(catalytic activity);GO:0004082(bisphosphoglycerate mutase activity);GO:0004619(phosphoglycerate mutase activity);GO:0006096(glycolytic process);GO:0006941(striated muscle contraction);GO:0016853(isomerase activity);GO:0016868(intramolecular transferase activity, phosphotransferases)","00010(Glycolysis / Gluconeogenesis);00260(Glycine, serine and threonine metabolism);04922(Glucagon signaling pathway);05230(Central carbon metabolism in cancer)","K01834","EC:5.4.2.11","phosphoglycerate mutase 2 [Source:NCBI gene;Acc:101123502]",{"v":1412.705811,"d":"1412.71"},{"v":1034.111084,"d":"1034.11"},{"v":1049.91394,"d":"1049.91"},{"v":1839.402222,"d":"1839.40"},{"v":1603.76001,"d":"1603.76"},{"v":2171.663818,"d":"2171.66"},{"v":0.622767438182702,"d":"0.62"},{"v":-0.683234580785799,"d":"-0.68"},{"v":0.059985671640326,"d":"0.06"},{"v":0.442522802123697,"d":"0.44"},"down","no"]
["MSTRG.4255","RPS6KC1","ENSOART00000010278","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005769(early endosome);GO:0006468(protein phosphorylation);GO:0035091(phosphatidylinositol binding)","NA","K20839","NA","ribosomal protein S6 kinase C1 [Source:NCBI gene;Acc:101112915]",{"v":4.77968186573427,"d":"4.78"},{"v":5.03130697109557,"d":"5.03"},{"v":5.36193748951049,"d":"5.36"},{"v":4.33793056596737,"d":"4.34"},{"v":3.2049055981352,"d":"3.20"},{"v":3.14283535990676,"d":"3.14"},{"v":1.41993194271869,"d":"1.42"},{"v":0.505821783071344,"d":"0.51"},{"v":0.060021794503434,"d":"0.06"},{"v":0.442522802123697,"d":"0.44"},"up","no"]
["MSTRG.9798","ZFAND5","ENSOART00000013848","GO:0003677(DNA binding);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger AN1-type containing 5 [Source:NCBI gene;Acc:100302558]",{"v":41.8690047403091,"d":"41.87"},{"v":34.6196452365767,"d":"34.62"},{"v":28.1300325108696,"d":"28.13"},{"v":32.6003252914484,"d":"32.60"},{"v":18.8578403841671,"d":"18.86"},{"v":21.0358923966737,"d":"21.04"},{"v":1.44313458605714,"d":"1.44"},{"v":0.52920585116867,"d":"0.53"},{"v":0.060027659845958,"d":"0.06"},{"v":0.442522802123697,"d":"0.44"},"up","no"]
["MSTRG.20526","RRAGD","ENSOART00000013847","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005813(centrosome);GO:0019003(GDP binding);GO:0046982(protein heterodimerization activity);GO:0051020(GTPase binding);GO:0071233(cellular response to leucine);GO:1904263(positive regulation of TORC1 signaling);GO:1990253(cellular response to leucine starvation)","04140(Autophagy - animal);04150(mTOR signaling pathway)","K16186","NA","Ras related GTP binding D [Source:NCBI gene;Acc:101114114]",{"v":14.3816334919628,"d":"14.38"},{"v":13.0117503883249,"d":"13.01"},{"v":13.7955062779188,"d":"13.80"},{"v":5.74756249386633,"d":"5.75"},{"v":11.7378921975465,"d":"11.74"},{"v":9.2399535499154,"d":"9.24"},{"v":1.54118843709605,"d":"1.54"},{"v":0.624043267202258,"d":"0.62"},{"v":0.0600282028124055,"d":"0.06"},{"v":0.442522802123697,"d":"0.44"},"up","no"]
["MSTRG.9891","PTPRD","ENSOART00000014973","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0006470(protein dephosphorylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0098978(glutamatergic synapse);GO:0099545(trans-synaptic signaling by trans-synaptic complex);GO:0099560(synaptic membrane adhesion);GO:1905606(regulation of presynapse assembly)","NA","K06777","EC:3.1.3.48","protein tyrosine phosphatase, receptor type D [Source:NCBI gene;Acc:101118505]",{"v":1.99834908539395,"d":"2.00"},{"v":1.3656617834434,"d":"1.37"},{"v":2.73534198341269,"d":"2.74"},{"v":3.54851760297957,"d":"3.55"},{"v":3.81382008646905,"d":"3.81"},{"v":2.90602916756259,"d":"2.91"},{"v":0.593994443048694,"d":"0.59"},{"v":-0.751478660534035,"d":"-0.75"},{"v":0.0600299392038459,"d":"0.06"},{"v":0.442522802123697,"d":"0.44"},"down","no"]
["MSTRG.549","DPYD","ENSOART00000019097","GO:0003824(catalytic activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006145(purine nucleobase catabolic process);GO:0006208(pyrimidine nucleobase catabolic process);GO:0006210(thymine catabolic process);GO:0006212(uracil catabolic process);GO:0006214(thymidine catabolic process);GO:0016491(oxidoreductase activity);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0017113(dihydropyrimidine dehydrogenase (NADP+) activity);GO:0019483(beta-alanine biosynthetic process);GO:0042803(protein homodimerization activity);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0055114(oxidation-reduction process)","00240(Pyrimidine metabolism);00410(beta-Alanine metabolism);00770(Pantothenate and CoA biosynthesis);00983(Drug metabolism - other enzymes)","K00207","EC:1.3.1.2","dihydropyrimidine dehydrogenase [Source:NCBI gene;Acc:101109311]",{"v":3.90369058072654,"d":"3.90"},{"v":4.01419116069627,"d":"4.01"},{"v":3.90848853834511,"d":"3.91"},{"v":3.27010098536831,"d":"3.27"},{"v":2.69761393012109,"d":"2.70"},{"v":2.40884682139253,"d":"2.41"},{"v":1.41184063954266,"d":"1.41"},{"v":0.497577254673956,"d":"0.50"},{"v":0.0601531264301482,"d":"0.06"},{"v":0.442522802123697,"d":"0.44"},"up","no"]
["MSTRG.14445","PLAT","ENSOART00000003401","GO:0001666(response to hypoxia);GO:0004252(serine-type endopeptidase activity);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0009986(cell surface);GO:0014909(smooth muscle cell migration);GO:0016787(hydrolase activity);GO:0030141(secretory granule);GO:0031639(plasminogen activation);GO:0045177(apical part of cell);GO:0045861(negative regulation of proteolysis);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0051219(phosphoprotein binding);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099183(trans-synaptic signaling by BDNF, modulating synaptic transmission)","04371(Apelin signaling pathway);04610(Complement and coagulation cascades);05202(Transcriptional misregulation in cancer);05215(Prostate cancer);05418(Fluid shear stress and atherosclerosis)","K01343","EC:3.4.21.68","plasminogen activator, tissue type [Source:NCBI gene;Acc:101118332]",{"v":2.347353,"d":"2.35"},{"v":1.629191,"d":"1.63"},{"v":2.801783,"d":"2.80"},{"v":1.610388,"d":"1.61"},{"v":0.948049,"d":"0.95"},{"v":1.657015,"d":"1.66"},{"v":1.6079715769507,"d":"1.61"},{"v":0.685241905176866,"d":"0.69"},{"v":0.0601666230226976,"d":"0.06"},{"v":0.442522802123697,"d":"0.44"},"up","no"]
["MSTRG.623","ENSOARG00000019307","ENSOART00000021027","GO:0004364(glutathione transferase activity);GO:0005515(protein binding);GO:0016740(transferase activity)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);00983(Drug metabolism - other enzymes);01524(Platinum drug resistance);05200(Pathways in cancer);05204(Chemical carcinogenesis);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis)","K00799","EC:2.5.1.18","glutathione S-transferase Mu 1-like [Source:NCBI gene;Acc:101108705]",{"v":38.3143348901478,"d":"38.31"},{"v":60.364241464532,"d":"60.36"},{"v":66.1578573118227,"d":"66.16"},{"v":35.6297171029557,"d":"35.63"},{"v":35.9100130463054,"d":"35.91"},{"v":39.9502122044335,"d":"39.95"},{"v":1.47848702929247,"d":"1.48"},{"v":0.564121586807905,"d":"0.56"},{"v":0.0603536990118717,"d":"0.06"},{"v":0.443313192078621,"d":"0.44"},"up","no"]
["MSTRG.13875","C1orf198","ENSOART00000003449","GO:0005829(cytosol)","NA","NA","NA","chromosome 1 open reading frame 198 [Source:HGNC Symbol;Acc:HGNC:25900]",{"v":6.45023090622656,"d":"6.45"},{"v":6.3690532708177,"d":"6.37"},{"v":9.45110712753188,"d":"9.45"},{"v":12.3918415873968,"d":"12.39"},{"v":10.9447862190548,"d":"10.94"},{"v":13.2424297621905,"d":"13.24"},{"v":0.608829007220452,"d":"0.61"},{"v":-0.715890998240125,"d":"-0.72"},{"v":0.0604142215683824,"d":"0.06"},{"v":0.443313192078621,"d":"0.44"},"down","no"]
["MSTRG.4861","LSM14B","ENSOART00000016006","NA","NA","K18749","NA","LSM family member 14B [Source:NCBI gene;Acc:101122208]",{"v":3.13564563946507,"d":"3.14"},{"v":4.62680452729258,"d":"4.63"},{"v":3.73252554407751,"d":"3.73"},{"v":2.697994492631,"d":"2.70"},{"v":2.41928065201965,"d":"2.42"},{"v":2.77479796670306,"d":"2.77"},{"v":1.4565216957124,"d":"1.46"},{"v":0.542527191394892,"d":"0.54"},{"v":0.0604196682650995,"d":"0.06"},{"v":0.443313192078621,"d":"0.44"},"up","no"]
["MSTRG.5881","DBP;CA11","ENSOART00000013016;ENSOART00000013059","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007623(circadian rhythm);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0004089(carbonate dehydratase activity);GO:0008270(zinc ion binding);GO:0016323(basolateral plasma membrane)","NA","K09056","NA","D-box binding PAR bZIP transcription factor [Source:NCBI gene;Acc:100192428];carbonic anhydrase 11 [Source:NCBI gene;Acc:443426]",{"v":1.8154375024,"d":"1.82"},{"v":1.36084532114286,"d":"1.36"},{"v":1.75566842468571,"d":"1.76"},{"v":2.28804170422857,"d":"2.29"},{"v":2.98569272662857,"d":"2.99"},{"v":2.76390373622857,"d":"2.76"},{"v":0.61360702555945,"d":"0.61"},{"v":-0.704613093660349,"d":"-0.70"},{"v":0.0604638220999416,"d":"0.06"},{"v":0.443313192078621,"d":"0.44"},"down","no"]
["MSTRG.16626","FAM118A","ENSOART00000021095","GO:0042802(identical protein binding)","NA","NA","NA","family with sequence similarity 118 member A [Source:NCBI gene;Acc:101119201]",{"v":1.54665075395526,"d":"1.55"},{"v":0.862167848881615,"d":"0.86"},{"v":1.05361175068194,"d":"1.05"},{"v":0.942113195853792,"d":"0.94"},{"v":0.565267009819967,"d":"0.57"},{"v":0.683985992362248,"d":"0.68"},{"v":1.58003274697857,"d":"1.58"},{"v":0.659954459297319,"d":"0.66"},{"v":0.0604651114839688,"d":"0.06"},{"v":0.443313192078621,"d":"0.44"},"up","no"]
["MSTRG.12701","ZRANB1","ENSOART00000011685","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007010(cytoskeleton organization);GO:0016477(cell migration);GO:0022604(regulation of cell morphogenesis);GO:0030177(positive regulation of Wnt signaling pathway);GO:0035523(protein K29-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding);GO:0070536(protein K63-linked deubiquitination);GO:0071947(protein deubiquitination involved in ubiquitin-dependent protein catabolic process);GO:1990168(protein K33-linked deubiquitination)","NA","K11862","EC:3.4.19.12","zinc finger RANBP2-type containing 1 [Source:NCBI gene;Acc:101114991]",{"v":2.54733827870461,"d":"2.55"},{"v":3.05678929365139,"d":"3.06"},{"v":2.37776891907602,"d":"2.38"},{"v":2.26008942009512,"d":"2.26"},{"v":1.76467855325734,"d":"1.76"},{"v":1.56817205752246,"d":"1.57"},{"v":1.42713786440928,"d":"1.43"},{"v":0.513124708809741,"d":"0.51"},{"v":0.0607083925521576,"d":"0.06"},{"v":0.443802439600959,"d":"0.44"},"up","no"]
["MSTRG.16780","PON3","ENSOART00000003298","GO:0004064(arylesterase activity);GO:0019439(aromatic compound catabolic process);GO:0032929(negative regulation of superoxide anion generation);GO:0042803(protein homodimerization activity);GO:0046395(carboxylic acid catabolic process)","NA","K01045","3.1.8.1;EC:3.1.1.2","paraoxonase 3 [Source:NCBI gene;Acc:100337686]",{"v":6.045111,"d":"6.05"},{"v":5.720041,"d":"5.72"},{"v":4.47729,"d":"4.48"},{"v":4.710093,"d":"4.71"},{"v":2.797493,"d":"2.80"},{"v":3.680887,"d":"3.68"},{"v":1.45171213265653,"d":"1.45"},{"v":0.537755402395247,"d":"0.54"},{"v":0.0607263758621712,"d":"0.06"},{"v":0.443802439600959,"d":"0.44"},"up","no"]
["MSTRG.10545","FAM126B","ENSOART00000018230","NA","NA","K21844","NA","family with sequence similarity 126 member B [Source:NCBI gene;Acc:101106405]",{"v":5.708992,"d":"5.71"},{"v":6.162402,"d":"6.16"},{"v":5.377658,"d":"5.38"},{"v":4.426564,"d":"4.43"},{"v":4.010251,"d":"4.01"},{"v":3.569763,"d":"3.57"},{"v":1.43663348541108,"d":"1.44"},{"v":0.522692047721499,"d":"0.52"},{"v":0.0608130782148349,"d":"0.06"},{"v":0.443802439600959,"d":"0.44"},"up","no"]
["MSTRG.11839","ANO5","ENSOART00000008470","GO:0005229(intracellular calcium activated chloride channel activity);GO:0005886(plasma membrane);GO:0006821(chloride transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031982(vesicle);GO:0034220(ion transmembrane transport);GO:0046983(protein dimerization activity)","NA","K19480","NA","anoctamin 5 [Source:NCBI gene;Acc:101120120]",{"v":10.7570707593211,"d":"10.76"},{"v":11.6261642488038,"d":"11.63"},{"v":10.1019543984833,"d":"10.10"},{"v":8.52125575363366,"d":"8.52"},{"v":7.08872554707953,"d":"7.09"},{"v":7.42901020014444,"d":"7.43"},{"v":1.41000917533213,"d":"1.41"},{"v":0.495704550682999,"d":"0.50"},{"v":0.0608389292785483,"d":"0.06"},{"v":0.443802439600959,"d":"0.44"},"up","no"]
["MSTRG.4614","KIF5B","ENSOART00000014787","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0007028(cytoplasm organization);GO:0008017(microtubule binding);GO:0030139(endocytic vesicle);GO:0031982(vesicle);GO:0032230(positive regulation of synaptic transmission, GABAergic);GO:0035253(ciliary rootlet);GO:0035617(stress granule disassembly);GO:0042391(regulation of membrane potential);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043227(membrane-bounded organelle);GO:0043268(positive regulation of potassium ion transport);GO:0045335(phagocytic vesicle);GO:0047496(vesicle transport along microtubule);GO:0051642(centrosome localization);GO:0071346(cellular response to interferon-gamma);GO:0072383(plus-end-directed vesicle transport along microtubule);GO:1903078(positive regulation of protein localization to plasma membrane)","04144(Endocytosis);04728(Dopaminergic synapse)","K10396","NA","kinesin family member 5B [Source:NCBI gene;Acc:100037703]",{"v":8.16630116996004,"d":"8.17"},{"v":8.62014332371226,"d":"8.62"},{"v":7.4462922491119,"d":"7.45"},{"v":6.02326433203819,"d":"6.02"},{"v":5.79100657326821,"d":"5.79"},{"v":5.17270130184281,"d":"5.17"},{"v":1.42654832463819,"d":"1.43"},{"v":0.512528619359173,"d":"0.51"},{"v":0.0608842151338895,"d":"0.06"},{"v":0.443802439600959,"d":"0.44"},"up","no"]
["MSTRG.758","HIST2H2AC","ENSOART00000014437","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 2-C [Source:NCBI gene;Acc:101122645]",{"v":30.509935,"d":"30.51"},{"v":16.447893,"d":"16.45"},{"v":19.44281,"d":"19.44"},{"v":29.611919,"d":"29.61"},{"v":31.604969,"d":"31.60"},{"v":49.933121,"d":"49.93"},{"v":0.597396604799195,"d":"0.60"},{"v":-0.743239056524368,"d":"-0.74"},{"v":0.060970784508748,"d":"0.06"},{"v":0.444235149245353,"d":"0.44"},"down","no"]
["MSTRG.4373","ENSOARG00000018728;CSRP1","ENSOART00000020388;ENSOART00000020346","GO:0005634(nucleus);GO:0046872(metal ion binding)","NA","NA","NA","cysteine and glycine rich protein 1 [Source:HGNC Symbol;Acc:HGNC:2469]",{"v":1.02465335747994,"d":"1.02"},{"v":0.799237226757905,"d":"0.80"},{"v":0.900121703161869,"d":"0.90"},{"v":1.15907486927796,"d":"1.16"},{"v":1.91485787564889,"d":"1.91"},{"v":1.55383226852289,"d":"1.55"},{"v":0.588623726460371,"d":"0.59"},{"v":-0.764582398757837,"d":"-0.76"},{"v":0.0610576920638255,"d":"0.06"},{"v":0.444609119779699,"d":"0.44"},"down","no"]
["MSTRG.6886","RF00017","ENSOART00000026303","NA","NA","NA","NA",null,{"v":3.241484,"d":"3.24"},{"v":1.069724,"d":"1.07"},{"v":3.39479,"d":"3.39"},{"v":2.027606,"d":"2.03"},{"v":1.009928,"d":"1.01"},{"v":21.063591,"d":"21.06"},{"v":0.319736028919812,"d":"0.32"},{"v":-1.64504677393045,"d":"-1.65"},{"v":0.06107657126812,"d":"0.06"},{"v":0.444609119779699,"d":"0.44"},"down","no"]
["MSTRG.21328","SLC26A7","ENSOART00000010431","GO:0001696(gastric acid secretion);GO:0005253(anion channel activity);GO:0005254(chloride channel activity);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0006820(anion transport);GO:0006821(chloride transport);GO:0008271(secondary active sulfate transmembrane transporter activity);GO:0008272(sulfate transport);GO:0008509(anion transmembrane transporter activity);GO:0015106(bicarbonate transmembrane transporter activity);GO:0015116(sulfate transmembrane transporter activity);GO:0015701(bicarbonate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0019531(oxalate transmembrane transporter activity);GO:0019532(oxalate transport);GO:0055085(transmembrane transport);GO:0098656(anion transmembrane transport);GO:1902358(sulfate transmembrane transport);GO:1902476(chloride transmembrane transport)","04971(Gastric acid secretion)","K13962","NA","solute carrier family 26 member 7 [Source:NCBI gene;Acc:101113767]",{"v":0.520465,"d":"0.52"},{"v":0.439532,"d":"0.44"},{"v":0.515107,"d":"0.52"},{"v":0.354259,"d":"0.35"},{"v":0.371315,"d":"0.37"},{"v":0.219188,"d":"0.22"},{"v":1.56134984260586,"d":"1.56"},{"v":0.642793829848769,"d":"0.64"},{"v":0.0611128225080283,"d":"0.06"},{"v":0.444674761992463,"d":"0.44"},"up","no"]
["MSTRG.9044","NT5DC2","ENSOART00000003408","GO:0046872(metal ion binding)","NA","NA","NA","5'-nucleotidase domain containing 2 [Source:NCBI gene;Acc:101111056]",{"v":1.93968997402218,"d":"1.94"},{"v":1.07085545154699,"d":"1.07"},{"v":1.84424598920023,"d":"1.84"},{"v":3.15269928225336,"d":"3.15"},{"v":2.74096041768827,"d":"2.74"},{"v":2.31882969614711,"d":"2.32"},{"v":0.591147358690232,"d":"0.59"},{"v":-0.758410290792153,"d":"-0.76"},{"v":0.061161645668311,"d":"0.06"},{"v":0.44476877449247,"d":"0.44"},"down","no"]
["MSTRG.22355","ARMCX1","ENSOART00000010965","GO:0005515(protein binding)","NA","NA","NA","armadillo repeat containing X-linked 1 [Source:NCBI gene;Acc:101106745]",{"v":2.046807,"d":"2.05"},{"v":0.930487,"d":"0.93"},{"v":1.437349,"d":"1.44"},{"v":3.040045,"d":"3.04"},{"v":2.362356,"d":"2.36"},{"v":2.488679,"d":"2.49"},{"v":0.559447249299209,"d":"0.56"},{"v":-0.837925990070385,"d":"-0.84"},{"v":0.0612331051247815,"d":"0.06"},{"v":0.44476877449247,"d":"0.44"},"down","no"]
["MSTRG.17370","TCAF1","ENSOART00000019845","GO:0005886(plasma membrane);GO:0030336(negative regulation of cell migration);GO:0044325(ion channel binding);GO:0090314(positive regulation of protein targeting to membrane);GO:1901529(positive regulation of anion channel activity)","NA","NA","NA","TRPM8 channel-associated factor 1 [Source:NCBI gene;Acc:101116226]",{"v":5.1996468334114,"d":"5.20"},{"v":3.03738573208431,"d":"3.04"},{"v":3.45047898126464,"d":"3.45"},{"v":7.05354551241218,"d":"7.05"},{"v":5.99421185136612,"d":"5.99"},{"v":5.90620788665105,"d":"5.91"},{"v":0.616626198916113,"d":"0.62"},{"v":-0.697531907609983,"d":"-0.70"},{"v":0.0612505649951424,"d":"0.06"},{"v":0.44476877449247,"d":"0.44"},"down","no"]
["MSTRG.17357","CASP2","ENSOART00000019286","GO:0004197(cysteine-type endopeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0008234(cysteine-type peptidase activity);GO:0016485(protein processing);GO:0019904(protein domain specific binding);GO:0035234(ectopic germ cell programmed cell death);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0071260(cellular response to mechanical stimulus);GO:0097153(cysteine-type endopeptidase activity involved in apoptotic process);GO:0097190(apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097194(execution phase of apoptosis);GO:0097200(cysteine-type endopeptidase activity involved in execution phase of apoptosis);GO:2001235(positive regulation of apoptotic signaling pathway)","04210(Apoptosis)","K02186","EC:3.4.22.55","caspase 2 [Source:NCBI gene;Acc:101115025]",{"v":1.73245527885862,"d":"1.73"},{"v":1.00309831128405,"d":"1.00"},{"v":1.6914376536965,"d":"1.69"},{"v":2.89074115175097,"d":"2.89"},{"v":2.18768656549935,"d":"2.19"},{"v":2.7347803540856,"d":"2.73"},{"v":0.566603526159804,"d":"0.57"},{"v":-0.819588514778424,"d":"-0.82"},{"v":0.0612756657389265,"d":"0.06"},{"v":0.44476877449247,"d":"0.44"},"down","no"]
["MSTRG.7823","TCN2","ENSOART00000009130","GO:0005615(extracellular space);GO:0015889(cobalamin transport);GO:0031419(cobalamin binding)","04977(Vitamin digestion and absorption)","K14619","NA","transcobalamin 2 [Source:NCBI gene;Acc:101112851]",{"v":4.96176186096592,"d":"4.96"},{"v":2.59175523959858,"d":"2.59"},{"v":3.09097965628267,"d":"3.09"},{"v":4.66431512398076,"d":"4.66"},{"v":6.26431578235417,"d":"6.26"},{"v":6.67571849634121,"d":"6.68"},{"v":0.604651527492918,"d":"0.60"},{"v":-0.725824166383359,"d":"-0.73"},{"v":0.0613471715278699,"d":"0.06"},{"v":0.44476877449247,"d":"0.44"},"down","no"]
["MSTRG.20521","ANKRD6","ENSOART00000013774","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0043231(intracellular membrane-bounded organelle);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2000096(positive regulation of Wnt signaling pathway, planar cell polarity pathway)","NA","K21435","NA","ankyrin repeat domain 6 [Source:NCBI gene;Acc:101109885]",{"v":2.95619395497749,"d":"2.96"},{"v":3.16996333416708,"d":"3.17"},{"v":1.8237373931966,"d":"1.82"},{"v":1.99452911605803,"d":"1.99"},{"v":1.7892711845923,"d":"1.79"},{"v":1.60067888944472,"d":"1.60"},{"v":1.47644635658827,"d":"1.48"},{"v":0.562128940291721,"d":"0.56"},{"v":0.0613738083256061,"d":"0.06"},{"v":0.44476877449247,"d":"0.44"},"up","no"]
["MSTRG.6413","ENSOARG00000017091","ENSOART00000018602","GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006457(protein folding)","NA","K04078","NA","10 kDa heat shock protein, mitochondrial [Source:NCBI gene;Acc:101122667]",{"v":4.924552,"d":"4.92"},{"v":6.818311,"d":"6.82"},{"v":9.067176,"d":"9.07"},{"v":17.160295,"d":"17.16"},{"v":13.790802,"d":"13.79"},{"v":8.202756,"d":"8.20"},{"v":0.531494026909689,"d":"0.53"},{"v":-0.911874616482239,"d":"-0.91"},{"v":0.0613960946431866,"d":"0.06"},{"v":0.44476877449247,"d":"0.44"},"down","no"]
["MSTRG.10494","CAVIN2","ENSOART00000015447","GO:0001786(phosphatidylserine binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0015629(actin cytoskeleton);GO:0045121(membrane raft);GO:0097320(plasma membrane tubulation)","NA","NA","NA","caveolae associated protein 2 [Source:NCBI gene;Acc:101118507]",{"v":15.273191,"d":"15.27"},{"v":6.385674,"d":"6.39"},{"v":8.082022,"d":"8.08"},{"v":16.048178,"d":"16.05"},{"v":17.235825,"d":"17.24"},{"v":16.634792,"d":"16.63"},{"v":0.595785354995047,"d":"0.60"},{"v":-0.74713543376332,"d":"-0.75"},{"v":0.0613981392519615,"d":"0.06"},{"v":0.44476877449247,"d":"0.44"},"down","no"]
["MSTRG.12647","PRDX3","ENSOART00000001921","GO:0001893(maternal placenta development);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005769(early endosome);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0006979(response to oxidative stress);GO:0007005(mitochondrion organization);GO:0008022(protein C-terminus binding);GO:0008284(positive regulation of cell population proliferation);GO:0008379(thioredoxin peroxidase activity);GO:0016209(antioxidant activity);GO:0016491(oxidoreductase activity);GO:0018171(peptidyl-cysteine oxidation);GO:0019900(kinase binding);GO:0019901(protein kinase binding);GO:0030099(myeloid cell differentiation);GO:0032496(response to lipopolysaccharide);GO:0032991(protein-containing complex);GO:0033673(negative regulation of kinase activity);GO:0034599(cellular response to oxidative stress);GO:0034614(cellular response to reactive oxygen species);GO:0042542(response to hydrogen peroxide);GO:0042744(hydrogen peroxide catabolic process);GO:0042802(identical protein binding);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045454(cell redox homeostasis);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051881(regulation of mitochondrial membrane potential);GO:0051920(peroxiredoxin activity);GO:0055114(oxidation-reduction process);GO:0098869(cellular oxidant detoxification)","NA","K20011","EC:1.11.1.15","peroxiredoxin 3 [Source:NCBI gene;Acc:101106731]",{"v":97.712471,"d":"97.71"},{"v":93.874329,"d":"93.87"},{"v":69.127541,"d":"69.13"},{"v":84.921936,"d":"84.92"},{"v":41.173923,"d":"41.17"},{"v":50.096531,"d":"50.10"},{"v":1.47971397062041,"d":"1.48"},{"v":0.565318329200216,"d":"0.57"},{"v":0.0614894685930522,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"up","no"]
["MSTRG.5657","SPINT2","ENSOART00000006049","GO:0001843(neural tube closure);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005737(cytoplasm);GO:0007163(establishment or maintenance of cell polarity);GO:0010951(negative regulation of endopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022408(negative regulation of cell-cell adhesion);GO:0060672(epithelial cell morphogenesis involved in placental branching);GO:0071711(basement membrane organization);GO:2000146(negative regulation of cell motility)","NA","NA","NA","serine peptidase inhibitor, Kunitz type 2 [Source:NCBI gene;Acc:101110167]",{"v":6.21091606643357,"d":"6.21"},{"v":4.96014006993007,"d":"4.96"},{"v":4.68918927482517,"d":"4.69"},{"v":10.6570688251748,"d":"10.66"},{"v":6.82447888111888,"d":"6.82"},{"v":8.50452797202797,"d":"8.50"},{"v":0.610336305008913,"d":"0.61"},{"v":-0.712323685209307,"d":"-0.71"},{"v":0.0615131154415432,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"down","no"]
["ENSOARG00000001264","ENSOARG00000001264","ENSOART00000001358","GO:0008158(hedgehog receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","04340(Hedgehog signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)","K11101","NA","patched 2 [Source:NCBI gene;Acc:101110291]",{"v":0.359187,"d":"0.36"},{"v":0.136112,"d":"0.14"},{"v":0.101341,"d":"0.10"},{"v":0.488579,"d":"0.49"},{"v":0.449401,"d":"0.45"},{"v":0.319427,"d":"0.32"},{"v":0.474500301016298,"d":"0.47"},{"v":-1.0755190924153,"d":"-1.08"},{"v":0.061769165274275,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"down","no"]
["MSTRG.13276","SLX4","ENSOART00000002223","GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006289(nucleotide-excision repair);GO:0008047(enzyme activator activity);GO:0008821(crossover junction endodeoxyribonuclease activity);GO:0010792(DNA double-strand break processing involved in repair via single-strand annealing);GO:0017108(5'-flap endonuclease activity);GO:0030054(cell junction);GO:0033557(Slx1-Slx4 complex);GO:0043085(positive regulation of catalytic activity);GO:0048257(3'-flap endonuclease activity);GO:0048476(Holliday junction resolvase complex);GO:0061820(telomeric D-loop disassembly);GO:0070522(ERCC4-ERCC1 complex);GO:0072429(response to intra-S DNA damage checkpoint signaling);GO:0090656(t-circle formation);GO:1904357(negative regulation of telomere maintenance via telomere lengthening)","03460(Fanconi anemia pathway)","K10484","NA","SLX4 structure-specific endonuclease subunit [Source:NCBI gene;Acc:101123086]",{"v":1.11747588617741,"d":"1.12"},{"v":1.44576055397221,"d":"1.45"},{"v":0.675671050053438,"d":"0.68"},{"v":1.69009028767367,"d":"1.69"},{"v":1.76185993053082,"d":"1.76"},{"v":2.15007145083719,"d":"2.15"},{"v":0.57816761190021,"d":"0.58"},{"v":-0.790440301464464,"d":"-0.79"},{"v":0.0617780192804424,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"down","no"]
["MSTRG.6493","SCUBE2","ENSOART00000014753;ENSOART00000014754","GO:0005509(calcium ion binding);GO:0005509(calcium ion binding)","NA","NA","NA","signal peptide, CUB domain and EGF like domain containing 2 [Source:NCBI gene;Acc:101102010]",{"v":2.16295453373615,"d":"2.16"},{"v":1.12146412084592,"d":"1.12"},{"v":1.57953261497147,"d":"1.58"},{"v":3.12203953205774,"d":"3.12"},{"v":2.37636659550185,"d":"2.38"},{"v":2.73016055253441,"d":"2.73"},{"v":0.59110553011864,"d":"0.59"},{"v":-0.758512377026665,"d":"-0.76"},{"v":0.0617813010614798,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"down","no"]
["MSTRG.10496","TMEFF2","ENSOART00000015461","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030336(negative regulation of cell migration);GO:0044319(wound healing, spreading of cells);GO:0045720(negative regulation of integrin biosynthetic process);GO:0051497(negative regulation of stress fiber assembly)","NA","NA","NA","transmembrane protein with EGF like and two follistatin like domains 2 [Source:NCBI gene;Acc:101118760]",{"v":0.532778,"d":"0.53"},{"v":0.374152,"d":"0.37"},{"v":0.570797,"d":"0.57"},{"v":1.398082,"d":"1.40"},{"v":0.497809,"d":"0.50"},{"v":1.207036,"d":"1.21"},{"v":0.476236469630127,"d":"0.48"},{"v":-1.07024999015502,"d":"-1.07"},{"v":0.0617839228855987,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"down","no"]
["MSTRG.1451","ENSOARG00000020389","ENSOART00000022201","GO:0004864(protein phosphatase inhibitor activity);GO:0009966(regulation of signal transduction);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA","K16833","NA","protein phosphatase 1 regulatory inhibitor subunit 2 [Source:NCBI gene;Acc:101104622]",{"v":46.617214,"d":"46.62"},{"v":40.054729,"d":"40.05"},{"v":33.467953,"d":"33.47"},{"v":31.95941,"d":"31.96"},{"v":21.986483,"d":"21.99"},{"v":29.098679,"d":"29.10"},{"v":1.44669173561398,"d":"1.45"},{"v":0.53275754185593,"d":"0.53"},{"v":0.0618009049318309,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"up","no"]
["MSTRG.9204","ENSOARG00000021937","ENSOART00000023839","NA","NA","NA","NA",null,{"v":3.3185680324802,"d":"3.32"},{"v":5.32849722262104,"d":"5.33"},{"v":5.28364988394912,"d":"5.28"},{"v":3.54808909773321,"d":"3.55"},{"v":3.66985271514962,"d":"3.67"},{"v":2.35470252713511,"d":"2.35"},{"v":1.45526300197049,"d":"1.46"},{"v":0.541279907326119,"d":"0.54"},{"v":0.0618429078498747,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"up","no"]
["MSTRG.18306","PCDHGC3","ENSOART00000000559","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050808(synapse organization)","NA","K16497","NA","protocadherin gamma-C4 [Source:NCBI gene;Acc:101105495]",{"v":4.61617533,"d":"4.62"},{"v":2.3343443025,"d":"2.33"},{"v":5.35039997678571,"d":"5.35"},{"v":6.626538085,"d":"6.63"},{"v":7.09716476857143,"d":"7.10"},{"v":6.96480599714286,"d":"6.96"},{"v":0.594577390668782,"d":"0.59"},{"v":-0.750063490353862,"d":"-0.75"},{"v":0.0618559378631289,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"down","no"]
["MSTRG.21026","FER1L6","ENSOART00000010257;ENSOART00000010251","GO:0009617(response to bacterium);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","K22127","NA","fer-1 like family member 6 [Source:NCBI gene;Acc:101106949]",{"v":0.0551011685543964,"d":"0.06"},{"v":0.0870397672131148,"d":"0.09"},{"v":0.0984878159463487,"d":"0.10"},{"v":0.205970281967213,"d":"0.21"},{"v":0.117484018032787,"d":"0.12"},{"v":0.1726902,"d":"0.17"},{"v":0.48499731774485,"d":"0.48"},{"v":-1.04395132632348,"d":"-1.04"},{"v":0.0618923710245936,"d":"0.06"},{"v":0.445188825590117,"d":"0.45"},"down","no"]
["MSTRG.7503","GUCY1B1","ENSOART00000008699","GO:0000166(nucleotide binding);GO:0004383(guanylate cyclase activity);GO:0006182(cGMP biosynthetic process);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016829(lyase activity);GO:0016849(phosphorus-oxygen lyase activity);GO:0019934(cGMP-mediated signaling);GO:0020037(heme binding);GO:0035556(intracellular signal transduction);GO:0099555(trans-synaptic signaling by nitric oxide, modulating synaptic transmission)","00230(Purine metabolism);04022(cGMP-PKG signaling pathway);04270(Vascular smooth muscle contraction);04540(Gap junction);04611(Platelet activation);04713(Circadian entrainment);04730(Long-term depression);04921(Oxytocin signaling pathway);04924(Renin secretion);04970(Salivary secretion)","K12319","EC:4.6.1.2","guanylate cyclase 1 soluble subunit beta 1 [Source:NCBI gene;Acc:443165]",{"v":3.17177109385113,"d":"3.17"},{"v":2.22724749375867,"d":"2.23"},{"v":2.32877271289875,"d":"2.33"},{"v":4.83855578663893,"d":"4.84"},{"v":4.05366448844198,"d":"4.05"},{"v":3.65348834327323,"d":"3.65"},{"v":0.615970889775245,"d":"0.62"},{"v":-0.699065922813375,"d":"-0.70"},{"v":0.0619885849563289,"d":"0.06"},{"v":0.445540937711843,"d":"0.45"},"down","no"]
["MSTRG.829","CHTOP","ENSOART00000000787","GO:0000346(transcription export complex);GO:0006406(mRNA export from nucleus);GO:0008284(positive regulation of cell population proliferation);GO:0008327(methyl-CpG binding);GO:0016607(nuclear speck);GO:0031062(positive regulation of histone methylation);GO:0032781(positive regulation of ATPase activity);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0051096(positive regulation of helicase activity)","NA","NA","NA","chromatin target of PRMT1 [Source:NCBI gene;Acc:101106216]",{"v":15.2063808494599,"d":"15.21"},{"v":5.47319060468858,"d":"5.47"},{"v":4.75566278694553,"d":"4.76"},{"v":5.16833794162262,"d":"5.17"},{"v":4.90949262261549,"d":"4.91"},{"v":5.25608684394392,"d":"5.26"},{"v":1.65875643933767,"d":"1.66"},{"v":0.730102066187781,"d":"0.73"},{"v":0.0619958972612266,"d":"0.06"},{"v":0.445540937711843,"d":"0.45"},"up","no"]
["MSTRG.18660","RF00283","ENSOART00000023736","NA","NA","NA","NA",null,{"v":17.543808,"d":"17.54"},{"v":18.988728,"d":"18.99"},{"v":17.397602,"d":"17.40"},{"v":26.813707,"d":"26.81"},{"v":37.347813,"d":"37.35"},{"v":31.318802,"d":"31.32"},{"v":0.564829871436755,"d":"0.56"},{"v":-0.82411170628874,"d":"-0.82"},{"v":0.0620957386226237,"d":"0.06"},{"v":0.445669986914374,"d":"0.45"},"down","no"]
["MSTRG.21285","ENSOARG00000002902","ENSOART00000003143","GO:0003676(nucleic acid binding)","NA","K09215","NA","odd-skipped related transciption factor 2 [Source:NCBI gene;Acc:101105924]",{"v":2.32538879123797,"d":"2.33"},{"v":2.36670826817126,"d":"2.37"},{"v":1.68043683106538,"d":"1.68"},{"v":1.41446734152008,"d":"1.41"},{"v":1.05745570793229,"d":"1.06"},{"v":1.67762266179887,"d":"1.68"},{"v":1.53571844580381,"d":"1.54"},{"v":0.618913740749309,"d":"0.62"},{"v":0.0622616134399958,"d":"0.06"},{"v":0.445920844216357,"d":"0.45"},"up","no"]
["MSTRG.11520","TRIM38","ENSOART00000001627;ENSOART00000001628","GO:0005515(protein binding);GO:0008270(zinc ion binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0046598(positive regulation of viral entry into host cell);GO:0046872(metal ion binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","NA","K12014","EC:2.3.2.27","tripartite motif containing 38 [Source:NCBI gene;Acc:101114398]",{"v":1.69466508136235,"d":"1.69"},{"v":0.702271771050142,"d":"0.70"},{"v":0.695260529801325,"d":"0.70"},{"v":2.07995847445601,"d":"2.08"},{"v":1.75597020056764,"d":"1.76"},{"v":1.82622667975402,"d":"1.83"},{"v":0.546116662024233,"d":"0.55"},{"v":-0.872718920765123,"d":"-0.87"},{"v":0.0622800246098784,"d":"0.06"},{"v":0.445920844216357,"d":"0.45"},"down","no"]
["MSTRG.14551","ENSOARG00000018872","ENSOART00000020551","NA","NA","K17422","NA","mitochondrial ribosomal protein L41 [Source:NCBI gene;Acc:101108465]",{"v":6.03641,"d":"6.04"},{"v":5.895673,"d":"5.90"},{"v":4.653105,"d":"4.65"},{"v":8.439355,"d":"8.44"},{"v":7.697005,"d":"7.70"},{"v":13.419549,"d":"13.42"},{"v":0.561146266893703,"d":"0.56"},{"v":-0.833551225981925,"d":"-0.83"},{"v":0.0622945520368392,"d":"0.06"},{"v":0.445920844216357,"d":"0.45"},"down","no"]
["ENSOARG00000010260","PABPC5","ENSOART00000011162","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","03013(RNA transport);03015(mRNA surveillance pathway);03018(RNA degradation)","K13126","NA","poly(A) binding protein cytoplasmic 5 [Source:NCBI gene;Acc:101113468]",{"v":0.895835,"d":"0.90"},{"v":0.41751,"d":"0.42"},{"v":0.277793,"d":"0.28"},{"v":1.154064,"d":"1.15"},{"v":1.257388,"d":"1.26"},{"v":0.891384,"d":"0.89"},{"v":0.481749018116552,"d":"0.48"},{"v":-1.05364636881229,"d":"-1.05"},{"v":0.0623476265257066,"d":"0.06"},{"v":0.446105191021795,"d":"0.45"},"down","no"]
["MSTRG.3454","ZNF750","ENSOART00000017626;ENSOART00000017628","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0005634(nucleus);GO:0008544(epidermis development);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1990841(promoter-specific chromatin binding);GO:1990841(promoter-specific chromatin binding)","NA","NA","NA","zinc finger protein 750 [Source:HGNC Symbol;Acc:HGNC:25843]",{"v":0.157552522707035,"d":"0.16"},{"v":0.168541827248442,"d":"0.17"},{"v":0.362541697239537,"d":"0.36"},{"v":0.550266093499555,"d":"0.55"},{"v":0.503548263579697,"d":"0.50"},{"v":0.389261777827248,"d":"0.39"},{"v":0.477200080118872,"d":"0.48"},{"v":-1.06733380963484,"d":"-1.07"},{"v":0.0624805287197838,"d":"0.06"},{"v":0.446542171176918,"d":"0.45"},"down","no"]
["MSTRG.15650","CRADD","ENSOART00000017282","GO:0002020(protease binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0007165(signal transduction);GO:0030674(protein binding, bridging);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0070513(death domain binding);GO:0071260(cellular response to mechanical stimulus);GO:0097190(apoptotic signaling pathway);GO:2001235(positive regulation of apoptotic signaling pathway)","NA","K02832","NA","CASP2 and RIPK1 domain containing adaptor with death domain [Source:NCBI gene;Acc:101115270]",{"v":2.55070696441409,"d":"2.55"},{"v":2.24828289324227,"d":"2.25"},{"v":2.35253885226456,"d":"2.35"},{"v":2.16823859561467,"d":"2.17"},{"v":1.57882261358735,"d":"1.58"},{"v":1.30387664773544,"d":"1.30"},{"v":1.41588134965832,"d":"1.42"},{"v":0.50170037316696,"d":"0.50"},{"v":0.0624907435778575,"d":"0.06"},{"v":0.446542171176918,"d":"0.45"},"up","no"]
["ENSOARG00000010039","AKAP4","ENSOART00000010926","GO:0005929(cilium);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0008104(protein localization);GO:0030018(Z disc);GO:0030317(flagellated sperm motility);GO:0031514(motile cilium);GO:0035686(sperm fibrous sheath);GO:0044458(motile cilium assembly);GO:0045184(establishment of protein localization);GO:0048471(perinuclear region of cytoplasm);GO:0051018(protein kinase A binding);GO:0097228(sperm principal piece)","NA","K16521","NA","A-kinase anchoring protein 4 [Source:NCBI gene;Acc:101102535]",{"v":0.343191,"d":"0.34"},{"v":0.19183,"d":"0.19"},{"v":0.166055,"d":"0.17"},{"v":0.462505,"d":"0.46"},{"v":0.424453,"d":"0.42"},{"v":0.49408,"d":"0.49"},{"v":0.507644250194419,"d":"0.51"},{"v":-0.978110263782433,"d":"-0.98"},{"v":0.0626812274154857,"d":"0.06"},{"v":0.447511622754722,"d":"0.45"},"down","no"]
["MSTRG.21545","ENSOARG00000014550","ENSOART00000015841","GO:0004739(pyruvate dehydrogenase (acetyl-transferring) activity);GO:0006086(acetyl-CoA biosynthetic process from pyruvate);GO:0016491(oxidoreductase activity);GO:0016624(oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor);GO:0043231(intracellular membrane-bounded organelle);GO:0055114(oxidation-reduction process)","00010(Glycolysis / Gluconeogenesis);00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);04066(HIF-1 signaling pathway);04922(Glucagon signaling pathway);05230(Central carbon metabolism in cancer)","K00161","EC:1.2.4.1","pyruvate dehydrogenase E1 alpha 1 subunit [Source:NCBI gene;Acc:101110118]",{"v":236.67775,"d":"236.68"},{"v":245.046005,"d":"245.05"},{"v":177.38092,"d":"177.38"},{"v":200.241119,"d":"200.24"},{"v":113.653778,"d":"113.65"},{"v":143.906219,"d":"143.91"},{"v":1.43971836669791,"d":"1.44"},{"v":0.525786623677075,"d":"0.53"},{"v":0.0629391222667617,"d":"0.06"},{"v":0.448477799666824,"d":"0.45"},"up","no"]
["MSTRG.19749","PTGDR","ENSOART00000022567","GO:0004930(G protein-coupled receptor activity);GO:0004956(prostaglandin D receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","prostaglandin D2 receptor [Source:HGNC Symbol;Acc:HGNC:9591]",{"v":0.876741976168653,"d":"0.88"},{"v":0.585444552703941,"d":"0.59"},{"v":1.22474509990834,"d":"1.22"},{"v":1.61550940238313,"d":"1.62"},{"v":1.22165621356554,"d":"1.22"},{"v":2.48611395783685,"d":"2.49"},{"v":0.504751176701807,"d":"0.50"},{"v":-0.986355726042089,"d":"-0.99"},{"v":0.0629846921410368,"d":"0.06"},{"v":0.448477799666824,"d":"0.45"},"down","no"]
["MSTRG.13091","NEDD4L","ENSOART00000005893;ENSOART00000005898","GO:0003254(regulation of membrane depolarization);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0010038(response to metal ion);GO:0015459(potassium channel regulator activity);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0017080(sodium channel regulator activity);GO:0019870(potassium channel inhibitor activity);GO:0019871(sodium channel inhibitor activity);GO:0031647(regulation of protein stability);GO:0034765(regulation of ion transmembrane transport);GO:0042391(regulation of membrane potential);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0044325(ion channel binding);GO:0060306(regulation of membrane repolarization);GO:0061630(ubiquitin protein ligase activity);GO:0070936(protein K48-linked ubiquitination);GO:1901016(regulation of potassium ion transmembrane transporter activity);GO:1901017(negative regulation of potassium ion transmembrane transporter activity);GO:1901380(negative regulation of potassium ion transmembrane transport);GO:1902306(negative regulation of sodium ion transmembrane transport);GO:1903861(positive regulation of dendrite extension);GO:2000009(negative regulation of protein localization to cell surface);GO:2000650(negative regulation of sodium ion transmembrane transporter activity);GO:2000650(negative regulation of sodium ion transmembrane transporter activity)","04120(Ubiquitin mediated proteolysis);04144(Endocytosis);04530(Tight junction);04960(Aldosterone-regulated sodium reabsorption);04960(Aldosterone-regulated sodium reabsorption)","K13305","EC:2.3.2.26","neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase [Source:NCBI gene;Acc:101122748]",{"v":1.68534144107018,"d":"1.69"},{"v":3.56854891413597,"d":"3.57"},{"v":2.91800332811344,"d":"2.92"},{"v":2.0839182360574,"d":"2.08"},{"v":1.96677127445635,"d":"1.97"},{"v":1.49327116382426,"d":"1.49"},{"v":1.4740172528903,"d":"1.47"},{"v":0.559753410805855,"d":"0.56"},{"v":0.0630637572289948,"d":"0.06"},{"v":0.448477799666824,"d":"0.45"},"up","no"]
["MSTRG.6561","ENSOARG00000003996","ENSOART00000004342","GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0007605(sensory perception of sound);GO:0008171(O-methyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016206(catechol O-methyltransferase activity);GO:0032259(methylation);GO:0042424(catecholamine catabolic process);GO:0045177(apical part of cell);GO:0060117(auditory receptor cell development);GO:1904591(positive regulation of protein import)","00140(Steroid hormone biosynthesis);00350(Tyrosine metabolism);04728(Dopaminergic synapse)","K00545","EC:2.1.1.6","transmembrane O-methyltransferase [Source:NCBI gene;Acc:101103091]",{"v":1.199947,"d":"1.20"},{"v":1.274995,"d":"1.27"},{"v":0.967388,"d":"0.97"},{"v":0.863656,"d":"0.86"},{"v":0.609154,"d":"0.61"},{"v":0.767425,"d":"0.77"},{"v":1.53659325918933,"d":"1.54"},{"v":0.619735329890182,"d":"0.62"},{"v":0.0631651659256357,"d":"0.06"},{"v":0.448708394567758,"d":"0.45"},"up","no"]
["MSTRG.12480","CHUK","ENSOART00000015052","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007249(I-kappaB kinase/NF-kappaB signaling);GO:0007252(I-kappaB phosphorylation);GO:0008384(IkappaB kinase activity);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0034614(cellular response to reactive oxygen species);GO:0038061(NIK/NF-kappaB signaling);GO:0042803(protein homodimerization activity);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0071276(cellular response to cadmium ion);GO:0071356(cellular response to tumor necrosis factor);GO:0097110(scaffold protein binding);GO:0098586(cellular response to virus);GO:1902741(positive regulation of interferon-alpha secretion)","01523(Antifolate resistance);04010(MAPK signaling pathway);04014(Ras signaling pathway);04062(Chemokine signaling pathway);04064(NF-kappa B signaling pathway);04068(FoxO signaling pathway);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04380(Osteoclast differentiation);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04625(C-type lectin receptor signaling pathway);04657(IL-17 signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04668(TNF signaling pathway);04920(Adipocytokine signaling pathway);05142(Chagas disease (American trypanosomiasis));05145(Toxoplasmosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05212(Pancreatic cancer);05215(Prostate cancer);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05222(Small cell lung cancer);05418(Fluid shear stress and atherosclerosis)","K04467","EC:2.7.11.10","conserved helix-loop-helix ubiquitous kinase [Source:NCBI gene;Acc:101111143]",{"v":7.932503,"d":"7.93"},{"v":7.856813,"d":"7.86"},{"v":6.894212,"d":"6.89"},{"v":6.74472,"d":"6.74"},{"v":4.644693,"d":"4.64"},{"v":4.576599,"d":"4.58"},{"v":1.42073850376663,"d":"1.42"},{"v":0.506641041536714,"d":"0.51"},{"v":0.0632667762247484,"d":"0.06"},{"v":0.448708394567758,"d":"0.45"},"up","no"]
["MSTRG.19073","PAQR3","ENSOART00000020509","GO:0001933(negative regulation of protein phosphorylation);GO:0005794(Golgi apparatus);GO:0010977(negative regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0034067(protein localization to Golgi apparatus);GO:0043407(negative regulation of MAP kinase activity)","NA","NA","NA","progestin and adipoQ receptor family member 3 [Source:NCBI gene;Acc:101112138]",{"v":3.14262580654831,"d":"3.14"},{"v":3.6012477147798,"d":"3.60"},{"v":2.28507382222735,"d":"2.29"},{"v":2.27162809476597,"d":"2.27"},{"v":1.77515182407194,"d":"1.78"},{"v":2.18206456536777,"d":"2.18"},{"v":1.44953809112588,"d":"1.45"},{"v":0.535593245200868,"d":"0.54"},{"v":0.063292077313033,"d":"0.06"},{"v":0.448708394567758,"d":"0.45"},"up","no"]
["MSTRG.9066","RBM15B","ENSOART00000008442","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0001510(RNA methylation);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0006406(mRNA export from nucleus);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0016607(nuclear speck);GO:0036396(RNA N6-methyladenosine methyltransferase complex)","NA","NA","NA","RNA binding motif protein 15B [Source:HGNC Symbol;Acc:HGNC:24303]",{"v":1.696382,"d":"1.70"},{"v":1.932607,"d":"1.93"},{"v":2.430457,"d":"2.43"},{"v":3.047811,"d":"3.05"},{"v":3.488843,"d":"3.49"},{"v":3.71645,"d":"3.72"},{"v":0.590986495406659,"d":"0.59"},{"v":-0.758802931036911,"d":"-0.76"},{"v":0.0633607538982461,"d":"0.06"},{"v":0.448708394567758,"d":"0.45"},"down","no"]
["MSTRG.6369","MIRLET7A2;ENSOARG00000023301","ENSOART00000025511;ENSOART00000025203","NA","NA","NA","NA","microRNA let-7a-2 [Source:HGNC Symbol;Acc:HGNC:31477]",{"v":3.63240684008131,"d":"3.63"},{"v":2.55857970794511,"d":"2.56"},{"v":2.61418051516178,"d":"2.61"},{"v":2.26104076300186,"d":"2.26"},{"v":2.41244569138574,"d":"2.41"},{"v":1.30984323776046,"d":"1.31"},{"v":1.47161656071589,"d":"1.47"},{"v":0.557401816764824,"d":"0.56"},{"v":0.0633657022906933,"d":"0.06"},{"v":0.448708394567758,"d":"0.45"},"up","no"]
["MSTRG.18651","ANK2","ENSOART00000000602;ENSOART00000000594","GO:0002027(regulation of heart rate);GO:0003283(atrial septum development);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0010628(positive regulation of gene expression);GO:0010881(regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0016323(basolateral plasma membrane);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030507(spectrin binding);GO:0033365(protein localization to organelle);GO:0034613(cellular protein localization);GO:0044325(ion channel binding);GO:0051279(regulation of release of sequestered calcium ion into cytosol);GO:0051924(regulation of calcium ion transport);GO:0055117(regulation of cardiac muscle contraction);GO:0060307(regulation of ventricular cardiac muscle cell membrane repolarization);GO:0070972(protein localization to endoplasmic reticulum);GO:0072659(protein localization to plasma membrane);GO:0086004(regulation of cardiac muscle cell contraction);GO:0086005(ventricular cardiac muscle cell action potential);GO:0086014(atrial cardiac muscle cell action potential);GO:0086070(SA node cell to atrial cardiac muscle cell communication);GO:0086091(regulation of heart rate by cardiac conduction);GO:0098907(regulation of SA node cell action potential);GO:0098910(regulation of atrial cardiac muscle cell action potential);GO:0140031(phosphorylation-dependent protein binding);GO:0140031(phosphorylation-dependent protein binding)","05205(Proteoglycans in cancer);05205(Proteoglycans in cancer)","K10380","NA","ankyrin 2 [Source:NCBI gene;Acc:101115623]",{"v":10.3779217325617,"d":"10.38"},{"v":11.4770632915821,"d":"11.48"},{"v":7.5405792996156,"d":"7.54"},{"v":8.39844659279575,"d":"8.40"},{"v":6.22432745618278,"d":"6.22"},{"v":6.02129868505161,"d":"6.02"},{"v":1.42392272602795,"d":"1.42"},{"v":0.509870855713573,"d":"0.51"},{"v":0.0633661219253172,"d":"0.06"},{"v":0.448708394567758,"d":"0.45"},"up","no"]
["MSTRG.8120","ENSOARG00000017437","ENSOART00000018978","GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":2.002428,"d":"2.00"},{"v":4.974466,"d":"4.97"},{"v":6.196489,"d":"6.20"},{"v":2.073116,"d":"2.07"},{"v":3.554927,"d":"3.55"},{"v":1.079343,"d":"1.08"},{"v":1.96401146437673,"d":"1.96"},{"v":0.973803351012681,"d":"0.97"},{"v":0.0633851530423401,"d":"0.06"},{"v":0.448708394567758,"d":"0.45"},"up","no"]
["MSTRG.5757","ARHGEF1","ENSOART00000009089","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0035023(regulation of Rho protein signal transduction)","04270(Vascular smooth muscle contraction);04611(Platelet activation);04810(Regulation of actin cytoskeleton);04928(Parathyroid hormone synthesis, secretion and action);05163(Human cytomegalovirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer)","K12330","NA","Rho guanine nucleotide exchange factor 1 [Source:NCBI gene;Acc:101104265]",{"v":2.21194316835406,"d":"2.21"},{"v":1.68492147873879,"d":"1.68"},{"v":1.70178202574487,"d":"1.70"},{"v":2.71000251171536,"d":"2.71"},{"v":3.16517049117732,"d":"3.17"},{"v":3.22511040497541,"d":"3.23"},{"v":0.615216737975121,"d":"0.62"},{"v":-0.700833340181238,"d":"-0.70"},{"v":0.0634122521820028,"d":"0.06"},{"v":0.448708394567758,"d":"0.45"},"down","no"]
["MSTRG.18144","MIDN","ENSOART00000012366","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol)","NA","NA","NA","midnolin [Source:NCBI gene;Acc:101113934]",{"v":8.28774295898022,"d":"8.29"},{"v":4.56818636460206,"d":"4.57"},{"v":6.34523816277169,"d":"6.35"},{"v":4.88197524889688,"d":"4.88"},{"v":3.79785061317209,"d":"3.80"},{"v":4.46917656038568,"d":"4.47"},{"v":1.46027560642654,"d":"1.46"},{"v":0.546240683146548,"d":"0.55"},{"v":0.0635332998117716,"d":"0.06"},{"v":0.448900952553783,"d":"0.45"},"up","no"]
["MSTRG.15229","RPS27A","ENSOART00000002843","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005840(ribosome);GO:0006412(translation);GO:0022627(cytosolic small ribosomal subunit)","03010(Ribosome)","K02977","NA","ribosomal protein S27a [Source:NCBI gene;Acc:100135694]",{"v":91.203606,"d":"91.20"},{"v":83.4678201486068,"d":"83.47"},{"v":73.226929,"d":"73.23"},{"v":96.9820321052632,"d":"96.98"},{"v":127.510055250774,"d":"127.51"},{"v":188.70472169969,"d":"188.70"},{"v":0.599952249667962,"d":"0.60"},{"v":-0.737080414013892,"d":"-0.74"},{"v":0.0635356504992524,"d":"0.06"},{"v":0.448900952553783,"d":"0.45"},"down","no"]
["MSTRG.20162","LIN52","ENSOART00000001033","GO:0006351(transcription, DNA-templated);GO:0070176(DRM complex)","04218(Cellular senescence)","K21775","NA","lin-52 DREAM MuvB core complex component [Source:NCBI gene;Acc:101106081]",{"v":5.42620910820743,"d":"5.43"},{"v":6.49350707268273,"d":"6.49"},{"v":3.48581832135566,"d":"3.49"},{"v":4.41423080236831,"d":"4.41"},{"v":2.919173,"d":"2.92"},{"v":3.10635910044916,"d":"3.11"},{"v":1.4756594230783,"d":"1.48"},{"v":0.561359790956319,"d":"0.56"},{"v":0.063626186365212,"d":"0.06"},{"v":0.449346181215909,"d":"0.45"},"up","no"]
["MSTRG.5792","RELB","ENSOART00000010399","GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010628(positive regulation of gene expression);GO:0017053(transcriptional repressor complex);GO:0019882(antigen processing and presentation);GO:0019901(protein kinase binding);GO:0030098(lymphocyte differentiation);GO:0032688(negative regulation of interferon-beta production);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0038061(NIK/NF-kappaB signaling);GO:0042088(T-helper 1 type immune response);GO:0042802(identical protein binding);GO:0043011(myeloid dendritic cell differentiation);GO:0045063(T-helper 1 cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated)","NA","NA","NA","RELB proto-oncogene, NF-kB subunit [Source:HGNC Symbol;Acc:HGNC:9956]",{"v":2.170419,"d":"2.17"},{"v":2.971591,"d":"2.97"},{"v":3.842633,"d":"3.84"},{"v":1.925784,"d":"1.93"},{"v":2.069218,"d":"2.07"},{"v":1.885143,"d":"1.89"},{"v":1.52796283084856,"d":"1.53"},{"v":0.611609448869292,"d":"0.61"},{"v":0.0638566594427846,"d":"0.06"},{"v":0.449844113712388,"d":"0.45"},"up","no"]
["MSTRG.16154","MCM5","ENSOART00000020170","GO:0000166(nucleotide binding);GO:0003677(DNA binding);GO:0003688(DNA replication origin binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006260(DNA replication);GO:0006270(DNA replication initiation);GO:0016787(hydrolase activity);GO:0042555(MCM complex)","03030(DNA replication);04110(Cell cycle)","K02209","EC:3.6.4.12","minichromosome maintenance complex component 5 [Source:NCBI gene;Acc:101104055]",{"v":1.460828,"d":"1.46"},{"v":0.973561,"d":"0.97"},{"v":1.265744,"d":"1.27"},{"v":2.1975,"d":"2.20"},{"v":1.735229,"d":"1.74"},{"v":2.334318,"d":"2.33"},{"v":0.590410922400933,"d":"0.59"},{"v":-0.760208683875395,"d":"-0.76"},{"v":0.0638619950750438,"d":"0.06"},{"v":0.449844113712388,"d":"0.45"},"down","no"]
["MSTRG.19311","EPB41L4A","ENSOART00000017603","GO:0005856(cytoskeleton);GO:0008092(cytoskeletal protein binding)","NA","NA","NA","erythrocyte membrane protein band 4.1 like 4A [Source:NCBI gene;Acc:101122032]",{"v":4.48690759640288,"d":"4.49"},{"v":3.71170925,"d":"3.71"},{"v":3.55183133309353,"d":"3.55"},{"v":7.20972881870504,"d":"7.21"},{"v":6.60775055395683,"d":"6.61"},{"v":5.11615105215827,"d":"5.12"},{"v":0.620612524690073,"d":"0.62"},{"v":-0.6882352824456,"d":"-0.69"},{"v":0.064175174646081,"d":"0.06"},{"v":0.451660453285004,"d":"0.45"},"down","no"]
["ENSOARG00000008907","TIMELESS","ENSOART00000009716","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0002009(morphogenesis of an epithelium);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus);GO:0007623(circadian rhythm);GO:0030324(lung development);GO:0035861(site of double-strand break);GO:0042752(regulation of circadian rhythm);GO:0042803(protein homodimerization activity);GO:0044770(cell cycle phase transition);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0048754(branching morphogenesis of an epithelial tube);GO:0072711(cellular response to hydroxyurea);GO:0072719(cellular response to cisplatin);GO:1904976(cellular response to bleomycin);GO:1905168(positive regulation of double-strand break repair via homologous recombination);GO:2000781(positive regulation of double-strand break repair)","NA","K03155","NA","timeless circadian regulator [Source:NCBI gene;Acc:443226]",{"v":0.332465,"d":"0.33"},{"v":0.061609,"d":"0.06"},{"v":0.210825,"d":"0.21"},{"v":0.590191,"d":"0.59"},{"v":0.354862,"d":"0.35"},{"v":0.380802,"d":"0.38"},{"v":0.456233147666977,"d":"0.46"},{"v":-1.13215682527048,"d":"-1.13"},{"v":0.0642218936605706,"d":"0.06"},{"v":0.451794519469968,"d":"0.45"},"down","no"]
["MSTRG.3102","ABCC3","ENSOART00000003876","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0022857(transmembrane transporter activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport)","01523(Antifolate resistance);02010(ABC transporters);04976(Bile secretion)","K05667","NA","ATP binding cassette subfamily C member 3 [Source:NCBI gene;Acc:101116746]",{"v":2.45835658158813,"d":"2.46"},{"v":1.3745390095986,"d":"1.37"},{"v":0.821721287783595,"d":"0.82"},{"v":1.19008943455497,"d":"1.19"},{"v":1.01563493970332,"d":"1.02"},{"v":0.734574295113438,"d":"0.73"},{"v":1.58304220161583,"d":"1.58"},{"v":0.662699716151236,"d":"0.66"},{"v":0.0643556729290369,"d":"0.06"},{"v":0.452345857763803,"d":"0.45"},"up","no"]
["MSTRG.8176","ENSOARG00000015492","ENSOART00000016853","NA","NA","K01076","EC:3.1.2.22","abhydrolase domain containing 17C [Source:NCBI gene;Acc:101109488]",{"v":0.585928552617377,"d":"0.59"},{"v":1.4157273869401,"d":"1.42"},{"v":0.479896863464652,"d":"0.48"},{"v":0.906544623853211,"d":"0.91"},{"v":2.34966128440367,"d":"2.35"},{"v":1.9783036848354,"d":"1.98"},{"v":0.474075509632633,"d":"0.47"},{"v":-1.07681122838739,"d":"-1.08"},{"v":0.0646092689003343,"d":"0.06"},{"v":0.453829427047073,"d":"0.45"},"down","no"]
["MSTRG.11748","FAT3","ENSOART00000003368","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K16506","NA","FAT atypical cadherin 3 [Source:NCBI gene;Acc:101107744]",{"v":0.231683,"d":"0.23"},{"v":0.164545,"d":"0.16"},{"v":0.182308,"d":"0.18"},{"v":0.261731,"d":"0.26"},{"v":0.372658,"d":"0.37"},{"v":0.357338,"d":"0.36"},{"v":0.583362155109219,"d":"0.58"},{"v":-0.77753629865337,"d":"-0.78"},{"v":0.0646223308356471,"d":"0.06"},{"v":0.453829427047073,"d":"0.45"},"down","no"]
["MSTRG.11421","MOG","ENSOART00000018171","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K17270","NA","myelin oligodendrocyte glycoprotein [Source:NCBI gene;Acc:101113019]",{"v":1.09804702895843,"d":"1.10"},{"v":0.724497423633816,"d":"0.72"},{"v":0.856446696870621,"d":"0.86"},{"v":1.59329115366651,"d":"1.59"},{"v":1.4899121391873,"d":"1.49"},{"v":1.35732825829052,"d":"1.36"},{"v":0.603304158208827,"d":"0.60"},{"v":-0.72904256886874,"d":"-0.73"},{"v":0.0648587191109082,"d":"0.06"},{"v":0.454655502545214,"d":"0.45"},"down","no"]
["MSTRG.14329","TUSC3","ENSOART00000010537","GO:0008250(oligosaccharyltransferase complex);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0018279(protein N-linked glycosylation via asparagine);GO:0050890(cognition);GO:1903830(magnesium ion transmembrane transport)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)","K12669","NA","tumor suppressor candidate 3 [Source:NCBI gene;Acc:101112376]",{"v":1.29266011277778,"d":"1.29"},{"v":1.81699908111111,"d":"1.82"},{"v":0.861911267222222,"d":"0.86"},{"v":2.79033328777778,"d":"2.79"},{"v":2.33083294944444,"d":"2.33"},{"v":2.08869105055556,"d":"2.09"},{"v":0.550852853612478,"d":"0.55"},{"v":-0.860261104066672,"d":"-0.86"},{"v":0.0649173655538749,"d":"0.06"},{"v":0.454727904231518,"d":"0.45"},"down","no"]
["MSTRG.1158","BTG3","ENSOART00000017191","GO:0005737(cytoplasm);GO:0045930(negative regulation of mitotic cell cycle)","03018(RNA degradation)","K14443","NA","BTG anti-proliferation factor 3 [Source:NCBI gene;Acc:100620049]",{"v":7.578776,"d":"7.58"},{"v":4.940465,"d":"4.94"},{"v":7.071952,"d":"7.07"},{"v":14.009932,"d":"14.01"},{"v":8.78506,"d":"8.79"},{"v":10.140569,"d":"10.14"},{"v":0.594834045790202,"d":"0.59"},{"v":-0.749440871358806,"d":"-0.75"},{"v":0.0650224941990691,"d":"0.07"},{"v":0.455239498387448,"d":"0.46"},"down","no"]
["MSTRG.19888","AP4E1","ENSOART00000022857;ENSOART00000022858","GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat);GO:0030124(AP-4 adaptor complex);GO:0030124(AP-4 adaptor complex)","04142(Lysosome);04142(Lysosome)","K12400","NA","adaptor related protein complex 4 subunit epsilon 1 [Source:NCBI gene;Acc:101106174]",{"v":3.42095043015983,"d":"3.42"},{"v":4.78880579054899,"d":"4.79"},{"v":3.17604641653926,"d":"3.18"},{"v":3.10693206546213,"d":"3.11"},{"v":2.592562638082,"d":"2.59"},{"v":2.22961504252953,"d":"2.23"},{"v":1.43594968437486,"d":"1.44"},{"v":0.522005198064422,"d":"0.52"},{"v":0.0650461630167758,"d":"0.07"},{"v":0.455239498387448,"d":"0.46"},"up","no"]
["MSTRG.4505","ENSOARG00000004432","ENSOART00000004822","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":36.462376,"d":"36.46"},{"v":23.437664,"d":"23.44"},{"v":27.319538,"d":"27.32"},{"v":38.671658,"d":"38.67"},{"v":49.196938,"d":"49.20"},{"v":56.242943,"d":"56.24"},{"v":0.605222722657899,"d":"0.61"},{"v":-0.724461941353741,"d":"-0.72"},{"v":0.0651631029506845,"d":"0.07"},{"v":0.455667299776778,"d":"0.46"},"down","no"]
["MSTRG.4073","MXRA8","ENSOART00000004264;ENSOART00000004262","GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0060857(establishment of glial blood-brain barrier);GO:0060857(establishment of glial blood-brain barrier)","NA","NA","NA","matrix remodeling associated 8 [Source:NCBI gene;Acc:101103998]",{"v":2.16175929682454,"d":"2.16"},{"v":1.06479992438105,"d":"1.06"},{"v":2.15650161733046,"d":"2.16"},{"v":2.55783567734123,"d":"2.56"},{"v":3.35379553121636,"d":"3.35"},{"v":3.1367778196986,"d":"3.14"},{"v":0.594917937697769,"d":"0.59"},{"v":-0.749237416452408,"d":"-0.75"},{"v":0.0652494063358936,"d":"0.07"},{"v":0.455853648866012,"d":"0.46"},"down","no"]
["MSTRG.4028","RNF207","ENSOART00000014031","GO:0008270(zinc ion binding);GO:0010628(positive regulation of gene expression);GO:0030544(Hsp70 protein binding);GO:0044325(ion channel binding);GO:0048471(perinuclear region of cytoplasm);GO:0051087(chaperone binding);GO:1902261(positive regulation of delayed rectifier potassium channel activity);GO:1903762(positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization)","NA","NA","NA","ring finger protein 207 [Source:NCBI gene;Acc:101117952]",{"v":0.443134,"d":"0.44"},{"v":0.189665,"d":"0.19"},{"v":0.143159,"d":"0.14"},{"v":1.060229,"d":"1.06"},{"v":0.251793,"d":"0.25"},{"v":0.508502,"d":"0.51"},{"v":0.426227833305136,"d":"0.43"},{"v":-1.23030328858004,"d":"-1.23"},{"v":0.0652679283705661,"d":"0.07"},{"v":0.455853648866012,"d":"0.46"},"down","no"]
["MSTRG.10495","MYO1B","ENSOART00000015303;ENSOART00000015301","GO:0000146(microfilament motor activity);GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005769(early endosome);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0006892(post-Golgi vesicle-mediated transport);GO:0007015(actin filament organization);GO:0010008(endosome membrane);GO:0016459(myosin complex);GO:0032588(trans-Golgi network membrane);GO:0048471(perinuclear region of cytoplasm);GO:0051015(actin filament binding);GO:0051015(actin filament binding)","NA","K10356","NA","myosin IB [Source:NCBI gene;Acc:101117822]",{"v":3.57529456272632,"d":"3.58"},{"v":1.93548916504386,"d":"1.94"},{"v":2.46233823746681,"d":"2.46"},{"v":4.33032914870846,"d":"4.33"},{"v":4.79372826201014,"d":"4.79"},{"v":3.83884489257262,"d":"3.84"},{"v":0.615072286953258,"d":"0.62"},{"v":-0.701172120369677,"d":"-0.70"},{"v":0.0653294668294132,"d":"0.07"},{"v":0.456049394780102,"d":"0.46"},"down","no"]
["MSTRG.2750","GIT1","ENSOART00000008475","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0032465(regulation of cytokinesis);GO:0043547(positive regulation of GTPase activity);GO:0044305(calyx of Held);GO:0044877(protein-containing complex binding);GO:0046872(metal ion binding);GO:0048013(ephrin receptor signaling pathway);GO:0099171(presynaptic modulation of chemical synaptic transmission);GO:2000300(regulation of synaptic vesicle exocytosis)","04144(Endocytosis);04810(Regulation of actin cytoskeleton)","K05737","NA","GIT ArfGAP 1 [Source:NCBI gene;Acc:101122040]",{"v":1.74698832353256,"d":"1.75"},{"v":1.90146380893831,"d":"1.90"},{"v":1.72547604415695,"d":"1.73"},{"v":3.09665767817812,"d":"3.10"},{"v":3.09423249705977,"d":"3.09"},{"v":2.42778063402117,"d":"2.43"},{"v":0.62352168861753,"d":"0.62"},{"v":-0.681488351164815,"d":"-0.68"},{"v":0.0653881772982065,"d":"0.07"},{"v":0.456264170480819,"d":"0.46"},"down","no"]
["MSTRG.11772","ME3","ENSOART00000004639","GO:0004470(malic enzyme activity);GO:0004471(malate dehydrogenase (decarboxylating) (NAD+) activity);GO:0004473(malate dehydrogenase (decarboxylating) (NADP+) activity);GO:0006090(pyruvate metabolic process);GO:0006108(malate metabolic process);GO:0016491(oxidoreductase activity);GO:0046872(metal ion binding);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process)","00620(Pyruvate metabolism)","K00029","EC:1.1.1.40","malic enzyme 3 [Source:NCBI gene;Acc:101102434]",{"v":1.364101,"d":"1.36"},{"v":0.830873,"d":"0.83"},{"v":0.336167,"d":"0.34"},{"v":1.306351,"d":"1.31"},{"v":1.788908,"d":"1.79"},{"v":1.874967,"d":"1.87"},{"v":0.509260745889624,"d":"0.51"},{"v":-0.973523577127511,"d":"-0.97"},{"v":0.0654199704683108,"d":"0.07"},{"v":0.456291019994267,"d":"0.46"},"down","no"]
["MSTRG.19390","ARSB","ENSOART00000018684","GO:0003824(catalytic activity);GO:0003943(N-acetylgalactosamine-4-sulfatase activity);GO:0008484(sulfuric ester hydrolase activity);GO:0010632(regulation of epithelial cell migration);GO:0061580(colon epithelial cell migration)","00531(Glycosaminoglycan degradation);04142(Lysosome)","K01135","EC:3.1.6.12","arylsulfatase B [Source:NCBI gene;Acc:101108314]",{"v":1.90938272573393,"d":"1.91"},{"v":1.20002150489289,"d":"1.20"},{"v":2.41396048294102,"d":"2.41"},{"v":3.05333301243057,"d":"3.05"},{"v":2.81964621105528,"d":"2.82"},{"v":3.34334044485586,"d":"3.34"},{"v":0.599302640569287,"d":"0.60"},{"v":-0.738643364349915,"d":"-0.74"},{"v":0.0654610406476401,"d":"0.07"},{"v":0.4563825242078,"d":"0.46"},"down","no"]
["MSTRG.19794","MYO1E","ENSOART00000022697","GO:0000166(nucleotide binding);GO:0001570(vasculogenesis);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0003094(glomerular filtration);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005903(brush border);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0006807(nitrogen compound metabolic process);GO:0006897(endocytosis);GO:0016459(myosin complex);GO:0030097(hemopoiesis);GO:0032836(glomerular basement membrane development);GO:0035091(phosphatidylinositol binding);GO:0035166(post-embryonic hemopoiesis);GO:0042623(ATPase activity, coupled);GO:0045334(clathrin-coated endocytic vesicle);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0051015(actin filament binding);GO:0072015(glomerular visceral epithelial cell development)","NA","K10356","NA","myosin IE [Source:NCBI gene;Acc:101115463]",{"v":7.422409,"d":"7.42"},{"v":7.959299,"d":"7.96"},{"v":12.121071,"d":"12.12"},{"v":7.435888,"d":"7.44"},{"v":6.050167,"d":"6.05"},{"v":5.560025,"d":"5.56"},{"v":1.44401257371596,"d":"1.44"},{"v":0.530083304523338,"d":"0.53"},{"v":0.065543499497639,"d":"0.07"},{"v":0.456414321424317,"d":"0.46"},"up","no"]
["MSTRG.5871","LIG1","ENSOART00000012580","GO:0000166(nucleotide binding);GO:0003677(DNA binding);GO:0003909(DNA ligase activity);GO:0003910(DNA ligase (ATP) activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0016874(ligase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0051103(DNA ligation involved in DNA repair);GO:0071897(DNA biosynthetic process)","03030(DNA replication);03410(Base excision repair);03420(Nucleotide excision repair);03430(Mismatch repair)","K10747","6.5.1.6;6.5.1.7;EC:6.5.1.1","DNA ligase 1 [Source:NCBI gene;Acc:101104173]",{"v":0.404335,"d":"0.40"},{"v":0.263674,"d":"0.26"},{"v":0.327178,"d":"0.33"},{"v":0.638778,"d":"0.64"},{"v":0.579309,"d":"0.58"},{"v":0.621437,"d":"0.62"},{"v":0.54100245498292,"d":"0.54"},{"v":-0.886292954100249,"d":"-0.89"},{"v":0.0655453293893663,"d":"0.07"},{"v":0.456414321424317,"d":"0.46"},"down","no"]
["MSTRG.17792","KANK2","ENSOART00000019366","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0008285(negative regulation of cell population proliferation);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0035023(regulation of Rho protein signal transduction);GO:0043069(negative regulation of programmed cell death);GO:0070563(negative regulation of vitamin D receptor signaling pathway);GO:0072073(kidney epithelium development);GO:0090521(glomerular visceral epithelial cell migration);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA","K22808","NA","KN motif and ankyrin repeat domains 2 [Source:NCBI gene;Acc:101117071]",{"v":3.68331359553987,"d":"3.68"},{"v":2.29691987822878,"d":"2.30"},{"v":2.98222649831542,"d":"2.98"},{"v":4.44987024402374,"d":"4.45"},{"v":4.99199788817584,"d":"4.99"},{"v":4.9324073730146,"d":"4.93"},{"v":0.623506900840532,"d":"0.62"},{"v":-0.68152256730504,"d":"-0.68"},{"v":0.0656308470111116,"d":"0.07"},{"v":0.456414321424317,"d":"0.46"},"down","no"]
["MSTRG.8709","TGFBR2","ENSOART00000016026","GO:0000166(nucleotide binding);GO:0001569(branching involved in blood vessel morphogenesis);GO:0001570(vasculogenesis);GO:0001701(in utero embryonic development);GO:0001947(heart looping);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002088(lens development in camera-type eye);GO:0002651(positive regulation of tolerance induction to self antigen);GO:0002663(positive regulation of B cell tolerance induction);GO:0002666(positive regulation of T cell tolerance induction);GO:0003148(outflow tract septum morphogenesis);GO:0003149(membranous septum morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003181(atrioventricular valve morphogenesis);GO:0003186(tricuspid valve morphogenesis);GO:0003214(cardiac left ventricle morphogenesis);GO:0003274(endocardial cushion fusion);GO:0003417(growth plate cartilage development);GO:0003430(growth plate cartilage chondrocyte growth);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0005024(transforming growth factor beta-activated receptor activity);GO:0005026(transforming growth factor beta receptor activity, type II);GO:0005524(ATP binding);GO:0005539(glycosaminoglycan binding);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007219(Notch signaling pathway);GO:0007224(smoothened signaling pathway);GO:0007369(gastrulation);GO:0007420(brain development);GO:0007507(heart development);GO:0009897(external side of plasma membrane);GO:0010468(regulation of gene expression);GO:0010634(positive regulation of epithelial cell migration);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0030154(cell differentiation);GO:0030324(lung development);GO:0032147(activation of protein kinase activity);GO:0034713(type I transforming growth factor beta receptor binding);GO:0035162(embryonic hemopoiesis);GO:0038023(signaling receptor activity);GO:0040008(regulation of growth);GO:0042127(regulation of cell population proliferation);GO:0042493(response to drug);GO:0043011(myeloid dendritic cell differentiation);GO:0043235(receptor complex);GO:0045121(membrane raft);GO:0045766(positive regulation of angiogenesis);GO:0046332(SMAD binding);GO:0046872(metal ion binding);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0050431(transforming growth factor beta binding);GO:0051138(positive regulation of NK T cell differentiation);GO:0051216(cartilage development);GO:0060389(pathway-restricted SMAD protein phosphorylation);GO:0060412(ventricular septum morphogenesis);GO:0060425(lung morphogenesis);GO:0060433(bronchus development);GO:0060434(bronchus morphogenesis);GO:0060439(trachea morphogenesis);GO:0060440(trachea formation);GO:0060443(mammary gland morphogenesis);GO:0060463(lung lobe morphogenesis);GO:0062009(secondary palate development);GO:0070723(response to cholesterol);GO:1905007(positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation);GO:1905317(inferior endocardial cushion morphogenesis);GO:1990086(lens fiber cell apoptotic process);GO:1990428(miRNA transport);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2000563(positive regulation of CD4-positive, alpha-beta T cell proliferation)","04010(MAPK signaling pathway);04060(Cytokine-cytokine receptor interaction);04068(FoxO signaling pathway);04144(Endocytosis);04218(Cellular senescence);04350(TGF-beta signaling pathway);04380(Osteoclast differentiation);04390(Hippo signaling pathway);04520(Adherens junction);04659(Th17 cell differentiation);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05142(Chagas disease (American trypanosomiasis));05161(Hepatitis B);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05220(Chronic myeloid leukemia);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K04388","EC:2.7.11.30","transforming growth factor beta receptor 2 [Source:NCBI gene;Acc:494191]",{"v":13.6099608768529,"d":"13.61"},{"v":10.9172863175599,"d":"10.92"},{"v":15.7179856465222,"d":"15.72"},{"v":20.5684023876853,"d":"20.57"},{"v":21.5119344213227,"d":"21.51"},{"v":22.3156768563284,"d":"22.32"},{"v":0.624964660857548,"d":"0.62"},{"v":-0.678153481187825,"d":"-0.68"},{"v":0.0656520370286028,"d":"0.07"},{"v":0.456414321424317,"d":"0.46"},"down","no"]
["MSTRG.4286","ENSOARG00000012084","ENSOART00000013141","GO:0005854(nascent polypeptide-associated complex)","NA","NA","NA","nascent polypeptide-associated complex subunit alpha-like [Source:NCBI gene;Acc:101119659]",{"v":6.58902,"d":"6.59"},{"v":8.569189,"d":"8.57"},{"v":6.382564,"d":"6.38"},{"v":10.288576,"d":"10.29"},{"v":12.051251,"d":"12.05"},{"v":13.382867,"d":"13.38"},{"v":0.602999678579673,"d":"0.60"},{"v":-0.72977086176969,"d":"-0.73"},{"v":0.0656577714448629,"d":"0.07"},{"v":0.456414321424317,"d":"0.46"},"down","no"]
["ENSOARG00000002229","PTPRU","ENSOART00000002433","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005911(cell-cell junction);GO:0006470(protein dephosphorylation);GO:0008013(beta-catenin binding);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0030336(negative regulation of cell migration);GO:0034109(homotypic cell-cell adhesion);GO:0034394(protein localization to cell surface);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2000049(positive regulation of cell-cell adhesion mediated by cadherin)","NA","K16662","EC:3.1.3.48","protein tyrosine phosphatase, receptor type U [Source:NCBI gene;Acc:101108816]",{"v":0.22775,"d":"0.23"},{"v":0.186948,"d":"0.19"},{"v":0.101509,"d":"0.10"},{"v":0.144965,"d":"0.14"},{"v":0.639235,"d":"0.64"},{"v":0.353951,"d":"0.35"},{"v":0.453548782191467,"d":"0.45"},{"v":-1.14067036433031,"d":"-1.14"},{"v":0.0656612714983906,"d":"0.07"},{"v":0.456414321424317,"d":"0.46"},"down","no"]
["ENSOARG00000016330","DSCC1","ENSOART00000017778","GO:0000775(chromosome, centromeric region);GO:0000785(chromatin);GO:0003689(DNA clamp loader activity);GO:0005654(nucleoplasm);GO:0006275(regulation of DNA replication);GO:0007064(mitotic sister chromatid cohesion);GO:0031390(Ctf18 RFC-like complex);GO:0034088(maintenance of mitotic sister chromatid cohesion);GO:0034421(post-translational protein acetylation);GO:0043142(single-stranded DNA-dependent ATPase activity);GO:1900264(positive regulation of DNA-directed DNA polymerase activity)","NA","K11271","NA","DNA replication and sister chromatid cohesion 1 [Source:NCBI gene;Acc:101116411]",{"v":0.448653,"d":"0.45"},{"v":0.280501,"d":"0.28"},{"v":0.194376,"d":"0.19"},{"v":0.562542,"d":"0.56"},{"v":0.618603,"d":"0.62"},{"v":0.609734,"d":"0.61"},{"v":0.51568531430655,"d":"0.52"},{"v":-0.955437133854384,"d":"-0.96"},{"v":0.065747253575223,"d":"0.07"},{"v":0.456429063085136,"d":"0.46"},"down","no"]
["MSTRG.17132","TNS3","ENSOART00000013632","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0008284(positive regulation of cell population proliferation);GO:0016477(cell migration);GO:0048286(lung alveolus development)","NA","K18080","NA","tensin 3 [Source:NCBI gene;Acc:101113323]",{"v":2.24468620043278,"d":"2.24"},{"v":0.554855015147417,"d":"0.55"},{"v":1.59582256911009,"d":"1.60"},{"v":2.38235448688125,"d":"2.38"},{"v":3.03840337868542,"d":"3.04"},{"v":2.55928436245605,"d":"2.56"},{"v":0.550794552095918,"d":"0.55"},{"v":-0.860413805027906,"d":"-0.86"},{"v":0.0658257314134556,"d":"0.07"},{"v":0.456585617042864,"d":"0.46"},"down","no"]
["MSTRG.16608","PACSIN2","ENSOART00000020778","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0005911(cell-cell junction);GO:0008092(cytoskeletal protein binding);GO:0008289(lipid binding);GO:0016607(nuclear speck);GO:0019898(extrinsic component of membrane);GO:0030036(actin cytoskeleton organization);GO:0036010(protein localization to endosome);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0045806(negative regulation of endocytosis);GO:0048858(cell projection morphogenesis);GO:0050804(modulation of chemical synaptic transmission);GO:0055038(recycling endosome membrane);GO:0070300(phosphatidic acid binding);GO:0070836(caveola assembly);GO:0072584(caveolin-mediated endocytosis);GO:0097320(plasma membrane tubulation);GO:0098978(glutamatergic synapse)","NA","K20123","NA","protein kinase C and casein kinase substrate in neurons 2 [Source:NCBI gene;Acc:101115867]",{"v":2.59251057927355,"d":"2.59"},{"v":2.40050081093591,"d":"2.40"},{"v":2.78929727182867,"d":"2.79"},{"v":2.2374524894485,"d":"2.24"},{"v":1.81848058500039,"d":"1.82"},{"v":1.44448253063466,"d":"1.44"},{"v":1.41485829813399,"d":"1.41"},{"v":0.500657570501484,"d":"0.50"},{"v":0.065994799501179,"d":"0.07"},{"v":0.457563943208174,"d":"0.46"},"up","no"]
["MSTRG.14379","DUSP26","ENSOART00000000507","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0002039(p53 binding);GO:0004647(phosphoserine phosphatase activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045785(positive regulation of cell adhesion);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:1902310(positive regulation of peptidyl-serine dephosphorylation)","NA","K14165","3.1.3.48;EC:3.1.3.16","dual specificity phosphatase 26 [Source:NCBI gene;Acc:101108886]",{"v":55.0687942659847,"d":"55.07"},{"v":56.2371585242967,"d":"56.24"},{"v":45.250658713555,"d":"45.25"},{"v":29.5723026956522,"d":"29.57"},{"v":39.0814103401534,"d":"39.08"},{"v":39.7875025319693,"d":"39.79"},{"v":1.4437002636326,"d":"1.44"},{"v":0.52977124564795,"d":"0.53"},{"v":0.0660458749520219,"d":"0.07"},{"v":0.457723703827085,"d":"0.46"},"up","no"]
["MSTRG.15068","PELI1","ENSOART00000021803","GO:0000209(protein polyubiquitination);GO:0001819(positive regulation of cytokine production);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0008063(Toll signaling pathway);GO:0008592(regulation of Toll signaling pathway);GO:0030890(positive regulation of B cell proliferation);GO:0031398(positive regulation of protein ubiquitination);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032496(response to lipopolysaccharide);GO:0034141(positive regulation of toll-like receptor 3 signaling pathway);GO:0034145(positive regulation of toll-like receptor 4 signaling pathway);GO:0042130(negative regulation of T cell proliferation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043331(response to dsRNA);GO:0050868(negative regulation of T cell activation);GO:0050871(positive regulation of B cell activation);GO:0060546(negative regulation of necroptotic process);GO:0061630(ubiquitin protein ligase activity);GO:0070534(protein K63-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination)","NA","K11964","EC:2.3.2.27","pellino E3 ubiquitin protein ligase 1 [Source:NCBI gene;Acc:101114854]",{"v":2.82999383982202,"d":"2.83"},{"v":3.15222795995551,"d":"3.15"},{"v":3.21852292992214,"d":"3.22"},{"v":2.22584668298109,"d":"2.23"},{"v":2.42398948387097,"d":"2.42"},{"v":1.85771373971079,"d":"1.86"},{"v":1.41385696027021,"d":"1.41"},{"v":0.4996361702553,"d":"0.50"},{"v":0.0660944605329143,"d":"0.07"},{"v":0.457866080433358,"d":"0.46"},"up","no"]
["MSTRG.15057","SPRED2","ENSOART00000021758","GO:0000188(inactivation of MAPK activity);GO:0005173(stem cell factor receptor binding);GO:0005886(plasma membrane);GO:0007275(multicellular organism development);GO:0009966(regulation of signal transduction);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0030291(protein serine/threonine kinase inhibitor activity);GO:0031410(cytoplasmic vesicle);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0090311(regulation of protein deacetylation)","NA","K04703","NA","sprouty related EVH1 domain containing 2 [Source:NCBI gene;Acc:101117408]",{"v":4.68107857217668,"d":"4.68"},{"v":2.61995345787796,"d":"2.62"},{"v":2.91800430236794,"d":"2.92"},{"v":5.30274764754098,"d":"5.30"},{"v":5.84918819444444,"d":"5.85"},{"v":5.3517811215847,"d":"5.35"},{"v":0.61919604868284,"d":"0.62"},{"v":-0.691531829742022,"d":"-0.69"},{"v":0.0662724713624072,"d":"0.07"},{"v":0.45863404822056,"d":"0.46"},"down","no"]
["MSTRG.9813","KLF9","ENSOART00000014016","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007623(circadian rhythm);GO:0010839(negative regulation of keratinocyte proliferation);GO:0071387(cellular response to cortisol stimulus);GO:0097067(cellular response to thyroid hormone stimulus)","NA","K09208","NA","Kruppel like factor 9 [Source:NCBI gene;Acc:101104718]",{"v":4.92888268443316,"d":"4.93"},{"v":5.56293974407783,"d":"5.56"},{"v":6.28535344007332,"d":"6.29"},{"v":6.61316042329385,"d":"6.61"},{"v":10.9540146738579,"d":"10.95"},{"v":10.2456879733503,"d":"10.25"},{"v":0.603216426372801,"d":"0.60"},{"v":-0.72925237927165,"d":"-0.73"},{"v":0.0662895856075773,"d":"0.07"},{"v":0.45863404822056,"d":"0.46"},"down","no"]
["MSTRG.10843","TINAGL1","ENSOART00000001498","GO:0005044(scavenger receptor activity);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006898(receptor-mediated endocytosis);GO:0006955(immune response);GO:0008234(cysteine-type peptidase activity);GO:0030247(polysaccharide binding);GO:0043236(laminin binding)","NA","NA","NA","tubulointerstitial nephritis antigen like 1 [Source:NCBI gene;Acc:101119187]",{"v":3.82481300271493,"d":"3.82"},{"v":5.37807307013575,"d":"5.38"},{"v":5.06512658868778,"d":"5.07"},{"v":3.71808735731523,"d":"3.72"},{"v":3.33281887707391,"d":"3.33"},{"v":3.00165404012066,"d":"3.00"},{"v":1.41934117000201,"d":"1.42"},{"v":0.505221414704436,"d":"0.51"},{"v":0.0663263216816073,"d":"0.07"},{"v":0.458693850240273,"d":"0.46"},"up","no"]
["MSTRG.1845","ANAPC13","ENSOART00000008952","GO:0005680(anaphase-promoting complex);GO:0070979(protein K11-linked ubiquitination)","04110(Cell cycle);04114(Oocyte meiosis);04120(Ubiquitin mediated proteolysis);04914(Progesterone-mediated oocyte maturation)","K12456","NA","anaphase promoting complex subunit 13 [Source:NCBI gene;Acc:101115335]",{"v":4.06785808644068,"d":"4.07"},{"v":3.18721751016949,"d":"3.19"},{"v":2.42697929830508,"d":"2.43"},{"v":2.56929345932203,"d":"2.57"},{"v":1.98568858813559,"d":"1.99"},{"v":1.72001057288136,"d":"1.72"},{"v":1.54295876994868,"d":"1.54"},{"v":0.625699511561725,"d":"0.63"},{"v":0.0663608430901755,"d":"0.07"},{"v":0.45873829211532,"d":"0.46"},"up","no"]
["ENSOARG00000002820","HCK","ENSOART00000003053;ENSOART00000003055","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation)","04062(Chemokine signaling pathway);04666(Fc gamma R-mediated phagocytosis);05167(Kaposi sarcoma-associated herpesvirus infection);05167(Kaposi sarcoma-associated herpesvirus infection)","K08893","EC:2.7.10.2","HCK proto-oncogene, Src family tyrosine kinase [Source:NCBI gene;Acc:101113167]",{"v":0.159867642885066,"d":"0.16"},{"v":0.0907871503127443,"d":"0.09"},{"v":0.0337214268960125,"d":"0.03"},{"v":0.197553758795934,"d":"0.20"},{"v":0.152061156958561,"d":"0.15"},{"v":0.27839603792025,"d":"0.28"},{"v":0.452820477779604,"d":"0.45"},{"v":-1.14298889262953,"d":"-1.14"},{"v":0.0665558892150023,"d":"0.07"},{"v":0.458795950483433,"d":"0.46"},"down","no"]
["MSTRG.15197","GCFC2","ENSOART00000001114","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000245(spliceosomal complex assembly);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0071008(U2-type post-mRNA release spliceosomal complex)","NA","K09061","NA","GC-rich sequence DNA-binding factor 2 [Source:NCBI gene;Acc:101117834]",{"v":1.813781,"d":"1.81"},{"v":1.287643,"d":"1.29"},{"v":1.627581,"d":"1.63"},{"v":1.156231,"d":"1.16"},{"v":0.975751,"d":"0.98"},{"v":0.966175,"d":"0.97"},{"v":1.52639294909845,"d":"1.53"},{"v":0.610126412197547,"d":"0.61"},{"v":0.0665658749813359,"d":"0.07"},{"v":0.458795950483433,"d":"0.46"},"up","no"]
["MSTRG.3386","TANC2","ENSOART00000013856","GO:0001701(in utero embryonic development);GO:0005515(protein binding)","NA","NA","NA","tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 [Source:NCBI gene;Acc:101102073]",{"v":2.0517879956778,"d":"2.05"},{"v":1.62597560589391,"d":"1.63"},{"v":1.9613726508186,"d":"1.96"},{"v":3.10913853542895,"d":"3.11"},{"v":2.99567247072692,"d":"3.00"},{"v":2.82513391761624,"d":"2.83"},{"v":0.631486117834675,"d":"0.63"},{"v":-0.663177075761642,"d":"-0.66"},{"v":0.0666285441710173,"d":"0.07"},{"v":0.4590341220356,"d":"0.46"},"down","no"]
["MSTRG.2047","EFHB","ENSOART00000017083","GO:0005509(calcium ion binding)","NA","NA","NA","EF-hand domain family member B [Source:NCBI gene;Acc:101120979]",{"v":0.458894487502042,"d":"0.46"},{"v":0.272992610031041,"d":"0.27"},{"v":2.01550397712792,"d":"2.02"},{"v":2.49096981996406,"d":"2.49"},{"v":1.75694161019441,"d":"1.76"},{"v":1.87028627446496,"d":"1.87"},{"v":0.449052352882425,"d":"0.45"},{"v":-1.15504444314838,"d":"-1.16"},{"v":0.0667081007376954,"d":"0.07"},{"v":0.45904228173132,"d":"0.46"},"down","no"]
["MSTRG.7665","WSB2","ENSOART00000003507","GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction)","NA","K10342","NA","WD repeat and SOCS box containing 2 [Source:NCBI gene;Acc:100499499]",{"v":27.713148,"d":"27.71"},{"v":31.780142,"d":"31.78"},{"v":33.247463,"d":"33.25"},{"v":24.955259,"d":"24.96"},{"v":20.814253,"d":"20.81"},{"v":20.435207,"d":"20.44"},{"v":1.4008178631496,"d":"1.40"},{"v":0.486269386166399,"d":"0.49"},{"v":0.0667140699747932,"d":"0.07"},{"v":0.45904228173132,"d":"0.46"},"up","no"]
["MSTRG.17717","DNASE2","ENSOART00000011234","GO:0000737(DNA catabolic process, endonucleolytic);GO:0004531(deoxyribonuclease II activity);GO:0006259(DNA metabolic process);GO:0006308(DNA catabolic process);GO:0030218(erythrocyte differentiation);GO:0050776(regulation of immune response)","04142(Lysosome)","K01158","EC:3.1.22.1","deoxyribonuclease 2, lysosomal [Source:NCBI gene;Acc:101105493]",{"v":1.501687,"d":"1.50"},{"v":1.345844,"d":"1.35"},{"v":1.834629,"d":"1.83"},{"v":2.635114,"d":"2.64"},{"v":2.255902,"d":"2.26"},{"v":3.398463,"d":"3.40"},{"v":0.564831637790505,"d":"0.56"},{"v":-0.824107194654459,"d":"-0.82"},{"v":0.0668792424642349,"d":"0.07"},{"v":0.459659105402303,"d":"0.46"},"down","no"]
["MSTRG.17390","ENSOARG00000018724","ENSOART00000020387","GO:0006511(ubiquitin-dependent protein catabolic process);GO:0031625(ubiquitin protein ligase binding)","04110(Cell cycle);04114(Oocyte meiosis);04120(Ubiquitin mediated proteolysis);04141(Protein processing in endoplasmic reticulum);04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04350(TGF-beta signaling pathway);04710(Circadian rhythm);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer)","K03347","NA","cullin 1 [Source:NCBI gene;Acc:101106584]",{"v":2.4380936209276,"d":"2.44"},{"v":4.85739008016591,"d":"4.86"},{"v":4.1080899428733,"d":"4.11"},{"v":2.60432098940422,"d":"2.60"},{"v":3.00338439811463,"d":"3.00"},{"v":2.08036898148567,"d":"2.08"},{"v":1.48328087068744,"d":"1.48"},{"v":0.568791809107841,"d":"0.57"},{"v":0.0669193625769392,"d":"0.07"},{"v":0.459659105402303,"d":"0.46"},"up","no"]
["MSTRG.2000","ETS2","ENSOART00000015820","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0019904(protein domain specific binding);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated)","04014(Ras signaling pathway);05166(Human T-cell leukemia virus 1 infection)","K21932","NA","ETS proto-oncogene 2, transcription factor [Source:NCBI gene;Acc:443026]",{"v":6.20514879282058,"d":"6.21"},{"v":7.48493916394251,"d":"7.48"},{"v":8.73779423993092,"d":"8.74"},{"v":5.13906525621415,"d":"5.14"},{"v":5.70009457904151,"d":"5.70"},{"v":4.9796189593536,"d":"4.98"},{"v":1.41780111397329,"d":"1.42"},{"v":0.503655168678566,"d":"0.50"},{"v":0.0669444728470527,"d":"0.07"},{"v":0.459659105402303,"d":"0.46"},"up","no"]
["MSTRG.11610","ENSOARG00000012390","ENSOART00000013472","GO:0005856(cytoskeleton)","04979(Cholesterol metabolism)","K10637","EC:2.3.2.27","myosin regulatory light chain interacting protein [Source:NCBI gene;Acc:101102848]",{"v":6.395429,"d":"6.40"},{"v":5.825132,"d":"5.83"},{"v":4.469907,"d":"4.47"},{"v":8.086535,"d":"8.09"},{"v":9.842875,"d":"9.84"},{"v":9.028548,"d":"9.03"},{"v":0.619129534959584,"d":"0.62"},{"v":-0.691686811630554,"d":"-0.69"},{"v":0.0670275213873308,"d":"0.07"},{"v":0.460035884494467,"d":"0.46"},"down","no"]
["MSTRG.8701","RBMS3","ENSOART00000015982","GO:0002357(defense response to tumor cell);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005737(cytoplasm);GO:0008143(poly(A) binding);GO:0008266(poly(U) RNA binding);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0045727(positive regulation of translation);GO:0090090(negative regulation of canonical Wnt signaling pathway)","NA","NA","NA","RNA binding motif single stranded interacting protein 3 [Source:NCBI gene;Acc:101103929]",{"v":2.44817400147026,"d":"2.45"},{"v":1.41210718468672,"d":"1.41"},{"v":1.24896418355576,"d":"1.25"},{"v":1.20649972743723,"d":"1.21"},{"v":1.21142417710925,"d":"1.21"},{"v":1.04669033318254,"d":"1.05"},{"v":1.47469386752325,"d":"1.47"},{"v":0.560415495732333,"d":"0.56"},{"v":0.0672475875196057,"d":"0.07"},{"v":0.461158592616599,"d":"0.46"},"up","no"]
["MSTRG.7282","TRIM2","ENSOART00000003600","GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","K11997","NA","tripartite motif containing 2 [Source:NCBI gene;Acc:101103349]",{"v":6.08679881842475,"d":"6.09"},{"v":4.45814165049226,"d":"4.46"},{"v":4.09241730351618,"d":"4.09"},{"v":4.45687575457103,"d":"4.46"},{"v":3.00414214894515,"d":"3.00"},{"v":2.75571610886076,"d":"2.76"},{"v":1.43268462844398,"d":"1.43"},{"v":0.518721069437241,"d":"0.52"},{"v":0.0672833915425049,"d":"0.07"},{"v":0.461210418600345,"d":"0.46"},"up","no"]
["MSTRG.2251","SLC46A3","ENSOART00000013160","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K20840","NA","solute carrier family 46 member 3 [Source:NCBI gene;Acc:101113342]",{"v":5.04489019268293,"d":"5.04"},{"v":4.10913908031359,"d":"4.11"},{"v":3.56649721480836,"d":"3.57"},{"v":3.73190262839721,"d":"3.73"},{"v":2.52176846097561,"d":"2.52"},{"v":2.67667753919861,"d":"2.68"},{"v":1.42441544186834,"d":"1.42"},{"v":0.510369980933044,"d":"0.51"},{"v":0.0675370071529546,"d":"0.07"},{"v":0.462429512679283,"d":"0.46"},"up","no"]
["ENSOARG00000000884","SAAL1","ENSOART00000000956","NA","NA","NA","NA","serum amyloid A like 1 [Source:NCBI gene;Acc:101119504]",{"v":1.437533,"d":"1.44"},{"v":0.882183,"d":"0.88"},{"v":0.784769,"d":"0.78"},{"v":1.939554,"d":"1.94"},{"v":1.684908,"d":"1.68"},{"v":1.847922,"d":"1.85"},{"v":0.56730028448296,"d":"0.57"},{"v":-0.817815507412899,"d":"-0.82"},{"v":0.0675462020908924,"d":"0.07"},{"v":0.462429512679283,"d":"0.46"},"down","no"]
["MSTRG.12606","NRAP","ENSOART00000013855","GO:0003779(actin binding);GO:0005916(fascia adherens);GO:0005927(muscle tendon junction);GO:0017166(vinculin binding);GO:0030016(myofibril);GO:0046872(metal ion binding);GO:0051371(muscle alpha-actinin binding)","NA","NA","NA","nebulin related anchoring protein [Source:NCBI gene;Acc:101122236]",{"v":267.147847298729,"d":"267.15"},{"v":201.897982731359,"d":"201.90"},{"v":246.200135799383,"d":"246.20"},{"v":166.031845714072,"d":"166.03"},{"v":175.423370632686,"d":"175.42"},{"v":166.475257385535,"d":"166.48"},{"v":1.40815722390865,"d":"1.41"},{"v":0.493808423101647,"d":"0.49"},{"v":0.0677208160934559,"d":"0.07"},{"v":0.463010768527839,"d":"0.46"},"up","no"]
["MSTRG.17018","ELMO1","ENSOART00000003895","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006909(phagocytosis);GO:0006911(phagocytosis, engulfment);GO:0016477(cell migration);GO:0016601(Rac protein signal transduction);GO:0017124(SH3 domain binding);GO:0030036(actin cytoskeleton organization);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0048870(cell motility)","04062(Chemokine signaling pathway);05100(Bacterial invasion of epithelial cells)","K12366","NA","engulfment and cell motility 1 [Source:NCBI gene;Acc:101114771]",{"v":5.2694849058131,"d":"5.27"},{"v":3.58611487417219,"d":"3.59"},{"v":3.7823636129507,"d":"3.78"},{"v":7.46711525386313,"d":"7.47"},{"v":6.39807134142752,"d":"6.40"},{"v":6.20549442604856,"d":"6.21"},{"v":0.629672873556172,"d":"0.63"},{"v":-0.667325577812384,"d":"-0.67"},{"v":0.0678578878367138,"d":"0.07"},{"v":0.463128515130499,"d":"0.46"},"down","no"]
["MSTRG.9055","ABHD14B","ENSOART00000007100","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0016787(hydrolase activity);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K13706","NA","abhydrolase domain containing 14B [Source:NCBI gene;Acc:101114818]",{"v":0.719251,"d":"0.72"},{"v":0.954211,"d":"0.95"},{"v":1.392318,"d":"1.39"},{"v":2.117312,"d":"2.12"},{"v":1.452491,"d":"1.45"},{"v":1.950738,"d":"1.95"},{"v":0.555340500143011,"d":"0.56"},{"v":-0.848555481552994,"d":"-0.85"},{"v":0.0678975796569841,"d":"0.07"},{"v":0.463128515130499,"d":"0.46"},"down","no"]
["MSTRG.9773","VPS13A","ENSOART00000013534","GO:0006914(autophagy);GO:0007399(nervous system development);GO:0007626(locomotory behavior);GO:0031045(dense core granule);GO:0035176(social behavior)","NA","K19525","NA","vacuolar protein sorting 13 homolog A [Source:NCBI gene;Acc:101112545]",{"v":2.12193,"d":"2.12"},{"v":2.48058,"d":"2.48"},{"v":2.32837,"d":"2.33"},{"v":1.567407,"d":"1.57"},{"v":1.857223,"d":"1.86"},{"v":1.46954,"d":"1.47"},{"v":1.41615023589291,"d":"1.42"},{"v":0.501974325505874,"d":"0.50"},{"v":0.0679717749503767,"d":"0.07"},{"v":0.463400059035387,"d":"0.46"},"up","no"]
["MSTRG.6576","PLEKHB1","ENSOART00000008545","GO:0016021(integral component of membrane)","NA","NA","NA","pleckstrin homology domain containing B1 [Source:NCBI gene;Acc:101102511]",{"v":2.69870410066794,"d":"2.70"},{"v":2.69481914599237,"d":"2.69"},{"v":1.97003048902672,"d":"1.97"},{"v":1.19828461116412,"d":"1.20"},{"v":1.63353271708015,"d":"1.63"},{"v":1.90207583492366,"d":"1.90"},{"v":1.55549639205616,"d":"1.56"},{"v":0.63737504857289,"d":"0.64"},{"v":0.0680348044156645,"d":"0.07"},{"v":0.463636179674028,"d":"0.46"},"up","no"]
["MSTRG.15049","C1D","ENSOART00000021699","GO:0000460(maturation of 5.8S rRNA);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0016922(nuclear receptor binding);GO:0017053(transcriptional repressor complex);GO:0045892(negative regulation of transcription, DNA-templated)","03018(RNA degradation)","K12592","NA","C1D nuclear receptor corepressor [Source:NCBI gene;Acc:101111532]",{"v":4.04004824671797,"d":"4.04"},{"v":4.36085231869624,"d":"4.36"},{"v":4.28607726075147,"d":"4.29"},{"v":3.6151569583522,"d":"3.62"},{"v":2.48531392394749,"d":"2.49"},{"v":2.72618361702128,"d":"2.73"},{"v":1.43734841180673,"d":"1.44"},{"v":0.523409812010739,"d":"0.52"},{"v":0.0681543312674135,"d":"0.07"},{"v":0.464124499479696,"d":"0.46"},"up","no"]
["MSTRG.5710","NUMBL","ENSOART00000007444","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007399(nervous system development);GO:0007405(neuroblast proliferation);GO:0007409(axonogenesis);GO:0019221(cytokine-mediated signaling pathway);GO:0019538(protein metabolic process);GO:0021670(lateral ventricle development);GO:0021849(neuroblast division in subventricular zone);GO:0030900(forebrain development);GO:0034332(adherens junction organization);GO:0050769(positive regulation of neurogenesis)","04330(Notch signaling pathway)","K06057","NA","NUMB like, endocytic adaptor protein [Source:NCBI gene;Acc:101120009]",{"v":0.856812,"d":"0.86"},{"v":0.82637,"d":"0.83"},{"v":1.276102,"d":"1.28"},{"v":1.447037,"d":"1.45"},{"v":2.173076,"d":"2.17"},{"v":1.643043,"d":"1.64"},{"v":0.562264162415098,"d":"0.56"},{"v":-0.830679999553538,"d":"-0.83"},{"v":0.0682060704346352,"d":"0.07"},{"v":0.464124499479696,"d":"0.46"},"down","no"]
["MSTRG.15724","ATF1","ENSOART00000019068","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042802(identical protein binding);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:1990590(ATF1-ATF4 transcription factor complex)","NA","NA","NA","activating transcription factor 1 [Source:HGNC Symbol;Acc:HGNC:783]",{"v":4.97241518737271,"d":"4.97"},{"v":4.30498410386965,"d":"4.30"},{"v":3.77732795315682,"d":"3.78"},{"v":3.98008894297352,"d":"3.98"},{"v":2.63070153971487,"d":"2.63"},{"v":2.62297912423625,"d":"2.62"},{"v":1.41380257469377,"d":"1.41"},{"v":0.499580674322735,"d":"0.50"},{"v":0.0682201616089705,"d":"0.07"},{"v":0.464124499479696,"d":"0.46"},"up","no"]
["MSTRG.16670","LMF2","ENSOART00000021632","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","lipase maturation factor 2 [Source:NCBI gene;Acc:101117495]",{"v":1.226784,"d":"1.23"},{"v":1.412121,"d":"1.41"},{"v":1.332983,"d":"1.33"},{"v":1.786084,"d":"1.79"},{"v":2.453965,"d":"2.45"},{"v":2.583538,"d":"2.58"},{"v":0.582082121910368,"d":"0.58"},{"v":-0.780705387604482,"d":"-0.78"},{"v":0.0683714291669233,"d":"0.07"},{"v":0.464353069025953,"d":"0.46"},"down","no"]
["MSTRG.1134","ADAMTS5","ENSOART00000016191","GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0042742(defense response to bacterium);GO:0050840(extracellular matrix binding);GO:0062023(collagen-containing extracellular matrix);GO:0120163(negative regulation of cold-induced thermogenesis)","NA","K08620","EC:3.4.24.-","ADAM metallopeptidase with thrombospondin type 1 motif 5 [Source:NCBI gene;Acc:101110635]",{"v":1.260209,"d":"1.26"},{"v":0.473247,"d":"0.47"},{"v":1.163296,"d":"1.16"},{"v":1.633932,"d":"1.63"},{"v":1.815905,"d":"1.82"},{"v":1.515427,"d":"1.52"},{"v":0.583403420241099,"d":"0.58"},{"v":-0.777434250731477,"d":"-0.78"},{"v":0.0684644975715083,"d":"0.07"},{"v":0.464418011921973,"d":"0.46"},"down","no"]
["MSTRG.6721","EXT2","ENSOART00000001771","GO:0001503(ossification);GO:0001707(mesoderm formation);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006486(protein glycosylation);GO:0008375(acetylglucosaminyltransferase activity);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0015014(heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process);GO:0015020(glucuronosyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030154(cell differentiation);GO:0033692(cellular polysaccharide biosynthetic process);GO:0042803(protein homodimerization activity);GO:0043541(UDP-N-acetylglucosamine transferase complex);GO:0046982(protein heterodimerization activity)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)","K02367","2.4.1.225;EC:2.4.1.224","exostosin glycosyltransferase 2 [Source:NCBI gene;Acc:101110867]",{"v":2.45867468706723,"d":"2.46"},{"v":1.97927051329015,"d":"1.98"},{"v":2.54320839669421,"d":"2.54"},{"v":3.81195330801876,"d":"3.81"},{"v":3.6685377082868,"d":"3.67"},{"v":3.55190281103417,"d":"3.55"},{"v":0.632786837227599,"d":"0.63"},{"v":-0.660208504659422,"d":"-0.66"},{"v":0.068487340225013,"d":"0.07"},{"v":0.464418011921973,"d":"0.46"},"down","no"]
["MSTRG.16769","GNG11","ENSOART00000001177","GO:0003924(GTPase activity);GO:0005834(heterotrimeric G-protein complex);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane)","04014(Ras signaling pathway);04062(Chemokine signaling pathway);04151(PI3K-Akt signaling pathway);04371(Apelin signaling pathway);04713(Circadian entrainment);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04727(GABAergic synapse);04728(Dopaminergic synapse);04926(Relaxin signaling pathway);05032(Morphine addiction);05034(Alcoholism);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer)","K04546","NA","G protein subunit gamma 11 [Source:NCBI gene;Acc:100192421]",{"v":48.268341,"d":"48.27"},{"v":21.563093,"d":"21.56"},{"v":28.409702,"d":"28.41"},{"v":55.603508,"d":"55.60"},{"v":47.175934,"d":"47.18"},{"v":60.476082,"d":"60.48"},{"v":0.601763012931801,"d":"0.60"},{"v":-0.732732660033559,"d":"-0.73"},{"v":0.0685140531605082,"d":"0.07"},{"v":0.464418011921973,"d":"0.46"},"down","no"]
["ENSOARG00000001478","DRP2","ENSOART00000001595","GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","NA","NA","dystrophin related protein 2 [Source:NCBI gene;Acc:101104809]",{"v":0.374364,"d":"0.37"},{"v":0.135077,"d":"0.14"},{"v":0.249538,"d":"0.25"},{"v":0.38579,"d":"0.39"},{"v":0.475075,"d":"0.48"},{"v":0.643441,"d":"0.64"},{"v":0.504537640613014,"d":"0.50"},{"v":-0.986966190471427,"d":"-0.99"},{"v":0.0685192914453719,"d":"0.07"},{"v":0.464418011921973,"d":"0.46"},"down","no"]
["MSTRG.15627","ATP2B1","ENSOART00000017065;ENSOART00000017068","GO:0000166(nucleotide binding);GO:0001772(immunological synapse);GO:0001818(negative regulation of cytokine production);GO:0003056(regulation of vascular smooth muscle contraction);GO:0005388(calcium-transporting ATPase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0008217(regulation of blood pressure);GO:0015085(calcium ion transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0030501(positive regulation of bone mineralization);GO:0051480(regulation of cytosolic calcium ion concentration);GO:0051481(negative regulation of cytosolic calcium ion concentration);GO:0051928(positive regulation of calcium ion transport);GO:0070588(calcium ion transmembrane transport);GO:0098793(presynapse);GO:0098978(glutamatergic synapse);GO:0098982(GABA-ergic synapse);GO:0099132(ATP hydrolysis coupled cation transmembrane transport);GO:0099509(regulation of presynaptic cytosolic calcium ion concentration);GO:1900076(regulation of cellular response to insulin stimulus);GO:1905056(calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration);GO:1990034(calcium ion export across plasma membrane);GO:1990034(calcium ion export across plasma membrane)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04925(Aldosterone synthesis and secretion);04970(Salivary secretion);04972(Pancreatic secretion);04972(Pancreatic secretion)","K05850","EC:7.2.2.10","ATPase plasma membrane Ca2+ transporting 1 [Source:NCBI gene;Acc:101111268]",{"v":5.03857156142146,"d":"5.04"},{"v":4.97724153072236,"d":"4.98"},{"v":4.4147910482348,"d":"4.41"},{"v":3.8871534869994,"d":"3.89"},{"v":3.68549696185869,"d":"3.69"},{"v":2.71686540522815,"d":"2.72"},{"v":1.40245705872039,"d":"1.40"},{"v":0.4879565981998,"d":"0.49"},{"v":0.0686893128357552,"d":"0.07"},{"v":0.465377219909631,"d":"0.47"},"up","no"]
["MSTRG.4164","CACYBP","ENSOART00000014886","GO:0005641(nuclear envelope lumen);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0015631(tubulin binding);GO:0019005(SCF ubiquitin ligase complex);GO:0019904(protein domain specific binding);GO:0030877(beta-catenin destruction complex);GO:0031625(ubiquitin protein ligase binding);GO:0042803(protein homodimerization activity);GO:0044548(S100 protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","04310(Wnt signaling pathway)","K04507","NA","calcyclin binding protein [Source:NCBI gene;Acc:101116245]",{"v":3.98929353050571,"d":"3.99"},{"v":7.12935576313214,"d":"7.13"},{"v":6.68375720032626,"d":"6.68"},{"v":4.2292570721044,"d":"4.23"},{"v":4.06433350538336,"d":"4.06"},{"v":3.85881987243067,"d":"3.86"},{"v":1.4649280130333,"d":"1.46"},{"v":0.550829771957037,"d":"0.55"},{"v":0.0687379615551038,"d":"0.07"},{"v":0.465451768486427,"d":"0.47"},"up","no"]
["MSTRG.8840","IL17RC","ENSOART00000006019","GO:0005102(signaling receptor binding);GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0030368(interleukin-17 receptor activity);GO:0050832(defense response to fungus);GO:0071621(granulocyte chemotaxis);GO:1900017(positive regulation of cytokine production involved in inflammatory response);GO:2000778(positive regulation of interleukin-6 secretion)","04060(Cytokine-cytokine receptor interaction);04657(IL-17 signaling pathway)","K05166","NA","interleukin 17 receptor C [Source:NCBI gene;Acc:101123416]",{"v":1.183051,"d":"1.18"},{"v":1.180779,"d":"1.18"},{"v":1.239326,"d":"1.24"},{"v":0.792521,"d":"0.79"},{"v":0.88289,"d":"0.88"},{"v":0.670169,"d":"0.67"},{"v":1.53614713631596,"d":"1.54"},{"v":0.619316407899577,"d":"0.62"},{"v":0.0687573288577451,"d":"0.07"},{"v":0.465451768486427,"d":"0.47"},"up","no"]
["MSTRG.14594","GTF3C4","ENSOART00000006308","GO:0000127(transcription factor TFIIIC complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion)","NA","K11310","EC:2.3.1.48","general transcription factor IIIC subunit 4 [Source:NCBI gene;Acc:101119386]",{"v":1.73513158692893,"d":"1.74"},{"v":1.89825564689086,"d":"1.90"},{"v":2.09742088515228,"d":"2.10"},{"v":3.77035972271574,"d":"3.77"},{"v":3.82938685638748,"d":"3.83"},{"v":1.98878394384518,"d":"1.99"},{"v":0.597673241510409,"d":"0.60"},{"v":-0.742571141724648,"d":"-0.74"},{"v":0.0688998901422141,"d":"0.07"},{"v":0.465643205924686,"d":"0.47"},"down","no"]
["MSTRG.1505","ETV5","ENSOART00000022385","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0007274(neuromuscular synaptic transmission);GO:0007626(locomotory behavior);GO:0034599(cellular response to oxidative stress);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050807(regulation of synapse organization);GO:0060762(regulation of branching involved in mammary gland duct morphogenesis);GO:0071340(skeletal muscle acetylcholine-gated channel clustering)","05202(Transcriptional misregulation in cancer);05215(Prostate cancer)","K15593","NA","ETS variant 5 [Source:NCBI gene;Acc:101115418]",{"v":2.09168643906132,"d":"2.09"},{"v":1.32362821347464,"d":"1.32"},{"v":1.72099781604845,"d":"1.72"},{"v":2.89202441256624,"d":"2.89"},{"v":2.72833456320969,"d":"2.73"},{"v":2.51068558629826,"d":"2.51"},{"v":0.631691590099238,"d":"0.63"},{"v":-0.662707729575624,"d":"-0.66"},{"v":0.0689166487686224,"d":"0.07"},{"v":0.465643205924686,"d":"0.47"},"down","no"]
["MSTRG.13777","RADIL","ENSOART00000003769","GO:0005874(microtubule);GO:0007165(signal transduction);GO:0032991(protein-containing complex);GO:0034446(substrate adhesion-dependent cell spreading)","NA","NA","NA","Rap associating with DIL domain [Source:HGNC Symbol;Acc:HGNC:22226]",{"v":0.291578,"d":"0.29"},{"v":0.091957,"d":"0.09"},{"v":0.23858,"d":"0.24"},{"v":0.25837,"d":"0.26"},{"v":0.616054,"d":"0.62"},{"v":0.417268,"d":"0.42"},{"v":0.481627973232009,"d":"0.48"},{"v":-1.05400890779162,"d":"-1.05"},{"v":0.0689873440890799,"d":"0.07"},{"v":0.465850022450991,"d":"0.47"},"down","no"]
["MSTRG.11376","ENSOARG00000001568","ENSOART00000001687","GO:0004866(endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0010951(negative regulation of endopeptidase activity)","NA","NA","NA","complement C4-A-like [Source:NCBI gene;Acc:101123159]",{"v":1.04380876235688,"d":"1.04"},{"v":1.21283386679698,"d":"1.21"},{"v":0.373331989946942,"d":"0.37"},{"v":1.98609088187657,"d":"1.99"},{"v":1.25175444177604,"d":"1.25"},{"v":1.71458003043843,"d":"1.71"},{"v":0.531047806087226,"d":"0.53"},{"v":-0.913086353442726,"d":"-0.91"},{"v":0.0691116770744513,"d":"0.07"},{"v":0.466420895405247,"d":"0.47"},"down","no"]
["MSTRG.20433","AMD1","ENSOART00000010807","GO:0004014(adenosylmethionine decarboxylase activity);GO:0006557(S-adenosylmethioninamine biosynthetic process);GO:0006596(polyamine biosynthetic process);GO:0006597(spermine biosynthetic process);GO:0008295(spermidine biosynthetic process);GO:0016829(lyase activity);GO:0016831(carboxy-lyase activity)","00270(Cysteine and methionine metabolism);00330(Arginine and proline metabolism)","K01611","EC:4.1.1.50","adenosylmethionine decarboxylase 1 [Source:NCBI gene;Acc:101110851]",{"v":2.87381233127643,"d":"2.87"},{"v":3.00409619746239,"d":"3.00"},{"v":3.80728027164945,"d":"3.81"},{"v":2.53944256590169,"d":"2.54"},{"v":2.39475320529709,"d":"2.39"},{"v":1.93990051376274,"d":"1.94"},{"v":1.40893993899628,"d":"1.41"},{"v":0.49461011302508,"d":"0.49"},{"v":0.0691795913209261,"d":"0.07"},{"v":0.466420895405247,"d":"0.47"},"up","no"]
["MSTRG.22362","ARMCX2","ENSOART00000011025","NA","NA","NA","NA","armadillo repeat containing X-linked 2 [Source:NCBI gene;Acc:101108027]",{"v":1.077784,"d":"1.08"},{"v":0.662555,"d":"0.66"},{"v":0.929237,"d":"0.93"},{"v":1.347458,"d":"1.35"},{"v":1.773204,"d":"1.77"},{"v":1.536118,"d":"1.54"},{"v":0.573266506040655,"d":"0.57"},{"v":-0.802722105019945,"d":"-0.80"},{"v":0.0692038009174023,"d":"0.07"},{"v":0.466420895405247,"d":"0.47"},"down","no"]
["MSTRG.11693","PXDC1","ENSOART00000000864","GO:0035091(phosphatidylinositol binding)","NA","NA","NA","PX domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21361]",{"v":11.350843,"d":"11.35"},{"v":16.366724,"d":"16.37"},{"v":14.339474,"d":"14.34"},{"v":8.235533,"d":"8.24"},{"v":10.420037,"d":"10.42"},{"v":9.511608,"d":"9.51"},{"v":1.49312227870325,"d":"1.49"},{"v":0.578332319293642,"d":"0.58"},{"v":0.0692147127368271,"d":"0.07"},{"v":0.466420895405247,"d":"0.47"},"up","no"]
["MSTRG.3922","METTL11B","ENSOART00000012898","GO:0006480(N-terminal protein amino acid methylation);GO:0008168(methyltransferase activity)","NA","K19579","EC:2.1.1.299","methyltransferase like 11B [Source:NCBI gene;Acc:101103252]",{"v":13.4416419621729,"d":"13.44"},{"v":7.80207109830658,"d":"7.80"},{"v":6.73884646932043,"d":"6.74"},{"v":7.74591723531999,"d":"7.75"},{"v":5.21493256806686,"d":"5.21"},{"v":6.03936684319331,"d":"6.04"},{"v":1.47274949808725,"d":"1.47"},{"v":0.558512061330423,"d":"0.56"},{"v":0.0692447482518936,"d":"0.07"},{"v":0.466430795980577,"d":"0.47"},"up","no"]
["MSTRG.8917","FRMD4B","ENSOART00000010792","GO:0001726(ruffle);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0090162(establishment of epithelial cell polarity)","NA","NA","NA","FERM domain containing 4B [Source:NCBI gene;Acc:101105366]",{"v":1.942442,"d":"1.94"},{"v":1.14667,"d":"1.15"},{"v":0.981844,"d":"0.98"},{"v":2.717855,"d":"2.72"},{"v":2.065856,"d":"2.07"},{"v":2.105118,"d":"2.11"},{"v":0.590950363262029,"d":"0.59"},{"v":-0.758891138229214,"d":"-0.76"},{"v":0.0693681551012416,"d":"0.07"},{"v":0.466619157463784,"d":"0.47"},"down","no"]
["MSTRG.15395","PAIP2B","ENSOART00000012357","GO:0000900(translation repressor activity, mRNA regulatory element binding);GO:0045947(negative regulation of translational initiation)","NA","NA","NA","poly(A) binding protein interacting protein 2B [Source:NCBI gene;Acc:101108470]",{"v":40.8983820948599,"d":"40.90"},{"v":35.0295488989316,"d":"35.03"},{"v":28.8626181261912,"d":"28.86"},{"v":29.4169449792088,"d":"29.42"},{"v":22.3196477825585,"d":"22.32"},{"v":23.0443154920589,"d":"23.04"},{"v":1.40130083422223,"d":"1.40"},{"v":0.48676670983718,"d":"0.49"},{"v":0.0693870231701414,"d":"0.07"},{"v":0.466619157463784,"d":"0.47"},"up","no"]
["MSTRG.17993","ENSOARG00000016673","ENSOART00000018159","GO:0003824(catalytic activity)","NA","NA","NA",null,{"v":3.09271721428571,"d":"3.09"},{"v":8.12022866428571,"d":"8.12"},{"v":3.1862296,"d":"3.19"},{"v":8.95152443571429,"d":"8.95"},{"v":6.3781889,"d":"6.38"},{"v":12.70398235,"d":"12.70"},{"v":0.513638146036846,"d":"0.51"},{"v":-0.961175744735202,"d":"-0.96"},{"v":0.0695360185681364,"d":"0.07"},{"v":0.467236259745075,"d":"0.47"},"down","no"]
["MSTRG.12164","SSH3","ENSOART00000011729","GO:0004725(protein tyrosine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation)","04360(Axon guidance);04810(Regulation of actin cytoskeleton)","K05766","3.1.3.48;EC:3.1.3.16","slingshot protein phosphatase 3 [Source:NCBI gene;Acc:101118488]",{"v":0.867885,"d":"0.87"},{"v":0.707599,"d":"0.71"},{"v":0.390393,"d":"0.39"},{"v":0.938551,"d":"0.94"},{"v":1.150525,"d":"1.15"},{"v":1.525557,"d":"1.53"},{"v":0.543866279093894,"d":"0.54"},{"v":-0.878676116578443,"d":"-0.88"},{"v":0.0695665822773984,"d":"0.07"},{"v":0.467249344066376,"d":"0.47"},"down","no"]
["MSTRG.2140","RB1","ENSOART00000008979","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000987(proximal promoter sequence-specific DNA binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001558(regulation of cell growth);GO:0001894(tissue homeostasis);GO:0003180(aortic valve morphogenesis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005819(spindle);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006469(negative regulation of protein kinase activity);GO:0006915(apoptotic process);GO:0007050(cell cycle arrest);GO:0007265(Ras protein signal transduction);GO:0007346(regulation of mitotic cell cycle);GO:0008024(cyclin/CDK positive transcription elongation factor complex);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010629(negative regulation of gene expression);GO:0016605(PML body);GO:0019899(enzyme binding);GO:0019900(kinase binding);GO:0030182(neuron differentiation);GO:0031134(sister chromatid biorientation);GO:0031175(neuron projection development);GO:0031625(ubiquitin protein ligase binding);GO:0034088(maintenance of mitotic sister chromatid cohesion);GO:0034349(glial cell apoptotic process);GO:0035189(Rb-E2F complex);GO:0035914(skeletal muscle cell differentiation);GO:0042551(neuron maturation);GO:0042802(identical protein binding);GO:0043353(enucleate erythrocyte differentiation);GO:0043550(regulation of lipid kinase activity);GO:0045445(myoblast differentiation);GO:0045651(positive regulation of macrophage differentiation);GO:0045786(negative regulation of cell cycle);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0045879(negative regulation of smoothened signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045930(negative regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048565(digestive tract development);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0050680(negative regulation of epithelial cell proliferation);GO:0050728(negative regulation of inflammatory response);GO:0051146(striated muscle cell differentiation);GO:0051219(phosphoprotein binding);GO:0051301(cell division);GO:0051402(neuron apoptotic process);GO:0051726(regulation of cell cycle);GO:0061676(importin-alpha family protein binding);GO:0071459(protein localization to chromosome, centromeric region);GO:0071466(cellular response to xenobiotic stimulus);GO:0071922(regulation of cohesin loading);GO:0071930(negative regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0097284(hepatocyte apoptotic process);GO:0097718(disordered domain specific binding);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1903055(positive regulation of extracellular matrix organization);GO:1904028(positive regulation of collagen fibril organization);GO:1904761(negative regulation of myofibroblast differentiation);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle);GO:2000679(positive regulation of transcription regulatory region DNA binding)","01522(Endocrine resistance);04110(Cell cycle);04218(Cellular senescence);04934(Cushing syndrome);05160(Hepatitis C);05161(Hepatitis B);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05212(Pancreatic cancer);05214(Glioma);05215(Prostate cancer);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K06618","NA","RB transcriptional corepressor 1 [Source:NCBI gene;Acc:100144755]",{"v":5.64542518854842,"d":"5.65"},{"v":5.3721592267949,"d":"5.37"},{"v":3.66055048087676,"d":"3.66"},{"v":4.06916375262805,"d":"4.07"},{"v":3.19497548199508,"d":"3.19"},{"v":3.04161630060389,"d":"3.04"},{"v":1.42426577518237,"d":"1.42"},{"v":0.510218385602164,"d":"0.51"},{"v":0.0697798543199306,"d":"0.07"},{"v":0.468489087720323,"d":"0.47"},"up","no"]
["MSTRG.3400","SMARCD2","ENSOART00000015067","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0016514(SWI/SNF complex);GO:0043044(ATP-dependent chromatin remodeling)","04714(Thermogenesis);05225(Hepatocellular carcinoma)","K11650","NA","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 [Source:NCBI gene;Acc:101104326]",{"v":5.96437,"d":"5.96"},{"v":4.164269,"d":"4.16"},{"v":6.265132,"d":"6.27"},{"v":8.652635,"d":"8.65"},{"v":9.083608,"d":"9.08"},{"v":8.556586,"d":"8.56"},{"v":0.623507306878237,"d":"0.62"},{"v":-0.681521627799173,"d":"-0.68"},{"v":0.0698696305457752,"d":"0.07"},{"v":0.468706379437723,"d":"0.47"},"down","no"]
["MSTRG.15867","KCNMB4","ENSOART00000021991","GO:0001508(action potential);GO:0005513(detection of calcium ion);GO:0005887(integral component of plasma membrane);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0015269(calcium-activated potassium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019228(neuronal action potential);GO:0071805(potassium ion transmembrane transport)","04022(cGMP-PKG signaling pathway);04270(Vascular smooth muscle contraction);04911(Insulin secretion)","K04941","NA","potassium calcium-activated channel subfamily M regulatory beta subunit 4 [Source:NCBI gene;Acc:100620050]",{"v":1.869539,"d":"1.87"},{"v":0.664836,"d":"0.66"},{"v":1.075487,"d":"1.08"},{"v":1.454587,"d":"1.45"},{"v":3.156317,"d":"3.16"},{"v":2.620368,"d":"2.62"},{"v":0.499201523604699,"d":"0.50"},{"v":-1.00230575745485,"d":"-1.00"},{"v":0.0703716666149362,"d":"0.07"},{"v":0.470652821165396,"d":"0.47"},"down","no"]
["ENSOARG00000009289","CKAP2","ENSOART00000010110","GO:0000281(mitotic cytokinesis);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005881(cytoplasmic microtubule);GO:0007026(negative regulation of microtubule depolymerization);GO:0015630(microtubule cytoskeleton);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K16769","NA","cytoskeleton associated protein 2 [Source:NCBI gene;Acc:101121357]",{"v":0.465546,"d":"0.47"},{"v":0.107451,"d":"0.11"},{"v":0.333963,"d":"0.33"},{"v":1.172661,"d":"1.17"},{"v":0.267005,"d":"0.27"},{"v":0.665745,"d":"0.67"},{"v":0.430775748773042,"d":"0.43"},{"v":-1.21499106160152,"d":"-1.21"},{"v":0.0706699609956184,"d":"0.07"},{"v":0.472135484098387,"d":"0.47"},"down","no"]
["MSTRG.3421","ENSOARG00000014212","ENSOART00000015481","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0098609(cell-cell adhesion)","04514(Cell adhesion molecules (CAMs));04650(Natural killer cell mediated cytotoxicity)","K06523","NA","intercellular adhesion molecule 2 [Source:NCBI gene;Acc:101102001]",{"v":2.10851531451276,"d":"2.11"},{"v":2.68454744667503,"d":"2.68"},{"v":2.73501790673358,"d":"2.74"},{"v":3.43762723295692,"d":"3.44"},{"v":4.29509635089921,"d":"4.30"},{"v":4.72897923253869,"d":"4.73"},{"v":0.604097271363052,"d":"0.60"},{"v":-0.727147224783481,"d":"-0.73"},{"v":0.0707203367425514,"d":"0.07"},{"v":0.472147092939467,"d":"0.47"},"down","no"]
["MSTRG.14811","ENSOARG00000019124","ENSOART00000020824","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0031124(mRNA 3'-end processing)","03015(mRNA surveillance pathway)","K14407","NA","cleavage stimulation factor subunit 2 tau variant [Source:NCBI gene;Acc:101109157]",{"v":2.917741,"d":"2.92"},{"v":2.532731,"d":"2.53"},{"v":0.653992,"d":"0.65"},{"v":3.499594,"d":"3.50"},{"v":4.642292,"d":"4.64"},{"v":3.640756,"d":"3.64"},{"v":0.518089576174851,"d":"0.52"},{"v":-0.948726537649751,"d":"-0.95"},{"v":0.0707426207338678,"d":"0.07"},{"v":0.472147092939467,"d":"0.47"},"down","no"]
["MSTRG.19855","PYGO1","ENSOART00000022766","GO:0001822(kidney development);GO:0002244(hematopoietic progenitor cell differentiation);GO:0005634(nucleus);GO:0007286(spermatid development);GO:0007289(spermatid nucleus differentiation);GO:0009791(post-embryonic development);GO:0034504(protein localization to nucleus);GO:0035064(methylated histone binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0060070(canonical Wnt signaling pathway)","NA","NA","NA","pygopus family PHD finger 1 [Source:NCBI gene;Acc:101104754]",{"v":3.10880141999559,"d":"3.11"},{"v":6.24615864268373,"d":"6.25"},{"v":3.24700485742662,"d":"3.25"},{"v":3.22177407007283,"d":"3.22"},{"v":2.89946204171265,"d":"2.90"},{"v":2.4022063194659,"d":"2.40"},{"v":1.47850648628781,"d":"1.48"},{"v":0.564140572653189,"d":"0.56"},{"v":0.0708053140487069,"d":"0.07"},{"v":0.472266816906571,"d":"0.47"},"up","no"]
["MSTRG.10514","HSPD1","ENSOART00000016837","GO:0001530(lipopolysaccharide binding);GO:0002039(p53 binding);GO:0002368(B cell cytokine production);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002842(positive regulation of T cell mediated immune response to tumor cell);GO:0003725(double-stranded RNA binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0006457(protein folding);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006986(response to unfolded protein);GO:0008035(high-density lipoprotein particle binding);GO:0009409(response to cold);GO:0009986(cell surface);GO:0016020(membrane);GO:0019899(enzyme binding);GO:0030135(coated vesicle);GO:0030141(secretory granule);GO:0031625(ubiquitin protein ligase binding);GO:0032727(positive regulation of interferon-alpha production);GO:0032729(positive regulation of interferon-gamma production);GO:0032733(positive regulation of interleukin-10 production);GO:0032735(positive regulation of interleukin-12 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032991(protein-containing complex);GO:0034185(apolipoprotein binding);GO:0034186(apolipoprotein A-I binding);GO:0042026(protein refolding);GO:0042100(B cell proliferation);GO:0042110(T cell activation);GO:0042113(B cell activation);GO:0043032(positive regulation of macrophage activation);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0046696(lipopolysaccharide receptor complex);GO:0048291(isotype switching to IgG isotypes);GO:0050821(protein stabilization);GO:0050870(positive regulation of T cell activation);GO:0051087(chaperone binding);GO:0051702(interaction with symbiont);GO:0070062(extracellular exosome);GO:0098761(cellular response to interleukin-7)","03018(RNA degradation);04940(Type I diabetes mellitus);05134(Legionellosis);05152(Tuberculosis)","K04077","NA","heat shock protein family D (Hsp60) member 1 [Source:NCBI gene;Acc:101122254]",{"v":22.378103,"d":"22.38"},{"v":28.750412,"d":"28.75"},{"v":26.808495,"d":"26.81"},{"v":17.664614,"d":"17.66"},{"v":18.041039,"d":"18.04"},{"v":19.519667,"d":"19.52"},{"v":1.41125501853136,"d":"1.41"},{"v":0.49697871134189,"d":"0.50"},{"v":0.0708447740562449,"d":"0.07"},{"v":0.47233706443053,"d":"0.47"},"up","no"]
["MSTRG.9015","IL17RB","ENSOART00000017286","GO:0005737(cytoplasm);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0030368(interleukin-17 receptor activity);GO:0050729(positive regulation of inflammatory response);GO:2000664(positive regulation of interleukin-5 secretion);GO:2000667(positive regulation of interleukin-13 secretion)","04060(Cytokine-cytokine receptor interaction);04657(IL-17 signaling pathway)","K05165","NA","interleukin 17 receptor B [Source:NCBI gene;Acc:101105858]",{"v":0.583177,"d":"0.58"},{"v":0.268983,"d":"0.27"},{"v":0.307987,"d":"0.31"},{"v":0.867063,"d":"0.87"},{"v":0.669337,"d":"0.67"},{"v":0.725604,"d":"0.73"},{"v":0.51288459260019,"d":"0.51"},{"v":-0.963293862455287,"d":"-0.96"},{"v":0.0711831741706226,"d":"0.07"},{"v":0.473947211902554,"d":"0.47"},"down","no"]
["MSTRG.20015","SNAPC1","ENSOART00000023032","GO:0005634(nucleus);GO:0005730(nucleolus)","NA","K15208","NA","small nuclear RNA activating complex polypeptide 1 [Source:NCBI gene;Acc:101106332]",{"v":2.253471,"d":"2.25"},{"v":2.277419,"d":"2.28"},{"v":1.606603,"d":"1.61"},{"v":1.886371,"d":"1.89"},{"v":0.9634,"d":"0.96"},{"v":1.044047,"d":"1.04"},{"v":1.57621465615496,"d":"1.58"},{"v":0.656464021013991,"d":"0.66"},{"v":0.0712287148257522,"d":"0.07"},{"v":0.473947211902554,"d":"0.47"},"up","no"]
["MSTRG.12177","NDUFV1","ENSOART00000014459","GO:0003954(NADH dehydrogenase activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005747(mitochondrial respiratory chain complex I);GO:0005829(cytosol);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0010181(FMN binding);GO:0016020(membrane);GO:0016651(oxidoreductase activity, acting on NAD(P)H);GO:0042775(mitochondrial ATP synthesis coupled electron transport);GO:0046872(metal ion binding);GO:0051287(NAD binding);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0055114(oxidation-reduction process);GO:0070469(respirasome)","00190(Oxidative phosphorylation);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K03942","1.6.99.3;EC:7.1.1.2","NADH:ubiquinone oxidoreductase core subunit V1 [Source:NCBI gene;Acc:101121129]",{"v":102.387446552815,"d":"102.39"},{"v":75.5932078134092,"d":"75.59"},{"v":68.1250360373182,"d":"68.13"},{"v":151.879717481973,"d":"151.88"},{"v":102.657840974067,"d":"102.66"},{"v":136.86479071031,"d":"136.86"},{"v":0.628779287931522,"d":"0.63"},{"v":-0.669374399063457,"d":"-0.67"},{"v":0.0712314097261678,"d":"0.07"},{"v":0.473947211902554,"d":"0.47"},"down","no"]
["MSTRG.17616","COLGALT1","ENSOART00000017527","GO:0005788(endoplasmic reticulum lumen);GO:0050211(procollagen galactosyltransferase activity);GO:1904028(positive regulation of collagen fibril organization)","00310(Lysine degradation);00514(Other types of O-glycan biosynthesis)","K11703","EC:2.4.1.50","procollagen galactosyltransferase 1 [Source:NCBI gene;Acc:101114107]",{"v":3.39523255953905,"d":"3.40"},{"v":2.39519746222791,"d":"2.40"},{"v":3.99876435339309,"d":"4.00"},{"v":4.8372520390525,"d":"4.84"},{"v":5.20121978873239,"d":"5.20"},{"v":5.70995328745198,"d":"5.71"},{"v":0.621598306086419,"d":"0.62"},{"v":-0.685945522615441,"d":"-0.69"},{"v":0.0712902709401748,"d":"0.07"},{"v":0.473986620069892,"d":"0.47"},"down","no"]
["MSTRG.17147","TMED4","ENSOART00000016494","GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K20346","NA","transmembrane p24 trafficking protein 4 [Source:NCBI gene;Acc:101115957]",{"v":7.42738683480099,"d":"7.43"},{"v":6.25681511976048,"d":"6.26"},{"v":7.62593986509334,"d":"7.63"},{"v":11.6773262155689,"d":"11.68"},{"v":9.73040523388517,"d":"9.73"},{"v":12.3297967013033,"d":"12.33"},{"v":0.631645025220273,"d":"0.63"},{"v":-0.662814081151568,"d":"-0.66"},{"v":0.0712953906719534,"d":"0.07"},{"v":0.473986620069892,"d":"0.47"},"down","no"]
["MSTRG.16296","RF00319","ENSOART00000026551","NA","NA","NA","NA",null,{"v":6.149393,"d":"6.15"},{"v":7.338102,"d":"7.34"},{"v":2.107936,"d":"2.11"},{"v":6.784355,"d":"6.78"},{"v":10.009225,"d":"10.01"},{"v":15.775876,"d":"15.78"},{"v":0.47883609109099,"d":"0.48"},{"v":-1.06239619892241,"d":"-1.06"},{"v":0.0714865388467661,"d":"0.07"},{"v":0.475063983024012,"d":"0.48"},"down","no"]
["MSTRG.6759","LRP4","ENSOART00000005131","GO:0001822(kidney development);GO:0001932(regulation of protein phosphorylation);GO:0001942(hair follicle development);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0008104(protein localization);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030279(negative regulation of ossification);GO:0030326(embryonic limb morphogenesis);GO:0030509(BMP signaling pathway);GO:0030971(receptor tyrosine kinase binding);GO:0031594(neuromuscular junction);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042803(protein homodimerization activity);GO:0043113(receptor clustering);GO:0048513(animal organ development);GO:0048856(anatomical structure development);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050771(negative regulation of axonogenesis);GO:0051124(synaptic growth at neuromuscular junction);GO:0060173(limb development);GO:0060828(regulation of canonical Wnt signaling pathway);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0150094(amyloid-beta clearance by cellular catabolic process);GO:1901631(positive regulation of presynaptic membrane organization);GO:1904395(positive regulation of skeletal muscle acetylcholine-gated channel clustering)","NA","K20051","NA","LDL receptor related protein 4 [Source:NCBI gene;Acc:101118728]",{"v":2.14068539106335,"d":"2.14"},{"v":2.13185278631222,"d":"2.13"},{"v":2.50485827850679,"d":"2.50"},{"v":4.1038190841629,"d":"4.10"},{"v":3.59874520656109,"d":"3.60"},{"v":3.08318362341629,"d":"3.08"},{"v":0.628365924165267,"d":"0.63"},{"v":-0.670323148454399,"d":"-0.67"},{"v":0.0715472498556646,"d":"0.07"},{"v":0.47512728274069,"d":"0.48"},"down","no"]
["MSTRG.14104","ADK","ENSOART00000009379","GO:0004001(adenosine kinase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006166(purine ribonucleoside salvage);GO:0006167(AMP biosynthetic process);GO:0006175(dATP biosynthetic process);GO:0016773(phosphotransferase activity, alcohol group as acceptor)","00230(Purine metabolism)","K00856","EC:2.7.1.20","adenosine kinase [Source:NCBI gene;Acc:101122324]",{"v":7.978158,"d":"7.98"},{"v":9.815926,"d":"9.82"},{"v":7.801993,"d":"7.80"},{"v":7.368721,"d":"7.37"},{"v":5.172482,"d":"5.17"},{"v":5.283318,"d":"5.28"},{"v":1.43600363790982,"d":"1.44"},{"v":0.522059404027127,"d":"0.52"},{"v":0.0715542618973148,"d":"0.07"},{"v":0.47512728274069,"d":"0.48"},"up","no"]
["MSTRG.7498","PDGFC","ENSOART00000007158","GO:0005161(platelet-derived growth factor receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007171(activation of transmembrane receptor protein tyrosine kinase activity);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0009887(animal organ morphogenesis);GO:0009986(cell surface);GO:0010469(regulation of signaling receptor activity);GO:0016020(membrane);GO:0042803(protein homodimerization activity);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048146(positive regulation of fibroblast proliferation);GO:0048565(digestive tract development);GO:0048568(embryonic organ development);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0060348(bone development);GO:0071230(cellular response to amino acid stimulus);GO:0120162(positive regulation of cold-induced thermogenesis)","NA","NA","NA","platelet derived growth factor C [Source:HGNC Symbol;Acc:HGNC:8801]",{"v":2.2003596350211,"d":"2.20"},{"v":1.42344441772152,"d":"1.42"},{"v":1.34777479535865,"d":"1.35"},{"v":1.21281627848101,"d":"1.21"},{"v":0.96640051371308,"d":"0.97"},{"v":0.833994858649789,"d":"0.83"},{"v":1.64992686348764,"d":"1.65"},{"v":0.722402075366723,"d":"0.72"},{"v":0.0716234474141614,"d":"0.07"},{"v":0.47520018259993,"d":"0.48"},"up","no"]
["MSTRG.8190","TM2D3","ENSOART00000018067","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","TM2 domain containing 3 [Source:NCBI gene;Acc:101119939]",{"v":2.369986,"d":"2.37"},{"v":2.680621,"d":"2.68"},{"v":1.957442,"d":"1.96"},{"v":3.81512,"d":"3.82"},{"v":3.682528,"d":"3.68"},{"v":4.659526,"d":"4.66"},{"v":0.5764537876977,"d":"0.58"},{"v":-0.794723138236068,"d":"-0.79"},{"v":0.0716660845468771,"d":"0.07"},{"v":0.475289938457112,"d":"0.48"},"down","no"]
["MSTRG.21862","ENSOARG00000005853","ENSOART00000006369","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":11.001001,"d":"11.00"},{"v":12.591265,"d":"12.59"},{"v":11.593284,"d":"11.59"},{"v":17.023026,"d":"17.02"},{"v":21.623661,"d":"21.62"},{"v":19.445713,"d":"19.45"},{"v":0.605682498915521,"d":"0.61"},{"v":-0.723366369302604,"d":"-0.72"},{"v":0.0717452368279046,"d":"0.07"},{"v":0.475458941667334,"d":"0.48"},"down","no"]
["MSTRG.20674","UST","ENSOART00000002759","GO:0008146(sulfotransferase activity);GO:0016021(integral component of membrane);GO:0030010(establishment of cell polarity);GO:0050770(regulation of axonogenesis)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)","K03193","EC:2.8.2.-","uronyl 2-sulfotransferase [Source:NCBI gene;Acc:101103732]",{"v":0.480040315270936,"d":"0.48"},{"v":0.284434801548205,"d":"0.28"},{"v":0.68819163617171,"d":"0.69"},{"v":0.54929957635468,"d":"0.55"},{"v":1.49198943842365,"d":"1.49"},{"v":0.768236662913441,"d":"0.77"},{"v":0.517050534375013,"d":"0.52"},{"v":-0.95162280442576,"d":"-0.95"},{"v":0.07177174500796,"d":"0.07"},{"v":0.475458941667334,"d":"0.48"},"down","no"]
["MSTRG.4336","TMEM9","ENSOART00000019479;ENSOART00000019477","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 9 [Source:NCBI gene;Acc:101103661]",{"v":3.12450949439602,"d":"3.12"},{"v":3.58580926400996,"d":"3.59"},{"v":3.59873802864259,"d":"3.60"},{"v":6.03876529576588,"d":"6.04"},{"v":5.19817205666252,"d":"5.20"},{"v":5.58384884495641,"d":"5.58"},{"v":0.612876037188521,"d":"0.61"},{"v":-0.706332796858198,"d":"-0.71"},{"v":0.0718021760521582,"d":"0.07"},{"v":0.475458941667334,"d":"0.48"},"down","no"]
["MSTRG.11643","TMEM170B","ENSOART00000016073;ENSOART00000016072","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090090(negative regulation of canonical Wnt signaling pathway)","NA","NA","NA","transmembrane protein 170B [Source:NCBI gene;Acc:101116100]",{"v":4.11314394976662,"d":"4.11"},{"v":4.0615600372305,"d":"4.06"},{"v":3.72241541075795,"d":"3.72"},{"v":3.53993422727273,"d":"3.54"},{"v":2.79657946321405,"d":"2.80"},{"v":2.1871594416537,"d":"2.19"},{"v":1.39577377186066,"d":"1.40"},{"v":0.481065127318961,"d":"0.48"},{"v":0.0718080444727857,"d":"0.07"},{"v":0.475458941667334,"d":"0.48"},"up","no"]
["MSTRG.9058","ABHD14A","ENSOART00000007040","NA","NA","K13706","NA","abhydrolase domain containing 14A [Source:NCBI gene;Acc:101114562]",{"v":1.621279,"d":"1.62"},{"v":1.021306,"d":"1.02"},{"v":1.362319,"d":"1.36"},{"v":2.712557,"d":"2.71"},{"v":2.231176,"d":"2.23"},{"v":2.084158,"d":"2.08"},{"v":0.569858582041184,"d":"0.57"},{"v":-0.811324155085924,"d":"-0.81"},{"v":0.0719449639514572,"d":"0.07"},{"v":0.476172424564002,"d":"0.48"},"down","no"]
["MSTRG.4462","ITIH5","ENSOART00000014722","GO:0004867(serine-type endopeptidase inhibitor activity);GO:0010951(negative regulation of endopeptidase activity);GO:0030212(hyaluronan metabolic process)","NA","NA","NA","inter-alpha-trypsin inhibitor heavy chain family member 5 [Source:NCBI gene;Acc:101114543]",{"v":6.50986234831006,"d":"6.51"},{"v":6.10782211900425,"d":"6.11"},{"v":8.19718388807934,"d":"8.20"},{"v":10.8689335300546,"d":"10.87"},{"v":10.7275626589759,"d":"10.73"},{"v":11.5715392843554,"d":"11.57"},{"v":0.627558070844912,"d":"0.63"},{"v":-0.672179130415749,"d":"-0.67"},{"v":0.0719972810756367,"d":"0.07"},{"v":0.476325609968799,"d":"0.48"},"down","no"]
["MSTRG.3747","ENSOARG00000005343","ENSOART00000005831;ENSOART00000005828","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0014069(postsynaptic density);GO:0021816(extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration);GO:0042803(protein homodimerization activity);GO:0043547(positive regulation of GTPase activity);GO:0045211(postsynaptic membrane);GO:0045335(phagocytic vesicle);GO:0046847(filopodium assembly);GO:0048365(Rac GTPase binding);GO:0048812(neuron projection morphogenesis);GO:0060996(dendritic spine development);GO:0060996(dendritic spine development)","04360(Axon guidance);04360(Axon guidance)","K07526","NA","SLIT-ROBO Rho GTPase activating protein 2 [Source:NCBI gene;Acc:101116493]",{"v":2.4450024525154,"d":"2.45"},{"v":1.55091058495893,"d":"1.55"},{"v":1.54717672497433,"d":"1.55"},{"v":3.97839964784394,"d":"3.98"},{"v":2.62867719070842,"d":"2.63"},{"v":2.434363087654,"d":"2.43"},{"v":0.61307599317031,"d":"0.61"},{"v":-0.705862182186925,"d":"-0.71"},{"v":0.0720323294772206,"d":"0.07"},{"v":0.476364469705977,"d":"0.48"},"down","no"]
["MSTRG.6723","CD82","ENSOART00000001928","GO:0016020(membrane);GO:0016021(integral component of membrane)","04115(p53 signaling pathway)","K06509","NA","CD82 molecule [Source:NCBI gene;Acc:101111121]",{"v":2.15000056560773,"d":"2.15"},{"v":1.4558286342081,"d":"1.46"},{"v":1.36445845096685,"d":"1.36"},{"v":2.23492702478514,"d":"2.23"},{"v":2.7636581337477,"d":"2.76"},{"v":2.94016262661142,"d":"2.94"},{"v":0.626079551246552,"d":"0.63"},{"v":-0.675582113612502,"d":"-0.68"},{"v":0.0721600161987685,"d":"0.07"},{"v":0.476890164506803,"d":"0.48"},"down","no"]
["MSTRG.2573","ENSOARG00000007848","ENSOART00000008542","NA","03015(mRNA surveillance pathway)","K14411","NA","musashi RNA binding protein 2 [Source:NCBI gene;Acc:101102321]",{"v":2.93018541555983,"d":"2.93"},{"v":5.07991661622891,"d":"5.08"},{"v":3.80479564175386,"d":"3.80"},{"v":2.89132131216457,"d":"2.89"},{"v":3.38790214897858,"d":"3.39"},{"v":1.83893784480034,"d":"1.84"},{"v":1.45536621265368,"d":"1.46"},{"v":0.541382223031678,"d":"0.54"},{"v":0.0721702349642522,"d":"0.07"},{"v":0.476890164506803,"d":"0.48"},"up","no"]
["MSTRG.16117","CRY1","ENSOART00000019387","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006094(gluconeogenesis);GO:0006975(DNA damage induced protein phosphorylation);GO:0007623(circadian rhythm);GO:0008134(transcription factor binding);GO:0009416(response to light stimulus);GO:0014823(response to activity);GO:0019900(kinase binding);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0019915(lipid storage);GO:0031397(negative regulation of protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032868(response to insulin);GO:0032922(circadian regulation of gene expression);GO:0033762(response to glucagon);GO:0035257(nuclear hormone receptor binding);GO:0042593(glucose homeostasis);GO:0042752(regulation of circadian rhythm);GO:0042754(negative regulation of circadian rhythm);GO:0042826(histone deacetylase binding);GO:0043153(entrainment of circadian clock by photoperiod);GO:0045721(negative regulation of gluconeogenesis);GO:0045744(negative regulation of G protein-coupled receptor signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0070888(E-box binding);GO:2000001(regulation of DNA damage checkpoint);GO:2000323(negative regulation of glucocorticoid receptor signaling pathway);GO:2000850(negative regulation of glucocorticoid secretion)","04710(Circadian rhythm)","K02295","NA","cryptochrome circadian regulator 1 [Source:NCBI gene;Acc:443263]",{"v":4.42245108482512,"d":"4.42"},{"v":6.42734601624897,"d":"6.43"},{"v":5.11445580198292,"d":"5.11"},{"v":3.99276621343982,"d":"3.99"},{"v":3.98294412255577,"d":"3.98"},{"v":3.27285560644451,"d":"3.27"},{"v":1.41922561371356,"d":"1.42"},{"v":0.505103952268579,"d":"0.51"},{"v":0.0722295793075795,"d":"0.07"},{"v":0.477039287630737,"d":"0.48"},"up","no"]
["MSTRG.19022","MTHFD2L","ENSOART00000016194","GO:0003824(catalytic activity);GO:0004488(methylenetetrahydrofolate dehydrogenase (NADP+) activity);GO:0055114(oxidation-reduction process)","00670(One carbon pool by folate)","K13403","3.5.4.9;EC:1.5.1.15","methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like [Source:NCBI gene;Acc:101104908]",{"v":1.03063913500931,"d":"1.03"},{"v":1.010845,"d":"1.01"},{"v":0.976808,"d":"0.98"},{"v":1.80176491247672,"d":"1.80"},{"v":2.107967,"d":"2.11"},{"v":1.543754,"d":"1.54"},{"v":0.553461067553861,"d":"0.55"},{"v":-0.853446258679893,"d":"-0.85"},{"v":0.0722512345854245,"d":"0.07"},{"v":0.477039287630737,"d":"0.48"},"down","no"]
["MSTRG.4453","PRKCQ","ENSOART00000014401","GO:0000166(nucleotide binding);GO:0001772(immunological synapse);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0006509(membrane protein ectodomain proteolysis);GO:0016235(aggresome);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0032740(positive regulation of interleukin-17 production);GO:0032753(positive regulation of interleukin-4 production);GO:0035556(intracellular signal transduction);GO:0042102(positive regulation of T cell proliferation);GO:0045086(positive regulation of interleukin-2 biosynthetic process);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046872(metal ion binding);GO:0050870(positive regulation of T cell activation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051973(positive regulation of telomerase activity);GO:0060326(cell chemotaxis);GO:0070233(negative regulation of T cell apoptotic process);GO:0090330(regulation of platelet aggregation);GO:1904355(positive regulation of telomere capping);GO:2000318(positive regulation of T-helper 17 type immune response);GO:2000570(positive regulation of T-helper 2 cell activation)","04064(NF-kappa B signaling pathway);04140(Autophagy - animal);04270(Vascular smooth muscle contraction);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04920(Adipocytokine signaling pathway);04931(Insulin resistance)","K18052","EC:2.7.11.13","protein kinase C theta [Source:NCBI gene;Acc:101113426]",{"v":11.5244389718058,"d":"11.52"},{"v":13.117603481987,"d":"13.12"},{"v":9.02242015238308,"d":"9.02"},{"v":7.54703567599015,"d":"7.55"},{"v":8.12124144461848,"d":"8.12"},{"v":7.91094074490938,"d":"7.91"},{"v":1.42771752643273,"d":"1.43"},{"v":0.513710570735217,"d":"0.51"},{"v":0.0723071302319314,"d":"0.07"},{"v":0.477160075711293,"d":"0.48"},"up","no"]
["MSTRG.13331","PMM2","ENSOART00000005798","GO:0004615(phosphomannomutase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0009298(GDP-mannose biosynthetic process);GO:0016853(isomerase activity);GO:0043025(neuronal cell body)","00051(Fructose and mannose metabolism);00520(Amino sugar and nucleotide sugar metabolism)","K17497","EC:5.4.2.8","phosphomannomutase 2 [Source:NCBI gene;Acc:101105711]",{"v":0.887971,"d":"0.89"},{"v":0.871916,"d":"0.87"},{"v":0.895712,"d":"0.90"},{"v":1.728986,"d":"1.73"},{"v":1.338539,"d":"1.34"},{"v":1.963272,"d":"1.96"},{"v":0.527868447087012,"d":"0.53"},{"v":-0.921749662240373,"d":"-0.92"},{"v":0.072327975709545,"d":"0.07"},{"v":0.477160075711293,"d":"0.48"},"down","no"]
["MSTRG.8345","GEMIN2","ENSOART00000009211","GO:0000245(spliceosomal complex assembly);GO:0000387(spliceosomal snRNP assembly);GO:0005634(nucleus);GO:0005681(spliceosomal complex);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016604(nuclear body);GO:0032797(SMN complex);GO:0034719(SMN-Sm protein complex);GO:0097504(Gemini of coiled bodies)","03013(RNA transport)","K13130","NA","gem nuclear organelle associated protein 2 [Source:NCBI gene;Acc:101122894]",{"v":0.467848148943308,"d":"0.47"},{"v":0.763015451190875,"d":"0.76"},{"v":0.549308442804428,"d":"0.55"},{"v":1.38788478228782,"d":"1.39"},{"v":0.822642376383764,"d":"0.82"},{"v":1.01438520228111,"d":"1.01"},{"v":0.552006331859734,"d":"0.55"},{"v":-0.857243279169704,"d":"-0.86"},{"v":0.0723970753729947,"d":"0.07"},{"v":0.477391875779397,"d":"0.48"},"down","no"]
["MSTRG.4926","PDRG1","ENSOART00000002617","GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0051082(unfolded protein binding)","NA","NA","NA","p53 and DNA damage regulated 1 [Source:NCBI gene;Acc:101103497]",{"v":10.754877,"d":"10.75"},{"v":9.371518,"d":"9.37"},{"v":6.13576,"d":"6.14"},{"v":7.034903,"d":"7.03"},{"v":4.421789,"d":"4.42"},{"v":5.476535,"d":"5.48"},{"v":1.55092440442687,"d":"1.55"},{"v":0.633128367859256,"d":"0.63"},{"v":0.0724215872308652,"d":"0.07"},{"v":0.477391875779397,"d":"0.48"},"up","no"]
["MSTRG.14157","PRXL2A","ENSOART00000011185","GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016209(antioxidant activity);GO:0045670(regulation of osteoclast differentiation);GO:0055114(oxidation-reduction process);GO:0098869(cellular oxidant detoxification)","NA","NA","NA","peroxiredoxin like 2A [Source:NCBI gene;Acc:101108716]",{"v":2.8572528550149,"d":"2.86"},{"v":3.49316209136048,"d":"3.49"},{"v":3.2379947428004,"d":"3.24"},{"v":3.1417831612049,"d":"3.14"},{"v":1.72272735981463,"d":"1.72"},{"v":1.77256864250248,"d":"1.77"},{"v":1.44467309383238,"d":"1.44"},{"v":0.530743071090318,"d":"0.53"},{"v":0.0724696426216849,"d":"0.07"},{"v":0.477515869542724,"d":"0.48"},"up","no"]
["MSTRG.2220","ENSOARG00000011001","ENSOART00000011967","NA","NA","NA","NA","NEDD4 binding protein 2 like 2 [Source:NCBI gene;Acc:101109457]",{"v":4.44177288079114,"d":"4.44"},{"v":4.34147079114264,"d":"4.34"},{"v":3.95130269160486,"d":"3.95"},{"v":3.79458965280017,"d":"3.79"},{"v":2.73489472815221,"d":"2.73"},{"v":2.64521226120606,"d":"2.65"},{"v":1.38800734893211,"d":"1.39"},{"v":0.473015206417499,"d":"0.47"},{"v":0.0727349250663729,"d":"0.07"},{"v":0.478437441987155,"d":"0.48"},"up","no"]
["MSTRG.21298","TSPYL5","ENSOART00000005053","GO:0005634(nucleus);GO:0006334(nucleosome assembly);GO:0008284(positive regulation of cell population proliferation);GO:0031398(positive regulation of protein ubiquitination);GO:0051897(positive regulation of protein kinase B signaling);GO:0071480(cellular response to gamma radiation)","NA","K11288","NA","TSPY like 5 [Source:NCBI gene;Acc:101108139]",{"v":0.770148220703792,"d":"0.77"},{"v":0.401937779637854,"d":"0.40"},{"v":0.542257119234711,"d":"0.54"},{"v":0.92139164707892,"d":"0.92"},{"v":0.806907373078237,"d":"0.81"},{"v":1.30875588247352,"d":"1.31"},{"v":0.564475511486936,"d":"0.56"},{"v":-0.825017100643188,"d":"-0.83"},{"v":0.0727827533979057,"d":"0.07"},{"v":0.478437441987155,"d":"0.48"},"down","no"]
["ENSOARG00000008834","HSPA1L","ENSOART00000009615","GO:0000166(nucleotide binding);GO:0002199(zona pellucida receptor complex);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0007339(binding of sperm to zona pellucida);GO:0008180(COP9 signalosome);GO:0031072(heat shock protein binding);GO:0031625(ubiquitin protein ligase binding);GO:0042026(protein refolding);GO:0044297(cell body);GO:0051082(unfolded protein binding);GO:1903955(positive regulation of protein targeting to mitochondrion)","03040(Spliceosome);04010(MAPK signaling pathway);04141(Protein processing in endoplasmic reticulum);04144(Endocytosis);04213(Longevity regulating pathway - multiple species);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);05134(Legionellosis);05145(Toxoplasmosis);05162(Measles);05164(Influenza A)","K03283","NA","heat shock protein family A (Hsp70) member 1 like [Source:NCBI gene;Acc:101117117]",{"v":0.903782,"d":"0.90"},{"v":1.203096,"d":"1.20"},{"v":1.195463,"d":"1.20"},{"v":0.463761,"d":"0.46"},{"v":0.952885,"d":"0.95"},{"v":0.593641,"d":"0.59"},{"v":1.64272116369454,"d":"1.64"},{"v":0.71608761729686,"d":"0.72"},{"v":0.0727846761968903,"d":"0.07"},{"v":0.478437441987155,"d":"0.48"},"up","no"]
["ENSOARG00000011441","ATP13A2","ENSOART00000012446","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005770(late endosome);GO:0005771(multivesicular body);GO:0005776(autophagosome);GO:0006812(cation transport);GO:0006874(cellular calcium ion homeostasis);GO:0006879(cellular iron ion homeostasis);GO:0006882(cellular zinc ion homeostasis);GO:0010821(regulation of mitochondrion organization);GO:0012506(vesicle membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016241(regulation of macroautophagy);GO:0016243(regulation of autophagosome size);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0030133(transport vesicle);GO:0031982(vesicle);GO:0034599(cellular response to oxidative stress);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0046872(metal ion binding);GO:0050714(positive regulation of protein secretion);GO:0052548(regulation of endopeptidase activity);GO:0055069(zinc ion homeostasis);GO:0070300(phosphatidic acid binding);GO:0071287(cellular response to manganese ion);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding);GO:0097734(extracellular exosome biogenesis);GO:1902047(polyamine transmembrane transport);GO:1903543(positive regulation of exosomal secretion);GO:1905037(autophagosome organization);GO:1905103(integral component of lysosomal membrane);GO:1905123(regulation of glucosylceramidase activity);GO:1905165(regulation of lysosomal protein catabolic process);GO:1990938(peptidyl-aspartic acid autophosphorylation)","NA","K13526","EC:7.2.2.-","ATPase cation transporting 13A2 [Source:NCBI gene;Acc:101108996]",{"v":0.352355,"d":"0.35"},{"v":0.223599,"d":"0.22"},{"v":0.320808,"d":"0.32"},{"v":0.670081,"d":"0.67"},{"v":0.531095,"d":"0.53"},{"v":0.445732,"d":"0.45"},{"v":0.544512504645068,"d":"0.54"},{"v":-0.876962914297285,"d":"-0.88"},{"v":0.0728319399282465,"d":"0.07"},{"v":0.478437441987155,"d":"0.48"},"down","no"]
["MSTRG.2970","NDEL1","ENSOART00000001407;ENSOART00000001409","GO:0000226(microtubule cytoskeleton organization);GO:0000776(kinetochore);GO:0001764(neuron migration);GO:0001833(inner cell mass cell proliferation);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005875(microtubule associated complex);GO:0007059(chromosome segregation);GO:0007100(mitotic centrosome separation);GO:0007399(nervous system development);GO:0008017(microtubule binding);GO:0008021(synaptic vesicle);GO:0008090(retrograde axonal transport);GO:0008286(insulin receptor signaling pathway);GO:0010975(regulation of neuron projection development);GO:0016477(cell migration);GO:0021799(cerebral cortex radially oriented cell migration);GO:0021955(central nervous system neuron axonogenesis);GO:0030424(axon);GO:0031252(cell leading edge);GO:0032418(lysosome localization);GO:0033157(regulation of intracellular protein transport);GO:0042802(identical protein binding);GO:0043014(alpha-tubulin binding);GO:0043203(axon hillock);GO:0043547(positive regulation of GTPase activity);GO:0047496(vesicle transport along microtubule);GO:0048487(beta-tubulin binding);GO:0051642(centrosome localization);GO:0060052(neurofilament cytoskeleton organization);GO:0060053(neurofilament cytoskeleton);GO:0090630(activation of GTPase activity);GO:1900029(positive regulation of ruffle assembly);GO:1904115(axon cytoplasm);GO:1990138(neuron projection extension);GO:2000574(regulation of microtubule motor activity);GO:2000574(regulation of microtubule motor activity)","NA","K16739","NA","nudE neurodevelopment protein 1 like 1 [Source:NCBI gene;Acc:101108583]",{"v":10.6081217949584,"d":"10.61"},{"v":7.72024212525321,"d":"7.72"},{"v":7.6074531701553,"d":"7.61"},{"v":6.65231308631555,"d":"6.65"},{"v":6.85472842842674,"d":"6.85"},{"v":4.78016413684447,"d":"4.78"},{"v":1.41824932603175,"d":"1.42"},{"v":0.50411117842386,"d":"0.50"},{"v":0.0728685443362398,"d":"0.07"},{"v":0.478437441987155,"d":"0.48"},"up","no"]
["MSTRG.22137","MIR542;MIR424","ENSOART00000026543;ENSOART00000023600","NA","NA","NA","NA","microRNA 542 [Source:HGNC Symbol;Acc:HGNC:32534];microRNA 424 [Source:HGNC Symbol;Acc:HGNC:31881]",{"v":1.20546589186708,"d":"1.21"},{"v":1.19327366532036,"d":"1.19"},{"v":1.32807192399486,"d":"1.33"},{"v":2.77149567266385,"d":"2.77"},{"v":2.65264078795667,"d":"2.65"},{"v":1.06155294988067,"d":"1.06"},{"v":0.57462071420628,"d":"0.57"},{"v":-0.799318094108767,"d":"-0.80"},{"v":0.0729455688728699,"d":"0.07"},{"v":0.478437441987155,"d":"0.48"},"down","no"]
["MSTRG.8075","RGMA","ENSOART00000011112","GO:0001843(neural tube closure);GO:0005102(signaling receptor binding);GO:0009986(cell surface);GO:0010975(regulation of neuron projection development);GO:0010977(negative regulation of neuron projection development);GO:0015026(coreceptor activity);GO:0030509(BMP signaling pathway);GO:0030510(regulation of BMP signaling pathway);GO:0031175(neuron projection development);GO:0043547(positive regulation of GTPase activity);GO:0048681(negative regulation of axon regeneration);GO:0051044(positive regulation of membrane protein ectodomain proteolysis);GO:1900121(negative regulation of receptor binding)","04350(TGF-beta signaling pathway);04360(Axon guidance)","K23096","NA","repulsive guidance molecule BMP co-receptor a [Source:NCBI gene;Acc:101113702]",{"v":1.48013733620503,"d":"1.48"},{"v":1.27715816455194,"d":"1.28"},{"v":1.55794246153846,"d":"1.56"},{"v":2.90116012446831,"d":"2.90"},{"v":2.31580682993295,"d":"2.32"},{"v":1.74509946726984,"d":"1.75"},{"v":0.61982142957775,"d":"0.62"},{"v":-0.690075459661371,"d":"-0.69"},{"v":0.0729649665278885,"d":"0.07"},{"v":0.478437441987155,"d":"0.48"},"down","no"]
["MSTRG.14493","ENSOARG00000004556","ENSOART00000004957","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":130.174728,"d":"130.17"},{"v":110.619385,"d":"110.62"},{"v":121.868034,"d":"121.87"},{"v":168.460648,"d":"168.46"},{"v":204.382721,"d":"204.38"},{"v":197.85524,"d":"197.86"},{"v":0.635470529068698,"d":"0.64"},{"v":-0.654102875325631,"d":"-0.65"},{"v":0.0731524872970503,"d":"0.07"},{"v":0.479115047166561,"d":"0.48"},"down","no"]
["MSTRG.1541","B3GNT5","ENSOART00000022503","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0007417(central nervous system development);GO:0008378(galactosyltransferase activity);GO:0008457(beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups)","NA","NA","NA","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 [Source:HGNC Symbol;Acc:HGNC:15684]",{"v":1.16648554206731,"d":"1.17"},{"v":0.478135106971154,"d":"0.48"},{"v":0.749576650240385,"d":"0.75"},{"v":1.75707778245192,"d":"1.76"},{"v":1.62513089783654,"d":"1.63"},{"v":1.015866046875,"d":"1.02"},{"v":0.544373947193705,"d":"0.54"},{"v":-0.877330071311134,"d":"-0.88"},{"v":0.0733538573351133,"d":"0.07"},{"v":0.479721730609743,"d":"0.48"},"down","no"]
["MSTRG.13954","FAM13C","ENSOART00000004558","NA","NA","NA","NA","family with sequence similarity 13 member C [Source:NCBI gene;Acc:101119609]",{"v":1.51166862227074,"d":"1.51"},{"v":0.91578785371179,"d":"0.92"},{"v":1.26085121179039,"d":"1.26"},{"v":2.15095512663755,"d":"2.15"},{"v":2.04721093395197,"d":"2.05"},{"v":2.06465760207424,"d":"2.06"},{"v":0.588920890390226,"d":"0.59"},{"v":-0.763854244714415,"d":"-0.76"},{"v":0.0733749659731665,"d":"0.07"},{"v":0.479721730609743,"d":"0.48"},"down","no"]
["MSTRG.2511","MCF2L","ENSOART00000008279","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0035023(regulation of Rho protein signal transduction);GO:0035091(phosphatidylinositol binding);GO:0035556(intracellular signal transduction)","NA","K20685","NA","MCF.2 cell line derived transforming sequence like [Source:NCBI gene;Acc:101118115]",{"v":1.09790273020833,"d":"1.10"},{"v":0.501063306666667,"d":"0.50"},{"v":0.492251774375,"d":"0.49"},{"v":1.28965357979167,"d":"1.29"},{"v":1.41554744729167,"d":"1.42"},{"v":0.92422702625,"d":"0.92"},{"v":0.576183845090793,"d":"0.58"},{"v":-0.79539888377196,"d":"-0.80"},{"v":0.0735105430478872,"d":"0.07"},{"v":0.480304180426531,"d":"0.48"},"down","no"]
["MSTRG.12672","RF00026","ENSOART00000023158;ENSOART00000024557","NA","NA","NA","NA",null,{"v":1.31345960473118,"d":"1.31"},{"v":2.45235540946237,"d":"2.45"},{"v":5.15646788282642,"d":"5.16"},{"v":1.24841495950845,"d":"1.25"},{"v":2.66655544491551,"d":"2.67"},{"v":1.29108638635945,"d":"1.29"},{"v":1.71382742363003,"d":"1.71"},{"v":0.777221842467822,"d":"0.78"},{"v":0.0735849928186312,"d":"0.07"},{"v":0.480403816318668,"d":"0.48"},"up","no"]
["MSTRG.4806","ENSOARG00000007835","ENSOART00000008532","GO:0004719(protein-L-isoaspartate (D-aspartate) O-methyltransferase activity);GO:0006464(cellular protein modification process);GO:0006479(protein methylation);GO:0032259(methylation)","NA","NA","NA","protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 [Source:NCBI gene;Acc:101106449]",{"v":14.3805315692252,"d":"14.38"},{"v":11.8110336964253,"d":"11.81"},{"v":8.85621137924152,"d":"8.86"},{"v":10.2933296438033,"d":"10.29"},{"v":6.63290235547088,"d":"6.63"},{"v":7.53057139938305,"d":"7.53"},{"v":1.43304814098544,"d":"1.43"},{"v":0.519087075471908,"d":"0.52"},{"v":0.0735943011136634,"d":"0.07"},{"v":0.480403816318668,"d":"0.48"},"up","no"]
["ENSOARG00000010332","SH2D4B","ENSOART00000011242","NA","NA","NA","NA","SH2 domain containing 4B [Source:NCBI gene;Acc:101109766]",{"v":0.236414,"d":"0.24"},{"v":0.064912,"d":"0.06"},{"v":0.090741,"d":"0.09"},{"v":0.287928,"d":"0.29"},{"v":0.275412,"d":"0.28"},{"v":0.228191,"d":"0.23"},{"v":0.49532740979191,"d":"0.50"},{"v":-1.01354563770118,"d":"-1.01"},{"v":0.0736209680562934,"d":"0.07"},{"v":0.480403816318668,"d":"0.48"},"down","no"]
["MSTRG.20933","TSTA3;PYCR3","ENSOART00000018104;ENSOART00000018188","GO:0001913(T cell mediated cytotoxicity);GO:0003824(catalytic activity);GO:0009226(nucleotide-sugar biosynthetic process);GO:0016491(oxidoreductase activity);GO:0019673(GDP-mannose metabolic process);GO:0042351('de novo' GDP-L-fucose biosynthetic process);GO:0042802(identical protein binding);GO:0047918(GDP-mannose 3,5-epimerase activity);GO:0050577(GDP-L-fucose synthase activity);GO:0050662(coenzyme binding);GO:0055114(oxidation-reduction process);GO:0004735(pyrroline-5-carboxylate reductase activity);GO:0006561(proline biosynthetic process);GO:0008652(cellular amino acid biosynthetic process);GO:0055129(L-proline biosynthetic process)","00051(Fructose and mannose metabolism);00520(Amino sugar and nucleotide sugar metabolism);00330(Arginine and proline metabolism)","K02377;K00286","EC:1.1.1.271;EC:1.5.1.2","tissue specific transplantation antigen P35B [Source:NCBI gene;Acc:101114115];pyrroline-5-carboxylate reductase 3 [Source:NCBI gene;Acc:101117514]",{"v":0.895393751563388,"d":"0.90"},{"v":0.675803959446655,"d":"0.68"},{"v":0.822367657191586,"d":"0.82"},{"v":1.10844922948645,"d":"1.11"},{"v":1.39580995755164,"d":"1.40"},{"v":1.40381576558651,"d":"1.40"},{"v":0.612466597293419,"d":"0.61"},{"v":-0.707296930336568,"d":"-0.71"},{"v":0.0736434806617851,"d":"0.07"},{"v":0.480403816318668,"d":"0.48"},"down","no"]
["MSTRG.18116","CDC34","ENSOART00000009441","GO:0000166(nucleotide binding);GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0035458(cellular response to interferon-beta);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043951(negative regulation of cAMP-mediated signaling);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070936(protein K48-linked ubiquitination)","04120(Ubiquitin mediated proteolysis)","K02207","EC:2.3.2.23","cell division cycle 34 [Source:NCBI gene;Acc:101107962]",{"v":47.426922,"d":"47.43"},{"v":52.990673,"d":"52.99"},{"v":50.889507,"d":"50.89"},{"v":27.486923,"d":"27.49"},{"v":31.96504,"d":"31.97"},{"v":43.934025,"d":"43.93"},{"v":1.46351652604993,"d":"1.46"},{"v":0.549439036772062,"d":"0.55"},{"v":0.0737152137205841,"d":"0.07"},{"v":0.480487828195488,"d":"0.48"},"up","no"]
["MSTRG.8897","RYBP","ENSOART00000010437","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0031519(PcG protein complex);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0035518(histone H2A monoubiquitination);GO:0043065(positive regulation of apoptotic process);GO:0045893(positive regulation of transcription, DNA-templated)","NA","NA","NA","RING1 and YY1 binding protein [Source:HGNC Symbol;Acc:HGNC:10480]",{"v":3.32084179885058,"d":"3.32"},{"v":3.73098765640394,"d":"3.73"},{"v":3.42565216174056,"d":"3.43"},{"v":2.65539759195402,"d":"2.66"},{"v":2.50743017692939,"d":"2.51"},{"v":2.30995356239737,"d":"2.31"},{"v":1.40208593728506,"d":"1.40"},{"v":0.48757477837517,"d":"0.49"},{"v":0.0738884481019862,"d":"0.07"},{"v":0.481021854933175,"d":"0.48"},"up","no"]
["MSTRG.11379","EHMT2","ENSOART00000003726","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0002039(p53 binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006275(regulation of DNA replication);GO:0006306(DNA methylation);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007130(synaptonemal complex assembly);GO:0007281(germ cell development);GO:0007286(spermatid development);GO:0008270(zinc ion binding);GO:0009566(fertilization);GO:0010424(DNA methylation on cytosine within a CG sequence);GO:0016571(histone methylation);GO:0016607(nuclear speck);GO:0018024(histone-lysine N-methyltransferase activity);GO:0034968(histone lysine methylation);GO:0035265(organ growth);GO:0036166(phenotypic switching);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0046976(histone methyltransferase activity (H3-K27 specific));GO:0048148(behavioral response to cocaine);GO:0048665(neuron fate specification);GO:0051567(histone H3-K9 methylation);GO:0070734(histone H3-K27 methylation);GO:0070742(C2H2 zinc finger domain binding);GO:0071314(cellular response to cocaine);GO:1902902(negative regulation of autophagosome assembly);GO:1990841(promoter-specific chromatin binding)","00310(Lysine degradation);04211(Longevity regulating pathway)","K11420","EC:2.1.1.43","euchromatic histone lysine methyltransferase 2 [Source:NCBI gene;Acc:101115739]",{"v":2.968797,"d":"2.97"},{"v":2.326026,"d":"2.33"},{"v":2.889757,"d":"2.89"},{"v":4.633447,"d":"4.63"},{"v":3.690992,"d":"3.69"},{"v":4.560276,"d":"4.56"},{"v":0.635216223253677,"d":"0.64"},{"v":-0.65468033588769,"d":"-0.65"},{"v":0.0739815365660086,"d":"0.07"},{"v":0.481021854933175,"d":"0.48"},"down","no"]
["ENSOARG00000012838","DOK1","ENSOART00000013953","GO:0005634(nucleus);GO:0005829(cytosol);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007265(Ras protein signal transduction);GO:0035556(intracellular signal transduction);GO:0038145(macrophage colony-stimulating factor signaling pathway)","NA","K14752","NA","docking protein 1 [Source:NCBI gene;Acc:101120650]",{"v":0.918522,"d":"0.92"},{"v":0.547532,"d":"0.55"},{"v":0.892109,"d":"0.89"},{"v":1.401398,"d":"1.40"},{"v":1.179954,"d":"1.18"},{"v":1.700514,"d":"1.70"},{"v":0.550732554451727,"d":"0.55"},{"v":-0.86057620447025,"d":"-0.86"},{"v":0.0740010750185737,"d":"0.07"},{"v":0.481021854933175,"d":"0.48"},"down","no"]
["ENSOARG00000020264","RMDN3","ENSOART00000022065;ENSOART00000022064","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0006874(cellular calcium ion homeostasis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","K23293","NA","regulator of microtubule dynamics 3 [Source:NCBI gene;Acc:101110764]",{"v":0.977050296472185,"d":"0.98"},{"v":0.877696215061058,"d":"0.88"},{"v":0.882770750339213,"d":"0.88"},{"v":1.46735739280868,"d":"1.47"},{"v":1.5975525834464,"d":"1.60"},{"v":1.6462082109905,"d":"1.65"},{"v":0.581075904502617,"d":"0.58"},{"v":-0.7832014632767,"d":"-0.78"},{"v":0.0742368439678431,"d":"0.07"},{"v":0.481610772916326,"d":"0.48"},"down","no"]
["MSTRG.18859","PGM2","ENSOART00000010707","GO:0000287(magnesium ion binding);GO:0004614(phosphoglucomutase activity);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0008973(phosphopentomutase activity);GO:0016868(intramolecular transferase activity, phosphotransferases);GO:0046872(metal ion binding);GO:0071704(organic substance metabolic process)","00010(Glycolysis / Gluconeogenesis);00030(Pentose phosphate pathway);00052(Galactose metabolism);00230(Purine metabolism);00500(Starch and sucrose metabolism);00520(Amino sugar and nucleotide sugar metabolism)","K15779","5.4.2.7;EC:5.4.2.2","phosphoglucomutase 2 [Source:NCBI gene;Acc:101111285]",{"v":4.04134624193548,"d":"4.04"},{"v":3.40833529139785,"d":"3.41"},{"v":3.90629984967742,"d":"3.91"},{"v":3.31861590430108,"d":"3.32"},{"v":2.33222696752688,"d":"2.33"},{"v":2.43346076473118,"d":"2.43"},{"v":1.40469506014795,"d":"1.40"},{"v":0.49025697531397,"d":"0.49"},{"v":0.0742414450900535,"d":"0.07"},{"v":0.481610772916326,"d":"0.48"},"up","no"]
["MSTRG.10126","MSTN","ENSOART00000017734","GO:0005102(signaling receptor binding);GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005623(cell);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0010469(regulation of signaling receptor activity);GO:0010592(positive regulation of lamellipodium assembly);GO:0010759(positive regulation of macrophage chemotaxis);GO:0014839(myoblast migration involved in skeletal muscle regeneration);GO:0033673(negative regulation of kinase activity);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045662(negative regulation of myoblast differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046716(muscle cell cellular homeostasis);GO:0048632(negative regulation of skeletal muscle tissue growth);GO:0051898(negative regulation of protein kinase B signaling);GO:0071549(cellular response to dexamethasone stimulus)","04060(Cytokine-cytokine receptor interaction)","K05497","NA","myostatin [Source:NCBI gene;Acc:443449]",{"v":7.436905,"d":"7.44"},{"v":11.682288,"d":"11.68"},{"v":10.015044,"d":"10.02"},{"v":6.750926,"d":"6.75"},{"v":7.424556,"d":"7.42"},{"v":6.13844,"d":"6.14"},{"v":1.434200495601,"d":"1.43"},{"v":0.520246721243478,"d":"0.52"},{"v":0.0745050821581387,"d":"0.07"},{"v":0.482937269344219,"d":"0.48"},"up","no"]
["MSTRG.4102","DDI2;RSC1A1","ENSOART00000010005;ENSOART00000005704","GO:0004190(aspartic-type endopeptidase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0010498(proteasomal protein catabolic process);GO:0016485(protein processing);GO:0031647(regulation of protein stability);GO:0042802(identical protein binding);GO:0043130(ubiquitin binding);GO:0072711(cellular response to hydroxyurea);GO:0097752(regulation of DNA stability);GO:0006355(regulation of transcription, DNA-templated);GO:0010829(negative regulation of glucose transmembrane transport);GO:0019871(sodium channel inhibitor activity);GO:0030054(cell junction);GO:0045920(negative regulation of exocytosis);GO:0051051(negative regulation of transport)","NA","K11885","NA","protein DDI1 homolog 2 [Source:NCBI gene;Acc:101110160]",{"v":13.2916429236569,"d":"13.29"},{"v":13.1329315884386,"d":"13.13"},{"v":12.2236249341292,"d":"12.22"},{"v":11.9443679899466,"d":"11.94"},{"v":9.07232274332391,"d":"9.07"},{"v":6.95144075924181,"d":"6.95"},{"v":1.38186562289911,"d":"1.38"},{"v":0.466617330195926,"d":"0.47"},{"v":0.0745592216344873,"d":"0.07"},{"v":0.483096417003138,"d":"0.48"},"up","no"]
["MSTRG.5625","CLIP3","ENSOART00000005669","GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0008017(microtubule binding);GO:0010828(positive regulation of glucose transmembrane transport);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0031115(negative regulation of microtubule polymerization);GO:0031901(early endosome membrane);GO:0032588(trans-Golgi network membrane);GO:0035594(ganglioside binding);GO:0043065(positive regulation of apoptotic process);GO:0044091(membrane biogenesis);GO:0045121(membrane raft);GO:0045444(fat cell differentiation);GO:0045807(positive regulation of endocytosis);GO:0055038(recycling endosome membrane);GO:0072321(chaperone-mediated protein transport);GO:1903078(positive regulation of protein localization to plasma membrane)","NA","K10423","NA","CAP-Gly domain containing linker protein 3 [Source:NCBI gene;Acc:101106102]",{"v":1.353833,"d":"1.35"},{"v":0.901847,"d":"0.90"},{"v":1.370332,"d":"1.37"},{"v":1.59345,"d":"1.59"},{"v":2.216295,"d":"2.22"},{"v":2.444259,"d":"2.44"},{"v":0.579790483024955,"d":"0.58"},{"v":-0.786396442421802,"d":"-0.79"},{"v":0.0748097619152184,"d":"0.07"},{"v":0.484527486137123,"d":"0.48"},"down","no"]
["MSTRG.4821","ARFGAP1","ENSOART00000012400","GO:0005096(GTPase activator activity);GO:0014069(postsynaptic density);GO:0030100(regulation of endocytosis);GO:0043547(positive regulation of GTPase activity);GO:0045202(synapse);GO:0046872(metal ion binding)","04144(Endocytosis)","K12492","NA","ADP ribosylation factor GTPase activating protein 1 [Source:NCBI gene;Acc:101110163]",{"v":3.47238061818182,"d":"3.47"},{"v":2.6971575970516,"d":"2.70"},{"v":3.10972769336609,"d":"3.11"},{"v":4.1977402034398,"d":"4.20"},{"v":4.96855437739558,"d":"4.97"},{"v":5.72359983882064,"d":"5.72"},{"v":0.623192189754551,"d":"0.62"},{"v":-0.682250942156882,"d":"-0.68"},{"v":0.0748798821504312,"d":"0.07"},{"v":0.484643916224996,"d":"0.48"},"down","no"]
["MSTRG.6084","TSEN34","ENSOART00000002991","GO:0000213(tRNA-intron endonuclease activity);GO:0000214(tRNA-intron endonuclease complex);GO:0000379(tRNA-type intron splice site recognition and cleavage);GO:0003676(nucleic acid binding);GO:0004518(nuclease activity);GO:0005634(nucleus);GO:0006388(tRNA splicing, via endonucleolytic cleavage and ligation);GO:0008033(tRNA processing);GO:0016829(lyase activity);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090501(RNA phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","NA","K15323","EC:4.6.1.16","tRNA splicing endonuclease subunit 34 [Source:NCBI gene;Acc:101107041]",{"v":1.121944,"d":"1.12"},{"v":1.073981,"d":"1.07"},{"v":1.035315,"d":"1.04"},{"v":1.616038,"d":"1.62"},{"v":1.960058,"d":"1.96"},{"v":2.314778,"d":"2.31"},{"v":0.548516230359026,"d":"0.55"},{"v":-0.866393784902378,"d":"-0.87"},{"v":0.0750208337881747,"d":"0.08"},{"v":0.485317026185942,"d":"0.49"},"down","no"]
["ENSOARG00000013285","NPAS2","ENSOART00000014450","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0045739(positive regulation of DNA repair);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0051775(response to redox state);GO:0051879(Hsp90 protein binding);GO:0060548(negative regulation of cell death);GO:2001020(regulation of response to DNA damage stimulus)","04710(Circadian rhythm)","K09026","NA","neuronal PAS domain protein 2 [Source:NCBI gene;Acc:101104647]",{"v":0.44373,"d":"0.44"},{"v":0.151449,"d":"0.15"},{"v":0.287819,"d":"0.29"},{"v":0.640684,"d":"0.64"},{"v":0.461863,"d":"0.46"},{"v":0.623986,"d":"0.62"},{"v":0.511428394360258,"d":"0.51"},{"v":-0.967395834062304,"d":"-0.97"},{"v":0.0752107988851782,"d":"0.08"},{"v":0.485968311910245,"d":"0.49"},"down","no"]
["MSTRG.21221","EBAG9","ENSOART00000013150","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0006915(apoptotic process);GO:0016021(integral component of membrane)","04915(Estrogen signaling pathway)","K22455","NA","estrogen receptor binding site associated, antigen, 9 [Source:NCBI gene;Acc:101117425]",{"v":3.36710552706186,"d":"3.37"},{"v":2.81304569716495,"d":"2.81"},{"v":2.47467666108247,"d":"2.47"},{"v":2.50200602835052,"d":"2.50"},{"v":1.68019623195876,"d":"1.68"},{"v":1.7807628943299,"d":"1.78"},{"v":1.4514302299043,"d":"1.45"},{"v":0.537475223435251,"d":"0.54"},{"v":0.0754501805506442,"d":"0.08"},{"v":0.486566280133605,"d":"0.49"},"up","no"]
["MSTRG.2","DTYMK","ENSOART00000019171","GO:0004798(thymidylate kinase activity);GO:0005524(ATP binding);GO:0006233(dTDP biosynthetic process);GO:0009165(nucleotide biosynthetic process);GO:0046940(nucleoside monophosphate phosphorylation);GO:0071363(cellular response to growth factor stimulus)","00240(Pyrimidine metabolism)","K00943","EC:2.7.4.9","deoxythymidylate kinase [Source:NCBI gene;Acc:101121994]",{"v":1.439037,"d":"1.44"},{"v":1.432741,"d":"1.43"},{"v":1.419051,"d":"1.42"},{"v":2.33325,"d":"2.33"},{"v":2.487252,"d":"2.49"},{"v":3.012865,"d":"3.01"},{"v":0.547763050039657,"d":"0.55"},{"v":-0.868376144146126,"d":"-0.87"},{"v":0.0756348994951308,"d":"0.08"},{"v":0.486732652962932,"d":"0.49"},"down","no"]
["MSTRG.8676","EGFR","ENSOART00000014976","GO:0000166(nucleotide binding);GO:0000902(cell morphogenesis);GO:0001892(embryonic placenta development);GO:0001934(positive regulation of protein phosphorylation);GO:0001942(hair follicle development);GO:0003682(chromatin binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0004888(transmembrane signaling receptor activity);GO:0005006(epidermal growth factor-activated receptor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007435(salivary gland morphogenesis);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0008544(epidermis development);GO:0009986(cell surface);GO:0010008(endosome membrane);GO:0010750(positive regulation of nitric oxide mediated signal transduction);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016323(basolateral plasma membrane);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019899(enzyme binding);GO:0019903(protein phosphatase binding);GO:0021795(cerebral cortex cell migration);GO:0030139(endocytic vesicle);GO:0030235(nitric-oxide synthase regulator activity);GO:0030307(positive regulation of cell growth);GO:0030335(positive regulation of cell migration);GO:0031625(ubiquitin protein ligase binding);GO:0031901(early endosome membrane);GO:0032991(protein-containing complex);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034614(cellular response to reactive oxygen species);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042127(regulation of cell population proliferation);GO:0042177(negative regulation of protein catabolic process);GO:0042327(positive regulation of phosphorylation);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043235(receptor complex);GO:0043406(positive regulation of MAP kinase activity);GO:0045121(membrane raft);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045739(positive regulation of DNA repair);GO:0045740(positive regulation of DNA replication);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046328(regulation of JNK cascade);GO:0046777(protein autophosphorylation);GO:0046982(protein heterodimerization activity);GO:0048146(positive regulation of fibroblast proliferation);GO:0048408(epidermal growth factor binding);GO:0048471(perinuclear region of cytoplasm);GO:0048546(digestive tract morphogenesis);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050999(regulation of nitric-oxide synthase activity);GO:0051015(actin filament binding);GO:0051897(positive regulation of protein kinase B signaling);GO:0060571(morphogenesis of an epithelial fold);GO:0061029(eyelid development in camera-type eye);GO:0070141(response to UV-A);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071230(cellular response to amino acid stimulus);GO:0071276(cellular response to cadmium ion);GO:0071363(cellular response to growth factor stimulus);GO:0071392(cellular response to estradiol stimulus);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0097489(multivesicular body, internal vesicle lumen);GO:0098609(cell-cell adhesion);GO:1900020(positive regulation of protein kinase C activity);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903800(positive regulation of production of miRNAs involved in gene silencing by miRNA);GO:1905208(negative regulation of cardiocyte differentiation)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04072(Phospholipase D signaling pathway);04144(Endocytosis);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04520(Adherens junction);04540(Gap junction);04630(Jak-STAT signaling pathway);04810(Regulation of actin cytoskeleton);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);05160(Hepatitis C);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05218(Melanoma);05219(Bladder cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer)","K04361","EC:2.7.10.1","epidermal growth factor receptor [Source:NCBI gene;Acc:780479]",{"v":4.965147,"d":"4.97"},{"v":4.933382,"d":"4.93"},{"v":5.903205,"d":"5.90"},{"v":9.429119,"d":"9.43"},{"v":8.483746,"d":"8.48"},{"v":7.144151,"d":"7.14"},{"v":0.630631117448303,"d":"0.63"},{"v":-0.665131735711741,"d":"-0.67"},{"v":0.0756437974671821,"d":"0.08"},{"v":0.486732652962932,"d":"0.49"},"down","no"]
["MSTRG.3404","DDX5;ENSOARG00000024483;ENSOARG00000021738","ENSOART00000016375;ENSOART00000026385;ENSOART00000023640","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000166(nucleotide binding);GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0001837(epithelial to mesenchymal transition);GO:0003676(nucleic acid binding);GO:0003724(RNA helicase activity);GO:0003730(mRNA 3'-UTR binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0009299(mRNA transcription);GO:0016787(hydrolase activity);GO:0030509(BMP signaling pathway);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0035500(MH2 domain binding);GO:0036002(pre-mRNA binding);GO:0043021(ribonucleoprotein complex binding);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0046332(SMAD binding);GO:0050681(androgen receptor binding);GO:0060765(regulation of androgen receptor signaling pathway);GO:0070412(R-SMAD binding);GO:0070878(primary miRNA binding);GO:0071013(catalytic step 2 spliceosome);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:1903800(positive regulation of production of miRNAs involved in gene silencing by miRNA);GO:1990904(ribonucleoprotein complex)","03040(Spliceosome);05202(Transcriptional misregulation in cancer);05205(Proteoglycans in cancer)","K12823","EC:3.6.4.13","DEAD-box helicase 5 [Source:NCBI gene;Acc:101106186]",{"v":43.5316653041039,"d":"43.53"},{"v":36.2345287369353,"d":"36.23"},{"v":44.4650238473575,"d":"44.47"},{"v":33.3441822072631,"d":"33.34"},{"v":31.9959992807795,"d":"32.00"},{"v":24.9500216392087,"d":"24.95"},{"v":1.37591027138692,"d":"1.38"},{"v":0.460386389192605,"d":"0.46"},{"v":0.0756775007576855,"d":"0.08"},{"v":0.486732652962932,"d":"0.49"},"up","no"]
["MSTRG.818","THEM4","ENSOART00000022957","GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006631(fatty acid metabolic process);GO:0016290(palmitoyl-CoA hydrolase activity);GO:0043491(protein kinase B signaling);GO:1902108(regulation of mitochondrial membrane permeability involved in apoptotic process)","NA","NA","NA","thioesterase superfamily member 4 [Source:HGNC Symbol;Acc:HGNC:17947]",{"v":6.458799,"d":"6.46"},{"v":4.40489,"d":"4.40"},{"v":4.735772,"d":"4.74"},{"v":5.124978,"d":"5.12"},{"v":1.897722,"d":"1.90"},{"v":2.788247,"d":"2.79"},{"v":1.59000563350307,"d":"1.59"},{"v":0.669031877089843,"d":"0.67"},{"v":0.0757166179890891,"d":"0.08"},{"v":0.486732652962932,"d":"0.49"},"up","no"]
["MSTRG.17395","PDIA4","ENSOART00000020562","GO:0003756(protein disulfide isomerase activity);GO:0016853(isomerase activity);GO:0045454(cell redox homeostasis);GO:0055114(oxidation-reduction process)","04141(Protein processing in endoplasmic reticulum);04918(Thyroid hormone synthesis)","K09582","EC:5.3.4.1","protein disulfide isomerase family A member 4 [Source:NCBI gene;Acc:100037677]",{"v":6.02996,"d":"6.03"},{"v":5.333172,"d":"5.33"},{"v":6.511265,"d":"6.51"},{"v":9.407247,"d":"9.41"},{"v":8.462646,"d":"8.46"},{"v":10.419084,"d":"10.42"},{"v":0.631850243294411,"d":"0.63"},{"v":-0.662345433412488,"d":"-0.66"},{"v":0.0762194786648906,"d":"0.08"},{"v":0.488235248191579,"d":"0.49"},"down","no"]
["MSTRG.2966","ENSOARG00000019001","ENSOART00000020686","NA","NA","NA","NA",null,{"v":4.93842330065359,"d":"4.94"},{"v":1.02110692810458,"d":"1.02"},{"v":0.55607862745098,"d":"0.56"},{"v":1.67017071895425,"d":"1.67"},{"v":0.762181732026144,"d":"0.76"},{"v":0.444563594771242,"d":"0.44"},{"v":2.26478936214729,"d":"2.26"},{"v":1.17937687794629,"d":"1.18"},{"v":0.0764702424097393,"d":"0.08"},{"v":0.489457513942071,"d":"0.49"},"up","no"]
["MSTRG.4204","ENSOARG00000005256","ENSOART00000005727","NA","NA","NA","NA",null,{"v":15.474577,"d":"15.47"},{"v":2.032074,"d":"2.03"},{"v":10.687208,"d":"10.69"},{"v":5.421002,"d":"5.42"},{"v":3.732954,"d":"3.73"},{"v":5.332779,"d":"5.33"},{"v":1.94618449222685,"d":"1.95"},{"v":0.960648479597191,"d":"0.96"},{"v":0.0766281652669145,"d":"0.08"},{"v":0.490191845370002,"d":"0.49"},"up","no"]
["MSTRG.3753","YOD1","ENSOART00000007554","GO:0003676(nucleic acid binding);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0016236(macroautophagy);GO:0016579(protein deubiquitination);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0031625(ubiquitin protein ligase binding);GO:0035523(protein K29-linked deubiquitination);GO:0035871(protein K11-linked deubiquitination);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:1904153(negative regulation of retrograde protein transport, ER to cytosol);GO:1904265(ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol);GO:1990167(protein K27-linked deubiquitination);GO:1990168(protein K33-linked deubiquitination);GO:1990380(Lys48-specific deubiquitinase activity)","04141(Protein processing in endoplasmic reticulum)","K13719","EC:3.1.2.-","YOD1 deubiquitinase [Source:NCBI gene;Acc:101119065]",{"v":1.637365,"d":"1.64"},{"v":3.3531,"d":"3.35"},{"v":2.492463,"d":"2.49"},{"v":1.610102,"d":"1.61"},{"v":1.518978,"d":"1.52"},{"v":1.675992,"d":"1.68"},{"v":1.55729778866997,"d":"1.56"},{"v":0.639044844968448,"d":"0.64"},{"v":0.0766450135490945,"d":"0.08"},{"v":0.490191845370002,"d":"0.49"},"up","no"]
["MSTRG.6363","SORL1","ENSOART00000019884","GO:0001540(amyloid-beta binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005641(nuclear envelope lumen);GO:0005768(endosome);GO:0005769(early endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0006605(protein targeting);GO:0006622(protein targeting to lysosome);GO:0006892(post-Golgi vesicle-mediated transport);GO:0014910(regulation of smooth muscle cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030169(low-density lipoprotein particle binding);GO:0030306(ADP-ribosylation factor binding);GO:0031985(Golgi cisterna);GO:0032091(negative regulation of protein binding);GO:0032460(negative regulation of protein oligomerization);GO:0034067(protein localization to Golgi apparatus);GO:0043407(negative regulation of MAP kinase activity);GO:0045053(protein retention in Golgi apparatus);GO:0045732(positive regulation of protein catabolic process);GO:0050768(negative regulation of neurogenesis);GO:0051604(protein maturation);GO:0055037(recycling endosome);GO:0070863(positive regulation of protein exit from endoplasmic reticulum);GO:1901215(negative regulation of neuron death);GO:1902430(negative regulation of amyloid-beta formation);GO:1902771(positive regulation of choline O-acetyltransferase activity);GO:1902948(negative regulation of tau-protein kinase activity);GO:1902953(positive regulation of ER to Golgi vesicle-mediated transport);GO:1902955(positive regulation of early endosome to recycling endosome transport);GO:1902960(negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:1902963(negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process);GO:1902966(positive regulation of protein localization to early endosome);GO:1902997(negative regulation of neurofibrillary tangle assembly);GO:2001137(positive regulation of endocytic recycling)","NA","NA","NA","sortilin related receptor 1 [Source:NCBI gene;Acc:101117962]",{"v":1.20359570489898,"d":"1.20"},{"v":2.3259195986948,"d":"2.33"},{"v":2.3643345952083,"d":"2.36"},{"v":3.12227176273914,"d":"3.12"},{"v":3.23667871517969,"d":"3.24"},{"v":3.54018981709279,"d":"3.54"},{"v":0.595390076628383,"d":"0.60"},{"v":-0.748092918521904,"d":"-0.75"},{"v":0.0767602511202221,"d":"0.08"},{"v":0.490736640677755,"d":"0.49"},"down","no"]
["MSTRG.21500","GPM6B","ENSOART00000012608","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030501(positive regulation of bone mineralization);GO:0032956(regulation of actin cytoskeleton organization);GO:0051893(regulation of focal adhesion assembly);GO:0085029(extracellular matrix assembly)","NA","NA","NA","glycoprotein M6B [Source:NCBI gene;Acc:101120549]",{"v":3.26421486738351,"d":"3.26"},{"v":0.50834091503268,"d":"0.51"},{"v":2.32525811933375,"d":"2.33"},{"v":3.86681673539954,"d":"3.87"},{"v":3.31406297448872,"d":"3.31"},{"v":4.50961007463631,"d":"4.51"},{"v":0.521604655933406,"d":"0.52"},{"v":-0.938971347515348,"d":"-0.94"},{"v":0.0768197085385092,"d":"0.08"},{"v":0.490856383653703,"d":"0.49"},"down","no"]
["MSTRG.644","RAP1A","ENSOART00000021380","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0008565(protein transporter activity);GO:0010976(positive regulation of neuron projection development);GO:0015031(protein transport);GO:0016020(membrane);GO:0017016(Ras GTPase binding);GO:0030054(cell junction);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0032486(Rap protein signal transduction);GO:0043005(neuron projection);GO:0044877(protein-containing complex binding);GO:0048471(perinuclear region of cytoplasm);GO:0061028(establishment of endothelial barrier);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071320(cellular response to cAMP);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane);GO:0098978(glutamatergic synapse);GO:1901888(regulation of cell junction assembly);GO:2000301(negative regulation of synaptic vesicle exocytosis);GO:2001214(positive regulation of vasculogenesis)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04510(Focal adhesion);04530(Tight junction);04611(Platelet activation);04670(Leukocyte transendothelial migration);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04934(Cushing syndrome);04972(Pancreatic secretion);05211(Renal cell carcinoma)","K04353","NA","RAP1A, member of RAS oncogene family [Source:NCBI gene;Acc:101115080]",{"v":3.35869542045455,"d":"3.36"},{"v":2.88687121338384,"d":"2.89"},{"v":3.38154190656566,"d":"3.38"},{"v":2.47380187289562,"d":"2.47"},{"v":2.51188666203704,"d":"2.51"},{"v":1.92777589520202,"d":"1.93"},{"v":1.39251581283054,"d":"1.39"},{"v":0.477693710303318,"d":"0.48"},{"v":0.0768892928444553,"d":"0.08"},{"v":0.490856383653703,"d":"0.49"},"up","no"]
["MSTRG.12083","TM7SF2","ENSOART00000013681","GO:0005783(endoplasmic reticulum);GO:0006695(cholesterol biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016628(oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor);GO:0031090(organelle membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0043235(receptor complex);GO:0050613(delta14-sterol reductase activity);GO:0055114(oxidation-reduction process)","00100(Steroid biosynthesis)","K00222","EC:1.3.1.70","transmembrane 7 superfamily member 2 [Source:NCBI gene;Acc:100037702]",{"v":1.780423,"d":"1.78"},{"v":0.907184,"d":"0.91"},{"v":2.018069,"d":"2.02"},{"v":2.4545,"d":"2.45"},{"v":2.67249,"d":"2.67"},{"v":3.162783,"d":"3.16"},{"v":0.567648354182919,"d":"0.57"},{"v":-0.816930606671755,"d":"-0.82"},{"v":0.0769189519859054,"d":"0.08"},{"v":0.490856383653703,"d":"0.49"},"down","no"]
["MSTRG.6705","ENSOARG00000019022","ENSOART00000020709","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","low density lipoprotein receptor class A domain containing 3 [Source:NCBI gene;Acc:101114902]",{"v":0.916336,"d":"0.92"},{"v":0.597412,"d":"0.60"},{"v":1.225809,"d":"1.23"},{"v":1.745855,"d":"1.75"},{"v":1.433524,"d":"1.43"},{"v":2.002535,"d":"2.00"},{"v":0.528676662715746,"d":"0.53"},{"v":-0.919542451405436,"d":"-0.92"},{"v":0.0771505561261413,"d":"0.08"},{"v":0.491424020794343,"d":"0.49"},"down","no"]
["ENSOARG00000019502","CELSR1","ENSOART00000021244","GO:0001736(establishment of planar polarity);GO:0001764(neuron migration);GO:0001843(neural tube closure);GO:0001942(hair follicle development);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007266(Rho protein signal transduction);GO:0007626(locomotory behavior);GO:0009952(anterior/posterior pattern specification);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0042060(wound healing);GO:0042249(establishment of planar polarity of embryonic epithelium);GO:0042472(inner ear morphogenesis);GO:0045176(apical protein localization);GO:0048105(establishment of body hair planar orientation);GO:0060488(orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis);GO:0060489(planar dichotomous subdivision of terminal units involved in lung branching morphogenesis);GO:0060490(lateral sprouting involved in lung morphogenesis);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:0090251(protein localization involved in establishment of planar polarity)","NA","K04600","NA","cadherin EGF LAG seven-pass G-type receptor 1 [Source:NCBI gene;Acc:101111090]",{"v":0.175794,"d":"0.18"},{"v":0.140763,"d":"0.14"},{"v":0.210703,"d":"0.21"},{"v":0.205974,"d":"0.21"},{"v":0.453733,"d":"0.45"},{"v":0.293261,"d":"0.29"},{"v":0.553281957001704,"d":"0.55"},{"v":-0.853913217859921,"d":"-0.85"},{"v":0.0771506805612854,"d":"0.08"},{"v":0.491424020794343,"d":"0.49"},"down","no"]
["MSTRG.12104","MAP3K11","ENSOART00000017687","GO:0000166(nucleotide binding);GO:0000186(activation of MAPKK activity);GO:0000187(activation of MAPK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005813(centrosome);GO:0005874(microtubule);GO:0006468(protein phosphorylation);GO:0007017(microtubule-based process);GO:0007257(activation of JUN kinase activity);GO:0008283(cell population proliferation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043507(positive regulation of JUN kinase activity);GO:0046330(positive regulation of JNK cascade);GO:0046777(protein autophosphorylation)","04010(MAPK signaling pathway);04932(Non-alcoholic fatty liver disease (NAFLD))","K04419","EC:2.7.11.25","mitogen-activated protein kinase kinase kinase 11 [Source:NCBI gene;Acc:101108969]",{"v":5.69855,"d":"5.70"},{"v":4.002945,"d":"4.00"},{"v":4.291456,"d":"4.29"},{"v":7.713453,"d":"7.71"},{"v":7.479534,"d":"7.48"},{"v":6.850099,"d":"6.85"},{"v":0.634800000326633,"d":"0.63"},{"v":-0.655625965971936,"d":"-0.66"},{"v":0.0771687401590333,"d":"0.08"},{"v":0.491424020794343,"d":"0.49"},"down","no"]
["MSTRG.12917","ESCO1","ENSOART00000009205","GO:0000785(chromatin);GO:0005694(chromosome);GO:0006275(regulation of DNA replication);GO:0007062(sister chromatid cohesion);GO:0008080(N-acetyltransferase activity);GO:0008270(zinc ion binding);GO:0016407(acetyltransferase activity);GO:0018394(peptidyl-lysine acetylation);GO:0034421(post-translational protein acetylation);GO:0061733(peptide-lysine-N-acetyltransferase activity)","NA","K11268","EC:2.3.1.-","establishment of sister chromatid cohesion N-acetyltransferase 1 [Source:NCBI gene;Acc:101123257]",{"v":1.18300283510349,"d":"1.18"},{"v":1.16672596595861,"d":"1.17"},{"v":0.902241487472767,"d":"0.90"},{"v":0.911104586056645,"d":"0.91"},{"v":0.685935252178649,"d":"0.69"},{"v":0.674117,"d":"0.67"},{"v":1.4318563270433,"d":"1.43"},{"v":0.517886739347368,"d":"0.52"},{"v":0.0772460729222031,"d":"0.08"},{"v":0.491539870403009,"d":"0.49"},"up","no"]
["ENSOARG00000001072","TRPC3","ENSOART00000001153","GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0010524(positive regulation of calcium ion transport into cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033198(response to ATP);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:1903244(positive regulation of cardiac muscle hypertrophy in response to stress)","04360(Axon guidance)","K04966","NA","transient receptor potential cation channel subfamily C member 3 [Source:NCBI gene;Acc:101105027]",{"v":0.685231,"d":"0.69"},{"v":0.483257,"d":"0.48"},{"v":0.232618,"d":"0.23"},{"v":0.754155,"d":"0.75"},{"v":0.919602,"d":"0.92"},{"v":0.921503,"d":"0.92"},{"v":0.539871149711397,"d":"0.54"},{"v":-0.889312972525834,"d":"-0.89"},{"v":0.0775843017493569,"d":"0.08"},{"v":0.49291691788463,"d":"0.49"},"down","no"]
["MSTRG.3908","SELP","ENSOART00000011670","GO:0001530(lipopolysaccharide binding);GO:0002687(positive regulation of leukocyte migration);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005887(integral component of plasma membrane);GO:0006954(inflammatory response);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0007159(leukocyte cell-cell adhesion);GO:0008201(heparin binding);GO:0009897(external side of plasma membrane);GO:0010572(positive regulation of platelet activation);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0031092(platelet alpha granule membrane);GO:0033623(regulation of integrin activation);GO:0033691(sialic acid binding);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0042806(fucose binding);GO:0048306(calcium-dependent protein binding);GO:0050900(leukocyte migration);GO:0050901(leukocyte tethering or rolling);GO:0070492(oligosaccharide binding)","04514(Cell adhesion molecules (CAMs));05144(Malaria);05150(Staphylococcus aureus infection)","K06496","NA","selectin P [Source:NCBI gene;Acc:443305]",{"v":0.631806,"d":"0.63"},{"v":2.046049,"d":"2.05"},{"v":1.302958,"d":"1.30"},{"v":0.742616,"d":"0.74"},{"v":0.605874,"d":"0.61"},{"v":0.983756,"d":"0.98"},{"v":1.70685811016505,"d":"1.71"},{"v":0.771343133193166,"d":"0.77"},{"v":0.0776541823666948,"d":"0.08"},{"v":0.49297725104331,"d":"0.49"},"up","no"]
["MSTRG.6728","TP53I11","ENSOART00000002122","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","tumor protein p53 inducible protein 11 [Source:NCBI gene;Acc:101111656]",{"v":2.65117493580147,"d":"2.65"},{"v":1.04251613439881,"d":"1.04"},{"v":1.40994591165959,"d":"1.41"},{"v":3.06046578629712,"d":"3.06"},{"v":2.45115305549936,"d":"2.45"},{"v":2.86831205725268,"d":"2.87"},{"v":0.60903091485384,"d":"0.61"},{"v":-0.715412632643565,"d":"-0.72"},{"v":0.07804239781036,"d":"0.08"},{"v":0.494335088380961,"d":"0.49"},"down","no"]
["MSTRG.5336","SPATA2L","ENSOART00000015621","NA","04217(Necroptosis)","K17595","NA","spermatogenesis associated 2 like [Source:NCBI gene;Acc:101107982]",{"v":0.428358,"d":"0.43"},{"v":0.305234,"d":"0.31"},{"v":0.390119,"d":"0.39"},{"v":0.585948,"d":"0.59"},{"v":0.785013,"d":"0.79"},{"v":0.549029,"d":"0.55"},{"v":0.585269194110386,"d":"0.59"},{"v":-0.772827751079692,"d":"-0.77"},{"v":0.0780799971174974,"d":"0.08"},{"v":0.494335088380961,"d":"0.49"},"down","no"]
["MSTRG.14726","SH3GLB2","ENSOART00000009664;ENSOART00000009663","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0042802(identical protein binding)","04144(Endocytosis);04144(Endocytosis)","K21269","NA","SH3 domain containing GRB2 like, endophilin B2 [Source:NCBI gene;Acc:101106157]",{"v":3.46350026424159,"d":"3.46"},{"v":2.03655063383665,"d":"2.04"},{"v":3.35266139087165,"d":"3.35"},{"v":4.32984509334249,"d":"4.33"},{"v":4.82268951990391,"d":"4.82"},{"v":4.89066247769389,"d":"4.89"},{"v":0.630391514953604,"d":"0.63"},{"v":-0.665679978584096,"d":"-0.67"},{"v":0.0781536369804598,"d":"0.08"},{"v":0.494417894078631,"d":"0.49"},"down","no"]
["ENSOARG00000005637","ETV4","ENSOART00000006143","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","05202(Transcriptional misregulation in cancer)","K15592","NA","ETS variant 4 [Source:NCBI gene;Acc:101110344]",{"v":1.010846,"d":"1.01"},{"v":0.394802,"d":"0.39"},{"v":0.736687,"d":"0.74"},{"v":1.503566,"d":"1.50"},{"v":1.004514,"d":"1.00"},{"v":1.502359,"d":"1.50"},{"v":0.534189648564658,"d":"0.53"},{"v":-0.904576074940409,"d":"-0.90"},{"v":0.0784267130090834,"d":"0.08"},{"v":0.495761273717504,"d":"0.50"},"down","no"]
["MSTRG.22375","ENSOARG00000010175","ENSOART00000011071","GO:0009055(electron transfer activity);GO:0022900(electron transport chain);GO:0050660(flavin adenine dinucleotide binding)","NA","NA","NA",null,{"v":11.508644,"d":"11.51"},{"v":12.025116,"d":"12.03"},{"v":2.896258,"d":"2.90"},{"v":5.598493,"d":"5.60"},{"v":4.950528,"d":"4.95"},{"v":5.083898,"d":"5.08"},{"v":1.69066429628401,"d":"1.69"},{"v":0.757590222038285,"d":"0.76"},{"v":0.0785554579683388,"d":"0.08"},{"v":0.495811725132302,"d":"0.50"},"up","no"]
["MSTRG.17557","ENSOARG00000010535;ENSOARG00000010646","ENSOART00000011467;ENSOART00000011581","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0005576(extracellular region);GO:0008083(growth factor activity);GO:0010469(regulation of signaling receptor activity)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","K04710","EC:2.3.1.24","ceramide synthase 1 [Source:NCBI gene;Acc:101107095]",{"v":1.00341023781321,"d":"1.00"},{"v":1.12538202095672,"d":"1.13"},{"v":1.02005003371298,"d":"1.02"},{"v":1.96358268519362,"d":"1.96"},{"v":1.65463067699317,"d":"1.65"},{"v":1.691451138041,"d":"1.69"},{"v":0.593039784782602,"d":"0.59"},{"v":-0.753799201948737,"d":"-0.75"},{"v":0.0785902346329527,"d":"0.08"},{"v":0.495835143387501,"d":"0.50"},"down","no"]
["MSTRG.2290","SACS","ENSOART00000014600","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0030544(Hsp70 protein binding);GO:0051087(chaperone binding);GO:0070628(proteasome binding);GO:0090084(negative regulation of inclusion body assembly)","NA","K17592","NA","sacsin molecular chaperone [Source:NCBI gene;Acc:101116919]",{"v":3.43465834052058,"d":"3.43"},{"v":5.063324,"d":"5.06"},{"v":9.221316,"d":"9.22"},{"v":4.08031600099686,"d":"4.08"},{"v":4.56195120446742,"d":"4.56"},{"v":3.17529714476648,"d":"3.18"},{"v":1.49940358396902,"d":"1.50"},{"v":0.58438875568322,"d":"0.58"},{"v":0.0786412441983177,"d":"0.08"},{"v":0.495874825576243,"d":"0.50"},"up","no"]
["ENSOARG00000008348","ZNF484","ENSOART00000009080","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 484 [Source:NCBI gene;Acc:101110387]",{"v":0.255828,"d":"0.26"},{"v":0.217363,"d":"0.22"},{"v":0.244795,"d":"0.24"},{"v":0.520611,"d":"0.52"},{"v":0.46018,"d":"0.46"},{"v":0.369128,"d":"0.37"},{"v":0.531873393885115,"d":"0.53"},{"v":-0.910845224633963,"d":"-0.91"},{"v":0.0787101083349442,"d":"0.08"},{"v":0.495874825576243,"d":"0.50"},"down","no"]
["MSTRG.12359","SGMS1","ENSOART00000015200","GO:0000138(Golgi trans cisterna);GO:0002950(ceramide phosphoethanolamine synthase activity);GO:0005515(protein binding);GO:0006686(sphingomyelin biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030173(integral component of Golgi membrane);GO:0033188(sphingomyelin synthase activity);GO:0046513(ceramide biosynthetic process);GO:0047493(ceramide cholinephosphotransferase activity)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","K04714","EC:2.7.8.27","sphingomyelin synthase 1 [Source:NCBI gene;Acc:101118575]",{"v":2.04484525597128,"d":"2.04"},{"v":2.64043840294785,"d":"2.64"},{"v":2.8151092260393,"d":"2.82"},{"v":2.03957030910809,"d":"2.04"},{"v":2.02590996934996,"d":"2.03"},{"v":1.221210531935,"d":"1.22"},{"v":1.4187311408894,"d":"1.42"},{"v":0.504601214869683,"d":"0.50"},{"v":0.0787180026882424,"d":"0.08"},{"v":0.495874825576243,"d":"0.50"},"up","no"]
["MSTRG.4319","NEK7","ENSOART00000016842","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0051973(positive regulation of telomerase activity);GO:1904355(positive regulation of telomere capping)","04621(NOD-like receptor signaling pathway)","K20876","EC:2.7.11.1","NIMA related kinase 7 [Source:NCBI gene;Acc:101102161]",{"v":23.2057835438644,"d":"23.21"},{"v":24.8032525146215,"d":"24.80"},{"v":17.914212602897,"d":"17.91"},{"v":20.16899134176,"d":"20.17"},{"v":12.9741991440284,"d":"12.97"},{"v":14.3716901100027,"d":"14.37"},{"v":1.38742322057361,"d":"1.39"},{"v":0.47240793552573,"d":"0.47"},{"v":0.078889583413926,"d":"0.08"},{"v":0.496572520425051,"d":"0.50"},"up","no"]
["MSTRG.19885","DMXL2","ENSOART00000022847","GO:0005515(protein binding);GO:0008021(synaptic vesicle);GO:0017137(Rab GTPase binding)","NA","NA","NA","Dmx like 2 [Source:NCBI gene;Acc:101105079]",{"v":0.290163,"d":"0.29"},{"v":0.139187,"d":"0.14"},{"v":0.179508,"d":"0.18"},{"v":0.459152,"d":"0.46"},{"v":0.320033,"d":"0.32"},{"v":0.289526,"d":"0.29"},{"v":0.569712485414672,"d":"0.57"},{"v":-0.811694071251283,"d":"-0.81"},{"v":0.0789689304564037,"d":"0.08"},{"v":0.496880422540332,"d":"0.50"},"down","no"]
["ENSOARG00000016290","APOBEC3F","ENSOART00000017747","GO:0003824(catalytic activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity)","05170(Human immunodeficiency virus 1 infection)","K18750","EC:3.5.4.-","apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F [Source:NCBI gene;Acc:100037691]",{"v":0.501902,"d":"0.50"},{"v":0.121202,"d":"0.12"},{"v":0.19044,"d":"0.19"},{"v":0.614396,"d":"0.61"},{"v":0.468363,"d":"0.47"},{"v":0.519899,"d":"0.52"},{"v":0.507621713428567,"d":"0.51"},{"v":-0.978174313364518,"d":"-0.98"},{"v":0.0792190356905326,"d":"0.08"},{"v":0.497304273262213,"d":"0.50"},"down","no"]
["MSTRG.14616","SSNA1","ENSOART00000002688","GO:0005813(centrosome);GO:0036064(ciliary basal body);GO:0042073(intraciliary transport);GO:0042802(identical protein binding);GO:0060830(ciliary receptor clustering involved in smoothened signaling pathway)","NA","NA","NA","SS nuclear autoantigen 1 [Source:HGNC Symbol;Acc:HGNC:11321]",{"v":5.965678,"d":"5.97"},{"v":5.99532,"d":"6.00"},{"v":5.750263,"d":"5.75"},{"v":8.679035,"d":"8.68"},{"v":10.976823,"d":"10.98"},{"v":10.374873,"d":"10.37"},{"v":0.589771224683142,"d":"0.59"},{"v":-0.761772660788259,"d":"-0.76"},{"v":0.0792683151346212,"d":"0.08"},{"v":0.497422386440467,"d":"0.50"},"down","no"]
["MSTRG.7584","PITPNM2","ENSOART00000006847","GO:0005509(calcium ion binding);GO:0005548(phospholipid transporter activity);GO:0005622(intracellular);GO:0008526(phosphatidylinositol transporter activity);GO:0015914(phospholipid transport);GO:0030971(receptor tyrosine kinase binding);GO:0046872(metal ion binding);GO:0048015(phosphatidylinositol-mediated signaling)","NA","NA","NA","phosphatidylinositol transfer protein membrane associated 2 [Source:NCBI gene;Acc:101118730]",{"v":2.14906521609722,"d":"2.15"},{"v":1.58761698045086,"d":"1.59"},{"v":1.43388996953153,"d":"1.43"},{"v":2.90282510567101,"d":"2.90"},{"v":2.66261349418809,"d":"2.66"},{"v":2.52163200827756,"d":"2.52"},{"v":0.639362807204544,"d":"0.64"},{"v":-0.645293272292568,"d":"-0.65"},{"v":0.079463598365092,"d":"0.08"},{"v":0.497875342041448,"d":"0.50"},"down","no"]
["MSTRG.9740","RUSC2","ENSOART00000013055","GO:0005515(protein binding);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle)","NA","K23291","NA","RUN and SH3 domain containing 2 [Source:NCBI gene;Acc:101117219]",{"v":4.0410470528806,"d":"4.04"},{"v":4.75837195032007,"d":"4.76"},{"v":4.79903526356805,"d":"4.80"},{"v":2.64955216045088,"d":"2.65"},{"v":3.68024958989702,"d":"3.68"},{"v":3.25183008864459,"d":"3.25"},{"v":1.41922111966667,"d":"1.42"},{"v":0.505099383897371,"d":"0.51"},{"v":0.0794709657968242,"d":"0.08"},{"v":0.497875342041448,"d":"0.50"},"up","no"]
["MSTRG.4426","BTBD3","ENSOART00000011736","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0021987(cerebral cortex development);GO:0048813(dendrite morphogenesis)","NA","K10478","NA","BTB domain containing 3 [Source:NCBI gene;Acc:101109555]",{"v":2.07248,"d":"2.07"},{"v":1.038754,"d":"1.04"},{"v":1.357069,"d":"1.36"},{"v":2.808193,"d":"2.81"},{"v":2.734872,"d":"2.73"},{"v":2.093034,"d":"2.09"},{"v":0.58515519508063,"d":"0.59"},{"v":-0.773108787320794,"d":"-0.77"},{"v":0.0795065625574996,"d":"0.08"},{"v":0.497875342041448,"d":"0.50"},"down","no"]
["MSTRG.20614","ENSOARG00000014798","ENSOART00000016115;ENSOART00000016114","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005525(GTP binding)","03015(mRNA surveillance pathway);05134(Legionellosis);05134(Legionellosis)","K14416","NA","HBS1 like translational GTPase [Source:NCBI gene;Acc:101109622]",{"v":5.1910490223346,"d":"5.19"},{"v":5.69618084365782,"d":"5.70"},{"v":4.62548848061525,"d":"4.63"},{"v":4.14823199304678,"d":"4.15"},{"v":3.77234250084282,"d":"3.77"},{"v":3.32572217572693,"d":"3.33"},{"v":1.37936236276938,"d":"1.38"},{"v":0.464001507103195,"d":"0.46"},{"v":0.0795539421476076,"d":"0.08"},{"v":0.497875342041448,"d":"0.50"},"up","no"]
["MSTRG.1593","SKIL","ENSOART00000000278","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032991(protein-containing complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0070306(lens fiber cell differentiation);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04550(Signaling pathways regulating pluripotency of stem cells)","K18499","NA","SKI like proto-oncogene [Source:NCBI gene;Acc:101117895]",{"v":4.72343326907674,"d":"4.72"},{"v":3.4229353392142,"d":"3.42"},{"v":3.42461160634268,"d":"3.42"},{"v":3.0030682192878,"d":"3.00"},{"v":2.59950922383375,"d":"2.60"},{"v":2.68548704903128,"d":"2.69"},{"v":1.39610161402449,"d":"1.40"},{"v":0.481403950655072,"d":"0.48"},{"v":0.0796344699027605,"d":"0.08"},{"v":0.498096318146227,"d":"0.50"},"up","no"]
["MSTRG.6706","COMMD9","ENSOART00000020723","GO:0005634(nucleus);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0042632(cholesterol homeostasis)","NA","K22565","NA","COMM domain containing 9 [Source:NCBI gene;Acc:101106458]",{"v":2.60762859228296,"d":"2.61"},{"v":2.43924974019293,"d":"2.44"},{"v":2.48853102829582,"d":"2.49"},{"v":3.92245486881029,"d":"3.92"},{"v":3.96158930160772,"d":"3.96"},{"v":4.27373260771704,"d":"4.27"},{"v":0.619801588586792,"d":"0.62"},{"v":-0.690121642248891,"d":"-0.69"},{"v":0.0796502625355095,"d":"0.08"},{"v":0.498096318146227,"d":"0.50"},"down","no"]
["MSTRG.12272","ENSOARG00000015719","ENSOART00000017110","GO:0003677(DNA binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0006351(transcription, DNA-templated)","NA","NA","NA",null,{"v":15.290349,"d":"15.29"},{"v":18.190603,"d":"18.19"},{"v":16.424583,"d":"16.42"},{"v":25.251379,"d":"25.25"},{"v":30.897045,"d":"30.90"},{"v":29.288069,"d":"29.29"},{"v":0.584124338998793,"d":"0.58"},{"v":-0.775652595365151,"d":"-0.78"},{"v":0.0797865457074435,"d":"0.08"},{"v":0.498566673674373,"d":"0.50"},"down","no"]
["MSTRG.3465","SLC16A3","ENSOART00000018418","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015129(lactate transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane);GO:0035873(lactate transmembrane transport);GO:0055085(transmembrane transport)","05230(Central carbon metabolism in cancer)","K08180","NA","solute carrier family 16 member 3 [Source:NCBI gene;Acc:101111643]",{"v":14.8088622286459,"d":"14.81"},{"v":8.13865825472723,"d":"8.14"},{"v":6.59569414214301,"d":"6.60"},{"v":20.526580811128,"d":"20.53"},{"v":12.650061297544,"d":"12.65"},{"v":15.8234033292762,"d":"15.82"},{"v":0.602922188366714,"d":"0.60"},{"v":-0.729956271370712,"d":"-0.73"},{"v":0.0799021559774355,"d":"0.08"},{"v":0.498967391353445,"d":"0.50"},"down","no"]
["MSTRG.6116","ENSOARG00000003749","ENSOART00000004072","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 154-like [Source:NCBI gene;Acc:101110699]",{"v":0.782284,"d":"0.78"},{"v":0.77681,"d":"0.78"},{"v":0.830002,"d":"0.83"},{"v":1.791805,"d":"1.79"},{"v":1.226294,"d":"1.23"},{"v":1.205248,"d":"1.21"},{"v":0.565687830055167,"d":"0.57"},{"v":-0.821921961041823,"d":"-0.82"},{"v":0.079923470303205,"d":"0.08"},{"v":0.498967391353445,"d":"0.50"},"down","no"]
["MSTRG.3230","TOP2A","ENSOART00000015607","GO:0000166(nucleotide binding);GO:0000228(nuclear chromosome);GO:0000287(magnesium ion binding);GO:0000793(condensed chromosome);GO:0002244(hematopoietic progenitor cell differentiation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003916(DNA topoisomerase activity);GO:0003918(DNA topoisomerase type II (ATP-hydrolyzing) activity);GO:0005080(protein kinase C binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005814(centriole);GO:0006259(DNA metabolic process);GO:0006265(DNA topological change);GO:0006266(DNA ligation);GO:0006974(cellular response to DNA damage stimulus);GO:0007059(chromosome segregation);GO:0007143(female meiotic nuclear division);GO:0008022(protein C-terminus binding);GO:0008094(DNA-dependent ATPase activity);GO:0008144(drug binding);GO:0008301(DNA binding, bending);GO:0009330(DNA topoisomerase complex (ATP-hydrolyzing));GO:0016853(isomerase activity);GO:0019035(viral integration complex);GO:0019899(enzyme binding);GO:0030261(chromosome condensation);GO:0030263(apoptotic chromosome condensation);GO:0032991(protein-containing complex);GO:0040016(embryonic cleavage);GO:0042752(regulation of circadian rhythm);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0043065(positive regulation of apoptotic process);GO:0043130(ubiquitin binding);GO:0045870(positive regulation of single stranded viral RNA replication via double stranded DNA intermediate);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0061505(DNA topoisomerase II activity);GO:1905463(negative regulation of DNA duplex unwinding);GO:1990904(ribonucleoprotein complex)","01524(Platinum drug resistance)","K03164","EC:5.6.2.2","DNA topoisomerase II alpha [Source:NCBI gene;Acc:101108762]",{"v":0.367292,"d":"0.37"},{"v":0.178961,"d":"0.18"},{"v":0.425221,"d":"0.43"},{"v":0.953336,"d":"0.95"},{"v":0.296122,"d":"0.30"},{"v":0.61645,"d":"0.62"},{"v":0.520644104639671,"d":"0.52"},{"v":-0.941630564839969,"d":"-0.94"},{"v":0.0799871045509103,"d":"0.08"},{"v":0.499055958390242,"d":"0.50"},"down","no"]
["MSTRG.13653","TMEM120A","ENSOART00000014751","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045444(fat cell differentiation);GO:0051260(protein homooligomerization);GO:0051291(protein heterooligomerization)","NA","NA","NA","transmembrane protein 120A [Source:NCBI gene;Acc:101118071]",{"v":1.88273934326172,"d":"1.88"},{"v":1.92109519238281,"d":"1.92"},{"v":1.44237702392578,"d":"1.44"},{"v":3.72543659521484,"d":"3.73"},{"v":2.28882099316406,"d":"2.29"},{"v":2.71647695898438,"d":"2.72"},{"v":0.600890054680988,"d":"0.60"},{"v":-0.734827050834117,"d":"-0.73"},{"v":0.0802588808345614,"d":"0.08"},{"v":0.499796722451075,"d":"0.50"},"down","no"]
["ENSOARG00000015147","ENSOARG00000015147","ENSOART00000016485","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0030272(5-formyltetrahydrofolate cyclo-ligase activity);GO:0046872(metal ion binding)","00670(One carbon pool by folate)","K01934","EC:6.3.3.2","5-formyltetrahydrofolate cyclo-ligase [Source:NCBI gene;Acc:101114310]",{"v":0.536384,"d":"0.54"},{"v":0.465188,"d":"0.47"},{"v":0.589594,"d":"0.59"},{"v":0.772138,"d":"0.77"},{"v":1.039675,"d":"1.04"},{"v":0.86061,"d":"0.86"},{"v":0.595402000356979,"d":"0.60"},{"v":-0.748064026317382,"d":"-0.75"},{"v":0.080394590531988,"d":"0.08"},{"v":0.500222256948726,"d":"0.50"},"down","no"]
["MSTRG.17304","ZC3HAV1L","ENSOART00000011787","GO:0005829(cytosol);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger CCCH-type containing, antiviral 1 like [Source:NCBI gene;Acc:101109793]",{"v":1.32213698553305,"d":"1.32"},{"v":0.712645643890496,"d":"0.71"},{"v":1.27162042421545,"d":"1.27"},{"v":2.28286318450924,"d":"2.28"},{"v":1.66539325973737,"d":"1.67"},{"v":1.54143394279991,"d":"1.54"},{"v":0.602293175119819,"d":"0.60"},{"v":-0.731462183760874,"d":"-0.73"},{"v":0.0805912046213373,"d":"0.08"},{"v":0.500910996976474,"d":"0.50"},"down","no"]
["MSTRG.9344","EIPR1","ENSOART00000005820","GO:0005515(protein binding)","NA","NA","NA","EARP complex and GARP complex interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:12383]",{"v":1.62390305509965,"d":"1.62"},{"v":1.31566252520516,"d":"1.32"},{"v":1.13797966471278,"d":"1.14"},{"v":1.91078436459555,"d":"1.91"},{"v":2.47067346424385,"d":"2.47"},{"v":2.26410270339977,"d":"2.26"},{"v":0.613574314045665,"d":"0.61"},{"v":-0.704690006072893,"d":"-0.70"},{"v":0.0809089095166033,"d":"0.08"},{"v":0.502144418947261,"d":"0.50"},"down","no"]
["MSTRG.17547","SLC25A42","ENSOART00000010427","GO:0005347(ATP transmembrane transporter activity);GO:0005739(mitochondrion);GO:0015217(ADP transmembrane transporter activity);GO:0015228(coenzyme A transmembrane transporter activity);GO:0015866(ADP transport);GO:0015867(ATP transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0035349(coenzyme A transmembrane transport);GO:0043262(adenosine-diphosphatase activity);GO:0055085(transmembrane transport);GO:0080121(AMP transport);GO:0080122(AMP transmembrane transporter activity)","NA","K15085","NA","solute carrier family 25 member 42 [Source:NCBI gene;Acc:101106587]",{"v":1.63345881944998,"d":"1.63"},{"v":1.25892495575927,"d":"1.26"},{"v":1.26805018573137,"d":"1.27"},{"v":2.07333519808689,"d":"2.07"},{"v":2.47250797768035,"d":"2.47"},{"v":2.18690956237545,"d":"2.19"},{"v":0.617939514898675,"d":"0.62"},{"v":-0.694462463596311,"d":"-0.69"},{"v":0.0809434168709696,"d":"0.08"},{"v":0.502144418947261,"d":"0.50"},"down","no"]
["MSTRG.18444","ADAM19","ENSOART00000013452","GO:0001890(placenta development);GO:0004222(metalloendopeptidase activity);GO:0005634(nucleus);GO:0005794(Golgi apparatus);GO:0006508(proteolysis);GO:0006509(membrane protein ectodomain proteolysis);GO:0008237(metallopeptidase activity);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017124(SH3 domain binding);GO:2000049(positive regulation of cell-cell adhesion mediated by cadherin)","NA","K08608","EC:3.4.24.-","ADAM metallopeptidase domain 19 [Source:NCBI gene;Acc:101113590]",{"v":3.92038496064625,"d":"3.92"},{"v":2.64768223623165,"d":"2.65"},{"v":3.68036824725725,"d":"3.68"},{"v":7.18458726663392,"d":"7.18"},{"v":4.49901539184542,"d":"4.50"},{"v":4.71455197658425,"d":"4.71"},{"v":0.624974923838155,"d":"0.62"},{"v":-0.67812978988081,"d":"-0.68"},{"v":0.0810062884818411,"d":"0.08"},{"v":0.502343592226168,"d":"0.50"},"down","no"]
["MSTRG.8446","PAPOLA","ENSOART00000018065;ENSOART00000018068","GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0004652(polynucleotide adenylyltransferase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006378(mRNA polyadenylation);GO:0016779(nucleotidyltransferase activity);GO:0031123(RNA 3'-end processing);GO:0031440(regulation of mRNA 3'-end processing);GO:0043631(RNA polyadenylation);GO:0046872(metal ion binding);GO:0046872(metal ion binding)","03015(mRNA surveillance pathway);03015(mRNA surveillance pathway)","K14376","EC:2.7.7.19","poly(A) polymerase alpha [Source:NCBI gene;Acc:101122058]",{"v":5.27518399977268,"d":"5.28"},{"v":5.22653428827044,"d":"5.23"},{"v":5.33405265350393,"d":"5.33"},{"v":4.40533974904202,"d":"4.41"},{"v":4.21095271624342,"d":"4.21"},{"v":2.98460172098461,"d":"2.98"},{"v":1.36504744266085,"d":"1.37"},{"v":0.44895109334447,"d":"0.45"},{"v":0.0811911883100292,"d":"0.08"},{"v":0.503004837142233,"d":"0.50"},"up","no"]
["ENSOARG00000018098","ENSOARG00000018098","ENSOART00000019699","GO:0005515(protein binding)","NA","K22449","NA","tubulin folding cofactor E like [Source:NCBI gene;Acc:101110865]",{"v":1.221113,"d":"1.22"},{"v":0.537459,"d":"0.54"},{"v":0.471315,"d":"0.47"},{"v":1.385761,"d":"1.39"},{"v":1.594337,"d":"1.59"},{"v":1.215777,"d":"1.22"},{"v":0.531447433491226,"d":"0.53"},{"v":-0.91200109587231,"d":"-0.91"},{"v":0.0812948896975997,"d":"0.08"},{"v":0.503368585127951,"d":"0.50"},"down","no"]
["ENSOARG00000013931","ENSOARG00000013931","ENSOART00000015173","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0043547(positive regulation of GTPase activity)","NA","K20652","NA","SH3 domain binding protein 1 [Source:NCBI gene;Acc:101123285]",{"v":0.682737,"d":"0.68"},{"v":0.298652,"d":"0.30"},{"v":0.350469,"d":"0.35"},{"v":0.589223,"d":"0.59"},{"v":1.068516,"d":"1.07"},{"v":0.851973,"d":"0.85"},{"v":0.530681608088896,"d":"0.53"},{"v":-0.914081544967177,"d":"-0.91"},{"v":0.0813793307355823,"d":"0.08"},{"v":0.503509553713751,"d":"0.50"},"down","no"]
["MSTRG.4764","CENPB","ENSOART00000005142","GO:0000775(chromosome, centromeric region);GO:0000780(condensed nuclear chromosome, centromeric region);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003696(satellite DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0016604(nuclear body);GO:0031618(nuclear pericentric heterochromatin)","NA","NA","NA","centromere protein B [Source:HGNC Symbol;Acc:HGNC:1852]",{"v":8.679563,"d":"8.68"},{"v":5.998714,"d":"6.00"},{"v":6.384778,"d":"6.38"},{"v":9.196033,"d":"9.20"},{"v":11.277136,"d":"11.28"},{"v":12.891084,"d":"12.89"},{"v":0.631306056814759,"d":"0.63"},{"v":-0.663588502356556,"d":"-0.66"},{"v":0.0814638310639365,"d":"0.08"},{"v":0.503534802765454,"d":"0.50"},"down","no"]
["MSTRG.16326","MANSC1","ENSOART00000022732","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","MANSC domain containing 1 [Source:NCBI gene;Acc:101112719]",{"v":2.91274579632249,"d":"2.91"},{"v":1.12543157072136,"d":"1.13"},{"v":1.93072039816124,"d":"1.93"},{"v":4.01848018387553,"d":"4.02"},{"v":2.92266336562942,"d":"2.92"},{"v":3.34146807850071,"d":"3.34"},{"v":0.580484606551534,"d":"0.58"},{"v":-0.78467028506822,"d":"-0.78"},{"v":0.081500843420438,"d":"0.08"},{"v":0.503534802765454,"d":"0.50"},"down","no"]
["ENSOARG00000007472","CASP3","ENSOART00000008135","GO:0001782(B cell homeostasis);GO:0004190(aspartic-type endopeptidase activity);GO:0004197(cysteine-type endopeptidase activity);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0007507(heart development);GO:0007605(sensory perception of sound);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0008627(intrinsic apoptotic signaling pathway in response to osmotic stress);GO:0009411(response to UV);GO:0009611(response to wounding);GO:0010033(response to organic substance);GO:0016485(protein processing);GO:0016787(hydrolase activity);GO:0030216(keratinocyte differentiation);GO:0030218(erythrocyte differentiation);GO:0030889(negative regulation of B cell proliferation);GO:0031647(regulation of protein stability);GO:0034349(glial cell apoptotic process);GO:0043029(T cell homeostasis);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0045165(cell fate commitment);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045786(negative regulation of cell cycle);GO:0046007(negative regulation of activated T cell proliferation);GO:0048011(neurotrophin TRK receptor signaling pathway);GO:0051402(neuron apoptotic process);GO:0071310(cellular response to organic substance);GO:0072734(cellular response to staurosporine);GO:0097153(cysteine-type endopeptidase activity involved in apoptotic process);GO:0097194(execution phase of apoptosis);GO:0097199(cysteine-type endopeptidase activity involved in apoptotic signaling pathway);GO:0097200(cysteine-type endopeptidase activity involved in execution phase of apoptosis);GO:1902004(positive regulation of amyloid-beta formation)","01524(Platinum drug resistance);04010(MAPK signaling pathway);04115(p53 signaling pathway);04210(Apoptosis);04215(Apoptosis - multiple species);04650(Natural killer cell mediated cytotoxicity);04657(IL-17 signaling pathway);04668(TNF signaling pathway);04726(Serotonergic synapse);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05010(Alzheimer disease);05012(Parkinson disease);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05133(Pertussis);05134(Legionellosis);05145(Toxoplasmosis);05146(Amoebiasis);05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05222(Small cell lung cancer);05416(Viral myocarditis)","K02187","EC:3.4.22.56","caspase 3 [Source:NCBI gene;Acc:443031]",{"v":1.410077,"d":"1.41"},{"v":0.514004,"d":"0.51"},{"v":0.965416,"d":"0.97"},{"v":1.759781,"d":"1.76"},{"v":1.934071,"d":"1.93"},{"v":1.333107,"d":"1.33"},{"v":0.574800192323033,"d":"0.57"},{"v":-0.798867550379101,"d":"-0.80"},{"v":0.0817641383383042,"d":"0.08"},{"v":0.504175451330101,"d":"0.50"},"down","no"]
["MSTRG.12148","CTSF","ENSOART00000007841","GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity)","04142(Lysosome);04210(Apoptosis)","K01373","EC:3.4.22.41","cathepsin F [Source:NCBI gene;Acc:780471]",{"v":10.3350448150384,"d":"10.34"},{"v":8.71765638748628,"d":"8.72"},{"v":8.5889951284303,"d":"8.59"},{"v":11.2476842431394,"d":"11.25"},{"v":14.9428984478595,"d":"14.94"},{"v":17.4330807387486,"d":"17.43"},{"v":0.633639959547867,"d":"0.63"},{"v":-0.658264775215234,"d":"-0.66"},{"v":0.0817782765922568,"d":"0.08"},{"v":0.504175451330101,"d":"0.50"},"down","no"]
["MSTRG.17884","ENSOARG00000008180","ENSOART00000008908","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0008201(heparin binding);GO:0010977(negative regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0021510(spinal cord development);GO:0021549(cerebellum development);GO:0021766(hippocampus development);GO:0021987(cerebral cortex development);GO:0022038(corpus callosum development);GO:0030517(negative regulation of axon extension);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0035374(chondroitin sulfate binding);GO:0048671(negative regulation of collateral sprouting);GO:0048681(negative regulation of axon regeneration);GO:0050804(modulation of chemical synaptic transmission);GO:0050808(synapse organization);GO:0061000(negative regulation of dendritic spine development);GO:0090557(establishment of endothelial intestinal barrier);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0099151(regulation of postsynaptic density assembly)","NA","NA","NA",null,{"v":3.49770031613924,"d":"3.50"},{"v":2.9057583778481,"d":"2.91"},{"v":2.74830421376582,"d":"2.75"},{"v":4.51204033037975,"d":"4.51"},{"v":4.93936708876582,"d":"4.94"},{"v":4.78095574477848,"d":"4.78"},{"v":0.643024830265074,"d":"0.64"},{"v":-0.637053646900798,"d":"-0.64"},{"v":0.0818439681029505,"d":"0.08"},{"v":0.504175451330101,"d":"0.50"},"down","no"]
["MSTRG.864","ADAR","ENSOART00000003197","GO:0001649(osteoblast differentiation);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002566(somatic diversification of immune receptors via somatic mutation);GO:0003723(RNA binding);GO:0003726(double-stranded RNA adenosine deaminase activity);GO:0004000(adenosine deaminase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006382(adenosine to inosine editing);GO:0006396(RNA processing);GO:0009615(response to virus);GO:0016553(base conversion or substitution editing);GO:0030218(erythrocyte differentiation);GO:0031054(pre-miRNA processing);GO:0035196(production of miRNAs involved in gene silencing by miRNA);GO:0035280(miRNA loading onto RISC involved in gene silencing by miRNA);GO:0035455(response to interferon-alpha);GO:0043066(negative regulation of apoptotic process);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0044530(supraspliceosomal complex);GO:0045070(positive regulation of viral genome replication);GO:0060216(definitive hemopoiesis);GO:0060339(negative regulation of type I interferon-mediated signaling pathway);GO:0061484(hematopoietic stem cell homeostasis);GO:0098586(cellular response to virus);GO:1900369(negative regulation of RNA interference)","04623(Cytosolic DNA-sensing pathway);05162(Measles);05164(Influenza A)","K12968","EC:3.5.4.37","adenosine deaminase, RNA specific [Source:NCBI gene;Acc:101104366]",{"v":3.32265695866388,"d":"3.32"},{"v":2.82489428740431,"d":"2.82"},{"v":2.84023991203897,"d":"2.84"},{"v":5.13091184050104,"d":"5.13"},{"v":4.14689031649269,"d":"4.15"},{"v":4.66516947807933,"d":"4.67"},{"v":0.644610875883781,"d":"0.64"},{"v":-0.633499565113501,"d":"-0.63"},{"v":0.0818514825492736,"d":"0.08"},{"v":0.504175451330101,"d":"0.50"},"down","no"]
["MSTRG.18402","GM2A","ENSOART00000009180","GO:0004563(beta-N-acetylhexosaminidase activity);GO:0006689(ganglioside catabolic process);GO:0007611(learning or memory);GO:0008047(enzyme activator activity);GO:0009313(oligosaccharide catabolic process);GO:0019915(lipid storage);GO:0043085(positive regulation of catalytic activity);GO:0050877(nervous system process);GO:0050885(neuromuscular process controlling balance)","04142(Lysosome)","K12383","NA","GM2 ganglioside activator [Source:NCBI gene;Acc:101105496]",{"v":4.44130933138686,"d":"4.44"},{"v":2.37025622627737,"d":"2.37"},{"v":3.25532253284672,"d":"3.26"},{"v":5.23297215912409,"d":"5.23"},{"v":4.87599912846715,"d":"4.88"},{"v":5.96692323065693,"d":"5.97"},{"v":0.626210135870434,"d":"0.63"},{"v":-0.675281234683431,"d":"-0.68"},{"v":0.0818822562590453,"d":"0.08"},{"v":0.504175451330101,"d":"0.50"},"down","no"]
["MSTRG.17100","ENSOARG00000009789","ENSOART00000010647","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0043565(sequence-specific DNA binding)","NA","K09304","NA","homeobox A4 [Source:NCBI gene;Acc:101114773]",{"v":2.302744,"d":"2.30"},{"v":2.247672,"d":"2.25"},{"v":2.573371,"d":"2.57"},{"v":3.397178,"d":"3.40"},{"v":4.40203,"d":"4.40"},{"v":4.607252,"d":"4.61"},{"v":0.574199812033408,"d":"0.57"},{"v":-0.800375236614148,"d":"-0.80"},{"v":0.0819192474509283,"d":"0.08"},{"v":0.504175451330101,"d":"0.50"},"down","no"]
["MSTRG.10732","OBSL1","ENSOART00000022037","GO:0000226(microtubule cytoskeleton organization);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0007030(Golgi organization);GO:0007088(regulation of mitotic nuclear division);GO:0034067(protein localization to Golgi apparatus);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1990393(3M complex)","NA","NA","NA","obscurin like 1 [Source:HGNC Symbol;Acc:HGNC:29092]",{"v":6.21121348699486,"d":"6.21"},{"v":7.38888816590742,"d":"7.39"},{"v":6.15071507376929,"d":"6.15"},{"v":9.58686404526084,"d":"9.59"},{"v":11.9363823213813,"d":"11.94"},{"v":9.76706736326231,"d":"9.77"},{"v":0.631211847128127,"d":"0.63"},{"v":-0.663803811537576,"d":"-0.66"},{"v":0.0820490844174865,"d":"0.08"},{"v":0.504531183422325,"d":"0.50"},"down","no"]
["MSTRG.2370","FBXL3","ENSOART00000017485","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0019005(SCF ubiquitin ligase complex);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0031648(protein destabilization);GO:0042752(regulation of circadian rhythm);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process)","04710(Circadian rhythm)","K10269","NA","F-box and leucine rich repeat protein 3 [Source:NCBI gene;Acc:100169937]",{"v":6.09267628069282,"d":"6.09"},{"v":3.74958818322296,"d":"3.75"},{"v":3.57751000475463,"d":"3.58"},{"v":2.83200183766344,"d":"2.83"},{"v":3.12288691119035,"d":"3.12"},{"v":3.35277627576838,"d":"3.35"},{"v":1.44179817743443,"d":"1.44"},{"v":0.527869230603435,"d":"0.53"},{"v":0.0821066322412456,"d":"0.08"},{"v":0.504531183422325,"d":"0.50"},"up","no"]
["ENSOARG00000006930","PLEKHH2","ENSOART00000007539","GO:0003779(actin binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0016604(nuclear body);GO:0030027(lamellipodium);GO:0030835(negative regulation of actin filament depolymerization);GO:0030864(cortical actin cytoskeleton);GO:0042802(identical protein binding)","NA","NA","NA","pleckstrin homology, MyTH4 and FERM domain containing H2 [Source:NCBI gene;Acc:101114431]",{"v":0.487197,"d":"0.49"},{"v":0.296408,"d":"0.30"},{"v":0.302049,"d":"0.30"},{"v":0.564093,"d":"0.56"},{"v":0.697767,"d":"0.70"},{"v":0.550469,"d":"0.55"},{"v":0.599038033381356,"d":"0.60"},{"v":-0.73928049115753,"d":"-0.74"},{"v":0.0821624459039663,"d":"0.08"},{"v":0.504531183422325,"d":"0.50"},"down","no"]
["MSTRG.5004","SOGA1","ENSOART00000017739","GO:0005615(extracellular space);GO:0010506(regulation of autophagy)","NA","NA","NA","suppressor of glucose, autophagy associated 1 [Source:NCBI gene;Acc:101121620]",{"v":1.277997,"d":"1.28"},{"v":0.966859,"d":"0.97"},{"v":1.256194,"d":"1.26"},{"v":2.033387,"d":"2.03"},{"v":1.895942,"d":"1.90"},{"v":1.693314,"d":"1.69"},{"v":0.622669801372771,"d":"0.62"},{"v":-0.68346078269676,"d":"-0.68"},{"v":0.0825223902442662,"d":"0.08"},{"v":0.506360611765644,"d":"0.51"},"down","no"]
["MSTRG.2249","MTUS2","ENSOART00000013106;ENSOART00000013108","NA","NA","NA","NA","microtubule associated scaffold protein 2 [Source:HGNC Symbol;Acc:HGNC:20595]",{"v":1.05500330170064,"d":"1.06"},{"v":0.156292957419187,"d":"0.16"},{"v":0.309418626119694,"d":"0.31"},{"v":0.854766123068934,"d":"0.85"},{"v":1.53374241373491,"d":"1.53"},{"v":0.719140854212645,"d":"0.72"},{"v":0.489345705997454,"d":"0.49"},{"v":-1.03107405483804,"d":"-1.03"},{"v":0.0825741169258246,"d":"0.08"},{"v":0.506487671361707,"d":"0.51"},"down","no"]
["MSTRG.3385","ENSOARG00000012392","ENSOART00000013476","GO:0005518(collagen binding);GO:0030246(carbohydrate binding);GO:0030574(collagen catabolic process)","04145(Phagosome);05152(Tuberculosis)","K06560","NA","mannose receptor C type 2 [Source:NCBI gene;Acc:101122041]",{"v":4.71144675384944,"d":"4.71"},{"v":3.23742427994012,"d":"3.24"},{"v":5.93977342942686,"d":"5.94"},{"v":6.59365475748503,"d":"6.59"},{"v":7.42043671000856,"d":"7.42"},{"v":8.15636728250642,"d":"8.16"},{"v":0.626448221925783,"d":"0.63"},{"v":-0.674732824059968,"d":"-0.67"},{"v":0.0826347330723772,"d":"0.08"},{"v":0.506669140670588,"d":"0.51"},"down","no"]
["MSTRG.5880","SPHK2","ENSOART00000013011","GO:0001568(blood vessel development);GO:0003376(sphingosine-1-phosphate receptor signaling pathway);GO:0003951(NAD+ kinase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006670(sphingosine metabolic process);GO:0007420(brain development);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0017050(D-erythro-sphingosine kinase activity);GO:0038036(sphingosine-1-phosphate receptor activity);GO:0043231(intracellular membrane-bounded organelle);GO:0046512(sphingosine biosynthetic process)","00600(Sphingolipid metabolism);04020(Calcium signaling pathway);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04666(Fc gamma R-mediated phagocytosis);05152(Tuberculosis)","K04718","EC:2.7.1.91","sphingosine kinase 2 [Source:NCBI gene;Acc:101106964]",{"v":0.512188,"d":"0.51"},{"v":0.549689,"d":"0.55"},{"v":0.550224,"d":"0.55"},{"v":0.813712,"d":"0.81"},{"v":1.200897,"d":"1.20"},{"v":0.766127,"d":"0.77"},{"v":0.579738961195885,"d":"0.58"},{"v":-0.786524650097279,"d":"-0.79"},{"v":0.082814142514935,"d":"0.08"},{"v":0.50716626206542,"d":"0.51"},"down","no"]
["MSTRG.9471","CAVIN4","ENSOART00000008254","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0010468(regulation of gene expression);GO:0030018(Z disc);GO:0035023(regulation of Rho protein signal transduction);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","caveolae associated protein 4 [Source:NCBI gene;Acc:101122919]",{"v":6.64889728017855,"d":"6.65"},{"v":9.31167456748029,"d":"9.31"},{"v":5.78842992819831,"d":"5.79"},{"v":5.70803345759331,"d":"5.71"},{"v":5.82163962674518,"d":"5.82"},{"v":3.83644815272106,"d":"3.84"},{"v":1.41538657936679,"d":"1.42"},{"v":0.501196144905187,"d":"0.50"},{"v":0.0828765556052426,"d":"0.08"},{"v":0.50716626206542,"d":"0.51"},"up","no"]
["MSTRG.4431","TASP1","ENSOART00000012007","GO:0004298(threonine-type endopeptidase activity);GO:0006508(proteolysis);GO:0016787(hydrolase activity);GO:0042802(identical protein binding);GO:0045893(positive regulation of transcription, DNA-templated)","NA","K08657","EC:3.4.25.-","taspase 1 [Source:NCBI gene;Acc:101110528]",{"v":0.784908,"d":"0.78"},{"v":0.3564,"d":"0.36"},{"v":0.485959,"d":"0.49"},{"v":0.368672,"d":"0.37"},{"v":0.354295,"d":"0.35"},{"v":0.316804,"d":"0.32"},{"v":1.56502441402963,"d":"1.57"},{"v":0.646185163052298,"d":"0.65"},{"v":0.0829274643798179,"d":"0.08"},{"v":0.50716626206542,"d":"0.51"},"up","no"]
["MSTRG.14766","AK1","ENSOART00000012305","GO:0001520(outer dense fiber);GO:0004017(adenylate kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006139(nucleobase-containing compound metabolic process);GO:0007050(cell cycle arrest);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019205(nucleobase-containing compound kinase activity);GO:0036126(sperm flagellum);GO:0046034(ATP metabolic process);GO:0046940(nucleoside monophosphate phosphorylation)","00230(Purine metabolism);00730(Thiamine metabolism)","K00939","EC:2.7.4.3","adenylate kinase 1 [Source:NCBI gene;Acc:100302085]",{"v":173.321577643535,"d":"173.32"},{"v":163.766395661508,"d":"163.77"},{"v":138.415724965052,"d":"138.42"},{"v":238.796051467798,"d":"238.80"},{"v":202.315468332501,"d":"202.32"},{"v":301.990039827758,"d":"301.99"},{"v":0.639890593834977,"d":"0.64"},{"v":-0.644102835437824,"d":"-0.64"},{"v":0.0829834796645779,"d":"0.08"},{"v":0.50716626206542,"d":"0.51"},"down","no"]
["MSTRG.4201","STX6","ENSOART00000020090","GO:0005484(SNAP receptor activity);GO:0005654(nucleoplasm);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0006906(vesicle fusion);GO:0007032(endosome organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0019905(syntaxin binding);GO:0031201(SNARE complex);GO:0032456(endocytic recycling);GO:0032588(trans-Golgi network membrane);GO:0032880(regulation of protein localization);GO:0042147(retrograde transport, endosome to Golgi);GO:0045335(phagocytic vesicle);GO:0048193(Golgi vesicle transport);GO:0048471(perinuclear region of cytoplasm);GO:0090161(Golgi ribbon formation);GO:1903827(regulation of cellular protein localization)","04130(SNARE interactions in vesicular transport)","K08498","NA","syntaxin 6 [Source:NCBI gene;Acc:101123650]",{"v":1.62140358287612,"d":"1.62"},{"v":1.23892397819809,"d":"1.24"},{"v":1.13348240773895,"d":"1.13"},{"v":2.22514737424199,"d":"2.23"},{"v":1.96620414727115,"d":"1.97"},{"v":1.99917278602368,"d":"2.00"},{"v":0.645148903454072,"d":"0.65"},{"v":-0.632295914999766,"d":"-0.63"},{"v":0.0830264220051977,"d":"0.08"},{"v":0.50716626206542,"d":"0.51"},"down","no"]
["MSTRG.18718","CISD2","ENSOART00000013180","GO:0000422(autophagy of mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0010259(multicellular organism aging);GO:0010506(regulation of autophagy);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032991(protein-containing complex);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0051537(2 iron, 2 sulfur cluster binding);GO:0097038(perinuclear endoplasmic reticulum)","NA","NA","NA","CDGSH iron sulfur domain 2 [Source:HGNC Symbol;Acc:HGNC:24212]",{"v":0.685321,"d":"0.69"},{"v":0.739742,"d":"0.74"},{"v":0.650335,"d":"0.65"},{"v":0.567037,"d":"0.57"},{"v":0.219244,"d":"0.22"},{"v":0.513844,"d":"0.51"},{"v":1.59630650898952,"d":"1.60"},{"v":0.674737692000631,"d":"0.67"},{"v":0.0833642799438819,"d":"0.08"},{"v":0.507885538627983,"d":"0.51"},"up","no"]
["MSTRG.16497","ANKRD54","ENSOART00000015630","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006913(nucleocytoplasmic transport);GO:0019887(protein kinase regulator activity);GO:0030496(midbody);GO:0044877(protein-containing complex binding);GO:0045648(positive regulation of erythrocyte differentiation);GO:0045859(regulation of protein kinase activity);GO:1902531(regulation of intracellular signal transduction)","NA","K21442","NA","ankyrin repeat domain 54 [Source:NCBI gene;Acc:101119635]",{"v":1.996788,"d":"2.00"},{"v":1.215688,"d":"1.22"},{"v":1.47566,"d":"1.48"},{"v":2.814468,"d":"2.81"},{"v":2.935555,"d":"2.94"},{"v":2.555616,"d":"2.56"},{"v":0.564452175202895,"d":"0.56"},{"v":-0.82507674510343,"d":"-0.83"},{"v":0.0833886759549849,"d":"0.08"},{"v":0.507885538627983,"d":"0.51"},"down","no"]
["MSTRG.10227","WIPF1","ENSOART00000000289","GO:0003779(actin binding);GO:0005884(actin filament);GO:0008154(actin polymerization or depolymerization);GO:0015629(actin cytoskeleton);GO:0017124(SH3 domain binding);GO:0030048(actin filament-based movement);GO:0051707(response to other organism)","04144(Endocytosis)","K19475","NA","WAS/WASL interacting protein family member 1 [Source:NCBI gene;Acc:101110390]",{"v":2.29917974470135,"d":"2.30"},{"v":1.45894589655588,"d":"1.46"},{"v":2.38979682369942,"d":"2.39"},{"v":3.52830352709538,"d":"3.53"},{"v":3.19612579455684,"d":"3.20"},{"v":2.94267986934008,"d":"2.94"},{"v":0.635962865784656,"d":"0.64"},{"v":-0.652985566661351,"d":"-0.65"},{"v":0.0833942267803196,"d":"0.08"},{"v":0.507885538627983,"d":"0.51"},"down","no"]
["MSTRG.2590","DYNLL2","ENSOART00000009102","GO:0003774(motor activity);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005856(cytoskeleton);GO:0005868(cytoplasmic dynein complex);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0007017(microtubule-based process);GO:0030286(dynein complex);GO:0031475(myosin V complex);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse)","04962(Vasopressin-regulated water reabsorption)","K10418","NA","dynein light chain LC8-type 2 [Source:NCBI gene;Acc:101121274]",{"v":46.505318,"d":"46.51"},{"v":50.672665,"d":"50.67"},{"v":28.495199,"d":"28.50"},{"v":30.707182,"d":"30.71"},{"v":27.608503,"d":"27.61"},{"v":29.953527,"d":"29.95"},{"v":1.42374876984288,"d":"1.42"},{"v":0.509694595406715,"d":"0.51"},{"v":0.0834197236424765,"d":"0.08"},{"v":0.507885538627983,"d":"0.51"},"up","no"]
["MSTRG.9123","PRKAR2A","ENSOART00000017569","GO:0000166(nucleotide binding);GO:0001932(regulation of protein phosphorylation);GO:0004862(cAMP-dependent protein kinase inhibitor activity);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0005930(axoneme);GO:0005952(cAMP-dependent protein kinase complex);GO:0008603(cAMP-dependent protein kinase regulator activity);GO:0019904(protein domain specific binding);GO:0030552(cAMP binding);GO:0031588(nucleotide-activated protein kinase complex);GO:0031625(ubiquitin protein ligase binding);GO:0032991(protein-containing complex);GO:0034236(protein kinase A catalytic subunit binding);GO:0044853(plasma membrane raft);GO:2000480(negative regulation of cAMP-dependent protein kinase activity)","04910(Insulin signaling pathway)","K04739","NA","protein kinase cAMP-dependent type II regulatory subunit alpha [Source:NCBI gene;Acc:101118483]",{"v":89.5536920029252,"d":"89.55"},{"v":111.278336658796,"d":"111.28"},{"v":79.7405052440451,"d":"79.74"},{"v":73.7221303727539,"d":"73.72"},{"v":68.2457720963226,"d":"68.25"},{"v":62.5053581648558,"d":"62.51"},{"v":1.37217224900655,"d":"1.37"},{"v":0.456461594622682,"d":"0.46"},{"v":0.0834318842317436,"d":"0.08"},{"v":0.507885538627983,"d":"0.51"},"up","no"]
["MSTRG.8082","KLHL25","ENSOART00000011654","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006446(regulation of translational initiation);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0031463(Cul3-RING ubiquitin ligase complex)","NA","K10462","NA","kelch like family member 25 [Source:NCBI gene;Acc:101121124]",{"v":1.78119617964493,"d":"1.78"},{"v":2.04361613886448,"d":"2.04"},{"v":1.91881446475655,"d":"1.92"},{"v":1.68802077869573,"d":"1.69"},{"v":1.1513101529267,"d":"1.15"},{"v":1.28887696308666,"d":"1.29"},{"v":1.3913123877863,"d":"1.39"},{"v":0.47644638085161,"d":"0.48"},{"v":0.0834552241633316,"d":"0.08"},{"v":0.507885538627983,"d":"0.51"},"up","no"]
["MSTRG.9593","NUDT2","ENSOART00000010115","GO:0008796(bis(5'-nucleosyl)-tetraphosphatase activity);GO:0016787(hydrolase activity)","00230(Purine metabolism);00240(Pyrimidine metabolism)","K01518","EC:3.6.1.17","nudix hydrolase 2 [Source:NCBI gene;Acc:101123091]",{"v":2.06977838996139,"d":"2.07"},{"v":2.97353023166023,"d":"2.97"},{"v":3.0652630965251,"d":"3.07"},{"v":4.16257684555985,"d":"4.16"},{"v":4.16847930888031,"d":"4.17"},{"v":5.59486052509653,"d":"5.59"},{"v":0.582264845090003,"d":"0.58"},{"v":-0.780252577858332,"d":"-0.78"},{"v":0.0836774972621588,"d":"0.08"},{"v":0.50803972032856,"d":"0.51"},"down","no"]
["MSTRG.1366","HCLS1","ENSOART00000021832","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008284(positive regulation of cell population proliferation);GO:0009725(response to hormone);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030041(actin filament polymerization);GO:0030218(erythrocyte differentiation);GO:0030833(regulation of actin filament polymerization);GO:0030854(positive regulation of granulocyte differentiation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0042307(positive regulation of protein import into nucleus);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0044877(protein-containing complex binding);GO:0045651(positive regulation of macrophage differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051897(positive regulation of protein kinase B signaling);GO:0071345(cellular response to cytokine stimulus);GO:2000107(negative regulation of leukocyte apoptotic process)","04530(Tight junction);05100(Bacterial invasion of epithelial cells);05205(Proteoglycans in cancer)","K06106","NA","hematopoietic cell-specific Lyn substrate 1 [Source:NCBI gene;Acc:101110196]",{"v":1.63952233306899,"d":"1.64"},{"v":1.12208645281523,"d":"1.12"},{"v":1.16428082038065,"d":"1.16"},{"v":3.12523505114988,"d":"3.13"},{"v":1.39362376883426,"d":"1.39"},{"v":2.16101610705789,"d":"2.16"},{"v":0.587719029045253,"d":"0.59"},{"v":-0.766801484522628,"d":"-0.77"},{"v":0.0836858131212314,"d":"0.08"},{"v":0.50803972032856,"d":"0.51"},"down","no"]
["MSTRG.14940","TP53I3","ENSOART00000019392","GO:0003960(NADPH:quinone reductase activity);GO:0006739(NADP metabolic process);GO:0016491(oxidoreductase activity);GO:0042803(protein homodimerization activity);GO:0048038(quinone binding);GO:0055114(oxidation-reduction process);GO:0070402(NADPH binding)","04115(p53 signaling pathway)","K10133","EC:1.-.-.-","tumor protein p53 inducible protein 3 [Source:NCBI gene;Acc:101106244]",{"v":0.812681,"d":"0.81"},{"v":1.026165,"d":"1.03"},{"v":0.940617,"d":"0.94"},{"v":1.160445,"d":"1.16"},{"v":1.926441,"d":"1.93"},{"v":2.047043,"d":"2.05"},{"v":0.541391008718664,"d":"0.54"},{"v":-0.885257167040267,"d":"-0.89"},{"v":0.0837052857879653,"d":"0.08"},{"v":0.50803972032856,"d":"0.51"},"down","no"]
["MSTRG.3062","RASD1","ENSOART00000001878","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016529(sarcoplasmic reticulum)","NA","NA","NA","ras related dexamethasone induced 1 [Source:HGNC Symbol;Acc:HGNC:15828]",{"v":13.896253,"d":"13.90"},{"v":45.133213,"d":"45.13"},{"v":70.168594,"d":"70.17"},{"v":30.486166,"d":"30.49"},{"v":19.047009,"d":"19.05"},{"v":28.167143,"d":"28.17"},{"v":1.6627738898057,"d":"1.66"},{"v":0.733591998911113,"d":"0.73"},{"v":0.0837357177594118,"d":"0.08"},{"v":0.50803972032856,"d":"0.51"},"up","no"]
["ENSOARG00000011049","DHX34","ENSOART00000012020","GO:0000166(nucleotide binding);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0016787(hydrolase activity);GO:2000623(negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)","NA","K20101","EC:3.6.4.13","DExH-box helicase 34 [Source:NCBI gene;Acc:101101915]",{"v":0.424106,"d":"0.42"},{"v":0.319979,"d":"0.32"},{"v":0.606835,"d":"0.61"},{"v":0.693275,"d":"0.69"},{"v":0.771691,"d":"0.77"},{"v":0.881284,"d":"0.88"},{"v":0.575778369738945,"d":"0.58"},{"v":-0.796414502680189,"d":"-0.80"},{"v":0.0838743664751689,"d":"0.08"},{"v":0.508163508648073,"d":"0.51"},"down","no"]
["MSTRG.18958","KDR","ENSOART00000001140","GO:0000166(nucleotide binding);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0005178(integrin binding);GO:0005524(ATP binding);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0010595(positive regulation of endothelial cell migration);GO:0010629(negative regulation of gene expression);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016239(positive regulation of macroautophagy);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019838(growth factor binding);GO:0030335(positive regulation of cell migration);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0038033(positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043410(positive regulation of MAPK cascade);GO:0043491(protein kinase B signaling);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045121(membrane raft);GO:0045296(cadherin binding);GO:0045766(positive regulation of angiogenesis);GO:0046777(protein autophosphorylation);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0050927(positive regulation of positive chemotaxis);GO:0051770(positive regulation of nitric-oxide synthase biosynthetic process);GO:0051894(positive regulation of focal adhesion assembly);GO:0051901(positive regulation of mitochondrial depolarization);GO:0070371(ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:0090141(positive regulation of mitochondrial fission);GO:1904881(cellular response to hydrogen sulfide);GO:2000352(negative regulation of endothelial cell apoptotic process)","01521(EGFR tyrosine kinase inhibitor resistance);04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04370(VEGF signaling pathway);04510(Focal adhesion);05205(Proteoglycans in cancer);05418(Fluid shear stress and atherosclerosis)","K05098","EC:2.7.10.1","kinase insert domain receptor [Source:NCBI gene;Acc:443087]",{"v":10.7786066960427,"d":"10.78"},{"v":6.58994826729789,"d":"6.59"},{"v":6.99800374654042,"d":"7.00"},{"v":13.7463789169701,"d":"13.75"},{"v":12.3395204360282,"d":"12.34"},{"v":12.0584056885166,"d":"12.06"},{"v":0.638799387834208,"d":"0.64"},{"v":-0.646565164682011,"d":"-0.65"},{"v":0.084016325765937,"d":"0.08"},{"v":0.508646113128001,"d":"0.51"},"down","no"]
["MSTRG.2809","SERPINF2","ENSOART00000015332","GO:0002020(protease binding);GO:0002034(regulation of blood vessel diameter by renin-angiotensin);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005577(fibrinogen complex);GO:0005615(extracellular space);GO:0009986(cell surface);GO:0010757(negative regulation of plasminogen activation);GO:0010951(negative regulation of endopeptidase activity);GO:0030199(collagen fibril organization);GO:0032967(positive regulation of collagen biosynthetic process);GO:0042803(protein homodimerization activity);GO:0045597(positive regulation of cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046330(positive regulation of JNK cascade);GO:0048514(blood vessel morphogenesis);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0051496(positive regulation of stress fiber assembly);GO:0051918(negative regulation of fibrinolysis);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071636(positive regulation of transforming growth factor beta production)","04610(Complement and coagulation cascades)","K03983","NA","serpin family F member 2 [Source:NCBI gene;Acc:101117258]",{"v":0.562543,"d":"0.56"},{"v":0.19871,"d":"0.20"},{"v":0.571496,"d":"0.57"},{"v":0.73802,"d":"0.74"},{"v":0.642686,"d":"0.64"},{"v":1.277351,"d":"1.28"},{"v":0.501399706627811,"d":"0.50"},{"v":-0.995966942845398,"d":"-1.00"},{"v":0.0841689560211233,"d":"0.08"},{"v":0.508963381361935,"d":"0.51"},"down","no"]
["MSTRG.22308","COL4A5","ENSOART00000019794","GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005587(collagen type IV trimer);GO:0005604(basement membrane);GO:0007528(neuromuscular junction development);GO:0031594(neuromuscular junction);GO:0038063(collagen-activated tyrosine kinase receptor signaling pathway)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);04974(Protein digestion and absorption);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K06237","NA","collagen type IV alpha 5 chain [Source:NCBI gene;Acc:101112706]",{"v":1.14892211656891,"d":"1.15"},{"v":0.915461566348974,"d":"0.92"},{"v":0.792878734237537,"d":"0.79"},{"v":1.59862699230205,"d":"1.60"},{"v":1.46519737646628,"d":"1.47"},{"v":1.49689940432551,"d":"1.50"},{"v":0.626493196981573,"d":"0.63"},{"v":-0.674629251316661,"d":"-0.67"},{"v":0.084205907907633,"d":"0.08"},{"v":0.508963381361935,"d":"0.51"},"down","no"]
["MSTRG.13598","SBDS","ENSOART00000011542","GO:0000922(spindle pole);GO:0001833(inner cell mass cell proliferation);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0007052(mitotic spindle organization);GO:0008017(microtubule binding);GO:0008283(cell population proliferation);GO:0019843(rRNA binding);GO:0030282(bone mineralization);GO:0030595(leukocyte chemotaxis);GO:0042254(ribosome biogenesis);GO:0042256(mature ribosome assembly);GO:0043022(ribosome binding);GO:0048539(bone marrow development)","03008(Ribosome biogenesis in eukaryotes)","K14574","NA","SBDS, ribosome maturation factor [Source:NCBI gene;Acc:101111067]",{"v":26.653648,"d":"26.65"},{"v":24.69643,"d":"24.70"},{"v":26.689224,"d":"26.69"},{"v":21.481375,"d":"21.48"},{"v":17.152334,"d":"17.15"},{"v":18.09231,"d":"18.09"},{"v":1.37572322852411,"d":"1.38"},{"v":0.460190254197855,"d":"0.46"},{"v":0.0842264602961674,"d":"0.08"},{"v":0.508963381361935,"d":"0.51"},"up","no"]
["MSTRG.11071","MFAP2","ENSOART00000012560","GO:0001527(microfibril);GO:0048048(embryonic eye morphogenesis);GO:0048050(post-embryonic eye morphogenesis)","NA","NA","NA","microfibril associated protein 2 [Source:NCBI gene;Acc:101110395]",{"v":1.02688823448413,"d":"1.03"},{"v":1.28545920993814,"d":"1.29"},{"v":1.41961765196568,"d":"1.42"},{"v":2.00554662382758,"d":"2.01"},{"v":2.1330995378168,"d":"2.13"},{"v":1.86320138255837,"d":"1.86"},{"v":0.621802714731182,"d":"0.62"},{"v":-0.685471179526069,"d":"-0.69"},{"v":0.0842624136444395,"d":"0.08"},{"v":0.508963381361935,"d":"0.51"},"down","no"]
["MSTRG.10778","ITM2C","ENSOART00000022521","GO:0001540(amyloid-beta binding);GO:0005524(ATP binding);GO:0005764(lysosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0010977(negative regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030182(neuron differentiation);GO:0048471(perinuclear region of cytoplasm);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","NA","K18265","NA","integral membrane protein 2C [Source:NCBI gene;Acc:100174906]",{"v":7.519513,"d":"7.52"},{"v":3.883643,"d":"3.88"},{"v":7.108292,"d":"7.11"},{"v":9.361773,"d":"9.36"},{"v":9.776279,"d":"9.78"},{"v":11.386271,"d":"11.39"},{"v":0.606449093072433,"d":"0.61"},{"v":-0.721541548064855,"d":"-0.72"},{"v":0.0842731649428171,"d":"0.08"},{"v":0.508963381361935,"d":"0.51"},"down","no"]
["MSTRG.15231","RTN4","ENSOART00000003137","GO:0001825(blastocyst formation);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0007399(nervous system development);GO:0007413(axonal fasciculation);GO:0010634(positive regulation of epithelial cell migration);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021801(cerebral cortex radial glia guided migration);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030308(negative regulation of cell growth);GO:0030517(negative regulation of axon extension);GO:0031625(ubiquitin protein ligase binding);GO:0033601(positive regulation of mammary gland epithelial cell proliferation);GO:0034165(positive regulation of toll-like receptor 9 signaling pathway);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0050821(protein stabilization);GO:0051292(nuclear pore complex assembly);GO:0051897(positive regulation of protein kinase B signaling);GO:0051960(regulation of nervous system development);GO:0060317(cardiac epithelial to mesenchymal transition);GO:0061462(protein localization to lysosome);GO:0071782(endoplasmic reticulum tubular network);GO:0071786(endoplasmic reticulum tubular network organization);GO:0071787(endoplasmic reticulum tubular network formation);GO:0090156(cellular sphingolipid homeostasis);GO:0098826(endoplasmic reticulum tubular network membrane);GO:1905552(positive regulation of protein localization to endoplasmic reticulum);GO:1905580(positive regulation of ERBB3 signaling pathway);GO:1990809(endoplasmic reticulum tubular network membrane organization);GO:2000172(regulation of branching morphogenesis of a nerve)","NA","NA","NA","reticulon 4 [Source:HGNC Symbol;Acc:HGNC:14085]",{"v":53.1961453537289,"d":"53.20"},{"v":56.3131770222497,"d":"56.31"},{"v":45.3422482466007,"d":"45.34"},{"v":45.0451404882571,"d":"45.05"},{"v":34.4380827200247,"d":"34.44"},{"v":33.9908215362587,"d":"33.99"},{"v":1.36464308618936,"d":"1.36"},{"v":0.448523672672221,"d":"0.45"},{"v":0.0844333358347341,"d":"0.08"},{"v":0.509470623617716,"d":"0.51"},"up","no"]
["MSTRG.14372","TTI2","ENSOART00000000420","GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol)","NA","K23115","NA","TELO2 interacting protein 2 [Source:NCBI gene;Acc:101108629]",{"v":2.34435541336487,"d":"2.34"},{"v":3.5300965487877,"d":"3.53"},{"v":2.97762867534004,"d":"2.98"},{"v":2.37717766528681,"d":"2.38"},{"v":1.675177,"d":"1.68"},{"v":2.00172368894145,"d":"2.00"},{"v":1.46216816492145,"d":"1.46"},{"v":0.548109246137331,"d":"0.55"},{"v":0.0844665974278179,"d":"0.08"},{"v":0.50948304499498,"d":"0.51"},"up","no"]
["MSTRG.19472","ENSOARG00000018666","ENSOART00000020321","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006414(translational elongation)","03010(Ribosome)","K02942","NA","ribosomal protein lateral stalk subunit P1 [Source:NCBI gene;Acc:101106848]",{"v":70.6773564492821,"d":"70.68"},{"v":68.8260785284854,"d":"68.83"},{"v":76.1918180676239,"d":"76.19"},{"v":84.7671111926818,"d":"84.77"},{"v":114.236856406207,"d":"114.24"},{"v":140.064133798055,"d":"140.06"},{"v":0.636141389168541,"d":"0.64"},{"v":-0.652580639468787,"d":"-0.65"},{"v":0.0846231073079359,"d":"0.08"},{"v":0.509899789443841,"d":"0.51"},"down","no"]
["MSTRG.751","ENSOARG00000012567","ENSOART00000013665","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11254","NA","histone H4 [Source:NCBI gene;Acc:101107948]",{"v":10.277257,"d":"10.28"},{"v":6.506856,"d":"6.51"},{"v":7.722991,"d":"7.72"},{"v":11.549217,"d":"11.55"},{"v":8.454501,"d":"8.45"},{"v":24.065529,"d":"24.07"},{"v":0.556104441721003,"d":"0.56"},{"v":-0.846572234595547,"d":"-0.85"},{"v":0.0846293746565904,"d":"0.08"},{"v":0.509899789443841,"d":"0.51"},"down","no"]
["MSTRG.6548","ENSOARG00000002505","ENSOART00000002710","GO:0004888(transmembrane signaling receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022848(acetylcholine-gated cation-selective channel activity);GO:0030054(cell junction);GO:0034220(ion transmembrane transport);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0060078(regulation of postsynaptic membrane potential);GO:0060079(excitatory postsynaptic potential)","NA","NA","NA",null,{"v":10.6732589434795,"d":"10.67"},{"v":11.8154463417722,"d":"11.82"},{"v":6.17392540447454,"d":"6.17"},{"v":7.3552246823668,"d":"7.36"},{"v":8.57067270061819,"d":"8.57"},{"v":2.52829576655873,"d":"2.53"},{"v":1.55317712659981,"d":"1.55"},{"v":0.635222366167934,"d":"0.64"},{"v":0.0847039913699805,"d":"0.08"},{"v":0.510161110693117,"d":"0.51"},"up","no"]
["MSTRG.9959","TEK","ENSOART00000015883","GO:0000166(nucleotide binding);GO:0001725(stress fiber);GO:0001934(positive regulation of protein phosphorylation);GO:0002040(sprouting angiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005815(microtubule organizing center);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005902(microvillus);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0009925(basal plasma membrane);GO:0009986(cell surface);GO:0010595(positive regulation of endothelial cell migration);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016525(negative regulation of angiogenesis);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0032878(regulation of establishment or maintenance of cell polarity);GO:0034446(substrate adhesion-dependent cell spreading);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045121(membrane raft);GO:0045766(positive regulation of angiogenesis);GO:0046777(protein autophosphorylation);GO:0048014(Tie signaling pathway);GO:0051259(protein complex oligomerization);GO:0051894(positive regulation of focal adhesion assembly);GO:0051897(positive regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1902533(positive regulation of intracellular signal transduction);GO:2000251(positive regulation of actin cytoskeleton reorganization)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);05323(Rheumatoid arthritis)","K05121","EC:2.7.10.1","TEK receptor tyrosine kinase [Source:NCBI gene;Acc:497272]",{"v":5.96588290514246,"d":"5.97"},{"v":4.30498223870744,"d":"4.30"},{"v":4.49927489298124,"d":"4.50"},{"v":7.28056013933287,"d":"7.28"},{"v":8.53294618832523,"d":"8.53"},{"v":7.02102509624739,"d":"7.02"},{"v":0.646833506789996,"d":"0.65"},{"v":-0.628533680720651,"d":"-0.63"},{"v":0.0848830783957093,"d":"0.08"},{"v":0.510874851648182,"d":"0.51"},"down","no"]
["MSTRG.20751","ENSOARG00000004523","ENSOART00000004922","GO:0004784(superoxide dismutase activity);GO:0006801(superoxide metabolic process);GO:0016491(oxidoreductase activity);GO:0019430(removal of superoxide radicals);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","04068(FoxO signaling pathway);04146(Peroxisome);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);05016(Huntington disease)","K04564","EC:1.15.1.1","superoxide dismutase 2 [Source:NCBI gene;Acc:780457]",{"v":70.971848,"d":"70.97"},{"v":71.338852,"d":"71.34"},{"v":52.279469,"d":"52.28"},{"v":60.230427,"d":"60.23"},{"v":35.055008,"d":"35.06"},{"v":43.307178,"d":"43.31"},{"v":1.40404430501646,"d":"1.40"},{"v":0.489588461012157,"d":"0.49"},{"v":0.0849101568358921,"d":"0.08"},{"v":0.510874851648182,"d":"0.51"},"up","no"]
["MSTRG.5447","CMTM3","ENSOART00000002197","GO:0001835(blastocyst hatching);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane);GO:0050861(positive regulation of B cell receptor signaling pathway)","NA","NA","NA","CKLF like MARVEL transmembrane domain containing 3 [Source:NCBI gene;Acc:101104422]",{"v":2.866208,"d":"2.87"},{"v":1.692054,"d":"1.69"},{"v":2.558303,"d":"2.56"},{"v":4.286986,"d":"4.29"},{"v":4.122658,"d":"4.12"},{"v":4.312824,"d":"4.31"},{"v":0.559369848680303,"d":"0.56"},{"v":-0.838125603554012,"d":"-0.84"},{"v":0.0849536138777661,"d":"0.08"},{"v":0.510874851648182,"d":"0.51"},"down","no"]
["MSTRG.4307","ENSOARG00000013891","ENSOART00000015124","GO:0002079(inner acrosomal membrane);GO:0007338(single fertilization);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane)","04610(Complement and coagulation cascades);05162(Measles)","K04007","NA","membrane cofactor protein [Source:NCBI gene;Acc:101122294]",{"v":4.54340998581743,"d":"4.54"},{"v":4.89150999587416,"d":"4.89"},{"v":4.95360007039711,"d":"4.95"},{"v":3.83197797498711,"d":"3.83"},{"v":3.30563123414131,"d":"3.31"},{"v":3.29430742160908,"d":"3.29"},{"v":1.3792786657912,"d":"1.38"},{"v":0.463913964567477,"d":"0.46"},{"v":0.0849805019064883,"d":"0.08"},{"v":0.510874851648182,"d":"0.51"},"up","no"]
["MSTRG.19922","BLOC1S6","ENSOART00000022923","GO:0005768(endosome);GO:0007596(blood coagulation);GO:0008089(anterograde axonal transport);GO:0030318(melanocyte differentiation);GO:0031083(BLOC-1 complex);GO:0031175(neuron projection development);GO:0032816(positive regulation of natural killer cell activation);GO:0033299(secretion of lysosomal enzymes);GO:0043473(pigmentation);GO:0048490(anterograde synaptic vesicle transport);GO:0061025(membrane fusion);GO:1904115(axon cytoplasm)","NA","K20188","NA","biogenesis of lysosomal organelles complex 1 subunit 6 [Source:NCBI gene;Acc:101113763]",{"v":6.32979714882901,"d":"6.33"},{"v":5.96530175875094,"d":"5.97"},{"v":4.82427275371443,"d":"4.82"},{"v":5.16401716368673,"d":"5.16"},{"v":3.62919381490808,"d":"3.63"},{"v":3.59095454469907,"d":"3.59"},{"v":1.38235972614334,"d":"1.38"},{"v":0.467133091552348,"d":"0.47"},{"v":0.0850102261102469,"d":"0.09"},{"v":0.510874851648182,"d":"0.51"},"up","no"]
["ENSOARG00000007006","LRRC1","ENSOART00000007623;ENSOART00000007624","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005829(cytosol)","NA","NA","NA","leucine rich repeat containing 1 [Source:NCBI gene;Acc:101114315]",{"v":0.735482139918809,"d":"0.74"},{"v":1.0438533767253,"d":"1.04"},{"v":0.731357345872801,"d":"0.73"},{"v":0.631988988903924,"d":"0.63"},{"v":0.582297159675237,"d":"0.58"},{"v":0.466422298782138,"d":"0.47"},{"v":1.49383009674205,"d":"1.49"},{"v":0.579016070130743,"d":"0.58"},{"v":0.0852886413236634,"d":"0.09"},{"v":0.511825606055605,"d":"0.51"},"up","no"]
["MSTRG.21259","RRM2B","ENSOART00000019607","GO:0001822(kidney development);GO:0003014(renal system process);GO:0004748(ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006264(mitochondrial DNA replication);GO:0006281(DNA repair);GO:0006979(response to oxidative stress);GO:0009200(deoxyribonucleoside triphosphate metabolic process);GO:0009263(deoxyribonucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:1902254(negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator)","00230(Purine metabolism);00240(Pyrimidine metabolism);00480(Glutathione metabolism);00983(Drug metabolism - other enzymes);04115(p53 signaling pathway)","K10808","EC:1.17.4.1","ribonucleotide reductase regulatory TP53 inducible subunit M2B [Source:NCBI gene;Acc:101123639]",{"v":3.514373,"d":"3.51"},{"v":4.475391,"d":"4.48"},{"v":3.88081,"d":"3.88"},{"v":2.910716,"d":"2.91"},{"v":3.050524,"d":"3.05"},{"v":2.349078,"d":"2.35"},{"v":1.42841393073045,"d":"1.43"},{"v":0.514414109113437,"d":"0.51"},{"v":0.0853325271581963,"d":"0.09"},{"v":0.511825606055605,"d":"0.51"},"up","no"]
["MSTRG.3947","TNFRSF1B","ENSOART00000018725","GO:0002724(regulation of T cell cytokine production);GO:0002739(regulation of cytokine secretion involved in immune response);GO:0003176(aortic valve development);GO:0003177(pulmonary valve development);GO:0003332(negative regulation of extracellular matrix constituent secretion);GO:0005031(tumor necrosis factor-activated receptor activity);GO:0005515(protein binding);GO:0006954(inflammatory response);GO:0007166(cell surface receptor signaling pathway);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0010614(negative regulation of cardiac muscle hypertrophy);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031625(ubiquitin protein ligase binding);GO:0031641(regulation of myelination);GO:0031643(positive regulation of myelination);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0042129(regulation of T cell proliferation);GO:0043120(tumor necrosis factor binding);GO:0045121(membrane raft);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0050728(negative regulation of inflammatory response);GO:0050779(RNA destabilization);GO:0051044(positive regulation of membrane protein ectodomain proteolysis);GO:0060548(negative regulation of cell death);GO:0071222(cellular response to lipopolysaccharide);GO:0097191(extrinsic apoptotic signaling pathway);GO:0150077(regulation of neuroinflammatory response);GO:0150079(negative regulation of neuroinflammatory response);GO:1901215(negative regulation of neuron death);GO:1902339(positive regulation of apoptotic process involved in morphogenesis);GO:2001141(regulation of RNA biosynthetic process)","04060(Cytokine-cytokine receptor interaction);04668(TNF signaling pathway);04920(Adipocytokine signaling pathway);05014(Amyotrophic lateral sclerosis (ALS));05170(Human immunodeficiency virus 1 infection)","K05141","NA","TNF receptor superfamily member 1B [Source:NCBI gene;Acc:100240715]",{"v":2.057598,"d":"2.06"},{"v":2.537306,"d":"2.54"},{"v":3.113433,"d":"3.11"},{"v":1.741359,"d":"1.74"},{"v":1.93167,"d":"1.93"},{"v":1.549513,"d":"1.55"},{"v":1.47597415205086,"d":"1.48"},{"v":0.561667456469741,"d":"0.56"},{"v":0.085339313019215,"d":"0.09"},{"v":0.511825606055605,"d":"0.51"},"up","no"]
["MSTRG.3650","CDC42EP4","ENSOART00000014755","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0007266(Rho protein signal transduction);GO:0008360(regulation of cell shape);GO:0015629(actin cytoskeleton);GO:0015630(microtubule cytoskeleton);GO:0031274(positive regulation of pseudopodium assembly);GO:0045335(phagocytic vesicle);GO:0071346(cellular response to interferon-gamma)","NA","NA","NA","CDC42 effector protein 4 [Source:NCBI gene;Acc:101107208]",{"v":3.803633,"d":"3.80"},{"v":3.746654,"d":"3.75"},{"v":2.116643,"d":"2.12"},{"v":4.806229,"d":"4.81"},{"v":5.241208,"d":"5.24"},{"v":6.152295,"d":"6.15"},{"v":0.596733945968983,"d":"0.60"},{"v":-0.744840246119037,"d":"-0.74"},{"v":0.0853704985358697,"d":"0.09"},{"v":0.511825606055605,"d":"0.51"},"down","no"]
["MSTRG.2462","EFNB2","ENSOART00000005936","GO:0001945(lymph vessel development);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0005102(signaling receptor binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0008284(positive regulation of cell population proliferation);GO:0009887(animal organ morphogenesis);GO:0010839(negative regulation of keratinocyte proliferation);GO:0010977(negative regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031295(T cell costimulation);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0048514(blood vessel morphogenesis);GO:0048845(venous blood vessel morphogenesis);GO:0050920(regulation of chemotaxis);GO:0072178(nephric duct morphogenesis);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane);GO:0099072(regulation of postsynaptic membrane neurotransmitter receptor levels);GO:0099149(regulation of postsynaptic neurotransmitter receptor internalization);GO:1901216(positive regulation of neuron death);GO:1903849(positive regulation of aorta morphogenesis);GO:2000727(positive regulation of cardiac muscle cell differentiation)","04360(Axon guidance)","K05463","NA","ephrin B2 [Source:NCBI gene;Acc:101115469]",{"v":3.338804,"d":"3.34"},{"v":2.997823,"d":"3.00"},{"v":2.756335,"d":"2.76"},{"v":4.322396,"d":"4.32"},{"v":5.227731,"d":"5.23"},{"v":5.04305,"d":"5.04"},{"v":0.623096807501204,"d":"0.62"},{"v":-0.682471769757005,"d":"-0.68"},{"v":0.0853878583350972,"d":"0.09"},{"v":0.511825606055605,"d":"0.51"},"down","no"]
["MSTRG.11579","CDKAL1","ENSOART00000010443","GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0005791(rough endoplasmic reticulum);GO:0006400(tRNA modification);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0035598(N6-threonylcarbomyladenosine methylthiotransferase activity);GO:0035600(tRNA methylthiolation);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:1990145(maintenance of translational fidelity)","NA","K15865","EC:2.8.4.5","CDK5 regulatory subunit associated protein 1 like 1 [Source:NCBI gene;Acc:101121212]",{"v":3.18228595719382,"d":"3.18"},{"v":2.87611869351962,"d":"2.88"},{"v":3.48996897562426,"d":"3.49"},{"v":3.04531659601665,"d":"3.05"},{"v":2.09324774762188,"d":"2.09"},{"v":1.71678562663496,"d":"1.72"},{"v":1.39283532828256,"d":"1.39"},{"v":0.478024701504625,"d":"0.48"},{"v":0.0854243473515051,"d":"0.09"},{"v":0.511856419653349,"d":"0.51"},"up","no"]
["MSTRG.5424","CCDC102A","ENSOART00000000421","GO:0003774(motor activity);GO:0016459(myosin complex)","NA","K16759","NA","coiled-coil domain containing 102A [Source:NCBI gene;Acc:101120432]",{"v":0.893205,"d":"0.89"},{"v":0.442361,"d":"0.44"},{"v":0.784831,"d":"0.78"},{"v":1.575186,"d":"1.58"},{"v":0.995076,"d":"1.00"},{"v":1.296645,"d":"1.30"},{"v":0.5483444520388,"d":"0.55"},{"v":-0.866845663134,"d":"-0.87"},{"v":0.0856092889794335,"d":"0.09"},{"v":0.512061193136695,"d":"0.51"},"down","no"]
["ENSOARG00000009832","TRMT9B","ENSOART00000010698","GO:0002098(tRNA wobble uridine modification);GO:0016300(tRNA (uracil) methyltransferase activity);GO:0030488(tRNA methylation)","NA","NA","NA","tRNA methyltransferase 9B (putative) [Source:NCBI gene;Acc:101102121]",{"v":0.581563,"d":"0.58"},{"v":0.440212,"d":"0.44"},{"v":1.092131,"d":"1.09"},{"v":0.534737,"d":"0.53"},{"v":0.434785,"d":"0.43"},{"v":0.259949,"d":"0.26"},{"v":1.71936222977199,"d":"1.72"},{"v":0.781873519244918,"d":"0.78"},{"v":0.0856207389424714,"d":"0.09"},{"v":0.512061193136695,"d":"0.51"},"up","no"]
["MSTRG.21017","TATDN1","ENSOART00000009712;ENSOART00000009713","GO:0005654(nucleoplasm);GO:0006259(DNA metabolic process);GO:0016788(hydrolase activity, acting on ester bonds);GO:0016888(endodeoxyribonuclease activity, producing 5'-phosphomonoesters);GO:0016888(endodeoxyribonuclease activity, producing 5'-phosphomonoesters)","NA","K03424","EC:3.1.21.-","TatD DNase domain containing 1 [Source:NCBI gene;Acc:101106439]",{"v":3.1131777890625,"d":"3.11"},{"v":2.5638525,"d":"2.56"},{"v":2.478789796875,"d":"2.48"},{"v":2.3214815625,"d":"2.32"},{"v":1.9359468046875,"d":"1.94"},{"v":1.128489375,"d":"1.13"},{"v":1.51428604674995,"d":"1.51"},{"v":0.598637754364564,"d":"0.60"},{"v":0.0856780487291432,"d":"0.09"},{"v":0.512061193136695,"d":"0.51"},"up","no"]
["MSTRG.1364","POLQ","ENSOART00000021785","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005524(ATP binding);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0043142(single-stranded DNA-dependent ATPase activity);GO:0051260(protein homooligomerization);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0071897(DNA biosynthetic process);GO:0097681(double-strand break repair via alternative nonhomologous end joining);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA","K02349","EC:2.7.7.7","DNA polymerase theta [Source:NCBI gene;Acc:101109663]",{"v":0.236839,"d":"0.24"},{"v":0.105721,"d":"0.11"},{"v":0.13066,"d":"0.13"},{"v":0.371933,"d":"0.37"},{"v":0.226672,"d":"0.23"},{"v":0.249315,"d":"0.25"},{"v":0.558095103311633,"d":"0.56"},{"v":-0.84141710655145,"d":"-0.84"},{"v":0.0857612899525199,"d":"0.09"},{"v":0.512371146119555,"d":"0.51"},"down","no"]
["MSTRG.709","WARS2","ENSOART00000022193;ENSOART00000022194","GO:0000166(nucleotide binding);GO:0001570(vasculogenesis);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004830(tryptophan-tRNA ligase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005886(plasma membrane);GO:0006412(translation);GO:0006418(tRNA aminoacylation for protein translation);GO:0006436(tryptophanyl-tRNA aminoacylation);GO:0016874(ligase activity);GO:0016874(ligase activity)","00970(Aminoacyl-tRNA biosynthesis);00970(Aminoacyl-tRNA biosynthesis)","K01867","EC:6.1.1.2","tryptophanyl tRNA synthetase 2, mitochondrial [Source:NCBI gene;Acc:101110551]",{"v":1.27679101382488,"d":"1.28"},{"v":0.522315437788018,"d":"0.52"},{"v":0.739216680052666,"d":"0.74"},{"v":1.33619661290323,"d":"1.34"},{"v":1.48140083607637,"d":"1.48"},{"v":1.64846168202765,"d":"1.65"},{"v":0.568358603683128,"d":"0.57"},{"v":-0.815126614965256,"d":"-0.82"},{"v":0.085806048362837,"d":"0.09"},{"v":0.512451045233505,"d":"0.51"},"down","no"]
["MSTRG.5618","TYROBP","ENSOART00000005629","GO:0002274(myeloid leukocyte activation);GO:0002281(macrophage activation involved in immune response);GO:0002282(microglial cell activation involved in immune response);GO:0002283(neutrophil activation involved in immune response);GO:0005102(signaling receptor binding);GO:0005623(cell);GO:0007229(integrin-mediated signaling pathway);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030036(actin cytoskeleton organization);GO:0030316(osteoclast differentiation);GO:0030889(negative regulation of B cell proliferation);GO:0030900(forebrain development);GO:0032816(positive regulation of natural killer cell activation);GO:0032911(negative regulation of transforming growth factor beta1 production);GO:0032930(positive regulation of superoxide anion generation);GO:0034241(positive regulation of macrophage fusion);GO:0042535(positive regulation of tumor necrosis factor biosynthetic process);GO:0042802(identical protein binding);GO:0043277(apoptotic cell clearance);GO:0045081(negative regulation of interleukin-10 biosynthetic process);GO:0045410(positive regulation of interleukin-6 biosynthetic process);GO:0048678(response to axon injury);GO:0050725(positive regulation of interleukin-1 beta biosynthetic process);GO:0050821(protein stabilization);GO:0097190(apoptotic signaling pathway);GO:0110090(positive regulation of hippocampal neuron apoptotic process);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1901216(positive regulation of neuron death);GO:1902685(positive regulation of receptor localization to synapse);GO:1904151(positive regulation of microglial cell mediated cytotoxicity);GO:2000010(positive regulation of protein localization to cell surface);GO:2001204(regulation of osteoclast development);GO:2001206(positive regulation of osteoclast development)","04380(Osteoclast differentiation);04650(Natural killer cell mediated cytotoxicity)","K07992","NA","TYRO protein tyrosine kinase binding protein [Source:NCBI gene;Acc:443208]",{"v":0.742362864864865,"d":"0.74"},{"v":0.409127668918919,"d":"0.41"},{"v":1.96972464527027,"d":"1.97"},{"v":2.50325893581081,"d":"2.50"},{"v":1.48411413006757,"d":"1.48"},{"v":2.75941823817568,"d":"2.76"},{"v":0.462622161912516,"d":"0.46"},{"v":-1.11209371495857,"d":"-1.11"},{"v":0.0859413011394779,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["MSTRG.4809","DNAJC5","ENSOART00000010572","GO:0005886(plasma membrane);GO:0008021(synaptic vesicle);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031594(neuromuscular junction);GO:0043524(negative regulation of neuron apoptotic process);GO:0061077(chaperone-mediated protein folding);GO:0098693(regulation of synaptic vesicle cycle);GO:0098793(presynapse)","04141(Protein processing in endoplasmic reticulum)","K09525","NA","DnaJ heat shock protein family (Hsp40) member C5 [Source:NCBI gene;Acc:101108591]",{"v":1.34380881130916,"d":"1.34"},{"v":1.39089593853718,"d":"1.39"},{"v":1.36931027166564,"d":"1.37"},{"v":2.28639672034419,"d":"2.29"},{"v":2.31608702642901,"d":"2.32"},{"v":2.17400190043024,"d":"2.17"},{"v":0.605625870867984,"d":"0.61"},{"v":-0.723501259815133,"d":"-0.72"},{"v":0.0859895751122755,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["MSTRG.11542","HFE","ENSOART00000001230","GO:0002626(negative regulation of T cell antigen processing and presentation);GO:0002725(negative regulation of T cell cytokine production);GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005769(early endosome);GO:0006879(cellular iron ion homeostasis);GO:0009897(external side of plasma membrane);GO:0010039(response to iron ion);GO:0010628(positive regulation of gene expression);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030509(BMP signaling pathway);GO:0030881(beta-2-microglobulin binding);GO:0031410(cytoplasmic vesicle);GO:0032092(positive regulation of protein binding);GO:0034756(regulation of iron ion transport);GO:0039706(co-receptor binding);GO:0042446(hormone biosynthetic process);GO:0045177(apical part of cell);GO:0045178(basal part of cell);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0048471(perinuclear region of cytoplasm);GO:0055037(recycling endosome);GO:0055072(iron ion homeostasis);GO:0060586(multicellular organismal iron ion homeostasis);GO:0071281(cellular response to iron ion);GO:0090277(positive regulation of peptide hormone secretion);GO:0098711(iron ion import across plasma membrane);GO:1900121(negative regulation of receptor binding);GO:1900122(positive regulation of receptor binding);GO:1904283(negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I);GO:1904434(positive regulation of ferrous iron binding);GO:1904437(positive regulation of transferrin receptor binding);GO:1990459(transferrin receptor binding);GO:1990712(HFE-transferrin receptor complex);GO:2000008(regulation of protein localization to cell surface);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process);GO:2000272(negative regulation of signaling receptor activity);GO:2000273(positive regulation of signaling receptor activity);GO:2001186(negative regulation of CD8-positive, alpha-beta T cell activation)","NA","NA","NA","homeostatic iron regulator [Source:NCBI gene;Acc:101105539]",{"v":0.993433,"d":"0.99"},{"v":0.851344,"d":"0.85"},{"v":0.859326,"d":"0.86"},{"v":1.440002,"d":"1.44"},{"v":1.877041,"d":"1.88"},{"v":1.529423,"d":"1.53"},{"v":0.557953568641563,"d":"0.56"},{"v":-0.841783024943453,"d":"-0.84"},{"v":0.0859988736105407,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["MSTRG.2897","PELP1","ENSOART00000008812;ENSOART00000008811","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0071391(cellular response to estrogen stimulus);GO:0071391(cellular response to estrogen stimulus)","NA","K16913","NA","proline, glutamate and leucine rich protein 1 [Source:NCBI gene;Acc:101116330]",{"v":2.18947116027088,"d":"2.19"},{"v":2.02201142437923,"d":"2.02"},{"v":2.24148496896163,"d":"2.24"},{"v":3.5219399238149,"d":"3.52"},{"v":3.94104891196388,"d":"3.94"},{"v":2.70450189277652,"d":"2.70"},{"v":0.634666676949962,"d":"0.63"},{"v":-0.655928998699787,"d":"-0.66"},{"v":0.0860704699640567,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["MSTRG.11226","RNF8","ENSOART00000015847;ENSOART00000015849","GO:0000151(ubiquitin ligase complex);GO:0000781(chromosome, telomeric region);GO:0003682(chromatin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006302(double-strand break repair);GO:0006325(chromatin organization);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006974(cellular response to DNA damage stimulus);GO:0007049(cell cycle);GO:0008270(zinc ion binding);GO:0010212(response to ionizing radiation);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0030496(midbody);GO:0031625(ubiquitin protein ligase binding);GO:0033522(histone H2A ubiquitination);GO:0033523(histone H2B ubiquitination);GO:0034244(negative regulation of transcription elongation from RNA polymerase II promoter);GO:0035861(site of double-strand break);GO:0042393(histone binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043130(ubiquitin binding);GO:0045739(positive regulation of DNA repair);GO:0046872(metal ion binding);GO:0051301(cell division);GO:0051865(protein autoubiquitination);GO:0070534(protein K63-linked ubiquitination);GO:0070535(histone H2A K63-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination)","NA","K10667","EC:2.3.2.27","ring finger protein 8 [Source:NCBI gene;Acc:101103680]",{"v":2.91152803128371,"d":"2.91"},{"v":2.50374929719525,"d":"2.50"},{"v":1.88194535976268,"d":"1.88"},{"v":2.13373176968716,"d":"2.13"},{"v":1.45298460895361,"d":"1.45"},{"v":1.39463532686084,"d":"1.39"},{"v":1.46490814534984,"d":"1.46"},{"v":0.550810205669471,"d":"0.55"},{"v":0.0860845526221521,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"up","no"]
["MSTRG.13691","PCOLCE","ENSOART00000018058","GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008201(heparin binding);GO:0010952(positive regulation of peptidase activity);GO:0016504(peptidase activator activity);GO:1990830(cellular response to leukemia inhibitory factor)","NA","NA","NA","procollagen C-endopeptidase enhancer [Source:NCBI gene;Acc:101104033]",{"v":16.7138198467696,"d":"16.71"},{"v":11.3333296563751,"d":"11.33"},{"v":24.5416649102344,"d":"24.54"},{"v":25.4614525643225,"d":"25.46"},{"v":28.246755130932,"d":"28.25"},{"v":30.997282373928,"d":"31.00"},{"v":0.620843045361376,"d":"0.62"},{"v":-0.687699506472368,"d":"-0.69"},{"v":0.0860855650154325,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["MSTRG.3853","ENSOARG00000017774","ENSOART00000019339","GO:0004735(pyrroline-5-carboxylate reductase activity);GO:0006561(proline biosynthetic process);GO:0008652(cellular amino acid biosynthetic process);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0055129(L-proline biosynthetic process)","00330(Arginine and proline metabolism)","K00286","EC:1.5.1.2","pyrroline-5-carboxylate reductase 2 [Source:NCBI gene;Acc:101111821]",{"v":0.697366,"d":"0.70"},{"v":1.092191,"d":"1.09"},{"v":0.885488,"d":"0.89"},{"v":1.317411,"d":"1.32"},{"v":1.922894,"d":"1.92"},{"v":1.699306,"d":"1.70"},{"v":0.541549729320791,"d":"0.54"},{"v":-0.884834271457578,"d":"-0.88"},{"v":0.0861296398073505,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["MSTRG.15235","ENSOARG00000003600","ENSOART00000003907","GO:0003998(acylphosphatase activity);GO:0016787(hydrolase activity)","NA","NA","NA",null,{"v":4.80471475364304,"d":"4.80"},{"v":4.54087927201395,"d":"4.54"},{"v":3.70730084805082,"d":"3.71"},{"v":4.02493699501806,"d":"4.02"},{"v":2.77147211333915,"d":"2.77"},{"v":2.66005768588865,"d":"2.66"},{"v":1.38031414456511,"d":"1.38"},{"v":0.464996646154818,"d":"0.46"},{"v":0.0861771111618278,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"up","no"]
["MSTRG.5428","KIFC3","ENSOART00000000941;ENSOART00000000942","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0005915(zonula adherens);GO:0007017(microtubule-based process);GO:0007018(microtubule-based movement);GO:0007030(Golgi organization);GO:0008017(microtubule binding);GO:0008569(ATP-dependent microtubule motor activity, minus-end-directed);GO:0045218(zonula adherens maintenance);GO:0090136(epithelial cell-cell adhesion);GO:0090136(epithelial cell-cell adhesion)","NA","K10406","NA","kinesin family member C3 [Source:NCBI gene;Acc:101103342]",{"v":1.79465778256513,"d":"1.79"},{"v":0.942239652304609,"d":"0.94"},{"v":1.16422970165331,"d":"1.16"},{"v":2.30971334068136,"d":"2.31"},{"v":1.94977638752505,"d":"1.95"},{"v":2.06120702755511,"d":"2.06"},{"v":0.617198908168952,"d":"0.62"},{"v":-0.696192585118428,"d":"-0.70"},{"v":0.0861797875249531,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["MSTRG.13593","ENSOARG00000010314","ENSOART00000011226","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0005975(carbohydrate metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.4815,"d":"0.48"},{"v":0.230363,"d":"0.23"},{"v":0.653594,"d":"0.65"},{"v":0.950965,"d":"0.95"},{"v":0.744836,"d":"0.74"},{"v":0.890111,"d":"0.89"},{"v":0.528036916956184,"d":"0.53"},{"v":-0.921289297788913,"d":"-0.92"},{"v":0.0862409834527037,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["ENSOARG00000015333","RRM2","ENSOART00000016686","GO:0005829(cytosol);GO:0009263(deoxyribonucleotide biosynthetic process);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00230(Purine metabolism);00240(Pyrimidine metabolism);00480(Glutathione metabolism);00983(Drug metabolism - other enzymes);04115(p53 signaling pathway)","K10808","EC:1.17.4.1","ribonucleotide reductase regulatory subunit M2 [Source:NCBI gene;Acc:101118093]",{"v":0.431967,"d":"0.43"},{"v":0.109704,"d":"0.11"},{"v":0.252284,"d":"0.25"},{"v":0.935682,"d":"0.94"},{"v":0.168401,"d":"0.17"},{"v":0.69423,"d":"0.69"},{"v":0.441499894623461,"d":"0.44"},{"v":-1.17951500135389,"d":"-1.18"},{"v":0.0862766207086541,"d":"0.09"},{"v":0.512636340222309,"d":"0.51"},"down","no"]
["MSTRG.1360","GTF2E1","ENSOART00000021727","GO:0005634(nucleus);GO:0005669(transcription factor TFIID complex);GO:0005829(cytosol);GO:0006366(transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0016251(RNA polymerase II general transcription initiation factor activity);GO:0043565(sequence-specific DNA binding);GO:0097550(transcriptional preinitiation complex)","03022(Basal transcription factors);05203(Viral carcinogenesis)","K03136","NA","general transcription factor IIE subunit 1 [Source:NCBI gene;Acc:101109136]",{"v":1.59628827445055,"d":"1.60"},{"v":1.30903154395604,"d":"1.31"},{"v":1.80156184331502,"d":"1.80"},{"v":1.41698703928571,"d":"1.42"},{"v":1.17781261785714,"d":"1.18"},{"v":0.75393116025641,"d":"0.75"},{"v":1.4055718176169,"d":"1.41"},{"v":0.491157170027548,"d":"0.49"},{"v":0.0864269279912021,"d":"0.09"},{"v":0.512732529569815,"d":"0.51"},"up","no"]
["MSTRG.15359","VIT","ENSOART00000010984","GO:0005539(glycosaminoglycan binding);GO:0005614(interstitial matrix);GO:0010811(positive regulation of cell-substrate adhesion);GO:0021510(spinal cord development);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0062023(collagen-containing extracellular matrix)","NA","NA","NA","vitrin [Source:NCBI gene;Acc:101123022]",{"v":2.68479860357413,"d":"2.68"},{"v":1.82394467077775,"d":"1.82"},{"v":3.10027240473194,"d":"3.10"},{"v":3.52479664585955,"d":"3.52"},{"v":4.41033667958721,"d":"4.41"},{"v":4.05382240775233,"d":"4.05"},{"v":0.634668760850738,"d":"0.63"},{"v":-0.655924261680357,"d":"-0.66"},{"v":0.0864271748325669,"d":"0.09"},{"v":0.512732529569815,"d":"0.51"},"down","no"]
["ENSOARG00000020575","EPHB3","ENSOART00000022416","GO:0000166(nucleotide binding);GO:0001525(angiogenesis);GO:0001655(urogenital system development);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0008046(axon guidance receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016477(cell migration);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0022407(regulation of cell-cell adhesion);GO:0031290(retinal ganglion cell axon guidance);GO:0034446(substrate adhesion-dependent cell spreading);GO:0043087(regulation of GTPase activity);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048538(thymus development);GO:0048546(digestive tract morphogenesis);GO:0050770(regulation of axonogenesis);GO:0051965(positive regulation of synapse assembly);GO:0060021(roof of mouth development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis)","04360(Axon guidance)","K05112","EC:2.7.10.1","EPH receptor B3 [Source:NCBI gene;Acc:101106389]",{"v":0.579098,"d":"0.58"},{"v":0.100785,"d":"0.10"},{"v":0.249707,"d":"0.25"},{"v":0.483457,"d":"0.48"},{"v":0.711738,"d":"0.71"},{"v":0.691926,"d":"0.69"},{"v":0.492596924097607,"d":"0.49"},{"v":-1.02152047558273,"d":"-1.02"},{"v":0.0864498195679631,"d":"0.09"},{"v":0.512732529569815,"d":"0.51"},"down","no"]
["MSTRG.9928","SLC24A2","ENSOART00000015546","GO:0005262(calcium channel activity);GO:0005623(cell);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0007601(visual perception);GO:0007612(learning);GO:0007613(memory);GO:0008273(calcium, potassium:sodium antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034220(ion transmembrane transport);GO:0035725(sodium ion transmembrane transport);GO:0055085(transmembrane transport);GO:0060291(long-term synaptic potentiation);GO:0060292(long-term synaptic depression);GO:0070588(calcium ion transmembrane transport)","NA","K13750","NA","solute carrier family 24 member 2 [Source:NCBI gene;Acc:101102456]",{"v":1.035709,"d":"1.04"},{"v":0.609209,"d":"0.61"},{"v":1.064919,"d":"1.06"},{"v":0.987735,"d":"0.99"},{"v":0.183333,"d":"0.18"},{"v":0.411824,"d":"0.41"},{"v":1.71195318442446,"d":"1.71"},{"v":0.775643249915372,"d":"0.78"},{"v":0.0865429885798447,"d":"0.09"},{"v":0.513098735487184,"d":"0.51"},"up","no"]
["MSTRG.11968","FTH1","ENSOART00000015612","GO:0005623(cell);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008199(ferric iron binding);GO:0046872(metal ion binding)","04216(Ferroptosis);04217(Necroptosis);04978(Mineral absorption)","K00522","EC:1.16.3.2","ferritin heavy chain 1 [Source:NCBI gene;Acc:443355]",{"v":711.490703431373,"d":"711.49"},{"v":614.419576718954,"d":"614.42"},{"v":874.497495176471,"d":"874.50"},{"v":1204.42891096078,"d":"1204.43"},{"v":977.787654006536,"d":"977.79"},{"v":1239.13918161438,"d":"1239.14"},{"v":0.64313913498333,"d":"0.64"},{"v":-0.636797214820491,"d":"-0.64"},{"v":0.0867723432633433,"d":"0.09"},{"v":0.514115315532977,"d":"0.51"},"down","no"]
["MSTRG.224","ENSOARG00000001136","ENSOART00000001218","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02995","NA","ribosomal protein S8 [Source:NCBI gene;Acc:101117800]",{"v":272.788696,"d":"272.79"},{"v":233.616165,"d":"233.62"},{"v":259.337555,"d":"259.34"},{"v":328.811493,"d":"328.81"},{"v":422.626984,"d":"422.63"},{"v":428.188812,"d":"428.19"},{"v":0.649139285891851,"d":"0.65"},{"v":-0.623400024204891,"d":"-0.62"},{"v":0.0867774258702159,"d":"0.09"},{"v":0.514115315532977,"d":"0.51"},"down","no"]
["MSTRG.6146","ENSOARG00000004023","ENSOART00000004368","GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,{"v":1.160109,"d":"1.16"},{"v":1.118108,"d":"1.12"},{"v":1.279153,"d":"1.28"},{"v":1.583708,"d":"1.58"},{"v":2.471081,"d":"2.47"},{"v":1.934705,"d":"1.93"},{"v":0.593934980150243,"d":"0.59"},{"v":-0.751623091385074,"d":"-0.75"},{"v":0.0870170705239162,"d":"0.09"},{"v":0.515122510516247,"d":"0.52"},"down","no"]
["MSTRG.19433","DENND4A","ENSOART00000019666","GO:0005515(protein binding);GO:0017112(Rab guanyl-nucleotide exchange factor activity)","NA","K20163","NA","DENN domain containing 4A [Source:NCBI gene;Acc:101122440]",{"v":5.01598804368227,"d":"5.02"},{"v":3.87791188727516,"d":"3.88"},{"v":3.55452011976315,"d":"3.55"},{"v":3.73454556094291,"d":"3.73"},{"v":2.5600315562507,"d":"2.56"},{"v":2.70067331259077,"d":"2.70"},{"v":1.383888102715,"d":"1.38"},{"v":0.46872729544247,"d":"0.47"},{"v":0.0870449715294608,"d":"0.09"},{"v":0.515122510516247,"d":"0.52"},"up","no"]
["MSTRG.8314","RF00003","ENSOART00000024451","NA","NA","NA","NA",null,{"v":770.599365,"d":"770.60"},{"v":111.2463,"d":"111.25"},{"v":485.457947,"d":"485.46"},{"v":444.819336,"d":"444.82"},{"v":367.590363,"d":"367.59"},{"v":2281.9729,"d":"2281.97"},{"v":0.441866371806081,"d":"0.44"},{"v":-1.17831795576954,"d":"-1.18"},{"v":0.0871497161275822,"d":"0.09"},{"v":0.51538593441911,"d":"0.52"},"down","no"]
["MSTRG.4292","TRAF3IP3","ENSOART00000014043","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","TRAF3 interacting protein 3 [Source:NCBI gene;Acc:101121532]",{"v":2.75629963658537,"d":"2.76"},{"v":2.75512014878049,"d":"2.76"},{"v":2.87108816341463,"d":"2.87"},{"v":4.17217883170732,"d":"4.17"},{"v":4.36913757804878,"d":"4.37"},{"v":4.74092142195122,"d":"4.74"},{"v":0.631106599278759,"d":"0.63"},{"v":-0.664044385619545,"d":"-0.66"},{"v":0.0873958754222752,"d":"0.09"},{"v":0.51646755479367,"d":"0.52"},"down","no"]
["MSTRG.10686","CTDSP1","ENSOART00000021298","GO:0001933(negative regulation of protein phosphorylation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006470(protein dephosphorylation);GO:0008420(RNA polymerase II CTD heptapeptide repeat phosphatase activity);GO:0016791(phosphatase activity);GO:0045665(negative regulation of neuron differentiation);GO:0050768(negative regulation of neurogenesis);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA","K15731","EC:3.1.3.16","CTD small phosphatase 1 [Source:NCBI gene;Acc:101110306]",{"v":9.15922653741916,"d":"9.16"},{"v":5.15607991961811,"d":"5.16"},{"v":8.00107045241762,"d":"8.00"},{"v":11.5895491669233,"d":"11.59"},{"v":10.790577579304,"d":"10.79"},{"v":12.5527619759778,"d":"12.55"},{"v":0.638835714014956,"d":"0.64"},{"v":-0.646483126233384,"d":"-0.65"},{"v":0.0874652744464389,"d":"0.09"},{"v":0.516581160075481,"d":"0.52"},"down","no"]
["MSTRG.11045","ALDH4A1","ENSOART00000011362","GO:0003842(1-pyrroline-5-carboxylate dehydrogenase activity);GO:0004029(aldehyde dehydrogenase (NAD) activity);GO:0010133(proline catabolic process to glutamate);GO:0016491(oxidoreductase activity);GO:0016620(oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor);GO:0042802(identical protein binding);GO:0055114(oxidation-reduction process)","NA","NA","NA","aldehyde dehydrogenase 4 family member A1 [Source:HGNC Symbol;Acc:HGNC:406]",{"v":9.28432445208845,"d":"9.28"},{"v":6.55441391786592,"d":"6.55"},{"v":5.24962909406809,"d":"5.25"},{"v":9.34899954054054,"d":"9.35"},{"v":11.5104349255879,"d":"11.51"},{"v":12.4355786539137,"d":"12.44"},{"v":0.633379160656591,"d":"0.63"},{"v":-0.658858694070014,"d":"-0.66"},{"v":0.0875510540094569,"d":"0.09"},{"v":0.516581160075481,"d":"0.52"},"down","no"]
["MSTRG.15132","ENSOARG00000015872","ENSOART00000017283","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016740(transferase activity)","NA","NA","NA","ubiquitin-conjugating enzyme E2 D3 [Source:NCBI gene;Acc:101104471]",{"v":17.098646,"d":"17.10"},{"v":9.946994,"d":"9.95"},{"v":15.362097,"d":"15.36"},{"v":14.244325,"d":"14.24"},{"v":5.179317,"d":"5.18"},{"v":8.308167,"d":"8.31"},{"v":1.52920918357688,"d":"1.53"},{"v":0.61278576933244,"d":"0.61"},{"v":0.0876811330916495,"d":"0.09"},{"v":0.516581160075481,"d":"0.52"},"up","no"]
["MSTRG.20155","ENSOARG00000000726","ENSOART00000000780;ENSOART00000000782","GO:0006693(prostaglandin metabolic process);GO:0047522(15-oxoprostaglandin 13-oxidase activity);GO:0055114(oxidation-reduction process);GO:0055114(oxidation-reduction process)","NA","K13949","EC:1.3.1.48","prostaglandin reductase 2 [Source:NCBI gene;Acc:101105000]",{"v":9.24393755768116,"d":"9.24"},{"v":11.564475986087,"d":"11.56"},{"v":9.49191324,"d":"9.49"},{"v":7.26850446202898,"d":"7.27"},{"v":6.9537461315942,"d":"6.95"},{"v":7.52582406318841,"d":"7.53"},{"v":1.39324180470743,"d":"1.39"},{"v":0.478445667255804,"d":"0.48"},{"v":0.0876952839806006,"d":"0.09"},{"v":0.516581160075481,"d":"0.52"},"up","no"]
["ENSOARG00000015503","KIF20B","ENSOART00000016876","GO:0000166(nucleotide binding);GO:0001843(neural tube closure);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0007018(microtubule-based movement);GO:0007088(regulation of mitotic nuclear division);GO:0008017(microtubule binding);GO:0008284(positive regulation of cell population proliferation);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:0015630(microtubule cytoskeleton);GO:0016887(ATPase activity);GO:0030496(midbody);GO:0032467(positive regulation of cytokinesis);GO:0035372(protein localization to microtubule);GO:0042803(protein homodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0048812(neuron projection morphogenesis);GO:0050699(WW domain binding);GO:0051233(spindle midzone);GO:0070201(regulation of establishment of protein localization);GO:0070938(contractile ring);GO:0090316(positive regulation of intracellular protein transport);GO:0097431(mitotic spindle pole);GO:1903438(positive regulation of mitotic cytokinetic process);GO:1990023(mitotic spindle midzone);GO:2000114(regulation of establishment of cell polarity);GO:2001222(regulation of neuron migration);GO:2001224(positive regulation of neuron migration)","NA","K10402","NA","kinesin family member 20B [Source:NCBI gene;Acc:101122564]",{"v":0.202857,"d":"0.20"},{"v":0.048169,"d":"0.05"},{"v":0.127346,"d":"0.13"},{"v":0.272486,"d":"0.27"},{"v":0.206713,"d":"0.21"},{"v":0.26882,"d":"0.27"},{"v":0.505832071110493,"d":"0.51"},{"v":-0.983269584249894,"d":"-0.98"},{"v":0.0877276953699585,"d":"0.09"},{"v":0.516581160075481,"d":"0.52"},"down","no"]
["MSTRG.13506","ENSOARG00000003361","ENSOART00000003653;ENSOART00000003657","GO:0008146(sulfotransferase activity);GO:0016740(transferase activity);GO:0016740(transferase activity)","05204(Chemical carcinogenesis);05204(Chemical carcinogenesis)","K01014","EC:2.8.2.1","sulfotransferase 1A1 [Source:NCBI gene;Acc:101114075]",{"v":6.3603944952919,"d":"6.36"},{"v":4.6720788488028,"d":"4.67"},{"v":5.03170812617702,"d":"5.03"},{"v":7.15978135673931,"d":"7.16"},{"v":7.68113942157654,"d":"7.68"},{"v":10.2347065221953,"d":"10.23"},{"v":0.640629296238753,"d":"0.64"},{"v":-0.642438320234115,"d":"-0.64"},{"v":0.08778410183535,"d":"0.09"},{"v":0.516581160075481,"d":"0.52"},"down","no"]
["MSTRG.22205","ZDHHC9","ENSOART00000016426","GO:0002178(palmitoyltransferase complex);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016409(palmitoyltransferase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoyltransferase activity);GO:0031228(intrinsic component of Golgi membrane);GO:0043849(Ras palmitoyltransferase activity)","NA","NA","NA","zinc finger DHHC-type containing 9 [Source:NCBI gene;Acc:101120553]",{"v":3.77323640456316,"d":"3.77"},{"v":2.39273586087924,"d":"2.39"},{"v":2.50355722314969,"d":"2.50"},{"v":4.22267615525876,"d":"4.22"},{"v":4.38716290038954,"d":"4.39"},{"v":4.84874529883139,"d":"4.85"},{"v":0.64416355095374,"d":"0.64"},{"v":-0.634501064632288,"d":"-0.63"},{"v":0.0878518066097693,"d":"0.09"},{"v":0.516730655015963,"d":"0.52"},"down","no"]
["MSTRG.15432","CCDC142;MRPL53","ENSOART00000013824;ENSOART00000013806","GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit)","NA","K17434","NA","coiled-coil domain containing 142 [Source:NCBI gene;Acc:101106927];mitochondrial ribosomal protein L53 [Source:NCBI gene;Acc:101118259]",{"v":2.9124101602289,"d":"2.91"},{"v":2.72206203147353,"d":"2.72"},{"v":3.32404455221745,"d":"3.32"},{"v":4.39331410529328,"d":"4.39"},{"v":4.63201054420601,"d":"4.63"},{"v":4.81751869012876,"d":"4.82"},{"v":0.647158717622285,"d":"0.65"},{"v":-0.62780851397542,"d":"-0.63"},{"v":0.0879047303733008,"d":"0.09"},{"v":0.516855757124687,"d":"0.52"},"down","no"]
["MSTRG.11912","FLI1","ENSOART00000014324","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0008015(blood circulation);GO:0009887(animal organ morphogenesis);GO:0016604(nuclear body);GO:0035855(megakaryocyte development);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","05202(Transcriptional misregulation in cancer)","K09436","NA","Fli-1 proto-oncogene, ETS transcription factor [Source:NCBI gene;Acc:101115412]",{"v":1.57853774324635,"d":"1.58"},{"v":1.15028478793908,"d":"1.15"},{"v":1.51105331782352,"d":"1.51"},{"v":2.72662158353103,"d":"2.73"},{"v":2.25619120792837,"d":"2.26"},{"v":1.69697462470345,"d":"1.70"},{"v":0.634732153114614,"d":"0.63"},{"v":-0.655780168976793,"d":"-0.66"},{"v":0.0879372569988968,"d":"0.09"},{"v":0.516860882749455,"d":"0.52"},"down","no"]
["MSTRG.7666","RFC5","ENSOART00000003643","GO:0003677(DNA binding);GO:0003689(DNA clamp loader activity);GO:0005524(ATP binding);GO:0005663(DNA replication factor C complex);GO:0006260(DNA replication);GO:0019899(enzyme binding);GO:0031390(Ctf18 RFC-like complex);GO:0043142(single-stranded DNA-dependent ATPase activity);GO:1900264(positive regulation of DNA-directed DNA polymerase activity)","03030(DNA replication);03420(Nucleotide excision repair);03430(Mismatch repair)","K10756","NA","replication factor C subunit 5 [Source:NCBI gene;Acc:101109740]",{"v":9.55704334214271,"d":"9.56"},{"v":9.97827897845091,"d":"9.98"},{"v":10.7275627906078,"d":"10.73"},{"v":8.85947539886156,"d":"8.86"},{"v":6.42120428237447,"d":"6.42"},{"v":6.78951246269567,"d":"6.79"},{"v":1.37121076762,"d":"1.37"},{"v":0.455450343567557,"d":"0.46"},{"v":0.088049164180454,"d":"0.09"},{"v":0.517332404727763,"d":"0.52"},"up","no"]
["MSTRG.10680","IGFBP5","ENSOART00000021151","GO:0001558(regulation of cell growth);GO:0001649(osteoblast differentiation);GO:0001968(fibronectin binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006006(glucose metabolic process);GO:0007565(female pregnancy);GO:0010906(regulation of glucose metabolic process);GO:0014912(negative regulation of smooth muscle cell migration);GO:0017148(negative regulation of translation);GO:0030336(negative regulation of cell migration);GO:0031069(hair follicle morphogenesis);GO:0031994(insulin-like growth factor I binding);GO:0040008(regulation of growth);GO:0042567(insulin-like growth factor ternary complex);GO:0042593(glucose homeostasis);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway);GO:0044342(type B pancreatic cell proliferation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045926(negative regulation of growth);GO:0048286(lung alveolus development);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051146(striated muscle cell differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0060056(mammary gland involution);GO:0060416(response to growth hormone);GO:0071320(cellular response to cAMP);GO:0071407(cellular response to organic cyclic compound);GO:1901862(negative regulation of muscle tissue development);GO:1904205(negative regulation of skeletal muscle hypertrophy);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1904754(positive regulation of vascular associated smooth muscle cell migration)","NA","NA","NA","insulin like growth factor binding protein 5 [Source:NCBI gene;Acc:443133]",{"v":79.4610051492051,"d":"79.46"},{"v":150.050396381574,"d":"150.05"},{"v":114.903972695475,"d":"114.90"},{"v":82.4637572825112,"d":"82.46"},{"v":70.2490761960864,"d":"70.25"},{"v":89.621838217285,"d":"89.62"},{"v":1.42123853683833,"d":"1.42"},{"v":0.507148712942901,"d":"0.51"},{"v":0.0882478514312449,"d":"0.09"},{"v":0.518206983265894,"d":"0.52"},"up","no"]
["MSTRG.20984","PHF20L1","ENSOART00000006558","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","K18402","NA","PHD finger protein 20 like 1 [Source:NCBI gene;Acc:101101898]",{"v":0.86009554909538,"d":"0.86"},{"v":0.725366169067276,"d":"0.73"},{"v":1.0054471587915,"d":"1.01"},{"v":1.88865821508871,"d":"1.89"},{"v":0.894955847971193,"d":"0.89"},{"v":1.42158346170736,"d":"1.42"},{"v":0.616120613049574,"d":"0.62"},{"v":-0.698715291344935,"d":"-0.70"},{"v":0.0885066019770137,"d":"0.09"},{"v":0.518989407572318,"d":"0.52"},"down","no"]
["MSTRG.5132","RIPOR3","ENSOART00000014841","NA","NA","NA","NA","RIPOR family member 3 [Source:NCBI gene;Acc:101118467]",{"v":0.13096,"d":"0.13"},{"v":0.219779,"d":"0.22"},{"v":0.161034,"d":"0.16"},{"v":0.42973,"d":"0.43"},{"v":0.365254,"d":"0.37"},{"v":0.218021,"d":"0.22"},{"v":0.505202837103469,"d":"0.51"},{"v":-0.985065353894096,"d":"-0.99"},{"v":0.0885218949099036,"d":"0.09"},{"v":0.518989407572318,"d":"0.52"},"down","no"]
["MSTRG.163","NT5C1A","ENSOART00000021874","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0005737(cytoplasm);GO:0008253(5'-nucleotidase activity);GO:0009117(nucleotide metabolic process);GO:0009128(purine nucleoside monophosphate catabolic process);GO:0016311(dephosphorylation)","00230(Purine metabolism);00240(Pyrimidine metabolism);00760(Nicotinate and nicotinamide metabolism)","K01081","EC:3.1.3.5","5'-nucleotidase, cytosolic IA [Source:NCBI gene;Acc:101119593]",{"v":33.1230998078991,"d":"33.12"},{"v":37.3279757663506,"d":"37.33"},{"v":28.3214202139016,"d":"28.32"},{"v":28.364091600743,"d":"28.36"},{"v":21.9275249959918,"d":"21.93"},{"v":22.1222966633102,"d":"22.12"},{"v":1.3639988690219,"d":"1.36"},{"v":0.447842448132486,"d":"0.45"},{"v":0.0885699667338321,"d":"0.09"},{"v":0.51908485887653,"d":"0.52"},"up","no"]
["MSTRG.19109","NUDT9","ENSOART00000005393","GO:0005739(mitochondrion);GO:0016787(hydrolase activity);GO:0043262(adenosine-diphosphatase activity);GO:0046032(ADP catabolic process);GO:0046709(IDP catabolic process);GO:0047631(ADP-ribose diphosphatase activity)","00230(Purine metabolism)","K13988","EC:3.6.1.13","nudix hydrolase 9 [Source:NCBI gene;Acc:100529154]",{"v":2.0732238928691,"d":"2.07"},{"v":2.06435886709073,"d":"2.06"},{"v":2.12063024137931,"d":"2.12"},{"v":1.76387926481419,"d":"1.76"},{"v":1.45875785972548,"d":"1.46"},{"v":1.38297003649146,"d":"1.38"},{"v":1.35882475046743,"d":"1.36"},{"v":0.44235940170142,"d":"0.44"},{"v":0.0887637469154121,"d":"0.09"},{"v":0.519847367157406,"d":"0.52"},"up","no"]
["MSTRG.10432","MGAT5","ENSOART00000012433","GO:0004864(protein phosphatase inhibitor activity);GO:0005794(Golgi apparatus);GO:0006487(protein N-linked glycosylation);GO:0008375(acetylglucosaminyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030144(alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity);GO:0030145(manganese ion binding);GO:0030335(positive regulation of cell migration);GO:1903614(negative regulation of protein tyrosine phosphatase activity);GO:1904894(positive regulation of receptor signaling pathway via STAT)","00510(N-Glycan biosynthesis)","K00744","EC:2.4.1.155","alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase [Source:NCBI gene;Acc:101107672]",{"v":1.516153,"d":"1.52"},{"v":0.863507,"d":"0.86"},{"v":1.516467,"d":"1.52"},{"v":2.474923,"d":"2.47"},{"v":2.067657,"d":"2.07"},{"v":1.639087,"d":"1.64"},{"v":0.630271252074885,"d":"0.63"},{"v":-0.665955234844207,"d":"-0.67"},{"v":0.0888536747905199,"d":"0.09"},{"v":0.520187451408967,"d":"0.52"},"down","no"]
["MSTRG.1789","CHST2","ENSOART00000006333","GO:0000139(Golgi membrane);GO:0001517(N-acetylglucosamine 6-O-sulfotransferase activity);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005975(carbohydrate metabolic process);GO:0006044(N-acetylglucosamine metabolic process);GO:0006790(sulfur compound metabolic process);GO:0008146(sulfotransferase activity);GO:0016740(transferase activity)","NA","NA","NA","carbohydrate sulfotransferase 2 [Source:HGNC Symbol;Acc:HGNC:1970]",{"v":1.304112,"d":"1.30"},{"v":0.675461,"d":"0.68"},{"v":0.814957,"d":"0.81"},{"v":1.424353,"d":"1.42"},{"v":1.644658,"d":"1.64"},{"v":1.779928,"d":"1.78"},{"v":0.576317829529305,"d":"0.58"},{"v":-0.795063441854391,"d":"-0.80"},{"v":0.088899109560446,"d":"0.09"},{"v":0.520208932743536,"d":"0.52"},"down","no"]
["MSTRG.4605","MRC1","ENSOART00000013248;ENSOART00000013254","GO:0004888(transmembrane signaling receptor activity);GO:0005537(mannose binding);GO:0005886(plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0009986(cell surface);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0038024(cargo receptor activity);GO:0071222(cellular response to lipopolysaccharide);GO:0071346(cellular response to interferon-gamma);GO:0071353(cellular response to interleukin-4);GO:0071353(cellular response to interleukin-4)","04145(Phagosome);05152(Tuberculosis);05152(Tuberculosis)","K06560","NA","mannose receptor C-type 1 [Source:NCBI gene;Acc:100505388]",{"v":1.32024236199696,"d":"1.32"},{"v":1.03260503302961,"d":"1.03"},{"v":2.01121857630979,"d":"2.01"},{"v":2.77504633485194,"d":"2.78"},{"v":1.81934734757024,"d":"1.82"},{"v":2.5393020785877,"d":"2.54"},{"v":0.611753867495824,"d":"0.61"},{"v":-0.708976777864416,"d":"-0.71"},{"v":0.0889400943247063,"d":"0.09"},{"v":0.520208932743536,"d":"0.52"},"down","no"]
["ENSOARG00000018095","ABCA3","ENSOART00000019704","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport);GO:0097208(alveolar lamellar body);GO:0097233(alveolar lamellar body membrane)","NA","NA","NA","ATP-binding cassette sub-family A member 3 [Source:NCBI gene;Acc:101115674]",{"v":0.116541,"d":"0.12"},{"v":0.164272,"d":"0.16"},{"v":0.114365,"d":"0.11"},{"v":0.208645,"d":"0.21"},{"v":0.278761,"d":"0.28"},{"v":0.254923,"d":"0.25"},{"v":0.532348864182862,"d":"0.53"},{"v":-0.909556097891703,"d":"-0.91"},{"v":0.0890838620560014,"d":"0.09"},{"v":0.520269694197124,"d":"0.52"},"down","no"]
["MSTRG.7735","ACADS","ENSOART00000014260","GO:0003995(acyl-CoA dehydrogenase activity);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0033539(fatty acid beta-oxidation using acyl-CoA dehydrogenase);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation);00650(Butanoate metabolism)","K00248","EC:1.3.8.1","acyl-CoA dehydrogenase short chain [Source:NCBI gene;Acc:101119850]",{"v":6.458880846875,"d":"6.46"},{"v":6.01490381979167,"d":"6.01"},{"v":4.65322571145833,"d":"4.65"},{"v":9.83918811510417,"d":"9.84"},{"v":7.8476813125,"d":"7.85"},{"v":9.0003319421875,"d":"9.00"},{"v":0.641768694319209,"d":"0.64"},{"v":-0.639874678673659,"d":"-0.64"},{"v":0.0890852290044692,"d":"0.09"},{"v":0.520269694197124,"d":"0.52"},"down","no"]
["MSTRG.17386","ENSOARG00000001382","ENSOART00000001479","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","03010(Ribosome)","K02940","NA","60S ribosomal protein L9 [Source:NCBI gene;Acc:101120489]",{"v":1.208381,"d":"1.21"},{"v":0.813038,"d":"0.81"},{"v":1.862318,"d":"1.86"},{"v":2.538674,"d":"2.54"},{"v":1.836421,"d":"1.84"},{"v":2.979196,"d":"2.98"},{"v":0.528091287113877,"d":"0.53"},{"v":-0.921140756055736,"d":"-0.92"},{"v":0.0891015045166687,"d":"0.09"},{"v":0.520269694197124,"d":"0.52"},"down","no"]
["MSTRG.8786","ENSOARG00000002247","ENSOART00000002429","NA","NA","NA","NA","xin actin binding repeat containing 1 [Source:NCBI gene;Acc:101112767]",{"v":49.6248619836884,"d":"49.62"},{"v":34.8431857616555,"d":"34.84"},{"v":95.3266677991479,"d":"95.33"},{"v":27.4554310138771,"d":"27.46"},{"v":45.338946653804,"d":"45.34"},{"v":43.3241334707243,"d":"43.32"},{"v":1.54837255302205,"d":"1.55"},{"v":0.630752639267055,"d":"0.63"},{"v":0.0891534620703178,"d":"0.09"},{"v":0.520269694197124,"d":"0.52"},"up","no"]
["MSTRG.3730","LRRN2","ENSOART00000003152","GO:0005515(protein binding)","NA","NA","NA","leucine rich repeat neuronal 2 [Source:NCBI gene;Acc:101109030]",{"v":0.979587,"d":"0.98"},{"v":0.666362,"d":"0.67"},{"v":0.978014,"d":"0.98"},{"v":1.120115,"d":"1.12"},{"v":1.598373,"d":"1.60"},{"v":1.740162,"d":"1.74"},{"v":0.588510647841836,"d":"0.59"},{"v":-0.764859576905471,"d":"-0.76"},{"v":0.0891863592637034,"d":"0.09"},{"v":0.520269694197124,"d":"0.52"},"down","no"]
["ENSOARG00000015313","SPOCK1","ENSOART00000016661","GO:0004869(cysteine-type endopeptidase inhibitor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0008191(metalloendopeptidase inhibitor activity);GO:0010812(negative regulation of cell-substrate adhesion);GO:0010951(negative regulation of endopeptidase activity);GO:0010977(negative regulation of neuron projection development)","NA","K08136","NA","SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1 [Source:NCBI gene;Acc:101120081]",{"v":0.443343,"d":"0.44"},{"v":0.297186,"d":"0.30"},{"v":0.382182,"d":"0.38"},{"v":0.797858,"d":"0.80"},{"v":0.430189,"d":"0.43"},{"v":0.75545,"d":"0.76"},{"v":0.566026064067654,"d":"0.57"},{"v":-0.821059607845422,"d":"-0.82"},{"v":0.0893623353511635,"d":"0.09"},{"v":0.520738119776516,"d":"0.52"},"down","no"]
["MSTRG.17374","ENSOARG00000018561","ENSOART00000020199","NA","NA","NA","NA",null,{"v":14.491009,"d":"14.49"},{"v":16.006845,"d":"16.01"},{"v":21.191795,"d":"21.19"},{"v":25.414021,"d":"25.41"},{"v":26.548567,"d":"26.55"},{"v":29.310959,"d":"29.31"},{"v":0.635995977879494,"d":"0.64"},{"v":-0.652910453138198,"d":"-0.65"},{"v":0.0894642914301615,"d":"0.09"},{"v":0.521146254181833,"d":"0.52"},"down","no"]
["MSTRG.17930","GIPC3","ENSOART00000013383","GO:0005515(protein binding)","NA","K20056","NA","GIPC PDZ domain containing family member 3 [Source:NCBI gene;Acc:101117930]",{"v":1.18611,"d":"1.19"},{"v":0.199511,"d":"0.20"},{"v":0.212503,"d":"0.21"},{"v":1.23634,"d":"1.24"},{"v":1.056505,"d":"1.06"},{"v":1.245671,"d":"1.25"},{"v":0.451636787851178,"d":"0.45"},{"v":-1.14676508997916,"d":"-1.15"},{"v":0.0896321977901065,"d":"0.09"},{"v":0.52172955799598,"d":"0.52"},"down","no"]
["MSTRG.5494","PSMB10","ENSOART00000003519","GO:0000502(proteasome complex);GO:0000902(cell morphogenesis);GO:0002376(immune system process);GO:0004175(endopeptidase activity);GO:0004298(threonine-type endopeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005839(proteasome core complex);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016787(hydrolase activity);GO:0042098(T cell proliferation);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:1990111(spermatoproteasome complex)","03050(Proteasome)","K02733","EC:3.4.25.1","proteasome subunit beta 10 [Source:NCBI gene;Acc:101116929]",{"v":3.157326,"d":"3.16"},{"v":3.061201,"d":"3.06"},{"v":2.445689,"d":"2.45"},{"v":3.519769,"d":"3.52"},{"v":5.124541,"d":"5.12"},{"v":5.96088,"d":"5.96"},{"v":0.593228571487259,"d":"0.59"},{"v":-0.753340011339034,"d":"-0.75"},{"v":0.0896397739583192,"d":"0.09"},{"v":0.52172955799598,"d":"0.52"},"down","no"]
["MSTRG.16020","SUOX","ENSOART00000011505","GO:0016491(oxidoreductase activity);GO:0020037(heme binding);GO:0030151(molybdenum ion binding);GO:0042128(nitrate assimilation);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00920(Sulfur metabolism)","K00387","EC:1.8.3.1","sulfite oxidase [Source:NCBI gene;Acc:101111953]",{"v":1.860568,"d":"1.86"},{"v":1.397878,"d":"1.40"},{"v":1.295001,"d":"1.30"},{"v":2.757112,"d":"2.76"},{"v":2.28079,"d":"2.28"},{"v":2.460598,"d":"2.46"},{"v":0.607247716209909,"d":"0.61"},{"v":-0.719642935829162,"d":"-0.72"},{"v":0.0896902245892015,"d":"0.09"},{"v":0.52172955799598,"d":"0.52"},"down","no"]
["MSTRG.7266","CPE","ENSOART00000017588","GO:0003214(cardiac left ventricle morphogenesis);GO:0004180(carboxypeptidase activity);GO:0004181(metallocarboxypeptidase activity);GO:0005794(Golgi apparatus);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0016055(Wnt signaling pathway);GO:0030070(insulin processing);GO:0030072(peptide hormone secretion);GO:0030667(secretory granule membrane);GO:0033366(protein localization to secretory granule);GO:0042043(neurexin family protein binding);GO:0050839(cell adhesion molecule binding);GO:0072657(protein localization to membrane)","04940(Type I diabetes mellitus)","K01294","EC:3.4.17.10","carboxypeptidase E [Source:NCBI gene;Acc:443028]",{"v":2.232083,"d":"2.23"},{"v":1.115041,"d":"1.12"},{"v":0.94077,"d":"0.94"},{"v":2.304746,"d":"2.30"},{"v":2.219964,"d":"2.22"},{"v":2.799042,"d":"2.80"},{"v":0.585477771502913,"d":"0.59"},{"v":-0.772313697092175,"d":"-0.77"},{"v":0.0897873925774349,"d":"0.09"},{"v":0.522097060542862,"d":"0.52"},"down","no"]
["MSTRG.539","CNN3","ENSOART00000018966","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005829(cytosol);GO:0015629(actin cytoskeleton);GO:0030855(epithelial cell differentiation);GO:0031032(actomyosin structure organization)","NA","NA","NA","calponin 3 [Source:NCBI gene;Acc:101108091]",{"v":19.5965573887734,"d":"19.60"},{"v":14.8745335883576,"d":"14.87"},{"v":18.57320602079,"d":"18.57"},{"v":26.4989794927235,"d":"26.50"},{"v":26.8700423451143,"d":"26.87"},{"v":28.0753636091476,"d":"28.08"},{"v":0.651294705053047,"d":"0.65"},{"v":-0.618617597101162,"d":"-0.62"},{"v":0.0900612413633147,"d":"0.09"},{"v":0.52298586429529,"d":"0.52"},"down","no"]
["MSTRG.22276","KLHL4","ENSOART00000018760","GO:0005515(protein binding);GO:0005815(microtubule organizing center);GO:0015630(microtubule cytoskeleton)","NA","K10442","NA","kelch like family member 4 [Source:NCBI gene;Acc:101108287]",{"v":1.588742,"d":"1.59"},{"v":0.723401,"d":"0.72"},{"v":0.463749,"d":"0.46"},{"v":1.716655,"d":"1.72"},{"v":1.728263,"d":"1.73"},{"v":1.546812,"d":"1.55"},{"v":0.556098186400306,"d":"0.56"},{"v":-0.8465884627898,"d":"-0.85"},{"v":0.09013720445163,"d":"0.09"},{"v":0.523093943055436,"d":"0.52"},"down","no"]
["MSTRG.1573","TBL1XR1","ENSOART00000022572","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008013(beta-catenin binding);GO:0017053(transcriptional repressor complex);GO:0042393(histone binding);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0072686(mitotic spindle);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04310(Wnt signaling pathway)","K04508","NA","transducin beta like 1 X-linked receptor 1 [Source:NCBI gene;Acc:101111508]",{"v":6.92083164948781,"d":"6.92"},{"v":6.64616471579449,"d":"6.65"},{"v":6.15685997228619,"d":"6.16"},{"v":5.74582056054951,"d":"5.75"},{"v":4.72796751203049,"d":"4.73"},{"v":4.02772099618836,"d":"4.03"},{"v":1.36012440112508,"d":"1.36"},{"v":0.443738610797979,"d":"0.44"},{"v":0.0901510506956147,"d":"0.09"},{"v":0.523093943055436,"d":"0.52"},"up","no"]
["MSTRG.10250","METAP1D","ENSOART00000001592;ENSOART00000001593","GO:0004177(aminopeptidase activity);GO:0005739(mitochondrion);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008235(metalloexopeptidase activity);GO:0016787(hydrolase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0070006(metalloaminopeptidase activity);GO:0070084(protein initiator methionine removal);GO:0070084(protein initiator methionine removal)","NA","K01265","EC:3.4.11.18","methionyl aminopeptidase type 1D, mitochondrial [Source:NCBI gene;Acc:101114168]",{"v":1.60142846716558,"d":"1.60"},{"v":2.15383138147802,"d":"2.15"},{"v":1.85110178858747,"d":"1.85"},{"v":1.2380969111319,"d":"1.24"},{"v":1.3050511253508,"d":"1.31"},{"v":1.4280575049579,"d":"1.43"},{"v":1.41175307566611,"d":"1.41"},{"v":0.497487774399359,"d":"0.50"},{"v":0.0902077135599527,"d":"0.09"},{"v":0.523236784016664,"d":"0.52"},"up","no"]
["MSTRG.21672","TMEM47","ENSOART00000020356","GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 47 [Source:HGNC Symbol;Acc:HGNC:18515]",{"v":2.919227,"d":"2.92"},{"v":2.753394,"d":"2.75"},{"v":3.565704,"d":"3.57"},{"v":5.531819,"d":"5.53"},{"v":5.588914,"d":"5.59"},{"v":5.159723,"d":"5.16"},{"v":0.567448786446768,"d":"0.57"},{"v":-0.817437903141684,"d":"-0.82"},{"v":0.0904660137603063,"d":"0.09"},{"v":0.523804635701518,"d":"0.52"},"down","no"]
["MSTRG.4615","ARHGAP12","ENSOART00000014969","GO:0001891(phagocytic cup);GO:0002011(morphogenesis of an epithelial sheet);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0006911(phagocytosis, engulfment);GO:0007015(actin filament organization);GO:0007165(signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0051058(negative regulation of small GTPase mediated signal transduction)","NA","K20636","NA","Rho GTPase activating protein 12 [Source:NCBI gene;Acc:101114797]",{"v":1.84483925122411,"d":"1.84"},{"v":1.96524941318267,"d":"1.97"},{"v":1.21957841186441,"d":"1.22"},{"v":1.53884923239171,"d":"1.54"},{"v":1.28677066798493,"d":"1.29"},{"v":0.665572268361582,"d":"0.67"},{"v":1.44067322369396,"d":"1.44"},{"v":0.526743137720521,"d":"0.53"},{"v":0.0908584712692136,"d":"0.09"},{"v":0.52533184096449,"d":"0.53"},"up","no"]
["MSTRG.9143","SHISA5","ENSOART00000000094","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","shisa family member 5 [Source:HGNC Symbol;Acc:HGNC:30376]",{"v":1.90377263867403,"d":"1.90"},{"v":1.96358177237569,"d":"1.96"},{"v":3.04074169723757,"d":"3.04"},{"v":3.96150369944751,"d":"3.96"},{"v":3.57633724198895,"d":"3.58"},{"v":4.15435864972376,"d":"4.15"},{"v":0.590829471771085,"d":"0.59"},{"v":-0.759186302438161,"d":"-0.76"},{"v":0.0910184109807693,"d":"0.09"},{"v":0.526045680436934,"d":"0.53"},"down","no"]
["MSTRG.3644","SLC9A3R1","ENSOART00000013311","GO:0003096(renal sodium ion transport);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005902(microvillus);GO:0007097(nuclear migration);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007605(sensory perception of sound);GO:0008013(beta-catenin binding);GO:0008285(negative regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0008361(regulation of cell size);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0010766(negative regulation of sodium ion transport);GO:0012505(endomembrane system);GO:0014067(negative regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0017081(chloride channel regulator activity);GO:0019902(phosphatase binding);GO:0019933(cAMP-mediated signaling);GO:0022612(gland morphogenesis);GO:0030033(microvillus assembly);GO:0030036(actin cytoskeleton organization);GO:0030165(PDZ domain binding);GO:0030336(negative regulation of cell migration);GO:0030643(cellular phosphate ion homeostasis);GO:0031526(brush border membrane);GO:0031698(beta-2 adrenergic receptor binding);GO:0032416(negative regulation of sodium:proton antiporter activity);GO:0032420(stereocilium);GO:0032426(stereocilium tip);GO:0032782(bile acid secretion);GO:0032947(protein-containing complex scaffold activity);GO:0034613(cellular protein localization);GO:0034635(glutathione transport);GO:0043621(protein self-association);GO:0044062(regulation of excretion);GO:0045177(apical part of cell);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0045859(regulation of protein kinase activity);GO:0045930(negative regulation of mitotic cell cycle);GO:0048471(perinuclear region of cytoplasm);GO:0050780(dopamine receptor binding);GO:0051683(establishment of Golgi localization);GO:0051898(negative regulation of protein kinase B signaling);GO:0060088(auditory receptor cell stereocilium organization);GO:0060158(phospholipase C-activating dopamine receptor signaling pathway);GO:0070293(renal absorption);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070851(growth factor receptor binding);GO:0071944(cell periphery);GO:0072659(protein localization to plasma membrane);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097225(sperm midpiece);GO:0097291(renal phosphate ion absorption);GO:2000146(negative regulation of cell motility);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04530(Tight junction);04928(Parathyroid hormone synthesis, secretion and action);05165(Human papillomavirus infection)","K13365","NA","SLC9A3 regulator 1 [Source:NCBI gene;Acc:780527]",{"v":1.854431,"d":"1.85"},{"v":1.74257,"d":"1.74"},{"v":2.801619,"d":"2.80"},{"v":1.261386,"d":"1.26"},{"v":1.234977,"d":"1.23"},{"v":1.632915,"d":"1.63"},{"v":1.54957355741125,"d":"1.55"},{"v":0.631871240496014,"d":"0.63"},{"v":0.091055247913534,"d":"0.09"},{"v":0.526045680436934,"d":"0.53"},"up","no"]
["MSTRG.16351","GABARAPL1","ENSOART00000022888","GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005776(autophagosome);GO:0006914(autophagy);GO:0030957(Tat protein binding);GO:0031625(ubiquitin protein ligase binding)","04068(FoxO signaling pathway);04136(Autophagy - other);04137(Mitophagy - animal);04140(Autophagy - animal);04371(Apelin signaling pathway);04621(NOD-like receptor signaling pathway);04727(GABAergic synapse);05167(Kaposi sarcoma-associated herpesvirus infection)","K08341","NA","GABA type A receptor associated protein like 1 [Source:NCBI gene;Acc:101117406]",{"v":7.84498048609955,"d":"7.84"},{"v":10.7458640624272,"d":"10.75"},{"v":8.93048993391044,"d":"8.93"},{"v":6.46275897203263,"d":"6.46"},{"v":6.84730711952722,"d":"6.85"},{"v":6.54701544381555,"d":"6.55"},{"v":1.38597076480791,"d":"1.39"},{"v":0.470896826081556,"d":"0.47"},{"v":0.0911905277802625,"d":"0.09"},{"v":0.526505989248984,"d":"0.53"},"up","no"]
["MSTRG.16378","C12orf57","ENSOART00000005592","GO:0005737(cytoplasm);GO:0009791(post-embryonic development);GO:0014819(regulation of skeletal muscle contraction);GO:0016607(nuclear speck);GO:0021540(corpus callosum morphogenesis);GO:0021678(third ventricle development);GO:0036343(psychomotor behavior);GO:0048593(camera-type eye morphogenesis);GO:0050890(cognition)","NA","NA","NA","chromosome 3 open reading frame, human C12orf57 [Source:NCBI gene;Acc:101108904]",{"v":11.051607,"d":"11.05"},{"v":7.123646,"d":"7.12"},{"v":11.157997,"d":"11.16"},{"v":13.952868,"d":"13.95"},{"v":14.537041,"d":"14.54"},{"v":19.371897,"d":"19.37"},{"v":0.612873864391996,"d":"0.61"},{"v":-0.706337911576572,"d":"-0.71"},{"v":0.0912939295983396,"d":"0.09"},{"v":0.526916678148352,"d":"0.53"},"down","no"]
["MSTRG.2685","ENSOARG00000009184","ENSOART00000009994","GO:0005576(extracellular region);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0060326(cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)","K05514","NA","C-C motif chemokine ligand 1 [Source:NCBI gene;Acc:101114628]",{"v":3.735008,"d":"3.74"},{"v":1.331452,"d":"1.33"},{"v":1.934762,"d":"1.93"},{"v":3.473754,"d":"3.47"},{"v":4.476861,"d":"4.48"},{"v":5.27633,"d":"5.28"},{"v":0.52931512151899,"d":"0.53"},{"v":-0.91780122529236,"d":"-0.92"},{"v":0.0913827481807222,"d":"0.09"},{"v":0.526980287517726,"d":"0.53"},"down","no"]
["ENSOARG00000021098","TMEM260","ENSOART00000022987","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 260 [Source:NCBI gene;Acc:101120752]",{"v":1.506944,"d":"1.51"},{"v":0.931627,"d":"0.93"},{"v":1.175507,"d":"1.18"},{"v":2.040778,"d":"2.04"},{"v":2.14978,"d":"2.15"},{"v":1.760759,"d":"1.76"},{"v":0.607273650521389,"d":"0.61"},{"v":-0.719581322582014,"d":"-0.72"},{"v":0.0913882896967341,"d":"0.09"},{"v":0.526980287517726,"d":"0.53"},"down","no"]
["ENSOARG00000018424","CCNF","ENSOART00000020054","GO:0000320(re-entry into mitotic cell cycle);GO:0001890(placenta development);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0005814(centriole);GO:0010826(negative regulation of centrosome duplication);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0030054(cell junction);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0051726(regulation of cell cycle)","NA","K10289","NA","cyclin F [Source:NCBI gene;Acc:101116197]",{"v":0.110862,"d":"0.11"},{"v":0.100187,"d":"0.10"},{"v":0.087992,"d":"0.09"},{"v":0.252567,"d":"0.25"},{"v":0.149672,"d":"0.15"},{"v":0.152674,"d":"0.15"},{"v":0.538897088372412,"d":"0.54"},{"v":-0.891918302930589,"d":"-0.89"},{"v":0.0914137090813055,"d":"0.09"},{"v":0.526980287517726,"d":"0.53"},"down","no"]
["MSTRG.903","ARHGEF2","ENSOART00000005554;ENSOART00000005552","GO:0000132(establishment of mitotic spindle orientation);GO:0000902(cell morphogenesis);GO:0002102(podosome);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007015(actin filament organization);GO:0007026(negative regulation of microtubule depolymerization);GO:0008017(microtubule binding);GO:0014069(postsynaptic density);GO:0017048(Rho GTPase binding);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031982(vesicle);GO:0032587(ruffle membrane);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0032991(protein-containing complex);GO:0035023(regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0043025(neuronal cell body);GO:0043198(dendritic shaft);GO:0045666(positive regulation of neuron differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048365(Rac GTPase binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050768(negative regulation of neurogenesis);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0055059(asymmetric neuroblast division);GO:0071225(cellular response to muramyl dipeptide);GO:0071802(negative regulation of podosome assembly);GO:2001224(positive regulation of neuron migration);GO:2001224(positive regulation of neuron migration)","04530(Tight junction);05418(Fluid shear stress and atherosclerosis);05418(Fluid shear stress and atherosclerosis)","K12791","NA","Rho/Rac guanine nucleotide exchange factor 2 [Source:NCBI gene;Acc:101121729]",{"v":8.30027274417975,"d":"8.30"},{"v":4.15406170817542,"d":"4.15"},{"v":4.30126729750948,"d":"4.30"},{"v":9.24651851678397,"d":"9.25"},{"v":8.37460582079047,"d":"8.37"},{"v":8.88706236870601,"d":"8.89"},{"v":0.632091584970421,"d":"0.63"},{"v":-0.661794486469229,"d":"-0.66"},{"v":0.091718953961183,"d":"0.09"},{"v":0.52806314537313,"d":"0.53"},"down","no"]
["MSTRG.20588","ENPP1","ENSOART00000015466;ENSOART00000015468","GO:0003676(nucleic acid binding);GO:0003824(catalytic activity);GO:0004527(exonuclease activity);GO:0004528(phosphodiesterase I activity);GO:0004551(nucleotide diphosphatase activity);GO:0005044(scavenger receptor activity);GO:0005158(insulin receptor binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006091(generation of precursor metabolites and energy);GO:0006796(phosphate-containing compound metabolic process);GO:0006898(receptor-mediated endocytosis);GO:0006955(immune response);GO:0009143(nucleoside triphosphate catabolic process);GO:0009986(cell surface);GO:0016787(hydrolase activity);GO:0030247(polysaccharide binding);GO:0030308(negative regulation of cell growth);GO:0030505(inorganic diphosphate transport);GO:0030643(cellular phosphate ion homeostasis);GO:0030730(sequestering of triglyceride);GO:0031953(negative regulation of protein autophosphorylation);GO:0032869(cellular response to insulin stimulus);GO:0042803(protein homodimerization activity);GO:0045599(negative regulation of fat cell differentiation);GO:0045719(negative regulation of glycogen biosynthetic process);GO:0046325(negative regulation of glucose import);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046872(metal ion binding);GO:0047429(nucleoside-triphosphate diphosphatase activity);GO:0050427(3'-phosphoadenosine 5'-phosphosulfate metabolic process);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","00230(Purine metabolism);00240(Pyrimidine metabolism);00500(Starch and sucrose metabolism);00740(Riboflavin metabolism);00760(Nicotinate and nicotinamide metabolism);00770(Pantothenate and CoA biosynthesis);00770(Pantothenate and CoA biosynthesis)","K01513","3.6.1.9;EC:3.1.4.1","ectonucleotide pyrophosphatase/phosphodiesterase 1 [Source:NCBI gene;Acc:101123048]",{"v":3.10268540080192,"d":"3.10"},{"v":2.57209003480353,"d":"2.57"},{"v":2.95883215252606,"d":"2.96"},{"v":4.29899119967923,"d":"4.30"},{"v":4.23157621106656,"d":"4.23"},{"v":4.67556973039294,"d":"4.68"},{"v":0.653757226345679,"d":"0.65"},{"v":-0.61317310652135,"d":"-0.61"},{"v":0.091813647172568,"d":"0.09"},{"v":0.528422006004121,"d":"0.53"},"down","no"]
["ENSOARG00000003953","ENSOARG00000003953","ENSOART00000004296","GO:0004044(amidophosphoribosyltransferase activity);GO:0006164(purine nucleotide biosynthetic process);GO:0006189('de novo' IMP biosynthetic process);GO:0009113(purine nucleobase biosynthetic process);GO:0009116(nucleoside metabolic process);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0046872(metal ion binding);GO:0051536(iron-sulfur cluster binding)","00230(Purine metabolism);00250(Alanine, aspartate and glutamate metabolism)","K00764","EC:2.4.2.14","phosphoribosyl pyrophosphate amidotransferase [Source:NCBI gene;Acc:101109095]",{"v":0.610609,"d":"0.61"},{"v":0.122895,"d":"0.12"},{"v":0.169591,"d":"0.17"},{"v":0.591942,"d":"0.59"},{"v":0.716355,"d":"0.72"},{"v":0.569476,"d":"0.57"},{"v":0.480939389372411,"d":"0.48"},{"v":-1.05607300580186,"d":"-1.06"},{"v":0.0921165244411454,"d":"0.09"},{"v":0.529791691114837,"d":"0.53"},"down","no"]
["MSTRG.13849","ACTA1","ENSOART00000003299","GO:0000166(nucleotide binding);GO:0001725(stress fiber);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005865(striated muscle thin filament);GO:0005884(actin filament);GO:0010628(positive regulation of gene expression);GO:0015629(actin cytoskeleton);GO:0030017(sarcomere);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0030240(skeletal muscle thin filament assembly);GO:0044297(cell body);GO:0048741(skeletal muscle fiber development);GO:0090131(mesenchyme migration)","NA","K10354","NA","actin, alpha 1, skeletal muscle [Source:NCBI gene;Acc:101107662]",{"v":16287.43457,"d":"16287.43"},{"v":16838.353516,"d":"16838.35"},{"v":17693.222656,"d":"17693.22"},{"v":19861.101562,"d":"19861.10"},{"v":28176.193359,"d":"28176.19"},{"v":31102.607422,"d":"31102.61"},{"v":0.64214143861014,"d":"0.64"},{"v":-0.639036993322696,"d":"-0.64"},{"v":0.0922068569880155,"d":"0.09"},{"v":0.529951475783185,"d":"0.53"},"down","no"]
["MSTRG.1128","ENSOARG00000014484","ENSOART00000015767;ENSOART00000015769","NA","NA","NA","NA","MAP3K7 C-terminal like [Source:NCBI gene;Acc:101108531]",{"v":2.12491244545455,"d":"2.12"},{"v":1.94720742727273,"d":"1.95"},{"v":1.07387907272727,"d":"1.07"},{"v":3.47842715454545,"d":"3.48"},{"v":2.29428152727273,"d":"2.29"},{"v":3.54035312727273,"d":"3.54"},{"v":0.552557155846566,"d":"0.55"},{"v":-0.855804392027546,"d":"-0.86"},{"v":0.0922092199105848,"d":"0.09"},{"v":0.529951475783185,"d":"0.53"},"down","no"]
["MSTRG.11879","ESAM","ENSOART00000011608","GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005923(bicellular tight junction);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0098609(cell-cell adhesion)","04514(Cell adhesion molecules (CAMs));04670(Leukocyte transendothelial migration)","K06787","NA","endothelial cell adhesion molecule [Source:NCBI gene;Acc:101108435]",{"v":3.40544897327121,"d":"3.41"},{"v":2.31521269503024,"d":"2.32"},{"v":2.06417968244237,"d":"2.06"},{"v":4.02213464255354,"d":"4.02"},{"v":3.99809600416871,"d":"4.00"},{"v":3.94849058778813,"d":"3.95"},{"v":0.650432172177021,"d":"0.65"},{"v":-0.620529476016357,"d":"-0.62"},{"v":0.0922991833832397,"d":"0.09"},{"v":0.530210499110056,"d":"0.53"},"down","no"]
["MSTRG.15516","ITPRIPL1","ENSOART00000015155","NA","NA","NA","NA","ITPRIP like 1 [Source:NCBI gene;Acc:101112636]",{"v":1.50680114345947,"d":"1.51"},{"v":1.04977836217982,"d":"1.05"},{"v":0.995130582692105,"d":"1.00"},{"v":1.34605882418046,"d":"1.35"},{"v":2.67840112353747,"d":"2.68"},{"v":1.72220041635923,"d":"1.72"},{"v":0.61804767696616,"d":"0.62"},{"v":-0.694209961175901,"d":"-0.69"},{"v":0.0923517062389148,"d":"0.09"},{"v":0.530210499110056,"d":"0.53"},"down","no"]
["MSTRG.17417","RARRES2","ENSOART00000001130","GO:0001523(retinoid metabolic process);GO:0001934(positive regulation of protein phosphorylation);GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0006954(inflammatory response);GO:0008286(insulin receptor signaling pathway);GO:0010759(positive regulation of macrophage chemotaxis);GO:0019732(antifungal humoral response);GO:0045087(innate immune response);GO:0048566(embryonic digestive tract development);GO:0050829(defense response to Gram-negative bacterium);GO:0050830(defense response to Gram-positive bacterium);GO:0050994(regulation of lipid catabolic process);GO:0061760(antifungal innate immune response);GO:0062023(collagen-containing extracellular matrix)","NA","K10044","NA","retinoic acid receptor responder 2 [Source:NCBI gene;Acc:101122516]",{"v":4.88535791489362,"d":"4.89"},{"v":3.5205645106383,"d":"3.52"},{"v":5.13076208510638,"d":"5.13"},{"v":6.87694182978723,"d":"6.88"},{"v":6.70762382978723,"d":"6.71"},{"v":7.49204582978723,"d":"7.49"},{"v":0.642260949653642,"d":"0.64"},{"v":-0.638768513612809,"d":"-0.64"},{"v":0.0923943294428227,"d":"0.09"},{"v":0.530268756113325,"d":"0.53"},"down","no"]
["MSTRG.1209","GBE1","ENSOART00000018346","GO:0003824(catalytic activity);GO:0003844(1,4-alpha-glucan branching enzyme activity);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0005975(carbohydrate metabolic process);GO:0005978(glycogen biosynthetic process);GO:0043169(cation binding)","00500(Starch and sucrose metabolism)","K00700","EC:2.4.1.18","1,4-alpha-glucan branching enzyme 1 [Source:NCBI gene;Acc:101120124]",{"v":6.982143,"d":"6.98"},{"v":5.363168,"d":"5.36"},{"v":5.836668,"d":"5.84"},{"v":3.954362,"d":"3.95"},{"v":4.696999,"d":"4.70"},{"v":4.49217,"d":"4.49"},{"v":1.38334051937794,"d":"1.38"},{"v":0.468156330131647,"d":"0.47"},{"v":0.0925411145031106,"d":"0.09"},{"v":0.530729331657296,"d":"0.53"},"up","no"]
["MSTRG.20226","STON2","ENSOART00000003210","GO:0002244(hematopoietic progenitor cell differentiation);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006897(endocytosis);GO:0008021(synaptic vesicle);GO:0016020(membrane);GO:0030100(regulation of endocytosis);GO:0030136(clathrin-coated vesicle);GO:0036465(synaptic vesicle recycling);GO:0048488(synaptic vesicle endocytosis)","NA","K20067","NA","stonin 2 [Source:NCBI gene;Acc:101117080]",{"v":3.82905840850112,"d":"3.83"},{"v":8.9124086147651,"d":"8.91"},{"v":7.58824409306488,"d":"7.59"},{"v":5.66477607123042,"d":"5.66"},{"v":3.94175777628635,"d":"3.94"},{"v":4.37773177816555,"d":"4.38"},{"v":1.45375607561367,"d":"1.45"},{"v":0.539785221097908,"d":"0.54"},{"v":0.0927217020402428,"d":"0.09"},{"v":0.53121401786424,"d":"0.53"},"up","no"]
["MSTRG.14767","ENG","ENSOART00000012385","GO:0001300(chronological cell aging);GO:0001525(angiogenesis);GO:0001569(branching involved in blood vessel morphogenesis);GO:0001570(vasculogenesis);GO:0001934(positive regulation of protein phosphorylation);GO:0001947(heart looping);GO:0003148(outflow tract septum morphogenesis);GO:0003198(epithelial to mesenchymal transition involved in endocardial cushion formation);GO:0003203(endocardial cushion morphogenesis);GO:0003208(cardiac ventricle morphogenesis);GO:0003209(cardiac atrium morphogenesis);GO:0003222(ventricular trabecula myocardium morphogenesis);GO:0003273(cell migration involved in endocardial cushion formation);GO:0005072(transforming growth factor beta receptor, cytoplasmic mediator activity);GO:0005114(type II transforming growth factor beta receptor binding);GO:0005534(galactose binding);GO:0005539(glycosaminoglycan binding);GO:0005615(extracellular space);GO:0006355(regulation of transcription, DNA-templated);GO:0007507(heart development);GO:0009897(external side of plasma membrane);GO:0010629(negative regulation of gene expression);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017015(regulation of transforming growth factor beta receptor signaling pathway);GO:0022009(central nervous system vasculogenesis);GO:0030336(negative regulation of cell migration);GO:0030513(positive regulation of BMP signaling pathway);GO:0031953(negative regulation of protein autophosphorylation);GO:0034713(type I transforming growth factor beta receptor binding);GO:0035912(dorsal aorta morphogenesis);GO:0036122(BMP binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043235(receptor complex);GO:0045766(positive regulation of angiogenesis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048745(smooth muscle tissue development);GO:0048844(artery morphogenesis);GO:0048845(venous blood vessel morphogenesis);GO:0050431(transforming growth factor beta binding);GO:0051897(positive regulation of protein kinase B signaling);GO:0055009(atrial cardiac muscle tissue morphogenesis);GO:0072563(endothelial microparticle);GO:0097084(vascular smooth muscle cell development);GO:1905007(positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation);GO:1905065(positive regulation of vascular smooth muscle cell differentiation);GO:1905222(atrioventricular canal morphogenesis)","NA","K06526","NA","endoglin [Source:NCBI gene;Acc:101123539]",{"v":7.772793,"d":"7.77"},{"v":5.762989,"d":"5.76"},{"v":6.028064,"d":"6.03"},{"v":9.724532,"d":"9.72"},{"v":9.479245,"d":"9.48"},{"v":10.901093,"d":"10.90"},{"v":0.649856518231103,"d":"0.65"},{"v":-0.621806874110222,"d":"-0.62"},{"v":0.0927636492835013,"d":"0.09"},{"v":0.531267928972644,"d":"0.53"},"down","no"]
["MSTRG.14123","LRMDA","ENSOART00000009840","GO:0005515(protein binding)","NA","NA","NA","leucine rich melanocyte differentiation associated [Source:HGNC Symbol;Acc:HGNC:23405]",{"v":0.495199907429964,"d":"0.50"},{"v":0.317081566991474,"d":"0.32"},{"v":0.674733812119367,"d":"0.67"},{"v":1.36867800959196,"d":"1.37"},{"v":0.876119042174178,"d":"0.88"},{"v":0.45111253182095,"d":"0.45"},{"v":0.551582032125214,"d":"0.55"},{"v":-0.858352633296626,"d":"-0.86"},{"v":0.0928268459665136,"d":"0.09"},{"v":0.531443457553027,"d":"0.53"},"down","no"]
["ENSOARG00000008094","EPHB1","ENSOART00000008817","GO:0000166(nucleotide binding);GO:0001525(angiogenesis);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0008046(axon guidance receptor activity);GO:0014719(skeletal muscle satellite cell activation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021545(cranial nerve development);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022008(neurogenesis);GO:0030010(establishment of cell polarity);GO:0030424(axon);GO:0031290(retinal ganglion cell axon guidance);GO:0031589(cell-substrate adhesion);GO:0031901(early endosome membrane);GO:0032433(filopodium tip);GO:0044877(protein-containing complex binding);GO:0045121(membrane raft);GO:0046328(regulation of JNK cascade);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048593(camera-type eye morphogenesis);GO:0050804(modulation of chemical synaptic transmission);GO:0050965(detection of temperature stimulus involved in sensory perception of pain);GO:0051965(positive regulation of synapse assembly);GO:0060326(cell chemotaxis);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0061351(neural precursor cell proliferation);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0098978(glutamatergic synapse);GO:1901214(regulation of neuron death);GO:1902723(negative regulation of skeletal muscle satellite cell proliferation);GO:1902725(negative regulation of satellite cell differentiation)","04360(Axon guidance)","K05110","EC:2.7.10.1","EPH receptor B1 [Source:NCBI gene;Acc:101114662]",{"v":0.494223,"d":"0.49"},{"v":0.240092,"d":"0.24"},{"v":0.195332,"d":"0.20"},{"v":0.533228,"d":"0.53"},{"v":0.445792,"d":"0.45"},{"v":0.753851,"d":"0.75"},{"v":0.536477902856012,"d":"0.54"},{"v":-0.898409346266397,"d":"-0.90"},{"v":0.0928913385688372,"d":"0.09"},{"v":0.531626279758841,"d":"0.53"},"down","no"]
["MSTRG.624","ENSOARG00000019297;ENSOARG00000019281;ENSOARG00000019285","ENSOART00000021014;ENSOART00000020997;ENSOART00000021001","GO:0004364(glutathione transferase activity);GO:0005515(protein binding);GO:0005515(protein binding)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);00983(Drug metabolism - other enzymes);01524(Platinum drug resistance);05200(Pathways in cancer);05204(Chemical carcinogenesis);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis);05418(Fluid shear stress and atherosclerosis)","K00799","EC:2.5.1.18","glutathione S-transferase Mu 1 [Source:NCBI gene;Acc:101108092];glutathione S-transferase Mu 1 [Source:NCBI gene;Acc:101107401];glutathione S-transferase Mu 1-like [Source:NCBI gene;Acc:101107831]",{"v":29.2338272855925,"d":"29.23"},{"v":23.5274227084399,"d":"23.53"},{"v":24.5294829360614,"d":"24.53"},{"v":19.1749452131287,"d":"19.17"},{"v":17.3581508638818,"d":"17.36"},{"v":19.678815602728,"d":"19.68"},{"v":1.37498851436417,"d":"1.37"},{"v":0.45941956748162,"d":"0.46"},{"v":0.0929953232465596,"d":"0.09"},{"v":0.531848559709221,"d":"0.53"},"up","no"]
["MSTRG.13491","SBK1","ENSOART00000001185","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","NA","NA","NA","SH3 domain binding kinase 1 [Source:HGNC Symbol;Acc:HGNC:17699]",{"v":2.6844230286356,"d":"2.68"},{"v":2.34257077116086,"d":"2.34"},{"v":1.63688082039584,"d":"1.64"},{"v":2.43809978832117,"d":"2.44"},{"v":1.21191099929815,"d":"1.21"},{"v":0.962729587380685,"d":"0.96"},{"v":1.44466717795542,"d":"1.44"},{"v":0.530737163301309,"d":"0.53"},{"v":0.0932496630658382,"d":"0.09"},{"v":0.531962382601382,"d":"0.53"},"up","no"]
["MSTRG.18318","ENSOARG00000001652","ENSOART00000001778","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0046872(metal ion binding)","NA","K11971","EC:2.3.2.31","ring finger protein 14 [Source:NCBI gene;Acc:101108651]",{"v":7.30033351492767,"d":"7.30"},{"v":8.8671151729763,"d":"8.87"},{"v":6.24112429886119,"d":"6.24"},{"v":6.3984710640197,"d":"6.40"},{"v":4.36914533087104,"d":"4.37"},{"v":5.43760968082487,"d":"5.44"},{"v":1.38279915886799,"d":"1.38"},{"v":0.467591631147612,"d":"0.47"},{"v":0.0933099386841299,"d":"0.09"},{"v":0.531962382601382,"d":"0.53"},"up","no"]
["MSTRG.15181","LIMS1","ENSOART00000000474","GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0008270(zinc ion binding);GO:0010628(positive regulation of gene expression);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0030054(cell junction);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0043547(positive regulation of GTPase activity);GO:0045184(establishment of protein localization);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0051894(positive regulation of focal adhesion assembly);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","NA","NA","NA","LIM zinc finger domain containing 1 [Source:NCBI gene;Acc:101116555]",{"v":3.44213413023523,"d":"3.44"},{"v":5.35316118230063,"d":"5.35"},{"v":3.10261487478485,"d":"3.10"},{"v":3.2373409265634,"d":"3.24"},{"v":2.57174978227195,"d":"2.57"},{"v":2.67617046270797,"d":"2.68"},{"v":1.4021855010453,"d":"1.40"},{"v":0.487677222198015,"d":"0.49"},{"v":0.0933410231597844,"d":"0.09"},{"v":0.531962382601382,"d":"0.53"},"up","no"]
["MSTRG.14030","SRGN","ENSOART00000005800","GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0008626(granzyme-mediated apoptotic signaling pathway);GO:0030502(negative regulation of bone mineralization)","NA","K06849","NA","serglycin [Source:NCBI gene;Acc:101107327]",{"v":6.579316,"d":"6.58"},{"v":3.790742,"d":"3.79"},{"v":3.830037,"d":"3.83"},{"v":9.207964,"d":"9.21"},{"v":6.200266,"d":"6.20"},{"v":8.481468,"d":"8.48"},{"v":0.59440244912263,"d":"0.59"},{"v":-0.750488034647135,"d":"-0.75"},{"v":0.0934096940608843,"d":"0.09"},{"v":0.532167998822791,"d":"0.53"},"down","no"]
["MSTRG.4767","HSPA12B","ENSOART00000001868","NA","NA","NA","NA","heat shock protein family A (Hsp70) member 12B [Source:NCBI gene;Acc:101121442]",{"v":4.67786094859916,"d":"4.68"},{"v":4.41812361592764,"d":"4.42"},{"v":4.39752930288992,"d":"4.40"},{"v":6.54272832737701,"d":"6.54"},{"v":7.39575362144275,"d":"7.40"},{"v":6.71723996117362,"d":"6.72"},{"v":0.653257916920757,"d":"0.65"},{"v":-0.614275391020436,"d":"-0.61"},{"v":0.0934469004173257,"d":"0.09"},{"v":0.532194276251864,"d":"0.53"},"down","no"]
["MSTRG.21172","HEY1","ENSOART00000008777","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007219(Notch signaling pathway);GO:0035939(microsatellite binding);GO:0045746(negative regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:2000678(negative regulation of transcription regulatory region DNA binding);GO:2000820(negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation)","05165(Human papillomavirus infection);05200(Pathways in cancer);05224(Breast cancer)","K09091","NA","hes related family bHLH transcription factor with YRPW motif 1 [Source:NCBI gene;Acc:101111557]",{"v":2.161958,"d":"2.16"},{"v":0.957299,"d":"0.96"},{"v":1.533419,"d":"1.53"},{"v":2.377227,"d":"2.38"},{"v":3.559831,"d":"3.56"},{"v":2.173063,"d":"2.17"},{"v":0.573687618224192,"d":"0.57"},{"v":-0.801662713936565,"d":"-0.80"},{"v":0.0936238292457112,"d":"0.09"},{"v":0.532484885218926,"d":"0.53"},"down","no"]
["MSTRG.5785","NECTIN2","ENSOART00000010199","GO:0001675(acrosome assembly);GO:0002860(positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target);GO:0002891(positive regulation of immunoglobulin mediated immune response);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005915(zonula adherens);GO:0007010(cytoskeleton organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007286(spermatid development);GO:0007289(spermatid nucleus differentiation);GO:0009566(fertilization);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019062(virion attachment to host cell);GO:0019064(fusion of virus membrane with host plasma membrane);GO:0030382(sperm mitochondrion organization);GO:0032990(cell part morphogenesis);GO:0033005(positive regulation of mast cell activation);GO:0042271(susceptibility to natural killer cell mediated cytotoxicity);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043296(apical junction complex);GO:0044291(cell-cell contact zone);GO:0044406(adhesion of symbiont to host);GO:0044782(cilium organization);GO:0045954(positive regulation of natural killer cell mediated cytotoxicity);GO:0046596(regulation of viral entry into host cell);GO:0046814(coreceptor-mediated virion attachment to host cell);GO:0050839(cell adhesion molecule binding);GO:0050862(positive regulation of T cell receptor signaling pathway);GO:0051654(establishment of mitochondrion localization);GO:0060370(susceptibility to T cell mediated cytotoxicity)","NA","NA","NA","nectin cell adhesion molecule 2 [Source:HGNC Symbol;Acc:HGNC:9707]",{"v":1.35258434565866,"d":"1.35"},{"v":0.968583076150102,"d":"0.97"},{"v":0.770496407442299,"d":"0.77"},{"v":1.71764929172555,"d":"1.72"},{"v":1.59337795014916,"d":"1.59"},{"v":1.5172203850683,"d":"1.52"},{"v":0.640328348529327,"d":"0.64"},{"v":-0.643116212712008,"d":"-0.64"},{"v":0.0936414941974462,"d":"0.09"},{"v":0.532484885218926,"d":"0.53"},"down","no"]
["MSTRG.13067","ME2","ENSOART00000004951","GO:0004470(malic enzyme activity);GO:0004471(malate dehydrogenase (decarboxylating) (NAD+) activity);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity);GO:0046872(metal ion binding);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process);GO:1902031(regulation of NADP metabolic process)","00620(Pyruvate metabolism)","K00027","EC:1.1.1.38","malic enzyme 2 [Source:NCBI gene;Acc:101117980]",{"v":2.33262713618427,"d":"2.33"},{"v":3.24753128393136,"d":"3.25"},{"v":2.63188875938332,"d":"2.63"},{"v":2.11376058832706,"d":"2.11"},{"v":1.87067165687804,"d":"1.87"},{"v":1.9937896511884,"d":"1.99"},{"v":1.37366048330408,"d":"1.37"},{"v":0.458025468798776,"d":"0.46"},{"v":0.0936453774185592,"d":"0.09"},{"v":0.532484885218926,"d":"0.53"},"up","no"]
["MSTRG.2147","CAB39L","ENSOART00000009199","NA","04150(mTOR signaling pathway);04152(AMPK signaling pathway)","K08272","NA","calcium binding protein 39 like [Source:NCBI gene;Acc:101115803]",{"v":0.623221,"d":"0.62"},{"v":0.873437,"d":"0.87"},{"v":0.959748,"d":"0.96"},{"v":0.719327,"d":"0.72"},{"v":0.466948,"d":"0.47"},{"v":0.441787,"d":"0.44"},{"v":1.50879143423285,"d":"1.51"},{"v":0.593393390626662,"d":"0.59"},{"v":0.0938139209616102,"d":"0.09"},{"v":0.532983194662899,"d":"0.53"},"up","no"]
["MSTRG.3819","C1orf115","ENSOART00000014207","NA","NA","NA","NA","chromosome 12 open reading frame, human C1orf115 [Source:NCBI gene;Acc:101105767]",{"v":5.018035,"d":"5.02"},{"v":1.127003,"d":"1.13"},{"v":1.700706,"d":"1.70"},{"v":5.455058,"d":"5.46"},{"v":4.80479,"d":"4.80"},{"v":4.904066,"d":"4.90"},{"v":0.51739570667573,"d":"0.52"},{"v":-0.950660012227931,"d":"-0.95"},{"v":0.0938917639750315,"d":"0.09"},{"v":0.533055051687471,"d":"0.53"},"down","no"]
["ENSOARG00000018123","SARM1","ENSOART00000019725","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005874(microtubule);GO:0007165(signal transduction);GO:0009749(response to glucose);GO:0009967(positive regulation of signal transduction);GO:0015630(microtubule cytoskeleton);GO:0030425(dendrite);GO:0031315(extrinsic component of mitochondrial outer membrane);GO:0034128(negative regulation of MyD88-independent toll-like receptor signaling pathway);GO:0035591(signaling adaptor activity);GO:0042981(regulation of apoptotic process);GO:0045202(synapse);GO:0048678(response to axon injury);GO:0048814(regulation of dendrite morphogenesis);GO:1901214(regulation of neuron death)","NA","NA","NA","sterile alpha and TIR motif containing 1 [Source:NCBI gene;Acc:101119487]",{"v":0.505646,"d":"0.51"},{"v":0.257856,"d":"0.26"},{"v":0.510984,"d":"0.51"},{"v":0.735125,"d":"0.74"},{"v":0.726468,"d":"0.73"},{"v":0.838155,"d":"0.84"},{"v":0.554185067233453,"d":"0.55"},{"v":-0.851560257612763,"d":"-0.85"},{"v":0.0939405770273794,"d":"0.09"},{"v":0.533146243205787,"d":"0.53"},"down","no"]
["MSTRG.16200","CARD10","ENSOART00000020967","GO:0007250(activation of NF-kappaB-inducing kinase activity);GO:0042981(regulation of apoptotic process);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis);GO:1900182(positive regulation of protein localization to nucleus)","04064(NF-kappa B signaling pathway)","K20912","NA","caspase recruitment domain family member 10 [Source:NCBI gene;Acc:101108123]",{"v":1.91534541954834,"d":"1.92"},{"v":1.29868936609033,"d":"1.30"},{"v":1.63496534174312,"d":"1.63"},{"v":2.31065792731122,"d":"2.31"},{"v":2.9889118368031,"d":"2.99"},{"v":2.1806882803458,"d":"2.18"},{"v":0.648239686192772,"d":"0.65"},{"v":-0.625400747602716,"d":"-0.63"},{"v":0.094008133533236,"d":"0.09"},{"v":0.5331590150506,"d":"0.53"},"down","no"]
["MSTRG.1024","PBX1","ENSOART00000012292","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001655(urogenital system development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008284(positive regulation of cell population proliferation);GO:0009887(animal organ morphogenesis);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0030278(regulation of ossification);GO:0030325(adrenal gland development);GO:0030326(embryonic limb morphogenesis);GO:0035162(embryonic hemopoiesis);GO:0042127(regulation of cell population proliferation);GO:0043565(sequence-specific DNA binding);GO:0045665(negative regulation of neuron differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048568(embryonic organ development);GO:0048706(embryonic skeletal system development);GO:0090575(RNA polymerase II transcription factor complex)","NA","NA","NA","PBX homeobox 1 [Source:HGNC Symbol;Acc:HGNC:8632]",{"v":5.46468262657629,"d":"5.46"},{"v":5.31806245602144,"d":"5.32"},{"v":6.20179631982976,"d":"6.20"},{"v":4.54796075394073,"d":"4.55"},{"v":4.1028819962169,"d":"4.10"},{"v":3.8739247602459,"d":"3.87"},{"v":1.35607638132361,"d":"1.36"},{"v":0.439438440902979,"d":"0.44"},{"v":0.0941301020990094,"d":"0.09"},{"v":0.533480148237634,"d":"0.53"},"up","no"]
["MSTRG.6822","ENSOARG00000011184","ENSOART00000012160","GO:0003676(nucleic acid binding)","NA","NA","NA","ZFP91 zinc finger protein [Source:NCBI gene;Acc:100885759]",{"v":16.6035073639144,"d":"16.60"},{"v":18.1750046953364,"d":"18.18"},{"v":17.1239104931193,"d":"17.12"},{"v":13.7093670554281,"d":"13.71"},{"v":12.0120355703364,"d":"12.01"},{"v":12.7514105210245,"d":"12.75"},{"v":1.34906751825872,"d":"1.35"},{"v":0.431962554230907,"d":"0.43"},{"v":0.0942498853431151,"d":"0.09"},{"v":0.533788459203046,"d":"0.53"},"up","no"]
["MSTRG.11782","CCDC89","ENSOART00000016570","NA","NA","NA","NA","coiled-coil domain containing 89 [Source:NCBI gene;Acc:101104101]",{"v":0.971337,"d":"0.97"},{"v":0.61445,"d":"0.61"},{"v":0.676511,"d":"0.68"},{"v":1.025894,"d":"1.03"},{"v":1.09794,"d":"1.10"},{"v":2.054704,"d":"2.05"},{"v":0.541408980844496,"d":"0.54"},{"v":-0.885209275837707,"d":"-0.89"},{"v":0.0943935666773745,"d":"0.09"},{"v":0.534271903587137,"d":"0.53"},"down","no"]
["MSTRG.5234","CMC2","ENSOART00000008841","GO:0005739(mitochondrion)","NA","K18172","NA","C-X9-C motif containing 2 [Source:NCBI gene;Acc:101120939]",{"v":7.6589507108674,"d":"7.66"},{"v":7.14685611764706,"d":"7.15"},{"v":18.0804235264207,"d":"18.08"},{"v":8.29196306879362,"d":"8.29"},{"v":6.75726102492522,"d":"6.76"},{"v":6.88773800997009,"d":"6.89"},{"v":1.49912418134711,"d":"1.50"},{"v":0.584119895222508,"d":"0.58"},{"v":0.0945759024708323,"d":"0.09"},{"v":0.534707526157808,"d":"0.53"},"up","no"]
["MSTRG.13787","ENSOARG00000004277","ENSOART00000004657","NA","NA","NA","NA",null,{"v":0.340058903010033,"d":"0.34"},{"v":0.780567964325529,"d":"0.78"},{"v":0.687617030100334,"d":"0.69"},{"v":0.978832829431438,"d":"0.98"},{"v":1.10192007580825,"d":"1.10"},{"v":1.46369855072464,"d":"1.46"},{"v":0.510161845888205,"d":"0.51"},{"v":-0.970973088550222,"d":"-0.97"},{"v":0.0946742209058057,"d":"0.09"},{"v":0.535078116632051,"d":"0.54"},"down","no"]
["MSTRG.16104","NUAK1","ENSOART00000018826","GO:0001650(fibrillar center);GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0015630(microtubule cytoskeleton);GO:0030155(regulation of cell adhesion);GO:0035507(regulation of myosin-light-chain-phosphatase activity);GO:2000772(regulation of cellular senescence)","NA","K08800","EC:2.7.11.1","NUAK family kinase 1 [Source:NCBI gene;Acc:101103312]",{"v":6.412914,"d":"6.41"},{"v":4.297108,"d":"4.30"},{"v":7.154182,"d":"7.15"},{"v":5.210159,"d":"5.21"},{"v":3.741627,"d":"3.74"},{"v":3.826748,"d":"3.83"},{"v":1.39798540270738,"d":"1.40"},{"v":0.4833492966564,"d":"0.48"},{"v":0.0947723961024187,"d":"0.09"},{"v":0.535336993011972,"d":"0.54"},"up","no"]
["MSTRG.4838","ENSOARG00000010995","ENSOART00000011963","GO:0007275(multicellular organism development);GO:0030154(cell differentiation)","NA","NA","NA",null,{"v":606.186401,"d":"606.19"},{"v":701.648621,"d":"701.65"},{"v":792.159851,"d":"792.16"},{"v":831.284607,"d":"831.28"},{"v":1154.973877,"d":"1154.97"},{"v":1296.885132,"d":"1296.89"},{"v":0.639629306121709,"d":"0.64"},{"v":-0.644692054086833,"d":"-0.64"},{"v":0.0948858697027371,"d":"0.09"},{"v":0.53555424289192,"d":"0.54"},"down","no"]
["MSTRG.981","ENSOARG00000009648","ENSOART00000010509","GO:0004729(oxygen-dependent protoporphyrinogen oxidase activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006782(protoporphyrinogen IX biosynthetic process);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism)","K00231","1.3.3.15;EC:1.3.3.4","protoporphyrinogen oxidase [Source:NCBI gene;Acc:101103440]",{"v":1.442512,"d":"1.44"},{"v":0.838448,"d":"0.84"},{"v":1.720888,"d":"1.72"},{"v":2.703172,"d":"2.70"},{"v":1.73736924899058,"d":"1.74"},{"v":2.284785,"d":"2.28"},{"v":0.595041467408462,"d":"0.60"},{"v":-0.748937884046691,"d":"-0.75"},{"v":0.0951092840413482,"d":"0.10"},{"v":0.536120730366241,"d":"0.54"},"down","no"]
["MSTRG.19422","CLPX","ENSOART00000019389;ENSOART00000019391","GO:0004176(ATP-dependent peptidase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006457(protein folding);GO:0009368(endopeptidase Clp complex);GO:0009841(mitochondrial endopeptidase Clp complex);GO:0010952(positive regulation of peptidase activity);GO:0016504(peptidase activator activity);GO:0016887(ATPase activity);GO:0042645(mitochondrial nucleoid);GO:0046034(ATP metabolic process);GO:0051082(unfolded protein binding);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0051603(proteolysis involved in cellular protein catabolic process)","NA","K03544","NA","caseinolytic mitochondrial matrix peptidase chaperone subunit [Source:NCBI gene;Acc:101111198]",{"v":9.90681365877128,"d":"9.91"},{"v":9.36225732765853,"d":"9.36"},{"v":6.96586504169751,"d":"6.97"},{"v":8.52374059067357,"d":"8.52"},{"v":5.08081724377005,"d":"5.08"},{"v":5.40591096496422,"d":"5.41"},{"v":1.38002572713749,"d":"1.38"},{"v":0.464695162704673,"d":"0.46"},{"v":0.0951526628718736,"d":"0.10"},{"v":0.536120730366241,"d":"0.54"},"up","no"]
["MSTRG.20542","ENSOARG00000020002","ENSOART00000021777","GO:0005198(structural molecule activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.521883,"d":"0.52"},{"v":0.072343,"d":"0.07"},{"v":0.740758,"d":"0.74"},{"v":0.156469,"d":"0.16"},{"v":0.171151,"d":"0.17"},{"v":0.281927,"d":"0.28"},{"v":2.19012479759559,"d":"2.19"},{"v":1.13101307975454,"d":"1.13"},{"v":0.0951767946640148,"d":"0.10"},{"v":0.536120730366241,"d":"0.54"},"up","no"]
["MSTRG.15255","FBXO11","ENSOART00000005379","GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0007605(sensory perception of sound);GO:0008270(zinc ion binding);GO:0016274(protein-arginine N-methyltransferase activity);GO:0016567(protein ubiquitination);GO:0035246(peptidyl-arginine N-methylation)","NA","K10297","NA","F-box protein 11 [Source:NCBI gene;Acc:101107682]",{"v":8.39785804157549,"d":"8.40"},{"v":9.18038224507659,"d":"9.18"},{"v":8.79060811487965,"d":"8.79"},{"v":7.68215620853392,"d":"7.68"},{"v":6.76598407221007,"d":"6.77"},{"v":5.12671681947484,"d":"5.13"},{"v":1.34707744054167,"d":"1.35"},{"v":0.429832790573054,"d":"0.43"},{"v":0.0952825146828268,"d":"0.10"},{"v":0.536120730366241,"d":"0.54"},"up","no"]
["MSTRG.17188","ENSOARG00000000717","ENSOART00000000768","GO:0005747(mitochondrial respiratory chain complex I);GO:0022904(respiratory electron transport chain)","NA","NA","NA",null,{"v":41.780479,"d":"41.78"},{"v":47.634884,"d":"47.63"},{"v":45.461689,"d":"45.46"},{"v":41.553131,"d":"41.55"},{"v":31.064659,"d":"31.06"},{"v":26.899717,"d":"26.90"},{"v":1.35530979488865,"d":"1.36"},{"v":0.438622658564562,"d":"0.44"},{"v":0.0953003509058304,"d":"0.10"},{"v":0.536120730366241,"d":"0.54"},"up","no"]
["MSTRG.17708","LYL1","ENSOART00000010291","GO:0001955(blood vessel maturation);GO:0003677(DNA binding);GO:0006355(regulation of transcription, DNA-templated);GO:0030183(B cell differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:0060216(definitive hemopoiesis)","NA","NA","NA","LYL1, basic helix-loop-helix family member [Source:HGNC Symbol;Acc:HGNC:6734]",{"v":0.758416759412891,"d":"0.76"},{"v":0.38091916145501,"d":"0.38"},{"v":0.404737494575622,"d":"0.40"},{"v":0.969572394384174,"d":"0.97"},{"v":0.977584354818124,"d":"0.98"},{"v":0.856631005743459,"d":"0.86"},{"v":0.550709807730577,"d":"0.55"},{"v":-0.860635792848057,"d":"-0.86"},{"v":0.0953512127011002,"d":"0.10"},{"v":0.536120730366241,"d":"0.54"},"down","no"]
["MSTRG.18960","CLOCK","ENSOART00000001733","GO:0000077(DNA damage checkpoint);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0007283(spermatogenesis);GO:0007623(circadian rhythm);GO:0016573(histone acetylation);GO:0031490(chromatin DNA binding);GO:0032922(circadian regulation of gene expression);GO:0033391(chromatoid body);GO:0042634(regulation of hair cycle);GO:0042752(regulation of circadian rhythm);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0050729(positive regulation of inflammatory response);GO:0050796(regulation of insulin secretion);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051775(response to redox state);GO:0070888(E-box binding);GO:0071479(cellular response to ionizing radiation);GO:2000074(regulation of type B pancreatic cell development);GO:2000323(negative regulation of glucocorticoid receptor signaling pathway)","04710(Circadian rhythm);04728(Dopaminergic synapse)","K02223","EC:2.3.1.48","clock circadian regulator [Source:NCBI gene;Acc:100171391]",{"v":5.537301,"d":"5.54"},{"v":4.95262,"d":"4.95"},{"v":4.487171,"d":"4.49"},{"v":4.377556,"d":"4.38"},{"v":3.759404,"d":"3.76"},{"v":2.971522,"d":"2.97"},{"v":1.34825730464342,"d":"1.35"},{"v":0.431095850161691,"d":"0.43"},{"v":0.0955705702110496,"d":"0.10"},{"v":0.536665960277474,"d":"0.54"},"up","no"]
["MSTRG.8749","STAC","ENSOART00000017888;ENSOART00000017889","GO:0005515(protein binding);GO:0006936(muscle contraction);GO:0030315(T-tubule);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0034605(cellular response to heat);GO:0035556(intracellular signal transduction);GO:0044325(ion channel binding);GO:0046872(metal ion binding);GO:1901385(regulation of voltage-gated calcium channel activity);GO:1901387(positive regulation of voltage-gated calcium channel activity);GO:1903078(positive regulation of protein localization to plasma membrane);GO:2001259(positive regulation of cation channel activity);GO:2001259(positive regulation of cation channel activity)","NA","NA","NA","SH3 and cysteine rich domain [Source:NCBI gene;Acc:101107476]",{"v":1.58116205417607,"d":"1.58"},{"v":1.62367630248307,"d":"1.62"},{"v":1.75736534537246,"d":"1.76"},{"v":2.33177768397291,"d":"2.33"},{"v":3.36342035214447,"d":"3.36"},{"v":2.49630374717833,"d":"2.50"},{"v":0.605774598273376,"d":"0.61"},{"v":-0.723147011493878,"d":"-0.72"},{"v":0.095600975840566,"d":"0.10"},{"v":0.536665960277474,"d":"0.54"},"down","no"]
["MSTRG.19577","TRDC","ENSOART00000021181","GO:0009897(external side of plasma membrane)","NA","NA","NA","T-cell receptor delta chain C region [Source:NCBI gene;Acc:101106528]",{"v":1.51219994182028,"d":"1.51"},{"v":1.6459954233871,"d":"1.65"},{"v":1.51737325633641,"d":"1.52"},{"v":1.24562201612903,"d":"1.25"},{"v":0.557041007488479,"d":"0.56"},{"v":1.21684971774194,"d":"1.22"},{"v":1.54845136352654,"d":"1.55"},{"v":0.630826069030636,"d":"0.63"},{"v":0.0957003368688695,"d":"0.10"},{"v":0.53697426130409,"d":"0.54"},"up","no"]
["MSTRG.2478","MYO16","ENSOART00000006309","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0014065(phosphatidylinositol 3-kinase signaling);GO:0016459(myosin complex);GO:0048812(neuron projection morphogenesis)","NA","K17481","NA","myosin XVI [Source:NCBI gene;Acc:101115289]",{"v":1.72986594863512,"d":"1.73"},{"v":1.21389459618801,"d":"1.21"},{"v":1.01033606670974,"d":"1.01"},{"v":2.42293014504927,"d":"2.42"},{"v":1.77904895008884,"d":"1.78"},{"v":2.00547337118398,"d":"2.01"},{"v":0.636991846975136,"d":"0.64"},{"v":-0.650653187717897,"d":"-0.65"},{"v":0.0958791455099212,"d":"0.10"},{"v":0.537498131762918,"d":"0.54"},"down","no"]
["MSTRG.1244","ENSOARG00000017511;ENSOARG00000017529","ENSOART00000019061;ENSOART00000019086","NA","NA","NA","NA","crystallin beta-gamma domain containing 3 [Source:NCBI gene;Acc:101103442]",{"v":5.79523888902566,"d":"5.80"},{"v":5.86103799176214,"d":"5.86"},{"v":4.93296691231891,"d":"4.93"},{"v":4.10924851784869,"d":"4.11"},{"v":4.56863634665278,"d":"4.57"},{"v":3.43406089669539,"d":"3.43"},{"v":1.36965968310837,"d":"1.37"},{"v":0.453817473855524,"d":"0.45"},{"v":0.0958898743411495,"d":"0.10"},{"v":0.537498131762918,"d":"0.54"},"up","no"]
["MSTRG.16156","RASD2","ENSOART00000020184","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0031681(G-protein beta-subunit binding)","NA","NA","NA","RASD family member 2 [Source:HGNC Symbol;Acc:HGNC:18229]",{"v":1.367709,"d":"1.37"},{"v":0.748182,"d":"0.75"},{"v":0.83031,"d":"0.83"},{"v":2.099448,"d":"2.10"},{"v":1.673393,"d":"1.67"},{"v":1.594173,"d":"1.59"},{"v":0.548946024735542,"d":"0.55"},{"v":-0.865263792058574,"d":"-0.87"},{"v":0.0959198419898469,"d":"0.10"},{"v":0.537498131762918,"d":"0.54"},"down","no"]
["MSTRG.9710","ZCCHC7","ENSOART00000012505","GO:0003676(nucleic acid binding);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0008270(zinc ion binding)","03018(RNA degradation)","K12597","NA","zinc finger CCHC-type containing 7 [Source:NCBI gene;Acc:101108453]",{"v":2.21727918572928,"d":"2.22"},{"v":1.75361213326338,"d":"1.75"},{"v":1.80900643756558,"d":"1.81"},{"v":1.17954906610703,"d":"1.18"},{"v":1.48536101993704,"d":"1.49"},{"v":1.25869838719832,"d":"1.26"},{"v":1.47310767523699,"d":"1.47"},{"v":0.558862886485772,"d":"0.56"},{"v":0.0959253770184433,"d":"0.10"},{"v":0.537498131762918,"d":"0.54"},"up","no"]
["MSTRG.376","KANK4","ENSOART00000009921","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0015630(microtubule cytoskeleton)","NA","K22808","NA","KN motif and ankyrin repeat domains 4 [Source:NCBI gene;Acc:101106979]",{"v":1.421052,"d":"1.42"},{"v":0.424824,"d":"0.42"},{"v":0.437708,"d":"0.44"},{"v":1.85118,"d":"1.85"},{"v":1.07985,"d":"1.08"},{"v":1.261527,"d":"1.26"},{"v":0.544675719376028,"d":"0.54"},{"v":-0.876530538919871,"d":"-0.88"},{"v":0.0961211128300498,"d":"0.10"},{"v":0.537546422189191,"d":"0.54"},"down","no"]
["MSTRG.6034","CCDC106","ENSOART00000001183","GO:0005634(nucleus);GO:0005829(cytosol)","NA","NA","NA","coiled-coil domain containing 106 [Source:HGNC Symbol;Acc:HGNC:30181]",{"v":1.47992391460341,"d":"1.48"},{"v":1.29478732542624,"d":"1.29"},{"v":1.48889228910304,"d":"1.49"},{"v":1.99888110600445,"d":"2.00"},{"v":2.30027645707932,"d":"2.30"},{"v":2.16757477005189,"d":"2.17"},{"v":0.659313438301119,"d":"0.66"},{"v":-0.600963607835502,"d":"-0.60"},{"v":0.0961230024388845,"d":"0.10"},{"v":0.537546422189191,"d":"0.54"},"down","no"]
["MSTRG.1318","BOC","ENSOART00000021107","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005887(integral component of plasma membrane);GO:0007224(smoothened signaling pathway);GO:0007411(axon guidance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045663(positive regulation of myoblast differentiation)","04340(Hedgehog signaling pathway);04360(Axon guidance)","K20020","NA","BOC cell adhesion associated, oncogene regulated [Source:NCBI gene;Acc:101123082]",{"v":2.28571505596842,"d":"2.29"},{"v":1.34846703019043,"d":"1.35"},{"v":1.42730391407339,"d":"1.43"},{"v":2.22697863399907,"d":"2.23"},{"v":2.89429976381793,"d":"2.89"},{"v":2.81351853506735,"d":"2.81"},{"v":0.637884755343368,"d":"0.64"},{"v":-0.648632294585004,"d":"-0.65"},{"v":0.09615481131768,"d":"0.10"},{"v":0.537546422189191,"d":"0.54"},"down","no"]
["MSTRG.18995","YTHDC1","ENSOART00000009399","GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0010608(posttranscriptional regulation of gene expression)","NA","K20100","NA","YTH domain containing 1 [Source:NCBI gene;Acc:101116479]",{"v":7.84730877176176,"d":"7.85"},{"v":7.74552606330696,"d":"7.75"},{"v":8.39463207913369,"d":"8.39"},{"v":6.63725265639317,"d":"6.64"},{"v":5.8102065939192,"d":"5.81"},{"v":5.25511568679717,"d":"5.26"},{"v":1.35502699462766,"d":"1.36"},{"v":0.438321593001671,"d":"0.44"},{"v":0.0961636659021023,"d":"0.10"},{"v":0.537546422189191,"d":"0.54"},"up","no"]
["MSTRG.3915","F5","ENSOART00000011026","GO:0005507(copper ion binding);GO:0005615(extracellular space);GO:0007596(blood coagulation);GO:0008015(blood circulation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031091(platelet alpha granule);GO:0035461(vitamin transmembrane transport);GO:0046872(metal ion binding);GO:0051180(vitamin transport);GO:0090482(vitamin transmembrane transporter activity)","04610(Complement and coagulation cascades);04977(Vitamin digestion and absorption)","K03902;K14610","NA","solute carrier family 19 member 2 [Source:NCBI gene;Acc:101123393]",{"v":0.608136697307945,"d":"0.61"},{"v":1.54362655121471,"d":"1.54"},{"v":0.509615547603414,"d":"0.51"},{"v":0.411691550558109,"d":"0.41"},{"v":0.677649203873933,"d":"0.68"},{"v":0.559414732435982,"d":"0.56"},{"v":1.61417433774951,"d":"1.61"},{"v":0.690796404280971,"d":"0.69"},{"v":0.0962043913739103,"d":"0.10"},{"v":0.537546422189191,"d":"0.54"},"up","no"]
["MSTRG.15045","CNRIP1","ENSOART00000021674","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008022(protein C-terminus binding);GO:0031718(type 1 cannabinoid receptor binding)","NA","NA","NA","cannabinoid receptor interacting protein 1 [Source:NCBI gene;Acc:101110489]",{"v":3.559668,"d":"3.56"},{"v":2.004283,"d":"2.00"},{"v":2.00977,"d":"2.01"},{"v":3.487293,"d":"3.49"},{"v":4.690819,"d":"4.69"},{"v":4.833818,"d":"4.83"},{"v":0.582059771302182,"d":"0.58"},{"v":-0.780760784823296,"d":"-0.78"},{"v":0.0963316693683217,"d":"0.10"},{"v":0.537928692696976,"d":"0.54"},"down","no"]
["MSTRG.4214","LAMC1","ENSOART00000020889","GO:0005201(extracellular matrix structural constituent);GO:0005604(basement membrane);GO:0007155(cell adhesion);GO:0016477(cell migration);GO:0022617(extracellular matrix disassembly);GO:0031581(hemidesmosome assembly);GO:0034446(substrate adhesion-dependent cell spreading);GO:0065003(protein-containing complex assembly)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);05020(Prion diseases);05145(Toxoplasmosis);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K05635","NA","laminin subunit gamma 1 [Source:NCBI gene;Acc:101105588]",{"v":32.4312629970776,"d":"32.43"},{"v":24.4832865491936,"d":"24.48"},{"v":30.0277788776924,"d":"30.03"},{"v":43.6231235896742,"d":"43.62"},{"v":43.7232787296244,"d":"43.72"},{"v":44.0676232674532,"d":"44.07"},{"v":0.661590937769191,"d":"0.66"},{"v":-0.595988621752099,"d":"-0.60"},{"v":0.0963721736651422,"d":"0.10"},{"v":0.537970889437416,"d":"0.54"},"down","no"]
["MSTRG.7130","CDH6","ENSOART00000013729","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007219(Notch signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding);GO:0098609(cell-cell adhesion)","NA","K06798","NA","cadherin 6 [Source:NCBI gene;Acc:101116091]",{"v":0.550716,"d":"0.55"},{"v":0.22737,"d":"0.23"},{"v":0.515586,"d":"0.52"},{"v":0.844127,"d":"0.84"},{"v":0.730288,"d":"0.73"},{"v":0.750913,"d":"0.75"},{"v":0.556339578760502,"d":"0.56"},{"v":-0.845962350341382,"d":"-0.85"},{"v":0.0964852211163458,"d":"0.10"},{"v":0.538318723792644,"d":"0.54"},"down","no"]
["MSTRG.8228","CSPG4","ENSOART00000002054","GO:0000187(activation of MAPK activity);GO:0005886(plasma membrane);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008283(cell population proliferation);GO:0008347(glial cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019901(protein kinase binding);GO:0035556(intracellular signal transduction);GO:0042995(cell projection);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation)","NA","K08115","NA","chondroitin sulfate proteoglycan 4 [Source:NCBI gene;Acc:101105108]",{"v":1.626796,"d":"1.63"},{"v":1.50526,"d":"1.51"},{"v":1.905749,"d":"1.91"},{"v":2.02931,"d":"2.03"},{"v":3.262347,"d":"3.26"},{"v":2.63402,"d":"2.63"},{"v":0.635630874182736,"d":"0.64"},{"v":-0.65373889318937,"d":"-0.65"},{"v":0.0966302063434591,"d":"0.10"},{"v":0.538759279092772,"d":"0.54"},"down","no"]
["MSTRG.8957","ENSOARG00000011822","ENSOART00000012857","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation)","NA","NA","NA",null,{"v":6.70820564182425,"d":"6.71"},{"v":4.60561410456062,"d":"4.61"},{"v":6.07378402431273,"d":"6.07"},{"v":9.36807306181471,"d":"9.37"},{"v":9.24992142952487,"d":"9.25"},{"v":8.06945780454473,"d":"8.07"},{"v":0.6515273012171,"d":"0.65"},{"v":-0.618102460982246,"d":"-0.62"},{"v":0.0966453900332391,"d":"0.10"},{"v":0.538759279092772,"d":"0.54"},"down","no"]
["MSTRG.6859","RANBP17","ENSOART00000003730;ENSOART00000003736","GO:0005634(nucleus);GO:0006886(intracellular protein transport);GO:0008536(Ran GTPase binding);GO:0008536(Ran GTPase binding)","NA","NA","NA","RAN binding protein 17 [Source:NCBI gene;Acc:101104527]",{"v":1.49618693506051,"d":"1.50"},{"v":1.14869459723879,"d":"1.15"},{"v":1.41931683569115,"d":"1.42"},{"v":2.16460572916312,"d":"2.16"},{"v":1.93948672831089,"d":"1.94"},{"v":2.14350159229589,"d":"2.14"},{"v":0.650522158708461,"d":"0.65"},{"v":-0.620329894647849,"d":"-0.62"},{"v":0.0969054898435534,"d":"0.10"},{"v":0.540024859442164,"d":"0.54"},"down","no"]
["ENSOARG00000013311","TONSL","ENSOART00000014479","GO:0000724(double-strand break repair via homologous recombination);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0016604(nuclear body);GO:0031297(replication fork processing);GO:0035101(FACT complex);GO:0042393(histone binding);GO:0042555(MCM complex);GO:0043596(nuclear replication fork)","NA","K09257","NA","tonsoku like, DNA repair protein [Source:NCBI gene;Acc:101116737]",{"v":0.095328,"d":"0.10"},{"v":0.166297,"d":"0.17"},{"v":0.169293,"d":"0.17"},{"v":0.401875,"d":"0.40"},{"v":0.25784,"d":"0.26"},{"v":0.183156,"d":"0.18"},{"v":0.511250238767261,"d":"0.51"},{"v":-0.967898483056423,"d":"-0.97"},{"v":0.0971508426859507,"d":"0.10"},{"v":0.540697002642414,"d":"0.54"},"down","no"]
["MSTRG.17798","DOCK6","ENSOART00000019544","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005829(cytosol);GO:0007264(small GTPase mediated signal transduction)","NA","K21852","NA","dedicator of cytokinesis 6 [Source:NCBI gene;Acc:101119818]",{"v":3.6830031479622,"d":"3.68"},{"v":2.02923669098248,"d":"2.03"},{"v":2.26556853327427,"d":"2.27"},{"v":4.13754216706045,"d":"4.14"},{"v":4.61843652283914,"d":"4.62"},{"v":3.61849376018901,"d":"3.62"},{"v":0.644698867317114,"d":"0.64"},{"v":-0.633302646094814,"d":"-0.63"},{"v":0.0972299280790854,"d":"0.10"},{"v":0.540697002642414,"d":"0.54"},"down","no"]
["MSTRG.20758","IGF2R","ENSOART00000005063","GO:0005520(insulin-like growth factor binding);GO:0005537(mannose binding);GO:0005634(nucleus);GO:0005641(nuclear envelope lumen);GO:0005768(endosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0007041(lysosomal transport);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030139(endocytic vesicle);GO:0030140(trans-Golgi network transport vesicle);GO:0038023(signaling receptor activity);GO:0042802(identical protein binding);GO:0051219(phosphoprotein binding)","04142(Lysosome);04144(Endocytosis)","K06564","NA","insulin like growth factor 2 receptor [Source:NCBI gene;Acc:443500]",{"v":13.6421379623165,"d":"13.64"},{"v":12.0401434237601,"d":"12.04"},{"v":17.8214888882842,"d":"17.82"},{"v":19.2133041573057,"d":"19.21"},{"v":25.1175768563508,"d":"25.12"},{"v":22.7105189905534,"d":"22.71"},{"v":0.648909036380937,"d":"0.65"},{"v":-0.623911838480749,"d":"-0.62"},{"v":0.0972363068178754,"d":"0.10"},{"v":0.540697002642414,"d":"0.54"},"down","no"]
["MSTRG.7692","ENSOARG00000009097","ENSOART00000009914","GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0005524(ATP binding);GO:0006955(immune response);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0051607(defense response to virus)","NA","NA","NA",null,{"v":0.683943555108203,"d":"0.68"},{"v":0.295402742828385,"d":"0.30"},{"v":0.51447603053179,"d":"0.51"},{"v":1.2416953041436,"d":"1.24"},{"v":0.791800914611642,"d":"0.79"},{"v":0.557464509310518,"d":"0.56"},{"v":0.576551513223269,"d":"0.58"},{"v":-0.794478580589486,"d":"-0.79"},{"v":0.0972911393099482,"d":"0.10"},{"v":0.540697002642414,"d":"0.54"},"down","no"]
["MSTRG.9292","KBTBD12","ENSOART00000005949","GO:0005515(protein binding)","NA","K21912","NA","kelch repeat and BTB domain containing 12 [Source:NCBI gene;Acc:101107230]",{"v":4.88229273463064,"d":"4.88"},{"v":8.42602284486035,"d":"8.43"},{"v":6.69843882411998,"d":"6.70"},{"v":4.71843587597091,"d":"4.72"},{"v":5.20278009138985,"d":"5.20"},{"v":4.5697779535614,"d":"4.57"},{"v":1.3806336896412,"d":"1.38"},{"v":0.465330593861448,"d":"0.47"},{"v":0.0973880278855801,"d":"0.10"},{"v":0.540697002642414,"d":"0.54"},"up","no"]
["MSTRG.7873","SMARCB1","ENSOART00000014413;ENSOART00000014412","GO:0000228(nuclear chromosome);GO:0001650(fibrillar center);GO:0001741(XY body);GO:0001824(blastocyst development);GO:0001835(blastocyst hatching);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006338(chromatin remodeling);GO:0008285(negative regulation of cell population proliferation);GO:0016514(SWI/SNF complex);GO:0030154(cell differentiation);GO:0043231(intracellular membrane-bounded organelle);GO:0071564(npBAF complex);GO:0071565(nBAF complex);GO:0071565(nBAF complex)","04714(Thermogenesis);05225(Hepatocellular carcinoma);05225(Hepatocellular carcinoma)","K11648","NA","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 [Source:NCBI gene;Acc:101110622]",{"v":4.3323105641814,"d":"4.33"},{"v":3.78782920599539,"d":"3.79"},{"v":5.43426345810915,"d":"5.43"},{"v":6.00747031206764,"d":"6.01"},{"v":6.44608951575711,"d":"6.45"},{"v":9.28997903996926,"d":"9.29"},{"v":0.623376135352207,"d":"0.62"},{"v":-0.681825169420462,"d":"-0.68"},{"v":0.0974078971498714,"d":"0.10"},{"v":0.540697002642414,"d":"0.54"},"down","no"]
["MSTRG.16720","DDC","ENSOART00000015673;ENSOART00000015675","GO:0003824(catalytic activity);GO:0004058(aromatic-L-amino-acid decarboxylase activity);GO:0005737(cytoplasm);GO:0006520(cellular amino acid metabolic process);GO:0009636(response to toxic substance);GO:0016829(lyase activity);GO:0016831(carboxy-lyase activity);GO:0019752(carboxylic acid metabolic process);GO:0019899(enzyme binding);GO:0030170(pyridoxal phosphate binding);GO:0036468(L-dopa decarboxylase activity);GO:0036468(L-dopa decarboxylase activity)","00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00380(Tryptophan metabolism);04726(Serotonergic synapse);04728(Dopaminergic synapse);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism);05034(Alcoholism)","K01593","4.1.1.105;EC:4.1.1.28","dopa decarboxylase [Source:NCBI gene;Acc:101106765]",{"v":0.784760937647878,"d":"0.78"},{"v":1.24326676102992,"d":"1.24"},{"v":1.85549925219207,"d":"1.86"},{"v":1.29550893736952,"d":"1.30"},{"v":0.501127223242867,"d":"0.50"},{"v":0.758045991231733,"d":"0.76"},{"v":1.52016052097382,"d":"1.52"},{"v":0.604223672738261,"d":"0.60"},{"v":0.0974303049813502,"d":"0.10"},{"v":0.540697002642414,"d":"0.54"},"up","no"]
["MSTRG.6249","ENSOARG00000016991","ENSOART00000018504","GO:0007525(somatic muscle development);GO:0046872(metal ion binding)","NA","NA","NA",null,{"v":10.324594,"d":"10.32"},{"v":13.758585,"d":"13.76"},{"v":13.564454,"d":"13.56"},{"v":13.09686,"d":"13.10"},{"v":25.447618,"d":"25.45"},{"v":23.62269,"d":"23.62"},{"v":0.605587068080695,"d":"0.61"},{"v":-0.723593697052244,"d":"-0.72"},{"v":0.0976728335567753,"d":"0.10"},{"v":0.54123270299852,"d":"0.54"},"down","no"]
["MSTRG.20555","ENSOARG00000013436","ENSOART00000014618","GO:0016491(oxidoreductase activity);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00520(Amino sugar and nucleotide sugar metabolism)","K00326","EC:1.6.2.2","cytochrome b5 reductase 4 [Source:NCBI gene;Acc:101117851]",{"v":1.2606213665706,"d":"1.26"},{"v":1.1598549925072,"d":"1.16"},{"v":1.46937144956772,"d":"1.47"},{"v":2.25139028645533,"d":"2.25"},{"v":1.80329692564842,"d":"1.80"},{"v":2.32863629740634,"d":"2.33"},{"v":0.609376573637588,"d":"0.61"},{"v":-0.714594055556275,"d":"-0.71"},{"v":0.0977026492314932,"d":"0.10"},{"v":0.54123270299852,"d":"0.54"},"down","no"]
["MSTRG.7074","PRKAA1","ENSOART00000010140;ENSOART00000010139","GO:0000166(nucleotide binding);GO:0003682(chromatin binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004679(AMP-activated protein kinase activity);GO:0005524(ATP binding);GO:0005623(cell);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006006(glucose metabolic process);GO:0006468(protein phosphorylation);GO:0008610(lipid biosynthetic process);GO:0009411(response to UV);GO:0010332(response to gamma radiation);GO:0010508(positive regulation of autophagy);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0019395(fatty acid oxidation);GO:0030424(axon);GO:0030425(dendrite);GO:0031669(cellular response to nutrient levels);GO:0032007(negative regulation of TOR signaling);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0034599(cellular response to oxidative stress);GO:0035174(histone serine kinase activity);GO:0035404(histone-serine phosphorylation);GO:0042149(cellular response to glucose starvation);GO:0042542(response to hydrogen peroxide);GO:0042593(glucose homeostasis);GO:0042752(regulation of circadian rhythm);GO:0043025(neuronal cell body);GO:0043066(negative regulation of apoptotic process);GO:0048643(positive regulation of skeletal muscle tissue development);GO:0050995(negative regulation of lipid catabolic process);GO:0061744(motor behavior);GO:0061762(CAMKK-AMPK signaling cascade);GO:0062028(regulation of stress granule assembly);GO:0070050(neuron cellular homeostasis);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0071277(cellular response to calcium ion);GO:0071333(cellular response to glucose stimulus);GO:0071380(cellular response to prostaglandin E stimulus);GO:1901563(response to camptothecin);GO:1903109(positive regulation of mitochondrial transcription);GO:1903829(positive regulation of cellular protein localization);GO:1903955(positive regulation of protein targeting to mitochondrion);GO:1904428(negative regulation of tubulin deacetylation);GO:1904927(cellular response to palmitoleic acid);GO:2000758(positive regulation of peptidyl-lysine acetylation);GO:2000758(positive regulation of peptidyl-lysine acetylation)","04068(FoxO signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04371(Apelin signaling pathway);04530(Tight junction);04710(Circadian rhythm);04714(Thermogenesis);04910(Insulin signaling pathway);04920(Adipocytokine signaling pathway);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD));05410(Hypertrophic cardiomyopathy (HCM));05418(Fluid shear stress and atherosclerosis);05418(Fluid shear stress and atherosclerosis)","K07198","EC:2.7.11.11","protein kinase AMP-activated catalytic subunit alpha 1 [Source:NCBI gene;Acc:101103425]",{"v":6.01081977391304,"d":"6.01"},{"v":6.89301126086956,"d":"6.89"},{"v":4.57176168695652,"d":"4.57"},{"v":4.2132412,"d":"4.21"},{"v":4.29475785217391,"d":"4.29"},{"v":4.04331203478261,"d":"4.04"},{"v":1.39233205205948,"d":"1.39"},{"v":0.477503315160484,"d":"0.48"},{"v":0.0977188883169792,"d":"0.10"},{"v":0.54123270299852,"d":"0.54"},"up","no"]
["MSTRG.770","C1orf54","ENSOART00000022643","NA","NA","NA","NA","chromosome 1 open reading frame, human C1orf54 [Source:NCBI gene;Acc:101103855]",{"v":3.980899,"d":"3.98"},{"v":1.844731,"d":"1.84"},{"v":2.566302,"d":"2.57"},{"v":4.924752,"d":"4.92"},{"v":4.201256,"d":"4.20"},{"v":5.697609,"d":"5.70"},{"v":0.566119051780682,"d":"0.57"},{"v":-0.820822618945549,"d":"-0.82"},{"v":0.0979778301512187,"d":"0.10"},{"v":0.541838378953466,"d":"0.54"},"down","no"]
["MSTRG.12218","ENSOARG00000002794;RF01946","ENSOART00000003030;ENSOART00000024011","GO:0005216(ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","04261(Adrenergic signaling in cardiomyocytes);04725(Cholinergic synapse);04971(Gastric acid secretion);04972(Pancreatic secretion);04974(Protein digestion and absorption)","K04926","NA","potassium voltage-gated channel subfamily Q member 1 [Source:NCBI gene;Acc:101119596]",{"v":1.47681898490418,"d":"1.48"},{"v":1.14827318175654,"d":"1.15"},{"v":1.14337467970451,"d":"1.14"},{"v":2.14342269790514,"d":"2.14"},{"v":2.4064864463795,"d":"2.41"},{"v":1.36941780750152,"d":"1.37"},{"v":0.636637725379926,"d":"0.64"},{"v":-0.651455445287186,"d":"-0.65"},{"v":0.0980186330409228,"d":"0.10"},{"v":0.541838378953466,"d":"0.54"},"down","no"]
["MSTRG.2920","ENSOARG00000012160","ENSOART00000013226","GO:0004864(protein phosphatase inhibitor activity);GO:0009966(regulation of signal transduction);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA","NA","NA",null,{"v":0.933286,"d":"0.93"},{"v":0.749284,"d":"0.75"},{"v":0.942088,"d":"0.94"},{"v":1.584813,"d":"1.58"},{"v":1.62141,"d":"1.62"},{"v":1.274041,"d":"1.27"},{"v":0.585826638787357,"d":"0.59"},{"v":-0.77145429775643,"d":"-0.77"},{"v":0.0980200564000944,"d":"0.10"},{"v":0.541838378953466,"d":"0.54"},"down","no"]
["MSTRG.11303","SUPT3H","ENSOART00000011202","GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006366(transcription by RNA polymerase II);GO:0016578(histone deubiquitination);GO:0030914(STAGA complex);GO:0033276(transcription factor TFTC complex);GO:0043966(histone H3 acetylation);GO:0046982(protein heterodimerization activity);GO:1903508(positive regulation of nucleic acid-templated transcription)","05202(Transcriptional misregulation in cancer)","K11313","NA","SPT3 homolog, SAGA and STAGA complex component [Source:NCBI gene;Acc:101119082]",{"v":1.554571,"d":"1.55"},{"v":0.961803,"d":"0.96"},{"v":1.326545,"d":"1.33"},{"v":1.919278,"d":"1.92"},{"v":2.115195,"d":"2.12"},{"v":2.316743,"d":"2.32"},{"v":0.60506822630501,"d":"0.61"},{"v":-0.724830267868205,"d":"-0.72"},{"v":0.0980605346525902,"d":"0.10"},{"v":0.541838378953466,"d":"0.54"},"down","no"]
["MSTRG.7075","TTC33","ENSOART00000010184","GO:0005515(protein binding)","NA","NA","NA","tetratricopeptide repeat domain 33 [Source:NCBI gene;Acc:101104092]",{"v":6.588675,"d":"6.59"},{"v":5.367494,"d":"5.37"},{"v":4.460283,"d":"4.46"},{"v":4.580709,"d":"4.58"},{"v":2.722002,"d":"2.72"},{"v":3.89925,"d":"3.90"},{"v":1.46549804985038,"d":"1.47"},{"v":0.551391048223252,"d":"0.55"},{"v":0.0982561420178698,"d":"0.10"},{"v":0.542735550361224,"d":"0.54"},"up","no"]
["MSTRG.14768","FPGS","ENSOART00000012481","GO:0000166(nucleotide binding);GO:0004326(tetrahydrofolylpolyglutamate synthase activity);GO:0005524(ATP binding);GO:0006536(glutamate metabolic process);GO:0006730(one-carbon metabolic process);GO:0006760(folic acid-containing compound metabolic process);GO:0009058(biosynthetic process);GO:0009396(folic acid-containing compound biosynthetic process);GO:0016874(ligase activity);GO:0046872(metal ion binding);GO:0046901(tetrahydrofolylpolyglutamate biosynthetic process)","00790(Folate biosynthesis);01523(Antifolate resistance)","K01930","EC:6.3.2.17","folylpolyglutamate synthase [Source:NCBI gene;Acc:101101964]",{"v":0.641856,"d":"0.64"},{"v":0.482681,"d":"0.48"},{"v":0.473666,"d":"0.47"},{"v":0.806105,"d":"0.81"},{"v":1.133366,"d":"1.13"},{"v":0.873571,"d":"0.87"},{"v":0.568140468574589,"d":"0.57"},{"v":-0.815680425260185,"d":"-0.82"},{"v":0.09837266155347,"d":"0.10"},{"v":0.542935594917659,"d":"0.54"},"down","no"]
["MSTRG.11121","KLHL31","ENSOART00000007653","GO:0001933(negative regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046329(negative regulation of JNK cascade)","NA","K10467","NA","kelch like family member 31 [Source:NCBI gene;Acc:101114565]",{"v":22.599038155465,"d":"22.60"},{"v":25.8888939022403,"d":"25.89"},{"v":18.1689573642227,"d":"18.17"},{"v":88.8394382219959,"d":"88.84"},{"v":26.7787431028513,"d":"26.78"},{"v":14.8067628094026,"d":"14.81"},{"v":0.511074701732794,"d":"0.51"},{"v":-0.968393915382437,"d":"-0.97"},{"v":0.0985064100073851,"d":"0.10"},{"v":0.543261107142047,"d":"0.54"},"down","no"]
["MSTRG.872","SHC1","ENSOART00000003476","GO:0000165(MAPK cascade);GO:0000187(activation of MAPK activity);GO:0001525(angiogenesis);GO:0001784(phosphotyrosine residue binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005168(neurotrophin TRKA receptor binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007507(heart development);GO:0030971(receptor tyrosine kinase binding);GO:0031532(actin cytoskeleton reorganization);GO:0035556(intracellular signal transduction);GO:0042127(regulation of cell population proliferation);GO:0042742(defense response to bacterium);GO:0043066(negative regulation of apoptotic process);GO:0043410(positive regulation of MAPK cascade);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046875(ephrin receptor binding);GO:0048408(epidermal growth factor binding);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071363(cellular response to growth factor stimulus);GO:0098609(cell-cell adhesion)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04012(ErbB signaling pathway);04014(Ras signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04510(Focal adhesion);04650(Natural killer cell mediated cytotoxicity);04722(Neurotrophin signaling pathway);04910(Insulin signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);05034(Alcoholism);05100(Bacterial invasion of epithelial cells);05206(MicroRNAs in cancer);05214(Glioma);05220(Chronic myeloid leukemia);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K06279","NA","SHC adaptor protein 1 [Source:NCBI gene;Acc:101113548]",{"v":7.69050758852062,"d":"7.69"},{"v":7.53077726003773,"d":"7.53"},{"v":8.71860579277823,"d":"8.72"},{"v":10.8713105610348,"d":"10.87"},{"v":13.1460739752088,"d":"13.15"},{"v":12.4636914696847,"d":"12.46"},{"v":0.656227646285605,"d":"0.66"},{"v":-0.607731720295025,"d":"-0.61"},{"v":0.0985176468794465,"d":"0.10"},{"v":0.543261107142047,"d":"0.54"},"down","no"]
["MSTRG.20552","TBX18","ENSOART00000014485","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0072001(renal system development)","NA","K10183","NA","T-box 18 [Source:NCBI gene;Acc:101117084]",{"v":1.013068,"d":"1.01"},{"v":1.248045,"d":"1.25"},{"v":1.11985,"d":"1.12"},{"v":0.313977,"d":"0.31"},{"v":1.005502,"d":"1.01"},{"v":0.789981,"d":"0.79"},{"v":1.60276231831843,"d":"1.60"},{"v":0.680560496854036,"d":"0.68"},{"v":0.098823453119966,"d":"0.10"},{"v":0.54433094019959,"d":"0.54"},"up","no"]
["MSTRG.3854","EPHX1","ENSOART00000019014","GO:0003824(catalytic activity);GO:0004301(epoxide hydrolase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0019439(aromatic compound catabolic process);GO:0033961(cis-stilbene-oxide hydrolase activity);GO:0097176(epoxide metabolic process)","00980(Metabolism of xenobiotics by cytochrome P450);04976(Bile secretion);05204(Chemical carcinogenesis)","K01253","EC:3.3.2.9","epoxide hydrolase 1 [Source:NCBI gene;Acc:101111038]",{"v":7.55589961542373,"d":"7.56"},{"v":6.32303308983051,"d":"6.32"},{"v":6.46929411271186,"d":"6.47"},{"v":6.27902960372881,"d":"6.28"},{"v":3.15444800033898,"d":"3.15"},{"v":5.19013334542373,"d":"5.19"},{"v":1.39146390643507,"d":"1.39"},{"v":0.47660348669145,"d":"0.48"},{"v":0.0990210724113094,"d":"0.10"},{"v":0.544604864845588,"d":"0.54"},"up","no"]
["MSTRG.3840","WDR26","ENSOART00000017835","GO:0005515(protein binding)","NA","K22382","NA","WD repeat domain 26 [Source:NCBI gene;Acc:101109551]",{"v":8.49683918300087,"d":"8.50"},{"v":9.78172169029409,"d":"9.78"},{"v":8.01973730032327,"d":"8.02"},{"v":7.0207552924387,"d":"7.02"},{"v":6.48025972553812,"d":"6.48"},{"v":6.02843378049357,"d":"6.03"},{"v":1.34659705171392,"d":"1.35"},{"v":0.429318211258566,"d":"0.43"},{"v":0.0992551025627152,"d":"0.10"},{"v":0.545071325377644,"d":"0.55"},"up","no"]
["MSTRG.14794","ENSOARG00000013275","ENSOART00000014435","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02918","NA","ribosomal protein L35 [Source:NCBI gene;Acc:101112126]",{"v":282.369296622739,"d":"282.37"},{"v":245.258388126615,"d":"245.26"},{"v":264.480961850129,"d":"264.48"},{"v":315.997291808786,"d":"316.00"},{"v":391.930601155039,"d":"391.93"},{"v":506.648150527132,"d":"506.65"},{"v":0.65216883771459,"d":"0.65"},{"v":-0.616682587791635,"d":"-0.62"},{"v":0.0993196567567039,"d":"0.10"},{"v":0.545071325377644,"d":"0.55"},"down","no"]
["MSTRG.2246","ENSOARG00000012028","ENSOART00000013083","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","05206(MicroRNAs in cancer)","K13863","NA","solute carrier family 7 member 1 [Source:NCBI gene;Acc:443452]",{"v":2.206354,"d":"2.21"},{"v":3.178572,"d":"3.18"},{"v":3.073802,"d":"3.07"},{"v":1.928087,"d":"1.93"},{"v":1.869434,"d":"1.87"},{"v":1.980407,"d":"1.98"},{"v":1.46397255209826,"d":"1.46"},{"v":0.549888504904101,"d":"0.55"},{"v":0.0993225119020553,"d":"0.10"},{"v":0.545071325377644,"d":"0.55"},"up","no"]
["MSTRG.467","TTLL7","ENSOART00000014947","GO:0005524(ATP binding);GO:0006464(cellular protein modification process);GO:0018095(protein polyglutamylation);GO:0043014(alpha-tubulin binding);GO:0048487(beta-tubulin binding);GO:0070740(tubulin-glutamic acid ligase activity)","NA","K16583","EC:6.-.-.-","tubulin tyrosine ligase like 7 [Source:NCBI gene;Acc:101108264]",{"v":3.22169290091874,"d":"3.22"},{"v":3.3379588940282,"d":"3.34"},{"v":3.09706193552986,"d":"3.10"},{"v":2.84437333137969,"d":"2.84"},{"v":2.26007312759385,"d":"2.26"},{"v":2.10608217083795,"d":"2.11"},{"v":1.33925183939381,"d":"1.34"},{"v":0.421427277526667,"d":"0.42"},{"v":0.0993455723076879,"d":"0.10"},{"v":0.545071325377644,"d":"0.55"},"up","no"]
["MSTRG.4160","RC3H1","ENSOART00000014145","GO:0000209(protein polyubiquitination);GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000932(P-body);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0001782(B cell homeostasis);GO:0002634(regulation of germinal center formation);GO:0002635(negative regulation of germinal center formation);GO:0003725(double-stranded RNA binding);GO:0003729(mRNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0010468(regulation of gene expression);GO:0010494(cytoplasmic stress granule);GO:0010608(posttranscriptional regulation of gene expression);GO:0030889(negative regulation of B cell proliferation);GO:0033962(cytoplasmic mRNA processing body assembly);GO:0035198(miRNA binding);GO:0035613(RNA stem-loop binding);GO:0042098(T cell proliferation);GO:0042129(regulation of T cell proliferation);GO:0043029(T cell homeostasis);GO:0043488(regulation of mRNA stability);GO:0045623(negative regulation of T-helper cell differentiation);GO:0046007(negative regulation of activated T cell proliferation);GO:0046872(metal ion binding);GO:0048535(lymph node development);GO:0048536(spleen development);GO:0050852(T cell receptor signaling pathway);GO:0050856(regulation of T cell receptor signaling pathway);GO:0050863(regulation of T cell activation);GO:0061014(positive regulation of mRNA catabolic process);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0061470(T follicular helper cell differentiation);GO:0071347(cellular response to interleukin-1);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:2000320(negative regulation of T-helper 17 cell differentiation);GO:2000628(regulation of miRNA metabolic process)","NA","K15690","NA","ring finger and CCCH-type domains 1 [Source:NCBI gene;Acc:101114887]",{"v":4.85717480956018,"d":"4.86"},{"v":4.15622947781809,"d":"4.16"},{"v":6.67271022143721,"d":"6.67"},{"v":5.04017122201006,"d":"5.04"},{"v":2.99282626675578,"d":"2.99"},{"v":3.28500977958119,"d":"3.29"},{"v":1.38594313794838,"d":"1.39"},{"v":0.470868068237965,"d":"0.47"},{"v":0.0994315835889123,"d":"0.10"},{"v":0.545279832549742,"d":"0.55"},"up","no"]
["MSTRG.356","FGGY","ENSOART00000009237","GO:0005623(cell);GO:0005975(carbohydrate metabolic process);GO:0016773(phosphotransferase activity, alcohol group as acceptor);GO:0019150(D-ribulokinase activity);GO:0019321(pentose metabolic process);GO:0046835(carbohydrate phosphorylation);GO:0070050(neuron cellular homeostasis)","NA","NA","NA","FGGY carbohydrate kinase domain containing [Source:NCBI gene;Acc:101104022]",{"v":3.66876038937031,"d":"3.67"},{"v":2.50674178336222,"d":"2.51"},{"v":2.59236696822646,"d":"2.59"},{"v":4.40176033622184,"d":"4.40"},{"v":4.95485652570768,"d":"4.95"},{"v":4.41193061062969,"d":"4.41"},{"v":0.63680422052024,"d":"0.64"},{"v":-0.65107819728557,"d":"-0.65"},{"v":0.0994848494099512,"d":"0.10"},{"v":0.545279832549742,"d":"0.55"},"down","no"]
["MSTRG.13176","FAM173A","ENSOART00000014811","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","family with sequence similarity 173 member A [Source:NCBI gene;Acc:101111148]",{"v":2.464555,"d":"2.46"},{"v":2.404327,"d":"2.40"},{"v":2.283101,"d":"2.28"},{"v":3.748827,"d":"3.75"},{"v":3.431804,"d":"3.43"},{"v":4.655939,"d":"4.66"},{"v":0.604227660546932,"d":"0.60"},{"v":-0.726835865107401,"d":"-0.73"},{"v":0.0996066755041015,"d":"0.10"},{"v":0.545654390612954,"d":"0.55"},"down","no"]
["MSTRG.21350","CA2","ENSOART00000014084","GO:0004064(arylesterase activity);GO:0004089(carbonate dehydratase activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0038166(angiotensin-activated signaling pathway);GO:0044070(regulation of anion transport);GO:0045177(apical part of cell);GO:0046872(metal ion binding)","00910(Nitrogen metabolism);04964(Proximal tubule bicarbonate reclamation);04966(Collecting duct acid secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion)","K18245","EC:4.2.1.1","carbonic anhydrase 2 [Source:NCBI gene;Acc:101113341]",{"v":18.781107,"d":"18.78"},{"v":16.916071,"d":"16.92"},{"v":8.021605,"d":"8.02"},{"v":40.663338,"d":"40.66"},{"v":14.051787,"d":"14.05"},{"v":22.138088,"d":"22.14"},{"v":0.568860836045983,"d":"0.57"},{"v":-0.813852334626637,"d":"-0.81"},{"v":0.0996229938146037,"d":"0.10"},{"v":0.545654390612954,"d":"0.55"},"down","no"]
["MSTRG.13483","GTF3C1","ENSOART00000000107","GO:0000127(transcription factor TFIIIC complex);GO:0005634(nucleus);GO:0005730(nucleolus);GO:1990904(ribonucleoprotein complex)","NA","K15199","NA","general transcription factor IIIC subunit 1 [Source:NCBI gene;Acc:101109667]",{"v":4.4065517916542,"d":"4.41"},{"v":3.25945228133413,"d":"3.26"},{"v":3.64711880272211,"d":"3.65"},{"v":5.69666984923721,"d":"5.70"},{"v":5.72406522599462,"d":"5.72"},{"v":5.73263159407718,"d":"5.73"},{"v":0.659527840441492,"d":"0.66"},{"v":-0.600494534092691,"d":"-0.60"},{"v":0.0997375067883986,"d":"0.10"},{"v":0.545654390612954,"d":"0.55"},"down","no"]
["MSTRG.533","GCLM","ENSOART00000018525","GO:0004357(glutamate-cysteine ligase activity);GO:0006534(cysteine metabolic process);GO:0006536(glutamate metabolic process);GO:0006749(glutathione metabolic process);GO:0006750(glutathione biosynthetic process);GO:0006979(response to oxidative stress);GO:0008637(apoptotic mitochondrial changes);GO:0017109(glutamate-cysteine ligase complex);GO:0035226(glutamate-cysteine ligase catalytic subunit binding);GO:0035229(positive regulation of glutamate-cysteine ligase activity);GO:0042493(response to drug);GO:0046982(protein heterodimerization activity);GO:0050880(regulation of blood vessel size);GO:0051900(regulation of mitochondrial depolarization);GO:1990830(cellular response to leukemia inhibitory factor);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","00270(Cysteine and methionine metabolism);00480(Glutathione metabolism);04216(Ferroptosis)","K11205","NA","glutamate-cysteine ligase modifier subunit [Source:NCBI gene;Acc:101117899]",{"v":2.79412249461567,"d":"2.79"},{"v":2.50885143705904,"d":"2.51"},{"v":2.22234422131452,"d":"2.22"},{"v":2.12602775120683,"d":"2.13"},{"v":1.70888955811363,"d":"1.71"},{"v":1.55611078054215,"d":"1.56"},{"v":1.39589666897488,"d":"1.40"},{"v":0.481192150233091,"d":"0.48"},{"v":0.0997685646804896,"d":"0.10"},{"v":0.545654390612954,"d":"0.55"},"up","no"]
["MSTRG.21204","TRPS1","ENSOART00000011753","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001501(skeletal system development);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0019904(protein domain specific binding);GO:0032991(protein-containing complex);GO:0043565(sequence-specific DNA binding);GO:0046872(metal ion binding);GO:0051291(protein heterooligomerization)","NA","K22040","NA","transcriptional repressor GATA binding 1 [Source:NCBI gene;Acc:101116062]",{"v":2.55370976398169,"d":"2.55"},{"v":2.3784893507129,"d":"2.38"},{"v":2.65790941789867,"d":"2.66"},{"v":1.9718117683485,"d":"1.97"},{"v":2.10863776066712,"d":"2.11"},{"v":1.51670022944178,"d":"1.52"},{"v":1.3560667232683,"d":"1.36"},{"v":0.439428165907919,"d":"0.44"},{"v":0.0998160505091375,"d":"0.10"},{"v":0.545654390612954,"d":"0.55"},"up","no"]
["MSTRG.7115","NPR3","ENSOART00000013212","GO:0001501(skeletal system development);GO:0002158(osteoclast proliferation);GO:0008217(regulation of blood pressure);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016941(natriuretic peptide receptor activity);GO:0017046(peptide hormone binding);GO:0031404(chloride ion binding);GO:0032991(protein-containing complex);GO:0033688(regulation of osteoblast proliferation);GO:0035810(positive regulation of urine volume);GO:0042277(peptide binding);GO:0042562(hormone binding);GO:0042803(protein homodimerization activity);GO:0120163(negative regulation of cold-induced thermogenesis)","NA","K12325","NA","natriuretic peptide receptor 3 [Source:NCBI gene;Acc:101114557]",{"v":0.99733,"d":"1.00"},{"v":0.22418,"d":"0.22"},{"v":0.450523,"d":"0.45"},{"v":1.111957,"d":"1.11"},{"v":1.055006,"d":"1.06"},{"v":1.05268,"d":"1.05"},{"v":0.519322483890295,"d":"0.52"},{"v":-0.945297407118433,"d":"-0.95"},{"v":0.0998951715834955,"d":"0.10"},{"v":0.545654390612954,"d":"0.55"},"down","no"]
["MSTRG.17373","TPK1","ENSOART00000020141","GO:0000166(nucleotide binding);GO:0004788(thiamine diphosphokinase activity);GO:0005524(ATP binding);GO:0006772(thiamine metabolic process);GO:0009229(thiamine diphosphate biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030975(thiamine binding)","00730(Thiamine metabolism)","K00949","EC:2.7.6.2","thiamin pyrophosphokinase 1 [Source:NCBI gene;Acc:101119979]",{"v":3.47985601041667,"d":"3.48"},{"v":3.07710077764423,"d":"3.08"},{"v":4.29062056971154,"d":"4.29"},{"v":2.66675463221154,"d":"2.67"},{"v":2.43455229286859,"d":"2.43"},{"v":2.67978477363782,"d":"2.68"},{"v":1.39409452783595,"d":"1.39"},{"v":0.479328387760525,"d":"0.48"},{"v":0.100003192222084,"d":"0.10"},{"v":0.545654390612954,"d":"0.55"},"up","no"]
["MSTRG.5776","ZNF576","ENSOART00000009580","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 576 [Source:NCBI gene;Acc:101108943]",{"v":1.18517541304348,"d":"1.19"},{"v":1.03469457114625,"d":"1.03"},{"v":1.39114597035573,"d":"1.39"},{"v":2.07233252173913,"d":"2.07"},{"v":2.10863786956522,"d":"2.11"},{"v":1.58318176284585,"d":"1.58"},{"v":0.626460901443332,"d":"0.63"},{"v":-0.674703623734504,"d":"-0.67"},{"v":0.100021043061279,"d":"0.10"},{"v":0.545654390612954,"d":"0.55"},"down","no"]
["MSTRG.17129","ENSOARG00000012311","ENSOART00000013389","GO:0005525(GTP binding)","NA","NA","NA","GTP binding protein 10 [Source:NCBI gene;Acc:101112643]",{"v":2.12646976596621,"d":"2.13"},{"v":1.46485802018953,"d":"1.46"},{"v":1.31750342645241,"d":"1.32"},{"v":1.36643486773795,"d":"1.37"},{"v":1.09376033621755,"d":"1.09"},{"v":0.906970511742892,"d":"0.91"},{"v":1.45785257604703,"d":"1.46"},{"v":0.543844835879241,"d":"0.54"},{"v":0.100058191255196,"d":"0.10"},{"v":0.545674731735086,"d":"0.55"},"up","no"]
["MSTRG.14624","ENSOARG00000002665","ENSOART00000002886","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005874(microtubule);GO:0007010(cytoskeleton organization);GO:0007017(microtubule-based process)","NA","NA","NA",null,{"v":47.1641005099818,"d":"47.16"},{"v":55.3760539800363,"d":"55.38"},{"v":46.6577002132486,"d":"46.66"},{"v":37.4170447196007,"d":"37.42"},{"v":30.5264425998185,"d":"30.53"},{"v":40.4915754255898,"d":"40.49"},{"v":1.37591892259161,"d":"1.38"},{"v":0.460395460286212,"d":"0.46"},{"v":0.100099568595851,"d":"0.10"},{"v":0.545677057419356,"d":"0.55"},"up","no"]
["MSTRG.2443","DOCK9","ENSOART00000003953","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0007264(small GTPase mediated signal transduction)","NA","K21853","NA","dedicator of cytokinesis 9 [Source:NCBI gene;Acc:101110423]",{"v":9.61390247121509,"d":"9.61"},{"v":6.44409915911318,"d":"6.44"},{"v":7.18315622231749,"d":"7.18"},{"v":11.2712954157276,"d":"11.27"},{"v":13.4556141735669,"d":"13.46"},{"v":10.8778484069084,"d":"10.88"},{"v":0.652754271075914,"d":"0.65"},{"v":-0.615388102533264,"d":"-0.62"},{"v":0.100237295650461,"d":"0.10"},{"v":0.545776809907437,"d":"0.55"},"down","no"]
["ENSOARG00000014350","ZNHIT6","ENSOART00000015625","GO:0001094(TFIID-class transcription factor complex binding);GO:0019899(enzyme binding);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0048254(snoRNA localization);GO:0051117(ATPase binding);GO:0051259(protein complex oligomerization);GO:0070761(pre-snoRNP complex)","NA","NA","NA","zinc finger HIT-type containing 6 [Source:NCBI gene;Acc:101114320]",{"v":0.810107,"d":"0.81"},{"v":0.9188,"d":"0.92"},{"v":1.701607,"d":"1.70"},{"v":0.743285,"d":"0.74"},{"v":0.931827,"d":"0.93"},{"v":0.483718,"d":"0.48"},{"v":1.58906166766258,"d":"1.59"},{"v":0.668175113298547,"d":"0.67"},{"v":0.100244038027462,"d":"0.10"},{"v":0.545776809907437,"d":"0.55"},"up","no"]
["MSTRG.15767","ADCY6","ENSOART00000020888","GO:0000166(nucleotide binding);GO:0004016(adenylate cyclase activity);GO:0005080(protein kinase C binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006171(cAMP biosynthetic process);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007212(dopamine receptor signaling pathway);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0046872(metal ion binding);GO:0071380(cellular response to prostaglandin E stimulus);GO:0071870(cellular response to catecholamine stimulus);GO:0097746(regulation of blood vessel diameter);GO:1904322(cellular response to forskolin)","00230(Purine metabolism);01522(Endocrine resistance);04015(Rap1 signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04114(Oocyte meiosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04713(Circadian entrainment);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04727(GABAergic synapse);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04913(Ovarian steroidogenesis);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04961(Endocrine and other factor-regulated calcium reabsorption);04962(Vasopressin-regulated water reabsorption);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);05032(Morphine addiction);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05414(Dilated cardiomyopathy (DCM))","K08046","EC:4.6.1.1","adenylate cyclase 6 [Source:NCBI gene;Acc:101105735]",{"v":2.333937,"d":"2.33"},{"v":2.118554,"d":"2.12"},{"v":2.526072,"d":"2.53"},{"v":3.666446,"d":"3.67"},{"v":4.050133,"d":"4.05"},{"v":3.012599,"d":"3.01"},{"v":0.650428485760978,"d":"0.65"},{"v":-0.620537652717083,"d":"-0.62"},{"v":0.100332997497123,"d":"0.10"},{"v":0.546014873557093,"d":"0.55"},"down","no"]
["MSTRG.12481","BLOC1S2","ENSOART00000015555","GO:0000930(gamma-tubulin complex);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0008089(anterograde axonal transport);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0031083(BLOC-1 complex);GO:0032418(lysosome localization);GO:0043015(gamma-tubulin binding);GO:0048490(anterograde synaptic vesicle transport);GO:0097345(mitochondrial outer membrane permeabilization);GO:0099078(BORC complex);GO:1904115(axon cytoplasm)","NA","K16750","NA","biogenesis of lysosomal organelles complex 1 subunit 2 [Source:NCBI gene;Acc:101121559]",{"v":9.156586,"d":"9.16"},{"v":9.173852,"d":"9.17"},{"v":11.506482,"d":"11.51"},{"v":7.209955,"d":"7.21"},{"v":6.588737,"d":"6.59"},{"v":7.020113,"d":"7.02"},{"v":1.43317159654457,"d":"1.43"},{"v":0.519211356747839,"d":"0.52"},{"v":0.100354644509115,"d":"0.10"},{"v":0.546014873557093,"d":"0.55"},"up","no"]
["MSTRG.10911","GPATCH3","ENSOART00000004304","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0032480(negative regulation of type I interferon production);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0045893(positive regulation of transcription, DNA-templated)","NA","NA","NA","G-patch domain containing 3 [Source:NCBI gene;Acc:101109595]",{"v":1.258769,"d":"1.26"},{"v":1.436332,"d":"1.44"},{"v":1.707876,"d":"1.71"},{"v":1.755729,"d":"1.76"},{"v":2.818573,"d":"2.82"},{"v":2.588044,"d":"2.59"},{"v":0.614739500158188,"d":"0.61"},{"v":-0.701952906300777,"d":"-0.70"},{"v":0.10045237501005,"d":"0.10"},{"v":0.546323879887468,"d":"0.55"},"down","no"]
["MSTRG.6801","SLC43A1","ENSOART00000010598","GO:0015175(neutral amino acid transmembrane transporter activity);GO:0015804(neutral amino acid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K08228","NA","solute carrier family 43 member 1 [Source:NCBI gene;Acc:101120439]",{"v":1.21421000736961,"d":"1.21"},{"v":1.24509121655329,"d":"1.25"},{"v":1.53688232426304,"d":"1.54"},{"v":2.03567136678005,"d":"2.04"},{"v":2.25246272619048,"d":"2.25"},{"v":2.04627262698413,"d":"2.05"},{"v":0.630869428639174,"d":"0.63"},{"v":-0.66458665409697,"d":"-0.66"},{"v":0.100478356890132,"d":"0.10"},{"v":0.546323879887468,"d":"0.55"},"down","no"]
["MSTRG.3574","ENSOARG00000006700","ENSOART00000007278","NA","NA","NA","NA","matrix remodeling associated 7 [Source:NCBI gene;Acc:101116331]",{"v":3.11733104797897,"d":"3.12"},{"v":2.365124170884,"d":"2.37"},{"v":4.12610535359842,"d":"4.13"},{"v":4.55752806999671,"d":"4.56"},{"v":4.83037139960565,"d":"4.83"},{"v":5.57189229740388,"d":"5.57"},{"v":0.642292400998056,"d":"0.64"},{"v":-0.638697866957921,"d":"-0.64"},{"v":0.100608511204768,"d":"0.10"},{"v":0.546816583512797,"d":"0.55"},"down","no"]
["MSTRG.13665","ORAI2","ENSOART00000015726","GO:0016020(membrane);GO:0016021(integral component of membrane)","04020(Calcium signaling pathway)","K16057","NA","ORAI calcium release-activated calcium modulator 2 [Source:NCBI gene;Acc:101119359]",{"v":1.28032677920293,"d":"1.28"},{"v":1.46085526996488,"d":"1.46"},{"v":1.18109232371354,"d":"1.18"},{"v":2.11719982287372,"d":"2.12"},{"v":2.0662124550313,"d":"2.07"},{"v":1.82907947595053,"d":"1.83"},{"v":0.652354220754842,"d":"0.65"},{"v":-0.616272551046175,"d":"-0.62"},{"v":0.100635952563446,"d":"0.10"},{"v":0.546816583512797,"d":"0.55"},"down","no"]
["MSTRG.19168","LDB2","ENSOART00000011170","GO:0001942(hair follicle development);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0006357(regulation of transcription by RNA polymerase II);GO:0010669(epithelial structure maintenance);GO:0019899(enzyme binding);GO:0030274(LIM domain binding);GO:0030334(regulation of cell migration);GO:0031252(cell leading edge);GO:0035019(somatic stem cell population maintenance);GO:0043549(regulation of kinase activity);GO:0044089(positive regulation of cellular component biogenesis);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","LIM domain binding 2 [Source:NCBI gene;Acc:101107704]",{"v":2.70510356400507,"d":"2.71"},{"v":1.73116072782003,"d":"1.73"},{"v":1.69237526520913,"d":"1.69"},{"v":3.25922191856781,"d":"3.26"},{"v":2.62373208048162,"d":"2.62"},{"v":3.70734791951838,"d":"3.71"},{"v":0.639045528396614,"d":"0.64"},{"v":-0.646009376153017,"d":"-0.65"},{"v":0.100871666572273,"d":"0.10"},{"v":0.547862940668391,"d":"0.55"},"down","no"]
["MSTRG.16641","PPARA","ENSOART00000021157","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006631(fatty acid metabolic process);GO:0008134(transcription factor binding);GO:0008144(drug binding);GO:0008270(zinc ion binding);GO:0008289(lipid binding);GO:0008544(epidermis development);GO:0010468(regulation of gene expression);GO:0010745(negative regulation of macrophage derived foam cell differentiation);GO:0010871(negative regulation of receptor biosynthetic process);GO:0010887(negative regulation of cholesterol storage);GO:0010891(negative regulation of sequestering of triglyceride);GO:0019217(regulation of fatty acid metabolic process);GO:0030522(intracellular receptor signaling pathway);GO:0031624(ubiquitin conjugating enzyme binding);GO:0032099(negative regulation of appetite);GO:0032922(circadian regulation of gene expression);GO:0038023(signaling receptor activity);GO:0042060(wound healing);GO:0042752(regulation of circadian rhythm);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045722(positive regulation of gluconeogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046321(positive regulation of fatty acid oxidation);GO:0046872(metal ion binding);GO:0050728(negative regulation of inflammatory response);GO:0070166(enamel mineralization);GO:0072363(regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter);GO:0072366(regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter);GO:0072369(regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter);GO:1902894(negative regulation of pri-miRNA transcription by RNA polymerase II);GO:1903038(negative regulation of leukocyte cell-cell adhesion)","03320(PPAR signaling pathway);04024(cAMP signaling pathway);04920(Adipocytokine signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD));05160(Hepatitis C)","K07294","NA","peroxisome proliferator activated receptor alpha [Source:NCBI gene;Acc:443457]",{"v":2.09754283247404,"d":"2.10"},{"v":4.76260499847506,"d":"4.76"},{"v":3.86574337237673,"d":"3.87"},{"v":2.51292443330187,"d":"2.51"},{"v":2.7363515150679,"d":"2.74"},{"v":2.25304141318713,"d":"2.25"},{"v":1.4296770832819,"d":"1.43"},{"v":0.51568932675457,"d":"0.52"},{"v":0.100931775810965,"d":"0.10"},{"v":0.547862940668391,"d":"0.55"},"up","no"]
["MSTRG.11274","ENSOARG00000005094","ENSOART00000005556","GO:0000226(microtubule cytoskeleton organization);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0031467(Cul7-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:1990393(3M complex)","04120(Ubiquitin mediated proteolysis)","K10613","NA","cullin 7 [Source:NCBI gene;Acc:101112931]",{"v":5.555375,"d":"5.56"},{"v":3.414203,"d":"3.41"},{"v":4.426025,"d":"4.43"},{"v":6.187519,"d":"6.19"},{"v":7.283788,"d":"7.28"},{"v":7.002921,"d":"7.00"},{"v":0.654266573567511,"d":"0.65"},{"v":-0.612049529491301,"d":"-0.61"},{"v":0.101032769274151,"d":"0.10"},{"v":0.547862940668391,"d":"0.55"},"down","no"]
["MSTRG.11906","ST3GAL4","ENSOART00000013972","GO:0003836(beta-galactoside (CMP) alpha-2,3-sialyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0009101(glycoprotein biosynthetic process);GO:0009247(glycolipid biosynthetic process);GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030259(lipid glycosylation);GO:0047288(monosialoganglioside sialyltransferase activity);GO:0050890(cognition);GO:0097503(sialylation);GO:1990743(protein sialylation)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)","K03494","EC:2.4.99.4","ST3 beta-galactoside alpha-2,3-sialyltransferase 4 [Source:NCBI gene;Acc:100127212]",{"v":1.6523052185904,"d":"1.65"},{"v":1.78918424540347,"d":"1.79"},{"v":1.72055786976507,"d":"1.72"},{"v":2.31145409703779,"d":"2.31"},{"v":3.30674128370787,"d":"3.31"},{"v":2.45242946705822,"d":"2.45"},{"v":0.639609377353675,"d":"0.64"},{"v":-0.644737004470507,"d":"-0.64"},{"v":0.101036638463341,"d":"0.10"},{"v":0.547862940668391,"d":"0.55"},"down","no"]
["MSTRG.19513","NFATC4","ENSOART00000020781","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001569(branching involved in blood vessel morphogenesis);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007507(heart development);GO:0007616(long-term memory);GO:0008134(transcription factor binding);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0016607(nuclear speck);GO:0030178(negative regulation of Wnt signaling pathway);GO:0031547(brain-derived neurotrophic factor receptor signaling pathway);GO:0032091(negative regulation of protein binding);GO:0032760(positive regulation of tumor necrosis factor production);GO:0033173(calcineurin-NFAT signaling cascade);GO:0034644(cellular response to UV);GO:0035562(negative regulation of chromatin binding);GO:0043065(positive regulation of apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0045333(cellular respiration);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050774(negative regulation of dendrite morphogenesis);GO:0051145(smooth muscle cell differentiation);GO:0055001(muscle cell development);GO:0060291(long-term synaptic potentiation);GO:0071285(cellular response to lithium ion);GO:1902894(negative regulation of pri-miRNA transcription by RNA polymerase II);GO:2000297(negative regulation of synapse maturation);GO:2001235(positive regulation of apoptotic signaling pathway)","04022(cGMP-PKG signaling pathway);04218(Cellular senescence);04310(Wnt signaling pathway);04360(Axon guidance);04625(C-type lectin receptor signaling pathway);04921(Oxytocin signaling pathway);05161(Hepatitis B);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection)","K17334","NA","nuclear factor of activated T cells 4 [Source:NCBI gene;Acc:101118617]",{"v":0.559742,"d":"0.56"},{"v":0.620197,"d":"0.62"},{"v":0.441263,"d":"0.44"},{"v":0.819256,"d":"0.82"},{"v":1.188567,"d":"1.19"},{"v":0.748703,"d":"0.75"},{"v":0.588132308565201,"d":"0.59"},{"v":-0.765787348943731,"d":"-0.77"},{"v":0.101056199257853,"d":"0.10"},{"v":0.547862940668391,"d":"0.55"},"down","no"]
["MSTRG.16646","TRMU","ENSOART00000021212","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0016740(transferase activity);GO:0016783(sulfurtransferase activity)","NA","K21027","EC:2.8.1.14","mitochondrial tRNA-specific 2-thiouridylase 1 [Source:NCBI gene;Acc:101110834]",{"v":1.99580405408728,"d":"2.00"},{"v":1.83864777197296,"d":"1.84"},{"v":1.90564667301782,"d":"1.91"},{"v":3.11725776889982,"d":"3.12"},{"v":2.86890413153042,"d":"2.87"},{"v":3.11181537676706,"d":"3.11"},{"v":0.63092029405973,"d":"0.63"},{"v":-0.664470337901476,"d":"-0.66"},{"v":0.101063398903307,"d":"0.10"},{"v":0.547862940668391,"d":"0.55"},"down","no"]
["MSTRG.14653","ENSOARG00000003677","ENSOART00000003990","GO:0042254(ribosome biogenesis);GO:1990904(ribonucleoprotein complex)","03010(Ribosome)","K02936","NA","ribosomal protein L7a [Source:NCBI gene;Acc:101110132]",{"v":217.643007182008,"d":"217.64"},{"v":184.700311758368,"d":"184.70"},{"v":204.859188035565,"d":"204.86"},{"v":224.414805042887,"d":"224.41"},{"v":313.443721453975,"d":"313.44"},{"v":403.185082049163,"d":"403.19"},{"v":0.645243750089445,"d":"0.65"},{"v":-0.632083832622564,"d":"-0.63"},{"v":0.101101077474167,"d":"0.10"},{"v":0.547885294722271,"d":"0.55"},"down","no"]
["ENSOARG00000019466","LRIF1","ENSOART00000021199","GO:0000784(nuclear chromosome, telomeric region);GO:0001740(Barr body);GO:0005634(nucleus);GO:0005815(microtubule organizing center);GO:0006355(regulation of transcription, DNA-templated);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0042974(retinoic acid receptor binding)","NA","K23220","NA","ligand dependent nuclear receptor interacting factor 1 [Source:NCBI gene;Acc:101105972]",{"v":2.00842,"d":"2.01"},{"v":1.693251,"d":"1.69"},{"v":1.68147,"d":"1.68"},{"v":1.071315,"d":"1.07"},{"v":1.559131,"d":"1.56"},{"v":1.066783,"d":"1.07"},{"v":1.45599339397154,"d":"1.46"},{"v":0.542003809859329,"d":"0.54"},{"v":0.101445833777224,"d":"0.10"},{"v":0.548892428039681,"d":"0.55"},"up","no"]
["MSTRG.3309","RF00004","ENSOART00000026862","NA","NA","NA","NA",null,{"v":0.806699,"d":"0.81"},{"v":1.981809,"d":"1.98"},{"v":6.638662,"d":"6.64"},{"v":5.302811,"d":"5.30"},{"v":7.405918,"d":"7.41"},{"v":8.544978,"d":"8.54"},{"v":0.443554152694398,"d":"0.44"},{"v":-1.17281784367704,"d":"-1.17"},{"v":0.1015085702447,"d":"0.10"},{"v":0.548892428039681,"d":"0.55"},"down","no"]
["MSTRG.3891","COX20","ENSOART00000005604","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0009060(aerobic respiration);GO:0033617(mitochondrial respiratory chain complex IV assembly)","04714(Thermogenesis)","K18184","NA","cytochrome c oxidase protein 20 homolog [Source:NCBI gene;Acc:101117005]",{"v":9.002738,"d":"9.00"},{"v":7.368633,"d":"7.37"},{"v":6.006141,"d":"6.01"},{"v":7.376008,"d":"7.38"},{"v":4.165191,"d":"4.17"},{"v":3.466716,"d":"3.47"},{"v":1.49104735734444,"d":"1.49"},{"v":0.576326079969423,"d":"0.58"},{"v":0.101607703088808,"d":"0.10"},{"v":0.548892428039681,"d":"0.55"},"up","no"]
["MSTRG.8600","EIF5;RF00400","ENSOART00000006131;ENSOART00000025668","GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation)","03013(RNA transport)","K03262","NA","eukaryotic translation initiation factor 5 [Source:NCBI gene;Acc:101104786];small nucleolar RNA, H/ACA box 28 [Source:HGNC Symbol;Acc:HGNC:32618]",{"v":13.7224609492514,"d":"13.72"},{"v":15.7740815323741,"d":"15.77"},{"v":15.3625445472487,"d":"15.36"},{"v":11.2696265507486,"d":"11.27"},{"v":12.0850253306436,"d":"12.09"},{"v":10.2080448938363,"d":"10.21"},{"v":1.33657576235004,"d":"1.34"},{"v":0.418541617505268,"d":"0.42"},{"v":0.101627778444261,"d":"0.10"},{"v":0.548892428039681,"d":"0.55"},"up","no"]
["MSTRG.19694","ENSOARG00000020521","ENSOART00000022357;ENSOART00000022356","GO:0003824(catalytic activity);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0005975(carbohydrate metabolic process);GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0030246(carbohydrate binding);GO:0030246(carbohydrate binding)","00052(Galactose metabolism);00500(Starch and sucrose metabolism);00500(Starch and sucrose metabolism)","K12317","EC:3.2.1.20","glucosidase alpha, neutral C [Source:NCBI gene;Acc:101117423]",{"v":5.50872573766379,"d":"5.51"},{"v":6.34228378087538,"d":"6.34"},{"v":4.18353530861444,"d":"4.18"},{"v":3.45603183189295,"d":"3.46"},{"v":4.24610579760245,"d":"4.25"},{"v":3.90778956621132,"d":"3.91"},{"v":1.3811064063419,"d":"1.38"},{"v":0.465824475271576,"d":"0.47"},{"v":0.101638476892294,"d":"0.10"},{"v":0.548892428039681,"d":"0.55"},"up","no"]
["MSTRG.14280","ACSL1","ENSOART00000008297","GO:0001676(long-chain fatty acid metabolic process);GO:0003824(catalytic activity);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005739(mitochondrion);GO:0008610(lipid biosynthetic process);GO:0033211(adiponectin-activated signaling pathway);GO:0044539(long-chain fatty acid import into cell);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:0120162(positive regulation of cold-induced thermogenesis)","00061(Fatty acid biosynthesis);00071(Fatty acid degradation);03320(PPAR signaling pathway);04146(Peroxisome);04216(Ferroptosis);04714(Thermogenesis);04920(Adipocytokine signaling pathway)","K01897","EC:6.2.1.3","acyl-CoA synthetase long chain family member 1 [Source:NCBI gene;Acc:101110905]",{"v":17.341934882973,"d":"17.34"},{"v":13.4662382524733,"d":"13.47"},{"v":12.5827769280138,"d":"12.58"},{"v":11.7475331987984,"d":"11.75"},{"v":9.99327651232147,"d":"9.99"},{"v":10.5316252994568,"d":"10.53"},{"v":1.34452048781691,"d":"1.34"},{"v":0.427091739180035,"d":"0.43"},{"v":0.101656706417932,"d":"0.10"},{"v":0.548892428039681,"d":"0.55"},"up","no"]
["MSTRG.17611","RPL18A","ENSOART00000015740","GO:0002181(cytoplasmic translation);GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation);GO:0022625(cytosolic large ribosomal subunit);GO:0042788(polysomal ribosome)","NA","NA","NA","ribosomal protein L18a [Source:HGNC Symbol;Acc:HGNC:10311]",{"v":248.670959,"d":"248.67"},{"v":219.254913,"d":"219.25"},{"v":242.793671,"d":"242.79"},{"v":276.467621,"d":"276.47"},{"v":367.210876,"d":"367.21"},{"v":444.115265,"d":"444.12"},{"v":0.65335872279069,"d":"0.65"},{"v":-0.614052782300306,"d":"-0.61"},{"v":0.101727545680118,"d":"0.10"},{"v":0.549093344087594,"d":"0.55"},"down","no"]
["MSTRG.5715","ENSOARG00000006978","ENSOART00000007589","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA","K07880","NA","RAB4B, member RAS oncogene family [Source:NCBI gene;Acc:101121286]",{"v":1.04569907503608,"d":"1.05"},{"v":1.00788354545455,"d":"1.01"},{"v":1.30003126406926,"d":"1.30"},{"v":1.76179531385281,"d":"1.76"},{"v":1.72570678571429,"d":"1.73"},{"v":1.88151637878788,"d":"1.88"},{"v":0.624623271102507,"d":"0.62"},{"v":-0.678941775162608,"d":"-0.68"},{"v":0.101771587567889,"d":"0.10"},{"v":0.549128313589467,"d":"0.55"},"down","no"]
["MSTRG.4597","TRDMT1","ENSOART00000012063","GO:0005737(cytoplasm);GO:0008168(methyltransferase activity);GO:0008175(tRNA methyltransferase activity);GO:0016740(transferase activity);GO:0030488(tRNA methylation);GO:0032259(methylation)","NA","K15336","EC:2.1.1.204","tRNA aspartic acid methyltransferase 1 [Source:NCBI gene;Acc:101110692]",{"v":3.191012,"d":"3.19"},{"v":2.755468,"d":"2.76"},{"v":2.529628,"d":"2.53"},{"v":2.238292,"d":"2.24"},{"v":2.083614,"d":"2.08"},{"v":1.590424,"d":"1.59"},{"v":1.43363242579491,"d":"1.43"},{"v":0.519675173649662,"d":"0.52"},{"v":0.101801286454882,"d":"0.10"},{"v":0.549128313589467,"d":"0.55"},"up","no"]
["MSTRG.11535","ENSOARG00000020071","ENSOART00000021852","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11254","NA","histone H4 [Source:NCBI gene;Acc:101109919]",{"v":25.3720409621212,"d":"25.37"},{"v":16.4935344545455,"d":"16.49"},{"v":27.6241048863636,"d":"27.62"},{"v":33.9392489393939,"d":"33.94"},{"v":29.4559465075758,"d":"29.46"},{"v":44.9396092878788,"d":"44.94"},{"v":0.641434490726296,"d":"0.64"},{"v":-0.640626163524481,"d":"-0.64"},{"v":0.10183610520646,"d":"0.10"},{"v":0.549134717903263,"d":"0.55"},"down","no"]
["MSTRG.9720","TMEM8B","ENSOART00000012726;ENSOART00000012729","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 8B [Source:NCBI gene;Acc:101112025]",{"v":0.673562620319114,"d":"0.67"},{"v":0.650814290133507,"d":"0.65"},{"v":0.426816976880495,"d":"0.43"},{"v":0.969749257245197,"d":"0.97"},{"v":0.934184317811788,"d":"0.93"},{"v":1.01116885542169,"d":"1.01"},{"v":0.60073151084628,"d":"0.60"},{"v":-0.735207753730913,"d":"-0.74"},{"v":0.101991837417842,"d":"0.10"},{"v":0.549531564404889,"d":"0.55"},"down","no"]
["MSTRG.20702","ARMT1","ENSOART00000003505","GO:0006479(protein methylation);GO:0008757(S-adenosylmethionine-dependent methyltransferase activity);GO:0019899(enzyme binding);GO:0032259(methylation);GO:0051998(protein carboxyl O-methyltransferase activity);GO:2001020(regulation of response to DNA damage stimulus)","NA","NA","NA","acidic residue methyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:17872]",{"v":1.049627,"d":"1.05"},{"v":1.025322,"d":"1.03"},{"v":0.798812,"d":"0.80"},{"v":0.754765,"d":"0.75"},{"v":0.457892,"d":"0.46"},{"v":0.598037,"d":"0.60"},{"v":1.58710472338231,"d":"1.59"},{"v":0.66639732598006,"d":"0.67"},{"v":0.102010667057277,"d":"0.10"},{"v":0.549531564404889,"d":"0.55"},"up","no"]
["MSTRG.19413","STYX","ENSOART00000019092","GO:0001691(pseudophosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0032091(negative regulation of protein binding);GO:0043086(negative regulation of catalytic activity);GO:0045204(MAPK export from nucleus);GO:0062026(negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:1990444(F-box domain binding)","NA","K18042","NA","serine/threonine/tyrosine interacting protein [Source:NCBI gene;Acc:101115709]",{"v":4.49341734224599,"d":"4.49"},{"v":4.57432629679144,"d":"4.57"},{"v":3.20072297576872,"d":"3.20"},{"v":3.52486541560829,"d":"3.52"},{"v":2.8187140556484,"d":"2.82"},{"v":2.69899602205882,"d":"2.70"},{"v":1.3567447265301,"d":"1.36"},{"v":0.440149301144908,"d":"0.44"},{"v":0.102076195840028,"d":"0.10"},{"v":0.5495883132123,"d":"0.55"},"up","no"]
["MSTRG.19117","AFF1","ENSOART00000004925","GO:0008023(transcription elongation factor complex)","05202(Transcriptional misregulation in cancer)","K15184","NA","AF4/FMR2 family member 1 [Source:NCBI gene;Acc:101111967]",{"v":5.06527438659493,"d":"5.07"},{"v":6.67261155462901,"d":"6.67"},{"v":6.47845353956512,"d":"6.48"},{"v":4.86374693467832,"d":"4.86"},{"v":4.86734121219458,"d":"4.87"},{"v":3.85349377830083,"d":"3.85"},{"v":1.34095694524335,"d":"1.34"},{"v":0.423262916674852,"d":"0.42"},{"v":0.10210098566913,"d":"0.10"},{"v":0.5495883132123,"d":"0.55"},"up","no"]
["MSTRG.139","ZC3H12A","ENSOART00000021517","GO:0000294(nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay);GO:0000932(P-body);GO:0001933(negative regulation of protein phosphorylation);GO:0002230(positive regulation of defense response to virus by host);GO:0002757(immune response-activating signal transduction);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0004518(nuclease activity);GO:0004521(endoribonuclease activity);GO:0004532(exoribonuclease activity);GO:0004540(ribonuclease activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005791(rough endoplasmic reticulum);GO:0005856(cytoskeleton);GO:0006974(cellular response to DNA damage stimulus);GO:0010468(regulation of gene expression);GO:0010508(positive regulation of autophagy);GO:0010595(positive regulation of endothelial cell migration);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010656(negative regulation of muscle cell apoptotic process);GO:0010884(positive regulation of lipid storage);GO:0010942(positive regulation of cell death);GO:0016579(protein deubiquitination);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032991(protein-containing complex);GO:0034599(cellular response to oxidative stress);GO:0035198(miRNA binding);GO:0035613(RNA stem-loop binding);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042149(cellular response to glucose starvation);GO:0042307(positive regulation of protein import into nucleus);GO:0042406(extrinsic component of endoplasmic reticulum membrane);GO:0043022(ribosome binding);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0044828(negative regulation by host of viral genome replication);GO:0045019(negative regulation of nitric oxide biosynthetic process);GO:0045600(positive regulation of fat cell differentiation);GO:0045766(positive regulation of angiogenesis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050713(negative regulation of interleukin-1 beta secretion);GO:0050852(T cell receptor signaling pathway);GO:0051259(protein complex oligomerization);GO:0055118(negative regulation of cardiac muscle contraction);GO:0061014(positive regulation of mRNA catabolic process);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0071222(cellular response to lipopolysaccharide);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0090501(RNA phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic);GO:0098586(cellular response to virus);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:1900119(positive regulation of execution phase of apoptosis);GO:1900165(negative regulation of interleukin-6 secretion);GO:1900745(positive regulation of p38MAPK cascade);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1902714(negative regulation of interferon-gamma secretion);GO:1903003(positive regulation of protein deubiquitination);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA);GO:1903936(cellular response to sodium arsenite);GO:1904468(negative regulation of tumor necrosis factor secretion);GO:1904637(cellular response to ionomycin);GO:1990869(cellular response to chemokine);GO:2000320(negative regulation of T-helper 17 cell differentiation);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2000627(positive regulation of miRNA catabolic process)","NA","K18668","EC:3.1.-.-","zinc finger CCCH-type containing 12A [Source:NCBI gene;Acc:101118325]",{"v":2.57368317304582,"d":"2.57"},{"v":0.761859374663073,"d":"0.76"},{"v":0.86292481671159,"d":"0.86"},{"v":0.92470653638814,"d":"0.92"},{"v":0.789564450134771,"d":"0.79"},{"v":0.801711440431267,"d":"0.80"},{"v":1.66871887475904,"d":"1.67"},{"v":0.738740927646895,"d":"0.74"},{"v":0.102149880678942,"d":"0.10"},{"v":0.5495883132123,"d":"0.55"},"up","no"]
["MSTRG.15134","ST3GAL5","ENSOART00000022425","GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0047291(lactosylceramide alpha-2,3-sialyltransferase activity);GO:0097503(sialylation)","00604(Glycosphingolipid biosynthesis - ganglio series)","K03370","EC:2.4.99.9","ST3 beta-galactoside alpha-2,3-sialyltransferase 5 [Source:NCBI gene;Acc:101104977]",{"v":1.004987,"d":"1.00"},{"v":0.837677,"d":"0.84"},{"v":1.421469,"d":"1.42"},{"v":1.81303,"d":"1.81"},{"v":1.344651,"d":"1.34"},{"v":2.41978,"d":"2.42"},{"v":0.585236364718642,"d":"0.59"},{"v":-0.772908678163413,"d":"-0.77"},{"v":0.102157373993749,"d":"0.10"},{"v":0.5495883132123,"d":"0.55"},"down","no"]
["ENSOARG00000001560","ARHGAP22","ENSOART00000001675","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization)","NA","K20642","NA","Rho GTPase activating protein 22 [Source:NCBI gene;Acc:101116628]",{"v":0.175852,"d":"0.18"},{"v":0.142027,"d":"0.14"},{"v":0.459714,"d":"0.46"},{"v":0.615268,"d":"0.62"},{"v":0.298587,"d":"0.30"},{"v":0.660032,"d":"0.66"},{"v":0.494058976279746,"d":"0.49"},{"v":-1.01724482694828,"d":"-1.02"},{"v":0.102189497728598,"d":"0.10"},{"v":0.5495883132123,"d":"0.55"},"down","no"]
["ENSOARG00000014063","CDC6","ENSOART00000015318","GO:0000278(mitotic cell cycle);GO:0000922(spindle pole);GO:0005634(nucleus);GO:0006270(DNA replication initiation);GO:0019900(kinase binding);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0032467(positive regulation of cytokinesis);GO:0051233(spindle midzone);GO:0051301(cell division);GO:0051984(positive regulation of chromosome segregation)","04110(Cell cycle)","K02213","NA","cell division cycle 6 [Source:NCBI gene;Acc:101107536]",{"v":0.223073,"d":"0.22"},{"v":0.033471,"d":"0.03"},{"v":0.365226,"d":"0.37"},{"v":0.5626,"d":"0.56"},{"v":0.314276,"d":"0.31"},{"v":0.5345,"d":"0.53"},{"v":0.440541712484837,"d":"0.44"},{"v":-1.1826494683729,"d":"-1.18"},{"v":0.102479583841879,"d":"0.10"},{"v":0.550156141402014,"d":"0.55"},"down","no"]
["MSTRG.5378","CYLD","ENSOART00000019071","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005813(centrosome);GO:0005819(spindle);GO:0005829(cytosol);GO:0005881(cytoplasmic microtubule);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007346(regulation of mitotic cell cycle);GO:0008270(zinc ion binding);GO:0010803(regulation of tumor necrosis factor-mediated signaling pathway);GO:0016579(protein deubiquitination);GO:0019901(protein kinase binding);GO:0030496(midbody);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0036064(ciliary basal body);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0043369(CD4-positive or CD8-positive, alpha-beta T cell lineage commitment);GO:0043393(regulation of protein binding);GO:0045087(innate immune response);GO:0045577(regulation of B cell differentiation);GO:0045582(positive regulation of T cell differentiation);GO:0046329(negative regulation of JNK cascade);GO:0048872(homeostasis of number of cells);GO:0050727(regulation of inflammatory response);GO:0050862(positive regulation of T cell receptor signaling pathway);GO:0060544(regulation of necroptotic process);GO:0061578(Lys63-specific deubiquitinase activity);GO:0070064(proline-rich region binding);GO:0070266(necroptotic process);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097542(ciliary tip);GO:1901026(ripoptosome assembly involved in necroptotic process);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1902017(regulation of cilium assembly);GO:1903753(negative regulation of p38MAPK cascade);GO:1903829(positive regulation of cellular protein localization);GO:1990108(protein linear deubiquitination);GO:1990380(Lys48-specific deubiquitinase activity);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001242(regulation of intrinsic apoptotic signaling pathway)","04217(Necroptosis);04380(Osteoclast differentiation);04622(RIG-I-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway)","K08601","EC:3.4.19.12","CYLD lysine 63 deubiquitinase [Source:NCBI gene;Acc:101113429]",{"v":2.52265667155383,"d":"2.52"},{"v":2.19909723386517,"d":"2.20"},{"v":2.40904537508984,"d":"2.41"},{"v":2.08842396780221,"d":"2.09"},{"v":1.67057133814863,"d":"1.67"},{"v":1.55439895960903,"d":"1.55"},{"v":1.34204219075722,"d":"1.34"},{"v":0.42443002730518,"d":"0.42"},{"v":0.102484537425719,"d":"0.10"},{"v":0.550156141402014,"d":"0.55"},"up","no"]
["MSTRG.21700","GPR34","ENSOART00000021068","GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","G protein-coupled receptor 34 [Source:HGNC Symbol;Acc:HGNC:4490]",{"v":0.384629,"d":"0.38"},{"v":0.410667,"d":"0.41"},{"v":0.511934,"d":"0.51"},{"v":1.080377,"d":"1.08"},{"v":0.545261,"d":"0.55"},{"v":0.850052,"d":"0.85"},{"v":0.528026529977501,"d":"0.53"},{"v":-0.921317677225167,"d":"-0.92"},{"v":0.102488754106172,"d":"0.10"},{"v":0.550156141402014,"d":"0.55"},"down","no"]
["MSTRG.11948","CYB561A3","ENSOART00000013921","GO:0005765(lysosomal membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0031902(late endosome membrane);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","NA","K16295","NA","cytochrome b ascorbate-dependent protein 3 [Source:NCBI gene;Acc:101106637]",{"v":1.30431541443012,"d":"1.30"},{"v":1.27573539247124,"d":"1.28"},{"v":1.2443110697107,"d":"1.24"},{"v":1.86594673928198,"d":"1.87"},{"v":2.11467396165911,"d":"2.11"},{"v":2.02643655873127,"d":"2.03"},{"v":0.636644818135236,"d":"0.64"},{"v":-0.651439372369255,"d":"-0.65"},{"v":0.102542035886904,"d":"0.10"},{"v":0.550156141402014,"d":"0.55"},"down","no"]
["ENSOARG00000004845","C18orf54","ENSOART00000005282","GO:0008285(negative regulation of cell population proliferation)","NA","NA","NA","chromosome 23 open reading frame, human C18orf54 [Source:NCBI gene;Acc:101119778]",{"v":0.718889,"d":"0.72"},{"v":0.933558,"d":"0.93"},{"v":0.798146,"d":"0.80"},{"v":0.428844,"d":"0.43"},{"v":0.519294,"d":"0.52"},{"v":0.580474,"d":"0.58"},{"v":1.60314913136885,"d":"1.60"},{"v":0.680908637020134,"d":"0.68"},{"v":0.102558919146824,"d":"0.10"},{"v":0.550156141402014,"d":"0.55"},"up","no"]
["MSTRG.10712","ENSOARG00000020032","ENSOART00000021811","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007010(cytoskeleton organization);GO:0007017(microtubule-based process)","04145(Phagosome);04210(Apoptosis);04530(Tight junction);04540(Gap junction)","K07374","NA","tubulin alpha-1D chain [Source:NCBI gene;Acc:101116286]",{"v":36.657616,"d":"36.66"},{"v":37.431576,"d":"37.43"},{"v":48.669567,"d":"48.67"},{"v":34.185364,"d":"34.19"},{"v":22.068708,"d":"22.07"},{"v":32.403923,"d":"32.40"},{"v":1.38463270007403,"d":"1.38"},{"v":0.46950332496853,"d":"0.47"},{"v":0.102563688691204,"d":"0.10"},{"v":0.550156141402014,"d":"0.55"},"up","no"]
["MSTRG.16821","ENSOARG00000008109","ENSOART00000008824","GO:0003674(molecular_function);GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005840(ribosome);GO:0006412(translation);GO:0008150(biological_process);GO:1904841(TORC2 complex binding)","03010(Ribosome)","K02893","NA","60S ribosomal protein L23a [Source:NCBI gene;Acc:101123112]",{"v":3.624214,"d":"3.62"},{"v":1.120544,"d":"1.12"},{"v":2.412956,"d":"2.41"},{"v":0.939186,"d":"0.94"},{"v":12.0151,"d":"12.02"},{"v":3.577962,"d":"3.58"},{"v":0.432954671379234,"d":"0.43"},{"v":-1.20771210642402,"d":"-1.21"},{"v":0.102779583969506,"d":"0.10"},{"v":0.550865077697924,"d":"0.55"},"down","no"]
["MSTRG.8351","ENSOARG00000013821","ENSOART00000015038","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0043066(negative regulation of apoptotic process);GO:0046872(metal ion binding);GO:0071157(negative regulation of cell cycle arrest)","01522(Endocrine resistance);01524(Platinum drug resistance);04068(FoxO signaling pathway);04110(Cell cycle);04115(p53 signaling pathway);04120(Ubiquitin mediated proteolysis);04144(Endocytosis);04151(PI3K-Akt signaling pathway);04218(Cellular senescence);04625(C-type lectin receptor signaling pathway);04919(Thyroid hormone signaling pathway);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05214(Glioma);05215(Prostate cancer);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia)","K06643","EC:2.3.2.27","E3 ubiquitin-protein ligase Mdm2-like [Source:NCBI gene;Acc:101103187]",{"v":4.145526,"d":"4.15"},{"v":4.198756,"d":"4.20"},{"v":4.990453,"d":"4.99"},{"v":2.839728,"d":"2.84"},{"v":2.470568,"d":"2.47"},{"v":3.913177,"d":"3.91"},{"v":1.44573903994732,"d":"1.45"},{"v":0.531807165186532,"d":"0.53"},{"v":0.102831746498241,"d":"0.10"},{"v":0.550865077697924,"d":"0.55"},"up","no"]
["MSTRG.6754","ARHGAP1","ENSOART00000004243","GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016197(endosomal transport);GO:0017137(Rab GTPase binding);GO:0033572(transferrin transport);GO:0043547(positive regulation of GTPase activity);GO:0048471(perinuclear region of cytoplasm);GO:0097443(sorting endosome);GO:2001136(negative regulation of endocytic recycling)","NA","K18470","NA","Rho GTPase activating protein 1 [Source:NCBI gene;Acc:101118219]",{"v":2.729663,"d":"2.73"},{"v":1.673154,"d":"1.67"},{"v":2.072411,"d":"2.07"},{"v":2.980579,"d":"2.98"},{"v":3.846034,"d":"3.85"},{"v":3.416867,"d":"3.42"},{"v":0.632131658381722,"d":"0.63"},{"v":-0.661703025230751,"d":"-0.66"},{"v":0.102966156484113,"d":"0.10"},{"v":0.551404199105478,"d":"0.55"},"down","no"]
["MSTRG.6898","UTP15","ENSOART00000005307","GO:0001650(fibrillar center);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0006364(rRNA processing);GO:0045943(positive regulation of transcription by RNA polymerase I);GO:2000234(positive regulation of rRNA processing)","03008(Ribosome biogenesis in eukaryotes)","K14549","NA","UTP15, small subunit processome component [Source:NCBI gene;Acc:101113099]",{"v":1.82479723971356,"d":"1.82"},{"v":2.23887232649593,"d":"2.24"},{"v":1.75886879718412,"d":"1.76"},{"v":1.75704050455152,"d":"1.76"},{"v":1.41952247639277,"d":"1.42"},{"v":1.12795062883845,"d":"1.13"},{"v":1.35265883470804,"d":"1.35"},{"v":0.435798011125077,"d":"0.44"},{"v":0.103097896075191,"d":"0.10"},{"v":0.551686321445551,"d":"0.55"},"up","no"]
["MSTRG.7978","TANGO2","ENSOART00000019608","GO:0005794(Golgi apparatus)","NA","NA","NA","transport and golgi organization 2 homolog [Source:NCBI gene;Acc:101121122]",{"v":0.789463580706781,"d":"0.79"},{"v":0.745078322190385,"d":"0.75"},{"v":0.866539279210442,"d":"0.87"},{"v":1.27951477395734,"d":"1.28"},{"v":1.49748507258835,"d":"1.50"},{"v":1.11958530850048,"d":"1.12"},{"v":0.616201388284342,"d":"0.62"},{"v":-0.698526162155215,"d":"-0.70"},{"v":0.103127966007404,"d":"0.10"},{"v":0.551686321445551,"d":"0.55"},"down","no"]
["ENSOARG00000016706","MEGF6","ENSOART00000018199","GO:0005509(calcium ion binding);GO:0005515(protein binding)","NA","NA","NA","multiple EGF like domains 6 [Source:NCBI gene;Acc:101119490]",{"v":0.174255,"d":"0.17"},{"v":0.109814,"d":"0.11"},{"v":0.069569,"d":"0.07"},{"v":0.094622,"d":"0.09"},{"v":0.328324,"d":"0.33"},{"v":0.287103,"d":"0.29"},{"v":0.498047317861162,"d":"0.50"},{"v":-1.00564528030342,"d":"-1.01"},{"v":0.103177077805795,"d":"0.10"},{"v":0.551686321445551,"d":"0.55"},"down","no"]
["MSTRG.12038","EML3","ENSOART00000016902;ENSOART00000016901","GO:0005515(protein binding);GO:0005515(protein binding)","NA","K18596","NA","EMAP like 3 [Source:NCBI gene;Acc:101111136]",{"v":1.56269838924731,"d":"1.56"},{"v":0.868631396129032,"d":"0.87"},{"v":1.32624248645161,"d":"1.33"},{"v":1.9084575888172,"d":"1.91"},{"v":2.14125358924731,"d":"2.14"},{"v":1.86472494021505,"d":"1.86"},{"v":0.6353221501902,"d":"0.64"},{"v":-0.654439776028079,"d":"-0.65"},{"v":0.103187777173855,"d":"0.10"},{"v":0.551686321445551,"d":"0.55"},"down","no"]
["MSTRG.3298","ENSOARG00000004027","ENSOART00000004373","GO:0005507(copper ion binding);GO:0008131(primary amine oxidase activity);GO:0009308(amine metabolic process);GO:0016491(oxidoreductase activity);GO:0046872(metal ion binding);GO:0048038(quinone binding);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism);00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00410(beta-Alanine metabolism)","K00276","EC:1.4.3.21","primary amine oxidase, lung isozyme [Source:NCBI gene;Acc:101113086]",{"v":11.5295885189394,"d":"11.53"},{"v":5.74239476911157,"d":"5.74"},{"v":10.1227542133264,"d":"10.12"},{"v":14.6279735606061,"d":"14.63"},{"v":14.0885421506543,"d":"14.09"},{"v":13.8738552322658,"d":"13.87"},{"v":0.643214343864301,"d":"0.64"},{"v":-0.636628515498704,"d":"-0.64"},{"v":0.103442923771498,"d":"0.10"},{"v":0.552688501093266,"d":"0.55"},"down","no"]
["MSTRG.5562","LRP3","ENSOART00000004783","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K20050","NA","LDL receptor related protein 3 [Source:NCBI gene;Acc:101118045]",{"v":0.893901740067755,"d":"0.89"},{"v":1.24695688327687,"d":"1.25"},{"v":1.19263735694487,"d":"1.19"},{"v":1.32211909300893,"d":"1.32"},{"v":1.96433541823221,"d":"1.96"},{"v":2.17180983184478,"d":"2.17"},{"v":0.610724540029303,"d":"0.61"},{"v":-0.711406278415425,"d":"-0.71"},{"v":0.103753730658891,"d":"0.10"},{"v":0.553986564486063,"d":"0.55"},"down","no"]
["MSTRG.20007","SIX4","ENSOART00000023023","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007519(skeletal muscle tissue development);GO:0008582(regulation of synaptic growth at neuromuscular junction);GO:0008584(male gonad development);GO:0010468(regulation of gene expression);GO:0030238(male sex determination);GO:0030910(olfactory placode formation);GO:0032880(regulation of protein localization);GO:0034504(protein localization to nucleus);GO:0042472(inner ear morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0043586(tongue development);GO:0045214(sarcomere organization);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046661(male sex differentiation);GO:0048538(thymus development);GO:0048699(generation of neurons);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0048856(anatomical structure development);GO:0050678(regulation of epithelial cell proliferation);GO:0051451(myoblast migration);GO:0060037(pharyngeal system development);GO:0061055(myotome development);GO:0061197(fungiform papilla morphogenesis);GO:0061551(trigeminal ganglion development);GO:0072075(metanephric mesenchyme development);GO:0072095(regulation of branch elongation involved in ureteric bud branching);GO:0072107(positive regulation of ureteric bud formation);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:0098528(skeletal muscle fiber differentiation);GO:1902725(negative regulation of satellite cell differentiation)","05202(Transcriptional misregulation in cancer)","K15615","NA","SIX homeobox 4 [Source:NCBI gene;Acc:101104155]",{"v":8.858811,"d":"8.86"},{"v":9.349762,"d":"9.35"},{"v":7.966197,"d":"7.97"},{"v":7.655775,"d":"7.66"},{"v":5.620012,"d":"5.62"},{"v":6.122297,"d":"6.12"},{"v":1.34934821397825,"d":"1.35"},{"v":0.432262699474786,"d":"0.43"},{"v":0.10397761501664,"d":"0.10"},{"v":0.554056291444068,"d":"0.55"},"up","no"]
["MSTRG.21685","MID1IP1","ENSOART00000020945","NA","NA","NA","NA","MID1 interacting protein 1 [Source:NCBI gene;Acc:101102702]",{"v":10.1942413939714,"d":"10.19"},{"v":5.58699201586462,"d":"5.59"},{"v":6.88707510629297,"d":"6.89"},{"v":5.52992372977261,"d":"5.53"},{"v":10.4740947572713,"d":"10.47"},{"v":24.2090330724484,"d":"24.21"},{"v":0.563705255807132,"d":"0.56"},{"v":-0.826987076119368,"d":"-0.83"},{"v":0.104098947915428,"d":"0.10"},{"v":0.554130420314961,"d":"0.55"},"down","no"]
["ENSOARG00000015467","DRAM1","ENSOART00000016827","GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0010506(regulation of autophagy);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K21955","NA","DNA damage regulated autophagy modulator 1 [Source:NCBI gene;Acc:101109084]",{"v":0.591319,"d":"0.59"},{"v":0.636871,"d":"0.64"},{"v":0.595485,"d":"0.60"},{"v":1.309304,"d":"1.31"},{"v":0.686684,"d":"0.69"},{"v":1.37897,"d":"1.38"},{"v":0.54035487256434,"d":"0.54"},{"v":-0.888020901064194,"d":"-0.89"},{"v":0.104120047129244,"d":"0.10"},{"v":0.554130420314961,"d":"0.55"},"down","no"]
["MSTRG.10881","RCC1","ENSOART00000003187","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000785(chromatin);GO:0000790(nuclear chromatin);GO:0000794(condensed nuclear chromosome);GO:0003682(chromatin binding);GO:0005087(Ran guanyl-nucleotide exchange factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0007088(regulation of mitotic nuclear division);GO:0008536(Ran GTPase binding);GO:0031491(nucleosome binding);GO:0031492(nucleosomal DNA binding);GO:0031965(nuclear membrane);GO:0032991(protein-containing complex);GO:0042393(histone binding);GO:0043199(sulfate binding);GO:0046982(protein heterodimerization activity);GO:0051225(spindle assembly);GO:0051290(protein heterotetramerization)","NA","K11493","NA","regulator of chromosome condensation 1 [Source:NCBI gene;Acc:101102961]",{"v":2.59408336976859,"d":"2.59"},{"v":1.92631801378631,"d":"1.93"},{"v":1.8461118835549,"d":"1.85"},{"v":3.40763358247169,"d":"3.41"},{"v":2.89510139734121,"d":"2.90"},{"v":3.37021023092073,"d":"3.37"},{"v":0.658177331558248,"d":"0.66"},{"v":-0.60345175577191,"d":"-0.60"},{"v":0.10425059579277,"d":"0.10"},{"v":0.554644421018036,"d":"0.55"},"down","no"]
["MSTRG.16106","ENSOARG00000017359","ENSOART00000018895","GO:0005783(endoplasmic reticulum);GO:0005791(rough endoplasmic reticulum);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016607(nuclear speck);GO:0036464(cytoplasmic ribonucleoprotein granule)","04141(Protein processing in endoplasmic reticulum)","K13999","NA","cytoskeleton associated protein 4 [Source:NCBI gene;Acc:101114945]",{"v":2.951294,"d":"2.95"},{"v":2.166973,"d":"2.17"},{"v":3.638743,"d":"3.64"},{"v":4.421109,"d":"4.42"},{"v":4.519206,"d":"4.52"},{"v":4.846486,"d":"4.85"},{"v":0.635173453218045,"d":"0.64"},{"v":-0.654777477921305,"d":"-0.65"},{"v":0.104541704058336,"d":"0.10"},{"v":0.555695630495831,"d":"0.56"},"down","no"]
["MSTRG.5162","ENSOARG00000015202","ENSOART00000016544","GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0051082(unfolded protein binding)","NA","NA","NA",null,{"v":5.95528833187773,"d":"5.96"},{"v":7.1024965371179,"d":"7.10"},{"v":4.58054897816594,"d":"4.58"},{"v":4.67394524454148,"d":"4.67"},{"v":3.97618005676856,"d":"3.98"},{"v":3.62126743231441,"d":"3.62"},{"v":1.43735387091241,"d":"1.44"},{"v":0.523415291412729,"d":"0.52"},{"v":0.104582123290519,"d":"0.10"},{"v":0.555695630495831,"d":"0.56"},"up","no"]
["ENSOARG00000020503","COL4A4","ENSOART00000022332","GO:0005201(extracellular matrix structural constituent);GO:0005581(collagen trimer);GO:0005587(collagen type IV trimer);GO:0005604(basement membrane);GO:0032836(glomerular basement membrane development)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);04974(Protein digestion and absorption);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K06237","NA","collagen type IV alpha 4 chain [Source:NCBI gene;Acc:101118172]",{"v":0.226285,"d":"0.23"},{"v":0.11151,"d":"0.11"},{"v":0.102817,"d":"0.10"},{"v":0.334941,"d":"0.33"},{"v":0.267392,"d":"0.27"},{"v":0.2088,"d":"0.21"},{"v":0.543205614862174,"d":"0.54"},{"v":-0.880429702764312,"d":"-0.88"},{"v":0.104584313603239,"d":"0.10"},{"v":0.555695630495831,"d":"0.56"},"down","no"]
["MSTRG.13260","THOC6;TNFRSF12A","ENSOART00000000975;ENSOART00000000800","GO:0000346(transcription export complex);GO:0000347(THO complex);GO:0000445(THO complex part of transcription export complex);GO:0000784(nuclear chromosome, telomeric region);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006406(mRNA export from nucleus);GO:0007417(central nervous system development);GO:0016604(nuclear body);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0046784(viral mRNA export from host cell nucleus);GO:0001726(ruffle);GO:0005886(plasma membrane);GO:0006931(substrate-dependent cell migration, cell attachment to substrate);GO:0007155(cell adhesion);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043065(positive regulation of apoptotic process);GO:0045765(regulation of angiogenesis);GO:0045773(positive regulation of axon extension);GO:0061041(regulation of wound healing);GO:0097191(extrinsic apoptotic signaling pathway);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","03013(RNA transport);04060(Cytokine-cytokine receptor interaction)","K13175;K05149","NA","THO complex 6 [Source:NCBI gene;Acc:101117811];TNF receptor superfamily member 12A [Source:NCBI gene;Acc:101117554]",{"v":5.46488030433763,"d":"5.46"},{"v":2.70134276951934,"d":"2.70"},{"v":7.87144676014068,"d":"7.87"},{"v":1.97148130269637,"d":"1.97"},{"v":4.41825137209848,"d":"4.42"},{"v":3.74131603892145,"d":"3.74"},{"v":1.58302168780261,"d":"1.58"},{"v":0.662681020902094,"d":"0.66"},{"v":0.104699887634002,"d":"0.10"},{"v":0.55612874602732,"d":"0.56"},"up","no"]
["MSTRG.9039","SEMA3G","ENSOART00000004811","GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0030517(negative regulation of axon extension)","04360(Axon guidance)","K06840","NA","semaphorin 3G [Source:NCBI gene;Acc:101111838]",{"v":2.04274543586387,"d":"2.04"},{"v":1.0198800039267,"d":"1.02"},{"v":0.862036159685864,"d":"0.86"},{"v":2.07949014921466,"d":"2.08"},{"v":2.49311801701571,"d":"2.49"},{"v":1.9449367617801,"d":"1.94"},{"v":0.60216870659524,"d":"0.60"},{"v":-0.731760358616421,"d":"-0.73"},{"v":0.104796398350653,"d":"0.10"},{"v":0.556287088450794,"d":"0.56"},"down","no"]
["MSTRG.338","USP24","ENSOART00000008360","GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity)","NA","K11840","EC:3.4.19.12","ubiquitin specific peptidase 24 [Source:NCBI gene;Acc:101119525]",{"v":9.26656756887577,"d":"9.27"},{"v":9.17643703814777,"d":"9.18"},{"v":9.29965420938544,"d":"9.30"},{"v":6.97660720713231,"d":"6.98"},{"v":7.99377818747572,"d":"7.99"},{"v":5.79406208375418,"d":"5.79"},{"v":1.33606535138094,"d":"1.34"},{"v":0.417990576530025,"d":"0.42"},{"v":0.104936470626216,"d":"0.10"},{"v":0.556287088450794,"d":"0.56"},"up","no"]
["MSTRG.8296","AKAP6","ENSOART00000007129","GO:0005635(nuclear envelope);GO:0016529(sarcoplasmic reticulum);GO:0031965(nuclear membrane);GO:0034704(calcium channel complex);GO:0044325(ion channel binding);GO:0048471(perinuclear region of cytoplasm);GO:0060306(regulation of membrane repolarization);GO:0071320(cellular response to cAMP);GO:1901381(positive regulation of potassium ion transmembrane transport);GO:1902261(positive regulation of delayed rectifier potassium channel activity)","NA","K16523","NA","A-kinase anchoring protein 6 [Source:NCBI gene;Acc:101117111]",{"v":18.4010461900784,"d":"18.40"},{"v":20.0969206999485,"d":"20.10"},{"v":14.3354264191795,"d":"14.34"},{"v":16.7806530768439,"d":"16.78"},{"v":12.1823855441437,"d":"12.18"},{"v":10.2128507647193,"d":"10.21"},{"v":1.34862013696828,"d":"1.35"},{"v":0.431484044590426,"d":"0.43"},{"v":0.104992293207117,"d":"0.10"},{"v":0.556287088450794,"d":"0.56"},"up","no"]
["MSTRG.14733","ENDOG","ENSOART00000010192","GO:0001701(in utero embryonic development);GO:0003676(nucleic acid binding);GO:0006309(apoptotic DNA fragmentation);GO:0016787(hydrolase activity);GO:0034612(response to tumor necrosis factor);GO:0043065(positive regulation of apoptotic process);GO:0046677(response to antibiotic);GO:0046872(metal ion binding)","04210(Apoptosis)","K01173","NA","endonuclease G [Source:NCBI gene;Acc:780458]",{"v":11.550902,"d":"11.55"},{"v":11.034659,"d":"11.03"},{"v":10.113544,"d":"10.11"},{"v":17.78026,"d":"17.78"},{"v":12.272471,"d":"12.27"},{"v":20.436676,"d":"20.44"},{"v":0.647642880812603,"d":"0.65"},{"v":-0.626729584404971,"d":"-0.63"},{"v":0.105063655126615,"d":"0.11"},{"v":0.556287088450794,"d":"0.56"},"down","no"]
["MSTRG.1057","MPZL1","ENSOART00000013270","GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane)","04514(Cell adhesion molecules (CAMs))","K06770","NA","myelin protein zero like 1 [Source:NCBI gene;Acc:101115590]",{"v":3.08654479506641,"d":"3.09"},{"v":2.10943272928526,"d":"2.11"},{"v":2.99157358633776,"d":"2.99"},{"v":4.31976084788109,"d":"4.32"},{"v":4.70542763504111,"d":"4.71"},{"v":3.49686616065781,"d":"3.50"},{"v":0.653850453758173,"d":"0.65"},{"v":-0.612967389274572,"d":"-0.61"},{"v":0.105084737687068,"d":"0.11"},{"v":0.556287088450794,"d":"0.56"},"down","no"]
["MSTRG.9929","MLLT3","ENSOART00000015563","GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007379(segment specification);GO:0008023(transcription elongation factor complex);GO:0009952(anterior/posterior pattern specification);GO:0042393(histone binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0070577(lysine-acetylated histone binding);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0140030(modification-dependent protein binding);GO:2000096(positive regulation of Wnt signaling pathway, planar cell polarity pathway)","05202(Transcriptional misregulation in cancer)","K15187","NA","MLLT3, super elongation complex subunit [Source:NCBI gene;Acc:101102874]",{"v":1.796568,"d":"1.80"},{"v":1.394849,"d":"1.39"},{"v":2.31355,"d":"2.31"},{"v":1.250017,"d":"1.25"},{"v":1.473998,"d":"1.47"},{"v":1.193447,"d":"1.19"},{"v":1.40523813632398,"d":"1.41"},{"v":0.490814635059557,"d":"0.49"},{"v":0.105146335159656,"d":"0.11"},{"v":0.556287088450794,"d":"0.56"},"up","no"]
["MSTRG.11144","PSMB9","ENSOART00000008562","GO:0000502(proteasome complex);GO:0002376(immune system process);GO:0004175(endopeptidase activity);GO:0004298(threonine-type endopeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005839(proteasome core complex);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016787(hydrolase activity);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:2000116(regulation of cysteine-type endopeptidase activity)","03050(Proteasome)","K02741","EC:3.4.25.1","proteasome subunit beta 9 [Source:NCBI gene;Acc:101115834]",{"v":4.444505,"d":"4.44"},{"v":3.40892,"d":"3.41"},{"v":2.13543,"d":"2.14"},{"v":5.348065,"d":"5.35"},{"v":4.563781,"d":"4.56"},{"v":6.543579,"d":"6.54"},{"v":0.607025038854967,"d":"0.61"},{"v":-0.72017206821388,"d":"-0.72"},{"v":0.105158738225757,"d":"0.11"},{"v":0.556287088450794,"d":"0.56"},"down","no"]
["MSTRG.16185","FOXRED2","ENSOART00000020558","GO:0005788(endoplasmic reticulum lumen);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0050660(flavin adenine dinucleotide binding)","NA","NA","NA","FAD dependent oxidoreductase domain containing 2 [Source:NCBI gene;Acc:101121924]",{"v":0.307929,"d":"0.31"},{"v":0.401999,"d":"0.40"},{"v":0.625846,"d":"0.63"},{"v":0.786277,"d":"0.79"},{"v":0.793934,"d":"0.79"},{"v":0.708761,"d":"0.71"},{"v":0.583569392723021,"d":"0.58"},{"v":-0.777023876684116,"d":"-0.78"},{"v":0.10524261557454,"d":"0.11"},{"v":0.55647714608196,"d":"0.56"},"down","no"]
["MSTRG.3320","MEOX1","ENSOART00000006265","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001757(somite specification);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0061053(somite development);GO:0061056(sclerotome development);GO:0071837(HMG box domain binding)","NA","K09322","NA","mesenchyme homeobox 1 [Source:NCBI gene;Acc:101110776]",{"v":1.171869,"d":"1.17"},{"v":0.978744,"d":"0.98"},{"v":1.927541,"d":"1.93"},{"v":1.169201,"d":"1.17"},{"v":0.707211,"d":"0.71"},{"v":0.825298,"d":"0.83"},{"v":1.50947140884847,"d":"1.51"},{"v":0.594043430781204,"d":"0.59"},{"v":0.105281189583051,"d":"0.11"},{"v":0.556500894629996,"d":"0.56"},"up","no"]
["MSTRG.8172","FAH","ENSOART00000016604;ENSOART00000016605;ENSOART00000016595","GO:0003677(DNA binding);GO:0003824(catalytic activity);GO:0004334(fumarylacetoacetase activity);GO:0005829(cytosol);GO:0006559(L-phenylalanine catabolic process);GO:0006572(tyrosine catabolic process);GO:0008270(zinc ion binding);GO:0009072(aromatic amino acid family metabolic process);GO:0046872(metal ion binding);GO:1902000(homogentisate catabolic process);GO:1902000(homogentisate catabolic process)","00350(Tyrosine metabolism);00350(Tyrosine metabolism)","K01555","EC:3.7.1.2","zinc finger AN1-type containing 6 [Source:NCBI gene;Acc:101114817]",{"v":4.7707361747246,"d":"4.77"},{"v":6.56716686531008,"d":"6.57"},{"v":6.33333482935537,"d":"6.33"},{"v":5.39991510511016,"d":"5.40"},{"v":3.48848313963688,"d":"3.49"},{"v":4.16835807313341,"d":"4.17"},{"v":1.35341714581824,"d":"1.35"},{"v":0.436606570614649,"d":"0.44"},{"v":0.105383824862869,"d":"0.11"},{"v":0.556863136686382,"d":"0.56"},"up","no"]
["MSTRG.12095","RF01955","ENSOART00000023506","NA","NA","NA","NA",null,{"v":310.182129,"d":"310.18"},{"v":235.741226,"d":"235.74"},{"v":348.22226,"d":"348.22"},{"v":242.921799,"d":"242.92"},{"v":261.359863,"d":"261.36"},{"v":144.218872,"d":"144.22"},{"v":1.37878932725752,"d":"1.38"},{"v":0.463402036446013,"d":"0.46"},{"v":0.105475374810962,"d":"0.11"},{"v":0.557162345822081,"d":"0.56"},"up","no"]
["MSTRG.12786","NFATC1","ENSOART00000004588","GO:0000790(nuclear chromatin);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body);GO:0033173(calcineurin-NFAT signaling cascade);GO:0035556(intracellular signal transduction);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1905064(negative regulation of vascular smooth muscle cell differentiation)","NA","NA","NA","nuclear factor of activated T cells 1 [Source:HGNC Symbol;Acc:HGNC:7775]",{"v":3.23031675741638,"d":"3.23"},{"v":4.74181190184375,"d":"4.74"},{"v":3.79755544592838,"d":"3.80"},{"v":3.11205700277745,"d":"3.11"},{"v":2.77873123413308,"d":"2.78"},{"v":2.74341613331758,"d":"2.74"},{"v":1.36314634221214,"d":"1.36"},{"v":0.446940452715693,"d":"0.45"},{"v":0.105546872248749,"d":"0.11"},{"v":0.557183747196114,"d":"0.56"},"up","no"]
["MSTRG.14479","LRRC3B","ENSOART00000004607","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","leucine rich repeat containing 3B [Source:NCBI gene;Acc:101121397]",{"v":1.153784,"d":"1.15"},{"v":1.070144,"d":"1.07"},{"v":0.750738,"d":"0.75"},{"v":1.432574,"d":"1.43"},{"v":1.73697,"d":"1.74"},{"v":2.132638,"d":"2.13"},{"v":0.561026762189604,"d":"0.56"},{"v":-0.833858502738984,"d":"-0.83"},{"v":0.105723988236937,"d":"0.11"},{"v":0.557399635368043,"d":"0.56"},"down","no"]
["MSTRG.527","ENSOARG00000016781","ENSOART00000018272","GO:0003774(motor activity);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0007017(microtubule-based process);GO:0030286(dynein complex)","NA","NA","NA","dynein light chain 1, cytoplasmic [Source:NCBI gene;Acc:101106123]",{"v":15.380228,"d":"15.38"},{"v":4.057555,"d":"4.06"},{"v":20.109816,"d":"20.11"},{"v":29.802238,"d":"29.80"},{"v":21.47257,"d":"21.47"},{"v":20.970774,"d":"20.97"},{"v":0.547405085614785,"d":"0.55"},{"v":-0.86931925690143,"d":"-0.87"},{"v":0.105724318393853,"d":"0.11"},{"v":0.557399635368043,"d":"0.56"},"down","no"]
["MSTRG.19382","ENSOARG00000011629","ENSOART00000012645","NA","NA","NA","NA","40S ribosomal protein S10 pseudogene [Source:NCBI gene;Acc:101113072]",{"v":16.10663,"d":"16.11"},{"v":11.470969,"d":"11.47"},{"v":16.038513,"d":"16.04"},{"v":17.096998,"d":"17.10"},{"v":23.615482,"d":"23.62"},{"v":27.256941,"d":"27.26"},{"v":0.641701979482803,"d":"0.64"},{"v":-0.640024661319445,"d":"-0.64"},{"v":0.105780768980363,"d":"0.11"},{"v":0.557517235607286,"d":"0.56"},"down","no"]
["MSTRG.1687","LXN","ENSOART00000002666","GO:0008191(metalloendopeptidase inhibitor activity);GO:0010951(negative regulation of endopeptidase activity);GO:0050965(detection of temperature stimulus involved in sensory perception of pain)","NA","NA","NA","latexin [Source:NCBI gene;Acc:101108098]",{"v":1.80096642698827,"d":"1.80"},{"v":0.43151105410691,"d":"0.43"},{"v":0.865813435462842,"d":"0.87"},{"v":2.38392244719687,"d":"2.38"},{"v":1.28392523468057,"d":"1.28"},{"v":2.00225051434159,"d":"2.00"},{"v":0.546426324437211,"d":"0.55"},{"v":-0.871901106830017,"d":"-0.87"},{"v":0.105815854097334,"d":"0.11"},{"v":0.557522189642229,"d":"0.56"},"down","no"]
["MSTRG.8299","EGLN3","ENSOART00000007261","GO:0001666(response to hypoxia);GO:0005506(iron ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0018126(protein hydroxylation);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0031418(L-ascorbic acid binding);GO:0031545(peptidyl-proline 4-dioxygenase activity);GO:0042127(regulation of cell population proliferation);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","04066(HIF-1 signaling pathway);05200(Pathways in cancer);05211(Renal cell carcinoma)","K09592","EC:1.14.11.29","egl-9 family hypoxia inducible factor 3 [Source:NCBI gene;Acc:101117367]",{"v":38.0966656337072,"d":"38.10"},{"v":26.2452417750885,"d":"26.25"},{"v":14.1859099876033,"d":"14.19"},{"v":26.0270883217237,"d":"26.03"},{"v":10.6311100191854,"d":"10.63"},{"v":15.8897901198347,"d":"15.89"},{"v":1.49440196849901,"d":"1.49"},{"v":0.579568260549596,"d":"0.58"},{"v":0.105896441665676,"d":"0.11"},{"v":0.557594973833493,"d":"0.56"},"up","no"]
["MSTRG.9090","GNAI2","ENSOART00000011062","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0007213(G protein-coupled acetylcholine receptor signaling pathway);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0019001(guanyl nucleotide binding);GO:0030425(dendrite);GO:0030496(midbody);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0044297(cell body);GO:0051301(cell division)","04015(Rap1 signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04071(Sphingolipid signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04360(Axon guidance);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04670(Leukocyte transendothelial migration);04713(Circadian entrainment);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04727(GABAergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);04924(Renin secretion);04926(Relaxin signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04971(Gastric acid secretion);05012(Parkinson disease);05030(Cocaine addiction);05032(Morphine addiction);05034(Alcoholism);05133(Pertussis);05142(Chagas disease (American trypanosomiasis));05145(Toxoplasmosis);05163(Human cytomegalovirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer)","K04630","NA","G protein subunit alpha i2 [Source:NCBI gene;Acc:100302341]",{"v":15.1923436523702,"d":"15.19"},{"v":9.94270032054176,"d":"9.94"},{"v":11.0836126794582,"d":"11.08"},{"v":18.6709379322799,"d":"18.67"},{"v":16.7144126433409,"d":"16.71"},{"v":19.189868979684,"d":"19.19"},{"v":0.66364655877687,"d":"0.66"},{"v":-0.591512991353906,"d":"-0.59"},{"v":0.105915981198808,"d":"0.11"},{"v":0.557594973833493,"d":"0.56"},"down","no"]
["MSTRG.7902","SNAP29","ENSOART00000017948","GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005776(autophagosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0016240(autophagosome membrane docking);GO:0020018(ciliary pocket membrane);GO:0031201(SNARE complex);GO:0060271(cilium assembly);GO:0097352(autophagosome maturation)","NA","NA","NA","synaptosomal-associated protein 29 [Source:NCBI gene;Acc:101117280]",{"v":1.6406005686227,"d":"1.64"},{"v":1.95606377546072,"d":"1.96"},{"v":1.68879576503395,"d":"1.69"},{"v":0.584338295344326,"d":"0.58"},{"v":1.95519190349176,"d":"1.96"},{"v":0.768807130213385,"d":"0.77"},{"v":1.59761825455567,"d":"1.60"},{"v":0.675922722375291,"d":"0.68"},{"v":0.105966266769067,"d":"0.11"},{"v":0.557594973833493,"d":"0.56"},"up","no"]
["MSTRG.18426","MRPL22","ENSOART00000011354;ENSOART00000011355","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation);GO:0015934(large ribosomal subunit);GO:0015934(large ribosomal subunit)","03010(Ribosome);03010(Ribosome)","K02890","NA","mitochondrial ribosomal protein L22 [Source:NCBI gene;Acc:101110505]",{"v":7.1922226291866,"d":"7.19"},{"v":6.40673229505582,"d":"6.41"},{"v":6.44868170972887,"d":"6.45"},{"v":4.86833768899522,"d":"4.87"},{"v":4.76723943620415,"d":"4.77"},{"v":4.89495870175439,"d":"4.89"},{"v":1.37969011416519,"d":"1.38"},{"v":0.464344266307352,"d":"0.46"},{"v":0.106127490579274,"d":"0.11"},{"v":0.557938859366288,"d":"0.56"},"up","no"]
["ENSOARG00000008066","FIGNL1","ENSOART00000008779","GO:0000166(nucleotide binding);GO:0000228(nuclear chromosome);GO:0001649(osteoblast differentiation);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007140(male meiotic nuclear division);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0033687(osteoblast proliferation);GO:0043066(negative regulation of apoptotic process);GO:0048471(perinuclear region of cytoplasm);GO:0051726(regulation of cell cycle);GO:0071479(cellular response to ionizing radiation);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","NA","K22766","EC:3.6.4.-","fidgetin like 1 [Source:NCBI gene;Acc:101107186]",{"v":0.45715,"d":"0.46"},{"v":0.310486,"d":"0.31"},{"v":0.406085,"d":"0.41"},{"v":0.722575,"d":"0.72"},{"v":0.62696,"d":"0.63"},{"v":0.706235,"d":"0.71"},{"v":0.570939842492108,"d":"0.57"},{"v":-0.808589351944497,"d":"-0.81"},{"v":0.10683628298475,"d":"0.11"},{"v":0.5605471814187,"d":"0.56"},"down","no"]
["MSTRG.3898","CHML","ENSOART00000005555","GO:0005092(GDP-dissociation inhibitor activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005968(Rab-protein geranylgeranyltransferase complex);GO:0006886(intracellular protein transport);GO:0007264(small GTPase mediated signal transduction);GO:0017137(Rab GTPase binding);GO:0018344(protein geranylgeranylation);GO:0043547(positive regulation of GTPase activity);GO:0050790(regulation of catalytic activity)","NA","NA","NA","CHM like, Rab escort protein 2 [Source:NCBI gene;Acc:101120764]",{"v":2.290373,"d":"2.29"},{"v":1.408413,"d":"1.41"},{"v":2.402462,"d":"2.40"},{"v":1.489855,"d":"1.49"},{"v":1.524449,"d":"1.52"},{"v":1.171873,"d":"1.17"},{"v":1.45747492282338,"d":"1.46"},{"v":0.543471060763957,"d":"0.54"},{"v":0.10700122032146,"d":"0.11"},{"v":0.561232227885899,"d":"0.56"},"up","no"]
["MSTRG.16580","PMM1","ENSOART00000020010","GO:0004615(phosphomannomutase activity);GO:0005737(cytoplasm);GO:0006013(mannose metabolic process);GO:0009298(GDP-mannose biosynthetic process);GO:0016853(isomerase activity);GO:0043025(neuronal cell body);GO:1990830(cellular response to leukemia inhibitory factor)","00051(Fructose and mannose metabolism);00520(Amino sugar and nucleotide sugar metabolism)","K17497","EC:5.4.2.8","phosphomannomutase 1 [Source:NCBI gene;Acc:101103393]",{"v":2.133146,"d":"2.13"},{"v":1.291904,"d":"1.29"},{"v":1.754677,"d":"1.75"},{"v":2.312991,"d":"2.31"},{"v":3.538633,"d":"3.54"},{"v":2.823779,"d":"2.82"},{"v":0.5970589493076,"d":"0.60"},{"v":-0.744054715030128,"d":"-0.74"},{"v":0.107114569552449,"d":"0.11"},{"v":0.561316762118056,"d":"0.56"},"down","no"]
["MSTRG.1322","NAA50","ENSOART00000021221","GO:0004596(peptide alpha-N-acetyltransferase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006474(N-terminal protein amino acid acetylation);GO:0010485(H4 histone acetyltransferase activity);GO:0031415(NatA complex);GO:0034087(establishment of mitotic sister chromatid cohesion);GO:0043967(histone H4 acetylation);GO:0052858(peptidyl-lysine acetyltransferase activity);GO:0071962(mitotic sister chromatid cohesion, centromeric)","NA","NA","NA","N(alpha)-acetyltransferase 50, NatE catalytic subunit [Source:HGNC Symbol;Acc:HGNC:29533]",{"v":6.06019487154375,"d":"6.06"},{"v":7.54603867740172,"d":"7.55"},{"v":7.32639000956589,"d":"7.33"},{"v":5.3882973488817,"d":"5.39"},{"v":5.4773219559969,"d":"5.48"},{"v":4.86087541429417,"d":"4.86"},{"v":1.33104190935769,"d":"1.33"},{"v":0.412555996847576,"d":"0.41"},{"v":0.107195380617475,"d":"0.11"},{"v":0.561316762118056,"d":"0.56"},"up","no"]
["MSTRG.5522","NQO1","ENSOART00000003909","GO:0003955(NAD(P)H dehydrogenase (quinone) activity);GO:0005829(cytosol);GO:0006979(response to oxidative stress);GO:0042802(identical protein binding);GO:0043086(negative regulation of catalytic activity);GO:0055114(oxidation-reduction process)","00130(Ubiquinone and other terpenoid-quinone biosynthesis);05200(Pathways in cancer);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis)","K00355","EC:1.6.5.2","NAD(P)H quinone dehydrogenase 1 [Source:NCBI gene;Acc:101121876]",{"v":12.616937,"d":"12.62"},{"v":20.444075,"d":"20.44"},{"v":17.786993,"d":"17.79"},{"v":13.360426,"d":"13.36"},{"v":10.676424,"d":"10.68"},{"v":13.022125,"d":"13.02"},{"v":1.3720834156908,"d":"1.37"},{"v":0.456368192695305,"d":"0.46"},{"v":0.107252081867192,"d":"0.11"},{"v":0.561316762118056,"d":"0.56"},"up","no"]
["MSTRG.19070","FRAS1","ENSOART00000019879;ENSOART00000019882","GO:0002009(morphogenesis of an epithelium);GO:0003338(metanephros morphogenesis);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0007154(cell communication);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030326(embryonic limb morphogenesis);GO:0043588(skin development);GO:0060021(roof of mouth development);GO:0060021(roof of mouth development)","NA","NA","NA","Fraser extracellular matrix complex subunit 1 [Source:NCBI gene;Acc:101107282]",{"v":4.05480137731976,"d":"4.05"},{"v":3.5495287964362,"d":"3.55"},{"v":5.96973743521104,"d":"5.97"},{"v":7.14948270881918,"d":"7.15"},{"v":7.22071401190672,"d":"7.22"},{"v":6.65480005501724,"d":"6.65"},{"v":0.645615680884556,"d":"0.65"},{"v":-0.631252475287082,"d":"-0.63"},{"v":0.107313984580451,"d":"0.11"},{"v":0.561316762118056,"d":"0.56"},"down","no"]
["MSTRG.10234","CDCA7","ENSOART00000000621;ENSOART00000000623","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0042127(regulation of cell population proliferation);GO:0042127(regulation of cell population proliferation)","NA","NA","NA","cell division cycle associated 7 [Source:NCBI gene;Acc:101111162]",{"v":1.14674931134352,"d":"1.15"},{"v":0.791088371681416,"d":"0.79"},{"v":0.629820390185036,"d":"0.63"},{"v":1.43375247586484,"d":"1.43"},{"v":1.18290663998391,"d":"1.18"},{"v":1.60145352574417,"d":"1.60"},{"v":0.608722026029235,"d":"0.61"},{"v":-0.716144525575275,"d":"-0.72"},{"v":0.107354750406308,"d":"0.11"},{"v":0.561316762118056,"d":"0.56"},"down","no"]
["MSTRG.11454","ENSOARG00000009214","ENSOART00000010033","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006352(DNA-templated transcription, initiation);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":20.013802,"d":"20.01"},{"v":14.879861,"d":"14.88"},{"v":12.40959,"d":"12.41"},{"v":22.285835,"d":"22.29"},{"v":23.674143,"d":"23.67"},{"v":28.205254,"d":"28.21"},{"v":0.637809007325697,"d":"0.64"},{"v":-0.648803622991206,"d":"-0.65"},{"v":0.107361112695657,"d":"0.11"},{"v":0.561316762118056,"d":"0.56"},"down","no"]
["MSTRG.17109","HNRNPA2B1","ENSOART00000011024","GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0031053(primary miRNA processing);GO:0035198(miRNA binding);GO:0043047(single-stranded telomeric DNA binding);GO:0050658(RNA transport);GO:0070062(extracellular exosome);GO:0071013(catalytic step 2 spliceosome);GO:1990247(N6-methyladenosine-containing RNA binding);GO:1990428(miRNA transport);GO:1990904(ribonucleoprotein complex)","NA","K13158","NA","heterogeneous nuclear ribonucleoprotein A2/B1 [Source:NCBI gene;Acc:101107187]",{"v":22.7130654868732,"d":"22.71"},{"v":17.6211603762142,"d":"17.62"},{"v":16.2720023969546,"d":"16.27"},{"v":15.9947069032554,"d":"15.99"},{"v":13.1588808510108,"d":"13.16"},{"v":13.2370665603833,"d":"13.24"},{"v":1.3353468866009,"d":"1.34"},{"v":0.417214563314639,"d":"0.42"},{"v":0.107417271812338,"d":"0.11"},{"v":0.561430606322618,"d":"0.56"},"up","no"]
["MSTRG.21878","OGT;ENSOARG00000017502","ENSOART00000018877;ENSOART00000019051;ENSOART00000019050","GO:0000123(histone acetyltransferase complex);GO:0005515(protein binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006110(regulation of glycolytic process);GO:0006111(regulation of gluconeogenesis);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006493(protein O-linked glycosylation);GO:0006915(apoptotic process);GO:0016262(protein N-acetylglucosaminyltransferase activity);GO:0016485(protein processing);GO:0016757(transferase activity, transferring glycosyl groups);GO:0031397(negative regulation of protein ubiquitination);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032868(response to insulin);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0035020(regulation of Rac protein signal transduction);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0043995(histone acetyltransferase activity (H4-K5 specific));GO:0043996(histone acetyltransferase activity (H4-K8 specific));GO:0045862(positive regulation of proteolysis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046626(regulation of insulin receptor signaling pathway);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0048015(phosphatidylinositol-mediated signaling);GO:0061087(positive regulation of histone H3-K27 methylation);GO:0080182(histone H3-K4 trimethylation);GO:0097363(protein O-GlcNAc transferase activity);GO:0120162(positive regulation of cold-induced thermogenesis)","00514(Other types of O-glycan biosynthesis);04931(Insulin resistance)","K09667","EC:2.4.1.255","O-linked N-acetylglucosamine (GlcNAc) transferase [Source:NCBI gene;Acc:101106996]",{"v":9.18690183834603,"d":"9.19"},{"v":9.38947195107784,"d":"9.39"},{"v":9.41468110498688,"d":"9.41"},{"v":7.79281580478465,"d":"7.79"},{"v":7.89985383847511,"d":"7.90"},{"v":5.32641768207048,"d":"5.33"},{"v":1.33169696957672,"d":"1.33"},{"v":0.413265831488907,"d":"0.41"},{"v":0.1075355668855,"d":"0.11"},{"v":0.561869035554062,"d":"0.56"},"up","no"]
["MSTRG.5487","GFOD2","ENSOART00000003400","GO:0016491(oxidoreductase activity);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0055114(oxidation-reduction process)","NA","NA","NA","glucose-fructose oxidoreductase domain containing 2 [Source:NCBI gene;Acc:101115644]",{"v":1.7587758921805,"d":"1.76"},{"v":1.42503804719256,"d":"1.43"},{"v":1.56262051636238,"d":"1.56"},{"v":2.24535112194282,"d":"2.25"},{"v":2.44846825904237,"d":"2.45"},{"v":2.69611231760248,"d":"2.70"},{"v":0.642283941087379,"d":"0.64"},{"v":-0.638716869442677,"d":"-0.64"},{"v":0.107884348014125,"d":"0.11"},{"v":0.562750529845189,"d":"0.56"},"down","no"]
["MSTRG.10446","ENSOARG00000011873","ENSOART00000012911","NA","NA","NA","NA",null,{"v":1.585999,"d":"1.59"},{"v":0.780303,"d":"0.78"},{"v":0.773793,"d":"0.77"},{"v":0.867671,"d":"0.87"},{"v":0.557558,"d":"0.56"},{"v":0.529595,"d":"0.53"},{"v":1.60633131166796,"d":"1.61"},{"v":0.683769484638682,"d":"0.68"},{"v":0.107911067426831,"d":"0.11"},{"v":0.562750529845189,"d":"0.56"},"up","no"]
["MSTRG.4957","ENSOARG00000009562;ENSOARG00000009354","ENSOART00000010413;ENSOART00000010183","GO:0004013(adenosylhomocysteinase activity);GO:0006730(one-carbon metabolic process);GO:0016787(hydrolase activity);GO:0019510(S-adenosylhomocysteine catabolic process);GO:0051287(NAD binding);GO:0051287(NAD binding)","00270(Cysteine and methionine metabolism)","K01251","EC:3.3.1.1","adenosylhomocysteinase [Source:NCBI gene;Acc:101112500];adenosylhomocysteinase [Source:NCBI gene;Acc:101112245]",{"v":5.95010921792763,"d":"5.95"},{"v":4.06285895476974,"d":"4.06"},{"v":9.65134725493421,"d":"9.65"},{"v":14.2185370139803,"d":"14.22"},{"v":5.79833947697368,"d":"5.80"},{"v":13.5298203312089,"d":"13.53"},{"v":0.586177397192805,"d":"0.59"},{"v":-0.770590755632576,"d":"-0.77"},{"v":0.108026319253859,"d":"0.11"},{"v":0.563091886551666,"d":"0.56"},"down","no"]
["MSTRG.699","GDAP2","ENSOART00000022125;ENSOART00000022127","GO:0032526(response to retinoic acid);GO:0032526(response to retinoic acid)","NA","NA","NA","ganglioside induced differentiation associated protein 2 [Source:NCBI gene;Acc:101108971]",{"v":1.4929935475793,"d":"1.49"},{"v":0.920268786310518,"d":"0.92"},{"v":1.31832537173066,"d":"1.32"},{"v":2.29293247746244,"d":"2.29"},{"v":1.91972911352254,"d":"1.92"},{"v":1.82737619699499,"d":"1.83"},{"v":0.617808668854118,"d":"0.62"},{"v":-0.694767980436699,"d":"-0.69"},{"v":0.108148956162789,"d":"0.11"},{"v":0.563091886551666,"d":"0.56"},"down","no"]
["MSTRG.11255","CCND3","ENSOART00000003164","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000307(cyclin-dependent protein kinase holoenzyme complex);GO:0001934(positive regulation of protein phosphorylation);GO:0004693(cyclin-dependent protein serine/threonine kinase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0019901(protein kinase binding);GO:0042098(T cell proliferation);GO:0042127(regulation of cell population proliferation);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0046626(regulation of insulin receptor signaling pathway);GO:0051726(regulation of cell cycle)","04110(Cell cycle);04115(p53 signaling pathway);04151(PI3K-Akt signaling pathway);04218(Cellular senescence);04310(Wnt signaling pathway);04390(Hippo signaling pathway);04510(Focal adhesion);04630(Jak-STAT signaling pathway);05162(Measles);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05203(Viral carcinogenesis)","K10152","NA","cyclin D3 [Source:NCBI gene;Acc:100147798]",{"v":2.59545750813397,"d":"2.60"},{"v":1.32584126602871,"d":"1.33"},{"v":2.14087293636364,"d":"2.14"},{"v":2.80899124641148,"d":"2.81"},{"v":3.16510821052632,"d":"3.17"},{"v":3.66085717416268,"d":"3.66"},{"v":0.629185158027423,"d":"0.63"},{"v":-0.668443455749756,"d":"-0.67"},{"v":0.108324265396921,"d":"0.11"},{"v":0.563654194371122,"d":"0.56"},"down","no"]
["MSTRG.20528","PM20D2","ENSOART00000013954","GO:0005654(nucleoplasm);GO:0006508(proteolysis);GO:0016787(hydrolase activity);GO:0016805(dipeptidase activity);GO:0032268(regulation of cellular protein metabolic process)","NA","NA","NA","peptidase M20 domain containing 2 [Source:NCBI gene;Acc:101111105]",{"v":2.75180483621474,"d":"2.75"},{"v":2.18863002957234,"d":"2.19"},{"v":2.30838627161056,"d":"2.31"},{"v":2.52451424476797,"d":"2.52"},{"v":0.670153011828935,"d":"0.67"},{"v":1.68927659463148,"d":"1.69"},{"v":1.48421467531295,"d":"1.48"},{"v":0.569699777006005,"d":"0.57"},{"v":0.108528800651504,"d":"0.11"},{"v":0.56424993199539,"d":"0.56"},"up","no"]
["MSTRG.15342","ATL2","ENSOART00000009878;ENSOART00000009881","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005783(endoplasmic reticulum);GO:0007029(endoplasmic reticulum organization);GO:0007030(Golgi organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042802(identical protein binding);GO:0051260(protein homooligomerization);GO:0098826(endoplasmic reticulum tubular network membrane);GO:1990809(endoplasmic reticulum tubular network membrane organization);GO:1990809(endoplasmic reticulum tubular network membrane organization)","NA","K17339","EC:3.6.5.-","atlastin GTPase 2 [Source:NCBI gene;Acc:101120404]",{"v":15.3918010325315,"d":"15.39"},{"v":17.167359093929,"d":"17.17"},{"v":15.5772235809851,"d":"15.58"},{"v":15.9815872208477,"d":"15.98"},{"v":10.6029377491409,"d":"10.60"},{"v":9.0902067628866,"d":"9.09"},{"v":1.34931312358228,"d":"1.35"},{"v":0.432225181065531,"d":"0.43"},{"v":0.108567315774028,"d":"0.11"},{"v":0.56424993199539,"d":"0.56"},"up","no"]
["MSTRG.3882","CNST","ENSOART00000004315","GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0010923(negative regulation of phosphatase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019902(phosphatase binding);GO:0030133(transport vesicle);GO:0032991(protein-containing complex);GO:0042998(positive regulation of Golgi to plasma membrane protein transport);GO:0043231(intracellular membrane-bounded organelle);GO:0071253(connexin binding)","NA","K17581","NA","consortin, connexin sorting protein [Source:NCBI gene;Acc:101115637]",{"v":10.325603,"d":"10.33"},{"v":8.242468,"d":"8.24"},{"v":6.643413,"d":"6.64"},{"v":7.360282,"d":"7.36"},{"v":6.043558,"d":"6.04"},{"v":5.097338,"d":"5.10"},{"v":1.36269614832093,"d":"1.36"},{"v":0.446463908306072,"d":"0.45"},{"v":0.10857871670318,"d":"0.11"},{"v":0.56424993199539,"d":"0.56"},"up","no"]
["MSTRG.2610","TRIM37","ENSOART00000012887","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003682(chromatin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0016235(aggresome);GO:0016567(protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0035098(ESC/E(Z) complex);GO:0035518(histone H2A monoubiquitination);GO:0036353(histone H2A-K119 monoubiquitination);GO:0042803(protein homodimerization activity);GO:0046600(negative regulation of centriole replication);GO:0046872(metal ion binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0070842(aggresome assembly)","04120(Ubiquitin mediated proteolysis)","K10608","EC:2.3.2.27","tripartite motif containing 37 [Source:NCBI gene;Acc:101106605]",{"v":1.459748,"d":"1.46"},{"v":0.658863,"d":"0.66"},{"v":1.048098,"d":"1.05"},{"v":1.955142,"d":"1.96"},{"v":1.937609,"d":"1.94"},{"v":1.30517,"d":"1.31"},{"v":0.609226073270448,"d":"0.61"},{"v":-0.71495040819506,"d":"-0.71"},{"v":0.108687072130664,"d":"0.11"},{"v":0.56445372574729,"d":"0.56"},"down","no"]
["MSTRG.5630","COX7A1","ENSOART00000005761","GO:0004129(cytochrome-c oxidase activity);GO:0005746(mitochondrial respirasome);GO:0009055(electron transfer activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022900(electron transport chain);GO:1902600(proton transmembrane transport)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);04714(Thermogenesis);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K02270","NA","cytochrome c oxidase subunit 7A1, mitochondrial [Source:NCBI gene;Acc:101121285]",{"v":97.0046883749294,"d":"97.00"},{"v":91.6699555437606,"d":"91.67"},{"v":52.6107239638622,"d":"52.61"},{"v":125.494113840768,"d":"125.49"},{"v":86.3503672411067,"d":"86.35"},{"v":173.508876498024,"d":"173.51"},{"v":0.626140561997113,"d":"0.63"},{"v":-0.675441531447412,"d":"-0.68"},{"v":0.109016892279638,"d":"0.11"},{"v":0.565836076958408,"d":"0.57"},"down","no"]
["MSTRG.3323","TMEM101","ENSOART00000007117","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 101 [Source:NCBI gene;Acc:101112911]",{"v":2.166662,"d":"2.17"},{"v":3.330237,"d":"3.33"},{"v":2.848396,"d":"2.85"},{"v":5.195047,"d":"5.20"},{"v":3.975796,"d":"3.98"},{"v":4.64907,"d":"4.65"},{"v":0.60386016901843,"d":"0.60"},{"v":-0.727713579805152,"d":"-0.73"},{"v":0.109022556229247,"d":"0.11"},{"v":0.565836076958408,"d":"0.57"},"down","no"]
["MSTRG.8735","CRTAP","ENSOART00000017022","GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0007283(spermatogenesis);GO:0018400(peptidyl-proline hydroxylation to 3-hydroxy-L-proline);GO:0050821(protein stabilization);GO:1901874(negative regulation of post-translational protein modification)","NA","K19606","NA","cartilage associated protein [Source:NCBI gene;Acc:101113179]",{"v":3.876368,"d":"3.88"},{"v":2.035012,"d":"2.04"},{"v":2.81975,"d":"2.82"},{"v":4.826232,"d":"4.83"},{"v":4.082646,"d":"4.08"},{"v":4.930022,"d":"4.93"},{"v":0.630912138970583,"d":"0.63"},{"v":-0.664488985871465,"d":"-0.66"},{"v":0.10914601933275,"d":"0.11"},{"v":0.566116964315484,"d":"0.57"},"down","no"]
["MSTRG.9662","LPL","ENSOART00000011666","GO:0004465(lipoprotein lipase activity);GO:0004806(triglyceride lipase activity);GO:0005102(signaling receptor binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0009749(response to glucose);GO:0009986(cell surface);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0010886(positive regulation of cholesterol storage);GO:0010890(positive regulation of sequestering of triglyceride);GO:0016020(membrane);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0019433(triglyceride catabolic process);GO:0031225(anchored component of membrane);GO:0031670(cellular response to nutrient);GO:0034185(apolipoprotein binding);GO:0034361(very-low-density lipoprotein particle);GO:0034371(chylomicron remodeling);GO:0034372(very-low-density lipoprotein particle remodeling);GO:0042627(chylomicron);GO:0042632(cholesterol homeostasis);GO:0042803(protein homodimerization activity);GO:0043395(heparan sulfate proteoglycan binding);GO:0045600(positive regulation of fat cell differentiation);GO:0050718(positive regulation of interleukin-1 beta secretion);GO:0050729(positive regulation of inflammatory response);GO:0052689(carboxylic ester hydrolase activity);GO:0055096(low-density lipoprotein particle mediated signaling);GO:0070328(triglyceride homeostasis);GO:0071398(cellular response to fatty acid);GO:0071813(lipoprotein particle binding);GO:0090197(positive regulation of chemokine secretion);GO:1904209(positive regulation of chemokine (C-C motif) ligand 2 secretion);GO:1904469(positive regulation of tumor necrosis factor secretion);GO:2000778(positive regulation of interleukin-6 secretion)","00561(Glycerolipid metabolism);03320(PPAR signaling pathway);04979(Cholesterol metabolism);05010(Alzheimer disease)","K01059","EC:3.1.1.34","lipoprotein lipase [Source:NCBI gene;Acc:443408]",{"v":3.02047307981985,"d":"3.02"},{"v":3.9488075068992,"d":"3.95"},{"v":3.03969183049061,"d":"3.04"},{"v":2.46851772221158,"d":"2.47"},{"v":2.51104354168264,"d":"2.51"},{"v":2.4345451946148,"d":"2.43"},{"v":1.34999038295742,"d":"1.35"},{"v":0.432949129861988,"d":"0.43"},{"v":0.109213385030758,"d":"0.11"},{"v":0.566286488022299,"d":"0.57"},"up","no"]
["MSTRG.4390","NAV1","ENSOART00000020624","GO:0022008(neurogenesis)","NA","K16776","NA","neuron navigator 1 [Source:NCBI gene;Acc:101112917]",{"v":2.32545597738847,"d":"2.33"},{"v":1.53475288633123,"d":"1.53"},{"v":1.76468331900591,"d":"1.76"},{"v":2.67810933387655,"d":"2.68"},{"v":3.043535128132,"d":"3.04"},{"v":2.73300389692402,"d":"2.73"},{"v":0.665301730353192,"d":"0.67"},{"v":-0.587919308922127,"d":"-0.59"},{"v":0.109300103114612,"d":"0.11"},{"v":0.566546613158515,"d":"0.57"},"down","no"]
["MSTRG.13703","CNPY4;MBLAC1","ENSOART00000019135;ENSOART00000019433","GO:0005102(signaling receptor binding);GO:1903078(positive regulation of protein localization to plasma membrane)","NA","K22816","NA","canopy FGF signaling regulator 4 [Source:NCBI gene;Acc:101107493];metallo-beta-lactamase domain containing 1 [Source:NCBI gene;Acc:101107250]",{"v":1.45402026570546,"d":"1.45"},{"v":1.02259107312049,"d":"1.02"},{"v":1.36178048609681,"d":"1.36"},{"v":1.85340791761071,"d":"1.85"},{"v":1.89170569515963,"d":"1.89"},{"v":2.27675833779609,"d":"2.28"},{"v":0.637408409948291,"d":"0.64"},{"v":-0.649710040769005,"d":"-0.65"},{"v":0.10933294819099,"d":"0.11"},{"v":0.566546613158515,"d":"0.57"},"down","no"]
["MSTRG.10458","PTPN4","ENSOART00000013979","GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0004726(non-membrane spanning protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006470(protein dephosphorylation);GO:0008092(cytoskeletal protein binding);GO:0009898(cytoplasmic side of plasma membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation)","NA","K18037","EC:3.1.3.48","protein tyrosine phosphatase, non-receptor type 4 [Source:NCBI gene;Acc:101112629]",{"v":9.7973413811722,"d":"9.80"},{"v":8.08698785244415,"d":"8.09"},{"v":7.49798922413651,"d":"7.50"},{"v":7.2789361336246,"d":"7.28"},{"v":6.25549836748825,"d":"6.26"},{"v":5.44576243030253,"d":"5.45"},{"v":1.33730532667661,"d":"1.34"},{"v":0.419328891753472,"d":"0.42"},{"v":0.109599619139224,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"up","no"]
["MSTRG.1056","ENSOARG00000012185","ENSOART00000013250","NA","NA","K18615","NA","RCSD domain containing 1 [Source:NCBI gene;Acc:101115084]",{"v":3.21690633679073,"d":"3.22"},{"v":10.214785128737,"d":"10.21"},{"v":2.98485997925564,"d":"2.98"},{"v":3.08775103843807,"d":"3.09"},{"v":3.63615167175107,"d":"3.64"},{"v":3.75908070530812,"d":"3.76"},{"v":1.56601902283985,"d":"1.57"},{"v":0.647101737526801,"d":"0.65"},{"v":0.109656636462253,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"up","no"]
["MSTRG.3506","BAHCC1","ENSOART00000020309","GO:0003682(chromatin binding)","NA","NA","NA","BAH domain and coiled-coil containing 1 [Source:NCBI gene;Acc:101109374]",{"v":0.863769168048229,"d":"0.86"},{"v":0.682709970108013,"d":"0.68"},{"v":0.771650980281336,"d":"0.77"},{"v":1.19936270622959,"d":"1.20"},{"v":1.16532990592816,"d":"1.17"},{"v":1.18444754345642,"d":"1.18"},{"v":0.653152599446001,"d":"0.65"},{"v":-0.614507999372828,"d":"-0.61"},{"v":0.109663035176883,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"down","no"]
["MSTRG.3694","CACNG1","ENSOART00000017242","GO:0005245(voltage-gated calcium channel activity);GO:0005891(voltage-gated calcium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0070296(sarcoplasmic reticulum calcium ion transport);GO:0070588(calcium ion transmembrane transport)","04010(MAPK signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04921(Oxytocin signaling pathway);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","K04866","NA","calcium voltage-gated channel auxiliary subunit gamma 1 [Source:NCBI gene;Acc:101110606]",{"v":75.2174,"d":"75.22"},{"v":59.826714,"d":"59.83"},{"v":65.049713,"d":"65.05"},{"v":96.378998,"d":"96.38"},{"v":97.226936,"d":"97.23"},{"v":105.232918,"d":"105.23"},{"v":0.669570993399479,"d":"0.67"},{"v":-0.578691064886137,"d":"-0.58"},{"v":0.109704073643768,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"down","no"]
["MSTRG.14081","CFAP70","ENSOART00000008271","GO:0005515(protein binding)","NA","NA","NA","cilia and flagella associated protein 70 [Source:NCBI gene;Acc:101118160]",{"v":0.888399,"d":"0.89"},{"v":0.752491,"d":"0.75"},{"v":1.001658,"d":"1.00"},{"v":0.765689,"d":"0.77"},{"v":0.525643,"d":"0.53"},{"v":0.539307,"d":"0.54"},{"v":1.44351125481321,"d":"1.44"},{"v":0.529582356067074,"d":"0.53"},{"v":0.109721375908664,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"up","no"]
["MSTRG.6253","TIMM8B","ENSOART00000017560","GO:0005739(mitochondrion);GO:0005758(mitochondrial intermembrane space);GO:0015031(protein transport);GO:0046872(metal ion binding);GO:0072321(chaperone-mediated protein transport)","NA","K17780","NA","translocase of inner mitochondrial membrane 8 homolog B [Source:NCBI gene;Acc:101111742]",{"v":32.734287,"d":"32.73"},{"v":34.865387,"d":"34.87"},{"v":28.644203,"d":"28.64"},{"v":53.094933,"d":"53.09"},{"v":42.193832,"d":"42.19"},{"v":52.224583,"d":"52.22"},{"v":0.652441818349889,"d":"0.65"},{"v":-0.616078840132942,"d":"-0.62"},{"v":0.109725281528283,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"down","no"]
["MSTRG.16789","SLC25A13","ENSOART00000004448;ENSOART00000004450","GO:0005313(L-glutamate transmembrane transporter activity);GO:0005509(calcium ion binding);GO:0005739(mitochondrion);GO:0006754(ATP biosynthetic process);GO:0015183(L-aspartate transmembrane transporter activity);GO:0015810(aspartate transmembrane transport);GO:0015813(L-glutamate transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0042802(identical protein binding);GO:0043490(malate-aspartate shuttle);GO:0045333(cellular respiration);GO:0051592(response to calcium ion);GO:0055085(transmembrane transport);GO:0070778(L-aspartate transmembrane transport);GO:0070778(L-aspartate transmembrane transport)","NA","K15105","NA","solute carrier family 25 member 13 [Source:NCBI gene;Acc:101118780]",{"v":0.882813215042373,"d":"0.88"},{"v":1.55827596822034,"d":"1.56"},{"v":1.54856409322034,"d":"1.55"},{"v":1.0234376440678,"d":"1.02"},{"v":0.941909423728814,"d":"0.94"},{"v":0.767899707627119,"d":"0.77"},{"v":1.45967547180753,"d":"1.46"},{"v":0.54564765180616,"d":"0.55"},{"v":0.109757587808859,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"up","no"]
["MSTRG.9742","ENSOARG00000012105","ENSOART00000013162","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":13.167892,"d":"13.17"},{"v":11.915923,"d":"11.92"},{"v":15.722991,"d":"15.72"},{"v":17.208471,"d":"17.21"},{"v":19.611557,"d":"19.61"},{"v":27.870888,"d":"27.87"},{"v":0.630796540274681,"d":"0.63"},{"v":-0.664753347476518,"d":"-0.66"},{"v":0.109953455965565,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"down","no"]
["MSTRG.5201","LDHD","ENSOART00000006953","GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0071949(FAD binding)","00620(Pyruvate metabolism)","K00102","EC:1.1.2.4","lactate dehydrogenase D [Source:NCBI gene;Acc:101115643]",{"v":2.80820873399716,"d":"2.81"},{"v":3.80519602588905,"d":"3.81"},{"v":1.10461621365576,"d":"1.10"},{"v":2.15433191379801,"d":"2.15"},{"v":1.12738148790896,"d":"1.13"},{"v":1.70666785945946,"d":"1.71"},{"v":1.54719949608208,"d":"1.55"},{"v":0.629659230046311,"d":"0.63"},{"v":0.110020288157894,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"up","no"]
["MSTRG.15949","CDK4","ENSOART00000005797","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","01522(Endocrine resistance);04110(Cell cycle);04115(p53 signaling pathway);04151(PI3K-Akt signaling pathway);04218(Cellular senescence);04530(Tight junction);04660(T cell receptor signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome);05160(Hepatitis C);05162(Measles);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05212(Pancreatic cancer);05214(Glioma);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma)","K02089","EC:2.7.11.22","cyclin dependent kinase 4 [Source:NCBI gene;Acc:100144756]",{"v":2.615124,"d":"2.62"},{"v":2.068998,"d":"2.07"},{"v":2.587165,"d":"2.59"},{"v":3.749971,"d":"3.75"},{"v":3.202812,"d":"3.20"},{"v":4.031294,"d":"4.03"},{"v":0.661984343336268,"d":"0.66"},{"v":-0.595130998788758,"d":"-0.60"},{"v":0.110024318900136,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"down","no"]
["MSTRG.21957","CHM","ENSOART00000002809;ENSOART00000002810","GO:0005092(GDP-dissociation inhibitor activity);GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005968(Rab-protein geranylgeranyltransferase complex);GO:0006612(protein targeting to membrane);GO:0006886(intracellular protein transport);GO:0007264(small GTPase mediated signal transduction);GO:0017137(Rab GTPase binding);GO:0018344(protein geranylgeranylation);GO:0043547(positive regulation of GTPase activity);GO:0050790(regulation of catalytic activity);GO:0050790(regulation of catalytic activity)","NA","NA","NA","CHM, Rab escort protein 1 [Source:NCBI gene;Acc:101102290]",{"v":3.78890917471166,"d":"3.79"},{"v":3.24989480222127,"d":"3.25"},{"v":2.97360072533106,"d":"2.97"},{"v":2.55036189918838,"d":"2.55"},{"v":2.34548348739855,"d":"2.35"},{"v":2.38324554720205,"d":"2.38"},{"v":1.37550207757224,"d":"1.38"},{"v":0.459958318716939,"d":"0.46"},{"v":0.110054512635875,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"up","no"]
["MSTRG.8428","DICER1","ENSOART00000016829","GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0004521(endoribonuclease activity);GO:0004525(ribonuclease III activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006396(RNA processing);GO:0016787(hydrolase activity);GO:0016891(endoribonuclease activity, producing 5'-phosphomonoesters);GO:0019904(protein domain specific binding);GO:0030422(production of siRNA involved in RNA interference);GO:0030423(targeting of mRNA for destruction involved in RNA interference);GO:0031047(gene silencing by RNA);GO:0031054(pre-miRNA processing);GO:0032720(negative regulation of tumor necrosis factor production);GO:0033168(conversion of ds siRNA to ss siRNA involved in RNA interference);GO:0035068(micro-ribonucleoprotein complex);GO:0035087(siRNA loading onto RISC involved in RNA interference);GO:0035196(production of miRNAs involved in gene silencing by miRNA);GO:0035197(siRNA binding);GO:0035280(miRNA loading onto RISC involved in gene silencing by miRNA);GO:0036404(conversion of ds siRNA to ss siRNA);GO:0038061(NIK/NF-kappaB signaling);GO:0070062(extracellular exosome);GO:0070578(RISC-loading complex);GO:0070883(pre-miRNA binding);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","05206(MicroRNAs in cancer)","K11592","EC:3.1.26.-","dicer 1, ribonuclease III [Source:NCBI gene;Acc:101120020]",{"v":14.3548110844727,"d":"14.35"},{"v":15.1872489622681,"d":"15.19"},{"v":13.719144654796,"d":"13.72"},{"v":12.4412537141494,"d":"12.44"},{"v":11.6632094971913,"d":"11.66"},{"v":8.6501256990991,"d":"8.65"},{"v":1.32076775012579,"d":"1.32"},{"v":0.401376798757496,"d":"0.40"},{"v":0.110100214465465,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"up","no"]
["ENSOARG00000007440","GRIN3A","ENSOART00000008117;ENSOART00000008115","GO:0004970(ionotropic glutamate receptor activity);GO:0004972(NMDA glutamate receptor activity);GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016358(dendrite development);GO:0016594(glycine binding);GO:0017146(NMDA selective glutamate receptor complex);GO:0034220(ion transmembrane transport);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0038023(signaling receptor activity);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0045471(response to ethanol);GO:0060078(regulation of postsynaptic membrane potential);GO:0060134(prepulse inhibition);GO:0070588(calcium ion transmembrane transport);GO:0098978(glutamatergic synapse);GO:1904315(transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential);GO:2000300(regulation of synaptic vesicle exocytosis);GO:2000300(regulation of synaptic vesicle exocytosis)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04724(Glutamatergic synapse);05030(Cocaine addiction);05031(Amphetamine addiction);05033(Nicotine addiction);05034(Alcoholism);05034(Alcoholism)","K05213","NA","glutamate ionotropic receptor NMDA type subunit 3A [Source:NCBI gene;Acc:101120547]",{"v":0.315905133858268,"d":"0.32"},{"v":0.250984787401575,"d":"0.25"},{"v":0.450689228346457,"d":"0.45"},{"v":0.608362551181102,"d":"0.61"},{"v":0.666793021872266,"d":"0.67"},{"v":0.493893193350831,"d":"0.49"},{"v":0.575212605175747,"d":"0.58"},{"v":-0.797832803628092,"d":"-0.80"},{"v":0.110119562484414,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"down","no"]
["MSTRG.1008","CCDC190","ENSOART00000011909","NA","NA","NA","NA","coiled-coil domain containing 190 [Source:NCBI gene;Acc:101110285]",{"v":0.8763059,"d":"0.88"},{"v":0.897618756097561,"d":"0.90"},{"v":1.62389147073171,"d":"1.62"},{"v":1.22252667560976,"d":"1.22"},{"v":2.20550022439024,"d":"2.21"},{"v":2.5702666097561,"d":"2.57"},{"v":0.566463798629192,"d":"0.57"},{"v":-0.819944335146905,"d":"-0.82"},{"v":0.110128841778363,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"down","no"]
["MSTRG.3809","TGFB2","ENSOART00000012598","GO:0000902(cell morphogenesis);GO:0001540(amyloid-beta binding);GO:0001654(eye development);GO:0001666(response to hypoxia);GO:0001837(epithelial to mesenchymal transition);GO:0001942(hair follicle development);GO:0003007(heart morphogenesis);GO:0005102(signaling receptor binding);GO:0005114(type II transforming growth factor beta receptor binding);GO:0005160(transforming growth factor beta receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006468(protein phosphorylation);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007435(salivary gland morphogenesis);GO:0007507(heart development);GO:0008083(growth factor activity);GO:0008219(cell death);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008347(glial cell migration);GO:0009611(response to wounding);GO:0010002(cardioblast differentiation);GO:0010469(regulation of signaling receptor activity);GO:0010629(negative regulation of gene expression);GO:0010634(positive regulation of epithelial cell migration);GO:0010693(negative regulation of alkaline phosphatase activity);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0010936(negative regulation of macrophage cytokine production);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016049(cell growth);GO:0016477(cell migration);GO:0016525(negative regulation of angiogenesis);GO:0023014(signal transduction by protein phosphorylation);GO:0030199(collagen fibril organization);GO:0030307(positive regulation of cell growth);GO:0030308(negative regulation of cell growth);GO:0031012(extracellular matrix);GO:0032147(activation of protein kinase activity);GO:0032570(response to progesterone);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0032909(regulation of transforming growth factor beta2 production);GO:0033630(positive regulation of cell adhesion mediated by integrin);GO:0034714(type III transforming growth factor beta receptor binding);GO:0042493(response to drug);GO:0042803(protein homodimerization activity);GO:0043525(positive regulation of neuron apoptotic process);GO:0045216(cell-cell junction organization);GO:0045726(positive regulation of integrin biosynthetic process);GO:0045747(positive regulation of Notch signaling pathway);GO:0045778(positive regulation of ossification);GO:0045823(positive regulation of heart contraction);GO:0048566(embryonic digestive tract development);GO:0050680(negative regulation of epithelial cell proliferation);GO:0050714(positive regulation of protein secretion);GO:0051781(positive regulation of cell division);GO:0051794(regulation of timing of catagen);GO:0051795(positive regulation of timing of catagen);GO:0051891(positive regulation of cardioblast differentiation);GO:0060038(cardiac muscle cell proliferation);GO:0060317(cardiac epithelial to mesenchymal transition);GO:0060389(pathway-restricted SMAD protein phosphorylation);GO:0060395(SMAD protein signal transduction);GO:0062023(collagen-containing extracellular matrix);GO:0097191(extrinsic apoptotic signaling pathway);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II)","04010(MAPK signaling pathway);04060(Cytokine-cytokine receptor interaction);04068(FoxO signaling pathway);04110(Cell cycle);04218(Cellular senescence);04350(TGF-beta signaling pathway);04380(Osteoclast differentiation);04390(Hippo signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05144(Malaria);05145(Toxoplasmosis);05146(Amoebiasis);05152(Tuberculosis);05161(Hepatitis B);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05220(Chronic myeloid leukemia);05225(Hepatocellular carcinoma);05226(Gastric cancer);05321(Inflammatory bowel disease (IBD));05323(Rheumatoid arthritis);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","K13376","NA","transforming growth factor beta 2 [Source:NCBI gene;Acc:554322]",{"v":6.18773149360795,"d":"6.19"},{"v":6.64903124266098,"d":"6.65"},{"v":8.6759227544981,"d":"8.68"},{"v":5.62306179734848,"d":"5.62"},{"v":5.16106675378788,"d":"5.16"},{"v":5.21303330326705,"d":"5.21"},{"v":1.34478138600851,"d":"1.34"},{"v":0.427371660547015,"d":"0.43"},{"v":0.110162481492119,"d":"0.11"},{"v":0.567244717061913,"d":"0.57"},"up","no"]
["MSTRG.391","AK4","ENSOART00000011080","GO:0004017(adenylate kinase activity);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006139(nucleobase-containing compound metabolic process);GO:0006165(nucleoside diphosphate phosphorylation);GO:0009142(nucleoside triphosphate biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019205(nucleobase-containing compound kinase activity);GO:0046033(AMP metabolic process);GO:0046034(ATP metabolic process);GO:0046039(GTP metabolic process);GO:0046899(nucleoside triphosphate adenylate kinase activity);GO:0046940(nucleoside monophosphate phosphorylation)","00230(Purine metabolism);00730(Thiamine metabolism)","K00939","EC:2.7.4.3","adenylate kinase 4 [Source:NCBI gene;Acc:101103031]",{"v":31.4105184997266,"d":"31.41"},{"v":17.2546431161837,"d":"17.25"},{"v":6.79602147731001,"d":"6.80"},{"v":18.593248006561,"d":"18.59"},{"v":7.51625122197922,"d":"7.52"},{"v":8.77427389311099,"d":"8.77"},{"v":1.58988486995971,"d":"1.59"},{"v":0.668922297866898,"d":"0.67"},{"v":0.110526545398984,"d":"0.11"},{"v":0.568939922217719,"d":"0.57"},"up","no"]
["MSTRG.8225","LINGO1","ENSOART00000001986","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","leucine rich repeat and Ig domain containing 1 [Source:NCBI gene;Acc:101117451]",{"v":35.6021907796723,"d":"35.60"},{"v":36.6163513142762,"d":"36.62"},{"v":31.8377653520562,"d":"31.84"},{"v":21.8238772781678,"d":"21.82"},{"v":28.4265160651956,"d":"28.43"},{"v":26.1900869575393,"d":"26.19"},{"v":1.36127228709702,"d":"1.36"},{"v":0.444955669306653,"d":"0.44"},{"v":0.110619866640439,"d":"0.11"},{"v":0.569240839112856,"d":"0.57"},"up","no"]
["ENSOARG00000020693","ARMC9","ENSOART00000022547","GO:0005515(protein binding);GO:0036064(ciliary basal body);GO:0060271(cilium assembly)","NA","K22864","NA","armadillo repeat containing 9 [Source:NCBI gene;Acc:101107335]",{"v":0.366878,"d":"0.37"},{"v":0.247774,"d":"0.25"},{"v":0.169829,"d":"0.17"},{"v":0.478758,"d":"0.48"},{"v":0.41582,"d":"0.42"},{"v":0.521375,"d":"0.52"},{"v":0.554030395076673,"d":"0.55"},{"v":-0.851962967667963,"d":"-0.85"},{"v":0.110705520080738,"d":"0.11"},{"v":0.569502120944642,"d":"0.57"},"down","no"]
["MSTRG.6543","PGAP2","ENSOART00000001934","GO:0000139(Golgi membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","post-GPI attachment to proteins 2 [Source:HGNC Symbol;Acc:HGNC:17893]",{"v":1.6371598774409,"d":"1.64"},{"v":1.4592643450668,"d":"1.46"},{"v":1.56034432476876,"d":"1.56"},{"v":2.22970135662898,"d":"2.23"},{"v":2.66801490544707,"d":"2.67"},{"v":2.25549537564234,"d":"2.26"},{"v":0.651003882329112,"d":"0.65"},{"v":-0.619261947809422,"d":"-0.62"},{"v":0.110843409428904,"d":"0.11"},{"v":0.570031870600044,"d":"0.57"},"down","no"]
["MSTRG.10049","OCA2","ENSOART00000017038","GO:0005765(lysosomal membrane);GO:0005789(endoplasmic reticulum membrane);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033162(melanosome membrane);GO:0055085(transmembrane transport)","NA","NA","NA","OCA2 melanosomal transmembrane protein [Source:NCBI gene;Acc:101102287]",{"v":0.441259,"d":"0.44"},{"v":0.112342,"d":"0.11"},{"v":0.480064,"d":"0.48"},{"v":0.560787,"d":"0.56"},{"v":0.761629,"d":"0.76"},{"v":0.590771,"d":"0.59"},{"v":0.54028435275799,"d":"0.54"},{"v":-0.888209194386641,"d":"-0.89"},{"v":0.111270812180216,"d":"0.11"},{"v":0.57116625564524,"d":"0.57"},"down","no"]
["MSTRG.8282","STRN3","ENSOART00000006245","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0017048(Rho GTPase binding);GO:0044877(protein-containing complex binding);GO:0051721(protein phosphatase 2A binding);GO:0070016(armadillo repeat domain binding);GO:0090443(FAR/SIN/STRIPAK complex)","NA","K17608","NA","striatin 3 [Source:NCBI gene;Acc:101102517]",{"v":4.36779557244318,"d":"4.37"},{"v":4.53334846803977,"d":"4.53"},{"v":4.44100788778409,"d":"4.44"},{"v":3.83524987286932,"d":"3.84"},{"v":3.36227354900568,"d":"3.36"},{"v":2.88673631889205,"d":"2.89"},{"v":1.32306706404333,"d":"1.32"},{"v":0.403886191254212,"d":"0.40"},{"v":0.111273876727554,"d":"0.11"},{"v":0.57116625564524,"d":"0.57"},"up","no"]
["MSTRG.13424","ACSM5","ENSOART00000013786","GO:0003824(catalytic activity)","00650(Butanoate metabolism)","K01896","EC:6.2.1.2","acyl-CoA synthetase medium chain family member 5 [Source:NCBI gene;Acc:101112785]",{"v":13.9229242099064,"d":"13.92"},{"v":8.86905737934159,"d":"8.87"},{"v":7.30538464512232,"d":"7.31"},{"v":10.9293158498943,"d":"10.93"},{"v":4.18761980972516,"d":"4.19"},{"v":5.80358487224404,"d":"5.80"},{"v":1.43865283794109,"d":"1.44"},{"v":0.524718496591085,"d":"0.52"},{"v":0.111424322686503,"d":"0.11"},{"v":0.571758749473672,"d":"0.57"},"up","no"]
["MSTRG.6884","CPEB4","ENSOART00000004623;ENSOART00000004618","GO:0002931(response to ischemia);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0006417(regulation of translation);GO:0014069(postsynaptic density);GO:0030425(dendrite);GO:0045182(translation regulator activity);GO:0045202(synapse);GO:0071230(cellular response to amino acid stimulus);GO:0071230(cellular response to amino acid stimulus)","04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);04914(Progesterone-mediated oocyte maturation)","K02602","NA","cytoplasmic polyadenylation element binding protein 4 [Source:NCBI gene;Acc:101110448]",{"v":12.1303662472912,"d":"12.13"},{"v":13.0931166038952,"d":"13.09"},{"v":14.3397517435194,"d":"14.34"},{"v":12.5126668804005,"d":"12.51"},{"v":6.88435186037581,"d":"6.88"},{"v":9.71588093046221,"d":"9.72"},{"v":1.35895891654487,"d":"1.36"},{"v":0.44250184183533,"d":"0.44"},{"v":0.111518634845359,"d":"0.11"},{"v":0.571887084927142,"d":"0.57"},"up","no"]
["MSTRG.16542","ATF4","ENSOART00000018266","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001085(RNA polymerase II transcription factor binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006094(gluconeogenesis);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006874(cellular calcium ion homeostasis);GO:0007623(circadian rhythm);GO:0010575(positive regulation of vascular endothelial growth factor production);GO:0010628(positive regulation of gene expression);GO:0019901(protein kinase binding);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0034198(cellular response to amino acid starvation);GO:0034399(nuclear periphery);GO:0034976(response to endoplasmic reticulum stress);GO:0036091(positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress);GO:0036499(PERK-mediated unfolded protein response);GO:0042149(cellular response to glucose starvation);GO:0042789(mRNA transcription by RNA polymerase II);GO:0043005(neuron projection);GO:0043522(leucine zipper domain binding);GO:0043525(positive regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045943(positive regulation of transcription by RNA polymerase I);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070169(positive regulation of biomineral tissue development);GO:0090575(RNA polymerase II transcription factor complex);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1903204(negative regulation of oxidative stress-induced neuron death);GO:1903351(cellular response to dopamine);GO:1905461(positive regulation of vascular associated smooth muscle cell apoptotic process);GO:1990037(Lewy body core);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress);GO:1990589(ATF4-CREB1 transcription factor complex);GO:1990590(ATF1-ATF4 transcription factor complex);GO:1990617(CHOP-ATF4 complex);GO:2000120(positive regulation of sodium-dependent phosphate transport)","04010(MAPK signaling pathway);04022(cGMP-PKG signaling pathway);04137(Mitophagy - animal);04141(Protein processing in endoplasmic reticulum);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04211(Longevity regulating pathway);04261(Adrenergic signaling in cardiomyocytes);04668(TNF signaling pathway);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04725(Cholinergic synapse);04728(Dopaminergic synapse);04911(Insulin secretion);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04918(Thyroid hormone synthesis);04922(Glucagon signaling pathway);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04932(Non-alcoholic fatty liver disease (NAFLD));04934(Cushing syndrome);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism);05161(Hepatitis B);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05203(Viral carcinogenesis);05215(Prostate cancer)","K04374","NA","activating transcription factor 4 [Source:NCBI gene;Acc:100216465]",{"v":423.280925971154,"d":"423.28"},{"v":407.857975625,"d":"407.86"},{"v":359.677603884615,"d":"359.68"},{"v":300.965390730769,"d":"300.97"},{"v":275.634525153846,"d":"275.63"},{"v":316.091111865385,"d":"316.09"},{"v":1.33396266845225,"d":"1.33"},{"v":0.415718292615133,"d":"0.42"},{"v":0.111519382558061,"d":"0.11"},{"v":0.571887084927142,"d":"0.57"},"up","no"]
["MSTRG.5020","KIAA1755","ENSOART00000020317","NA","NA","NA","NA","KIAA1755 ortholog [Source:NCBI gene;Acc:101123397]",{"v":0.962185,"d":"0.96"},{"v":0.25783,"d":"0.26"},{"v":0.476011,"d":"0.48"},{"v":0.682364,"d":"0.68"},{"v":1.285845,"d":"1.29"},{"v":1.031192,"d":"1.03"},{"v":0.565454902495532,"d":"0.57"},{"v":-0.822516127330926,"d":"-0.82"},{"v":0.111583253234895,"d":"0.11"},{"v":0.571916165289095,"d":"0.57"},"down","no"]
["ENSOARG00000016115","SYT9","ENSOART00000017545","GO:0000149(SNARE binding);GO:0001786(phosphatidylserine binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017158(regulation of calcium ion-dependent exocytosis);GO:0030285(integral component of synaptic vesicle membrane);GO:0031045(dense core granule);GO:0042802(identical protein binding);GO:0050796(regulation of insulin secretion);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0099502(calcium-dependent activation of synaptic vesicle fusion)","NA","NA","NA","synaptotagmin 9 [Source:HGNC Symbol;Acc:HGNC:19265]",{"v":0.283635,"d":"0.28"},{"v":0.518415,"d":"0.52"},{"v":0.419689,"d":"0.42"},{"v":0.955671,"d":"0.96"},{"v":0.770044,"d":"0.77"},{"v":0.573424,"d":"0.57"},{"v":0.531389794179473,"d":"0.53"},{"v":-0.912157575053023,"d":"-0.91"},{"v":0.111595106725322,"d":"0.11"},{"v":0.571916165289095,"d":"0.57"},"down","no"]
["MSTRG.10890","RPA2","ENSOART00000003516","GO:0000723(telomere maintenance);GO:0000724(double-strand break repair via homologous recombination);GO:0000781(chromosome, telomeric region);GO:0000785(chromatin);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003697(single-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0006298(mismatch repair);GO:0006310(DNA recombination);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016604(nuclear body);GO:0016605(PML body);GO:0019899(enzyme binding);GO:0019903(protein phosphatase binding);GO:0031571(mitotic G1 DNA damage checkpoint);GO:0031625(ubiquitin protein ligase binding);GO:0034502(protein localization to chromosome);GO:0035861(site of double-strand break);GO:0098505(G-rich strand telomeric DNA binding);GO:2000001(regulation of DNA damage checkpoint)","03030(DNA replication);03420(Nucleotide excision repair);03430(Mismatch repair);03440(Homologous recombination);03460(Fanconi anemia pathway)","K10739","NA","replication protein A2 [Source:NCBI gene;Acc:101105309]",{"v":16.9905259935743,"d":"16.99"},{"v":14.9245948184739,"d":"14.92"},{"v":14.2999197686747,"d":"14.30"},{"v":12.8223790698795,"d":"12.82"},{"v":10.3188533518072,"d":"10.32"},{"v":11.3254629967872,"d":"11.33"},{"v":1.34086079386514,"d":"1.34"},{"v":0.423159466604729,"d":"0.42"},{"v":0.111672324819933,"d":"0.11"},{"v":0.571952860621035,"d":"0.57"},"up","no"]
["MSTRG.5433","NDRG4","ENSOART00000001543","GO:0005737(cytoplasm);GO:0008542(visual learning);GO:0010642(negative regulation of platelet-derived growth factor receptor signaling pathway);GO:0014912(negative regulation of smooth muscle cell migration);GO:0016323(basolateral plasma membrane);GO:0031253(cell projection membrane);GO:0048278(vesicle docking);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0060973(cell migration involved in heart development);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:2001135(regulation of endocytic recycling)","NA","NA","NA","NDRG family member 4 [Source:NCBI gene;Acc:101122719]",{"v":2.55062226959746,"d":"2.55"},{"v":0.782868310646186,"d":"0.78"},{"v":0.823137877383475,"d":"0.82"},{"v":1.66105035381356,"d":"1.66"},{"v":2.78130417717161,"d":"2.78"},{"v":2.72336552701271,"d":"2.72"},{"v":0.580071287181779,"d":"0.58"},{"v":-0.785697885433664,"d":"-0.79"},{"v":0.111715225010365,"d":"0.11"},{"v":0.571993162110139,"d":"0.57"},"down","no"]
["MSTRG.14085","PPP3CB;MSS51","ENSOART00000008426;ENSOART00000008334","GO:0001915(negative regulation of T cell mediated cytotoxicity);GO:0001946(lymphangiogenesis);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005509(calcium ion binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005955(calcineurin complex);GO:0006468(protein phosphorylation);GO:0006470(protein dephosphorylation);GO:0007507(heart development);GO:0008144(drug binding);GO:0010468(regulation of gene expression);GO:0016787(hydrolase activity);GO:0017156(calcium ion regulated exocytosis);GO:0019899(enzyme binding);GO:0030018(Z disc);GO:0030217(T cell differentiation);GO:0030315(T-tubule);GO:0030346(protein phosphatase 2B binding);GO:0031987(locomotion involved in locomotory behavior);GO:0033173(calcineurin-NFAT signaling cascade);GO:0033192(calmodulin-dependent protein phosphatase activity);GO:0034097(response to cytokine);GO:0035176(social behavior);GO:0035690(cellular response to drug);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0043029(T cell homeostasis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0098978(glutamatergic synapse);GO:1900242(regulation of synaptic vesicle endocytosis);GO:0046872(metal ion binding)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04114(Oocyte meiosis);04218(Cellular senescence);04310(Wnt signaling pathway);04360(Axon guidance);04370(VEGF signaling pathway);04380(Osteoclast differentiation);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04720(Long-term potentiation);04724(Glutamatergic synapse);04728(Dopaminergic synapse);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04924(Renin secretion);05010(Alzheimer disease);05014(Amyotrophic lateral sclerosis (ALS));05031(Amphetamine addiction);05152(Tuberculosis);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection)","K04348;K17656","EC:3.1.3.16","protein phosphatase 3 catalytic subunit beta [Source:NCBI gene;Acc:101108104];MSS51 mitochondrial translational activator [Source:NCBI gene;Acc:101119107]",{"v":29.7480083221301,"d":"29.75"},{"v":23.1881348768025,"d":"23.19"},{"v":20.9035145357102,"d":"20.90"},{"v":24.0641665039173,"d":"24.06"},{"v":15.0160271545362,"d":"15.02"},{"v":15.9745019251732,"d":"15.97"},{"v":1.3412054494513,"d":"1.34"},{"v":0.423530250069865,"d":"0.42"},{"v":0.111904741945234,"d":"0.11"},{"v":0.572604395638289,"d":"0.57"},"up","no"]
["MSTRG.21887","SLC16A2","ENSOART00000019618","GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0015349(thyroid hormone transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0070327(thyroid hormone transport)","04919(Thyroid hormone signaling pathway)","K08231","NA","solute carrier family 16 member 2 [Source:NCBI gene;Acc:101104210]",{"v":1.24892013367609,"d":"1.25"},{"v":1.04919431362468,"d":"1.05"},{"v":0.891738622107969,"d":"0.89"},{"v":1.83367835475578,"d":"1.83"},{"v":1.38149333676093,"d":"1.38"},{"v":1.78248511053985,"d":"1.78"},{"v":0.638269732346587,"d":"0.64"},{"v":-0.6477618601108,"d":"-0.65"},{"v":0.111990671976728,"d":"0.11"},{"v":0.572864565174193,"d":"0.57"},"down","no"]
["MSTRG.16517","CBY1","ENSOART00000017128","GO:0036064(ciliary basal body);GO:0045444(fat cell differentiation);GO:0055007(cardiac muscle cell differentiation);GO:0060271(cilium assembly);GO:0090090(negative regulation of canonical Wnt signaling pathway)","NA","NA","NA","chibby family member 1, beta catenin antagonist [Source:NCBI gene;Acc:101105234]",{"v":6.09271827098151,"d":"6.09"},{"v":4.16755782290185,"d":"4.17"},{"v":3.98272243100996,"d":"3.98"},{"v":6.20039964793741,"d":"6.20"},{"v":7.38157654267425,"d":"7.38"},{"v":8.37662954125178,"d":"8.38"},{"v":0.648629457571878,"d":"0.65"},{"v":-0.624533549465801,"d":"-0.62"},{"v":0.112090110144015,"d":"0.11"},{"v":0.573193648115089,"d":"0.57"},"down","no"]
["MSTRG.16571","TEF","ENSOART00000019846","GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K09058","NA","TEF, PAR bZIP transcription factor [Source:NCBI gene;Acc:100192430]",{"v":5.28388031971415,"d":"5.28"},{"v":4.87847053503185,"d":"4.88"},{"v":5.01604384239553,"d":"5.02"},{"v":7.5038262424266,"d":"7.50"},{"v":7.54143926153488,"d":"7.54"},{"v":7.70772590111853,"d":"7.71"},{"v":0.667094468015871,"d":"0.67"},{"v":-0.584037017304225,"d":"-0.58"},{"v":0.112203280636899,"d":"0.11"},{"v":0.573413197570982,"d":"0.57"},"down","no"]
["MSTRG.11145","ENSOARG00000007906","ENSOART00000008605","GO:0002376(immune system process);GO:0002504(antigen processing and presentation of peptide or polysaccharide antigen via MHC class II);GO:0006955(immune response);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019882(antigen processing and presentation);GO:0042613(MHC class II protein complex)","04145(Phagosome);04514(Cell adhesion molecules (CAMs));04612(Antigen processing and presentation);04640(Hematopoietic cell lineage);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04672(Intestinal immune network for IgA production);04940(Type I diabetes mellitus);05140(Leishmaniasis);05145(Toxoplasmosis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05164(Influenza A);05166(Human T-cell leukemia virus 1 infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05310(Asthma);05320(Autoimmune thyroid disease);05321(Inflammatory bowel disease (IBD));05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis)","K06752","NA","HLA class II histocompatibility antigen, DM beta chain [Source:NCBI gene;Acc:101109746]",{"v":0.269324,"d":"0.27"},{"v":0.215936,"d":"0.22"},{"v":0.284143,"d":"0.28"},{"v":0.440296,"d":"0.44"},{"v":0.309679,"d":"0.31"},{"v":0.529523,"d":"0.53"},{"v":0.601331928615754,"d":"0.60"},{"v":-0.733766532274402,"d":"-0.73"},{"v":0.112251037518363,"d":"0.11"},{"v":0.573477766145128,"d":"0.57"},"down","no"]
["MSTRG.13066","MAPK4","ENSOART00000004861","GO:0000165(MAPK cascade);GO:0004672(protein kinase activity);GO:0004707(MAP kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0019901(protein kinase binding);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity)","04657(IL-17 signaling pathway)","K06855","EC:2.7.11.24","mitogen-activated protein kinase 4 [Source:NCBI gene;Acc:101112939]",{"v":0.925198,"d":"0.93"},{"v":0.624695,"d":"0.62"},{"v":0.807588,"d":"0.81"},{"v":0.718052,"d":"0.72"},{"v":0.480837,"d":"0.48"},{"v":0.403755,"d":"0.40"},{"v":1.47099480608295,"d":"1.47"},{"v":0.556792152607969,"d":"0.56"},{"v":0.112434863077589,"d":"0.11"},{"v":0.574017708635547,"d":"0.57"},"up","no"]
["ENSOARG00000010838","DGKA","ENSOART00000011793","GO:0000166(nucleotide binding);GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005509(calcium ion binding);GO:0005524(ATP binding);GO:0005543(phospholipid binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006654(phosphatidic acid biosynthetic process);GO:0007165(signal transduction);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0035556(intracellular signal transduction);GO:0046339(diacylglycerol metabolic process);GO:0046486(glycerolipid metabolic process);GO:0046834(lipid phosphorylation)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)","K00901","EC:2.7.1.107","diacylglycerol kinase alpha [Source:NCBI gene;Acc:101113224]",{"v":2.280346,"d":"2.28"},{"v":2.194574,"d":"2.19"},{"v":3.086624,"d":"3.09"},{"v":1.940896,"d":"1.94"},{"v":2.061755,"d":"2.06"},{"v":1.413566,"d":"1.41"},{"v":1.39609325106435,"d":"1.40"},{"v":0.481395308564028,"d":"0.48"},{"v":0.112462190710749,"d":"0.11"},{"v":0.574017708635547,"d":"0.57"},"up","no"]
["MSTRG.2641","ENSOARG00000017636","ENSOART00000019194","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005509(calcium ion binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity)","NA","K11837","EC:3.4.19.12","ubiquitin specific peptidase 32 [Source:NCBI gene;Acc:101109460]",{"v":7.805675,"d":"7.81"},{"v":9.554029,"d":"9.55"},{"v":8.389333,"d":"8.39"},{"v":7.393874,"d":"7.39"},{"v":6.58717,"d":"6.59"},{"v":5.257028,"d":"5.26"},{"v":1.33844165881072,"d":"1.34"},{"v":0.420554254870481,"d":"0.42"},{"v":0.112630827936742,"d":"0.11"},{"v":0.574519262277765,"d":"0.57"},"up","no"]
["MSTRG.9977","ENSOARG00000014827","ENSOART00000016136","NA","NA","NA","NA","coiled-coil domain containing 25 [Source:NCBI gene;Acc:101114166]",{"v":6.839248,"d":"6.84"},{"v":7.959593,"d":"7.96"},{"v":6.094414,"d":"6.09"},{"v":6.399667,"d":"6.40"},{"v":4.688912,"d":"4.69"},{"v":3.756968,"d":"3.76"},{"v":1.40737522167422,"d":"1.41"},{"v":0.493007018183468,"d":"0.49"},{"v":0.112797151686976,"d":"0.11"},{"v":0.574579749605992,"d":"0.57"},"up","no"]
["MSTRG.5313","CDT1","ENSOART00000014695","GO:0000076(DNA replication checkpoint);GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0007059(chromosome segregation);GO:0016604(nuclear body);GO:0030174(regulation of DNA-dependent DNA replication initiation);GO:0031334(positive regulation of protein complex assembly);GO:0033044(regulation of chromosome organization);GO:0033262(regulation of nuclear cell cycle DNA replication);GO:0035563(positive regulation of chromatin binding);GO:0045740(positive regulation of DNA replication);GO:0051301(cell division);GO:0051315(attachment of mitotic spindle microtubules to kinetochore);GO:0051383(kinetochore organization);GO:0071163(DNA replication preinitiation complex assembly);GO:0072708(response to sorbitol);GO:1902426(deactivation of mitotic spindle assembly checkpoint);GO:1902595(regulation of DNA replication origin binding);GO:1905341(negative regulation of protein localization to kinetochore);GO:1905342(positive regulation of protein localization to kinetochore);GO:2000105(positive regulation of DNA-dependent DNA replication);GO:2001178(positive regulation of mediator complex assembly)","NA","NA","NA","chromatin licensing and DNA replication factor 1 [Source:HGNC Symbol;Acc:HGNC:24576]",{"v":0.673914,"d":"0.67"},{"v":0.714023,"d":"0.71"},{"v":0.820541,"d":"0.82"},{"v":1.124179,"d":"1.12"},{"v":1.155504,"d":"1.16"},{"v":1.214285,"d":"1.21"},{"v":0.632083064298242,"d":"0.63"},{"v":-0.661813934306606,"d":"-0.66"},{"v":0.112836303452529,"d":"0.11"},{"v":0.574579749605992,"d":"0.57"},"down","no"]
["MSTRG.292","GPX7","ENSOART00000006012","GO:0004096(catalase activity);GO:0004601(peroxidase activity);GO:0004602(glutathione peroxidase activity);GO:0005783(endoplasmic reticulum);GO:0006979(response to oxidative stress);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0098869(cellular oxidant detoxification)","NA","NA","NA","glutathione peroxidase 7 [Source:HGNC Symbol;Acc:HGNC:4559]",{"v":3.734528,"d":"3.73"},{"v":1.279675,"d":"1.28"},{"v":3.658655,"d":"3.66"},{"v":4.986195,"d":"4.99"},{"v":4.292069,"d":"4.29"},{"v":5.818661,"d":"5.82"},{"v":0.574478445113823,"d":"0.57"},{"v":-0.79967533206085,"d":"-0.80"},{"v":0.112842524237538,"d":"0.11"},{"v":0.574579749605992,"d":"0.57"},"down","no"]
["MSTRG.12144","DPP3","ENSOART00000006104","GO:0004177(aminopeptidase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008239(dipeptidyl-peptidase activity);GO:0008270(zinc ion binding);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)","NA","K01277","EC:3.4.14.4","dipeptidyl peptidase 3 [Source:NCBI gene;Acc:101115241]",{"v":2.546216,"d":"2.55"},{"v":2.630854,"d":"2.63"},{"v":3.318198,"d":"3.32"},{"v":3.662423,"d":"3.66"},{"v":4.387925,"d":"4.39"},{"v":5.120706,"d":"5.12"},{"v":0.644995305614873,"d":"0.64"},{"v":-0.632639434492227,"d":"-0.63"},{"v":0.112863642782785,"d":"0.11"},{"v":0.574579749605992,"d":"0.57"},"down","no"]
["MSTRG.7092","EGFLAM","ENSOART00000010974;ENSOART00000010972","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005539(glycosaminoglycan binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019800(peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0031012(extracellular matrix)","NA","NA","NA","EGF like, fibronectin type III and laminin G domains [Source:NCBI gene;Acc:101106626]",{"v":4.15515629444675,"d":"4.16"},{"v":2.56972993120597,"d":"2.57"},{"v":3.63737913758807,"d":"3.64"},{"v":5.28174731102362,"d":"5.28"},{"v":5.35721651015334,"d":"5.36"},{"v":5.00591171902196,"d":"5.01"},{"v":0.662342460738364,"d":"0.66"},{"v":-0.59435074694901,"d":"-0.59"},{"v":0.112868820902327,"d":"0.11"},{"v":0.574579749605992,"d":"0.57"},"down","no"]
["MSTRG.14646","ENSOARG00000003241","ENSOART00000003513","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.81184,"d":"0.81"},{"v":0.523787,"d":"0.52"},{"v":0.796726,"d":"0.80"},{"v":1.270213,"d":"1.27"},{"v":0.999017,"d":"1.00"},{"v":1.45361,"d":"1.45"},{"v":0.572775891523675,"d":"0.57"},{"v":-0.80395732489554,"d":"-0.80"},{"v":0.112889014988732,"d":"0.11"},{"v":0.574579749605992,"d":"0.57"},"down","no"]
["MSTRG.4655","RIN2","ENSOART00000002008","GO:0007165(signal transduction)","NA","NA","NA","Ras and Rab interactor 2 [Source:NCBI gene;Acc:101123061]",{"v":2.68060965914878,"d":"2.68"},{"v":1.65392060240087,"d":"1.65"},{"v":2.05284137504547,"d":"2.05"},{"v":3.31306282466351,"d":"3.31"},{"v":3.1531271647872,"d":"3.15"},{"v":3.3722585823936,"d":"3.37"},{"v":0.649225494238442,"d":"0.65"},{"v":-0.623208441136408,"d":"-0.62"},{"v":0.112945119306355,"d":"0.11"},{"v":0.574627540300201,"d":"0.57"},"down","no"]
["MSTRG.21273","RNF19A","ENSOART00000001089","GO:0004842(ubiquitin-protein transferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0046872(metal ion binding);GO:0098686(hippocampal mossy fiber to CA3 synapse);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:0099576(regulation of protein catabolic process at postsynapse, modulating synaptic transmission)","NA","K11972","EC:2.3.2.31","ring finger protein 19A, RBR E3 ubiquitin protein ligase [Source:NCBI gene;Acc:101103734]",{"v":7.416909,"d":"7.42"},{"v":6.111797,"d":"6.11"},{"v":6.441386,"d":"6.44"},{"v":5.646142,"d":"5.65"},{"v":5.281106,"d":"5.28"},{"v":3.954976,"d":"3.95"},{"v":1.34187551537996,"d":"1.34"},{"v":0.424250840186307,"d":"0.42"},{"v":0.113168923234458,"d":"0.11"},{"v":0.575149950117637,"d":"0.58"},"up","no"]
["ENSOARG00000006286","SGPL1","ENSOART00000006837;ENSOART00000006838","GO:0001553(luteinization);GO:0001570(vasculogenesis);GO:0001822(kidney development);GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0006631(fatty acid metabolic process);GO:0006672(ceramide metabolic process);GO:0006807(nitrogen compound metabolic process);GO:0007283(spermatogenesis);GO:0008117(sphinganine-1-phosphate aldolase activity);GO:0008209(androgen metabolic process);GO:0008210(estrogen metabolic process);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010761(fibroblast migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0016831(carboxy-lyase activity);GO:0019752(carboxylic acid metabolic process);GO:0030097(hemopoiesis);GO:0030149(sphingolipid catabolic process);GO:0030170(pyridoxal phosphate binding);GO:0033327(Leydig cell differentiation);GO:0040014(regulation of multicellular organism growth);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0097190(apoptotic signaling pathway);GO:0097190(apoptotic signaling pathway)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway);04071(Sphingolipid signaling pathway)","K01634","EC:4.1.2.27","sphingosine-1-phosphate lyase 1 [Source:NCBI gene;Acc:101111155]",{"v":1.83885579084228,"d":"1.84"},{"v":2.16441291464104,"d":"2.16"},{"v":2.29152671905031,"d":"2.29"},{"v":1.73775873713963,"d":"1.74"},{"v":1.33457523007349,"d":"1.33"},{"v":1.3560991780667,"d":"1.36"},{"v":1.42144980358191,"d":"1.42"},{"v":0.507363153252443,"d":"0.51"},{"v":0.113170643589199,"d":"0.11"},{"v":0.575149950117637,"d":"0.58"},"up","no"]
["MSTRG.17682","IL27RA","ENSOART00000007421","GO:0002692(negative regulation of cellular extravasation);GO:0002827(positive regulation of T-helper 1 type immune response);GO:0002829(negative regulation of type 2 immune response);GO:0005515(protein binding);GO:0032729(positive regulation of interferon-gamma production);GO:0045509(interleukin-27 receptor activity);GO:0048302(regulation of isotype switching to IgG isotypes);GO:0050830(defense response to Gram-positive bacterium);GO:1900165(negative regulation of interleukin-6 secretion);GO:1904468(negative regulation of tumor necrosis factor secretion);GO:1905077(negative regulation of interleukin-17 secretion);GO:2000317(negative regulation of T-helper 17 type immune response);GO:2000408(negative regulation of T cell extravasation)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway);04659(Th17 cell differentiation)","K19598","NA","interleukin 27 receptor subunit alpha [Source:NCBI gene;Acc:101102232]",{"v":3.28466415443038,"d":"3.28"},{"v":2.36233503164557,"d":"2.36"},{"v":2.8235418556962,"d":"2.82"},{"v":4.11784556582278,"d":"4.12"},{"v":4.25794953924051,"d":"4.26"},{"v":4.50938474683544,"d":"4.51"},{"v":0.65738632592885,"d":"0.66"},{"v":-0.60518664716979,"d":"-0.61"},{"v":0.11317716742577,"d":"0.11"},{"v":0.575149950117637,"d":"0.58"},"down","no"]
["MSTRG.8179","TLNRD1","ENSOART00000017048","GO:0001725(stress fiber);GO:0003779(actin binding)","NA","NA","NA","talin rod domain containing 1 [Source:HGNC Symbol;Acc:HGNC:13519]",{"v":1.357327,"d":"1.36"},{"v":1.132733,"d":"1.13"},{"v":1.229558,"d":"1.23"},{"v":1.965883,"d":"1.97"},{"v":1.912434,"d":"1.91"},{"v":2.351449,"d":"2.35"},{"v":0.597071864336478,"d":"0.60"},{"v":-0.744023508318263,"d":"-0.74"},{"v":0.113286183307353,"d":"0.11"},{"v":0.575524829198025,"d":"0.58"},"down","no"]
["MSTRG.7400","MGARP","ENSOART00000015121","GO:0005739(mitochondrion);GO:0008089(anterograde axonal transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:1904115(axon cytoplasm)","NA","NA","NA","mitochondria localized glutamic acid rich protein [Source:NCBI gene;Acc:101116766]",{"v":3.29788017162284,"d":"3.30"},{"v":3.57518898386172,"d":"3.58"},{"v":2.29168352871303,"d":"2.29"},{"v":1.59659662931105,"d":"1.60"},{"v":1.11471756270992,"d":"1.11"},{"v":3.2475396315229,"d":"3.25"},{"v":1.53800595812352,"d":"1.54"},{"v":0.621061092206505,"d":"0.62"},{"v":0.113356559668852,"d":"0.11"},{"v":0.575703236787876,"d":"0.58"},"up","no"]
["MSTRG.9061","TEX264","ENSOART00000007698","NA","NA","NA","NA","testis expressed 264 [Source:NCBI gene;Acc:101114144]",{"v":1.91439134556575,"d":"1.91"},{"v":1.22812669215087,"d":"1.23"},{"v":1.32284149133537,"d":"1.32"},{"v":2.03803126044852,"d":"2.04"},{"v":2.03119996228338,"d":"2.03"},{"v":3.10230132619776,"d":"3.10"},{"v":0.622650667564555,"d":"0.62"},{"v":-0.683505115462368,"d":"-0.68"},{"v":0.113562047644019,"d":"0.11"},{"v":0.576015496398336,"d":"0.58"},"down","no"]
["MSTRG.1103","IL10RB","ENSOART00000014403","GO:0005515(protein binding);GO:0007596(blood coagulation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT)","NA","NA","NA","interleukin 10 receptor subunit beta [Source:HGNC Symbol;Acc:HGNC:5965]",{"v":3.18582,"d":"3.19"},{"v":1.808204,"d":"1.81"},{"v":1.777152,"d":"1.78"},{"v":3.598691,"d":"3.60"},{"v":3.633274,"d":"3.63"},{"v":3.727662,"d":"3.73"},{"v":0.617829055678628,"d":"0.62"},{"v":-0.694720374297716,"d":"-0.69"},{"v":0.113590167691112,"d":"0.11"},{"v":0.576015496398336,"d":"0.58"},"down","no"]
["MSTRG.18804","PPM1K","ENSOART00000001752","GO:0003824(catalytic activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005739(mitochondrion);GO:0006470(protein dephosphorylation);GO:0016787(hydrolase activity);GO:0043169(cation binding);GO:0046872(metal ion binding)","NA","K17505","EC:3.1.3.16","protein phosphatase, Mg2+/Mn2+ dependent 1K [Source:NCBI gene;Acc:101119821]",{"v":21.8550281218905,"d":"21.86"},{"v":16.5495962114428,"d":"16.55"},{"v":7.91289295541523,"d":"7.91"},{"v":13.9499063296977,"d":"13.95"},{"v":8.94695940413318,"d":"8.95"},{"v":9.24475610352086,"d":"9.24"},{"v":1.44104480860151,"d":"1.44"},{"v":0.527115196124817,"d":"0.53"},{"v":0.11364029310738,"d":"0.11"},{"v":0.576015496398336,"d":"0.58"},"up","no"]
["MSTRG.4900","ENSOARG00000018587","ENSOART00000020231","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0016853(isomerase activity)","NA","K09568","EC:5.2.1.8","FKBP prolyl isomerase 1A [Source:NCBI gene;Acc:101105938]",{"v":30.1526600060286,"d":"30.15"},{"v":20.6467962682743,"d":"20.65"},{"v":30.2013417196684,"d":"30.20"},{"v":47.237587853052,"d":"47.24"},{"v":35.1643694476262,"d":"35.16"},{"v":40.9484970685757,"d":"40.95"},{"v":0.656672068280288,"d":"0.66"},{"v":-0.60675500375656,"d":"-0.61"},{"v":0.113669576214087,"d":"0.11"},{"v":0.576015496398336,"d":"0.58"},"down","no"]
["MSTRG.5659","PSMD8","ENSOART00000006105","GO:0000502(proteasome complex);GO:0005838(proteasome regulatory particle);GO:0006508(proteolysis);GO:0022624(proteasome accessory complex)","03050(Proteasome);05169(Epstein-Barr virus infection)","K03031","NA","proteasome 26S subunit, non-ATPase 8 [Source:NCBI gene;Acc:101111572]",{"v":8.129363,"d":"8.13"},{"v":7.172077,"d":"7.17"},{"v":6.915356,"d":"6.92"},{"v":9.87798,"d":"9.88"},{"v":10.612326,"d":"10.61"},{"v":13.01157,"d":"13.01"},{"v":0.663150803853492,"d":"0.66"},{"v":-0.592591111077208,"d":"-0.59"},{"v":0.113770821648985,"d":"0.11"},{"v":0.576015496398336,"d":"0.58"},"down","no"]
["MSTRG.10415","TTN","ENSOART00000018808","GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","K12567","EC:2.7.11.1","titin [Source:NCBI gene;Acc:101122837]",{"v":1676.75095206674,"d":"1676.75"},{"v":1990.72703136444,"d":"1990.73"},{"v":1883.43978246991,"d":"1883.44"},{"v":1526.11331468715,"d":"1526.11"},{"v":1453.10957680976,"d":"1453.11"},{"v":1222.00008618897,"d":"1222.00"},{"v":1.32126235512466,"d":"1.32"},{"v":0.401916962312775,"d":"0.40"},{"v":0.11384921403862,"d":"0.11"},{"v":0.576233715692061,"d":"0.58"},"up","no"]
["MSTRG.662","ENSOARG00000019837","ENSOART00000021599","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":32.981087,"d":"32.98"},{"v":25.056705,"d":"25.06"},{"v":35.278084,"d":"35.28"},{"v":27.107805,"d":"27.11"},{"v":19.725941,"d":"19.73"},{"v":22.32091,"d":"22.32"},{"v":1.34937951249443,"d":"1.35"},{"v":0.432296162809115,"d":"0.43"},{"v":0.114213914420297,"d":"0.11"},{"v":0.57772143576661,"d":"0.58"},"up","no"]
["MSTRG.13001","IMPA2","ENSOART00000001854","GO:0005737(cytoplasm);GO:0006021(inositol biosynthetic process);GO:0008934(inositol monophosphate 1-phosphatase activity);GO:0016787(hydrolase activity);GO:0042803(protein homodimerization activity);GO:0046854(phosphatidylinositol phosphorylation);GO:0046855(inositol phosphate dephosphorylation);GO:0046872(metal ion binding);GO:0052832(inositol monophosphate 3-phosphatase activity);GO:0052833(inositol monophosphate 4-phosphatase activity);GO:0052834(inositol monophosphate phosphatase activity)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)","K01092","EC:3.1.3.25","inositol monophosphatase 2 [Source:NCBI gene;Acc:101105968]",{"v":1.49968822569764,"d":"1.50"},{"v":0.15363327598896,"d":"0.15"},{"v":0.99402289757743,"d":"0.99"},{"v":1.52467657221711,"d":"1.52"},{"v":1.7253773799448,"d":"1.73"},{"v":1.88209361637535,"d":"1.88"},{"v":0.515835595900171,"d":"0.52"},{"v":-0.955016763294287,"d":"-0.96"},{"v":0.114264126915568,"d":"0.11"},{"v":0.577796427462803,"d":"0.58"},"down","no"]
["MSTRG.13536","ENSOARG00000006258","ENSOART00000006799","GO:0003676(nucleic acid binding)","NA","NA","NA",null,{"v":5.63321121549214,"d":"5.63"},{"v":3.79079764181712,"d":"3.79"},{"v":4.03147206697728,"d":"4.03"},{"v":5.86057989866045,"d":"5.86"},{"v":6.22702356668608,"d":"6.23"},{"v":8.55655140885265,"d":"8.56"},{"v":0.651781630504189,"d":"0.65"},{"v":-0.617539402451819,"d":"-0.62"},{"v":0.114331148697976,"d":"0.11"},{"v":0.57795634549243,"d":"0.58"},"down","no"]
["MSTRG.6971","ENSOARG00000005393","ENSOART00000005876","NA","NA","NA","NA",null,{"v":1.84215591287512,"d":"1.84"},{"v":1.75590455566312,"d":"1.76"},{"v":2.08647083639884,"d":"2.09"},{"v":1.925363517909,"d":"1.93"},{"v":1.19514038528558,"d":"1.20"},{"v":0.839764842207164,"d":"0.84"},{"v":1.43539029050424,"d":"1.44"},{"v":0.521443066947723,"d":"0.52"},{"v":0.114426305461789,"d":"0.11"},{"v":0.578079429325523,"d":"0.58"},"up","no"]
["MSTRG.22016","SSR4","ENSOART00000007055","GO:0005783(endoplasmic reticulum);GO:0016021(integral component of membrane)","04141(Protein processing in endoplasmic reticulum)","K04571","NA","signal sequence receptor subunit 4 [Source:NCBI gene;Acc:101110652]",{"v":4.511976,"d":"4.51"},{"v":4.052374,"d":"4.05"},{"v":4.152841,"d":"4.15"},{"v":5.488545,"d":"5.49"},{"v":6.366267,"d":"6.37"},{"v":7.269083,"d":"7.27"},{"v":0.664989585019161,"d":"0.66"},{"v":-0.588596349399658,"d":"-0.59"},{"v":0.114532720532427,"d":"0.11"},{"v":0.57820091227694,"d":"0.58"},"down","no"]
["MSTRG.11532","ENSOARG00000020067","ENSOART00000021847","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 1 [Source:NCBI gene;Acc:101105036]",{"v":2.048922,"d":"2.05"},{"v":0.765729,"d":"0.77"},{"v":3.160991,"d":"3.16"},{"v":4.20098,"d":"4.20"},{"v":1.870372,"d":"1.87"},{"v":5.944348,"d":"5.94"},{"v":0.49731950697837,"d":"0.50"},{"v":-1.00775507402416,"d":"-1.01"},{"v":0.114554269181397,"d":"0.11"},{"v":0.57820091227694,"d":"0.58"},"down","no"]
["MSTRG.21156","GDAP1","ENSOART00000007131","GO:0000266(mitochondrial fission);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006626(protein targeting to mitochondrion);GO:0008053(mitochondrial fusion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031307(integral component of mitochondrial outer membrane);GO:0032526(response to retinoic acid)","NA","K22077","NA","ganglioside induced differentiation associated protein 1 [Source:NCBI gene;Acc:101108759]",{"v":2.94391527429699,"d":"2.94"},{"v":2.9411639125555,"d":"2.94"},{"v":2.79390183682782,"d":"2.79"},{"v":1.98409002417366,"d":"1.98"},{"v":2.21835241835224,"d":"2.22"},{"v":2.24850396817958,"d":"2.25"},{"v":1.34538104506299,"d":"1.35"},{"v":0.428014837441072,"d":"0.43"},{"v":0.114743316118731,"d":"0.11"},{"v":0.578785562430225,"d":"0.58"},"up","no"]
["MSTRG.16263","ENSOARG00000020231","ENSOART00000022027","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005840(ribosome);GO:0006412(translation);GO:0022627(cytosolic small ribosomal subunit);GO:0030154(cell differentiation)","NA","NA","NA","40S ribosomal protein S3a [Source:NCBI gene;Acc:101116132]",{"v":70.907623,"d":"70.91"},{"v":141.876099,"d":"141.88"},{"v":101.705399,"d":"101.71"},{"v":155.565338,"d":"155.57"},{"v":179.219269,"d":"179.22"},{"v":161.937225,"d":"161.94"},{"v":0.633129250095051,"d":"0.63"},{"v":-0.659428046360795,"d":"-0.66"},{"v":0.114981967135253,"d":"0.11"},{"v":0.579699125442561,"d":"0.58"},"down","no"]
["MSTRG.2840","ASPA","ENSOART00000018299","GO:0005829(cytosol);GO:0016788(hydrolase activity, acting on ester bonds);GO:0016811(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides);GO:0042802(identical protein binding);GO:0046872(metal ion binding)","00250(Alanine, aspartate and glutamate metabolism);00340(Histidine metabolism)","K01437","EC:3.5.1.15","aspartoacylase [Source:NCBI gene;Acc:101121435]",{"v":1.544793,"d":"1.54"},{"v":0.947676,"d":"0.95"},{"v":0.556145,"d":"0.56"},{"v":0.730828,"d":"0.73"},{"v":0.602088,"d":"0.60"},{"v":0.509721,"d":"0.51"},{"v":1.65448430700132,"d":"1.65"},{"v":0.726381607565388,"d":"0.73"},{"v":0.115075088056136,"d":"0.12"},{"v":0.579915322404731,"d":"0.58"},"up","no"]
["MSTRG.17851","SLC25A23","ENSOART00000006276","GO:0002082(regulation of oxidative phosphorylation);GO:0005509(calcium ion binding);GO:0005739(mitochondrion);GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0036444(calcium import into the mitochondrion);GO:0043457(regulation of cellular respiration);GO:0051282(regulation of sequestering of calcium ion);GO:0051503(adenine nucleotide transport);GO:0051561(positive regulation of mitochondrial calcium ion concentration);GO:0055085(transmembrane transport);GO:0071277(cellular response to calcium ion);GO:0097274(urea homeostasis);GO:1900069(regulation of cellular hyperosmotic salinity response)","NA","K14684","NA","solute carrier family 25 member 23 [Source:NCBI gene;Acc:101109176]",{"v":1.429458,"d":"1.43"},{"v":1.313876,"d":"1.31"},{"v":0.819853,"d":"0.82"},{"v":1.48362,"d":"1.48"},{"v":2.01084,"d":"2.01"},{"v":2.475328,"d":"2.48"},{"v":0.596869939100015,"d":"0.60"},{"v":-0.744511499507136,"d":"-0.74"},{"v":0.115140051322884,"d":"0.12"},{"v":0.579915322404731,"d":"0.58"},"down","no"]
["ENSOARG00000011908","ENSOARG00000011908","ENSOART00000012953","GO:0005515(protein binding)","NA","K16272","EC:2.3.2.27","ring finger protein 135 [Source:NCBI gene;Acc:101116159]",{"v":1.420651,"d":"1.42"},{"v":0.33784,"d":"0.34"},{"v":0.460841,"d":"0.46"},{"v":1.746534,"d":"1.75"},{"v":1.302112,"d":"1.30"},{"v":1.230464,"d":"1.23"},{"v":0.518643362755339,"d":"0.52"},{"v":-0.947185262747858,"d":"-0.95"},{"v":0.115307977682425,"d":"0.12"},{"v":0.579915322404731,"d":"0.58"},"down","no"]
["MSTRG.5445","CDH11","ENSOART00000001968","GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021957(corticospinal tract morphogenesis);GO:0045202(synapse);GO:0046872(metal ion binding);GO:0050804(modulation of chemical synaptic transmission);GO:0098609(cell-cell adhesion);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse)","NA","K06803","NA","cadherin 11 [Source:NCBI gene;Acc:101106961]",{"v":3.225361,"d":"3.23"},{"v":1.549786,"d":"1.55"},{"v":3.659827,"d":"3.66"},{"v":4.50209,"d":"4.50"},{"v":4.445615,"d":"4.45"},{"v":4.350724,"d":"4.35"},{"v":0.634283493185548,"d":"0.63"},{"v":-0.65680029742606,"d":"-0.66"},{"v":0.115330227473583,"d":"0.12"},{"v":0.579915322404731,"d":"0.58"},"down","no"]
["MSTRG.5743","MEGF8","ENSOART00000008478","GO:0003143(embryonic heart tube morphogenesis);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0007368(determination of left/right symmetry);GO:0010468(regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030326(embryonic limb morphogenesis);GO:0030509(BMP signaling pathway);GO:0035108(limb morphogenesis);GO:0042074(cell migration involved in gastrulation);GO:0045879(negative regulation of smoothened signaling pathway);GO:0048704(embryonic skeletal system morphogenesis);GO:0048842(positive regulation of axon extension involved in axon guidance);GO:0055113(epiboly involved in gastrulation with mouth forming second);GO:0060971(embryonic heart tube left/right pattern formation);GO:0060972(left/right pattern formation);GO:0060976(coronary vasculature development);GO:0061371(determination of heart left/right asymmetry);GO:0071907(determination of digestive tract left/right asymmetry);GO:0097094(craniofacial suture morphogenesis);GO:0097155(fasciculation of sensory neuron axon)","NA","NA","NA","multiple EGF like domains 8 [Source:NCBI gene;Acc:101123065]",{"v":2.07870633225268,"d":"2.08"},{"v":1.96346163257687,"d":"1.96"},{"v":1.99330666155811,"d":"1.99"},{"v":2.87874435150801,"d":"2.88"},{"v":3.40788344041654,"d":"3.41"},{"v":2.76696944041654,"d":"2.77"},{"v":0.666638295420062,"d":"0.67"},{"v":-0.585023898612786,"d":"-0.59"},{"v":0.115360119277346,"d":"0.12"},{"v":0.579915322404731,"d":"0.58"},"down","no"]
["MSTRG.3473","ENSOARG00000017637","ENSOART00000019191","GO:0006281(DNA repair);GO:0051382(kinetochore assembly)","03460(Fanconi anemia pathway)","K15360","NA","centromere protein X [Source:NCBI gene;Acc:101107297]",{"v":0.137160099861304,"d":"0.14"},{"v":0.129369644937587,"d":"0.13"},{"v":1.7331380554785,"d":"1.73"},{"v":1.9271499667129,"d":"1.93"},{"v":0.846759750346741,"d":"0.85"},{"v":2.53452712343967,"d":"2.53"},{"v":0.376696165059638,"d":"0.38"},{"v":-1.40852674882692,"d":"-1.41"},{"v":0.115385763462682,"d":"0.12"},{"v":0.579915322404731,"d":"0.58"},"down","no"]
["MSTRG.11935","TMEM132A","ENSOART00000017213","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K17599","NA","transmembrane protein 132A [Source:NCBI gene;Acc:101121638]",{"v":0.773615,"d":"0.77"},{"v":0.372965,"d":"0.37"},{"v":0.860416,"d":"0.86"},{"v":1.038968,"d":"1.04"},{"v":1.298993,"d":"1.30"},{"v":1.034231,"d":"1.03"},{"v":0.595160655146563,"d":"0.60"},{"v":-0.74864893890702,"d":"-0.75"},{"v":0.11542611763203,"d":"0.12"},{"v":0.579915322404731,"d":"0.58"},"down","no"]
["MSTRG.19006","JCHAIN","ENSOART00000012614","GO:0002250(adaptive immune response);GO:0003094(glomerular filtration);GO:0003697(single-stranded DNA binding);GO:0005615(extracellular space);GO:0019731(antibacterial humoral response);GO:0019862(IgA binding);GO:0030674(protein binding, bridging);GO:0031210(phosphatidylcholine binding);GO:0032461(positive regulation of protein oligomerization);GO:0034987(immunoglobulin receptor binding);GO:0042803(protein homodimerization activity);GO:0042834(peptidoglycan binding);GO:0045087(innate immune response);GO:0060267(positive regulation of respiratory burst);GO:0071748(monomeric IgA immunoglobulin complex);GO:0071750(dimeric IgA immunoglobulin complex);GO:0071751(secretory IgA immunoglobulin complex);GO:0071752(secretory dimeric IgA immunoglobulin complex);GO:0071756(pentameric IgM immunoglobulin complex)","NA","NA","NA","joining chain of multimeric IgA and IgM [Source:NCBI gene;Acc:101121603]",{"v":3.09722290890824,"d":"3.10"},{"v":2.11726250636303,"d":"2.12"},{"v":2.28362066510382,"d":"2.28"},{"v":3.92840022103148,"d":"3.93"},{"v":3.45928436704622,"d":"3.46"},{"v":4.28060313529806,"d":"4.28"},{"v":0.642605518318999,"d":"0.64"},{"v":-0.637994725006655,"d":"-0.64"},{"v":0.115446623841317,"d":"0.12"},{"v":0.579915322404731,"d":"0.58"},"down","no"]
["MSTRG.21524","CTPS2","ENSOART00000014076","GO:0000166(nucleotide binding);GO:0003883(CTP synthase activity);GO:0005524(ATP binding);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0006541(glutamine metabolic process);GO:0016874(ligase activity);GO:0044210('de novo' CTP biosynthetic process)","00240(Pyrimidine metabolism)","K01937","EC:6.3.4.2","CTP synthase 2 [Source:NCBI gene;Acc:101105631]",{"v":1.425019,"d":"1.43"},{"v":1.122028,"d":"1.12"},{"v":0.985449,"d":"0.99"},{"v":2.364533,"d":"2.36"},{"v":1.917405,"d":"1.92"},{"v":1.471964,"d":"1.47"},{"v":0.613930511850914,"d":"0.61"},{"v":-0.703852722486235,"d":"-0.70"},{"v":0.11592019945653,"d":"0.12"},{"v":0.581488484401295,"d":"0.58"},"down","no"]
["MSTRG.10951","CLIC4","ENSOART00000006991","GO:0001525(angiogenesis);GO:0001886(endothelial cell morphogenesis);GO:0005244(voltage-gated ion channel activity);GO:0005254(chloride channel activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005911(cell-cell junction);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0007035(vacuolar acidification);GO:0009566(fertilization);GO:0009986(cell surface);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0016363(nuclear matrix);GO:0030216(keratinocyte differentiation);GO:0030336(negative regulation of cell migration);GO:0030496(midbody);GO:0034220(ion transmembrane transport);GO:0034707(chloride channel complex);GO:0034765(regulation of ion transmembrane transport);GO:0035264(multicellular organism growth);GO:0045177(apical part of cell);GO:0048471(perinuclear region of cytoplasm);GO:0048754(branching morphogenesis of an epithelial tube);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0071277(cellular response to calcium ion);GO:1902476(chloride transmembrane transport)","NA","K05024","NA","chloride intracellular channel 4 [Source:NCBI gene;Acc:101115514]",{"v":50.175179,"d":"50.18"},{"v":46.47353,"d":"46.47"},{"v":55.132778,"d":"55.13"},{"v":39.550041,"d":"39.55"},{"v":38.97411,"d":"38.97"},{"v":36.212433,"d":"36.21"},{"v":1.32286914694968,"d":"1.32"},{"v":0.403670362914232,"d":"0.40"},{"v":0.116072135270003,"d":"0.12"},{"v":0.581916769369808,"d":"0.58"},"up","no"]
["MSTRG.9559","AGTPBP1","ENSOART00000009642;ENSOART00000009647","GO:0001754(eye photoreceptor cell differentiation);GO:0004181(metallocarboxypeptidase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0007005(mitochondrion organization);GO:0007628(adult walking behavior);GO:0008270(zinc ion binding);GO:0015631(tubulin binding);GO:0021549(cerebellum development);GO:0021680(cerebellar Purkinje cell layer development);GO:0021702(cerebellar Purkinje cell differentiation);GO:0021772(olfactory bulb development);GO:0035609(C-terminal protein deglutamylation);GO:0035610(protein side chain deglutamylation);GO:0042133(neurotransmitter metabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0050905(neuromuscular process);GO:0060041(retina development in camera-type eye);GO:0060041(retina development in camera-type eye)","NA","NA","NA","ATP/GTP binding protein 1 [Source:NCBI gene;Acc:101115757]",{"v":11.3049591702036,"d":"11.30"},{"v":10.266415699437,"d":"10.27"},{"v":6.89271016414032,"d":"6.89"},{"v":8.34785800563014,"d":"8.35"},{"v":6.67464720571676,"d":"6.67"},{"v":6.15517460805544,"d":"6.16"},{"v":1.34406059948564,"d":"1.34"},{"v":0.42659818618698,"d":"0.43"},{"v":0.116112495995029,"d":"0.12"},{"v":0.581916769369808,"d":"0.58"},"up","no"]
["MSTRG.12305","HRAS","ENSOART00000008012","GO:0000166(nucleotide binding);GO:0001934(positive regulation of protein phosphorylation);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0007050(cell cycle arrest);GO:0007093(mitotic cell cycle checkpoint);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0007265(Ras protein signal transduction);GO:0007569(cell aging);GO:0008022(protein C-terminus binding);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010863(positive regulation of phospholipase C activity);GO:0016020(membrane);GO:0019003(GDP binding);GO:0030335(positive regulation of cell migration);GO:0032729(positive regulation of interferon-gamma production);GO:0034260(negative regulation of GTPase activity);GO:0042088(T-helper 1 type immune response);GO:0042832(defense response to protozoan);GO:0043406(positive regulation of MAP kinase activity);GO:0043410(positive regulation of MAPK cascade);GO:0043524(negative regulation of neuron apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046330(positive regulation of JNK cascade);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050852(T cell receptor signaling pathway);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071480(cellular response to gamma radiation);GO:0090303(positive regulation of wound healing);GO:0090314(positive regulation of protein targeting to membrane);GO:0090398(cellular senescence);GO:0097193(intrinsic apoptotic signaling pathway);GO:0098696(regulation of neurotransmitter receptor localization to postsynaptic specialization membrane);GO:0098978(glutamatergic synapse);GO:1900029(positive regulation of ruffle assembly);GO:2000251(positive regulation of actin cytoskeleton reorganization);GO:2000630(positive regulation of miRNA metabolic process)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04062(Chemokine signaling pathway);04068(FoxO signaling pathway);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04137(Mitophagy - animal);04140(Autophagy - animal);04144(Endocytosis);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04218(Cellular senescence);04360(Axon guidance);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04510(Focal adhesion);04540(Gap junction);04550(Signaling pathways regulating pluripotency of stem cells);04625(C-type lectin receptor signaling pathway);04630(Jak-STAT signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04714(Thermogenesis);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04725(Cholinergic synapse);04726(Serotonergic synapse);04730(Long-term depression);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04916(Melanogenesis);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05034(Alcoholism);05160(Hepatitis C);05161(Hepatitis B);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05216(Thyroid cancer);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer)","K02833","NA","HRas proto-oncogene, GTPase [Source:NCBI gene;Acc:101104357]",{"v":2.134257,"d":"2.13"},{"v":2.382214,"d":"2.38"},{"v":3.620104,"d":"3.62"},{"v":4.449433,"d":"4.45"},{"v":4.147139,"d":"4.15"},{"v":4.981108,"d":"4.98"},{"v":0.599261066691806,"d":"0.60"},{"v":-0.738743448186148,"d":"-0.74"},{"v":0.116217103709556,"d":"0.12"},{"v":0.582262310331278,"d":"0.58"},"down","no"]
["MSTRG.6269","ENSOARG00000000924","ENSOART00000000989","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA","NA","NA",null,{"v":6.87928,"d":"6.88"},{"v":4.58143,"d":"4.58"},{"v":3.374869,"d":"3.37"},{"v":4.073828,"d":"4.07"},{"v":2.882404,"d":"2.88"},{"v":3.400801,"d":"3.40"},{"v":1.43241592452201,"d":"1.43"},{"v":0.518450462657721,"d":"0.52"},{"v":0.116298012943283,"d":"0.12"},{"v":0.582435640431257,"d":"0.58"},"up","no"]
["MSTRG.16425","CCND2","ENSOART00000011262","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007616(long-term memory);GO:0008344(adult locomotory behavior);GO:0051726(regulation of cell cycle);GO:0071481(cellular response to X-ray);GO:0097129(cyclin D2-CDK4 complex)","04068(FoxO signaling pathway);04110(Cell cycle);04115(p53 signaling pathway);04151(PI3K-Akt signaling pathway);04218(Cellular senescence);04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04510(Focal adhesion);04630(Jak-STAT signaling pathway);04917(Prolactin signaling pathway);05162(Measles);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05203(Viral carcinogenesis);05206(MicroRNAs in cancer)","K10151","NA","cyclin D2 [Source:NCBI gene;Acc:100147799]",{"v":9.386664,"d":"9.39"},{"v":7.702329,"d":"7.70"},{"v":9.733271,"d":"9.73"},{"v":13.305476,"d":"13.31"},{"v":12.786242,"d":"12.79"},{"v":14.335418,"d":"14.34"},{"v":0.663471782913338,"d":"0.66"},{"v":-0.5918929850065,"d":"-0.59"},{"v":0.116551928038491,"d":"0.12"},{"v":0.583223990503366,"d":"0.58"},"down","no"]
["MSTRG.8763","GOLGA4","ENSOART00000000320;ENSOART00000000317","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0043001(Golgi to plasma membrane protein transport);GO:0043231(intracellular membrane-bounded organelle);GO:0045773(positive regulation of axon extension);GO:0051020(GTPase binding);GO:0051020(GTPase binding)","NA","K20283","NA","golgin A4 [Source:NCBI gene;Acc:101109394]",{"v":5.36965590555612,"d":"5.37"},{"v":6.38370578778267,"d":"6.38"},{"v":6.25311741870459,"d":"6.25"},{"v":4.14370481397728,"d":"4.14"},{"v":5.84369462416863,"d":"5.84"},{"v":3.1465399585593,"d":"3.15"},{"v":1.37098844209381,"d":"1.37"},{"v":0.455216408750815,"d":"0.46"},{"v":0.116697752053632,"d":"0.12"},{"v":0.583720482380281,"d":"0.58"},"up","no"]
["MSTRG.5208","ENSOARG00000006663","ENSOART00000007242","NA","NA","NA","NA","craniofacial development protein 1 [Source:NCBI gene;Acc:101116755]",{"v":7.784185,"d":"7.78"},{"v":7.228472,"d":"7.23"},{"v":6.592498,"d":"6.59"},{"v":6.090966,"d":"6.09"},{"v":4.857604,"d":"4.86"},{"v":4.857629,"d":"4.86"},{"v":1.36687858984946,"d":"1.37"},{"v":0.450885104245453,"d":"0.45"},{"v":0.116885609309027,"d":"0.12"},{"v":0.584356469319593,"d":"0.58"},"up","no"]
["MSTRG.7405","PCDH18","ENSOART00000015633","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007399(nervous system development);GO:0007420(brain development);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K16499","NA","protocadherin 18 [Source:NCBI gene;Acc:101118052]",{"v":2.20394620955646,"d":"2.20"},{"v":1.8584055401757,"d":"1.86"},{"v":2.278620125991,"d":"2.28"},{"v":3.77313415727448,"d":"3.77"},{"v":2.77716873023356,"d":"2.78"},{"v":2.97717329162203,"d":"2.98"},{"v":0.665545812605972,"d":"0.67"},{"v":-0.587390117939334,"d":"-0.59"},{"v":0.116924603092242,"d":"0.12"},{"v":0.584372488304292,"d":"0.58"},"down","no"]
["MSTRG.5321","CBFA2T3","ENSOART00000014933","GO:0001666(response to hypoxia);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008285(negative regulation of cell population proliferation);GO:0030851(granulocyte differentiation);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0045820(negative regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:1903715(regulation of aerobic respiration)","NA","K22752","NA","CBFA2/RUNX1 translocation partner 3 [Source:NCBI gene;Acc:101109116]",{"v":2.2699314403183,"d":"2.27"},{"v":2.36302764340186,"d":"2.36"},{"v":3.15774587516578,"d":"3.16"},{"v":3.63298472861406,"d":"3.63"},{"v":4.73582992108753,"d":"4.74"},{"v":3.55571357907825,"d":"3.56"},{"v":0.653334438848749,"d":"0.65"},{"v":-0.614106405176196,"d":"-0.61"},{"v":0.117275333860142,"d":"0.12"},{"v":0.585946037719831,"d":"0.59"},"down","no"]
["MSTRG.20099","SLC10A1","ENSOART00000023089;ENSOART00000023088","GO:0008508(bile acid:sodium symporter activity);GO:0015721(bile acid and bile salt transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","04976(Bile secretion);05161(Hepatitis B);05161(Hepatitis B)","K14341","NA","solute carrier family 10 member 1 [Source:NCBI gene;Acc:101120497]",{"v":2.44444127821843,"d":"2.44"},{"v":1.78555688407566,"d":"1.79"},{"v":2.33255719280049,"d":"2.33"},{"v":2.14370530628432,"d":"2.14"},{"v":1.56283014521049,"d":"1.56"},{"v":0.711504362416107,"d":"0.71"},{"v":1.48539977716618,"d":"1.49"},{"v":0.57085126699551,"d":"0.57"},{"v":0.117327878299223,"d":"0.12"},{"v":0.586029243459686,"d":"0.59"},"up","no"]
["MSTRG.5008","MANBAL","ENSOART00000019441","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","mannosidase beta like [Source:NCBI gene;Acc:101102831]",{"v":3.233632,"d":"3.23"},{"v":2.741892,"d":"2.74"},{"v":1.868464,"d":"1.87"},{"v":4.174216,"d":"4.17"},{"v":3.322316,"d":"3.32"},{"v":6.68991,"d":"6.69"},{"v":0.552921444291669,"d":"0.55"},{"v":-0.854853569185456,"d":"-0.85"},{"v":0.117449301725534,"d":"0.12"},{"v":0.586456329839302,"d":"0.59"},"down","no"]
["MSTRG.19978","ENSOARG00000000943","ENSOART00000001011","NA","NA","NA","NA","translationally-controlled tumor protein pseudogene [Source:NCBI gene;Acc:101116579]",{"v":4.982909,"d":"4.98"},{"v":4.296036,"d":"4.30"},{"v":4.71104,"d":"4.71"},{"v":5.882375,"d":"5.88"},{"v":4.197037,"d":"4.20"},{"v":14.59561,"d":"14.60"},{"v":0.566969504626987,"d":"0.57"},{"v":-0.818656955322292,"d":"-0.82"},{"v":0.117781174088287,"d":"0.12"},{"v":0.587394932960766,"d":"0.59"},"down","no"]
["MSTRG.4932","POFUT1","ENSOART00000003591","GO:0001525(angiogenesis);GO:0001756(somitogenesis);GO:0005783(endoplasmic reticulum);GO:0005975(carbohydrate metabolic process);GO:0006004(fucose metabolic process);GO:0006493(protein O-linked glycosylation);GO:0007219(Notch signaling pathway);GO:0007399(nervous system development);GO:0007507(heart development);GO:0008417(fucosyltransferase activity);GO:0008593(regulation of Notch signaling pathway);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0036066(protein O-linked fucosylation);GO:0046922(peptide-O-fucosyltransferase activity)","00514(Other types of O-glycan biosynthesis)","K03691","EC:2.4.1.221","protein O-fucosyltransferase 1 [Source:NCBI gene;Acc:101104000]",{"v":1.959798,"d":"1.96"},{"v":0.975978,"d":"0.98"},{"v":1.919037,"d":"1.92"},{"v":2.740742,"d":"2.74"},{"v":2.53721,"d":"2.54"},{"v":2.693952,"d":"2.69"},{"v":0.608990399282279,"d":"0.61"},{"v":-0.715508610626072,"d":"-0.72"},{"v":0.117941049301586,"d":"0.12"},{"v":0.587780799154496,"d":"0.59"},"down","no"]
["MSTRG.9083","HYAL2;HYAL1","ENSOART00000010462;ENSOART00000010520","GO:0000302(response to reactive oxygen species);GO:0001618(virus receptor activity);GO:0002244(hematopoietic progenitor cell differentiation);GO:0003713(transcription coactivator activity);GO:0003824(catalytic activity);GO:0004415(hyalurononglucosaminidase activity);GO:0005540(hyaluronic acid binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0005975(carbohydrate metabolic process);GO:0006027(glycosaminoglycan catabolic process);GO:0008152(metabolic process);GO:0009615(response to virus);GO:0009986(cell surface);GO:0010259(multicellular organism aging);GO:0010764(negative regulation of fibroblast migration);GO:0016020(membrane);GO:0016032(viral process);GO:0016324(apical plasma membrane);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0019064(fusion of virus membrane with host plasma membrane);GO:0019087(transformation of host cell by virus);GO:0019899(enzyme binding);GO:0030139(endocytic vesicle);GO:0030214(hyaluronan catabolic process);GO:0030294(receptor signaling protein tyrosine kinase inhibitor activity);GO:0030308(negative regulation of cell growth);GO:0030971(receptor tyrosine kinase binding);GO:0031225(anchored component of membrane);GO:0031362(anchored component of external side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0033906(hyaluronoglucuronidase activity);GO:0035810(positive regulation of urine volume);GO:0042117(monocyte activation);GO:0042307(positive regulation of protein import into nucleus);GO:0043407(negative regulation of MAP kinase activity);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0045121(membrane raft);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046658(anchored component of plasma membrane);GO:0046677(response to antibiotic);GO:0046718(viral entry into host cell);GO:0048471(perinuclear region of cytoplasm);GO:0048705(skeletal system morphogenesis);GO:0050431(transforming growth factor beta binding);GO:0050729(positive regulation of inflammatory response);GO:0051216(cartilage development);GO:0051607(defense response to virus);GO:0051898(negative regulation of protein kinase B signaling);GO:0060586(multicellular organismal iron ion homeostasis);GO:0061099(negative regulation of protein tyrosine kinase activity);GO:0070295(renal water absorption);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0071493(cellular response to UV-B);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0090575(RNA polymerase II transcription factor complex);GO:2000484(positive regulation of interleukin-8 secretion);GO:2000778(positive regulation of interleukin-6 secretion);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:0005615(extracellular space);GO:0006954(inflammatory response);GO:0008134(transcription factor binding);GO:0010634(positive regulation of epithelial cell migration);GO:0030212(hyaluronan metabolic process);GO:0030213(hyaluronan biosynthetic process);GO:0030307(positive regulation of cell growth);GO:0036117(hyaluranon cable);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0045766(positive regulation of angiogenesis);GO:0045785(positive regulation of cell adhesion);GO:0045927(positive regulation of growth);GO:0050501(hyaluronan synthase activity);GO:0050679(positive regulation of epithelial cell proliferation);GO:0060272(embryonic skeletal joint morphogenesis);GO:0071467(cellular response to pH);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1900106(positive regulation of hyaluranon cable assembly)","00531(Glycosaminoglycan degradation);00531(Glycosaminoglycan degradation)","K01197","EC:3.2.1.35","hyaluronidase 2 [Source:NCBI gene;Acc:443154];hyaluronidase 1 [Source:NCBI gene;Acc:101121207]",{"v":2.0287375940749,"d":"2.03"},{"v":2.03289926226942,"d":"2.03"},{"v":2.2978051215204,"d":"2.30"},{"v":2.98007185030743,"d":"2.98"},{"v":3.2087615254332,"d":"3.21"},{"v":3.36631822604807,"d":"3.37"},{"v":0.665551133346147,"d":"0.67"},{"v":-0.58737858428585,"d":"-0.59"},{"v":0.117990200212765,"d":"0.12"},{"v":0.587780799154496,"d":"0.59"},"down","no"]
["MSTRG.2689","TMEM98","ENSOART00000010851","GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 98 [Source:NCBI gene;Acc:101120587]",{"v":1.307549,"d":"1.31"},{"v":1.697396,"d":"1.70"},{"v":0.834458,"d":"0.83"},{"v":2.109582,"d":"2.11"},{"v":2.20271,"d":"2.20"},{"v":2.468602,"d":"2.47"},{"v":0.56620896890587,"d":"0.57"},{"v":-0.820593492776273,"d":"-0.82"},{"v":0.118028225333241,"d":"0.12"},{"v":0.587780799154496,"d":"0.59"},"down","no"]
["MSTRG.18362","ABLIM3","ENSOART00000005457","GO:0001725(stress fiber);GO:0003779(actin binding);GO:0006351(transcription, DNA-templated);GO:0030027(lamellipodium);GO:0030032(lamellipodium assembly);GO:0030036(actin cytoskeleton organization);GO:0045202(synapse);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0060271(cilium assembly);GO:0098978(glutamatergic synapse)","04360(Axon guidance)","K07520","NA","actin binding LIM protein family member 3 [Source:NCBI gene;Acc:101118949]",{"v":7.3080292311617,"d":"7.31"},{"v":4.80522538706829,"d":"4.81"},{"v":5.78260341640502,"d":"5.78"},{"v":8.60308275529827,"d":"8.60"},{"v":9.63524458084772,"d":"9.64"},{"v":8.55481850009812,"d":"8.55"},{"v":0.667926720662514,"d":"0.67"},{"v":-0.582238263948397,"d":"-0.58"},{"v":0.118033679531353,"d":"0.12"},{"v":0.587780799154496,"d":"0.59"},"down","no"]
["MSTRG.11530","ENSOARG00000000749","ENSOART00000000798","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":0.122372,"d":"0.12"},{"v":0.432546,"d":"0.43"},{"v":0.277248,"d":"0.28"},{"v":0.106396,"d":"0.11"},{"v":0.236164,"d":"0.24"},{"v":0.138519,"d":"0.14"},{"v":1.72979074122961,"d":"1.73"},{"v":0.790597520607489,"d":"0.79"},{"v":0.118044508684298,"d":"0.12"},{"v":0.587780799154496,"d":"0.59"},"up","no"]
["MSTRG.17508","MGAT4B","ENSOART00000003183","GO:0006487(protein N-linked glycosylation);GO:0008375(acetylglucosaminyltransferase activity);GO:0016757(transferase activity, transferring glycosyl groups)","00510(N-Glycan biosynthesis)","K00738","EC:2.4.1.145","alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B [Source:NCBI gene;Acc:101119044]",{"v":4.492006,"d":"4.49"},{"v":4.283285,"d":"4.28"},{"v":3.721375,"d":"3.72"},{"v":6.036594,"d":"6.04"},{"v":5.869428,"d":"5.87"},{"v":6.89582,"d":"6.90"},{"v":0.664651154924076,"d":"0.66"},{"v":-0.589330760456334,"d":"-0.59"},{"v":0.118162050060624,"d":"0.12"},{"v":0.587897586524283,"d":"0.59"},"down","no"]
["MSTRG.15615","C3H12orf29","ENSOART00000016833","GO:0002244(hematopoietic progenitor cell differentiation)","NA","NA","NA","chromosome 3 open reading frame, human C12orf29 [Source:NCBI gene;Acc:100528013]",{"v":2.266371,"d":"2.27"},{"v":1.715945,"d":"1.72"},{"v":1.734804,"d":"1.73"},{"v":1.370706,"d":"1.37"},{"v":1.149656,"d":"1.15"},{"v":1.405516,"d":"1.41"},{"v":1.45626532459745,"d":"1.46"},{"v":0.542273231641198,"d":"0.54"},{"v":0.118182537629018,"d":"0.12"},{"v":0.587897586524283,"d":"0.59"},"up","no"]
["MSTRG.2946","TP53","ENSOART00000016945","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000733(DNA strand renaturation);GO:0000790(nuclear chromatin);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001046(core promoter sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001094(TFIID-class transcription factor complex binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001756(somitogenesis);GO:0001836(release of cytochrome c from mitochondria);GO:0002020(protease binding);GO:0002039(p53 binding);GO:0002309(T cell proliferation involved in immune response);GO:0002326(B cell lineage commitment);GO:0002360(T cell lineage commitment);GO:0002931(response to ischemia);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0003730(mRNA 3'-UTR binding);GO:0005507(copper ion binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005667(transcription factor complex);GO:0005669(transcription factor TFIID complex);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006289(nucleotide-excision repair);GO:0006302(double-strand break repair);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006606(protein import into nucleus);GO:0006914(autophagy);GO:0006915(apoptotic process);GO:0006974(cellular response to DNA damage stimulus);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0006979(response to oxidative stress);GO:0006983(ER overload response);GO:0007049(cell cycle);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007265(Ras protein signal transduction);GO:0007275(multicellular organism development);GO:0007369(gastrulation);GO:0007406(negative regulation of neuroblast proliferation);GO:0007417(central nervous system development);GO:0007507(heart development);GO:0007569(cell aging);GO:0007623(circadian rhythm);GO:0008104(protein localization);GO:0008134(transcription factor binding);GO:0008156(negative regulation of DNA replication);GO:0008285(negative regulation of cell population proliferation);GO:0008340(determination of adult lifespan);GO:0009299(mRNA transcription);GO:0009303(rRNA transcription);GO:0009411(response to UV);GO:0009651(response to salt stress);GO:0009792(embryo development ending in birth or egg hatching);GO:0010165(response to X-ray);GO:0010332(response to gamma radiation);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010666(positive regulation of cardiac muscle cell apoptotic process);GO:0016032(viral process);GO:0016363(nuclear matrix);GO:0016604(nuclear body);GO:0016605(PML body);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0021549(cerebellum development);GO:0030308(negative regulation of cell growth);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030971(receptor tyrosine kinase binding);GO:0031065(positive regulation of histone deacetylation);GO:0031497(chromatin assembly);GO:0031571(mitotic G1 DNA damage checkpoint);GO:0031625(ubiquitin protein ligase binding);GO:0032461(positive regulation of protein oligomerization);GO:0032991(protein-containing complex);GO:0033077(T cell differentiation in thymus);GO:0034103(regulation of tissue remodeling);GO:0034644(cellular response to UV);GO:0035033(histone deacetylase regulator activity);GO:0035035(histone acetyltransferase binding);GO:0035264(multicellular organism growth);GO:0035690(cellular response to drug);GO:0035794(positive regulation of mitochondrial membrane permeability);GO:0035861(site of double-strand break);GO:0036003(positive regulation of transcription from RNA polymerase II promoter in response to stress);GO:0042127(regulation of cell population proliferation);GO:0042149(cellular response to glucose starvation);GO:0042493(response to drug);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043504(mitochondrial DNA repair);GO:0043516(regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043523(regulation of neuron apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0043621(protein self-association);GO:0044212(transcription regulatory region DNA binding);GO:0045861(negative regulation of proteolysis);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045899(positive regulation of RNA polymerase II transcriptional preinitiation complex assembly);GO:0045930(negative regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046677(response to antibiotic);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0047485(protein N-terminus binding);GO:0048147(negative regulation of fibroblast proliferation);GO:0048512(circadian behavior);GO:0048568(embryonic organ development);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050821(protein stabilization);GO:0051087(chaperone binding);GO:0051123(RNA polymerase II preinitiation complex assembly);GO:0051262(protein tetramerization);GO:0051276(chromosome organization);GO:0051289(protein homotetramerization);GO:0051402(neuron apoptotic process);GO:0051721(protein phosphatase 2A binding);GO:0051726(regulation of cell cycle);GO:0051974(negative regulation of telomerase activity);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0060411(cardiac septum morphogenesis);GO:0061419(positive regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0062100(positive regulation of programmed necrotic cell death);GO:0065003(protein-containing complex assembly);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070243(regulation of thymocyte apoptotic process);GO:0070245(positive regulation of thymocyte apoptotic process);GO:0070266(necroptotic process);GO:0071158(positive regulation of cell cycle arrest);GO:0071456(cellular response to hypoxia);GO:0071479(cellular response to ionizing radiation);GO:0071480(cellular response to gamma radiation);GO:0071494(cellular response to UV-C);GO:0071850(mitotic cell cycle arrest);GO:0072331(signal transduction by p53 class mediator);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0072363(regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter);GO:0072717(cellular response to actinomycin D);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090343(positive regulation of cell aging);GO:0090399(replicative senescence);GO:0090403(oxidative stress-induced premature senescence);GO:0097252(oligodendrocyte apoptotic process);GO:0097371(MDM2/MDM4 family protein binding);GO:0097718(disordered domain specific binding);GO:1900119(positive regulation of execution phase of apoptosis);GO:1901525(negative regulation of mitophagy);GO:1902108(regulation of mitochondrial membrane permeability involved in apoptotic process);GO:1902253(regulation of intrinsic apoptotic signaling pathway by p53 class mediator);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA);GO:1903800(positive regulation of production of miRNAs involved in gene silencing by miRNA);GO:1904024(negative regulation of glucose catabolic process to lactate via pyruvate);GO:1990144(intrinsic apoptotic signaling pathway in response to hypoxia);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress);GO:1990841(promoter-specific chromatin binding);GO:2000269(regulation of fibroblast apoptotic process);GO:2000378(negative regulation of reactive oxygen species metabolic process);GO:2000379(positive regulation of reactive oxygen species metabolic process);GO:2000772(regulation of cellular senescence);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","01522(Endocrine resistance);01524(Platinum drug resistance);04010(MAPK signaling pathway);04071(Sphingolipid signaling pathway);04110(Cell cycle);04115(p53 signaling pathway);04137(Mitophagy - animal);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04211(Longevity regulating pathway);04216(Ferroptosis);04218(Cellular senescence);04310(Wnt signaling pathway);04722(Neurotrophin signaling pathway);04919(Thyroid hormone signaling pathway);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington disease);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05216(Thyroid cancer);05217(Basal cell carcinoma);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05230(Central carbon metabolism in cancer);05418(Fluid shear stress and atherosclerosis)","K04451","NA","tumor protein p53 [Source:NCBI gene;Acc:443421]",{"v":3.83265464084268,"d":"3.83"},{"v":3.11566047944275,"d":"3.12"},{"v":3.51345625110432,"d":"3.51"},{"v":5.64231490180088,"d":"5.64"},{"v":4.25450312028542,"d":"4.25"},{"v":5.81044978831125,"d":"5.81"},{"v":0.666046539581155,"d":"0.67"},{"v":-0.586305106664225,"d":"-0.59"},{"v":0.118249207491793,"d":"0.12"},{"v":0.587897586524283,"d":"0.59"},"down","no"]
["MSTRG.1010","RGS5","ENSOART00000012081","GO:0005829(cytosol)","NA","K16449","NA","regulator of G protein signaling 5 [Source:NCBI gene;Acc:101110554]",{"v":40.1732461960243,"d":"40.17"},{"v":29.8484197719492,"d":"29.85"},{"v":29.2910767084484,"d":"29.29"},{"v":29.3000195571507,"d":"29.30"},{"v":23.8164885891773,"d":"23.82"},{"v":22.0759310955273,"d":"22.08"},{"v":1.32078096784417,"d":"1.32"},{"v":0.40139123660347,"d":"0.40"},{"v":0.11829241674366,"d":"0.12"},{"v":0.587897586524283,"d":"0.59"},"up","no"]
["MSTRG.16189","CSF2RB","ENSOART00000020792","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway)","04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04630(Jak-STAT signaling pathway);05200(Pathways in cancer)","K04738","NA","colony stimulating factor 2 receptor beta common subunit [Source:NCBI gene;Acc:101123199]",{"v":0.679936,"d":"0.68"},{"v":0.409359,"d":"0.41"},{"v":0.647193,"d":"0.65"},{"v":0.828266,"d":"0.83"},{"v":1.11404,"d":"1.11"},{"v":0.898641,"d":"0.90"},{"v":0.611235619671891,"d":"0.61"},{"v":-0.71019947620833,"d":"-0.71"},{"v":0.118845117540091,"d":"0.12"},{"v":0.589818565104742,"d":"0.59"},"down","no"]
["MSTRG.5917","ENSOARG00000013207","ENSOART00000014358","GO:0005509(calcium ion binding)","NA","NA","NA","reticulocalbin 3 [Source:NCBI gene;Acc:101106617]",{"v":1.86433125189621,"d":"1.86"},{"v":0.804345156087824,"d":"0.80"},{"v":2.63471190898204,"d":"2.63"},{"v":3.36419710419162,"d":"3.36"},{"v":2.46790261157685,"d":"2.47"},{"v":3.10690937724551,"d":"3.11"},{"v":0.59328592932194,"d":"0.59"},{"v":-0.753200527390613,"d":"-0.75"},{"v":0.118890498034233,"d":"0.12"},{"v":0.589864494652978,"d":"0.59"},"down","no"]
["MSTRG.14389","ERLIN2","ENSOART00000000753","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0031625(ubiquitin protein ligase binding);GO:0032933(SREBP signaling pathway);GO:0032991(protein-containing complex);GO:0045121(membrane raft);GO:0045541(negative regulation of cholesterol biosynthetic process);GO:0045717(negative regulation of fatty acid biosynthetic process)","NA","NA","NA","ER lipid raft associated 2 [Source:NCBI gene;Acc:101110479]",{"v":3.34661079911132,"d":"3.35"},{"v":2.57476380238541,"d":"2.57"},{"v":2.49470173292797,"d":"2.49"},{"v":4.35984069621141,"d":"4.36"},{"v":4.37007520884004,"d":"4.37"},{"v":3.90437358746492,"d":"3.90"},{"v":0.666129768469352,"d":"0.67"},{"v":-0.586124839377243,"d":"-0.59"},{"v":0.119242932590246,"d":"0.12"},{"v":0.591074257235439,"d":"0.59"},"down","no"]
["MSTRG.253","RAD54L","ENSOART00000002453","GO:0000724(double-strand break repair via homologous recombination);GO:0000733(DNA strand renaturation);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006302(double-strand break repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008340(determination of adult lifespan);GO:0010212(response to ionizing radiation);GO:0032991(protein-containing complex);GO:0036310(annealing helicase activity);GO:0042493(response to drug);GO:0051276(chromosome organization)","03440(Homologous recombination)","K10875","EC:3.6.4.-","RAD54 like [Source:NCBI gene;Acc:101102597]",{"v":0.531230485457064,"d":"0.53"},{"v":0.545197579639889,"d":"0.55"},{"v":0.101505468144044,"d":"0.10"},{"v":0.922569988919667,"d":"0.92"},{"v":0.638459966759003,"d":"0.64"},{"v":0.733262720914127,"d":"0.73"},{"v":0.513419035530515,"d":"0.51"},{"v":-0.961791308603231,"d":"-0.96"},{"v":0.119301338404536,"d":"0.12"},{"v":0.591184295438321,"d":"0.59"},"down","no"]
["MSTRG.11639","PHACTR1","ENSOART00000015057","GO:0003779(actin binding);GO:0004864(protein phosphatase inhibitor activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0008157(protein phosphatase 1 binding);GO:0019888(protein phosphatase regulator activity);GO:0031032(actomyosin structure organization);GO:0031532(actin cytoskeleton reorganization);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0043149(stress fiber assembly);GO:0043666(regulation of phosphoprotein phosphatase activity);GO:0048870(cell motility)","NA","NA","NA","phosphatase and actin regulator 1 [Source:HGNC Symbol;Acc:HGNC:20990]",{"v":0.578647868761553,"d":"0.58"},{"v":0.437430130868762,"d":"0.44"},{"v":0.878375553049908,"d":"0.88"},{"v":1.11933608650647,"d":"1.12"},{"v":0.935999006284658,"d":"0.94"},{"v":1.09416559297597,"d":"1.09"},{"v":0.601509172943332,"d":"0.60"},{"v":-0.733341356390503,"d":"-0.73"},{"v":0.119388296235122,"d":"0.12"},{"v":0.591343762765562,"d":"0.59"},"down","no"]
["MSTRG.13337","C16orf72","ENSOART00000006053","NA","NA","NA","NA","chromosome 16 open reading frame 72 [Source:HGNC Symbol;Acc:HGNC:30103]",{"v":12.9063563951191,"d":"12.91"},{"v":13.3110816226824,"d":"13.31"},{"v":11.2380284390154,"d":"11.24"},{"v":11.6777330515028,"d":"11.68"},{"v":9.42517704342084,"d":"9.43"},{"v":7.39440989503988,"d":"7.39"},{"v":1.31435048874801,"d":"1.31"},{"v":0.39435004046524,"d":"0.39"},{"v":0.119499845541232,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"up","no"]
["MSTRG.11954","SYT7","ENSOART00000014335","GO:0005544(calcium-dependent phospholipid binding);GO:0005829(cytosol);GO:0006887(exocytosis);GO:0016020(membrane)","NA","K19907","NA","synaptotagmin 7 [Source:NCBI gene;Acc:101109661]",{"v":0.592748,"d":"0.59"},{"v":0.4298,"d":"0.43"},{"v":0.188862,"d":"0.19"},{"v":0.795224,"d":"0.80"},{"v":0.734065,"d":"0.73"},{"v":0.66191,"d":"0.66"},{"v":0.552852570670213,"d":"0.55"},{"v":-0.855033286977531,"d":"-0.86"},{"v":0.119619721816544,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"down","no"]
["MSTRG.12990","RALBP1","ENSOART00000001157","GO:0005096(GTPase activator activity);GO:0006855(drug transmembrane transport);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0015238(drug transmembrane transporter activity);GO:0016020(membrane);GO:0017160(Ral GTPase binding);GO:0022857(transmembrane transporter activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048365(Rac GTPase binding);GO:0055085(transmembrane transport);GO:1900753(doxorubicin transport)","04014(Ras signaling pathway);05200(Pathways in cancer);05212(Pancreatic cancer)","K08773","NA","ralA binding protein 1 [Source:NCBI gene;Acc:101107653]",{"v":2.17401197780399,"d":"2.17"},{"v":1.85860941882908,"d":"1.86"},{"v":1.95973826914004,"d":"1.96"},{"v":1.62226618528844,"d":"1.62"},{"v":1.61543056315677,"d":"1.62"},{"v":1.26916330913575,"d":"1.27"},{"v":1.32960854990236,"d":"1.33"},{"v":0.4110015643434,"d":"0.41"},{"v":0.119679591023471,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"up","no"]
["MSTRG.4113","KAZN","ENSOART00000011461","GO:0001533(cornified envelope);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0030057(desmosome)","NA","NA","NA","kazrin, periplakin interacting protein [Source:NCBI gene;Acc:101110432]",{"v":0.478441,"d":"0.48"},{"v":0.303766,"d":"0.30"},{"v":0.345824,"d":"0.35"},{"v":0.589976,"d":"0.59"},{"v":0.538037,"d":"0.54"},{"v":0.842213,"d":"0.84"},{"v":0.572538886401865,"d":"0.57"},{"v":-0.804554411609817,"d":"-0.80"},{"v":0.119727738036134,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"down","no"]
["ENSOARG00000005032","PTPN6","ENSOART00000005483","GO:0001784(phosphotyrosine residue binding);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002924(negative regulation of humoral immune response mediated by circulating immunoglobulin);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005001(transmembrane receptor protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005911(cell-cell junction);GO:0006470(protein dephosphorylation);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0017124(SH3 domain binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019901(protein kinase binding);GO:0030154(cell differentiation);GO:0030220(platelet formation);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032991(protein-containing complex);GO:0033277(abortive mitotic cell cycle);GO:0033630(positive regulation of cell adhesion mediated by integrin);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0035556(intracellular signal transduction);GO:0035855(megakaryocyte development);GO:0042105(alpha-beta T cell receptor complex);GO:0042130(negative regulation of T cell proliferation);GO:0042169(SH2 domain binding);GO:0042267(natural killer cell mediated cytotoxicity);GO:0043407(negative regulation of MAP kinase activity);GO:0043409(negative regulation of MAPK cascade);GO:0045577(regulation of B cell differentiation);GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation);GO:0050839(cell adhesion molecule binding);GO:0050853(B cell receptor signaling pathway);GO:0050859(negative regulation of B cell receptor signaling pathway);GO:0050860(negative regulation of T cell receptor signaling pathway);GO:0051279(regulation of release of sequestered calcium ion into cytosol);GO:0070372(regulation of ERK1 and ERK2 cascade);GO:0070527(platelet aggregation);GO:0140031(phosphorylation-dependent protein binding);GO:2000045(regulation of G1/S transition of mitotic cell cycle)","04520(Adherens junction);04630(Jak-STAT signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);05140(Leishmaniasis);05205(Proteoglycans in cancer)","K05697","EC:3.1.3.48","protein tyrosine phosphatase, non-receptor type 6 [Source:NCBI gene;Acc:101108643]",{"v":0.964533,"d":"0.96"},{"v":0.438142,"d":"0.44"},{"v":0.814287,"d":"0.81"},{"v":1.260036,"d":"1.26"},{"v":0.836235,"d":"0.84"},{"v":1.698724,"d":"1.70"},{"v":0.584180479816179,"d":"0.58"},{"v":-0.775513943058677,"d":"-0.78"},{"v":0.119743395012606,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"down","no"]
["MSTRG.10288","SCN9A","ENSOART00000005097;ENSOART00000005098","GO:0001518(voltage-gated sodium channel complex);GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005272(sodium channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0006954(inflammatory response);GO:0009636(response to toxic substance);GO:0009791(post-embryonic development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019233(sensory perception of pain);GO:0034220(ion transmembrane transport);GO:0034765(regulation of ion transmembrane transport);GO:0035725(sodium ion transmembrane transport);GO:0048266(behavioral response to pain);GO:0055085(transmembrane transport);GO:0055085(transmembrane transport)","04742(Taste transduction);04742(Taste transduction)","K04841","NA","sodium voltage-gated channel alpha subunit 9 [Source:NCBI gene;Acc:101122924]",{"v":0.0731756621004566,"d":"0.07"},{"v":0.0513481680365297,"d":"0.05"},{"v":0.0724016182648402,"d":"0.07"},{"v":0.185079945205479,"d":"0.19"},{"v":0.138293187214612,"d":"0.14"},{"v":0.0572061616438356,"d":"0.06"},{"v":0.517436054649753,"d":"0.52"},{"v":-0.950547511193003,"d":"-0.95"},{"v":0.11975837347096,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"down","no"]
["MSTRG.13206","ENSOARG00000016438","ENSOART00000017902","GO:0003677(DNA binding);GO:0004518(nuclease activity);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0048476(Holliday junction resolvase complex);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","NA","NA","NA",null,{"v":1.210281,"d":"1.21"},{"v":1.097616,"d":"1.10"},{"v":0.859967,"d":"0.86"},{"v":1.644516,"d":"1.64"},{"v":2.311075,"d":"2.31"},{"v":1.233153,"d":"1.23"},{"v":0.610526169724311,"d":"0.61"},{"v":-0.711874958360506,"d":"-0.71"},{"v":0.119776836881941,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"down","no"]
["MSTRG.2265","ENSOARG00000012610","ENSOART00000013708","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02889","NA","ribosomal protein L21 [Source:NCBI gene;Acc:101115288]",{"v":27.6544798688616,"d":"27.65"},{"v":29.4835190904018,"d":"29.48"},{"v":38.9123670530134,"d":"38.91"},{"v":41.5636511534598,"d":"41.56"},{"v":47.5380916344866,"d":"47.54"},{"v":57.5772084810268,"d":"57.58"},{"v":0.654834011160497,"d":"0.65"},{"v":-0.610798839571467,"d":"-0.61"},{"v":0.119792889767311,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"down","no"]
["MSTRG.16078","MYBPC1","ENSOART00000016451","GO:0005515(protein binding);GO:0006936(muscle contraction)","NA","K12557","NA","myosin binding protein C, slow type [Source:NCBI gene;Acc:101107588]",{"v":108.256388907549,"d":"108.26"},{"v":128.989228566011,"d":"128.99"},{"v":123.066655031622,"d":"123.07"},{"v":68.7274678874691,"d":"68.73"},{"v":106.988935009716,"d":"106.99"},{"v":89.2133323967142,"d":"89.21"},{"v":1.36002956446346,"d":"1.36"},{"v":0.443638013270634,"d":"0.44"},{"v":0.119815052953608,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"up","no"]
["MSTRG.5137","NFATC2","ENSOART00000015513","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001816(cytokine production);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006974(cellular response to DNA damage stimulus);GO:0008134(transcription factor binding);GO:0010628(positive regulation of gene expression);GO:0014904(myotube cell development);GO:0016477(cell migration);GO:0019902(phosphatase binding);GO:0030890(positive regulation of B cell proliferation);GO:0033173(calcineurin-NFAT signaling cascade);GO:0042493(response to drug);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0044798(nuclear transcription factor complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050853(B cell receptor signaling pathway);GO:1901741(positive regulation of myoblast fusion);GO:1905064(negative regulation of vascular smooth muscle cell differentiation);GO:1990904(ribonucleoprotein complex)","NA","NA","NA","nuclear factor of activated T cells 2 [Source:HGNC Symbol;Acc:HGNC:7776]",{"v":2.08218218029266,"d":"2.08"},{"v":3.05643014619412,"d":"3.06"},{"v":3.43660140931669,"d":"3.44"},{"v":2.00492645348369,"d":"2.00"},{"v":2.20805727198282,"d":"2.21"},{"v":2.08210658544771,"d":"2.08"},{"v":1.36220662647779,"d":"1.36"},{"v":0.445945555321414,"d":"0.45"},{"v":0.119842745574019,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"up","no"]
["MSTRG.14957","KIF3C","ENSOART00000020098;ENSOART00000020097","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0072384(organelle transport along microtubule);GO:0072384(organelle transport along microtubule)","NA","K20197","NA","kinesin family member 3C [Source:NCBI gene;Acc:101109434]",{"v":3.22566593319559,"d":"3.23"},{"v":3.79048226101928,"d":"3.79"},{"v":4.08201954028926,"d":"4.08"},{"v":2.73083596625344,"d":"2.73"},{"v":2.74012796280992,"d":"2.74"},{"v":2.78379940358127,"d":"2.78"},{"v":1.344456199079,"d":"1.34"},{"v":0.427022754540761,"d":"0.43"},{"v":0.119853540433524,"d":"0.12"},{"v":0.591407859836382,"d":"0.59"},"up","no"]
["MSTRG.22114","FHL1","ENSOART00000012416;ENSOART00000012418","GO:0046872(metal ion binding);GO:0046872(metal ion binding)","04630(Jak-STAT signaling pathway);04630(Jak-STAT signaling pathway)","K14365","NA","four and a half LIM domains 1 [Source:NCBI gene;Acc:100307044]",{"v":447.062729755024,"d":"447.06"},{"v":257.612292658612,"d":"257.61"},{"v":228.697636191866,"d":"228.70"},{"v":403.997457916268,"d":"404.00"},{"v":476.070239058613,"d":"476.07"},{"v":541.09799913134,"d":"541.10"},{"v":0.656765541951091,"d":"0.66"},{"v":-0.606549658637008,"d":"-0.61"},{"v":0.120077760738746,"d":"0.12"},{"v":0.59233524995234,"d":"0.59"},"down","no"]
["MSTRG.11957","DAGLA","ENSOART00000014519","GO:0006629(lipid metabolic process);GO:0007216(G protein-coupled glutamate receptor signaling pathway);GO:0007405(neuroblast proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0019369(arachidonic acid metabolic process);GO:0022008(neurogenesis);GO:0042136(neurotransmitter biosynthetic process);GO:0043196(varicosity);GO:0045211(postsynaptic membrane);GO:0046340(diacylglycerol catabolic process);GO:0071926(endocannabinoid signaling pathway);GO:0098921(retrograde trans-synaptic signaling by endocannabinoid);GO:0099055(integral component of postsynaptic membrane)","NA","NA","NA","diacylglycerol lipase alpha [Source:HGNC Symbol;Acc:HGNC:1165]",{"v":0.53585043880597,"d":"0.54"},{"v":0.473751914925373,"d":"0.47"},{"v":1.01813993097015,"d":"1.02"},{"v":1.39468010932836,"d":"1.39"},{"v":1.00686923432836,"d":"1.01"},{"v":1.05779628358209,"d":"1.06"},{"v":0.586163541663804,"d":"0.59"},{"v":-0.770624857150858,"d":"-0.77"},{"v":0.120212077944833,"d":"0.12"},{"v":0.592639736921264,"d":"0.59"},"down","no"]
["MSTRG.12784","CTDP1","ENSOART00000004540","GO:0000922(spindle pole);GO:0001096(TFIIF-class transcription factor complex binding);GO:0004721(phosphoprotein phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005819(spindle);GO:0006470(protein dephosphorylation);GO:0008420(RNA polymerase II CTD heptapeptide repeat phosphatase activity);GO:0010458(exit from mitosis);GO:0030496(midbody);GO:0030957(Tat protein binding);GO:0032991(protein-containing complex);GO:0043231(intracellular membrane-bounded organelle);GO:0043923(positive regulation by host of viral transcription);GO:0051233(spindle midzone);GO:0070940(dephosphorylation of RNA polymerase II C-terminal domain)","NA","NA","NA","CTD phosphatase subunit 1 [Source:HGNC Symbol;Acc:HGNC:2498]",{"v":1.23854197896213,"d":"1.24"},{"v":1.06876052945302,"d":"1.07"},{"v":1.57356626788219,"d":"1.57"},{"v":1.71737399789621,"d":"1.72"},{"v":2.39775927910238,"d":"2.40"},{"v":1.9909208997195,"d":"1.99"},{"v":0.635577193385344,"d":"0.64"},{"v":-0.653860737948242,"d":"-0.65"},{"v":0.120424494270555,"d":"0.12"},{"v":0.593507739948574,"d":"0.59"},"down","no"]
["MSTRG.18976","IGFBP7","ENSOART00000006270","GO:0001558(regulation of cell growth);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region)","NA","NA","NA","insulin like growth factor binding protein 7 [Source:NCBI gene;Acc:100270713]",{"v":43.1452858561644,"d":"43.15"},{"v":27.9845430422374,"d":"27.98"},{"v":31.6405651883562,"d":"31.64"},{"v":56.0685454452055,"d":"56.07"},{"v":37.9224394063927,"d":"37.92"},{"v":61.9573242123288,"d":"61.96"},{"v":0.659002939522928,"d":"0.66"},{"v":-0.601643194410192,"d":"-0.60"},{"v":0.120559305272965,"d":"0.12"},{"v":0.59399285953439,"d":"0.59"},"down","no"]
["MSTRG.12813","FBXO15","ENSOART00000005179","GO:0005515(protein binding)","NA","K10298","NA","F-box protein 15 [Source:NCBI gene;Acc:101101855]",{"v":1.074703,"d":"1.07"},{"v":0.834635,"d":"0.83"},{"v":1.219723,"d":"1.22"},{"v":0.59372,"d":"0.59"},{"v":0.844323,"d":"0.84"},{"v":0.574575,"d":"0.57"},{"v":1.55472176041355,"d":"1.55"},{"v":0.636656412646001,"d":"0.64"},{"v":0.120702310902313,"d":"0.12"},{"v":0.594159581674095,"d":"0.59"},"up","no"]
["MSTRG.18989","UBA6","ENSOART00000007899","GO:0004839(ubiquitin activating enzyme activity);GO:0005737(cytoplasm);GO:0006464(cellular protein modification process);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007612(learning);GO:0007626(locomotory behavior);GO:0008641(ubiquitin-like modifier activating enzyme activity);GO:0016567(protein ubiquitination);GO:0019780(FAT10 activating enzyme activity);GO:0021764(amygdala development);GO:0021766(hippocampus development);GO:0060996(dendritic spine development)","04120(Ubiquitin mediated proteolysis)","K10699","EC:6.2.1.45","ubiquitin like modifier activating enzyme 6 [Source:NCBI gene;Acc:101115278]",{"v":5.108232,"d":"5.11"},{"v":3.878855,"d":"3.88"},{"v":4.249481,"d":"4.25"},{"v":3.818681,"d":"3.82"},{"v":3.247063,"d":"3.25"},{"v":2.964282,"d":"2.96"},{"v":1.31969428593705,"d":"1.32"},{"v":0.400203760459012,"d":"0.40"},{"v":0.120829894617708,"d":"0.12"},{"v":0.594513278665935,"d":"0.59"},"up","no"]
["MSTRG.19131","EVC","ENSOART00000007273","GO:0003416(endochondral bone growth);GO:0005929(cilium);GO:0007224(smoothened signaling pathway);GO:0036064(ciliary basal body);GO:0045880(positive regulation of smoothened signaling pathway);GO:0060170(ciliary membrane);GO:0098797(plasma membrane protein complex)","04340(Hedgehog signaling pathway)","K19605","NA","ellis-van Creveld syndrome protein [Source:NCBI gene;Acc:101113496]",{"v":0.956997,"d":"0.96"},{"v":0.664355,"d":"0.66"},{"v":1.064538,"d":"1.06"},{"v":1.415926,"d":"1.42"},{"v":1.413267,"d":"1.41"},{"v":1.29076,"d":"1.29"},{"v":0.6519224855235,"d":"0.65"},{"v":-0.617227658650236,"d":"-0.62"},{"v":0.120846985049745,"d":"0.12"},{"v":0.594513278665935,"d":"0.59"},"down","no"]
["MSTRG.16051","CDK17","ENSOART00000013542","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K15595","EC:2.7.11.22","cyclin dependent kinase 17 [Source:NCBI gene;Acc:101122426]",{"v":2.18306222941773,"d":"2.18"},{"v":2.4604114002703,"d":"2.46"},{"v":2.18387578285843,"d":"2.18"},{"v":1.99523031664602,"d":"2.00"},{"v":1.71089604978038,"d":"1.71"},{"v":1.49754156582949,"d":"1.50"},{"v":1.31202634399976,"d":"1.31"},{"v":0.391796687925691,"d":"0.39"},{"v":0.121143606229891,"d":"0.12"},{"v":0.595370558723177,"d":"0.60"},"up","no"]
["ENSOARG00000014614","ENSOARG00000014614","ENSOART00000015905","GO:0005216(ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)","NA","NA","NA",null,{"v":0.390747,"d":"0.39"},{"v":0.234221,"d":"0.23"},{"v":0.230738,"d":"0.23"},{"v":0.646013,"d":"0.65"},{"v":0.41414,"d":"0.41"},{"v":0.432111,"d":"0.43"},{"v":0.573428026140147,"d":"0.57"},{"v":-0.802315677254673,"d":"-0.80"},{"v":0.121350658363142,"d":"0.12"},{"v":0.595370558723177,"d":"0.60"},"down","no"]
["MSTRG.17580","RAB3A","ENSOART00000014323","GO:0001669(acrosomal vesicle);GO:0001778(plasma membrane repair);GO:0003016(respiratory system process);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005768(endosome);GO:0006887(exocytosis);GO:0007005(mitochondrion organization);GO:0007274(neuromuscular synaptic transmission);GO:0007409(axonogenesis);GO:0008021(synaptic vesicle);GO:0009791(post-embryonic development);GO:0016079(synaptic vesicle exocytosis);GO:0016188(synaptic vesicle maturation);GO:0017156(calcium ion regulated exocytosis);GO:0017157(regulation of exocytosis);GO:0030324(lung development);GO:0030742(GTP-dependent protein binding);GO:0031489(myosin V binding);GO:0031630(regulation of synaptic vesicle fusion to presynaptic active zone membrane);GO:0032418(lysosome localization);GO:0043195(terminal bouton);GO:0045055(regulated exocytosis);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048471(perinuclear region of cytoplasm);GO:0048489(synaptic vesicle transport);GO:0048786(presynaptic active zone);GO:0048790(maintenance of presynaptic active zone structure);GO:0050975(sensory perception of touch);GO:0051602(response to electrical stimulus);GO:0060478(acrosomal vesicle exocytosis);GO:0061670(evoked neurotransmitter secretion);GO:0097091(synaptic vesicle clustering);GO:0098993(anchored component of synaptic vesicle membrane);GO:1903307(positive regulation of regulated secretory pathway);GO:1905684(regulation of plasma membrane repair)","04721(Synaptic vesicle cycle);04911(Insulin secretion)","K07882","NA","RAB3A, member RAS oncogene family [Source:NCBI gene;Acc:101109534]",{"v":1.456881275,"d":"1.46"},{"v":2.891125425,"d":"2.89"},{"v":2.4854078,"d":"2.49"},{"v":4.205820075,"d":"4.21"},{"v":3.371958425,"d":"3.37"},{"v":3.95895605,"d":"3.96"},{"v":0.592317910270372,"d":"0.59"},{"v":-0.755556384463404,"d":"-0.76"},{"v":0.121382581094491,"d":"0.12"},{"v":0.595370558723177,"d":"0.60"},"down","no"]
["MSTRG.9962","ENSOARG00000008968","ENSOART00000009769","GO:0006596(polyamine biosynthetic process);GO:0006597(spermine biosynthetic process);GO:0016740(transferase activity);GO:0016768(spermine synthase activity)","00270(Cysteine and methionine metabolism);00330(Arginine and proline metabolism);00410(beta-Alanine metabolism);00480(Glutathione metabolism)","K00802","EC:2.5.1.22","spermine synthase [Source:NCBI gene;Acc:101112287]",{"v":5.451561,"d":"5.45"},{"v":5.8351,"d":"5.84"},{"v":5.86891,"d":"5.87"},{"v":3.553414,"d":"3.55"},{"v":4.905976,"d":"4.91"},{"v":3.927683,"d":"3.93"},{"v":1.38495760862958,"d":"1.38"},{"v":0.469841818328003,"d":"0.47"},{"v":0.121410950853558,"d":"0.12"},{"v":0.595370558723177,"d":"0.60"},"up","no"]
["MSTRG.6142","TRIM28","ENSOART00000004293","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0001701(in utero embryonic development);GO:0001837(epithelial to mesenchymal transition);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0004672(protein kinase activity);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005719(nuclear euchromatin);GO:0005720(nuclear heterochromatin);GO:0006281(DNA repair);GO:0006468(protein phosphorylation);GO:0007265(Ras protein signal transduction);GO:0007566(embryo implantation);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0016925(protein sumoylation);GO:0031625(ubiquitin protein ligase binding);GO:0035851(Krueppel-associated box domain binding);GO:0042307(positive regulation of protein import into nucleus);GO:0043045(DNA methylation involved in embryo development);GO:0043388(positive regulation of DNA binding);GO:0043565(sequence-specific DNA binding);GO:0045087(innate immune response);GO:0045739(positive regulation of DNA repair);GO:0045869(negative regulation of single stranded viral RNA replication via double stranded DNA intermediate);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0051259(protein complex oligomerization);GO:0060028(convergent extension involved in axis elongation);GO:0060669(embryonic placenta morphogenesis);GO:0070087(chromo shadow domain binding);GO:0090309(positive regulation of methylation-dependent chromatin silencing);GO:0090575(RNA polymerase II transcription factor complex);GO:1901536(negative regulation of DNA demethylation);GO:1902187(negative regulation of viral release from host cell);GO:1990841(promoter-specific chromatin binding);GO:2000653(regulation of genetic imprinting)","NA","K08882","EC:2.3.2.27","tripartite motif containing 28 [Source:NCBI gene;Acc:101121196]",{"v":22.3485861674074,"d":"22.35"},{"v":18.1522936992593,"d":"18.15"},{"v":20.3071178148148,"d":"20.31"},{"v":26.2565194948148,"d":"26.26"},{"v":31.8499490177778,"d":"31.85"},{"v":32.5541031896296,"d":"32.55"},{"v":0.670721533515225,"d":"0.67"},{"v":-0.576214174366022,"d":"-0.58"},{"v":0.121458802738051,"d":"0.12"},{"v":0.595370558723177,"d":"0.60"},"down","no"]
["MSTRG.5219","ADAT1","ENSOART00000007496","GO:0003723(RNA binding);GO:0004000(adenosine deaminase activity);GO:0006396(RNA processing);GO:0008033(tRNA processing);GO:0008251(tRNA-specific adenosine deaminase activity)","NA","K15440","EC:3.5.4.34","adenosine deaminase, tRNA specific 1 [Source:NCBI gene;Acc:101118042]",{"v":1.028634,"d":"1.03"},{"v":1.108553,"d":"1.11"},{"v":0.860483,"d":"0.86"},{"v":1.537673,"d":"1.54"},{"v":1.697308,"d":"1.70"},{"v":1.615262,"d":"1.62"},{"v":0.618045322677647,"d":"0.62"},{"v":-0.694215456750041,"d":"-0.69"},{"v":0.121785625607473,"d":"0.12"},{"v":0.596728173406257,"d":"0.60"},"down","no"]
["MSTRG.9683","TBC1D2","ENSOART00000012075","GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0030054(cell junction);GO:0031410(cytoplasmic vesicle);GO:0043547(positive regulation of GTPase activity);GO:0045296(cadherin binding)","NA","K20165","NA","TBC1 domain family member 2 [Source:NCBI gene;Acc:101102700]",{"v":0.456334,"d":"0.46"},{"v":0.644465,"d":"0.64"},{"v":0.296226,"d":"0.30"},{"v":0.352116,"d":"0.35"},{"v":0.215822,"d":"0.22"},{"v":0.30972,"d":"0.31"},{"v":1.59176467371117,"d":"1.59"},{"v":0.670627063793141,"d":"0.67"},{"v":0.121866363331665,"d":"0.12"},{"v":0.596728173406257,"d":"0.60"},"up","no"]
["MSTRG.17323","KDM7A","ENSOART00000013634","GO:0005506(iron ion binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0008270(zinc ion binding);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0032454(histone demethylase activity (H3-K9 specific));GO:0033169(histone H3-K9 demethylation);GO:0035064(methylated histone binding);GO:0035574(histone H4-K20 demethylation);GO:0035575(histone demethylase activity (H4-K20 specific));GO:0045893(positive regulation of transcription, DNA-templated);GO:0051864(histone demethylase activity (H3-K36 specific));GO:0055114(oxidation-reduction process);GO:0070544(histone H3-K36 demethylation);GO:0071557(histone H3-K27 demethylation);GO:0071558(histone demethylase activity (H3-K27 specific))","NA","K11445","EC:1.14.11.-","lysine demethylase 7A [Source:NCBI gene;Acc:101111627]",{"v":10.127461,"d":"10.13"},{"v":10.164477,"d":"10.16"},{"v":7.733857,"d":"7.73"},{"v":8.740776,"d":"8.74"},{"v":6.90843,"d":"6.91"},{"v":5.513041,"d":"5.51"},{"v":1.32432983132651,"d":"1.32"},{"v":0.405262477702676,"d":"0.41"},{"v":0.121892005689031,"d":"0.12"},{"v":0.596728173406257,"d":"0.60"},"up","no"]
["MSTRG.3352","HEXIM2","ENSOART00000010726","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0017069(snRNA binding);GO:0042802(identical protein binding);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045892(negative regulation of transcription, DNA-templated);GO:0097322(7SK snRNA binding)","NA","K15189","NA","HEXIM P-TEFb complex subunit 2 [Source:NCBI gene;Acc:101118541]",{"v":8.5454732440489,"d":"8.55"},{"v":7.65245571670598,"d":"7.65"},{"v":7.86492786639502,"d":"7.86"},{"v":6.79162405039674,"d":"6.79"},{"v":5.50967203667167,"d":"5.51"},{"v":5.91224785974694,"d":"5.91"},{"v":1.32115182511514,"d":"1.32"},{"v":0.401796268821276,"d":"0.40"},{"v":0.121941428157807,"d":"0.12"},{"v":0.596728173406257,"d":"0.60"},"up","no"]
["MSTRG.21045","ZHX2","ENSOART00000021955","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006402(mRNA catabolic process);GO:0035019(somatic stem cell population maintenance);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045665(negative regulation of neuron differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0060040(retinal bipolar neuron differentiation)","NA","NA","NA","zinc fingers and homeoboxes 2 [Source:NCBI gene;Acc:101109810]",{"v":5.36839364665764,"d":"5.37"},{"v":1.72471460770487,"d":"1.72"},{"v":6.2921815542085,"d":"6.29"},{"v":4.22148550445224,"d":"4.22"},{"v":2.93642321817719,"d":"2.94"},{"v":1.71310835458135,"d":"1.71"},{"v":1.50887882325886,"d":"1.51"},{"v":0.593476948937361,"d":"0.59"},{"v":0.122074153111847,"d":"0.12"},{"v":0.596989213774635,"d":"0.60"},"up","no"]
["MSTRG.20034","ZBTB1","ENSOART00000001074","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002711(positive regulation of T cell mediated immunity);GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006338(chromatin remodeling);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0019985(translesion synthesis);GO:0030183(B cell differentiation);GO:0031965(nuclear membrane);GO:0032825(positive regulation of natural killer cell differentiation);GO:0033077(T cell differentiation in thymus);GO:0034644(cellular response to UV);GO:0042789(mRNA transcription by RNA polymerase II);GO:0042803(protein homodimerization activity);GO:0045582(positive regulation of T cell differentiation);GO:0046982(protein heterodimerization activity);GO:0048538(thymus development);GO:0051260(protein homooligomerization);GO:0070530(K63-linked polyubiquitin modification-dependent protein binding);GO:2000176(positive regulation of pro-T cell differentiation)","NA","K10488","NA","zinc finger and BTB domain containing 1 [Source:NCBI gene;Acc:101109805]",{"v":3.350325,"d":"3.35"},{"v":3.601816,"d":"3.60"},{"v":3.107574,"d":"3.11"},{"v":2.498845,"d":"2.50"},{"v":1.953361,"d":"1.95"},{"v":2.807747,"d":"2.81"},{"v":1.3856446453579,"d":"1.39"},{"v":0.470557319443145,"d":"0.47"},{"v":0.122098832181372,"d":"0.12"},{"v":0.596989213774635,"d":"0.60"},"up","no"]
["MSTRG.15998","CNPY2","ENSOART00000010236","GO:0010629(negative regulation of gene expression);GO:0010988(regulation of low-density lipoprotein particle clearance);GO:0045716(positive regulation of low-density lipoprotein particle receptor biosynthetic process)","NA","K22936","NA","canopy FGF signaling regulator 2 [Source:NCBI gene;Acc:101108903]",{"v":3.58923845124283,"d":"3.59"},{"v":2.65668785914595,"d":"2.66"},{"v":2.7908808362014,"d":"2.79"},{"v":4.6995405347355,"d":"4.70"},{"v":3.90089156978968,"d":"3.90"},{"v":5.39564243913321,"d":"5.40"},{"v":0.645667263231657,"d":"0.65"},{"v":-0.631137213799675,"d":"-0.63"},{"v":0.122139653103614,"d":"0.12"},{"v":0.596989213774635,"d":"0.60"},"down","no"]
["MSTRG.17918","NMRK2","ENSOART00000012310","GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0045662(negative regulation of myoblast differentiation)","00760(Nicotinate and nicotinamide metabolism)","K10524","2.7.1.173;EC:2.7.1.22","nicotinamide riboside kinase 2 [Source:NCBI gene;Acc:101114607]",{"v":22.246542831251,"d":"22.25"},{"v":23.2188813017555,"d":"23.22"},{"v":27.0499913599557,"d":"27.05"},{"v":31.2817517466393,"d":"31.28"},{"v":38.8381765407243,"d":"38.84"},{"v":38.0525673161474,"d":"38.05"},{"v":0.670368332434114,"d":"0.67"},{"v":-0.576974095789448,"d":"-0.58"},{"v":0.122154640079682,"d":"0.12"},{"v":0.596989213774635,"d":"0.60"},"down","no"]
["MSTRG.5061","ADA","ENSOART00000004534","GO:0001666(response to hypoxia);GO:0001701(in utero embryonic development);GO:0001829(trophectodermal cell differentiation);GO:0001889(liver development);GO:0001890(placenta development);GO:0002314(germinal center B cell differentiation);GO:0002636(positive regulation of germinal center formation);GO:0002686(negative regulation of leukocyte migration);GO:0002906(negative regulation of mature B cell apoptotic process);GO:0004000(adenosine deaminase activity);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006154(adenosine catabolic process);GO:0006157(deoxyadenosine catabolic process);GO:0008270(zinc ion binding);GO:0009168(purine ribonucleoside monophosphate biosynthetic process);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010460(positive regulation of heart rate);GO:0016020(membrane);GO:0019239(deaminase activity);GO:0030324(lung development);GO:0030890(positive regulation of B cell proliferation);GO:0032261(purine nucleotide salvage);GO:0033089(positive regulation of T cell differentiation in thymus);GO:0033632(regulation of cell-cell adhesion mediated by integrin);GO:0042110(T cell activation);GO:0043066(negative regulation of apoptotic process);GO:0045580(regulation of T cell differentiation);GO:0045582(positive regulation of T cell differentiation);GO:0045987(positive regulation of smooth muscle contraction);GO:0046061(dATP catabolic process);GO:0046101(hypoxanthine biosynthetic process);GO:0046103(inosine biosynthetic process);GO:0046111(xanthine biosynthetic process);GO:0046638(positive regulation of alpha-beta T cell differentiation);GO:0048286(lung alveolus development);GO:0048541(Peyer's patch development);GO:0048566(embryonic digestive tract development);GO:0050728(negative regulation of inflammatory response);GO:0050850(positive regulation of calcium-mediated signaling);GO:0050862(positive regulation of T cell receptor signaling pathway);GO:0050870(positive regulation of T cell activation);GO:0060169(negative regulation of adenosine receptor signaling pathway);GO:0060407(negative regulation of penile erection);GO:0070244(negative regulation of thymocyte apoptotic process);GO:0070256(negative regulation of mucus secretion)","NA","NA","NA","adenosine deaminase [Source:HGNC Symbol;Acc:HGNC:186]",{"v":1.29381917808989,"d":"1.29"},{"v":0.89938367247191,"d":"0.90"},{"v":0.70748206235955,"d":"0.71"},{"v":1.39805224747191,"d":"1.40"},{"v":1.76230305337079,"d":"1.76"},{"v":1.39181208623595,"d":"1.39"},{"v":0.637209633625283,"d":"0.64"},{"v":-0.650160016538954,"d":"-0.65"},{"v":0.122195497264906,"d":"0.12"},{"v":0.597010197289462,"d":"0.60"},"down","no"]
["MSTRG.3754","PFKFB2","ENSOART00000007645","GO:0003824(catalytic activity);GO:0003873(6-phosphofructo-2-kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006000(fructose metabolic process);GO:0006003(fructose 2,6-bisphosphate metabolic process);GO:0006096(glycolytic process);GO:0019901(protein kinase binding);GO:0046835(carbohydrate phosphorylation)","00051(Fructose and mannose metabolism);04152(AMPK signaling pathway);04919(Thyroid hormone signaling pathway)","K19029","3.1.3.46;EC:2.7.1.105","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 [Source:NCBI gene;Acc:101119324]",{"v":1.8463240591733,"d":"1.85"},{"v":4.403791,"d":"4.40"},{"v":3.119813,"d":"3.12"},{"v":2.533863,"d":"2.53"},{"v":2.374926,"d":"2.37"},{"v":1.83058,"d":"1.83"},{"v":1.39032720410076,"d":"1.39"},{"v":0.475424451424753,"d":"0.48"},{"v":0.122641190762706,"d":"0.12"},{"v":0.5986503326677,"d":"0.60"},"up","no"]
["MSTRG.18597","ENSOARG00000000241","ENSOART00000000253","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","03010(Ribosome)","K02940","NA","60S ribosomal protein L9 [Source:NCBI gene;Acc:101107098]",{"v":12.506771,"d":"12.51"},{"v":11.453794,"d":"11.45"},{"v":8.728065,"d":"8.73"},{"v":9.211206,"d":"9.21"},{"v":23.420481,"d":"23.42"},{"v":20.116947,"d":"20.12"},{"v":0.619705715981195,"d":"0.62"},{"v":-0.690344819526536,"d":"-0.69"},{"v":0.122722891390078,"d":"0.12"},{"v":0.598870104786967,"d":"0.60"},"down","no"]
["MSTRG.8626","ENSOARG00000008354","ENSOART00000009091","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0007154(cell communication);GO:0007275(multicellular organism development);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.527080403331872,"d":"0.53"},{"v":0.513227531784305,"d":"0.51"},{"v":0.372992952652345,"d":"0.37"},{"v":1.02632538360368,"d":"1.03"},{"v":0.855698016220956,"d":"0.86"},{"v":0.557044103463393,"d":"0.56"},{"v":0.579443121546778,"d":"0.58"},{"v":-0.787261042438543,"d":"-0.79"},{"v":0.122911381310122,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"down","no"]
["MSTRG.17526","GUK1","ENSOART00000006803","GO:0004385(guanylate kinase activity);GO:0006163(purine nucleotide metabolic process);GO:0046037(GMP metabolic process);GO:0046710(GDP metabolic process)","NA","NA","NA","guanylate kinase 1 [Source:HGNC Symbol;Acc:HGNC:4693]",{"v":2.23504427758007,"d":"2.24"},{"v":0.897257224495848,"d":"0.90"},{"v":0.685474173190985,"d":"0.69"},{"v":1.06811777876631,"d":"1.07"},{"v":2.64894328706999,"d":"2.65"},{"v":3.01676625860024,"d":"3.02"},{"v":0.566954792768815,"d":"0.57"},{"v":-0.818694391198526,"d":"-0.82"},{"v":0.122949943819323,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"down","no"]
["ENSOARG00000005446","NAIP","ENSOART00000005942","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0006915(apoptotic process);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process)","04621(NOD-like receptor signaling pathway);05134(Legionellosis)","K12807","NA","NLR family apoptosis inhibitory protein [Source:NCBI gene;Acc:101110450]",{"v":0.289503,"d":"0.29"},{"v":0.583011,"d":"0.58"},{"v":0.242156,"d":"0.24"},{"v":0.281999,"d":"0.28"},{"v":0.233229,"d":"0.23"},{"v":0.201134,"d":"0.20"},{"v":1.55601497566873,"d":"1.56"},{"v":0.637855945426313,"d":"0.64"},{"v":0.122984109601733,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"up","no"]
["MSTRG.11259","C6orf132","ENSOART00000003450","NA","NA","NA","NA","chromosome 20 open reading frame, human C6orf132 [Source:NCBI gene;Acc:101110098]",{"v":0.319456,"d":"0.32"},{"v":0.43968,"d":"0.44"},{"v":0.454913,"d":"0.45"},{"v":0.771479,"d":"0.77"},{"v":0.568171,"d":"0.57"},{"v":0.656985,"d":"0.66"},{"v":0.608047539986027,"d":"0.61"},{"v":-0.717743970197383,"d":"-0.72"},{"v":0.123100737131619,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"down","no"]
["MSTRG.19625","ZNF770","ENSOART00000000809","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 770 [Source:NCBI gene;Acc:101111809]",{"v":2.348593,"d":"2.35"},{"v":2.196351,"d":"2.20"},{"v":1.586595,"d":"1.59"},{"v":1.729576,"d":"1.73"},{"v":1.310946,"d":"1.31"},{"v":1.331317,"d":"1.33"},{"v":1.4025079606088,"d":"1.40"},{"v":0.488008959567216,"d":"0.49"},{"v":0.123137735199782,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"up","no"]
["MSTRG.6500","ENSOARG00000014217","ENSOART00000015485","NA","NA","NA","NA","elongation factor 1-alpha 1 pseudogene [Source:NCBI gene;Acc:101107729]",{"v":35.240669,"d":"35.24"},{"v":11.140775,"d":"11.14"},{"v":21.91567,"d":"21.92"},{"v":46.342468,"d":"46.34"},{"v":37.287289,"d":"37.29"},{"v":26.739946,"d":"26.74"},{"v":0.618803096715772,"d":"0.62"},{"v":-0.692447678311616,"d":"-0.69"},{"v":0.123183651430124,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"down","no"]
["MSTRG.17501","MAPK9","ENSOART00000001779","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004705(JUN kinase activity);GO:0004707(MAP kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007254(JNK cascade);GO:0007258(JUN phosphorylation);GO:0008134(transcription factor binding);GO:0010628(positive regulation of gene expression);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0031398(positive regulation of protein ubiquitination);GO:0034614(cellular response to reactive oxygen species);GO:0042752(regulation of circadian rhythm);GO:0046686(response to cadmium ion);GO:0061833(protein localization to tricellular tight junction);GO:0071276(cellular response to cadmium ion);GO:0071803(positive regulation of podosome assembly);GO:1901485(positive regulation of transcription factor catabolic process);GO:2001235(positive regulation of apoptotic signaling pathway)","01522(Endocrine resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04014(Ras signaling pathway);04024(cAMP signaling pathway);04068(FoxO signaling pathway);04071(Sphingolipid signaling pathway);04137(Mitophagy - animal);04140(Autophagy - animal);04141(Protein processing in endoplasmic reticulum);04210(Apoptosis);04215(Apoptosis - multiple species);04217(Necroptosis);04310(Wnt signaling pathway);04380(Osteoclast differentiation);04510(Focal adhesion);04530(Tight junction);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04657(IL-17 signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04664(Fc epsilon RI signaling pathway);04668(TNF signaling pathway);04722(Neurotrophin signaling pathway);04723(Retrograde endocannabinoid signaling);04728(Dopaminergic synapse);04750(Inflammatory mediator regulation of TRP channels);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04920(Adipocytokine signaling pathway);04926(Relaxin signaling pathway);04930(Type II diabetes mellitus);04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD));04933(AGE-RAGE signaling pathway in diabetic complications);05132(Salmonella infection);05133(Pertussis);05142(Chagas disease (American trypanosomiasis));05145(Toxoplasmosis);05152(Tuberculosis);05161(Hepatitis B);05162(Measles);05164(Influenza A);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05231(Choline metabolism in cancer);05418(Fluid shear stress and atherosclerosis)","K04440","EC:2.7.11.24","mitogen-activated protein kinase 9 [Source:NCBI gene;Acc:101120826]",{"v":3.61040420948666,"d":"3.61"},{"v":3.39730702717665,"d":"3.40"},{"v":2.40821083517866,"d":"2.41"},{"v":3.07636329743332,"d":"3.08"},{"v":2.29299748817313,"d":"2.29"},{"v":1.64259765349774,"d":"1.64"},{"v":1.34283768987155,"d":"1.34"},{"v":0.425284935317363,"d":"0.43"},{"v":0.123205525938116,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"up","no"]
["MSTRG.873","FLAD1","ENSOART00000003589","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0003919(FMN adenylyltransferase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006747(FAD biosynthetic process);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity)","00740(Riboflavin metabolism)","K00953","EC:2.7.7.2","flavin adenine dinucleotide synthetase 1 [Source:NCBI gene;Acc:101114227]",{"v":2.701588,"d":"2.70"},{"v":2.193138,"d":"2.19"},{"v":2.540189,"d":"2.54"},{"v":3.609591,"d":"3.61"},{"v":3.088916,"d":"3.09"},{"v":4.865713,"d":"4.87"},{"v":0.642924036381183,"d":"0.64"},{"v":-0.637279806494716,"d":"-0.64"},{"v":0.12322246094508,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"down","no"]
["MSTRG.458","ADGRL4","ENSOART00000014717;ENSOART00000014715","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","K04595","NA","adhesion G protein-coupled receptor L4 [Source:NCBI gene;Acc:101103604]",{"v":4.27426695265075,"d":"4.27"},{"v":2.62819014002428,"d":"2.63"},{"v":2.83120174747066,"d":"2.83"},{"v":5.152065,"d":"5.15"},{"v":4.92989344435451,"d":"4.93"},{"v":4.58051813193039,"d":"4.58"},{"v":0.663848210737395,"d":"0.66"},{"v":-0.591074688631585,"d":"-0.59"},{"v":0.123237258376033,"d":"0.12"},{"v":0.599409578422362,"d":"0.60"},"down","no"]
["MSTRG.4790","EBF4","ENSOART00000006494","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0008134(transcription factor binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0046983(protein dimerization activity)","NA","NA","NA","EBF family member 4 [Source:HGNC Symbol;Acc:HGNC:29278]",{"v":0.885641,"d":"0.89"},{"v":0.513804,"d":"0.51"},{"v":0.452802,"d":"0.45"},{"v":0.839277,"d":"0.84"},{"v":1.279272,"d":"1.28"},{"v":1.057534,"d":"1.06"},{"v":0.583185955782642,"d":"0.58"},{"v":-0.777972117620835,"d":"-0.78"},{"v":0.123501044990117,"d":"0.12"},{"v":0.600159774698973,"d":"0.60"},"down","no"]
["MSTRG.5084","PLTP","ENSOART00000007771","GO:0005319(lipid transporter activity);GO:0005548(phospholipid transporter activity);GO:0005615(extracellular space);GO:0006629(lipid metabolic process);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0008429(phosphatidylethanolamine binding);GO:0008525(phosphatidylcholine transporter activity);GO:0010189(vitamin E biosynthetic process);GO:0010875(positive regulation of cholesterol efflux);GO:0015914(phospholipid transport);GO:0019992(diacylglycerol binding);GO:0030317(flagellated sperm motility);GO:0031210(phosphatidylcholine binding);GO:0034364(high-density lipoprotein particle);GO:0034375(high-density lipoprotein particle remodeling);GO:0035620(ceramide transporter activity);GO:0035627(ceramide transport);GO:0070300(phosphatidic acid binding);GO:0097001(ceramide binding);GO:1901611(phosphatidylglycerol binding);GO:1904121(phosphatidylethanolamine transporter activity);GO:1990050(phosphatidic acid transporter activity)","03320(PPAR signaling pathway);04979(Cholesterol metabolism)","K08761","NA","phospholipid transfer protein [Source:NCBI gene;Acc:101115982]",{"v":1.78749135922787,"d":"1.79"},{"v":1.10467337570621,"d":"1.10"},{"v":3.13761073822976,"d":"3.14"},{"v":2.47115463747646,"d":"2.47"},{"v":3.75916308709981,"d":"3.76"},{"v":3.85048477966102,"d":"3.85"},{"v":0.598144390848777,"d":"0.60"},{"v":-0.741434304750916,"d":"-0.74"},{"v":0.123501431802638,"d":"0.12"},{"v":0.600159774698973,"d":"0.60"},"down","no"]
["MSTRG.15473","ENSOARG00000013272","ENSOART00000014429","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02910","NA","ribosomal protein L31 [Source:NCBI gene;Acc:101104219]",{"v":111.835280168142,"d":"111.84"},{"v":96.8353916460177,"d":"96.84"},{"v":108.904917530973,"d":"108.90"},{"v":123.040868902655,"d":"123.04"},{"v":165.313703,"d":"165.31"},{"v":185.738441318584,"d":"185.74"},{"v":0.669859248056317,"d":"0.67"},{"v":-0.578070108964012,"d":"-0.58"},{"v":0.123595217967751,"d":"0.12"},{"v":0.600159774698973,"d":"0.60"},"down","no"]
["MSTRG.5756","RPS19","ENSOART00000009101","GO:0000028(ribosomal small subunit assembly);GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0002548(monocyte chemotaxis);GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005840(ribosome);GO:0006364(rRNA processing);GO:0006412(translation);GO:0007000(nucleolus organization);GO:0014069(postsynaptic density);GO:0017134(fibroblast growth factor binding);GO:0019901(protein kinase binding);GO:0022627(cytosolic small ribosomal subunit);GO:0030218(erythrocyte differentiation);GO:0030490(maturation of SSU-rRNA);GO:0031640(killing of cells of other organism);GO:0042274(ribosomal small subunit biogenesis);GO:0042803(protein homodimerization activity);GO:0050829(defense response to Gram-negative bacterium);GO:0051262(protein tetramerization);GO:0060265(positive regulation of respiratory burst involved in inflammatory response);GO:0060266(negative regulation of respiratory burst involved in inflammatory response);GO:0061844(antimicrobial humoral immune response mediated by antimicrobial peptide)","03010(Ribosome)","K02966","NA","ribosomal protein S19 [Source:NCBI gene;Acc:101106101]",{"v":190.03804,"d":"190.04"},{"v":143.316467,"d":"143.32"},{"v":208.623856,"d":"208.62"},{"v":234.749023,"d":"234.75"},{"v":266.098663,"d":"266.10"},{"v":306.901215,"d":"306.90"},{"v":0.67097381665147,"d":"0.67"},{"v":-0.575671625517203,"d":"-0.58"},{"v":0.123650396774445,"d":"0.12"},{"v":0.600159774698973,"d":"0.60"},"down","no"]
["MSTRG.8728","CMTM8","ENSOART00000016342","GO:0005654(nucleoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","CKLF-like MARVEL transmembrane domain-containing protein 8 [Source:NCBI gene;Acc:101111667]",{"v":2.858558,"d":"2.86"},{"v":1.992303,"d":"1.99"},{"v":1.988823,"d":"1.99"},{"v":4.177565,"d":"4.18"},{"v":4.032611,"d":"4.03"},{"v":3.522686,"d":"3.52"},{"v":0.582951031044258,"d":"0.58"},{"v":-0.778553395401167,"d":"-0.78"},{"v":0.123665427008775,"d":"0.12"},{"v":0.600159774698973,"d":"0.60"},"down","no"]
["MSTRG.17872","ENSOARG00000007018","ENSOART00000007636","GO:0005747(mitochondrial respiratory chain complex I);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032981(mitochondrial respiratory chain complex I assembly)","00190(Oxidative phosphorylation);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K03956","NA","NADH:ubiquinone oxidoreductase subunit A11 [Source:NCBI gene;Acc:101108484]",{"v":30.037203,"d":"30.04"},{"v":26.642649,"d":"26.64"},{"v":24.518442,"d":"24.52"},{"v":35.083378,"d":"35.08"},{"v":38.577576,"d":"38.58"},{"v":48.800018,"d":"48.80"},{"v":0.663054462772025,"d":"0.66"},{"v":-0.592800717846549,"d":"-0.59"},{"v":0.123757983756895,"d":"0.12"},{"v":0.600159774698973,"d":"0.60"},"down","no"]
["MSTRG.18157","ENSOARG00000012324","ENSOART00000013395","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA","NA","NA",null,{"v":3.320671,"d":"3.32"},{"v":2.389544,"d":"2.39"},{"v":2.457988,"d":"2.46"},{"v":3.377426,"d":"3.38"},{"v":4.624658,"d":"4.62"},{"v":4.976174,"d":"4.98"},{"v":0.629375914702882,"d":"0.63"},{"v":-0.668006125026962,"d":"-0.67"},{"v":0.123759061820887,"d":"0.12"},{"v":0.600159774698973,"d":"0.60"},"down","no"]
["MSTRG.4727","PRNP","ENSOART00000005076","GO:0001540(amyloid-beta binding);GO:0001933(negative regulation of protein phosphorylation);GO:0002020(protease binding);GO:0005507(copper ion binding);GO:0005515(protein binding);GO:0005539(glycosaminoglycan binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006979(response to oxidative stress);GO:0007611(learning or memory);GO:0008017(microtubule binding);GO:0009986(cell surface);GO:0010942(positive regulation of cell death);GO:0015631(tubulin binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016234(inclusion body);GO:0030425(dendrite);GO:0031225(anchored component of membrane);GO:0031648(protein destabilization);GO:0031802(type 5 metabotropic glutamate receptor binding);GO:0031965(nuclear membrane);GO:0032147(activation of protein kinase activity);GO:0032689(negative regulation of interferon-gamma production);GO:0032700(negative regulation of interleukin-17 production);GO:0032703(negative regulation of interleukin-2 production);GO:0032880(regulation of protein localization);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0035690(cellular response to drug);GO:0038023(signaling receptor activity);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043525(positive regulation of neuron apoptotic process);GO:0044877(protein-containing complex binding);GO:0045121(membrane raft);GO:0046007(negative regulation of activated T cell proliferation);GO:0046872(metal ion binding);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050860(negative regulation of T cell receptor signaling pathway);GO:0051260(protein homooligomerization);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070885(negative regulation of calcineurin-NFAT signaling cascade);GO:0071280(cellular response to copper ion);GO:0090314(positive regulation of protein targeting to membrane);GO:0090647(modulation of age-related behavioral decline);GO:1900449(regulation of glutamate receptor signaling pathway);GO:1901216(positive regulation of neuron death);GO:1901379(regulation of potassium ion transmembrane transport);GO:1902430(negative regulation of amyloid-beta formation);GO:1902938(regulation of intracellular calcium activated chloride channel activity);GO:1902951(negative regulation of dendritic spine maintenance);GO:1902992(negative regulation of amyloid precursor protein catabolic process);GO:1903078(positive regulation of protein localization to plasma membrane);GO:1903135(cupric ion binding);GO:1903136(cuprous ion binding);GO:1904645(response to amyloid-beta);GO:1904646(cellular response to amyloid-beta);GO:1905664(regulation of calcium ion import across plasma membrane);GO:1990535(neuron projection maintenance)","04216(Ferroptosis);05020(Prion diseases)","K05634","NA","prion protein [Source:NCBI gene;Acc:493887]",{"v":6.68906172081882,"d":"6.69"},{"v":5.99929462325784,"d":"6.00"},{"v":6.13797543292683,"d":"6.14"},{"v":4.77472000043554,"d":"4.77"},{"v":4.26775765679442,"d":"4.27"},{"v":5.11525808079268,"d":"5.12"},{"v":1.32975583987224,"d":"1.33"},{"v":0.411161372837597,"d":"0.41"},{"v":0.123961664913168,"d":"0.12"},{"v":0.600679526296694,"d":"0.60"},"up","no"]
["MSTRG.17277","ENSOARG00000007414","ENSOART00000008078","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00040(Pentose and glucuronate interconversions);00051(Fructose and mannose metabolism);00052(Galactose metabolism);00561(Glycerolipid metabolism);00790(Folate biosynthesis)","K00011","EC:1.1.1.21","aldo-keto reductase family 1 member B [Source:NCBI gene;Acc:101120824]",{"v":19.30703,"d":"19.31"},{"v":20.683285,"d":"20.68"},{"v":25.230043,"d":"25.23"},{"v":32.933559,"d":"32.93"},{"v":28.274504,"d":"28.27"},{"v":37.232536,"d":"37.23"},{"v":0.662535159908972,"d":"0.66"},{"v":-0.593931076278379,"d":"-0.59"},{"v":0.123976604827282,"d":"0.12"},{"v":0.600679526296694,"d":"0.60"},"down","no"]
["MSTRG.19789","VPS13C","ENSOART00000022677","GO:0005741(mitochondrial outer membrane);GO:0005829(cytosol);GO:0007005(mitochondrion organization);GO:1905090(negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization)","NA","K19525","NA","vacuolar protein sorting 13 homolog C [Source:NCBI gene;Acc:101112983]",{"v":6.808306,"d":"6.81"},{"v":7.469492,"d":"7.47"},{"v":6.389934,"d":"6.39"},{"v":6.300367,"d":"6.30"},{"v":5.438138,"d":"5.44"},{"v":3.887873,"d":"3.89"},{"v":1.32261820365538,"d":"1.32"},{"v":0.403396663138479,"d":"0.40"},{"v":0.124091630529484,"d":"0.12"},{"v":0.601058482137471,"d":"0.60"},"up","no"]
["MSTRG.17699","CCDC130","ENSOART00000008990","GO:0009615(response to virus)","NA","K13115","NA","coiled-coil domain containing 130 [Source:NCBI gene;Acc:101102978]",{"v":1.75059849002849,"d":"1.75"},{"v":1.25793342051282,"d":"1.26"},{"v":1.50953811794872,"d":"1.51"},{"v":1.87324134358974,"d":"1.87"},{"v":2.65619514586895,"d":"2.66"},{"v":2.61890778575499,"d":"2.62"},{"v":0.632044268510693,"d":"0.63"},{"v":-0.661902486288466,"d":"-0.66"},{"v":0.124241787543157,"d":"0.12"},{"v":0.601492831475853,"d":"0.60"},"down","no"]
["MSTRG.7339","ZNF827","ENSOART00000009337","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 827 [Source:NCBI gene;Acc:101109647]",{"v":1.221786,"d":"1.22"},{"v":0.866009,"d":"0.87"},{"v":1.044095,"d":"1.04"},{"v":1.971227,"d":"1.97"},{"v":1.441724,"d":"1.44"},{"v":1.464264,"d":"1.46"},{"v":0.6421472090117,"d":"0.64"},{"v":-0.639024029056865,"d":"-0.64"},{"v":0.124259789836187,"d":"0.12"},{"v":0.601492831475853,"d":"0.60"},"down","no"]
["MSTRG.7036","ITGA2","ENSOART00000008936;ENSOART00000008938","GO:0001540(amyloid-beta binding);GO:0005518(collagen binding);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006929(substrate-dependent cell migration);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031589(cell-substrate adhesion);GO:0033627(cell adhesion mediated by integrin);GO:0034666(integrin alpha2-beta1 complex);GO:0038064(collagen receptor activity);GO:0038065(collagen-activated signaling pathway);GO:0044877(protein-containing complex binding);GO:0045178(basal part of cell);GO:0048333(mesodermal cell differentiation);GO:0098639(collagen binding involved in cell-matrix adhesion);GO:0098639(collagen binding involved in cell-matrix adhesion)","04145(Phagosome);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04611(Platelet activation);04640(Hematopoietic cell lineage);04810(Regulation of actin cytoskeleton);05165(Human papillomavirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05222(Small cell lung cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05414(Dilated cardiomyopathy (DCM))","K06481","NA","integrin subunit alpha 2 [Source:NCBI gene;Acc:101119848]",{"v":0.284736706524783,"d":"0.28"},{"v":0.2675167758331,"d":"0.27"},{"v":0.396409873704845,"d":"0.40"},{"v":0.474683643657239,"d":"0.47"},{"v":0.568101394287315,"d":"0.57"},{"v":0.475815474096892,"d":"0.48"},{"v":0.624695796254833,"d":"0.62"},{"v":-0.678774273232233,"d":"-0.68"},{"v":0.124291818557051,"d":"0.12"},{"v":0.601492831475853,"d":"0.60"},"down","no"]
["MSTRG.18749","ENSOARG00000016064","ENSOART00000017494","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K17345","NA","tetraspanin 5 [Source:NCBI gene;Acc:101112980]",{"v":1.9892,"d":"1.99"},{"v":0.938639,"d":"0.94"},{"v":0.882658,"d":"0.88"},{"v":2.230224,"d":"2.23"},{"v":2.406329,"d":"2.41"},{"v":2.043581,"d":"2.04"},{"v":0.570422240032909,"d":"0.57"},{"v":-0.809897863176229,"d":"-0.81"},{"v":0.124387345219075,"d":"0.12"},{"v":0.601690064479675,"d":"0.60"},"down","no"]
["MSTRG.5822","ENSOARG00000010203","ENSOART00000011097","GO:0000387(spliceosomal snRNP assembly);GO:0005634(nucleus);GO:0005685(U1 snRNP);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0030532(small nuclear ribonucleoprotein complex)","03040(Spliceosome)","K11096","NA","small nuclear ribonucleoprotein D2 polypeptide [Source:NCBI gene;Acc:101114635]",{"v":23.228347580756,"d":"23.23"},{"v":24.2393318642612,"d":"24.24"},{"v":23.1964588230241,"d":"23.20"},{"v":32.8991336116838,"d":"32.90"},{"v":32.445142709622,"d":"32.45"},{"v":40.2781895876289,"d":"40.28"},{"v":0.669025643928502,"d":"0.67"},{"v":-0.579866584081269,"d":"-0.58"},{"v":0.12446606665657,"d":"0.12"},{"v":0.601690064479675,"d":"0.60"},"down","no"]
["MSTRG.1927","FAM207A","ENSOART00000013485","GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005730(nucleolus);GO:0030686(90S preribosome);GO:0030688(preribosome, small subunit precursor)","NA","NA","NA","family with sequence similarity 207 member A [Source:HGNC Symbol;Acc:HGNC:15811]",{"v":1.01269504079861,"d":"1.01"},{"v":1.63011921267361,"d":"1.63"},{"v":1.64069852748843,"d":"1.64"},{"v":1.0283593287037,"d":"1.03"},{"v":1.07625088049769,"d":"1.08"},{"v":0.955554826967593,"d":"0.96"},{"v":1.39976528400677,"d":"1.40"},{"v":0.485184932892757,"d":"0.49"},{"v":0.124475711286545,"d":"0.12"},{"v":0.601690064479675,"d":"0.60"},"up","no"]
["MSTRG.19861","CCPG1","ENSOART00000022774","GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045787(positive regulation of cell cycle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2001106(regulation of Rho guanyl-nucleotide exchange factor activity)","NA","K19758","NA","dynein axonemal assembly factor 4 [Source:NCBI gene;Acc:101122030]",{"v":4.61934666850829,"d":"4.62"},{"v":4.34518119993094,"d":"4.35"},{"v":4.05382419993094,"d":"4.05"},{"v":2.94194951899171,"d":"2.94"},{"v":3.39731394751381,"d":"3.40"},{"v":3.41428052762431,"d":"3.41"},{"v":1.33473044015645,"d":"1.33"},{"v":0.416548407143603,"d":"0.42"},{"v":0.124580508572334,"d":"0.12"},{"v":0.601690064479675,"d":"0.60"},"up","no"]
["ENSOARG00000006210","OGG1","ENSOART00000006757","GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003824(catalytic activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0006355(regulation of transcription, DNA-templated);GO:0006974(cellular response to DNA damage stimulus);GO:0006979(response to oxidative stress);GO:0008017(microtubule binding);GO:0008534(oxidized purine nucleobase lesion DNA N-glycosylase activity);GO:0009314(response to radiation);GO:0016363(nuclear matrix);GO:0016607(nuclear speck);GO:0032357(oxidized purine DNA binding);GO:0032991(protein-containing complex);GO:0033683(nucleotide-excision repair, DNA incision);GO:0034039(8-oxo-7,8-dihydroguanine DNA N-glycosylase activity);GO:1901291(negative regulation of double-strand break repair via single-strand annealing)","03410(Base excision repair)","K03660","4.2.99.18;EC:3.2.2.-","8-oxoguanine DNA glycosylase [Source:NCBI gene;Acc:101104015]",{"v":0.774262,"d":"0.77"},{"v":0.551837,"d":"0.55"},{"v":0.567452,"d":"0.57"},{"v":1.080804,"d":"1.08"},{"v":0.974132,"d":"0.97"},{"v":1.222265,"d":"1.22"},{"v":0.577795197792263,"d":"0.58"},{"v":-0.791369881552641,"d":"-0.79"},{"v":0.124615060080474,"d":"0.12"},{"v":0.601690064479675,"d":"0.60"},"down","no"]
["ENSOARG00000008638","SLC35F1","ENSOART00000009403","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K15287","NA","solute carrier family 35 member F1 [Source:NCBI gene;Acc:101102315]",{"v":0.662371,"d":"0.66"},{"v":0.512315,"d":"0.51"},{"v":0.696464,"d":"0.70"},{"v":0.967129,"d":"0.97"},{"v":1.189857,"d":"1.19"},{"v":1.076898,"d":"1.08"},{"v":0.578607643316829,"d":"0.58"},{"v":-0.789342713717236,"d":"-0.79"},{"v":0.124615440079633,"d":"0.12"},{"v":0.601690064479675,"d":"0.60"},"down","no"]
["MSTRG.13425","THUMPD1","ENSOART00000014249","GO:0003723(RNA binding);GO:0006400(tRNA modification)","NA","K06963","NA","THUMP domain containing 1 [Source:NCBI gene;Acc:101121057]",{"v":2.194552,"d":"2.19"},{"v":1.616489,"d":"1.62"},{"v":1.95424,"d":"1.95"},{"v":1.20465,"d":"1.20"},{"v":1.392103,"d":"1.39"},{"v":1.365586,"d":"1.37"},{"v":1.45501962351025,"d":"1.46"},{"v":0.541038610556252,"d":"0.54"},{"v":0.124701586826147,"d":"0.12"},{"v":0.601690064479675,"d":"0.60"},"up","no"]
["MSTRG.10836","PTP4A2","ENSOART00000000732","GO:0004725(protein tyrosine phosphatase activity);GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation)","NA","K18041","EC:3.1.3.48","protein tyrosine phosphatase type IVA, member 2 [Source:NCBI gene;Acc:101118084]",{"v":63.880291,"d":"63.88"},{"v":57.803516,"d":"57.80"},{"v":47.579891,"d":"47.58"},{"v":54.819801,"d":"54.82"},{"v":37.697342,"d":"37.70"},{"v":36.330124,"d":"36.33"},{"v":1.31367705300261,"d":"1.31"},{"v":0.393610655191625,"d":"0.39"},{"v":0.124737926767743,"d":"0.12"},{"v":0.601690064479675,"d":"0.60"},"up","no"]
["MSTRG.17977","SEPT8","ENSOART00000016005","GO:0000166(nucleotide binding);GO:0005525(GTP binding)","05100(Bacterial invasion of epithelial cells)","K16939","NA","septin 8 [Source:NCBI gene;Acc:101122277]",{"v":2.81123577175464,"d":"2.81"},{"v":2.18324307667618,"d":"2.18"},{"v":2.40566198056348,"d":"2.41"},{"v":3.79332240995007,"d":"3.79"},{"v":3.51073226533524,"d":"3.51"},{"v":3.66108359700428,"d":"3.66"},{"v":0.674878934057354,"d":"0.67"},{"v":-0.567299373316934,"d":"-0.57"},{"v":0.125028590870888,"d":"0.13"},{"v":0.602563785588182,"d":"0.60"},"down","no"]
["MSTRG.9866","CDC37L1","ENSOART00000014617","GO:0005737(cytoplasm);GO:0005829(cytosol)","NA","NA","NA","cell division cycle 37 like 1 [Source:NCBI gene;Acc:101112951]",{"v":5.403514,"d":"5.40"},{"v":5.448503,"d":"5.45"},{"v":4.484061,"d":"4.48"},{"v":3.689574,"d":"3.69"},{"v":3.436736,"d":"3.44"},{"v":4.002808,"d":"4.00"},{"v":1.3780137833025,"d":"1.38"},{"v":0.462590318377996,"d":"0.46"},{"v":0.125103578707982,"d":"0.13"},{"v":0.602563785588182,"d":"0.60"},"up","no"]
["MSTRG.228","PLK3","ENSOART00000001288;ENSOART00000001287","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000166(nucleotide binding);GO:0000302(response to reactive oxygen species);GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005795(Golgi stack);GO:0005813(centrosome);GO:0006468(protein phosphorylation);GO:0006970(response to osmotic stress);GO:0006974(cellular response to DNA damage stimulus);GO:0009314(response to radiation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0031122(cytoplasmic microtubule organization);GO:0032465(regulation of cytokinesis);GO:0043066(negative regulation of apoptotic process);GO:0051302(regulation of cell division);GO:0090166(Golgi disassembly);GO:0090316(positive regulation of intracellular protein transport);GO:1904716(positive regulation of chaperone-mediated autophagy);GO:2000777(positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia);GO:2000777(positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia)","04068(FoxO signaling pathway);04625(C-type lectin receptor signaling pathway);05152(Tuberculosis);05152(Tuberculosis)","K08862","EC:2.7.11.21","polo like kinase 3 [Source:NCBI gene;Acc:101109760]",{"v":8.27770884919473,"d":"8.28"},{"v":3.04642130600293,"d":"3.05"},{"v":2.77799517423133,"d":"2.78"},{"v":4.38393235285505,"d":"4.38"},{"v":1.68318750219619,"d":"1.68"},{"v":2.9665070102489,"d":"2.97"},{"v":1.56107015927323,"d":"1.56"},{"v":0.642535377905821,"d":"0.64"},{"v":0.125324115189526,"d":"0.13"},{"v":0.602914600122152,"d":"0.60"},"up","no"]
["MSTRG.21446","ENSOARG00000008896","ENSOART00000009684","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity)","NA","K19584","EC:2.7.11.11","protein kinase X-linked [Source:NCBI gene;Acc:101116807]",{"v":1.619074,"d":"1.62"},{"v":1.225323,"d":"1.23"},{"v":1.476325,"d":"1.48"},{"v":2.117505,"d":"2.12"},{"v":2.175485,"d":"2.18"},{"v":2.68761,"d":"2.69"},{"v":0.618961407328883,"d":"0.62"},{"v":-0.69207863567555,"d":"-0.69"},{"v":0.125774363081991,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.18147","CIRBP","ENSOART00000012406","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0008266(poly(U) RNA binding);GO:0010494(cytoplasmic stress granule);GO:0017148(negative regulation of translation);GO:0030308(negative regulation of cell growth);GO:0030371(translation repressor activity);GO:0034063(stress granule assembly);GO:0070417(cellular response to cold);GO:1902806(regulation of cell cycle G1/S phase transition)","NA","K13195","NA","cold inducible RNA binding protein [Source:NCBI gene;Acc:101117758]",{"v":4.07188549530201,"d":"4.07"},{"v":2.56815590442953,"d":"2.57"},{"v":3.41296369261745,"d":"3.41"},{"v":4.99250504885906,"d":"4.99"},{"v":5.34021081288591,"d":"5.34"},{"v":4.74001736483222,"d":"4.74"},{"v":0.666966298761455,"d":"0.67"},{"v":-0.584314229786466,"d":"-0.58"},{"v":0.125782278179018,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.4485","UPF2","ENSOART00000015884","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0001889(liver development);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0031100(animal organ regeneration);GO:0035145(exon-exon junction complex);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042162(telomeric DNA binding)","03013(RNA transport);03015(mRNA surveillance pathway)","K14327","NA","UPF2, regulator of nonsense mediated mRNA decay [Source:NCBI gene;Acc:101116751]",{"v":2.86571580364807,"d":"2.87"},{"v":2.84020150751073,"d":"2.84"},{"v":2.69857175643777,"d":"2.70"},{"v":2.12289023712446,"d":"2.12"},{"v":1.94962488090129,"d":"1.95"},{"v":2.25521171566524,"d":"2.26"},{"v":1.32820036143915,"d":"1.33"},{"v":0.409472796271359,"d":"0.41"},{"v":0.125824284252104,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"up","no"]
["MSTRG.12408","MYOF","ENSOART00000002434","GO:0001778(plasma membrane repair);GO:0005543(phospholipid binding);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006071(glycerol metabolic process);GO:0007520(myoblast fusion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0033292(T-tubule organization);GO:0034605(cellular response to heat);GO:0043231(intracellular membrane-bounded organelle);GO:0048747(muscle fiber development)","NA","K22125","NA","myoferlin [Source:NCBI gene;Acc:101104107]",{"v":2.07478854675315,"d":"2.07"},{"v":2.44721782287082,"d":"2.45"},{"v":3.30436232908656,"d":"3.30"},{"v":2.06115436197977,"d":"2.06"},{"v":1.80271866157053,"d":"1.80"},{"v":1.96266084340978,"d":"1.96"},{"v":1.34322890373824,"d":"1.34"},{"v":0.425705179782442,"d":"0.43"},{"v":0.125912691671021,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"up","no"]
["ENSOARG00000014562","ENSOARG00000014562","ENSOART00000015858","GO:0005515(protein binding)","NA","K17582","NA","marker of proliferation Ki-67 [Source:NCBI gene;Acc:101106643]",{"v":0.565241,"d":"0.57"},{"v":0.198822,"d":"0.20"},{"v":0.578328,"d":"0.58"},{"v":1.141252,"d":"1.14"},{"v":0.379149,"d":"0.38"},{"v":0.839718,"d":"0.84"},{"v":0.568781065700501,"d":"0.57"},{"v":-0.814054655377744,"d":"-0.81"},{"v":0.125958326507497,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.6772","SLC39A13","ENSOART00000007152","GO:0005385(zinc ion transmembrane transporter activity);GO:0005794(Golgi apparatus);GO:0006882(cellular zinc ion homeostasis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030001(metal ion transport);GO:0042803(protein homodimerization activity);GO:0046873(metal ion transmembrane transporter activity);GO:0048471(perinuclear region of cytoplasm);GO:0055085(transmembrane transport);GO:0061448(connective tissue development);GO:0071577(zinc ion transmembrane transport)","NA","K14719","NA","solute carrier family 39 member 13 [Source:NCBI gene;Acc:100302551]",{"v":1.43884126416382,"d":"1.44"},{"v":1.83701427645051,"d":"1.84"},{"v":1.71817820136519,"d":"1.72"},{"v":2.69425104027304,"d":"2.69"},{"v":2.5747932116041,"d":"2.57"},{"v":2.70679268805461,"d":"2.71"},{"v":0.626145416410965,"d":"0.63"},{"v":-0.675430346400369,"d":"-0.68"},{"v":0.126005912972996,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.19194","ENSOARG00000013494","ENSOART00000014675","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","NA","NA","NA",null,{"v":0.880255257589696,"d":"0.88"},{"v":0.941631287028519,"d":"0.94"},{"v":0.706952697332107,"d":"0.71"},{"v":0.961871046918123,"d":"0.96"},{"v":1.42650528978841,"d":"1.43"},{"v":2.04418747470101,"d":"2.04"},{"v":0.570513894338568,"d":"0.57"},{"v":-0.809666072441321,"d":"-0.81"},{"v":0.126042004081208,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.7244","ENSOARG00000015565","ENSOART00000016936","NA","NA","NA","NA",null,{"v":1.84464887644934,"d":"1.84"},{"v":2.21056292796046,"d":"2.21"},{"v":2.09520495875309,"d":"2.10"},{"v":1.92032460425775,"d":"1.92"},{"v":1.3315994004942,"d":"1.33"},{"v":1.38117161908382,"d":"1.38"},{"v":1.32749618452099,"d":"1.33"},{"v":0.408707714452741,"d":"0.41"},{"v":0.126064782257667,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"up","no"]
["MSTRG.13588","ENSOARG00000010228","ENSOART00000011124","NA","NA","NA","NA",null,{"v":40.1965039664179,"d":"40.20"},{"v":45.1218985699627,"d":"45.12"},{"v":37.0861947434702,"d":"37.09"},{"v":37.1962896604478,"d":"37.20"},{"v":25.5255416604478,"d":"25.53"},{"v":30.3448421063433,"d":"30.34"},{"v":1.3152355485828,"d":"1.32"},{"v":0.39532119825558,"d":"0.40"},{"v":0.126077065024886,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"up","no"]
["MSTRG.3252","FKBP10","ENSOART00000019224","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005509(calcium ion binding);GO:0005528(FK506 binding);GO:0016853(isomerase activity);GO:0018208(peptidyl-proline modification)","NA","K09575","EC:5.2.1.8","FKBP prolyl isomerase 10 [Source:NCBI gene;Acc:101108933]",{"v":1.06951080437112,"d":"1.07"},{"v":0.774330626740947,"d":"0.77"},{"v":1.81848104263981,"d":"1.82"},{"v":1.65659374351832,"d":"1.66"},{"v":2.01507139297193,"d":"2.02"},{"v":2.20538230876366,"d":"2.21"},{"v":0.623156867094792,"d":"0.62"},{"v":-0.68233271672204,"d":"-0.68"},{"v":0.126118913009219,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.813","MRPL9","ENSOART00000022926","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02939","NA","mitochondrial ribosomal protein L9 [Source:NCBI gene;Acc:101119267]",{"v":12.207975,"d":"12.21"},{"v":11.871636,"d":"11.87"},{"v":13.668117,"d":"13.67"},{"v":16.688383,"d":"16.69"},{"v":18.953402,"d":"18.95"},{"v":20.549257,"d":"20.55"},{"v":0.671774835568986,"d":"0.67"},{"v":-0.573950341112807,"d":"-0.57"},{"v":0.1261275408583,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.14573","C9orf116","ENSOART00000002087","NA","NA","NA","NA","chromosome 3 open reading frame, human C9orf116 [Source:NCBI gene;Acc:101109255]",{"v":7.313775,"d":"7.31"},{"v":7.348163,"d":"7.35"},{"v":5.061707,"d":"5.06"},{"v":8.191328,"d":"8.19"},{"v":9.844364,"d":"9.84"},{"v":14.241759,"d":"14.24"},{"v":0.611065756090839,"d":"0.61"},{"v":-0.710600459717715,"d":"-0.71"},{"v":0.126229097532583,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.7639","MYL2","ENSOART00000019344","GO:0003007(heart morphogenesis);GO:0003785(actin monomer binding);GO:0005509(calcium ion binding);GO:0005856(cytoskeleton);GO:0007507(heart development);GO:0009791(post-embryonic development);GO:0015629(actin cytoskeleton);GO:0030016(myofibril);GO:0030308(negative regulation of cell growth);GO:0042694(muscle cell fate specification);GO:0048747(muscle fiber development);GO:0055003(cardiac myofibril assembly);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060047(heart contraction);GO:0060048(cardiac muscle contraction);GO:0097512(cardiac myofibril);GO:0098735(positive regulation of the force of heart contraction)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04371(Apelin signaling pathway);04510(Focal adhesion);04530(Tight junction);04670(Leukocyte transendothelial migration);04810(Regulation of actin cytoskeleton);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","K10351","NA","myosin light chain 2 [Source:NCBI gene;Acc:100196904]",{"v":494.606128552124,"d":"494.61"},{"v":893.451642947233,"d":"893.45"},{"v":699.275363972973,"d":"699.28"},{"v":933.997591146718,"d":"934.00"},{"v":1116.56363119305,"d":"1116.56"},{"v":1176.7725086731,"d":"1176.77"},{"v":0.646767055856117,"d":"0.65"},{"v":-0.628681900249339,"d":"-0.63"},{"v":0.12624211087848,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"down","no"]
["MSTRG.11599","RBM24","ENSOART00000012989","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0003197(endocardial cushion development);GO:0003730(mRNA 3'-UTR binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006974(cellular response to DNA damage stimulus);GO:0010830(regulation of myotube differentiation);GO:0010831(positive regulation of myotube differentiation);GO:0035925(mRNA 3'-UTR AU-rich region binding);GO:0043488(regulation of mRNA stability);GO:0048255(mRNA stabilization);GO:0061157(mRNA destabilization);GO:0061158(3'-UTR-mediated mRNA destabilization);GO:0097157(pre-mRNA intronic binding);GO:1902811(positive regulation of skeletal muscle fiber differentiation);GO:1905870(positive regulation of 3'-UTR-mediated mRNA stabilization);GO:1990715(mRNA CDS binding);GO:1990825(sequence-specific mRNA binding);GO:2000738(positive regulation of stem cell differentiation);GO:2000766(negative regulation of cytoplasmic translation)","NA","NA","NA","RNA binding motif protein 24 [Source:HGNC Symbol;Acc:HGNC:21539]",{"v":3.91466033180207,"d":"3.91"},{"v":6.75066621341383,"d":"6.75"},{"v":4.44321120567004,"d":"4.44"},{"v":4.2760795883318,"d":"4.28"},{"v":3.99082835798661,"d":"3.99"},{"v":2.91987289408059,"d":"2.92"},{"v":1.3505706392606,"d":"1.35"},{"v":0.433569099488332,"d":"0.43"},{"v":0.126281480700427,"d":"0.13"},{"v":0.604138299700138,"d":"0.60"},"up","no"]
["MSTRG.12001","ATL3","ENSOART00000003114;ENSOART00000003115","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005783(endoplasmic reticulum);GO:0007029(endoplasmic reticulum organization);GO:0007030(Golgi organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042802(identical protein binding);GO:0051260(protein homooligomerization);GO:0071782(endoplasmic reticulum tubular network);GO:0098826(endoplasmic reticulum tubular network membrane);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization)","NA","K17339","EC:3.6.5.-","atlastin GTPase 3 [Source:NCBI gene;Acc:101120873]",{"v":4.4578358967587,"d":"4.46"},{"v":2.79465909003601,"d":"2.79"},{"v":3.84610820888355,"d":"3.85"},{"v":5.25754216926771,"d":"5.26"},{"v":6.17978979471789,"d":"6.18"},{"v":5.41832679111645,"d":"5.42"},{"v":0.658449684876233,"d":"0.66"},{"v":-0.602854893058438,"d":"-0.60"},{"v":0.126795800615319,"d":"0.13"},{"v":0.605146120274116,"d":"0.61"},"down","no"]
["ENSOARG00000004339","RHPN2","ENSOART00000004725","GO:0005515(protein binding);GO:0007165(signal transduction)","NA","NA","NA","rhophilin Rho GTPase binding protein 2 [Source:NCBI gene;Acc:101117270]",{"v":0.316906,"d":"0.32"},{"v":0.328244,"d":"0.33"},{"v":0.273238,"d":"0.27"},{"v":0.793521,"d":"0.79"},{"v":0.543603,"d":"0.54"},{"v":0.333528,"d":"0.33"},{"v":0.549718313568595,"d":"0.55"},{"v":-0.863235552105305,"d":"-0.86"},{"v":0.126825699631187,"d":"0.13"},{"v":0.605146120274116,"d":"0.61"},"down","no"]
["MSTRG.7707","MAPKAPK5;ENSOARG00000004766","ENSOART00000011510;ENSOART00000005191","GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0007265(Ras protein signal transduction);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0046777(protein autophosphorylation);GO:0051973(positive regulation of telomerase activity);GO:0090400(stress-induced premature senescence);GO:1904355(positive regulation of telomere capping);GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","04010(MAPK signaling pathway)","K04442;K08607","EC:2.7.11.1;EC:3.4.24.-","mitogen-activated protein kinase-activated protein kinase 5 [Source:NCBI gene;Acc:101116258];disintegrin and metalloproteinase domain-containing protein 1a-like [Source:NCBI gene;Acc:101110970]",{"v":4.09369443977678,"d":"4.09"},{"v":3.82647948728879,"d":"3.83"},{"v":3.74819658781584,"d":"3.75"},{"v":3.51416844923268,"d":"3.51"},{"v":2.87003167733685,"d":"2.87"},{"v":2.49870167849946,"d":"2.50"},{"v":1.31357643830115,"d":"1.31"},{"v":0.393500154753523,"d":"0.39"},{"v":0.127023363688632,"d":"0.13"},{"v":0.605735246001165,"d":"0.61"},"up","no"]
["MSTRG.17039","KBTBD2","ENSOART00000007371","GO:0005515(protein binding)","NA","K10470","NA","kelch repeat and BTB domain containing 2 [Source:NCBI gene;Acc:101120743]",{"v":5.38356820221263,"d":"5.38"},{"v":4.15123464948732,"d":"4.15"},{"v":3.58811086799784,"d":"3.59"},{"v":3.38225165682677,"d":"3.38"},{"v":3.21262014824609,"d":"3.21"},{"v":3.24290305342688,"d":"3.24"},{"v":1.3339310879187,"d":"1.33"},{"v":0.415684137522539,"d":"0.42"},{"v":0.127342021479807,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"up","no"]
["MSTRG.21714","DIPK2B","ENSOART00000004846","NA","NA","NA","NA","divergent protein kinase domain 2B [Source:NCBI gene;Acc:101107931]",{"v":8.318227,"d":"8.32"},{"v":5.45564,"d":"5.46"},{"v":7.059555,"d":"7.06"},{"v":11.685384,"d":"11.69"},{"v":10.652234,"d":"10.65"},{"v":8.730659,"d":"8.73"},{"v":0.670568953662928,"d":"0.67"},{"v":-0.576542404826617,"d":"-0.58"},{"v":0.127451416200704,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"down","no"]
["MSTRG.10026","ENSOARG00000009285","ENSOART00000010105","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0051082(unfolded protein binding)","NA","NA","NA",null,{"v":0.936483,"d":"0.94"},{"v":1.012244,"d":"1.01"},{"v":1.16433,"d":"1.16"},{"v":1.06795,"d":"1.07"},{"v":2.129117,"d":"2.13"},{"v":1.963964,"d":"1.96"},{"v":0.60318510003137,"d":"0.60"},{"v":-0.729327303509482,"d":"-0.73"},{"v":0.127621102065991,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"down","no"]
["MSTRG.19370","ENSOARG00000016987","ENSOART00000018502","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA","NA","NA","angiogenic factor with G-patch and FHA domains 1 [Source:NCBI gene;Acc:100037685]",{"v":3.36804389741664,"d":"3.37"},{"v":3.1868043606188,"d":"3.19"},{"v":2.69167498993692,"d":"2.69"},{"v":2.68523403289276,"d":"2.69"},{"v":2.5080678829979,"d":"2.51"},{"v":1.81395850480625,"d":"1.81"},{"v":1.31956323767581,"d":"1.32"},{"v":0.400060490865144,"d":"0.40"},{"v":0.127686283590853,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"up","no"]
["MSTRG.17347","ENSOARG00000016314","ENSOART00000017766","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":1.23908555324459,"d":"1.24"},{"v":0.632452712146423,"d":"0.63"},{"v":0.967727121464226,"d":"0.97"},{"v":0.652730515806988,"d":"0.65"},{"v":0.462858756239601,"d":"0.46"},{"v":0.668404392678869,"d":"0.67"},{"v":1.59152212420675,"d":"1.59"},{"v":0.670407212431893,"d":"0.67"},{"v":0.127715098176944,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"up","no"]
["MSTRG.7504","GUCY1A1","ENSOART00000008958","GO:0000166(nucleotide binding);GO:0004383(guanylate cyclase activity);GO:0006182(cGMP biosynthetic process);GO:0008074(guanylate cyclase complex, soluble);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016829(lyase activity);GO:0016849(phosphorus-oxygen lyase activity);GO:0020037(heme binding);GO:0035556(intracellular signal transduction)","00230(Purine metabolism);04022(cGMP-PKG signaling pathway);04270(Vascular smooth muscle contraction);04540(Gap junction);04611(Platelet activation);04713(Circadian entrainment);04730(Long-term depression);04921(Oxytocin signaling pathway);04924(Renin secretion);04970(Salivary secretion)","K12318","EC:4.6.1.2","guanylate cyclase 1 soluble subunit alpha 1 [Source:NCBI gene;Acc:101110000]",{"v":4.38109228259731,"d":"4.38"},{"v":2.80190618746727,"d":"2.80"},{"v":2.64729895121313,"d":"2.65"},{"v":5.37334622927212,"d":"5.37"},{"v":5.16942711406877,"d":"5.17"},{"v":4.25150495252225,"d":"4.25"},{"v":0.664466168926031,"d":"0.66"},{"v":-0.589732347854147,"d":"-0.59"},{"v":0.127751781300203,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"down","no"]
["MSTRG.8078","CHD2","ENSOART00000011269;ENSOART00000011273","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006974(cellular response to DNA damage stimulus);GO:0007517(muscle organ development);GO:0042393(histone binding);GO:0043231(intracellular membrane-bounded organelle);GO:0060218(hematopoietic stem cell differentiation);GO:0060218(hematopoietic stem cell differentiation)","NA","K20091","EC:3.6.4.12","chromodomain helicase DNA binding protein 2 [Source:NCBI gene;Acc:101119938]",{"v":4.71600964901166,"d":"4.72"},{"v":4.8655275897111,"d":"4.87"},{"v":4.66109901735935,"d":"4.66"},{"v":5.16487650844737,"d":"5.16"},{"v":2.91607733193952,"d":"2.92"},{"v":2.70667638879034,"d":"2.71"},{"v":1.32027479191492,"d":"1.32"},{"v":0.400838232367047,"d":"0.40"},{"v":0.127762905239563,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"up","no"]
["MSTRG.13510","MAPK3;GDPD3","ENSOART00000004038;ENSOART00000004098","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000187(activation of MAPK activity);GO:0001784(phosphotyrosine residue binding);GO:0001934(positive regulation of protein phosphorylation);GO:0002741(positive regulation of cytokine secretion involved in immune response);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004707(MAP kinase activity);GO:0004708(MAP kinase kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006351(transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0006975(DNA damage induced protein phosphorylation);GO:0009887(animal organ morphogenesis);GO:0010628(positive regulation of gene expression);GO:0010759(positive regulation of macrophage chemotaxis);GO:0014032(neural crest cell development);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019233(sensory perception of pain);GO:0019902(phosphatase binding);GO:0030278(regulation of ossification);GO:0030509(BMP signaling pathway);GO:0030641(regulation of cellular pH);GO:0030878(thyroid gland development);GO:0031143(pseudopodium);GO:0031281(positive regulation of cyclase activity);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0032496(response to lipopolysaccharide);GO:0033129(positive regulation of histone phosphorylation);GO:0034198(cellular response to amino acid starvation);GO:0034614(cellular response to reactive oxygen species);GO:0035066(positive regulation of histone acetylation);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042473(outer ear morphogenesis);GO:0042802(identical protein binding);GO:0043330(response to exogenous dsRNA);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048538(thymus development);GO:0051090(regulation of DNA-binding transcription factor activity);GO:0051216(cartilage development);GO:0051403(stress-activated MAPK cascade);GO:0051973(positive regulation of telomerase activity);GO:0060020(Bergmann glial cell differentiation);GO:0060324(face development);GO:0060425(lung morphogenesis);GO:0060440(trachea formation);GO:0061308(cardiac neural crest cell development involved in heart development);GO:0070371(ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070849(response to epidermal growth factor);GO:0071260(cellular response to mechanical stimulus);GO:0071276(cellular response to cadmium ion);GO:0071356(cellular response to tumor necrosis factor);GO:1903351(cellular response to dopamine);GO:1904355(positive regulation of telomere capping);GO:1904417(positive regulation of xenophagy);GO:1905050(positive regulation of metallopeptidase activity);GO:2000657(negative regulation of apolipoprotein binding);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006644(phospholipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034638(phosphatidylcholine catabolic process);GO:0048471(perinuclear region of cytoplasm)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);01524(Platinum drug resistance);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04114(Oocyte meiosis);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04218(Cellular senescence);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04350(TGF-beta signaling pathway);04360(Axon guidance);04370(VEGF signaling pathway);04371(Apelin signaling pathway);04380(Osteoclast differentiation);04510(Focal adhesion);04520(Adherens junction);04540(Gap junction);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04657(IL-17 signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);04668(TNF signaling pathway);04713(Circadian entrainment);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04730(Long-term depression);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04921(Oxytocin signaling pathway);04926(Relaxin signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);04930(Type II diabetes mellitus);04933(AGE-RAGE signaling pathway in diabetic complications);04934(Cushing syndrome);04960(Aldosterone-regulated sodium reabsorption);05010(Alzheimer disease);05020(Prion diseases);05034(Alcoholism);05132(Salmonella infection);05133(Pertussis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05145(Toxoplasmosis);05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05163(Human cytomegalovirus infection);05164(Influenza A);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05205(Proteoglycans in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05216(Thyroid cancer);05218(Melanoma);05219(Bladder cancer);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05230(Central carbon metabolism in cancer);05231(Choline metabolism in cancer);00565(Ether lipid metabolism)","K04371;K22387","EC:2.7.11.24;EC:3.1.4.39","mitogen-activated protein kinase 3 [Source:NCBI gene;Acc:101123008];glycerophosphodiester phosphodiesterase domain containing 3 [Source:NCBI gene;Acc:101114996]",{"v":4.85488790470685,"d":"4.85"},{"v":3.67953953889348,"d":"3.68"},{"v":3.6500764629232,"d":"3.65"},{"v":5.85667943980182,"d":"5.86"},{"v":5.79388199603634,"d":"5.79"},{"v":6.36578586705202,"d":"6.37"},{"v":0.676302676767832,"d":"0.68"},{"v":-0.56425903100967,"d":"-0.56"},{"v":0.127782695467563,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"down","no"]
["MSTRG.693","TTF2","ENSOART00000022070","GO:0005524(ATP binding);GO:0005829(cytosol);GO:0008270(zinc ion binding)","04918(Thyroid hormone synthesis)","K15173","EC:3.6.4.-","transcription termination factor 2 [Source:NCBI gene;Acc:101107238]",{"v":1.55372131309981,"d":"1.55"},{"v":1.95254840810941,"d":"1.95"},{"v":1.43824173680422,"d":"1.44"},{"v":1.20737699304223,"d":"1.21"},{"v":1.29105864947217,"d":"1.29"},{"v":1.10885579798464,"d":"1.11"},{"v":1.37069919067294,"d":"1.37"},{"v":0.454911996543511,"d":"0.45"},{"v":0.127800088306593,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"up","no"]
["MSTRG.4112","TMEM51","ENSOART00000011303","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 51 [Source:NCBI gene;Acc:101111728]",{"v":2.28754,"d":"2.29"},{"v":2.44587,"d":"2.45"},{"v":1.780706,"d":"1.78"},{"v":3.575011,"d":"3.58"},{"v":2.814829,"d":"2.81"},{"v":4.030889,"d":"4.03"},{"v":0.625111352574278,"d":"0.63"},{"v":-0.677814891516538,"d":"-0.68"},{"v":0.12781279046745,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"down","no"]
["MSTRG.3701","TMEM183A","ENSOART00000000712","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 183A [Source:NCBI gene;Acc:101109550]",{"v":4.2446688959907,"d":"4.24"},{"v":3.91814506914585,"d":"3.92"},{"v":5.32556053108658,"d":"5.33"},{"v":6.9603111353864,"d":"6.96"},{"v":6.75191998954096,"d":"6.75"},{"v":6.57121757117955,"d":"6.57"},{"v":0.664994138734012,"d":"0.66"},{"v":-0.588586470148182,"d":"-0.59"},{"v":0.12781878347896,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"down","no"]
["MSTRG.10919","RPS6KA1","ENSOART00000004784","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0035556(intracellular signal transduction);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000491(positive regulation of hepatic stellate cell activation)","04010(MAPK signaling pathway);04114(Oocyte meiosis);04150(mTOR signaling pathway);04714(Thermogenesis);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04914(Progesterone-mediated oocyte maturation);04931(Insulin resistance)","K04373","EC:2.7.11.1","ribosomal protein S6 kinase A1 [Source:NCBI gene;Acc:101110124]",{"v":0.741728,"d":"0.74"},{"v":0.362537,"d":"0.36"},{"v":0.640713,"d":"0.64"},{"v":1.185726,"d":"1.19"},{"v":0.830585,"d":"0.83"},{"v":0.830773,"d":"0.83"},{"v":0.612900076007593,"d":"0.61"},{"v":-0.706276211182078,"d":"-0.71"},{"v":0.12784577733525,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"down","no"]
["MSTRG.4293","HSD11B1","ENSOART00000014154","GO:0003845(11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0030324(lung development);GO:0055114(oxidation-reduction process)","00140(Steroid hormone biosynthesis);00980(Metabolism of xenobiotics by cytochrome P450);05204(Chemical carcinogenesis)","K15680","EC:1.1.1.146","hydroxysteroid 11-beta dehydrogenase 1 [Source:NCBI gene;Acc:443409]",{"v":1.778543,"d":"1.78"},{"v":1.709725,"d":"1.71"},{"v":1.497161,"d":"1.50"},{"v":2.163041,"d":"2.16"},{"v":2.556216,"d":"2.56"},{"v":3.209809,"d":"3.21"},{"v":0.628753626215244,"d":"0.63"},{"v":-0.669433279479871,"d":"-0.67"},{"v":0.12785172098479,"d":"0.13"},{"v":0.606320912064957,"d":"0.61"},"down","no"]
["ENSOARG00000010454","TAF1C","ENSOART00000011386","GO:0001164(RNA polymerase I CORE element sequence-specific DNA binding);GO:0001188(RNA polymerase I preinitiation complex assembly);GO:0001650(fibrillar center);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006360(transcription by RNA polymerase I)","NA","K15214","NA","TATA-box binding protein associated factor, RNA polymerase I subunit C [Source:NCBI gene;Acc:101123064]",{"v":0.513456,"d":"0.51"},{"v":0.394823,"d":"0.39"},{"v":0.404576,"d":"0.40"},{"v":0.828005,"d":"0.83"},{"v":0.760819,"d":"0.76"},{"v":0.609426,"d":"0.61"},{"v":0.59722733992949,"d":"0.60"},{"v":-0.743647884073545,"d":"-0.74"},{"v":0.127931759253761,"d":"0.13"},{"v":0.606348262727261,"d":"0.61"},"down","no"]
["ENSOARG00000003926","CARMIL1","ENSOART00000004283;ENSOART00000004284","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0016477(cell migration);GO:0016607(nuclear speck);GO:0030027(lamellipodium);GO:0030032(lamellipodium assembly);GO:0030335(positive regulation of cell migration);GO:0030838(positive regulation of actin filament polymerization);GO:0031252(cell leading edge);GO:0031529(ruffle organization);GO:0031941(filamentous actin);GO:0044351(macropinocytosis);GO:0044354(macropinosome);GO:0044877(protein-containing complex binding);GO:0046415(urate metabolic process);GO:0051496(positive regulation of stress fiber assembly);GO:0051638(barbed-end actin filament uncapping);GO:0051639(actin filament network formation);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1902745(positive regulation of lamellipodium organization);GO:2000813(negative regulation of barbed-end actin filament capping);GO:2000813(negative regulation of barbed-end actin filament capping)","NA","K20493","NA","capping protein regulator and myosin 1 linker 1 [Source:NCBI gene;Acc:101116184]",{"v":0.588027333488915,"d":"0.59"},{"v":0.345200901750292,"d":"0.35"},{"v":0.396058430805134,"d":"0.40"},{"v":0.494563298949825,"d":"0.49"},{"v":0.836297275145858,"d":"0.84"},{"v":0.836457486114352,"d":"0.84"},{"v":0.613332528551679,"d":"0.61"},{"v":-0.705258627463754,"d":"-0.71"},{"v":0.127976182534176,"d":"0.13"},{"v":0.606382794085322,"d":"0.61"},"down","no"]
["ENSOARG00000019445","ENSOARG00000019445","ENSOART00000021175;ENSOART00000021176","NA","NA","NA","NA",null,{"v":0.419802942209516,"d":"0.42"},{"v":0.302619808045742,"d":"0.30"},{"v":0.269759470696345,"d":"0.27"},{"v":0.27669536777619,"d":"0.28"},{"v":0.154813261997141,"d":"0.15"},{"v":0.218443138247907,"d":"0.22"},{"v":1.52654746054815,"d":"1.53"},{"v":0.610272443808079,"d":"0.61"},{"v":0.12806853116265,"d":"0.13"},{"v":0.606644321677908,"d":"0.61"},"up","no"]
["MSTRG.8995","SLMAP","ENSOART00000014292;ENSOART00000014293","GO:0005515(protein binding);GO:0006936(muscle contraction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0072659(protein localization to plasma membrane);GO:1900825(regulation of membrane depolarization during cardiac muscle cell action potential);GO:1902305(regulation of sodium ion transmembrane transport);GO:1905150(regulation of voltage-gated sodium channel activity);GO:1905150(regulation of voltage-gated sodium channel activity)","NA","NA","NA","sarcolemma associated protein [Source:NCBI gene;Acc:101123588]",{"v":4.38957020690881,"d":"4.39"},{"v":4.18161722539551,"d":"4.18"},{"v":3.71374524613379,"d":"3.71"},{"v":3.46005732624282,"d":"3.46"},{"v":3.24636146560408,"d":"3.25"},{"v":2.61995671600403,"d":"2.62"},{"v":1.31722475339929,"d":"1.32"},{"v":0.397501528548213,"d":"0.40"},{"v":0.128192230324639,"d":"0.13"},{"v":0.607054157987445,"d":"0.61"},"up","no"]
["ENSOARG00000021016","CLEC1A","ENSOART00000022897","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding)","NA","K10069","NA","C-type lectin domain family 1 member A [Source:NCBI gene;Acc:101118775]",{"v":0.744365,"d":"0.74"},{"v":0.831373,"d":"0.83"},{"v":0.802697,"d":"0.80"},{"v":1.232179,"d":"1.23"},{"v":1.76487,"d":"1.76"},{"v":1.163098,"d":"1.16"},{"v":0.571718980122577,"d":"0.57"},{"v":-0.806621908736414,"d":"-0.81"},{"v":0.128309047147217,"d":"0.13"},{"v":0.607079142804915,"d":"0.61"},"down","no"]
["MSTRG.16744","AKAP9","ENSOART00000018537","GO:0003677(DNA binding);GO:0005794(Golgi apparatus);GO:0005795(Golgi stack);GO:0005801(cis-Golgi network);GO:0005813(centrosome);GO:0007020(microtubule nucleation);GO:0007165(signal transduction);GO:0008076(voltage-gated potassium channel complex);GO:0015459(potassium channel regulator activity);GO:0031116(positive regulation of microtubule polymerization);GO:0032947(protein-containing complex scaffold activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034237(protein kinase A regulatory subunit binding);GO:0043231(intracellular membrane-bounded organelle);GO:0044325(ion channel binding);GO:0051661(maintenance of centrosome location);GO:0060306(regulation of membrane repolarization);GO:0060307(regulation of ventricular cardiac muscle cell membrane repolarization);GO:0071320(cellular response to cAMP);GO:0086091(regulation of heart rate by cardiac conduction);GO:0098909(regulation of cardiac muscle cell action potential involved in regulation of contraction);GO:0098962(regulation of postsynaptic neurotransmitter receptor activity);GO:0098978(glutamatergic synapse);GO:1901018(positive regulation of potassium ion transmembrane transporter activity);GO:1903358(regulation of Golgi organization)","NA","K16551","NA","A-kinase anchoring protein 9 [Source:NCBI gene;Acc:101109958]",{"v":3.82522109266146,"d":"3.83"},{"v":3.19567457145025,"d":"3.20"},{"v":2.776428183198,"d":"2.78"},{"v":2.44762585353267,"d":"2.45"},{"v":2.92888095598391,"d":"2.93"},{"v":2.00943548561888,"d":"2.01"},{"v":1.32648258757213,"d":"1.33"},{"v":0.407605737769234,"d":"0.41"},{"v":0.128449020761755,"d":"0.13"},{"v":0.607301199526525,"d":"0.61"},"up","no"]
["MSTRG.10144","GULP1","ENSOART00000017981","GO:0005515(protein binding);GO:0006911(phagocytosis, engulfment)","NA","K23285","NA","GULP PTB domain containing engulfment adaptor 1 [Source:NCBI gene;Acc:101115004]",{"v":1.751031,"d":"1.75"},{"v":0.873789,"d":"0.87"},{"v":0.715504,"d":"0.72"},{"v":1.491558,"d":"1.49"},{"v":2.096225,"d":"2.10"},{"v":2.087981,"d":"2.09"},{"v":0.588524117634208,"d":"0.59"},{"v":-0.764826556975682,"d":"-0.76"},{"v":0.128460702235223,"d":"0.13"},{"v":0.607301199526525,"d":"0.61"},"down","no"]
["MSTRG.5728","DMAC2","ENSOART00000007964","GO:0005747(mitochondrial respiratory chain complex I);GO:0032981(mitochondrial respiratory chain complex I assembly)","NA","NA","NA","distal membrane arm assembly complex 2 [Source:NCBI gene;Acc:101122972]",{"v":7.24981626835552,"d":"7.25"},{"v":5.61114193688278,"d":"5.61"},{"v":9.14167564620008,"d":"9.14"},{"v":6.53776278488622,"d":"6.54"},{"v":5.38496835337055,"d":"5.38"},{"v":4.49077005882353,"d":"4.49"},{"v":1.3405204402917,"d":"1.34"},{"v":0.422793217740944,"d":"0.42"},{"v":0.128496387067462,"d":"0.13"},{"v":0.607301199526525,"d":"0.61"},"up","no"]
["ENSOARG00000005331","HEPH","ENSOART00000005815","GO:0004322(ferroxidase activity);GO:0005507(copper ion binding);GO:0005886(plasma membrane);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008198(ferrous iron binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016491(oxidoreductase activity);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00860(Porphyrin and chlorophyll metabolism);04978(Mineral absorption)","K14735","EC:1.16.3.1","hephaestin [Source:NCBI gene;Acc:101113655]",{"v":0.158456,"d":"0.16"},{"v":0.109704,"d":"0.11"},{"v":0.149445,"d":"0.15"},{"v":0.279302,"d":"0.28"},{"v":0.156239,"d":"0.16"},{"v":0.263867,"d":"0.26"},{"v":0.597083533502619,"d":"0.60"},{"v":-0.743995312577314,"d":"-0.74"},{"v":0.128630333034874,"d":"0.13"},{"v":0.607567954010726,"d":"0.61"},"down","no"]
["MSTRG.3533","LGALS3BP","ENSOART00000003532","GO:0005044(scavenger receptor activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0006898(receptor-mediated endocytosis);GO:0016020(membrane)","NA","K17300","NA","galectin 3 binding protein [Source:NCBI gene;Acc:101112495]",{"v":2.986985,"d":"2.99"},{"v":1.893824,"d":"1.89"},{"v":1.556133,"d":"1.56"},{"v":3.077017,"d":"3.08"},{"v":3.181462,"d":"3.18"},{"v":3.723938,"d":"3.72"},{"v":0.644828001074289,"d":"0.64"},{"v":-0.633013701930443,"d":"-0.63"},{"v":0.128635620836298,"d":"0.13"},{"v":0.607567954010726,"d":"0.61"},"down","no"]
["MSTRG.11398","ABHD16A","ENSOART00000006729","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0047372(acylglycerol lipase activity);GO:0052651(monoacylglycerol catabolic process);GO:1905344(prostaglandin catabolic process)","NA","NA","NA","abhydrolase domain containing 16A [Source:NCBI gene;Acc:101118906]",{"v":6.034834,"d":"6.03"},{"v":5.119042,"d":"5.12"},{"v":5.408008,"d":"5.41"},{"v":8.569326,"d":"8.57"},{"v":6.841262,"d":"6.84"},{"v":9.144242,"d":"9.14"},{"v":0.674485793630011,"d":"0.67"},{"v":-0.568140038185834,"d":"-0.57"},{"v":0.128839153652757,"d":"0.13"},{"v":0.608177421463491,"d":"0.61"},"down","no"]
["MSTRG.17030","BMPER","ENSOART00000006561","GO:0001657(ureteric bud development);GO:0002043(blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010594(regulation of endothelial cell migration);GO:0030514(negative regulation of BMP signaling pathway);GO:0042118(endothelial cell activation);GO:0048839(inner ear development);GO:0060393(regulation of pathway-restricted SMAD protein phosphorylation);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:1903672(positive regulation of sprouting angiogenesis)","NA","NA","NA","BMP binding endothelial regulator [Source:NCBI gene;Acc:101118437]",{"v":1.056084,"d":"1.06"},{"v":0.695728,"d":"0.70"},{"v":1.312025,"d":"1.31"},{"v":1.972899,"d":"1.97"},{"v":1.476676,"d":"1.48"},{"v":1.495986,"d":"1.50"},{"v":0.619512528507888,"d":"0.62"},{"v":-0.69079463635775,"d":"-0.69"},{"v":0.128902470894169,"d":"0.13"},{"v":0.608300446462425,"d":"0.61"},"down","no"]
["MSTRG.3995","SPSB1;H6PD","ENSOART00000009448;ENSOART00000009543","GO:0005515(protein binding);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:1990756(protein binding, bridging involved in substrate recognition for ubiquitination);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0006098(pentose-phosphate shunt);GO:0017057(6-phosphogluconolactonase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process)","00030(Pentose phosphate pathway)","K10343;K13937","3.1.1.31;EC:1.1.1.47","splA/ryanodine receptor domain and SOCS box containing 1 [Source:NCBI gene;Acc:101117602];hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase [Source:NCBI gene;Acc:101114124]",{"v":1.83993203657441,"d":"1.84"},{"v":3.45666355786118,"d":"3.46"},{"v":2.29322781898276,"d":"2.29"},{"v":1.06657384874656,"d":"1.07"},{"v":2.19578026257064,"d":"2.20"},{"v":1.97038967181568,"d":"1.97"},{"v":1.45044812587294,"d":"1.45"},{"v":0.536498699614423,"d":"0.54"},{"v":0.128947796569251,"d":"0.13"},{"v":0.608338521347219,"d":"0.61"},"up","no"]
["MSTRG.18672","GAR1","ENSOART00000005348","GO:0000784(nuclear chromosome, telomeric region);GO:0001522(pseudouridine synthesis);GO:0001650(fibrillar center);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005697(telomerase holoenzyme complex);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0007004(telomere maintenance via telomerase);GO:0031429(box H/ACA snoRNP complex);GO:0034513(box H/ACA snoRNA binding);GO:0042254(ribosome biogenesis);GO:0070034(telomerase RNA binding);GO:0090661(box H/ACA telomerase RNP complex)","03008(Ribosome biogenesis in eukaryotes)","K11128","NA","GAR1 ribonucleoprotein [Source:NCBI gene;Acc:101119047]",{"v":1.136856,"d":"1.14"},{"v":1.525655,"d":"1.53"},{"v":1.741516,"d":"1.74"},{"v":1.2399,"d":"1.24"},{"v":0.762668,"d":"0.76"},{"v":0.813812,"d":"0.81"},{"v":1.56371902939234,"d":"1.56"},{"v":0.644981311035666,"d":"0.64"},{"v":0.129105923754053,"d":"0.13"},{"v":0.608557021667489,"d":"0.61"},"up","no"]
["MSTRG.9531","PTCH1","ENSOART00000009343","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001701(in utero embryonic development);GO:0001709(cell fate determination);GO:0001841(neural tube formation);GO:0001843(neural tube closure);GO:0003007(heart morphogenesis);GO:0005113(patched binding);GO:0005119(smoothened binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0005929(cilium);GO:0007165(signal transduction);GO:0007224(smoothened signaling pathway);GO:0007346(regulation of mitotic cell cycle);GO:0007389(pattern specification process);GO:0007420(brain development);GO:0008158(hedgehog receptor activity);GO:0008201(heparin binding);GO:0008285(negative regulation of cell population proliferation);GO:0008544(epidermis development);GO:0008589(regulation of smoothened signaling pathway);GO:0009887(animal organ morphogenesis);GO:0009953(dorsal/ventral pattern formation);GO:0009957(epidermal cell fate specification);GO:0010157(response to chlorate);GO:0010875(positive regulation of cholesterol efflux);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0021522(spinal cord motor neuron differentiation);GO:0021532(neural tube patterning);GO:0021904(dorsal/ventral neural tube patterning);GO:0021997(neural plate axis specification);GO:0030326(embryonic limb morphogenesis);GO:0030332(cyclin binding);GO:0030496(midbody);GO:0030879(mammary gland development);GO:0032880(regulation of protein localization);GO:0035108(limb morphogenesis);GO:0035137(hindlimb morphogenesis);GO:0040008(regulation of growth);GO:0040015(negative regulation of multicellular organism growth);GO:0042127(regulation of cell population proliferation);GO:0042593(glucose homeostasis);GO:0043231(intracellular membrane-bounded organelle);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043616(keratinocyte proliferation);GO:0044877(protein-containing complex binding);GO:0045606(positive regulation of epidermal cell differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045879(negative regulation of smoothened signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048471(perinuclear region of cytoplasm);GO:0048568(embryonic organ development);GO:0050680(negative regulation of epithelial cell proliferation);GO:0051782(negative regulation of cell division);GO:0060037(pharyngeal system development);GO:0060603(mammary gland duct morphogenesis);GO:0060644(mammary gland epithelial cell differentiation);GO:0060831(smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:0061005(cell differentiation involved in kidney development);GO:0061053(somite development);GO:0071397(cellular response to cholesterol);GO:0072001(renal system development);GO:0072203(cell proliferation involved in metanephros development);GO:0072659(protein localization to plasma membrane);GO:0097108(hedgehog family protein binding)","04024(cAMP signaling pathway);04340(Hedgehog signaling pathway);04360(Axon guidance);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma)","K06225","NA","patched 1 [Source:NCBI gene;Acc:101112193]",{"v":1.93417331282993,"d":"1.93"},{"v":0.947933853109938,"d":"0.95"},{"v":1.16483740188203,"d":"1.16"},{"v":2.59437641863668,"d":"2.59"},{"v":2.07045041496443,"d":"2.07"},{"v":1.66476394170301,"d":"1.66"},{"v":0.639369070052946,"d":"0.64"},{"v":-0.645279140510148,"d":"-0.65"},{"v":0.129368183083085,"d":"0.13"},{"v":0.60891027339455,"d":"0.61"},"down","no"]
["ENSOARG00000020270","EPHA4","ENSOART00000022072;ENSOART00000022071","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005004(GPI-linked ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007628(adult walking behavior);GO:0008045(motor neuron axon guidance);GO:0010977(negative regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031901(early endosome membrane);GO:0042731(PH domain binding);GO:0042802(identical protein binding);GO:0043087(regulation of GTPase activity);GO:0043507(positive regulation of JUN kinase activity);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0048681(negative regulation of axon regeneration);GO:0048710(regulation of astrocyte differentiation);GO:0050770(regulation of axonogenesis);GO:0050821(protein stabilization);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0072178(nephric duct morphogenesis);GO:0097155(fasciculation of sensory neuron axon);GO:0097156(fasciculation of motor neuron axon);GO:0097161(DH domain binding);GO:0097485(neuron projection guidance);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098883(synapse pruning);GO:0098978(glutamatergic synapse);GO:0099055(integral component of postsynaptic membrane);GO:0099056(integral component of presynaptic membrane);GO:0106030(neuron projection fasciculation);GO:1900272(negative regulation of long-term synaptic potentiation);GO:1902004(positive regulation of amyloid-beta formation);GO:1902961(positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process);GO:1903051(negative regulation of proteolysis involved in cellular protein catabolic process);GO:1904646(cellular response to amyloid-beta);GO:1905244(regulation of modification of synaptic structure);GO:1990782(protein tyrosine kinase binding);GO:2001108(positive regulation of Rho guanyl-nucleotide exchange factor activity);GO:2001108(positive regulation of Rho guanyl-nucleotide exchange factor activity)","04360(Axon guidance);04360(Axon guidance)","K05105","EC:2.7.10.1","EPH receptor A4 [Source:NCBI gene;Acc:101118852]",{"v":0.78493035971223,"d":"0.78"},{"v":0.217114174717369,"d":"0.22"},{"v":0.348305722507708,"d":"0.35"},{"v":0.896635376670092,"d":"0.90"},{"v":0.581293529290853,"d":"0.58"},{"v":0.860153720966084,"d":"0.86"},{"v":0.577545994904418,"d":"0.58"},{"v":-0.791992249695171,"d":"-0.79"},{"v":0.129386389961377,"d":"0.13"},{"v":0.60891027339455,"d":"0.61"},"down","no"]
["MSTRG.2618","TUBD1","ENSOART00000015398","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005874(microtubule);GO:0007010(cytoskeleton organization);GO:0007017(microtubule-based process)","NA","K10390","NA","tubulin delta 1 [Source:NCBI gene;Acc:101106182]",{"v":0.876899,"d":"0.88"},{"v":0.866195,"d":"0.87"},{"v":0.481856,"d":"0.48"},{"v":1.423825,"d":"1.42"},{"v":0.992212,"d":"0.99"},{"v":1.272428,"d":"1.27"},{"v":0.603218411995234,"d":"0.60"},{"v":-0.729247630324512,"d":"-0.73"},{"v":0.12941276599197,"d":"0.13"},{"v":0.60891027339455,"d":"0.61"},"down","no"]
["MSTRG.5768","ENSOARG00000008686","ENSOART00000009454","NA","NA","NA","NA","zinc finger protein 575 [Source:NCBI gene;Acc:101106029]",{"v":0.305802,"d":"0.31"},{"v":0.294,"d":"0.29"},{"v":0.398996,"d":"0.40"},{"v":0.210549,"d":"0.21"},{"v":0.769142,"d":"0.77"},{"v":0.946542,"d":"0.95"},{"v":0.518523979186319,"d":"0.52"},{"v":-0.94751738674904,"d":"-0.95"},{"v":0.129440771094851,"d":"0.13"},{"v":0.60891027339455,"d":"0.61"},"down","no"]
["MSTRG.16951","SFRP4","ENSOART00000009693","GO:0002092(positive regulation of receptor internalization);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007275(multicellular organism development);GO:0008285(negative regulation of cell population proliferation);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0030510(regulation of BMP signaling pathway);GO:0043065(positive regulation of apoptotic process);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045606(positive regulation of epidermal cell differentiation);GO:0055062(phosphate ion homeostasis);GO:0060349(bone morphogenesis);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:1902174(positive regulation of keratinocyte apoptotic process);GO:2000051(negative regulation of non-canonical Wnt signaling pathway);GO:2000119(negative regulation of sodium-dependent phosphate transport)","04310(Wnt signaling pathway)","K02185","NA","secreted frizzled related protein 4 [Source:NCBI gene;Acc:101107858]",{"v":3.739954,"d":"3.74"},{"v":2.881528,"d":"2.88"},{"v":3.572695,"d":"3.57"},{"v":1.022711,"d":"1.02"},{"v":2.493455,"d":"2.49"},{"v":2.964181,"d":"2.96"},{"v":1.57309122489891,"d":"1.57"},{"v":0.65360233629277,"d":"0.65"},{"v":0.12944191321365,"d":"0.13"},{"v":0.60891027339455,"d":"0.61"},"up","no"]
["MSTRG.4866","PPP1R3D","ENSOART00000005217","GO:0005515(protein binding);GO:0005975(carbohydrate metabolic process);GO:0005977(glycogen metabolic process)","04910(Insulin signaling pathway);04931(Insulin resistance)","K07189","NA","protein phosphatase 1 regulatory subunit 3D [Source:NCBI gene;Acc:101113779]",{"v":1.604273,"d":"1.60"},{"v":1.974058,"d":"1.97"},{"v":1.760782,"d":"1.76"},{"v":1.146356,"d":"1.15"},{"v":1.238331,"d":"1.24"},{"v":1.205246,"d":"1.21"},{"v":1.48724586224868,"d":"1.49"},{"v":0.572643164489557,"d":"0.57"},{"v":0.129616140822697,"d":"0.13"},{"v":0.609378735200977,"d":"0.61"},"up","no"]
["MSTRG.4936","NOL4L","ENSOART00000004219","GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA","NA","NA","nucleolar protein 4 like [Source:NCBI gene;Acc:101113950]",{"v":0.264473,"d":"0.26"},{"v":0.337529,"d":"0.34"},{"v":0.400114,"d":"0.40"},{"v":0.679381,"d":"0.68"},{"v":0.636765,"d":"0.64"},{"v":0.455193,"d":"0.46"},{"v":0.565739251492797,"d":"0.57"},{"v":-0.821790824967169,"d":"-0.82"},{"v":0.129673358151701,"d":"0.13"},{"v":0.609472248676159,"d":"0.61"},"down","no"]
["MSTRG.20029","HSPA2","ENSOART00000001084","GO:0000166(nucleotide binding);GO:0000795(synaptonemal complex);GO:0001673(male germ cell nucleus);GO:0001934(positive regulation of protein phosphorylation);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0007140(male meiotic nuclear division);GO:0007141(male meiosis I);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0009408(response to heat);GO:0009409(response to cold);GO:0009986(cell surface);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0019899(enzyme binding);GO:0032781(positive regulation of ATPase activity);GO:0036128(CatSper complex);GO:0042026(protein refolding);GO:0051082(unfolded protein binding);GO:0051861(glycolipid binding);GO:0070194(synaptonemal complex disassembly);GO:0072687(meiotic spindle);GO:0090084(negative regulation of inclusion body assembly);GO:0097718(disordered domain specific binding);GO:1901896(positive regulation of calcium-transporting ATPase activity)","03040(Spliceosome);04010(MAPK signaling pathway);04141(Protein processing in endoplasmic reticulum);04144(Endocytosis);04213(Longevity regulating pathway - multiple species);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);05134(Legionellosis);05145(Toxoplasmosis);05162(Measles);05164(Influenza A)","K03283","NA","heat shock protein family A (Hsp70) member 2 [Source:NCBI gene;Acc:101110063]",{"v":3.017565,"d":"3.02"},{"v":2.245243,"d":"2.25"},{"v":3.634674,"d":"3.63"},{"v":4.049982,"d":"4.05"},{"v":4.870504,"d":"4.87"},{"v":4.731175,"d":"4.73"},{"v":0.651750874856913,"d":"0.65"},{"v":-0.617607480569748,"d":"-0.62"},{"v":0.129821825507496,"d":"0.13"},{"v":0.609554274674517,"d":"0.61"},"down","no"]
["MSTRG.10854","LAPTM5","ENSOART00000002258","GO:0005764(lysosome);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:1990830(cellular response to leukemia inhibitory factor)","04142(Lysosome)","K12387","NA","lysosomal protein transmembrane 5 [Source:NCBI gene;Acc:101121575]",{"v":9.551568,"d":"9.55"},{"v":4.88641,"d":"4.89"},{"v":6.978152,"d":"6.98"},{"v":11.348756,"d":"11.35"},{"v":9.609598,"d":"9.61"},{"v":11.444474,"d":"11.44"},{"v":0.660933977737993,"d":"0.66"},{"v":-0.597421930184958,"d":"-0.60"},{"v":0.129834698527707,"d":"0.13"},{"v":0.609554274674517,"d":"0.61"},"down","no"]
["MSTRG.12571","XPNPEP1","ENSOART00000009825","GO:0004177(aminopeptidase activity);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0010815(bradykinin catabolic process);GO:0016787(hydrolase activity);GO:0030145(manganese ion binding);GO:0042803(protein homodimerization activity);GO:0046872(metal ion binding);GO:0070006(metalloaminopeptidase activity)","NA","K01262","EC:3.4.11.9","X-prolyl aminopeptidase 1 [Source:NCBI gene;Acc:101117381]",{"v":4.31170887025316,"d":"4.31"},{"v":4.07631240822785,"d":"4.08"},{"v":3.91823993987342,"d":"3.92"},{"v":6.67324100316456,"d":"6.67"},{"v":5.87565261708861,"d":"5.88"},{"v":5.69226054746836,"d":"5.69"},{"v":0.674642684624137,"d":"0.67"},{"v":-0.567804494367947,"d":"-0.57"},{"v":0.129840137635838,"d":"0.13"},{"v":0.609554274674517,"d":"0.61"},"down","no"]
["MSTRG.20994","FAM49B","ENSOART00000008482","GO:0001916(positive regulation of T cell mediated cytotoxicity);GO:0005929(cilium);GO:0023030(MHC class Ib protein binding, via antigen binding groove);GO:0032729(positive regulation of interferon-gamma production);GO:0050870(positive regulation of T cell activation);GO:2000568(positive regulation of memory T cell activation)","NA","NA","NA","family with sequence similarity 49 member B [Source:NCBI gene;Acc:101103327]",{"v":2.12318908590679,"d":"2.12"},{"v":1.98472102709152,"d":"1.98"},{"v":1.91830614528355,"d":"1.92"},{"v":1.89389367504211,"d":"1.89"},{"v":1.30502667026951,"d":"1.31"},{"v":1.40208102891634,"d":"1.40"},{"v":1.30976189053911,"d":"1.31"},{"v":0.389304559425519,"d":"0.39"},{"v":0.130104701813379,"d":"0.13"},{"v":0.610620744814274,"d":"0.61"},"up","no"]
["ENSOARG00000006003","IQGAP3","ENSOART00000006538","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000187(activation of MAPK activity);GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005911(cell-cell junction);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0008361(regulation of cell size);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016328(lateral plasma membrane);GO:0017016(Ras GTPase binding);GO:0017048(Rho GTPase binding);GO:0033601(positive regulation of mammary gland epithelial cell proliferation);GO:0043087(regulation of GTPase activity);GO:0070371(ERK1 and ERK2 cascade);GO:0070856(myosin VI light chain binding);GO:0071310(cellular response to organic substance)","04810(Regulation of actin cytoskeleton)","K05767","NA","IQ motif containing GTPase activating protein 3 [Source:NCBI gene;Acc:101108447]",{"v":0.179472,"d":"0.18"},{"v":0.032087,"d":"0.03"},{"v":0.092212,"d":"0.09"},{"v":0.359255,"d":"0.36"},{"v":0.116439,"d":"0.12"},{"v":0.152474,"d":"0.15"},{"v":0.483582417442468,"d":"0.48"},{"v":-1.04816630424925,"d":"-1.05"},{"v":0.130150379486634,"d":"0.13"},{"v":0.610624285005159,"d":"0.61"},"down","no"]
["MSTRG.3883","ENSOARG00000004242","ENSOART00000004621;ENSOART00000004617","GO:0000154(rRNA modification);GO:0000179(rRNA (adenine-N6,N6-)-dimethyltransferase activity);GO:0003712(transcription coregulator activity);GO:0003723(RNA binding);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0006364(rRNA processing);GO:0006391(transcription initiation from mitochondrial promoter);GO:0008168(methyltransferase activity);GO:0008649(rRNA methyltransferase activity);GO:0016740(transferase activity);GO:0031167(rRNA methylation);GO:0032259(methylation);GO:0032259(methylation)","NA","K17653","EC:2.1.1.-","transcription factor B2, mitochondrial [Source:NCBI gene;Acc:101115889]",{"v":3.44562131727795,"d":"3.45"},{"v":4.39514313477684,"d":"4.40"},{"v":4.27406613300928,"d":"4.27"},{"v":3.61288249447636,"d":"3.61"},{"v":2.64673880556783,"d":"2.65"},{"v":2.79274720857269,"d":"2.79"},{"v":1.33830506055206,"d":"1.34"},{"v":0.42040700923898,"d":"0.42"},{"v":0.130234186197604,"d":"0.13"},{"v":0.610701835793933,"d":"0.61"},"up","no"]
["MSTRG.5055","FITM2","ENSOART00000004184","GO:0005789(endoplasmic reticulum membrane);GO:0007010(cytoskeleton organization);GO:0010866(regulation of triglyceride biosynthetic process);GO:0010890(positive regulation of sequestering of triglyceride);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019915(lipid storage);GO:0022604(regulation of cell morphogenesis);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0030730(sequestering of triglyceride);GO:0034389(lipid droplet organization);GO:0035356(cellular triglyceride homeostasis)","NA","NA","NA","fat storage inducing transmembrane protein 2 [Source:NCBI gene;Acc:101108768]",{"v":2.52963578061608,"d":"2.53"},{"v":2.82304882644628,"d":"2.82"},{"v":2.53017321036814,"d":"2.53"},{"v":4.97177144252442,"d":"4.97"},{"v":2.96518382419234,"d":"2.97"},{"v":3.99320991810669,"d":"3.99"},{"v":0.660750098201357,"d":"0.66"},{"v":-0.597823360605686,"d":"-0.60"},{"v":0.130364041847199,"d":"0.13"},{"v":0.610784526622972,"d":"0.61"},"down","no"]
["MSTRG.3334","GRN","ENSOART00000008883","GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005770(late endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007041(lysosomal transport);GO:0007042(lysosomal lumen acidification);GO:0016020(membrane);GO:0030335(positive regulation of cell migration);GO:0043524(negative regulation of neuron apoptotic process);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050821(protein stabilization);GO:0051087(chaperone binding);GO:0060266(negative regulation of respiratory burst involved in inflammatory response);GO:1902564(negative regulation of neutrophil activation);GO:1905247(positive regulation of aspartic-type peptidase activity);GO:1905673(positive regulation of lysosome organization)","NA","NA","NA","granulin precursor [Source:NCBI gene;Acc:101115470]",{"v":4.90070223866348,"d":"4.90"},{"v":4.03213920811456,"d":"4.03"},{"v":5.01858786778043,"d":"5.02"},{"v":6.50261277708831,"d":"6.50"},{"v":6.64693194176611,"d":"6.65"},{"v":7.35983473842482,"d":"7.36"},{"v":0.680246291391659,"d":"0.68"},{"v":-0.55587090876404,"d":"-0.56"},{"v":0.130450527868867,"d":"0.13"},{"v":0.611014405921649,"d":"0.61"},"down","no"]
["MSTRG.9384","ATP6V1G1","ENSOART00000006513","GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008553(proton-exporting ATPase activity, phosphorylative mechanism);GO:0016471(vacuolar proton-transporting V-type ATPase complex);GO:0016887(ATPase activity);GO:0036295(cellular response to increased oxygen levels);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0051117(ATPase binding);GO:1902600(proton transmembrane transport)","00190(Oxidative phosphorylation);04145(Phagosome);04150(mTOR signaling pathway);04721(Synaptic vesicle cycle);04966(Collecting duct acid secretion);05165(Human papillomavirus infection);05323(Rheumatoid arthritis)","K02152","NA","ATPase H+ transporting V1 subunit G1 [Source:NCBI gene;Acc:101103451]",{"v":12.949527,"d":"12.95"},{"v":12.2575521888412,"d":"12.26"},{"v":14.5665848497854,"d":"14.57"},{"v":20.7536135536481,"d":"20.75"},{"v":16.1799395686695,"d":"16.18"},{"v":22.3884518240343,"d":"22.39"},{"v":0.670470663872471,"d":"0.67"},{"v":-0.576753885817425,"d":"-0.58"},{"v":0.130533889225019,"d":"0.13"},{"v":0.611229522014945,"d":"0.61"},"down","no"]
["MSTRG.7015","HSPB3","ENSOART00000006087","GO:0005634(nucleus);GO:0005737(cytoplasm)","NA","K09544","NA","heat shock protein family B (small) member 3 [Source:NCBI gene;Acc:101118384]",{"v":17.0449690016593,"d":"17.04"},{"v":15.3666284441372,"d":"15.37"},{"v":15.6391379170354,"d":"15.64"},{"v":13.0511888373894,"d":"13.05"},{"v":10.3091211205752,"d":"10.31"},{"v":13.0083913705752,"d":"13.01"},{"v":1.32121119554865,"d":"1.32"},{"v":0.401861099754307,"d":"0.40"},{"v":0.130647419995957,"d":"0.13"},{"v":0.611496491164399,"d":"0.61"},"up","no"]
["MSTRG.12068","CDC42BPG","ENSOART00000011182","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0031252(cell leading edge);GO:0031532(actin cytoskeleton reorganization)","NA","K16307","EC:2.7.11.1","CDC42 binding protein kinase gamma [Source:NCBI gene;Acc:101118650]",{"v":0.161678,"d":"0.16"},{"v":0.059072,"d":"0.06"},{"v":0.150788,"d":"0.15"},{"v":0.212081,"d":"0.21"},{"v":0.256986,"d":"0.26"},{"v":0.199546,"d":"0.20"},{"v":0.555684678580883,"d":"0.56"},{"v":-0.847661632248962,"d":"-0.85"},{"v":0.130665804610031,"d":"0.13"},{"v":0.611496491164399,"d":"0.61"},"down","no"]
["MSTRG.2629","MED13","ENSOART00000016306","GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0016592(mediator complex);GO:0042632(cholesterol homeostasis);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046966(thyroid hormone receptor binding);GO:0070328(triglyceride homeostasis)","04919(Thyroid hormone signaling pathway)","K15164","NA","mediator complex subunit 13 [Source:NCBI gene;Acc:101107616]",{"v":15.0052543577473,"d":"15.01"},{"v":15.5007475568037,"d":"15.50"},{"v":14.7128336545346,"d":"14.71"},{"v":13.9395016103497,"d":"13.94"},{"v":11.525723265109,"d":"11.53"},{"v":9.43928710229911,"d":"9.44"},{"v":1.29550115463297,"d":"1.30"},{"v":0.373510301340098,"d":"0.37"},{"v":0.130736569107216,"d":"0.13"},{"v":0.611512714936877,"d":"0.61"},"up","no"]
["MSTRG.17016","DNAJB9","ENSOART00000003801","GO:0005783(endoplasmic reticulum);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0051787(misfolded protein binding)","NA","K09515","NA","DnaJ heat shock protein family (Hsp40) member B9 [Source:NCBI gene;Acc:101113840]",{"v":2.70760543408881,"d":"2.71"},{"v":3.65196978492137,"d":"3.65"},{"v":4.16159217992599,"d":"4.16"},{"v":2.79327031614246,"d":"2.79"},{"v":2.71088576595745,"d":"2.71"},{"v":2.42876731267345,"d":"2.43"},{"v":1.32626610334698,"d":"1.33"},{"v":0.407370268258072,"d":"0.41"},{"v":0.130774807368145,"d":"0.13"},{"v":0.611512714936877,"d":"0.61"},"up","no"]
["MSTRG.12733","BNIP3","ENSOART00000016721","GO:0005635(nuclear envelope);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005741(mitochondrial outer membrane);GO:0006915(apoptotic process);GO:0008626(granzyme-mediated apoptotic signaling pathway);GO:0009617(response to bacterium);GO:0010637(negative regulation of mitochondrial fusion);GO:0010821(regulation of mitochondrion organization);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016239(positive regulation of macroautophagy);GO:0031307(integral component of mitochondrial outer membrane);GO:0031966(mitochondrial membrane);GO:0035694(mitochondrial protein catabolic process);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043068(positive regulation of programmed cell death);GO:0043243(positive regulation of protein complex disassembly);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0045837(negative regulation of membrane potential);GO:0046902(regulation of mitochondrial membrane permeability);GO:0046982(protein heterodimerization activity);GO:0050873(brown fat cell differentiation);GO:0051020(GTPase binding);GO:0051607(defense response to virus);GO:0060548(negative regulation of cell death);GO:0071260(cellular response to mechanical stimulus);GO:0071279(cellular response to cobalt ion);GO:0071456(cellular response to hypoxia);GO:0072593(reactive oxygen species metabolic process);GO:0090141(positive regulation of mitochondrial fission);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097193(intrinsic apoptotic signaling pathway);GO:0097345(mitochondrial outer membrane permeabilization);GO:1901998(toxin transport);GO:1903715(regulation of aerobic respiration);GO:1990144(intrinsic apoptotic signaling pathway in response to hypoxia);GO:2000378(negative regulation of reactive oxygen species metabolic process)","04068(FoxO signaling pathway);04137(Mitophagy - animal);04140(Autophagy - animal);05134(Legionellosis)","K15464","NA","BCL2 interacting protein 3 [Source:NCBI gene;Acc:101108441]",{"v":9.75966689526824,"d":"9.76"},{"v":8.25557751618185,"d":"8.26"},{"v":10.7293043621132,"d":"10.73"},{"v":10.3806749422584,"d":"10.38"},{"v":5.57466040080773,"d":"5.57"},{"v":5.81457831512307,"d":"5.81"},{"v":1.32037954880682,"d":"1.32"},{"v":0.400952698123649,"d":"0.40"},{"v":0.130849320647568,"d":"0.13"},{"v":0.611512714936877,"d":"0.61"},"up","no"]
["MSTRG.16187","IFT27","ENSOART00000020678","GO:0001822(kidney development);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005929(cilium);GO:0006886(intracellular protein transport);GO:0007224(smoothened signaling pathway);GO:0007283(spermatogenesis);GO:0030992(intraciliary transport particle B);GO:0036126(sperm flagellum);GO:0042073(intraciliary transport);GO:0060122(inner ear receptor cell stereocilium organization);GO:0090102(cochlea development);GO:0097225(sperm midpiece);GO:0097228(sperm principal piece)","NA","K07934","NA","intraflagellar transport 27 [Source:NCBI gene;Acc:100145882]",{"v":1.715586,"d":"1.72"},{"v":0.757088,"d":"0.76"},{"v":0.813944,"d":"0.81"},{"v":2.364277,"d":"2.36"},{"v":1.24949,"d":"1.25"},{"v":2.352585,"d":"2.35"},{"v":0.550858883284124,"d":"0.55"},{"v":-0.860245312318086,"d":"-0.86"},{"v":0.130876512137456,"d":"0.13"},{"v":0.611512714936877,"d":"0.61"},"down","no"]
["MSTRG.15820","ANO6","ENSOART00000021324","GO:0002407(dendritic cell chemotaxis);GO:0002543(activation of blood coagulation via clotting cascade);GO:0005227(calcium activated cation channel activity);GO:0005229(intracellular calcium activated chloride channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005247(voltage-gated chloride channel activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006812(cation transport);GO:0006821(chloride transport);GO:0007596(blood coagulation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017121(plasma membrane phospholipid scrambling);GO:0017128(phospholipid scramblase activity);GO:0030501(positive regulation of bone mineralization);GO:0032060(bleb assembly);GO:0034707(chloride channel complex);GO:0034767(positive regulation of ion transmembrane transport);GO:0035590(purinergic nucleotide receptor signaling pathway);GO:0035630(bone mineralization involved in bone maturation);GO:0035725(sodium ion transmembrane transport);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0045794(negative regulation of cell volume);GO:0046931(pore complex assembly);GO:0046983(protein dimerization activity);GO:0060100(positive regulation of phagocytosis, engulfment);GO:0061588(calcium activated phospholipid scrambling);GO:0061589(calcium activated phosphatidylserine scrambling);GO:0061590(calcium activated phosphatidylcholine scrambling);GO:0061591(calcium activated galactosylceramide scrambling);GO:0070588(calcium ion transmembrane transport);GO:0090026(positive regulation of monocyte chemotaxis);GO:0097045(phosphatidylserine exposure on blood platelet);GO:1902476(chloride transmembrane transport);GO:2000353(positive regulation of endothelial cell apoptotic process)","NA","K19500","NA","anoctamin 6 [Source:NCBI gene;Acc:101108825]",{"v":5.06561822848242,"d":"5.07"},{"v":3.55291292700848,"d":"3.55"},{"v":6.96411014855472,"d":"6.96"},{"v":4.32645984781554,"d":"4.33"},{"v":4.17488470131817,"d":"4.17"},{"v":3.08250959145616,"d":"3.08"},{"v":1.34520351473039,"d":"1.35"},{"v":0.427824453437045,"d":"0.43"},{"v":0.13089398203726,"d":"0.13"},{"v":0.611512714936877,"d":"0.61"},"up","no"]
["MSTRG.20235","FLRT2","ENSOART00000019109","GO:0003007(heart morphogenesis);GO:0005104(fibroblast growth factor receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005887(integral component of plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0007411(axon guidance);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045499(chemorepellent activity);GO:0051965(positive regulation of synapse assembly);GO:0061343(cell adhesion involved in heart morphogenesis);GO:0071711(basement membrane organization);GO:2001222(regulation of neuron migration)","NA","K16362","NA","fibronectin leucine rich transmembrane protein 2 [Source:NCBI gene;Acc:101117848]",{"v":12.215937,"d":"12.22"},{"v":15.841931,"d":"15.84"},{"v":16.545444,"d":"16.55"},{"v":10.665699,"d":"10.67"},{"v":11.493186,"d":"11.49"},{"v":11.388851,"d":"11.39"},{"v":1.3295476034508,"d":"1.33"},{"v":0.410935432729924,"d":"0.41"},{"v":0.130993058297068,"d":"0.13"},{"v":0.611625580747649,"d":"0.61"},"up","no"]
["ENSOARG00000007640","PLEKHA6","ENSOART00000008326","NA","NA","NA","NA","pleckstrin homology domain containing A6 [Source:NCBI gene;Acc:101114717]",{"v":0.243219,"d":"0.24"},{"v":0.228813,"d":"0.23"},{"v":0.198294,"d":"0.20"},{"v":0.443611,"d":"0.44"},{"v":0.308381,"d":"0.31"},{"v":0.386325,"d":"0.39"},{"v":0.588874628069334,"d":"0.59"},{"v":-0.763967579193821,"d":"-0.76"},{"v":0.131130458178089,"d":"0.13"},{"v":0.611797873755864,"d":"0.61"},"down","no"]
["MSTRG.18127","PLPPR3","ENSOART00000010428","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K19582","NA","phospholipid phosphatase related 3 [Source:NCBI gene;Acc:101110057]",{"v":0.570288,"d":"0.57"},{"v":0.474325,"d":"0.47"},{"v":0.145824,"d":"0.15"},{"v":0.203666,"d":"0.20"},{"v":0.321163,"d":"0.32"},{"v":0.154477,"d":"0.15"},{"v":1.75243115768152,"d":"1.75"},{"v":0.809357770671127,"d":"0.81"},{"v":0.131164698461311,"d":"0.13"},{"v":0.611797873755864,"d":"0.61"},"up","no"]
["MSTRG.6639","LGR4","ENSOART00000016230;ENSOART00000016232","GO:0001649(osteoblast differentiation);GO:0001942(hair follicle development);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007283(spermatogenesis);GO:0007623(circadian rhythm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016500(protein-hormone receptor activity);GO:0030282(bone mineralization);GO:0030539(male genitalia development);GO:0032922(circadian regulation of gene expression);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0035239(tube morphogenesis);GO:0036335(intestinal stem cell homeostasis);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046849(bone remodeling);GO:0048565(digestive tract development);GO:0050673(epithelial cell proliferation);GO:0050710(negative regulation of cytokine secretion);GO:0061290(canonical Wnt signaling pathway involved in metanephric kidney development);GO:0072202(cell differentiation involved in metanephros development);GO:0072224(metanephric glomerulus development);GO:0072282(metanephric nephron tubule morphogenesis);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0120163(negative regulation of cold-induced thermogenesis);GO:2001013(epithelial cell proliferation involved in renal tubule morphogenesis);GO:2001013(epithelial cell proliferation involved in renal tubule morphogenesis)","04310(Wnt signaling pathway);04310(Wnt signaling pathway)","K04309","NA","leucine rich repeat containing G protein-coupled receptor 4 [Source:NCBI gene;Acc:101110791]",{"v":8.01423547293447,"d":"8.01"},{"v":6.31630667450142,"d":"6.32"},{"v":5.48554338265669,"d":"5.49"},{"v":6.83288308903134,"d":"6.83"},{"v":2.25819994266382,"d":"2.26"},{"v":4.91488000854701,"d":"4.91"},{"v":1.41483205925624,"d":"1.41"},{"v":0.500630815136744,"d":"0.50"},{"v":0.131288965636615,"d":"0.13"},{"v":0.611797873755864,"d":"0.61"},"up","no"]
["MSTRG.11531","ENSOARG00000000885","ENSOART00000000946","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,{"v":13.696982,"d":"13.70"},{"v":5.725958,"d":"5.73"},{"v":9.323936,"d":"9.32"},{"v":23.059258,"d":"23.06"},{"v":9.006747,"d":"9.01"},{"v":15.754889,"d":"15.75"},{"v":0.601136315017448,"d":"0.60"},{"v":-0.734235918093429,"d":"-0.73"},{"v":0.131292243363581,"d":"0.13"},{"v":0.611797873755864,"d":"0.61"},"down","no"]
["ENSOARG00000011962","TRPM2","ENSOART00000013030","GO:0001659(temperature homeostasis);GO:0002407(dendritic cell chemotaxis);GO:0005216(ion channel activity);GO:0005261(cation channel activity);GO:0005384(manganese ion transmembrane transporter activity);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006812(cation transport);GO:0006828(manganese ion transport);GO:0006979(response to oxidative stress);GO:0009408(response to heat);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0030659(cytoplasmic vesicle membrane);GO:0033194(response to hydroperoxide);GO:0034220(ion transmembrane transport);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0047631(ADP-ribose diphosphatase activity);GO:0051209(release of sequestered calcium ion into cytosol);GO:0055085(transmembrane transport);GO:0071415(cellular response to purine-containing compound);GO:0071502(cellular response to temperature stimulus);GO:0097028(dendritic cell differentiation);GO:0098655(cation transmembrane transport);GO:0098703(calcium ion import across plasma membrane);GO:0099604(ligand-gated calcium channel activity)","04621(NOD-like receptor signaling pathway);04921(Oxytocin signaling pathway)","K04977","EC:3.6.1.13","transient receptor potential cation channel subfamily M member 2 [Source:NCBI gene;Acc:101103450]",{"v":1.228551,"d":"1.23"},{"v":0.974808,"d":"0.97"},{"v":0.940912,"d":"0.94"},{"v":0.938864,"d":"0.94"},{"v":0.747712,"d":"0.75"},{"v":0.624446,"d":"0.62"},{"v":1.36055433483541,"d":"1.36"},{"v":0.444194572928876,"d":"0.44"},{"v":0.131444346735863,"d":"0.13"},{"v":0.612331895435998,"d":"0.61"},"up","no"]
["MSTRG.18729","PPP3CA","ENSOART00000014826","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005516(calmodulin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005955(calcineurin complex);GO:0006470(protein dephosphorylation);GO:0006606(protein import into nucleus);GO:0006816(calcium ion transport);GO:0008144(drug binding);GO:0009898(cytoplasmic side of plasma membrane);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0014883(transition between fast and slow fiber);GO:0014898(cardiac muscle hypertrophy in response to stress);GO:0016018(cyclosporin A binding);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0019722(calcium-mediated signaling);GO:0019899(enzyme binding);GO:0030018(Z disc);GO:0030335(positive regulation of cell migration);GO:0033173(calcineurin-NFAT signaling cascade);GO:0033192(calmodulin-dependent protein phosphatase activity);GO:0033555(multicellular organismal response to stress);GO:0035562(negative regulation of chromatin binding);GO:0035690(cellular response to drug);GO:0043197(dendritic spine);GO:0045785(positive regulation of cell adhesion);GO:0045807(positive regulation of endocytosis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0048741(skeletal muscle fiber development);GO:0050774(negative regulation of dendrite morphogenesis);GO:0050804(modulation of chemical synaptic transmission);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051592(response to calcium ion);GO:0060079(excitatory postsynaptic potential);GO:0070262(peptidyl-serine dephosphorylation);GO:0070886(positive regulation of calcineurin-NFAT signaling cascade);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099170(postsynaptic modulation of chemical synaptic transmission);GO:1903244(positive regulation of cardiac muscle hypertrophy in response to stress);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA);GO:1905205(positive regulation of connective tissue replacement)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04114(Oocyte meiosis);04218(Cellular senescence);04310(Wnt signaling pathway);04360(Axon guidance);04370(VEGF signaling pathway);04380(Osteoclast differentiation);04625(C-type lectin receptor signaling pathway);04650(Natural killer cell mediated cytotoxicity);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04720(Long-term potentiation);04724(Glutamatergic synapse);04728(Dopaminergic synapse);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04924(Renin secretion);05010(Alzheimer disease);05014(Amyotrophic lateral sclerosis (ALS));05031(Amphetamine addiction);05152(Tuberculosis);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection)","K04348","EC:3.1.3.16","protein phosphatase 3 catalytic subunit alpha [Source:NCBI gene;Acc:101122602]",{"v":7.56441688298412,"d":"7.56"},{"v":6.79975174168056,"d":"6.80"},{"v":7.53048446128471,"d":"7.53"},{"v":6.5358990197564,"d":"6.54"},{"v":5.70268660385703,"d":"5.70"},{"v":4.66726906198797,"d":"4.67"},{"v":1.29509294224544,"d":"1.30"},{"v":0.373055636525797,"d":"0.37"},{"v":0.131817409744302,"d":"0.13"},{"v":0.613622530154849,"d":"0.61"},"up","no"]
["MSTRG.4952","EIF2S2","ENSOART00000009983","GO:0001701(in utero embryonic development);GO:0002176(male germ cell proliferation);GO:0003743(translation initiation factor activity);GO:0005737(cytoplasm);GO:0005850(eukaryotic translation initiation factor 2 complex);GO:0006413(translational initiation);GO:0008584(male gonad development)","03013(RNA transport)","K03238","NA","eukaryotic translation initiation factor 2 subunit 2 [Source:NCBI gene;Acc:101111733]",{"v":10.2785316325065,"d":"10.28"},{"v":11.2592753942559,"d":"11.26"},{"v":11.298844158181,"d":"11.30"},{"v":10.2608511879896,"d":"10.26"},{"v":9.08342837793734,"d":"9.08"},{"v":5.41458923346388,"d":"5.41"},{"v":1.32625813606441,"d":"1.33"},{"v":0.407361601525545,"d":"0.41"},{"v":0.132180794373958,"d":"0.13"},{"v":0.614010813808813,"d":"0.61"},"up","no"]
["MSTRG.16824","SCIN","ENSOART00000008256","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005903(brush border);GO:0008285(negative regulation of cell population proliferation);GO:0042989(sequestering of actin monomers);GO:0043065(positive regulation of apoptotic process);GO:0045654(positive regulation of megakaryocyte differentiation);GO:0051014(actin filament severing);GO:0051015(actin filament binding);GO:0051127(positive regulation of actin nucleation);GO:0051693(actin filament capping)","04666(Fc gamma R-mediated phagocytosis);04810(Regulation of actin cytoskeleton);05203(Viral carcinogenesis)","K05768","NA","scinderin [Source:NCBI gene;Acc:101123369]",{"v":0.925134,"d":"0.93"},{"v":0.64416,"d":"0.64"},{"v":0.820428,"d":"0.82"},{"v":1.516795,"d":"1.52"},{"v":0.99269,"d":"0.99"},{"v":1.314201,"d":"1.31"},{"v":0.624978620106358,"d":"0.62"},{"v":-0.678121257423212,"d":"-0.68"},{"v":0.132478706081602,"d":"0.13"},{"v":0.614322090454943,"d":"0.61"},"down","no"]
["MSTRG.21443","ARSE","ENSOART00000009252","GO:0003824(catalytic activity);GO:0005794(Golgi apparatus);GO:0008484(sulfuric ester hydrolase activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K18222","EC:3.1.6.-","arylsulfatase E [Source:NCBI gene;Acc:101115759]",{"v":0.499851,"d":"0.50"},{"v":0.499013,"d":"0.50"},{"v":0.70628,"d":"0.71"},{"v":0.977116,"d":"0.98"},{"v":1.16219,"d":"1.16"},{"v":0.764898,"d":"0.76"},{"v":0.587129554259962,"d":"0.59"},{"v":-0.768249215630989,"d":"-0.77"},{"v":0.133110118430131,"d":"0.13"},{"v":0.615180850468175,"d":"0.62"},"down","no"]
["MSTRG.11053","RCC2","ENSOART00000011856;ENSOART00000011857","GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0007229(integrin-mediated signaling pathway);GO:0008017(microtubule binding);GO:0010762(regulation of fibroblast migration);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030334(regulation of cell migration);GO:0030496(midbody);GO:0031267(small GTPase binding);GO:0031901(early endosome membrane);GO:0034260(negative regulation of GTPase activity);GO:0034506(chromosome, centromeric core domain);GO:0045184(establishment of protein localization);GO:0048041(focal adhesion assembly);GO:0048365(Rac GTPase binding);GO:0051895(negative regulation of focal adhesion assembly);GO:0051987(positive regulation of attachment of spindle microtubules to kinetochore);GO:0072356(chromosome passenger complex localization to kinetochore);GO:0090630(activation of GTPase activity);GO:1900025(negative regulation of substrate adhesion-dependent cell spreading);GO:1900027(regulation of ruffle assembly);GO:1990023(mitotic spindle midzone);GO:1990023(mitotic spindle midzone)","NA","NA","NA","regulator of chromosome condensation 2 [Source:NCBI gene;Acc:101107424]",{"v":2.206462692607,"d":"2.21"},{"v":1.85384617120623,"d":"1.85"},{"v":2.69486459533074,"d":"2.69"},{"v":4.10462810894942,"d":"4.10"},{"v":3.16682590272374,"d":"3.17"},{"v":3.17727400389105,"d":"3.18"},{"v":0.646506775665096,"d":"0.65"},{"v":-0.629262604716941,"d":"-0.63"},{"v":0.13369835717362,"d":"0.13"},{"v":0.615978209912774,"d":"0.62"},"down","no"]
["MSTRG.14764","ENSOARG00000011307","ENSOART00000012294","GO:0001574(ganglioside biosynthetic process);GO:0001665(alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0097503(sialylation)","00604(Glycosphingolipid biosynthesis - ganglio series)","K03376","EC:2.4.99.-","ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 [Source:NCBI gene;Acc:101123278]",{"v":1.83197120112782,"d":"1.83"},{"v":0.986797245300752,"d":"0.99"},{"v":0.901494744360902,"d":"0.90"},{"v":1.4172121212406,"d":"1.42"},{"v":2.16811267857143,"d":"2.17"},{"v":2.42691971522556,"d":"2.43"},{"v":0.618781086079333,"d":"0.62"},{"v":-0.692498995444594,"d":"-0.69"},{"v":0.134204771619304,"d":"0.13"},{"v":0.616009988772008,"d":"0.62"},"down","no"]
["MSTRG.14","STK25","ENSOART00000019229","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006468(protein phosphorylation);GO:0007163(establishment or maintenance of cell polarity);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0036481(intrinsic apoptotic signaling pathway in response to hydrogen peroxide);GO:0042542(response to hydrogen peroxide);GO:0042803(protein homodimerization activity);GO:0046777(protein autophosphorylation);GO:0050772(positive regulation of axonogenesis);GO:0051645(Golgi localization);GO:0051683(establishment of Golgi localization);GO:0090168(Golgi reassembly)","NA","K08838","EC:2.7.11.1","serine/threonine kinase 25 [Source:NCBI gene;Acc:101123003]",{"v":4.743834,"d":"4.74"},{"v":4.789414,"d":"4.79"},{"v":3.575942,"d":"3.58"},{"v":5.470566,"d":"5.47"},{"v":7.768796,"d":"7.77"},{"v":6.804962,"d":"6.80"},{"v":0.654010082854378,"d":"0.65"},{"v":-0.612615217005171,"d":"-0.61"},{"v":0.13517637654999,"d":"0.14"},{"v":0.617560122078411,"d":"0.62"},"down","no"]
["MSTRG.20773","ENSOARG00000002798","ENSOART00000003028","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA","60S ribosomal protein L34 pseudogene [Source:NCBI gene;Acc:101113502]",{"v":1.571576,"d":"1.57"},{"v":1.481478,"d":"1.48"},{"v":1.65293,"d":"1.65"},{"v":2.2425,"d":"2.24"},{"v":2.584701,"d":"2.58"},{"v":3.278246,"d":"3.28"},{"v":0.580595246628594,"d":"0.58"},{"v":-0.784395334313464,"d":"-0.78"},{"v":0.135931428466803,"d":"0.14"},{"v":0.618758952887079,"d":"0.62"},"down","no"]
["ENSOARG00000007567","TTC39C","ENSOART00000008240;ENSOART00000008244","GO:0005515(protein binding);GO:0005515(protein binding)","NA","NA","NA","tetratricopeptide repeat domain 39C [Source:NCBI gene;Acc:101119866]",{"v":1.14030145668827,"d":"1.14"},{"v":1.20722202003536,"d":"1.21"},{"v":1.45248515851503,"d":"1.45"},{"v":0.941399002946376,"d":"0.94"},{"v":0.920469836181497,"d":"0.92"},{"v":0.819625145550972,"d":"0.82"},{"v":1.41712368439036,"d":"1.42"},{"v":0.502965679970426,"d":"0.50"},{"v":0.136554308932925,"d":"0.14"},{"v":0.620579321906394,"d":"0.62"},"up","no"]
["MSTRG.2919","YBX2","ENSOART00000012573","GO:0001650(fibrillar center);GO:0003676(nucleic acid binding)","NA","K09277","NA","Y-box binding protein 2 [Source:NCBI gene;Acc:101118116]",{"v":1.89577029826464,"d":"1.90"},{"v":0.209595011569053,"d":"0.21"},{"v":0.333854113882863,"d":"0.33"},{"v":0.543564548806941,"d":"0.54"},{"v":0.41506835285611,"d":"0.42"},{"v":0.348893824656544,"d":"0.35"},{"v":1.86552165597596,"d":"1.87"},{"v":0.899579107829728,"d":"0.90"},{"v":0.137492314860397,"d":"0.14"},{"v":0.622578217635558,"d":"0.62"},"up","no"]
["ENSOARG00000010701","CAMTA1","ENSOART00000011648","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0035307(positive regulation of protein dephosphorylation);GO:0043565(sequence-specific DNA binding);GO:0050885(neuromuscular process controlling balance);GO:0070886(positive regulation of calcineurin-NFAT signaling cascade)","NA","K21596","NA","calmodulin binding transcription activator 1 [Source:NCBI gene;Acc:101115890]",{"v":0.293896,"d":"0.29"},{"v":0.202855,"d":"0.20"},{"v":0.331343,"d":"0.33"},{"v":0.192127,"d":"0.19"},{"v":0.230343,"d":"0.23"},{"v":0.155853,"d":"0.16"},{"v":1.43188840838078,"d":"1.43"},{"v":0.517919063168635,"d":"0.52"},{"v":0.138034262026682,"d":"0.14"},{"v":0.622920220424332,"d":"0.62"},"up","no"]
["ENSOARG00000009791","RGS1","ENSOART00000010653","GO:0001965(G-protein alpha-subunit binding);GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0009617(response to bacterium);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0043547(positive regulation of GTPase activity);GO:0061737(leukotriene signaling pathway)","NA","K16449","NA","regulator of G protein signaling 1 [Source:NCBI gene;Acc:101122711]",{"v":0.616712,"d":"0.62"},0,{"v":0.43634,"d":"0.44"},{"v":1.350134,"d":"1.35"},{"v":0.316866,"d":"0.32"},{"v":1.151463,"d":"1.15"},{"v":0.373626334636999,"d":"0.37"},{"v":-1.42033194949924,"d":"-1.42"},{"v":0.139099364451793,"d":"0.14"},{"v":0.625417393457795,"d":"0.63"},"down","no"]
["ENSOARG00000010901","MEAK7","ENSOART00000011854","GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0016020(membrane);GO:0030334(regulation of cell migration);GO:0031667(response to nutrient levels);GO:0031929(TOR signaling);GO:0032868(response to insulin);GO:0042127(regulation of cell population proliferation);GO:0043200(response to amino acid);GO:0150032(positive regulation of protein localization to lysosome);GO:1903204(negative regulation of oxidative stress-induced neuron death)","NA","NA","NA","MTOR associated protein, eak-7 homolog [Source:NCBI gene;Acc:101103171]",{"v":0.839555,"d":"0.84"},{"v":0.38382,"d":"0.38"},{"v":0.635977,"d":"0.64"},{"v":1.179563,"d":"1.18"},{"v":1.189254,"d":"1.19"},{"v":0.783223,"d":"0.78"},{"v":0.589888453192218,"d":"0.59"},{"v":-0.761485925567205,"d":"-0.76"},{"v":0.139670466341807,"d":"0.14"},{"v":0.626652048957946,"d":"0.63"},"down","no"]
["MSTRG.6644","METTL15","ENSOART00000016766","GO:0008168(methyltransferase activity);GO:0032259(methylation)","NA","NA","NA","methyltransferase like 15 [Source:NCBI gene;Acc:101117961]",{"v":2.433511,"d":"2.43"},{"v":1.920073,"d":"1.92"},{"v":1.717464,"d":"1.72"},{"v":2.166363,"d":"2.17"},{"v":0.908314,"d":"0.91"},{"v":1.164794,"d":"1.16"},{"v":1.43202960935456,"d":"1.43"},{"v":0.518061322788878,"d":"0.52"},{"v":0.141334764528079,"d":"0.14"},{"v":0.630667871044794,"d":"0.63"},"up","no"]
["MSTRG.20914","GRINA","ENSOART00000016917","GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0044325(ion channel binding);GO:1902236(negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway)","NA","K06890","NA","glutamate ionotropic receptor NMDA type subunit associated protein 1 [Source:NCBI gene;Acc:101114619]",{"v":1.382101,"d":"1.38"},{"v":1.54676,"d":"1.55"},{"v":1.076913,"d":"1.08"},{"v":1.50955,"d":"1.51"},{"v":2.391517,"d":"2.39"},{"v":2.388946,"d":"2.39"},{"v":0.636846696501263,"d":"0.64"},{"v":-0.650981970153972,"d":"-0.65"},{"v":0.14210447706057,"d":"0.14"},{"v":0.631955092490114,"d":"0.63"},"down","no"]
["MSTRG.18965","ENSOARG00000004185","ENSOART00000004556","GO:0004639(phosphoribosylaminoimidazolesuccinocarboxamide synthase activity);GO:0006164(purine nucleotide biosynthetic process);GO:0006189('de novo' IMP biosynthetic process)","00230(Purine metabolism)","K01587","6.3.2.6;EC:4.1.1.21","phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase [Source:NCBI gene;Acc:101117419]",{"v":0.745032,"d":"0.75"},{"v":0.288953,"d":"0.29"},{"v":0.767113,"d":"0.77"},{"v":1.080299,"d":"1.08"},{"v":1.108036,"d":"1.11"},{"v":0.96211,"d":"0.96"},{"v":0.571696379400371,"d":"0.57"},{"v":-0.806678941291698,"d":"-0.81"},{"v":0.142225699884015,"d":"0.14"},{"v":0.631955092490114,"d":"0.63"},"down","no"]
["MSTRG.11534","ENSOARG00000000974","ENSOART00000001038","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006334(nucleosome assembly)","NA","K11275","NA","histone H1.4-like [Source:NCBI gene;Acc:101109652]",{"v":5.136275,"d":"5.14"},{"v":2.091571,"d":"2.09"},{"v":2.060753,"d":"2.06"},{"v":5.499016,"d":"5.50"},{"v":3.532352,"d":"3.53"},{"v":6.397404,"d":"6.40"},{"v":0.602030997671104,"d":"0.60"},{"v":-0.732090323790966,"d":"-0.73"},{"v":0.142736339635591,"d":"0.14"},{"v":0.632332277949596,"d":"0.63"},"down","no"]
["MSTRG.6826","DTX4","ENSOART00000012707","GO:0007219(Notch signaling pathway);GO:0016567(protein ubiquitination);GO:0046872(metal ion binding)","04330(Notch signaling pathway)","K06058","EC:2.3.2.27","deltex E3 ubiquitin ligase 4 [Source:NCBI gene;Acc:101110361]",{"v":0.628689,"d":"0.63"},{"v":0.600212,"d":"0.60"},{"v":1.003522,"d":"1.00"},{"v":1.075922,"d":"1.08"},{"v":0.846837,"d":"0.85"},{"v":2.019664,"d":"2.02"},{"v":0.566256588904844,"d":"0.57"},{"v":-0.820472162576104,"d":"-0.82"},{"v":0.144161449870411,"d":"0.14"},{"v":0.634979269890498,"d":"0.63"},"down","no"]
["ENSOARG00000000944","TRIM21","ENSOART00000001014","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006513(protein monoubiquitination);GO:0008270(zinc ion binding);GO:0010508(positive regulation of autophagy);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0031648(protein destabilization);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032897(negative regulation of viral transcription);GO:0034341(response to interferon-gamma);GO:0042802(identical protein binding);GO:0045087(innate immune response);GO:0045787(positive regulation of cell cycle);GO:0046598(positive regulation of viral entry into host cell);GO:0046872(metal ion binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051865(protein autoubiquitination);GO:0070206(protein trimerization);GO:0090086(negative regulation of protein deubiquitination);GO:1902187(negative regulation of viral release from host cell)","05322(Systemic lupus erythematosus)","K10651","EC:2.3.2.27","tripartite motif containing 21 [Source:NCBI gene;Acc:101114640]",{"v":1.16928,"d":"1.17"},{"v":0.426514,"d":"0.43"},{"v":0.605273,"d":"0.61"},{"v":0.994158,"d":"0.99"},{"v":1.351671,"d":"1.35"},{"v":1.400491,"d":"1.40"},{"v":0.587527760575712,"d":"0.59"},{"v":-0.767271074531056,"d":"-0.77"},{"v":0.14441602723281,"d":"0.14"},{"v":0.635414953558964,"d":"0.64"},"down","no"]
["MSTRG.8430","CLMN","ENSOART00000017120;ENSOART00000017117","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031175(neuron projection development);GO:0031175(neuron projection development)","NA","NA","NA","calmin [Source:NCBI gene;Acc:101115830]",{"v":1.34015595522388,"d":"1.34"},{"v":0.948602395522388,"d":"0.95"},{"v":1.11576426119403,"d":"1.12"},{"v":0.916647992537313,"d":"0.92"},{"v":0.860123643656716,"d":"0.86"},{"v":0.693210337686567,"d":"0.69"},{"v":1.37835929490264,"d":"1.38"},{"v":0.462952002272417,"d":"0.46"},{"v":0.14498518448942,"d":"0.14"},{"v":0.635451387793142,"d":"0.64"},"up","no"]
["MSTRG.14269","STOX2","ENSOART00000008015","GO:0001893(maternal placenta development);GO:0006357(regulation of transcription by RNA polymerase II);GO:0009617(response to bacterium);GO:0009792(embryo development ending in birth or egg hatching)","NA","NA","NA","storkhead box 2 [Source:HGNC Symbol;Acc:HGNC:25450]",{"v":1.314674,"d":"1.31"},{"v":0.941629,"d":"0.94"},{"v":1.08602,"d":"1.09"},{"v":1.873738,"d":"1.87"},{"v":1.795489,"d":"1.80"},{"v":1.444039,"d":"1.44"},{"v":0.653657173321318,"d":"0.65"},{"v":-0.613393917921914,"d":"-0.61"},{"v":0.1457734365139,"d":"0.15"},{"v":0.636010795437911,"d":"0.64"},"down","no"]
["ENSOARG00000013969","ENSOARG00000013969","ENSOART00000015205","GO:0005730(nucleolus)","NA","K14851","NA","nucleolar protein 12 [Source:NCBI gene;Acc:101101972]",{"v":1.020814,"d":"1.02"},{"v":0.879485,"d":"0.88"},{"v":0.879465,"d":"0.88"},{"v":1.260279,"d":"1.26"},{"v":1.450449,"d":"1.45"},{"v":1.877092,"d":"1.88"},{"v":0.605900841794142,"d":"0.61"},{"v":-0.722846384946554,"d":"-0.72"},{"v":0.146382550669436,"d":"0.15"},{"v":0.636673390547649,"d":"0.64"},"down","no"]
["MSTRG.5524","NOB1","ENSOART00000003919","GO:0000469(cleavage involved in rRNA processing);GO:0004521(endoribonuclease activity);GO:0007601(visual perception);GO:0042274(ribosomal small subunit biogenesis);GO:0046872(metal ion binding);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","03008(Ribosome biogenesis in eukaryotes)","K11883","NA","NIN1 (RPN12) binding protein 1 homolog [Source:NCBI gene;Acc:101122620]",{"v":6.96748294258101,"d":"6.97"},{"v":5.7488081642979,"d":"5.75"},{"v":10.0507569084707,"d":"10.05"},{"v":8.71463664638999,"d":"8.71"},{"v":11.5531655252985,"d":"11.55"},{"v":14.3208794633314,"d":"14.32"},{"v":0.658222486060259,"d":"0.66"},{"v":-0.603352782534026,"d":"-0.60"},{"v":0.147012429510148,"d":"0.15"},{"v":0.63718153895247,"d":"0.64"},"down","no"]
["MSTRG.8868","ITPR1","ENSOART00000008881","GO:0001666(response to hypoxia);GO:0005216(ion channel activity);GO:0005220(inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0005262(calcium channel activity);GO:0005635(nuclear envelope);GO:0005637(nuclear inner membrane);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005955(calcineurin complex);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0009791(post-embryonic development);GO:0014069(postsynaptic density);GO:0015278(calcium-release channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0019855(calcium channel inhibitor activity);GO:0031088(platelet dense granule membrane);GO:0031094(platelet dense tubular network);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0032991(protein-containing complex);GO:0035091(phosphatidylinositol binding);GO:0042045(epithelial fluid transport);GO:0048016(inositol phosphate-mediated signaling);GO:0050849(negative regulation of calcium-mediated signaling);GO:0050882(voluntary musculoskeletal movement);GO:0051209(release of sequestered calcium ion into cytosol);GO:0055085(transmembrane transport);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098695(inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels);GO:0099566(regulation of postsynaptic cytosolic calcium ion concentration)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04070(Phosphatidylinositol signaling system);04114(Oocyte meiosis);04140(Autophagy - animal);04210(Apoptosis);04218(Cellular senescence);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04713(Circadian entrainment);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);04750(Inflammatory mediator regulation of TRP channels);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);05010(Alzheimer disease);05016(Huntington disease);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05205(Proteoglycans in cancer)","K04958","NA","inositol 1,4,5-trisphosphate receptor type 1 [Source:NCBI gene;Acc:101108864]",{"v":4.14914985231539,"d":"4.15"},{"v":2.94603423644941,"d":"2.95"},{"v":3.67588504264947,"d":"3.68"},{"v":5.41443881139886,"d":"5.41"},{"v":5.79979128660826,"d":"5.80"},{"v":4.55501572494464,"d":"4.56"},{"v":0.683042756283071,"d":"0.68"},{"v":-0.549952205468785,"d":"-0.55"},{"v":0.148216378056406,"d":"0.15"},{"v":0.639386267081902,"d":"0.64"},"down","no"]
["MSTRG.21339","OSGIN2","ENSOART00000011935","NA","NA","NA","NA","oxidative stress induced growth inhibitor family member 2 [Source:NCBI gene;Acc:101112070]",{"v":3.990172,"d":"3.99"},{"v":3.591413,"d":"3.59"},{"v":2.333411,"d":"2.33"},{"v":2.753293,"d":"2.75"},{"v":2.080576,"d":"2.08"},{"v":2.421118,"d":"2.42"},{"v":1.3666455915083,"d":"1.37"},{"v":0.450639161257683,"d":"0.45"},{"v":0.148260983155774,"d":"0.15"},{"v":0.639409755141963,"d":"0.64"},"up","no"]
["MSTRG.15149","RMND5A","ENSOART00000022568","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm)","NA","NA","NA","required for meiotic nuclear division 5 homolog A [Source:NCBI gene;Acc:101107681]",{"v":76.2999166312783,"d":"76.30"},{"v":74.9290786054757,"d":"74.93"},{"v":65.8728129885759,"d":"65.87"},{"v":61.1853203779791,"d":"61.19"},{"v":58.8952266541264,"d":"58.90"},{"v":49.551657727792,"d":"49.55"},{"v":1.27983839231838,"d":"1.28"},{"v":0.355961649818705,"d":"0.36"},{"v":0.148968206310009,"d":"0.15"},{"v":0.6402613510476,"d":"0.64"},"up","no"]
["MSTRG.4608","CACNB2","ENSOART00000014004","GO:0005245(voltage-gated calcium channel activity);GO:0005515(protein binding);GO:0005891(voltage-gated calcium channel complex);GO:0007268(chemical synaptic transmission);GO:0007601(visual perception);GO:0008331(high voltage-gated calcium channel activity);GO:0051015(actin filament binding);GO:0051928(positive regulation of calcium ion transport);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0086007(voltage-gated calcium channel activity involved in cardiac muscle cell action potential);GO:0086045(membrane depolarization during AV node cell action potential);GO:0086056(voltage-gated calcium channel activity involved in AV node cell action potential);GO:0086091(regulation of heart rate by cardiac conduction);GO:0098684(photoreceptor ribbon synapse);GO:0098793(presynapse);GO:0098912(membrane depolarization during atrial cardiac muscle cell action potential);GO:0099533(positive regulation of presynaptic cytosolic calcium concentration);GO:0099635(voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels);GO:0099703(induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration);GO:1990454(L-type voltage-gated calcium channel complex)","04010(MAPK signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04921(Oxytocin signaling pathway);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","K04863","NA","calcium voltage-gated channel auxiliary subunit beta 2 [Source:NCBI gene;Acc:101112498]",{"v":1.264361,"d":"1.26"},{"v":0.421305,"d":"0.42"},{"v":0.445331,"d":"0.45"},{"v":1.118224,"d":"1.12"},{"v":1.446208,"d":"1.45"},{"v":1.039621,"d":"1.04"},{"v":0.591277930707456,"d":"0.59"},{"v":-0.758091664991128,"d":"-0.76"},{"v":0.149952330773889,"d":"0.15"},{"v":0.64218728038273,"d":"0.64"},"down","no"]
["MSTRG.19417","ERO1A","ENSOART00000019144","GO:0003756(protein disulfide isomerase activity);GO:0005783(endoplasmic reticulum);GO:0006457(protein folding);GO:0015035(protein disulfide oxidoreductase activity);GO:0016491(oxidoreductase activity);GO:0016671(oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor);GO:0019471(4-hydroxyproline metabolic process);GO:0022417(protein maturation by protein folding);GO:0030198(extracellular matrix organization);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0034976(response to endoplasmic reticulum stress);GO:0045454(cell redox homeostasis);GO:0050873(brown fat cell differentiation);GO:0051085(chaperone cofactor-dependent protein refolding);GO:0051209(release of sequestered calcium ion into cytosol);GO:0055114(oxidation-reduction process);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)","K10950","EC:1.8.4.-","endoplasmic reticulum oxidoreductase 1 alpha [Source:NCBI gene;Acc:101109883]",{"v":1.388682,"d":"1.39"},{"v":1.248848,"d":"1.25"},{"v":1.141822,"d":"1.14"},{"v":1.256151,"d":"1.26"},{"v":0.527723,"d":"0.53"},{"v":0.783589,"d":"0.78"},{"v":1.4720180972423,"d":"1.47"},{"v":0.557795408243582,"d":"0.56"},{"v":0.150770853732679,"d":"0.15"},{"v":0.643941014843624,"d":"0.64"},"up","no"]
["MSTRG.15347","QPCT","ENSOART00000010080","GO:0008270(zinc ion binding);GO:0016603(glutaminyl-peptide cyclotransferase activity);GO:0017186(peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase)","NA","K00683","EC:2.3.2.5","glutaminyl-peptide cyclotransferase [Source:NCBI gene;Acc:443019]",{"v":2.469084,"d":"2.47"},{"v":1.471477,"d":"1.47"},{"v":2.660297,"d":"2.66"},{"v":3.585636,"d":"3.59"},{"v":3.469087,"d":"3.47"},{"v":3.244304,"d":"3.24"},{"v":0.640920545212669,"d":"0.64"},{"v":-0.641782577563833,"d":"-0.64"},{"v":0.152118295071366,"d":"0.15"},{"v":0.645060074626865,"d":"0.65"},"down","no"]
["MSTRG.13221","NTHL1","ENSOART00000018726","GO:0003690(double-stranded DNA binding);GO:0003824(catalytic activity);GO:0003906(DNA-(apurinic or apyrimidinic site) endonuclease activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006285(base-excision repair, AP site formation);GO:0006296(nucleotide-excision repair, DNA incision, 5'-to lesion);GO:0019104(DNA N-glycosylase activity);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0140078(class I DNA-(apurinic or apyrimidinic site) endonuclease activity)","03410(Base excision repair)","K10773","EC:4.2.99.18","nth like DNA glycosylase 1 [Source:NCBI gene;Acc:101113646]",{"v":0.88277621929299,"d":"0.88"},{"v":1.1536530215698,"d":"1.15"},{"v":0.642201429598562,"d":"0.64"},{"v":1.13160952486519,"d":"1.13"},{"v":1.75030469562612,"d":"1.75"},{"v":1.46211762312762,"d":"1.46"},{"v":0.616623166424544,"d":"0.62"},{"v":-0.697539002623648,"d":"-0.70"},{"v":0.152396208836842,"d":"0.15"},{"v":0.645060074626865,"d":"0.65"},"down","no"]
["ENSOARG00000019272","ENSOARG00000019272","ENSOART00000020987","GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity)","NA","K11846","EC:3.4.19.12","ubiquitin specific peptidase 18 [Source:NCBI gene;Acc:101103965]",{"v":1.542251,"d":"1.54"},{"v":0.770116,"d":"0.77"},{"v":0.963836,"d":"0.96"},{"v":1.96761,"d":"1.97"},{"v":1.745449,"d":"1.75"},{"v":1.63172,"d":"1.63"},{"v":0.612972585021757,"d":"0.61"},{"v":-0.706105543544889,"d":"-0.71"},{"v":0.153406150138857,"d":"0.15"},{"v":0.646779838866512,"d":"0.65"},"down","no"]
["MSTRG.1993","DYRK1A","ENSOART00000015649","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0007623(circadian rhythm);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030424(axon);GO:0030425(dendrite);GO:0031115(negative regulation of microtubule polymerization);GO:0033120(positive regulation of RNA splicing);GO:0034205(amyloid-beta formation);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042802(identical protein binding);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043621(protein self-association);GO:0046777(protein autophosphorylation);GO:0048025(negative regulation of mRNA splicing, via spliceosome);GO:0048156(tau protein binding);GO:0090312(positive regulation of protein deacetylation);GO:1990904(ribonucleoprotein complex)","NA","K08825","EC:2.7.12.1","dual specificity tyrosine phosphorylation regulated kinase 1A [Source:NCBI gene;Acc:101117130]",{"v":2.89479177591224,"d":"2.89"},{"v":4.40102128588586,"d":"4.40"},{"v":3.8127753780444,"d":"3.81"},{"v":3.50236189027153,"d":"3.50"},{"v":3.07503852871983,"d":"3.08"},{"v":1.95700330062033,"d":"1.96"},{"v":1.3016244373717,"d":"1.30"},{"v":0.380313242281657,"d":"0.38"},{"v":0.15404348146909,"d":"0.15"},{"v":0.647961014197243,"d":"0.65"},"up","no"]
["MSTRG.9212","CAND2","ENSOART00000016505","GO:0005634(nucleus);GO:0005829(cytosol);GO:0010265(SCF complex assembly);GO:0017025(TBP-class protein binding)","NA","NA","NA","cullin associated and neddylation dissociated 2 (putative) [Source:HGNC Symbol;Acc:HGNC:30689]",{"v":15.6445978726477,"d":"15.64"},{"v":14.5633869061269,"d":"14.56"},{"v":12.9248551238512,"d":"12.92"},{"v":8.97039315623632,"d":"8.97"},{"v":12.0589567862144,"d":"12.06"},{"v":11.5483660363239,"d":"11.55"},{"v":1.32399827939835,"d":"1.32"},{"v":0.404901247292353,"d":"0.40"},{"v":0.154268294384738,"d":"0.15"},{"v":0.648530564035532,"d":"0.65"},"up","no"]
["MSTRG.13191","ENSOARG00000016416","ENSOART00000017872","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion)","NA","K17412","NA","mitochondrial ribosomal protein S34 [Source:NCBI gene;Acc:101110811]",{"v":11.470054,"d":"11.47"},{"v":11.013277,"d":"11.01"},{"v":10.085472,"d":"10.09"},{"v":12.482186,"d":"12.48"},{"v":16.339077,"d":"16.34"},{"v":20.574598,"d":"20.57"},{"v":0.659342753434341,"d":"0.66"},{"v":-0.600899462537289,"d":"-0.60"},{"v":0.155888963544066,"d":"0.16"},{"v":0.652525861890429,"d":"0.65"},"down","no"]
["MSTRG.14258","ING2","ENSOART00000007792","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0007141(male meiosis I);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0008285(negative regulation of cell population proliferation);GO:0016580(Sin3 complex);GO:0016602(CCAAT-binding factor complex);GO:0030317(flagellated sperm motility);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031065(positive regulation of histone deacetylation);GO:0035064(methylated histone binding);GO:0035091(phosphatidylinositol binding);GO:0042981(regulation of apoptotic process);GO:0044877(protein-containing complex binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0048133(male germ-line stem cell asymmetric division);GO:0072520(seminiferous tubule development);GO:2000772(regulation of cellular senescence);GO:2001234(negative regulation of apoptotic signaling pathway)","NA","K19198","NA","inhibitor of growth family member 2 [Source:NCBI gene;Acc:101108806]",{"v":5.181435,"d":"5.18"},{"v":2.714533,"d":"2.71"},{"v":2.861686,"d":"2.86"},{"v":5.375567,"d":"5.38"},{"v":6.121897,"d":"6.12"},{"v":4.995709,"d":"5.00"},{"v":0.65224890322802,"d":"0.65"},{"v":-0.616505481768478,"d":"-0.62"},{"v":0.157246351429932,"d":"0.16"},{"v":0.654962034391848,"d":"0.65"},"down","no"]
["MSTRG.12684","ACADSB","ENSOART00000010011","GO:0003995(acyl-CoA dehydrogenase activity);GO:0005739(mitochondrion);GO:0016491(oxidoreductase activity);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation)","K09478","EC:1.3.99.12","acyl-CoA dehydrogenase short/branched chain [Source:NCBI gene;Acc:101102606]",{"v":6.85902990144322,"d":"6.86"},{"v":6.5773507987087,"d":"6.58"},{"v":4.77325610748196,"d":"4.77"},{"v":5.10673084390429,"d":"5.11"},{"v":4.324334761109,"d":"4.32"},{"v":4.62330753247246,"d":"4.62"},{"v":1.29565627933026,"d":"1.30"},{"v":0.373683040849343,"d":"0.37"},{"v":0.158378657789009,"d":"0.16"},{"v":0.656105227613109,"d":"0.66"},"up","no"]
["MSTRG.2989","ZNF18","ENSOART00000016672","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","K09229","NA","zinc finger protein 18 [Source:NCBI gene;Acc:101114536]",{"v":0.756381,"d":"0.76"},{"v":0.827122,"d":"0.83"},{"v":0.651389,"d":"0.65"},{"v":1.650416,"d":"1.65"},{"v":1.040553,"d":"1.04"},{"v":1.04131,"d":"1.04"},{"v":0.598800893502335,"d":"0.60"},{"v":-0.739851720768211,"d":"-0.74"},{"v":0.159071735809773,"d":"0.16"},{"v":0.656105227613109,"d":"0.66"},"down","no"]
["MSTRG.4862","TAF4","ENSOART00000016197","GO:0000790(nuclear chromatin);GO:0001541(ovarian follicle development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005829(cytosol);GO:0006352(DNA-templated transcription, initiation);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0017162(aryl hydrocarbon receptor binding);GO:0032991(protein-containing complex);GO:0033276(transcription factor TFTC complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0071339(MLL1 complex)","03022(Basal transcription factors);05016(Huntington disease)","K03129","NA","TATA-box binding protein associated factor 4 [Source:NCBI gene;Acc:101122456]",{"v":2.05722632568703,"d":"2.06"},{"v":1.81914299818306,"d":"1.82"},{"v":1.97053494867136,"d":"1.97"},{"v":3.32160476856689,"d":"3.32"},{"v":1.98985514898933,"d":"1.99"},{"v":3.3485104319782,"d":"3.35"},{"v":0.675164467838599,"d":"0.68"},{"v":-0.566689114156715,"d":"-0.57"},{"v":0.159302931917758,"d":"0.16"},{"v":0.656105227613109,"d":"0.66"},"down","no"]
["ENSOARG00000019101","MAP2","ENSOART00000020798;ENSOART00000020797","GO:0000226(microtubule cytoskeleton organization);GO:0001578(microtubule bundle formation);GO:0002162(dystroglycan binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007409(axonogenesis);GO:0008017(microtubule binding);GO:0014069(postsynaptic density);GO:0015631(tubulin binding);GO:0016358(dendrite development);GO:0021954(central nervous system neuron development);GO:0030010(establishment of cell polarity);GO:0030425(dendrite);GO:0030517(negative regulation of axon extension);GO:0031175(neuron projection development);GO:0034399(nuclear periphery);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043194(axon initial segment);GO:0043198(dendritic shaft);GO:0043203(axon hillock);GO:0044297(cell body);GO:0048813(dendrite morphogenesis);GO:0050770(regulation of axonogenesis);GO:0071310(cellular response to organic substance);GO:0097442(CA3 pyramidal cell dendrite);GO:1903827(regulation of cellular protein localization);GO:1990769(proximal neuron projection);GO:1990769(proximal neuron projection)","NA","K10430","NA","microtubule associated protein 2 [Source:NCBI gene;Acc:101121239]",{"v":0.390911028292354,"d":"0.39"},{"v":0.214389139104075,"d":"0.21"},{"v":0.20540656887841,"d":"0.21"},{"v":0.402448621926575,"d":"0.40"},{"v":0.525409215055574,"d":"0.53"},{"v":0.354357855506905,"d":"0.35"},{"v":0.632270171878091,"d":"0.63"},{"v":-0.66138693468054,"d":"-0.66"},{"v":0.159757428958449,"d":"0.16"},{"v":0.656561615915819,"d":"0.66"},"down","no"]
["MSTRG.6073","ENSOARG00000001913","ENSOART00000002062","GO:0019901(protein kinase binding)","04270(Vascular smooth muscle contraction);04510(Focal adhesion);04810(Regulation of actin cytoskeleton);04921(Oxytocin signaling pathway);05205(Proteoglycans in cancer)","K17457","NA","protein phosphatase 1 regulatory subunit 12C [Source:NCBI gene;Acc:101122546]",{"v":0.880005,"d":"0.88"},{"v":0.582263,"d":"0.58"},{"v":0.85272,"d":"0.85"},{"v":1.103584,"d":"1.10"},{"v":1.321159,"d":"1.32"},{"v":1.244952,"d":"1.24"},{"v":0.630839347684208,"d":"0.63"},{"v":-0.664655445953501,"d":"-0.66"},{"v":0.160269990013673,"d":"0.16"},{"v":0.656684666736074,"d":"0.66"},"down","no"]
["MSTRG.16097","ENSOARG00000016743","ENSOART00000018229","GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0046982(protein heterodimerization activity)","04612(Antigen processing and presentation);05152(Tuberculosis);05166(Human T-cell leukemia virus 1 infection)","K08065","NA","nuclear transcription factor Y subunit beta [Source:NCBI gene;Acc:101112718]",{"v":3.20663871921182,"d":"3.21"},{"v":2.91776840915677,"d":"2.92"},{"v":2.85878279020574,"d":"2.86"},{"v":2.78540300869313,"d":"2.79"},{"v":2.10010828890177,"d":"2.10"},{"v":2.10019399826137,"d":"2.10"},{"v":1.28593886202198,"d":"1.29"},{"v":0.362822053587777,"d":"0.36"},{"v":0.160460012583189,"d":"0.16"},{"v":0.656782109281858,"d":"0.66"},"up","no"]
["MSTRG.3161","NFE2L1","ENSOART00000007989","GO:0000209(protein polyubiquitination);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006002(fructose 6-phosphate metabolic process);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006749(glutathione metabolic process);GO:0007088(regulation of mitotic nuclear division);GO:0010468(regulation of gene expression);GO:0010906(regulation of glucose metabolic process);GO:0015485(cholesterol binding);GO:0019216(regulation of lipid metabolic process);GO:0019217(regulation of fatty acid metabolic process);GO:0019725(cellular homeostasis);GO:0019904(protein domain specific binding);GO:0021522(spinal cord motor neuron differentiation);GO:0021781(glial cell fate commitment);GO:0030218(erythrocyte differentiation);GO:0032991(protein-containing complex);GO:0034599(cellular response to oxidative stress);GO:0034976(response to endoplasmic reticulum stress);GO:0042632(cholesterol homeostasis);GO:0042883(cysteine transport);GO:0044877(protein-containing complex binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050727(regulation of inflammatory response);GO:0051156(glucose 6-phosphate metabolic process);GO:0061136(regulation of proteasomal protein catabolic process);GO:0061396(regulation of transcription from RNA polymerase II promoter in response to copper ion);GO:0070417(cellular response to cold);GO:0071397(cellular response to cholesterol);GO:1903353(regulation of nucleus organization);GO:1905897(regulation of response to endoplasmic reticulum stress);GO:1990841(promoter-specific chromatin binding)","NA","K09040","NA","nuclear factor, erythroid 2 like 1 [Source:NCBI gene;Acc:101116413]",{"v":18.3910259411989,"d":"18.39"},{"v":29.7982029889271,"d":"29.80"},{"v":19.8038730124475,"d":"19.80"},{"v":16.0025505089729,"d":"16.00"},{"v":18.4430417506682,"d":"18.44"},{"v":17.4742631940435,"d":"17.47"},{"v":1.30957802845247,"d":"1.31"},{"v":0.389102022199161,"d":"0.39"},{"v":0.161532530462543,"d":"0.16"},{"v":0.658059670008083,"d":"0.66"},"up","no"]
["ENSOARG00000009484","ARMC5","ENSOART00000010327","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion)","04934(Cushing syndrome)","K22499","NA","armadillo repeat containing 5 [Source:NCBI gene;Acc:101106993]",{"v":0.421708,"d":"0.42"},{"v":0.309596,"d":"0.31"},{"v":0.148023,"d":"0.15"},{"v":0.642238,"d":"0.64"},{"v":0.449923,"d":"0.45"},{"v":0.438334,"d":"0.44"},{"v":0.574537649583958,"d":"0.57"},{"v":-0.799526658781282,"d":"-0.80"},{"v":0.162277842502866,"d":"0.16"},{"v":0.659943365476162,"d":"0.66"},"down","no"]
["MSTRG.202","CDC20","ENSOART00000022377","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005680(anaphase-promoting complex);GO:0005829(cytosol);GO:0007064(mitotic sister chromatid cohesion);GO:0008022(protein C-terminus binding);GO:0010997(anaphase-promoting complex binding);GO:0019899(enzyme binding);GO:0031145(anaphase-promoting complex-dependent catabolic process);GO:0031915(positive regulation of synaptic plasticity);GO:0040020(regulation of meiotic nuclear division);GO:0090129(positive regulation of synapse maturation);GO:0090307(mitotic spindle assembly);GO:0097027(ubiquitin-protein transferase activator activity);GO:1904668(positive regulation of ubiquitin protein ligase activity)","04110(Cell cycle);04114(Oocyte meiosis);04120(Ubiquitin mediated proteolysis);05166(Human T-cell leukemia virus 1 infection);05203(Viral carcinogenesis)","K03363","NA","cell division cycle 20 [Source:NCBI gene;Acc:101110548]",{"v":0.613969,"d":"0.61"},{"v":0.134252,"d":"0.13"},{"v":0.158013,"d":"0.16"},{"v":1.002436,"d":"1.00"},{"v":0.167904,"d":"0.17"},{"v":0.688502,"d":"0.69"},{"v":0.487526104962122,"d":"0.49"},{"v":-1.03644862373574,"d":"-1.04"},{"v":0.163773320803886,"d":"0.16"},{"v":0.663216959842721,"d":"0.66"},"down","no"]
["MSTRG.390","CACHD1","ENSOART00000010884","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","cache domain containing 1 [Source:NCBI gene;Acc:101110191]",{"v":9.423441,"d":"9.42"},{"v":7.541556,"d":"7.54"},{"v":8.334005,"d":"8.33"},{"v":7.144473,"d":"7.14"},{"v":6.916731,"d":"6.92"},{"v":5.762568,"d":"5.76"},{"v":1.27619516608645,"d":"1.28"},{"v":0.35184897456859,"d":"0.35"},{"v":0.165367649945449,"d":"0.17"},{"v":0.666861691358186,"d":"0.67"},"up","no"]
["MSTRG.837","GATAD2B","ENSOART00000001590","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0043565(sequence-specific DNA binding);GO:0046872(metal ion binding)","NA","K23194","NA","GATA zinc finger domain containing 2B [Source:NCBI gene;Acc:101106983]",{"v":5.49926428416486,"d":"5.50"},{"v":5.51352262183659,"d":"5.51"},{"v":6.6686309579718,"d":"6.67"},{"v":5.84643118067607,"d":"5.85"},{"v":3.94568503705712,"d":"3.95"},{"v":4.00278394920463,"d":"4.00"},{"v":1.2817358335329,"d":"1.28"},{"v":0.358098952344321,"d":"0.36"},{"v":0.166730388610107,"d":"0.17"},{"v":0.669745794755887,"d":"0.67"},"up","no"]
["MSTRG.9868","AK3","ENSOART00000014629","GO:0000166(nucleotide binding);GO:0004017(adenylate kinase activity);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006139(nucleobase-containing compound metabolic process);GO:0006172(ADP biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016776(phosphotransferase activity, phosphate group as acceptor);GO:0019205(nucleobase-containing compound kinase activity);GO:0046033(AMP metabolic process);GO:0046039(GTP metabolic process);GO:0046041(ITP metabolic process);GO:0046051(UTP metabolic process);GO:0046899(nucleoside triphosphate adenylate kinase activity);GO:0046940(nucleoside monophosphate phosphorylation)","00230(Purine metabolism)","K00944","EC:2.7.4.10","adenylate kinase 3 [Source:NCBI gene;Acc:101113201]",{"v":8.24532761870011,"d":"8.25"},{"v":9.39135912155074,"d":"9.39"},{"v":8.20083033523375,"d":"8.20"},{"v":7.52768501527936,"d":"7.53"},{"v":6.38380236009122,"d":"6.38"},{"v":6.45567136898518,"d":"6.46"},{"v":1.26858720942826,"d":"1.27"},{"v":0.343222701337142,"d":"0.34"},{"v":0.166862193352949,"d":"0.17"},{"v":0.669745794755887,"d":"0.67"},"up","no"]
["MSTRG.4750","CRLS1","ENSOART00000019977","GO:0008654(phospholipid biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016780(phosphotransferase activity, for other substituted phosphate groups)","00564(Glycerophospholipid metabolism)","K08744","EC:2.7.8.41","cardiolipin synthase 1 [Source:NCBI gene;Acc:101116926]",{"v":11.516758,"d":"11.52"},{"v":9.795347,"d":"9.80"},{"v":9.882789,"d":"9.88"},{"v":10.097477,"d":"10.10"},{"v":6.989132,"d":"6.99"},{"v":6.989336,"d":"6.99"},{"v":1.29568720978553,"d":"1.30"},{"v":0.37371748106511,"d":"0.37"},{"v":0.16766896936526,"d":"0.17"},{"v":0.670675877461041,"d":"0.67"},"up","no"]
["MSTRG.3446","RF00001","ENSOART00000026621","NA","NA","NA","NA",null,{"v":2.7721062559727,"d":"2.77"},{"v":2.86028917423646,"d":"2.86"},{"v":1.99262018740702,"d":"1.99"},{"v":2.09233009136256,"d":"2.09"},{"v":2.46131207097226,"d":"2.46"},{"v":1.2465364712523,"d":"1.25"},{"v":1.31461737634458,"d":"1.31"},{"v":0.394642959537005,"d":"0.39"},{"v":0.168455076559993,"d":"0.17"},{"v":0.672085080986322,"d":"0.67"},"up","no"]
["MSTRG.12648","GRK5","ENSOART00000002257","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004703(G protein-coupled receptor kinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007217(tachykinin receptor signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016607(nuclear speck);GO:0016740(transferase activity);GO:0031965(nuclear membrane);GO:0043066(negative regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0047696(beta-adrenergic receptor kinase activity);GO:0051726(regulation of cell cycle)","04062(Chemokine signaling pathway);04144(Endocytosis);05032(Morphine addiction)","K08291","EC:2.7.11.16","G protein-coupled receptor kinase 5 [Source:NCBI gene;Acc:101107151]",{"v":3.286025,"d":"3.29"},{"v":2.644682,"d":"2.64"},{"v":3.036899,"d":"3.04"},{"v":4.339174,"d":"4.34"},{"v":4.506589,"d":"4.51"},{"v":3.921263,"d":"3.92"},{"v":0.702403676470934,"d":"0.70"},{"v":-0.509627698743443,"d":"-0.51"},{"v":0.168615938281952,"d":"0.17"},{"v":0.672322598355974,"d":"0.67"},"down","no"]
["MSTRG.2674","PEX12","ENSOART00000007097","GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0005779(integral component of peroxisomal membrane);GO:0006625(protein targeting to peroxisome);GO:0007031(peroxisome organization);GO:0008022(protein C-terminus binding);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016558(protein import into peroxisome matrix)","04146(Peroxisome)","K13345","NA","peroxisomal biogenesis factor 12 [Source:NCBI gene;Acc:101116741]",{"v":0.685869,"d":"0.69"},{"v":1.226227,"d":"1.23"},{"v":0.916621,"d":"0.92"},{"v":1.276906,"d":"1.28"},{"v":1.689285,"d":"1.69"},{"v":1.713994,"d":"1.71"},{"v":0.604402817409996,"d":"0.60"},{"v":-0.726417709278804,"d":"-0.73"},{"v":0.1698992680311,"d":"0.17"},{"v":0.675460250404627,"d":"0.68"},"down","no"]
["MSTRG.616","AMIGO1","ENSOART00000012411","GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007155(cell adhesion);GO:0007413(axonal fasciculation);GO:0008076(voltage-gated potassium channel complex);GO:0015459(potassium channel regulator activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030425(dendrite);GO:0032809(neuronal cell body membrane);GO:0042552(myelination);GO:0051965(positive regulation of synapse assembly);GO:1901381(positive regulation of potassium ion transmembrane transport)","NA","K22529","NA","adhesion molecule with Ig like domain 1 [Source:NCBI gene;Acc:101106213]",{"v":3.990758,"d":"3.99"},{"v":5.048518,"d":"5.05"},{"v":3.86248,"d":"3.86"},{"v":2.546181,"d":"2.55"},{"v":2.786213,"d":"2.79"},{"v":4.106316,"d":"4.11"},{"v":1.36689823079637,"d":"1.37"},{"v":0.450905834464896,"d":"0.45"},{"v":0.170578164646966,"d":"0.17"},{"v":0.676185596012655,"d":"0.68"},"up","no"]
["MSTRG.12493","LZTS2","ENSOART00000017541","GO:0001822(kidney development);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008285(negative regulation of cell population proliferation);GO:0016055(Wnt signaling pathway);GO:0030178(negative regulation of Wnt signaling pathway);GO:0031982(vesicle);GO:0051301(cell division);GO:0060682(primary ureteric bud growth);GO:0072197(ureter morphogenesis);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1900181(negative regulation of protein localization to nucleus)","NA","NA","NA","leucine zipper tumor suppressor 2 [Source:NCBI gene;Acc:101112180]",{"v":3.0368568269132,"d":"3.04"},{"v":2.39537955932203,"d":"2.40"},{"v":2.76634768567026,"d":"2.77"},{"v":3.36083514175655,"d":"3.36"},{"v":4.06627671494607,"d":"4.07"},{"v":4.59983417668207,"d":"4.60"},{"v":0.681684614626827,"d":"0.68"},{"v":-0.552823672577737,"d":"-0.55"},{"v":0.171449211902159,"d":"0.17"},{"v":0.677170472167018,"d":"0.68"},"down","no"]
["MSTRG.21302","PTDSS1","ENSOART00000005479","GO:0006659(phosphatidylserine biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane)","00564(Glycerophospholipid metabolism)","K08729","EC:2.7.8.-","phosphatidylserine synthase 1 [Source:NCBI gene;Acc:101108059]",{"v":6.193881,"d":"6.19"},{"v":3.842785,"d":"3.84"},{"v":5.483993,"d":"5.48"},{"v":7.217794,"d":"7.22"},{"v":7.424019,"d":"7.42"},{"v":7.687955,"d":"7.69"},{"v":0.69506584215295,"d":"0.70"},{"v":-0.524778447053677,"d":"-0.52"},{"v":0.17188782957054,"d":"0.17"},{"v":0.677618799444419,"d":"0.68"},"down","no"]
["MSTRG.2589","ENSOARG00000008323","ENSOART00000009053","GO:0001701(in utero embryonic development);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0050733(RS domain binding);GO:0060048(cardiac muscle contraction)","03040(Spliceosome);04657(IL-17 signaling pathway);05168(Herpes simplex virus 1 infection)","K12890","NA","serine and arginine rich splicing factor 1 [Source:NCBI gene;Acc:101121021]",{"v":5.83591877820849,"d":"5.84"},{"v":5.48092623949712,"d":"5.48"},{"v":5.28890986642221,"d":"5.29"},{"v":4.978672248088,"d":"4.98"},{"v":4.40257017443688,"d":"4.40"},{"v":3.7322092173913,"d":"3.73"},{"v":1.26631457072533,"d":"1.27"},{"v":0.340635835454938,"d":"0.34"},{"v":0.17262382570888,"d":"0.17"},{"v":0.678023158140973,"d":"0.68"},"up","no"]
["MSTRG.8289","NUBPL","ENSOART00000006912","GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0070584(mitochondrion morphogenesis)","NA","K03593","NA","nucleotide binding protein like [Source:NCBI gene;Acc:101116606]",{"v":2.094679,"d":"2.09"},{"v":1.976025,"d":"1.98"},{"v":2.435428,"d":"2.44"},{"v":1.874074,"d":"1.87"},{"v":1.570208,"d":"1.57"},{"v":1.366632,"d":"1.37"},{"v":1.35236921715915,"d":"1.35"},{"v":0.435489082866207,"d":"0.44"},{"v":0.17314176911898,"d":"0.17"},{"v":0.67876561972982,"d":"0.68"},"up","no"]
["ENSOARG00000015297","GBP5","ENSOART00000016648","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0034067(protein localization to Golgi apparatus);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0050702(interleukin-1 beta secretion);GO:0051289(protein homotetramerization);GO:0071346(cellular response to interferon-gamma);GO:1900227(positive regulation of NLRP3 inflammasome complex assembly)","04621(NOD-like receptor signaling pathway)","K20898","NA","guanylate binding protein 5 [Source:NCBI gene;Acc:101120367]",{"v":0.67424,"d":"0.67"},{"v":0.112036,"d":"0.11"},{"v":0.111678,"d":"0.11"},{"v":0.691194,"d":"0.69"},{"v":0.580611,"d":"0.58"},{"v":0.467016,"d":"0.47"},{"v":0.516415433215955,"d":"0.52"},{"v":-0.95339597826353,"d":"-0.95"},{"v":0.173624254290478,"d":"0.17"},{"v":0.679112867064023,"d":"0.68"},"down","no"]
["MSTRG.11496","TUBB","ENSOART00000012644","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005200(structural constituent of cytoskeleton);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005641(nuclear envelope lumen);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0007017(microtubule-based process);GO:0009987(cellular process);GO:0031625(ubiquitin protein ligase binding);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042288(MHC class I protein binding);GO:0044297(cell body);GO:0050807(regulation of synapse organization);GO:0051225(spindle assembly)","04145(Phagosome);04540(Gap junction)","K07375","NA","tubulin beta class I [Source:NCBI gene;Acc:100303606]",{"v":48.399891,"d":"48.40"},{"v":35.845108,"d":"35.85"},{"v":61.713558,"d":"61.71"},{"v":67.751404,"d":"67.75"},{"v":60.942429,"d":"60.94"},{"v":82.440498,"d":"82.44"},{"v":0.691306602335553,"d":"0.69"},{"v":-0.532602390692761,"d":"-0.53"},{"v":0.174644907096621,"d":"0.17"},{"v":0.680838083500124,"d":"0.68"},"down","no"]
["MSTRG.1953","COL6A2","ENSOART00000014022","GO:0005576(extracellular region);GO:0031012(extracellular matrix);GO:0032991(protein-containing complex);GO:0042383(sarcolemma);GO:0070208(protein heterotrimerization)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04974(Protein digestion and absorption);05165(Human papillomavirus infection)","K06238","NA","collagen type VI alpha 2 chain [Source:NCBI gene;Acc:101106490]",{"v":13.7968644984295,"d":"13.80"},{"v":9.91826328484492,"d":"9.92"},{"v":22.0548488164507,"d":"22.05"},{"v":21.7251705318021,"d":"21.73"},{"v":23.0982197616804,"d":"23.10"},{"v":23.0385940021594,"d":"23.04"},{"v":0.674456797495449,"d":"0.67"},{"v":-0.568202060958068,"d":"-0.57"},{"v":0.175717561778111,"d":"0.18"},{"v":0.682086579884165,"d":"0.68"},"down","no"]
["MSTRG.9967","ACO1","ENSOART00000016012","GO:0003723(RNA binding);GO:0003994(aconitate hydratase activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006101(citrate metabolic process);GO:0006879(cellular iron ion homeostasis);GO:0010040(response to iron(II) ion);GO:0030350(iron-responsive element binding);GO:0051536(iron-sulfur cluster binding);GO:0051538(3 iron, 4 sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding)","00020(Citrate cycle (TCA cycle));00630(Glyoxylate and dicarboxylate metabolism)","K01681","EC:4.2.1.3","aconitase 1 [Source:NCBI gene;Acc:101112791]",{"v":11.42728,"d":"11.43"},{"v":9.579688,"d":"9.58"},{"v":10.748325,"d":"10.75"},{"v":16.213171,"d":"16.21"},{"v":14.345309,"d":"14.35"},{"v":14.458351,"d":"14.46"},{"v":0.705409339009225,"d":"0.71"},{"v":-0.503467418962851,"d":"-0.50"},{"v":0.176607404842407,"d":"0.18"},{"v":0.682765175495924,"d":"0.68"},"down","no"]
["MSTRG.5375","ADCY7","ENSOART00000018722","GO:0000166(nucleotide binding);GO:0002819(regulation of adaptive immune response);GO:0004016(adenylate cyclase activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006171(cAMP biosynthetic process);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0046872(metal ion binding);GO:0071285(cellular response to lithium ion);GO:0071361(cellular response to ethanol);GO:1900016(negative regulation of cytokine production involved in inflammatory response)","00230(Purine metabolism);01522(Endocrine resistance);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04114(Oocyte meiosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04713(Circadian entrainment);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04727(GABAergic synapse);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04913(Ovarian steroidogenesis);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);05032(Morphine addiction);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05414(Dilated cardiomyopathy (DCM))","K08047","EC:4.6.1.1","adenylate cyclase 7 [Source:NCBI gene;Acc:101112667]",{"v":1.335071,"d":"1.34"},{"v":0.742242,"d":"0.74"},{"v":1.129563,"d":"1.13"},{"v":1.797029,"d":"1.80"},{"v":1.561176,"d":"1.56"},{"v":1.396622,"d":"1.40"},{"v":0.674446409932475,"d":"0.67"},{"v":-0.568224280618468,"d":"-0.57"},{"v":0.176949157838359,"d":"0.18"},{"v":0.682765175495924,"d":"0.68"},"down","no"]
["MSTRG.6860","NPM1","ENSOART00000003858","GO:0001047(core promoter binding);GO:0003676(nucleic acid binding);GO:0003713(transcription coactivator activity);GO:0003723(RNA binding);GO:0004860(protein kinase inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006281(DNA repair);GO:0006334(nucleosome assembly);GO:0006913(nucleocytoplasmic transport);GO:0007098(centrosome cycle);GO:0007569(cell aging);GO:0008104(protein localization);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0010826(negative regulation of centrosome duplication);GO:0019901(protein kinase binding);GO:0030957(Tat protein binding);GO:0031616(spindle pole centrosome);GO:0032071(regulation of endodeoxyribonuclease activity);GO:0032991(protein-containing complex);GO:0032993(protein-DNA complex);GO:0033613(activating transcription factor binding);GO:0034644(cellular response to UV);GO:0042393(histone binding);GO:0042803(protein homodimerization activity);GO:0043023(ribosomal large subunit binding);GO:0043024(ribosomal small subunit binding);GO:0043066(negative regulation of apoptotic process);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045727(positive regulation of translation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046599(regulation of centriole replication);GO:0046982(protein heterodimerization activity);GO:0051059(NF-kappaB binding);GO:0051082(unfolded protein binding);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051259(protein complex oligomerization);GO:0060699(regulation of endoribonuclease activity);GO:0060735(regulation of eIF2 alpha phosphorylation by dsRNA);GO:1902629(regulation of mRNA stability involved in cellular response to UV);GO:1902751(positive regulation of cell cycle G2/M phase transition);GO:1990904(ribonucleoprotein complex)","NA","K11276","NA","nucleophosmin 1 [Source:NCBI gene;Acc:101104783]",{"v":1.83849852028123,"d":"1.84"},{"v":1.81463372579773,"d":"1.81"},{"v":1.4748410394808,"d":"1.47"},{"v":2.51400431260141,"d":"2.51"},{"v":2.54826333856138,"d":"2.55"},{"v":2.38334953596539,"d":"2.38"},{"v":0.688723735948296,"d":"0.69"},{"v":-0.538002696433496,"d":"-0.54"},{"v":0.177850457321942,"d":"0.18"},{"v":0.6836668086217,"d":"0.68"},"down","no"]
["ENSOARG00000011288","TLR7","ENSOART00000012274","GO:0001932(regulation of protein phosphorylation);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007252(I-kappaB phosphorylation);GO:0016021(integral component of membrane);GO:0032009(early phagosome);GO:0032722(positive regulation of chemokine production);GO:0032755(positive regulation of interleukin-6 production);GO:0032757(positive regulation of interleukin-8 production);GO:0034154(toll-like receptor 7 signaling pathway);GO:0035197(siRNA binding);GO:0043235(receptor complex);GO:0045078(positive regulation of interferon-gamma biosynthetic process);GO:0045356(positive regulation of interferon-alpha biosynthetic process);GO:0045359(positive regulation of interferon-beta biosynthetic process);GO:0045416(positive regulation of interleukin-8 biosynthetic process);GO:0051607(defense response to virus);GO:0071260(cellular response to mechanical stimulus);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04620(Toll-like receptor signaling pathway);05162(Measles);05164(Influenza A)","K05404","NA","Ovis aries toll like receptor 7 (TLR7), mRNA. [Source:RefSeq mRNA;Acc:NM_001135059]",{"v":0.763645,"d":"0.76"},{"v":0.284537,"d":"0.28"},{"v":1.031377,"d":"1.03"},{"v":0.663288,"d":"0.66"},{"v":0.25027,"d":"0.25"},{"v":0.453254,"d":"0.45"},{"v":1.52146674158553,"d":"1.52"},{"v":0.605462797688165,"d":"0.61"},{"v":0.17839022146962,"d":"0.18"},{"v":0.684441453564119,"d":"0.68"},"up","no"]
["MSTRG.1304","PHLDB2","ENSOART00000020914","GO:0000226(microtubule cytoskeleton organization);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0010470(regulation of gastrulation);GO:0010717(regulation of epithelial to mesenchymal transition);GO:0031252(cell leading edge);GO:0045111(intermediate filament cytoskeleton);GO:0045180(basal cortex);GO:0045184(establishment of protein localization);GO:0051497(negative regulation of stress fiber assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0070507(regulation of microtubule cytoskeleton organization);GO:1903690(negative regulation of wound healing, spreading of epidermal cells);GO:1904261(positive regulation of basement membrane assembly involved in embryonic body morphogenesis)","NA","NA","NA","pleckstrin homology like domain family B member 2 [Source:NCBI gene;Acc:101118837]",{"v":3.65622296966898,"d":"3.66"},{"v":1.75871819276366,"d":"1.76"},{"v":2.50139562648191,"d":"2.50"},{"v":4.04728125773672,"d":"4.05"},{"v":3.95968874056967,"d":"3.96"},{"v":3.46302544711316,"d":"3.46"},{"v":0.690177849379694,"d":"0.69"},{"v":-0.534959922335132,"d":"-0.53"},{"v":0.179346212457816,"d":"0.18"},{"v":0.685960402204548,"d":"0.69"},"down","no"]
["MSTRG.4190","ABL2","ENSOART00000018080","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0001784(phosphotyrosine residue binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005623(cell);GO:0006468(protein phosphorylation);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0010863(positive regulation of phospholipase C activity);GO:0010976(positive regulation of neuron projection development);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030145(manganese ion binding);GO:0051353(positive regulation of oxidoreductase activity);GO:0071300(cellular response to retinoic acid)","04012(ErbB signaling pathway);04014(Ras signaling pathway);05416(Viral myocarditis)","K08887","EC:2.7.10.2","ABL proto-oncogene 2, non-receptor tyrosine kinase [Source:NCBI gene;Acc:101121110]",{"v":2.33994950107296,"d":"2.34"},{"v":2.27114675579399,"d":"2.27"},{"v":3.00845164206009,"d":"3.01"},{"v":2.31462858390558,"d":"2.31"},{"v":2.127291322103,"d":"2.13"},{"v":1.5676743195279,"d":"1.57"},{"v":1.26789723448372,"d":"1.27"},{"v":0.34243781700027,"d":"0.34"},{"v":0.179433936882604,"d":"0.18"},{"v":0.686074534982662,"d":"0.69"},"up","no"]
["MSTRG.322","LRRC42","ENSOART00000007330","GO:0005515(protein binding)","NA","NA","NA","leucine rich repeat containing 42 [Source:NCBI gene;Acc:101120708]",{"v":2.834818,"d":"2.83"},{"v":2.130299,"d":"2.13"},{"v":2.527302,"d":"2.53"},{"v":3.532501,"d":"3.53"},{"v":3.995077,"d":"4.00"},{"v":3.524821,"d":"3.52"},{"v":0.677899793519941,"d":"0.68"},{"v":-0.560856063526075,"d":"-0.56"},{"v":0.180003300146635,"d":"0.18"},{"v":0.686074534982662,"d":"0.69"},"down","no"]
["MSTRG.8205","ENSOARG00000000753","ENSOART00000000807","GO:0005515(protein binding)","03018(RNA degradation)","K12602","NA","WD repeat domain 61 [Source:NCBI gene;Acc:101121805]",{"v":5.74997105566406,"d":"5.75"},{"v":4.45598091796875,"d":"4.46"},{"v":3.92997645605469,"d":"3.93"},{"v":8.33001073242187,"d":"8.33"},{"v":6.58880881640625,"d":"6.59"},{"v":5.93915114160156,"d":"5.94"},{"v":0.67772309394286,"d":"0.68"},{"v":-0.561232161639175,"d":"-0.56"},{"v":0.181271196471146,"d":"0.18"},{"v":0.6878526762303,"d":"0.69"},"down","no"]
["MSTRG.3494","MRPL12","ENSOART00000019825","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005840(ribosome);GO:0006390(mitochondrial transcription);GO:0006412(translation);GO:0045893(positive regulation of transcription, DNA-templated)","NA","NA","NA","mitochondrial ribosomal protein L12 [Source:NCBI gene;Acc:101116242]",{"v":9.06132703452915,"d":"9.06"},{"v":6.8521260690583,"d":"6.85"},{"v":5.88509044170404,"d":"5.89"},{"v":11.104126864574,"d":"11.10"},{"v":7.34499704887892,"d":"7.34"},{"v":13.3935149246637,"d":"13.39"},{"v":0.684570887988026,"d":"0.68"},{"v":-0.546728153179887,"d":"-0.55"},{"v":0.182780105961221,"d":"0.18"},{"v":0.689712008886768,"d":"0.69"},"down","no"]
["ENSOARG00000018102","RACGAP1","ENSOART00000019705","GO:0000281(mitotic cytokinesis);GO:0000915(actomyosin contractile ring assembly);GO:0005096(GTPase activator activity);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007165(signal transduction);GO:0007283(spermatogenesis);GO:0007405(neuroblast proliferation);GO:0008017(microtubule binding);GO:0008272(sulfate transport);GO:0019901(protein kinase binding);GO:0030496(midbody);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0032154(cleavage furrow);GO:0032467(positive regulation of cytokinesis);GO:0035556(intracellular signal transduction);GO:0043014(alpha-tubulin binding);GO:0043015(gamma-tubulin binding);GO:0043547(positive regulation of GTPase activity);GO:0045995(regulation of embryonic development);GO:0046872(metal ion binding);GO:0048487(beta-tubulin binding);GO:0051233(spindle midzone);GO:0051256(mitotic spindle midzone assembly);GO:0051988(regulation of attachment of spindle microtubules to kinetochore);GO:0072686(mitotic spindle);GO:0097149(centralspindlin complex)","NA","K16733","NA","Rac GTPase activating protein 1 [Source:NCBI gene;Acc:101120998]",{"v":1.205864,"d":"1.21"},{"v":1.077,"d":"1.08"},{"v":1.033589,"d":"1.03"},{"v":2.053918,"d":"2.05"},{"v":1.37882,"d":"1.38"},{"v":1.599038,"d":"1.60"},{"v":0.659101875759175,"d":"0.66"},{"v":-0.601426618587069,"d":"-0.60"},{"v":0.183298633270897,"d":"0.18"},{"v":0.689767246841948,"d":"0.69"},"down","no"]
["MSTRG.3056","GID4","ENSOART00000001219","GO:0000151(ubiquitin ligase complex)","NA","NA","NA","GID complex subunit 4 homolog [Source:HGNC Symbol;Acc:HGNC:28453]",{"v":3.327261,"d":"3.33"},{"v":2.366823,"d":"2.37"},{"v":2.963539,"d":"2.96"},{"v":2.211258,"d":"2.21"},{"v":1.647106,"d":"1.65"},{"v":2.399801,"d":"2.40"},{"v":1.38341239005363,"d":"1.38"},{"v":0.468231282590962,"d":"0.47"},{"v":0.184347232918902,"d":"0.18"},{"v":0.691139319793971,"d":"0.69"},"up","no"]
["MSTRG.3182","ARHGAP23","ENSOART00000010007","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0043547(positive regulation of GTPase activity)","NA","NA","NA","Rho GTPase activating protein 23 [Source:HGNC Symbol;Acc:HGNC:29293]",{"v":2.62103025187673,"d":"2.62"},{"v":2.88737805570921,"d":"2.89"},{"v":3.98016344073489,"d":"3.98"},{"v":4.72897475543264,"d":"4.73"},{"v":4.82441338324773,"d":"4.82"},{"v":4.19451864855788,"d":"4.19"},{"v":0.690183014415603,"d":"0.69"},{"v":-0.534949125779118,"d":"-0.53"},{"v":0.18491005119344,"d":"0.18"},{"v":0.691662010787972,"d":"0.69"},"down","no"]
["MSTRG.20584","EPB41L2","ENSOART00000015107","GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008092(cytoskeletal protein binding);GO:0008180(COP9 signalosome);GO:0030054(cell junction);GO:0030507(spectrin binding);GO:0030866(cortical actin cytoskeleton organization);GO:0042731(PH domain binding);GO:0099738(cell cortex region);GO:1904778(positive regulation of protein localization to cell cortex)","NA","K06107","NA","erythrocyte membrane protein band 4.1 like 2 [Source:NCBI gene;Acc:101120756]",{"v":2.18980572953862,"d":"2.19"},{"v":2.83084116040747,"d":"2.83"},{"v":2.93663421390717,"d":"2.94"},{"v":2.31946227229409,"d":"2.32"},{"v":2.4743093651053,"d":"2.47"},{"v":1.50583256717626,"d":"1.51"},{"v":1.26313984901997,"d":"1.26"},{"v":0.337014376511239,"d":"0.34"},{"v":0.185336352049875,"d":"0.19"},{"v":0.691680616153697,"d":"0.69"},"up","no"]
["MSTRG.776","TARS2","ENSOART00000022676","GO:0000166(nucleotide binding);GO:0002161(aminoacyl-tRNA editing activity);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004829(threonine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006418(tRNA aminoacylation for protein translation);GO:0006435(threonyl-tRNA aminoacylation);GO:0042803(protein homodimerization activity);GO:0043039(tRNA aminoacylation);GO:0106074(aminoacyl-tRNA metabolism involved in translational fidelity)","00970(Aminoacyl-tRNA biosynthesis)","K01868","EC:6.1.1.3","threonyl-tRNA synthetase 2, mitochondrial [Source:NCBI gene;Acc:101105117]",{"v":4.07302634971098,"d":"4.07"},{"v":2.6924560070448,"d":"2.69"},{"v":2.89190386777457,"d":"2.89"},{"v":5.02355432532514,"d":"5.02"},{"v":3.93214338186416,"d":"3.93"},{"v":4.78292972705925,"d":"4.78"},{"v":0.702936757747414,"d":"0.70"},{"v":-0.508533197038191,"d":"-0.51"},{"v":0.1860715360218,"d":"0.19"},{"v":0.692478269622356,"d":"0.69"},"down","no"]
["MSTRG.18741","METAP1","ENSOART00000017216","GO:0004177(aminopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008235(metalloexopeptidase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0070006(metalloaminopeptidase activity);GO:0070084(protein initiator methionine removal)","NA","K01265","EC:3.4.11.18","methionyl aminopeptidase 1 [Source:NCBI gene;Acc:101123124]",{"v":8.70405876933121,"d":"8.70"},{"v":8.06628871811983,"d":"8.07"},{"v":6.43287836239663,"d":"6.43"},{"v":7.44034497635282,"d":"7.44"},{"v":5.38322138546351,"d":"5.38"},{"v":5.519216100972,"d":"5.52"},{"v":1.26497852203828,"d":"1.26"},{"v":0.339112889732301,"d":"0.34"},{"v":0.186256863131773,"d":"0.19"},{"v":0.692478269622356,"d":"0.69"},"up","no"]
["MSTRG.13838","DNAAF5","ENSOART00000006586","GO:0003341(cilium movement);GO:0005737(cytoplasm);GO:0036158(outer dynein arm assembly);GO:0036159(inner dynein arm assembly);GO:0045505(dynein intermediate chain binding)","NA","NA","NA","dynein axonemal assembly factor 5 [Source:HGNC Symbol;Acc:HGNC:26013]",{"v":1.08387518789734,"d":"1.08"},{"v":1.05976983141041,"d":"1.06"},{"v":0.976351528137509,"d":"0.98"},{"v":1.61572419307747,"d":"1.62"},{"v":1.41969412691312,"d":"1.42"},{"v":1.5001519566753,"d":"1.50"},{"v":0.687895095242307,"d":"0.69"},{"v":-0.539739525764184,"d":"-0.54"},{"v":0.186677650921178,"d":"0.19"},{"v":0.692901269434189,"d":"0.69"},"down","no"]
["MSTRG.12172","TMEM134","ENSOART00000013429","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0048471(perinuclear region of cytoplasm)","NA","NA","NA","transmembrane protein 134 [Source:NCBI gene;Acc:101110633]",{"v":1.91143670793651,"d":"1.91"},{"v":2.82224833174603,"d":"2.82"},{"v":0.847431011111111,"d":"0.85"},{"v":1.38669669047619,"d":"1.39"},{"v":1.13401714285714,"d":"1.13"},{"v":1.18030927142857,"d":"1.18"},{"v":1.50799276114022,"d":"1.51"},{"v":0.592629503213891,"d":"0.59"},{"v":0.187889992960443,"d":"0.19"},{"v":0.694778780922788,"d":"0.69"},"up","no"]
["MSTRG.1059","SFT2D2","ENSOART00000013621","GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport)","NA","NA","NA","SFT2 domain containing 2 [Source:NCBI gene;Acc:101118149]",{"v":4.344934,"d":"4.34"},{"v":2.842966,"d":"2.84"},{"v":3.110897,"d":"3.11"},{"v":5.589104,"d":"5.59"},{"v":4.62791,"d":"4.63"},{"v":5.328858,"d":"5.33"},{"v":0.662477923399858,"d":"0.66"},{"v":-0.594055716297332,"d":"-0.59"},{"v":0.188940726753752,"d":"0.19"},{"v":0.696079464448389,"d":"0.70"},"down","no"]
["ENSOARG00000015850","TYW5","ENSOART00000017264","GO:0000049(tRNA binding);GO:0005506(iron ion binding);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0031591(wybutosine biosynthetic process);GO:0042803(protein homodimerization activity);GO:0055114(oxidation-reduction process)","NA","K18066","EC:1.14.11.42","tRNA-yW synthesizing protein 5 [Source:NCBI gene;Acc:101103128]",{"v":2.786398,"d":"2.79"},{"v":2.299092,"d":"2.30"},{"v":2.863728,"d":"2.86"},{"v":2.299271,"d":"2.30"},{"v":1.645314,"d":"1.65"},{"v":1.982137,"d":"1.98"},{"v":1.34125035728013,"d":"1.34"},{"v":0.42357855528465,"d":"0.42"},{"v":0.189947629171804,"d":"0.19"},{"v":0.69774238225359,"d":"0.70"},"up","no"]
["MSTRG.12050","ENSOARG00000006676","ENSOART00000007251","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0046872(metal ion binding)","NA","NA","NA",null,{"v":6.0849885389479,"d":"6.08"},{"v":6.41345452655539,"d":"6.41"},{"v":4.81226396433991,"d":"4.81"},{"v":11.0269119984826,"d":"11.03"},{"v":6.70084651289833,"d":"6.70"},{"v":7.41161703110774,"d":"7.41"},{"v":0.688589380455611,"d":"0.69"},{"v":-0.538284163300135,"d":"-0.54"},{"v":0.191050750286813,"d":"0.19"},{"v":0.698523355026825,"d":"0.70"},"down","no"]
["MSTRG.4633","WAC","ENSOART00000016634","GO:0000993(RNA polymerase II complex binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0010390(histone monoubiquitination);GO:0016239(positive regulation of macroautophagy);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0044783(G1 DNA damage checkpoint);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071894(histone H2B conserved C-terminal lysine ubiquitination)","NA","NA","NA","WW domain containing adaptor with coiled-coil [Source:NCBI gene;Acc:101117863]",{"v":10.190738492478,"d":"10.19"},{"v":9.1526866923742,"d":"9.15"},{"v":10.2019772045651,"d":"10.20"},{"v":8.98693699014352,"d":"8.99"},{"v":7.34446290472073,"d":"7.34"},{"v":7.2281974106865,"d":"7.23"},{"v":1.25407077235808,"d":"1.25"},{"v":0.326618767636708,"d":"0.33"},{"v":0.191392593249322,"d":"0.19"},{"v":0.698649287407764,"d":"0.70"},"up","no"]
["MSTRG.2787","MRM3","ENSOART00000012367","GO:0001510(RNA methylation);GO:0003723(RNA binding);GO:0005739(mitochondrion);GO:0006396(RNA processing);GO:0008168(methyltransferase activity);GO:0008173(RNA methyltransferase activity);GO:0032259(methylation)","NA","K20095","EC:2.1.1.-","mitochondrial rRNA methyltransferase 3 [Source:NCBI gene;Acc:101102000]",{"v":1.91239267863031,"d":"1.91"},{"v":2.17250659720989,"d":"2.17"},{"v":1.8147999752695,"d":"1.81"},{"v":1.7906513868104,"d":"1.79"},{"v":1.44842999454661,"d":"1.45"},{"v":1.46786319581484,"d":"1.47"},{"v":1.25340316937713,"d":"1.25"},{"v":0.325850546267289,"d":"0.33"},{"v":0.191459054650803,"d":"0.19"},{"v":0.698735682686255,"d":"0.70"},"up","no"]
["MSTRG.13283","ADCY9","ENSOART00000003177","GO:0000166(nucleotide binding);GO:0004016(adenylate cyclase activity);GO:0005887(integral component of plasma membrane);GO:0006171(cAMP biosynthetic process);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0009190(cyclic nucleotide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0016849(phosphorus-oxygen lyase activity);GO:0035556(intracellular signal transduction);GO:0071880(adenylate cyclase-activating adrenergic receptor signaling pathway)","00230(Purine metabolism);01522(Endocrine resistance);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04114(Oocyte meiosis);04211(Longevity regulating pathway);04213(Longevity regulating pathway - multiple species);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04713(Circadian entrainment);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04727(GABAergic synapse);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04913(Ovarian steroidogenesis);04914(Progesterone-mediated oocyte maturation);04915(Estrogen signaling pathway);04916(Melanogenesis);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04961(Endocrine and other factor-regulated calcium reabsorption);04962(Vasopressin-regulated water reabsorption);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);05032(Morphine addiction);05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05414(Dilated cardiomyopathy (DCM))","K08049","EC:4.6.1.1","adenylate cyclase 9 [Source:NCBI gene;Acc:101122401]",{"v":26.881499810372,"d":"26.88"},{"v":27.2388566084489,"d":"27.24"},{"v":22.0372199981085,"d":"22.04"},{"v":22.7073355587957,"d":"22.71"},{"v":19.0912330469735,"d":"19.09"},{"v":19.4561869317465,"d":"19.46"},{"v":1.24329247172142,"d":"1.24"},{"v":0.314165715432077,"d":"0.31"},{"v":0.19265419150056,"d":"0.19"},{"v":0.700291357815122,"d":"0.70"},"up","no"]
["MSTRG.21190","CCN3","ENSOART00000010313","GO:0001525(angiogenesis);GO:0002062(chondrocyte differentiation);GO:0005112(Notch binding);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005921(gap junction);GO:0010761(fibroblast migration);GO:0010832(negative regulation of myotube differentiation);GO:0014909(smooth muscle cell migration);GO:0030308(negative regulation of cell growth);GO:0033627(cell adhesion mediated by integrin);GO:0035767(endothelial cell chemotaxis);GO:0043231(intracellular membrane-bounded organelle);GO:0044342(type B pancreatic cell proliferation);GO:0045747(positive regulation of Notch signaling pathway);GO:0046676(negative regulation of insulin secretion);GO:0048659(smooth muscle cell proliferation);GO:0050728(negative regulation of inflammatory response);GO:0060326(cell chemotaxis);GO:0060392(negative regulation of SMAD protein signal transduction);GO:0061484(hematopoietic stem cell homeostasis);GO:0071603(endothelial cell-cell adhesion);GO:0090027(negative regulation of monocyte chemotaxis);GO:1901223(negative regulation of NIK/NF-kappaB signaling);GO:1902731(negative regulation of chondrocyte proliferation);GO:1990523(bone regeneration)","NA","NA","NA","cellular communication network factor 3 [Source:NCBI gene;Acc:101113859]",{"v":7.240942,"d":"7.24"},{"v":4.292356,"d":"4.29"},{"v":4.444807,"d":"4.44"},{"v":2.869179,"d":"2.87"},{"v":4.526592,"d":"4.53"},{"v":4.385795,"d":"4.39"},{"v":1.35619534788499,"d":"1.36"},{"v":0.439565000838995,"d":"0.44"},{"v":0.193636340375388,"d":"0.19"},{"v":0.700651315255495,"d":"0.70"},"up","no"]
["MSTRG.16469","HDHD5","ENSOART00000014438","NA","NA","NA","NA","haloacid dehalogenase like hydrolase domain containing 5 [Source:NCBI gene;Acc:101117069]",{"v":3.83349800087642,"d":"3.83"},{"v":3.01341296581946,"d":"3.01"},{"v":1.45198251621385,"d":"1.45"},{"v":4.59090408851884,"d":"4.59"},{"v":3.92918012532866,"d":"3.93"},{"v":4.18969312269939,"d":"4.19"},{"v":0.652953491092744,"d":"0.65"},{"v":-0.614947860480818,"d":"-0.61"},{"v":0.194135795900044,"d":"0.19"},{"v":0.700651315255495,"d":"0.70"},"down","no"]
["MSTRG.13672","ZNHIT1","ENSOART00000016326","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006338(chromatin remodeling);GO:0043486(histone exchange);GO:0046872(metal ion binding)","NA","K11663","NA","zinc finger HIT-type containing 1 [Source:NCBI gene;Acc:101121482]",{"v":6.05787980637636,"d":"6.06"},{"v":6.57187757387247,"d":"6.57"},{"v":6.72644876671851,"d":"6.73"},{"v":7.72608116485225,"d":"7.73"},{"v":7.76234479937792,"d":"7.76"},{"v":12.5759423180404,"d":"12.58"},{"v":0.689707530641103,"d":"0.69"},{"v":-0.535943375813082,"d":"-0.54"},{"v":0.194761375288403,"d":"0.19"},{"v":0.700651315255495,"d":"0.70"},"down","no"]
["MSTRG.12200","FADD","ENSOART00000020101","GO:0001916(positive regulation of T cell mediated cytotoxicity);GO:0002020(protease binding);GO:0002376(immune system process);GO:0002821(positive regulation of adaptive immune response);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0031264(death-inducing signaling complex);GO:0031265(CD95 death-inducing signaling complex);GO:0032729(positive regulation of interferon-gamma production);GO:0032757(positive regulation of interleukin-8 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0032813(tumor necrosis factor receptor superfamily binding);GO:0033077(T cell differentiation in thymus);GO:0035877(death effector domain binding);GO:0036462(TRAIL-activated apoptotic signaling pathway);GO:0042104(positive regulation of activated T cell proliferation);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043029(T cell homeostasis);GO:0043065(positive regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0045651(positive regulation of macrophage differentiation);GO:0045862(positive regulation of proteolysis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048535(lymph node development);GO:0048536(spleen development);GO:0048538(thymus development);GO:0051607(defense response to virus);GO:0060340(positive regulation of type I interferon-mediated signaling pathway);GO:0060546(negative regulation of necroptotic process);GO:0070236(negative regulation of activation-induced cell death of T cells);GO:0071260(cellular response to mechanical stimulus);GO:0089720(caspase binding);GO:0097049(motor neuron apoptotic process);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097202(activation of cysteine-type endopeptidase activity);GO:0097342(ripoptosome);GO:0097527(necroptotic signaling pathway);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2000454(positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","01524(Platinum drug resistance);04210(Apoptosis);04215(Apoptosis - multiple species);04217(Necroptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04657(IL-17 signaling pathway);04668(TNF signaling pathway);05010(Alzheimer disease);05142(Chagas disease (American trypanosomiasis));05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer)","K02373","NA","Fas associated via death domain [Source:NCBI gene;Acc:101116783]",{"v":0.923816,"d":"0.92"},{"v":1.20786,"d":"1.21"},{"v":1.214007,"d":"1.21"},{"v":1.415665,"d":"1.42"},{"v":1.751987,"d":"1.75"},{"v":2.274048,"d":"2.27"},{"v":0.614823125126339,"d":"0.61"},{"v":-0.701756665256116,"d":"-0.70"},{"v":0.195086334075769,"d":"0.20"},{"v":0.700651315255495,"d":"0.70"},"down","no"]
["MSTRG.9602","DCAF12","ENSOART00000010186","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0080008(Cul4-RING E3 ubiquitin ligase complex)","NA","K11803","NA","DDB1 and CUL4 associated factor 12 [Source:NCBI gene;Acc:101102205]",{"v":12.97045,"d":"12.97"},{"v":11.254078,"d":"11.25"},{"v":12.370684,"d":"12.37"},{"v":15.742408,"d":"15.74"},{"v":18.143356,"d":"18.14"},{"v":17.701006,"d":"17.70"},{"v":0.709391419544197,"d":"0.71"},{"v":-0.49534621465077,"d":"-0.50"},{"v":0.195353452400279,"d":"0.20"},{"v":0.700651315255495,"d":"0.70"},"down","no"]
["MSTRG.21102","ARMC1","ENSOART00000018553","GO:0005515(protein binding);GO:0030001(metal ion transport);GO:0046872(metal ion binding)","NA","K17306","NA","armadillo repeat containing 1 [Source:NCBI gene;Acc:101119911]",{"v":3.119685557336,"d":"3.12"},{"v":2.98968594641963,"d":"2.99"},{"v":3.37550583775664,"d":"3.38"},{"v":2.82692875312969,"d":"2.83"},{"v":2.5762064682023,"d":"2.58"},{"v":2.25260249724587,"d":"2.25"},{"v":1.2389240188435,"d":"1.24"},{"v":0.309087712095992,"d":"0.31"},{"v":0.1968233345306,"d":"0.20"},{"v":0.703070640537639,"d":"0.70"},"up","no"]
["MSTRG.16115","MTERF2","ENSOART00000020125","GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-templated);GO:0042645(mitochondrial nucleoid)","NA","K15031","NA","mitochondrial transcription termination factor 2 [Source:NCBI gene;Acc:101117236]",{"v":3.732277,"d":"3.73"},{"v":3.396738,"d":"3.40"},{"v":3.56633,"d":"3.57"},{"v":3.475898,"d":"3.48"},{"v":2.509801,"d":"2.51"},{"v":2.253331,"d":"2.25"},{"v":1.29813157616855,"d":"1.30"},{"v":0.376436619597014,"d":"0.38"},{"v":0.196849314330966,"d":"0.20"},{"v":0.703070640537639,"d":"0.70"},"up","no"]
["MSTRG.17951","ZNF555","ENSOART00000014605","GO:0003676(nucleic acid binding);GO:0003677(DNA binding)","NA","NA","NA","zinc finger protein 555 [Source:HGNC Symbol;Acc:HGNC:28382]",{"v":0.197379,"d":"0.20"},{"v":0.27171,"d":"0.27"},{"v":0.294487,"d":"0.29"},{"v":0.410681,"d":"0.41"},{"v":0.564333,"d":"0.56"},{"v":0.306662,"d":"0.31"},{"v":0.595763671942051,"d":"0.60"},{"v":-0.747187940260872,"d":"-0.75"},{"v":0.19800408789722,"d":"0.20"},{"v":0.704179932784811,"d":"0.70"},"down","no"]
["MSTRG.7184","ENSOARG00000013884","ENSOART00000015112","NA","NA","NA","NA","death associated protein [Source:NCBI gene;Acc:101105188]",{"v":3.529222,"d":"3.53"},{"v":0.735433,"d":"0.74"},{"v":2.809385,"d":"2.81"},{"v":2.698319,"d":"2.70"},{"v":4.88123,"d":"4.88"},{"v":4.717114,"d":"4.72"},{"v":0.575281277530335,"d":"0.58"},{"v":-0.797660576262059,"d":"-0.80"},{"v":0.198367845031012,"d":"0.20"},{"v":0.704579111086874,"d":"0.70"},"down","no"]
["MSTRG.11814","THRSP","ENSOART00000016620","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0009617(response to bacterium);GO:0010866(regulation of triglyceride biosynthetic process);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046890(regulation of lipid biosynthetic process)","NA","NA","NA","thyroid hormone responsive [Source:NCBI gene;Acc:101110189]",{"v":2.345938,"d":"2.35"},{"v":3.367595,"d":"3.37"},{"v":1.465524,"d":"1.47"},{"v":0.240354,"d":"0.24"},{"v":1.968379,"d":"1.97"},{"v":1.855947,"d":"1.86"},{"v":1.76620471968273,"d":"1.77"},{"v":0.820652574556923,"d":"0.82"},{"v":0.199445144213293,"d":"0.20"},{"v":0.705948474900206,"d":"0.71"},"up","no"]
["MSTRG.14753","ENSOARG00000010579","ENSOART00000011511","GO:0001522(pseudouridine synthesis);GO:0003723(RNA binding);GO:0006396(RNA processing);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity)","NA","NA","NA","TruB pseudouridine synthase family member 2 [Source:NCBI gene;Acc:101108213]",{"v":7.473876,"d":"7.47"},{"v":6.073357,"d":"6.07"},{"v":4.850585,"d":"4.85"},{"v":4.548106,"d":"4.55"},{"v":4.580776,"d":"4.58"},{"v":5.114498,"d":"5.11"},{"v":1.29167500972382,"d":"1.29"},{"v":0.36924312820634,"d":"0.37"},{"v":0.200141523640794,"d":"0.20"},{"v":0.706557385213889,"d":"0.71"},"up","no"]
["MSTRG.17899","PLIN5","ENSOART00000010156","GO:0005737(cytoplasm);GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0010867(positive regulation of triglyceride biosynthetic process);GO:0010890(positive regulation of sequestering of triglyceride);GO:0010897(negative regulation of triglyceride catabolic process);GO:0019915(lipid storage);GO:0031999(negative regulation of fatty acid beta-oxidation);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0034389(lipid droplet organization);GO:0035359(negative regulation of peroxisome proliferator activated receptor signaling pathway);GO:0035473(lipase binding);GO:0042802(identical protein binding);GO:0050995(negative regulation of lipid catabolic process);GO:0051646(mitochondrion localization);GO:0060192(negative regulation of lipase activity);GO:2000378(negative regulation of reactive oxygen species metabolic process)","03320(PPAR signaling pathway)","K20255","NA","perilipin 5 [Source:NCBI gene;Acc:100135434]",{"v":5.09503938179597,"d":"5.10"},{"v":6.13313017898595,"d":"6.13"},{"v":3.67153403359805,"d":"3.67"},{"v":7.43817015638363,"d":"7.44"},{"v":5.90335501282834,"d":"5.90"},{"v":8.29326895235186,"d":"8.29"},{"v":0.688691720876102,"d":"0.69"},{"v":-0.538069761146131,"d":"-0.54"},{"v":0.20038934137555,"d":"0.20"},{"v":0.706557385213889,"d":"0.71"},"down","no"]
["MSTRG.10840","PEF1","ENSOART00000001325","GO:0000139(Golgi membrane);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0014029(neural crest formation);GO:0014032(neural crest cell development);GO:0030127(COPII vesicle coat);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0048208(COPII vesicle coating);GO:0048306(calcium-dependent protein binding);GO:0051592(response to calcium ion);GO:0060090(molecular adaptor activity);GO:1902527(positive regulation of protein monoubiquitination)","NA","NA","NA","penta-EF-hand domain containing 1 [Source:NCBI gene;Acc:101118674]",{"v":2.57771804690832,"d":"2.58"},{"v":3.36066903678038,"d":"3.36"},{"v":2.64018966204691,"d":"2.64"},{"v":3.77155621561834,"d":"3.77"},{"v":3.7942466380597,"d":"3.79"},{"v":4.65796879904051,"d":"4.66"},{"v":0.701794584311279,"d":"0.70"},{"v":-0.510879280258436,"d":"-0.51"},{"v":0.201615090193856,"d":"0.20"},{"v":0.708042011945455,"d":"0.71"},"down","no"]
["MSTRG.20437","SLC22A16","ENSOART00000010902;ENSOART00000010900","GO:0005275(amine transmembrane transporter activity);GO:0007338(single fertilization);GO:0015101(organic cation transmembrane transporter activity);GO:0015226(carnitine transmembrane transporter activity);GO:0015695(organic cation transport);GO:0015837(amine transport);GO:0015879(carnitine transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0030317(flagellated sperm motility);GO:0046717(acid secretion);GO:0055085(transmembrane transport);GO:1902603(carnitine transmembrane transport);GO:1902603(carnitine transmembrane transport)","NA","K08212","NA","solute carrier family 22 member 16 [Source:NCBI gene;Acc:101111717]",{"v":2.17721297149527,"d":"2.18"},{"v":1.48219474186018,"d":"1.48"},{"v":1.49735236368104,"d":"1.50"},{"v":1.74365035716919,"d":"1.74"},{"v":1.32191363914486,"d":"1.32"},{"v":1.0352868788549,"d":"1.04"},{"v":1.25748539364383,"d":"1.26"},{"v":0.33054164246421,"d":"0.33"},{"v":0.20241511487566,"d":"0.20"},{"v":0.709082599375621,"d":"0.71"},"up","no"]
["MSTRG.4578","NMT2","ENSOART00000008733","GO:0004379(glycylpeptide N-tetradecanoyltransferase activity);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006499(N-terminal protein myristoylation);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018008(N-terminal peptidyl-glycine N-myristoylation);GO:0019898(extrinsic component of membrane)","NA","K00671","EC:2.3.1.97","N-myristoyltransferase 2 [Source:NCBI gene;Acc:101117182]",{"v":1.302063,"d":"1.30"},{"v":1.62015,"d":"1.62"},{"v":1.432065,"d":"1.43"},{"v":1.961756,"d":"1.96"},{"v":2.292825,"d":"2.29"},{"v":2.262176,"d":"2.26"},{"v":0.668166390123185,"d":"0.67"},{"v":-0.581720680340966,"d":"-0.58"},{"v":0.202729572536329,"d":"0.20"},{"v":0.709235487318391,"d":"0.71"},"down","no"]
["MSTRG.1578","NCEH1","ENSOART00000022591","GO:0006470(protein dephosphorylation);GO:0006805(xenobiotic metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0017171(serine hydrolase activity);GO:0042301(phosphate ion binding);GO:0052689(carboxylic ester hydrolase activity);GO:0060395(SMAD protein signal transduction)","04927(Cortisol synthesis and secretion);04934(Cushing syndrome);04976(Bile secretion);04979(Cholesterol metabolism)","K14349","EC:3.1.1.-","neutral cholesterol ester hydrolase 1 [Source:NCBI gene;Acc:101113553]",{"v":2.55938303436019,"d":"2.56"},{"v":2.91182220023697,"d":"2.91"},{"v":1.85102633412322,"d":"1.85"},{"v":2.08435352132701,"d":"2.08"},{"v":1.86187123459716,"d":"1.86"},{"v":1.65078180331754,"d":"1.65"},{"v":1.30824066243589,"d":"1.31"},{"v":0.387627961757509,"d":"0.39"},{"v":0.202991550572009,"d":"0.20"},{"v":0.709246472210177,"d":"0.71"},"up","no"]
["MSTRG.7668","NOS1","ENSOART00000004598;ENSOART00000004599","GO:0001666(response to hypoxia);GO:0002028(regulation of sodium ion transport);GO:0004517(nitric-oxide synthase activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006809(nitric oxide biosynthetic process);GO:0006941(striated muscle contraction);GO:0009408(response to heat);GO:0010181(FMN binding);GO:0016491(oxidoreductase activity);GO:0016529(sarcoplasmic reticulum);GO:0018119(peptidyl-cysteine S-nitrosylation);GO:0020037(heme binding);GO:0030018(Z disc);GO:0030315(T-tubule);GO:0033017(sarcoplasmic reticulum membrane);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033555(multicellular organismal response to stress);GO:0035066(positive regulation of histone acetylation);GO:0042311(vasodilation);GO:0042383(sarcolemma);GO:0042738(exogenous drug catabolic process);GO:0043267(negative regulation of potassium ion transport);GO:0044305(calyx of Held);GO:0045121(membrane raft);GO:0045202(synapse);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0050660(flavin adenine dinucleotide binding);GO:0050661(NADP binding);GO:0050767(regulation of neurogenesis);GO:0051346(negative regulation of hydrolase activity);GO:0051612(negative regulation of serotonin uptake);GO:0051926(negative regulation of calcium ion transport);GO:0055114(oxidation-reduction process);GO:0071363(cellular response to growth factor stimulus);GO:0098735(positive regulation of the force of heart contraction);GO:0098924(retrograde trans-synaptic signaling by nitric oxide);GO:0099163(synaptic signaling by nitric oxide);GO:0140196(positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process);GO:0140196(positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process)","00220(Arginine biosynthesis);00330(Arginine and proline metabolism);04020(Calcium signaling pathway);04145(Phagosome);04371(Apelin signaling pathway);04713(Circadian entrainment);04730(Long-term depression);04926(Relaxin signaling pathway);04970(Salivary secretion);05010(Alzheimer disease);05014(Amyotrophic lateral sclerosis (ALS));05014(Amyotrophic lateral sclerosis (ALS))","K13240","EC:1.14.13.39","nitric oxide synthase 1 [Source:NCBI gene;Acc:443533]",{"v":8.70776344823278,"d":"8.71"},{"v":7.95991448702844,"d":"7.96"},{"v":6.16701689378793,"d":"6.17"},{"v":6.93399143109604,"d":"6.93"},{"v":5.58005442609782,"d":"5.58"},{"v":5.88543313275021,"d":"5.89"},{"v":1.24105116462967,"d":"1.24"},{"v":0.311562594465762,"d":"0.31"},{"v":0.203845311172728,"d":"0.20"},{"v":0.709289481843228,"d":"0.71"},"up","no"]
["ENSOARG00000017890","BTBD11","ENSOART00000019465","GO:0005515(protein binding);GO:0060395(SMAD protein signal transduction)","NA","K10483","NA","BTB domain containing 11 [Source:NCBI gene;Acc:101103558]",{"v":0.389197,"d":"0.39"},{"v":0.169936,"d":"0.17"},{"v":0.325512,"d":"0.33"},{"v":0.528498,"d":"0.53"},{"v":0.615148,"d":"0.62"},{"v":0.332623,"d":"0.33"},{"v":0.599243769258855,"d":"0.60"},{"v":-0.73878509160717,"d":"-0.74"},{"v":0.204648611618534,"d":"0.20"},{"v":0.709501031048772,"d":"0.71"},"down","no"]
["MSTRG.7396","SETD7","ENSOART00000014199","GO:0002039(p53 binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0006974(cellular response to DNA damage stimulus);GO:0008168(methyltransferase activity);GO:0016279(protein-lysine N-methyltransferase activity);GO:0016740(transferase activity);GO:0018022(peptidyl-lysine methylation);GO:0018024(histone-lysine N-methyltransferase activity);GO:0018026(peptidyl-lysine monomethylation);GO:0018027(peptidyl-lysine dimethylation);GO:0032259(methylation);GO:0034968(histone lysine methylation);GO:0051570(regulation of histone H3-K9 methylation);GO:0070828(heterochromatin organization)","00310(Lysine degradation);04068(FoxO signaling pathway)","K11431","EC:2.1.1.43","SET domain containing 7, histone lysine methyltransferase [Source:NCBI gene;Acc:101115990]",{"v":42.240791040331,"d":"42.24"},{"v":37.6741972587714,"d":"37.67"},{"v":40.4842775307145,"d":"40.48"},{"v":29.7389030111901,"d":"29.74"},{"v":37.5868618665346,"d":"37.59"},{"v":29.330930416249,"d":"29.33"},{"v":1.24563813674399,"d":"1.25"},{"v":0.316885020089296,"d":"0.32"},{"v":0.205511809370883,"d":"0.21"},{"v":0.710966156076238,"d":"0.71"},"up","no"]
["MSTRG.850","NUP210L","ENSOART00000001964","GO:0007286(spermatid development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0060009(Sertoli cell development)","03013(RNA transport)","K14314","NA","nucleoporin 210 like [Source:NCBI gene;Acc:101102613]",{"v":0.512325007377599,"d":"0.51"},{"v":0.556761505298457,"d":"0.56"},{"v":0.514720841716969,"d":"0.51"},{"v":0.363954184842388,"d":"0.36"},{"v":0.420795768075117,"d":"0.42"},{"v":0.422680280482897,"d":"0.42"},{"v":1.31171748940944,"d":"1.31"},{"v":0.391457033587342,"d":"0.39"},{"v":0.205966456851131,"d":"0.21"},{"v":0.7110423827865,"d":"0.71"},"up","no"]
["MSTRG.13580","C16orf58","ENSOART00000010623","NA","NA","NA","NA","chromosome 24 open reading frame, human C16orf58 [Source:NCBI gene;Acc:101107249]",{"v":0.775761,"d":"0.78"},{"v":0.286697,"d":"0.29"},{"v":0.455418,"d":"0.46"},{"v":0.777944,"d":"0.78"},{"v":0.904519,"d":"0.90"},{"v":0.764261,"d":"0.76"},{"v":0.620370748805341,"d":"0.62"},{"v":-0.688797431640955,"d":"-0.69"},{"v":0.207170369045164,"d":"0.21"},{"v":0.712223470895887,"d":"0.71"},"down","no"]
["MSTRG.11917","JAM3","ENSOART00000014809","GO:0001525(angiogenesis);GO:0005178(integrin binding);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0005887(integral component of plasma membrane);GO:0005923(bicellular tight junction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030057(desmosome);GO:0044291(cell-cell contact zone);GO:0090022(regulation of neutrophil chemotaxis)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration)","K06785","NA","junctional adhesion molecule 3 [Source:NCBI gene;Acc:101117375]",{"v":8.47125137211538,"d":"8.47"},{"v":6.58777223125,"d":"6.59"},{"v":6.85935543605769,"d":"6.86"},{"v":9.29159671009615,"d":"9.29"},{"v":11.3952719168269,"d":"11.40"},{"v":9.82334677884615,"d":"9.82"},{"v":0.718394765422682,"d":"0.72"},{"v":-0.477151256955088,"d":"-0.48"},{"v":0.207679978135879,"d":"0.21"},{"v":0.712843952701834,"d":"0.71"},"down","no"]
["MSTRG.12507","OGA;NPM3","ENSOART00000018510;ENSOART00000018425","GO:0005829(cytosol);GO:0006044(N-acetylglucosamine metabolic process);GO:0006517(protein deglycosylation);GO:0016231(beta-N-acetylglucosaminidase activity);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0009303(rRNA transcription);GO:0015629(actin cytoskeleton)","04931(Insulin resistance)","K15719;K11278","2.3.1.48;EC:3.2.1.169","O-GlcNAcase [Source:NCBI gene;Acc:101113978];nucleophosmin/nucleoplasmin 3 [Source:NCBI gene;Acc:101103609]",{"v":8.18742534883721,"d":"8.19"},{"v":7.87335125392835,"d":"7.87"},{"v":11.7506551477058,"d":"11.75"},{"v":9.45928607877645,"d":"9.46"},{"v":7.23955083867589,"d":"7.24"},{"v":5.44640804839723,"d":"5.45"},{"v":1.25586471467621,"d":"1.26"},{"v":0.328681061380978,"d":"0.33"},{"v":0.208140291072084,"d":"0.21"},{"v":0.713374196604742,"d":"0.71"},"up","no"]
["MSTRG.15109","KCMF1","ENSOART00000022265","GO:0003676(nucleic acid binding);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0046872(metal ion binding);GO:0061630(ubiquitin protein ligase activity)","NA","K22376","EC:2.3.2.27","potassium channel modulatory factor 1 [Source:NCBI gene;Acc:101122775]",{"v":9.46558351463603,"d":"9.47"},{"v":10.2557030759969,"d":"10.26"},{"v":9.07811475378328,"d":"9.08"},{"v":8.04698572937148,"d":"8.05"},{"v":7.46796245774881,"d":"7.47"},{"v":7.67467874483597,"d":"7.67"},{"v":1.24190878227236,"d":"1.24"},{"v":0.312559212047811,"d":"0.31"},{"v":0.209272537306321,"d":"0.21"},{"v":0.714139280936892,"d":"0.71"},"up","no"]
["MSTRG.18621","PRSS12","ENSOART00000018993","GO:0004252(serine-type endopeptidase activity);GO:0005044(scavenger receptor activity);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0006887(exocytosis);GO:0006898(receptor-mediated endocytosis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0030424(axon);GO:0030425(dendrite);GO:0031410(cytoplasmic vesicle);GO:0031638(zymogen activation);GO:0043083(synaptic cleft);GO:0043195(terminal bouton);GO:0045202(synapse)","NA","K09624","EC:3.4.21.-","serine protease 12 [Source:NCBI gene;Acc:101115965]",{"v":0.613865359150451,"d":"0.61"},{"v":0.642659071092458,"d":"0.64"},{"v":1.12178325473738,"d":"1.12"},{"v":0.680624463945059,"d":"0.68"},{"v":0.712691845097291,"d":"0.71"},{"v":0.423273897240239,"d":"0.42"},{"v":1.3092152961934,"d":"1.31"},{"v":0.388702363295381,"d":"0.39"},{"v":0.209907094923946,"d":"0.21"},{"v":0.714254188833589,"d":"0.71"},"up","no"]
["MSTRG.1281","ENSOARG00000018519","ENSOART00000020157","NA","03010(Ribosome)","K02896","NA","ribosomal protein L24 [Source:NCBI gene;Acc:101112181]",{"v":185.061060458101,"d":"185.06"},{"v":170.641153050279,"d":"170.64"},{"v":166.848612499069,"d":"166.85"},{"v":187.095849288641,"d":"187.10"},{"v":252.235557590317,"d":"252.24"},{"v":289.415469068901,"d":"289.42"},{"v":0.717053950080792,"d":"0.72"},{"v":-0.479846425631171,"d":"-0.48"},{"v":0.211150664275707,"d":"0.21"},{"v":0.715637745607912,"d":"0.72"},"down","no"]
["ENSOARG00000010353","HNMT","ENSOART00000011264","GO:0001695(histamine catabolic process);GO:0005737(cytoplasm);GO:0008170(N-methyltransferase activity);GO:0032259(methylation);GO:0046539(histamine N-methyltransferase activity)","00340(Histidine metabolism)","K00546","EC:2.1.1.8","histamine N-methyltransferase [Source:NCBI gene;Acc:101102876]",{"v":1.149803,"d":"1.15"},{"v":0.762536,"d":"0.76"},{"v":0.82504,"d":"0.83"},{"v":1.342523,"d":"1.34"},{"v":1.269078,"d":"1.27"},{"v":1.680882,"d":"1.68"},{"v":0.637714581513776,"d":"0.64"},{"v":-0.649017225706248,"d":"-0.65"},{"v":0.211299242402972,"d":"0.21"},{"v":0.715637745607912,"d":"0.72"},"down","no"]
["ENSOARG00000005338","ZFP82","ENSOART00000005816","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 14 homolog [Source:NCBI gene;Acc:101122457]",{"v":0.749815,"d":"0.75"},{"v":0.301597,"d":"0.30"},{"v":0.552883,"d":"0.55"},{"v":1.0325,"d":"1.03"},{"v":0.890815,"d":"0.89"},{"v":0.64514,"d":"0.65"},{"v":0.624614797611794,"d":"0.62"},{"v":-0.678961346553101,"d":"-0.68"},{"v":0.21237625635178,"d":"0.21"},{"v":0.716021658306936,"d":"0.72"},"down","no"]
["MSTRG.15124","VAMP5","ENSOART00000022371","GO:0005770(late endosome);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007519(skeletal muscle tissue development);GO:0009986(cell surface);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0030659(cytoplasmic vesicle membrane);GO:0031301(integral component of organelle membrane);GO:0043001(Golgi to plasma membrane protein transport);GO:0048471(perinuclear region of cytoplasm)","NA","NA","NA","vesicle associated membrane protein 5 [Source:HGNC Symbol;Acc:HGNC:12646]",{"v":5.85555922927281,"d":"5.86"},{"v":7.83167789717462,"d":"7.83"},{"v":4.74403060120426,"d":"4.74"},{"v":7.73806354793886,"d":"7.74"},{"v":9.29536381472904,"d":"9.30"},{"v":9.4484786864289,"d":"9.45"},{"v":0.695994755569353,"d":"0.70"},{"v":-0.522851659707889,"d":"-0.52"},{"v":0.21261575744848,"d":"0.21"},{"v":0.716117103528311,"d":"0.72"},"down","no"]
["MSTRG.10966","ID3","ENSOART00000007960","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001656(metanephros development);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-templated);GO:0007417(central nervous system development);GO:0007507(heart development);GO:0007623(circadian rhythm);GO:0008134(transcription factor binding);GO:0010629(negative regulation of gene expression);GO:0019904(protein domain specific binding);GO:0030855(epithelial cell differentiation);GO:0030903(notochord development);GO:0042476(odontogenesis);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045662(negative regulation of myoblast differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046983(protein dimerization activity);GO:0072750(cellular response to leptomycin B);GO:1901707(leptomycin B binding)","04350(TGF-beta signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells)","K17694","NA","inhibitor of DNA binding 3, HLH protein [Source:NCBI gene;Acc:100415775]",{"v":6.567813,"d":"6.57"},{"v":2.691869,"d":"2.69"},{"v":2.231123,"d":"2.23"},{"v":6.373892,"d":"6.37"},{"v":3.565711,"d":"3.57"},{"v":7.440046,"d":"7.44"},{"v":0.661164388302664,"d":"0.66"},{"v":-0.596919074738006,"d":"-0.60"},{"v":0.21423275946338,"d":"0.21"},{"v":0.717831315032526,"d":"0.72"},"down","no"]
["MSTRG.15590","OTOGL","ENSOART00000016428","GO:0005576(extracellular region);GO:0007605(sensory perception of sound);GO:0046373(L-arabinose metabolic process);GO:0046556(alpha-L-arabinofuranosidase activity)","NA","NA","NA","otogelin like [Source:NCBI gene;Acc:101103553]",{"v":1.196432,"d":"1.20"},{"v":0.802973,"d":"0.80"},{"v":0.695153,"d":"0.70"},{"v":1.424748,"d":"1.42"},{"v":1.427807,"d":"1.43"},{"v":1.023836,"d":"1.02"},{"v":0.695120280694078,"d":"0.70"},{"v":-0.524665457559582,"d":"-0.52"},{"v":0.214259055740558,"d":"0.21"},{"v":0.717831315032526,"d":"0.72"},"down","no"]
["MSTRG.6779","CELF1","ENSOART00000007532;ENSOART00000007529","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006376(mRNA splice site selection);GO:0007286(spermatid development);GO:0031369(translation initiation factor binding);GO:0040018(positive regulation of multicellular organism growth);GO:0040018(positive regulation of multicellular organism growth)","NA","K13207","NA","CUGBP Elav-like family member 1 [Source:NCBI gene;Acc:101118301]",{"v":4.73197980129506,"d":"4.73"},{"v":5.01902495409297,"d":"5.02"},{"v":6.04431237170194,"d":"6.04"},{"v":5.00956399516768,"d":"5.01"},{"v":4.11090755639316,"d":"4.11"},{"v":3.65042116072291,"d":"3.65"},{"v":1.23682169155623,"d":"1.24"},{"v":0.306637526789842,"d":"0.31"},{"v":0.21534742726712,"d":"0.22"},{"v":0.72023613117934,"d":"0.72"},"up","no"]
["MSTRG.18762","PDLIM5","ENSOART00000018990","GO:0005515(protein binding);GO:0015629(actin cytoskeleton);GO:0046872(metal ion binding)","NA","NA","NA","PDZ and LIM domain 5 [Source:NCBI gene;Acc:101114358]",{"v":12.541143993935,"d":"12.54"},{"v":9.06020072995725,"d":"9.06"},{"v":11.1212328446956,"d":"11.12"},{"v":12.1430080711563,"d":"12.14"},{"v":6.10302110675107,"d":"6.10"},{"v":7.90271355128758,"d":"7.90"},{"v":1.25140156478932,"d":"1.25"},{"v":0.323544813139323,"d":"0.32"},{"v":0.215969290481247,"d":"0.22"},{"v":0.720593375439218,"d":"0.72"},"up","no"]
["MSTRG.5549","ENSOARG00000004057","ENSOART00000004410","NA","NA","K23168","NA","chromosome 14 open reading frame, human C19orf12 [Source:NCBI gene;Acc:101106870]",{"v":4.90053414406089,"d":"4.90"},{"v":5.14590534275618,"d":"5.15"},{"v":2.66047361701549,"d":"2.66"},{"v":3.0831373723838,"d":"3.08"},{"v":3.26738053846154,"d":"3.27"},{"v":3.51999365724382,"d":"3.52"},{"v":1.28736114801925,"d":"1.29"},{"v":0.364416834729445,"d":"0.36"},{"v":0.216911320163634,"d":"0.22"},{"v":0.722212079044008,"d":"0.72"},"up","no"]
["MSTRG.11125","MLIP","ENSOART00000007388","NA","NA","NA","NA","muscular LMNA interacting protein [Source:HGNC Symbol;Acc:HGNC:21355]",{"v":5.36858850502414,"d":"5.37"},{"v":5.02477874532599,"d":"5.02"},{"v":7.84528240656741,"d":"7.85"},{"v":5.41292093144333,"d":"5.41"},{"v":5.43496317330886,"d":"5.43"},{"v":3.83761268528112,"d":"3.84"},{"v":1.24194979016955,"d":"1.24"},{"v":0.312606849131964,"d":"0.31"},{"v":0.218435536372795,"d":"0.22"},{"v":0.724921836970527,"d":"0.72"},"up","no"]
["MSTRG.5690","PAF1","ENSOART00000006585","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000993(RNA polymerase II complex binding);GO:0001711(endodermal cell fate commitment);GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006378(mRNA polyadenylation);GO:0010390(histone monoubiquitination);GO:0016020(membrane);GO:0016570(histone modification);GO:0016584(nucleosome positioning);GO:0016593(Cdc73/Paf1 complex);GO:0019827(stem cell population maintenance);GO:0030054(cell junction);GO:0031062(positive regulation of histone methylation);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0032968(positive regulation of transcription elongation from RNA polymerase II promoter);GO:0033523(histone H2B ubiquitination);GO:0034504(protein localization to nucleus);GO:0045638(negative regulation of myeloid cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071222(cellular response to lipopolysaccharide);GO:1902808(positive regulation of cell cycle G1/S phase transition)","NA","K15174","NA","PAF1 homolog, Paf1/RNA polymerase II complex component [Source:NCBI gene;Acc:101115394]",{"v":10.07896,"d":"10.08"},{"v":10.262245,"d":"10.26"},{"v":10.080634,"d":"10.08"},{"v":7.853963,"d":"7.85"},{"v":8.731994,"d":"8.73"},{"v":8.003311,"d":"8.00"},{"v":1.23719986296461,"d":"1.24"},{"v":0.307078578743264,"d":"0.31"},{"v":0.219421344641314,"d":"0.22"},{"v":0.725344322852812,"d":"0.73"},"up","no"]
["MSTRG.16537","TAB1","ENSOART00000018086","GO:0000185(activation of MAPKKK activity);GO:0001701(in utero embryonic development);GO:0003007(heart morphogenesis);GO:0003279(cardiac septum development);GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005829(cytosol);GO:0006470(protein dephosphorylation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016607(nuclear speck);GO:0019209(kinase activator activity);GO:0030324(lung development);GO:0035904(aorta development);GO:0060976(coronary vasculature development)","NA","NA","NA","TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [Source:HGNC Symbol;Acc:HGNC:18157]",{"v":3.38415225852037,"d":"3.38"},{"v":3.09956969492934,"d":"3.10"},{"v":2.89010745552785,"d":"2.89"},{"v":3.95029373067332,"d":"3.95"},{"v":4.56290874314214,"d":"4.56"},{"v":4.45819736575229,"d":"4.46"},{"v":0.722653647633603,"d":"0.72"},{"v":-0.468623734800073,"d":"-0.47"},{"v":0.220132129825202,"d":"0.22"},{"v":0.726198929921455,"d":"0.73"},"down","no"]
["ENSOARG00000013469","PRMT2","ENSOART00000014653","GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006479(protein methylation);GO:0008168(methyltransferase activity);GO:0016571(histone methylation);GO:0016740(transferase activity);GO:0030331(estrogen receptor binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032259(methylation);GO:0033142(progesterone receptor binding);GO:0042054(histone methyltransferase activity);GO:0042803(protein homodimerization activity);GO:0042974(retinoic acid receptor binding);GO:0042975(peroxisome proliferator activated receptor binding);GO:0043065(positive regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046966(thyroid hormone receptor binding);GO:0050681(androgen receptor binding);GO:0060765(regulation of androgen receptor signaling pathway)","NA","K11435","EC:2.1.1.319","protein arginine methyltransferase 2 [Source:NCBI gene;Acc:101113453]",{"v":0.720022,"d":"0.72"},{"v":0.483672,"d":"0.48"},{"v":0.444724,"d":"0.44"},{"v":0.785899,"d":"0.79"},{"v":0.91858,"d":"0.92"},{"v":0.730988,"d":"0.73"},{"v":0.676838569358566,"d":"0.68"},{"v":-0.563116312722519,"d":"-0.56"},{"v":0.221102756929785,"d":"0.22"},{"v":0.727624793966969,"d":"0.73"},"down","no"]
["MSTRG.877","ADAM15","ENSOART00000003856","GO:0001953(negative regulation of cell-matrix adhesion);GO:0002418(immune response to tumor cell);GO:0004222(metalloendopeptidase activity);GO:0005178(integrin binding);GO:0006508(proteolysis);GO:0007229(integrin-mediated signaling pathway);GO:0008237(metallopeptidase activity);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017124(SH3 domain binding);GO:0030308(negative regulation of cell growth);GO:0030336(negative regulation of cell migration);GO:0045087(innate immune response);GO:0060317(cardiac epithelial to mesenchymal transition);GO:0070062(extracellular exosome);GO:1900121(negative regulation of receptor binding);GO:1904628(cellular response to phorbol 13-acetate 12-myristate)","NA","K06836","EC:3.4.24.-","ADAM metallopeptidase domain 15 [Source:NCBI gene;Acc:101105128]",{"v":5.63230271654994,"d":"5.63"},{"v":7.02065329303354,"d":"7.02"},{"v":5.66732263029856,"d":"5.67"},{"v":6.55600478105418,"d":"6.56"},{"v":10.2765820575009,"d":"10.28"},{"v":9.14844301437523,"d":"9.15"},{"v":0.705140586943122,"d":"0.71"},{"v":-0.504017172318695,"d":"-0.50"},{"v":0.222023312346202,"d":"0.22"},{"v":0.728829240850179,"d":"0.73"},"down","no"]
["MSTRG.11272","ENSOARG00000004853","ENSOART00000005288","GO:0007283(spermatogenesis)","NA","NA","NA","male-enhanced antigen 1 [Source:NCBI gene;Acc:101111668]",{"v":7.26332486886246,"d":"7.26"},{"v":5.62667818145776,"d":"5.63"},{"v":6.62301560201281,"d":"6.62"},{"v":9.91695742573955,"d":"9.92"},{"v":7.58011245776151,"d":"7.58"},{"v":9.60799322964318,"d":"9.61"},{"v":0.719903088617803,"d":"0.72"},{"v":-0.474125386916772,"d":"-0.47"},{"v":0.22212799384418,"d":"0.22"},{"v":0.728879799736287,"d":"0.73"},"down","no"]
["MSTRG.886","FAM189B","ENSOART00000004294","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050699(WW domain binding)","NA","NA","NA","family with sequence similarity 189 member B [Source:NCBI gene;Acc:101117807]",{"v":3.23865890776871,"d":"3.24"},{"v":3.07285002731465,"d":"3.07"},{"v":2.61857635083363,"d":"2.62"},{"v":3.25526558318553,"d":"3.26"},{"v":4.24559895849592,"d":"4.25"},{"v":5.04028284533523,"d":"5.04"},{"v":0.712062860784327,"d":"0.71"},{"v":-0.489923487208757,"d":"-0.49"},{"v":0.223438484868523,"d":"0.22"},{"v":0.730164112440698,"d":"0.73"},"down","no"]
["MSTRG.6913","BDP1","ENSOART00000005846;ENSOART00000005838","GO:0000126(transcription factor TFIIIB complex);GO:0000995(RNA polymerase III general transcription initiation factor activity);GO:0003677(DNA binding);GO:0006383(transcription by RNA polymerase III);GO:0006383(transcription by RNA polymerase III)","NA","K15198","NA","B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB [Source:NCBI gene;Acc:101117279]",{"v":2.48961388509209,"d":"2.49"},{"v":2.35016449102282,"d":"2.35"},{"v":2.24954577087918,"d":"2.25"},{"v":2.13585325923781,"d":"2.14"},{"v":1.95709452461485,"d":"1.96"},{"v":1.69566976555079,"d":"1.70"},{"v":1.22470073147684,"d":"1.22"},{"v":0.29242925456525,"d":"0.29"},{"v":0.223768896075997,"d":"0.22"},{"v":0.73049632983614,"d":"0.73"},"up","no"]
["MSTRG.18176","UQCRQ;LEAP2","ENSOART00000014388;ENSOART00000014426","GO:0005739(mitochondrion);GO:0008121(ubiquinol-cytochrome-c reductase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021539(subthalamus development);GO:0021548(pons development);GO:0021680(cerebellar Purkinje cell layer development);GO:0021766(hippocampus development);GO:0021794(thalamus development);GO:0021854(hypothalamus development);GO:0021860(pyramidal neuron development);GO:0022900(electron transport chain);GO:0030901(midbrain development);GO:0042742(defense response to bacterium)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);04714(Thermogenesis);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K00418","NA","cytochrome b-c1 complex subunit 8 [Source:NCBI gene;Acc:101121420];liver enriched antimicrobial peptide 2 [Source:NCBI gene;Acc:101121678]",{"v":7.19421393856414,"d":"7.19"},{"v":4.06238976806591,"d":"4.06"},{"v":2.73771630003923,"d":"2.74"},{"v":3.5612023809337,"d":"3.56"},{"v":2.42775784338956,"d":"2.43"},{"v":4.39543257395057,"d":"4.40"},{"v":1.34763007125419,"d":"1.35"},{"v":0.430424526482116,"d":"0.43"},{"v":0.22444637559235,"d":"0.22"},{"v":0.730984460717732,"d":"0.73"},"up","no"]
["MSTRG.15931","USP15;ENSOARG00000023974","ENSOART00000004976;ENSOART00000025876","GO:0003824(catalytic activity);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030509(BMP signaling pathway);GO:0035520(monoubiquitinated protein deubiquitination);GO:0035616(histone H2B conserved C-terminal lysine deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042802(identical protein binding);GO:0046332(SMAD binding);GO:0060389(pathway-restricted SMAD protein phosphorylation);GO:0061649(ubiquitin modification-dependent histone binding)","04137(Mitophagy - animal)","K21343","EC:3.4.19.12","ubiquitin specific peptidase 15 [Source:NCBI gene;Acc:101113139]",{"v":5.26634696242205,"d":"5.27"},{"v":5.32822777863472,"d":"5.33"},{"v":4.10720912061044,"d":"4.11"},{"v":4.85831971578602,"d":"4.86"},{"v":3.73889365211684,"d":"3.74"},{"v":3.37737247686249,"d":"3.38"},{"v":1.22774883843637,"d":"1.23"},{"v":0.296015457611303,"d":"0.30"},{"v":0.225183037551481,"d":"0.23"},{"v":0.731537192856925,"d":"0.73"},"up","no"]
["MSTRG.3611","ITGB4","ENSOART00000010637","GO:0001664(G protein-coupled receptor binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006914(autophagy);GO:0007154(cell communication);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009611(response to wounding);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0030056(hemidesmosome);GO:0031252(cell leading edge);GO:0031581(hemidesmosome assembly);GO:0031994(insulin-like growth factor I binding);GO:0035878(nail development);GO:0038132(neuregulin binding);GO:0043235(receptor complex);GO:0043588(skin development);GO:0048333(mesodermal cell differentiation);GO:0048565(digestive tract development);GO:0048870(cell motility);GO:0072001(renal system development);GO:0097186(amelogenesis)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04810(Regulation of actin cytoskeleton);05165(Human papillomavirus infection);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","K06525","NA","integrin subunit beta 4 [Source:NCBI gene;Acc:101119919]",{"v":1.78143147337983,"d":"1.78"},{"v":1.52991530260248,"d":"1.53"},{"v":1.53495521619323,"d":"1.53"},{"v":1.84285509644497,"d":"1.84"},{"v":2.35967621023984,"d":"2.36"},{"v":2.4988325585984,"d":"2.50"},{"v":0.723181443300233,"d":"0.72"},{"v":-0.467570435942619,"d":"-0.47"},{"v":0.225993646766989,"d":"0.23"},{"v":0.732583733256184,"d":"0.73"},"down","no"]
["MSTRG.16643","CDPF1","ENSOART00000021173","NA","NA","NA","NA","cysteine rich DPF motif domain containing 1 [Source:NCBI gene;Acc:101120820]",{"v":8.13775254133088,"d":"8.14"},{"v":11.7582569519917,"d":"11.76"},{"v":10.0010706087958,"d":"10.00"},{"v":9.0930140617085,"d":"9.09"},{"v":7.73228826364264,"d":"7.73"},{"v":7.43578018201704,"d":"7.44"},{"v":1.23230610559271,"d":"1.23"},{"v":0.301360666882721,"d":"0.30"},{"v":0.226655235375645,"d":"0.23"},{"v":0.733075673284036,"d":"0.73"},"up","no"]
["MSTRG.21398","ENSOARG00000017405","ENSOART00000018946","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02871","NA","mitochondrial ribosomal protein L13 [Source:NCBI gene;Acc:101121019]",{"v":5.4937482692953,"d":"5.49"},{"v":5.82831367785235,"d":"5.83"},{"v":9.00651622231543,"d":"9.01"},{"v":10.5178056711409,"d":"10.52"},{"v":8.19266136157718,"d":"8.19"},{"v":10.3440706610738,"d":"10.34"},{"v":0.69966964829066,"d":"0.70"},{"v":-0.515254186070627,"d":"-0.52"},{"v":0.226873936578849,"d":"0.23"},{"v":0.733211112630967,"d":"0.73"},"down","no"]
["MSTRG.14089","FUT11","ENSOART00000008822","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0008417(fucosyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0032580(Golgi cisterna membrane);GO:0036065(fucosylation);GO:0046920(alpha-(1->3)-fucosyltransferase activity)","NA","K11257","EC:2.4.1.-","fucosyltransferase 11 [Source:NCBI gene;Acc:101108628]",{"v":2.29124558308338,"d":"2.29"},{"v":1.418638,"d":"1.42"},{"v":2.185331,"d":"2.19"},{"v":2.78345262267547,"d":"2.78"},{"v":2.78369169406119,"d":"2.78"},{"v":2.59822166466707,"d":"2.60"},{"v":0.721977997864331,"d":"0.72"},{"v":-0.469973222948996,"d":"-0.47"},{"v":0.227942670712656,"d":"0.23"},{"v":0.733993683667298,"d":"0.73"},"down","no"]
["MSTRG.9606","ENSOARG00000009458","ENSOART00000010297;ENSOART00000010299","GO:0015267(channel activity);GO:0015793(glycerol transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0070295(renal water absorption);GO:0070295(renal water absorption)","03320(PPAR signaling pathway);04923(Regulation of lipolysis in adipocytes);04923(Regulation of lipolysis in adipocytes)","K08771","NA","aquaporin 7 [Source:NCBI gene;Acc:101103697]",{"v":8.57897447413793,"d":"8.58"},{"v":8.22757778189655,"d":"8.23"},{"v":5.80907428189655,"d":"5.81"},{"v":9.21354564051724,"d":"9.21"},{"v":10.4882566241379,"d":"10.49"},{"v":11.9958707956897,"d":"12.00"},{"v":0.713479077624286,"d":"0.71"},{"v":-0.487056970792847,"d":"-0.49"},{"v":0.227969629200344,"d":"0.23"},{"v":0.733993683667298,"d":"0.73"},"down","no"]
["MSTRG.10178","ITPRID2","ENSOART00000018336","GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0051015(actin filament binding)","NA","NA","NA","sperm-specific antigen 2 [Source:NCBI gene;Acc:101120052]",{"v":3.8908570967632,"d":"3.89"},{"v":3.31994493219762,"d":"3.32"},{"v":3.76979396166951,"d":"3.77"},{"v":3.10638279284497,"d":"3.11"},{"v":3.33824258177172,"d":"3.34"},{"v":2.49567941056218,"d":"2.50"},{"v":1.22821271248312,"d":"1.23"},{"v":0.296560440731704,"d":"0.30"},{"v":0.228879378896095,"d":"0.23"},{"v":0.735085170419415,"d":"0.74"},"up","no"]
["MSTRG.12053","RPS6KA4","ENSOART00000008251","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0033129(positive regulation of histone phosphorylation);GO:0035066(positive regulation of histone acetylation);GO:0035556(intracellular signal transduction);GO:0043987(histone H3-S10 phosphorylation);GO:0043988(histone H3-S28 phosphorylation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070498(interleukin-1-mediated signaling pathway)","04010(MAPK signaling pathway);04668(TNF signaling pathway)","K16510","EC:2.7.11.1","ribosomal protein S6 kinase A4 [Source:NCBI gene;Acc:101117122]",{"v":0.820379,"d":"0.82"},{"v":0.931716,"d":"0.93"},{"v":0.834026,"d":"0.83"},{"v":1.002204,"d":"1.00"},{"v":1.369183,"d":"1.37"},{"v":1.427424,"d":"1.43"},{"v":0.680771167610076,"d":"0.68"},{"v":-0.554758158372893,"d":"-0.55"},{"v":0.229504542921948,"d":"0.23"},{"v":0.735318364793322,"d":"0.74"},"down","no"]
["MSTRG.11414","ENSOARG00000015002;ENSOARG00000014493;ENSOARG00000014069","ENSOART00000016352;ENSOART00000015779;ENSOART00000015330","GO:0002376(immune system process);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0006955(immune response);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019882(antigen processing and presentation);GO:0042612(MHC class I protein complex);GO:0042612(MHC class I protein complex)","NA","NA","NA",null,{"v":24.4581628468215,"d":"24.46"},{"v":3.85306557926985,"d":"3.85"},{"v":28.9727102267041,"d":"28.97"},{"v":19.430716756191,"d":"19.43"},{"v":8.01672499374521,"d":"8.02"},{"v":11.203161549783,"d":"11.20"},{"v":1.48209688238454,"d":"1.48"},{"v":0.56763975747323,"d":"0.57"},{"v":0.230445654120176,"d":"0.23"},{"v":0.736079848913325,"d":"0.74"},"up","no"]
["MSTRG.16665","ALG12","ENSOART00000021377","GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005789(endoplasmic reticulum membrane);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0052824(dolichyl-pyrophosphate Man7GlcNAc2 alpha-1,6-mannosyltransferase activity);GO:0097502(mannosylation)","00510(N-Glycan biosynthesis)","K03847","EC:2.4.1.260","ALG12, alpha-1,6-mannosyltransferase [Source:NCBI gene;Acc:101112896]",{"v":1.670769,"d":"1.67"},{"v":1.479754,"d":"1.48"},{"v":1.003852,"d":"1.00"},{"v":2.05665,"d":"2.06"},{"v":2.061013,"d":"2.06"},{"v":1.93515,"d":"1.94"},{"v":0.68635442727208,"d":"0.69"},{"v":-0.542974331285455,"d":"-0.54"},{"v":0.231551223892956,"d":"0.23"},{"v":0.737273148797924,"d":"0.74"},"down","no"]
["ENSOARG00000018761","EFNA5","ENSOART00000020428","GO:0005169(neurotrophin TRKB receptor binding);GO:0005604(basement membrane);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0007411(axon guidance);GO:0016020(membrane);GO:0022407(regulation of cell-cell adhesion);GO:0022604(regulation of cell morphogenesis);GO:0031290(retinal ganglion cell axon guidance);GO:0031362(anchored component of external side of plasma membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0043087(regulation of GTPase activity);GO:0045499(chemorepellent activity);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0048668(collateral sprouting);GO:0048672(positive regulation of collateral sprouting);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050919(negative chemotaxis);GO:0051893(regulation of focal adhesion assembly);GO:0051965(positive regulation of synapse assembly);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0071372(cellular response to follicle-stimulating hormone stimulus);GO:0071944(cell periphery);GO:0098982(GABA-ergic synapse);GO:0099560(synaptic membrane adhesion);GO:1900025(negative regulation of substrate adhesion-dependent cell spreading);GO:1904322(cellular response to forskolin)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04360(Axon guidance)","K05462","NA","ephrin A5 [Source:NCBI gene;Acc:101115792]",{"v":0.499072,"d":"0.50"},{"v":0.361718,"d":"0.36"},{"v":0.413078,"d":"0.41"},{"v":0.984964,"d":"0.98"},{"v":0.692498,"d":"0.69"},{"v":0.388605,"d":"0.39"},{"v":0.616566645708973,"d":"0.62"},{"v":-0.697671248536347,"d":"-0.70"},{"v":0.232223519655275,"d":"0.23"},{"v":0.737582291554333,"d":"0.74"},"down","no"]
["MSTRG.14383","ENSOARG00000000596","ENSOART00000000640","NA","NA","NA","NA","coiled-coil domain-containing protein 25-like [Source:NCBI gene;Acc:101109940]",{"v":1.07104061580381,"d":"1.07"},{"v":1.08977832370572,"d":"1.09"},{"v":1.12923587493188,"d":"1.13"},{"v":1.04688088119891,"d":"1.05"},{"v":0.862516549318801,"d":"0.86"},{"v":0.686866069754768,"d":"0.69"},{"v":1.26722684892967,"d":"1.27"},{"v":0.341674807455149,"d":"0.34"},{"v":0.233049721951031,"d":"0.23"},{"v":0.738450584128941,"d":"0.74"},"up","no"]
["ENSOARG00000004521","PEX6","ENSOART00000004924","GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0006625(protein targeting to peroxisome);GO:0007031(peroxisome organization);GO:0008022(protein C-terminus binding);GO:0016561(protein import into peroxisome matrix, translocation);GO:0016887(ATPase activity);GO:0042623(ATPase activity, coupled);GO:0044877(protein-containing complex binding);GO:0050821(protein stabilization);GO:0097733(photoreceptor cell cilium)","04146(Peroxisome)","K13339","NA","peroxisomal biogenesis factor 6 [Source:NCBI gene;Acc:101111400]",{"v":1.111948,"d":"1.11"},{"v":0.96106,"d":"0.96"},{"v":0.889887,"d":"0.89"},{"v":1.314168,"d":"1.31"},{"v":1.720084,"d":"1.72"},{"v":1.236776,"d":"1.24"},{"v":0.693719404321395,"d":"0.69"},{"v":-0.527575855502529,"d":"-0.53"},{"v":0.233747352335706,"d":"0.23"},{"v":0.739369773137817,"d":"0.74"},"down","no"]
["MSTRG.10075","CYFIP1","ENSOART00000017188","GO:0005737(cytoplasm);GO:0005845(mRNA cap binding complex);GO:0006417(regulation of translation);GO:0016601(Rac protein signal transduction);GO:0030027(lamellipodium);GO:0030032(lamellipodium assembly);GO:0031175(neuron projection development);GO:0031209(SCAR complex);GO:0043005(neuron projection);GO:0045182(translation regulator activity);GO:0048365(Rac GTPase binding);GO:0048471(perinuclear region of cytoplasm);GO:0048675(axon extension);GO:0050890(cognition);GO:0051388(positive regulation of neurotrophin TRK receptor signaling pathway);GO:0097484(dendrite extension);GO:0098794(postsynapse);GO:0099563(modification of synaptic structure);GO:0099578(regulation of translation at postsynapse, modulating synaptic transmission);GO:1905274(regulation of modification of postsynaptic actin cytoskeleton);GO:2000601(positive regulation of Arp2/3 complex-mediated actin nucleation)","03013(RNA transport);04810(Regulation of actin cytoskeleton)","K05749","NA","cytoplasmic FMR1 interacting protein 1 [Source:NCBI gene;Acc:100188913]",{"v":5.62170181156148,"d":"5.62"},{"v":4.53946187083663,"d":"4.54"},{"v":4.88600714632494,"d":"4.89"},{"v":6.93614148074969,"d":"6.94"},{"v":6.95182467370442,"d":"6.95"},{"v":6.79772975443152,"d":"6.80"},{"v":0.727419125515592,"d":"0.73"},{"v":-0.459141236836802,"d":"-0.46"},{"v":0.234558799235436,"d":"0.23"},{"v":0.740072671288155,"d":"0.74"},"down","no"]
["MSTRG.4484","ECHDC3","ENSOART00000015596","GO:0003824(catalytic activity)","NA","NA","NA","enoyl-CoA hydratase domain containing 3 [Source:NCBI gene;Acc:101108411]",{"v":9.1322285408805,"d":"9.13"},{"v":11.5561200090566,"d":"11.56"},{"v":6.53419096754717,"d":"6.53"},{"v":12.2998196437736,"d":"12.30"},{"v":12.2987331124528,"d":"12.30"},{"v":13.8819368623899,"d":"13.88"},{"v":0.707437451739554,"d":"0.71"},{"v":-0.499325497549563,"d":"-0.50"},{"v":0.23530639230173,"d":"0.24"},{"v":0.740571082016702,"d":"0.74"},"down","no"]
["MSTRG.4831","ENSOARG00000010368","ENSOART00000011289","GO:0000166(nucleotide binding);GO:0000723(telomere maintenance);GO:0000732(strand displacement);GO:0000781(chromosome, telomeric region);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006139(nucleobase-containing compound metabolic process);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0008026(ATP-dependent helicase activity);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016787(hydrolase activity);GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides);GO:0031297(replication fork processing);GO:0032206(positive regulation of telomere maintenance);GO:0032508(DNA duplex unwinding);GO:0043247(telomere maintenance in response to DNA damage);GO:0045910(negative regulation of DNA recombination);GO:0046872(metal ion binding);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0070182(DNA polymerase binding);GO:0090657(telomeric loop disassembly);GO:1902990(mitotic telomere maintenance via semi-conservative replication);GO:1904430(negative regulation of t-circle formation);GO:1904506(negative regulation of telomere maintenance in response to DNA damage);GO:1904535(positive regulation of telomeric loop disassembly)","NA","K11136","EC:3.6.4.12","regulator of telomere elongation helicase 1 [Source:NCBI gene;Acc:101117606]",{"v":1.6906067156799,"d":"1.69"},{"v":1.46000159856864,"d":"1.46"},{"v":1.36877152439818,"d":"1.37"},{"v":2.25037139882889,"d":"2.25"},{"v":2.09232850748211,"d":"2.09"},{"v":1.91784802277163,"d":"1.92"},{"v":0.721882475757829,"d":"0.72"},{"v":-0.470164112958195,"d":"-0.47"},{"v":0.236197864498573,"d":"0.24"},{"v":0.74111264567949,"d":"0.74"},"down","no"]
["MSTRG.3258","DNAJC7","ENSOART00000019786","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0031072(heat shock protein binding);GO:0051085(chaperone cofactor-dependent protein refolding)","NA","K09527","NA","DnaJ heat shock protein family (Hsp40) member C7 [Source:NCBI gene;Acc:101120677]",{"v":29.944685,"d":"29.94"},{"v":26.548683,"d":"26.55"},{"v":24.870369,"d":"24.87"},{"v":27.402126,"d":"27.40"},{"v":18.920708,"d":"18.92"},{"v":20.559114,"d":"20.56"},{"v":1.21652761967998,"d":"1.22"},{"v":0.282769075165776,"d":"0.28"},{"v":0.236556030845447,"d":"0.24"},{"v":0.74122349704821,"d":"0.74"},"up","no"]
["MSTRG.6890","ENSOARG00000004593","ENSOART00000005010","GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004563(beta-N-acetylhexosaminidase activity);GO:0005975(carbohydrate metabolic process);GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0102148(N-acetyl-beta-D-galactosaminidase activity)","00511(Other glycan degradation);00520(Amino sugar and nucleotide sugar metabolism);00531(Glycosaminoglycan degradation);00603(Glycosphingolipid biosynthesis - globo and isoglobo series);00604(Glycosphingolipid biosynthesis - ganglio series);04142(Lysosome)","K12373","EC:3.2.1.52","hexosaminidase subunit beta [Source:NCBI gene;Acc:101111906]",{"v":1.339268,"d":"1.34"},{"v":1.008835,"d":"1.01"},{"v":1.233803,"d":"1.23"},{"v":1.426323,"d":"1.43"},{"v":1.531458,"d":"1.53"},{"v":2.104065,"d":"2.10"},{"v":0.707628402760574,"d":"0.71"},{"v":-0.498936138860885,"d":"-0.50"},{"v":0.237990909369249,"d":"0.24"},{"v":0.742826720957906,"d":"0.74"},"down","no"]
["MSTRG.2908","BCL6B","ENSOART00000010461","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus)","NA","K22648","NA","BCL6B, transcription repressor [Source:NCBI gene;Acc:101114452]",{"v":4.64606306603894,"d":"4.65"},{"v":2.54083904746151,"d":"2.54"},{"v":2.55026475022267,"d":"2.55"},{"v":5.92799593128897,"d":"5.93"},{"v":3.63974129507571,"d":"3.64"},{"v":4.18108441888281,"d":"4.18"},{"v":0.708218283352954,"d":"0.71"},{"v":-0.497734006083474,"d":"-0.50"},{"v":0.239292469778418,"d":"0.24"},{"v":0.744789829687763,"d":"0.74"},"down","no"]
["MSTRG.17342","AGK","ENSOART00000014935","GO:0001727(lipid kinase activity);GO:0001729(ceramide kinase activity);GO:0003951(NAD+ kinase activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0016020(membrane);GO:0016301(kinase activity);GO:0031305(integral component of mitochondrial inner membrane);GO:0042721(TIM22 mitochondrial import inner membrane insertion complex);GO:0043231(intracellular membrane-bounded organelle);GO:0045039(protein insertion into mitochondrial inner membrane);GO:0046513(ceramide biosynthetic process);GO:0046834(lipid phosphorylation)","00561(Glycerolipid metabolism)","K09881","EC:2.7.1.94","acylglycerol kinase [Source:NCBI gene;Acc:101108220]",{"v":2.42450747347528,"d":"2.42"},{"v":1.7577435676651,"d":"1.76"},{"v":1.74601152002887,"d":"1.75"},{"v":3.81880489317936,"d":"3.82"},{"v":2.36383976578852,"d":"2.36"},{"v":2.2936710259834,"d":"2.29"},{"v":0.699391431550172,"d":"0.70"},{"v":-0.515827973624107,"d":"-0.52"},{"v":0.239774393277428,"d":"0.24"},{"v":0.745387476527867,"d":"0.75"},"down","no"]
["MSTRG.17989","ENSOARG00000016418","ENSOART00000017883","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction)","04015(Rap1 signaling pathway);04530(Tight junction)","K08020","NA","Rap guanine nucleotide exchange factor 6 [Source:NCBI gene;Acc:101102808]",{"v":2.26185985442227,"d":"2.26"},{"v":2.365878,"d":"2.37"},{"v":2.12140752536166,"d":"2.12"},{"v":2.03479905145578,"d":"2.03"},{"v":1.90444455099799,"d":"1.90"},{"v":1.63044788866508,"d":"1.63"},{"v":1.21176287601311,"d":"1.21"},{"v":0.277107412449902,"d":"0.28"},{"v":0.240236561577106,"d":"0.24"},{"v":0.74561784332106,"d":"0.75"},"up","no"]
["MSTRG.6866","UBTD2","ENSOART00000004149","GO:0005515(protein binding)","NA","NA","NA","ubiquitin domain containing 2 [Source:NCBI gene;Acc:101107388]",{"v":6.13168,"d":"6.13"},{"v":3.526061,"d":"3.53"},{"v":3.464006,"d":"3.46"},{"v":8.494733,"d":"8.49"},{"v":5.868154,"d":"5.87"},{"v":4.944728,"d":"4.94"},{"v":0.679615115590403,"d":"0.68"},{"v":-0.557210154453514,"d":"-0.56"},{"v":0.241061336782211,"d":"0.24"},{"v":0.746719748046582,"d":"0.75"},"down","no"]
["ENSOARG00000009000","ITGAM","ENSOART00000009807","GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008305(integrin complex);GO:0009986(cell surface);GO:0010668(ectodermal cell differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031072(heat shock protein binding);GO:0032930(positive regulation of superoxide anion generation);GO:0043315(positive regulation of neutrophil degranulation);GO:0044853(plasma membrane raft)","04015(Rap1 signaling pathway);04145(Phagosome);04514(Cell adhesion molecules (CAMs));04610(Complement and coagulation cascades);04640(Hematopoietic cell lineage);04670(Leukocyte transendothelial migration);04810(Regulation of actin cytoskeleton);05133(Pertussis);05134(Legionellosis);05140(Leishmaniasis);05146(Amoebiasis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05202(Transcriptional misregulation in cancer);05221(Acute myeloid leukemia)","K06461","NA","integrin subunit alpha M [Source:NCBI gene;Acc:443217]",{"v":0.371146,"d":"0.37"},{"v":0.175372,"d":"0.18"},{"v":0.340584,"d":"0.34"},{"v":0.51762,"d":"0.52"},{"v":0.322297,"d":"0.32"},{"v":0.538352,"d":"0.54"},{"v":0.643634878242201,"d":"0.64"},{"v":-0.635685587807261,"d":"-0.64"},{"v":0.242078367473184,"d":"0.24"},{"v":0.74743966882861,"d":"0.75"},"down","no"]
["MSTRG.20202","ANGEL1","ENSOART00000002368","GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005801(cis-Golgi network);GO:0005829(cytosol);GO:0008190(eukaryotic initiation factor 4E binding);GO:0019904(protein domain specific binding);GO:0048471(perinuclear region of cytoplasm)","NA","K18729","NA","angel homolog 1 [Source:NCBI gene;Acc:101109279]",{"v":1.965059,"d":"1.97"},{"v":1.274738,"d":"1.27"},{"v":1.530716,"d":"1.53"},{"v":2.279498,"d":"2.28"},{"v":1.870894,"d":"1.87"},{"v":2.651696,"d":"2.65"},{"v":0.70133067963837,"d":"0.70"},{"v":-0.511833254949981,"d":"-0.51"},{"v":0.242379636071179,"d":"0.24"},{"v":0.74743966882861,"d":"0.75"},"down","no"]
["MSTRG.13274","NAA60","ENSOART00000001925","GO:0000139(Golgi membrane);GO:0004596(peptide alpha-N-acetyltransferase activity);GO:0006334(nucleosome assembly);GO:0006474(N-terminal protein amino acid acetylation);GO:0008283(cell population proliferation);GO:0010485(H4 histone acetyltransferase activity);GO:0017196(N-terminal peptidyl-methionine acetylation);GO:0042803(protein homodimerization activity);GO:0043967(histone H4 acetylation)","NA","K21121","EC:2.3.1.259","N(alpha)-acetyltransferase 60, NatF catalytic subunit [Source:NCBI gene;Acc:101120793]",{"v":2.63060544271612,"d":"2.63"},{"v":2.49646557194137,"d":"2.50"},{"v":3.09096307508226,"d":"3.09"},{"v":2.91440319443613,"d":"2.91"},{"v":4.12989105683518,"d":"4.13"},{"v":4.32012791325157,"d":"4.32"},{"v":0.72313699462825,"d":"0.72"},{"v":-0.467659110576064,"d":"-0.47"},{"v":0.244000197935818,"d":"0.24"},{"v":0.748822708664711,"d":"0.75"},"down","no"]
["MSTRG.20329","PHIP","ENSOART00000007513;ENSOART00000007518","GO:0005158(insulin receptor binding);GO:0005515(protein binding);GO:0007010(cytoskeleton organization);GO:0008286(insulin receptor signaling pathway);GO:0022604(regulation of cell morphogenesis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070577(lysine-acetylated histone binding);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","NA","K11797","NA","pleckstrin homology domain interacting protein [Source:NCBI gene;Acc:101111888]",{"v":4.00817477963442,"d":"4.01"},{"v":4.07663436309084,"d":"4.08"},{"v":3.46933169700886,"d":"3.47"},{"v":3.67492573615214,"d":"3.67"},{"v":3.06351231979321,"d":"3.06"},{"v":2.84549029579025,"d":"2.85"},{"v":1.20557462615439,"d":"1.21"},{"v":0.269720957826031,"d":"0.27"},{"v":0.244998122953517,"d":"0.24"},{"v":0.749855204487844,"d":"0.75"},"up","no"]
["MSTRG.3529","ENGASE","ENSOART00000003342","GO:0005737(cytoplasm);GO:0006517(protein deglycosylation);GO:0033925(mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity)","00511(Other glycan degradation)","K01227","EC:3.2.1.96","endo-beta-N-acetylglucosaminidase [Source:NCBI gene;Acc:101112239]",{"v":1.513287,"d":"1.51"},{"v":1.524662,"d":"1.52"},{"v":1.803743,"d":"1.80"},{"v":2.44879,"d":"2.45"},{"v":2.117373,"d":"2.12"},{"v":2.293852,"d":"2.29"},{"v":0.705784462570417,"d":"0.71"},{"v":-0.502700424502426,"d":"-0.50"},{"v":0.245134429031665,"d":"0.25"},{"v":0.749963454605401,"d":"0.75"},"down","no"]
["MSTRG.19037","RCHY1","ENSOART00000016621","GO:0000151(ubiquitin ligase complex);GO:0002039(p53 binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0031398(positive regulation of protein ubiquitination);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0042803(protein homodimerization activity)","04115(p53 signaling pathway);04120(Ubiquitin mediated proteolysis);05162(Measles)","K10144","EC:2.3.2.27","ring finger and CHY zinc finger domain containing 1 [Source:NCBI gene;Acc:100302546]",{"v":10.649909,"d":"10.65"},{"v":12.408641,"d":"12.41"},{"v":7.604743,"d":"7.60"},{"v":9.025567,"d":"9.03"},{"v":6.471742,"d":"6.47"},{"v":8.821074,"d":"8.82"},{"v":1.26091002843404,"d":"1.26"},{"v":0.334465336599619,"d":"0.33"},{"v":0.246100331243925,"d":"0.25"},{"v":0.751357127415817,"d":"0.75"},"up","no"]
["MSTRG.13720","ENSOARG00000018781","ENSOART00000020453","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005885(Arp2/3 protein complex);GO:0015629(actin cytoskeleton);GO:0030833(regulation of actin filament polymerization);GO:0034314(Arp2/3 complex-mediated actin nucleation)","04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05132(Salmonella infection)","K05757","NA","actin related protein 2/3 complex subunit 1A [Source:NCBI gene;Acc:101113818]",{"v":4.71004373718887,"d":"4.71"},{"v":3.72668262335286,"d":"3.73"},{"v":3.10764702855051,"d":"3.11"},{"v":6.10083285212299,"d":"6.10"},{"v":4.58688203221083,"d":"4.59"},{"v":5.19766863836018,"d":"5.20"},{"v":0.726729283721721,"d":"0.73"},{"v":-0.460510053669188,"d":"-0.46"},{"v":0.246999778869928,"d":"0.25"},{"v":0.751866590117112,"d":"0.75"},"down","no"]
["MSTRG.4591","RSU1","ENSOART00000009874","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0010811(positive regulation of cell-substrate adhesion);GO:0043547(positive regulation of GTPase activity)","NA","NA","NA","Ras suppressor protein 1 [Source:NCBI gene;Acc:100302548]",{"v":3.77399815837104,"d":"3.77"},{"v":3.50866944886878,"d":"3.51"},{"v":4.03696577918552,"d":"4.04"},{"v":4.9802699520362,"d":"4.98"},{"v":4.93405121447964,"d":"4.93"},{"v":5.62404346244344,"d":"5.62"},{"v":0.728495800988517,"d":"0.73"},{"v":-0.457007438191948,"d":"-0.46"},{"v":0.247835505303557,"d":"0.25"},{"v":0.752386636706923,"d":"0.75"},"down","no"]
["MSTRG.595","SLC25A24","ENSOART00000020505;ENSOART00000020501","GO:0005347(ATP transmembrane transporter activity);GO:0005509(calcium ion binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006839(mitochondrial transport);GO:0010941(regulation of cell death);GO:0015867(ATP transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0034599(cellular response to oxidative stress);GO:0055085(transmembrane transport);GO:0071277(cellular response to calcium ion);GO:0071277(cellular response to calcium ion)","NA","K14684","NA","solute carrier family 25 member 24 [Source:NCBI gene;Acc:101121132]",{"v":1.58435877733935,"d":"1.58"},{"v":1.6283096059752,"d":"1.63"},{"v":1.24337442953777,"d":"1.24"},{"v":2.29256682919955,"d":"2.29"},{"v":1.88219307666291,"d":"1.88"},{"v":2.24557702931229,"d":"2.25"},{"v":0.694051240276697,"d":"0.69"},{"v":-0.526885917149834,"d":"-0.53"},{"v":0.248423249343107,"d":"0.25"},{"v":0.752386636706923,"d":"0.75"},"down","no"]
["MSTRG.478","DDAH1","ENSOART00000015593","GO:0000052(citrulline metabolic process);GO:0003073(regulation of systemic arterial blood pressure);GO:0006527(arginine catabolic process);GO:0008285(negative regulation of cell population proliferation);GO:0016403(dimethylargininase activity);GO:0043116(negative regulation of vascular permeability);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:1900038(negative regulation of cellular response to hypoxia)","NA","K01482","EC:3.5.3.18","dimethylarginine dimethylaminohydrolase 1 [Source:NCBI gene;Acc:101113635]",{"v":1.424508,"d":"1.42"},{"v":1.78933,"d":"1.79"},{"v":1.723732,"d":"1.72"},{"v":2.218908,"d":"2.22"},{"v":2.283522,"d":"2.28"},{"v":2.445988,"d":"2.45"},{"v":0.710603478374502,"d":"0.71"},{"v":-0.49288334426866,"d":"-0.49"},{"v":0.249065649563379,"d":"0.25"},{"v":0.752743837691103,"d":"0.75"},"down","no"]
["MSTRG.19411","SERINC5","ENSOART00000019066","GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006658(phosphatidylserine metabolic process);GO:0006665(sphingolipid metabolic process);GO:0009597(detection of virus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042552(myelination);GO:0043209(myelin sheath);GO:0045087(innate immune response);GO:0051607(defense response to virus)","NA","NA","NA","serine incorporator 5 [Source:NCBI gene;Acc:101109361]",{"v":7.424549,"d":"7.42"},{"v":4.349804,"d":"4.35"},{"v":4.645873,"d":"4.65"},{"v":8.869907,"d":"8.87"},{"v":7.052145,"d":"7.05"},{"v":6.748763,"d":"6.75"},{"v":0.724289179722917,"d":"0.72"},{"v":-0.465362272087422,"d":"-0.47"},{"v":0.250545852671192,"d":"0.25"},{"v":0.755428871068943,"d":"0.76"},"down","no"]
["MSTRG.16849","RF00003","ENSOART00000026461","NA","NA","NA","NA",null,{"v":541.695374,"d":"541.70"},{"v":1005.769409,"d":"1005.77"},{"v":2277.47876,"d":"2277.48"},{"v":1058.690796,"d":"1058.69"},{"v":2202.763428,"d":"2202.76"},{"v":2754.759521,"d":"2754.76"},{"v":0.635772548170992,"d":"0.64"},{"v":-0.653417370755918,"d":"-0.65"},{"v":0.250896162128824,"d":"0.25"},{"v":0.755428871068943,"d":"0.76"},"down","no"]
["MSTRG.15471","TBC1D8","ENSOART00000014417","GO:0005509(calcium ion binding)","NA","K19951","NA","TBC1 domain family member 8 [Source:NCBI gene;Acc:101103960]",{"v":1.72588117378917,"d":"1.73"},{"v":2.06831190527066,"d":"2.07"},{"v":1.73059853062678,"d":"1.73"},{"v":2.54215989031339,"d":"2.54"},{"v":2.75914752279202,"d":"2.76"},{"v":2.34248354202279,"d":"2.34"},{"v":0.722781620025864,"d":"0.72"},{"v":-0.468368275229797,"d":"-0.47"},{"v":0.251740623052663,"d":"0.25"},{"v":0.755428871068943,"d":"0.76"},"down","no"]
["ENSOARG00000001671","ENSOARG00000001671","ENSOART00000001796","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,{"v":1.146086,"d":"1.15"},{"v":1.176625,"d":"1.18"},{"v":1.263385,"d":"1.26"},{"v":1.275242,"d":"1.28"},{"v":0.805985,"d":"0.81"},{"v":0.622244,"d":"0.62"},{"v":1.3264784419733,"d":"1.33"},{"v":0.407601228969592,"d":"0.41"},{"v":0.251817393845896,"d":"0.25"},{"v":0.755428871068943,"d":"0.76"},"up","no"]
["MSTRG.13409","TMC7","ENSOART00000012676","GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K21988","NA","transmembrane channel like 7 [Source:NCBI gene;Acc:101116696]",{"v":3.129979,"d":"3.13"},{"v":2.232936,"d":"2.23"},{"v":1.458596,"d":"1.46"},{"v":2.21845,"d":"2.22"},{"v":1.820194,"d":"1.82"},{"v":1.291041,"d":"1.29"},{"v":1.2799088501478,"d":"1.28"},{"v":0.356041071067365,"d":"0.36"},{"v":0.252560628459445,"d":"0.25"},{"v":0.756404056055693,"d":"0.76"},"up","no"]
["MSTRG.1320","USF3","ENSOART00000021202","GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0046983(protein dimerization activity)","NA","NA","NA","upstream transcription factor family member 3 [Source:NCBI gene;Acc:101123595]",{"v":4.81046142697906,"d":"4.81"},{"v":4.49956244614838,"d":"4.50"},{"v":4.63628819758608,"d":"4.64"},{"v":4.49385934376997,"d":"4.49"},{"v":4.04526836464324,"d":"4.05"},{"v":3.007937,"d":"3.01"},{"v":1.20777984906867,"d":"1.21"},{"v":0.272357507972818,"d":"0.27"},{"v":0.253930731286219,"d":"0.25"},{"v":0.758260036593722,"d":"0.76"},"up","no"]
["MSTRG.6906","MRPS27","ENSOART00000005588","GO:0000049(tRNA binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005763(mitochondrial small ribosomal subunit);GO:0008283(cell population proliferation);GO:0019843(rRNA binding);GO:0070131(positive regulation of mitochondrial translation);GO:0097177(mitochondrial ribosome binding)","NA","K17406","NA","mitochondrial ribosomal protein S27 [Source:NCBI gene;Acc:101116256]",{"v":21.225845,"d":"21.23"},{"v":19.952141,"d":"19.95"},{"v":19.410112,"d":"19.41"},{"v":19.668877,"d":"19.67"},{"v":13.379977,"d":"13.38"},{"v":16.939323,"d":"16.94"},{"v":1.21204856100273,"d":"1.21"},{"v":0.277447501875507,"d":"0.28"},{"v":0.254525234619113,"d":"0.25"},{"v":0.758927690076858,"d":"0.76"},"up","no"]
["MSTRG.13157","NME4","ENSOART00000013010","GO:0000166(nucleotide binding);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005758(mitochondrial intermembrane space);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006183(GTP biosynthetic process);GO:0006228(UTP biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0006869(lipid transport);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:1901612(cardiolipin binding)","00230(Purine metabolism);00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)","K00940","EC:2.7.4.6","NME/NM23 nucleoside diphosphate kinase 4 [Source:NCBI gene;Acc:101109849]",{"v":6.402026,"d":"6.40"},{"v":7.550791,"d":"7.55"},{"v":3.479908,"d":"3.48"},{"v":7.174249,"d":"7.17"},{"v":8.357363,"d":"8.36"},{"v":9.853099,"d":"9.85"},{"v":0.686741125396306,"d":"0.69"},{"v":-0.542161733094735,"d":"-0.54"},{"v":0.255766398271234,"d":"0.26"},{"v":0.760268296190189,"d":"0.76"},"down","no"]
["MSTRG.16500","MICALL1","ENSOART00000015857","GO:0005515(protein binding);GO:0005770(late endosome);GO:0006612(protein targeting to membrane);GO:0006897(endocytosis);GO:0006898(receptor-mediated endocytosis);GO:0017137(Rab GTPase binding);GO:0019898(extrinsic component of membrane);GO:0031175(neuron projection development);GO:0032456(endocytic recycling);GO:0032458(slow endocytic recycling);GO:0036010(protein localization to endosome);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0055038(recycling endosome membrane);GO:0070300(phosphatidic acid binding);GO:0097320(plasma membrane tubulation);GO:1990126(retrograde transport, endosome to plasma membrane)","NA","K19948","NA","MICAL like 1 [Source:NCBI gene;Acc:101119899]",{"v":3.79430383102493,"d":"3.79"},{"v":3.56536750934903,"d":"3.57"},{"v":3.75673069182825,"d":"3.76"},{"v":4.3867945017313,"d":"4.39"},{"v":5.58875425034626,"d":"5.59"},{"v":5.14240611876731,"d":"5.14"},{"v":0.73531123271444,"d":"0.74"},{"v":-0.443573070987376,"d":"-0.44"},{"v":0.256443286442848,"d":"0.26"},{"v":0.76109865746361,"d":"0.76"},"down","no"]
["MSTRG.13846","RAB4A","ENSOART00000003285;ENSOART00000003284","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0008565(protein transporter activity);GO:0015031(protein transport);GO:0019003(GDP binding);GO:0019882(antigen processing and presentation);GO:0030100(regulation of endocytosis);GO:0031982(vesicle);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular exosome);GO:0070062(extracellular exosome)","04144(Endocytosis);04144(Endocytosis)","K07879","NA","RAB4A, member RAS oncogene family [Source:NCBI gene;Acc:100302066]",{"v":1.19840113036925,"d":"1.20"},{"v":0.807916043707611,"d":"0.81"},{"v":0.873763602110023,"d":"0.87"},{"v":1.50884446119066,"d":"1.51"},{"v":1.46177701582517,"d":"1.46"},{"v":1.27131574981161,"d":"1.27"},{"v":0.678954124538261,"d":"0.68"},{"v":-0.558613996907876,"d":"-0.56"},{"v":0.257619087278827,"d":"0.26"},{"v":0.762189111897777,"d":"0.76"},"down","no"]
["MSTRG.10461","EPB41L5","ENSOART00000014013","GO:0000904(cell morphogenesis involved in differentiation);GO:0001701(in utero embryonic development);GO:0001756(somitogenesis);GO:0001837(epithelial to mesenchymal transition);GO:0001839(neural plate morphogenesis);GO:0001954(positive regulation of cell-matrix adhesion);GO:0003382(epithelial cell morphogenesis);GO:0003383(apical constriction);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005925(focal adhesion);GO:0006931(substrate-dependent cell migration, cell attachment to substrate);GO:0007398(ectoderm development);GO:0007492(endoderm development);GO:0007498(mesoderm development);GO:0007509(mesoderm migration involved in gastrulation);GO:0008092(cytoskeletal protein binding);GO:0009826(unidimensional cell growth);GO:0010608(posttranscriptional regulation of gene expression);GO:0010634(positive regulation of epithelial cell migration);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0019904(protein domain specific binding);GO:0022408(negative regulation of cell-cell adhesion);GO:0030036(actin cytoskeleton organization);GO:0031032(actomyosin structure organization);GO:0031252(cell leading edge);GO:0032091(negative regulation of protein binding);GO:0032092(positive regulation of protein binding);GO:0032525(somite rostral/caudal axis specification);GO:0032587(ruffle membrane);GO:0048318(axial mesoderm development);GO:0048319(axial mesoderm morphogenesis);GO:0048339(paraxial mesoderm development);GO:0048617(embryonic foregut morphogenesis);GO:0051894(positive regulation of focal adhesion assembly);GO:0070201(regulation of establishment of protein localization);GO:0070986(left/right axis specification);GO:0071560(cellular response to transforming growth factor beta stimulus)","NA","NA","NA","erythrocyte membrane protein band 4.1 like 5 [Source:NCBI gene;Acc:101112882]",{"v":2.02661508597092,"d":"2.03"},{"v":1.30402933190761,"d":"1.30"},{"v":1.58211562147134,"d":"1.58"},{"v":2.3905200774166,"d":"2.39"},{"v":2.36261554576561,"d":"2.36"},{"v":2.09765424422583,"d":"2.10"},{"v":0.717108557470408,"d":"0.72"},{"v":-0.479736561079812,"d":"-0.48"},{"v":0.258252994095271,"d":"0.26"},{"v":0.762189111897777,"d":"0.76"},"down","no"]
["MSTRG.15774","CCNT1","ENSOART00000020905","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0008024(cyclin/CDK positive transcription elongation factor complex);GO:0008134(transcription factor binding);GO:0017069(snRNA binding);GO:0019901(protein kinase binding);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070063(RNA polymerase binding);GO:0097322(7SK snRNA binding);GO:1900364(negative regulation of mRNA polyadenylation)","05202(Transcriptional misregulation in cancer)","K15188","NA","cyclin T1 [Source:NCBI gene;Acc:101106415]",{"v":4.09004409929499,"d":"4.09"},{"v":3.41399984245898,"d":"3.41"},{"v":3.52461468089873,"d":"3.52"},{"v":3.6590178575476,"d":"3.66"},{"v":2.91763192014232,"d":"2.92"},{"v":2.56098390037557,"d":"2.56"},{"v":1.20694908673419,"d":"1.21"},{"v":0.271364819535091,"d":"0.27"},{"v":0.258253891725507,"d":"0.26"},{"v":0.762189111897777,"d":"0.76"},"up","no"]
["MSTRG.21286","STK3","ENSOART00000003339;ENSOART00000003340","GO:0000287(magnesium ion binding);GO:0001841(neural tube formation);GO:0003157(endocardium development);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007417(central nervous system development);GO:0008285(negative regulation of cell population proliferation);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0035329(hippo signaling);GO:0035556(intracellular signal transduction);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0045600(positive regulation of fat cell differentiation);GO:0046330(positive regulation of JNK cascade);GO:0046621(negative regulation of organ growth);GO:0050821(protein stabilization);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051897(positive regulation of protein kinase B signaling);GO:0060215(primitive hemopoiesis);GO:0060706(cell differentiation involved in embryonic placenta development);GO:0060800(regulation of cell differentiation involved in embryonic placenta development);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097284(hepatocyte apoptotic process);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors)","04010(MAPK signaling pathway);04390(Hippo signaling pathway);04392(Hippo signaling pathway - multiple species);04392(Hippo signaling pathway - multiple species)","K04412","NA","serine/threonine kinase 3 [Source:NCBI gene;Acc:101106085]",{"v":2.64001183877221,"d":"2.64"},{"v":2.33174832924071,"d":"2.33"},{"v":2.59196303134087,"d":"2.59"},{"v":2.26347116252019,"d":"2.26"},{"v":2.22225149886914,"d":"2.22"},{"v":1.68945705331179,"d":"1.69"},{"v":1.22485879744471,"d":"1.22"},{"v":0.292615443947955,"d":"0.29"},{"v":0.258935531911032,"d":"0.26"},{"v":0.762333098637457,"d":"0.76"},"up","no"]
["MSTRG.1855","ENSOARG00000008623","ENSOART00000009387","GO:0000166(nucleotide binding);GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006414(translational elongation)","NA","NA","NA",null,{"v":8.084073,"d":"8.08"},{"v":7.781323,"d":"7.78"},{"v":0.011334,"d":"0.01"},{"v":10.760699,"d":"10.76"},{"v":11.206306,"d":"11.21"},{"v":14.007264,"d":"14.01"},{"v":0.441335722485424,"d":"0.44"},{"v":-1.18005156858688,"d":"-1.18"},{"v":0.260835027430121,"d":"0.26"},{"v":0.765578703555459,"d":"0.77"},"down","no"]
["MSTRG.500","ENSOARG00000015432","ENSOART00000016792","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA","K20908","NA","guanylate-binding protein 6-like [Source:NCBI gene;Acc:101120875]",{"v":1.99447,"d":"1.99"},{"v":1.358417,"d":"1.36"},{"v":1.42883,"d":"1.43"},{"v":2.784459,"d":"2.78"},{"v":1.97056,"d":"1.97"},{"v":2.017959,"d":"2.02"},{"v":0.705999192674183,"d":"0.71"},{"v":-0.502261561143908,"d":"-0.50"},{"v":0.261120982195425,"d":"0.26"},{"v":0.765867324822509,"d":"0.77"},"down","no"]
["MSTRG.21684","TSPAN7","ENSOART00000000951","GO:0016020(membrane);GO:0016021(integral component of membrane)","05202(Transcriptional misregulation in cancer)","K06571","NA","tetraspanin 7 [Source:NCBI gene;Acc:101102457]",{"v":36.1693803621186,"d":"36.17"},{"v":30.1252190713875,"d":"30.13"},{"v":33.4046138756477,"d":"33.40"},{"v":35.1684157921704,"d":"35.17"},{"v":50.1548847944732,"d":"50.15"},{"v":50.3628428411054,"d":"50.36"},{"v":0.734778148973202,"d":"0.73"},{"v":-0.444619371046613,"d":"-0.44"},{"v":0.26232055296329,"d":"0.26"},{"v":0.767503423641954,"d":"0.77"},"down","no"]
["MSTRG.6112","ENSOARG00000003715","ENSOART00000004033","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","NA","NA",null,{"v":1.193077,"d":"1.19"},{"v":0.744563,"d":"0.74"},{"v":0.786501,"d":"0.79"},{"v":1.490144,"d":"1.49"},{"v":1.430674,"d":"1.43"},{"v":1.013431,"d":"1.01"},{"v":0.692417028002041,"d":"0.69"},{"v":-0.530286890818238,"d":"-0.53"},{"v":0.262770445468064,"d":"0.26"},{"v":0.767946274136845,"d":"0.77"},"down","no"]
["MSTRG.21014","ENSOARG00000020156","ENSOART00000021945","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","03010(Ribosome)","K02940","NA","60S ribosomal protein L9 [Source:NCBI gene;Acc:101105336]",{"v":1.861007,"d":"1.86"},{"v":2.309848,"d":"2.31"},{"v":3.332552,"d":"3.33"},{"v":4.459552,"d":"4.46"},{"v":2.168896,"d":"2.17"},{"v":4.764071,"d":"4.76"},{"v":0.658625805232363,"d":"0.66"},{"v":-0.602469056456342,"d":"-0.60"},{"v":0.263642921671883,"d":"0.26"},{"v":0.768982069499556,"d":"0.77"},"down","no"]
["MSTRG.5368","TENT4B","ENSOART00000018706","GO:0003723(RNA binding);GO:0004652(polynucleotide adenylyltransferase activity);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006378(mRNA polyadenylation);GO:0010587(miRNA catabolic process);GO:0016779(nucleotidyltransferase activity);GO:0031499(TRAMP complex);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0033500(carbohydrate homeostasis);GO:0043629(ncRNA polyadenylation);GO:0043630(ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process);GO:0043631(RNA polyadenylation);GO:0060212(negative regulation of nuclear-transcribed mRNA poly(A) tail shortening);GO:0070568(guanylyltransferase activity);GO:0071044(histone mRNA catabolic process);GO:0071050(snoRNA polyadenylation);GO:0071076(RNA 3' uridylation);GO:1905870(positive regulation of 3'-UTR-mediated mRNA stabilization)","03018(RNA degradation)","K03514","EC:2.7.7.19","terminal nucleotidyltransferase 4B [Source:NCBI gene;Acc:101116340]",{"v":5.766371,"d":"5.77"},{"v":7.101585,"d":"7.10"},{"v":6.18434,"d":"6.18"},{"v":5.215432,"d":"5.22"},{"v":5.868238,"d":"5.87"},{"v":4.638376,"d":"4.64"},{"v":1.2118203953862,"d":"1.21"},{"v":0.277175891973839,"d":"0.28"},{"v":0.264411796958994,"d":"0.26"},{"v":0.769308264074423,"d":"0.77"},"up","no"]
["MSTRG.9726","GBA2","ENSOART00000012856;ENSOART00000012855","GO:0000139(Golgi membrane);GO:0003824(catalytic activity);GO:0004348(glucosylceramidase activity);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006629(lipid metabolic process);GO:0006680(glucosylceramide catabolic process);GO:0008152(metabolic process);GO:0008203(cholesterol metabolic process);GO:0008206(bile acid metabolic process);GO:0008422(beta-glucosidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016139(glycoside catabolic process);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0019898(extrinsic component of membrane);GO:0021954(central nervous system neuron development);GO:0030259(lipid glycosylation);GO:0030833(regulation of actin filament polymerization);GO:0031113(regulation of microtubule polymerization);GO:0042406(extrinsic component of endoplasmic reticulum membrane);GO:0046527(glucosyltransferase activity);GO:0050295(steryl-beta-glucosidase activity);GO:0090498(extrinsic component of Golgi membrane);GO:0097035(regulation of membrane lipid distribution);GO:0097035(regulation of membrane lipid distribution)","00511(Other glycan degradation);00600(Sphingolipid metabolism);00600(Sphingolipid metabolism)","K17108","EC:3.2.1.45","glucosylceramidase beta 2 [Source:NCBI gene;Acc:101113987]",{"v":19.6523113424612,"d":"19.65"},{"v":17.3883930669746,"d":"17.39"},{"v":14.787288112834,"d":"14.79"},{"v":17.0142668327285,"d":"17.01"},{"v":12.982450834708,"d":"12.98"},{"v":12.986179082481,"d":"12.99"},{"v":1.20578175137462,"d":"1.21"},{"v":0.2699688005187,"d":"0.27"},{"v":0.264483401948728,"d":"0.26"},{"v":0.769308264074423,"d":"0.77"},"up","no"]
["MSTRG.8815","ABHD5","ENSOART00000004593","GO:0005811(lipid droplet);GO:0005829(cytosol);GO:0006654(phosphatidic acid biosynthetic process);GO:0010891(negative regulation of sequestering of triglyceride);GO:0010898(positive regulation of triglyceride catabolic process);GO:0042171(lysophosphatidic acid acyltransferase activity);GO:0050996(positive regulation of lipid catabolic process);GO:0051006(positive regulation of lipoprotein lipase activity)","04923(Regulation of lipolysis in adipocytes)","K13699","EC:2.3.1.51","abhydrolase domain containing 5 [Source:NCBI gene;Acc:100125355]",{"v":3.811249,"d":"3.81"},{"v":4.711008,"d":"4.71"},{"v":2.872674,"d":"2.87"},{"v":3.494688,"d":"3.49"},{"v":3.174567,"d":"3.17"},{"v":2.522138,"d":"2.52"},{"v":1.23973928652599,"d":"1.24"},{"v":0.310036758045389,"d":"0.31"},{"v":0.265583895742687,"d":"0.27"},{"v":0.770377304971858,"d":"0.77"},"up","no"]
["MSTRG.3880","AHCTF1","ENSOART00000003496","GO:0000777(condensed chromosome kinetochore);GO:0000785(chromatin);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005643(nuclear pore);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016363(nuclear matrix);GO:0031080(nuclear pore outer ring);GO:0031965(nuclear membrane);GO:0032465(regulation of cytokinesis);GO:0051292(nuclear pore complex assembly)","NA","NA","NA","AT-hook containing transcription factor 1 [Source:NCBI gene;Acc:101114886]",{"v":2.13571083693517,"d":"2.14"},{"v":2.18185693422739,"d":"2.18"},{"v":2.44287703801145,"d":"2.44"},{"v":2.53580955231913,"d":"2.54"},{"v":2.02272864098403,"d":"2.02"},{"v":0.93753305441189,"d":"0.94"},{"v":1.23005043138489,"d":"1.23"},{"v":0.298717466472947,"d":"0.30"},{"v":0.266229269591075,"d":"0.27"},{"v":0.771427065462834,"d":"0.77"},"up","no"]
["MSTRG.5117","KCNB1","ENSOART00000013692","GO:0001508(action potential);GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005251(delayed rectifier potassium channel activity);GO:0005267(potassium channel activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030425(dendrite);GO:0032809(neuronal cell body membrane);GO:0034765(regulation of ion transmembrane transport);GO:0042593(glucose homeostasis);GO:0044325(ion channel binding);GO:0046676(negative regulation of insulin secretion);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport);GO:0071333(cellular response to glucose stimulus);GO:0071805(potassium ion transmembrane transport);GO:0090314(positive regulation of protein targeting to membrane);GO:0098900(regulation of action potential);GO:1900454(positive regulation of long-term synaptic depression)","NA","K04885","NA","potassium voltage-gated channel subfamily B member 1 [Source:NCBI gene;Acc:101121535]",{"v":6.258019,"d":"6.26"},{"v":6.430643,"d":"6.43"},{"v":7.654532,"d":"7.65"},{"v":5.186048,"d":"5.19"},{"v":5.723646,"d":"5.72"},{"v":5.801132,"d":"5.80"},{"v":1.21736615532949,"d":"1.22"},{"v":0.283763162322282,"d":"0.28"},{"v":0.267762419717721,"d":"0.27"},{"v":0.772461894999615,"d":"0.77"},"up","no"]
["MSTRG.3482","SIRT7","ENSOART00000019356","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003682(chromatin binding);GO:0005730(nucleolus);GO:0005731(nucleolus organizer region);GO:0007072(positive regulation of transcription involved in exit from mitosis);GO:0009303(rRNA transcription);GO:0070403(NAD+ binding);GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0097372(NAD-dependent histone deacetylase activity (H3-K18 specific))","NA","K11417","EC:3.5.1.-","sirtuin 7 [Source:NCBI gene;Acc:101108066]",{"v":1.95406,"d":"1.95"},{"v":1.518231,"d":"1.52"},{"v":1.753023,"d":"1.75"},{"v":2.487036,"d":"2.49"},{"v":1.973063,"d":"1.97"},{"v":3.01855,"d":"3.02"},{"v":0.698697585620077,"d":"0.70"},{"v":-0.517259939904332,"d":"-0.52"},{"v":0.268129663755223,"d":"0.27"},{"v":0.772461894999615,"d":"0.77"},"down","no"]
["MSTRG.11060","ENSOARG00000010812","ENSOART00000011769","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding)","NA","NA","NA",null,{"v":3.37480898180279,"d":"3.37"},{"v":3.70652711189166,"d":"3.71"},{"v":3.53772727752857,"d":"3.54"},{"v":3.08119745916208,"d":"3.08"},{"v":3.49387882640711,"d":"3.49"},{"v":2.29088729183242,"d":"2.29"},{"v":1.19773370130799,"d":"1.20"},{"v":0.260307181491901,"d":"0.26"},{"v":0.268813660836374,"d":"0.27"},{"v":0.772880692751597,"d":"0.77"},"up","no"]
["MSTRG.8317","SNX6","ENSOART00000007349","GO:0006886(intracellular protein transport);GO:0034713(type I transforming growth factor beta receptor binding);GO:0035091(phosphatidylinositol binding)","04144(Endocytosis)","K17920","NA","sorting nexin 6 [Source:NCBI gene;Acc:101118137]",{"v":6.07352627686567,"d":"6.07"},{"v":6.44251485522388,"d":"6.44"},{"v":5.75570605895522,"d":"5.76"},{"v":6.40316171119403,"d":"6.40"},{"v":4.47831320373134,"d":"4.48"},{"v":4.17756076791045,"d":"4.18"},{"v":1.21334111797549,"d":"1.21"},{"v":0.278985205880235,"d":"0.28"},{"v":0.269591901303498,"d":"0.27"},{"v":0.773785225833385,"d":"0.77"},"up","no"]
["MSTRG.12906","NPC1","ENSOART00000008614","GO:0005319(lipid transporter activity);GO:0005576(extracellular region);GO:0005635(nuclear envelope);GO:0005764(lysosome);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006486(protein glycosylation);GO:0006897(endocytosis);GO:0006914(autophagy);GO:0007628(adult walking behavior);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016242(negative regulation of macroautophagy);GO:0030301(cholesterol transport);GO:0031579(membrane raft organization);GO:0031982(vesicle);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux);GO:0042493(response to drug);GO:0042632(cholesterol homeostasis);GO:0045121(membrane raft);GO:0046718(viral entry into host cell);GO:0048471(perinuclear region of cytoplasm);GO:0071383(cellular response to steroid hormone stimulus);GO:0071404(cellular response to low-density lipoprotein particle stimulus);GO:0090150(establishment of protein localization to membrane);GO:1905103(integral component of lysosomal membrane)","04142(Lysosome);04979(Cholesterol metabolism)","K12385","NA","NPC intracellular cholesterol transporter 1 [Source:NCBI gene;Acc:101120623]",{"v":2.35674218256131,"d":"2.36"},{"v":2.62314260163488,"d":"2.62"},{"v":2.74163310245232,"d":"2.74"},{"v":1.90967181253406,"d":"1.91"},{"v":2.47216644904632,"d":"2.47"},{"v":1.9928762506812,"d":"1.99"},{"v":1.21127273571176,"d":"1.21"},{"v":0.276523745426331,"d":"0.28"},{"v":0.271680031716105,"d":"0.27"},{"v":0.776337339492573,"d":"0.78"},"up","no"]
["MSTRG.21185","PAG1","ENSOART00000009644","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035556(intracellular signal transduction);GO:0042169(SH2 domain binding);GO:0045121(membrane raft);GO:0050863(regulation of T cell activation);GO:0050868(negative regulation of T cell activation)","NA","NA","NA","phosphoprotein membrane anchor with glycosphingolipid microdomains 1 [Source:NCBI gene;Acc:101112826]",{"v":2.132077,"d":"2.13"},{"v":1.550422,"d":"1.55"},{"v":2.108623,"d":"2.11"},{"v":3.040068,"d":"3.04"},{"v":3.191026,"d":"3.19"},{"v":2.013309,"d":"2.01"},{"v":0.702430727852581,"d":"0.70"},{"v":-0.509572137897217,"d":"-0.51"},{"v":0.272445504092129,"d":"0.27"},{"v":0.777300400282419,"d":"0.78"},"down","no"]
["MSTRG.5544","POP4","ENSOART00000004393","GO:0001682(tRNA 5'-leader removal);GO:0003723(RNA binding);GO:0004526(ribonuclease P activity);GO:0004540(ribonuclease activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006396(RNA processing);GO:0008033(tRNA processing);GO:0030677(ribonuclease P complex);GO:0030681(multimeric ribonuclease P complex);GO:0033204(ribonuclease P RNA binding);GO:0090501(RNA phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","03008(Ribosome biogenesis in eukaryotes);03013(RNA transport)","K03538","EC:3.1.26.5","POP4 homolog, ribonuclease P/MRP subunit [Source:NCBI gene;Acc:101106353]",{"v":1.11504404247911,"d":"1.12"},{"v":0.657313673050139,"d":"0.66"},{"v":1.34305855222841,"d":"1.34"},{"v":1.69903863405292,"d":"1.70"},{"v":1.14020146309192,"d":"1.14"},{"v":1.63600636385794,"d":"1.64"},{"v":0.696144066009625,"d":"0.70"},{"v":-0.522542194259155,"d":"-0.52"},{"v":0.272944717960646,"d":"0.27"},{"v":0.77825273224386,"d":"0.78"},"down","no"]
["ENSOARG00000003106","ENSOARG00000003106","ENSOART00000003366","NA","NA","NA","NA",null,{"v":0.515544,"d":"0.52"},{"v":0.487347,"d":"0.49"},{"v":1.176678,"d":"1.18"},{"v":1.136791,"d":"1.14"},{"v":1.059683,"d":"1.06"},{"v":1.198213,"d":"1.20"},{"v":0.642053008127112,"d":"0.64"},{"v":-0.63923568320156,"d":"-0.64"},{"v":0.273776710831336,"d":"0.27"},{"v":0.778570863696829,"d":"0.78"},"down","no"]
["MSTRG.7289","FAM160A1","ENSOART00000005315","NA","NA","NA","NA","family with sequence similarity 160 member A1 [Source:NCBI gene;Acc:101105280]",{"v":3.95203570018691,"d":"3.95"},{"v":3.70009188964092,"d":"3.70"},{"v":4.47679497692003,"d":"4.48"},{"v":3.75935597476778,"d":"3.76"},{"v":3.68148442469982,"d":"3.68"},{"v":2.77985338590281,"d":"2.78"},{"v":1.1867024706394,"d":"1.19"},{"v":0.246958268645804,"d":"0.25"},{"v":0.274233553875271,"d":"0.27"},{"v":0.778570863696829,"d":"0.78"},"up","no"]
["MSTRG.10389","SPOPL","ENSOART00000011169","GO:0005515(protein binding);GO:0031397(negative regulation of protein ubiquitination);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process)","04340(Hedgehog signaling pathway)","K10523","NA","speckle type BTB/POZ protein like [Source:NCBI gene;Acc:101102622]",{"v":4.26858202259279,"d":"4.27"},{"v":4.12373652698583,"d":"4.12"},{"v":3.49547845346961,"d":"3.50"},{"v":4.56007569212838,"d":"4.56"},{"v":2.86900529729245,"d":"2.87"},{"v":2.47249803460642,"d":"2.47"},{"v":1.20059608413983,"d":"1.20"},{"v":0.263750867595809,"d":"0.26"},{"v":0.274889092645178,"d":"0.27"},{"v":0.778570863696829,"d":"0.78"},"up","no"]
["MSTRG.13188","JPT2","ENSOART00000017657","GO:0005829(cytosol);GO:0005886(plasma membrane)","NA","NA","NA","Jupiter microtubule associated homolog 2 [Source:HGNC Symbol;Acc:HGNC:14137]",{"v":2.37320530374016,"d":"2.37"},{"v":1.81579010314961,"d":"1.82"},{"v":2.1814435273622,"d":"2.18"},{"v":3.2791109246063,"d":"3.28"},{"v":2.63840179370079,"d":"2.64"},{"v":2.66812955472441,"d":"2.67"},{"v":0.741987463682508,"d":"0.74"},{"v":-0.430533283022231,"d":"-0.43"},{"v":0.275647614659821,"d":"0.28"},{"v":0.7791401920096,"d":"0.78"},"down","no"]
["MSTRG.7968","CDC45","ENSOART00000019313","GO:0005634(nucleus);GO:0005813(centrosome);GO:0006270(DNA replication initiation)","NA","NA","NA","cell division cycle 45 [Source:HGNC Symbol;Acc:HGNC:1739]",{"v":0.365554,"d":"0.37"},{"v":0.159427,"d":"0.16"},{"v":0.288643,"d":"0.29"},{"v":0.518343,"d":"0.52"},{"v":0.236543,"d":"0.24"},{"v":0.525031,"d":"0.53"},{"v":0.635684970197286,"d":"0.64"},{"v":-0.653616116379318,"d":"-0.65"},{"v":0.276465170797531,"d":"0.28"},{"v":0.779910730611971,"d":"0.78"},"down","no"]
["MSTRG.15257","MSH6","ENSOART00000005493","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0000400(four-way junction DNA binding);GO:0000790(nuclear chromatin);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0003690(double-stranded DNA binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006298(mismatch repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008340(determination of adult lifespan);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0009411(response to UV);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016447(somatic recombination of immunoglobulin gene segments);GO:0016887(ATPase activity);GO:0019899(enzyme binding);GO:0030983(mismatched DNA binding);GO:0032137(guanine/thymine mispair binding);GO:0032142(single guanine insertion binding);GO:0032143(single thymine insertion binding);GO:0032301(MutSalpha complex);GO:0032357(oxidized purine DNA binding);GO:0032405(MutLalpha complex binding);GO:0035064(methylated histone binding);GO:0043231(intracellular membrane-bounded organelle);GO:0043531(ADP binding);GO:0045190(isotype switching);GO:0045830(positive regulation of isotype switching);GO:0045910(negative regulation of DNA recombination);GO:0051096(positive regulation of helicase activity);GO:0097193(intrinsic apoptotic signaling pathway)","01524(Platinum drug resistance);03430(Mismatch repair);05200(Pathways in cancer);05210(Colorectal cancer)","K08737","NA","mutS homolog 6 [Source:NCBI gene;Acc:101107426]",{"v":6.471433,"d":"6.47"},{"v":5.057764,"d":"5.06"},{"v":4.329145,"d":"4.33"},{"v":4.712679,"d":"4.71"},{"v":4.495848,"d":"4.50"},{"v":3.95051,"d":"3.95"},{"v":1.20512937230893,"d":"1.21"},{"v":0.269188030081691,"d":"0.27"},{"v":0.277110694973526,"d":"0.28"},{"v":0.780175583375704,"d":"0.78"},"up","no"]
["MSTRG.238","TESK2","ENSOART00000001770","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0016604(nuclear body)","NA","K08842","EC:2.7.12.1","testis associated actin remodelling kinase 2 [Source:NCBI gene;Acc:101111066]",{"v":1.270407,"d":"1.27"},{"v":1.370918,"d":"1.37"},{"v":1.533951,"d":"1.53"},{"v":1.960478,"d":"1.96"},{"v":1.847721,"d":"1.85"},{"v":2.087181,"d":"2.09"},{"v":0.708228477214361,"d":"0.71"},{"v":-0.497713240554251,"d":"-0.50"},{"v":0.277487157240759,"d":"0.28"},{"v":0.780175583375704,"d":"0.78"},"down","no"]
["MSTRG.21854","STARD8","ENSOART00000016058","GO:0007165(signal transduction);GO:0008289(lipid binding)","NA","K20632","NA","StAR related lipid transfer domain containing 8 [Source:NCBI gene;Acc:101120222]",{"v":2.21042289249852,"d":"2.21"},{"v":2.27912302244536,"d":"2.28"},{"v":2.08627994939949,"d":"2.09"},{"v":3.38230440637921,"d":"3.38"},{"v":2.72684204548139,"d":"2.73"},{"v":2.77260966528844,"d":"2.77"},{"v":0.740374513509401,"d":"0.74"},{"v":-0.433672861843188,"d":"-0.43"},{"v":0.278089711655789,"d":"0.28"},{"v":0.780175583375704,"d":"0.78"},"down","no"]
["MSTRG.1958","S100B","ENSOART00000014610","GO:0001726(ruffle);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007611(learning or memory);GO:0007613(memory);GO:0008270(zinc ion binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0044548(S100 protein binding);GO:0046872(metal ion binding);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0050786(RAGE receptor binding)","NA","NA","NA","S100 calcium binding protein B [Source:NCBI gene;Acc:101113190]",{"v":3.19898396045576,"d":"3.20"},{"v":3.49259493565684,"d":"3.49"},{"v":2.97943119839142,"d":"2.98"},{"v":2.46356702345844,"d":"2.46"},{"v":2.57485888605898,"d":"2.57"},{"v":2.80635277077748,"d":"2.81"},{"v":1.23279578540519,"d":"1.23"},{"v":0.301933834790264,"d":"0.30"},{"v":0.278604366316862,"d":"0.28"},{"v":0.780282475933515,"d":"0.78"},"up","no"]
["MSTRG.3116","PPP1R9B","ENSOART00000005638","GO:0001932(regulation of protein phosphorylation);GO:0003779(actin binding);GO:0005515(protein binding);GO:0007015(actin filament organization);GO:0008157(protein phosphatase 1 binding);GO:0016358(dendrite development);GO:0019722(calcium-mediated signaling);GO:0030175(filopodium);GO:0030864(cortical actin cytoskeleton);GO:0042127(regulation of cell population proliferation);GO:0050804(modulation of chemical synaptic transmission);GO:0071315(cellular response to morphine);GO:2000474(regulation of opioid receptor signaling pathway)","NA","K17551","NA","protein phosphatase 1 regulatory subunit 9B [Source:NCBI gene;Acc:101117778]",{"v":3.8562319644328,"d":"3.86"},{"v":3.20061585960314,"d":"3.20"},{"v":4.10938516622988,"d":"4.11"},{"v":4.90515726132535,"d":"4.91"},{"v":4.39897817184575,"d":"4.40"},{"v":5.70958583676526,"d":"5.71"},{"v":0.743735199921768,"d":"0.74"},{"v":-0.427139040435779,"d":"-0.43"},{"v":0.279569822518758,"d":"0.28"},{"v":0.781086231991612,"d":"0.78"},"down","no"]
["MSTRG.1147","MRPL39","ENSOART00000016646","GO:0000166(nucleotide binding);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit)","NA","K17420","NA","mitochondrial ribosomal protein L39 [Source:NCBI gene;Acc:101113977]",{"v":20.279503,"d":"20.28"},{"v":18.158234,"d":"18.16"},{"v":14.672367,"d":"14.67"},{"v":18.642065,"d":"18.64"},{"v":11.917553,"d":"11.92"},{"v":13.814863,"d":"13.81"},{"v":1.19686141230587,"d":"1.20"},{"v":0.259256108543423,"d":"0.26"},{"v":0.280197046845617,"d":"0.28"},{"v":0.78123548180035,"d":"0.78"},"up","no"]
["MSTRG.1040","POGK","ENSOART00000012824","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA","pogo transposable element derived with KRAB domain [Source:NCBI gene;Acc:101113291]",{"v":1.45783301770076,"d":"1.46"},{"v":0.768559975591578,"d":"0.77"},{"v":1.11183997596423,"d":"1.11"},{"v":1.62586234451276,"d":"1.63"},{"v":1.35583583882989,"d":"1.36"},{"v":1.60992256567915,"d":"1.61"},{"v":0.727027154838027,"d":"0.73"},{"v":-0.45991884433462,"d":"-0.46"},{"v":0.280807862948123,"d":"0.28"},{"v":0.781549534800675,"d":"0.78"},"down","no"]
["MSTRG.13173","ENSOARG00000013557","ENSOART00000014742","GO:0005515(protein binding);GO:0032008(positive regulation of TOR signaling)","NA","NA","NA",null,{"v":1.449152,"d":"1.45"},{"v":1.020554,"d":"1.02"},{"v":1.109325,"d":"1.11"},{"v":1.212528,"d":"1.21"},{"v":1.917321,"d":"1.92"},{"v":1.969721,"d":"1.97"},{"v":0.701829958212163,"d":"0.70"},{"v":-0.510806563160884,"d":"-0.51"},{"v":0.281214084635205,"d":"0.28"},{"v":0.781726627083563,"d":"0.78"},"down","no"]
["ENSOARG00000007916","WWOX","ENSOART00000008619;ENSOART00000008621","GO:0001649(osteoblast differentiation);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005902(microvillus);GO:0019899(enzyme binding);GO:0030178(negative regulation of Wnt signaling pathway);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048705(skeletal system morphogenesis);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090575(RNA polymerase II transcription factor complex);GO:0097191(extrinsic apoptotic signaling pathway);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","NA","NA","NA","WW domain containing oxidoreductase [Source:HGNC Symbol;Acc:HGNC:12799]",{"v":1.12059024269663,"d":"1.12"},{"v":0.949457433707865,"d":"0.95"},{"v":1.02481078651685,"d":"1.02"},{"v":0.677463903370787,"d":"0.68"},{"v":0.816498687640449,"d":"0.82"},{"v":0.832548316853933,"d":"0.83"},{"v":1.33025744794862,"d":"1.33"},{"v":0.411705481016422,"d":"0.41"},{"v":0.282858007011756,"d":"0.28"},{"v":0.783461499319416,"d":"0.78"},"up","no"]
["MSTRG.10219","ATF2","ENSOART00000000205","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001158(enhancer sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003151(outflow tract morphogenesis);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005741(mitochondrial outer membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006970(response to osmotic stress);GO:0006974(cellular response to DNA damage stimulus);GO:0008140(cAMP response element binding protein binding);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016525(negative regulation of angiogenesis);GO:0019901(protein kinase binding);GO:0031573(intra-S DNA damage checkpoint);GO:0032915(positive regulation of transforming growth factor beta2 production);GO:0035497(cAMP response element binding);GO:0035861(site of double-strand break);GO:0043565(sequence-specific DNA binding);GO:0045444(fat cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060612(adipose tissue development);GO:0110024(positive regulation of cardiac muscle myoblast proliferation);GO:1902110(positive regulation of mitochondrial membrane permeability involved in apoptotic process)","04010(MAPK signaling pathway);04022(cGMP-PKG signaling pathway);04151(PI3K-Akt signaling pathway);04211(Longevity regulating pathway);04261(Adrenergic signaling in cardiomyocytes);04668(TNF signaling pathway);04714(Thermogenesis);04728(Dopaminergic synapse);04911(Insulin secretion);04915(Estrogen signaling pathway);04918(Thyroid hormone synthesis);04922(Glucagon signaling pathway);04925(Aldosterone synthesis and secretion);04926(Relaxin signaling pathway);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism);05161(Hepatitis B);05163(Human cytomegalovirus infection);05164(Influenza A);05166(Human T-cell leukemia virus 1 infection);05203(Viral carcinogenesis)","K04450","NA","activating transcription factor 2 [Source:NCBI gene;Acc:101108548]",{"v":6.63169923133236,"d":"6.63"},{"v":5.15801554298264,"d":"5.16"},{"v":5.92525054361012,"d":"5.93"},{"v":5.58692514515792,"d":"5.59"},{"v":4.6682166852123,"d":"4.67"},{"v":4.61256090817821,"d":"4.61"},{"v":1.19150655817152,"d":"1.19"},{"v":0.252786892288142,"d":"0.25"},{"v":0.283009057045353,"d":"0.28"},{"v":0.783544094182221,"d":"0.78"},"up","no"]
["MSTRG.16287","AEBP2","ENSOART00000022293","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0035098(ESC/E(Z) complex)","NA","K17452","NA","AE binding protein 2 [Source:NCBI gene;Acc:101121336]",{"v":4.68948179467052,"d":"4.69"},{"v":4.33447051167114,"d":"4.33"},{"v":4.65912627638918,"d":"4.66"},{"v":4.11876024602355,"d":"4.12"},{"v":3.31001117041933,"d":"3.31"},{"v":4.00076946271432,"d":"4.00"},{"v":1.19716782392223,"d":"1.20"},{"v":0.259625409398336,"d":"0.26"},{"v":0.283739388774279,"d":"0.28"},{"v":0.783642885640466,"d":"0.78"},"up","no"]
["MSTRG.1863","DNAJC13","ENSOART00000009835","GO:0005829(cytosol);GO:0007032(endosome organization);GO:0010008(endosome membrane);GO:0031901(early endosome membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0071203(WASH complex);GO:1902954(regulation of early endosome to recycling endosome transport);GO:2000641(regulation of early endosome to late endosome transport)","NA","K09533","NA","DnaJ heat shock protein family (Hsp40) member C13 [Source:NCBI gene;Acc:101119603]",{"v":4.522854,"d":"4.52"},{"v":3.755993,"d":"3.76"},{"v":4.028611,"d":"4.03"},{"v":4.350997,"d":"4.35"},{"v":3.071298,"d":"3.07"},{"v":2.94173,"d":"2.94"},{"v":1.18751720494692,"d":"1.19"},{"v":0.247948415600882,"d":"0.25"},{"v":0.284728646757957,"d":"0.28"},{"v":0.784312110692383,"d":"0.78"},"up","no"]
["MSTRG.12814","ENSOARG00000004782","ENSOART00000005208","GO:0005854(nascent polypeptide-associated complex)","NA","NA","NA",null,{"v":2.695793,"d":"2.70"},{"v":2.059871,"d":"2.06"},{"v":1.847347,"d":"1.85"},{"v":3.033961,"d":"3.03"},{"v":4.051547,"d":"4.05"},{"v":2.452881,"d":"2.45"},{"v":0.692256417724209,"d":"0.69"},{"v":-0.530621571393067,"d":"-0.53"},{"v":0.285233390041493,"d":"0.29"},{"v":0.784584028402542,"d":"0.78"},"down","no"]
["MSTRG.1623","MECOM","ENSOART00000000973","GO:0000118(histone deacetylase complex);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0016607(nuclear speck);GO:0043069(negative regulation of programmed cell death);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046329(negative regulation of JNK cascade);GO:0051726(regulation of cell cycle)","04010(MAPK signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)","K04462","NA","MDS1 and EVI1 complex locus [Source:NCBI gene;Acc:101121055]",{"v":1.6207156917847,"d":"1.62"},{"v":0.856666884419264,"d":"0.86"},{"v":0.953074036827195,"d":"0.95"},{"v":1.5201218203966,"d":"1.52"},{"v":1.74251821983003,"d":"1.74"},{"v":1.4821722674221,"d":"1.48"},{"v":0.722991003775048,"d":"0.72"},{"v":-0.467950399149243,"d":"-0.47"},{"v":0.286330787862995,"d":"0.29"},{"v":0.785777864430519,"d":"0.79"},"down","no"]
["MSTRG.10222","CHN1","ENSOART00000000245","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0008045(motor neuron axon guidance);GO:0035556(intracellular signal transduction);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0046872(metal ion binding);GO:0046875(ephrin receptor binding);GO:0050770(regulation of axonogenesis)","NA","K20630","NA","chimerin 1 [Source:NCBI gene;Acc:101109591]",{"v":0.603835,"d":"0.60"},{"v":0.492588,"d":"0.49"},{"v":0.644968,"d":"0.64"},{"v":0.73026,"d":"0.73"},{"v":0.740177,"d":"0.74"},{"v":1.114377,"d":"1.11"},{"v":0.673700699547434,"d":"0.67"},{"v":-0.569820297516912,"d":"-0.57"},{"v":0.28753140737051,"d":"0.29"},{"v":0.787245121916392,"d":"0.79"},"down","no"]
["ENSOARG00000007558","GAS2","ENSOART00000008227","GO:0001544(initiation of primordial ovarian follicle growth);GO:0001547(antral ovarian follicle growth);GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0006915(apoptotic process);GO:0008017(microtubule binding);GO:0008593(regulation of Notch signaling pathway);GO:0030728(ovulation);GO:0071711(basement membrane organization)","NA","NA","NA","growth arrest specific 2 [Source:NCBI gene;Acc:101112173]",{"v":0.280284,"d":"0.28"},{"v":0.166997,"d":"0.17"},{"v":0.144163,"d":"0.14"},{"v":0.167232,"d":"0.17"},{"v":0.140025,"d":"0.14"},{"v":0.132359,"d":"0.13"},{"v":1.3453650458582,"d":"1.35"},{"v":0.427997680881047,"d":"0.43"},{"v":0.28773425145414,"d":"0.29"},{"v":0.787245121916392,"d":"0.79"},"up","no"]
["MSTRG.15288","PREPL","ENSOART00000006742","GO:0004252(serine-type endopeptidase activity);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0070008(serine-type exopeptidase activity);GO:2000300(regulation of synaptic vesicle exocytosis)","NA","K22582","EC:3.4.21.-","prolyl endopeptidase like [Source:NCBI gene;Acc:101111355]",{"v":7.60668872477805,"d":"7.61"},{"v":7.27967963357546,"d":"7.28"},{"v":6.90861542803336,"d":"6.91"},{"v":6.81811375302663,"d":"6.82"},{"v":5.81470353053538,"d":"5.81"},{"v":5.78004187032553,"d":"5.78"},{"v":1.18368275150713,"d":"1.18"},{"v":0.243282464280283,"d":"0.24"},{"v":0.289079447645525,"d":"0.29"},{"v":0.787676352666645,"d":"0.79"},"up","no"]
["MSTRG.10846","FABP3","ENSOART00000001726","GO:0005615(extracellular space);GO:0005623(cell);GO:0008092(cytoskeletal protein binding);GO:0008289(lipid binding);GO:0015909(long-chain fatty acid transport);GO:0032365(intracellular lipid transport);GO:0036041(long-chain fatty acid binding);GO:0042632(cholesterol homeostasis);GO:0046320(regulation of fatty acid oxidation);GO:0055091(phospholipid homeostasis);GO:0070538(oleic acid binding);GO:0140214(positive regulation of long-chain fatty acid import into cell);GO:2001245(regulation of phosphatidylcholine biosynthetic process)","03320(PPAR signaling pathway)","K08752","NA","fatty acid binding protein 3 [Source:NCBI gene;Acc:100913166]",{"v":17.225487,"d":"17.23"},{"v":21.166451,"d":"21.17"},{"v":14.749373,"d":"14.75"},{"v":23.277243,"d":"23.28"},{"v":20.975052,"d":"20.98"},{"v":27.908577,"d":"27.91"},{"v":0.736428337506786,"d":"0.74"},{"v":-0.441382952727067,"d":"-0.44"},{"v":0.289373936613281,"d":"0.29"},{"v":0.787676352666645,"d":"0.79"},"down","no"]
["MSTRG.13189","ENSOARG00000016411","ENSOART00000017869","GO:0000166(nucleotide binding);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006183(GTP biosynthetic process);GO:0006228(UTP biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity)","NA","NA","NA","nucleoside diphosphate kinase 3 [Source:NCBI gene;Acc:101110560]",{"v":2.536035,"d":"2.54"},{"v":2.022002,"d":"2.02"},{"v":2.16788,"d":"2.17"},{"v":2.579068,"d":"2.58"},{"v":3.741233,"d":"3.74"},{"v":3.759352,"d":"3.76"},{"v":0.667276641368507,"d":"0.67"},{"v":-0.583643093017023,"d":"-0.58"},{"v":0.290038889113523,"d":"0.29"},{"v":0.788898047883659,"d":"0.79"},"down","no"]
["MSTRG.393","JAK1","ENSOART00000011009","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019903(protein phosphatase binding);GO:0031625(ubiquitin protein ligase binding);GO:0035556(intracellular signal transduction);GO:0038110(interleukin-2-mediated signaling pathway);GO:0046677(response to antibiotic);GO:1903672(positive regulation of sprouting angiogenesis)","01521(EGFR tyrosine kinase inhibitor resistance);04151(PI3K-Akt signaling pathway);04217(Necroptosis);04380(Osteoclast differentiation);04550(Signaling pathways regulating pluripotency of stem cells);04621(NOD-like receptor signaling pathway);04630(Jak-STAT signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);05140(Leishmaniasis);05145(Toxoplasmosis);05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05163(Human cytomegalovirus infection);05164(Influenza A);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05212(Pancreatic cancer)","K11217","EC:2.7.10.2","Janus kinase 1 [Source:NCBI gene;Acc:101110716]",{"v":4.0821956624164,"d":"4.08"},{"v":5.49384081780111,"d":"5.49"},{"v":3.793393882701,"d":"3.79"},{"v":4.15557700320853,"d":"4.16"},{"v":3.7199673583974,"d":"3.72"},{"v":3.40737474915099,"d":"3.41"},{"v":1.18492654530975,"d":"1.18"},{"v":0.244797627898248,"d":"0.24"},{"v":0.29090370646682,"d":"0.29"},{"v":0.789187019231135,"d":"0.79"},"up","no"]
["MSTRG.4995","EPB41L1","ENSOART00000016831","GO:0003779(actin binding);GO:0005198(structural molecule activity);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008092(cytoskeletal protein binding);GO:0030866(cortical actin cytoskeleton organization)","NA","K06107","NA","erythrocyte membrane protein band 4.1 like 1 [Source:NCBI gene;Acc:101120768]",{"v":0.760686,"d":"0.76"},{"v":0.627679,"d":"0.63"},{"v":0.781897,"d":"0.78"},{"v":1.060072,"d":"1.06"},{"v":1.038407,"d":"1.04"},{"v":0.952145,"d":"0.95"},{"v":0.711415762807871,"d":"0.71"},{"v":-0.491235154402682,"d":"-0.49"},{"v":0.291314500099202,"d":"0.29"},{"v":0.789187019231135,"d":"0.79"},"down","no"]
["MSTRG.2196","UFM1","ENSOART00000010767","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0007420(brain development);GO:0033146(regulation of intracellular estrogen receptor signaling pathway);GO:0034976(response to endoplasmic reticulum stress);GO:0071569(protein ufmylation);GO:1990592(protein K69-linked ufmylation)","NA","NA","NA","ubiquitin fold modifier 1 [Source:HGNC Symbol;Acc:HGNC:20597]",{"v":1.35630713314968,"d":"1.36"},{"v":1.05394514306703,"d":"1.05"},{"v":1.15836323415978,"d":"1.16"},{"v":1.26935521652893,"d":"1.27"},{"v":0.821309347658402,"d":"0.82"},{"v":0.844512614141414,"d":"0.84"},{"v":1.21580923179854,"d":"1.22"},{"v":0.281916878510954,"d":"0.28"},{"v":0.292016456100909,"d":"0.29"},{"v":0.789187019231135,"d":"0.79"},"up","no"]
["MSTRG.915","TSACC","ENSOART00000006457","GO:0005737(cytoplasm);GO:0051087(chaperone binding)","NA","NA","NA","TSSK6 activating cochaperone [Source:NCBI gene;Acc:101104873]",{"v":3.013329,"d":"3.01"},{"v":2.473405,"d":"2.47"},{"v":2.135113,"d":"2.14"},{"v":1.812867,"d":"1.81"},{"v":2.100626,"d":"2.10"},{"v":1.804717,"d":"1.80"},{"v":1.33290785053365,"d":"1.33"},{"v":0.414577044362749,"d":"0.41"},{"v":0.292231055789731,"d":"0.29"},{"v":0.789207522152617,"d":"0.79"},"up","no"]
["MSTRG.14448","ENSOARG00000003340","ENSOART00000003623","GO:0003676(nucleic acid binding)","NA","NA","NA",null,{"v":1.277729,"d":"1.28"},{"v":1.01938,"d":"1.02"},{"v":0.926063,"d":"0.93"},{"v":0.812169,"d":"0.81"},{"v":0.723164,"d":"0.72"},{"v":0.907088,"d":"0.91"},{"v":1.31966274446543,"d":"1.32"},{"v":0.400169278784755,"d":"0.40"},{"v":0.294118956519393,"d":"0.29"},{"v":0.791556670850281,"d":"0.79"},"up","no"]
["ENSOARG00000018635","DZANK1","ENSOART00000020285;ENSOART00000020286","GO:0005515(protein binding);GO:0005515(protein binding)","NA","NA","NA","double zinc ribbon and ankyrin repeat domains 1 [Source:NCBI gene;Acc:101121697]",{"v":0.173529153395212,"d":"0.17"},{"v":0.235945,"d":"0.24"},{"v":0.2924,"d":"0.29"},{"v":0.404103719101124,"d":"0.40"},{"v":0.389557462139717,"d":"0.39"},{"v":0.236293465559355,"d":"0.24"},{"v":0.68146122314779,"d":"0.68"},{"v":-0.553296528486382,"d":"-0.55"},{"v":0.294343527324349,"d":"0.29"},{"v":0.791876872925762,"d":"0.79"},"down","no"]
["MSTRG.20586","RF00001","ENSOART00000026158","NA","NA","NA","NA",null,{"v":3.76462148633999,"d":"3.76"},{"v":4.42936762792471,"d":"4.43"},{"v":3.95220335012121,"d":"3.95"},{"v":4.11416627992809,"d":"4.11"},{"v":4.06000860616131,"d":"4.06"},{"v":2.03479440217362,"d":"2.03"},{"v":1.18975697951703,"d":"1.19"},{"v":0.250666917860513,"d":"0.25"},{"v":0.295151484838553,"d":"0.30"},{"v":0.792767469064631,"d":"0.79"},"up","no"]
["MSTRG.17744","FBXL12","ENSOART00000014588","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006511(ubiquitin-dependent protein catabolic process)","NA","K10278","NA","F-box and leucine rich repeat protein 12 [Source:NCBI gene;Acc:101110231]",{"v":0.891633,"d":"0.89"},{"v":0.786135,"d":"0.79"},{"v":0.639359,"d":"0.64"},{"v":1.237926,"d":"1.24"},{"v":0.892038,"d":"0.89"},{"v":1.293539,"d":"1.29"},{"v":0.676829259387242,"d":"0.68"},{"v":-0.563136157250366,"d":"-0.56"},{"v":0.296690866989367,"d":"0.30"},{"v":0.793939822829325,"d":"0.79"},"down","no"]
["MSTRG.10925","CEP85","ENSOART00000005447","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0046602(regulation of mitotic centrosome separation)","NA","K16766","NA","centrosomal protein 85 [Source:NCBI gene;Acc:101112118]",{"v":14.6816243772038,"d":"14.68"},{"v":12.0261761063961,"d":"12.03"},{"v":9.04762690200902,"d":"9.05"},{"v":12.8093817078721,"d":"12.81"},{"v":7.86524267056171,"d":"7.87"},{"v":9.04642876281263,"d":"9.05"},{"v":1.20303366154909,"d":"1.20"},{"v":0.266677010486164,"d":"0.27"},{"v":0.296723782031632,"d":"0.30"},{"v":0.793939822829325,"d":"0.79"},"up","no"]
["MSTRG.16603","CYB5R3","ENSOART00000020712","GO:0004128(cytochrome-b5 reductase activity, acting on NAD(P)H);GO:0005783(endoplasmic reticulum);GO:0005811(lipid droplet);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00520(Amino sugar and nucleotide sugar metabolism)","K00326","EC:1.6.2.2","NADH-cytochrome b5 reductase 3 [Source:NCBI gene;Acc:101106419]",{"v":7.91737834433962,"d":"7.92"},{"v":7.73206326613704,"d":"7.73"},{"v":12.6635085089374,"d":"12.66"},{"v":7.56639819414101,"d":"7.57"},{"v":15.3939930692651,"d":"15.39"},{"v":16.5449139155909,"d":"16.54"},{"v":0.716687290254541,"d":"0.72"},{"v":-0.480584324925235,"d":"-0.48"},{"v":0.297413205983589,"d":"0.30"},{"v":0.794790568951035,"d":"0.79"},"down","no"]
["MSTRG.7569","NCOR2","ENSOART00000000405","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0003677(DNA binding);GO:0003714(transcription corepressor activity);GO:0005112(Notch binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016363(nuclear matrix);GO:0016604(nuclear body);GO:0017053(transcriptional repressor complex);GO:0042826(histone deacetylase binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0047485(protein N-terminus binding);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0072365(regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter);GO:1903799(negative regulation of production of miRNAs involved in gene silencing by miRNA)","04330(Notch signaling pathway);05169(Epstein-Barr virus infection)","K06065","NA","nuclear receptor corepressor 2 [Source:NCBI gene;Acc:101121042]",{"v":3.13230628705719,"d":"3.13"},{"v":3.38192563261924,"d":"3.38"},{"v":3.42465203945676,"d":"3.42"},{"v":4.34755236273006,"d":"4.35"},{"v":4.85600928799723,"d":"4.86"},{"v":4.01368735854938,"d":"4.01"},{"v":0.751963131825501,"d":"0.75"},{"v":-0.411266165479683,"d":"-0.41"},{"v":0.298146070960381,"d":"0.30"},{"v":0.795056189227681,"d":"0.80"},"down","no"]
["MSTRG.8107","FANCI","ENSOART00000012360","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0031398(positive regulation of protein ubiquitination);GO:0070182(DNA polymerase binding)","03460(Fanconi anemia pathway)","K10895","NA","FA complementation group I [Source:NCBI gene;Acc:101103510]",{"v":1.086077,"d":"1.09"},{"v":0.551276,"d":"0.55"},{"v":0.809826,"d":"0.81"},{"v":1.417324,"d":"1.42"},{"v":0.766103,"d":"0.77"},{"v":1.243114,"d":"1.24"},{"v":0.714183487079244,"d":"0.71"},{"v":-0.485633317704205,"d":"-0.49"},{"v":0.298795246695013,"d":"0.30"},{"v":0.795358459086433,"d":"0.80"},"down","no"]
["MSTRG.4748","SHLD1","ENSOART00000019467","GO:0005694(chromosome);GO:0035861(site of double-strand break);GO:0045830(positive regulation of isotype switching);GO:2000042(negative regulation of double-strand break repair via homologous recombination);GO:2001032(regulation of double-strand break repair via nonhomologous end joining);GO:2001034(positive regulation of double-strand break repair via nonhomologous end joining)","NA","NA","NA","shieldin complex subunit 1 [Source:NCBI gene;Acc:101115387]",{"v":1.8368,"d":"1.84"},{"v":1.446625,"d":"1.45"},{"v":1.27789,"d":"1.28"},{"v":1.573648,"d":"1.57"},{"v":0.576814,"d":"0.58"},{"v":1.204983,"d":"1.20"},{"v":1.35937707219162,"d":"1.36"},{"v":0.44294569504931,"d":"0.44"},{"v":0.299528005876457,"d":"0.30"},{"v":0.795767927693181,"d":"0.80"},"up","no"]
["MSTRG.12207","DHCR7","ENSOART00000001472","GO:0001568(blood vessel development);GO:0005640(nuclear outer membrane);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006695(cholesterol biosynthetic process);GO:0009791(post-embryonic development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016126(sterol biosynthetic process);GO:0016628(oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor);GO:0030154(cell differentiation);GO:0030324(lung development);GO:0035264(multicellular organism growth);GO:0042127(regulation of cell population proliferation);GO:0047598(7-dehydrocholesterol reductase activity);GO:0055114(oxidation-reduction process)","00100(Steroid biosynthesis)","K00213","EC:1.3.1.21","7-dehydrocholesterol reductase [Source:NCBI gene;Acc:101118320]",{"v":0.711995,"d":"0.71"},{"v":0.543931548494983,"d":"0.54"},{"v":0.622237,"d":"0.62"},{"v":1.527008,"d":"1.53"},{"v":0.522518,"d":"0.52"},{"v":0.841494,"d":"0.84"},{"v":0.649654291044331,"d":"0.65"},{"v":-0.622255892555873,"d":"-0.62"},{"v":0.300352208449078,"d":"0.30"},{"v":0.796318887705311,"d":"0.80"},"down","no"]
["MSTRG.9215","MKRN2","ENSOART00000017158","GO:0046872(metal ion binding)","NA","K15687","EC:2.3.2.27","makorin ring finger protein 2 [Source:NCBI gene;Acc:101103765]",{"v":11.245467,"d":"11.25"},{"v":13.85762,"d":"13.86"},{"v":11.861807,"d":"11.86"},{"v":11.0153,"d":"11.02"},{"v":10.577423,"d":"10.58"},{"v":9.736389,"d":"9.74"},{"v":1.17988961832049,"d":"1.18"},{"v":0.238651898103742,"d":"0.24"},{"v":0.300439310317433,"d":"0.30"},{"v":0.796318887705311,"d":"0.80"},"up","no"]
["MSTRG.14226","COG2","ENSOART00000003364","GO:0005795(Golgi stack);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0007030(Golgi organization);GO:0008565(protein transporter activity);GO:0015031(protein transport);GO:0016020(membrane);GO:0017119(Golgi transport complex)","NA","K20289","NA","component of oligomeric golgi complex 2 [Source:NCBI gene;Acc:101122408]",{"v":4.91289,"d":"4.91"},{"v":3.565655,"d":"3.57"},{"v":3.798609,"d":"3.80"},{"v":5.596046,"d":"5.60"},{"v":5.498069,"d":"5.50"},{"v":5.179635,"d":"5.18"},{"v":0.754414563330517,"d":"0.75"},{"v":-0.406570568606696,"d":"-0.41"},{"v":0.30164825062115,"d":"0.30"},{"v":0.79754365163668,"d":"0.80"},"down","no"]
["MSTRG.9251","TMEM43","ENSOART00000001136","GO:0005637(nuclear inner membrane);GO:0005639(integral component of nuclear inner membrane);GO:0005788(endoplasmic reticulum lumen);GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043621(protein self-association);GO:0071763(nuclear membrane organization)","NA","NA","NA","transmembrane protein 43 [Source:NCBI gene;Acc:101105535]",{"v":4.85214583222342,"d":"4.85"},{"v":5.76447331342642,"d":"5.76"},{"v":6.40242337980666,"d":"6.40"},{"v":7.38784927432868,"d":"7.39"},{"v":7.60444132287862,"d":"7.60"},{"v":7.8199153566058,"d":"7.82"},{"v":0.746049836649477,"d":"0.75"},{"v":-0.422656088152765,"d":"-0.42"},{"v":0.301795177250872,"d":"0.30"},{"v":0.79754365163668,"d":"0.80"},"down","no"]
["MSTRG.21029","FAM91A1","ENSOART00000010495","GO:0005802(trans-Golgi network);GO:0006886(intracellular protein transport);GO:0031410(cytoplasmic vesicle);GO:0099041(vesicle tethering to Golgi)","NA","NA","NA","family with sequence similarity 91 member A1 [Source:NCBI gene;Acc:101103162]",{"v":3.58340993525641,"d":"3.58"},{"v":2.02860561752137,"d":"2.03"},{"v":2.99897531581197,"d":"3.00"},{"v":2.74714732542735,"d":"2.75"},{"v":2.37410215128205,"d":"2.37"},{"v":2.0784255948718,"d":"2.08"},{"v":1.19602492931651,"d":"1.20"},{"v":0.258247460628391,"d":"0.26"},{"v":0.302854897185404,"d":"0.30"},{"v":0.798355628227845,"d":"0.80"},"up","no"]
["MSTRG.2616","YPEL2","ENSOART00000013664","GO:0046872(metal ion binding)","NA","NA","NA","yippee like 2 [Source:NCBI gene;Acc:101104253]",{"v":1.68681462937145,"d":"1.69"},{"v":0.924046674211866,"d":"0.92"},{"v":2.1371364424907,"d":"2.14"},{"v":1.63507357364402,"d":"1.64"},{"v":1.21245792101038,"d":"1.21"},{"v":1.05774063046799,"d":"1.06"},{"v":1.21579177940775,"d":"1.22"},{"v":0.281896169128501,"d":"0.28"},{"v":0.303510929853115,"d":"0.30"},{"v":0.798695404896303,"d":"0.80"},"up","no"]
["MSTRG.18408","SPARC","ENSOART00000009839","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005615(extracellular space);GO:0062023(collagen-containing extracellular matrix)","NA","NA","NA","secreted protein acidic and cysteine rich [Source:NCBI gene;Acc:100307048]",{"v":236.535419164854,"d":"236.54"},{"v":161.310956954328,"d":"161.31"},{"v":344.631512832101,"d":"344.63"},{"v":329.905418647238,"d":"329.91"},{"v":298.5221580796,"d":"298.52"},{"v":378.779332310135,"d":"378.78"},{"v":0.737165206363798,"d":"0.74"},{"v":-0.439940116418744,"d":"-0.44"},{"v":0.304524615107706,"d":"0.30"},{"v":0.799849363538785,"d":"0.80"},"down","no"]
["MSTRG.9998","MTMR9","ENSOART00000016514","GO:0005737(cytoplasm);GO:0010507(negative regulation of autophagy);GO:0010922(positive regulation of phosphatase activity);GO:0019903(protein phosphatase binding);GO:0030234(enzyme regulator activity);GO:0032991(protein-containing complex);GO:0050821(protein stabilization);GO:0060304(regulation of phosphatidylinositol dephosphorylation)","NA","K18084","NA","myotubularin related protein 9 [Source:NCBI gene;Acc:101117905]",{"v":3.96028432411124,"d":"3.96"},{"v":3.82144789506881,"d":"3.82"},{"v":3.3493552756594,"d":"3.35"},{"v":3.37349854286124,"d":"3.37"},{"v":3.20739341585436,"d":"3.21"},{"v":2.86433115008601,"d":"2.86"},{"v":1.17848857211926,"d":"1.18"},{"v":0.236937768747768,"d":"0.24"},{"v":0.305592439555773,"d":"0.31"},{"v":0.800012457671859,"d":"0.80"},"up","no"]
["MSTRG.20618","PDE7B","ENSOART00000016364","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)","00230(Purine metabolism);05032(Morphine addiction)","K18436","EC:3.1.4.53","phosphodiesterase 7B [Source:NCBI gene;Acc:101111290]",{"v":4.01990719899983,"d":"4.02"},{"v":2.98839551129505,"d":"2.99"},{"v":4.08358136678738,"d":"4.08"},{"v":5.06734439489567,"d":"5.07"},{"v":5.06216424607691,"d":"5.06"},{"v":4.5906292183135,"d":"4.59"},{"v":0.753517676472373,"d":"0.75"},{"v":-0.408286739056416,"d":"-0.41"},{"v":0.306402085497175,"d":"0.31"},{"v":0.800597415906206,"d":"0.80"},"down","no"]
["MSTRG.1270","ABI3BP","ENSOART00000019807;ENSOART00000019809","GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005539(glycosaminoglycan binding);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0031012(extracellular matrix)","NA","NA","NA","ABI family member 3 binding protein [Source:NCBI gene;Acc:101108803]",{"v":2.46564214521023,"d":"2.47"},{"v":1.53665857358041,"d":"1.54"},{"v":3.51749243530559,"d":"3.52"},{"v":2.68145120491981,"d":"2.68"},{"v":3.58449302459905,"d":"3.58"},{"v":4.01998538729952,"d":"4.02"},{"v":0.731075696046055,"d":"0.73"},{"v":-0.451907303406753,"d":"-0.45"},{"v":0.306632432549045,"d":"0.31"},{"v":0.800619977954825,"d":"0.80"},"down","no"]
["MSTRG.12824","TMX3","ENSOART00000005454","GO:0005789(endoplasmic reticulum membrane);GO:0009986(cell surface);GO:0016972(thiol oxidase activity);GO:0018171(peptidyl-cysteine oxidation);GO:0045454(cell redox homeostasis)","NA","K09585","EC:5.3.4.1","thioredoxin related transmembrane protein 3 [Source:NCBI gene;Acc:101113033]",{"v":6.430169,"d":"6.43"},{"v":6.673988,"d":"6.67"},{"v":6.661477,"d":"6.66"},{"v":6.26879,"d":"6.27"},{"v":5.446944,"d":"5.45"},{"v":5.181096,"d":"5.18"},{"v":1.16978356295234,"d":"1.17"},{"v":0.226241622509084,"d":"0.23"},{"v":0.306945176508176,"d":"0.31"},{"v":0.800735076214331,"d":"0.80"},"up","no"]
["MSTRG.18872","LIAS","ENSOART00000012771","GO:0001843(neural tube closure);GO:0003824(catalytic activity);GO:0005739(mitochondrion);GO:0006954(inflammatory response);GO:0006979(response to oxidative stress);GO:0009107(lipoate biosynthetic process);GO:0009249(protein lipoylation);GO:0016740(transferase activity);GO:0016783(sulfurtransferase activity);GO:0016992(lipoate synthase activity);GO:0032496(response to lipopolysaccharide);GO:0046872(metal ion binding);GO:0051536(iron-sulfur cluster binding);GO:0051539(4 iron, 4 sulfur cluster binding)","00785(Lipoic acid metabolism)","K03644","EC:2.8.1.8","lipoic acid synthetase [Source:NCBI gene;Acc:101113851]",{"v":8.17221363995485,"d":"8.17"},{"v":7.1258621969526,"d":"7.13"},{"v":5.62773711060948,"d":"5.63"},{"v":8.85525340124154,"d":"8.86"},{"v":3.15647370428894,"d":"3.16"},{"v":5.16800844074492,"d":"5.17"},{"v":1.21805209929752,"d":"1.22"},{"v":0.284575842431988,"d":"0.28"},{"v":0.307874730002457,"d":"0.31"},{"v":0.801473902893283,"d":"0.80"},"up","no"]
["MSTRG.12028","BAD","ENSOART00000006828","GO:0001836(release of cytochrome c from mitochondria);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005829(cytosol);GO:0006007(glucose catabolic process);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0008283(cell population proliferation);GO:0008289(lipid binding);GO:0008625(extrinsic apoptotic signaling pathway via death domain receptors);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0008656(cysteine-type endopeptidase activator activity involved in apoptotic process);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0019050(suppression by virus of host apoptotic process);GO:0019221(cytokine-mediated signaling pathway);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0032024(positive regulation of insulin secretion);GO:0033133(positive regulation of glucokinase activity);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0042593(glucose homeostasis);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0044342(type B pancreatic cell proliferation);GO:0045579(positive regulation of B cell differentiation);GO:0045582(positive regulation of T cell differentiation);GO:0045862(positive regulation of proteolysis);GO:0046031(ADP metabolic process);GO:0046034(ATP metabolic process);GO:0046902(regulation of mitochondrial membrane permeability);GO:0046931(pore complex assembly);GO:0046982(protein heterodimerization activity);GO:0050679(positive regulation of epithelial cell proliferation);GO:0060139(positive regulation of apoptotic process by virus);GO:0060154(cellular process regulating host cell cycle in response to virus);GO:0071260(cellular response to mechanical stimulus);GO:0071316(cellular response to nicotine);GO:0071396(cellular response to lipid);GO:0071456(cellular response to hypoxia);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097193(intrinsic apoptotic signaling pathway);GO:0097202(activation of cysteine-type endopeptidase activity);GO:1902220(positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress);GO:2000078(positive regulation of type B pancreatic cell development)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);01524(Platinum drug resistance);04012(ErbB signaling pathway);04014(Ras signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04062(Chemokine signaling pathway);04140(Autophagy - animal);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04370(VEGF signaling pathway);04510(Focal adhesion);04722(Neurotrophin signaling pathway);04910(Insulin signaling pathway);04919(Thyroid hormone signaling pathway);05010(Alzheimer disease);05014(Amyotrophic lateral sclerosis (ALS));05145(Toxoplasmosis);05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05165(Human papillomavirus infection);05168(Herpes simplex virus 1 infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05213(Endometrial cancer);05215(Prostate cancer);05218(Melanoma);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer);05225(Hepatocellular carcinoma)","K02158","NA","BCL2 associated agonist of cell death [Source:NCBI gene;Acc:780444]",{"v":3.504662,"d":"3.50"},{"v":3.256655,"d":"3.26"},{"v":2.554016,"d":"2.55"},{"v":3.361376,"d":"3.36"},{"v":4.953754,"d":"4.95"},{"v":4.780076,"d":"4.78"},{"v":0.711354445283259,"d":"0.71"},{"v":-0.491359506864141,"d":"-0.49"},{"v":0.309054593615736,"d":"0.31"},{"v":0.803093347257059,"d":"0.80"},"down","no"]
["MSTRG.18195","TCF7","ENSOART00000014978","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005719(nuclear euchromatin);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008013(beta-catenin binding);GO:0016055(Wnt signaling pathway);GO:0016604(nuclear body);GO:0021915(neural tube development);GO:0030538(embryonic genitalia morphogenesis);GO:0033153(T cell receptor V(D)J recombination);GO:0042127(regulation of cell population proliferation);GO:0044212(transcription regulatory region DNA binding);GO:0044336(canonical Wnt signaling pathway involved in negative regulation of apoptotic process);GO:0046632(alpha-beta T cell differentiation);GO:0048557(embryonic digestive tract morphogenesis);GO:0048619(embryonic hindgut morphogenesis);GO:0060070(canonical Wnt signaling pathway);GO:0071353(cellular response to interleukin-4)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04520(Adherens junction);04916(Melanogenesis);04934(Cushing syndrome);05165(Human papillomavirus infection);05200(Pathways in cancer);05210(Colorectal cancer);05213(Endometrial cancer);05215(Prostate cancer);05216(Thyroid cancer);05217(Basal cell carcinoma);05221(Acute myeloid leukemia);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC))","K02620","NA","transcription factor 7 [Source:NCBI gene;Acc:101101980]",{"v":0.993273,"d":"0.99"},{"v":1.343979,"d":"1.34"},{"v":0.92244,"d":"0.92"},{"v":0.724015,"d":"0.72"},{"v":0.831854,"d":"0.83"},{"v":0.920238,"d":"0.92"},{"v":1.31645845676298,"d":"1.32"},{"v":0.396661995240645,"d":"0.40"},{"v":0.310195896081646,"d":"0.31"},{"v":0.803355807528922,"d":"0.80"},"up","no"]
["ENSOARG00000012761","FMO4","ENSOART00000013873","GO:0004497(monooxygenase activity);GO:0004499(N,N-dimethylaniline monooxygenase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0031090(organelle membrane);GO:0042737(drug catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0050660(flavin adenine dinucleotide binding);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process)","00982(Drug metabolism - cytochrome P450)","K00485","EC:1.14.13.8","flavin containing monooxygenase 4 [Source:NCBI gene;Acc:101105344]",{"v":0.847349,"d":"0.85"},{"v":0.510444,"d":"0.51"},{"v":0.831737,"d":"0.83"},{"v":1.089715,"d":"1.09"},{"v":1.171676,"d":"1.17"},{"v":0.888712,"d":"0.89"},{"v":0.695066161328693,"d":"0.70"},{"v":-0.524777784565136,"d":"-0.52"},{"v":0.310673326047906,"d":"0.31"},{"v":0.803355807528922,"d":"0.80"},"down","no"]
["MSTRG.8923","TMF1","ENSOART00000011134","GO:0001675(acrosome assembly);GO:0001819(positive regulation of cytokine production);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0007286(spermatid development);GO:0007289(spermatid nucleus differentiation);GO:0008584(male gonad development);GO:0010629(negative regulation of gene expression);GO:0030317(flagellated sperm motility);GO:0032275(luteinizing hormone secretion);GO:0033327(Leydig cell differentiation);GO:0042742(defense response to bacterium);GO:0043066(negative regulation of apoptotic process);GO:0061136(regulation of proteasomal protein catabolic process);GO:0071407(cellular response to organic cyclic compound);GO:2000845(positive regulation of testosterone secretion)","NA","K20286","NA","TATA element modulatory factor 1 [Source:NCBI gene;Acc:101116869]",{"v":4.25087191623711,"d":"4.25"},{"v":3.83502768170103,"d":"3.84"},{"v":3.15085092912371,"d":"3.15"},{"v":3.88164578543814,"d":"3.88"},{"v":3.01056159085052,"d":"3.01"},{"v":2.62657268234536,"d":"2.63"},{"v":1.18048221072926,"d":"1.18"},{"v":0.239376301044694,"d":"0.24"},{"v":0.311151675699978,"d":"0.31"},{"v":0.803355807528922,"d":"0.80"},"up","no"]
["MSTRG.8263","PML","ENSOART00000004613","GO:0000784(nuclear chromosome, telomeric region);GO:0000792(heterochromatin);GO:0001666(response to hypoxia);GO:0001932(regulation of protein phosphorylation);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006606(protein import into nucleus);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007182(common-partner SMAD protein phosphorylation);GO:0007569(cell aging);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell population proliferation);GO:0008630(intrinsic apoptotic signaling pathway in response to DNA damage);GO:0008631(intrinsic apoptotic signaling pathway in response to oxidative stress);GO:0009411(response to UV);GO:0010332(response to gamma radiation);GO:0010522(regulation of calcium ion transport into cytosol);GO:0010761(fibroblast migration);GO:0016363(nuclear matrix);GO:0016525(negative regulation of angiogenesis);GO:0016605(PML body);GO:0030099(myeloid cell differentiation);GO:0030155(regulation of cell adhesion);GO:0030308(negative regulation of cell growth);GO:0030578(PML body organization);GO:0031625(ubiquitin protein ligase binding);GO:0032183(SUMO binding);GO:0032206(positive regulation of telomere maintenance);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0032922(circadian regulation of gene expression);GO:0034097(response to cytokine);GO:0042406(extrinsic component of endoplasmic reticulum membrane);GO:0042752(regulation of circadian rhythm);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0042803(protein homodimerization activity);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0045087(innate immune response);GO:0045165(cell fate commitment);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046332(SMAD binding);GO:0048146(positive regulation of fibroblast proliferation);GO:0048384(retinoic acid receptor signaling pathway);GO:0050711(negative regulation of interleukin-1 secretion);GO:0050713(negative regulation of interleukin-1 beta secretion);GO:0051457(maintenance of protein location in nucleus);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0065003(protein-containing complex assembly);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0071353(cellular response to interleukin-4);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090398(cellular senescence);GO:0097191(extrinsic apoptotic signaling pathway);GO:1902187(negative regulation of viral release from host cell);GO:1990830(cellular response to leukemia inhibitory factor);GO:2000059(negative regulation of ubiquitin-dependent protein catabolic process);GO:2000779(regulation of double-strand break repair);GO:2001235(positive regulation of apoptotic signaling pathway);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","04120(Ubiquitin mediated proteolysis);04144(Endocytosis);05164(Influenza A);05168(Herpes simplex virus 1 infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05221(Acute myeloid leukemia)","K10054","NA","promyelocytic leukemia [Source:NCBI gene;Acc:101111580]",{"v":1.140076,"d":"1.14"},{"v":0.949457,"d":"0.95"},{"v":1.026784,"d":"1.03"},{"v":1.471317,"d":"1.47"},{"v":1.666087,"d":"1.67"},{"v":1.165888,"d":"1.17"},{"v":0.724170472280292,"d":"0.72"},{"v":-0.465598742104296,"d":"-0.47"},{"v":0.311469478640473,"d":"0.31"},{"v":0.803355807528922,"d":"0.80"},"down","no"]
["MSTRG.3623","SLC25A19","ENSOART00000011620","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K15108","NA","solute carrier family 25 member 19 [Source:NCBI gene;Acc:100217405]",{"v":2.10990370451237,"d":"2.11"},{"v":2.66826151200873,"d":"2.67"},{"v":2.24496843340611,"d":"2.24"},{"v":3.75568622889374,"d":"3.76"},{"v":2.7953594639738,"d":"2.80"},{"v":3.02496754112082,"d":"3.02"},{"v":0.73340893316645,"d":"0.73"},{"v":-0.447310256221957,"d":"-0.45"},{"v":0.311639067839866,"d":"0.31"},{"v":0.803355807528922,"d":"0.80"},"down","no"]
["ENSOARG00000007592","PTGS2","ENSOART00000008268;ENSOART00000008267","GO:0001516(prostaglandin biosynthetic process);GO:0004601(peroxidase activity);GO:0004666(prostaglandin-endoperoxide synthase activity);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0006954(inflammatory response);GO:0006979(response to oxidative stress);GO:0007566(embryo implantation);GO:0008217(regulation of blood pressure);GO:0019371(cyclooxygenase pathway);GO:0019899(enzyme binding);GO:0020037(heme binding);GO:0031394(positive regulation of prostaglandin biosynthetic process);GO:0031622(positive regulation of fever generation);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0042127(regulation of cell population proliferation);GO:0042803(protein homodimerization activity);GO:0043005(neuron projection);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0046697(decidualization);GO:0050873(brown fat cell differentiation);GO:0055114(oxidation-reduction process);GO:0071456(cellular response to hypoxia);GO:0071471(cellular response to non-ionic osmotic stress);GO:0071498(cellular response to fluid shear stress);GO:0090336(positive regulation of brown fat cell differentiation);GO:0098869(cellular oxidant detoxification);GO:0150077(regulation of neuroinflammatory response);GO:1902219(negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress);GO:1902219(negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress)","00590(Arachidonic acid metabolism);04064(NF-kappa B signaling pathway);04370(VEGF signaling pathway);04625(C-type lectin receptor signaling pathway);04657(IL-17 signaling pathway);04668(TNF signaling pathway);04723(Retrograde endocannabinoid signaling);04726(Serotonergic synapse);04913(Ovarian steroidogenesis);04921(Oxytocin signaling pathway);04923(Regulation of lipolysis in adipocytes);05140(Leishmaniasis);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05200(Pathways in cancer);05204(Chemical carcinogenesis);05206(MicroRNAs in cancer);05222(Small cell lung cancer);05222(Small cell lung cancer)","K11987","EC:1.14.99.1","prostaglandin-endoperoxide synthase 2 [Source:NCBI gene;Acc:443460]",{"v":1.08768725144092,"d":"1.09"},{"v":0.279355227665706,"d":"0.28"},{"v":0.351205634005764,"d":"0.35"},{"v":0.649715213256484,"d":"0.65"},{"v":0.156877279538905,"d":"0.16"},{"v":0.376848129682997,"d":"0.38"},{"v":1.45190901890287,"d":"1.45"},{"v":0.537951052445179,"d":"0.54"},{"v":0.312789035458522,"d":"0.31"},{"v":0.804454212889634,"d":"0.80"},"up","no"]
["MSTRG.7486","GASK1B","ENSOART00000006555","GO:0005794(Golgi apparatus)","NA","NA","NA","golgi associated kinase 1B [Source:NCBI gene;Acc:101112349]",{"v":1.94385914470673,"d":"1.94"},{"v":1.90489985607794,"d":"1.90"},{"v":2.12636904825737,"d":"2.13"},{"v":2.69008863774276,"d":"2.69"},{"v":3.00588298666056,"d":"3.01"},{"v":2.23601846374158,"d":"2.24"},{"v":0.753294946494251,"d":"0.75"},{"v":-0.408713243894956,"d":"-0.41"},{"v":0.313248400634021,"d":"0.31"},{"v":0.804454212889634,"d":"0.80"},"down","no"]
["MSTRG.9377","TRIM32","ENSOART00000006368","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0030307(positive regulation of cell growth);GO:0030335(positive regulation of cell migration);GO:0032897(negative regulation of viral transcription);GO:0042802(identical protein binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043130(ubiquitin binding);GO:0043621(protein self-association);GO:0045087(innate immune response);GO:0045787(positive regulation of cell cycle);GO:0045862(positive regulation of proteolysis);GO:0046872(metal ion binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0061630(ubiquitin protein ligase activity);GO:1902187(negative regulation of viral release from host cell);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","04120(Ubiquitin mediated proteolysis)","K10607","EC:2.3.2.27","tripartite motif containing 32 [Source:NCBI gene;Acc:101117567]",{"v":0.88368,"d":"0.88"},{"v":0.763397,"d":"0.76"},{"v":0.691557,"d":"0.69"},{"v":1.03103,"d":"1.03"},{"v":1.048862,"d":"1.05"},{"v":1.225261,"d":"1.23"},{"v":0.707572085165195,"d":"0.71"},{"v":-0.499050962331205,"d":"-0.50"},{"v":0.314449961131424,"d":"0.31"},{"v":0.805831842540191,"d":"0.81"},"down","no"]
["MSTRG.8844","ENSOARG00000006145","ENSOART00000006682","GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005885(Arp2/3 protein complex);GO:0015629(actin cytoskeleton);GO:0030041(actin filament polymerization);GO:0030833(regulation of actin filament polymerization);GO:0034314(Arp2/3 complex-mediated actin nucleation)","04144(Endocytosis);04666(Fc gamma R-mediated phagocytosis);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05132(Salmonella infection)","K05755;K16608","EC:6.3.2.-","tubulin monoglycylase TTLL3-like [Source:NCBI gene;Acc:101103096]",{"v":8.26857899003736,"d":"8.27"},{"v":7.13715446575342,"d":"7.14"},{"v":6.91130065255293,"d":"6.91"},{"v":9.02421828144458,"d":"9.02"},{"v":9.96195015193026,"d":"9.96"},{"v":10.4632972503113,"d":"10.46"},{"v":0.757807776482223,"d":"0.76"},{"v":-0.400096150297044,"d":"-0.40"},{"v":0.3149937721454,"d":"0.31"},{"v":0.806020735243706,"d":"0.81"},"down","no"]
["MSTRG.16465","CACNA1C","ENSOART00000014241","GO:0002520(immune system development);GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005262(calcium channel activity);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007507(heart development);GO:0008331(high voltage-gated calcium channel activity);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0035115(embryonic forelimb morphogenesis);GO:0043010(camera-type eye development);GO:0051393(alpha-actinin binding);GO:0055085(transmembrane transport);GO:0061337(cardiac conduction);GO:0061577(calcium ion transmembrane transport via high voltage-gated calcium channel);GO:0070588(calcium ion transmembrane transport);GO:0086002(cardiac muscle cell action potential involved in contraction);GO:0086007(voltage-gated calcium channel activity involved in cardiac muscle cell action potential);GO:0086012(membrane depolarization during cardiac muscle cell action potential);GO:0086045(membrane depolarization during AV node cell action potential);GO:0086056(voltage-gated calcium channel activity involved in AV node cell action potential);GO:0086091(regulation of heart rate by cardiac conduction);GO:0098911(regulation of ventricular cardiac muscle cell action potential);GO:0098912(membrane depolarization during atrial cardiac muscle cell action potential);GO:1990454(L-type voltage-gated calcium channel complex)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04713(Circadian entrainment);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04727(GABAergic synapse);04728(Dopaminergic synapse);04742(Taste transduction);04911(Insulin secretion);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04930(Type II diabetes mellitus);04934(Cushing syndrome);05010(Alzheimer disease);05031(Amphetamine addiction);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","K04850","NA","calcium voltage-gated channel subunit alpha1 C [Source:NCBI gene;Acc:101116562]",{"v":1.05011328220433,"d":"1.05"},{"v":0.637184139922265,"d":"0.64"},{"v":0.742634936146585,"d":"0.74"},{"v":1.23569753956135,"d":"1.24"},{"v":1.15729120530261,"d":"1.16"},{"v":0.897803094530816,"d":"0.90"},{"v":0.738403544455148,"d":"0.74"},{"v":-0.437518616720045,"d":"-0.44"},{"v":0.316013129016905,"d":"0.32"},{"v":0.807116398411178,"d":"0.81"},"down","no"]
["ENSOARG00000001724","ZNF174","ENSOART00000001853","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-templated);GO:0015629(actin cytoskeleton);GO:0042803(protein homodimerization activity);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","K09230","NA","zinc finger protein 174 [Source:NCBI gene;Acc:101119780]",{"v":0.502859,"d":"0.50"},{"v":0.407823,"d":"0.41"},{"v":0.592907,"d":"0.59"},{"v":0.848152,"d":"0.85"},{"v":0.66718,"d":"0.67"},{"v":0.578349,"d":"0.58"},{"v":0.718155726684246,"d":"0.72"},{"v":-0.477631379314308,"d":"-0.48"},{"v":0.316816824004661,"d":"0.32"},{"v":0.807829776585253,"d":"0.81"},"down","no"]
["MSTRG.2984","DHRS7C","ENSOART00000003582","GO:0004745(retinol dehydrogenase activity);GO:0010880(regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0014801(longitudinal sarcoplasmic reticulum);GO:0016491(oxidoreductase activity);GO:0033017(sarcoplasmic reticulum membrane);GO:0055114(oxidation-reduction process)","NA","K11167","EC:1.1.-.-","dehydrogenase/reductase 7C [Source:NCBI gene;Acc:101110775]",{"v":65.1235625335788,"d":"65.12"},{"v":47.7845086085355,"d":"47.78"},{"v":66.3117980864385,"d":"66.31"},{"v":55.6677634627383,"d":"55.67"},{"v":43.81601492526,"d":"43.82"},{"v":52.4602795073657,"d":"52.46"},{"v":1.17951219488933,"d":"1.18"},{"v":0.238190334571794,"d":"0.24"},{"v":0.318152629387058,"d":"0.32"},{"v":0.808835985136247,"d":"0.81"},"up","no"]
["MSTRG.204","MED8","ENSOART00000000102","GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex)","NA","K15129","NA","mediator complex subunit 8 [Source:NCBI gene;Acc:101107155]",{"v":1.98864103406202,"d":"1.99"},{"v":2.081151175394,"d":"2.08"},{"v":2.19011937773259,"d":"2.19"},{"v":3.01393404677173,"d":"3.01"},{"v":2.42355758617184,"d":"2.42"},{"v":3.04397044331469,"d":"3.04"},{"v":0.73806986707064,"d":"0.74"},{"v":-0.438170703933164,"d":"-0.44"},{"v":0.318665929125516,"d":"0.32"},{"v":0.808835985136247,"d":"0.81"},"down","no"]
["MSTRG.2987","ENSOARG00000014673","ENSOART00000015972","GO:0005507(copper ion binding);GO:0005743(mitochondrial inner membrane);GO:0006825(copper ion transport);GO:0006878(cellular copper ion homeostasis);GO:0008535(respiratory chain complex IV assembly);GO:0046872(metal ion binding)","NA","K07152","NA","protein SCO1 homolog, mitochondrial [Source:NCBI gene;Acc:101113508]",{"v":1.701029,"d":"1.70"},{"v":2.783839,"d":"2.78"},{"v":1.782365,"d":"1.78"},{"v":3.606251,"d":"3.61"},{"v":2.148966,"d":"2.15"},{"v":3.24542,"d":"3.25"},{"v":0.696309938952099,"d":"0.70"},{"v":-0.522198478672423,"d":"-0.52"},{"v":0.31892975174309,"d":"0.32"},{"v":0.808835985136247,"d":"0.81"},"down","no"]
["MSTRG.973","ARHGAP30","ENSOART00000010239","GO:0007165(signal transduction);GO:0043231(intracellular membrane-bounded organelle)","NA","K20645","NA","Rho GTPase activating protein 30 [Source:NCBI gene;Acc:101123168]",{"v":0.538646,"d":"0.54"},{"v":0.382753,"d":"0.38"},{"v":0.511071,"d":"0.51"},{"v":0.609472,"d":"0.61"},{"v":0.670909,"d":"0.67"},{"v":0.676774,"d":"0.68"},{"v":0.731914437027215,"d":"0.73"},{"v":-0.450253091858324,"d":"-0.45"},{"v":0.319738751162608,"d":"0.32"},{"v":0.808835985136247,"d":"0.81"},"down","no"]
["MSTRG.10814","KIAA1522","ENSOART00000022780","NA","NA","NA","NA","KIAA1522 ortholog [Source:NCBI gene;Acc:101105225]",{"v":0.298811,"d":"0.30"},{"v":0.274099,"d":"0.27"},{"v":0.277768,"d":"0.28"},{"v":0.479981,"d":"0.48"},{"v":0.415624,"d":"0.42"},{"v":0.348925,"d":"0.35"},{"v":0.683533542783219,"d":"0.68"},{"v":-0.548915958490369,"d":"-0.55"},{"v":0.32028360125659,"d":"0.32"},{"v":0.809433497027735,"d":"0.81"},"down","no"]
["MSTRG.16581","ENSOARG00000018451","ENSOART00000020077","GO:0003723(RNA binding);GO:0005730(nucleolus);GO:0042254(ribosome biogenesis);GO:1990904(ribonucleoprotein complex)","03008(Ribosome biogenesis in eukaryotes);03040(Spliceosome)","K12845","NA","small nuclear ribonucleoprotein 13 [Source:NCBI gene;Acc:101112386]",{"v":14.1624778763884,"d":"14.16"},{"v":15.4924752443569,"d":"15.49"},{"v":14.5375369290577,"d":"14.54"},{"v":19.1951210953063,"d":"19.20"},{"v":17.292062981727,"d":"17.29"},{"v":22.0967443697599,"d":"22.10"},{"v":0.754344941035139,"d":"0.75"},{"v":-0.406703716056715,"d":"-0.41"},{"v":0.321283709256522,"d":"0.32"},{"v":0.810091216147255,"d":"0.81"},"down","no"]
["MSTRG.11904","TIRAP","ENSOART00000013655","GO:0005080(protein kinase C binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007250(activation of NF-kappaB-inducing kinase activity);GO:0032496(response to lipopolysaccharide);GO:0032738(positive regulation of interleukin-15 production);GO:0032757(positive regulation of interleukin-8 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0034137(positive regulation of toll-like receptor 2 signaling pathway);GO:0034145(positive regulation of toll-like receptor 4 signaling pathway);GO:0035662(Toll-like receptor 4 binding);GO:0035663(Toll-like receptor 2 binding);GO:0035665(TIRAP-dependent toll-like receptor 4 signaling pathway);GO:0042802(identical protein binding);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045410(positive regulation of interleukin-6 biosynthetic process);GO:0046330(positive regulation of JNK cascade);GO:0046982(protein heterodimerization activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070935(3'-UTR-mediated mRNA stabilization);GO:0090073(positive regulation of protein homodimerization activity)","04064(NF-kappa B signaling pathway);04620(Toll-like receptor signaling pathway);05133(Pertussis);05152(Tuberculosis);05161(Hepatitis B)","K05403","NA","TIR domain containing adaptor protein [Source:NCBI gene;Acc:101118490]",{"v":0.192530841326391,"d":"0.19"},{"v":0.53017411126336,"d":"0.53"},{"v":0.794266517676076,"d":"0.79"},{"v":0.296988755549466,"d":"0.30"},{"v":0.954291125787887,"d":"0.95"},{"v":1.13423622965196,"d":"1.13"},{"v":0.63590912812436,"d":"0.64"},{"v":-0.653107476816518,"d":"-0.65"},{"v":0.321577505149347,"d":"0.32"},{"v":0.810187931558438,"d":"0.81"},"down","no"]
["MSTRG.10299","COBLL1","ENSOART00000006226","GO:0003785(actin monomer binding)","NA","NA","NA","cordon-bleu WH2 repeat protein like 1 [Source:NCBI gene;Acc:101110310]",{"v":2.0515147602649,"d":"2.05"},{"v":1.82092518913907,"d":"1.82"},{"v":3.53504010834437,"d":"3.54"},{"v":2.04948702357616,"d":"2.05"},{"v":2.11801846384106,"d":"2.12"},{"v":1.95255031761589,"d":"1.95"},{"v":1.21036152181104,"d":"1.21"},{"v":0.275438029171933,"d":"0.28"},{"v":0.322762591598509,"d":"0.32"},{"v":0.811403786854573,"d":"0.81"},"up","no"]
["MSTRG.5655","PPP1R14A","ENSOART00000006040","GO:0005737(cytoplasm);GO:0035690(cellular response to drug);GO:0042325(regulation of phosphorylation)","04270(Vascular smooth muscle contraction)","K12328","NA","protein phosphatase 1 regulatory inhibitor subunit 14A [Source:NCBI gene;Acc:101110786]",{"v":5.34699253472222,"d":"5.35"},{"v":3.25654286805556,"d":"3.26"},{"v":2.68862732638889,"d":"2.69"},{"v":4.60669975694444,"d":"4.61"},{"v":5.17065485416667,"d":"5.17"},{"v":5.967593625,"d":"5.97"},{"v":0.717192750324072,"d":"0.72"},{"v":-0.479567189955436,"d":"-0.48"},{"v":0.323934769910026,"d":"0.32"},{"v":0.812584739871546,"d":"0.81"},"down","no"]
["MSTRG.3391","DCAF7","ENSOART00000014440","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0016363(nuclear matrix);GO:0016604(nuclear body);GO:0032991(protein-containing complex);GO:0080008(Cul4-RING E3 ubiquitin ligase complex)","NA","K11805","NA","DDB1 and CUL4 associated factor 7 [Source:NCBI gene;Acc:101102573]",{"v":9.997289,"d":"10.00"},{"v":7.711791,"d":"7.71"},{"v":8.445287,"d":"8.45"},{"v":11.973114,"d":"11.97"},{"v":11.039865,"d":"11.04"},{"v":11.376926,"d":"11.38"},{"v":0.760524549282704,"d":"0.76"},{"v":-0.394933276843197,"d":"-0.39"},{"v":0.323954978224648,"d":"0.32"},{"v":0.812584739871546,"d":"0.81"},"down","no"]
["MSTRG.16222","CCDC91","ENSOART00000021411","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0048193(Golgi vesicle transport);GO:0090160(Golgi to lysosome transport)","NA","NA","NA","coiled-coil domain containing 91 [Source:NCBI gene;Acc:101109260]",{"v":1.189581,"d":"1.19"},{"v":1.319103,"d":"1.32"},{"v":1.374978,"d":"1.37"},{"v":1.295304,"d":"1.30"},{"v":1.263923,"d":"1.26"},{"v":0.492977,"d":"0.49"},{"v":1.2724123289269,"d":"1.27"},{"v":0.347566255923989,"d":"0.35"},{"v":0.324807647243682,"d":"0.32"},{"v":0.813289259959338,"d":"0.81"},"up","no"]
["MSTRG.11628","RANBP9","ENSOART00000014408","GO:0000151(ubiquitin ligase complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0019899(enzyme binding);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","NA","NA","NA","RAN binding protein 9 [Source:NCBI gene;Acc:101114566]",{"v":10.904932,"d":"10.90"},{"v":12.860123,"d":"12.86"},{"v":10.137701,"d":"10.14"},{"v":9.742001,"d":"9.74"},{"v":10.105534,"d":"10.11"},{"v":9.085725,"d":"9.09"},{"v":1.17175720952288,"d":"1.17"},{"v":0.228673671378414,"d":"0.23"},{"v":0.326638107482139,"d":"0.33"},{"v":0.814715259670151,"d":"0.81"},"up","no"]
["MSTRG.7786","TTC28","ENSOART00000002278","GO:0005515(protein binding);GO:0007346(regulation of mitotic cell cycle);GO:0019900(kinase binding);GO:0030496(midbody)","NA","NA","NA","tetratricopeptide repeat domain 28 [Source:NCBI gene;Acc:101119674]",{"v":2.16452889353667,"d":"2.16"},{"v":2.53291243631082,"d":"2.53"},{"v":3.33926974778504,"d":"3.34"},{"v":4.46996294662309,"d":"4.47"},{"v":4.29475737167756,"d":"4.29"},{"v":2.31114328329702,"d":"2.31"},{"v":0.725605818807054,"d":"0.73"},{"v":-0.462742069657061,"d":"-0.46"},{"v":0.326865854855706,"d":"0.33"},{"v":0.814715259670151,"d":"0.81"},"down","no"]
["MSTRG.15478","CHST10","ENSOART00000014483","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0008146(sulfotransferase activity);GO:0016021(integral component of membrane);GO:0016051(carbohydrate biosynthetic process);GO:0016740(transferase activity)","00515(Mannose type O-glycan biosynthesis)","K09674","EC:2.8.2.-","carbohydrate sulfotransferase 10 [Source:NCBI gene;Acc:101110832]",{"v":2.87570832072006,"d":"2.88"},{"v":2.70158100330639,"d":"2.70"},{"v":2.64214556171932,"d":"2.64"},{"v":3.87532185892726,"d":"3.88"},{"v":3.27562132072006,"d":"3.28"},{"v":3.72621933688464,"d":"3.73"},{"v":0.755659839894203,"d":"0.76"},{"v":-0.404191143160675,"d":"-0.40"},{"v":0.327756006322861,"d":"0.33"},{"v":0.815668354098411,"d":"0.82"},"down","no"]
["MSTRG.2997","ELAC2","ENSOART00000017150","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008033(tRNA processing);GO:0042645(mitochondrial nucleoid);GO:0072684(mitochondrial tRNA 3'-trailer cleavage, endonucleolytic)","03013(RNA transport)","K00784","EC:3.1.26.11","elaC ribonuclease Z 2 [Source:NCBI gene;Acc:101104921]",{"v":2.87616486432962,"d":"2.88"},{"v":3.33864583974505,"d":"3.34"},{"v":2.62759589824721,"d":"2.63"},{"v":2.52383040154792,"d":"2.52"},{"v":2.66387288162987,"d":"2.66"},{"v":2.39715782745277,"d":"2.40"},{"v":1.16579677245887,"d":"1.17"},{"v":0.221316312620808,"d":"0.22"},{"v":0.328957730038293,"d":"0.33"},{"v":0.816320111670702,"d":"0.82"},"up","no"]
["MSTRG.9200","VGLL4","ENSOART00000013987","GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA","vestigial like family member 4 [Source:HGNC Symbol;Acc:HGNC:28966]",{"v":1.93248338662093,"d":"1.93"},{"v":2.12815087958834,"d":"2.13"},{"v":1.56920629914237,"d":"1.57"},{"v":2.60777896946827,"d":"2.61"},{"v":1.35010301475129,"d":"1.35"},{"v":0.677573965008576,"d":"0.68"},{"v":1.21451711050972,"d":"1.21"},{"v":0.280382815271127,"d":"0.28"},{"v":0.329617965417447,"d":"0.33"},{"v":0.816320111670702,"d":"0.82"},"up","no"]
["MSTRG.6515","ENSOARG00000016510","ENSOART00000017977;ENSOART00000017978","GO:0005525(GTP binding);GO:0005525(GTP binding)","NA","NA","NA",null,{"v":1.70387292470334,"d":"1.70"},{"v":0.567641027400216,"d":"0.57"},{"v":0.366076301186624,"d":"0.37"},{"v":0.59017089600863,"d":"0.59"},{"v":0.827725191154261,"d":"0.83"},{"v":0.559760613160734,"d":"0.56"},{"v":1.33369469678866,"d":"1.33"},{"v":0.415428449251819,"d":"0.42"},{"v":0.330270642534466,"d":"0.33"},{"v":0.816320111670702,"d":"0.82"},"up","no"]
["MSTRG.20119","PCNX1","ENSOART00000023100","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","pecanex 1 [Source:NCBI gene;Acc:101103403]",{"v":9.33135346207542,"d":"9.33"},{"v":8.61597355512378,"d":"8.62"},{"v":8.28895750259067,"d":"8.29"},{"v":7.88094938737766,"d":"7.88"},{"v":8.39179896286701,"d":"8.39"},{"v":6.39361196229131,"d":"6.39"},{"v":1.15749878489664,"d":"1.16"},{"v":0.211010678993496,"d":"0.21"},{"v":0.330417664014678,"d":"0.33"},{"v":0.816320111670702,"d":"0.82"},"up","no"]
["MSTRG.21541","PHKA2;ADGRG2","ENSOART00000015505;ENSOART00000015501;ENSOART00000015694","GO:0003824(catalytic activity);GO:0005516(calmodulin binding);GO:0005886(plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0005977(glycogen metabolic process);GO:0016020(membrane);GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005829(cytosol);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016021(integral component of membrane)","04020(Calcium signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04922(Glucagon signaling pathway)","K07190;K08451","NA","phosphorylase kinase regulatory subunit alpha 2 [Source:NCBI gene;Acc:101108807];adhesion G protein-coupled receptor G2 [Source:NCBI gene;Acc:101109070]",{"v":0.33593804756179,"d":"0.34"},{"v":0.187433333066132,"d":"0.19"},{"v":0.390549614428858,"d":"0.39"},{"v":0.497072713961256,"d":"0.50"},{"v":0.374635083233133,"d":"0.37"},{"v":0.407500029659319,"d":"0.41"},{"v":0.714442935597592,"d":"0.71"},{"v":-0.485109310743448,"d":"-0.49"},{"v":0.331269219931802,"d":"0.33"},{"v":0.816953716699938,"d":"0.82"},"down","no"]
["MSTRG.11503","PPP1R10","ENSOART00000013923","GO:0000784(nuclear chromosome, telomeric region);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0016604(nuclear body);GO:0032206(positive regulation of telomere maintenance);GO:0046872(metal ion binding);GO:1904290(negative regulation of mitotic DNA damage checkpoint)","NA","K17552","NA","protein phosphatase 1 regulatory subunit 10 [Source:NCBI gene;Acc:101105696]",{"v":8.85061695833333,"d":"8.85"},{"v":4.15184812325349,"d":"4.15"},{"v":6.32515149376248,"d":"6.33"},{"v":5.35705417190619,"d":"5.36"},{"v":5.10588185903194,"d":"5.11"},{"v":5.52322515194611,"d":"5.52"},{"v":1.20902175039012,"d":"1.21"},{"v":0.273840199010283,"d":"0.27"},{"v":0.331919007390906,"d":"0.33"},{"v":0.817431908397996,"d":"0.82"},"up","no"]
["MSTRG.8711","GADL1","ENSOART00000016039","GO:0003824(catalytic activity);GO:0016829(lyase activity);GO:0016831(carboxy-lyase activity);GO:0019752(carboxylic acid metabolic process);GO:0030170(pyridoxal phosphate binding)","00410(beta-Alanine metabolism);00430(Taurine and hypotaurine metabolism);00770(Pantothenate and CoA biosynthesis)","K18966","4.1.1.11;EC:4.1.1.29","glutamate decarboxylase like 1 [Source:NCBI gene;Acc:101110627]",{"v":13.1379929653941,"d":"13.14"},{"v":6.61319282123636,"d":"6.61"},{"v":5.53504271545697,"d":"5.54"},{"v":18.5517470861627,"d":"18.55"},{"v":7.25030230355616,"d":"7.25"},{"v":9.64500436668176,"d":"9.65"},{"v":0.713352051086094,"d":"0.71"},{"v":-0.487313848503892,"d":"-0.49"},{"v":0.333346875269674,"d":"0.33"},{"v":0.818427035147648,"d":"0.82"},"down","no"]
["MSTRG.18610","PDE5A","ENSOART00000017446;ENSOART00000017445","GO:0004112(cyclic-nucleotide phosphodiesterase activity);GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0010749(regulation of nitric oxide mediated signal transduction);GO:0016787(hydrolase activity);GO:0030553(cGMP binding);GO:0042130(negative regulation of T cell proliferation);GO:0043406(positive regulation of MAP kinase activity);GO:0046068(cGMP metabolic process);GO:0046069(cGMP catabolic process);GO:0046872(metal ion binding);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity);GO:0055118(negative regulation of cardiac muscle contraction);GO:0055119(relaxation of cardiac muscle);GO:0060282(positive regulation of oocyte development);GO:0060282(positive regulation of oocyte development)","00230(Purine metabolism);04022(cGMP-PKG signaling pathway);04022(cGMP-PKG signaling pathway)","K13762","EC:3.1.4.35","phosphodiesterase 5A [Source:NCBI gene;Acc:101109357]",{"v":3.06827289102474,"d":"3.07"},{"v":1.94496980678445,"d":"1.94"},{"v":3.12695394063604,"d":"3.13"},{"v":4.00271909342756,"d":"4.00"},{"v":3.80729157328622,"d":"3.81"},{"v":2.96907498233216,"d":"2.97"},{"v":0.755184335989178,"d":"0.76"},{"v":-0.405099254214488,"d":"-0.41"},{"v":0.333903819637716,"d":"0.33"},{"v":0.818427035147648,"d":"0.82"},"down","no"]
["MSTRG.1423","ENSOARG00000020275","ENSOART00000022079","GO:0003729(mRNA binding);GO:0005623(cell);GO:0006406(mRNA export from nucleus)","NA","NA","NA","forty-two-three domain containing 1 [Source:NCBI gene;Acc:101119777]",{"v":23.943726,"d":"23.94"},{"v":22.073259,"d":"22.07"},{"v":17.953535,"d":"17.95"},{"v":20.915689,"d":"20.92"},{"v":16.911707,"d":"16.91"},{"v":17.089151,"d":"17.09"},{"v":1.16486784939337,"d":"1.16"},{"v":0.220166294931986,"d":"0.22"},{"v":0.33443117841397,"d":"0.33"},{"v":0.818427035147648,"d":"0.82"},"up","no"]
["ENSOARG00000018920","LMBR1L","ENSOART00000020600","GO:0004888(transmembrane signaling receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","limb development membrane protein 1 like [Source:NCBI gene;Acc:101102713]",{"v":0.688426,"d":"0.69"},{"v":0.591433,"d":"0.59"},{"v":0.681913,"d":"0.68"},{"v":0.979396,"d":"0.98"},{"v":0.874547,"d":"0.87"},{"v":0.80337,"d":"0.80"},{"v":0.738254018250767,"d":"0.74"},{"v":-0.437810791046348,"d":"-0.44"},{"v":0.334988061843981,"d":"0.33"},{"v":0.818815130806665,"d":"0.82"},"down","no"]
["MSTRG.9421","PTPN3","ENSOART00000007582","GO:0001784(phosphotyrosine residue binding);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006470(protein dephosphorylation);GO:0008092(cytoskeletal protein binding);GO:0009898(cytoplasmic side of plasma membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0017080(sodium channel regulator activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0045930(negative regulation of mitotic cell cycle);GO:0051045(negative regulation of membrane protein ectodomain proteolysis);GO:0051117(ATPase binding);GO:0098902(regulation of membrane depolarization during action potential);GO:2000649(regulation of sodium ion transmembrane transporter activity)","NA","K18027","EC:3.1.3.48","protein tyrosine phosphatase, non-receptor type 3 [Source:NCBI gene;Acc:101114749]",{"v":2.520133,"d":"2.52"},{"v":1.159134,"d":"1.16"},{"v":2.952803,"d":"2.95"},{"v":1.922606,"d":"1.92"},{"v":2.049083,"d":"2.05"},{"v":1.380683,"d":"1.38"},{"v":1.23908988388699,"d":"1.24"},{"v":0.309280844729991,"d":"0.31"},{"v":0.335862839490095,"d":"0.34"},{"v":0.81977744175109,"d":"0.82"},"up","no"]
["MSTRG.19522","NEDD8","ENSOART00000020870","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008104(protein localization);GO:0031625(ubiquitin protein ligase binding);GO:0045116(protein neddylation)","NA","K12158","NA","neural precursor cell expressed, developmentally down-regulated 8 [Source:NCBI gene;Acc:101115212]",{"v":32.1229424232633,"d":"32.12"},{"v":39.1708513990307,"d":"39.17"},{"v":27.3455597964459,"d":"27.35"},{"v":42.0308408287561,"d":"42.03"},{"v":35.4294016930533,"d":"35.43"},{"v":54.0258816607431,"d":"54.03"},{"v":0.750188312508103,"d":"0.75"},{"v":-0.414675308051597,"d":"-0.41"},{"v":0.336516020967593,"d":"0.34"},{"v":0.81977744175109,"d":"0.82"},"down","no"]
["MSTRG.8773","MYD88","ENSOART00000001104","GO:0002238(response to molecule of fungal origin);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0009615(response to virus);GO:0009682(induced systemic resistance);GO:0010468(regulation of gene expression);GO:0010628(positive regulation of gene expression);GO:0016064(immunoglobulin mediated immune response);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032494(response to peptidoglycan);GO:0032496(response to lipopolysaccharide);GO:0032675(regulation of interleukin-6 production);GO:0032680(regulation of tumor necrosis factor production);GO:0032740(positive regulation of interleukin-17 production);GO:0032747(positive regulation of interleukin-23 production);GO:0032755(positive regulation of interleukin-6 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0035325(Toll-like receptor binding);GO:0042127(regulation of cell population proliferation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0044130(negative regulation of growth of symbiont in host);GO:0045080(positive regulation of chemokine biosynthetic process);GO:0045351(type I interferon biosynthetic process);GO:0046330(positive regulation of JNK cascade);GO:0050671(positive regulation of lymphocyte proliferation);GO:0050727(regulation of inflammatory response);GO:0050830(defense response to Gram-positive bacterium);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070976(TIR domain binding);GO:0090557(establishment of endothelial intestinal barrier);GO:0140052(cellular response to oxidised low-density lipoprotein particle stimulus);GO:1900017(positive regulation of cytokine production involved in inflammatory response);GO:1902622(regulation of neutrophil migration);GO:2000338(regulation of chemokine (C-X-C motif) ligand 1 production);GO:2000341(regulation of chemokine (C-X-C motif) ligand 2 production)","04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);05132(Salmonella infection);05133(Pertussis);05134(Legionellosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis);05144(Malaria);05145(Toxoplasmosis);05152(Tuberculosis);05161(Hepatitis B);05162(Measles);05164(Influenza A);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection)","K04729","NA","MYD88, innate immune signal transduction adaptor [Source:NCBI gene;Acc:678682]",{"v":2.575913,"d":"2.58"},{"v":1.786601,"d":"1.79"},{"v":2.711951,"d":"2.71"},{"v":4.089511,"d":"4.09"},{"v":2.640954,"d":"2.64"},{"v":3.287911,"d":"3.29"},{"v":0.706148880816611,"d":"0.71"},{"v":-0.501955708881494,"d":"-0.50"},{"v":0.336767302587087,"d":"0.34"},{"v":0.81977744175109,"d":"0.82"},"down","no"]
["MSTRG.5791","GEMIN7","ENSOART00000012414","GO:0000387(spliceosomal snRNP assembly);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016604(nuclear body);GO:0032797(SMN complex);GO:0034719(SMN-Sm protein complex);GO:0097504(Gemini of coiled bodies)","NA","NA","NA","gem nuclear organelle associated protein 7 [Source:HGNC Symbol;Acc:HGNC:20045]",{"v":1.3832480956341,"d":"1.38"},{"v":1.37480517775468,"d":"1.37"},{"v":1.11606953222453,"d":"1.12"},{"v":1.60670302286902,"d":"1.61"},{"v":1.98179144906445,"d":"1.98"},{"v":1.67955709043659,"d":"1.68"},{"v":0.735399560871111,"d":"0.74"},{"v":-0.443399779821894,"d":"-0.44"},{"v":0.337669354308609,"d":"0.34"},{"v":0.820387385582455,"d":"0.82"},"down","no"]
["MSTRG.8947","PRICKLE2","ENSOART00000012259","GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","04310(Wnt signaling pathway)","K04511","NA","prickle planar cell polarity protein 2 [Source:NCBI gene;Acc:101106372]",{"v":1.430525,"d":"1.43"},{"v":0.624749,"d":"0.62"},{"v":1.232992,"d":"1.23"},{"v":1.422226,"d":"1.42"},{"v":1.690006,"d":"1.69"},{"v":1.410436,"d":"1.41"},{"v":0.727063317493126,"d":"0.73"},{"v":-0.459847085824155,"d":"-0.46"},{"v":0.339334419927286,"d":"0.34"},{"v":0.822613358348169,"d":"0.82"},"down","no"]
["MSTRG.21224","NUDCD1","ENSOART00000015705","GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA","NA","NA","NudC domain containing 1 [Source:NCBI gene;Acc:101118365]",{"v":1.88710636363636,"d":"1.89"},{"v":1.51917276306818,"d":"1.52"},{"v":1.45815279431818,"d":"1.46"},{"v":1.43933529659091,"d":"1.44"},{"v":1.59381265625,"d":"1.59"},{"v":1.04861749147727,"d":"1.05"},{"v":1.19174704852137,"d":"1.19"},{"v":0.253078052436033,"d":"0.25"},{"v":0.33976847634808,"d":"0.34"},{"v":0.822984673165918,"d":"0.82"},"up","no"]
["MSTRG.18936","OCIAD1","ENSOART00000019648","GO:0005768(endosome);GO:2000736(regulation of stem cell differentiation)","NA","NA","NA","OCIA domain containing 1 [Source:NCBI gene;Acc:101103237]",{"v":9.80068342222222,"d":"9.80"},{"v":10.6047145641975,"d":"10.60"},{"v":9.3837455037037,"d":"9.38"},{"v":9.71436141777778,"d":"9.71"},{"v":8.24265983432099,"d":"8.24"},{"v":7.90157440395062,"d":"7.90"},{"v":1.15200159692951,"d":"1.15"},{"v":0.204142716676658,"d":"0.20"},{"v":0.340508244703424,"d":"0.34"},{"v":0.823177648941597,"d":"0.82"},"up","no"]
["MSTRG.10695","USP37","ENSOART00000021347","GO:0000082(G1/S transition of mitotic cell cycle);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005634(nucleus);GO:0006275(regulation of DNA replication);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016579(protein deubiquitination);GO:0019901(protein kinase binding);GO:0035871(protein K11-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0071108(protein K48-linked deubiquitination)","NA","K11850","EC:3.4.19.12","ubiquitin specific peptidase 37 [Source:NCBI gene;Acc:101110822]",{"v":3.785153,"d":"3.79"},{"v":3.451802,"d":"3.45"},{"v":2.800517,"d":"2.80"},{"v":3.26814,"d":"3.27"},{"v":3.079103,"d":"3.08"},{"v":2.262795,"d":"2.26"},{"v":1.16578718932483,"d":"1.17"},{"v":0.221304453266674,"d":"0.22"},{"v":0.341007558621683,"d":"0.34"},{"v":0.823299041427597,"d":"0.82"},"up","no"]
["MSTRG.4497","PDSS1","ENSOART00000017644;ENSOART00000017645","GO:0000010(trans-hexaprenyltranstransferase activity);GO:0006744(ubiquinone biosynthetic process);GO:0008299(isoprenoid biosynthetic process);GO:0016740(transferase activity);GO:0046982(protein heterodimerization activity);GO:0050347(trans-octaprenyltranstransferase activity);GO:0051290(protein heterotetramerization);GO:1990234(transferase complex);GO:1990234(transferase complex)","00900(Terpenoid backbone biosynthesis);00900(Terpenoid backbone biosynthesis)","K12504","EC:2.5.1.91","decaprenyl diphosphate synthase subunit 1 [Source:NCBI gene;Acc:101121954]",{"v":2.06241846087426,"d":"2.06"},{"v":2.83583858985429,"d":"2.84"},{"v":2.18256693308149,"d":"2.18"},{"v":3.85996832271991,"d":"3.86"},{"v":2.57743975445224,"d":"2.58"},{"v":3.21084770966001,"d":"3.21"},{"v":0.733896793394914,"d":"0.73"},{"v":-0.446350901200783,"d":"-0.45"},{"v":0.341496245906426,"d":"0.34"},{"v":0.82370163621704,"d":"0.82"},"down","no"]
["MSTRG.12842","KIAA1328","ENSOART00000005760","NA","NA","NA","NA","KIAA1328 ortholog [Source:NCBI gene;Acc:101115087]",{"v":1.009919,"d":"1.01"},{"v":1.122822,"d":"1.12"},{"v":1.136118,"d":"1.14"},{"v":1.02704,"d":"1.03"},{"v":1.003089,"d":"1.00"},{"v":0.746256,"d":"0.75"},{"v":1.17737957812047,"d":"1.18"},{"v":0.235579509152088,"d":"0.24"},{"v":0.341768035625024,"d":"0.34"},{"v":0.82370163621704,"d":"0.82"},"up","no"]
["MSTRG.16373","PEX5","ENSOART00000004521","GO:0000038(very long-chain fatty acid metabolic process);GO:0001764(neuron migration);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006635(fatty acid beta-oxidation);GO:0007005(mitochondrion organization);GO:0007006(mitochondrial membrane organization);GO:0007029(endoplasmic reticulum organization);GO:0007031(peroxisome organization);GO:0016558(protein import into peroxisome matrix);GO:0021795(cerebral cortex cell migration);GO:0021895(cerebral cortex neuron differentiation);GO:0040018(positive regulation of multicellular organism growth);GO:0044255(cellular lipid metabolic process);GO:0048468(cell development);GO:0050905(neuromuscular process)","04146(Peroxisome)","K13342","NA","peroxisomal biogenesis factor 5 [Source:NCBI gene;Acc:101105736]",{"v":3.38278844263217,"d":"3.38"},{"v":3.26095667716535,"d":"3.26"},{"v":3.14377994713161,"d":"3.14"},{"v":4.09977035826772,"d":"4.10"},{"v":4.1896421723847,"d":"4.19"},{"v":4.46804111867267,"d":"4.47"},{"v":0.767200519474113,"d":"0.77"},{"v":-0.382324397677208,"d":"-0.38"},{"v":0.342726360338569,"d":"0.34"},{"v":0.824218478346952,"d":"0.82"},"down","no"]
["MSTRG.9636","LOXL2","ENSOART00000011021","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000785(chromatin);GO:0001666(response to hypoxia);GO:0001837(epithelial to mesenchymal transition);GO:0001935(endothelial cell proliferation);GO:0002040(sprouting angiogenesis);GO:0004720(protein-lysine 6-oxidase activity);GO:0005044(scavenger receptor activity);GO:0005507(copper ion binding);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0006464(cellular protein modification process);GO:0006898(receptor-mediated endocytosis);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0016020(membrane);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0018057(peptidyl-lysine oxidation);GO:0030199(collagen fibril organization);GO:0032332(positive regulation of chondrocyte differentiation);GO:0043542(endothelial cell migration);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046688(response to copper ion);GO:0055114(oxidation-reduction process);GO:0070492(oligosaccharide binding);GO:0070828(heterochromatin organization);GO:1902455(negative regulation of stem cell population maintenance)","NA","K00280","EC:1.4.3.-","lysyl oxidase like 2 [Source:NCBI gene;Acc:101120812]",{"v":1.931054,"d":"1.93"},{"v":1.31544,"d":"1.32"},{"v":4.570546,"d":"4.57"},{"v":3.797004,"d":"3.80"},{"v":3.411021,"d":"3.41"},{"v":3.774448,"d":"3.77"},{"v":0.711774114992133,"d":"0.71"},{"v":-0.490508627411285,"d":"-0.49"},{"v":0.343457126967236,"d":"0.34"},{"v":0.824822469351527,"d":"0.82"},"down","no"]
["MSTRG.5599","FXYD1","ENSOART00000005127","GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0010734(negative regulation of protein glutathionylation);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0017080(sodium channel regulator activity);GO:0030315(T-tubule);GO:0042383(sarcolemma);GO:0043269(regulation of ion transport);GO:0086036(regulation of cardiac muscle cell membrane potential);GO:0099106(ion channel regulator activity);GO:1903278(positive regulation of sodium ion export across plasma membrane);GO:2000649(regulation of sodium ion transmembrane transporter activity)","04024(cAMP signaling pathway)","K13360","NA","phospholemman [Source:NCBI gene;Acc:101115476]",{"v":42.7199561519274,"d":"42.72"},{"v":40.1437452403628,"d":"40.14"},{"v":34.290015909297,"d":"34.29"},{"v":42.6364008900227,"d":"42.64"},{"v":48.2121419637188,"d":"48.21"},{"v":61.9184790634921,"d":"61.92"},{"v":0.766878321193294,"d":"0.77"},{"v":-0.38293040808089,"d":"-0.38"},{"v":0.344205270646229,"d":"0.34"},{"v":0.825405627131822,"d":"0.83"},"down","no"]
["MSTRG.21506","MOSPD2","ENSOART00000012940;ENSOART00000012938","GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0090023(positive regulation of neutrophil chemotaxis);GO:0090026(positive regulation of monocyte chemotaxis);GO:0090026(positive regulation of monocyte chemotaxis)","NA","NA","NA","motile sperm domain containing 2 [Source:NCBI gene;Acc:101122573]",{"v":3.49162353227991,"d":"3.49"},{"v":3.38178203792325,"d":"3.38"},{"v":3.84258316613996,"d":"3.84"},{"v":3.49387095665914,"d":"3.49"},{"v":3.45623298826185,"d":"3.46"},{"v":2.1858819020316,"d":"2.19"},{"v":1.17294279083385,"d":"1.17"},{"v":0.230132649007463,"d":"0.23"},{"v":0.344954222264348,"d":"0.34"},{"v":0.825607651416221,"d":"0.83"},"up","no"]
["MSTRG.21751","APEX2","ENSOART00000006254","GO:0001650(fibrillar center);GO:0003677(DNA binding);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006974(cellular response to DNA damage stimulus);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0016829(lyase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:0140078(class I DNA-(apurinic or apyrimidinic site) endonuclease activity)","03410(Base excision repair)","K10772","EC:4.2.99.18","apurinic/apyrimidinic endodeoxyribonuclease 2 [Source:NCBI gene;Acc:101116123]",{"v":3.82973903308091,"d":"3.83"},{"v":4.10911207453169,"d":"4.11"},{"v":4.68654344240733,"d":"4.69"},{"v":6.52807258668792,"d":"6.53"},{"v":4.89886356436827,"d":"4.90"},{"v":5.20125655878836,"d":"5.20"},{"v":0.75927641508179,"d":"0.76"},{"v":-0.39730289953599,"d":"-0.40"},{"v":0.345871697252074,"d":"0.35"},{"v":0.825845613329456,"d":"0.83"},"down","no"]
["MSTRG.6399","C11orf58","ENSOART00000006217","NA","NA","NA","NA","chromosome 15 open reading frame, human C11orf58 [Source:NCBI gene;Acc:101115649]",{"v":4.830336,"d":"4.83"},{"v":4.911626,"d":"4.91"},{"v":4.29164,"d":"4.29"},{"v":4.681425,"d":"4.68"},{"v":3.746337,"d":"3.75"},{"v":3.752919,"d":"3.75"},{"v":1.15211965570726,"d":"1.15"},{"v":0.204290558560543,"d":"0.20"},{"v":0.346551609463553,"d":"0.35"},{"v":0.826054768429282,"d":"0.83"},"up","no"]
["MSTRG.1086","ITSN1","ENSOART00000014030","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0007264(small GTPase mediated signal transduction);GO:0019209(kinase activator activity);GO:0030027(lamellipodium);GO:0030139(endocytic vesicle);GO:0032947(protein-containing complex scaffold activity);GO:0033674(positive regulation of kinase activity);GO:0034613(cellular protein localization);GO:0035023(regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0043524(negative regulation of neuron apoptotic process);GO:0044305(calyx of Held);GO:0048488(synaptic vesicle endocytosis);GO:0051897(positive regulation of protein kinase B signaling);GO:0070064(proline-rich region binding);GO:0098833(presynaptic endocytic zone)","NA","K20045","NA","intersectin 1 [Source:NCBI gene;Acc:101120620]",{"v":2.09476221349114,"d":"2.09"},{"v":2.03008908569903,"d":"2.03"},{"v":2.49068326136869,"d":"2.49"},{"v":1.95997683990389,"d":"1.96"},{"v":2.06961563940554,"d":"2.07"},{"v":1.68247705561983,"d":"1.68"},{"v":1.1581677218922,"d":"1.16"},{"v":0.211844194622947,"d":"0.21"},{"v":0.347101791758681,"d":"0.35"},{"v":0.826617581976908,"d":"0.83"},"up","no"]
["MSTRG.19921","ENSOARG00000021037","ENSOART00000022919","GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00920(Sulfur metabolism)","K22470","EC:1.8.5.8","sulfide quinone oxidoreductase [Source:NCBI gene;Acc:101113498]",{"v":2.12120386869648,"d":"2.12"},{"v":1.43835456898192,"d":"1.44"},{"v":1.7061533549001,"d":"1.71"},{"v":2.37175624611481,"d":"2.37"},{"v":2.37107141071995,"d":"2.37"},{"v":2.21603729844592,"d":"2.22"},{"v":0.756691188349999,"d":"0.76"},{"v":-0.402223449807118,"d":"-0.40"},{"v":0.347614506135642,"d":"0.35"},{"v":0.826617581976908,"d":"0.83"},"down","no"]
["ENSOARG00000020249","CD2","ENSOART00000022045","GO:0005102(signaling receptor binding);GO:0007155(cell adhesion);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032760(positive regulation of tumor necrosis factor production);GO:0034113(heterotypic cell-cell adhesion);GO:1902715(positive regulation of interferon-gamma secretion);GO:2000484(positive regulation of interleukin-8 secretion)","04514(Cell adhesion molecules (CAMs));04640(Hematopoietic cell lineage)","K06449","NA","CD2 molecule [Source:NCBI gene;Acc:101106727]",{"v":0.316935,"d":"0.32"},{"v":0.140536,"d":"0.14"},{"v":0.306329,"d":"0.31"},{"v":0.501942,"d":"0.50"},{"v":0.235044,"d":"0.24"},{"v":0.392019,"d":"0.39"},{"v":0.676524904672698,"d":"0.68"},{"v":-0.56378505028429,"d":"-0.56"},{"v":0.348408426325194,"d":"0.35"},{"v":0.827223031123712,"d":"0.83"},"down","no"]
["MSTRG.20485","SIM1","ENSOART00000012770","GO:0001657(ureteric bud development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity)","NA","K09100","NA","SIM bHLH transcription factor 1 [Source:NCBI gene;Acc:101123562]",{"v":0.812208,"d":"0.81"},{"v":0.075736,"d":"0.08"},{"v":1.122343,"d":"1.12"},{"v":0.590241,"d":"0.59"},{"v":1.453829,"d":"1.45"},{"v":1.19744,"d":"1.20"},{"v":0.620169920808512,"d":"0.62"},{"v":-0.689264540160208,"d":"-0.69"},{"v":0.349308442701908,"d":"0.35"},{"v":0.828035460574441,"d":"0.83"},"down","no"]
["MSTRG.4685","ACSS1","ENSOART00000007204","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0003987(acetate-CoA ligase activity);GO:0005524(ATP binding);GO:0005759(mitochondrial matrix);GO:0006085(acetyl-CoA biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016208(AMP binding);GO:0016874(ligase activity);GO:0019427(acetyl-CoA biosynthetic process from acetate)","00010(Glycolysis / Gluconeogenesis);00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00640(Propanoate metabolism)","K01895","EC:6.2.1.1","acyl-CoA synthetase short chain family member 1 [Source:NCBI gene;Acc:780456]",{"v":7.486289,"d":"7.49"},{"v":8.273264,"d":"8.27"},{"v":5.453545,"d":"5.45"},{"v":9.877124,"d":"9.88"},{"v":8.790312,"d":"8.79"},{"v":9.30253,"d":"9.30"},{"v":0.758424161116249,"d":"0.76"},{"v":-0.398923169987468,"d":"-0.40"},{"v":0.35091466527976,"d":"0.35"},{"v":0.829311553277379,"d":"0.83"},"down","no"]
["ENSOARG00000019296","ZFHX2","ENSOART00000021012","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0030534(adult behavior);GO:0043565(sequence-specific DNA binding);GO:0046872(metal ion binding);GO:0051930(regulation of sensory perception of pain)","NA","K09379","NA","zinc finger homeobox 2 [Source:NCBI gene;Acc:101122193]",{"v":0.676671,"d":"0.68"},{"v":0.393666,"d":"0.39"},{"v":0.348335,"d":"0.35"},{"v":0.7629,"d":"0.76"},{"v":0.519734,"d":"0.52"},{"v":0.640367,"d":"0.64"},{"v":0.737738565918583,"d":"0.74"},{"v":-0.438818439135727,"d":"-0.44"},{"v":0.351429150636236,"d":"0.35"},{"v":0.829311553277379,"d":"0.83"},"down","no"]
["MSTRG.6487","TMEM41B","ENSOART00000013909","GO:0000045(autophagosome assembly);GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 41B [Source:NCBI gene;Acc:101105684]",{"v":3.584388,"d":"3.58"},{"v":3.139305,"d":"3.14"},{"v":1.699036,"d":"1.70"},{"v":2.726037,"d":"2.73"},{"v":1.946934,"d":"1.95"},{"v":2.133528,"d":"2.13"},{"v":1.23745393924248,"d":"1.24"},{"v":0.307374825908872,"d":"0.31"},{"v":0.352038004900827,"d":"0.35"},{"v":0.829330680983268,"d":"0.83"},"up","no"]
["MSTRG.11980","TAF6L","ENSOART00000018565","GO:0000124(SAGA complex);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0006352(DNA-templated transcription, initiation);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0030914(STAGA complex);GO:0043966(histone H3 acetylation);GO:0046695(SLIK (SAGA-like) complex);GO:0046982(protein heterodimerization activity);GO:1903508(positive regulation of nucleic acid-templated transcription)","03022(Basal transcription factors)","K03131","NA","TATA-box binding protein associated factor 6 like [Source:NCBI gene;Acc:101112524]",{"v":1.091793,"d":"1.09"},{"v":0.963884,"d":"0.96"},{"v":1.064569,"d":"1.06"},{"v":1.715691,"d":"1.72"},{"v":1.54021,"d":"1.54"},{"v":1.04849,"d":"1.05"},{"v":0.724898365413365,"d":"0.72"},{"v":-0.464149359059971,"d":"-0.46"},{"v":0.352408052741141,"d":"0.35"},{"v":0.82948229568363,"d":"0.83"},"down","no"]
["MSTRG.19343","SIMC1","ENSOART00000018038","NA","NA","NA","NA","SUMO interacting motifs containing 1 [Source:NCBI gene;Acc:101102985]",{"v":2.33960115159345,"d":"2.34"},{"v":1.99399970327304,"d":"1.99"},{"v":2.18516881589147,"d":"2.19"},{"v":1.82986500861326,"d":"1.83"},{"v":2.09481334431525,"d":"2.09"},{"v":1.67766576593454,"d":"1.68"},{"v":1.16357894703564,"d":"1.16"},{"v":0.218569098695877,"d":"0.22"},{"v":0.353875203176747,"d":"0.35"},{"v":0.83077991624298,"d":"0.83"},"up","no"]
["MSTRG.5945","ENSOARG00000014733","ENSOART00000016035;ENSOART00000016034","GO:0009055(electron transfer activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022900(electron transport chain);GO:0022900(electron transport chain)","NA","K03521","NA","V-set and immunoglobulin domain containing 10 like [Source:NCBI gene;Acc:101122129]",{"v":11.7056486563662,"d":"11.71"},{"v":11.1419393570815,"d":"11.14"},{"v":10.0905051945637,"d":"10.09"},{"v":13.6785096329041,"d":"13.68"},{"v":13.6353946082976,"d":"13.64"},{"v":15.4936118949928,"d":"15.49"},{"v":0.769446494003927,"d":"0.77"},{"v":-0.378107087396982,"d":"-0.38"},{"v":0.354178516210999,"d":"0.35"},{"v":0.830791319952708,"d":"0.83"},"down","no"]
["MSTRG.1678","ENSOARG00000002227","ENSOART00000002402","NA","NA","NA","NA","schwannomin interacting protein 1 [Source:NCBI gene;Acc:101107061]",{"v":21.8565364580686,"d":"21.86"},{"v":25.2800489453621,"d":"25.28"},{"v":21.9989325762389,"d":"22.00"},{"v":21.6490277986023,"d":"21.65"},{"v":17.922682341169,"d":"17.92"},{"v":20.3457964199492,"d":"20.35"},{"v":1.15384504378134,"d":"1.15"},{"v":0.206449489513094,"d":"0.21"},{"v":0.355393753484191,"d":"0.36"},{"v":0.83242398140828,"d":"0.83"},"up","no"]
["MSTRG.12992","APCDD1","ENSOART00000001442","GO:0001942(hair follicle development);GO:0005887(integral component of plasma membrane);GO:0017147(Wnt-protein binding);GO:0030178(negative regulation of Wnt signaling pathway);GO:0042802(identical protein binding)","NA","NA","NA","APC down-regulated 1 [Source:NCBI gene;Acc:101104951]",{"v":1.367799,"d":"1.37"},{"v":0.960427,"d":"0.96"},{"v":0.961153,"d":"0.96"},{"v":0.73807,"d":"0.74"},{"v":1.755533,"d":"1.76"},{"v":2.099973,"d":"2.10"},{"v":0.716082415965252,"d":"0.72"},{"v":-0.481802453959613,"d":"-0.48"},{"v":0.356274883906313,"d":"0.36"},{"v":0.832702018955379,"d":"0.83"},"down","no"]
["MSTRG.16839","TSPAN13","ENSOART00000009732","GO:0005246(calcium channel regulator activity);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:1903169(regulation of calcium ion transmembrane transport)","NA","K17356","NA","tetraspanin 13 [Source:NCBI gene;Acc:101105070]",{"v":8.75575018609155,"d":"8.76"},{"v":5.11026075580986,"d":"5.11"},{"v":4.19232015316901,"d":"4.19"},{"v":8.82551269559859,"d":"8.83"},{"v":8.3251030778169,"d":"8.33"},{"v":6.62232669929577,"d":"6.62"},{"v":0.759616993807116,"d":"0.76"},{"v":-0.396655913719319,"d":"-0.40"},{"v":0.357277588270277,"d":"0.36"},{"v":0.833375494468154,"d":"0.83"},"down","no"]
["MSTRG.203","ELOVL1","ENSOART00000022381","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006636(unsaturated fatty acid biosynthetic process);GO:0009922(fatty acid elongase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0019367(fatty acid elongation, saturated fatty acid);GO:0030148(sphingolipid biosynthetic process);GO:0034625(fatty acid elongation, monounsaturated fatty acid);GO:0035338(long-chain fatty-acyl-CoA biosynthetic process);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0102336(3-oxo-arachidoyl-CoA synthase activity);GO:0102337(3-oxo-cerotoyl-CoA synthase activity);GO:0102338(3-oxo-lignoceronyl-CoA synthase activity);GO:0102756(very-long-chain 3-ketoacyl-CoA synthase activity)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)","K10247","EC:2.3.1.199","ELOVL fatty acid elongase 1 [Source:NCBI gene;Acc:101110801]",{"v":3.30907461290323,"d":"3.31"},{"v":2.84307566129032,"d":"2.84"},{"v":2.95138012580645,"d":"2.95"},{"v":3.39243277419355,"d":"3.39"},{"v":3.75827218387097,"d":"3.76"},{"v":4.85149319354839,"d":"4.85"},{"v":0.758488593922825,"d":"0.76"},{"v":-0.398800609358632,"d":"-0.40"},{"v":0.358196226559576,"d":"0.36"},{"v":0.833591276938875,"d":"0.83"},"down","no"]
["MSTRG.1750","TM4SF1","ENSOART00000005317","GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane 4 L six family member 1 [Source:NCBI gene;Acc:101121479]",{"v":19.213442,"d":"19.21"},{"v":19.770933,"d":"19.77"},{"v":18.45653,"d":"18.46"},{"v":18.252934,"d":"18.25"},{"v":15.964834,"d":"15.96"},{"v":15.867818,"d":"15.87"},{"v":1.14685500535024,"d":"1.15"},{"v":0.197683005752248,"d":"0.20"},{"v":0.358534631765187,"d":"0.36"},{"v":0.833924995364954,"d":"0.83"},"up","no"]
["ENSOARG00000020335","ENSOARG00000020335","ENSOART00000022143","GO:0000151(ubiquitin ligase complex);GO:0003682(chromatin binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006302(double-strand break repair);GO:0006325(chromatin organization);GO:0006974(cellular response to DNA damage stimulus);GO:0010212(response to ionizing radiation);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0033522(histone H2A ubiquitination);GO:0042393(histone binding);GO:0043130(ubiquitin binding);GO:0045739(positive regulation of DNA repair);GO:0046872(metal ion binding)","NA","K20779","EC:2.3.2.31","ring finger protein 168 [Source:NCBI gene;Acc:101121991]",{"v":1.115923,"d":"1.12"},{"v":1.116619,"d":"1.12"},{"v":1.190558,"d":"1.19"},{"v":1.135229,"d":"1.14"},{"v":0.928305,"d":"0.93"},{"v":0.883664,"d":"0.88"},{"v":1.16147608677802,"d":"1.16"},{"v":0.21595945131253,"d":"0.22"},{"v":0.360064454440914,"d":"0.36"},{"v":0.835493991128758,"d":"0.84"},"up","no"]
["MSTRG.2652","AATF","ENSOART00000000182","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0007155(cell adhesion);GO:0007346(regulation of mitotic cell cycle);GO:0032929(negative regulation of superoxide anion generation);GO:0040016(embryonic cleavage);GO:0042254(ribosome biogenesis);GO:0042985(negative regulation of amyloid precursor protein biosynthetic process);GO:0043066(negative regulation of apoptotic process);GO:0043522(leucine zipper domain binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:2000378(negative regulation of reactive oxygen species metabolic process)","NA","K14782","NA","apoptosis antagonizing transcription factor [Source:NCBI gene;Acc:101109984]",{"v":1.966552,"d":"1.97"},{"v":1.759654,"d":"1.76"},{"v":2.222108,"d":"2.22"},{"v":2.239151,"d":"2.24"},{"v":2.476673,"d":"2.48"},{"v":3.22452,"d":"3.22"},{"v":0.749125478694626,"d":"0.75"},{"v":-0.416720704202597,"d":"-0.42"},{"v":0.360366694136115,"d":"0.36"},{"v":0.835876618828211,"d":"0.84"},"down","no"]
["ENSOARG00000013201","DPAGT1","ENSOART00000014355","GO:0003975(UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity);GO:0003976(UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity);GO:0006487(protein N-linked glycosylation);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0008963(phospho-N-acetylmuramoyl-pentapeptide-transferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle)","00510(N-Glycan biosynthesis)","K01001","EC:2.7.8.15","dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 [Source:NCBI gene;Acc:101107219]",{"v":1.090126,"d":"1.09"},{"v":0.981921,"d":"0.98"},{"v":0.770517,"d":"0.77"},{"v":1.696887,"d":"1.70"},{"v":1.071594,"d":"1.07"},{"v":1.233777,"d":"1.23"},{"v":0.710240069480778,"d":"0.71"},{"v":-0.493621339976934,"d":"-0.49"},{"v":0.361211474338378,"d":"0.36"},{"v":0.835876618828211,"d":"0.84"},"down","no"]
["MSTRG.16919","KMT2E","ENSOART00000002492","GO:0000785(chromatin);GO:0002446(neutrophil mediated immunity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006306(DNA methylation);GO:0019899(enzyme binding);GO:0030218(erythrocyte differentiation);GO:0032991(protein-containing complex);GO:0035064(methylated histone binding);GO:0035327(transcriptionally active chromatin);GO:0042119(neutrophil activation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905437(positive regulation of histone H3-K4 trimethylation)","00310(Lysine degradation)","K09189","EC:2.1.1.43","lysine methyltransferase 2E [Source:NCBI gene;Acc:101121766]",{"v":4.63403446463932,"d":"4.63"},{"v":4.41864563295615,"d":"4.42"},{"v":4.58323853665724,"d":"4.58"},{"v":4.24553378052805,"d":"4.25"},{"v":4.14115680905233,"d":"4.14"},{"v":3.53277037682697,"d":"3.53"},{"v":1.14400463852207,"d":"1.14"},{"v":0.194092901731,"d":"0.19"},{"v":0.361690690717074,"d":"0.36"},{"v":0.835876618828211,"d":"0.84"},"up","no"]
["MSTRG.20891","ADCK5","ENSOART00000014950","NA","NA","K08869","NA","aarF domain containing kinase 5 [Source:NCBI gene;Acc:101112143]",{"v":1.44392375671459,"d":"1.44"},{"v":0.973867647609495,"d":"0.97"},{"v":1.0774303624206,"d":"1.08"},{"v":1.62975766020283,"d":"1.63"},{"v":1.72120911244846,"d":"1.72"},{"v":1.19272108035217,"d":"1.19"},{"v":0.769247774015612,"d":"0.77"},{"v":-0.378479731071844,"d":"-0.38"},{"v":0.362447502547409,"d":"0.36"},{"v":0.835876618828211,"d":"0.84"},"down","no"]
["MSTRG.19460","FEM1B","ENSOART00000020063","GO:0002070(epithelial cell maturation);GO:0004842(ubiquitin-protein transferase activity);GO:0005123(death receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016567(protein ubiquitination);GO:0051438(regulation of ubiquitin-protein transferase activity);GO:0060442(branching involved in prostate gland morphogenesis);GO:0060743(epithelial cell maturation involved in prostate gland development);GO:1902041(regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2000001(regulation of DNA damage checkpoint)","NA","NA","NA","fem-1 homolog B [Source:HGNC Symbol;Acc:HGNC:3649]",{"v":4.88880960381729,"d":"4.89"},{"v":2.81696078467525,"d":"2.82"},{"v":4.61666750199203,"d":"4.62"},{"v":2.92498657324192,"d":"2.92"},{"v":3.95805856397665,"d":"3.96"},{"v":3.48405187964421,"d":"3.48"},{"v":1.18861026094781,"d":"1.19"},{"v":0.249275740507288,"d":"0.25"},{"v":0.363062435853455,"d":"0.36"},{"v":0.835876618828211,"d":"0.84"},"up","no"]
["MSTRG.15017","YPEL5","ENSOART00000021382","GO:0000151(ubiquitin ligase complex);GO:0046872(metal ion binding)","NA","NA","NA","yippee like 5 [Source:NCBI gene;Acc:101103386]",{"v":4.73783520812414,"d":"4.74"},{"v":5.64272502875399,"d":"5.64"},{"v":5.49509236376084,"d":"5.50"},{"v":4.59938800228206,"d":"4.60"},{"v":4.71136580191693,"d":"4.71"},{"v":4.49104024874487,"d":"4.49"},{"v":1.1502600705198,"d":"1.15"},{"v":0.201960087282606,"d":"0.20"},{"v":0.364665417366044,"d":"0.36"},{"v":0.837734178818963,"d":"0.84"},"up","no"]
["MSTRG.21756","MAGED2","ENSOART00000006630","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0007565(female pregnancy);GO:0070294(renal sodium ion absorption)","NA","NA","NA","melanoma-associated antigen D2 [Source:NCBI gene;Acc:101116800]",{"v":9.38737784091976,"d":"9.39"},{"v":6.80174668418583,"d":"6.80"},{"v":8.56235037494134,"d":"8.56"},{"v":10.843369964336,"d":"10.84"},{"v":9.38564211309244,"d":"9.39"},{"v":11.7975844997654,"d":"11.80"},{"v":0.772841249003413,"d":"0.77"},{"v":-0.371755997421071,"d":"-0.37"},{"v":0.365161000547596,"d":"0.37"},{"v":0.837997022760528,"d":"0.84"},"down","no"]
["MSTRG.6990","MIER3","ENSOART00000007959","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0032991(protein-containing complex)","NA","NA","NA","MIER family member 3 [Source:NCBI gene;Acc:101111746]",{"v":3.623855,"d":"3.62"},{"v":3.688282,"d":"3.69"},{"v":3.323501,"d":"3.32"},{"v":3.817225,"d":"3.82"},{"v":2.595591,"d":"2.60"},{"v":2.730756,"d":"2.73"},{"v":1.16318195996051,"d":"1.16"},{"v":0.218076799475597,"d":"0.22"},{"v":0.366636954012573,"d":"0.37"},{"v":0.839836340387482,"d":"0.84"},"up","no"]
["MSTRG.1358","NDUFB4","ENSOART00000021671","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I);GO:0006979(response to oxidative stress);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031965(nuclear membrane);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0055114(oxidation-reduction process)","00190(Oxidative phosphorylation);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K03960","NA","NADH:ubiquinone oxidoreductase subunit B4 [Source:NCBI gene;Acc:101108353]",{"v":48.120602,"d":"48.12"},{"v":52.170631,"d":"52.17"},{"v":40.955555,"d":"40.96"},{"v":59.256672,"d":"59.26"},{"v":56.909943,"d":"56.91"},{"v":66.987488,"d":"66.99"},{"v":0.771190957158082,"d":"0.77"},{"v":-0.374839959994381,"d":"-0.37"},{"v":0.368164651680751,"d":"0.37"},{"v":0.841813812161225,"d":"0.84"},"down","no"]
["MSTRG.16042","NTN4","ENSOART00000012886","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0016322(neuron remodeling);GO:0043237(laminin-1 binding);GO:0060668(regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling)","NA","NA","NA","netrin 4 [Source:HGNC Symbol;Acc:HGNC:13658]",{"v":3.11781626882591,"d":"3.12"},{"v":2.49454178461538,"d":"2.49"},{"v":3.66702278299595,"d":"3.67"},{"v":3.05918449473684,"d":"3.06"},{"v":2.48362191417004,"d":"2.48"},{"v":2.49691933765182,"d":"2.50"},{"v":1.15419121608833,"d":"1.15"},{"v":0.206882256608665,"d":"0.21"},{"v":0.368439069391142,"d":"0.37"},{"v":0.842087503502038,"d":"0.84"},"up","no"]
["MSTRG.10436","NCKAP5","ENSOART00000012546;ENSOART00000012543","NA","NA","NA","NA","NCK associated protein 5 [Source:NCBI gene;Acc:101116712]",{"v":0.433750915017668,"d":"0.43"},{"v":0.177940797879859,"d":"0.18"},{"v":0.327449531448763,"d":"0.33"},{"v":0.584020175618375,"d":"0.58"},{"v":0.409624691872792,"d":"0.41"},{"v":0.318005980918728,"d":"0.32"},{"v":0.715999418202492,"d":"0.72"},{"v":-0.481969679683753,"d":"-0.48"},{"v":0.369768545610708,"d":"0.37"},{"v":0.842531511684571,"d":"0.84"},"down","no"]
["MSTRG.22357","GLA","ENSOART00000001773","GO:0003824(catalytic activity);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004557(alpha-galactosidase activity);GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0008152(metabolic process);GO:0009311(oligosaccharide metabolic process);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0042803(protein homodimerization activity)","00052(Galactose metabolism);00561(Glycerolipid metabolism);00600(Sphingolipid metabolism);00603(Glycosphingolipid biosynthesis - globo and isoglobo series);04142(Lysosome)","K01189","EC:3.2.1.22","galactosidase alpha [Source:NCBI gene;Acc:101106236]",{"v":3.243752,"d":"3.24"},{"v":2.353245,"d":"2.35"},{"v":2.813249,"d":"2.81"},{"v":2.386892,"d":"2.39"},{"v":1.984487,"d":"1.98"},{"v":2.617439,"d":"2.62"},{"v":1.20338603752451,"d":"1.20"},{"v":0.267099522881733,"d":"0.27"},{"v":0.370523294110621,"d":"0.37"},{"v":0.842878769830891,"d":"0.84"},"up","no"]
["ENSOARG00000008409","CCDC82","ENSOART00000009149","NA","NA","NA","NA","coiled-coil domain containing 82 [Source:NCBI gene;Acc:101123145]",{"v":0.79264,"d":"0.79"},{"v":0.716942,"d":"0.72"},{"v":0.601074,"d":"0.60"},{"v":0.488077,"d":"0.49"},{"v":0.674837,"d":"0.67"},{"v":0.535474,"d":"0.54"},{"v":1.24274076359466,"d":"1.24"},{"v":0.313525380797556,"d":"0.31"},{"v":0.371355399476475,"d":"0.37"},{"v":0.842878769830891,"d":"0.84"},"up","no"]
["MSTRG.4042","RER1","ENSOART00000020277","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0007528(neuromuscular junction development);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030173(integral component of Golgi membrane);GO:0033130(acetylcholine receptor binding);GO:0071340(skeletal muscle acetylcholine-gated channel clustering);GO:1903078(positive regulation of protein localization to plasma membrane)","NA","NA","NA","retention in endoplasmic reticulum sorting receptor 1 [Source:NCBI gene;Acc:101103910]",{"v":17.188984,"d":"17.19"},{"v":16.493147,"d":"16.49"},{"v":19.540695,"d":"19.54"},{"v":23.671547,"d":"23.67"},{"v":21.524477,"d":"21.52"},{"v":23.294838,"d":"23.29"},{"v":0.777079225546906,"d":"0.78"},{"v":-0.363866401689502,"d":"-0.36"},{"v":0.372364494792967,"d":"0.37"},{"v":0.84373681251451,"d":"0.84"},"down","no"]
["MSTRG.6441","ENSOARG00000017111","ENSOART00000018624","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02921","NA","putative 60S ribosomal protein L37a [Source:NCBI gene;Acc:101121371]",{"v":459.113342,"d":"459.11"},{"v":398.178864,"d":"398.18"},{"v":503.919861,"d":"503.92"},{"v":480.883667,"d":"480.88"},{"v":606.282898,"d":"606.28"},{"v":659.859131,"d":"659.86"},{"v":0.779159728512659,"d":"0.78"},{"v":-0.360008982375357,"d":"-0.36"},{"v":0.373612984241263,"d":"0.37"},{"v":0.844398665251033,"d":"0.84"},"down","no"]
["MSTRG.18571","NUDT12","ENSOART00000020361","GO:0000210(NAD+ diphosphatase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0006742(NADP catabolic process);GO:0016787(hydrolase activity);GO:0019677(NAD catabolic process);GO:0035529(NADH pyrophosphatase activity);GO:0046872(metal ion binding)","00760(Nicotinate and nicotinamide metabolism);04146(Peroxisome)","K03426","EC:3.6.1.22","nudix hydrolase 12 [Source:NCBI gene;Acc:101115365]",{"v":2.070208,"d":"2.07"},{"v":2.372375,"d":"2.37"},{"v":1.971164,"d":"1.97"},{"v":2.366265,"d":"2.37"},{"v":1.229823,"d":"1.23"},{"v":1.778586,"d":"1.78"},{"v":1.19332763252246,"d":"1.19"},{"v":0.254990194686342,"d":"0.25"},{"v":0.374600689601559,"d":"0.37"},{"v":0.845138579375469,"d":"0.85"},"up","no"]
["MSTRG.13646","NSUN5","ENSOART00000014059","GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0032259(methylation)","NA","K15264","EC:2.1.1.311","NOP2/Sun RNA methyltransferase family member 5 [Source:NCBI gene;Acc:101114486]",{"v":1.62427127666875,"d":"1.62"},{"v":2.09573712726138,"d":"2.10"},{"v":1.05949345414847,"d":"1.06"},{"v":2.90560732907049,"d":"2.91"},{"v":1.11431269463506,"d":"1.11"},{"v":2.67401873112913,"d":"2.67"},{"v":0.714004419987652,"d":"0.71"},{"v":-0.48599508971628,"d":"-0.49"},{"v":0.375758831230879,"d":"0.38"},{"v":0.845749364216759,"d":"0.85"},"down","no"]
["MSTRG.11039","EMC1","ENSOART00000010909","GO:0005783(endoplasmic reticulum);GO:0016021(integral component of membrane);GO:0032991(protein-containing complex);GO:0072546(ER membrane protein complex)","NA","NA","NA","ER membrane protein complex subunit 1 [Source:NCBI gene;Acc:101109679]",{"v":6.10567691272142,"d":"6.11"},{"v":5.43663245555556,"d":"5.44"},{"v":5.79475704138486,"d":"5.79"},{"v":7.79857211272142,"d":"7.80"},{"v":7.79714921658615,"d":"7.80"},{"v":6.7379167821256,"d":"6.74"},{"v":0.77627596198877,"d":"0.78"},{"v":-0.365358480853938,"d":"-0.37"},{"v":0.37613618164893,"d":"0.38"},{"v":0.845749364216759,"d":"0.85"},"down","no"]
["MSTRG.3530","C1QTNF1","ENSOART00000003461","GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005615(extracellular space);GO:0005887(integral component of plasma membrane);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0010544(negative regulation of platelet activation);GO:0010628(positive regulation of gene expression);GO:0010906(regulation of glucose metabolic process);GO:0043410(positive regulation of MAPK cascade);GO:0051260(protein homooligomerization);GO:0051897(positive regulation of protein kinase B signaling);GO:0070208(protein heterotrimerization);GO:0090331(negative regulation of platelet aggregation);GO:2000860(positive regulation of aldosterone secretion)","NA","NA","NA","C1q and TNF related 1 [Source:NCBI gene;Acc:101122202]",{"v":2.45282561322983,"d":"2.45"},{"v":2.36010754708066,"d":"2.36"},{"v":6.90795126560918,"d":"6.91"},{"v":3.07981261761728,"d":"3.08"},{"v":2.70334887073912,"d":"2.70"},{"v":3.6960306317921,"d":"3.70"},{"v":1.23648558625648,"d":"1.24"},{"v":0.306245422293567,"d":"0.31"},{"v":0.376347560978342,"d":"0.38"},{"v":0.845953052815855,"d":"0.85"},"up","no"]
["MSTRG.17161","ENSOARG00000017342","ENSOART00000018882","GO:0000502(proteasome complex);GO:0000932(P-body);GO:0004175(endopeptidase activity);GO:0004298(threonine-type endopeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005839(proteasome core complex);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0016787(hydrolase activity);GO:0019773(proteasome core complex, alpha-subunit complex);GO:0051603(proteolysis involved in cellular protein catabolic process)","03050(Proteasome)","K02726","EC:3.4.25.1","proteasome subunit alpha 2 [Source:NCBI gene;Acc:101119978]",{"v":6.73974797305134,"d":"6.74"},{"v":8.48270653487975,"d":"8.48"},{"v":6.50886043100802,"d":"6.51"},{"v":6.74640319750981,"d":"6.75"},{"v":5.98367666655296,"d":"5.98"},{"v":6.26996802592529,"d":"6.27"},{"v":1.1437505349863,"d":"1.14"},{"v":0.193772418213639,"d":"0.19"},{"v":0.377868552386259,"d":"0.38"},{"v":0.847039775310658,"d":"0.85"},"up","no"]
["MSTRG.17544","BORCS8","ENSOART00000010161","GO:0007507(heart development);GO:0099078(BORC complex)","NA","K20822","NA","BLOC-1 related complex subunit 8 [Source:NCBI gene;Acc:101106256]",{"v":2.28313722302158,"d":"2.28"},{"v":2.50817774152107,"d":"2.51"},{"v":1.89655180421377,"d":"1.90"},{"v":1.99859857553957,"d":"2.00"},{"v":2.93332404881809,"d":"2.93"},{"v":3.96212530883864,"d":"3.96"},{"v":0.751948586176887,"d":"0.75"},{"v":-0.411294072616614,"d":"-0.41"},{"v":0.37839982018991,"d":"0.38"},{"v":0.847183911156019,"d":"0.85"},"down","no"]
["MSTRG.8722","ENSOARG00000014924","ENSOART00000016243","NA","NA","NA","NA",null,{"v":1.171301,"d":"1.17"},{"v":1.282213,"d":"1.28"},{"v":0.940756,"d":"0.94"},{"v":1.974853,"d":"1.97"},{"v":1.70161,"d":"1.70"},{"v":1.100653,"d":"1.10"},{"v":0.7105270209055,"d":"0.71"},{"v":-0.49303857957116,"d":"-0.49"},{"v":0.379478721242069,"d":"0.38"},{"v":0.84740507787001,"d":"0.85"},"down","no"]
["MSTRG.13987","REEP3","ENSOART00000005120;ENSOART00000005122","GO:0006998(nuclear envelope organization);GO:0007084(mitotic nuclear envelope reassembly);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","K17338","NA","receptor accessory protein 3 [Source:NCBI gene;Acc:101122325]",{"v":4.47650695413609,"d":"4.48"},{"v":3.94258184589726,"d":"3.94"},{"v":4.25648170847231,"d":"4.26"},{"v":3.46849302318212,"d":"3.47"},{"v":4.15671767878586,"d":"4.16"},{"v":3.40313288709139,"d":"3.40"},{"v":1.14936303953029,"d":"1.15"},{"v":0.200834561782298,"d":"0.20"},{"v":0.379980839595561,"d":"0.38"},{"v":0.84740507787001,"d":"0.85"},"up","no"]
["MSTRG.3455","ENSOARG00000016357","ENSOART00000017811","GO:0005515(protein binding)","NA","K22991","NA","WD repeat domain 45B [Source:NCBI gene;Acc:101109194]",{"v":4.920186,"d":"4.92"},{"v":4.481102,"d":"4.48"},{"v":5.449843,"d":"5.45"},{"v":6.745315,"d":"6.75"},{"v":6.3456,"d":"6.35"},{"v":6.345215,"d":"6.35"},{"v":0.764099180238041,"d":"0.76"},{"v":-0.388168182345156,"d":"-0.39"},{"v":0.380722582528432,"d":"0.38"},{"v":0.847456678727132,"d":"0.85"},"down","no"]
["MSTRG.4563","PHYH","ENSOART00000006084","GO:0001561(fatty acid alpha-oxidation);GO:0003824(catalytic activity);GO:0005777(peroxisome);GO:0006103(2-oxoglutarate metabolic process);GO:0006720(isoprenoid metabolic process);GO:0008198(ferrous iron binding);GO:0031406(carboxylic acid binding);GO:0048037(cofactor binding);GO:0048244(phytanoyl-CoA dioxygenase activity);GO:0097089(methyl-branched fatty acid metabolic process)","04146(Peroxisome)","K00477","EC:1.14.11.18","phytanoyl-CoA 2-hydroxylase [Source:NCBI gene;Acc:101107212]",{"v":56.586418,"d":"56.59"},{"v":78.407845,"d":"78.41"},{"v":41.781834,"d":"41.78"},{"v":57.908825,"d":"57.91"},{"v":42.493824,"d":"42.49"},{"v":51.951813,"d":"51.95"},{"v":1.16029484584442,"d":"1.16"},{"v":0.214491459306871,"d":"0.21"},{"v":0.381251412244015,"d":"0.38"},{"v":0.847456678727132,"d":"0.85"},"up","no"]
["ENSOARG00000015988","FGD6","ENSOART00000017415","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0035023(regulation of Rho protein signal transduction);GO:0043087(regulation of GTPase activity);GO:0046872(metal ion binding)","NA","K05724","NA","FYVE, RhoGEF and PH domain containing 6 [Source:NCBI gene;Acc:101116817]",{"v":1.464656,"d":"1.46"},{"v":0.807996,"d":"0.81"},{"v":0.504867,"d":"0.50"},{"v":1.648489,"d":"1.65"},{"v":1.283646,"d":"1.28"},{"v":0.882481,"d":"0.88"},{"v":0.728125452208033,"d":"0.73"},{"v":-0.457741054235713,"d":"-0.46"},{"v":0.381634204620421,"d":"0.38"},{"v":0.847716526172301,"d":"0.85"},"down","no"]
["MSTRG.368","PATJ","ENSOART00000009808","GO:0005515(protein binding);GO:0045177(apical part of cell)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection)","K06092","NA","PATJ, crumbs cell polarity complex component [Source:NCBI gene;Acc:101106044]",{"v":3.83036686095413,"d":"3.83"},{"v":2.57546763635169,"d":"2.58"},{"v":2.32560696083585,"d":"2.33"},{"v":2.75484865199106,"d":"2.75"},{"v":2.71576513773163,"d":"2.72"},{"v":2.08075087199369,"d":"2.08"},{"v":1.15627331605478,"d":"1.16"},{"v":0.209482457622418,"d":"0.21"},{"v":0.382452949000422,"d":"0.38"},{"v":0.847978860571947,"d":"0.85"},"up","no"]
["MSTRG.6571","ATG16L2","ENSOART00000007061","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0039689(negative stranded viral RNA replication)","04140(Autophagy - animal)","K20868","NA","autophagy related 16 like 2 [Source:NCBI gene;Acc:101103839]",{"v":0.79418609492635,"d":"0.79"},{"v":0.894703299509002,"d":"0.89"},{"v":0.714921021276596,"d":"0.71"},{"v":1.24652180687398,"d":"1.25"},{"v":1.02034224549918,"d":"1.02"},{"v":1.00407271358429,"d":"1.00"},{"v":0.734899690122355,"d":"0.73"},{"v":-0.444380751658224,"d":"-0.44"},{"v":0.383510817767146,"d":"0.38"},{"v":0.848762477772367,"d":"0.85"},"down","no"]
["MSTRG.5003","NDRG3","ENSOART00000017450","GO:0005737(cytoplasm)","NA","NA","NA","NDRG family member 3 [Source:NCBI gene;Acc:101122617]",{"v":2.10940051525424,"d":"2.11"},{"v":1.69808747570621,"d":"1.70"},{"v":1.5256827299435,"d":"1.53"},{"v":2.07671723389831,"d":"2.08"},{"v":2.0399720180791,"d":"2.04"},{"v":2.83713341920904,"d":"2.84"},{"v":0.766940857293103,"d":"0.77"},{"v":-0.38281276641571,"d":"-0.38"},{"v":0.384283307690329,"d":"0.38"},{"v":0.848762477772367,"d":"0.85"},"down","no"]
["MSTRG.19292","SRP19","ENSOART00000017496","GO:0005730(nucleolus);GO:0005786(signal recognition particle, endoplasmic reticulum targeting);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0008312(7S RNA binding);GO:0042493(response to drug);GO:0043022(ribosome binding);GO:0048500(signal recognition particle)","03060(Protein export)","K03105","NA","signal recognition particle 19 [Source:NCBI gene;Acc:101104068]",{"v":6.672333,"d":"6.67"},{"v":7.260387,"d":"7.26"},{"v":5.438903,"d":"5.44"},{"v":6.247117,"d":"6.25"},{"v":5.515411,"d":"5.52"},{"v":4.646211,"d":"4.65"},{"v":1.18056744031336,"d":"1.18"},{"v":0.239480458361608,"d":"0.24"},{"v":0.385264281802927,"d":"0.39"},{"v":0.849435448102943,"d":"0.85"},"up","no"]
["MSTRG.10217","LNPK","ENSOART00000000163","GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0007029(endoplasmic reticulum organization);GO:0007596(blood coagulation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0032330(regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0042733(embryonic digit morphogenesis);GO:0042802(identical protein binding);GO:0071786(endoplasmic reticulum tubular network organization);GO:0071788(endoplasmic reticulum tubular network maintenance);GO:0098826(endoplasmic reticulum tubular network membrane);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization)","NA","K23292","NA","lunapark, ER junction formation factor [Source:NCBI gene;Acc:101107574]",{"v":3.75326699879774,"d":"3.75"},{"v":4.93214971645242,"d":"4.93"},{"v":3.80351619245353,"d":"3.80"},{"v":3.84399260011098,"d":"3.84"},{"v":3.53103364875613,"d":"3.53"},{"v":3.56202696596689,"d":"3.56"},{"v":1.14189193948191,"d":"1.14"},{"v":0.191426130779667,"d":"0.19"},{"v":0.386432702976067,"d":"0.39"},{"v":0.850001687286452,"d":"0.85"},"up","no"]
["MSTRG.19445","ZWILCH","ENSOART00000019831","GO:0000776(kinetochore);GO:0007093(mitotic cell cycle checkpoint);GO:1990423(RZZ complex)","NA","K11579","NA","zwilch kinetochore protein [Source:NCBI gene;Acc:101102815]",{"v":0.676975,"d":"0.68"},{"v":0.809132,"d":"0.81"},{"v":0.563149,"d":"0.56"},{"v":0.759258,"d":"0.76"},{"v":0.493449,"d":"0.49"},{"v":0.413511,"d":"0.41"},{"v":1.22988468495719,"d":"1.23"},{"v":0.298523053581269,"d":"0.30"},{"v":0.386841141749902,"d":"0.39"},{"v":0.850001687286452,"d":"0.85"},"up","no"]
["MSTRG.19354","POLK","ENSOART00000018273","GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0034644(cellular response to UV);GO:0042276(error-prone translesion synthesis);GO:0090734(site of DNA damage)","03460(Fanconi anemia pathway);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05213(Endometrial cancer);05214(Glioma);05216(Thyroid cancer);05217(Basal cell carcinoma);05218(Melanoma);05220(Chronic myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K03511","EC:2.7.7.7","DNA polymerase kappa [Source:NCBI gene;Acc:101109360]",{"v":1.078541,"d":"1.08"},{"v":0.806211,"d":"0.81"},{"v":0.548473,"d":"0.55"},{"v":0.697299,"d":"0.70"},{"v":0.76409,"d":"0.76"},{"v":0.552383,"d":"0.55"},{"v":1.20829219991141,"d":"1.21"},{"v":0.272969382135596,"d":"0.27"},{"v":0.387591496708295,"d":"0.39"},{"v":0.850001687286452,"d":"0.85"},"up","no"]
["MSTRG.20709","ENSOARG00000002677","ENSOART00000002898","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","03040(Spliceosome)","K12741","NA","heterogeneous nuclear ribonucleoprotein A1-like [Source:NCBI gene;Acc:101104501]",{"v":3.007342,"d":"3.01"},{"v":2.278887,"d":"2.28"},{"v":2.847769,"d":"2.85"},{"v":2.821859,"d":"2.82"},{"v":4.371298,"d":"4.37"},{"v":3.61851,"d":"3.62"},{"v":0.752335231930469,"d":"0.75"},{"v":-0.410552441394044,"d":"-0.41"},{"v":0.387615999660651,"d":"0.39"},{"v":0.850001687286452,"d":"0.85"},"down","no"]
["MSTRG.5790","CLPTM1","ENSOART00000010362","GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033081(regulation of T cell differentiation in thymus)","NA","NA","NA","CLPTM1, transmembrane protein [Source:NCBI gene;Acc:101112757]",{"v":11.9762204091333,"d":"11.98"},{"v":9.99726675955266,"d":"10.00"},{"v":10.8663696919851,"d":"10.87"},{"v":11.2911876463187,"d":"11.29"},{"v":14.9553547865797,"d":"14.96"},{"v":15.674438499534,"d":"15.67"},{"v":0.783375200919126,"d":"0.78"},{"v":-0.352224636853093,"d":"-0.35"},{"v":0.388873874376853,"d":"0.39"},{"v":0.851068180096377,"d":"0.85"},"down","no"]
["MSTRG.2691","PSMD11","ENSOART00000011402","GO:0000502(proteasome complex);GO:0005515(protein binding);GO:0005838(proteasome regulatory particle);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0022624(proteasome accessory complex);GO:0043248(proteasome assembly);GO:0048863(stem cell differentiation)","03050(Proteasome);05169(Epstein-Barr virus infection)","K03036","NA","proteasome 26S subunit, non-ATPase 11 [Source:NCBI gene;Acc:101121105]",{"v":7.62254399041931,"d":"7.62"},{"v":9.54523319273361,"d":"9.55"},{"v":9.09098064962051,"d":"9.09"},{"v":7.64785794002737,"d":"7.65"},{"v":7.42153085541869,"d":"7.42"},{"v":7.91778734142093,"d":"7.92"},{"v":1.1423220354004,"d":"1.14"},{"v":0.19196942248777,"d":"0.19"},{"v":0.389533637577726,"d":"0.39"},{"v":0.851068180096377,"d":"0.85"},"up","no"]
["MSTRG.21088","RAB2A","ENSOART00000017477;ENSOART00000017474","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0007030(Golgi organization);GO:0019003(GDP binding);GO:0019003(GDP binding)","04152(AMPK signaling pathway);04152(AMPK signaling pathway)","K07877","NA","RAB2A, member RAS oncogene family [Source:NCBI gene;Acc:101110853]",{"v":6.93657969514296,"d":"6.94"},{"v":8.86751900447813,"d":"8.87"},{"v":7.5493946102308,"d":"7.55"},{"v":7.81761372993455,"d":"7.82"},{"v":6.67533598380985,"d":"6.68"},{"v":6.10384415018946,"d":"6.10"},{"v":1.13384119218405,"d":"1.13"},{"v":0.181218587993862,"d":"0.18"},{"v":0.389829674114454,"d":"0.39"},{"v":0.851068180096377,"d":"0.85"},"up","no"]
["MSTRG.17954","SLC39A3","ENSOART00000014830","GO:0000902(cell morphogenesis);GO:0001701(in utero embryonic development);GO:0005385(zinc ion transmembrane transporter activity);GO:0006829(zinc ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030001(metal ion transport);GO:0043029(T cell homeostasis);GO:0046873(metal ion transmembrane transporter activity);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0055085(transmembrane transport);GO:0060173(limb development);GO:0071577(zinc ion transmembrane transport)","NA","K14709","NA","solute carrier family 39 member 3 [Source:NCBI gene;Acc:100147781]",{"v":1.2265565281746,"d":"1.23"},{"v":1.71352544861111,"d":"1.71"},{"v":1.58069615277778,"d":"1.58"},{"v":2.00045850079365,"d":"2.00"},{"v":1.76996419027778,"d":"1.77"},{"v":2.12107811130952,"d":"2.12"},{"v":0.767338965266116,"d":"0.77"},{"v":-0.382064078460815,"d":"-0.38"},{"v":0.390614060856782,"d":"0.39"},{"v":0.851414548881262,"d":"0.85"},"down","no"]
["MSTRG.15410","CCT7","ENSOART00000012863","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005832(chaperonin-containing T-complex);GO:0005874(microtubule);GO:0006457(protein folding);GO:0007339(binding of sperm to zona pellucida);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0042802(identical protein binding);GO:0044297(cell body);GO:0050821(protein stabilization);GO:0051082(unfolded protein binding);GO:1901998(toxin transport);GO:1904851(positive regulation of establishment of protein localization to telomere)","NA","K09499","NA","chaperonin containing TCP1 subunit 7 [Source:NCBI gene;Acc:101112301]",{"v":42.647667,"d":"42.65"},{"v":48.408207,"d":"48.41"},{"v":46.610935,"d":"46.61"},{"v":54.105743,"d":"54.11"},{"v":59.668621,"d":"59.67"},{"v":62.89278,"d":"62.89"},{"v":0.779243983250219,"d":"0.78"},{"v":-0.35985298442534,"d":"-0.36"},{"v":0.391675716337634,"d":"0.39"},{"v":0.852394049453226,"d":"0.85"},"down","no"]
["MSTRG.3483","ENSOARG00000023078;PCYT2","ENSOART00000024980;ENSOART00000019488","GO:0003824(catalytic activity);GO:0009058(biosynthetic process)","00440(Phosphonate and phosphinate metabolism);00564(Glycerophospholipid metabolism)","K00967","EC:2.7.7.14","phosphate cytidylyltransferase 2, ethanolamine [Source:NCBI gene;Acc:101113687]",{"v":4.32274718489583,"d":"4.32"},{"v":4.53606098995536,"d":"4.54"},{"v":2.99327828534226,"d":"2.99"},{"v":4.61152868080357,"d":"4.61"},{"v":4.4507777202381,"d":"4.45"},{"v":6.25110276525298,"d":"6.25"},{"v":0.773967855980777,"d":"0.77"},{"v":-0.369654444512643,"d":"-0.37"},{"v":0.393090949849541,"d":"0.39"},{"v":0.853464700645542,"d":"0.85"},"down","no"]
["MSTRG.8886","PPP4R2","ENSOART00000010286","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0019888(protein phosphatase regulator activity);GO:0030289(protein phosphatase 4 complex);GO:0030674(protein binding, bridging);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA","K15425","NA","protein phosphatase 4 regulatory subunit 2 [Source:NCBI gene;Acc:101113890]",{"v":10.050734,"d":"10.05"},{"v":8.64772,"d":"8.65"},{"v":7.02177,"d":"7.02"},{"v":9.115246,"d":"9.12"},{"v":6.926921,"d":"6.93"},{"v":6.50862,"d":"6.51"},{"v":1.14054662482511,"d":"1.14"},{"v":0.189725424316923,"d":"0.19"},{"v":0.3938672338778,"d":"0.39"},{"v":0.853874815846077,"d":"0.85"},"up","no"]
["MSTRG.18942","USP46","ENSOART00000020202","GO:0001662(behavioral fear response);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008343(adult feeding behavior);GO:0016579(protein deubiquitination);GO:0032228(regulation of synaptic transmission, GABAergic);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0048149(behavioral response to ethanol);GO:0060013(righting reflex);GO:0101005(ubiquitinyl hydrolase activity)","NA","K11842","EC:3.4.19.12","ubiquitin specific peptidase 46 [Source:NCBI gene;Acc:101114871]",{"v":3.16975394348042,"d":"3.17"},{"v":2.32123245711453,"d":"2.32"},{"v":2.29299802379772,"d":"2.29"},{"v":3.72433224194348,"d":"3.72"},{"v":3.14182641695588,"d":"3.14"},{"v":3.10100499355478,"d":"3.10"},{"v":0.780962839159973,"d":"0.78"},{"v":-0.356674193171985,"d":"-0.36"},{"v":0.393946334761008,"d":"0.39"},{"v":0.853874815846077,"d":"0.85"},"down","no"]
["MSTRG.18634","ENSOARG00000018416","ENSOART00000020043;ENSOART00000020042","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006468(protein phosphorylation)","04012(ErbB signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04066(HIF-1 signaling pathway);04114(Oocyte meiosis);04217(Necroptosis);04261(Adrenergic signaling in cardiomyocytes);04310(Wnt signaling pathway);04360(Axon guidance);04713(Circadian entrainment);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04725(Cholinergic synapse);04728(Dopaminergic synapse);04740(Olfactory transduction);04750(Inflammatory mediator regulation of TRP channels);04911(Insulin secretion);04912(GnRH signaling pathway);04916(Melanogenesis);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04925(Aldosterone synthesis and secretion);04934(Cushing syndrome);04971(Gastric acid secretion);05031(Amphetamine addiction);05152(Tuberculosis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05214(Glioma);05214(Glioma)","K04515","EC:2.7.11.17","calcium/calmodulin dependent protein kinase II delta [Source:NCBI gene;Acc:101113850]",{"v":7.54870288059132,"d":"7.55"},{"v":9.046380344916,"d":"9.05"},{"v":8.74723515393847,"d":"8.75"},{"v":8.10341543732271,"d":"8.10"},{"v":7.60068549269038,"d":"7.60"},{"v":6.81733373532621,"d":"6.82"},{"v":1.12525328674766,"d":"1.13"},{"v":0.170249778691586,"d":"0.17"},{"v":0.394595277952044,"d":"0.39"},{"v":0.854082909676654,"d":"0.85"},"up","no"]
["MSTRG.5731","EXOSC5","ENSOART00000008066","GO:0000178(exosome (RNase complex));GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006401(RNA catabolic process);GO:0035327(transcriptionally active chromatin);GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay);GO:0045006(DNA deamination);GO:0051607(defense response to virus)","03018(RNA degradation)","K12590","NA","exosome component 5 [Source:NCBI gene;Acc:101123655]",{"v":2.024285,"d":"2.02"},{"v":2.405845,"d":"2.41"},{"v":2.009029,"d":"2.01"},{"v":2.961802,"d":"2.96"},{"v":2.800874,"d":"2.80"},{"v":2.854715,"d":"2.85"},{"v":0.747228366451052,"d":"0.75"},{"v":-0.420378870887077,"d":"-0.42"},{"v":0.395157217467406,"d":"0.40"},{"v":0.854153045773502,"d":"0.85"},"down","no"]
["MSTRG.8098","AEN","ENSOART00000011918","GO:0003676(nucleic acid binding);GO:0004527(exonuclease activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0010212(response to ionizing radiation);GO:0031965(nuclear membrane);GO:0042771(intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","NA","K18340","EC:3.1.-.-","apoptosis enhancing nuclease [Source:NCBI gene;Acc:101116260]",{"v":0.974074972639012,"d":"0.97"},{"v":1.55411558340688,"d":"1.55"},{"v":1.78331211032657,"d":"1.78"},{"v":1.72353624360106,"d":"1.72"},{"v":1.7190237396293,"d":"1.72"},{"v":2.46153881729921,"d":"2.46"},{"v":0.730255846325902,"d":"0.73"},{"v":-0.453526091772486,"d":"-0.45"},{"v":0.395855079404188,"d":"0.40"},{"v":0.854559445557679,"d":"0.85"},"down","no"]
["MSTRG.6105","ENSOARG00000003593","ENSOART00000003901","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 805-like [Source:NCBI gene;Acc:101104520]",{"v":1.897135,"d":"1.90"},{"v":1.612125,"d":"1.61"},{"v":1.875972,"d":"1.88"},{"v":2.685897,"d":"2.69"},{"v":2.117579,"d":"2.12"},{"v":2.231008,"d":"2.23"},{"v":0.765547551177883,"d":"0.77"},{"v":-0.385436102899843,"d":"-0.39"},{"v":0.397299561172539,"d":"0.40"},{"v":0.856044765746268,"d":"0.86"},"down","no"]
["MSTRG.20087","GALNT16","ENSOART00000023081","GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018242(protein O-linked glycosylation via serine);GO:0018243(protein O-linked glycosylation via threonine);GO:0030246(carbohydrate binding)","00512(Mucin type O-glycan biosynthesis)","K00710","EC:2.4.1.41","polypeptide N-acetylgalactosaminyltransferase 16 [Source:NCBI gene;Acc:101117847]",{"v":1.45753748269699,"d":"1.46"},{"v":1.72067728887084,"d":"1.72"},{"v":3.65170052087734,"d":"3.65"},{"v":2.96066928042242,"d":"2.96"},{"v":2.95315957351747,"d":"2.95"},{"v":3.2432059413485,"d":"3.24"},{"v":0.745865386026424,"d":"0.75"},{"v":-0.423012818879121,"d":"-0.42"},{"v":0.398263847371359,"d":"0.40"},{"v":0.856254879428648,"d":"0.86"},"down","no"]
["MSTRG.10896","FAM76A","ENSOART00000003606","GO:0005654(nucleoplasm)","NA","NA","NA","family with sequence similarity 76 member A [Source:NCBI gene;Acc:101105983]",{"v":9.152987,"d":"9.15"},{"v":8.817978,"d":"8.82"},{"v":7.177596,"d":"7.18"},{"v":7.223959,"d":"7.22"},{"v":7.958334,"d":"7.96"},{"v":6.65058,"d":"6.65"},{"v":1.15186677447352,"d":"1.15"},{"v":0.203973863550068,"d":"0.20"},{"v":0.399234155797592,"d":"0.40"},{"v":0.856254879428648,"d":"0.86"},"up","no"]
["MSTRG.11114","BMP5","ENSOART00000006934","GO:0003323(type B pancreatic cell development);GO:0005576(extracellular region);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0010894(negative regulation of steroid biosynthetic process);GO:0032348(negative regulation of aldosterone biosynthetic process);GO:0043569(negative regulation of insulin-like growth factor receptor signaling pathway);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050679(positive regulation of epithelial cell proliferation);GO:0070700(BMP receptor binding);GO:1900006(positive regulation of dendrite development);GO:2000065(negative regulation of cortisol biosynthetic process)","04060(Cytokine-cytokine receptor interaction);04350(TGF-beta signaling pathway);04390(Hippo signaling pathway)","K04663","NA","bone morphogenetic protein 5 [Source:NCBI gene;Acc:101107231]",{"v":3.897713,"d":"3.90"},{"v":2.058776,"d":"2.06"},{"v":2.050311,"d":"2.05"},{"v":3.620798,"d":"3.62"},{"v":3.521875,"d":"3.52"},{"v":3.36937,"d":"3.37"},{"v":0.761678771671691,"d":"0.76"},{"v":-0.392745407177051,"d":"-0.39"},{"v":0.39961142569888,"d":"0.40"},{"v":0.856254879428648,"d":"0.86"},"down","no"]
["MSTRG.17584","MAST3","ENSOART00000014866","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity)","NA","K08789","EC:2.7.11.1","microtubule associated serine/threonine kinase 3 [Source:NCBI gene;Acc:101111802]",{"v":0.718585,"d":"0.72"},{"v":0.514668,"d":"0.51"},{"v":0.764246,"d":"0.76"},{"v":1.174106,"d":"1.17"},{"v":0.767308,"d":"0.77"},{"v":0.741765,"d":"0.74"},{"v":0.744452382789221,"d":"0.74"},{"v":-0.425748521850077,"d":"-0.43"},{"v":0.400031578774301,"d":"0.40"},{"v":0.856254879428648,"d":"0.86"},"down","no"]
["MSTRG.1755","GYG1","ENSOART00000005716","GO:0005978(glycogen biosynthetic process);GO:0008466(glycogenin glucosyltransferase activity);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030145(manganese ion binding);GO:0042803(protein homodimerization activity);GO:0102751(UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity)","00500(Starch and sucrose metabolism)","K00750","EC:2.4.1.186","glycogenin 1 [Source:NCBI gene;Acc:101103289]",{"v":24.748818620114,"d":"24.75"},{"v":31.0865195896383,"d":"31.09"},{"v":27.7944699095005,"d":"27.79"},{"v":24.2323048745197,"d":"24.23"},{"v":22.3250015428647,"d":"22.33"},{"v":27.0168905957334,"d":"27.02"},{"v":1.13667306629717,"d":"1.14"},{"v":0.184817361128763,"d":"0.18"},{"v":0.400542730214355,"d":"0.40"},{"v":0.856297712059149,"d":"0.86"},"up","no"]
["MSTRG.21311","NDUFAF6","ENSOART00000006439","GO:0005743(mitochondrial inner membrane);GO:0032981(mitochondrial respiratory chain complex I assembly)","04714(Thermogenesis)","K18163","NA","NADH:ubiquinone oxidoreductase complex assembly factor 6 [Source:NCBI gene;Acc:101109102]",{"v":3.51403067334614,"d":"3.51"},{"v":3.26148444441394,"d":"3.26"},{"v":2.75228468020862,"d":"2.75"},{"v":3.56386607493824,"d":"3.56"},{"v":2.42427878589075,"d":"2.42"},{"v":2.44230390172934,"d":"2.44"},{"v":1.13016519835622,"d":"1.13"},{"v":0.176533669480997,"d":"0.18"},{"v":0.401224901348781,"d":"0.40"},{"v":0.856297712059149,"d":"0.86"},"up","no"]
["ENSOARG00000008962","ENSOARG00000008962","ENSOART00000009763","NA","NA","NA","NA",null,{"v":0.304764,"d":"0.30"},{"v":0.60598,"d":"0.61"},{"v":0.602939,"d":"0.60"},{"v":0.564414,"d":"0.56"},{"v":0.625643,"d":"0.63"},{"v":0.898437,"d":"0.90"},{"v":0.724772491565693,"d":"0.72"},{"v":-0.464399895346049,"d":"-0.46"},{"v":0.402133337616126,"d":"0.40"},{"v":0.856526123916792,"d":"0.86"},"down","no"]
["MSTRG.11497","MDC1","ENSOART00000012778","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005925(focal adhesion);GO:0008022(protein C-terminus binding);GO:0016604(nuclear body);GO:0042802(identical protein binding);GO:0070975(FHA domain binding)","NA","K20780","NA","mediator of DNA damage checkpoint 1 [Source:NCBI gene;Acc:101107143]",{"v":2.57726989164046,"d":"2.58"},{"v":2.1739848081761,"d":"2.17"},{"v":2.29044069378931,"d":"2.29"},{"v":3.04563734145702,"d":"3.05"},{"v":2.73508605411426,"d":"2.74"},{"v":3.17233369667191,"d":"3.17"},{"v":0.786512955413487,"d":"0.79"},{"v":-0.346457565029169,"d":"-0.35"},{"v":0.402508338264684,"d":"0.40"},{"v":0.856659366445187,"d":"0.86"},"down","no"]
["MSTRG.9481","SEMA4D","ENSOART00000008460;ENSOART00000008465","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001934(positive regulation of protein phosphorylation);GO:0004888(transmembrane signaling receptor activity);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005887(integral component of plasma membrane);GO:0007162(negative regulation of cell adhesion);GO:0008360(regulation of cell shape);GO:0010693(negative regulation of alkaline phosphatase activity);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030215(semaphorin receptor binding);GO:0030335(positive regulation of cell migration);GO:0031344(regulation of cell projection organization);GO:0038023(signaling receptor activity);GO:0043547(positive regulation of GTPase activity);GO:0043931(ossification involved in bone maturation);GO:0045668(negative regulation of osteoblast differentiation);GO:0048672(positive regulation of collateral sprouting);GO:0048814(regulation of dendrite morphogenesis);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation);GO:0050772(positive regulation of axonogenesis);GO:0070486(leukocyte aggregation);GO:0071526(semaphorin-plexin signaling pathway);GO:1900220(semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis);GO:1905704(positive regulation of inhibitory synapse assembly);GO:1905704(positive regulation of inhibitory synapse assembly)","04360(Axon guidance);04360(Axon guidance)","K06521","NA","semaphorin 4D [Source:NCBI gene;Acc:101104121]",{"v":9.96204787302604,"d":"9.96"},{"v":12.0654985646607,"d":"12.07"},{"v":10.2184083960734,"d":"10.22"},{"v":12.9635730746906,"d":"12.96"},{"v":6.41585318587281,"d":"6.42"},{"v":8.93728303798549,"d":"8.94"},{"v":1.13876066932017,"d":"1.14"},{"v":0.187464571044394,"d":"0.19"},{"v":0.404055662576923,"d":"0.40"},{"v":0.858145272965141,"d":"0.86"},"up","no"]
["MSTRG.20718","SCAF8","ENSOART00000004524","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm)","NA","K13191","NA","SR-related CTD associated factor 8 [Source:NCBI gene;Acc:101108316]",{"v":2.70963758948294,"d":"2.71"},{"v":2.5563250202163,"d":"2.56"},{"v":2.87476002843276,"d":"2.87"},{"v":2.7748132451179,"d":"2.77"},{"v":2.39061530198341,"d":"2.39"},{"v":2.06822086696985,"d":"2.07"},{"v":1.12539634866688,"d":"1.13"},{"v":0.170433187711297,"d":"0.17"},{"v":0.405279826230998,"d":"0.41"},{"v":0.858908346548604,"d":"0.86"},"up","no"]
["MSTRG.4241","HMCN1","ENSOART00000005655","GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005938(cell cortex);GO:0009617(response to bacterium);GO:0030054(cell junction)","NA","K17341","NA","hemicentin 1 [Source:NCBI gene;Acc:101109289]",{"v":0.512635,"d":"0.51"},{"v":0.18673,"d":"0.19"},{"v":0.193184,"d":"0.19"},{"v":0.441454,"d":"0.44"},{"v":0.432859,"d":"0.43"},{"v":0.320993,"d":"0.32"},{"v":0.746711720680729,"d":"0.75"},{"v":-0.421376718560991,"d":"-0.42"},{"v":0.405997688608694,"d":"0.41"},{"v":0.859287186158252,"d":"0.86"},"down","no"]
["ENSOARG00000017757","CYB5D1","ENSOART00000019322","NA","NA","NA","NA","cytochrome b5 domain-containing protein 1 [Source:NCBI gene;Acc:101105010]",{"v":0.674448,"d":"0.67"},{"v":0.468837,"d":"0.47"},{"v":0.339291,"d":"0.34"},{"v":0.520029,"d":"0.52"},{"v":0.357066,"d":"0.36"},{"v":0.364418,"d":"0.36"},{"v":1.1941687279956,"d":"1.19"},{"v":0.256006694094077,"d":"0.26"},{"v":0.406309323031964,"d":"0.41"},{"v":0.859440628599453,"d":"0.86"},"up","no"]
["MSTRG.20206","CIPC","ENSOART00000002474","GO:0042754(negative regulation of circadian rhythm);GO:0045892(negative regulation of transcription, DNA-templated)","NA","NA","NA","CLOCK interacting pacemaker [Source:NCBI gene;Acc:100171393]",{"v":2.69873044133739,"d":"2.70"},{"v":5.2809110070922,"d":"5.28"},{"v":2.75453411570415,"d":"2.75"},{"v":2.97138023343465,"d":"2.97"},{"v":2.94713371448835,"d":"2.95"},{"v":3.31421142836879,"d":"3.31"},{"v":1.16262264138143,"d":"1.16"},{"v":0.21738290958012,"d":"0.22"},{"v":0.406577474876123,"d":"0.41"},{"v":0.85947656781167,"d":"0.86"},"up","no"]
["MSTRG.16937","BCAP29","ENSOART00000006295","GO:0005783(endoplasmic reticulum);GO:0006886(intracellular protein transport);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0070973(protein localization to endoplasmic reticulum exit site)","NA","NA","NA","B cell receptor associated protein 29 [Source:NCBI gene;Acc:101104394]",{"v":1.5046103764425,"d":"1.50"},{"v":1.68794553521687,"d":"1.69"},{"v":1.01206336251492,"d":"1.01"},{"v":1.23164291683247,"d":"1.23"},{"v":1.06869466613609,"d":"1.07"},{"v":1.25699561480302,"d":"1.26"},{"v":1.18195823680733,"d":"1.18"},{"v":0.241179060375513,"d":"0.24"},{"v":0.407814855822572,"d":"0.41"},{"v":0.860179058961716,"d":"0.86"},"up","no"]
["MSTRG.1359","RABL3","ENSOART00000021707","NA","NA","K07933","NA","RAB, member of RAS oncogene family like 3 [Source:NCBI gene;Acc:101108873]",{"v":2.915828,"d":"2.92"},{"v":4.103866,"d":"4.10"},{"v":2.512505,"d":"2.51"},{"v":4.229564,"d":"4.23"},{"v":1.744131,"d":"1.74"},{"v":2.022848,"d":"2.02"},{"v":1.19203998527864,"d":"1.19"},{"v":0.253432629756184,"d":"0.25"},{"v":0.409132487733487,"d":"0.41"},{"v":0.861066613805101,"d":"0.86"},"up","no"]
["MSTRG.792","CDC42SE1","ENSOART00000022797","GO:0005886(plasma membrane);GO:0017048(Rho GTPase binding);GO:0035023(regulation of Rho protein signal transduction)","NA","NA","NA","CDC42 small effector 1 [Source:NCBI gene;Acc:101110804]",{"v":7.81249719320066,"d":"7.81"},{"v":4.31849185489221,"d":"4.32"},{"v":4.15760645356551,"d":"4.16"},{"v":7.58340760420122,"d":"7.58"},{"v":6.40836975981205,"d":"6.41"},{"v":6.83676224018795,"d":"6.84"},{"v":0.782032528981191,"d":"0.78"},{"v":-0.354699476582597,"d":"-0.35"},{"v":0.410061029076493,"d":"0.41"},{"v":0.861549420454025,"d":"0.86"},"down","no"]
["MSTRG.6014","ENSOARG00000019908","ENSOART00000021675","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":11.829304,"d":"11.83"},{"v":8.851486,"d":"8.85"},{"v":9.788145,"d":"9.79"},{"v":10.525064,"d":"10.53"},{"v":6.794257,"d":"6.79"},{"v":8.797225,"d":"8.80"},{"v":1.16665255045594,"d":"1.17"},{"v":0.222374965184666,"d":"0.22"},{"v":0.410651896089801,"d":"0.41"},{"v":0.861549420454025,"d":"0.86"},"up","no"]
["MSTRG.10555","ALS2","ENSOART00000018995","GO:0001662(behavioral fear response);GO:0001726(ruffle);GO:0001881(receptor recycling);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006979(response to oxidative stress);GO:0007032(endosome organization);GO:0007528(neuromuscular junction development);GO:0007626(locomotory behavior);GO:0008104(protein localization);GO:0014069(postsynaptic density);GO:0016050(vesicle organization);GO:0016197(endosomal transport);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0030027(lamellipodium);GO:0030425(dendrite);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0031982(vesicle);GO:0032991(protein-containing complex);GO:0035023(regulation of Rho protein signal transduction);GO:0035249(synaptic transmission, glutamatergic);GO:0042803(protein homodimerization activity);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0043539(protein serine/threonine kinase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0045860(positive regulation of protein kinase activity);GO:0048812(neuron projection morphogenesis);GO:0051036(regulation of endosome size);GO:0071902(positive regulation of protein serine/threonine kinase activity)","05014(Amyotrophic lateral sclerosis (ALS))","K04575","NA","ALS2, alsin Rho guanine nucleotide exchange factor [Source:NCBI gene;Acc:101109592]",{"v":6.46444177069369,"d":"6.46"},{"v":6.39280159844115,"d":"6.39"},{"v":5.97827176882307,"d":"5.98"},{"v":5.78525935806703,"d":"5.79"},{"v":5.84772711317225,"d":"5.85"},{"v":5.14398209696025,"d":"5.14"},{"v":1.12270074664504,"d":"1.12"},{"v":0.166973431866233,"d":"0.17"},{"v":0.411168134337124,"d":"0.41"},{"v":0.861549420454025,"d":"0.86"},"up","no"]
["MSTRG.4051","TMEM52","ENSOART00000001783","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 52 [Source:NCBI gene;Acc:101123315]",{"v":4.77482138926892,"d":"4.77"},{"v":2.13690374839675,"d":"2.14"},{"v":3.79627275331338,"d":"3.80"},{"v":3.00054771269773,"d":"3.00"},{"v":5.62846278302693,"d":"5.63"},{"v":5.21856798995297,"d":"5.22"},{"v":0.773275840397236,"d":"0.77"},{"v":-0.370944955528459,"d":"-0.37"},{"v":0.4121477021853,"d":"0.41"},{"v":0.861549420454025,"d":"0.86"},"down","no"]
["MSTRG.4801","STK35","ENSOART00000007926","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0016604(nuclear body)","NA","NA","NA","serine/threonine kinase 35 [Source:HGNC Symbol;Acc:HGNC:16254]",{"v":2.29380749434018,"d":"2.29"},{"v":1.66523336922848,"d":"1.67"},{"v":2.47818556404528,"d":"2.48"},{"v":2.57345519228478,"d":"2.57"},{"v":3.1213183668454,"d":"3.12"},{"v":2.51714802472446,"d":"2.52"},{"v":0.783887956293944,"d":"0.78"},{"v":-0.351280634999379,"d":"-0.35"},{"v":0.412494524523394,"d":"0.41"},{"v":0.861549420454025,"d":"0.86"},"down","no"]
["MSTRG.784","CERS2","ENSOART00000022754","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030148(sphingolipid biosynthetic process);GO:0046513(ceramide biosynthetic process);GO:0050291(sphingosine N-acyltransferase activity)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","K04710","EC:2.3.1.24","ceramide synthase 2 [Source:NCBI gene;Acc:101109498]",{"v":7.235766,"d":"7.24"},{"v":6.759304,"d":"6.76"},{"v":7.769409,"d":"7.77"},{"v":9.944156,"d":"9.94"},{"v":9.948617,"d":"9.95"},{"v":7.943553,"d":"7.94"},{"v":0.781873261579132,"d":"0.78"},{"v":-0.354993323300611,"d":"-0.35"},{"v":0.412867780293962,"d":"0.41"},{"v":0.86182482785365,"d":"0.86"},"down","no"]
["MSTRG.10688","AAMP","ENSOART00000021238","GO:0005515(protein binding);GO:0005829(cytosol);GO:0015630(microtubule cytoskeleton);GO:0045171(intercellular bridge)","NA","NA","NA","angio associated migratory cell protein [Source:NCBI gene;Acc:101110742]",{"v":9.35598458267717,"d":"9.36"},{"v":10.0123685053064,"d":"10.01"},{"v":9.02562695001712,"d":"9.03"},{"v":10.1808719168093,"d":"10.18"},{"v":11.8177645665868,"d":"11.82"},{"v":14.0748419404314,"d":"14.07"},{"v":0.787115112781741,"d":"0.79"},{"v":-0.345353454713682,"d":"-0.35"},{"v":0.414656575918647,"d":"0.41"},{"v":0.8631454068842,"d":"0.86"},"down","no"]
["MSTRG.17089","ENSOARG00000009300","ENSOART00000010121","GO:0008442(3-hydroxyisobutyrate dehydrogenase activity);GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process)","00280(Valine, leucine and isoleucine degradation)","K00020","EC:1.1.1.31","3-hydroxyisobutyrate dehydrogenase [Source:NCBI gene;Acc:101113492]",{"v":61.625465,"d":"61.63"},{"v":62.483742,"d":"62.48"},{"v":46.225052,"d":"46.23"},{"v":64.416115,"d":"64.42"},{"v":41.538219,"d":"41.54"},{"v":45.165909,"d":"45.17"},{"v":1.12714389295946,"d":"1.13"},{"v":0.172671703981834,"d":"0.17"},{"v":0.415077977183303,"d":"0.42"},{"v":0.863362192541271,"d":"0.86"},"up","no"]
["MSTRG.12081","VPS51","ENSOART00000013412;ENSOART00000013416","GO:0000938(GARP complex);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006914(autophagy);GO:0007041(lysosomal transport);GO:0016020(membrane);GO:0032456(endocytic recycling);GO:0042147(retrograde transport, endosome to Golgi);GO:0043231(intracellular membrane-bounded organelle);GO:0055037(recycling endosome);GO:1990745(EARP complex);GO:1990745(EARP complex)","NA","K20296","NA","VPS51, GARP complex subunit [Source:NCBI gene;Acc:101120711]",{"v":4.1955075,"d":"4.20"},{"v":3.83213699279424,"d":"3.83"},{"v":4.33451661809448,"d":"4.33"},{"v":4.99927456044836,"d":"5.00"},{"v":5.1687623142514,"d":"5.17"},{"v":5.43096511649319,"d":"5.43"},{"v":0.792496924987142,"d":"0.79"},{"v":-0.335522757508387,"d":"-0.34"},{"v":0.416467906721662,"d":"0.42"},{"v":0.863614188582767,"d":"0.86"},"down","no"]
["MSTRG.232","HECTD3","ENSOART00000001551","GO:0004842(ubiquitin-protein transferase activity);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0019905(syntaxin binding);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0048471(perinuclear region of cytoplasm)","NA","K12233","EC:2.3.2.26","HECT domain E3 ubiquitin protein ligase 3 [Source:NCBI gene;Acc:101110558]",{"v":3.911183,"d":"3.91"},{"v":3.51703,"d":"3.52"},{"v":3.246482,"d":"3.25"},{"v":4.276802,"d":"4.28"},{"v":5.005511,"d":"5.01"},{"v":4.272563,"d":"4.27"},{"v":0.787516979129872,"d":"0.79"},{"v":-0.34461706606377,"d":"-0.34"},{"v":0.417082722441252,"d":"0.42"},{"v":0.863614188582767,"d":"0.86"},"down","no"]
["MSTRG.9119","SLC25A20","ENSOART00000017517","GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","04714(Thermogenesis)","K15109","NA","solute carrier family 25 member 20 [Source:NCBI gene;Acc:100147786]",{"v":7.7051506379822,"d":"7.71"},{"v":8.6643218189911,"d":"8.66"},{"v":6.86662596373228,"d":"6.87"},{"v":12.5413732205737,"d":"12.54"},{"v":8.28514895252225,"d":"8.29"},{"v":9.05170129014177,"d":"9.05"},{"v":0.777693441154403,"d":"0.78"},{"v":-0.362726523331656,"d":"-0.36"},{"v":0.417791810549604,"d":"0.42"},{"v":0.863944857833697,"d":"0.86"},"down","no"]
["MSTRG.1768","ZIC4","ENSOART00000005957","GO:0003676(nucleic acid binding)","NA","K09225","NA","Zic family member 4 [Source:NCBI gene;Acc:101102113]",{"v":0.149851,"d":"0.15"},{"v":0.642694,"d":"0.64"},{"v":0.356898,"d":"0.36"},{"v":0.210962,"d":"0.21"},{"v":0.285233,"d":"0.29"},{"v":0.40292,"d":"0.40"},{"v":1.27841599795354,"d":"1.28"},{"v":0.354357367214439,"d":"0.35"},{"v":0.41856302077319,"d":"0.42"},{"v":0.864444346469092,"d":"0.86"},"up","no"]
["MSTRG.18898","SLC30A9","ENSOART00000015219","GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005856(cytoskeleton);GO:0006812(cation transport);GO:0006829(zinc ion transport);GO:0006882(cellular zinc ion homeostasis);GO:0008324(cation transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016922(nuclear receptor binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0031410(cytoplasmic vesicle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0055085(transmembrane transport);GO:0098655(cation transmembrane transport)","NA","K14696","NA","solute carrier family 30 member 9 [Source:NCBI gene;Acc:101118788]",{"v":3.509563,"d":"3.51"},{"v":2.72786,"d":"2.73"},{"v":3.624353,"d":"3.62"},{"v":3.18207,"d":"3.18"},{"v":2.968122,"d":"2.97"},{"v":2.472198,"d":"2.47"},{"v":1.14374042463864,"d":"1.14"},{"v":0.193759665246587,"d":"0.19"},{"v":0.419342627317456,"d":"0.42"},{"v":0.86538641934675,"d":"0.87"},"up","no"]
["MSTRG.6161","AASDHPPT","ENSOART00000002820","GO:0000287(magnesium ion binding);GO:0008897(holo-[acyl-carrier-protein] synthase activity)","00770(Pantothenate and CoA biosynthesis)","K06133","EC:2.7.8.-","aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase [Source:NCBI gene;Acc:101115306]",{"v":2.50598677052905,"d":"2.51"},{"v":2.71001563453424,"d":"2.71"},{"v":2.6827452742616,"d":"2.68"},{"v":2.8046682473223,"d":"2.80"},{"v":2.39012206426485,"d":"2.39"},{"v":1.81233753975982,"d":"1.81"},{"v":1.12724469238941,"d":"1.13"},{"v":0.17280071708876,"d":"0.17"},{"v":0.421004104515657,"d":"0.42"},{"v":0.866782873258795,"d":"0.87"},"up","no"]
["ENSOARG00000006568","SUSD1","ENSOART00000007138","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","sushi domain containing 1 [Source:NCBI gene;Acc:101121153]",{"v":0.094326,"d":"0.09"},{"v":0.141557,"d":"0.14"},{"v":0.102886,"d":"0.10"},{"v":0.094573,"d":"0.09"},{"v":0.049213,"d":"0.05"},{"v":0.123539,"d":"0.12"},{"v":1.2672552136912,"d":"1.27"},{"v":0.341707099418386,"d":"0.34"},{"v":0.421549839263842,"d":"0.42"},{"v":0.867321796307966,"d":"0.87"},"up","no"]
["MSTRG.9578","ENSOARG00000009133","ENSOART00000009943","GO:0004896(cytokine receptor activity);GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway);04640(Hematopoietic cell lineage)","K05056","NA","interleukin 11 receptor subunit alpha [Source:NCBI gene;Acc:101120724]",{"v":2.45374872778603,"d":"2.45"},{"v":2.08104488053492,"d":"2.08"},{"v":2.13400883506687,"d":"2.13"},{"v":2.02366458246657,"d":"2.02"},{"v":1.95896077622585,"d":"1.96"},{"v":1.93343234546805,"d":"1.93"},{"v":1.12723755866985,"d":"1.13"},{"v":0.172791587026347,"d":"0.17"},{"v":0.42301292980278,"d":"0.42"},{"v":0.868495314977423,"d":"0.87"},"up","no"]
["MSTRG.22263","WDR44","ENSOART00000018300","GO:0005515(protein binding);GO:0005794(Golgi apparatus)","NA","K20241","NA","WD repeat domain 44 [Source:NCBI gene;Acc:101105308]",{"v":4.417519,"d":"4.42"},{"v":3.033196,"d":"3.03"},{"v":3.130772,"d":"3.13"},{"v":3.029324,"d":"3.03"},{"v":2.912226,"d":"2.91"},{"v":3.299998,"d":"3.30"},{"v":1.14499075263149,"d":"1.14"},{"v":0.195335946630891,"d":"0.20"},{"v":0.424051188423621,"d":"0.42"},{"v":0.869537015465863,"d":"0.87"},"up","no"]
["MSTRG.12712","DHX32","ENSOART00000012848","GO:0000166(nucleotide binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0016787(hydrolase activity)","NA","K18994","EC:3.6.4.13","DEAH-box helicase 32 (putative) [Source:NCBI gene;Acc:101115922]",{"v":5.37235700920387,"d":"5.37"},{"v":9.14487740312931,"d":"9.14"},{"v":8.07277406672803,"d":"8.07"},{"v":10.4119625149563,"d":"10.41"},{"v":9.50483412195122,"d":"9.50"},{"v":9.30181254256788,"d":"9.30"},{"v":0.773137706189299,"d":"0.77"},{"v":-0.371202694524263,"d":"-0.37"},{"v":0.424673336551865,"d":"0.42"},{"v":0.869537015465863,"d":"0.87"},"down","no"]
["MSTRG.331","ACOT11","ENSOART00000007880","GO:0005829(cytosol);GO:0008289(lipid binding);GO:0016787(hydrolase activity);GO:0016790(thiolester hydrolase activity)","NA","K12417","EC:3.1.2.-","acyl-CoA thioesterase 11 [Source:NCBI gene;Acc:101118240]",{"v":2.43793107717265,"d":"2.44"},{"v":3.37320502340672,"d":"3.37"},{"v":1.75282553858633,"d":"1.75"},{"v":2.27226135225956,"d":"2.27"},{"v":2.5315624806489,"d":"2.53"},{"v":1.82461629756663,"d":"1.82"},{"v":1.14113750600076,"d":"1.14"},{"v":0.190472645502716,"d":"0.19"},{"v":0.425387893998828,"d":"0.43"},{"v":0.870099104979788,"d":"0.87"},"up","no"]
["MSTRG.655","PPM1J","ENSOART00000021505;ENSOART00000021507","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0003924(GTPase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0006470(protein dephosphorylation);GO:0007264(small GTPase mediated signal transduction);GO:0044319(wound healing, spreading of cells);GO:1902766(skeletal muscle satellite cell migration);GO:1902766(skeletal muscle satellite cell migration)","NA","K07857;K17504","EC:3.1.3.16","ras homolog family member C [Source:NCBI gene;Acc:101118144]",{"v":7.15353780997625,"d":"7.15"},{"v":7.00898238527316,"d":"7.01"},{"v":6.24509181092637,"d":"6.25"},{"v":7.73411531971496,"d":"7.73"},{"v":8.25570437529691,"d":"8.26"},{"v":9.81981050023753,"d":"9.82"},{"v":0.790697574966885,"d":"0.79"},{"v":-0.338802094909877,"d":"-0.34"},{"v":0.426329252248526,"d":"0.43"},{"v":0.870099104979788,"d":"0.87"},"down","no"]
["MSTRG.8070","ENSOARG00000010167","ENSOART00000011064","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0046872(metal ion binding)","NA","NA","NA",null,{"v":2.0131021890411,"d":"2.01"},{"v":1.99100297123288,"d":"1.99"},{"v":2.71921578127854,"d":"2.72"},{"v":2.92242419680365,"d":"2.92"},{"v":2.73799074520548,"d":"2.74"},{"v":2.87614256164384,"d":"2.88"},{"v":0.787591595168834,"d":"0.79"},{"v":-0.34448037937281,"d":"-0.34"},{"v":0.426517165374863,"d":"0.43"},{"v":0.870099104979788,"d":"0.87"},"down","no"]
["MSTRG.7698","ERP29","ENSOART00000011432","GO:0000187(activation of MAPK activity);GO:0001934(positive regulation of protein phosphorylation);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0009306(protein secretion);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0050709(negative regulation of protein secretion);GO:1902235(regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway)","04141(Protein processing in endoplasmic reticulum)","K09586","NA","endoplasmic reticulum protein 29 [Source:NCBI gene;Acc:100145868]",{"v":13.371318,"d":"13.37"},{"v":15.976911,"d":"15.98"},{"v":14.325562,"d":"14.33"},{"v":17.19729,"d":"17.20"},{"v":18.652172,"d":"18.65"},{"v":19.485584,"d":"19.49"},{"v":0.78926095046528,"d":"0.79"},{"v":-0.341425722786087,"d":"-0.34"},{"v":0.426974843270097,"d":"0.43"},{"v":0.87037652227703,"d":"0.87"},"down","no"]
["MSTRG.9973","SCARA3","ENSOART00000016120","GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","scavenger receptor class A member 3 [Source:NCBI gene;Acc:101107766]",{"v":1.622763,"d":"1.62"},{"v":1.686766,"d":"1.69"},{"v":1.739281,"d":"1.74"},{"v":1.491097,"d":"1.49"},{"v":2.450984,"d":"2.45"},{"v":2.578853,"d":"2.58"},{"v":0.774246449971737,"d":"0.77"},{"v":-0.369135231930803,"d":"-0.37"},{"v":0.427686831906897,"d":"0.43"},{"v":0.87037652227703,"d":"0.87"},"down","no"]
["MSTRG.20164","NPC2","ENSOART00000001152","GO:0015485(cholesterol binding);GO:0030301(cholesterol transport);GO:0032367(intracellular cholesterol transport);GO:0033344(cholesterol efflux)","04142(Lysosome);04979(Cholesterol metabolism)","K13443","NA","NPC intracellular cholesterol transporter 2 [Source:NCBI gene;Acc:100037669]",{"v":9.916384,"d":"9.92"},{"v":5.323632,"d":"5.32"},{"v":10.248668,"d":"10.25"},{"v":9.327463,"d":"9.33"},{"v":9.938412,"d":"9.94"},{"v":13.724019,"d":"13.72"},{"v":0.772620972956142,"d":"0.77"},{"v":-0.372167254530641,"d":"-0.37"},{"v":0.428654627742439,"d":"0.43"},{"v":0.870469251776782,"d":"0.87"},"down","no"]
["ENSOARG00000009952","FLVCR1","ENSOART00000010835","GO:0001568(blood vessel development);GO:0001701(in utero embryonic development);GO:0005739(mitochondrion);GO:0006839(mitochondrial transport);GO:0015232(heme transporter activity);GO:0015886(heme transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030218(erythrocyte differentiation);GO:0035108(limb morphogenesis);GO:0035264(multicellular organism growth);GO:0042733(embryonic digit morphogenesis);GO:0046620(regulation of organ growth);GO:0048536(spleen development);GO:0048704(embryonic skeletal system morphogenesis);GO:0055085(transmembrane transport);GO:0060323(head morphogenesis);GO:0097037(heme export)","NA","K08220","NA","feline leukemia virus subgroup C cellular receptor 1 [Source:NCBI gene;Acc:101103169]",{"v":0.619162,"d":"0.62"},{"v":0.563429,"d":"0.56"},{"v":0.850391,"d":"0.85"},{"v":1.25628,"d":"1.26"},{"v":0.655704,"d":"0.66"},{"v":0.902027,"d":"0.90"},{"v":0.722449912242703,"d":"0.72"},{"v":-0.469030526462917,"d":"-0.47"},{"v":0.429261039736848,"d":"0.43"},{"v":0.870469251776782,"d":"0.87"},"down","no"]
["MSTRG.14207","TIMM23B","ENSOART00000002565","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005744(TIM23 mitochondrial import inner membrane translocase complex);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0015450(P-P-bond-hydrolysis-driven protein transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0071806(protein transmembrane transport)","NA","K17794","NA","mitochondrial import inner membrane translocase subunit Tim23 [Source:NCBI gene;Acc:101118849]",{"v":52.86681,"d":"52.87"},{"v":50.413025,"d":"50.41"},{"v":52.405205,"d":"52.41"},{"v":43.915676,"d":"43.92"},{"v":44.458561,"d":"44.46"},{"v":49.740379,"d":"49.74"},{"v":1.12721625349195,"d":"1.13"},{"v":0.172764319335758,"d":"0.17"},{"v":0.429512754356212,"d":"0.43"},{"v":0.870469251776782,"d":"0.87"},"up","no"]
["MSTRG.18399","TNIP1","ENSOART00000008734","GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0007159(leukocyte cell-cell adhesion);GO:0009101(glycoprotein biosynthetic process);GO:0042802(identical protein binding);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0050727(regulation of inflammatory response);GO:0051019(mitogen-activated protein kinase binding);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0085032(modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade);GO:1903003(positive regulation of protein deubiquitination)","NA","NA","NA","TNFAIP3 interacting protein 1 [Source:NCBI gene;Acc:101104657]",{"v":5.70811555764075,"d":"5.71"},{"v":5.19637836282395,"d":"5.20"},{"v":6.07190184256777,"d":"6.07"},{"v":5.08122521730712,"d":"5.08"},{"v":7.94155629609771,"d":"7.94"},{"v":8.50456457298183,"d":"8.50"},{"v":0.788596778019373,"d":"0.79"},{"v":-0.342640278868426,"d":"-0.34"},{"v":0.430743015878925,"d":"0.43"},{"v":0.870469251776782,"d":"0.87"},"down","no"]
["MSTRG.22036","CETN2","ENSOART00000008953","GO:0005509(calcium ion binding);GO:0005813(centrosome);GO:0005814(centriole);GO:0005929(cilium);GO:0006289(nucleotide-excision repair);GO:0007099(centriole replication);GO:0007283(spermatogenesis);GO:0008017(microtubule binding);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0032391(photoreceptor connecting cilium);GO:0032465(regulation of cytokinesis);GO:0032795(heterotrimeric G-protein binding);GO:0036064(ciliary basal body);GO:0044615(nuclear pore nuclear basket);GO:0070390(transcription export complex 2);GO:0071942(XPC complex)","03420(Nucleotide excision repair)","K10840","NA","centrin 2 [Source:NCBI gene;Acc:100302545]",{"v":5.367081,"d":"5.37"},{"v":7.018601,"d":"7.02"},{"v":6.579693,"d":"6.58"},{"v":6.27619,"d":"6.28"},{"v":4.6973,"d":"4.70"},{"v":5.446716,"d":"5.45"},{"v":1.15500225758434,"d":"1.16"},{"v":0.207895671556965,"d":"0.21"},{"v":0.430994257212542,"d":"0.43"},{"v":0.870469251776782,"d":"0.87"},"up","no"]
["MSTRG.20811","PHF10","ENSOART00000005533","GO:0005634(nucleus);GO:0046872(metal ion binding);GO:0071564(npBAF complex)","05225(Hepatocellular carcinoma)","K22197","NA","PHD finger protein 10 [Source:NCBI gene;Acc:101115467]",{"v":3.93673162462423,"d":"3.94"},{"v":3.536609775977,"d":"3.54"},{"v":3.84309197425173,"d":"3.84"},{"v":5.17577280995948,"d":"5.18"},{"v":4.359177944321,"d":"4.36"},{"v":4.71566884903934,"d":"4.72"},{"v":0.794101147168133,"d":"0.79"},{"v":-0.332605315196663,"d":"-0.33"},{"v":0.431268784227985,"d":"0.43"},{"v":0.870469251776782,"d":"0.87"},"down","no"]
["MSTRG.13660","PRKRIP1","ENSOART00000015766","GO:0003014(renal system process);GO:0003725(double-stranded RNA binding);GO:0004860(protein kinase inhibitor activity);GO:0005730(nucleolus);GO:0006469(negative regulation of protein kinase activity);GO:0019901(protein kinase binding);GO:0042326(negative regulation of phosphorylation)","NA","NA","NA","PRKR interacting protein 1 [Source:NCBI gene;Acc:101119782]",{"v":2.426801,"d":"2.43"},{"v":2.967191,"d":"2.97"},{"v":2.423325,"d":"2.42"},{"v":1.885027,"d":"1.89"},{"v":2.219108,"d":"2.22"},{"v":2.501615,"d":"2.50"},{"v":1.18341096771752,"d":"1.18"},{"v":0.242951170995183,"d":"0.24"},{"v":0.431602566232593,"d":"0.43"},{"v":0.870469251776782,"d":"0.87"},"up","no"]
["MSTRG.13539","ZNF768","ENSOART00000011724","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005665(RNA polymerase II, core complex);GO:0006366(transcription by RNA polymerase II)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 768 [Source:NCBI gene;Acc:101122492]",{"v":18.89444,"d":"18.89"},{"v":16.156002,"d":"16.16"},{"v":16.340643,"d":"16.34"},{"v":23.364231,"d":"23.36"},{"v":18.956165,"d":"18.96"},{"v":22.3822,"d":"22.38"},{"v":0.794266199149104,"d":"0.79"},{"v":-0.332305485719755,"d":"-0.33"},{"v":0.432272725781502,"d":"0.43"},{"v":0.8708389729486,"d":"0.87"},"down","no"]
["MSTRG.5337","ZNF276","ENSOART00000015631","GO:0000776(kinetochore);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0008270(zinc ion binding)","NA","NA","NA","zinc finger protein 276 [Source:NCBI gene;Acc:101111739]",{"v":1.997347,"d":"2.00"},{"v":1.967841,"d":"1.97"},{"v":2.007198,"d":"2.01"},{"v":2.654171,"d":"2.65"},{"v":2.806597,"d":"2.81"},{"v":2.248581,"d":"2.25"},{"v":0.774693946272247,"d":"0.77"},{"v":-0.36830162889083,"d":"-0.37"},{"v":0.43368246224583,"d":"0.43"},{"v":0.871346220612127,"d":"0.87"},"down","no"]
["MSTRG.9788","NMRK1","ENSOART00000013673","NA","00760(Nicotinate and nicotinamide metabolism)","K10524","2.7.1.173;EC:2.7.1.22","nicotinamide riboside kinase 1 [Source:NCBI gene;Acc:101122328]",{"v":1.3953519749894,"d":"1.40"},{"v":1.20077592284866,"d":"1.20"},{"v":1.51684517465028,"d":"1.52"},{"v":2.06618320347605,"d":"2.07"},{"v":1.558139412039,"d":"1.56"},{"v":1.7136230805426,"d":"1.71"},{"v":0.77051609489508,"d":"0.77"},{"v":-0.376103002154052,"d":"-0.38"},{"v":0.434294580705927,"d":"0.43"},{"v":0.871346220612127,"d":"0.87"},"down","no"]
["MSTRG.20941","ENSOARG00000001296","ENSOART00000001387","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 696 [Source:NCBI gene;Acc:101115041]",{"v":2.0758951362916,"d":"2.08"},{"v":1.96844136925515,"d":"1.97"},{"v":0.913166450079239,"d":"0.91"},{"v":2.73663187321712,"d":"2.74"},{"v":1.76266835816165,"d":"1.76"},{"v":2.17054396988906,"d":"2.17"},{"v":0.743271177861043,"d":"0.74"},{"v":-0.428039429778557,"d":"-0.43"},{"v":0.43489583832599,"d":"0.43"},{"v":0.871346220612127,"d":"0.87"},"down","no"]
["MSTRG.8329","PSMA6","ENSOART00000008087","GO:0000502(proteasome complex);GO:0000932(P-body);GO:0003723(RNA binding);GO:0004175(endopeptidase activity);GO:0004298(threonine-type endopeptidase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005839(proteasome core complex);GO:0005844(polysome);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0016363(nuclear matrix);GO:0016787(hydrolase activity);GO:0019773(proteasome core complex, alpha-subunit complex);GO:0051059(NF-kappaB binding);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051603(proteolysis involved in cellular protein catabolic process)","03050(Proteasome)","K02730","EC:3.4.25.1","proteasome subunit alpha 6 [Source:NCBI gene;Acc:100192424]",{"v":10.0994071429249,"d":"10.10"},{"v":12.3280416356957,"d":"12.33"},{"v":11.5643291000237,"d":"11.56"},{"v":9.45130037022991,"d":"9.45"},{"v":9.65979877719839,"d":"9.66"},{"v":11.0308223842143,"d":"11.03"},{"v":1.12772431720918,"d":"1.13"},{"v":0.173414430498085,"d":"0.17"},{"v":0.435902817515621,"d":"0.44"},{"v":0.871946758958093,"d":"0.87"},"up","no"]
["MSTRG.6653","DNAJC24","ENSOART00000017375","GO:0001671(ATPase activator activity);GO:0008198(ferrous iron binding);GO:0008270(zinc ion binding);GO:0032781(positive regulation of ATPase activity);GO:0046872(metal ion binding)","NA","K17867","NA","DnaJ heat shock protein family (Hsp40) member C24 [Source:NCBI gene;Acc:101119247]",{"v":2.691941,"d":"2.69"},{"v":2.612515,"d":"2.61"},{"v":2.864455,"d":"2.86"},{"v":2.697146,"d":"2.70"},{"v":2.347479,"d":"2.35"},{"v":1.923764,"d":"1.92"},{"v":1.17228113987322,"d":"1.17"},{"v":0.229318602576733,"d":"0.23"},{"v":0.436614644247354,"d":"0.44"},{"v":0.871958841113384,"d":"0.87"},"up","no"]
["MSTRG.1514","MAGEF1","ENSOART00000002462","GO:0016567(protein ubiquitination);GO:0097428(protein maturation by iron-sulfur cluster transfer);GO:2000042(negative regulation of double-strand break repair via homologous recombination);GO:2000060(positive regulation of ubiquitin-dependent protein catabolic process)","NA","NA","NA","MAGE family member F1 [Source:NCBI gene;Acc:101119098]",{"v":1.435365,"d":"1.44"},{"v":0.434569,"d":"0.43"},{"v":1.195751,"d":"1.20"},{"v":1.175847,"d":"1.18"},{"v":1.301651,"d":"1.30"},{"v":1.730276,"d":"1.73"},{"v":0.728576439704224,"d":"0.73"},{"v":-0.456847752114453,"d":"-0.46"},{"v":0.436620252630024,"d":"0.44"},{"v":0.871958841113384,"d":"0.87"},"down","no"]
["MSTRG.6993","MAP3K1","ENSOART00000008053","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0008270(zinc ion binding);GO:0019901(protein kinase binding);GO:0071260(cellular response to mechanical stimulus)","04010(MAPK signaling pathway);04120(Ubiquitin mediated proteolysis);04530(Tight junction);04622(RIG-I-like receptor signaling pathway);04722(Neurotrophin signaling pathway);04912(GnRH signaling pathway);05161(Hepatitis B);05166(Human T-cell leukemia virus 1 infection)","K04416","EC:2.7.11.25","mitogen-activated protein kinase kinase kinase 1 [Source:NCBI gene;Acc:101112260]",{"v":6.97979857250928,"d":"6.98"},{"v":5.4431930619469,"d":"5.44"},{"v":5.19373010462461,"d":"5.19"},{"v":6.34166102654867,"d":"6.34"},{"v":4.83678642734799,"d":"4.84"},{"v":4.64184779917214,"d":"4.64"},{"v":1.1135520201915,"d":"1.11"},{"v":0.155168955987665,"d":"0.16"},{"v":0.438367944414299,"d":"0.44"},{"v":0.873589942977458,"d":"0.87"},"up","no"]
["MSTRG.1603","MYNN","ENSOART00000000813","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:1990830(cellular response to leukemia inhibitory factor)","NA","NA","NA","myoneurin [Source:NCBI gene;Acc:101120539]",{"v":3.69517824127617,"d":"3.70"},{"v":3.88799352662014,"d":"3.89"},{"v":3.34570324526421,"d":"3.35"},{"v":3.35089280478564,"d":"3.35"},{"v":3.39673734955135,"d":"3.40"},{"v":3.04885118085743,"d":"3.05"},{"v":1.11559187826939,"d":"1.12"},{"v":0.15780933641044,"d":"0.16"},{"v":0.439098623068351,"d":"0.44"},{"v":0.873856978443226,"d":"0.87"},"up","no"]
["MSTRG.7538","STX2","ENSOART00000016871","GO:0005484(SNAP receptor activity);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0007340(acrosome reaction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0016323(basolateral plasma membrane);GO:0030027(lamellipodium);GO:0030154(cell differentiation);GO:0033194(response to hydroperoxide);GO:0046983(protein dimerization activity);GO:0051259(protein complex oligomerization);GO:0061025(membrane fusion);GO:1903575(cornified envelope assembly)","04130(SNARE interactions in vesicular transport);04721(Synaptic vesicle cycle)","K08486","NA","syntaxin 2 [Source:NCBI gene;Acc:101118731]",{"v":1.39212900874243,"d":"1.39"},{"v":1.01106301815736,"d":"1.01"},{"v":1.34029147545393,"d":"1.34"},{"v":1.70506962743779,"d":"1.71"},{"v":1.65550940685945,"d":"1.66"},{"v":1.52499221519839,"d":"1.52"},{"v":0.766232506125089,"d":"0.77"},{"v":-0.384145863917139,"d":"-0.38"},{"v":0.439938195397274,"d":"0.44"},{"v":0.874187094672795,"d":"0.87"},"down","no"]
["MSTRG.16799","RPA3","ENSOART00000006232","GO:0000724(double-strand break repair via homologous recombination);GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003697(single-stranded DNA binding);GO:0005634(nucleus);GO:0005662(DNA replication factor A complex);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0006298(mismatch repair);GO:0006310(DNA recombination);GO:0007346(regulation of mitotic cell cycle);GO:0042127(regulation of cell population proliferation)","03030(DNA replication);03420(Nucleotide excision repair);03430(Mismatch repair);03440(Homologous recombination);03460(Fanconi anemia pathway)","K10740","NA","replication protein A3 [Source:NCBI gene;Acc:101121087]",{"v":22.940538,"d":"22.94"},{"v":26.276897,"d":"26.28"},{"v":34.644222,"d":"34.64"},{"v":26.672523,"d":"26.67"},{"v":24.108482,"d":"24.11"},{"v":23.865583,"d":"23.87"},{"v":1.12344929951788,"d":"1.12"},{"v":0.167935018167491,"d":"0.17"},{"v":0.441242051927232,"d":"0.44"},{"v":0.875088087436881,"d":"0.88"},"up","no"]
["MSTRG.12073","ATG2A","ENSOART00000011718","GO:0000045(autophagosome assembly);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006914(autophagy);GO:0043231(intracellular membrane-bounded organelle)","04136(Autophagy - other);04140(Autophagy - animal)","K17906","NA","autophagy related 2A [Source:NCBI gene;Acc:101119171]",{"v":2.90384639394993,"d":"2.90"},{"v":2.23159496905424,"d":"2.23"},{"v":2.48411359840056,"d":"2.48"},{"v":3.01072187413074,"d":"3.01"},{"v":3.6727280337274,"d":"3.67"},{"v":2.88949770897079,"d":"2.89"},{"v":0.795946584729013,"d":"0.80"},{"v":-0.329256478857487,"d":"-0.33"},{"v":0.442082320391617,"d":"0.44"},{"v":0.875607028174527,"d":"0.88"},"down","no"]
["MSTRG.16935","ENSOARG00000004735","ENSOART00000005152","NA","NA","NA","NA",null,{"v":1.82205575415199,"d":"1.82"},{"v":1.24637923100151,"d":"1.25"},{"v":2.03081808077504,"d":"2.03"},{"v":1.19945518344238,"d":"1.20"},{"v":1.46987771514846,"d":"1.47"},{"v":1.70767076396578,"d":"1.71"},{"v":1.16501000662861,"d":"1.17"},{"v":0.220342346683395,"d":"0.22"},{"v":0.442215119574678,"d":"0.44"},{"v":0.875607028174527,"d":"0.88"},"up","no"]
["MSTRG.12501","POLL","ENSOART00000018029","GO:0000724(double-strand break repair via homologous recombination);GO:0003677(DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006287(base-excision repair, gap-filling);GO:0006289(nucleotide-excision repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0016779(nucleotidyltransferase activity);GO:0034061(DNA polymerase activity);GO:0046872(metal ion binding);GO:0051575(5'-deoxyribose-5-phosphate lyase activity);GO:0071897(DNA biosynthetic process)","03410(Base excision repair);03450(Non-homologous end-joining)","K03512","4.2.99.-;EC:2.7.7.7","DNA polymerase lambda [Source:NCBI gene;Acc:101102947]",{"v":2.235461,"d":"2.24"},{"v":2.09584,"d":"2.10"},{"v":1.288773,"d":"1.29"},{"v":2.442006,"d":"2.44"},{"v":2.406857,"d":"2.41"},{"v":2.440734,"d":"2.44"},{"v":0.770971838360886,"d":"0.77"},{"v":-0.375249931762766,"d":"-0.38"},{"v":0.444312713116453,"d":"0.44"},{"v":0.877068809907661,"d":"0.88"},"down","no"]
["MSTRG.20667","STXBP5","ENSOART00000002550;ENSOART00000002551","GO:0005515(protein binding);GO:0005829(cytosol);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0016192(vesicle-mediated transport)","NA","K08518","NA","syntaxin binding protein 5 [Source:NCBI gene;Acc:101121429]",{"v":3.15525595159896,"d":"3.16"},{"v":3.501667960242,"d":"3.50"},{"v":2.75150159723423,"d":"2.75"},{"v":3.45500321348315,"d":"3.46"},{"v":2.51623781158168,"d":"2.52"},{"v":2.48693642610199,"d":"2.49"},{"v":1.11234666846311,"d":"1.11"},{"v":0.153606481343226,"d":"0.15"},{"v":0.44486401367686,"d":"0.44"},{"v":0.877068809907661,"d":"0.88"},"up","no"]
["MSTRG.4738","SLC23A2","ENSOART00000018360","GO:0005215(transporter activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008520(L-ascorbate:sodium symporter activity);GO:0009925(basal plasma membrane);GO:0015229(L-ascorbic acid transmembrane transporter activity);GO:0015882(L-ascorbic acid transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport);GO:0070890(sodium-dependent L-ascorbate transmembrane transporter activity);GO:0070904(transepithelial L-ascorbic acid transport)","NA","K14611","NA","solute carrier family 23 member 2 [Source:NCBI gene;Acc:101113871]",{"v":2.564931,"d":"2.56"},{"v":1.754094,"d":"1.75"},{"v":1.629934,"d":"1.63"},{"v":2.472219,"d":"2.47"},{"v":2.484111,"d":"2.48"},{"v":2.612794,"d":"2.61"},{"v":0.785950791663606,"d":"0.79"},{"v":-0.347489106634093,"d":"-0.35"},{"v":0.444959233282755,"d":"0.44"},{"v":0.877068809907661,"d":"0.88"},"down","no"]
["MSTRG.9240","CCDC174","ENSOART00000019981","GO:0005634(nucleus);GO:0005654(nucleoplasm)","NA","NA","NA","coiled-coil domain containing 174 [Source:NCBI gene;Acc:101104788]",{"v":1.63304487458927,"d":"1.63"},{"v":1.9074723033954,"d":"1.91"},{"v":1.38068615991238,"d":"1.38"},{"v":1.49572781325301,"d":"1.50"},{"v":1.60385158488499,"d":"1.60"},{"v":1.18713127491785,"d":"1.19"},{"v":1.14801387666056,"d":"1.15"},{"v":0.199140080749124,"d":"0.20"},{"v":0.445653291719629,"d":"0.45"},{"v":0.877336260814818,"d":"0.88"},"up","no"]
["MSTRG.3168","SP2","ENSOART00000008439","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0035264(multicellular organism growth);GO:0042826(histone deacetylase binding)","NA","K09192","NA","Sp2 transcription factor [Source:NCBI gene;Acc:101117430]",{"v":2.95246795419847,"d":"2.95"},{"v":2.28955650477099,"d":"2.29"},{"v":2.04872585305344,"d":"2.05"},{"v":2.62274694465649,"d":"2.62"},{"v":2.78028036164122,"d":"2.78"},{"v":3.70462211545802,"d":"3.70"},{"v":0.800508448931648,"d":"0.80"},{"v":-0.32101146520334,"d":"-0.32"},{"v":0.447233776918557,"d":"0.45"},{"v":0.878858239201613,"d":"0.88"},"down","no"]
["MSTRG.14896","DDX1","ENSOART00000017831","GO:0002735(positive regulation of myeloid dendritic cell cytokine production);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003725(double-stranded RNA binding);GO:0004518(nuclease activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006388(tRNA splicing, via endonucleolytic cleavage and ligation);GO:0007275(multicellular organism development);GO:0008026(ATP-dependent helicase activity);GO:0008143(poly(A) binding);GO:0009615(response to virus);GO:0010494(cytoplasmic stress granule);GO:0032508(DNA duplex unwinding);GO:0033677(DNA/RNA helicase activity);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043330(response to exogenous dsRNA);GO:0071920(cleavage body);GO:0072669(tRNA-splicing ligase complex);GO:0090305(nucleic acid phosphodiester bond hydrolysis);GO:1903506(regulation of nucleic acid-templated transcription);GO:1903608(protein localization to cytoplasmic stress granule);GO:1990904(ribonucleoprotein complex)","NA","K13177","EC:3.6.4.13","DEAD-box helicase 1 [Source:NCBI gene;Acc:101122091]",{"v":27.1210831930393,"d":"27.12"},{"v":27.0282991699717,"d":"27.03"},{"v":24.660493732497,"d":"24.66"},{"v":24.6324008377175,"d":"24.63"},{"v":21.698485513962,"d":"21.70"},{"v":24.2432978935654,"d":"24.24"},{"v":1.11669553021887,"d":"1.12"},{"v":0.159235885086983,"d":"0.16"},{"v":0.447726730475728,"d":"0.45"},{"v":0.879297817561666,"d":"0.88"},"up","no"]
["MSTRG.8207","HYKK","ENSOART00000001025","NA","00310(Lysine degradation)","K18201","EC:2.7.1.81","hydroxylysine kinase [Source:NCBI gene;Acc:101122555]",{"v":2.570906,"d":"2.57"},{"v":2.277751,"d":"2.28"},{"v":1.170952,"d":"1.17"},{"v":1.478261,"d":"1.48"},{"v":1.833445,"d":"1.83"},{"v":1.734851,"d":"1.73"},{"v":1.19281502220227,"d":"1.19"},{"v":0.254370332016556,"d":"0.25"},{"v":0.448472580585072,"d":"0.45"},{"v":0.879539665774206,"d":"0.88"},"up","no"]
["MSTRG.1307","ATG3","ENSOART00000021036","GO:0000045(autophagosome assembly);GO:0000153(cytoplasmic ubiquitin ligase complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0006914(autophagy);GO:0015031(protein transport);GO:0016236(macroautophagy);GO:0016567(protein ubiquitination);GO:0019776(Atg8 ligase activity);GO:0019777(Atg12 transferase activity);GO:0019787(ubiquitin-like protein transferase activity);GO:0019899(enzyme binding);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0050765(negative regulation of phagocytosis);GO:1902017(regulation of cilium assembly)","04136(Autophagy - other);04140(Autophagy - animal);05167(Kaposi sarcoma-associated herpesvirus infection)","K08343","NA","autophagy related 3 [Source:NCBI gene;Acc:101121560]",{"v":7.649575,"d":"7.65"},{"v":7.177443,"d":"7.18"},{"v":8.483572,"d":"8.48"},{"v":6.444731,"d":"6.44"},{"v":7.368259,"d":"7.37"},{"v":6.797791,"d":"6.80"},{"v":1.13099013569646,"d":"1.13"},{"v":0.177586346441915,"d":"0.18"},{"v":0.449211616250632,"d":"0.45"},{"v":0.879647620987698,"d":"0.88"},"up","no"]
["ENSOARG00000006698","RRP9","ENSOART00000007282","GO:0005515(protein binding);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0031428(box C/D snoRNP complex);GO:0034511(U3 snoRNA binding)","NA","K14793","NA","ribosomal RNA processing 9, U3 small nucleolar RNA binding protein [Source:NCBI gene;Acc:101115318]",{"v":0.446779,"d":"0.45"},{"v":0.729561,"d":"0.73"},{"v":0.775455,"d":"0.78"},{"v":0.554915,"d":"0.55"},{"v":0.555147,"d":"0.56"},{"v":0.56769,"d":"0.57"},{"v":1.16333939700266,"d":"1.16"},{"v":0.218272055487005,"d":"0.22"},{"v":0.449890207227608,"d":"0.45"},{"v":0.880159034700741,"d":"0.88"},"up","no"]
["MSTRG.17715","CALR","ENSOART00000010745","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002502(peptide antigen assembly with MHC class I protein complex);GO:0003729(mRNA binding);GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005829(cytosol);GO:0005844(polysome);GO:0006457(protein folding);GO:0006611(protein export from nucleus);GO:0008284(positive regulation of cell population proliferation);GO:0009897(external side of plasma membrane);GO:0010595(positive regulation of endothelial cell migration);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0017148(negative regulation of translation);GO:0030246(carbohydrate binding);GO:0030866(cortical actin cytoskeleton organization);GO:0031625(ubiquitin protein ligase binding);GO:0033144(negative regulation of intracellular steroid hormone receptor signaling pathway);GO:0034504(protein localization to nucleus);GO:0040020(regulation of meiotic nuclear division);GO:0042824(MHC class I peptide loading complex);GO:0044322(endoplasmic reticulum quality control compartment);GO:0045665(negative regulation of neuron differentiation);GO:0045787(positive regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0048387(negative regulation of retinoic acid receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0050681(androgen receptor binding);GO:0050766(positive regulation of phagocytosis);GO:0050821(protein stabilization);GO:0051082(unfolded protein binding);GO:0071157(negative regulation of cell cycle arrest);GO:0090398(cellular senescence);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1901164(negative regulation of trophoblast cell migration);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:2000510(positive regulation of dendritic cell chemotaxis)","04141(Protein processing in endoplasmic reticulum);04145(Phagosome);04612(Antigen processing and presentation);05142(Chagas disease (American trypanosomiasis));05163(Human cytomegalovirus infection);05166(Human T-cell leukemia virus 1 infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection)","K08057","NA","calreticulin [Source:NCBI gene;Acc:101104396]",{"v":60.723206,"d":"60.72"},{"v":49.705376,"d":"49.71"},{"v":63.970711,"d":"63.97"},{"v":74.005226,"d":"74.01"},{"v":66.054344,"d":"66.05"},{"v":77.954773,"d":"77.95"},{"v":0.799944125694519,"d":"0.80"},{"v":-0.322028860385568,"d":"-0.32"},{"v":0.450270211004264,"d":"0.45"},{"v":0.880585939067866,"d":"0.88"},"down","no"]
["MSTRG.5354","ITFG1","ENSOART00000017582","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K17257","NA","integrin alpha FG-GAP repeat containing 1 [Source:NCBI gene;Acc:101110080]",{"v":6.09309318659622,"d":"6.09"},{"v":5.8423399557842,"d":"5.84"},{"v":6.34855123359288,"d":"6.35"},{"v":6.32047863153504,"d":"6.32"},{"v":5.18850754115684,"d":"5.19"},{"v":5.0289940631257,"d":"5.03"},{"v":1.10557541581615,"d":"1.11"},{"v":0.144797440633981,"d":"0.14"},{"v":0.451456258517897,"d":"0.45"},{"v":0.881548201965258,"d":"0.88"},"up","no"]
["MSTRG.15007","PPP1CB","ENSOART00000021286;ENSOART00000021285","GO:0000164(protein phosphatase type 1 complex);GO:0000784(nuclear chromosome, telomeric region);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0016787(hydrolase activity);GO:0019901(protein kinase binding);GO:0030155(regulation of cell adhesion);GO:0042752(regulation of circadian rhythm);GO:0046872(metal ion binding);GO:0050115(myosin-light-chain-phosphatase activity);GO:0072357(PTW/PP1 phosphatase complex);GO:0072357(PTW/PP1 phosphatase complex)","03015(mRNA surveillance pathway);04022(cGMP-PKG signaling pathway);04024(cAMP signaling pathway);04114(Oocyte meiosis);04218(Cellular senescence);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04390(Hippo signaling pathway);04510(Focal adhesion);04611(Platelet activation);04720(Long-term potentiation);04728(Dopaminergic synapse);04750(Inflammatory mediator regulation of TRP channels);04810(Regulation of actin cytoskeleton);04910(Insulin signaling pathway);04921(Oxytocin signaling pathway);04931(Insulin resistance);05031(Amphetamine addiction);05034(Alcoholism);05168(Herpes simplex virus 1 infection);05205(Proteoglycans in cancer);05205(Proteoglycans in cancer)","K06269","EC:3.1.3.16","protein phosphatase 1 catalytic subunit beta [Source:NCBI gene;Acc:101123197]",{"v":53.2806610995935,"d":"53.28"},{"v":53.6117234607046,"d":"53.61"},{"v":44.0860180460705,"d":"44.09"},{"v":56.3167176097561,"d":"56.32"},{"v":37.1398882554201,"d":"37.14"},{"v":42.6565718163957,"d":"42.66"},{"v":1.10921223924088,"d":"1.11"},{"v":0.149535440526009,"d":"0.15"},{"v":0.452414618544536,"d":"0.45"},{"v":0.881987113300358,"d":"0.88"},"up","no"]
["MSTRG.18204","CAMLG","ENSOART00000015578","GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0031397(negative regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0050821(protein stabilization)","NA","K22385","NA","calcium modulating ligand [Source:NCBI gene;Acc:101119046]",{"v":6.341633,"d":"6.34"},{"v":6.836998,"d":"6.84"},{"v":7.244928,"d":"7.24"},{"v":5.773315,"d":"5.77"},{"v":5.791067,"d":"5.79"},{"v":6.443307,"d":"6.44"},{"v":1.13415769230577,"d":"1.13"},{"v":0.181621245298619,"d":"0.18"},{"v":0.452823336193287,"d":"0.45"},{"v":0.881987113300358,"d":"0.88"},"up","no"]
["MSTRG.14971","MAPRE3","ENSOART00000020730","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0008017(microtubule binding);GO:0008022(protein C-terminus binding);GO:0015630(microtubule cytoskeleton);GO:0019901(protein kinase binding);GO:0030496(midbody);GO:0035371(microtubule plus-end);GO:0042802(identical protein binding);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045860(positive regulation of protein kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:1903033(positive regulation of microtubule plus-end binding)","NA","K10436","NA","microtubule associated protein RP/EB family member 3 [Source:NCBI gene;Acc:101112123]",{"v":27.881725,"d":"27.88"},{"v":39.809025,"d":"39.81"},{"v":38.927517,"d":"38.93"},{"v":21.807648,"d":"21.81"},{"v":34.681873,"d":"34.68"},{"v":36.433971,"d":"36.43"},{"v":1.14737688721384,"d":"1.15"},{"v":0.198339361713446,"d":"0.20"},{"v":0.453461534953451,"d":"0.45"},{"v":0.882177998656017,"d":"0.88"},"up","no"]
["MSTRG.15251","ENSOARG00000004567","ENSOART00000004978;ENSOART00000004980;ENSOART00000004975","GO:0005672(transcription factor TFIIA complex);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006886(intracellular protein transport);GO:0006897(endocytosis);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0030100(regulation of endocytosis);GO:0030131(clathrin adaptor complex);GO:0030131(clathrin adaptor complex)","03022(Basal transcription factors);05203(Viral carcinogenesis);05203(Viral carcinogenesis)","K03122;K20067","NA","general transcription factor IIA subunit 1 like [Source:NCBI gene;Acc:101105897]",{"v":1.68921222611314,"d":"1.69"},{"v":0.708420010141024,"d":"0.71"},{"v":1.07447303977183,"d":"1.07"},{"v":1.73264402440184,"d":"1.73"},{"v":1.4447849706861,"d":"1.44"},{"v":1.25574616304865,"d":"1.26"},{"v":0.783209585042752,"d":"0.78"},{"v":-0.35252967390767,"d":"-0.35"},{"v":0.454712269188527,"d":"0.45"},{"v":0.882918602834462,"d":"0.88"},"down","no"]
["MSTRG.5864","NAPA","ENSOART00000012228","GO:0005515(protein binding);GO:0006886(intracellular protein transport);GO:0007420(brain development);GO:0010807(regulation of synaptic vesicle priming);GO:0016082(synaptic vesicle priming);GO:0019905(syntaxin binding);GO:0030182(neuron differentiation);GO:0035249(synaptic transmission, glutamatergic);GO:0035494(SNARE complex disassembly);GO:0045176(apical protein localization);GO:0070044(synaptobrevin 2-SNAP-25-syntaxin-1a complex);GO:0098793(presynapse);GO:0098978(glutamatergic synapse)","04721(Synaptic vesicle cycle)","K15296","NA","NSF attachment protein alpha [Source:NCBI gene;Acc:101119072]",{"v":20.328899,"d":"20.33"},{"v":19.878002,"d":"19.88"},{"v":22.216393,"d":"22.22"},{"v":24.827692,"d":"24.83"},{"v":22.755581,"d":"22.76"},{"v":30.445795,"d":"30.45"},{"v":0.800000507503178,"d":"0.80"},{"v":-0.321927179672254,"d":"-0.32"},{"v":0.455888604247805,"d":"0.46"},{"v":0.883424617949245,"d":"0.88"},"down","no"]
["MSTRG.4849","MIR1-1;oar-mir-133","ENSOART00000023725;ENSOART00000024840","NA","05206(MicroRNAs in cancer)","K16970","NA","microRNA 1-1 [Source:HGNC Symbol;Acc:HGNC:31499];oar-mir-133 [Source:miRBase;Acc:MI0014122]",{"v":23.4719773256355,"d":"23.47"},{"v":20.6464507345074,"d":"20.65"},{"v":22.3189438032896,"d":"22.32"},{"v":28.5348896155508,"d":"28.53"},{"v":32.8788346665559,"d":"32.88"},{"v":21.7997563231434,"d":"21.80"},{"v":0.798396742693645,"d":"0.80"},{"v":-0.324822260120644,"d":"-0.32"},{"v":0.456813839122356,"d":"0.46"},{"v":0.883960223416666,"d":"0.88"},"down","no"]
["MSTRG.3602","MRPL38;TRIM65","ENSOART00000009685;ENSOART00000009739","GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0010508(positive regulation of autophagy);GO:0046872(metal ion binding)","NA","K17419;K12031","NA","mitochondrial ribosomal protein L38 [Source:NCBI gene;Acc:101107615];tripartite motif-containing protein 47 [Source:NCBI gene;Acc:101107878]",{"v":4.24324238834681,"d":"4.24"},{"v":4.4411869028436,"d":"4.44"},{"v":4.16495515430722,"d":"4.16"},{"v":5.82180442333426,"d":"5.82"},{"v":4.62498943127962,"d":"4.62"},{"v":5.61351784025648,"d":"5.61"},{"v":0.800070676685665,"d":"0.80"},{"v":-0.321800644387247,"d":"-0.32"},{"v":0.456924695552213,"d":"0.46"},{"v":0.884007615323146,"d":"0.88"},"down","no"]
["MSTRG.11504","ATAT1","ENSOART00000013486","GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005819(spindle);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0005905(clathrin-coated pit);GO:0005925(focal adhesion);GO:0007283(spermatogenesis);GO:0016020(membrane);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0019799(tubulin N-acetyltransferase activity);GO:0021542(dentate gyrus development);GO:0030054(cell junction);GO:0030424(axon);GO:0042995(cell projection);GO:0045598(regulation of fat cell differentiation);GO:0048666(neuron development);GO:0050662(coenzyme binding);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0071929(alpha-tubulin acetylation);GO:0072686(mitotic spindle);GO:0097427(microtubule bundle);GO:1900227(positive regulation of NLRP3 inflammasome complex assembly)","NA","K19573","EC:2.3.1.108","alpha tubulin acetyltransferase 1 [Source:NCBI gene;Acc:101106803]",{"v":1.435578212086,"d":"1.44"},{"v":0.966769566531087,"d":"0.97"},{"v":1.67641397908193,"d":"1.68"},{"v":1.45590792562464,"d":"1.46"},{"v":2.04776338756537,"d":"2.05"},{"v":1.78648675421267,"d":"1.79"},{"v":0.771009430291291,"d":"0.77"},{"v":-0.375179588895851,"d":"-0.38"},{"v":0.457966857349761,"d":"0.46"},{"v":0.884074431154798,"d":"0.88"},"down","no"]
["MSTRG.1367","GOLGB1","ENSOART00000021843","GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:1905793(protein localization to pericentriolar material)","NA","K20478","NA","golgin B1 [Source:NCBI gene;Acc:101110468]",{"v":1.334164,"d":"1.33"},{"v":1.153702,"d":"1.15"},{"v":1.311926,"d":"1.31"},{"v":0.989378,"d":"0.99"},{"v":1.257858,"d":"1.26"},{"v":1.151246,"d":"1.15"},{"v":1.11808507445383,"d":"1.12"},{"v":0.161029966198145,"d":"0.16"},{"v":0.458055681633786,"d":"0.46"},{"v":0.884074431154798,"d":"0.88"},"up","no"]
["MSTRG.15974","ZBTB39","ENSOART00000019486","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA","K10511","NA","zinc finger and BTB domain containing 39 [Source:NCBI gene;Acc:101103709]",{"v":1.556648,"d":"1.56"},{"v":1.189745,"d":"1.19"},{"v":1.217545,"d":"1.22"},{"v":2.046592,"d":"2.05"},{"v":1.401508,"d":"1.40"},{"v":1.665599,"d":"1.67"},{"v":0.775160602921682,"d":"0.78"},{"v":-0.367432846391681,"d":"-0.37"},{"v":0.459041625748552,"d":"0.46"},{"v":0.884497482325037,"d":"0.88"},"down","no"]
["MSTRG.2670","CCL14","ENSOART00000005265","GO:0005576(extracellular region);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0060326(cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)","K21092","NA","C-C motif chemokine 14 [Source:NCBI gene;Acc:101115044]",{"v":30.736958,"d":"30.74"},{"v":25.979166,"d":"25.98"},{"v":18.959583,"d":"18.96"},{"v":37.352711,"d":"37.35"},{"v":27.29274,"d":"27.29"},{"v":31.345964,"d":"31.35"},{"v":0.788359115239629,"d":"0.79"},{"v":-0.34307513556645,"d":"-0.34"},{"v":0.459740132727265,"d":"0.46"},{"v":0.884867821425377,"d":"0.88"},"down","no"]
["MSTRG.7012","DHX29","ENSOART00000008537","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003724(RNA helicase activity);GO:0003743(translation initiation factor activity);GO:0004004(ATP-dependent RNA helicase activity);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006412(translation);GO:0006413(translational initiation);GO:0016282(eukaryotic 43S preinitiation complex);GO:0016787(hydrolase activity);GO:0016818(hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides);GO:0043024(ribosomal small subunit binding);GO:0045948(positive regulation of translational initiation)","NA","K18995","EC:3.6.4.13","DExH-box helicase 29 [Source:NCBI gene;Acc:101114811]",{"v":3.29413514054867,"d":"3.29"},{"v":3.81645253119128,"d":"3.82"},{"v":3.77999892296129,"d":"3.78"},{"v":3.23256639815859,"d":"3.23"},{"v":3.58838665614431,"d":"3.59"},{"v":3.00793725253664,"d":"3.01"},{"v":1.10801792010263,"d":"1.11"},{"v":0.147981214450396,"d":"0.15"},{"v":0.460959214059,"d":"0.46"},{"v":0.885364500539698,"d":"0.89"},"up","no"]
["MSTRG.429","RF00279;RABGGTB","ENSOART00000024086;ENSOART00000013735","GO:0003824(catalytic activity);GO:0004659(prenyltransferase activity);GO:0004663(Rab geranylgeranyltransferase activity);GO:0005968(Rab-protein geranylgeranyltransferase complex);GO:0016740(transferase activity);GO:0018344(protein geranylgeranylation);GO:0046872(metal ion binding)","NA","K05956","EC:2.5.1.60","small nucleolar RNA, C/D box 45C [Source:HGNC Symbol;Acc:HGNC:32720];Rab geranylgeranyltransferase subunit beta [Source:NCBI gene;Acc:100302071]",{"v":1.897166648514,"d":"1.90"},{"v":1.80611162858615,"d":"1.81"},{"v":1.93944176241196,"d":"1.94"},{"v":2.27079290121972,"d":"2.27"},{"v":2.76639587957396,"d":"2.77"},{"v":2.01121496048789,"d":"2.01"},{"v":0.800567085347771,"d":"0.80"},{"v":-0.320905793153542,"d":"-0.32"},{"v":0.46189823839686,"d":"0.46"},{"v":0.885513024766164,"d":"0.89"},"down","no"]
["MSTRG.13227","RAB26","ENSOART00000019230","GO:0000139(Golgi membrane);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0019002(GMP binding);GO:0030667(secretory granule membrane);GO:0035272(exocrine system development);GO:0043001(Golgi to plasma membrane protein transport);GO:0045055(regulated exocytosis);GO:0098993(anchored component of synaptic vesicle membrane);GO:0099575(regulation of protein catabolic process at presynapse, modulating synaptic transmission)","NA","K07913","NA","RAB26, member RAS oncogene family [Source:NCBI gene;Acc:101113902]",{"v":1.376643,"d":"1.38"},{"v":1.282012,"d":"1.28"},{"v":0.550022,"d":"0.55"},{"v":1.102941,"d":"1.10"},{"v":0.437218,"d":"0.44"},{"v":1.012052,"d":"1.01"},{"v":1.25721462684707,"d":"1.26"},{"v":0.330230962133953,"d":"0.33"},{"v":0.462688228686686,"d":"0.46"},{"v":0.885553995518416,"d":"0.89"},"up","no"]
["MSTRG.15695","AAAS","ENSOART00000017997","GO:0005515(protein binding);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006913(nucleocytoplasmic transport);GO:0007612(learning);GO:0009566(fertilization);GO:0031965(nuclear membrane)","03013(RNA transport)","K14320","NA","aladin WD repeat nucleoporin [Source:NCBI gene;Acc:101104648]",{"v":1.65132710940499,"d":"1.65"},{"v":1.46445288291747,"d":"1.46"},{"v":1.58928694817658,"d":"1.59"},{"v":2.4304376353167,"d":"2.43"},{"v":1.74283963915547,"d":"1.74"},{"v":1.8606353243762,"d":"1.86"},{"v":0.779770482820226,"d":"0.78"},{"v":-0.358878550429906,"d":"-0.36"},{"v":0.463146561283034,"d":"0.46"},{"v":0.885553995518416,"d":"0.89"},"down","no"]
["MSTRG.4492","ACBD5;YME1L1","ENSOART00000017392;ENSOART00000017160","GO:0000062(fatty-acyl-CoA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005777(peroxisome);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030242(autophagy of peroxisome);GO:0004176(ATP-dependent peptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006508(proteolysis);GO:0006515(protein quality control for misfolded or incompletely synthesized proteins);GO:0007005(mitochondrion organization);GO:0008283(cell population proliferation);GO:0016604(nuclear body);GO:0034214(protein hexamerization);GO:0034982(mitochondrial protein processing);GO:0035694(mitochondrial protein catabolic process);GO:0043066(negative regulation of apoptotic process)","NA","K08955","EC:3.4.24.-","acyl-CoA binding domain containing 5 [Source:NCBI gene;Acc:101119491];YME1 like 1 ATPase [Source:NCBI gene;Acc:101118628]",{"v":6.17028684338033,"d":"6.17"},{"v":6.50002349222168,"d":"6.50"},{"v":5.99961367485011,"d":"6.00"},{"v":5.81877099740723,"d":"5.82"},{"v":5.55814453005996,"d":"5.56"},{"v":5.50999847010209,"d":"5.51"},{"v":1.10558530783893,"d":"1.11"},{"v":0.14481034894232,"d":"0.14"},{"v":0.463570162842263,"d":"0.46"},{"v":0.885697825753389,"d":"0.89"},"up","no"]
["MSTRG.20178","ZC2HC1C","ENSOART00000001776","NA","NA","NA","NA","zinc finger C2HC-type containing 1C [Source:NCBI gene;Acc:101107707]",{"v":0.39128,"d":"0.39"},{"v":0.151292,"d":"0.15"},{"v":0.581078,"d":"0.58"},{"v":0.791407,"d":"0.79"},{"v":0.504649,"d":"0.50"},{"v":0.310992,"d":"0.31"},{"v":0.699201268412642,"d":"0.70"},{"v":-0.516220292870692,"d":"-0.52"},{"v":0.464579807220507,"d":"0.46"},{"v":0.886102340332426,"d":"0.89"},"down","no"]
["MSTRG.2912","ACADVL","ENSOART00000011600","GO:0001659(temperature homeostasis);GO:0003995(acyl-CoA dehydrogenase activity);GO:0004466(long-chain-acyl-CoA dehydrogenase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0009062(fatty acid catabolic process);GO:0009409(response to cold);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0030855(epithelial cell differentiation);GO:0031966(mitochondrial membrane);GO:0033539(fatty acid beta-oxidation using acyl-CoA dehydrogenase);GO:0042645(mitochondrial nucleoid);GO:0045717(negative regulation of fatty acid biosynthetic process);GO:0046322(negative regulation of fatty acid oxidation);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0090181(regulation of cholesterol metabolic process)","00071(Fatty acid degradation)","K09479","EC:1.3.8.9","acyl-CoA dehydrogenase very long chain [Source:NCBI gene;Acc:101117173]",{"v":61.03434,"d":"61.03"},{"v":58.308918,"d":"58.31"},{"v":43.152039,"d":"43.15"},{"v":81.2668,"d":"81.27"},{"v":53.400455,"d":"53.40"},{"v":69.028763,"d":"69.03"},{"v":0.797734283642206,"d":"0.80"},{"v":-0.326019813989858,"d":"-0.33"},{"v":0.465742623415851,"d":"0.47"},{"v":0.887047245299748,"d":"0.89"},"down","no"]
["MSTRG.13889","SIPA1L2","ENSOART00000003619;ENSOART00000003617","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0051056(regulation of small GTPase mediated signal transduction)","04015(Rap1 signaling pathway);04015(Rap1 signaling pathway)","K17702","NA","signal induced proliferation associated 1 like 2 [Source:NCBI gene;Acc:101112448]",{"v":2.18885268437634,"d":"2.19"},{"v":1.57691418072462,"d":"1.58"},{"v":1.44112974165831,"d":"1.44"},{"v":2.24932289288272,"d":"2.25"},{"v":2.25199339639124,"d":"2.25"},{"v":1.97379056522984,"d":"1.97"},{"v":0.804140645669435,"d":"0.80"},{"v":-0.314480241413232,"d":"-0.31"},{"v":0.467500345026948,"d":"0.47"},{"v":0.88869091514434,"d":"0.89"},"down","no"]
["MSTRG.12476","CUTC","ENSOART00000013891","GO:0005507(copper ion binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0051262(protein tetramerization);GO:0055070(copper ion homeostasis)","NA","K06201","NA","cutC copper transporter [Source:NCBI gene;Acc:101119521]",{"v":32.475395,"d":"32.48"},{"v":38.2537,"d":"38.25"},{"v":31.237585,"d":"31.24"},{"v":33.749413,"d":"33.75"},{"v":32.378696,"d":"32.38"},{"v":26.699484,"d":"26.70"},{"v":1.09845226731237,"d":"1.10"},{"v":0.135472179540045,"d":"0.14"},{"v":0.46813867120002,"d":"0.47"},{"v":0.88869091514434,"d":"0.89"},"up","no"]
["MSTRG.16029","GDF11","ENSOART00000012211","GO:0005576(extracellular region);GO:0005654(nucleoplasm);GO:0008083(growth factor activity);GO:0010469(regulation of signaling receptor activity);GO:0032991(protein-containing complex);GO:0043231(intracellular membrane-bounded organelle);GO:0060395(SMAD protein signal transduction)","NA","NA","NA","growth differentiation factor 11 [Source:HGNC Symbol;Acc:HGNC:4216]",{"v":0.670127,"d":"0.67"},{"v":0.769031,"d":"0.77"},{"v":0.490766,"d":"0.49"},{"v":0.630962,"d":"0.63"},{"v":1.064721,"d":"1.06"},{"v":0.93042,"d":"0.93"},{"v":0.734900344731338,"d":"0.73"},{"v":-0.444379466583914,"d":"-0.44"},{"v":0.468773804908154,"d":"0.47"},{"v":0.888879187845818,"d":"0.89"},"down","no"]
["MSTRG.6581","RAB6A","ENSOART00000008700","GO:0000139(Golgi membrane);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0006890(retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum);GO:0016020(membrane);GO:0018125(peptidyl-cysteine methylation);GO:0019882(antigen processing and presentation);GO:0019904(protein domain specific binding);GO:0031410(cytoplasmic vesicle);GO:0031489(myosin V binding);GO:0034067(protein localization to Golgi apparatus);GO:0070381(endosome to plasma membrane transport vesicle)","NA","K07893","NA","RAB6A, member RAS oncogene family [Source:NCBI gene;Acc:101103262]",{"v":11.3235717448025,"d":"11.32"},{"v":11.7333267094595,"d":"11.73"},{"v":10.2400399391892,"d":"10.24"},{"v":11.7485682302495,"d":"11.75"},{"v":8.60245660758836,"d":"8.60"},{"v":9.84769846049896,"d":"9.85"},{"v":1.10259424097194,"d":"1.10"},{"v":0.140901971131788,"d":"0.14"},{"v":0.469043260154298,"d":"0.47"},{"v":0.889080375179868,"d":"0.89"},"up","no"]
["MSTRG.15510","ANKRD39","ENSOART00000014942","GO:0005515(protein binding)","NA","NA","NA","ankyrin repeat domain 39 [Source:NCBI gene;Acc:101113669]",{"v":2.442546,"d":"2.44"},{"v":2.705403,"d":"2.71"},{"v":1.866539,"d":"1.87"},{"v":2.96868,"d":"2.97"},{"v":3.576628,"d":"3.58"},{"v":2.623509,"d":"2.62"},{"v":0.765037408860925,"d":"0.77"},{"v":-0.386397800338784,"d":"-0.39"},{"v":0.469642203146133,"d":"0.47"},{"v":0.889185102557083,"d":"0.89"},"down","no"]
["MSTRG.13063","MBD1;CFAP53","ENSOART00000004592;ENSOART00000004496","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0008270(zinc ion binding);GO:0008327(methyl-CpG binding);GO:0010385(double-stranded methylated DNA binding);GO:0003341(cilium movement);GO:0007368(determination of left/right symmetry);GO:0060271(cilium assembly)","NA","K11589","NA","methyl-CpG binding domain protein 1 [Source:NCBI gene;Acc:101116619];cilia and flagella associated protein 53 [Source:HGNC Symbol;Acc:HGNC:26530]",{"v":2.7933335205202,"d":"2.79"},{"v":2.31152950421064,"d":"2.31"},{"v":2.36135416693316,"d":"2.36"},{"v":3.32607364225562,"d":"3.33"},{"v":3.19598382070142,"d":"3.20"},{"v":2.74851626447074,"d":"2.75"},{"v":0.805367327976106,"d":"0.81"},{"v":-0.312281148457846,"d":"-0.31"},{"v":0.470625984704747,"d":"0.47"},{"v":0.88970488343859,"d":"0.89"},"down","no"]
["MSTRG.3221","NR1D1","ENSOART00000014161","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001222(transcription corepressor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005978(glycogen biosynthetic process);GO:0006355(regulation of transcription, DNA-templated);GO:0007623(circadian rhythm);GO:0008270(zinc ion binding);GO:0010498(proteasomal protein catabolic process);GO:0010871(negative regulation of receptor biosynthetic process);GO:0016604(nuclear body);GO:0019216(regulation of lipid metabolic process);GO:0020037(heme binding);GO:0030425(dendrite);GO:0032922(circadian regulation of gene expression);GO:0034144(negative regulation of toll-like receptor 4 signaling pathway);GO:0035947(regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter);GO:0042632(cholesterol homeostasis);GO:0042752(regulation of circadian rhythm);GO:0043197(dendritic spine);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0044321(response to leptin);GO:0045598(regulation of fat cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0060086(circadian temperature homeostasis);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0061469(regulation of type B pancreatic cell proliferation);GO:0070859(positive regulation of bile acid biosynthetic process);GO:0070888(E-box binding);GO:0071222(cellular response to lipopolysaccharide);GO:0120163(negative regulation of cold-induced thermogenesis)","04710(Circadian rhythm)","K03728","NA","nuclear receptor subfamily 1 group D member 1 [Source:NCBI gene;Acc:100174903]",{"v":10.5393399424255,"d":"10.54"},{"v":9.40192618864843,"d":"9.40"},{"v":10.4834181915067,"d":"10.48"},{"v":14.5891921363822,"d":"14.59"},{"v":9.15691385749285,"d":"9.16"},{"v":14.3394684552879,"d":"14.34"},{"v":0.798850608468354,"d":"0.80"},{"v":-0.324002362163638,"d":"-0.32"},{"v":0.471391533381805,"d":"0.47"},{"v":0.889732162961524,"d":"0.89"},"down","no"]
["MSTRG.20448","ENSOARG00000010506","ENSOART00000011438","NA","NA","NA","NA",null,{"v":0.537385036200495,"d":"0.54"},{"v":0.98768363799505,"d":"0.99"},{"v":0.40521748019802,"d":"0.41"},{"v":0.634857783725247,"d":"0.63"},{"v":1.01441993811881,"d":"1.01"},{"v":0.931140273824257,"d":"0.93"},{"v":0.748051733336959,"d":"0.75"},{"v":-0.418790048239927,"d":"-0.42"},{"v":0.472178326367673,"d":"0.47"},{"v":0.889732162961524,"d":"0.89"},"down","no"]
["MSTRG.19636","SPRED1","ENSOART00000021809;ENSOART00000021808","GO:0000188(inactivation of MAPK activity);GO:0005173(stem cell factor receptor binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0007275(multicellular organism development);GO:0009966(regulation of signal transduction);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010923(negative regulation of phosphatase activity);GO:0016020(membrane);GO:0016525(negative regulation of angiogenesis);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0030291(protein serine/threonine kinase inhibitor activity);GO:0031410(cytoplasmic vesicle);GO:0043409(negative regulation of MAPK cascade);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0060979(vasculogenesis involved in coronary vascular morphogenesis);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis);GO:0090311(regulation of protein deacetylation);GO:0090311(regulation of protein deacetylation)","NA","K04703","NA","sprouty related EVH1 domain containing 1 [Source:NCBI gene;Acc:101112323]",{"v":2.28998617274939,"d":"2.29"},{"v":1.62487942544317,"d":"1.62"},{"v":2.21239659193604,"d":"2.21"},{"v":2.89212329996524,"d":"2.89"},{"v":2.38894580326729,"d":"2.39"},{"v":2.33554052832812,"d":"2.34"},{"v":0.804460578462535,"d":"0.80"},{"v":-0.313906369588214,"d":"-0.31"},{"v":0.472622903392783,"d":"0.47"},{"v":0.889732162961524,"d":"0.89"},"down","no"]
["MSTRG.15696","C12orf10;ENSOARG00000016558","ENSOART00000018015;ENSOART00000018016;ENSOART00000018031","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0035641(locomotory exploration behavior);GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0051082(unfolded protein binding)","NA","K04797","NA","chromosome 3 open reading frame, human C12orf10 [Source:NCBI gene;Acc:101105232];prefoldin subunit 5 [Source:NCBI gene;Acc:101105486]",{"v":15.3337388982913,"d":"15.33"},{"v":13.5467343307567,"d":"13.55"},{"v":15.4332098641172,"d":"15.43"},{"v":15.8335003681855,"d":"15.83"},{"v":18.3396085777055,"d":"18.34"},{"v":20.5827583498779,"d":"20.58"},{"v":0.809295611259351,"d":"0.81"},{"v":-0.30526132301228,"d":"-0.31"},{"v":0.473701244881831,"d":"0.47"},{"v":0.889836800596281,"d":"0.89"},"down","no"]
["MSTRG.15038","ANTXR1","ENSOART00000021588","GO:0001568(blood vessel development);GO:0004888(transmembrane signaling receptor activity);GO:0005518(collagen binding);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022414(reproductive process);GO:0031258(lamellipodium membrane);GO:0031527(filopodium membrane);GO:0031532(actin cytoskeleton reorganization);GO:0034446(substrate adhesion-dependent cell spreading);GO:0038023(signaling receptor activity);GO:0051015(actin filament binding);GO:1901202(negative regulation of extracellular matrix assembly);GO:1905050(positive regulation of metallopeptidase activity)","04621(NOD-like receptor signaling pathway)","K20909","NA","ANTXR cell adhesion molecule 1 [Source:NCBI gene;Acc:101108204]",{"v":7.25606,"d":"7.26"},{"v":4.492257,"d":"4.49"},{"v":9.223092,"d":"9.22"},{"v":8.615228,"d":"8.62"},{"v":9.054873,"d":"9.05"},{"v":8.677538,"d":"8.68"},{"v":0.795950217778526,"d":"0.80"},{"v":-0.329249893779222,"d":"-0.33"},{"v":0.474094450871356,"d":"0.47"},{"v":0.889976338678719,"d":"0.89"},"down","no"]
["MSTRG.12005","MARK2","ENSOART00000003775","GO:0000166(nucleotide binding);GO:0000226(microtubule cytoskeleton organization);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0010976(positive regulation of neuron projection development);GO:0016020(membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016328(lateral plasma membrane);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0030010(establishment of cell polarity);GO:0030425(dendrite);GO:0035556(intracellular signal transduction);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0050321(tau-protein kinase activity);GO:0050770(regulation of axonogenesis);GO:0070507(regulation of microtubule cytoskeleton organization);GO:0097427(microtubule bundle)","NA","K08798","EC:2.7.11.1","serine/threonine-protein kinase MARK2 [Source:NCBI gene;Acc:101121302]",{"v":4.06888871271394,"d":"4.07"},{"v":3.92966188801956,"d":"3.93"},{"v":3.5597516400978,"d":"3.56"},{"v":4.26652423471883,"d":"4.27"},{"v":5.19898915476773,"d":"5.20"},{"v":4.86319894938875,"d":"4.86"},{"v":0.806653240533862,"d":"0.81"},{"v":-0.30997946558874,"d":"-0.31"},{"v":0.47608417277451,"d":"0.48"},{"v":0.891025706123164,"d":"0.89"},"down","no"]
["MSTRG.20928","SCRIB","ENSOART00000017809","GO:0001843(neural tube closure);GO:0001921(positive regulation of receptor recycling);GO:0002093(auditory receptor cell morphogenesis);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005913(cell-cell adherens junction);GO:0008104(protein localization);GO:0008283(cell population proliferation);GO:0016080(synaptic vesicle targeting);GO:0016323(basolateral plasma membrane);GO:0016331(morphogenesis of embryonic epithelium);GO:0016477(cell migration);GO:0021747(cochlear nucleus development);GO:0030054(cell junction);GO:0031252(cell leading edge);GO:0034750(Scrib-APC-beta-catenin complex);GO:0035089(establishment of apical/basal cell polarity);GO:0035748(myelin sheath abaxonal region);GO:0042060(wound healing);GO:0042734(presynaptic membrane);GO:0043065(positive regulation of apoptotic process);GO:0044291(cell-cell contact zone);GO:0045211(postsynaptic membrane);GO:0045930(negative regulation of mitotic cell cycle);GO:0048488(synaptic vesicle endocytosis);GO:0050918(positive chemotaxis);GO:0060088(auditory receptor cell stereocilium organization);GO:0060561(apoptotic process involved in morphogenesis);GO:0060603(mammary gland duct morphogenesis);GO:0071896(protein localization to adherens junction);GO:0090630(activation of GTPase activity);GO:0098609(cell-cell adhesion)","04390(Hippo signaling pathway);04530(Tight junction);05165(Human papillomavirus infection);05203(Viral carcinogenesis)","K16175","NA","scribbled planar cell polarity protein [Source:NCBI gene;Acc:101111976]",{"v":3.53450130974084,"d":"3.53"},{"v":3.417383969437,"d":"3.42"},{"v":2.86684210795353,"d":"2.87"},{"v":3.5019314432529,"d":"3.50"},{"v":4.537895687042,"d":"4.54"},{"v":4.14066118337802,"d":"4.14"},{"v":0.80610293563597,"d":"0.81"},{"v":-0.310964018851916,"d":"-0.31"},{"v":0.476091268193455,"d":"0.48"},{"v":0.891025706123164,"d":"0.89"},"down","no"]
["MSTRG.20352","RNF217","ENSOART00000008718","GO:0004842(ubiquitin-protein transferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0046872(metal ion binding)","NA","K11977","EC:2.3.2.31","ring finger protein 217 [Source:NCBI gene;Acc:101119141]",{"v":1.53477177887585,"d":"1.53"},{"v":4.98630221523258,"d":"4.99"},{"v":4.00658714196798,"d":"4.01"},{"v":2.13580632508196,"d":"2.14"},{"v":4.30918127614387,"d":"4.31"},{"v":2.56582688121823,"d":"2.57"},{"v":1.168336242699,"d":"1.17"},{"v":0.224455536087231,"d":"0.22"},{"v":0.477915161590518,"d":"0.48"},{"v":0.891783406978394,"d":"0.89"},"up","no"]
["MSTRG.10241","PDK1","ENSOART00000001085","GO:0004672(protein kinase activity);GO:0004740(pyruvate dehydrogenase (acetyl-transferring) kinase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0005967(mitochondrial pyruvate dehydrogenase complex);GO:0006468(protein phosphorylation);GO:0008283(cell population proliferation);GO:0008631(intrinsic apoptotic signaling pathway in response to oxidative stress);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0010906(regulation of glucose metabolic process);GO:0097411(hypoxia-inducible factor-1alpha signaling pathway)","04066(HIF-1 signaling pathway);04360(Axon guidance);05230(Central carbon metabolism in cancer)","K12077","EC:2.7.11.2","pyruvate dehydrogenase kinase 1 [Source:NCBI gene;Acc:101113205]",{"v":9.91672,"d":"9.92"},{"v":8.222547,"d":"8.22"},{"v":8.007262,"d":"8.01"},{"v":8.318678,"d":"8.32"},{"v":8.063178,"d":"8.06"},{"v":7.279346,"d":"7.28"},{"v":1.10503807033979,"d":"1.11"},{"v":0.1440960736387,"d":"0.14"},{"v":0.478087047403843,"d":"0.48"},{"v":0.891783406978394,"d":"0.89"},"up","no"]
["ENSOARG00000005655","MMP28","ENSOART00000006158","GO:0004222(metalloendopeptidase activity);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0010760(negative regulation of macrophage chemotaxis);GO:0016787(hydrolase activity);GO:0031012(extracellular matrix);GO:0046872(metal ion binding)","NA","K08006","EC:3.4.24.-","matrix metallopeptidase 28 [Source:NCBI gene;Acc:101112075]",{"v":0.92147,"d":"0.92"},{"v":0.66405,"d":"0.66"},{"v":0.372326,"d":"0.37"},{"v":0.425262,"d":"0.43"},{"v":1.378222,"d":"1.38"},{"v":0.864173,"d":"0.86"},{"v":0.733919690574913,"d":"0.73"},{"v":-0.446305890603888,"d":"-0.45"},{"v":0.478811522829731,"d":"0.48"},{"v":0.892007986816796,"d":"0.89"},"down","no"]
["MSTRG.11522","ENSOARG00000020055","ENSOART00000021835","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 1 [Source:NCBI gene;Acc:101108348]",{"v":19.648613,"d":"19.65"},{"v":9.956766,"d":"9.96"},{"v":24.6124,"d":"24.61"},{"v":25.850794,"d":"25.85"},{"v":17.541248,"d":"17.54"},{"v":25.958397,"d":"25.96"},{"v":0.781794315678377,"d":"0.78"},{"v":-0.355138999864188,"d":"-0.36"},{"v":0.480590100695432,"d":"0.48"},{"v":0.893138265854882,"d":"0.89"},"down","no"]
["MSTRG.12538","CNNM2","ENSOART00000002916","GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0010960(magnesium ion homeostasis);GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0043231(intracellular membrane-bounded organelle);GO:1903830(magnesium ion transmembrane transport)","NA","K16302","NA","cyclin and CBS domain divalent metal cation transport mediator 2 [Source:NCBI gene;Acc:101109844]",{"v":1.139986,"d":"1.14"},{"v":1.058065,"d":"1.06"},{"v":1.20488,"d":"1.20"},{"v":1.503242,"d":"1.50"},{"v":1.430208,"d":"1.43"},{"v":1.394879,"d":"1.39"},{"v":0.786199708940794,"d":"0.79"},{"v":-0.347032265225776,"d":"-0.35"},{"v":0.480916229800119,"d":"0.48"},{"v":0.893218555225954,"d":"0.89"},"down","no"]
["ENSOARG00000010272","DUSP4","ENSOART00000011177","GO:0000188(inactivation of MAPK activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0008330(protein tyrosine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0017017(MAP kinase tyrosine/serine/threonine phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0035970(peptidyl-threonine dephosphorylation);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:1990439(MAP kinase serine/threonine phosphatase activity)","04010(MAPK signaling pathway)","K04459","3.1.3.48;EC:3.1.3.16","dual specificity phosphatase 4 [Source:NCBI gene;Acc:101103535]",{"v":0.808931,"d":"0.81"},{"v":0.827593,"d":"0.83"},{"v":0.754889,"d":"0.75"},{"v":0.948698,"d":"0.95"},{"v":1.256924,"d":"1.26"},{"v":0.92012,"d":"0.92"},{"v":0.765070501660086,"d":"0.77"},{"v":-0.386335395828726,"d":"-0.39"},{"v":0.481937278874438,"d":"0.48"},{"v":0.89340053240938,"d":"0.89"},"down","no"]
["MSTRG.20870","PHF3","ENSOART00000013466","GO:0006351(transcription, DNA-templated);GO:0046872(metal ion binding)","NA","NA","NA","PHD finger protein 3 [Source:NCBI gene;Acc:101110245]",{"v":2.16614743004799,"d":"2.17"},{"v":2.23391998744924,"d":"2.23"},{"v":2.11378890611542,"d":"2.11"},{"v":2.28307900873631,"d":"2.28"},{"v":1.90999295287314,"d":"1.91"},{"v":1.76088630220253,"d":"1.76"},{"v":1.09403795508674,"d":"1.09"},{"v":0.129662789927143,"d":"0.13"},{"v":0.483225003533147,"d":"0.48"},{"v":0.894568918105354,"d":"0.89"},"up","no"]
["MSTRG.6878","RPL26L1","ENSOART00000004371","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0015934(large ribosomal subunit)","03010(Ribosome)","K02898","NA","ribosomal protein L26 like 1 [Source:NCBI gene;Acc:101108162]",{"v":7.468177,"d":"7.47"},{"v":6.670845,"d":"6.67"},{"v":8.486309,"d":"8.49"},{"v":9.773067,"d":"9.77"},{"v":6.831641,"d":"6.83"},{"v":12.244486,"d":"12.24"},{"v":0.784262153043167,"d":"0.78"},{"v":-0.350592114427972,"d":"-0.35"},{"v":0.483403388487398,"d":"0.48"},{"v":0.894628940374453,"d":"0.89"},"down","no"]
["MSTRG.21093","ASPH","ENSOART00000018078","GO:0004597(peptide-aspartate beta-dioxygenase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0007389(pattern specification process);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0018193(peptidyl-amino acid modification);GO:0031647(regulation of protein stability);GO:0032541(cortical endoplasmic reticulum);GO:0035108(limb morphogenesis);GO:0042264(peptidyl-aspartic acid hydroxylation);GO:0045862(positive regulation of proteolysis);GO:0055114(oxidation-reduction process);GO:0060021(roof of mouth development);GO:0060325(face morphogenesis);GO:0097202(activation of cysteine-type endopeptidase activity);GO:1901879(regulation of protein depolymerization)","NA","NA","NA","aspartate beta-hydroxylase [Source:HGNC Symbol;Acc:HGNC:757]",{"v":9.26558939193491,"d":"9.27"},{"v":9.0504905246728,"d":"9.05"},{"v":8.44566041342412,"d":"8.45"},{"v":9.71994330420941,"d":"9.72"},{"v":7.63256427935975,"d":"7.63"},{"v":7.18582798514326,"d":"7.19"},{"v":1.09060943661372,"d":"1.09"},{"v":0.125134543695549,"d":"0.13"},{"v":0.484022653229517,"d":"0.48"},{"v":0.894828111631743,"d":"0.89"},"up","no"]
["MSTRG.21981","VAMP7","ENSOART00000004090","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0006906(vesicle fusion);GO:0008333(endosome to lysosome transport);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0030027(lamellipodium);GO:0030133(transport vesicle);GO:0030141(secretory granule);GO:0030667(secretory granule membrane);GO:0031091(platelet alpha granule);GO:0031143(pseudopodium);GO:0031201(SNARE complex);GO:0035493(SNARE complex assembly);GO:0035577(azurophil granule membrane);GO:0043001(Golgi to plasma membrane protein transport);GO:0043005(neuron projection);GO:0043231(intracellular membrane-bounded organelle);GO:0043308(eosinophil degranulation);GO:0043312(neutrophil degranulation);GO:0043320(natural killer cell degranulation);GO:0045177(apical part of cell);GO:0045335(phagocytic vesicle);GO:0048471(perinuclear region of cytoplasm);GO:0050775(positive regulation of dendrite morphogenesis);GO:1900483(regulation of protein targeting to vacuolar membrane);GO:1903595(positive regulation of histamine secretion by mast cell)","04130(SNARE interactions in vesicular transport)","K08515","NA","vesicle associated membrane protein 7 [Source:NCBI gene;Acc:100307050]",{"v":1.91263928,"d":"1.91"},{"v":1.73753556,"d":"1.74"},{"v":1.43000716,"d":"1.43"},{"v":1.90660012,"d":"1.91"},{"v":1.58351472,"d":"1.58"},{"v":1.07065312,"d":"1.07"},{"v":1.11388740768123,"d":"1.11"},{"v":0.155603411682221,"d":"0.16"},{"v":0.485524994544713,"d":"0.49"},{"v":0.895770699346222,"d":"0.90"},"up","no"]
["MSTRG.16760","CDK6","ENSOART00000020213","GO:0000307(cyclin-dependent protein kinase holoenzyme complex);GO:0001726(ruffle);GO:0001954(positive regulation of cell-matrix adhesion);GO:0003323(type B pancreatic cell development);GO:0004672(protein kinase activity);GO:0004693(cyclin-dependent protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0009615(response to virus);GO:0010468(regulation of gene expression);GO:0030332(cyclin binding);GO:0042063(gliogenesis);GO:0043697(cell dedifferentiation);GO:0045638(negative regulation of myeloid cell differentiation);GO:0045646(regulation of erythrocyte differentiation);GO:0045656(negative regulation of monocyte differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045786(negative regulation of cell cycle);GO:0048146(positive regulation of fibroblast proliferation);GO:0050680(negative regulation of epithelial cell proliferation);GO:0098770(FBXO family protein binding);GO:2000773(negative regulation of cellular senescence)","04110(Cell cycle);04115(p53 signaling pathway);04151(PI3K-Akt signaling pathway);04218(Cellular senescence);04934(Cushing syndrome);05160(Hepatitis C);05162(Measles);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05206(MicroRNAs in cancer);05212(Pancreatic cancer);05214(Glioma);05218(Melanoma);05220(Chronic myeloid leukemia);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma)","K02091","EC:2.7.11.22","cyclin dependent kinase 6 [Source:NCBI gene;Acc:100144761]",{"v":3.168577,"d":"3.17"},{"v":2.498819,"d":"2.50"},{"v":4.991033,"d":"4.99"},{"v":4.228145,"d":"4.23"},{"v":5.797445,"d":"5.80"},{"v":3.775843,"d":"3.78"},{"v":0.772269734599298,"d":"0.77"},{"v":-0.372823261899759,"d":"-0.37"},{"v":0.485990459713299,"d":"0.49"},{"v":0.895770699346222,"d":"0.90"},"down","no"]
["MSTRG.5651","SIPA1L3","ENSOART00000006022","GO:0001725(stress fiber);GO:0003382(epithelial cell morphogenesis);GO:0005096(GTPase activator activity);GO:0043547(positive regulation of GTPase activity);GO:0045177(apical part of cell);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0061689(tricellular tight junction);GO:0090162(establishment of epithelial cell polarity)","04015(Rap1 signaling pathway)","K17703","NA","signal induced proliferation associated 1 like 3 [Source:NCBI gene;Acc:101109993]",{"v":1.10085212980769,"d":"1.10"},{"v":0.652598129554656,"d":"0.65"},{"v":1.10472578770243,"d":"1.10"},{"v":1.13516725126518,"d":"1.14"},{"v":1.15035848380567,"d":"1.15"},{"v":1.31220885526316,"d":"1.31"},{"v":0.794437714984258,"d":"0.79"},{"v":-0.331993980166617,"d":"-0.33"},{"v":0.486626679683681,"d":"0.49"},{"v":0.895927073460733,"d":"0.90"},"down","no"]
["MSTRG.12100","SSSCA1;FAM89B","ENSOART00000016930;ENSOART00000016928;ENSOART00000016991","GO:0001222(transcription corepressor binding);GO:0005737(cytoplasm);GO:0030010(establishment of cell polarity);GO:0030027(lamellipodium);GO:0030335(positive regulation of cell migration);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0060392(negative regulation of SMAD protein signal transduction)","NA","NA","NA","Sjogren syndrome/scleroderma autoantigen 1 [Source:NCBI gene;Acc:101108437];family with sequence similarity 89 member B [Source:HGNC Symbol;Acc:HGNC:16708]",{"v":1.80788838691353,"d":"1.81"},{"v":2.12005857584683,"d":"2.12"},{"v":1.80384089669682,"d":"1.80"},{"v":2.08119720239849,"d":"2.08"},{"v":2.01275302019777,"d":"2.01"},{"v":3.05002159457185,"d":"3.05"},{"v":0.802325093960026,"d":"0.80"},{"v":-0.317741174401949,"d":"-0.32"},{"v":0.488618227664114,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"down","no"]
["MSTRG.3954","KIAA2013","ENSOART00000019751","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","KIAA2013 ortholog [Source:NCBI gene;Acc:100037670]",{"v":4.44968464438811,"d":"4.45"},{"v":7.20465590689099,"d":"7.20"},{"v":10.9211979151878,"d":"10.92"},{"v":6.73812493247292,"d":"6.74"},{"v":6.72355229914727,"d":"6.72"},{"v":6.66372005669509,"d":"6.66"},{"v":1.12174374215083,"d":"1.12"},{"v":0.165743135703003,"d":"0.17"},{"v":0.489179887761668,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"up","no"]
["MSTRG.10094","POLR2D","ENSOART00000017418","GO:0000166(nucleotide binding);GO:0003824(catalytic activity);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005665(RNA polymerase II, core complex);GO:0005829(cytosol);GO:0006352(DNA-templated transcription, initiation);GO:0006366(transcription by RNA polymerase II);GO:0016607(nuclear speck);GO:0030880(RNA polymerase complex);GO:0044237(cellular metabolic process)","03020(RNA polymerase);05016(Huntington disease)","K03012","NA","RNA polymerase II subunit D [Source:NCBI gene;Acc:101107845]",{"v":3.021806,"d":"3.02"},{"v":4.46788,"d":"4.47"},{"v":4.023058,"d":"4.02"},{"v":4.321743,"d":"4.32"},{"v":4.577822,"d":"4.58"},{"v":5.892262,"d":"5.89"},{"v":0.778317918401831,"d":"0.78"},{"v":-0.361568523718287,"d":"-0.36"},{"v":0.489639510014119,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"down","no"]
["MSTRG.20604","ENSOARG00000014593","ENSOART00000015885","GO:0016032(viral process);GO:0019068(virion assembly)","NA","NA","NA",null,{"v":11.804882,"d":"11.80"},{"v":19.784266,"d":"19.78"},{"v":30.474434,"d":"30.47"},{"v":13.560133,"d":"13.56"},{"v":27.926638,"d":"27.93"},{"v":12.269977,"d":"12.27"},{"v":1.15452634895251,"d":"1.15"},{"v":0.20730109911405,"d":"0.21"},{"v":0.489658980255813,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"up","no"]
["MSTRG.12367","ENSOARG00000014146","ENSOART00000015407","GO:0004438(phosphatidylinositol-3-phosphatase activity);GO:0004721(phosphoprotein phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0006629(lipid metabolic process);GO:0007399(nervous system development);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0008285(negative regulation of cell population proliferation);GO:0016311(dephosphorylation);GO:0016314(phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity);GO:0016605(PML body);GO:0016787(hydrolase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0046855(inositol phosphate dephosphorylation);GO:0046856(phosphatidylinositol dephosphorylation);GO:0051717(inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity);GO:0051800(phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity)","00562(Inositol phosphate metabolism);01521(EGFR tyrosine kinase inhibitor resistance);04068(FoxO signaling pathway);04070(Phosphatidylinositol signaling system);04071(Sphingolipid signaling pathway);04115(p53 signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04218(Cellular senescence);04510(Focal adhesion);04931(Insulin resistance);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05206(MicroRNAs in cancer);05213(Endometrial cancer);05214(Glioma);05215(Prostate cancer);05218(Melanoma);05222(Small cell lung cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05230(Central carbon metabolism in cancer)","K01110","3.1.3.48;3.1.3.67;EC:3.1.3.16","phosphatase and tensin homolog [Source:NCBI gene;Acc:101119351]",{"v":6.020656,"d":"6.02"},{"v":4.892904,"d":"4.89"},{"v":5.577583,"d":"5.58"},{"v":6.863103,"d":"6.86"},{"v":7.147696,"d":"7.15"},{"v":6.310025,"d":"6.31"},{"v":0.81153908916292,"d":"0.81"},{"v":-0.301267508575822,"d":"-0.30"},{"v":0.490737443044878,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"down","no"]
["MSTRG.3890","HNRNPU","ENSOART00000005429","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000228(nuclear chromosome);GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000776(kinetochore);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000993(RNA polymerase II complex binding);GO:0001097(TFIIH-class transcription factor complex binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0003697(single-stranded DNA binding);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005697(telomerase holoenzyme complex);GO:0005813(centrosome);GO:0007346(regulation of mitotic cell cycle);GO:0008143(poly(A) binding);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0009986(cell surface);GO:0016363(nuclear matrix);GO:0016607(nuclear speck);GO:0017069(snRNA binding);GO:0017130(poly(C) RNA binding);GO:0030496(midbody);GO:0031490(chromatin DNA binding);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0032839(dendrite cytoplasm);GO:0032922(circadian regulation of gene expression);GO:0032991(protein-containing complex);GO:0033673(negative regulation of kinase activity);GO:0034046(poly(G) binding);GO:0034244(negative regulation of transcription elongation from RNA polymerase II promoter);GO:0036002(pre-mRNA binding);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042802(identical protein binding);GO:0043021(ribonucleoprotein complex binding);GO:0043565(sequence-specific DNA binding);GO:0044877(protein-containing complex binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048255(mRNA stabilization);GO:0051457(maintenance of protein location in nucleus);GO:0055013(cardiac muscle cell development);GO:0070034(telomerase RNA binding);GO:0070934(CRD-mediated mRNA stabilization);GO:0070937(CRD-mediated mRNA stability complex);GO:0071013(catalytic step 2 spliceosome);GO:0071385(cellular response to glucocorticoid stimulus);GO:0072686(mitotic spindle);GO:0090336(positive regulation of brown fat cell differentiation);GO:0090575(RNA polymerase II transcription factor complex);GO:0098577(inactive sex chromosome);GO:0098963(dendritic transport of messenger ribonucleoprotein complex);GO:0099122(RNA polymerase II C-terminal domain binding);GO:1901673(regulation of mitotic spindle assembly);GO:1902275(regulation of chromatin organization);GO:1902425(positive regulation of attachment of mitotic spindle microtubules to kinetochore);GO:1902889(protein localization to spindle microtubule);GO:1990023(mitotic spindle midzone);GO:1990280(RNA localization to chromatin);GO:1990498(mitotic spindle microtubule);GO:1990830(cellular response to leukemia inhibitory factor);GO:1990837(sequence-specific double-stranded DNA binding);GO:1990841(promoter-specific chromatin binding);GO:1990845(adaptive thermogenesis);GO:1990904(ribonucleoprotein complex);GO:2000648(positive regulation of stem cell proliferation);GO:2000737(negative regulation of stem cell differentiation)","03040(Spliceosome)","K12888","NA","heterogeneous nuclear ribonucleoprotein U [Source:NCBI gene;Acc:101107118]",{"v":11.3304339012505,"d":"11.33"},{"v":10.6380502192013,"d":"10.64"},{"v":10.1709832402582,"d":"10.17"},{"v":11.0363922937475,"d":"11.04"},{"v":9.86774231141589,"d":"9.87"},{"v":8.68185358959258,"d":"8.68"},{"v":1.08630704335935,"d":"1.09"},{"v":0.119431936773507,"d":"0.12"},{"v":0.491161116263741,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"up","no"]
["MSTRG.17433","TMEM176A","ENSOART00000001890","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 176A [Source:NCBI gene;Acc:101112310]",{"v":0.347082,"d":"0.35"},{"v":0.378794,"d":"0.38"},{"v":0.951892,"d":"0.95"},{"v":0.886142,"d":"0.89"},{"v":0.68949,"d":"0.69"},{"v":0.679074,"d":"0.68"},{"v":0.744118301898341,"d":"0.74"},{"v":-0.426396091841317,"d":"-0.43"},{"v":0.492183434135497,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"down","no"]
["MSTRG.17143","H2AFV","ENSOART00000015577","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A.V [Source:NCBI gene;Acc:101118100]",{"v":2.25176521674141,"d":"2.25"},{"v":2.31644244693572,"d":"2.32"},{"v":1.99437921350274,"d":"1.99"},{"v":2.53730113751868,"d":"2.54"},{"v":2.80050476781266,"d":"2.80"},{"v":2.7713355142003,"d":"2.77"},{"v":0.809282578470423,"d":"0.81"},{"v":-0.305284556168485,"d":"-0.31"},{"v":0.492807986678167,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"down","no"]
["MSTRG.3841","ENSOARG00000005051","ENSOART00000005500","NA","NA","NA","NA",null,{"v":56.06971,"d":"56.07"},{"v":51.781235,"d":"51.78"},{"v":72.083702,"d":"72.08"},{"v":74.193581,"d":"74.19"},{"v":71.121277,"d":"71.12"},{"v":77.044678,"d":"77.04"},{"v":0.809205893467955,"d":"0.81"},{"v":-0.305421267766709,"d":"-0.31"},{"v":0.493379763471104,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"down","no"]
["MSTRG.9889","DMAC1","ENSOART00000014926","GO:0005743(mitochondrial inner membrane);GO:0005747(mitochondrial respiratory chain complex I);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032981(mitochondrial respiratory chain complex I assembly)","NA","NA","NA","distal membrane arm assembly complex 1 [Source:NCBI gene;Acc:101118249]",{"v":9.03336,"d":"9.03"},{"v":8.917408,"d":"8.92"},{"v":7.04621,"d":"7.05"},{"v":10.290216,"d":"10.29"},{"v":9.498642,"d":"9.50"},{"v":11.892902,"d":"11.89"},{"v":0.789002189272313,"d":"0.79"},{"v":-0.341898791546059,"d":"-0.34"},{"v":0.494311380708534,"d":"0.49"},{"v":0.897123719770803,"d":"0.90"},"down","no"]
["MSTRG.11287","MRPS18A","ENSOART00000009007","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005763(mitochondrial small ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02963","NA","mitochondrial ribosomal protein S18A [Source:NCBI gene;Acc:101116355]",{"v":6.19474203580097,"d":"6.19"},{"v":7.88326941353155,"d":"7.88"},{"v":7.93605062075243,"d":"7.94"},{"v":7.22521787287621,"d":"7.23"},{"v":5.87899590109223,"d":"5.88"},{"v":6.98769615382282,"d":"6.99"},{"v":1.09566796532543,"d":"1.10"},{"v":0.131810665676489,"d":"0.13"},{"v":0.49500053558434,"d":"0.50"},{"v":0.897123719770803,"d":"0.90"},"up","no"]
["MSTRG.17145","ZMIZ2","ENSOART00000015954","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0043596(nuclear replication fork);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K22403","NA","zinc finger MIZ-type containing 2 [Source:NCBI gene;Acc:101115116]",{"v":3.45648170972569,"d":"3.46"},{"v":3.21985306566916,"d":"3.22"},{"v":3.39791492369077,"d":"3.40"},{"v":4.06750765951787,"d":"4.07"},{"v":4.19970935095594,"d":"4.20"},{"v":4.10120994713217,"d":"4.10"},{"v":0.814513416590171,"d":"0.81"},{"v":-0.295989632000671,"d":"-0.30"},{"v":0.49544233733696,"d":"0.50"},{"v":0.897123719770803,"d":"0.90"},"down","no"]
["MSTRG.9582","RPP25L","ENSOART00000003827","GO:0003676(nucleic acid binding)","03008(Ribosome biogenesis in eukaryotes);03013(RNA transport)","K14525","EC:3.1.26.5","ribonuclease P/MRP subunit p25 like [Source:NCBI gene;Acc:101121490]",{"v":4.636929,"d":"4.64"},{"v":5.026407,"d":"5.03"},{"v":3.16481,"d":"3.16"},{"v":5.04685,"d":"5.05"},{"v":4.910362,"d":"4.91"},{"v":6.448157,"d":"6.45"},{"v":0.781948031769356,"d":"0.78"},{"v":-0.354855365615571,"d":"-0.35"},{"v":0.495792223478785,"d":"0.50"},{"v":0.897413639433316,"d":"0.90"},"down","no"]
["MSTRG.10942","LDLRAP1","ENSOART00000006519","GO:0001540(amyloid-beta binding);GO:0001784(phosphotyrosine residue binding);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005883(neurofilament);GO:0006898(receptor-mediated endocytosis);GO:0009898(cytoplasmic side of plasma membrane);GO:0009925(basal plasma membrane);GO:0009967(positive regulation of signal transduction);GO:0030159(receptor signaling complex scaffold activity);GO:0030276(clathrin binding);GO:0031623(receptor internalization);GO:0034383(low-density lipoprotein particle clearance);GO:0035591(signaling adaptor activity);GO:0035612(AP-2 adaptor complex binding);GO:0035615(clathrin adaptor activity);GO:0035650(AP-1 adaptor complex binding);GO:0042632(cholesterol homeostasis);GO:0042982(amyloid precursor protein metabolic process);GO:0043393(regulation of protein binding);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0050750(low-density lipoprotein particle receptor binding);GO:0055037(recycling endosome);GO:0071345(cellular response to cytokine stimulus);GO:0090118(receptor-mediated endocytosis involved in cholesterol transport);GO:1903076(regulation of protein localization to plasma membrane);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905581(positive regulation of low-density lipoprotein particle clearance);GO:1905602(positive regulation of receptor-mediated endocytosis involved in cholesterol transport)","04144(Endocytosis);04979(Cholesterol metabolism)","K12474","NA","low density lipoprotein receptor adaptor protein 1 [Source:NCBI gene;Acc:101118341]",{"v":4.119723,"d":"4.12"},{"v":3.552408,"d":"3.55"},{"v":4.352867,"d":"4.35"},{"v":5.623572,"d":"5.62"},{"v":3.837004,"d":"3.84"},{"v":5.711131,"d":"5.71"},{"v":0.792593608616354,"d":"0.79"},{"v":-0.335346761261339,"d":"-0.34"},{"v":0.496849595266983,"d":"0.50"},{"v":0.898226109265233,"d":"0.90"},"down","no"]
["MSTRG.9130","ARIH2","ENSOART00000017412","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0031466(Cul5-RING ubiquitin ligase complex);GO:0031624(ubiquitin conjugating enzyme binding);GO:0046872(metal ion binding);GO:0048588(developmental cell growth);GO:0070534(protein K63-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination);GO:0071425(hematopoietic stem cell proliferation)","NA","K11969","EC:2.3.2.31","ariadne RBR E3 ubiquitin protein ligase 2 [Source:NCBI gene;Acc:101109306]",{"v":34.8764260993479,"d":"34.88"},{"v":38.074844127733,"d":"38.07"},{"v":25.4499821758727,"d":"25.45"},{"v":28.1719348741849,"d":"28.17"},{"v":31.3322568074415,"d":"31.33"},{"v":29.9682656873801,"d":"29.97"},{"v":1.09979378343352,"d":"1.10"},{"v":0.137233036924372,"d":"0.14"},{"v":0.497512126314945,"d":"0.50"},{"v":0.898239281361669,"d":"0.90"},"up","no"]
["MSTRG.21922","MAGT1","ENSOART00000020067;ENSOART00000020068","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","K19478","NA","magnesium transporter 1 [Source:NCBI gene;Acc:101117139]",{"v":2.7168451676429,"d":"2.72"},{"v":2.65622448050899,"d":"2.66"},{"v":2.33746414057766,"d":"2.34"},{"v":2.58012533892143,"d":"2.58"},{"v":2.39162291819834,"d":"2.39"},{"v":2.11474398788124,"d":"2.11"},{"v":1.08806071073721,"d":"1.09"},{"v":0.121759057172723,"d":"0.12"},{"v":0.498502773483217,"d":"0.50"},{"v":0.898741695179876,"d":"0.90"},"up","no"]
["MSTRG.732","POLR3C","ENSOART00000022430","GO:0003677(DNA binding);GO:0003697(single-stranded DNA binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005654(nucleoplasm);GO:0005666(RNA polymerase III complex);GO:0006351(transcription, DNA-templated);GO:0032728(positive regulation of interferon-beta production);GO:0045089(positive regulation of innate immune response)","03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway)","K03023","NA","RNA polymerase III subunit C [Source:NCBI gene;Acc:101116616]",{"v":1.59612900543085,"d":"1.60"},{"v":1.66056734395366,"d":"1.66"},{"v":1.37403005973932,"d":"1.37"},{"v":1.48954597646633,"d":"1.49"},{"v":2.23229866618392,"d":"2.23"},{"v":2.07008620347574,"d":"2.07"},{"v":0.79951341480901,"d":"0.80"},{"v":-0.322805854407434,"d":"-0.32"},{"v":0.499926535581321,"d":"0.50"},{"v":0.89994449763288,"d":"0.90"},"down","no"]
["MSTRG.14010","MYPN","ENSOART00000005367","GO:0008092(cytoskeletal protein binding);GO:0017124(SH3 domain binding);GO:0030018(Z disc);GO:0031674(I band);GO:0045214(sarcomere organization);GO:0051371(muscle alpha-actinin binding)","NA","K22028","NA","myopalladin [Source:NCBI gene;Acc:101104119]",{"v":30.2019396402298,"d":"30.20"},{"v":33.1716172475975,"d":"33.17"},{"v":30.4936485085055,"d":"30.49"},{"v":28.8598165251298,"d":"28.86"},{"v":28.8561912230752,"d":"28.86"},{"v":28.5549340340219,"d":"28.55"},{"v":1.08805124248303,"d":"1.09"},{"v":0.121746502852307,"d":"0.12"},{"v":0.501325107336562,"d":"0.50"},{"v":0.900474089803931,"d":"0.90"},"up","no"]
["MSTRG.10968","ENSOARG00000007158","ENSOART00000007787","NA","NA","NA","NA",null,{"v":7.82302137739526,"d":"7.82"},{"v":7.41302694056512,"d":"7.41"},{"v":7.96641456576811,"d":"7.97"},{"v":7.87066351607665,"d":"7.87"},{"v":6.40259521500487,"d":"6.40"},{"v":7.02547781000325,"d":"7.03"},{"v":1.08938212550643,"d":"1.09"},{"v":0.123510100861966,"d":"0.12"},{"v":0.502295181797641,"d":"0.50"},{"v":0.901162040258421,"d":"0.90"},"up","no"]
["MSTRG.6689","ABTB2","ENSOART00000020085","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0046982(protein heterodimerization activity);GO:0097237(cellular response to toxic substance)","NA","K10521","NA","ankyrin repeat and BTB domain containing 2 [Source:NCBI gene;Acc:101103837]",{"v":1.38834066514509,"d":"1.39"},{"v":1.77474025432018,"d":"1.77"},{"v":0.993184998369742,"d":"0.99"},{"v":1.3648939778285,"d":"1.36"},{"v":1.14566898271927,"d":"1.15"},{"v":1.20800775024454,"d":"1.21"},{"v":1.11770522630439,"d":"1.12"},{"v":0.160539754708662,"d":"0.16"},{"v":0.50326721618273,"d":"0.50"},{"v":0.90211297681761,"d":"0.90"},"up","no"]
["MSTRG.6623","THAP12","ENSOART00000013809","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0046983(protein dimerization activity)","NA","NA","NA","THAP domain containing 12 [Source:NCBI gene;Acc:101108951]",{"v":5.06925530052292,"d":"5.07"},{"v":4.75046333558905,"d":"4.75"},{"v":4.53280295601353,"d":"4.53"},{"v":4.83813050753614,"d":"4.84"},{"v":4.11680463734236,"d":"4.12"},{"v":4.19483491110428,"d":"4.19"},{"v":1.091465594533,"d":"1.09"},{"v":0.126266654031004,"d":"0.13"},{"v":0.504087934311001,"d":"0.50"},{"v":0.902438885608973,"d":"0.90"},"up","no"]
["MSTRG.17874","ENSOARG00000007052","ENSOART00000007675","GO:0002943(tRNA dihydrouridine synthesis);GO:0003824(catalytic activity);GO:0008033(tRNA processing);GO:0016491(oxidoreductase activity);GO:0017150(tRNA dihydrouridine synthase activity);GO:0046872(metal ion binding);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","NA","K05544","EC:1.3.1.89","dihydrouridine synthase 3 like [Source:NCBI gene;Acc:101110760]",{"v":1.44868518698225,"d":"1.45"},{"v":1.74039517751479,"d":"1.74"},{"v":1.72598623550296,"d":"1.73"},{"v":1.73881734201183,"d":"1.74"},{"v":2.17188447573964,"d":"2.17"},{"v":2.23663478461538,"d":"2.24"},{"v":0.799544081921201,"d":"0.80"},{"v":-0.322750517697189,"d":"-0.32"},{"v":0.505331428548285,"d":"0.51"},{"v":0.903264056237429,"d":"0.90"},"down","no"]
["MSTRG.9612","SMU1","ENSOART00000010419","GO:0000398(mRNA splicing, via spliceosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0071005(U2-type precatalytic spliceosome)","NA","K13111","NA","SMU1, DNA replication regulator and spliceosomal factor [Source:NCBI gene;Acc:101104884]",{"v":5.10043889126853,"d":"5.10"},{"v":5.0588265160626,"d":"5.06"},{"v":5.09326540321252,"d":"5.09"},{"v":5.06795000205931,"d":"5.07"},{"v":4.26020090733114,"d":"4.26"},{"v":4.70557271169687,"d":"4.71"},{"v":1.08684845322341,"d":"1.09"},{"v":0.120150789467999,"d":"0.12"},{"v":0.506086779182661,"d":"0.51"},{"v":0.903793604997757,"d":"0.90"},"up","no"]
["MSTRG.1899","PDXK","ENSOART00000012336","GO:0008478(pyridoxal kinase activity);GO:0009443(pyridoxal 5'-phosphate salvage);GO:0016310(phosphorylation)","00750(Vitamin B6 metabolism)","K00868","EC:2.7.1.35","pyridoxal kinase [Source:NCBI gene;Acc:443049]",{"v":0.921814739130435,"d":"0.92"},{"v":2.06728491884058,"d":"2.07"},{"v":1.69900713381642,"d":"1.70"},{"v":1.50848172560386,"d":"1.51"},{"v":1.36153630193237,"d":"1.36"},{"v":1.37589614927536,"d":"1.38"},{"v":1.10414544349267,"d":"1.10"},{"v":0.142930223551799,"d":"0.14"},{"v":0.506680767641294,"d":"0.51"},{"v":0.903865789800836,"d":"0.90"},"up","no"]
["MSTRG.7615","RNF34","ENSOART00000015775","GO:0002039(p53 binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0031625(ubiquitin protein ligase binding);GO:0035872(nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0046872(metal ion binding);GO:0061630(ubiquitin protein ligase activity);GO:0070417(cellular response to cold);GO:0070936(protein K48-linked ubiquitination);GO:1901797(negative regulation of signal transduction by p53 class mediator);GO:1901981(phosphatidylinositol phosphate binding);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:2000374(regulation of oxygen metabolic process);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)","NA","K20804","EC:2.3.2.31","ring finger protein 34 [Source:NCBI gene;Acc:101102266]",{"v":14.211735,"d":"14.21"},{"v":13.725202,"d":"13.73"},{"v":11.121955,"d":"11.12"},{"v":13.075946,"d":"13.08"},{"v":11.512735,"d":"11.51"},{"v":11.318336,"d":"11.32"},{"v":1.08777880379203,"d":"1.09"},{"v":0.121385219165488,"d":"0.12"},{"v":0.508016737522844,"d":"0.51"},{"v":0.904250010760014,"d":"0.90"},"up","no"]
["MSTRG.814","RORC","ENSOART00000022945","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0008142(oxysterol binding);GO:0008270(zinc ion binding);GO:0016604(nuclear body);GO:0030522(intracellular receptor signaling pathway);GO:0036315(cellular response to sterol);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0046872(metal ion binding);GO:0098531(ligand-activated transcription factor activity)","04659(Th17 cell differentiation);04710(Circadian rhythm);05321(Inflammatory bowel disease (IBD))","K08534","NA","RAR related orphan receptor C [Source:NCBI gene;Acc:101119104]",{"v":2.55532135025538,"d":"2.56"},{"v":1.21925316731156,"d":"1.22"},{"v":3.58942821173193,"d":"3.59"},{"v":2.36422503049064,"d":"2.36"},{"v":2.33620651323325,"d":"2.34"},{"v":1.80661941572512,"d":"1.81"},{"v":1.13169587501162,"d":"1.13"},{"v":0.178486309263399,"d":"0.18"},{"v":0.508946632654655,"d":"0.51"},{"v":0.904442636221003,"d":"0.90"},"up","no"]
["MSTRG.5508","CDH3","ENSOART00000003741","GO:0001895(retina homeostasis);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0010628(positive regulation of gene expression);GO:0010838(positive regulation of keratinocyte proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022405(hair cycle process);GO:0031424(keratinization);GO:0032773(positive regulation of monophenol monooxygenase activity);GO:0032912(negative regulation of transforming growth factor beta2 production);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0046872(metal ion binding);GO:0048023(positive regulation of melanin biosynthetic process);GO:0051796(negative regulation of timing of catagen);GO:0060901(regulation of hair cycle by canonical Wnt signaling pathway);GO:0090263(positive regulation of canonical Wnt signaling pathway);GO:0098609(cell-cell adhesion);GO:1902910(positive regulation of melanosome transport)","04514(Cell adhesion molecules (CAMs))","K06796","NA","cadherin 3 [Source:NCBI gene;Acc:101111652]",{"v":0.40176,"d":"0.40"},{"v":0.243742,"d":"0.24"},{"v":0.323117,"d":"0.32"},{"v":0.569509,"d":"0.57"},{"v":0.257163,"d":"0.26"},{"v":0.454772,"d":"0.45"},{"v":0.75588086564844,"d":"0.76"},{"v":-0.403769225628914,"d":"-0.40"},{"v":0.509147093074873,"d":"0.51"},{"v":0.904442636221003,"d":"0.90"},"down","no"]
["MSTRG.13384","PDXDC1","ENSOART00000009011","GO:0003824(catalytic activity);GO:0005794(Golgi apparatus);GO:0016831(carboxy-lyase activity);GO:0019752(carboxylic acid metabolic process);GO:0030170(pyridoxal phosphate binding);GO:0043231(intracellular membrane-bounded organelle)","NA","NA","NA","pyridoxal dependent decarboxylase domain containing 1 [Source:NCBI gene;Acc:101113644]",{"v":5.513023,"d":"5.51"},{"v":4.64911,"d":"4.65"},{"v":4.920781,"d":"4.92"},{"v":5.457965,"d":"5.46"},{"v":4.34818,"d":"4.35"},{"v":4.132199,"d":"4.13"},{"v":1.08211664169,"d":"1.08"},{"v":0.113856016094499,"d":"0.11"},{"v":0.509638607073045,"d":"0.51"},{"v":0.904697923975318,"d":"0.90"},"up","no"]
["MSTRG.157","AKIRIN1","ENSOART00000021754","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0010592(positive regulation of lamellipodium assembly);GO:0010759(positive regulation of macrophage chemotaxis);GO:0014839(myoblast migration involved in skeletal muscle regeneration);GO:0031965(nuclear membrane);GO:0045663(positive regulation of myoblast differentiation);GO:1902723(negative regulation of skeletal muscle satellite cell proliferation);GO:1902725(negative regulation of satellite cell differentiation)","NA","NA","NA","akirin 1 [Source:HGNC Symbol;Acc:HGNC:25744]",{"v":4.02688118437433,"d":"4.03"},{"v":3.70943591071045,"d":"3.71"},{"v":3.46232178407384,"d":"3.46"},{"v":4.14080823309723,"d":"4.14"},{"v":3.11666419102812,"d":"3.12"},{"v":3.06270611890964,"d":"3.06"},{"v":1.08512065294805,"d":"1.09"},{"v":0.117855462699644,"d":"0.12"},{"v":0.510425428276385,"d":"0.51"},{"v":0.904697923975318,"d":"0.90"},"up","no"]
["MSTRG.19003","UTP3","ENSOART00000008489","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0007420(brain development)","NA","K14767","NA","UTP3, small subunit processome component [Source:NCBI gene;Acc:101122028]",{"v":1.085623,"d":"1.09"},{"v":0.985612,"d":"0.99"},{"v":1.019487,"d":"1.02"},{"v":1.714595,"d":"1.71"},{"v":1.05109,"d":"1.05"},{"v":1.21972,"d":"1.22"},{"v":0.775510142632932,"d":"0.78"},{"v":-0.366782444985708,"d":"-0.37"},{"v":0.510989949338438,"d":"0.51"},{"v":0.904868919931677,"d":"0.90"},"down","no"]
["MSTRG.17159","C7orf25","ENSOART00000009300","NA","NA","NA","NA","chromosome 4 open reading frame, human C7orf25 [Source:NCBI gene;Acc:101120235]",{"v":6.314204,"d":"6.31"},{"v":6.734884,"d":"6.73"},{"v":5.842385,"d":"5.84"},{"v":7.220036,"d":"7.22"},{"v":4.949906,"d":"4.95"},{"v":5.154259,"d":"5.15"},{"v":1.09046720249898,"d":"1.09"},{"v":0.124946379328839,"d":"0.12"},{"v":0.51239865922013,"d":"0.51"},{"v":0.905512840600559,"d":"0.91"},"up","no"]
["ENSOARG00000020656","SP100","ENSOART00000022504","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000723(telomere maintenance);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0010596(negative regulation of endothelial cell migration);GO:0016604(nuclear body);GO:0016605(PML body);GO:0019900(kinase binding);GO:0019904(protein domain specific binding);GO:0030870(Mre11 complex);GO:0034340(response to type I interferon);GO:0034341(response to interferon-gamma);GO:0043392(negative regulation of DNA binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045185(maintenance of protein location);GO:0045765(regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046826(negative regulation of protein export from nucleus);GO:0046872(metal ion binding);GO:0046983(protein dimerization activity);GO:0051271(negative regulation of cellular component movement);GO:0070087(chromo shadow domain binding);GO:1902041(regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902044(regulation of Fas signaling pathway)","NA","NA","NA","SP100 nuclear antigen [Source:HGNC Symbol;Acc:HGNC:11206]",{"v":0.486141,"d":"0.49"},{"v":0.273109,"d":"0.27"},{"v":0.3468,"d":"0.35"},{"v":0.662947,"d":"0.66"},{"v":0.397126,"d":"0.40"},{"v":0.394497,"d":"0.39"},{"v":0.760396543308332,"d":"0.76"},{"v":-0.395176121242905,"d":"-0.40"},{"v":0.512732325137058,"d":"0.51"},{"v":0.905657010475755,"d":"0.91"},"down","no"]
["MSTRG.22026","HAUS7","ENSOART00000008362","GO:0005813(centrosome);GO:0007098(centrosome cycle);GO:0031996(thioesterase binding);GO:0051225(spindle assembly);GO:0070652(HAUS complex)","NA","NA","NA","HAUS augmin like complex subunit 7 [Source:HGNC Symbol;Acc:HGNC:32979]",{"v":1.042018,"d":"1.04"},{"v":1.045652,"d":"1.05"},{"v":0.930255,"d":"0.93"},{"v":1.331605,"d":"1.33"},{"v":1.153702,"d":"1.15"},{"v":1.441538,"d":"1.44"},{"v":0.768536827911466,"d":"0.77"},{"v":-0.379813700069297,"d":"-0.38"},{"v":0.513730457664639,"d":"0.51"},{"v":0.905754336761498,"d":"0.91"},"down","no"]
["MSTRG.783","SETDB1","ENSOART00000022750","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007265(Ras protein signal transduction);GO:0008168(methyltransferase activity);GO:0008270(zinc ion binding);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0032259(methylation);GO:0034968(histone lysine methylation);GO:0043231(intracellular membrane-bounded organelle);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0051567(histone H3-K9 methylation);GO:0090309(positive regulation of methylation-dependent chromatin silencing);GO:1990841(promoter-specific chromatin binding)","00310(Lysine degradation);04550(Signaling pathways regulating pluripotency of stem cells)","K11421","EC:2.1.1.43","SET domain bifurcated histone lysine methyltransferase 1 [Source:NCBI gene;Acc:101109230]",{"v":4.12166672850751,"d":"4.12"},{"v":3.75491869319271,"d":"3.75"},{"v":4.09862444918504,"d":"4.10"},{"v":4.93091869431128,"d":"4.93"},{"v":4.72126819143496,"d":"4.72"},{"v":4.9636035599233,"d":"4.96"},{"v":0.819333714136094,"d":"0.82"},{"v":-0.287476914487237,"d":"-0.29"},{"v":0.514139535997596,"d":"0.51"},{"v":0.906084224907582,"d":"0.91"},"down","no"]
["MSTRG.2588","VEZF1","ENSOART00000008937","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001525(angiogenesis);GO:0001885(endothelial cell development);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0045603(positive regulation of endothelial cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","vascular endothelial zinc finger 1 [Source:NCBI gene;Acc:101120760]",{"v":3.93996678219056,"d":"3.94"},{"v":3.68012041976848,"d":"3.68"},{"v":4.32793898121104,"d":"4.33"},{"v":4.32942464505788,"d":"4.33"},{"v":3.9049286398041,"d":"3.90"},{"v":2.80656848548531,"d":"2.81"},{"v":1.08215839507703,"d":"1.08"},{"v":0.113911681297295,"d":"0.11"},{"v":0.515822564048171,"d":"0.52"},{"v":0.906858441351208,"d":"0.91"},"up","no"]
["MSTRG.913","SMG5;ENSOARG00000005692","ENSOART00000006296;ENSOART00000006200","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0031625(ubiquitin protein ligase binding);GO:0032204(regulation of telomere maintenance);GO:0035303(regulation of dephosphorylation);GO:0042162(telomeric DNA binding);GO:0042826(histone deacetylase binding);GO:0051721(protein phosphatase 2A binding);GO:0070034(telomerase RNA binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","03015(mRNA surveillance pathway)","K11125","NA","SMG5, nonsense mediated mRNA decay factor [Source:NCBI gene;Acc:101102770];progestin and adipoQ receptor family member 6 [Source:NCBI gene;Acc:101102524]",{"v":3.72465052557583,"d":"3.72"},{"v":5.16778023232625,"d":"5.17"},{"v":4.86629750952238,"d":"4.87"},{"v":3.91047612354173,"d":"3.91"},{"v":4.54129921457772,"d":"4.54"},{"v":4.13581810160535,"d":"4.14"},{"v":1.09303881900123,"d":"1.09"},{"v":0.128344638874479,"d":"0.13"},{"v":0.516331794843684,"d":"0.52"},{"v":0.906913247225438,"d":"0.91"},"up","no"]
["ENSOARG00000015969","KCTD18","ENSOART00000017385","GO:0051260(protein homooligomerization)","NA","K21921","NA","potassium channel tetramerization domain containing 18 [Source:NCBI gene;Acc:101104044]",{"v":1.04159,"d":"1.04"},{"v":0.795318,"d":"0.80"},{"v":0.928556,"d":"0.93"},{"v":1.394175,"d":"1.39"},{"v":1.255263,"d":"1.26"},{"v":0.936642,"d":"0.94"},{"v":0.771166287422478,"d":"0.77"},{"v":-0.3748861113064,"d":"-0.37"},{"v":0.516789266512665,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"down","no"]
["MSTRG.20794","MPC1","ENSOART00000005309","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006850(mitochondrial pyruvate transmembrane transport)","NA","K22138","NA","mitochondrial pyruvate carrier 1 [Source:NCBI gene;Acc:101114529]",{"v":9.19733366135239,"d":"9.20"},{"v":9.81306377339197,"d":"9.81"},{"v":7.11949012732271,"d":"7.12"},{"v":11.9262109257834,"d":"11.93"},{"v":7.74899398229797,"d":"7.75"},{"v":12.6386529993403,"d":"12.64"},{"v":0.808627915519357,"d":"0.81"},{"v":-0.306452085581282,"d":"-0.31"},{"v":0.517444937273032,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"down","no"]
["MSTRG.8253","EDC3","ENSOART00000003774","GO:0003729(mRNA binding);GO:0031087(deadenylation-independent decapping of nuclear-transcribed mRNA);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0042802(identical protein binding);GO:1990174(phosphodiesterase decapping endonuclease activity)","03018(RNA degradation)","K12615","NA","enhancer of mRNA decapping 3 [Source:NCBI gene;Acc:101109486]",{"v":3.15378269860896,"d":"3.15"},{"v":3.15380261757562,"d":"3.15"},{"v":3.02957516891146,"d":"3.03"},{"v":4.17023748023846,"d":"4.17"},{"v":3.18985718105542,"d":"3.19"},{"v":4.11276862000442,"d":"4.11"},{"v":0.813847446462329,"d":"0.81"},{"v":-0.297169704398857,"d":"-0.30"},{"v":0.518287266422865,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"down","no"]
["MSTRG.16152","TOM1","ENSOART00000020061;ENSOART00000020060","GO:0005622(intracellular);GO:0005623(cell);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0030276(clathrin binding);GO:0030276(clathrin binding)","NA","NA","NA","target of myb1 membrane trafficking protein [Source:NCBI gene;Acc:101120652]",{"v":5.72198969183673,"d":"5.72"},{"v":6.26541639897959,"d":"6.27"},{"v":6.43930907721089,"d":"6.44"},{"v":6.39632587619048,"d":"6.40"},{"v":7.43378047755102,"d":"7.43"},{"v":8.73115835306123,"d":"8.73"},{"v":0.816741233591889,"d":"0.82"},{"v":-0.292049030159907,"d":"-0.29"},{"v":0.518644128353272,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"down","no"]
["MSTRG.3970","CASZ1","ENSOART00000004987","GO:0003676(nucleic acid binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0043231(intracellular membrane-bounded organelle);GO:0045893(positive regulation of transcription, DNA-templated)","NA","NA","NA","castor zinc finger 1 [Source:NCBI gene;Acc:101112837]",{"v":3.73524264666713,"d":"3.74"},{"v":3.44991432052438,"d":"3.45"},{"v":3.60392471998335,"d":"3.60"},{"v":4.6720316995214,"d":"4.67"},{"v":4.10392449774572,"d":"4.10"},{"v":4.41360857779011,"d":"4.41"},{"v":0.818001342059298,"d":"0.82"},{"v":-0.28982488475126,"d":"-0.29"},{"v":0.519171621449372,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"down","no"]
["MSTRG.14195","GLUD1","ENSOART00000000827","GO:0000166(nucleotide binding);GO:0004353(glutamate dehydrogenase [NAD(P)+] activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006520(cellular amino acid metabolic process);GO:0006541(glutamine metabolic process);GO:0016491(oxidoreductase activity);GO:0016639(oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor);GO:0032024(positive regulation of insulin secretion);GO:0055114(oxidation-reduction process);GO:0072350(tricarboxylic acid metabolic process)","00220(Arginine biosynthesis);00250(Alanine, aspartate and glutamate metabolism);00471(D-Glutamine and D-glutamate metabolism);00910(Nitrogen metabolism);04217(Necroptosis);04964(Proximal tubule bicarbonate reclamation)","K00261","EC:1.4.1.3","Ovis aries glutamate dehydrogenase 1 (GLUD1), mRNA. [Source:RefSeq mRNA;Acc:NM_001278567]",{"v":19.4851651821536,"d":"19.49"},{"v":20.9486200013418,"d":"20.95"},{"v":16.9925258208655,"d":"16.99"},{"v":20.4933589023817,"d":"20.49"},{"v":15.5964049057363,"d":"15.60"},{"v":16.9205938866152,"d":"16.92"},{"v":1.08330359389494,"d":"1.08"},{"v":0.115437612316055,"d":"0.12"},{"v":0.519835476001741,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"up","no"]
["MSTRG.10519","SF3B1","ENSOART00000016733","GO:0000245(spliceosomal complex assembly);GO:0000398(mRNA splicing, via spliceosome);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005686(U2 snRNP);GO:0005689(U12-type spliceosomal complex);GO:0016607(nuclear speck);GO:0034693(U11/U12 snRNP);GO:0071005(U2-type precatalytic spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)","K12828","NA","splicing factor 3b subunit 1 [Source:NCBI gene;Acc:101121573]",{"v":18.5331296690641,"d":"18.53"},{"v":16.5606814535454,"d":"16.56"},{"v":14.7611566007785,"d":"14.76"},{"v":16.4575406815874,"d":"16.46"},{"v":17.6782398836521,"d":"17.68"},{"v":11.9387686717719,"d":"11.94"},{"v":1.08205003736292,"d":"1.08"},{"v":0.113767215418155,"d":"0.11"},{"v":0.519955545321081,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"up","no"]
["MSTRG.2757","CPD","ENSOART00000011553","GO:0004181(metallocarboxypeptidase activity);GO:0004185(serine-type carboxypeptidase activity);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K07752","EC:3.4.17.22","carboxypeptidase D [Source:NCBI gene;Acc:101122802]",{"v":11.531602768231,"d":"11.53"},{"v":8.01717193561974,"d":"8.02"},{"v":9.19255763345367,"d":"9.19"},{"v":12.0893637051745,"d":"12.09"},{"v":11.496587500361,"d":"11.50"},{"v":11.3627572563177,"d":"11.36"},{"v":0.822386108164077,"d":"0.82"},{"v":-0.282112200311878,"d":"-0.28"},{"v":0.520330792095621,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"down","no"]
["ENSOARG00000005030","KCTD13","ENSOART00000005477","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0016477(cell migration);GO:0016567(protein ubiquitination);GO:0016604(nuclear body);GO:0017049(GTP-Rho binding);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0035024(negative regulation of Rho protein signal transduction);GO:0042802(identical protein binding);GO:0043149(stress fiber assembly);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0050806(positive regulation of synaptic transmission);GO:0051260(protein homooligomerization)","NA","K15074","NA","potassium channel tetramerization domain containing 13 [Source:NCBI gene;Acc:101118408]",{"v":0.869666,"d":"0.87"},{"v":0.417947,"d":"0.42"},{"v":1.117434,"d":"1.12"},{"v":0.691302,"d":"0.69"},{"v":1.449705,"d":"1.45"},{"v":1.052185,"d":"1.05"},{"v":0.753179577050174,"d":"0.75"},{"v":-0.40893421401103,"d":"-0.41"},{"v":0.521278410412466,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"down","no"]
["MSTRG.22","MTERF4;PASK","ENSOART00000019678;ENSOART00000019612;ENSOART00000019676","GO:0003690(double-stranded DNA binding);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0006390(mitochondrial transcription);GO:0006626(protein targeting to mitochondrion);GO:0007507(heart development);GO:0019843(rRNA binding);GO:0042255(ribosome assembly);GO:0043010(camera-type eye development);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0035091(phosphatidylinositol binding);GO:0043576(regulation of respiratory gaseous exchange);GO:0045719(negative regulation of glycogen biosynthetic process);GO:0046777(protein autophosphorylation);GO:0070092(regulation of glucagon secretion);GO:0097009(energy homeostasis);GO:0043010(camera-type eye development)","NA","K15032;K08801","EC:2.7.11.1","mitochondrial transcription termination factor 4 [Source:NCBI gene;Acc:101121891];PAS domain containing serine/threonine kinase [Source:NCBI gene;Acc:101102694]",{"v":2.28227502166934,"d":"2.28"},{"v":2.71566793065811,"d":"2.72"},{"v":2.82145615505618,"d":"2.82"},{"v":3.84564152327448,"d":"3.85"},{"v":2.91806166677368,"d":"2.92"},{"v":2.9124229434992,"d":"2.91"},{"v":0.808112564828355,"d":"0.81"},{"v":-0.307371829869801,"d":"-0.31"},{"v":0.521646247714707,"d":"0.52"},{"v":0.90707560518485,"d":"0.91"},"down","no"]
["MSTRG.12902","CABYR","ENSOART00000008180","GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0019904(protein domain specific binding);GO:0031514(motile cilium);GO:0035686(sperm fibrous sheath);GO:0046982(protein heterodimerization activity);GO:0048240(sperm capacitation);GO:0097228(sperm principal piece);GO:0097229(sperm end piece)","NA","NA","NA","calcium binding tyrosine phosphorylation regulated [Source:NCBI gene;Acc:101119268]",{"v":1.043244,"d":"1.04"},{"v":0.572587,"d":"0.57"},{"v":0.754086,"d":"0.75"},{"v":0.740492,"d":"0.74"},{"v":1.20278,"d":"1.20"},{"v":1.100641,"d":"1.10"},{"v":0.778575800293898,"d":"0.78"},{"v":-0.361090591376785,"d":"-0.36"},{"v":0.52246304233776,"d":"0.52"},{"v":0.907334027776722,"d":"0.91"},"down","no"]
["MSTRG.17644","ENSOARG00000019122","ENSOART00000020822","GO:0003676(nucleic acid binding)","NA","NA","NA",null,{"v":12.599212,"d":"12.60"},{"v":4.491837,"d":"4.49"},{"v":3.709051,"d":"3.71"},{"v":8.542603,"d":"8.54"},{"v":5.656424,"d":"5.66"},{"v":12.625902,"d":"12.63"},{"v":0.775401865928517,"d":"0.78"},{"v":-0.366983888090016,"d":"-0.37"},{"v":0.523229398389483,"d":"0.52"},{"v":0.907508988411248,"d":"0.91"},"down","no"]
["MSTRG.4665","XRN2","ENSOART00000004841","GO:0000738(DNA catabolic process, exonucleolytic);GO:0001147(transcription termination site sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0004518(nuclease activity);GO:0004527(exonuclease activity);GO:0004534(5'-3' exoribonuclease activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006139(nucleobase-containing compound metabolic process);GO:0006397(mRNA processing);GO:0007283(spermatogenesis);GO:0008409(5'-3' exonuclease activity);GO:0016070(RNA metabolic process);GO:0016235(aggresome);GO:0016787(hydrolase activity);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic)","03008(Ribosome biogenesis in eukaryotes);03018(RNA degradation)","K12619","EC:3.1.13.-","5'-3' exoribonuclease 2 [Source:NCBI gene;Acc:101102410]",{"v":4.91062548595147,"d":"4.91"},{"v":4.02238522541507,"d":"4.02"},{"v":4.264711,"d":"4.26"},{"v":5.60240337196679,"d":"5.60"},{"v":4.76515675702427,"d":"4.77"},{"v":5.72732892369093,"d":"5.73"},{"v":0.819994575182693,"d":"0.82"},{"v":-0.28631372952605,"d":"-0.29"},{"v":0.523947113592193,"d":"0.52"},{"v":0.90759806362495,"d":"0.91"},"down","no"]
["MSTRG.18400","ANXA6","ENSOART00000008915","GO:0005509(calcium ion binding);GO:0005525(GTP binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005739(mitochondrion);GO:0005765(lysosomal membrane);GO:0006816(calcium ion transport);GO:0006937(regulation of muscle contraction);GO:0008289(lipid binding);GO:0015276(ligand-gated ion channel activity);GO:0015485(cholesterol binding);GO:0031902(late endosome membrane);GO:0034220(ion transmembrane transport);GO:0042803(protein homodimerization activity);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0051260(protein homooligomerization);GO:0051560(mitochondrial calcium ion homeostasis);GO:0097190(apoptotic signaling pathway)","NA","K17094","NA","annexin A6 [Source:NCBI gene;Acc:101105245]",{"v":38.0692716007278,"d":"38.07"},{"v":38.9395027296595,"d":"38.94"},{"v":45.8474688923837,"d":"45.85"},{"v":52.4844292719002,"d":"52.48"},{"v":44.834470404471,"d":"44.83"},{"v":52.4561414385235,"d":"52.46"},{"v":0.820271804355748,"d":"0.82"},{"v":-0.285826056106715,"d":"-0.29"},{"v":0.524620776861028,"d":"0.52"},{"v":0.907719613734713,"d":"0.91"},"down","no"]
["MSTRG.18199","CDKL3","ENSOART00000015089;ENSOART00000015090","GO:0004672(protein kinase activity);GO:0004721(phosphoprotein phosphatase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006470(protein dephosphorylation);GO:0016787(hydrolase activity);GO:0016787(hydrolase activity)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04114(Oocyte meiosis);04136(Autophagy - other);04140(Autophagy - animal);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04530(Tight junction);04728(Dopaminergic synapse);04730(Long-term depression);05142(Chagas disease (American trypanosomiasis));05160(Hepatitis C);05165(Human papillomavirus infection);05165(Human papillomavirus infection)","K04382;K08824","EC:3.1.3.16;EC:2.7.11.22","protein phosphatase 2 catalytic subunit alpha [Source:NCBI gene;Acc:443009]",{"v":7.41881982495748,"d":"7.42"},{"v":9.3388390287614,"d":"9.34"},{"v":7.84316431807639,"d":"7.84"},{"v":8.65596033709603,"d":"8.66"},{"v":6.76987835487861,"d":"6.77"},{"v":7.33540304623473,"d":"7.34"},{"v":1.08082078538351,"d":"1.08"},{"v":0.112127324670168,"d":"0.11"},{"v":0.525845733309891,"d":"0.53"},{"v":0.907719613734713,"d":"0.91"},"up","no"]
["MSTRG.6087","LENG1","ENSOART00000003166","NA","NA","NA","NA","leukocyte receptor cluster member 1 [Source:NCBI gene;Acc:101102751]",{"v":2.35049,"d":"2.35"},{"v":1.616132,"d":"1.62"},{"v":1.527717,"d":"1.53"},{"v":1.672797,"d":"1.67"},{"v":2.796406,"d":"2.80"},{"v":2.481508,"d":"2.48"},{"v":0.790471507159483,"d":"0.79"},{"v":-0.339214633847745,"d":"-0.34"},{"v":0.525956565346942,"d":"0.53"},{"v":0.907719613734713,"d":"0.91"},"down","no"]
["MSTRG.3086","MAP2K3","ENSOART00000002828","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000187(activation of MAPK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004708(MAP kinase kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006954(inflammatory response);GO:0019901(protein kinase binding);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0038066(p38MAPK cascade);GO:0042035(regulation of cytokine biosynthetic process);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045860(positive regulation of protein kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060048(cardiac muscle contraction)","04010(MAPK signaling pathway);04015(Rap1 signaling pathway);04218(Cellular senescence);04620(Toll-like receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04668(TNF signaling pathway);04714(Thermogenesis);04750(Inflammatory mediator regulation of TRP channels);04912(GnRH signaling pathway);05014(Amyotrophic lateral sclerosis (ALS));05145(Toxoplasmosis);05161(Hepatitis B);05164(Influenza A);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection)","K04432","EC:2.7.12.2","mitogen-activated protein kinase kinase 3 [Source:NCBI gene;Acc:101122959]",{"v":3.73565087595202,"d":"3.74"},{"v":4.96398325295126,"d":"4.96"},{"v":6.13473721487053,"d":"6.13"},{"v":5.40411539204113,"d":"5.40"},{"v":6.75329649333587,"d":"6.75"},{"v":6.20187308139756,"d":"6.20"},{"v":0.808003763252223,"d":"0.81"},{"v":-0.307566082587673,"d":"-0.31"},{"v":0.526741997803552,"d":"0.53"},{"v":0.907719613734713,"d":"0.91"},"down","no"]
["ENSOARG00000011329","ENSOARG00000011329","ENSOART00000012316","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 59 like [Source:NCBI gene;Acc:101108652]",{"v":0.252934,"d":"0.25"},{"v":0.380309,"d":"0.38"},{"v":0.474301,"d":"0.47"},{"v":0.147919,"d":"0.15"},{"v":0.326151,"d":"0.33"},{"v":0.4338,"d":"0.43"},{"v":1.21993677508894,"d":"1.22"},{"v":0.286806380059266,"d":"0.29"},{"v":0.527114380987476,"d":"0.53"},{"v":0.907978015905001,"d":"0.91"},"up","no"]
["MSTRG.7799","EWSR1","ENSOART00000003957","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0042802(identical protein binding);GO:0046872(metal ion binding)","05202(Transcriptional misregulation in cancer)","K13209","NA","EWS RNA binding protein 1 [Source:NCBI gene;Acc:101121203]",{"v":4.21901377468297,"d":"4.22"},{"v":3.18337430163043,"d":"3.18"},{"v":4.19012206310386,"d":"4.19"},{"v":4.97537452513587,"d":"4.98"},{"v":5.04414248950785,"d":"5.04"},{"v":4.13837560250604,"d":"4.14"},{"v":0.818801953998083,"d":"0.82"},{"v":-0.288413549658451,"d":"-0.29"},{"v":0.528395819139714,"d":"0.53"},{"v":0.908555325953502,"d":"0.91"},"down","no"]
["MSTRG.6240","FDX1","ENSOART00000014540","GO:0005739(mitochondrion);GO:0008203(cholesterol metabolic process);GO:0009055(electron transfer activity);GO:0022900(electron transport chain);GO:0042446(hormone biosynthetic process);GO:0051536(iron-sulfur cluster binding);GO:0051537(2 iron, 2 sulfur cluster binding);GO:0071320(cellular response to cAMP);GO:1904322(cellular response to forskolin)","NA","K22070","NA","ferredoxin 1 [Source:NCBI gene;Acc:101106360]",{"v":6.676692,"d":"6.68"},{"v":10.57004,"d":"10.57"},{"v":6.147223,"d":"6.15"},{"v":9.439888,"d":"9.44"},{"v":9.160945,"d":"9.16"},{"v":10.964724,"d":"10.96"},{"v":0.791257036016605,"d":"0.79"},{"v":-0.337781671555063,"d":"-0.34"},{"v":0.528865392218319,"d":"0.53"},{"v":0.908555325953502,"d":"0.91"},"down","no"]
["MSTRG.16080","ENSOARG00000015533","ENSOART00000016895;ENSOART00000016897","GO:0071203(WASH complex);GO:0071203(WASH complex)","04144(Endocytosis);04144(Endocytosis)","K18463","NA","WASH complex subunit 3 [Source:NCBI gene;Acc:101109346]",{"v":5.39031923529412,"d":"5.39"},{"v":4.95375285294118,"d":"4.95"},{"v":5.79044595721925,"d":"5.79"},{"v":5.45865112834225,"d":"5.46"},{"v":4.35240615240642,"d":"4.35"},{"v":4.84677560962567,"d":"4.85"},{"v":1.1007437570154,"d":"1.10"},{"v":0.138478661900548,"d":"0.14"},{"v":0.530082791118325,"d":"0.53"},{"v":0.908674345702842,"d":"0.91"},"up","no"]
["MSTRG.8806","ENSOARG00000003982","ENSOART00000004328","NA","NA","NA","NA",null,{"v":1.216964,"d":"1.22"},{"v":1.103445,"d":"1.10"},{"v":1.296532,"d":"1.30"},{"v":1.37527,"d":"1.38"},{"v":1.565787,"d":"1.57"},{"v":1.579224,"d":"1.58"},{"v":0.800158441477421,"d":"0.80"},{"v":-0.321642394760964,"d":"-0.32"},{"v":0.530631813525786,"d":"0.53"},{"v":0.908801297021169,"d":"0.91"},"down","no"]
["MSTRG.3326","G6PC3","ENSOART00000007328","GO:0004346(glucose-6-phosphatase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006094(gluconeogenesis);GO:0015760(glucose-6-phosphate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity)","00010(Glycolysis / Gluconeogenesis);00052(Galactose metabolism);00500(Starch and sucrose metabolism);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04910(Insulin signaling pathway);04920(Adipocytokine signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);04973(Carbohydrate digestion and absorption)","K01084","EC:3.1.3.9","glucose-6-phosphatase catalytic subunit 3 [Source:NCBI gene;Acc:101113421]",{"v":1.154728,"d":"1.15"},{"v":1.117598,"d":"1.12"},{"v":0.661898,"d":"0.66"},{"v":1.250035,"d":"1.25"},{"v":1.104726,"d":"1.10"},{"v":1.445373,"d":"1.45"},{"v":0.772136982537984,"d":"0.77"},{"v":-0.373071280428651,"d":"-0.37"},{"v":0.531812092160735,"d":"0.53"},{"v":0.909449920486016,"d":"0.91"},"down","no"]
["MSTRG.7128","ENSOARG00000012525","ENSOART00000013625","GO:0003723(RNA binding);GO:0004525(ribonuclease III activity);GO:0006396(RNA processing);GO:0016075(rRNA catabolic process);GO:0090501(RNA phosphodiester bond hydrolysis);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","03008(Ribosome biogenesis in eukaryotes);05205(Proteoglycans in cancer)","K03685","EC:3.1.26.3","drosha ribonuclease III [Source:NCBI gene;Acc:101115827]",{"v":1.306857,"d":"1.31"},{"v":1.264326,"d":"1.26"},{"v":1.360693,"d":"1.36"},{"v":1.640275,"d":"1.64"},{"v":1.3896,"d":"1.39"},{"v":1.769174,"d":"1.77"},{"v":0.819303157771467,"d":"0.82"},{"v":-0.287530719593757,"d":"-0.29"},{"v":0.532146549969816,"d":"0.53"},{"v":0.909478179206713,"d":"0.91"},"down","no"]
["MSTRG.17533","JMJD4","ENSOART00000007523","GO:0005737(cytoplasm);GO:0016706(2-oxoglutarate-dependent dioxygenase activity);GO:0018126(protein hydroxylation);GO:0045905(positive regulation of translational termination);GO:0055114(oxidation-reduction process)","NA","NA","NA","jumonji domain containing 4 [Source:NCBI gene;Acc:101103319]",{"v":2.18765519137397,"d":"2.19"},{"v":1.70514593672521,"d":"1.71"},{"v":2.02043054416322,"d":"2.02"},{"v":2.29232023243802,"d":"2.29"},{"v":2.62781737964876,"d":"2.63"},{"v":2.28551139772727,"d":"2.29"},{"v":0.820638316438757,"d":"0.82"},{"v":-0.285181578183548,"d":"-0.29"},{"v":0.533089756162625,"d":"0.53"},{"v":0.910109738459153,"d":"0.91"},"down","no"]
["MSTRG.11539","ENSOARG00000020076","ENSOART00000021858","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11252","NA","histone H2B type 1 [Source:NCBI gene;Acc:101111915]",{"v":110.794769,"d":"110.79"},{"v":54.084053,"d":"54.08"},{"v":91.537437,"d":"91.54"},{"v":115.540985,"d":"115.54"},{"v":82.361732,"d":"82.36"},{"v":115.340919,"d":"115.34"},{"v":0.818584097267981,"d":"0.82"},{"v":-0.288797455244741,"d":"-0.29"},{"v":0.534433629593685,"d":"0.53"},{"v":0.911260683375698,"d":"0.91"},"down","no"]
["MSTRG.22295","TMEM164","ENSOART00000019481","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 164 [Source:NCBI gene;Acc:101111164]",{"v":1.55965999545729,"d":"1.56"},{"v":1.8442620112858,"d":"1.84"},{"v":1.18838447187422,"d":"1.19"},{"v":2.17669423331086,"d":"2.18"},{"v":1.60936829406963,"d":"1.61"},{"v":1.87715990311247,"d":"1.88"},{"v":0.810899895771455,"d":"0.81"},{"v":-0.302404267729551,"d":"-0.30"},{"v":0.53566685873566,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"down","no"]
["MSTRG.10171","DUSP19","ENSOART00000018225","GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity)","NA","K14165","3.1.3.48;EC:3.1.3.16","dual specificity phosphatase 19 [Source:NCBI gene;Acc:101117733]",{"v":2.85168541893051,"d":"2.85"},{"v":1.59622183014012,"d":"1.60"},{"v":1.12736562196168,"d":"1.13"},{"v":2.42382449814126,"d":"2.42"},{"v":1.20430568773234,"d":"1.20"},{"v":1.32805421504146,"d":"1.33"},{"v":1.12491231561177,"d":"1.12"},{"v":0.169812550987026,"d":"0.17"},{"v":0.53660952002567,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"up","no"]
["MSTRG.9563","RMI1","ENSOART00000003800","GO:0000166(nucleotide binding);GO:0002021(response to dietary excess);GO:0002023(reduction of food intake in response to dietary excess);GO:0005654(nucleoplasm);GO:0009749(response to glucose);GO:0016604(nuclear body);GO:0031422(RecQ helicase-Topo III complex);GO:0035264(multicellular organism growth);GO:0042593(glucose homeostasis)","03460(Fanconi anemia pathway)","K10990","NA","RecQ mediated genome instability 1 [Source:NCBI gene;Acc:101117302]",{"v":1.30568,"d":"1.31"},{"v":1.270444,"d":"1.27"},{"v":0.672888,"d":"0.67"},{"v":1.101207,"d":"1.10"},{"v":0.633267,"d":"0.63"},{"v":1.109722,"d":"1.11"},{"v":1.14233055668456,"d":"1.14"},{"v":0.191980184399179,"d":"0.19"},{"v":0.536866634701671,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"up","no"]
["MSTRG.21240","ZFPM2","ENSOART00000016856","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0001570(vasculogenesis);GO:0001701(in utero embryonic development);GO:0003148(outflow tract septum morphogenesis);GO:0003221(right ventricular cardiac muscle tissue morphogenesis);GO:0003676(nucleic acid binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007507(heart development);GO:0008134(transcription factor binding);GO:0030324(lung development);GO:0045599(negative regulation of fat cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048568(embryonic organ development);GO:0048738(cardiac muscle tissue development);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060412(ventricular septum morphogenesis);GO:0060548(negative regulation of cell death);GO:2000020(positive regulation of male gonad development);GO:2000195(negative regulation of female gonad development)","05206(MicroRNAs in cancer)","K17442","NA","zinc finger protein, FOG family member 2 [Source:NCBI gene;Acc:101121179]",{"v":0.934556548795037,"d":"0.93"},{"v":0.652213726556908,"d":"0.65"},{"v":0.906892016225245,"d":"0.91"},{"v":1.01944196826533,"d":"1.02"},{"v":1.02952615986638,"d":"1.03"},{"v":1.02236153853496,"d":"1.02"},{"v":0.811916193380691,"d":"0.81"},{"v":-0.300597275893085,"d":"-0.30"},{"v":0.537610581634022,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"down","no"]
["MSTRG.3835","CAPN2","ENSOART00000016443","GO:0000785(chromatin);GO:0001824(blastocyst development);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0007520(myoblast fusion);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016787(hydrolase activity);GO:0031143(pseudopodium);GO:0045121(membrane raft);GO:0051493(regulation of cytoskeleton organization);GO:0051603(proteolysis involved in cellular protein catabolic process);GO:0071230(cellular response to amino acid stimulus);GO:0097038(perinuclear endoplasmic reticulum)","04141(Protein processing in endoplasmic reticulum);04210(Apoptosis);04217(Necroptosis);04218(Cellular senescence);04510(Focal adhesion);05010(Alzheimer disease)","K03853","EC:3.4.22.53","calpain 2 [Source:NCBI gene;Acc:100127211]",{"v":7.60634790207062,"d":"7.61"},{"v":8.15825212363709,"d":"8.16"},{"v":9.30221433259978,"d":"9.30"},{"v":6.93754769860958,"d":"6.94"},{"v":8.38195169290787,"d":"8.38"},{"v":7.76192959597879,"d":"7.76"},{"v":1.0860165708062,"d":"1.09"},{"v":0.11904611643651,"d":"0.12"},{"v":0.53805884443835,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"up","no"]
["MSTRG.3480","PYCR1","ENSOART00000019321","GO:0004735(pyrroline-5-carboxylate reductase activity);GO:0005739(mitochondrion);GO:0006561(proline biosynthetic process);GO:0008652(cellular amino acid biosynthetic process);GO:0016491(oxidoreductase activity);GO:0034599(cellular response to oxidative stress);GO:0042802(identical protein binding);GO:0051881(regulation of mitochondrial membrane potential);GO:0055114(oxidation-reduction process);GO:0055129(L-proline biosynthetic process);GO:1903206(negative regulation of hydrogen peroxide-induced cell death)","00330(Arginine and proline metabolism)","K00286","EC:1.5.1.2","pyrroline-5-carboxylate reductase 1 [Source:NCBI gene;Acc:101113161]",{"v":3.470617,"d":"3.47"},{"v":2.074448,"d":"2.07"},{"v":3.202887,"d":"3.20"},{"v":3.502255,"d":"3.50"},{"v":3.051095,"d":"3.05"},{"v":4.31093,"d":"4.31"},{"v":0.805203105958241,"d":"0.81"},{"v":-0.312575357623255,"d":"-0.31"},{"v":0.538298152467586,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"down","no"]
["MSTRG.749","HIST2H2BF","ENSOART00000022518","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005829(cytosol);GO:0046982(protein heterodimerization activity)","05034(Alcoholism);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus)","K11252","NA","histone H2B type 2-F [Source:NCBI gene;Acc:101120455]",{"v":8.67625207731719,"d":"8.68"},{"v":8.21300805775501,"d":"8.21"},{"v":7.04122685142059,"d":"7.04"},{"v":7.71325585468095,"d":"7.71"},{"v":6.33972132743363,"d":"6.34"},{"v":7.97685327992548,"d":"7.98"},{"v":1.0862764934904,"d":"1.09"},{"v":0.11939136374725,"d":"0.12"},{"v":0.538790991900527,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"up","no"]
["MSTRG.215","B4GALT2;ENSOARG00000000705","ENSOART00000000737;ENSOART00000000758","GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0007420(brain development);GO:0007613(memory);GO:0007626(locomotory behavior);GO:0008542(visual learning);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0021680(cerebellar Purkinje cell layer development);GO:0043231(intracellular membrane-bounded organelle)","00052(Galactose metabolism);00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis);00515(Mannose type O-glycan biosynthesis);00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)","K07967","2.4.1.-;2.4.1.38;2.4.1.90;EC:2.4.1.22","beta-1,4-galactosyltransferase 2 [Source:NCBI gene;Acc:101114825];coiled-coil domain containing 24 [Source:NCBI gene;Acc:101107922]",{"v":1.47214589807243,"d":"1.47"},{"v":1.20120627993575,"d":"1.20"},{"v":1.39030079205607,"d":"1.39"},{"v":1.32891135908294,"d":"1.33"},{"v":1.9799482619743,"d":"1.98"},{"v":1.62621429380841,"d":"1.63"},{"v":0.823422919325186,"d":"0.82"},{"v":-0.2802944893948,"d":"-0.28"},{"v":0.539383697409053,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"down","no"]
["MSTRG.17356","GSTK1","ENSOART00000019204","GO:0004364(glutathione transferase activity);GO:0004602(glutathione peroxidase activity);GO:0005102(signaling receptor binding);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0006749(glutathione metabolic process);GO:0015035(protein disulfide oxidoreductase activity);GO:0016740(transferase activity);GO:0030855(epithelial cell differentiation);GO:0055114(oxidation-reduction process);GO:0098869(cellular oxidant detoxification)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);04146(Peroxisome);05204(Chemical carcinogenesis)","K13299","EC:2.5.1.18","glutathione S-transferase kappa 1 [Source:NCBI gene;Acc:101114517]",{"v":5.58639034101383,"d":"5.59"},{"v":5.81551549423963,"d":"5.82"},{"v":6.59998460829493,"d":"6.60"},{"v":7.72542600691244,"d":"7.73"},{"v":6.92326901267281,"d":"6.92"},{"v":7.52262257488479,"d":"7.52"},{"v":0.811944999066651,"d":"0.81"},{"v":-0.300546091936623,"d":"-0.30"},{"v":0.540336539042055,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"down","no"]
["MSTRG.16905","PSMC2","ENSOART00000020777","GO:0000166(nucleotide binding);GO:0000502(proteasome complex);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0030163(protein catabolic process);GO:0036402(proteasome-activating ATPase activity);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:1901800(positive regulation of proteasomal protein catabolic process)","03050(Proteasome);05169(Epstein-Barr virus infection)","K03061","NA","proteasome 26S subunit, ATPase 2 [Source:NCBI gene;Acc:101119977]",{"v":41.6827676163388,"d":"41.68"},{"v":45.9655541740804,"d":"45.97"},{"v":44.2326136565441,"d":"44.23"},{"v":43.3439891330197,"d":"43.34"},{"v":37.5573523781009,"d":"37.56"},{"v":41.8771331971771,"d":"41.88"},{"v":1.07413726844458,"d":"1.07"},{"v":0.103178373071724,"d":"0.10"},{"v":0.540989594282187,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"up","no"]
["MSTRG.3402","POLG2","ENSOART00000016300","GO:0001701(in utero embryonic development);GO:0003887(DNA-directed DNA polymerase activity);GO:0005739(mitochondrion);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0022904(respiratory electron transport chain);GO:0032042(mitochondrial DNA metabolic process);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0070584(mitochondrion morphogenesis);GO:0071897(DNA biosynthetic process)","NA","K02333","NA","DNA polymerase gamma 2, accessory subunit [Source:NCBI gene;Acc:101105931]",{"v":1.80644270260223,"d":"1.81"},{"v":2.20905768401487,"d":"2.21"},{"v":1.80439581784387,"d":"1.80"},{"v":1.89903311152416,"d":"1.90"},{"v":1.92087378438662,"d":"1.92"},{"v":1.46956576579926,"d":"1.47"},{"v":1.10027909711881,"d":"1.10"},{"v":0.137869524619484,"d":"0.14"},{"v":0.542456841692615,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"up","no"]
["MSTRG.19535","EMC9;PSME2","ENSOART00000020924;ENSOART00000020922","GO:0005737(cytoplasm);GO:0072546(ER membrane protein complex);GO:0008537(proteasome activator complex);GO:0042802(identical protein binding)","03050(Proteasome);04612(Antigen processing and presentation)","K06697","NA","ER membrane protein complex subunit 9 [Source:NCBI gene;Acc:101117671];proteasome activator subunit 2 [Source:NCBI gene;Acc:100135691]",{"v":4.63969289703632,"d":"4.64"},{"v":4.83409256518714,"d":"4.83"},{"v":4.51312278196744,"d":"4.51"},{"v":5.39344258118826,"d":"5.39"},{"v":5.11077993223876,"d":"5.11"},{"v":6.4093762871852,"d":"6.41"},{"v":0.826962281006962,"d":"0.83"},{"v":-0.274106567480177,"d":"-0.27"},{"v":0.542609196038028,"d":"0.54"},{"v":0.911461561032238,"d":"0.91"},"down","no"]
["ENSOARG00000005631","PHF19","ENSOART00000006135","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0019827(stem cell population maintenance);GO:0035064(methylated histone binding);GO:0035098(ESC/E(Z) complex);GO:0046872(metal ion binding);GO:0048863(stem cell differentiation);GO:0061087(positive regulation of histone H3-K27 methylation)","NA","K11486","NA","PHD finger protein 19 [Source:NCBI gene;Acc:101115767]",{"v":0.866052,"d":"0.87"},{"v":0.892709,"d":"0.89"},{"v":1.178033,"d":"1.18"},{"v":0.798265,"d":"0.80"},{"v":1.020239,"d":"1.02"},{"v":0.824945,"d":"0.82"},{"v":1.11097055399972,"d":"1.11"},{"v":0.151820578957826,"d":"0.15"},{"v":0.543289809807282,"d":"0.54"},{"v":0.91158671798978,"d":"0.91"},"up","no"]
["MSTRG.16956","STARD3NL","ENSOART00000009849","GO:0005789(endoplasmic reticulum membrane);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031902(late endosome membrane);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0044232(organelle membrane contact site);GO:0099044(vesicle tethering to endoplasmic reticulum);GO:0140284(endoplasmic reticulum-endosome membrane contact site)","NA","NA","NA","STARD3 N-terminal like [Source:NCBI gene;Acc:101108381]",{"v":1.87884561538462,"d":"1.88"},{"v":1.63656246153846,"d":"1.64"},{"v":1.70011084615385,"d":"1.70"},{"v":2.11238188461538,"d":"2.11"},{"v":1.131594,"d":"1.13"},{"v":1.4786805,"d":"1.48"},{"v":1.1043612954919,"d":"1.10"},{"v":0.143212231846682,"d":"0.14"},{"v":0.543431844127339,"d":"0.54"},{"v":0.91158671798978,"d":"0.91"},"up","no"]
["MSTRG.22020","ABCD1","ENSOART00000007672","GO:0000038(very long-chain fatty acid metabolic process);GO:0000166(nucleotide binding);GO:0002082(regulation of oxidative phosphorylation);GO:0005324(long-chain fatty acid transporter activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0005779(integral component of peroxisomal membrane);GO:0005789(endoplasmic reticulum membrane);GO:0006635(fatty acid beta-oxidation);GO:0007031(peroxisome organization);GO:0015607(fatty-acyl-CoA transmembrane transporter activity);GO:0015910(long-chain fatty acid import into peroxisome);GO:0015916(fatty-acyl-CoA transport);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0019899(enzyme binding);GO:0030497(fatty acid elongation);GO:0031966(mitochondrial membrane);GO:0031998(regulation of fatty acid beta-oxidation);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0036113(very long-chain fatty-acyl-CoA catabolic process);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0042758(long-chain fatty acid catabolic process);GO:0042760(very long-chain fatty acid catabolic process);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043217(myelin maintenance);GO:0043531(ADP binding);GO:0048471(perinuclear region of cytoplasm);GO:0051900(regulation of mitochondrial depolarization);GO:0055085(transmembrane transport);GO:0055089(fatty acid homeostasis);GO:0055092(sterol homeostasis);GO:1900016(negative regulation of cytokine production involved in inflammatory response);GO:1900407(regulation of cellular response to oxidative stress);GO:1903427(negative regulation of reactive oxygen species biosynthetic process);GO:1990535(neuron projection maintenance);GO:2001280(positive regulation of unsaturated fatty acid biosynthetic process)","NA","NA","NA","ATP binding cassette subfamily D member 1 [Source:HGNC Symbol;Acc:HGNC:61]",{"v":3.98758772780083,"d":"3.99"},{"v":4.88712121991701,"d":"4.89"},{"v":4.05068187883817,"d":"4.05"},{"v":5.07988051618257,"d":"5.08"},{"v":3.33288528796681,"d":"3.33"},{"v":3.64111025228216,"d":"3.64"},{"v":1.07230162032896,"d":"1.07"},{"v":0.100710768619803,"d":"0.10"},{"v":0.544179489530838,"d":"0.54"},{"v":0.911592449359979,"d":"0.91"},"up","no"]
["MSTRG.3698","ENSOARG00000000211","ENSOART00000000218","GO:0000387(spliceosomal snRNP assembly);GO:0000398(mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005681(spliceosomal complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006397(mRNA processing);GO:0008380(RNA splicing)","NA","NA","NA",null,{"v":1.174237,"d":"1.17"},{"v":3.053883,"d":"3.05"},{"v":4.723638,"d":"4.72"},{"v":1.461457,"d":"1.46"},{"v":0.902158,"d":"0.90"},{"v":10.53651,"d":"10.54"},{"v":0.693928004573599,"d":"0.69"},{"v":-0.527142104753282,"d":"-0.53"},{"v":0.545126812255694,"d":"0.55"},{"v":0.911592449359979,"d":"0.91"},"down","no"]
["MSTRG.8178","MESD","ENSOART00000017006","GO:0005886(plasma membrane);GO:0006457(protein folding);GO:0006909(phagocytosis);GO:0034394(protein localization to cell surface);GO:0042802(identical protein binding);GO:0050750(low-density lipoprotein particle receptor binding);GO:1904395(positive regulation of skeletal muscle acetylcholine-gated channel clustering)","NA","NA","NA","mesoderm development LRP chaperone [Source:NCBI gene;Acc:101116430]",{"v":4.547489,"d":"4.55"},{"v":3.831493,"d":"3.83"},{"v":3.885571,"d":"3.89"},{"v":4.919984,"d":"4.92"},{"v":4.633264,"d":"4.63"},{"v":5.595421,"d":"5.60"},{"v":0.809612580484794,"d":"0.81"},{"v":-0.304696386794357,"d":"-0.30"},{"v":0.545591023660104,"d":"0.55"},{"v":0.911592449359979,"d":"0.91"},"down","no"]
["MSTRG.18835","DHX15","ENSOART00000006414","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003725(double-stranded RNA binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005689(U12-type spliceosomal complex);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0071008(U2-type post-mRNA release spliceosomal complex)","03040(Spliceosome)","K12820","EC:3.6.4.13","DEAH-box helicase 15 [Source:NCBI gene;Acc:101103896]",{"v":4.78086236542164,"d":"4.78"},{"v":4.95102076934925,"d":"4.95"},{"v":5.34141390566038,"d":"5.34"},{"v":5.35475521909896,"d":"5.35"},{"v":4.65145804736234,"d":"4.65"},{"v":4.07330011628803,"d":"4.07"},{"v":1.07058366512152,"d":"1.07"},{"v":0.0983975454098921,"d":"0.10"},{"v":0.546195530030656,"d":"0.55"},{"v":0.911592449359979,"d":"0.91"},"up","no"]
["MSTRG.1847","AMOTL2","ENSOART00000008991","GO:0005923(bicellular tight junction);GO:0016324(apical plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042802(identical protein binding)","04530(Tight junction)","K06104","NA","angiomotin like 2 [Source:NCBI gene;Acc:101114081]",{"v":6.6293779453869,"d":"6.63"},{"v":2.74101633035714,"d":"2.74"},{"v":4.79943634583333,"d":"4.80"},{"v":7.58366004017857,"d":"7.58"},{"v":4.72114594479167,"d":"4.72"},{"v":5.149523703125,"d":"5.15"},{"v":0.811823248144667,"d":"0.81"},{"v":-0.300762439869279,"d":"-0.30"},{"v":0.547015425594707,"d":"0.55"},{"v":0.911592449359979,"d":"0.91"},"down","no"]
["MSTRG.20882","ARHGAP39","ENSOART00000013799","GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0007165(signal transduction);GO:0098978(glutamatergic synapse);GO:0099173(postsynapse organization)","NA","K20649","NA","Rho GTPase activating protein 39 [Source:NCBI gene;Acc:101106270]",{"v":0.678304,"d":"0.68"},{"v":0.595824,"d":"0.60"},{"v":0.615493,"d":"0.62"},{"v":0.782274,"d":"0.78"},{"v":0.719888,"d":"0.72"},{"v":0.836028,"d":"0.84"},{"v":0.80815545357734,"d":"0.81"},{"v":-0.307295264121076,"d":"-0.31"},{"v":0.547170908888958,"d":"0.55"},{"v":0.911592449359979,"d":"0.91"},"down","no"]
["MSTRG.1861","ACAD11","ENSOART00000009707","GO:0004466(long-chain-acyl-CoA dehydrogenase activity);GO:0005634(nucleus);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0017099(very-long-chain-acyl-CoA dehydrogenase activity);GO:0031966(mitochondrial membrane);GO:0033539(fatty acid beta-oxidation using acyl-CoA dehydrogenase);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process);GO:0070991(medium-chain-acyl-CoA dehydrogenase activity)","NA","K11730","NA","acyl-CoA dehydrogenase family member 11 [Source:NCBI gene;Acc:101118915]",{"v":2.866155,"d":"2.87"},{"v":2.172585,"d":"2.17"},{"v":1.619582,"d":"1.62"},{"v":1.986721,"d":"1.99"},{"v":2.094906,"d":"2.09"},{"v":1.952942,"d":"1.95"},{"v":1.10336330564784,"d":"1.10"},{"v":0.141907906935681,"d":"0.14"},{"v":0.548645654765825,"d":"0.55"},{"v":0.912371144009685,"d":"0.91"},"up","no"]
["MSTRG.21297","MTDH","ENSOART00000004737","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0001650(fibrillar center);GO:0003713(transcription coactivator activity);GO:0003725(double-stranded RNA binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0010508(positive regulation of autophagy);GO:0016604(nuclear body);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045766(positive regulation of angiogenesis);GO:0048471(perinuclear region of cytoplasm);GO:0051059(NF-kappaB binding);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051897(positive regulation of protein kinase B signaling);GO:1903508(positive regulation of nucleic acid-templated transcription)","NA","NA","NA","metadherin [Source:NCBI gene;Acc:101107364]",{"v":8.64317414631597,"d":"8.64"},{"v":7.67671308221564,"d":"7.68"},{"v":6.89600495593102,"d":"6.90"},{"v":8.21434300191604,"d":"8.21"},{"v":6.66586761400453,"d":"6.67"},{"v":6.73625633025605,"d":"6.74"},{"v":1.0739910570154,"d":"1.07"},{"v":0.10298198023836,"d":"0.10"},{"v":0.548663171425227,"d":"0.55"},{"v":0.912371144009685,"d":"0.91"},"up","no"]
["MSTRG.16057","ENSOARG00000012899","ENSOART00000014020","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","thymopoietin [Source:NCBI gene;Acc:101120072]",{"v":3.09853487643584,"d":"3.10"},{"v":2.42362013291762,"d":"2.42"},{"v":2.27987579586478,"d":"2.28"},{"v":3.75954229241877,"d":"3.76"},{"v":2.46493676271743,"d":"2.46"},{"v":3.26462753085002,"d":"3.26"},{"v":0.822209207423226,"d":"0.82"},{"v":-0.282422567026561,"d":"-0.28"},{"v":0.549645478958116,"d":"0.55"},{"v":0.912530612053606,"d":"0.91"},"down","no"]
["MSTRG.21376","TAF2","ENSOART00000017401;ENSOART00000017399","GO:0000086(G2/M transition of mitotic cell cycle);GO:0001094(TFIID-class transcription factor complex binding);GO:0005669(transcription factor TFIID complex);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0033276(transcription factor TFTC complex);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045944(positive regulation of transcription by RNA polymerase II)","03022(Basal transcription factors);03022(Basal transcription factors)","K03128","NA","TATA-box binding protein associated factor 2 [Source:NCBI gene;Acc:101116155]",{"v":11.4370238711424,"d":"11.44"},{"v":13.422985752301,"d":"13.42"},{"v":11.6355979242014,"d":"11.64"},{"v":11.3162183088793,"d":"11.32"},{"v":11.6837693129399,"d":"11.68"},{"v":10.9523217647537,"d":"10.95"},{"v":1.07490795786862,"d":"1.07"},{"v":0.104213130129585,"d":"0.10"},{"v":0.550883530800908,"d":"0.55"},{"v":0.912530612053606,"d":"0.91"},"up","no"]
["MSTRG.3593","RNF157","ENSOART00000008396","NA","NA","NA","NA","ring finger protein 157 [Source:NCBI gene;Acc:101117601]",{"v":3.12989927192322,"d":"3.13"},{"v":4.3943746339857,"d":"4.39"},{"v":2.85382033524652,"d":"2.85"},{"v":4.00700662532932,"d":"4.01"},{"v":2.71246832075649,"d":"2.71"},{"v":2.97404178998871,"d":"2.97"},{"v":1.07062220283102,"d":"1.07"},{"v":0.0984494770463756,"d":"0.10"},{"v":0.551138972635147,"d":"0.55"},{"v":0.912530612053606,"d":"0.91"},"up","no"]
["MSTRG.9926","ENSOARG00000014242","ENSOART00000015514","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","01521(EGFR tyrosine kinase inhibitor resistance);03010(Ribosome);04066(HIF-1 signaling pathway);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04371(Apelin signaling pathway);04714(Thermogenesis);04910(Insulin signaling pathway);05205(Proteoglycans in cancer)","K02991","NA","ribosomal protein S6 [Source:NCBI gene;Acc:100037665]",{"v":40.290984899217,"d":"40.29"},{"v":35.2339893670119,"d":"35.23"},{"v":46.1326182283405,"d":"46.13"},{"v":44.4499716276838,"d":"44.45"},{"v":49.9444630037888,"d":"49.94"},{"v":51.8877036534478,"d":"51.89"},{"v":0.831664028984943,"d":"0.83"},{"v":-0.265927260761479,"d":"-0.27"},{"v":0.551768449591004,"d":"0.55"},{"v":0.912609780242477,"d":"0.91"},"down","no"]
["MSTRG.1491","ST6GAL1","ENSOART00000022336","GO:0000139(Golgi membrane);GO:0003835(beta-galactoside alpha-2,6-sialyltransferase activity);GO:0005794(Golgi apparatus);GO:0006054(N-acetylneuraminate metabolic process);GO:0006486(protein glycosylation);GO:0008373(sialyltransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018279(protein N-linked glycosylation via asparagine);GO:0042803(protein homodimerization activity);GO:0097503(sialylation)","00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis)","K00778","EC:2.4.99.1","ST6 beta-galactoside alpha-2,6-sialyltransferase 1 [Source:NCBI gene;Acc:100913159]",{"v":1.33618501698754,"d":"1.34"},{"v":0.540781158550396,"d":"0.54"},{"v":0.725088929218573,"d":"0.73"},{"v":0.962404075311438,"d":"0.96"},{"v":0.963668821630804,"d":"0.96"},{"v":1.32895946262741,"d":"1.33"},{"v":0.799394542762864,"d":"0.80"},{"v":-0.323020370960409,"d":"-0.32"},{"v":0.552764154456475,"d":"0.55"},{"v":0.912609780242477,"d":"0.91"},"down","no"]
["MSTRG.7046","ENSOARG00000005671","ENSOART00000006174","GO:0003924(GTPase activity);GO:0005525(GTP binding)","NA","NA","NA",null,{"v":0.752239,"d":"0.75"},{"v":1.35101,"d":"1.35"},{"v":0.702386,"d":"0.70"},{"v":0.769863,"d":"0.77"},{"v":0.696927,"d":"0.70"},{"v":1.005999,"d":"1.01"},{"v":1.134603478097,"d":"1.13"},{"v":0.182188191671795,"d":"0.18"},{"v":0.553283514362446,"d":"0.55"},{"v":0.912609780242477,"d":"0.91"},"up","no"]
["MSTRG.11299","SLC35B2","ENSOART00000010281","GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046963(3'-phosphoadenosine 5'-phosphosulfate transport);GO:0046964(3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity);GO:0055085(transmembrane transport);GO:1902559(3'-phospho-5'-adenylyl sulfate transmembrane transport)","NA","NA","NA","solute carrier family 35 member B2 [Source:HGNC Symbol;Acc:HGNC:16872]",{"v":3.95593229408616,"d":"3.96"},{"v":3.09270389296227,"d":"3.09"},{"v":3.36999045169922,"d":"3.37"},{"v":4.01122679314958,"d":"4.01"},{"v":3.88444764971903,"d":"3.88"},{"v":4.64238995557934,"d":"4.64"},{"v":0.83095973251161,"d":"0.83"},{"v":-0.267149527775459,"d":"-0.27"},{"v":0.553596359729554,"d":"0.55"},{"v":0.912609780242477,"d":"0.91"},"down","no"]
["MSTRG.5279","ZDHHC7","ENSOART00000012114","GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016409(palmitoyltransferase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoyltransferase activity)","NA","K20029","EC:2.3.1.225","zinc finger DHHC-type containing 7 [Source:NCBI gene;Acc:100302557]",{"v":10.4425462795733,"d":"10.44"},{"v":10.7902649209288,"d":"10.79"},{"v":11.3390980363979,"d":"11.34"},{"v":12.5323137747098,"d":"12.53"},{"v":13.6678520316912,"d":"13.67"},{"v":13.0483992648259,"d":"13.05"},{"v":0.829887899794289,"d":"0.83"},{"v":-0.269011622684751,"d":"-0.27"},{"v":0.553782927938262,"d":"0.55"},{"v":0.912609780242477,"d":"0.91"},"down","no"]
["MSTRG.3405","CEP95","ENSOART00000016470","GO:0000922(spindle pole);GO:0005813(centrosome)","NA","K16544","NA","centrosomal protein 95 [Source:NCBI gene;Acc:101106443]",{"v":1.368606,"d":"1.37"},{"v":1.036087,"d":"1.04"},{"v":1.138836,"d":"1.14"},{"v":1.725497,"d":"1.73"},{"v":1.342788,"d":"1.34"},{"v":1.288431,"d":"1.29"},{"v":0.813348632318471,"d":"0.81"},{"v":-0.298054215766105,"d":"-0.30"},{"v":0.554781111519128,"d":"0.55"},{"v":0.912893904519075,"d":"0.91"},"down","no"]
["MSTRG.505","ZNF326","ENSOART00000017021","GO:0000993(RNA polymerase II complex binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0032784(regulation of DNA-templated transcription, elongation);GO:0043231(intracellular membrane-bounded organelle);GO:0043484(regulation of RNA splicing);GO:0044609(DBIRD complex)","NA","K13204","NA","zinc finger protein 326 [Source:NCBI gene;Acc:101114840]",{"v":1.71759452453881,"d":"1.72"},{"v":1.52134281447964,"d":"1.52"},{"v":1.43339781865646,"d":"1.43"},{"v":2.18315654994779,"d":"2.18"},{"v":2.1388168663418,"d":"2.14"},{"v":1.39208164531848,"d":"1.39"},{"v":0.817691658077933,"d":"0.82"},{"v":-0.290371172531985,"d":"-0.29"},{"v":0.556103877849789,"d":"0.56"},{"v":0.913579245148542,"d":"0.91"},"down","no"]
["MSTRG.20872","PTP4A1","ENSOART00000013533","GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0009898(cytoplasmic side of plasma membrane);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity)","NA","K18041","EC:3.1.3.48","protein tyrosine phosphatase type IVA, member 1 [Source:NCBI gene;Acc:101110683]",{"v":10.9709667419558,"d":"10.97"},{"v":12.2996139747634,"d":"12.30"},{"v":10.3385037867508,"d":"10.34"},{"v":11.8800025722397,"d":"11.88"},{"v":9.41110782649842,"d":"9.41"},{"v":10.2177410107256,"d":"10.22"},{"v":1.06665533651841,"d":"1.07"},{"v":0.0930940799831805,"d":"0.09"},{"v":0.556598407559221,"d":"0.56"},{"v":0.913636007911024,"d":"0.91"},"up","no"]
["MSTRG.14805","PSMB7","ENSOART00000014792","GO:0000502(proteasome complex);GO:0004175(endopeptidase activity);GO:0004298(threonine-type endopeptidase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005839(proteasome core complex);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016787(hydrolase activity);GO:0051603(proteolysis involved in cellular protein catabolic process)","03050(Proteasome)","K02739","EC:3.4.25.1","proteasome subunit beta 7 [Source:NCBI gene;Acc:100135690]",{"v":47.367214,"d":"47.37"},{"v":53.329582,"d":"53.33"},{"v":45.953564,"d":"45.95"},{"v":46.076462,"d":"46.08"},{"v":46.157677,"d":"46.16"},{"v":44.965397,"d":"44.97"},{"v":1.06888378981107,"d":"1.07"},{"v":0.0961050102363217,"d":"0.10"},{"v":0.55698794985177,"d":"0.56"},{"v":0.913636007911024,"d":"0.91"},"up","no"]
["MSTRG.2869","ENSOARG00000004258","ENSOART00000004638","GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0005634(nucleus)","NA","K11543","NA","MIS12, kinetochore complex component [Source:NCBI gene;Acc:101105171]",{"v":3.232656,"d":"3.23"},{"v":2.036262,"d":"2.04"},{"v":1.873321,"d":"1.87"},{"v":3.057598,"d":"3.06"},{"v":1.417127,"d":"1.42"},{"v":1.806832,"d":"1.81"},{"v":1.1370173031941,"d":"1.14"},{"v":0.185254209412542,"d":"0.19"},{"v":0.557967394022142,"d":"0.56"},{"v":0.914223286153215,"d":"0.91"},"up","no"]
["MSTRG.6810","SERPING1","ENSOART00000010920;ENSOART00000010921","GO:0001869(negative regulation of complement activation, lectin pathway);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0010951(negative regulation of endopeptidase activity);GO:0030193(regulation of blood coagulation);GO:0045916(negative regulation of complement activation);GO:0045916(negative regulation of complement activation)","04610(Complement and coagulation cascades);05133(Pertussis);05133(Pertussis)","K04001","NA","serpin family G member 1 [Source:NCBI gene;Acc:101121454]",{"v":3.75211809038961,"d":"3.75"},{"v":2.93550794805195,"d":"2.94"},{"v":2.94556138285714,"d":"2.95"},{"v":4.26464376779221,"d":"4.26"},{"v":2.72565513194805,"d":"2.73"},{"v":4.7827674825974,"d":"4.78"},{"v":0.818239455079496,"d":"0.82"},{"v":-0.289404989982182,"d":"-0.29"},{"v":0.558995478793222,"d":"0.56"},{"v":0.914223286153215,"d":"0.91"},"down","no"]
["MSTRG.14973","AGBL5","ENSOART00000020760","GO:0004181(metallocarboxypeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0015630(microtubule cytoskeleton);GO:0015631(tubulin binding);GO:0030496(midbody);GO:0035608(protein deglutamylation);GO:0035611(protein branching point deglutamylation);GO:0045171(intercellular bridge);GO:0051607(defense response to virus);GO:0072686(mitotic spindle)","NA","NA","NA","ATP/GTP binding protein like 5 [Source:NCBI gene;Acc:101112799]",{"v":0.444026,"d":"0.44"},{"v":0.462852,"d":"0.46"},{"v":0.469126,"d":"0.47"},{"v":0.440346,"d":"0.44"},{"v":0.644267,"d":"0.64"},{"v":0.650565,"d":"0.65"},{"v":0.793004521726301,"d":"0.79"},{"v":-0.334599002661119,"d":"-0.33"},{"v":0.559807671969828,"d":"0.56"},{"v":0.914223286153215,"d":"0.91"},"down","no"]
["ENSOARG00000020446","ENSOARG00000020446","ENSOART00000022267","GO:0005515(protein binding)","NA","NA","NA",null,{"v":0.274634,"d":"0.27"},{"v":0.370019,"d":"0.37"},{"v":0.220363,"d":"0.22"},{"v":0.366043,"d":"0.37"},{"v":0.282742,"d":"0.28"},{"v":0.10767,"d":"0.11"},{"v":1.14351283288497,"d":"1.14"},{"v":0.193472556248598,"d":"0.19"},{"v":0.559867949331798,"d":"0.56"},{"v":0.914223286153215,"d":"0.91"},"up","no"]
["MSTRG.12126","SART1","ENSOART00000000748","GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0015030(Cajal body);GO:0016607(nuclear speck);GO:0045585(positive regulation of cytotoxic T cell differentiation);GO:0071005(U2-type precatalytic spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)","K11984","NA","spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP [Source:NCBI gene;Acc:101103685]",{"v":6.757633,"d":"6.76"},{"v":5.393945,"d":"5.39"},{"v":5.212152,"d":"5.21"},{"v":5.371479,"d":"5.37"},{"v":7.807924,"d":"7.81"},{"v":7.649745,"d":"7.65"},{"v":0.833626512231801,"d":"0.83"},{"v":-0.262526933805119,"d":"-0.26"},{"v":0.5608078714722,"d":"0.56"},{"v":0.914237811025005,"d":"0.91"},"down","no"]
["MSTRG.10311","RBMS1","ENSOART00000007474;ENSOART00000007470","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005829(cytosol);GO:0005829(cytosol)","NA","NA","NA","RNA binding motif single stranded interacting protein 1 [Source:NCBI gene;Acc:101109149]",{"v":2.34576180993069,"d":"2.35"},{"v":2.45475402411469,"d":"2.45"},{"v":2.4989733908668,"d":"2.50"},{"v":2.37831192746606,"d":"2.38"},{"v":2.29684090439571,"d":"2.30"},{"v":2.16281284553309,"d":"2.16"},{"v":1.06749427670324,"d":"1.07"},{"v":0.0942283349567795,"d":"0.09"},{"v":0.560960160941535,"d":"0.56"},{"v":0.914237811025005,"d":"0.91"},"up","no"]
["MSTRG.9091","SEMA3F","ENSOART00000011593;ENSOART00000011596","GO:0001755(neural crest cell migration);GO:0005515(protein binding);GO:0007411(axon guidance);GO:0021612(facial nerve structural organization);GO:0021637(trigeminal nerve structural organization);GO:0021675(nerve development);GO:0021785(branchiomotor neuron axon guidance);GO:0036486(ventral trunk neural crest cell migration);GO:0045499(chemorepellent activity);GO:0048843(negative regulation of axon extension involved in axon guidance);GO:0048846(axon extension involved in axon guidance);GO:0050919(negative chemotaxis);GO:0061549(sympathetic ganglion development);GO:0097490(sympathetic neuron projection extension);GO:0097491(sympathetic neuron projection guidance);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:1901166(neural crest cell migration involved in autonomic nervous system development);GO:1902285(semaphorin-plexin signaling pathway involved in neuron projection guidance);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance);GO:1902287(semaphorin-plexin signaling pathway involved in axon guidance)","04360(Axon guidance);04360(Axon guidance)","K06840","NA","semaphorin 3F [Source:NCBI gene;Acc:101122223]",{"v":1.75218015316901,"d":"1.75"},{"v":1.78814098314889,"d":"1.79"},{"v":1.91393605055332,"d":"1.91"},{"v":1.92167174044266,"d":"1.92"},{"v":2.21233029678068,"d":"2.21"},{"v":2.47160166750503,"d":"2.47"},{"v":0.825701545335969,"d":"0.83"},{"v":-0.276307689601015,"d":"-0.28"},{"v":0.561837791412906,"d":"0.56"},{"v":0.9144800824288,"d":"0.91"},"down","no"]
["MSTRG.22200","OCRL","ENSOART00000016084","GO:0001701(in utero embryonic development);GO:0001750(photoreceptor outer segment);GO:0004439(phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity);GO:0005096(GTPase activator activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0016787(hydrolase activity);GO:0030136(clathrin-coated vesicle);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0046856(phosphatidylinositol dephosphorylation);GO:0048365(Rac GTPase binding);GO:0052745(inositol phosphate phosphatase activity);GO:0060271(cilium assembly)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)","K01099","EC:3.1.3.36","OCRL, inositol polyphosphate-5-phosphatase [Source:NCBI gene;Acc:101119794]",{"v":6.89620466215741,"d":"6.90"},{"v":6.18512481113844,"d":"6.19"},{"v":6.134824702565,"d":"6.13"},{"v":7.10540332572031,"d":"7.11"},{"v":4.95842405165144,"d":"4.96"},{"v":5.9370648388967,"d":"5.94"},{"v":1.06751120694418,"d":"1.07"},{"v":0.0942512156236814,"d":"0.09"},{"v":0.562394439072178,"d":"0.56"},{"v":0.914610676954092,"d":"0.91"},"up","no"]
["MSTRG.3319","DHX8","ENSOART00000005902","GO:0000166(nucleotide binding);GO:0000398(mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016604(nuclear body);GO:0016787(hydrolase activity);GO:0042802(identical protein binding);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)","K12818","EC:3.6.4.13","DEAH-box helicase 8 [Source:NCBI gene;Acc:101110072]",{"v":7.064167,"d":"7.06"},{"v":6.571857,"d":"6.57"},{"v":6.61852,"d":"6.62"},{"v":8.749082,"d":"8.75"},{"v":7.380792,"d":"7.38"},{"v":8.233028,"d":"8.23"},{"v":0.831368282809659,"d":"0.83"},{"v":-0.266440385541937,"d":"-0.27"},{"v":0.563647628578812,"d":"0.56"},{"v":0.915421337745448,"d":"0.92"},"down","no"]
["MSTRG.10409","RAB3GAP1","ENSOART00000012001;ENSOART00000012000","GO:0005096(GTPase activator activity);GO:0005794(Golgi apparatus);GO:0005811(lipid droplet);GO:0007420(brain development);GO:0010628(positive regulation of gene expression);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0021854(hypothalamus development);GO:0032991(protein-containing complex);GO:0034389(lipid droplet organization);GO:0043010(camera-type eye development);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0060079(excitatory postsynaptic potential);GO:0060325(face morphogenesis);GO:0061646(positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization);GO:0071782(endoplasmic reticulum tubular network);GO:0097051(establishment of protein localization to endoplasmic reticulum membrane);GO:1903061(positive regulation of protein lipidation);GO:1903233(regulation of calcium ion-dependent exocytosis of neurotransmitter);GO:1903373(positive regulation of endoplasmic reticulum tubular network organization);GO:2000786(positive regulation of autophagosome assembly);GO:2000786(positive regulation of autophagosome assembly)","NA","K18270","NA","RAB3 GTPase activating protein catalytic subunit 1 [Source:NCBI gene;Acc:101105474]",{"v":4.04655536170213,"d":"4.05"},{"v":4.35656275559193,"d":"4.36"},{"v":3.43302650163666,"d":"3.43"},{"v":4.52020387902346,"d":"4.52"},{"v":3.07906266366612,"d":"3.08"},{"v":3.50883275981997,"d":"3.51"},{"v":1.06554184443208,"d":"1.07"},{"v":0.0915872496849305,"d":"0.09"},{"v":0.56440143355484,"d":"0.56"},{"v":0.915421337745448,"d":"0.92"},"up","no"]
["MSTRG.5730","BCKDHA","ENSOART00000008057","GO:0003826(alpha-ketoacid dehydrogenase activity);GO:0003863(3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity);GO:0009083(branched-chain amino acid catabolic process);GO:0016491(oxidoreductase activity);GO:0016624(oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor);GO:0055114(oxidation-reduction process)","00280(Valine, leucine and isoleucine degradation);00640(Propanoate metabolism)","K00166","EC:1.2.4.4","branched chain keto acid dehydrogenase E1, alpha polypeptide [Source:NCBI gene;Acc:100145857]",{"v":20.236357,"d":"20.24"},{"v":18.39551,"d":"18.40"},{"v":16.030142,"d":"16.03"},{"v":20.383165,"d":"20.38"},{"v":18.846125,"d":"18.85"},{"v":26.36841,"d":"26.37"},{"v":0.833291548331725,"d":"0.83"},{"v":-0.263106747265006,"d":"-0.26"},{"v":0.56595035939228,"d":"0.57"},{"v":0.916470070438881,"d":"0.92"},"down","no"]
["MSTRG.10740","ENSOARG00000020405","ENSOART00000022219","GO:0005515(protein binding);GO:0005769(early endosome);GO:0034141(positive regulation of toll-like receptor 3 signaling pathway);GO:0034145(positive regulation of toll-like receptor 4 signaling pathway);GO:0046872(metal ion binding)","NA","K23299","NA","WD repeat and FYVE domain containing 1 [Source:NCBI gene;Acc:101121495]",{"v":6.366984,"d":"6.37"},{"v":5.243366,"d":"5.24"},{"v":6.296778,"d":"6.30"},{"v":6.103095,"d":"6.10"},{"v":5.662742,"d":"5.66"},{"v":4.996959,"d":"5.00"},{"v":1.06826617707452,"d":"1.07"},{"v":0.0952711643473359,"d":"0.10"},{"v":0.566197577897679,"d":"0.57"},{"v":0.916470070438881,"d":"0.92"},"up","no"]
["MSTRG.19737","NIN","ENSOART00000022522;ENSOART00000022526","GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005813(centrosome);GO:0005814(centriole);GO:0005886(plasma membrane);GO:0008104(protein localization);GO:0010457(centriole-centriole cohesion);GO:0019900(kinase binding);GO:0021540(corpus callosum morphogenesis);GO:0021957(corticospinal tract morphogenesis);GO:0030424(axon);GO:0030425(dendrite);GO:0031116(positive regulation of microtubule polymerization);GO:0034454(microtubule anchoring at centrosome);GO:0036449(microtubule minus-end);GO:0044295(axonal growth cone);GO:0045177(apical part of cell);GO:0048668(collateral sprouting);GO:0050772(positive regulation of axonogenesis);GO:0051642(centrosome localization);GO:0072686(mitotic spindle);GO:0090222(centrosome-templated microtubule nucleation);GO:0097431(mitotic spindle pole);GO:0097539(ciliary transition fiber);GO:0120103(centriolar subdistal appendage);GO:0120103(centriolar subdistal appendage)","NA","K16476","NA","ninein [Source:NCBI gene;Acc:101104912]",{"v":3.31855685174913,"d":"3.32"},{"v":2.69717807247025,"d":"2.70"},{"v":2.67365473239689,"d":"2.67"},{"v":3.36562939858638,"d":"3.37"},{"v":2.27359600787331,"d":"2.27"},{"v":2.50409721248993,"d":"2.50"},{"v":1.06705703104479,"d":"1.07"},{"v":0.0936372860092809,"d":"0.09"},{"v":0.566590467829524,"d":"0.57"},{"v":0.916470070438881,"d":"0.92"},"up","no"]
["MSTRG.13244","ENSOARG00000018598","ENSOART00000020240","GO:0005975(carbohydrate metabolic process);GO:0006044(N-acetylglucosamine metabolic process);GO:0008448(N-acetylglucosamine-6-phosphate deacetylase activity);GO:0016787(hydrolase activity);GO:0016810(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds);GO:0046872(metal ion binding);GO:0047419(N-acetylgalactosamine-6-phosphate deacetylase activity)","00520(Amino sugar and nucleotide sugar metabolism)","K01443","EC:3.5.1.25","amidohydrolase domain containing 2 [Source:NCBI gene;Acc:101116953]",{"v":7.054823,"d":"7.05"},{"v":7.288999,"d":"7.29"},{"v":7.631762,"d":"7.63"},{"v":7.989386,"d":"7.99"},{"v":8.742153,"d":"8.74"},{"v":9.714195,"d":"9.71"},{"v":0.830968957034809,"d":"0.83"},{"v":-0.26713351243863,"d":"-0.27"},{"v":0.568015910048833,"d":"0.57"},{"v":0.916976572706757,"d":"0.92"},"down","no"]
["MSTRG.11807","ENSOARG00000005855;RF00016","ENSOART00000006372;ENSOART00000025686;ENSOART00000024724","GO:0000166(nucleotide binding);GO:0005524(ATP binding)","NA","NA","NA","heat shock cognate 71 kDa protein-like [Source:NCBI gene;Acc:101114987]",{"v":19.9553469998375,"d":"19.96"},{"v":22.3811322737612,"d":"22.38"},{"v":23.6768453879773,"d":"23.68"},{"v":15.984575143948,"d":"15.98"},{"v":22.5790563504468,"d":"22.58"},{"v":22.488052333225,"d":"22.49"},{"v":1.08126951662735,"d":"1.08"},{"v":0.112726173246358,"d":"0.11"},{"v":0.568812036818653,"d":"0.57"},{"v":0.916976572706757,"d":"0.92"},"up","no"]
["MSTRG.13554","RNF40","ENSOART00000008354","GO:0000151(ubiquitin ligase complex);GO:0003730(mRNA 3'-UTR binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0010390(histone monoubiquitination);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0031625(ubiquitin protein ligase binding);GO:0033503(HULC complex);GO:0033523(histone H2B ubiquitination);GO:0042803(protein homodimerization activity);GO:0046872(metal ion binding);GO:1900364(negative regulation of mRNA polyadenylation);GO:2001168(positive regulation of histone H2B ubiquitination)","NA","K10696","EC:2.3.2.27","ring finger protein 40 [Source:NCBI gene;Acc:101102446]",{"v":6.250308,"d":"6.25"},{"v":5.411965,"d":"5.41"},{"v":5.546478,"d":"5.55"},{"v":7.06821,"d":"7.07"},{"v":6.412679,"d":"6.41"},{"v":7.130529,"d":"7.13"},{"v":0.834913493093973,"d":"0.83"},{"v":-0.260301369815213,"d":"-0.26"},{"v":0.569686561647138,"d":"0.57"},{"v":0.917239012374606,"d":"0.92"},"down","no"]
["MSTRG.1688","MLF1","ENSOART00000002702","GO:0007050(cell cycle arrest);GO:0019904(protein domain specific binding)","05202(Transcriptional misregulation in cancer)","K15622","NA","myeloid leukemia factor 1 [Source:NCBI gene;Acc:101108357]",{"v":26.2705175999375,"d":"26.27"},{"v":29.7236217682698,"d":"29.72"},{"v":19.6009044275453,"d":"19.60"},{"v":30.3385909540912,"d":"30.34"},{"v":18.2491893088695,"d":"18.25"},{"v":22.1705528850718,"d":"22.17"},{"v":1.06835535028222,"d":"1.07"},{"v":0.0953915878692072,"d":"0.10"},{"v":0.570157351187653,"d":"0.57"},{"v":0.917239012374606,"d":"0.92"},"up","no"]
["MSTRG.3590","PRPSAP1","ENSOART00000008096","GO:0000287(magnesium ion binding);GO:0004749(ribose phosphate diphosphokinase activity);GO:0009165(nucleotide biosynthetic process);GO:0042802(identical protein binding)","NA","NA","NA","phosphoribosyl pyrophosphate synthetase associated protein 1 [Source:HGNC Symbol;Acc:HGNC:9466]",{"v":6.74550794706369,"d":"6.75"},{"v":5.58181367162945,"d":"5.58"},{"v":5.79006159139785,"d":"5.79"},{"v":7.61282052936311,"d":"7.61"},{"v":7.1907202688172,"d":"7.19"},{"v":6.95212223076923,"d":"6.95"},{"v":0.83276630944241,"d":"0.83"},{"v":-0.264016391023732,"d":"-0.26"},{"v":0.571106425136326,"d":"0.57"},{"v":0.917524393017203,"d":"0.92"},"down","no"]
["MSTRG.295","COA7","ENSOART00000006041","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion)","04714(Thermogenesis)","K18180","NA","cytochrome c oxidase assembly factor 7 [Source:NCBI gene;Acc:101116001]",{"v":0.873047,"d":"0.87"},{"v":1.556663,"d":"1.56"},{"v":0.854885,"d":"0.85"},{"v":1.392586,"d":"1.39"},{"v":0.752349,"d":"0.75"},{"v":0.861605,"d":"0.86"},{"v":1.09248338621804,"d":"1.09"},{"v":0.127611340318014,"d":"0.13"},{"v":0.571430085345685,"d":"0.57"},{"v":0.917524393017203,"d":"0.92"},"up","no"]
["MSTRG.6039","FIZ1","ENSOART00000001249","GO:0001934(positive regulation of protein phosphorylation);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0030971(receptor tyrosine kinase binding)","NA","NA","NA","FLT3 interacting zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:25917]",{"v":1.44508380340883,"d":"1.45"},{"v":1.22854962082652,"d":"1.23"},{"v":1.34295457483073,"d":"1.34"},{"v":1.35774771515293,"d":"1.36"},{"v":1.75155027737567,"d":"1.75"},{"v":1.73518195190287,"d":"1.74"},{"v":0.829106125969823,"d":"0.83"},{"v":-0.270371315710311,"d":"-0.27"},{"v":0.571776881200301,"d":"0.57"},{"v":0.917524393017203,"d":"0.92"},"down","no"]
["MSTRG.6980","PLK2","ENSOART00000007869","GO:0000082(G1/S transition of mitotic cell cycle);GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0000785(chromatin);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0006468(protein phosphorylation);GO:0007052(mitotic spindle organization);GO:0007093(mitotic cell cycle checkpoint);GO:0007613(memory);GO:0010508(positive regulation of autophagy);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016525(negative regulation of angiogenesis);GO:0016740(transferase activity);GO:0018105(peptidyl-serine phosphorylation);GO:0043008(ATP-dependent protein binding);GO:0043066(negative regulation of apoptotic process);GO:0045732(positive regulation of protein catabolic process);GO:0046599(regulation of centriole replication);GO:0048167(regulation of synaptic plasticity);GO:0071866(negative regulation of apoptotic process in bone marrow cell);GO:0090050(positive regulation of cell migration involved in sprouting angiogenesis);GO:2000773(negative regulation of cellular senescence)","04068(FoxO signaling pathway)","K08861","EC:2.7.11.21","polo like kinase 2 [Source:NCBI gene;Acc:101110619]",{"v":11.1179915085643,"d":"11.12"},{"v":6.33909695203986,"d":"6.34"},{"v":6.65430626315789,"d":"6.65"},{"v":9.54085277888508,"d":"9.54"},{"v":5.91629586203675,"d":"5.92"},{"v":6.83317136250389,"d":"6.83"},{"v":1.0816980070298,"d":"1.08"},{"v":0.113297777748055,"d":"0.11"},{"v":0.572340509777065,"d":"0.57"},{"v":0.917524393017203,"d":"0.92"},"up","no"]
["MSTRG.11152","SLC39A7","ENSOART00000009562","GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030001(metal ion transport);GO:0046873(metal ion transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K14713","NA","solute carrier family 39 member 7 [Source:NCBI gene;Acc:100302555]",{"v":8.10597972610755,"d":"8.11"},{"v":7.02782768180552,"d":"7.03"},{"v":6.87554061382001,"d":"6.88"},{"v":9.77511377486765,"d":"9.78"},{"v":7.58266333741989,"d":"7.58"},{"v":9.05841756255224,"d":"9.06"},{"v":0.833176325835302,"d":"0.83"},{"v":-0.263306248169919,"d":"-0.26"},{"v":0.573249264589867,"d":"0.57"},{"v":0.917524393017203,"d":"0.92"},"down","no"]
["MSTRG.16524","ENSOARG00000016145","ENSOART00000017580","GO:0005634(nucleus)","NA","NA","NA",null,{"v":0.692182,"d":"0.69"},{"v":0.463833,"d":"0.46"},{"v":1.166051,"d":"1.17"},{"v":0.722454,"d":"0.72"},{"v":1.187994,"d":"1.19"},{"v":1.030815,"d":"1.03"},{"v":0.789479213521538,"d":"0.79"},{"v":-0.341026813531654,"d":"-0.34"},{"v":0.573916845136122,"d":"0.57"},{"v":0.917711594875761,"d":"0.92"},"down","no"]
["MSTRG.9614","TRIM35","ENSOART00000010585","GO:0005515(protein binding);GO:0008270(zinc ion binding);GO:0043065(positive regulation of apoptotic process);GO:0045087(innate immune response);GO:0045930(negative regulation of mitotic cell cycle);GO:0046872(metal ion binding);GO:1902187(negative regulation of viral release from host cell)","NA","K12012","NA","tripartite motif containing 35 [Source:NCBI gene;Acc:101119023]",{"v":1.090193,"d":"1.09"},{"v":1.105339,"d":"1.11"},{"v":1.295851,"d":"1.30"},{"v":1.289815,"d":"1.29"},{"v":1.89738,"d":"1.90"},{"v":1.12033,"d":"1.12"},{"v":0.810531105449185,"d":"0.81"},{"v":-0.303060542313967,"d":"-0.30"},{"v":0.574783326028061,"d":"0.57"},{"v":0.918393399294078,"d":"0.92"},"down","no"]
["MSTRG.21967","DKC1;ENSOARG00000002987","ENSOART00000003302;ENSOART00000003236;ENSOART00000003238","GO:0000455(enzyme-directed rRNA pseudouridine synthesis);GO:0001522(pseudouridine synthesis);GO:0001650(fibrillar center);GO:0003720(telomerase activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005697(telomerase holoenzyme complex);GO:0005730(nucleolus);GO:0006396(RNA processing);GO:0007004(telomere maintenance via telomerase);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0015030(Cajal body);GO:0031118(rRNA pseudouridine synthesis);GO:0031429(box H/ACA snoRNP complex);GO:0032212(positive regulation of telomere maintenance via telomerase);GO:0033979(box H/ACA snoRNA metabolic process);GO:0034513(box H/ACA snoRNA binding);GO:0051973(positive regulation of telomerase activity);GO:0070034(telomerase RNA binding);GO:0090661(box H/ACA telomerase RNP complex);GO:0090666(scaRNA localization to Cajal body);GO:0090669(telomerase RNA stabilization);GO:1904851(positive regulation of establishment of protein localization to telomere);GO:1904872(regulation of telomerase RNA localization to Cajal body);GO:1904874(positive regulation of telomerase RNA localization to Cajal body)","03008(Ribosome biogenesis in eukaryotes)","K11131","EC:5.4.99.-","dyskerin pseudouridine synthase 1 [Source:NCBI gene;Acc:100216437]",{"v":4.50422393165829,"d":"4.50"},{"v":4.9100893798995,"d":"4.91"},{"v":4.97642717487437,"d":"4.98"},{"v":6.32818194472362,"d":"6.33"},{"v":5.68922950552764,"d":"5.69"},{"v":5.37362485628141,"d":"5.37"},{"v":0.827480331406502,"d":"0.83"},{"v":-0.27320307435063,"d":"-0.27"},{"v":0.57599449223886,"d":"0.58"},{"v":0.918553359619206,"d":"0.92"},"down","no"]
["MSTRG.17406","ZNF746","ENSOART00000000374;ENSOART00000000375","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0031625(ubiquitin protein ligase binding);GO:0046872(metal ion binding);GO:1901216(positive regulation of neuron death);GO:1901216(positive regulation of neuron death)","05168(Herpes simplex virus 1 infection);05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 746 [Source:NCBI gene;Acc:101108126]",{"v":2.13466294199042,"d":"2.13"},{"v":1.54898315513571,"d":"1.55"},{"v":2.47266491218733,"d":"2.47"},{"v":2.52044177887174,"d":"2.52"},{"v":2.16985463677488,"d":"2.17"},{"v":2.72940280814263,"d":"2.73"},{"v":0.829725144325921,"d":"0.83"},{"v":-0.269294588052704,"d":"-0.27"},{"v":0.576503197213296,"d":"0.58"},{"v":0.918609514985812,"d":"0.92"},"down","no"]
["MSTRG.18287","APBB3;SRA1","ENSOART00000019756;ENSOART00000019701","GO:0001540(amyloid-beta binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0015629(actin cytoskeleton);GO:0002153(steroid receptor RNA activator RNA binding);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008283(cell population proliferation);GO:0015630(microtubule cytoskeleton);GO:0030154(cell differentiation);GO:0030374(nuclear receptor transcription coactivator activity);GO:0031252(cell leading edge);GO:0042981(regulation of apoptotic process);GO:0045171(intercellular bridge);GO:0045662(negative regulation of myoblast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071391(cellular response to estrogen stimulus);GO:1903508(positive regulation of nucleic acid-templated transcription);GO:1990904(ribonucleoprotein complex)","NA","NA","NA","amyloid beta precursor protein binding family B member 3 [Source:NCBI gene;Acc:101118948];steroid receptor RNA activator 1 [Source:NCBI gene;Acc:101118694]",{"v":3.00137733893534,"d":"3.00"},{"v":2.3524411727792,"d":"2.35"},{"v":1.95908634324033,"d":"1.96"},{"v":2.69335811019124,"d":"2.69"},{"v":2.28311374029307,"d":"2.28"},{"v":1.88153407459227,"d":"1.88"},{"v":1.06633107857416,"d":"1.07"},{"v":0.0926554411541357,"d":"0.09"},{"v":0.577634981971354,"d":"0.58"},{"v":0.918609514985812,"d":"0.92"},"up","no"]
["MSTRG.6088","PRPF31","ENSOART00000003286","GO:0000244(spliceosomal tri-snRNP complex assembly);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005687(U4 snRNP);GO:0005690(U4atac snRNP);GO:0015030(Cajal body);GO:0016607(nuclear speck);GO:0030621(U4 snRNA binding);GO:0030622(U4atac snRNA binding);GO:0043021(ribonucleoprotein complex binding);GO:0046540(U4/U6 x U5 tri-snRNP complex);GO:0070990(snRNP binding);GO:0071005(U2-type precatalytic spliceosome);GO:0071166(ribonucleoprotein complex localization);GO:0071339(MLL1 complex)","03040(Spliceosome)","K12844","NA","pre-mRNA processing factor 31 [Source:NCBI gene;Acc:101103004]",{"v":3.71472527036011,"d":"3.71"},{"v":3.49472101274238,"d":"3.49"},{"v":4.12170938282548,"d":"4.12"},{"v":4.91134612022161,"d":"4.91"},{"v":4.34670331191136,"d":"4.35"},{"v":4.44508508144044,"d":"4.45"},{"v":0.826902461966208,"d":"0.83"},{"v":-0.274210929863923,"d":"-0.27"},{"v":0.577802396917897,"d":"0.58"},{"v":0.918609514985812,"d":"0.92"},"down","no"]
["MSTRG.14260","TRAPPC11","ENSOART00000007929","GO:0005794(Golgi apparatus);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007030(Golgi organization);GO:0030008(TRAPP complex);GO:0051259(protein complex oligomerization);GO:0061635(regulation of protein complex stability)","NA","K20308","NA","trafficking protein particle complex 11 [Source:NCBI gene;Acc:101109589]",{"v":3.77490190279793,"d":"3.77"},{"v":3.3150080746114,"d":"3.32"},{"v":3.5685707442487,"d":"3.57"},{"v":4.7368193761658,"d":"4.74"},{"v":4.21994351792746,"d":"4.22"},{"v":3.8372661173057,"d":"3.84"},{"v":0.833082425572254,"d":"0.83"},{"v":-0.263468851299676,"d":"-0.26"},{"v":0.578656128162021,"d":"0.58"},{"v":0.918609514985812,"d":"0.92"},"down","no"]
["MSTRG.5557","ENSOARG00000004181","ENSOART00000004552","GO:0003677(DNA binding)","NA","K06875","NA","programmed cell death 5 [Source:NCBI gene;Acc:101108153]",{"v":6.67657911010558,"d":"6.68"},{"v":7.47850096983409,"d":"7.48"},{"v":7.03010784313725,"d":"7.03"},{"v":5.1859124841629,"d":"5.19"},{"v":6.10891968325792,"d":"6.11"},{"v":7.97919583257918,"d":"7.98"},{"v":1.09915726609284,"d":"1.10"},{"v":0.136397820118001,"d":"0.14"},{"v":0.579091450360922,"d":"0.58"},{"v":0.918609514985812,"d":"0.92"},"up","no"]
["MSTRG.16569","ENSOARG00000018130","ENSOART00000019733","GO:0005515(protein binding)","NA","NA","NA",null,{"v":0.347793,"d":"0.35"},{"v":0.387037,"d":"0.39"},{"v":0.559055,"d":"0.56"},{"v":0.62369,"d":"0.62"},{"v":0.384144,"d":"0.38"},{"v":0.650374,"d":"0.65"},{"v":0.780291133561049,"d":"0.78"},{"v":-0.357915588118904,"d":"-0.36"},{"v":0.579333204941957,"d":"0.58"},{"v":0.918609514985812,"d":"0.92"},"down","no"]
["ENSOARG00000009224","NEK3","ENSOART00000010044","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0030010(establishment of cell polarity);GO:0048812(neuron projection morphogenesis);GO:0090043(regulation of tubulin deacetylation)","NA","K20873","EC:2.7.11.1","NIMA related kinase 3 [Source:NCBI gene;Acc:101121103]",{"v":0.290862,"d":"0.29"},{"v":0.375409,"d":"0.38"},{"v":0.265831,"d":"0.27"},{"v":0.364616,"d":"0.36"},{"v":0.234244,"d":"0.23"},{"v":0.25493,"d":"0.25"},{"v":1.09172278897621,"d":"1.09"},{"v":0.12660657261273,"d":"0.13"},{"v":0.58015598574985,"d":"0.58"},{"v":0.918985559458783,"d":"0.92"},"up","no"]
["MSTRG.2953","KDM6B","ENSOART00000019134","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006338(chromatin remodeling);GO:0008013(beta-catenin binding);GO:0010468(regulation of gene expression);GO:0016577(histone demethylation);GO:0043565(sequence-specific DNA binding);GO:0045165(cell fate commitment);GO:0045446(endothelial cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0048333(mesodermal cell differentiation);GO:0055007(cardiac muscle cell differentiation);GO:0070301(cellular response to hydrogen peroxide);GO:0071557(histone H3-K27 demethylation);GO:0071558(histone demethylase activity (H3-K27 specific));GO:0120162(positive regulation of cold-induced thermogenesis)","NA","K11448","EC:1.14.11.-","lysine demethylase 6B [Source:NCBI gene;Acc:101119656]",{"v":5.01132188079704,"d":"5.01"},{"v":5.43088693105272,"d":"5.43"},{"v":3.68894889190619,"d":"3.69"},{"v":5.03202853747135,"d":"5.03"},{"v":3.25889986298713,"d":"3.26"},{"v":4.86668129818374,"d":"4.87"},{"v":1.07399125125396,"d":"1.07"},{"v":0.102982241159509,"d":"0.10"},{"v":0.5804644216093,"d":"0.58"},{"v":0.919057000796051,"d":"0.92"},"up","no"]
["MSTRG.13494","ATXN2L","ENSOART00000002719;ENSOART00000002725","GO:0005829(cytosol);GO:0010494(cytoplasmic stress granule);GO:0010603(regulation of cytoplasmic mRNA processing body assembly);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0034063(stress granule assembly);GO:0034063(stress granule assembly)","NA","NA","NA","ataxin 2 like [Source:NCBI gene;Acc:100037683]",{"v":8.11397622026432,"d":"8.11"},{"v":7.05242008527376,"d":"7.05"},{"v":8.82234238546256,"d":"8.82"},{"v":9.41981964789175,"d":"9.42"},{"v":9.49268097923222,"d":"9.49"},{"v":9.73138380490875,"d":"9.73"},{"v":0.837482037323605,"d":"0.84"},{"v":-0.255869847644001,"d":"-0.26"},{"v":0.58168886233567,"d":"0.58"},{"v":0.919413089350825,"d":"0.92"},"down","no"]
["MSTRG.2811","SERPINF1","ENSOART00000015502","GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0016525(negative regulation of angiogenesis);GO:0050769(positive regulation of neurogenesis);GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development)","04310(Wnt signaling pathway)","K19614","NA","serpin family F member 1 [Source:NCBI gene;Acc:100192425]",{"v":16.9353027673301,"d":"16.94"},{"v":10.2870697185999,"d":"10.29"},{"v":26.2525886932052,"d":"26.25"},{"v":17.0281428819492,"d":"17.03"},{"v":20.8178411448181,"d":"20.82"},{"v":27.1072346170213,"d":"27.11"},{"v":0.823284238959711,"d":"0.82"},{"v":-0.280537487641339,"d":"-0.28"},{"v":0.582696484812051,"d":"0.58"},{"v":0.919878612488352,"d":"0.92"},"down","no"]
["ENSOARG00000001534","PIEZO2","ENSOART00000001649","GO:0008381(mechanosensitive ion channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K22128","NA","piezo type mechanosensitive ion channel component 2 [Source:NCBI gene;Acc:101105203]",{"v":0.310115,"d":"0.31"},{"v":0.216449,"d":"0.22"},{"v":0.652743,"d":"0.65"},{"v":0.269868,"d":"0.27"},{"v":0.689233,"d":"0.69"},{"v":0.523371,"d":"0.52"},{"v":0.795500353463674,"d":"0.80"},{"v":-0.330065523300019,"d":"-0.33"},{"v":0.583083142580782,"d":"0.58"},{"v":0.920041869009591,"d":"0.92"},"down","no"]
["MSTRG.19488","HEXA","ENSOART00000020616","GO:0001501(skeletal system development);GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004563(beta-N-acetylhexosaminidase activity);GO:0005764(lysosome);GO:0005975(carbohydrate metabolic process);GO:0006689(ganglioside catabolic process);GO:0007040(lysosome organization);GO:0007605(sensory perception of sound);GO:0007626(locomotory behavior);GO:0007628(adult walking behavior);GO:0008152(metabolic process);GO:0016020(membrane);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0019915(lipid storage);GO:0019953(sexual reproduction);GO:0030203(glycosaminoglycan metabolic process);GO:0042552(myelination);GO:0048667(cell morphogenesis involved in neuron differentiation);GO:0050884(neuromuscular process controlling posture);GO:0050885(neuromuscular process controlling balance);GO:0060395(SMAD protein signal transduction);GO:0102148(N-acetyl-beta-D-galactosaminidase activity)","00511(Other glycan degradation);00520(Amino sugar and nucleotide sugar metabolism);00531(Glycosaminoglycan degradation);00603(Glycosphingolipid biosynthesis - globo and isoglobo series);00604(Glycosphingolipid biosynthesis - ganglio series);04142(Lysosome)","K12373","EC:3.2.1.52","hexosaminidase subunit alpha [Source:NCBI gene;Acc:100145856]",{"v":3.929896,"d":"3.93"},{"v":4.047087,"d":"4.05"},{"v":4.180342,"d":"4.18"},{"v":5.458031,"d":"5.46"},{"v":4.49063,"d":"4.49"},{"v":4.773123,"d":"4.77"},{"v":0.825805146984903,"d":"0.83"},{"v":-0.2761266844788,"d":"-0.28"},{"v":0.583450714309475,"d":"0.58"},{"v":0.920041869009591,"d":"0.92"},"down","no"]
["MSTRG.5153","ENSOARG00000014961","ENSOART00000016283","GO:0003676(nucleic acid binding)","NA","NA","NA",null,{"v":2.37350940333333,"d":"2.37"},{"v":1.0454462725,"d":"1.05"},{"v":1.54282803041667,"d":"1.54"},{"v":2.02220344458333,"d":"2.02"},{"v":1.84804549166667,"d":"1.85"},{"v":2.13599404375,"d":"2.14"},{"v":0.82610439217529,"d":"0.83"},{"v":-0.275603992955241,"d":"-0.28"},{"v":0.583960867351566,"d":"0.58"},{"v":0.920041869009591,"d":"0.92"},"down","no"]
["MSTRG.562","SASS6","ENSOART00000019504","GO:0005813(centrosome);GO:0005814(centriole);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0007099(centriole replication);GO:0051298(centrosome duplication);GO:0098536(deuterosome)","NA","K16487","NA","SAS-6 centriolar assembly protein [Source:NCBI gene;Acc:101112610]",{"v":0.557345,"d":"0.56"},{"v":0.431191,"d":"0.43"},{"v":0.548177,"d":"0.55"},{"v":0.791389,"d":"0.79"},{"v":0.419073,"d":"0.42"},{"v":0.68866,"d":"0.69"},{"v":0.809170237615066,"d":"0.81"},{"v":-0.305484838306538,"d":"-0.31"},{"v":0.58503833099401,"d":"0.59"},{"v":0.920409262336699,"d":"0.92"},"down","no"]
["MSTRG.14088","ENSOARG00000007887","ENSOART00000008585","GO:0005515(protein binding)","NA","NA","NA","synaptopodin 2 like [Source:NCBI gene;Acc:101108364]",{"v":18.2200943959297,"d":"18.22"},{"v":21.2958965356152,"d":"21.30"},{"v":16.12881139963,"d":"16.13"},{"v":19.4771773219241,"d":"19.48"},{"v":23.0696515800185,"d":"23.07"},{"v":24.0628765231267,"d":"24.06"},{"v":0.835385804156887,"d":"0.84"},{"v":-0.259485467123395,"d":"-0.26"},{"v":0.586830826036703,"d":"0.59"},{"v":0.920943708230221,"d":"0.92"},"down","no"]
["MSTRG.8210","FBXO22","ENSOART00000001416","GO:0000209(protein polyubiquitination);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006913(nucleocytoplasmic transport);GO:0009267(cellular response to starvation);GO:0010830(regulation of myotube differentiation);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0048742(regulation of skeletal muscle fiber development);GO:2000060(positive regulation of ubiquitin-dependent protein catabolic process)","NA","K10302","NA","F-box protein 22 [Source:NCBI gene;Acc:101102339]",{"v":2.473998,"d":"2.47"},{"v":2.059902,"d":"2.06"},{"v":2.208701,"d":"2.21"},{"v":2.624547,"d":"2.62"},{"v":2.767487,"d":"2.77"},{"v":2.815826,"d":"2.82"},{"v":0.821480995046212,"d":"0.82"},{"v":-0.283700896059842,"d":"-0.28"},{"v":0.587316888351623,"d":"0.59"},{"v":0.920943708230221,"d":"0.92"},"down","no"]
["MSTRG.2943","MPDU1","ENSOART00000016095","GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K09660","NA","mannose-P-dolichol utilization defect 1 [Source:NCBI gene;Acc:101102251]",{"v":1.92874,"d":"1.93"},{"v":1.249528,"d":"1.25"},{"v":1.468529,"d":"1.47"},{"v":2.242106,"d":"2.24"},{"v":1.679602,"d":"1.68"},{"v":1.89606,"d":"1.90"},{"v":0.798725043693733,"d":"0.80"},{"v":-0.324229145387062,"d":"-0.32"},{"v":0.588298401344684,"d":"0.59"},{"v":0.921369789550234,"d":"0.92"},"down","no"]
["MSTRG.6435","FAR1","ENSOART00000008052","GO:0005777(peroxisome);GO:0005779(integral component of peroxisomal membrane);GO:0006629(lipid metabolic process);GO:0008611(ether lipid biosynthetic process);GO:0010025(wax biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0035336(long-chain fatty-acyl-CoA metabolic process);GO:0046474(glycerophospholipid biosynthetic process);GO:0055114(oxidation-reduction process);GO:0080019(fatty-acyl-CoA reductase (alcohol-forming) activity);GO:0102965(alcohol-forming fatty acyl-CoA reductase activity)","04146(Peroxisome)","K13356","EC:1.2.1.84","fatty acyl-CoA reductase 1 [Source:NCBI gene;Acc:101119501]",{"v":3.31855970442964,"d":"3.32"},{"v":2.93018224813799,"d":"2.93"},{"v":2.54285385613485,"d":"2.54"},{"v":2.72110204704038,"d":"2.72"},{"v":2.72890123324187,"d":"2.73"},{"v":2.77459296785574,"d":"2.77"},{"v":1.06893950091384,"d":"1.07"},{"v":0.0961802027296039,"d":"0.10"},{"v":0.588778318481574,"d":"0.59"},{"v":0.921369789550234,"d":"0.92"},"up","no"]
["MSTRG.5478","ATP6V0D1","ENSOART00000003248","GO:0005769(early endosome);GO:0005813(centrosome);GO:0006811(ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008553(proton-exporting ATPase activity, phosphorylative mechanism);GO:0015078(proton transmembrane transporter activity);GO:0015991(ATP hydrolysis coupled proton transport);GO:0016020(membrane);GO:0016471(vacuolar proton-transporting V-type ATPase complex);GO:0033179(proton-transporting V-type ATPase, V0 domain);GO:0036295(cellular response to increased oxygen levels)","00190(Oxidative phosphorylation);04142(Lysosome);04145(Phagosome);04721(Synaptic vesicle cycle);04966(Collecting duct acid secretion);05152(Tuberculosis);05165(Human papillomavirus infection);05203(Viral carcinogenesis);05323(Rheumatoid arthritis)","K02146","NA","ATPase H+ transporting V0 subunit d1 [Source:NCBI gene;Acc:101108509]",{"v":14.207551,"d":"14.21"},{"v":16.731215,"d":"16.73"},{"v":19.51104,"d":"19.51"},{"v":18.01107,"d":"18.01"},{"v":18.973341,"d":"18.97"},{"v":23.522547,"d":"23.52"},{"v":0.833785198720451,"d":"0.83"},{"v":-0.262252333105821,"d":"-0.26"},{"v":0.588973146056601,"d":"0.59"},{"v":0.921443456078844,"d":"0.92"},"down","no"]
["MSTRG.19657","CCDC32","ENSOART00000022026","NA","NA","NA","NA","coiled-coil domain containing 32 [Source:NCBI gene;Acc:101108835]",{"v":3.22599113489736,"d":"3.23"},{"v":3.343861771261,"d":"3.34"},{"v":2.47488945747801,"d":"2.47"},{"v":3.84174153079179,"d":"3.84"},{"v":3.20708667155425,"d":"3.21"},{"v":3.81896668035191,"d":"3.82"},{"v":0.83225184697183,"d":"0.83"},{"v":-0.264907927822643,"d":"-0.26"},{"v":0.591120555069056,"d":"0.59"},{"v":0.923074573048477,"d":"0.92"},"down","no"]
["MSTRG.14857","IAH1","ENSOART00000016480","NA","NA","NA","NA","isoamyl acetate hydrolyzing esterase 1 (putative) [Source:NCBI gene;Acc:101117317]",{"v":6.384241,"d":"6.38"},{"v":5.630801,"d":"5.63"},{"v":5.746318,"d":"5.75"},{"v":7.114541,"d":"7.11"},{"v":6.772533,"d":"6.77"},{"v":7.394391,"d":"7.39"},{"v":0.834592919237468,"d":"0.83"},{"v":-0.260855414190589,"d":"-0.26"},{"v":0.591394114935088,"d":"0.59"},{"v":0.923074573048477,"d":"0.92"},"down","no"]
["MSTRG.3049","SMCR8","ENSOART00000020253","GO:0000785(chromatin);GO:0004860(protein kinase inhibitor activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006469(negative regulation of protein kinase activity);GO:0010506(regulation of autophagy);GO:0010629(negative regulation of gene expression);GO:0016242(negative regulation of macroautophagy);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0019901(protein kinase binding);GO:0032008(positive regulation of TOR signaling);GO:0032045(guanyl-nucleotide exchange factor complex);GO:1901098(positive regulation of autophagosome maturation);GO:1902902(negative regulation of autophagosome assembly);GO:1903432(regulation of TORC1 signaling);GO:1990316(Atg1/ULK1 kinase complex)","NA","NA","NA","Smith-Magenis syndrome chromosome region, candidate 8 [Source:NCBI gene;Acc:101120176]",{"v":3.131925,"d":"3.13"},{"v":3.650678,"d":"3.65"},{"v":3.361559,"d":"3.36"},{"v":3.551205,"d":"3.55"},{"v":3.017844,"d":"3.02"},{"v":3.027772,"d":"3.03"},{"v":1.05703357393037,"d":"1.06"},{"v":0.0800212009151075,"d":"0.08"},{"v":0.592316366332971,"d":"0.59"},{"v":0.923454753125633,"d":"0.92"},"up","no"]
["ENSOARG00000003623","ENSOARG00000003623","ENSOART00000003931","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein OZF-like [Source:NCBI gene;Acc:101113523]",{"v":0.976698,"d":"0.98"},{"v":1.397614,"d":"1.40"},{"v":1.383077,"d":"1.38"},{"v":1.278887,"d":"1.28"},{"v":1.270188,"d":"1.27"},{"v":0.898758,"d":"0.90"},{"v":1.08978277080125,"d":"1.09"},{"v":0.124040587552059,"d":"0.12"},{"v":0.593940748443018,"d":"0.59"},{"v":0.924403365466455,"d":"0.92"},"up","no"]
["MSTRG.10745","DOCK10","ENSOART00000022259","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0007264(small GTPase mediated signal transduction)","NA","K21853","NA","dedicator of cytokinesis 10 [Source:NCBI gene;Acc:101123187]",{"v":1.307297,"d":"1.31"},{"v":0.886364,"d":"0.89"},{"v":1.087648,"d":"1.09"},{"v":1.276402,"d":"1.28"},{"v":1.461401,"d":"1.46"},{"v":1.186539,"d":"1.19"},{"v":0.836142466686135,"d":"0.84"},{"v":-0.258179317090304,"d":"-0.26"},{"v":0.594405006322265,"d":"0.59"},{"v":0.924403365466455,"d":"0.92"},"down","no"]
["MSTRG.4532","PIP4K2A","ENSOART00000001979","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005776(autophagosome);GO:0010506(regulation of autophagy);GO:0016301(kinase activity);GO:0016307(phosphatidylinositol phosphate kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0035855(megakaryocyte development);GO:0046488(phosphatidylinositol metabolic process);GO:0046854(phosphatidylinositol phosphorylation);GO:2000786(positive regulation of autophagosome assembly)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04810(Regulation of actin cytoskeleton)","K00920","EC:2.7.1.149","phosphatidylinositol-5-phosphate 4-kinase type 2 alpha [Source:NCBI gene;Acc:101103999]",{"v":2.159333,"d":"2.16"},{"v":0.924681,"d":"0.92"},{"v":2.045855,"d":"2.05"},{"v":2.351815,"d":"2.35"},{"v":2.090183,"d":"2.09"},{"v":1.775007,"d":"1.78"},{"v":0.825135093183937,"d":"0.83"},{"v":-0.277297754545835,"d":"-0.28"},{"v":0.594877522308488,"d":"0.59"},{"v":0.924403365466455,"d":"0.92"},"down","no"]
["MSTRG.7367","ZNF330","ENSOART00000013238","GO:0000775(chromosome, centromeric region);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0008270(zinc ion binding);GO:0030496(midbody)","NA","NA","NA","zinc finger protein 330 [Source:NCBI gene;Acc:101113532]",{"v":1.86744728275365,"d":"1.87"},{"v":1.96744195170301,"d":"1.97"},{"v":0.978072010452334,"d":"0.98"},{"v":1.72463729608939,"d":"1.72"},{"v":1.72776297062534,"d":"1.73"},{"v":1.02948171238061,"d":"1.03"},{"v":1.07387058993474,"d":"1.07"},{"v":0.102820147412411,"d":"0.10"},{"v":0.595598203869029,"d":"0.60"},{"v":0.924403365466455,"d":"0.92"},"up","no"]
["MSTRG.20731","ARID1B","ENSOART00000004627","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006338(chromatin remodeling);GO:0007270(neuron-neuron synaptic transmission);GO:0016514(SWI/SNF complex);GO:0060996(dendritic spine development);GO:0070603(SWI/SNF superfamily-type complex);GO:0071565(nBAF complex);GO:0097026(dendritic cell dendrite assembly)","04714(Thermogenesis);05225(Hepatocellular carcinoma)","K11653","NA","AT-rich interaction domain 1B [Source:NCBI gene;Acc:101108839]",{"v":4.15763538953812,"d":"4.16"},{"v":4.05644756255797,"d":"4.06"},{"v":4.17379197783343,"d":"4.17"},{"v":4.10045844745873,"d":"4.10"},{"v":4.30926548376925,"d":"4.31"},{"v":3.33218175324615,"d":"3.33"},{"v":1.05501400392864,"d":"1.06"},{"v":0.0772621489460298,"d":"0.08"},{"v":0.595967932633923,"d":"0.60"},{"v":0.92446935246501,"d":"0.92"},"up","no"]
["ENSOARG00000016618","RAP1GAP2","ENSOART00000018102","GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008361(regulation of cell size);GO:0010977(negative regulation of neuron projection development);GO:0031965(nuclear membrane);GO:0043005(neuron projection);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction)","NA","K17708","NA","RAP1 GTPase activating protein 2 [Source:NCBI gene;Acc:101105513]",{"v":0.305426,"d":"0.31"},{"v":0.402956,"d":"0.40"},{"v":0.312164,"d":"0.31"},{"v":0.404548,"d":"0.40"},{"v":0.588439,"d":"0.59"},{"v":0.309173,"d":"0.31"},{"v":0.783733181790256,"d":"0.78"},{"v":-0.351565515579549,"d":"-0.35"},{"v":0.596493151629444,"d":"0.60"},{"v":0.92475694832943,"d":"0.92"},"down","no"]
["MSTRG.276","RNF11","ENSOART00000004844","GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein transferase activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0051865(protein autoubiquitination)","NA","K11980","NA","ring finger protein 11 [Source:NCBI gene;Acc:101109924]",{"v":38.602837,"d":"38.60"},{"v":40.30275,"d":"40.30"},{"v":29.341755,"d":"29.34"},{"v":39.876015,"d":"39.88"},{"v":32.317001,"d":"32.32"},{"v":30.348442,"d":"30.35"},{"v":1.05564465447722,"d":"1.06"},{"v":0.0781242840358667,"d":"0.08"},{"v":0.597421973055854,"d":"0.60"},{"v":0.925082319476939,"d":"0.93"},"up","no"]
["MSTRG.13068","ELAC1","ENSOART00000005033","GO:0005634(nucleus);GO:0005829(cytosol);GO:0016891(endoribonuclease activity, producing 5'-phosphomonoesters);GO:0042779(tRNA 3'-trailer cleavage);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","03013(RNA transport)","K00784","EC:3.1.26.11","elaC ribonuclease Z 1 [Source:NCBI gene;Acc:101118238]",{"v":1.51689374534161,"d":"1.52"},{"v":1.97041469720497,"d":"1.97"},{"v":1.3287982636646,"d":"1.33"},{"v":1.88979057826087,"d":"1.89"},{"v":1.44950211149068,"d":"1.45"},{"v":1.22971056987578,"d":"1.23"},{"v":1.05408257174323,"d":"1.05"},{"v":0.0759878851710318,"d":"0.08"},{"v":0.599092508102663,"d":"0.60"},{"v":0.925730978614886,"d":"0.93"},"up","no"]
["MSTRG.16588","SREBF2","ENSOART00000020376","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0006355(regulation of transcription, DNA-templated);GO:0008022(protein C-terminus binding);GO:0009267(cellular response to starvation);GO:0010886(positive regulation of cholesterol storage);GO:0016020(membrane);GO:0032937(SREBP-SCAP-Insig complex);GO:0042632(cholesterol homeostasis);GO:0043231(intracellular membrane-bounded organelle);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0070888(E-box binding);GO:0071404(cellular response to low-density lipoprotein particle stimulus);GO:0072368(regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter);GO:0090370(negative regulation of cholesterol efflux);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II)","NA","K09107","NA","sterol regulatory element binding transcription factor 2 [Source:NCBI gene;Acc:101104393]",{"v":5.77950244101433,"d":"5.78"},{"v":4.47890011403371,"d":"4.48"},{"v":3.84711618428099,"d":"3.85"},{"v":5.5534091014333,"d":"5.55"},{"v":6.45622895731611,"d":"6.46"},{"v":4.79628155788313,"d":"4.80"},{"v":0.839318469985363,"d":"0.84"},{"v":-0.252709765879009,"d":"-0.25"},{"v":0.599231355475593,"d":"0.60"},{"v":0.925730978614886,"d":"0.93"},"down","no"]
["MSTRG.13639","TBL2","ENSOART00000013537","GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0019901(protein kinase binding);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0031369(translation initiation factor binding);GO:0042149(cellular response to glucose starvation);GO:0051219(phosphoprotein binding);GO:0071456(cellular response to hypoxia)","NA","NA","NA","transducin beta like 2 [Source:NCBI gene;Acc:101115752]",{"v":4.190391,"d":"4.19"},{"v":3.146086,"d":"3.15"},{"v":3.576358,"d":"3.58"},{"v":4.212252,"d":"4.21"},{"v":5.184399,"d":"5.18"},{"v":3.724685,"d":"3.72"},{"v":0.831686270361494,"d":"0.83"},{"v":-0.265888678962242,"d":"-0.27"},{"v":0.60018714487672,"d":"0.60"},{"v":0.925847781678176,"d":"0.93"},"down","no"]
["MSTRG.6467","CTR9","ENSOART00000011415","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001711(endodermal cell fate commitment);GO:0001826(inner cell mass cell differentiation);GO:0001829(trophectodermal cell differentiation);GO:0001832(blastocyst growth);GO:0001835(blastocyst hatching);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0010390(histone monoubiquitination);GO:0016570(histone modification);GO:0016593(Cdc73/Paf1 complex);GO:0019827(stem cell population maintenance);GO:0032968(positive regulation of transcription elongation from RNA polymerase II promoter);GO:0033523(histone H2B ubiquitination);GO:0035327(transcriptionally active chromatin);GO:0042169(SH2 domain binding);GO:0045638(negative regulation of myeloid cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051571(positive regulation of histone H3-K4 methylation);GO:0070102(interleukin-6-mediated signaling pathway);GO:0071222(cellular response to lipopolysaccharide);GO:0080182(histone H3-K4 trimethylation);GO:1900364(negative regulation of mRNA polyadenylation);GO:2000653(regulation of genetic imprinting);GO:2001162(positive regulation of histone H3-K79 methylation);GO:2001168(positive regulation of histone H2B ubiquitination)","NA","K15176","NA","CTR9 homolog, Paf1/RNA polymerase II complex component [Source:NCBI gene;Acc:101123659]",{"v":1.55247188868008,"d":"1.55"},{"v":1.53640373413664,"d":"1.54"},{"v":1.44216416935662,"d":"1.44"},{"v":1.60790059440637,"d":"1.61"},{"v":1.41323142118063,"d":"1.41"},{"v":1.28803610501879,"d":"1.29"},{"v":1.05148828390023,"d":"1.05"},{"v":0.0724327750785253,"d":"0.07"},{"v":0.600786028285717,"d":"0.60"},{"v":0.925847781678176,"d":"0.93"},"up","no"]
["MSTRG.21086","SDCBP","ENSOART00000016938","GO:0005137(interleukin-5 receptor binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005895(interleukin-5 receptor complex);GO:0007265(Ras protein signal transduction);GO:0007268(chemical synaptic transmission);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030036(actin cytoskeleton organization);GO:0030307(positive regulation of cell growth);GO:0030335(positive regulation of cell migration);GO:0031965(nuclear membrane);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle)","NA","K17254","NA","syndecan binding protein [Source:NCBI gene;Acc:101117086]",{"v":19.993070387051,"d":"19.99"},{"v":19.7190823724008,"d":"19.72"},{"v":21.073481084121,"d":"21.07"},{"v":21.6553234579395,"d":"21.66"},{"v":16.1258980581285,"d":"16.13"},{"v":19.7399391999055,"d":"19.74"},{"v":1.05675256004861,"d":"1.06"},{"v":0.0796376073911492,"d":"0.08"},{"v":0.601436967177462,"d":"0.60"},{"v":0.925866645430422,"d":"0.93"},"up","no"]
["MSTRG.3148","ATP5MC1","ENSOART00000007234","GO:0005739(mitochondrion);GO:0005753(mitochondrial proton-transporting ATP synthase complex);GO:0006811(ion transport);GO:0008289(lipid binding);GO:0015078(proton transmembrane transporter activity);GO:0015986(ATP synthesis coupled proton transport);GO:0015991(ATP hydrolysis coupled proton transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031966(mitochondrial membrane);GO:0033177(proton-transporting two-sector ATPase complex, proton-transporting domain);GO:0045263(proton-transporting ATP synthase complex, coupling factor F(o))","00190(Oxidative phosphorylation);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K02128","NA","ATP synthase membrane subunit c locus 1 [Source:NCBI gene;Acc:443410]",{"v":139.637038553985,"d":"139.64"},{"v":128.72076372108,"d":"128.72"},{"v":116.476895136247,"d":"116.48"},{"v":171.709948835476,"d":"171.71"},{"v":87.8879487403599,"d":"87.89"},{"v":105.926936661954,"d":"105.93"},{"v":1.05282777355959,"d":"1.05"},{"v":0.0742694529321664,"d":"0.07"},{"v":0.602254460930295,"d":"0.60"},{"v":0.9261967106969,"d":"0.93"},"up","no"]
["MSTRG.15437","LOXL3","ENSOART00000013937","GO:0001837(epithelial to mesenchymal transition);GO:0001968(fibronectin binding);GO:0004720(protein-lysine 6-oxidase activity);GO:0005044(scavenger receptor activity);GO:0005507(copper ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006898(receptor-mediated endocytosis);GO:0006954(inflammatory response);GO:0016020(membrane);GO:0016641(oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor);GO:0018057(peptidyl-lysine oxidation);GO:0021510(spinal cord development);GO:0030324(lung development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0055114(oxidation-reduction process);GO:0060021(roof of mouth development);GO:0061053(somite development);GO:1905590(fibronectin fibril organization);GO:2000329(negative regulation of T-helper 17 cell lineage commitment);GO:2001046(positive regulation of integrin-mediated signaling pathway)","NA","K00280","EC:1.4.3.-","lysyl oxidase like 3 [Source:NCBI gene;Acc:101119969]",{"v":0.892832,"d":"0.89"},{"v":0.555497,"d":"0.56"},{"v":1.136392,"d":"1.14"},{"v":0.864851,"d":"0.86"},{"v":1.208081,"d":"1.21"},{"v":1.08696,"d":"1.09"},{"v":0.817977639742118,"d":"0.82"},{"v":-0.289866688730207,"d":"-0.29"},{"v":0.602449677399127,"d":"0.60"},{"v":0.9261967106969,"d":"0.93"},"down","no"]
["MSTRG.17396","ZNF786","ENSOART00000020617","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 786 [Source:NCBI gene;Acc:101107089]",{"v":0.51275202244898,"d":"0.51"},{"v":0.898909383673469,"d":"0.90"},{"v":0.847865066326531,"d":"0.85"},{"v":0.882557470408163,"d":"0.88"},{"v":0.93410794744898,"d":"0.93"},{"v":0.995286016836735,"d":"1.00"},{"v":0.803543917782834,"d":"0.80"},{"v":-0.315551218173058,"d":"-0.32"},{"v":0.603201905116993,"d":"0.60"},{"v":0.9261967106969,"d":"0.93"},"down","no"]
["MSTRG.11815","NARS2;GAB2","ENSOART00000006830;ENSOART00000006895","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004816(asparagine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006421(asparaginyl-tRNA aminoacylation);GO:0005068(transmembrane receptor protein tyrosine kinase adaptor activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0030316(osteoclast differentiation)","00970(Aminoacyl-tRNA biosynthesis);04014(Ras signaling pathway);04071(Sphingolipid signaling pathway);04072(Phospholipase D signaling pathway);04380(Osteoclast differentiation);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis);05220(Chronic myeloid leukemia)","K01893;K08091","EC:6.1.1.22","asparaginyl-tRNA synthetase 2, mitochondrial [Source:NCBI gene;Acc:101108871];GRB2 associated binding protein 2 [Source:NCBI gene;Acc:101115743]",{"v":3.30471589010194,"d":"3.30"},{"v":3.54071995307317,"d":"3.54"},{"v":3.51179395253031,"d":"3.51"},{"v":3.07304647131914,"d":"3.07"},{"v":3.66791658682671,"d":"3.67"},{"v":3.04211469726763,"d":"3.04"},{"v":1.05868828344682,"d":"1.06"},{"v":0.0822778696656927,"d":"0.08"},{"v":0.603909839281355,"d":"0.60"},{"v":0.926611843171742,"d":"0.93"},"up","no"]
["MSTRG.20213","SPTLC2","ENSOART00000002811","GO:0003824(catalytic activity);GO:0004758(serine C-palmitoyltransferase activity);GO:0006686(sphingomyelin biosynthetic process);GO:0009058(biosynthetic process);GO:0016740(transferase activity);GO:0017059(serine C-palmitoyltransferase complex);GO:0030148(sphingolipid biosynthetic process);GO:0030170(pyridoxal phosphate binding);GO:0046511(sphinganine biosynthetic process);GO:0046512(sphingosine biosynthetic process);GO:0046513(ceramide biosynthetic process);GO:0060612(adipose tissue development);GO:1904504(positive regulation of lipophagy)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","K00654","EC:2.3.1.50","serine palmitoyltransferase long chain base subunit 2 [Source:NCBI gene;Acc:101115373]",{"v":6.430471,"d":"6.43"},{"v":6.164311,"d":"6.16"},{"v":5.338606,"d":"5.34"},{"v":7.186911,"d":"7.19"},{"v":6.511569,"d":"6.51"},{"v":7.566531,"d":"7.57"},{"v":0.843328413984832,"d":"0.84"},{"v":-0.245833531383058,"d":"-0.25"},{"v":0.604584107713963,"d":"0.60"},{"v":0.926671946214262,"d":"0.93"},"down","no"]
["MSTRG.21788","CLCN5","ENSOART00000010989","GO:0005247(voltage-gated chloride channel activity);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042802(identical protein binding);GO:0045177(apical part of cell);GO:0055085(transmembrane transport);GO:1902476(chloride transmembrane transport)","NA","K05012","NA","chloride voltage-gated channel 5 [Source:NCBI gene;Acc:101103039]",{"v":2.61101470145678,"d":"2.61"},{"v":3.30496435192639,"d":"3.30"},{"v":3.68285300258769,"d":"3.68"},{"v":3.82699074583094,"d":"3.83"},{"v":4.3152910662258,"d":"4.32"},{"v":3.37059674333908,"d":"3.37"},{"v":0.833747356039998,"d":"0.83"},{"v":-0.26231781362346,"d":"-0.26"},{"v":0.605687696199861,"d":"0.61"},{"v":0.927388288029945,"d":"0.93"},"down","no"]
["MSTRG.15345","ENSOARG00000016373","ENSOART00000017825","GO:0005634(nucleus);GO:0006334(nucleosome assembly)","NA","K11290","NA","protein SET [Source:NCBI gene;Acc:101119456]",{"v":1.264724,"d":"1.26"},{"v":0.656312,"d":"0.66"},{"v":1.444809,"d":"1.44"},{"v":1.241768,"d":"1.24"},{"v":0.878906,"d":"0.88"},{"v":0.862012,"d":"0.86"},{"v":1.1284610582542,"d":"1.13"},{"v":0.174356633830679,"d":"0.17"},{"v":0.607639082903714,"d":"0.61"},{"v":0.928690327533498,"d":"0.93"},"up","no"]
["MSTRG.180","NFYC","ENSOART00000022100","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016602(CCAAT-binding factor complex);GO:0032993(protein-DNA complex);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0090575(RNA polymerase II transcription factor complex)","04612(Antigen processing and presentation);05152(Tuberculosis)","K08066","NA","nuclear transcription factor Y subunit gamma [Source:NCBI gene;Acc:101102681]",{"v":2.16381185886368,"d":"2.16"},{"v":2.2867585459747,"d":"2.29"},{"v":2.52268616874122,"d":"2.52"},{"v":3.11233817355953,"d":"3.11"},{"v":2.61963443957037,"d":"2.62"},{"v":2.59503860911464,"d":"2.60"},{"v":0.837426104933237,"d":"0.84"},{"v":-0.255966203235334,"d":"-0.26"},{"v":0.608425496167114,"d":"0.61"},{"v":0.929053726869601,"d":"0.93"},"down","no"]
["MSTRG.14948","ENSOARG00000018065","ENSOART00000019658","GO:0000776(kinetochore);GO:0034508(centromere complex assembly)","NA","K11507","NA","centromere protein O [Source:NCBI gene;Acc:101107680]",{"v":0.995834,"d":"1.00"},{"v":1.474979,"d":"1.47"},{"v":1.665875,"d":"1.67"},{"v":1.386139,"d":"1.39"},{"v":1.187618,"d":"1.19"},{"v":1.192514,"d":"1.19"},{"v":1.0983511276804,"d":"1.10"},{"v":0.135339337751914,"d":"0.14"},{"v":0.608864030543859,"d":"0.61"},{"v":0.929112355580428,"d":"0.93"},"up","no"]
["MSTRG.15616","CEP290","ENSOART00000016927;ENSOART00000016921","GO:0000930(gamma-tubulin complex);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0032991(protein-containing complex);GO:0034451(centriolar satellite);GO:0035869(ciliary transition zone);GO:0042802(identical protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0060271(cilium assembly);GO:0070201(regulation of establishment of protein localization);GO:0090316(positive regulation of intracellular protein transport);GO:0090316(positive regulation of intracellular protein transport)","NA","K16533","NA","centrosomal protein 290 [Source:NCBI gene;Acc:101109526]",{"v":0.34113551669051,"d":"0.34"},{"v":0.226817652956605,"d":"0.23"},{"v":0.284525391392465,"d":"0.28"},{"v":0.276937387339056,"d":"0.28"},{"v":0.292031757153076,"d":"0.29"},{"v":0.215970223295184,"d":"0.22"},{"v":1.08604383475204,"d":"1.09"},{"v":0.119082334176461,"d":"0.12"},{"v":0.609559213800216,"d":"0.61"},{"v":0.929133947248873,"d":"0.93"},"up","no"]
["MSTRG.17754","ENSOARG00000014981","ENSOART00000016302","NA","NA","NA","NA",null,{"v":1.78131040474961,"d":"1.78"},{"v":1.70148235363965,"d":"1.70"},{"v":2.02705948477026,"d":"2.03"},{"v":1.96641275942179,"d":"1.97"},{"v":1.14754955343314,"d":"1.15"},{"v":1.98198003510583,"d":"1.98"},{"v":1.08122342580355,"d":"1.08"},{"v":0.112664674777044,"d":"0.11"},{"v":0.610317713288457,"d":"0.61"},{"v":0.929275300706207,"d":"0.93"},"up","no"]
["ENSOARG00000009164","GALT","ENSOART00000009977","GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0006011(UDP-glucose metabolic process);GO:0006012(galactose metabolic process);GO:0008108(UDP-glucose:hexose-1-phosphate uridylyltransferase activity);GO:0008270(zinc ion binding);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0033499(galactose catabolic process via UDP-galactose);GO:0046872(metal ion binding)","00052(Galactose metabolism);00520(Amino sugar and nucleotide sugar metabolism);04917(Prolactin signaling pathway)","K00965","EC:2.7.7.12","galactose-1-phosphate uridylyltransferase [Source:NCBI gene;Acc:101120986]",{"v":1.236529,"d":"1.24"},{"v":1.075873,"d":"1.08"},{"v":1.253019,"d":"1.25"},{"v":1.484901,"d":"1.48"},{"v":1.095978,"d":"1.10"},{"v":1.802593,"d":"1.80"},{"v":0.813378299211219,"d":"0.81"},{"v":-0.298001594421709,"d":"-0.30"},{"v":0.610836631582781,"d":"0.61"},{"v":0.929275300706207,"d":"0.93"},"down","no"]
["MSTRG.19072","ENSOARG00000018773","ENSOART00000020442","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","05202(Transcriptional misregulation in cancer)","K08854","EC:2.7.11.1","BMP2 inducible kinase [Source:NCBI gene;Acc:101107523]",{"v":2.36180004629062,"d":"2.36"},{"v":2.48972634334764,"d":"2.49"},{"v":2.24951380748007,"d":"2.25"},{"v":2.31347562139792,"d":"2.31"},{"v":2.36642174310239,"d":"2.37"},{"v":2.03110105763335,"d":"2.03"},{"v":1.05811978344359,"d":"1.06"},{"v":0.0815029556166123,"d":"0.08"},{"v":0.611860533408035,"d":"0.61"},{"v":0.929389814479865,"d":"0.93"},"up","no"]
["MSTRG.7430","MFSD8","ENSOART00000016976","GO:0005654(nucleoplasm);GO:0005764(lysosome);GO:0007040(lysosome organization);GO:0010506(regulation of autophagy);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0048666(neuron development);GO:0055085(transmembrane transport)","04142(Lysosome)","K12307","NA","major facilitator superfamily domain containing 8 [Source:NCBI gene;Acc:101121711]",{"v":1.536071,"d":"1.54"},{"v":1.419767,"d":"1.42"},{"v":1.339577,"d":"1.34"},{"v":2.481523,"d":"2.48"},{"v":1.565899,"d":"1.57"},{"v":1.277897,"d":"1.28"},{"v":0.806602383819636,"d":"0.81"},{"v":-0.310070425419689,"d":"-0.31"},{"v":0.612959105988872,"d":"0.61"},{"v":0.929732610335134,"d":"0.93"},"down","no"]
["MSTRG.7635","TCTN1","ENSOART00000018697","GO:0001701(in utero embryonic development);GO:0001841(neural tube formation);GO:0005615(extracellular space);GO:0008589(regulation of smoothened signaling pathway);GO:0016020(membrane);GO:0021523(somatic motor neuron differentiation);GO:0021537(telencephalon development);GO:0021904(dorsal/ventral neural tube patterning);GO:0021956(central nervous system interneuron axonogenesis);GO:0035869(ciliary transition zone);GO:0036038(MKS complex);GO:0060271(cilium assembly);GO:1904491(protein localization to ciliary transition zone)","NA","K19382","NA","tectonic family member 1 [Source:NCBI gene;Acc:101106035]",{"v":1.254594,"d":"1.25"},{"v":1.63426,"d":"1.63"},{"v":1.366462,"d":"1.37"},{"v":1.966549,"d":"1.97"},{"v":1.637883,"d":"1.64"},{"v":1.595836,"d":"1.60"},{"v":0.818287826704316,"d":"0.82"},{"v":-0.289319705118257,"d":"-0.29"},{"v":0.613337929919135,"d":"0.61"},{"v":0.929732610335134,"d":"0.93"},"down","no"]
["MSTRG.4498","ENSOARG00000016337","ENSOART00000017789","NA","NA","NA","NA","UPF0061 protein azo1574-like [Source:NCBI gene;Acc:101109989]",{"v":1.06073357967033,"d":"1.06"},{"v":1.18723488076923,"d":"1.19"},{"v":1.16565843626374,"d":"1.17"},{"v":1.31812790384615,"d":"1.32"},{"v":1.48422879945055,"d":"1.48"},{"v":1.34923356538462,"d":"1.35"},{"v":0.822245615723437,"d":"0.82"},{"v":-0.282358684366568,"d":"-0.28"},{"v":0.614639390590223,"d":"0.61"},{"v":0.930237252942763,"d":"0.93"},"down","no"]
["MSTRG.11976","ENSOARG00000015641","ENSOART00000017018","NA","NA","NA","NA",null,{"v":45.225811,"d":"45.23"},{"v":28.746948,"d":"28.75"},{"v":33.764297,"d":"33.76"},{"v":40.524403,"d":"40.52"},{"v":26.238386,"d":"26.24"},{"v":34.551701,"d":"34.55"},{"v":1.06339237358842,"d":"1.06"},{"v":0.0886740248852593,"d":"0.09"},{"v":0.614653832936813,"d":"0.61"},{"v":0.930237252942763,"d":"0.93"},"up","no"]
["MSTRG.1553","TTC14","ENSOART00000022534","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA","NA","NA","tetratricopeptide repeat domain 14 [Source:NCBI gene;Acc:101105376]",{"v":2.11527417992993,"d":"2.12"},{"v":1.38500550025025,"d":"1.39"},{"v":1.68305715790791,"d":"1.68"},{"v":1.91082748648649,"d":"1.91"},{"v":1.76683613138138,"d":"1.77"},{"v":1.19443300125125,"d":"1.19"},{"v":1.06388219349912,"d":"1.06"},{"v":0.0893384062298391,"d":"0.09"},{"v":0.61532573541716,"d":"0.62"},{"v":0.930253071373088,"d":"0.93"},"up","no"]
["MSTRG.17171","LSM8","ENSOART00000019563","GO:0000398(mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005681(spliceosomal complex);GO:0005688(U6 snRNP);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0046540(U4/U6 x U5 tri-snRNP complex);GO:0071005(U2-type precatalytic spliceosome);GO:0120115(Lsm2-8 complex)","03018(RNA degradation);03040(Spliceosome)","K12627","NA","LSM8 homolog, U6 small nuclear RNA associated [Source:NCBI gene;Acc:101102229]",{"v":8.462567,"d":"8.46"},{"v":9.488706,"d":"9.49"},{"v":7.378246,"d":"7.38"},{"v":9.151174,"d":"9.15"},{"v":7.050087,"d":"7.05"},{"v":7.429132,"d":"7.43"},{"v":1.07190426329346,"d":"1.07"},{"v":0.100176057810998,"d":"0.10"},{"v":0.616055990494276,"d":"0.62"},{"v":0.93043772202299,"d":"0.93"},"up","no"]
["MSTRG.21246","DCAF13","ENSOART00000017671","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0030054(cell junction)","NA","K11806","NA","DDB1 and CUL4 associated factor 13 [Source:NCBI gene;Acc:101102821]",{"v":0.973591,"d":"0.97"},{"v":0.773434,"d":"0.77"},{"v":0.876005,"d":"0.88"},{"v":0.715647,"d":"0.72"},{"v":0.688816,"d":"0.69"},{"v":1.015468,"d":"1.02"},{"v":1.08392759958858,"d":"1.08"},{"v":0.116268395803563,"d":"0.12"},{"v":0.617247705853227,"d":"0.62"},{"v":0.931300801768436,"d":"0.93"},"up","no"]
["MSTRG.15415","STAMBP","ENSOART00000013156","GO:0000281(mitotic cytokinesis);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0014067(negative regulation of phosphatidylinositol 3-kinase signaling);GO:0016579(protein deubiquitination);GO:0019904(protein domain specific binding);GO:0032154(cleavage furrow);GO:0046580(negative regulation of Ras protein signal transduction)","04144(Endocytosis)","K11866","EC:3.4.19.12","STAM binding protein [Source:NCBI gene;Acc:101114002]",{"v":1.32838549815089,"d":"1.33"},{"v":1.42544914866864,"d":"1.43"},{"v":0.942247867233728,"d":"0.94"},{"v":1.68775633690828,"d":"1.69"},{"v":1.37225282285503,"d":"1.37"},{"v":1.42220237684911,"d":"1.42"},{"v":0.824611351753981,"d":"0.82"},{"v":-0.278213773115121,"d":"-0.28"},{"v":0.618788315837644,"d":"0.62"},{"v":0.932202826025607,"d":"0.93"},"down","no"]
["MSTRG.22102","RBMX","ENSOART00000011838","GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0003682(chromatin binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005719(nuclear euchromatin);GO:0006366(transcription by RNA polymerase II);GO:0006509(membrane protein ectodomain proteolysis);GO:0019904(protein domain specific binding);GO:0042802(identical protein binding);GO:0044530(supraspliceosomal complex);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051259(protein complex oligomerization);GO:0070062(extracellular exosome);GO:0071013(catalytic step 2 spliceosome);GO:0071347(cellular response to interleukin-1)","03040(Spliceosome)","K12885","NA","RNA binding motif protein X-linked [Source:NCBI gene;Acc:101103540]",{"v":9.2340902420965,"d":"9.23"},{"v":8.48178602287854,"d":"8.48"},{"v":7.67513338144759,"d":"7.68"},{"v":10.2179845212146,"d":"10.22"},{"v":10.6564724733777,"d":"10.66"},{"v":9.17220808610649,"d":"9.17"},{"v":0.845052506766655,"d":"0.85"},{"v":-0.242887109825746,"d":"-0.24"},{"v":0.619525572872266,"d":"0.62"},{"v":0.932466619289252,"d":"0.93"},"down","no"]
["MSTRG.11153","VPS52","ENSOART00000009777","GO:0000938(GARP complex);GO:0005794(Golgi apparatus);GO:0007041(lysosomal transport);GO:0010668(ectodermal cell differentiation);GO:0016020(membrane);GO:0019905(syntaxin binding);GO:0032456(endocytic recycling);GO:0048471(perinuclear region of cytoplasm);GO:0048611(embryonic ectodermal digestive tract development);GO:0055037(recycling endosome);GO:1990745(EARP complex)","NA","K20298","NA","VPS52, GARP complex subunit [Source:NCBI gene;Acc:101116872]",{"v":3.17865498425926,"d":"3.18"},{"v":3.24147876882716,"d":"3.24"},{"v":2.91412836388889,"d":"2.91"},{"v":3.88569387839506,"d":"3.89"},{"v":3.72177614907407,"d":"3.72"},{"v":3.44761815679012,"d":"3.45"},{"v":0.844340810439293,"d":"0.84"},{"v":-0.244102647749789,"d":"-0.24"},{"v":0.621069010402013,"d":"0.62"},{"v":0.93280151149798,"d":"0.93"},"down","no"]
["MSTRG.8842","RPUSD3","ENSOART00000006450","GO:0001522(pseudouridine synthesis);GO:0003723(RNA binding);GO:0009451(RNA modification);GO:0009982(pseudouridine synthase activity);GO:0070131(positive regulation of mitochondrial translation)","NA","K22537","EC:5.4.99.-","RNA pseudouridine synthase D3 [Source:NCBI gene;Acc:101102844]",{"v":5.832101,"d":"5.83"},{"v":6.155108,"d":"6.16"},{"v":5.835292,"d":"5.84"},{"v":6.50978,"d":"6.51"},{"v":7.277206,"d":"7.28"},{"v":7.404332,"d":"7.40"},{"v":0.841028434380533,"d":"0.84"},{"v":-0.249773517419645,"d":"-0.25"},{"v":0.62137870303029,"d":"0.62"},{"v":0.93280151149798,"d":"0.93"},"down","no"]
["MSTRG.17759","COL5A3","ENSOART00000015311","GO:0005201(extracellular matrix structural constituent);GO:0005588(collagen type V trimer);GO:0007160(cell-matrix adhesion);GO:0008201(heparin binding)","04974(Protein digestion and absorption)","K19721","NA","collagen type V alpha 3 chain [Source:NCBI gene;Acc:101115457]",{"v":7.23820787235206,"d":"7.24"},{"v":5.75301916878502,"d":"5.75"},{"v":8.74285617302173,"d":"8.74"},{"v":8.00039206409731,"d":"8.00"},{"v":8.6684269461528,"d":"8.67"},{"v":9.02627056771901,"d":"9.03"},{"v":0.845845784978058,"d":"0.85"},{"v":-0.24153344044044,"d":"-0.24"},{"v":0.62183834078739,"d":"0.62"},{"v":0.93280151149798,"d":"0.93"},"down","no"]
["ENSOARG00000013758","ENSOARG00000013758","ENSOART00000014971","GO:0003824(catalytic activity)","00280(Valine, leucine and isoleucine degradation)","K18660","EC:6.2.1.-","acyl-CoA synthetase family member 3 [Source:NCBI gene;Acc:101109383]",{"v":1.966365,"d":"1.97"},{"v":1.225723,"d":"1.23"},{"v":1.787509,"d":"1.79"},{"v":1.960632,"d":"1.96"},{"v":1.373031,"d":"1.37"},{"v":1.270101,"d":"1.27"},{"v":1.08163602652091,"d":"1.08"},{"v":0.113215110003318,"d":"0.11"},{"v":0.622077147152223,"d":"0.62"},{"v":0.93280151149798,"d":"0.93"},"up","no"]
["MSTRG.8949","PSMD6","ENSOART00000012287","GO:0000502(proteasome complex);GO:0005515(protein binding);GO:0030234(enzyme regulator activity);GO:0050790(regulation of catalytic activity)","03050(Proteasome);05169(Epstein-Barr virus infection)","K03037","NA","proteasome 26S subunit, non-ATPase 6 [Source:NCBI gene;Acc:101119337]",{"v":5.01053340067912,"d":"5.01"},{"v":6.09612462195812,"d":"6.10"},{"v":5.27546298698359,"d":"5.28"},{"v":5.17001502490096,"d":"5.17"},{"v":6.82804783191851,"d":"6.83"},{"v":7.3860151931711,"d":"7.39"},{"v":0.845132843943991,"d":"0.85"},{"v":-0.242749962681049,"d":"-0.24"},{"v":0.622832057954811,"d":"0.62"},{"v":0.932833456199916,"d":"0.93"},"down","no"]
["ENSOARG00000008205","IGSF8","ENSOART00000008929","GO:0016021(integral component of membrane)","NA","NA","NA","immunoglobulin superfamily member 8 [Source:HGNC Symbol;Acc:HGNC:17813]",{"v":0.731332,"d":"0.73"},{"v":0.621146,"d":"0.62"},{"v":0.858609,"d":"0.86"},{"v":0.913763,"d":"0.91"},{"v":0.952618,"d":"0.95"},{"v":0.846793,"d":"0.85"},{"v":0.814944784226887,"d":"0.81"},{"v":-0.295225780599615,"d":"-0.30"},{"v":0.623514596490957,"d":"0.62"},{"v":0.932833456199916,"d":"0.93"},"down","no"]
["MSTRG.21201","RAD21","ENSOART00000011271","GO:0000785(chromatin);GO:0000794(condensed nuclear chromosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007062(sister chromatid cohesion);GO:0008278(cohesin complex);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0016363(nuclear matrix);GO:0045841(negative regulation of mitotic metaphase/anaphase transition);GO:0045876(positive regulation of sister chromatid cohesion);GO:0071168(protein localization to chromatin)","04110(Cell cycle)","K06670","NA","RAD21 cohesin complex component [Source:NCBI gene;Acc:101115132]",{"v":18.5796000062305,"d":"18.58"},{"v":14.392804086189,"d":"14.39"},{"v":14.6046154652129,"d":"14.60"},{"v":19.0331137871236,"d":"19.03"},{"v":16.8471459522326,"d":"16.85"},{"v":20.0662969792316,"d":"20.07"},{"v":0.850401210514986,"d":"0.85"},{"v":-0.233784444393316,"d":"-0.23"},{"v":0.624013050140863,"d":"0.62"},{"v":0.933048084496338,"d":"0.93"},"down","no"]
["ENSOARG00000016104","PDE1B","ENSOART00000017542","GO:0001505(regulation of neurotransmitter levels);GO:0001975(response to amphetamine);GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity);GO:0007165(signal transduction);GO:0007626(locomotory behavior);GO:0008081(phosphoric diester hydrolase activity);GO:0008542(visual learning);GO:0016787(hydrolase activity);GO:0030224(monocyte differentiation);GO:0036006(cellular response to macrophage colony-stimulating factor stimulus);GO:0042053(regulation of dopamine metabolic process);GO:0042428(serotonin metabolic process);GO:0046872(metal ion binding);GO:0047555(3',5'-cyclic-GMP phosphodiesterase activity);GO:0097011(cellular response to granulocyte macrophage colony-stimulating factor stimulus)","00230(Purine metabolism);04020(Calcium signaling pathway);04740(Olfactory transduction);04742(Taste transduction);04924(Renin secretion);05032(Morphine addiction)","K13755","EC:3.1.4.17","phosphodiesterase 1B [Source:NCBI gene;Acc:101118773]",{"v":1.102765,"d":"1.10"},{"v":0.847251,"d":"0.85"},{"v":0.776858,"d":"0.78"},{"v":0.920997,"d":"0.92"},{"v":0.657228,"d":"0.66"},{"v":0.901692,"d":"0.90"},{"v":1.09958276829426,"d":"1.10"},{"v":0.136956203477503,"d":"0.14"},{"v":0.625371624744929,"d":"0.63"},{"v":0.933707068238707,"d":"0.93"},"up","no"]
["MSTRG.4762","MAVS;PANK2","ENSOART00000001007;ENSOART00000000805","GO:0001934(positive regulation of protein phosphorylation);GO:0002218(activation of innate immune response);GO:0002230(positive regulation of defense response to virus by host);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005778(peroxisomal membrane);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019901(protein kinase binding);GO:0031966(mitochondrial membrane);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032757(positive regulation of interleukin-8 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0035549(positive regulation of interferon-beta secretion);GO:0035591(signaling adaptor activity);GO:0042307(positive regulation of protein import into nucleus);GO:0042742(defense response to bacterium);GO:0045071(negative regulation of viral genome replication);GO:0045087(innate immune response);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050700(CARD domain binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051607(defense response to virus);GO:0060340(positive regulation of type I interferon-mediated signaling pathway);GO:0060760(positive regulation of response to cytokine stimulus);GO:0071360(cellular response to exogenous dsRNA);GO:0071651(positive regulation of chemokine (C-C motif) ligand 5 production);GO:0071660(positive regulation of IP-10 production);GO:1900063(regulation of peroxisome organization);GO:1902741(positive regulation of interferon-alpha secretion);GO:1904469(positive regulation of tumor necrosis factor secretion);GO:2000778(positive regulation of interleukin-6 secretion);GO:0004594(pantothenate kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005758(mitochondrial intermembrane space);GO:0005829(cytosol);GO:0007286(spermatid development);GO:0009060(aerobic respiration);GO:0015937(coenzyme A biosynthetic process);GO:0016310(phosphorylation);GO:0019217(regulation of fatty acid metabolic process);GO:0051881(regulation of mitochondrial membrane potential);GO:0070584(mitochondrion morphogenesis);GO:0090207(regulation of triglyceride metabolic process);GO:1904251(regulation of bile acid metabolic process)","04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05164(Influenza A);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);00770(Pantothenate and CoA biosynthesis)","K12648;K09680","EC:2.7.1.33","mitochondrial antiviral signaling protein [Source:NCBI gene;Acc:101119838];pantothenate kinase 2 [Source:NCBI gene;Acc:100217410]",{"v":4.96343984954617,"d":"4.96"},{"v":5.82482057116381,"d":"5.82"},{"v":4.98615444879532,"d":"4.99"},{"v":5.57846676115573,"d":"5.58"},{"v":5.09602686418286,"d":"5.10"},{"v":4.50603280497077,"d":"4.51"},{"v":1.03912172887563,"d":"1.04"},{"v":0.0553646699864567,"d":"0.06"},{"v":0.625902470149658,"d":"0.63"},{"v":0.933735544321939,"d":"0.93"},"up","no"]
["MSTRG.4565","BEND7","ENSOART00000006587;ENSOART00000006588","NA","NA","NA","NA","BEN domain containing 7 [Source:NCBI gene;Acc:101115641]",{"v":3.4791483657442,"d":"3.48"},{"v":3.12435597307405,"d":"3.12"},{"v":2.70962618324607,"d":"2.71"},{"v":2.89266653403141,"d":"2.89"},{"v":3.33298079955123,"d":"3.33"},{"v":2.5101285302917,"d":"2.51"},{"v":1.06609082778526,"d":"1.07"},{"v":0.0923303566836197,"d":"0.09"},{"v":0.626096055373353,"d":"0.63"},{"v":0.933853694357916,"d":"0.93"},"up","no"]
["MSTRG.20489","FAXC","ENSOART00000012968","NA","NA","NA","NA","failed axon connections homolog [Source:NCBI gene;Acc:101104245]",{"v":5.3920293608455,"d":"5.39"},{"v":4.13729676899849,"d":"4.14"},{"v":1.08986732159034,"d":"1.09"},{"v":5.68499368595873,"d":"5.68"},{"v":3.91060491394061,"d":"3.91"},{"v":3.61264448817313,"d":"3.61"},{"v":0.803982284443557,"d":"0.80"},{"v":-0.314764382571477,"d":"-0.31"},{"v":0.626883120144958,"d":"0.63"},{"v":0.933967493659664,"d":"0.93"},"down","no"]
["MSTRG.21915","ZDHHC15","ENSOART00000019862","GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016409(palmitoyltransferase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoyltransferase activity)","NA","K20028","EC:2.3.1.225","zinc finger DHHC-type containing 15 [Source:NCBI gene;Acc:101115857]",{"v":1.210202,"d":"1.21"},{"v":0.701858,"d":"0.70"},{"v":0.683109,"d":"0.68"},{"v":1.072702,"d":"1.07"},{"v":0.578785,"d":"0.58"},{"v":0.677805,"d":"0.68"},{"v":1.11414498482801,"d":"1.11"},{"v":0.155936984277675,"d":"0.16"},{"v":0.628373029875418,"d":"0.63"},{"v":0.934688424141917,"d":"0.93"},"up","no"]
["MSTRG.15689","PCBP2;RF02271","ENSOART00000017934;ENSOART00000025863","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0019899(enzyme binding);GO:0031625(ubiquitin protein ligase binding);GO:0039694(viral RNA genome replication);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0050687(negative regulation of defense response to virus);GO:0075522(IRES-dependent viral translational initiation);GO:1990829(C-rich single-stranded DNA binding)","04216(Ferroptosis)","K13162","NA","poly(rC) binding protein 2 [Source:NCBI gene;Acc:101103142]",{"v":24.339583750417,"d":"24.34"},{"v":21.3555331934715,"d":"21.36"},{"v":21.5733420437217,"d":"21.57"},{"v":25.3783537749583,"d":"25.38"},{"v":24.4855737190851,"d":"24.49"},{"v":28.9180617710269,"d":"28.92"},{"v":0.853855806576277,"d":"0.85"},{"v":-0.227935637104192,"d":"-0.23"},{"v":0.628787251279297,"d":"0.63"},{"v":0.934758474682479,"d":"0.93"},"down","no"]
["MSTRG.5317","CTU2","ENSOART00000014252;ENSOART00000014254","GO:0000049(tRNA binding);GO:0002098(tRNA wobble uridine modification);GO:0005737(cytoplasm);GO:0008033(tRNA processing);GO:0016779(nucleotidyltransferase activity);GO:0032447(protein urmylation);GO:0034227(tRNA thio-modification);GO:0034227(tRNA thio-modification)","04122(Sulfur relay system);04122(Sulfur relay system)","K14169","NA","cytosolic thiouridylase subunit 2 [Source:NCBI gene;Acc:101106960]",{"v":1.81499512365591,"d":"1.81"},{"v":1.50520272132617,"d":"1.51"},{"v":1.38597259587814,"d":"1.39"},{"v":1.87147408198925,"d":"1.87"},{"v":1.40912650448029,"d":"1.41"},{"v":1.15647171370968,"d":"1.16"},{"v":1.06064767992853,"d":"1.06"},{"v":0.0849455093807427,"d":"0.08"},{"v":0.630206671998136,"d":"0.63"},{"v":0.935540916482005,"d":"0.94"},"up","no"]
["MSTRG.20685","ENSOARG00000002898","ENSOART00000003139","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","LDL receptor related protein 11 [Source:NCBI gene;Acc:101104759]",{"v":3.651353,"d":"3.65"},{"v":4.698256,"d":"4.70"},{"v":3.76042,"d":"3.76"},{"v":8.008385,"d":"8.01"},{"v":3.18804,"d":"3.19"},{"v":3.970688,"d":"3.97"},{"v":0.798439953602245,"d":"0.80"},{"v":-0.324744180547813,"d":"-0.32"},{"v":0.630956625316103,"d":"0.63"},{"v":0.935588025631803,"d":"0.94"},"down","no"]
["MSTRG.5480","CTCF","ENSOART00000003312;ENSOART00000003309","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000775(chromosome, centromeric region);GO:0000793(condensed chromosome);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006306(DNA methylation);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006355(regulation of transcription, DNA-templated);GO:0008285(negative regulation of cell population proliferation);GO:0010216(maintenance of DNA methylation);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016584(nucleosome positioning);GO:0031060(regulation of histone methylation);GO:0035065(regulation of histone acetylation);GO:0040029(regulation of gene expression, epigenetic);GO:0040030(regulation of molecular function, epigenetic);GO:0043035(chromatin insulator sequence binding);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071459(protein localization to chromosome, centromeric region);GO:0071459(protein localization to chromosome, centromeric region)","NA","K23195","NA","CCCTC-binding factor [Source:NCBI gene;Acc:101114297]",{"v":11.158916298086,"d":"11.16"},{"v":10.6591598885731,"d":"10.66"},{"v":10.8812097686185,"d":"10.88"},{"v":12.4518085563767,"d":"12.45"},{"v":8.81162505135494,"d":"8.81"},{"v":10.0533220716316,"d":"10.05"},{"v":1.04414666353276,"d":"1.04"},{"v":0.0623243708066468,"d":"0.06"},{"v":0.631939977261988,"d":"0.63"},{"v":0.935588025631803,"d":"0.94"},"up","no"]
["MSTRG.12956","TGIF1","ENSOART00000011310","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA","TGFB induced factor homeobox 1 [Source:HGNC Symbol;Acc:HGNC:11776]",{"v":1.886956,"d":"1.89"},{"v":1.251659,"d":"1.25"},{"v":1.457071,"d":"1.46"},{"v":2.236586,"d":"2.24"},{"v":1.552182,"d":"1.55"},{"v":1.769605,"d":"1.77"},{"v":0.826804174530929,"d":"0.83"},{"v":-0.274382421944195,"d":"-0.27"},{"v":0.632405346071376,"d":"0.63"},{"v":0.935588025631803,"d":"0.94"},"down","no"]
["MSTRG.21557","SMPX","ENSOART00000017498","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005927(muscle tendon junction);GO:0031430(M band);GO:0043034(costamere);GO:0043292(contractile fiber)","NA","NA","NA","small muscle protein X-linked [Source:NCBI gene;Acc:101112026]",{"v":94.7717835138178,"d":"94.77"},{"v":146.635837012282,"d":"146.64"},{"v":149.76905687001,"d":"149.77"},{"v":103.470479814739,"d":"103.47"},{"v":124.121334607984,"d":"124.12"},{"v":141.91212585261,"d":"141.91"},{"v":1.05865360219062,"d":"1.06"},{"v":0.0822306080716483,"d":"0.08"},{"v":0.633581730541285,"d":"0.63"},{"v":0.935588025631803,"d":"0.94"},"up","no"]
["ENSOARG00000011539","BRIX1","ENSOART00000012550;ENSOART00000012549","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005730(nucleolus)","NA","K14820","NA","BRX1, biogenesis of ribosomes [Source:NCBI gene;Acc:101112163]",{"v":0.461375269105535,"d":"0.46"},{"v":0.490809045776671,"d":"0.49"},{"v":0.411814516759242,"d":"0.41"},{"v":0.411858238651599,"d":"0.41"},{"v":0.403448730128328,"d":"0.40"},{"v":0.450528265083317,"d":"0.45"},{"v":1.07754847957472,"d":"1.08"},{"v":0.107752778519625,"d":"0.11"},{"v":0.633955293821051,"d":"0.63"},{"v":0.935588025631803,"d":"0.94"},"up","no"]
["ENSOARG00000008195","CYP4V2","ENSOART00000008927","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0010430(fatty acid omega-oxidation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","NA","K07427","EC:1.14.14.79","cytochrome P450 4V2 [Source:NCBI gene;Acc:101116121]",{"v":0.591982,"d":"0.59"},{"v":0.40387,"d":"0.40"},{"v":0.443275,"d":"0.44"},{"v":0.524734,"d":"0.52"},{"v":0.611434,"d":"0.61"},{"v":0.579763,"d":"0.58"},{"v":0.838685821283023,"d":"0.84"},{"v":-0.253797628637748,"d":"-0.25"},{"v":0.634203866392404,"d":"0.63"},{"v":0.935588025631803,"d":"0.94"},"down","no"]
["MSTRG.15321","MAP4K3","ENSOART00000008901","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000185(activation of MAPKKK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0008349(MAP kinase kinase kinase kinase activity);GO:0009411(response to UV);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0034612(response to tumor necrosis factor);GO:0035556(intracellular signal transduction)","04010(MAPK signaling pathway)","K04406","EC:2.7.11.1","mitogen-activated protein kinase kinase kinase kinase 3 [Source:NCBI gene;Acc:101118350]",{"v":3.55409718189608,"d":"3.55"},{"v":3.22526627553706,"d":"3.23"},{"v":2.99678015270212,"d":"3.00"},{"v":3.78787773664239,"d":"3.79"},{"v":3.22352528459514,"d":"3.22"},{"v":2.38264223483689,"d":"2.38"},{"v":1.04067452770826,"d":"1.04"},{"v":0.0575189344577862,"d":"0.06"},{"v":0.635376712657848,"d":"0.64"},{"v":0.935936146844841,"d":"0.94"},"up","no"]
["MSTRG.8604","BAG5","ENSOART00000015185","GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0007030(Golgi organization);GO:0010977(negative regulation of neuron projection development);GO:0016234(inclusion body);GO:0019901(protein kinase binding);GO:0031397(negative regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051087(chaperone binding);GO:0090083(regulation of inclusion body assembly);GO:1902176(negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway)","NA","K09559","NA","BCL2 associated athanogene 5 [Source:NCBI gene;Acc:101105952]",{"v":8.092594,"d":"8.09"},{"v":8.62532,"d":"8.63"},{"v":7.947711,"d":"7.95"},{"v":9.28337,"d":"9.28"},{"v":7.067448,"d":"7.07"},{"v":7.404777,"d":"7.40"},{"v":1.03830802806665,"d":"1.04"},{"v":0.0542345021162838,"d":"0.05"},{"v":0.635940699425903,"d":"0.64"},{"v":0.935936146844841,"d":"0.94"},"up","no"]
["MSTRG.13108","LMAN1","ENSOART00000006243","GO:0005537(mannose binding);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007030(Golgi organization);GO:0010638(positive regulation of organelle organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0044220(host cell perinuclear region of cytoplasm)","04141(Protein processing in endoplasmic reticulum)","K10080","NA","lectin, mannose binding 1 [Source:NCBI gene;Acc:101117293]",{"v":2.53675415593136,"d":"2.54"},{"v":3.05528561427506,"d":"3.06"},{"v":2.5972296431236,"d":"2.60"},{"v":3.63514913553842,"d":"3.64"},{"v":2.97991040114399,"d":"2.98"},{"v":3.10031468341209,"d":"3.10"},{"v":0.842918577072615,"d":"0.84"},{"v":-0.246534816183691,"d":"-0.25"},{"v":0.636773502868647,"d":"0.64"},{"v":0.936221901358671,"d":"0.94"},"down","no"]
["MSTRG.19163","ENSOARG00000009499","ENSOART00000010346","GO:0003953(NAD+ nucleosidase activity)","NA","NA","NA",null,{"v":1.73832580207321,"d":"1.74"},{"v":2.44934681729835,"d":"2.45"},{"v":0.846009831227729,"d":"0.85"},{"v":2.25355915484289,"d":"2.25"},{"v":0.839546036605118,"d":"0.84"},{"v":1.56074681146744,"d":"1.56"},{"v":1.08161635725543,"d":"1.08"},{"v":0.113188874736478,"d":"0.11"},{"v":0.637233306928058,"d":"0.64"},{"v":0.936221901358671,"d":"0.94"},"up","no"]
["MSTRG.15489","EIF5B","ENSOART00000014583;ENSOART00000014585","GO:0003743(translation initiation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation);GO:0006446(regulation of translational initiation)","03013(RNA transport);03013(RNA transport)","K03243","NA","eukaryotic translation initiation factor 5B [Source:NCBI gene;Acc:101106067]",{"v":2.54056754630872,"d":"2.54"},{"v":2.97777753825503,"d":"2.98"},{"v":2.76651273127517,"d":"2.77"},{"v":3.24287953127517,"d":"3.24"},{"v":3.81890193610738,"d":"3.82"},{"v":2.75799279409396,"d":"2.76"},{"v":0.843691269802489,"d":"0.84"},{"v":-0.245212921793501,"d":"-0.25"},{"v":0.638799469126718,"d":"0.64"},{"v":0.936967097727367,"d":"0.94"},"down","no"]
["MSTRG.3920","KIFAP3","ENSOART00000012691","GO:0000794(condensed nuclear chromosome);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005871(kinesin complex);GO:0005876(spindle microtubule);GO:0005930(axoneme);GO:0007017(microtubule-based process);GO:0008104(protein localization);GO:0008285(negative regulation of cell population proliferation);GO:0015630(microtubule cytoskeleton);GO:0016939(kinesin II complex);GO:0019894(kinesin binding);GO:0019903(protein phosphatase binding);GO:0032391(photoreceptor connecting cilium);GO:0036064(ciliary basal body);GO:0043066(negative regulation of apoptotic process);GO:0046587(positive regulation of calcium-dependent cell-cell adhesion);GO:0120170(intraciliary transport particle B binding);GO:1990075(periciliary membrane compartment)","NA","NA","NA","kinesin associated protein 3 [Source:NCBI gene;Acc:101102827]",{"v":6.26007043112377,"d":"6.26"},{"v":4.98538601216986,"d":"4.99"},{"v":4.93731777550492,"d":"4.94"},{"v":5.74715076825479,"d":"5.75"},{"v":4.51629256369757,"d":"4.52"},{"v":5.17350852563439,"d":"5.17"},{"v":1.04831409517192,"d":"1.05"},{"v":0.0680710409734853,"d":"0.07"},{"v":0.640037931355452,"d":"0.64"},{"v":0.937941064725526,"d":"0.94"},"up","no"]
["MSTRG.2402","ENSOARG00000000563;ENSOARG00000017192;ENSOARG00000000573","ENSOART00000000601;ENSOART00000018709;ENSOART00000000612","GO:0005886(plasma membrane);GO:0009966(regulation of signal transduction);GO:0016020(membrane);GO:0031225(anchored component of membrane);GO:0046658(anchored component of plasma membrane);GO:0062023(collagen-containing extracellular matrix);GO:0062023(collagen-containing extracellular matrix)","NA","NA","NA",null,{"v":1.02020159400107,"d":"1.02"},{"v":0.957291210498125,"d":"0.96"},{"v":1.54544324209962,"d":"1.55"},{"v":1.00770965149081,"d":"1.01"},{"v":1.19026249669702,"d":"1.19"},{"v":1.10882082413855,"d":"1.11"},{"v":1.06536335237231,"d":"1.07"},{"v":0.0913455593361893,"d":"0.09"},{"v":0.640526035242229,"d":"0.64"},{"v":0.937961776898406,"d":"0.94"},"up","no"]
["MSTRG.16030","ENSOARG00000011326;RDH5","ENSOART00000012314;ENSOART00000012223","GO:0031083(BLOC-1 complex);GO:0001523(retinoid metabolic process);GO:0004745(retinol dehydrogenase activity);GO:0005788(endoplasmic reticulum lumen);GO:0005789(endoplasmic reticulum membrane);GO:0008202(steroid metabolic process);GO:0042803(protein homodimerization activity);GO:0047023(androsterone dehydrogenase activity);GO:0047044(androstan-3-alpha,17-beta-diol dehydrogenase activity);GO:0055114(oxidation-reduction process)","00830(Retinol metabolism)","K20185;K00061","EC:1.1.1.315","biogenesis of lysosomal organelles complex 1 subunit 1 [Source:NCBI gene;Acc:101105150];retinol dehydrogenase 5 [Source:NCBI gene;Acc:101115199]",{"v":4.41672252451402,"d":"4.42"},{"v":4.32067588611732,"d":"4.32"},{"v":3.57061526234302,"d":"3.57"},{"v":4.36707914278342,"d":"4.37"},{"v":4.60876928814726,"d":"4.61"},{"v":5.43787638259075,"d":"5.44"},{"v":0.853909300490341,"d":"0.85"},{"v":-0.227845255348243,"d":"-0.23"},{"v":0.641410920445097,"d":"0.64"},{"v":0.938536333802815,"d":"0.94"},"down","no"]
["MSTRG.13426","REXO5","ENSOART00000014582;ENSOART00000014580","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005730(nucleolus);GO:0005730(nucleolus)","03008(Ribosome biogenesis in eukaryotes);03008(Ribosome biogenesis in eukaryotes)","K14570","EC:3.1.-.-","RNA exonuclease 5 [Source:NCBI gene;Acc:101121819]",{"v":0.632989222723544,"d":"0.63"},{"v":1.12170667924528,"d":"1.12"},{"v":0.527732899097621,"d":"0.53"},{"v":0.705262472108285,"d":"0.71"},{"v":0.70631466611977,"d":"0.71"},{"v":0.703169767432322,"d":"0.70"},{"v":1.07929170859986,"d":"1.08"},{"v":0.110084845986754,"d":"0.11"},{"v":0.642612394253347,"d":"0.64"},{"v":0.938536333802815,"d":"0.94"},"up","no"]
["MSTRG.7838","DRG1","ENSOART00000011238","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0008017(microtubule binding);GO:0016604(nuclear body);GO:0030955(potassium ion binding);GO:0031116(positive regulation of microtubule polymerization);GO:0042802(identical protein binding);GO:1901673(regulation of mitotic spindle assembly)","NA","NA","NA","developmentally regulated GTP binding protein 1 [Source:NCBI gene;Acc:101115484]",{"v":6.810197,"d":"6.81"},{"v":8.633568,"d":"8.63"},{"v":7.678137,"d":"7.68"},{"v":8.395638,"d":"8.40"},{"v":9.187186,"d":"9.19"},{"v":9.68384,"d":"9.68"},{"v":0.847991598825584,"d":"0.85"},{"v":-0.237878123014815,"d":"-0.24"},{"v":0.64312482565047,"d":"0.64"},{"v":0.938536333802815,"d":"0.94"},"down","no"]
["MSTRG.649","ST7L","ENSOART00000021448","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030308(negative regulation of cell growth)","NA","NA","NA","suppression of tumorigenicity 7 like [Source:NCBI gene;Acc:101117032]",{"v":2.73196372507823,"d":"2.73"},{"v":2.82116887259723,"d":"2.82"},{"v":2.65323940858292,"d":"2.65"},{"v":3.79788027581582,"d":"3.80"},{"v":3.42067408672329,"d":"3.42"},{"v":2.57828130800179,"d":"2.58"},{"v":0.837655369777708,"d":"0.84"},{"v":-0.255571286019393,"d":"-0.26"},{"v":0.643797228529296,"d":"0.64"},{"v":0.938536333802815,"d":"0.94"},"down","no"]
["MSTRG.7199","ATPSCKMT","ENSOART00000015579","GO:0005739(mitochondrion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016279(protein-lysine N-methyltransferase activity);GO:0018022(peptidyl-lysine methylation);GO:0018023(peptidyl-lysine trimethylation);GO:0030061(mitochondrial crista);GO:1904058(positive regulation of sensory perception of pain);GO:1905273(positive regulation of proton-transporting ATP synthase activity, rotational mechanism);GO:1905706(regulation of mitochondrial ATP synthesis coupled proton transport)","NA","NA","NA","ATP synthase c subunit lysine N-methyltransferase [Source:NCBI gene;Acc:101122627]",{"v":3.43449068183197,"d":"3.43"},{"v":3.70457716166212,"d":"3.70"},{"v":2.06659974431301,"d":"2.07"},{"v":2.92188790112223,"d":"2.92"},{"v":3.74160228055808,"d":"3.74"},{"v":4.19087617167122,"d":"4.19"},{"v":0.848107322724061,"d":"0.85"},{"v":-0.237681254432938,"d":"-0.24"},{"v":0.64457327958519,"d":"0.64"},{"v":0.938536333802815,"d":"0.94"},"down","no"]
["MSTRG.15720","TFCP2","ENSOART00000018933","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000987(proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0032991(protein-containing complex);GO:0042789(mRNA transcription by RNA polymerase II);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K09275","NA","transcription factor CP2 [Source:NCBI gene;Acc:101115865]",{"v":5.093985,"d":"5.09"},{"v":4.444875,"d":"4.44"},{"v":4.193381,"d":"4.19"},{"v":4.581274,"d":"4.58"},{"v":4.260118,"d":"4.26"},{"v":4.20708,"d":"4.21"},{"v":1.05240222763248,"d":"1.05"},{"v":0.0736862073896491,"d":"0.07"},{"v":0.645324339158797,"d":"0.65"},{"v":0.938536333802815,"d":"0.94"},"up","no"]
["MSTRG.5956","ENSOARG00000013898","ENSOART00000015129","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0004879(nuclear receptor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008270(zinc ion binding);GO:0010875(positive regulation of cholesterol efflux);GO:0010884(positive regulation of lipid storage);GO:0030522(intracellular receptor signaling pathway);GO:0042632(cholesterol homeostasis);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0044255(cellular lipid metabolic process);GO:0045861(negative regulation of proteolysis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0046965(retinoid X receptor binding);GO:0055088(lipid homeostasis);GO:0090108(positive regulation of high-density lipoprotein particle assembly);GO:0090187(positive regulation of pancreatic juice secretion);GO:0090340(positive regulation of secretion of lysosomal enzymes);GO:0120163(negative regulation of cold-induced thermogenesis)","04931(Insulin resistance)","K08535","NA","nuclear receptor subfamily 1 group H member 2 [Source:NCBI gene;Acc:101111571]",{"v":2.86455087439102,"d":"2.86"},{"v":2.20170633170938,"d":"2.20"},{"v":2.59907193772506,"d":"2.60"},{"v":2.90082882736708,"d":"2.90"},{"v":3.08561099300996,"d":"3.09"},{"v":2.95687482482525,"d":"2.96"},{"v":0.857101583464648,"d":"0.86"},{"v":-0.222461892561756,"d":"-0.22"},{"v":0.646316513558773,"d":"0.65"},{"v":0.938536333802815,"d":"0.94"},"down","no"]
["MSTRG.15076","WDPCP","ENSOART00000021845","GO:0001822(kidney development);GO:0002093(auditory receptor cell morphogenesis);GO:0005515(protein binding);GO:0007224(smoothened signaling pathway);GO:0007399(nervous system development);GO:0010762(regulation of fibroblast migration);GO:0042733(embryonic digit morphogenesis);GO:0043010(camera-type eye development);GO:0044782(cilium organization);GO:0045184(establishment of protein localization);GO:0048568(embryonic organ development);GO:0051893(regulation of focal adhesion assembly);GO:0055123(digestive system development);GO:0060021(roof of mouth development);GO:0060271(cilium assembly);GO:0060541(respiratory system development);GO:0072358(cardiovascular system development);GO:0090521(glomerular visceral epithelial cell migration);GO:0097541(axonemal basal plate);GO:1900027(regulation of ruffle assembly);GO:2000114(regulation of establishment of cell polarity)","NA","K22863","NA","WD repeat containing planar cell polarity effector [Source:NCBI gene;Acc:101119202]",{"v":0.892601,"d":"0.89"},{"v":0.49492,"d":"0.49"},{"v":0.453113,"d":"0.45"},{"v":0.952428,"d":"0.95"},{"v":0.606958,"d":"0.61"},{"v":0.70057,"d":"0.70"},{"v":0.8144556796681,"d":"0.81"},{"v":-0.296091901308756,"d":"-0.30"},{"v":0.646324943548275,"d":"0.65"},{"v":0.938536333802815,"d":"0.94"},"down","no"]
["MSTRG.6631","ACER3","ENSOART00000014392","GO:0005509(calcium ion binding);GO:0006629(lipid metabolic process);GO:0006672(ceramide metabolic process);GO:0006954(inflammatory response);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0016811(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides);GO:0017040(N-acylsphingosine amidohydrolase activity);GO:0030173(integral component of Golgi membrane);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0042552(myelination);GO:0043067(regulation of programmed cell death);GO:0046512(sphingosine biosynthetic process);GO:0046514(ceramide catabolic process);GO:0070774(phytoceramidase activity);GO:0071602(phytosphingosine biosynthetic process);GO:0071633(dihydroceramidase activity)","00600(Sphingolipid metabolism)","K04711","EC:3.5.1.-","alkaline ceramidase 3 [Source:NCBI gene;Acc:101112511]",{"v":1.158028,"d":"1.16"},{"v":0.720031,"d":"0.72"},{"v":1.387293,"d":"1.39"},{"v":0.85994,"d":"0.86"},{"v":1.311131,"d":"1.31"},{"v":1.84085,"d":"1.84"},{"v":0.813912337755405,"d":"0.81"},{"v":-0.297054677172267,"d":"-0.30"},{"v":0.64758528801495,"d":"0.65"},{"v":0.939223004326533,"d":"0.94"},"down","no"]
["MSTRG.10400","DARS","ENSOART00000011474","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004815(aspartate-tRNA ligase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006422(aspartyl-tRNA aminoacylation);GO:0017101(aminoacyl-tRNA synthetase multienzyme complex);GO:0045202(synapse)","00970(Aminoacyl-tRNA biosynthesis)","K22503","EC:6.1.1.12","aspartyl-tRNA synthetase [Source:NCBI gene;Acc:100302097]",{"v":15.214838,"d":"15.21"},{"v":13.911151,"d":"13.91"},{"v":14.075376,"d":"14.08"},{"v":16.822176,"d":"16.82"},{"v":12.99831,"d":"13.00"},{"v":11.919727,"d":"11.92"},{"v":1.03500585873867,"d":"1.04"},{"v":0.0496389342456658,"d":"0.05"},{"v":0.648515822839363,"d":"0.65"},{"v":0.939737919102966,"d":"0.94"},"up","no"]
["MSTRG.8239","MAN2C1","ENSOART00000002632","GO:0003824(catalytic activity);GO:0004559(alpha-mannosidase activity);GO:0005654(nucleoplasm);GO:0005975(carbohydrate metabolic process);GO:0006013(mannose metabolic process);GO:0030246(carbohydrate binding)","00511(Other glycan degradation)","K01191","EC:3.2.1.24","mannosidase alpha class 2C member 1 [Source:NCBI gene;Acc:101118225]",{"v":3.4267764774665,"d":"3.43"},{"v":3.04560117113276,"d":"3.05"},{"v":3.12718509683313,"d":"3.13"},{"v":4.32195752405603,"d":"4.32"},{"v":3.95595419397077,"d":"3.96"},{"v":3.02959482369062,"d":"3.03"},{"v":0.848954869936726,"d":"0.85"},{"v":-0.236240232097306,"d":"-0.24"},{"v":0.649368578108126,"d":"0.65"},{"v":0.939737919102966,"d":"0.94"},"down","no"]
["MSTRG.5404","NUP93","ENSOART00000020341","GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005643(nuclear pore);GO:0006913(nucleocytoplasmic transport);GO:0006998(nuclear envelope organization);GO:0015031(protein transport);GO:0016020(membrane);GO:0017056(structural constituent of nuclear pore);GO:0031965(nuclear membrane);GO:0034399(nuclear periphery);GO:0051028(mRNA transport);GO:0051292(nuclear pore complex assembly);GO:0060391(positive regulation of SMAD protein signal transduction);GO:0060395(SMAD protein signal transduction)","03013(RNA transport)","K14309","NA","nucleoporin 93 [Source:NCBI gene;Acc:101120350]",{"v":4.83868051214734,"d":"4.84"},{"v":4.89989671081505,"d":"4.90"},{"v":5.20719830838558,"d":"5.21"},{"v":7.2315850869906,"d":"7.23"},{"v":4.81156730956113,"d":"4.81"},{"v":5.64093320297806,"d":"5.64"},{"v":0.845153991549632,"d":"0.85"},{"v":-0.242713862836756,"d":"-0.24"},{"v":0.649933801930294,"d":"0.65"},{"v":0.939737919102966,"d":"0.94"},"down","no"]
["MSTRG.10780","PSMD1","ENSOART00000022531","GO:0000502(proteasome complex);GO:0008540(proteasome regulatory particle, base subcomplex);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0031625(ubiquitin protein ligase binding);GO:0042176(regulation of protein catabolic process);GO:0050790(regulation of catalytic activity)","03050(Proteasome);05169(Epstein-Barr virus infection)","K03032","NA","proteasome 26S subunit, non-ATPase 1 [Source:NCBI gene;Acc:101122259]",{"v":12.3526715220946,"d":"12.35"},{"v":14.8001289046136,"d":"14.80"},{"v":13.2635254485108,"d":"13.26"},{"v":13.6706341903835,"d":"13.67"},{"v":12.768070874051,"d":"12.77"},{"v":12.5063260693011,"d":"12.51"},{"v":1.03777875376273,"d":"1.04"},{"v":0.0534989052840538,"d":"0.05"},{"v":0.650302957490218,"d":"0.65"},{"v":0.939737919102966,"d":"0.94"},"up","no"]
["MSTRG.11670","SNRNP48","ENSOART00000018857","GO:0005654(nucleoplasm);GO:0005689(U12-type spliceosomal complex);GO:0005829(cytosol)","NA","K13156","NA","small nuclear ribonucleoprotein U11/U12 subunit 48 [Source:NCBI gene;Acc:101118908]",{"v":3.255799,"d":"3.26"},{"v":3.390252,"d":"3.39"},{"v":3.662773,"d":"3.66"},{"v":3.318483,"d":"3.32"},{"v":5.085935,"d":"5.09"},{"v":3.913257,"d":"3.91"},{"v":0.836913134986919,"d":"0.84"},{"v":-0.256850204760459,"d":"-0.26"},{"v":0.651344537375542,"d":"0.65"},{"v":0.940249994373,"d":"0.94"},"down","no"]
["MSTRG.6476","SBF2","ENSOART00000012706","GO:0005774(vacuolar membrane);GO:0016020(membrane);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0019208(phosphatase regulator activity);GO:0019902(phosphatase binding);GO:0035091(phosphatidylinositol binding);GO:0043087(regulation of GTPase activity);GO:0051262(protein tetramerization)","NA","K18061","NA","SET binding factor 2 [Source:NCBI gene;Acc:101123068]",{"v":5.33167557432349,"d":"5.33"},{"v":4.42958168380082,"d":"4.43"},{"v":4.42504067490424,"d":"4.43"},{"v":5.77109803496849,"d":"5.77"},{"v":5.7180148816261,"d":"5.72"},{"v":5.10443368034104,"d":"5.10"},{"v":0.854928622410858,"d":"0.85"},{"v":-0.226124119792312,"d":"-0.23"},{"v":0.652164357157263,"d":"0.65"},{"v":0.940377524257446,"d":"0.94"},"down","no"]
["MSTRG.21315","INTS8","ENSOART00000007082","GO:0005515(protein binding);GO:0016180(snRNA processing);GO:0032039(integrator complex);GO:0034472(snRNA 3'-end processing)","NA","K13145","NA","integrator complex subunit 8 [Source:NCBI gene;Acc:101109456]",{"v":4.72201157582152,"d":"4.72"},{"v":5.57663237895689,"d":"5.58"},{"v":4.61260209195056,"d":"4.61"},{"v":5.213205731836,"d":"5.21"},{"v":4.74966101854085,"d":"4.75"},{"v":4.43633563762436,"d":"4.44"},{"v":1.03556055710103,"d":"1.04"},{"v":0.0504119213757419,"d":"0.05"},{"v":0.652323894105272,"d":"0.65"},{"v":0.940377524257446,"d":"0.94"},"up","no"]
["MSTRG.788","PRUNE1","ENSOART00000022784","GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0015631(tubulin binding);GO:0016311(dephosphorylation);GO:0016462(pyrophosphatase activity);GO:0016791(phosphatase activity);GO:0031113(regulation of microtubule polymerization);GO:0050767(regulation of neurogenesis)","00230(Purine metabolism)","K01514","EC:3.6.1.11","prune exopolyphosphatase 1 [Source:NCBI gene;Acc:101117814]",{"v":5.822572,"d":"5.82"},{"v":5.650432,"d":"5.65"},{"v":4.509661,"d":"4.51"},{"v":6.288459,"d":"6.29"},{"v":3.520563,"d":"3.52"},{"v":5.430521,"d":"5.43"},{"v":1.04876274833176,"d":"1.05"},{"v":0.0686883475835478,"d":"0.07"},{"v":0.653008819725889,"d":"0.65"},{"v":0.940377524257446,"d":"0.94"},"up","no"]
["MSTRG.976","ENSOARG00000009504","ENSOART00000010351","GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0051082(unfolded protein binding)","NA","K09549","NA","prefoldin subunit 2 [Source:NCBI gene;Acc:101102106]",{"v":10.484665,"d":"10.48"},{"v":11.80503,"d":"11.81"},{"v":12.680173,"d":"12.68"},{"v":9.53244,"d":"9.53"},{"v":9.946747,"d":"9.95"},{"v":13.391731,"d":"13.39"},{"v":1.06385431645079,"d":"1.06"},{"v":0.0893006026021898,"d":"0.09"},{"v":0.653793045574137,"d":"0.65"},{"v":0.940377524257446,"d":"0.94"},"up","no"]
["ENSOARG00000001261","SPAG1","ENSOART00000001349","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol)","NA","K19870","NA","sperm associated antigen 1 [Source:NCBI gene;Acc:101104833]",{"v":0.414038,"d":"0.41"},{"v":0.270539,"d":"0.27"},{"v":0.356223,"d":"0.36"},{"v":0.408781,"d":"0.41"},{"v":0.274928,"d":"0.27"},{"v":0.274371,"d":"0.27"},{"v":1.08633934535738,"d":"1.09"},{"v":0.119474835546741,"d":"0.12"},{"v":0.654683417274908,"d":"0.65"},{"v":0.940377524257446,"d":"0.94"},"up","no"]
["MSTRG.2519","DCUN1D2","ENSOART00000009135","NA","NA","NA","NA","defective in cullin neddylation 1 domain containing 2 [Source:HGNC Symbol;Acc:HGNC:20328]",{"v":2.07548404828326,"d":"2.08"},{"v":1.24509745922747,"d":"1.25"},{"v":1.64497226072961,"d":"1.64"},{"v":1.80988324678112,"d":"1.81"},{"v":1.86882610300429,"d":"1.87"},{"v":1.02077915236051,"d":"1.02"},{"v":1.05661579254273,"d":"1.06"},{"v":0.0794508781799035,"d":"0.08"},{"v":0.655768388867596,"d":"0.66"},{"v":0.940574707699338,"d":"0.94"},"up","no"]
["MSTRG.17712","NFIX","ENSOART00000010382","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006260(DNA replication);GO:0006355(regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K09171","NA","nuclear factor I X [Source:NCBI gene;Acc:101103719]",{"v":62.4687211112065,"d":"62.47"},{"v":62.0349854920567,"d":"62.03"},{"v":56.8613977294976,"d":"56.86"},{"v":60.0383548915844,"d":"60.04"},{"v":52.4761769871189,"d":"52.48"},{"v":61.8317583688278,"d":"61.83"},{"v":1.04025789178115,"d":"1.04"},{"v":0.0569412332424061,"d":"0.06"},{"v":0.656231242009173,"d":"0.66"},{"v":0.940815147908138,"d":"0.94"},"up","no"]
["MSTRG.14327","MICU3","ENSOART00000010409","GO:0005509(calcium ion binding);GO:0006851(mitochondrial calcium ion transmembrane transport)","NA","NA","NA","mitochondrial calcium uptake family member 3 [Source:NCBI gene;Acc:101111603]",{"v":2.77573526154094,"d":"2.78"},{"v":2.36200378269262,"d":"2.36"},{"v":1.82203307849445,"d":"1.82"},{"v":2.34090201447644,"d":"2.34"},{"v":2.27018083689883,"d":"2.27"},{"v":2.05623380891105,"d":"2.06"},{"v":1.04386404266407,"d":"1.04"},{"v":0.0619338213454024,"d":"0.06"},{"v":0.657543796640081,"d":"0.66"},{"v":0.941153159543919,"d":"0.94"},"up","no"]
["MSTRG.13967","ANK3","ENSOART00000004652","GO:0000281(mitotic cytokinesis);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0007009(plasma membrane organization);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0009925(basal plasma membrane);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0042383(sarcolemma);GO:0043001(Golgi to plasma membrane protein transport);GO:0043194(axon initial segment);GO:0045184(establishment of protein localization);GO:0071709(membrane assembly);GO:0072659(protein localization to plasma membrane);GO:0072660(maintenance of protein location in plasma membrane)","NA","NA","NA","ankyrin 3 [Source:HGNC Symbol;Acc:HGNC:494]",{"v":5.64833365754722,"d":"5.65"},{"v":4.59962198504335,"d":"4.60"},{"v":4.73677701067922,"d":"4.74"},{"v":5.31070262128955,"d":"5.31"},{"v":5.27017774682781,"d":"5.27"},{"v":3.90859795188609,"d":"3.91"},{"v":1.03418027359775,"d":"1.03"},{"v":0.0484876916066096,"d":"0.05"},{"v":0.658859888513114,"d":"0.66"},{"v":0.941624284849397,"d":"0.94"},"up","no"]
["MSTRG.17064","SCRN1","ENSOART00000009522","GO:0005634(nucleus);GO:0006508(proteolysis);GO:0016805(dipeptidase activity);GO:0031965(nuclear membrane)","NA","K14358","NA","secernin 1 [Source:NCBI gene;Acc:101103468]",{"v":1.594175,"d":"1.59"},{"v":1.744554,"d":"1.74"},{"v":2.481027,"d":"2.48"},{"v":1.908114,"d":"1.91"},{"v":1.707686,"d":"1.71"},{"v":1.924116,"d":"1.92"},{"v":1.05051340128623,"d":"1.05"},{"v":0.0710945664334842,"d":"0.07"},{"v":0.658876064355808,"d":"0.66"},{"v":0.941624284849397,"d":"0.94"},"up","no"]
["MSTRG.20598","SLC2A12","ENSOART00000015984","GO:0005215(transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport);GO:1904659(glucose transmembrane transport)","NA","K08149","NA","solute carrier family 2 member 12 [Source:NCBI gene;Acc:101107449]",{"v":5.243041,"d":"5.24"},{"v":4.070485,"d":"4.07"},{"v":3.929718,"d":"3.93"},{"v":5.319336,"d":"5.32"},{"v":3.603055,"d":"3.60"},{"v":3.78347,"d":"3.78"},{"v":1.042294103485,"d":"1.04"},{"v":0.0597624194314094,"d":"0.06"},{"v":0.660158812840357,"d":"0.66"},{"v":0.942084325278231,"d":"0.94"},"up","no"]
["ENSOARG00000014301","KCTD16","ENSOART00000015574","GO:0005515(protein binding);GO:0051260(protein homooligomerization)","NA","NA","NA","potassium channel tetramerization domain containing 16 [Source:HGNC Symbol;Acc:HGNC:29244]",{"v":0.660871,"d":"0.66"},{"v":1.038431,"d":"1.04"},{"v":0.708335,"d":"0.71"},{"v":0.320034,"d":"0.32"},{"v":1.289725,"d":"1.29"},{"v":0.519984,"d":"0.52"},{"v":1.13048241031899,"d":"1.13"},{"v":0.176938544727228,"d":"0.18"},{"v":0.661220249956364,"d":"0.66"},{"v":0.942414733054628,"d":"0.94"},"up","no"]
["MSTRG.2257","PAN3","ENSOART00000013370;ENSOART00000013373","GO:0000166(nucleotide binding);GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening);GO:0000290(deadenylation-dependent decapping of nuclear-transcribed mRNA);GO:0000932(P-body);GO:0003723(RNA binding);GO:0004535(poly(A)-specific ribonuclease activity);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0006468(protein phosphorylation);GO:0006605(protein targeting);GO:0010606(positive regulation of cytoplasmic mRNA processing body assembly);GO:0031251(PAN complex);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic);GO:0090503(RNA phosphodiester bond hydrolysis, exonucleolytic)","03018(RNA degradation);03018(RNA degradation)","K12572","NA","poly(A) specific ribonuclease subunit PAN3 [Source:NCBI gene;Acc:101113862]",{"v":3.78521491935759,"d":"3.79"},{"v":2.90926327900222,"d":"2.91"},{"v":3.21784496087476,"d":"3.22"},{"v":3.5394621371946,"d":"3.54"},{"v":3.69784335742354,"d":"3.70"},{"v":2.31512266854604,"d":"2.32"},{"v":1.03767576054204,"d":"1.04"},{"v":0.0533557194827352,"d":"0.05"},{"v":0.661711239664608,"d":"0.66"},{"v":0.942414733054628,"d":"0.94"},"up","no"]
["MSTRG.13712","COPS6","ENSOART00000019502","GO:0000338(protein deneddylation);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008180(COP9 signalosome)","NA","NA","NA","COP9 signalosome complex subunit 6 [Source:NCBI gene;Acc:101108276]",{"v":23.12715348,"d":"23.13"},{"v":22.953265536,"d":"22.95"},{"v":21.589498752,"d":"21.59"},{"v":25.08098748,"d":"25.08"},{"v":25.983247872,"d":"25.98"},{"v":27.715045752,"d":"27.72"},{"v":0.858981153669909,"d":"0.86"},{"v":-0.219301616381868,"d":"-0.22"},{"v":0.662340275116359,"d":"0.66"},{"v":0.942541978033218,"d":"0.94"},"down","no"]
["MSTRG.15368","RASGRP3","ENSOART00000011227","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005509(calcium ion binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0007264(small GTPase mediated signal transduction);GO:0007265(Ras protein signal transduction);GO:0017016(Ras GTPase binding);GO:0019900(kinase binding);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0035556(intracellular signal transduction);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04662(B cell receptor signaling pathway);05200(Pathways in cancer)","K12362","NA","RAS guanyl releasing protein 3 [Source:NCBI gene;Acc:101101969]",{"v":6.94948859655248,"d":"6.95"},{"v":4.29081094741436,"d":"4.29"},{"v":3.60283419637792,"d":"3.60"},{"v":5.75900488304604,"d":"5.76"},{"v":4.39000866528475,"d":"4.39"},{"v":4.02184251145538,"d":"4.02"},{"v":1.04744086579684,"d":"1.05"},{"v":0.0668687975954559,"d":"0.07"},{"v":0.663456682053359,"d":"0.66"},{"v":0.942541978033218,"d":"0.94"},"up","no"]
["MSTRG.8998","DENND6A","ENSOART00000014595;ENSOART00000014592","GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0043231(intracellular membrane-bounded organelle);GO:0055037(recycling endosome);GO:2000049(positive regulation of cell-cell adhesion mediated by cadherin);GO:2000049(positive regulation of cell-cell adhesion mediated by cadherin)","NA","NA","NA","DENN domain containing 6A [Source:NCBI gene;Acc:101102518]",{"v":3.73123070359281,"d":"3.73"},{"v":1.85106161976048,"d":"1.85"},{"v":2.01752256886228,"d":"2.02"},{"v":3.74874183832335,"d":"3.75"},{"v":2.86450006586826,"d":"2.86"},{"v":2.40739714371257,"d":"2.41"},{"v":0.842491851392866,"d":"0.84"},{"v":-0.247265362316255,"d":"-0.25"},{"v":0.66367008338118,"d":"0.66"},{"v":0.942541978033218,"d":"0.94"},"down","no"]
["MSTRG.11591","NHLRC1","ENSOART00000021884","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005634(nucleus);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process)","NA","NA","NA","NHL repeat containing E3 ubiquitin protein ligase 1 [Source:HGNC Symbol;Acc:HGNC:21576]",{"v":1.196151,"d":"1.20"},{"v":1.464006,"d":"1.46"},{"v":0.392602,"d":"0.39"},{"v":1.317751,"d":"1.32"},{"v":1.0393,"d":"1.04"},{"v":1.476763,"d":"1.48"},{"v":0.796272067450325,"d":"0.80"},{"v":-0.328666644899908,"d":"-0.33"},{"v":0.665571292746105,"d":"0.67"},{"v":0.943518672335337,"d":"0.94"},"down","no"]
["MSTRG.3208","STARD3","ENSOART00000012483","GO:0005739(mitochondrion);GO:0005768(endosome);GO:0005770(late endosome);GO:0005789(endoplasmic reticulum membrane);GO:0006701(progesterone biosynthetic process);GO:0008289(lipid binding);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017127(cholesterol transporter activity);GO:0030301(cholesterol transport);GO:0031902(late endosome membrane);GO:0042803(protein homodimerization activity);GO:0044232(organelle membrane contact site);GO:0099044(vesicle tethering to endoplasmic reticulum);GO:0140284(endoplasmic reticulum-endosome membrane contact site)","04979(Cholesterol metabolism)","K22291","NA","StAR related lipid transfer domain containing 3 [Source:NCBI gene;Acc:101103332]",{"v":1.865086,"d":"1.87"},{"v":1.119428,"d":"1.12"},{"v":1.429884,"d":"1.43"},{"v":1.22941,"d":"1.23"},{"v":2.082563,"d":"2.08"},{"v":1.853112,"d":"1.85"},{"v":0.854661249524451,"d":"0.85"},{"v":-0.226575383041777,"d":"-0.23"},{"v":0.665711561544704,"d":"0.67"},{"v":0.94358819070965,"d":"0.94"},"down","no"]
["MSTRG.4780","DDRGK1","ENSOART00000004497","GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0008284(positive regulation of cell population proliferation);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030335(positive regulation of cell migration);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0033146(regulation of intracellular estrogen receptor signaling pathway);GO:0034976(response to endoplasmic reticulum stress);GO:0044389(ubiquitin-like protein ligase binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051216(cartilage development);GO:1901800(positive regulation of proteasomal protein catabolic process);GO:1903721(positive regulation of I-kappaB phosphorylation);GO:1905050(positive regulation of metallopeptidase activity);GO:1905552(positive regulation of protein localization to endoplasmic reticulum);GO:1905636(positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding);GO:1990592(protein K69-linked ufmylation)","NA","NA","NA","DDRGK domain containing 1 [Source:NCBI gene;Acc:101122540]",{"v":1.768324,"d":"1.77"},{"v":1.52865,"d":"1.53"},{"v":1.675093,"d":"1.68"},{"v":1.889495,"d":"1.89"},{"v":2.021627,"d":"2.02"},{"v":1.887794,"d":"1.89"},{"v":0.857413178600966,"d":"0.86"},{"v":-0.221937503069374,"d":"-0.22"},{"v":0.666664424428429,"d":"0.67"},{"v":0.943714773575095,"d":"0.94"},"down","no"]
["MSTRG.7720","RNF10","ENSOART00000013770","GO:0004842(ubiquitin-protein transferase activity);GO:0005737(cytoplasm);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051865(protein autoubiquitination)","NA","NA","NA","ring finger protein 10 [Source:NCBI gene;Acc:101112262]",{"v":59.8738246621005,"d":"59.87"},{"v":63.3465949340753,"d":"63.35"},{"v":55.9225903364726,"d":"55.92"},{"v":58.3938425062785,"d":"58.39"},{"v":53.4151886612443,"d":"53.42"},{"v":61.1471603564498,"d":"61.15"},{"v":1.03577101434856,"d":"1.04"},{"v":0.0507050908832803,"d":"0.05"},{"v":0.667469078736556,"d":"0.67"},{"v":0.943946400930949,"d":"0.94"},"up","no"]
["MSTRG.19843","ENSOARG00000020876","ENSOART00000022745;ENSOART00000022746","GO:0003676(nucleic acid binding);GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 280D [Source:NCBI gene;Acc:101120087]",{"v":3.53105609100231,"d":"3.53"},{"v":2.46663944527044,"d":"2.47"},{"v":2.27158172160984,"d":"2.27"},{"v":2.78416443552935,"d":"2.78"},{"v":2.33760038451679,"d":"2.34"},{"v":2.76450080364009,"d":"2.76"},{"v":1.04856692032361,"d":"1.05"},{"v":0.0684189382472176,"d":"0.07"},{"v":0.668965396070543,"d":"0.67"},{"v":0.944706725185149,"d":"0.94"},"up","no"]
["MSTRG.16346","YBX3","ENSOART00000022789","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0008584(male gonad development);GO:0009566(fertilization);GO:0043066(negative regulation of apoptotic process);GO:0046622(positive regulation of organ growth);GO:0048642(negative regulation of skeletal muscle tissue development);GO:0060546(negative regulation of necroptotic process);GO:0071356(cellular response to tumor necrosis factor);GO:0071474(cellular hyperosmotic response);GO:1902219(negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress);GO:1905538(polysome binding)","04530(Tight junction)","K06099","NA","Y-box-binding protein 3 [Source:NCBI gene;Acc:101122777]",{"v":127.680725599662,"d":"127.68"},{"v":128.663066079024,"d":"128.66"},{"v":131.511304958416,"d":"131.51"},{"v":137.670091139635,"d":"137.67"},{"v":139.999546007519,"d":"140.00"},{"v":171.791901971459,"d":"171.79"},{"v":0.8629327826307,"d":"0.86"},{"v":-0.212679908533086,"d":"-0.21"},{"v":0.669555366443853,"d":"0.67"},{"v":0.944818945924745,"d":"0.94"},"down","no"]
["MSTRG.19040","G3BP2","ENSOART00000017036","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005829(cytosol);GO:0034063(stress granule assembly)","NA","NA","NA","G3BP stress granule assembly factor 2 [Source:NCBI gene;Acc:101107022]",{"v":20.8204818770165,"d":"20.82"},{"v":18.9097410667823,"d":"18.91"},{"v":19.4780186728534,"d":"19.48"},{"v":23.4520013947962,"d":"23.45"},{"v":16.7795293148309,"d":"16.78"},{"v":17.463918685863,"d":"17.46"},{"v":1.02622030397566,"d":"1.03"},{"v":0.0373404749366613,"d":"0.04"},{"v":0.67079990669506,"d":"0.67"},{"v":0.945288636828308,"d":"0.95"},"up","no"]
["MSTRG.8698","CMC1","ENSOART00000015814","GO:0005739(mitochondrion)","NA","NA","NA","C-X9-C motif containing 1 [Source:HGNC Symbol;Acc:HGNC:28783]",{"v":1.94373686996198,"d":"1.94"},{"v":1.50073366058302,"d":"1.50"},{"v":1.03599568795944,"d":"1.04"},{"v":1.74459943624842,"d":"1.74"},{"v":1.56416069961977,"d":"1.56"},{"v":1.94308499493029,"d":"1.94"},{"v":0.853122304050736,"d":"0.85"},{"v":-0.229175513016628,"d":"-0.23"},{"v":0.671892087907075,"d":"0.67"},{"v":0.945750065113572,"d":"0.95"},"down","no"]
["ENSOARG00000003133","EML6","ENSOART00000003440","GO:0005515(protein binding)","NA","K18598","NA","EMAP like 6 [Source:NCBI gene;Acc:101101879]",{"v":0.277377,"d":"0.28"},{"v":0.200163,"d":"0.20"},{"v":0.3236,"d":"0.32"},{"v":0.250012,"d":"0.25"},{"v":0.340406,"d":"0.34"},{"v":0.152899,"d":"0.15"},{"v":1.07779049853562,"d":"1.08"},{"v":0.10807677354751,"d":"0.11"},{"v":0.67247491621175,"d":"0.67"},{"v":0.945832580920445,"d":"0.95"},"up","no"]
["MSTRG.20464","SEC63","ENSOART00000011873","GO:0001889(liver development);GO:0005783(endoplasmic reticulum);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0006620(posttranslational protein targeting to endoplasmic reticulum membrane);GO:0006807(nitrogen compound metabolic process);GO:0010259(multicellular organism aging);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031204(posttranslational protein targeting to membrane, translocation)","03060(Protein export);04141(Protein processing in endoplasmic reticulum)","K09540","NA","SEC63 homolog, protein translocation regulator [Source:NCBI gene;Acc:101118280]",{"v":2.58745693418224,"d":"2.59"},{"v":2.34247294493137,"d":"2.34"},{"v":2.66065771489995,"d":"2.66"},{"v":2.47408449098727,"d":"2.47"},{"v":2.30158987415247,"d":"2.30"},{"v":2.53395723466182,"d":"2.53"},{"v":1.03843640960232,"d":"1.04"},{"v":0.0544128730334951,"d":"0.05"},{"v":0.673541307522737,"d":"0.67"},{"v":0.946123193019759,"d":"0.95"},"up","no"]
["MSTRG.2820","SRR","ENSOART00000016667","GO:0000287(magnesium ion binding);GO:0003941(L-serine ammonia-lyase activity);GO:0005509(calcium ion binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006520(cellular amino acid metabolic process);GO:0006563(L-serine metabolic process);GO:0009069(serine family amino acid metabolic process);GO:0016594(glycine binding);GO:0018114(threonine racemase activity);GO:0030165(PDZ domain binding);GO:0030170(pyridoxal phosphate binding);GO:0030378(serine racemase activity);GO:0032496(response to lipopolysaccharide);GO:0042803(protein homodimerization activity);GO:0042866(pyruvate biosynthetic process);GO:0043025(neuronal cell body);GO:0051289(protein homotetramerization);GO:0070178(D-serine metabolic process);GO:0070179(D-serine biosynthetic process)","00260(Glycine, serine and threonine metabolism)","K12235","EC:5.1.1.18","serine racemase [Source:NCBI gene;Acc:101118200]",{"v":0.773626908375246,"d":"0.77"},{"v":2.50745916553685,"d":"2.51"},{"v":1.49833787710475,"d":"1.50"},{"v":2.26427597419637,"d":"2.26"},{"v":1.59709435294118,"d":"1.60"},{"v":0.7097196133829,"d":"0.71"},{"v":1.04557644089424,"d":"1.05"},{"v":0.064298539562778,"d":"0.06"},{"v":0.673609538017554,"d":"0.67"},{"v":0.946123193019759,"d":"0.95"},"up","no"]
["MSTRG.18532","ENSOARG00000016729","ENSOART00000018218","NA","NA","NA","NA",null,{"v":0.46746,"d":"0.47"},{"v":0.331776,"d":"0.33"},{"v":0.272405,"d":"0.27"},{"v":0.560939,"d":"0.56"},{"v":0.402179,"d":"0.40"},{"v":0.32352,"d":"0.32"},{"v":0.832900163060628,"d":"0.83"},{"v":-0.263784519932116,"d":"-0.26"},{"v":0.674862331876633,"d":"0.67"},{"v":0.946581234849383,"d":"0.95"},"down","no"]
["ENSOARG00000010768","AFG1L","ENSOART00000011715","GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006123(mitochondrial electron transport, cytochrome c to oxygen);GO:0007005(mitochondrion organization);GO:0031966(mitochondrial membrane);GO:0035694(mitochondrial protein catabolic process)","NA","K18798","EC:3.6.4.7","AFG1 like ATPase [Source:NCBI gene;Acc:101116838]",{"v":1.707505,"d":"1.71"},{"v":1.505681,"d":"1.51"},{"v":1.565504,"d":"1.57"},{"v":2.114723,"d":"2.11"},{"v":1.845762,"d":"1.85"},{"v":1.716103,"d":"1.72"},{"v":0.841824349415529,"d":"0.84"},{"v":-0.248408855257117,"d":"-0.25"},{"v":0.675602634272556,"d":"0.68"},{"v":0.946838450021586,"d":"0.95"},"down","no"]
["MSTRG.15494","UNC50","ENSOART00000014699","GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","unc-50 inner nuclear membrane RNA binding protein [Source:NCBI gene;Acc:101109083]",{"v":5.69425153814433,"d":"5.69"},{"v":5.53897096907216,"d":"5.54"},{"v":4.50768628556701,"d":"4.51"},{"v":5.05699056082474,"d":"5.06"},{"v":5.90895478247423,"d":"5.91"},{"v":4.12198543092784,"d":"4.12"},{"v":1.04327816904304,"d":"1.04"},{"v":0.0611238746296385,"d":"0.06"},{"v":0.676612913080804,"d":"0.68"},{"v":0.947323538122903,"d":"0.95"},"up","no"]
["MSTRG.101","GIGYF2","ENSOART00000021078","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0007631(feeding behavior);GO:0008344(adult locomotory behavior);GO:0009791(post-embryonic development);GO:0010494(cytoplasmic stress granule);GO:0016021(integral component of membrane);GO:0016441(posttranscriptional gene silencing);GO:0017148(negative regulation of translation);GO:0021522(spinal cord motor neuron differentiation);GO:0031571(mitotic G1 DNA damage checkpoint);GO:0031982(vesicle);GO:0032991(protein-containing complex);GO:0035264(multicellular organism growth);GO:0043204(perikaryon);GO:0044267(cellular protein metabolic process);GO:0048009(insulin-like growth factor receptor signaling pathway);GO:0048873(homeostasis of number of cells within a tissue);GO:0050881(musculoskeletal movement);GO:0050885(neuromuscular process controlling balance);GO:0061157(mRNA destabilization);GO:0070064(proline-rich region binding);GO:1990635(proximal dendrite)","NA","K18730","NA","GRB10 interacting GYF protein 2 [Source:NCBI gene;Acc:101105449]",{"v":4.79382413192497,"d":"4.79"},{"v":5.66223249342567,"d":"5.66"},{"v":5.30043120704769,"d":"5.30"},{"v":5.91389593364306,"d":"5.91"},{"v":5.59665810071879,"d":"5.60"},{"v":3.86041389428471,"d":"3.86"},{"v":1.02508104275159,"d":"1.03"},{"v":0.0357379734905906,"d":"0.04"},{"v":0.677639590934821,"d":"0.68"},{"v":0.947789895561398,"d":"0.95"},"up","no"]
["ENSOARG00000004906","HAUS5","ENSOART00000005354","GO:0005813(centrosome);GO:0007098(centrosome cycle);GO:0051225(spindle assembly);GO:0070652(HAUS complex)","NA","K16588","NA","HAUS augmin like complex subunit 5 [Source:NCBI gene;Acc:101116420]",{"v":1.328437,"d":"1.33"},{"v":0.856433,"d":"0.86"},{"v":1.34028,"d":"1.34"},{"v":1.19938,"d":"1.20"},{"v":1.704542,"d":"1.70"},{"v":1.26716,"d":"1.27"},{"v":0.845140421598041,"d":"0.85"},{"v":-0.24273702720589,"d":"-0.24"},{"v":0.678779463043624,"d":"0.68"},{"v":0.948235559380778,"d":"0.95"},"down","no"]
["MSTRG.8859","ARL8B","ENSOART00000008498","GO:0000166(nucleotide binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0007059(chromosome segregation);GO:0008089(anterograde axonal transport);GO:0019003(GDP binding);GO:0030424(axon);GO:0030496(midbody);GO:0032418(lysosome localization);GO:0043014(alpha-tubulin binding);GO:0045202(synapse);GO:0048487(beta-tubulin binding);GO:0051233(spindle midzone);GO:1904115(axon cytoplasm)","NA","K07955","NA","ADP ribosylation factor like GTPase 8B [Source:NCBI gene;Acc:100302317]",{"v":7.01519301751759,"d":"7.02"},{"v":7.79483688621051,"d":"7.79"},{"v":7.10690281299596,"d":"7.11"},{"v":8.27248549812846,"d":"8.27"},{"v":6.72959241907471,"d":"6.73"},{"v":6.36920192364126,"d":"6.37"},{"v":1.02553206358923,"d":"1.03"},{"v":0.0363725988465605,"d":"0.04"},{"v":0.679317027474796,"d":"0.68"},{"v":0.948235559380778,"d":"0.95"},"up","no"]
["MSTRG.857","HAX1;UBAP2L","ENSOART00000002457;ENSOART00000002350","GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005758(mitochondrial intermembrane space);GO:0005783(endoplasmic reticulum);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0016529(sarcoplasmic reticulum);GO:0019966(interleukin-1 binding);GO:0030027(lamellipodium);GO:0030833(regulation of actin filament polymerization);GO:0030854(positive regulation of granulocyte differentiation);GO:0031410(cytoplasmic vesicle);GO:0031965(nuclear membrane);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0043066(negative regulation of apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0051897(positive regulation of protein kinase B signaling);GO:0071345(cellular response to cytokine stimulus);GO:2000251(positive regulation of actin cytoskeleton reorganization);GO:0005515(protein binding);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0007339(binding of sperm to zona pellucida);GO:0031519(PcG protein complex);GO:0061484(hematopoietic stem cell homeostasis)","NA","K16220","NA","HCLS1 associated protein X-1 [Source:NCBI gene;Acc:101111760];ubiquitin associated protein 2 like [Source:NCBI gene;Acc:101110012]",{"v":4.69056496310255,"d":"4.69"},{"v":5.03429537310802,"d":"5.03"},{"v":5.74265499386056,"d":"5.74"},{"v":4.96593436982554,"d":"4.97"},{"v":4.81848931353717,"d":"4.82"},{"v":5.17613789259012,"d":"5.18"},{"v":1.03388601099929,"d":"1.03"},{"v":0.0480771330113276,"d":"0.05"},{"v":0.67975577656098,"d":"0.68"},{"v":0.948235559380778,"d":"0.95"},"up","no"]
["MSTRG.10358","MMADHC","ENSOART00000010141;ENSOART00000010143","GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0009108(coenzyme biosynthetic process);GO:0009235(cobalamin metabolic process);GO:0009235(cobalamin metabolic process)","NA","NA","NA","metabolism of cobalamin associated D [Source:NCBI gene;Acc:101120894]",{"v":33.7809492302839,"d":"33.78"},{"v":32.9212776498423,"d":"32.92"},{"v":29.1717601892744,"d":"29.17"},{"v":33.5247797791798,"d":"33.52"},{"v":27.9803442460568,"d":"27.98"},{"v":31.4281030662461,"d":"31.43"},{"v":1.03164379490473,"d":"1.03"},{"v":0.0449449242176186,"d":"0.04"},{"v":0.681472679617699,"d":"0.68"},{"v":0.948924263414445,"d":"0.95"},"up","no"]
["MSTRG.13325","METTL22","ENSOART00000005688","GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006479(protein methylation);GO:0008276(protein methyltransferase activity);GO:0031072(heat shock protein binding);GO:0032991(protein-containing complex)","NA","K23040","EC:2.1.1.-","methyltransferase like 22 [Source:NCBI gene;Acc:101105796]",{"v":5.64363798020434,"d":"5.64"},{"v":5.8370940083014,"d":"5.84"},{"v":4.97425204661558,"d":"4.97"},{"v":5.76350038761175,"d":"5.76"},{"v":6.01102678863346,"d":"6.01"},{"v":7.29927161238825,"d":"7.30"},{"v":0.862700934274679,"d":"0.86"},{"v":-0.213067576521033,"d":"-0.21"},{"v":0.68211354345464,"d":"0.68"},{"v":0.949253325198634,"d":"0.95"},"down","no"]
["MSTRG.5063","STK4","ENSOART00000005148","GO:0000287(magnesium ion binding);GO:0000902(cell morphogenesis);GO:0001569(branching involved in blood vessel morphogenesis);GO:0001841(neural tube formation);GO:0001934(positive regulation of protein phosphorylation);GO:0003157(endocardium development);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0007417(central nervous system development);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0016604(nuclear body);GO:0018105(peptidyl-serine phosphorylation);GO:0030216(keratinocyte differentiation);GO:0032092(positive regulation of protein binding);GO:0032991(protein-containing complex);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035329(hippo signaling);GO:0035556(intracellular signal transduction);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0045600(positive regulation of fat cell differentiation);GO:0046621(negative regulation of organ growth);GO:0046777(protein autophosphorylation);GO:0046983(protein dimerization activity);GO:0050821(protein stabilization);GO:0060215(primitive hemopoiesis);GO:0060706(cell differentiation involved in embryonic placenta development);GO:0060800(regulation of cell differentiation involved in embryonic placenta development);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097284(hepatocyte apoptotic process);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04068(FoxO signaling pathway);05200(Pathways in cancer);05223(Non-small cell lung cancer)","K04411","NA","serine/threonine kinase 4 [Source:NCBI gene;Acc:101110437]",{"v":1.54167401203753,"d":"1.54"},{"v":0.943526641175429,"d":"0.94"},{"v":0.848289596034696,"d":"0.85"},{"v":1.55962873605948,"d":"1.56"},{"v":1.1258428472296,"d":"1.13"},{"v":1.22203982828819,"d":"1.22"},{"v":0.853098020231268,"d":"0.85"},{"v":-0.229216579396421,"d":"-0.23"},{"v":0.683272659558117,"d":"0.68"},{"v":0.94961853860066,"d":"0.95"},"down","no"]
["ENSOARG00000016209","GLMN","ENSOART00000017666","GO:0001570(vasculogenesis);GO:0001843(neural tube closure);GO:0005171(hepatocyte growth factor receptor binding);GO:0031397(negative regulation of protein ubiquitination);GO:0031461(cullin-RING ubiquitin ligase complex);GO:0031462(Cul2-RING ubiquitin ligase complex);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0031464(Cul4A-RING E3 ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:0032434(regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0040029(regulation of gene expression, epigenetic);GO:0042130(negative regulation of T cell proliferation);GO:0042327(positive regulation of phosphorylation);GO:0042692(muscle cell differentiation);GO:0045086(positive regulation of interleukin-2 biosynthetic process);GO:0050715(positive regulation of cytokine secretion);GO:0055105(ubiquitin-protein transferase inhibitor activity);GO:0072359(circulatory system development)","NA","NA","NA","glomulin, FKBP associated protein [Source:NCBI gene;Acc:101103436]",{"v":0.870079,"d":"0.87"},{"v":1.024982,"d":"1.02"},{"v":0.905219,"d":"0.91"},{"v":1.185184,"d":"1.19"},{"v":0.755367,"d":"0.76"},{"v":0.737155,"d":"0.74"},{"v":1.0457757498396,"d":"1.05"},{"v":0.0645735214899913,"d":"0.06"},{"v":0.683702623878205,"d":"0.68"},{"v":0.94961853860066,"d":"0.95"},"up","no"]
["MSTRG.1524","EIF4G1","ENSOART00000022439;ENSOART00000022441","GO:0001662(behavioral fear response);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0006412(translation);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation);GO:0007005(mitochondrion organization);GO:0008135(translation factor activity, RNA binding);GO:0008190(eukaryotic initiation factor 4E binding);GO:0008284(positive regulation of cell population proliferation);GO:0010507(negative regulation of autophagy);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010942(positive regulation of cell death);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0030307(positive regulation of cell growth);GO:0031669(cellular response to nutrient levels);GO:0032270(positive regulation of cellular protein metabolic process);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034645(cellular macromolecule biosynthetic process);GO:0042802(identical protein binding);GO:0045666(positive regulation of neuron differentiation);GO:0097009(energy homeostasis);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:1905537(positive regulation of eukaryotic translation initiation factor 4F complex assembly);GO:1905606(regulation of presynapse assembly);GO:1905612(positive regulation of mRNA cap binding);GO:1905618(positive regulation of miRNA mediated inhibition of translation);GO:1905696(regulation of polysome binding);GO:1905696(regulation of polysome binding)","03013(RNA transport);05416(Viral myocarditis);05416(Viral myocarditis)","K03260","NA","eukaryotic translation initiation factor 4 gamma 1 [Source:NCBI gene;Acc:494441]",{"v":49.4129562255711,"d":"49.41"},{"v":53.7102738691307,"d":"53.71"},{"v":54.4990518034581,"d":"54.50"},{"v":54.9053248006028,"d":"54.91"},{"v":62.3572088096447,"d":"62.36"},{"v":64.7809399522525,"d":"64.78"},{"v":0.865849672133642,"d":"0.87"},{"v":-0.207811527317821,"d":"-0.21"},{"v":0.685346790381484,"d":"0.69"},{"v":0.95043939917867,"d":"0.95"},"down","no"]
["MSTRG.21203","EIF3H","ENSOART00000011615;ENSOART00000011616","GO:0001732(formation of cytoplasmic translation initiation complex);GO:0002183(cytoplasmic translational initiation);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0016282(eukaryotic 43S preinitiation complex);GO:0033290(eukaryotic 48S preinitiation complex);GO:0071541(eukaryotic translation initiation factor 3 complex, eIF3m);GO:0071541(eukaryotic translation initiation factor 3 complex, eIF3m)","03013(RNA transport);05162(Measles);05162(Measles)","K03247","NA","eukaryotic translation initiation factor 3 subunit H [Source:NCBI gene;Acc:101115801]",{"v":69.5738558712256,"d":"69.57"},{"v":51.9503576376554,"d":"51.95"},{"v":68.8664422966252,"d":"68.87"},{"v":66.0709906598579,"d":"66.07"},{"v":55.6615625222025,"d":"55.66"},{"v":62.3412455674956,"d":"62.34"},{"v":1.03431698100904,"d":"1.03"},{"v":0.0486783876340484,"d":"0.05"},{"v":0.685944588583039,"d":"0.69"},{"v":0.950518134039599,"d":"0.95"},"up","no"]
["MSTRG.13408","COQ7","ENSOART00000012553","GO:0004497(monooxygenase activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006744(ubiquinone biosynthetic process);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016709(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen);GO:0031314(extrinsic component of mitochondrial inner membrane);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00130(Ubiquinone and other terpenoid-quinone biosynthesis)","K06134","EC:1.14.99.60","coenzyme Q7, hydroxylase [Source:NCBI gene;Acc:101116112]",{"v":9.65362836619718,"d":"9.65"},{"v":7.74157441079812,"d":"7.74"},{"v":7.73593459976526,"d":"7.74"},{"v":10.3280740187793,"d":"10.33"},{"v":4.91998583568075,"d":"4.92"},{"v":8.78890278755869,"d":"8.79"},{"v":1.04552050735516,"d":"1.05"},{"v":0.0642213599374769,"d":"0.06"},{"v":0.687269386976889,"d":"0.69"},{"v":0.951173746121523,"d":"0.95"},"up","no"]
["MSTRG.11249","FOXP4","ENSOART00000002216","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding)","NA","K09409","NA","forkhead box P4 [Source:NCBI gene;Acc:101108524]",{"v":1.57759154329004,"d":"1.58"},{"v":1.18021026190476,"d":"1.18"},{"v":1.54139954256854,"d":"1.54"},{"v":1.08165581529582,"d":"1.08"},{"v":1.32336716402116,"d":"1.32"},{"v":1.64460386099086,"d":"1.64"},{"v":1.0616290135603,"d":"1.06"},{"v":0.0862797041813243,"d":"0.09"},{"v":0.687594054991723,"d":"0.69"},{"v":0.951282471606918,"d":"0.95"},"up","no"]
["MSTRG.6856","DOCK2","ENSOART00000003289","GO:0001766(membrane raft polarization);GO:0001768(establishment of T cell polarity);GO:0001771(immunological synapse formation);GO:0002277(myeloid dendritic cell activation involved in immune response);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0006935(chemotaxis);GO:0007010(cytoskeleton organization);GO:0007264(small GTPase mediated signal transduction);GO:0016020(membrane);GO:0030036(actin cytoskeleton organization);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0042098(T cell proliferation);GO:0042110(T cell activation);GO:0042608(T cell receptor binding);GO:0043547(positive regulation of GTPase activity);GO:0044351(macropinocytosis);GO:0045059(positive thymic T cell selection);GO:0045060(negative thymic T cell selection);GO:0046631(alpha-beta T cell activation);GO:0046633(alpha-beta T cell proliferation);GO:0050766(positive regulation of phagocytosis)","04062(Chemokine signaling pathway);04666(Fc gamma R-mediated phagocytosis)","K12367","NA","dedicator of cytokinesis 2 [Source:NCBI gene;Acc:101104011]",{"v":1.41152219869771,"d":"1.41"},{"v":1.0197555562352,"d":"1.02"},{"v":1.28070581945541,"d":"1.28"},{"v":1.51281960852407,"d":"1.51"},{"v":0.957612838200474,"d":"0.96"},{"v":1.10587270915549,"d":"1.11"},{"v":1.03793815476993,"d":"1.04"},{"v":0.0537204837103849,"d":"0.05"},{"v":0.688079662978484,"d":"0.69"},{"v":0.951318476204607,"d":"0.95"},"up","no"]
["MSTRG.13719","ENSOARG00000018538","ENSOART00000020175","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","K09229","NA","zinc finger with KRAB and SCAN domains 5 [Source:NCBI gene;Acc:101109324]",{"v":4.09301799101913,"d":"4.09"},{"v":4.07224721593128,"d":"4.07"},{"v":3.48633699531433,"d":"3.49"},{"v":4.10599196798126,"d":"4.11"},{"v":3.82600009176103,"d":"3.83"},{"v":3.42006565404139,"d":"3.42"},{"v":1.02638680105699,"d":"1.03"},{"v":0.0375745231512384,"d":"0.04"},{"v":0.688668278982386,"d":"0.69"},{"v":0.951364597375881,"d":"0.95"},"up","no"]
["MSTRG.9010","CACNA2D3","ENSOART00000016903","NA","04010(MAPK signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04921(Oxytocin signaling pathway);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","K04860","NA","calcium voltage-gated channel auxiliary subunit alpha2delta 3 [Source:NCBI gene;Acc:101105365]",{"v":1.16176546671579,"d":"1.16"},{"v":1.2368024920167,"d":"1.24"},{"v":2.24506173544584,"d":"2.25"},{"v":0.986413124293785,"d":"0.99"},{"v":1.87155133431589,"d":"1.87"},{"v":1.49678227659052,"d":"1.50"},{"v":1.06633748792853,"d":"1.07"},{"v":0.0926641126785448,"d":"0.09"},{"v":0.68951236365388,"d":"0.69"},{"v":0.951558508925723,"d":"0.95"},"up","no"]
["MSTRG.17880","SAFB2","ENSOART00000008692","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0016604(nuclear body);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0050684(regulation of mRNA processing);GO:0060008(Sertoli cell differentiation);GO:0060765(regulation of androgen receptor signaling pathway)","NA","NA","NA","scaffold attachment factor B2 [Source:NCBI gene;Acc:101112057]",{"v":3.9934776281407,"d":"3.99"},{"v":3.31414256155779,"d":"3.31"},{"v":3.93650222663317,"d":"3.94"},{"v":3.57654812361809,"d":"3.58"},{"v":4.34225895150754,"d":"4.34"},{"v":2.97096742085427,"d":"2.97"},{"v":1.03253950947125,"d":"1.03"},{"v":0.0461969865141598,"d":"0.05"},{"v":0.690852307521573,"d":"0.69"},{"v":0.951877041885456,"d":"0.95"},"up","no"]
["MSTRG.6777","RAPSN","ENSOART00000007401","GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007271(synaptic transmission, cholinergic);GO:0016020(membrane);GO:0031594(neuromuscular junction);GO:0033130(acetylcholine receptor binding);GO:0043525(positive regulation of neuron apoptotic process);GO:0045202(synapse);GO:0099634(postsynaptic specialization membrane)","NA","NA","NA","receptor associated protein of the synapse [Source:HGNC Symbol;Acc:HGNC:9863]",{"v":3.03980357123716,"d":"3.04"},{"v":3.36614500446628,"d":"3.37"},{"v":4.16821324519875,"d":"4.17"},{"v":3.55719415364002,"d":"3.56"},{"v":4.71850923492631,"d":"4.72"},{"v":4.03349549888343,"d":"4.03"},{"v":0.859045492528634,"d":"0.86"},{"v":-0.219193560604424,"d":"-0.22"},{"v":0.691068481849101,"d":"0.69"},{"v":0.951877041885456,"d":"0.95"},"down","no"]
["MSTRG.4814","ZNF512B","ENSOART00000010086","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 512B [Source:NCBI gene;Acc:101108330]",{"v":3.57883123890897,"d":"3.58"},{"v":4.54380784357542,"d":"4.54"},{"v":3.40836372264213,"d":"3.41"},{"v":4.15386572987184,"d":"4.15"},{"v":5.07680454814328,"d":"5.08"},{"v":4.19457375616168,"d":"4.19"},{"v":0.858904521643846,"d":"0.86"},{"v":-0.219430328840021,"d":"-0.22"},{"v":0.692279108153318,"d":"0.69"},{"v":0.952117205410214,"d":"0.95"},"down","no"]
["MSTRG.19822","RNF111","ENSOART00000022704","GO:0000209(protein polyubiquitination);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007389(pattern specification process);GO:0016567(protein ubiquitination);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030579(ubiquitin-dependent SMAD protein catabolic process);GO:0031398(positive regulation of protein ubiquitination);GO:0032184(SUMO polymer binding);GO:0032991(protein-containing complex);GO:0045893(positive regulation of transcription, DNA-templated);GO:0061630(ubiquitin protein ligase activity)","NA","K10635","EC:2.3.2.27","ring finger protein 111 [Source:NCBI gene;Acc:101115967]",{"v":3.98016403311125,"d":"3.98"},{"v":3.26153590268524,"d":"3.26"},{"v":3.93314175206945,"d":"3.93"},{"v":4.05592194346861,"d":"4.06"},{"v":3.22943697274379,"d":"3.23"},{"v":3.57947521259843,"d":"3.58"},{"v":1.02853311476086,"d":"1.03"},{"v":0.0405882437726124,"d":"0.04"},{"v":0.693417712316618,"d":"0.69"},{"v":0.952283580298004,"d":"0.95"},"up","no"]
["MSTRG.3596","SRP68","ENSOART00000008969","GO:0003723(RNA binding);GO:0005047(signal recognition particle binding);GO:0005737(cytoplasm);GO:0005786(signal recognition particle, endoplasmic reticulum targeting);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0008312(7S RNA binding);GO:0019904(protein domain specific binding);GO:0030942(endoplasmic reticulum signal peptide binding);GO:0042493(response to drug);GO:0043022(ribosome binding);GO:0048500(signal recognition particle)","03060(Protein export)","K03107","NA","signal recognition particle 68 [Source:NCBI gene;Acc:101106535]",{"v":15.402415,"d":"15.40"},{"v":18.847868,"d":"18.85"},{"v":17.125362,"d":"17.13"},{"v":17.742962,"d":"17.74"},{"v":15.677431,"d":"15.68"},{"v":16.720558,"d":"16.72"},{"v":1.0246244631459,"d":"1.02"},{"v":0.0350952419938922,"d":"0.04"},{"v":0.693681216153469,"d":"0.69"},{"v":0.952370080412424,"d":"0.95"},"up","no"]
["MSTRG.3082","USP22","ENSOART00000002563","GO:0000124(SAGA complex);GO:0003713(transcription coactivator activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0008270(zinc ion binding);GO:0010485(H4 histone acetyltransferase activity);GO:0016574(histone ubiquitination);GO:0016578(histone deubiquitination);GO:0016579(protein deubiquitination);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0019899(enzyme binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0043967(histone H4 acetylation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045931(positive regulation of mitotic cell cycle);GO:0046872(metal ion binding);GO:0070461(SAGA-type complex)","NA","K11366","EC:3.4.19.12","ubiquitin specific peptidase 22 [Source:NCBI gene;Acc:101114202]",{"v":5.94045384313025,"d":"5.94"},{"v":6.50336443782383,"d":"6.50"},{"v":5.53413555243881,"d":"5.53"},{"v":8.79973866821512,"d":"8.80"},{"v":6.13163944130784,"d":"6.13"},{"v":6.11419134125424,"d":"6.11"},{"v":0.854239362609833,"d":"0.85"},{"v":-0.227287717237902,"d":"-0.23"},{"v":0.694371940979582,"d":"0.69"},{"v":0.952373373583912,"d":"0.95"},"down","no"]
["MSTRG.7759","CORO1C","ENSOART00000019511","GO:0001755(neural crest cell migration);GO:0001932(regulation of protein phosphorylation);GO:0001933(negative regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0010008(endosome membrane);GO:0010632(regulation of epithelial cell migration);GO:0010633(negative regulation of epithelial cell migration);GO:0010762(regulation of fibroblast migration);GO:0015629(actin cytoskeleton);GO:0016197(endosomal transport);GO:0016328(lateral plasma membrane);GO:0016600(flotillin complex);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0031982(vesicle);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045184(establishment of protein localization);GO:0048365(Rac GTPase binding);GO:0051015(actin filament binding);GO:0051893(regulation of focal adhesion assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0090148(membrane fission);GO:0090630(activation of GTPase activity);GO:0097750(endosome membrane tubulation);GO:0140285(endosome fission);GO:1900024(regulation of substrate adhesion-dependent cell spreading);GO:1900025(negative regulation of substrate adhesion-dependent cell spreading);GO:1900027(regulation of ruffle assembly);GO:2000394(positive regulation of lamellipodium morphogenesis)","NA","K13886","NA","coronin 1C [Source:NCBI gene;Acc:101102337]",{"v":5.29520103361956,"d":"5.30"},{"v":3.95241895415514,"d":"3.95"},{"v":4.97869971488866,"d":"4.98"},{"v":5.63495646252365,"d":"5.63"},{"v":5.3775948615922,"d":"5.38"},{"v":2.8582324241013,"d":"2.86"},{"v":1.02563200183205,"d":"1.03"},{"v":0.0365131828299216,"d":"0.04"},{"v":0.695754370995341,"d":"0.70"},{"v":0.953004456257715,"d":"0.95"},"up","no"]
["ENSOARG00000014574","DMTF1","ENSOART00000015871","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA","K21625","NA","cyclin D binding myb like transcription factor 1 [Source:NCBI gene;Acc:101111877]",{"v":2.339278,"d":"2.34"},{"v":1.703221,"d":"1.70"},{"v":1.712194,"d":"1.71"},{"v":2.072349,"d":"2.07"},{"v":1.956194,"d":"1.96"},{"v":1.522559,"d":"1.52"},{"v":1.0366757807729,"d":"1.04"},{"v":0.0519647633820491,"d":"0.05"},{"v":0.696711965849609,"d":"0.70"},{"v":0.953004456257715,"d":"0.95"},"up","no"]
["MSTRG.20381","ASF1A","ENSOART00000009342","GO:0000790(nuclear chromatin);GO:0001649(osteoblast differentiation);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006333(chromatin assembly or disassembly);GO:0006334(nucleosome assembly);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0006336(DNA replication-independent nucleosome assembly);GO:0032991(protein-containing complex);GO:0042393(histone binding);GO:0042692(muscle cell differentiation)","NA","K10753","NA","anti-silencing function 1A histone chaperone [Source:NCBI gene;Acc:100307033]",{"v":2.690285,"d":"2.69"},{"v":2.668188,"d":"2.67"},{"v":2.201986,"d":"2.20"},{"v":3.096227,"d":"3.10"},{"v":2.19063,"d":"2.19"},{"v":1.920614,"d":"1.92"},{"v":1.04897529244308,"d":"1.05"},{"v":0.0689806970861645,"d":"0.07"},{"v":0.697282826955003,"d":"0.70"},{"v":0.953004456257715,"d":"0.95"},"up","no"]
["MSTRG.8224","HMG20A","ENSOART00000001901;ENSOART00000001900","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0033234(negative regulation of protein sumoylation);GO:0042802(identical protein binding);GO:0045665(negative regulation of neuron differentiation);GO:0046982(protein heterodimerization activity);GO:0046982(protein heterodimerization activity)","NA","NA","NA","high mobility group 20A [Source:NCBI gene;Acc:101104609]",{"v":5.20887250626148,"d":"5.21"},{"v":4.93055759392219,"d":"4.93"},{"v":4.89778678243446,"d":"4.90"},{"v":5.45041922441142,"d":"5.45"},{"v":4.75862566371682,"d":"4.76"},{"v":4.49513265252964,"d":"4.50"},{"v":1.02264930092413,"d":"1.02"},{"v":0.0323114837331026,"d":"0.03"},{"v":0.698648606867294,"d":"0.70"},{"v":0.953127838851438,"d":"0.95"},"up","no"]
["MSTRG.844","ENSOARG00000001610","ENSOART00000001735","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0032793(positive regulation of CREB transcription factor activity)","04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);05166(Human T-cell leukemia virus 1 infection)","K16333","NA","CREB regulated transcription coactivator 2 [Source:NCBI gene;Acc:101102117]",{"v":3.28780783672777,"d":"3.29"},{"v":2.86064679395791,"d":"2.86"},{"v":2.91842444059742,"d":"2.92"},{"v":2.94985125492193,"d":"2.95"},{"v":3.59674740088255,"d":"3.60"},{"v":3.86632000169722,"d":"3.87"},{"v":0.870733688556293,"d":"0.87"},{"v":-0.199696552811064,"d":"-0.20"},{"v":0.699383498875124,"d":"0.70"},{"v":0.953221599689823,"d":"0.95"},"down","no"]
["MSTRG.17648","FAM32A","ENSOART00000000318","GO:0005634(nucleus);GO:0005730(nucleolus)","NA","K13120","NA","family with sequence similarity 32 member A [Source:NCBI gene;Acc:101116725]",{"v":8.932275,"d":"8.93"},{"v":7.012465,"d":"7.01"},{"v":7.006654,"d":"7.01"},{"v":6.9719,"d":"6.97"},{"v":6.466736,"d":"6.47"},{"v":8.318913,"d":"8.32"},{"v":1.05487038085034,"d":"1.05"},{"v":0.0770657360007215,"d":"0.08"},{"v":0.699581985641103,"d":"0.70"},{"v":0.953407450258571,"d":"0.95"},"up","no"]
["MSTRG.3216","PSMD3","ENSOART00000013607","GO:0000502(proteasome complex);GO:0005838(proteasome regulatory particle);GO:0022624(proteasome accessory complex);GO:0030234(enzyme regulator activity);GO:0042176(regulation of protein catabolic process);GO:0050790(regulation of catalytic activity)","03050(Proteasome);05169(Epstein-Barr virus infection)","K03033","NA","proteasome 26S subunit, non-ATPase 3 [Source:NCBI gene;Acc:101105833]",{"v":28.074667,"d":"28.07"},{"v":26.8906,"d":"26.89"},{"v":26.981684,"d":"26.98"},{"v":29.166058,"d":"29.17"},{"v":31.855902,"d":"31.86"},{"v":33.247711,"d":"33.25"},{"v":0.869282242429805,"d":"0.87"},{"v":-0.202103421135878,"d":"-0.20"},{"v":0.701170899198723,"d":"0.70"},{"v":0.954226960772451,"d":"0.95"},"down","no"]
["MSTRG.17401","ZNF212","ENSOART00000000221","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0042802(identical protein binding);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger protein 212 [Source:HGNC Symbol;Acc:HGNC:13004]",{"v":0.913252314535732,"d":"0.91"},{"v":0.699744481769567,"d":"0.70"},{"v":1.38983147982499,"d":"1.39"},{"v":1.12667292999514,"d":"1.13"},{"v":1.02993357997083,"d":"1.03"},{"v":1.38535251239669,"d":"1.39"},{"v":0.847787412889733,"d":"0.85"},{"v":-0.238225548046567,"d":"-0.24"},{"v":0.702989050485344,"d":"0.70"},{"v":0.954973580145595,"d":"0.95"},"down","no"]
["MSTRG.4802","ENSOARG00000007425","ENSOART00000008084","GO:0016020(membrane);GO:0016021(integral component of membrane)","04380(Osteoclast differentiation)","K06551","NA","signal regulatory protein alpha [Source:NCBI gene;Acc:101105677]",{"v":1.970489,"d":"1.97"},{"v":1.69805,"d":"1.70"},{"v":2.288369,"d":"2.29"},{"v":1.890817,"d":"1.89"},{"v":2.395505,"d":"2.40"},{"v":2.59725,"d":"2.60"},{"v":0.865380357756119,"d":"0.87"},{"v":-0.208593719782099,"d":"-0.21"},{"v":0.703356280243778,"d":"0.70"},{"v":0.954973580145595,"d":"0.95"},"down","no"]
["MSTRG.15357","STRN","ENSOART00000010958","GO:0005515(protein binding);GO:0005923(bicellular tight junction);GO:0008285(negative regulation of cell population proliferation);GO:0016055(Wnt signaling pathway);GO:0030331(estrogen receptor binding);GO:0044877(protein-containing complex binding);GO:0051721(protein phosphatase 2A binding);GO:0070016(armadillo repeat domain binding);GO:0090443(FAR/SIN/STRIPAK complex)","NA","K17608","NA","striatin [Source:NCBI gene;Acc:101122771]",{"v":3.11906637572143,"d":"3.12"},{"v":2.10764025779146,"d":"2.11"},{"v":2.44431510869565,"d":"2.44"},{"v":2.78495106233167,"d":"2.78"},{"v":2.43932718449404,"d":"2.44"},{"v":2.24471619796075,"d":"2.24"},{"v":1.02704879470932,"d":"1.03"},{"v":0.0385047251934884,"d":"0.04"},{"v":0.704251740973434,"d":"0.70"},{"v":0.954973580145595,"d":"0.95"},"up","no"]
["MSTRG.11366","PBX2","ENSOART00000000142","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0008134(transcription factor binding);GO:0009954(proximal/distal pattern formation);GO:0030326(embryonic limb morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K15609","NA","PBX homeobox 2 [Source:NCBI gene;Acc:101122392]",{"v":10.414862,"d":"10.41"},{"v":8.424991,"d":"8.42"},{"v":7.987843,"d":"7.99"},{"v":8.89928,"d":"8.90"},{"v":11.17522,"d":"11.18"},{"v":10.617202,"d":"10.62"},{"v":0.874102583167268,"d":"0.87"},{"v":-0.194125493030979,"d":"-0.19"},{"v":0.705362977292125,"d":"0.71"},{"v":0.954973580145595,"d":"0.95"},"down","no"]
["MSTRG.16108","POLR3B","ENSOART00000019009","GO:0003677(DNA binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005666(RNA polymerase III complex);GO:0006351(transcription, DNA-templated);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0032549(ribonucleoside binding);GO:0032728(positive regulation of interferon-beta production);GO:0045089(positive regulation of innate immune response)","03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway)","K03021","EC:2.7.7.6","RNA polymerase III subunit B [Source:NCBI gene;Acc:101115446]",{"v":5.22435868451121,"d":"5.22"},{"v":4.53056684024545,"d":"4.53"},{"v":3.8262530325857,"d":"3.83"},{"v":5.2045757824799,"d":"5.20"},{"v":4.07353972429116,"d":"4.07"},{"v":4.01086615911976,"d":"4.01"},{"v":1.02198790688391,"d":"1.02"},{"v":0.0313781250604269,"d":"0.03"},{"v":0.706185032988659,"d":"0.71"},{"v":0.954973580145595,"d":"0.95"},"up","no"]
["MSTRG.8776","EXOG","ENSOART00000001556","GO:0003676(nucleic acid binding);GO:0004519(endonuclease activity);GO:0005743(mitochondrial inner membrane);GO:0008409(5'-3' exonuclease activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0032991(protein-containing complex);GO:0046872(metal ion binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","NA","K15050","NA","exo/endonuclease G [Source:NCBI gene;Acc:101111131]",{"v":2.301348,"d":"2.30"},{"v":2.12635,"d":"2.13"},{"v":1.709182,"d":"1.71"},{"v":1.916088,"d":"1.92"},{"v":2.29162,"d":"2.29"},{"v":1.669765,"d":"1.67"},{"v":1.04413580462216,"d":"1.04"},{"v":0.0623093669968558,"d":"0.06"},{"v":0.706941914957944,"d":"0.71"},{"v":0.954973580145595,"d":"0.95"},"up","no"]
["MSTRG.7766","HPS4","ENSOART00000000903","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0006605(protein targeting);GO:0006996(organelle organization);GO:0007040(lysosome organization);GO:0007596(blood coagulation);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0030318(melanocyte differentiation);GO:0031085(BLOC-3 complex);GO:0031410(cytoplasmic vesicle);GO:0042470(melanosome);GO:0042803(protein homodimerization activity);GO:0042827(platelet dense granule);GO:0046983(protein dimerization activity);GO:0050821(protein stabilization);GO:1903232(melanosome assembly)","NA","K20194","NA","HPS4, biogenesis of lysosomal organelles complex 3 subunit 2 [Source:NCBI gene;Acc:101118387]",{"v":0.875361,"d":"0.88"},{"v":1.115885,"d":"1.12"},{"v":0.716434,"d":"0.72"},{"v":0.734986,"d":"0.73"},{"v":0.931123,"d":"0.93"},{"v":0.904419,"d":"0.90"},{"v":1.053355575197,"d":"1.05"},{"v":0.0749925208656881,"d":"0.07"},{"v":0.707889083673216,"d":"0.71"},{"v":0.955125859581976,"d":"0.96"},"up","no"]
["MSTRG.11199","SRPK1","ENSOART00000013602","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007059(chromosome segregation);GO:0035556(intracellular signal transduction);GO:0045070(positive regulation of viral genome replication);GO:0045071(negative regulation of viral genome replication);GO:0050684(regulation of mRNA processing)","05168(Herpes simplex virus 1 infection)","K15409","EC:2.7.11.1","SRSF protein kinase 1 [Source:NCBI gene;Acc:101119590]",{"v":3.32499168552036,"d":"3.32"},{"v":2.81898222624434,"d":"2.82"},{"v":2.8604232239819,"d":"2.86"},{"v":3.40169283936652,"d":"3.40"},{"v":3.00906950678733,"d":"3.01"},{"v":2.40946925565611,"d":"2.41"},{"v":1.02087989774541,"d":"1.02"},{"v":0.0298131491549944,"d":"0.03"},{"v":0.707950087101854,"d":"0.71"},{"v":0.955125859581976,"d":"0.96"},"up","no"]
["MSTRG.15523","STARD7","ENSOART00000015239","GO:0008289(lipid binding)","NA","NA","NA","StAR related lipid transfer domain containing 7 [Source:NCBI gene;Acc:101115449]",{"v":9.76827497420464,"d":"9.77"},{"v":9.87548454686156,"d":"9.88"},{"v":8.15045821840069,"d":"8.15"},{"v":10.3736512123818,"d":"10.37"},{"v":7.82794103955288,"d":"7.83"},{"v":9.00080086156492,"d":"9.00"},{"v":1.02175634413847,"d":"1.02"},{"v":0.0310512011551918,"d":"0.03"},{"v":0.70894412063597,"d":"0.71"},{"v":0.95555756524152,"d":"0.96"},"up","no"]
["MSTRG.21177","TPD52","ENSOART00000009024;ENSOART00000009025","GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0030183(B cell differentiation);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0048471(perinuclear region of cytoplasm)","NA","NA","NA","tumor protein D52 [Source:NCBI gene;Acc:101112068]",{"v":10.4117978789474,"d":"10.41"},{"v":9.21762763552632,"d":"9.22"},{"v":10.773077,"d":"10.77"},{"v":12.670343,"d":"12.67"},{"v":11.3013083039474,"d":"11.30"},{"v":11.091602,"d":"11.09"},{"v":0.867075917084141,"d":"0.87"},{"v":-0.205769780326165,"d":"-0.21"},{"v":0.710183557693409,"d":"0.71"},{"v":0.95555756524152,"d":"0.96"},"down","no"]
["MSTRG.19915","MYEF2","ENSOART00000022909","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0006357(regulation of transcription by RNA polymerase II)","NA","NA","NA","myelin expression factor 2 [Source:NCBI gene;Acc:101109884]",{"v":1.706928,"d":"1.71"},{"v":1.003402,"d":"1.00"},{"v":1.155407,"d":"1.16"},{"v":1.979488,"d":"1.98"},{"v":1.508198,"d":"1.51"},{"v":1.041287,"d":"1.04"},{"v":0.853557086783251,"d":"0.85"},{"v":-0.228440449466905,"d":"-0.23"},{"v":0.71049802935976,"d":"0.71"},{"v":0.95555756524152,"d":"0.96"},"down","no"]
["MSTRG.5213","ENSOARG00000010936","ENSOART00000011892","GO:0005739(mitochondrion);GO:0009055(electron transfer activity);GO:0020037(heme binding);GO:0022900(electron transport chain);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0070469(respirasome)","NA","NA","NA",null,{"v":0.12204,"d":"0.12"},{"v":13.383703,"d":"13.38"},{"v":8.499371,"d":"8.50"},{"v":14.510979,"d":"14.51"},{"v":0.361488,"d":"0.36"},{"v":4.159265,"d":"4.16"},{"v":1.156232864145,"d":"1.16"},{"v":0.209431984443024,"d":"0.21"},{"v":0.711470496350444,"d":"0.71"},{"v":0.9561114950857,"d":"0.96"},"up","no"]
["MSTRG.6247","PPP2R1B","ENSOART00000015920","GO:0005515(protein binding);GO:0045121(membrane raft);GO:0060561(apoptotic process involved in morphogenesis);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04114(Oocyte meiosis);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04530(Tight junction);04728(Dopaminergic synapse);04730(Long-term depression);05142(Chagas disease (American trypanosomiasis));05160(Hepatitis C);05165(Human papillomavirus infection)","K03456","NA","protein phosphatase 2 scaffold subunit Abeta [Source:NCBI gene;Acc:101108511]",{"v":2.45868992292555,"d":"2.46"},{"v":1.57609228140374,"d":"1.58"},{"v":2.86596477402427,"d":"2.87"},{"v":3.0645235611676,"d":"3.06"},{"v":2.78182958904559,"d":"2.78"},{"v":2.17109737389308,"d":"2.17"},{"v":0.860715879393943,"d":"0.86"},{"v":-0.216391009455043,"d":"-0.22"},{"v":0.712106313800662,"d":"0.71"},{"v":0.9561114950857,"d":"0.96"},"down","no"]
["MSTRG.10317","MARCH7","ENSOART00000007857;ENSOART00000007854","GO:0002643(regulation of tolerance induction);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell population proliferation);GO:0019899(enzyme binding);GO:0031624(ubiquitin conjugating enzyme binding);GO:0042130(negative regulation of T cell proliferation);GO:0043130(ubiquitin binding);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0046872(metal ion binding);GO:0050821(protein stabilization);GO:0051865(protein autoubiquitination);GO:0097371(MDM2/MDM4 family protein binding);GO:1901799(negative regulation of proteasomal protein catabolic process);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1902916(positive regulation of protein polyubiquitination);GO:1905524(negative regulation of protein autoubiquitination);GO:1905524(negative regulation of protein autoubiquitination)","NA","K10662","EC:2.3.2.27","membrane associated ring-CH-type finger 7 [Source:NCBI gene;Acc:101110480]",{"v":2.15873817285141,"d":"2.16"},{"v":2.04029247641232,"d":"2.04"},{"v":2.32276747303882,"d":"2.32"},{"v":2.50634956165997,"d":"2.51"},{"v":2.13233945568942,"d":"2.13"},{"v":1.78810609617135,"d":"1.79"},{"v":1.0147823304001,"d":"1.01"},{"v":0.0211703042286359,"d":"0.02"},{"v":0.713295098779153,"d":"0.71"},{"v":0.956816883589886,"d":"0.96"},"up","no"]
["MSTRG.13920","ACTN2","ENSOART00000004036","GO:0003779(actin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006936(muscle contraction);GO:0008092(cytoskeletal protein binding);GO:0019904(protein domain specific binding);GO:0030017(sarcomere);GO:0030018(Z disc);GO:0030035(microspike assembly);GO:0030175(filopodium);GO:0030274(LIM domain binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0030375(thyroid hormone receptor coactivator activity);GO:0031432(titin binding);GO:0042391(regulation of membrane potential);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043267(negative regulation of potassium ion transport);GO:0043268(positive regulation of potassium ion transport);GO:0044325(ion channel binding);GO:0045214(sarcomere organization);GO:0046983(protein dimerization activity);GO:0048041(focal adhesion assembly);GO:0051015(actin filament binding);GO:0051289(protein homotetramerization);GO:0051373(FATZ binding);GO:0051695(actin filament uncapping);GO:0055013(cardiac muscle cell development);GO:0070080(titin Z domain binding);GO:0072659(protein localization to plasma membrane);GO:0086097(phospholipase C-activating angiotensin-activated signaling pathway);GO:1901017(negative regulation of potassium ion transmembrane transporter activity);GO:1901018(positive regulation of potassium ion transmembrane transporter activity);GO:1903508(positive regulation of nucleic acid-templated transcription);GO:2000009(negative regulation of protein localization to cell surface);GO:2001137(positive regulation of endocytic recycling);GO:2001259(positive regulation of cation channel activity)","05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC))","K21073","NA","actinin alpha 2 [Source:NCBI gene;Acc:101116372]",{"v":63.5058484023614,"d":"63.51"},{"v":64.550003092,"d":"64.55"},{"v":76.633229382747,"d":"76.63"},{"v":63.0122209639036,"d":"63.01"},{"v":69.9834967307711,"d":"69.98"},{"v":67.0736950414699,"d":"67.07"},{"v":1.02309032689098,"d":"1.02"},{"v":0.0329335237781574,"d":"0.03"},{"v":0.714181604960885,"d":"0.71"},{"v":0.956816883589886,"d":"0.96"},"up","no"]
["MSTRG.2774","SLC6A4","ENSOART00000011004","GO:0005328(neurotransmitter:sodium symporter activity);GO:0005335(serotonin:sodium symporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006836(neurotransmitter transport);GO:0006837(serotonin transport);GO:0008504(monoamine transmembrane transporter activity);GO:0009636(response to toxic substance);GO:0010628(positive regulation of gene expression);GO:0012505(endomembrane system);GO:0015293(symporter activity);GO:0015844(monoamine transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017137(Rab GTPase binding);GO:0035176(social behavior);GO:0045121(membrane raft);GO:0045787(positive regulation of cell cycle);GO:0046621(negative regulation of organ growth);GO:0048854(brain morphogenesis);GO:0050998(nitric-oxide synthase binding);GO:0051610(serotonin uptake);GO:0055085(transmembrane transport);GO:0071310(cellular response to organic substance);GO:0090067(regulation of thalamus size);GO:0098793(presynapse)","04721(Synaptic vesicle cycle);04726(Serotonergic synapse)","K05037","NA","solute carrier family 6 member 4 [Source:NCBI gene;Acc:443491]",{"v":0.641877,"d":"0.64"},{"v":0.408047,"d":"0.41"},{"v":0.465016,"d":"0.47"},{"v":0.656755,"d":"0.66"},{"v":0.325642,"d":"0.33"},{"v":0.445097,"d":"0.45"},{"v":1.0612584010861,"d":"1.06"},{"v":0.0857759744212166,"d":"0.09"},{"v":0.714399182738474,"d":"0.71"},{"v":0.956816883589886,"d":"0.96"},"up","no"]
["MSTRG.14090","SEC24C","ENSOART00000008719;ENSOART00000008722","GO:0000139(Golgi membrane);GO:0000149(SNARE binding);GO:0001701(in utero embryonic development);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0008270(zinc ion binding);GO:0015031(protein transport);GO:0030127(COPII vesicle coat);GO:0090110(COPII-coated vesicle cargo loading);GO:0090110(COPII-coated vesicle cargo loading)","04141(Protein processing in endoplasmic reticulum);04141(Protein processing in endoplasmic reticulum)","K14007","NA","SEC24 homolog C, COPII coat complex component [Source:NCBI gene;Acc:101119874]",{"v":11.0960586060731,"d":"11.10"},{"v":10.9252756874613,"d":"10.93"},{"v":11.8985639256352,"d":"11.90"},{"v":12.6374237919851,"d":"12.64"},{"v":10.6995416155753,"d":"10.70"},{"v":10.0354390609378,"d":"10.04"},{"v":1.01640558297764,"d":"1.02"},{"v":0.0234762050533319,"d":"0.02"},{"v":0.715124533999441,"d":"0.72"},{"v":0.956816883589886,"d":"0.96"},"up","no"]
["MSTRG.3941","SUCO","ENSOART00000015503","GO:0005791(rough endoplasmic reticulum);GO:0016020(membrane);GO:0032967(positive regulation of collagen biosynthetic process);GO:0045669(positive regulation of osteoblast differentiation);GO:0046850(regulation of bone remodeling)","NA","NA","NA","SUN domain containing ossification factor [Source:NCBI gene;Acc:101108241]",{"v":2.56919457383079,"d":"2.57"},{"v":2.11570518838676,"d":"2.12"},{"v":1.5384606904887,"d":"1.54"},{"v":2.4281945170783,"d":"2.43"},{"v":1.800603547031,"d":"1.80"},{"v":1.82533700604309,"d":"1.83"},{"v":1.02795203288215,"d":"1.03"},{"v":0.0397729459154443,"d":"0.04"},{"v":0.716420483407873,"d":"0.72"},{"v":0.956816883589886,"d":"0.96"},"up","no"]
["MSTRG.19195","ENSOARG00000013502","ENSOART00000014682","GO:0019901(protein kinase binding);GO:0061098(positive regulation of protein tyrosine kinase activity)","NA","NA","NA","docking protein 7 [Source:NCBI gene;Acc:101121682]",{"v":2.27599580679785,"d":"2.28"},{"v":1.65735537745975,"d":"1.66"},{"v":1.89814147406082,"d":"1.90"},{"v":2.21711342039356,"d":"2.22"},{"v":2.18082807334526,"d":"2.18"},{"v":1.11932653846154,"d":"1.12"},{"v":1.05695293835358,"d":"1.06"},{"v":0.0799111410390042,"d":"0.08"},{"v":0.716552979518147,"d":"0.72"},{"v":0.956816883589886,"d":"0.96"},"up","no"]
["MSTRG.14584","NACC2","ENSOART00000005192","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0003714(transcription corepressor activity);GO:0004407(histone deacetylase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0008285(negative regulation of cell population proliferation);GO:0016575(histone deacetylation);GO:0034629(cellular protein-containing complex localization);GO:0042803(protein homodimerization activity);GO:0042826(histone deacetylase binding);GO:0044877(protein-containing complex binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0051260(protein homooligomerization);GO:1900477(negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter);GO:1902231(positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","NA","NA","NA","NACC family member 2 [Source:HGNC Symbol;Acc:HGNC:23846]",{"v":2.118284,"d":"2.12"},{"v":1.383713,"d":"1.38"},{"v":1.541397,"d":"1.54"},{"v":1.549976,"d":"1.55"},{"v":1.686083,"d":"1.69"},{"v":1.61294,"d":"1.61"},{"v":1.04008971748602,"d":"1.04"},{"v":0.0567079797024384,"d":"0.06"},{"v":0.717546728879105,"d":"0.72"},{"v":0.956956735155619,"d":"0.96"},"up","no"]
["MSTRG.231","UROD","ENSOART00000001578","GO:0004853(uroporphyrinogen decarboxylase activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006779(porphyrin-containing compound biosynthetic process);GO:0006782(protoporphyrinogen IX biosynthetic process);GO:0006783(heme biosynthetic process);GO:0016829(lyase activity);GO:0016831(carboxy-lyase activity);GO:0042168(heme metabolic process)","00860(Porphyrin and chlorophyll metabolism)","K01599","EC:4.1.1.37","uroporphyrinogen decarboxylase [Source:NCBI gene;Acc:497117]",{"v":10.444301,"d":"10.44"},{"v":9.69402,"d":"9.69"},{"v":9.433938,"d":"9.43"},{"v":13.039705,"d":"13.04"},{"v":9.184338,"d":"9.18"},{"v":11.801373,"d":"11.80"},{"v":0.869122628801952,"d":"0.87"},{"v":-0.202368346521006,"d":"-0.20"},{"v":0.718353684833874,"d":"0.72"},{"v":0.957027484150268,"d":"0.96"},"down","no"]
["MSTRG.8131","FURIN","ENSOART00000013894","GO:0000139(Golgi membrane);GO:0002020(protease binding);GO:0004175(endopeptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005783(endoplasmic reticulum);GO:0005802(trans-Golgi network);GO:0006465(signal peptide processing);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0009966(regulation of signal transduction);GO:0009986(cell surface);GO:0010951(negative regulation of endopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016485(protein processing);GO:0016486(peptide hormone processing);GO:0016787(hydrolase activity);GO:0019058(viral life cycle);GO:0030140(trans-Golgi network transport vesicle);GO:0031638(zymogen activation);GO:0032804(negative regulation of low-density lipoprotein particle receptor catabolic process);GO:0032902(nerve growth factor production);GO:0032911(negative regulation of transforming growth factor beta1 production);GO:0032940(secretion by cell);GO:0042176(regulation of protein catabolic process);GO:0042277(peptide binding);GO:0043043(peptide biosynthetic process);GO:0045121(membrane raft);GO:0045714(regulation of low-density lipoprotein particle receptor biosynthetic process);GO:0048406(nerve growth factor binding);GO:0052548(regulation of endopeptidase activity);GO:0090472(dibasic protein processing);GO:1901394(positive regulation of transforming growth factor beta1 activation)","05164(Influenza A)","K01349","EC:3.4.21.75","furin, paired basic amino acid cleaving enzyme [Source:NCBI gene;Acc:780454]",{"v":6.29076684789392,"d":"6.29"},{"v":5.63506739723089,"d":"5.64"},{"v":5.93963321957878,"d":"5.94"},{"v":5.64312488787052,"d":"5.64"},{"v":6.70822931981279,"d":"6.71"},{"v":5.12444181298752,"d":"5.12"},{"v":1.02229777937279,"d":"1.02"},{"v":0.031815492018917,"d":"0.03"},{"v":0.719177249316927,"d":"0.72"},{"v":0.957290429331937,"d":"0.96"},"up","no"]
["MSTRG.16536","ENSOARG00000016513","ENSOART00000017982","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":2.815261,"d":"2.82"},{"v":2.973371,"d":"2.97"},{"v":2.055962,"d":"2.06"},{"v":1.945868,"d":"1.95"},{"v":2.852051,"d":"2.85"},{"v":2.550923,"d":"2.55"},{"v":1.06745988007362,"d":"1.07"},{"v":0.0941818479192812,"d":"0.09"},{"v":0.719942267091404,"d":"0.72"},{"v":0.957317055040528,"d":"0.96"},"up","no"]
["MSTRG.7382","TBC1D9","ENSOART00000013459","GO:0005509(calcium ion binding)","NA","K19951","NA","TBC1 domain family member 9 [Source:NCBI gene;Acc:101104859]",{"v":2.12962958847403,"d":"2.13"},{"v":1.40253046536797,"d":"1.40"},{"v":2.0408978538961,"d":"2.04"},{"v":2.34873432575758,"d":"2.35"},{"v":2.02880461038961,"d":"2.03"},{"v":2.05106741098485,"d":"2.05"},{"v":0.866915410091081,"d":"0.87"},{"v":-0.206036866602719,"d":"-0.21"},{"v":0.720700243532092,"d":"0.72"},{"v":0.957317055040528,"d":"0.96"},"down","no"]
["MSTRG.7674","C12orf49","ENSOART00000006101","NA","NA","NA","NA","chromosome 17 open reading frame, human C12orf49 [Source:NCBI gene;Acc:101110621]",{"v":8.54029275202355,"d":"8.54"},{"v":8.22462276747608,"d":"8.22"},{"v":6.50016034878587,"d":"6.50"},{"v":8.20186099116998,"d":"8.20"},{"v":7.99942403384842,"d":"8.00"},{"v":10.3752365423105,"d":"10.38"},{"v":0.87539958189584,"d":"0.88"},{"v":-0.19198639996334,"d":"-0.19"},{"v":0.721737190691211,"d":"0.72"},{"v":0.957317055040528,"d":"0.96"},"down","no"]
["MSTRG.5459","CBFB","ENSOART00000002893","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000209(protein polyubiquitination);GO:0001503(ossification);GO:0001649(osteoblast differentiation);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0030098(lymphocyte differentiation);GO:0030099(myeloid cell differentiation);GO:0043371(negative regulation of CD4-positive, alpha-beta T cell differentiation);GO:0043378(positive regulation of CD8-positive, alpha-beta T cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048469(cell maturation);GO:0060216(definitive hemopoiesis)","NA","NA","NA","core-binding factor subunit beta [Source:NCBI gene;Acc:101106455]",{"v":2.82423491233176,"d":"2.82"},{"v":1.93623276427792,"d":"1.94"},{"v":2.07399899890869,"d":"2.07"},{"v":2.27490738450346,"d":"2.27"},{"v":2.88616830083667,"d":"2.89"},{"v":2.61564740960349,"d":"2.62"},{"v":0.878836316026489,"d":"0.88"},{"v":-0.186333607615029,"d":"-0.19"},{"v":0.722258746908972,"d":"0.72"},{"v":0.957317055040528,"d":"0.96"},"down","no"]
["MSTRG.3010","ENSOARG00000011486;ENSOARG00000006444;ENSOARG00000012656;MYH8;MYH4","ENSOART00000012521;ENSOART00000007008;ENSOART00000013790;ENSOART00000007963;ENSOART00000010516","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0016459(myosin complex);GO:0051015(actin filament binding);GO:0001778(plasma membrane repair);GO:0005794(Golgi apparatus);GO:0005826(actomyosin contractile ring);GO:0005911(cell-cell junction);GO:0014823(response to activity);GO:0030016(myofibril);GO:0031672(A band);GO:0070252(actin-mediated cell contraction);GO:0000146(microfilament motor activity);GO:0003009(skeletal muscle contraction);GO:0005737(cytoplasm);GO:0016887(ATPase activity);GO:0030049(muscle filament sliding);GO:0046034(ATP metabolic process);GO:0003725(double-stranded RNA binding);GO:0006936(muscle contraction);GO:0051015(actin filament binding)","04530(Tight junction);04530(Tight junction)","K10352","NA","myosin heavy chain 1 [Source:NCBI gene;Acc:442994];myosin-13 [Source:NCBI gene;Acc:101103165];myosin heavy chain 2 [Source:NCBI gene;Acc:443471];myosin-8 [Source:NCBI gene;Acc:101111723];myosin-4 [Source:NCBI gene;Acc:101111980]",{"v":595.252420679845,"d":"595.25"},{"v":696.817370790629,"d":"696.82"},{"v":619.977992938202,"d":"619.98"},{"v":583.262801029606,"d":"583.26"},{"v":654.574943007733,"d":"654.57"},{"v":637.02032568886,"d":"637.02"},{"v":1.01983601600729,"d":"1.02"},{"v":0.0283371934591784,"d":"0.03"},{"v":0.72284084890773,"d":"0.72"},{"v":0.957317055040528,"d":"0.96"},"up","no"]
["MSTRG.16246","ITPR2","ENSOART00000021679","GO:0001666(response to hypoxia);GO:0005216(ion channel activity);GO:0005220(inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity);GO:0005262(calcium channel activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0015278(calcium-release channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0033017(sarcoplasmic reticulum membrane);GO:0035091(phosphatidylinositol binding);GO:0043235(receptor complex);GO:0048016(inositol phosphate-mediated signaling);GO:0051209(release of sequestered calcium ion into cytosol);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding);GO:0071320(cellular response to cAMP);GO:0071361(cellular response to ethanol);GO:0097110(scaffold protein binding)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04070(Phosphatidylinositol signaling system);04114(Oocyte meiosis);04210(Apoptosis);04218(Cellular senescence);04270(Vascular smooth muscle contraction);04371(Apelin signaling pathway);04540(Gap junction);04611(Platelet activation);04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);04750(Inflammatory mediator regulation of TRP channels);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04918(Thyroid hormone synthesis);04921(Oxytocin signaling pathway);04922(Glucagon signaling pathway);04924(Renin secretion);04925(Aldosterone synthesis and secretion);04927(Cortisol synthesis and secretion);04928(Parathyroid hormone synthesis, secretion and action);04934(Cushing syndrome);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);05010(Alzheimer disease);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05205(Proteoglycans in cancer)","K04959","NA","inositol 1,4,5-trisphosphate receptor type 2 [Source:NCBI gene;Acc:101113317]",{"v":6.68844,"d":"6.69"},{"v":5.102025,"d":"5.10"},{"v":5.10014,"d":"5.10"},{"v":6.075327,"d":"6.08"},{"v":6.190882,"d":"6.19"},{"v":4.294854,"d":"4.29"},{"v":1.01989860191945,"d":"1.02"},{"v":0.0284257269226498,"d":"0.03"},{"v":0.723558605127159,"d":"0.72"},{"v":0.957317055040528,"d":"0.96"},"up","no"]
["MSTRG.14078","FAM149B1","ENSOART00000008146","NA","NA","NA","NA","family with sequence similarity 149 member B1 [Source:NCBI gene;Acc:101117643]",{"v":2.37804,"d":"2.38"},{"v":2.414939,"d":"2.41"},{"v":1.898795,"d":"1.90"},{"v":2.597356,"d":"2.60"},{"v":2.050178,"d":"2.05"},{"v":1.888069,"d":"1.89"},{"v":1.02389542326852,"d":"1.02"},{"v":0.0340683715523687,"d":"0.03"},{"v":0.724203754393777,"d":"0.72"},{"v":0.957317055040528,"d":"0.96"},"up","no"]
["MSTRG.14788","MVB12B","ENSOART00000013732","GO:0000813(ESCRT I complex);GO:0005634(nucleus);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008289(lipid binding);GO:0019075(virus maturation);GO:0031982(vesicle);GO:0042058(regulation of epidermal growth factor receptor signaling pathway);GO:0046755(viral budding)","04144(Endocytosis)","K12186","NA","multivesicular body subunit 12B [Source:NCBI gene;Acc:101111622]",{"v":7.31432508036163,"d":"7.31"},{"v":8.97699504218985,"d":"8.98"},{"v":8.42728708488197,"d":"8.43"},{"v":7.59091917679558,"d":"7.59"},{"v":7.86382455750879,"d":"7.86"},{"v":8.70515461275741,"d":"8.71"},{"v":1.02312546403738,"d":"1.02"},{"v":0.0329830710322536,"d":"0.03"},{"v":0.724626414342579,"d":"0.72"},{"v":0.957317055040528,"d":"0.96"},"up","no"]
["MSTRG.2050","KAT2B","ENSOART00000017202","GO:0000123(histone acetyltransferase complex);GO:0000776(kinetochore);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003682(chromatin binding);GO:0003712(transcription coregulator activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004468(lysine N-acetyltransferase activity, acting on acetyl phosphate as donor);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0005813(centrosome);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006473(protein acetylation);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0010835(regulation of protein ADP-ribosylation);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0018076(N-terminal peptidyl-lysine acetylation);GO:0018393(internal peptidyl-lysine acetylation);GO:0018394(peptidyl-lysine acetylation);GO:0019901(protein kinase binding);GO:0031672(A band);GO:0031674(I band);GO:0032869(cellular response to insulin stimulus);GO:0032991(protein-containing complex);GO:0035948(positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter);GO:0042641(actomyosin);GO:0042826(histone deacetylase binding);GO:0043966(histone H3 acetylation);GO:0043970(histone H3-K9 acetylation);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046600(negative regulation of centriole replication);GO:0061733(peptide-lysine-N-acetyltransferase activity)","04330(Notch signaling pathway);04919(Thyroid hormone signaling pathway);05166(Human T-cell leukemia virus 1 infection);05203(Viral carcinogenesis)","K06062","EC:2.3.1.48","lysine acetyltransferase 2B [Source:NCBI gene;Acc:101115756]",{"v":11.279008990224,"d":"11.28"},{"v":11.2319021148676,"d":"11.23"},{"v":12.2092084887984,"d":"12.21"},{"v":10.1995525286151,"d":"10.20"},{"v":14.1931198535642,"d":"14.19"},{"v":9.66246561272913,"d":"9.66"},{"v":1.01952661589805,"d":"1.02"},{"v":0.0278994390356253,"d":"0.03"},{"v":0.72542590180796,"d":"0.73"},{"v":0.957317055040528,"d":"0.96"},"up","no"]
["MSTRG.11246","OARD1","ENSOART00000000906","GO:0001883(purine nucleoside binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006974(cellular response to DNA damage stimulus);GO:0042278(purine nucleoside metabolic process);GO:0051725(protein de-ADP-ribosylation);GO:0061463(O-acetyl-ADP-ribose deacetylase activity);GO:0090734(site of DNA damage);GO:0140291(peptidyl-glutamate ADP-deribosylation);GO:0140293(ADP-ribosylglutamate hydrolase activity)","NA","NA","NA","O-acyl-ADP-ribose deacylase 1 [Source:NCBI gene;Acc:101104185]",{"v":8.880458,"d":"8.88"},{"v":9.032436,"d":"9.03"},{"v":7.242869,"d":"7.24"},{"v":9.055227,"d":"9.06"},{"v":6.642681,"d":"6.64"},{"v":8.727197,"d":"8.73"},{"v":1.0299142214537,"d":"1.03"},{"v":0.0425241845573339,"d":"0.04"},{"v":0.725994122655479,"d":"0.73"},{"v":0.957464109955977,"d":"0.96"},"up","no"]
["ENSOARG00000009339","SLC43A3","ENSOART00000010168;ENSOART00000010167;ENSOART00000010164","GO:0006955(immune response);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0055085(transmembrane transport)","NA","K08230","NA","proteoglycan 3-like [Source:NCBI gene;Acc:101105022]",{"v":0.624652330921554,"d":"0.62"},{"v":0.41549257083016,"d":"0.42"},{"v":0.347608969535415,"d":"0.35"},{"v":0.649493152322925,"d":"0.65"},{"v":0.516238935262757,"d":"0.52"},{"v":0.479445309596344,"d":"0.48"},{"v":0.843528408343179,"d":"0.84"},{"v":-0.245491438483973,"d":"-0.25"},{"v":0.726435381418613,"d":"0.73"},{"v":0.957464109955977,"d":"0.96"},"down","no"]
["MSTRG.7879","ENSOARG00000013541;ENSOARG00000013589","ENSOART00000014726;ENSOART00000014784","GO:0004364(glutathione transferase activity);GO:0005515(protein binding);GO:0006749(glutathione metabolic process);GO:0005515(protein binding)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);00983(Drug metabolism - other enzymes);01524(Platinum drug resistance);05200(Pathways in cancer);05204(Chemical carcinogenesis);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis);05418(Fluid shear stress and atherosclerosis)","K00799","EC:2.5.1.18","glutathione S-transferase theta 2B [Source:NCBI gene;Acc:101111664];glutathione S-transferase theta-1 [Source:NCBI gene;Acc:101118990]",{"v":0.418834818656911,"d":"0.42"},{"v":0.311341106872224,"d":"0.31"},{"v":0.17496763051999,"d":"0.17"},{"v":0.371671805330546,"d":"0.37"},{"v":0.436408754376796,"d":"0.44"},{"v":0.275798527305984,"d":"0.28"},{"v":0.83509642993785,"d":"0.84"},{"v":-0.259985297347771,"d":"-0.26"},{"v":0.727136823571073,"d":"0.73"},{"v":0.957464109955977,"d":"0.96"},"down","no"]
["MSTRG.15717","SMAGP","ENSOART00000018891","GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction)","NA","NA","NA","small cell adhesion glycoprotein [Source:HGNC Symbol;Acc:HGNC:26918]",{"v":1.03178188459215,"d":"1.03"},{"v":1.1235050755287,"d":"1.12"},{"v":1.41431876012085,"d":"1.41"},{"v":1.16113815407855,"d":"1.16"},{"v":1.35733153595166,"d":"1.36"},{"v":1.60678189486405,"d":"1.61"},{"v":0.865306187218445,"d":"0.87"},{"v":-0.20871737645148,"d":"-0.21"},{"v":0.727728820487121,"d":"0.73"},{"v":0.957625726917033,"d":"0.96"},"down","no"]
["MSTRG.2647","PIGW","ENSOART00000004248","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0072659(protein localization to plasma membrane)","00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis)","K05283","EC:2.3.-.-","phosphatidylinositol glycan anchor biosynthesis class W [Source:NCBI gene;Acc:101110522]",{"v":1.394124,"d":"1.39"},{"v":1.086165,"d":"1.09"},{"v":0.867165,"d":"0.87"},{"v":1.336843,"d":"1.34"},{"v":0.917437,"d":"0.92"},{"v":0.957906,"d":"0.96"},{"v":1.04211088648042,"d":"1.04"},{"v":0.0595087966797253,"d":"0.06"},{"v":0.728530058936655,"d":"0.73"},{"v":0.957876980612216,"d":"0.96"},"up","no"]
["MSTRG.15034","GFPT1","ENSOART00000021583","GO:0004360(glutamine-fructose-6-phosphate transaminase (isomerizing) activity);GO:0032922(circadian regulation of gene expression);GO:0097367(carbohydrate derivative binding);GO:1901135(carbohydrate derivative metabolic process);GO:1901137(carbohydrate derivative biosynthetic process)","00250(Alanine, aspartate and glutamate metabolism);00520(Amino sugar and nucleotide sugar metabolism);04931(Insulin resistance)","K00820","EC:2.6.1.16","glutamine--fructose-6-phosphate transaminase 1 [Source:NCBI gene;Acc:101116643]",{"v":11.2418044111134,"d":"11.24"},{"v":8.58142724584786,"d":"8.58"},{"v":8.09239771498872,"d":"8.09"},{"v":8.52500254336682,"d":"8.53"},{"v":9.69603795242977,"d":"9.70"},{"v":8.96604328316588,"d":"8.97"},{"v":1.02679748953256,"d":"1.03"},{"v":0.0381516737145576,"d":"0.04"},{"v":0.729652812764685,"d":"0.73"},{"v":0.957998374078775,"d":"0.96"},"up","no"]
["MSTRG.9059","PCBP4","ENSOART00000007176","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005829(cytosol);GO:0043488(regulation of mRNA stability)","NA","K21444","NA","poly(rC) binding protein 4 [Source:NCBI gene;Acc:101112854]",{"v":5.59831657947633,"d":"5.60"},{"v":5.01815607802169,"d":"5.02"},{"v":6.03154191880455,"d":"6.03"},{"v":5.09339162258662,"d":"5.09"},{"v":6.34367591483734,"d":"6.34"},{"v":7.48688681407035,"d":"7.49"},{"v":0.879732336438868,"d":"0.88"},{"v":-0.184863452536893,"d":"-0.18"},{"v":0.730101701399342,"d":"0.73"},{"v":0.958056785377197,"d":"0.96"},"down","no"]
["MSTRG.21016","NDUFB9","ENSOART00000009606","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0032981(mitochondrial respiratory chain complex I assembly)","00190(Oxidative phosphorylation);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K03965","NA","NADH:ubiquinone oxidoreductase subunit B9 [Source:NCBI gene;Acc:101106179]",{"v":100.887253,"d":"100.89"},{"v":97.96566,"d":"97.97"},{"v":84.649361,"d":"84.65"},{"v":101.268745,"d":"101.27"},{"v":87.970856,"d":"87.97"},{"v":134.205841,"d":"134.21"},{"v":0.876507247240788,"d":"0.88"},{"v":-0.19016207519163,"d":"-0.19"},{"v":0.730634444373075,"d":"0.73"},{"v":0.958200397403973,"d":"0.96"},"down","no"]
["MSTRG.9049","WDR82;oar-let-7g","ENSOART00000006185;ENSOART00000026440","GO:0000784(nuclear chromosome, telomeric region);GO:0000785(chromatin);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0035097(histone methyltransferase complex);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0048188(Set1C/COMPASS complex);GO:0051568(histone H3-K4 methylation);GO:0072357(PTW/PP1 phosphatase complex)","03015(mRNA surveillance pathway);05206(MicroRNAs in cancer)","K14962;K16980","NA","WD repeat domain 82 [Source:NCBI gene;Acc:101112353];oar-let-7g [Source:miRBase;Acc:MI0025246]",{"v":16.973482793161,"d":"16.97"},{"v":16.8942141032527,"d":"16.89"},{"v":15.5157443401168,"d":"15.52"},{"v":20.3999549619683,"d":"20.40"},{"v":14.4856159254379,"d":"14.49"},{"v":14.127545365638,"d":"14.13"},{"v":1.00755563024343,"d":"1.01"},{"v":0.0108594965801898,"d":"0.01"},{"v":0.731274870420427,"d":"0.73"},{"v":0.95843804255746,"d":"0.96"},"up","no"]
["MSTRG.291","CC2D1B","ENSOART00000005614","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0005654(nucleoplasm);GO:0043231(intracellular membrane-bounded organelle)","NA","K18260","NA","coiled-coil and C2 domain containing 1B [Source:NCBI gene;Acc:101114826]",{"v":4.27260601820349,"d":"4.27"},{"v":3.78435282500813,"d":"3.78"},{"v":3.87016811052118,"d":"3.87"},{"v":4.40212465554231,"d":"4.40"},{"v":3.5736039128833,"d":"3.57"},{"v":3.79281790963268,"d":"3.79"},{"v":1.01347494152911,"d":"1.01"},{"v":0.0193104181796459,"d":"0.02"},{"v":0.73241038339566,"d":"0.73"},{"v":0.958917258744227,"d":"0.96"},"up","no"]
["MSTRG.20592","ENSOARG00000014536","ENSOART00000015823","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02951","NA","ribosomal protein S12 [Source:NCBI gene;Acc:100037667]",{"v":133.878779948025,"d":"133.88"},{"v":92.5304569085239,"d":"92.53"},{"v":136.722868762994,"d":"136.72"},{"v":118.193086403326,"d":"118.19"},{"v":139.754839278586,"d":"139.75"},{"v":154.46487235343,"d":"154.46"},{"v":0.880506393956339,"d":"0.88"},{"v":-0.183594614402021,"d":"-0.18"},{"v":0.73319137804518,"d":"0.73"},{"v":0.959028183987959,"d":"0.96"},"down","no"]
["MSTRG.11672","RIOK1","ENSOART00000019312","GO:0000166(nucleotide binding);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0030490(maturation of SSU-rRNA);GO:0030688(preribosome, small subunit precursor);GO:0034708(methyltransferase complex);GO:0042274(ribosomal small subunit biogenesis);GO:2000234(positive regulation of rRNA processing)","03008(Ribosome biogenesis in eukaryotes)","K07178","EC:2.7.11.1","RIO kinase 1 [Source:NCBI gene;Acc:101107559]",{"v":0.965272,"d":"0.97"},{"v":1.292952,"d":"1.29"},{"v":1.415946,"d":"1.42"},{"v":1.438628,"d":"1.44"},{"v":0.767489,"d":"0.77"},{"v":1.340484,"d":"1.34"},{"v":1.03596936898174,"d":"1.04"},{"v":0.0509813467778938,"d":"0.05"},{"v":0.734513660084479,"d":"0.73"},{"v":0.959302681066263,"d":"0.96"},"up","no"]
["MSTRG.18613","ENSOARG00000000250","ENSOART00000000263","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","chromosome 6 open reading frame, human C4orf3 [Source:NCBI gene;Acc:101115708]",{"v":3.02587339006313,"d":"3.03"},{"v":2.18508784957453,"d":"2.19"},{"v":2.82725880839967,"d":"2.83"},{"v":3.19322541257206,"d":"3.19"},{"v":2.0390023722207,"d":"2.04"},{"v":2.64381056629152,"d":"2.64"},{"v":1.02059178608884,"d":"1.02"},{"v":0.0294059358057176,"d":"0.03"},{"v":0.734803825373473,"d":"0.73"},{"v":0.959353054061822,"d":"0.96"},"up","no"]
["MSTRG.2152","SETDB2","ENSOART00000009236","GO:0000278(mitotic cell cycle);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005829(cytosol);GO:0007059(chromosome segregation);GO:0008270(zinc ion binding);GO:0018024(histone-lysine N-methyltransferase activity);GO:0034968(histone lysine methylation);GO:0046974(histone methyltransferase activity (H3-K9 specific));GO:0051567(histone H3-K9 methylation)","00310(Lysine degradation)","K18494","EC:2.1.1.43","SET domain bifurcated histone lysine methyltransferase 2 [Source:NCBI gene;Acc:101116064]",{"v":1.381602,"d":"1.38"},{"v":0.91491,"d":"0.91"},{"v":0.980821,"d":"0.98"},{"v":1.326108,"d":"1.33"},{"v":1.0792,"d":"1.08"},{"v":0.778967,"d":"0.78"},{"v":1.02922423471591,"d":"1.03"},{"v":0.0415573331256862,"d":"0.04"},{"v":0.736496389262962,"d":"0.74"},{"v":0.960374621552765,"d":"0.96"},"up","no"]
["MSTRG.6330","RPS25;SLC37A4","ENSOART00000013277;ENSOART00000013457;ENSOART00000013458","GO:0001780(neutrophil homeostasis);GO:0001816(cytokine production);GO:0002318(myeloid progenitor cell differentiation);GO:0005623(cell);GO:0005977(glycogen metabolic process);GO:0006089(lactate metabolic process);GO:0006641(triglyceride metabolic process);GO:0006874(cellular calcium ion homeostasis);GO:0008202(steroid metabolic process);GO:0015760(glucose-6-phosphate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0030593(neutrophil chemotaxis);GO:0032682(negative regulation of chemokine production);GO:0035166(post-embryonic hemopoiesis);GO:0042593(glucose homeostasis);GO:0042632(cholesterol homeostasis);GO:0043085(positive regulation of catalytic activity);GO:0045730(respiratory burst);GO:0055085(transmembrane transport);GO:0055085(transmembrane transport)","03010(Ribosome);04973(Carbohydrate digestion and absorption);04973(Carbohydrate digestion and absorption)","K02975;K08171","NA","ribosomal protein S25 [Source:NCBI gene;Acc:443521];solute carrier family 37 member 4 [Source:NCBI gene;Acc:101105355]",{"v":17.1893320728708,"d":"17.19"},{"v":15.0080881726637,"d":"15.01"},{"v":16.9398452773751,"d":"16.94"},{"v":15.2248126423764,"d":"15.22"},{"v":16.6292235819311,"d":"16.63"},{"v":16.4249844462853,"d":"16.42"},{"v":1.01777676598232,"d":"1.02"},{"v":0.0254211626640651,"d":"0.03"},{"v":0.737005542022158,"d":"0.74"},{"v":0.960554477182136,"d":"0.96"},"up","no"]
["ENSOARG00000005981","PIGN","ENSOART00000006508;ENSOART00000006507","GO:0003824(catalytic activity);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0051377(mannose-ethanolamine phosphotransferase activity);GO:0051377(mannose-ethanolamine phosphotransferase activity)","00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis);00563(Glycosylphosphatidylinositol (GPI)-anchor biosynthesis)","K05285","EC:2.7.-.-","phosphatidylinositol glycan anchor biosynthesis class N [Source:NCBI gene;Acc:101118324]",{"v":2.123451,"d":"2.12"},{"v":1.52802176448829,"d":"1.53"},{"v":1.951849,"d":"1.95"},{"v":2.219625,"d":"2.22"},{"v":2.00247951664612,"d":"2.00"},{"v":2.183371,"d":"2.18"},{"v":0.874770616159059,"d":"0.87"},{"v":-0.193023334301973,"d":"-0.19"},{"v":0.739478319782381,"d":"0.74"},{"v":0.960801190270808,"d":"0.96"},"down","no"]
["MSTRG.15743","COX14;GPD1;ASIC1;SMARCD1","ENSOART00000018363;ENSOART00000019543;ENSOART00000019646;ENSOART00000019561","GO:0005739(mitochondrion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033617(mitochondrial respiratory chain complex IV assembly);GO:0004367(glycerol-3-phosphate dehydrogenase [NAD+] activity);GO:0005975(carbohydrate metabolic process);GO:0006072(glycerol-3-phosphate metabolic process);GO:0006094(gluconeogenesis);GO:0006116(NADH oxidation);GO:0006127(glycerophosphate shuttle);GO:0009331(glycerol-3-phosphate dehydrogenase complex);GO:0016491(oxidoreductase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0042803(protein homodimerization activity);GO:0045821(positive regulation of glycolytic process);GO:0046168(glycerol-3-phosphate catabolic process);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process);GO:0071320(cellular response to cAMP);GO:0071356(cellular response to tumor necrosis factor);GO:0001662(behavioral fear response);GO:0001975(response to amphetamine);GO:0005261(cation channel activity);GO:0005272(sodium channel activity);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006812(cation transport);GO:0006814(sodium ion transport);GO:0007613(memory);GO:0008306(associative learning);GO:0010447(response to acidic pH);GO:0015280(ligand-gated sodium channel activity);GO:0022839(ion gated channel activity);GO:0034220(ion transmembrane transport);GO:0035725(sodium ion transmembrane transport);GO:0042391(regulation of membrane potential);GO:0044736(acid-sensing ion channel activity);GO:0045202(synapse);GO:0046929(negative regulation of neurotransmitter secretion);GO:0050915(sensory perception of sour taste);GO:0070588(calcium ion transmembrane transport);GO:0071467(cellular response to pH);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0016514(SWI/SNF complex);GO:0032947(protein-containing complex scaffold activity);GO:0043231(intracellular membrane-bounded organelle);GO:0048096(chromatin-mediated maintenance of transcription);GO:0071564(npBAF complex);GO:0071565(nBAF complex)","04714(Thermogenesis);00564(Glycerophospholipid metabolism);04750(Inflammatory mediator regulation of TRP channels);05225(Hepatocellular carcinoma)","K18181;K00006;K04829;K11650","EC:1.1.1.8","cytochrome c oxidase assembly protein COX14 [Source:NCBI gene;Acc:101119459];glycerol-3-phosphate dehydrogenase 1 [Source:NCBI gene;Acc:101119894];acid sensing ion channel subunit 1 [Source:NCBI gene;Acc:101120562];SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 [Source:NCBI gene;Acc:101120315]",{"v":27.5324532933279,"d":"27.53"},{"v":14.2861100421155,"d":"14.29"},{"v":13.4092008444025,"d":"13.41"},{"v":18.5677795653683,"d":"18.57"},{"v":14.7386290252182,"d":"14.74"},{"v":19.9028767775282,"d":"19.90"},{"v":1.0379347100373,"d":"1.04"},{"v":0.0537156956534898,"d":"0.05"},{"v":0.739512078062561,"d":"0.74"},{"v":0.960801190270808,"d":"0.96"},"up","no"]
["MSTRG.3029","AKAP10","ENSOART00000019160","GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0008104(protein localization);GO:0032991(protein-containing complex);GO:0051018(protein kinase A binding)","NA","K16526","NA","A-kinase anchoring protein 10 [Source:NCBI gene;Acc:101118286]",{"v":3.735301,"d":"3.74"},{"v":3.558583,"d":"3.56"},{"v":3.406572,"d":"3.41"},{"v":4.776834,"d":"4.78"},{"v":3.117027,"d":"3.12"},{"v":2.710318,"d":"2.71"},{"v":1.00907915643446,"d":"1.01"},{"v":0.0130393499806631,"d":"0.01"},{"v":0.739953845323642,"d":"0.74"},{"v":0.960801190270808,"d":"0.96"},"up","no"]
["MSTRG.5702","SERTAD1","ENSOART00000012346","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0030308(negative regulation of cell growth);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","SERTA domain containing 1 [Source:NCBI gene;Acc:101119071]",{"v":14.0517167906977,"d":"14.05"},{"v":8.51925476744186,"d":"8.52"},{"v":9.95707341860465,"d":"9.96"},{"v":9.35123481395349,"d":"9.35"},{"v":8.37650606976744,"d":"8.38"},{"v":13.4391965116279,"d":"13.44"},{"v":1.04367152165546,"d":"1.04"},{"v":0.0616677189518169,"d":"0.06"},{"v":0.74068543995053,"d":"0.74"},{"v":0.960801190270808,"d":"0.96"},"up","no"]
["MSTRG.6310","UBE4A","ENSOART00000010354","GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein transferase activity);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0034450(ubiquitin-ubiquitin ligase activity)","04120(Ubiquitin mediated proteolysis)","K10596","EC:2.3.2.27","ubiquitination factor E4A [Source:NCBI gene;Acc:101123231]",{"v":14.2018926736461,"d":"14.20"},{"v":12.7002030695844,"d":"12.70"},{"v":11.808387444427,"d":"11.81"},{"v":11.3214715960327,"d":"11.32"},{"v":13.7826714938602,"d":"13.78"},{"v":12.812903820529,"d":"12.81"},{"v":1.02092558207684,"d":"1.02"},{"v":0.0298777082514091,"d":"0.03"},{"v":0.742019728460911,"d":"0.74"},{"v":0.961108411745759,"d":"0.96"},"up","no"]
["MSTRG.13040","SMAD2","ENSOART00000003971;ENSOART00000003969","GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001657(ureteric bud development);GO:0001701(in utero embryonic development);GO:0001706(endoderm formation);GO:0001707(mesoderm formation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007182(common-partner SMAD protein phosphorylation);GO:0007183(SMAD protein complex assembly);GO:0007352(zygotic specification of dorsal/ventral axis);GO:0007369(gastrulation);GO:0007389(pattern specification process);GO:0007492(endoderm development);GO:0007507(heart development);GO:0008134(transcription factor binding);GO:0009749(response to glucose);GO:0009791(post-embryonic development);GO:0009880(embryonic pattern specification);GO:0009952(anterior/posterior pattern specification);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0017015(regulation of transforming growth factor beta receptor signaling pathway);GO:0019902(phosphatase binding);GO:0030073(insulin secretion);GO:0030324(lung development);GO:0030513(positive regulation of BMP signaling pathway);GO:0030618(transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity);GO:0031016(pancreas development);GO:0031625(ubiquitin protein ligase binding);GO:0032444(activin responsive factor complex);GO:0032924(activin receptor signaling pathway);GO:0032991(protein-containing complex);GO:0033613(activating transcription factor binding);GO:0034713(type I transforming growth factor beta receptor binding);GO:0035265(organ growth);GO:0035556(intracellular signal transduction);GO:0038092(nodal signaling pathway);GO:0042803(protein homodimerization activity);GO:0045165(cell fate commitment);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046332(SMAD binding);GO:0046982(protein heterodimerization activity);GO:0048156(tau protein binding);GO:0048340(paraxial mesoderm morphogenesis);GO:0048589(developmental growth);GO:0048617(embryonic foregut morphogenesis);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0051098(regulation of binding);GO:0060039(pericardium development);GO:0060395(SMAD protein signal transduction);GO:0062009(secondary palate development);GO:0070410(co-SMAD binding);GO:0070411(I-SMAD binding);GO:0070412(R-SMAD binding);GO:0070723(response to cholesterol);GO:0070878(primary miRNA binding);GO:0071141(SMAD protein complex);GO:0071144(heteromeric SMAD protein complex);GO:0097718(disordered domain specific binding);GO:1900224(positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry);GO:1900224(positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry)","04068(FoxO signaling pathway);04110(Cell cycle);04144(Endocytosis);04218(Cellular senescence);04350(TGF-beta signaling pathway);04371(Apelin signaling pathway);04390(Hippo signaling pathway);04520(Adherens junction);04550(Signaling pathways regulating pluripotency of stem cells);04659(Th17 cell differentiation);04926(Relaxin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05142(Chagas disease (American trypanosomiasis));05161(Hepatitis B);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05321(Inflammatory bowel disease (IBD));05321(Inflammatory bowel disease (IBD))","K04500","NA","SMAD family member 2 [Source:NCBI gene;Acc:101114231]",{"v":12.2266818450226,"d":"12.23"},{"v":10.311485,"d":"10.31"},{"v":10.2205190192308,"d":"10.22"},{"v":12.5043620011312,"d":"12.50"},{"v":10.3163432115385,"d":"10.32"},{"v":9.60631403733032,"d":"9.61"},{"v":1.01022809440783,"d":"1.01"},{"v":0.014681068738068,"d":"0.01"},{"v":0.74233081808009,"d":"0.74"},{"v":0.961108411745759,"d":"0.96"},"up","no"]
["MSTRG.22069","ATP11C","ENSOART00000011154;ENSOART00000011159","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0002329(pre-B cell differentiation);GO:0004012(phospholipid-translocating ATPase activity);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0015914(phospholipid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045332(phospholipid translocation);GO:0045579(positive regulation of B cell differentiation);GO:0045579(positive regulation of B cell differentiation)","NA","K01530","EC:7.6.2.1","ATPase phospholipid transporting 11C [Source:NCBI gene;Acc:101122839]",{"v":0.661372401709402,"d":"0.66"},{"v":0.736516444444444,"d":"0.74"},{"v":0.833485264957265,"d":"0.83"},{"v":0.708552247863248,"d":"0.71"},{"v":0.803834316239316,"d":"0.80"},{"v":0.65646235042735,"d":"0.66"},{"v":1.02882874697371,"d":"1.03"},{"v":0.0410028593424584,"d":"0.04"},{"v":0.743155841004227,"d":"0.74"},{"v":0.961433212258697,"d":"0.96"},"up","no"]
["MSTRG.21473","MID1","ENSOART00000011603;ENSOART00000011602","GO:0005515(protein binding);GO:0005622(intracellular);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0031625(ubiquitin protein ligase binding);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0035372(protein localization to microtubule);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0051219(phosphoprotein binding);GO:0051219(phosphoprotein binding)","04120(Ubiquitin mediated proteolysis);04120(Ubiquitin mediated proteolysis)","K08285","EC:2.3.2.27","midline 1 [Source:NCBI gene;Acc:101117818]",{"v":0.846486723334886,"d":"0.85"},{"v":0.535874853749418,"d":"0.54"},{"v":0.740421765719609,"d":"0.74"},{"v":0.979802375407546,"d":"0.98"},{"v":0.751895624592455,"d":"0.75"},{"v":0.739132651141127,"d":"0.74"},{"v":0.859137530054327,"d":"0.86"},{"v":-0.219038999559094,"d":"-0.22"},{"v":0.744497136705646,"d":"0.74"},{"v":0.962101246389378,"d":"0.96"},"down","no"]
["MSTRG.20738","SNX9","ENSOART00000004669","GO:0000281(mitotic cytokinesis);GO:0005515(protein binding);GO:0005545(1-phosphatidylinositol binding);GO:0005737(cytoplasm);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0006897(endocytosis);GO:0006898(receptor-mediated endocytosis);GO:0016197(endosomal transport);GO:0030136(clathrin-coated vesicle);GO:0030659(cytoplasmic vesicle membrane);GO:0030838(positive regulation of actin filament polymerization);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0031625(ubiquitin protein ligase binding);GO:0032437(cuticular plate);GO:0032461(positive regulation of protein oligomerization);GO:0035091(phosphatidylinositol binding);GO:0036089(cleavage furrow formation);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043547(positive regulation of GTPase activity);GO:0045860(positive regulation of protein kinase activity);GO:0051044(positive regulation of membrane protein ectodomain proteolysis);GO:0060988(lipid tube assembly);GO:0071933(Arp2/3 complex binding);GO:0097320(plasma membrane tubulation)","NA","K17923","NA","sorting nexin 9 [Source:NCBI gene;Acc:101109101]",{"v":4.46515894808628,"d":"4.47"},{"v":3.54730854662719,"d":"3.55"},{"v":3.42305180831042,"d":"3.42"},{"v":3.56233846225418,"d":"3.56"},{"v":3.8776447100867,"d":"3.88"},{"v":3.78458896965532,"d":"3.78"},{"v":1.01879333647279,"d":"1.02"},{"v":0.0268614286537861,"d":"0.03"},{"v":0.745801652278774,"d":"0.75"},{"v":0.962671359076248,"d":"0.96"},"up","no"]
["MSTRG.10715","ENSOARG00000019940","ENSOART00000021708","GO:0005794(Golgi apparatus);GO:0006914(autophagy);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle)","04136(Autophagy - other);04137(Mitophagy - animal);04140(Autophagy - animal)","K17907","NA","autophagy related 9A [Source:NCBI gene;Acc:100913171]",{"v":13.9754726522709,"d":"13.98"},{"v":14.0969943260698,"d":"14.10"},{"v":11.0540855586768,"d":"11.05"},{"v":13.7425947265687,"d":"13.74"},{"v":12.581412905487,"d":"12.58"},{"v":12.411632987267,"d":"12.41"},{"v":1.01009178914934,"d":"1.01"},{"v":0.0144863996439673,"d":"0.01"},{"v":0.746181277468143,"d":"0.75"},{"v":0.962671359076248,"d":"0.96"},"up","no"]
["MSTRG.2937","EIF4A1","ENSOART00000015761","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0003725(double-stranded RNA binding);GO:0003743(translation initiation factor activity);GO:0004004(ATP-dependent RNA helicase activity);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006413(translational initiation);GO:0016787(hydrolase activity)","NA","K08593","EC:3.4.22.68","SUMO specific peptidase 3 [Source:NCBI gene;Acc:101123643]",{"v":26.1310893957038,"d":"26.13"},{"v":21.181306316563,"d":"21.18"},{"v":22.1286167897117,"d":"22.13"},{"v":27.2196864867157,"d":"27.22"},{"v":22.9083443510458,"d":"22.91"},{"v":28.6628362091577,"d":"28.66"},{"v":0.881333270017539,"d":"0.88"},{"v":-0.182240427520089,"d":"-0.18"},{"v":0.746493051949703,"d":"0.75"},{"v":0.962671359076248,"d":"0.96"},"down","no"]
["MSTRG.19907","SECISBP2L","ENSOART00000022887","GO:0035368(selenocysteine insertion sequence binding)","NA","NA","NA","SECIS binding protein 2 like [Source:NCBI gene;Acc:101109804]",{"v":8.990324,"d":"8.99"},{"v":6.584167,"d":"6.58"},{"v":6.65822,"d":"6.66"},{"v":8.195929,"d":"8.20"},{"v":7.330996,"d":"7.33"},{"v":6.445197,"d":"6.45"},{"v":1.01185998330066,"d":"1.01"},{"v":0.0170096700982627,"d":"0.02"},{"v":0.746993851487961,"d":"0.75"},{"v":0.962737043736319,"d":"0.96"},"up","no"]
["MSTRG.21067","TCEA1","ENSOART00000015141","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005669(transcription factor TFIID complex);GO:0005730(nucleolus);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","K03145","NA","transcription elongation factor A1 [Source:NCBI gene;Acc:101107711]",{"v":1.81791,"d":"1.82"},{"v":1.382124,"d":"1.38"},{"v":1.340599,"d":"1.34"},{"v":1.564034,"d":"1.56"},{"v":1.444212,"d":"1.44"},{"v":1.442387,"d":"1.44"},{"v":1.02022184260082,"d":"1.02"},{"v":0.0288828937856848,"d":"0.03"},{"v":0.748698410483028,"d":"0.75"},{"v":0.963080759338315,"d":"0.96"},"up","no"]
["MSTRG.5949","VRK3","ENSOART00000014920","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006468(protein phosphorylation);GO:0019903(protein phosphatase binding);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","NA","K08816","EC:2.7.11.1","VRK serine/threonine kinase 3 [Source:NCBI gene;Acc:101109637]",{"v":11.5566224636542,"d":"11.56"},{"v":10.0038446277014,"d":"10.00"},{"v":9.53382540176817,"d":"9.53"},{"v":10.2537563462672,"d":"10.25"},{"v":9.18377035510805,"d":"9.18"},{"v":11.1200550063851,"d":"11.12"},{"v":1.01756391557736,"d":"1.02"},{"v":0.0251194163985977,"d":"0.03"},{"v":0.749657369200421,"d":"0.75"},{"v":0.963080759338315,"d":"0.96"},"up","no"]
["MSTRG.22046","MTMR1","ENSOART00000009669","GO:0004438(phosphatidylinositol-3-phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0046856(phosphatidylinositol dephosphorylation);GO:0052629(phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity);GO:0052866(phosphatidylinositol phosphate phosphatase activity)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)","K18081","3.1.3.95;EC:3.1.3.64","myotubularin related protein 1 [Source:NCBI gene;Acc:101107677]",{"v":5.09589950245098,"d":"5.10"},{"v":7.76171850895141,"d":"7.76"},{"v":7.21194315654305,"d":"7.21"},{"v":6.88108360507246,"d":"6.88"},{"v":6.36146986242541,"d":"6.36"},{"v":6.64289241432225,"d":"6.64"},{"v":1.00925879596663,"d":"1.01"},{"v":0.0132961603553512,"d":"0.01"},{"v":0.750149498642592,"d":"0.75"},{"v":0.963080759338315,"d":"0.96"},"up","no"]
["MSTRG.8901","EIF4E3","ENSOART00000010473","GO:0003723(RNA binding);GO:0003743(translation initiation factor activity);GO:0005737(cytoplasm);GO:0006412(translation);GO:0006413(translational initiation)","NA","NA","NA","eukaryotic translation initiation factor 4E family member 3 [Source:NCBI gene;Acc:101114394]",{"v":2.41868091175105,"d":"2.42"},{"v":2.34716831800588,"d":"2.35"},{"v":2.17439110357641,"d":"2.17"},{"v":2.32246101238582,"d":"2.32"},{"v":2.81711814553336,"d":"2.82"},{"v":2.72953949775507,"d":"2.73"},{"v":0.881959039762208,"d":"0.88"},{"v":-0.181216439676138,"d":"-0.18"},{"v":0.751062148352277,"d":"0.75"},{"v":0.963080759338315,"d":"0.96"},"down","no"]
["MSTRG.4272","TMEM206","ENSOART00000011561","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 206 [Source:NCBI gene;Acc:101116749]",{"v":1.84115834324009,"d":"1.84"},{"v":1.84331301748252,"d":"1.84"},{"v":1.40857188811189,"d":"1.41"},{"v":2.15450651806527,"d":"2.15"},{"v":1.74777262179487,"d":"1.75"},{"v":1.97647676398601,"d":"1.98"},{"v":0.866347120400491,"d":"0.87"},{"v":-0.206982907647694,"d":"-0.21"},{"v":0.751742299401691,"d":"0.75"},{"v":0.963080759338315,"d":"0.96"},"down","no"]
["MSTRG.7732","UNC119B","ENSOART00000014177","GO:0008289(lipid binding);GO:0035869(ciliary transition zone);GO:0042953(lipoprotein transport);GO:0060271(cilium assembly)","NA","NA","NA","unc-119 lipid binding chaperone B [Source:NCBI gene;Acc:101113013]",{"v":5.170473,"d":"5.17"},{"v":4.196519,"d":"4.20"},{"v":5.880232,"d":"5.88"},{"v":5.982386,"d":"5.98"},{"v":5.513297,"d":"5.51"},{"v":6.027614,"d":"6.03"},{"v":0.870111600573796,"d":"0.87"},{"v":-0.200727641893076,"d":"-0.20"},{"v":0.751765861770394,"d":"0.75"},{"v":0.963080759338315,"d":"0.96"},"down","no"]
["MSTRG.6688","NAT10","ENSOART00000019908;ENSOART00000019907","GO:0000154(rRNA modification);GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005697(telomerase holoenzyme complex);GO:0005730(nucleolus);GO:0006364(rRNA processing);GO:0008033(tRNA processing);GO:0008080(N-acetyltransferase activity);GO:0016072(rRNA metabolic process);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0030496(midbody);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0034470(ncRNA processing);GO:0042274(ribosomal small subunit biogenesis);GO:0045727(positive regulation of translation);GO:0051391(tRNA acetylation);GO:0070182(DNA polymerase binding);GO:0070182(DNA polymerase binding)","03008(Ribosome biogenesis in eukaryotes);03008(Ribosome biogenesis in eukaryotes)","K14521","EC:2.3.1.-","N-acetyltransferase 10 [Source:NCBI gene;Acc:101103589]",{"v":2.27191369415369,"d":"2.27"},{"v":2.24728815062548,"d":"2.25"},{"v":2.10500343247383,"d":"2.11"},{"v":2.49398501710493,"d":"2.49"},{"v":2.32642190400817,"d":"2.33"},{"v":1.75978593336737,"d":"1.76"},{"v":1.00668862201243,"d":"1.01"},{"v":0.00961751358719382,"d":"0.01"},{"v":0.752654653217878,"d":"0.75"},{"v":0.963080759338315,"d":"0.96"},"up","no"]
["ENSOARG00000006836","DPY19L4","ENSOART00000007435","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","dpy-19 like 4 [Source:NCBI gene;Acc:101110069]",{"v":2.466032,"d":"2.47"},{"v":2.375689,"d":"2.38"},{"v":2.025876,"d":"2.03"},{"v":2.825662,"d":"2.83"},{"v":2.687766,"d":"2.69"},{"v":2.35981,"d":"2.36"},{"v":0.872270976693452,"d":"0.87"},{"v":-0.197151707589264,"d":"-0.20"},{"v":0.753085158084606,"d":"0.75"},{"v":0.963212788751797,"d":"0.96"},"down","no"]
["MSTRG.1227","PROS1","ENSOART00000018803;ENSOART00000018804","GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0030195(negative regulation of blood coagulation);GO:0030195(negative regulation of blood coagulation)","04610(Complement and coagulation cascades);04610(Complement and coagulation cascades)","K03908","NA","protein S [Source:NCBI gene;Acc:101122999]",{"v":2.57282501803998,"d":"2.57"},{"v":1.83774571623598,"d":"1.84"},{"v":2.73918924427109,"d":"2.74"},{"v":3.13021322428084,"d":"3.13"},{"v":2.30619987323257,"d":"2.31"},{"v":2.75674909410044,"d":"2.76"},{"v":0.872649632868884,"d":"0.87"},{"v":-0.19652556403628,"d":"-0.20"},{"v":0.753858025088269,"d":"0.75"},{"v":0.963220426765886,"d":"0.96"},"down","no"]
["MSTRG.5884","RASIP1","ENSOART00000013134","GO:0001525(angiogenesis);GO:0001570(vasculogenesis);GO:0005515(protein binding);GO:0005911(cell-cell junction);GO:0010507(negative regulation of autophagy);GO:0032991(protein-containing complex);GO:0033625(positive regulation of integrin activation);GO:0035024(negative regulation of Rho protein signal transduction);GO:0042803(protein homodimerization activity);GO:0043087(regulation of GTPase activity);GO:0048754(branching morphogenesis of an epithelial tube);GO:0051020(GTPase binding);GO:1905709(negative regulation of membrane permeability);GO:2000299(negative regulation of Rho-dependent protein serine/threonine kinase activity)","NA","NA","NA","Ras interacting protein 1 [Source:NCBI gene;Acc:101107986]",{"v":4.8489137250232,"d":"4.85"},{"v":3.00473056557377,"d":"3.00"},{"v":3.31156927420353,"d":"3.31"},{"v":5.34551055521188,"d":"5.35"},{"v":3.74753125471698,"d":"3.75"},{"v":3.65332660408289,"d":"3.65"},{"v":0.875952522486866,"d":"0.88"},{"v":-0.191075418472996,"d":"-0.19"},{"v":0.7550675564952,"d":"0.76"},{"v":0.963364909948474,"d":"0.96"},"down","no"]
["MSTRG.556","PALMD","ENSOART00000019243","GO:0008360(regulation of cell shape);GO:0016020(membrane)","NA","K16519","NA","palmdelphin [Source:NCBI gene;Acc:101110980]",{"v":2.05238833033873,"d":"2.05"},{"v":1.27653689057437,"d":"1.28"},{"v":1.93935985434462,"d":"1.94"},{"v":1.95637320427099,"d":"1.96"},{"v":2.13570204594993,"d":"2.14"},{"v":1.86886427466863,"d":"1.87"},{"v":0.883801127869241,"d":"0.88"},{"v":-0.178206322685495,"d":"-0.18"},{"v":0.755737039007143,"d":"0.76"},{"v":0.963364909948474,"d":"0.96"},"down","no"]
["MSTRG.15635","BTG1","ENSOART00000018250","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008285(negative regulation of cell population proliferation);GO:0019899(enzyme binding);GO:0045603(positive regulation of endothelial cell differentiation);GO:0045663(positive regulation of myoblast differentiation);GO:0045766(positive regulation of angiogenesis);GO:2000271(positive regulation of fibroblast apoptotic process)","03018(RNA degradation)","K14443","NA","BTG anti-proliferation factor 1 [Source:NCBI gene;Acc:100217400]",{"v":4.82909739452055,"d":"4.83"},{"v":5.02476195890411,"d":"5.02"},{"v":5.89270654178082,"d":"5.89"},{"v":4.49249631438356,"d":"4.49"},{"v":5.32840183219178,"d":"5.33"},{"v":5.65934972808219,"d":"5.66"},{"v":1.01720373101932,"d":"1.02"},{"v":0.0246086588366786,"d":"0.02"},{"v":0.75709901545983,"d":"0.76"},{"v":0.964257062519897,"d":"0.96"},"up","no"]
["MSTRG.6750","AMBRA1","ENSOART00000003926","GO:0000045(autophagosome assembly);GO:0000422(autophagy of mitochondrion);GO:0000423(mitophagy);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005930(axoneme);GO:0006914(autophagy);GO:0008285(negative regulation of cell population proliferation);GO:0021915(neural tube development);GO:0031625(ubiquitin protein ligase binding);GO:0043524(negative regulation of neuron apoptotic process);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045335(phagocytic vesicle);GO:0051020(GTPase binding);GO:0098780(response to mitochondrial depolarisation)","04137(Mitophagy - animal);04140(Autophagy - animal)","K17985","NA","autophagy and beclin 1 regulator 1 [Source:NCBI gene;Acc:101117963]",{"v":4.5925749961282,"d":"4.59"},{"v":3.83649217896322,"d":"3.84"},{"v":3.911210961282,"d":"3.91"},{"v":5.0171239950527,"d":"5.02"},{"v":4.91235070660357,"d":"4.91"},{"v":4.09086171950957,"d":"4.09"},{"v":0.880169902181797,"d":"0.88"},{"v":-0.184146055937762,"d":"-0.18"},{"v":0.758234207361772,"d":"0.76"},{"v":0.964257062519897,"d":"0.96"},"down","no"]
["MSTRG.9936","ENSOARG00000009447","ENSOART00000010287","NA","NA","NA","NA",null,{"v":3.274396,"d":"3.27"},{"v":2.915738,"d":"2.92"},{"v":3.155633,"d":"3.16"},{"v":3.860705,"d":"3.86"},{"v":3.37955,"d":"3.38"},{"v":3.428203,"d":"3.43"},{"v":0.876018539886458,"d":"0.88"},{"v":-0.190966691819805,"d":"-0.19"},{"v":0.758484904759878,"d":"0.76"},{"v":0.964257062519897,"d":"0.96"},"down","no"]
["MSTRG.15999","CS","ENSOART00000010249;ENSOART00000010254","GO:0004108(citrate (Si)-synthase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005975(carbohydrate metabolic process);GO:0006099(tricarboxylic acid cycle);GO:0006101(citrate metabolic process);GO:0016740(transferase activity);GO:0046912(transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer);GO:0046912(transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer)","00020(Citrate cycle (TCA cycle));00630(Glyoxylate and dicarboxylate metabolism);00630(Glyoxylate and dicarboxylate metabolism)","K01647","EC:2.3.3.1","citrate synthase [Source:NCBI gene;Acc:101109163]",{"v":201.614950611345,"d":"201.61"},{"v":172.03882715126,"d":"172.04"},{"v":167.181811571429,"d":"167.18"},{"v":240.770249033613,"d":"240.77"},{"v":165.116023573529,"d":"165.12"},{"v":208.331266985294,"d":"208.33"},{"v":0.88052775193119,"d":"0.88"},{"v":-0.183559620140866,"d":"-0.18"},{"v":0.760145719266418,"d":"0.76"},{"v":0.964768428866633,"d":"0.96"},"down","no"]
["MSTRG.5498","ESRP2","ENSOART00000003648","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0003676(nucleic acid binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0043484(regulation of RNA splicing);GO:0050679(positive regulation of epithelial cell proliferation);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0060445(branching involved in salivary gland morphogenesis)","NA","K14947","NA","epithelial splicing regulatory protein 2 [Source:NCBI gene;Acc:101118043]",{"v":0.548715092093023,"d":"0.55"},{"v":0.180694755348837,"d":"0.18"},{"v":0.329439259534884,"d":"0.33"},{"v":0.51646512,"d":"0.52"},{"v":0.288965944186047,"d":"0.29"},{"v":0.201691205581395,"d":"0.20"},{"v":1.05136103009741,"d":"1.05"},{"v":0.0722581658668707,"d":"0.07"},{"v":0.760660774110859,"d":"0.76"},{"v":0.96488490931142,"d":"0.96"},"up","no"]
["MSTRG.18067","HK3","ENSOART00000003536","GO:0000166(nucleotide binding);GO:0001678(cellular glucose homeostasis);GO:0004396(hexokinase activity);GO:0005524(ATP binding);GO:0005536(glucose binding);GO:0005623(cell);GO:0005975(carbohydrate metabolic process);GO:0006096(glycolytic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0016773(phosphotransferase activity, alcohol group as acceptor);GO:0046835(carbohydrate phosphorylation)","00010(Glycolysis / Gluconeogenesis);00051(Fructose and mannose metabolism);00052(Galactose metabolism);00500(Starch and sucrose metabolism);00520(Amino sugar and nucleotide sugar metabolism);00524(Neomycin, kanamycin and gentamicin biosynthesis);04066(HIF-1 signaling pathway);04910(Insulin signaling pathway);04930(Type II diabetes mellitus);04973(Carbohydrate digestion and absorption);05230(Central carbon metabolism in cancer)","K00844","EC:2.7.1.1","hexokinase 3 [Source:NCBI gene;Acc:101119209]",{"v":0.164707,"d":"0.16"},{"v":0.108466,"d":"0.11"},{"v":0.129047,"d":"0.13"},{"v":0.211591,"d":"0.21"},{"v":0.185697,"d":"0.19"},{"v":0.082991,"d":"0.08"},{"v":0.837471552993156,"d":"0.84"},{"v":-0.255887908671641,"d":"-0.26"},{"v":0.761764619590403,"d":"0.76"},{"v":0.96488490931142,"d":"0.96"},"down","no"]
["MSTRG.21274","POLR2K","ENSOART00000001583","GO:0003677(DNA binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005634(nucleus);GO:0005665(RNA polymerase II, core complex);GO:0006351(transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0008270(zinc ion binding)","03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway);05016(Huntington disease)","K03009","NA","RNA polymerase II subunit K [Source:NCBI gene;Acc:101104250]",{"v":2.73412604084321,"d":"2.73"},{"v":1.93796616073781,"d":"1.94"},{"v":1.92155124374177,"d":"1.92"},{"v":2.91918170619236,"d":"2.92"},{"v":1.2158409314888,"d":"1.22"},{"v":2.30546529644269,"d":"2.31"},{"v":1.02378010994904,"d":"1.02"},{"v":0.0339058829631022,"d":"0.03"},{"v":0.762192893207906,"d":"0.76"},{"v":0.96488490931142,"d":"0.96"},"up","no"]
["ENSOARG00000009194","ATP10A","ENSOART00000010013;ENSOART00000010012","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004012(phospholipid-translocating ATPase activity);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0015914(phospholipid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045332(phospholipid translocation);GO:0045332(phospholipid translocation)","NA","K01530","EC:7.6.2.1","ATPase phospholipid transporting 10A (putative) [Source:NCBI gene;Acc:101107997]",{"v":0.476622383845127,"d":"0.48"},{"v":0.500347620605251,"d":"0.50"},{"v":0.942230162438807,"d":"0.94"},{"v":0.486798450155763,"d":"0.49"},{"v":0.961520983978638,"d":"0.96"},{"v":0.772068949710725,"d":"0.77"},{"v":0.864353363065986,"d":"0.86"},{"v":-0.210306862449942,"d":"-0.21"},{"v":0.762734123902143,"d":"0.76"},{"v":0.964941476637333,"d":"0.96"},"down","no"]
["MSTRG.16672","ENSOARG00000020414","ENSOART00000022230","GO:0001701(in utero embryonic development);GO:0003012(muscle system process);GO:0005507(copper ion binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006825(copper ion transport);GO:0006878(cellular copper ion homeostasis);GO:0008535(respiratory chain complex IV assembly);GO:0014823(response to activity);GO:0022904(respiratory electron transport chain);GO:0045454(cell redox homeostasis);GO:0046872(metal ion binding);GO:0055070(copper ion homeostasis)","NA","K07152","NA","protein SCO2 homolog, mitochondrial [Source:NCBI gene;Acc:101121590]",{"v":1.765046,"d":"1.77"},{"v":1.477015,"d":"1.48"},{"v":1.535868,"d":"1.54"},{"v":2.066624,"d":"2.07"},{"v":1.710764,"d":"1.71"},{"v":1.776386,"d":"1.78"},{"v":0.860303101998749,"d":"0.86"},{"v":-0.217083055177834,"d":"-0.22"},{"v":0.764078391325988,"d":"0.76"},{"v":0.965299451735789,"d":"0.97"},"down","no"]
["MSTRG.7821","PES1","ENSOART00000008943","GO:0000463(maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000466(maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000793(condensed chromosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0007000(nucleolus organization);GO:0008283(cell population proliferation);GO:0030687(preribosome, large subunit precursor);GO:0033365(protein localization to organelle);GO:0042254(ribosome biogenesis);GO:0042273(ribosomal large subunit biogenesis);GO:0043021(ribonucleoprotein complex binding);GO:0051726(regulation of cell cycle);GO:0070545(PeBoW complex)","NA","NA","NA","pescadillo ribosomal biogenesis factor 1 [Source:HGNC Symbol;Acc:HGNC:8848]",{"v":1.31984764325245,"d":"1.32"},{"v":1.27634472818221,"d":"1.28"},{"v":1.44802678607918,"d":"1.45"},{"v":1.120044149851,"d":"1.12"},{"v":1.70345829054917,"d":"1.70"},{"v":1.7577545602384,"d":"1.76"},{"v":0.882775001915441,"d":"0.88"},{"v":-0.17988231837728,"d":"-0.18"},{"v":0.764802170061561,"d":"0.76"},{"v":0.965299451735789,"d":"0.97"},"down","no"]
["MSTRG.11404","GPANK1","ENSOART00000007515","GO:0003676(nucleic acid binding)","NA","NA","NA","G-patch domain and ankyrin repeats 1 [Source:NCBI gene;Acc:101120117]",{"v":9.4745201321519,"d":"9.47"},{"v":10.1566350567089,"d":"10.16"},{"v":8.38079206582279,"d":"8.38"},{"v":9.95318477822785,"d":"9.95"},{"v":10.0807469832911,"d":"10.08"},{"v":11.6450359787342,"d":"11.65"},{"v":0.88424431895519,"d":"0.88"},{"v":-0.177483049880029,"d":"-0.18"},{"v":0.765031787049722,"d":"0.77"},{"v":0.965299451735789,"d":"0.97"},"down","no"]
["MSTRG.6799","CLP1","ENSOART00000011035","GO:0000166(nucleotide binding);GO:0000214(tRNA-intron endonuclease complex);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005849(mRNA cleavage factor complex);GO:0006388(tRNA splicing, via endonucleolytic cleavage and ligation);GO:0006397(mRNA processing);GO:0008033(tRNA processing);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0021695(cerebellar cortex development);GO:0030423(targeting of mRNA for destruction involved in RNA interference);GO:0031124(mRNA 3'-end processing);GO:0035087(siRNA loading onto RISC involved in RNA interference);GO:0046404(ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity);GO:0051733(polydeoxyribonucleotide kinase activity);GO:0051734(ATP-dependent polynucleotide kinase activity);GO:0051736(ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity)","03015(mRNA surveillance pathway)","K14399","EC:2.7.1.78","cleavage and polyadenylation factor I subunit 1 [Source:NCBI gene;Acc:101106031]",{"v":1.30002578429319,"d":"1.30"},{"v":1.29773690314136,"d":"1.30"},{"v":1.64455948167539,"d":"1.64"},{"v":1.6184802513089,"d":"1.62"},{"v":1.41170358900524,"d":"1.41"},{"v":1.83904601308901,"d":"1.84"},{"v":0.871251162264386,"d":"0.87"},{"v":-0.198839419324439,"d":"-0.20"},{"v":0.765650521523638,"d":"0.77"},{"v":0.965564277795511,"d":"0.97"},"down","no"]
["MSTRG.2816","DPH1;OVCA2","ENSOART00000016022;ENSOART00000016116","GO:0005654(nucleoplasm);GO:0008283(cell population proliferation);GO:0016740(transferase activity);GO:0017183(peptidyl-diphthamide biosynthetic process from peptidyl-histidine);GO:0030054(cell junction);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0032526(response to retinoic acid)","NA","K07561","EC:2.5.1.108","diphthamide biosynthesis 1 [Source:NCBI gene;Acc:101104511];OVCA2, serine hydrolase domain containing [Source:HGNC Symbol;Acc:HGNC:24203]",{"v":3.21571912164074,"d":"3.22"},{"v":2.29390325601132,"d":"2.29"},{"v":2.01783694342291,"d":"2.02"},{"v":2.39278599009901,"d":"2.39"},{"v":2.78960924611033,"d":"2.79"},{"v":2.19112591937765,"d":"2.19"},{"v":1.02087715790594,"d":"1.02"},{"v":0.0298092772420191,"d":"0.03"},{"v":0.766270877708007,"d":"0.77"},{"v":0.96563508700908,"d":"0.97"},"up","no"]
["MSTRG.21227","EIF3E","ENSOART00000016096","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0001732(formation of cytoplasmic translation initiation complex);GO:0002183(cytoplasmic translational initiation);GO:0003743(translation initiation factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0016282(eukaryotic 43S preinitiation complex);GO:0016604(nuclear body);GO:0016605(PML body);GO:0033290(eukaryotic 48S preinitiation complex);GO:0045727(positive regulation of translation);GO:0047485(protein N-terminus binding);GO:0071540(eukaryotic translation initiation factor 3 complex, eIF3e);GO:1902416(positive regulation of mRNA binding)","03013(RNA transport);05160(Hepatitis C)","K03250","NA","eukaryotic translation initiation factor 3 subunit E [Source:NCBI gene;Acc:101118881]",{"v":8.99458168736617,"d":"8.99"},{"v":9.97098395985011,"d":"9.97"},{"v":9.20661941755889,"d":"9.21"},{"v":10.8579672869379,"d":"10.86"},{"v":11.1743511236617,"d":"11.17"},{"v":9.968545998394,"d":"9.97"},{"v":0.880357002383273,"d":"0.88"},{"v":-0.183839410770187,"d":"-0.18"},{"v":0.767369163870264,"d":"0.77"},{"v":0.965991752772653,"d":"0.97"},"down","no"]
["MSTRG.3478","ASPSCR1","ENSOART00000019198","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0009898(cytoplasmic side of plasma membrane);GO:0012506(vesicle membrane);GO:0019898(extrinsic component of membrane);GO:0031401(positive regulation of protein modification process);GO:0042593(glucose homeostasis);GO:0043231(intracellular membrane-bounded organelle);GO:0046324(regulation of glucose import);GO:0048471(perinuclear region of cytoplasm)","05202(Transcriptional misregulation in cancer)","K15627","NA","ASPSCR1, UBX domain containing tether for SLC2A4 [Source:NCBI gene;Acc:101107539]",{"v":4.50273613793103,"d":"4.50"},{"v":4.43682142381716,"d":"4.44"},{"v":5.37595424979952,"d":"5.38"},{"v":4.94741760946271,"d":"4.95"},{"v":5.43530680513232,"d":"5.44"},{"v":5.78074413071371,"d":"5.78"},{"v":0.885670781083842,"d":"0.89"},{"v":-0.175157570782686,"d":"-0.18"},{"v":0.767918480584826,"d":"0.77"},{"v":0.965991752772653,"d":"0.97"},"down","no"]
["MSTRG.2933","ENSOARG00000014311","ENSOART00000015581","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005730(nucleolus);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0016926(protein desumoylation);GO:0019538(protein metabolic process);GO:0071339(MLL1 complex)","NA","K08593","EC:3.4.22.68","SUMO specific peptidase 3 [Source:NCBI gene;Acc:101123643]",{"v":4.406878,"d":"4.41"},{"v":3.932948,"d":"3.93"},{"v":4.173073,"d":"4.17"},{"v":5.202211,"d":"5.20"},{"v":4.186492,"d":"4.19"},{"v":4.753602,"d":"4.75"},{"v":0.884784976706414,"d":"0.88"},{"v":-0.176601205489202,"d":"-0.18"},{"v":0.768726772462124,"d":"0.77"},{"v":0.966068624199454,"d":"0.97"},"down","no"]
["ENSOARG00000008583","CACNA1A","ENSOART00000009374","GO:0001505(regulation of neurotransmitter levels);GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005262(calcium channel activity);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0007268(chemical synaptic transmission);GO:0007270(neuron-neuron synaptic transmission);GO:0007274(neuromuscular synaptic transmission);GO:0007416(synapse assembly);GO:0007628(adult walking behavior);GO:0008331(high voltage-gated calcium channel activity);GO:0010817(regulation of hormone levels);GO:0014051(gamma-aminobutyric acid secretion);GO:0014056(regulation of acetylcholine secretion, neurotransmission);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017156(calcium ion regulated exocytosis);GO:0017158(regulation of calcium ion-dependent exocytosis);GO:0019226(transmission of nerve impulse);GO:0021522(spinal cord motor neuron differentiation);GO:0021590(cerebellum maturation);GO:0021679(cerebellar molecular layer development);GO:0021680(cerebellar Purkinje cell layer development);GO:0021702(cerebellar Purkinje cell differentiation);GO:0021750(vestibular nucleus development);GO:0021953(central nervous system neuron differentiation);GO:0030425(dendrite);GO:0030644(cellular chloride ion homeostasis);GO:0031335(regulation of sulfur amino acid metabolic process);GO:0032353(negative regulation of hormone biosynthetic process);GO:0034765(regulation of ion transmembrane transport);GO:0035249(synaptic transmission, glutamatergic);GO:0042391(regulation of membrane potential);GO:0042593(glucose homeostasis);GO:0043025(neuronal cell body);GO:0043113(receptor clustering);GO:0043524(negative regulation of neuron apoptotic process);GO:0048265(response to pain);GO:0048266(behavioral response to pain);GO:0048791(calcium ion-regulated exocytosis of neurotransmitter);GO:0048813(dendrite morphogenesis);GO:0050770(regulation of axonogenesis);GO:0050877(nervous system process);GO:0050883(musculoskeletal movement, spinal reflex action);GO:0050885(neuromuscular process controlling balance);GO:0050905(neuromuscular process);GO:0051899(membrane depolarization);GO:0055085(transmembrane transport);GO:0060024(rhythmic synaptic transmission);GO:0070588(calcium ion transmembrane transport);GO:0098793(presynapse);GO:0098978(glutamatergic synapse);GO:0099509(regulation of presynaptic cytosolic calcium ion concentration);GO:0099626(voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04721(Synaptic vesicle cycle);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04727(GABAergic synapse);04728(Dopaminergic synapse);04730(Long-term depression);04742(Taste transduction);04930(Type II diabetes mellitus);05032(Morphine addiction);05033(Nicotine addiction)","K04344","NA","calcium voltage-gated channel subunit alpha1 A [Source:NCBI gene;Acc:101120920]",{"v":0.382731,"d":"0.38"},{"v":0.320001,"d":"0.32"},{"v":0.508894,"d":"0.51"},{"v":0.475163,"d":"0.48"},{"v":0.449509,"d":"0.45"},{"v":0.270489,"d":"0.27"},{"v":1.01377638661235,"d":"1.01"},{"v":0.0197394654554802,"d":"0.02"},{"v":0.770174115436405,"d":"0.77"},{"v":0.966068624199454,"d":"0.97"},"up","no"]
["MSTRG.19580","RAB2B","ENSOART00000021373","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0045921(positive regulation of exocytosis)","NA","K07878","NA","RAB2B, member RAS oncogene family [Source:NCBI gene;Acc:101108752]",{"v":4.100847,"d":"4.10"},{"v":2.931177,"d":"2.93"},{"v":2.986288,"d":"2.99"},{"v":4.327682,"d":"4.33"},{"v":3.705802,"d":"3.71"},{"v":3.443783,"d":"3.44"},{"v":0.872883065280262,"d":"0.87"},{"v":-0.19613969697731,"d":"-0.20"},{"v":0.770534496895651,"d":"0.77"},{"v":0.966068624199454,"d":"0.97"},"down","no"]
["MSTRG.632","RBM15","ENSOART00000021159","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000381(regulation of alternative mRNA splicing, via spliceosome);GO:0001510(RNA methylation);GO:0001569(branching involved in blood vessel morphogenesis);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0007221(positive regulation of transcription of Notch receptor target);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0016607(nuclear speck);GO:0036396(RNA N6-methyladenosine methyltransferase complex);GO:0038163(thrombopoietin-mediated signaling pathway);GO:0045638(negative regulation of myeloid cell differentiation);GO:0045652(regulation of megakaryocyte differentiation);GO:0048536(spleen development);GO:0060412(ventricular septum morphogenesis);GO:0060674(placenta blood vessel development)","NA","NA","NA","RNA binding motif protein 15 [Source:HGNC Symbol;Acc:HGNC:14959]",{"v":4.92684473902946,"d":"4.93"},{"v":5.64373191101332,"d":"5.64"},{"v":5.73628869306931,"d":"5.74"},{"v":5.90550707297396,"d":"5.91"},{"v":5.40019615939372,"d":"5.40"},{"v":4.99827638137147,"d":"5.00"},{"v":1.00017699539875,"d":"1.00"},{"v":0.000255327788780505,"d":"0.00"},{"v":0.770895893876679,"d":"0.77"},{"v":0.966068624199454,"d":"0.97"},"up","no"]
["MSTRG.20956","PTK2","ENSOART00000003724","GO:0000226(microtubule cytoskeleton organization);GO:0001525(angiogenesis);GO:0001568(blood vessel development);GO:0001570(vasculogenesis);GO:0001725(stress fiber);GO:0001764(neuron migration);GO:0001932(regulation of protein phosphorylation);GO:0001934(positive regulation of protein phosphorylation);GO:0003779(actin binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006468(protein phosphorylation);GO:0007097(nuclear migration);GO:0007172(signal complex assembly);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0008432(JUN kinase binding);GO:0010507(negative regulation of autophagy);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0010632(regulation of epithelial cell migration);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0016324(apical plasma membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0021955(central nervous system neuron axonogenesis);GO:0022408(negative regulation of cell-cell adhesion);GO:0030027(lamellipodium);GO:0030198(extracellular matrix organization);GO:0030335(positive regulation of cell migration);GO:0033628(regulation of cell adhesion mediated by integrin);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042127(regulation of cell population proliferation);GO:0042169(SH2 domain binding);GO:0043066(negative regulation of apoptotic process);GO:0043542(endothelial cell migration);GO:0045667(regulation of osteoblast differentiation);GO:0045860(positive regulation of protein kinase activity);GO:0046621(negative regulation of organ growth);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0050771(negative regulation of axonogenesis);GO:0051893(regulation of focal adhesion assembly);GO:0051897(positive regulation of protein kinase B signaling);GO:0051964(negative regulation of synapse assembly);GO:0060396(growth hormone receptor signaling pathway);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:1900024(regulation of substrate adhesion-dependent cell spreading);GO:2000060(positive regulation of ubiquitin-dependent protein catabolic process);GO:2000811(negative regulation of anoikis)","01522(Endocrine resistance);04012(ErbB signaling pathway);04062(Chemokine signaling pathway);04151(PI3K-Akt signaling pathway);04360(Axon guidance);04370(VEGF signaling pathway);04510(Focal adhesion);04670(Leukocyte transendothelial migration);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05146(Amoebiasis);05163(Human cytomegalovirus infection);05165(Human papillomavirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05205(Proteoglycans in cancer);05222(Small cell lung cancer);05418(Fluid shear stress and atherosclerosis)","K05725","EC:2.7.10.2","protein tyrosine kinase 2 [Source:NCBI gene;Acc:101120842]",{"v":3.48548693359777,"d":"3.49"},{"v":3.2260555850595,"d":"3.23"},{"v":3.30039651557221,"d":"3.30"},{"v":4.30994758021155,"d":"4.31"},{"v":3.91995931702659,"d":"3.92"},{"v":3.1562453936389,"d":"3.16"},{"v":0.879308371999501,"d":"0.88"},{"v":-0.185558890002435,"d":"-0.19"},{"v":0.771674510628148,"d":"0.77"},{"v":0.966068624199454,"d":"0.97"},"down","no"]
["MSTRG.9638","R3HCC1","ENSOART00000011041;ENSOART00000011042","GO:0003676(nucleic acid binding);GO:0003676(nucleic acid binding)","NA","NA","NA","R3H domain and coiled-coil containing 1 [Source:NCBI gene;Acc:101121074]",{"v":1.66930502594719,"d":"1.67"},{"v":2.48323562135476,"d":"2.48"},{"v":1.67732524615385,"d":"1.68"},{"v":2.3357157924225,"d":"2.34"},{"v":2.08580393134328,"d":"2.09"},{"v":2.24724290838117,"d":"2.25"},{"v":0.874205038480868,"d":"0.87"},{"v":-0.193956401766738,"d":"-0.19"},{"v":0.772453971294288,"d":"0.77"},{"v":0.966068624199454,"d":"0.97"},"down","no"]
["MSTRG.21558","MBTPS2","ENSOART00000017578","GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031293(membrane protein intracellular domain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070977(bone maturation);GO:1990440(positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress)","04141(Protein processing in endoplasmic reticulum)","K07765","EC:3.4.24.85","membrane bound transcription factor peptidase, site 2 [Source:NCBI gene;Acc:101106915]",{"v":3.986144,"d":"3.99"},{"v":3.445265,"d":"3.45"},{"v":4.221585,"d":"4.22"},{"v":4.373835,"d":"4.37"},{"v":3.986932,"d":"3.99"},{"v":3.22403,"d":"3.22"},{"v":1.00588676694119,"d":"1.01"},{"v":0.00846790955014315,"d":"0.01"},{"v":0.773582372168248,"d":"0.77"},{"v":0.966068624199454,"d":"0.97"},"up","no"]
["MSTRG.11903","SRPRA","ENSOART00000013482","GO:0003924(GTPase activity);GO:0005047(signal recognition particle binding);GO:0005525(GTP binding);GO:0005785(signal recognition particle receptor complex);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0006886(intracellular protein transport);GO:0016020(membrane)","03060(Protein export)","K13431","NA","SRP receptor subunit alpha [Source:NCBI gene;Acc:101113709]",{"v":22.5438588267477,"d":"22.54"},{"v":22.6815251219183,"d":"22.68"},{"v":23.0131993745356,"d":"23.01"},{"v":25.8498535764944,"d":"25.85"},{"v":26.1515174488349,"d":"26.15"},{"v":25.0744854069571,"d":"25.07"},{"v":0.885343173360018,"d":"0.89"},{"v":-0.175691319308748,"d":"-0.18"},{"v":0.774001630784282,"d":"0.77"},{"v":0.966068624199454,"d":"0.97"},"down","no"]
["MSTRG.3306","IFI35","ENSOART00000004802","GO:0005634(nucleus)","NA","NA","NA","interferon induced protein 35 [Source:NCBI gene;Acc:101108064]",{"v":3.699138,"d":"3.70"},{"v":2.664082,"d":"2.66"},{"v":1.956343,"d":"1.96"},{"v":3.707125,"d":"3.71"},{"v":2.981041,"d":"2.98"},{"v":2.861569,"d":"2.86"},{"v":0.871182603496327,"d":"0.87"},{"v":-0.198952949487459,"d":"-0.20"},{"v":0.774517994295099,"d":"0.77"},{"v":0.966104076590712,"d":"0.97"},"down","no"]
["MSTRG.15050","ETAA1","ENSOART00000021715","GO:0006974(cellular response to DNA damage stimulus);GO:0031297(replication fork processing);GO:0043539(protein serine/threonine kinase activator activity);GO:0043596(nuclear replication fork);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:2000001(regulation of DNA damage checkpoint)","NA","NA","NA","ETAA1, ATR kinase activator [Source:NCBI gene;Acc:101111788]",{"v":3.303139,"d":"3.30"},{"v":2.189399,"d":"2.19"},{"v":2.199979,"d":"2.20"},{"v":2.814131,"d":"2.81"},{"v":2.625159,"d":"2.63"},{"v":2.15723,"d":"2.16"},{"v":1.01263697061286,"d":"1.01"},{"v":0.0181170620308796,"d":"0.02"},{"v":0.775177487210796,"d":"0.78"},{"v":0.966104076590712,"d":"0.97"},"up","no"]
["ENSOARG00000000813","ENSOARG00000000813","ENSOART00000000873","GO:0016021(integral component of membrane)","NA","K17988","NA","tectonin beta-propeller repeat containing 1 [Source:NCBI gene;Acc:101104628]",{"v":0.506341,"d":"0.51"},{"v":0.645795,"d":"0.65"},{"v":0.541992,"d":"0.54"},{"v":0.703087,"d":"0.70"},{"v":0.973253,"d":"0.97"},{"v":0.323416,"d":"0.32"},{"v":0.847167354417239,"d":"0.85"},{"v":-0.239281098720236,"d":"-0.24"},{"v":0.776254980392296,"d":"0.78"},{"v":0.966104076590712,"d":"0.97"},"down","no"]
["MSTRG.13378","BFAR","ENSOART00000008419","GO:0000209(protein polyubiquitination);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030674(protein binding, bridging);GO:0043066(negative regulation of apoptotic process);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity);GO:0070534(protein K63-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination);GO:0089720(caspase binding);GO:1903895(negative regulation of IRE1-mediated unfolded protein response)","NA","K15684","NA","bifunctional apoptosis regulator [Source:NCBI gene;Acc:101112619]",{"v":5.52124928836375,"d":"5.52"},{"v":4.52292692402034,"d":"4.52"},{"v":5.40234993060126,"d":"5.40"},{"v":5.8753273763087,"d":"5.88"},{"v":6.08864494196829,"d":"6.09"},{"v":5.43719409452587,"d":"5.44"},{"v":0.887671882249262,"d":"0.89"},{"v":-0.171901595485013,"d":"-0.17"},{"v":0.776442476282329,"d":"0.78"},{"v":0.966104076590712,"d":"0.97"},"down","no"]
["MSTRG.13623","ENSOARG00000011276","ENSOART00000012270;ENSOART00000012271","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II)","03022(Basal transcription factors);04022(cGMP-PKG signaling pathway);04022(cGMP-PKG signaling pathway)","K03121","NA","general transcription factor IIi [Source:NCBI gene;Acc:101113297]",{"v":6.83562838197613,"d":"6.84"},{"v":6.49557340891541,"d":"6.50"},{"v":6.76662413399438,"d":"6.77"},{"v":9.71478790812566,"d":"9.71"},{"v":6.45515003983854,"d":"6.46"},{"v":6.73735017348192,"d":"6.74"},{"v":0.877355094078991,"d":"0.88"},{"v":-0.188767228520516,"d":"-0.19"},{"v":0.777219687857949,"d":"0.78"},{"v":0.966104076590712,"d":"0.97"},"down","no"]
["ENSOARG00000007603","ENSOARG00000007603","ENSOART00000008276","GO:0002218(activation of innate immune response);GO:0035458(cellular response to interferon-beta)","04621(NOD-like receptor signaling pathway)","K20914","NA","interferon gamma inducible protein 16 [Source:NCBI gene;Acc:101112936]",{"v":0.75426,"d":"0.75"},{"v":0.332816,"d":"0.33"},{"v":0.460806,"d":"0.46"},{"v":0.776696,"d":"0.78"},{"v":0.366617,"d":"0.37"},{"v":0.671075,"d":"0.67"},{"v":0.853115210197598,"d":"0.85"},{"v":-0.229187509314514,"d":"-0.23"},{"v":0.77795374738733,"d":"0.78"},{"v":0.966104076590712,"d":"0.97"},"down","no"]
["MSTRG.10406","R3HDM1","ENSOART00000011745","GO:0003676(nucleic acid binding)","NA","NA","NA","R3H domain containing 1 [Source:NCBI gene;Acc:101104555]",{"v":2.70795099976937,"d":"2.71"},{"v":2.54315296563653,"d":"2.54"},{"v":2.94006022140221,"d":"2.94"},{"v":3.29625108071956,"d":"3.30"},{"v":2.71653119072878,"d":"2.72"},{"v":3.22657185124539,"d":"3.23"},{"v":0.886551600689159,"d":"0.89"},{"v":-0.173723490958153,"d":"-0.17"},{"v":0.778558427821831,"d":"0.78"},{"v":0.966104076590712,"d":"0.97"},"down","no"]
["MSTRG.17591","HIST3H2A","ENSOART00000001580","GO:0000786(nucleosome);GO:0000788(nuclear nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006337(nucleosome disassembly);GO:0046982(protein heterodimerization activity);GO:0070914(UV-damage excision repair)","04217(Necroptosis);05034(Alcoholism);05322(Systemic lupus erythematosus)","K11251","NA","histone H2A type 3 [Source:NCBI gene;Acc:101123292]",{"v":3.064395,"d":"3.06"},{"v":2.033878,"d":"2.03"},{"v":1.559124,"d":"1.56"},{"v":2.324251,"d":"2.32"},{"v":1.451442,"d":"1.45"},{"v":2.530434,"d":"2.53"},{"v":1.05570296950886,"d":"1.06"},{"v":0.0782039779773355,"d":"0.08"},{"v":0.779268309251519,"d":"0.78"},{"v":0.966104076590712,"d":"0.97"},"up","no"]
["MSTRG.4095","SPEN","ENSOART00000009229","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001085(RNA polymerase II transcription factor binding);GO:0003676(nucleic acid binding);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0017053(transcriptional repressor complex);GO:0045892(negative regulation of transcription, DNA-templated);GO:0050769(positive regulation of neurogenesis)","NA","NA","NA","spen family transcriptional repressor [Source:NCBI gene;Acc:101108848]",{"v":3.91184473488341,"d":"3.91"},{"v":4.62842863747288,"d":"4.63"},{"v":4.39005820146421,"d":"4.39"},{"v":4.38746713028742,"d":"4.39"},{"v":4.58409350901573,"d":"4.58"},{"v":3.9642726837039,"d":"3.96"},{"v":0.999574689233452,"d":"1.00"},{"v":-0.00061372425475582,"d":"-0.00"},{"v":0.780317174075409,"d":"0.78"},{"v":0.966326796989252,"d":"0.97"},"down","no"]
["MSTRG.12212","NAP1L4","ENSOART00000002481;ENSOART00000002482","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006334(nucleosome assembly);GO:0031491(nucleosome binding);GO:0031491(nucleosome binding)","NA","K11282","NA","nucleosome assembly protein 1 like 4 [Source:NCBI gene;Acc:101102274]",{"v":12.4937638083481,"d":"12.49"},{"v":12.972145883659,"d":"12.97"},{"v":11.0065095857904,"d":"11.01"},{"v":12.4956654460036,"d":"12.50"},{"v":11.2622664856128,"d":"11.26"},{"v":12.6051332550622,"d":"12.61"},{"v":1.00300728474229,"d":"1.00"},{"v":0.00433208413894202,"d":"0.00"},{"v":0.781227917676859,"d":"0.78"},{"v":0.966769694953945,"d":"0.97"},"up","no"]
["MSTRG.15549","TMEM19","ENSOART00000015918","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 19 [Source:NCBI gene;Acc:101120066]",{"v":4.471574,"d":"4.47"},{"v":4.779957,"d":"4.78"},{"v":4.362514,"d":"4.36"},{"v":5.476224,"d":"5.48"},{"v":4.733222,"d":"4.73"},{"v":3.454051,"d":"3.45"},{"v":0.996380721567839,"d":"1.00"},{"v":-0.00523098696531861,"d":"-0.01"},{"v":0.78216282950489,"d":"0.78"},{"v":0.966967762788903,"d":"0.97"},"down","no"]
["MSTRG.14738","ENSOARG00000009652","ENSOART00000010511","GO:0005634(nucleus);GO:0006334(nucleosome assembly)","NA","K11290","NA","SET nuclear proto-oncogene [Source:NCBI gene;Acc:101118680]",{"v":7.24953979530279,"d":"7.25"},{"v":5.83273721528897,"d":"5.83"},{"v":6.28213701105227,"d":"6.28"},{"v":7.12711884319595,"d":"7.13"},{"v":6.07102230025328,"d":"6.07"},{"v":6.14552800322358,"d":"6.15"},{"v":1.00107243743749,"d":"1.00"},{"v":0.00154637112770913,"d":"0.00"},{"v":0.783061905105829,"d":"0.78"},{"v":0.966967762788903,"d":"0.97"},"up","no"]
["MSTRG.3304","ENSOARG00000004172","ENSOART00000004539","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004813(alanine-tRNA ligase activity);GO:0005524(ATP binding);GO:0006419(alanyl-tRNA aminoacylation);GO:0043039(tRNA aminoacylation)","NA","K07050","EC:3.1.1.-","alanyl-tRNA editing protein Aarsd1 [Source:NCBI gene;Acc:101107295]",{"v":8.03030619008265,"d":"8.03"},{"v":8.78146204495868,"d":"8.78"},{"v":7.24217473950413,"d":"7.24"},{"v":9.66658732165289,"d":"9.67"},{"v":8.00180415371901,"d":"8.00"},{"v":9.49689037652893,"d":"9.50"},{"v":0.88546635023639,"d":"0.89"},{"v":-0.175490612607533,"d":"-0.18"},{"v":0.783216542597943,"d":"0.78"},{"v":0.966967762788903,"d":"0.97"},"down","no"]
["MSTRG.16939","PRKAR2B","ENSOART00000005398","GO:0000166(nucleotide binding);GO:0001932(regulation of protein phosphorylation);GO:0004862(cAMP-dependent protein kinase inhibitor activity);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005886(plasma membrane);GO:0005952(cAMP-dependent protein kinase complex);GO:0006631(fatty acid metabolic process);GO:0007612(learning);GO:0008603(cAMP-dependent protein kinase regulator activity);GO:0019901(protein kinase binding);GO:0030552(cAMP binding);GO:0031625(ubiquitin protein ligase binding);GO:0034236(protein kinase A catalytic subunit binding);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0050804(modulation of chemical synaptic transmission);GO:0097546(ciliary base);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000480(negative regulation of cAMP-dependent protein kinase activity)","04910(Insulin signaling pathway)","K04739","NA","protein kinase cAMP-dependent type II regulatory subunit beta [Source:NCBI gene;Acc:101106003]",{"v":1.894601,"d":"1.89"},{"v":0.976149,"d":"0.98"},{"v":1.307492,"d":"1.31"},{"v":1.484932,"d":"1.48"},{"v":1.709676,"d":"1.71"},{"v":1.538553,"d":"1.54"},{"v":0.882759322997887,"d":"0.88"},{"v":-0.179907942230958,"d":"-0.18"},{"v":0.78443810352263,"d":"0.78"},{"v":0.967419193857296,"d":"0.97"},"down","no"]
["MSTRG.3761","ENSOARG00000008900","ENSOART00000009692","GO:0000166(nucleotide binding);GO:0005388(calcium-transporting ATPase activity);GO:0005524(ATP binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0070588(calcium ion transmembrane transport);GO:0099132(ATP hydrolysis coupled cation transmembrane transport)","NA","NA","NA",null,{"v":4.3780258155414,"d":"4.38"},{"v":2.23185622216561,"d":"2.23"},{"v":2.77564137375796,"d":"2.78"},{"v":3.39294694522293,"d":"3.39"},{"v":3.7170070466242,"d":"3.72"},{"v":3.38464087388535,"d":"3.38"},{"v":0.894319745692241,"d":"0.89"},{"v":-0.161137365211059,"d":"-0.16"},{"v":0.784663861830027,"d":"0.78"},{"v":0.967446470781602,"d":"0.97"},"down","no"]
["MSTRG.9689","NCBP1","ENSOART00000012216;ENSOART00000012218","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000245(spliceosomal complex assembly);GO:0000339(RNA cap binding);GO:0000340(RNA 7-methylguanosine cap binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005845(mRNA cap binding complex);GO:0005846(nuclear cap binding complex);GO:0006370(7-methylguanosine mRNA capping);GO:0006406(mRNA export from nucleus);GO:0006446(regulation of translational initiation);GO:0016070(RNA metabolic process);GO:0030307(positive regulation of cell growth);GO:0031442(positive regulation of mRNA 3'-end processing);GO:0034518(RNA cap binding complex);GO:0045292(mRNA cis splicing, via spliceosome);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0051028(mRNA transport);GO:0098789(pre-mRNA cleavage required for polyadenylation);GO:1905216(positive regulation of RNA binding);GO:1990904(ribonucleoprotein complex);GO:1990904(ribonucleoprotein complex)","03013(RNA transport);03015(mRNA surveillance pathway);03040(Spliceosome);03040(Spliceosome)","K12882","NA","nuclear cap binding protein subunit 1 [Source:NCBI gene;Acc:101104206]",{"v":4.1017327756537,"d":"4.10"},{"v":3.65658924258405,"d":"3.66"},{"v":3.35077928301472,"d":"3.35"},{"v":4.32170500878928,"d":"4.32"},{"v":3.67762444407822,"d":"3.68"},{"v":3.14534455833883,"d":"3.15"},{"v":0.996808097758796,"d":"1.00"},{"v":-0.0046123064722736,"d":"-0.00"},{"v":0.785118585793908,"d":"0.79"},{"v":0.967703459089556,"d":"0.97"},"down","no"]
["MSTRG.7425","LARP1B","ENSOART00000016652","GO:0003723(RNA binding)","NA","NA","NA","La ribonucleoprotein domain family member 1B [Source:HGNC Symbol;Acc:HGNC:24704]",{"v":1.59976153864319,"d":"1.60"},{"v":2.43335647778016,"d":"2.43"},{"v":1.94745289920567,"d":"1.95"},{"v":2.41432802640618,"d":"2.41"},{"v":2.20350809081151,"d":"2.20"},{"v":2.19258384907686,"d":"2.19"},{"v":0.878150091364037,"d":"0.88"},{"v":-0.187460551982535,"d":"-0.19"},{"v":0.786388879150231,"d":"0.79"},{"v":0.967801435705666,"d":"0.97"},"down","no"]
["MSTRG.19465","ENSOARG00000018551","ENSOART00000020194","GO:0005515(protein binding)","NA","K18646","NA","acidic nuclear phosphoprotein 32 family member A [Source:NCBI gene;Acc:101105917]",{"v":12.6703642154696,"d":"12.67"},{"v":11.0419588692449,"d":"11.04"},{"v":11.9772342081031,"d":"11.98"},{"v":13.9418595174954,"d":"13.94"},{"v":12.1565856887661,"d":"12.16"},{"v":13.9684606519337,"d":"13.97"},{"v":0.890749024123053,"d":"0.89"},{"v":-0.166909097099771,"d":"-0.17"},{"v":0.787463038862793,"d":"0.79"},{"v":0.968054246239398,"d":"0.97"},"down","no"]
["MSTRG.6329","CCDC84","ENSOART00000013161","NA","NA","NA","NA","coiled-coil domain containing 84 [Source:NCBI gene;Acc:101104854]",{"v":0.929299,"d":"0.93"},{"v":1.183336,"d":"1.18"},{"v":1.776935,"d":"1.78"},{"v":1.31124,"d":"1.31"},{"v":0.993139,"d":"0.99"},{"v":1.484651,"d":"1.48"},{"v":1.02653449563609,"d":"1.03"},{"v":0.0377821085443478,"d":"0.04"},{"v":0.788366348557356,"d":"0.79"},{"v":0.968435580743643,"d":"0.97"},"up","no"]
["MSTRG.11688","ECI2","ENSOART00000000302","GO:0000062(fatty-acyl-CoA binding);GO:0003824(catalytic activity);GO:0005102(signaling receptor binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0043231(intracellular membrane-bounded organelle)","00071(Fatty acid degradation);04146(Peroxisome)","K13239","EC:5.3.3.8","enoyl-CoA delta isomerase 2 [Source:NCBI gene;Acc:101121214]",{"v":14.7751744929312,"d":"14.78"},{"v":13.251299628181,"d":"13.25"},{"v":11.6128150230914,"d":"11.61"},{"v":17.368685065033,"d":"17.37"},{"v":11.4862059321395,"d":"11.49"},{"v":15.8717332723845,"d":"15.87"},{"v":0.886257118473927,"d":"0.89"},{"v":-0.17420278466972,"d":"-0.17"},{"v":0.788783834758547,"d":"0.79"},{"v":0.968507825963083,"d":"0.97"},"down","no"]
["MSTRG.19792","GTF2A2;BNIP2","ENSOART00000022691;ENSOART00000022690","GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005672(transcription factor TFIIA complex);GO:0006366(transcription by RNA polymerase II);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0008134(transcription factor binding);GO:0016251(RNA polymerase II general transcription initiation factor activity);GO:0017025(TBP-class protein binding);GO:0030054(cell junction);GO:0042803(protein homodimerization activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051123(RNA polymerase II preinitiation complex assembly);GO:0001824(blastocyst development);GO:0005814(centriole);GO:0007098(centrosome cycle);GO:0031616(spindle pole centrosome);GO:0043410(positive regulation of MAPK cascade);GO:0045666(positive regulation of neuron differentiation);GO:0051057(positive regulation of small GTPase mediated signal transduction);GO:0051146(striated muscle cell differentiation)","03022(Basal transcription factors);05203(Viral carcinogenesis)","K03123;K18448","NA","general transcription factor IIA subunit 2 [Source:NCBI gene;Acc:101114960];BCL2 interacting protein 2 [Source:NCBI gene;Acc:101103240]",{"v":3.61229247456243,"d":"3.61"},{"v":2.97013472275379,"d":"2.97"},{"v":2.62162627794632,"d":"2.62"},{"v":3.3336603588098,"d":"3.33"},{"v":2.92442927992999,"d":"2.92"},{"v":2.93478574597433,"d":"2.93"},{"v":1.00121595149294,"d":"1.00"},{"v":0.00175318151286249,"d":"0.00"},{"v":0.790148366601577,"d":"0.79"},{"v":0.968830758923921,"d":"0.97"},"up","no"]
["MSTRG.20008","MNAT1","ENSOART00000023025","GO:0005654(nucleoplasm);GO:0005675(transcription factor TFIIH holo complex);GO:0005829(cytosol);GO:0006289(nucleotide-excision repair);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0006468(protein phosphorylation);GO:0007512(adult heart development);GO:0008094(DNA-dependent ATPase activity);GO:0008353(RNA polymerase II CTD heptapeptide repeat kinase activity);GO:0019907(cyclin-dependent protein kinase activating kinase holoenzyme complex);GO:0021591(ventricular system development);GO:0045737(positive regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0051592(response to calcium ion);GO:0061575(cyclin-dependent protein serine/threonine kinase activator activity);GO:1905775(negative regulation of DNA helicase activity)","03022(Basal transcription factors);03420(Nucleotide excision repair)","K10842","NA","MNAT1, CDK activating kinase assembly factor [Source:NCBI gene;Acc:101104405]",{"v":4.63394066825321,"d":"4.63"},{"v":5.15360323560209,"d":"5.15"},{"v":4.46722081913375,"d":"4.47"},{"v":5.31515183436459,"d":"5.32"},{"v":4.98245152118039,"d":"4.98"},{"v":4.03622608710138,"d":"4.04"},{"v":0.994484047687768,"d":"0.99"},{"v":-0.00797986561449795,"d":"-0.01"},{"v":0.790436372872024,"d":"0.79"},{"v":0.968864581957391,"d":"0.97"},"down","no"]
["MSTRG.8817","ENSOARG00000024351","ENSOART00000026253","NA","NA","NA","NA",null,{"v":4.0268641116518,"d":"4.03"},{"v":3.12726024929035,"d":"3.13"},{"v":3.23347200209516,"d":"3.23"},{"v":4.67155160671803,"d":"4.67"},{"v":3.95261818194107,"d":"3.95"},{"v":3.09801376517302,"d":"3.10"},{"v":0.886148584462447,"d":"0.89"},{"v":-0.17437947274973,"d":"-0.17"},{"v":0.791489063304763,"d":"0.79"},{"v":0.968992435679367,"d":"0.97"},"down","no"]
["ENSOARG00000000318","ENSOARG00000000318","ENSOART00000000338","NA","00230(Purine metabolism)","K01952","EC:6.3.5.3","phosphoribosylformylglycinamidine synthase [Source:NCBI gene;Acc:101122962]",{"v":0.621883,"d":"0.62"},{"v":0.480015,"d":"0.48"},{"v":0.865507,"d":"0.87"},{"v":0.959542,"d":"0.96"},{"v":0.629891,"d":"0.63"},{"v":0.688265,"d":"0.69"},{"v":0.863769033471514,"d":"0.86"},{"v":-0.211282498715066,"d":"-0.21"},{"v":0.792490876100047,"d":"0.79"},{"v":0.969005740471803,"d":"0.97"},"down","no"]
["MSTRG.20662","EPM2A","ENSOART00000002107","GO:0000045(autophagosome assembly);GO:0001558(regulation of cell growth);GO:0001932(regulation of protein phosphorylation);GO:0004721(phosphoprotein phosphatase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0005977(glycogen metabolic process);GO:0005978(glycogen biosynthetic process);GO:0006470(protein dephosphorylation);GO:0006816(calcium ion transport);GO:0006914(autophagy);GO:0007005(mitochondrion organization);GO:0007399(nervous system development);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0010468(regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0014009(glial cell proliferation);GO:0015813(L-glutamate transmembrane transport);GO:0016055(Wnt signaling pathway);GO:0016239(positive regulation of macroautophagy);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0019203(carbohydrate phosphatase activity);GO:0030246(carbohydrate binding);GO:0030247(polysaccharide binding);GO:0030425(dendrite);GO:0031396(regulation of protein ubiquitination);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0042306(regulation of protein import into nucleus);GO:0042325(regulation of phosphorylation);GO:0042803(protein homodimerization activity);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043204(perikaryon);GO:0044260(cellular macromolecule metabolic process);GO:0045786(negative regulation of cell cycle);GO:0045859(regulation of protein kinase activity);GO:0046838(phosphorylated carbohydrate dephosphorylation);GO:0046959(habituation);GO:0051260(protein homooligomerization);GO:0061136(regulation of proteasomal protein catabolic process);GO:0098554(cytoplasmic side of endoplasmic reticulum membrane);GO:0098556(cytoplasmic side of rough endoplasmic reticulum membrane);GO:1903076(regulation of protein localization to plasma membrane);GO:1904666(regulation of ubiquitin protein ligase activity);GO:2000465(regulation of glycogen (starch) synthase activity);GO:2001069(glycogen binding);GO:2001070(starch binding)","NA","NA","NA","EPM2A, laforin glucan phosphatase [Source:HGNC Symbol;Acc:HGNC:3413]",{"v":6.99287979755119,"d":"6.99"},{"v":9.80806612222926,"d":"9.81"},{"v":9.16961927549082,"d":"9.17"},{"v":10.7622173261558,"d":"10.76"},{"v":7.49535768819928,"d":"7.50"},{"v":7.9964112227148,"d":"8.00"},{"v":0.989204647277585,"d":"0.99"},{"v":-0.0156590773708178,"d":"-0.02"},{"v":0.793192812820737,"d":"0.79"},{"v":0.969005740471803,"d":"0.97"},"down","no"]
["MSTRG.2544","COX11","ENSOART00000005349","GO:0005507(copper ion binding);GO:0005739(mitochondrion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031305(integral component of mitochondrial inner membrane);GO:0032991(protein-containing complex);GO:0033132(negative regulation of glucokinase activity);GO:0055065(metal ion homeostasis)","00190(Oxidative phosphorylation);04714(Thermogenesis)","K02258","NA","cytochrome c oxidase assembly protein COX11, mitochondrial [Source:NCBI gene;Acc:101118455]",{"v":6.31679811706102,"d":"6.32"},{"v":5.05070036695724,"d":"5.05"},{"v":4.05228468410129,"d":"4.05"},{"v":5.44807700166044,"d":"5.45"},{"v":4.53086085512661,"d":"4.53"},{"v":5.36963631672893,"d":"5.37"},{"v":1.00463945339799,"d":"1.00"},{"v":0.00667783760193777,"d":"0.01"},{"v":0.793834536280217,"d":"0.79"},{"v":0.969005740471803,"d":"0.97"},"up","no"]
["MSTRG.2277","NUP58","ENSOART00000014274","GO:0005643(nuclear pore);GO:0006913(nucleocytoplasmic transport)","03013(RNA transport)","K14307","NA","nucleoporin 58 [Source:NCBI gene;Acc:101115885]",{"v":4.12893713816231,"d":"4.13"},{"v":3.53300430181086,"d":"3.53"},{"v":3.3994801676727,"d":"3.40"},{"v":3.84131041784038,"d":"3.84"},{"v":3.60338320657277,"d":"3.60"},{"v":3.60692234875922,"d":"3.61"},{"v":1.00088725798085,"d":"1.00"},{"v":0.00127947516058863,"d":"0.00"},{"v":0.794311596802499,"d":"0.79"},{"v":0.969005740471803,"d":"0.97"},"up","no"]
["MSTRG.21539","CDKL5","ENSOART00000014974;ENSOART00000014975","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0016301(kinase activity);GO:0036064(ciliary basal body);GO:0046777(protein autophosphorylation);GO:0097542(ciliary tip);GO:0098978(glutamatergic synapse);GO:0099175(regulation of postsynapse organization);GO:1902017(regulation of cilium assembly);GO:1902017(regulation of cilium assembly)","NA","K08824","EC:2.7.11.22","cyclin dependent kinase like 5 [Source:NCBI gene;Acc:101108546]",{"v":1.47908046377793,"d":"1.48"},{"v":1.36367812728504,"d":"1.36"},{"v":2.1035600352065,"d":"2.10"},{"v":1.72919580670278,"d":"1.73"},{"v":2.12927705687204,"d":"2.13"},{"v":1.07286509918754,"d":"1.07"},{"v":1.00303784969115,"d":"1.00"},{"v":0.00437604715789956,"d":"0.00"},{"v":0.794926528718936,"d":"0.79"},{"v":0.969005740471803,"d":"0.97"},"up","no"]
["MSTRG.17294","LUZP6","ENSOART00000001274","NA","NA","NA","NA","leucine zipper protein 6 [Source:HGNC Symbol;Acc:HGNC:33955]",{"v":15.846653,"d":"15.85"},{"v":10.451576,"d":"10.45"},{"v":23.716846,"d":"23.72"},{"v":14.100128,"d":"14.10"},{"v":14.213893,"d":"14.21"},{"v":20.113781,"d":"20.11"},{"v":1.03277606941566,"d":"1.03"},{"v":0.0465274772765915,"d":"0.05"},{"v":0.795087995152782,"d":"0.80"},{"v":0.969005740471803,"d":"0.97"},"up","no"]
["MSTRG.14410","NSD3","ENSOART00000001552","GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008168(methyltransferase activity);GO:0016571(histone methylation);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0032259(methylation);GO:0034968(histone lysine methylation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:2001255(positive regulation of histone H3-K36 trimethylation)","00310(Lysine degradation)","K11425","EC:2.1.1.43","nuclear receptor binding SET domain protein 3 [Source:NCBI gene;Acc:101112880]",{"v":3.39449859912718,"d":"3.39"},{"v":2.86799312936409,"d":"2.87"},{"v":3.1386187665212,"d":"3.14"},{"v":3.72713477945761,"d":"3.73"},{"v":3.41167835052993,"d":"3.41"},{"v":2.34102614697631,"d":"2.34"},{"v":0.991695135365565,"d":"0.99"},{"v":-0.012031416104415,"d":"-0.01"},{"v":0.79588508807792,"d":"0.80"},{"v":0.969005740471803,"d":"0.97"},"down","no"]
["MSTRG.14682","RAPGEF1","ENSOART00000007101","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0007264(small GTPase mediated signal transduction);GO:0010976(positive regulation of neuron projection development);GO:0017034(Rap guanyl-nucleotide exchange factor activity);GO:0032486(Rap protein signal transduction);GO:0038180(nerve growth factor signaling pathway);GO:0043547(positive regulation of GTPase activity);GO:0061028(establishment of endothelial barrier);GO:0071320(cellular response to cAMP);GO:1901888(regulation of cell junction assembly);GO:1990090(cellular response to nerve growth factor stimulus)","04015(Rap1 signaling pathway);04510(Focal adhesion);04722(Neurotrophin signaling pathway);04910(Insulin signaling pathway);05211(Renal cell carcinoma)","K06277","NA","Rap guanine nucleotide exchange factor 1 [Source:NCBI gene;Acc:101121164]",{"v":4.83333073562829,"d":"4.83"},{"v":4.68734583728781,"d":"4.69"},{"v":5.39735151450729,"d":"5.40"},{"v":4.93328807203482,"d":"4.93"},{"v":6.06458535517111,"d":"6.06"},{"v":3.99669692499593,"d":"4.00"},{"v":0.994895334579078,"d":"0.99"},{"v":-0.00738333629262177,"d":"-0.01"},{"v":0.796647378943907,"d":"0.80"},{"v":0.969189121555771,"d":"0.97"},"down","no"]
["MSTRG.6734","CRY2","ENSOART00000002583","GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006606(protein import into nucleus);GO:0007623(circadian rhythm);GO:0009416(response to light stimulus);GO:0014823(response to activity);GO:0016607(nuclear speck);GO:0019900(kinase binding);GO:0019901(protein kinase binding);GO:0019915(lipid storage);GO:0032868(response to insulin);GO:0032922(circadian regulation of gene expression);GO:0035257(nuclear hormone receptor binding);GO:0042593(glucose homeostasis);GO:0042752(regulation of circadian rhythm);GO:0042754(negative regulation of circadian rhythm);GO:0043153(entrainment of circadian clock by photoperiod);GO:0045892(negative regulation of transcription, DNA-templated);GO:0071949(FAD binding);GO:2000323(negative regulation of glucocorticoid receptor signaling pathway);GO:2000850(negative regulation of glucocorticoid secretion)","04710(Circadian rhythm)","K02295","NA","cryptochrome circadian regulator 2 [Source:NCBI gene;Acc:100169934]",{"v":6.98040342630318,"d":"6.98"},{"v":8.49663664275015,"d":"8.50"},{"v":7.46116074176153,"d":"7.46"},{"v":8.35035011893349,"d":"8.35"},{"v":9.11705954718394,"d":"9.12"},{"v":8.36622495206711,"d":"8.37"},{"v":0.887919998476267,"d":"0.89"},{"v":-0.171498399168923,"d":"-0.17"},{"v":0.797633120062574,"d":"0.80"},{"v":0.969585123316317,"d":"0.97"},"down","no"]
["MSTRG.17538","GATAD2A","ENSOART00000008575","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0016581(NuRD complex);GO:0030674(protein binding, bridging);GO:0045892(negative regulation of transcription, DNA-templated)","NA","K23194","NA","GATA zinc finger domain containing 2A [Source:NCBI gene;Acc:101105075]",{"v":2.07367632290363,"d":"2.07"},{"v":2.33244654443054,"d":"2.33"},{"v":2.78276364580726,"d":"2.78"},{"v":2.81781944555695,"d":"2.82"},{"v":2.6726752640801,"d":"2.67"},{"v":2.63323618710889,"d":"2.63"},{"v":0.884924255186866,"d":"0.88"},{"v":-0.176374121435116,"d":"-0.18"},{"v":0.798359494088271,"d":"0.80"},{"v":0.969911742520333,"d":"0.97"},"down","no"]
["MSTRG.4922","TPX2","ENSOART00000001525","GO:0000922(spindle pole);GO:0005654(nucleoplasm);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005874(microtubule);GO:0015630(microtubule cytoskeleton);GO:0019901(protein kinase binding);GO:0032147(activation of protein kinase activity);GO:0043203(axon hillock);GO:0045171(intercellular bridge);GO:0060236(regulation of mitotic spindle organization);GO:0061676(importin-alpha family protein binding);GO:0072686(mitotic spindle);GO:0090307(mitotic spindle assembly)","NA","K16812","NA","TPX2, microtubule nucleation factor [Source:NCBI gene;Acc:101102581]",{"v":1.62951500926088,"d":"1.63"},{"v":1.46000168984798,"d":"1.46"},{"v":1.54221233426525,"d":"1.54"},{"v":2.12189041097327,"d":"2.12"},{"v":1.06993099178752,"d":"1.07"},{"v":1.46927102830683,"d":"1.47"},{"v":0.99370031851379,"d":"0.99"},{"v":-0.00911726742741215,"d":"-0.01"},{"v":0.799496451909229,"d":"0.80"},{"v":0.97028153375431,"d":"0.97"},"down","no"]
["MSTRG.4104","PLEKHM2;SLC25A34","ENSOART00000009756;ENSOART00000009604","GO:0007030(Golgi organization);GO:0010008(endosome membrane);GO:0019894(kinesin binding);GO:0032418(lysosome localization);GO:0032880(regulation of protein localization);GO:1903527(positive regulation of membrane tubulation);GO:0001835(blastocyst hatching);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","05132(Salmonella infection)","K15348;K15117","NA","pleckstrin homology and RUN domain containing M2 [Source:NCBI gene;Acc:101109632];solute carrier family 25 member 34 [Source:NCBI gene;Acc:101109896]",{"v":16.1661833389617,"d":"16.17"},{"v":16.7925026272683,"d":"16.79"},{"v":14.6867588079573,"d":"14.69"},{"v":25.7179072317322,"d":"25.72"},{"v":13.6025403703057,"d":"13.60"},{"v":15.0736511234352,"d":"15.07"},{"v":0.875930402205095,"d":"0.88"},{"v":-0.191111851068308,"d":"-0.19"},{"v":0.800052278405506,"d":"0.80"},{"v":0.970668271794108,"d":"0.97"},"down","no"]
["MSTRG.5291","MTHFSD","ENSOART00000012589;ENSOART00000012590","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003723(RNA binding)","NA","NA","NA","methenyltetrahydrofolate synthetase domain containing [Source:NCBI gene;Acc:101105679]",{"v":2.30742318143813,"d":"2.31"},{"v":2.06532116638796,"d":"2.07"},{"v":1.96920057901338,"d":"1.97"},{"v":2.6539168770903,"d":"2.65"},{"v":1.68976003971572,"d":"1.69"},{"v":2.03356438545151,"d":"2.03"},{"v":0.994465259546387,"d":"0.99"},{"v":-0.00800712177261179,"d":"-0.01"},{"v":0.800718065772004,"d":"0.80"},{"v":0.971069188749999,"d":"0.97"},"down","no"]
["MSTRG.13444","IGSF6","ENSOART00000017390","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","immunoglobulin superfamily member 6 [Source:NCBI gene;Acc:101104452]",{"v":0.499872,"d":"0.50"},{"v":0.350894,"d":"0.35"},{"v":0.325242,"d":"0.33"},{"v":0.313361,"d":"0.31"},{"v":0.398544,"d":"0.40"},{"v":0.432037,"d":"0.43"},{"v":1.02803114143899,"d":"1.03"},{"v":0.0398839677604958,"d":"0.04"},{"v":0.80138561590407,"d":"0.80"},{"v":0.971131389081317,"d":"0.97"},"up","no"]
["MSTRG.12045","UBXN1","ENSOART00000017906","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0031397(negative regulation of protein ubiquitination);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0031625(ubiquitin protein ligase binding);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0034098(VCP-NPL4-UFD1 AAA ATPase complex);GO:0036435(K48-linked polyubiquitin modification-dependent protein binding);GO:0043130(ubiquitin binding);GO:0051117(ATPase binding);GO:0071796(K6-linked polyubiquitin modification-dependent protein binding);GO:1903094(negative regulation of protein K48-linked deubiquitination);GO:1904293(negative regulation of ERAD pathway);GO:1904855(proteasome regulatory particle binding);GO:2000157(negative regulation of ubiquitin-specific protease activity)","NA","NA","NA","UBX domain protein 1 [Source:NCBI gene;Acc:101113110]",{"v":35.2914132502058,"d":"35.29"},{"v":30.9744992238683,"d":"30.97"},{"v":29.923532181893,"d":"29.92"},{"v":31.8126751711934,"d":"31.81"},{"v":36.8689286872428,"d":"36.87"},{"v":38.4107953983539,"d":"38.41"},{"v":0.898191144502426,"d":"0.90"},{"v":-0.154905596601333,"d":"-0.15"},{"v":0.802233448778195,"d":"0.80"},{"v":0.971221750696995,"d":"0.97"},"down","no"]
["MSTRG.20935","LYNX1","ENSOART00000001775","GO:0005886(plasma membrane);GO:0007271(synaptic transmission, cholinergic);GO:0008200(ion channel inhibitor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030548(acetylcholine receptor regulator activity);GO:0030550(acetylcholine receptor inhibitor activity);GO:0033130(acetylcholine receptor binding);GO:0099601(regulation of neurotransmitter receptor activity);GO:2000272(negative regulation of signaling receptor activity)","NA","NA","NA","Ly6/neurotoxin 1 [Source:NCBI gene;Acc:101119226]",{"v":7.81500398594446,"d":"7.82"},{"v":4.60454080562222,"d":"4.60"},{"v":6.15352767706548,"d":"6.15"},{"v":5.38180988069935,"d":"5.38"},{"v":5.80509950257113,"d":"5.81"},{"v":7.0889621145012,"d":"7.09"},{"v":1.01626193152522,"d":"1.02"},{"v":0.0232722905056813,"d":"0.02"},{"v":0.80366478967449,"d":"0.80"},{"v":0.971747346812703,"d":"0.97"},"up","no"]
["ENSOARG00000019292","ENSOARG00000019292","ENSOART00000021008","GO:0004583(dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity);GO:0005789(endoplasmic reticulum membrane);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0106073(dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity)","00510(N-Glycan biosynthesis)","K03850","EC:2.4.1.256","ALG10, alpha-1,2-glucosyltransferase [Source:NCBI gene;Acc:101104224]",{"v":1.470366,"d":"1.47"},{"v":1.172463,"d":"1.17"},{"v":1.307327,"d":"1.31"},{"v":1.934414,"d":"1.93"},{"v":0.887878,"d":"0.89"},{"v":1.151125,"d":"1.15"},{"v":0.994145844747732,"d":"0.99"},{"v":-0.00847057905591162,"d":"-0.01"},{"v":0.804814437665308,"d":"0.80"},{"v":0.97228144661392,"d":"0.97"},"down","no"]
["MSTRG.13142","POLR3K","ENSOART00000011322","GO:0003676(nucleic acid binding);GO:0003899(DNA-directed 5'-3' RNA polymerase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006351(transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0042779(tRNA 3'-trailer cleavage);GO:0046872(metal ion binding)","03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway)","K03019","NA","RNA polymerase III subunit K [Source:NCBI gene;Acc:101107752]",{"v":39.731319,"d":"39.73"},{"v":46.399162,"d":"46.40"},{"v":33.17355,"d":"33.17"},{"v":40.95908,"d":"40.96"},{"v":31.113892,"d":"31.11"},{"v":47.110939,"d":"47.11"},{"v":1.00100785415575,"d":"1.00"},{"v":0.00145329396121788,"d":"0.00"},{"v":0.805711233051841,"d":"0.81"},{"v":0.972587380540877,"d":"0.97"},"up","no"]
["MSTRG.13181","LMF1","ENSOART00000015722","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0006641(triglyceride metabolic process);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0009306(protein secretion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0033578(protein glycosylation in Golgi);GO:0034382(chylomicron remnant clearance);GO:0051006(positive regulation of lipoprotein lipase activity);GO:0051604(protein maturation);GO:0090181(regulation of cholesterol metabolic process);GO:0090207(regulation of triglyceride metabolic process)","NA","NA","NA","lipase maturation factor 1 [Source:HGNC Symbol;Acc:HGNC:14154]",{"v":1.060304,"d":"1.06"},{"v":1.226872,"d":"1.23"},{"v":1.235591,"d":"1.24"},{"v":1.319198,"d":"1.32"},{"v":1.527767,"d":"1.53"},{"v":1.166765,"d":"1.17"},{"v":0.877679116432844,"d":"0.88"},{"v":-0.188234514747129,"d":"-0.19"},{"v":0.806367828542041,"d":"0.81"},{"v":0.972693107597107,"d":"0.97"},"down","no"]
["MSTRG.13697","MEPCE","ENSOART00000018458","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001510(RNA methylation);GO:0008168(methyltransferase activity);GO:0008173(RNA methyltransferase activity);GO:0008757(S-adenosylmethionine-dependent methyltransferase activity);GO:0016073(snRNA metabolic process);GO:0035562(negative regulation of chromatin binding);GO:0040031(snRNA modification);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle)","NA","K15190","EC:2.1.1.-","methylphosphate capping enzyme [Source:NCBI gene;Acc:101105971]",{"v":9.215474,"d":"9.22"},{"v":6.66889,"d":"6.67"},{"v":7.657982,"d":"7.66"},{"v":8.156293,"d":"8.16"},{"v":7.558993,"d":"7.56"},{"v":7.82956,"d":"7.83"},{"v":0.999893819649532,"d":"1.00"},{"v":-0.000153193998300426,"d":"-0.00"},{"v":0.806841335901137,"d":"0.81"},{"v":0.972932441754631,"d":"0.97"},"down","no"]
["ENSOARG00000003760","DHODH","ENSOART00000004086","GO:0003824(catalytic activity);GO:0004152(dihydroorotate dehydrogenase activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006207('de novo' pyrimidine nucleobase biosynthetic process);GO:0016020(membrane);GO:0016627(oxidoreductase activity, acting on the CH-CH group of donors);GO:0055114(oxidation-reduction process)","00240(Pyrimidine metabolism)","K00254","EC:1.3.5.2","dihydroorotate dehydrogenase (quinone) [Source:NCBI gene;Acc:101102664]",{"v":1.216441,"d":"1.22"},{"v":1.471346,"d":"1.47"},{"v":0.906278,"d":"0.91"},{"v":1.527032,"d":"1.53"},{"v":1.492736,"d":"1.49"},{"v":1.109552,"d":"1.11"},{"v":0.870376962792906,"d":"0.87"},{"v":-0.200287723161552,"d":"-0.20"},{"v":0.807581199961424,"d":"0.81"},{"v":0.973138682464472,"d":"0.97"},"down","no"]
["MSTRG.1826","DBR1","ENSOART00000008263","GO:0000375(RNA splicing, via transesterification reactions);GO:0000398(mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008419(RNA lariat debranching enzyme activity);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","NA","K18328","EC:3.1.-.-","debranching RNA lariats 1 [Source:NCBI gene;Acc:101111415]",{"v":1.675185,"d":"1.68"},{"v":1.255876,"d":"1.26"},{"v":1.151678,"d":"1.15"},{"v":1.315555,"d":"1.32"},{"v":1.119724,"d":"1.12"},{"v":1.571106,"d":"1.57"},{"v":1.01905807854213,"d":"1.02"},{"v":0.0272362764664145,"d":"0.03"},{"v":0.808536249887373,"d":"0.81"},{"v":0.973164174733319,"d":"0.97"},"up","no"]
["MSTRG.13890","NTPCR","ENSOART00000003626","GO:0016311(dephosphorylation);GO:0098519(nucleotide phosphatase activity, acting on free nucleotides)","00230(Purine metabolism);00730(Thiamine metabolism)","K06928","EC:3.6.1.15","nucleoside-triphosphatase, cancer-related [Source:NCBI gene;Acc:101112698]",{"v":37.106815,"d":"37.11"},{"v":31.107773,"d":"31.11"},{"v":28.397913,"d":"28.40"},{"v":31.76506,"d":"31.77"},{"v":28.935427,"d":"28.94"},{"v":35.682781,"d":"35.68"},{"v":1.00237834849094,"d":"1.00"},{"v":0.00342715769928878,"d":"0.00"},{"v":0.809309094757451,"d":"0.81"},{"v":0.973164174733319,"d":"0.97"},"up","no"]
["MSTRG.2862","SMTNL2","ENSOART00000000690","GO:0005515(protein binding)","NA","NA","NA","smoothelin like 2 [Source:NCBI gene;Acc:101112746]",{"v":26.6985779185051,"d":"26.70"},{"v":32.3053258141708,"d":"32.31"},{"v":30.4090020609914,"d":"30.41"},{"v":29.9564412828964,"d":"29.96"},{"v":27.7468946369063,"d":"27.75"},{"v":32.3466583646509,"d":"32.35"},{"v":0.992925169003633,"d":"0.99"},{"v":-0.0102431005731447,"d":"-0.01"},{"v":0.810189535413391,"d":"0.81"},{"v":0.973371099279901,"d":"0.97"},"down","no"]
["MSTRG.21830","CDK16;UBA1","ENSOART00000014663;ENSOART00000014783","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006887(exocytosis);GO:0007283(spermatogenesis);GO:0008021(synaptic vesicle);GO:0015630(microtubule cytoskeleton);GO:0030252(growth hormone secretion);GO:0031175(neuron projection development);GO:0031234(extrinsic component of cytoplasmic side of plasma membrane);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0000166(nucleotide binding);GO:0000792(heterochromatin);GO:0004839(ubiquitin activating enzyme activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005765(lysosomal membrane);GO:0006464(cellular protein modification process);GO:0006974(cellular response to DNA damage stimulus);GO:0008641(ubiquitin-like modifier activating enzyme activity);GO:0010008(endosome membrane);GO:0016567(protein ubiquitination);GO:0016874(ligase activity);GO:0030057(desmosome);GO:0030867(rough endoplasmic reticulum membrane)","04120(Ubiquitin mediated proteolysis);05012(Parkinson disease)","K08820;K03178","EC:2.7.11.22;EC:6.2.1.45","cyclin dependent kinase 16 [Source:NCBI gene;Acc:101116802];ubiquitin like modifier activating enzyme 1 [Source:NCBI gene;Acc:101117052]",{"v":12.3789751657151,"d":"12.38"},{"v":12.6164624289016,"d":"12.62"},{"v":14.2102803444127,"d":"14.21"},{"v":14.1991794778412,"d":"14.20"},{"v":14.1994751290783,"d":"14.20"},{"v":15.3213417724986,"d":"15.32"},{"v":0.89674568128478,"d":"0.90"},{"v":-0.157229202687873,"d":"-0.16"},{"v":0.811294474170393,"d":"0.81"},{"v":0.973373822778811,"d":"0.97"},"down","no"]
["MSTRG.17707","TRMT1","ENSOART00000010233","GO:0000049(tRNA binding);GO:0003723(RNA binding);GO:0004809(tRNA (guanine-N2-)-methyltransferase activity);GO:0008033(tRNA processing);GO:0008168(methyltransferase activity);GO:0016740(transferase activity);GO:0030488(tRNA methylation);GO:0032259(methylation);GO:0046872(metal ion binding)","NA","K00555","2.1.1.216;EC:2.1.1.215","tRNA methyltransferase 1 [Source:NCBI gene;Acc:101121680]",{"v":2.08947614686623,"d":"2.09"},{"v":1.89390577970065,"d":"1.89"},{"v":2.44888699158092,"d":"2.45"},{"v":1.8260586847521,"d":"1.83"},{"v":1.95376613751169,"d":"1.95"},{"v":2.56436947287184,"d":"2.56"},{"v":1.01388271211676,"d":"1.01"},{"v":0.0198907682836284,"d":"0.02"},{"v":0.811871431318665,"d":"0.81"},{"v":0.973434919266498,"d":"0.97"},"up","no"]
["MSTRG.20069","ZFYVE26","ENSOART00000023073","GO:0000281(mitotic cytokinesis);GO:0000724(double-strand break repair via homologous recombination);GO:0005813(centrosome);GO:0030496(midbody);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032465(regulation of cytokinesis);GO:0046872(metal ion binding)","NA","K19027","NA","zinc finger FYVE-type containing 26 [Source:NCBI gene;Acc:101116056]",{"v":4.460516,"d":"4.46"},{"v":3.875964,"d":"3.88"},{"v":3.667657,"d":"3.67"},{"v":4.578609,"d":"4.58"},{"v":4.560026,"d":"4.56"},{"v":4.248019,"d":"4.25"},{"v":0.896724229968146,"d":"0.90"},{"v":-0.157263714232155,"d":"-0.16"},{"v":0.81276643377912,"d":"0.81"},{"v":0.9739358821918,"d":"0.97"},"down","no"]
["MSTRG.8981","KCTD6","ENSOART00000013216","GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0030506(ankyrin binding);GO:0042802(identical protein binding);GO:0045879(negative regulation of smoothened signaling pathway);GO:0051260(protein homooligomerization);GO:0097602(cullin family protein binding)","NA","NA","NA","potassium channel tetramerization domain containing 6 [Source:HGNC Symbol;Acc:HGNC:22235]",{"v":1.20254613263612,"d":"1.20"},{"v":1.2288816752988,"d":"1.23"},{"v":1.2927906064077,"d":"1.29"},{"v":1.49592283416335,"d":"1.50"},{"v":1.27905556673307,"d":"1.28"},{"v":1.00480872410359,"d":"1.00"},{"v":0.985298454960638,"d":"0.99"},{"v":-0.0213672999914142,"d":"-0.02"},{"v":0.814006650797672,"d":"0.81"},{"v":0.974228739265527,"d":"0.97"},"down","no"]
["MSTRG.13026","PSTPIP2","ENSOART00000003083;ENSOART00000003087","GO:0003779(actin binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0016020(membrane);GO:0016477(cell migration);GO:0016477(cell migration)","NA","K20124","NA","proline-serine-threonine phosphatase interacting protein 2 [Source:NCBI gene;Acc:101111145]",{"v":11.308027152546,"d":"11.31"},{"v":12.3850853756603,"d":"12.39"},{"v":18.2345089657722,"d":"18.23"},{"v":16.2779500929643,"d":"16.28"},{"v":8.78139308725967,"d":"8.78"},{"v":16.878569759138,"d":"16.88"},{"v":0.999754602824457,"d":"1.00"},{"v":-0.000354076734695727,"d":"-0.00"},{"v":0.814132952683168,"d":"0.81"},{"v":0.974228739265527,"d":"0.97"},"down","no"]
["MSTRG.13779","AP5Z1","ENSOART00000003894","GO:0000724(double-strand break repair via homologous recombination);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0016197(endosomal transport);GO:0016607(nuclear speck);GO:0044599(AP-5 adaptor complex)","NA","K19025","NA","adaptor related protein complex 5 subunit zeta 1 [Source:NCBI gene;Acc:101110022]",{"v":0.464047,"d":"0.46"},{"v":0.586535,"d":"0.59"},{"v":0.484306,"d":"0.48"},{"v":0.424592,"d":"0.42"},{"v":0.80427,"d":"0.80"},{"v":0.510921,"d":"0.51"},{"v":0.882229565411318,"d":"0.88"},{"v":-0.180773985831556,"d":"-0.18"},{"v":0.814824320773215,"d":"0.81"},{"v":0.974407406418091,"d":"0.97"},"down","no"]
["MSTRG.9953","C9orf72","ENSOART00000015979","GO:0000932(P-body);GO:0001933(negative regulation of protein phosphorylation);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005768(endosome);GO:0005776(autophagosome);GO:0006897(endocytosis);GO:0006914(autophagy);GO:0010494(cytoplasmic stress granule);GO:0010506(regulation of autophagy);GO:0016239(positive regulation of macroautophagy);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0034063(stress granule assembly);GO:0043005(neuron projection);GO:0043204(perikaryon);GO:0044295(axonal growth cone);GO:0044304(main axon);GO:0048675(axon extension);GO:0110053(regulation of actin filament organization);GO:1902774(late endosome to lysosome transport);GO:1903432(regulation of TORC1 signaling);GO:1904425(negative regulation of GTP binding);GO:1990316(Atg1/ULK1 kinase complex);GO:2000785(regulation of autophagosome assembly)","NA","NA","NA","chromosome 2 open reading frame, human C9orf72 [Source:NCBI gene;Acc:101111774]",{"v":5.000846,"d":"5.00"},{"v":4.798255,"d":"4.80"},{"v":4.831166,"d":"4.83"},{"v":5.403799,"d":"5.40"},{"v":5.51342,"d":"5.51"},{"v":5.433562,"d":"5.43"},{"v":0.894774812285725,"d":"0.89"},{"v":-0.160403449467003,"d":"-0.16"},{"v":0.815745524462637,"d":"0.82"},{"v":0.974407406418091,"d":"0.97"},"down","no"]
["MSTRG.13175","JMJD8","ENSOART00000014546","NA","NA","NA","NA","jumonji domain containing 8 [Source:HGNC Symbol;Acc:HGNC:14148]",{"v":2.329594,"d":"2.33"},{"v":2.636461,"d":"2.64"},{"v":3.326121,"d":"3.33"},{"v":2.92847,"d":"2.93"},{"v":3.009692,"d":"3.01"},{"v":3.342451,"d":"3.34"},{"v":0.893494427577144,"d":"0.89"},{"v":-0.162469363194059,"d":"-0.16"},{"v":0.816172109868889,"d":"0.82"},{"v":0.974407406418091,"d":"0.97"},"down","no"]
["MSTRG.5191","AARS","ENSOART00000005765","GO:0000049(tRNA binding);GO:0000166(nucleotide binding);GO:0002161(aminoacyl-tRNA editing activity);GO:0002196(Ser-tRNA(Ala) hydrolase activity);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004813(alanine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006400(tRNA modification);GO:0006412(translation);GO:0006419(alanyl-tRNA aminoacylation);GO:0008270(zinc ion binding);GO:0016874(ligase activity);GO:0021680(cerebellar Purkinje cell layer development);GO:0043039(tRNA aminoacylation);GO:0043524(negative regulation of neuron apoptotic process);GO:0045182(translation regulator activity);GO:0046872(metal ion binding);GO:0050885(neuromuscular process controlling balance);GO:0050905(neuromuscular process);GO:0106074(aminoacyl-tRNA metabolism involved in translational fidelity);GO:0140018(regulation of cytoplasmic translational fidelity)","00970(Aminoacyl-tRNA biosynthesis)","K01872","EC:6.1.1.7","alanyl-tRNA synthetase [Source:NCBI gene;Acc:101114460]",{"v":17.1787628913649,"d":"17.18"},{"v":19.3204098386544,"d":"19.32"},{"v":19.0403181907007,"d":"19.04"},{"v":19.3110389753589,"d":"19.31"},{"v":20.8298156335976,"d":"20.83"},{"v":21.7754070929934,"d":"21.78"},{"v":0.897009757922302,"d":"0.90"},{"v":-0.156804415618474,"d":"-0.16"},{"v":0.817147976193074,"d":"0.82"},{"v":0.974407406418091,"d":"0.97"},"down","no"]
["MSTRG.10819","BSDC1","ENSOART00000022811","NA","NA","NA","NA","BSD domain containing 1 [Source:NCBI gene;Acc:101113659]",{"v":5.361785,"d":"5.36"},{"v":4.507485,"d":"4.51"},{"v":4.845512,"d":"4.85"},{"v":5.76494254036244,"d":"5.76"},{"v":5.77183763756178,"d":"5.77"},{"v":4.87952286490939,"d":"4.88"},{"v":0.896351752377257,"d":"0.90"},{"v":-0.157863099407394,"d":"-0.16"},{"v":0.817402321762038,"d":"0.82"},{"v":0.974407406418091,"d":"0.97"},"down","no"]
["MSTRG.663","PHTF1","ENSOART00000021605","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","putative homeodomain transcription factor 1 [Source:NCBI gene;Acc:101119349]",{"v":0.687568,"d":"0.69"},{"v":0.540373,"d":"0.54"},{"v":0.655816,"d":"0.66"},{"v":0.717821,"d":"0.72"},{"v":0.706708,"d":"0.71"},{"v":0.682908,"d":"0.68"},{"v":0.893861595862652,"d":"0.89"},{"v":-0.161876630839477,"d":"-0.16"},{"v":0.818901816824425,"d":"0.82"},{"v":0.974719803324672,"d":"0.97"},"down","no"]
["MSTRG.21941","SH3BGRL","ENSOART00000001317","NA","NA","NA","NA","SH3 domain binding glutamate rich protein like [Source:NCBI gene;Acc:101120635]",{"v":2.73410122073579,"d":"2.73"},{"v":1.43235181270903,"d":"1.43"},{"v":1.95751266555184,"d":"1.96"},{"v":3.2917325819398,"d":"3.29"},{"v":1.64803859197324,"d":"1.65"},{"v":2.00726191638796,"d":"2.01"},{"v":0.881522459932794,"d":"0.88"},{"v":-0.181930767065254,"d":"-0.18"},{"v":0.81971577919408,"d":"0.82"},{"v":0.975036005149044,"d":"0.98"},"down","no"]
["MSTRG.961","PEA15","ENSOART00000009232","GO:0000077(DNA damage checkpoint);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0042981(regulation of apoptotic process);GO:0046325(negative regulation of glucose import);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902043(positive regulation of extrinsic apoptotic signaling pathway via death domain receptors)","NA","NA","NA","proliferation and apoptosis adaptor protein 15 [Source:NCBI gene;Acc:101118912]",{"v":7.20566796609747,"d":"7.21"},{"v":6.47581538626449,"d":"6.48"},{"v":6.44997657920977,"d":"6.45"},{"v":6.46262262894179,"d":"6.46"},{"v":9.29695173650754,"d":"9.30"},{"v":4.50169092695999,"d":"4.50"},{"v":0.993593422771764,"d":"0.99"},{"v":-0.00927247141548652,"d":"-0.01"},{"v":0.820075032955563,"d":"0.82"},{"v":0.975211150812853,"d":"0.98"},"down","no"]
["MSTRG.13815","ENSOARG00000005341","ENSOART00000005822","GO:0001510(RNA methylation);GO:0008168(methyltransferase activity);GO:0032259(methylation)","NA","K02427","EC:2.1.1.166","mitochondrial rRNA methyltransferase 2 [Source:NCBI gene;Acc:101119526]",{"v":1.80878455149182,"d":"1.81"},{"v":1.62810922232916,"d":"1.63"},{"v":1.86280325168431,"d":"1.86"},{"v":2.05255330943215,"d":"2.05"},{"v":1.58518383782483,"d":"1.59"},{"v":1.68529761886429,"d":"1.69"},{"v":0.995615707647729,"d":"1.00"},{"v":-0.00633910325190169,"d":"-0.01"},{"v":0.820907742191355,"d":"0.82"},{"v":0.975634256349642,"d":"0.98"},"down","no"]
["MSTRG.6089","TFPT","ENSOART00000003295","GO:0005654(nucleoplasm);GO:0006915(apoptotic process);GO:0031011(Ino80 complex);GO:0031965(nuclear membrane);GO:0097190(apoptotic signaling pathway)","NA","K11670","NA","TCF3 fusion partner [Source:NCBI gene;Acc:101108076]",{"v":0.972044303995006,"d":"0.97"},{"v":1.31787320661673,"d":"1.32"},{"v":1.08440435642946,"d":"1.08"},{"v":1.19313069538077,"d":"1.19"},{"v":1.18662593757803,"d":"1.19"},{"v":1.42929386766542,"d":"1.43"},{"v":0.885869553708521,"d":"0.89"},{"v":-0.174833820568864,"d":"-0.17"},{"v":0.822340648707589,"d":"0.82"},{"v":0.975717642006475,"d":"0.98"},"down","no"]
["MSTRG.3327","HDAC5","ENSOART00000007505","GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0004407(histone deacetylase activity);GO:0005080(protein kinase C binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006325(chromatin organization);GO:0006476(protein deacetylation);GO:0008134(transcription factor binding);GO:0010832(negative regulation of myotube differentiation);GO:0016575(histone deacetylation);GO:0016607(nuclear speck);GO:0016787(hydrolase activity);GO:0032041(NAD-dependent histone deacetylase activity (H3-K14 specific));GO:0033558(protein deacetylase activity);GO:0040029(regulation of gene expression, epigenetic);GO:0042826(histone deacetylase binding);GO:0043393(regulation of protein binding);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0070491(repressing transcription factor binding);GO:0070932(histone H3 deacetylation);GO:0090051(negative regulation of cell migration involved in sprouting angiogenesis)","04371(Apelin signaling pathway);05034(Alcoholism);05203(Viral carcinogenesis)","K11406","EC:3.5.1.98","histone deacetylase 5 [Source:NCBI gene;Acc:101113686]",{"v":2.94390448310866,"d":"2.94"},{"v":1.64654419112591,"d":"1.65"},{"v":1.75584723293129,"d":"1.76"},{"v":2.15792866048136,"d":"2.16"},{"v":2.57144319227201,"d":"2.57"},{"v":2.27752048976696,"d":"2.28"},{"v":0.905721908791757,"d":"0.91"},{"v":-0.142859939089061,"d":"-0.14"},{"v":0.822727141061489,"d":"0.82"},{"v":0.975717642006475,"d":"0.98"},"down","no"]
["MSTRG.16392","ING4","ENSOART00000007750","GO:0000123(histone acetyltransferase complex);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006325(chromatin organization);GO:0006473(protein acetylation);GO:0006915(apoptotic process);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0007050(cell cycle arrest);GO:0008285(negative regulation of cell population proliferation);GO:0016573(histone acetylation);GO:0035064(methylated histone binding);GO:0043065(positive regulation of apoptotic process);GO:0043966(histone H3 acetylation);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043983(histone H4-K12 acetylation);GO:0045111(intermediate filament cytoskeleton);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045926(negative regulation of growth);GO:0046872(metal ion binding);GO:1903508(positive regulation of nucleic acid-templated transcription)","NA","K11346","NA","inhibitor of growth family member 4 [Source:NCBI gene;Acc:101111956]",{"v":8.23633645049505,"d":"8.24"},{"v":8.11773396881188,"d":"8.12"},{"v":7.03685760544554,"d":"7.04"},{"v":8.00290003267327,"d":"8.00"},{"v":7.44239258712871,"d":"7.44"},{"v":8.10507803267327,"d":"8.11"},{"v":0.993229718968095,"d":"0.99"},{"v":-0.00980066506165859,"d":"-0.01"},{"v":0.823615999113273,"d":"0.82"},{"v":0.975852719077539,"d":"0.98"},"down","no"]
["MSTRG.9600","UBE2R2","ENSOART00000010172","GO:0000166(nucleotide binding);GO:0004842(ubiquitin-protein transferase activity);GO:0005524(ATP binding);GO:0006513(protein monoubiquitination);GO:0016740(transferase activity);GO:0061631(ubiquitin conjugating enzyme activity);GO:0070936(protein K48-linked ubiquitination)","04120(Ubiquitin mediated proteolysis)","K02207","EC:2.3.2.23","ubiquitin conjugating enzyme E2 R2 [Source:NCBI gene;Acc:101103036]",{"v":5.842313,"d":"5.84"},{"v":5.8376,"d":"5.84"},{"v":5.634703,"d":"5.63"},{"v":5.319228,"d":"5.32"},{"v":5.491923,"d":"5.49"},{"v":6.563753,"d":"6.56"},{"v":0.996530167878913,"d":"1.00"},{"v":-0.00501461456912968,"d":"-0.01"},{"v":0.82401843065146,"d":"0.82"},{"v":0.975868977247727,"d":"0.98"},"down","no"]
["MSTRG.11627","MCUR1","ENSOART00000014160","GO:0006851(mitochondrial calcium ion transmembrane transport);GO:0031305(integral component of mitochondrial inner membrane);GO:0036444(calcium import into the mitochondrion);GO:0051561(positive regulation of mitochondrial calcium ion concentration);GO:0070509(calcium ion import)","NA","K22137","NA","mitochondrial calcium uniporter regulator 1 [Source:NCBI gene;Acc:101114316]",{"v":2.81891673351968,"d":"2.82"},{"v":3.35088760144421,"d":"3.35"},{"v":2.72957535150245,"d":"2.73"},{"v":4.05132987491265,"d":"4.05"},{"v":3.18143685814116,"d":"3.18"},{"v":2.80154313440484,"d":"2.80"},{"v":0.886895043507387,"d":"0.89"},{"v":-0.173164710959328,"d":"-0.17"},{"v":0.82471514410856,"d":"0.82"},{"v":0.975870144235329,"d":"0.98"},"down","no"]
["MSTRG.8349","ENSOARG00000008691","ENSOART00000009476","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","CTAGE family member 5, ER export factor [Source:NCBI gene;Acc:101102181]",{"v":1.99631865420756,"d":"2.00"},{"v":1.66991120985592,"d":"1.67"},{"v":1.33078105032366,"d":"1.33"},{"v":2.30492538149927,"d":"2.30"},{"v":1.46396085237001,"d":"1.46"},{"v":1.83403839381917,"d":"1.83"},{"v":0.891857600527586,"d":"0.89"},{"v":-0.165114715921863,"d":"-0.17"},{"v":0.825412428160299,"d":"0.83"},{"v":0.975981905062014,"d":"0.98"},"down","no"]
["MSTRG.7557","ZNF664","ENSOART00000004966","GO:0003676(nucleic acid binding);GO:0005634(nucleus)","NA","NA","NA","zinc finger protein 664 [Source:HGNC Symbol;Acc:HGNC:25406]",{"v":5.41231407524423,"d":"5.41"},{"v":5.39750166867595,"d":"5.40"},{"v":6.2583374784868,"d":"6.26"},{"v":8.12057188671794,"d":"8.12"},{"v":5.49191669361879,"d":"5.49"},{"v":5.60616073228019,"d":"5.61"},{"v":0.888103682250024,"d":"0.89"},{"v":-0.171199980095674,"d":"-0.17"},{"v":0.825921383962035,"d":"0.83"},{"v":0.976230227112502,"d":"0.98"},"down","no"]
["MSTRG.7701","TRAFD1","ENSOART00000010982","GO:0045824(negative regulation of innate immune response)","NA","NA","NA","TRAF-type zinc finger domain containing 1 [Source:NCBI gene;Acc:101115231]",{"v":2.68036220026247,"d":"2.68"},{"v":2.59479231994751,"d":"2.59"},{"v":2.25772915459318,"d":"2.26"},{"v":2.5777571335958,"d":"2.58"},{"v":2.81603401312336,"d":"2.82"},{"v":2.95723898215223,"d":"2.96"},{"v":0.902030475109926,"d":"0.90"},{"v":-0.148751919114854,"d":"-0.15"},{"v":0.827351074999686,"d":"0.83"},{"v":0.976660734204632,"d":"0.98"},"down","no"]
["MSTRG.4140","DARS2","ENSOART00000013752","GO:0000166(nucleotide binding);GO:0003676(nucleic acid binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004815(aspartate-tRNA ligase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006418(tRNA aminoacylation for protein translation);GO:0016874(ligase activity);GO:0042803(protein homodimerization activity);GO:0043039(tRNA aminoacylation);GO:0050560(aspartate-tRNA(Asn) ligase activity);GO:0070145(mitochondrial asparaginyl-tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)","K01876","EC:6.1.1.12","aspartyl-tRNA synthetase 2, mitochondrial [Source:NCBI gene;Acc:101114203]",{"v":1.65701091609843,"d":"1.66"},{"v":1.2849992434035,"d":"1.28"},{"v":1.20875944678328,"d":"1.21"},{"v":1.97260590335013,"d":"1.97"},{"v":1.24387682122739,"d":"1.24"},{"v":1.4508164719834,"d":"1.45"},{"v":0.889330088232545,"d":"0.89"},{"v":-0.169209098478294,"d":"-0.17"},{"v":0.827954169254741,"d":"0.83"},{"v":0.977006264045054,"d":"0.98"},"down","no"]
["MSTRG.1436","SMCO1","ENSOART00000022149","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","single-pass membrane protein with coiled-coil domains 1 [Source:NCBI gene;Acc:101122239]",{"v":1.621822,"d":"1.62"},{"v":1.686893,"d":"1.69"},{"v":0.793351,"d":"0.79"},{"v":2.446317,"d":"2.45"},{"v":0.771941,"d":"0.77"},{"v":0.888116,"d":"0.89"},{"v":0.998950899260516,"d":"1.00"},{"v":-0.00151432691395334,"d":"-0.00"},{"v":0.829068088467316,"d":"0.83"},{"v":0.977280387454273,"d":"0.98"},"down","no"]
["MSTRG.7753","USP30","ENSOART00000018554","GO:0000422(autophagy of mitochondrion);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008053(mitochondrial fusion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016579(protein deubiquitination);GO:0035871(protein K11-linked deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0044313(protein K6-linked deubiquitination)","04137(Mitophagy - animal)","K11851","EC:3.4.19.12","ubiquitin specific peptidase 30 [Source:NCBI gene;Acc:101123665]",{"v":6.081792,"d":"6.08"},{"v":5.176973,"d":"5.18"},{"v":4.741736,"d":"4.74"},{"v":6.221687,"d":"6.22"},{"v":4.913012,"d":"4.91"},{"v":5.053436,"d":"5.05"},{"v":0.988409165107654,"d":"0.99"},{"v":-0.0168197066467488,"d":"-0.02"},{"v":0.829583333677088,"d":"0.83"},{"v":0.977357123901215,"d":"0.98"},"down","no"]
["MSTRG.4256","ANGEL2","ENSOART00000010491;ENSOART00000010486","GO:0003730(mRNA 3'-UTR binding);GO:0005737(cytoplasm);GO:0015030(Cajal body);GO:0045930(negative regulation of mitotic cell cycle);GO:0070935(3'-UTR-mediated mRNA stabilization);GO:0070935(3'-UTR-mediated mRNA stabilization)","NA","K18729","NA","angel homolog 2 [Source:NCBI gene;Acc:101113611]",{"v":7.84498848029109,"d":"7.84"},{"v":5.438991594906,"d":"5.44"},{"v":7.5630519223772,"d":"7.56"},{"v":7.86366486658581,"d":"7.86"},{"v":7.01286797756216,"d":"7.01"},{"v":6.21623529714979,"d":"6.22"},{"v":0.988349744230946,"d":"0.99"},{"v":-0.0169064407484878,"d":"-0.02"},{"v":0.830345286696764,"d":"0.83"},{"v":0.977389947016796,"d":"0.98"},"down","no"]
["MSTRG.10211","ENSOARG00000017504","ENSOART00000019052","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding)","NA","NA","NA",null,{"v":12.768888,"d":"12.77"},{"v":9.974737,"d":"9.97"},{"v":18.641911,"d":"18.64"},{"v":12.79047,"d":"12.79"},{"v":14.107924,"d":"14.11"},{"v":14.364178,"d":"14.36"},{"v":1.00298003721145,"d":"1.00"},{"v":0.00429289159051404,"d":"0.00"},{"v":0.831154903468151,"d":"0.83"},{"v":0.977389947016796,"d":"0.98"},"up","no"]
["MSTRG.10874","TAF12","ENSOART00000003062","GO:0000124(SAGA complex);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005669(transcription factor TFIID complex);GO:0006352(DNA-templated transcription, initiation);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0008134(transcription factor binding);GO:0030914(STAGA complex);GO:0033276(transcription factor TFTC complex);GO:0043966(histone H3 acetylation);GO:0046695(SLIK (SAGA-like) complex);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:1903508(positive regulation of nucleic acid-templated transcription)","03022(Basal transcription factors)","K03126","NA","TATA-box binding protein associated factor 12 [Source:NCBI gene;Acc:101101958]",{"v":3.62882704420661,"d":"3.63"},{"v":2.94131338180549,"d":"2.94"},{"v":3.09228279688227,"d":"3.09"},{"v":3.19192850046533,"d":"3.19"},{"v":2.92664170311773,"d":"2.93"},{"v":3.58527758120056,"d":"3.59"},{"v":0.995731119983744,"d":"1.00"},{"v":-0.00617187491909358,"d":"-0.01"},{"v":0.832229734734721,"d":"0.83"},{"v":0.977555540328264,"d":"0.98"},"down","no"]
["MSTRG.19772","HERC1","ENSOART00000022636","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0010507(negative regulation of autophagy);GO:0016567(protein ubiquitination);GO:0016740(transferase activity);GO:0021702(cerebellar Purkinje cell differentiation);GO:0031175(neuron projection development);GO:0050885(neuromuscular process controlling balance)","04120(Ubiquitin mediated proteolysis)","K10594","EC:2.3.2.26","HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 [Source:NCBI gene;Acc:101110595]",{"v":7.87698232143572,"d":"7.88"},{"v":8.93898154460353,"d":"8.94"},{"v":8.17634792506007,"d":"8.18"},{"v":9.24086541970365,"d":"9.24"},{"v":8.90189365693833,"d":"8.90"},{"v":7.35740049224069,"d":"7.36"},{"v":0.980084525494379,"d":"0.98"},{"v":-0.0290219178503492,"d":"-0.03"},{"v":0.832755908465956,"d":"0.83"},{"v":0.977555540328264,"d":"0.98"},"down","no"]
["MSTRG.21222","PKHD1L1","ENSOART00000014297;ENSOART00000014282","GO:0000124(SAGA complex);GO:0003713(transcription coactivator activity);GO:0005643(nuclear pore);GO:0005929(cilium);GO:0006406(mRNA export from nucleus);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated)","NA","NA","NA","PKHD1 like 1 [Source:NCBI gene;Acc:101117676]",{"v":3.37717125055766,"d":"3.38"},{"v":1.14880736248048,"d":"1.15"},{"v":0.84950860216373,"d":"0.85"},{"v":2.13559924353112,"d":"2.14"},{"v":1.46696373293553,"d":"1.47"},{"v":1.65383255426054,"d":"1.65"},{"v":1.02265653027412,"d":"1.02"},{"v":0.0323216824498101,"d":"0.03"},{"v":0.832938430788609,"d":"0.83"},{"v":0.977555540328264,"d":"0.98"},"up","no"]
["MSTRG.12295","DEAF1;ENSOARG00000023625","ENSOART00000006836;ENSOART00000025527","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001650(fibrillar center);GO:0001662(behavioral fear response);GO:0001843(neural tube closure);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006366(transcription by RNA polymerase II);GO:0008542(visual learning);GO:0033599(regulation of mammary gland epithelial cell proliferation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0048706(embryonic skeletal system development)","NA","K23041","NA","DEAF1 transcription factor [Source:NCBI gene;Acc:101103106]",{"v":5.07059641407223,"d":"5.07"},{"v":4.59857349003736,"d":"4.60"},{"v":5.68967011643836,"d":"5.69"},{"v":5.69086013636364,"d":"5.69"},{"v":5.01891096326276,"d":"5.02"},{"v":4.86812241594022,"d":"4.87"},{"v":0.985938182540548,"d":"0.99"},{"v":-0.0204309011624756,"d":"-0.02"},{"v":0.833910399445631,"d":"0.83"},{"v":0.977580576970107,"d":"0.98"},"down","no"]
["MSTRG.21722","ARHGEF9","ENSOART00000005169","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0014069(postsynaptic density);GO:0035023(regulation of Rho protein signal transduction);GO:0098982(GABA-ergic synapse);GO:0099150(regulation of postsynaptic specialization assembly)","NA","K20686","NA","Cdc42 guanine nucleotide exchange factor 9 [Source:NCBI gene;Acc:101110030]",{"v":2.94962837212223,"d":"2.95"},{"v":1.57219802888238,"d":"1.57"},{"v":2.00672894725827,"d":"2.01"},{"v":2.93900936793638,"d":"2.94"},{"v":1.95592340895772,"d":"1.96"},{"v":1.67321812055253,"d":"1.67"},{"v":0.993971583509273,"d":"0.99"},{"v":-0.00872348748236072,"d":"-0.01"},{"v":0.834776959083917,"d":"0.83"},{"v":0.977580576970107,"d":"0.98"},"down","no"]
["MSTRG.19896","USP8","ENSOART00000022866","GO:0000281(mitotic cytokinesis);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007032(endosome organization);GO:0016579(protein deubiquitination);GO:0019897(extrinsic component of plasma membrane);GO:0030496(midbody);GO:0031647(regulation of protein stability);GO:0032880(regulation of protein localization);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0070536(protein K63-linked deubiquitination);GO:0071108(protein K48-linked deubiquitination);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04137(Mitophagy - animal);04144(Endocytosis);04934(Cushing syndrome)","K11839","EC:3.4.19.12","ubiquitin specific peptidase 8 [Source:NCBI gene;Acc:101106943]",{"v":2.06803830786993,"d":"2.07"},{"v":1.82697855397345,"d":"1.83"},{"v":2.11203275870695,"d":"2.11"},{"v":2.2136598549163,"d":"2.21"},{"v":2.18889133288436,"d":"2.19"},{"v":1.70124967250337,"d":"1.70"},{"v":0.984149017641955,"d":"0.98"},{"v":-0.0230513131279231,"d":"-0.02"},{"v":0.835628865713257,"d":"0.84"},{"v":0.977724695045938,"d":"0.98"},"down","no"]
["MSTRG.5024","ACTR5","ENSOART00000000230","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006302(double-strand break repair);GO:0031011(Ino80 complex);GO:0070914(UV-damage excision repair)","NA","K11672","NA","ARP5 actin related protein 5 homolog [Source:NCBI gene;Acc:101105517]",{"v":1.356042,"d":"1.36"},{"v":1.021352,"d":"1.02"},{"v":1.68677,"d":"1.69"},{"v":1.500651,"d":"1.50"},{"v":1.553021,"d":"1.55"},{"v":1.491029,"d":"1.49"},{"v":0.894264331140816,"d":"0.89"},{"v":-0.16122676139835,"d":"-0.16"},{"v":0.836639054860294,"d":"0.84"},{"v":0.978204265260971,"d":"0.98"},"down","no"]
["MSTRG.5778","ZNF45","ENSOART00000009793","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 45 [Source:NCBI gene;Acc:101109474]",{"v":1.714777,"d":"1.71"},{"v":1.349293,"d":"1.35"},{"v":1.325746,"d":"1.33"},{"v":1.676088,"d":"1.68"},{"v":1.498217,"d":"1.50"},{"v":1.717326,"d":"1.72"},{"v":0.897413562061406,"d":"0.90"},{"v":-0.156155108142003,"d":"-0.16"},{"v":0.837683646145483,"d":"0.84"},{"v":0.978376149804252,"d":"0.98"},"down","no"]
["ENSOARG00000002030","TMEM69","ENSOART00000002185","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 69 [Source:NCBI gene;Acc:101122991]",{"v":0.981429,"d":"0.98"},{"v":0.936234,"d":"0.94"},{"v":0.700381,"d":"0.70"},{"v":1.014052,"d":"1.01"},{"v":0.709203,"d":"0.71"},{"v":1.189734,"d":"1.19"},{"v":0.898748330323252,"d":"0.90"},{"v":-0.15401090954305,"d":"-0.15"},{"v":0.838339033935879,"d":"0.84"},{"v":0.978584566517079,"d":"0.98"},"down","no"]
["MSTRG.18141","STK11","ENSOART00000012224","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0001558(regulation of cell growth);GO:0001894(tissue homeostasis);GO:0001944(vasculature development);GO:0002039(p53 binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006470(protein dephosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007050(cell cycle arrest);GO:0007409(axonogenesis);GO:0008285(negative regulation of cell population proliferation);GO:0010212(response to ionizing radiation);GO:0010508(positive regulation of autophagy);GO:0016020(membrane);GO:0030010(establishment of cell polarity);GO:0030111(regulation of Wnt signaling pathway);GO:0030275(LRR domain binding);GO:0030295(protein kinase activator activity);GO:0030308(negative regulation of cell growth);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0032147(activation of protein kinase activity);GO:0042593(glucose homeostasis);GO:0043276(anoikis);GO:0045059(positive thymic T cell selection);GO:0046777(protein autophosphorylation);GO:0048814(regulation of dendrite morphogenesis);GO:0050772(positive regulation of axonogenesis);GO:0050852(T cell receptor signaling pathway);GO:0051645(Golgi localization);GO:0051896(regulation of protein kinase B signaling);GO:0060070(canonical Wnt signaling pathway);GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development);GO:0071493(cellular response to UV-B);GO:0072332(intrinsic apoptotic signaling pathway by p53 class mediator);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097484(dendrite extension);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900182(positive regulation of protein localization to nucleus);GO:1904262(negative regulation of TORC1 signaling)","04068(FoxO signaling pathway);04140(Autophagy - animal);04150(mTOR signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04211(Longevity regulating pathway);04530(Tight junction);04920(Adipocytokine signaling pathway)","K07298","EC:2.7.11.1","serine/threonine kinase 11 [Source:NCBI gene;Acc:101117245]",{"v":14.6200197441213,"d":"14.62"},{"v":15.8322288236386,"d":"15.83"},{"v":13.0309019254332,"d":"13.03"},{"v":15.2967614198639,"d":"15.30"},{"v":15.7632276939975,"d":"15.76"},{"v":17.1083208694307,"d":"17.11"},{"v":0.90273357126866,"d":"0.90"},{"v":-0.14762783489473,"d":"-0.15"},{"v":0.838871883935209,"d":"0.84"},{"v":0.978584566517079,"d":"0.98"},"down","no"]
["ENSOARG00000011990","MMS22L","ENSOART00000013044","GO:0000724(double-strand break repair via homologous recombination);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0031297(replication fork processing);GO:0035101(FACT complex);GO:0042555(MCM complex);GO:0043596(nuclear replication fork)","NA","NA","NA","MMS22 like, DNA repair protein [Source:NCBI gene;Acc:101105004]",{"v":0.514808,"d":"0.51"},{"v":0.431896,"d":"0.43"},{"v":0.376862,"d":"0.38"},{"v":0.485081,"d":"0.49"},{"v":0.373414,"d":"0.37"},{"v":0.466082,"d":"0.47"},{"v":0.999236737464111,"d":"1.00"},{"v":-0.00110157552458653,"d":"-0.00"},{"v":0.840237860549421,"d":"0.84"},{"v":0.978584566517079,"d":"0.98"},"down","no"]
["MSTRG.263","CMPK1","ENSOART00000003891","GO:0000166(nucleotide binding);GO:0004127(cytidylate kinase activity);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006139(nucleobase-containing compound metabolic process);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006207('de novo' pyrimidine nucleobase biosynthetic process);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0009041(uridylate kinase activity);GO:0009142(nucleoside triphosphate biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0019205(nucleobase-containing compound kinase activity);GO:0046940(nucleoside monophosphate phosphorylation)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)","K13800","EC:2.7.4.14","cytidine/uridine monophosphate kinase 1 [Source:NCBI gene;Acc:101106892]",{"v":2.43037864873765,"d":"2.43"},{"v":2.45526708013172,"d":"2.46"},{"v":2.31543717398463,"d":"2.32"},{"v":2.52912979034028,"d":"2.53"},{"v":2.1737069780461,"d":"2.17"},{"v":2.55971974862788,"d":"2.56"},{"v":0.991535540685124,"d":"0.99"},{"v":-0.0122636094214136,"d":"-0.01"},{"v":0.840707267246065,"d":"0.84"},{"v":0.978584566517079,"d":"0.98"},"down","no"]
["MSTRG.17667","GIPC1","ENSOART00000005967","GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005938(cell cortex);GO:0006605(protein targeting);GO:0007268(chemical synaptic transmission);GO:0008021(synaptic vesicle);GO:0012506(vesicle membrane);GO:0014047(glutamate secretion);GO:0016020(membrane);GO:0017022(myosin binding);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0031647(regulation of protein stability);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032467(positive regulation of cytokinesis);GO:0042803(protein homodimerization activity);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0043542(endothelial cell migration);GO:0048023(positive regulation of melanin biosynthetic process);GO:0048167(regulation of synaptic plasticity);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098761(cellular response to interleukin-7);GO:0098793(presynapse);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse);GO:2000300(regulation of synaptic vesicle exocytosis)","NA","K20056","NA","GIPC PDZ domain containing family member 1 [Source:NCBI gene;Acc:101122352]",{"v":2.99673,"d":"3.00"},{"v":3.016682,"d":"3.02"},{"v":2.103865,"d":"2.10"},{"v":3.186512,"d":"3.19"},{"v":2.390898,"d":"2.39"},{"v":3.491985,"d":"3.49"},{"v":0.895018576211533,"d":"0.90"},{"v":-0.160010468901374,"d":"-0.16"},{"v":0.841117285104082,"d":"0.84"},{"v":0.978584566517079,"d":"0.98"},"down","no"]
["ENSOARG00000018389","GSAP","ENSOART00000020017","GO:0001540(amyloid-beta binding);GO:0005802(trans-Golgi network);GO:0030162(regulation of proteolysis);GO:1902004(positive regulation of amyloid-beta formation)","NA","NA","NA","gamma-secretase activating protein [Source:NCBI gene;Acc:101103230]",{"v":1.440414,"d":"1.44"},{"v":0.852815,"d":"0.85"},{"v":1.007836,"d":"1.01"},{"v":1.41908,"d":"1.42"},{"v":1.398809,"d":"1.40"},{"v":0.893103,"d":"0.89"},{"v":0.889537083345909,"d":"0.89"},{"v":-0.16887334454494,"d":"-0.17"},{"v":0.841467930000911,"d":"0.84"},{"v":0.978584566517079,"d":"0.98"},"down","no"]
["MSTRG.4177","RASAL2","ENSOART00000017396;ENSOART00000017398","GO:0005096(GTPase activator activity);GO:0007165(signal transduction);GO:0043087(regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity)","04014(Ras signaling pathway);04014(Ras signaling pathway)","K17633","NA","RAS protein activator like 2 [Source:NCBI gene;Acc:101119234]",{"v":2.85015975719313,"d":"2.85"},{"v":2.26489874456634,"d":"2.26"},{"v":2.65664577002691,"d":"2.66"},{"v":3.02757055061064,"d":"3.03"},{"v":2.86452656406541,"d":"2.86"},{"v":2.70253425460567,"d":"2.70"},{"v":0.904251030423878,"d":"0.90"},{"v":-0.145204758006787,"d":"-0.15"},{"v":0.842288342927046,"d":"0.84"},{"v":0.978638101278241,"d":"0.98"},"down","no"]
["ENSOARG00000016051","ENSOARG00000016051","ENSOART00000017482","GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003676(nucleic acid binding)","03013(RNA transport);03015(mRNA surveillance pathway)","K14328","NA","UPF3B, regulator of nonsense mediated mRNA decay [Source:NCBI gene;Acc:101101868]",{"v":0.653571,"d":"0.65"},{"v":0.599964,"d":"0.60"},{"v":0.584272,"d":"0.58"},{"v":0.708827,"d":"0.71"},{"v":0.553375,"d":"0.55"},{"v":0.564179,"d":"0.56"},{"v":1.006256087859,"d":"1.01"},{"v":0.00899751157251103,"d":"0.01"},{"v":0.842583908371451,"d":"0.84"},{"v":0.978639212966926,"d":"0.98"},"up","no"]
["MSTRG.16909","ENSOARG00000019029","ENSOART00000020715","GO:0003677(DNA binding);GO:0005634(nucleus)","NA","K09522","NA","DnaJ heat shock protein family (Hsp40) member C2 [Source:NCBI gene;Acc:101119299]",{"v":2.281027,"d":"2.28"},{"v":1.773993,"d":"1.77"},{"v":2.403415,"d":"2.40"},{"v":2.524637,"d":"2.52"},{"v":1.939218,"d":"1.94"},{"v":2.06001,"d":"2.06"},{"v":0.989970669227521,"d":"0.99"},{"v":-0.014542313116179,"d":"-0.01"},{"v":0.844226036301047,"d":"0.84"},{"v":0.97921182194652,"d":"0.98"},"down","no"]
["MSTRG.20168","FCF1","ENSOART00000001375","GO:0032040(small-subunit processome)","03008(Ribosome biogenesis in eukaryotes)","K14566","NA","FCF1, rRNA-processing protein [Source:NCBI gene;Acc:101107871]",{"v":3.553409,"d":"3.55"},{"v":3.255433,"d":"3.26"},{"v":3.51982,"d":"3.52"},{"v":3.558224,"d":"3.56"},{"v":3.595262,"d":"3.60"},{"v":4.330551,"d":"4.33"},{"v":0.899392957372046,"d":"0.90"},{"v":-0.152976507749684,"d":"-0.15"},{"v":0.844264173331026,"d":"0.84"},{"v":0.97921182194652,"d":"0.98"},"down","no"]
["MSTRG.5893","ENSOARG00000012450","ENSOART00000013538","GO:0005623(cell);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008199(ferric iron binding);GO:0046872(metal ion binding)","04216(Ferroptosis);04217(Necroptosis);04978(Mineral absorption)","K13625","NA","ferritin light chain [Source:NCBI gene;Acc:101103834]",{"v":44.076126,"d":"44.08"},{"v":25.653418,"d":"25.65"},{"v":27.915165,"d":"27.92"},{"v":29.564526,"d":"29.56"},{"v":27.930763,"d":"27.93"},{"v":39.560043,"d":"39.56"},{"v":1.00607258754213,"d":"1.01"},{"v":0.00873439849250501,"d":"0.01"},{"v":0.845389032665287,"d":"0.85"},{"v":0.979373805255471,"d":"0.98"},"up","no"]
["ENSOARG00000005139","APLP1","ENSOART00000005603;ENSOART00000005606","GO:0005886(plasma membrane);GO:0008201(heparin binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031694(alpha-2A adrenergic receptor binding);GO:0031695(alpha-2B adrenergic receptor binding);GO:0031696(alpha-2C adrenergic receptor binding);GO:0042802(identical protein binding);GO:0046914(transition metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0071874(cellular response to norepinephrine stimulus);GO:0106072(negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0106072(negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway)","NA","K05639","NA","amyloid beta precursor like protein 1 [Source:NCBI gene;Acc:101105352]",{"v":1.45609612566641,"d":"1.46"},{"v":1.03707554607768,"d":"1.04"},{"v":1.48302609177456,"d":"1.48"},{"v":1.09293882901752,"d":"1.09"},{"v":1.44155607882711,"d":"1.44"},{"v":1.41952817897944,"d":"1.42"},{"v":1.00560813030366,"d":"1.01"},{"v":0.00806821905299084,"d":"0.01"},{"v":0.845905479820732,"d":"0.85"},{"v":0.979373805255471,"d":"0.98"},"up","no"]
["MSTRG.4604","TMEM236","ENSOART00000012806","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 236 [Source:NCBI gene;Acc:101118719]",{"v":0.42869,"d":"0.43"},{"v":0.246518,"d":"0.25"},{"v":1.539491,"d":"1.54"},{"v":0.793683,"d":"0.79"},{"v":0.761741,"d":"0.76"},{"v":0.995463,"d":"1.00"},{"v":0.868207411774806,"d":"0.87"},{"v":-0.203888356142324,"d":"-0.20"},{"v":0.846236709930279,"d":"0.85"},{"v":0.979398426406408,"d":"0.98"},"down","no"]
["MSTRG.10197","OSBPL6","ENSOART00000018875","GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006869(lipid transport);GO:0031965(nuclear membrane);GO:0097038(perinuclear endoplasmic reticulum)","NA","K20463","NA","oxysterol binding protein like 6 [Source:NCBI gene;Acc:101102536]",{"v":2.53962942445308,"d":"2.54"},{"v":2.72789381476181,"d":"2.73"},{"v":2.68598636352484,"d":"2.69"},{"v":2.58528198241668,"d":"2.59"},{"v":2.94835820220814,"d":"2.95"},{"v":2.55512296176651,"d":"2.56"},{"v":0.983278834946238,"d":"0.98"},{"v":-0.0243275056347942,"d":"-0.02"},{"v":0.847722499122544,"d":"0.85"},{"v":0.979827965226617,"d":"0.98"},"down","no"]
["MSTRG.11020","EIF4G3","ENSOART00000009492;ENSOART00000009489","GO:0000339(RNA cap binding);GO:0003723(RNA binding);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0006413(translational initiation);GO:0006413(translational initiation)","NA","NA","NA","eukaryotic translation initiation factor 4 gamma 3 [Source:HGNC Symbol;Acc:HGNC:3298]",{"v":3.85407513213691,"d":"3.85"},{"v":4.32445498678631,"d":"4.32"},{"v":4.20614365330153,"d":"4.21"},{"v":4.37166150935181,"d":"4.37"},{"v":4.59520635286991,"d":"4.60"},{"v":3.70226097224746,"d":"3.70"},{"v":0.977547385778373,"d":"0.98"},{"v":-0.0327614573568704,"d":"-0.03"},{"v":0.848101738969046,"d":"0.85"},{"v":0.979827965226617,"d":"0.98"},"down","no"]
["MSTRG.18072","NSD1","ENSOART00000004183;ENSOART00000004180","GO:0000414(regulation of histone H3-K36 methylation);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0003712(transcription coregulator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0008168(methyltransferase activity);GO:0008270(zinc ion binding);GO:0010452(histone H3-K36 methylation);GO:0016740(transferase activity);GO:0018024(histone-lysine N-methyltransferase activity);GO:0032259(methylation);GO:0033135(regulation of peptidyl-serine phosphorylation);GO:0034968(histone lysine methylation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0046975(histone methyltransferase activity (H3-K36 specific));GO:0050681(androgen receptor binding);GO:1903025(regulation of RNA polymerase II regulatory region sequence-specific DNA binding);GO:1903025(regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","00310(Lysine degradation);00310(Lysine degradation)","K15588","EC:2.1.1.43","nuclear receptor binding SET domain protein 1 [Source:NCBI gene;Acc:101120917]",{"v":6.91294706071751,"d":"6.91"},{"v":6.26309846658802,"d":"6.26"},{"v":6.17133513378669,"d":"6.17"},{"v":7.70458307771841,"d":"7.70"},{"v":6.9229806434668,"d":"6.92"},{"v":5.18514733085837,"d":"5.19"},{"v":0.976513542759038,"d":"0.98"},{"v":-0.0342880426484939,"d":"-0.03"},{"v":0.849484444519887,"d":"0.85"},{"v":0.980312237970305,"d":"0.98"},"down","no"]
["MSTRG.9930","FOCAD","ENSOART00000015598","GO:0005925(focal adhesion)","NA","NA","NA","focadhesin [Source:NCBI gene;Acc:101103125]",{"v":4.05011276089918,"d":"4.05"},{"v":3.50774622649864,"d":"3.51"},{"v":3.16782880245232,"d":"3.17"},{"v":3.85865275579019,"d":"3.86"},{"v":4.06269307050409,"d":"4.06"},{"v":3.89227275510899,"d":"3.89"},{"v":0.907908759364745,"d":"0.91"},{"v":-0.139380774272068,"d":"-0.14"},{"v":0.85057233073306,"d":"0.85"},{"v":0.980602708168723,"d":"0.98"},"down","no"]
["ENSOARG00000003268","NAALAD2","ENSOART00000003549","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K01301","EC:3.4.17.21","N-acetylated alpha-linked acidic dipeptidase 2 [Source:NCBI gene;Acc:101120451]",{"v":0.334117,"d":"0.33"},{"v":0.246369,"d":"0.25"},{"v":0.394127,"d":"0.39"},{"v":0.455125,"d":"0.46"},{"v":0.329434,"d":"0.33"},{"v":0.330808,"d":"0.33"},{"v":0.873804765606298,"d":"0.87"},{"v":-0.194617120831228,"d":"-0.19"},{"v":0.851808401400503,"d":"0.85"},{"v":0.98139483333809,"d":"0.98"},"down","no"]
["MSTRG.18495","SSBP2","ENSOART00000016802;ENSOART00000016803","NA","NA","NA","NA","single stranded DNA binding protein 2 [Source:NCBI gene;Acc:101118446]",{"v":3.99742768322551,"d":"4.00"},{"v":3.31866128858595,"d":"3.32"},{"v":4.14093383294824,"d":"4.14"},{"v":3.40959296048983,"d":"3.41"},{"v":4.03736081989372,"d":"4.04"},{"v":4.12037876166821,"d":"4.12"},{"v":0.990463684095617,"d":"0.99"},{"v":-0.0138240160226287,"d":"-0.01"},{"v":0.852012986075927,"d":"0.85"},{"v":0.981422789181499,"d":"0.98"},"down","no"]
["MSTRG.9869","RCL1","ENSOART00000014645","GO:0000447(endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000480(endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003824(catalytic activity);GO:0005730(nucleolus);GO:0006396(RNA processing);GO:0042254(ribosome biogenesis)","03008(Ribosome biogenesis in eukaryotes)","K11108","NA","RNA terminal phosphate cyclase like 1 [Source:NCBI gene;Acc:101113654]",{"v":3.222546,"d":"3.22"},{"v":2.35666,"d":"2.36"},{"v":3.114828,"d":"3.11"},{"v":3.750633,"d":"3.75"},{"v":2.815384,"d":"2.82"},{"v":3.113053,"d":"3.11"},{"v":0.898230305184279,"d":"0.90"},{"v":-0.15484269719482,"d":"-0.15"},{"v":0.85346169613348,"d":"0.85"},{"v":0.981929441861797,"d":"0.98"},"down","no"]
["MSTRG.6333","HYOU1","ENSOART00000013627","GO:0000166(nucleotide binding);GO:0002931(response to ischemia);GO:0005524(ATP binding);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0034663(endoplasmic reticulum chaperone complex);GO:0034976(response to endoplasmic reticulum stress);GO:0043066(negative regulation of apoptotic process);GO:0071456(cellular response to hypoxia);GO:1903298(negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway);GO:1903382(negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway)","04141(Protein processing in endoplasmic reticulum)","K09486","NA","hypoxia up-regulated 1 [Source:NCBI gene;Acc:101105848]",{"v":3.95002814554519,"d":"3.95"},{"v":3.5603494649405,"d":"3.56"},{"v":4.13777898745577,"d":"4.14"},{"v":4.97318181344484,"d":"4.97"},{"v":3.39984862672885,"d":"3.40"},{"v":3.56841363846896,"d":"3.57"},{"v":0.975439529861741,"d":"0.98"},{"v":-0.0358756558538327,"d":"-0.04"},{"v":0.854136689292203,"d":"0.85"},{"v":0.981929441861797,"d":"0.98"},"down","no"]
["MSTRG.10698","TNS1","ENSOART00000021177","GO:0005515(protein binding);GO:0005925(focal adhesion);GO:0007044(cell-substrate junction assembly);GO:0010761(fibroblast migration);GO:0030055(cell-substrate junction)","NA","NA","NA","tensin 1 [Source:HGNC Symbol;Acc:HGNC:11973]",{"v":8.37103429664235,"d":"8.37"},{"v":8.49709542542517,"d":"8.50"},{"v":9.05352742556325,"d":"9.05"},{"v":9.11359679175201,"d":"9.11"},{"v":10.738172309806,"d":"10.74"},{"v":8.7451800776241,"d":"8.75"},{"v":0.906448341227291,"d":"0.91"},{"v":-0.141703292213955,"d":"-0.14"},{"v":0.856301153596941,"d":"0.86"},{"v":0.98333045872462,"d":"0.98"},"down","no"]
["MSTRG.21060","SNAI2","ENSOART00000014159","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001649(osteoblast differentiation);GO:0001837(epithelial to mesenchymal transition);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0007219(Notch signaling pathway);GO:0007605(sensory perception of sound);GO:0010839(negative regulation of keratinocyte proliferation);GO:0010957(negative regulation of vitamin D biosynthetic process);GO:0014032(neural crest cell development);GO:0030335(positive regulation of cell migration);GO:0032331(negative regulation of chondrocyte differentiation);GO:0032642(regulation of chemokine production);GO:0035921(desmosome disassembly);GO:0043473(pigmentation);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0043565(sequence-specific DNA binding);GO:0045667(regulation of osteoblast differentiation);GO:0070563(negative regulation of vitamin D receptor signaling pathway);GO:0070888(E-box binding);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:1900387(negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage);GO:2000810(regulation of bicellular tight junction assembly);GO:2000811(negative regulation of anoikis)","04390(Hippo signaling pathway);04520(Adherens junction)","K05706","NA","snail family transcriptional repressor 2 [Source:NCBI gene;Acc:100127220]",{"v":7.76957548090169,"d":"7.77"},{"v":3.37328925297433,"d":"3.37"},{"v":4.06344267188478,"d":"4.06"},{"v":6.3773442391985,"d":"6.38"},{"v":4.65718083844709,"d":"4.66"},{"v":5.65888255416406,"d":"5.66"},{"v":0.910916916494919,"d":"0.91"},{"v":-0.134608621131077,"d":"-0.13"},{"v":0.85662161170119,"d":"0.86"},{"v":0.98333045872462,"d":"0.98"},"down","no"]
["MSTRG.13497","ATP2A1;SH2B1","ENSOART00000002312;ENSOART00000002308;ENSOART00000002489","GO:0000166(nucleotide binding);GO:0005388(calcium-transporting ATPase activity);GO:0005509(calcium ion binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0008637(apoptotic mitochondrial changes);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016529(sarcoplasmic reticulum);GO:0016787(hydrolase activity);GO:0031448(positive regulation of fast-twitch skeletal muscle fiber contraction);GO:0032470(positive regulation of endoplasmic reticulum calcium ion concentration);GO:0032471(negative regulation of endoplasmic reticulum calcium ion concentration);GO:0033017(sarcoplasmic reticulum membrane);GO:0034976(response to endoplasmic reticulum stress);GO:0042803(protein homodimerization activity);GO:0051561(positive regulation of mitochondrial calcium ion concentration);GO:0051659(maintenance of mitochondrion location);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0090076(relaxation of skeletal muscle);GO:0099132(ATP hydrolysis coupled cation transmembrane transport);GO:0007165(signal transduction);GO:0009967(positive regulation of signal transduction);GO:0030032(lamellipodium assembly);GO:0035591(signaling adaptor activity);GO:0045840(positive regulation of mitotic nuclear division);GO:2000278(regulation of DNA biosynthetic process)","04020(Calcium signaling pathway);04022(cGMP-PKG signaling pathway);04972(Pancreatic secretion);05010(Alzheimer disease);04722(Neurotrophin signaling pathway)","K05853;K12459","EC:7.2.2.10","ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [Source:NCBI gene;Acc:101111766];SH2B adaptor protein 1 [Source:NCBI gene;Acc:101112187]",{"v":885.258522381868,"d":"885.26"},{"v":796.374990130593,"d":"796.37"},{"v":751.083878217033,"d":"751.08"},{"v":982.143129235479,"d":"982.14"},{"v":775.318134673567,"d":"775.32"},{"v":923.091621372547,"d":"923.09"},{"v":0.907543143090772,"d":"0.91"},{"v":-0.139961866827312,"d":"-0.14"},{"v":0.857934978805944,"d":"0.86"},{"v":0.983496310856793,"d":"0.98"},"down","no"]
["MSTRG.9372","CDK5RAP2","ENSOART00000006249","GO:0000132(establishment of mitotic spindle orientation);GO:0000226(microtubule cytoskeleton organization);GO:0000242(pericentriolar material);GO:0000922(spindle pole);GO:0001578(microtubule bundle formation);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005874(microtubule);GO:0007059(chromosome segregation);GO:0007098(centrosome cycle);GO:0007099(centriole replication);GO:0007420(brain development);GO:0008017(microtubule binding);GO:0008274(gamma-tubulin ring complex);GO:0015631(tubulin binding);GO:0019901(protein kinase binding);GO:0022008(neurogenesis);GO:0030054(cell junction);GO:0031023(microtubule organizing center organization);GO:0031116(positive regulation of microtubule polymerization);GO:0035371(microtubule plus-end);GO:0043015(gamma-tubulin binding);GO:0044212(transcription regulatory region DNA binding);GO:0045665(negative regulation of neuron differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046600(negative regulation of centriole replication);GO:0048471(perinuclear region of cytoplasm);GO:0090266(regulation of mitotic cell cycle spindle assembly checkpoint);GO:0097431(mitotic spindle pole)","NA","K16542","NA","CDK5 regulatory subunit associated protein 2 [Source:NCBI gene;Acc:101116809]",{"v":2.65048016941102,"d":"2.65"},{"v":2.36386731934769,"d":"2.36"},{"v":2.89498933090564,"d":"2.89"},{"v":3.24137055953135,"d":"3.24"},{"v":3.13213217827739,"d":"3.13"},{"v":2.40336668318556,"d":"2.40"},{"v":0.901156943356727,"d":"0.90"},{"v":-0.150149710619027,"d":"-0.15"},{"v":0.858149209768113,"d":"0.86"},{"v":0.983496310856793,"d":"0.98"},"down","no"]
["ENSOARG00000003641","ENSOARG00000003641","ENSOART00000003952","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger protein OZF-like [Source:NCBI gene;Acc:101114301]",{"v":0.278067,"d":"0.28"},{"v":0.224804,"d":"0.22"},{"v":0.247071,"d":"0.25"},{"v":0.41392,"d":"0.41"},{"v":0.249424,"d":"0.25"},{"v":0.196618,"d":"0.20"},{"v":0.872064114460872,"d":"0.87"},{"v":-0.197493888538329,"d":"-0.20"},{"v":0.85860887550745,"d":"0.86"},{"v":0.983496310856793,"d":"0.98"},"down","no"]
["MSTRG.9978","SCARA5","ENSOART00000016188","GO:0005044(scavenger receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006879(cellular iron ion homeostasis);GO:0006897(endocytosis);GO:0006898(receptor-mediated endocytosis);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034605(cellular response to heat);GO:0034755(iron ion transmembrane transport);GO:0055072(iron ion homeostasis);GO:0070207(protein homotrimerization);GO:0070287(ferritin receptor activity)","NA","NA","NA","scavenger receptor class A member 5 [Source:NCBI gene;Acc:101114933]",{"v":5.6499815116144,"d":"5.65"},{"v":4.29386914518002,"d":"4.29"},{"v":5.11081864498645,"d":"5.11"},{"v":4.76393843050716,"d":"4.76"},{"v":5.92983317982966,"d":"5.93"},{"v":5.76088271215641,"d":"5.76"},{"v":0.914918600337984,"d":"0.91"},{"v":-0.128284701340534,"d":"-0.13"},{"v":0.860424266071022,"d":"0.86"},{"v":0.983814363856512,"d":"0.98"},"down","no"]
["MSTRG.14941","ENSOARG00000017832","ENSOART00000019402","NA","NA","NA","NA","family with sequence similarity 228 member B [Source:NCBI gene;Acc:101107005]",{"v":0.607425,"d":"0.61"},{"v":0.527261,"d":"0.53"},{"v":0.487538,"d":"0.49"},{"v":0.669883,"d":"0.67"},{"v":0.516774,"d":"0.52"},{"v":0.446609,"d":"0.45"},{"v":0.993239313130868,"d":"0.99"},{"v":-0.00978672932862652,"d":"-0.01"},{"v":0.860487509086801,"d":"0.86"},{"v":0.983814363856512,"d":"0.98"},"down","no"]
["MSTRG.2715","NLK","ENSOART00000018809","GO:0000165(MAPK cascade);GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004707(MAP kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0006468(protein phosphorylation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008134(transcription factor binding);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018107(peptidyl-threonine phosphorylation);GO:0030178(negative regulation of Wnt signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0035556(intracellular signal transduction);GO:0042169(SH2 domain binding);GO:0042501(serine phosphorylation of STAT protein);GO:0046777(protein autophosphorylation);GO:0050821(protein stabilization)","04010(MAPK signaling pathway);04068(FoxO signaling pathway);04310(Wnt signaling pathway);04520(Adherens junction)","K04468","EC:2.7.11.24","nemo like kinase [Source:NCBI gene;Acc:101103076]",{"v":1.91178725405529,"d":"1.91"},{"v":1.62956055586018,"d":"1.63"},{"v":1.44327115284441,"d":"1.44"},{"v":1.79279362462874,"d":"1.79"},{"v":1.68164023303633,"d":"1.68"},{"v":1.59095048480695,"d":"1.59"},{"v":0.984055429114245,"d":"0.98"},{"v":-0.0231885140220026,"d":"-0.02"},{"v":0.860851167151741,"d":"0.86"},{"v":0.983814363856512,"d":"0.98"},"down","no"]
["MSTRG.9925","DENND4C","ENSOART00000015495","GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030904(retromer complex);GO:0032593(insulin-responsive compartment);GO:0032869(cellular response to insulin stimulus);GO:0072659(protein localization to plasma membrane)","NA","K20163","NA","DENN domain containing 4C [Source:NCBI gene;Acc:101123605]",{"v":3.61333191826047,"d":"3.61"},{"v":2.82275856261384,"d":"2.82"},{"v":3.2706792389572,"d":"3.27"},{"v":4.24704133390255,"d":"4.25"},{"v":3.76964290323315,"d":"3.77"},{"v":2.74815969706284,"d":"2.75"},{"v":0.901710213279947,"d":"0.90"},{"v":-0.149264232399934,"d":"-0.15"},{"v":0.862109831537705,"d":"0.86"},{"v":0.98420694103669,"d":"0.98"},"down","no"]
["ENSOARG00000004852","SCN1A","ENSOART00000005300","GO:0001508(action potential);GO:0001518(voltage-gated sodium channel complex);GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005248(voltage-gated sodium channel activity);GO:0005272(sodium channel activity);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0007628(adult walking behavior);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016604(nuclear body);GO:0019227(neuronal action potential propagation);GO:0019228(neuronal action potential);GO:0030018(Z disc);GO:0030315(T-tubule);GO:0030424(axon);GO:0033268(node of Ranvier);GO:0034220(ion transmembrane transport);GO:0034706(sodium channel complex);GO:0034765(regulation of ion transmembrane transport);GO:0035725(sodium ion transmembrane transport);GO:0042391(regulation of membrane potential);GO:0043025(neuronal cell body);GO:0043194(axon initial segment);GO:0050884(neuromuscular process controlling posture);GO:0050966(detection of mechanical stimulus involved in sensory perception of pain);GO:0055085(transmembrane transport);GO:0086002(cardiac muscle cell action potential involved in contraction)","04728(Dopaminergic synapse)","K04833","NA","sodium voltage-gated channel alpha subunit 1 [Source:NCBI gene;Acc:101123531]",{"v":0.235171,"d":"0.24"},{"v":0.301961,"d":"0.30"},{"v":0.491441,"d":"0.49"},{"v":0.382973,"d":"0.38"},{"v":0.487952,"d":"0.49"},{"v":0.289448,"d":"0.29"},{"v":0.886415833529391,"d":"0.89"},{"v":-0.173944443249453,"d":"-0.17"},{"v":0.862675938400907,"d":"0.86"},{"v":0.984399519338179,"d":"0.98"},"down","no"]
["MSTRG.15404","ENSOARG00000011678","ENSOART00000012700","GO:0017137(Rab GTPase binding)","NA","NA","NA",null,{"v":1.41858529402808,"d":"1.42"},{"v":1.42921744222636,"d":"1.43"},{"v":1.59889273693115,"d":"1.60"},{"v":1.71688025105735,"d":"1.72"},{"v":1.54399224970394,"d":"1.54"},{"v":1.64587848062934,"d":"1.65"},{"v":0.906240298325746,"d":"0.91"},{"v":-0.142034449432156,"d":"-0.14"},{"v":0.863741328051729,"d":"0.86"},{"v":0.984965459465246,"d":"0.98"},"down","no"]
["MSTRG.7263","TMEM192","ENSOART00000017380","GO:0005654(nucleoplasm);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005770(late endosome);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042803(protein homodimerization activity);GO:0048471(perinuclear region of cytoplasm)","NA","NA","NA","transmembrane protein 192 [Source:HGNC Symbol;Acc:HGNC:26775]",{"v":1.619254,"d":"1.62"},{"v":0.69373,"d":"0.69"},{"v":1.188677,"d":"1.19"},{"v":1.449589,"d":"1.45"},{"v":1.353179,"d":"1.35"},{"v":0.69193,"d":"0.69"},{"v":1.00199244684376,"d":"1.00"},{"v":0.00287163334138581,"d":"0.00"},{"v":0.864718700816587,"d":"0.86"},{"v":0.985241057730203,"d":"0.99"},"up","no"]
["MSTRG.5172","ENSOARG00000004471","ENSOART00000004860","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0008121(ubiquinol-cytochrome-c reductase activity);GO:0016020(membrane);GO:0016491(oxidoreductase activity);GO:0016679(oxidoreductase activity, acting on diphenols and related substances as donors);GO:0022900(electron transport chain);GO:0051537(2 iron, 2 sulfur cluster binding);GO:0055114(oxidation-reduction process);GO:0070469(respirasome)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);04714(Thermogenesis);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K00411","EC:7.1.1.8","cytochrome b-c1 complex subunit Rieske, mitochondrial [Source:NCBI gene;Acc:101113001]",{"v":209.063065,"d":"209.06"},{"v":202.522568,"d":"202.52"},{"v":148.800934,"d":"148.80"},{"v":252.775162,"d":"252.78"},{"v":153.802734,"d":"153.80"},{"v":213.537476,"d":"213.54"},{"v":0.903681141128042,"d":"0.90"},{"v":-0.146114279393846,"d":"-0.15"},{"v":0.865072406775718,"d":"0.87"},{"v":0.985241057730203,"d":"0.99"},"down","no"]
["MSTRG.19581","CHD8","ENSOART00000021394","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000166(nucleotide binding);GO:0001701(in utero embryonic development);GO:0001964(startle response);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003682(chromatin binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0007420(brain development);GO:0008013(beta-catenin binding);GO:0008094(DNA-dependent ATPase activity);GO:0016055(Wnt signaling pathway);GO:0016787(hydrolase activity);GO:0016817(hydrolase activity, acting on acid anhydrides);GO:0030178(negative regulation of Wnt signaling pathway);GO:0032508(DNA duplex unwinding);GO:0032991(protein-containing complex);GO:0035064(methylated histone binding);GO:0035176(social behavior);GO:0042393(histone binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0043066(negative regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045945(positive regulation of transcription by RNA polymerase III);GO:0048565(digestive tract development);GO:0060134(prepulse inhibition);GO:0071339(MLL1 complex);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:2000270(negative regulation of fibroblast apoptotic process)","04310(Wnt signaling pathway)","K04494","EC:3.6.4.12","chromodomain helicase DNA binding protein 8 [Source:NCBI gene;Acc:101109181]",{"v":5.7753390474085,"d":"5.78"},{"v":5.62151875558831,"d":"5.62"},{"v":5.60079235237043,"d":"5.60"},{"v":7.04875952014247,"d":"7.05"},{"v":5.67930642864161,"d":"5.68"},{"v":6.04526947089167,"d":"6.05"},{"v":0.90541450282471,"d":"0.91"},{"v":-0.143349679194348,"d":"-0.14"},{"v":0.865519120335423,"d":"0.87"},{"v":0.985241057730203,"d":"0.99"},"down","no"]
["MSTRG.2296","ZDHHC20","ENSOART00000014813;ENSOART00000014812","GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016409(palmitoyltransferase activity);GO:0016740(transferase activity);GO:0016746(transferase activity, transferring acyl groups);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoyltransferase activity);GO:0030173(integral component of Golgi membrane);GO:0030173(integral component of Golgi membrane)","NA","K20028","EC:2.3.1.225","zinc finger DHHC-type containing 20 [Source:NCBI gene;Acc:101117089]",{"v":3.32019951916239,"d":"3.32"},{"v":3.03303013453181,"d":"3.03"},{"v":3.27981853832477,"d":"3.28"},{"v":3.55091853259581,"d":"3.55"},{"v":3.58856526708811,"d":"3.59"},{"v":3.44886979889372,"d":"3.45"},{"v":0.909777719674285,"d":"0.91"},{"v":-0.13641399121956,"d":"-0.14"},{"v":0.866559934813126,"d":"0.87"},{"v":0.985468068424372,"d":"0.99"},"down","no"]
["MSTRG.14240","ANGPT2","ENSOART00000006805","GO:0001525(angiogenesis);GO:0005615(extracellular space);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016525(negative regulation of angiogenesis);GO:0030971(receptor tyrosine kinase binding);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0048014(Tie signaling pathway);GO:0048514(blood vessel morphogenesis);GO:0050928(negative regulation of positive chemotaxis)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);05167(Kaposi sarcoma-associated herpesvirus infection)","K05466","NA","angiopoietin 2 [Source:NCBI gene;Acc:497273]",{"v":2.177018,"d":"2.18"},{"v":2.06234,"d":"2.06"},{"v":2.490896,"d":"2.49"},{"v":2.649707,"d":"2.65"},{"v":1.870962,"d":"1.87"},{"v":2.326751,"d":"2.33"},{"v":0.982889029736747,"d":"0.98"},{"v":-0.0248995524677365,"d":"-0.02"},{"v":0.867651466325426,"d":"0.87"},{"v":0.985468068424372,"d":"0.99"},"down","no"]
["MSTRG.14023","CCAR1","ENSOART00000005678","GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0008284(positive regulation of cell population proliferation);GO:0030335(positive regulation of cell migration);GO:0030374(nuclear receptor transcription coactivator activity);GO:1903507(negative regulation of nucleic acid-templated transcription);GO:1903508(positive regulation of nucleic acid-templated transcription)","NA","NA","NA","cell division cycle and apoptosis regulator 1 [Source:NCBI gene;Acc:101106390]",{"v":2.83556064769231,"d":"2.84"},{"v":2.43750410807692,"d":"2.44"},{"v":2.701393025,"d":"2.70"},{"v":3.55595285346154,"d":"3.56"},{"v":2.65752405615385,"d":"2.66"},{"v":2.61437411192308,"d":"2.61"},{"v":0.90332944691895,"d":"0.90"},{"v":-0.14667585606764,"d":"-0.15"},{"v":0.867996816968741,"d":"0.87"},{"v":0.985468068424372,"d":"0.99"},"down","no"]
["MSTRG.10984","KDM1A","ENSOART00000008407","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000784(nuclear chromosome, telomeric region);GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0002052(positive regulation of neuroblast proliferation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006482(protein demethylation);GO:0008134(transcription factor binding);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016491(oxidoreductase activity);GO:0019899(enzyme binding);GO:0030374(nuclear receptor transcription coactivator activity);GO:0032091(negative regulation of protein binding);GO:0032451(demethylase activity);GO:0032452(histone demethylase activity);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0032454(histone demethylase activity (H3-K9 specific));GO:0032991(protein-containing complex);GO:0033169(histone H3-K9 demethylation);GO:0033184(positive regulation of histone ubiquitination);GO:0034644(cellular response to UV);GO:0034648(histone demethylase activity (H3-dimethyl-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0042162(telomeric DNA binding);GO:0043426(MRF binding);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0043518(negative regulation of DNA damage response, signal transduction by p53 class mediator);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050660(flavin adenine dinucleotide binding);GO:0050681(androgen receptor binding);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0055114(oxidation-reduction process);GO:0061752(telomeric repeat-containing RNA binding);GO:0071480(cellular response to gamma radiation);GO:1902166(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator);GO:1903827(regulation of cellular protein localization);GO:1990391(DNA repair complex)","04714(Thermogenesis)","K11450","EC:1.-.-.-","lysine demethylase 1A [Source:NCBI gene;Acc:101121409]",{"v":4.34187556752359,"d":"4.34"},{"v":4.13795103351773,"d":"4.14"},{"v":4.1509614868207,"d":"4.15"},{"v":4.87081021770257,"d":"4.87"},{"v":4.05774275138301,"d":"4.06"},{"v":4.04905809729906,"d":"4.05"},{"v":0.973275283351573,"d":"0.97"},{"v":-0.0390801770798736,"d":"-0.04"},{"v":0.869116782464565,"d":"0.87"},{"v":0.985890155552971,"d":"0.99"},"down","no"]
["MSTRG.5358","LONP2","ENSOART00000018367","GO:0000166(nucleotide binding);GO:0002020(protease binding);GO:0004176(ATP-dependent peptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005102(signaling receptor binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0006508(proteolysis);GO:0006515(protein quality control for misfolded or incompletely synthesized proteins);GO:0006625(protein targeting to peroxisome);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016485(protein processing);GO:0016558(protein import into peroxisome matrix);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0019899(enzyme binding);GO:0030163(protein catabolic process);GO:0031998(regulation of fatty acid beta-oxidation)","NA","K01338","EC:3.4.21.53","lon peptidase 2, peroxisomal [Source:NCBI gene;Acc:101110861]",{"v":18.185837,"d":"18.19"},{"v":18.782578,"d":"18.78"},{"v":19.225321,"d":"19.23"},{"v":18.482685,"d":"18.48"},{"v":21.793949,"d":"21.79"},{"v":21.343479,"d":"21.34"},{"v":0.911938217315505,"d":"0.91"},{"v":-0.132992007988365,"d":"-0.13"},{"v":0.870077502340859,"d":"0.87"},{"v":0.986071853789248,"d":"0.99"},"down","no"]
["MSTRG.17642","C19orf44","ENSOART00000020635","NA","NA","NA","NA","chromosome 5 open reading frame, human C19orf44 [Source:NCBI gene;Acc:101117416]",{"v":0.927783,"d":"0.93"},{"v":0.784732,"d":"0.78"},{"v":0.893875,"d":"0.89"},{"v":0.984816,"d":"0.98"},{"v":1.030597,"d":"1.03"},{"v":0.640705,"d":"0.64"},{"v":0.981277940211994,"d":"0.98"},{"v":-0.0272662671356983,"d":"-0.03"},{"v":0.870839975692972,"d":"0.87"},{"v":0.986272994470416,"d":"0.99"},"down","no"]
["MSTRG.10893","PPP1R8","ENSOART00000003560","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0008283(cell population proliferation);GO:0016607(nuclear speck);GO:0019888(protein phosphatase regulator activity);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA","K13216","EC:3.1.4.-","protein phosphatase 1 regulatory subunit 8 [Source:NCBI gene;Acc:101105555]",{"v":7.328575,"d":"7.33"},{"v":6.673609,"d":"6.67"},{"v":6.498656,"d":"6.50"},{"v":7.769393,"d":"7.77"},{"v":7.112609,"d":"7.11"},{"v":7.67133,"d":"7.67"},{"v":0.908993846230792,"d":"0.91"},{"v":-0.13765756729127,"d":"-0.14"},{"v":0.871262891380429,"d":"0.87"},{"v":0.986391097946662,"d":"0.99"},"down","no"]
["MSTRG.14678","NOTCH1","ENSOART00000004157","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001708(cell fate specification);GO:0001837(epithelial to mesenchymal transition);GO:0001889(liver development);GO:0001947(heart looping);GO:0002040(sprouting angiogenesis);GO:0002437(inflammatory response to antigenic stimulus);GO:0003157(endocardium development);GO:0003160(endocardium morphogenesis);GO:0003162(atrioventricular node development);GO:0003169(coronary vein morphogenesis);GO:0003180(aortic valve morphogenesis);GO:0003181(atrioventricular valve morphogenesis);GO:0003182(coronary sinus valve morphogenesis);GO:0003184(pulmonary valve morphogenesis);GO:0003197(endocardial cushion development);GO:0003198(epithelial to mesenchymal transition involved in endocardial cushion formation);GO:0003203(endocardial cushion morphogenesis);GO:0003207(cardiac chamber formation);GO:0003208(cardiac ventricle morphogenesis);GO:0003209(cardiac atrium morphogenesis);GO:0003213(cardiac right atrium morphogenesis);GO:0003214(cardiac left ventricle morphogenesis);GO:0003219(cardiac right ventricle formation);GO:0003222(ventricular trabecula myocardium morphogenesis);GO:0003241(growth involved in heart morphogenesis);GO:0003252(negative regulation of cell proliferation involved in heart valve morphogenesis);GO:0003256(regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation);GO:0003270(Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation);GO:0003273(cell migration involved in endocardial cushion formation);GO:0003332(negative regulation of extracellular matrix constituent secretion);GO:0003344(pericardium morphogenesis);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0004857(enzyme inhibitor activity);GO:0005112(Notch binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006959(humoral immune response);GO:0007219(Notch signaling pathway);GO:0007221(positive regulation of transcription of Notch receptor target);GO:0007368(determination of left/right symmetry);GO:0007386(compartment pattern specification);GO:0007409(axonogenesis);GO:0007440(foregut morphogenesis);GO:0007492(endoderm development);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0008544(epidermis development);GO:0008593(regulation of Notch signaling pathway);GO:0009912(auditory receptor cell fate commitment);GO:0009986(cell surface);GO:0010001(glial cell differentiation);GO:0010468(regulation of gene expression);GO:0010614(negative regulation of cardiac muscle hypertrophy);GO:0010628(positive regulation of gene expression);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0010832(negative regulation of myotube differentiation);GO:0014031(mesenchymal cell development);GO:0014807(regulation of somitogenesis);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0019899(enzyme binding);GO:0021915(neural tube development);GO:0030154(cell differentiation);GO:0030182(neuron differentiation);GO:0030216(keratinocyte differentiation);GO:0030279(negative regulation of ossification);GO:0030324(lung development);GO:0030326(embryonic limb morphogenesis);GO:0030334(regulation of cell migration);GO:0030335(positive regulation of cell migration);GO:0030513(positive regulation of BMP signaling pathway);GO:0030514(negative regulation of BMP signaling pathway);GO:0030900(forebrain development);GO:0031069(hair follicle morphogenesis);GO:0031410(cytoplasmic vesicle);GO:0031490(chromatin DNA binding);GO:0032495(response to muramyl dipeptide);GO:0035116(embryonic hindlimb morphogenesis);GO:0035914(skeletal muscle cell differentiation);GO:0042127(regulation of cell population proliferation);GO:0043065(positive regulation of apoptotic process);GO:0043086(negative regulation of catalytic activity);GO:0043565(sequence-specific DNA binding);GO:0045070(positive regulation of viral genome replication);GO:0045165(cell fate commitment);GO:0045596(negative regulation of cell differentiation);GO:0045607(regulation of inner ear auditory receptor cell differentiation);GO:0045608(negative regulation of inner ear auditory receptor cell differentiation);GO:0045618(positive regulation of keratinocyte differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0045955(negative regulation of calcium ion-dependent exocytosis);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046533(negative regulation of photoreceptor cell differentiation);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0048103(somatic stem cell division);GO:0048663(neuron fate commitment);GO:0048711(positive regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0048754(branching morphogenesis of an epithelial tube);GO:0048845(venous blood vessel morphogenesis);GO:0048873(homeostasis of number of cells within a tissue);GO:0050678(regulation of epithelial cell proliferation);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050767(regulation of neurogenesis);GO:0050768(negative regulation of neurogenesis);GO:0050793(regulation of developmental process);GO:0055008(cardiac muscle tissue morphogenesis);GO:0060038(cardiac muscle cell proliferation);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060253(negative regulation of glial cell proliferation);GO:0060317(cardiac epithelial to mesenchymal transition);GO:0060411(cardiac septum morphogenesis);GO:0060412(ventricular septum morphogenesis);GO:0060528(secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development);GO:0060548(negative regulation of cell death);GO:0060740(prostate gland epithelium morphogenesis);GO:0060768(regulation of epithelial cell proliferation involved in prostate gland development);GO:0060842(arterial endothelial cell differentiation);GO:0060843(venous endothelial cell differentiation);GO:0060948(cardiac vascular smooth muscle cell development);GO:0060956(endocardial cell differentiation);GO:0060979(vasculogenesis involved in coronary vascular morphogenesis);GO:0060982(coronary artery morphogenesis);GO:0061314(Notch signaling involved in heart development);GO:0061384(heart trabecula morphogenesis);GO:0061419(positive regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0070168(negative regulation of biomineral tissue development);GO:0070986(left/right axis specification);GO:0071944(cell periphery);GO:0072017(distal tubule development);GO:0072044(collecting duct development);GO:0072144(glomerular mesangial cell development);GO:0072602(interleukin-4 secretion);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1901201(regulation of extracellular matrix assembly);GO:1902263(apoptotic process involved in embryonic digit morphogenesis);GO:1902339(positive regulation of apoptotic process involved in morphogenesis);GO:1903849(positive regulation of aorta morphogenesis);GO:2000974(negative regulation of pro-B cell differentiation)","NA","NA","NA","notch 1 [Source:HGNC Symbol;Acc:HGNC:7881]",{"v":3.79071092274887,"d":"3.79"},{"v":3.92001108833922,"d":"3.92"},{"v":4.20926285938833,"d":"4.21"},{"v":4.37797852869502,"d":"4.38"},{"v":3.38414784427927,"d":"3.38"},{"v":4.43724889679542,"d":"4.44"},{"v":0.977097974845841,"d":"0.98"},{"v":-0.0334248645898866,"d":"-0.03"},{"v":0.871549753189398,"d":"0.87"},{"v":0.986391097946662,"d":"0.99"},"down","no"]
["MSTRG.9311","ENSOARG00000006895;ENSOARG00000006803","ENSOART00000007497;ENSOART00000007397","GO:0005515(protein binding)","NA","NA","NA",null,{"v":1.35391514759677,"d":"1.35"},{"v":1.39227010888983,"d":"1.39"},{"v":1.10158765801786,"d":"1.10"},{"v":1.38528132922161,"d":"1.39"},{"v":1.51501663887707,"d":"1.52"},{"v":1.3560069532114,"d":"1.36"},{"v":0.90401721343783,"d":"0.90"},{"v":-0.14557785155557,"d":"-0.15"},{"v":0.872714739950342,"d":"0.87"},{"v":0.986522094003295,"d":"0.99"},"down","no"]
["MSTRG.16566","ENSOARG00000023924","ENSOART00000025826","NA","NA","NA","NA",null,{"v":10.3740534621542,"d":"10.37"},{"v":8.45304753740105,"d":"8.45"},{"v":9.81156309917282,"d":"9.81"},{"v":11.0927144642889,"d":"11.09"},{"v":10.6777550587032,"d":"10.68"},{"v":9.62868844143022,"d":"9.63"},{"v":0.912083825024158,"d":"0.91"},{"v":-0.132761673579286,"d":"-0.13"},{"v":0.873686171868994,"d":"0.87"},{"v":0.986688879117232,"d":"0.99"},"down","no"]
["MSTRG.19383","AP3B1","ENSOART00000018642","GO:0006622(protein targeting to lysosome);GO:0006886(intracellular protein transport);GO:0007596(blood coagulation);GO:0008089(anterograde axonal transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0016182(synaptic vesicle budding from endosome);GO:0016192(vesicle-mediated transport);GO:0019882(antigen processing and presentation);GO:0019903(protein phosphatase binding);GO:0030117(membrane coat);GO:0030123(AP-3 adaptor complex);GO:0030131(clathrin adaptor complex);GO:0030742(GTP-dependent protein binding);GO:0032438(melanosome organization);GO:0045202(synapse);GO:0048007(antigen processing and presentation, exogenous lipid antigen via MHC class Ib);GO:0048490(anterograde synaptic vesicle transport);GO:0051138(positive regulation of NK T cell differentiation);GO:0098794(postsynapse);GO:1904115(axon cytoplasm)","04142(Lysosome)","K12397","NA","adaptor related protein complex 3 subunit beta 1 [Source:NCBI gene;Acc:101112650]",{"v":2.38097608814258,"d":"2.38"},{"v":1.96167382529098,"d":"1.96"},{"v":2.14445328455383,"d":"2.14"},{"v":2.35487161287585,"d":"2.35"},{"v":2.7132033764549,"d":"2.71"},{"v":2.04963459420466,"d":"2.05"},{"v":0.911403186917498,"d":"0.91"},{"v":-0.13383867962352,"d":"-0.13"},{"v":0.87458383007555,"d":"0.87"},{"v":0.986785261380503,"d":"0.99"},"down","no"]
["MSTRG.21070","ENSOARG00000014089","ENSOART00000015338","GO:0003735(structural constituent of ribosome);GO:0006412(translation);GO:0015934(large ribosomal subunit)","03010(Ribosome)","K02876","NA","mitochondrial ribosomal protein L15 [Source:NCBI gene;Acc:101114367]",{"v":15.081595,"d":"15.08"},{"v":15.178995,"d":"15.18"},{"v":16.843369,"d":"16.84"},{"v":16.594494,"d":"16.59"},{"v":14.118981,"d":"14.12"},{"v":17.463388,"d":"17.46"},{"v":0.977729890798411,"d":"0.98"},{"v":-0.0324921358736565,"d":"-0.03"},{"v":0.875651562130613,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.5377","BRD7","ENSOART00000018776","GO:0002039(p53 binding);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell population proliferation);GO:0035066(positive regulation of histone acetylation);GO:0042393(histone binding);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0070577(lysine-acetylated histone binding);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","05225(Hepatocellular carcinoma)","K11723","NA","bromodomain containing 7 [Source:NCBI gene;Acc:101116595]",{"v":3.02257518258238,"d":"3.02"},{"v":2.52568209431742,"d":"2.53"},{"v":2.4449437726967,"d":"2.44"},{"v":3.26835775319435,"d":"3.27"},{"v":2.70164232246133,"d":"2.70"},{"v":2.80788286835911,"d":"2.81"},{"v":0.910606931144676,"d":"0.91"},{"v":-0.135099654320064,"d":"-0.14"},{"v":0.876294603644568,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.8449","CCNK","ENSOART00000000532","GO:0002944(cyclin K-CDK12 complex);GO:0002945(cyclin K-CDK13 complex);GO:0004693(cyclin-dependent protein serine/threonine kinase activity);GO:0005654(nucleoplasm);GO:0006468(protein phosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0008353(RNA polymerase II CTD heptapeptide repeat kinase activity);GO:0019901(protein kinase binding);GO:0044828(negative regulation by host of viral genome replication);GO:0071157(negative regulation of cell cycle arrest);GO:2001165(positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues)","NA","NA","NA","cyclin K [Source:NCBI gene;Acc:101117113]",{"v":10.1534170823096,"d":"10.15"},{"v":11.124085514742,"d":"11.12"},{"v":11.3445795687961,"d":"11.34"},{"v":11.7872356621622,"d":"11.79"},{"v":10.5372300700246,"d":"10.54"},{"v":11.194485965602,"d":"11.19"},{"v":0.973242912247752,"d":"0.97"},{"v":-0.0391281618673373,"d":"-0.04"},{"v":0.87692361683283,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.9192","SACM1L","ENSOART00000011059","GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032281(AMPA glutamate receptor complex);GO:0042578(phosphoric ester hydrolase activity);GO:0043812(phosphatidylinositol-4-phosphate phosphatase activity);GO:0046856(phosphatidylinositol dephosphorylation)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)","K21797","EC:3.1.3.-","SAC1 like phosphatidylinositide phosphatase [Source:NCBI gene;Acc:101118997]",{"v":2.975877,"d":"2.98"},{"v":2.607466,"d":"2.61"},{"v":2.37109,"d":"2.37"},{"v":3.721347,"d":"3.72"},{"v":2.891736,"d":"2.89"},{"v":2.216289,"d":"2.22"},{"v":0.900905862840528,"d":"0.90"},{"v":-0.150551730589344,"d":"-0.15"},{"v":0.877222652102967,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.278","EPS15","ENSOART00000004912","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005905(clathrin-coated pit);GO:0006895(Golgi to endosome transport);GO:0016235(aggresome);GO:0019065(receptor-mediated endocytosis of virus by host cell);GO:0030122(AP-2 adaptor complex);GO:0030132(clathrin coat of coated pit);GO:0030136(clathrin-coated vesicle);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0046718(viral entry into host cell);GO:0048268(clathrin coat assembly);GO:0060170(ciliary membrane)","04144(Endocytosis)","K12472","NA","epidermal growth factor receptor pathway substrate 15 [Source:NCBI gene;Acc:101110462]",{"v":9.54801287175763,"d":"9.55"},{"v":6.56466546759355,"d":"6.56"},{"v":8.13307451172442,"d":"8.13"},{"v":9.6549968996334,"d":"9.65"},{"v":8.83843828947914,"d":"8.84"},{"v":8.0328335072975,"d":"8.03"},{"v":0.914028019868355,"d":"0.91"},{"v":-0.129689702573922,"d":"-0.13"},{"v":0.878024778535225,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.3811","EPRS","ENSOART00000012871","GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004818(glutamate-tRNA ligase activity);GO:0004827(proline-tRNA ligase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006412(translation);GO:0006418(tRNA aminoacylation for protein translation);GO:0006424(glutamyl-tRNA aminoacylation);GO:0006433(prolyl-tRNA aminoacylation);GO:0008270(zinc ion binding);GO:0017101(aminoacyl-tRNA synthetase multienzyme complex);GO:0017148(negative regulation of translation);GO:0032869(cellular response to insulin stimulus);GO:0035613(RNA stem-loop binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043039(tRNA aminoacylation);GO:0044539(long-chain fatty acid import into cell);GO:0051020(GTPase binding);GO:0071346(cellular response to interferon-gamma);GO:0097452(GAIT complex);GO:0140212(regulation of long-chain fatty acid import into cell);GO:1990904(ribonucleoprotein complex)","00860(Porphyrin and chlorophyll metabolism);00970(Aminoacyl-tRNA biosynthesis)","K14163","6.1.1.15;EC:6.1.1.17","glutamyl-prolyl-tRNA synthetase [Source:NCBI gene;Acc:101104590]",{"v":11.188297,"d":"11.19"},{"v":11.028965,"d":"11.03"},{"v":10.686213,"d":"10.69"},{"v":12.706546,"d":"12.71"},{"v":12.070889,"d":"12.07"},{"v":11.373363,"d":"11.37"},{"v":0.910172854275582,"d":"0.91"},{"v":-0.135787536032378,"d":"-0.14"},{"v":0.878878046658793,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["ENSOARG00000010518","ST8SIA2","ENSOART00000011445","GO:0001574(ganglioside biosynthetic process);GO:0003828(alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006491(N-glycan processing);GO:0008373(sialyltransferase activity);GO:0009311(oligosaccharide metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0055037(recycling endosome);GO:0097503(sialylation)","NA","K06612","EC:2.4.99.-","ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 [Source:NCBI gene;Acc:101114980]",{"v":0.182541,"d":"0.18"},{"v":0.560062,"d":"0.56"},{"v":1.008925,"d":"1.01"},{"v":1.041157,"d":"1.04"},{"v":0.637616,"d":"0.64"},{"v":0.380066,"d":"0.38"},{"v":0.850735778756862,"d":"0.85"},{"v":-0.233216965168937,"d":"-0.23"},{"v":0.879336324559124,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.10029","HPF1","ENSOART00000016835","GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus);GO:0010835(regulation of protein ADP-ribosylation);GO:0018312(peptidyl-serine ADP-ribosylation);GO:0042393(histone binding)","NA","NA","NA","chromosome 2 open reading frame, human C4orf27 [Source:NCBI gene;Acc:101114249]",{"v":2.66063688702929,"d":"2.66"},{"v":2.43306190077705,"d":"2.43"},{"v":2.71676532695756,"d":"2.72"},{"v":3.38546770113568,"d":"3.39"},{"v":2.56223518230723,"d":"2.56"},{"v":2.68695260011955,"d":"2.69"},{"v":0.904548436197883,"d":"0.90"},{"v":-0.144730337434386,"d":"-0.14"},{"v":0.880265954226101,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.16908","PMPCB","ENSOART00000020649","GO:0003824(catalytic activity);GO:0004222(metalloendopeptidase activity);GO:0005739(mitochondrion);GO:0006508(proteolysis);GO:0006627(protein processing involved in protein targeting to mitochondrion);GO:0017087(mitochondrial processing peptidase complex);GO:0046872(metal ion binding)","NA","K17732","EC:3.4.24.64","peptidase, mitochondrial processing beta subunit [Source:NCBI gene;Acc:101119715]",{"v":13.364211,"d":"13.36"},{"v":12.219816,"d":"12.22"},{"v":12.059896,"d":"12.06"},{"v":17.257515,"d":"17.26"},{"v":9.008883,"d":"9.01"},{"v":12.582879,"d":"12.58"},{"v":0.968973579611276,"d":"0.97"},{"v":-0.04547076576242,"d":"-0.05"},{"v":0.880878319785761,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.941","ENSOARG00000006795","ENSOART00000007385","GO:0005506(iron ion binding);GO:0008610(lipid biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","NA","NA","NA",null,{"v":4.012824,"d":"4.01"},{"v":2.407359,"d":"2.41"},{"v":3.052364,"d":"3.05"},{"v":3.879133,"d":"3.88"},{"v":2.279743,"d":"2.28"},{"v":3.407872,"d":"3.41"},{"v":0.990153289289108,"d":"0.99"},{"v":-0.0142762034548791,"d":"-0.01"},{"v":0.88133655376701,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.17634","SIN3B","ENSOART00000020142","GO:0000805(X chromosome);GO:0000806(Y chromosome);GO:0001741(XY body);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0030849(autosome);GO:0045892(negative regulation of transcription, DNA-templated)","NA","K23213","NA","SIN3 transcription regulator family member B [Source:NCBI gene;Acc:101116395]",{"v":4.77876167281455,"d":"4.78"},{"v":3.90031684891359,"d":"3.90"},{"v":3.37031309499747,"d":"3.37"},{"v":5.27010773547246,"d":"5.27"},{"v":4.06172571753411,"d":"4.06"},{"v":3.9247005128853,"d":"3.92"},{"v":0.908939821504463,"d":"0.91"},{"v":-0.137743314319521,"d":"-0.14"},{"v":0.882554091218426,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.15775","KANSL2","ENSOART00000020919","GO:0000123(histone acetyltransferase complex);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0015629(actin cytoskeleton);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0043995(histone acetyltransferase activity (H4-K5 specific));GO:0043996(histone acetyltransferase activity (H4-K8 specific));GO:0046972(histone acetyltransferase activity (H4-K16 specific))","NA","K18401","NA","KAT8 regulatory NSL complex subunit 2 [Source:NCBI gene;Acc:101106671]",{"v":5.73041227935399,"d":"5.73"},{"v":5.09839690178961,"d":"5.10"},{"v":6.75812623963335,"d":"6.76"},{"v":7.22288061065037,"d":"7.22"},{"v":6.0601271440419,"d":"6.06"},{"v":4.90069129637713,"d":"4.90"},{"v":0.967181395346655,"d":"0.97"},{"v":-0.0481416016436581,"d":"-0.05"},{"v":0.882769546372366,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.158","NDUFS5","ENSOART00000021757","GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I);GO:0032981(mitochondrial respiratory chain complex I assembly)","00190(Oxidative phosphorylation);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K03938","NA","NADH:ubiquinone oxidoreductase subunit S5 [Source:NCBI gene;Acc:101118232]",{"v":139.34736913745,"d":"139.35"},{"v":132.130741691235,"d":"132.13"},{"v":147.523974151394,"d":"147.52"},{"v":157.441777820717,"d":"157.44"},{"v":137.467083482072,"d":"137.47"},{"v":163.341947414343,"d":"163.34"},{"v":0.914350999517209,"d":"0.91"},{"v":-0.129180003941837,"d":"-0.13"},{"v":0.883447540338614,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["ENSOARG00000020205","CCDC14","ENSOART00000021999","GO:0005813(centrosome);GO:0034451(centriolar satellite);GO:0071539(protein localization to centrosome)","NA","K16541","NA","coiled-coil domain containing 14 [Source:NCBI gene;Acc:101120380]",{"v":0.691192,"d":"0.69"},{"v":0.239979,"d":"0.24"},{"v":0.221627,"d":"0.22"},{"v":0.574445,"d":"0.57"},{"v":0.261841,"d":"0.26"},{"v":0.313232,"d":"0.31"},{"v":1.00285336984719,"d":"1.00"},{"v":0.00411068066725573,"d":"0.00"},{"v":0.883830183262994,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"up","no"]
["MSTRG.15427","ENSOARG00000012523","ENSOART00000013619","GO:0000922(spindle pole);GO:0005814(centriole);GO:0005869(dynactin complex);GO:0008017(microtubule binding);GO:0010970(transport along microtubule);GO:0031252(cell leading edge);GO:0032402(melanosome transport);GO:0032991(protein-containing complex);GO:0035371(microtubule plus-end);GO:0070840(dynein complex binding)","04962(Vasopressin-regulated water reabsorption);05016(Huntington disease)","K04648","NA","dynactin subunit 1 [Source:NCBI gene;Acc:101116037]",{"v":10.8670056341662,"d":"10.87"},{"v":11.3146016590354,"d":"11.31"},{"v":15.3208686497385,"d":"15.32"},{"v":12.5393963549099,"d":"12.54"},{"v":14.0229929219059,"d":"14.02"},{"v":14.4258960373039,"d":"14.43"},{"v":0.914955960112369,"d":"0.91"},{"v":-0.128225791552502,"d":"-0.13"},{"v":0.884451673260968,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.9983","ZNF395","ENSOART00000016263","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001158(enhancer sequence-specific DNA binding);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006357(regulation of transcription by RNA polymerase II)","NA","NA","NA","zinc finger protein 395 [Source:NCBI gene;Acc:101108553]",{"v":8.586735,"d":"8.59"},{"v":5.878099,"d":"5.88"},{"v":5.659335,"d":"5.66"},{"v":6.724113,"d":"6.72"},{"v":7.623285,"d":"7.62"},{"v":6.157745,"d":"6.16"},{"v":0.981420563611773,"d":"0.98"},{"v":-0.0270565945124832,"d":"-0.03"},{"v":0.884938169238371,"d":"0.88"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.10341","PRPF40A","ENSOART00000008880","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0016363(nuclear matrix);GO:0016477(cell migration);GO:0016607(nuclear speck);GO:0032465(regulation of cytokinesis);GO:0045292(mRNA cis splicing, via spliceosome);GO:0070064(proline-rich region binding)","03040(Spliceosome)","K12821","NA","pre-mRNA processing factor 40 homolog A [Source:NCBI gene;Acc:101116380]",{"v":2.02446804808743,"d":"2.02"},{"v":2.47925805027322,"d":"2.48"},{"v":2.23834908306011,"d":"2.24"},{"v":2.35967170273224,"d":"2.36"},{"v":2.46696920437159,"d":"2.47"},{"v":2.57716564699454,"d":"2.58"},{"v":0.910622817081666,"d":"0.91"},{"v":-0.135074486092345,"d":"-0.14"},{"v":0.885123222289299,"d":"0.89"},{"v":0.986894608338119,"d":"0.99"},"down","no"]
["MSTRG.13745","RBAK","ENSOART00000002856","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","RB associated KRAB zinc finger [Source:NCBI gene;Acc:101117386]",{"v":1.487114,"d":"1.49"},{"v":1.504034,"d":"1.50"},{"v":1.768563,"d":"1.77"},{"v":2.171601,"d":"2.17"},{"v":1.451003,"d":"1.45"},{"v":1.300319,"d":"1.30"},{"v":0.966846525935912,"d":"0.97"},{"v":-0.0486411957164588,"d":"-0.05"},{"v":0.886906790230682,"d":"0.89"},{"v":0.987271884059795,"d":"0.99"},"down","no"]
["MSTRG.13734","ENSOARG00000001066","ENSOART00000001145","GO:0016192(vesicle-mediated transport);GO:0035658(Mon1-Ccz1 complex)","NA","NA","NA","CCZ1 homolog, vacuolar protein trafficking and biogenesis associated [Source:NCBI gene;Acc:101115090]",{"v":3.62779206281619,"d":"3.63"},{"v":2.83352506281619,"d":"2.83"},{"v":3.18756216399663,"d":"3.19"},{"v":3.89088377740303,"d":"3.89"},{"v":3.6140404970489,"d":"3.61"},{"v":3.08987055185497,"d":"3.09"},{"v":0.910718843339072,"d":"0.91"},{"v":-0.1349223602079,"d":"-0.13"},{"v":0.887596030207608,"d":"0.89"},{"v":0.987271884059795,"d":"0.99"},"down","no"]
["MSTRG.14752","COQ4","ENSOART00000011427","GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006744(ubiquinone biosynthetic process);GO:0016020(membrane);GO:0031314(extrinsic component of mitochondrial inner membrane);GO:0032991(protein-containing complex)","NA","K18586","NA","coenzyme Q4 [Source:NCBI gene;Acc:101120646]",{"v":10.884921,"d":"10.88"},{"v":8.068929,"d":"8.07"},{"v":5.997759,"d":"6.00"},{"v":8.338496,"d":"8.34"},{"v":7.764619,"d":"7.76"},{"v":9.171043,"d":"9.17"},{"v":0.987237992260712,"d":"0.99"},{"v":-0.0185301795415976,"d":"-0.02"},{"v":0.887638252376126,"d":"0.89"},{"v":0.987271884059795,"d":"0.99"},"down","no"]
["MSTRG.8081","SLCO3A1","ENSOART00000011452","GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K14353","NA","solute carrier organic anion transporter family member 3A1 [Source:NCBI gene;Acc:101120608]",{"v":2.50583846138314,"d":"2.51"},{"v":1.39248949520444,"d":"1.39"},{"v":2.05488816405856,"d":"2.05"},{"v":2.16092519030793,"d":"2.16"},{"v":2.13344072892479,"d":"2.13"},{"v":1.7601180908632,"d":"1.76"},{"v":0.98327390256859,"d":"0.98"},{"v":-0.0243347425795625,"d":"-0.02"},{"v":0.888276678655158,"d":"0.89"},{"v":0.987271884059795,"d":"0.99"},"down","no"]
["MSTRG.566","ENSOARG00000018242","ENSOART00000019850","GO:0007155(cell adhesion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0098609(cell-cell adhesion)","04064(NF-kappa B signaling pathway);04514(Cell adhesion molecules (CAMs));04668(TNF signaling pathway);04670(Leukocyte transendothelial migration);04933(AGE-RAGE signaling pathway in diabetic complications);05143(African trypanosomiasis);05144(Malaria);05418(Fluid shear stress and atherosclerosis)","K06527","NA","vascular cell adhesion protein 1-like [Source:NCBI gene;Acc:101113636]",{"v":1.134685,"d":"1.13"},{"v":0.610531,"d":"0.61"},{"v":0.759196,"d":"0.76"},{"v":0.950192,"d":"0.95"},{"v":0.728408,"d":"0.73"},{"v":1.057782,"d":"1.06"},{"v":0.915227479204293,"d":"0.92"},{"v":-0.127797725991549,"d":"-0.13"},{"v":0.889386283858668,"d":"0.89"},{"v":0.987386905623259,"d":"0.99"},"down","no"]
["MSTRG.9666","ENSOARG00000010804","ENSOART00000011750","NA","NA","NA","NA",null,{"v":1.733017,"d":"1.73"},{"v":1.070247,"d":"1.07"},{"v":0.6311,"d":"0.63"},{"v":1.171831,"d":"1.17"},{"v":1.591334,"d":"1.59"},{"v":0.663906,"d":"0.66"},{"v":1.00212805629063,"d":"1.00"},{"v":0.00306687417295585,"d":"0.00"},{"v":0.889653297536074,"d":"0.89"},{"v":0.987441985056693,"d":"0.99"},"up","no"]
["MSTRG.7047","MRPS30","ENSOART00000009268","GO:0003735(structural constituent of ribosome);GO:0005739(mitochondrion);GO:0005762(mitochondrial large ribosomal subunit);GO:0005840(ribosome);GO:0006412(translation)","NA","K17409","NA","mitochondrial ribosomal protein S30 [Source:NCBI gene;Acc:101121547]",{"v":2.73801519791667,"d":"2.74"},{"v":2.79401184708333,"d":"2.79"},{"v":2.8474308825,"d":"2.85"},{"v":3.70251867916667,"d":"3.70"},{"v":3.27696959916667,"d":"3.28"},{"v":2.30323023333333,"d":"2.30"},{"v":0.902694390330652,"d":"0.90"},{"v":-0.14769045289575,"d":"-0.15"},{"v":0.890853215974419,"d":"0.89"},{"v":0.988130100407866,"d":"0.99"},"down","no"]
["MSTRG.10195","FKBP7","ENSOART00000018831","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005509(calcium ion binding);GO:0005783(endoplasmic reticulum);GO:0016853(isomerase activity)","NA","K09573","EC:5.2.1.8","FKBP prolyl isomerase 7 [Source:NCBI gene;Acc:101123607]",{"v":3.20763,"d":"3.21"},{"v":1.977344,"d":"1.98"},{"v":3.454448,"d":"3.45"},{"v":3.014451,"d":"3.01"},{"v":2.854564,"d":"2.85"},{"v":3.571317,"d":"3.57"},{"v":0.915160822733777,"d":"0.92"},{"v":-0.127902802012191,"d":"-0.13"},{"v":0.891800372201949,"d":"0.89"},{"v":0.988145797863289,"d":"0.99"},"down","no"]
["MSTRG.8124","ENSOARG00000012205","ENSOART00000013285","GO:0005623(cell);GO:0006886(intracellular protein transport);GO:0006904(vesicle docking involved in exocytosis);GO:0016192(vesicle-mediated transport);GO:0017185(peptidyl-lysine hydroxylation);GO:0030199(collagen fibril organization);GO:0032963(collagen metabolic process);GO:0035855(megakaryocyte development);GO:0070889(platelet alpha granule organization);GO:0090330(regulation of platelet aggregation)","NA","K23281","NA","VPS33B, late endosome and lysosome associated [Source:NCBI gene;Acc:101105854]",{"v":1.091218,"d":"1.09"},{"v":0.77295,"d":"0.77"},{"v":0.722482,"d":"0.72"},{"v":1.198461,"d":"1.20"},{"v":0.711625,"d":"0.71"},{"v":0.93011,"d":"0.93"},{"v":0.910729400365327,"d":"0.91"},{"v":-0.134905636626018,"d":"-0.13"},{"v":0.892971938187356,"d":"0.89"},{"v":0.988353916492008,"d":"0.99"},"down","no"]
["MSTRG.13551","ENSOARG00000007180","ENSOART00000007834","GO:0005524(ATP binding)","NA","NA","NA","Snf2 related CREBBP activator protein [Source:NCBI gene;Acc:101123522]",{"v":6.15392128075831,"d":"6.15"},{"v":5.576134649551,"d":"5.58"},{"v":6.11707481096017,"d":"6.12"},{"v":6.78115936119426,"d":"6.78"},{"v":6.2923573671809,"d":"6.29"},{"v":6.40637921805204,"d":"6.41"},{"v":0.916182036616208,"d":"0.92"},{"v":-0.126293818364966,"d":"-0.13"},{"v":0.893661892982374,"d":"0.89"},{"v":0.988353916492008,"d":"0.99"},"down","no"]
["MSTRG.12086","SYVN1","ENSOART00000014079","GO:0000836(Hrd1p ubiquitin ligase complex);GO:0000839(Hrd1p ubiquitin ligase ERAD-L complex);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005790(smooth endoplasmic reticulum);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016567(protein ubiquitination);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0030970(retrograde protein transport, ER to cytosol);GO:0036503(ERAD pathway);GO:0036513(Derlin-1 retrotranslocation complex);GO:0050821(protein stabilization);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding);GO:0051117(ATPase binding);GO:0061630(ubiquitin protein ligase activity);GO:0070936(protein K48-linked ubiquitination);GO:1902236(negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway);GO:1990381(ubiquitin-specific protease binding)","04120(Ubiquitin mediated proteolysis);04141(Protein processing in endoplasmic reticulum)","K10601","EC:2.3.2.27","synoviolin 1 [Source:NCBI gene;Acc:101121218]",{"v":3.6068524721209,"d":"3.61"},{"v":3.5917596154247,"d":"3.59"},{"v":4.25286403491402,"d":"4.25"},{"v":4.17757735487233,"d":"4.18"},{"v":4.15961227618551,"d":"4.16"},{"v":3.47557598124023,"d":"3.48"},{"v":0.969415334080419,"d":"0.97"},{"v":-0.0448131918478608,"d":"-0.04"},{"v":0.893970150593312,"d":"0.89"},{"v":0.988353916492008,"d":"0.99"},"down","no"]
["ENSOARG00000001172","NXPE4","ENSOART00000001250","NA","NA","NA","NA","neurexophilin and PC-esterase domain family member 4 [Source:HGNC Symbol;Acc:HGNC:23117]",{"v":0.087537,"d":"0.09"},{"v":0.177465,"d":"0.18"},{"v":0.119231,"d":"0.12"},{"v":0.234217,"d":"0.23"},{"v":0.052919,"d":"0.05"},{"v":0.112666,"d":"0.11"},{"v":0.961058223820791,"d":"0.96"},{"v":-0.0573042584013414,"d":"-0.06"},{"v":0.8943859850733,"d":"0.89"},{"v":0.988461781797539,"d":"0.99"},"down","no"]
["MSTRG.3271","STAT5A","ENSOART00000000892","GO:0001938(positive regulation of endothelial cell proliferation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007165(signal transduction);GO:0038026(reelin-mediated signaling pathway);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0060397(growth hormone receptor signaling pathway via JAK-STAT)","04012(ErbB signaling pathway);04217(Necroptosis);04630(Jak-STAT signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04917(Prolactin signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05161(Hepatitis B);05162(Measles);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05203(Viral carcinogenesis);05220(Chronic myeloid leukemia);05221(Acute myeloid leukemia);05223(Non-small cell lung cancer)","K11223","NA","signal transducer and activator of transcription 5A [Source:NCBI gene;Acc:443419]",{"v":6.76431543971313,"d":"6.76"},{"v":5.19135942895563,"d":"5.19"},{"v":7.76144281196773,"d":"7.76"},{"v":5.72347108404303,"d":"5.72"},{"v":7.89169556185567,"d":"7.89"},{"v":6.51381545517705,"d":"6.51"},{"v":0.979538735820265,"d":"0.98"},{"v":-0.0298255499485355,"d":"-0.03"},{"v":0.89524671812535,"d":"0.90"},{"v":0.988555500915115,"d":"0.99"},"down","no"]
["MSTRG.10983","LUZP1","ENSOART00000008307","GO:0003281(ventricular septum development);GO:0005634(nucleus);GO:0021503(neural fold bending);GO:0060840(artery development)","NA","NA","NA","leucine zipper protein 1 [Source:NCBI gene;Acc:101122671]",{"v":3.319825,"d":"3.32"},{"v":2.434592,"d":"2.43"},{"v":3.168215,"d":"3.17"},{"v":3.352595,"d":"3.35"},{"v":2.985329,"d":"2.99"},{"v":3.359453,"d":"3.36"},{"v":0.920107777598004,"d":"0.92"},{"v":-0.120125232523075,"d":"-0.12"},{"v":0.896325029410157,"d":"0.90"},{"v":0.988665474216011,"d":"0.99"},"down","no"]
["MSTRG.4574","HSPA14","ENSOART00000007711","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005840(ribosome)","NA","NA","NA","heat shock protein family A (Hsp70) member 14 [Source:NCBI gene;Acc:101108674]",{"v":2.00068612728858,"d":"2.00"},{"v":2.42072529206626,"d":"2.42"},{"v":2.71167921098518,"d":"2.71"},{"v":2.66225662859634,"d":"2.66"},{"v":2.33515714734089,"d":"2.34"},{"v":2.38195833565824,"d":"2.38"},{"v":0.966625686097539,"d":"0.97"},{"v":-0.0489707629469098,"d":"-0.05"},{"v":0.896669560449098,"d":"0.90"},{"v":0.988665474216011,"d":"0.99"},"down","no"]
["MSTRG.10230","ENSOARG00000000339","ENSOART00000000360","GO:0003714(transcription corepressor activity)","04330(Notch signaling pathway);05169(Epstein-Barr virus infection)","K06066","NA","corepressor interacting with RBPJ, 1 [Source:NCBI gene;Acc:101105893]",{"v":1.3995450794897,"d":"1.40"},{"v":1.49644709911678,"d":"1.50"},{"v":1.94783638910697,"d":"1.95"},{"v":2.12046244651619,"d":"2.12"},{"v":1.38391395044161,"d":"1.38"},{"v":1.84311711432777,"d":"1.84"},{"v":0.905812892991985,"d":"0.91"},{"v":-0.142715020587414,"d":"-0.14"},{"v":0.897733328968953,"d":"0.90"},{"v":0.989014897470148,"d":"0.99"},"down","no"]
["MSTRG.5359","ENSOARG00000016927","ENSOART00000018438","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007275(multicellular organism development);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0046872(metal ion binding)","04115(p53 signaling pathway);04120(Ubiquitin mediated proteolysis);04310(Wnt signaling pathway)","K04506","EC:2.3.2.27","siah E3 ubiquitin protein ligase 1 [Source:NCBI gene;Acc:101111116]",{"v":3.94655641908081,"d":"3.95"},{"v":2.7700035473753,"d":"2.77"},{"v":2.56425373644086,"d":"2.56"},{"v":4.57680933522108,"d":"4.58"},{"v":3.08518709170115,"d":"3.09"},{"v":2.56473520932259,"d":"2.56"},{"v":0.907505352932564,"d":"0.91"},{"v":-0.14002194199772,"d":"-0.14"},{"v":0.89892255357144,"d":"0.90"},{"v":0.98908245368521,"d":"0.99"},"down","no"]
["MSTRG.9914","PSIP1","ENSOART00000015250;ENSOART00000015252","NA","NA","NA","NA","PC4 and SFRS1 interacting protein 1 [Source:NCBI gene;Acc:100233239]",{"v":2.56312132138443,"d":"2.56"},{"v":2.03089231149567,"d":"2.03"},{"v":1.80945798207664,"d":"1.81"},{"v":2.26597676514215,"d":"2.27"},{"v":1.81050724227441,"d":"1.81"},{"v":2.43953477132262,"d":"2.44"},{"v":0.982727618258304,"d":"0.98"},{"v":-0.0251364934198326,"d":"-0.03"},{"v":0.899975499309989,"d":"0.90"},{"v":0.98908245368521,"d":"0.99"},"down","no"]
["MSTRG.3733","RBBP5;ENSOARG00000004965","ENSOART00000003745;ENSOART00000005407","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006974(cellular response to DNA damage stimulus);GO:0035064(methylated histone binding);GO:0035097(histone methyltransferase complex);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0043627(response to estrogen);GO:0044212(transcription regulatory region DNA binding);GO:0044666(MLL3/4 complex);GO:0048188(Set1C/COMPASS complex);GO:0051568(histone H3-K4 methylation);GO:0071339(MLL1 complex);GO:0016020(membrane);GO:0016021(integral component of membrane)","04934(Cushing syndrome)","K14961","NA","RB binding protein 5, histone lysine methyltransferase complex subunit [Source:NCBI gene;Acc:101113868];transmembrane protein 81 [Source:NCBI gene;Acc:101113609]",{"v":3.51590713959144,"d":"3.52"},{"v":3.58938960554475,"d":"3.59"},{"v":4.11016104717899,"d":"4.11"},{"v":4.7347275598249,"d":"4.73"},{"v":3.46942977140078,"d":"3.47"},{"v":4.08806736867704,"d":"4.09"},{"v":0.912402601329273,"d":"0.91"},{"v":-0.132257534998062,"d":"-0.13"},{"v":0.900340334943385,"d":"0.90"},{"v":0.98908245368521,"d":"0.99"},"down","no"]
["MSTRG.1597","PHC3","ENSOART00000000457","GO:0005515(protein binding);GO:0005634(nucleus);GO:0008270(zinc ion binding);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex)","NA","K11458","NA","polyhomeotic homolog 3 [Source:NCBI gene;Acc:101118840]",{"v":3.09559954004803,"d":"3.10"},{"v":1.86219458179121,"d":"1.86"},{"v":1.94237393431276,"d":"1.94"},{"v":3.02049327885295,"d":"3.02"},{"v":2.71270303531572,"d":"2.71"},{"v":1.40454465404718,"d":"1.40"},{"v":0.966715952130828,"d":"0.97"},{"v":-0.0488360466028295,"d":"-0.05"},{"v":0.900564023444941,"d":"0.90"},{"v":0.98908245368521,"d":"0.99"},"down","no"]
["MSTRG.5018","RPRD1B","ENSOART00000020066","GO:0000993(RNA polymerase II complex binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0008284(positive regulation of cell population proliferation);GO:0010564(regulation of cell cycle process);GO:0016591(RNA polymerase II, holoenzyme);GO:0042802(identical protein binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0070940(dephosphorylation of RNA polymerase II C-terminal domain)","NA","K15559","NA","regulation of nuclear pre-mRNA domain containing 1B [Source:NCBI gene;Acc:101104081]",{"v":11.7741,"d":"11.77"},{"v":12.070968,"d":"12.07"},{"v":11.502674,"d":"11.50"},{"v":12.229481,"d":"12.23"},{"v":10.269787,"d":"10.27"},{"v":13.857999,"d":"13.86"},{"v":0.972233198936543,"d":"0.97"},{"v":-0.040625696079372,"d":"-0.04"},{"v":0.901424907953701,"d":"0.90"},{"v":0.98908245368521,"d":"0.99"},"down","no"]
["MSTRG.906","UBQLN4","ENSOART00000005755","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005776(autophagosome);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0031595(nuclear proteasome complex);GO:0031597(cytosolic proteasome complex);GO:0032434(regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0042802(identical protein binding);GO:1901097(negative regulation of autophagosome maturation)","04141(Protein processing in endoplasmic reticulum)","K04523","NA","ubiquilin 4 [Source:NCBI gene;Acc:101107407]",{"v":9.495950925,"d":"9.50"},{"v":8.65353436029412,"d":"8.65"},{"v":8.87430126985294,"d":"8.87"},{"v":9.22631749338235,"d":"9.23"},{"v":9.44128411176471,"d":"9.44"},{"v":10.6073701169118,"d":"10.61"},{"v":0.923102054946973,"d":"0.92"},{"v":-0.115437938861657,"d":"-0.12"},{"v":0.902401684927557,"d":"0.90"},{"v":0.989229126315329,"d":"0.99"},"down","no"]
["MSTRG.2695","RHOT1","ENSOART00000012390;ENSOART00000012386","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005509(calcium ion binding);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0007005(mitochondrion organization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0019725(cellular homeostasis);GO:0031307(integral component of mitochondrial outer membrane);GO:0047497(mitochondrion transport along microtubule);GO:0097345(mitochondrial outer membrane permeabilization);GO:0097345(mitochondrial outer membrane permeabilization)","04137(Mitophagy - animal);04137(Mitophagy - animal)","K07870","EC:3.6.5.-","ras homolog family member T1 [Source:NCBI gene;Acc:101115887]",{"v":2.09921818604507,"d":"2.10"},{"v":1.73437349473749,"d":"1.73"},{"v":1.89014860915057,"d":"1.89"},{"v":2.38141677953195,"d":"2.38"},{"v":1.96201555510154,"d":"1.96"},{"v":1.60283318951213,"d":"1.60"},{"v":0.962577312885054,"d":"0.96"},{"v":-0.0550256742585195,"d":"-0.06"},{"v":0.903281678781853,"d":"0.90"},{"v":0.989519171496149,"d":"0.99"},"down","no"]
["MSTRG.11732","ENSOARG00000002077","ENSOART00000002236","GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0016592(mediator complex);GO:0019827(stem cell population maintenance)","04919(Thyroid hormone signaling pathway)","K15133","NA","mediator complex subunit 17 [Source:NCBI gene;Acc:101106726]",{"v":2.66054273157163,"d":"2.66"},{"v":2.51041272600835,"d":"2.51"},{"v":2.77409382892907,"d":"2.77"},{"v":2.94906081446453,"d":"2.95"},{"v":2.56748772183588,"d":"2.57"},{"v":3.12192862197497,"d":"3.12"},{"v":0.919727996143157,"d":"0.92"},{"v":-0.120720838758296,"d":"-0.12"},{"v":0.904920254694101,"d":"0.90"},{"v":0.990251184146188,"d":"0.99"},"down","no"]
["MSTRG.19626","AQR","ENSOART00000021780","GO:0000398(mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0071007(U2-type catalytic step 2 spliceosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)","K12874","NA","aquarius intron-binding spliceosomal factor [Source:NCBI gene;Acc:101103571]",{"v":6.35473,"d":"6.35"},{"v":5.752941,"d":"5.75"},{"v":5.82794,"d":"5.83"},{"v":7.077434,"d":"7.08"},{"v":6.361781,"d":"6.36"},{"v":6.105257,"d":"6.11"},{"v":0.917682043290809,"d":"0.92"},{"v":-0.123933716875362,"d":"-0.12"},{"v":0.905984350576847,"d":"0.91"},{"v":0.990685271646046,"d":"0.99"},"down","no"]
["ENSOARG00000009941","PARS2","ENSOART00000010819","GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004827(proline-tRNA ligase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006418(tRNA aminoacylation for protein translation);GO:0006433(prolyl-tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)","K01881","EC:6.1.1.15","prolyl-tRNA synthetase 2, mitochondrial [Source:NCBI gene;Acc:101122641]",{"v":0.988551,"d":"0.99"},{"v":0.821671,"d":"0.82"},{"v":0.773961,"d":"0.77"},{"v":1.214295,"d":"1.21"},{"v":0.611038,"d":"0.61"},{"v":0.832467,"d":"0.83"},{"v":0.972301527579201,"d":"0.97"},{"v":-0.0405243068960269,"d":"-0.04"},{"v":0.90640133463117,"d":"0.91"},{"v":0.9907399928313,"d":"0.99"},"down","no"]
["MSTRG.705","TBX15","ENSOART00000022187","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0070722(Tle3-Aes complex)","NA","K10182","NA","T-box 15 [Source:NCBI gene;Acc:101110282]",{"v":3.79300649459609,"d":"3.79"},{"v":4.33207763394159,"d":"4.33"},{"v":4.96769923359976,"d":"4.97"},{"v":4.87600039159503,"d":"4.88"},{"v":5.18087939134369,"d":"5.18"},{"v":4.26739326758156,"d":"4.27"},{"v":0.914027770621273,"d":"0.91"},{"v":-0.129690095983718,"d":"-0.13"},{"v":0.906656185873855,"d":"0.91"},{"v":0.9907738160552,"d":"0.99"},"down","no"]
["MSTRG.6063","HSPBP1","ENSOART00000001731","GO:0031398(positive regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process)","04141(Protein processing in endoplasmic reticulum)","K09562","NA","HSPA (Hsp70) binding protein 1 [Source:NCBI gene;Acc:101121446]",{"v":1.144166,"d":"1.14"},{"v":1.067572,"d":"1.07"},{"v":1.074402,"d":"1.07"},{"v":1.047763,"d":"1.05"},{"v":1.232013,"d":"1.23"},{"v":1.282915,"d":"1.28"},{"v":0.922375810868807,"d":"0.92"},{"v":-0.11657341580618,"d":"-0.12"},{"v":0.907976623956976,"d":"0.91"},{"v":0.990861963668001,"d":"0.99"},"down","no"]
["MSTRG.15988","BAZ2A","ENSOART00000009154","GO:0001164(RNA polymerase I CORE element sequence-specific DNA binding);GO:0001188(RNA polymerase I preinitiation complex assembly);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016607(nuclear speck);GO:0042393(histone binding);GO:0046872(metal ion binding)","NA","K15224","NA","bromodomain adjacent to zinc finger domain 2A [Source:NCBI gene;Acc:101106579]",{"v":5.29589061158554,"d":"5.30"},{"v":4.71495448071449,"d":"4.71"},{"v":4.40700531511529,"d":"4.41"},{"v":5.12729582771136,"d":"5.13"},{"v":5.3396504030743,"d":"5.34"},{"v":4.44722711208369,"d":"4.45"},{"v":0.966721391521755,"d":"0.97"},{"v":-0.0488279290578341,"d":"-0.05"},{"v":0.908380404753529,"d":"0.91"},{"v":0.990861963668001,"d":"0.99"},"down","no"]
["MSTRG.16293","ENSOARG00000020598","ENSOART00000022440","GO:0003824(catalytic activity);GO:0004139(deoxyribose-phosphate aldolase activity);GO:0005737(cytoplasm);GO:0009264(deoxyribonucleotide catabolic process);GO:0016829(lyase activity)","00030(Pentose phosphate pathway)","K01619","EC:4.1.2.4","deoxyribose-phosphate aldolase [Source:NCBI gene;Acc:101103966]",{"v":2.01271941186264,"d":"2.01"},{"v":1.54646415546306,"d":"1.55"},{"v":1.84384340645161,"d":"1.84"},{"v":2.0512083182102,"d":"2.05"},{"v":2.05304500978148,"d":"2.05"},{"v":1.76471219895942,"d":"1.76"},{"v":0.920609764866715,"d":"0.92"},{"v":-0.119338349642453,"d":"-0.12"},{"v":0.909170882865485,"d":"0.91"},{"v":0.990900577819808,"d":"0.99"},"down","no"]
["MSTRG.19578","METTL3","ENSOART00000021365","GO:0000398(mRNA splicing, via spliceosome);GO:0001510(RNA methylation);GO:0001734(mRNA (N6-adenosine)-methyltransferase activity);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus);GO:0008173(RNA methyltransferase activity);GO:0009048(dosage compensation by inactivation of X chromosome);GO:0016422(mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity);GO:0016607(nuclear speck);GO:0031053(primary miRNA processing);GO:0034644(cellular response to UV);GO:0036396(RNA N6-methyladenosine methyltransferase complex);GO:0046982(protein heterodimerization activity);GO:0080009(mRNA methylation);GO:1903679(positive regulation of cap-independent translational initiation);GO:1904047(S-adenosyl-L-methionine binding);GO:1990744(primary miRNA methylation)","NA","K05925","EC:2.1.1.348","methyltransferase like 3 [Source:NCBI gene;Acc:101108050]",{"v":4.559526,"d":"4.56"},{"v":3.75536,"d":"3.76"},{"v":3.860141,"d":"3.86"},{"v":5.064554,"d":"5.06"},{"v":4.42978,"d":"4.43"},{"v":3.813073,"d":"3.81"},{"v":0.914906036916132,"d":"0.91"},{"v":-0.128304512185829,"d":"-0.13"},{"v":0.910091365267559,"d":"0.91"},{"v":0.991217749791999,"d":"0.99"},"down","no"]
["MSTRG.4020","NOL9","ENSOART00000012731","GO:0000460(maturation of 5.8S rRNA);GO:0005730(nucleolus);GO:0016310(phosphorylation);GO:0045111(intermediate filament cytoskeleton);GO:0051731(polynucleotide 5'-hydroxyl-kinase activity)","NA","K06947","EC:2.7.1.-","nucleolar protein 9 [Source:NCBI gene;Acc:101121280]",{"v":1.715292,"d":"1.72"},{"v":1.549826,"d":"1.55"},{"v":1.766587,"d":"1.77"},{"v":1.905491,"d":"1.91"},{"v":1.554139,"d":"1.55"},{"v":2.018441,"d":"2.02"},{"v":0.918517667989334,"d":"0.92"},{"v":-0.122620622570396,"d":"-0.12"},{"v":0.911180397896903,"d":"0.91"},{"v":0.991347127729032,"d":"0.99"},"down","no"]
["MSTRG.18559","ENSOARG00000018255","ENSOART00000019863","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","family with sequence similarity 174 member A [Source:NCBI gene;Acc:101112055]",{"v":3.20669923962838,"d":"3.21"},{"v":2.5639962838379,"d":"2.56"},{"v":2.66230496620215,"d":"2.66"},{"v":3.16184565721608,"d":"3.16"},{"v":2.66283652090341,"d":"2.66"},{"v":3.29597867755887,"d":"3.30"},{"v":0.92460410743353,"d":"0.92"},{"v":-0.113092323314132,"d":"-0.11"},{"v":0.911992402578818,"d":"0.91"},{"v":0.991469889983809,"d":"0.99"},"down","no"]
["MSTRG.10710","CNPPD1","ENSOART00000021597;ENSOART00000021598","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0019901(protein kinase binding);GO:0019901(protein kinase binding)","NA","NA","NA","cyclin Pas1/PHO80 domain containing 1 [Source:NCBI gene;Acc:101112796]",{"v":3.86959147418182,"d":"3.87"},{"v":3.45207207927273,"d":"3.45"},{"v":4.09178581309091,"d":"4.09"},{"v":4.26791660290909,"d":"4.27"},{"v":4.11051547636364,"d":"4.11"},{"v":4.053654744,"d":"4.05"},{"v":0.918063839867946,"d":"0.92"},{"v":-0.123333616347876,"d":"-0.12"},{"v":0.913283236725961,"d":"0.91"},{"v":0.991978292054872,"d":"0.99"},"down","no"]
["MSTRG.3223","MSL1","ENSOART00000014275","GO:0043984(histone H4-K16 acetylation);GO:0072487(MSL complex)","NA","K13163","NA","MSL complex subunit 1 [Source:NCBI gene;Acc:101106604]",{"v":8.28413861392405,"d":"8.28"},{"v":8.90784641071428,"d":"8.91"},{"v":7.58610891749548,"d":"7.59"},{"v":10.1461601828662,"d":"10.15"},{"v":8.27248528187161,"d":"8.27"},{"v":8.61873504498192,"d":"8.62"},{"v":0.916438407678816,"d":"0.92"},{"v":-0.125890172029778,"d":"-0.13"},{"v":0.913583052989342,"d":"0.91"},{"v":0.991978292054872,"d":"0.99"},"down","no"]
["MSTRG.8847","BRPF1","ENSOART00000006862;ENSOART00000006865","GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0043966(histone H3 acetylation);GO:0043972(histone H3-K23 acetylation);GO:0043994(histone acetyltransferase activity (H3-K23 specific));GO:0045893(positive regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0070776(MOZ/MORF histone acetyltransferase complex);GO:0070776(MOZ/MORF histone acetyltransferase complex)","NA","K11348","NA","bromodomain and PHD finger containing 1 [Source:NCBI gene;Acc:101104433]",{"v":3.2907233958021,"d":"3.29"},{"v":2.84757010644678,"d":"2.85"},{"v":2.84165197151424,"d":"2.84"},{"v":3.38909985307346,"d":"3.39"},{"v":2.74185652323838,"d":"2.74"},{"v":3.58522583358321,"d":"3.59"},{"v":0.924225717444642,"d":"0.92"},{"v":-0.113682860486096,"d":"-0.11"},{"v":0.914555009968055,"d":"0.91"},{"v":0.991978292054872,"d":"0.99"},"down","no"]
["MSTRG.16027","ORMDL2","ENSOART00000012108","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006672(ceramide metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0090155(negative regulation of sphingolipid biosynthetic process);GO:1900060(negative regulation of ceramide biosynthetic process)","NA","NA","NA","ORMDL sphingolipid biosynthesis regulator 2 [Source:NCBI gene;Acc:101114692]",{"v":4.414253,"d":"4.41"},{"v":2.514671,"d":"2.51"},{"v":2.541945,"d":"2.54"},{"v":2.994562,"d":"2.99"},{"v":2.563157,"d":"2.56"},{"v":4.660285,"d":"4.66"},{"v":0.92688053361498,"d":"0.93"},{"v":-0.109544694189889,"d":"-0.11"},{"v":0.915003984360511,"d":"0.92"},{"v":0.991978292054872,"d":"0.99"},"down","no"]
["MSTRG.8183","MTMR10","ENSOART00000017593","GO:0005737(cytoplasm)","NA","K18085","NA","myotubularin related protein 10 [Source:NCBI gene;Acc:101118477]",{"v":9.57233,"d":"9.57"},{"v":9.020383,"d":"9.02"},{"v":6.779829,"d":"6.78"},{"v":10.658951,"d":"10.66"},{"v":8.009672,"d":"8.01"},{"v":7.766232,"d":"7.77"},{"v":0.959813927483241,"d":"0.96"},{"v":-0.059173347299788,"d":"-0.06"},{"v":0.916192502096057,"d":"0.92"},{"v":0.992352758779916,"d":"0.99"},"down","no"]
["MSTRG.955","CASQ1","ENSOART00000009146","GO:0005509(calcium ion binding);GO:0005759(mitochondrial matrix);GO:0005783(endoplasmic reticulum);GO:0007029(endoplasmic reticulum organization);GO:0009408(response to heat);GO:0010880(regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum);GO:0014809(regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion);GO:0016529(sarcoplasmic reticulum);GO:0033018(sarcoplasmic reticulum lumen);GO:0042802(identical protein binding);GO:0045214(sarcomere organization);GO:0051258(protein polymerization);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:1901341(positive regulation of store-operated calcium channel activity);GO:2001256(regulation of store-operated calcium entry)","NA","NA","NA","calsequestrin 1 [Source:NCBI gene;Acc:101118652]",{"v":462.221741,"d":"462.22"},{"v":430.585907,"d":"430.59"},{"v":400.964752,"d":"400.96"},{"v":486.695374,"d":"486.70"},{"v":386.762878,"d":"386.76"},{"v":467.469818,"d":"467.47"},{"v":0.964833557403269,"d":"0.96"},{"v":-0.0516480091073294,"d":"-0.05"},{"v":0.917122505299402,"d":"0.92"},{"v":0.992462235226597,"d":"0.99"},"down","no"]
["MSTRG.3955","MFN2","ENSOART00000019330","GO:0001825(blastocyst formation);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0006626(protein targeting to mitochondrion);GO:0007006(mitochondrial membrane organization);GO:0008053(mitochondrial fusion);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031625(ubiquitin protein ligase binding);GO:0034497(protein localization to phagophore assembly site);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048593(camera-type eye morphogenesis);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0051646(mitochondrion localization);GO:0061734(parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization);GO:0120162(positive regulation of cold-induced thermogenesis);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905461(positive regulation of vascular associated smooth muscle cell apoptotic process)","04137(Mitophagy - animal);04621(NOD-like receptor signaling pathway)","K06030","EC:3.6.5.-","mitofusin 2 [Source:NCBI gene;Acc:101110526]",{"v":65.044477706156,"d":"65.04"},{"v":53.5822156297423,"d":"53.58"},{"v":54.8999874937366,"d":"54.90"},{"v":70.6821240524338,"d":"70.68"},{"v":56.1175058836793,"d":"56.12"},{"v":61.3609776365426,"d":"61.36"},{"v":0.922226405772154,"d":"0.92"},{"v":-0.116807120385467,"d":"-0.12"},{"v":0.918026708285379,"d":"0.92"},{"v":0.992684774363156,"d":"0.99"},"down","no"]
["MSTRG.9956","IFT74","ENSOART00000015835","GO:0003334(keratinocyte development);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0005929(cilium);GO:0007219(Notch signaling pathway);GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0008544(epidermis development);GO:0030992(intraciliary transport particle B);GO:0033630(positive regulation of cell adhesion mediated by integrin);GO:0035735(intraciliary transport involved in cilium assembly);GO:0042073(intraciliary transport);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048487(beta-tubulin binding);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060271(cilium assembly);GO:1905515(non-motile cilium assembly)","NA","K19679","NA","intraflagellar transport 74 [Source:NCBI gene;Acc:101110029]",{"v":0.231448,"d":"0.23"},{"v":0.221213,"d":"0.22"},{"v":0.294341,"d":"0.29"},{"v":0.247242,"d":"0.25"},{"v":0.183623,"d":"0.18"},{"v":0.324717,"d":"0.32"},{"v":0.988644515089031,"d":"0.99"},{"v":-0.0164762276041616,"d":"-0.02"},{"v":0.919040854112344,"d":"0.92"},{"v":0.993181825685105,"d":"0.99"},"down","no"]
["MSTRG.19739","PYGL","ENSOART00000022540;ENSOART00000022538","GO:0002060(purine nucleobase binding);GO:0004645(phosphorylase activity);GO:0005524(ATP binding);GO:0005975(carbohydrate metabolic process);GO:0005977(glycogen metabolic process);GO:0008144(drug binding);GO:0008184(glycogen phosphorylase activity);GO:0009617(response to bacterium);GO:0016208(AMP binding);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0019842(vitamin binding);GO:0030170(pyridoxal phosphate binding);GO:0032052(bile acid binding);GO:0042593(glucose homeostasis);GO:0070266(necroptotic process);GO:0102250(linear malto-oligosaccharide phosphorylase activity);GO:0102499(SHG alpha-glucan phosphorylase activity);GO:0102499(SHG alpha-glucan phosphorylase activity)","00500(Starch and sucrose metabolism);04217(Necroptosis);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04931(Insulin resistance);04931(Insulin resistance)","K00688","EC:2.4.1.1","glycogen phosphorylase L [Source:NCBI gene;Acc:554320]",{"v":3.35939157038089,"d":"3.36"},{"v":2.93522634516205,"d":"2.94"},{"v":3.24251702271114,"d":"3.24"},{"v":3.64075719233499,"d":"3.64"},{"v":2.90473356115448,"d":"2.90"},{"v":3.34298861935179,"d":"3.34"},{"v":0.964469316126386,"d":"0.96"},{"v":-0.0521927541520811,"d":"-0.05"},{"v":0.919748192128635,"d":"0.92"},{"v":0.993181825685105,"d":"0.99"},"down","no"]
["MSTRG.19539","BCL2L2-PABPN1","ENSOART00000021058","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0006915(apoptotic process);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0046982(protein heterodimerization activity);GO:0097136(Bcl-2 family protein complex);GO:0097718(disordered domain specific binding);GO:1904247(positive regulation of polynucleotide adenylyltransferase activity)","NA","NA","NA","BCL2 like 2 [Source:NCBI gene;Acc:780446]",{"v":3.80742173708641,"d":"3.81"},{"v":3.34444201797191,"d":"3.34"},{"v":4.03555604855987,"d":"4.04"},{"v":4.15766906629374,"d":"4.16"},{"v":4.16530349916687,"d":"4.17"},{"v":3.31858189657224,"d":"3.32"},{"v":0.960990204538771,"d":"0.96"},{"v":-0.0574063693361637,"d":"-0.06"},{"v":0.92024954380966,"d":"0.92"},{"v":0.993181825685105,"d":"0.99"},"down","no"]
["MSTRG.7811","ZMAT5","ENSOART00000005982","GO:0005654(nucleoplasm);GO:0005689(U12-type spliceosomal complex);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","K13152","NA","zinc finger matrin-type 5 [Source:NCBI gene;Acc:101108518]",{"v":1.85152421818182,"d":"1.85"},{"v":2.19069816969697,"d":"2.19"},{"v":1.95755584242424,"d":"1.96"},{"v":2.00272128484848,"d":"2.00"},{"v":1.68126848484848,"d":"1.68"},{"v":2.82287626666667,"d":"2.82"},{"v":0.92206881112555,"d":"0.92"},{"v":-0.117053676374548,"d":"-0.12"},{"v":0.921319303056059,"d":"0.92"},{"v":0.993809974255093,"d":"0.99"},"down","no"]
["MSTRG.13852","ENSOARG00000003083","ENSOART00000003341","GO:0005515(protein binding);GO:0030914(STAGA complex);GO:0033276(transcription factor TFTC complex)","NA","NA","NA",null,{"v":2.39824767898458,"d":"2.40"},{"v":2.09352932615681,"d":"2.09"},{"v":2.04988247397172,"d":"2.05"},{"v":2.26431172975578,"d":"2.26"},{"v":2.4413468155527,"d":"2.44"},{"v":2.35981526606684,"d":"2.36"},{"v":0.925862815963046,"d":"0.93"},{"v":-0.111129648044916,"d":"-0.11"},{"v":0.922086797833527,"d":"0.92"},{"v":0.99400043143165,"d":"0.99"},"down","no"]
["ENSOARG00000007672","DZIP1L","ENSOART00000008355","GO:0003676(nucleic acid binding);GO:0005814(centriole);GO:0032880(regulation of protein localization);GO:0036064(ciliary basal body);GO:0060271(cilium assembly)","NA","K16470","NA","DAZ interacting zinc finger protein 1 like [Source:NCBI gene;Acc:101112535]",{"v":0.133268,"d":"0.13"},{"v":0.222459,"d":"0.22"},{"v":0.768781,"d":"0.77"},{"v":0.102351,"d":"0.10"},{"v":0.637134,"d":"0.64"},{"v":0.379643,"d":"0.38"},{"v":1.00480731426611,"d":"1.00"},{"v":0.00691887115053189,"d":"0.01"},{"v":0.923096461993652,"d":"0.92"},{"v":0.99415067089238,"d":"0.99"},"up","no"]
["MSTRG.4873","NPEPL1","ENSOART00000018422","GO:0004177(aminopeptidase activity);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008235(metalloexopeptidase activity);GO:0019538(protein metabolic process);GO:0030145(manganese ion binding)","NA","K09611","EC:3.4.11.-","aminopeptidase like 1 [Source:NCBI gene;Acc:101102662]",{"v":7.67009159988092,"d":"7.67"},{"v":6.80939393033641,"d":"6.81"},{"v":5.79577589937481,"d":"5.80"},{"v":5.5269235915451,"d":"5.53"},{"v":7.60662268949092,"d":"7.61"},{"v":7.66284416939565,"d":"7.66"},{"v":0.974941371576878,"d":"0.97"},{"v":-0.0366126303619896,"d":"-0.04"},{"v":0.923693343467376,"d":"0.92"},{"v":0.994183388654652,"d":"0.99"},"down","no"]
["MSTRG.8792","EIF1B","ENSOART00000002838","GO:0003743(translation initiation factor activity);GO:0006413(translational initiation)","03013(RNA transport)","K03113","NA","eukaryotic translation initiation factor 1B [Source:NCBI gene;Acc:101114218]",{"v":11.3024156789298,"d":"11.30"},{"v":9.38765166889632,"d":"9.39"},{"v":10.473258541806,"d":"10.47"},{"v":11.5507655886288,"d":"11.55"},{"v":9.46457595317726,"d":"9.46"},{"v":11.2535196856187,"d":"11.25"},{"v":0.965739871326694,"d":"0.97"},{"v":-0.0502934533267418,"d":"-0.05"},{"v":0.924226765475731,"d":"0.92"},{"v":0.994372445525299,"d":"0.99"},"down","no"]
["MSTRG.1691","ENSOARG00000002537","ENSOART00000002744","GO:0000380(alternative mRNA splicing, via spliceosome);GO:0000398(mRNA splicing, via spliceosome)","NA","NA","NA","arginine and serine rich coiled-coil 1 [Source:NCBI gene;Acc:101108795]",{"v":3.373358,"d":"3.37"},{"v":2.35054567760844,"d":"2.35"},{"v":1.72369416647128,"d":"1.72"},{"v":2.4461,"d":"2.45"},{"v":2.477405,"d":"2.48"},{"v":3.113495,"d":"3.11"},{"v":0.926663909926555,"d":"0.93"},{"v":-0.109881909651371,"d":"-0.11"},{"v":0.925722378283289,"d":"0.93"},{"v":0.994839826128012,"d":"0.99"},"down","no"]
["MSTRG.4570","ENSOARG00000006835","ENSOART00000007429","GO:0007605(sensory perception of sound)","NA","NA","NA",null,{"v":1.93410014859197,"d":"1.93"},{"v":1.53387478220491,"d":"1.53"},{"v":1.21352053565009,"d":"1.21"},{"v":2.44833595326543,"d":"2.45"},{"v":1.40477358508089,"d":"1.40"},{"v":1.30033837028161,"d":"1.30"},{"v":0.908420061568719,"d":"0.91"},{"v":-0.138568527981581,"d":"-0.14"},{"v":0.926091493606878,"d":"0.93"},{"v":0.994948144993624,"d":"0.99"},"down","no"]
["MSTRG.1390","HACD2","ENSOART00000021986","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016829(lyase activity);GO:0018812(3-hydroxyacyl-CoA dehydratase activity);GO:0019899(enzyme binding);GO:0030148(sphingolipid biosynthetic process);GO:0030497(fatty acid elongation);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0102158(very-long-chain 3-hydroxyacyl-CoA dehydratase activity);GO:0102343(3-hydroxy-arachidoyl-CoA dehydratase activity);GO:0102344(3-hydroxy-behenoyl-CoA dehydratase activity);GO:0102345(3-hydroxy-lignoceroyl-CoA dehydratase activity)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)","K10703","EC:4.2.1.134","3-hydroxyacyl-CoA dehydratase 2 [Source:NCBI gene;Acc:101120135]",{"v":2.080949,"d":"2.08"},{"v":2.086391,"d":"2.09"},{"v":2.233358,"d":"2.23"},{"v":2.181225,"d":"2.18"},{"v":2.309595,"d":"2.31"},{"v":2.459516,"d":"2.46"},{"v":0.920919218869419,"d":"0.92"},{"v":-0.118853483248029,"d":"-0.12"},{"v":0.926891388582676,"d":"0.93"},{"v":0.994987207409621,"d":"0.99"},"down","no"]
["ENSOARG00000004884","ENSOARG00000004884","ENSOART00000005338","GO:0005813(centrosome);GO:0036064(ciliary basal body);GO:0044782(cilium organization)","NA","K16484","NA","rotatin [Source:NCBI gene;Acc:101103281]",{"v":1.78808,"d":"1.79"},{"v":1.252799,"d":"1.25"},{"v":1.154084,"d":"1.15"},{"v":1.808375,"d":"1.81"},{"v":1.391845,"d":"1.39"},{"v":1.169531,"d":"1.17"},{"v":0.960000466845823,"d":"0.96"},{"v":-0.0588929874744131,"d":"-0.06"},{"v":0.927521452476478,"d":"0.93"},{"v":0.994987207409621,"d":"0.99"},"down","no"]
["MSTRG.2132","ESD","ENSOART00000008818","GO:0005737(cytoplasm);GO:0016787(hydrolase activity);GO:0016788(hydrolase activity, acting on ester bonds);GO:0018738(S-formylglutathione hydrolase activity);GO:0042802(identical protein binding);GO:0046294(formaldehyde catabolic process);GO:0052689(carboxylic ester hydrolase activity)","NA","NA","NA","esterase D [Source:NCBI gene;Acc:101113080]",{"v":9.86251671563342,"d":"9.86"},{"v":9.30586297708895,"d":"9.31"},{"v":7.82298235983828,"d":"7.82"},{"v":10.6261073005391,"d":"10.63"},{"v":8.97379363207547,"d":"8.97"},{"v":9.61854708760108,"d":"9.62"},{"v":0.923778088209404,"d":"0.92"},{"v":-0.114381768668525,"d":"-0.11"},{"v":0.928183353213715,"d":"0.93"},{"v":0.994987207409621,"d":"0.99"},"down","no"]
["MSTRG.3961","FBXO6","ENSOART00000000934","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006516(glycoprotein catabolic process);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0030246(carbohydrate binding);GO:0030433(ubiquitin-dependent ERAD pathway);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0044322(endoplasmic reticulum quality control compartment);GO:0061630(ubiquitin protein ligase activity)","04141(Protein processing in endoplasmic reticulum)","K10100","NA","F-box protein 6 [Source:NCBI gene;Acc:101112337]",{"v":2.02627269912152,"d":"2.03"},{"v":1.51450357320644,"d":"1.51"},{"v":1.60350610834553,"d":"1.60"},{"v":1.68404132650073,"d":"1.68"},{"v":1.66553136676428,"d":"1.67"},{"v":2.16537065592972,"d":"2.17"},{"v":0.932789705160731,"d":"0.93"},{"v":-0.100376228728368,"d":"-0.10"},{"v":0.929105118219556,"d":"0.93"},{"v":0.994987207409621,"d":"0.99"},"down","no"]
["MSTRG.13261","HCFC1R1","ENSOART00000000924","GO:0005654(nucleoplasm)","NA","NA","NA","host cell factor C1 regulator 1 [Source:HGNC Symbol;Acc:HGNC:21198]",{"v":1.66709505674061,"d":"1.67"},{"v":1.88216987841297,"d":"1.88"},{"v":2.94529385750853,"d":"2.95"},{"v":1.67996065145051,"d":"1.68"},{"v":2.21880630802048,"d":"2.22"},{"v":2.74984904095563,"d":"2.75"},{"v":0.976828680171238,"d":"0.98"},{"v":-0.0338225357031292,"d":"-0.03"},{"v":0.930057233272963,"d":"0.93"},{"v":0.994987207409621,"d":"0.99"},"down","no"]
["MSTRG.963","COPA","ENSOART00000009459","GO:0000139(Golgi membrane);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat);GO:0030126(COPI vesicle coat);GO:0030157(pancreatic juice secretion)","NA","K05236","NA","coatomer protein complex subunit alpha [Source:NCBI gene;Acc:101120034]",{"v":24.35947,"d":"24.36"},{"v":19.907984,"d":"19.91"},{"v":22.905407,"d":"22.91"},{"v":28.328321,"d":"28.33"},{"v":21.201399,"d":"21.20"},{"v":23.241142,"d":"23.24"},{"v":0.92307359228478,"d":"0.92"},{"v":-0.115482423189744,"d":"-0.12"},{"v":0.930510827746426,"d":"0.93"},{"v":0.994987207409621,"d":"0.99"},"down","no"]
["MSTRG.7025","NDUFS4","ENSOART00000008797","GO:0001932(regulation of protein phosphorylation);GO:0005739(mitochondrion);GO:0005747(mitochondrial respiratory chain complex I);GO:0007420(brain development);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0016651(oxidoreductase activity, acting on NAD(P)H);GO:0019933(cAMP-mediated signaling);GO:0022900(electron transport chain);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0045333(cellular respiration);GO:0048146(positive regulation of fibroblast proliferation);GO:0051591(response to cAMP);GO:0072593(reactive oxygen species metabolic process)","00190(Oxidative phosphorylation);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K03937","NA","NADH:ubiquinone oxidoreductase subunit S4 [Source:NCBI gene;Acc:101118899]",{"v":65.348831,"d":"65.35"},{"v":58.872391,"d":"58.87"},{"v":59.896538,"d":"59.90"},{"v":70.624466,"d":"70.62"},{"v":52.65416,"d":"52.65"},{"v":68.148743,"d":"68.15"},{"v":0.96181523552152,"d":"0.96"},{"v":-0.0561683156510226,"d":"-0.06"},{"v":0.931410988039404,"d":"0.93"},{"v":0.995358244172223,"d":"1.00"},"down","no"]
["MSTRG.2855","ANKFY1","ENSOART00000020573","GO:0005515(protein binding);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016197(endosomal transport);GO:0017137(Rab GTPase binding);GO:0030904(retromer complex);GO:0034058(endosomal vesicle fusion);GO:0042147(retrograde transport, endosome to Golgi);GO:0043231(intracellular membrane-bounded organelle);GO:0044354(macropinosome);GO:0046872(metal ion binding);GO:0048549(positive regulation of pinocytosis);GO:0090160(Golgi to lysosome transport);GO:1901981(phosphatidylinositol phosphate binding)","NA","K20129","NA","ankyrin repeat and FYVE domain containing 1 [Source:NCBI gene;Acc:101102652]",{"v":2.89127304307793,"d":"2.89"},{"v":2.72817574350543,"d":"2.73"},{"v":2.77766119434397,"d":"2.78"},{"v":3.48397126109832,"d":"3.48"},{"v":2.84531084939165,"d":"2.85"},{"v":2.78065951496218,"d":"2.78"},{"v":0.921752336751177,"d":"0.92"},{"v":-0.117548926161097,"d":"-0.12"},{"v":0.932319158939092,"d":"0.93"},{"v":0.995391960271707,"d":"1.00"},"down","no"]
["MSTRG.19520","RABGGTA","ENSOART00000020844","GO:0004663(Rab geranylgeranyltransferase activity);GO:0005654(nucleoplasm);GO:0005968(Rab-protein geranylgeranyltransferase complex);GO:0008270(zinc ion binding);GO:0008318(protein prenyltransferase activity);GO:0018342(protein prenylation);GO:0018344(protein geranylgeranylation)","NA","K14050","EC:2.5.1.60","Rab geranylgeranyltransferase subunit alpha [Source:NCBI gene;Acc:101114020]",{"v":9.69241633072844,"d":"9.69"},{"v":9.39947620987999,"d":"9.40"},{"v":7.6846062874686,"d":"7.68"},{"v":8.85066887524421,"d":"8.85"},{"v":8.92304746915992,"d":"8.92"},{"v":9.96707201367569,"d":"9.97"},{"v":0.965239288892742,"d":"0.97"},{"v":-0.0510414549893943,"d":"-0.05"},{"v":0.932367028104683,"d":"0.93"},{"v":0.995391960271707,"d":"1.00"},"down","no"]
["ENSOARG00000020543","DGKG","ENSOART00000022379","GO:0000166(nucleotide binding);GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005509(calcium ion binding);GO:0005524(ATP binding);GO:0007165(signal transduction);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0035556(intracellular signal transduction);GO:0046486(glycerolipid metabolic process);GO:0046834(lipid phosphorylation)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)","K00901","EC:2.7.1.107","diacylglycerol kinase gamma [Source:NCBI gene;Acc:101114659]",{"v":0.279118466239155,"d":"0.28"},{"v":0.317934116937005,"d":"0.32"},{"v":0.266242910222558,"d":"0.27"},{"v":0.381542114296492,"d":"0.38"},{"v":0.457127258015843,"d":"0.46"},{"v":0.125325178800453,"d":"0.13"},{"v":0.895539806114228,"d":"0.90"},{"v":-0.159170534471486,"d":"-0.16"},{"v":0.933545529623564,"d":"0.93"},{"v":0.995407776257884,"d":"1.00"},"down","no"]
["MSTRG.21770","HUWE1","ENSOART00000008481;ENSOART00000008490","GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006284(base-excision repair);GO:0006513(protein monoubiquitination);GO:0016567(protein ubiquitination);GO:0016574(histone ubiquitination);GO:0016740(transferase activity);GO:0031398(positive regulation of protein ubiquitination);GO:0032922(circadian regulation of gene expression);GO:0032922(circadian regulation of gene expression)","04120(Ubiquitin mediated proteolysis);04120(Ubiquitin mediated proteolysis)","K10592","EC:2.3.2.26","HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase [Source:NCBI gene;Acc:101119368]",{"v":17.5145321238466,"d":"17.51"},{"v":17.4110930020371,"d":"17.41"},{"v":18.3525732411624,"d":"18.35"},{"v":20.2137815154584,"d":"20.21"},{"v":19.5835285639904,"d":"19.58"},{"v":17.8550738240863,"d":"17.86"},{"v":0.924128279867699,"d":"0.92"},{"v":-0.113834966315809,"d":"-0.11"},{"v":0.93375446764569,"d":"0.93"},{"v":0.995436258102412,"d":"1.00"},"down","no"]
["MSTRG.822","S100A11","ENSOART00000022965","GO:0001726(ruffle);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0042127(regulation of cell population proliferation);GO:0042803(protein homodimerization activity);GO:0044548(S100 protein binding);GO:0046872(metal ion binding);GO:0048306(calcium-dependent protein binding)","NA","NA","NA","S100 calcium binding protein A11 [Source:HGNC Symbol;Acc:HGNC:10488]",{"v":27.1050435,"d":"27.11"},{"v":21.006413825,"d":"21.01"},{"v":35.6517582083333,"d":"35.65"},{"v":28.5056238,"d":"28.51"},{"v":26.28287505,"d":"26.28"},{"v":35.12844255,"d":"35.13"},{"v":0.931562108643225,"d":"0.93"},{"v":-0.102276135871282,"d":"-0.10"},{"v":0.934699924323912,"d":"0.93"},{"v":0.995436258102412,"d":"1.00"},"down","no"]
["MSTRG.17087","JAZF1","ENSOART00000009952","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001650(fibrillar center);GO:0003676(nucleic acid binding);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0017053(transcriptional repressor complex)","NA","K19495","NA","JAZF zinc finger 1 [Source:NCBI gene;Acc:101113233]",{"v":1.94084965545087,"d":"1.94"},{"v":1.48334595020188,"d":"1.48"},{"v":2.93440047106326,"d":"2.93"},{"v":2.11499441588156,"d":"2.11"},{"v":2.33485066756393,"d":"2.33"},{"v":2.44514708479139,"d":"2.45"},{"v":0.922204974504266,"d":"0.92"},{"v":-0.116840647015119,"d":"-0.12"},{"v":0.935145677398866,"d":"0.94"},{"v":0.995440290799184,"d":"1.00"},"down","no"]
["MSTRG.17638","ENSOARG00000018801","ENSOART00000020476","GO:0005634(nucleus)","NA","NA","NA",null,{"v":1.156901,"d":"1.16"},{"v":1.137651,"d":"1.14"},{"v":0.996957,"d":"1.00"},{"v":1.160373,"d":"1.16"},{"v":0.978402,"d":"0.98"},{"v":1.406557,"d":"1.41"},{"v":0.928406422868154,"d":"0.93"},{"v":-0.10717159136914,"d":"-0.11"},{"v":0.936680209072043,"d":"0.94"},{"v":0.996047589474539,"d":"1.00"},"down","no"]
["MSTRG.19421","ENSOARG00000017783","ENSOART00000019351","GO:0000813(ESCRT I complex);GO:0043130(ubiquitin binding);GO:0043162(ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway)","NA","NA","NA",null,{"v":1.2327501315265,"d":"1.23"},{"v":0.953581595456357,"d":"0.95"},{"v":1.4725144703069,"d":"1.47"},{"v":1.34537443961738,"d":"1.35"},{"v":1.17436063013153,"d":"1.17"},{"v":1.42851033678756,"d":"1.43"},{"v":0.926701818289309,"d":"0.93"},{"v":-0.109822892473996,"d":"-0.11"},{"v":0.937216117852978,"d":"0.94"},{"v":0.996085710623149,"d":"1.00"},"down","no"]
["MSTRG.18152","DAZAP1","ENSOART00000012754","GO:0001893(maternal placenta development);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0008266(poly(U) RNA binding);GO:0008283(cell population proliferation);GO:0032991(protein-containing complex);GO:0034046(poly(G) binding);GO:0035613(RNA stem-loop binding);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:1990904(ribonucleoprotein complex)","03015(mRNA surveillance pathway)","K14411","NA","DAZ associated protein 1 [Source:NCBI gene;Acc:101115209]",{"v":3.51494535187915,"d":"3.51"},{"v":3.80503929992631,"d":"3.81"},{"v":4.22018193515107,"d":"4.22"},{"v":4.3584639119381,"d":"4.36"},{"v":4.38741387582903,"d":"4.39"},{"v":3.36441393036109,"d":"3.36"},{"v":0.95292226277933,"d":"0.95"},{"v":-0.0695695677166188,"d":"-0.07"},{"v":0.938182378021432,"d":"0.94"},{"v":0.996399236915178,"d":"1.00"},"down","no"]
["MSTRG.4857","MTG2","ENSOART00000015656","GO:0000287(magnesium ion binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0005761(mitochondrial ribosome);GO:0044065(regulation of respiratory system process);GO:0070129(regulation of mitochondrial translation)","NA","K03979","EC:3.6.5.-","mitochondrial ribosome associated GTPase 2 [Source:NCBI gene;Acc:101113258]",{"v":3.880597,"d":"3.88"},{"v":2.714734,"d":"2.71"},{"v":2.732348,"d":"2.73"},{"v":3.61495,"d":"3.61"},{"v":3.350435,"d":"3.35"},{"v":2.725048,"d":"2.73"},{"v":0.962565759445424,"d":"0.96"},{"v":-0.0550429904676879,"d":"-0.06"},{"v":0.939274187608017,"d":"0.94"},{"v":0.996780770522794,"d":"1.00"},"down","no"]
["ENSOARG00000014425","MERTK","ENSOART00000015708","GO:0000166(nucleotide binding);GO:0001779(natural killer cell differentiation);GO:0001818(negative regulation of cytokine production);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006909(phagocytosis);GO:0007283(spermatogenesis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016028(rhabdomere);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030168(platelet activation);GO:0032940(secretion by cell);GO:0034446(substrate adhesion-dependent cell spreading);GO:0043277(apoptotic cell clearance);GO:0043491(protein kinase B signaling);GO:0050766(positive regulation of phagocytosis);GO:0051250(negative regulation of lymphocyte activation);GO:0060041(retina development in camera-type eye);GO:0060068(vagina development);GO:0097350(neutrophil clearance);GO:2000107(negative regulation of leukocyte apoptotic process)","NA","K05117","EC:2.7.10.1","MER proto-oncogene, tyrosine kinase [Source:NCBI gene;Acc:101118263]",{"v":1.02867029784975,"d":"1.03"},{"v":0.892235978762941,"d":"0.89"},{"v":0.895562229360234,"d":"0.90"},{"v":1.0580251234404,"d":"1.06"},{"v":1.11828328643483,"d":"1.12"},{"v":0.76214131032652,"d":"0.76"},{"v":0.958487901497784,"d":"0.96"},{"v":-0.0611678732801217,"d":"-0.06"},{"v":0.939492692731204,"d":"0.94"},{"v":0.996818291436422,"d":"1.00"},"down","no"]
["MSTRG.6325","BCL9L","ENSOART00000012756","GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0008013(beta-catenin binding);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0022604(regulation of cell morphogenesis);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0035019(somatic stem cell population maintenance);GO:0035914(skeletal muscle cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060070(canonical Wnt signaling pathway);GO:1990907(beta-catenin-TCF complex)","NA","K22649","NA","BCL9 like [Source:NCBI gene;Acc:101114641]",{"v":7.820506,"d":"7.82"},{"v":6.762323,"d":"6.76"},{"v":6.38215,"d":"6.38"},{"v":5.93465,"d":"5.93"},{"v":8.291332,"d":"8.29"},{"v":8.150045,"d":"8.15"},{"v":0.936939296685689,"d":"0.94"},{"v":-0.0939725146736054,"d":"-0.09"},{"v":0.941055573600977,"d":"0.94"},{"v":0.997038839655124,"d":"1.00"},"down","no"]
["MSTRG.20583","MED23","ENSOART00000015253","GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated)","NA","K15166","NA","mediator complex subunit 23 [Source:NCBI gene;Acc:101121942]",{"v":3.7180495849093,"d":"3.72"},{"v":2.75516995600154,"d":"2.76"},{"v":2.79131551447318,"d":"2.79"},{"v":4.1263055650328,"d":"4.13"},{"v":2.70048347703589,"d":"2.70"},{"v":2.87280483925125,"d":"2.87"},{"v":0.955146696731934,"d":"0.96"},{"v":-0.0662057676085839,"d":"-0.07"},{"v":0.941276101933863,"d":"0.94"},{"v":0.997038839655124,"d":"1.00"},"down","no"]
["MSTRG.5876","GRWD1","ENSOART00000012787","GO:0003682(chromatin binding);GO:0003688(DNA replication origin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006334(nucleosome assembly);GO:0006337(nucleosome disassembly);GO:0032991(protein-containing complex);GO:0042393(histone binding)","NA","K14848","NA","glutamate rich WD repeat containing 1 [Source:NCBI gene;Acc:101122298]",{"v":3.233412,"d":"3.23"},{"v":3.302391,"d":"3.30"},{"v":3.502253,"d":"3.50"},{"v":4.176267,"d":"4.18"},{"v":3.25849,"d":"3.26"},{"v":3.100729,"d":"3.10"},{"v":0.95278528204584,"d":"0.95"},{"v":-0.0697769672473401,"d":"-0.07"},{"v":0.942302497240725,"d":"0.94"},{"v":0.997038839655124,"d":"1.00"},"down","no"]
["MSTRG.15912","GNS","ENSOART00000003524","GO:0003824(catalytic activity);GO:0005764(lysosome);GO:0008449(N-acetylglucosamine-6-sulfatase activity);GO:0008484(sulfuric ester hydrolase activity);GO:0016787(hydrolase activity);GO:0030203(glycosaminoglycan metabolic process);GO:0046872(metal ion binding)","00531(Glycosaminoglycan degradation);04142(Lysosome)","K01137","EC:3.1.6.14","glucosamine (N-acetyl)-6-sulfatase [Source:NCBI gene;Acc:101110316]",{"v":9.256276,"d":"9.26"},{"v":7.45366,"d":"7.45"},{"v":8.864738,"d":"8.86"},{"v":9.492938,"d":"9.49"},{"v":8.380669,"d":"8.38"},{"v":9.586556,"d":"9.59"},{"v":0.93133729759725,"d":"0.93"},{"v":-0.102624339087894,"d":"-0.10"},{"v":0.94357755190693,"d":"0.94"},{"v":0.997038839655124,"d":"1.00"},"down","no"]
["ENSOARG00000016777","SLF1","ENSOART00000018274","GO:0000786(nucleosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006974(cellular response to DNA damage stimulus);GO:0031334(positive regulation of protein complex assembly);GO:0031625(ubiquitin protein ligase binding);GO:0034184(positive regulation of maintenance of mitotic sister chromatid cohesion);GO:0035861(site of double-strand break);GO:0042405(nuclear inclusion body);GO:0044877(protein-containing complex binding);GO:1990166(protein localization to site of double-strand break);GO:2000781(positive regulation of double-strand break repair)","NA","NA","NA","SMC5-SMC6 complex localization factor 1 [Source:NCBI gene;Acc:101108386]",{"v":0.691718,"d":"0.69"},{"v":0.378183,"d":"0.38"},{"v":0.525833,"d":"0.53"},{"v":0.63477,"d":"0.63"},{"v":0.444096,"d":"0.44"},{"v":0.566831,"d":"0.57"},{"v":0.969640219311331,"d":"0.97"},{"v":-0.0444785538759953,"d":"-0.04"},{"v":0.944047279169871,"d":"0.94"},{"v":0.997038839655124,"d":"1.00"},"down","no"]
["MSTRG.9736","TESK1","ENSOART00000013024","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0046872(metal ion binding)","NA","K08841","EC:2.7.12.1","testis associated actin remodelling kinase 1 [Source:NCBI gene;Acc:101109153]",{"v":7.60215299323181,"d":"7.60"},{"v":7.12440841398759,"d":"7.12"},{"v":6.45539269204738,"d":"6.46"},{"v":5.23915324534687,"d":"5.24"},{"v":8.77722106937394,"d":"8.78"},{"v":8.53772618443316,"d":"8.54"},{"v":0.939161998504943,"d":"0.94"},{"v":-0.0905540613091145,"d":"-0.09"},{"v":0.944866652862993,"d":"0.94"},{"v":0.997335490849244,"d":"1.00"},"down","no"]
["ENSOARG00000012065","TCFL5","ENSOART00000013125","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001673(male germ cell nucleus);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007283(spermatogenesis);GO:0042127(regulation of cell population proliferation);GO:0045595(regulation of cell differentiation);GO:0046983(protein dimerization activity)","NA","K09092","NA","transcription factor like 5 [Source:NCBI gene;Acc:101119924]",{"v":1.083528,"d":"1.08"},{"v":0.84583,"d":"0.85"},{"v":1.216089,"d":"1.22"},{"v":0.738154,"d":"0.74"},{"v":1.101531,"d":"1.10"},{"v":1.504118,"d":"1.50"},{"v":0.940679519696585,"d":"0.94"},{"v":-0.0882248003028029,"d":"-0.09"},{"v":0.945241791927442,"d":"0.95"},{"v":0.997442721182017,"d":"1.00"},"down","no"]
["ENSOARG00000002888","SPDL1","ENSOART00000003131","GO:0000132(establishment of mitotic spindle orientation);GO:0000775(chromosome, centromeric region);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000922(spindle pole);GO:0000940(condensed chromosome outer kinetochore);GO:0005634(nucleus);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005856(cytoskeleton);GO:0007049(cell cycle);GO:0007080(mitotic metaphase plate congression);GO:0007094(mitotic spindle assembly checkpoint);GO:0019899(enzyme binding);GO:0034501(protein localization to kinetochore);GO:0043515(kinetochore binding);GO:0051301(cell division)","NA","NA","NA","spindle apparatus coiled-coil protein 1 [Source:NCBI gene;Acc:101104782]",{"v":0.750384,"d":"0.75"},{"v":0.395756,"d":"0.40"},{"v":0.27367,"d":"0.27"},{"v":0.438386,"d":"0.44"},{"v":0.536054,"d":"0.54"},{"v":0.544105,"d":"0.54"},{"v":0.934980524120128,"d":"0.93"},{"v":-0.0969917812752673,"d":"-0.10"},{"v":0.94641262230878,"d":"0.95"},{"v":0.997495158440413,"d":"1.00"},"down","no"]
["MSTRG.9159","SMARCC1","ENSOART00000003552","GO:0001741(XY body);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0008286(insulin receptor signaling pathway);GO:0009887(animal organ morphogenesis);GO:0016514(SWI/SNF complex);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0047485(protein N-terminus binding);GO:0071564(npBAF complex);GO:0071565(nBAF complex)","04714(Thermogenesis);05225(Hepatocellular carcinoma)","K11649","NA","SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1 [Source:NCBI gene;Acc:101121808]",{"v":5.079476,"d":"5.08"},{"v":5.294335,"d":"5.29"},{"v":5.621415,"d":"5.62"},{"v":6.239694,"d":"6.24"},{"v":5.460395,"d":"5.46"},{"v":5.107313,"d":"5.11"},{"v":0.951677481147889,"d":"0.95"},{"v":-0.0714553608320412,"d":"-0.07"},{"v":0.947114938063273,"d":"0.95"},{"v":0.99757662664515,"d":"1.00"},"down","no"]
["MSTRG.11931","ENSOARG00000015563","ENSOART00000016931","NA","NA","K14822","NA","coiled-coil domain containing 86 [Source:NCBI gene;Acc:101121127]",{"v":3.377083,"d":"3.38"},{"v":2.291297,"d":"2.29"},{"v":4.368744,"d":"4.37"},{"v":2.931871,"d":"2.93"},{"v":3.593791,"d":"3.59"},{"v":3.816462,"d":"3.82"},{"v":0.970508959281478,"d":"0.97"},{"v":-0.0431865636060251,"d":"-0.04"},{"v":0.948287962291676,"d":"0.95"},{"v":0.99757662664515,"d":"1.00"},"down","no"]
["MSTRG.5106","STAU1","ENSOART00000013274;ENSOART00000013276","GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0030425(dendrite);GO:0036464(cytoplasmic ribonucleoprotein granule);GO:0044297(cell body);GO:0045070(positive regulation of viral genome replication);GO:0046726(positive regulation by virus of viral protein levels in host cell);GO:0046726(positive regulation by virus of viral protein levels in host cell)","NA","K17597","NA","staufen double-stranded RNA binding protein 1 [Source:NCBI gene;Acc:101120429]",{"v":10.3018403603392,"d":"10.30"},{"v":13.109997403392,"d":"13.11"},{"v":11.3974598121331,"d":"11.40"},{"v":10.7343217569472,"d":"10.73"},{"v":12.8884913736464,"d":"12.89"},{"v":12.7153382815395,"d":"12.72"},{"v":0.957927033245881,"d":"0.96"},{"v":-0.0620123270088461,"d":"-0.06"},{"v":0.948924509995975,"d":"0.95"},{"v":0.99782758954745,"d":"1.00"},"down","no"]
["MSTRG.6354","ARHGEF12","ENSOART00000018910;ENSOART00000018915","GO:0001664(G protein-coupled receptor binding);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007266(Rho protein signal transduction);GO:0035023(regulation of Rho protein signal transduction);GO:0035556(intracellular signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0043547(positive regulation of GTPase activity)","04270(Vascular smooth muscle contraction);04360(Axon guidance);04611(Platelet activation);04625(C-type lectin receptor signaling pathway);04810(Regulation of actin cytoskeleton);05152(Tuberculosis);05163(Human cytomegalovirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05205(Proteoglycans in cancer)","K07532","NA","Rho guanine nucleotide exchange factor 12 [Source:NCBI gene;Acc:101117190]",{"v":8.20257989945086,"d":"8.20"},{"v":8.68845716767658,"d":"8.69"},{"v":8.08642761550843,"d":"8.09"},{"v":9.67029633904563,"d":"9.67"},{"v":9.17474867553494,"d":"9.17"},{"v":7.44801318557091,"d":"7.45"},{"v":0.94996422601354,"d":"0.95"},{"v":-0.0740549097854977,"d":"-0.07"},{"v":0.949927514289339,"d":"0.95"},{"v":0.998096296867202,"d":"1.00"},"down","no"]
["MSTRG.17579","ENSOARG00000012952","ENSOART00000014091;ENSOART00000014089","GO:0004114(3',5'-cyclic-nucleotide phosphodiesterase activity);GO:0005929(cilium);GO:0007165(signal transduction);GO:0008081(phosphoric diester hydrolase activity);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0046872(metal ion binding)","00230(Purine metabolism);04024(cAMP signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05032(Morphine addiction);05032(Morphine addiction)","K13293","EC:3.1.4.53","phosphodiesterase 4C [Source:NCBI gene;Acc:101111282]",{"v":13.7816670191054,"d":"13.78"},{"v":15.3517293119802,"d":"15.35"},{"v":9.61371385884468,"d":"9.61"},{"v":16.6817087475837,"d":"16.68"},{"v":11.797141158013,"d":"11.80"},{"v":12.3704938617667,"d":"12.37"},{"v":0.948536906996467,"d":"0.95"},{"v":-0.0762241857683891,"d":"-0.08"},{"v":0.950692212915145,"d":"0.95"},{"v":0.998271877351738,"d":"1.00"},"down","no"]
["MSTRG.22358","HNRNPH2","ENSOART00000010929","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:1990904(ribonucleoprotein complex)","NA","K12898","NA","heterogeneous nuclear ribonucleoprotein H2 [Source:NCBI gene;Acc:101106495]",{"v":7.30581909616062,"d":"7.31"},{"v":6.75230275167312,"d":"6.75"},{"v":7.39147987072913,"d":"7.39"},{"v":8.03178055265939,"d":"8.03"},{"v":6.94863762768581,"d":"6.95"},{"v":8.04399225854174,"d":"8.04"},{"v":0.931602647350991,"d":"0.93"},{"v":-0.102213355601872,"d":"-0.10"},{"v":0.951837958452006,"d":"0.95"},{"v":0.998271877351738,"d":"1.00"},"down","no"]
["MSTRG.10972","TCEA3","ENSOART00000008166","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-templated);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","NA","NA","transcription elongation factor A3 [Source:NCBI gene;Acc:101121158]",{"v":40.2763857548846,"d":"40.28"},{"v":33.9157887868561,"d":"33.92"},{"v":42.1772898010657,"d":"42.18"},{"v":34.9065302930728,"d":"34.91"},{"v":40.0344486927176,"d":"40.03"},{"v":48.8563003960924,"d":"48.86"},{"v":0.940000175479111,"d":"0.94"},{"v":-0.0892670687749384,"d":"-0.09"},{"v":0.951857373660243,"d":"0.95"},{"v":0.998271877351738,"d":"1.00"},"down","no"]
["MSTRG.2120","ZC3H13","ENSOART00000008484","GO:0005654(nucleoplasm);GO:0016607(nuclear speck);GO:0036396(RNA N6-methyladenosine methyltransferase complex);GO:0046872(metal ion binding);GO:0080009(mRNA methylation);GO:2000036(regulation of stem cell population maintenance)","NA","K22909","NA","zinc finger CCCH-type containing 13 [Source:NCBI gene;Acc:101111891]",{"v":2.26408089744322,"d":"2.26"},{"v":1.70011776960434,"d":"1.70"},{"v":2.13148299014426,"d":"2.13"},{"v":2.32026257220397,"d":"2.32"},{"v":2.14068304842165,"d":"2.14"},{"v":1.91773002285388,"d":"1.92"},{"v":0.955634366425738,"d":"0.96"},{"v":-0.0654693581081081,"d":"-0.07"},{"v":0.952892334108589,"d":"0.95"},{"v":0.99836205858003,"d":"1.00"},"down","no"]
["MSTRG.21759","ENSOARG00000006221","ENSOART00000006764","NA","03008(Ribosome biogenesis in eukaryotes)","K14538","NA","G protein nucleolar 3 like [Source:NCBI gene;Acc:101108370]",{"v":6.67960336608775,"d":"6.68"},{"v":7.36073956032907,"d":"7.36"},{"v":9.91158318327239,"d":"9.91"},{"v":9.12396733363803,"d":"9.12"},{"v":7.52258193738574,"d":"7.52"},{"v":8.50994,"d":"8.51"},{"v":0.952117199329478,"d":"0.95"},{"v":-0.0707889242065455,"d":"-0.07"},{"v":0.953396934315574,"d":"0.95"},{"v":0.99836205858003,"d":"1.00"},"down","no"]
["MSTRG.2142","RCBTB2","ENSOART00000009069","GO:0001669(acrosomal vesicle);GO:0005515(protein binding)","NA","K11494","NA","RCC1 and BTB domain containing protein 2 [Source:NCBI gene;Acc:101114369]",{"v":3.38701507325789,"d":"3.39"},{"v":2.40921122235458,"d":"2.41"},{"v":2.1751548495136,"d":"2.18"},{"v":2.81498955032758,"d":"2.81"},{"v":2.81571246634902,"d":"2.82"},{"v":2.66043408735358,"d":"2.66"},{"v":0.961434120138411,"d":"0.96"},{"v":-0.0567400909944509,"d":"-0.06"},{"v":0.953894215747956,"d":"0.95"},{"v":0.99836205858003,"d":"1.00"},"down","no"]
["ENSOARG00000000770","ZNF202","ENSOART00000000821","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","K09229","NA","zinc finger protein 202 [Source:NCBI gene;Acc:101113358]",{"v":1.121213,"d":"1.12"},{"v":1.180932,"d":"1.18"},{"v":0.978579,"d":"0.98"},{"v":1.291315,"d":"1.29"},{"v":1.081062,"d":"1.08"},{"v":1.066228,"d":"1.07"},{"v":0.954085741165386,"d":"0.95"},{"v":-0.0678091716380083,"d":"-0.07"},{"v":0.954924987161907,"d":"0.95"},{"v":0.998530512572061,"d":"1.00"},"down","no"]
["MSTRG.6780","PTPMT1","ENSOART00000007693","GO:0004725(protein tyrosine phosphatase activity);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:2001242(regulation of intrinsic apoptotic signaling pathway)","NA","NA","NA","protein tyrosine phosphatase, mitochondrial 1 [Source:HGNC Symbol;Acc:HGNC:26965]",{"v":10.671426,"d":"10.67"},{"v":12.712903,"d":"12.71"},{"v":7.862245,"d":"7.86"},{"v":8.950437,"d":"8.95"},{"v":9.289193,"d":"9.29"},{"v":14.08065,"d":"14.08"},{"v":0.966779186318931,"d":"0.97"},{"v":-0.0487416810698531,"d":"-0.05"},{"v":0.955522546219799,"d":"0.96"},{"v":0.998530512572061,"d":"1.00"},"down","no"]
["MSTRG.16333","LRP6","ENSOART00000022744;ENSOART00000022743","GO:0001933(negative regulation of protein phosphorylation);GO:0005041(low-density lipoprotein particle receptor activity);GO:0005102(signaling receptor binding);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006469(negative regulation of protein kinase activity);GO:0006898(receptor-mediated endocytosis);GO:0007275(multicellular organism development);GO:0009986(cell surface);GO:0014029(neural crest formation);GO:0014033(neural crest cell differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0019210(kinase inhibitor activity);GO:0019534(toxin transmembrane transporter activity);GO:0031410(cytoplasmic vesicle);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042813(Wnt-activated receptor activity);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060070(canonical Wnt signaling pathway);GO:0071397(cellular response to cholesterol);GO:0071901(negative regulation of protein serine/threonine kinase activity);GO:0071936(coreceptor activity involved in Wnt signaling pathway);GO:0072659(protein localization to plasma membrane);GO:1901998(toxin transport);GO:1990851(Wnt-Frizzled-LRP5/6 complex);GO:1990909(Wnt signalosome);GO:1990909(Wnt signalosome)","04150(mTOR signaling pathway);04310(Wnt signaling pathway);04928(Parathyroid hormone synthesis, secretion and action);05200(Pathways in cancer);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer);05226(Gastric cancer)","K03068","NA","LDL receptor related protein 6 [Source:NCBI gene;Acc:101112971]",{"v":8.77887119503546,"d":"8.78"},{"v":6.90692759492635,"d":"6.91"},{"v":7.94834729678123,"d":"7.95"},{"v":10.0024521628478,"d":"10.00"},{"v":7.91919177577741,"d":"7.92"},{"v":6.95987852782324,"d":"6.96"},{"v":0.949867361155756,"d":"0.95"},{"v":-0.074202024351891,"d":"-0.07"},{"v":0.956155634583695,"d":"0.96"},{"v":0.998533266336202,"d":"1.00"},"down","no"]
["MSTRG.19983","TIMM9","ENSOART00000023001","GO:0005215(transporter activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0015031(protein transport);GO:0042719(mitochondrial intermembrane space protein transporter complex);GO:0042803(protein homodimerization activity);GO:0045039(protein insertion into mitochondrial inner membrane);GO:0046872(metal ion binding);GO:0051087(chaperone binding);GO:0072321(chaperone-mediated protein transport)","NA","K17777","NA","translocase of inner mitochondrial membrane 9 [Source:NCBI gene;Acc:101123381]",{"v":2.62956535129534,"d":"2.63"},{"v":3.41566417098446,"d":"3.42"},{"v":2.6919716507772,"d":"2.69"},{"v":2.95505778549223,"d":"2.96"},{"v":3.10881652020725,"d":"3.11"},{"v":3.35540044559585,"d":"3.36"},{"v":0.927587463340048,"d":"0.93"},{"v":-0.108444773285684,"d":"-0.11"},{"v":0.957202398674774,"d":"0.96"},{"v":0.998638229983613,"d":"1.00"},"down","no"]
["MSTRG.17493","ESYT2","ENSOART00000010589","GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0061817(endoplasmic reticulum-plasma membrane tethering)","NA","NA","NA","extended synaptotagmin 2 [Source:NCBI gene;Acc:101118945]",{"v":5.06451344666595,"d":"5.06"},{"v":4.66820289419648,"d":"4.67"},{"v":4.72540854058143,"d":"4.73"},{"v":5.41261586036961,"d":"5.41"},{"v":5.20114083021723,"d":"5.20"},{"v":4.90778984296985,"d":"4.91"},{"v":0.931487390781984,"d":"0.93"},{"v":-0.1023918548449,"d":"-0.10"},{"v":0.957319495494612,"d":"0.96"},{"v":0.998638229983613,"d":"1.00"},"down","no"]
["MSTRG.16236","MED21","ENSOART00000021567","GO:0001824(blastocyst development);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0016592(mediator complex);GO:0019827(stem cell population maintenance);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K15152","NA","mediator complex subunit 21 [Source:NCBI gene;Acc:101112043]",{"v":13.378998,"d":"13.38"},{"v":11.876541,"d":"11.88"},{"v":13.527586,"d":"13.53"},{"v":12.788279,"d":"12.79"},{"v":11.45704,"d":"11.46"},{"v":16.070877,"d":"16.07"},{"v":0.961973818164789,"d":"0.96"},{"v":-0.0559304658794017,"d":"-0.06"},{"v":0.958035558314971,"d":"0.96"},{"v":0.99868763472699,"d":"1.00"},"down","no"]
["MSTRG.17955","GNG7","ENSOART00000014837","GO:0003924(GTPase activity);GO:0005834(heterotrimeric G-protein complex);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane)","NA","NA","NA","guanine nucleotide binding protein (G protein), gamma 7 [Source:NCBI gene;Acc:101120325]",{"v":3.29937792976295,"d":"3.30"},{"v":4.48329508604039,"d":"4.48"},{"v":3.87503245917471,"d":"3.88"},{"v":3.54093197541703,"d":"3.54"},{"v":4.17241691132572,"d":"4.17"},{"v":4.77622853116769,"d":"4.78"},{"v":0.933394708636062,"d":"0.93"},{"v":-0.099440806122001,"d":"-0.10"},{"v":0.958970006766656,"d":"0.96"},{"v":0.99868763472699,"d":"1.00"},"down","no"]
["MSTRG.5078","ACOT8","ENSOART00000007390","GO:0005102(signaling receptor binding);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0006637(acyl-CoA metabolic process);GO:0016290(palmitoyl-CoA hydrolase activity);GO:0016559(peroxisome fission);GO:0043649(dicarboxylic acid catabolic process);GO:0045225(negative regulation of CD4 biosynthetic process);GO:0047617(acyl-CoA hydrolase activity);GO:0052815(medium-chain acyl-CoA hydrolase activity)","00120(Primary bile acid biosynthesis);04146(Peroxisome)","K11992","EC:3.1.2.27","acyl-CoA thioesterase 8 [Source:NCBI gene;Acc:101115474]",{"v":3.214271,"d":"3.21"},{"v":2.70498520371325,"d":"2.70"},{"v":2.254629,"d":"2.25"},{"v":2.663335,"d":"2.66"},{"v":3.16416334553894,"d":"3.16"},{"v":2.890982,"d":"2.89"},{"v":0.937535542865065,"d":"0.94"},{"v":-0.0930547094121041,"d":"-0.09"},{"v":0.959885902711365,"d":"0.96"},{"v":0.99868763472699,"d":"1.00"},"down","no"]
["MSTRG.4446","ENSOARG00000012398","ENSOART00000013477","GO:0005509(calcium ion binding)","NA","NA","NA",null,{"v":0.322186,"d":"0.32"},{"v":0.190823,"d":"0.19"},{"v":0.138494,"d":"0.14"},{"v":0.267839,"d":"0.27"},{"v":0.277497,"d":"0.28"},{"v":0.160923,"d":"0.16"},{"v":0.922470368519197,"d":"0.92"},{"v":-0.116425525044402,"d":"-0.12"},{"v":0.960366878899747,"d":"0.96"},{"v":0.99868763472699,"d":"1.00"},"down","no"]
["MSTRG.6564","INPPL1","ENSOART00000004994","GO:0001958(endochondral ossification);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006006(glucose metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006897(endocytosis);GO:0007015(actin filament organization);GO:0008285(negative regulation of cell population proliferation);GO:0009791(post-embryonic development);GO:0010629(negative regulation of gene expression);GO:0016787(hydrolase activity);GO:0032868(response to insulin);GO:0042169(SH2 domain binding);GO:0044255(cellular lipid metabolic process);GO:0046856(phosphatidylinositol dephosphorylation);GO:0097178(ruffle assembly)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04662(B cell receptor signaling pathway);04666(Fc gamma R-mediated phagocytosis);04910(Insulin signaling pathway)","K15909","EC:3.1.3.86","inositol polyphosphate phosphatase like 1 [Source:NCBI gene;Acc:101121707]",{"v":33.2283658533835,"d":"33.23"},{"v":29.9263549285714,"d":"29.93"},{"v":27.7857712443609,"d":"27.79"},{"v":31.5675799862155,"d":"31.57"},{"v":32.2330639674185,"d":"32.23"},{"v":33.2756863132832,"d":"33.28"},{"v":0.936793673352396,"d":"0.94"},{"v":-0.0941967622740499,"d":"-0.09"},{"v":0.961356051359777,"d":"0.96"},{"v":0.99868763472699,"d":"1.00"},"down","no"]
["MSTRG.9455","SLC44A1","ENSOART00000007943;ENSOART00000007946","GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0015220(choline transmembrane transporter activity);GO:0015871(choline transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","05231(Choline metabolism in cancer);05231(Choline metabolism in cancer)","K06515","NA","solute carrier family 44 member 1 [Source:NCBI gene;Acc:101102625]",{"v":4.0407462409042,"d":"4.04"},{"v":3.93806943961249,"d":"3.94"},{"v":4.34094932163617,"d":"4.34"},{"v":4.27460396275565,"d":"4.27"},{"v":4.80394114381055,"d":"4.80"},{"v":4.12603958428418,"d":"4.13"},{"v":0.932991479140527,"d":"0.93"},{"v":-0.100064189649385,"d":"-0.10"},{"v":0.962159840761382,"d":"0.96"},{"v":0.99868763472699,"d":"1.00"},"down","no"]
["MSTRG.4961","MAP1LC3A","ENSOART00000010865","GO:0000045(autophagosome assembly);GO:0000421(autophagosome membrane);GO:0000422(autophagy of mitochondrion);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005776(autophagosome);GO:0005829(cytosol);GO:0006914(autophagy);GO:0008429(phosphatidylethanolamine binding);GO:0009267(cellular response to starvation);GO:0016236(macroautophagy);GO:0031090(organelle membrane);GO:0031625(ubiquitin protein ligase binding);GO:0044754(autolysosome);GO:0097352(autophagosome maturation)","04216(Ferroptosis)","K10435","NA","microtubule associated protein 1 light chain 3 alpha [Source:NCBI gene;Acc:101118292]",{"v":17.4998999795918,"d":"17.50"},{"v":16.0733522585034,"d":"16.07"},{"v":12.0322114557823,"d":"12.03"},{"v":12.8291513639456,"d":"12.83"},{"v":18.151742829932,"d":"18.15"},{"v":17.4454043129252,"d":"17.45"},{"v":0.941749939600917,"d":"0.94"},{"v":-0.0865840592418629,"d":"-0.09"},{"v":0.962238106585543,"d":"0.96"},{"v":0.99868763472699,"d":"1.00"},"down","no"]
["MSTRG.15377","SLC30A6","ENSOART00000011604;ENSOART00000011601","GO:0005794(Golgi apparatus);GO:0006812(cation transport);GO:0008324(cation transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0098655(cation transmembrane transport);GO:0098655(cation transmembrane transport)","NA","K14693","NA","solute carrier family 30 member 6 [Source:NCBI gene;Acc:101104388]",{"v":3.47584764755839,"d":"3.48"},{"v":3.11915490021231,"d":"3.12"},{"v":3.83237645859873,"d":"3.83"},{"v":4.03429999150743,"d":"4.03"},{"v":3.62597033121019,"d":"3.63"},{"v":3.55473491719745,"d":"3.55"},{"v":0.929770319612298,"d":"0.93"},{"v":-0.10505372240927,"d":"-0.11"},{"v":0.96287648621487,"d":"0.96"},{"v":0.99868763472699,"d":"1.00"},"down","no"]
["MSTRG.15485","LIPT1","ENSOART00000017998","GO:0006464(cellular protein modification process);GO:0009249(protein lipoylation)","00785(Lipoic acid metabolism)","K10105","NA","lipoyltransferase 1 [Source:NCBI gene;Acc:101107774]",{"v":1.31227,"d":"1.31"},{"v":1.131856,"d":"1.13"},{"v":1.754071,"d":"1.75"},{"v":1.898794,"d":"1.90"},{"v":1.363462,"d":"1.36"},{"v":1.30799,"d":"1.31"},{"v":0.918593222334203,"d":"0.92"},{"v":-0.122501955940858,"d":"-0.12"},{"v":0.96357323458904,"d":"0.96"},{"v":0.998789952114252,"d":"1.00"},"down","no"]
["MSTRG.20057","GPHN","ENSOART00000023061;ENSOART00000023060","GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006777(Mo-molybdopterin cofactor biosynthetic process);GO:0008940(nitrate reductase activity);GO:0010038(response to metal ion);GO:0016740(transferase activity);GO:0018315(molybdenum incorporation into molybdenum-molybdopterin complex);GO:0030425(dendrite);GO:0032324(molybdopterin cofactor biosynthetic process);GO:0043546(molybdopterin cofactor binding);GO:0045211(postsynaptic membrane);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0061598(molybdopterin adenylyltransferase activity);GO:0061599(molybdopterin molybdotransferase activity);GO:0097112(gamma-aminobutyric acid receptor clustering);GO:0097112(gamma-aminobutyric acid receptor clustering)","00790(Folate biosynthesis);04727(GABAergic synapse);04727(GABAergic synapse)","K15376","2.7.7.75;EC:2.10.1.1","gephyrin [Source:NCBI gene;Acc:101112228]",{"v":3.09000116666667,"d":"3.09"},{"v":3.61113960606061,"d":"3.61"},{"v":3.37769346338384,"d":"3.38"},{"v":3.31940350631313,"d":"3.32"},{"v":4.01116304545455,"d":"4.01"},{"v":3.48112865151515,"d":"3.48"},{"v":0.932215905702818,"d":"0.93"},{"v":-0.101263966173976,"d":"-0.10"},{"v":0.964533723425759,"d":"0.96"},{"v":0.998789952114252,"d":"1.00"},"down","no"]
["MSTRG.18282","PFDN1","ENSOART00000019017","GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0044183(protein folding chaperone);GO:0051082(unfolded protein binding)","NA","K09548","NA","prefoldin subunit 1 [Source:NCBI gene;Acc:101117841]",{"v":20.20871,"d":"20.21"},{"v":25.029066,"d":"25.03"},{"v":21.571636,"d":"21.57"},{"v":22.272718,"d":"22.27"},{"v":18.841257,"d":"18.84"},{"v":30.21599,"d":"30.22"},{"v":0.936624769127533,"d":"0.94"},{"v":-0.094456904143833,"d":"-0.09"},{"v":0.965136834533929,"d":"0.97"},{"v":0.998789952114252,"d":"1.00"},"down","no"]
["MSTRG.3918","SCYL3","ENSOART00000012454","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006468(protein phosphorylation);GO:0030027(lamellipodium)","NA","K17542","NA","SCY1 like pseudokinase 3 [Source:NCBI gene;Acc:101102577]",{"v":4.61139928169423,"d":"4.61"},{"v":3.76109587931535,"d":"3.76"},{"v":3.71498901160429,"d":"3.71"},{"v":4.36959434957934,"d":"4.37"},{"v":3.88546036089353,"d":"3.89"},{"v":4.62089684450247,"d":"4.62"},{"v":0.938764340717265,"d":"0.94"},{"v":-0.0911650532472393,"d":"-0.09"},{"v":0.965840483101594,"d":"0.97"},{"v":0.999065150971354,"d":"1.00"},"down","no"]
["MSTRG.8736","FBXL2","ENSOART00000017166","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006513(protein monoubiquitination);GO:0010506(regulation of autophagy);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0019903(protein phosphatase binding);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0036312(phosphatidylinositol 3-kinase regulatory subunit binding);GO:0044830(modulation by host of viral RNA genome replication)","NA","K10268","NA","F-box and leucine rich repeat protein 2 [Source:NCBI gene;Acc:101113704]",{"v":0.686224,"d":"0.69"},{"v":0.641457,"d":"0.64"},{"v":1.100235,"d":"1.10"},{"v":0.934225,"d":"0.93"},{"v":1.062103,"d":"1.06"},{"v":0.640363,"d":"0.64"},{"v":0.920819314815426,"d":"0.92"},{"v":-0.119009999583834,"d":"-0.12"},{"v":0.967781507400952,"d":"0.97"},{"v":0.999460501901828,"d":"1.00"},"down","no"]
["MSTRG.17442","AGAP3","ENSOART00000003484","GO:0003924(GTPase activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0043547(positive regulation of GTPase activity);GO:0046872(metal ion binding)","04144(Endocytosis)","K12491","NA","ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 [Source:NCBI gene;Acc:101113584]",{"v":5.24831792639507,"d":"5.25"},{"v":4.70149661143444,"d":"4.70"},{"v":4.16497652618966,"d":"4.16"},{"v":4.36520417459774,"d":"4.37"},{"v":4.82197713420062,"d":"4.82"},{"v":5.52279526566244,"d":"5.52"},{"v":0.959538650015597,"d":"0.96"},{"v":-0.0595871758426187,"d":"-0.06"},{"v":0.968613238620073,"d":"0.97"},{"v":0.999460501901828,"d":"1.00"},"down","no"]
["MSTRG.14225","TFAM","ENSOART00000003301","GO:0001018(mitochondrial promoter sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006390(mitochondrial transcription);GO:0006391(transcription initiation from mitochondrial promoter);GO:0008301(DNA binding, bending);GO:0032991(protein-containing complex);GO:0042645(mitochondrial nucleoid);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-templated)","04371(Apelin signaling pathway);05016(Huntington disease)","K11830","NA","transcription factor A, mitochondrial [Source:NCBI gene;Acc:101122161]",{"v":3.334486,"d":"3.33"},{"v":4.014347,"d":"4.01"},{"v":2.979044,"d":"2.98"},{"v":4.407157,"d":"4.41"},{"v":3.397998,"d":"3.40"},{"v":3.379311,"d":"3.38"},{"v":0.923412615318425,"d":"0.92"},{"v":-0.114952652804384,"d":"-0.11"},{"v":0.969302463612441,"d":"0.97"},{"v":0.999460501901828,"d":"1.00"},"down","no"]
["MSTRG.7767","SRRD","ENSOART00000001165","NA","NA","NA","NA","SRR1 domain containing [Source:NCBI gene;Acc:101118644]",{"v":3.10884731320622,"d":"3.11"},{"v":4.51973947210452,"d":"4.52"},{"v":2.58053679696328,"d":"2.58"},{"v":3.80551263312147,"d":"3.81"},{"v":3.23868050388418,"d":"3.24"},{"v":3.7403916634887,"d":"3.74"},{"v":0.946640391923669,"d":"0.95"},{"v":-0.0791116135624798,"d":"-0.08"},{"v":0.969427212995264,"d":"0.97"},{"v":0.999460501901828,"d":"1.00"},"down","no"]
["MSTRG.4960","DYNLRB1","ENSOART00000010857","GO:0003774(motor activity);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005856(cytoskeleton);GO:0005868(cytoplasmic dynein complex);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0030286(dynein complex);GO:0045505(dynein intermediate chain binding)","NA","K10419","NA","dynein light chain roadblock-type 1 [Source:NCBI gene;Acc:101112751]",{"v":8.85478838264151,"d":"8.85"},{"v":7.93645029735849,"d":"7.94"},{"v":11.1726117109434,"d":"11.17"},{"v":4.96684574113207,"d":"4.97"},{"v":10.1176047932075,"d":"10.12"},{"v":13.5518379056604,"d":"13.55"},{"v":0.97651797472059,"d":"0.98"},{"v":-0.0342814949108924,"d":"-0.03"},{"v":0.96956490013842,"d":"0.97"},{"v":0.999460501901828,"d":"1.00"},"down","no"]
["MSTRG.7826","RF01882;RF01883;RF01891;RF01892","ENSOART00000024998;ENSOART00000024907;ENSOART00000025827;ENSOART00000023569","NA","NA","NA","NA",null,{"v":5.19840140708893,"d":"5.20"},{"v":5.91391392197987,"d":"5.91"},{"v":5.39454576027685,"d":"5.39"},{"v":6.7383322809354,"d":"6.74"},{"v":6.25913047892198,"d":"6.26"},{"v":4.81826477453859,"d":"4.82"},{"v":0.926533090353826,"d":"0.93"},{"v":-0.110085593068851,"d":"-0.11"},{"v":0.97078665722453,"d":"0.97"},{"v":0.999747999947154,"d":"1.00"},"down","no"]
["MSTRG.1964","FBXO25","ENSOART00000014697;ENSOART00000014701","GO:0005515(protein binding);GO:0005634(nucleus);GO:0005634(nucleus)","04068(FoxO signaling pathway);04068(FoxO signaling pathway)","K10305","NA","F-box protein 25 [Source:NCBI gene;Acc:101113718]",{"v":4.17115055715572,"d":"4.17"},{"v":3.25071744554455,"d":"3.25"},{"v":2.8755407659766,"d":"2.88"},{"v":3.87983663906391,"d":"3.88"},{"v":3.44720030333033,"d":"3.45"},{"v":3.64421124032403,"d":"3.64"},{"v":0.938581335248361,"d":"0.94"},{"v":-0.0914463238588904,"d":"-0.09"},{"v":0.972274025080515,"d":"0.97"},{"v":0.999900816247489,"d":"1.00"},"down","no"]
["MSTRG.11252","USP49","ENSOART00000002894","GO:0000398(mRNA splicing, via spliceosome);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0008270(zinc ion binding);GO:0016579(protein deubiquitination);GO:0016787(hydrolase activity);GO:0035616(histone H2B conserved C-terminal lysine deubiquitination);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity);GO:0042393(histone binding);GO:0046872(metal ion binding)","NA","K11834","EC:3.4.19.12","ubiquitin specific peptidase 49 [Source:NCBI gene;Acc:101109570]",{"v":0.876531,"d":"0.88"},{"v":0.622909,"d":"0.62"},{"v":0.718661,"d":"0.72"},{"v":0.986679,"d":"0.99"},{"v":0.958033,"d":"0.96"},{"v":0.467572,"d":"0.47"},{"v":0.919502430062132,"d":"0.92"},{"v":-0.121074707488916,"d":"-0.12"},{"v":0.972730035402877,"d":"0.97"},{"v":0.999983379591902,"d":"1.00"},"down","no"]
["MSTRG.18961","EXOC1","ENSOART00000002572;ENSOART00000002569","GO:0000145(exocyst);GO:0005737(cytoplasm);GO:0006887(exocytosis);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050714(positive regulation of protein secretion);GO:0098592(cytoplasmic side of apical plasma membrane);GO:0098592(cytoplasmic side of apical plasma membrane)","NA","K19983","NA","exocyst complex component 1 [Source:NCBI gene;Acc:101107281]",{"v":2.47953111264877,"d":"2.48"},{"v":1.91453664074177,"d":"1.91"},{"v":2.04965361693883,"d":"2.05"},{"v":2.20199397370606,"d":"2.20"},{"v":2.53694518350401,"d":"2.54"},{"v":2.01245151231663,"d":"2.01"},{"v":0.95442875190351,"d":"0.95"},{"v":-0.0672905904084822,"d":"-0.07"},{"v":0.973785895480791,"d":"0.97"},1,"down","no"]
["MSTRG.21814","WDR13","ENSOART00000013287","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005815(microtubule organizing center);GO:0005886(plasma membrane);GO:1904691(negative regulation of type B pancreatic cell proliferation);GO:1990841(promoter-specific chromatin binding)","NA","NA","NA","WD repeat domain 13 [Source:NCBI gene;Acc:101110568]",{"v":6.616679,"d":"6.62"},{"v":6.24954,"d":"6.25"},{"v":6.267175,"d":"6.27"},{"v":7.731943,"d":"7.73"},{"v":6.121251,"d":"6.12"},{"v":6.639343,"d":"6.64"},{"v":0.933676196363583,"d":"0.93"},{"v":-0.0990057921645169,"d":"-0.10"},{"v":0.974852459959042,"d":"0.97"},1,"down","no"]
["MSTRG.3827","MIA3","ENSOART00000014804;ENSOART00000014806","GO:0000139(Golgi membrane);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0002687(positive regulation of leukocyte migration);GO:0005515(protein binding);GO:0005789(endoplasmic reticulum membrane);GO:0006887(exocytosis);GO:0006888(endoplasmic reticulum to Golgi vesicle-mediated transport);GO:0007029(endoplasmic reticulum organization);GO:0007162(negative regulation of cell adhesion);GO:0015031(protein transport);GO:0016021(integral component of membrane);GO:0030336(negative regulation of cell migration);GO:0042060(wound healing);GO:0042953(lipoprotein transport);GO:0042954(lipoprotein transporter activity);GO:0043231(intracellular membrane-bounded organelle);GO:0070971(endoplasmic reticulum exit site);GO:0070973(protein localization to endoplasmic reticulum exit site);GO:0090110(COPII-coated vesicle cargo loading);GO:0140052(cellular response to oxidised low-density lipoprotein particle stimulus);GO:1903038(negative regulation of leukocyte cell-cell adhesion);GO:2000402(negative regulation of lymphocyte migration);GO:2000402(negative regulation of lymphocyte migration)","NA","NA","NA","MIA SH3 domain ER export factor 3 [Source:NCBI gene;Acc:101102578]",{"v":3.44766509346011,"d":"3.45"},{"v":3.65381411931818,"d":"3.65"},{"v":4.01890526576994,"d":"4.02"},{"v":3.72207452365492,"d":"3.72"},{"v":4.11256542022263,"d":"4.11"},{"v":3.87212900718924,"d":"3.87"},{"v":0.949910647850864,"d":"0.95"},{"v":-0.0741362803543468,"d":"-0.07"},{"v":0.975673906416847,"d":"0.98"},1,"down","no"]
["MSTRG.12878","GAREM1","ENSOART00000006580","GO:0007173(epidermal growth factor receptor signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0070064(proline-rich region binding);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071364(cellular response to epidermal growth factor stimulus)","NA","NA","NA","GRB2 associated regulator of MAPK1 subtype 1 [Source:NCBI gene;Acc:101118155]",{"v":1.835795,"d":"1.84"},{"v":1.842254,"d":"1.84"},{"v":2.021309,"d":"2.02"},{"v":1.92918,"d":"1.93"},{"v":2.595253,"d":"2.60"},{"v":1.590396,"d":"1.59"},{"v":0.932055172761168,"d":"0.93"},{"v":-0.10151273752604,"d":"-0.10"},{"v":0.976046853368828,"d":"0.98"},1,"down","no"]
["MSTRG.518","ENSOARG00000016489;RF00068","ENSOART00000017956;ENSOART00000026202","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0008097(5S rRNA binding)","03010(Ribosome)","K02932","NA","ribosomal protein L5 [Source:NCBI gene;Acc:101104192];small nucleolar RNA, C/D box 21 [Source:HGNC Symbol;Acc:HGNC:10144]",{"v":28.1443846243017,"d":"28.14"},{"v":26.2147245465549,"d":"26.21"},{"v":17.3016830428305,"d":"17.30"},{"v":23.3884063407821,"d":"23.39"},{"v":25.2052189478585,"d":"25.21"},{"v":26.4214522914339,"d":"26.42"},{"v":0.955285184331018,"d":"0.96"},{"v":-0.0659966050890994,"d":"-0.07"},{"v":0.976361479687283,"d":"0.98"},1,"down","no"]
["ENSOARG00000018518","ZNF655","ENSOART00000020156","GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)","NA","NA","NA","zinc finger protein 655 [Source:NCBI gene;Acc:101108539]",{"v":1.408736,"d":"1.41"},{"v":1.438978,"d":"1.44"},{"v":1.41427,"d":"1.41"},{"v":2.047502,"d":"2.05"},{"v":1.019057,"d":"1.02"},{"v":1.461128,"d":"1.46"},{"v":0.941315952273203,"d":"0.94"},{"v":-0.0872490507106044,"d":"-0.09"},{"v":0.978050481683274,"d":"0.98"},1,"down","no"]
["MSTRG.3002","ENSOARG00000016613","ENSOART00000018095","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","trans-golgi network vesicle protein 23 homolog B [Source:NCBI gene;Acc:101105932]",{"v":3.47055441309524,"d":"3.47"},{"v":3.04522011706349,"d":"3.05"},{"v":3.19649960119048,"d":"3.20"},{"v":3.88048780873016,"d":"3.88"},{"v":3.07071060357143,"d":"3.07"},{"v":3.29793597777778,"d":"3.30"},{"v":0.947618965827025,"d":"0.95"},{"v":-0.0776210216460898,"d":"-0.08"},{"v":0.97852398177722,"d":"0.98"},1,"down","no"]
["ENSOARG00000002377","UGGT2","ENSOART00000002597","GO:0003980(UDP-glucose:glycoprotein glucosyltransferase activity);GO:0006486(protein glycosylation);GO:0032991(protein-containing complex);GO:0097359(UDP-glucosylation)","04141(Protein processing in endoplasmic reticulum)","K11718","EC:2.4.1.-","UDP-glucose glycoprotein glucosyltransferase 2 [Source:NCBI gene;Acc:101108761]",{"v":0.335747,"d":"0.34"},{"v":0.336739,"d":"0.34"},{"v":0.420588,"d":"0.42"},{"v":0.513504,"d":"0.51"},{"v":0.387796,"d":"0.39"},{"v":0.282739,"d":"0.28"},{"v":0.923173983289402,"d":"0.92"},{"v":-0.115325528083609,"d":"-0.12"},{"v":0.979245137555408,"d":"0.98"},1,"down","no"]
["MSTRG.16931","SYPL1","ENSOART00000004778","GO:0008021(synaptic vesicle);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030141(secretory granule)","NA","NA","NA","synaptophysin like 1 [Source:NCBI gene;Acc:101105241]",{"v":10.6706514765418,"d":"10.67"},{"v":10.0520889406905,"d":"10.05"},{"v":9.48447817438773,"d":"9.48"},{"v":12.280437041015,"d":"12.28"},{"v":9.24376626497492,"d":"9.24"},{"v":10.4341228323989,"d":"10.43"},{"v":0.945206531181077,"d":"0.95"},{"v":-0.0812984968176713,"d":"-0.08"},{"v":0.980268202871655,"d":"0.98"},1,"down","no"]
["MSTRG.6629","TSKU","ENSOART00000007394","GO:0005515(protein binding);GO:0005615(extracellular space);GO:0010468(regulation of gene expression);GO:0021540(corpus callosum morphogenesis);GO:0021670(lateral ventricle development);GO:0021960(anterior commissure morphogenesis);GO:0030178(negative regulation of Wnt signaling pathway);GO:0043010(camera-type eye development);GO:0061073(ciliary body morphogenesis)","NA","NA","NA","tsukushi, small leucine rich proteoglycan [Source:HGNC Symbol;Acc:HGNC:28850]",{"v":0.751063,"d":"0.75"},{"v":0.441193,"d":"0.44"},{"v":1.416209,"d":"1.42"},{"v":1.09114,"d":"1.09"},0,{"v":1.587082,"d":"1.59"},{"v":0.973953988877696,"d":"0.97"},{"v":-0.0380744761586954,"d":"-0.04"},{"v":0.981549467909437,"d":"0.98"},1,"down","no"]
["MSTRG.1265","CMSS1","ENSOART00000019476","NA","NA","NA","NA","cms1 ribosomal small subunit homolog [Source:NCBI gene;Acc:101108270]",{"v":20.1990520232328,"d":"20.20"},{"v":13.1255460169104,"d":"13.13"},{"v":13.4852863932054,"d":"13.49"},{"v":23.0089617410878,"d":"23.01"},{"v":18.3544049492687,"d":"18.35"},{"v":8.62552687393358,"d":"8.63"},{"v":0.936405691259139,"d":"0.94"},{"v":-0.0947943920410406,"d":"-0.09"},{"v":0.982069169082137,"d":"0.98"},1,"down","no"]
["MSTRG.14365","ENSOARG00000000103","ENSOART00000000103","GO:0004721(phosphoprotein phosphatase activity);GO:0006470(protein dephosphorylation);GO:0016787(hydrolase activity)","03015(mRNA surveillance pathway);04071(Sphingolipid signaling pathway);04114(Oocyte meiosis);04136(Autophagy - other);04140(Autophagy - animal);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04530(Tight junction);04728(Dopaminergic synapse);04730(Long-term depression);05142(Chagas disease (American trypanosomiasis));05160(Hepatitis C);05165(Human papillomavirus infection)","K04382","EC:3.1.3.16","protein phosphatase 2 catalytic subunit beta [Source:NCBI gene;Acc:101114930]",{"v":11.279247,"d":"11.28"},{"v":13.713846,"d":"13.71"},{"v":13.512114,"d":"13.51"},{"v":11.730883,"d":"11.73"},{"v":12.927616,"d":"12.93"},{"v":15.773129,"d":"15.77"},{"v":0.952353612869608,"d":"0.95"},{"v":-0.0704307431921538,"d":"-0.07"},{"v":0.982095171280452,"d":"0.98"},1,"down","no"]
["MSTRG.12489","SLF2","ENSOART00000017196","GO:0000785(chromatin);GO:0005634(nucleus);GO:0006974(cellular response to DNA damage stimulus);GO:0031334(positive regulation of protein complex assembly);GO:0031625(ubiquitin protein ligase binding);GO:0034184(positive regulation of maintenance of mitotic sister chromatid cohesion);GO:0035861(site of double-strand break);GO:0043231(intracellular membrane-bounded organelle);GO:0044877(protein-containing complex binding);GO:1990166(protein localization to site of double-strand break);GO:2000781(positive regulation of double-strand break repair)","NA","NA","NA","SMC5-SMC6 complex localization factor 2 [Source:NCBI gene;Acc:101122318]",{"v":3.21980253631855,"d":"3.22"},{"v":2.49932367065344,"d":"2.50"},{"v":3.31531018130105,"d":"3.32"},{"v":3.29761743100933,"d":"3.30"},{"v":4.27985847184947,"d":"4.28"},{"v":2.09362503981914,"d":"2.09"},{"v":0.934168347721888,"d":"0.93"},{"v":-0.098245531528618,"d":"-0.10"},{"v":0.983456204026877,"d":"0.98"},1,"down","no"]
["MSTRG.15072","UGP2","ENSOART00000021839","GO:0003983(UTP:glucose-1-phosphate uridylyltransferase activity);GO:0006011(UDP-glucose metabolic process);GO:0016740(transferase activity);GO:0016779(nucleotidyltransferase activity);GO:0042802(identical protein binding);GO:0070569(uridylyltransferase activity)","00040(Pentose and glucuronate interconversions);00052(Galactose metabolism);00500(Starch and sucrose metabolism);00520(Amino sugar and nucleotide sugar metabolism)","K00963","EC:2.7.7.9","UDP-glucose pyrophosphorylase 2 [Source:NCBI gene;Acc:101115777]",{"v":16.5213356048632,"d":"16.52"},{"v":19.4425316593845,"d":"19.44"},{"v":16.2217979521277,"d":"16.22"},{"v":16.6186109067249,"d":"16.62"},{"v":21.0007031177812,"d":"21.00"},{"v":17.9593648649316,"d":"17.96"},{"v":0.938951163632155,"d":"0.94"},{"v":-0.0908779719581938,"d":"-0.09"},{"v":0.983649713271358,"d":"0.98"},1,"down","no"]
["MSTRG.20033","ZBTB25","ENSOART00000023048","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0010467(gene expression)","NA","K10504","NA","zinc finger and BTB domain containing 25 [Source:NCBI gene;Acc:101109541]",{"v":2.367221,"d":"2.37"},{"v":2.320354,"d":"2.32"},{"v":2.294858,"d":"2.29"},{"v":2.670134,"d":"2.67"},{"v":2.161081,"d":"2.16"},{"v":2.537165,"d":"2.54"},{"v":0.947621186746612,"d":"0.95"},{"v":-0.0776176404284959,"d":"-0.08"},{"v":0.984495299149133,"d":"0.98"},1,"down","no"]
["MSTRG.8380","TP53BP1","ENSOART00000011049","GO:0000776(kinetochore);GO:0000781(chromosome, telomeric region);GO:0000784(nuclear chromosome, telomeric region);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0002039(p53 binding);GO:0003684(damaged DNA binding);GO:0003712(transcription coregulator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005657(replication fork);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006974(cellular response to DNA damage stimulus);GO:0016604(nuclear body);GO:0035064(methylated histone binding);GO:0035861(site of double-strand break);GO:0042162(telomeric DNA binding);GO:0043565(sequence-specific DNA binding);GO:0045830(positive regulation of isotype switching);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051260(protein homooligomerization);GO:0061649(ubiquitin modification-dependent histone binding);GO:1990391(DNA repair complex);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","04621(NOD-like receptor signaling pathway)","K20915","NA","tumor protein p53 binding protein 1 [Source:NCBI gene;Acc:101107637]",{"v":2.9186470506538,"d":"2.92"},{"v":2.31330201472642,"d":"2.31"},{"v":2.25951732525073,"d":"2.26"},{"v":2.65806730125682,"d":"2.66"},{"v":2.62956586797004,"d":"2.63"},{"v":2.65254420820109,"d":"2.65"},{"v":0.943488543710298,"d":"0.94"},{"v":-0.0839230948493305,"d":"-0.08"},{"v":0.98518189039524,"d":"0.99"},1,"down","no"]
["MSTRG.3618","TSEN54","ENSOART00000011274","GO:0006388(tRNA splicing, via endonucleolytic cleavage and ligation)","NA","K15326","NA","tRNA splicing endonuclease subunit 54 [Source:NCBI gene;Acc:101120680]",{"v":5.027714,"d":"5.03"},{"v":3.677463,"d":"3.68"},{"v":3.331047,"d":"3.33"},{"v":3.775154,"d":"3.78"},{"v":4.353557,"d":"4.35"},{"v":4.55615,"d":"4.56"},{"v":0.948865265453046,"d":"0.95"},{"v":-0.0757248492244043,"d":"-0.08"},{"v":0.985711999792667,"d":"0.99"},1,"down","no"]
["MSTRG.7839","EIF4ENIF1","ENSOART00000011548;ENSOART00000011545","GO:0000932(P-body);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0017148(negative regulation of translation);GO:0019827(stem cell population maintenance);GO:0043231(intracellular membrane-bounded organelle);GO:0045665(negative regulation of neuron differentiation);GO:0045665(negative regulation of neuron differentiation)","NA","K18728","NA","eukaryotic translation initiation factor 4E nuclear import factor 1 [Source:NCBI gene;Acc:101116175]",{"v":5.31093044272179,"d":"5.31"},{"v":6.76190238242894,"d":"6.76"},{"v":6.23678309560723,"d":"6.24"},{"v":6.33692716106805,"d":"6.34"},{"v":6.80418942118863,"d":"6.80"},{"v":6.27095700258398,"d":"6.27"},{"v":0.943207630072882,"d":"0.94"},{"v":-0.084352705848965,"d":"-0.08"},{"v":0.986719636567789,"d":"0.99"},1,"down","no"]
["MSTRG.1906","ENSOARG00000011590","ENSOART00000012609;ENSOART00000012616","NA","NA","K20307","NA","trafficking protein particle complex 10 [Source:NCBI gene;Acc:101107491]",{"v":3.66045344004474,"d":"3.66"},{"v":3.89135831610738,"d":"3.89"},{"v":4.22473729328859,"d":"4.22"},{"v":4.58917940067114,"d":"4.59"},{"v":4.44068919642058,"d":"4.44"},{"v":3.58477602527964,"d":"3.58"},{"v":0.933561697691877,"d":"0.93"},{"v":-0.0991827237345034,"d":"-0.10"},{"v":0.98795164546245,"d":"0.99"},1,"down","no"]
["MSTRG.12552","SLK","ENSOART00000005646","GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0030334(regulation of cell migration);GO:0031122(cytoplasmic microtubule organization);GO:0031252(cell leading edge);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048471(perinuclear region of cytoplasm);GO:0051893(regulation of focal adhesion assembly)","04114(Oocyte meiosis)","K08836","EC:2.7.11.1","STE20 like kinase [Source:NCBI gene;Acc:101114150]",{"v":2.4990013353235,"d":"2.50"},{"v":2.20661524905568,"d":"2.21"},{"v":2.06399499975631,"d":"2.06"},{"v":2.68968386048495,"d":"2.69"},{"v":2.37707946630925,"d":"2.38"},{"v":2.11307533897892,"d":"2.11"},{"v":0.942864025121732,"d":"0.94"},{"v":-0.0848783668578331,"d":"-0.08"},{"v":0.988377117362993,"d":"0.99"},1,"down","no"]
["MSTRG.14273","PRIMPOL","ENSOART00000008167","GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0003896(DNA primase activity);GO:0005634(nucleus);GO:0005759(mitochondrial matrix);GO:0006264(mitochondrial DNA replication);GO:0006269(DNA replication, synthesis of RNA primer);GO:0009411(response to UV);GO:0019985(translesion synthesis);GO:0031297(replication fork processing)","NA","K22761","2.7.7.7;EC:2.7.7.102","primase and DNA directed polymerase [Source:NCBI gene;Acc:101110117]",{"v":0.964019,"d":"0.96"},{"v":0.443704,"d":"0.44"},{"v":0.766087,"d":"0.77"},{"v":0.74924,"d":"0.75"},{"v":0.786124,"d":"0.79"},{"v":0.729234,"d":"0.73"},{"v":0.959909882460375,"d":"0.96"},{"v":-0.0590291247099999,"d":"-0.06"},{"v":0.988959333193209,"d":"0.99"},1,"down","no"]
["MSTRG.7048","NNT","ENSOART00000009332","GO:0005739(mitochondrion);GO:0008746(NAD(P)+ transhydrogenase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0072593(reactive oxygen species metabolic process);GO:1902600(proton transmembrane transport)","00760(Nicotinate and nicotinamide metabolism)","K00323","7.1.1.1;EC:1.6.1.2","nicotinamide nucleotide transhydrogenase [Source:NCBI gene;Acc:101121801]",{"v":21.2096570286161,"d":"21.21"},{"v":25.8377225838937,"d":"25.84"},{"v":23.6816179677873,"d":"23.68"},{"v":32.3962290803753,"d":"32.40"},{"v":21.0664516975762,"d":"21.07"},{"v":22.7152272864738,"d":"22.72"},{"v":0.928471250752647,"d":"0.93"},{"v":-0.107070855743056,"d":"-0.11"},{"v":0.990044715212887,"d":"0.99"},1,"down","no"]
["MSTRG.10095","AMMECR1L","ENSOART00000017408;ENSOART00000017406","NA","NA","NA","NA","AMMECR1 like [Source:NCBI gene;Acc:101107573]",{"v":4.07119994714627,"d":"4.07"},{"v":3.30164564782529,"d":"3.30"},{"v":3.20683074215452,"d":"3.21"},{"v":4.43303022352725,"d":"4.43"},{"v":3.56572535529455,"d":"3.57"},{"v":3.28903261112131,"d":"3.29"},{"v":0.937267439740947,"d":"0.94"},{"v":-0.0934673298888545,"d":"-0.09"},{"v":0.990557545907779,"d":"0.99"},1,"down","no"]
["MSTRG.641","ENSOARG00000019607","ENSOART00000021351","GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o));GO:0015078(proton transmembrane transporter activity);GO:0015986(ATP synthesis coupled proton transport)","00190(Oxidative phosphorylation);04714(Thermogenesis);05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K02127","NA","ATP synthase peripheral stalk-membrane subunit b [Source:NCBI gene;Acc:101114570]",{"v":147.422089,"d":"147.42"},{"v":134.336044,"d":"134.34"},{"v":120.341377,"d":"120.34"},{"v":166.162476,"d":"166.16"},{"v":113.890892,"d":"113.89"},{"v":148.024963,"d":"148.02"},{"v":0.939312926820395,"d":"0.94"},{"v":-0.090322231190154,"d":"-0.09"},{"v":0.990984014964157,"d":"0.99"},1,"down","no"]
["ENSOARG00000012145","WAS","ENSOART00000013211","GO:0002625(regulation of T cell antigen processing and presentation);GO:0003779(actin binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005911(cell-cell junction);GO:0006955(immune response);GO:0007015(actin filament organization);GO:0008064(regulation of actin polymerization or depolymerization);GO:0008154(actin polymerization or depolymerization);GO:0010591(regulation of lamellipodium assembly);GO:0012506(vesicle membrane);GO:0016197(endosomal transport);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030041(actin filament polymerization);GO:0030048(actin filament-based movement);GO:0031267(small GTPase binding);GO:0032488(Cdc42 protein signal transduction);GO:0035861(site of double-strand break);GO:0042110(T cell activation);GO:0042802(identical protein binding);GO:0043274(phospholipase binding);GO:0045335(phagocytic vesicle);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048365(Rac GTPase binding);GO:0051492(regulation of stress fiber assembly);GO:0051497(negative regulation of stress fiber assembly);GO:0071346(cellular response to interferon-gamma);GO:1905168(positive regulation of double-strand break repair via homologous recombination);GO:2000146(negative regulation of cell motility);GO:2000601(positive regulation of Arp2/3 complex-mediated actin nucleation)","04062(Chemokine signaling pathway);04144(Endocytosis);04520(Adherens junction);04530(Tight junction);04666(Fc gamma R-mediated phagocytosis);04810(Regulation of actin cytoskeleton);05100(Bacterial invasion of epithelial cells);05132(Salmonella infection);05231(Choline metabolism in cancer)","K05747","NA","Wiskott-Aldrich syndrome [Source:NCBI gene;Acc:101114336]",{"v":0.476239,"d":"0.48"},{"v":0.278096,"d":"0.28"},{"v":0.636377,"d":"0.64"},{"v":0.575999,"d":"0.58"},{"v":0.306715,"d":"0.31"},{"v":0.580752,"d":"0.58"},{"v":0.950286511610109,"d":"0.95"},{"v":-0.0735655429591396,"d":"-0.07"},{"v":0.991514524892522,"d":"0.99"},1,"down","no"]
["MSTRG.14775","FAM129B","ENSOART00000012974","GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0008285(negative regulation of cell population proliferation);GO:0032274(gonadotropin secretion);GO:0043066(negative regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:2000279(negative regulation of DNA biosynthetic process);GO:2000679(positive regulation of transcription regulatory region DNA binding)","NA","NA","NA","family with sequence similarity 129 member B [Source:NCBI gene;Acc:101110580]",{"v":3.45107308073601,"d":"3.45"},{"v":3.98622948178746,"d":"3.99"},{"v":4.31839243109275,"d":"4.32"},{"v":4.61479960720991,"d":"4.61"},{"v":3.64668596845663,"d":"3.65"},{"v":4.28956695005633,"d":"4.29"},{"v":0.936630212448191,"d":"0.94"},{"v":-0.094448519752175,"d":"-0.09"},{"v":0.992598425036359,"d":"0.99"},1,"down","no"]
["MSTRG.5616","ENSOARG00000005044","ENSOART00000005497","NA","NA","NA","NA",null,{"v":0.433511,"d":"0.43"},{"v":0.476892,"d":"0.48"},{"v":0.739616,"d":"0.74"},{"v":0.612227,"d":"0.61"},{"v":0.555817,"d":"0.56"},{"v":0.576544,"d":"0.58"},{"v":0.945792932199465,"d":"0.95"},{"v":-0.0804037341435391,"d":"-0.08"},{"v":0.992968237246485,"d":"0.99"},1,"down","no"]
["MSTRG.2921","ACAP1","ENSOART00000013405","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0043547(positive regulation of GTPase activity);GO:0046872(metal ion binding)","04144(Endocytosis)","K12489","NA","ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 [Source:NCBI gene;Acc:101119319]",{"v":1.725813,"d":"1.73"},{"v":0.945714,"d":"0.95"},{"v":0.89364,"d":"0.89"},{"v":1.561689,"d":"1.56"},{"v":1.22239,"d":"1.22"},{"v":0.984403,"d":"0.98"},{"v":0.946048568097181,"d":"0.95"},{"v":-0.0800138445633654,"d":"-0.08"},{"v":0.993321747947217,"d":"0.99"},1,"down","no"]
["MSTRG.7327","ARHGAP10","ENSOART00000007922","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0043066(negative regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity)","05100(Bacterial invasion of epithelial cells)","K13736","NA","Rho GTPase activating protein 10 [Source:NCBI gene;Acc:101107633]",{"v":8.93334626901347,"d":"8.93"},{"v":8.83926884571925,"d":"8.84"},{"v":9.11363083137766,"d":"9.11"},{"v":7.55258249934811,"d":"7.55"},{"v":11.4615135897436,"d":"11.46"},{"v":9.2808237327249,"d":"9.28"},{"v":0.950214600904432,"d":"0.95"},{"v":-0.0736747196576779,"d":"-0.07"},{"v":0.993779878665349,"d":"0.99"},1,"down","no"]
["MSTRG.20192","TGFB3","ENSOART00000002207","GO:0001666(response to hypoxia);GO:0005114(type II transforming growth factor beta receptor binding);GO:0005160(transforming growth factor beta receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007435(salivary gland morphogenesis);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0010936(negative regulation of macrophage cytokine production);GO:0016049(cell growth);GO:0030501(positive regulation of bone mineralization);GO:0031012(extracellular matrix);GO:0032570(response to progesterone);GO:0032967(positive regulation of collagen biosynthetic process);GO:0034713(type I transforming growth factor beta receptor binding);GO:0034714(type III transforming growth factor beta receptor binding);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0043932(ossification involved in bone remodeling);GO:0045216(cell-cell junction organization);GO:0045893(positive regulation of transcription, DNA-templated);GO:0050431(transforming growth factor beta binding);GO:0050714(positive regulation of protein secretion);GO:0051496(positive regulation of stress fiber assembly);GO:0051781(positive regulation of cell division);GO:0060325(face morphogenesis);GO:0062023(collagen-containing extracellular matrix);GO:0070483(detection of hypoxia);GO:1904706(negative regulation of vascular smooth muscle cell proliferation);GO:1905075(positive regulation of tight junction disassembly)","04010(MAPK signaling pathway);04060(Cytokine-cytokine receptor interaction);04068(FoxO signaling pathway);04110(Cell cycle);04218(Cellular senescence);04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05144(Malaria);05145(Toxoplasmosis);05146(Amoebiasis);05152(Tuberculosis);05161(Hepatitis B);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05210(Colorectal cancer);05211(Renal cell carcinoma);05212(Pancreatic cancer);05220(Chronic myeloid leukemia);05225(Hepatocellular carcinoma);05226(Gastric cancer);05321(Inflammatory bowel disease (IBD));05323(Rheumatoid arthritis);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","K13377","NA","transforming growth factor beta 3 [Source:NCBI gene;Acc:554323]",{"v":1.36162925248661,"d":"1.36"},{"v":0.857377686814588,"d":"0.86"},{"v":1.46118631369549,"d":"1.46"},{"v":1.29144497679163,"d":"1.29"},{"v":1.467606,"d":"1.47"},{"v":1.13747718005611,"d":"1.14"},{"v":0.944480087107579,"d":"0.94"},{"v":-0.0824077149322544,"d":"-0.08"},{"v":0.994767925084392,"d":"0.99"},1,"down","no"]
["MSTRG.14861","KLF11","ENSOART00000016669","GO:0000083(regulation of transcription involved in G1/S transition of mitotic cell cycle);GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0008285(negative regulation of cell population proliferation);GO:0016604(nuclear body);GO:0043065(positive regulation of apoptotic process);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-templated)","NA","K09209","NA","Kruppel like factor 11 [Source:NCBI gene;Acc:101117833]",{"v":10.808894,"d":"10.81"},{"v":11.318902,"d":"11.32"},{"v":10.994001,"d":"10.99"},{"v":9.462173,"d":"9.46"},{"v":13.399464,"d":"13.40"},{"v":12.116377,"d":"12.12"},{"v":0.946931892702656,"d":"0.95"},{"v":-0.0786674301162013,"d":"-0.08"},{"v":0.995600302498942,"d":"1.00"},1,"down","no"]
["MSTRG.14712","TOR1B","ENSOART00000009258","GO:0005524(ATP binding);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0007029(endoplasmic reticulum organization);GO:0016887(ATPase activity);GO:0051260(protein homooligomerization);GO:0071763(nuclear membrane organization)","NA","K22990","NA","torsin family 1 member B [Source:NCBI gene;Acc:101103637]",{"v":1.62190469945355,"d":"1.62"},{"v":1.72765649271403,"d":"1.73"},{"v":1.57176130418944,"d":"1.57"},{"v":2.093938571949,"d":"2.09"},{"v":1.49331026867031,"d":"1.49"},{"v":1.67755178415301,"d":"1.68"},{"v":0.934759518375845,"d":"0.93"},{"v":-0.0973328381981806,"d":"-0.10"},{"v":0.99668330555137,"d":"1.00"},1,"down","no"]
["MSTRG.20199","GPATCH2L","ENSOART00000002272;ENSOART00000002275","NA","NA","K17569","NA","G-patch domain containing 2 like [Source:NCBI gene;Acc:101112322]",{"v":2.59331370984176,"d":"2.59"},{"v":2.06014383199473,"d":"2.06"},{"v":2.35190913222249,"d":"2.35"},{"v":2.98380770145049,"d":"2.98"},{"v":2.66265142268041,"d":"2.66"},{"v":1.84061715032366,"d":"1.84"},{"v":0.935661186992425,"d":"0.94"},{"v":-0.0959418859501661,"d":"-0.10"},{"v":0.997535003744776,"d":"1.00"},1,"down","no"]
["ENSOARG00000003862","PHLPP2","ENSOART00000004200","GO:0003824(catalytic activity);GO:0005515(protein binding);GO:0005737(cytoplasm)","04151(PI3K-Akt signaling pathway)","K16340","EC:3.1.3.16","PH domain and leucine rich repeat protein phosphatase 2 [Source:NCBI gene;Acc:101104420]",{"v":1.285345,"d":"1.29"},{"v":1.137466,"d":"1.14"},{"v":1.464658,"d":"1.46"},{"v":1.235979,"d":"1.24"},{"v":1.613916,"d":"1.61"},{"v":1.264969,"d":"1.26"},{"v":0.94473814930457,"d":"0.94"},{"v":-0.0820135783026372,"d":"-0.08"},{"v":0.997747543243534,"d":"1.00"},1,"down","no"]
["MSTRG.17550","ENSOARG00000009936","ENSOART00000010815","GO:0005829(cytosol);GO:0008022(protein C-terminus binding);GO:0014069(postsynaptic density);GO:0019904(protein domain specific binding);GO:0045178(basal part of cell);GO:0098962(regulation of postsynaptic neurotransmitter receptor activity);GO:0098978(glutamatergic synapse)","04068(FoxO signaling pathway);04724(Glutamatergic synapse)","K15010","NA","homer scaffold protein 3 [Source:NCBI gene;Acc:101106936]",{"v":4.86297628199792,"d":"4.86"},{"v":3.35806614099896,"d":"3.36"},{"v":3.85062387903226,"d":"3.85"},{"v":3.3077032198231,"d":"3.31"},{"v":4.69288875728408,"d":"4.69"},{"v":4.60960277419355,"d":"4.61"},{"v":0.957294200455069,"d":"0.96"},{"v":-0.0629657257558716,"d":"-0.06"},{"v":0.998670855943285,"d":"1.00"},1,"down","no"]
["MSTRG.12949","MYOM1","ENSOART00000011131","GO:0005515(protein binding);GO:0006936(muscle contraction);GO:0010628(positive regulation of gene expression);GO:0010737(protein kinase A signaling);GO:0019900(kinase binding);GO:0030017(sarcomere);GO:0031430(M band);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0050714(positive regulation of protein secretion)","NA","NA","NA","myomesin 1 [Source:NCBI gene;Acc:101104877]",{"v":205.462332946059,"d":"205.46"},{"v":211.883539376816,"d":"211.88"},{"v":179.329597464297,"d":"179.33"},{"v":223.776211823184,"d":"223.78"},{"v":206.590329810046,"d":"206.59"},{"v":203.492700311901,"d":"203.49"},{"v":0.941337493094125,"d":"0.94"},{"v":-0.0872160368432893,"d":"-0.09"},{"v":0.998821802235353,"d":"1.00"},1,"down","no"]
["MSTRG.19374","ENSOARG00000011611","ENSOART00000012627","GO:0003677(DNA binding);GO:0005634(nucleus)","NA","NA","NA","high mobility group protein B1 pseudogene [Source:NCBI gene;Acc:101111968]",{"v":1.656746,"d":"1.66"},{"v":1.234527,"d":"1.23"},{"v":1.100601,"d":"1.10"},{"v":1.896851,"d":"1.90"},{"v":1.486927,"d":"1.49"},{"v":0.895158,"d":"0.90"},{"v":0.93291276149024,"d":"0.93"},{"v":-0.100185916757663,"d":"-0.10"},{"v":0.999999999999999,"d":"1.00"},1,"down","no"]
["MSTRG.14125","RF00026","ENSOART00000023351","NA","NA","NA","NA","RNA, U6 small nuclear 718, pseudogene [Source:HGNC Symbol;Acc:HGNC:47681]",{"v":0.107595,"d":"0.11"},{"v":0.075843,"d":"0.08"},{"v":0.255323,"d":"0.26"},{"v":0.287157,"d":"0.29"},{"v":0.06624,"d":"0.07"},0,{"v":1.24155270135287,"d":"1.24"},{"v":0.312145502245088,"d":"0.31"},1,1,"up","no"]
["ENSOARG00000007988","PLD4","ENSOART00000008697","GO:0002244(hematopoietic progenitor cell differentiation);GO:0003824(catalytic activity);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0006909(phagocytosis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032588(trans-Golgi network membrane);GO:0045335(phagocytic vesicle)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism)","K16860","EC:3.1.4.4","phospholipase D family member 4 [Source:NCBI gene;Acc:101104691]",{"v":0.04432,"d":"0.04"},0,{"v":0.056525,"d":"0.06"},{"v":0.147146,"d":"0.15"},0,{"v":0.10283,"d":"0.10"},{"v":0.403418728197907,"d":"0.40"},{"v":-1.30965003411182,"d":"-1.31"},1,1,"down","no"]
["ENSOARG00000017826","CAMKK1","ENSOART00000019393","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation)","05034(Alcoholism)","K00908","EC:2.7.11.17","calcium/calmodulin dependent protein kinase kinase 1 [Source:NCBI gene;Acc:101102157]",{"v":0.05214,"d":"0.05"},{"v":0.202773,"d":"0.20"},{"v":0.327846,"d":"0.33"},{"v":0.191219,"d":"0.19"},{"v":0.186076,"d":"0.19"},{"v":0.144613,"d":"0.14"},{"v":1.11659334595369,"d":"1.12"},{"v":0.159103863892319,"d":"0.16"},1,1,"up","no"]
["MSTRG.12006","ENSOARG00000024938","ENSOART00000026840","NA","NA","NA","NA",null,{"v":0.372445,"d":"0.37"},{"v":0.546659,"d":"0.55"},0,{"v":0.088255,"d":"0.09"},{"v":0.462265,"d":"0.46"},{"v":0.107087,"d":"0.11"},{"v":1.39764935592231,"d":"1.40"},{"v":0.48300246091101,"d":"0.48"},1,1,"up","no"]
["ENSOARG00000001186","ENSOARG00000001186","ENSOART00000001269","GO:0005044(scavenger receptor activity);GO:0006898(receptor-mediated endocytosis);GO:0016020(membrane)","NA","NA","NA",null,0,0,{"v":0.006952,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000001305","HTR1F","ENSOART00000001393","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0051378(serotonin binding);GO:0098664(G protein-coupled serotonin receptor signaling pathway)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse);04742(Taste transduction)","K04153","NA","5-hydroxytryptamine receptor 1F [Source:NCBI gene;Acc:101121647]",{"v":0.031798,"d":"0.03"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000019260","GCSAM","ENSOART00000020974","GO:0003779(actin binding);GO:0019901(protein kinase binding);GO:0045159(myosin II binding);GO:0050855(regulation of B cell receptor signaling pathway);GO:2000401(regulation of lymphocyte migration);GO:2000402(negative regulation of lymphocyte migration)","NA","NA","NA","germinal center associated signaling and motility [Source:NCBI gene;Acc:101120459]",{"v":0.0073342972027972,"d":"0.01"},{"v":0.204386339160839,"d":"0.20"},0,0,0,{"v":0.237613762237762,"d":"0.24"},{"v":0.891028509332652,"d":"0.89"},{"v":-0.166456501956296,"d":"-0.17"},1,1,"down","no"]
["ENSOARG00000020608","DNER","ENSOART00000022451","GO:0005112(Notch binding);GO:0005509(calcium ion binding);GO:0005769(early endosome);GO:0005886(plasma membrane);GO:0007220(Notch receptor processing);GO:0007417(central nervous system development);GO:0010001(glial cell differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0048741(skeletal muscle fiber development)","NA","NA","NA","delta/notch like EGF repeat containing [Source:HGNC Symbol;Acc:HGNC:24456]",{"v":0.07226,"d":"0.07"},{"v":0.016321,"d":"0.02"},0,{"v":0.073734,"d":"0.07"},{"v":0.390991,"d":"0.39"},{"v":0.326341,"d":"0.33"},{"v":0.111976750359641,"d":"0.11"},{"v":-3.1587288770935,"d":"-3.16"},1,1,"down","no"]
["MSTRG.11054","PADI6","ENSOART00000011966","GO:0004668(protein-arginine deiminase activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0007010(cytoskeleton organization);GO:0007028(cytoplasm organization);GO:0018101(protein citrullination);GO:0034613(cellular protein localization);GO:0043143(regulation of translation by machinery localization);GO:0045111(intermediate filament cytoskeleton)","NA","K01481","EC:3.5.3.15","peptidyl arginine deiminase 6 [Source:NCBI gene;Acc:101107679]",0,0,0,0,{"v":0.016369,"d":"0.02"},{"v":0.011576,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["MSTRG.18180","FSTL4","ENSOART00000014815","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0030141(secretory granule);GO:0031549(negative regulation of brain-derived neurotrophic factor receptor signaling pathway);GO:0048403(brain-derived neurotrophic factor binding);GO:0048670(regulation of collateral sprouting);GO:0048671(negative regulation of collateral sprouting);GO:0061000(negative regulation of dendritic spine development)","NA","NA","NA","follistatin like 4 [Source:NCBI gene;Acc:101123036]",{"v":0.1137,"d":"0.11"},{"v":0.152259,"d":"0.15"},{"v":0.081517,"d":"0.08"},{"v":0.026591,"d":"0.03"},{"v":0.105801,"d":"0.11"},{"v":0.090836,"d":"0.09"},{"v":1.55659684268998,"d":"1.56"},{"v":0.638395335960561,"d":"0.64"},1,1,"up","no"]
["MSTRG.19500","RF00015","ENSOART00000026160","NA","NA","NA","NA",null,{"v":0.143184,"d":"0.14"},{"v":0.183946,"d":"0.18"},{"v":0.148111,"d":"0.15"},0,{"v":0.680918,"d":"0.68"},0,{"v":0.697941602366217,"d":"0.70"},{"v":-0.518821765474225,"d":"-0.52"},1,1,"down","no"]
["ENSOARG00000024437","RF00322","ENSOART00000026339","NA","NA","NA","NA",null,{"v":0.105371,"d":"0.11"},0,0,{"v":0.029332,"d":"0.03"},0,0,{"v":3.59235647074867,"d":"3.59"},{"v":1.84493051629968,"d":"1.84"},1,1,"up","no"]
["ENSOARG00000010694","ENSOARG00000010694","ENSOART00000011635","NA","NA","NA","NA","kelch domain containing 7A [Source:NCBI gene;Acc:101110125]",0,{"v":0.01045,"d":"0.01"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000015803","ENSOARG00000015803","ENSOART00000017205","GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0016758(transferase activity, transferring hexosyl groups)","NA","NA","NA",null,{"v":0.127409,"d":"0.13"},{"v":0.098567,"d":"0.10"},{"v":0.049646,"d":"0.05"},{"v":0.089025,"d":"0.09"},{"v":0.151957,"d":"0.15"},{"v":0.145827,"d":"0.15"},{"v":0.712553223942566,"d":"0.71"},{"v":-0.488930315038165,"d":"-0.49"},1,1,"down","no"]
["MSTRG.8800","ENSOARG00000003166","ENSOART00000003435","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding);GO:0016032(viral process);GO:0019068(virion assembly)","NA","NA","NA",null,{"v":0.467165,"d":"0.47"},{"v":0.125251,"d":"0.13"},{"v":0.135816,"d":"0.14"},{"v":0.433729,"d":"0.43"},{"v":0.209344,"d":"0.21"},{"v":0.350232,"d":"0.35"},{"v":0.733140374809348,"d":"0.73"},{"v":-0.447838636430114,"d":"-0.45"},1,1,"down","no"]
["ENSOARG00000007309","MON1B","ENSOART00000007951","GO:0005737(cytoplasm);GO:0019085(early viral transcription);GO:0019086(late viral transcription);GO:0035658(Mon1-Ccz1 complex)","NA","K20195","NA","MON1 homolog B, secretory trafficking associated [Source:NCBI gene;Acc:101118722]",{"v":0.2714,"d":"0.27"},{"v":0.239857,"d":"0.24"},{"v":0.322997,"d":"0.32"},{"v":0.217483,"d":"0.22"},{"v":0.436403,"d":"0.44"},{"v":0.225782,"d":"0.23"},{"v":0.948373704624927,"d":"0.95"},{"v":-0.0764724328404665,"d":"-0.08"},1,1,"down","no"]
["ENSOARG00000004226","NRXN1","ENSOART00000004600","GO:0005246(calcium channel regulator activity);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0007268(chemical synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0007416(synapse assembly);GO:0007612(learning);GO:0009986(cell surface);GO:0030534(adult behavior);GO:0031965(nuclear membrane);GO:0031982(vesicle);GO:0032991(protein-containing complex);GO:0033130(acetylcholine receptor binding);GO:0035176(social behavior);GO:0042297(vocal learning);GO:0042734(presynaptic membrane);GO:0043025(neuronal cell body);GO:0050839(cell adhesion molecule binding);GO:0050885(neuromuscular process controlling balance);GO:0051965(positive regulation of synapse assembly);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060134(prepulse inhibition);GO:0071625(vocalization behavior);GO:0090129(positive regulation of synapse maturation);GO:0097104(postsynaptic membrane assembly);GO:0097109(neuroligin family protein binding);GO:0097116(gephyrin clustering involved in postsynaptic density assembly);GO:0097118(neuroligin clustering involved in postsynaptic membrane assembly);GO:0097119(postsynaptic density protein 95 clustering);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098693(regulation of synaptic vesicle cycle);GO:0098978(glutamatergic synapse);GO:0098982(GABA-ergic synapse);GO:0099056(integral component of presynaptic membrane);GO:0099059(integral component of presynaptic active zone membrane);GO:0099150(regulation of postsynaptic specialization assembly);GO:0099151(regulation of postsynaptic density assembly);GO:0099542(trans-synaptic signaling by endocannabinoid);GO:0099560(synaptic membrane adhesion);GO:1905606(regulation of presynapse assembly);GO:2000463(positive regulation of excitatory postsynaptic potential);GO:2000821(regulation of grooming behavior)","NA","NA","NA","neurexin 1 [Source:HGNC Symbol;Acc:HGNC:8008]",{"v":0.095495,"d":"0.10"},{"v":0.036251,"d":"0.04"},{"v":0.020468,"d":"0.02"},{"v":0.028332,"d":"0.03"},{"v":0.106203,"d":"0.11"},{"v":0.110455,"d":"0.11"},{"v":0.621306992122127,"d":"0.62"},{"v":-0.686621804581455,"d":"-0.69"},1,1,"down","no"]
["ENSOARG00000015310","HPGD","ENSOART00000016662","GO:0003824(catalytic activity);GO:0004957(prostaglandin E receptor activity);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006693(prostaglandin metabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007565(female pregnancy);GO:0007567(parturition);GO:0016323(basolateral plasma membrane);GO:0016404(15-hydroxyprostaglandin dehydrogenase (NAD+) activity);GO:0016491(oxidoreductase activity);GO:0045786(negative regulation of cell cycle);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process);GO:0070403(NAD+ binding);GO:0097070(ductus arteriosus closure)","05202(Transcriptional misregulation in cancer)","K00069","EC:1.1.1.141","15-hydroxyprostaglandin dehydrogenase [Source:NCBI gene;Acc:101112958]",{"v":0.321539,"d":"0.32"},{"v":0.247853,"d":"0.25"},{"v":0.486049,"d":"0.49"},{"v":0.369228,"d":"0.37"},{"v":0.831736,"d":"0.83"},{"v":0.419512,"d":"0.42"},{"v":0.651315415964198,"d":"0.65"},{"v":-0.618571720705254,"d":"-0.62"},1,1,"down","no"]
["ENSOARG00000021545","RF00020","ENSOART00000023447","NA","NA","NA","NA",null,0,0,0,{"v":0.204386,"d":"0.20"},{"v":0.200971,"d":"0.20"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.1160","RF00100","ENSOART00000026875","NA","NA","NA","NA",null,0,0,0,{"v":0.157077,"d":"0.16"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000010705","ENSOARG00000010705","ENSOART00000011645","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,{"v":0.039908,"d":"0.04"},{"v":0.064899,"d":"0.06"},{"v":0.047314,"d":"0.05"},{"v":0.047245,"d":"0.05"},{"v":0.046416,"d":"0.05"},{"v":0.743443873027132,"d":"0.74"},{"v":-0.427704266075635,"d":"-0.43"},1,1,"down","no"]
["ENSOARG00000012258","HSD17B14","ENSOART00000013328","GO:0004303(estradiol 17-beta-dehydrogenase activity);GO:0005829(cytosol);GO:0006706(steroid catabolic process);GO:0016491(oxidoreductase activity);GO:0042802(identical protein binding);GO:0047045(testosterone 17-beta-dehydrogenase (NADP+) activity);GO:0055114(oxidation-reduction process)","NA","NA","NA","hydroxysteroid 17-beta dehydrogenase 14 [Source:NCBI gene;Acc:101123575]",{"v":0.07201,"d":"0.07"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.13680","ENSOARG00000017830","ENSOART00000019398","GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0016790(thiolester hydrolase activity);GO:0071567(UFM1 hydrolase activity)","NA","NA","NA","UFM1 specific peptidase 1 (inactive) [Source:NCBI gene;Acc:101123261]",{"v":0.491463,"d":"0.49"},{"v":0.842299,"d":"0.84"},{"v":0.959756,"d":"0.96"},{"v":1.061701,"d":"1.06"},{"v":0.785568,"d":"0.79"},{"v":1.022759,"d":"1.02"},{"v":0.799127395272799,"d":"0.80"},{"v":-0.323502581874781,"d":"-0.32"},1,1,"down","no"]
["MSTRG.7987","RF00105","ENSOART00000024575","NA","NA","NA","NA",null,0,0,0,{"v":0.039769,"d":"0.04"},{"v":0.030212,"d":"0.03"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.7877","ENSOARG00000013508","ENSOART00000014690","NA","NA","NA","NA",null,{"v":0.076453,"d":"0.08"},{"v":0.085507,"d":"0.09"},{"v":0.036285,"d":"0.04"},{"v":0.100616,"d":"0.10"},{"v":0.155131,"d":"0.16"},{"v":0.184114,"d":"0.18"},{"v":0.450699198155781,"d":"0.45"},{"v":-1.14976321154744,"d":"-1.15"},1,1,"down","no"]
["MSTRG.9337","ENSOARG00000005250","ENSOART00000005728","GO:0004447(iodide peroxidase activity);GO:0004601(peroxidase activity);GO:0006590(thyroid hormone generation);GO:0006979(response to oxidative stress);GO:0016021(integral component of membrane);GO:0020037(heme binding);GO:0055114(oxidation-reduction process);GO:0098869(cellular oxidant detoxification)","NA","NA","NA",null,{"v":0.059238,"d":"0.06"},{"v":0.134975,"d":"0.13"},{"v":0.229598,"d":"0.23"},{"v":0.271444,"d":"0.27"},{"v":1.157552,"d":"1.16"},{"v":0.550544,"d":"0.55"},{"v":0.214095699000778,"d":"0.21"},{"v":-2.22367228138054,"d":"-2.22"},1,1,"down","no"]
["ENSOARG00000009960","PAK5","ENSOART00000010841","GO:0000166(nucleotide binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0007010(cytoskeleton organization);GO:0007612(learning);GO:0007613(memory);GO:0007626(locomotory behavior);GO:0016049(cell growth);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0045202(synapse);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04012(ErbB signaling pathway);04014(Ras signaling pathway);04360(Axon guidance);04510(Focal adhesion);04660(T cell receptor signaling pathway);04810(Regulation of actin cytoskeleton);05170(Human immunodeficiency virus 1 infection);05211(Renal cell carcinoma)","K05736","EC:2.7.11.1","p21 (RAC1) activated kinase 5 [Source:NCBI gene;Acc:101107882]",0,0,0,0,0,{"v":0.028793,"d":"0.03"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000009674","ENSOARG00000009674","ENSOART00000010535","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00062(Fatty acid elongation);00140(Steroid hormone biosynthesis);01040(Biosynthesis of unsaturated fatty acids)","K10251","1.1.1.330;EC:1.1.1.62","Ovis aries estradiol 17-beta-dehydrogenase 12-B-like (LOC101112590), mRNA. [Source:RefSeq mRNA;Acc:NM_001306107]",{"v":0.099621,"d":"0.10"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000012948","FHL2","ENSOART00000014074","GO:0001649(osteoblast differentiation);GO:0005634(nucleus);GO:0006357(regulation of transcription by RNA polymerase II);GO:0030018(Z disc);GO:0045892(negative regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0055014(atrial cardiac muscle cell development);GO:0055015(ventricular cardiac muscle cell development);GO:0060347(heart trabecula formation);GO:0070885(negative regulation of calcineurin-NFAT signaling cascade)","04380(Osteoclast differentiation)","K14380","NA","four and a half LIM domains 2 [Source:NCBI gene;Acc:101122510]",{"v":0.299666,"d":"0.30"},{"v":0.10173,"d":"0.10"},{"v":0.167553,"d":"0.17"},{"v":0.446543,"d":"0.45"},{"v":0.458705,"d":"0.46"},{"v":0.259104,"d":"0.26"},{"v":0.488640033254548,"d":"0.49"},{"v":-1.0331560294569,"d":"-1.03"},1,1,"down","no"]
["MSTRG.11709","RF00003","ENSOART00000025263","NA","NA","NA","NA",null,{"v":0.11426,"d":"0.11"},{"v":0.133007,"d":"0.13"},0,0,0,{"v":0.08257,"d":"0.08"},{"v":2.99463485527431,"d":"2.99"},{"v":1.582380101645,"d":"1.58"},1,1,"up","no"]
["ENSOARG00000018576","ENSOARG00000018576","ENSOART00000020216","NA","NA","NA","NA",null,{"v":0.04576,"d":"0.05"},0,0,{"v":0.232925,"d":"0.23"},0,0,{"v":0.196458087367178,"d":"0.20"},{"v":-2.34770653607847,"d":"-2.35"},1,1,"down","no"]
["ENSOARG00000008558","BCO1","ENSOART00000009317","GO:0001523(retinoid metabolic process);GO:0003834(beta-carotene 15,15'-monooxygenase activity);GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen);GO:0042574(retinal metabolic process);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:1901810(beta-carotene metabolic process)","00830(Retinol metabolism)","K00515","EC:1.13.11.63","Ovis aries beta-carotene oxygenase 1 (BCO1), mRNA. [Source:RefSeq mRNA;Acc:NM_001308571]",{"v":0.065463,"d":"0.07"},0,{"v":0.052135,"d":"0.05"},0,{"v":0.020257,"d":"0.02"},0,{"v":5.80530187095819,"d":"5.81"},{"v":2.53737108800577,"d":"2.54"},1,1,"up","no"]
["MSTRG.8009","RF00108","ENSOART00000025128","NA","NA","NA","NA",null,{"v":0.798958,"d":"0.80"},{"v":0.971099,"d":"0.97"},{"v":0.809447,"d":"0.81"},{"v":0.682544,"d":"0.68"},{"v":0.868227,"d":"0.87"},{"v":0.468256,"d":"0.47"},{"v":1.27759757546581,"d":"1.28"},{"v":0.35343348001991,"d":"0.35"},1,1,"up","no"]
["MSTRG.3527","CCDC40","ENSOART00000002623","GO:0001947(heart looping);GO:0003341(cilium movement);GO:0003351(epithelial cilium movement);GO:0003356(regulation of cilium beat frequency);GO:0005737(cytoplasm);GO:0005929(cilium);GO:0005930(axoneme);GO:0030317(flagellated sperm motility);GO:0030324(lung development);GO:0031514(motile cilium);GO:0035082(axoneme assembly);GO:0035469(determination of pancreatic left/right asymmetry);GO:0036159(inner dynein arm assembly);GO:0044458(motile cilium assembly);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0061512(protein localization to cilium);GO:0070286(axonemal dynein complex assembly);GO:0071907(determination of digestive tract left/right asymmetry);GO:0071910(determination of liver left/right asymmetry)","NA","NA","NA","coiled-coil domain containing 40 [Source:NCBI gene;Acc:101110430]",{"v":0.006546,"d":"0.01"},{"v":0.056675,"d":"0.06"},{"v":0.112538,"d":"0.11"},{"v":0.008098,"d":"0.01"},{"v":0.019929,"d":"0.02"},{"v":0.034328,"d":"0.03"},{"v":2.81868334536124,"d":"2.82"},{"v":1.49502141273031,"d":"1.50"},1,1,"up","no"]
["MSTRG.21137","ENSOARG00000022988","ENSOART00000024890","NA","NA","NA","NA",null,{"v":0.928562,"d":"0.93"},{"v":1.1754,"d":"1.18"},{"v":0.615476,"d":"0.62"},{"v":0.838423,"d":"0.84"},{"v":1.289755,"d":"1.29"},{"v":0.252173,"d":"0.25"},{"v":1.14245252065767,"d":"1.14"},{"v":0.192134209366434,"d":"0.19"},1,1,"up","no"]
["ENSOARG00000011019","CLCF1","ENSOART00000011983","GO:0002639(positive regulation of immunoglobulin production);GO:0005102(signaling receptor binding);GO:0005125(cytokine activity);GO:0005127(ciliary neurotrophic factor receptor binding);GO:0005576(extracellular region);GO:0007166(cell surface receptor signaling pathway);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0030183(B cell differentiation);GO:0030890(positive regulation of B cell proliferation);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043524(negative regulation of neuron apoptotic process);GO:0046982(protein heterodimerization activity);GO:0048295(positive regulation of isotype switching to IgE isotypes);GO:0048711(positive regulation of astrocyte differentiation);GO:0097058(CRLF-CLCF1 complex);GO:0097059(CNTFR-CLCF1 complex)","04060(Cytokine-cytokine receptor interaction)","K05421","NA","cardiotrophin like cytokine factor 1 [Source:NCBI gene;Acc:101108788]",{"v":0.131442,"d":"0.13"},{"v":0.13593,"d":"0.14"},{"v":0.256371,"d":"0.26"},{"v":0.059983,"d":"0.06"},{"v":0.097589,"d":"0.10"},{"v":0.215658,"d":"0.22"},{"v":1.40327144120248,"d":"1.40"},{"v":0.488794103041283,"d":"0.49"},1,1,"up","no"]
["ENSOARG00000014670","ENSOARG00000014670","ENSOART00000015970","NA","NA","NA","NA",null,{"v":0.04858,"d":"0.05"},{"v":0.145602,"d":"0.15"},{"v":0.094564,"d":"0.09"},{"v":0.057357,"d":"0.06"},{"v":0.285865,"d":"0.29"},{"v":0.080925,"d":"0.08"},{"v":0.680768695758782,"d":"0.68"},{"v":-0.55476339674703,"d":"-0.55"},1,1,"down","no"]
["ENSOARG00000015770","ENSOARG00000015770","ENSOART00000017167","NA","NA","NA","NA",null,{"v":0.170652,"d":"0.17"},0,0,{"v":0.191977,"d":"0.19"},{"v":0.148965,"d":"0.15"},{"v":0.204413,"d":"0.20"},{"v":0.312919107737162,"d":"0.31"},{"v":-1.67613833852655,"d":"-1.68"},1,1,"down","no"]
["ENSOARG00000016346","ENSOARG00000016346","ENSOART00000017798","GO:0005515(protein binding)","NA","NA","NA",null,{"v":0.447929,"d":"0.45"},{"v":0.073668,"d":"0.07"},{"v":0.10552,"d":"0.11"},{"v":0.271847,"d":"0.27"},{"v":0.035977,"d":"0.04"},{"v":0.053744,"d":"0.05"},{"v":1.73443722895831,"d":"1.73"},{"v":0.794467628972955,"d":"0.79"},1,1,"up","no"]
["MSTRG.10905","RF00026","ENSOART00000024289","NA","NA","NA","NA","RNA, U6 small nuclear 842, pseudogene [Source:HGNC Symbol;Acc:HGNC:47805]",{"v":0.639306,"d":"0.64"},{"v":1.849107,"d":"1.85"},{"v":0.909405,"d":"0.91"},{"v":0.295036,"d":"0.30"},{"v":0.901593,"d":"0.90"},{"v":0.599794,"d":"0.60"},{"v":1.89143536906397,"d":"1.89"},{"v":0.919481479890355,"d":"0.92"},1,1,"up","no"]
["ENSOARG00000003870","AOC2","ENSOART00000004204","GO:0005507(copper ion binding);GO:0007601(visual perception);GO:0008131(primary amine oxidase activity);GO:0009308(amine metabolic process);GO:0016491(oxidoreductase activity);GO:0046872(metal ion binding);GO:0048038(quinone binding);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism);00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00410(beta-Alanine metabolism)","K00276","EC:1.4.3.21","amine oxidase, copper containing 2 [Source:NCBI gene;Acc:101106783]",{"v":0.382639,"d":"0.38"},{"v":0.444378,"d":"0.44"},{"v":0.463434,"d":"0.46"},{"v":0.529504,"d":"0.53"},{"v":0.609871,"d":"0.61"},{"v":0.255711,"d":"0.26"},{"v":0.924997455354007,"d":"0.92"},{"v":-0.112478698072688,"d":"-0.11"},1,1,"down","no"]
["MSTRG.18285","RF00026","ENSOART00000024210","NA","NA","NA","NA",null,0,{"v":0.288268,"d":"0.29"},{"v":0.019719,"d":"0.02"},0,{"v":0.176948,"d":"0.18"},0,{"v":1.74055089630852,"d":"1.74"},{"v":0.79954400123673,"d":"0.80"},1,1,"up","no"]
["ENSOARG00000006707","TINAG","ENSOART00000007291","GO:0005044(scavenger receptor activity);GO:0005604(basement membrane);GO:0006508(proteolysis);GO:0006898(receptor-mediated endocytosis);GO:0006955(immune response);GO:0007155(cell adhesion);GO:0008234(cysteine-type peptidase activity);GO:0030247(polysaccharide binding)","NA","NA","NA","tubulointerstitial nephritis antigen [Source:NCBI gene;Acc:101108430]",{"v":0.234276,"d":"0.23"},0,{"v":0.053043,"d":"0.05"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.19214","ENSOARG00000013314","ENSOART00000014480","NA","NA","NA","NA",null,0,0,0,0,{"v":0.121071,"d":"0.12"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000012215","CPLANE2","ENSOART00000013284","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005654(nucleoplasm)","NA","NA","NA","ciliogenesis and planar polarity effector 2 [Source:HGNC Symbol;Acc:HGNC:28127]",{"v":0.692179,"d":"0.69"},{"v":0.282833,"d":"0.28"},{"v":0.473763,"d":"0.47"},{"v":1.341915,"d":"1.34"},{"v":1.251462,"d":"1.25"},{"v":1.07812,"d":"1.08"},{"v":0.394600622035099,"d":"0.39"},{"v":-1.34153486460834,"d":"-1.34"},1,1,"down","no"]
["ENSOARG00000024094","RF00026","ENSOART00000025996","NA","NA","NA","NA","RNA, U6 small nuclear 812, pseudogene [Source:HGNC Symbol;Acc:HGNC:47775]",{"v":0.243656,"d":"0.24"},0,0,{"v":0.217593,"d":"0.22"},0,0,{"v":1.11977866935058,"d":"1.12"},{"v":0.163213603546073,"d":"0.16"},1,1,"up","no"]
["ENSOARG00000006016","MPP3","ENSOART00000006546","GO:0005515(protein binding)","NA","NA","NA","membrane palmitoylated protein 3 [Source:NCBI gene;Acc:101111034]",{"v":0.102785,"d":"0.10"},0,0,{"v":0.125784,"d":"0.13"},{"v":0.085535,"d":"0.09"},{"v":0.062035,"d":"0.06"},{"v":0.376014252580902,"d":"0.38"},{"v":-1.41114074751082,"d":"-1.41"},1,1,"down","no"]
["ENSOARG00000024473","ENSOARG00000024473","ENSOART00000026375","NA","NA","NA","NA",null,0,0,0,{"v":0.128852,"d":"0.13"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000021561","RF00408","ENSOART00000023463","NA","NA","NA","NA",null,{"v":0.042302,"d":"0.04"},0,0,0,{"v":0.272863,"d":"0.27"},0,{"v":0.15503017998043,"d":"0.16"},{"v":-2.68937900022802,"d":"-2.69"},1,1,"down","no"]
["MSTRG.8543","oar-mir-381","ENSOART00000025981","NA","NA","NA","NA","oar-mir-381 [Source:miRBase;Acc:MI0016940]",{"v":0.479135,"d":"0.48"},{"v":1.589551,"d":"1.59"},{"v":1.583439,"d":"1.58"},{"v":1.770713,"d":"1.77"},{"v":2.230839,"d":"2.23"},{"v":1.837118,"d":"1.84"},{"v":0.625506322501528,"d":"0.63"},{"v":-0.676903627929517,"d":"-0.68"},1,1,"down","no"]
["MSTRG.6344","C1QTNF5","ENSOART00000016781","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0009306(protein secretion);GO:0016020(membrane);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0030133(transport vesicle);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0048839(inner ear development);GO:0070206(protein trimerization)","NA","NA","NA","C1q and TNF related 5 [Source:HGNC Symbol;Acc:HGNC:14344]",{"v":0.147582447548291,"d":"0.15"},{"v":0.190611287072808,"d":"0.19"},{"v":0.216631093907875,"d":"0.22"},{"v":0.207737465973254,"d":"0.21"},{"v":0.216229775928678,"d":"0.22"},{"v":0.268306272213967,"d":"0.27"},{"v":0.801453207750609,"d":"0.80"},{"v":-0.319309802725606,"d":"-0.32"},1,1,"down","no"]
["ENSOARG00000018367","KIF1A","ENSOART00000019997","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0042802(identical protein binding)","NA","K10392","NA","kinesin family member 1A [Source:NCBI gene;Acc:101103691]",{"v":0.082602,"d":"0.08"},{"v":0.05852,"d":"0.06"},{"v":0.021617,"d":"0.02"},{"v":0.051326,"d":"0.05"},{"v":0.085757,"d":"0.09"},{"v":0.120789,"d":"0.12"},{"v":0.631084413972824,"d":"0.63"},{"v":-0.664095101605511,"d":"-0.66"},1,1,"down","no"]
["MSTRG.9281","ENSOARG00000023476","ENSOART00000025378","NA","NA","NA","NA",null,{"v":0.015715,"d":"0.02"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000017532","ENSOARG00000017532","ENSOART00000019084","NA","NA","NA","NA",null,0,0,0,0,{"v":0.02216,"d":"0.02"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.21499","RF00026","ENSOART00000023940","NA","NA","NA","NA",null,{"v":0.124148,"d":"0.12"},{"v":0.105873,"d":"0.11"},{"v":0.496461,"d":"0.50"},{"v":0.480487,"d":"0.48"},0,0,{"v":1.51197014695507,"d":"1.51"},{"v":0.596429654595321,"d":"0.60"},1,1,"up","no"]
["ENSOARG00000020388","MCHR1","ENSOART00000022199","GO:0004930(G protein-coupled receptor activity);GO:0005102(signaling receptor binding);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030273(melanin-concentrating hormone receptor activity);GO:0060170(ciliary membrane);GO:0097730(non-motile cilium)","04080(Neuroactive ligand-receptor interaction)","K04320","NA","melanin concentrating hormone receptor 1 [Source:NCBI gene;Acc:101108822]",{"v":0.129879,"d":"0.13"},{"v":0.092485,"d":"0.09"},{"v":0.088308,"d":"0.09"},{"v":0.141662,"d":"0.14"},{"v":0.106203,"d":"0.11"},{"v":0.350977,"d":"0.35"},{"v":0.518787927366484,"d":"0.52"},{"v":-0.946783187639998,"d":"-0.95"},1,1,"down","no"]
["ENSOARG00000007274","CYP2B6","ENSOART00000007923","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0006805(xenobiotic metabolic process);GO:0008202(steroid metabolic process);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0017144(drug metabolic process);GO:0020037(heme binding);GO:0042180(cellular ketone metabolic process);GO:0042738(exogenous drug catabolic process);GO:0055114(oxidation-reduction process)","NA","NA","NA","cytochrome P450 family 2 subfamily B member 6 [Source:HGNC Symbol;Acc:HGNC:2615]",{"v":0.08515,"d":"0.09"},{"v":0.057009,"d":"0.06"},{"v":0.141888,"d":"0.14"},{"v":0.010928,"d":"0.01"},0,0,{"v":25.9925878477306,"d":"25.99"},{"v":4.70002837199209,"d":"4.70"},1,1,"up","no"]
["ENSOARG00000007454","KCNG3","ENSOART00000008118","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005251(delayed rectifier potassium channel activity);GO:0005267(potassium channel activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA","K04902","NA","potassium voltage-gated channel modifier subfamily G member 3 [Source:NCBI gene;Acc:101115443]",{"v":0.135328,"d":"0.14"},0,{"v":0.027548,"d":"0.03"},{"v":0.119489,"d":"0.12"},{"v":0.221897,"d":"0.22"},{"v":0.054921,"d":"0.05"},{"v":0.410984413598549,"d":"0.41"},{"v":-1.28284441351196,"d":"-1.28"},1,1,"down","no"]
["ENSOARG00000007987","GZMK","ENSOART00000008693","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016787(hydrolase activity)","NA","K08663","EC:3.4.21.-","granzyme K [Source:NCBI gene;Acc:101117363]",{"v":0.154897,"d":"0.15"},0,{"v":0.084804,"d":"0.08"},0,0,{"v":0.175845,"d":"0.18"},{"v":1.36313799084421,"d":"1.36"},{"v":0.446931613962559,"d":"0.45"},1,1,"up","no"]
["ENSOARG00000007770","TMPRSS11D","ENSOART00000008456","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity)","NA","K09641","EC:3.4.21.-","transmembrane serine protease 11D [Source:NCBI gene;Acc:101120751]",0,{"v":0.005333,"d":"0.01"},{"v":0.011887,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000008833","ENSOARG00000008833","ENSOART00000009614","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,0,0,0,{"v":0.078021,"d":"0.08"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017419","PROKR2","ENSOART00000018960","GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007623(circadian rhythm);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K08380","NA","prokineticin receptor 2 [Source:NCBI gene;Acc:101114889]",0,0,{"v":0.075162,"d":"0.08"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000014187","ENSOARG00000014187","ENSOART00000015455","GO:0003676(nucleic acid binding);GO:0005198(structural molecule activity);GO:0008270(zinc ion binding);GO:0016032(viral process)","NA","NA","NA",null,{"v":0.134491,"d":"0.13"},{"v":0.505361,"d":"0.51"},{"v":0.46932,"d":"0.47"},{"v":0.335879,"d":"0.34"},{"v":0.146056,"d":"0.15"},{"v":0.17176,"d":"0.17"},{"v":1.6967729598666,"d":"1.70"},{"v":0.762793535070454,"d":"0.76"},1,1,"up","no"]
["MSTRG.10103","SFT2D3","ENSOART00000021321","GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport)","NA","NA","NA","SFT2 domain containing 3 [Source:NCBI gene;Acc:101108631]",{"v":0.068456,"d":"0.07"},{"v":0.254724,"d":"0.25"},{"v":0.196419,"d":"0.20"},{"v":0.161768,"d":"0.16"},{"v":0.421706,"d":"0.42"},{"v":0.335052,"d":"0.34"},{"v":0.565687852058624,"d":"0.57"},{"v":-0.821921904925576,"d":"-0.82"},1,1,"down","no"]
["ENSOARG00000015535","JAKMIP3","ENSOART00000016900","GO:0008017(microtubule binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019900(kinase binding)","NA","NA","NA","Janus kinase and microtubule interacting protein 3 [Source:NCBI gene;Acc:101108708]",0,0,0,{"v":0.013753,"d":"0.01"},{"v":0.042496,"d":"0.04"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000023397","RF00026","ENSOART00000025299","NA","NA","NA","NA",null,{"v":0.283105,"d":"0.28"},0,{"v":0.124115,"d":"0.12"},{"v":0.174613,"d":"0.17"},{"v":0.235931,"d":"0.24"},{"v":0.038886,"d":"0.04"},{"v":0.906081035978907,"d":"0.91"},{"v":-0.142288010425152,"d":"-0.14"},1,1,"down","no"]
["ENSOARG00000004495","HELLS","ENSOART00000004892","GO:0000775(chromosome, centromeric region);GO:0001655(urogenital system development);GO:0003682(chromatin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005721(pericentric heterochromatin);GO:0006306(DNA methylation);GO:0006342(chromatin silencing);GO:0006346(methylation-dependent chromatin silencing);GO:0007275(multicellular organism development);GO:0010216(maintenance of DNA methylation);GO:0031508(pericentric heterochromatin assembly);GO:0043066(negative regulation of apoptotic process);GO:0046651(lymphocyte proliferation);GO:1990830(cellular response to leukemia inhibitory factor);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway)","NA","K19001","NA","helicase, lymphoid specific [Source:NCBI gene;Acc:101106217]",{"v":0.108839,"d":"0.11"},{"v":0.045381,"d":"0.05"},{"v":0.035268,"d":"0.04"},{"v":0.072938,"d":"0.07"},{"v":0.077763,"d":"0.08"},{"v":0.073991,"d":"0.07"},{"v":0.843323304790558,"d":"0.84"},{"v":-0.245842271787683,"d":"-0.25"},1,1,"down","no"]
["MSTRG.13250","KCTD5","ENSOART00000020337","GO:0005515(protein binding);GO:0005829(cytosol);GO:0042802(identical protein binding);GO:0044877(protein-containing complex binding);GO:0051260(protein homooligomerization)","NA","K21914","NA","potassium channel tetramerization domain containing 5 [Source:NCBI gene;Acc:101116367]",{"v":2.127556,"d":"2.13"},{"v":1.508905,"d":"1.51"},{"v":2.216731,"d":"2.22"},{"v":1.959467,"d":"1.96"},{"v":1.967763,"d":"1.97"},{"v":2.241536,"d":"2.24"},{"v":0.948843253253568,"d":"0.95"},{"v":-0.0757583178953986,"d":"-0.08"},1,1,"down","no"]
["MSTRG.5953","KCNC3","ENSOART00000015055","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0051262(protein tetramerization);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA","K04889","NA","potassium voltage-gated channel subfamily C member 3 [Source:NCBI gene;Acc:101116251]",{"v":0.214294,"d":"0.21"},{"v":0.090643,"d":"0.09"},{"v":0.135679,"d":"0.14"},{"v":0.303603,"d":"0.30"},{"v":0.333351,"d":"0.33"},{"v":0.09798,"d":"0.10"},{"v":0.599531386491848,"d":"0.60"},{"v":-0.738092811721846,"d":"-0.74"},1,1,"down","no"]
["ENSOARG00000005362","CATSPERE","ENSOART00000005847","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0036128(CatSper complex);GO:0097228(sperm principal piece)","NA","NA","NA","catsper channel auxiliary subunit epsilon [Source:NCBI gene;Acc:101107374]",0,0,0,0,0,{"v":0.006404,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["MSTRG.5770","ENSOARG00000008759","ENSOART00000009537;ENSOART00000009536","GO:0004859(phospholipase inhibitor activity);GO:0005576(extracellular region);GO:0043086(negative regulation of catalytic activity);GO:0043086(negative regulation of catalytic activity)","NA","NA","NA","phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein-like [Source:NCBI gene;Acc:101108413]",{"v":0.0775697267355982,"d":"0.08"},0,0,0,{"v":0.000856111521418021,"d":"0.00"},{"v":0.0762198234859675,"d":"0.08"},{"v":1.00640656163516,"d":"1.01"},{"v":0.00921323353775977,"d":"0.01"},1,1,"up","no"]
["ENSOARG00000013673","ENSOARG00000013673","ENSOART00000014880","GO:0003924(GTPase activity);GO:0005509(calcium ion binding);GO:0005525(GTP binding)","NA","NA","NA","RAB44, member RAS oncogene family [Source:NCBI gene;Acc:101102185]",{"v":0.007996,"d":"0.01"},0,0,{"v":0.016818,"d":"0.02"},{"v":0.042836,"d":"0.04"},{"v":0.044758,"d":"0.04"},{"v":0.0765812358732713,"d":"0.08"},{"v":-3.70686524708662,"d":"-3.71"},1,1,"down","no"]
["ENSOARG00000016997","ENSOARG00000016997","ENSOART00000018513","NA","NA","NA","NA",null,{"v":0.26653,"d":"0.27"},{"v":0.233473,"d":"0.23"},{"v":0.282244,"d":"0.28"},{"v":0.311332,"d":"0.31"},{"v":0.263142,"d":"0.26"},{"v":0.200495,"d":"0.20"},{"v":1.00939134339567,"d":"1.01"},{"v":0.0134856191576472,"d":"0.01"},1,1,"up","no"]
["ENSOARG00000010540","SV2B","ENSOART00000011470","GO:0005215(transporter activity);GO:0007268(chemical synaptic transmission);GO:0008021(synaptic vesicle);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","04512(ECM-receptor interaction)","K06258","NA","synaptic vesicle glycoprotein 2B [Source:NCBI gene;Acc:101120867]",0,{"v":0.03767,"d":"0.04"},0,{"v":0.02885,"d":"0.03"},{"v":0.011075,"d":"0.01"},{"v":0.026623,"d":"0.03"},{"v":0.566057582496844,"d":"0.57"},{"v":-0.820979275474861,"d":"-0.82"},1,1,"down","no"]
["ENSOARG00000018009","ENSOARG00000018009","ENSOART00000019606","NA","03008(Ribosome biogenesis in eukaryotes);03013(RNA transport);03015(mRNA surveillance pathway);05164(Influenza A)","K14285","NA","nuclear transport factor 2 like export factor 2 [Source:NCBI gene;Acc:105605624]",{"v":0.099346,"d":"0.10"},{"v":0.215505,"d":"0.22"},{"v":0.138075,"d":"0.14"},{"v":0.360719,"d":"0.36"},{"v":0.346393,"d":"0.35"},{"v":0.039805,"d":"0.04"},{"v":0.606394017005906,"d":"0.61"},{"v":-0.721672575676662,"d":"-0.72"},1,1,"down","no"]
["MSTRG.4830","TNFRSF6B","ENSOART00000011230","NA","04060(Cytokine-cytokine receptor interaction)","K05143","NA","TNF receptor superfamily member 6b [Source:NCBI gene;Acc:101117352]",{"v":0.194277,"d":"0.19"},{"v":0.288977,"d":"0.29"},{"v":0.172519,"d":"0.17"},{"v":0.18864,"d":"0.19"},{"v":0.412701,"d":"0.41"},{"v":0.26168,"d":"0.26"},{"v":0.759857523745077,"d":"0.76"},{"v":-0.396199161931023,"d":"-0.40"},1,1,"down","no"]
["ENSOARG00000009173","ENSOARG00000009173","ENSOART00000009985","NA","NA","NA","NA",null,0,{"v":0.010747,"d":"0.01"},{"v":0.024446,"d":"0.02"},0,{"v":0.02157,"d":"0.02"},0,{"v":1.63157162726008,"d":"1.63"},{"v":0.706262324251481,"d":"0.71"},1,1,"up","no"]
["ENSOARG00000022868","RF00619","ENSOART00000024770","NA","NA","NA","NA",null,0,0,0,0,{"v":0.066051,"d":"0.07"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.18122","FSTL3","ENSOART00000009964","GO:0001968(fibronectin binding);GO:0002244(hematopoietic progenitor cell differentiation);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription by RNA polymerase II);GO:0022409(positive regulation of cell-cell adhesion);GO:0030514(negative regulation of BMP signaling pathway);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0045671(negative regulation of osteoclast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048185(activin binding);GO:0090101(negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway)","NA","NA","NA","follistatin like 3 [Source:HGNC Symbol;Acc:HGNC:3973]",{"v":0.61908,"d":"0.62"},{"v":0.480856,"d":"0.48"},{"v":0.736138,"d":"0.74"},{"v":0.317519,"d":"0.32"},{"v":0.441018,"d":"0.44"},{"v":0.703894,"d":"0.70"},{"v":1.25549444725939,"d":"1.26"},{"v":0.328255647941111,"d":"0.33"},1,1,"up","no"]
["MSTRG.3210","PNMT","ENSOART00000012653","GO:0008168(methyltransferase activity);GO:0032259(methylation)","00350(Tyrosine metabolism)","K00553","EC:2.1.1.28","phenylethanolamine N-methyltransferase [Source:NCBI gene;Acc:101103826]",{"v":2.05539089587184,"d":"2.06"},{"v":0.169730024645718,"d":"0.17"},{"v":0.134911053604436,"d":"0.13"},{"v":0.235078447319778,"d":"0.24"},{"v":0.144347837338262,"d":"0.14"},{"v":0.148887545286506,"d":"0.15"},{"v":4.46710239323039,"d":"4.47"},{"v":2.15933932392988,"d":"2.16"},1,1,"up","no"]
["ENSOARG00000008340","TBX21","ENSOART00000009074","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0009615(response to virus);GO:0010628(positive regulation of gene expression);GO:0030217(T cell differentiation);GO:0032703(negative regulation of interleukin-2 production);GO:0043025(neuronal cell body);GO:0043161(proteasome-mediated ubiquitin-dependent protein catabolic process);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045580(regulation of T cell differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0048304(positive regulation of isotype switching to IgG isotypes);GO:0050776(regulation of immune response);GO:0071310(cellular response to organic substance);GO:0072676(lymphocyte migration);GO:2000320(negative regulation of T-helper 17 cell differentiation);GO:2000329(negative regulation of T-helper 17 cell lineage commitment);GO:2000552(negative regulation of T-helper 2 cell cytokine production)","04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);05321(Inflammatory bowel disease (IBD))","K10166","NA","T-box 21 [Source:NCBI gene;Acc:101118711]",{"v":0.137541,"d":"0.14"},{"v":0.1061,"d":"0.11"},{"v":0.168671,"d":"0.17"},{"v":0.483933,"d":"0.48"},{"v":0.170963,"d":"0.17"},{"v":0.128555,"d":"0.13"},{"v":0.526276691203406,"d":"0.53"},{"v":-0.926106595610398,"d":"-0.93"},1,1,"down","no"]
["MSTRG.16889","MAGI2","ENSOART00000019073;ENSOART00000019076","GO:0002092(positive regulation of receptor internalization);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0007165(signal transduction);GO:0019902(phosphatase binding);GO:0030159(receptor signaling complex scaffold activity);GO:0030425(dendrite);GO:0031697(beta-1 adrenergic receptor binding);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0032947(protein-containing complex scaffold activity);GO:0046332(SMAD binding);GO:0051898(negative regulation of protein kinase B signaling);GO:0060395(SMAD protein signal transduction);GO:0070697(activin receptor binding);GO:0070699(type II activin receptor binding);GO:0097118(neuroligin clustering involved in postsynaptic membrane assembly);GO:2000809(positive regulation of synaptic vesicle clustering);GO:2000809(positive regulation of synaptic vesicle clustering)","NA","NA","NA","membrane associated guanylate kinase, WW and PDZ domain containing 2 [Source:HGNC Symbol;Acc:HGNC:18957]",{"v":0.0987551386543873,"d":"0.10"},{"v":0.105343264517779,"d":"0.11"},{"v":0.115257826554106,"d":"0.12"},{"v":0.228765031721668,"d":"0.23"},{"v":0.260246440266053,"d":"0.26"},{"v":0.187450123816833,"d":"0.19"},{"v":0.472098093531007,"d":"0.47"},{"v":-1.0828414379546,"d":"-1.08"},1,1,"down","no"]
["MSTRG.13587","RF00398","ENSOART00000025283","NA","NA","NA","NA",null,{"v":0.654439,"d":"0.65"},{"v":0.583244,"d":"0.58"},{"v":0.489369,"d":"0.49"},{"v":1.405411,"d":"1.41"},{"v":0.869393,"d":"0.87"},{"v":0.74391,"d":"0.74"},{"v":0.572115145720992,"d":"0.57"},{"v":-0.805622557249787,"d":"-0.81"},1,1,"down","no"]
["ENSOARG00000015337","ENSOARG00000015337","ENSOART00000016689","GO:0006144(purine nucleobase metabolic process);GO:0016787(hydrolase activity);GO:0033971(hydroxyisourate hydrolase activity)","00230(Purine metabolism)","K07127","EC:3.5.2.17","5-hydroxyisourate hydrolase-like [Source:NCBI gene;Acc:101109035]",{"v":0.337118,"d":"0.34"},{"v":0.096062,"d":"0.10"},0,{"v":0.112719,"d":"0.11"},{"v":0.357948,"d":"0.36"},{"v":0.506872,"d":"0.51"},{"v":0.44313321514538,"d":"0.44"},{"v":-1.17418762649371,"d":"-1.17"},1,1,"down","no"]
["MSTRG.20938","RHPN1","ENSOART00000001034","GO:0005515(protein binding);GO:0007165(signal transduction)","NA","NA","NA","rhophilin Rho GTPase binding protein 1 [Source:NCBI gene;Acc:101114282]",{"v":0.150809,"d":"0.15"},{"v":0.097061,"d":"0.10"},{"v":0.064658,"d":"0.06"},{"v":0.054427,"d":"0.05"},{"v":0.083378,"d":"0.08"},{"v":0.135347,"d":"0.14"},{"v":1.1441541705717,"d":"1.14"},{"v":0.194281463072028,"d":"0.19"},1,1,"up","no"]
["ENSOARG00000008859","C1QTNF7","ENSOART00000009643;ENSOART00000009645","GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen trimer);GO:0005581(collagen trimer)","NA","NA","NA","C1q and TNF related 7 [Source:NCBI gene;Acc:101105159]",{"v":0.181819304216107,"d":"0.18"},{"v":0.0967294885130018,"d":"0.10"},{"v":0.216089104771522,"d":"0.22"},{"v":0.129893286543802,"d":"0.13"},{"v":0.228889611714214,"d":"0.23"},{"v":0.182206030800303,"d":"0.18"},{"v":0.914321663405627,"d":"0.91"},{"v":-0.129226292229031,"d":"-0.13"},1,1,"down","no"]
["ENSOARG00000017919","SHTN1","ENSOART00000019500","GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0015630(microtubule cytoskeleton);GO:0019894(kinesin binding);GO:0030424(axon);GO:0030426(growth cone);GO:0031252(cell leading edge);GO:0043204(perikaryon);GO:0044295(axonal growth cone);GO:0048471(perinuclear region of cytoplasm);GO:0048812(neuron projection morphogenesis);GO:0061163(endoplasmic reticulum polarization);GO:2000114(regulation of establishment of cell polarity);GO:2001222(regulation of neuron migration);GO:2001224(positive regulation of neuron migration)","NA","NA","NA","shootin 1 [Source:NCBI gene;Acc:101104358]",{"v":0.187952,"d":"0.19"},{"v":0.085434,"d":"0.09"},{"v":0.242871,"d":"0.24"},{"v":0.332936,"d":"0.33"},{"v":0.289996,"d":"0.29"},{"v":0.177798,"d":"0.18"},{"v":0.64473293120028,"d":"0.64"},{"v":-0.633226420589309,"d":"-0.63"},1,1,"down","no"]
["ENSOARG00000007975","ENSOARG00000007975","ENSOART00000008684","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":0.433409,"d":"0.43"},{"v":0.347953,"d":"0.35"},{"v":0.254054,"d":"0.25"},{"v":0.519237,"d":"0.52"},{"v":0.509964,"d":"0.51"},{"v":0.097817,"d":"0.10"},{"v":0.918721795037879,"d":"0.92"},{"v":-0.122300040427693,"d":"-0.12"},1,1,"down","no"]
["ENSOARG00000003813","ENSOARG00000003813","ENSOART00000004143","NA","NA","NA","NA","chromosome 24 open reading frame, human C16orf71 [Source:NCBI gene;Acc:101103526]",{"v":0.119211,"d":"0.12"},{"v":0.132357,"d":"0.13"},{"v":0.086158,"d":"0.09"},{"v":0.134656,"d":"0.13"},{"v":0.164836,"d":"0.16"},{"v":0.134879,"d":"0.13"},{"v":0.777505864802208,"d":"0.78"},{"v":-0.363074537214347,"d":"-0.36"},1,1,"down","no"]
["MSTRG.6062","BRSK1","ENSOART00000001681","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006468(protein phosphorylation);GO:0006974(cellular response to DNA damage stimulus);GO:0007095(mitotic G2 DNA damage checkpoint);GO:0007409(axonogenesis);GO:0008306(associative learning);GO:0009411(response to UV);GO:0010975(regulation of neuron projection development);GO:0019901(protein kinase binding);GO:0030010(establishment of cell polarity);GO:0030054(cell junction);GO:0030182(neuron differentiation);GO:0043015(gamma-tubulin binding);GO:0048167(regulation of synaptic plasticity);GO:0048812(neuron projection morphogenesis);GO:0050321(tau-protein kinase activity);GO:0050770(regulation of axonogenesis);GO:0051298(centrosome duplication);GO:0090176(microtubule cytoskeleton organization involved in establishment of planar polarity);GO:0098793(presynapse);GO:0099504(synaptic vesicle cycle)","NA","K08796","EC:2.7.11.1","BR serine/threonine kinase 1 [Source:NCBI gene;Acc:101121543]",{"v":0.014819,"d":"0.01"},{"v":0.049246,"d":"0.05"},{"v":0.156007,"d":"0.16"},{"v":0.144187,"d":"0.14"},{"v":0.035198,"d":"0.04"},{"v":0.102219,"d":"0.10"},{"v":0.781494581042883,"d":"0.78"},{"v":-0.355692225411194,"d":"-0.36"},1,1,"down","no"]
["MSTRG.7850","ENSOARG00000022696","ENSOART00000024598","NA","NA","NA","NA",null,{"v":0.845551,"d":"0.85"},{"v":0.075785,"d":"0.08"},0,{"v":1.288523,"d":"1.29"},0,0,{"v":0.715032638144604,"d":"0.72"},{"v":-0.483918998710053,"d":"-0.48"},1,1,"down","no"]
["ENSOARG00000013851","UNC79","ENSOART00000015083","GO:0005515(protein binding);GO:0030534(adult behavior);GO:0035264(multicellular organism growth);GO:0048149(behavioral response to ethanol)","NA","NA","NA","unc-79 homolog, NALCN channel complex subunit [Source:NCBI gene;Acc:101116179]",0,0,0,0,{"v":0.00814,"d":"0.01"},{"v":0.00444,"d":"0.00"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000018338","RGL3","ENSOART00000019959","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005622(intracellular);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0008321(Ral guanyl-nucleotide exchange factor activity);GO:0017016(Ras GTPase binding);GO:0031267(small GTPase binding);GO:0043547(positive regulation of GTPase activity)","NA","K17639","NA","ral guanine nucleotide dissociation stimulator like 3 [Source:NCBI gene;Acc:101120830]",{"v":0.009039,"d":"0.01"},0,{"v":0.06128,"d":"0.06"},{"v":0.005117,"d":"0.01"},0,{"v":0.004705,"d":"0.00"},{"v":7.15933618407656,"d":"7.16"},{"v":2.8398258265485,"d":"2.84"},1,1,"up","no"]
["ENSOARG00000011249","VAX2","ENSOART00000012229","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001162(RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007409(axonogenesis);GO:0007601(visual perception);GO:0009950(dorsal/ventral axis specification);GO:0030900(forebrain development);GO:0031490(chromatin DNA binding);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0048048(embryonic eye morphogenesis);GO:0060041(retina development in camera-type eye)","NA","K09318","NA","ventral anterior homeobox 2 [Source:NCBI gene;Acc:101107945]",0,{"v":0.029914,"d":"0.03"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000022750","ENSOARG00000022750","ENSOART00000024652","NA","NA","NA","NA",null,0,0,0,0,{"v":0.128799,"d":"0.13"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.4309","ENSOARG00000022000","ENSOART00000023902","NA","NA","NA","NA",null,{"v":0.066307,"d":"0.07"},{"v":0.806804,"d":"0.81"},{"v":0.239768,"d":"0.24"},{"v":0.297971,"d":"0.30"},0,0,{"v":3.73485674780432,"d":"3.73"},{"v":1.90105290882557,"d":"1.90"},1,1,"up","no"]
["ENSOARG00000024815","RF00100","ENSOART00000026717","NA","NA","NA","NA","RNA, 7SK small nuclear pseudogene 89 [Source:HGNC Symbol;Acc:HGNC:45813]",0,0,0,{"v":0.049636,"d":"0.05"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000023792","RF00001","ENSOART00000025694","NA","NA","NA","NA",null,0,0,0,{"v":0.021688,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000004549","ENSOARG00000004549","ENSOART00000004950","NA","NA","NA","NA",null,0,{"v":0.034682,"d":"0.03"},0,{"v":0.03956,"d":"0.04"},{"v":0.039261,"d":"0.04"},{"v":0.095533,"d":"0.10"},{"v":0.198917145577388,"d":"0.20"},{"v":-2.32976046088065,"d":"-2.33"},1,1,"down","no"]
["MSTRG.7576","RF00026","ENSOART00000026575","NA","NA","NA","NA",null,{"v":0.150834,"d":"0.15"},0,0,{"v":0.028867,"d":"0.03"},0,0,{"v":5.22513596840683,"d":"5.23"},{"v":2.38546857946988,"d":"2.39"},1,1,"up","no"]
["ENSOARG00000009631","GJA9","ENSOART00000010479","GO:0005886(plasma membrane);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction)","NA","K07618","NA","gap junction protein alpha 9 [Source:NCBI gene;Acc:101117710]",{"v":0.057516,"d":"0.06"},{"v":0.093141,"d":"0.09"},{"v":0.045485,"d":"0.05"},{"v":0.070831,"d":"0.07"},{"v":0.070802,"d":"0.07"},0,{"v":1.38486087281919,"d":"1.38"},{"v":0.469741046183606,"d":"0.47"},1,1,"up","no"]
["MSTRG.2398","MIR20A","ENSOART00000027057","NA","NA","NA","NA","microRNA 20a [Source:HGNC Symbol;Acc:HGNC:31577]",{"v":0.993187,"d":"0.99"},{"v":1.090029,"d":"1.09"},0,{"v":0.515409,"d":"0.52"},{"v":0.128799,"d":"0.13"},{"v":0.454621,"d":"0.45"},{"v":1.89585094678062,"d":"1.90"},{"v":0.922845542931612,"d":"0.92"},1,1,"up","no"]
["ENSOARG00000022755","RF02196","ENSOART00000024657","NA","NA","NA","NA",null,0,0,{"v":0.086684,"d":"0.09"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.13983","MIR1296","ENSOART00000023767","NA","NA","NA","NA","microRNA 1296 [Source:HGNC Symbol;Acc:HGNC:35249]",{"v":4.21968,"d":"4.22"},{"v":2.682037,"d":"2.68"},{"v":3.124704,"d":"3.12"},{"v":1.85066,"d":"1.85"},{"v":3.389821,"d":"3.39"},{"v":3.239451,"d":"3.24"},{"v":1.18237044825359,"d":"1.18"},{"v":0.241682116840633,"d":"0.24"},1,1,"up","no"]
["ENSOARG00000018425","ENSOARG00000018425","ENSOART00000020049","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006939(smooth muscle contraction);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007268(chemical synaptic transmission);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0040012(regulation of locomotion);GO:0042310(vasoconstriction);GO:0050795(regulation of behavior);GO:0098664(G protein-coupled serotonin receptor signaling pathway)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse);04742(Taste transduction)","K04153","NA","5-hydroxytryptamine receptor 1D [Source:NCBI gene;Acc:101122172]",0,0,0,0,{"v":0.032029,"d":"0.03"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000013256","ERI2","ENSOART00000014416;ENSOART00000014415","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding);GO:0008270(zinc ion binding)","NA","K18417","EC:3.1.-.-","ERI1 exoribonuclease family member 2 [Source:NCBI gene;Acc:101121562]",{"v":0.22354829787234,"d":"0.22"},{"v":0.0887098893617021,"d":"0.09"},{"v":0.236375421276596,"d":"0.24"},{"v":0.135249089361702,"d":"0.14"},{"v":0.058472885106383,"d":"0.06"},{"v":0.0856158978723404,"d":"0.09"},{"v":1.96405021601233,"d":"1.96"},{"v":0.973831816345996,"d":"0.97"},1,1,"up","no"]
["ENSOARG00000012404","ENSOARG00000012404","ENSOART00000013480","GO:0005515(protein binding)","NA","NA","NA",null,{"v":0.044218,"d":"0.04"},{"v":0.030487,"d":"0.03"},{"v":0.044869,"d":"0.04"},0,{"v":0.067288,"d":"0.07"},{"v":0.080444,"d":"0.08"},{"v":0.809398099260824,"d":"0.81"},{"v":-0.305078633809608,"d":"-0.31"},1,1,"down","no"]
["MSTRG.1421","IQCG","ENSOART00000022063","GO:0002177(manchette);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0007286(spermatid development);GO:0007288(sperm axoneme assembly);GO:0030544(Hsp70 protein binding);GO:0031514(motile cilium);GO:0036126(sperm flagellum)","NA","NA","NA","IQ motif containing G [Source:NCBI gene;Acc:101119097]",{"v":0.056239,"d":"0.06"},{"v":0.032768,"d":"0.03"},{"v":0.025436,"d":"0.03"},{"v":0.023634,"d":"0.02"},{"v":0.143588,"d":"0.14"},{"v":0.018822,"d":"0.02"},{"v":0.615139429382297,"d":"0.62"},{"v":-0.701014641704473,"d":"-0.70"},1,1,"down","no"]
["MSTRG.11759","ENSOARG00000024679","ENSOART00000026581","NA","NA","NA","NA",null,{"v":0.071797,"d":"0.07"},{"v":0.214865,"d":"0.21"},{"v":0.127106,"d":"0.13"},{"v":0.079174,"d":"0.08"},0,0,{"v":5.22605905979236,"d":"5.23"},{"v":2.38572342867403,"d":"2.39"},1,1,"up","no"]
["MSTRG.5505","SMPD3","ENSOART00000003716","GO:0000137(Golgi cis cisterna);GO:0001501(skeletal system development);GO:0001503(ossification);GO:0001932(regulation of protein phosphorylation);GO:0001958(endochondral ossification);GO:0002063(chondrocyte development);GO:0002244(hematopoietic progenitor cell differentiation);GO:0002685(regulation of leukocyte migration);GO:0003433(chondrocyte development involved in endochondral bone morphogenesis);GO:0004767(sphingomyelin phosphodiesterase activity);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006665(sphingolipid metabolic process);GO:0006672(ceramide metabolic process);GO:0006684(sphingomyelin metabolic process);GO:0006685(sphingomyelin catabolic process);GO:0007165(signal transduction);GO:0015774(polysaccharide transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030072(peptide hormone secretion);GO:0030282(bone mineralization);GO:0030324(lung development);GO:0030509(BMP signaling pathway);GO:0032963(collagen metabolic process);GO:0034614(cellular response to reactive oxygen species);GO:0035264(multicellular organism growth);GO:0043491(protein kinase B signaling);GO:0045840(positive regulation of mitotic nuclear division);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048286(lung alveolus development);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0051216(cartilage development);GO:0051260(protein homooligomerization);GO:0060348(bone development);GO:0060541(respiratory system development);GO:0061035(regulation of cartilage development);GO:0061751(neutral sphingomyelin phosphodiesterase activity);GO:0070301(cellular response to hydrogen peroxide);GO:0070314(G1 to G0 transition);GO:0071286(cellular response to magnesium ion);GO:0071356(cellular response to tumor necrosis factor);GO:0071461(cellular response to redox state);GO:0071897(DNA biosynthetic process);GO:0085029(extracellular matrix assembly);GO:0090520(sphingolipid mediated signaling pathway);GO:0097187(dentinogenesis);GO:0098868(bone growth);GO:0140014(mitotic nuclear division);GO:0140052(cellular response to oxidised low-density lipoprotein particle stimulus);GO:1900125(regulation of hyaluronan biosynthetic process);GO:1900126(negative regulation of hyaluronan biosynthetic process);GO:1901653(cellular response to peptide)","00600(Sphingolipid metabolism)","K12352","EC:3.1.4.12","sphingomyelin phosphodiesterase 3 [Source:NCBI gene;Acc:101119496]",{"v":0.062313,"d":"0.06"},{"v":0.045894,"d":"0.05"},{"v":0.245065,"d":"0.25"},{"v":0.287291,"d":"0.29"},{"v":0.270813,"d":"0.27"},{"v":0.290165,"d":"0.29"},{"v":0.416462230731053,"d":"0.42"},{"v":-1.26374243244847,"d":"-1.26"},1,1,"down","no"]
["ENSOARG00000018169","TIPIN","ENSOART00000019773","GO:0000076(DNA replication checkpoint);GO:0000077(DNA damage checkpoint);GO:0000790(nuclear chromatin);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0008284(positive regulation of cell population proliferation);GO:0009411(response to UV);GO:0031573(intra-S DNA damage checkpoint);GO:0043231(intracellular membrane-bounded organelle);GO:0044770(cell cycle phase transition);GO:0048478(replication fork protection)","NA","K10904","NA","TIMELESS interacting protein [Source:NCBI gene;Acc:101123380]",{"v":0.939571,"d":"0.94"},{"v":0.661493,"d":"0.66"},{"v":0.882385,"d":"0.88"},{"v":1.150425,"d":"1.15"},{"v":0.648862,"d":"0.65"},{"v":0.79582,"d":"0.80"},{"v":0.956973643090632,"d":"0.96"},{"v":-0.0634489042471949,"d":"-0.06"},1,1,"down","no"]
["MSTRG.17095","RF01978","ENSOART00000025438","NA","NA","NA","NA",null,{"v":0.70229,"d":"0.70"},{"v":0.682702,"d":"0.68"},{"v":0.122898,"d":"0.12"},{"v":1.491908,"d":"1.49"},{"v":0.871288,"d":"0.87"},{"v":2.006257,"d":"2.01"},{"v":0.345098116400382,"d":"0.35"},{"v":-1.53492149554814,"d":"-1.53"},1,1,"down","no"]
["MSTRG.16342","ENSOARG00000020298","ENSOART00000022103","NA","NA","NA","NA",null,{"v":4.474121,"d":"4.47"},{"v":3.114705,"d":"3.11"},{"v":3.594782,"d":"3.59"},{"v":2.408611,"d":"2.41"},{"v":2.580971,"d":"2.58"},{"v":2.512019,"d":"2.51"},{"v":1.49082949093134,"d":"1.49"},{"v":0.576115263218553,"d":"0.58"},1,1,"up","no"]
["ENSOARG00000019482","ENSOARG00000019482","ENSOART00000021218","NA","NA","NA","NA",null,{"v":0.035116,"d":"0.04"},{"v":0.032122,"d":"0.03"},{"v":0.030864,"d":"0.03"},{"v":0.055732,"d":"0.06"},0,{"v":0.028531,"d":"0.03"},{"v":1.16423578557611,"d":"1.16"},{"v":0.21938326806845,"d":"0.22"},1,1,"up","no"]
["ENSOARG00000006119","MMP7","ENSOART00000006649","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0031012(extracellular matrix);GO:0046872(metal ion binding)","04310(Wnt signaling pathway);05166(Human T-cell leukemia virus 1 infection)","K01397","EC:3.4.24.23","matrix metallopeptidase 7 [Source:NCBI gene;Acc:100192317]",0,{"v":0.038062,"d":"0.04"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000006872","HOXB9","ENSOART00000007468","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006351(transcription, DNA-templated);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0030879(mammary gland development);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048706(embryonic skeletal system development);GO:0060326(cell chemotaxis);GO:0090575(RNA polymerase II transcription factor complex)","NA","K09294","NA","homeobox B9 [Source:NCBI gene;Acc:101114883]",{"v":0.092988,"d":"0.09"},{"v":0.082372,"d":"0.08"},{"v":0.106344,"d":"0.11"},{"v":0.177621,"d":"0.18"},0,{"v":0.103338,"d":"0.10"},{"v":1.00265163244459,"d":"1.00"},{"v":0.00382043402021461,"d":"0.00"},1,1,"up","no"]
["ENSOARG00000004337","ENSOARG00000004337","ENSOART00000004719","NA","NA","NA","NA",null,0,{"v":0.020121,"d":"0.02"},{"v":0.04453,"d":"0.04"},0,{"v":0.049815,"d":"0.05"},0,{"v":1.29782194118238,"d":"1.30"},{"v":0.376092461769704,"d":"0.38"},1,1,"up","no"]
["ENSOARG00000012375","MLXIPL","ENSOART00000013454","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell population proliferation);GO:0010255(glucose mediated signaling pathway);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0042593(glucose homeostasis);GO:0045723(positive regulation of fatty acid biosynthetic process);GO:0045821(positive regulation of glycolytic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046889(positive regulation of lipid biosynthetic process);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0071157(negative regulation of cell cycle arrest);GO:0090324(negative regulation of oxidative phosphorylation)","04931(Insulin resistance);04932(Non-alcoholic fatty liver disease (NAFLD))","K09113","NA","MLX interacting protein like [Source:NCBI gene;Acc:101115503]",{"v":0.149404,"d":"0.15"},{"v":0.23505,"d":"0.24"},{"v":0.106524,"d":"0.11"},{"v":0.542324,"d":"0.54"},{"v":0.092575,"d":"0.09"},{"v":0.071233,"d":"0.07"},{"v":0.695306260019373,"d":"0.70"},{"v":-0.524279516347941,"d":"-0.52"},1,1,"down","no"]
["ENSOARG00000013421","IFI44L","ENSOART00000014603","GO:0051607(defense response to virus)","NA","NA","NA","interferon induced protein 44 like [Source:NCBI gene;Acc:101103357]",{"v":0.134806,"d":"0.13"},{"v":0.060266,"d":"0.06"},{"v":0.042521,"d":"0.04"},{"v":0.271666,"d":"0.27"},{"v":0.149423,"d":"0.15"},{"v":0.120983,"d":"0.12"},{"v":0.438305243583878,"d":"0.44"},{"v":-1.18999215650573,"d":"-1.19"},1,1,"down","no"]
["MSTRG.424","LRRIQ3","ENSOART00000013279","GO:0005515(protein binding)","NA","NA","NA","leucine rich repeats and IQ motif containing 3 [Source:NCBI gene;Acc:101119772]",{"v":0.050564,"d":"0.05"},{"v":0.032676,"d":"0.03"},{"v":0.080113,"d":"0.08"},{"v":0.177423,"d":"0.18"},{"v":0.070194,"d":"0.07"},0,{"v":0.65970026290602,"d":"0.66"},{"v":-0.600117415025416,"d":"-0.60"},1,1,"down","no"]
["ENSOARG00000019979","RHBDL2","ENSOART00000021750","GO:0004252(serine-type endopeptidase activity);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity)","NA","K02857","EC:3.4.21.105","rhomboid like 2 [Source:NCBI gene;Acc:101117975]",{"v":0.132374,"d":"0.13"},{"v":0.126381,"d":"0.13"},{"v":0.087632,"d":"0.09"},{"v":0.313861,"d":"0.31"},{"v":0.152867,"d":"0.15"},{"v":0.041456,"d":"0.04"},{"v":0.681617288226312,"d":"0.68"},{"v":-0.552966167008384,"d":"-0.55"},1,1,"down","no"]
["ENSOARG00000020119","CASR","ENSOART00000021904","GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0005513(detection of calcium ion);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016597(amino acid binding);GO:0032781(positive regulation of ATPase activity);GO:0042803(protein homodimerization activity);GO:0051924(regulation of calcium ion transport);GO:0070509(calcium ion import)","04621(NOD-like receptor signaling pathway);04928(Parathyroid hormone synthesis, secretion and action)","K04612","NA","calcium sensing receptor [Source:NCBI gene;Acc:101112527]",{"v":0.010498,"d":"0.01"},0,0,0,{"v":0.021782,"d":"0.02"},{"v":0.010662,"d":"0.01"},{"v":0.323572925656516,"d":"0.32"},{"v":-1.62783719680788,"d":"-1.63"},1,1,"down","no"]
["MSTRG.3158","ENSOARG00000024262","ENSOART00000026164","NA","NA","NA","NA",null,{"v":0.187856,"d":"0.19"},{"v":0.335011,"d":"0.34"},{"v":0.228633,"d":"0.23"},{"v":0.257705,"d":"0.26"},{"v":0.0322,"d":"0.03"},0,{"v":2.59222848864283,"d":"2.59"},{"v":1.37419288832426,"d":"1.37"},1,1,"up","no"]
["ENSOARG00000012762","KIF19","ENSOART00000013878","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005929(cilium);GO:0005930(axoneme);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0008574(ATP-dependent microtubule motor activity, plus-end-directed);GO:0060404(axonemal microtubule depolymerization);GO:0070462(plus-end specific microtubule depolymerization)","NA","K10401","NA","kinesin family member 19 [Source:NCBI gene;Acc:101106188]",{"v":0.040198,"d":"0.04"},0,{"v":0.005332,"d":"0.01"},{"v":0.029055,"d":"0.03"},{"v":0.013091,"d":"0.01"},0,{"v":1.08029231718313,"d":"1.08"},{"v":0.111421745247928,"d":"0.11"},1,1,"up","no"]
["ENSOARG00000011510","CAMKV","ENSOART00000012515","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0098978(glutamatergic synapse);GO:0099159(regulation of modification of postsynaptic structure)","NA","K08812","EC:2.7.11.-","CaM kinase like vesicle associated [Source:NCBI gene;Acc:101123415]",{"v":0.130756,"d":"0.13"},0,0,{"v":0.252342,"d":"0.25"},{"v":0.034727,"d":"0.03"},{"v":0.138535,"d":"0.14"},{"v":0.307224556160187,"d":"0.31"},{"v":-1.70263456100713,"d":"-1.70"},1,1,"down","no"]
["MSTRG.4441","ENSOARG00000012203","ENSOART00000013272","NA","NA","NA","NA",null,{"v":0.346783,"d":"0.35"},{"v":0.269203,"d":"0.27"},{"v":0.254998,"d":"0.25"},{"v":0.209962,"d":"0.21"},{"v":0.186063,"d":"0.19"},{"v":0.200581,"d":"0.20"},{"v":1.4598981572428,"d":"1.46"},{"v":0.545867729950839,"d":"0.55"},1,1,"up","no"]
["MSTRG.7534","RF00562","ENSOART00000025362","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 49 [Source:HGNC Symbol;Acc:HGNC:32642]",{"v":2.455273,"d":"2.46"},{"v":1.858444,"d":"1.86"},{"v":0.92991,"d":"0.93"},{"v":2.368901,"d":"2.37"},{"v":2.487803,"d":"2.49"},{"v":3.231691,"d":"3.23"},{"v":0.648290173761296,"d":"0.65"},{"v":-0.625288388964442,"d":"-0.63"},1,1,"down","no"]
["ENSOARG00000008768","ENSOARG00000008768","ENSOART00000009552","NA","NA","NA","NA",null,{"v":0.216454,"d":"0.22"},{"v":0.438235,"d":"0.44"},0,{"v":0.190968,"d":"0.19"},{"v":0.056575,"d":"0.06"},{"v":0.102512,"d":"0.10"},{"v":1.87024610418363,"d":"1.87"},{"v":0.903228125687056,"d":"0.90"},1,1,"up","no"]
["ENSOARG00000015875","ENSOARG00000015875","ENSOART00000017284","GO:0035556(intracellular signal transduction)","NA","NA","NA",null,0,0,0,0,0,{"v":0.058385,"d":"0.06"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000005248","PCYOX1L","ENSOART00000005722","GO:0001735(prenylcysteine oxidase activity);GO:0016491(oxidoreductase activity);GO:0016670(oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor);GO:0030328(prenylcysteine catabolic process);GO:0055114(oxidation-reduction process)","NA","NA","NA","prenylcysteine oxidase 1 like [Source:NCBI gene;Acc:101119723]",{"v":0.22828,"d":"0.23"},0,{"v":0.289674,"d":"0.29"},{"v":0.314091,"d":"0.31"},{"v":0.101575,"d":"0.10"},{"v":0.286672,"d":"0.29"},{"v":0.737471132132962,"d":"0.74"},{"v":-0.439341517856016,"d":"-0.44"},1,1,"down","no"]
["MSTRG.20929","FAM83H","ENSOART00000017899","GO:0019901(protein kinase binding);GO:0030335(positive regulation of cell migration);GO:0044380(protein localization to cytoskeleton);GO:0045095(keratin filament);GO:0045104(intermediate filament cytoskeleton organization);GO:1990254(keratin filament binding)","NA","NA","NA","family with sequence similarity 83 member H [Source:NCBI gene;Acc:101116996]",{"v":0.102969,"d":"0.10"},{"v":0.062437,"d":"0.06"},{"v":0.074562,"d":"0.07"},{"v":0.102646,"d":"0.10"},{"v":0.118703,"d":"0.12"},{"v":0.159725,"d":"0.16"},{"v":0.629714963497903,"d":"0.63"},{"v":-0.667229145325992,"d":"-0.67"},1,1,"down","no"]
["MSTRG.14461","RF00001","ENSOART00000026134","NA","NA","NA","NA",null,0,0,0,0,{"v":0.009908,"d":"0.01"},{"v":0.009699,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000000397","TSGA10IP","ENSOART00000000424","NA","NA","NA","NA","testis specific 10 interacting protein [Source:NCBI gene;Acc:101111918]",0,{"v":0.087981,"d":"0.09"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.20446","PPIL6","ENSOART00000011389;ENSOART00000011388","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0003755(peptidyl-prolyl cis-trans isomerase activity)","NA","K12739","EC:5.2.1.8","peptidylprolyl isomerase like 6 [Source:NCBI gene;Acc:101114364]",{"v":0.0744576506024096,"d":"0.07"},{"v":0.0164573632993513,"d":"0.02"},{"v":0.0580866506024096,"d":"0.06"},{"v":0.0120916626506024,"d":"0.01"},{"v":0.00310380722891566,"d":"0.00"},{"v":0.0200995273401297,"d":"0.02"},{"v":4.22160861996684,"d":"4.22"},{"v":2.07779283443927,"d":"2.08"},1,1,"up","no"]
["MSTRG.8425","ENSOARG00000014375","ENSOART00000015650","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","interferon alpha-inducible protein 27-like protein 2 [Source:NCBI gene;Acc:101116867]",0,0,{"v":0.078972,"d":"0.08"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000009715","TGM7","ENSOART00000010577","GO:0003810(protein-glutamine gamma-glutamyltransferase activity);GO:0018149(peptide cross-linking);GO:0046872(metal ion binding)","NA","K05623","EC:2.3.2.13","transglutaminase 7 [Source:NCBI gene;Acc:101106629]",0,{"v":0.006249,"d":"0.01"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000000889","TEX45","ENSOART00000000953","NA","NA","NA","NA","testis expressed 45 [Source:NCBI gene;Acc:101122860]",{"v":0.01183,"d":"0.01"},0,0,0,{"v":0.011657,"d":"0.01"},0,{"v":1.01484086814789,"d":"1.01"},{"v":0.0212535237331548,"d":"0.02"},1,1,"up","no"]
["ENSOARG00000011385","TMEM42","ENSOART00000012374","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 42 [Source:HGNC Symbol;Acc:HGNC:28444]",{"v":0.319382,"d":"0.32"},0,{"v":0.070187,"d":"0.07"},{"v":0.332415,"d":"0.33"},{"v":0.403948,"d":"0.40"},{"v":0.506268,"d":"0.51"},{"v":0.313503365037569,"d":"0.31"},{"v":-1.6734471663833,"d":"-1.67"},1,1,"down","no"]
["MSTRG.4545","ENSOARG00000022555","ENSOART00000024457","NA","NA","NA","NA",null,{"v":0.395018,"d":"0.40"},{"v":1.140742,"d":"1.14"},{"v":1.823648,"d":"1.82"},{"v":2.032353,"d":"2.03"},{"v":2.653553,"d":"2.65"},{"v":0.310918,"d":"0.31"},{"v":0.672308650454769,"d":"0.67"},{"v":-0.572804382343175,"d":"-0.57"},1,1,"down","no"]
["ENSOARG00000012827","ENSOARG00000012827","ENSOART00000013941","NA","NA","NA","NA","epididymal secretory protein E3-beta-like [Source:NCBI gene;Acc:105613768]",{"v":0.034231,"d":"0.03"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.13198","PTX4","ENSOART00000017094","NA","NA","NA","NA","pentraxin 4 [Source:NCBI gene;Acc:101108979]",{"v":0.129506,"d":"0.13"},{"v":0.041622,"d":"0.04"},{"v":0.036484,"d":"0.04"},0,0,{"v":0.084204,"d":"0.08"},{"v":2.46558358272766,"d":"2.47"},{"v":1.30192916070469,"d":"1.30"},1,1,"up","no"]
["ENSOARG00000018924","TMEM232","ENSOART00000020607","NA","NA","NA","NA","transmembrane protein 232 [Source:NCBI gene;Acc:101107020]",0,0,{"v":0.038448,"d":"0.04"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000000421","BEX4","ENSOART00000000446","GO:0000922(spindle pole);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0007059(chromosome segregation);GO:0030334(regulation of cell migration);GO:0042127(regulation of cell population proliferation);GO:0042826(histone deacetylase binding);GO:0043014(alpha-tubulin binding);GO:1904428(negative regulation of tubulin deacetylation)","NA","NA","NA","brain expressed X-linked 4 [Source:HGNC Symbol;Acc:HGNC:25475]",{"v":0.272972,"d":"0.27"},0,{"v":0.317235,"d":"0.32"},{"v":0.297454,"d":"0.30"},0,0,{"v":1.98419587566481,"d":"1.98"},{"v":0.988554452590464,"d":"0.99"},1,1,"up","no"]
["MSTRG.18427","ENSOARG00000010503","ENSOART00000011430","NA","NA","NA","NA",null,{"v":0.693253,"d":"0.69"},{"v":0.420093,"d":"0.42"},{"v":0.663669,"d":"0.66"},{"v":0.201088,"d":"0.20"},{"v":0.478376,"d":"0.48"},{"v":0.418139,"d":"0.42"},{"v":1.6189961215485,"d":"1.62"},{"v":0.695099529538289,"d":"0.70"},1,1,"up","no"]
["MSTRG.15611","ENSOARG00000021993","ENSOART00000023895","NA","NA","NA","NA",null,{"v":0.248297,"d":"0.25"},0,0,{"v":0.556265,"d":"0.56"},0,{"v":0.093796,"d":"0.09"},{"v":0.381959539181708,"d":"0.38"},{"v":-1.38850827263023,"d":"-1.39"},1,1,"down","no"]
["ENSOARG00000024512","RF00026","ENSOART00000026414","NA","NA","NA","NA",null,0,0,0,{"v":0.134006,"d":"0.13"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.9026","RF00619","ENSOART00000026427","NA","NA","NA","NA",null,{"v":0.124148,"d":"0.12"},0,0,0,0,{"v":0.107073,"d":"0.11"},{"v":1.15947064152494,"d":"1.16"},{"v":0.21346629056382,"d":"0.21"},1,1,"up","no"]
["ENSOARG00000010536","DMTN","ENSOART00000011475","GO:0003779(actin binding);GO:0005102(signaling receptor binding);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0010591(regulation of lamellipodium assembly);GO:0010763(positive regulation of fibroblast migration);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010812(negative regulation of cell-substrate adhesion);GO:0014069(postsynaptic density);GO:0014731(spectrin-associated cytoskeleton);GO:0016020(membrane);GO:0030036(actin cytoskeleton organization);GO:0030194(positive regulation of blood coagulation);GO:0030507(spectrin binding);GO:0030863(cortical cytoskeleton);GO:0031095(platelet dense tubular network membrane);GO:0031253(cell projection membrane);GO:0031410(cytoplasmic vesicle);GO:0032956(regulation of actin cytoskeleton organization);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0035585(calcium-mediated signaling using extracellular calcium source);GO:0043621(protein self-association);GO:0048471(perinuclear region of cytoplasm);GO:0048821(erythrocyte development);GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation);GO:0051489(regulation of filopodium assembly);GO:0051895(negative regulation of focal adhesion assembly);GO:0065003(protein-containing complex assembly);GO:0070560(protein secretion by platelet);GO:0071277(cellular response to calcium ion);GO:0071320(cellular response to cAMP);GO:0090303(positive regulation of wound healing);GO:0090315(negative regulation of protein targeting to membrane);GO:0090527(actin filament reorganization);GO:1900025(negative regulation of substrate adhesion-dependent cell spreading);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:1901731(positive regulation of platelet aggregation);GO:2001046(positive regulation of integrin-mediated signaling pathway)","NA","NA","NA","dematin actin binding protein [Source:NCBI gene;Acc:101117729]",{"v":0.118148,"d":"0.12"},0,0,0,{"v":0.144213,"d":"0.14"},{"v":0.034932,"d":"0.03"},{"v":0.659510452426805,"d":"0.66"},{"v":-0.600532570293303,"d":"-0.60"},1,1,"down","no"]
["ENSOARG00000018182","EFR3B","ENSOART00000019796","GO:0005886(plasma membrane);GO:0046854(phosphatidylinositol phosphorylation);GO:0072659(protein localization to plasma membrane)","NA","K21842","NA","EFR3 homolog B [Source:NCBI gene;Acc:101108899]",{"v":0.123283,"d":"0.12"},{"v":0.037491,"d":"0.04"},{"v":0.192258,"d":"0.19"},{"v":0.070385,"d":"0.07"},{"v":0.278714,"d":"0.28"},{"v":0.152014,"d":"0.15"},{"v":0.704495792366193,"d":"0.70"},{"v":-0.505337004889789,"d":"-0.51"},1,1,"down","no"]
["MSTRG.21850","RF00600","ENSOART00000026256","NA","NA","NA","NA",null,{"v":0.027588,"d":"0.03"},0,0,0,{"v":0.312159,"d":"0.31"},{"v":0.024517,"d":"0.02"},{"v":0.0819422827881999,"d":"0.08"},{"v":-3.60924810509245,"d":"-3.61"},1,1,"down","no"]
["MSTRG.1162","MIR125B2","ENSOART00000024207","NA","NA","NA","NA","microRNA 125b-2 [Source:HGNC Symbol;Acc:HGNC:31507]",{"v":0.232015,"d":"0.23"},{"v":0.763072,"d":"0.76"},{"v":0.583952,"d":"0.58"},0,{"v":0.367394,"d":"0.37"},{"v":0.016536,"d":"0.02"},{"v":4.11283046388665,"d":"4.11"},{"v":2.04013160333573,"d":"2.04"},1,1,"up","no"]
["MSTRG.6018","ENSOARG00000000589","ENSOART00000000633","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","NA","NA",null,0,0,0,0,{"v":0.014292,"d":"0.01"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.8006","RF00108","ENSOART00000023948","NA","NA","NA","NA",null,{"v":0.356596,"d":"0.36"},{"v":0.564392,"d":"0.56"},{"v":0.907098,"d":"0.91"},{"v":0.843023,"d":"0.84"},{"v":0.717986,"d":"0.72"},{"v":1.649854,"d":"1.65"},{"v":0.569344129600048,"d":"0.57"},{"v":-0.812627168199339,"d":"-0.81"},1,1,"down","no"]
["MSTRG.16957","ENSOARG00000009129","ENSOART00000009937","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.120893,"d":"0.12"},{"v":0.216082,"d":"0.22"},{"v":0.20223,"d":"0.20"},{"v":0.13655,"d":"0.14"},{"v":0.034691,"d":"0.03"},{"v":0.132028,"d":"0.13"},{"v":1.777975988314,"d":"1.78"},{"v":0.830235840605126,"d":"0.83"},1,1,"up","no"]
["ENSOARG00000017170","ENSOARG00000017170","ENSOART00000018682","GO:0008299(isoprenoid biosynthetic process);GO:0016740(transferase activity)","NA","NA","NA",null,0,0,0,0,0,{"v":0.032067,"d":"0.03"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000018609","CACNA1E","ENSOART00000020260","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0005262(calcium channel activity);GO:0005509(calcium ion binding);GO:0005891(voltage-gated calcium channel complex);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04930(Type II diabetes mellitus)","K04852","NA","calcium voltage-gated channel subunit alpha1 E [Source:NCBI gene;Acc:101102503]",{"v":0.004638,"d":"0.00"},{"v":0.004377,"d":"0.00"},0,{"v":0.017216,"d":"0.02"},0,{"v":0.00984,"d":"0.01"},{"v":0.333197811945594,"d":"0.33"},{"v":-1.58554916809028,"d":"-1.59"},1,1,"down","no"]
["MSTRG.17429","ENSOARG00000001437","ENSOART00000001538","GO:0005525(GTP binding)","NA","NA","NA",null,{"v":0.203192,"d":"0.20"},0,{"v":0.087932,"d":"0.09"},{"v":0.283141,"d":"0.28"},{"v":0.130041,"d":"0.13"},{"v":0.132168,"d":"0.13"},{"v":0.533829650683048,"d":"0.53"},{"v":-0.905548655077427,"d":"-0.91"},1,1,"down","no"]
["MSTRG.11198","ARMC12","ENSOART00000013426","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","armadillo repeat containing 12 [Source:NCBI gene;Acc:101118823]",{"v":0.299723,"d":"0.30"},{"v":0.243671,"d":"0.24"},{"v":0.261649,"d":"0.26"},{"v":0.336161,"d":"0.34"},{"v":0.552014,"d":"0.55"},{"v":0.253376,"d":"0.25"},{"v":0.705218601709429,"d":"0.71"},{"v":-0.503857565436295,"d":"-0.50"},1,1,"down","no"]
["ENSOARG00000016983","ENSOARG00000016983","ENSOART00000018494","GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding)","NA","K12028","NA","tripartite motif-containing protein 59 [Source:NCBI gene;Acc:101108249]",{"v":0.109259,"d":"0.11"},{"v":0.013267,"d":"0.01"},{"v":0.058105,"d":"0.06"},{"v":0.034478,"d":"0.03"},{"v":0.030043,"d":"0.03"},{"v":0.014705,"d":"0.01"},{"v":2.27994597733067,"d":"2.28"},{"v":1.1889996405477,"d":"1.19"},1,1,"up","no"]
["ENSOARG00000001692","RGS22","ENSOART00000001822","GO:0001965(G-protein alpha-subunit binding);GO:0005634(nucleus);GO:0005737(cytoplasm)","NA","NA","NA","regulator of G protein signaling 22 [Source:NCBI gene;Acc:101105337]",{"v":0.035096,"d":"0.04"},{"v":0.008048,"d":"0.01"},{"v":0.035008,"d":"0.04"},{"v":0.027738,"d":"0.03"},{"v":0.027726,"d":"0.03"},{"v":0.036093,"d":"0.04"},{"v":0.853588474939109,"d":"0.85"},{"v":-0.228387397708673,"d":"-0.23"},1,1,"down","no"]
["ENSOARG00000012025","FAM3D","ENSOART00000013080","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046676(negative regulation of insulin secretion);GO:0070093(negative regulation of glucagon secretion)","NA","NA","NA","family with sequence similarity 3 member D [Source:HGNC Symbol;Acc:HGNC:18665]",0,0,{"v":0.013405,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000015204","ENSOARG00000015204","ENSOART00000016546","NA","NA","NA","NA",null,0,{"v":0.609802,"d":"0.61"},0,{"v":0.239932,"d":"0.24"},{"v":0.286652,"d":"0.29"},{"v":0.067391,"d":"0.07"},{"v":1.02664590260533,"d":"1.03"},{"v":0.0379386717789683,"d":"0.04"},1,1,"up","no"]
["MSTRG.19030","CXCL1","ENSOART00000016080","GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006952(defense response);GO:0006955(immune response);GO:0008009(chemokine activity);GO:0010469(regulation of signaling receptor activity);GO:0060326(cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04621(NOD-like receptor signaling pathway);04657(IL-17 signaling pathway);04668(TNF signaling pathway);05132(Salmonella infection);05134(Legionellosis);05167(Kaposi sarcoma-associated herpesvirus infection)","K05505","NA","chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) [Source:NCBI gene;Acc:443380]",0,{"v":0.146753,"d":"0.15"},{"v":0.526582,"d":"0.53"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000019017","RGS8","ENSOART00000020705","GO:0005096(GTPase activator activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0043547(positive regulation of GTPase activity)","NA","K16449","NA","regulator of G protein signaling 8 [Source:NCBI gene;Acc:101103997]",{"v":0.793589,"d":"0.79"},{"v":0.502361,"d":"0.50"},{"v":0.224606,"d":"0.22"},{"v":0.254295,"d":"0.25"},{"v":0.588654,"d":"0.59"},{"v":0.559933,"d":"0.56"},{"v":1.08388018379308,"d":"1.08"},{"v":0.116205284550276,"d":"0.12"},1,1,"up","no"]
["ENSOARG00000016687","KIF6","ENSOART00000018170","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding)","NA","K10397","NA","kinesin family member 6 [Source:NCBI gene;Acc:101106209]",{"v":0.020965,"d":"0.02"},0,{"v":0.007533,"d":"0.01"},0,{"v":0.021673,"d":"0.02"},0,{"v":1.31490794998385,"d":"1.31"},{"v":0.394961807312229,"d":"0.39"},1,1,"up","no"]
["ENSOARG00000017298","PSD2","ENSOART00000018828","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0030425(dendrite);GO:0032012(regulation of ARF protein signal transduction);GO:0032154(cleavage furrow);GO:0032587(ruffle membrane);GO:0043025(neuronal cell body);GO:0098794(postsynapse);GO:0098978(glutamatergic synapse)","04144(Endocytosis)","K12494","NA","pleckstrin and Sec7 domain containing 2 [Source:NCBI gene;Acc:101116827]",{"v":0.031634,"d":"0.03"},{"v":0.013332,"d":"0.01"},{"v":0.007727,"d":"0.01"},{"v":0.023946,"d":"0.02"},{"v":0.053598,"d":"0.05"},{"v":0.029069,"d":"0.03"},{"v":0.494245542288464,"d":"0.49"},{"v":-1.01670014086475,"d":"-1.02"},1,1,"down","no"]
["ENSOARG00000003038","ENSOARG00000003038","ENSOART00000003290","GO:0005856(cytoskeleton)","NA","K16454","NA","centriole, cilia and spindle associated protein [Source:NCBI gene;Acc:101101863]",{"v":0.326309,"d":"0.33"},{"v":0.083532,"d":"0.08"},{"v":0.604643,"d":"0.60"},{"v":0.661964,"d":"0.66"},{"v":1.143816,"d":"1.14"},{"v":0.403748,"d":"0.40"},{"v":0.459140594733355,"d":"0.46"},{"v":-1.12299210188874,"d":"-1.12"},1,1,"down","no"]
["ENSOARG00000002723","CLDN20","ENSOART00000002948","GO:0005198(structural molecule activity);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)","K06087","NA","uncharacterized LOC101106178 [Source:NCBI gene;Acc:101106178]",{"v":0.053287,"d":"0.05"},{"v":0.068629,"d":"0.07"},{"v":0.106546,"d":"0.11"},{"v":0.376751,"d":"0.38"},{"v":0.636938,"d":"0.64"},{"v":0.302262,"d":"0.30"},{"v":0.173609807660012,"d":"0.17"},{"v":-2.52607964328709,"d":"-2.53"},1,1,"down","no"]
["MSTRG.17694","oar-mir-27a","ENSOART00000026527","NA","NA","NA","NA","oar-mir-27a [Source:miRBase;Acc:MI0025275]",{"v":0.641433,"d":"0.64"},0,{"v":0.149575,"d":"0.15"},{"v":0.583139,"d":"0.58"},{"v":0.264203,"d":"0.26"},{"v":0.604568,"d":"0.60"},{"v":0.54480511877458,"d":"0.54"},{"v":-0.876187836478625,"d":"-0.88"},1,1,"down","no"]
["ENSOARG00000003412","ENSOARG00000003412","ENSOART00000003704","NA","NA","NA","NA",null,0,{"v":0.035923,"d":"0.04"},{"v":0.069564,"d":"0.07"},{"v":0.267802,"d":"0.27"},{"v":0.144231,"d":"0.14"},{"v":0.201767,"d":"0.20"},{"v":0.171858911697621,"d":"0.17"},{"v":-2.54070343067431,"d":"-2.54"},1,1,"down","no"]
["MSTRG.10563","RF00575","ENSOART00000024776","NA","NA","NA","NA","small nucleolar RNA, C/D box 70B [Source:HGNC Symbol;Acc:HGNC:52233]",{"v":0.620742,"d":"0.62"},{"v":1.263438,"d":"1.26"},0,{"v":0.860497,"d":"0.86"},{"v":0.82461,"d":"0.82"},{"v":0.955068,"d":"0.96"},{"v":0.713657238630015,"d":"0.71"},{"v":-0.486696764135849,"d":"-0.49"},1,1,"down","no"]
["ENSOARG00000013416","ENSOARG00000013416","ENSOART00000014593","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.130122,"d":"0.13"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000013096","IL18R1","ENSOART00000014232","GO:0004908(interleukin-1 receptor activity);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030101(natural killer cell activation);GO:0032729(positive regulation of interferon-gamma production);GO:0035655(interleukin-18-mediated signaling pathway);GO:0042007(interleukin-18 binding);GO:0042008(interleukin-18 receptor activity);GO:0045063(T-helper 1 cell differentiation);GO:0045092(interleukin-18 receptor complex);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1901224(positive regulation of NIK/NF-kappaB signaling);GO:2000556(positive regulation of T-helper 1 cell cytokine production)","04060(Cytokine-cytokine receptor interaction);04668(TNF signaling pathway);05321(Inflammatory bowel disease (IBD))","K05173","NA","interleukin 18 receptor 1 [Source:NCBI gene;Acc:101102552]",{"v":0.02866,"d":"0.03"},{"v":0.030199,"d":"0.03"},{"v":0.062322,"d":"0.06"},{"v":0.061339,"d":"0.06"},{"v":0.080346,"d":"0.08"},{"v":0.01548,"d":"0.02"},{"v":0.771043171189514,"d":"0.77"},{"v":-0.3751164550877,"d":"-0.38"},1,1,"down","no"]
["MSTRG.9664","ENSOARG00000010794","ENSOART00000011738","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.132898,"d":"0.13"},{"v":0.266945,"d":"0.27"},{"v":0.134948,"d":"0.13"},{"v":0.393169,"d":"0.39"},{"v":1.228957,"d":"1.23"},{"v":1.051611,"d":"1.05"},{"v":0.200016306764652,"d":"0.20"},{"v":-2.32181047123997,"d":"-2.32"},1,1,"down","no"]
["ENSOARG00000006625","C19orf67","ENSOART00000007200","NA","NA","NA","NA","chromosome 5 open reading frame, human C19orf67 [Source:NCBI gene;Acc:101123552]",{"v":0.014723,"d":"0.01"},0,0,0,{"v":0.054634,"d":"0.05"},{"v":0.081705,"d":"0.08"},{"v":0.10798817653056,"d":"0.11"},{"v":-3.21105473244772,"d":"-3.21"},1,1,"down","no"]
["ENSOARG00000005485","ENSOARG00000005485","ENSOART00000005979","GO:0005634(nucleus);GO:0007276(gamete generation);GO:0051726(regulation of cell cycle)","NA","NA","NA","spindlin-2B [Source:NCBI gene;Acc:101114167]",0,0,0,0,{"v":0.022544,"d":"0.02"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.3451","B3GNTL1","ENSOART00000017303","NA","NA","NA","NA","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1 [Source:NCBI gene;Acc:101103996]",{"v":0.530754,"d":"0.53"},{"v":0.442963,"d":"0.44"},{"v":0.871252,"d":"0.87"},{"v":0.833937,"d":"0.83"},{"v":0.563153,"d":"0.56"},{"v":0.705382,"d":"0.71"},{"v":0.877523695916046,"d":"0.88"},{"v":-0.188490011613754,"d":"-0.19"},1,1,"down","no"]
["MSTRG.18310","RF00026","ENSOART00000024946","NA","NA","NA","NA",null,{"v":0.56853,"d":"0.57"},{"v":0.858514,"d":"0.86"},{"v":0.808489,"d":"0.81"},{"v":0.464832,"d":"0.46"},{"v":0.058983,"d":"0.06"},{"v":0.288703,"d":"0.29"},{"v":2.75136427746831,"d":"2.75"},{"v":1.46014716346546,"d":"1.46"},1,1,"up","no"]
["ENSOARG00000011748","ADGRF2","ENSOART00000012776","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K08454","NA","adhesion G protein-coupled receptor F2 [Source:NCBI gene;Acc:101121719]",0,0,0,{"v":0.017625,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.13521","ENSOARG00000005811","ENSOART00000006326","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.455174,"d":"0.46"},{"v":0.382534,"d":"0.38"},{"v":0.279774,"d":"0.28"},{"v":0.230003,"d":"0.23"},{"v":0.481551,"d":"0.48"},{"v":0.606444,"d":"0.61"},{"v":0.84786319857845,"d":"0.85"},{"v":-0.238096587945217,"d":"-0.24"},1,1,"down","no"]
["MSTRG.7627","RAD9B","ENSOART00000018555","GO:0000077(DNA damage checkpoint);GO:0006281(DNA repair);GO:0030896(checkpoint clamp complex)","04218(Cellular senescence)","K10995","NA","RAD9 checkpoint clamp component B [Source:NCBI gene;Acc:101105531]",{"v":0.310097,"d":"0.31"},{"v":0.519373,"d":"0.52"},{"v":0.215555,"d":"0.22"},{"v":0.31949,"d":"0.32"},{"v":0.297381,"d":"0.30"},{"v":0.147322,"d":"0.15"},{"v":1.36748831774172,"d":"1.37"},{"v":0.451528508331854,"d":"0.45"},1,1,"up","no"]
["MSTRG.13635","RF00421","ENSOART00000024275","NA","NA","NA","NA",null,{"v":2.276053,"d":"2.28"},{"v":1.360539,"d":"1.36"},{"v":2.133168,"d":"2.13"},{"v":3.40673,"d":"3.41"},{"v":1.953976,"d":"1.95"},{"v":1.676026,"d":"1.68"},{"v":0.819948805780865,"d":"0.82"},{"v":-0.286394258268474,"d":"-0.29"},1,1,"down","no"]
["ENSOARG00000022769","RF00026","ENSOART00000024671","NA","NA","NA","NA",null,0,0,0,{"v":0.085902,"d":"0.09"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000001230","ENSOARG00000001230","ENSOART00000001315","NA","NA","NA","NA",null,{"v":0.102184,"d":"0.10"},{"v":0.274276,"d":"0.27"},{"v":0.12977,"d":"0.13"},{"v":0.27951,"d":"0.28"},{"v":0.093132,"d":"0.09"},0,{"v":1.35848884452101,"d":"1.36"},{"v":0.442002718655,"d":"0.44"},1,1,"up","no"]
["MSTRG.7302","ENSOARG00000021867","ENSOART00000023769","NA","NA","NA","NA",null,0,0,{"v":0.079106,"d":"0.08"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.2992","MIR744","ENSOART00000023974","NA","NA","NA","NA","microRNA 744 [Source:HGNC Symbol;Acc:HGNC:33658]",{"v":0.055867,"d":"0.06"},0,{"v":0.41951,"d":"0.42"},{"v":0.085043,"d":"0.09"},{"v":0.265326,"d":"0.27"},0,{"v":1.35678955615366,"d":"1.36"},{"v":0.440196969955289,"d":"0.44"},1,1,"up","no"]
["MSTRG.11827","ENSOARG00000007319","ENSOART00000007962","GO:0006629(lipid metabolic process);GO:0008081(phosphoric diester hydrolase activity);GO:0008889(glycerophosphodiester phosphodiesterase activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","glycerophosphodiester phosphodiesterase domain-containing protein 4-like [Source:NCBI gene;Acc:101117288]",0,{"v":0.0181867771084337,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.7888","ENSOARG00000013849","ENSOART00000015073","GO:0002682(regulation of immune system process);GO:0006508(proteolysis);GO:0006750(glutathione biosynthetic process);GO:0006751(glutathione catabolic process);GO:0007283(spermatogenesis);GO:0019344(cysteine biosynthetic process);GO:0031982(vesicle);GO:0036374(glutathione hydrolase activity);GO:0050727(regulation of inflammatory response)","NA","NA","NA",null,{"v":0.023201,"d":"0.02"},{"v":0.035232,"d":"0.04"},{"v":0.049843,"d":"0.05"},{"v":0.034497,"d":"0.03"},{"v":0.146159,"d":"0.15"},{"v":0.097076,"d":"0.10"},{"v":0.389857848573445,"d":"0.39"},{"v":-1.35897991589282,"d":"-1.36"},1,1,"down","no"]
["ENSOARG00000003622","EDARADD","ENSOART00000003930","GO:0005515(protein binding);GO:0007165(signal transduction)","NA","NA","NA","EDAR associated death domain [Source:NCBI gene;Acc:101115598]",0,0,0,{"v":0.109788,"d":"0.11"},{"v":0.058528,"d":"0.06"},{"v":0.139144,"d":"0.14"},"-inf","-inf",1,1,"down","no"]
["MSTRG.1916","ENSOARG00000012089","ENSOART00000013146","GO:0005882(intermediate filament);GO:0045095(keratin filament)","NA","NA","NA",null,0,0,{"v":0.00680982610767032,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000004945","SAPCD1","ENSOART00000005383","NA","NA","NA","NA","suppressor APC domain containing 1 [Source:NCBI gene;Acc:101117626]",{"v":0.276804,"d":"0.28"},0,0,{"v":0.113736,"d":"0.11"},0,{"v":0.098396,"d":"0.10"},{"v":1.30486678106085,"d":"1.30"},{"v":0.383902523949593,"d":"0.38"},1,1,"up","no"]
["MSTRG.7551","BRI3BP","ENSOART00000019266","GO:0005739(mitochondrion);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","BRI3 binding protein [Source:HGNC Symbol;Acc:HGNC:14251]",{"v":1.244805,"d":"1.24"},{"v":0.573689,"d":"0.57"},{"v":0.464233,"d":"0.46"},{"v":1.483338,"d":"1.48"},{"v":1.104614,"d":"1.10"},{"v":0.971789,"d":"0.97"},{"v":0.641262103057498,"d":"0.64"},{"v":-0.641013944762209,"d":"-0.64"},1,1,"down","no"]
["ENSOARG00000000402","GJB5","ENSOART00000000423","GO:0005886(plasma membrane);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0060707(trophoblast giant cell differentiation);GO:0060708(spongiotrophoblast differentiation);GO:0060713(labyrinthine layer morphogenesis)","NA","K07624","NA","gap junction protein beta 5 [Source:NCBI gene;Acc:101106891]",0,0,0,{"v":0.054855,"d":"0.05"},{"v":0.072359,"d":"0.07"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000014434","SAXO2","ENSOART00000015715","GO:0008017(microtubule binding)","NA","NA","NA","stabilizer of axonemal microtubules 2 [Source:HGNC Symbol;Acc:HGNC:33727]",{"v":0.051409,"d":"0.05"},0,{"v":0.034809,"d":"0.03"},{"v":0.013873,"d":"0.01"},{"v":0.053335,"d":"0.05"},{"v":0.091371,"d":"0.09"},{"v":0.543691157088896,"d":"0.54"},{"v":-0.879140731396824,"d":"-0.88"},1,1,"down","no"]
["MSTRG.17127","ENSOARG00000011920","ENSOART00000012965","GO:0016020(membrane);GO:0016021(integral component of membrane)","04978(Mineral absorption)","K14737","EC:1.16.1.-","STEAP family member 1 [Source:NCBI gene;Acc:101111709]",{"v":0.066078,"d":"0.07"},{"v":0.173687,"d":"0.17"},{"v":0.358535,"d":"0.36"},{"v":0.447825,"d":"0.45"},{"v":0.389175,"d":"0.39"},{"v":0.09475,"d":"0.09"},{"v":0.642125033539039,"d":"0.64"},{"v":-0.639073850961256,"d":"-0.64"},1,1,"down","no"]
["ENSOARG00000005756","BRINP1","ENSOART00000006268","GO:0001662(behavioral fear response);GO:0005737(cytoplasm);GO:0007614(short-term memory);GO:0008219(cell death);GO:0035176(social behavior);GO:0035640(exploration behavior);GO:0042711(maternal behavior);GO:0045666(positive regulation of neuron differentiation);GO:0045786(negative regulation of cell cycle);GO:0045930(negative regulation of mitotic cell cycle);GO:0050768(negative regulation of neurogenesis);GO:0071300(cellular response to retinoic acid);GO:0071625(vocalization behavior)","NA","NA","NA","BMP/retinoic acid inducible neural specific 1 [Source:NCBI gene;Acc:101123181]",{"v":0.054956,"d":"0.05"},{"v":0.034591,"d":"0.03"},0,{"v":0.270487,"d":"0.27"},{"v":0.26784,"d":"0.27"},0,{"v":0.166343133448629,"d":"0.17"},{"v":-2.58776578108061,"d":"-2.59"},1,1,"down","no"]
["MSTRG.12294","ENSOARG00000006177","ENSOART00000006717","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035869(ciliary transition zone)","NA","NA","NA",null,{"v":0.243582,"d":"0.24"},{"v":1.071816,"d":"1.07"},{"v":0.879067,"d":"0.88"},{"v":0.900248,"d":"0.90"},{"v":0.428987,"d":"0.43"},{"v":1.112923,"d":"1.11"},{"v":0.89857617729893,"d":"0.90"},{"v":-0.154287280687126,"d":"-0.15"},1,1,"down","no"]
["ENSOARG00000009095","ENSOARG00000009095","ENSOART00000009903","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","family with sequence similarity 205 member A [Source:NCBI gene;Acc:101116458]",0,0,0,0,{"v":0.01394,"d":"0.01"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.12450","RF00400","ENSOART00000025756","NA","NA","NA","NA",null,{"v":0.244088,"d":"0.24"},{"v":0.761374,"d":"0.76"},{"v":0.198795,"d":"0.20"},{"v":0.456443,"d":"0.46"},{"v":0.237951,"d":"0.24"},0,{"v":1.73425605635993,"d":"1.73"},{"v":0.794316922762883,"d":"0.79"},1,1,"up","no"]
["ENSOARG00000005324","ENSOARG00000005324","ENSOART00000005802","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 529 [Source:NCBI gene;Acc:101106618]",{"v":0.046309,"d":"0.05"},0,{"v":0.050327,"d":"0.05"},{"v":0.090333,"d":"0.09"},{"v":0.066297,"d":"0.07"},{"v":0.032791,"d":"0.03"},{"v":0.510165187597996,"d":"0.51"},{"v":-0.970963638505314,"d":"-0.97"},1,1,"down","no"]
["ENSOARG00000008484","LTA","ENSOART00000009233","GO:0002876(positive regulation of chronic inflammatory response to antigenic stimulus);GO:0002925(positive regulation of humoral immune response mediated by circulating immunoglobulin);GO:0005125(cytokine activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006955(immune response);GO:0006959(humoral immune response);GO:0010469(regulation of signaling receptor activity);GO:0016020(membrane);GO:0032729(positive regulation of interferon-gamma production);GO:0044130(negative regulation of growth of symbiont in host);GO:0048535(lymph node development);GO:0050830(defense response to Gram-positive bacterium)","04060(Cytokine-cytokine receptor interaction);04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04940(Type I diabetes mellitus);05166(Human T-cell leukemia virus 1 infection);05168(Herpes simplex virus 1 infection)","K05468","NA","lymphotoxin alpha [Source:NCBI gene;Acc:101123078]",0,0,0,{"v":0.034146,"d":"0.03"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000008167","LST1","ENSOART00000008886","GO:0000902(cell morphogenesis);GO:0005737(cytoplasm);GO:0006955(immune response);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016358(dendrite development);GO:0050672(negative regulation of lymphocyte proliferation)","NA","NA","NA","leukocyte specific transcript 1 [Source:NCBI gene;Acc:101122559]",{"v":0.02034,"d":"0.02"},0,{"v":0.063334,"d":"0.06"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000022269","ENSOARG00000022269","ENSOART00000024171","NA","NA","NA","NA",null,0,{"v":0.067765,"d":"0.07"},{"v":0.007757,"d":"0.01"},0,{"v":0.006708,"d":"0.01"},0,{"v":11.2584973166369,"d":"11.26"},{"v":3.49294237714507,"d":"3.49"},1,1,"up","no"]
["ENSOARG00000003839","ENSOARG00000003839","ENSOART00000004166","NA","NA","NA","NA",null,0,{"v":0.345105,"d":"0.35"},{"v":0.273868,"d":"0.27"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.21906","RF02123","ENSOART00000026864","NA","NA","NA","NA",null,0,0,0,0,{"v":0.307175,"d":"0.31"},{"v":0.292823,"d":"0.29"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000009174","ENSOARG00000009174","ENSOART00000009986","GO:0005198(structural molecule activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.047506,"d":"0.05"},{"v":0.043401,"d":"0.04"},{"v":0.077441,"d":"0.08"},{"v":0.103714,"d":"0.10"},{"v":0.054633,"d":"0.05"},0,{"v":1.06315875892818,"d":"1.06"},{"v":0.088357047119702,"d":"0.09"},1,1,"up","no"]
["MSTRG.10852","RF00188","ENSOART00000024365","NA","NA","NA","NA",null,{"v":0.341043,"d":"0.34"},{"v":1.397851,"d":"1.40"},{"v":0.658054,"d":"0.66"},{"v":0.427487,"d":"0.43"},{"v":0.701576,"d":"0.70"},{"v":0.192096,"d":"0.19"},{"v":1.81427670704283,"d":"1.81"},{"v":0.859394507373792,"d":"0.86"},1,1,"up","no"]
["ENSOARG00000011189","NUF2","ENSOART00000012170","GO:0000776(kinetochore);GO:0005634(nucleus);GO:0031262(Ndc80 complex)","NA","K11548","NA","NDC80 kinetochore complex component NUF2 [Source:NCBI gene;Acc:101110805]",{"v":0.045384,"d":"0.05"},0,{"v":0.101551,"d":"0.10"},{"v":0.113121,"d":"0.11"},{"v":0.063172,"d":"0.06"},{"v":0.122671,"d":"0.12"},{"v":0.491480579601557,"d":"0.49"},{"v":-1.02479368394931,"d":"-1.02"},1,1,"down","no"]
["ENSOARG00000024964","RF00100","ENSOART00000026866","NA","NA","NA","NA",null,{"v":0.145014,"d":"0.15"},0,0,{"v":0.38006,"d":"0.38"},{"v":0.148281,"d":"0.15"},0,{"v":0.274470465097352,"d":"0.27"},{"v":-1.86527718117622,"d":"-1.87"},1,1,"down","no"]
["MSTRG.8495","RF00181","ENSOART00000023785","NA","NA","NA","NA",null,{"v":0.017243,"d":"0.02"},{"v":0.031156,"d":"0.03"},{"v":0.286155,"d":"0.29"},{"v":0.171803,"d":"0.17"},{"v":0.717339,"d":"0.72"},{"v":0.126086,"d":"0.13"},{"v":0.329535828405048,"d":"0.33"},{"v":-1.60149276576255,"d":"-1.60"},1,1,"down","no"]
["MSTRG.13550","CCDC189","ENSOART00000008242","NA","NA","NA","NA","coiled-coil domain containing 189 [Source:NCBI gene;Acc:101102198]",0,{"v":0.068905,"d":"0.07"},{"v":0.055527,"d":"0.06"},{"v":0.195048,"d":"0.20"},{"v":0.205937,"d":"0.21"},{"v":0.037091,"d":"0.04"},{"v":0.284042038367772,"d":"0.28"},{"v":-1.81582362974726,"d":"-1.82"},1,1,"down","no"]
["ENSOARG00000007898","PRR19","ENSOART00000008598","NA","NA","NA","NA","proline rich 19 [Source:NCBI gene;Acc:101123577]",{"v":0.048988,"d":"0.05"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000010818","ENSOARG00000010818","ENSOART00000011765","GO:0004756(selenide, water dikinase activity);GO:0005524(ATP binding);GO:0016260(selenocysteine biosynthetic process);GO:0016310(phosphorylation)","NA","NA","NA",null,0,{"v":0.03201,"d":"0.03"},0,0,{"v":0.114788,"d":"0.11"},0,{"v":0.278861901940969,"d":"0.28"},{"v":-1.84237724777548,"d":"-1.84"},1,1,"down","no"]
["ENSOARG00000002474","SAMD15","ENSOART00000002680","GO:0005515(protein binding)","NA","NA","NA","sterile alpha motif domain containing 15 [Source:NCBI gene;Acc:101110598]",{"v":0.078246,"d":"0.08"},{"v":0.040681,"d":"0.04"},{"v":0.093225,"d":"0.09"},{"v":0.040663,"d":"0.04"},{"v":0.045547,"d":"0.05"},{"v":0.079467,"d":"0.08"},{"v":1.2805157022399,"d":"1.28"},{"v":0.356724943997265,"d":"0.36"},1,1,"up","no"]
["ENSOARG00000014597","DFFB","ENSOART00000015890","GO:0003677(DNA binding);GO:0004518(nuclease activity);GO:0004536(deoxyribonuclease activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006309(apoptotic DNA fragmentation);GO:0006915(apoptotic process);GO:0016787(hydrolase activity)","04210(Apoptosis)","K02311","EC:3.-.-.-","DNA fragmentation factor subunit beta [Source:NCBI gene;Acc:101101905]",{"v":0.463619,"d":"0.46"},{"v":0.238244,"d":"0.24"},{"v":0.482297,"d":"0.48"},{"v":0.505675,"d":"0.51"},{"v":0.588704,"d":"0.59"},{"v":0.70241,"d":"0.70"},{"v":0.659042324947448,"d":"0.66"},{"v":-0.601556974068317,"d":"-0.60"},1,1,"down","no"]
["MSTRG.11947","TKFC","ENSOART00000013779","GO:0004371(glycerone kinase activity);GO:0005524(ATP binding);GO:0006071(glycerol metabolic process);GO:0034012(FAD-AMP lyase (cyclizing) activity);GO:0039534(negative regulation of MDA-5 signaling pathway);GO:0044262(cellular carbohydrate metabolic process);GO:0045088(regulation of innate immune response);GO:0046835(carbohydrate phosphorylation);GO:0050354(triokinase activity)","00051(Fructose and mannose metabolism);00561(Glycerolipid metabolism);04622(RIG-I-like receptor signaling pathway)","K00863","2.7.1.29;4.6.1.15;EC:2.7.1.28","triokinase and FMN cyclase [Source:NCBI gene;Acc:101106378]",{"v":0.400887,"d":"0.40"},{"v":0.168218,"d":"0.17"},{"v":0.388756,"d":"0.39"},{"v":0.396179,"d":"0.40"},{"v":0.283852,"d":"0.28"},{"v":0.329776,"d":"0.33"},{"v":0.948558486918787,"d":"0.95"},{"v":-0.0761913637532017,"d":"-0.08"},1,1,"down","no"]
["ENSOARG00000007293","ABCB9","ENSOART00000007934","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0015440(peptide-transporting ATPase activity);GO:0015833(peptide transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0022857(transmembrane transporter activity);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0055085(transmembrane transport)","02010(ABC transporters);04142(Lysosome)","K05656","NA","ATP binding cassette subfamily B member 9 [Source:NCBI gene;Acc:101119252]",{"v":0.518242,"d":"0.52"},{"v":0.54363,"d":"0.54"},{"v":0.566814,"d":"0.57"},{"v":0.82625,"d":"0.83"},{"v":0.440522,"d":"0.44"},{"v":0.48013,"d":"0.48"},{"v":0.932328201582001,"d":"0.93"},{"v":-0.101090187814353,"d":"-0.10"},1,1,"down","no"]
["ENSOARG00000010955","ENSOARG00000010955","ENSOART00000011917","NA","NA","NA","NA",null,0,0,{"v":0.158477,"d":"0.16"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.1311","ENSOARG00000019343","ENSOART00000021066","GO:0038023(signaling receptor activity);GO:0150077(regulation of neuroinflammatory response)","NA","NA","NA",null,0,{"v":0.043649,"d":"0.04"},{"v":0.408321,"d":"0.41"},{"v":0.164567,"d":"0.16"},{"v":0.228665,"d":"0.23"},{"v":0.336705,"d":"0.34"},{"v":0.619190423283105,"d":"0.62"},{"v":-0.691544936694471,"d":"-0.69"},1,1,"down","no"]
["ENSOARG00000018090","C3orf20","ENSOART00000019694","GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","chromosome 19 open reading frame, human C3orf20 [Source:NCBI gene;Acc:101109126]",{"v":0.073879,"d":"0.07"},{"v":0.039829,"d":"0.04"},{"v":0.073538,"d":"0.07"},{"v":0.031283,"d":"0.03"},{"v":0.052985,"d":"0.05"},{"v":0.025739,"d":"0.03"},{"v":1.70212804639705,"d":"1.70"},{"v":0.76733957107406,"d":"0.77"},1,1,"up","no"]
["MSTRG.21171","STMN2","ENSOART00000008658","GO:0005737(cytoplasm);GO:0007026(negative regulation of microtubule depolymerization);GO:0010976(positive regulation of neuron projection development);GO:0010977(negative regulation of neuron projection development);GO:0030027(lamellipodium);GO:0030426(growth cone);GO:0031110(regulation of microtubule polymerization or depolymerization);GO:0031115(negative regulation of microtubule polymerization);GO:0031117(positive regulation of microtubule depolymerization);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:1990090(cellular response to nerve growth factor stimulus)","NA","NA","NA","stathmin 2 [Source:NCBI gene;Acc:101111294]",{"v":1.73407624221267,"d":"1.73"},{"v":0.347571371106337,"d":"0.35"},{"v":0.35748162244898,"d":"0.36"},{"v":0.135703,"d":"0.14"},{"v":0.0973256428571429,"d":"0.10"},{"v":0.250395602040816,"d":"0.25"},{"v":5.04552525346104,"d":"5.05"},{"v":2.33500446578724,"d":"2.34"},1,1,"up","no"]
["ENSOARG00000015279","GAS8","ENSOART00000016631","GO:0005874(microtubule);GO:0005929(cilium);GO:0005930(axoneme);GO:0008017(microtubule binding);GO:0017137(Rab GTPase binding);GO:0031514(motile cilium);GO:0035082(axoneme assembly);GO:0048870(cell motility);GO:0060294(cilium movement involved in cell motility);GO:1903566(positive regulation of protein localization to cilium)","NA","K19942","NA","growth arrest specific 8 [Source:NCBI gene;Acc:101108770]",{"v":0.053396,"d":"0.05"},{"v":0.055953,"d":"0.06"},{"v":0.024038,"d":"0.02"},{"v":0.135534,"d":"0.14"},0,0,{"v":0.984158956424218,"d":"0.98"},{"v":-0.0230367436275469,"d":"-0.02"},1,1,"down","no"]
["MSTRG.8318","RF00012","ENSOART00000024038","NA","NA","NA","NA",null,{"v":0.272562,"d":"0.27"},{"v":0.468023,"d":"0.47"},{"v":0.601959,"d":"0.60"},{"v":0.366644,"d":"0.37"},{"v":0.486509,"d":"0.49"},{"v":0.297449,"d":"0.30"},{"v":1.16681876096165,"d":"1.17"},{"v":0.222580488236577,"d":"0.22"},1,1,"up","no"]
["MSTRG.748","RF00003","ENSOART00000026868","NA","NA","NA","NA",null,{"v":1.505488,"d":"1.51"},{"v":1.246097,"d":"1.25"},{"v":1.724748,"d":"1.72"},{"v":2.778968,"d":"2.78"},{"v":2.045863,"d":"2.05"},{"v":5.117762,"d":"5.12"},{"v":0.450217865701633,"d":"0.45"},{"v":-1.15130478743394,"d":"-1.15"},1,1,"down","no"]
["ENSOARG00000014251","KLK5","ENSOART00000015524","GO:0002803(positive regulation of antibacterial peptide production);GO:0004252(serine-type endopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016787(hydrolase activity);GO:0045745(positive regulation of G protein-coupled receptor signaling pathway);GO:0097209(epidermal lamellar body)","NA","K09617","EC:3.4.21.-","kallikrein related peptidase 5 [Source:NCBI gene;Acc:101112504]",0,0,0,{"v":0.019379,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.5840","DACT3","ENSOART00000011589","GO:0005080(protein kinase C binding);GO:0005737(cytoplasm);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0030178(negative regulation of Wnt signaling pathway);GO:0030308(negative regulation of cell growth);GO:0042802(identical protein binding);GO:0051018(protein kinase A binding);GO:0070097(delta-catenin binding);GO:0090090(negative regulation of canonical Wnt signaling pathway)","NA","K22154","NA","dishevelled binding antagonist of beta catenin 3 [Source:NCBI gene;Acc:101121703]",{"v":0.403396,"d":"0.40"},{"v":0.410632,"d":"0.41"},{"v":0.288127,"d":"0.29"},{"v":0.379966,"d":"0.38"},{"v":0.529594,"d":"0.53"},{"v":0.536123,"d":"0.54"},{"v":0.762376675937948,"d":"0.76"},{"v":-0.391424112606173,"d":"-0.39"},1,1,"down","no"]
["ENSOARG00000005701","CPLX4","ENSOART00000006209","GO:0000149(SNARE binding);GO:0006836(neurotransmitter transport);GO:0019905(syntaxin binding);GO:0045202(synapse);GO:0046928(regulation of neurotransmitter secretion)","04721(Synaptic vesicle cycle)","K15295","NA","complexin 4 [Source:NCBI gene;Acc:101102111]",{"v":0.031596,"d":"0.03"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.13515","DOC2A","ENSOART00000004720","GO:0005509(calcium ion binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0007268(chemical synaptic transmission);GO:0016020(membrane);GO:0017158(regulation of calcium ion-dependent exocytosis);GO:0030054(cell junction);GO:0061669(spontaneous neurotransmitter secretion);GO:0098793(presynapse)","NA","K19916","NA","double C2 domain alpha [Source:NCBI gene;Acc:101116792]",{"v":0.025633,"d":"0.03"},0,0,0,{"v":0.016652,"d":"0.02"},0,{"v":1.53933461446073,"d":"1.54"},{"v":0.622306873089464,"d":"0.62"},1,1,"up","no"]
["ENSOARG00000011315","SPEF2","ENSOART00000012322","GO:0005515(protein binding)","NA","NA","NA","sperm flagellar 2 [Source:NCBI gene;Acc:101111394]",0,{"v":0.004566,"d":"0.00"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.1171","oar-mir-99a","ENSOART00000024109","NA","05206(MicroRNAs in cancer)","K17367","NA","oar-mir-99a [Source:miRBase;Acc:MI0025285]",{"v":0.018392,"d":"0.02"},0,{"v":0.980664,"d":"0.98"},{"v":0.122489,"d":"0.12"},{"v":0.257598,"d":"0.26"},0,{"v":2.62849295029822,"d":"2.63"},{"v":1.39423586556095,"d":"1.39"},1,1,"up","no"]
["ENSOARG00000013743","GABRB2","ENSOART00000014952","GO:0004888(transmembrane signaling receptor activity);GO:0004890(GABA-A receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0007605(sensory perception of sound);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016917(GABA receptor activity);GO:0022851(GABA-gated chloride ion channel activity);GO:0034220(ion transmembrane transport);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0048666(neuron development);GO:0060078(regulation of postsynaptic membrane potential);GO:0060119(inner ear receptor cell development);GO:0060384(innervation);GO:0090102(cochlea development);GO:0098982(GABA-ergic synapse);GO:0099060(integral component of postsynaptic specialization membrane);GO:1901215(negative regulation of neuron death);GO:1902476(chloride transmembrane transport);GO:1904315(transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential);GO:1904862(inhibitory synapse assembly)","04080(Neuroactive ligand-receptor interaction);04723(Retrograde endocannabinoid signaling);04726(Serotonergic synapse);04727(GABAergic synapse);05032(Morphine addiction);05033(Nicotine addiction)","K05181","NA","gamma-aminobutyric acid type A receptor beta2 subunit [Source:NCBI gene;Acc:100913155]",{"v":0.0442846737044146,"d":"0.04"},0,{"v":0.0811170580614203,"d":"0.08"},{"v":0.0523077519193858,"d":"0.05"},{"v":0.0558703286948177,"d":"0.06"},{"v":0.0272862317658349,"d":"0.03"},{"v":0.925717848211023,"d":"0.93"},{"v":-0.111355556925266,"d":"-0.11"},1,1,"down","no"]
["MSTRG.4880","ENSOARG00000022110","ENSOART00000024012","NA","NA","NA","NA",null,{"v":0.243755,"d":"0.24"},0,{"v":0.166496,"d":"0.17"},{"v":0.276561,"d":"0.28"},{"v":0.978558,"d":"0.98"},0,{"v":0.326862233780223,"d":"0.33"},{"v":-1.61324539959777,"d":"-1.61"},1,1,"down","no"]
["ENSOARG00000008808","MPZL2","ENSOART00000009588","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0098609(cell-cell adhesion)","NA","NA","NA","myelin protein zero like 2 [Source:NCBI gene;Acc:101122302]",{"v":0.056285,"d":"0.06"},{"v":0.019063,"d":"0.02"},{"v":0.021952,"d":"0.02"},{"v":0.028497,"d":"0.03"},{"v":0.031126,"d":"0.03"},{"v":0.027724,"d":"0.03"},{"v":1.1139478173263,"d":"1.11"},{"v":0.155681651485961,"d":"0.16"},1,1,"up","no"]
["MSTRG.7573","RF00100","ENSOART00000026901","NA","NA","NA","NA",null,{"v":0.868643,"d":"0.87"},{"v":0.402927,"d":"0.40"},{"v":0.849043,"d":"0.85"},{"v":0.794453,"d":"0.79"},{"v":1.362234,"d":"1.36"},{"v":1.513037,"d":"1.51"},{"v":0.577867163852104,"d":"0.58"},{"v":-0.791190200910221,"d":"-0.79"},1,1,"down","no"]
["ENSOARG00000003549","CNIH2","ENSOART00000003853","GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0030425(dendrite);GO:0043197(dendritic spine);GO:2000311(regulation of AMPA receptor activity)","NA","K20368","NA","cornichon family AMPA receptor auxiliary protein 2 [Source:NCBI gene;Acc:101113182]",{"v":0.058089,"d":"0.06"},{"v":0.025407,"d":"0.03"},{"v":0.114403,"d":"0.11"},{"v":0.086541,"d":"0.09"},{"v":0.025433,"d":"0.03"},{"v":0.252151,"d":"0.25"},{"v":0.543491932715414,"d":"0.54"},{"v":-0.879669474019036,"d":"-0.88"},1,1,"down","no"]
["ENSOARG00000014518","ENSOARG00000014518","ENSOART00000015803","NA","NA","NA","NA",null,0,{"v":0.105365,"d":"0.11"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.13651","RF00026","ENSOART00000025241","NA","NA","NA","NA","RNA, U6 small nuclear 174, pseudogene [Source:HGNC Symbol;Acc:HGNC:47137]",{"v":1.124362,"d":"1.12"},{"v":0.975601,"d":"0.98"},{"v":1.408591,"d":"1.41"},{"v":1.196139,"d":"1.20"},{"v":1.037683,"d":"1.04"},{"v":0.96349,"d":"0.96"},{"v":1.09734489471156,"d":"1.10"},{"v":0.1340170350279,"d":"0.13"},1,1,"up","no"]
["MSTRG.9697","ENSOARG00000022918","ENSOART00000024820","NA","NA","NA","NA",null,{"v":0.017243,"d":"0.02"},{"v":1.093583,"d":"1.09"},{"v":0.401651,"d":"0.40"},0,{"v":0.438274,"d":"0.44"},{"v":0.478078,"d":"0.48"},{"v":1.65054149497136,"d":"1.65"},{"v":0.722939408682775,"d":"0.72"},1,1,"up","no"]
["ENSOARG00000000274","TEKT1","ENSOART00000000291","NA","NA","K18628","NA","tektin 1 [Source:NCBI gene;Acc:101103164]",0,0,0,{"v":0.014721,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000014799","RASGRF1","ENSOART00000016121","GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005088(Ras guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005829(cytosol);GO:0007264(small GTPase mediated signal transduction);GO:0008283(cell population proliferation);GO:0030426(growth cone);GO:0031175(neuron projection development);GO:0034976(response to endoplasmic reticulum stress);GO:0035020(regulation of Rac protein signal transduction);GO:0035023(regulation of Rho protein signal transduction);GO:0035254(glutamate receptor binding);GO:0035556(intracellular signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0046578(regulation of Ras protein signal transduction);GO:0048168(regulation of neuronal synaptic plasticity);GO:0090630(activation of GTPase activity);GO:2000310(regulation of NMDA receptor activity)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04510(Focal adhesion)","K04349","NA","Ras protein specific guanine nucleotide releasing factor 1 [Source:NCBI gene;Acc:101113014]",0,0,0,0,0,{"v":0.005565,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["MSTRG.15041","GKN1","ENSOART00000021610","NA","NA","NA","NA","gastrokine 1 [Source:NCBI gene;Acc:100101239]",{"v":0.0172008006345849,"d":"0.02"},0,{"v":0.00925454547858276,"d":"0.01"},0,{"v":0.00960355288207298,"d":"0.01"},0,{"v":2.75474571109532,"d":"2.75"},{"v":1.46191915063905,"d":"1.46"},1,1,"up","no"]
["ENSOARG00000007698","SHC3","ENSOART00000008382","GO:0001784(phosphotyrosine residue binding);GO:0005515(protein binding);GO:0007165(signal transduction);GO:0007417(central nervous system development);GO:0007611(learning or memory);GO:0035249(synaptic transmission, glutamatergic);GO:0035556(intracellular signal transduction)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04012(ErbB signaling pathway);04014(Ras signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04510(Focal adhesion);04650(Natural killer cell mediated cytotoxicity);04722(Neurotrophin signaling pathway);04910(Insulin signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);05034(Alcoholism);05100(Bacterial invasion of epithelial cells);05214(Glioma);05220(Chronic myeloid leukemia);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K17448","NA","SHC adaptor protein 3 [Source:NCBI gene;Acc:101107936]",{"v":0.02733,"d":"0.03"},{"v":0.152614,"d":"0.15"},{"v":0.027323,"d":"0.03"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000001673","ENSOARG00000001673","ENSOART00000001800","NA","NA","NA","NA",null,0,{"v":0.441169,"d":"0.44"},{"v":0.127899,"d":"0.13"},0,0,{"v":0.267537,"d":"0.27"},{"v":2.12706279879045,"d":"2.13"},{"v":1.08886262764091,"d":"1.09"},1,1,"up","no"]
["MSTRG.9637","RF00410","ENSOART00000026558","NA","NA","NA","NA",null,{"v":0.618003,"d":"0.62"},{"v":0.222675,"d":"0.22"},{"v":0.689022,"d":"0.69"},{"v":0.306972,"d":"0.31"},{"v":0.134481,"d":"0.13"},0,{"v":3.46514804520527,"d":"3.47"},{"v":1.79291699147383,"d":"1.79"},1,1,"up","no"]
["ENSOARG00000008637","TPGS1","ENSOART00000009401","GO:0005813(centrosome);GO:0007268(chemical synaptic transmission);GO:0007288(sperm axoneme assembly);GO:0008017(microtubule binding);GO:0015631(tubulin binding);GO:0018095(protein polyglutamylation);GO:0030534(adult behavior);GO:0051648(vesicle localization);GO:0070740(tubulin-glutamic acid ligase activity)","NA","K16581","NA","tubulin polyglutamylase complex subunit 1 [Source:NCBI gene;Acc:101114106]",{"v":0.101282,"d":"0.10"},{"v":0.0703,"d":"0.07"},{"v":0.097392,"d":"0.10"},{"v":0.099815,"d":"0.10"},{"v":0.111893,"d":"0.11"},{"v":0.201908,"d":"0.20"},{"v":0.650298827898341,"d":"0.65"},{"v":-0.620825271427162,"d":"-0.62"},1,1,"down","no"]
["MSTRG.17140","RF00411","ENSOART00000023502","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 9 [Source:HGNC Symbol;Acc:HGNC:32597]",{"v":0.382791,"d":"0.38"},{"v":0.802981,"d":"0.80"},{"v":0.56228,"d":"0.56"},{"v":0.211825,"d":"0.21"},{"v":0.342488,"d":"0.34"},{"v":0.928454,"d":"0.93"},{"v":1.17891212847332,"d":"1.18"},{"v":0.237456189445582,"d":"0.24"},1,1,"up","no"]
["MSTRG.10603","RF00403","ENSOART00000026852","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 41 [Source:HGNC Symbol;Acc:HGNC:32634]",{"v":0.974657,"d":"0.97"},{"v":1.064705,"d":"1.06"},{"v":0.840094,"d":"0.84"},{"v":0.683687,"d":"0.68"},{"v":0.359484,"d":"0.36"},{"v":0.654896,"d":"0.65"},{"v":1.69572578702725,"d":"1.70"},{"v":0.76190289296681,"d":"0.76"},1,1,"up","no"]
["ENSOARG00000018489","FSCN2","ENSOART00000020122","GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0007015(actin filament organization);GO:0015629(actin cytoskeleton);GO:0030036(actin cytoskeleton organization);GO:0030674(protein binding, bridging);GO:0032420(stereocilium);GO:0042462(eye photoreceptor cell development);GO:0051015(actin filament binding)","NA","K17455","NA","fascin actin-bundling protein 2, retinal [Source:NCBI gene;Acc:101118036]",{"v":0.062238,"d":"0.06"},{"v":0.028109,"d":"0.03"},{"v":0.08791,"d":"0.09"},0,{"v":0.051439,"d":"0.05"},{"v":0.012449,"d":"0.01"},{"v":2.79014838467318,"d":"2.79"},{"v":1.48034184898623,"d":"1.48"},1,1,"up","no"]
["ENSOARG00000006201","ENSOARG00000006201","ENSOART00000006741","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.092034,"d":"0.09"},{"v":0.072062,"d":"0.07"},{"v":0.036021,"d":"0.04"},{"v":0.315695,"d":"0.32"},{"v":0.062797,"d":"0.06"},{"v":0.06638,"d":"0.07"},{"v":0.449830513046449,"d":"0.45"},{"v":-1.15254656910348,"d":"-1.15"},1,1,"down","no"]
["MSTRG.17753","ANGPTL6","ENSOART00000016201","GO:0030141(secretory granule)","NA","NA","NA","angiopoietin like 6 [Source:NCBI gene;Acc:101111541]",{"v":0.154717,"d":"0.15"},{"v":0.124212,"d":"0.12"},{"v":0.106737,"d":"0.11"},{"v":0.124045,"d":"0.12"},{"v":0.159634,"d":"0.16"},0,{"v":1.35951550872641,"d":"1.36"},{"v":0.443092609056728,"d":"0.44"},1,1,"up","no"]
["MSTRG.5990","ZNF432","ENSOART00000016321;ENSOART00000016322","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection);05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 432 [Source:NCBI gene;Acc:101103836]",{"v":0.530825540366972,"d":"0.53"},{"v":0.326863849541284,"d":"0.33"},{"v":0.228044621559633,"d":"0.23"},{"v":0.356189920183486,"d":"0.36"},{"v":0.315338238990826,"d":"0.32"},{"v":0.150295689908257,"d":"0.15"},{"v":1.32112740787449,"d":"1.32"},{"v":0.401769604998951,"d":"0.40"},1,1,"up","no"]
["MSTRG.15285","CAMKMT","ENSOART00000006642","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007005(mitochondrion organization);GO:0018022(peptidyl-lysine methylation);GO:0018025(calmodulin-lysine N-methyltransferase activity);GO:0031072(heat shock protein binding);GO:0032991(protein-containing complex)","00310(Lysine degradation)","K18826","EC:2.1.1.60","calmodulin-lysine N-methyltransferase [Source:NCBI gene;Acc:101116304]",{"v":0.322682,"d":"0.32"},{"v":0.141299,"d":"0.14"},{"v":0.337544,"d":"0.34"},{"v":0.317483,"d":"0.32"},{"v":0.02907,"d":"0.03"},{"v":0.106668,"d":"0.11"},{"v":1.76850807884012,"d":"1.77"},{"v":0.822532809525663,"d":"0.82"},1,1,"up","no"]
["MSTRG.11552","RF00026","ENSOART00000024668","NA","NA","NA","NA",null,0,{"v":0.201263,"d":"0.20"},{"v":0.104396,"d":"0.10"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000021397","ENSOARG00000021397","ENSOART00000023299","NA","NA","NA","NA",null,0,0,0,0,{"v":0.127429,"d":"0.13"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000014145","ENSOARG00000014145","ENSOART00000015402","GO:0003676(nucleic acid binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 2 [Source:NCBI gene;Acc:101116980]",{"v":0.467599,"d":"0.47"},{"v":0.44572,"d":"0.45"},{"v":0.135486,"d":"0.14"},{"v":0.254397,"d":"0.25"},{"v":0.248707,"d":"0.25"},{"v":0.083461,"d":"0.08"},{"v":1.78804565563919,"d":"1.79"},{"v":0.838383574509663,"d":"0.84"},1,1,"up","no"]
["MSTRG.702","SPAG17","ENSOART00000022167","GO:0003351(epithelial cilium movement);GO:1904158(axonemal central apparatus assembly);GO:1990716(axonemal central apparatus)","NA","NA","NA","sperm associated antigen 17 [Source:NCBI gene;Acc:101109497]",{"v":0.003001,"d":"0.00"},{"v":0.004763,"d":"0.00"},{"v":0.016045,"d":"0.02"},{"v":0.005271,"d":"0.01"},{"v":0.005569,"d":"0.01"},{"v":0.005491,"d":"0.01"},{"v":1.45790214928663,"d":"1.46"},{"v":0.543893892863574,"d":"0.54"},1,1,"up","no"]
["ENSOARG00000014851","EFCAB12","ENSOART00000016163","NA","NA","NA","NA","EF-hand calcium binding domain 12 [Source:NCBI gene;Acc:101107051]",0,0,0,0,0,{"v":0.099929,"d":"0.10"},"-inf","-inf",1,1,"down","no"]
["MSTRG.17775","CDKN2D","ENSOART00000018107","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0000082(G1/S transition of mitotic cell cycle);GO:0000731(DNA synthesis involved in DNA repair);GO:0004861(cyclin-dependent protein serine/threonine kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007050(cell cycle arrest);GO:0007605(sensory perception of sound);GO:0008285(negative regulation of cell population proliferation);GO:0009411(response to UV);GO:0019901(protein kinase binding);GO:0030308(negative regulation of cell growth);GO:0032526(response to retinoic acid);GO:0033280(response to vitamin D);GO:0042326(negative regulation of phosphorylation);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045736(negative regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0048102(autophagic cell death);GO:0097129(cyclin D2-CDK4 complex);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage);GO:1902807(negative regulation of cell cycle G1/S phase transition)","04068(FoxO signaling pathway);04110(Cell cycle)","K06623","NA","cyclin dependent kinase inhibitor 2D [Source:NCBI gene;Acc:101118528]",{"v":0.835272,"d":"0.84"},{"v":1.783818,"d":"1.78"},{"v":0.834542,"d":"0.83"},{"v":1.439246,"d":"1.44"},{"v":1.300106,"d":"1.30"},{"v":1.101,"d":"1.10"},{"v":0.899300897417737,"d":"0.90"},{"v":-0.153124186510368,"d":"-0.15"},1,1,"down","no"]
["MSTRG.8767","ENSOARG00000021896","ENSOART00000023798","NA","NA","NA","NA",null,{"v":1.120478,"d":"1.12"},{"v":0.014198,"d":"0.01"},0,{"v":0.596961,"d":"0.60"},{"v":0.632583,"d":"0.63"},{"v":0.43412,"d":"0.43"},{"v":0.682034353090528,"d":"0.68"},{"v":-0.552083687331223,"d":"-0.55"},1,1,"down","no"]
["MSTRG.6742","ENSOARG00000023374","ENSOART00000025276","NA","NA","NA","NA",null,{"v":0.450988,"d":"0.45"},{"v":1.753396,"d":"1.75"},{"v":1.469119,"d":"1.47"},{"v":0.244556,"d":"0.24"},{"v":1.210448,"d":"1.21"},{"v":0.388552,"d":"0.39"},{"v":1.99261807072853,"d":"1.99"},{"v":0.994665212299938,"d":"0.99"},1,1,"up","no"]
["MSTRG.3729","RF00334","ENSOART00000023628","NA","NA","NA","NA",null,{"v":0.37531,"d":"0.38"},{"v":0.641914,"d":"0.64"},0,0,{"v":1.061106,"d":"1.06"},{"v":0.620733,"d":"0.62"},{"v":0.60482840509704,"d":"0.60"},{"v":-0.7254021991605,"d":"-0.73"},1,1,"down","no"]
["MSTRG.952","ENSOARG00000022176","ENSOART00000024078","NA","NA","NA","NA",null,{"v":3.827908,"d":"3.83"},{"v":1.883393,"d":"1.88"},{"v":2.173741,"d":"2.17"},{"v":2.920653,"d":"2.92"},{"v":3.37203,"d":"3.37"},{"v":2.97704,"d":"2.98"},{"v":0.850623260263548,"d":"0.85"},{"v":-0.233407788938437,"d":"-0.23"},1,1,"down","no"]
["ENSOARG00000009472","ENSOARG00000009472","ENSOART00000010317","NA","NA","NA","NA",null,{"v":0.118237,"d":"0.12"},{"v":0.053411,"d":"0.05"},0,{"v":0.190892,"d":"0.19"},{"v":0.131525,"d":"0.13"},{"v":0.080055,"d":"0.08"},{"v":0.426484326860005,"d":"0.43"},{"v":-1.22943537087445,"d":"-1.23"},1,1,"down","no"]
["ENSOARG00000017151","SLITRK1","ENSOART00000018665","GO:0005515(protein binding);GO:0007399(nervous system development);GO:0007409(axonogenesis);GO:0007416(synapse assembly);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030534(adult behavior);GO:0035264(multicellular organism growth);GO:0042592(homeostatic process);GO:0045202(synapse);GO:0050772(positive regulation of axonogenesis);GO:0051965(positive regulation of synapse assembly);GO:0098978(glutamatergic synapse);GO:0098982(GABA-ergic synapse);GO:0099061(integral component of postsynaptic density membrane);GO:0099560(synaptic membrane adhesion);GO:1905606(regulation of presynapse assembly)","NA","NA","NA","SLIT and NTRK like family member 1 [Source:NCBI gene;Acc:101105580]",{"v":0.021968,"d":"0.02"},{"v":0.059166,"d":"0.06"},{"v":0.19748,"d":"0.20"},0,{"v":0.01004,"d":"0.01"},{"v":0.067897,"d":"0.07"},{"v":3.57486174730872,"d":"3.57"},{"v":1.83788744879204,"d":"1.84"},1,1,"up","no"]
["MSTRG.19173","ENSOARG00000010341","ENSOART00000011246","NA","NA","NA","NA",null,{"v":0.529759,"d":"0.53"},{"v":0.091372,"d":"0.09"},{"v":0.237447,"d":"0.24"},{"v":0.980404,"d":"0.98"},{"v":0.7328,"d":"0.73"},{"v":0.475426,"d":"0.48"},{"v":0.392290154114674,"d":"0.39"},{"v":-1.35000696846595,"d":"-1.35"},1,1,"down","no"]
["ENSOARG00000000639","ZNF467","ENSOART00000000679","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 467 [Source:NCBI gene;Acc:101108650]",{"v":0.159099,"d":"0.16"},{"v":0.046967,"d":"0.05"},0,{"v":0.059826,"d":"0.06"},{"v":0.340372,"d":"0.34"},{"v":0.167114,"d":"0.17"},{"v":0.363232224948529,"d":"0.36"},{"v":-1.46103589470592,"d":"-1.46"},1,1,"down","no"]
["ENSOARG00000005303","ZNF567","ENSOART00000005782","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 567 [Source:NCBI gene;Acc:101103664]",{"v":0.503675,"d":"0.50"},{"v":0.324395,"d":"0.32"},{"v":0.391687,"d":"0.39"},{"v":0.42462,"d":"0.42"},{"v":0.351281,"d":"0.35"},{"v":0.383339,"d":"0.38"},{"v":1.0522040302267,"d":"1.05"},{"v":0.0734144811090607,"d":"0.07"},1,1,"up","no"]
["ENSOARG00000012771","C9orf85","ENSOART00000013882","NA","NA","NA","NA","chromosome 2 open reading frame, human C9orf85 [Source:NCBI gene;Acc:101101954]",{"v":0.908725,"d":"0.91"},{"v":0.920896,"d":"0.92"},{"v":1.267603,"d":"1.27"},{"v":1.329538,"d":"1.33"},{"v":0.394763,"d":"0.39"},{"v":0.407197,"d":"0.41"},{"v":1.45307384759451,"d":"1.45"},{"v":0.539108024960483,"d":"0.54"},1,1,"up","no"]
["MSTRG.8498","RF00181","ENSOART00000026296","NA","NA","NA","NA",null,{"v":0.185416,"d":"0.19"},{"v":0.252001,"d":"0.25"},0,{"v":0.261052,"d":"0.26"},{"v":0.168944,"d":"0.17"},{"v":0.027837,"d":"0.03"},{"v":0.955407321010062,"d":"0.96"},{"v":-0.0658121630808588,"d":"-0.07"},1,1,"down","no"]
["ENSOARG00000020171","SLC22A15","ENSOART00000021962","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K08211","NA","solute carrier family 22 member 15 [Source:NCBI gene;Acc:101105960]",{"v":0.021218,"d":"0.02"},{"v":0.045613,"d":"0.05"},{"v":0.091468,"d":"0.09"},0,0,{"v":0.020677,"d":"0.02"},{"v":7.65580113169222,"d":"7.66"},{"v":2.93655335463484,"d":"2.94"},1,1,"up","no"]
["ENSOARG00000006501","ENSOARG00000006501","ENSOART00000007066","NA","NA","NA","NA",null,0,{"v":0.02321,"d":"0.02"},{"v":0.010542,"d":"0.01"},{"v":0.04995,"d":"0.05"},0,0,{"v":0.675715715715716,"d":"0.68"},{"v":-0.565511685347792,"d":"-0.57"},1,1,"down","no"]
["MSTRG.11318","CYP39A1","ENSOART00000011702","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006699(bile acid biosynthetic process);GO:0006707(cholesterol catabolic process);GO:0008387(steroid 7-alpha-hydroxylase activity);GO:0008396(oxysterol 7-alpha-hydroxylase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","00120(Primary bile acid biosynthesis)","K07439","EC:1.14.14.26","24-hydroxycholesterol 7-alpha-hydroxylase [Source:NCBI gene;Acc:101120701]",{"v":0.530685,"d":"0.53"},{"v":0.271394,"d":"0.27"},{"v":0.299723,"d":"0.30"},{"v":0.624614,"d":"0.62"},{"v":0.635447,"d":"0.64"},{"v":0.853272,"d":"0.85"},{"v":0.521357495482255,"d":"0.52"},{"v":-0.939655125279232,"d":"-0.94"},1,1,"down","no"]
["ENSOARG00000003278","CCDC170","ENSOART00000003556","NA","NA","NA","NA","coiled-coil domain containing 170 [Source:NCBI gene;Acc:101105760]",{"v":0.0141652811735941,"d":"0.01"},0,{"v":0.010679706601467,"d":"0.01"},{"v":0.029561858190709,"d":"0.03"},0,0,{"v":0.840440665630066,"d":"0.84"},{"v":-0.250782124828511,"d":"-0.25"},1,1,"down","no"]
["MSTRG.3197","ENSOARG00000010734","ENSOART00000011675","GO:0003700(DNA-binding transcription factor activity);GO:0006357(regulation of transcription by RNA polymerase II)","NA","NA","NA",null,{"v":0.45744,"d":"0.46"},{"v":0.299371,"d":"0.30"},{"v":0.16203,"d":"0.16"},{"v":0.562834,"d":"0.56"},{"v":0.186141,"d":"0.19"},{"v":0.22244,"d":"0.22"},{"v":0.945878949779446,"d":"0.95"},{"v":-0.0802725304846643,"d":"-0.08"},1,1,"down","no"]
["ENSOARG00000013358","MORN3","ENSOART00000014529","NA","NA","NA","NA","MORN repeat containing 3 [Source:NCBI gene;Acc:101123583]",0,0,{"v":0.078516,"d":"0.08"},{"v":0.111636,"d":"0.11"},{"v":0.028938,"d":"0.03"},0,{"v":0.558538563318964,"d":"0.56"},{"v":-0.840271202382227,"d":"-0.84"},1,1,"down","no"]
["ENSOARG00000010833","ENSOARG00000010833","ENSOART00000011784","GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005030(neurotrophin receptor activity);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0038179(neurotrophin signaling pathway)","NA","NA","NA",null,{"v":0.382843,"d":"0.38"},{"v":0.18634,"d":"0.19"},{"v":0.376415,"d":"0.38"},{"v":0.18225,"d":"0.18"},{"v":0.487164,"d":"0.49"},{"v":0.203216,"d":"0.20"},{"v":1.08361848664382,"d":"1.08"},{"v":0.115856911389612,"d":"0.12"},1,1,"up","no"]
["ENSOARG00000001207","SLC22A14","ENSOART00000001292","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K08210","NA","solute carrier family 22 member 14 [Source:NCBI gene;Acc:101115994]",{"v":0.018612,"d":"0.02"},0,{"v":0.020707,"d":"0.02"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.16697","MAPK8IP2","ENSOART00000021763","GO:0001662(behavioral fear response);GO:0005078(MAP-kinase scaffold activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007254(JNK cascade);GO:0007617(mating behavior);GO:0010469(regulation of signaling receptor activity);GO:0014069(postsynaptic density);GO:0019894(kinesin binding);GO:0019901(protein kinase binding);GO:0035176(social behavior);GO:0043025(neuronal cell body);GO:0043410(positive regulation of MAPK cascade);GO:0046328(regulation of JNK cascade);GO:0046958(nonassociative learning);GO:0048813(dendrite morphogenesis);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0060079(excitatory postsynaptic potential);GO:2000310(regulation of NMDA receptor activity);GO:2000311(regulation of AMPA receptor activity);GO:2001234(negative regulation of apoptotic signaling pathway)","04010(MAPK signaling pathway)","K04435","NA","mitogen-activated protein kinase 8 interacting protein 2 [Source:NCBI gene;Acc:101119037]",{"v":0.079337,"d":"0.08"},{"v":0.031941,"d":"0.03"},{"v":0.051473,"d":"0.05"},{"v":0.141856,"d":"0.14"},{"v":0.098855,"d":"0.10"},0,{"v":0.676126142968124,"d":"0.68"},{"v":-0.564635663679896,"d":"-0.56"},1,1,"down","no"]
["MSTRG.13055","RF00151","ENSOART00000025837","NA","NA","NA","NA","small nucleolar RNA, C/D box 58A [Source:HGNC Symbol;Acc:HGNC:10208]",{"v":1.732434,"d":"1.73"},{"v":0.708662,"d":"0.71"},{"v":1.583409,"d":"1.58"},{"v":1.971831,"d":"1.97"},{"v":2.187632,"d":"2.19"},{"v":0.62279,"d":"0.62"},{"v":0.841549997459357,"d":"0.84"},{"v":-0.248879108603757,"d":"-0.25"},1,1,"down","no"]
["ENSOARG00000015843","PHACTR3","ENSOART00000017252","GO:0003779(actin binding);GO:0004864(protein phosphatase inhibitor activity);GO:0005654(nucleoplasm);GO:0008157(protein phosphatase 1 binding);GO:0019888(protein phosphatase regulator activity);GO:0032515(negative regulation of phosphoprotein phosphatase activity);GO:0043666(regulation of phosphoprotein phosphatase activity)","NA","K17594","NA","phosphatase and actin regulator 3 [Source:NCBI gene;Acc:101114041]",{"v":0.017261,"d":"0.02"},0,0,0,{"v":0.031498,"d":"0.03"},0,{"v":0.548003047812559,"d":"0.55"},{"v":-0.867744177884339,"d":"-0.87"},1,1,"down","no"]
["ENSOARG00000013347","CHGA","ENSOART00000014516","GO:0002551(mast cell chemotaxis);GO:0030141(secretory granule);GO:0032762(mast cell cytokine production);GO:0033366(protein localization to secretory granule);GO:0033604(negative regulation of catecholamine secretion);GO:0042629(mast cell granule);GO:0043303(mast cell degranulation);GO:0045576(mast cell activation);GO:0048471(perinuclear region of cytoplasm);GO:0050829(defense response to Gram-negative bacterium);GO:0050830(defense response to Gram-positive bacterium);GO:2000707(positive regulation of dense core granule biogenesis)","NA","K19990","NA","chromogranin A [Source:NCBI gene;Acc:101114907]",0,{"v":0.069973,"d":"0.07"},{"v":0.050753,"d":"0.05"},{"v":0.329389,"d":"0.33"},{"v":0.308663,"d":"0.31"},{"v":0.400235,"d":"0.40"},{"v":0.116274209346741,"d":"0.12"},{"v":-3.10439696517675,"d":"-3.10"},1,1,"down","no"]
["ENSOARG00000020500","ENSOARG00000020500","ENSOART00000022329","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0016787(hydrolase activity);GO:0030163(protein catabolic process)","NA","NA","NA",null,0,0,0,0,0,{"v":0.060265,"d":"0.06"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017024","ENSOARG00000017024","ENSOART00000018532","GO:0005634(nucleus);GO:0006334(nucleosome assembly)","NA","NA","NA",null,0,0,0,{"v":0.095319,"d":"0.10"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000004858","ENSOARG00000004858","ENSOART00000005295","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","NA","K11299","NA","non-histone chromosomal protein HMG-14 [Source:NCBI gene;Acc:101103182]",{"v":0.113296,"d":"0.11"},{"v":0.374852,"d":"0.37"},{"v":0.064288,"d":"0.06"},{"v":0.374135,"d":"0.37"},{"v":0.208772,"d":"0.21"},{"v":0.080899,"d":"0.08"},{"v":0.832225077808878,"d":"0.83"},{"v":-0.264954332477545,"d":"-0.26"},1,1,"down","no"]
["ENSOARG00000012665","ENSOARG00000012665","ENSOART00000013767","NA","NA","NA","NA",null,{"v":0.109708,"d":"0.11"},{"v":0.023933,"d":"0.02"},{"v":0.111187,"d":"0.11"},{"v":0.039645,"d":"0.04"},{"v":0.074822,"d":"0.07"},{"v":0.027291,"d":"0.03"},{"v":1.72708418572497,"d":"1.73"},{"v":0.788338407920552,"d":"0.79"},1,1,"up","no"]
["MSTRG.5302","ENSOARG00000012077","ENSOART00000013133","NA","NA","NA","NA",null,0,{"v":0.202067,"d":"0.20"},{"v":0.475902,"d":"0.48"},{"v":0.363871,"d":"0.36"},{"v":0.244969,"d":"0.24"},{"v":0.178465,"d":"0.18"},{"v":0.861126247134211,"d":"0.86"},{"v":-0.215703332570022,"d":"-0.22"},1,1,"down","no"]
["ENSOARG00000002213","ENSOARG00000002213","ENSOART00000002387","GO:0044666(MLL3/4 complex);GO:0048188(Set1C/COMPASS complex)","NA","NA","NA",null,0,0,0,{"v":0.038739,"d":"0.04"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.21447","ENSOARG00000018078","ENSOART00000019675","NA","NA","NA","NA",null,{"v":0.573651,"d":"0.57"},0,0,{"v":0.207349,"d":"0.21"},{"v":0.094749,"d":"0.09"},{"v":0.195651,"d":"0.20"},{"v":1.15249051228631,"d":"1.15"},{"v":0.204754873922442,"d":"0.20"},1,1,"up","no"]
["ENSOARG00000006809","ENSOARG00000006809","ENSOART00000007400","NA","NA","NA","NA","CD48 antigen-like [Source:NCBI gene;Acc:101112109]",{"v":0.254673,"d":"0.25"},{"v":0.225927,"d":"0.23"},{"v":0.246419,"d":"0.25"},{"v":0.143476,"d":"0.14"},{"v":0.357364,"d":"0.36"},{"v":0.169354,"d":"0.17"},{"v":1.0847888820252,"d":"1.08"},{"v":0.117414297516377,"d":"0.12"},1,1,"up","no"]
["ENSOARG00000011170","CRHR1","ENSOART00000012147","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0015056(corticotrophin-releasing factor receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030325(adrenal gland development);GO:0042596(fear response);GO:0048149(behavioral response to ethanol);GO:0051458(corticotropin secretion);GO:0051867(general adaptation syndrome, behavioral process);GO:0071376(cellular response to corticotropin-releasing hormone stimulus);GO:2000852(regulation of corticosterone secretion)","04080(Neuroactive ligand-receptor interaction);04730(Long-term depression);04934(Cushing syndrome)","K04578","NA","corticotropin releasing hormone receptor 1 [Source:NCBI gene;Acc:443025]",0,{"v":0.024035,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.11189","DEF6","ENSOART00000012716","GO:0005654(nucleoplasm);GO:0005829(cytosol)","NA","NA","NA","DEF6, guanine nucleotide exchange factor [Source:NCBI gene;Acc:101117371]",{"v":0.08853,"d":"0.09"},{"v":0.046623,"d":"0.05"},{"v":0.063678,"d":"0.06"},{"v":0.156414,"d":"0.16"},{"v":0.070324,"d":"0.07"},{"v":0.071718,"d":"0.07"},{"v":0.666198702656338,"d":"0.67"},{"v":-0.585975550351367,"d":"-0.59"},1,1,"down","no"]
["MSTRG.7255","CEP72","ENSOART00000017314","GO:0005515(protein binding);GO:0005813(centrosome);GO:0007051(spindle organization);GO:0007099(centriole replication);GO:0033566(gamma-tubulin complex localization);GO:0034451(centriolar satellite);GO:0042802(identical protein binding);GO:1904779(regulation of protein localization to centrosome)","NA","K16532","NA","centrosomal protein 72 [Source:NCBI gene;Acc:101109828]",{"v":0.199292,"d":"0.20"},{"v":0.072178,"d":"0.07"},{"v":0.021761,"d":"0.02"},{"v":0.090897,"d":"0.09"},{"v":0.219745,"d":"0.22"},{"v":0.231708,"d":"0.23"},{"v":0.540667465658707,"d":"0.54"},{"v":-0.887186549166581,"d":"-0.89"},1,1,"down","no"]
["MSTRG.11405","AIF1","ENSOART00000008641","GO:0001726(ruffle);GO:0001891(phagocytic cup);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005884(actin filament);GO:0006911(phagocytosis, engulfment);GO:0008284(positive regulation of cell population proliferation);GO:0016601(Rac protein signal transduction);GO:0030027(lamellipodium);GO:0030041(actin filament polymerization);GO:0030046(parallel actin filament bundle assembly);GO:0030335(positive regulation of cell migration);GO:0032587(ruffle membrane);GO:0034599(cellular response to oxidative stress);GO:0042102(positive regulation of T cell proliferation);GO:0048471(perinuclear region of cytoplasm);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0050921(positive regulation of chemotaxis);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:0051764(actin crosslink formation);GO:0071346(cellular response to interferon-gamma);GO:0071672(negative regulation of smooth muscle cell chemotaxis);GO:0071673(positive regulation of smooth muscle cell chemotaxis);GO:0071677(positive regulation of mononuclear cell migration);GO:0090026(positive regulation of monocyte chemotaxis);GO:0090197(positive regulation of chemokine secretion);GO:0090271(positive regulation of fibroblast growth factor production);GO:0097178(ruffle assembly);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:2000406(positive regulation of T cell migration);GO:2000778(positive regulation of interleukin-6 secretion)","NA","K18617","NA","allograft inflammatory factor 1 [Source:NCBI gene;Acc:101121889]",{"v":1.304214,"d":"1.30"},{"v":0.794119,"d":"0.79"},{"v":0.544181,"d":"0.54"},{"v":1.285331,"d":"1.29"},{"v":1.249119,"d":"1.25"},{"v":1.526572,"d":"1.53"},{"v":0.650701719911884,"d":"0.65"},{"v":-0.619931727870224,"d":"-0.62"},1,1,"down","no"]
["ENSOARG00000018657","ENSOARG00000018657","ENSOART00000020305","GO:0005576(extracellular region);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042157(lipoprotein metabolic process)","NA","NA","NA",null,{"v":0.0993183765957447,"d":"0.10"},{"v":0.417821170921986,"d":"0.42"},{"v":0.19575580070922,"d":"0.20"},{"v":0.0257705758865248,"d":"0.03"},{"v":0.167164762411348,"d":"0.17"},{"v":0.138069038297872,"d":"0.14"},{"v":2.15373390394052,"d":"2.15"},{"v":1.10684001442261,"d":"1.11"},1,1,"up","no"]
["ENSOARG00000012061","PTCHD4","ENSOART00000013120","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","patched domain containing 4 [Source:NCBI gene;Acc:101122472]",0,0,0,{"v":0.013574,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.4579","ENSOARG00000023393","ENSOART00000025295","NA","NA","NA","NA",null,0,0,{"v":0.124115,"d":"0.12"},0,0,{"v":0.252173,"d":"0.25"},{"v":0.492181954451904,"d":"0.49"},{"v":-1.02273633164636,"d":"-1.02"},1,1,"down","no"]
["ENSOARG00000000599","ENSOARG00000000599","ENSOART00000000643","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,0,{"v":0.056635,"d":"0.06"},{"v":0.169362,"d":"0.17"},0,0,{"v":0.334402050046646,"d":"0.33"},{"v":-1.58034440302161,"d":"-1.58"},1,1,"down","no"]
["MSTRG.2400","MIR92A1","ENSOART00000023329","NA","NA","NA","NA","microRNA 92a-1 [Source:HGNC Symbol;Acc:HGNC:31643]",{"v":0.312111,"d":"0.31"},{"v":0.756834,"d":"0.76"},{"v":0.279549,"d":"0.28"},0,0,{"v":0.671675,"d":"0.67"},{"v":2.00765846577586,"d":"2.01"},{"v":1.00551386508569,"d":"1.01"},1,1,"up","no"]
["ENSOARG00000019703","OSCP1","ENSOART00000021457","GO:0005215(transporter activity);GO:0005737(cytoplasm);GO:0009925(basal plasma membrane);GO:0015893(drug transport)","NA","NA","NA","organic solute carrier partner 1 [Source:NCBI gene;Acc:101113543]",{"v":0.066573,"d":"0.07"},{"v":0.117147,"d":"0.12"},{"v":0.146866,"d":"0.15"},{"v":0.103302,"d":"0.10"},{"v":0.297229,"d":"0.30"},{"v":0.270709,"d":"0.27"},{"v":0.492500446934032,"d":"0.49"},{"v":-1.02180306110166,"d":"-1.02"},1,1,"down","no"]
["MSTRG.10550","ENSOARG00000016909","ENSOART00000018415","GO:0004197(cysteine-type endopeptidase activity);GO:0005515(protein binding);GO:0006508(proteolysis);GO:0042981(regulation of apoptotic process);GO:0097190(apoptotic signaling pathway);GO:0097199(cysteine-type endopeptidase activity involved in apoptotic signaling pathway)","NA","NA","NA",null,{"v":0.166383,"d":"0.17"},{"v":0.00837,"d":"0.01"},{"v":0.048522,"d":"0.05"},0,{"v":0.020379,"d":"0.02"},{"v":0.025721,"d":"0.03"},{"v":4.84327548806941,"d":"4.84"},{"v":2.27598306652985,"d":"2.28"},1,1,"up","no"]
["ENSOARG00000003230","C3orf33","ENSOART00000003503","GO:0005615(extracellular space);GO:0051090(regulation of DNA-binding transcription factor activity);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","NA","NA","NA","chromosome 1 open reading frame, human C3orf33 [Source:NCBI gene;Acc:101121061]",{"v":0.193677,"d":"0.19"},{"v":0.024211,"d":"0.02"},{"v":0.083349,"d":"0.08"},{"v":0.118182,"d":"0.12"},{"v":0.077741,"d":"0.08"},{"v":0.103423,"d":"0.10"},{"v":1.00631710462141,"d":"1.01"},{"v":0.00908499021020637,"d":"0.01"},1,1,"up","no"]
["MSTRG.9698","ENSOARG00000021376","ENSOART00000023278","NA","NA","NA","NA",null,{"v":0.045463,"d":"0.05"},{"v":0.345966,"d":"0.35"},{"v":0.37759,"d":"0.38"},{"v":0.502706,"d":"0.50"},{"v":0.567804,"d":"0.57"},{"v":0.060379,"d":"0.06"},{"v":0.680012804085989,"d":"0.68"},{"v":-0.556366183498726,"d":"-0.56"},1,1,"down","no"]
["ENSOARG00000009590","COLEC10","ENSOART00000010439","GO:0005537(mannose binding);GO:0005581(collagen trimer);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0042056(chemoattractant activity);GO:0050918(positive chemotaxis);GO:1904888(cranial skeletal system development)","NA","K10065","NA","collectin subfamily member 10 [Source:NCBI gene;Acc:101114116]",0,0,0,{"v":0.050922,"d":"0.05"},{"v":0.165338,"d":"0.17"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000015520","ENSOARG00000015520","ENSOART00000016882","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","NA","NA","NA",null,0,{"v":0.034194,"d":"0.03"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000015918","ENSOARG00000015918","ENSOART00000017330","GO:0003676(nucleic acid binding);GO:0004190(aspartic-type endopeptidase activity);GO:0005198(structural molecule activity);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0016032(viral process)","NA","NA","NA",null,{"v":0.119761638888889,"d":"0.12"},{"v":0.0930873888888889,"d":"0.09"},{"v":0.309974194444444,"d":"0.31"},{"v":0.169239111111111,"d":"0.17"},0,{"v":0.0511941666666667,"d":"0.05"},{"v":2.37179806739202,"d":"2.37"},{"v":1.24598118544318,"d":"1.25"},1,1,"up","no"]
["ENSOARG00000023752","RF00099","ENSOART00000025654","NA","NA","NA","NA",null,{"v":0.048107,"d":"0.05"},{"v":0.176656,"d":"0.18"},0,0,{"v":0.154559,"d":"0.15"},0,{"v":1.45422136530386,"d":"1.45"},{"v":0.540246896711275,"d":"0.54"},1,1,"up","no"]
["MSTRG.11990","RF00087","ENSOART00000023520","NA","NA","NA","NA","small nucleolar RNA, C/D box 26 [Source:HGNC Symbol;Acc:HGNC:10148]",{"v":0.16609,"d":"0.17"},{"v":0.478964,"d":"0.48"},{"v":1.60008,"d":"1.60"},{"v":1.490508,"d":"1.49"},{"v":1.41853,"d":"1.42"},{"v":0.236838,"d":"0.24"},{"v":0.71367530061579,"d":"0.71"},{"v":-0.486660251358914,"d":"-0.49"},1,1,"down","no"]
["ENSOARG00000002305","ENSOARG00000002305","ENSOART00000002495","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.008409,"d":"0.01"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000018347","LY86","ENSOART00000019967","GO:0006955(immune response);GO:0031666(positive regulation of lipopolysaccharide-mediated signaling pathway)","NA","NA","NA","lymphocyte antigen 86 [Source:NCBI gene;Acc:101108087]",{"v":0.191654,"d":"0.19"},0,{"v":0.105972,"d":"0.11"},{"v":0.313724,"d":"0.31"},{"v":0.086184,"d":"0.09"},{"v":0.73997,"d":"0.74"},{"v":0.261103381239045,"d":"0.26"},{"v":-1.9373069544897,"d":"-1.94"},1,1,"down","no"]
["ENSOARG00000008845","FAT2","ENSOART00000009633","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0010631(epithelial cell migration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031589(cell-substrate adhesion)","NA","K16506","NA","FAT atypical cadherin 2 [Source:NCBI gene;Acc:101106258]",0,{"v":0.015547,"d":"0.02"},{"v":0.013234,"d":"0.01"},{"v":0.00756,"d":"0.01"},{"v":0.013816,"d":"0.01"},{"v":0.005378,"d":"0.01"},{"v":1.07576437168274,"d":"1.08"},{"v":0.10536211411092,"d":"0.11"},1,1,"up","no"]
["MSTRG.18917","GABRA2","ENSOART00000016861","GO:0004888(transmembrane signaling receptor activity);GO:0004890(GABA-A receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022851(GABA-gated chloride ion channel activity);GO:0030424(axon);GO:0030425(dendrite);GO:0034220(ion transmembrane transport);GO:0043025(neuronal cell body);GO:0060077(inhibitory synapse);GO:0098794(postsynapse);GO:0098982(GABA-ergic synapse);GO:0099060(integral component of postsynaptic specialization membrane);GO:1902476(chloride transmembrane transport);GO:1904862(inhibitory synapse assembly)","04080(Neuroactive ligand-receptor interaction);04723(Retrograde endocannabinoid signaling);04727(GABAergic synapse);04742(Taste transduction);05032(Morphine addiction);05033(Nicotine addiction)","K05175","NA","gamma-aminobutyric acid type A receptor alpha2 subunit [Source:NCBI gene;Acc:101121265]",{"v":0.062412,"d":"0.06"},0,{"v":0.029215,"d":"0.03"},{"v":0.022375,"d":"0.02"},{"v":0.013763,"d":"0.01"},{"v":0.10458,"d":"0.10"},{"v":0.65113915774812,"d":"0.65"},{"v":-0.618962193986912,"d":"-0.62"},1,1,"down","no"]
["MSTRG.8529","oar-mir-329a","ENSOART00000024408","NA","NA","NA","NA","oar-mir-329a [Source:miRBase;Acc:MI0016926]",{"v":0.589705,"d":"0.59"},{"v":1.343792,"d":"1.34"},{"v":2.729342,"d":"2.73"},{"v":1.371534,"d":"1.37"},{"v":3.522158,"d":"3.52"},{"v":1.55547,"d":"1.56"},{"v":0.723014711058584,"d":"0.72"},{"v":-0.467903093139257,"d":"-0.47"},1,1,"down","no"]
["MSTRG.20296","RF00026","ENSOART00000024037","NA","NA","NA","NA",null,{"v":4.032388,"d":"4.03"},{"v":1.223889,"d":"1.22"},{"v":0.716705,"d":"0.72"},{"v":2.080586,"d":"2.08"},{"v":0.948314,"d":"0.95"},{"v":1.112527,"d":"1.11"},{"v":1.44225215125125,"d":"1.44"},{"v":0.528323415312429,"d":"0.53"},1,1,"up","no"]
["MSTRG.15159","RF00001","ENSOART00000025303","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.025645,"d":"0.03"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000003094","OPN1SW","ENSOART00000003355","GO:0001750(photoreceptor outer segment);GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007601(visual perception);GO:0007602(phototransduction);GO:0009881(photoreceptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0018298(protein-chromophore linkage);GO:0050896(response to stimulus)","NA","K04252","NA","opsin 1, short wave sensitive [Source:NCBI gene;Acc:101112218]",{"v":0.073235,"d":"0.07"},{"v":0.206804,"d":"0.21"},{"v":0.032099,"d":"0.03"},{"v":0.115449,"d":"0.12"},{"v":0.079056,"d":"0.08"},0,{"v":1.60478136808822,"d":"1.60"},{"v":0.68237676111086,"d":"0.68"},1,1,"up","no"]
["ENSOARG00000018511","NTN3","ENSOART00000020150","GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005794(Golgi apparatus)","04360(Axon guidance)","K06844","NA","netrin 3 [Source:NCBI gene;Acc:101116446]",{"v":0.322231,"d":"0.32"},{"v":0.355715,"d":"0.36"},{"v":0.25042,"d":"0.25"},{"v":0.506535,"d":"0.51"},{"v":0.88696,"d":"0.89"},{"v":0.329305,"d":"0.33"},{"v":0.538870443464128,"d":"0.54"},{"v":-0.89198963645274,"d":"-0.89"},1,1,"down","no"]
["MSTRG.13453","RF00026","ENSOART00000026978","NA","NA","NA","NA",null,0,0,0,{"v":0.027441,"d":"0.03"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000004197","ENSOARG00000004197","ENSOART00000004565","NA","NA","NA","NA",null,0,0,0,0,{"v":0.016304,"d":"0.02"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000014220","PCDHGA2","ENSOART00000015489","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","protocadherin gamma subfamily A, 2 [Source:NCBI gene;Acc:101104993]",{"v":0.225639,"d":"0.23"},{"v":0.113788,"d":"0.11"},{"v":0.231733,"d":"0.23"},{"v":0.134508,"d":"0.13"},{"v":0.106229,"d":"0.11"},{"v":0.05884,"d":"0.06"},{"v":1.90655490908848,"d":"1.91"},{"v":0.930968081511922,"d":"0.93"},1,1,"up","no"]
["MSTRG.8562","oar-mir-409","ENSOART00000024144","NA","NA","NA","NA","oar-mir-409 [Source:miRBase;Acc:MI0016958]",{"v":0.376133,"d":"0.38"},0,{"v":0.076707,"d":"0.08"},{"v":0.144563,"d":"0.14"},{"v":0.655472,"d":"0.66"},{"v":0.496855,"d":"0.50"},{"v":0.349173792688663,"d":"0.35"},{"v":-1.51798281363179,"d":"-1.52"},1,1,"down","no"]
["MSTRG.13522","ENSOARG00000005487","ENSOART00000005981","NA","NA","NA","NA",null,{"v":0.175715,"d":"0.18"},{"v":0.198134,"d":"0.20"},0,{"v":0.28215,"d":"0.28"},0,0,{"v":1.32500088605352,"d":"1.33"},{"v":0.405993324434017,"d":"0.41"},1,1,"up","no"]
["MSTRG.8241","MIR631","ENSOART00000023874","NA","NA","NA","NA","microRNA 631 [Source:HGNC Symbol;Acc:HGNC:32887]",{"v":0.508181,"d":"0.51"},{"v":0.143568,"d":"0.14"},{"v":0.496461,"d":"0.50"},0,{"v":0.271337,"d":"0.27"},{"v":0.142898,"d":"0.14"},{"v":2.77188069574034,"d":"2.77"},{"v":1.4708651639081,"d":"1.47"},1,1,"up","no"]
["ENSOARG00000019899","FBXO48","ENSOART00000021666","GO:0005515(protein binding)","NA","NA","NA","F-box protein 48 [Source:NCBI gene;Acc:101109950]",{"v":0.19892,"d":"0.20"},{"v":0.088384,"d":"0.09"},{"v":0.096041,"d":"0.10"},{"v":0.168143,"d":"0.17"},{"v":0.060372,"d":"0.06"},0,{"v":1.67754851979082,"d":"1.68"},{"v":0.746354494144863,"d":"0.75"},1,1,"up","no"]
["MSTRG.3846","ENSOARG00000016755","ENSOART00000018255","GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005858(axonemal dynein complex);GO:0007018(microtubule-based movement);GO:0016887(ATPase activity);GO:0030286(dynein complex);GO:0060285(cilium-dependent cell motility)","05016(Huntington disease)","K10408","NA","dynein axonemal heavy chain 14 [Source:NCBI gene;Acc:101104330]",0,{"v":0.002652,"d":"0.00"},{"v":0.005201,"d":"0.01"},{"v":0.016535,"d":"0.02"},{"v":0.002676,"d":"0.00"},{"v":0.016999,"d":"0.02"},{"v":0.216873791770229,"d":"0.22"},{"v":-2.20507237460029,"d":"-2.21"},1,1,"down","no"]
["ENSOARG00000010000","ASGR2","ENSOART00000010882","GO:0009100(glycoprotein metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding);GO:0031647(regulation of protein stability);GO:0044322(endoplasmic reticulum quality control compartment);GO:0048471(perinuclear region of cytoplasm);GO:0055088(lipid homeostasis)","04918(Thyroid hormone synthesis)","K10064","NA","asialoglycoprotein receptor 2 [Source:NCBI gene;Acc:101115381]",0,{"v":0.020656,"d":"0.02"},{"v":0.021254,"d":"0.02"},0,{"v":0.061832,"d":"0.06"},0,{"v":0.677804373140122,"d":"0.68"},{"v":-0.56105914988131,"d":"-0.56"},1,1,"down","no"]
["MSTRG.18325","ENSOARG00000024489","ENSOART00000026391","NA","NA","NA","NA",null,0,0,0,{"v":0.041687,"d":"0.04"},{"v":0.670513,"d":"0.67"},{"v":0.040793,"d":"0.04"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000010773","FAM83A","ENSOART00000011721","GO:0007173(epidermal growth factor receptor signaling pathway);GO:0008283(cell population proliferation);GO:0019901(protein kinase binding);GO:0036312(phosphatidylinositol 3-kinase regulatory subunit binding)","NA","NA","NA","family with sequence similarity 83 member A [Source:NCBI gene;Acc:101108840]",0,{"v":0.024182,"d":"0.02"},{"v":0.063484,"d":"0.06"},{"v":0.08334,"d":"0.08"},{"v":0.055537,"d":"0.06"},{"v":0.081551,"d":"0.08"},{"v":0.397708095160324,"d":"0.40"},{"v":-1.33021816706962,"d":"-1.33"},1,1,"down","no"]
["ENSOARG00000010249","NXPH2","ENSOART00000011149","NA","NA","NA","NA","neurexophilin 2 [Source:HGNC Symbol;Acc:HGNC:8076]",{"v":0.236368,"d":"0.24"},{"v":0.118022,"d":"0.12"},{"v":0.043533,"d":"0.04"},{"v":0.287252,"d":"0.29"},0,{"v":0.255813,"d":"0.26"},{"v":0.732735492068169,"d":"0.73"},{"v":-0.448635596596925,"d":"-0.45"},1,1,"down","no"]
["MSTRG.284","ENSOARG00000013703","ENSOART00000014910","NA","NA","NA","NA",null,{"v":0.867953,"d":"0.87"},{"v":1.027614,"d":"1.03"},{"v":1.461767,"d":"1.46"},{"v":0.92064,"d":"0.92"},{"v":1.067405,"d":"1.07"},{"v":1.049594,"d":"1.05"},{"v":1.10524456658609,"d":"1.11"},{"v":0.144365641979315,"d":"0.14"},1,1,"up","no"]
["MSTRG.5161","ENSOARG00000005622","ENSOART00000006125","NA","NA","NA","NA",null,{"v":0.534062,"d":"0.53"},{"v":0.123783,"d":"0.12"},{"v":0.27898,"d":"0.28"},{"v":0.262348,"d":"0.26"},{"v":0.113134,"d":"0.11"},{"v":0.31976,"d":"0.32"},{"v":1.34748044565777,"d":"1.35"},{"v":0.430264337054029,"d":"0.43"},1,1,"up","no"]
["ENSOARG00000018763","UNC119","ENSOART00000020431","GO:0000281(mitotic cytokinesis);GO:0000922(spindle pole);GO:0005813(centrosome);GO:0007399(nervous system development);GO:0008289(lipid binding);GO:0042953(lipoprotein transport);GO:0045171(intercellular bridge);GO:0051233(spindle midzone);GO:0061098(positive regulation of protein tyrosine kinase activity)","NA","NA","NA","unc-119 lipid binding chaperone [Source:NCBI gene;Acc:101119999]",{"v":0.757423,"d":"0.76"},{"v":0.475568,"d":"0.48"},{"v":0.546107,"d":"0.55"},{"v":0.558152,"d":"0.56"},{"v":1.519093,"d":"1.52"},{"v":0.892451,"d":"0.89"},{"v":0.599084216027499,"d":"0.60"},{"v":-0.73916927133062,"d":"-0.74"},1,1,"down","no"]
["MSTRG.6148","ENSOARG00000019943","ENSOART00000021709","GO:0003677(DNA binding)","NA","NA","NA",null,{"v":0.427995,"d":"0.43"},{"v":0.290679,"d":"0.29"},{"v":0.657103,"d":"0.66"},{"v":0.343219,"d":"0.34"},{"v":0.138153,"d":"0.14"},{"v":0.789838,"d":"0.79"},{"v":1.0822578488212,"d":"1.08"},{"v":0.114044263395603,"d":"0.11"},1,1,"up","no"]
["ENSOARG00000013371","CCNJL","ENSOART00000014542","GO:0005634(nucleus)","NA","NA","NA","cyclin J like [Source:NCBI gene;Acc:101115368]",0,{"v":0.0494985352112676,"d":"0.05"},{"v":0.0410799718309859,"d":"0.04"},{"v":0.116390882629108,"d":"0.12"},{"v":0.0278162535211268,"d":"0.03"},{"v":0.0556438873239437,"d":"0.06"},{"v":0.453230138468401,"d":"0.45"},{"v":-1.14168429557094,"d":"-1.14"},1,1,"down","no"]
["ENSOARG00000002349","AQP10","ENSOART00000002543","GO:0006833(water transport);GO:0009636(response to toxic substance);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K09878","NA","aquaporin 10 [Source:NCBI gene;Acc:101102866]",0,0,0,0,{"v":0.018324,"d":"0.02"},{"v":0.026066,"d":"0.03"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000004428","ENSOARG00000004428","ENSOART00000004821","NA","NA","NA","NA",null,0,{"v":0.032609,"d":"0.03"},0,{"v":0.058585,"d":"0.06"},0,0,{"v":0.556610053768029,"d":"0.56"},{"v":-0.845261127306086,"d":"-0.85"},1,1,"down","no"]
["ENSOARG00000007534","ENSOARG00000007534","ENSOART00000008202","NA","NA","K05810","EC:1.10.3.-","laccase domain containing 1 [Source:NCBI gene;Acc:101109625]",{"v":0.561379,"d":"0.56"},{"v":0.213937,"d":"0.21"},{"v":0.387149,"d":"0.39"},{"v":0.528677,"d":"0.53"},{"v":0.586537,"d":"0.59"},{"v":0.370165,"d":"0.37"},{"v":0.782604978258074,"d":"0.78"},{"v":-0.353643807437574,"d":"-0.35"},1,1,"down","no"]
["ENSOARG00000021938","RF00001","ENSOART00000023840","NA","NA","NA","NA",null,0,0,{"v":0.015645,"d":"0.02"},{"v":0.01949,"d":"0.02"},0,{"v":0.044501,"d":"0.04"},{"v":0.244487506055539,"d":"0.24"},{"v":-2.03216735327741,"d":"-2.03"},1,1,"down","no"]
["ENSOARG00000004584","ENSOARG00000004584","ENSOART00000004988","GO:0005813(centrosome);GO:0008017(microtubule binding);GO:0034453(microtubule anchoring)","NA","NA","NA",null,0,{"v":0.010088,"d":"0.01"},0,{"v":0.035142,"d":"0.04"},0,{"v":0.012012,"d":"0.01"},{"v":0.213937311786911,"d":"0.21"},{"v":-2.22473997687438,"d":"-2.22"},1,1,"down","no"]
["ENSOARG00000024061","ENSOARG00000024061","ENSOART00000025963","NA","NA","NA","NA",null,0,0,{"v":0.24823,"d":"0.25"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000004326","CCDC81","ENSOART00000004713","GO:0005813(centrosome)","NA","NA","NA","coiled-coil domain containing 81 [Source:NCBI gene;Acc:101113447]",0,0,{"v":0.036233,"d":"0.04"},{"v":0.010457,"d":"0.01"},{"v":0.048416,"d":"0.05"},0,{"v":0.615443412090432,"d":"0.62"},{"v":-0.700301882937354,"d":"-0.70"},1,1,"down","no"]
["MSTRG.7910","ENSOARG00000015779","ENSOART00000017180","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.008817,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000010611","ENSOARG00000010611","ENSOART00000011543","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.112582,"d":"0.11"},"-inf","-inf",1,1,"down","no"]
["MSTRG.19384","ENSOARG00000023220","ENSOART00000025122","NA","NA","NA","NA",null,0,{"v":0.424513,"d":"0.42"},0,{"v":0.088076,"d":"0.09"},{"v":0.701058,"d":"0.70"},0,{"v":0.537947927728371,"d":"0.54"},{"v":-0.894461565309693,"d":"-0.89"},1,1,"down","no"]
["MSTRG.8202","ACSBG1","ENSOART00000000716","GO:0000038(very long-chain fatty acid metabolic process);GO:0001676(long-chain fatty acid metabolic process);GO:0003824(catalytic activity);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005737(cytoplasm);GO:0031957(very long-chain fatty acid-CoA ligase activity);GO:0051384(response to glucocorticoid)","00061(Fatty acid biosynthesis);00071(Fatty acid degradation);03320(PPAR signaling pathway);04920(Adipocytokine signaling pathway)","K15013","EC:6.2.1.3","acyl-CoA synthetase bubblegum family member 1 [Source:NCBI gene;Acc:101121296]",{"v":0.0194388244648318,"d":"0.02"},{"v":0.0217974856269113,"d":"0.02"},{"v":0.023330320795107,"d":"0.02"},{"v":0.0223640749235474,"d":"0.02"},{"v":0.0251872018348624,"d":"0.03"},{"v":0.0217474058103976,"d":"0.02"},{"v":0.931715127812729,"d":"0.93"},{"v":-0.1020391770407,"d":"-0.10"},1,1,"down","no"]
["ENSOARG00000006116","ENSOARG00000006116","ENSOART00000006646","NA","NA","NA","NA",null,{"v":0.008418,"d":"0.01"},{"v":0.009246,"d":"0.01"},0,{"v":0.021706,"d":"0.02"},{"v":0.018543,"d":"0.02"},{"v":0.037736,"d":"0.04"},{"v":0.226505097134064,"d":"0.23"},{"v":-2.14238457871168,"d":"-2.14"},1,1,"down","no"]
["MSTRG.7073","RF00577","ENSOART00000024889","NA","NA","NA","NA",null,{"v":0.089232,"d":"0.09"},{"v":0.49001,"d":"0.49"},{"v":0.2428,"d":"0.24"},{"v":1.080749,"d":"1.08"},{"v":0.174684,"d":"0.17"},0,{"v":0.654787631040446,"d":"0.65"},{"v":-0.610901025373939,"d":"-0.61"},1,1,"down","no"]
["ENSOARG00000007008","ABHD15","ENSOART00000007622","NA","NA","K13707","NA","abhydrolase domain containing 15 [Source:NCBI gene;Acc:101121787]",{"v":0.107541,"d":"0.11"},{"v":0.096004,"d":"0.10"},{"v":0.118217,"d":"0.12"},{"v":0.079876,"d":"0.08"},{"v":0.138317,"d":"0.14"},0,{"v":1.47466692332018,"d":"1.47"},{"v":0.560389135940558,"d":"0.56"},1,1,"up","no"]
["ENSOARG00000004439","C1orf185","ENSOART00000004829","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","chromosome 1 open reading frame, human C1orf185 [Source:NCBI gene;Acc:101109658]",0,{"v":0.045486,"d":"0.05"},{"v":0.052084,"d":"0.05"},{"v":0.131191,"d":"0.13"},{"v":0.073983,"d":"0.07"},{"v":0.250666,"d":"0.25"},{"v":0.214044401544401,"d":"0.21"},{"v":-2.22401799338549,"d":"-2.22"},1,1,"down","no"]
["ENSOARG00000018145","ENSOARG00000018145","ENSOART00000019754","GO:0000166(nucleotide binding);GO:0000724(double-strand break repair via homologous recombination);GO:0003677(DNA binding);GO:0005524(ATP binding);GO:0006270(DNA replication initiation);GO:0006974(cellular response to DNA damage stimulus);GO:0007292(female gamete generation);GO:0048232(male gamete generation);GO:0097362(MCM8-MCM9 complex)","NA","K10737","EC:3.6.4.12","minichromosome maintenance 8 homologous recombination repair factor [Source:NCBI gene;Acc:101116498]",{"v":0.087745,"d":"0.09"},{"v":0.061488,"d":"0.06"},{"v":0.174938,"d":"0.17"},{"v":0.11342,"d":"0.11"},{"v":0.038383,"d":"0.04"},{"v":0.167436,"d":"0.17"},{"v":1.01544924022441,"d":"1.02"},{"v":0.022118124708604,"d":"0.02"},1,1,"up","no"]
["ENSOARG00000007487","AGBL2","ENSOART00000008154","GO:0004181(metallocarboxypeptidase activity);GO:0005814(centriole);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0035610(protein side chain deglutamylation);GO:0036064(ciliary basal body)","NA","NA","NA","ATP/GTP binding protein like 2 [Source:NCBI gene;Acc:101120523]",{"v":0.03241,"d":"0.03"},0,{"v":0.031034,"d":"0.03"},{"v":0.06087,"d":"0.06"},{"v":0.053476,"d":"0.05"},{"v":0.02572,"d":"0.03"},{"v":0.452957891279825,"d":"0.45"},{"v":-1.14255115690165,"d":"-1.14"},1,1,"down","no"]
["ENSOARG00000017835","GHRH","ENSOART00000019404","GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0016608(growth hormone-releasing hormone activity);GO:0021984(adenohypophysis development);GO:0030252(growth hormone secretion);GO:0031770(growth hormone-releasing hormone receptor binding);GO:0032094(response to food);GO:0040018(positive regulation of multicellular organism growth);GO:0043195(terminal bouton);GO:0046887(positive regulation of hormone secretion);GO:0060124(positive regulation of growth hormone secretion)","04080(Neuroactive ligand-receptor interaction)","K05260","NA","growth hormone releasing hormone [Source:NCBI gene;Acc:100101237]",0,0,0,0,{"v":0.070131,"d":"0.07"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000024321","RF00139","ENSOART00000026223","NA","NA","NA","NA",null,{"v":0.335765,"d":"0.34"},{"v":0.414661,"d":"0.41"},{"v":0.262334,"d":"0.26"},{"v":0.269419,"d":"0.27"},{"v":0.303458,"d":"0.30"},{"v":0.47951,"d":"0.48"},{"v":0.962345601000393,"d":"0.96"},{"v":-0.0553730020253821,"d":"-0.06"},1,1,"down","no"]
["MSTRG.8991","ENSOARG00000023572","ENSOART00000025474","NA","NA","NA","NA",null,{"v":0.080346,"d":"0.08"},{"v":0.122101,"d":"0.12"},{"v":1.347986,"d":"1.35"},0,{"v":1.23908,"d":"1.24"},{"v":0.342178,"d":"0.34"},{"v":0.980506027479387,"d":"0.98"},{"v":-0.0284015957418482,"d":"-0.03"},1,1,"down","no"]
["ENSOARG00000021603","RF00026","ENSOART00000023505","NA","NA","NA","NA","RNA, U6 small nuclear 887, pseudogene [Source:HGNC Symbol;Acc:HGNC:47850]",{"v":0.161494,"d":"0.16"},{"v":0.10122,"d":"0.10"},{"v":0.042381,"d":"0.04"},{"v":0.126757,"d":"0.13"},{"v":0.01466,"d":"0.01"},{"v":0.185542,"d":"0.19"},{"v":0.933129230270462,"d":"0.93"},{"v":-0.099851199277013,"d":"-0.10"},1,1,"down","no"]
["ENSOARG00000001710","CD19","ENSOART00000001843","GO:0001923(B-1 B cell differentiation);GO:0002322(B cell proliferation involved in immune response);GO:0005887(integral component of plasma membrane);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016064(immunoglobulin mediated immune response);GO:0019724(B cell mediated immunity);GO:0032991(protein-containing complex);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0050851(antigen receptor-mediated signaling pathway);GO:0050853(B cell receptor signaling pathway);GO:0050855(regulation of B cell receptor signaling pathway);GO:0050864(regulation of B cell activation);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol)","04151(PI3K-Akt signaling pathway);04640(Hematopoietic cell lineage);04662(B cell receptor signaling pathway);05169(Epstein-Barr virus infection);05340(Primary immunodeficiency)","K06465","NA","CD19 molecule [Source:NCBI gene;Acc:101111510]",{"v":0.041507,"d":"0.04"},{"v":0.042531,"d":"0.04"},{"v":0.056196,"d":"0.06"},{"v":0.05923,"d":"0.06"},{"v":0.183104,"d":"0.18"},{"v":0.097819,"d":"0.10"},{"v":0.412267420837094,"d":"0.41"},{"v":-1.27834763718759,"d":"-1.28"},1,1,"down","no"]
["ENSOARG00000011804","FANCB","ENSOART00000012842","GO:0036297(interstrand cross-link repair);GO:0043240(Fanconi anaemia nuclear complex)","03460(Fanconi anemia pathway)","K10889","NA","FA complementation group B [Source:NCBI gene;Acc:101123188]",{"v":0.0364332990033223,"d":"0.04"},0,{"v":0.0499846544850498,"d":"0.05"},{"v":0.0641310299003322,"d":"0.06"},{"v":0.040222950166113,"d":"0.04"},{"v":0.066556803986711,"d":"0.07"},{"v":0.505631952759018,"d":"0.51"},{"v":-0.983840459239451,"d":"-0.98"},1,1,"down","no"]
["MSTRG.16396","VAMP1","ENSOART00000008963","GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016082(synaptic vesicle priming);GO:0016192(vesicle-mediated transport);GO:0031594(neuromuscular junction);GO:0031630(regulation of synaptic vesicle fusion to presynaptic active zone membrane);GO:0035493(SNARE complex assembly);GO:0035579(specific granule membrane);GO:0070821(tertiary granule membrane);GO:0098793(presynapse);GO:0098978(glutamatergic synapse)","04130(SNARE interactions in vesicular transport)","K08510","NA","vesicle associated membrane protein 1 [Source:NCBI gene;Acc:101113747]",{"v":0.312858,"d":"0.31"},{"v":0.386849,"d":"0.39"},{"v":0.959125,"d":"0.96"},{"v":0.771678,"d":"0.77"},{"v":0.026896,"d":"0.03"},{"v":0.501873,"d":"0.50"},{"v":1.27558601004116,"d":"1.28"},{"v":0.351160180066471,"d":"0.35"},1,1,"up","no"]
["MSTRG.10374","RF01985","ENSOART00000024812","NA","NA","NA","NA","ZEB2 antisense RNA 1 [Source:HGNC Symbol;Acc:HGNC:37149]",{"v":0.209628,"d":"0.21"},{"v":0.428424,"d":"0.43"},{"v":0.111907,"d":"0.11"},{"v":0.118291,"d":"0.12"},{"v":0.489859,"d":"0.49"},{"v":0.814394,"d":"0.81"},{"v":0.527195643860577,"d":"0.53"},{"v":-0.923589645267323,"d":"-0.92"},1,1,"down","no"]
["ENSOARG00000001807","ENSOARG00000001807","ENSOART00000001941","NA","NA","NA","NA",null,{"v":0.164695,"d":"0.16"},{"v":0.072644,"d":"0.07"},{"v":0.033432,"d":"0.03"},{"v":0.180803,"d":"0.18"},{"v":0.26559,"d":"0.27"},{"v":0.158169,"d":"0.16"},{"v":0.447879621941174,"d":"0.45"},{"v":-1.15881706833032,"d":"-1.16"},1,1,"down","no"]
["ENSOARG00000006672","ENSOARG00000006672","ENSOART00000007249","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,0,{"v":0.036227,"d":"0.04"},0,{"v":0.058687,"d":"0.06"},0,{"v":0.192804,"d":"0.19"},{"v":0.144048892405692,"d":"0.14"},{"v":-2.79536952725288,"d":"-2.80"},1,1,"down","no"]
["ENSOARG00000004422","ENSOARG00000004422","ENSOART00000004813","NA","NA","NA","NA",null,{"v":0.183077,"d":"0.18"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000020916","ENSOARG00000020916","ENSOART00000022787","NA","NA","NA","NA",null,0,0,0,{"v":0.111976,"d":"0.11"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000006414","DIAPH3","ENSOART00000006982","GO:0003779(actin binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007010(cytoskeleton organization);GO:0016043(cellular component organization);GO:0017048(Rho GTPase binding);GO:0030036(actin cytoskeleton organization);GO:0030041(actin filament polymerization)","04810(Regulation of actin cytoskeleton)","K05745","NA","diaphanous related formin 3 [Source:NCBI gene;Acc:101105168]",{"v":0.201669,"d":"0.20"},0,{"v":0.139408,"d":"0.14"},{"v":0.2399,"d":"0.24"},{"v":0.07138,"d":"0.07"},{"v":0.294695,"d":"0.29"},{"v":0.56285655348818,"d":"0.56"},{"v":-0.829160803025921,"d":"-0.83"},1,1,"down","no"]
["ENSOARG00000014399","ENSOARG00000014399","ENSOART00000015677","NA","NA","K16811","NA","trichoplein keratin filament binding [Source:NCBI gene;Acc:101122891]",{"v":0.17596,"d":"0.18"},{"v":0.116738,"d":"0.12"},{"v":0.113463,"d":"0.11"},{"v":0.319802,"d":"0.32"},{"v":0.161165,"d":"0.16"},{"v":0.219729,"d":"0.22"},{"v":0.579653658647973,"d":"0.58"},{"v":-0.786736943260033,"d":"-0.79"},1,1,"down","no"]
["MSTRG.3951","RF01293","ENSOART00000025934","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 59A [Source:HGNC Symbol;Acc:HGNC:32653]",{"v":0.166714,"d":"0.17"},{"v":0.307645,"d":"0.31"},{"v":0.444155,"d":"0.44"},{"v":0.114126,"d":"0.11"},0,{"v":0.149502,"d":"0.15"},{"v":3.48412915168343,"d":"3.48"},{"v":1.80079810356931,"d":"1.80"},1,1,"up","no"]
["ENSOARG00000012097","MSI1","ENSOART00000013158","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003727(single-stranded RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005844(polysome);GO:0008266(poly(U) RNA binding);GO:0042802(identical protein binding)","03015(mRNA surveillance pathway)","K14411","NA","musashi RNA binding protein 1 [Source:NCBI gene;Acc:101112004]",{"v":0.017862,"d":"0.02"},{"v":0.036167,"d":"0.04"},{"v":0.017794,"d":"0.02"},{"v":0.073367,"d":"0.07"},0,{"v":0.16269,"d":"0.16"},{"v":0.304261258933224,"d":"0.30"},{"v":-1.71661744523812,"d":"-1.72"},1,1,"down","no"]
["MSTRG.2770","ENSOARG00000004017","ENSOART00000004363","NA","NA","NA","NA",null,0,{"v":0.653034,"d":"0.65"},{"v":0.124115,"d":"0.12"},{"v":0.137443,"d":"0.14"},{"v":0.415019,"d":"0.42"},{"v":0.169516,"d":"0.17"},{"v":1.07641645590309,"d":"1.08"},{"v":0.106236351709982,"d":"0.11"},1,1,"up","no"]
["ENSOARG00000020268","ZNF684","ENSOART00000022067","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 684 [Source:NCBI gene;Acc:101122402]",{"v":0.287115,"d":"0.29"},{"v":0.229266,"d":"0.23"},{"v":0.166728,"d":"0.17"},{"v":0.307995,"d":"0.31"},{"v":0.227407,"d":"0.23"},{"v":0.256799,"d":"0.26"},{"v":0.862292524245741,"d":"0.86"},{"v":-0.213750722455874,"d":"-0.21"},1,1,"down","no"]
["MSTRG.19665","CHAC1","ENSOART00000022117","GO:0003839(gamma-glutamylcyclotransferase activity);GO:0005112(Notch binding);GO:0005802(trans-Golgi network);GO:0006751(glutathione catabolic process);GO:0016829(lyase activity);GO:0022008(neurogenesis);GO:0061928(glutathione specific gamma-glutamylcyclotransferase activity)","NA","NA","NA","ChaC glutathione specific gamma-glutamylcyclotransferase 1 [Source:HGNC Symbol;Acc:HGNC:28680]",{"v":0.436945,"d":"0.44"},{"v":0.177139,"d":"0.18"},{"v":1.103324,"d":"1.10"},{"v":0.053306,"d":"0.05"},{"v":1.458834,"d":"1.46"},{"v":1.610141,"d":"1.61"},{"v":0.550049146761614,"d":"0.55"},{"v":-0.862367566029076,"d":"-0.86"},1,1,"down","no"]
["ENSOARG00000000327","LAMA1","ENSOART00000000354","GO:0002011(morphogenesis of an epithelial sheet);GO:0005102(signaling receptor binding);GO:0005201(extracellular matrix structural constituent);GO:0005604(basement membrane);GO:0005606(laminin-1 complex);GO:0005608(laminin-3 complex);GO:0005615(extracellular space);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0007155(cell adhesion);GO:0007166(cell surface receptor signaling pathway);GO:0008022(protein C-terminus binding);GO:0009888(tissue development);GO:0016020(membrane);GO:0030155(regulation of cell adhesion);GO:0030334(regulation of cell migration);GO:0031012(extracellular matrix);GO:0031175(neuron projection development);GO:0043208(glycosphingolipid binding);GO:0043256(laminin complex);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0045995(regulation of embryonic development);GO:0060041(retina development in camera-type eye);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0060445(branching involved in salivary gland morphogenesis);GO:0061304(retinal blood vessel morphogenesis)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);05145(Toxoplasmosis);05146(Amoebiasis);05165(Human papillomavirus infection);05200(Pathways in cancer);05222(Small cell lung cancer)","K05637","NA","laminin subunit alpha 1 [Source:NCBI gene;Acc:101102692]",{"v":0.0160791977295588,"d":"0.02"},{"v":0.00435126268141974,"d":"0.00"},{"v":0.004879019758586,"d":"0.00"},{"v":0.0180153009053025,"d":"0.02"},{"v":0.0154918070843512,"d":"0.02"},{"v":0.00681412904152896,"d":"0.01"},{"v":0.627696024057776,"d":"0.63"},{"v":-0.671862024233527,"d":"-0.67"},1,1,"down","no"]
["ENSOARG00000009443","SRCIN1","ENSOART00000010285","GO:0005737(cytoplasm);GO:0015629(actin cytoskeleton);GO:0019901(protein kinase binding);GO:0030334(regulation of cell migration);GO:0034446(substrate adhesion-dependent cell spreading);GO:0061001(regulation of dendritic spine morphogenesis);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0061099(negative regulation of protein tyrosine kinase activity)","NA","K19930","NA","SRC kinase signaling inhibitor 1 [Source:NCBI gene;Acc:101102076]",{"v":0.079163,"d":"0.08"},{"v":0.074041,"d":"0.07"},{"v":0.033881,"d":"0.03"},{"v":0.154024,"d":"0.15"},{"v":0.087798,"d":"0.09"},{"v":0.100457,"d":"0.10"},{"v":0.546586264421714,"d":"0.55"},{"v":-0.871478889141982,"d":"-0.87"},1,1,"down","no"]
["ENSOARG00000010699","SLC18A1","ENSOART00000011643","GO:0006855(drug transmembrane transport);GO:0015238(drug transmembrane transporter activity);GO:0015893(drug transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045202(synapse);GO:0055085(transmembrane transport)","04721(Synaptic vesicle cycle);04726(Serotonergic synapse);04728(Dopaminergic synapse);05012(Parkinson disease);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)","K08155","NA","solute carrier family 18 member A1 [Source:NCBI gene;Acc:101121491]",{"v":0.027377,"d":"0.03"},{"v":0.007512,"d":"0.01"},0,{"v":0.005836,"d":"0.01"},{"v":0.012532,"d":"0.01"},0,{"v":1.89944468641115,"d":"1.90"},{"v":0.925577699998592,"d":"0.93"},1,1,"up","no"]
["ENSOARG00000004875","ENSOARG00000004875","ENSOART00000005321","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K08443","NA","adhesion G protein-coupled receptor E2 [Source:NCBI gene;Acc:101116830]",{"v":0.088985,"d":"0.09"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.12745","ENSOARG00000016417","ENSOART00000017876","NA","NA","NA","NA",null,{"v":0.015801,"d":"0.02"},{"v":0.182362,"d":"0.18"},{"v":0.190382,"d":"0.19"},{"v":0.068924,"d":"0.07"},{"v":0.032005,"d":"0.03"},{"v":0.085364,"d":"0.09"},{"v":2.08566612808855,"d":"2.09"},{"v":1.06050823077139,"d":"1.06"},1,1,"up","no"]
["ENSOARG00000011921","KCNV1","ENSOART00000012967","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA","K04934","NA","potassium voltage-gated channel modifier subfamily V member 1 [Source:NCBI gene;Acc:101117169]",0,0,0,0,{"v":0.129948,"d":"0.13"},{"v":0.062239,"d":"0.06"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000020549","SFTPB","ENSOART00000022386","GO:0006629(lipid metabolic process)","NA","NA","NA","surfactant protein B [Source:NCBI gene;Acc:443043]",0,0,0,0,{"v":0.012956,"d":"0.01"},{"v":0.042344,"d":"0.04"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017172","ODF1","ENSOART00000018687","GO:0001520(outer dense fiber)","NA","NA","NA","outer dense fiber of sperm tails 1 [Source:NCBI gene;Acc:101123129]",0,0,{"v":0.0168,"d":"0.02"},{"v":0.034883,"d":"0.03"},0,0,{"v":0.481609953272368,"d":"0.48"},{"v":-1.05406288678414,"d":"-1.05"},1,1,"down","no"]
["MSTRG.5038","RF00026","ENSOART00000026780","NA","NA","NA","NA",null,{"v":0.943295,"d":"0.94"},{"v":1.792502,"d":"1.79"},{"v":3.6527,"d":"3.65"},{"v":1.536594,"d":"1.54"},{"v":1.584108,"d":"1.58"},{"v":1.760496,"d":"1.76"},{"v":1.30879693878429,"d":"1.31"},{"v":0.388241278999047,"d":"0.39"},1,1,"up","no"]
["ENSOARG00000016692","ENSOARG00000016692","ENSOART00000018184","GO:0005515(protein binding)","NA","NA","NA","ankyrin repeat domain 31 [Source:NCBI gene;Acc:101104753]",{"v":0.013153,"d":"0.01"},{"v":0.079416,"d":"0.08"},{"v":0.019759,"d":"0.02"},{"v":0.006714,"d":"0.01"},{"v":0.013016,"d":"0.01"},{"v":0.02954,"d":"0.03"},{"v":2.27984574791963,"d":"2.28"},{"v":1.18893621639019,"d":"1.19"},1,1,"up","no"]
["ENSOARG00000016463","ENSOARG00000016463","ENSOART00000017928","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031224(intrinsic component of membrane)","NA","NA","NA",null,{"v":0.105049,"d":"0.11"},{"v":0.099221,"d":"0.10"},0,{"v":0.092509,"d":"0.09"},0,0,{"v":2.20810948123966,"d":"2.21"},{"v":1.14281170478176,"d":"1.14"},1,1,"up","no"]
["ENSOARG00000024930","ENSOARG00000024930","ENSOART00000026832","NA","NA","NA","NA",null,{"v":0.60848,"d":"0.61"},{"v":0.112162,"d":"0.11"},{"v":1.870922,"d":"1.87"},{"v":0.862197,"d":"0.86"},{"v":0.128799,"d":"0.13"},{"v":0.113633,"d":"0.11"},{"v":2.34609448059032,"d":"2.35"},{"v":1.23026111393524,"d":"1.23"},1,1,"up","no"]
["MSTRG.6443","ENSOARG00000021420","ENSOART00000023322","NA","NA","NA","NA",null,{"v":0.753031,"d":"0.75"},{"v":1.56108,"d":"1.56"},{"v":1.023442,"d":"1.02"},{"v":1.155446,"d":"1.16"},{"v":1.627935,"d":"1.63"},{"v":0.611829,"d":"0.61"},{"v":0.983018134371659,"d":"0.98"},{"v":-0.0247100637469964,"d":"-0.02"},1,1,"down","no"]
["ENSOARG00000006553","SPI1","ENSOART00000007122","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001085(RNA polymerase II transcription factor binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001944(vasculature development);GO:0002320(lymphoid progenitor cell differentiation);GO:0002573(myeloid leukocyte differentiation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0030098(lymphocyte differentiation);GO:0030218(erythrocyte differentiation);GO:0030225(macrophage differentiation);GO:0030851(granulocyte differentiation);GO:0035019(somatic stem cell population maintenance);GO:0043011(myeloid dendritic cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0043966(histone H3 acetylation);GO:0044027(hypermethylation of CpG island);GO:0045347(negative regulation of MHC class II biosynthetic process);GO:0045646(regulation of erythrocyte differentiation);GO:0045814(negative regulation of gene expression, epigenetic);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051525(NFAT protein binding);GO:0060033(anatomical structure regression);GO:0061614(pri-miRNA transcription by RNA polymerase II);GO:0070102(interleukin-6-mediated signaling pathway);GO:0090241(negative regulation of histone H4 acetylation);GO:1902262(apoptotic process involved in blood vessel morphogenesis);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II)","04380(Osteoclast differentiation);05166(Human T-cell leukemia virus 1 infection);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05221(Acute myeloid leukemia)","K09438","NA","Spi-1 proto-oncogene [Source:NCBI gene;Acc:101119756]",{"v":0.667117,"d":"0.67"},{"v":0.335702,"d":"0.34"},{"v":0.473908,"d":"0.47"},{"v":0.567219,"d":"0.57"},{"v":1.173818,"d":"1.17"},{"v":0.76591,"d":"0.77"},{"v":0.589053936920086,"d":"0.59"},{"v":-0.763528353931008,"d":"-0.76"},1,1,"down","no"]
["MSTRG.14491","ENSOARG00000004406","ENSOART00000004793","NA","NA","NA","NA",null,{"v":0.131788,"d":"0.13"},0,{"v":0.049073,"d":"0.05"},{"v":0.53045,"d":"0.53"},{"v":0.230638,"d":"0.23"},{"v":0.139711,"d":"0.14"},{"v":0.200778420047092,"d":"0.20"},{"v":-2.31632388020081,"d":"-2.32"},1,1,"down","no"]
["MSTRG.20734","RF00001","ENSOART00000023707","NA","NA","NA","NA",null,0,{"v":0.203723,"d":"0.20"},{"v":0.049393,"d":"0.05"},{"v":0.0355,"d":"0.04"},{"v":0.076228,"d":"0.08"},{"v":0.023159,"d":"0.02"},{"v":1.87650403671221,"d":"1.88"},{"v":0.908047393735907,"d":"0.91"},1,1,"up","no"]
["ENSOARG00000020276","RIMS3","ENSOART00000022078","GO:0006887(exocytosis);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0042391(regulation of membrane potential);GO:0044325(ion channel binding)","NA","K15298","NA","regulating synaptic membrane exocytosis 3 [Source:NCBI gene;Acc:101102435]",{"v":0.108084,"d":"0.11"},{"v":0.137333,"d":"0.14"},{"v":0.14045,"d":"0.14"},{"v":0.114818,"d":"0.11"},{"v":0.132052,"d":"0.13"},{"v":0.140935,"d":"0.14"},{"v":0.99500264308093,"d":"1.00"},{"v":-0.00722773691480934,"d":"-0.01"},1,1,"down","no"]
["ENSOARG00000021892","MIR802","ENSOART00000023794","NA","NA","NA","NA","microRNA 802 [Source:HGNC Symbol;Acc:HGNC:33140]",0,0,0,0,{"v":0.128799,"d":"0.13"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000019050","NCF4","ENSOART00000020740","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006909(phagocytosis);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016176(superoxide-generating NADPH oxidase activator activity);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0035091(phosphatidylinositol binding);GO:0043020(NADPH oxidase complex);GO:0043085(positive regulation of catalytic activity);GO:0045730(respiratory burst)","04145(Phagosome);04380(Osteoclast differentiation);04670(Leukocyte transendothelial migration);05140(Leishmaniasis)","K08012","NA","neutrophil cytosolic factor 4 [Source:NCBI gene;Acc:101122939]",{"v":0.044626,"d":"0.04"},{"v":0.009204,"d":"0.01"},{"v":0.035903,"d":"0.04"},{"v":0.12508,"d":"0.13"},{"v":0.024661,"d":"0.02"},{"v":0.037153,"d":"0.04"},{"v":0.480127772962214,"d":"0.48"},{"v":-1.05850970386904,"d":"-1.06"},1,1,"down","no"]
["MSTRG.22284","TRPC5","ENSOART00000019119","GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034704(calcium channel complex);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding)","04360(Axon guidance)","K04968","NA","transient receptor potential cation channel subfamily C member 5 [Source:NCBI gene;Acc:101109334]",{"v":0.023804,"d":"0.02"},{"v":0.010814,"d":"0.01"},0,{"v":0.007592,"d":"0.01"},0,0,{"v":4.55979978925184,"d":"4.56"},{"v":2.18897048022453,"d":"2.19"},1,1,"up","no"]
["ENSOARG00000024322","RF02196","ENSOART00000026224","NA","NA","NA","NA",null,0,0,0,{"v":0.019289,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000006081","GPR162","ENSOART00000006613","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K08440","NA","G protein-coupled receptor 162 [Source:NCBI gene;Acc:101109088]",0,0,0,{"v":0.016883,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.3492","GCGR","ENSOART00000019741","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0004967(glucagon receptor activity);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007188(adenylate cyclase-modulating G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042593(glucose homeostasis);GO:0042594(response to starvation);GO:0070873(regulation of glycogen metabolic process);GO:0071377(cellular response to glucagon stimulus)","04080(Neuroactive ligand-receptor interaction);04922(Glucagon signaling pathway)","K04583","NA","glucagon receptor [Source:NCBI gene;Acc:101115976]",0,0,{"v":0.057427,"d":"0.06"},{"v":0.045456,"d":"0.05"},{"v":0.01831,"d":"0.02"},0,{"v":0.900589655929492,"d":"0.90"},{"v":-0.151058187743834,"d":"-0.15"},1,1,"down","no"]
["MSTRG.16790","RF00156;ENSOARG00000004267","ENSOART00000026783;ENSOART00000004648","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,0,{"v":0.0702601132075472,"d":"0.07"},{"v":0.0660390754716981,"d":"0.07"},{"v":0.146842924528302,"d":"0.15"},{"v":0.053463820754717,"d":"0.05"},{"v":0.0164149811320755,"d":"0.02"},{"v":0.628913357852211,"d":"0.63"},{"v":-0.669066816744213,"d":"-0.67"},1,1,"down","no"]
["ENSOARG00000011449","PRLR","ENSOART00000012452","GO:0004896(cytokine receptor activity);GO:0004925(prolactin receptor activity);GO:0005515(protein binding);GO:0007171(activation of transmembrane receptor protein tyrosine kinase activity);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017046(peptide hormone binding);GO:0038161(prolactin signaling pathway);GO:0046872(metal ion binding)","NA","NA","NA","prolactin receptor [Source:HGNC Symbol;Acc:HGNC:9446]",{"v":0.331558,"d":"0.33"},{"v":0.233246,"d":"0.23"},{"v":0.04473,"d":"0.04"},{"v":0.226082,"d":"0.23"},{"v":0.144403,"d":"0.14"},{"v":0.165188,"d":"0.17"},{"v":1.13788449296492,"d":"1.14"},{"v":0.186354116621368,"d":"0.19"},1,1,"up","no"]
["MSTRG.6580","RF00026","ENSOART00000023352","NA","NA","NA","NA",null,{"v":0.935888,"d":"0.94"},{"v":0.064709,"d":"0.06"},0,{"v":0.021062,"d":"0.02"},{"v":0.13623,"d":"0.14"},0,{"v":6.36139790962032,"d":"6.36"},{"v":2.66934383086665,"d":"2.67"},1,1,"up","no"]
["ENSOARG00000006441","SERPINB12","ENSOART00000007000;ENSOART00000007001","GO:0002244(hematopoietic progenitor cell differentiation);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0010951(negative regulation of endopeptidase activity);GO:0010951(negative regulation of endopeptidase activity)","NA","NA","NA","serpin family B member 12 [Source:HGNC Symbol;Acc:HGNC:14220]",{"v":0.00520684963277928,"d":"0.01"},{"v":0.0145463753382296,"d":"0.01"},0,{"v":0.0453193409354465,"d":"0.05"},0,{"v":0.0206167680711249,"d":"0.02"},{"v":0.29958129572129,"d":"0.30"},{"v":-1.73898054256102,"d":"-1.74"},1,1,"down","no"]
["MSTRG.20633","ABRACL","ENSOART00000001223","NA","NA","NA","NA","ABRA C-terminal like [Source:NCBI gene;Acc:101115375]",{"v":2.21875398461538,"d":"2.22"},{"v":0.584970015384615,"d":"0.58"},{"v":1.86586558461538,"d":"1.87"},{"v":2.27374852307692,"d":"2.27"},{"v":0.505618584615385,"d":"0.51"},{"v":0.878639523076923,"d":"0.88"},{"v":1.2765393986269,"d":"1.28"},{"v":0.352238065223681,"d":"0.35"},1,1,"up","no"]
["MSTRG.19527","TSSK4","ENSOART00000020887","GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0032793(positive regulation of CREB transcription factor activity)","NA","K08811","EC:2.7.11.1","testis specific serine kinase 4 [Source:NCBI gene;Acc:101115710]",{"v":0.246212,"d":"0.25"},{"v":0.180709,"d":"0.18"},{"v":0.07132,"d":"0.07"},{"v":0.331966,"d":"0.33"},{"v":0.324792,"d":"0.32"},{"v":0.052287,"d":"0.05"},{"v":0.70269305897369,"d":"0.70"},{"v":-0.509033446836058,"d":"-0.51"},1,1,"down","no"]
["MSTRG.20019","KCNH5","ENSOART00000023036","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0009986(cell surface);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA","K04908","NA","potassium voltage-gated channel subfamily H member 5 [Source:NCBI gene;Acc:101106850]",{"v":0.023599,"d":"0.02"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000000834","EDAR","ENSOART00000000894","GO:0001942(hair follicle development);GO:0004888(transmembrane signaling receptor activity);GO:0005886(plasma membrane);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042475(odontogenesis of dentin-containing tooth);GO:0043473(pigmentation);GO:0045177(apical part of cell);GO:0060662(salivary gland cavitation);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04060(Cytokine-cytokine receptor interaction)","K05162","NA","ectodysplasin A receptor [Source:NCBI gene;Acc:101109349]",0,{"v":0.008578,"d":"0.01"},0,0,{"v":0.017248,"d":"0.02"},0,{"v":0.497333024118738,"d":"0.50"},{"v":-1.00771586211695,"d":"-1.01"},1,1,"down","no"]
["MSTRG.2436","RF00026","ENSOART00000025536","NA","NA","NA","NA",null,{"v":0.405633,"d":"0.41"},0,0,{"v":0.239844,"d":"0.24"},0,0,{"v":1.69123680392255,"d":"1.69"},{"v":0.758078677445112,"d":"0.76"},1,1,"up","no"]
["MSTRG.20591","RF00026","ENSOART00000026635","NA","NA","NA","NA",null,0,0,0,{"v":0.461526,"d":"0.46"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000010631","DOK2","ENSOART00000011564","NA","NA","NA","NA","docking protein 2 [Source:NCBI gene;Acc:101119612]",{"v":0.282012,"d":"0.28"},{"v":0.203977,"d":"0.20"},{"v":0.22942,"d":"0.23"},{"v":0.248229,"d":"0.25"},{"v":0.263004,"d":"0.26"},{"v":0.182415,"d":"0.18"},{"v":1.03137181971259,"d":"1.03"},{"v":0.044564532270567,"d":"0.04"},1,1,"up","no"]
["MSTRG.3479","ENSOARG00000023365","ENSOART00000025267","NA","NA","NA","NA",null,{"v":0.801464,"d":"0.80"},{"v":0.049692,"d":"0.05"},{"v":0.369204,"d":"0.37"},{"v":0.546399,"d":"0.55"},{"v":0.154885,"d":"0.15"},{"v":0.339955,"d":"0.34"},{"v":1.1720267873178,"d":"1.17"},{"v":0.229005543726807,"d":"0.23"},1,1,"up","no"]
["ENSOARG00000006322","LIF","ENSOART00000006873","GO:0001974(blood vessel remodeling);GO:0005102(signaling receptor binding);GO:0005125(cytokine activity);GO:0005146(leukemia inhibitory factor receptor binding);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0006955(immune response);GO:0007260(tyrosine phosphorylation of STAT protein);GO:0007566(embryo implantation);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0010628(positive regulation of gene expression);GO:0019827(stem cell population maintenance);GO:0030324(lung development);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0033141(positive regulation of peptidyl-serine phosphorylation of STAT protein);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043410(positive regulation of MAPK cascade);GO:0045595(regulation of cell differentiation);GO:0045651(positive regulation of macrophage differentiation);GO:0045835(negative regulation of meiotic nuclear division);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046697(decidualization);GO:0046888(negative regulation of hormone secretion);GO:0048286(lung alveolus development);GO:0048644(muscle organ morphogenesis);GO:0048666(neuron development);GO:0048711(positive regulation of astrocyte differentiation);GO:0048861(leukemia inhibitory factor signaling pathway);GO:0048863(stem cell differentiation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0060135(maternal process involved in female pregnancy);GO:0060426(lung vasculature development);GO:0060463(lung lobe morphogenesis);GO:0060707(trophoblast giant cell differentiation);GO:0060708(spongiotrophoblast differentiation);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0072108(positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0072307(regulation of metanephric nephron tubule epithelial cell differentiation);GO:1900182(positive regulation of protein localization to nucleus);GO:1901676(positive regulation of histone H3-K27 acetylation);GO:1903025(regulation of RNA polymerase II regulatory region sequence-specific DNA binding)","04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells);04630(Jak-STAT signaling pathway);04668(TNF signaling pathway)","K05419","NA","LIF, interleukin 6 family cytokine [Source:NCBI gene;Acc:101110180]",{"v":0.261017,"d":"0.26"},0,{"v":0.459369,"d":"0.46"},0,{"v":0.077739,"d":"0.08"},0,{"v":9.26672583902546,"d":"9.27"},{"v":3.21205968942391,"d":"3.21"},1,1,"up","no"]
["ENSOARG00000016049","ENSOARG00000016049","ENSOART00000017478","NA","NA","NA","NA",null,{"v":0.065067,"d":"0.07"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.12631","ENSOARG00000022300","ENSOART00000024202","NA","NA","NA","NA",null,{"v":0.124148,"d":"0.12"},0,{"v":0.24823,"d":"0.25"},0,{"v":0.522254,"d":"0.52"},{"v":0.04318,"d":"0.04"},{"v":0.658570231008394,"d":"0.66"},{"v":-0.60259079483873,"d":"-0.60"},1,1,"down","no"]
["ENSOARG00000014173","ANO4","ENSOART00000015453","GO:0005229(intracellular calcium activated chloride channel activity);GO:0005886(plasma membrane);GO:0006821(chloride transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017128(phospholipid scramblase activity);GO:0034220(ion transmembrane transport);GO:0046983(protein dimerization activity);GO:0061588(calcium activated phospholipid scrambling);GO:0061589(calcium activated phosphatidylserine scrambling);GO:0061590(calcium activated phosphatidylcholine scrambling);GO:0061591(calcium activated galactosylceramide scrambling)","NA","K19499","NA","anoctamin 4 [Source:NCBI gene;Acc:101106248]",0,0,0,0,{"v":0.0104100722269991,"d":"0.01"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.4607","ENSOARG00000004547","ENSOART00000004947","GO:0106035(protein maturation by [4Fe-4S] cluster transfer)","NA","NA","NA","MIP18 family protein FAM96A pseudogene [Source:NCBI gene;Acc:101112243]",{"v":0.563423,"d":"0.56"},{"v":0.99785,"d":"1.00"},{"v":0.947953,"d":"0.95"},{"v":0.871287,"d":"0.87"},{"v":0.639195,"d":"0.64"},{"v":0.436734,"d":"0.44"},{"v":1.28862232027674,"d":"1.29"},{"v":0.365829489064662,"d":"0.37"},1,1,"up","no"]
["ENSOARG00000005085","ENSOARG00000005085","ENSOART00000005542","NA","NA","NA","NA",null,0,0,0,0,{"v":0.035401,"d":"0.04"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000018741","UBXN10","ENSOART00000020407","GO:0005515(protein binding);GO:0005929(cilium);GO:0030992(intraciliary transport particle B);GO:0060271(cilium assembly)","NA","NA","NA","UBX domain protein 10 [Source:NCBI gene;Acc:101103384]",{"v":0.112262,"d":"0.11"},{"v":0.112162,"d":"0.11"},{"v":0.102549,"d":"0.10"},{"v":0.252679,"d":"0.25"},{"v":0.039584,"d":"0.04"},{"v":0.195836,"d":"0.20"},{"v":0.669890739378692,"d":"0.67"},{"v":-0.578002286795614,"d":"-0.58"},1,1,"down","no"]
["MSTRG.17693","oar-mir-23a","ENSOART00000025186","NA","05206(MicroRNAs in cancer)","K17165","NA","oar-mir-23a [Source:miRBase;Acc:MI0025270]",{"v":1.372435,"d":"1.37"},{"v":0.437894,"d":"0.44"},{"v":0.97592,"d":"0.98"},{"v":1.221449,"d":"1.22"},{"v":0.340523,"d":"0.34"},{"v":1.443948,"d":"1.44"},{"v":0.926920543460904,"d":"0.93"},{"v":-0.109482419971771,"d":"-0.11"},1,1,"down","no"]
["ENSOARG00000000189","ENSOARG00000000189","ENSOART00000000193","GO:0005102(signaling receptor binding);GO:0007399(nervous system development)","NA","NA","NA",null,0,0,0,{"v":0.20488,"d":"0.20"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000014416","ENSOARG00000014416","ENSOART00000015695","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 243 [Source:NCBI gene;Acc:101112130]",{"v":1.899129,"d":"1.90"},{"v":2.297787,"d":"2.30"},{"v":2.507469,"d":"2.51"},{"v":1.520989,"d":"1.52"},{"v":3.233475,"d":"3.23"},{"v":2.357079,"d":"2.36"},{"v":0.942746883482248,"d":"0.94"},{"v":-0.0850576187510111,"d":"-0.09"},1,1,"down","no"]
["ENSOARG00000002418","ENSOARG00000002418","ENSOART00000002618","NA","NA","NA","NA",null,0,{"v":0.120632,"d":"0.12"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000000999","SPINK8","ENSOART00000001069","GO:0005515(protein binding)","NA","NA","NA","serine peptidase inhibitor, Kazal type 8 (putative) [Source:HGNC Symbol;Acc:HGNC:33160]",0,{"v":0.032567,"d":"0.03"},0,0,{"v":0.025243,"d":"0.03"},0,{"v":1.29013984074793,"d":"1.29"},{"v":0.367527450624695,"d":"0.37"},1,1,"up","no"]
["ENSOARG00000015180","BAMBI","ENSOART00000016520","GO:0005109(frizzled binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008284(positive regulation of cell population proliferation);GO:0008360(regulation of cell shape);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016477(cell migration);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032092(positive regulation of protein binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0090263(positive regulation of canonical Wnt signaling pathway)","04310(Wnt signaling pathway);04350(TGF-beta signaling pathway)","K10162","NA","BMP and activin membrane bound inhibitor [Source:NCBI gene;Acc:443242]",{"v":0.670717,"d":"0.67"},{"v":0.68644,"d":"0.69"},{"v":0.317125,"d":"0.32"},{"v":0.608955,"d":"0.61"},{"v":0.338916,"d":"0.34"},{"v":0.494907,"d":"0.49"},{"v":1.16045711814292,"d":"1.16"},{"v":0.214693212397528,"d":"0.21"},1,1,"up","no"]
["ENSOARG00000005566","ENSOARG00000005566","ENSOART00000006063","GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001568(blood vessel development);GO:0001890(placenta development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0042475(odontogenesis of dentin-containing tooth);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0071895(odontoblast differentiation)","NA","K09315","NA","distal-less homeobox 3 [Source:NCBI gene;Acc:101109372]",0,0,{"v":0.175837,"d":"0.18"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.17365","ENSOARG00000018164","ENSOART00000019768","GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste)","NA","NA","NA",null,0,0,0,{"v":0.070264,"d":"0.07"},{"v":0.041938,"d":"0.04"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000016293","ENSOARG00000016293","ENSOART00000017742","GO:0005515(protein binding)","NA","NA","NA","WD repeat-containing protein 61 pseudogene [Source:NCBI gene;Acc:101116466]",{"v":0.409365,"d":"0.41"},{"v":0.279184,"d":"0.28"},{"v":0.18455,"d":"0.18"},{"v":0.331395,"d":"0.33"},{"v":0.308388,"d":"0.31"},{"v":0.174708,"d":"0.17"},{"v":1.07195659620548,"d":"1.07"},{"v":0.100246491890082,"d":"0.10"},1,1,"up","no"]
["ENSOARG00000006942","ENSOARG00000006942","ENSOART00000007546","GO:0006508(proteolysis);GO:0007267(cell-cell signaling);GO:0007275(multicellular organism development);GO:0008233(peptidase activity)","NA","NA","NA",null,0,0,0,{"v":0.065285,"d":"0.07"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.4263","BATF3","ENSOART00000011380","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0009615(response to virus);GO:0043011(myeloid dendritic cell differentiation);GO:0097028(dendritic cell differentiation)","NA","NA","NA","basic leucine zipper ATF-like transcription factor 3 [Source:HGNC Symbol;Acc:HGNC:28915]",{"v":0.017424,"d":"0.02"},{"v":0.266411,"d":"0.27"},{"v":0.13364,"d":"0.13"},0,{"v":0.297552,"d":"0.30"},{"v":0.506632,"d":"0.51"},{"v":0.519128706863106,"d":"0.52"},{"v":-0.945835826568278,"d":"-0.95"},1,1,"down","no"]
["ENSOARG00000017772","LRRC10","ENSOART00000019337","GO:0003779(actin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005856(cytoskeleton);GO:0030016(myofibril);GO:0030017(sarcomere);GO:0051393(alpha-actinin binding);GO:0055013(cardiac muscle cell development)","NA","NA","NA","leucine rich repeat containing 10 [Source:NCBI gene;Acc:101101971]",{"v":0.126513,"d":"0.13"},{"v":0.179727,"d":"0.18"},{"v":0.167408,"d":"0.17"},{"v":0.106457,"d":"0.11"},{"v":0.334111,"d":"0.33"},0,{"v":1.07508489041419,"d":"1.08"},{"v":0.104450581809336,"d":"0.10"},1,1,"up","no"]
["ENSOARG00000003216","TRIM67","ENSOART00000003491","GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0010976(positive regulation of neuron projection development);GO:0046580(negative regulation of Ras protein signal transduction);GO:0046872(metal ion binding);GO:2000060(positive regulation of ubiquitin-dependent protein catabolic process)","NA","K10649","NA","tripartite motif containing 67 [Source:NCBI gene;Acc:101113651]",0,{"v":0.009803,"d":"0.01"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.9266","ENSOARG00000002857","ENSOART00000003096","NA","NA","NA","NA",null,0,{"v":0.103215,"d":"0.10"},{"v":0.008658,"d":"0.01"},{"v":0.166612,"d":"0.17"},{"v":0.010772,"d":"0.01"},{"v":0.063928,"d":"0.06"},{"v":0.463603136188834,"d":"0.46"},{"v":-1.10903776894683,"d":"-1.11"},1,1,"down","no"]
["MSTRG.3126","RF00156","ENSOART00000024076","NA","NA","NA","NA",null,0,0,{"v":0.282983,"d":"0.28"},{"v":0.3144,"d":"0.31"},{"v":0.141164,"d":"0.14"},0,{"v":0.621170680738601,"d":"0.62"},{"v":-0.686938358773317,"d":"-0.69"},1,1,"down","no"]
["ENSOARG00000000592","UNC5CL","ENSOART00000000638","GO:0005042(netrin receptor activity);GO:0005515(protein binding);GO:0006508(proteolysis);GO:0007165(signal transduction);GO:0008233(peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0038007(netrin-activated signaling pathway);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0046330(positive regulation of JNK cascade)","NA","NA","NA","unc-5 family C-terminal like [Source:NCBI gene;Acc:101107479]",{"v":0.064988,"d":"0.06"},{"v":0.026644,"d":"0.03"},0,{"v":0.031027,"d":"0.03"},{"v":0.063596,"d":"0.06"},{"v":0.016681,"d":"0.02"},{"v":0.823258822683821,"d":"0.82"},{"v":-0.280582026938296,"d":"-0.28"},1,1,"down","no"]
["MSTRG.16083","PARPBP","ENSOART00000017075","GO:0005654(nucleoplasm);GO:2000042(negative regulation of double-strand break repair via homologous recombination)","NA","NA","NA","PARP1 binding protein [Source:NCBI gene;Acc:101110135]",{"v":0.079522,"d":"0.08"},{"v":0.017767,"d":"0.02"},{"v":0.110853,"d":"0.11"},{"v":0.081047,"d":"0.08"},{"v":0.020262,"d":"0.02"},0,{"v":2.05452625136957,"d":"2.05"},{"v":1.03880576442075,"d":"1.04"},1,1,"up","no"]
["MSTRG.7200","RF00004","ENSOART00000023454","NA","NA","NA","NA",null,0,{"v":0.081422,"d":"0.08"},0,0,{"v":0.348234,"d":"0.35"},0,{"v":0.23381404457922,"d":"0.23"},{"v":-2.09656650361387,"d":"-2.10"},1,1,"down","no"]
["MSTRG.19045","CXCL10","ENSOART00000018092","GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006952(defense response);GO:0006955(immune response);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0008009(chemokine activity);GO:0008201(heparin binding);GO:0009617(response to bacterium);GO:0009897(external side of plasma membrane);GO:0010469(regulation of signaling receptor activity);GO:0010818(T cell chemotaxis);GO:0010819(regulation of T cell chemotaxis);GO:0016525(negative regulation of angiogenesis);GO:0042056(chemoattractant activity);GO:0042118(endothelial cell activation);GO:0042127(regulation of cell population proliferation);GO:0042981(regulation of apoptotic process);GO:0045662(negative regulation of myoblast differentiation);GO:0048248(CXCR3 chemokine receptor binding);GO:0050918(positive chemotaxis);GO:0051281(positive regulation of release of sequestered calcium ion into cytosol);GO:0051607(defense response to virus);GO:0070098(chemokine-mediated signaling pathway);GO:0071222(cellular response to lipopolysaccharide);GO:0090026(positive regulation of monocyte chemotaxis);GO:1901509(regulation of endothelial tube morphogenesis);GO:1901740(negative regulation of myoblast fusion);GO:2000406(positive regulation of T cell migration)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04620(Toll-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04657(IL-17 signaling pathway);04668(TNF signaling pathway);05160(Hepatitis C);05164(Influenza A);05169(Epstein-Barr virus infection)","K12671","NA","C-X-C motif chemokine ligand 10 [Source:NCBI gene;Acc:442997]",{"v":1.382105,"d":"1.38"},0,{"v":0.891903,"d":"0.89"},{"v":0.742256,"d":"0.74"},{"v":0.838236,"d":"0.84"},0,{"v":1.43879753899419,"d":"1.44"},{"v":0.524863596915706,"d":"0.52"},1,1,"up","no"]
["MSTRG.15776","RF00410","ENSOART00000026616","NA","NA","NA","NA",null,{"v":0.52124,"d":"0.52"},{"v":0.541843,"d":"0.54"},{"v":0.469995,"d":"0.47"},{"v":0.156328,"d":"0.16"},{"v":0.439905,"d":"0.44"},{"v":0.375478,"d":"0.38"},{"v":1.5777098334793,"d":"1.58"},{"v":0.657831894645558,"d":"0.66"},1,1,"up","no"]
["MSTRG.15101","FAM161A","ENSOART00000021961","GO:0000235(astral microtubule);GO:0001917(photoreceptor inner segment);GO:0005813(centrosome);GO:0005876(spindle microtubule);GO:0008017(microtubule binding);GO:0032391(photoreceptor connecting cilium);GO:0036064(ciliary basal body);GO:0042802(identical protein binding);GO:0060271(cilium assembly);GO:0072686(mitotic spindle);GO:0097431(mitotic spindle pole);GO:1901985(positive regulation of protein acetylation)","NA","K16772","NA","FAM161A, centrosomal protein [Source:NCBI gene;Acc:101117915]",{"v":0.117007,"d":"0.12"},{"v":0.230546,"d":"0.23"},{"v":0.268372,"d":"0.27"},{"v":0.109292,"d":"0.11"},{"v":0.147248,"d":"0.15"},{"v":0.164384,"d":"0.16"},{"v":1.46326890365007,"d":"1.46"},{"v":0.54919491664933,"d":"0.55"},1,1,"up","no"]
["ENSOARG00000022813","RF00401","ENSOART00000024715","NA","NA","NA","NA",null,{"v":0.072503,"d":"0.07"},{"v":0.112162,"d":"0.11"},0,0,{"v":0.28851,"d":"0.29"},0,{"v":0.64006446916918,"d":"0.64"},{"v":-0.643710869983442,"d":"-0.64"},1,1,"down","no"]
["MSTRG.20240","RF00015","ENSOART00000025047","NA","NA","NA","NA",null,{"v":0.254133,"d":"0.25"},{"v":0.104972,"d":"0.10"},{"v":0.105021,"d":"0.11"},{"v":0.220811,"d":"0.22"},{"v":0.119442,"d":"0.12"},{"v":0.07813,"d":"0.08"},{"v":1.1093328361812,"d":"1.11"},{"v":0.149692286208202,"d":"0.15"},1,1,"up","no"]
["MSTRG.480","ENSOARG00000024189","ENSOART00000026091","NA","NA","NA","NA",null,{"v":0.307104,"d":"0.31"},{"v":0.199236,"d":"0.20"},{"v":0.151878,"d":"0.15"},{"v":0.515409,"d":"0.52"},{"v":0.696532,"d":"0.70"},{"v":0.358351,"d":"0.36"},{"v":0.419169173631401,"d":"0.42"},{"v":-1.25439547220183,"d":"-1.25"},1,1,"down","no"]
["ENSOARG00000020888","BCL2L14","ENSOART00000022758","GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0019901(protein kinase binding);GO:0042981(regulation of apoptotic process);GO:0043229(intracellular organelle)","NA","NA","NA","BCL2 like 14 [Source:NCBI gene;Acc:101113402]",{"v":0.093466,"d":"0.09"},{"v":0.136046,"d":"0.14"},{"v":0.033418,"d":"0.03"},{"v":0.120535,"d":"0.12"},{"v":0.113106,"d":"0.11"},{"v":0.074284,"d":"0.07"},{"v":0.853876755703499,"d":"0.85"},{"v":-0.227900241395727,"d":"-0.23"},1,1,"down","no"]
["MSTRG.4490","CAMK1D","ENSOART00000016762;ENSOART00000016764","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0010976(positive regulation of neuron projection development);GO:0032793(positive regulation of CREB transcription factor activity);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0050766(positive regulation of phagocytosis);GO:0050773(regulation of dendrite development);GO:0060267(positive regulation of respiratory burst);GO:0071622(regulation of granulocyte chemotaxis);GO:0090023(positive regulation of neutrophil chemotaxis);GO:0090023(positive regulation of neutrophil chemotaxis)","04020(Calcium signaling pathway);04921(Oxytocin signaling pathway);04925(Aldosterone synthesis and secretion);05214(Glioma);05214(Glioma)","K08794","EC:2.7.11.17","calcium/calmodulin dependent protein kinase ID [Source:NCBI gene;Acc:101108939]",{"v":0.466532240244835,"d":"0.47"},{"v":0.45317726855394,"d":"0.45"},{"v":0.713358123947972,"d":"0.71"},{"v":0.335392062739097,"d":"0.34"},{"v":0.461031961744453,"d":"0.46"},{"v":0.682043394032135,"d":"0.68"},{"v":1.10456788718839,"d":"1.10"},{"v":0.143482090037905,"d":"0.14"},1,1,"up","no"]
["ENSOARG00000003871","PRPH2","ENSOART00000004205","GO:0001750(photoreceptor outer segment);GO:0007601(visual perception);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0060041(retina development in camera-type eye)","NA","K17343","NA","peripherin 2 [Source:NCBI gene;Acc:101109569]",0,{"v":0.022017,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.13380","PLA2G10","ENSOART00000008447","GO:0004620(phospholipase activity);GO:0004623(phospholipase A2 activity);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006629(lipid metabolic process);GO:0006644(phospholipid metabolic process);GO:0007411(axon guidance);GO:0010884(positive regulation of lipid storage);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0032270(positive regulation of cellular protein metabolic process);GO:0032308(positive regulation of prostaglandin secretion);GO:0042632(cholesterol homeostasis);GO:0043030(regulation of macrophage activation);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0050482(arachidonic acid secretion);GO:0051977(lysophospholipid transport);GO:0090238(positive regulation of arachidonic acid secretion);GO:0090370(negative regulation of cholesterol efflux);GO:0102567(phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine));GO:0102568(phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine));GO:1990830(cellular response to leukemia inhibitory factor)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);00590(Arachidonic acid metabolism);00591(Linoleic acid metabolism);00592(alpha-Linolenic acid metabolism);04014(Ras signaling pathway);04270(Vascular smooth muscle contraction);04972(Pancreatic secretion);04975(Fat digestion and absorption)","K01047","EC:3.1.1.4","phospholipase A2 group X [Source:NCBI gene;Acc:101109935]",{"v":0.082137,"d":"0.08"},{"v":0.189669,"d":"0.19"},{"v":0.108316,"d":"0.11"},{"v":0.149668,"d":"0.15"},{"v":0.125998,"d":"0.13"},0,{"v":1.37892231903826,"d":"1.38"},{"v":0.463541185572035,"d":"0.46"},1,1,"up","no"]
["MSTRG.791","C1orf56","ENSOART00000022795","GO:0042127(regulation of cell population proliferation)","NA","NA","NA","chromosome 1 open reading frame, human C1orf56 [Source:NCBI gene;Acc:101110552]",{"v":0.1043,"d":"0.10"},{"v":0.120442,"d":"0.12"},{"v":0.355179,"d":"0.36"},{"v":0.137181,"d":"0.14"},{"v":0.314843,"d":"0.31"},{"v":0.106079,"d":"0.11"},{"v":1.03909314230527,"d":"1.04"},{"v":0.0553249804395596,"d":"0.06"},1,1,"up","no"]
["ENSOARG00000018682","ENSOARG00000018682","ENSOART00000020332","GO:0005576(extracellular region);GO:0006869(lipid transport);GO:0008289(lipid binding);GO:0042157(lipoprotein metabolic process)","NA","NA","NA",null,0,0,{"v":0.080587,"d":"0.08"},0,0,{"v":0.055916,"d":"0.06"},{"v":1.44121539452035,"d":"1.44"},{"v":0.527285967285023,"d":"0.53"},1,1,"up","no"]
["ENSOARG00000017345","SLC10A4","ENSOART00000018880","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K14344","NA","solute carrier family 10 member 4 [Source:NCBI gene;Acc:101113071]",0,0,{"v":0.013498,"d":"0.01"},{"v":0.028533,"d":"0.03"},0,{"v":0.02792,"d":"0.03"},{"v":0.239101553504685,"d":"0.24"},{"v":-2.06430459124424,"d":"-2.06"},1,1,"down","no"]
["MSTRG.380","ANGPTL3","ENSOART00000010292","GO:0004857(enzyme inhibitor activity);GO:0004859(phospholipase inhibitor activity);GO:0005178(integrin binding);GO:0005615(extracellular space);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0006071(glycerol metabolic process);GO:0006631(fatty acid metabolic process);GO:0006644(phospholipid metabolic process);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0008083(growth factor activity);GO:0008203(cholesterol metabolic process);GO:0009395(phospholipid catabolic process);GO:0009986(cell surface);GO:0010469(regulation of signaling receptor activity);GO:0010519(negative regulation of phospholipase activity);GO:0019915(lipid storage);GO:0030335(positive regulation of cell migration);GO:0042632(cholesterol homeostasis);GO:0045766(positive regulation of angiogenesis);GO:0048844(artery morphogenesis);GO:0050996(positive regulation of lipid catabolic process);GO:0051005(negative regulation of lipoprotein lipase activity);GO:0055088(lipid homeostasis);GO:0055090(acylglycerol homeostasis);GO:0055091(phospholipid homeostasis);GO:0070328(triglyceride homeostasis)","04979(Cholesterol metabolism)","K22288","NA","angiopoietin like 3 [Source:NCBI gene;Acc:101107481]",{"v":0.152921,"d":"0.15"},{"v":0.115893,"d":"0.12"},{"v":0.054973,"d":"0.05"},{"v":0.058049,"d":"0.06"},{"v":0.161661,"d":"0.16"},{"v":0.065527,"d":"0.07"},{"v":1.13515076936022,"d":"1.14"},{"v":0.18288392726304,"d":"0.18"},1,1,"up","no"]
["ENSOARG00000023863","RF01879","ENSOART00000025765","NA","NA","NA","NA",null,0,{"v":0.05849,"d":"0.06"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000014469","KLK14","ENSOART00000015751","GO:0004252(serine-type endopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0009566(fertilization);GO:0016787(hydrolase activity);GO:0045744(negative regulation of G protein-coupled receptor signaling pathway);GO:0045745(positive regulation of G protein-coupled receptor signaling pathway);GO:0048730(epidermis morphogenesis);GO:0070684(seminal clot liquefaction)","NA","NA","NA","kallikrein-14 [Source:NCBI gene;Acc:101120354]",{"v":0.045945,"d":"0.05"},{"v":0.041509,"d":"0.04"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000024786","RF00619","ENSOART00000026688","NA","NA","NA","NA",null,0,0,{"v":0.283106,"d":"0.28"},{"v":0.269419,"d":"0.27"},{"v":0.438555,"d":"0.44"},0,{"v":0.399881916567558,"d":"0.40"},{"v":-1.3223540537198,"d":"-1.32"},1,1,"down","no"]
["ENSOARG00000005161","DNAH1","ENSOART00000005640","GO:0003341(cilium movement);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005858(axonemal dynein complex);GO:0005930(axoneme);GO:0007018(microtubule-based movement);GO:0007288(sperm axoneme assembly);GO:0016887(ATPase activity);GO:0030286(dynein complex);GO:0030317(flagellated sperm motility);GO:0036126(sperm flagellum);GO:0036156(inner dynein arm);GO:0036159(inner dynein arm assembly)","05016(Huntington disease)","K10408","NA","dynein axonemal heavy chain 1 [Source:NCBI gene;Acc:101112094]",{"v":0.016249,"d":"0.02"},{"v":0.011775,"d":"0.01"},{"v":0.012463,"d":"0.01"},{"v":0.003154,"d":"0.00"},{"v":0.002841,"d":"0.00"},{"v":0.005525,"d":"0.01"},{"v":3.51449652777778,"d":"3.51"},{"v":1.8133180295814,"d":"1.81"},1,1,"up","no"]
["ENSOARG00000011372","BATF2","ENSOART00000012365","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0042832(defense response to protozoan);GO:0043011(myeloid dendritic cell differentiation)","NA","NA","NA","basic leucine zipper ATF-like transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:25163]",{"v":0.189187,"d":"0.19"},{"v":0.130218,"d":"0.13"},0,0,0,{"v":0.124433,"d":"0.12"},{"v":2.5668833830254,"d":"2.57"},{"v":1.36001775382037,"d":"1.36"},1,1,"up","no"]
["ENSOARG00000017057","ARHGEF16","ENSOART00000018574","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0017048(Rho GTPase binding);GO:0030165(PDZ domain binding);GO:0030971(receptor tyrosine kinase binding);GO:0035023(regulation of Rho protein signal transduction);GO:0060326(cell chemotaxis);GO:0090630(activation of GTPase activity);GO:1903078(positive regulation of protein localization to plasma membrane)","NA","K20688","NA","Rho guanine nucleotide exchange factor 16 [Source:NCBI gene;Acc:101119743]",{"v":0.014987,"d":"0.01"},{"v":0.031092,"d":"0.03"},{"v":0.029966,"d":"0.03"},0,{"v":0.010213,"d":"0.01"},{"v":0.015221,"d":"0.02"},{"v":2.98989541558544,"d":"2.99"},{"v":1.5800950208598,"d":"1.58"},1,1,"up","no"]
["ENSOARG00000022457","RF00026","ENSOART00000024359","NA","NA","NA","NA",null,{"v":0.182641,"d":"0.18"},0,{"v":0.279259,"d":"0.28"},0,0,{"v":0.121237,"d":"0.12"},{"v":3.80989301945776,"d":"3.81"},{"v":1.92975048788535,"d":"1.93"},1,1,"up","no"]
["ENSOARG00000022591","RF00026","ENSOART00000024493","NA","NA","NA","NA",null,0,0,0,{"v":0.262522,"d":"0.26"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.19197","SORCS2","ENSOART00000012689","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","sortilin related VPS10 domain containing receptor 2 [Source:NCBI gene;Acc:101118613]",{"v":0.031908,"d":"0.03"},{"v":0.026535,"d":"0.03"},{"v":0.086603,"d":"0.09"},{"v":0.091827,"d":"0.09"},{"v":0.248059,"d":"0.25"},{"v":0.162691,"d":"0.16"},{"v":0.288604532240831,"d":"0.29"},{"v":-1.79283413882114,"d":"-1.79"},1,1,"down","no"]
["MSTRG.17033","RF00026","ENSOART00000024699","NA","NA","NA","NA",null,0,0,0,0,{"v":0.613902,"d":"0.61"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.14024","RF00607","ENSOART00000023284","NA","NA","NA","NA","small nucleolar RNA, C/D box 98 [Source:HGNC Symbol;Acc:HGNC:32761]",{"v":0.345706,"d":"0.35"},{"v":1.506427,"d":"1.51"},{"v":0.496461,"d":"0.50"},{"v":1.270682,"d":"1.27"},{"v":1.408863,"d":"1.41"},{"v":1.47812,"d":"1.48"},{"v":0.564882933088645,"d":"0.56"},{"v":-0.823976181964696,"d":"-0.82"},1,1,"down","no"]
["MSTRG.17351","ENSOARG00000016464","ENSOART00000017929","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.165764,"d":"0.17"},"-inf","-inf",1,1,"down","no"]
["MSTRG.14633","ENSOARG00000002850","ENSOART00000003084","NA","NA","NA","NA",null,0,0,0,0,{"v":0.047026,"d":"0.05"},{"v":0.104392,"d":"0.10"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017130","KRT2","ENSOART00000018648","GO:0005198(structural molecule activity);GO:0005882(intermediate filament);GO:0045095(keratin filament)","NA","K07605","NA","hair keratin type II intermediate filament [Source:NCBI gene;Acc:443415]",0,0,0,0,{"v":0.025188,"d":"0.03"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000010063","ENSOARG00000010063","ENSOART00000010951","GO:0045666(positive regulation of neuron differentiation);GO:0045930(negative regulation of mitotic cell cycle)","NA","NA","NA",null,{"v":0.349563,"d":"0.35"},{"v":0.119505,"d":"0.12"},0,{"v":0.177449,"d":"0.18"},0,{"v":0.294763,"d":"0.29"},{"v":0.993341973520368,"d":"0.99"},{"v":-0.00963762127454896,"d":"-0.01"},1,1,"down","no"]
["MSTRG.17469","RNF32","ENSOART00000007599","GO:0005515(protein binding);GO:0005768(endosome);GO:0016235(aggresome)","NA","NA","NA","ring finger protein 32 [Source:NCBI gene;Acc:101106934]",0,{"v":0.037851,"d":"0.04"},{"v":0.039829,"d":"0.04"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000003524","ANKRD65","ENSOART00000003826","GO:0005515(protein binding)","NA","NA","NA","ankyrin repeat domain 65 [Source:NCBI gene;Acc:101105587]",0,0,0,{"v":0.045527,"d":"0.05"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000011164","ENSOARG00000011164","ENSOART00000012141","GO:0005525(GTP binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.601872,"d":"0.60"},{"v":0.095187,"d":"0.10"},{"v":0.059637,"d":"0.06"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.19059","SOWAHB","ENSOART00000018962","GO:0005515(protein binding)","NA","NA","NA","sosondowah ankyrin repeat domain family member B [Source:HGNC Symbol;Acc:HGNC:32958]",{"v":0.058001,"d":"0.06"},{"v":0.027476,"d":"0.03"},{"v":0.061189,"d":"0.06"},{"v":0.116781,"d":"0.12"},{"v":0.062427,"d":"0.06"},{"v":0.06893,"d":"0.07"},{"v":0.591066261515769,"d":"0.59"},{"v":-0.758608222011371,"d":"-0.76"},1,1,"down","no"]
["MSTRG.8881","ENSOARG00000008794","ENSOART00000009572","GO:0006457(protein folding);GO:0031072(heat shock protein binding);GO:0046872(metal ion binding);GO:0051082(unfolded protein binding)","NA","NA","NA",null,{"v":0.143419,"d":"0.14"},{"v":0.443805,"d":"0.44"},{"v":0.366148,"d":"0.37"},{"v":0.191691,"d":"0.19"},{"v":0.135062,"d":"0.14"},{"v":0.144201,"d":"0.14"},{"v":2.02434208011823,"d":"2.02"},{"v":1.01745310208247,"d":"1.02"},1,1,"up","no"]
["MSTRG.21519","CA5B","ENSOART00000013810","GO:0004089(carbonate dehydratase activity);GO:0005739(mitochondrion);GO:0008270(zinc ion binding);GO:0009617(response to bacterium);GO:0046872(metal ion binding)","00910(Nitrogen metabolism)","K01672","EC:4.2.1.1","carbonic anhydrase 5B [Source:NCBI gene;Acc:101104372]",{"v":0.552758,"d":"0.55"},{"v":0.233459,"d":"0.23"},{"v":0.276528,"d":"0.28"},{"v":0.491963,"d":"0.49"},{"v":0.398966,"d":"0.40"},{"v":0.398495,"d":"0.40"},{"v":0.824201348819318,"d":"0.82"},{"v":-0.27893127027241,"d":"-0.28"},1,1,"down","no"]
["MSTRG.12112","ENSOARG00000017902","ENSOART00000019478","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.028152,"d":"0.03"},"-inf","-inf",1,1,"down","no"]
["MSTRG.4534","ENSOARG00000001952","ENSOART00000002100","NA","NA","NA","NA",null,{"v":0.18193,"d":"0.18"},{"v":0.231186,"d":"0.23"},{"v":1.119348,"d":"1.12"},{"v":0.254963,"d":"0.25"},{"v":0.212381,"d":"0.21"},{"v":0.15962,"d":"0.16"},{"v":2.44426155249743,"d":"2.44"},{"v":1.28939867153196,"d":"1.29"},1,1,"up","no"]
["MSTRG.5824","BHMG1","ENSOART00000011125","GO:0003677(DNA binding);GO:0005634(nucleus)","NA","NA","NA","basic helix-loop-helix and HMG-box containing 1 [Source:HGNC Symbol;Acc:HGNC:44318]",0,0,0,0,{"v":0.011479,"d":"0.01"},{"v":0.015297,"d":"0.02"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017327","CELA1","ENSOART00000018863","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0006954(inflammatory response);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0009791(post-embryonic development);GO:0016055(Wnt signaling pathway);GO:0016787(hydrolase activity);GO:0031017(exocrine pancreas development);GO:0035264(multicellular organism growth);GO:0042127(regulation of cell population proliferation);GO:0045595(regulation of cell differentiation);GO:0045766(positive regulation of angiogenesis);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048771(tissue remodeling);GO:0055123(digestive system development);GO:0060309(elastin catabolic process);GO:0061113(pancreas morphogenesis)","NA","K01326","EC:3.4.21.36","chymotrypsin like elastase family member 1 [Source:NCBI gene;Acc:101114258]",{"v":0.030522,"d":"0.03"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.9500","oar-let-7a","ENSOART00000025618","NA","05206(MicroRNAs in cancer)","K16980","NA","oar-let-7a [Source:miRBase;Acc:MI0025243]",{"v":0.248297,"d":"0.25"},{"v":0.189274,"d":"0.19"},{"v":0.232716,"d":"0.23"},{"v":0.415549,"d":"0.42"},{"v":0.721275,"d":"0.72"},{"v":0.224678,"d":"0.22"},{"v":0.492314370452632,"d":"0.49"},{"v":-1.02234824302906,"d":"-1.02"},1,1,"down","no"]
["MSTRG.1210","ENSOARG00000016921","ENSOART00000018429","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0008097(5S rRNA binding)","NA","NA","NA",null,{"v":0.406097,"d":"0.41"},{"v":0.641506,"d":"0.64"},{"v":0.361514,"d":"0.36"},{"v":0.234333,"d":"0.23"},{"v":0.192954,"d":"0.19"},{"v":0.352848,"d":"0.35"},{"v":1.80624763662699,"d":"1.81"},{"v":0.852995699929582,"d":"0.85"},1,1,"up","no"]
["ENSOARG00000000126","ENSOARG00000000126","ENSOART00000000130","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation);GO:0008097(5S rRNA binding)","NA","NA","NA",null,{"v":0.483304,"d":"0.48"},{"v":0.339523,"d":"0.34"},{"v":0.619618,"d":"0.62"},{"v":0.401475,"d":"0.40"},{"v":0.262093,"d":"0.26"},{"v":0.517055,"d":"0.52"},{"v":1.22176596593493,"d":"1.22"},{"v":0.288967957725286,"d":"0.29"},1,1,"up","no"]
["ENSOARG00000005043","PACRGL","ENSOART00000005490","NA","NA","NA","NA","parkin coregulated like [Source:NCBI gene;Acc:101123211]",{"v":0.679169,"d":"0.68"},{"v":0.541142,"d":"0.54"},{"v":0.517462,"d":"0.52"},{"v":1.014151,"d":"1.01"},{"v":0.555184,"d":"0.56"},{"v":0.663045,"d":"0.66"},{"v":0.778439602576622,"d":"0.78"},{"v":-0.361342986788459,"d":"-0.36"},1,1,"down","no"]
["ENSOARG00000020862","AZIN2","ENSOART00000022728","GO:0003824(catalytic activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005801(cis-Golgi network);GO:0005802(trans-Golgi network);GO:0006591(ornithine metabolic process);GO:0006596(polyamine biosynthetic process);GO:0015489(putrescine transmembrane transporter activity);GO:0015847(putrescine transport);GO:0030133(transport vesicle);GO:0030424(axon);GO:0030425(dendrite);GO:0031410(cytoplasmic vesicle);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0042177(negative regulation of protein catabolic process);GO:0042978(ornithine decarboxylase activator activity);GO:0043085(positive regulation of catalytic activity);GO:0043204(perikaryon);GO:0048471(perinuclear region of cytoplasm);GO:0098629(trans-Golgi network membrane organization);GO:1902269(positive regulation of polyamine transmembrane transport);GO:1990005(granular vesicle)","00330(Arginine and proline metabolism)","K01583","EC:4.1.1.19","antizyme inhibitor 2 [Source:NCBI gene;Acc:101110393]",{"v":0.01545,"d":"0.02"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.22260","ENSOARG00000022683","ENSOART00000024585","NA","NA","NA","NA",null,{"v":0.349167,"d":"0.35"},{"v":0.051408,"d":"0.05"},{"v":0.19393,"d":"0.19"},{"v":0.481854,"d":"0.48"},{"v":0.327364,"d":"0.33"},{"v":0.055163,"d":"0.06"},{"v":0.687781198337307,"d":"0.69"},{"v":-0.539978416993404,"d":"-0.54"},1,1,"down","no"]
["MSTRG.18713","ENSOARG00000011059","ENSOART00000012039","NA","NA","K11498","NA","centromere protein E [Source:NCBI gene;Acc:101105752]",{"v":0.019406,"d":"0.02"},{"v":0.009178,"d":"0.01"},{"v":0.020385,"d":"0.02"},{"v":0.043744,"d":"0.04"},{"v":0.016954,"d":"0.02"},{"v":0.044511,"d":"0.04"},{"v":0.465444971437805,"d":"0.47"},{"v":-1.10331748376629,"d":"-1.10"},1,1,"down","no"]
["MSTRG.5646","ENSOARG00000005481","ENSOART00000005972","GO:0005515(protein binding)","NA","NA","NA",null,0,0,0,0,{"v":0.002187,"d":"0.00"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000020243","INHA","ENSOART00000022040","GO:0005102(signaling receptor binding);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0008083(growth factor activity);GO:0010469(regulation of signaling receptor activity);GO:0034673(inhibin-betaglycan-ActRII complex);GO:0042127(regulation of cell population proliferation);GO:0042541(hemoglobin biosynthetic process);GO:0043512(inhibin A complex);GO:0051726(regulation of cell cycle)","04060(Cytokine-cytokine receptor interaction)","K05500","NA","Ovis aries inhibin subunit alpha (INHA), mRNA. [Source:RefSeq mRNA;Acc:NM_001308579]",{"v":0.111661,"d":"0.11"},{"v":0.18062,"d":"0.18"},{"v":0.137529,"d":"0.14"},{"v":0.297086,"d":"0.30"},{"v":0.590002,"d":"0.59"},{"v":0.261764,"d":"0.26"},{"v":0.374121296737961,"d":"0.37"},{"v":-1.41842200169648,"d":"-1.42"},1,1,"down","no"]
["ENSOARG00000001133","XKRX","ENSOART00000001212","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","XK related X-linked [Source:NCBI gene;Acc:101104045]",0,{"v":0.055369,"d":"0.06"},0,0,{"v":0.023561,"d":"0.02"},{"v":0.031122,"d":"0.03"},{"v":1.01254503227694,"d":"1.01"},{"v":0.0179860723408687,"d":"0.02"},1,1,"up","no"]
["ENSOARG00000022121","MIR216B","ENSOART00000024023","NA","NA","NA","NA","microRNA 216b [Source:HGNC Symbol;Acc:HGNC:33668]",{"v":0.124148,"d":"0.12"},{"v":0.354746,"d":"0.35"},{"v":0.323277,"d":"0.32"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.6127","ENSOARG00000003827","ENSOART00000004153","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","04722(Neurotrophin signaling pathway)","K12458","NA","zinc finger protein 274 [Source:NCBI gene;Acc:101119156]",{"v":0.710172,"d":"0.71"},{"v":1.119253,"d":"1.12"},{"v":0.537719,"d":"0.54"},{"v":0.842031,"d":"0.84"},{"v":0.38933,"d":"0.39"},{"v":0.555867,"d":"0.56"},{"v":1.32447790656816,"d":"1.32"},{"v":0.405423778512825,"d":"0.41"},1,1,"up","no"]
["ENSOARG00000012175","DGUOK","ENSOART00000013242","GO:0000166(nucleotide binding);GO:0004138(deoxyguanosine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006139(nucleobase-containing compound metabolic process);GO:0006468(protein phosphorylation);GO:0009157(deoxyribonucleoside monophosphate biosynthetic process);GO:0009165(nucleotide biosynthetic process);GO:0019206(nucleoside kinase activity);GO:0046070(dGTP metabolic process);GO:0046122(purine deoxyribonucleoside metabolic process)","00230(Purine metabolism)","K00904","EC:2.7.1.113","deoxyguanosine kinase [Source:NCBI gene;Acc:101114690]",{"v":1.077749,"d":"1.08"},{"v":0.789266,"d":"0.79"},{"v":0.404068,"d":"0.40"},{"v":1.081658,"d":"1.08"},{"v":1.033944,"d":"1.03"},{"v":0.758181,"d":"0.76"},{"v":0.790276440496725,"d":"0.79"},{"v":-0.339570695304411,"d":"-0.34"},1,1,"down","no"]
["ENSOARG00000007232","EXO1","ENSOART00000007870","GO:0002455(humoral immune response mediated by circulating immunoglobulin);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003824(catalytic activity);GO:0004518(nuclease activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006281(DNA repair);GO:0006298(mismatch repair);GO:0006310(DNA recombination);GO:0016446(somatic hypermutation of immunoglobulin genes);GO:0016604(nuclear body);GO:0016788(hydrolase activity, acting on ester bonds);GO:0035312(5'-3' exodeoxyribonuclease activity);GO:0045145(single-stranded DNA 5'-3' exodeoxyribonuclease activity);GO:0045190(isotype switching);GO:0048256(flap endonuclease activity);GO:0051908(double-stranded DNA 5'-3' exodeoxyribonuclease activity);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","03430(Mismatch repair)","K10746","EC:3.1.-.-","exonuclease 1 [Source:NCBI gene;Acc:101120258]",{"v":0.060246,"d":"0.06"},{"v":0.011646,"d":"0.01"},{"v":0.039096,"d":"0.04"},{"v":0.198798,"d":"0.20"},{"v":0.053492,"d":"0.05"},{"v":0.019637,"d":"0.02"},{"v":0.408153658886392,"d":"0.41"},{"v":-1.29281570450599,"d":"-1.29"},1,1,"down","no"]
["ENSOARG00000020964","ENSOARG00000020964","ENSOART00000022839","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding)","NA","NA","NA","NKG2-A/NKG2-B type II integral membrane protein-like [Source:NCBI gene;Acc:101116388]",{"v":0.517552,"d":"0.52"},{"v":0.070699,"d":"0.07"},0,{"v":0.141871,"d":"0.14"},0,0,{"v":4.14637945739439,"d":"4.15"},{"v":2.05185215124007,"d":"2.05"},1,1,"up","no"]
["ENSOARG00000019658","B3GALT1","ENSOART00000021409","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006682(galactosylceramide biosynthetic process);GO:0008378(galactosyltransferase activity);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0009312(oligosaccharide biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030259(lipid glycosylation)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)","K07819","EC:2.4.1.86","beta-1,3-galactosyltransferase 1 [Source:NCBI gene;Acc:101122666]",{"v":0.107064,"d":"0.11"},{"v":0.103587,"d":"0.10"},{"v":0.155112,"d":"0.16"},0,{"v":0.018512,"d":"0.02"},{"v":0.021336,"d":"0.02"},{"v":9.17895502911062,"d":"9.18"},{"v":3.19832992050934,"d":"3.20"},1,1,"up","no"]
["MSTRG.19259","ENSOARG00000015189","ENSOART00000016528","NA","NA","NA","NA",null,0,0,{"v":0.01027,"d":"0.01"},{"v":0.010208,"d":"0.01"},0,0,{"v":1.0060736677116,"d":"1.01"},{"v":0.00873594744068795,"d":"0.01"},1,1,"up","no"]
["MSTRG.11417","ENSOARG00000025162","ENSOART00000027064","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.019686,"d":"0.02"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000006128","RNF125","ENSOART00000006662","GO:0000139(Golgi membrane);GO:0000209(protein polyubiquitination);GO:0002039(p53 binding);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008270(zinc ion binding);GO:0031624(ubiquitin conjugating enzyme binding);GO:0032480(negative regulation of type I interferon production);GO:0034098(VCP-NPL4-UFD1 AAA ATPase complex);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0061630(ubiquitin protein ligase activity);GO:1990830(cellular response to leukemia inhibitory factor)","04622(RIG-I-like receptor signaling pathway)","K12170","EC:2.3.2.27","ring finger protein 125 [Source:NCBI gene;Acc:101114324]",{"v":0.973658,"d":"0.97"},{"v":0.542328,"d":"0.54"},{"v":1.753651,"d":"1.75"},{"v":1.107792,"d":"1.11"},{"v":1.082491,"d":"1.08"},{"v":0.535513,"d":"0.54"},{"v":1.19951639814572,"d":"1.20"},{"v":0.262452880317297,"d":"0.26"},1,1,"up","no"]
["ENSOARG00000008721","ENSOARG00000008721","ENSOART00000009500","NA","NA","NA","NA","chromosome 20 open reading frame, human C6orf141 [Source:NCBI gene;Acc:101117798]",{"v":0.099184,"d":"0.10"},0,{"v":0.052164,"d":"0.05"},{"v":0.263307,"d":"0.26"},0,0,{"v":0.574796720178347,"d":"0.57"},{"v":-0.798876265165763,"d":"-0.80"},1,1,"down","no"]
["MSTRG.14489","RF02271","ENSOART00000024710","NA","NA","NA","NA",null,{"v":1.021783,"d":"1.02"},{"v":0.591688,"d":"0.59"},{"v":0.54527,"d":"0.55"},{"v":1.871978,"d":"1.87"},{"v":0.496383,"d":"0.50"},{"v":1.003733,"d":"1.00"},{"v":0.64017818008632,"d":"0.64"},{"v":-0.643454590165267,"d":"-0.64"},1,1,"down","no"]
["MSTRG.5666","CCER2","ENSOART00000006425","NA","NA","NA","NA","coiled-coil glutamate rich protein 2 [Source:NCBI gene;Acc:101113431]",{"v":0.11896,"d":"0.12"},{"v":0.190743,"d":"0.19"},{"v":0.272092,"d":"0.27"},{"v":0.283016,"d":"0.28"},{"v":0.202762,"d":"0.20"},0,{"v":1.19765613098988,"d":"1.20"},{"v":0.26021374341198,"d":"0.26"},1,1,"up","no"]
["MSTRG.2658","RF00015","ENSOART00000024052","NA","NA","NA","NA",null,{"v":0.020691,"d":"0.02"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.4911","ENSOARG00000019159","ENSOART00000020865","GO:0003713(transcription coactivator activity);GO:0006357(regulation of transcription by RNA polymerase II);GO:0045165(cell fate commitment);GO:1903508(positive regulation of nucleic acid-templated transcription)","NA","NA","NA",null,{"v":0.589825,"d":"0.59"},{"v":0.768062,"d":"0.77"},{"v":0.521697,"d":"0.52"},{"v":0.578969,"d":"0.58"},{"v":0.722456,"d":"0.72"},{"v":0.504809,"d":"0.50"},{"v":1.04060935626281,"d":"1.04"},{"v":0.0574285839564325,"d":"0.06"},1,1,"up","no"]
["ENSOARG00000021452","RF00026","ENSOART00000023354","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.073059,"d":"0.07"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000008596","ENSOARG00000008596","ENSOART00000009354","NA","NA","NA","NA",null,0,{"v":0.121509,"d":"0.12"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.12682","ENSOARG00000021300","ENSOART00000023202","NA","NA","NA","NA",null,{"v":0.032907,"d":"0.03"},{"v":0.178379,"d":"0.18"},{"v":0.24823,"d":"0.25"},{"v":0.128852,"d":"0.13"},{"v":0.299497,"d":"0.30"},0,{"v":1.07276076283591,"d":"1.07"},{"v":0.101328375485836,"d":"0.10"},1,1,"up","no"]
["MSTRG.18461","RF00438","ENSOART00000024399","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 33 [Source:HGNC Symbol;Acc:HGNC:32623]",{"v":1.063856,"d":"1.06"},{"v":1.647924,"d":"1.65"},{"v":0.987193,"d":"0.99"},{"v":0.775096,"d":"0.78"},{"v":0.444852,"d":"0.44"},{"v":0.37147,"d":"0.37"},{"v":2.3243252244225,"d":"2.32"},{"v":1.21681194775891,"d":"1.22"},1,1,"up","no"]
["ENSOARG00000006131","KIF5A","ENSOART00000006671","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding);GO:0016192(vesicle-mediated transport);GO:0019894(kinesin binding);GO:0032839(dendrite cytoplasm);GO:0035253(ciliary rootlet);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0098971(anterograde dendritic transport of neurotransmitter receptor complex)","04144(Endocytosis);04728(Dopaminergic synapse)","K10396","NA","kinesin family member 5A [Source:NCBI gene;Acc:101119383]",{"v":0.038157,"d":"0.04"},{"v":0.005431,"d":"0.01"},{"v":0.010373,"d":"0.01"},{"v":0.019304,"d":"0.02"},{"v":0.025854,"d":"0.03"},0,{"v":1.19493777403782,"d":"1.19"},{"v":0.256935492327816,"d":"0.26"},1,1,"up","no"]
["ENSOARG00000009516","ENSOARG00000009516","ENSOART00000010360","GO:0005515(protein binding)","NA","NA","NA",null,{"v":0.167642,"d":"0.17"},{"v":0.005425,"d":"0.01"},{"v":0.097466,"d":"0.10"},0,{"v":0.342059,"d":"0.34"},{"v":0.043104,"d":"0.04"},{"v":0.702385743178862,"d":"0.70"},{"v":-0.509664533120437,"d":"-0.51"},1,1,"down","no"]
["ENSOARG00000011585","ENSOARG00000011585","ENSOART00000012597","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 501-like [Source:NCBI gene;Acc:101104423]",0,{"v":0.167974,"d":"0.17"},{"v":0.024022,"d":"0.02"},{"v":0.151927,"d":"0.15"},{"v":0.12703,"d":"0.13"},{"v":0.066218,"d":"0.07"},{"v":0.556228000289708,"d":"0.56"},{"v":-0.846251723697311,"d":"-0.85"},1,1,"down","no"]
["MSTRG.8556","oar-mir-154b","ENSOART00000023679","NA","NA","NA","NA","oar-mir-154b [Source:miRBase;Acc:MI0016953]",{"v":0.124148,"d":"0.12"},{"v":0.658568,"d":"0.66"},{"v":0.142334,"d":"0.14"},{"v":0.341636,"d":"0.34"},{"v":0.353311,"d":"0.35"},{"v":0.4708,"d":"0.47"},{"v":0.793525524835149,"d":"0.79"},{"v":-0.333651464818933,"d":"-0.33"},1,1,"down","no"]
["MSTRG.7801","RASL10A","ENSOART00000004255","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0016020(membrane)","NA","NA","NA","RAS like family 10 member A [Source:HGNC Symbol;Acc:HGNC:16954]",{"v":0.265546,"d":"0.27"},{"v":0.187926,"d":"0.19"},{"v":0.118701,"d":"0.12"},0,{"v":0.274762,"d":"0.27"},0,{"v":2.08243134057839,"d":"2.08"},{"v":1.05826892956921,"d":"1.06"},1,1,"up","no"]
["MSTRG.6069","ENSOARG00000001804","ENSOART00000001938","GO:0007368(determination of left/right symmetry);GO:0007507(heart development);GO:0070286(axonemal dynein complex assembly)","NA","NA","NA",null,{"v":0.067433,"d":"0.07"},{"v":0.066766,"d":"0.07"},{"v":0.019517,"d":"0.02"},{"v":0.045904,"d":"0.05"},{"v":0.058823,"d":"0.06"},{"v":0.049372,"d":"0.05"},{"v":0.997514584779915,"d":"1.00"},{"v":-0.003590159581622,"d":"-0.00"},1,1,"down","no"]
["MSTRG.16936","ENSOARG00000008307","ENSOART00000009039","NA","NA","NA","NA",null,{"v":0.068971,"d":"0.07"},{"v":0.195677,"d":"0.20"},0,0,0,{"v":0.035408,"d":"0.04"},{"v":7.47424310890194,"d":"7.47"},{"v":2.90192748990319,"d":"2.90"},1,1,"up","no"]
["ENSOARG00000022342","RF00026","ENSOART00000024244","NA","NA","NA","NA",null,{"v":0.074257,"d":"0.07"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000003013","PGLYRP2","ENSOART00000003262","GO:0002221(pattern recognition receptor signaling pathway);GO:0008270(zinc ion binding);GO:0008745(N-acetylmuramoyl-L-alanine amidase activity);GO:0009253(peptidoglycan catabolic process);GO:0016019(peptidoglycan receptor activity);GO:0016045(detection of bacterium);GO:0042834(peptidoglycan binding);GO:0050830(defense response to Gram-positive bacterium)","NA","K01446","NA","peptidoglycan recognition protein 2 [Source:NCBI gene;Acc:101119301]",0,0,{"v":0.019348,"d":"0.02"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000019395","ALX3","ENSOART00000021121","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007389(pattern specification process);GO:0035115(embryonic forelimb morphogenesis);GO:0035116(embryonic hindlimb morphogenesis);GO:0042981(regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048704(embryonic skeletal system morphogenesis)","NA","NA","NA","ALX homeobox 3 [Source:HGNC Symbol;Acc:HGNC:449]",0,0,{"v":0.062256,"d":"0.06"},0,0,{"v":0.069521,"d":"0.07"},{"v":0.895499201680068,"d":"0.90"},{"v":-0.159235948809817,"d":"-0.16"},1,1,"down","no"]
["ENSOARG00000012024","ENSOARG00000012024","ENSOART00000013078","GO:0004930(G protein-coupled receptor activity);GO:0004957(prostaglandin E receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.612241,"d":"0.61"},{"v":0.733403,"d":"0.73"},{"v":0.134859,"d":"0.13"},{"v":0.755634,"d":"0.76"},{"v":0.398545,"d":"0.40"},{"v":0.442443,"d":"0.44"},{"v":0.927272078175047,"d":"0.93"},{"v":-0.108935381450581,"d":"-0.11"},1,1,"down","no"]
["MSTRG.12793","RF00026","ENSOART00000026816","NA","NA","NA","NA",null,{"v":0.334156,"d":"0.33"},{"v":0.117404,"d":"0.12"},{"v":0.389745,"d":"0.39"},{"v":0.385353,"d":"0.39"},{"v":0.169726,"d":"0.17"},{"v":1.180734,"d":"1.18"},{"v":0.484674904497201,"d":"0.48"},{"v":-1.04491071032969,"d":"-1.04"},1,1,"down","no"]
["ENSOARG00000002540","PGC","ENSOART00000002750","GO:0002803(positive regulation of antibacterial peptide production);GO:0004190(aspartic-type endopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016787(hydrolase activity)","NA","K01377","EC:3.4.23.3","progastricsin [Source:NCBI gene;Acc:101106633]",0,0,0,0,0,{"v":0.012185,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["MSTRG.18575","ENSOARG00000024168","ENSOART00000026070","NA","NA","NA","NA",null,{"v":0.213811,"d":"0.21"},{"v":0.169801,"d":"0.17"},{"v":0.42406,"d":"0.42"},{"v":0.386557,"d":"0.39"},{"v":0.386397,"d":"0.39"},0,{"v":1.04491599758847,"d":"1.04"},{"v":0.0633869664844132,"d":"0.06"},1,1,"up","no"]
["ENSOARG00000021596","RF00026","ENSOART00000023498","NA","NA","NA","NA",null,{"v":0.013923,"d":"0.01"},0,{"v":0.213432,"d":"0.21"},{"v":0.131261,"d":"0.13"},{"v":0.257598,"d":"0.26"},0,{"v":0.58467207908265,"d":"0.58"},{"v":-0.774300397585793,"d":"-0.77"},1,1,"down","no"]
["ENSOARG00000011843","FBXO41","ENSOART00000012882","GO:0005515(protein binding)","NA","K10316","NA","F-box protein 41 [Source:NCBI gene;Acc:101104391]",0,{"v":0.003419,"d":"0.00"},0,{"v":0.01756,"d":"0.02"},{"v":0.036182,"d":"0.04"},{"v":0.055828,"d":"0.06"},{"v":0.0312037966596696,"d":"0.03"},{"v":-5.00213461296808,"d":"-5.00"},1,1,"down","no"]
["ENSOARG00000010762","ENSOARG00000010762","ENSOART00000011707","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","contactin-associated protein-like 3 [Source:NCBI gene;Acc:101123612]",{"v":0.025063,"d":"0.03"},{"v":0.00424,"d":"0.00"},0,{"v":0.009673,"d":"0.01"},{"v":0.019458,"d":"0.02"},{"v":0.009245,"d":"0.01"},{"v":0.763576193454242,"d":"0.76"},{"v":-0.389155971350472,"d":"-0.39"},1,1,"down","no"]
["MSTRG.7287","RF00026","ENSOART00000025367","NA","NA","NA","NA",null,{"v":0.106744,"d":"0.11"},{"v":0.078619,"d":"0.08"},{"v":0.220392,"d":"0.22"},{"v":0.814058,"d":"0.81"},{"v":0.030093,"d":"0.03"},0,{"v":0.480666373670114,"d":"0.48"},{"v":-1.05689221555602,"d":"-1.06"},1,1,"down","no"]
["ENSOARG00000014318","KLK7","ENSOART00000015589","GO:0002803(positive regulation of antibacterial peptide production);GO:0004252(serine-type endopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016787(hydrolase activity);GO:0097209(epidermal lamellar body)","NA","K08668","EC:3.4.21.117","kallikrein related peptidase 7 [Source:NCBI gene;Acc:101115562]",0,{"v":0.034983,"d":"0.03"},0,{"v":0.051482,"d":"0.05"},0,0,{"v":0.67951905520376,"d":"0.68"},{"v":-0.557414086996222,"d":"-0.56"},1,1,"down","no"]
["MSTRG.22332","ENSOARG00000000445","ENSOART00000000473","NA","NA","NA","NA",null,{"v":0.465136,"d":"0.47"},{"v":0.480471,"d":"0.48"},{"v":0.462122,"d":"0.46"},{"v":0.688571,"d":"0.69"},{"v":0.560993,"d":"0.56"},{"v":0.657678,"d":"0.66"},{"v":0.738096686209721,"d":"0.74"},{"v":-0.438118281882453,"d":"-0.44"},1,1,"down","no"]
["MSTRG.2399","oar-mir-19b","ENSOART00000024151","NA","05206(MicroRNAs in cancer)","K17005","NA","oar-mir-19b [Source:miRBase;Acc:MI0025263]",{"v":0.07463,"d":"0.07"},{"v":0.229482,"d":"0.23"},{"v":0.054211,"d":"0.05"},0,0,{"v":0.110144,"d":"0.11"},{"v":3.25322305345729,"d":"3.25"},{"v":1.70186974247882,"d":"1.70"},1,1,"up","no"]
["ENSOARG00000008929","RFX6","ENSOART00000009729","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003309(type B pancreatic cell differentiation);GO:0003310(pancreatic A cell differentiation);GO:0003311(pancreatic D cell differentiation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0031018(endocrine pancreas development);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0042593(glucose homeostasis);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050796(regulation of insulin secretion);GO:0090104(pancreatic epsilon cell differentiation)","04950(Maturity onset diabetes of the young)","K19521","NA","regulatory factor X6 [Source:NCBI gene;Acc:101103984]",0,{"v":0.005875,"d":"0.01"},0,0,{"v":0.00871,"d":"0.01"},0,{"v":0.67451205510907,"d":"0.67"},{"v":-0.568083867146503,"d":"-0.57"},1,1,"down","no"]
["ENSOARG00000010159","ENSOARG00000010159","ENSOART00000011054","NA","NA","NA","NA","protein BEX2 [Source:NCBI gene;Acc:101109336]",0,0,0,0,0,{"v":0.058645,"d":"0.06"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000003855","KLHDC8A","ENSOART00000004192","GO:0005515(protein binding)","NA","NA","NA","kelch domain containing 8A [Source:NCBI gene;Acc:101110350]",0,{"v":0.038293,"d":"0.04"},0,0,{"v":0.106033,"d":"0.11"},0,{"v":0.361142285892128,"d":"0.36"},{"v":-1.46936074057927,"d":"-1.47"},1,1,"down","no"]
["ENSOARG00000012023","GRB7","ENSOART00000013081","GO:0005070(SH3/SH2 adaptor activity);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0007165(signal transduction);GO:0009967(positive regulation of signal transduction);GO:0010494(cytoplasmic stress granule);GO:0017148(negative regulation of translation);GO:0019901(protein kinase binding);GO:0030335(positive regulation of cell migration);GO:0034063(stress granule assembly);GO:0035091(phosphatidylinositol binding);GO:0042802(identical protein binding)","NA","NA","NA","growth factor receptor bound protein 7 [Source:NCBI gene;Acc:101104589]",{"v":0.039032,"d":"0.04"},0,{"v":0.044405,"d":"0.04"},{"v":0.02134,"d":"0.02"},{"v":0.071107,"d":"0.07"},0,{"v":0.90253875193354,"d":"0.90"},{"v":-0.147939217156702,"d":"-0.15"},1,1,"down","no"]
["MSTRG.21679","ENSOARG00000019136","ENSOART00000020840","GO:0005623(cell);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008199(ferric iron binding);GO:0046872(metal ion binding)","NA","NA","NA",null,0,0,0,{"v":0.202728,"d":"0.20"},{"v":0.092735,"d":"0.09"},{"v":0.298044,"d":"0.30"},"-inf","-inf",1,1,"down","no"]
["MSTRG.17519","ENSOARG00000001453","ENSOART00000001553","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":0.012415,"d":"0.01"},{"v":0.081102,"d":"0.08"},{"v":0.301059,"d":"0.30"},{"v":0.318166,"d":"0.32"},{"v":0.203436,"d":"0.20"},{"v":0.194949,"d":"0.19"},{"v":0.550660036759421,"d":"0.55"},{"v":-0.860766183803783,"d":"-0.86"},1,1,"down","no"]
["MSTRG.10407","ENSOARG00000022220","ENSOART00000024122","NA","NA","NA","NA",null,{"v":0.105925,"d":"0.11"},0,{"v":0.24823,"d":"0.25"},0,{"v":0.257598,"d":"0.26"},0,{"v":1.37483598475143,"d":"1.37"},{"v":0.459259518201251,"d":"0.46"},1,1,"up","no"]
["MSTRG.2611","SKA2","ENSOART00000013132","GO:0000278(mitotic cell cycle);GO:0000940(condensed chromosome outer kinetochore);GO:0005876(spindle microtubule);GO:0007059(chromosome segregation);GO:0008017(microtubule binding);GO:0031110(regulation of microtubule polymerization or depolymerization);GO:0051301(cell division)","NA","NA","NA","uncharacterized LOC101103247 [Source:NCBI gene;Acc:101103247]",{"v":1.120038,"d":"1.12"},{"v":0.608419,"d":"0.61"},{"v":1.214945,"d":"1.21"},{"v":1.339878,"d":"1.34"},{"v":1.219324,"d":"1.22"},{"v":1.506893,"d":"1.51"},{"v":0.723889136874569,"d":"0.72"},{"v":-0.466159328418842,"d":"-0.47"},1,1,"down","no"]
["ENSOARG00000016219","ENSOARG00000016219","ENSOART00000017658","GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0016853(isomerase activity)","NA","NA","NA",null,0,{"v":0.389107,"d":"0.39"},{"v":0.186173,"d":"0.19"},{"v":0.256114,"d":"0.26"},{"v":0.106537,"d":"0.11"},{"v":0.392658,"d":"0.39"},{"v":0.761648543840998,"d":"0.76"},{"v":-0.392802662818698,"d":"-0.39"},1,1,"down","no"]
["ENSOARG00000006105","ENSOARG00000006105","ENSOART00000006637","NA","NA","NA","NA",null,{"v":0.08488,"d":"0.08"},{"v":0.076685,"d":"0.08"},0,{"v":0.043891,"d":"0.04"},{"v":0.221246,"d":"0.22"},{"v":0.134983,"d":"0.13"},{"v":0.403791362591223,"d":"0.40"},{"v":-1.3083180442479,"d":"-1.31"},1,1,"down","no"]
["ENSOARG00000006915","IQCF6","ENSOART00000007516","GO:0005515(protein binding)","NA","NA","NA","IQ motif containing F6 [Source:HGNC Symbol;Acc:HGNC:35158]",0,0,{"v":0.032717,"d":"0.03"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000019663","PTHLH","ENSOART00000021413","GO:0001501(skeletal system development);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0010468(regulation of gene expression);GO:0010469(regulation of signaling receptor activity);GO:0030282(bone mineralization);GO:0032331(negative regulation of chondrocyte differentiation);GO:0051428(peptide hormone receptor binding);GO:0061182(negative regulation of chondrocyte development)","04928(Parathyroid hormone synthesis, secretion and action)","K22608","NA","parathyroid hormone like hormone [Source:NCBI gene;Acc:443135]",{"v":0.175642,"d":"0.18"},{"v":0.315669,"d":"0.32"},{"v":1.313553,"d":"1.31"},0,{"v":0.36737,"d":"0.37"},{"v":0.359872,"d":"0.36"},{"v":2.48179285574816,"d":"2.48"},{"v":1.31138270513136,"d":"1.31"},1,1,"up","no"]
["ENSOARG00000010214","ENSOARG00000010214","ENSOART00000011113","GO:0005509(calcium ion binding)","NA","NA","NA",null,{"v":0.013341,"d":"0.01"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.3839","RF00026","ENSOART00000025882","NA","NA","NA","NA",null,{"v":0.78898,"d":"0.79"},{"v":0.578632,"d":"0.58"},{"v":0.51734,"d":"0.52"},{"v":0.172205,"d":"0.17"},{"v":0.363526,"d":"0.36"},0,{"v":3.5184672904872,"d":"3.52"},{"v":1.81494710103013,"d":"1.81"},1,1,"up","no"]
["ENSOARG00000019925","HGD","ENSOART00000021692","GO:0004411(homogentisate 1,2-dioxygenase activity);GO:0006520(cellular amino acid metabolic process);GO:0006559(L-phenylalanine catabolic process);GO:0006570(tyrosine metabolic process);GO:0042802(identical protein binding);GO:0055114(oxidation-reduction process)","00350(Tyrosine metabolism)","K00451","EC:1.13.11.5","homogentisate 1,2-dioxygenase [Source:NCBI gene;Acc:101108617]",{"v":0.116922,"d":"0.12"},{"v":0.012756,"d":"0.01"},{"v":0.189699,"d":"0.19"},{"v":0.025153,"d":"0.03"},{"v":0.096878,"d":"0.10"},0,{"v":2.61717924134032,"d":"2.62"},{"v":1.38801273284511,"d":"1.39"},1,1,"up","no"]
["ENSOARG00000009115","GPR173","ENSOART00000009923","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","G protein-coupled receptor 173 [Source:HGNC Symbol;Acc:HGNC:18186]",{"v":0.058762,"d":"0.06"},0,{"v":0.145968,"d":"0.15"},{"v":0.126283,"d":"0.13"},{"v":0.274141,"d":"0.27"},{"v":0.309532,"d":"0.31"},{"v":0.288369983491935,"d":"0.29"},{"v":-1.79400709300297,"d":"-1.79"},1,1,"down","no"]
["ENSOARG00000020008","ENSOARG00000020008","ENSOART00000021784","GO:0004190(aspartic-type endopeptidase activity);GO:0006508(proteolysis)","NA","NA","NA",null,{"v":0.277525,"d":"0.28"},{"v":0.326552,"d":"0.33"},{"v":0.251992,"d":"0.25"},{"v":0.1688,"d":"0.17"},0,{"v":0.110215,"d":"0.11"},{"v":3.06818271419099,"d":"3.07"},{"v":1.61738439972748,"d":"1.62"},1,1,"up","no"]
["MSTRG.22202","ENSOARG00000014897","ENSOART00000016212","NA","NA","NA","NA",null,0,0,0,0,{"v":0.038507,"d":"0.04"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.15188","EVA1A","ENSOART00000001061","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle)","NA","NA","NA","eva-1 homolog A, regulator of programmed cell death [Source:HGNC Symbol;Acc:HGNC:25816]",0,{"v":0.200339,"d":"0.20"},0,0,{"v":0.022448,"d":"0.02"},{"v":0.235587,"d":"0.24"},{"v":0.776402426027477,"d":"0.78"},{"v":-0.365123468834315,"d":"-0.37"},1,1,"down","no"]
["MSTRG.4442","ENSOARG00000024050","ENSOART00000025952","NA","NA","NA","NA",null,{"v":0.124148,"d":"0.12"},0,{"v":0.42715,"d":"0.43"},{"v":0.338028,"d":"0.34"},{"v":0.438251,"d":"0.44"},{"v":0.176848,"d":"0.18"},{"v":0.57840980268107,"d":"0.58"},{"v":-0.789836092115055,"d":"-0.79"},1,1,"down","no"]
["MSTRG.13503","APOBR","ENSOART00000003391","GO:0006869(lipid transport);GO:0006898(receptor-mediated endocytosis);GO:0030228(lipoprotein particle receptor activity)","NA","NA","NA","apolipoprotein B receptor [Source:NCBI gene;Acc:101122247]",{"v":0.206919,"d":"0.21"},{"v":0.186277,"d":"0.19"},{"v":0.270678,"d":"0.27"},{"v":0.22508,"d":"0.23"},{"v":0.231179,"d":"0.23"},{"v":0.220274,"d":"0.22"},{"v":0.981288421998631,"d":"0.98"},{"v":-0.0272508566793765,"d":"-0.03"},1,1,"down","no"]
["ENSOARG00000008838","CNTN6","ENSOART00000009627","GO:0005112(Notch binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007399(nervous system development);GO:0022008(neurogenesis);GO:0030182(neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway);GO:0098688(parallel fiber to Purkinje cell synapse);GO:0099026(anchored component of presynaptic membrane)","NA","K06764","NA","contactin 6 [Source:NCBI gene;Acc:101112602]",0,0,0,{"v":0.004696,"d":"0.00"},0,{"v":0.004595,"d":"0.00"},"-inf","-inf",1,1,"down","no"]
["MSTRG.6498","C11orf16","ENSOART00000015313","NA","NA","NA","NA","chromosome 15 open reading frame, human C11orf16 [Source:NCBI gene;Acc:101106876]",0,{"v":0.0188091639950678,"d":"0.02"},0,{"v":0.0107959161528977,"d":"0.01"},{"v":0.0581261849568434,"d":"0.06"},0,{"v":0.272904680678828,"d":"0.27"},{"v":-1.87353095592125,"d":"-1.87"},1,1,"down","no"]
["ENSOARG00000010696","ENSOARG00000010696","ENSOART00000011637","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,{"v":0.086614,"d":"0.09"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000008015","RASSF10","ENSOART00000008725","GO:0007165(signal transduction);GO:0050769(positive regulation of neurogenesis);GO:2000179(positive regulation of neural precursor cell proliferation)","NA","K09856","NA","Ras association domain family member 10 [Source:NCBI gene;Acc:101121799]",{"v":0.02783,"d":"0.03"},{"v":0.143343,"d":"0.14"},{"v":0.050484,"d":"0.05"},{"v":0.033267,"d":"0.03"},0,{"v":0.028264,"d":"0.03"},{"v":3.60236303651818,"d":"3.60"},{"v":1.84894357952082,"d":"1.85"},1,1,"up","no"]
["MSTRG.3287","PSMC3IP","ENSOART00000002571","GO:0005654(nucleoplasm);GO:0007131(reciprocal meiotic recombination);GO:0030374(nuclear receptor transcription coactivator activity);GO:1903508(positive regulation of nucleic acid-templated transcription)","NA","K06695","NA","PSMC3 interacting protein [Source:NCBI gene;Acc:101103491]",{"v":0.306348,"d":"0.31"},{"v":0.053034,"d":"0.05"},{"v":0.052963,"d":"0.05"},{"v":0.224213,"d":"0.22"},{"v":0.194497,"d":"0.19"},{"v":0.130835,"d":"0.13"},{"v":0.750338916740212,"d":"0.75"},{"v":-0.41438570853578,"d":"-0.41"},1,1,"down","no"]
["MSTRG.11162","ENSOARG00000022285","ENSOART00000024187","NA","NA","NA","NA",null,{"v":1.042481,"d":"1.04"},{"v":0.524524,"d":"0.52"},{"v":0.412501,"d":"0.41"},{"v":0.386557,"d":"0.39"},{"v":0.846664,"d":"0.85"},{"v":0.482095,"d":"0.48"},{"v":1.15401826835405,"d":"1.15"},{"v":0.206666062332779,"d":"0.21"},1,1,"up","no"]
["ENSOARG00000010752","ENSOARG00000010752","ENSOART00000011696","GO:0006081(cellular aldehyde metabolic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0016620(oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor);GO:0055114(oxidation-reduction process)","NA","NA","NA",null,{"v":0.024145,"d":"0.02"},0,0,{"v":0.057842,"d":"0.06"},0,0,{"v":0.417430241001349,"d":"0.42"},{"v":-1.26039297363664,"d":"-1.26"},1,1,"down","no"]
["ENSOARG00000007109","ELOVL4","ENSOART00000007733","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006636(unsaturated fatty acid biosynthetic process);GO:0009922(fatty acid elongase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0019367(fatty acid elongation, saturated fatty acid);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0034626(fatty acid elongation, polyunsaturated fatty acid);GO:0035338(long-chain fatty-acyl-CoA biosynthetic process);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0102336(3-oxo-arachidoyl-CoA synthase activity);GO:0102337(3-oxo-cerotoyl-CoA synthase activity);GO:0102338(3-oxo-lignoceronyl-CoA synthase activity);GO:0102756(very-long-chain 3-ketoacyl-CoA synthase activity)","NA","NA","NA","ELOVL fatty acid elongase 4 [Source:HGNC Symbol;Acc:HGNC:14415]",0,0,0,0,{"v":0.155905,"d":"0.16"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000016531","ENSOARG00000016531","ENSOART00000018000","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":0.3389,"d":"0.34"},{"v":0.166827,"d":"0.17"},{"v":0.55131,"d":"0.55"},0,{"v":0.007481,"d":"0.01"},0,{"v":141.296217083278,"d":"141.30"},{"v":7.14257903075972,"d":"7.14"},1,1,"up","no"]
["ENSOARG00000012035","GRIN2C","ENSOART00000013092","GO:0004970(ionotropic glutamate receptor activity);GO:0004972(NMDA glutamate receptor activity);GO:0005216(ion channel activity);GO:0005261(cation channel activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0009611(response to wounding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017146(NMDA selective glutamate receptor complex);GO:0019722(calcium-mediated signaling);GO:0022849(glutamate-gated calcium ion channel activity);GO:0030054(cell junction);GO:0033058(directional locomotion);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0038023(signaling receptor activity);GO:0042177(negative regulation of protein catabolic process);GO:0042391(regulation of membrane potential);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0050885(neuromuscular process controlling balance);GO:0060079(excitatory postsynaptic potential);GO:0097553(calcium ion transmembrane import into cytosol);GO:0098978(glutamatergic synapse);GO:1903539(protein localization to postsynaptic membrane);GO:1904315(transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04713(Circadian entrainment);04720(Long-term potentiation);04724(Glutamatergic synapse);05010(Alzheimer disease);05014(Amyotrophic lateral sclerosis (ALS));05030(Cocaine addiction);05031(Amphetamine addiction);05033(Nicotine addiction);05034(Alcoholism)","K05211","NA","glutamate ionotropic receptor NMDA type subunit 2C [Source:NCBI gene;Acc:101102915]",0,{"v":0.032006,"d":"0.03"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000018998","CENPA","ENSOART00000020684","GO:0000132(establishment of mitotic spindle orientation);GO:0000281(mitotic cytokinesis);GO:0000775(chromosome, centromeric region);GO:0000778(condensed nuclear chromosome kinetochore);GO:0000780(condensed nuclear chromosome, centromeric region);GO:0000786(nucleosome);GO:0000788(nuclear nucleosome);GO:0000939(condensed chromosome inner kinetochore);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0031618(nuclear pericentric heterochromatin);GO:0046982(protein heterodimerization activity);GO:0051382(kinetochore assembly);GO:0071459(protein localization to chromosome, centromeric region)","NA","K11495","NA","centromere protein A [Source:NCBI gene;Acc:101110750]",0,0,0,{"v":0.299443,"d":"0.30"},0,{"v":0.484532,"d":"0.48"},"-inf","-inf",1,1,"down","no"]
["MSTRG.7303","RF00619","ENSOART00000026844","NA","NA","NA","NA",null,{"v":0.658183,"d":"0.66"},{"v":1.380665,"d":"1.38"},{"v":0.790003,"d":"0.79"},{"v":0.697439,"d":"0.70"},{"v":0.405819,"d":"0.41"},{"v":0.614421,"d":"0.61"},{"v":1.64690317573889,"d":"1.65"},{"v":0.719755739042709,"d":"0.72"},1,1,"up","no"]
["ENSOARG00000024333","RF00026","ENSOART00000026235","NA","NA","NA","NA","RNA, U6 small nuclear 1060, pseudogene [Source:HGNC Symbol;Acc:HGNC:48023]",0,0,{"v":0.744691,"d":"0.74"},0,0,{"v":0.419502,"d":"0.42"},{"v":1.77517866422568,"d":"1.78"},{"v":0.827964233079747,"d":"0.83"},1,1,"up","no"]
["ENSOARG00000008586","EBPL","ENSOART00000009345","GO:0005783(endoplasmic reticulum);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016125(sterol metabolic process);GO:0047750(cholestenol delta-isomerase activity)","NA","NA","NA","EBP like [Source:NCBI gene;Acc:101117596]",{"v":0.721384,"d":"0.72"},{"v":0.628073,"d":"0.63"},{"v":0.351402,"d":"0.35"},{"v":0.600579,"d":"0.60"},{"v":0.726865,"d":"0.73"},{"v":0.857963,"d":"0.86"},{"v":0.778280201353798,"d":"0.78"},{"v":-0.361638437972292,"d":"-0.36"},1,1,"down","no"]
["MSTRG.16260","RF00100","ENSOART00000026221","NA","NA","NA","NA",null,0,{"v":0.269732,"d":"0.27"},{"v":0.187485,"d":"0.19"},{"v":0.104328,"d":"0.10"},{"v":0.06187,"d":"0.06"},{"v":0.052568,"d":"0.05"},{"v":2.08998198988874,"d":"2.09"},{"v":1.06349051014819,"d":"1.06"},1,1,"up","no"]
["ENSOARG00000009821","ENSOARG00000009821","ENSOART00000010683;ENSOART00000010684","GO:0016032(viral process);GO:0019068(virion assembly);GO:0019068(virion assembly)","NA","NA","NA",null,{"v":0.0803677298076923,"d":"0.08"},{"v":0.115113063461538,"d":"0.12"},{"v":0.183166303846154,"d":"0.18"},{"v":0.0286607625,"d":"0.03"},{"v":0.0150487269230769,"d":"0.02"},{"v":0.00581596442307692,"d":"0.01"},{"v":7.6455048406344,"d":"7.65"},{"v":2.93461176738502,"d":"2.93"},1,1,"up","no"]
["ENSOARG00000015812","HFM1","ENSOART00000017229","GO:0000712(resolution of meiotic recombination intermediates);GO:0003676(nucleic acid binding);GO:0005524(ATP binding)","NA","K15271","EC:3.6.4.12","HFM1, ATP dependent DNA helicase homolog [Source:NCBI gene;Acc:101123510]",{"v":0.050676,"d":"0.05"},{"v":0.05082,"d":"0.05"},{"v":0.039296,"d":"0.04"},{"v":0.124646,"d":"0.12"},{"v":0.067757,"d":"0.07"},{"v":0.103671,"d":"0.10"},{"v":0.475529766207097,"d":"0.48"},{"v":-1.07239244420049,"d":"-1.07"},1,1,"down","no"]
["ENSOARG00000017690","OR10AD1","ENSOART00000019249","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","NA","NA","NA","olfactory receptor family 10 subfamily AD member 1 [Source:HGNC Symbol;Acc:HGNC:14819]",{"v":0.010158,"d":"0.01"},{"v":0.036236,"d":"0.04"},{"v":0.034476,"d":"0.03"},{"v":0.054968,"d":"0.05"},0,{"v":0.047123,"d":"0.05"},{"v":0.792136427305051,"d":"0.79"},{"v":-0.336179172099717,"d":"-0.34"},1,1,"down","no"]
["MSTRG.588","NTNG1","ENSOART00000020470;ENSOART00000020468","GO:0005886(plasma membrane);GO:0007409(axonogenesis);GO:0046658(anchored component of plasma membrane);GO:0050804(modulation of chemical synaptic transmission);GO:0050839(cell adhesion molecule binding);GO:0098632(cell-cell adhesion mediator activity);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099029(anchored component of presynaptic active zone membrane);GO:0099560(synaptic membrane adhesion);GO:0099560(synaptic membrane adhesion)","04360(Axon guidance);04514(Cell adhesion molecules (CAMs));04514(Cell adhesion molecules (CAMs))","K07522","NA","netrin G1 [Source:NCBI gene;Acc:101120121]",{"v":0.389278711433757,"d":"0.39"},{"v":0.231614485934664,"d":"0.23"},{"v":0.307897283121597,"d":"0.31"},{"v":0.18334395553539,"d":"0.18"},{"v":0.28938898185118,"d":"0.29"},{"v":0.360981950544465,"d":"0.36"},{"v":1.11403849677547,"d":"1.11"},{"v":0.155799087388394,"d":"0.16"},1,1,"up","no"]
["MSTRG.7514","RF00026","ENSOART00000026968","NA","NA","NA","NA",null,{"v":0.331836,"d":"0.33"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000005953","ENSOARG00000005953","ENSOART00000006470","NA","NA","NA","NA",null,0,0,0,0,{"v":0.126688,"d":"0.13"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.12763","CFAP46","ENSOART00000018738","GO:0005515(protein binding);GO:0035082(axoneme assembly);GO:0060294(cilium movement involved in cell motility)","NA","NA","NA","cilia- and flagella-associated protein 46 [Source:NCBI gene;Acc:101110287]",{"v":0.087963,"d":"0.09"},{"v":0.069292,"d":"0.07"},{"v":0.095881,"d":"0.10"},{"v":0.080757,"d":"0.08"},{"v":0.100072,"d":"0.10"},{"v":0.129971,"d":"0.13"},{"v":0.814465894465895,"d":"0.81"},{"v":-0.296073807327614,"d":"-0.30"},1,1,"down","no"]
["MSTRG.21150","ENSOARG00000024274","ENSOART00000026176","NA","NA","NA","NA",null,{"v":0.268988,"d":"0.27"},0,{"v":0.179278,"d":"0.18"},{"v":0.054583,"d":"0.05"},0,0,{"v":8.212557023249,"d":"8.21"},{"v":3.03783148271021,"d":"3.04"},1,1,"up","no"]
["MSTRG.7806","ENSOARG00000005225","ENSOART00000005694","NA","NA","NA","NA",null,{"v":0.208141,"d":"0.21"},{"v":0.159957,"d":"0.16"},{"v":0.444073,"d":"0.44"},{"v":0.320419,"d":"0.32"},0,0,{"v":2.53471548191587,"d":"2.53"},{"v":1.34182381592067,"d":"1.34"},1,1,"up","no"]
["ENSOARG00000001745","CDH8","ENSOART00000001876","GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007268(chemical synaptic transmission);GO:0009409(response to cold);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0035249(synaptic transmission, glutamatergic);GO:0042802(identical protein binding);GO:0043083(synaptic cleft);GO:0043679(axon terminus);GO:0046872(metal ion binding);GO:0050807(regulation of synapse organization);GO:0097060(synaptic membrane);GO:0098609(cell-cell adhesion);GO:0098978(glutamatergic synapse)","NA","K06800","NA","cadherin 8 [Source:NCBI gene;Acc:101106707]",{"v":0.01347,"d":"0.01"},{"v":0.040782,"d":"0.04"},{"v":0.013467,"d":"0.01"},{"v":0.195733,"d":"0.20"},{"v":0.013975,"d":"0.01"},{"v":0.068404,"d":"0.07"},{"v":0.243495426303072,"d":"0.24"},{"v":-2.03803342119103,"d":"-2.04"},1,1,"down","no"]
["ENSOARG00000005110","SERPINB8","ENSOART00000005566","GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0005829(cytosol);GO:0010951(negative regulation of endopeptidase activity);GO:0090136(epithelial cell-cell adhesion)","NA","K13965","NA","serpin family B member 8 [Source:NCBI gene;Acc:101104287]",{"v":0.56374,"d":"0.56"},{"v":0.444851,"d":"0.44"},{"v":0.866587,"d":"0.87"},{"v":0.745316,"d":"0.75"},{"v":0.550525,"d":"0.55"},{"v":0.617557,"d":"0.62"},{"v":0.980025065354934,"d":"0.98"},{"v":-0.0291094464750084,"d":"-0.03"},1,1,"down","no"]
["MSTRG.8508","RF00181","ENSOART00000025042","NA","NA","NA","NA",null,{"v":0.21188,"d":"0.21"},{"v":0.830002,"d":"0.83"},{"v":0.797647,"d":"0.80"},{"v":1.391605,"d":"1.39"},{"v":1.883901,"d":"1.88"},{"v":0.623707,"d":"0.62"},{"v":0.471769303190157,"d":"0.47"},{"v":-1.08384654569552,"d":"-1.08"},1,1,"down","no"]
["ENSOARG00000024107","RF00026","ENSOART00000026009","NA","NA","NA","NA",null,0,{"v":0.091197,"d":"0.09"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000005150","ONECUT2","ENSOART00000005607","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001889(liver development);GO:0001952(regulation of cell-matrix adhesion);GO:0002064(epithelial cell development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0009653(anatomical structure morphogenesis);GO:0015629(actin cytoskeleton);GO:0030335(positive regulation of cell migration);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0031016(pancreas development);GO:0031018(endocrine pancreas development);GO:0045165(cell fate commitment);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048935(peripheral nervous system neuron development);GO:0060271(cilium assembly)","NA","NA","NA","one cut homeobox 2 [Source:NCBI gene;Acc:101114994]",{"v":0.088581,"d":"0.09"},0,0,{"v":0.032735,"d":"0.03"},0,0,{"v":2.70600274935085,"d":"2.71"},{"v":1.43616330512111,"d":"1.44"},1,1,"up","no"]
["ENSOARG00000012674","SLC39A12","ENSOART00000013783","GO:0005385(zinc ion transmembrane transporter activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0010975(regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030001(metal ion transport);GO:0031113(regulation of microtubule polymerization);GO:0046873(metal ion transmembrane transporter activity);GO:0048471(perinuclear region of cytoplasm);GO:0055085(transmembrane transport);GO:0071578(zinc ion import across plasma membrane)","NA","K14718","NA","solute carrier family 39 member 12 [Source:NCBI gene;Acc:101111648]",0,{"v":0.0342908343451865,"d":"0.03"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000001333","MDM1","ENSOART00000001437","GO:0005634(nucleus);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0008017(microtubule binding);GO:0045494(photoreceptor cell maintenance);GO:0046600(negative regulation of centriole replication)","NA","K17886","NA","Mdm1 nuclear protein [Source:NCBI gene;Acc:101106759]",{"v":0.110653,"d":"0.11"},{"v":0.138347,"d":"0.14"},{"v":0.067824,"d":"0.07"},{"v":0.121346,"d":"0.12"},{"v":0.078385,"d":"0.08"},{"v":0.114908,"d":"0.11"},{"v":1.00694446651559,"d":"1.01"},{"v":0.00998412019496019,"d":"0.01"},1,1,"up","no"]
["ENSOARG00000018765","LRRC49","ENSOART00000020437","GO:0005515(protein binding)","NA","K16606","NA","leucine rich repeat containing 49 [Source:NCBI gene;Acc:101107966]",{"v":0.132282,"d":"0.13"},{"v":0.107323,"d":"0.11"},{"v":0.030988,"d":"0.03"},{"v":0.107052,"d":"0.11"},{"v":0.136439,"d":"0.14"},{"v":0.022828,"d":"0.02"},{"v":1.01604842313166,"d":"1.02"},{"v":0.022969160128958,"d":"0.02"},1,1,"up","no"]
["ENSOARG00000003929","VIP","ENSOART00000004271","GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0010469(regulation of signaling receptor activity);GO:0032880(regulation of protein localization);GO:0045732(positive regulation of protein catabolic process);GO:0048255(mRNA stabilization);GO:0051428(peptide hormone receptor binding);GO:0070459(prolactin secretion)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction)","K05264","NA","vasoactive intestinal peptide [Source:NCBI gene;Acc:100145884]",0,0,0,0,0,{"v":0.03268,"d":"0.03"},"-inf","-inf",1,1,"down","no"]
["MSTRG.20681","ENSOARG00000024105","ENSOART00000026007","NA","NA","NA","NA",null,0,{"v":0.340355,"d":"0.34"},0,0,{"v":0.248715,"d":"0.25"},{"v":0.19855,"d":"0.20"},{"v":0.760969447642896,"d":"0.76"},{"v":-0.394089563128204,"d":"-0.39"},1,1,"down","no"]
["ENSOARG00000014372","EFHC1","ENSOART00000015651","GO:0000281(mitotic cytokinesis);GO:0000922(spindle pole);GO:0005509(calcium ion binding);GO:0005813(centrosome);GO:0007052(mitotic spindle organization);GO:0021795(cerebral cortex cell migration);GO:0043014(alpha-tubulin binding);GO:0051302(regulation of cell division);GO:0072686(mitotic spindle)","NA","K23029","NA","EF-hand domain containing 1 [Source:NCBI gene;Acc:101105193]",{"v":0.093459,"d":"0.09"},{"v":0.253937,"d":"0.25"},{"v":0.180216,"d":"0.18"},{"v":0.299985,"d":"0.30"},{"v":0.16778,"d":"0.17"},{"v":0.31018,"d":"0.31"},{"v":0.678212470033228,"d":"0.68"},{"v":-0.560190783998354,"d":"-0.56"},1,1,"down","no"]
["ENSOARG00000012624","ENSOARG00000012624","ENSOART00000013724","NA","NA","NA","NA","chromosome 3 open reading frame, human C2orf81 [Source:NCBI gene;Acc:101116894]",0,0,0,{"v":0.018751,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000005599","DENND1C","ENSOART00000006103","GO:0017112(Rab guanyl-nucleotide exchange factor activity)","NA","K20160","NA","DENN domain containing 1C [Source:NCBI gene;Acc:101105327]",{"v":0.272529,"d":"0.27"},{"v":0.288546,"d":"0.29"},{"v":0.244643,"d":"0.24"},{"v":0.228374,"d":"0.23"},{"v":0.373954,"d":"0.37"},{"v":0.324602,"d":"0.32"},{"v":0.86923284390407,"d":"0.87"},{"v":-0.202185407203971,"d":"-0.20"},1,1,"down","no"]
["MSTRG.17614","UNC13A","ENSOART00000017217","GO:0005509(calcium ion binding);GO:0005543(phospholipid binding);GO:0007268(chemical synaptic transmission);GO:0016082(synaptic vesicle priming);GO:0016188(synaptic vesicle maturation);GO:0019992(diacylglycerol binding);GO:0035249(synaptic transmission, glutamatergic);GO:0035556(intracellular signal transduction);GO:0045202(synapse);GO:0046872(metal ion binding);GO:0098793(presynapse);GO:1903861(positive regulation of dendrite extension)","04721(Synaptic vesicle cycle)","K15293","NA","unc-13 homolog A [Source:NCBI gene;Acc:101113588]",0,{"v":0.00579,"d":"0.01"},{"v":0.006752,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000016085","ENSOARG00000016085","ENSOART00000017515","NA","NA","NA","NA",null,0,0,{"v":0.03267,"d":"0.03"},{"v":0.067834,"d":"0.07"},0,0,{"v":0.48161688828611,"d":"0.48"},{"v":-1.05404211263312,"d":"-1.05"},1,1,"down","no"]
["MSTRG.1389","RF00100","ENSOART00000023901","NA","NA","NA","NA","RNA, 7SK small nuclear pseudogene 159 [Source:HGNC Symbol;Acc:HGNC:45883]",{"v":0.120289,"d":"0.12"},{"v":0.452427,"d":"0.45"},{"v":0.2627,"d":"0.26"},{"v":0.449648,"d":"0.45"},{"v":0.252927,"d":"0.25"},{"v":0.016332,"d":"0.02"},{"v":1.16206407782926,"d":"1.16"},{"v":0.216689623146651,"d":"0.22"},1,1,"up","no"]
["MSTRG.2806","MIR22","ENSOART00000025049","NA","NA","NA","NA","microRNA 22 [Source:HGNC Symbol;Acc:HGNC:31599]",{"v":1.530292,"d":"1.53"},{"v":1.064952,"d":"1.06"},{"v":1.753291,"d":"1.75"},{"v":1.003692,"d":"1.00"},{"v":1.838437,"d":"1.84"},{"v":2.049236,"d":"2.05"},{"v":0.889022798339523,"d":"0.89"},{"v":-0.169707678498647,"d":"-0.17"},1,1,"down","no"]
["ENSOARG00000014696","IGLON5","ENSOART00000015998","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","IgLON family member 5 [Source:HGNC Symbol;Acc:HGNC:34550]",0,{"v":0.05589,"d":"0.06"},{"v":0.156449,"d":"0.16"},{"v":0.13324,"d":"0.13"},{"v":0.057374,"d":"0.06"},{"v":0.223199,"d":"0.22"},{"v":0.513127910432973,"d":"0.51"},{"v":-0.962609595087668,"d":"-0.96"},1,1,"down","no"]
["MSTRG.17387","ENSOARG00000018641","ENSOART00000020290","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0071205(protein localization to juxtaparanode region of axon)","NA","NA","NA",null,{"v":0.179718,"d":"0.18"},{"v":0.06468,"d":"0.06"},{"v":0.532979,"d":"0.53"},{"v":0.088941,"d":"0.09"},{"v":0.109371,"d":"0.11"},{"v":0.141918,"d":"0.14"},{"v":2.28485730241307,"d":"2.28"},{"v":1.19210406658334,"d":"1.19"},1,1,"up","no"]
["MSTRG.14107","ENSOARG00000022092","ENSOART00000023994","NA","NA","NA","NA",null,{"v":0.273126,"d":"0.27"},{"v":1.618129,"d":"1.62"},{"v":1.085595,"d":"1.09"},{"v":0.321272,"d":"0.32"},{"v":0.894724,"d":"0.89"},{"v":0.416926,"d":"0.42"},{"v":1.82302032797647,"d":"1.82"},{"v":0.866330648545089,"d":"0.87"},1,1,"up","no"]
["ENSOARG00000022724","RF01975","ENSOART00000024626","NA","NA","NA","NA",null,{"v":0.122162,"d":"0.12"},{"v":0.110368,"d":"0.11"},0,{"v":0.124729,"d":"0.12"},{"v":0.178258,"d":"0.18"},0,{"v":0.767458669843921,"d":"0.77"},{"v":-0.381839036152734,"d":"-0.38"},1,1,"down","no"]
["ENSOARG00000019560","ENSOARG00000019560","ENSOART00000021303","NA","NA","NA","NA",null,{"v":0.082087,"d":"0.08"},0,0,{"v":0.036262,"d":"0.04"},0,0,{"v":2.26371959627158,"d":"2.26"},{"v":1.17869526465296,"d":"1.18"},1,1,"up","no"]
["ENSOARG00000013904","ENSOARG00000013904","ENSOART00000015131","GO:0004800(thyroxine 5'-deiodinase activity);GO:0016491(oxidoreductase activity);GO:0042446(hormone biosynthetic process);GO:0055114(oxidation-reduction process)","NA","NA","NA",null,{"v":0.037307,"d":"0.04"},{"v":0.348666,"d":"0.35"},{"v":0.280513,"d":"0.28"},{"v":0.138614,"d":"0.14"},{"v":0.174009,"d":"0.17"},{"v":0.301206,"d":"0.30"},{"v":1.0857844774359,"d":"1.09"},{"v":0.118737764107549,"d":"0.12"},1,1,"up","no"]
["ENSOARG00000006418","HMGCLL1","ENSOART00000006973","GO:0003824(catalytic activity);GO:0004419(hydroxymethylglutaryl-CoA lyase activity);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0016020(membrane);GO:0046951(ketone body biosynthetic process);GO:0048471(perinuclear region of cytoplasm)","00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);00650(Butanoate metabolism);04146(Peroxisome)","K01640","EC:4.1.3.4","3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1 [Source:NCBI gene;Acc:101113541]",{"v":0.636775,"d":"0.64"},{"v":0.507749,"d":"0.51"},{"v":0.141471,"d":"0.14"},{"v":0.359556,"d":"0.36"},{"v":0.39875,"d":"0.40"},{"v":0.484938,"d":"0.48"},{"v":1.03438665298204,"d":"1.03"},{"v":0.0487755648307435,"d":"0.05"},1,1,"up","no"]
["ENSOARG00000011143","ENSOARG00000011143","ENSOART00000012119","GO:0006887(exocytosis);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0048786(presynaptic active zone)","NA","NA","NA",null,0,0,0,{"v":0.191599,"d":"0.19"},{"v":0.200598,"d":"0.20"},{"v":0.222008,"d":"0.22"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000002513","ENSOARG00000002513","ENSOART00000002724;ENSOART00000002723","NA","NA","NA","NA",null,{"v":0.0261346509405793,"d":"0.03"},{"v":0.0346427270827113,"d":"0.03"},{"v":0.100109103911615,"d":"0.10"},{"v":0.0539013789190803,"d":"0.05"},{"v":0.0760857853090475,"d":"0.08"},{"v":0.072022643774261,"d":"0.07"},{"v":0.796429062162185,"d":"0.80"},{"v":-0.328382228082755,"d":"-0.33"},1,1,"down","no"]
["ENSOARG00000011229","ENSOARG00000011229","ENSOART00000012209","GO:0003735(structural constituent of ribosome);GO:0005737(cytoplasm);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,0,0,0,{"v":0.030982,"d":"0.03"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.13528","RF00026","ENSOART00000025395","NA","NA","NA","NA",null,0,0,0,{"v":0.474466,"d":"0.47"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.6352","ENSOARG00000016404","ENSOART00000017864","GO:0005515(protein binding)","NA","NA","NA",null,{"v":0.017424,"d":"0.02"},0,0,{"v":0.017245,"d":"0.02"},0,{"v":0.02626,"d":"0.03"},{"v":0.400505689001264,"d":"0.40"},{"v":-1.32010535928054,"d":"-1.32"},1,1,"down","no"]
["MSTRG.18679","RF02216","ENSOART00000025715","NA","NA","NA","NA",null,{"v":0.516835,"d":"0.52"},{"v":1.243539,"d":"1.24"},{"v":1.269708,"d":"1.27"},{"v":0.633057,"d":"0.63"},{"v":2.489181,"d":"2.49"},{"v":1.021711,"d":"1.02"},{"v":0.731206392742768,"d":"0.73"},{"v":-0.451649411337697,"d":"-0.45"},1,1,"down","no"]
["ENSOARG00000022048","RF00026","ENSOART00000023950","NA","NA","NA","NA","RNA, U6 small nuclear 197, pseudogene [Source:HGNC Symbol;Acc:HGNC:47160]",0,0,0,0,{"v":0.216671,"d":"0.22"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000008529","PLEKHG6","ENSOART00000009279","GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005813(centrosome);GO:0030054(cell junction);GO:0035023(regulation of Rho protein signal transduction)","NA","NA","NA","pleckstrin homology and RhoGEF domain containing G6 [Source:NCBI gene;Acc:101110410]",{"v":0.079729,"d":"0.08"},{"v":0.104053,"d":"0.10"},{"v":0.146702,"d":"0.15"},{"v":0.12946,"d":"0.13"},{"v":0.099464,"d":"0.10"},{"v":0.060234,"d":"0.06"},{"v":1.14291840447091,"d":"1.14"},{"v":0.192722409967849,"d":"0.19"},1,1,"up","no"]
["MSTRG.1487","RTP4","ENSOART00000022322","NA","NA","NA","NA","receptor transporter protein 4 [Source:NCBI gene;Acc:100125352]",{"v":0.122388,"d":"0.12"},{"v":0.025508,"d":"0.03"},{"v":0.075635,"d":"0.08"},{"v":0.143376,"d":"0.14"},{"v":0.254768,"d":"0.25"},{"v":0.176267,"d":"0.18"},{"v":0.389148188318121,"d":"0.39"},{"v":-1.3616084542245,"d":"-1.36"},1,1,"down","no"]
["ENSOARG00000004474","ZNF365","ENSOART00000004866","GO:0000723(telomere maintenance);GO:0005815(microtubule organizing center);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0010977(negative regulation of neuron projection development);GO:0021687(cerebellar molecular layer morphogenesis);GO:0043231(intracellular membrane-bounded organelle);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0060997(dendritic spine morphogenesis);GO:0110026(regulation of DNA strand resection involved in replication fork processing);GO:0140059(dendrite arborization)","NA","K16737","NA","zinc finger protein 365 [Source:NCBI gene;Acc:101122160]",{"v":0.346627,"d":"0.35"},{"v":0.193984,"d":"0.19"},{"v":0.09296,"d":"0.09"},{"v":0.069522,"d":"0.07"},{"v":0.197637,"d":"0.20"},{"v":0.158863,"d":"0.16"},{"v":1.48717906586984,"d":"1.49"},{"v":0.572578367557812,"d":"0.57"},1,1,"up","no"]
["ENSOARG00000008718","ENSOARG00000008718","ENSOART00000009494","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","NA","NA","NA","cytochrome P450 2J2-like [Source:NCBI gene;Acc:101104943]",0,0,{"v":0.059825,"d":"0.06"},0,{"v":0.043501,"d":"0.04"},0,{"v":1.37525574124733,"d":"1.38"},{"v":0.459699925780375,"d":"0.46"},1,1,"up","no"]
["MSTRG.1419","RF00026","ENSOART00000023546","NA","NA","NA","NA","RNA, U6 small nuclear 139, pseudogene [Source:HGNC Symbol;Acc:HGNC:47102]",{"v":0.553635,"d":"0.55"},{"v":0.172791,"d":"0.17"},{"v":0.427135,"d":"0.43"},{"v":0.128852,"d":"0.13"},{"v":0.961932,"d":"0.96"},0,{"v":1.05755218265028,"d":"1.06"},{"v":0.0807288518023309,"d":"0.08"},1,1,"up","no"]
["MSTRG.2311","ENSOARG00000017062","ENSOART00000018571","GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0006954(inflammatory response);GO:0010469(regulation of signaling receptor activity)","NA","NA","NA",null,0,{"v":0.086697,"d":"0.09"},{"v":0.075989,"d":"0.08"},{"v":0.23097,"d":"0.23"},{"v":0.193199,"d":"0.19"},{"v":0.147101,"d":"0.15"},{"v":0.284779526318553,"d":"0.28"},{"v":-1.81208266466602,"d":"-1.81"},1,1,"down","no"]
["MSTRG.5559","FAAP24","ENSOART00000004706","GO:0003682(chromatin binding);GO:0005654(nucleoplasm);GO:0036297(interstrand cross-link repair);GO:0043231(intracellular membrane-bounded organelle);GO:0043240(Fanconi anaemia nuclear complex)","03460(Fanconi anemia pathway)","K10898","NA","FA core complex associated protein 24 [Source:NCBI gene;Acc:101110081]",{"v":0.758823,"d":"0.76"},{"v":0.646014,"d":"0.65"},{"v":0.708507,"d":"0.71"},{"v":1.009881,"d":"1.01"},{"v":0.623759,"d":"0.62"},{"v":1.252582,"d":"1.25"},{"v":0.732218103804905,"d":"0.73"},{"v":-0.449654650735927,"d":"-0.45"},1,1,"down","no"]
["MSTRG.6757","RF00573","ENSOART00000026931","NA","NA","NA","NA","small nucleolar RNA, C/D box 67 [Source:HGNC Symbol;Acc:HGNC:32728]",0,{"v":0.112162,"d":"0.11"},{"v":0.328738,"d":"0.33"},0,{"v":0.993261,"d":"0.99"},{"v":0.127222,"d":"0.13"},{"v":0.393491021282786,"d":"0.39"},{"v":-1.34559737833779,"d":"-1.35"},1,1,"down","no"]
["MSTRG.1759","ENSOARG00000022907","ENSOART00000024809","NA","NA","NA","NA",null,0,{"v":0.073095,"d":"0.07"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000007530","BSND","ENSOART00000008198","GO:0005254(chloride channel activity);GO:0005887(integral component of plasma membrane);GO:0006821(chloride transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0032991(protein-containing complex);GO:1902476(chloride transmembrane transport)","NA","K19331","NA","barttin CLCNK type accessory beta subunit [Source:NCBI gene;Acc:101123422]",0,0,{"v":0.022189,"d":"0.02"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000012284","NIPAL4","ENSOART00000013356","GO:0015095(magnesium ion transmembrane transporter activity);GO:0015693(magnesium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:1903830(magnesium ion transmembrane transport)","NA","K22733","NA","NIPA like domain containing 4 [Source:NCBI gene;Acc:101113410]",{"v":0.342867,"d":"0.34"},{"v":0.051596,"d":"0.05"},{"v":0.159811,"d":"0.16"},{"v":0.158403,"d":"0.16"},{"v":0.213963,"d":"0.21"},{"v":0.242921,"d":"0.24"},{"v":0.900838145450822,"d":"0.90"},{"v":-0.150660176119793,"d":"-0.15"},1,1,"down","no"]
["ENSOARG00000006714","P2RY6","ENSOART00000007297","GO:0001621(ADP receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030321(transepithelial chloride transport);GO:0032962(positive regulation of inositol trisphosphate biosynthetic process);GO:0035589(G protein-coupled purinergic nucleotide receptor signaling pathway);GO:0045028(G protein-coupled purinergic nucleotide receptor activity);GO:0045029(UDP-activated nucleotide receptor activity);GO:0045030(UTP-activated nucleotide receptor activity);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071380(cellular response to prostaglandin E stimulus);GO:0071407(cellular response to organic cyclic compound);GO:0071415(cellular response to purine-containing compound);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:1905835(cellular response to pyrimidine ribonucleotide)","04080(Neuroactive ligand-receptor interaction)","K04272","NA","pyrimidinergic receptor P2Y6 [Source:NCBI gene;Acc:101123660]",{"v":0.153456,"d":"0.15"},{"v":0.044547,"d":"0.04"},{"v":0.139582,"d":"0.14"},{"v":0.130027,"d":"0.13"},{"v":0.1686,"d":"0.17"},{"v":0.360119,"d":"0.36"},{"v":0.512466109851141,"d":"0.51"},{"v":-0.964471494691418,"d":"-0.96"},1,1,"down","no"]
["ENSOARG00000004391","ENSOARG00000004391","ENSOART00000004779","NA","NA","NA","NA","ciliary associated calcium binding coiled-coil 1 [Source:NCBI gene;Acc:101121486]",{"v":0.478917,"d":"0.48"},{"v":0.185308,"d":"0.19"},{"v":0.213571,"d":"0.21"},{"v":0.439599,"d":"0.44"},{"v":0.42247,"d":"0.42"},{"v":0.302969,"d":"0.30"},{"v":0.753448385374554,"d":"0.75"},{"v":-0.408419410820966,"d":"-0.41"},1,1,"down","no"]
["ENSOARG00000003214","NLRP5","ENSOART00000003488","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding)","NA","K22626","NA","NLR family pyrin domain containing 5 [Source:NCBI gene;Acc:101109385]",0,{"v":0.004035,"d":"0.00"},0,{"v":0.012024,"d":"0.01"},{"v":0.018945,"d":"0.02"},0,{"v":0.130291581904485,"d":"0.13"},{"v":-2.94018422001415,"d":"-2.94"},1,1,"down","no"]
["MSTRG.13751","GRID2IP","ENSOART00000002515","GO:0005515(protein binding);GO:0045202(synapse);GO:0060292(long-term synaptic depression)","NA","NA","NA","Grid2 interacting protein [Source:NCBI gene;Acc:101106134]",0,{"v":0.008342,"d":"0.01"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000007959","SPTBN2","ENSOART00000008671","GO:0003779(actin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0007416(synapse assembly);GO:0008091(spectrin);GO:0016192(vesicle-mediated transport);GO:0016324(apical plasma membrane);GO:0021692(cerebellar Purkinje cell layer morphogenesis);GO:0030054(cell junction);GO:0030534(adult behavior);GO:0035264(multicellular organism growth);GO:0043025(neuronal cell body);GO:0051693(actin filament capping);GO:0098688(parallel fiber to Purkinje cell synapse);GO:0098793(presynapse);GO:0098918(structural constituent of synapse);GO:0098978(glutamatergic synapse);GO:0099173(postsynapse organization);GO:0099189(postsynaptic spectrin-associated cytoskeleton)","NA","K06115","NA","spectrin beta chain, non-erythrocytic 2 [Source:NCBI gene;Acc:101106728]",{"v":0.027333,"d":"0.03"},{"v":0.084256,"d":"0.08"},{"v":0.032633,"d":"0.03"},{"v":0.036116,"d":"0.04"},{"v":0.01974,"d":"0.02"},{"v":0.047708,"d":"0.05"},{"v":1.3925881580472,"d":"1.39"},{"v":0.477768660528812,"d":"0.48"},1,1,"up","no"]
["ENSOARG00000003515","ATP6V1FNB","ENSOART00000003818","NA","NA","NA","NA","ATP6V1F neighbor [Source:NCBI gene;Acc:105608858]",{"v":0.210708,"d":"0.21"},0,{"v":0.438759,"d":"0.44"},{"v":0.058831,"d":"0.06"},{"v":0.084234,"d":"0.08"},{"v":0.152624,"d":"0.15"},{"v":2.1964530300417,"d":"2.20"},{"v":1.13517564850855,"d":"1.14"},1,1,"up","no"]
["ENSOARG00000010475","PGLYRP1","ENSOART00000011400","GO:0002221(pattern recognition receptor signaling pathway);GO:0002376(immune system process);GO:0008270(zinc ion binding);GO:0008745(N-acetylmuramoyl-L-alanine amidase activity);GO:0009253(peptidoglycan catabolic process);GO:0016019(peptidoglycan receptor activity);GO:0016045(detection of bacterium);GO:0031640(killing of cells of other organism);GO:0042834(peptidoglycan binding);GO:0045087(innate immune response);GO:0050830(defense response to Gram-positive bacterium);GO:0051714(positive regulation of cytolysis in other organism);GO:0061844(antimicrobial humoral immune response mediated by antimicrobial peptide)","NA","K01446","NA","peptidoglycan recognition protein 1 [Source:NCBI gene;Acc:101115395]",0,0,0,0,{"v":0.113187,"d":"0.11"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000000958","TMEM30B","ENSOART00000001026","GO:0015247(aminophospholipid transmembrane transporter activity);GO:0015917(aminophospholipid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0070863(positive regulation of protein exit from endoplasmic reticulum)","NA","NA","NA","transmembrane protein 30B [Source:NCBI gene;Acc:101118618]",{"v":0.063892,"d":"0.06"},0,0,{"v":0.117351,"d":"0.12"},0,{"v":0.032709,"d":"0.03"},{"v":0.425776356124217,"d":"0.43"},{"v":-1.23183225747252,"d":"-1.23"},1,1,"down","no"]
["MSTRG.6150","ENSOARG00000004056","ENSOART00000004408","GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,{"v":0.515171,"d":"0.52"},{"v":0.447433,"d":"0.45"},{"v":0.430689,"d":"0.43"},{"v":0.504391,"d":"0.50"},{"v":0.564398,"d":"0.56"},{"v":0.496831,"d":"0.50"},{"v":0.889930506764093,"d":"0.89"},{"v":-0.168235412135508,"d":"-0.17"},1,1,"down","no"]
["MSTRG.16533","RF01151","ENSOART00000027026","NA","NA","NA","NA",null,{"v":2.580513,"d":"2.58"},{"v":2.247253,"d":"2.25"},{"v":4.519125,"d":"4.52"},{"v":3.019977,"d":"3.02"},{"v":2.893378,"d":"2.89"},{"v":1.678525,"d":"1.68"},{"v":1.23116948634594,"d":"1.23"},{"v":0.300029381058394,"d":"0.30"},1,1,"up","no"]
["MSTRG.17748","ENSOARG00000013408","ENSOART00000014584","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,{"v":0.21188,"d":"0.21"},{"v":0.337702,"d":"0.34"},0,{"v":0.269028,"d":"0.27"},{"v":0.439188,"d":"0.44"},0,{"v":0.776009014199058,"d":"0.78"},{"v":-0.365854683886369,"d":"-0.37"},1,1,"down","no"]
["ENSOARG00000005415","ENSOARG00000005415","ENSOART00000005899","NA","NA","NA","NA",null,0,{"v":0.064123,"d":"0.06"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000019980","ENSOARG00000019980","ENSOART00000021753","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding)","NA","NA","NA","POU domain, class 3, transcription factor 2 [Source:NCBI gene;Acc:101112574]",{"v":0.121726,"d":"0.12"},0,{"v":0.132793,"d":"0.13"},{"v":0.041694,"d":"0.04"},{"v":0.029529,"d":"0.03"},{"v":0.126701,"d":"0.13"},{"v":1.28594308926659,"d":"1.29"},{"v":0.362826796126468,"d":"0.36"},1,1,"up","no"]
["MSTRG.9777","RF01894","ENSOART00000025986","NA","NA","NA","NA",null,{"v":0.307646,"d":"0.31"},{"v":0.083711,"d":"0.08"},{"v":0.170129,"d":"0.17"},0,{"v":0.018534,"d":"0.02"},{"v":0.126394,"d":"0.13"},{"v":3.87424100242879,"d":"3.87"},{"v":1.95391370153907,"d":"1.95"},1,1,"up","no"]
["ENSOARG00000007616","FANCF","ENSOART00000008290","GO:0036297(interstrand cross-link repair);GO:0043240(Fanconi anaemia nuclear complex)","NA","NA","NA","FA complementation group F [Source:HGNC Symbol;Acc:HGNC:3587]",{"v":0.205779,"d":"0.21"},{"v":0.061011,"d":"0.06"},{"v":0.066289,"d":"0.07"},{"v":0.193238,"d":"0.19"},{"v":0.289576,"d":"0.29"},{"v":0.323448,"d":"0.32"},{"v":0.413115091620342,"d":"0.41"},{"v":-1.27538433024373,"d":"-1.28"},1,1,"down","no"]
["MSTRG.6479","ENSOARG00000012115","ENSOART00000013175","GO:0003676(nucleic acid binding);GO:0003964(RNA-directed DNA polymerase activity);GO:0004523(RNA-DNA hybrid ribonuclease activity);GO:0006278(RNA-dependent DNA biosynthetic process);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","NA","NA","NA",null,{"v":0.004624,"d":"0.00"},{"v":0.015375,"d":"0.02"},{"v":0.025967,"d":"0.03"},{"v":0.065972,"d":"0.07"},0,{"v":0.134782,"d":"0.13"},{"v":0.228966795182163,"d":"0.23"},{"v":-2.12678970136608,"d":"-2.13"},1,1,"down","no"]
["MSTRG.2602","RF00012","ENSOART00000025499","NA","NA","NA","NA",null,{"v":0.012183,"d":"0.01"},{"v":0.6207,"d":"0.62"},{"v":0.125275,"d":"0.13"},{"v":0.695441,"d":"0.70"},{"v":0.176346,"d":"0.18"},{"v":0.329946,"d":"0.33"},{"v":0.630887227029631,"d":"0.63"},{"v":-0.66454595266768,"d":"-0.66"},1,1,"down","no"]
["ENSOARG00000003464","ENSOARG00000003464","ENSOART00000003762","GO:0005680(anaphase-promoting complex);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0031145(anaphase-promoting complex-dependent catabolic process)","04110(Cell cycle);04114(Oocyte meiosis);04120(Ubiquitin mediated proteolysis);04914(Progesterone-mediated oocyte maturation);05166(Human T-cell leukemia virus 1 infection)","K03359","NA","cell division cycle 26 [Source:NCBI gene;Acc:101114750]",{"v":0.651538,"d":"0.65"},{"v":0.046517,"d":"0.05"},{"v":0.156828,"d":"0.16"},{"v":0.201769,"d":"0.20"},{"v":0.511702,"d":"0.51"},{"v":0.057179,"d":"0.06"},{"v":1.10930123921365,"d":"1.11"},{"v":0.14965119354772,"d":"0.15"},1,1,"up","no"]
["ENSOARG00000008502","TRIML1","ENSOART00000009254","GO:0005515(protein binding);GO:0007275(multicellular organism development);GO:0046872(metal ion binding)","NA","K12038","NA","tripartite motif family like 1 [Source:NCBI gene;Acc:101117391]",0,{"v":0.025502,"d":"0.03"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000001698","ENSOARG00000001698","ENSOART00000001827","GO:0004843(thiol-dependent ubiquitin-specific protease activity);GO:0005622(intracellular);GO:0006508(proteolysis);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008233(peptidase activity);GO:0008234(cysteine-type peptidase activity);GO:0016787(hydrolase activity);GO:0036459(thiol-dependent ubiquitinyl hydrolase activity)","NA","NA","NA",null,0,{"v":0.083358,"d":"0.08"},{"v":0.296579,"d":"0.30"},{"v":0.264004,"d":"0.26"},{"v":0.314426,"d":"0.31"},{"v":0.091444,"d":"0.09"},{"v":0.567176812355756,"d":"0.57"},{"v":-0.818129542181525,"d":"-0.82"},1,1,"down","no"]
["MSTRG.18568","C5orf30","ENSOART00000020251","GO:0005737(cytoplasm);GO:0010764(negative regulation of fibroblast migration);GO:0035869(ciliary transition zone);GO:1900016(negative regulation of cytokine production involved in inflammatory response)","NA","NA","NA","chromosome 5 open reading frame 30 [Source:HGNC Symbol;Acc:HGNC:25052]",{"v":0.684365,"d":"0.68"},{"v":0.288753,"d":"0.29"},{"v":0.584419,"d":"0.58"},{"v":1.018968,"d":"1.02"},{"v":0.723887,"d":"0.72"},{"v":0.840607,"d":"0.84"},{"v":0.602887520698969,"d":"0.60"},{"v":-0.730039227863718,"d":"-0.73"},1,1,"down","no"]
["ENSOARG00000003569","KSR2","ENSOART00000003886","GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction);GO:0046872(metal ion binding)","04014(Ras signaling pathway)","K18529","EC:2.7.11.1","kinase suppressor of ras 2 [Source:NCBI gene;Acc:101110179]",0,{"v":0.021413,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000005861","ENSOARG00000005861","ENSOART00000006376","NA","NA","NA","NA",null,{"v":0.611372,"d":"0.61"},{"v":0.253424,"d":"0.25"},{"v":0.244718,"d":"0.24"},{"v":0.497783,"d":"0.50"},{"v":0.49697,"d":"0.50"},{"v":0.245631,"d":"0.25"},{"v":0.894492350755895,"d":"0.89"},{"v":-0.160858949752406,"d":"-0.16"},1,1,"down","no"]
["MSTRG.13586","RF00414","ENSOART00000024363","NA","NA","NA","NA",null,{"v":0.392828,"d":"0.39"},{"v":0.59513,"d":"0.60"},{"v":0.254714,"d":"0.25"},{"v":0.528871,"d":"0.53"},{"v":0.901593,"d":"0.90"},{"v":0.846849,"d":"0.85"},{"v":0.545674661322357,"d":"0.55"},{"v":-0.873887041892059,"d":"-0.87"},1,1,"down","no"]
["ENSOARG00000017050","SLC27A6","ENSOART00000018564","GO:0001676(long-chain fatty acid metabolic process);GO:0003824(catalytic activity);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0015908(fatty acid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031957(very long-chain fatty acid-CoA ligase activity)","03320(PPAR signaling pathway);04931(Insulin resistance)","K08749","NA","solute carrier family 27 member 6 [Source:NCBI gene;Acc:101104743]",{"v":0.014703,"d":"0.01"},{"v":0.003061,"d":"0.00"},{"v":0.060446,"d":"0.06"},{"v":0.042984,"d":"0.04"},{"v":0.038448,"d":"0.04"},{"v":0.023691,"d":"0.02"},{"v":0.743985616848834,"d":"0.74"},{"v":-0.426653364281795,"d":"-0.43"},1,1,"down","no"]
["ENSOARG00000001643","ENSOARG00000001643","ENSOART00000001768","NA","NA","NA","NA",null,{"v":0.093436,"d":"0.09"},{"v":0.075901,"d":"0.08"},{"v":0.032489,"d":"0.03"},{"v":0.050517,"d":"0.05"},{"v":0.126854,"d":"0.13"},{"v":0.036501,"d":"0.04"},{"v":0.943676591606194,"d":"0.94"},{"v":-0.0836355781263051,"d":"-0.08"},1,1,"down","no"]
["ENSOARG00000003816","ENSOARG00000003816","ENSOART00000004144","NA","NA","NA","NA",null,0,0,0,{"v":0.040623,"d":"0.04"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.4106","AGMAT","ENSOART00000010213","GO:0016787(hydrolase activity);GO:0016813(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines);GO:0046872(metal ion binding)","00330(Arginine and proline metabolism)","K01480","EC:3.5.3.11","agmatinase [Source:NCBI gene;Acc:101110431]",{"v":0.162582,"d":"0.16"},{"v":0.135692,"d":"0.14"},{"v":0.043604,"d":"0.04"},{"v":0.133673,"d":"0.13"},{"v":0.239032,"d":"0.24"},{"v":0.148171,"d":"0.15"},{"v":0.656351991644845,"d":"0.66"},{"v":-0.607458376981621,"d":"-0.61"},1,1,"down","no"]
["ENSOARG00000008568","ENSOARG00000008568","ENSOART00000009325","NA","NA","NA","NA",null,{"v":0.39366,"d":"0.39"},{"v":0.75576,"d":"0.76"},{"v":0.393829,"d":"0.39"},{"v":0.323127,"d":"0.32"},{"v":0.627816,"d":"0.63"},{"v":0.891047,"d":"0.89"},{"v":0.837816166211543,"d":"0.84"},{"v":-0.255294372668834,"d":"-0.26"},1,1,"down","no"]
["MSTRG.8455","MIR342","ENSOART00000024390","NA","NA","NA","NA","microRNA 342 [Source:HGNC Symbol;Acc:HGNC:31778]",{"v":0.12679,"d":"0.13"},{"v":0.010739,"d":"0.01"},0,{"v":0.012337,"d":"0.01"},{"v":0.030145,"d":"0.03"},{"v":0.008048,"d":"0.01"},{"v":2.72172966554522,"d":"2.72"},{"v":1.44452377898539,"d":"1.44"},1,1,"up","no"]
["ENSOARG00000016756","ENSOARG00000016756","ENSOART00000018241","NA","NA","NA","NA",null,{"v":2.737494,"d":"2.74"},{"v":2.659736,"d":"2.66"},{"v":2.207383,"d":"2.21"},{"v":3.078602,"d":"3.08"},{"v":3.082637,"d":"3.08"},{"v":2.835814,"d":"2.84"},{"v":0.845233767101294,"d":"0.85"},{"v":-0.24257769077533,"d":"-0.24"},1,1,"down","no"]
["ENSOARG00000002159","LRRC15","ENSOART00000002327","GO:0001968(fibronectin binding);GO:0005515(protein binding);GO:0005518(collagen binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030335(positive regulation of cell migration);GO:0043236(laminin binding);GO:0046813(receptor-mediated virion attachment to host cell);GO:0062023(collagen-containing extracellular matrix);GO:1903077(negative regulation of protein localization to plasma membrane)","NA","NA","NA","leucine rich repeat containing 15 [Source:NCBI gene;Acc:101103371]",{"v":0.136457,"d":"0.14"},{"v":0.12814,"d":"0.13"},{"v":0.223125,"d":"0.22"},{"v":0.492649,"d":"0.49"},{"v":0.096728,"d":"0.10"},{"v":0.396148,"d":"0.40"},{"v":0.494885467136805,"d":"0.49"},{"v":-1.01483341840787,"d":"-1.01"},1,1,"down","no"]
["MSTRG.5977","ENSOARG00000014875","ENSOART00000016190","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.185685,"d":"0.19"},{"v":0.031948,"d":"0.03"},{"v":0.030444,"d":"0.03"},{"v":0.062999,"d":"0.06"},{"v":0.105405,"d":"0.11"},0,{"v":1.47310633951688,"d":"1.47"},{"v":0.558861578341306,"d":"0.56"},1,1,"up","no"]
["ENSOARG00000023868","RF00561","ENSOART00000025770","NA","NA","NA","NA",null,0,{"v":0.074186,"d":"0.07"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.7094","GDNF","ENSOART00000011053","GO:0001656(metanephros development);GO:0001657(ureteric bud development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001755(neural crest cell migration);GO:0001759(organ induction);GO:0001941(postsynaptic membrane organization);GO:0003337(mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0005576(extracellular region);GO:0007399(nervous system development);GO:0007422(peripheral nervous system development);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0010468(regulation of gene expression);GO:0010469(regulation of signaling receptor activity);GO:0021516(dorsal spinal cord development);GO:0021784(postganglionic parasympathetic fiber development);GO:0030432(peristalsis);GO:0031175(neuron projection development);GO:0032770(positive regulation of monooxygenase activity);GO:0042803(protein homodimerization activity);GO:0043524(negative regulation of neuron apoptotic process);GO:0045597(positive regulation of cell differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048255(mRNA stabilization);GO:0048484(enteric nervous system development);GO:0048485(sympathetic nervous system development);GO:0048568(embryonic organ development);GO:0051584(regulation of dopamine uptake involved in synaptic transmission);GO:0060676(ureteric bud formation);GO:0060688(regulation of morphogenesis of a branching structure);GO:0071679(commissural neuron axon guidance);GO:0072107(positive regulation of ureteric bud formation);GO:0072108(positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand);GO:2001260(regulation of semaphorin-plexin signaling pathway)","NA","NA","NA","glial cell derived neurotrophic factor [Source:HGNC Symbol;Acc:HGNC:4232]",{"v":0.964747,"d":"0.96"},{"v":0.076464,"d":"0.08"},{"v":0.447398,"d":"0.45"},{"v":0.170766,"d":"0.17"},{"v":0.142989,"d":"0.14"},{"v":0.068956,"d":"0.07"},{"v":3.88964257625205,"d":"3.89"},{"v":1.95963759038886,"d":"1.96"},1,1,"up","no"]
["ENSOARG00000012292","GSDMB","ENSOART00000013362","NA","NA","K22142","NA","gasdermin B [Source:NCBI gene;Acc:101105086]",{"v":0.021902,"d":"0.02"},{"v":0.023277,"d":"0.02"},{"v":0.05547,"d":"0.06"},{"v":0.02718,"d":"0.03"},{"v":0.08416,"d":"0.08"},{"v":0.022345,"d":"0.02"},{"v":0.75288177432023,"d":"0.75"},{"v":-0.409504759861452,"d":"-0.41"},1,1,"down","no"]
["ENSOARG00000021178","ENSOARG00000021178","ENSOART00000023077","NA","NA","NA","NA",null,{"v":0.095957,"d":"0.10"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000002450","ENSOARG00000002450","ENSOART00000002653","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","putative killer cell immunoglobulin-like receptor like protein KIR3DP1 [Source:NCBI gene;Acc:101104523]",{"v":0.293074,"d":"0.29"},{"v":0.069107,"d":"0.07"},{"v":0.133431,"d":"0.13"},{"v":0.103507,"d":"0.10"},0,0,{"v":4.78819789965896,"d":"4.79"},{"v":2.25948278113612,"d":"2.26"},1,1,"up","no"]
["ENSOARG00000020253","LMLN","ENSOART00000022054;ENSOART00000022053","GO:0004222(metalloendopeptidase activity);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006508(proteolysis);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","K13539","EC:3.4.24.-","leishmanolysin like peptidase [Source:NCBI gene;Acc:101118237]",{"v":0.174977858645929,"d":"0.17"},{"v":0.352402108874657,"d":"0.35"},{"v":0.289470381518756,"d":"0.29"},{"v":0.392238782250686,"d":"0.39"},{"v":0.314121867337603,"d":"0.31"},{"v":0.263683012808783,"d":"0.26"},{"v":0.842075857720492,"d":"0.84"},{"v":-0.247977891729145,"d":"-0.25"},1,1,"down","no"]
["ENSOARG00000022967","RF00026","ENSOART00000024869","NA","NA","NA","NA","RNA, U6 small nuclear 1315, pseudogene [Source:HGNC Symbol;Acc:HGNC:48278]",0,{"v":0.19707,"d":"0.20"},0,{"v":0.057803,"d":"0.06"},{"v":0.092687,"d":"0.09"},0,{"v":1.30952222739052,"d":"1.31"},{"v":0.389040547717474,"d":"0.39"},1,1,"up","no"]
["ENSOARG00000011783","ENSOARG00000011783","ENSOART00000012810","GO:0003700(DNA-binding transcription factor activity);GO:0006355(regulation of transcription, DNA-templated)","NA","K09076","NA","mesoderm posterior bHLH transcription factor 2 [Source:NCBI gene;Acc:101102093]",{"v":0.152555,"d":"0.15"},{"v":0.053239,"d":"0.05"},{"v":0.041323,"d":"0.04"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000013525","PDCD1LG2","ENSOART00000014706","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032689(negative regulation of interferon-gamma production);GO:0032693(negative regulation of interleukin-10 production);GO:0046007(negative regulation of activated T cell proliferation)","NA","NA","NA","programmed cell death 1 ligand 2 [Source:HGNC Symbol;Acc:HGNC:18731]",{"v":0.230836,"d":"0.23"},{"v":0.096582,"d":"0.10"},{"v":0.087964,"d":"0.09"},{"v":0.157494,"d":"0.16"},{"v":0.075447,"d":"0.08"},0,{"v":1.78320690646988,"d":"1.78"},{"v":0.834474109367632,"d":"0.83"},1,1,"up","no"]
["MSTRG.16679","PANX2","ENSOART00000021491","GO:0002931(response to ischemia);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005921(gap junction);GO:0006811(ion transport);GO:0006812(cation transport);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0050716(positive regulation of interleukin-1 secretion);GO:0055085(transmembrane transport)","NA","K20857","NA","pannexin 2 [Source:NCBI gene;Acc:101114697]",{"v":0.056788,"d":"0.06"},{"v":0.061676,"d":"0.06"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000002432","SIGLEC15","ENSOART00000002637","GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032956(regulation of actin cytoskeleton organization);GO:0032991(protein-containing complex);GO:0045124(regulation of bone resorption);GO:2001204(regulation of osteoclast development)","NA","NA","NA","sialic acid binding Ig like lectin 15 [Source:HGNC Symbol;Acc:HGNC:27596]",0,0,0,{"v":0.079702,"d":"0.08"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000003740","SUCNR1","ENSOART00000004064","GO:0002001(renin secretion into blood stream);GO:0002281(macrophage activation involved in immune response);GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032611(interleukin-1 beta production);GO:0038023(signaling receptor activity);GO:0042593(glucose homeostasis);GO:0050729(positive regulation of inflammatory response);GO:0050921(positive regulation of chemotaxis);GO:0051592(response to calcium ion);GO:0060177(regulation of angiotensin metabolic process)","04024(cAMP signaling pathway)","K10042","NA","succinate receptor 1 [Source:NCBI gene;Acc:101122570]",{"v":0.053813,"d":"0.05"},{"v":0.016733,"d":"0.02"},{"v":0.018673,"d":"0.02"},{"v":0.072232,"d":"0.07"},{"v":0.035719,"d":"0.04"},{"v":0.012859,"d":"0.01"},{"v":0.738506746130287,"d":"0.74"},{"v":-0.437316995069596,"d":"-0.44"},1,1,"down","no"]
["ENSOARG00000007345","FNDC8","ENSOART00000007990","GO:0005515(protein binding)","NA","NA","NA","fibronectin type III domain containing 8 [Source:NCBI gene;Acc:101117943]",0,{"v":0.049524,"d":"0.05"},{"v":0.02272,"d":"0.02"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000012412","ENSOARG00000012412","ENSOART00000013496","NA","NA","NA","NA",null,{"v":0.010857,"d":"0.01"},{"v":0.017309,"d":"0.02"},0,0,{"v":0.123499,"d":"0.12"},{"v":0.099105,"d":"0.10"},{"v":0.126529622109216,"d":"0.13"},{"v":-2.98245291813213,"d":"-2.98"},1,1,"down","no"]
["ENSOARG00000002328","TNMD","ENSOART00000002520","GO:0001886(endothelial cell morphogenesis);GO:0001937(negative regulation of endothelial cell proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016525(negative regulation of angiogenesis)","NA","NA","NA","tenomodulin [Source:NCBI gene;Acc:100125616]",{"v":0.179942,"d":"0.18"},0,{"v":0.045909,"d":"0.05"},{"v":0.013769,"d":"0.01"},{"v":0.335736,"d":"0.34"},{"v":0.121261,"d":"0.12"},{"v":0.479752148625857,"d":"0.48"},{"v":-1.05963882717452,"d":"-1.06"},1,1,"down","no"]
["ENSOARG00000007908","MMP9","ENSOART00000008611","GO:0001501(skeletal system development);GO:0001503(ossification);GO:0001934(positive regulation of protein phosphorylation);GO:0004175(endopeptidase activity);GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0007566(embryo implantation);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0030198(extracellular matrix organization);GO:0030335(positive regulation of cell migration);GO:0030574(collagen catabolic process);GO:0031012(extracellular matrix);GO:0034614(cellular response to reactive oxygen species);GO:0035987(endodermal cell differentiation);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043388(positive regulation of DNA binding);GO:0045742(positive regulation of epidermal growth factor receptor signaling pathway);GO:0046872(metal ion binding);GO:0050900(leukocyte migration);GO:0051549(positive regulation of keratinocyte migration);GO:0071276(cellular response to cadmium ion);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:1900122(positive regulation of receptor binding);GO:1904645(response to amyloid-beta);GO:1904707(positive regulation of vascular smooth muscle cell proliferation);GO:2000697(negative regulation of epithelial cell differentiation involved in kidney development);GO:2001243(negative regulation of intrinsic apoptotic signaling pathway);GO:2001258(negative regulation of cation channel activity);GO:2001268(negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway)","01522(Endocrine resistance);04657(IL-17 signaling pathway);04668(TNF signaling pathway);04670(Leukocyte transendothelial migration);04915(Estrogen signaling pathway);04926(Relaxin signaling pathway);05161(Hepatitis B);05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05205(Proteoglycans in cancer);05206(MicroRNAs in cancer);05215(Prostate cancer);05219(Bladder cancer);05418(Fluid shear stress and atherosclerosis)","K01403","EC:3.4.24.35","matrix metallopeptidase 9 [Source:NCBI gene;Acc:100192422]",{"v":0.126399,"d":"0.13"},{"v":0.04847,"d":"0.05"},{"v":0.07366,"d":"0.07"},{"v":0.144705,"d":"0.14"},{"v":0.281677,"d":"0.28"},{"v":0.146126,"d":"0.15"},{"v":0.434105724286822,"d":"0.43"},{"v":-1.20388164823354,"d":"-1.20"},1,1,"down","no"]
["MSTRG.21877","RF00026","ENSOART00000023369","NA","NA","NA","NA",null,0,0,{"v":0.177819,"d":"0.18"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.20756","RF00429","ENSOART00000027025","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 29 [Source:HGNC Symbol;Acc:HGNC:32619]",{"v":4.459373,"d":"4.46"},{"v":5.80297,"d":"5.80"},{"v":0.744691,"d":"0.74"},{"v":2.180144,"d":"2.18"},{"v":1.834211,"d":"1.83"},{"v":1.398915,"d":"1.40"},{"v":2.03334287777997,"d":"2.03"},{"v":1.02385351393479,"d":"1.02"},1,1,"up","no"]
["ENSOARG00000020084","PTPRN","ENSOART00000021867","GO:0000302(response to reactive oxygen species);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0006470(protein dephosphorylation);GO:0008134(transcription factor binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016311(dephosphorylation);GO:0016787(hydrolase activity);GO:0016791(phosphatase activity);GO:0030073(insulin secretion);GO:0030507(spectrin binding);GO:0044389(ubiquitin-like protein ligase binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:1904692(positive regulation of type B pancreatic cell proliferation);GO:1990502(dense core granule maturation)","04940(Type I diabetes mellitus)","K07817","EC:3.1.3.48","protein tyrosine phosphatase, receptor type N [Source:NCBI gene;Acc:101113312]",{"v":0.010038,"d":"0.01"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000004688","ENSOARG00000004688","ENSOART00000005099","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","04080(Neuroactive ligand-receptor interaction);04142(Lysosome);04614(Renin-angiotensin system);05146(Amoebiasis);05322(Systemic lupus erythematosus)","K01319","EC:3.4.21.20","cathepsin G-like [Source:NCBI gene;Acc:101121553]",{"v":0.008792,"d":"0.01"},0,{"v":0.012935,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.12544","ENSOARG00000022511","ENSOART00000024413","NA","NA","NA","NA",null,{"v":0.020691,"d":"0.02"},{"v":0.353312,"d":"0.35"},{"v":0.078606,"d":"0.08"},{"v":0.382262,"d":"0.38"},{"v":0.562422,"d":"0.56"},{"v":0.504346,"d":"0.50"},{"v":0.31235309137837,"d":"0.31"},{"v":-1.67875028646889,"d":"-1.68"},1,1,"down","no"]
["ENSOARG00000022501","RF00017","ENSOART00000024403","NA","NA","NA","NA",null,0,{"v":0.133673,"d":"0.13"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.8523","oar-mir-380","ENSOART00000024516","NA","NA","NA","NA","oar-mir-380 [Source:miRBase;Acc:MI0016920]",{"v":0.682213,"d":"0.68"},{"v":1.649767,"d":"1.65"},{"v":2.196719,"d":"2.20"},{"v":1.464913,"d":"1.46"},{"v":2.213342,"d":"2.21"},{"v":1.151916,"d":"1.15"},{"v":0.937585646553714,"d":"0.94"},{"v":-0.092977611095932,"d":"-0.09"},1,1,"down","no"]
["MSTRG.13630","RF00601","ENSOART00000023699","NA","NA","NA","NA",null,{"v":0.214693,"d":"0.21"},0,{"v":0.415273,"d":"0.42"},{"v":0.578382,"d":"0.58"},0,{"v":0.126086,"d":"0.13"},{"v":0.894243599425382,"d":"0.89"},{"v":-0.161260207761697,"d":"-0.16"},1,1,"down","no"]
["MSTRG.17093","HOXA2","ENSOART00000010709","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001709(cell fate determination);GO:0002076(osteoblast development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0007379(segment specification);GO:0007389(pattern specification process);GO:0008045(motor neuron axon guidance);GO:0009952(anterior/posterior pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0021568(rhombomere 2 development);GO:0021569(rhombomere 3 development);GO:0021658(rhombomere 3 morphogenesis);GO:0035284(brain segmentation);GO:0042474(middle ear morphogenesis);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0045165(cell fate commitment);GO:0045665(negative regulation of neuron differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048703(embryonic viscerocranium morphogenesis);GO:0048704(embryonic skeletal system morphogenesis);GO:0071300(cellular response to retinoic acid)","NA","K09302","NA","homeobox A2 [Source:NCBI gene;Acc:101106161]",{"v":0.194199,"d":"0.19"},0,{"v":0.092795,"d":"0.09"},{"v":0.062256,"d":"0.06"},{"v":0.299703,"d":"0.30"},{"v":0.065265,"d":"0.07"},{"v":0.67176469486733,"d":"0.67"},{"v":-0.573972119318301,"d":"-0.57"},1,1,"down","no"]
["MSTRG.20387","ENSOARG00000008676","ENSOART00000009445","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0005515(protein binding);GO:0005614(interstitial matrix);GO:0005615(extracellular space);GO:0030198(extracellular matrix organization);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0031012(extracellular matrix)","NA","NA","NA","leucine-rich repeat transmembrane protein FLRT1-like [Source:NCBI gene;Acc:101102818]",{"v":0.068084,"d":"0.07"},{"v":0.07647,"d":"0.08"},{"v":0.033952,"d":"0.03"},0,{"v":0.094402,"d":"0.09"},0,{"v":1.89091332810746,"d":"1.89"},{"v":0.919083237441452,"d":"0.92"},1,1,"up","no"]
["ENSOARG00000004959","ZC3H12B","ENSOART00000005399","GO:0046872(metal ion binding)","NA","K18668","EC:3.1.-.-","zinc finger CCCH-type containing 12B [Source:NCBI gene;Acc:101112028]",{"v":0.039411,"d":"0.04"},{"v":0.082717,"d":"0.08"},{"v":0.017071,"d":"0.02"},{"v":0.109072,"d":"0.11"},{"v":0.027768,"d":"0.03"},0,{"v":1.01723911137094,"d":"1.02"},{"v":0.0246588377424507,"d":"0.02"},1,1,"up","no"]
["MSTRG.4812","RF00026","ENSOART00000026017","NA","NA","NA","NA",null,0,{"v":0.305082,"d":"0.31"},{"v":0.009929,"d":"0.01"},{"v":0.099646,"d":"0.10"},{"v":0.343464,"d":"0.34"},{"v":0.164753,"d":"0.16"},{"v":0.518226968905823,"d":"0.52"},{"v":-0.948343998523595,"d":"-0.95"},1,1,"down","no"]
["ENSOARG00000018837","RGSL1","ENSOART00000020517","NA","NA","NA","NA","regulator of G protein signaling like 1 [Source:NCBI gene;Acc:101103253]",0,{"v":0.010414,"d":"0.01"},{"v":0.016374,"d":"0.02"},{"v":0.037824,"d":"0.04"},{"v":0.009194,"d":"0.01"},{"v":0.006891,"d":"0.01"},{"v":0.49691146190803,"d":"0.50"},{"v":-1.00893927498131,"d":"-1.01"},1,1,"down","no"]
["ENSOARG00000020327","ENSOARG00000020327","ENSOART00000022135","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.192886,"d":"0.19"},{"v":0.371974,"d":"0.37"},{"v":0.107286,"d":"0.11"},0,{"v":0.095326,"d":"0.10"},0,{"v":7.0510249040136,"d":"7.05"},{"v":2.81783297615961,"d":"2.82"},1,1,"up","no"]
["ENSOARG00000013606","ATP10B","ENSOART00000014810","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004012(phospholipid-translocating ATPase activity);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0015914(phospholipid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045332(phospholipid translocation)","NA","K01530","EC:7.6.2.1","ATPase phospholipid transporting 10B (putative) [Source:NCBI gene;Acc:101117246]",{"v":0.015678,"d":"0.02"},0,0,{"v":0.031391,"d":"0.03"},0,{"v":0.039808,"d":"0.04"},{"v":0.220199721906207,"d":"0.22"},{"v":-2.18311544798685,"d":"-2.18"},1,1,"down","no"]
["ENSOARG00000004805","ENSOARG00000004805","ENSOART00000005237","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis)","NA","NA","NA",null,0,0,0,{"v":0.033968,"d":"0.03"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000018484","ENSOARG00000018484","ENSOART00000020118","NA","NA","NA","NA","60S ribosomal protein L17 pseudogene [Source:NCBI gene;Acc:101104815]",0,0,0,{"v":0.064554,"d":"0.06"},{"v":0.034312,"d":"0.03"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000016819","POU2F3","ENSOART00000018317","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0043922(negative regulation by host of viral transcription);GO:0045944(positive regulation of transcription by RNA polymerase II)","05168(Herpes simplex virus 1 infection)","K09364","NA","POU class 2 homeobox 3 [Source:NCBI gene;Acc:101110172]",{"v":0.02147,"d":"0.02"},0,{"v":0.047903,"d":"0.05"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000007481","RWDD2A","ENSOART00000008144","GO:0005515(protein binding)","NA","NA","NA","RWD domain containing 2A [Source:HGNC Symbol;Acc:HGNC:21385]",{"v":0.358516,"d":"0.36"},{"v":0.423158,"d":"0.42"},{"v":0.296774,"d":"0.30"},{"v":0.491619,"d":"0.49"},{"v":0.369084,"d":"0.37"},{"v":0.572785,"d":"0.57"},{"v":0.752324400343777,"d":"0.75"},{"v":-0.410573212438965,"d":"-0.41"},1,1,"down","no"]
["ENSOARG00000010062","ENSOARG00000010062","ENSOART00000010950","NA","NA","NA","NA","UPF0472 protein C16orf72 [Source:NCBI gene;Acc:101114938]",{"v":0.044204,"d":"0.04"},{"v":0.073055,"d":"0.07"},{"v":0.120365,"d":"0.12"},{"v":0.045879,"d":"0.05"},0,{"v":0.044894,"d":"0.04"},{"v":2.61778282088286,"d":"2.62"},{"v":1.3883454119386,"d":"1.39"},1,1,"up","no"]
["MSTRG.16808","ENSOARG00000022799","ENSOART00000024701","NA","NA","NA","NA",null,0,0,{"v":0.059507,"d":"0.06"},{"v":0.257705,"d":"0.26"},{"v":0.039461,"d":"0.04"},{"v":0.146813,"d":"0.15"},{"v":0.134031114084225,"d":"0.13"},{"v":-2.8993601470071,"d":"-2.90"},1,1,"down","no"]
["ENSOARG00000006287","BSPRY","ENSOART00000006834","GO:0005515(protein binding);GO:1990830(cellular response to leukemia inhibitory factor)","NA","NA","NA","B-box and SPRY domain containing [Source:NCBI gene;Acc:101119885]",{"v":0.071524,"d":"0.07"},0,0,{"v":0.13115,"d":"0.13"},{"v":0.048589,"d":"0.05"},0,{"v":0.397932557764314,"d":"0.40"},{"v":-1.32940415362513,"d":"-1.33"},1,1,"down","no"]
["ENSOARG00000010753","ENSOARG00000010753","ENSOART00000011698","GO:0008146(sulfotransferase activity);GO:0016740(transferase activity)","NA","NA","NA",null,0,0,0,{"v":0.056864,"d":"0.06"},{"v":0.043135,"d":"0.04"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.20420","RF00026","ENSOART00000024731","NA","NA","NA","NA",null,{"v":0.380801,"d":"0.38"},{"v":0.621207,"d":"0.62"},{"v":0.72321,"d":"0.72"},{"v":0.242837,"d":"0.24"},{"v":0.476804,"d":"0.48"},{"v":0.338251,"d":"0.34"},{"v":1.63080730358108,"d":"1.63"},{"v":0.705586323072662,"d":"0.71"},1,1,"up","no"]
["MSTRG.16864","ENSOARG00000013712","ENSOART00000014943","NA","NA","NA","NA",null,{"v":0.364935,"d":"0.36"},{"v":0.519328,"d":"0.52"},{"v":0.332055,"d":"0.33"},{"v":0.299255,"d":"0.30"},{"v":0.322584,"d":"0.32"},{"v":0.095701,"d":"0.10"},{"v":1.69512222315132,"d":"1.70"},{"v":0.761389299542839,"d":"0.76"},1,1,"up","no"]
["ENSOARG00000003379","EFCAB11","ENSOART00000003673;ENSOART00000003675","GO:0005509(calcium ion binding);GO:0005509(calcium ion binding)","NA","NA","NA","EF-hand calcium binding domain 11 [Source:NCBI gene;Acc:101119643]",{"v":0.620311224277457,"d":"0.62"},{"v":0.84945149132948,"d":"0.85"},{"v":0.720442751445087,"d":"0.72"},{"v":1.26278083352601,"d":"1.26"},{"v":0.966181130635838,"d":"0.97"},{"v":0.723352408092486,"d":"0.72"},{"v":0.741860517171016,"d":"0.74"},{"v":-0.430780134593818,"d":"-0.43"},1,1,"down","no"]
["ENSOARG00000008305","ENSOARG00000008305","ENSOART00000009036","NA","NA","NA","NA",null,0,{"v":0.115275,"d":"0.12"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000018867","OTOF","ENSOART00000020553","GO:0005509(calcium ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016079(synaptic vesicle exocytosis);GO:0045202(synapse);GO:0098793(presynapse)","NA","K19949","NA","otoferlin [Source:NCBI gene;Acc:101111175]",0,0,0,0,{"v":0.006057,"d":"0.01"},{"v":0.005929,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["MSTRG.5486","C16orf86","ENSOART00000003395","NA","NA","NA","NA","chromosome 14 open reading frame, human C16orf86 [Source:NCBI gene;Acc:101115393]",{"v":0.066625,"d":"0.07"},{"v":0.160253,"d":"0.16"},{"v":0.142462,"d":"0.14"},{"v":0.225377,"d":"0.23"},{"v":0.336447,"d":"0.34"},{"v":0.268226,"d":"0.27"},{"v":0.44496114691886,"d":"0.44"},{"v":-1.16824872643672,"d":"-1.17"},1,1,"down","no"]
["ENSOARG00000021691","ENSOARG00000021691","ENSOART00000023593","NA","NA","NA","NA",null,0,0,0,0,{"v":0.056672,"d":"0.06"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.13177","ENSOARG00000013663","ENSOART00000014867","NA","NA","NA","NA","coiled-coil domain containing 78 [Source:NCBI gene;Acc:101104626]",{"v":0.07679,"d":"0.08"},{"v":0.084067,"d":"0.08"},{"v":0.07189,"d":"0.07"},{"v":0.138968,"d":"0.14"},{"v":0.056625,"d":"0.06"},{"v":0.043304,"d":"0.04"},{"v":0.974256688028732,"d":"0.97"},{"v":-0.0376261647180779,"d":"-0.04"},1,1,"down","no"]
["ENSOARG00000009705","CCN6","ENSOART00000010562","GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0051881(regulation of mitochondrial membrane potential);GO:1903426(regulation of reactive oxygen species biosynthetic process)","NA","K23090","NA","cellular communication network factor 6 [Source:NCBI gene;Acc:101109099]",0,0,0,{"v":0.095309,"d":"0.10"},{"v":0.028848,"d":"0.03"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.12515","ELOVL3","ENSOART00000019158","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006633(fatty acid biosynthetic process);GO:0006636(unsaturated fatty acid biosynthetic process);GO:0009922(fatty acid elongase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0019367(fatty acid elongation, saturated fatty acid);GO:0034625(fatty acid elongation, monounsaturated fatty acid);GO:0034626(fatty acid elongation, polyunsaturated fatty acid);GO:0035338(long-chain fatty-acyl-CoA biosynthetic process);GO:0042761(very long-chain fatty acid biosynthetic process);GO:0102336(3-oxo-arachidoyl-CoA synthase activity);GO:0102337(3-oxo-cerotoyl-CoA synthase activity);GO:0102338(3-oxo-lignoceronyl-CoA synthase activity);GO:0102756(very-long-chain 3-ketoacyl-CoA synthase activity)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)","K10248","EC:2.3.1.199","ELOVL fatty acid elongase 3 [Source:NCBI gene;Acc:101106896]",0,{"v":0.072351,"d":"0.07"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.5080","SPATA25","ENSOART00000007467","GO:0007283(spermatogenesis)","NA","NA","NA","spermatogenesis associated 25 [Source:NCBI gene;Acc:101113353]",0,0,{"v":0.112449,"d":"0.11"},0,{"v":0.165851,"d":"0.17"},{"v":0.114398,"d":"0.11"},{"v":0.401246748427291,"d":"0.40"},{"v":-1.31743839373486,"d":"-1.32"},1,1,"down","no"]
["ENSOARG00000000981","ENSOARG00000000981","ENSOART00000001050","NA","NA","NA","NA",null,0,0,0,{"v":0.032873,"d":"0.03"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000023639","RF00015","ENSOART00000025541","NA","NA","NA","NA","RNA, U4 small nuclear 54, pseudogene [Source:HGNC Symbol;Acc:HGNC:46990]",{"v":0.503128,"d":"0.50"},{"v":0.172039,"d":"0.17"},{"v":0.816548,"d":"0.82"},{"v":0.668482,"d":"0.67"},{"v":0.110399,"d":"0.11"},{"v":0.2152,"d":"0.22"},{"v":1.50059703384332,"d":"1.50"},{"v":0.585536611650848,"d":"0.59"},1,1,"up","no"]
["ENSOARG00000000492","NLRP12","ENSOART00000000526","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0009968(negative regulation of signal transduction);GO:0031953(negative regulation of protein autophosphorylation);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0043122(regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045345(positive regulation of MHC class I biosynthetic process);GO:0045409(negative regulation of interleukin-6 biosynthetic process);GO:0045751(negative regulation of Toll signaling pathway);GO:0050710(negative regulation of cytokine secretion);GO:0050711(negative regulation of interleukin-1 secretion);GO:0050728(negative regulation of inflammatory response);GO:1901224(positive regulation of NIK/NF-kappaB signaling)","04621(NOD-like receptor signaling pathway)","K20865","NA","NLR family pyrin domain containing 12 [Source:NCBI gene;Acc:101117610]",0,0,0,{"v":0.009609,"d":"0.01"},0,{"v":0.004701,"d":"0.00"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000005241","MARCH9","ENSOART00000005709","GO:0005795(Golgi stack);GO:0005802(trans-Golgi network);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0046872(metal ion binding)","NA","K10659","EC:2.3.2.27","membrane associated ring-CH-type finger 9 [Source:NCBI gene;Acc:101119129]",{"v":1.089806,"d":"1.09"},{"v":0.603013,"d":"0.60"},{"v":0.386651,"d":"0.39"},{"v":0.537714,"d":"0.54"},{"v":0.765424,"d":"0.77"},{"v":0.424458,"d":"0.42"},{"v":1.20367840629406,"d":"1.20"},{"v":0.267449990420812,"d":"0.27"},1,1,"up","no"]
["ENSOARG00000015994","GAL","ENSOART00000017419","GO:0004966(galanin receptor activity);GO:0005179(hormone activity);GO:0005184(neuropeptide hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010469(regulation of signaling receptor activity);GO:0010737(protein kinase A signaling);GO:0019933(cAMP-mediated signaling);GO:0031764(type 1 galanin receptor binding);GO:0031765(type 2 galanin receptor binding);GO:0031766(type 3 galanin receptor binding);GO:0043025(neuronal cell body);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0051464(positive regulation of cortisol secretion);GO:0051795(positive regulation of timing of catagen);GO:1902608(positive regulation of large conductance calcium-activated potassium channel activity);GO:1902891(negative regulation of root hair elongation)","04080(Neuroactive ligand-receptor interaction)","K05244","NA","galanin and GMAP prepropeptide [Source:NCBI gene;Acc:100037696]",0,0,{"v":0.078433,"d":"0.08"},0,{"v":0.116133,"d":"0.12"},0,{"v":0.675372202560857,"d":"0.68"},{"v":-0.566245293766563,"d":"-0.57"},1,1,"down","no"]
["MSTRG.1081","ENSOARG00000012683","ENSOART00000013788","GO:0005249(voltage-gated potassium channel activity);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0071805(potassium ion transmembrane transport)","NA","NA","NA",null,0,0,{"v":0.111481,"d":"0.11"},0,0,{"v":0.087793,"d":"0.09"},{"v":1.26981650017655,"d":"1.27"},{"v":0.344620029743421,"d":"0.34"},1,1,"up","no"]
["MSTRG.18083","F12","ENSOART00000005365","GO:0002353(plasma kallikrein-kinin cascade);GO:0002542(Factor XII activation);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0007596(blood coagulation);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0010756(positive regulation of plasminogen activation);GO:0016485(protein processing);GO:0016540(protein autoprocessing);GO:0016787(hydrolase activity);GO:0030193(regulation of blood coagulation);GO:0030194(positive regulation of blood coagulation);GO:0031638(zymogen activation);GO:0051788(response to misfolded protein);GO:0051919(positive regulation of fibrinolysis)","04610(Complement and coagulation cascades)","K01328","EC:3.4.21.38","coagulation factor XII [Source:NCBI gene;Acc:101106770]",0,{"v":0.015451,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000024635","RF00026","ENSOART00000026537","NA","NA","NA","NA",null,0,{"v":0.496869,"d":"0.50"},0,0,0,{"v":0.179113,"d":"0.18"},{"v":2.77405325129946,"d":"2.77"},{"v":1.47199548219946,"d":"1.47"},1,1,"up","no"]
["MSTRG.5772","ENSOARG00000008767","ENSOART00000009548","GO:0004859(phospholipase inhibitor activity);GO:0005576(extracellular region);GO:0043086(negative regulation of catalytic activity)","NA","NA","NA","phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein-like [Source:NCBI gene;Acc:101108679]",0,0,0,{"v":0.022107,"d":"0.02"},{"v":0.001684,"d":"0.00"},{"v":0.014525,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000019312","PHF21B","ENSOART00000021031","NA","NA","NA","NA","PHD finger protein 21B [Source:NCBI gene;Acc:101108478]",0,{"v":0.060295,"d":"0.06"},{"v":0.063612,"d":"0.06"},{"v":0.121073,"d":"0.12"},{"v":0.093884,"d":"0.09"},0,{"v":0.576426913289635,"d":"0.58"},{"v":-0.794790398578299,"d":"-0.79"},1,1,"down","no"]
["MSTRG.12998","GNAL","ENSOART00000001742","GO:0000166(nucleotide binding);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0019001(guanyl nucleotide binding);GO:0031683(G-protein beta/gamma-subunit complex binding)","04020(Calcium signaling pathway);04728(Dopaminergic synapse);04740(Olfactory transduction);05012(Parkinson disease);05142(Chagas disease (American trypanosomiasis));05146(Amoebiasis)","K04633","NA","G protein subunit alpha L [Source:NCBI gene;Acc:101105461]",0,0,{"v":0.226333,"d":"0.23"},{"v":0.219435,"d":"0.22"},{"v":0.12949,"d":"0.13"},{"v":0.261123,"d":"0.26"},{"v":0.371008510805707,"d":"0.37"},{"v":-1.43047581274114,"d":"-1.43"},1,1,"down","no"]
["MSTRG.4408","ENSOARG00000009375","ENSOART00000010203","NA","NA","NA","NA",null,{"v":0.266402,"d":"0.27"},{"v":0.05164,"d":"0.05"},0,{"v":0.227102,"d":"0.23"},0,{"v":0.033292,"d":"0.03"},{"v":1.2213875895758,"d":"1.22"},{"v":0.288521091256291,"d":"0.29"},1,1,"up","no"]
["MSTRG.16894","ENSOARG00000018026","ENSOART00000019620","GO:0003676(nucleic acid binding);GO:0003964(RNA-directed DNA polymerase activity);GO:0004523(RNA-DNA hybrid ribonuclease activity);GO:0006278(RNA-dependent DNA biosynthetic process);GO:0008270(zinc ion binding);GO:0015074(DNA integration);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","NA","NA","NA",null,{"v":0.064804,"d":"0.06"},{"v":0.08887,"d":"0.09"},{"v":0.039496,"d":"0.04"},{"v":0.082914,"d":"0.08"},{"v":0.053123,"d":"0.05"},{"v":0.074407,"d":"0.07"},{"v":0.917916405314478,"d":"0.92"},{"v":-0.123565321563833,"d":"-0.12"},1,1,"down","no"]
["MSTRG.21518","ENSOARG00000012651","ENSOART00000013753","GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008241(peptidyl-dipeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.694668,"d":"0.69"},{"v":0.747386,"d":"0.75"},{"v":0.984889,"d":"0.98"},{"v":0.809393,"d":"0.81"},{"v":0.694014,"d":"0.69"},{"v":0.562696,"d":"0.56"},{"v":1.17464763373365,"d":"1.17"},{"v":0.232228047594608,"d":"0.23"},1,1,"up","no"]
["MSTRG.8193","RF00015","ENSOART00000023283","NA","NA","NA","NA",null,0,0,0,{"v":0.128852,"d":"0.13"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000004873","ATP4A","ENSOART00000005310","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0005524(ATP binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008556(potassium-transporting ATPase activity);GO:0008900(potassium:proton exchanging ATPase activity);GO:0015991(ATP hydrolysis coupled proton transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0071805(potassium ion transmembrane transport)","00190(Oxidative phosphorylation);04966(Collecting duct acid secretion);04971(Gastric acid secretion)","K01542","EC:7.2.2.19","ATPase H+/K+ transporting subunit alpha [Source:NCBI gene;Acc:101116166]",0,0,{"v":0.001489,"d":"0.00"},{"v":0.035347,"d":"0.04"},{"v":0.027288,"d":"0.03"},0,{"v":0.0237726510736809,"d":"0.02"},{"v":-5.39455339134991,"d":"-5.39"},1,1,"down","no"]
["ENSOARG00000006277","TMEM71","ENSOART00000006827","GO:0005739(mitochondrion);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 71 [Source:NCBI gene;Acc:101102316]",{"v":0.060665980911983,"d":"0.06"},{"v":0.164651420996819,"d":"0.16"},{"v":0.0130061930010604,"d":"0.01"},{"v":0.180276998939555,"d":"0.18"},0,{"v":0.105951951219512,"d":"0.11"},{"v":0.832632739551391,"d":"0.83"},{"v":-0.26424780777627,"d":"-0.26"},1,1,"down","no"]
["ENSOARG00000006940","ENSOARG00000006940","ENSOART00000007538","NA","NA","NA","NA",null,0,0,0,{"v":0.072609,"d":"0.07"},{"v":0.88576,"d":"0.89"},{"v":0.266681,"d":"0.27"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000023389","RF00026","ENSOART00000025291","NA","NA","NA","NA",null,0,{"v":0.098661,"d":"0.10"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.20035","RF01299","ENSOART00000023947","NA","NA","NA","NA",null,0,0,0,{"v":0.257705,"d":"0.26"},0,{"v":0.630432,"d":"0.63"},"-inf","-inf",1,1,"down","no"]
["MSTRG.15965","NDUFA4L2","ENSOART00000007719","GO:0016020(membrane);GO:0016021(integral component of membrane)","00190(Oxidative phosphorylation);04714(Thermogenesis);04723(Retrograde endocannabinoid signaling);04932(Non-alcoholic fatty liver disease (NAFLD));05010(Alzheimer disease);05012(Parkinson disease);05016(Huntington disease)","K03948","NA","NDUFA4, mitochondrial complex associated like 2 [Source:NCBI gene;Acc:101123455]",{"v":1.774287,"d":"1.77"},{"v":1.478079,"d":"1.48"},{"v":1.148536,"d":"1.15"},{"v":3.320877,"d":"3.32"},{"v":2.786255,"d":"2.79"},{"v":4.66472,"d":"4.66"},{"v":0.40855574324638,"d":"0.41"},{"v":-1.29139516212573,"d":"-1.29"},1,1,"down","no"]
["ENSOARG00000020657","ENSOARG00000020657","ENSOART00000022505","GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","04142(Lysosome)","K06562","NA","lysosomal associated membrane protein 3 [Source:NCBI gene;Acc:101103444]",{"v":0.30648,"d":"0.31"},{"v":0.231998,"d":"0.23"},{"v":0.326126,"d":"0.33"},{"v":0.224636,"d":"0.22"},{"v":0.066282,"d":"0.07"},{"v":0.434649,"d":"0.43"},{"v":1.19162530820724,"d":"1.19"},{"v":0.252930669550486,"d":"0.25"},1,1,"up","no"]
["ENSOARG00000012725","TMC1","ENSOART00000013838","GO:0005245(voltage-gated calcium channel activity);GO:0005887(integral component of plasma membrane);GO:0008381(mechanosensitive ion channel activity);GO:0009897(external side of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032426(stereocilium tip);GO:0050910(detection of mechanical stimulus involved in sensory perception of sound);GO:0060005(vestibular reflex);GO:0060117(auditory receptor cell development);GO:0070588(calcium ion transmembrane transport);GO:1903169(regulation of calcium ion transmembrane transport)","NA","K21988","NA","transmembrane channel like 1 [Source:NCBI gene;Acc:101114592]",{"v":0.0352209493575208,"d":"0.04"},{"v":0.00545072864701436,"d":"0.01"},0,{"v":0.0423076389518771,"d":"0.04"},{"v":0.00885905794910557,"d":"0.01"},0,{"v":0.794885745375407,"d":"0.79"},{"v":-0.331180588485537,"d":"-0.33"},1,1,"down","no"]
["ENSOARG00000002913","PON1","ENSOART00000003154","GO:0004063(aryldialkylphosphatase activity);GO:0004064(arylesterase activity);GO:0005509(calcium ion binding);GO:0005543(phospholipid binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0008203(cholesterol metabolic process);GO:0009636(response to toxic substance);GO:0010875(positive regulation of cholesterol efflux);GO:0016311(dephosphorylation);GO:0019439(aromatic compound catabolic process);GO:0032411(positive regulation of transporter activity);GO:0034364(high-density lipoprotein particle);GO:0034366(spherical high-density lipoprotein particle);GO:0042803(protein homodimerization activity);GO:0046395(carboxylic acid catabolic process);GO:0046434(organophosphate catabolic process);GO:0046470(phosphatidylcholine metabolic process);GO:0051099(positive regulation of binding)","NA","K01045","3.1.8.1;EC:3.1.1.2","paraoxonase 1 [Source:NCBI gene;Acc:101116983]",{"v":0.047489,"d":"0.05"},{"v":0.015666,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.6414","RF00026","ENSOART00000025174","NA","NA","NA","NA","RNA, U6 small nuclear 381, pseudogene [Source:HGNC Symbol;Acc:HGNC:47344]",{"v":1.978252,"d":"1.98"},{"v":2.175112,"d":"2.18"},{"v":2.808252,"d":"2.81"},{"v":2.484321,"d":"2.48"},{"v":1.21697,"d":"1.22"},{"v":1.64148,"d":"1.64"},{"v":1.30299726490243,"d":"1.30"},{"v":0.381834055574622,"d":"0.38"},1,1,"up","no"]
["MSTRG.16568","ENSOARG00000021610","ENSOART00000023512","NA","NA","NA","NA",null,0,0,{"v":0.163123,"d":"0.16"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000013364","HHIPL2","ENSOART00000014532","GO:0003824(catalytic activity)","NA","NA","NA","HHIP like 2 [Source:NCBI gene;Acc:101102325]",{"v":0.033642,"d":"0.03"},0,0,0,0,{"v":0.00661,"d":"0.01"},{"v":5.08956127080181,"d":"5.09"},{"v":2.34754129879242,"d":"2.35"},1,1,"up","no"]
["MSTRG.19583","RF00377","ENSOART00000026516","NA","NA","NA","NA","small nucleolar RNA, C/D box 9 [Source:HGNC Symbol;Acc:HGNC:32705]",0,{"v":0.26034,"d":"0.26"},{"v":0.302887,"d":"0.30"},{"v":0.442117,"d":"0.44"},{"v":0.213877,"d":"0.21"},{"v":0.761145,"d":"0.76"},{"v":0.397439488998609,"d":"0.40"},{"v":-1.33119287113694,"d":"-1.33"},1,1,"down","no"]
["ENSOARG00000019048","ENSOARG00000019048","ENSOART00000020741","GO:0005623(cell);GO:0006886(intracellular protein transport);GO:0017137(Rab GTPase binding);GO:0046872(metal ion binding)","NA","NA","NA",null,0,{"v":0.011118,"d":"0.01"},0,{"v":0.038316,"d":"0.04"},{"v":0.031781,"d":"0.03"},0,{"v":0.1586087849694,"d":"0.16"},{"v":-2.65645541413054,"d":"-2.66"},1,1,"down","no"]
["MSTRG.18919","GABRB1","ENSOART00000017052","GO:0004888(transmembrane signaling receptor activity);GO:0004890(GABA-A receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022851(GABA-gated chloride ion channel activity);GO:0034220(ion transmembrane transport);GO:1902476(chloride transmembrane transport);GO:1902711(GABA-A receptor complex)","04080(Neuroactive ligand-receptor interaction);04723(Retrograde endocannabinoid signaling);04726(Serotonergic synapse);04727(GABAergic synapse);05032(Morphine addiction);05033(Nicotine addiction)","K05181","NA","gamma-aminobutyric acid type A receptor beta1 subunit [Source:NCBI gene;Acc:101122358]",{"v":0.020667,"d":"0.02"},{"v":0.003774,"d":"0.00"},{"v":0.010795,"d":"0.01"},{"v":0.056111,"d":"0.06"},{"v":0.02952,"d":"0.03"},0,{"v":0.411486494377036,"d":"0.41"},{"v":-1.28108301494526,"d":"-1.28"},1,1,"down","no"]
["MSTRG.8090","ENSOARG00000010790","ENSOART00000011737","GO:0046854(phosphatidylinositol phosphorylation)","NA","NA","NA",null,{"v":0.407081,"d":"0.41"},{"v":0.726313,"d":"0.73"},{"v":1.06512,"d":"1.07"},{"v":0.505981,"d":"0.51"},{"v":0.445291,"d":"0.45"},{"v":0.090651,"d":"0.09"},{"v":2.11005419786299,"d":"2.11"},{"v":1.0772800557969,"d":"1.08"},1,1,"up","no"]
["MSTRG.17967","ENSOARG00000014380","ENSOART00000015655","GO:0008083(growth factor activity);GO:0008406(gonad development);GO:0010469(regulation of signaling receptor activity)","NA","NA","NA",null,{"v":0.073153,"d":"0.07"},{"v":0.154227,"d":"0.15"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000001158","LAT","ENSOART00000001236","GO:0001772(immunological synapse);GO:0002260(lymphocyte homeostasis);GO:0005070(SH3/SH2 adaptor activity);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007229(integrin-mediated signaling pathway);GO:0007265(Ras protein signal transduction);GO:0008180(COP9 signalosome);GO:0009967(positive regulation of signal transduction);GO:0010467(gene expression);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019722(calcium-mediated signaling);GO:0019901(protein kinase binding);GO:0035556(intracellular signal transduction);GO:0045860(positive regulation of protein kinase activity);GO:0048872(homeostasis of number of cells);GO:0050863(regulation of T cell activation)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04064(NF-kappa B signaling pathway);04650(Natural killer cell mediated cytotoxicity);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04666(Fc gamma R-mediated phagocytosis)","K07362","NA","linker for activation of T cells [Source:NCBI gene;Acc:101110725]",{"v":0.097347,"d":"0.10"},{"v":0.031532,"d":"0.03"},{"v":0.049225,"d":"0.05"},{"v":0.157818,"d":"0.16"},{"v":0.155175,"d":"0.16"},{"v":0.271646,"d":"0.27"},{"v":0.304639273124099,"d":"0.30"},{"v":-1.71482615342636,"d":"-1.71"},1,1,"down","no"]
["ENSOARG00000008380","RAB6B","ENSOART00000009121","GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0031489(myosin V binding)","NA","K07894","NA","RAB6B, member RAS oncogene family [Source:NCBI gene;Acc:101116194]",0,0,0,0,{"v":0.067999,"d":"0.07"},{"v":0.050387,"d":"0.05"},"-inf","-inf",1,1,"down","no"]
["MSTRG.1734","ENSOARG00000015222","ENSOART00000016563","NA","NA","NA","NA",null,{"v":0.112653,"d":"0.11"},{"v":0.44138,"d":"0.44"},{"v":1.52271,"d":"1.52"},{"v":0.515409,"d":"0.52"},{"v":0.362545,"d":"0.36"},{"v":0.35491,"d":"0.35"},{"v":1.68448669115166,"d":"1.68"},{"v":0.752309030011852,"d":"0.75"},1,1,"up","no"]
["MSTRG.13467","CACNG3","ENSOART00000019238","GO:0005244(voltage-gated ion channel activity);GO:0005262(calcium channel activity);GO:0006605(protein targeting);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0008104(protein localization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032281(AMPA glutamate receptor complex);GO:0034765(regulation of ion transmembrane transport);GO:0036477(somatodendritic compartment);GO:0070588(calcium ion transmembrane transport);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane);GO:0099645(neurotransmitter receptor localization to postsynaptic specialization membrane)","04010(MAPK signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04921(Oxytocin signaling pathway);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","K04868","NA","calcium voltage-gated channel auxiliary subunit gamma 3 [Source:NCBI gene;Acc:101105970]",{"v":0.087807,"d":"0.09"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.5851","TMEM160","ENSOART00000011848","NA","NA","NA","NA","transmembrane protein 160 [Source:HGNC Symbol;Acc:HGNC:26042]",{"v":0.8254570056926,"d":"0.83"},{"v":0.460079227703985,"d":"0.46"},{"v":0.18765555028463,"d":"0.19"},{"v":1.10099080075901,"d":"1.10"},{"v":1.00938839278937,"d":"1.01"},{"v":1.39970657305503,"d":"1.40"},{"v":0.41970250348235,"d":"0.42"},{"v":-1.25256102611005,"d":"-1.25"},1,1,"down","no"]
["MSTRG.2819","RF00026","ENSOART00000023218","NA","NA","NA","NA",null,{"v":0.306985,"d":"0.31"},{"v":0.424178,"d":"0.42"},{"v":0.485178,"d":"0.49"},{"v":0.407642,"d":"0.41"},{"v":0.211933,"d":"0.21"},{"v":0.169644,"d":"0.17"},{"v":1.54119578976178,"d":"1.54"},{"v":0.624050149961579,"d":"0.62"},1,1,"up","no"]
["ENSOARG00000019891","ENSOARG00000019891","ENSOART00000021656","GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016503(pheromone receptor activity);GO:0019236(response to pheromone)","NA","K04614","NA","vomeronasal type-1 receptor 4-like [Source:NCBI gene;Acc:101106874]",0,{"v":0.017005,"d":"0.02"},0,{"v":0.018427,"d":"0.02"},{"v":0.029291,"d":"0.03"},0,{"v":0.356364474621736,"d":"0.36"},{"v":-1.48857457071437,"d":"-1.49"},1,1,"down","no"]
["ENSOARG00000000116","ADAD1","ENSOART00000000122","GO:0003723(RNA binding);GO:0004000(adenosine deaminase activity);GO:0005634(nucleus);GO:0006396(RNA processing);GO:0007286(spermatid development)","NA","NA","NA","adenosine deaminase domain containing 1 [Source:NCBI gene;Acc:101104272]",0,{"v":0.005021,"d":"0.01"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.8528","oar-mir-329b","ENSOART00000024149","NA","NA","NA","NA","oar-mir-329b [Source:miRBase;Acc:MI0016925]",0,{"v":0.7978,"d":"0.80"},{"v":0.56052,"d":"0.56"},{"v":1.897455,"d":"1.90"},{"v":1.926792,"d":"1.93"},{"v":0.327418,"d":"0.33"},{"v":0.327174760005925,"d":"0.33"},{"v":-1.6118666394525,"d":"-1.61"},1,1,"down","no"]
["ENSOARG00000018736","BPI","ENSOART00000020401","GO:0001530(lipopolysaccharide binding);GO:0005615(extracellular space);GO:0006955(immune response);GO:0008289(lipid binding);GO:0032715(negative regulation of interleukin-6 production);GO:0032717(negative regulation of interleukin-8 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0043031(negative regulation of macrophage activation);GO:0050829(defense response to Gram-negative bacterium)","NA","NA","NA","bactericidal permeability increasing protein [Source:NCBI gene;Acc:101104332]",0,0,0,{"v":0.106297,"d":"0.11"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.12140","RIN1","ENSOART00000004429","GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007613(memory);GO:0008306(associative learning);GO:0017016(Ras GTPase binding);GO:0030425(dendrite);GO:0031914(negative regulation of synaptic plasticity);GO:0043025(neuronal cell body)","04014(Ras signaling pathway)","K17638","NA","Ras and Rab interactor 1 [Source:NCBI gene;Acc:101113711]",{"v":0.026963,"d":"0.03"},{"v":0.050331,"d":"0.05"},0,{"v":0.010412,"d":"0.01"},{"v":0.009273,"d":"0.01"},0,{"v":3.92654305308611,"d":"3.93"},{"v":1.97325971580314,"d":"1.97"},1,1,"up","no"]
["ENSOARG00000007151","TTK","ENSOART00000007781","GO:0000776(kinetochore);GO:0004672(protein kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007093(mitotic cell cycle checkpoint);GO:0007094(mitotic spindle assembly checkpoint);GO:0016321(female meiosis chromosome segregation);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0033316(meiotic spindle assembly checkpoint);GO:0034501(protein localization to kinetochore);GO:0034502(protein localization to chromosome);GO:0042803(protein homodimerization activity);GO:0043515(kinetochore binding);GO:0046777(protein autophosphorylation);GO:0051304(chromosome separation);GO:1903096(protein localization to meiotic spindle midzone)","04110(Cell cycle)","K08866","EC:2.7.12.1","TTK protein kinase [Source:NCBI gene;Acc:101113682]",{"v":0.130973,"d":"0.13"},{"v":0.037719,"d":"0.04"},{"v":0.073109,"d":"0.07"},{"v":0.14052,"d":"0.14"},{"v":0.024842,"d":"0.02"},{"v":0.047811,"d":"0.05"},{"v":1.13429468084607,"d":"1.13"},{"v":0.181795489810281,"d":"0.18"},1,1,"up","no"]
["ENSOARG00000012225","ENSOARG00000012225","ENSOART00000013292","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.152881,"d":"0.15"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000016419","SAYSD1","ENSOART00000017879","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043231(intracellular membrane-bounded organelle)","NA","NA","NA","SAYSVFN motif domain containing 1 [Source:NCBI gene;Acc:101102766]",{"v":0.649752,"d":"0.65"},{"v":0.643296,"d":"0.64"},{"v":0.504991,"d":"0.50"},{"v":0.641826,"d":"0.64"},{"v":0.668117,"d":"0.67"},{"v":0.756302,"d":"0.76"},{"v":0.870196419108092,"d":"0.87"},{"v":-0.200587014742575,"d":"-0.20"},1,1,"down","no"]
["ENSOARG00000008978","ZNF283","ENSOART00000009778","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger protein 283 [Source:NCBI gene;Acc:101109117]",{"v":0.574609,"d":"0.57"},{"v":0.20617,"d":"0.21"},{"v":0.389055,"d":"0.39"},{"v":0.455506,"d":"0.46"},{"v":0.363322,"d":"0.36"},{"v":0.399527,"d":"0.40"},{"v":0.960174990048057,"d":"0.96"},{"v":-0.058630736690848,"d":"-0.06"},1,1,"down","no"]
["MSTRG.9459","ENSOARG00000023981","ENSOART00000025883","NA","NA","NA","NA",null,{"v":0.883502,"d":"0.88"},{"v":0.532499,"d":"0.53"},{"v":0.494051,"d":"0.49"},{"v":0.103832,"d":"0.10"},{"v":1.328005,"d":"1.33"},{"v":0.975639,"d":"0.98"},{"v":0.79338361005468,"d":"0.79"},{"v":-0.333909500702722,"d":"-0.33"},1,1,"down","no"]
["ENSOARG00000020519","KNG1","ENSOART00000022351","GO:0004869(cysteine-type endopeptidase inhibitor activity);GO:0005102(signaling receptor binding);GO:0005615(extracellular space);GO:0005623(cell);GO:0007162(negative regulation of cell adhesion);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0010951(negative regulation of endopeptidase activity);GO:0030195(negative regulation of blood coagulation);GO:0045861(negative regulation of proteolysis)","04022(cGMP-PKG signaling pathway);04071(Sphingolipid signaling pathway);04080(Neuroactive ligand-receptor interaction);04610(Complement and coagulation cascades);04750(Inflammatory mediator regulation of TRP channels);04810(Regulation of actin cytoskeleton);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis);05200(Pathways in cancer)","K03898","NA","kininogen 1 [Source:NCBI gene;Acc:101112781]",{"v":0.0670817351598173,"d":"0.07"},0,{"v":0.122477838660578,"d":"0.12"},0,0,{"v":0.0179120547945206,"d":"0.02"},{"v":10.5827933196354,"d":"10.58"},{"v":3.40364857077912,"d":"3.40"},1,1,"up","no"]
["ENSOARG00000015312","GCM1","ENSOART00000016663","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0006366(transcription by RNA polymerase II);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0042826(histone deacetylase binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060018(astrocyte fate commitment);GO:0060143(positive regulation of syncytium formation by plasma membrane fusion);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0060706(cell differentiation involved in embryonic placenta development);GO:0060800(regulation of cell differentiation involved in embryonic placenta development)","04928(Parathyroid hormone synthesis, secretion and action)","K21598","NA","glial cells missing transcription factor 1 [Source:NCBI gene;Acc:101108000]",0,0,0,{"v":0.025142,"d":"0.03"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.2200","RFXAP","ENSOART00000011287","GO:0016607(nuclear speck)","NA","NA","NA","regulatory factor X associated protein [Source:HGNC Symbol;Acc:HGNC:9988]",{"v":0.87614,"d":"0.88"},{"v":1.08667,"d":"1.09"},{"v":1.036252,"d":"1.04"},{"v":1.627047,"d":"1.63"},{"v":1.365473,"d":"1.37"},{"v":1.195956,"d":"1.20"},{"v":0.716027022716616,"d":"0.72"},{"v":-0.481914059348123,"d":"-0.48"},1,1,"down","no"]
["ENSOARG00000008174","ENSOARG00000008174","ENSOART00000008896","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":0.07336,"d":"0.07"},{"v":0.022432,"d":"0.02"},{"v":0.007146,"d":"0.01"},{"v":0.222563,"d":"0.22"},{"v":0.145582,"d":"0.15"},{"v":0.146719,"d":"0.15"},{"v":0.199932409335281,"d":"0.20"},{"v":-2.3224157408768,"d":"-2.32"},1,1,"down","no"]
["MSTRG.9113","CCDC36","ENSOART00000015544","GO:0000794(condensed nuclear chromosome);GO:0006310(DNA recombination);GO:0007129(synapsis);GO:0007283(spermatogenesis);GO:0042138(meiotic DNA double-strand break formation);GO:0048477(oogenesis);GO:0060629(regulation of homologous chromosome segregation)","NA","NA","NA","coiled-coil domain containing 36 [Source:NCBI gene;Acc:101105694]",{"v":0.230729,"d":"0.23"},{"v":0.113805,"d":"0.11"},{"v":0.220433,"d":"0.22"},{"v":0.161834,"d":"0.16"},{"v":0.244917,"d":"0.24"},{"v":0.122125,"d":"0.12"},{"v":1.068240948729,"d":"1.07"},{"v":0.0952370930273533,"d":"0.10"},1,1,"up","no"]
["MSTRG.14715","PRRX2","ENSOART00000009286","GO:0003677(DNA binding);GO:0005634(nucleus);GO:0007275(multicellular organism development)","NA","NA","NA","paired related homeobox 2 [Source:HGNC Symbol;Acc:HGNC:21338]",{"v":0.148267,"d":"0.15"},0,0,0,{"v":0.459295,"d":"0.46"},0,{"v":0.322814313240945,"d":"0.32"},{"v":-1.63122354730038,"d":"-1.63"},1,1,"down","no"]
["ENSOARG00000017114","ABCA4","ENSOART00000018641","GO:0000166(nucleotide binding);GO:0001750(photoreceptor outer segment);GO:0004012(phospholipid-translocating ATPase activity);GO:0005524(ATP binding);GO:0005548(phospholipid transporter activity);GO:0005887(integral component of plasma membrane);GO:0006649(phospholipid transfer to membrane);GO:0006869(lipid transport);GO:0007601(visual perception);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0045332(phospholipid translocation);GO:0045494(photoreceptor cell maintenance);GO:0055085(transmembrane transport);GO:0090555(phosphatidylethanolamine-translocating ATPase activity)","02010(ABC transporters)","K05644","NA","ATP binding cassette subfamily A member 4 [Source:NCBI gene;Acc:101107561]",{"v":0.024453,"d":"0.02"},{"v":0.012664,"d":"0.01"},{"v":0.039511,"d":"0.04"},{"v":0.010279,"d":"0.01"},{"v":0.04432,"d":"0.04"},{"v":0.005194,"d":"0.01"},{"v":1.28155469703812,"d":"1.28"},{"v":0.357895054487191,"d":"0.36"},1,1,"up","no"]
["ENSOARG00000018555","ENSOARG00000018555","ENSOART00000020196","GO:0046872(metal ion binding)","NA","NA","NA","testis expressed 13B [Source:NCBI gene;Acc:101115101]",{"v":0.080298,"d":"0.08"},0,0,{"v":0.05556,"d":"0.06"},0,0,{"v":1.44524838012959,"d":"1.45"},{"v":0.531317455347132,"d":"0.53"},1,1,"up","no"]
["MSTRG.4519","ENSOARG00000004460","ENSOART00000004850","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02957","NA","40S ribosomal protein S15a [Source:NCBI gene;Acc:101119296]",{"v":0.730659,"d":"0.73"},{"v":0.744538,"d":"0.74"},{"v":0.515599,"d":"0.52"},{"v":0.627901,"d":"0.63"},{"v":2.83702,"d":"2.84"},{"v":1.260885,"d":"1.26"},{"v":0.421260627287705,"d":"0.42"},{"v":-1.24721501276645,"d":"-1.25"},1,1,"down","no"]
["ENSOARG00000017876","C11orf91","ENSOART00000019449","NA","NA","NA","NA","chromosome 15 open reading frame, human C11orf91 [Source:NCBI gene;Acc:101102420]",0,{"v":0.066748,"d":"0.07"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.8015","RF00108","ENSOART00000024685","NA","NA","NA","NA",null,{"v":0.115064,"d":"0.12"},{"v":0.329648,"d":"0.33"},{"v":0.07568,"d":"0.08"},{"v":0.754258,"d":"0.75"},{"v":0.100526,"d":"0.10"},{"v":0.229108,"d":"0.23"},{"v":0.480114254925767,"d":"0.48"},{"v":-1.05855032363693,"d":"-1.06"},1,1,"down","no"]
["ENSOARG00000012711","RBM47","ENSOART00000013818","GO:0002244(hematopoietic progenitor cell differentiation);GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0016554(cytidine to uridine editing)","NA","NA","NA","RNA binding motif protein 47 [Source:NCBI gene;Acc:101115877]",{"v":0.134498273821138,"d":"0.13"},{"v":0.010286245203252,"d":"0.01"},{"v":0.19312323902439,"d":"0.19"},{"v":0.0820048650406504,"d":"0.08"},{"v":0.123983357398374,"d":"0.12"},{"v":0.119634644552846,"d":"0.12"},{"v":1.03772735978403,"d":"1.04"},{"v":0.0534274568428867,"d":"0.05"},1,1,"up","no"]
["ENSOARG00000006009","WHRN","ENSOART00000006534","GO:0001895(retina homeostasis);GO:0001917(photoreceptor inner segment);GO:0002141(stereocilia ankle link);GO:0002142(stereocilia ankle link complex);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005884(actin filament);GO:0005929(cilium);GO:0007605(sensory perception of sound);GO:0010628(positive regulation of gene expression);GO:0021694(cerebellar Purkinje cell layer formation);GO:0032391(photoreceptor connecting cilium);GO:0032420(stereocilium);GO:0032421(stereocilium bundle);GO:0032426(stereocilium tip);GO:0036064(ciliary basal body);GO:0042803(protein homodimerization activity);GO:0045184(establishment of protein localization);GO:0046982(protein heterodimerization activity);GO:0050910(detection of mechanical stimulus involved in sensory perception of sound);GO:0050953(sensory perception of light stimulus);GO:0060088(auditory receptor cell stereocilium organization);GO:0060122(inner ear receptor cell stereocilium organization);GO:1990075(periciliary membrane compartment);GO:1990227(paranodal junction maintenance);GO:1990696(USH2 complex)","NA","NA","NA","whirlin [Source:HGNC Symbol;Acc:HGNC:16361]",{"v":0.161912,"d":"0.16"},{"v":0.049482,"d":"0.05"},{"v":0.067549,"d":"0.07"},{"v":0.076808,"d":"0.08"},{"v":0.210485,"d":"0.21"},{"v":0.058428,"d":"0.06"},{"v":0.806844247239826,"d":"0.81"},{"v":-0.309637891547446,"d":"-0.31"},1,1,"down","no"]
["ENSOARG00000016025","ZNF831","ENSOART00000017454","GO:0003676(nucleic acid binding)","NA","NA","NA","zinc finger protein 831 [Source:HGNC Symbol;Acc:HGNC:16167]",{"v":0.044267,"d":"0.04"},{"v":0.018825,"d":"0.02"},{"v":0.071712,"d":"0.07"},{"v":0.052611,"d":"0.05"},{"v":0.052476,"d":"0.05"},{"v":0.027364,"d":"0.03"},{"v":1.01776506028645,"d":"1.02"},{"v":0.0254045697852821,"d":"0.03"},1,1,"up","no"]
["ENSOARG00000011413","LRRC52","ENSOART00000012404","GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0005515(protein binding);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022414(reproductive process);GO:0044325(ion channel binding);GO:0071805(potassium ion transmembrane transport);GO:0099104(potassium channel activator activity);GO:1903818(positive regulation of voltage-gated potassium channel activity)","NA","NA","NA","leucine rich repeat containing 52 [Source:NCBI gene;Acc:101112100]",0,0,0,{"v":0.038329,"d":"0.04"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000015335","CBLN4","ENSOART00000016687","GO:0005515(protein binding);GO:0005615(extracellular space);GO:0009306(protein secretion)","NA","NA","NA","cerebellin-4 [Source:NCBI gene;Acc:101102832]",{"v":0.014126,"d":"0.01"},{"v":0.019177,"d":"0.02"},{"v":0.022101,"d":"0.02"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.17363","EPHA1","ENSOART00000019708","GO:0000166(nucleotide binding);GO:0001954(positive regulation of cell-matrix adhesion);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral component of plasma membrane);GO:0006468(protein phosphorylation);GO:0006469(negative regulation of protein kinase activity);GO:0007166(cell surface receptor signaling pathway);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019901(protein kinase binding);GO:0030335(positive regulation of cell migration);GO:0030336(negative regulation of cell migration);GO:0034446(substrate adhesion-dependent cell spreading);GO:0043087(regulation of GTPase activity);GO:0045766(positive regulation of angiogenesis);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0051496(positive regulation of stress fiber assembly);GO:0090630(activation of GTPase activity)","04360(Axon guidance)","K05102","EC:2.7.10.1","EPH receptor A1 [Source:NCBI gene;Acc:101115703]",{"v":0.313,"d":"0.31"},{"v":0.076146,"d":"0.08"},{"v":0.162351,"d":"0.16"},{"v":0.327257,"d":"0.33"},{"v":0.211471,"d":"0.21"},{"v":0.198855,"d":"0.20"},{"v":0.747708393496054,"d":"0.75"},{"v":-0.419452366596497,"d":"-0.42"},1,1,"down","no"]
["ENSOARG00000003203","GUCA1A","ENSOART00000003474","GO:0001750(photoreceptor outer segment);GO:0005509(calcium ion binding);GO:0007601(visual perception);GO:0007602(phototransduction);GO:0008048(calcium sensitive guanylate cyclase activator activity);GO:0030249(guanylate cyclase regulator activity);GO:0031282(regulation of guanylate cyclase activity);GO:0031284(positive regulation of guanylate cyclase activity)","04744(Phototransduction)","K08328","NA","guanylate cyclase activator 1A [Source:NCBI gene;Acc:101108346]",{"v":0.062452,"d":"0.06"},{"v":0.064994,"d":"0.06"},0,0,{"v":0.076379,"d":"0.08"},0,{"v":1.66860000785556,"d":"1.67"},{"v":0.738638157310423,"d":"0.74"},1,1,"up","no"]
["MSTRG.6320","TREH","ENSOART00000012250","GO:0003824(catalytic activity);GO:0004555(alpha,alpha-trehalase activity);GO:0005991(trehalose metabolic process);GO:0005993(trehalose catabolic process);GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds)","00500(Starch and sucrose metabolism)","K01194","EC:3.2.1.28","trehalase [Source:NCBI gene;Acc:101103668]",0,{"v":0.040938,"d":"0.04"},{"v":0.023354,"d":"0.02"},0,{"v":0.06911,"d":"0.07"},0,{"v":0.930285052814354,"d":"0.93"},{"v":-0.104255248269251,"d":"-0.10"},1,1,"down","no"]
["MSTRG.16893","TMEM60","ENSOART00000008974","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane protein 60 [Source:NCBI gene;Acc:101117242]",{"v":1.695761,"d":"1.70"},{"v":1.372373,"d":"1.37"},{"v":1.168985,"d":"1.17"},{"v":1.774222,"d":"1.77"},{"v":1.633068,"d":"1.63"},{"v":2.01991,"d":"2.02"},{"v":0.780719155365566,"d":"0.78"},{"v":-0.3571244274781,"d":"-0.36"},1,1,"down","no"]
["ENSOARG00000008655","GLS2","ENSOART00000009425","GO:0004359(glutaminase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0006541(glutamine metabolic process);GO:0042981(regulation of apoptotic process);GO:0072593(reactive oxygen species metabolic process)","00220(Arginine biosynthesis);00250(Alanine, aspartate and glutamate metabolism);00471(D-Glutamine and D-glutamate metabolism);04724(Glutamatergic synapse);04727(GABAergic synapse);04964(Proximal tubule bicarbonate reclamation);05206(MicroRNAs in cancer);05230(Central carbon metabolism in cancer)","K01425","EC:3.5.1.2","glutaminase 2 [Source:NCBI gene;Acc:101107269]",{"v":0.046904,"d":"0.05"},{"v":0.064131,"d":"0.06"},{"v":0.02786,"d":"0.03"},{"v":0.036068,"d":"0.04"},{"v":0.012248,"d":"0.01"},{"v":0.113163,"d":"0.11"},{"v":0.860142804946773,"d":"0.86"},{"v":-0.217351892183042,"d":"-0.22"},1,1,"down","no"]
["ENSOARG00000020752","FABP1","ENSOART00000022608","GO:0003682(chromatin binding);GO:0005504(fatty acid binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008289(lipid binding);GO:0016209(antioxidant activity);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0070301(cellular response to hydrogen peroxide);GO:0071456(cellular response to hypoxia);GO:0098869(cellular oxidant detoxification)","03320(PPAR signaling pathway);04975(Fat digestion and absorption)","K08750","NA","fatty acid binding protein 1 [Source:NCBI gene;Acc:101108999]",{"v":0.160017,"d":"0.16"},0,{"v":0.227549,"d":"0.23"},0,0,{"v":0.149674,"d":"0.15"},{"v":2.58940096476342,"d":"2.59"},{"v":1.37261838164817,"d":"1.37"},1,1,"up","no"]
["ENSOARG00000002460","ENSOARG00000002460","ENSOART00000002660","GO:0005515(protein binding);GO:0005634(nucleus);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007275(multicellular organism development);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0046872(metal ion binding)","NA","NA","NA",null,{"v":0.054427,"d":"0.05"},{"v":0.125446,"d":"0.13"},0,{"v":0.313718,"d":"0.31"},0,{"v":0.190403,"d":"0.19"},{"v":0.356805211447252,"d":"0.36"},{"v":-1.48679140767231,"d":"-1.49"},1,1,"down","no"]
["ENSOARG00000009794","DGKI","ENSOART00000010664","GO:0000166(nucleotide binding);GO:0003951(NAD+ kinase activity);GO:0004143(diacylglycerol kinase activity);GO:0005095(GTPase inhibitor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007205(protein kinase C-activating G protein-coupled receptor signaling pathway);GO:0007269(neurotransmitter secretion);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0017016(Ras GTPase binding);GO:0032045(guanyl-nucleotide exchange factor complex);GO:0032991(protein-containing complex);GO:0034260(negative regulation of GTPase activity);GO:0035556(intracellular signal transduction);GO:0043087(regulation of GTPase activity);GO:0043197(dendritic spine);GO:0045202(synapse);GO:0046579(positive regulation of Ras protein signal transduction);GO:0046834(lipid phosphorylation);GO:0046959(habituation);GO:0048471(perinuclear region of cytoplasm);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0060079(excitatory postsynaptic potential);GO:0098685(Schaffer collateral - CA1 synapse);GO:0098793(presynapse);GO:0098978(glutamatergic synapse);GO:1900452(regulation of long-term synaptic depression);GO:2000300(regulation of synaptic vesicle exocytosis)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);04070(Phosphatidylinositol signaling system);04072(Phospholipase D signaling pathway);05231(Choline metabolism in cancer)","K00901","EC:2.7.1.107","diacylglycerol kinase iota [Source:NCBI gene;Acc:101108481]",{"v":0.108356,"d":"0.11"},0,{"v":0.136916,"d":"0.14"},{"v":0.008533,"d":"0.01"},{"v":0.049897,"d":"0.05"},0,{"v":4.19770665753894,"d":"4.20"},{"v":2.06960135231358,"d":"2.07"},1,1,"up","no"]
["MSTRG.8232","RF00026","ENSOART00000024226","NA","NA","NA","NA",null,0,{"v":0.165623,"d":"0.17"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000018749","SLC12A3","ENSOART00000020417","GO:0005215(transporter activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0015377(cation:chloride symporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0055085(transmembrane transport);GO:0070062(extracellular exosome);GO:1902476(chloride transmembrane transport)","NA","K14426","NA","solute carrier family 12 member 3 [Source:NCBI gene;Acc:101120940]",0,0,0,{"v":0.01151,"d":"0.01"},{"v":0.023421,"d":"0.02"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017180","C10orf82","ENSOART00000018696","NA","NA","NA","NA","chromosome 22 open reading frame, human C10orf82 [Source:NCBI gene;Acc:101120621]",0,0,0,0,{"v":0.048192,"d":"0.05"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000001545","PGF","ENSOART00000001660","GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0016020(membrane)","NA","NA","NA","placental growth factor [Source:HGNC Symbol;Acc:HGNC:8893]",0,{"v":0.078122,"d":"0.08"},{"v":0.521717,"d":"0.52"},{"v":0.245543,"d":"0.25"},{"v":0.3181,"d":"0.32"},{"v":0.762861,"d":"0.76"},{"v":0.452195394812228,"d":"0.45"},{"v":-1.1449817952247,"d":"-1.14"},1,1,"down","no"]
["ENSOARG00000011076","CD40LG","ENSOART00000012047","GO:0005125(cytokine activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007257(activation of JUN kinase activity);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010469(regulation of signaling receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030168(platelet activation);GO:0030183(B cell differentiation);GO:0032733(positive regulation of interleukin-10 production);GO:0032735(positive regulation of interleukin-12 production);GO:0032753(positive regulation of interleukin-4 production);GO:0042100(B cell proliferation);GO:0042102(positive regulation of T cell proliferation);GO:0043066(negative regulation of apoptotic process);GO:0045190(isotype switching);GO:0048305(immunoglobulin secretion);GO:0051023(regulation of immunoglobulin secretion);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:2000353(positive regulation of endothelial cell apoptotic process)","04060(Cytokine-cytokine receptor interaction);04064(NF-kappa B signaling pathway);04514(Cell adhesion molecules (CAMs));04660(T cell receptor signaling pathway);04672(Intestinal immune network for IgA production);05144(Malaria);05145(Toxoplasmosis);05310(Asthma);05320(Autoimmune thyroid disease);05322(Systemic lupus erythematosus);05330(Allograft rejection);05340(Primary immunodeficiency);05416(Viral myocarditis)","K03161","NA","CD40 ligand [Source:NCBI gene;Acc:767628]",{"v":0.093506,"d":"0.09"},{"v":0.061033,"d":"0.06"},{"v":0.080746,"d":"0.08"},{"v":0.080492,"d":"0.08"},{"v":0.073606,"d":"0.07"},0,{"v":1.52685304157095,"d":"1.53"},{"v":0.610561210530521,"d":"0.61"},1,1,"up","no"]
["MSTRG.22274","LRCH2","ENSOART00000018635","GO:0005515(protein binding)","NA","NA","NA","leucine rich repeats and calponin homology domain containing 2 [Source:NCBI gene;Acc:101109945]",{"v":0.24593,"d":"0.25"},{"v":0.213103,"d":"0.21"},{"v":0.221862,"d":"0.22"},{"v":0.484103,"d":"0.48"},{"v":0.312815,"d":"0.31"},{"v":0.447273,"d":"0.45"},{"v":0.547259223061411,"d":"0.55"},{"v":-0.869703731268562,"d":"-0.87"},1,1,"down","no"]
["MSTRG.10410","ENSOARG00000019847","ENSOART00000021609","NA","NA","NA","NA",null,0,0,0,0,{"v":0.041548,"d":"0.04"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000015217","TRPC7","ENSOART00000016564","GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0006828(manganese ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)","NA","K04970","NA","short transient receptor potential channel 7 [Source:NCBI gene;Acc:101106522]",0,0,{"v":0.021792,"d":"0.02"},{"v":0.040944,"d":"0.04"},{"v":0.072895,"d":"0.07"},0,{"v":0.191428245153243,"d":"0.19"},{"v":-2.38512438033978,"d":"-2.39"},1,1,"down","no"]
["MSTRG.754","ENSOARG00000020683","ENSOART00000022535","GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0046982(protein heterodimerization activity)","NA","NA","NA",null,0,{"v":0.821992,"d":"0.82"},{"v":0.693414,"d":"0.69"},{"v":0.6982,"d":"0.70"},0,{"v":0.716533,"d":"0.72"},{"v":1.07116042391038,"d":"1.07"},{"v":0.0991745636062762,"d":"0.10"},1,1,"up","no"]
["MSTRG.14696","RF00554","ENSOART00000025732","NA","NA","NA","NA",null,{"v":0.70915,"d":"0.71"},{"v":0.132556,"d":"0.13"},{"v":0.183352,"d":"0.18"},{"v":0.958583,"d":"0.96"},{"v":0.079036,"d":"0.08"},{"v":0.082147,"d":"0.08"},{"v":0.915421614873108,"d":"0.92"},{"v":-0.127491737729118,"d":"-0.13"},1,1,"down","no"]
["ENSOARG00000012560","SCTR","ENSOART00000013659","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005881(cytoplasmic microtubule);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0015055(secretin receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017046(peptide hormone binding)","04080(Neuroactive ligand-receptor interaction);04972(Pancreatic secretion);04976(Bile secretion)","K04588","NA","secretin receptor [Source:NCBI gene;Acc:101112114]",{"v":0.040631,"d":"0.04"},0,0,{"v":0.061731,"d":"0.06"},0,0,{"v":0.658194424195299,"d":"0.66"},{"v":-0.603414289968497,"d":"-0.60"},1,1,"down","no"]
["ENSOARG00000016008","ENSOARG00000016008","ENSOART00000017429","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation);GO:0019843(rRNA binding)","NA","NA","NA","60S ribosomal protein L9 pseudogene [Source:NCBI gene;Acc:101115015]",{"v":0.112251,"d":"0.11"},{"v":0.061339,"d":"0.06"},{"v":0.156383,"d":"0.16"},{"v":0.10033,"d":"0.10"},{"v":0.233314,"d":"0.23"},{"v":0.240739,"d":"0.24"},{"v":0.574482531690527,"d":"0.57"},{"v":-0.799665069425192,"d":"-0.80"},1,1,"down","no"]
["ENSOARG00000006156","ADAMTS14","ENSOART00000006701","GO:0004222(metalloendopeptidase activity);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0030199(collagen fibril organization)","NA","K08628","EC:3.4.24.-","ADAM metallopeptidase with thrombospondin type 1 motif 14 [Source:NCBI gene;Acc:101106305]",{"v":0.036525,"d":"0.04"},{"v":0.031296,"d":"0.03"},{"v":0.031985,"d":"0.03"},{"v":0.085445,"d":"0.09"},{"v":0.066636,"d":"0.07"},{"v":0.067579,"d":"0.07"},{"v":0.454365838113448,"d":"0.45"},{"v":-1.13807372623545,"d":"-1.14"},1,1,"down","no"]
["ENSOARG00000008679","ENSOARG00000008679","ENSOART00000009447","NA","NA","NA","NA",null,0,{"v":0.099309,"d":"0.10"},{"v":0.048513,"d":"0.05"},{"v":0.021217,"d":"0.02"},{"v":0.055995,"d":"0.06"},{"v":0.224678,"d":"0.22"},{"v":0.489655172413793,"d":"0.49"},{"v":-1.03016197051025,"d":"-1.03"},1,1,"down","no"]
["MSTRG.11751","RF00026","ENSOART00000024901","NA","NA","NA","NA","RNA, U6 small nuclear 715, pseudogene [Source:HGNC Symbol;Acc:HGNC:47678]",0,{"v":0.112162,"d":"0.11"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000011217","SLC37A2","ENSOART00000012198","GO:0015760(glucose-6-phosphate transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0030176(integral component of endoplasmic reticulum membrane);GO:0035435(phosphate ion transmembrane transport);GO:0055085(transmembrane transport);GO:0061513(glucose 6-phosphate:inorganic phosphate antiporter activity)","NA","K13783","NA","solute carrier family 37 member 2 [Source:NCBI gene;Acc:101109494]",{"v":0.117141,"d":"0.12"},{"v":0.221129,"d":"0.22"},{"v":0.199052,"d":"0.20"},{"v":0.48388,"d":"0.48"},{"v":0.3465,"d":"0.35"},{"v":0.312111,"d":"0.31"},{"v":0.470307424741201,"d":"0.47"},{"v":-1.08832398669156,"d":"-1.09"},1,1,"down","no"]
["MSTRG.420","MIR186","ENSOART00000025334","NA","NA","NA","NA","microRNA 186 [Source:HGNC Symbol;Acc:HGNC:31557]",{"v":1.44936,"d":"1.45"},{"v":3.196628,"d":"3.20"},{"v":1.525463,"d":"1.53"},{"v":2.049651,"d":"2.05"},{"v":1.888553,"d":"1.89"},{"v":2.725519,"d":"2.73"},{"v":0.926126581191925,"d":"0.93"},{"v":-0.110718703154172,"d":"-0.11"},1,1,"down","no"]
["ENSOARG00000004025","ENSOARG00000004025","ENSOART00000004372","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus)","NA","NA","NA",null,0,0,{"v":0.236973,"d":"0.24"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.15772","ENSOARG00000024179","ENSOART00000026081","NA","NA","NA","NA",null,{"v":0.120793,"d":"0.12"},{"v":0.065175,"d":"0.07"},{"v":0.041931,"d":"0.04"},{"v":0.743513,"d":"0.74"},{"v":0.23149,"d":"0.23"},{"v":0.821266,"d":"0.82"},{"v":0.126873536201983,"d":"0.13"},{"v":-2.97853691752608,"d":"-2.98"},1,1,"down","no"]
["ENSOARG00000014547","ENSOARG00000014547","ENSOART00000015836","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,0,{"v":0.039416,"d":"0.04"},{"v":0.049776,"d":"0.05"},0,0,{"v":0.791867566698811,"d":"0.79"},{"v":-0.336668923222198,"d":"-0.34"},1,1,"down","no"]
["MSTRG.5260","ENSOARG00000009646","ENSOART00000010501","GO:0016032(viral process);GO:0019068(virion assembly)","NA","NA","NA",null,{"v":0.29395918742586,"d":"0.29"},{"v":0.354338381376038,"d":"0.35"},{"v":0.447054065243179,"d":"0.45"},{"v":0.36758831198102,"d":"0.37"},{"v":0.329789998220641,"d":"0.33"},{"v":0.211119300118624,"d":"0.21"},{"v":1.20567365461635,"d":"1.21"},{"v":0.269839458995895,"d":"0.27"},1,1,"up","no"]
["MSTRG.5603","SBSN","ENSOART00000005269","NA","NA","NA","NA","suprabasin [Source:NCBI gene;Acc:101120596]",{"v":0.362517,"d":"0.36"},{"v":0.260917,"d":"0.26"},{"v":0.499535,"d":"0.50"},{"v":0.02544,"d":"0.03"},{"v":0.167827,"d":"0.17"},{"v":0.165701,"d":"0.17"},{"v":3.12832620177843,"d":"3.13"},{"v":1.64539095546852,"d":"1.65"},1,1,"up","no"]
["MSTRG.3887","ENSOARG00000004829","ENSOART00000005263","NA","NA","NA","NA",null,{"v":1.347642,"d":"1.35"},{"v":0.804047,"d":"0.80"},{"v":0.492581,"d":"0.49"},{"v":1.324122,"d":"1.32"},{"v":0.528443,"d":"0.53"},{"v":1.308435,"d":"1.31"},{"v":0.836529579247074,"d":"0.84"},{"v":-0.257511540782019,"d":"-0.26"},1,1,"down","no"]
["MSTRG.12399","RF00622","ENSOART00000024223","NA","NA","NA","NA",null,{"v":0.27058,"d":"0.27"},{"v":0.198441,"d":"0.20"},{"v":0.940412,"d":"0.94"},{"v":0.510454,"d":"0.51"},{"v":0.184942,"d":"0.18"},0,{"v":2.02680630892326,"d":"2.03"},{"v":1.0192082247162,"d":"1.02"},1,1,"up","no"]
["ENSOARG00000003570","LGI1","ENSOART00000003877","GO:0005102(signaling receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0007411(axon guidance);GO:0016020(membrane);GO:0030307(positive regulation of cell growth);GO:0031175(neuron projection development);GO:0043083(synaptic cleft);GO:0098978(glutamatergic synapse);GO:0099645(neurotransmitter receptor localization to postsynaptic specialization membrane)","NA","NA","NA","leucine rich glioma inactivated 1 [Source:NCBI gene;Acc:101105294]",{"v":0.618963,"d":"0.62"},{"v":0.331357,"d":"0.33"},{"v":0.331148,"d":"0.33"},{"v":0.192602,"d":"0.19"},{"v":0.421172,"d":"0.42"},{"v":0.299596,"d":"0.30"},{"v":1.40301082803245,"d":"1.40"},{"v":0.488526143304525,"d":"0.49"},1,1,"up","no"]
["ENSOARG00000022325","ENSOARG00000022325","ENSOART00000024227","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.099935,"d":"0.10"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000024710","ENSOARG00000024710","ENSOART00000026612","NA","NA","NA","NA",null,{"v":0.037176,"d":"0.04"},{"v":0.049918,"d":"0.05"},{"v":0.040235,"d":"0.04"},{"v":0.364228,"d":"0.36"},0,0,{"v":0.349585973620919,"d":"0.35"},{"v":-1.51628079389752,"d":"-1.52"},1,1,"down","no"]
["ENSOARG00000019673","UPK1B","ENSOART00000021424","GO:0009617(response to bacterium);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0030855(epithelial cell differentiation);GO:0120001(apical plasma membrane urothelial plaque)","NA","K17347","NA","uroplakin 1B [Source:NCBI gene;Acc:101104704]",0,{"v":0.107927,"d":"0.11"},0,{"v":0.022235,"d":"0.02"},0,{"v":0.171836,"d":"0.17"},{"v":0.556121213370364,"d":"0.56"},{"v":-0.846528724764153,"d":"-0.85"},1,1,"down","no"]
["MSTRG.19857","DNAAF4","ENSOART00000022770","GO:0003341(cilium movement);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007368(determination of left/right symmetry);GO:0030331(estrogen receptor binding);GO:0033146(regulation of intracellular estrogen receptor signaling pathway);GO:0036158(outer dynein arm assembly);GO:0036159(inner dynein arm assembly);GO:0061136(regulation of proteasomal protein catabolic process)","NA","K19758","NA","dynein axonemal assembly factor 4 [Source:NCBI gene;Acc:101122030]",{"v":0.118549,"d":"0.12"},{"v":0.254122,"d":"0.25"},{"v":0.115203,"d":"0.12"},{"v":0.148132,"d":"0.15"},{"v":0.145527,"d":"0.15"},{"v":0.104586,"d":"0.10"},{"v":1.22505995053296,"d":"1.23"},{"v":0.292852351856654,"d":"0.29"},1,1,"up","no"]
["MSTRG.10927","CATSPER4","ENSOART00000005639","GO:0001669(acrosomal vesicle);GO:0005216(ion channel activity);GO:0005227(calcium activated cation channel activity);GO:0005245(voltage-gated calcium channel activity);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030317(flagellated sperm motility);GO:0034220(ion transmembrane transport);GO:0036128(CatSper complex);GO:0048240(sperm capacitation);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport);GO:0097228(sperm principal piece)","NA","K16892","NA","cation channel sperm associated 4 [Source:NCBI gene;Acc:101116549]",{"v":0.147157,"d":"0.15"},{"v":0.100938,"d":"0.10"},{"v":0.161118,"d":"0.16"},{"v":0.201497,"d":"0.20"},{"v":0.145946,"d":"0.15"},{"v":0.067215,"d":"0.07"},{"v":0.98686869661263,"d":"0.99"},{"v":-0.0190699487539977,"d":"-0.02"},1,1,"down","no"]
["MSTRG.6976","MIR582","ENSOART00000025019","NA","NA","NA","NA","microRNA 582 [Source:HGNC Symbol;Acc:HGNC:32838]",{"v":0.302471,"d":"0.30"},{"v":0.509829,"d":"0.51"},{"v":0.523541,"d":"0.52"},{"v":0.032799,"d":"0.03"},{"v":0.188515,"d":"0.19"},{"v":0.137549,"d":"0.14"},{"v":3.72242610689873,"d":"3.72"},{"v":1.89624321045443,"d":"1.90"},1,1,"up","no"]
["ENSOARG00000023008","RF00026","ENSOART00000024910","NA","NA","NA","NA",null,0,0,{"v":0.388287,"d":"0.39"},0,{"v":0.089805,"d":"0.09"},{"v":0.282248,"d":"0.28"},{"v":1.04363356833569,"d":"1.04"},{"v":0.0616152541094882,"d":"0.06"},1,1,"up","no"]
["MSTRG.1941","ENSOARG00000015823","ENSOART00000017231","NA","NA","NA","NA",null,0,0,{"v":0.04098,"d":"0.04"},0,{"v":0.028622,"d":"0.03"},0,{"v":1.431765774579,"d":"1.43"},{"v":0.517795498543516,"d":"0.52"},1,1,"up","no"]
["MSTRG.12508","RF00001","ENSOART00000023655","NA","NA","NA","NA",null,0,{"v":0.06396,"d":"0.06"},{"v":0.024618,"d":"0.02"},{"v":0.079867,"d":"0.08"},0,0,{"v":1.10906882692476,"d":"1.11"},{"v":0.149348899477885,"d":"0.15"},1,1,"up","no"]
["MSTRG.14892","FAM84A","ENSOART00000021140","NA","NA","K22805","NA","protein FAM84A [Source:NCBI gene;Acc:101105319]",{"v":0.376686,"d":"0.38"},{"v":0.049463,"d":"0.05"},{"v":0.108697,"d":"0.11"},{"v":0.45085,"d":"0.45"},{"v":0.475996,"d":"0.48"},{"v":0.336641,"d":"0.34"},{"v":0.423309460247711,"d":"0.42"},{"v":-1.2402153640861,"d":"-1.24"},1,1,"down","no"]
["ENSOARG00000022054","RF00026","ENSOART00000023956","NA","NA","NA","NA","RNA, U6 small nuclear 1164, pseudogene [Source:HGNC Symbol;Acc:HGNC:48127]",0,{"v":0.012942,"d":"0.01"},0,{"v":0.044603,"d":"0.04"},0,0,{"v":0.290159854718293,"d":"0.29"},{"v":-1.78508016681714,"d":"-1.79"},1,1,"down","no"]
["MSTRG.4555","ENKUR","ENSOART00000003852","GO:0001669(acrosomal vesicle);GO:0005516(calmodulin binding);GO:0097228(sperm principal piece)","NA","NA","NA","enkurin, TRPC channel interacting protein [Source:NCBI gene;Acc:101105676]",{"v":0.036531,"d":"0.04"},{"v":0.066916,"d":"0.07"},{"v":0.065023,"d":"0.07"},{"v":0.158077,"d":"0.16"},0,{"v":0.062584,"d":"0.06"},{"v":0.763478820453093,"d":"0.76"},{"v":-0.389339958888295,"d":"-0.39"},1,1,"down","no"]
["ENSOARG00000015658","KCNH8","ENSOART00000017041","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA","K04911","NA","potassium voltage-gated channel subfamily H member 8 [Source:NCBI gene;Acc:101120717]",{"v":0.00837,"d":"0.01"},0,0,0,{"v":0.009103,"d":"0.01"},{"v":0.008063,"d":"0.01"},{"v":0.487591751135966,"d":"0.49"},{"v":-1.03625437560663,"d":"-1.04"},1,1,"down","no"]
["MSTRG.16647","ENSOARG00000019524","ENSOART00000021264","NA","NA","NA","NA",null,{"v":0.209197,"d":"0.21"},0,0,0,{"v":0.069384,"d":"0.07"},0,{"v":3.01506110918944,"d":"3.02"},{"v":1.5921872429317,"d":"1.59"},1,1,"up","no"]
["MSTRG.15690","RF00026","ENSOART00000026000","NA","NA","NA","NA",null,{"v":4.573765,"d":"4.57"},{"v":2.464427,"d":"2.46"},{"v":4.661861,"d":"4.66"},{"v":2.909414,"d":"2.91"},{"v":1.550403,"d":"1.55"},{"v":2.350863,"d":"2.35"},{"v":1.71789791915051,"d":"1.72"},{"v":0.780644311266352,"d":"0.78"},1,1,"up","no"]
["ENSOARG00000010481","ENSOARG00000010481","ENSOART00000011408","GO:0005125(cytokine activity);GO:0010469(regulation of signaling receptor activity)","NA","NA","NA",null,{"v":0.167093,"d":"0.17"},0,{"v":0.384835,"d":"0.38"},0,{"v":0.178213,"d":"0.18"},0,{"v":3.09701312474399,"d":"3.10"},{"v":1.63087749698188,"d":"1.63"},1,1,"up","no"]
["ENSOARG00000014461","COL24A1","ENSOART00000015762","GO:0005201(extracellular matrix structural constituent)","04974(Protein digestion and absorption)","K19721","NA","collagen type XXIV alpha 1 chain [Source:NCBI gene;Acc:101114569]",{"v":0.088209,"d":"0.09"},{"v":0.043661,"d":"0.04"},{"v":0.066898,"d":"0.07"},{"v":0.073557,"d":"0.07"},{"v":0.167271,"d":"0.17"},{"v":0.113958,"d":"0.11"},{"v":0.560247585868665,"d":"0.56"},{"v":-0.83586356777429,"d":"-0.84"},1,1,"down","no"]
["ENSOARG00000023012","MIR217","ENSOART00000024914","NA","NA","NA","NA","microRNA 217 [Source:HGNC Symbol;Acc:HGNC:31594]",0,{"v":0.225363,"d":"0.23"},0,0,0,{"v":0.098067,"d":"0.10"},{"v":2.29805133225244,"d":"2.30"},{"v":1.20041102424987,"d":"1.20"},1,1,"up","no"]
["ENSOARG00000005344","CPA1","ENSOART00000005825","GO:0004180(carboxypeptidase activity);GO:0004181(metallocarboxypeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008270(zinc ion binding)","04972(Pancreatic secretion);04974(Protein digestion and absorption)","K08779","EC:3.4.17.1","carboxypeptidase A1 [Source:NCBI gene;Acc:101117326]",0,{"v":0.023284,"d":"0.02"},0,{"v":0.068555,"d":"0.07"},0,0,{"v":0.339639705346072,"d":"0.34"},{"v":-1.55792296886612,"d":"-1.56"},1,1,"down","no"]
["MSTRG.15173","ENSOARG00000021374","ENSOART00000023276","NA","NA","NA","NA",null,{"v":0.020132,"d":"0.02"},{"v":0.040419,"d":"0.04"},0,0,{"v":0.010443,"d":"0.01"},{"v":0.036349,"d":"0.04"},{"v":1.29404599076765,"d":"1.29"},{"v":0.371888892039342,"d":"0.37"},1,1,"up","no"]
["ENSOARG00000010724","ACTL8","ENSOART00000011664","GO:0030855(epithelial cell differentiation)","NA","NA","NA","actin like 8 [Source:NCBI gene;Acc:101106921]",0,0,0,0,{"v":0.064342,"d":"0.06"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000000376","ENSOARG00000000376","ENSOART00000000397","NA","NA","NA","NA",null,0,0,{"v":0.284735,"d":"0.28"},0,{"v":0.118697,"d":"0.12"},{"v":0.184597,"d":"0.18"},{"v":0.938808548800834,"d":"0.94"},{"v":-0.0910971157697663,"d":"-0.09"},1,1,"down","no"]
["ENSOARG00000004602","HCAR1","ENSOART00000005005","GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","04024(cAMP signaling pathway)","K08401","NA","hydroxycarboxylic acid receptor 1 [Source:NCBI gene;Acc:101119758]",{"v":0.07242,"d":"0.07"},{"v":0.206521,"d":"0.21"},{"v":0.072401,"d":"0.07"},{"v":0.219611,"d":"0.22"},{"v":0.035522,"d":"0.04"},{"v":0.21815,"d":"0.22"},{"v":0.742350771103124,"d":"0.74"},{"v":-0.429827053387739,"d":"-0.43"},1,1,"down","no"]
["ENSOARG00000015839","TMC3","ENSOART00000017256","GO:0005887(integral component of plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K21988","NA","transmembrane channel like 3 [Source:NCBI gene;Acc:101117450]",{"v":0.009553,"d":"0.01"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000024161","RF00026","ENSOART00000026063","NA","NA","NA","NA","RNA, U6 small nuclear 1263, pseudogene [Source:HGNC Symbol;Acc:HGNC:48226]",0,0,0,0,{"v":0.037154,"d":"0.04"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.16086","STAB2","ENSOART00000017435","GO:0005041(low-density lipoprotein particle receptor activity);GO:0005044(scavenger receptor activity);GO:0005509(calcium ion binding);GO:0005540(hyaluronic acid binding);GO:0005829(cytosol);GO:0005887(integral component of plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030169(low-density lipoprotein particle binding);GO:0042742(defense response to bacterium);GO:0050830(defense response to Gram-positive bacterium)","NA","K19013","NA","stabilin 2 [Source:NCBI gene;Acc:101111181]",{"v":0.002525,"d":"0.00"},{"v":0.027575,"d":"0.03"},{"v":0.031164,"d":"0.03"},{"v":0.001395,"d":"0.00"},{"v":0.017063,"d":"0.02"},0,{"v":3.31910282804204,"d":"3.32"},{"v":1.73079332577304,"d":"1.73"},1,1,"up","no"]
["ENSOARG00000014548","ENSOARG00000014548","ENSOART00000015845","GO:0004866(endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0010951(negative regulation of endopeptidase activity)","NA","NA","NA",null,0,0,{"v":0.013906,"d":"0.01"},{"v":0.038599,"d":"0.04"},{"v":0.02424,"d":"0.02"},{"v":0.013162,"d":"0.01"},{"v":0.182971276693728,"d":"0.18"},{"v":-2.45031090661818,"d":"-2.45"},1,1,"down","no"]
["ENSOARG00000010993","ISM1","ENSOART00000011961","NA","NA","NA","NA","isthmin 1 [Source:NCBI gene;Acc:101105349]",{"v":0.186324,"d":"0.19"},{"v":0.435849,"d":"0.44"},{"v":0.221061,"d":"0.22"},{"v":0.175226,"d":"0.18"},{"v":0.171838,"d":"0.17"},{"v":0.411044,"d":"0.41"},{"v":1.11228743134224,"d":"1.11"},{"v":0.15352964974153,"d":"0.15"},1,1,"up","no"]
["MSTRG.9873","MLANA","ENSOART00000014776","GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042470(melanosome)","NA","K17303","NA","melan-A [Source:NCBI gene;Acc:101116206]",{"v":0.713765,"d":"0.71"},{"v":0.852057,"d":"0.85"},{"v":0.347023,"d":"0.35"},{"v":0.101783,"d":"0.10"},{"v":0.577592,"d":"0.58"},{"v":0.308471,"d":"0.31"},{"v":1.93637975959816,"d":"1.94"},{"v":0.953361919327943,"d":"0.95"},1,1,"up","no"]
["ENSOARG00000023713","RF00415","ENSOART00000025615","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 37 [Source:HGNC Symbol;Acc:HGNC:32630]",{"v":0.428255,"d":"0.43"},{"v":0.032928,"d":"0.03"},0,0,0,{"v":0.057838,"d":"0.06"},{"v":7.97370241018016,"d":"7.97"},{"v":2.99524976292631,"d":"3.00"},1,1,"up","no"]
["ENSOARG00000001315","ENSOARG00000001315","ENSOART00000001433","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K08206","NA","solute carrier family 22 member 10-like [Source:NCBI gene;Acc:101118571]",{"v":0.01305,"d":"0.01"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000008387","ENSOARG00000008387","ENSOART00000009125","NA","NA","NA","NA",null,0,0,0,{"v":0.129786,"d":"0.13"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000004359","SKA1","ENSOART00000004742","GO:0000278(mitotic cell cycle);GO:0000940(condensed chromosome outer kinetochore);GO:0005876(spindle microtubule);GO:0007059(chromosome segregation);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0031110(regulation of microtubule polymerization or depolymerization);GO:0051301(cell division)","NA","NA","NA","spindle and kinetochore associated complex subunit 1 [Source:NCBI gene;Acc:101117037]",{"v":0.047036,"d":"0.05"},0,0,{"v":0.046825,"d":"0.05"},0,{"v":0.095592,"d":"0.10"},{"v":0.33026956051595,"d":"0.33"},{"v":-1.59828408595525,"d":"-1.60"},1,1,"down","no"]
["MSTRG.36","ANKMY1","ENSOART00000020079","GO:0005515(protein binding)","NA","NA","NA","ankyrin repeat and MYND domain containing 1 [Source:NCBI gene;Acc:101104451]",{"v":0.047944,"d":"0.05"},{"v":0.081039,"d":"0.08"},{"v":0.05377,"d":"0.05"},{"v":0.069617,"d":"0.07"},{"v":0.033238,"d":"0.03"},{"v":0.024734,"d":"0.02"},{"v":1.43235702137332,"d":"1.43"},{"v":0.51839113559611,"d":"0.52"},1,1,"up","no"]
["ENSOARG00000005859","SLC25A22","ENSOART00000006380","GO:0005313(L-glutamate transmembrane transporter activity);GO:0005743(mitochondrial inner membrane);GO:0015813(L-glutamate transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K15107","NA","solute carrier family 25 member 22 [Source:NCBI gene;Acc:101103435]",{"v":0.42105,"d":"0.42"},{"v":0.357417,"d":"0.36"},{"v":0.356106,"d":"0.36"},{"v":0.305997,"d":"0.31"},{"v":0.50059,"d":"0.50"},{"v":0.595104,"d":"0.60"},{"v":0.809431607964951,"d":"0.81"},{"v":-0.305018908143514,"d":"-0.31"},1,1,"down","no"]
["ENSOARG00000019713","TMEM37","ENSOART00000021469","GO:0005244(voltage-gated ion channel activity);GO:0005262(calcium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034220(ion transmembrane transport);GO:0070588(calcium ion transmembrane transport)","NA","NA","NA","transmembrane protein 37 [Source:HGNC Symbol;Acc:HGNC:18216]",{"v":0.056927,"d":"0.06"},0,{"v":0.038345,"d":"0.04"},{"v":0.029542,"d":"0.03"},0,0,{"v":3.22496784239388,"d":"3.22"},{"v":1.68928477484591,"d":"1.69"},1,1,"up","no"]
["MSTRG.17424","ENSOARG00000001356","ENSOART00000001453","GO:0005525(GTP binding)","NA","NA","NA","GTPase IMAP family member 6 [Source:NCBI gene;Acc:101110230]",{"v":0.340681,"d":"0.34"},{"v":0.094906,"d":"0.09"},{"v":0.064651,"d":"0.06"},{"v":0.299206,"d":"0.30"},{"v":0.069763,"d":"0.07"},{"v":0.066077,"d":"0.07"},{"v":1.14985082037302,"d":"1.15"},{"v":0.201446700588239,"d":"0.20"},1,1,"up","no"]
["MSTRG.372","ENSOARG00000010031","ENSOART00000010911","NA","NA","NA","NA",null,{"v":0.280864,"d":"0.28"},{"v":0.240917,"d":"0.24"},{"v":0.097921,"d":"0.10"},{"v":0.22492,"d":"0.22"},{"v":0.290369,"d":"0.29"},0,{"v":1.20262998045757,"d":"1.20"},{"v":0.266192829153295,"d":"0.27"},1,1,"up","no"]
["MSTRG.13405","ENSOARG00000021288","ENSOART00000023190","NA","NA","NA","NA",null,{"v":0.110199,"d":"0.11"},{"v":0.142408,"d":"0.14"},{"v":0.066939,"d":"0.07"},0,0,{"v":0.66585,"d":"0.67"},{"v":0.479906885935271,"d":"0.48"},{"v":-1.05917358120105,"d":"-1.06"},1,1,"down","no"]
["MSTRG.8904","ENSOARG00000022792","ENSOART00000024694","NA","NA","NA","NA",null,{"v":0.086273,"d":"0.09"},0,{"v":0.044177,"d":"0.04"},{"v":0.093909,"d":"0.09"},0,0,{"v":1.38911073486034,"d":"1.39"},{"v":0.474161610310013,"d":"0.47"},1,1,"up","no"]
["ENSOARG00000017535","ENSOARG00000017535","ENSOART00000019087","GO:0003676(nucleic acid binding)","NA","NA","NA",null,{"v":0.087763,"d":"0.09"},{"v":0.079572,"d":"0.08"},{"v":0.049802,"d":"0.05"},{"v":0.044734,"d":"0.04"},{"v":0.06286,"d":"0.06"},0,{"v":2.01811439299589,"d":"2.02"},{"v":1.0130079532007,"d":"1.01"},1,1,"up","no"]
["ENSOARG00000004669","SLC22A1","ENSOART00000005087","GO:0005215(transporter activity);GO:0006812(cation transport);GO:0015101(organic cation transmembrane transporter activity);GO:0015695(organic cation transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","04976(Bile secretion);05231(Choline metabolism in cancer)","K08198","NA","solute carrier family 22 member 1 [Source:NCBI gene;Acc:101112740]",{"v":0.242039,"d":"0.24"},0,0,0,{"v":0.044762,"d":"0.04"},0,{"v":5.40724275054734,"d":"5.41"},{"v":2.43489312563565,"d":"2.43"},1,1,"up","no"]
["MSTRG.13793","AMZ1","ENSOART00000004901","GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding)","NA","K06974","EC:3.4.-.-","archaelysin family metallopeptidase 1 [Source:NCBI gene;Acc:101111338]",{"v":0.034839,"d":"0.03"},{"v":0.047458,"d":"0.05"},{"v":0.111815,"d":"0.11"},{"v":0.069344,"d":"0.07"},{"v":0.019804,"d":"0.02"},{"v":0.038268,"d":"0.04"},{"v":1.52345074401959,"d":"1.52"},{"v":0.607342855779283,"d":"0.61"},1,1,"up","no"]
["ENSOARG00000019854","GPR156","ENSOART00000021618","GO:0004930(G protein-coupled receptor activity);GO:0004965(G protein-coupled GABA receptor activity);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction)","K04617","NA","G protein-coupled receptor 156 [Source:NCBI gene;Acc:101107652]",{"v":0.164236,"d":"0.16"},{"v":0.11382,"d":"0.11"},{"v":0.109577,"d":"0.11"},{"v":0.10095,"d":"0.10"},{"v":0.184739,"d":"0.18"},{"v":0.095978,"d":"0.10"},{"v":1.01563142739613,"d":"1.02"},{"v":0.0223769431140531,"d":"0.02"},1,1,"up","no"]
["MSTRG.9468","PLPPR1","ENSOART00000008243","GO:0005654(nucleoplasm);GO:0007399(nervous system development);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K19581","NA","phospholipid phosphatase related 1 [Source:NCBI gene;Acc:101122409]",{"v":0.03230975,"d":"0.03"},{"v":0.095700875,"d":"0.10"},{"v":0.01657240625,"d":"0.02"},{"v":0.0882201875,"d":"0.09"},{"v":0.23686325,"d":"0.24"},{"v":0.1311009375,"d":"0.13"},{"v":0.316939902314717,"d":"0.32"},{"v":-1.6577187903341,"d":"-1.66"},1,1,"down","no"]
["ENSOARG00000017923","ENSOARG00000017923","ENSOART00000019503","NA","NA","NA","NA",null,0,{"v":0.074972,"d":"0.07"},0,0,{"v":0.076325,"d":"0.08"},{"v":0.148813,"d":"0.15"},{"v":0.333004646039318,"d":"0.33"},{"v":-1.58638578914901,"d":"-1.59"},1,1,"down","no"]
["ENSOARG00000021729","RF00026","ENSOART00000023631","NA","NA","NA","NA","RNA, U6 small nuclear 625, pseudogene [Source:HGNC Symbol;Acc:HGNC:47588]",0,0,0,{"v":0.02354,"d":"0.02"},{"v":0.10403,"d":"0.10"},{"v":0.145484,"d":"0.15"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000020966","SCG3","ENSOART00000022841","GO:0030667(secretory granule membrane);GO:0033366(protein localization to secretory granule)","NA","NA","NA","secretogranin III [Source:NCBI gene;Acc:101104667]",{"v":0.113668,"d":"0.11"},{"v":0.018477,"d":"0.02"},{"v":0.158368,"d":"0.16"},{"v":0.174118,"d":"0.17"},{"v":0.136625,"d":"0.14"},{"v":0.108402,"d":"0.11"},{"v":0.693108590106049,"d":"0.69"},{"v":-0.528846696154588,"d":"-0.53"},1,1,"down","no"]
["MSTRG.21916","ENSOARG00000018305","ENSOART00000019920","GO:0003676(nucleic acid binding);GO:0003964(RNA-directed DNA polymerase activity);GO:0004523(RNA-DNA hybrid ribonuclease activity);GO:0006278(RNA-dependent DNA biosynthetic process);GO:0090502(RNA phosphodiester bond hydrolysis, endonucleolytic)","NA","NA","NA",null,{"v":0.01997,"d":"0.02"},0,{"v":0.000353,"d":"0.00"},{"v":0.008827,"d":"0.01"},0,{"v":0.009705,"d":"0.01"},{"v":1.09664364342758,"d":"1.10"},{"v":0.133094795219743,"d":"0.13"},1,1,"up","no"]
["ENSOARG00000009422","ENSOARG00000009422","ENSOART00000010255","GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity)","NA","NA","NA",null,0,{"v":0.166166,"d":"0.17"},0,0,{"v":0.198062,"d":"0.20"},{"v":0.256064,"d":"0.26"},{"v":0.365902855154737,"d":"0.37"},{"v":-1.45046742175885,"d":"-1.45"},1,1,"down","no"]
["ENSOARG00000001196","ENSOARG00000001196","ENSOART00000001289","NA","NA","NA","NA","radial spoke head 10 homolog B [Source:NCBI gene;Acc:101115338]",{"v":0.038383,"d":"0.04"},{"v":0.058659,"d":"0.06"},{"v":0.106014,"d":"0.11"},{"v":0.004927,"d":"0.00"},{"v":0.041714,"d":"0.04"},{"v":0.065419,"d":"0.07"},{"v":1.81202927003391,"d":"1.81"},{"v":0.857606259684209,"d":"0.86"},1,1,"up","no"]
["MSTRG.2625","ENSOARG00000023319","ENSOART00000025221","NA","NA","NA","NA",null,{"v":0.139454,"d":"0.14"},{"v":0.233544,"d":"0.23"},{"v":0.266933,"d":"0.27"},0,0,{"v":0.595888,"d":"0.60"},{"v":1.0739115404237,"d":"1.07"},{"v":0.102875161435036,"d":"0.10"},1,1,"up","no"]
["MSTRG.8500","RF00181","ENSOART00000026187","NA","NA","NA","NA",null,{"v":0.347615,"d":"0.35"},{"v":0.66101,"d":"0.66"},{"v":0.08142,"d":"0.08"},0,{"v":0.386397,"d":"0.39"},{"v":0.126086,"d":"0.13"},{"v":2.12698762690665,"d":"2.13"},{"v":1.08881164089034,"d":"1.09"},1,1,"up","no"]
["ENSOARG00000014794","CLCA4","ENSOART00000016106","GO:0005229(intracellular calcium activated chloride channel activity);GO:0006821(chloride transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034220(ion transmembrane transport)","04924(Renin secretion);04972(Pancreatic secretion)","K05030","NA","chloride channel accessory 4 [Source:NCBI gene;Acc:101115586]",0,0,0,{"v":0.011639,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000007253","ENSOARG00000007253","ENSOART00000007888","NA","NA","NA","NA",null,{"v":0.788192,"d":"0.79"},{"v":0.426451,"d":"0.43"},{"v":0.232086,"d":"0.23"},{"v":0.696881,"d":"0.70"},{"v":0.743648,"d":"0.74"},{"v":0.576587,"d":"0.58"},{"v":0.717226475819933,"d":"0.72"},{"v":-0.479499349808353,"d":"-0.48"},1,1,"down","no"]
["MSTRG.3555","AFMID","ENSOART00000005953","GO:0004061(arylformamidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006569(tryptophan catabolic process);GO:0016787(hydrolase activity);GO:0019441(tryptophan catabolic process to kynurenine);GO:0034354('de novo' NAD biosynthetic process from tryptophan)","00380(Tryptophan metabolism);00630(Glyoxylate and dicarboxylate metabolism)","K01432","EC:3.5.1.9","arylformamidase [Source:NCBI gene;Acc:101123646]",{"v":0.090045,"d":"0.09"},{"v":0.112211,"d":"0.11"},{"v":0.344867,"d":"0.34"},{"v":0.697694,"d":"0.70"},{"v":0.225774,"d":"0.23"},{"v":0.468272,"d":"0.47"},{"v":0.393121560061506,"d":"0.39"},{"v":-1.34695260687997,"d":"-1.35"},1,1,"down","no"]
["ENSOARG00000000855","SH3RF3","ENSOART00000000916","GO:0005515(protein binding);GO:0046330(positive regulation of JNK cascade);GO:0051865(protein autoubiquitination);GO:0061630(ubiquitin protein ligase activity)","NA","NA","NA","SH3 domain containing ring finger 3 [Source:HGNC Symbol;Acc:HGNC:24699]",{"v":0.291865,"d":"0.29"},{"v":0.224117,"d":"0.22"},{"v":0.396479,"d":"0.40"},{"v":0.221638,"d":"0.22"},{"v":0.393719,"d":"0.39"},{"v":0.559651,"d":"0.56"},{"v":0.776557265993083,"d":"0.78"},{"v":-0.364835777077216,"d":"-0.36"},1,1,"down","no"]
["MSTRG.20366","ENSOARG00000021813","ENSOART00000023715","NA","NA","NA","NA",null,{"v":0.048369,"d":"0.05"},0,0,0,0,{"v":0.201411,"d":"0.20"},{"v":0.240150736553614,"d":"0.24"},{"v":-2.05798786149164,"d":"-2.06"},1,1,"down","no"]
["MSTRG.16223","RF00026","ENSOART00000024676","NA","NA","NA","NA",null,{"v":0.255258,"d":"0.26"},0,0,0,0,{"v":0.095449,"d":"0.10"},{"v":2.67428679189934,"d":"2.67"},{"v":1.41915418909043,"d":"1.42"},1,1,"up","no"]
["ENSOARG00000012134","B4GALNT3","ENSOART00000013204","GO:0005794(Golgi apparatus);GO:0008376(acetylgalactosaminyltransferase activity);GO:0016740(transferase activity);GO:0032580(Golgi cisterna membrane);GO:0033842(N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity)","NA","K09656","EC:2.4.1.244","beta-1,4-N-acetyl-galactosaminyltransferase 3 [Source:NCBI gene;Acc:101115274]",{"v":0.056218,"d":"0.06"},{"v":0.134976,"d":"0.13"},{"v":0.150713,"d":"0.15"},{"v":0.222425,"d":"0.22"},{"v":0.187769,"d":"0.19"},{"v":0.118961,"d":"0.12"},{"v":0.646137710122743,"d":"0.65"},{"v":-0.630086418299155,"d":"-0.63"},1,1,"down","no"]
["ENSOARG00000020433","ATP13A4","ENSOART00000022255","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0006812(cation transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0016887(ATPase activity);GO:0046872(metal ion binding)","NA","K14951","EC:7.2.2.-","ATPase 13A4 [Source:NCBI gene;Acc:101107059]",0,{"v":0.00802936885245902,"d":"0.01"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000011078","ENSOARG00000011078","ENSOART00000012049","NA","NA","NA","NA",null,0,0,{"v":0.030798,"d":"0.03"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000024809","RF00026","ENSOART00000026711","NA","NA","NA","NA",null,{"v":0.215434,"d":"0.22"},{"v":0.183638,"d":"0.18"},{"v":0.570687,"d":"0.57"},{"v":0.088428,"d":"0.09"},{"v":0.185622,"d":"0.19"},{"v":0.268243,"d":"0.27"},{"v":1.78825653290749,"d":"1.79"},{"v":0.838553712027985,"d":"0.84"},1,1,"up","no"]
["MSTRG.10031","RF00026","ENSOART00000025995","NA","NA","NA","NA","RNA, U6 small nuclear 143, pseudogene [Source:HGNC Symbol;Acc:HGNC:47106]",{"v":0.272403,"d":"0.27"},{"v":0.555367,"d":"0.56"},{"v":0.12291,"d":"0.12"},{"v":1.03207,"d":"1.03"},{"v":0.042516,"d":"0.04"},{"v":1.08214,"d":"1.08"},{"v":0.440797764760104,"d":"0.44"},{"v":-1.18181118671715,"d":"-1.18"},1,1,"down","no"]
["ENSOARG00000004452","CHST8","ENSOART00000004845","GO:0000139(Golgi membrane);GO:0001537(N-acetylgalactosamine 4-O-sulfotransferase activity);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0006790(sulfur compound metabolic process);GO:0008146(sulfotransferase activity);GO:0016021(integral component of membrane);GO:0016051(carbohydrate biosynthetic process);GO:0016740(transferase activity);GO:0030166(proteoglycan biosynthetic process);GO:0042446(hormone biosynthetic process)","NA","NA","NA","carbohydrate sulfotransferase 8 [Source:HGNC Symbol;Acc:HGNC:15993]",0,0,0,{"v":0.101141,"d":"0.10"},0,{"v":0.105718,"d":"0.11"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000007632","PBX4","ENSOART00000008311","GO:0001741(XY body);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding)","NA","NA","NA","PBX homeobox 4 [Source:HGNC Symbol;Acc:HGNC:13403]",{"v":0.133651,"d":"0.13"},0,0,{"v":0.013194,"d":"0.01"},0,0,{"v":10.1296801576474,"d":"10.13"},{"v":3.34051671697698,"d":"3.34"},1,1,"up","no"]
["MSTRG.8504","RF00181","ENSOART00000024561","NA","NA","NA","NA",null,{"v":0.031727,"d":"0.03"},{"v":0.362658,"d":"0.36"},{"v":0.584824,"d":"0.58"},{"v":0.607038,"d":"0.61"},{"v":0.875833,"d":"0.88"},{"v":0.560033,"d":"0.56"},{"v":0.479322082682299,"d":"0.48"},{"v":-1.06093268749389,"d":"-1.06"},1,1,"down","no"]
["ENSOARG00000002708","ENSOARG00000002708","ENSOART00000002931","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0055114(oxidation-reduction process)","NA","NA","NA",null,0,{"v":0.027892,"d":"0.03"},0,{"v":0.064085,"d":"0.06"},0,0,{"v":0.435234454240462,"d":"0.44"},{"v":-1.20013532645551,"d":"-1.20"},1,1,"down","no"]
["ENSOARG00000014023","CCR8","ENSOART00000015269","GO:0004930(G protein-coupled receptor activity);GO:0004950(chemokine receptor activity);GO:0005623(cell);GO:0006935(chemotaxis);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016493(C-C chemokine receptor activity);GO:0070098(chemokine-mediated signaling pathway)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);05167(Kaposi sarcoma-associated herpesvirus infection);05203(Viral carcinogenesis)","K04183","NA","C-C motif chemokine receptor 8 [Source:NCBI gene;Acc:101113281]",{"v":0.641257,"d":"0.64"},{"v":0.342338,"d":"0.34"},{"v":0.312222,"d":"0.31"},{"v":0.275942,"d":"0.28"},{"v":0.014473,"d":"0.01"},{"v":0.151089,"d":"0.15"},{"v":2.93500625135899,"d":"2.94"},{"v":1.5533635761786,"d":"1.55"},1,1,"up","no"]
["MSTRG.3862","RF00478","ENSOART00000026328","NA","NA","NA","NA",null,{"v":2.630622,"d":"2.63"},{"v":1.768207,"d":"1.77"},{"v":1.650231,"d":"1.65"},{"v":2.647394,"d":"2.65"},{"v":2.677552,"d":"2.68"},{"v":9.647926,"d":"9.65"},{"v":0.404001316514293,"d":"0.40"},{"v":-1.30756810060943,"d":"-1.31"},1,1,"down","no"]
["ENSOARG00000016773","ENSOARG00000016773","ENSOART00000018265","GO:0005198(structural molecule activity);GO:0005882(intermediate filament)","04915(Estrogen signaling pathway)","K07604","NA","keratin 18 [Source:NCBI gene;Acc:101108117]",{"v":0.454842,"d":"0.45"},{"v":0.394256,"d":"0.39"},{"v":0.130974,"d":"0.13"},{"v":0.230083,"d":"0.23"},{"v":0.082283,"d":"0.08"},{"v":0.082334,"d":"0.08"},{"v":2.48308082087661,"d":"2.48"},{"v":1.31213122002474,"d":"1.31"},1,1,"up","no"]
["MSTRG.14135","ENSOARG00000021280","ENSOART00000023182","NA","NA","NA","NA",null,{"v":0.372445,"d":"0.37"},{"v":0.002804,"d":"0.00"},{"v":0.124115,"d":"0.12"},{"v":0.674864,"d":"0.67"},{"v":0.330048,"d":"0.33"},{"v":0.126086,"d":"0.13"},{"v":0.441525095535094,"d":"0.44"},{"v":-1.17943265435204,"d":"-1.18"},1,1,"down","no"]
["MSTRG.21407","ENSOARG00000017796","ENSOART00000019361","NA","NA","NA","NA",null,0,{"v":0.003284,"d":"0.00"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000015172","FCHO1","ENSOART00000016517","GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0072583(clathrin-dependent endocytosis)","NA","K20042","NA","FCH domain only 1 [Source:NCBI gene;Acc:101110837]",{"v":0.085002,"d":"0.09"},{"v":0.020772,"d":"0.02"},{"v":0.060021,"d":"0.06"},{"v":0.019271,"d":"0.02"},{"v":0.005313,"d":"0.01"},{"v":0.104785,"d":"0.10"},{"v":1.28156668135334,"d":"1.28"},{"v":0.357908545625213,"d":"0.36"},1,1,"up","no"]
["ENSOARG00000012339","OR5AU1","ENSOART00000013415","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","NA","NA","NA","olfactory receptor family 5 subfamily AU member 1 [Source:HGNC Symbol;Acc:HGNC:15362]",0,{"v":0.135605,"d":"0.14"},0,{"v":0.023616,"d":"0.02"},0,0,{"v":5.7420816395664,"d":"5.74"},{"v":2.52157384258973,"d":"2.52"},1,1,"up","no"]
["ENSOARG00000019067","WNT2","ENSOART00000020761","GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0005102(signaling receptor binding);GO:0005109(frizzled binding);GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0007267(cell-cell signaling);GO:0007275(multicellular organism development);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0016055(Wnt signaling pathway);GO:0031232(extrinsic component of external side of plasma membrane);GO:0033278(cell proliferation in midbrain);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048018(receptor ligand activity);GO:0048146(positive regulation of fibroblast proliferation);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0055009(atrial cardiac muscle tissue morphogenesis);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060070(canonical Wnt signaling pathway);GO:0060317(cardiac epithelial to mesenchymal transition);GO:0060492(lung induction);GO:0060501(positive regulation of epithelial cell proliferation involved in lung morphogenesis);GO:0060716(labyrinthine layer blood vessel development);GO:0061180(mammary gland epithelium development);GO:0062023(collagen-containing extracellular matrix);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:1904948(midbrain dopaminergic neuron differentiation);GO:1904954(canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation)","04150(mTOR signaling pathway);04310(Wnt signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);04934(Cushing syndrome);05165(Human papillomavirus infection);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K00182","NA","Wnt family member 2 [Source:NCBI gene;Acc:100126577]",{"v":0.027676,"d":"0.03"},{"v":0.100015,"d":"0.10"},{"v":0.174222,"d":"0.17"},{"v":0.051068,"d":"0.05"},{"v":0.061678,"d":"0.06"},{"v":0.084146,"d":"0.08"},{"v":1.53339394185645,"d":"1.53"},{"v":0.616728385157834,"d":"0.62"},1,1,"up","no"]
["MSTRG.9809","TRPM3","ENSOART00000013983","GO:0005216(ion channel activity);GO:0005227(calcium activated cation channel activity);GO:0005261(cation channel activity);GO:0006811(ion transport);GO:0006812(cation transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016048(detection of temperature stimulus);GO:0034220(ion transmembrane transport);GO:0050951(sensory perception of temperature stimulus);GO:0051262(protein tetramerization);GO:0055085(transmembrane transport);GO:0098655(cation transmembrane transport)","NA","K04978","NA","transient receptor potential cation channel subfamily M member 3 [Source:NCBI gene;Acc:101103123]",{"v":0.088019,"d":"0.09"},{"v":0.107148,"d":"0.11"},{"v":0.220031,"d":"0.22"},{"v":0.087661,"d":"0.09"},{"v":0.167563,"d":"0.17"},{"v":0.146591,"d":"0.15"},{"v":1.03330637233553,"d":"1.03"},{"v":0.0472680725151914,"d":"0.05"},1,1,"up","no"]
["MSTRG.16398","CD27","ENSOART00000009063","GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045579(positive regulation of B cell differentiation);GO:0045582(positive regulation of T cell differentiation);GO:0046330(positive regulation of JNK cascade);GO:0070233(negative regulation of T cell apoptotic process);GO:0097191(extrinsic apoptotic signaling pathway)","04060(Cytokine-cytokine receptor interaction)","K05144","NA","CD27 molecule [Source:NCBI gene;Acc:101114260]",{"v":0.174237,"d":"0.17"},{"v":0.085773,"d":"0.09"},{"v":0.162584,"d":"0.16"},{"v":0.318358,"d":"0.32"},0,{"v":0.325975,"d":"0.33"},{"v":0.655862729365095,"d":"0.66"},{"v":-0.608534201366298,"d":"-0.61"},1,1,"down","no"]
["MSTRG.8001","RF00108","ENSOART00000023850","NA","NA","NA","NA",null,{"v":2.293407,"d":"2.29"},{"v":3.095561,"d":"3.10"},{"v":1.147732,"d":"1.15"},{"v":3.369558,"d":"3.37"},{"v":3.561593,"d":"3.56"},{"v":1.200532,"d":"1.20"},{"v":0.803855733185861,"d":"0.80"},{"v":-0.314991488623545,"d":"-0.31"},1,1,"down","no"]
["ENSOARG00000024923","ENSOARG00000024923","ENSOART00000026825","NA","NA","NA","NA",null,0,0,{"v":0.12551,"d":"0.13"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.3706","ENSOARG00000001628","ENSOART00000001749","NA","NA","NA","NA",null,{"v":1.462201,"d":"1.46"},{"v":0.160522,"d":"0.16"},{"v":0.571059,"d":"0.57"},{"v":0.722498,"d":"0.72"},{"v":0.722884,"d":"0.72"},{"v":0.495863,"d":"0.50"},{"v":1.13009022560264,"d":"1.13"},{"v":0.176437960988332,"d":"0.18"},1,1,"up","no"]
["MSTRG.5717","ENSOARG00000007062","ENSOART00000007685","GO:0005506(iron ion binding);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0055114(oxidation-reduction process)","NA","NA","NA",null,{"v":0.359693,"d":"0.36"},{"v":0.16868,"d":"0.17"},{"v":0.340448,"d":"0.34"},{"v":0.415095,"d":"0.42"},{"v":0.34069,"d":"0.34"},{"v":0.519293,"d":"0.52"},{"v":0.681386550469854,"d":"0.68"},{"v":-0.553454623769425,"d":"-0.55"},1,1,"down","no"]
["MSTRG.683","RF00019","ENSOART00000023663","NA","NA","NA","NA","RNY4 pseudogene 13 [Source:HGNC Symbol;Acc:HGNC:34063]",0,0,0,{"v":0.008053,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000009907","ENSOARG00000009907","ENSOART00000010779","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,0,0,{"v":0.101595,"d":"0.10"},{"v":0.061661,"d":"0.06"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.13168","WFIKKN1","ENSOART00000013662","GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0010951(negative regulation of endopeptidase activity);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0048019(receptor antagonist activity);GO:0050431(transforming growth factor beta binding);GO:2000272(negative regulation of signaling receptor activity)","NA","NA","NA","WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 [Source:NCBI gene;Acc:101102865]",0,{"v":0.104955,"d":"0.10"},{"v":0.041038,"d":"0.04"},{"v":0.038482,"d":"0.04"},{"v":0.14564,"d":"0.15"},{"v":0.078854,"d":"0.08"},{"v":0.555157124604527,"d":"0.56"},{"v":-0.849031943593977,"d":"-0.85"},1,1,"down","no"]
["ENSOARG00000003477","FRA10AC1","ENSOART00000003779","NA","NA","K13121","NA","fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 [Source:NCBI gene;Acc:101105041]",{"v":0.653852,"d":"0.65"},{"v":0.575294,"d":"0.58"},{"v":0.582888,"d":"0.58"},{"v":0.536987,"d":"0.54"},{"v":0.612529,"d":"0.61"},{"v":0.549174,"d":"0.55"},{"v":1.06672435818189,"d":"1.07"},{"v":0.093187431590405,"d":"0.09"},1,1,"up","no"]
["ENSOARG00000002233","APOA5","ENSOART00000002410","GO:0005543(phospholipid binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006641(triglyceride metabolic process);GO:0006869(lipid transport);GO:0008047(enzyme activator activity);GO:0008201(heparin binding);GO:0008289(lipid binding);GO:0010898(positive regulation of triglyceride catabolic process);GO:0010902(positive regulation of very-low-density lipoprotein particle remodeling);GO:0019433(triglyceride catabolic process);GO:0019899(enzyme binding);GO:0031210(phosphatidylcholine binding);GO:0034361(very-low-density lipoprotein particle);GO:0034364(high-density lipoprotein particle);GO:0034370(triglyceride-rich lipoprotein particle remodeling);GO:0035473(lipase binding);GO:0042157(lipoprotein metabolic process);GO:0042246(tissue regeneration);GO:0042627(chylomicron);GO:0042632(cholesterol homeostasis);GO:0045723(positive regulation of fatty acid biosynthetic process);GO:0050750(low-density lipoprotein particle receptor binding);GO:0050996(positive regulation of lipid catabolic process);GO:0051006(positive regulation of lipoprotein lipase activity);GO:0055090(acylglycerol homeostasis);GO:0060229(lipase activator activity);GO:0060230(lipoprotein lipase activator activity);GO:0070325(lipoprotein particle receptor binding);GO:0070328(triglyceride homeostasis)","NA","NA","NA","apolipoprotein A5 [Source:HGNC Symbol;Acc:HGNC:17288]",{"v":0.034851,"d":"0.03"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000017615","TOX3","ENSOART00000019167","GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0034056(estrogen response element binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051219(phosphoprotein binding)","NA","NA","NA","TOX high mobility group box family member 3 [Source:NCBI gene;Acc:101117611]",{"v":0.038896,"d":"0.04"},0,0,{"v":0.13628,"d":"0.14"},0,0,{"v":0.285412386263575,"d":"0.29"},{"v":-1.80888014895498,"d":"-1.81"},1,1,"down","no"]
["MSTRG.16288","ENSOARG00000020236","ENSOART00000022034","GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030173(integral component of Golgi membrane)","NA","NA","NA",null,{"v":1.040882,"d":"1.04"},{"v":0.389717,"d":"0.39"},{"v":1.287783,"d":"1.29"},{"v":1.904758,"d":"1.90"},{"v":1.061682,"d":"1.06"},{"v":1.433966,"d":"1.43"},{"v":0.617757088777717,"d":"0.62"},{"v":-0.694888434277404,"d":"-0.69"},1,1,"down","no"]
["MSTRG.10013","SCRG1","ENSOART00000016713","GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0044306(neuron projection terminus);GO:0097168(mesenchymal stem cell proliferation)","NA","NA","NA","stimulator of chondrogenesis 1 [Source:NCBI gene;Acc:101120634]",{"v":0.339452,"d":"0.34"},{"v":0.102504,"d":"0.10"},{"v":0.606096,"d":"0.61"},{"v":0.146033,"d":"0.15"},0,{"v":0.131754,"d":"0.13"},{"v":3.77286194098356,"d":"3.77"},{"v":1.91565930907924,"d":"1.92"},1,1,"up","no"]
["ENSOARG00000013386","ENSOARG00000013386","ENSOART00000014557","NA","NA","NA","NA","adrenomedullin 5 (putative) [Source:NCBI gene;Acc:101108073]",{"v":0.340653,"d":"0.34"},{"v":0.547573,"d":"0.55"},{"v":0.554306,"d":"0.55"},{"v":0.653216,"d":"0.65"},{"v":0.403999,"d":"0.40"},{"v":0.093089,"d":"0.09"},{"v":1.25404414832949,"d":"1.25"},{"v":0.326588138773809,"d":"0.33"},1,1,"up","no"]
["MSTRG.4842","ENSOARG00000012168","ENSOART00000013240","GO:0008584(male gonad development);GO:0008585(female gonad development)","04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04974(Protein digestion and absorption);05165(Human papillomavirus infection)","K08131","NA","collagen type IX alpha 3 chain [Source:NCBI gene;Acc:101120183]",0,{"v":0.017821,"d":"0.02"},0,0,{"v":0.035727,"d":"0.04"},{"v":0.015703,"d":"0.02"},{"v":0.34650981917169,"d":"0.35"},{"v":-1.52903185978437,"d":"-1.53"},1,1,"down","no"]
["MSTRG.22140","MIR450A1","ENSOART00000025237","NA","NA","NA","NA","microRNA 450a-1 [Source:HGNC Symbol;Acc:HGNC:28008]",0,0,0,{"v":0.257705,"d":"0.26"},{"v":0.548003,"d":"0.55"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.11833","ENSOARG00000007523","ENSOART00000008190","GO:0005739(mitochondrion);GO:0065003(protein-containing complex assembly)","NA","NA","NA",null,{"v":0.040338,"d":"0.04"},0,{"v":0.087306,"d":"0.09"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000012703","ZNF791","ENSOART00000013808","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 791-like [Source:NCBI gene;Acc:105610484]",{"v":0.079888,"d":"0.08"},{"v":0.078757,"d":"0.08"},{"v":0.109646,"d":"0.11"},{"v":0.124548,"d":"0.12"},{"v":0.12118,"d":"0.12"},{"v":0.083577,"d":"0.08"},{"v":0.814718877636234,"d":"0.81"},{"v":-0.29562575800324,"d":"-0.30"},1,1,"down","no"]
["MSTRG.19862","MIR628","ENSOART00000023495","NA","NA","NA","NA","microRNA 628 [Source:HGNC Symbol;Acc:HGNC:32884]",{"v":0.741504,"d":"0.74"},{"v":0.889142,"d":"0.89"},{"v":0.444558,"d":"0.44"},{"v":0.379529,"d":"0.38"},{"v":0.132312,"d":"0.13"},{"v":0.394307,"d":"0.39"},{"v":2.29013803484641,"d":"2.29"},{"v":1.19543455735573,"d":"1.20"},1,1,"up","no"]
["MSTRG.9865","ENSOARG00000008538","ENSOART00000009287","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA","60S ribosomal protein L35a pseudogene [Source:NCBI gene;Acc:101112702]",{"v":0.60993,"d":"0.61"},{"v":0.239819,"d":"0.24"},{"v":0.173873,"d":"0.17"},{"v":0.104088,"d":"0.10"},{"v":0.319722,"d":"0.32"},{"v":0.615665,"d":"0.62"},{"v":0.984749031963251,"d":"0.98"},{"v":-0.0221720012582536,"d":"-0.02"},1,1,"down","no"]
["MSTRG.17380","ENSOARG00000001351","ENSOART00000001448","NA","NA","NA","NA",null,0,0,{"v":0.547666,"d":"0.55"},{"v":0.094626,"d":"0.09"},{"v":0.094587,"d":"0.09"},{"v":0.092595,"d":"0.09"},{"v":1.94340118094589,"d":"1.94"},{"v":0.958583750649133,"d":"0.96"},1,1,"up","no"]
["MSTRG.13170","RHBDL1","ENSOART00000014379","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity)","NA","K02857","EC:3.4.21.105","rhomboid like 1 [Source:NCBI gene;Acc:101110639]",{"v":0.035363,"d":"0.04"},0,0,0,{"v":0.130108,"d":"0.13"},0,{"v":0.271797276109079,"d":"0.27"},{"v":-1.87939709707351,"d":"-1.88"},1,1,"down","no"]
["MSTRG.5264","ENSOARG00000009707","ENSOART00000010564","NA","NA","NA","NA",null,{"v":0.285238,"d":"0.29"},{"v":0.492633,"d":"0.49"},{"v":0.394302,"d":"0.39"},{"v":0.097365,"d":"0.10"},{"v":0.140303,"d":"0.14"},{"v":0.281013,"d":"0.28"},{"v":2.2599111978268,"d":"2.26"},{"v":1.17626608371481,"d":"1.18"},1,1,"up","no"]
["ENSOARG00000015778","STARD5","ENSOART00000017176","GO:0008289(lipid binding);GO:0015485(cholesterol binding);GO:0017127(cholesterol transporter activity);GO:0032052(bile acid binding);GO:0070508(cholesterol import)","NA","NA","NA","StAR related lipid transfer domain containing 5 [Source:NCBI gene;Acc:101117196]",{"v":0.735415,"d":"0.74"},{"v":0.36147,"d":"0.36"},{"v":0.625409,"d":"0.63"},{"v":0.631417,"d":"0.63"},{"v":0.596448,"d":"0.60"},{"v":1.046792,"d":"1.05"},{"v":0.757166465097815,"d":"0.76"},{"v":-0.401317579393093,"d":"-0.40"},1,1,"down","no"]
["ENSOARG00000019187","SCUBE1","ENSOART00000020893","GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0019897(extrinsic component of plasma membrane);GO:0042802(identical protein binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0046982(protein heterodimerization activity);GO:0051260(protein homooligomerization)","NA","NA","NA","signal peptide, CUB domain and EGF like domain containing 1 [Source:NCBI gene;Acc:101107434]",0,0,0,0,{"v":0.023794,"d":"0.02"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.18785","RF00191","ENSOART00000024108","NA","NA","NA","NA",null,{"v":0.115816,"d":"0.12"},{"v":0.619904,"d":"0.62"},{"v":0.324865,"d":"0.32"},{"v":1.053303,"d":"1.05"},{"v":1.155301,"d":"1.16"},{"v":2.672778,"d":"2.67"},{"v":0.217271461237822,"d":"0.22"},{"v":-2.20242940695161,"d":"-2.20"},1,1,"down","no"]
["ENSOARG00000001023","ENSOARG00000001023","ENSOART00000001097","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0038023(signaling receptor activity)","NA","NA","NA",null,0,{"v":0.018716,"d":"0.02"},0,{"v":0.057102,"d":"0.06"},{"v":0.177804,"d":"0.18"},0,{"v":0.0796744229606736,"d":"0.08"},{"v":-3.64973952440403,"d":"-3.65"},1,1,"down","no"]
["MSTRG.6596","LIPT2","ENSOART00000010925","GO:0005739(mitochondrion);GO:0006464(cellular protein modification process);GO:0009249(protein lipoylation);GO:0033819(lipoyl(octanoyl) transferase activity);GO:2000376(positive regulation of oxygen metabolic process)","00785(Lipoic acid metabolism)","K03801","EC:2.3.1.181","lipoyl(octanoyl) transferase 2 [Source:NCBI gene;Acc:101105357]",{"v":0.54386,"d":"0.54"},{"v":0.770607,"d":"0.77"},{"v":0.166501,"d":"0.17"},{"v":0.78492,"d":"0.78"},{"v":0.38547,"d":"0.39"},{"v":0.480694,"d":"0.48"},{"v":0.896967083443362,"d":"0.90"},{"v":-0.156873052244913,"d":"-0.16"},1,1,"down","no"]
["MSTRG.21479","RF02271","ENSOART00000025608","NA","NA","NA","NA",null,{"v":0.758848,"d":"0.76"},{"v":0.261491,"d":"0.26"},{"v":0.812992,"d":"0.81"},{"v":0.379695,"d":"0.38"},{"v":0.637136,"d":"0.64"},0,{"v":1.80298496013595,"d":"1.80"},{"v":0.850387362367717,"d":"0.85"},1,1,"up","no"]
["MSTRG.11832","ENSOARG00000007473","ENSOART00000008138","NA","NA","NA","NA","leucine zipper protein 2 [Source:NCBI gene;Acc:101118830]",{"v":0.547789,"d":"0.55"},{"v":0.217258,"d":"0.22"},{"v":0.282067,"d":"0.28"},{"v":0.149664,"d":"0.15"},{"v":0.298491,"d":"0.30"},{"v":0.140963,"d":"0.14"},{"v":1.77742659365356,"d":"1.78"},{"v":0.829789978883341,"d":"0.83"},1,1,"up","no"]
["ENSOARG00000024260","RF00006","ENSOART00000026162","NA","NA","NA","NA","vault RNA 1-1 [Source:HGNC Symbol;Acc:HGNC:12654]",0,{"v":0.417429,"d":"0.42"},0,{"v":0.031881,"d":"0.03"},{"v":0.160667,"d":"0.16"},{"v":0.168982,"d":"0.17"},{"v":1.15461787403535,"d":"1.15"},{"v":0.207415464238487,"d":"0.21"},1,1,"up","no"]
["MSTRG.12560","GSTO2","ENSOART00000008205","GO:0004364(glutathione transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006805(xenobiotic metabolic process);GO:0016491(oxidoreductase activity);GO:0019852(L-ascorbic acid metabolic process);GO:0042802(identical protein binding);GO:0045174(glutathione dehydrogenase (ascorbate) activity);GO:0055114(oxidation-reduction process);GO:0071243(cellular response to arsenic-containing substance);GO:0098869(cellular oxidant detoxification)","00480(Glutathione metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);00983(Drug metabolism - other enzymes);01524(Platinum drug resistance);05200(Pathways in cancer);05204(Chemical carcinogenesis);05225(Hepatocellular carcinoma);05418(Fluid shear stress and atherosclerosis)","K00799","EC:2.5.1.18","glutathione S-transferase omega 2 [Source:NCBI gene;Acc:101115496]",{"v":0.047854,"d":"0.05"},{"v":0.022983,"d":"0.02"},0,{"v":0.003005,"d":"0.00"},{"v":0.028954,"d":"0.03"},0,{"v":2.21649613567383,"d":"2.22"},{"v":1.14828084725434,"d":"1.15"},1,1,"up","no"]
["ENSOARG00000000662","KREMEN2","ENSOART00000000713","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030279(negative regulation of ossification);GO:0060173(limb development)","NA","K23091","NA","kringle containing transmembrane protein 2 [Source:NCBI gene;Acc:101119273]",0,{"v":0.020623,"d":"0.02"},0,{"v":0.031232,"d":"0.03"},0,0,{"v":0.660316342213115,"d":"0.66"},{"v":-0.598770743139275,"d":"-0.60"},1,1,"down","no"]
["ENSOARG00000008296","GABRQ","ENSOART00000009028","GO:0004888(transmembrane signaling receptor activity);GO:0004890(GABA-A receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034220(ion transmembrane transport);GO:0043235(receptor complex)","04080(Neuroactive ligand-receptor interaction);04723(Retrograde endocannabinoid signaling);04727(GABAergic synapse);05032(Morphine addiction);05033(Nicotine addiction)","K05192","NA","gamma-aminobutyric acid type A receptor theta subunit [Source:NCBI gene;Acc:101113305]",0,0,0,0,0,{"v":0.016251,"d":"0.02"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000016182","ENSOARG00000016182","ENSOART00000017619","NA","NA","NA","NA",null,{"v":0.050771,"d":"0.05"},0,{"v":0.05224,"d":"0.05"},0,{"v":0.162633,"d":"0.16"},0,{"v":0.633395436350556,"d":"0.63"},{"v":-0.658821622182042,"d":"-0.66"},1,1,"down","no"]
["MSTRG.435","RF00003","ENSOART00000026138","NA","NA","NA","NA",null,{"v":0.47923,"d":"0.48"},{"v":0.188245,"d":"0.19"},{"v":0.351515,"d":"0.35"},{"v":0.485674,"d":"0.49"},{"v":1.505057,"d":"1.51"},{"v":0.130495,"d":"0.13"},{"v":0.480377856956308,"d":"0.48"},{"v":-1.0577584434183,"d":"-1.06"},1,1,"down","no"]
["MSTRG.4969","MMP24","ENSOART00000013065","GO:0004222(metalloendopeptidase activity);GO:0005887(integral component of plasma membrane);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0010001(glial cell differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0031012(extracellular matrix);GO:0032588(trans-Golgi network membrane);GO:0044331(cell-cell adhesion mediated by cadherin);GO:0045296(cadherin binding);GO:0046872(metal ion binding);GO:0050965(detection of temperature stimulus involved in sensory perception of pain);GO:0097150(neuronal stem cell population maintenance);GO:0098742(cell-cell adhesion via plasma-membrane adhesion molecules)","04928(Parathyroid hormone synthesis, secretion and action)","K08002","EC:3.4.24.-","matrix metallopeptidase 24 [Source:NCBI gene;Acc:101119580]",{"v":0.182914,"d":"0.18"},{"v":0.094359,"d":"0.09"},{"v":0.23428,"d":"0.23"},{"v":0.207156,"d":"0.21"},{"v":0.199966,"d":"0.20"},{"v":0.19288,"d":"0.19"},{"v":0.852585491381695,"d":"0.85"},{"v":-0.230083590007487,"d":"-0.23"},1,1,"down","no"]
["ENSOARG00000019676","GALNT14","ENSOART00000021428","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030246(carbohydrate binding)","00512(Mucin type O-glycan biosynthesis)","K00710","EC:2.4.1.41","polypeptide N-acetylgalactosaminyltransferase 14 [Source:NCBI gene;Acc:101104386]",0,0,{"v":0.086533,"d":"0.09"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000013695","A1CF","ENSOART00000014905","GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0003727(single-stranded RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007566(embryo implantation);GO:0010609(mRNA localization resulting in posttranscriptional regulation of gene expression);GO:0016554(cytidine to uridine editing);GO:0016556(mRNA modification);GO:0030895(apolipoprotein B mRNA editing enzyme complex)","NA","NA","NA","APOBEC1 complementation factor [Source:NCBI gene;Acc:101118147]",0,0,{"v":0.032713,"d":"0.03"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.5124","RF00156","ENSOART00000025331","NA","NA","NA","NA",null,{"v":0.758998,"d":"0.76"},{"v":1.899113,"d":"1.90"},{"v":1.116097,"d":"1.12"},{"v":1.527681,"d":"1.53"},{"v":0.878175,"d":"0.88"},{"v":0.737414,"d":"0.74"},{"v":1.20072663181973,"d":"1.20"},{"v":0.263907731551927,"d":"0.26"},1,1,"up","no"]
["MSTRG.1072","ENSOARG00000012650","ENSOART00000013754","NA","NA","NA","NA",null,{"v":0.152777,"d":"0.15"},{"v":0.072995,"d":"0.07"},{"v":0.041912,"d":"0.04"},{"v":0.129158,"d":"0.13"},{"v":0.144076,"d":"0.14"},{"v":0.116432,"d":"0.12"},{"v":0.686957548259278,"d":"0.69"},{"v":-0.541707146947546,"d":"-0.54"},1,1,"down","no"]
["ENSOARG00000005238","ENO2","ENSOART00000005711","GO:0000015(phosphopyruvate hydratase complex);GO:0000287(magnesium ion binding);GO:0001917(photoreceptor inner segment);GO:0004634(phosphopyruvate hydratase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006096(glycolytic process);GO:0016020(membrane);GO:0043025(neuronal cell body);GO:0043204(perikaryon)","00010(Glycolysis / Gluconeogenesis);03018(RNA degradation);04066(HIF-1 signaling pathway)","K01689","EC:4.2.1.11","enolase 2 [Source:NCBI gene;Acc:101109164]",{"v":0.101948,"d":"0.10"},{"v":0.034497,"d":"0.03"},{"v":0.040313,"d":"0.04"},{"v":0.072716,"d":"0.07"},{"v":0.093046,"d":"0.09"},{"v":0.082459,"d":"0.08"},{"v":0.712099298608901,"d":"0.71"},{"v":-0.489849663215502,"d":"-0.49"},1,1,"down","no"]
["ENSOARG00000007717","GINS1","ENSOART00000008400","GO:0000811(GINS complex);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006260(DNA replication)","NA","K10732","NA","GINS complex subunit 1 [Source:NCBI gene;Acc:101106192]",{"v":0.355041,"d":"0.36"},{"v":0.301671,"d":"0.30"},{"v":0.661621,"d":"0.66"},{"v":1.983585,"d":"1.98"},{"v":0.186116,"d":"0.19"},{"v":0.68427,"d":"0.68"},{"v":0.461929360879981,"d":"0.46"},{"v":-1.11425584605975,"d":"-1.11"},1,1,"down","no"]
["MSTRG.194","CLDN19","ENSOART00000022269","GO:0005198(structural molecule activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0019227(neuronal action potential propagation);GO:0030054(cell junction);GO:0043296(apical junction complex);GO:0043297(apical junction assembly)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)","K06087","NA","claudin 19 [Source:NCBI gene;Acc:101102362]",{"v":0.088609,"d":"0.09"},{"v":0.01726,"d":"0.02"},{"v":0.182163,"d":"0.18"},{"v":0.332567,"d":"0.33"},{"v":0.2721,"d":"0.27"},0,{"v":0.476348138727597,"d":"0.48"},{"v":-1.0699117431322,"d":"-1.07"},1,1,"down","no"]
["ENSOARG00000010100","YPEL4","ENSOART00000010988","NA","NA","NA","NA","yippee like 4 [Source:NCBI gene;Acc:101121709]",{"v":0.060258,"d":"0.06"},{"v":0.163321,"d":"0.16"},{"v":0.19175,"d":"0.19"},0,0,{"v":0.063803,"d":"0.06"},{"v":6.50955284234284,"d":"6.51"},{"v":2.70255844442145,"d":"2.70"},1,1,"up","no"]
["ENSOARG00000024850","RF00026","ENSOART00000026752","NA","NA","NA","NA",null,{"v":0.223228,"d":"0.22"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.4881","MIR296","ENSOART00000026398","NA","NA","NA","NA","microRNA 296 [Source:HGNC Symbol;Acc:HGNC:31617]",0,0,0,0,{"v":0.227875,"d":"0.23"},{"v":0.176198,"d":"0.18"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000011304","ENSOARG00000011304","ENSOART00000012288","GO:0005509(calcium ion binding);GO:0016020(membrane);GO:0030198(extracellular matrix organization)","NA","NA","NA","EGF like domain multiple 6 [Source:NCBI gene;Acc:101121916]",0,0,0,{"v":0.0484277757459095,"d":"0.05"},0,{"v":0.135309554379211,"d":"0.14"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000013942","SPATA1","ENSOART00000015180","NA","NA","NA","NA","spermatogenesis associated 1 [Source:NCBI gene;Acc:101111511]",{"v":0.042846,"d":"0.04"},0,0,0,0,{"v":0.050085,"d":"0.05"},{"v":0.855465708295897,"d":"0.86"},{"v":-0.225218070053447,"d":"-0.23"},1,1,"down","no"]
["MSTRG.21312","RF00397","ENSOART00000024332","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 14B [Source:HGNC Symbol;Acc:HGNC:32603]",{"v":0.587636,"d":"0.59"},{"v":3.111467,"d":"3.11"},{"v":2.703873,"d":"2.70"},{"v":1.336246,"d":"1.34"},{"v":2.007357,"d":"2.01"},{"v":4.949124,"d":"4.95"},{"v":0.772119472882684,"d":"0.77"},{"v":-0.373103996617445,"d":"-0.37"},1,1,"down","no"]
["ENSOARG00000010920","LRRC38","ENSOART00000011875","GO:0005249(voltage-gated potassium channel activity);GO:0005515(protein binding);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0044325(ion channel binding);GO:0071805(potassium ion transmembrane transport);GO:0099104(potassium channel activator activity);GO:1903818(positive regulation of voltage-gated potassium channel activity)","NA","NA","NA","leucine rich repeat containing 38 [Source:HGNC Symbol;Acc:HGNC:27005]",0,0,{"v":0.111997,"d":"0.11"},0,0,{"v":0.071851,"d":"0.07"},{"v":1.55873961392326,"d":"1.56"},{"v":0.640379947229714,"d":"0.64"},1,1,"up","no"]
["ENSOARG00000002590","SPP1","ENSOART00000002808","GO:0001503(ossification);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0006710(androgen catabolic process);GO:0007155(cell adhesion);GO:0033280(response to vitamin D);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071394(cellular response to testosterone stimulus);GO:2000866(positive regulation of estradiol secretion)","04151(PI3K-Akt signaling pathway);04371(Apelin signaling pathway);04510(Focal adhesion);04512(ECM-receptor interaction);04620(Toll-like receptor signaling pathway);05165(Human papillomavirus infection)","K06250","NA","secreted phosphoprotein 1 [Source:NCBI gene;Acc:443058]",{"v":0.2777,"d":"0.28"},0,0,{"v":0.262952,"d":"0.26"},0,0,{"v":1.05608628190696,"d":"1.06"},{"v":0.0787277072287824,"d":"0.08"},1,1,"up","no"]
["MSTRG.18135","GRIN3B","ENSOART00000011145","GO:0004970(ionotropic glutamate receptor activity);GO:0005216(ion channel activity);GO:0005262(calcium channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017146(NMDA selective glutamate receptor complex);GO:0034220(ion transmembrane transport);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0038023(signaling receptor activity);GO:0043025(neuronal cell body);GO:0051205(protein insertion into membrane);GO:0051924(regulation of calcium ion transport);GO:0070588(calcium ion transmembrane transport)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04724(Glutamatergic synapse);05030(Cocaine addiction);05031(Amphetamine addiction);05033(Nicotine addiction);05034(Alcoholism)","K05214","NA","glutamate ionotropic receptor NMDA type subunit 3B [Source:NCBI gene;Acc:101112396]",{"v":0.025229,"d":"0.03"},{"v":0.022789,"d":"0.02"},{"v":0.087128,"d":"0.09"},0,{"v":0.17447,"d":"0.17"},{"v":0.00551,"d":"0.01"},{"v":0.750894543838204,"d":"0.75"},{"v":-0.413317786035371,"d":"-0.41"},1,1,"down","no"]
["ENSOARG00000002252","ENSOARG00000002252","ENSOART00000002436","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","NA","NA","solute carrier family 22 member 9-like [Source:NCBI gene;Acc:101119594]",{"v":0.03333,"d":"0.03"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000001438","SPEF1","ENSOART00000001541","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007026(negative regulation of microtubule depolymerization);GO:0008017(microtubule binding);GO:0031514(motile cilium)","NA","NA","NA","sperm flagellar 1 [Source:NCBI gene;Acc:101120936]",{"v":0.127721,"d":"0.13"},{"v":0.141717,"d":"0.14"},{"v":0.280217,"d":"0.28"},{"v":0.59678,"d":"0.60"},{"v":0.119245,"d":"0.12"},{"v":0.027198,"d":"0.03"},{"v":0.739555960996901,"d":"0.74"},{"v":-0.435268777044959,"d":"-0.44"},1,1,"down","no"]
["ENSOARG00000014637","HESX1","ENSOART00000015930","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0007420(brain development);GO:0008022(protein C-terminus binding);GO:0021983(pituitary gland development);GO:0030916(otic vesicle formation);GO:0043565(sequence-specific DNA binding);GO:0043584(nose development);GO:0045892(negative regulation of transcription, DNA-templated);GO:0047485(protein N-terminus binding);GO:0048853(forebrain morphogenesis)","04550(Signaling pathways regulating pluripotency of stem cells)","K09354","NA","HESX homeobox 1 [Source:NCBI gene;Acc:101103514]",{"v":0.230053,"d":"0.23"},{"v":0.167575,"d":"0.17"},{"v":0.311776,"d":"0.31"},{"v":0.226669,"d":"0.23"},{"v":0.438413,"d":"0.44"},{"v":0.126086,"d":"0.13"},{"v":0.896654060831581,"d":"0.90"},{"v":-0.157376610285283,"d":"-0.16"},1,1,"down","no"]
["ENSOARG00000019045","TRAT1","ENSOART00000020734","GO:0001920(negative regulation of receptor recycling);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042101(T cell receptor complex);GO:0050850(positive regulation of calcium-mediated signaling);GO:0050862(positive regulation of T cell receptor signaling pathway);GO:0051051(negative regulation of transport)","NA","NA","NA","T-cell receptor-associated transmembrane adapter 1 [Source:NCBI gene;Acc:101116441]",{"v":0.06969,"d":"0.07"},{"v":0.062419,"d":"0.06"},0,{"v":0.01502,"d":"0.02"},{"v":0.073674,"d":"0.07"},0,{"v":1.48949196112477,"d":"1.49"},{"v":0.574820337298936,"d":"0.57"},1,1,"up","no"]
["MSTRG.17350","TRBV25-1","ENSOART00000017923","NA","NA","NA","NA","T cell receptor beta variable 25-1 [Source:HGNC Symbol;Acc:HGNC:12205]",0,0,{"v":0.174829,"d":"0.17"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.21908","oar-mir-374a","ENSOART00000024494","NA","NA","NA","NA","oar-mir-374a [Source:miRBase;Acc:MI0025283]",{"v":0.298301,"d":"0.30"},{"v":0.224325,"d":"0.22"},{"v":0.436127,"d":"0.44"},{"v":0.914494,"d":"0.91"},{"v":0.017889,"d":"0.02"},{"v":0.677714,"d":"0.68"},{"v":0.595462882049963,"d":"0.60"},{"v":-0.747916513836457,"d":"-0.75"},1,1,"down","no"]
["ENSOARG00000019628","ENSOARG00000019628","ENSOART00000021376","GO:0005515(protein binding)","NA","K19683","NA","tetratricopeptide repeat protein 30B [Source:NCBI gene;Acc:101104297]",{"v":0.161636,"d":"0.16"},{"v":0.273227,"d":"0.27"},{"v":0.260193,"d":"0.26"},{"v":0.175102,"d":"0.18"},{"v":0.32523,"d":"0.33"},{"v":0.206853,"d":"0.21"},{"v":0.982848900924086,"d":"0.98"},{"v":-0.0249584551710194,"d":"-0.02"},1,1,"down","no"]
["MSTRG.9779","ENSOARG00000023614","ENSOART00000025516","NA","NA","NA","NA",null,{"v":0.062552,"d":"0.06"},{"v":0.09275,"d":"0.09"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.2608","PRR11","ENSOART00000013281","GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0051726(regulation of cell cycle)","NA","NA","NA","proline rich 11 [Source:NCBI gene;Acc:101103489]",{"v":0.111904,"d":"0.11"},{"v":0.056235,"d":"0.06"},{"v":0.138245,"d":"0.14"},{"v":0.46641,"d":"0.47"},{"v":0.207553,"d":"0.21"},{"v":0.092694,"d":"0.09"},{"v":0.39963634324085,"d":"0.40"},{"v":-1.32324030597836,"d":"-1.32"},1,1,"down","no"]
["MSTRG.19645","FSIP1","ENSOART00000021856","NA","NA","NA","NA","fibrous sheath interacting protein 1 [Source:NCBI gene;Acc:101106849]",0,{"v":0.0163803604350078,"d":"0.02"},{"v":0.0181258166752978,"d":"0.02"},{"v":0.0369004474365614,"d":"0.04"},0,{"v":0.060407030554117,"d":"0.06"},{"v":0.354609715746729,"d":"0.35"},{"v":-1.49569603054133,"d":"-1.50"},1,1,"down","no"]
["MSTRG.21525","S100G","ENSOART00000014146","GO:0005509(calcium ion binding);GO:0046872(metal ion binding)","04978(Mineral absorption)","K14734","NA","S100 calcium binding protein G [Source:NCBI gene;Acc:101105882]",{"v":0.615569,"d":"0.62"},{"v":0.208827,"d":"0.21"},0,{"v":0.925589,"d":"0.93"},{"v":0.13605,"d":"0.14"},{"v":0.37931,"d":"0.38"},{"v":0.572120179131947,"d":"0.57"},{"v":-0.805609864621155,"d":"-0.81"},1,1,"down","no"]
["MSTRG.18743","ENSOARG00000022377","ENSOART00000024279","NA","NA","NA","NA",null,{"v":0.436071,"d":"0.44"},0,0,0,0,{"v":0.105597,"d":"0.11"},{"v":4.12957754481661,"d":"4.13"},{"v":2.04599420170003,"d":"2.05"},1,1,"up","no"]
["ENSOARG00000005803","TMEM79","ENSOART00000006318","GO:0002070(epithelial cell maturation);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031069(hair follicle morphogenesis);GO:0032588(trans-Golgi network membrane);GO:0042335(cuticle development);GO:0042802(identical protein binding);GO:0045055(regulated exocytosis);GO:0045684(positive regulation of epidermis development);GO:0061436(establishment of skin barrier);GO:0070268(cornification)","NA","NA","NA","transmembrane protein 79 [Source:NCBI gene;Acc:101103024]",{"v":0.059963,"d":"0.06"},{"v":0.073008,"d":"0.07"},{"v":0.122661,"d":"0.12"},{"v":0.115434,"d":"0.12"},{"v":0.098544,"d":"0.10"},{"v":0.152186,"d":"0.15"},{"v":0.698135261795261,"d":"0.70"},{"v":-0.518421513157368,"d":"-0.52"},1,1,"down","no"]
["MSTRG.5075","ENSOARG00000006310","ENSOART00000006860","GO:0005576(extracellular region);GO:0010466(negative regulation of peptidase activity);GO:0030414(peptidase inhibitor activity)","NA","NA","NA","WAP four-disulfide core domain 3 [Source:NCBI gene;Acc:101114545]",{"v":0.121254,"d":"0.12"},0,{"v":0.174282,"d":"0.17"},{"v":0.962037,"d":"0.96"},{"v":0.974849,"d":"0.97"},{"v":0.533149,"d":"0.53"},{"v":0.119648507004961,"d":"0.12"},{"v":-3.06312570010018,"d":"-3.06"},1,1,"down","no"]
["MSTRG.19833","RF00026","ENSOART00000025652","NA","NA","NA","NA",null,{"v":0.496593,"d":"0.50"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.17859","ENSOARG00000016508","ENSOART00000017974","GO:0006457(protein folding);GO:0016272(prefoldin complex);GO:0051082(unfolded protein binding)","NA","NA","NA",null,{"v":1.285625,"d":"1.29"},{"v":0.625201,"d":"0.63"},{"v":0.636359,"d":"0.64"},{"v":0.551361,"d":"0.55"},{"v":0.266821,"d":"0.27"},{"v":0.224465,"d":"0.22"},{"v":2.44299844530316,"d":"2.44"},{"v":1.2886529454905,"d":"1.29"},1,1,"up","no"]
["MSTRG.20988","ENSOARG00000007044","ENSOART00000007665","GO:0004623(phospholipase A2 activity);GO:0005198(structural molecule activity);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0006644(phospholipid metabolic process);GO:0016042(lipid catabolic process);GO:0031012(extracellular matrix);GO:0045299(otolith mineralization);GO:0050482(arachidonic acid secretion)","NA","NA","NA","otoconin 90 [Source:NCBI gene;Acc:101121180]",0,{"v":0.051041,"d":"0.05"},{"v":0.071064,"d":"0.07"},{"v":0.020516,"d":"0.02"},{"v":0.067036,"d":"0.07"},{"v":0.02116,"d":"0.02"},{"v":1.1231970711605,"d":"1.12"},{"v":0.167611078800219,"d":"0.17"},1,1,"up","no"]
["MSTRG.14593","SPACA9","ENSOART00000006263","GO:0001669(acrosomal vesicle);GO:0005737(cytoplasm);GO:0005881(cytoplasmic microtubule);GO:0036064(ciliary basal body);GO:0048306(calcium-dependent protein binding)","NA","NA","NA","sperm acrosome associated 9 [Source:NCBI gene;Acc:101113214]",{"v":0.329302,"d":"0.33"},{"v":0.179718,"d":"0.18"},{"v":0.172864,"d":"0.17"},{"v":0.189309,"d":"0.19"},{"v":0.371447,"d":"0.37"},{"v":0.144938,"d":"0.14"},{"v":0.966260163753695,"d":"0.97"},{"v":-0.0495164105640468,"d":"-0.05"},1,1,"down","no"]
["MSTRG.13326","RF00001","ENSOART00000026828","NA","NA","NA","NA",null,0,0,0,{"v":0.078827,"d":"0.08"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000022128","RF00026","ENSOART00000024030","NA","NA","NA","NA",null,0,{"v":0.199167,"d":"0.20"},{"v":0.366546,"d":"0.37"},0,{"v":0.114354,"d":"0.11"},{"v":0.109589,"d":"0.11"},{"v":2.52614727854856,"d":"2.53"},{"v":1.33693875307543,"d":"1.34"},1,1,"up","no"]
["ENSOARG00000018414","SLC5A10","ENSOART00000020040","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K14390","NA","solute carrier family 5 member 10 [Source:NCBI gene;Acc:101119654]",{"v":0.043776,"d":"0.04"},{"v":0.053053,"d":"0.05"},{"v":0.025036,"d":"0.03"},{"v":0.095965,"d":"0.10"},{"v":0.147189,"d":"0.15"},{"v":0.071908,"d":"0.07"},{"v":0.386796884422749,"d":"0.39"},{"v":-1.37035192066711,"d":"-1.37"},1,1,"down","no"]
["MSTRG.16386","CDCA3","ENSOART00000006155","GO:0005913(cell-cell adherens junction)","NA","NA","NA","cell division cycle associated 3 [Source:NCBI gene;Acc:101110222]",{"v":0.309852,"d":"0.31"},{"v":0.061668,"d":"0.06"},{"v":0.336778,"d":"0.34"},{"v":0.540689,"d":"0.54"},{"v":0.277759,"d":"0.28"},{"v":0.3655,"d":"0.37"},{"v":0.598250936696544,"d":"0.60"},{"v":-0.741177344257895,"d":"-0.74"},1,1,"down","no"]
["ENSOARG00000011165","HEMGN","ENSOART00000012143","GO:0030154(cell differentiation)","NA","NA","NA","hemogen [Source:NCBI gene;Acc:101103212]",0,0,{"v":0.025253,"d":"0.03"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000022401","RF00026","ENSOART00000024303","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.073059,"d":"0.07"},"-inf","-inf",1,1,"down","no"]
["MSTRG.11752","RF00026","ENSOART00000024548","NA","NA","NA","NA",null,0,{"v":0.051364,"d":"0.05"},0,0,0,{"v":0.136692,"d":"0.14"},{"v":0.375764492435548,"d":"0.38"},{"v":-1.41209934800002,"d":"-1.41"},1,1,"down","no"]
["ENSOARG00000007978","ENSOARG00000007978","ENSOART00000008687","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016787(hydrolase activity)","04080(Neuroactive ligand-receptor interaction)","K01352","EC:3.4.21.78","granzyme A [Source:NCBI gene;Acc:101117107]",{"v":0.078497,"d":"0.08"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.4280","ENSOARG00000022944","ENSOART00000024846","NA","NA","NA","NA",null,{"v":1.26717,"d":"1.27"},{"v":0.140525,"d":"0.14"},{"v":0.426557,"d":"0.43"},{"v":0.786444,"d":"0.79"},{"v":2.658886,"d":"2.66"},{"v":0.417389,"d":"0.42"},{"v":0.474860325071536,"d":"0.47"},{"v":-1.07442487188473,"d":"-1.07"},1,1,"down","no"]
["ENSOARG00000011343","RLBP1","ENSOART00000012334","GO:0005502(11-cis retinal binding);GO:0007601(visual perception);GO:0016918(retinal binding)","NA","K19625","NA","retinaldehyde binding protein 1 [Source:NCBI gene;Acc:101103269]",{"v":0.034737,"d":"0.03"},0,{"v":0.030684,"d":"0.03"},0,0,{"v":0.103498,"d":"0.10"},{"v":0.632099170998473,"d":"0.63"},{"v":-0.661777172112198,"d":"-0.66"},1,1,"down","no"]
["ENSOARG00000000417","S100A9","ENSOART00000000444","GO:0002523(leukocyte migration involved in inflammatory response);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006914(autophagy);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0008017(microtubule binding);GO:0008270(zinc ion binding);GO:0030054(cell junction);GO:0030593(neutrophil chemotaxis);GO:0035606(peptidyl-cysteine S-trans-nitrosylation);GO:0035662(Toll-like receptor 4 binding);GO:0035821(modification of morphology or physiology of other organism);GO:0045087(innate immune response);GO:0046872(metal ion binding);GO:0050544(arachidonic acid binding);GO:0050727(regulation of inflammatory response);GO:0050729(positive regulation of inflammatory response);GO:0050786(RAGE receptor binding);GO:0061844(antimicrobial humoral immune response mediated by antimicrobial peptide);GO:0070488(neutrophil aggregation);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04657(IL-17 signaling pathway)","K21128","NA","S100 calcium binding protein A9 [Source:NCBI gene;Acc:101122157]",{"v":0.722488,"d":"0.72"},{"v":0.208583,"d":"0.21"},{"v":0.093942,"d":"0.09"},{"v":1.102511,"d":"1.10"},{"v":0.617848,"d":"0.62"},{"v":0.733134,"d":"0.73"},{"v":0.417777022392157,"d":"0.42"},{"v":-1.25919494808426,"d":"-1.26"},1,1,"down","no"]
["ENSOARG00000008179","SLC25A21","ENSOART00000008906","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K15110","NA","solute carrier family 25 member 21 [Source:NCBI gene;Acc:101121458]",0,{"v":0.191281,"d":"0.19"},0,{"v":0.529821,"d":"0.53"},{"v":0.089682,"d":"0.09"},0,{"v":0.308765252145672,"d":"0.31"},{"v":-1.69541769130279,"d":"-1.70"},1,1,"down","no"]
["ENSOARG00000020391","AP1S3","ENSOART00000022202","GO:0006605(protein targeting);GO:0006886(intracellular protein transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat);GO:0043231(intracellular membrane-bounded organelle)","04142(Lysosome);05170(Human immunodeficiency virus 1 infection)","K12395","NA","adaptor related protein complex 1 subunit sigma 3 [Source:NCBI gene;Acc:101117145]",{"v":0.081415,"d":"0.08"},{"v":0.050827,"d":"0.05"},{"v":0.075318,"d":"0.08"},{"v":0.103358,"d":"0.10"},{"v":0.112975,"d":"0.11"},{"v":0.103677,"d":"0.10"},{"v":0.648604731102153,"d":"0.65"},{"v":-0.62458854763894,"d":"-0.62"},1,1,"down","no"]
["ENSOARG00000012260","ENSOARG00000012260","ENSOART00000013331","NA","NA","NA","NA",null,0,0,0,{"v":0.041959,"d":"0.04"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000003137","OR13C3","ENSOART00000003402","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","K04257","NA","olfactory receptor 13C3 [Source:NCBI gene;Acc:101104639]",0,0,{"v":0.12315,"d":"0.12"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.16353","ENSOARG00000021054","ENSOART00000022939","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding)","NA","NA","NA",null,{"v":1.258522,"d":"1.26"},{"v":0.551863,"d":"0.55"},{"v":0.669124,"d":"0.67"},{"v":1.048571,"d":"1.05"},{"v":0.149599,"d":"0.15"},{"v":0.280333,"d":"0.28"},{"v":1.67704022244121,"d":"1.68"},{"v":0.745917291180481,"d":"0.75"},1,1,"up","no"]
["ENSOARG00000009741","ENSOARG00000009741","ENSOART00000010594","GO:0005515(protein binding)","NA","K22868","NA","WD repeat domain 34 [Source:NCBI gene;Acc:101107182]",{"v":0.438254,"d":"0.44"},{"v":0.146778,"d":"0.15"},{"v":0.185894,"d":"0.19"},{"v":0.464951,"d":"0.46"},{"v":0.275271,"d":"0.28"},{"v":0.78829,"d":"0.79"},{"v":0.504363721056819,"d":"0.50"},{"v":-0.987463588717191,"d":"-0.99"},1,1,"down","no"]
["ENSOARG00000011022","MORN4","ENSOART00000011988","GO:0005737(cytoplasm);GO:0032426(stereocilium tip);GO:0032433(filopodium tip);GO:0048678(response to axon injury)","NA","NA","NA","MORN repeat containing 4 [Source:NCBI gene;Acc:101114990]",{"v":1.004448,"d":"1.00"},{"v":0.852027,"d":"0.85"},{"v":0.175914,"d":"0.18"},{"v":0.449376,"d":"0.45"},{"v":0.441359,"d":"0.44"},{"v":0.523216,"d":"0.52"},{"v":1.43738290789426,"d":"1.44"},{"v":0.523444436000871,"d":"0.52"},1,1,"up","no"]
["ENSOARG00000021003","ENSOARG00000021003","ENSOART00000022882","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding)","NA","NA","NA",null,{"v":0.069384,"d":"0.07"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.17991","RF02271","ENSOART00000026129","NA","NA","NA","NA",null,{"v":0.387051,"d":"0.39"},{"v":0.975153,"d":"0.98"},{"v":0.796528,"d":"0.80"},{"v":0.366092,"d":"0.37"},{"v":1.082669,"d":"1.08"},{"v":0.464295,"d":"0.46"},{"v":1.12842070488266,"d":"1.13"},{"v":0.174305042639711,"d":"0.17"},1,1,"up","no"]
["MSTRG.20303","ENSOARG00000006317","ENSOART00000006868","GO:0046872(metal ion binding)","NA","NA","NA",null,{"v":0.077326,"d":"0.08"},0,{"v":0.176942,"d":"0.18"},{"v":0.087325,"d":"0.09"},0,{"v":0.058717,"d":"0.06"},{"v":1.74106079073143,"d":"1.74"},{"v":0.799966576886571,"d":"0.80"},1,1,"up","no"]
["MSTRG.22099","ENSOARG00000010850","ENSOART00000011798","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K17086","NA","transmembrane 9 superfamily member 2-like [Source:NCBI gene;Acc:101116968]",{"v":0.069966,"d":"0.07"},{"v":0.015213,"d":"0.02"},{"v":0.025593,"d":"0.03"},{"v":0.144058,"d":"0.14"},{"v":0.034811,"d":"0.03"},0,{"v":0.619291213122453,"d":"0.62"},{"v":-0.691310118514782,"d":"-0.69"},1,1,"down","no"]
["ENSOARG00000016691","ENSOARG00000016691","ENSOART00000018176","GO:0003676(nucleic acid binding)","NA","NA","NA",null,{"v":0.032672,"d":"0.03"},{"v":0.175991,"d":"0.18"},{"v":0.520498,"d":"0.52"},{"v":0.374363,"d":"0.37"},{"v":0.029832,"d":"0.03"},{"v":0.143229,"d":"0.14"},{"v":1.33198580990238,"d":"1.33"},{"v":0.413578712970351,"d":"0.41"},1,1,"up","no"]
["ENSOARG00000001897","ZMAT1","ENSOART00000002038","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger matrin-type 1 [Source:NCBI gene;Acc:101121243]",0,{"v":0.024661,"d":"0.02"},0,{"v":0.07036,"d":"0.07"},{"v":0.012444,"d":"0.01"},0,{"v":0.297823776629148,"d":"0.30"},{"v":-1.74746915945068,"d":"-1.75"},1,1,"down","no"]
["ENSOARG00000012044","TSPEAR","ENSOART00000013103","GO:0007605(sensory perception of sound)","NA","NA","NA","thrombospondin type laminin G domain and EAR repeats [Source:NCBI gene;Acc:101103696]",0,0,0,0,{"v":0.021018,"d":"0.02"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.17978","CCNI2","ENSOART00000016102","NA","NA","NA","NA","cyclin I family member 2 [Source:HGNC Symbol;Acc:HGNC:33869]",{"v":0.173713,"d":"0.17"},{"v":0.237612,"d":"0.24"},{"v":0.154185,"d":"0.15"},{"v":0.096508,"d":"0.10"},{"v":0.232273,"d":"0.23"},{"v":0.291374,"d":"0.29"},{"v":0.911884931992808,"d":"0.91"},{"v":-0.133076308344853,"d":"-0.13"},1,1,"down","no"]
["MSTRG.10877","RF00405","ENSOART00000024663","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 44 [Source:HGNC Symbol;Acc:HGNC:32637]",{"v":2.108627,"d":"2.11"},{"v":2.451305,"d":"2.45"},{"v":2.363874,"d":"2.36"},{"v":2.053769,"d":"2.05"},{"v":3.473641,"d":"3.47"},{"v":3.632443,"d":"3.63"},{"v":0.755886147954558,"d":"0.76"},{"v":-0.403759143709185,"d":"-0.40"},1,1,"down","no"]
["ENSOARG00000011733","ENSOARG00000011733","ENSOART00000012760","GO:0005515(protein binding)","NA","NA","NA",null,0,0,0,{"v":0.010923,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000015391","ARNT2","ENSOART00000016749","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001666(response to hypoxia);GO:0001701(in utero embryonic development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0007417(central nervous system development);GO:0007420(brain development);GO:0017162(aryl hydrocarbon receptor binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity)","05200(Pathways in cancer);05202(Transcriptional misregulation in cancer);05211(Renal cell carcinoma)","K15589","NA","Ovis aries aryl hydrocarbon receptor nuclear translocator 2 (ARNT2), mRNA. [Source:RefSeq mRNA;Acc:NM_001308560]",{"v":0.168843,"d":"0.17"},{"v":0.049618,"d":"0.05"},{"v":0.124575,"d":"0.12"},{"v":0.203238,"d":"0.20"},{"v":0.242995,"d":"0.24"},{"v":0.267266,"d":"0.27"},{"v":0.480779931016021,"d":"0.48"},{"v":-1.05655141936228,"d":"-1.06"},1,1,"down","no"]
["ENSOARG00000023000","RF00026","ENSOART00000024902","NA","NA","NA","NA","RNA, U6 small nuclear 335, pseudogene [Source:HGNC Symbol;Acc:HGNC:47298]",0,{"v":0.354307,"d":"0.35"},{"v":0.134555,"d":"0.13"},0,0,{"v":0.226248,"d":"0.23"},{"v":2.16073512252042,"d":"2.16"},{"v":1.11152222775144,"d":"1.11"},1,1,"up","no"]
["ENSOARG00000012385","GJA10","ENSOART00000013462","GO:0005243(gap junction channel activity);GO:0005886(plasma membrane);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication);GO:0007276(gamete generation);GO:0007416(synapse assembly);GO:0009416(response to light stimulus);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0050908(detection of light stimulus involved in visual perception);GO:0055085(transmembrane transport)","NA","K07631","NA","gap junction protein alpha 10 [Source:NCBI gene;Acc:101113598]",{"v":0.064953,"d":"0.06"},0,{"v":0.084337,"d":"0.08"},{"v":0.055143,"d":"0.06"},{"v":0.044924,"d":"0.04"},0,{"v":1.4919004267141,"d":"1.49"},{"v":0.57715124961488,"d":"0.58"},1,1,"up","no"]
["ENSOARG00000014152","ACP4","ENSOART00000015411","GO:0004725(protein tyrosine phosphatase activity);GO:0010955(negative regulation of protein processing);GO:0010977(negative regulation of neuron projection development);GO:0030971(receptor tyrosine kinase binding);GO:0042476(odontogenesis);GO:0048168(regulation of neuronal synaptic plasticity);GO:0120154(negative regulation of ERBB4 signaling pathway);GO:1990264(peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity)","NA","K19284","EC:3.1.3.2","acid phosphatase 4 [Source:NCBI gene;Acc:101119583]",0,0,0,0,{"v":0.032922,"d":"0.03"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.9479","CKS2","ENSOART00000008404","GO:0000079(regulation of cyclin-dependent protein serine/threonine kinase activity);GO:0003682(chromatin binding);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007049(cell cycle);GO:0007127(meiosis I);GO:0008283(cell population proliferation);GO:0016538(cyclin-dependent protein serine/threonine kinase regulator activity);GO:0044772(mitotic cell cycle phase transition);GO:0051301(cell division)","NA","NA","NA","uncharacterized LOC101103869 [Source:NCBI gene;Acc:101103869]",{"v":0.283721,"d":"0.28"},{"v":0.123926,"d":"0.12"},{"v":0.485978,"d":"0.49"},{"v":0.301114,"d":"0.30"},{"v":0.164834,"d":"0.16"},0,{"v":1.91786422519251,"d":"1.92"},{"v":0.939500588669402,"d":"0.94"},1,1,"up","no"]
["MSTRG.6617","KLHL35","ENSOART00000012636","GO:0005515(protein binding)","NA","K10461","NA","kelch like family member 35 [Source:NCBI gene;Acc:101106624]",{"v":0.013556,"d":"0.01"},{"v":0.116677,"d":"0.12"},{"v":0.073114,"d":"0.07"},{"v":0.110874,"d":"0.11"},0,0,{"v":1.83403683460505,"d":"1.83"},{"v":0.875022614161098,"d":"0.88"},1,1,"up","no"]
["ENSOARG00000013484","KIAA1211L","ENSOART00000014668","NA","NA","NA","NA","KIAA1211 like [Source:HGNC Symbol;Acc:HGNC:33454]",0,0,0,{"v":0.01264,"d":"0.01"},{"v":0.012825,"d":"0.01"},{"v":0.024847,"d":"0.02"},"-inf","-inf",1,1,"down","no"]
["MSTRG.20319","RF00026","ENSOART00000025400","NA","NA","NA","NA",null,{"v":0.321115,"d":"0.32"},{"v":0.362371,"d":"0.36"},{"v":0.381893,"d":"0.38"},{"v":0.950286,"d":"0.95"},{"v":1.266937,"d":"1.27"},{"v":0.546778,"d":"0.55"},{"v":0.385448123933385,"d":"0.39"},{"v":-1.37539138878112,"d":"-1.38"},1,1,"down","no"]
["ENSOARG00000024707","RF00619","ENSOART00000026609","NA","NA","NA","NA",null,{"v":1.103541,"d":"1.10"},0,{"v":0.569354,"d":"0.57"},{"v":0.255659,"d":"0.26"},{"v":0.380264,"d":"0.38"},0,{"v":2.63065654175112,"d":"2.63"},{"v":1.39542290268184,"d":"1.40"},1,1,"up","no"]
["MSTRG.10334","GALNT13","ENSOART00000008723","GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0006493(protein O-linked glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0018242(protein O-linked glycosylation via serine);GO:0018243(protein O-linked glycosylation via threonine);GO:0030246(carbohydrate binding)","00512(Mucin type O-glycan biosynthesis)","K00710","EC:2.4.1.41","polypeptide N-acetylgalactosaminyltransferase 13 [Source:NCBI gene;Acc:101115605]",0,0,{"v":0.00518,"d":"0.01"},{"v":0.02153,"d":"0.02"},0,{"v":0.015843,"d":"0.02"},{"v":0.138602734594493,"d":"0.14"},{"v":-2.8509723731482,"d":"-2.85"},1,1,"down","no"]
["ENSOARG00000020048","ENSOARG00000020048","ENSOART00000021828","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport)","NA","NA","NA",null,{"v":0.461357,"d":"0.46"},{"v":0.828077,"d":"0.83"},{"v":0.396104,"d":"0.40"},{"v":1.060587,"d":"1.06"},{"v":1.215514,"d":"1.22"},{"v":0.934413,"d":"0.93"},{"v":0.525005653300375,"d":"0.53"},{"v":-0.929595136976215,"d":"-0.93"},1,1,"down","no"]
["MSTRG.2049","PP2D1","ENSOART00000017151","GO:0003824(catalytic activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0006470(protein dephosphorylation)","NA","NA","NA","protein phosphatase 2C like domain containing 1 [Source:NCBI gene;Acc:101115506]",{"v":0.178921,"d":"0.18"},{"v":0.417692,"d":"0.42"},{"v":0.184027,"d":"0.18"},{"v":0.224381,"d":"0.22"},{"v":0.267806,"d":"0.27"},{"v":0.167346,"d":"0.17"},{"v":1.18362538341524,"d":"1.18"},{"v":0.243212541264787,"d":"0.24"},1,1,"up","no"]
["ENSOARG00000011083","IL23R","ENSOART00000012056","GO:0002230(positive regulation of defense response to virus by host);GO:0002827(positive regulation of T-helper 1 type immune response);GO:0005143(interleukin-12 receptor binding);GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032496(response to lipopolysaccharide);GO:0032693(negative regulation of interleukin-10 production);GO:0032729(positive regulation of interferon-gamma production);GO:0032735(positive regulation of interleukin-12 production);GO:0034341(response to interferon-gamma);GO:0038155(interleukin-23-mediated signaling pathway);GO:0042019(interleukin-23 binding);GO:0042020(interleukin-23 receptor activity);GO:0043235(receptor complex);GO:0072536(interleukin-23 receptor complex)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway);04659(Th17 cell differentiation);05200(Pathways in cancer);05321(Inflammatory bowel disease (IBD))","K05065","NA","interleukin 23 receptor [Source:NCBI gene;Acc:101103528]",0,0,0,{"v":0.008,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000008520","ENSOARG00000008520","ENSOART00000009269","NA","NA","NA","NA",null,0,{"v":0.066804,"d":"0.07"},0,{"v":0.081035,"d":"0.08"},{"v":0.038357,"d":"0.04"},{"v":0.054221,"d":"0.05"},{"v":0.384786853519034,"d":"0.38"},{"v":-1.37786858550625,"d":"-1.38"},1,1,"down","no"]
["MSTRG.4622","ENSOARG00000023731","ENSOART00000025633","NA","NA","NA","NA",null,{"v":0.329727,"d":"0.33"},{"v":0.116987,"d":"0.12"},{"v":0.492457,"d":"0.49"},{"v":0.432279,"d":"0.43"},{"v":0.357313,"d":"0.36"},{"v":0.119308,"d":"0.12"},{"v":1.03330509406975,"d":"1.03"},{"v":0.0472662878084661,"d":"0.05"},1,1,"up","no"]
["ENSOARG00000007066","GLTPD2","ENSOART00000007689","GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0120009(intermembrane lipid transfer);GO:0120013(intermembrane lipid transfer activity)","NA","NA","NA","glycolipid transfer protein domain containing 2 [Source:HGNC Symbol;Acc:HGNC:33756]",{"v":0.243286,"d":"0.24"},{"v":0.204638,"d":"0.20"},{"v":0.123384,"d":"0.12"},{"v":0.413118,"d":"0.41"},{"v":0.077314,"d":"0.08"},{"v":0.285823,"d":"0.29"},{"v":0.735979800452171,"d":"0.74"},{"v":-0.442261923968372,"d":"-0.44"},1,1,"down","no"]
["ENSOARG00000021642","ENSOARG00000021642","ENSOART00000023544","NA","NA","NA","NA",null,{"v":0.124148,"d":"0.12"},0,{"v":0.742893,"d":"0.74"},{"v":0.515409,"d":"0.52"},{"v":0.851194,"d":"0.85"},{"v":0.285065,"d":"0.29"},{"v":0.524948718507594,"d":"0.52"},{"v":-0.929751600048298,"d":"-0.93"},1,1,"down","no"]
["MSTRG.15747","ENSOARG00000021206","ENSOART00000023108","NA","NA","NA","NA",null,{"v":0.124148,"d":"0.12"},{"v":0.152319,"d":"0.15"},0,{"v":0.776296,"d":"0.78"},{"v":1.28322,"d":"1.28"},{"v":0.241276,"d":"0.24"},{"v":0.120161666069771,"d":"0.12"},{"v":-3.0569513734777,"d":"-3.06"},1,1,"down","no"]
["ENSOARG00000020393","ENSOARG00000020393","ENSOART00000022206;ENSOART00000022204","GO:0003796(lysozyme activity);GO:0003824(catalytic activity);GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0019835(cytolysis);GO:0042742(defense response to bacterium);GO:0042742(defense response to bacterium)","04970(Salivary secretion);04970(Salivary secretion)","K13915","EC:3.2.1.17","Ovis aries lysozyme C-1-like (LOC443320), mRNA. [Source:RefSeq mRNA;Acc:NM_001308588]",{"v":0.0383627300613497,"d":"0.04"},{"v":0.0454337261866322,"d":"0.05"},{"v":0.0363083629318696,"d":"0.04"},{"v":0.0448341344849855,"d":"0.04"},0,{"v":0.0250822166612851,"d":"0.03"},{"v":1.7178359169314,"d":"1.72"},{"v":0.780592240705411,"d":"0.78"},1,1,"up","no"]
["ENSOARG00000023350","ENSOARG00000023350","ENSOART00000025252","NA","NA","NA","NA",null,0,{"v":0.080116,"d":"0.08"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000016727","HGF","ENSOART00000018220","GO:0000187(activation of MAPK activity);GO:0000902(cell morphogenesis);GO:0001889(liver development);GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0014068(positive regulation of phosphatidylinositol 3-kinase signaling);GO:0030335(positive regulation of cell migration);GO:0032715(negative regulation of interleukin-6 production);GO:0032733(positive regulation of interleukin-10 production);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0035729(cellular response to hepatocyte growth factor stimulus);GO:0042056(chemoattractant activity);GO:0042802(identical protein binding);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0048012(hepatocyte growth factor receptor signaling pathway);GO:0050673(epithelial cell proliferation);GO:0050728(negative regulation of inflammatory response);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050918(positive chemotaxis);GO:0051450(myoblast proliferation);GO:0060326(cell chemotaxis);GO:0060665(regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling);GO:0090201(negative regulation of release of cytochrome c from mitochondria);GO:1900744(regulation of p38MAPK cascade);GO:1901299(negative regulation of hydrogen peroxide-mediated programmed cell death);GO:1902042(negative regulation of extrinsic apoptotic signaling pathway via death domain receptors);GO:1902947(regulation of tau-protein kinase activity);GO:2000573(positive regulation of DNA biosynthetic process)","01521(EGFR tyrosine kinase inhibitor resistance);04010(MAPK signaling pathway);04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);05144(Malaria);05200(Pathways in cancer);05205(Proteoglycans in cancer);05211(Renal cell carcinoma);05218(Melanoma);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K05460","NA","hepatocyte growth factor [Source:NCBI gene;Acc:443075]",{"v":0.097419,"d":"0.10"},{"v":0.024482,"d":"0.02"},{"v":0.214984,"d":"0.21"},{"v":0.051499,"d":"0.05"},{"v":0.046056,"d":"0.05"},{"v":0.137637,"d":"0.14"},{"v":1.43238290418041,"d":"1.43"},{"v":0.518417204976519,"d":"0.52"},1,1,"up","no"]
["MSTRG.7298","RF00026","ENSOART00000025808","NA","NA","NA","NA",null,{"v":2.02338,"d":"2.02"},{"v":1.244571,"d":"1.24"},{"v":1.300823,"d":"1.30"},{"v":2.598109,"d":"2.60"},{"v":2.74441,"d":"2.74"},{"v":1.522736,"d":"1.52"},{"v":0.665492250469939,"d":"0.67"},{"v":-0.587506228560389,"d":"-0.59"},1,1,"down","no"]
["ENSOARG00000005154","ENSOARG00000005154","ENSOART00000005615","GO:0005515(protein binding);GO:0005634(nucleus);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033085(negative regulation of T cell differentiation in thymus);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0050852(T cell receptor signaling pathway);GO:0051059(NF-kappaB binding);GO:0070245(positive regulation of thymocyte apoptotic process);GO:2000321(positive regulation of T-helper 17 cell differentiation)","NA","K14214","NA","NFKB inhibitor delta [Source:NCBI gene;Acc:101104928]",{"v":0.35039,"d":"0.35"},{"v":0.267538,"d":"0.27"},{"v":0.13711,"d":"0.14"},{"v":0.288286,"d":"0.29"},{"v":0.203589,"d":"0.20"},{"v":0.47879,"d":"0.48"},{"v":0.777856418022696,"d":"0.78"},{"v":-0.362424217469663,"d":"-0.36"},1,1,"down","no"]
["ENSOARG00000021044","ENSOARG00000021044","ENSOART00000022928","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding)","05167(Kaposi sarcoma-associated herpesvirus infection)","K10071","NA","C-type lectin domain family 2 member B [Source:NCBI gene;Acc:101120999]",{"v":1.036551,"d":"1.04"},{"v":0.446992,"d":"0.45"},{"v":1.734493,"d":"1.73"},{"v":0.423811,"d":"0.42"},0,0,{"v":7.59309220383614,"d":"7.59"},{"v":2.92468752709633,"d":"2.92"},1,1,"up","no"]
["ENSOARG00000024099","RF00493","ENSOART00000026001","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.240405,"d":"0.24"},"-inf","-inf",1,1,"down","no"]
["MSTRG.15945","AVIL","ENSOART00000005453","GO:0003779(actin binding);GO:0007010(cytoskeleton organization);GO:0010976(positive regulation of neuron projection development);GO:0051015(actin filament binding);GO:0060271(cilium assembly)","NA","K08017","NA","advillin [Source:NCBI gene;Acc:101114855]",{"v":0.131313,"d":"0.13"},{"v":0.168491,"d":"0.17"},{"v":0.153356,"d":"0.15"},{"v":0.227553,"d":"0.23"},{"v":0.109345,"d":"0.11"},{"v":0.071983,"d":"0.07"},{"v":1.10829312195969,"d":"1.11"},{"v":0.1483394966129,"d":"0.15"},1,1,"up","no"]
["ENSOARG00000009120","CACNA2D2","ENSOART00000009936","GO:0005245(voltage-gated calcium channel activity);GO:0005891(voltage-gated calcium channel complex);GO:0007528(neuromuscular junction development);GO:0040014(regulation of multicellular organism growth);GO:0046622(positive regulation of organ growth);GO:0048747(muscle fiber development);GO:0060024(rhythmic synaptic transmission);GO:0070588(calcium ion transmembrane transport)","04010(MAPK signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04921(Oxytocin signaling pathway);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","K04859","NA","calcium voltage-gated channel auxiliary subunit alpha2delta 2 [Source:NCBI gene;Acc:101115165]",{"v":0.027105,"d":"0.03"},0,{"v":0.003847,"d":"0.00"},{"v":0.035941,"d":"0.04"},{"v":0.029684,"d":"0.03"},{"v":0.016878,"d":"0.02"},{"v":0.375162115317019,"d":"0.38"},{"v":-1.41441394614871,"d":"-1.41"},1,1,"down","no"]
["MSTRG.225","RF00218","ENSOART00000026895","NA","NA","NA","NA","small nucleolar RNA, C/D box 46 [Source:HGNC Symbol;Acc:HGNC:10186]",{"v":2.133203,"d":"2.13"},{"v":1.515271,"d":"1.52"},{"v":3.456132,"d":"3.46"},{"v":1.53136,"d":"1.53"},{"v":2.078123,"d":"2.08"},{"v":1.431808,"d":"1.43"},{"v":1.4092830586451,"d":"1.41"},{"v":0.494961410291928,"d":"0.49"},1,1,"up","no"]
["MSTRG.3150","HOXB7","ENSOART00000007506","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0016604(nuclear body);GO:0030099(myeloid cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis)","NA","K09307","NA","homeobox B7 [Source:NCBI gene;Acc:101115137]",{"v":0.639725,"d":"0.64"},0,{"v":0.222231,"d":"0.22"},{"v":0.266768,"d":"0.27"},{"v":0.47699,"d":"0.48"},{"v":0.321051,"d":"0.32"},{"v":0.809493533582079,"d":"0.81"},{"v":-0.304908538888648,"d":"-0.30"},1,1,"down","no"]
["MSTRG.11050","PADI4","ENSOART00000011986","GO:0004668(protein-arginine deiminase activity);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006338(chromatin remodeling);GO:0016990(arginine deiminase activity);GO:0018101(protein citrullination);GO:0019546(arginine deiminase pathway);GO:0019827(stem cell population maintenance);GO:0032991(protein-containing complex);GO:0034618(arginine binding);GO:0036413(histone H3-R26 citrullination);GO:0036414(histone citrullination);GO:0042803(protein homodimerization activity)","NA","NA","NA","peptidyl arginine deiminase 4 [Source:HGNC Symbol;Acc:HGNC:18368]",{"v":0.013762,"d":"0.01"},{"v":0.024866,"d":"0.02"},0,{"v":0.390669,"d":"0.39"},{"v":0.11212,"d":"0.11"},{"v":0.152741,"d":"0.15"},{"v":0.0589263649260903,"d":"0.06"},{"v":-4.08494291840713,"d":"-4.08"},1,1,"down","no"]
["ENSOARG00000022408","RF00026","ENSOART00000024310","NA","NA","NA","NA",null,0,0,0,{"v":0.128852,"d":"0.13"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.7837","ENSOARG00000010261","ENSOART00000011160","NA","NA","NA","NA",null,0,0,0,{"v":0.034652,"d":"0.03"},0,{"v":0.124814,"d":"0.12"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000019547","SPDYA","ENSOART00000021289","GO:0000082(G1/S transition of mitotic cell cycle);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006974(cellular response to DNA damage stimulus);GO:0008284(positive regulation of cell population proliferation);GO:0019901(protein kinase binding);GO:0030295(protein kinase activator activity);GO:0032147(activation of protein kinase activity);GO:0045860(positive regulation of protein kinase activity)","04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)","K08694","NA","speedy/RINGO cell cycle regulator family member A [Source:NCBI gene;Acc:101123454]",{"v":0.219396,"d":"0.22"},{"v":0.217523,"d":"0.22"},{"v":0.294531,"d":"0.29"},{"v":0.251195,"d":"0.25"},{"v":0.223509,"d":"0.22"},{"v":0.241027,"d":"0.24"},{"v":1.02196216176189,"d":"1.02"},{"v":0.031341781354746,"d":"0.03"},1,1,"up","no"]
["MSTRG.21534","ENSOARG00000013513","ENSOART00000014692","GO:0005515(protein binding)","NA","K11464","NA","Scm polycomb group protein like 1 [Source:NCBI gene;Acc:101103129]",{"v":0.647231,"d":"0.65"},{"v":0.425653,"d":"0.43"},{"v":0.328374,"d":"0.33"},{"v":0.74909,"d":"0.75"},{"v":0.795164,"d":"0.80"},{"v":0.417778,"d":"0.42"},{"v":0.714187128446427,"d":"0.71"},{"v":-0.485625961934884,"d":"-0.49"},1,1,"down","no"]
["MSTRG.9442","RF00026","ENSOART00000023810","NA","NA","NA","NA","RNA, U6 small nuclear 414, pseudogene [Source:HGNC Symbol;Acc:HGNC:47377]",{"v":0.124148,"d":"0.12"},{"v":0.581108,"d":"0.58"},{"v":0.081561,"d":"0.08"},{"v":0.009817,"d":"0.01"},{"v":0.158239,"d":"0.16"},0,{"v":4.68187389917647,"d":"4.68"},{"v":2.22708607766165,"d":"2.23"},1,1,"up","no"]
["ENSOARG00000004888","ENSOARG00000004888","ENSOART00000005323","GO:0045735(nutrient reservoir activity)","NA","NA","NA",null,0,0,0,0,{"v":0.080332,"d":"0.08"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000009584","ENSOARG00000009584","ENSOART00000010434","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,0,0,0,0,{"v":0.026937,"d":"0.03"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000016573","TARSL2","ENSOART00000018053","GO:0000166(nucleotide binding);GO:0004812(aminoacyl-tRNA ligase activity);GO:0004829(threonine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006418(tRNA aminoacylation for protein translation);GO:0006435(threonyl-tRNA aminoacylation);GO:0043039(tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)","K01868","EC:6.1.1.3","threonyl-tRNA synthetase like 2 [Source:NCBI gene;Acc:101111581]",0,{"v":0.050044,"d":"0.05"},{"v":0.131753,"d":"0.13"},{"v":0.032422,"d":"0.03"},{"v":0.05115,"d":"0.05"},{"v":0.015366,"d":"0.02"},{"v":1.83748408093958,"d":"1.84"},{"v":0.877731751201241,"d":"0.88"},1,1,"up","no"]
["MSTRG.21934","FGF16","ENSOART00000020373","GO:0005104(fibroblast growth factor receptor binding);GO:0005576(extracellular region);GO:0008083(growth factor activity);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010469(regulation of signaling receptor activity);GO:2000546(positive regulation of endothelial cell chemotaxis to fibroblast growth factor)","NA","NA","NA","fibroblast growth factor 16 [Source:HGNC Symbol;Acc:HGNC:3672]",{"v":0.188501,"d":"0.19"},0,{"v":0.110713,"d":"0.11"},{"v":0.223827,"d":"0.22"},{"v":0.059059,"d":"0.06"},{"v":0.149869,"d":"0.15"},{"v":0.691416621413964,"d":"0.69"},{"v":-0.532372808985539,"d":"-0.53"},1,1,"down","no"]
["MSTRG.13699","ZCWPW1","ENSOART00000018491","GO:0008270(zinc ion binding);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger CW-type and PWWP domain containing 1 [Source:NCBI gene;Acc:101106228]",{"v":0.028342,"d":"0.03"},{"v":0.045304,"d":"0.05"},{"v":0.024944,"d":"0.02"},{"v":0.081719,"d":"0.08"},{"v":0.062653,"d":"0.06"},{"v":0.043001,"d":"0.04"},{"v":0.526169725627492,"d":"0.53"},{"v":-0.926399852737758,"d":"-0.93"},1,1,"down","no"]
["ENSOARG00000015130","C8orf74","ENSOART00000016466","NA","NA","NA","NA","chromosome 2 open reading frame, human C8orf74 [Source:NCBI gene;Acc:101117647]",0,0,0,{"v":0.034212,"d":"0.03"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000013121","KCNH6","ENSOART00000014266","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA","K04909","NA","potassium voltage-gated channel subfamily H member 6 [Source:NCBI gene;Acc:101102319]",{"v":0.017183,"d":"0.02"},0,{"v":0.034275,"d":"0.03"},{"v":0.01181,"d":"0.01"},0,0,{"v":4.3571549534293,"d":"4.36"},{"v":2.12338642070521,"d":"2.12"},1,1,"up","no"]
["ENSOARG00000002619","CLEC4D","ENSOART00000002835","GO:0002250(adaptive immune response);GO:0002292(T cell differentiation involved in immune response);GO:0005886(plasma membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding);GO:0030887(positive regulation of myeloid dendritic cell activation);GO:0034987(immunoglobulin receptor binding);GO:0038094(Fc-gamma receptor signaling pathway);GO:0042742(defense response to bacterium);GO:0045087(innate immune response)","04625(C-type lectin receptor signaling pathway)","K10058","NA","C-type lectin domain family 4 member D [Source:NCBI gene;Acc:101104735]",0,{"v":0.093087,"d":"0.09"},{"v":0.292715,"d":"0.29"},{"v":0.032496,"d":"0.03"},{"v":0.112193,"d":"0.11"},0,{"v":2.66642246473471,"d":"2.67"},{"v":1.41490537738559,"d":"1.41"},1,1,"up","no"]
["ENSOARG00000006907","CDH2","ENSOART00000007509;ENSOART00000007508","GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0005913(cell-cell adherens junction);GO:0005916(fascia adherens);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0008013(beta-catenin binding);GO:0009966(regulation of signal transduction);GO:0009986(cell surface);GO:0010001(glial cell differentiation);GO:0014069(postsynaptic density);GO:0014704(intercalated disc);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016339(calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0016342(catenin complex);GO:0016477(cell migration);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0021537(telencephalon development);GO:0021987(cerebral cortex development);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030864(cortical actin cytoskeleton);GO:0042383(sarcolemma);GO:0042802(identical protein binding);GO:0043410(positive regulation of MAPK cascade);GO:0044331(cell-cell adhesion mediated by cadherin);GO:0044853(plasma membrane raft);GO:0045202(synapse);GO:0045294(alpha-catenin binding);GO:0045295(gamma-catenin binding);GO:0046872(metal ion binding);GO:0048514(blood vessel morphogenesis);GO:0048854(brain morphogenesis);GO:0048872(homeostasis of number of cells);GO:0051146(striated muscle cell differentiation);GO:0060019(radial glial cell differentiation);GO:0060563(neuroepithelial cell differentiation);GO:0070445(regulation of oligodendrocyte progenitor proliferation);GO:0072659(protein localization to plasma membrane);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0097118(neuroligin clustering involved in postsynaptic membrane assembly);GO:0097150(neuronal stem cell population maintenance);GO:0098609(cell-cell adhesion);GO:1902897(regulation of postsynaptic density protein 95 clustering);GO:2000809(positive regulation of synaptic vesicle clustering);GO:2000809(positive regulation of synaptic vesicle clustering)","04514(Cell adhesion molecules (CAMs));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC))","K06736","NA","cadherin 2 [Source:NCBI gene;Acc:100170321]",{"v":0.0913463887665198,"d":"0.09"},{"v":0.0174172883259912,"d":"0.02"},{"v":0.0542896030837004,"d":"0.05"},{"v":0.0982110561674009,"d":"0.10"},{"v":0.0462042614537445,"d":"0.05"},{"v":0.0728469977973568,"d":"0.07"},{"v":0.750490391590136,"d":"0.75"},{"v":-0.414094493519743,"d":"-0.41"},1,1,"down","no"]
["ENSOARG00000017811","NDST3","ENSOART00000019384","GO:0008146(sulfotransferase activity);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0015014(heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process);GO:0015016([heparan sulfate]-glucosamine N-sulfotransferase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0042328(heparan sulfate N-acetylglucosaminyltransferase activity)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)","K02578","2.8.2.-;EC:3.1.1.-","N-deacetylase and N-sulfotransferase 3 [Source:NCBI gene;Acc:101111805]",{"v":0.141187,"d":"0.14"},{"v":0.035619,"d":"0.04"},{"v":0.0649,"d":"0.06"},{"v":0.205778,"d":"0.21"},{"v":0.319866,"d":"0.32"},{"v":0.328672,"d":"0.33"},{"v":0.282923414755196,"d":"0.28"},{"v":-1.82151651570238,"d":"-1.82"},1,1,"down","no"]
["ENSOARG00000000746","ENSOARG00000000746","ENSOART00000000796","NA","NA","NA","NA","family with sequence similarity 25 member A [Source:NCBI gene;Acc:101113302]",0,0,0,0,{"v":0.142313,"d":"0.14"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000005728","GNB3","ENSOART00000006239","GO:0005515(protein binding);GO:0006884(cell volume homeostasis);GO:0007165(signal transduction);GO:0010468(regulation of gene expression);GO:0010906(regulation of glucose metabolic process);GO:0030425(dendrite);GO:0032350(regulation of hormone metabolic process);GO:0045598(regulation of fat cell differentiation);GO:0051020(GTPase binding);GO:0090181(regulation of cholesterol metabolic process);GO:0090207(regulation of triglyceride metabolic process);GO:1903725(regulation of phospholipid metabolic process)","04014(Ras signaling pathway);04062(Chemokine signaling pathway);04151(PI3K-Akt signaling pathway);04371(Apelin signaling pathway);04713(Circadian entrainment);04723(Retrograde endocannabinoid signaling);04724(Glutamatergic synapse);04725(Cholinergic synapse);04726(Serotonergic synapse);04727(GABAergic synapse);04728(Dopaminergic synapse);04742(Taste transduction);04926(Relaxin signaling pathway);05032(Morphine addiction);05034(Alcoholism);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05170(Human immunodeficiency virus 1 infection);05200(Pathways in cancer)","K07825","NA","G protein subunit beta 3 [Source:NCBI gene;Acc:101110493]",{"v":0.260357,"d":"0.26"},0,{"v":0.3317,"d":"0.33"},{"v":0.247576,"d":"0.25"},{"v":0.357755,"d":"0.36"},0,{"v":0.978071501376933,"d":"0.98"},{"v":-0.0319881584304129,"d":"-0.03"},1,1,"down","no"]
["ENSOARG00000021080","ENSOARG00000021080","ENSOART00000022966","GO:0005509(calcium ion binding);GO:0008270(zinc ion binding);GO:0046872(metal ion binding);GO:0046914(transition metal ion binding)","NA","NA","NA",null,{"v":0.00917,"d":"0.01"},{"v":0.021395,"d":"0.02"},{"v":0.006785,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000004040","TBX6","ENSOART00000004394","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000790(nuclear chromatin);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001707(mesoderm formation);GO:0001708(cell fate specification);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0010977(negative regulation of neuron projection development);GO:0014043(negative regulation of neuron maturation);GO:0023019(signal transduction involved in regulation of gene expression);GO:0032525(somite rostral/caudal axis specification);GO:0043433(negative regulation of DNA-binding transcription factor activity);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K10180","NA","T-box 6 [Source:NCBI gene;Acc:101115502]",{"v":0.101392,"d":"0.10"},{"v":0.039265,"d":"0.04"},{"v":0.129003,"d":"0.13"},{"v":0.04214,"d":"0.04"},{"v":0.061843,"d":"0.06"},0,{"v":2.59330852158526,"d":"2.59"},{"v":1.374793851422,"d":"1.37"},1,1,"up","no"]
["MSTRG.8517","RF00181","ENSOART00000026663","NA","NA","NA","NA",null,{"v":0.015306,"d":"0.02"},{"v":0.236617,"d":"0.24"},{"v":0.518564,"d":"0.52"},{"v":0.944329,"d":"0.94"},{"v":1.048036,"d":"1.05"},{"v":0.421439,"d":"0.42"},{"v":0.31920031618143,"d":"0.32"},{"v":-1.64746601427587,"d":"-1.65"},1,1,"down","no"]
["MSTRG.4169","PAPPA2","ENSOART00000016060","GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0060349(bone morphogenesis)","NA","K08647","EC:3.4.24.-","pappalysin 2 [Source:NCBI gene;Acc:101118205]",{"v":0.016613,"d":"0.02"},{"v":0.015009,"d":"0.02"},{"v":0.037284,"d":"0.04"},{"v":0.027602,"d":"0.03"},{"v":0.017195,"d":"0.02"},{"v":0.050651,"d":"0.05"},{"v":0.721921884167295,"d":"0.72"},{"v":-0.470085356696615,"d":"-0.47"},1,1,"down","no"]
["ENSOARG00000011317","CCDC180","ENSOART00000012308","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","coiled-coil domain containing 180 [Source:NCBI gene;Acc:101104813]",{"v":0.00146177917434175,"d":"0.00"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000011569","DEPDC1","ENSOART00000012584","GO:0005634(nucleus);GO:0007165(signal transduction);GO:0017053(transcriptional repressor complex);GO:0035556(intracellular signal transduction);GO:0045892(negative regulation of transcription, DNA-templated)","NA","NA","NA","DEP domain containing 1 [Source:NCBI gene;Acc:101116779]",{"v":0.12807,"d":"0.13"},{"v":0.060711,"d":"0.06"},{"v":0.065949,"d":"0.07"},{"v":0.098152,"d":"0.10"},0,0,{"v":2.59526041242155,"d":"2.60"},{"v":1.37587930808589,"d":"1.38"},1,1,"up","no"]
["MSTRG.858","RF00418","ENSOART00000025348","NA","NA","NA","NA",null,{"v":1.131834,"d":"1.13"},{"v":1.465479,"d":"1.47"},{"v":0.716607,"d":"0.72"},{"v":1.90551,"d":"1.91"},{"v":0.635534,"d":"0.64"},{"v":1.640964,"d":"1.64"},{"v":0.792423161313895,"d":"0.79"},{"v":-0.3356570462799,"d":"-0.34"},1,1,"down","no"]
["ENSOARG00000005115","METTL18","ENSOART00000005570","GO:0031072(heat shock protein binding);GO:0032991(protein-containing complex)","NA","NA","NA","methyltransferase like 18 [Source:NCBI gene;Acc:101102324]",{"v":0.224065,"d":"0.22"},{"v":0.079473,"d":"0.08"},{"v":0.181859,"d":"0.18"},{"v":0.224515,"d":"0.22"},{"v":0.265978,"d":"0.27"},{"v":0.158451,"d":"0.16"},{"v":0.747979794866737,"d":"0.75"},{"v":-0.418928795682561,"d":"-0.42"},1,1,"down","no"]
["MSTRG.6251","PIH1D2","ENSOART00000017207","GO:0017160(Ral GTPase binding)","NA","NA","NA","PIH1 domain containing 2 [Source:NCBI gene;Acc:101110702]",{"v":0.683762,"d":"0.68"},{"v":0.653775,"d":"0.65"},{"v":0.383981,"d":"0.38"},{"v":0.220612,"d":"0.22"},{"v":0.318913,"d":"0.32"},{"v":0.151047,"d":"0.15"},{"v":2.49288705594782,"d":"2.49"},{"v":1.31781752080971,"d":"1.32"},1,1,"up","no"]
["ENSOARG00000013009","ATP8A2","ENSOART00000014163","GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0004012(phospholipid-translocating ATPase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0015914(phospholipid transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045332(phospholipid translocation)","NA","K14802","EC:7.6.2.1","phospholipid-transporting ATPase IB [Source:NCBI gene;Acc:101115632]",{"v":0.008298,"d":"0.01"},{"v":0.008958,"d":"0.01"},{"v":0.028028,"d":"0.03"},{"v":0.009889,"d":"0.01"},{"v":0.066716,"d":"0.07"},0,{"v":0.591136348802298,"d":"0.59"},{"v":-0.758437160672241,"d":"-0.76"},1,1,"down","no"]
["ENSOARG00000017094","MZB1","ENSOART00000018607","GO:0002642(positive regulation of immunoglobulin biosynthetic process);GO:0005576(extracellular region);GO:0005788(endoplasmic reticulum lumen);GO:0008284(positive regulation of cell population proliferation);GO:0030888(regulation of B cell proliferation);GO:0033622(integrin activation);GO:0034663(endoplasmic reticulum chaperone complex);GO:0042127(regulation of cell population proliferation);GO:0046626(regulation of insulin receptor signaling pathway)","NA","NA","NA","marginal zone B and B1 cell specific protein [Source:NCBI gene;Acc:101114700]",{"v":0.40741,"d":"0.41"},{"v":0.110355,"d":"0.11"},{"v":0.104107,"d":"0.10"},{"v":0.353721,"d":"0.35"},{"v":0.215784,"d":"0.22"},{"v":0.309035,"d":"0.31"},{"v":0.707847109977918,"d":"0.71"},{"v":-0.498490312963454,"d":"-0.50"},1,1,"down","no"]
["MSTRG.20559","RF00026","ENSOART00000023145","NA","NA","NA","NA",null,{"v":0.225306,"d":"0.23"},0,{"v":0.136757,"d":"0.14"},0,{"v":0.118066,"d":"0.12"},{"v":0.088728,"d":"0.09"},{"v":1.75083899919727,"d":"1.75"},{"v":0.808046424868594,"d":"0.81"},1,1,"up","no"]
["MSTRG.5910","RF00133","ENSOART00000024965","NA","NA","NA","NA","small nucleolar RNA, C/D box 32A [Source:HGNC Symbol;Acc:HGNC:10159]",{"v":1.35972,"d":"1.36"},{"v":1.472799,"d":"1.47"},{"v":1.640094,"d":"1.64"},{"v":3.824154,"d":"3.82"},{"v":1.887519,"d":"1.89"},{"v":2.018883,"d":"2.02"},{"v":0.578562913197964,"d":"0.58"},{"v":-0.789454247700422,"d":"-0.79"},1,1,"down","no"]
["ENSOARG00000017670","PLPPR4","ENSOART00000019225","GO:0005887(integral component of plasma membrane);GO:0007409(axonogenesis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042577(lipid phosphatase activity);GO:0046839(phospholipid dephosphorylation);GO:0048839(inner ear development);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane)","NA","K19582","NA","phospholipid phosphatase related 4 [Source:NCBI gene;Acc:101110549]",{"v":0.097402,"d":"0.10"},0,{"v":0.034483,"d":"0.03"},{"v":0.092669,"d":"0.09"},{"v":0.080295,"d":"0.08"},{"v":0.162732,"d":"0.16"},{"v":0.392870335065059,"d":"0.39"},{"v":-1.34787485829531,"d":"-1.35"},1,1,"down","no"]
["ENSOARG00000013084","ZWINT","ENSOART00000014221","GO:0000070(mitotic sister chromatid segregation);GO:0000776(kinetochore);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007093(mitotic cell cycle checkpoint);GO:0016604(nuclear body);GO:0047485(protein N-terminus binding);GO:0051649(establishment of localization in cell)","NA","K19943","NA","ZW10 interacting kinetochore protein [Source:NCBI gene;Acc:101115332]",{"v":0.556008,"d":"0.56"},{"v":0.895591,"d":"0.90"},{"v":0.527705,"d":"0.53"},{"v":1.453383,"d":"1.45"},{"v":0.721929,"d":"0.72"},{"v":0.737591,"d":"0.74"},{"v":0.679495335066084,"d":"0.68"},{"v":-0.55746444838348,"d":"-0.56"},1,1,"down","no"]
["ENSOARG00000021185","PLEKHD1","ENSOART00000023084","NA","NA","NA","NA","pleckstrin homology and coiled-coil domain containing D1 [Source:NCBI gene;Acc:101118957]",{"v":0.044566,"d":"0.04"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.7427","RF00004","ENSOART00000023724","NA","NA","NA","NA","RNA, U2 small nuclear 23, pseudogene [Source:HGNC Symbol;Acc:HGNC:48516]",{"v":0.221941,"d":"0.22"},{"v":0.261294,"d":"0.26"},{"v":0.007627,"d":"0.01"},{"v":1.215099,"d":"1.22"},{"v":0.694363,"d":"0.69"},{"v":0.435315,"d":"0.44"},{"v":0.209342722143726,"d":"0.21"},{"v":-2.25606133162006,"d":"-2.26"},1,1,"down","no"]
["ENSOARG00000012709","BTBD17","ENSOART00000013816","GO:0005515(protein binding)","NA","NA","NA","BTB domain containing 17 [Source:NCBI gene;Acc:101105933]",0,0,0,{"v":0.031907,"d":"0.03"},{"v":0.059979,"d":"0.06"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000020581","THPO","ENSOART00000022423","GO:0001934(positive regulation of protein phosphorylation);GO:0005125(cytokine activity);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0008283(cell population proliferation);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0030099(myeloid cell differentiation);GO:0035855(megakaryocyte development);GO:0038163(thrombopoietin-mediated signaling pathway);GO:0043410(positive regulation of MAPK cascade);GO:0045654(positive regulation of megakaryocyte differentiation);GO:0051897(positive regulation of protein kinase B signaling);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0097696(receptor signaling pathway via STAT);GO:1902035(positive regulation of hematopoietic stem cell proliferation)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway);04640(Hematopoietic cell lineage)","K06854","NA","thrombopoietin [Source:NCBI gene;Acc:101119601]",{"v":0.426575,"d":"0.43"},{"v":0.409515,"d":"0.41"},{"v":0.392574,"d":"0.39"},{"v":0.172948,"d":"0.17"},{"v":0.239431,"d":"0.24"},{"v":0.138086,"d":"0.14"},{"v":2.2320474507916,"d":"2.23"},{"v":1.15836769754975,"d":"1.16"},1,1,"up","no"]
["ENSOARG00000018652","ZDBF2","ENSOART00000020299","GO:0003676(nucleic acid binding);GO:0008270(zinc ion binding)","NA","NA","NA","zinc finger DBF-type containing 2 [Source:NCBI gene;Acc:101105062]",0,0,{"v":0.016099,"d":"0.02"},{"v":0.0197,"d":"0.02"},0,0,{"v":0.817208121827411,"d":"0.82"},{"v":-0.291224552512376,"d":"-0.29"},1,1,"down","no"]
["MSTRG.15769","TEX49","ENSOART00000020890","NA","NA","NA","NA","testis expressed 49 [Source:HGNC Symbol;Acc:HGNC:48628]",{"v":0.294953,"d":"0.29"},{"v":0.215576,"d":"0.22"},{"v":0.183473,"d":"0.18"},{"v":0.346471,"d":"0.35"},{"v":0.261417,"d":"0.26"},{"v":0.323923,"d":"0.32"},{"v":0.744788374466496,"d":"0.74"},{"v":-0.425097541097037,"d":"-0.43"},1,1,"down","no"]
["MSTRG.18774","GRID2","ENSOART00000019848","GO:0004970(ionotropic glutamate receptor activity);GO:0005216(ion channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007157(heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules);GO:0008328(ionotropic glutamate receptor complex);GO:0010975(regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021707(cerebellar granule cell differentiation);GO:0030054(cell junction);GO:0030165(PDZ domain binding);GO:0034220(ion transmembrane transport);GO:0034613(cellular protein localization);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0035249(synaptic transmission, glutamatergic);GO:0036477(somatodendritic compartment);GO:0038023(signaling receptor activity);GO:0043197(dendritic spine);GO:0043523(regulation of neuron apoptotic process);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0051965(positive regulation of synapse assembly);GO:0060079(excitatory postsynaptic potential);GO:0060134(prepulse inhibition);GO:0097110(scaffold protein binding);GO:0098688(parallel fiber to Purkinje cell synapse);GO:0098978(glutamatergic synapse);GO:0099061(integral component of postsynaptic density membrane);GO:0099151(regulation of postsynaptic density assembly);GO:1900454(positive regulation of long-term synaptic depression);GO:1904861(excitatory synapse assembly)","04080(Neuroactive ligand-receptor interaction);04730(Long-term depression)","K05207","NA","glutamate ionotropic receptor delta type subunit 2 [Source:NCBI gene;Acc:101117078]",{"v":0.012593,"d":"0.01"},{"v":0.028202,"d":"0.03"},{"v":0.004829,"d":"0.00"},0,{"v":0.014965,"d":"0.01"},{"v":0.050389,"d":"0.05"},{"v":0.698105701257765,"d":"0.70"},{"v":-0.518482601238847,"d":"-0.52"},1,1,"down","no"]
["ENSOARG00000016938","CXorf58","ENSOART00000018450","NA","NA","NA","NA","chromosome X open reading frame, human CXorf58 [Source:NCBI gene;Acc:101114165]",{"v":0.07192,"d":"0.07"},{"v":0.058706,"d":"0.06"},{"v":0.052335,"d":"0.05"},{"v":0.073318,"d":"0.07"},{"v":0.016878,"d":"0.02"},{"v":0.047587,"d":"0.05"},{"v":1.3278924105296,"d":"1.33"},{"v":0.409138260326892,"d":"0.41"},1,1,"up","no"]
["ENSOARG00000005849","SOST","ENSOART00000006366","GO:0005615(extracellular space);GO:0008134(transcription factor binding);GO:0009612(response to mechanical stimulus);GO:0030279(negative regulation of ossification);GO:0030514(negative regulation of BMP signaling pathway);GO:0031333(negative regulation of protein complex assembly);GO:0045893(positive regulation of transcription, DNA-templated);GO:0071374(cellular response to parathyroid hormone stimulus);GO:0090090(negative regulation of canonical Wnt signaling pathway)","NA","NA","NA","sclerostin [Source:HGNC Symbol;Acc:HGNC:13771]",{"v":0.073257,"d":"0.07"},0,0,0,{"v":0.101637,"d":"0.10"},0,{"v":0.720770979072582,"d":"0.72"},{"v":-0.472387170848764,"d":"-0.47"},1,1,"down","no"]
["ENSOARG00000012178","ENSOARG00000012178","ENSOART00000013244","GO:0016020(membrane);GO:0016798(hydrolase activity, acting on glycosyl bonds)","NA","NA","NA",null,0,0,{"v":0.084873,"d":"0.08"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.9237","ENSOARG00000017972","ENSOART00000019558","NA","NA","NA","NA",null,{"v":0.325526,"d":"0.33"},{"v":0.047951,"d":"0.05"},{"v":0.447966,"d":"0.45"},{"v":0.140151,"d":"0.14"},{"v":6.070089,"d":"6.07"},{"v":0.498733,"d":"0.50"},{"v":0.122439455338395,"d":"0.12"},{"v":-3.02985956260293,"d":"-3.03"},1,1,"down","no"]
["MSTRG.7285","ENSOARG00000023290","ENSOART00000025192","NA","NA","NA","NA",null,{"v":0.392875,"d":"0.39"},{"v":0.841928,"d":"0.84"},{"v":0.592297,"d":"0.59"},{"v":1.114002,"d":"1.11"},{"v":0.893441,"d":"0.89"},{"v":0.663949,"d":"0.66"},{"v":0.683950539643751,"d":"0.68"},{"v":-0.548036095493595,"d":"-0.55"},1,1,"down","no"]
["MSTRG.3615","ENSOARG00000000186","ENSOART00000000190","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","small integral membrane protein 6 [Source:NCBI gene;Acc:105616429]",{"v":0.375894,"d":"0.38"},{"v":0.123379,"d":"0.12"},{"v":0.239267,"d":"0.24"},{"v":0.36365,"d":"0.36"},{"v":0.483712,"d":"0.48"},0,{"v":0.871575548584902,"d":"0.87"},{"v":-0.198302371620922,"d":"-0.20"},1,1,"down","no"]
["ENSOARG00000017344","BIN2","ENSOART00000018883;ENSOART00000018881","GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005737(cytoplasm)","NA","K20119","NA","bridging integrator 2 [Source:NCBI gene;Acc:101114507]",{"v":0.462024,"d":"0.46"},{"v":0.222717265082267,"d":"0.22"},{"v":0.457176288848263,"d":"0.46"},{"v":0.52254676416819,"d":"0.52"},{"v":0.424644,"d":"0.42"},{"v":0.390474722120658,"d":"0.39"},{"v":0.853664511520447,"d":"0.85"},{"v":-0.22825888998338,"d":"-0.23"},1,1,"down","no"]
["ENSOARG00000008521","ENSOARG00000008521","ENSOART00000009272","GO:0000187(activation of MAPK activity);GO:0005515(protein binding);GO:0030971(receptor tyrosine kinase binding);GO:0035556(intracellular signal transduction)","01521(EGFR tyrosine kinase inhibitor resistance);01522(Endocrine resistance);04012(ErbB signaling pathway);04014(Ras signaling pathway);04062(Chemokine signaling pathway);04072(Phospholipase D signaling pathway);04370(VEGF signaling pathway);04510(Focal adhesion);04650(Natural killer cell mediated cytotoxicity);04722(Neurotrophin signaling pathway);04910(Insulin signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04926(Relaxin signaling pathway);05034(Alcoholism);05100(Bacterial invasion of epithelial cells);05214(Glioma);05220(Chronic myeloid leukemia);05224(Breast cancer);05225(Hepatocellular carcinoma);05226(Gastric cancer)","K17447","NA","SHC adaptor protein 2 [Source:NCBI gene;Acc:101113847]",{"v":0.229347,"d":"0.23"},{"v":0.054849,"d":"0.05"},{"v":0.033824,"d":"0.03"},{"v":0.297454,"d":"0.30"},{"v":0.629804,"d":"0.63"},{"v":0.434705,"d":"0.43"},{"v":0.233501203777195,"d":"0.23"},{"v":-2.09849810735537,"d":"-2.10"},1,1,"down","no"]
["ENSOARG00000012907","TRIM50","ENSOART00000014029","GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0016235(aggresome);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0070201(regulation of establishment of protein localization)","NA","K12024","NA","tripartite motif containing 50 [Source:NCBI gene;Acc:101116793]",0,0,0,{"v":0.010338,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000011085","CCDC120","ENSOART00000012064","GO:0005814(centriole);GO:0008104(protein localization);GO:0034454(microtubule anchoring at centrosome);GO:0120103(centriolar subdistal appendage)","NA","NA","NA","coiled-coil domain containing 120 [Source:NCBI gene;Acc:101113309]",{"v":0.294099,"d":"0.29"},{"v":0.227049,"d":"0.23"},{"v":0.199005,"d":"0.20"},{"v":0.314606,"d":"0.31"},{"v":0.409672,"d":"0.41"},{"v":0.483669,"d":"0.48"},{"v":0.596179302568739,"d":"0.60"},{"v":-0.746181804428722,"d":"-0.75"},1,1,"down","no"]
["MSTRG.19793","RF00413","ENSOART00000025152","NA","NA","NA","NA",null,{"v":0.173414,"d":"0.17"},{"v":0.856351,"d":"0.86"},{"v":1.803611,"d":"1.80"},{"v":0.972528,"d":"0.97"},{"v":1.293101,"d":"1.29"},{"v":0.543372,"d":"0.54"},{"v":1.00867746220097,"d":"1.01"},{"v":0.0124649275940337,"d":"0.01"},1,1,"up","no"]
["MSTRG.8035","ENSOARG00000022547","ENSOART00000024449","NA","NA","NA","NA",null,0,0,{"v":0.081508,"d":"0.08"},{"v":0.096159,"d":"0.10"},0,0,{"v":0.847637766615709,"d":"0.85"},{"v":-0.238480226271937,"d":"-0.24"},1,1,"down","no"]
["ENSOARG00000020934","ENSOARG00000020934","ENSOART00000022806","GO:0003676(nucleic acid binding);GO:0005515(protein binding)","NA","K10495","NA","zinc finger and BTB domain containing 8B [Source:NCBI gene;Acc:101113392]",{"v":0.067422,"d":"0.07"},{"v":0.034331,"d":"0.03"},0,{"v":0.111996,"d":"0.11"},{"v":0.111949,"d":"0.11"},{"v":0.133945,"d":"0.13"},{"v":0.284313615915505,"d":"0.28"},{"v":-1.81444490285962,"d":"-1.81"},1,1,"down","no"]
["ENSOARG00000023291","ENSOARG00000023291","ENSOART00000025193","NA","NA","NA","NA",null,0,0,{"v":0.310288,"d":"0.31"},{"v":0.257705,"d":"0.26"},0,0,{"v":1.20404338293786,"d":"1.20"},{"v":0.267887374839914,"d":"0.27"},1,1,"up","no"]
["MSTRG.19640","RF00026","ENSOART00000026794","NA","NA","NA","NA",null,{"v":0.30863,"d":"0.31"},{"v":0.148851,"d":"0.15"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000008949","ENSOARG00000008949","ENSOART00000009748","NA","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);05163(Human cytomegalovirus infection);05167(Kaposi sarcoma-associated herpesvirus infection)","K04176","NA","C-C chemokine receptor type 1-like [Source:NCBI gene;Acc:101103766]",0,{"v":0.070125,"d":"0.07"},0,{"v":0.046289,"d":"0.05"},0,{"v":0.111689,"d":"0.11"},{"v":0.443890921520718,"d":"0.44"},{"v":-1.17172289199361,"d":"-1.17"},1,1,"down","no"]
["ENSOARG00000020373","MELTF","ENSOART00000022183","GO:0005506(iron ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006826(iron ion transport);GO:0009986(cell surface);GO:0010756(positive regulation of plasminogen activation);GO:0046658(anchored component of plasma membrane);GO:0090091(positive regulation of extracellular matrix disassembly);GO:1900025(negative regulation of substrate adhesion-dependent cell spreading)","NA","K06569","NA","melanotransferrin [Source:NCBI gene;Acc:101102773]",{"v":0.063166,"d":"0.06"},{"v":0.042801,"d":"0.04"},{"v":0.078937,"d":"0.08"},{"v":0.01639,"d":"0.02"},{"v":0.065532,"d":"0.07"},{"v":0.148016,"d":"0.15"},{"v":0.804147204898712,"d":"0.80"},{"v":-0.314468473659659,"d":"-0.31"},1,1,"down","no"]
["ENSOARG00000009525","MAL2","ENSOART00000010371","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0045056(transcytosis);GO:0045121(membrane raft)","NA","NA","NA","mal, T cell differentiation protein 2 [Source:NCBI gene;Acc:101120090]",{"v":0.234364,"d":"0.23"},{"v":0.135573,"d":"0.14"},0,{"v":0.031665,"d":"0.03"},{"v":0.233293,"d":"0.23"},{"v":0.076247,"d":"0.08"},{"v":1.08420744127431,"d":"1.08"},{"v":0.116640813763571,"d":"0.12"},1,1,"up","no"]
["MSTRG.19391","ENSOARG00000021412","ENSOART00000023314","NA","NA","NA","NA",null,{"v":0.197441,"d":"0.20"},{"v":0.166217,"d":"0.17"},{"v":1.018343,"d":"1.02"},{"v":0.850736,"d":"0.85"},{"v":0.515196,"d":"0.52"},0,{"v":1.01176412881461,"d":"1.01"},{"v":0.0168729957120063,"d":"0.02"},1,1,"up","no"]
["ENSOARG00000015930","ENSOARG00000015930","ENSOART00000017346","GO:0000166(nucleotide binding);GO:0004040(amidase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006412(translation);GO:0016874(ligase activity);GO:0016884(carbon-nitrogen ligase activity, with glutamine as amido-N-donor);GO:0030956(glutamyl-tRNA(Gln) amidotransferase complex);GO:0032543(mitochondrial translation);GO:0050567(glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity);GO:0070681(glutaminyl-tRNAGln biosynthesis via transamidation)","NA","NA","NA",null,{"v":0.07542,"d":"0.08"},{"v":0.091005,"d":"0.09"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000022485","RF00001","ENSOART00000024387","NA","NA","NA","NA",null,{"v":0.058088,"d":"0.06"},0,{"v":0.150305,"d":"0.15"},0,0,{"v":0.027762,"d":"0.03"},{"v":7.50641164181255,"d":"7.51"},{"v":2.90812340790643,"d":"2.91"},1,1,"up","no"]
["MSTRG.20061","ENSOARG00000023776","ENSOART00000025678","NA","NA","NA","NA",null,{"v":0.073898,"d":"0.07"},0,{"v":0.124115,"d":"0.12"},0,{"v":0.128799,"d":"0.13"},{"v":0.61242,"d":"0.61"},{"v":0.267145067786983,"d":"0.27"},{"v":-1.9043047134929,"d":"-1.90"},1,1,"down","no"]
["ENSOARG00000006531","ENSOARG00000006531","ENSOART00000007095","NA","NA","NA","NA",null,{"v":0.063112,"d":"0.06"},{"v":0.046632,"d":"0.05"},{"v":0.009029,"d":"0.01"},{"v":0.11605,"d":"0.12"},{"v":0.146834,"d":"0.15"},{"v":0.138832,"d":"0.14"},{"v":0.295664101006681,"d":"0.30"},{"v":-1.75796901018364,"d":"-1.76"},1,1,"down","no"]
["MSTRG.22032","ENSOARG00000007962","ENSOART00000008667","NA","NA","NA","NA","protein CXorf40A-like [Source:NCBI gene;Acc:101112543]",{"v":1.130169,"d":"1.13"},{"v":1.248221,"d":"1.25"},{"v":1.200304,"d":"1.20"},{"v":1.039246,"d":"1.04"},{"v":0.741002,"d":"0.74"},{"v":0.957352,"d":"0.96"},{"v":1.30723772647575,"d":"1.31"},{"v":0.386521524928911,"d":"0.39"},1,1,"up","no"]
["ENSOARG00000017898","ENSOARG00000017898","ENSOART00000019473","NA","NA","NA","NA",null,{"v":0.261503,"d":"0.26"},{"v":0.22104,"d":"0.22"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000009963","ENSOARG00000009963","ENSOART00000010843","GO:0005576(extracellular region);GO:0006953(acute-phase response);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034364(high-density lipoprotein particle)","NA","K17310","NA","serum amyloid A protein-like [Source:NCBI gene;Acc:101121216]",{"v":0.078424,"d":"0.08"},{"v":0.035408,"d":"0.04"},{"v":0.045468,"d":"0.05"},{"v":0.017812,"d":"0.02"},{"v":0.074712,"d":"0.07"},{"v":0.040257,"d":"0.04"},{"v":1.19971983943486,"d":"1.20"},{"v":0.262697544627602,"d":"0.26"},1,1,"up","no"]
["MSTRG.10292","RF00026","ENSOART00000025800","NA","NA","NA","NA",null,{"v":0.250617,"d":"0.25"},0,0,0,{"v":0.469454,"d":"0.47"},0,{"v":0.533847831736443,"d":"0.53"},{"v":-0.905499520922206,"d":"-0.91"},1,1,"down","no"]
["ENSOARG00000015200","C4orf17","ENSOART00000016541","NA","NA","NA","NA","chromosome 6 open reading frame, human C4orf17 [Source:NCBI gene;Acc:101111454]",{"v":0.168116,"d":"0.17"},{"v":0.065931,"d":"0.07"},{"v":0.03322,"d":"0.03"},{"v":0.109653,"d":"0.11"},{"v":0.01709,"d":"0.02"},{"v":0.031396,"d":"0.03"},{"v":1.69007645172918,"d":"1.69"},{"v":0.757088509250562,"d":"0.76"},1,1,"up","no"]
["ENSOARG00000021917","RF00026","ENSOART00000023819","NA","NA","NA","NA",null,0,{"v":0.112162,"d":"0.11"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.3436","C17orf58","ENSOART00000016768","NA","NA","NA","NA","chromosome 11 open reading frame, human C17orf58 [Source:NCBI gene;Acc:101107206]",{"v":0.985164,"d":"0.99"},{"v":0.383794,"d":"0.38"},0,{"v":0.656095,"d":"0.66"},{"v":0.619024,"d":"0.62"},{"v":0.777962,"d":"0.78"},{"v":0.666782265288121,"d":"0.67"},{"v":-0.584712362070434,"d":"-0.58"},1,1,"down","no"]
["MSTRG.17718","SYCE2","ENSOART00000011001","GO:0000801(central element);GO:0005634(nucleus);GO:0007130(synaptonemal complex assembly)","NA","NA","NA","synaptonemal complex central element protein 2 [Source:HGNC Symbol;Acc:HGNC:27411]",{"v":0.059084,"d":"0.06"},{"v":0.023106,"d":"0.02"},0,{"v":0.119566,"d":"0.12"},{"v":0.029537,"d":"0.03"},0,{"v":0.551229686860761,"d":"0.55"},{"v":-0.859274507401248,"d":"-0.86"},1,1,"down","no"]
["MSTRG.9620","PNMA2","ENSOART00000008856","NA","NA","NA","NA","PNMA family member 2 [Source:NCBI gene;Acc:101109768]",{"v":0.115735,"d":"0.12"},{"v":0.206145,"d":"0.21"},{"v":0.167874,"d":"0.17"},{"v":0.234459,"d":"0.23"},{"v":0.28968,"d":"0.29"},{"v":0.273649,"d":"0.27"},{"v":0.613889905588954,"d":"0.61"},{"v":-0.703948147602073,"d":"-0.70"},1,1,"down","no"]
["MSTRG.2959","RF00096","ENSOART00000026340","NA","NA","NA","NA",null,{"v":2.482967,"d":"2.48"},{"v":1.05812,"d":"1.06"},{"v":1.047679,"d":"1.05"},{"v":4.562889,"d":"4.56"},{"v":3.455792,"d":"3.46"},{"v":8.403287,"d":"8.40"},{"v":0.279428506985277,"d":"0.28"},{"v":-1.83944888448945,"d":"-1.84"},1,1,"down","no"]
["ENSOARG00000009256","CD3G","ENSOART00000010074","GO:0004888(transmembrane signaling receptor activity);GO:0007163(establishment or maintenance of cell polarity);GO:0007166(cell surface receptor signaling pathway);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042105(alpha-beta T cell receptor complex);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0051260(protein homooligomerization);GO:0070228(regulation of lymphocyte apoptotic process)","04640(Hematopoietic cell lineage);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);05142(Chagas disease (American trypanosomiasis));05162(Measles);05166(Human T-cell leukemia virus 1 infection);05169(Epstein-Barr virus infection);05170(Human immunodeficiency virus 1 infection)","K06452","NA","CD3g molecule [Source:NCBI gene;Acc:443398]",{"v":1.005952,"d":"1.01"},{"v":0.551697,"d":"0.55"},{"v":0.439034,"d":"0.44"},{"v":0.252055,"d":"0.25"},0,{"v":0.176897,"d":"0.18"},{"v":4.65479354333352,"d":"4.65"},{"v":2.21871718054148,"d":"2.22"},1,1,"up","no"]
["MSTRG.7803","RF01200","ENSOART00000023139","NA","NA","NA","NA","small nucleolar RNA, C/D box 125 [Source:HGNC Symbol;Acc:HGNC:33564]",{"v":0.245737,"d":"0.25"},{"v":0.54578,"d":"0.55"},{"v":0.312207,"d":"0.31"},{"v":0.394527,"d":"0.39"},{"v":0.718353,"d":"0.72"},{"v":0.527743,"d":"0.53"},{"v":0.672746877253336,"d":"0.67"},{"v":-0.571864305686972,"d":"-0.57"},1,1,"down","no"]
["MSTRG.450","RF00026","ENSOART00000023106","NA","NA","NA","NA",null,{"v":0.482799,"d":"0.48"},{"v":0.073736,"d":"0.07"},0,0,{"v":0.127606,"d":"0.13"},{"v":0.241666,"d":"0.24"},{"v":1.5071139972703,"d":"1.51"},{"v":0.591788545719035,"d":"0.59"},1,1,"up","no"]
["ENSOARG00000011673","ENSOARG00000011673","ENSOART00000012692","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 114 [Source:NCBI gene;Acc:101105435]",{"v":0.410113,"d":"0.41"},{"v":0.294352,"d":"0.29"},{"v":0.261515,"d":"0.26"},{"v":0.480611,"d":"0.48"},{"v":0.32086,"d":"0.32"},{"v":0.219771,"d":"0.22"},{"v":0.945887458604327,"d":"0.95"},{"v":-0.0802595525193024,"d":"-0.08"},1,1,"down","no"]
["MSTRG.11377","ENSOARG00000001720","ENSOART00000001847","NA","NA","NA","NA",null,{"v":0.146637,"d":"0.15"},{"v":0.026207,"d":"0.03"},{"v":0.087128,"d":"0.09"},{"v":0.297418,"d":"0.30"},{"v":0.183984,"d":"0.18"},{"v":0.058988,"d":"0.06"},{"v":0.481082181387516,"d":"0.48"},{"v":-1.05564472988821,"d":"-1.06"},1,1,"down","no"]
["MSTRG.16944","DUS4L","ENSOART00000006220","GO:0002943(tRNA dihydrouridine synthesis);GO:0003824(catalytic activity);GO:0008033(tRNA processing);GO:0016491(oxidoreductase activity);GO:0017150(tRNA dihydrouridine synthase activity);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","NA","K05545","EC:1.3.1.90","dihydrouridine synthase 4 like [Source:NCBI gene;Acc:101104143]",{"v":0.743461,"d":"0.74"},{"v":0.844469,"d":"0.84"},{"v":0.585246,"d":"0.59"},{"v":0.714543,"d":"0.71"},{"v":0.757461,"d":"0.76"},{"v":0.801027,"d":"0.80"},{"v":0.956069670849188,"d":"0.96"},{"v":-0.0648123405660656,"d":"-0.06"},1,1,"down","no"]
["MSTRG.4990","CNBD2","ENSOART00000016658","GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0030552(cAMP binding)","NA","NA","NA","cyclic nucleotide binding domain containing 2 [Source:NCBI gene;Acc:101120512]",0,0,0,{"v":0.04064,"d":"0.04"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.13871","ENSOARG00000003172","ENSOART00000003441","NA","NA","NA","NA",null,{"v":0.039044,"d":"0.04"},{"v":0.066354,"d":"0.07"},{"v":0.01585,"d":"0.02"},{"v":0.087241,"d":"0.09"},{"v":0.067739,"d":"0.07"},{"v":0.03403,"d":"0.03"},{"v":0.641489868260938,"d":"0.64"},{"v":-0.640501615426076,"d":"-0.64"},1,1,"down","no"]
["ENSOARG00000004394","FAM169A","ENSOART00000004786","NA","NA","NA","NA","family with sequence similarity 169 member A [Source:NCBI gene;Acc:101111393]",{"v":0.04878,"d":"0.05"},{"v":0.016083,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000007796","NRSN1","ENSOART00000008485","GO:0007399(nervous system development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030133(transport vesicle)","NA","NA","NA","neurensin 1 [Source:NCBI gene;Acc:101119514]",{"v":0.209741,"d":"0.21"},{"v":0.110441,"d":"0.11"},{"v":0.175222,"d":"0.18"},{"v":0.105515,"d":"0.11"},0,{"v":0.189039,"d":"0.19"},{"v":1.6818783652573,"d":"1.68"},{"v":0.750073372545837,"d":"0.75"},1,1,"up","no"]
["MSTRG.4326","MIR181B1","ENSOART00000023893","NA","NA","NA","NA","microRNA 181b-1 [Source:HGNC Symbol;Acc:HGNC:31550]",0,{"v":0.055062,"d":"0.06"},{"v":0.370089,"d":"0.37"},{"v":0.440441,"d":"0.44"},{"v":0.23418,"d":"0.23"},{"v":0.526124,"d":"0.53"},{"v":0.354072679877909,"d":"0.35"},{"v":-1.49788256470054,"d":"-1.50"},1,1,"down","no"]
["ENSOARG00000002173","PLAC8","ENSOART00000002343","GO:0003682(chromatin binding);GO:0008284(positive regulation of cell population proliferation);GO:0009409(response to cold);GO:0040015(negative regulation of multicellular organism growth);GO:0042742(defense response to bacterium);GO:0043066(negative regulation of apoptotic process);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0050873(brown fat cell differentiation);GO:0120162(positive regulation of cold-induced thermogenesis)","NA","NA","NA","placenta specific 8 [Source:NCBI gene;Acc:101117765]",{"v":0.159265,"d":"0.16"},0,0,{"v":0.533513,"d":"0.53"},0,{"v":0.315737,"d":"0.32"},{"v":0.187536061230497,"d":"0.19"},{"v":-2.41476005737954,"d":"-2.41"},1,1,"down","no"]
["ENSOARG00000005159","ENSOARG00000005159","ENSOART00000005620","GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0010951(negative regulation of endopeptidase activity);GO:0043066(negative regulation of apoptotic process)","04610(Complement and coagulation cascades)","K19821","NA","plasminogen activator inhibitor 2-like [Source:NCBI gene;Acc:101104705]",{"v":0.0384704587155963,"d":"0.04"},{"v":0.0241817889908257,"d":"0.02"},0,{"v":0.0277797247706422,"d":"0.03"},0,{"v":0.0810696330275229,"d":"0.08"},{"v":0.575586746433502,"d":"0.58"},{"v":-0.79689472218858,"d":"-0.80"},1,1,"down","no"]
["ENSOARG00000020860","ALDH1A2","ENSOART00000022726","GO:0001568(blood vessel development);GO:0001758(retinal dehydrogenase activity);GO:0001936(regulation of endothelial cell proliferation);GO:0003007(heart morphogenesis);GO:0004028(3-chloroallyl aldehyde dehydrogenase activity);GO:0005737(cytoplasm);GO:0008284(positive regulation of cell population proliferation);GO:0008285(negative regulation of cell population proliferation);GO:0009855(determination of bilateral symmetry);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0010628(positive regulation of gene expression);GO:0014032(neural crest cell development);GO:0016331(morphogenesis of embryonic epithelium);GO:0016491(oxidoreductase activity);GO:0016620(oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor);GO:0021915(neural tube development);GO:0030182(neuron differentiation);GO:0030324(lung development);GO:0030326(embryonic limb morphogenesis);GO:0030900(forebrain development);GO:0030902(hindbrain development);GO:0031016(pancreas development);GO:0031076(embryonic camera-type eye development);GO:0034097(response to cytokine);GO:0035115(embryonic forelimb morphogenesis);GO:0035799(ureter maturation);GO:0042573(retinoic acid metabolic process);GO:0042574(retinal metabolic process);GO:0042904(9-cis-retinoic acid biosynthetic process);GO:0043010(camera-type eye development);GO:0043065(positive regulation of apoptotic process);GO:0048384(retinoic acid receptor signaling pathway);GO:0048566(embryonic digestive tract development);GO:0048738(cardiac muscle tissue development);GO:0055114(oxidation-reduction process);GO:0060324(face development);GO:0071300(cellular response to retinoic acid);GO:0090242(retinoic acid receptor signaling pathway involved in somitogenesis)","00830(Retinol metabolism)","K07249","EC:1.2.1.36","aldehyde dehydrogenase 1 family member A2 [Source:NCBI gene;Acc:101117509]",{"v":0.136334,"d":"0.14"},{"v":0.037446,"d":"0.04"},{"v":0.015814,"d":"0.02"},{"v":0.147759,"d":"0.15"},0,{"v":0.331919,"d":"0.33"},{"v":0.395252648651804,"d":"0.40"},{"v":-1.33915296453896,"d":"-1.34"},1,1,"down","no"]
["ENSOARG00000013310","ZNF157","ENSOART00000014474","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","05168(Herpes simplex virus 1 infection)","K09228","NA","zinc finger protein 157 [Source:NCBI gene;Acc:101117142]",{"v":0.011803,"d":"0.01"},0,0,{"v":0.019214,"d":"0.02"},{"v":0.012699,"d":"0.01"},0,{"v":0.369849277723812,"d":"0.37"},{"v":-1.43499063652855,"d":"-1.43"},1,1,"down","no"]
["MSTRG.16966","RF02183","ENSOART00000023859","NA","NA","NA","NA",null,{"v":0.060397,"d":"0.06"},{"v":0.178854,"d":"0.18"},{"v":0.2063,"d":"0.21"},{"v":0.031342,"d":"0.03"},{"v":0.16361,"d":"0.16"},{"v":0.063043,"d":"0.06"},{"v":1.72697532897924,"d":"1.73"},{"v":0.788247473131151,"d":"0.79"},1,1,"up","no"]
["MSTRG.902","ENSOARG00000006693","ENSOART00000007272","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","04080(Neuroactive ligand-receptor interaction);04926(Relaxin signaling pathway)","K08398","NA","relaxin family peptide/INSL5 receptor 4 [Source:NCBI gene;Acc:101121474]",{"v":0.424087,"d":"0.42"},{"v":0.302328,"d":"0.30"},{"v":0.389978,"d":"0.39"},{"v":0.393137,"d":"0.39"},{"v":0.548682,"d":"0.55"},{"v":0.278865,"d":"0.28"},{"v":0.914563474248864,"d":"0.91"},{"v":-0.128844792812559,"d":"-0.13"},1,1,"down","no"]
["MSTRG.11864","LDHC","ENSOART00000010375","GO:0003824(catalytic activity);GO:0004459(L-lactate dehydrogenase activity);GO:0005737(cytoplasm);GO:0005929(cilium);GO:0005975(carbohydrate metabolic process);GO:0006090(pyruvate metabolic process);GO:0006754(ATP biosynthetic process);GO:0016491(oxidoreductase activity);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0019244(lactate biosynthetic process from pyruvate);GO:0019516(lactate oxidation);GO:0019752(carboxylic acid metabolic process);GO:0030317(flagellated sperm motility);GO:0031514(motile cilium);GO:0055114(oxidation-reduction process)","00010(Glycolysis / Gluconeogenesis);00270(Cysteine and methionine metabolism);00620(Pyruvate metabolism);00640(Propanoate metabolism);04922(Glucagon signaling pathway)","K00016","EC:1.1.1.27","L-lactate dehydrogenase C chain [Source:NCBI gene;Acc:101118315]",{"v":0.014273,"d":"0.01"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000007970","GZMA","ENSOART00000008678","GO:0004252(serine-type endopeptidase activity);GO:0005634(nucleus);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0009617(response to bacterium);GO:0016787(hydrolase activity);GO:0032078(negative regulation of endodeoxyribonuclease activity);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0043392(negative regulation of DNA binding);GO:0051354(negative regulation of oxidoreductase activity);GO:0051603(proteolysis involved in cellular protein catabolic process)","04080(Neuroactive ligand-receptor interaction)","K01352","EC:3.4.21.78","granzyme A-like [Source:NCBI gene;Acc:101116862]",{"v":0.042497,"d":"0.04"},{"v":0.040551,"d":"0.04"},0,{"v":0.174942,"d":"0.17"},0,{"v":0.056554,"d":"0.06"},{"v":0.358744859522411,"d":"0.36"},{"v":-1.47896993541864,"d":"-1.48"},1,1,"down","no"]
["MSTRG.18172","ENSOARG00000013103","ENSOART00000014244","GO:0003824(catalytic activity)","NA","NA","NA","pyruvate dehydrogenase E1 component subunit beta, mitochondrial-like [Source:NCBI gene;Acc:101120918]",{"v":0.16747626283725,"d":"0.17"},{"v":0.151307047867711,"d":"0.15"},{"v":0.589466623150566,"d":"0.59"},{"v":0.2126232845953,"d":"0.21"},{"v":0.199084121845083,"d":"0.20"},{"v":0.158897089643168,"d":"0.16"},{"v":1.59173287292594,"d":"1.59"},{"v":0.670598240880929,"d":"0.67"},1,1,"up","no"]
["ENSOARG00000006002","MAGEE2","ENSOART00000006526","NA","NA","NA","NA","MAGE family member E2 [Source:NCBI gene;Acc:101116125]",{"v":0.460818,"d":"0.46"},{"v":0.110735,"d":"0.11"},{"v":0.348265,"d":"0.35"},{"v":0.55254,"d":"0.55"},{"v":0.275132,"d":"0.28"},{"v":0.36703,"d":"0.37"},{"v":0.769914171065253,"d":"0.77"},{"v":-0.377230469703439,"d":"-0.38"},1,1,"down","no"]
["ENSOARG00000003158","CEP55","ENSOART00000003430","GO:0000281(mitotic cytokinesis);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005886(plasma membrane);GO:0014066(regulation of phosphatidylinositol 3-kinase signaling);GO:0030496(midbody);GO:0045171(intercellular bridge);GO:0045184(establishment of protein localization);GO:0061952(midbody abscission);GO:0072001(renal system development);GO:0090543(Flemming body);GO:1904888(cranial skeletal system development)","NA","K16456","NA","centrosomal protein 55 [Source:NCBI gene;Acc:101104542]",{"v":0.146843,"d":"0.15"},{"v":0.021796,"d":"0.02"},{"v":0.062058,"d":"0.06"},{"v":0.02577,"d":"0.03"},{"v":0.044111,"d":"0.04"},{"v":0.088171,"d":"0.09"},{"v":1.45962721129755,"d":"1.46"},{"v":0.545599951923011,"d":"0.55"},1,1,"up","no"]
["ENSOARG00000008091","HLA-DOA","ENSOART00000008805","GO:0002376(immune system process);GO:0002504(antigen processing and presentation of peptide or polysaccharide antigen via MHC class II);GO:0002587(negative regulation of antigen processing and presentation of peptide antigen via MHC class II);GO:0006955(immune response);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019882(antigen processing and presentation);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0023026(MHC class II protein complex binding);GO:0042613(MHC class II protein complex);GO:0045580(regulation of T cell differentiation)","04145(Phagosome);04514(Cell adhesion molecules (CAMs));04612(Antigen processing and presentation);04640(Hematopoietic cell lineage);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04672(Intestinal immune network for IgA production);04940(Type I diabetes mellitus);05140(Leishmaniasis);05145(Toxoplasmosis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05164(Influenza A);05166(Human T-cell leukemia virus 1 infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05310(Asthma);05320(Autoimmune thyroid disease);05321(Inflammatory bowel disease (IBD));05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis)","K06752","NA","HLA class II histocompatibility antigen, DO alpha chain [Source:NCBI gene;Acc:101110545]",{"v":0.317488,"d":"0.32"},{"v":0.092106,"d":"0.09"},{"v":0.114885,"d":"0.11"},{"v":0.216465,"d":"0.22"},{"v":0.379703,"d":"0.38"},{"v":0.185697,"d":"0.19"},{"v":0.670805062254993,"d":"0.67"},{"v":-0.576034518593009,"d":"-0.58"},1,1,"down","no"]
["ENSOARG00000013399","SLC1A1","ENSOART00000014573","GO:0005313(L-glutamate transmembrane transporter activity);GO:0005314(high-affinity glutamate transmembrane transporter activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0010460(positive regulation of heart rate);GO:0015108(chloride transmembrane transporter activity);GO:0015293(symporter activity);GO:0015501(glutamate:sodium symporter activity);GO:0015813(L-glutamate transmembrane transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0033229(cysteine transmembrane transporter activity);GO:0042883(cysteine transport);GO:0051260(protein homooligomerization);GO:0051938(L-glutamate import);GO:0055085(transmembrane transport);GO:0070779(D-aspartate import across plasma membrane);GO:0098712(L-glutamate import across plasma membrane);GO:0140009(L-aspartate import across plasma membrane);GO:1902476(chloride transmembrane transport);GO:1903712(cysteine transmembrane transport)","04721(Synaptic vesicle cycle);04724(Glutamatergic synapse);04974(Protein digestion and absorption)","K05612","NA","solute carrier family 1 member 1 [Source:NCBI gene;Acc:443514]",{"v":0.0373130300353357,"d":"0.04"},0,0,{"v":0.0320992049469965,"d":"0.03"},{"v":0.0849553886925795,"d":"0.08"},{"v":0.0295122349823322,"d":"0.03"},{"v":0.254580319340814,"d":"0.25"},{"v":-1.97380720073398,"d":"-1.97"},1,1,"down","no"]
["ENSOARG00000013368","NR6A1","ENSOART00000014538","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006355(regulation of transcription, DNA-templated);GO:0007276(gamete generation);GO:0008270(zinc ion binding);GO:0042803(protein homodimerization activity);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046872(metal ion binding)","NA","K08561","NA","nuclear receptor subfamily 6 group A member 1 [Source:NCBI gene;Acc:100302637]",{"v":0.583699,"d":"0.58"},{"v":0.407246,"d":"0.41"},{"v":0.405887,"d":"0.41"},{"v":0.6953,"d":"0.70"},{"v":0.544274,"d":"0.54"},{"v":0.281779,"d":"0.28"},{"v":0.918151145723576,"d":"0.92"},{"v":-0.123196425739978,"d":"-0.12"},1,1,"down","no"]
["ENSOARG00000014136","ENSOARG00000014136","ENSOART00000015393","NA","NA","K17521","NA","C-type lectin domain containing 11A [Source:NCBI gene;Acc:101119074]",0,0,{"v":0.170957,"d":"0.17"},{"v":0.048264,"d":"0.05"},{"v":0.121987,"d":"0.12"},{"v":0.111235,"d":"0.11"},{"v":0.607337487477175,"d":"0.61"},{"v":-0.719429673619245,"d":"-0.72"},1,1,"down","no"]
["ENSOARG00000009684","ENSOARG00000009684","ENSOART00000010540","GO:0016012(sarcoglycan complex);GO:0016021(integral component of membrane)","NA","NA","NA","sarcoglycan zeta [Source:NCBI gene;Acc:101122410]",{"v":0.044935,"d":"0.04"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000005716","ENSOARG00000005716","ENSOART00000006223","GO:0003824(catalytic activity);GO:0004514(nicotinate-nucleotide diphosphorylase (carboxylating) activity);GO:0009435(NAD biosynthetic process);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0016763(transferase activity, transferring pentosyl groups);GO:0019363(pyridine nucleotide biosynthetic process)","NA","NA","NA",null,0,0,{"v":0.215145,"d":"0.22"},{"v":0.287457,"d":"0.29"},{"v":0.056229,"d":"0.06"},{"v":0.203436,"d":"0.20"},{"v":0.393230394683453,"d":"0.39"},{"v":-1.34655325600555,"d":"-1.35"},1,1,"down","no"]
["MSTRG.3099","ANKRD40CL","ENSOART00000003555","NA","NA","NA","NA","ankyrin repeat domain-containing protein 40-like [Source:NCBI gene;Acc:101104325]",{"v":0.325728,"d":"0.33"},{"v":0.86106,"d":"0.86"},{"v":0.661162,"d":"0.66"},{"v":0.222184,"d":"0.22"},{"v":0.574281,"d":"0.57"},0,{"v":2.32018983885042,"d":"2.32"},{"v":1.21424285206117,"d":"1.21"},1,1,"up","no"]
["MSTRG.17155","ENSOARG00000025007","ENSOART00000026909","NA","NA","NA","NA",null,{"v":0.002002,"d":"0.00"},{"v":0.316587,"d":"0.32"},{"v":0.24823,"d":"0.25"},{"v":0.141322,"d":"0.14"},{"v":0.128799,"d":"0.13"},{"v":0.101683,"d":"0.10"},{"v":1.5245102258179,"d":"1.52"},{"v":0.608345827413782,"d":"0.61"},1,1,"up","no"]
["ENSOARG00000023270","RF00026","ENSOART00000025172","NA","NA","NA","NA",null,0,0,{"v":0.366546,"d":"0.37"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000002758","CLHC1","ENSOART00000002996","NA","NA","NA","NA","clathrin heavy chain linker domain containing 1 [Source:NCBI gene;Acc:101123282]",{"v":0.050386,"d":"0.05"},{"v":0.02537,"d":"0.03"},0,{"v":0.009982,"d":"0.01"},{"v":0.04843,"d":"0.05"},{"v":0.059064,"d":"0.06"},{"v":0.644863631720522,"d":"0.64"},{"v":-0.632933986508044,"d":"-0.63"},1,1,"down","no"]
["MSTRG.558","RF00001","ENSOART00000023206","NA","NA","NA","NA",null,{"v":0.017299,"d":"0.02"},0,0,{"v":0.009505,"d":"0.01"},0,0,{"v":1.81998947922146,"d":"1.82"},{"v":0.863930110688316,"d":"0.86"},1,1,"up","no"]
["MSTRG.11561","ENSOARG00000006127","ENSOART00000006661","NA","NA","NA","NA",null,{"v":0.00785899870633894,"d":"0.01"},{"v":0.236871558861578,"d":"0.24"},0,{"v":0.307962186287193,"d":"0.31"},{"v":0.811090276843467,"d":"0.81"},{"v":0.126002421733506,"d":"0.13"},{"v":0.196562063683335,"d":"0.20"},{"v":-2.3469431852997,"d":"-2.35"},1,1,"down","no"]
["ENSOARG00000014801","CHMP4C","ENSOART00000016109","GO:0006997(nucleus organization);GO:0007034(vacuolar transport);GO:0007080(mitotic metaphase plate congression);GO:0009838(abscission);GO:0010824(regulation of centrosome duplication);GO:0030496(midbody);GO:0032466(negative regulation of cytokinesis);GO:0042803(protein homodimerization activity);GO:0044878(mitotic cytokinesis checkpoint);GO:0050792(regulation of viral process);GO:0061952(midbody abscission);GO:0090543(Flemming body);GO:0090611(ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway);GO:1901673(regulation of mitotic spindle assembly);GO:1902188(positive regulation of viral release from host cell)","04144(Endocytosis);04217(Necroptosis)","K12194","NA","charged multivesicular body protein 4C [Source:NCBI gene;Acc:101119649]",{"v":0.570824,"d":"0.57"},{"v":0.885538,"d":"0.89"},{"v":0.334996,"d":"0.33"},{"v":0.124163,"d":"0.12"},{"v":0.401739,"d":"0.40"},{"v":0.182399,"d":"0.18"},{"v":2.52909144558599,"d":"2.53"},{"v":1.33861920216853,"d":"1.34"},1,1,"up","no"]
["ENSOARG00000013081","MS4A1","ENSOART00000014218","GO:0002115(store-operated calcium entry);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0009617(response to bacterium);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019865(immunoglobulin binding);GO:0030183(B cell differentiation);GO:0042113(B cell activation);GO:0044853(plasma membrane raft);GO:0050853(B cell receptor signaling pathway);GO:0051262(protein tetramerization);GO:1902656(calcium ion import into cytosol)","04640(Hematopoietic cell lineage)","K06466","NA","membrane spanning 4-domains A1 [Source:NCBI gene;Acc:101113271]",{"v":0.07529,"d":"0.08"},0,0,{"v":0.039071,"d":"0.04"},0,0,{"v":1.92700468378081,"d":"1.93"},{"v":0.946360078254876,"d":"0.95"},1,1,"up","no"]
["ENSOARG00000008291","STX1B","ENSOART00000009021","GO:0001956(positive regulation of neurotransmitter secretion);GO:0005102(signaling receptor binding);GO:0005484(SNAP receptor activity);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0006904(vesicle docking involved in exocytosis);GO:0010468(regulation of gene expression);GO:0010807(regulation of synaptic vesicle priming);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016079(synaptic vesicle exocytosis);GO:0016081(synaptic vesicle docking);GO:0016192(vesicle-mediated transport);GO:0019901(protein kinase binding);GO:0030424(axon);GO:0031594(neuromuscular junction);GO:0031629(synaptic vesicle fusion to presynaptic active zone membrane);GO:0048791(calcium ion-regulated exocytosis of neurotransmitter);GO:0061669(spontaneous neurotransmitter secretion);GO:0098793(presynapse);GO:1903422(negative regulation of synaptic vesicle recycling);GO:1904050(positive regulation of spontaneous neurotransmitter secretion);GO:2000463(positive regulation of excitatory postsynaptic potential)","04130(SNARE interactions in vesicular transport);04721(Synaptic vesicle cycle)","K08486","NA","syntaxin 1B [Source:NCBI gene;Acc:443479]",{"v":0.164646,"d":"0.16"},{"v":0.108693,"d":"0.11"},{"v":0.139637,"d":"0.14"},0,{"v":0.153733,"d":"0.15"},{"v":0.0865,"d":"0.09"},{"v":1.71906440830361,"d":"1.72"},{"v":0.781623599382253,"d":"0.78"},1,1,"up","no"]
["MSTRG.18937","CWH43","ENSOART00000019820","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","cell wall biogenesis 43 C-terminal homolog [Source:NCBI gene;Acc:101104067]",0,0,0,{"v":0.015027,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000022697","RF00026","ENSOART00000024599","NA","NA","NA","NA","RNA, U6 small nuclear 476, pseudogene [Source:HGNC Symbol;Acc:HGNC:47439]",0,0,0,{"v":0.605726,"d":"0.61"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000019989","GJD2","ENSOART00000021762","GO:0001508(action potential);GO:0005886(plasma membrane);GO:0005921(gap junction);GO:0005922(connexin complex);GO:0007154(cell communication);GO:0007267(cell-cell signaling);GO:0007268(chemical synaptic transmission);GO:0007601(visual perception);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction)","04540(Gap junction)","K07373","NA","gap junction protein delta 2 [Source:NCBI gene;Acc:101103323]",0,{"v":0.010411,"d":"0.01"},{"v":0.011521,"d":"0.01"},{"v":0.017941,"d":"0.02"},{"v":0.023911,"d":"0.02"},{"v":0.023408,"d":"0.02"},{"v":0.336071100214527,"d":"0.34"},{"v":-1.57316160868243,"d":"-1.57"},1,1,"down","no"]
["MSTRG.4148","RF00136","ENSOART00000024571","NA","NA","NA","NA",null,{"v":0.514329,"d":"0.51"},{"v":1.276029,"d":"1.28"},{"v":0.863971,"d":"0.86"},{"v":0.890253,"d":"0.89"},{"v":0.873157,"d":"0.87"},{"v":0.558383,"d":"0.56"},{"v":1.14322379299102,"d":"1.14"},{"v":0.193107847502412,"d":"0.19"},1,1,"up","no"]
["MSTRG.19558","RF00026","ENSOART00000026137","NA","NA","NA","NA",null,0,0,{"v":0.289201,"d":"0.29"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.4796","RF00275","ENSOART00000025913","NA","NA","NA","NA","small nucleolar RNA, C/D box 56 [Source:HGNC Symbol;Acc:HGNC:10206]",{"v":0.61025,"d":"0.61"},{"v":0.778818,"d":"0.78"},{"v":1.926408,"d":"1.93"},{"v":1.241338,"d":"1.24"},{"v":2.273031,"d":"2.27"},{"v":1.045984,"d":"1.05"},{"v":0.727021789760573,"d":"0.73"},{"v":-0.459929490703389,"d":"-0.46"},1,1,"down","no"]
["ENSOARG00000001668","TFEC","ENSOART00000001799","GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0034605(cellular response to heat);GO:0046983(protein dimerization activity)","NA","K15591","NA","transcription factor EC [Source:NCBI gene;Acc:101109437]",{"v":0.14464,"d":"0.14"},{"v":0.049805,"d":"0.05"},{"v":0.188301,"d":"0.19"},{"v":0.305588,"d":"0.31"},{"v":0.196792,"d":"0.20"},{"v":0.061192,"d":"0.06"},{"v":0.679143037624296,"d":"0.68"},{"v":-0.558212635382747,"d":"-0.56"},1,1,"down","no"]
["MSTRG.7397","ENSOARG00000022352","ENSOART00000024254","NA","NA","NA","NA",null,{"v":1.294856,"d":"1.29"},{"v":3.32399,"d":"3.32"},{"v":2.676018,"d":"2.68"},{"v":2.516836,"d":"2.52"},{"v":3.304237,"d":"3.30"},{"v":0.652821,"d":"0.65"},{"v":1.12681239451866,"d":"1.13"},{"v":0.172247338023442,"d":"0.17"},1,1,"up","no"]
["ENSOARG00000003594","FOXD2","ENSOART00000003903","GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","forkhead box D2 [Source:HGNC Symbol;Acc:HGNC:3803]",{"v":0.127471,"d":"0.13"},{"v":0.102611,"d":"0.10"},{"v":0.081737,"d":"0.08"},0,{"v":0.160862,"d":"0.16"},{"v":0.097863,"d":"0.10"},{"v":1.2052140303411,"d":"1.21"},{"v":0.269289373087912,"d":"0.27"},1,1,"up","no"]
["ENSOARG00000012634","TRPM6","ENSOART00000013749","GO:0004674(protein serine/threonine kinase activity);GO:0005216(ion channel activity);GO:0005261(cation channel activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0006811(ion transport);GO:0006812(cation transport);GO:0009636(response to toxic substance);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0030001(metal ion transport);GO:0031526(brush border membrane);GO:0034220(ion transmembrane transport);GO:0051262(protein tetramerization);GO:0055085(transmembrane transport);GO:0098655(cation transmembrane transport)","04978(Mineral absorption)","K04981","EC:2.7.11.1","transient receptor potential cation channel subfamily M member 6 [Source:NCBI gene;Acc:101114337]",{"v":0.041149,"d":"0.04"},{"v":0.010393,"d":"0.01"},{"v":0.018739,"d":"0.02"},{"v":0.005927,"d":"0.01"},{"v":0.023868,"d":"0.02"},0,{"v":2.35881859372378,"d":"2.36"},{"v":1.23806447156658,"d":"1.24"},1,1,"up","no"]
["ENSOARG00000007861","TLL2","ENSOART00000008567","GO:0004222(metalloendopeptidase activity);GO:0005509(calcium ion binding);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0046872(metal ion binding);GO:0048632(negative regulation of skeletal muscle tissue growth)","NA","K13047","EC:3.4.24.-","tolloid like 2 [Source:NCBI gene;Acc:101107749]",{"v":0.337266,"d":"0.34"},{"v":0.146257,"d":"0.15"},{"v":0.116378,"d":"0.12"},{"v":0.190268,"d":"0.19"},{"v":0.144737,"d":"0.14"},{"v":0.251236,"d":"0.25"},{"v":1.02330099737139,"d":"1.02"},{"v":0.0332305669241263,"d":"0.03"},1,1,"up","no"]
["ENSOARG00000000511","LRFN2","ENSOART00000000547","GO:0005515(protein binding);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050804(modulation of chemical synaptic transmission);GO:0098685(Schaffer collateral - CA1 synapse);GO:0099175(regulation of postsynapse organization)","NA","K16355","NA","leucine rich repeat and fibronectin type III domain containing 2 [Source:NCBI gene;Acc:101107233]",{"v":0.01734,"d":"0.02"},0,0,0,{"v":0.071959,"d":"0.07"},0,{"v":0.240970552675829,"d":"0.24"},{"v":-2.05307123932112,"d":"-2.05"},1,1,"down","no"]
["ENSOARG00000008847","VANGL2","ENSOART00000009631","GO:0001725(stress fiber);GO:0001736(establishment of planar polarity);GO:0001843(neural tube closure);GO:0001942(hair follicle development);GO:0001947(heart looping);GO:0003149(membranous septum morphogenesis);GO:0003150(muscular septum morphogenesis);GO:0003402(planar cell polarity pathway involved in axis elongation);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007266(Rho protein signal transduction);GO:0007275(multicellular organism development);GO:0009952(anterior/posterior pattern specification);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0022007(convergent extension involved in neural plate elongation);GO:0030111(regulation of Wnt signaling pathway);GO:0030134(COPII-coated ER to Golgi transport vesicle);GO:0032835(glomerulus development);GO:0032956(regulation of actin cytoskeleton organization);GO:0035019(somatic stem cell population maintenance);GO:0035567(non-canonical Wnt signaling pathway);GO:0035787(cell migration involved in kidney development);GO:0036342(post-anal tail morphogenesis);GO:0036514(dopaminergic neuron axon guidance);GO:0036515(serotonergic neuron axon guidance);GO:0042060(wound healing);GO:0043507(positive regulation of JUN kinase activity);GO:0045176(apical protein localization);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0048103(somatic stem cell division);GO:0048105(establishment of body hair planar orientation);GO:0048546(digestive tract morphogenesis);GO:0060028(convergent extension involved in axis elongation);GO:0060029(convergent extension involved in organogenesis);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:0060119(inner ear receptor cell development);GO:0060122(inner ear receptor cell stereocilium organization);GO:0060187(cell pole);GO:0060488(orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis);GO:0060489(planar dichotomous subdivision of terminal units involved in lung branching morphogenesis);GO:0060490(lateral sprouting involved in lung morphogenesis);GO:0060993(kidney morphogenesis);GO:0061346(planar cell polarity pathway involved in heart morphogenesis);GO:0071944(cell periphery);GO:0090102(cochlea development);GO:0090103(cochlea morphogenesis);GO:0090175(regulation of establishment of planar polarity);GO:0090177(establishment of planar polarity involved in neural tube closure);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:1904938(planar cell polarity pathway involved in axon guidance);GO:1905515(non-motile cilium assembly)","04310(Wnt signaling pathway)","K04510","NA","VANGL planar cell polarity protein 2 [Source:NCBI gene;Acc:101102530]",{"v":0.060254,"d":"0.06"},{"v":0.051474,"d":"0.05"},{"v":0.012668,"d":"0.01"},{"v":0.208077,"d":"0.21"},{"v":0.11556,"d":"0.12"},{"v":0.205318,"d":"0.21"},{"v":0.235173124367857,"d":"0.24"},{"v":-2.08820489677363,"d":"-2.09"},1,1,"down","no"]
["ENSOARG00000018325","GRHL2","ENSOART00000019945","GO:0001161(intronic transcription regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0001843(neural tube closure);GO:0003208(cardiac ventricle morphogenesis);GO:0003382(epithelial cell morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005911(cell-cell junction);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0007155(cell adhesion);GO:0007420(brain development);GO:0008283(cell population proliferation);GO:0008544(epidermis development);GO:0010468(regulation of gene expression);GO:0021915(neural tube development);GO:0030323(respiratory tube development);GO:0031490(chromatin DNA binding);GO:0034329(cell junction assembly);GO:0035264(multicellular organism growth);GO:0042733(embryonic digit morphogenesis);GO:0043010(camera-type eye development);GO:0043565(sequence-specific DNA binding);GO:0044030(regulation of DNA methylation);GO:0045617(negative regulation of keratinocyte differentiation);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048568(embryonic organ development);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0051973(positive regulation of telomerase activity);GO:0060324(face development);GO:0060463(lung lobe morphogenesis);GO:0060487(lung epithelial cell differentiation);GO:0060672(epithelial cell morphogenesis involved in placental branching);GO:0070830(bicellular tight junction assembly);GO:0090132(epithelium migration)","NA","K09275","NA","grainyhead like transcription factor 2 [Source:NCBI gene;Acc:101102496]",{"v":0.0500318234334964,"d":"0.05"},{"v":0.0381892532028884,"d":"0.04"},{"v":0.0244585206149546,"d":"0.02"},{"v":0.0590376710924761,"d":"0.06"},{"v":0.0337221616585139,"d":"0.03"},{"v":0.0285772427207081,"d":"0.03"},{"v":0.928649358106723,"d":"0.93"},{"v":-0.10679413209244,"d":"-0.11"},1,1,"down","no"]
["MSTRG.18056","ENSOARG00000023167","ENSOART00000025069","NA","NA","NA","NA",null,0,0,{"v":0.115456,"d":"0.12"},{"v":0.127354,"d":"0.13"},0,0,{"v":0.906575372583507,"d":"0.91"},{"v":-0.141501124413772,"d":"-0.14"},1,1,"down","no"]
["ENSOARG00000017691","ENO4","ENSOART00000019257","GO:0000015(phosphopyruvate hydratase complex);GO:0000287(magnesium ion binding);GO:0004634(phosphopyruvate hydratase activity);GO:0006096(glycolytic process)","00010(Glycolysis / Gluconeogenesis);03018(RNA degradation);04066(HIF-1 signaling pathway)","K01689","EC:4.2.1.11","enolase 4 [Source:NCBI gene;Acc:101104109]",{"v":0.012424,"d":"0.01"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000004223","PTCRA","ENSOART00000004594","NA","04330(Notch signaling pathway);05202(Transcriptional misregulation in cancer)","K06056","NA","pre T cell antigen receptor alpha [Source:NCBI gene;Acc:101110628]",{"v":0.061919,"d":"0.06"},0,{"v":0.045903,"d":"0.05"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.11640","ENSOARG00000023426","ENSOART00000025328","NA","NA","NA","NA",null,0,0,{"v":0.282469,"d":"0.28"},{"v":0.539106,"d":"0.54"},{"v":0.136201,"d":"0.14"},{"v":0.330433,"d":"0.33"},{"v":0.280856881500189,"d":"0.28"},{"v":-1.83209294290703,"d":"-1.83"},1,1,"down","no"]
["ENSOARG00000024948","RF00026","ENSOART00000026850","NA","NA","NA","NA",null,0,0,0,{"v":0.10779,"d":"0.11"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.14798","RF00264","ENSOART00000026930","NA","NA","NA","NA",null,{"v":0.248297,"d":"0.25"},{"v":0.224325,"d":"0.22"},{"v":0.157309,"d":"0.16"},{"v":0.256206,"d":"0.26"},{"v":0.173729,"d":"0.17"},{"v":0.159807,"d":"0.16"},{"v":1.06814674891732,"d":"1.07"},{"v":0.0951098674293025,"d":"0.10"},1,1,"up","no"]
["ENSOARG00000009393","PLA2G2F","ENSOART00000010226","GO:0004623(phospholipase A2 activity);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0006629(lipid metabolic process);GO:0006644(phospholipid metabolic process);GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity);GO:0042130(negative regulation of T cell proliferation);GO:0050482(arachidonic acid secretion);GO:0102567(phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine));GO:0102568(phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine))","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);00590(Arachidonic acid metabolism);00591(Linoleic acid metabolism);00592(alpha-Linolenic acid metabolism);04014(Ras signaling pathway);04270(Vascular smooth muscle contraction);04972(Pancreatic secretion);04975(Fat digestion and absorption)","K01047","EC:3.1.1.4","phospholipase A2 group IIF [Source:NCBI gene;Acc:101106664]",0,0,0,{"v":0.035582,"d":"0.04"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017171","SLITRK6","ENSOART00000018685","GO:0001964(startle response);GO:0002088(lens development in camera-type eye);GO:0002093(auditory receptor cell morphogenesis);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0007409(axonogenesis);GO:0007416(synapse assembly);GO:0007601(visual perception);GO:0008344(adult locomotory behavior);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021562(vestibulocochlear nerve development);GO:0031223(auditory behavior);GO:0035264(multicellular organism growth);GO:0042472(inner ear morphogenesis);GO:0043010(camera-type eye development);GO:0048812(neuron projection morphogenesis);GO:0051965(positive regulation of synapse assembly);GO:0060005(vestibular reflex);GO:0060007(linear vestibuloocular reflex);GO:0060384(innervation);GO:0071944(cell periphery);GO:0090102(cochlea development)","NA","NA","NA","SLIT and NTRK like family member 6 [Source:NCBI gene;Acc:101105831]",{"v":0.180945,"d":"0.18"},0,0,{"v":0.061853,"d":"0.06"},{"v":0.043035,"d":"0.04"},{"v":0.154704,"d":"0.15"},{"v":0.697036118216278,"d":"0.70"},{"v":-0.520694680943647,"d":"-0.52"},1,1,"down","no"]
["ENSOARG00000004494","SPINK7","ENSOART00000004886","GO:0005515(protein binding)","NA","NA","NA","serine peptidase inhibitor, Kazal type 7 (putative) [Source:NCBI gene;Acc:101117075]",0,0,0,{"v":0.267849,"d":"0.27"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000008189","ENSOARG00000008189","ENSOART00000008912","GO:0004862(cAMP-dependent protein kinase inhibitor activity);GO:0006469(negative regulation of protein kinase activity);GO:0071901(negative regulation of protein serine/threonine kinase activity)","NA","NA","NA","cAMP-dependent protein kinase inhibitor beta [Source:NCBI gene;Acc:101121016]",{"v":0.111954,"d":"0.11"},0,{"v":0.132638,"d":"0.13"},{"v":0.249879,"d":"0.25"},{"v":0.126201,"d":"0.13"},{"v":0.128014,"d":"0.13"},{"v":0.485211091582126,"d":"0.49"},{"v":-1.04331556506449,"d":"-1.04"},1,1,"down","no"]
["MSTRG.15011","RF00325","ENSOART00000025156","NA","NA","NA","NA","small nucleolar RNA, C/D box 53 [Source:HGNC Symbol;Acc:HGNC:10203]",{"v":0.00955,"d":"0.01"},{"v":0.749187,"d":"0.75"},{"v":0.124115,"d":"0.12"},{"v":0.863972,"d":"0.86"},{"v":0.196501,"d":"0.20"},{"v":0.054961,"d":"0.05"},{"v":0.791487438969944,"d":"0.79"},{"v":-0.337361640140279,"d":"-0.34"},1,1,"down","no"]
["ENSOARG00000008737","TMEM108","ENSOART00000009518","GO:0005769(early endosome);GO:0006898(receptor-mediated endocytosis);GO:0008090(retrograde axonal transport);GO:0010008(endosome membrane);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021542(dentate gyrus development);GO:0030424(axon);GO:0031175(neuron projection development);GO:0036477(somatodendritic compartment);GO:0051388(positive regulation of neurotrophin TRK receptor signaling pathway);GO:0097106(postsynaptic density organization);GO:0097484(dendrite extension);GO:0098815(modulation of excitatory postsynaptic potential);GO:1904115(axon cytoplasm);GO:1990416(cellular response to brain-derived neurotrophic factor stimulus)","NA","NA","NA","transmembrane protein 108 [Source:NCBI gene;Acc:101115599]",{"v":0.061135,"d":"0.06"},{"v":0.035059,"d":"0.04"},{"v":0.01886,"d":"0.02"},0,0,{"v":0.062089,"d":"0.06"},{"v":1.85304965452818,"d":"1.85"},{"v":0.889901540502666,"d":"0.89"},1,1,"up","no"]
["MSTRG.2745","RF00026","ENSOART00000025858","NA","NA","NA","NA",null,0,{"v":0.259311,"d":"0.26"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.18646","MIR302D","ENSOART00000023228","NA","NA","NA","NA","microRNA 302d [Source:HGNC Symbol;Acc:HGNC:31765]",0,0,{"v":0.24823,"d":"0.25"},0,{"v":0.128799,"d":"0.13"},0,{"v":1.92726651604438,"d":"1.93"},{"v":0.946556091503137,"d":"0.95"},1,1,"up","no"]
["MSTRG.17523","WNT9A","ENSOART00000007161","GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0007093(mitotic cell cycle checkpoint);GO:0007275(multicellular organism development);GO:0008285(negative regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0016055(Wnt signaling pathway);GO:0032331(negative regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045597(positive regulation of cell differentiation);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048018(receptor ligand activity);GO:0048704(embryonic skeletal system morphogenesis);GO:0048856(anatomical structure development);GO:0060070(canonical Wnt signaling pathway);GO:0060548(negative regulation of cell death);GO:0061037(negative regulation of cartilage development)","NA","NA","NA","Wnt family member 9A [Source:HGNC Symbol;Acc:HGNC:12778]",{"v":0.347717,"d":"0.35"},{"v":0.659324,"d":"0.66"},{"v":0.390952,"d":"0.39"},{"v":0.575855,"d":"0.58"},{"v":0.738039,"d":"0.74"},{"v":0.833595,"d":"0.83"},{"v":0.650989597618428,"d":"0.65"},{"v":-0.6192936046212,"d":"-0.62"},1,1,"down","no"]
["ENSOARG00000017209","DMGDH","ENSOART00000018736","GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016491(oxidoreductase activity);GO:0042426(choline catabolic process);GO:0047865(dimethylglycine dehydrogenase activity);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism)","K00315","EC:1.5.8.4","dimethylglycine dehydrogenase [Source:NCBI gene;Acc:101113594]",{"v":0.0733114196023718,"d":"0.07"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000019615","ENSOARG00000019615","ENSOART00000021361;ENSOART00000021359","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.0233558785857238,"d":"0.02"},{"v":0.0127271474316211,"d":"0.01"},{"v":0.0280824629753169,"d":"0.03"},{"v":0.039208083388926,"d":"0.04"},0,0,{"v":1.63653725065237,"d":"1.64"},{"v":0.710646441197105,"d":"0.71"},1,1,"up","no"]
["ENSOARG00000002772","TDRD10","ENSOART00000003006","GO:0003676(nucleic acid binding);GO:0003723(RNA binding)","NA","NA","NA","tudor domain containing 10 [Source:NCBI gene;Acc:101103865]",{"v":0.089232,"d":"0.09"},0,{"v":0.129052,"d":"0.13"},{"v":0.094687,"d":"0.09"},{"v":0.036907,"d":"0.04"},{"v":0.362122,"d":"0.36"},{"v":0.442124622252469,"d":"0.44"},{"v":-1.17747501358706,"d":"-1.18"},1,1,"down","no"]
["ENSOARG00000024591","RF00156","ENSOART00000026493","NA","NA","NA","NA",null,{"v":0.628323,"d":"0.63"},{"v":0.654138,"d":"0.65"},{"v":1.578443,"d":"1.58"},{"v":1.214753,"d":"1.21"},{"v":0.415893,"d":"0.42"},{"v":0.851805,"d":"0.85"},{"v":1.15245134747876,"d":"1.15"},{"v":0.204705846331228,"d":"0.20"},1,1,"up","no"]
["MSTRG.290","RF00026","ENSOART00000025310","NA","NA","NA","NA",null,0,0,{"v":0.146154,"d":"0.15"},{"v":0.23362,"d":"0.23"},0,{"v":0.021211,"d":"0.02"},{"v":0.573533047392193,"d":"0.57"},{"v":-0.802051477111468,"d":"-0.80"},1,1,"down","no"]
["ENSOARG00000001247","TRBV15","ENSOART00000001328","NA","NA","NA","NA","T cell receptor beta variable 15 [Source:HGNC Symbol;Acc:HGNC:12190]",0,0,{"v":0.052553,"d":"0.05"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.1492","ENSOARG00000021333","ENSOART00000023235","NA","NA","NA","NA",null,0,0,{"v":0.360088,"d":"0.36"},{"v":1.154899,"d":"1.15"},{"v":0.386397,"d":"0.39"},{"v":0.099624,"d":"0.10"},{"v":0.219442751627136,"d":"0.22"},{"v":-2.18808347729536,"d":"-2.19"},1,1,"down","no"]
["ENSOARG00000018613","ALOX15B","ENSOART00000020261","GO:0005506(iron ion binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0008285(negative regulation of cell population proliferation);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0016020(membrane);GO:0016165(linoleate 13S-lipoxygenase activity);GO:0016491(oxidoreductase activity);GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen);GO:0019369(arachidonic acid metabolic process);GO:0019372(lipoxygenase pathway);GO:0019898(extrinsic component of membrane);GO:0035360(positive regulation of peroxisome proliferator activated receptor signaling pathway);GO:0036403(arachidonate 8(S)-lipoxygenase activity);GO:0043651(linoleic acid metabolic process);GO:0045618(positive regulation of keratinocyte differentiation);GO:0045786(negative regulation of cell cycle);GO:0045926(negative regulation of growth);GO:0046872(metal ion binding);GO:0050473(arachidonate 15-lipoxygenase activity);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process);GO:0090197(positive regulation of chemokine secretion)","00590(Arachidonic acid metabolism);04726(Serotonergic synapse)","K08022","1.13.11.-;EC:1.13.11.33","arachidonate 15-lipoxygenase, type B [Source:NCBI gene;Acc:101121185]",0,0,0,{"v":0.007723,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.8553","oar-mir-485","ENSOART00000025236","NA","NA","K17154","NA","oar-mir-485 [Source:miRBase;Acc:MI0016950]",{"v":0.163294,"d":"0.16"},{"v":0.625482,"d":"0.63"},{"v":0.164369,"d":"0.16"},0,{"v":1.040835,"d":"1.04"},{"v":0.1481,"d":"0.15"},{"v":0.801679654480691,"d":"0.80"},{"v":-0.318902233790575,"d":"-0.32"},1,1,"down","no"]
["MSTRG.3312","RF00004","ENSOART00000025355","NA","NA","NA","NA",null,{"v":0.170298,"d":"0.17"},{"v":0.347263,"d":"0.35"},{"v":3.711465,"d":"3.71"},{"v":0.882312,"d":"0.88"},{"v":0.654942,"d":"0.65"},{"v":1.326383,"d":"1.33"},{"v":1.47680240198042,"d":"1.48"},{"v":0.562476804603923,"d":"0.56"},1,1,"up","no"]
["MSTRG.12520","PSD","ENSOART00000000715","GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0014069(postsynaptic density);GO:0031175(neuron projection development);GO:0032012(regulation of ARF protein signal transduction);GO:0032154(cleavage furrow);GO:0032587(ruffle membrane);GO:0043197(dendritic spine);GO:0098999(extrinsic component of postsynaptic endosome membrane);GO:0099092(postsynaptic density, intracellular component)","04144(Endocytosis)","K12494","NA","pleckstrin and Sec7 domain containing [Source:NCBI gene;Acc:101107649]",{"v":0.327398,"d":"0.33"},{"v":0.195287,"d":"0.20"},{"v":0.199557,"d":"0.20"},{"v":0.22818,"d":"0.23"},{"v":0.134035,"d":"0.13"},{"v":0.19926,"d":"0.20"},{"v":1.28632975644508,"d":"1.29"},{"v":0.363260531471469,"d":"0.36"},1,1,"up","no"]
["MSTRG.11338","TMEM14A","ENSOART00000016019","GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031966(mitochondrial membrane);GO:0043066(negative regulation of apoptotic process);GO:1901029(negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway)","NA","NA","NA","transmembrane protein 14A [Source:NCBI gene;Acc:101105448]",{"v":2.100908,"d":"2.10"},{"v":1.043324,"d":"1.04"},{"v":0.881761,"d":"0.88"},{"v":0.383527,"d":"0.38"},{"v":0.925011,"d":"0.93"},{"v":0.966662,"d":"0.97"},{"v":1.76951169127989,"d":"1.77"},{"v":0.82335129377546,"d":"0.82"},1,1,"up","no"]
["ENSOARG00000005437","ENSOARG00000005437","ENSOART00000005921","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,{"v":0.044256,"d":"0.04"},{"v":0.13817,"d":"0.14"},{"v":0.086288,"d":"0.09"},{"v":0.29453,"d":"0.29"},0,0,{"v":0.912348487420636,"d":"0.91"},{"v":-0.132343102687965,"d":"-0.13"},1,1,"down","no"]
["MSTRG.4832","STMN3","ENSOART00000011485","GO:0001835(blastocyst hatching);GO:0005737(cytoplasm);GO:0015631(tubulin binding);GO:0019904(protein domain specific binding);GO:0031110(regulation of microtubule polymerization or depolymerization);GO:0031122(cytoplasmic microtubule organization);GO:0031175(neuron projection development);GO:0035021(negative regulation of Rac protein signal transduction);GO:0043087(regulation of GTPase activity);GO:0051493(regulation of cytoskeleton organization)","NA","NA","NA","stathmin 3 [Source:NCBI gene;Acc:101108850]",0,0,0,{"v":0.001085,"d":"0.00"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000011257","FAM92B","ENSOART00000012239","GO:0036064(ciliary basal body)","NA","NA","NA","family with sequence similarity 92 member B [Source:NCBI gene;Acc:101104678]",0,{"v":0.014085,"d":"0.01"},0,{"v":0.11732,"d":"0.12"},0,0,{"v":0.120056256392772,"d":"0.12"},{"v":-3.05821750738202,"d":"-3.06"},1,1,"down","no"]
["MSTRG.14623","SLC34A3","ENSOART00000002745","GO:0005436(sodium:phosphate symporter activity);GO:0006814(sodium ion transport);GO:0006817(phosphate ion transport);GO:0015321(sodium-dependent phosphate transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030643(cellular phosphate ion homeostasis);GO:0031526(brush border membrane);GO:0035725(sodium ion transmembrane transport);GO:0044341(sodium-dependent phosphate transport)","04928(Parathyroid hormone synthesis, secretion and action)","K14683","NA","solute carrier family 34 member 3 [Source:NCBI gene;Acc:101109348]",{"v":0.060636,"d":"0.06"},{"v":0.006883,"d":"0.01"},{"v":0.017182,"d":"0.02"},{"v":0.050225,"d":"0.05"},{"v":0.057494,"d":"0.06"},{"v":0.063384,"d":"0.06"},{"v":0.495029309830921,"d":"0.50"},{"v":-1.01441414768324,"d":"-1.01"},1,1,"down","no"]
["ENSOARG00000007103","ENSOARG00000007103","ENSOART00000007727","GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0016787(hydrolase activity)","NA","NA","NA","serine protease 44-like [Source:NCBI gene;Acc:101102270]",0,0,0,0,{"v":0.019512,"d":"0.02"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017854","ENSOARG00000017854","ENSOART00000019422","GO:0005758(mitochondrial intermembrane space)","NA","NA","NA",null,0,0,0,0,0,{"v":0.096585,"d":"0.10"},"-inf","-inf",1,1,"down","no"]
["MSTRG.5100","ENSOARG00000022100","ENSOART00000024002","NA","NA","NA","NA",null,{"v":0.248297,"d":"0.25"},0,0,{"v":0.403634,"d":"0.40"},{"v":0.499678,"d":"0.50"},0,{"v":0.274874019165028,"d":"0.27"},{"v":-1.86315754377719,"d":"-1.86"},1,1,"down","no"]
["ENSOARG00000010618","ENSOARG00000010618","ENSOART00000011549","GO:0004721(phosphoprotein phosphatase activity);GO:0005634(nucleus);GO:0006397(mRNA processing);GO:0006470(protein dephosphorylation)","NA","NA","NA",null,0,{"v":0.056381,"d":"0.06"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000018119","SLC5A11","ENSOART00000019732","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)","NA","K14391","NA","solute carrier family 5 member 11 [Source:NCBI gene;Acc:101107154]",{"v":0.038613,"d":"0.04"},0,0,{"v":0.016809,"d":"0.02"},{"v":0.0077,"d":"0.01"},{"v":0.010787,"d":"0.01"},{"v":1.09397665457842,"d":"1.09"},{"v":0.129581951399845,"d":"0.13"},1,1,"up","no"]
["ENSOARG00000020721","PIF1","ENSOART00000022575","GO:0000002(mitochondrial genome maintenance);GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0000723(telomere maintenance);GO:0000784(nuclear chromosome, telomeric region);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006974(cellular response to DNA damage stimulus);GO:0010521(telomerase inhibitor activity);GO:0016787(hydrolase activity);GO:0017116(single-stranded DNA-dependent ATP-dependent DNA helicase activity);GO:0032204(regulation of telomere maintenance);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0032508(DNA duplex unwinding);GO:0033682(ATP-dependent 5'-3' DNA/RNA helicase activity);GO:0042162(telomeric DNA binding);GO:0043141(ATP-dependent 5'-3' DNA helicase activity);GO:0051880(G-quadruplex DNA binding);GO:0051974(negative regulation of telomerase activity)","NA","K15255","EC:3.6.4.12","PIF1 5'-to-3' DNA helicase [Source:NCBI gene;Acc:101122527]",{"v":0.090179,"d":"0.09"},{"v":0.065926,"d":"0.07"},{"v":0.013888,"d":"0.01"},{"v":0.098473,"d":"0.10"},{"v":0.108266,"d":"0.11"},{"v":0.043896,"d":"0.04"},{"v":0.678249246912841,"d":"0.68"},{"v":-0.560112554261109,"d":"-0.56"},1,1,"down","no"]
["MSTRG.1596","ENSOARG00000000352","ENSOART00000000372","NA","NA","NA","NA",null,0,0,0,{"v":0.248994,"d":"0.25"},{"v":0.031461,"d":"0.03"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000022065","RF00026","ENSOART00000023967","NA","NA","NA","NA",null,{"v":0.092821,"d":"0.09"},0,0,{"v":0.113197,"d":"0.11"},0,{"v":0.107232,"d":"0.11"},{"v":0.421092505976981,"d":"0.42"},{"v":-1.2477908942463,"d":"-1.25"},1,1,"down","no"]
["MSTRG.8473","RF00181","ENSOART00000025452","NA","NA","NA","NA",null,{"v":0.248297,"d":"0.25"},{"v":1.628539,"d":"1.63"},{"v":1.424907,"d":"1.42"},{"v":2.535212,"d":"2.54"},{"v":4.24535,"d":"4.25"},{"v":2.138556,"d":"2.14"},{"v":0.37018716424651,"d":"0.37"},{"v":-1.43367322236647,"d":"-1.43"},1,1,"down","no"]
["ENSOARG00000000788","BAIAP2L1","ENSOART00000000847","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0009617(response to bacterium);GO:0015629(actin cytoskeleton);GO:0030833(regulation of actin filament polymerization);GO:0030838(positive regulation of actin filament polymerization);GO:0046626(regulation of insulin receptor signaling pathway);GO:0070064(proline-rich region binding);GO:2000251(positive regulation of actin cytoskeleton reorganization)","NA","K20127","NA","BAI1 associated protein 2 like 1 [Source:NCBI gene;Acc:101114328]",{"v":0.016344,"d":"0.02"},{"v":0.034516,"d":"0.03"},0,0,0,{"v":0.028587,"d":"0.03"},{"v":1.7791303739462,"d":"1.78"},{"v":0.831172234581408,"d":"0.83"},1,1,"up","no"]
["ENSOARG00000023269","ENSOARG00000023269","ENSOART00000025171","NA","NA","NA","NA",null,0,0,0,0,{"v":0.389464,"d":"0.39"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000016474","ENSOARG00000016474","ENSOART00000017941","GO:0000387(spliceosomal snRNP assembly);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006821(chloride transport);GO:0006884(cell volume homeostasis);GO:0034709(methylosome);GO:0034715(pICln-Sm protein complex)","NA","NA","NA","methylosome subunit pICln pseudogene [Source:NCBI gene;Acc:101107178]",0,0,0,0,0,{"v":0.004929,"d":"0.00"},"-inf","-inf",1,1,"down","no"]
["MSTRG.3627","ARMC7","ENSOART00000012249","GO:0005515(protein binding)","NA","NA","NA","armadillo repeat containing 7 [Source:NCBI gene;Acc:101122203]",{"v":1.089885,"d":"1.09"},{"v":1.496438,"d":"1.50"},{"v":1.019325,"d":"1.02"},{"v":1.361475,"d":"1.36"},{"v":0.871668,"d":"0.87"},{"v":0.868877,"d":"0.87"},{"v":1.16235485264441,"d":"1.16"},{"v":0.217050573043002,"d":"0.22"},1,1,"up","no"]
["MSTRG.18333","RF00026","ENSOART00000026263","NA","NA","NA","NA",null,{"v":0.440901,"d":"0.44"},{"v":0.361645,"d":"0.36"},0,{"v":0.305874,"d":"0.31"},0,{"v":0.771837,"d":"0.77"},{"v":0.744676448509851,"d":"0.74"},{"v":-0.42531436397249,"d":"-0.43"},1,1,"down","no"]
["ENSOARG00000014606","TRPV4","ENSOART00000015907","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0002024(diet induced thermogenesis);GO:0005034(osmosensor activity);GO:0005216(ion channel activity);GO:0005261(cation channel activity);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0005929(cilium);GO:0006811(ion transport);GO:0006816(calcium ion transport);GO:0006874(cellular calcium ion homeostasis);GO:0006970(response to osmotic stress);GO:0007043(cell-cell junction assembly);GO:0007204(positive regulation of cytosolic calcium ion concentration);GO:0007231(osmosensory signaling pathway);GO:0010628(positive regulation of gene expression);GO:0010759(positive regulation of macrophage chemotaxis);GO:0015275(stretch-activated, cation-selective, calcium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019901(protein kinase binding);GO:0030103(vasopressin secretion);GO:0032868(response to insulin);GO:0034605(cellular response to heat);GO:0042169(SH2 domain binding);GO:0042538(hyperosmotic salinity response);GO:0042593(glucose homeostasis);GO:0042802(identical protein binding);GO:0043117(positive regulation of vascular permeability);GO:0046330(positive regulation of JNK cascade);GO:0047484(regulation of response to osmotic stress);GO:0050729(positive regulation of inflammatory response);GO:0050891(multicellular organismal water homeostasis);GO:0055085(transmembrane transport);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0071470(cellular response to osmotic stress);GO:0071476(cellular hypotonic response);GO:0071477(cellular hypotonic salinity response);GO:0071639(positive regulation of monocyte chemotactic protein-1 production);GO:0071642(positive regulation of macrophage inflammatory protein 1 alpha production);GO:0071651(positive regulation of chemokine (C-C motif) ligand 5 production);GO:0097009(energy homeostasis);GO:0097497(blood vessel endothelial cell delamination);GO:1903444(negative regulation of brown fat cell differentiation);GO:1903759(signal transduction involved in regulation of aerobic respiration);GO:2000340(positive regulation of chemokine (C-X-C motif) ligand 1 production);GO:2000778(positive regulation of interleukin-6 secretion)","04218(Cellular senescence);04750(Inflammatory mediator regulation of TRP channels);05418(Fluid shear stress and atherosclerosis)","K04973","NA","transient receptor potential cation channel subfamily V member 4 [Source:NCBI gene;Acc:101113534]",0,0,{"v":0.024646,"d":"0.02"},0,{"v":0.008479,"d":"0.01"},{"v":0.013067,"d":"0.01"},{"v":1.14387821405365,"d":"1.14"},{"v":0.193933460041399,"d":"0.19"},1,1,"up","no"]
["ENSOARG00000014468","PDZD3","ENSOART00000015754","GO:0005515(protein binding);GO:0005903(brush border);GO:0006811(ion transport);GO:0007168(receptor guanylyl cyclase signaling pathway);GO:0008022(protein C-terminus binding);GO:0010754(negative regulation of cGMP-mediated signaling);GO:0030251(guanylate cyclase inhibitor activity);GO:0031283(negative regulation of guanylate cyclase activity);GO:0035003(subapical complex);GO:0045177(apical part of cell);GO:1990381(ubiquitin-specific protease binding)","NA","NA","NA","PDZ domain containing 3 [Source:HGNC Symbol;Acc:HGNC:19891]",{"v":0.0529,"d":"0.05"},0,0,{"v":0.127193,"d":"0.13"},{"v":0.06859,"d":"0.07"},0,{"v":0.270197105979579,"d":"0.27"},{"v":-1.88791587252306,"d":"-1.89"},1,1,"down","no"]
["MSTRG.3556","ENSOARG00000005594","ENSOART00000006093","GO:0003735(structural constituent of ribosome);GO:0005622(intracellular);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,0,{"v":0.03747,"d":"0.04"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000007152","TM4SF5","ENSOART00000007784","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","transmembrane 4 L six family member 5 [Source:NCBI gene;Acc:101111205]",{"v":0.042057,"d":"0.04"},0,0,{"v":0.024533,"d":"0.02"},0,0,{"v":1.71430318346717,"d":"1.71"},{"v":0.777622280164491,"d":"0.78"},1,1,"up","no"]
["ENSOARG00000020258","CD101","ENSOART00000022058","GO:0002763(positive regulation of myeloid leukocyte differentiation);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K06522","NA","CD101 molecule [Source:NCBI gene;Acc:101106981]",{"v":0.087705,"d":"0.09"},{"v":0.015112,"d":"0.02"},{"v":0.171139,"d":"0.17"},{"v":0.226109,"d":"0.23"},{"v":0.193442,"d":"0.19"},{"v":0.092539,"d":"0.09"},{"v":0.534976273701888,"d":"0.53"},{"v":-0.902453185750517,"d":"-0.90"},1,1,"down","no"]
["ENSOARG00000011730","KCNA2","ENSOART00000012758","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005267(potassium channel activity);GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0014059(regulation of dopamine secretion);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021633(optic nerve structural organization);GO:0030424(axon);GO:0030425(dendrite);GO:0032809(neuronal cell body membrane);GO:0034765(regulation of ion transmembrane transport);GO:0043204(perikaryon);GO:0043679(axon terminus);GO:0044224(juxtaparanode region of axon);GO:0045188(regulation of circadian sleep/wake cycle, non-REM sleep);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport)","NA","K04875","NA","potassium voltage-gated channel subfamily A member 2 [Source:NCBI gene;Acc:101112012]",{"v":0.440189,"d":"0.44"},{"v":0.863196,"d":"0.86"},{"v":0.553554,"d":"0.55"},{"v":0.072759,"d":"0.07"},{"v":0.145507,"d":"0.15"},{"v":0.468117,"d":"0.47"},{"v":2.70539771526976,"d":"2.71"},{"v":1.43584069744212,"d":"1.44"},1,1,"up","no"]
["ENSOARG00000003078","ENSOARG00000003078","ENSOART00000003334","NA","NA","NA","NA",null,{"v":0.326924,"d":"0.33"},0,0,{"v":0.184688,"d":"0.18"},{"v":0.163414,"d":"0.16"},{"v":0.378522,"d":"0.38"},{"v":0.449921830272603,"d":"0.45"},{"v":-1.15225372649906,"d":"-1.15"},1,1,"down","no"]
["MSTRG.5996","RF00026","ENSOART00000026448","NA","NA","NA","NA",null,0,{"v":0.067088,"d":"0.07"},0,{"v":0.045761,"d":"0.05"},0,0,{"v":1.46605187823693,"d":"1.47"},{"v":0.551936156098527,"d":"0.55"},1,1,"up","no"]
["ENSOARG00000004150","ENSOARG00000004150","ENSOART00000004510","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","NA","NA","NA",null,{"v":0.066899,"d":"0.07"},0,{"v":0.073146,"d":"0.07"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000012671","ENSOARG00000012671","ENSOART00000013771","GO:0003676(nucleic acid binding);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0016787(hydrolase activity);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","NA","K01168","EC:4.6.1.18","ribonuclease pancreatic [Source:NCBI gene;Acc:101113761]",0,0,0,{"v":0.081811,"d":"0.08"},0,{"v":0.008577,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["MSTRG.8526","oar-mir-323a","ENSOART00000024391","NA","NA","NA","NA","oar-mir-323a [Source:miRBase;Acc:MI0016923]",{"v":0.421613,"d":"0.42"},{"v":0.96393,"d":"0.96"},{"v":1.389845,"d":"1.39"},{"v":1.103537,"d":"1.10"},{"v":2.11562,"d":"2.12"},{"v":1.951218,"d":"1.95"},{"v":0.536786596716873,"d":"0.54"},{"v":-0.897579446247018,"d":"-0.90"},1,1,"down","no"]
["MSTRG.5654","RF00026","ENSOART00000023240","NA","NA","NA","NA",null,0,{"v":0.121776,"d":"0.12"},0,{"v":0.035588,"d":"0.04"},{"v":0.111626,"d":"0.11"},0,{"v":0.827203934408412,"d":"0.83"},{"v":-0.273685047365552,"d":"-0.27"},1,1,"down","no"]
["MSTRG.15332","GEMIN6","ENSOART00000009532","GO:0000245(spliceosomal complex assembly);GO:0000387(spliceosomal snRNP assembly);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0016604(nuclear body);GO:0032797(SMN complex);GO:0034719(SMN-Sm protein complex);GO:0097504(Gemini of coiled bodies)","NA","NA","NA","gem nuclear organelle associated protein 6 [Source:NCBI gene;Acc:101118517]",{"v":1.362411,"d":"1.36"},{"v":1.041028,"d":"1.04"},{"v":1.063526,"d":"1.06"},{"v":1.478073,"d":"1.48"},{"v":1.694954,"d":"1.69"},{"v":1.997249,"d":"2.00"},{"v":0.670557045697367,"d":"0.67"},{"v":-0.576568024437108,"d":"-0.58"},1,1,"down","no"]
["ENSOARG00000015761","HTR7","ENSOART00000017157","GO:0004930(G protein-coupled receptor activity);GO:0004993(G protein-coupled serotonin receptor activity);GO:0006939(smooth muscle contraction);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007268(chemical synaptic transmission);GO:0007623(circadian rhythm);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0042310(vasoconstriction);GO:0098664(G protein-coupled serotonin receptor signaling pathway)","04014(Ras signaling pathway);04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04726(Serotonergic synapse)","K04163","NA","5-hydroxytryptamine receptor 7 [Source:NCBI gene;Acc:101122994]",0,{"v":0.175721,"d":"0.18"},{"v":0.145407,"d":"0.15"},{"v":0.313467,"d":"0.31"},{"v":0.285435,"d":"0.29"},{"v":0.312882,"d":"0.31"},{"v":0.35219745027331,"d":"0.35"},{"v":-1.50554363004353,"d":"-1.51"},1,1,"down","no"]
["ENSOARG00000018791","JHY","ENSOART00000020465","GO:0007420(brain development);GO:0032053(ciliary basal body organization);GO:0033326(cerebrospinal fluid secretion);GO:0035082(axoneme assembly)","NA","NA","NA","junctional cadherin complex regulator [Source:NCBI gene;Acc:101112344]",{"v":0.082076,"d":"0.08"},0,{"v":0.019426,"d":"0.02"},{"v":0.011685,"d":"0.01"},{"v":0.215204,"d":"0.22"},{"v":0.095261,"d":"0.10"},{"v":0.315076827564799,"d":"0.32"},{"v":-1.66622444014047,"d":"-1.67"},1,1,"down","no"]
["ENSOARG00000000487","ENSOARG00000000487","ENSOART00000000514","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.093652412044374,"d":"0.09"},{"v":0.0595915055467512,"d":"0.06"},0,{"v":0.0494393914421553,"d":"0.05"},0,0,{"v":3.0996319558347,"d":"3.10"},{"v":1.63209692291424,"d":"1.63"},1,1,"up","no"]
["ENSOARG00000023025","RF00026","ENSOART00000024927","NA","NA","NA","NA",null,{"v":0.012053,"d":"0.01"},{"v":0.519432,"d":"0.52"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.17727","BEST2","ENSOART00000012262","GO:0005254(chloride channel activity);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034707(chloride channel complex);GO:1902476(chloride transmembrane transport)","04970(Salivary secretion)","K13879","NA","bestrophin 2 [Source:NCBI gene;Acc:101123465]",{"v":0.035691,"d":"0.04"},{"v":0.013357,"d":"0.01"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.1009","ENSOARG00000007477","ENSOART00000008140","GO:0005515(protein binding)","NA","NA","NA",null,{"v":2.243538,"d":"2.24"},{"v":1.659736,"d":"1.66"},{"v":1.247555,"d":"1.25"},{"v":1.582276,"d":"1.58"},{"v":2.717557,"d":"2.72"},{"v":3.045837,"d":"3.05"},{"v":0.701206152740322,"d":"0.70"},{"v":-0.512089439792469,"d":"-0.51"},1,1,"down","no"]
["ENSOARG00000023281","RF00026","ENSOART00000025183","NA","NA","NA","NA",null,{"v":0.182742,"d":"0.18"},0,{"v":0.230831,"d":"0.23"},{"v":0.319722,"d":"0.32"},{"v":0.556725,"d":"0.56"},{"v":0.275151,"d":"0.28"},{"v":0.359129661565928,"d":"0.36"},{"v":-1.47742328057363,"d":"-1.48"},1,1,"down","no"]
["ENSOARG00000008796","MIP","ENSOART00000009579","GO:0002088(lens development in camera-type eye);GO:0005212(structural constituent of eye lens);GO:0005516(calmodulin binding);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0005921(gap junction);GO:0006833(water transport);GO:0007601(visual perception);GO:0015250(water channel activity);GO:0015267(channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030054(cell junction);GO:0045785(positive regulation of cell adhesion);GO:0050896(response to stimulus);GO:0051289(protein homotetramerization);GO:0055085(transmembrane transport);GO:1990349(gap junction-mediated intercellular transport)","NA","K09863","NA","major intrinsic protein of lens fiber [Source:NCBI gene;Acc:100294602]",{"v":0.030403,"d":"0.03"},{"v":0.159322,"d":"0.16"},0,{"v":0.094199,"d":"0.09"},0,0,{"v":2.0140871983779,"d":"2.01"},{"v":1.01012614508457,"d":"1.01"},1,1,"up","no"]
["ENSOARG00000011161","ENSOARG00000011161","ENSOART00000012138","NA","NA","NA","NA",null,0,0,{"v":0.02338,"d":"0.02"},{"v":0.024273,"d":"0.02"},0,0,{"v":0.963210151196803,"d":"0.96"},{"v":-0.0540774982588969,"d":"-0.05"},1,1,"down","no"]
["MSTRG.11742","RF00402","ENSOART00000024645","NA","NA","NA","NA",null,{"v":2.882784,"d":"2.88"},{"v":1.867901,"d":"1.87"},{"v":3.446886,"d":"3.45"},{"v":3.359292,"d":"3.36"},{"v":1.644977,"d":"1.64"},{"v":1.420706,"d":"1.42"},{"v":1.27589150152335,"d":"1.28"},{"v":0.351505651305388,"d":"0.35"},1,1,"up","no"]
["ENSOARG00000008079","NCR3","ENSOART00000008792","GO:0002429(immune response-activating cell surface receptor signaling pathway);GO:0030101(natural killer cell activation);GO:0042802(identical protein binding);GO:0045954(positive regulation of natural killer cell mediated cytotoxicity)","04650(Natural killer cell mediated cytotoxicity)","K06743","NA","natural cytotoxicity triggering receptor 3 [Source:NCBI gene;Acc:101122313]",{"v":0.397637,"d":"0.40"},{"v":0.272461,"d":"0.27"},{"v":0.158032,"d":"0.16"},{"v":0.147276,"d":"0.15"},{"v":0.103805,"d":"0.10"},{"v":0.226166,"d":"0.23"},{"v":1.73522306059546,"d":"1.74"},{"v":0.7951211312358,"d":"0.80"},1,1,"up","no"]
["MSTRG.18372","ENSOARG00000014367","ENSOART00000015641","NA","NA","NA","NA","protein preY, mitochondrial [Source:NCBI gene;Acc:101121259]",{"v":0.554529,"d":"0.55"},{"v":0.819436,"d":"0.82"},{"v":1.163625,"d":"1.16"},{"v":1.63213,"d":"1.63"},{"v":1.140151,"d":"1.14"},{"v":2.006784,"d":"2.01"},{"v":0.530980432364908,"d":"0.53"},{"v":-0.913269398924354,"d":"-0.91"},1,1,"down","no"]
["ENSOARG00000013928","MMP17","ENSOART00000015171","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0031012(extracellular matrix);GO:0046872(metal ion binding)","04928(Parathyroid hormone synthesis, secretion and action)","K07997","EC:3.4.24.-","matrix metallopeptidase 17 [Source:NCBI gene;Acc:101117966]",{"v":0.16036,"d":"0.16"},{"v":0.091932,"d":"0.09"},{"v":0.030418,"d":"0.03"},{"v":0.042976,"d":"0.04"},{"v":0.097619,"d":"0.10"},{"v":0.082848,"d":"0.08"},{"v":1.26524437999848,"d":"1.27"},{"v":0.339416066153525,"d":"0.34"},1,1,"up","no"]
["MSTRG.9286","ENSOARG00000004795","ENSOART00000005224;ENSOART00000005225","NA","NA","NA","NA",null,{"v":0.114319676623377,"d":"0.11"},{"v":0.105751803896104,"d":"0.11"},{"v":0.148722546753247,"d":"0.15"},{"v":0.10390572987013,"d":"0.10"},{"v":0.131452972727273,"d":"0.13"},{"v":0.0199239727272727,"d":"0.02"},{"v":1.44464964887917,"d":"1.44"},{"v":0.530719658048063,"d":"0.53"},1,1,"up","no"]
["ENSOARG00000023946","RF00026","ENSOART00000025848","NA","NA","NA","NA",null,0,0,{"v":0.706413,"d":"0.71"},{"v":0.747825,"d":"0.75"},{"v":0.317785,"d":"0.32"},0,{"v":0.662918891526919,"d":"0.66"},{"v":-0.593095728244834,"d":"-0.59"},1,1,"down","no"]
["ENSOARG00000008447","ZNF26","ENSOART00000009191","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","NA","NA","zinc finger protein 26 [Source:HGNC Symbol;Acc:HGNC:13053]",{"v":0.404096,"d":"0.40"},{"v":0.330509,"d":"0.33"},{"v":0.314312,"d":"0.31"},{"v":0.129683,"d":"0.13"},{"v":0.326844,"d":"0.33"},{"v":0.321428,"d":"0.32"},{"v":1.34830035156275,"d":"1.35"},{"v":0.431141911536941,"d":"0.43"},1,1,"up","no"]
["MSTRG.16110","ENSOARG00000018456","ENSOART00000020088","GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)","03010(Ribosome)","K02957","NA","40S ribosomal protein S15a [Source:NCBI gene;Acc:101116302]",{"v":0.868612,"d":"0.87"},{"v":0.965353,"d":"0.97"},{"v":1.202623,"d":"1.20"},{"v":0.699562,"d":"0.70"},{"v":1.409481,"d":"1.41"},{"v":1.989556,"d":"1.99"},{"v":0.740884385127699,"d":"0.74"},{"v":-0.432679667088461,"d":"-0.43"},1,1,"down","no"]
["ENSOARG00000019083","KIAA1324","ENSOART00000020779","GO:0000045(autophagosome assembly);GO:0005764(lysosome);GO:0005770(late endosome);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0009267(cellular response to starvation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0044090(positive regulation of vacuole organization);GO:2000786(positive regulation of autophagosome assembly)","NA","NA","NA","KIAA1324 ortholog [Source:NCBI gene;Acc:101103105]",0,{"v":0.019752,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000011642","GPR68","ENSOART00000012660","GO:0004930(G protein-coupled receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032024(positive regulation of insulin secretion);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0045656(negative regulation of monocyte differentiation);GO:0071467(cellular response to pH);GO:2001206(positive regulation of osteoclast development)","NA","NA","NA","G protein-coupled receptor 68 [Source:HGNC Symbol;Acc:HGNC:4519]",{"v":0.067721,"d":"0.07"},{"v":0.036372,"d":"0.04"},{"v":0.027277,"d":"0.03"},{"v":0.073265,"d":"0.07"},{"v":0.066706,"d":"0.07"},{"v":0.03265,"d":"0.03"},{"v":0.761031392472526,"d":"0.76"},{"v":-0.393972128897933,"d":"-0.39"},1,1,"down","no"]
["ENSOARG00000005747","ENSOARG00000005747","ENSOART00000006256","GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0016491(oxidoreductase activity);GO:0016705(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen);GO:0020037(heme binding);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","NA","NA","NA",null,{"v":0.006605,"d":"0.01"},{"v":0.184099,"d":"0.18"},{"v":0.231076,"d":"0.23"},{"v":0.220874,"d":"0.22"},{"v":0.082555,"d":"0.08"},0,{"v":1.39004511763872,"d":"1.39"},{"v":0.47513171024179,"d":"0.48"},1,1,"up","no"]
["ENSOARG00000018143","SLC47A1","ENSOART00000019750","GO:0006855(drug transmembrane transport);GO:0015238(drug transmembrane transporter activity);GO:0015297(antiporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0055085(transmembrane transport)","NA","K03327","NA","multidrug and toxin extrusion protein 1 [Source:NCBI gene;Acc:101108763]",0,{"v":0.010632,"d":"0.01"},{"v":0.036567,"d":"0.04"},{"v":0.060639,"d":"0.06"},{"v":0.11098,"d":"0.11"},{"v":0.085613,"d":"0.09"},{"v":0.183488057473409,"d":"0.18"},{"v":-2.44624192819258,"d":"-2.45"},1,1,"down","no"]
["MSTRG.17869","ENSOARG00000006861","ENSOART00000007456","NA","NA","NA","NA",null,{"v":0.181322,"d":"0.18"},{"v":0.132425,"d":"0.13"},{"v":0.091654,"d":"0.09"},{"v":0.263686,"d":"0.26"},{"v":0.196086,"d":"0.20"},{"v":0.08745,"d":"0.09"},{"v":0.740834615567357,"d":"0.74"},{"v":-0.432776584652299,"d":"-0.43"},1,1,"down","no"]
["ENSOARG00000022735","ENSOARG00000022735","ENSOART00000024637","NA","NA","NA","NA",null,{"v":0.203826,"d":"0.20"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000012417","CD300E","ENSOART00000013504","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K06719","NA","CD300e molecule [Source:NCBI gene;Acc:101103409]",{"v":0.115164,"d":"0.12"},0,{"v":0.304801,"d":"0.30"},{"v":0.119528,"d":"0.12"},{"v":0.198283,"d":"0.20"},{"v":0.291851,"d":"0.29"},{"v":0.688848903162736,"d":"0.69"},{"v":-0.537740527869857,"d":"-0.54"},1,1,"down","no"]
["MSTRG.19517","CIDEB","ENSOART00000020815","GO:0005622(intracellular);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0010942(positive regulation of cell death);GO:0042802(identical protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097194(execution phase of apoptosis);GO:0097202(activation of cysteine-type endopeptidase activity)","NA","NA","NA","cell death inducing DFFA like effector b [Source:NCBI gene;Acc:101113497]",{"v":0.046373,"d":"0.05"},{"v":0.0362,"d":"0.04"},0,{"v":0.025575,"d":"0.03"},0,{"v":0.043209,"d":"0.04"},{"v":1.20046813212375,"d":"1.20"},{"v":0.263597105994599,"d":"0.26"},1,1,"up","no"]
["ENSOARG00000023148","RF00026","ENSOART00000025050","NA","NA","NA","NA",null,0,0,{"v":0.121795,"d":"0.12"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.11389","RF00282","ENSOART00000024845","NA","NA","NA","NA","small nucleolar RNA, C/D box 48 [Source:HGNC Symbol;Acc:HGNC:10188]",{"v":0.575418,"d":"0.58"},{"v":2.00646,"d":"2.01"},{"v":1.247063,"d":"1.25"},{"v":1.419421,"d":"1.42"},{"v":1.880875,"d":"1.88"},{"v":0.382262,"d":"0.38"},{"v":1.03975035831072,"d":"1.04"},{"v":0.0562371821547491,"d":"0.06"},1,1,"up","no"]
["ENSOARG00000001948","ENSOARG00000001948","ENSOART00000002097","GO:0005198(structural molecule activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.049488,"d":"0.05"},0,{"v":0.118146,"d":"0.12"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.6974","ENSOARG00000007198","ENSOART00000007829","NA","NA","NA","NA",null,{"v":0.097096,"d":"0.10"},0,0,{"v":0.207427,"d":"0.21"},{"v":0.373532,"d":"0.37"},{"v":0.097761,"d":"0.10"},{"v":0.143057520037718,"d":"0.14"},{"v":-2.80533275775777,"d":"-2.81"},1,1,"down","no"]
["ENSOARG00000001440","WNT7A","ENSOART00000001544","GO:0000578(embryonic axis specification);GO:0001502(cartilage condensation);GO:0002062(chondrocyte differentiation);GO:0005102(signaling receptor binding);GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0007275(multicellular organism development);GO:0010469(regulation of signaling receptor activity);GO:0016055(Wnt signaling pathway);GO:0021846(cell proliferation in forebrain);GO:0032270(positive regulation of cellular protein metabolic process);GO:0035115(embryonic forelimb morphogenesis);GO:0035116(embryonic hindlimb morphogenesis);GO:0035313(wound healing, spreading of epidermal cells);GO:0042733(embryonic digit morphogenesis);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048018(receptor ligand activity);GO:0048864(stem cell development);GO:0050768(negative regulation of neurogenesis);GO:0051965(positive regulation of synapse assembly);GO:0060054(positive regulation of epithelial cell proliferation involved in wound healing);GO:0060070(canonical Wnt signaling pathway);GO:0060071(Wnt signaling pathway, planar cell polarity pathway);GO:0060997(dendritic spine morphogenesis);GO:0062009(secondary palate development);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:0098978(glutamatergic synapse);GO:1904891(positive regulation of excitatory synapse assembly);GO:1905606(regulation of presynapse assembly);GO:2000463(positive regulation of excitatory postsynaptic potential)","NA","NA","NA","Wnt family member 7A [Source:HGNC Symbol;Acc:HGNC:12786]",0,0,0,{"v":0.04486,"d":"0.04"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000024595","RF02045","ENSOART00000026497","NA","NA","NA","NA",null,0,{"v":0.048691,"d":"0.05"},{"v":0.10391,"d":"0.10"},0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.6662","PRRG4","ENSOART00000018342","GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","proline rich and Gla domain 4 [Source:NCBI gene;Acc:101122380]",0,0,0,{"v":0.1025,"d":"0.10"},0,{"v":0.149739,"d":"0.15"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000018415","LRRC66","ENSOART00000020041","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","leucine rich repeat containing 66 [Source:NCBI gene;Acc:101104319]",{"v":0.032775,"d":"0.03"},0,{"v":0.020528,"d":"0.02"},{"v":0.025733,"d":"0.03"},{"v":0.017062,"d":"0.02"},{"v":0.038315,"d":"0.04"},{"v":0.657169276291456,"d":"0.66"},{"v":-0.605663061309766,"d":"-0.61"},1,1,"down","no"]
["ENSOARG00000021019","CLEC9A","ENSOART00000022899","GO:0006898(receptor-mediated endocytosis);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030246(carbohydrate binding);GO:0050715(positive regulation of cytokine secretion)","NA","K17515","NA","C-type lectin domain containing 9A [Source:NCBI gene;Acc:101119033]",0,{"v":0.054633,"d":"0.05"},{"v":0.312437,"d":"0.31"},{"v":0.078552,"d":"0.08"},0,0,{"v":4.67295549444954,"d":"4.67"},{"v":2.22433529694106,"d":"2.22"},1,1,"up","no"]
["ENSOARG00000006300","WDR31","ENSOART00000006852","GO:0005515(protein binding)","NA","NA","NA","WD repeat domain 31 [Source:NCBI gene;Acc:101107069]",{"v":0.281856,"d":"0.28"},0,{"v":0.088237,"d":"0.09"},{"v":0.504213,"d":"0.50"},{"v":0.204748,"d":"0.20"},{"v":0.172815,"d":"0.17"},{"v":0.419713169784616,"d":"0.42"},{"v":-1.25252436198315,"d":"-1.25"},1,1,"down","no"]
["MSTRG.3343","RF00026","ENSOART00000023758","NA","NA","NA","NA",null,{"v":0.466427,"d":"0.47"},{"v":0.315522,"d":"0.32"},{"v":0.51154,"d":"0.51"},{"v":0.64667,"d":"0.65"},{"v":0.854648,"d":"0.85"},{"v":0.440713,"d":"0.44"},{"v":0.666049615067937,"d":"0.67"},{"v":-0.58629844499868,"d":"-0.59"},1,1,"down","no"]
["ENSOARG00000009188","ENSOARG00000009188","ENSOART00000010001","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,{"v":0.171634,"d":"0.17"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.2322","RF00420","ENSOART00000026128","NA","NA","NA","NA",null,{"v":0.024595,"d":"0.02"},{"v":0.063488,"d":"0.06"},0,{"v":0.080229,"d":"0.08"},{"v":0.193199,"d":"0.19"},0,{"v":0.32214330646459,"d":"0.32"},{"v":-1.6342254763213,"d":"-1.63"},1,1,"down","no"]
["ENSOARG00000009944","RGS18","ENSOART00000010823","GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008277(regulation of G protein-coupled receptor signaling pathway);GO:0043547(positive regulation of GTPase activity)","NA","K16449","NA","regulator of G protein signaling 18 [Source:NCBI gene;Acc:101123221]",0,0,0,{"v":0.040109,"d":"0.04"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000000688","ENSOARG00000000688","ENSOART00000000739","NA","NA","NA","NA",null,0,{"v":0.091089,"d":"0.09"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.8546","oar-mir-544","ENSOART00000024743","NA","NA","NA","NA","oar-mir-544 [Source:miRBase;Acc:MI0016943]",{"v":0.661305,"d":"0.66"},{"v":0.89841,"d":"0.90"},{"v":0.989235,"d":"0.99"},{"v":1.981264,"d":"1.98"},{"v":1.696066,"d":"1.70"},{"v":0.519326,"d":"0.52"},{"v":0.607376444483417,"d":"0.61"},{"v":-0.719337136474071,"d":"-0.72"},1,1,"down","no"]
["ENSOARG00000014939","CLDN15","ENSOART00000016262","GO:0005198(structural molecule activity);GO:0005886(plasma membrane);GO:0005923(bicellular tight junction);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016328(lateral plasma membrane);GO:0030054(cell junction)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)","K06087","NA","claudin 15 [Source:NCBI gene;Acc:101121229]",{"v":0.369756,"d":"0.37"},{"v":0.291812,"d":"0.29"},{"v":0.146946,"d":"0.15"},{"v":0.103151,"d":"0.10"},{"v":0.055634,"d":"0.06"},{"v":0.207473,"d":"0.21"},{"v":2.20749853928105,"d":"2.21"},{"v":1.14241248323153,"d":"1.14"},1,1,"up","no"]
["ENSOARG00000023654","ENSOARG00000023654","ENSOART00000025556","NA","NA","NA","NA",null,0,0,{"v":0.175222,"d":"0.18"},0,{"v":0.248506,"d":"0.25"},0,{"v":0.705101687685609,"d":"0.71"},{"v":-0.50409676114812,"d":"-0.50"},1,1,"down","no"]
["ENSOARG00000008342","CCKAR","ENSOART00000009075","GO:0001764(neuron migration);GO:0004930(G protein-coupled receptor activity);GO:0004951(cholecystokinin receptor activity);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007409(axonogenesis);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0017046(peptide hormone binding);GO:0030900(forebrain development);GO:0038188(cholecystokinin signaling pathway)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction);04911(Insulin secretion);04972(Pancreatic secretion)","K04194","NA","cholecystokinin A receptor [Source:NCBI gene;Acc:101108047]",{"v":0.0719938073970691,"d":"0.07"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000024743","RF00004","ENSOART00000026645","NA","NA","NA","NA",null,0,0,0,{"v":0.120049,"d":"0.12"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000012078","REEP6","ENSOART00000013135","GO:0001917(photoreceptor inner segment);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032386(regulation of intracellular transport);GO:0044317(rod spherule);GO:0045177(apical part of cell);GO:0050908(detection of light stimulus involved in visual perception)","NA","K17279","NA","receptor accessory protein 6 [Source:NCBI gene;Acc:101118947]",{"v":0.266557,"d":"0.27"},{"v":0.148976,"d":"0.15"},{"v":0.076873,"d":"0.08"},{"v":0.167137,"d":"0.17"},{"v":0.487904,"d":"0.49"},{"v":0.44953,"d":"0.45"},{"v":0.445789360756348,"d":"0.45"},{"v":-1.1655659093512,"d":"-1.17"},1,1,"down","no"]
["MSTRG.743","RF00003","ENSOART00000024708","NA","NA","NA","NA",null,{"v":1.519455,"d":"1.52"},{"v":2.374879,"d":"2.37"},{"v":1.284252,"d":"1.28"},{"v":3.272286,"d":"3.27"},{"v":4.367962,"d":"4.37"},{"v":4.634585,"d":"4.63"},{"v":0.421886472915762,"d":"0.42"},{"v":-1.24507326419241,"d":"-1.25"},1,1,"down","no"]
["MSTRG.10598","ENSOARG00000021424","ENSOART00000023326","NA","NA","NA","NA",null,0,0,0,{"v":0.311131,"d":"0.31"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000007914","ENSOARG00000007914","ENSOART00000008625","NA","NA","NA","NA",null,0,0,{"v":0.005261,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000016629","FZD1","ENSOART00000018112","GO:0001934(positive regulation of protein phosphorylation);GO:0003149(membranous septum morphogenesis);GO:0003150(muscular septum morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0004888(transmembrane signaling receptor activity);GO:0005102(signaling receptor binding);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0007166(cell surface receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0007275(multicellular organism development);GO:0009986(cell surface);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016055(Wnt signaling pathway);GO:0017147(Wnt-protein binding);GO:0030165(PDZ domain binding);GO:0030514(negative regulation of BMP signaling pathway);GO:0030855(epithelial cell differentiation);GO:0035425(autocrine signaling);GO:0042493(response to drug);GO:0042813(Wnt-activated receptor activity);GO:0044338(canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation);GO:0044339(canonical Wnt signaling pathway involved in osteoblast differentiation);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0060022(hard palate development);GO:0060070(canonical Wnt signaling pathway);GO:0060412(ventricular septum morphogenesis);GO:0090090(negative regulation of canonical Wnt signaling pathway);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:1903204(negative regulation of oxidative stress-induced neuron death);GO:1905606(regulation of presynapse assembly)","NA","NA","NA","frizzled class receptor 1 [Source:HGNC Symbol;Acc:HGNC:4038]",{"v":0.421913,"d":"0.42"},{"v":0.119364,"d":"0.12"},{"v":0.164654,"d":"0.16"},{"v":0.088506,"d":"0.09"},{"v":0.269618,"d":"0.27"},{"v":0.235475,"d":"0.24"},{"v":1.18923886327302,"d":"1.19"},{"v":0.250038515125031,"d":"0.25"},1,1,"up","no"]
["ENSOARG00000003885","ENSOARG00000003885","ENSOART00000004223","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","K09229","NA","zinc finger protein 500 [Source:NCBI gene;Acc:101103529]",{"v":0.33106,"d":"0.33"},{"v":0.213993,"d":"0.21"},{"v":0.178137,"d":"0.18"},{"v":0.269289,"d":"0.27"},{"v":0.317859,"d":"0.32"},{"v":0.545036,"d":"0.55"},{"v":0.638756597867484,"d":"0.64"},{"v":-0.646661806822952,"d":"-0.65"},1,1,"down","no"]
["ENSOARG00000017733","ENSOARG00000017733","ENSOART00000019299","NA","NA","NA","NA","coiled-coil domain containing 7 [Source:NCBI gene;Acc:101111568]",{"v":0.051628,"d":"0.05"},0,0,{"v":0.024668,"d":"0.02"},0,0,{"v":2.09291389654613,"d":"2.09"},{"v":1.06551295966762,"d":"1.07"},1,1,"up","no"]
["ENSOARG00000004385","ENSOARG00000004385","ENSOART00000004774","GO:0003676(nucleic acid binding)","NA","K09226","NA","Zic family member 5 [Source:NCBI gene;Acc:101112236]",{"v":0.034955,"d":"0.03"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000008604","OSBP2","ENSOART00000009370","GO:0007286(spermatid development);GO:0015485(cholesterol binding);GO:0097440(apical dendrite)","NA","K20462","NA","oxysterol binding protein 2 [Source:NCBI gene;Acc:101102934]",0,0,0,0,{"v":0.039635,"d":"0.04"},{"v":0.03807,"d":"0.04"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000008471","RAP1GAP","ENSOART00000009222","GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0030695(GTPase regulator activity);GO:0043547(positive regulation of GTPase activity);GO:0050790(regulation of catalytic activity);GO:0051056(regulation of small GTPase mediated signal transduction)","04015(Rap1 signaling pathway)","K17700","NA","RAP1 GTPase activating protein [Source:NCBI gene;Acc:101104377]",{"v":0.074313,"d":"0.07"},0,0,0,{"v":0.096482,"d":"0.10"},{"v":0.034288,"d":"0.03"},{"v":0.568272539573297,"d":"0.57"},{"v":-0.815345092640139,"d":"-0.82"},1,1,"down","no"]
["MSTRG.19270","ENSOARG00000015586","ENSOART00000016958","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,0,0,{"v":0.011,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000014546","ENSOARG00000014546","ENSOART00000015833","GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.107354,"d":"0.11"},{"v":0.056833,"d":"0.06"},0,{"v":0.257705,"d":"0.26"},0,{"v":0.394376,"d":"0.39"},{"v":0.251789271578224,"d":"0.25"},{"v":-1.98971128192826,"d":"-1.99"},1,1,"down","no"]
["ENSOARG00000023275","RF00026","ENSOART00000025177","NA","NA","NA","NA",null,0,0,0,0,{"v":0.09107,"d":"0.09"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.7606","RF00004","ENSOART00000023267","NA","NA","NA","NA","RNA, U2 small nuclear 49, pseudogene [Source:HGNC Symbol;Acc:HGNC:48542]",{"v":1.093329,"d":"1.09"},{"v":0.384822,"d":"0.38"},{"v":0.707662,"d":"0.71"},{"v":0.652092,"d":"0.65"},{"v":1.567648,"d":"1.57"},{"v":0.990579,"d":"0.99"},{"v":0.680870966405519,"d":"0.68"},{"v":-0.554546679565159,"d":"-0.55"},1,1,"down","no"]
["ENSOARG00000012020","STMND1","ENSOART00000013075","GO:0031110(regulation of microtubule polymerization or depolymerization)","NA","NA","NA","stathmin domain containing 1 [Source:NCBI gene;Acc:101112771]",0,0,0,{"v":0.021635,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000021446","RF00156","ENSOART00000023348","NA","NA","NA","NA",null,0,0,0,{"v":0.009545,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.18475","ENSOARG00000014307","ENSOART00000015590","GO:0005509(calcium ion binding);GO:0005887(integral component of plasma membrane);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","teneurin-2 [Source:NCBI gene;Acc:101120408]",{"v":0.025078,"d":"0.03"},{"v":0.032497,"d":"0.03"},{"v":0.019384,"d":"0.02"},{"v":0.046778,"d":"0.05"},{"v":0.024734,"d":"0.02"},{"v":0.048348,"d":"0.05"},{"v":0.642074086434173,"d":"0.64"},{"v":-0.639188320959614,"d":"-0.64"},1,1,"down","no"]
["MSTRG.10923","UBXN11","ENSOART00000005324","NA","NA","NA","NA","UBX domain protein 11 [Source:NCBI gene;Acc:101116293]",{"v":0.160526,"d":"0.16"},{"v":0.069471,"d":"0.07"},{"v":0.102717,"d":"0.10"},{"v":0.103005,"d":"0.10"},{"v":0.285396,"d":"0.29"},{"v":0.103734,"d":"0.10"},{"v":0.676062462535686,"d":"0.68"},{"v":-0.564771549226887,"d":"-0.56"},1,1,"down","no"]
["ENSOARG00000003151","FOXI1","ENSOART00000003416","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006355(regulation of transcription, DNA-templated);GO:0042472(inner ear morphogenesis);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","NA","NA","forkhead box I1 [Source:HGNC Symbol;Acc:HGNC:3815]",0,0,0,{"v":0.0164010157977883,"d":"0.02"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000016768","SCNN1B","ENSOART00000018263","GO:0005272(sodium channel activity);GO:0005886(plasma membrane);GO:0005887(integral component of plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0009897(external side of plasma membrane);GO:0015280(ligand-gated sodium channel activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016324(apical plasma membrane);GO:0030659(cytoplasmic vesicle membrane);GO:0031410(cytoplasmic vesicle);GO:0034706(sodium channel complex);GO:0035725(sodium ion transmembrane transport);GO:0050699(WW domain binding);GO:0050891(multicellular organismal water homeostasis);GO:0050896(response to stimulus);GO:0050909(sensory perception of taste);GO:0055078(sodium ion homeostasis);GO:0070062(extracellular exosome)","04742(Taste transduction);04960(Aldosterone-regulated sodium reabsorption)","K04825","NA","sodium channel epithelial 1 beta subunit [Source:NCBI gene;Acc:100170325]",{"v":0.018417,"d":"0.02"},0,0,0,{"v":0.019039,"d":"0.02"},0,{"v":0.967330216923158,"d":"0.97"},{"v":-0.0479196291835713,"d":"-0.05"},1,1,"down","no"]
["ENSOARG00000002360","HPSE","ENSOART00000002558","GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005764(lysosome);GO:0007160(cell-matrix adhesion);GO:0010575(positive regulation of vascular endothelial growth factor production);GO:0016020(membrane);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0030194(positive regulation of blood coagulation);GO:0030200(heparan sulfate proteoglycan catabolic process);GO:0030305(heparanase activity);GO:0033690(positive regulation of osteoblast proliferation);GO:0042060(wound healing);GO:0043231(intracellular membrane-bounded organelle);GO:0045121(membrane raft);GO:0045545(syndecan binding);GO:0046983(protein dimerization activity);GO:0051797(regulation of hair follicle development);GO:0051798(positive regulation of hair follicle development);GO:0051897(positive regulation of protein kinase B signaling);GO:0060055(angiogenesis involved in wound healing);GO:0061042(vascular wound healing)","00531(Glycosaminoglycan degradation);05205(Proteoglycans in cancer)","K07964","EC:3.2.1.166","heparanase [Source:NCBI gene;Acc:101118612]",{"v":0.095175,"d":"0.10"},{"v":0.063085,"d":"0.06"},{"v":0.041054,"d":"0.04"},{"v":0.07781,"d":"0.08"},{"v":0.086353,"d":"0.09"},{"v":0.041411,"d":"0.04"},{"v":0.969548678334809,"d":"0.97"},{"v":-0.0446147610429455,"d":"-0.04"},1,1,"down","no"]
["MSTRG.14180","RF02271","ENSOART00000023438","NA","NA","NA","NA",null,{"v":0.154288,"d":"0.15"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.3379","RF00003","ENSOART00000024497","NA","NA","NA","NA",null,{"v":1.2383,"d":"1.24"},{"v":0.04961,"d":"0.05"},{"v":0.989739,"d":"0.99"},{"v":0.559806,"d":"0.56"},{"v":0.76041,"d":"0.76"},{"v":0.918168,"d":"0.92"},{"v":1.01754167292118,"d":"1.02"},{"v":0.025087880570724,"d":"0.03"},1,1,"up","no"]
["MSTRG.18932","RF00026","ENSOART00000026569","NA","NA","NA","NA",null,{"v":0.326034,"d":"0.33"},{"v":0.220132,"d":"0.22"},{"v":0.307388,"d":"0.31"},{"v":0.2565,"d":"0.26"},0,{"v":0.067167,"d":"0.07"},{"v":2.63713631602851,"d":"2.64"},{"v":1.39897214737821,"d":"1.40"},1,1,"up","no"]
["MSTRG.10721","ENSOARG00000023421","ENSOART00000025323","NA","NA","NA","NA",null,0,{"v":0.117039,"d":"0.12"},0,{"v":0.121383,"d":"0.12"},{"v":0.604795,"d":"0.60"},{"v":0.010964,"d":"0.01"},{"v":0.158774021830258,"d":"0.16"},{"v":-2.65495321290121,"d":"-2.65"},1,1,"down","no"]
["ENSOARG00000004028","PARD6G","ENSOART00000004374","GO:0005515(protein binding);GO:0007163(establishment or maintenance of cell polarity)","NA","NA","NA","par-6 family cell polarity regulator gamma [Source:HGNC Symbol;Acc:HGNC:16076]",{"v":0.416595,"d":"0.42"},{"v":0.207435,"d":"0.21"},{"v":0.15117,"d":"0.15"},{"v":0.517822,"d":"0.52"},{"v":0.15629,"d":"0.16"},{"v":0.467267,"d":"0.47"},{"v":0.679178432405012,"d":"0.68"},{"v":-0.558137448653022,"d":"-0.56"},1,1,"down","no"]
["ENSOARG00000013806","ENSOARG00000013806","ENSOART00000015026","GO:0016020(membrane);GO:0016021(integral component of membrane)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","K12349","EC:3.5.1.23","N-acylsphingosine amidohydrolase 2 [Source:NCBI gene;Acc:101121732]",0,0,{"v":0.027346,"d":"0.03"},0,{"v":0.028358,"d":"0.03"},{"v":0.050383,"d":"0.05"},{"v":0.347290483991821,"d":"0.35"},{"v":-1.52578521450394,"d":"-1.53"},1,1,"down","no"]
["ENSOARG00000004705","ENSOARG00000004705","ENSOART00000005116","GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005840(ribosome);GO:0006412(translation)","NA","NA","NA",null,{"v":0.130634,"d":"0.13"},{"v":0.117743,"d":"0.12"},{"v":0.087066,"d":"0.09"},0,{"v":0.251511,"d":"0.25"},{"v":0.17627,"d":"0.18"},{"v":0.784146560973957,"d":"0.78"},{"v":-0.350804768315733,"d":"-0.35"},1,1,"down","no"]
["ENSOARG00000002819","ALOX5","ENSOART00000003058","GO:0002540(leukotriene production involved in inflammatory response);GO:0004051(arachidonate 5-lipoxygenase activity);GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005641(nuclear envelope lumen);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006691(leukotriene metabolic process);GO:0006954(inflammatory response);GO:0016363(nuclear matrix);GO:0016491(oxidoreductase activity);GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen);GO:0019370(leukotriene biosynthetic process);GO:0031965(nuclear membrane);GO:0046872(metal ion binding);GO:0051213(dioxygenase activity);GO:0055114(oxidation-reduction process)","00590(Arachidonic acid metabolism);04664(Fc epsilon RI signaling pathway);04726(Serotonergic synapse);04913(Ovarian steroidogenesis);05145(Toxoplasmosis)","K00461","EC:1.13.11.34","arachidonate 5-lipoxygenase [Source:NCBI gene;Acc:101117390]",{"v":0.220358,"d":"0.22"},{"v":0.053269,"d":"0.05"},{"v":0.218227,"d":"0.22"},{"v":0.183901,"d":"0.18"},{"v":0.290659,"d":"0.29"},{"v":0.479361,"d":"0.48"},{"v":0.515612928114592,"d":"0.52"},{"v":-0.955639657617233,"d":"-0.96"},1,1,"down","no"]
["MSTRG.6964","ENSOARG00000022653","ENSOART00000024555","NA","NA","NA","NA",null,{"v":1.086843,"d":"1.09"},0,0,{"v":0.886142,"d":"0.89"},{"v":0.386397,"d":"0.39"},{"v":1.535157,"d":"1.54"},{"v":0.387094258067825,"d":"0.39"},{"v":-1.36924318720163,"d":"-1.37"},1,1,"down","no"]
["ENSOARG00000011995","CTH","ENSOART00000013047;ENSOART00000013049","GO:0003824(catalytic activity);GO:0004123(cystathionine gamma-lyase activity);GO:0018272(protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine);GO:0019343(cysteine biosynthetic process via cystathionine);GO:0019344(cysteine biosynthetic process);GO:0019346(transsulfuration);GO:0030170(pyridoxal phosphate binding);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0044524(protein sulfhydration);GO:0044540(L-cystine L-cysteine-lyase (deaminating));GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051289(protein homotetramerization);GO:0070814(hydrogen sulfide biosynthetic process);GO:1904831(positive regulation of aortic smooth muscle cell differentiation);GO:1990830(cellular response to leukemia inhibitory factor);GO:2001234(negative regulation of apoptotic signaling pathway);GO:2001234(negative regulation of apoptotic signaling pathway)","00260(Glycine, serine and threonine metabolism);00270(Cysteine and methionine metabolism);00450(Selenocompound metabolism);00450(Selenocompound metabolism)","K01758","EC:4.4.1.1","cystathionine gamma-lyase [Source:NCBI gene;Acc:101118487]",{"v":1.11665851168224,"d":"1.12"},{"v":0.740737817757009,"d":"0.74"},{"v":0.435061023364486,"d":"0.44"},{"v":1.24150828504673,"d":"1.24"},{"v":0.798222537383177,"d":"0.80"},{"v":0.427881411214953,"d":"0.43"},{"v":0.929018474437368,"d":"0.93"},{"v":-0.106220808597881,"d":"-0.11"},1,1,"down","no"]
["MSTRG.8445","AK7","ENSOART00000017780","GO:0004017(adenylate kinase activity);GO:0004127(cytidylate kinase activity);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0006139(nucleobase-containing compound metabolic process);GO:0006165(nucleoside diphosphate phosphorylation);GO:0009142(nucleoside triphosphate biosynthetic process);GO:0019205(nucleobase-containing compound kinase activity);GO:0046940(nucleoside monophosphate phosphorylation)","00230(Purine metabolism);00730(Thiamine metabolism)","K00939","EC:2.7.4.3","adenylate kinase 7 [Source:NCBI gene;Acc:101121552]",{"v":0.029726,"d":"0.03"},0,0,{"v":0.007713,"d":"0.01"},{"v":0.015365,"d":"0.02"},0,{"v":1.28806655689401,"d":"1.29"},{"v":0.365207142225885,"d":"0.37"},1,1,"up","no"]
["ENSOARG00000007862","ENSOARG00000007862","ENSOART00000008564","NA","NA","NA","NA","coiled-coil domain containing 110 [Source:NCBI gene;Acc:101109769]",0,0,{"v":0.047873,"d":"0.05"},0,{"v":0.029367,"d":"0.03"},0,{"v":1.63016310825076,"d":"1.63"},{"v":0.705016322549417,"d":"0.71"},1,1,"up","no"]
["MSTRG.11907","KIRREL3","ENSOART00000014162","GO:0001764(neuron migration);GO:0002121(inter-male aggressive behavior);GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007416(synapse assembly);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0021740(principal sensory nucleus of trigeminal nerve development);GO:0021766(hippocampus development);GO:0030097(hemopoiesis);GO:0030424(axon);GO:0030425(dendrite);GO:0043198(dendritic shaft);GO:0048812(neuron projection morphogenesis);GO:0072102(glomerulus morphogenesis)","NA","NA","NA","kirre like nephrin family adhesion molecule 3 [Source:NCBI gene;Acc:101114734]",{"v":0.133659,"d":"0.13"},{"v":0.129141,"d":"0.13"},{"v":0.154362,"d":"0.15"},{"v":0.256141,"d":"0.26"},{"v":0.383959,"d":"0.38"},{"v":0.187844,"d":"0.19"},{"v":0.503852917588629,"d":"0.50"},{"v":-0.988925444562913,"d":"-0.99"},1,1,"down","no"]
["MSTRG.19462","RF00001","ENSOART00000026455","NA","NA","NA","NA",null,0,0,{"v":0.031029,"d":"0.03"},0,{"v":0.011103,"d":"0.01"},0,{"v":2.79465009456904,"d":"2.79"},{"v":1.48266766108958,"d":"1.48"},1,1,"up","no"]
["ENSOARG00000023438","RF02193","ENSOART00000025340","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.18428,"d":"0.18"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000017310","TTC34","ENSOART00000018843","GO:0005515(protein binding)","NA","NA","NA","tetratricopeptide repeat domain 34 [Source:NCBI gene;Acc:101120260]",0,0,0,0,0,{"v":0.007616,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000013283","CA1","ENSOART00000014443","GO:0004064(arylesterase activity);GO:0004089(carbonate dehydratase activity);GO:0008270(zinc ion binding);GO:0016836(hydro-lyase activity);GO:0046872(metal ion binding)","NA","NA","NA","carbonic anhydrase 1 [Source:NCBI gene;Acc:101113601]",{"v":0.016565,"d":"0.02"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000023155","MIR181B2","ENSOART00000025057","NA","NA","NA","NA","microRNA 181b-2 [Source:HGNC Symbol;Acc:HGNC:31551]",{"v":0.165996,"d":"0.17"},{"v":0.115943,"d":"0.12"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.14406","RF00026","ENSOART00000025797","NA","NA","NA","NA",null,0,0,{"v":0.42081,"d":"0.42"},{"v":0.036815,"d":"0.04"},{"v":0.060106,"d":"0.06"},{"v":0.241365,"d":"0.24"},{"v":1.24394742909846,"d":"1.24"},{"v":0.314925516512277,"d":"0.31"},1,1,"up","no"]
["MSTRG.4858","SS18L1","ENSOART00000015744","GO:0000776(kinetochore);GO:0000780(condensed nuclear chromosome, centromeric region);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0016358(dendrite development);GO:0050775(positive regulation of dendrite morphogenesis);GO:0071565(nBAF complex);GO:1903508(positive regulation of nucleic acid-templated transcription)","NA","NA","NA","SS18L1, nBAF chromatin remodeling complex subunit [Source:NCBI gene;Acc:101113515]",{"v":0.583354,"d":"0.58"},{"v":0.510461,"d":"0.51"},{"v":0.216659,"d":"0.22"},{"v":0.516089,"d":"0.52"},{"v":0.282796,"d":"0.28"},{"v":0.322082,"d":"0.32"},{"v":1.1690567162102,"d":"1.17"},{"v":0.225344923206038,"d":"0.23"},1,1,"up","no"]
["ENSOARG00000004608","ENSOARG00000004608","ENSOART00000005014","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005509(calcium ion binding);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,0,0,0,0,{"v":0.012609,"d":"0.01"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000003664","ENSOARG00000003664","ENSOART00000003980","GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-templated);GO:0046872(metal ion binding)","NA","NA","NA",null,{"v":0.143481,"d":"0.14"},{"v":0.093091,"d":"0.09"},{"v":0.512759,"d":"0.51"},{"v":0.688406,"d":"0.69"},{"v":0.350186,"d":"0.35"},{"v":0.268517,"d":"0.27"},{"v":0.573273537248998,"d":"0.57"},{"v":-0.802704410235594,"d":"-0.80"},1,1,"down","no"]
["MSTRG.6737","LARGE2","ENSOART00000003092","GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0035269(protein O-linked mannosylation)","00515(Mannose type O-glycan biosynthesis)","K09668","2.4.1.-;EC:2.4.2.-","LARGE xylosyl- and glucuronyltransferase 2 [Source:NCBI gene;Acc:101117447]",{"v":0.014118,"d":"0.01"},{"v":0.064181,"d":"0.06"},{"v":0.061617,"d":"0.06"},{"v":0.122522,"d":"0.12"},0,{"v":0.035478,"d":"0.04"},{"v":0.885544303797468,"d":"0.89"},{"v":-0.175363608045698,"d":"-0.18"},1,1,"down","no"]
["MSTRG.13204","IGFALS","ENSOART00000018034","GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0042567(insulin-like growth factor ternary complex)","NA","NA","NA","insulin like growth factor binding protein acid labile subunit [Source:HGNC Symbol;Acc:HGNC:5468]",{"v":0.179064,"d":"0.18"},{"v":0.233586,"d":"0.23"},{"v":0.414768,"d":"0.41"},{"v":0.181635,"d":"0.18"},{"v":0.63073,"d":"0.63"},{"v":0.323638,"d":"0.32"},{"v":0.728358992009704,"d":"0.73"},{"v":-0.457278396748438,"d":"-0.46"},1,1,"down","no"]
["ENSOARG00000015190","ENSOARG00000015190","ENSOART00000016532","GO:0003824(catalytic activity);GO:0006567(threonine catabolic process);GO:0008743(L-threonine 3-dehydrogenase activity);GO:0042802(identical protein binding);GO:0050662(coenzyme binding);GO:0055114(oxidation-reduction process)","00260(Glycine, serine and threonine metabolism)","K15789","EC:1.1.1.103","L-threonine 3-dehydrogenase, mitochondrial [Source:NCBI gene;Acc:101118164]",{"v":0.016152,"d":"0.02"},0,{"v":0.012294,"d":"0.01"},0,{"v":0.006129,"d":"0.01"},0,{"v":4.64121390112579,"d":"4.64"},{"v":2.21450218899317,"d":"2.21"},1,1,"up","no"]
["ENSOARG00000022464","RF00004","ENSOART00000024366","NA","NA","NA","NA",null,{"v":0.440071,"d":"0.44"},0,{"v":0.208877,"d":"0.21"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000005901","ENSOARG00000005901","ENSOART00000006421","GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,0,{"v":0.279803,"d":"0.28"},0,0,0,{"v":0.15049,"d":"0.15"},{"v":1.8592796863579,"d":"1.86"},{"v":0.894743807251026,"d":"0.89"},1,1,"up","no"]
["ENSOARG00000009205","CDA","ENSOART00000010021","GO:0001882(nucleoside binding);GO:0003824(catalytic activity);GO:0004126(cytidine deaminase activity);GO:0008270(zinc ion binding);GO:0009972(cytidine deamination);GO:0016787(hydrolase activity);GO:0030308(negative regulation of cell growth);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0045980(negative regulation of nucleotide metabolic process);GO:0046872(metal ion binding);GO:0051289(protein homotetramerization)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)","K01489","EC:3.5.4.5","cytidine deaminase [Source:NCBI gene;Acc:101102378]",0,{"v":0.17492,"d":"0.17"},{"v":0.125593,"d":"0.13"},0,0,{"v":0.105823,"d":"0.11"},{"v":2.83977018228551,"d":"2.84"},{"v":1.50577417962686,"d":"1.51"},1,1,"up","no"]
["MSTRG.862","ENSOARG00000006605","ENSOART00000007179","NA","NA","NA","NA",null,0,0,0,0,{"v":0.206078,"d":"0.21"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.15565","ENSOARG00000016660","ENSOART00000018140","GO:0005680(anaphase-promoting complex);GO:0090266(regulation of mitotic cell cycle spindle assembly checkpoint)","NA","NA","NA","anaphase-promoting complex subunit 15 pseudogene [Source:NCBI gene;Acc:101120997]",{"v":0.732153,"d":"0.73"},{"v":1.09352,"d":"1.09"},{"v":0.94564,"d":"0.95"},{"v":0.382078,"d":"0.38"},{"v":0.331796,"d":"0.33"},{"v":1.007471,"d":"1.01"},{"v":1.60996952964107,"d":"1.61"},{"v":0.687033384084169,"d":"0.69"},1,1,"up","no"]
["ENSOARG00000014027","PEAK3","ENSOART00000015272","NA","NA","NA","NA","PEAK family member 3 [Source:NCBI gene;Acc:101121345]",0,0,0,0,0,{"v":0.024288,"d":"0.02"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000019612","SALL2","ENSOART00000021355","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001654(eye development);GO:0003676(nucleic acid binding);GO:0021915(neural tube development);GO:0044877(protein-containing complex binding);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II)","NA","K19871","NA","spalt like transcription factor 2 [Source:NCBI gene;Acc:101107790]",{"v":0.151533,"d":"0.15"},{"v":0.047041,"d":"0.05"},{"v":0.048857,"d":"0.05"},{"v":0.218185,"d":"0.22"},{"v":0.270077,"d":"0.27"},{"v":0.246469,"d":"0.25"},{"v":0.336764067393373,"d":"0.34"},{"v":-1.57018988332074,"d":"-1.57"},1,1,"down","no"]
["ENSOARG00000004508","ENSOARG00000004508","ENSOART00000004905","NA","NA","NA","NA",null,0,{"v":0.058723,"d":"0.06"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.17703","STX10","ENSOART00000010056","GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016192(vesicle-mediated transport);GO:0019905(syntaxin binding);GO:0031982(vesicle);GO:0032880(regulation of protein localization);GO:0042147(retrograde transport, endosome to Golgi);GO:0048193(Golgi vesicle transport);GO:0048471(perinuclear region of cytoplasm)","04130(SNARE interactions in vesicular transport)","K08498","NA","syntaxin 10 [Source:NCBI gene;Acc:101121171]",{"v":1.227502,"d":"1.23"},{"v":1.25254,"d":"1.25"},{"v":1.100806,"d":"1.10"},{"v":1.25358,"d":"1.25"},{"v":1.314153,"d":"1.31"},{"v":1.732774,"d":"1.73"},{"v":0.832657172747306,"d":"0.83"},{"v":-0.264205473225003,"d":"-0.26"},1,1,"down","no"]
["MSTRG.17542","NR2C2AP","ENSOART00000009920","GO:0005654(nucleoplasm)","NA","NA","NA","nuclear receptor 2C2 associated protein [Source:NCBI gene;Acc:101106004]",{"v":1.294545,"d":"1.29"},{"v":1.046999,"d":"1.05"},{"v":1.307165,"d":"1.31"},{"v":1.450706,"d":"1.45"},{"v":1.658705,"d":"1.66"},{"v":1.663586,"d":"1.66"},{"v":0.764448207279409,"d":"0.76"},{"v":-0.387509335135601,"d":"-0.39"},1,1,"down","no"]
["ENSOARG00000013456","ENSOARG00000013456","ENSOART00000014637","NA","NA","NA","NA",null,0,0,{"v":0.008309,"d":"0.01"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000000877","ENSOARG00000000877","ENSOART00000000940;ENSOART00000000939","GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019898(extrinsic component of membrane);GO:0019898(extrinsic component of membrane)","NA","K19914","NA","synaptotagmin-15 [Source:NCBI gene;Acc:101115343]",{"v":0.327657,"d":"0.33"},{"v":0.361581967741935,"d":"0.36"},{"v":0.25716,"d":"0.26"},{"v":0.044635,"d":"0.04"},{"v":0.380677,"d":"0.38"},{"v":0.286912,"d":"0.29"},{"v":1.32879398579932,"d":"1.33"},{"v":0.410117448704069,"d":"0.41"},1,1,"up","no"]
["MSTRG.10824","LCK","ENSOART00000022844","GO:0000166(nucleotide binding);GO:0000242(pericentriolar material);GO:0001772(immunological synapse);GO:0001784(phosphotyrosine residue binding);GO:0004672(protein kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0006470(protein dephosphorylation);GO:0006882(cellular zinc ion homeostasis);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0008022(protein C-terminus binding);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016740(transferase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0030217(T cell differentiation);GO:0034116(positive regulation of heterotypic cell-cell adhesion);GO:0042169(SH2 domain binding);GO:0042493(response to drug);GO:0042608(T cell receptor binding);GO:0042609(CD4 receptor binding);GO:0042610(CD8 receptor binding);GO:0042802(identical protein binding);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045121(membrane raft);GO:0050870(positive regulation of T cell activation);GO:0051117(ATPase binding);GO:1903039(positive regulation of leukocyte cell-cell adhesion);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04064(NF-kappa B signaling pathway);04380(Osteoclast differentiation);04650(Natural killer cell mediated cytotoxicity);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04660(T cell receptor signaling pathway);05166(Human T-cell leukemia virus 1 infection);05340(Primary immunodeficiency)","K05856","EC:2.7.10.2","LCK proto-oncogene, Src family tyrosine kinase [Source:NCBI gene;Acc:100216439]",{"v":0.429265946547884,"d":"0.43"},{"v":0.209866937639198,"d":"0.21"},{"v":0.397136486636971,"d":"0.40"},{"v":0.474586442093541,"d":"0.47"},{"v":0.142603914253898,"d":"0.14"},{"v":0.296119986080178,"d":"0.30"},{"v":1.1346300624053,"d":"1.13"},{"v":0.182221994318432,"d":"0.18"},1,1,"up","no"]
["ENSOARG00000023419","RF00026","ENSOART00000025321","NA","NA","NA","NA",null,{"v":0.188031,"d":"0.19"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.14163","ENSOARG00000010046","ENSOART00000010936","GO:0005581(collagen trimer)","04145(Phagosome)","K10068","NA","surfactant protein D [Source:NCBI gene;Acc:101106651]",{"v":0.0129895686900958,"d":"0.01"},{"v":0.0613758067092652,"d":"0.06"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.13214","RF00264","ENSOART00000025689","NA","NA","NA","NA",null,{"v":1.265572,"d":"1.27"},{"v":0.910692,"d":"0.91"},{"v":0.602978,"d":"0.60"},{"v":1.113515,"d":"1.11"},{"v":1.948326,"d":"1.95"},{"v":2.137823,"d":"2.14"},{"v":0.534504152576013,"d":"0.53"},{"v":-0.903726938564518,"d":"-0.90"},1,1,"down","no"]
["MSTRG.8011","RF00108","ENSOART00000025465","NA","NA","NA","NA",null,{"v":0.629505,"d":"0.63"},{"v":0.818126,"d":"0.82"},{"v":1.244073,"d":"1.24"},{"v":0.91561,"d":"0.92"},{"v":0.556109,"d":"0.56"},{"v":0.269973,"d":"0.27"},{"v":1.54545350153759,"d":"1.55"},{"v":0.628030248107299,"d":"0.63"},1,1,"up","no"]
["ENSOARG00000011292","ENSOARG00000011292","ENSOART00000012279","GO:0003874(6-pyruvoyltetrahydropterin synthase activity);GO:0006729(tetrahydrobiopterin biosynthetic process)","NA","NA","NA",null,{"v":0.182218,"d":"0.18"},{"v":0.341311,"d":"0.34"},{"v":0.539167,"d":"0.54"},{"v":0.496705,"d":"0.50"},0,{"v":0.033894,"d":"0.03"},{"v":2.00282322431818,"d":"2.00"},{"v":1.0020350898205,"d":"1.00"},1,1,"up","no"]
["MSTRG.18599","CCNA2","ENSOART00000015443","GO:0000086(G2/M transition of mitotic cell cycle);GO:0000307(cyclin-dependent protein kinase holoenzyme complex);GO:0001939(female pronucleus);GO:0001940(male pronucleus);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006275(regulation of DNA replication);GO:0007265(Ras protein signal transduction);GO:0016572(histone phosphorylation);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0044843(cell cycle G1/S phase transition);GO:0045893(positive regulation of transcription, DNA-templated);GO:0051726(regulation of cell cycle);GO:0097124(cyclin A2-CDK2 complex);GO:0097472(cyclin-dependent protein kinase activity)","04110(Cell cycle);04152(AMPK signaling pathway);04218(Cellular senescence);04914(Progesterone-mediated oocyte maturation);05161(Hepatitis B);05165(Human papillomavirus infection);05166(Human T-cell leukemia virus 1 infection);05169(Epstein-Barr virus infection);05203(Viral carcinogenesis)","K06627","NA","cyclin A2 [Source:NCBI gene;Acc:100144758]",{"v":0.47415,"d":"0.47"},{"v":0.131053,"d":"0.13"},{"v":0.263774,"d":"0.26"},{"v":0.818126,"d":"0.82"},{"v":0.346797,"d":"0.35"},{"v":0.538202,"d":"0.54"},{"v":0.510225027522936,"d":"0.51"},{"v":-0.970794427233434,"d":"-0.97"},1,1,"down","no"]
["ENSOARG00000022899","RF01874","ENSOART00000024801","NA","NA","NA","NA",null,{"v":0.14346,"d":"0.14"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.4103","RF00026","ENSOART00000023626","NA","NA","NA","NA",null,{"v":0.997962,"d":"1.00"},{"v":1.22408,"d":"1.22"},{"v":0.359218,"d":"0.36"},{"v":0.353105,"d":"0.35"},{"v":0.357913,"d":"0.36"},{"v":0.155183,"d":"0.16"},{"v":2.97997808822664,"d":"2.98"},{"v":1.57530172259247,"d":"1.58"},1,1,"up","no"]
["ENSOARG00000015616","ABCA13","ENSOART00000017000;ENSOART00000017002","GO:0000166(nucleotide binding);GO:0005524(ATP binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016887(ATPase activity);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport);GO:0055085(transmembrane transport)","NA","NA","NA","ATP binding cassette subfamily A member 13 [Source:HGNC Symbol;Acc:HGNC:14638]",{"v":0.00469,"d":"0.00"},{"v":0.0158468756028939,"d":"0.02"},{"v":0.009053,"d":"0.01"},{"v":0.004851,"d":"0.00"},0,{"v":0.001628,"d":"0.00"},{"v":4.56704361828892,"d":"4.57"},{"v":2.19126056847445,"d":"2.19"},1,1,"up","no"]
["MSTRG.14654","RF00049","ENSOART00000024425","NA","NA","NA","NA",null,{"v":0.960874,"d":"0.96"},{"v":2.361556,"d":"2.36"},{"v":1.355066,"d":"1.36"},{"v":1.154376,"d":"1.15"},{"v":1.305634,"d":"1.31"},{"v":1.791118,"d":"1.79"},{"v":1.10029526281025,"d":"1.10"},{"v":0.137890721051915,"d":"0.14"},1,1,"up","no"]
["ENSOARG00000010412","RIPK4","ENSOART00000011333","GO:0002009(morphogenesis of an epithelium);GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","NA","K08848","EC:2.7.11.1","receptor interacting serine/threonine kinase 4 [Source:NCBI gene;Acc:101103283]",{"v":0.032753,"d":"0.03"},0,0,{"v":0.017027,"d":"0.02"},0,{"v":0.016662,"d":"0.02"},{"v":0.972216450473448,"d":"0.97"},{"v":-0.0406505493067692,"d":"-0.04"},1,1,"down","no"]
["ENSOARG00000011795","ENSOARG00000011795","ENSOART00000012825","GO:0004930(G protein-coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007608(sensory perception of smell);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0050896(response to stimulus);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","NA","NA","NA",null,0,{"v":0.021303,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000018770","CXorf21","ENSOART00000020440","NA","NA","NA","NA","chromosome X open reading frame, human CXorf21 [Source:NCBI gene;Acc:101118078]",{"v":0.038771,"d":"0.04"},{"v":0.035027,"d":"0.04"},{"v":0.145145,"d":"0.15"},0,{"v":0.234491,"d":"0.23"},{"v":0.09844,"d":"0.10"},{"v":0.657622750660047,"d":"0.66"},{"v":-0.604667884528546,"d":"-0.60"},1,1,"down","no"]
["MSTRG.3773","ENSOARG00000009329","ENSOART00000010151","GO:0005634(nucleus);GO:0006334(nucleosome assembly)","NA","NA","NA",null,{"v":0.450106,"d":"0.45"},{"v":0.249732,"d":"0.25"},{"v":0.636363,"d":"0.64"},{"v":0.334483,"d":"0.33"},{"v":0.313044,"d":"0.31"},{"v":0.28795,"d":"0.29"},{"v":1.4283632841855,"d":"1.43"},{"v":0.514362955303571,"d":"0.51"},1,1,"up","no"]
["ENSOARG00000006292","IL10","ENSOART00000006848","GO:0001818(negative regulation of cytokine production);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002237(response to molecule of bacterial origin);GO:0002740(negative regulation of cytokine secretion involved in immune response);GO:0002875(negative regulation of chronic inflammatory response to antigenic stimulus);GO:0002904(positive regulation of B cell apoptotic process);GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0008285(negative regulation of cell population proliferation);GO:0010468(regulation of gene expression);GO:0010507(negative regulation of autophagy);GO:0030886(negative regulation of myeloid dendritic cell activation);GO:0030889(negative regulation of B cell proliferation);GO:0032689(negative regulation of interferon-gamma production);GO:0032695(negative regulation of interleukin-12 production);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032800(receptor biosynthetic process);GO:0034115(negative regulation of heterotypic cell-cell adhesion);GO:0035729(cellular response to hepatocyte growth factor stimulus);GO:0042742(defense response to bacterium);GO:0042832(defense response to protozoan);GO:0044130(negative regulation of growth of symbiont in host);GO:0045347(negative regulation of MHC class II biosynthetic process);GO:0045348(positive regulation of MHC class II biosynthetic process);GO:0045787(positive regulation of cell cycle);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046427(positive regulation of receptor signaling pathway via JAK-STAT);GO:0046983(protein dimerization activity);GO:0050715(positive regulation of cytokine secretion);GO:0050728(negative regulation of inflammatory response);GO:0051045(negative regulation of membrane protein ectodomain proteolysis);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051384(response to glucocorticoid);GO:0060302(negative regulation of cytokine activity);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0071222(cellular response to lipopolysaccharide);GO:1902740(negative regulation of interferon-alpha secretion);GO:1902895(positive regulation of pri-miRNA transcription by RNA polymerase II);GO:1903034(regulation of response to wounding);GO:1903208(negative regulation of hydrogen peroxide-induced neuron death);GO:1903672(positive regulation of sprouting angiogenesis);GO:1904706(negative regulation of vascular smooth muscle cell proliferation);GO:2000352(negative regulation of endothelial cell apoptotic process)","04060(Cytokine-cytokine receptor interaction);04068(FoxO signaling pathway);04625(C-type lectin receptor signaling pathway);04630(Jak-STAT signaling pathway);04660(T cell receptor signaling pathway);04672(Intestinal immune network for IgA production);05133(Pertussis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis);05144(Malaria);05145(Toxoplasmosis);05146(Amoebiasis);05150(Staphylococcus aureus infection);05152(Tuberculosis);05310(Asthma);05320(Autoimmune thyroid disease);05321(Inflammatory bowel disease (IBD));05322(Systemic lupus erythematosus);05330(Allograft rejection)","K05443","NA","interleukin 10 [Source:NCBI gene;Acc:443342]",0,0,0,{"v":0.132681,"d":"0.13"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.7685","CFAP73","ENSOART00000008847","NA","NA","NA","NA","cilia and flagella associated protein 73 [Source:NCBI gene;Acc:101112598]",{"v":0.126195,"d":"0.13"},{"v":0.087766,"d":"0.09"},{"v":0.242741,"d":"0.24"},{"v":0.224258,"d":"0.22"},{"v":0.184719,"d":"0.18"},{"v":0.078751,"d":"0.08"},{"v":0.936386674539907,"d":"0.94"},{"v":-0.094823690885944,"d":"-0.09"},1,1,"down","no"]
["ENSOARG00000019431","ENSOARG00000019431","ENSOART00000021161","NA","NA","NA","NA",null,0,{"v":0.059922,"d":"0.06"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000001405","FRMPD2","ENSOART00000001515","GO:0005515(protein binding);GO:0005545(1-phosphatidylinositol binding);GO:0005856(cytoskeleton);GO:0005923(bicellular tight junction);GO:0016323(basolateral plasma membrane);GO:0070830(bicellular tight junction assembly)","NA","NA","NA","FERM and PDZ domain containing 2 [Source:NCBI gene;Acc:101115935]",0,0,0,{"v":0.01371,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000000464","IL20RA","ENSOART00000000492","GO:0005515(protein binding);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0042015(interleukin-20 binding);GO:0045124(regulation of bone resorption);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway)","K05136","NA","interleukin 20 receptor subunit alpha [Source:NCBI gene;Acc:101112653]",{"v":0.019949,"d":"0.02"},0,0,0,{"v":0.006487,"d":"0.01"},{"v":0.129885,"d":"0.13"},{"v":0.146283694600065,"d":"0.15"},{"v":-2.77315912534674,"d":"-2.77"},1,1,"down","no"]
["ENSOARG00000008974","ADAM11","ENSOART00000009781","GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K16067","EC:3.4.24.-","ADAM metallopeptidase domain 11 [Source:NCBI gene;Acc:101117948]",{"v":0.043333,"d":"0.04"},{"v":0.098022,"d":"0.10"},{"v":0.214191,"d":"0.21"},0,{"v":0.124174,"d":"0.12"},{"v":0.044081,"d":"0.04"},{"v":2.11313779679653,"d":"2.11"},{"v":1.07938684785642,"d":"1.08"},1,1,"up","no"]
["MSTRG.15529","ENSOARG00000014211","ENSOART00000015480","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","myelin and lymphocyte protein [Source:NCBI gene;Acc:101115527]",{"v":1.633814,"d":"1.63"},{"v":1.877142,"d":"1.88"},{"v":0.540251,"d":"0.54"},{"v":0.323154,"d":"0.32"},{"v":1.702824,"d":"1.70"},{"v":1.342738,"d":"1.34"},{"v":1.20259677574482,"d":"1.20"},{"v":0.266152995674567,"d":"0.27"},1,1,"up","no"]
["MSTRG.11075","ENSOARG00000011979","ENSOART00000013032","GO:0005509(calcium ion binding)","NA","NA","NA",null,{"v":0.019663,"d":"0.02"},{"v":0.022076,"d":"0.02"},{"v":0.024694,"d":"0.02"},{"v":0.055572,"d":"0.06"},{"v":0.110301,"d":"0.11"},{"v":0.051218,"d":"0.05"},{"v":0.306014528469628,"d":"0.31"},{"v":-1.7083279463697,"d":"-1.71"},1,1,"down","no"]
["MSTRG.11322","ADGRF1","ENSOART00000012557","GO:0004888(transmembrane signaling receptor activity);GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007189(adenylate cyclase-activating G protein-coupled receptor signaling pathway);GO:0007416(synapse assembly);GO:0007613(memory);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031175(neuron projection development);GO:0032793(positive regulation of CREB transcription factor activity)","NA","K08453","NA","adhesion G protein-coupled receptor F1 [Source:NCBI gene;Acc:101121464]",{"v":0.058464,"d":"0.06"},{"v":0.039195,"d":"0.04"},{"v":0.042438,"d":"0.04"},{"v":0.07877,"d":"0.08"},{"v":0.074063,"d":"0.07"},{"v":0.045983,"d":"0.05"},{"v":0.704656566875905,"d":"0.70"},{"v":-0.505007801894316,"d":"-0.51"},1,1,"down","no"]
["ENSOARG00000019656","KCND3","ENSOART00000021405","GO:0005216(ion channel activity);GO:0005244(voltage-gated ion channel activity);GO:0005249(voltage-gated potassium channel activity);GO:0005250(A-type (transient outward) potassium channel activity);GO:0005267(potassium channel activity);GO:0005515(protein binding);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0008076(voltage-gated potassium channel complex);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0034765(regulation of ion transmembrane transport);GO:0044325(ion channel binding);GO:0051260(protein homooligomerization);GO:0055085(transmembrane transport);GO:0071805(potassium ion transmembrane transport);GO:0086009(membrane repolarization);GO:0086091(regulation of heart rate by cardiac conduction);GO:0097623(potassium ion export across plasma membrane);GO:0098915(membrane repolarization during ventricular cardiac muscle cell action potential);GO:0098982(GABA-ergic synapse);GO:0099060(integral component of postsynaptic specialization membrane);GO:0099625(ventricular cardiac muscle cell membrane repolarization);GO:1902282(voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization)","NA","K04893","NA","potassium voltage-gated channel subfamily D member 3 [Source:NCBI gene;Acc:101115919]",{"v":0.015574,"d":"0.02"},{"v":0.060073,"d":"0.06"},{"v":0.017785,"d":"0.02"},0,{"v":0.036912,"d":"0.04"},0,{"v":2.53120936280884,"d":"2.53"},{"v":1.33982684138546,"d":"1.34"},1,1,"up","no"]
["MSTRG.2772","EFCAB5","ENSOART00000010304","GO:0005509(calcium ion binding)","NA","NA","NA","EF-hand calcium binding domain 5 [Source:NCBI gene;Acc:101122536]",{"v":0.013548,"d":"0.01"},{"v":0.06201,"d":"0.06"},{"v":0.117764,"d":"0.12"},{"v":0.006709,"d":"0.01"},{"v":0.025117,"d":"0.03"},{"v":0.013679,"d":"0.01"},{"v":4.2483683111746,"d":"4.25"},{"v":2.08690884563155,"d":"2.09"},1,1,"up","no"]
["MSTRG.15602","ENSOARG00000015220","ENSOART00000016571","GO:0005515(protein binding);GO:0045202(synapse)","NA","NA","NA","PTPRF interacting protein alpha 2 [Source:NCBI gene;Acc:101104729]",{"v":0.032251,"d":"0.03"},{"v":0.056424,"d":"0.06"},{"v":0.016657,"d":"0.02"},{"v":0.031654,"d":"0.03"},{"v":0.045365,"d":"0.05"},{"v":0.045416,"d":"0.05"},{"v":0.860309552007188,"d":"0.86"},{"v":-0.2170722388036,"d":"-0.22"},1,1,"down","no"]
["MSTRG.7880","ENSOARG00000013634","ENSOART00000014834","NA","NA","NA","NA",null,{"v":1.985563,"d":"1.99"},{"v":2.540514,"d":"2.54"},{"v":0.676144,"d":"0.68"},{"v":2.011107,"d":"2.01"},{"v":2.065414,"d":"2.07"},{"v":3.264649,"d":"3.26"},{"v":0.708636497996913,"d":"0.71"},{"v":-0.496882322172982,"d":"-0.50"},1,1,"down","no"]
["ENSOARG00000015696","ENSOARG00000015696","ENSOART00000017084","GO:0004930(G protein-coupled receptor activity);GO:0007186(G protein-coupled receptor signaling pathway);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","K08396","NA","mas-related G-protein coupled receptor member A6-like [Source:NCBI gene;Acc:101118574]",0,0,0,{"v":0.153046,"d":"0.15"},0,0,"-inf","-inf",1,1,"down","no"]
["MSTRG.10485","STAT1","ENSOART00000015140","GO:0000981(DNA-binding transcription factor activity, RNA polymerase II-specific);GO:0001937(negative regulation of endothelial cell proliferation);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007165(signal transduction);GO:0007259(receptor signaling pathway via JAK-STAT);GO:0007584(response to nutrient);GO:0008015(blood circulation);GO:0008284(positive regulation of cell population proliferation);GO:0016525(negative regulation of angiogenesis);GO:0019221(cytokine-mediated signaling pathway);GO:0032869(cellular response to insulin stimulus);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0034097(response to cytokine);GO:0042802(identical protein binding);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0043434(response to peptide hormone);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0051591(response to cAMP);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0072136(metanephric mesenchymal cell proliferation involved in metanephros development);GO:0072162(metanephric mesenchymal cell differentiation);GO:0072308(negative regulation of metanephric nephron tubule epithelial cell differentiation)","04062(Chemokine signaling pathway);04217(Necroptosis);04380(Osteoclast differentiation);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04625(C-type lectin receptor signaling pathway);04630(Jak-STAT signaling pathway);04658(Th1 and Th2 cell differentiation);04659(Th17 cell differentiation);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04933(AGE-RAGE signaling pathway in diabetic complications);05140(Leishmaniasis);05145(Toxoplasmosis);05152(Tuberculosis);05160(Hepatitis C);05161(Hepatitis B);05162(Measles);05164(Influenza A);05165(Human papillomavirus infection);05167(Kaposi sarcoma-associated herpesvirus infection);05168(Herpes simplex virus 1 infection);05169(Epstein-Barr virus infection);05200(Pathways in cancer);05212(Pancreatic cancer);05321(Inflammatory bowel disease (IBD))","K11220;K11222","NA","signal transducer and activator of transcription 1 [Source:NCBI gene;Acc:100307049]",{"v":0.101062,"d":"0.10"},{"v":0.132314,"d":"0.13"},{"v":0.12009,"d":"0.12"},{"v":0.07502,"d":"0.08"},{"v":0.056143,"d":"0.06"},{"v":0.058127,"d":"0.06"},{"v":1.86732526810714,"d":"1.87"},{"v":0.900973251512952,"d":"0.90"},1,1,"up","no"]
["ENSOARG00000024959","ENSOARG00000024959","ENSOART00000026861","NA","NA","NA","NA",null,0,0,0,0,0,{"v":0.478828,"d":"0.48"},"-inf","-inf",1,1,"down","no"]
["MSTRG.9680","RF00001","ENSOART00000025911","NA","NA","NA","NA",null,0,{"v":0.013196,"d":"0.01"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.11801","DDIAS","ENSOART00000006218","GO:0097752(regulation of DNA stability);GO:1902230(negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage)","NA","NA","NA","DNA damage induced apoptosis suppressor [Source:NCBI gene;Acc:101114477]",{"v":0.069628,"d":"0.07"},{"v":0.046531,"d":"0.05"},{"v":0.041907,"d":"0.04"},{"v":0.108891,"d":"0.11"},{"v":0.09262,"d":"0.09"},{"v":0.078466,"d":"0.08"},{"v":0.564567803783882,"d":"0.56"},{"v":-0.824781237877583,"d":"-0.82"},1,1,"down","no"]
["MSTRG.16004","SLC39A5","ENSOART00000010543","GO:0001654(eye development);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016323(basolateral plasma membrane);GO:0030001(metal ion transport);GO:0030509(BMP signaling pathway);GO:0034224(cellular response to zinc ion starvation);GO:0046873(metal ion transmembrane transporter activity);GO:0048026(positive regulation of mRNA splicing, via spliceosome);GO:0055085(transmembrane transport)","NA","K14711","NA","solute carrier family 39 member 5 [Source:NCBI gene;Acc:101102637]",{"v":0.227936,"d":"0.23"},{"v":0.164442,"d":"0.16"},{"v":0.252293,"d":"0.25"},{"v":0.057144,"d":"0.06"},{"v":0.105053,"d":"0.11"},0,{"v":3.97461728638631,"d":"3.97"},{"v":1.9908159508085,"d":"1.99"},1,1,"up","no"]
["MSTRG.21753","RF00614","ENSOART00000025358","NA","NA","NA","NA","small nucleolar RNA, H/ACA box 11G [Source:HGNC Symbol;Acc:HGNC:52190]",{"v":0.378219,"d":"0.38"},{"v":1.633745,"d":"1.63"},{"v":0.071198,"d":"0.07"},{"v":1.034814,"d":"1.03"},{"v":0.467271,"d":"0.47"},{"v":0.126086,"d":"0.13"},{"v":1.27944914876877,"d":"1.28"},{"v":0.355522809138215,"d":"0.36"},1,1,"up","no"]
["ENSOARG00000008288","NECAB3","ENSOART00000009027","GO:0000137(Golgi cis cisterna);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0019538(protein metabolic process);GO:0042984(regulation of amyloid precursor protein biosynthetic process)","NA","NA","NA","N-terminal EF-hand calcium binding protein 3 [Source:NCBI gene;Acc:101117268]",{"v":0.206602382978723,"d":"0.21"},{"v":0.198897970212766,"d":"0.20"},{"v":0.454189319148936,"d":"0.45"},{"v":0.523630570212766,"d":"0.52"},{"v":0.647870038297872,"d":"0.65"},{"v":0.298071289361702,"d":"0.30"},{"v":0.584993271567789,"d":"0.58"},{"v":-0.773508063578684,"d":"-0.77"},1,1,"down","no"]
["ENSOARG00000002044","PIMREG","ENSOART00000002202","GO:0005634(nucleus);GO:0005730(nucleolus)","NA","NA","NA","PICALM interacting mitotic regulator [Source:NCBI gene;Acc:101104673]",{"v":0.198605,"d":"0.20"},0,{"v":0.18135,"d":"0.18"},{"v":0.537441,"d":"0.54"},{"v":0.147792,"d":"0.15"},{"v":0.230124,"d":"0.23"},{"v":0.415089413201625,"d":"0.42"},{"v":-1.26850595821514,"d":"-1.27"},1,1,"down","no"]
["ENSOARG00000016236","NLRP14","ENSOART00000017685","GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0007283(spermatogenesis)","NA","K22666","NA","NLR family pyrin domain containing 14 [Source:NCBI gene;Acc:101107305]",0,{"v":0.009673,"d":"0.01"},{"v":0.042814,"d":"0.04"},0,{"v":0.022215,"d":"0.02"},{"v":0.021747,"d":"0.02"},{"v":1.19391747418225,"d":"1.19"},{"v":0.255703118258721,"d":"0.26"},1,1,"up","no"]
["MSTRG.18967","ENSOARG00000004859","ENSOART00000005296","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0001829(trophectodermal cell differentiation);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0007507(heart development);GO:0008016(regulation of heart contraction);GO:0016575(histone deacetylation);GO:0030154(cell differentiation);GO:0043393(regulation of protein binding);GO:0043415(positive regulation of skeletal muscle tissue regeneration);GO:0048286(lung alveolus development);GO:0051155(positive regulation of striated muscle cell differentiation)","NA","NA","NA",null,{"v":1.854289,"d":"1.85"},{"v":0.708313,"d":"0.71"},{"v":0.673849,"d":"0.67"},{"v":1.830998,"d":"1.83"},{"v":1.103908,"d":"1.10"},{"v":1.563702,"d":"1.56"},{"v":0.719433878212994,"d":"0.72"},{"v":-0.475065997161253,"d":"-0.48"},1,1,"down","no"]
["MSTRG.281","ENSOARG00000004620","ENSOART00000005026","GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006457(protein folding);GO:0051082(unfolded protein binding)","NA","NA","NA",null,{"v":0.07311,"d":"0.07"},{"v":0.086247,"d":"0.09"},0,{"v":0.062473,"d":"0.06"},{"v":0.098098,"d":"0.10"},0,{"v":0.99243948160004,"d":"0.99"},{"v":-0.0109489646796218,"d":"-0.01"},1,1,"down","no"]
["ENSOARG00000015118","BDNF","ENSOART00000016454","GO:0005102(signaling receptor binding);GO:0005576(extracellular region);GO:0005739(mitochondrion);GO:0007416(synapse assembly);GO:0008083(growth factor activity);GO:0010469(regulation of signaling receptor activity);GO:0016607(nuclear speck);GO:0048668(collateral sprouting);GO:0048672(positive regulation of collateral sprouting);GO:0051965(positive regulation of synapse assembly);GO:1900122(positive regulation of receptor binding)","04010(MAPK signaling pathway);04014(Ras signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04722(Neurotrophin signaling pathway);05016(Huntington disease);05030(Cocaine addiction);05034(Alcoholism)","K04355","NA","brain derived neurotrophic factor [Source:NCBI gene;Acc:101117275]",{"v":0.522585,"d":"0.52"},{"v":0.125515,"d":"0.13"},0,{"v":0.163619,"d":"0.16"},{"v":0.076716,"d":"0.08"},{"v":0.111146,"d":"0.11"},{"v":1.84391190419966,"d":"1.84"},{"v":0.882769730382045,"d":"0.88"},1,1,"up","no"]
["ENSOARG00000002606","DEUP1","ENSOART00000002827","GO:0042802(identical protein binding);GO:0098535(de novo centriole assembly involved in multi-ciliated epithelial cell differentiation);GO:0098536(deuterosome);GO:1903251(multi-ciliated epithelial cell differentiation)","NA","NA","NA","deuterosome assembly protein 1 [Source:NCBI gene;Acc:101119682]",{"v":0.025617,"d":"0.03"},0,0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000020792","ENSOARG00000020792","ENSOART00000022653","NA","NA","NA","NA",null,0,0,0,{"v":0.086562,"d":"0.09"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000001184","CHRNB4","ENSOART00000001264","GO:0001508(action potential);GO:0004888(transmembrane signaling receptor activity);GO:0005216(ion channel activity);GO:0005230(extracellular ligand-gated ion channel activity);GO:0005886(plasma membrane);GO:0005892(acetylcholine-gated channel complex);GO:0006811(ion transport);GO:0006939(smooth muscle contraction);GO:0006940(regulation of smooth muscle contraction);GO:0007165(signal transduction);GO:0007626(locomotory behavior);GO:0015464(acetylcholine receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0022848(acetylcholine-gated cation-selective channel activity);GO:0030054(cell junction);GO:0034220(ion transmembrane transport);GO:0035094(response to nicotine);GO:0035095(behavioral response to nicotine);GO:0042391(regulation of membrane potential);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0051971(positive regulation of transmission of nerve impulse);GO:0060078(regulation of postsynaptic membrane potential);GO:0060079(excitatory postsynaptic potential);GO:0060084(synaptic transmission involved in micturition);GO:0098981(cholinergic synapse);GO:1904315(transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential)","04080(Neuroactive ligand-receptor interaction);04725(Cholinergic synapse)","K04815","NA","cholinergic receptor nicotinic beta 4 subunit [Source:NCBI gene;Acc:101123499]",{"v":0.046784,"d":"0.05"},0,{"v":0.035141,"d":"0.04"},{"v":0.024322,"d":"0.02"},0,0,{"v":3.36834964229915,"d":"3.37"},{"v":1.75204190118039,"d":"1.75"},1,1,"up","no"]
["ENSOARG00000015107","ENSOARG00000015107","ENSOART00000016439","GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)","NA","NA","NA","non-histone chromosomal protein HMG-14 pseudogene [Source:NCBI gene;Acc:101118305]",0,{"v":0.188245,"d":"0.19"},{"v":0.076379,"d":"0.08"},{"v":0.074788,"d":"0.07"},{"v":0.201455,"d":"0.20"},0,{"v":0.95793920569933,"d":"0.96"},{"v":-0.0619939946870288,"d":"-0.06"},1,1,"down","no"]
["MSTRG.14743","RF00156","ENSOART00000026750","NA","NA","NA","NA",null,{"v":0.418184,"d":"0.42"},0,{"v":0.143712,"d":"0.14"},0,{"v":0.361993,"d":"0.36"},{"v":0.046453,"d":"0.05"},{"v":1.3756922579729,"d":"1.38"},{"v":0.460157775598485,"d":"0.46"},1,1,"up","no"]
["MSTRG.17873","ENSOARG00000016518","ENSOART00000017989","NA","NA","NA","NA",null,0,0,0,0,{"v":0.83106,"d":"0.83"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000001666","SPAG6","ENSOART00000001803","GO:0005515(protein binding);GO:0015630(microtubule cytoskeleton)","NA","NA","NA","sperm associated antigen 6 [Source:NCBI gene;Acc:101103745]",0,{"v":0.020552,"d":"0.02"},0,0,0,0,"inf","inf",1,1,"up","no"]
["MSTRG.4751","LRRN4","ENSOART00000020069","GO:0005515(protein binding);GO:0005887(integral component of plasma membrane);GO:0007616(long-term memory);GO:0008542(visual learning)","NA","NA","NA","leucine rich repeat neuronal 4 [Source:NCBI gene;Acc:101109900]",{"v":0.028002,"d":"0.03"},{"v":0.058887,"d":"0.06"},{"v":0.128183,"d":"0.13"},{"v":0.167246,"d":"0.17"},0,{"v":0.142765,"d":"0.14"},{"v":0.693756028011909,"d":"0.69"},{"v":-0.527499692976744,"d":"-0.53"},1,1,"down","no"]
["ENSOARG00000014822","IKZF1","ENSOART00000016131","GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0019904(protein domain specific binding);GO:0030098(lymphocyte differentiation);GO:0030218(erythrocyte differentiation);GO:0031618(nuclear pericentric heterochromatin);GO:0032991(protein-containing complex);GO:0051291(protein heterooligomerization)","NA","NA","NA","IKAROS family zinc finger 1 [Source:HGNC Symbol;Acc:HGNC:13176]",{"v":0.688091,"d":"0.69"},{"v":0.155625,"d":"0.16"},{"v":0.420732,"d":"0.42"},{"v":0.339957,"d":"0.34"},{"v":0.199739,"d":"0.20"},{"v":0.493689,"d":"0.49"},{"v":1.22359817492996,"d":"1.22"},{"v":0.29112986014421,"d":"0.29"},1,1,"up","no"]
["ENSOARG00000016715","ENSOARG00000016715","ENSOART00000018204","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.130177,"d":"0.13"},{"v":0.19396,"d":"0.19"},{"v":0.398832,"d":"0.40"},{"v":0.370865,"d":"0.37"},{"v":0.347876,"d":"0.35"},{"v":0.201727,"d":"0.20"},{"v":0.785436321523399,"d":"0.79"},{"v":-0.348433779707015,"d":"-0.35"},1,1,"down","no"]
["MSTRG.900","RF00426","ENSOART00000023914","NA","NA","NA","NA","small Cajal body-specific RNA 4 [Source:HGNC Symbol;Acc:HGNC:32560]",{"v":0.957054,"d":"0.96"},{"v":2.782297,"d":"2.78"},{"v":1.582932,"d":"1.58"},{"v":3.008798,"d":"3.01"},{"v":3.673656,"d":"3.67"},{"v":0.705689,"d":"0.71"},{"v":0.720381698080289,"d":"0.72"},{"v":-0.473166566092108,"d":"-0.47"},1,1,"down","no"]
["MSTRG.543","RWDD3","ENSOART00000019067","GO:0005515(protein binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033235(positive regulation of protein sumoylation);GO:1902073(positive regulation of hypoxia-inducible factor-1alpha signaling pathway)","NA","NA","NA","RWD domain containing 3 [Source:HGNC Symbol;Acc:HGNC:21393]",{"v":0.750057978910369,"d":"0.75"},{"v":0.74068320913884,"d":"0.74"},{"v":1.08543424253076,"d":"1.09"},{"v":0.405902066783831,"d":"0.41"},{"v":0.613765876977153,"d":"0.61"},{"v":0.55414392970123,"d":"0.55"},{"v":1.63690176317749,"d":"1.64"},{"v":0.71096774268602,"d":"0.71"},1,1,"up","no"]
["ENSOARG00000007134","HOXB2","ENSOART00000007760","GO:0002011(morphogenesis of an epithelial sheet);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-templated);GO:0009952(anterior/posterior pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0016607(nuclear speck);GO:0021569(rhombomere 3 development);GO:0021570(rhombomere 4 development);GO:0021612(facial nerve structural organization);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0048704(embryonic skeletal system morphogenesis);GO:0048705(skeletal system morphogenesis);GO:0048857(neural nucleus development)","NA","K09302","NA","homeobox B2 [Source:NCBI gene;Acc:101121362]",{"v":0.235924,"d":"0.24"},{"v":0.071449,"d":"0.07"},0,{"v":0.246333,"d":"0.25"},{"v":0.672747,"d":"0.67"},{"v":0.303489,"d":"0.30"},{"v":0.251415666518618,"d":"0.25"},{"v":-1.99185354336084,"d":"-1.99"},1,1,"down","no"]
["ENSOARG00000024076","RF00026","ENSOART00000025978","NA","NA","NA","NA",null,0,0,{"v":0.070102,"d":"0.07"},0,{"v":0.100177,"d":"0.10"},0,{"v":0.699781386945107,"d":"0.70"},{"v":-0.515023803157713,"d":"-0.52"},1,1,"down","no"]
["ENSOARG00000009892","ABHD16B","ENSOART00000010766","NA","NA","NA","NA","abhydrolase domain containing 16B [Source:NCBI gene;Acc:101116851]",{"v":0.090239,"d":"0.09"},{"v":0.13342,"d":"0.13"},{"v":0.128783,"d":"0.13"},{"v":0.164863,"d":"0.16"},{"v":0.151079,"d":"0.15"},{"v":0.130735,"d":"0.13"},{"v":0.789031000029104,"d":"0.79"},{"v":-0.341846111873372,"d":"-0.34"},1,1,"down","no"]
["ENSOARG00000021135","ENSOARG00000021135","ENSOART00000023029","NA","NA","NA","NA",null,0,{"v":0.17316,"d":"0.17"},0,0,{"v":0.53575,"d":"0.54"},0,{"v":0.323210452636491,"d":"0.32"},{"v":-1.62945423923892,"d":"-1.63"},1,1,"down","no"]
["MSTRG.6854","C5orf58","ENSOART00000003425","NA","NA","NA","NA","chromosome 5 open reading frame 58 [Source:HGNC Symbol;Acc:HGNC:37272]",0,0,0,{"v":0.183902,"d":"0.18"},0,{"v":0.088285,"d":"0.09"},"-inf","-inf",1,1,"down","no"]
["ENSOARG00000008083","DYNLRB2","ENSOART00000008799","GO:0003774(motor activity);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005868(cytoplasmic dynein complex);GO:0005874(microtubule);GO:0007018(microtubule-based movement);GO:0030286(dynein complex);GO:0045505(dynein intermediate chain binding)","NA","K10419","NA","dynein light chain roadblock-type 2 [Source:NCBI gene;Acc:101120685]",{"v":1.264056,"d":"1.26"},{"v":0.815349,"d":"0.82"},{"v":0.763079,"d":"0.76"},{"v":0.428206,"d":"0.43"},{"v":1.633623,"d":"1.63"},{"v":1.154731,"d":"1.15"},{"v":0.883703086527222,"d":"0.88"},{"v":-0.178366371817967,"d":"-0.18"},1,1,"down","no"]
["MSTRG.6824","CNTF","ENSOART00000012191","GO:0005127(ciliary neurotrophic factor receptor binding);GO:0005138(interleukin-6 receptor binding);GO:0005615(extracellular space);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell population proliferation);GO:0010469(regulation of signaling receptor activity);GO:0010628(positive regulation of gene expression);GO:0042531(positive regulation of tyrosine phosphorylation of STAT protein);GO:0043524(negative regulation of neuron apoptotic process);GO:0044877(protein-containing complex binding);GO:0046533(negative regulation of photoreceptor cell differentiation);GO:0046668(regulation of retinal cell programmed cell death);GO:0048644(muscle organ morphogenesis);GO:0048666(neuron development);GO:0070120(ciliary neurotrophic factor-mediated signaling pathway)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway)","K05420","NA","ciliary neurotrophic factor [Source:NCBI gene;Acc:101107894]",0,0,0,{"v":0.045,"d":"0.05"},{"v":0.092557,"d":"0.09"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.14252","DCTD","ENSOART00000007604","GO:0003824(catalytic activity);GO:0004132(dCMP deaminase activity);GO:0006220(pyrimidine nucleotide metabolic process);GO:0008270(zinc ion binding);GO:0016787(hydrolase activity);GO:0042802(identical protein binding);GO:0046872(metal ion binding)","00240(Pyrimidine metabolism)","K01493","EC:3.5.4.12","dCMP deaminase [Source:NCBI gene;Acc:101108545]",{"v":2.04036641551247,"d":"2.04"},{"v":0.465308775623269,"d":"0.47"},{"v":0.991228354570637,"d":"0.99"},{"v":0.254676232686981,"d":"0.25"},{"v":0.773685939058172,"d":"0.77"},{"v":0.292409650969529,"d":"0.29"},{"v":2.64762125112491,"d":"2.65"},{"v":1.40469675575341,"d":"1.40"},1,1,"up","no"]
["MSTRG.1832","ENSOARG00000015625","ENSOART00000016998","NA","03008(Ribosome biogenesis in eukaryotes);03013(RNA transport);03015(mRNA surveillance pathway);05164(Influenza A)","K14285","NA","NTF2-related export protein 2-like [Source:NCBI gene;Acc:105604278]",{"v":0.773833,"d":"0.77"},{"v":0.71277,"d":"0.71"},{"v":0.734539,"d":"0.73"},{"v":1.043203,"d":"1.04"},{"v":1.417843,"d":"1.42"},{"v":0.279247,"d":"0.28"},{"v":0.81054909091838,"d":"0.81"},{"v":-0.303028529650713,"d":"-0.30"},1,1,"down","no"]
["ENSOARG00000011885","DPP10","ENSOART00000012929","GO:0006508(proteolysis);GO:0008076(voltage-gated potassium channel complex);GO:0008236(serine-type peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0044325(ion channel binding);GO:1903078(positive regulation of protein localization to plasma membrane)","NA","K23014","NA","dipeptidyl peptidase like 10 [Source:NCBI gene;Acc:101109248]",0,0,0,{"v":0.013025,"d":"0.01"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000018542","ENSOARG00000018542","ENSOART00000020182","GO:0003676(nucleic acid binding);GO:0003700(DNA-binding transcription factor activity);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-templated)","NA","NA","NA",null,{"v":0.186085,"d":"0.19"},{"v":0.366287,"d":"0.37"},{"v":0.322005,"d":"0.32"},{"v":0.536386,"d":"0.54"},{"v":0.418214,"d":"0.42"},{"v":0.485848,"d":"0.49"},{"v":0.607017400142178,"d":"0.61"},{"v":-0.720190222987892,"d":"-0.72"},1,1,"down","no"]
["ENSOARG00000003988","ENSOARG00000003988","ENSOART00000004335","GO:0005044(scavenger receptor activity);GO:0006898(receptor-mediated endocytosis);GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA",null,{"v":0.326672,"d":"0.33"},{"v":0.022386,"d":"0.02"},{"v":0.042269,"d":"0.04"},0,0,{"v":0.083555,"d":"0.08"},{"v":4.68346598049189,"d":"4.68"},{"v":2.22757658582688,"d":"2.23"},1,1,"up","no"]
["MSTRG.14862","ENSOARG00000019367","ENSOART00000021090","NA","NA","NA","NA",null,{"v":0.64265,"d":"0.64"},{"v":0.468443,"d":"0.47"},{"v":0.78728,"d":"0.79"},{"v":0.401716,"d":"0.40"},{"v":0.578333,"d":"0.58"},{"v":0.56368,"d":"0.56"},{"v":1.2297320319823,"d":"1.23"},{"v":0.298343975525227,"d":"0.30"},1,1,"up","no"]
["MSTRG.16631","ENSOARG00000021848","ENSOART00000023750","NA","NA","NA","NA",null,{"v":0.877542,"d":"0.88"},{"v":0.961831,"d":"0.96"},{"v":1.018425,"d":"1.02"},{"v":3.311329,"d":"3.31"},{"v":2.374842,"d":"2.37"},{"v":1.665031,"d":"1.67"},{"v":0.388752478846317,"d":"0.39"},{"v":-1.36307622039554,"d":"-1.36"},1,1,"down","no"]
["ENSOARG00000003970","ENSOARG00000003970","ENSOART00000004313","GO:0016055(Wnt signaling pathway);GO:0042813(Wnt-activated receptor activity)","NA","NA","NA",null,{"v":0.729274,"d":"0.73"},{"v":0.815117,"d":"0.82"},{"v":0.618625,"d":"0.62"},{"v":0.448957,"d":"0.45"},{"v":0.115941,"d":"0.12"},{"v":0.110603,"d":"0.11"},{"v":3.20209148469062,"d":"3.20"},{"v":1.67901452666243,"d":"1.68"},1,1,"up","no"]
["MSTRG.15238","ENSOARG00000003610","ENSOART00000003917","GO:0005634(nucleus);GO:0006334(nucleosome assembly)","NA","NA","NA",null,{"v":0.652221,"d":"0.65"},{"v":0.802135,"d":"0.80"},{"v":0.616546,"d":"0.62"},{"v":0.356701,"d":"0.36"},{"v":0.51453,"d":"0.51"},{"v":0.183794,"d":"0.18"},{"v":1.9628937702898,"d":"1.96"},{"v":0.972982097805065,"d":"0.97"},1,1,"up","no"]
["ENSOARG00000006558","IL24","ENSOART00000007128","GO:0016020(membrane);GO:0016021(integral component of membrane)","04060(Cytokine-cytokine receptor interaction);04630(Jak-STAT signaling pathway)","K22668","NA","interleukin 24 [Source:NCBI gene;Acc:101113424]",{"v":0.098214,"d":"0.10"},{"v":0.004228,"d":"0.00"},{"v":0.019776,"d":"0.02"},0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000023394","RF00089","ENSOART00000025296","NA","NA","NA","NA",null,{"v":0.712027,"d":"0.71"},{"v":0.862661,"d":"0.86"},{"v":0.799448,"d":"0.80"},{"v":1.417376,"d":"1.42"},{"v":1.367543,"d":"1.37"},{"v":3.133618,"d":"3.13"},{"v":0.401135618481392,"d":"0.40"},{"v":-1.31783802022089,"d":"-1.32"},1,1,"down","no"]
["MSTRG.8008","RF00108","ENSOART00000026441","NA","NA","NA","NA",null,{"v":0.79356,"d":"0.79"},{"v":0.861171,"d":"0.86"},{"v":1.247898,"d":"1.25"},{"v":1.031752,"d":"1.03"},{"v":0.92586,"d":"0.93"},{"v":0.960495,"d":"0.96"},{"v":0.994695876470602,"d":"0.99"},{"v":-0.00767259895454766,"d":"-0.01"},1,1,"down","no"]
["ENSOARG00000000647","ENSOARG00000000647","ENSOART00000000697","GO:0000166(nucleotide binding);GO:0003774(motor activity);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0007018(microtubule-based movement);GO:0008017(microtubule binding)","NA","K10398","NA","kinesin family member 11 [Source:NCBI gene;Acc:101102946]",{"v":0.106006,"d":"0.11"},{"v":0.108295,"d":"0.11"},{"v":0.086551,"d":"0.09"},{"v":0.510363,"d":"0.51"},{"v":0.146582,"d":"0.15"},{"v":0.210825,"d":"0.21"},{"v":0.346695552969105,"d":"0.35"},{"v":-1.52825876354006,"d":"-1.53"},1,1,"down","no"]
["MSTRG.20834","MIR30C2","ENSOART00000025739","NA","NA","NA","NA","microRNA 30c-2 [Source:HGNC Symbol;Acc:HGNC:31627]",0,{"v":0.109018,"d":"0.11"},{"v":0.120635,"d":"0.12"},0,{"v":0.096298,"d":"0.10"},{"v":0.136692,"d":"0.14"},{"v":0.985677496888278,"d":"0.99"},{"v":-0.0208124054321734,"d":"-0.02"},1,1,"down","no"]
["MSTRG.2650","RF00614","ENSOART00000025884","NA","NA","NA","NA",null,{"v":0.225377,"d":"0.23"},{"v":0.552184,"d":"0.55"},{"v":0.698864,"d":"0.70"},{"v":0.679944,"d":"0.68"},{"v":1.156219,"d":"1.16"},{"v":0.683776,"d":"0.68"},{"v":0.585897118938197,"d":"0.59"},{"v":-0.77128073916201,"d":"-0.77"},1,1,"down","no"]
["ENSOARG00000001400","GPR37","ENSOART00000001500","GO:0000151(ubiquitin ligase complex);GO:0004930(G protein-coupled receptor activity);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0007186(G protein-coupled receptor signaling pathway);GO:0007193(adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway);GO:0008528(G protein-coupled peptide receptor activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030544(Hsp70 protein binding);GO:0031072(heat shock protein binding);GO:0031625(ubiquitin protein ligase binding);GO:0031987(locomotion involved in locomotory behavior);GO:0036505(prosaposin receptor activity);GO:0042277(peptide binding);GO:0042416(dopamine biosynthetic process);GO:0043235(receptor complex);GO:0043410(positive regulation of MAPK cascade);GO:0045964(positive regulation of dopamine metabolic process);GO:1903206(negative regulation of hydrogen peroxide-induced cell death)","05012(Parkinson disease)","K04243","NA","G protein-coupled receptor 37 [Source:NCBI gene;Acc:101107437]",{"v":0.038489,"d":"0.04"},0,{"v":0.019273,"d":"0.02"},{"v":0.139779,"d":"0.14"},0,{"v":0.146846,"d":"0.15"},{"v":0.201524640209333,"d":"0.20"},{"v":-2.31097184851876,"d":"-2.31"},1,1,"down","no"]
["ENSOARG00000019630","ADORA3","ENSOART00000021378","GO:0001609(G protein-coupled adenosine receptor activity);GO:0001973(adenosine receptor signaling pathway);GO:0004930(G protein-coupled receptor activity);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007186(G protein-coupled receptor signaling pathway);GO:0008285(negative regulation of cell population proliferation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0030336(negative regulation of cell migration);GO:0032088(negative regulation of NF-kappaB transcription factor activity)","04022(cGMP-PKG signaling pathway);04071(Sphingolipid signaling pathway);04080(Neuroactive ligand-receptor interaction)","K04268","NA","adenosine A3 receptor [Source:NCBI gene;Acc:443330]",{"v":0.163942,"d":"0.16"},{"v":0.211157,"d":"0.21"},{"v":0.538879,"d":"0.54"},{"v":0.247035,"d":"0.25"},{"v":0.16862,"d":"0.17"},{"v":0.231405,"d":"0.23"},{"v":1.41250888634748,"d":"1.41"},{"v":0.498259943810383,"d":"0.50"},1,1,"up","no"]
["MSTRG.8542","oar-mir-3956","ENSOART00000025564","NA","NA","NA","NA","oar-mir-3956 [Source:miRBase;Acc:MI0016939]",{"v":0.241884,"d":"0.24"},{"v":0.898169,"d":"0.90"},{"v":1.570202,"d":"1.57"},{"v":0.382562,"d":"0.38"},{"v":2.915451,"d":"2.92"},{"v":1.128913,"d":"1.13"},{"v":0.61222053406811,"d":"0.61"},{"v":-0.707876660768261,"d":"-0.71"},1,1,"down","no"]
["ENSOARG00000020854","TRIM62","ENSOART00000022719","GO:0004842(ubiquitin-protein transferase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0016567(protein ubiquitination);GO:0032897(negative regulation of viral transcription);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB signaling);GO:0045087(innate immune response);GO:0046596(regulation of viral entry into host cell);GO:0051091(positive regulation of DNA-binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:1902186(regulation of viral release from host cell)","NA","NA","NA","tripartite motif containing 62 [Source:HGNC Symbol;Acc:HGNC:25574]",{"v":0.107751,"d":"0.11"},{"v":0.036025,"d":"0.04"},{"v":0.048792,"d":"0.05"},{"v":0.256186,"d":"0.26"},{"v":0.115917,"d":"0.12"},{"v":0.575902,"d":"0.58"},{"v":0.203129730328427,"d":"0.20"},{"v":-2.29952668509878,"d":"-2.30"},1,1,"down","no"]
["ENSOARG00000018362","MT3","ENSOART00000019982","GO:0001666(response to hypoxia);GO:0001934(positive regulation of protein phosphorylation);GO:0005507(copper ion binding);GO:0005737(cytoplasm);GO:0006112(energy reserve metabolic process);GO:0006707(cholesterol catabolic process);GO:0006829(zinc ion transport);GO:0006875(cellular metal ion homeostasis);GO:0006882(cellular zinc ion homeostasis);GO:0006915(apoptotic process);GO:0006979(response to oxidative stress);GO:0008021(synaptic vesicle);GO:0008144(drug binding);GO:0008270(zinc ion binding);GO:0010507(negative regulation of autophagy);GO:0010628(positive regulation of gene expression);GO:0010940(positive regulation of necrotic cell death);GO:0010942(positive regulation of cell death);GO:0014002(astrocyte development);GO:0016234(inclusion body);GO:0016570(histone modification);GO:0019430(removal of superoxide radicals);GO:0030295(protein kinase activator activity);GO:0030308(negative regulation of cell growth);GO:0030517(negative regulation of axon extension);GO:0030949(positive regulation of vascular endothelial growth factor receptor signaling pathway);GO:0032095(regulation of response to food);GO:0032148(activation of protein kinase B activity);GO:0033210(leptin-mediated signaling pathway);GO:0034599(cellular response to oxidative stress);GO:0035690(cellular response to drug);GO:0036091(positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043085(positive regulation of catalytic activity);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043491(protein kinase B signaling);GO:0043524(negative regulation of neuron apoptotic process);GO:0044242(cellular lipid catabolic process);GO:0045892(negative regulation of transcription, DNA-templated);GO:0045893(positive regulation of transcription, DNA-templated);GO:0046870(cadmium ion binding);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0050768(negative regulation of neurogenesis);GO:0050821(protein stabilization);GO:0051354(negative regulation of oxidoreductase activity);GO:0055069(zinc ion homeostasis);GO:0055073(cadmium ion homeostasis);GO:0060049(regulation of protein glycosylation);GO:0060547(negative regulation of necrotic cell death);GO:0070371(ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071276(cellular response to cadmium ion);GO:0071456(cellular response to hypoxia);GO:0071732(cellular response to nitric oxide);GO:0097214(positive regulation of lysosomal membrane permeability);GO:2000117(negative regulation of cysteine-type endopeptidase activity);GO:2000376(positive regulation of oxygen metabolic process);GO:2000378(negative regulation of reactive oxygen species metabolic process)","NA","K14740","NA","metallothionein 3 [Source:NCBI gene;Acc:443168]",0,0,0,0,{"v":0.066965,"d":"0.07"},0,"-inf","-inf",1,1,"down","no"]
["MSTRG.5069","TP53TG5","ENSOART00000005853","NA","NA","NA","NA","TP53 target 5 [Source:NCBI gene;Acc:101109202]",{"v":0.260559,"d":"0.26"},{"v":0.424667,"d":"0.42"},{"v":0.440904,"d":"0.44"},{"v":0.373636,"d":"0.37"},{"v":0.301303,"d":"0.30"},{"v":0.218061,"d":"0.22"},{"v":1.26106382978723,"d":"1.26"},{"v":0.33464130071525,"d":"0.33"},1,1,"up","no"]
["MSTRG.21455","RF00026","ENSOART00000023754","NA","NA","NA","NA","RNA, U6 small nuclear 457, pseudogene [Source:HGNC Symbol;Acc:HGNC:47420]",{"v":0.358257,"d":"0.36"},{"v":0.242484,"d":"0.24"},{"v":0.475184,"d":"0.48"},{"v":1.059044,"d":"1.06"},{"v":0.267411,"d":"0.27"},{"v":0.141697,"d":"0.14"},{"v":0.732843057122151,"d":"0.73"},{"v":-0.448423825524924,"d":"-0.45"},1,1,"down","no"]
["ENSOARG00000003300","DPEP2","ENSOART00000003578;ENSOART00000003576","GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008235(metalloexopeptidase activity);GO:0008237(metallopeptidase activity);GO:0008239(dipeptidyl-peptidase activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016787(hydrolase activity);GO:0016805(dipeptidase activity);GO:0031225(anchored component of membrane);GO:0046872(metal ion binding);GO:0046872(metal ion binding)","NA","K01273","EC:3.4.13.19","dipeptidase 2 [Source:NCBI gene;Acc:101110863]",{"v":0.00540387096774194,"d":"0.01"},0,{"v":0.00832258064516129,"d":"0.01"},{"v":0.00686770546984572,"d":"0.01"},{"v":0.0188351612903226,"d":"0.02"},0,{"v":0.534043604590251,"d":"0.53"},{"v":-0.904970552304449,"d":"-0.90"},1,1,"down","no"]
["MSTRG.11837","RF00067","ENSOART00000026673","NA","NA","NA","NA",null,0,0,0,{"v":0.168224,"d":"0.17"},{"v":0.000894,"d":"0.00"},0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000014643","EQTN","ENSOART00000015937","GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0007342(fusion of sperm to egg plasma membrane involved in single fertilization);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0060478(acrosomal vesicle exocytosis)","NA","NA","NA","equatorin [Source:HGNC Symbol;Acc:HGNC:1359]",{"v":0.0778,"d":"0.08"},{"v":0.056908,"d":"0.06"},0,0,0,0,"inf","inf",1,1,"up","no"]
["ENSOARG00000023276","RF01986","ENSOART00000025178","NA","NA","NA","NA",null,{"v":0.022498,"d":"0.02"},0,{"v":0.119049,"d":"0.12"},{"v":0.199853,"d":"0.20"},{"v":0.002552,"d":"0.00"},{"v":0.1146,"d":"0.11"},{"v":0.446513461932777,"d":"0.45"},{"v":-1.16322442307751,"d":"-1.16"},1,1,"down","no"]
["ENSOARG00000021882","ENSOARG00000021882","ENSOART00000023784","NA","NA","NA","NA",null,0,0,{"v":0.128712,"d":"0.13"},{"v":0.299065,"d":"0.30"},0,{"v":0.23972,"d":"0.24"},{"v":0.238893064951697,"d":"0.24"},{"v":-2.06556312181735,"d":"-2.07"},1,1,"down","no"]
["ENSOARG00000004271","CLSTN3","ENSOART00000004656","GO:0001558(regulation of cell growth);GO:0005509(calcium ion binding);GO:0007156(homophilic cell adhesion via plasma membrane adhesion molecules);GO:0007416(synapse assembly);GO:0009986(cell surface);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0032991(protein-containing complex);GO:0035249(synaptic transmission, glutamatergic);GO:0045211(postsynaptic membrane);GO:0050806(positive regulation of synaptic transmission);GO:0051932(synaptic transmission, GABAergic);GO:0051965(positive regulation of synapse assembly);GO:0098978(glutamatergic synapse);GO:0098982(GABA-ergic synapse);GO:0099061(integral component of postsynaptic density membrane);GO:1902474(positive regulation of protein localization to synapse);GO:1905606(regulation of presynapse assembly)","NA","K22661","NA","calsyntenin 3 [Source:NCBI gene;Acc:101106761]",{"v":0.046133,"d":"0.05"},{"v":0.022866,"d":"0.02"},{"v":0.0506,"d":"0.05"},{"v":0.01092,"d":"0.01"},{"v":0.022658,"d":"0.02"},{"v":0.039929,"d":"0.04"},{"v":1.6270423224999,"d":"1.63"},{"v":0.702251778771099,"d":"0.70"},1,1,"up","no"]
["ENSOARG00000009265","ENSOARG00000009265","ENSOART00000010083","GO:0016020(membrane);GO:0016021(integral component of membrane)","NA","NA","NA","calcium homeostasis modulator family member 4 [Source:NCBI gene;Acc:101105416]",0,0,0,{"v":0.093265,"d":"0.09"},0,0,"-inf","-inf",1,1,"down","no"]
["ENSOARG00000001822","SFXN2","ENSOART00000001957","GO:0005739(mitochondrion);GO:0006811(ion transport);GO:0015075(ion transmembrane transporter activity);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0031966(mitochondrial membrane);GO:0034220(ion transmembrane transport);GO:0055085(transmembrane transport);GO:1990542(mitochondrial transmembrane transport)","NA","NA","NA","sideroflexin 2 [Source:NCBI gene;Acc:101109054]",{"v":0.272871,"d":"0.27"},{"v":0.052357,"d":"0.05"},{"v":0.05787,"d":"0.06"},{"v":0.078942,"d":"0.08"},{"v":0.402776,"d":"0.40"},{"v":0.114315,"d":"0.11"},{"v":0.642746290893289,"d":"0.64"},{"v":-0.637678715188676,"d":"-0.64"},1,1,"down","no"]
["ENSOARG00000015329","GALNT15","ENSOART00000016682","GO:0000139(Golgi membrane);GO:0005794(Golgi apparatus);GO:0006486(protein glycosylation);GO:0016020(membrane);GO:0016021(integral component of membrane);GO:0016740(transferase activity);GO:0016757(transferase activity, transferring glycosyl groups);GO:0030133(transport vesicle);GO:0030246(carbohydrate binding)","00512(Mucin type O-glycan biosynthesis)","K00710","EC:2.4.1.41","polypeptide N-acetylgalactosaminyltransferase 15 [Source:NCBI gene;Acc:101113458]",{"v":0.213346,"d":"0.21"},{"v":0.109473,"d":"0.11"},{"v":0.281964,"d":"0.28"},{"v":0.20259,"d":"0.20"},{"v":0.428184,"d":"0.43"},{"v":0.502165,"d":"0.50"},{"v":0.533817796015496,"d":"0.53"},{"v":-0.905580693125458,"d":"-0.91"},1,1,"down","no"]
["ENSOARG00000001731","CIDEA","ENSOART00000001860","GO:0001659(temperature homeostasis);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005740(mitochondrial envelope);GO:0005811(lipid droplet);GO:0006629(lipid metabolic process);GO:0006915(apoptotic process);GO:0008219(cell death);GO:0010890(positive regulation of sequestering of triglyceride);GO:0019915(lipid storage);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032720(negative regulation of tumor necrosis factor production);GO:0035634(response to stilbenoid);GO:0042803(protein homodimerization activity);GO:0050710(negative regulation of cytokine secretion);GO:0050995(negative regulation of lipid catabolic process);GO:0120163(negative regulation of cold-induced thermogenesis);GO:1900118(negative regulation of execution phase of apoptosis);GO:1902510(regulation of apoptotic DNA fragmentation)","NA","NA","NA","cell death inducing DFFA like effector a [Source:NCBI gene;Acc:101108619]",{"v":0.198405,"d":"0.20"},{"v":0.795503,"d":"0.80"},{"v":0.332019,"d":"0.33"},{"v":0.342412,"d":"0.34"},{"v":0.609463,"d":"0.61"},{"v":0.162365,"d":"0.16"},{"v":1.18998330700747,"d":"1.19"},{"v":0.250941335662243,"d":"0.25"},1,1,"up","no"]
["MSTRG.16561","ENSOARG00000021559","ENSOART00000023461","NA","NA","NA","NA",null,{"v":0.557861,"d":"0.56"},{"v":0.520026,"d":"0.52"},{"v":0.610905,"d":"0.61"},{"v":1.21824,"d":"1.22"},{"v":0.883193,"d":"0.88"},{"v":0.134274,"d":"0.13"},{"v":0.755372685240061,"d":"0.76"},{"v":-0.404739478942462,"d":"-0.40"},1,1,"down","no"]
["MSTRG.4955","RF00045","ENSOART00000026846","NA","NA","NA","NA",null,{"v":0.604603,"d":"0.60"},{"v":0.575487,"d":"0.58"},{"v":0.493151,"d":"0.49"},{"v":1.748741,"d":"1.75"},{"v":0.810039,"d":"0.81"},{"v":0.711232,"d":"0.71"},{"v":0.51169261764177,"d":"0.51"},{"v":-0.966650675626641,"d":"-0.97"},1,1,"down","no"]
["ENSOARG00000016843","TTPA","ENSOART00000018344","NA","NA","NA","NA","alpha tocopherol transfer protein [Source:NCBI gene;Acc:100526668]",{"v":0.110549,"d":"0.11"},{"v":0.037255,"d":"0.04"},0,0,{"v":0.034306,"d":"0.03"},0,{"v":4.30840086282283,"d":"4.31"},{"v":2.10715248755657,"d":"2.11"},1,1,"up","no"]
["MSTRG.8471","oar-mir-379","ENSOART00000024057","NA","NA","K17134","NA","oar-mir-379 [Source:miRBase;Acc:MI0016917]",{"v":0.422104,"d":"0.42"},{"v":0.362509,"d":"0.36"},{"v":1.780309,"d":"1.78"},{"v":1.207089,"d":"1.21"},{"v":2.099939,"d":"2.10"},{"v":0.818049,"d":"0.82"},{"v":0.621787666024174,"d":"0.62"},{"v":-0.685506095677416,"d":"-0.69"},1,1,"down","no"]
["MSTRG.18604","TNIP3","ENSOART00000016601","GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0031593(polyubiquitin modification-dependent protein binding);GO:0034142(toll-like receptor 4 signaling pathway);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB signaling);GO:0071222(cellular response to lipopolysaccharide)","NA","NA","NA","TNFAIP3 interacting protein 3 [Source:NCBI gene;Acc:101114957]",0,{"v":0.144137,"d":"0.14"},{"v":0.015547,"d":"0.02"},{"v":0.05259,"d":"0.05"},{"v":0.029825,"d":"0.03"},{"v":0.072187,"d":"0.07"},{"v":1.03287150230916,"d":"1.03"},{"v":0.0466607822644907,"d":"0.05"},1,1,"up","no"]
["MSTRG.20091","RF00026","ENSOART00000026131","NA","NA","NA","NA",null,{"v":2.613262,"d":"2.61"},{"v":1.405917,"d":"1.41"},{"v":2.006734,"d":"2.01"},{"v":4.053108,"d":"4.05"},{"v":3.050369,"d":"3.05"},{"v":2.507996,"d":"2.51"},{"v":0.626950000275712,"d":"0.63"},{"v":-0.673577703264487,"d":"-0.67"},1,1,"down","no"]
["MSTRG.5587","RF00026","ENSOART00000025015","NA","NA","NA","NA",null,0,0,0,{"v":0.235824,"d":"0.24"},0,{"v":0.064233,"d":"0.06"},"-inf","-inf",1,1,"down","no"]
["MSTRG.4027","HES3","ENSOART00000013930","GO:0000122(negative regulation of transcription by RNA polymerase II);GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001227(DNA-binding transcription repressor activity, RNA polymerase II-specific);GO:0001701(in utero embryonic development);GO:0021555(midbrain-hindbrain boundary morphogenesis);GO:0021557(oculomotor nerve development);GO:0021558(trochlear nerve development);GO:0021575(hindbrain morphogenesis);GO:0021915(neural tube development);GO:0030901(midbrain development);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046983(protein dimerization activity);GO:0050767(regulation of neurogenesis);GO:0060164(regulation of timing of neuron differentiation)","05165(Human papillomavirus infection)","K09088","NA","transcription factor HES-3 [Source:NCBI gene;Acc:101117436]",{"v":0.115516,"d":"0.12"},{"v":0.125837,"d":"0.13"},{"v":0.426928,"d":"0.43"},{"v":0.206562,"d":"0.21"},{"v":0.025464,"d":"0.03"},0,{"v":2.88019877082741,"d":"2.88"},{"v":1.52616837965074,"d":"1.53"},1,1,"up","no"]
["ENSOARG00000014951","PLAG1","ENSOART00000016272","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0003676(nucleic acid binding);GO:0006351(transcription, DNA-templated);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016607(nuclear speck);GO:0022612(gland morphogenesis);GO:0035264(multicellular organism growth);GO:0035265(organ growth);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0060252(positive regulation of glial cell proliferation);GO:0060736(prostate gland growth)","NA","K19484","NA","PLAG1 zinc finger [Source:NCBI gene;Acc:101115630]",{"v":0.195306,"d":"0.20"},{"v":0.07973,"d":"0.08"},{"v":0.114558,"d":"0.11"},{"v":0.410835,"d":"0.41"},{"v":0.224778,"d":"0.22"},{"v":0.240548,"d":"0.24"},{"v":0.444660285038937,"d":"0.44"},{"v":-1.16922453916585,"d":"-1.17"},1,1,"down","no"]
["ENSOARG00000022495","ENSOARG00000022495","ENSOART00000024397","NA","NA","NA","NA",null,{"v":0.123298,"d":"0.12"},{"v":0.444808,"d":"0.44"},0,{"v":0.013238,"d":"0.01"},{"v":0.07675,"d":"0.08"},{"v":0.224537,"d":"0.22"},{"v":1.80623479850568,"d":"1.81"},{"v":0.852985445765426,"d":"0.85"},1,1,"up","no"]
["ENSOARG00000013764","HNF1A","ENSOART00000014999","GO:0000978(RNA polymerase II proximal promoter sequence-specific DNA binding);GO:0001228(DNA-binding transcription activator activity, RNA polymerase II-specific);GO:0001750(photoreceptor outer segment);GO:0001824(blastocyst development);GO:0001889(liver development);GO:0001890(placenta development);GO:0003677(DNA binding);GO:0003700(DNA-binding transcription factor activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-templated);GO:0006357(regulation of transcription by RNA polymerase II);GO:0006633(fatty acid biosynthetic process);GO:0006699(bile acid biosynthetic process);GO:0006783(heme biosynthetic process);GO:0006979(response to oxidative stress);GO:0008104(protein localization);GO:0008203(cholesterol metabolic process);GO:0009749(response to glucose);GO:0015721(bile acid and bile salt transport);GO:0015908(fatty acid transport);GO:0016573(histone acetylation);GO:0030073(insulin secretion);GO:0030111(regulation of Wnt signaling pathway);GO:0030326(embryonic limb morphogenesis);GO:0031016(pancreas development);GO:0031018(endocrine pancreas development);GO:0035623(renal glucose absorption);GO:0042593(glucose homeostasis);GO:0042803(protein homodimerization activity);GO:0043691(reverse cholesterol transport);GO:0045120(pronucleus);GO:0045453(bone resorption);GO:0045893(positive regulation of transcription, DNA-templated);GO:0045944(positive regulation of transcription by RNA polymerase II);GO:0046323(glucose import);GO:0046883(regulation of hormone secretion);GO:0046982(protein heterodimerization activity);GO:0046983(protein dimerization activity);GO:0048341(paraxial mesoderm formation);GO:0048608(reproductive structure development);GO:0050796(regulation of insulin secretion);GO:0060395(SMAD protein signal transduction)","04550(Signaling pathways regulating pluripotency of stem cells);04950(Maturity onset diabetes of the young)","K08036","NA","HNF1 homeobox A [Source:NCBI gene;Acc:443207]",0,{"v":0.012075,"d":"0.01"},0,{"v":0.022378,"d":"0.02"},0,0,{"v":0.53959245687729,"d":"0.54"},{"v":-0.890057914321327,"d":"-0.89"},1,1,"down","no"]
["ENSOARG00000009554","CCL11","ENSOART00000010403","GO:0001938(positive regulation of endothelial cell proliferation);GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006955(immune response);GO:0007010(cytoskeleton organization);GO:0008009(chemokine activity);GO:0008360(regulation of cell shape);GO:0010469(regulation of signaling receptor activity);GO:0030335(positive regulation of cell migration);GO:0030838(positive regulation of actin filament polymerization);GO:0031728(CCR3 chemokine receptor binding);GO:0043547(positive regulation of GTPase activity);GO:0046983(protein dimerization activity);GO:0048018(receptor ligand activity);GO:0048245(eosinophil chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway);04657(IL-17 signaling pathway);05310(Asthma)","K16597","NA","eotaxin [Source:NCBI gene;Acc:101119832]",{"v":0.684783,"d":"0.68"},{"v":0.563018,"d":"0.56"},{"v":0.847793,"d":"0.85"},{"v":0.341395,"d":"0.34"},{"v":0.094025,"d":"0.09"},0,{"v":4.81281061963162,"d":"4.81"},{"v":2.26687965548776,"d":"2.27"},1,1,"up","no"]
["ENSOARG00000017872","AMMECR1","ENSOART00000019442","GO:0005634(nucleus)","NA","NA","NA","Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 [Source:HGNC Symbol;Acc:HGNC:467]",{"v":0.447127,"d":"0.45"},{"v":0.275958,"d":"0.28"},{"v":0.342177,"d":"0.34"},{"v":0.542804,"d":"0.54"},{"v":0.755146,"d":"0.76"},{"v":0.56586,"d":"0.57"},{"v":0.571550748198582,"d":"0.57"},{"v":-0.807046493343539,"d":"-0.81"},1,1,"down","no"]

{"sheet":"Table S2B-Type statistics ","index":1,"n_rows":8,"n_cols":6,"rows_kept":8}
["Sample","class code \"i\"","class code \"j\"","class code \"o\"","class code \"u\"","class code \"x\""]
["Mth_12_1",1636,316,267,3805,471]
["Mth_12_2",1637,316,263,3810,466]
["Mth_12_3",1637,316,256,3832,466]
["Mth_2_1",1643,322,264,3840,463]
["Mth_2_2",1653,316,265,3831,476]
["Mth_2_3",1622,323,264,3749,467]
["All(novel)",1710,350,304,4046,525]